|
Code
|
Display
|
|
30974-0
|
Number of brothers and sisters |
|
44655-9
|
Number of carcinoma positive tissue chips CAP cancer protocols |
|
70109-4
|
Number of chromosome 13 present [#] in Amniotic fluid by NAA with probe detection |
|
70110-2
|
Number of chromosome 18 present [#] in Amniotic fluid by NAA with probe detection |
|
70111-0
|
Number of chromosome 21 present [#] in Amniotic fluid by NAA with probe detection |
|
92515-6
|
Number of cigarettes smoked in Lifetime |
|
30950-0
|
Number of days hospitalized due to vaccination adverse event |
|
11878-6
|
Number of fetuses by US |
|
33747-7
|
Number of fragmented pieces |
|
92656-8
|
Number of menstrual periods per year |
|
57804-7
|
Number of occult blood specimens recommended by testing kit protocol [#] in Stool |
|
92048-8
|
Donated item [#] Donor |
|
30960-9
|
Number of previous doses |
|
19800-2
|
Number of specimens obtained Gastrointestinal tract upper EGD |
|
42185-9
|
Number of specimens obtained of Unspecified specimen |
|
38527-8
|
Number of specimens received of Stool |
|
42186-7
|
Number of specimens received of Unspecified specimen |
|
38526-0
|
Number of specimens tested of Stool |
|
42187-5
|
Number of specimens tested of Unspecified specimen |
|
55423-8
|
Number of steps in unspecified time Pedometer |
|
44656-7
|
Number of tissue chips CAP cancer protocols |
|
92257-5
|
Number of visits with usual provider 12 months |
|
76090-0
|
Erythrocytes.hyperchromic/100 erythrocytes in Blood by Automated count |
|
76069-4
|
Erythrocytes.hypochromic/100 erythrocytes in Blood by Automated count |
|
93418-2
|
(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
26809-4
|
Homocystine [Presence] in 24 hour Urine |
|
6884-1
|
Homocystine [Mass/time] in 24 hour Urine |
|
25928-3
|
Homocystine [Moles/volume] in 24 hour Urine |
|
25441-7
|
Homocystine [Moles/time] in 24 hour Urine |
|
13399-1
|
Homocystine [Mass/volume] in Amniotic fluid |
|
26882-1
|
Homocystine [Moles/volume] in Amniotic fluid |
|
13372-8
|
Homocystine [Mass/volume] in Cerebral spinal fluid |
|
22660-5
|
Homocystine [Moles/volume] in Cerebral spinal fluid |
|
38486-7
|
Homocystine [Presence] in DBS |
|
54302-5
|
Homocystine [Moles/volume] in DBS |
|
55879-1
|
Homocystine [Moles/volume] in Body fluid |
|
2429-9
|
Homocystine [Presence] in Serum or Plasma |
|
27352-4
|
Homocystine [Units/volume] in Serum or Plasma |
|
2430-7
|
Homocystine [Mass/volume] in Serum or Plasma |
|
20646-6
|
Homocystine [Moles/volume] in Serum or Plasma |
|
14053-3
|
Homocystine [Presence] in Urine |
|
2431-5
|
Homocystine [Mass/volume] in Urine |
|
26999-3
|
Homocystine [Moles/volume] in Urine |
|
22715-7
|
Homocystine [Moles/volume] in Unspecified specimen |
|
44378-8
|
Homocystine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56682-8
|
Homocystine/Creatinine [Ratio] in 24 hour Urine |
|
25929-1
|
Homocystine/Creatinine [Molar ratio] in 24 hour Urine |
|
13759-6
|
Homocystine/Creatinine [Mass Ratio] in Urine |
|
30051-7
|
Homocystine/Creatinine [Ratio] in Urine |
|
22707-4
|
Homocystine/Creatinine [Molar ratio] in Urine |
|
11770-5
|
[Percentile] Body weight.10th Estimated.pop birth wgt gestational age corr.ref |
|
11771-3
|
[Percentile] Body weight.25th Estimated.pop birth wgt gestational age corr.ref |
|
11772-1
|
[Percentile] Body weight.50th Estimated.pop birth wgt gestational age corr.ref |
|
11773-9
|
[Percentile] Body weight.75th Estimated.pop birth wgt gestational age corr.ref |
|
11774-7
|
[Percentile] Body weight.90th Estimated.pop birth wgt gestational age corr.ref |
|
89421-2
|
1 step (curb) - functional ability [CMS Assessment] |
|
83196-6
|
1 step (curb) - functional ability during 3 day assessment period [CMS Assessment] |
|
89420-4
|
1 step (curb) - functional goal [CMS Assessment] |
|
83195-8
|
1 step (curb) - functional goal during 3 day assessment period [CMS Assessment] |
|
38624-3
|
1,1,2-Trichloroethane [Mass/volume] in Air |
|
38334-9
|
1,1,2-Trichloroethane [Mass/volume] in Water |
|
38699-5
|
1,1-Dichloroethane [Mass/volume] in Air |
|
38735-7
|
1,1-Dichloroethylene [Mass/volume] in Air |
|
38292-9
|
1,1-Dichloroethylene [Mass/volume] in Water |
|
28050-3
|
1,2,3-Trichlorobenzene [Mass/volume] in Serum or Plasma |
|
38623-5
|
1,2,4-Trichlorobenzene [Mass/volume] in Air |
|
28049-5
|
1,2,4-Trichlorobenzene [Mass/volume] in Serum or Plasma |
|
38332-3
|
1,2,4-Trichlorobenzene [Mass/volume] in Water |
|
62290-2
|
1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma |
|
62291-0
|
1,25-Dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
|
57474-9
|
Calcitriol [Mass/volume] in Serum or Plasma --1 hour post dose calcium |
|
57473-1
|
Calcitriol [Moles/volume] in Serum or Plasma --1 hour post dose calcium |
|
57470-7
|
Calcitriol [Mass/volume] in Serum or Plasma --2 hours post dose calcium |
|
57469-9
|
Calcitriol [Moles/volume] in Serum or Plasma --2 hours post dose calcium |
|
57472-3
|
Calcitriol [Mass/volume] in Serum or Plasma --3 hours post dose calcium |
|
57471-5
|
Calcitriol [Moles/volume] in Serum or Plasma --3 hours post dose calcium |
|
57467-3
|
Calcitriol [Mass/volume] in Serum or Plasma --pre dose calcium |
|
57468-1
|
Calcitriol [Moles/volume] in Serum or Plasma --pre dose calcium |
|
1649-3
|
Calcitriol [Mass/volume] in Serum or Plasma |
|
14566-4
|
Calcitriol [Moles/volume] in Serum or Plasma |
|
38695-3
|
1,2-Dichloroethane [Mass/volume] in Air |
|
80630-7
|
1,2-Dichloroethane [Mass/volume] in Blood |
|
54935-2
|
1,2-Dichloroethane [Mass/volume] in Serum or Plasma |
|
38291-1
|
1,2-Dichloroethane [Mass/volume] in Water |
|
18434-1
|
1,2-Dichlorobenzene [Mass/volume] in Blood |
|
38289-5
|
1,2-Dichlorobenzene [Mass/volume] in Water |
|
38617-7
|
1,2-Dichloropropane [Mass/volume] in Air |
|
38296-0
|
1,2-Dichloropropane [Mass/volume] in Water |
|
38756-3
|
1,2-Dimethylbenzene [Mass/volume] in Air |
|
13650-7
|
1,2-Dimethylbenzene [Mass/volume] in Blood |
|
29144-3
|
1,2-Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
35578-4
|
1,2-Glyceryl dinitrate [Mass/volume] in Blood |
|
88923-8
|
1,3 beta glucan [Mass/volume] in Lower respiratory specimen |
|
93812-6
|
1,3 beta glucan [Presence] in Serum |
|
42176-8
|
1,3 beta glucan [Mass/volume] in Serum |
|
62468-4
|
1,3 beta glucan [Mass/volume] in Unspecified specimen |
|
28051-1
|
1,3,5-Trichlorobenzene [Mass/volume] in Serum or Plasma |
|
80631-5
|
1,3-Dimethylbenzene+1,4-Dimethylbenzene [Mass/volume] in Blood |
|
38642-5
|
1,3-Butadiene [Mass/volume] in Air |
|
18240-2
|
1,3-Dichlorobenzene [Mass/volume] in Blood |
|
74642-0
|
1,3-Dichlorobenzene [Mass/volume] in Serum or Plasma |
|
38757-1
|
1,3-Dimethylbenzene [Mass/volume] in Air |
|
13644-0
|
1,3-Dimethylbenzene [Mass/volume] in Blood |
|
29145-0
|
1,3-Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
38719-1
|
1,3-Propane sultone [Mass/volume] in Air |
|
38723-3
|
1,4-Benzoquinone [Mass/volume] in Air |
|
79513-8
|
1,4-Cyclohexanediol [Moles/volume] in Serum or Plasma |
|
79471-9
|
1,4-Cyclohexanediol/Creatinine [Molar ratio] in Urine |
|
38590-6
|
1,4-Dichlorobenzene [Mass/volume] in Air |
|
17424-3
|
1,4-Dichlorobenzene [Mass/volume] in Blood |
|
13006-2
|
1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma |
|
38290-3
|
1,4-Dichlorobenzene [Mass/volume] in Water |
|
38593-0
|
1,4-Dioxane [Mass/volume] in Air |
|
14033-5
|
1,4-Dioxane [Mass/volume] in Blood by Gas chromatography |
|
14258-8
|
1,4-Dioxane [Mass/volume] in Blood |
|
27423-3
|
1,4-Dioxane [Presence] in Serum or Plasma |
|
12997-3
|
1,4-Dioxane [Mass/volume] in Serum or Plasma |
|
16292-5
|
1,4-Dioxane [Mass/volume] in Urine |
|
38758-9
|
1,4-Dimethylbenzene [Mass/volume] in Air |
|
13651-5
|
1,4-Dimethylbenzene [Mass/volume] in Blood |
|
29143-5
|
1,4-Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
53835-5
|
1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma |
|
54424-7
|
Plateletpheresis half units given [#] |
|
82624-8
|
One-third mean filling rate Left ventricle SPECT --resting |
|
83163-6
|
Number of 10 foot marks [NIH Toolbox] --2M post trial start |
|
32401-2
|
10 minute Apgar Color |
|
32402-0
|
10 minute Apgar Heart rate |
|
32403-8
|
10 minute Apgar Muscle tone |
|
32404-6
|
10 minute Apgar Reflex irritability |
|
32405-3
|
10 minute Apgar Respiratory effort |
|
9271-8
|
10 minute Apgar Score |
|
60035-3
|
10-Hydroxycarbazepine [Mass/volume] in Blood |
|
31019-3
|
10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma |
|
48348-7
|
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
|
87766-2
|
10-Hydroxycarbazepine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
93198-0
|
10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
56521-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
13600-2
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
|
56518-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
57497-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
57496-2
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
57503-5
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 day post dose metyraPONE |
|
57502-7
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose metyraPONE |
|
13601-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
50075-1
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
55468-3
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
40809-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
58910-1
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
58909-3
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
13872-7
|
11-Deoxycortisol [Mass/time] in 24 hour Urine |
|
34204-8
|
11-Deoxycortisol [Moles/volume] in 24 hour Urine |
|
25315-3
|
11-Deoxycortisol [Moles/time] in 24 hour Urine |
|
57672-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
|
57499-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
57498-8
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
57505-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post dose metyraPONE |
|
57504-3
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose metyraPONE |
|
56517-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
49324-7
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 hours post dose metyraPONE |
|
13602-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
50073-6
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
56519-2
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
58908-5
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
57507-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin |
|
50074-4
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin |
|
56520-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
57002-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
|
1356-5
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyraPONE PO |
|
21035-1
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --morning specimen |
|
55809-8
|
11-Deoxycortisol [Mass/volume] in Amniotic fluid |
|
50071-0
|
11-Deoxycortisol [Moles/volume] in Amniotic fluid |
|
40810-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --baseline |
|
55467-5
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --baseline |
|
53338-0
|
11-Deoxycortisol [Mass/volume] in DBS |
|
53339-8
|
11-Deoxycortisol [Moles/volume] in DBS |
|
21034-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --evening specimen |
|
1357-3
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post 750 mg metyraPONE q4h X 6 |
|
16295-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
|
41289-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post dose metyraPONE |
|
57506-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
50072-8
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
58985-3
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
57495-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre dose dexamethasone |
|
57494-7
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
57501-9
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre dose metyraPONE |
|
57500-1
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose metyraPONE |
|
93773-0
|
11-Deoxycortisol [Moles/volume] in Saliva (oral fluid) |
|
1657-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma |
|
14567-2
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma |
|
50721-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
18351-7
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50720-2
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50719-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50718-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50717-8
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50716-0
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
42572-8
|
11-Deoxycortisol [Mass/volume] in Urine |
|
34205-5
|
11-Deoxycortisol [Moles/volume] in Urine |
|
45184-9
|
11-Deoxycortisol/Cortisol [Mass Ratio] in Serum or Plasma |
|
34206-3
|
11-Deoxycortisol/Creatinine [Molar ratio] in Urine |
|
1354-0
|
11-Deoxycorticosteroids [Mass/volume] in Plasma --9 hours post 3 g metyraPONE PO overnight |
|
16293-3
|
11-Deoxycorticosteroids [Mass/volume] in Plasma |
|
1355-7
|
11-Deoxycorticosteroids [Mass/volume] in Plasma --pre 3 g metyraPONE PO overnight |
|
11061-9
|
11-Dehydro thromboxane beta 2 [Mass/time] in 24 hour Urine |
|
33351-8
|
11-Dehydro thromboxane beta 2 [Mass/volume] in Urine |
|
49734-7
|
11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine |
|
82846-7
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine |
|
82847-5
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in Urine |
|
82849-1
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82848-3
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
56611-7
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
56608-3
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
57493-9
|
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
40816-1
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
56613-3
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
56609-1
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
16110-9
|
11-Deoxycorticosterone [Mass/time] in 24 hour Urine |
|
40818-7
|
11-Deoxycorticosterone [Moles/volume] in 24 hour Urine |
|
55808-0
|
11-Deoxycorticosterone [Moles/time] in 24 hour Urine |
|
56612-5
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
57492-1
|
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
56556-4
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
56610-9
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
56555-6
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --baseline |
|
53347-1
|
11-Deoxycorticosterone [Mass/volume] in DBS |
|
53348-9
|
11-Deoxycorticosterone [Moles/volume] in DBS |
|
16294-1
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
|
57491-3
|
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
56606-7
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
40811-2
|
11-Deoxycorticosterone [Presence] in Serum or Plasma |
|
1656-8
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
|
25561-2
|
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
|
56602-6
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
56603-4
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
56604-2
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
56605-9
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
59987-8
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
59986-0
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
59985-2
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
59984-5
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
42855-7
|
11-Deoxycorticosterone [Mass/volume] in Urine |
|
26943-1
|
11-Ketoandrosterone [Mass/volume] in 24 hour Urine |
|
6702-5
|
11-Ketoandrosterone [Mass/time] in 24 hour Urine |
|
34213-9
|
11-Ketoandrosterone [Moles/volume] in 24 hour Urine |
|
15005-2
|
11-Ketoandrosterone [Moles/time] in 24 hour Urine |
|
57481-4
|
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57482-2
|
11-Ketoandrosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57477-2
|
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57478-0
|
11-Ketoandrosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57479-8
|
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57480-6
|
11-Ketoandrosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57475-6
|
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57476-4
|
11-Ketoandrosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
1661-8
|
11-Ketoandrosterone [Mass/volume] in Serum |
|
26944-9
|
11-Ketoandrosterone [Mass/volume] in Urine |
|
34214-7
|
11-Ketoandrosterone [Moles/volume] in Urine |
|
40814-6
|
11-Ketoandrosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34215-4
|
11-Ketoandrosterone/Creatinine [Molar ratio] in Urine |
|
43359-9
|
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine |
|
6703-3
|
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine |
|
34216-2
|
11-Ketoetiocholanolone [Moles/volume] in 24 hour Urine |
|
15006-0
|
11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
|
57489-7
|
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57490-5
|
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57485-5
|
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57486-3
|
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57487-1
|
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57488-9
|
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57483-0
|
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57484-8
|
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
1662-6
|
11-Ketoetiocholanolone [Mass/volume] in Serum |
|
34217-0
|
11-Ketoetiocholanolone [Moles/volume] in Urine |
|
40815-3
|
11-Ketoetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34396-2
|
11-Ketoetiocholanolone/Creatinine [Molar ratio] in Urine |
|
6704-1
|
11-Ketopregnanetriol [Mass/time] in 24 hour Urine |
|
93242-6
|
11-Ketotestosterone [Mass/volume] in Serum or Plasma |
|
50070-2
|
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
50069-4
|
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
50067-8
|
11-Hydroxyandrostenedione [Moles/volume] in Body fluid |
|
50068-6
|
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
1658-4
|
11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
|
47086-4
|
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma |
|
6701-7
|
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine |
|
34207-1
|
11-Hydroxyandrosterone [Moles/volume] in 24 hour Urine |
|
15003-7
|
11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
|
57514-2
|
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57515-9
|
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57510-0
|
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57511-8
|
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57512-6
|
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57513-4
|
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57508-4
|
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57509-2
|
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
16296-6
|
11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma |
|
1659-2
|
11-Hydroxyandrosterone [Mass/volume] in Urine |
|
34208-9
|
11-Hydroxyandrosterone [Moles/volume] in Urine |
|
40812-0
|
11-Hydroxyandrosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34209-7
|
11-Hydroxyandrosterone/Creatinine [Molar ratio] in Urine |
|
6700-9
|
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine |
|
34210-5
|
11-Hydroxyetiocholanolone [Moles/volume] in 24 hour Urine |
|
15004-5
|
11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
|
57522-5
|
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57523-3
|
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57518-3
|
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57519-1
|
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57520-9
|
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57521-7
|
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57516-7
|
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57517-5
|
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
1660-0
|
11-Hydroxyetiocholanolone [Mass/volume] in Serum |
|
26950-6
|
11-Hydroxyetiocholanolone [Mass/volume] in Urine |
|
34211-3
|
11-Hydroxyetiocholanolone [Moles/volume] in Urine |
|
40813-8
|
11-Hydroxyetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34212-1
|
11-Hydroxyetiocholanolone/Creatinine [Molar ratio] in Urine |
|
93243-4
|
11-Hydroxytestosterone [Mass/volume] in Serum or Plasma |
|
80111-8
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method |
|
70178-9
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood |
|
80112-6
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Body fluid by Confirmatory method |
|
78752-3
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Body fluid by Screen method |
|
78751-5
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/mass] in Hair |
|
78753-1
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method |
|
40864-1
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
|
80113-4
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
78754-9
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method |
|
48935-1
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Unspecified specimen |
|
48934-4
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Unspecified specimen |
|
40865-8
|
11-Oxo-Androsterone [Mass/time] in 24 hour Urine |
|
40866-6
|
11-Oxo-Androsterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
60547-7
|
11-Oxo-Androsterone/Creatinine [Mass Ratio] in Urine |
|
40867-4
|
11-Oxo-Etiocholanolone [Mass/time] in 24 hour Urine |
|
40868-2
|
11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
60548-5
|
11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in Urine |
|
9445-8
|
11-Oxopregnanetriol [Mass/time] in 24 hour Urine |
|
1663-4
|
11-Oxycorticosterone [Mass/volume] in Serum |
|
89419-6
|
12 steps - functional ability [CMS Assessment] |
|
83192-5
|
12 steps - functional ability during 3 day assessment period [CMS Assessment] |
|
89418-8
|
12 steps - functional goal [CMS Assessment] |
|
83191-7
|
12 steps - functional goal during 3 day assessment period [CMS Assessment] |
|
82256-9
|
Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH |
|
27072-8
|
14-3-3 Ag [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31989-7
|
14-3-3 Ag [Presence] in Cerebral spinal fluid |
|
24031-7
|
14-3-3 Ag [Presence] in Cerebral spinal fluid by Immunoblot |
|
31990-5
|
14-3-3 Ag [Units/volume] in Cerebral spinal fluid |
|
36924-9
|
14-3-3 Ag [Mass/volume] in Cerebral spinal fluid |
|
75880-5
|
14-3-3 eta Ag [Mass/volume] in Serum by Immunoassay |
|
91065-3
|
14-3-3 protein [Presence] in Tissue by NAA with probe detection |
|
80607-5
|
14-Hydroxyclarithromycin [Mass/volume] in DBS |
|
80606-7
|
14-Hydroxyclarithromycin [Mass/volume] in Serum or Plasma |
|
30977-3
|
15 day report Form VAERS |
|
44277-2
|
15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine [Mass Ratio] in Urine |
|
73846-8
|
16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine |
|
73845-0
|
16-Alpha hydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine |
|
73844-3
|
16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in Urine |
|
44278-0
|
16-Alpha hydroxydehydroepiandrosterone/Creatinine [Mass Ratio] in Urine |
|
81801-3
|
16-Alpha hydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine |
|
74508-3
|
16-Alpha hydroxypregnenolone [Moles/volume] in 24 hour Urine |
|
74506-7
|
16-Alpha hydroxypregnenolone [Moles/time] in 24 hour Urine |
|
74507-5
|
16-Alpha hydroxypregnenolone [Moles/volume] in Urine |
|
44279-8
|
16-Alpha hydroxypregnenolone/16-Alpha hydroxydehydroepiandrosterone [Mass Ratio] in Urine |
|
43688-1
|
16-Alpha hydroxypregnenolone/Creatinine [Mass Ratio] in Urine |
|
81799-9
|
16-Alpha hydroxypregnenolone/Creatinine [Molar ratio] in Urine |
|
49825-3
|
16-Alpha hydroxyestrone [Mass/volume] in Serum or Plasma |
|
74504-2
|
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine |
|
74505-9
|
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine |
|
74503-4
|
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in Urine |
|
81802-1
|
16-Beta,18-dihydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine |
|
73847-6
|
16-Ketoandrostenediol [Moles/volume] in 24 hour Urine |
|
73848-4
|
16-Ketoandrostenediol [Moles/time] in 24 hour Urine |
|
73849-2
|
16-Ketoandrostenediol [Moles/volume] in Urine |
|
81800-5
|
16-Ketoandrostenediol/Creatinine [Molar ratio] in Urine |
|
61106-1
|
16p11.2 chromosome region deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44280-6
|
17 Alpha-hydroxypregnanolone/Creatinine [Mass Ratio] in Urine |
|
1574-3
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
|
43726-9
|
17-Ketogenic steroids [Presence] in 24 hour Urine |
|
27866-3
|
17-Ketogenic steroids [Mass/volume] in 24 hour Urine |
|
1673-3
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine |
|
50798-8
|
17-Ketogenic steroids [Moles/volume] in 24 hour Urine |
|
27979-4
|
17-Ketogenic steroids [Moles/time] in 24 hour Urine |
|
1575-0
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
|
57525-8
|
17-Ketogenic steroids [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
1577-6
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1576-8
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
1578-4
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
|
16300-6
|
17-Ketogenic steroids [Mass/time] in 72 hour Urine |
|
1671-7
|
17-Ketogenic steroids [Mass/volume] in Blood |
|
16301-4
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --baseline |
|
1581-8
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1579-2
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
|
1580-0
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
|
57524-1
|
17-Ketogenic steroids [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
21038-5
|
17-Ketosteroids [Mass/volume] in 24 hour Urine |
|
6766-0
|
17-Ketosteroids [Mass/time] in 24 hour Urine |
|
25317-9
|
17-Ketosteroids [Moles/volume] in 24 hour Urine |
|
14572-2
|
17-Ketosteroids [Moles/time] in 24 hour Urine |
|
50244-3
|
17-Ketosteroids [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
50077-7
|
17-Ketosteroids [Mass/volume] in Urine --2 days post dose dexamethasone |
|
50242-7
|
17-Ketosteroids [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
50264-1
|
17-Ketosteroids [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
29353-0
|
17-Ketosteroids.total neutral [Mass/time] in 12 hour Urine |
|
12769-6
|
17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine |
|
50243-5
|
17-Ketosteroids [Mass/time] in 24 hour Urine --post dose dexamethasone |
|
50076-9
|
17-Ketosteroids [Mass/volume] in Urine --post dose dexamethasone |
|
50241-9
|
17-Ketosteroids [Mass/volume] in 24 hour Urine --post high dose dexamethasone |
|
50263-3
|
17-Ketosteroids [Mass/time] in 24 hour Urine --post high dose dexamethasone |
|
47978-2
|
17-Ketosteroids [Mass/volume] in Serum |
|
34222-0
|
17-Ketosteroids [Moles/volume] in Urine |
|
44281-4
|
17-Ketosteroids/Creatinine [Mass Ratio] in 24 hour Urine |
|
33347-6
|
17-Ketosteroids/Creatinine [Mass Ratio] in Urine |
|
34223-8
|
17-Ketosteroids/Creatinine [Molar ratio] in Urine |
|
26012-5
|
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --1 day post XXX challenge |
|
6866-8
|
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine |
|
21036-9
|
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine |
|
25852-5
|
17-Hydroxycorticosteroids [Moles/volume] in 24 hour Urine |
|
14568-0
|
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine |
|
26013-3
|
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --2 days post XXX challenge |
|
57529-0
|
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
50248-4
|
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57527-4
|
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
50246-8
|
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
1664-2
|
17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid |
|
50247-6
|
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --post dose dexamethasone |
|
50245-0
|
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --post high dose dexamethasone |
|
1665-9
|
17-Hydroxycorticosteroids [Mass/volume] in Plasma |
|
57528-2
|
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57526-6
|
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
1666-7
|
17-Hydroxycorticosteroids [Mass/volume] in Urine |
|
34218-8
|
17-Hydroxycorticosteroids [Moles/volume] in Urine |
|
41404-5
|
17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in 24 hour Urine |
|
38472-7
|
17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in Urine |
|
34219-6
|
17-Hydroxycorticosteroids/Creatinine [Molar ratio] in Urine |
|
53336-4
|
17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in DBS |
|
53337-2
|
17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar ratio] in DBS |
|
32152-1
|
17-Hydroxyketosteroids [Mass/time] in 24 hour Urine |
|
1667-5
|
17-Hydroxyketosteroids [Mass/volume] in Urine |
|
56616-6
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
56614-1
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
77649-2
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
10964-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
|
56575-4
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
77650-0
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
57547-2
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
57548-0
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
14114-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
55470-9
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
48341-2
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
32539-9
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
74350-0
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20M post dose corticotropin |
|
56615-8
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
59155-2
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
61174-9
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge |
|
9616-4
|
17-Hydroxyprogesterone [Mass/time] in 24 hour Urine |
|
34220-4
|
17-Hydroxyprogesterone [Moles/volume] in 24 hour Urine |
|
14571-4
|
17-Hydroxyprogesterone [Moles/time] in 24 hour Urine |
|
57549-8
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
57550-6
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
56617-4
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
32538-1
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
10965-2
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
55469-1
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
48340-4
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
53141-8
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
16108-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM |
|
56576-2
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
57003-6
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
40754-4
|
17-Hydroxyprogesterone [Mass/volume] in Amniotic fluid |
|
69796-1
|
17-Hydroxyprogesterone [Moles/volume] in Amniotic fluid |
|
27996-8
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --baseline |
|
32288-3
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --baseline |
|
92726-9
|
17-Hydroxyprogesterone [Mass/volume] in DBS by LC/MS/MS |
|
32854-2
|
17-Hydroxyprogesterone [Presence] in DBS |
|
48616-7
|
17-Hydroxyprogesterone [Units/volume] in DBS |
|
38473-5
|
17-Hydroxyprogesterone [Mass/volume] in DBS |
|
53340-6
|
17-Hydroxyprogesterone [Moles/volume] in DBS |
|
47533-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
50080-1
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
57545-6
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --pre dose dexamethasone |
|
57546-4
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
51420-8
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
72490-6
|
17-Hydroxyprogesterone [Moles/volume] in Saliva (oral fluid) |
|
1668-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
|
14569-8
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
|
51680-7
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
57538-1
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1st specimen post dose gonadotropin releasing hormone |
|
57533-2
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
57534-0
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
57535-7
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
12716-7
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
57539-9
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post dose gonadotropin releasing hormone |
|
58815-2
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen |
|
12717-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
57540-7
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post dose gonadotropin releasing hormone |
|
58814-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen |
|
12718-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
57541-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post dose gonadotropin releasing hormone |
|
12719-1
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
57542-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post dose gonadotropin releasing hormone |
|
51679-9
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
57543-1
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --6th specimen post dose gonadotropin releasing hormone |
|
51681-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
57544-9
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --7th specimen post dose gonadotropin releasing hormone |
|
57536-5
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
57537-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
26908-4
|
17-Hydroxyprogesterone [Units/volume] in Urine |
|
1670-9
|
17-Hydroxyprogesterone [Mass/volume] in Urine |
|
14570-6
|
17-Hydroxyprogesterone [Moles/volume] in Urine |
|
63042-6
|
17-Hydroxyprogesterone/Creatinine [Mass Ratio] in Urine |
|
34221-2
|
17-Hydroxyprogesterone/Creatinine [Molar ratio] in Urine |
|
13603-6
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
|
57531-6
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
13604-4
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
50079-3
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
49325-4
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
21037-7
|
17-Hydroxypregnenolone [Mass/time] in 24 hour Urine |
|
57532-4
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
13605-1
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
50249-2
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
56522-6
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
16298-2
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
16299-0
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
51670-8
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --baseline |
|
50078-5
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
57530-8
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
6765-2
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma |
|
25316-1
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma |
|
51677-3
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
51676-5
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
51678-1
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
51672-4
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
51673-2
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
51674-0
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
51675-7
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
16297-4
|
17-Hydroxypregnenolone [Mass/volume] in Urine |
|
83138-8
|
17-Hydroxypregnenetriol [Moles/time] in 24 hour Urine |
|
83140-4
|
17-Hydroxypregnenetriol [Moles/volume] in Urine |
|
83139-6
|
17-Hydroxypregnenetriol/Creatinine [Molar ratio] in Urine |
|
57556-3
|
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
9639-6
|
18-Hydroxycorticosterone [Mass/time] in 24 hour Urine |
|
57555-5
|
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
57554-8
|
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
1674-1
|
18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma |
|
50082-7
|
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma |
|
42573-6
|
18-Hydroxycorticosterone [Mass/volume] in Urine |
|
57559-7
|
18-Hydroxycortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
21039-3
|
18-Hydroxycortisol [Mass/volume] in 24 hour Urine |
|
14148-1
|
18-Hydroxycortisol [Mass/time] in 24 hour Urine |
|
55812-2
|
18-Hydroxycortisol [Moles/volume] in 24 hour Urine |
|
55811-4
|
18-Hydroxycortisol [Moles/time] in 24 hour Urine |
|
57558-9
|
18-Hydroxycortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
57557-1
|
18-Hydroxycortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
55810-6
|
18-Hydroxycortisol [Moles/volume] in Serum or Plasma |
|
27199-9
|
18-Hydroxycortisol/Creatinine [Mass Ratio] in 24 hour Urine |
|
6767-8
|
18-Hydroxycorticosteroids [Mass/volume] in Serum |
|
13480-9
|
18-Hydroxydeoxycortisol/Creatinine [Mass Ratio] in Urine |
|
57553-0
|
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
26988-6
|
18-Hydroxydeoxycorticosterone [Mass/time] in 24 hour Urine |
|
57552-2
|
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
57551-4
|
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
11206-0
|
18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma |
|
50081-9
|
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma |
|
46108-7
|
18q chromosome deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
45181-5
|
19q chromosome deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
93802-7
|
19q/19p chromosome deletion [# Ratio] in Tissue by FISH |
|
38692-0
|
1-Butene oxide [Mass/volume] in Air |
|
32406-1
|
1 minute Apgar Color |
|
32407-9
|
1 minute Apgar Heart rate |
|
32408-7
|
1 minute Apgar Muscle tone |
|
32409-5
|
1 minute Apgar Reflex irritability |
|
32410-3
|
1 minute Apgar Respiratory effort |
|
9272-6
|
1 minute Apgar Score |
|
6865-0
|
1-Methylhistidine [Mass/time] in 24 hour Urine |
|
25853-3
|
1-Methylhistidine [Moles/volume] in 24 hour Urine |
|
25318-7
|
1-Methylhistidine [Moles/time] in 24 hour Urine |
|
13406-4
|
1-Methylhistidine [Mass/volume] in Amniotic fluid |
|
27162-7
|
1-Methylhistidine [Moles/volume] in Amniotic fluid |
|
13377-7
|
1-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
|
26584-3
|
1-Methylhistidine [Moles/volume] in Cerebral spinal fluid |
|
50065-2
|
1-Methylhistidine [Moles/volume] in DBS |
|
50066-0
|
1-Methylhistidine [Moles/volume] in Body fluid |
|
70179-7
|
1-Methylhistidine [Moles/volume] in Serum or Plasma from Fetus |
|
1651-9
|
1-Methylhistidine [Presence] in Serum or Plasma |
|
27399-5
|
1-Methylhistidine [Units/volume] in Serum or Plasma |
|
1652-7
|
1-Methylhistidine [Mass/volume] in Serum or Plasma |
|
20633-4
|
1-Methylhistidine [Moles/volume] in Serum or Plasma |
|
16302-2
|
1-Methylhistidine [Presence] in Urine |
|
1653-5
|
1-Methylhistidine [Mass/volume] in Urine |
|
27044-7
|
1-Methylhistidine [Moles/volume] in Urine |
|
56666-1
|
1-Methylhistidine/Creatinine [Ratio] in 24 hour Urine |
|
25854-1
|
1-Methylhistidine/Creatinine [Molar ratio] in 24 hour Urine |
|
13665-5
|
1-Methylhistidine/Creatinine [Mass Ratio] in Urine |
|
28606-2
|
1-Methylhistidine/Creatinine [Ratio] in Urine |
|
26574-4
|
1-Methylhistidine/Creatinine [Molar ratio] in Urine |
|
1654-3
|
1-Naphthalene [Mass/volume] in Urine |
|
60036-1
|
1-Naphthol [Mass/volume] in Blood |
|
60037-9
|
1-Naphthol [Mass/volume] in Body fluid |
|
9681-8
|
1-Naphthol [Mass/volume] in Serum or Plasma |
|
60038-7
|
1-Naphthol [Mass/mass] in Tissue |
|
42574-4
|
1-Naphthol [Presence] in Urine |
|
35480-3
|
1-Naphthol [Mass/volume] in Urine |
|
78755-6
|
1-Hydroxymidazolam [Mass/volume] in Blood |
|
79131-9
|
1-Hydroxymidazolam [Mass/volume] in Body fluid |
|
59588-4
|
1-Hydroxymidazolam [Mass/mass] in Meconium |
|
69797-9
|
1-Hydroxymidazolam [Mass/volume] in Serum or Plasma |
|
59590-0
|
1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method |
|
94108-8
|
1-Hydroxymidazolam [Presence] in Urine by Screen method |
|
59589-2
|
1-Hydroxymidazolam [Mass/volume] in Urine |
|
45180-7
|
1p chromosome deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
82250-2
|
Chromosome region 1p subtelomere and 1p36 deletion and 1q25 rearrangement in Blood or Tissue by FISH |
|
93800-1
|
1p/1q chromosome deletion [# Ratio] in Tissue by FISH |
|
42634-6
|
1p and 19q chromosome deletion [Presence] in Fixed tissue by Molecular genetics method |
|
14259-6
|
1-Pentanol [Mass/volume] in Blood |
|
88097-1
|
First degree burn area/Body surface area [Area/Area] Estimated |
|
49588-7
|
First trimester maternal screen with nuchal translucency [Interpretation] Narrative |
|
50679-0
|
First trimester maternal screen with nuchal translucency [Interpretation] |
|
62443-7
|
Single view Teeth Document XR |
|
84420-9
|
2-minute Walk Endurance Test - national percentile [NIH Toolbox] |
|
83171-9
|
2-minute Walk Endurance Test - scale score age adjusted [NIH Toolbox] |
|
84415-9
|
2-minute Walk Endurance Test - scale score fully adjusted [NIH Toolbox] |
|
73987-0
|
2,2',3,4,4',5-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
74375-7
|
2,2',3,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
74376-5
|
2,2',4,4',5,5'-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73988-8
|
2,2',4,5,5'-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73991-2
|
2,2',5,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73992-0
|
2,2',5-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
38287-9
|
2,2-Dichloropropionate [Mass/volume] in Water |
|
73989-6
|
2,3',4,4',5-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73990-4
|
2,3',4',5-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
87651-6
|
2,3,5-trimethylphenyl methylcarbamate [Mass/mass] in Unspecified specimen |
|
1675-8
|
2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells |
|
15007-8
|
2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
|
49217-3
|
2,3-Diphosphoglycerate [Moles/mass] in Red Blood Cells |
|
1676-6
|
2,3-Diphosphoglycerate [Mass/volume] in Serum |
|
74374-0
|
2,4,4'-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13005-4
|
2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma |
|
38331-5
|
2,4,5-Trichlorophenoxyacetate [Mass/volume] in Water |
|
38729-0
|
2,4,5-Trichlorophenol [Mass/volume] in Air |
|
38730-8
|
2,4,6-Trichlorophenol [Mass/volume] in Air |
|
38582-3
|
2,4-Dichlorophenoxyacetate [Mass/volume] in Air |
|
27338-3
|
2,4-Dichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
|
9806-1
|
2,4-Dichlorophenoxyacetate [Mass/volume] in Urine |
|
38286-1
|
2,4-Dichlorophenoxyacetate [Mass/volume] in Water |
|
43725-1
|
2,4-Dichlorophenol [Presence] in Urine |
|
38741-5
|
2,4-Dinitrophenol [Mass/volume] in Air |
|
38742-3
|
2,4-Dinitrotoluene [Mass/volume] in Air |
|
38754-8
|
2,4-Toluene diisocyanate [Mass/volume] in Air |
|
38727-4
|
2,4 toluenediamine [Mass/volume] in Air |
|
12984-1
|
2,4 toluenediamine [Mass/volume] in Blood |
|
6971-6
|
2,4 toluenediamine [Mass/volume] in Urine |
|
43724-4
|
2,5-Dichlorophenol [Presence] in Urine |
|
69798-7
|
2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine |
|
79475-0
|
2,5-Furandicarboxylate [Moles/volume] in Serum or Plasma |
|
79522-9
|
2,5-Furandicarboxylate/Creatinine [Molar ratio] in Urine |
|
12986-6
|
2,5-Hexanedione [Mass/volume] in Blood |
|
31170-4
|
2,5-Hexanedione [Mass/volume] in Urine |
|
31171-2
|
2,5-Hexanedione/Creatinine [Mass Ratio] in Urine |
|
12985-8
|
2,6 toluenediamine [Mass/volume] in Blood |
|
6972-4
|
2,6 toluenediamine [Mass/volume] in Urine |
|
79680-5
|
2,8-dihydroxyadenine [Moles/volume] in Cerebral spinal fluid |
|
79692-0
|
2,8-dihydroxyadenine [Moles/volume] in Serum or Plasma |
|
79687-0
|
2,8-dihydroxyadenine/Creatinine [Molar ratio] in Urine |
|
1678-2
|
20-Hydroxyprogesterone [Mass/volume] in Serum |
|
53628-4
|
20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
57564-7
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
50097-5
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
57565-4
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
50096-7
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
50094-2
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin |
|
50093-4
|
21-Deoxycortisol [Moles/volume] in Amniotic fluid |
|
53341-4
|
21-Deoxycortisol [Mass/volume] in DBS |
|
53342-2
|
21-Deoxycortisol [Moles/volume] in DBS |
|
50095-9
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
57563-9
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
74872-3
|
21-Deoxycortisol [Mass/volume] in Serum or Plasma |
|
50250-0
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma |
|
57562-1
|
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
57561-3
|
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
57560-5
|
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
69799-5
|
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
|
85363-0
|
21-Hydroxylase Ab [Presence] in Serum |
|
17781-6
|
21-Hydroxylase Ab [Units/volume] in Serum |
|
1679-0
|
24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma |
|
49054-0
|
25-Hydroxycalciferol [Mass/volume] in Serum or Plasma |
|
46269-7
|
25-Hydroxycalciferol [Moles/volume] in Serum or Plasma |
|
86918-0
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 goal [Mass/volume] Serum or Plasma |
|
83070-3
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma by Immunoassay |
|
83071-1
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Moles/volume] in Serum or Plasma by Immunoassay |
|
62292-8
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
|
68438-1
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Moles/volume] in Serum or Plasma |
|
57569-6
|
Calcidiol [Moles/volume] in Serum or Plasma --1 hour post dose calcium |
|
57567-0
|
Calcidiol [Moles/volume] in Serum or Plasma --2 hours post dose calcium |
|
57568-8
|
Calcidiol [Moles/volume] in Serum or Plasma --3 hours post dose calcium |
|
55814-8
|
Calcidiol [Moles/volume] in Cord blood |
|
57566-2
|
Calcidiol [Moles/volume] in Serum or Plasma --pre dose calcium |
|
1989-3
|
Calcidiol [Mass/volume] in Serum or Plasma |
|
35196-5
|
Calcidiol [Mass or Moles/volume] in Serum or Plasma |
|
14635-7
|
Calcidiol [Moles/volume] in Serum or Plasma |
|
73998-7
|
25H-NBOMe [Presence] in Urine by Confirmatory method |
|
74000-1
|
25I-NBOMe [Presence] in Urine by Confirmatory method |
|
80159-7
|
27-Norcholestanehexol/Creatinine [Ratio] in Urine |
|
38687-0
|
2-Acetylaminofluorene [Mass/volume] in Air |
|
80165-4
|
2-Amino-4-hydroxypteridine [Moles/volume] in Cerebral spinal fluid |
|
80166-2
|
2-Amino-4-hydroxypteridine [Moles/volume] in Serum or Plasma |
|
80167-0
|
2-Amino-4-hydroxypteridine/Creatinine [Molar ratio] in Serum or Plasma |
|
38728-2
|
2-Aminotoluene [Mass/volume] in Air |
|
17572-9
|
2-Butanol [Mass/volume] in Blood |
|
9682-6
|
2-Butanol [Mass/volume] in Unspecified specimen |
|
35585-9
|
2-Butoxyacetate [Mass/volume] in Urine |
|
38655-7
|
2-Chloroacetophenone [Mass/volume] in Air |
|
38651-6
|
2-Chloro-1,3-Butadiene [Mass/volume] in Air |
|
73999-5
|
2C-C-NBOMe [Presence] in Urine by Confirmatory method |
|
69805-0
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --12 hours post dose ifosfamide |
|
69810-0
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --1 day post dose ifosfamide |
|
69809-2
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --1 day post dose ifosfamide |
|
50266-6
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
|
69812-6
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --2 days post dose ifosfamide |
|
69811-8
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --2 days post dose ifosfamide |
|
50267-4
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
|
69814-2
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --3 days post dose ifosfamide |
|
69813-4
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --3 days post dose ifosfamide |
|
50268-2
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
|
50271-6
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
|
69816-7
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --4 days post dose ifosfamide |
|
69815-9
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --4 days post dose ifosfamide |
|
50269-0
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
|
69818-3
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide |
|
69817-5
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --5 days post dose ifosfamide |
|
50270-8
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide |
|
69821-7
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --6 days post dose ifosfamide |
|
69820-9
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --6 days post dose ifosfamide |
|
69819-1
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide |
|
50272-4
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
|
69824-1
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --7 days post dose ifosfamide |
|
69823-3
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --7 days post dose ifosfamide |
|
69822-5
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --7 days post dose ifosfamide |
|
69806-8
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --post dose ifosfamide |
|
69808-4
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --pre dose ifosfamide |
|
69807-6
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --pre dose ifosfamide |
|
50265-8
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
|
47807-3
|
2-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
35587-5
|
2-Ethoxyacetate [Mass/volume] in Urine |
|
30576-3
|
2-Ethyl-3-Hydroxypropionate [Presence] in Urine |
|
49809-7
|
2-Ethyl-3-Hydroxypropionate/Creatinine [Molar ratio] in 24 hour Urine |
|
13668-9
|
2-Ethyl-3-Hydroxypropionate/Creatinine [Mass Ratio] in Urine |
|
29523-8
|
2-Ethyl-3-Hydroxypropionate/Creatinine [Molar ratio] in Urine |
|
69825-8
|
2-Ethylhydracrylate [Moles/volume] in Cerebral spinal fluid |
|
69826-6
|
2-Ethylhydracrylate [Moles/volume] in Serum or Plasma |
|
47808-1
|
2-Ethylhydracrylate/Creatinine [Molar ratio] in Urine |
|
16303-0
|
2-Hexanol [Mass/volume] in Urine |
|
16304-8
|
2-Hexanol/Creatinine [Mass Ratio] in Urine |
|
59190-9
|
2-Hydroxycaproate/Creatinine [Molar ratio] in Urine |
|
59191-7
|
2-Ketobutyrate/Creatinine [Molar ratio] in Urine |
|
17683-4
|
2-Methyl-2-Propanol [Mass/volume] in Blood |
|
9683-4
|
2-Methyl-2-Propanol [Mass/volume] in Unspecified specimen |
|
46750-6
|
2-methyl-3-hydroxybutyric Acidemias/Beta-Ketothiolase Deficiency newborn screen interpretation |
|
69788-8
|
2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Cerebral spinal fluid |
|
69789-6
|
2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Serum or Plasma |
|
30577-1
|
2-methyl-3-hydroxybutyrate (C5-OH) [Presence] in Urine |
|
49815-4
|
2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Molar ratio] in 24 hour Urine |
|
13675-4
|
2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Mass Ratio] in Urine |
|
25082-9
|
2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Molar ratio] in Urine |
|
50087-6
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid |
|
50088-4
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid |
|
50086-8
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in DBS |
|
50090-0
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
50089-2
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Urine |
|
50091-8
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
|
47810-7
|
2-Methyl-3-Hydroxyvalerate [Moles/volume] in Plasma |
|
50085-0
|
2-Methyl-3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
|
47811-5
|
2-Methyl-3-Oxobutyrate/Creatinine [Molar ratio] in Urine |
|
69790-4
|
2-Methylbutyrylglycine [Moles/volume] in Serum or Plasma |
|
29884-4
|
2-Methylbutyrylglycine [Presence] in Urine |
|
27097-5
|
2-Methylbutyrylglycine/Creatinine [Mass Ratio] in Urine |
|
24435-0
|
2-Methylbutyrylglycine/Creatinine [Molar ratio] in Urine |
|
34626-2
|
2-Methylcitrate [Moles/volume] in Amniotic fluid |
|
50092-6
|
2-Methylcitrate [Moles/volume] in Cerebral spinal fluid |
|
82386-4
|
2-Methylcitrate [Moles/volume] in DBS |
|
12540-1
|
2-Methylcitrate [Mass/volume] in Serum or Plasma |
|
26904-3
|
2-Methylcitrate [Moles/volume] in Serum or Plasma |
|
29876-0
|
2-Methylcitrate [Presence] in Urine |
|
12539-3
|
2-Methylcitrate [Mass/volume] in Urine |
|
26811-0
|
2-Methylcitrate [Moles/volume] in Urine |
|
44284-8
|
2-Methylcitrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13773-7
|
2-Methylcitrate/Creatinine [Mass Ratio] in Urine |
|
25114-0
|
2-Methylcitrate/Creatinine [Molar ratio] in Urine |
|
47812-3
|
2-Methylglutaconate/Creatinine [Molar ratio] in Urine |
|
69827-4
|
2-Methylglutarate [Moles/volume] in Serum or Plasma |
|
47813-1
|
2-Methylglutarate/Creatinine [Molar ratio] in Urine |
|
17276-7
|
2-Methylpentane [Mass/volume] in Blood |
|
16305-5
|
2-Methoxyethanol [Mass/volume] in Blood |
|
69786-2
|
2-Methylacetoacetate [Moles/volume] in Cerebral spinal fluid |
|
69787-0
|
2-Methylacetoacetate [Moles/volume] in Serum or Plasma |
|
59377-2
|
2-Methylacetoacetate/Creatinine [Molar ratio] in Urine |
|
79608-6
|
2-Methyltyrosine [Moles/volume] in Serum or Plasma |
|
80894-9
|
2-Methyltyrosine/Creatinine [Molar ratio] in Urine |
|
83143-8
|
2-Minute Walk Endurance Test [NIH Toolbox] |
|
83168-5
|
2-minute Walk Endurance Test - unadjusted scale score [NIH Toolbox] |
|
88098-9
|
Second degree burn area/Body surface area [Area/Area] Estimated |
|
64118-3
|
Second most predominant hemoglobin in DBS |
|
49572-1
|
Second trimester triple maternal screen [Interpretation] in Serum or Plasma Narrative |
|
49092-0
|
Second trimester quad maternal screen [Interpretation] in Serum or Plasma Narrative |
|
49032-6
|
Second trimester penta maternal screen [Interpretation] in Serum or Plasma |
|
38711-8
|
2-Nitropropane [Mass/volume] in Air |
|
93775-5
|
2-Octenoate/Creatinine [Molar ratio] in Urine |
|
69838-1
|
2-Hydroxy-3-Methylvalerate [Moles/volume] in Cerebral spinal fluid |
|
69839-9
|
2-Hydroxy-3-Methylvalerate [Moles/volume] in Serum or Plasma |
|
29880-2
|
2-Hydroxy-3-Methylvalerate [Presence] in Urine |
|
49810-5
|
2-Hydroxy-3-Methylvalerate/Creatinine [Molar ratio] in 24 hour Urine |
|
13669-7
|
2-Hydroxy-3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
|
29505-5
|
2-Hydroxy-3-Methylvalerate/Creatinine [Molar ratio] in Urine |
|
69840-7
|
2-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid |
|
69841-5
|
2-Hydroxyadipate [Moles/volume] in Serum or Plasma |
|
49811-3
|
2-Hydroxyadipate/Creatinine [Molar ratio] in 24 hour Urine |
|
13670-5
|
2-Hydroxyadipate/Creatinine [Mass Ratio] in Urine |
|
29500-6
|
2-Hydroxyadipate/Creatinine [Molar ratio] in Urine |
|
49826-1
|
2-Hydroxyestrone [Mass/volume] in Serum or Plasma |
|
49827-9
|
2-Hydroxyestrone/16-Alpha hydroxyestrone [Mass Ratio] in Serum or Plasma |
|
94110-4
|
2-Hydroxyethylflurazepam [Presence] in Urine by Screen method |
|
43635-2
|
2-Hydroxyglutarate [Presence] in 24 hour Urine |
|
75036-4
|
2-Hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
69844-9
|
2-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
75037-2
|
2-Hydroxyglutarate [Moles/volume] in DBS |
|
69845-6
|
2-Hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
29881-0
|
2-Hydroxyglutarate [Presence] in Urine |
|
49812-1
|
2-Hydroxyglutarate/Creatinine [Molar ratio] in 24 hour Urine |
|
13672-1
|
2-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine |
|
29502-2
|
2-Hydroxyglutarate/Creatinine [Molar ratio] in Urine |
|
69846-4
|
2-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
69847-2
|
2-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma |
|
27981-0
|
2-Hydroxyisobutyrate [Presence] in Urine |
|
29501-4
|
2-Hydroxyisobutyrate/Creatinine [Molar ratio] in Urine |
|
69848-0
|
2-Hydroxyisocaproate [Moles/volume] in Cerebral spinal fluid |
|
69849-8
|
2-Hydroxyisocaproate [Moles/volume] in Serum or Plasma |
|
43226-0
|
2-Hydroxyisocaproate [Presence] in Urine |
|
44282-2
|
2-Hydroxyisocaproate/Creatinine [Mass Ratio] in 24 hour Urine |
|
49813-9
|
2-Hydroxyisocaproate/Creatinine [Molar ratio] in 24 hour Urine |
|
13673-9
|
2-Hydroxyisocaproate/Creatinine [Mass Ratio] in Urine |
|
29503-0
|
2-Hydroxyisocaproate/Creatinine [Molar ratio] in Urine |
|
69780-5
|
2-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid |
|
69781-3
|
2-Hydroxyisovalerate [Moles/volume] in Serum or Plasma |
|
29882-8
|
2-Hydroxyisovalerate [Presence] in Urine |
|
49814-7
|
2-Hydroxyisovalerate/Creatinine [Molar ratio] in 24 hour Urine |
|
13674-7
|
2-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine |
|
29504-8
|
2-Hydroxyisovalerate/Creatinine [Molar ratio] in Urine |
|
69782-1
|
2-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
|
69783-9
|
2-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
29883-6
|
2-Hydroxyphenylacetate [Presence] in Urine |
|
44283-0
|
2-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
|
47534-3
|
2-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
69784-7
|
2-Hydroxysebacate [Moles/volume] in Cerebral spinal fluid |
|
69785-4
|
2-Hydroxysebacate [Moles/volume] in Serum or Plasma |
|
47809-9
|
2-Hydroxysebacate/Creatinine [Molar ratio] in Urine |
|
48608-4
|
2-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine |
|
35869-7
|
2-Oxo,3-Methylvalerate [Moles/volume] in Serum or Plasma |
|
29864-6
|
2-Oxo,3-Methylvalerate [Presence] in Urine |
|
49816-2
|
2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in 24 hour Urine |
|
13676-2
|
2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
|
25083-7
|
2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in Urine |
|
80114-2
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Blood by Confirmatory method |
|
78756-4
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Blood by Screen method |
|
78757-2
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Screen method |
|
45185-6
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine |
|
69801-9
|
2-Oxoadipate [Moles/volume] in Cerebral spinal fluid |
|
69768-0
|
2-Oxoadipate [Moles/volume] in Serum or Plasma |
|
13677-0
|
2-Oxoadipate/Creatinine [Mass Ratio] in Urine |
|
28584-1
|
2-Oxoadipate/Creatinine [Ratio] in Urine |
|
29506-3
|
2-Oxoadipate/Creatinine [Molar ratio] in Urine |
|
69804-3
|
2-Oxoisocaproate [Moles/volume] in Cerebral spinal fluid |
|
4100-4
|
2-Oxoisocaproate [Mass] of Dose |
|
35870-5
|
2-Oxoisocaproate [Moles/volume] in Serum or Plasma |
|
29865-3
|
2-Oxoisocaproate [Presence] in Urine |
|
3290-4
|
2-Oxoisocaproate [Mass/volume] in Urine |
|
49817-0
|
2-Oxoisocaproate/Creatinine [Molar ratio] in 24 hour Urine |
|
13679-6
|
2-Oxoisocaproate/Creatinine [Mass Ratio] in Urine |
|
25084-5
|
2-Oxoisocaproate/Creatinine [Molar ratio] in Urine |
|
35868-9
|
2-Oxoisovalerate [Moles/volume] in Serum or Plasma |
|
29866-1
|
2-Oxoisovalerate [Presence] in Urine |
|
49818-8
|
2-Oxoisovalerate/Creatinine [Molar ratio] in 24 hour Urine |
|
13680-4
|
2-Oxoisovalerate/Creatinine [Mass Ratio] in Urine |
|
25085-2
|
2-Oxoisovalerate/Creatinine [Molar ratio] in Urine |
|
4101-2
|
2-Pyridone [Mass] of Dose |
|
3291-2
|
2-Pyridone [Mass/volume] in Serum or Plasma |
|
3292-0
|
2-Pyridone/N'-methylnicotinamide [Mass Ratio] in Serum or Plasma |
|
38667-2
|
3,3'-Dimethoxybenzidine [Mass/volume] in Air |
|
87737-3
|
3,4,5-trimethylphenyl methylcarbamate [Mass/mass] in Unspecified specimen |
|
79480-0
|
3,4-Dihydroxyhydrocinnamate [Moles/volume] in Serum or Plasma |
|
79490-9
|
3,4-Dihydroxyhydrocinnamate/Creatinine [Molar ratio] in Urine |
|
79488-3
|
3,4-Dihydroxybutyrate [Moles/volume] in Serum or Plasma |
|
79474-3
|
3,4-Dihydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
69830-8
|
3,4-Dihydroxyphenylacetate [Moles/volume] in 24 hour Urine |
|
53548-4
|
3,4-Dihydroxyphenylacetate [Moles/time] in 24 hour Urine |
|
53544-3
|
3,4-Dihydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
|
53547-6
|
3,4-Dihydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
55816-3
|
3,4-Dihydroxyphenylacetate [Moles/volume] in Urine |
|
53551-8
|
3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
69831-6
|
3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
47814-9
|
3,4-Dihydroxyphenyllactate/Creatinine [Molar ratio] in Urine |
|
86194-8
|
3,4-Dimethylmethcathinone [Mass/volume] in Urine by Confirmatory method |
|
47815-6
|
3,4-Hydroxymandelate/Creatinine [Molar ratio] in Urine |
|
79526-0
|
3,5-Dihydroxybenzoate [Moles/volume] in Serum or Plasma |
|
79486-7
|
3,5-Dihydroxybenzoate/Creatinine [Molar ratio] in Urine |
|
48078-0
|
3,6-Epoxydecanedioate/Creatinine [Molar ratio] in Urine |
|
48079-8
|
3,6-Epoxydodecanedioate/Creatinine [Molar ratio] in Urine |
|
48080-6
|
3,6-Epoxyoctanedioate/Creatinine [Molar ratio] in Urine |
|
48081-4
|
3,6-Epoxytetradecanedioate/Creatinine [Molar ratio] in Urine |
|
82865-7
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in 24 hour Urine |
|
82864-0
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/time] in 24 hour Urine |
|
82863-2
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in Urine |
|
83134-7
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone/Creatinine [Molar ratio] in Urine |
|
57571-2
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone |
|
57575-3
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
34224-6
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in 24 hour Urine |
|
25855-8
|
3-Alpha-Androstanediol glucuronide [Moles/time] in 24 hour Urine |
|
57572-0
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone |
|
57574-6
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
57573-8
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
57570-4
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
1680-8
|
3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum |
|
15008-6
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
|
34225-3
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Urine |
|
34226-1
|
3-Alpha-Androstanediol glucuronide/Creatinine [Molar ratio] in Urine |
|
13610-1
|
3-Beta-Androstanediol [Mass/volume] in Serum or Plasma |
|
47816-4
|
3-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
50285-6
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
|
50286-4
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
|
50287-2
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
|
50290-6
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
|
50288-0
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
|
50289-8
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide |
|
50291-4
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
|
50145-2
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
|
72404-7
|
3-epi-25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
|
72403-9
|
3-epi-25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
|
72888-1
|
3-epi-25-Hydroxyvitamin D3/25-hydroxyvitamin D.total in Serum or Plasma |
|
75088-5
|
3-Indolelactate [Moles/volume] in Serum or Plasma |
|
47821-4
|
3-Indolelactate/Creatinine [Molar ratio] in Urine |
|
50392-0
|
3-Keto n-Valerate [Moles/volume] in Cerebral spinal fluid |
|
53467-7
|
3-Keto n-Valerate [Moles/volume] in Serum or Plasma |
|
50393-8
|
3-Keto n-Valerate/Creatinine [Molar ratio] in Urine |
|
59376-4
|
3-Keto, 2-Methylvalerate/Creatinine [Molar ratio] in Urine |
|
74296-5
|
3-Methylcrotonyl-CoA carboxylase deficiency newborn screen interpretation |
|
82218-9
|
3-Methylcrotonyl-CoA carboxylase [Enzymatic activity/mass] in Fibroblast |
|
59192-5
|
3-Methyl crotonate/Creatinine [Molar ratio] in Urine |
|
21043-5
|
3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in 24 hour Urine |
|
9695-8
|
3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine |
|
53496-6
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in 24 hour Urine |
|
53098-0
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in 24 hour Urine |
|
47538-4
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Cerebral spinal fluid |
|
50135-3
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Serum or Plasma |
|
43634-5
|
3-Methoxy-4-Hydroxyphenylglycol [Presence] in Urine |
|
1684-0
|
3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine |
|
50136-1
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Urine |
|
50137-9
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in Urine |
|
50138-7
|
3-Methoxy-4-Hydroxyphenylglycol/Creatinine [Molar ratio] in Urine |
|
40848-4
|
3-Methylcrotonylglycine [Mass/time] in 24 hour Urine |
|
72441-9
|
3-Methylcrotonylglycine [Moles/volume] in Amniotic fluid |
|
40927-6
|
3-Methylcrotonylglycine [Moles/volume] in Blood |
|
72442-7
|
3-Methylcrotonylglycine [Moles/volume] in Cerebral spinal fluid |
|
41039-9
|
3-Methylcrotonylglycine [Moles/volume] in Serum or Plasma |
|
29628-5
|
3-Methylcrotonylglycine [Presence] in Urine |
|
44285-5
|
3-Methylcrotonylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
13691-1
|
3-Methylcrotonylglycine/Creatinine [Mass Ratio] in Urine |
|
24436-8
|
3-Methylcrotonylglycine/Creatinine [Molar ratio] in Urine |
|
93465-3
|
3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
72440-1
|
3-Methylglutaconate [Moles/volume] in Cerebral spinal fluid |
|
33273-4
|
3-Methylglutaconate [Moles/volume] in Serum or Plasma |
|
29629-3
|
3-Methylglutaconate [Presence] in Urine |
|
13692-9
|
3-Methylglutaconate/Creatinine [Mass Ratio] in Urine |
|
25087-8
|
3-Methylglutaconate/Creatinine [Molar ratio] in Urine |
|
72438-5
|
3-Methylglutarate [Moles/volume] in Cerebral spinal fluid |
|
72439-3
|
3-Methylglutarate [Moles/volume] in Serum or Plasma |
|
29630-1
|
3-Methylglutarate [Presence] in Urine |
|
13693-7
|
3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
|
29518-8
|
3-Methylglutarate/Creatinine [Molar ratio] in Urine |
|
17860-8
|
3-Methylhistidine [Mass/volume] in 24 hour Urine |
|
6867-6
|
3-Methylhistidine [Mass/time] in 24 hour Urine |
|
25856-6
|
3-Methylhistidine [Moles/volume] in 24 hour Urine |
|
25319-5
|
3-Methylhistidine [Moles/time] in 24 hour Urine |
|
13407-2
|
3-Methylhistidine [Mass/volume] in Amniotic fluid |
|
27176-7
|
3-Methylhistidine [Moles/volume] in Amniotic fluid |
|
72423-7
|
3-Methylhistidine [Moles/volume] in Blood from Fetus |
|
13378-5
|
3-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
|
26585-0
|
3-Methylhistidine [Moles/volume] in Cerebral spinal fluid |
|
47539-2
|
3-Methylhistidine [Moles/volume] in DBS |
|
47540-0
|
3-Methylhistidine [Moles/volume] in Body fluid |
|
1685-7
|
3-Methylhistidine [Presence] in Serum or Plasma |
|
27973-7
|
3-Methylhistidine [Units/volume] in Serum or Plasma |
|
1686-5
|
3-Methylhistidine [Mass/volume] in Serum or Plasma |
|
20635-9
|
3-Methylhistidine [Moles/volume] in Serum or Plasma |
|
72424-5
|
3-Methylhistidine/Amino acids.total in Serum or Plasma |
|
16306-3
|
3-Methylhistidine [Presence] in Urine |
|
1687-3
|
3-Methylhistidine [Mass/volume] in Urine |
|
27046-2
|
3-Methylhistidine [Moles/volume] in Urine |
|
44286-3
|
3-Methylhistidine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56667-9
|
3-Methylhistidine/Creatinine [Ratio] in 24 hour Urine |
|
25857-4
|
3-Methylhistidine/Creatinine [Molar ratio] in 24 hour Urine |
|
13694-5
|
3-Methylhistidine/Creatinine [Mass Ratio] in Urine |
|
28594-0
|
3-Methylhistidine/Creatinine [Ratio] in Urine |
|
26575-1
|
3-Methylhistidine/Creatinine [Molar ratio] in Urine |
|
10973-6
|
3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma |
|
72443-5
|
3-Methyladipate [Moles/volume] in Serum or Plasma |
|
47822-2
|
3-Methyladipate/Creatinine [Molar ratio] in Urine |
|
46749-8
|
3-Methylcrotonic/Hydroxymethylglutaric/Methylglutaconic newborn screen interpretation |
|
54344-7
|
3-Methoxytyramine [Mass/volume] in 24 hour Urine |
|
32618-1
|
3-Methoxytyramine [Mass/time] in 24 hour Urine |
|
48380-0
|
3-Methoxytyramine [Moles/volume] in 24 hour Urine |
|
40409-5
|
3-Methoxytyramine [Moles/time] in 24 hour Urine |
|
50139-5
|
3-Methoxytyramine [Moles/volume] in Cerebral spinal fluid |
|
50140-3
|
3-Methoxytyramine [Moles/volume] in Serum or Plasma |
|
54343-9
|
3-Methoxytyramine/Creatinine [Mass Ratio] in 24 hour Urine |
|
48381-8
|
3-Methoxytyramine/Creatinine [Molar ratio] in 24 hour Urine |
|
80156-3
|
3-Methoxytyramine/Creatinine [Molar ratio] in Urine |
|
82219-7
|
3-Methylglutaconyl-CoA hydratase [Enzymatic activity/mass] in Fibroblast |
|
48750-4
|
3-Hydroxy fatty acids pattern [Interpretation] in Serum or Plasma |
|
69833-2
|
3-Hydroxy,3-Methylglutarate [Moles/volume] in Amniotic fluid |
|
69832-4
|
3-Hydroxy,3-Methylglutarate [Moles/volume] in Cerebral spinal fluid |
|
69834-0
|
3-Hydroxy,3-Methylglutarate [Moles/volume] in Serum or Plasma |
|
29867-9
|
3-Hydroxy,3-Methylglutarate [Presence] in Urine |
|
49819-6
|
3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in 24 hour Urine |
|
13682-0
|
3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
|
26583-5
|
3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in Urine |
|
47817-2
|
3-Hydroxy,4-Methoxybenzoate/Creatinine [Molar ratio] in Urine |
|
79479-2
|
3-Hydroxyadipate 3,6-lactone [Moles/volume] in Serum or Plasma |
|
48082-2
|
3-Hydroxyadipate 3,6-lactone/Creatinine [Molar ratio] in Urine |
|
69835-7
|
3-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid |
|
69836-5
|
3-Hydroxyadipate [Moles/volume] in Serum or Plasma |
|
29621-0
|
3-Hydroxyadipate [Presence] in Urine |
|
49820-4
|
3-Hydroxyadipate/Creatinine [Molar ratio] in 24 hour Urine |
|
13683-8
|
3-Hydroxyadipate/Creatinine [Mass Ratio] in Urine |
|
29508-9
|
3-Hydroxyadipate/Creatinine [Molar ratio] in Urine |
|
55888-2
|
3-Hydroxyanthranilate [Moles/time] in 24 hour Urine |
|
55887-4
|
3-Hydroxyanthranilate [Moles/volume] in Serum or Plasma |
|
55889-0
|
3-Hydroxyanthranilate [Moles/volume] in Urine |
|
55886-6
|
3-Hydroxyanthranilate/Creatinine [Molar ratio] in Urine |
|
79497-4
|
3-Hydroxybenzoate [Moles/volume] in Serum or Plasma |
|
79518-7
|
3-Hydroxybenzoate/Creatinine [Molar ratio] in Urine |
|
50103-1
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Amniotic fluid |
|
50101-5
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebral spinal fluid |
|
50102-3
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
|
74595-0
|
3-Hydroxybutyrylcarnitine (C4-OH) [Enzymatic activity/mass] in Fibroblast |
|
18442-4
|
3-Hydroxybutyrylcarnitine (C4-OH) [Mass/volume] in Serum or Plasma |
|
39000-5
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma |
|
53105-3
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Urine |
|
50251-8
|
3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine |
|
69012-3
|
3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method |
|
40901-1
|
3-Hydroxybenzoylecgonine [Mass/mass] in Meconium |
|
50593-3
|
3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
50594-1
|
3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method |
|
48763-7
|
3-Hydroxydecanoate (3-OH-C10:0) [Moles/volume] in Serum or Plasma |
|
48755-3
|
3-Hydroxydecanoate.free (3-OH-C10:0) [Moles/volume] in Serum or Plasma |
|
81811-2
|
3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS |
|
74509-1
|
3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma |
|
81810-4
|
3-Hydroxydecanoylcarnitine (C10-OH)/Creatinine [Molar ratio] in Urine |
|
53182-2
|
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS |
|
82478-9
|
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Serum or Plasma |
|
48083-0
|
3-Hydroxydodecanedienedioate/Creatinine [Molar ratio] in Urine |
|
21041-9
|
3-Hydroxydodecanedioate (3-OH-D-C12)/Creatinine [Mass Ratio] in Urine |
|
48084-8
|
3-Hydroxydodecanedioate (3-OH-D-C12)/Creatinine [Molar ratio] in Urine |
|
48754-6
|
3-Hydroxydodecanoate (3-OH-C12:0) [Moles/volume] in Serum or Plasma |
|
29623-6
|
3-Hydroxydodecanoate (3-OH-C12:0) [Presence] in Urine |
|
48753-8
|
3-Hydroxydodecanoate.free (3-OH-C12:0) [Moles/volume] in Serum or Plasma |
|
21042-7
|
3-Hydroxydodecanoate (3-OH-C12:0)/Creatinine [Mass Ratio] in Urine |
|
75078-6
|
3-Hydroxydodecanoate (3-OH-C12:0)/Creatinine [Molar ratio] in Urine |
|
53189-7
|
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS |
|
30233-1
|
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Serum or Plasma |
|
81809-6
|
3-Hydroxydodecanoylcarnitine (C12-OH)/Creatinine [Molar ratio] in Urine |
|
48085-5
|
3-Hydroxydodecenedioate/Creatinine [Molar ratio] in Urine |
|
53188-9
|
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS |
|
59195-8
|
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Serum or Plasma |
|
74510-9
|
3-Hydroxyeicosanoylcarnitine (C20-OH) [Moles/volume] in Serum or Plasma |
|
69850-6
|
3-Hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
69837-3
|
3-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
82505-9
|
3-Hydroxyglutarate [Moles/volume] in DBS |
|
69851-4
|
3-Hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
29624-4
|
3-Hydroxyglutarate [Presence] in Urine |
|
49821-2
|
3-Hydroxyglutarate/Creatinine [Molar ratio] in 24 hour Urine |
|
13685-3
|
3-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine |
|
29510-5
|
3-Hydroxyglutarate/Creatinine [Molar ratio] in Urine |
|
48759-5
|
3-Hydroxyhexanoate (3-OH-C6:0) [Moles/volume] in Serum or Plasma |
|
48758-7
|
3-Hydroxyhexanoate.free (3-OH-C6:0) [Moles/volume] in Serum or Plasma |
|
47818-0
|
3-Hydroxyhexanoate (3-OH-C6:0)/Creatinine [Molar ratio] in Urine |
|
53173-1
|
3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
|
30236-4
|
3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Serum or Plasma |
|
79510-4
|
3-Hydroxyhippurate [Moles/volume] in Serum or Plasma |
|
79501-3
|
3-Hydroxyhippurate/Creatinine [Molar ratio] in Urine |
|
69852-2
|
3-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
69853-0
|
3-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma |
|
27272-4
|
3-Hydroxyisobutyrate [Presence] in Urine |
|
49822-0
|
3-Hydroxyisobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13686-1
|
3-Hydroxyisobutyrate/Creatinine [Mass Ratio] in Urine |
|
29511-3
|
3-Hydroxyisobutyrate/Creatinine [Molar ratio] in Urine |
|
72449-2
|
3-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid |
|
72450-0
|
3-Hydroxyisovalerate [Moles/volume] in Serum or Plasma |
|
26685-8
|
3-Hydroxyisovalerate [Presence] in Urine |
|
1683-2
|
3-Hydroxyisovalerate [Mass/volume] in Urine |
|
49823-8
|
3-Hydroxyisovalerate/Creatinine [Molar ratio] in 24 hour Urine |
|
13687-9
|
3-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine |
|
29514-7
|
3-Hydroxyisovalerate/Creatinine [Molar ratio] in Urine |
|
50105-6
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid |
|
50104-9
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid |
|
50106-4
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
|
18444-0
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Mass/volume] in Serum or Plasma |
|
39001-3
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
50107-2
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Urine |
|
53171-5
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS |
|
53172-3
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
50252-6
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
|
51412-5
|
3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
74930-9
|
3-Hydroxykynurenin [Moles/volume] in Cerebral spinal fluid |
|
74430-0
|
3-Hydroxykynurenin [Moles/volume] in Serum or Plasma |
|
50111-4
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Amniotic fluid |
|
50110-6
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Cerebral spinal fluid |
|
50109-8
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS |
|
18464-8
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Mass/volume] in Serum or Plasma |
|
30237-2
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Serum or Plasma |
|
50108-0
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Urine |
|
50112-2
|
3-Hydroxylinoleoylcarnitine (C18:2-OH)/Creatinine [Molar ratio] in Urine |
|
48762-9
|
3-Hydroxymyristate (3-OH-C14:0) [Moles/volume] in Serum or Plasma |
|
48752-0
|
3-Hydroxymyristate.free (3-OH-C14:0) [Moles/volume] in Serum or Plasma |
|
50274-0
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Amniotic fluid |
|
50276-5
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Cerebral spinal fluid |
|
50275-7
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in DBS |
|
74604-0
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Enzymatic activity/mass] in Fibroblast |
|
50277-3
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma |
|
50273-2
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Urine |
|
50278-1
|
3-Hydroxymyristoleylcarnitine (C14:1-OH)/Creatinine [Molar ratio] in Urine |
|
48757-9
|
3-Hydroxyoctanoate (3-OH-C8:0) [Moles/volume] in Serum or Plasma |
|
48756-1
|
3-Hydroxyoctanoate.free (3-OH-C8:0) [Moles/volume] in Serum or Plasma |
|
53178-0
|
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
|
53179-8
|
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
53402-4
|
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS |
|
50115-5
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Amniotic fluid |
|
50114-8
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Cerebral spinal fluid |
|
50113-0
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS |
|
18465-5
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Mass/volume] in Serum or Plasma |
|
30312-3
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Serum or Plasma |
|
50116-3
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Urine |
|
50117-1
|
3-Hydroxyoleoylcarnitine (C18:1-OH)/Creatinine [Molar ratio] in Urine |
|
48761-1
|
3-Hydroxypalmitate (3-OH-C16:0) [Moles/volume] in Serum or Plasma |
|
48751-2
|
3-Hydroxypalmitate.free (3-OH-C16:0) [Moles/volume] in Serum or Plasma |
|
50120-5
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Amniotic fluid |
|
50119-7
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Cerebral spinal fluid |
|
50121-3
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS |
|
74599-2
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Enzymatic activity/mass] in Fibroblast |
|
30235-6
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Serum or Plasma |
|
50118-9
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Urine |
|
50122-1
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH)/Creatinine [Molar ratio] in Urine |
|
50126-2
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Amniotic fluid |
|
41041-5
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Blood |
|
50124-7
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Cerebral spinal fluid |
|
50125-4
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS |
|
74597-6
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Enzymatic activity/mass] in Fibroblast |
|
18461-4
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Mass/volume] in Serum or Plasma |
|
30234-9
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Serum or Plasma |
|
50123-9
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Urine |
|
53201-0
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
59196-6
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
|
50127-0
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Creatinine [Molar ratio] in Urine |
|
79491-7
|
3-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
44427-3
|
3-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
|
44426-5
|
3-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
50129-6
|
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Amniotic fluid |
|
50128-8
|
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Cerebral spinal fluid |
|
47536-8
|
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Plasma |
|
29625-1
|
3-Hydroxypropionate (3-OH-C3) [Presence] in Urine |
|
49824-6
|
3-Hydroxypropionate (3-OH-C3)/Creatinine [Molar ratio] in 24 hour Urine |
|
13688-7
|
3-Hydroxypropionate (3-OH-C3)/Creatinine [Mass Ratio] in Urine |
|
29515-4
|
3-Hydroxypropionate (3-OH-C3)/Creatinine [Molar ratio] in Urine |
|
72447-6
|
3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Cerebral spinal fluid |
|
72448-4
|
3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Serum or Plasma |
|
29626-9
|
3-Hydroxysebacate ( 3-OH-C8) [Presence] in Urine |
|
79525-2
|
3-Hydroxysebacate (3-OH-C8) unsaturated [Moles/volume] in Serum or Plasma |
|
49931-9
|
3-Hydroxysebacate (3-OH-C8) unsaturated/Creatinine [Molar ratio] in Urine |
|
47537-6
|
3-Hydroxysebacate ( 3-OH-C8)/Creatinine [Molar ratio] in Urine |
|
50133-8
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Amniotic fluid |
|
50131-2
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Cerebral spinal fluid |
|
50132-0
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS |
|
35656-8
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Serum or Plasma |
|
50130-4
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Urine |
|
50134-6
|
3-Hydroxystearoylcarnitine (C18-OH)/Creatinine [Molar ratio] in Urine |
|
72445-0
|
3-Hydroxysuberate [Moles/volume] in Cerebral spinal fluid |
|
72446-8
|
3-Hydroxysuberate [Moles/volume] in Serum or Plasma |
|
79493-3
|
3-Hydroxysuberate.unsaturated [Moles/volume] in Serum or Plasma |
|
49932-7
|
3-Hydroxysuberate.unsaturated/Creatinine [Molar ratio] in Urine |
|
47819-8
|
3-Hydroxysuberate/Creatinine [Molar ratio] in Urine |
|
48086-3
|
3-Hydroxytetradecadienedioate/Creatinine [Molar ratio] in Urine |
|
53196-2
|
3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS |
|
18458-0
|
3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Mass/volume] in Serum or Plasma |
|
72444-3
|
3-Hydroxytetradecanedioate [Moles/volume] in Serum or Plasma |
|
48087-1
|
3-Hydroxytetradecanedioate/Creatinine [Molar ratio] in Urine |
|
50282-3
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Amniotic fluid |
|
50280-7
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Cerebral spinal fluid |
|
50281-5
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS |
|
74602-4
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Enzymatic activity/mass] in Fibroblast |
|
30238-0
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Serum or Plasma |
|
50279-9
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Urine |
|
50284-9
|
3-Hydroxytetradecanoylcarnitine (C14-OH)/Creatinine [Molar ratio] in Urine |
|
48088-9
|
3-Hydroxytetradecenedioate/Creatinine [Molar ratio] in Urine |
|
53197-0
|
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS |
|
18459-8
|
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Mass/volume] in Serum or Plasma |
|
30190-3
|
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma |
|
79269-7
|
3-Hydroxytrimethyl-L-lysine [Moles/volume] in Cerebral spinal fluid |
|
79270-5
|
3-Hydroxytrimethyl-L-lysine [Moles/volume] in DBS |
|
79268-9
|
3-Hydroxytrimethyl-L-lysine [Moles/volume] in Serum or Plasma |
|
79271-3
|
3-Hydroxytrimethyl-L-lysine/Creatinine [Molar ratio] in Urine |
|
79272-1
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid |
|
79273-9
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in DBS |
|
79274-7
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Serum or Plasma |
|
79275-4
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Urine |
|
50098-3
|
3-Hydroxyvalerate [Moles/volume] in Cerebral spinal fluid |
|
47820-6
|
3-Hydroxyvalerate [Moles/volume] in Plasma |
|
29627-7
|
3-Hydroxyvalerate [Presence] in Urine |
|
13689-5
|
3-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine |
|
29516-2
|
3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
|
53488-3
|
3-O-Methyldopa [Moles/volume] in 24 hour Urine |
|
53097-2
|
3-O-Methyldopa [Moles/time] in 24 hour Urine |
|
34596-7
|
3-O-Methyldopa [Moles/volume] in Cerebral spinal fluid |
|
11229-2
|
3-O-Methyldopa [Mass/volume] in Serum or Plasma |
|
50141-1
|
3-O-Methyldopa [Moles/volume] in Serum or Plasma |
|
50142-9
|
3-O-Methyldopa [Moles/volume] in Urine |
|
50143-7
|
3-O-Methyldopa [Moles/time] in Urine |
|
50144-5
|
3-O-Methyldopa/Creatinine [Molar ratio] in Urine |
|
48133-3
|
3-Oxovalerate [Moles/volume] in Plasma |
|
78982-6
|
D-3-phosphoglycerate dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
85095-8
|
D-3-phosphoglycerate dehydrogenase IgG Ab [Presence] in Serum by Line blot |
|
88099-7
|
Third degree burn area/Body surface area [Area/Area] Estimated |
|
64119-1
|
Third most predominant hemoglobin in DBS |
|
92878-8
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
92879-6
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
83169-3
|
Walk 4 meters at usual pace - trial 1 [Time] [NIH Toolbox] |
|
83170-1
|
Walk 4 meters at usual pace - trial 2 [Time] [NIH Toolbox] |
|
83172-7
|
4-Meter Walk Gait Speed Test - computed score [NIH Toolbox] |
|
83144-6
|
4-Meter Walk Gait Speed Test [NIH Toolbox] |
|
89417-0
|
4 steps - functional ability [CMS Assessment] |
|
83194-1
|
4 steps - functional ability during 3 day assessment period [CMS Assessment] |
|
89416-2
|
4 steps - functional goal [CMS Assessment] |
|
83193-3
|
4 steps - functional goal during 3 day assessment period [CMS Assessment] |
|
38746-4
|
4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Air |
|
10913-2
|
4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine |
|
38748-0
|
Methylenedianiline [Mass/volume] in Air |
|
17272-6
|
Methylenedianiline [Mass/volume] in Blood |
|
33646-1
|
Methylenedianiline [Mass/volume] in Serum or Plasma |
|
27409-2
|
Methylenedianiline [Mass/volume] in Urine |
|
72435-1
|
4,5-Dihydroxyhexanoate [Moles/volume] in Serum or Plasma |
|
48137-4
|
4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine |
|
72434-4
|
4,5-Dihydroxyhexanolactone [Moles/volume] in Serum or Plasma |
|
48106-9
|
4,5-Dihydroxyhexanolactone/Creatinine [Molar ratio] in Urine |
|
38690-4
|
4,6-Dinitro-O-Cresol [Mass/volume] in Air |
|
38632-6
|
4-Biphenylamine [Mass/volume] in Air |
|
79520-3
|
4-Deoxythreonate [Moles/volume] in Serum or Plasma |
|
79527-8
|
4-Deoxythreonate/Creatinine [Molar ratio] in Urine |
|
86195-5
|
4-Ethylmethcathinone [Mass/volume] in Urine by Confirmatory method |
|
93469-5
|
4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
93464-6
|
p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method |
|
86192-2
|
4-Methylethcathinone [Mass/volume] in Urine by Confirmatory method |
|
93461-2
|
4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
93472-9
|
4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
78983-4
|
4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Cerebral spinal fluid |
|
79505-4
|
4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Serum or Plasma |
|
47823-0
|
4-Hydroxy-3-Methoxyphenyllactate/Creatinine [Molar ratio] in Urine |
|
90749-3
|
4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
43733-5
|
4-Hydroxybenzoate [Presence] in 24 hour Urine |
|
75075-2
|
4-Hydroxybenzoate [Moles/volume] in Serum or Plasma |
|
43732-7
|
4-Hydroxybenzoate [Presence] in Urine |
|
47541-8
|
4-Hydroxybenzoate/Creatinine [Molar ratio] in Urine |
|
51189-9
|
4-Hydroxybupivacaine [Mass/volume] in Serum or Plasma |
|
74109-0
|
4-hydroxycoumarins [Presence] in Unspecified specimen by Screen method |
|
29869-5
|
4-Hydroxycyclohexylacetate [Presence] in Urine |
|
79178-0
|
4-Hydroxycyclohexylacetate/Creatinine [Molar ratio] in Urine |
|
93772-2
|
4-hydroxyglutamate/Creatinine [Molar ratio] in Urine |
|
13544-2
|
4-Hydroxyglutethimide [Presence] in Serum or Plasma |
|
35637-8
|
4-Hydroxyglutethimide [Mass/volume] in Serum or Plasma by Screen method |
|
79503-9
|
4-Hydroxyhippurate [Moles/volume] in Serum or Plasma |
|
79498-2
|
4-Hydroxyhippurate/Creatinine [Molar ratio] in Urine |
|
50293-0
|
4-Hydroxyifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
|
50294-8
|
4-Hydroxyifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
|
50295-5
|
4-Hydroxyifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
|
50298-9
|
4-Hydroxyifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
|
50296-3
|
4-Hydroxyifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
|
50297-1
|
4-Hydroxyifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide |
|
50299-7
|
4-Hydroxyifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
|
50292-2
|
4-Hydroxyifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
|
79508-8
|
4-Hydroxymandelate [Moles/volume] in Serum or Plasma |
|
44861-3
|
4-Hydroxymandelate/Creatinine [Mass Ratio] in Urine |
|
47543-4
|
4-Hydroxymandelate/Creatinine [Molar ratio] in Urine |
|
79132-7
|
4-Hydroxymidazolam [Mass/volume] in Body fluid |
|
54402-3
|
4-Hydroxymidazolam [Mass/volume] in Serum or Plasma |
|
78758-0
|
4-Hydroxymidazolam [Mass/volume] in Urine |
|
72431-0
|
4-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
|
72432-8
|
4-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
27270-8
|
4-Hydroxyphenylacetate [Presence] in Urine |
|
13696-0
|
4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
|
28585-8
|
4-Hydroxyphenylacetate/Creatinine [Ratio] in Urine |
|
25088-6
|
4-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
72429-4
|
4-Hydroxyphenyllactate [Moles/volume] in Cerebral spinal fluid |
|
72430-2
|
4-Hydroxyphenyllactate [Moles/volume] in Serum or Plasma |
|
29870-3
|
4-Hydroxyphenyllactate [Presence] in Urine |
|
13697-8
|
4-Hydroxyphenyllactate/Creatinine [Mass Ratio] in Urine |
|
28586-6
|
4-Hydroxyphenyllactate/Creatinine [Ratio] in Urine |
|
25089-4
|
4-Hydroxyphenyllactate/Creatinine [Molar ratio] in Urine |
|
72427-8
|
4-Hydroxyphenylpyruvate [Moles/volume] in Cerebral spinal fluid |
|
72428-6
|
4-Hydroxyphenylpyruvate [Moles/volume] in Serum or Plasma |
|
29871-1
|
4-Hydroxyphenylpyruvate [Presence] in Urine |
|
13698-6
|
4-Hydroxyphenylpyruvate/Creatinine [Mass Ratio] in Urine |
|
29519-6
|
4-Hydroxyphenylpyruvate/Creatinine [Molar ratio] in Urine |
|
59346-7
|
4-Hydroxy-Tamoxifen [Mass/volume] in Blood |
|
59350-9
|
4-Hydroxy-Tamoxifen [Mass/volume] in Serum or Plasma |
|
79502-1
|
4-Hydroxyvalerate [Moles/volume] in Serum or Plasma |
|
79485-9
|
4-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
|
73749-4
|
4p16.3 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
1688-1
|
4-Pyridoxate [Mass/volume] in Serum or Plasma |
|
78201-1
|
4q12 chromosome region rearrangements [Identifier] in Blood or Tissue by FISH Nominal |
|
78206-0
|
4q12 chromosome region rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
92936-4
|
4q25 g.111710169C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
92935-6
|
4q25 g.111720761T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
35586-7
|
4-Tert-Butylphenol [Mass/volume] in Urine |
|
88100-3
|
Fourth degree burn area/Body surface area [Area/Area] Estimated |
|
64120-9
|
Fourth most predominant hemoglobin in DBS |
|
54429-6
|
5% plasma protein fraction given [Volume] |
|
79693-8
|
5,6-Dihydrouracil [Moles/volume] in Cerebral spinal fluid |
|
79682-1
|
5,6-Dihydrouracil [Moles/volume] in Serum or Plasma |
|
79685-4
|
5,6-Dihydrouracil/Creatinine [Molar ratio] in Urine |
|
79676-3
|
5,6-Dihydrouridine [Moles/volume] in Cerebral spinal fluid |
|
79667-2
|
5,6-Dihydrouridine [Moles/volume] in Serum or Plasma |
|
79678-9
|
5,6-Dihydrouridine/Creatinine [Molar ratio] in Urine |
|
44862-1
|
5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine |
|
21044-3
|
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine |
|
57619-9
|
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57620-7
|
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57615-7
|
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57616-5
|
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57617-3
|
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57618-1
|
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57613-2
|
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57614-0
|
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
79652-4
|
5-Aminoimidazole-4-carboxamide [Moles/volume] in Cerebral spinal fluid |
|
79679-7
|
5-Aminoimidazole-4-carboxamide [Moles/volume] in Serum or Plasma |
|
79672-2
|
5-Aminoimidazole-4-carboxamide/Creatinine [Moles/volume] in Urine |
|
80161-3
|
5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine [Ratio] in Urine |
|
80160-5
|
5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine [Ratio] in Urine |
|
43722-8
|
5-Ethyl-5-Phenylhydantoin [Presence] in Unspecified specimen |
|
90746-9
|
5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
88022-9
|
5-F PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
4102-0
|
5-Fluorocytosine [Mass] of Dose |
|
7014-4
|
5-Fluorocytosine [Susceptibility] by Gradient strip |
|
254-3
|
5-Fluorocytosine [Susceptibility] by Disk diffusion (KB) |
|
253-5
|
5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
252-7
|
5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) |
|
25142-1
|
5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak |
|
3639-2
|
5-Fluorocytosine [Mass/volume] in Serum or Plasma |
|
46218-4
|
5-Fluorocytosine [Moles/volume] in Serum or Plasma |
|
18855-7
|
5-Fluorocytosine [Susceptibility] |
|
255-0
|
5-Fluorocytosine [Susceptibility] by Serum bactericidal titer |
|
25143-9
|
5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough |
|
10974-4
|
5-Fluorocytosine [Mass/volume] in Urine |
|
23805-5
|
5-Fluorocytosine [Mass/volume] in Unspecified specimen |
|
44909-0
|
5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine |
|
32411-1
|
5 minute Apgar Color |
|
32412-9
|
5 minute Apgar Heart rate |
|
32413-7
|
5 minute Apgar Muscle tone |
|
32414-5
|
5 minute Apgar Reflex irritability |
|
32415-2
|
5 minute Apgar Respiratory effort |
|
9274-2
|
5 minute Apgar Score |
|
33274-2
|
5-Methyltetrahydrofolate [Presence] in Cerebral spinal fluid |
|
34637-9
|
5-Methyltetrahydrofolate [Mass/volume] in Cerebral spinal fluid |
|
47547-5
|
5-Methyltetrahydrofolate [Moles/volume] in Cerebral spinal fluid |
|
50153-6
|
5-Methyltetrahydrofolate [Moles/volume] in Serum or Plasma |
|
50039-7
|
5-Methyltetrahydrofolate/Folate in Serum or Plasma |
|
1696-4
|
5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum |
|
1689-9
|
5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid |
|
1690-7
|
5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
|
72426-0
|
5-Hydroxyhexanoate [Moles/volume] in Serum or Plasma |
|
44287-1
|
5-Hydroxyhexanoate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13699-4
|
5-Hydroxyhexanoate/Creatinine [Mass Ratio] in Urine |
|
29521-2
|
5-Hydroxyhexanoate/Creatinine [Molar ratio] in Urine |
|
12172-3
|
5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
|
31203-3
|
5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine |
|
1695-6
|
5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
|
25971-3
|
5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine |
|
14573-0
|
5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
|
1692-3
|
5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
|
47544-2
|
5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid |
|
74769-1
|
5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma |
|
1693-1
|
5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma |
|
50149-4
|
5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma |
|
72820-4
|
5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method |
|
48168-9
|
5-Hydroxyindoleacetate [Presence] in Urine |
|
1694-9
|
5-Hydroxyindoleacetate [Mass/volume] in Urine |
|
15009-4
|
5-Hydroxyindoleacetate [Moles/volume] in Urine |
|
44288-9
|
5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine |
|
47545-9
|
5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
11145-0
|
5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine |
|
29520-4
|
5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine |
|
79528-6
|
5-Hydroxymethyl-2-Furoate [Moles/volume] in Serum or Plasma |
|
44836-5
|
5-Hydroxymethyl-2-Furoate [Presence] in Urine |
|
79477-6
|
5-Hydroxymethyl-2-Furoate/Creatinine [Molar ratio] in Urine |
|
79686-2
|
5-Hydroxymethyluracil [Moles/volume] in Cerebral spinal fluid |
|
79688-8
|
5-Hydroxymethyluracil [Moles/volume] in Serum or Plasma |
|
78690-5
|
5-Hydroxymethyluracil/Creatinine [Molar ratio] in Urine |
|
26046-3
|
5-Hydroxypropafenone [Moles/volume] in Serum or Plasma |
|
58794-9
|
5-Hydroxytryptophan [Mass/volume] in 24 hour Urine |
|
21045-0
|
5-Hydroxytryptophan [Mass/time] in 24 hour Urine |
|
53497-4
|
5-Hydroxytryptophan [Moles/volume] in 24 hour Urine |
|
56663-8
|
5-Hydroxytryptophan [Moles/time] in 24 hour Urine |
|
47546-7
|
5-Hydroxytryptophan [Moles/volume] in Cerebral spinal fluid |
|
74768-3
|
5-Hydroxytryptophan [Moles/volume] in Platelet rich plasma |
|
50150-2
|
5-Hydroxytryptophan [Moles/volume] in Serum or Plasma |
|
56525-9
|
5-Hydroxytryptophan [Mass/volume] in Urine |
|
50151-0
|
5-Hydroxytryptophan [Moles/volume] in Urine |
|
53110-3
|
5-Hydroxytryptophan/Creatinine [Molar ratio] in 24 hour Urine |
|
50152-8
|
5-Hydroxytryptophan/Creatinine [Molar ratio] in Urine |
|
43633-7
|
5-Oxoproline [Presence] in 24 hour Urine |
|
75089-3
|
5-Oxoproline [Moles/volume] in Serum or Plasma |
|
29872-9
|
5-Oxoproline [Presence] in Urine |
|
13700-0
|
5-Oxoproline/Creatinine [Mass Ratio] in Urine |
|
29522-0
|
5-Oxoproline/Creatinine [Molar ratio] in Urine |
|
53232-5
|
5-Oxoproline+Pipecolate [Moles/volume] in DBS |
|
53394-3
|
5-Oxoproline+Pipecolate/Phenylalanine [Molar ratio] in DBS |
|
73751-0
|
5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
79624-3
|
5-S-cysteinyldopa [Moles/volume] in Serum or Plasma |
|
79643-3
|
5-S-cysteinyldopa/Creatinine [Molar ratio] in Urine |
|
64121-7
|
Fifth most predominant hemoglobin in DBS |
|
60514-7
|
6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method |
|
57611-6
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57612-4
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57607-4
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57608-2
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57609-0
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57610-8
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57605-8
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57606-6
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
44863-9
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine |
|
57603-3
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57604-1
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57599-3
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57600-9
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57601-7
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57602-5
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57597-7
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57598-5
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
44864-7
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine [Mass Ratio] in Urine |
|
87824-9
|
6-Beta naltrexol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
82526-5
|
6-Beta naltrexol [Mass/volume] in Serum or Plasma |
|
82524-0
|
6-Beta naltrexol [Mass/volume] in Urine by Confirmatory method |
|
82527-3
|
6-Beta naltrexol/Creatinine [Mass Ratio] in Urine |
|
13611-9
|
6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine |
|
80115-9
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method |
|
78759-8
|
6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method |
|
77755-7
|
6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19324-3
|
6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method |
|
19323-5
|
6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method |
|
80116-7
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Body fluid by Confirmatory method |
|
78760-6
|
6-Monoacetylmorphine (6-MAM) [Presence] in Body fluid by Screen method |
|
73941-7
|
6-monoacetylmorphine free [Mass/volume] in Blood |
|
16248-7
|
6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method |
|
46263-0
|
6-monoacetylmorphine free [Presence] in Serum or Plasma |
|
49749-5
|
6-monoacetylmorphine free [Mass/volume] in Serum or Plasma |
|
47004-7
|
6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method |
|
51740-9
|
6-monoacetylmorphine free [Mass/volume] in Urine |
|
14843-7
|
6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
|
26721-1
|
6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair |
|
29345-6
|
6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium |
|
72763-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74677-6
|
6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method |
|
87816-5
|
6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method |
|
57300-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) |
|
14844-5
|
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
|
43184-1
|
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method |
|
18343-4
|
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method |
|
74130-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood |
|
12788-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma |
|
19593-3
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
|
70197-9
|
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method |
|
10976-9
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
|
19322-7
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method |
|
19321-9
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method |
|
10975-1
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine |
|
55520-1
|
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine |
|
32099-4
|
6-Monoacetylmorphine (6-MAM) [Presence] in Unspecified specimen |
|
58384-9
|
6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine |
|
32654-6
|
6-Methylmercaptopurine [Entitic substance] in Red Blood Cells |
|
43631-1
|
6-Methylmercaptopurine metabolite [Presence] in Red Blood Cells |
|
43632-9
|
6-Methylmercaptopurine [Presence] in Red Blood Cells |
|
50300-3
|
6-Hydroxyheptanoate [Moles/volume] in Urine |
|
76065-2
|
6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy in Blood or Tissue by FISH |
|
1697-2
|
6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
48998-9
|
6-Phosphogluconate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
|
32660-3
|
6-Thioguanine [Entitic substance] in Red Blood Cells |
|
43630-3
|
6-Thioguanine [Presence] in Red Blood Cells |
|
79276-2
|
7,8-Dihydrobiopterin [Moles/volume] in Cerebral spinal fluid |
|
92759-0
|
7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in Blood |
|
92760-8
|
7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in DBS |
|
92758-2
|
7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in Serum or Plasma |
|
59592-6
|
7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method |
|
59591-8
|
7-Aminoclonazepam [Mass/volume] in Blood |
|
77756-5
|
7-Aminoclonazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
59594-2
|
7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59593-4
|
7-Aminoclonazepam [Mass/volume] in Body fluid |
|
61070-9
|
7-Aminoclonazepam [Presence] in Gastric fluid |
|
78761-4
|
7-Aminoclonazepam [Mass/mass] in Hair |
|
73563-9
|
7-Aminoclonazepam [Mass/mass] in Meconium by Confirmatory method |
|
59595-9
|
7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61029-5
|
7-Aminoclonazepam [Presence] in Serum or Plasma |
|
28059-4
|
7-Aminoclonazepam [Mass/volume] in Serum or Plasma |
|
59597-5
|
7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method |
|
59596-7
|
7-Aminoclonazepam [Mass/mass] in Tissue |
|
51776-3
|
7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method |
|
61030-3
|
7-Aminoclonazepam [Presence] in Urine |
|
58365-8
|
7-Aminoclonazepam [Presence] in Urine by Confirmatory method |
|
94112-0
|
7-Aminoclonazepam [Presence] in Urine by Screen method |
|
28073-5
|
7-Aminoclonazepam [Mass/volume] in Urine |
|
61031-1
|
7-Aminoclonazepam [Presence] in Unspecified specimen |
|
58364-1
|
7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine |
|
80117-5
|
7-Aminoflunitrazepam [Mass/volume] in Body fluid by Confirmatory method |
|
61071-7
|
7-Aminoflunitrazepam [Presence] in Gastric fluid |
|
78762-2
|
7-Aminoflunitrazepam [Mass/mass] in Hair |
|
61032-9
|
7-Aminoflunitrazepam [Presence] in Serum or Plasma |
|
73829-4
|
7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood |
|
21046-8
|
7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma |
|
51777-1
|
7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method |
|
61033-7
|
7-Aminoflunitrazepam [Presence] in Urine |
|
94111-2
|
7-Aminoflunitrazepam [Presence] in Urine by Screen method |
|
27084-3
|
7-Aminoflunitrazepam [Mass/volume] in Urine |
|
61034-5
|
7-Aminoflunitrazepam [Presence] in Unspecified specimen |
|
57303-0
|
7-Aminonitrazepam [Mass/volume] in Saliva (oral fluid) |
|
31182-9
|
7-Aminonitrazepam [Mass/volume] in Serum or Plasma |
|
92762-4
|
7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in Blood |
|
92763-2
|
7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in DBS |
|
92761-6
|
7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in Serum or Plasma |
|
40597-7
|
7-Dehydrocholesterol [Presence] in Amniotic fluid |
|
48610-0
|
7-Dehydrocholesterol [Mass/volume] in Amniotic fluid |
|
46700-1
|
7-Dehydrocholesterol [Moles/volume] in Amniotic fluid |
|
50799-6
|
7-Dehydrocholesterol [Moles/volume] in Body fluid |
|
22676-1
|
7-Dehydrocholesterol [Presence] in Serum or Plasma |
|
33275-9
|
7-Dehydrocholesterol [Mass/volume] in Serum or Plasma |
|
32289-1
|
7-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
|
79323-2
|
7-Isobiopterin/Creatinine [Molar ratio] in Urine |
|
92764-0
|
7-Ketocholesterol [Moles/volume] in Serum or Plasma |
|
79277-0
|
7-lathosterol [Moles/volume] in Serum or Plasma |
|
89976-5
|
7-Hydroxychlorpromazine [Mass/volume] in Urine by Confirmatory method |
|
89977-3
|
7-Hydroxychlorpromazine [Presence] in Urine by Screen method |
|
89973-2
|
7-Hydroxyfluphenazine [Mass/volume] in Urine by Confirmatory method |
|
89974-0
|
7-Hydroxyfluphenazine [Presence] in Urine by Screen method |
|
72731-3
|
7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method |
|
75643-7
|
7-Hydroxymitragynine [Presence] in Urine by Confirmatory method |
|
72729-7
|
7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine |
|
72425-2
|
7-Hydroxyoctanoate [Moles/volume] in Serum or Plasma |
|
47825-5
|
7-Hydroxyoctanoate/Creatinine [Molar ratio] in Urine |
|
78764-8
|
7-Hydroxyquetiapine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
77758-1
|
7-Hydroxyquetiapine cutoff [Mass/volume] in Urine for Confirmatory method |
|
77757-3
|
7-Hydroxyquetiapine [Mass/volume] in Urine by Confirmatory method |
|
78918-0
|
7-Hydroxyquetiapine [Z-score] in Urine |
|
76022-3
|
8(9)-Cholestenol [Moles/volume] in Serum or Plasma |
|
34671-8
|
8-Dehydrocholesterol [Mass/volume] in Serum or Plasma |
|
56535-8
|
8-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
|
79278-8
|
8-lathosterol [Moles/volume] in Serum or Plasma |
|
43629-5
|
8-Hydroxyamoxapine [Presence] in Serum or Plasma |
|
1698-0
|
8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
|
14574-8
|
8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
|
75226-1
|
8-Hydroxyamoxapine [Presence] in Urine |
|
18360-8
|
8-Hydroxyamoxapine [Mass/volume] in Urine |
|
59265-9
|
8-Hydroxydeoxyguanosine/Creatinine [Mass Ratio] in Urine |
|
34575-1
|
8-Hydroxyloxapine [Presence] in Serum, Plasma or Blood |
|
9696-6
|
8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
|
89971-6
|
8-Hydroxyloxapine [Presence] in Urine by Screen method |
|
21047-6
|
8-Hydroxyloxapine [Mass/volume] in Urine |
|
87777-9
|
8-Hydroxyloxapine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
84427-4
|
9-Hole Pegboard Dexterity - unadjusted scale score Hand.dominant [NIH Toolbox] |
|
60115-3
|
9-Hydroxyrisperidone [Mass/volume] in Blood |
|
77759-9
|
9-Hydroxyrisperidone cutoff [Mass/volume] in Urine for Confirmatory method |
|
79133-5
|
9-Hydroxyrisperidone [Mass/volume] in Body fluid |
|
78771-3
|
9-Hydroxyrisperidone [Mass/mass] in Hair |
|
89982-3
|
9-Hydroxyrisperidone [Presence] in Serum or Plasma by Screen method |
|
9383-1
|
9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma |
|
39455-1
|
9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma |
|
92654-3
|
9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method |
|
90471-4
|
9-Hydroxyrisperidone [Presence] in Urine by Screen method |
|
60116-1
|
9-Hydroxyrisperidone [Mass/volume] in Urine |
|
57906-0
|
9p21 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
92934-9
|
9p21 g.22124478A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
92933-1
|
9p21 g.22125503G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
78207-8
|
9q34 chromosome region deletion [Interpretation] in Blood or Tissue by FISH Narrative |
|
78202-9
|
9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH |
|
44076-8
|
Alpha tocopherol and Beta+gamma tocopherol [Interpretation] in Serum or Plasma |
|
49245-4
|
Alpha tocopherol and Beta+gamma tocopherol [Interpretation] in Serum or Plasma Narrative |
|
815-1
|
A Ab [Presence] in Serum or Plasma from Blood product unit |
|
816-9
|
A Ab [Presence] in Serum or Plasma from Donor |
|
817-7
|
A Ab [Presence] in Serum or Plasma |
|
30314-9
|
A Ab [Titer] in Serum or Plasma |
|
38358-8
|
A Ab [Titer] in Serum or Plasma by Antihuman globulin |
|
38359-6
|
A Ab [Titer] in Serum or Plasma by Immediate spin |
|
818-5
|
A Ag [Presence] on Red Blood Cells from Blood product unit |
|
819-3
|
A Ag [Presence] on Red Blood Cells from Donor |
|
820-1
|
A Ag [Presence] on Red Blood Cells |
|
58774-1
|
Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Units/volume] in Serum |
|
82021-7
|
Alternaria alternata recombinant (rAlt a) 1 IgE Ab RAST class [Presence] in Serum |
|
64977-2
|
Alternaria alternata recombinant (rAlt a) 6 IgE Ab [Units/volume] in Serum |
|
45163-3
|
Alternaria alternata Ab [Presence] in Serum |
|
57033-3
|
Alternaria alternata Ab [Presence] in Serum by Immune diffusion (ID) |
|
39578-0
|
Alternaria alternata Ab [Mass/volume] in Serum |
|
7077-1
|
Alternaria alternata triggered histamine release [Units/volume] in Blood |
|
6020-2
|
Alternaria alternata IgE Ab [Units/volume] in Serum |
|
15530-9
|
Alternaria alternata IgE Ab RAST class [Presence] in Serum |
|
40996-1
|
Alternaria alternata IgE Ab/IgE total in Serum |
|
51540-3
|
Alternaria alternata IgG Ab [Presence] in Serum |
|
7076-3
|
Alternaria alternata IgG Ab [Units/volume] in Serum |
|
21065-8
|
Alternaria alternata IgG Ab RAST class [Presence] in Serum |
|
26951-4
|
Alternaria alternata IgG Ab [Mass/volume] in Serum |
|
26403-6
|
Alternaria alternata IgG4 Ab [Units/volume] in Serum |
|
26404-4
|
Alternaria alternata IgG4 Ab RAST class [Presence] in Serum |
|
56170-4
|
Alternaria alternata IgG4 Ab [Mass/volume] in Serum |
|
48239-8
|
Alternaria alternata triggered leukotriene release [Mass/volume] by Leukocytes |
|
30037-6
|
Alternaria alternata+American house dust mite IgE Ab [Presence] in Serum by Multidisk |
|
30031-9
|
Alternaria alternata+American house dust mite IgG Ab [Presence] in Serum by Multidisk |
|
63196-0
|
Alternaria alternata+American house dust mite IgG Ab [Mass/volume] in Serum by Multidisk |
|
16414-5
|
Aspergillus amstelodami Ab [Units/volume] in Serum |
|
6023-6
|
Aspergillus amstelodami IgE Ab [Units/volume] in Serum |
|
63168-9
|
Aspergillus amstelodami IgG Ab [Mass/volume] in Serum |
|
92989-3
|
Acinetobacter baumannii DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85770-6
|
Acinetobacter baumannii DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93406-7
|
Acinetobacter baumannii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92988-5
|
Acinetobacter baumannii DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61360-4
|
Acinetobacter baumannii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43621-2
|
Actinomyces bovis Ab [Presence] in Serum |
|
43094-2
|
Angiostrongylus cantonensis Ab [Presence] in Unspecified specimen |
|
41411-0
|
Angiostrongylus cantonensis Ab [Presence] in Unspecified specimen by Immunoblot |
|
41430-0
|
Angiostrongylus cantonensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91667-6
|
Aspergillus clavatus Ab [Units/volume] in Serum |
|
31228-0
|
Aspergillus clavatus Ab [Presence] in Serum |
|
24507-6
|
Aspergillus clavatus Ab [Presence] in Serum by Immune diffusion (ID) |
|
26669-2
|
Absidia corymbifera Ab [Presence] in Serum |
|
43093-4
|
Angiostrongylus costaricensis Ab [Presence] in Serum |
|
41412-8
|
Angiostrongylus costaricensis Ab [Presence] in Serum by Agglutination |
|
41431-8
|
Angiostrongylus costaricensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32662-9
|
Afipia felis IgG Ab [Presence] in Serum |
|
31218-1
|
Afipia felis IgG Ab [Units/volume] in Serum |
|
22081-4
|
Afipia felis IgG Ab [Titer] in Serum |
|
9582-8
|
Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence |
|
32663-7
|
Afipia felis IgM Ab [Presence] in Serum |
|
31219-9
|
Afipia felis IgM Ab [Units/volume] in Serum |
|
22082-2
|
Afipia felis IgM Ab [Titer] in Serum |
|
9583-6
|
Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence |
|
16415-2
|
Aspergillus flavus Ab [Presence] in Cerebral spinal fluid |
|
21084-9
|
Aspergillus flavus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
13193-8
|
Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid |
|
31229-8
|
Aspergillus flavus Ab [Presence] in Body fluid |
|
27377-1
|
Aspergillus flavus Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
9490-4
|
Aspergillus flavus Ab [Presence] in Serum |
|
23820-4
|
Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31230-6
|
Aspergillus flavus Ab [Units/volume] in Serum |
|
43090-0
|
Aspergillus flavus Ab [Titer] in Serum |
|
27309-4
|
Aspergillus flavus Ab [Titer] in Serum by Immune diffusion (ID) |
|
47421-3
|
Aspergillus flavus B Ab [Presence] in Serum |
|
44025-5
|
Aspergillus flavus B Ab [Presence] in Serum by Immune diffusion (ID) |
|
47422-1
|
Aspergillus flavus H Ab [Presence] in Serum |
|
44026-3
|
Aspergillus flavus H Ab [Presence] in Serum by Immune diffusion (ID) |
|
6024-4
|
Aspergillus flavus IgE Ab [Units/volume] in Serum |
|
82020-9
|
Aspergillus flavus IgE Ab RAST class [Presence] in Serum |
|
19725-1
|
Aspergillus flavus IgG Ab [Presence] in Serum |
|
30986-4
|
Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Units/volume] in Serum |
|
51568-4
|
Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab RAST class [Presence] in Serum |
|
30990-6
|
Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Units/volume] in Serum |
|
51569-2
|
Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab RAST class [Presence] in Serum |
|
30991-4
|
Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Units/volume] in Serum |
|
51570-0
|
Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab RAST class [Presence] in Serum |
|
30992-2
|
Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Units/volume] in Serum |
|
51571-8
|
Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab RAST class [Presence] in Serum |
|
30993-0
|
Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Units/volume] in Serum |
|
51572-6
|
Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab RAST class [Presence] in Serum |
|
18468-9
|
Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid |
|
21085-6
|
Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
40828-6
|
Aspergillus fumigatus Ab [Presence] in Body fluid |
|
27375-5
|
Aspergillus fumigatus Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
9632-1
|
Aspergillus fumigatus Ab [Presence] in Serum |
|
23821-2
|
Aspergillus fumigatus Ab [Presence] in Serum by Immune diffusion (ID) |
|
5050-0
|
Aspergillus fumigatus Ab [Units/volume] in Serum |
|
54435-3
|
Aspergillus fumigatus Ab [Titer] in Serum |
|
10645-0
|
Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
|
47423-9
|
Aspergillus fumigatus B Ab [Presence] in Serum |
|
44027-1
|
Aspergillus fumigatus B Ab [Presence] in Serum by Immune diffusion (ID) |
|
7104-3
|
Aspergillus fumigatus triggered histamine release [Units/volume] in Blood |
|
62478-3
|
Aspergillus fumigatus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47424-7
|
Aspergillus fumigatus H Ab [Presence] in Serum |
|
44028-9
|
Aspergillus fumigatus H Ab [Presence] in Serum by Immune diffusion (ID) |
|
6025-1
|
Aspergillus fumigatus IgE Ab [Units/volume] in Serum |
|
15549-9
|
Aspergillus fumigatus IgE Ab RAST class [Presence] in Serum |
|
38438-8
|
Aspergillus fumigatus IgE Ab/IgE total in Serum |
|
7103-5
|
Aspergillus fumigatus IgG Ab [Units/volume] in Serum |
|
24162-0
|
Aspergillus fumigatus IgG Ab RAST class [Presence] in Serum |
|
19726-9
|
Aspergillus fumigatus IgG Ab [Presence] in Serum |
|
26954-8
|
Aspergillus fumigatus IgG Ab [Mass/volume] in Serum |
|
26405-1
|
Aspergillus fumigatus IgG4 Ab [Units/volume] in Serum |
|
26406-9
|
Aspergillus fumigatus IgG4 Ab RAST class [Presence] in Serum |
|
56180-3
|
Aspergillus fumigatus IgG4 Ab [Mass/volume] in Serum |
|
42579-3
|
Aspergillus fumigatus IgM Ab [Units/volume] in Serum |
|
48241-4
|
Aspergillus fumigatus triggered leukotriene release [Mass/volume] by Leukocytes |
|
44045-3
|
Aspergillus fumigatus O Ab [Presence] in Serum |
|
11030-4
|
Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum |
|
42486-1
|
Aspergillus fumigatus 1 Ab [Presence] in Cerebral spinal fluid |
|
11583-2
|
Aspergillus fumigatus 1 Ab [Presence] in Serum |
|
6808-0
|
Aspergillus fumigatus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
|
44438-0
|
Aspergillus fumigatus 1 Ab [Units/volume] in Serum |
|
29334-0
|
Aspergillus fumigatus 2 Ab [Presence] in Serum |
|
30036-8
|
Aspergillus fumigatus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
|
22085-5
|
Aspergillus fumigatus 3 Ab [Presence] in Serum |
|
15151-4
|
Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
|
44439-8
|
Aspergillus fumigatus 3 Ab [Units/volume] in Serum |
|
42487-9
|
Aspergillus fumigatus 6 Ab [Presence] in Cerebral spinal fluid |
|
11592-3
|
Aspergillus fumigatus 6 Ab [Presence] in Serum |
|
6809-8
|
Aspergillus fumigatus 6 Ab [Presence] in Serum by Immune diffusion (ID) |
|
44440-6
|
Aspergillus fumigatus 6 Ab [Units/volume] in Serum |
|
46157-4
|
Aspergillus glaucus Ab [Presence] in Serum |
|
43823-4
|
Aspergillus glaucus Ab [Presence] in Serum by Immune diffusion (ID) |
|
13194-6
|
Aspergillus glaucus Ab [Units/volume] in Serum |
|
80610-9
|
A IgG Ab [Presence] in Serum or Plasma |
|
50761-6
|
A IgG Ab [Titer] in Serum or Plasma |
|
50762-4
|
A IgM Ab [Titer] in Serum or Plasma |
|
43620-4
|
Actinomyces israelii Ab [Presence] in Serum |
|
5049-2
|
Ascaris lumbricoides Ab [Units/volume] in Serum by Immunoassay |
|
7806-3
|
Ascaris lumbricoides Ab [Units/volume] in Serum |
|
21075-7
|
Ascaris lumbricoides IgE Ab [Units/volume] in Serum |
|
21076-5
|
Ascaris lumbricoides IgE Ab RAST class [Presence] in Serum |
|
40607-4
|
Ascaris lumbricoides IgG Ab [Units/volume] in Serum by Immunoassay |
|
41161-1
|
Ascaris lumbricoides IgG Ab [Units/volume] in Serum |
|
40608-2
|
Ascaris lumbricoides IgM Ab [Units/volume] in Serum by Immunoassay |
|
41160-3
|
Ascaris lumbricoides IgM Ab [Units/volume] in Serum |
|
44436-4
|
Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum by Immunoassay |
|
46156-6
|
Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum |
|
44435-6
|
Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum by Immunoassay |
|
46155-8
|
Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum |
|
22084-8
|
Anaplasma marginale Ab [Presence] in Serum |
|
15433-6
|
Anaplasma marginale Ab [Presence] in Serum by Agglutination |
|
20685-4
|
Anaplasma marginale Ab [Presence] in Serum by Card agglutination |
|
20686-2
|
Anaplasma marginale Ab [Presence] in Serum by Complement fixation |
|
22795-9
|
Anaplasma marginale Ab [Presence] in Serum by Immunoassay |
|
22794-2
|
Anaplasma marginale Ab [Presence] in Serum by Immunofluorescence |
|
31222-3
|
Anaplasma marginale Ab [Units/volume] in Serum |
|
43095-9
|
Anaplasma marginale Ab [Titer] in Serum |
|
23657-0
|
Anaplasma marginale Ab [Titer] in Serum by Complement fixation |
|
22796-7
|
Anaplasma marginale Ag [Presence] in Tissue by Immunofluorescence |
|
22797-5
|
Anaplasma marginale DNA [Presence] in Tissue by NAA with probe detection |
|
22798-3
|
Anaplasma marginale rRNA [Presence] in Tissue by Probe |
|
31231-4
|
Aspergillus nidulans Ab [Presence] in Serum |
|
24508-4
|
Aspergillus nidulans Ab [Presence] in Serum by Immune diffusion (ID) |
|
47425-4
|
Aspergillus nidulans B Ab [Presence] in Serum |
|
44029-7
|
Aspergillus nidulans B Ab [Presence] in Serum by Immune diffusion (ID) |
|
47426-2
|
Aspergillus nidulans H Ab [Presence] in Serum |
|
44030-5
|
Aspergillus nidulans H Ab [Presence] in Serum by Immune diffusion (ID) |
|
7105-0
|
Aspergillus nidulans IgE Ab [Units/volume] in Serum |
|
18416-8
|
Aspergillus nidulans IgG Ab [Units/volume] in Serum |
|
63169-7
|
Aspergillus nidulans IgG Ab [Mass/volume] in Serum |
|
18395-4
|
Aspergillus niger Ab [Presence] in Cerebral spinal fluid |
|
21086-4
|
Aspergillus niger Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
31232-2
|
Aspergillus niger Ab [Presence] in Body fluid |
|
27364-9
|
Aspergillus niger Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
44441-4
|
Aspergillus niger Ab [Units/volume] in Serum by Complement fixation |
|
22086-3
|
Aspergillus niger Ab [Presence] in Serum |
|
10894-4
|
Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
|
5051-8
|
Aspergillus niger Ab [Units/volume] in Serum |
|
43089-2
|
Aspergillus niger Ab [Titer] in Serum |
|
27313-6
|
Aspergillus niger Ab [Titer] in Serum by Immune diffusion (ID) |
|
47427-0
|
Aspergillus niger B Ab [Presence] in Serum |
|
44031-3
|
Aspergillus niger B Ab [Presence] in Serum by Immune diffusion (ID) |
|
47428-8
|
Aspergillus niger H Ab [Presence] in Serum |
|
44032-1
|
Aspergillus niger H Ab [Presence] in Serum by Immune diffusion (ID) |
|
6830-4
|
Aspergillus niger IgE Ab [Units/volume] in Serum |
|
15550-7
|
Aspergillus niger IgE Ab RAST class [Presence] in Serum |
|
61221-8
|
Aspergillus niger IgE Ab/IgE total in Serum |
|
19727-7
|
Aspergillus niger IgG Ab [Presence] in Serum |
|
58914-3
|
Aspergillus niger IgG Ab [Mass/volume] in Serum |
|
56181-1
|
Aspergillus niger IgG4 Ab [Mass/volume] in Serum |
|
87558-3
|
Anaplasma phagocytophilum groEL gene [Presence] in Blood by NAA with non-probe detection |
|
43992-7
|
Anaplasma phagocytophilum Ab [Interpretation] in Serum by Immunofluorescence |
|
7877-4
|
Anaplasma phagocytophilum Ab [Presence] in Serum |
|
6403-0
|
Anaplasma phagocytophilum Ab [Presence] in Serum by Immunoassay |
|
31363-5
|
Anaplasma phagocytophilum Ab [Units/volume] in Serum |
|
33609-9
|
Anaplasma phagocytophilum Ab [Titer] in Serum |
|
30338-8
|
Anaplasma phagocytophilum Ab [Titer] in Serum by Immunofluorescence |
|
54034-4
|
Anaplasma phagocytophilum Ag [Presence] in Tissue by Immune stain |
|
30039-2
|
Anaplasma phagocytophilum DNA [Presence] in Blood by NAA with probe detection |
|
29560-0
|
Anaplasma phagocytophilum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29844-8
|
Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid |
|
29806-7
|
Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
29856-2
|
Anaplasma phagocytophilum IgG Ab [Presence] in Serum |
|
29819-0
|
Anaplasma phagocytophilum IgG Ab [Presence] in Serum by Immunoblot |
|
16808-8
|
Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum |
|
49213-2
|
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid |
|
48877-5
|
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
32691-8
|
Anaplasma phagocytophilum IgG Ab [Titer] in Serum |
|
23877-4
|
Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence |
|
29832-3
|
Anaplasma phagocytophilum IgG Ab [Presence] in Unspecified specimen |
|
29793-7
|
Anaplasma phagocytophilum IgG Ab [Presence] in Unspecified specimen by Immunoblot |
|
29845-5
|
Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid |
|
29807-5
|
Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
29857-0
|
Anaplasma phagocytophilum IgM Ab [Presence] in Serum |
|
29820-8
|
Anaplasma phagocytophilum IgM Ab [Presence] in Serum by Immunoblot |
|
16809-6
|
Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum |
|
49214-0
|
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid |
|
48876-7
|
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
32692-6
|
Anaplasma phagocytophilum IgM Ab [Titer] in Serum |
|
23878-2
|
Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence |
|
29833-1
|
Anaplasma phagocytophilum IgM Ab [Presence] in Unspecified specimen |
|
29794-5
|
Anaplasma phagocytophilum IgM Ab [Presence] in Unspecified specimen by Immunoblot |
|
48872-6
|
Anaplasma phagocytophilum [Presence] in Unspecified specimen by Organism specific culture |
|
31212-4
|
Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum |
|
23644-8
|
Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum by Immunoassay |
|
86717-6
|
Actinobacillus pleuropneumoniae serotype 1 Ab [Titer] in Serum by Complement fixation |
|
87362-0
|
Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control in Serum by Immunoassay |
|
87366-1
|
Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control in Serum by Immunoassay |
|
87355-4
|
Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control in Serum by Immunoassay |
|
87368-7
|
Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control in Serum by Immunoassay |
|
87356-2
|
Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control in Serum by Immunoassay |
|
87357-0
|
Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control in Serum by Immunoassay |
|
31213-2
|
Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum |
|
23645-5
|
Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum by Immunoassay |
|
86718-4
|
Actinobacillus pleuropneumoniae serotype 3 Ab [Titer] in Serum by Complement fixation |
|
87359-6
|
Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control in Serum by Immunoassay |
|
87363-8
|
Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control in Serum by Immunoassay |
|
87360-4
|
Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control in Serum by Immunoassay |
|
87365-3
|
Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control in Serum by Immunoassay |
|
31214-0
|
Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum |
|
23646-3
|
Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum by Immunoassay |
|
86719-2
|
Actinobacillus pleuropneumoniae serotype 5 Ab [Titer] in Serum by Complement fixation |
|
87358-8
|
Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control in Serum by Immunoassay |
|
31215-7
|
Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum |
|
23647-1
|
Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum by Immunoassay |
|
86720-0
|
Actinobacillus pleuropneumoniae serotype 7 Ab [Titer] in Serum by Complement fixation |
|
20673-0
|
Actinobacillus pleuropneumoniae Ab [Presence] in Serum |
|
22764-5
|
Actinobacillus pleuropneumoniae Ab [Presence] in Serum by Complement fixation |
|
31216-5
|
Actinobacillus pleuropneumoniae Ab [Units/volume] in Serum |
|
23648-9
|
Actinobacillus pleuropneumoniae Ab [Titer] in Serum |
|
86715-0
|
Actinobacillus pleuropneumoniae Ab [Titer] in Serum by Complement fixation |
|
87354-7
|
Actinobacillus pleuropneumoniae Ab/Positive control in Serum or Plasma by Immunoassay |
|
23649-7
|
Actinobacillus pleuropneumoniae biovar 2 serotype [Identifier] in Unspecified specimen by Agglutination |
|
86716-8
|
Actinobacillus pleuropneumoniae DNA [Cycle Threshold #] in Isolate by NAA with probe detection |
|
88364-5
|
Actinobacillus pleuropneumoniae IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay |
|
20672-2
|
Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate |
|
86721-8
|
Actinobacillus pleuropneumoniae serotype identified in Isolate by NAA with probe detection |
|
23650-5
|
Actinobacillus pleuropneumoniae serotype [Identifier] in Unspecified specimen by Agglutination |
|
42489-5
|
Aureobasidium pullulans Ab [Presence] in Cerebral spinal fluid |
|
11584-0
|
Aureobasidium pullulans Ab [Presence] in Serum |
|
6810-6
|
Aureobasidium pullulans Ab [Presence] in Serum by Immune diffusion (ID) |
|
6029-3
|
Aureobasidium pullulans IgE Ab [Units/volume] in Serum |
|
15964-0
|
Aureobasidium pullulans IgE Ab RAST class [Presence] in Serum |
|
61225-9
|
Aureobasidium pullulans IgE Ab/IgE total in Serum |
|
31235-5
|
Aureobasidium pullulans IgG Ab [Units/volume] in Serum |
|
33276-7
|
Aureobasidium pullulans IgG Ab RAST class [Presence] in Serum |
|
33572-9
|
Aureobasidium pullulans IgG Ab [Presence] in Serum |
|
26955-5
|
Aureobasidium pullulans IgG Ab [Mass/volume] in Serum |
|
23652-1
|
Aeromonas salmonicida DNA [Presence] in Tissue by NAA with probe detection |
|
24406-1
|
Aeromonas salmonicida serotype [Identifier] in Isolate |
|
24405-3
|
Aeromonas salmonicida [Presence] in Unspecified specimen |
|
6254-7
|
Acarus siro IgE Ab [Units/volume] in Serum |
|
16035-8
|
Acarus siro IgE Ab RAST class [Presence] in Serum |
|
48234-9
|
Acarus siro triggered leukotriene release [Mass/volume] by Leukocytes |
|
91427-5
|
A sudden noise made me jump in past 7 days [PROMIS.PEDS] |
|
92054-6
|
A sudden noise made my child jump in past 7 days [PROMIS.PARENTPROXY] |
|
86723-4
|
Actinobacillus suis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86722-6
|
Actinobacillus suis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23651-3
|
Actinobacillus suis serotype [Identifier] in Isolate by Agglutination |
|
16416-0
|
Aspergillus terreus Ab [Units/volume] in Serum |
|
31234-8
|
Aspergillus terreus Ab [Presence] in Serum |
|
24509-2
|
Aspergillus terreus Ab [Presence] in Serum by Immune diffusion (ID) |
|
62479-1
|
Aspergillus terreus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6026-9
|
Aspergillus terreus IgE Ab [Units/volume] in Serum |
|
21087-2
|
Aspergillus terreus IgE Ab RAST class [Presence] in Serum |
|
63166-3
|
Aspergillus terreus IgG Ab [Mass/volume] in Serum |
|
74667-7
|
Atopobium vaginae DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
69565-0
|
Atopobium vaginae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
14980-7
|
A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
|
14981-5
|
A variant subtype Ab [Presence] in Serum or Plasma from Donor |
|
14982-3
|
A variant subtype Ab [Presence] in Serum or Plasma |
|
43911-7
|
Aspergillus versicolor Ab [Presence] in Serum |
|
16417-8
|
Aspergillus versicolor Ab [Units/volume] in Serum |
|
6027-7
|
Aspergillus versicolor IgE Ab [Units/volume] in Serum |
|
25328-6
|
Aspergillus versicolor IgE Ab RAST class [Presence] in Serum |
|
51542-9
|
Aspergillus versicolor IgG Ab [Presence] in Serum |
|
56182-9
|
Aspergillus versicolor IgG4 Ab [Mass/volume] in Serum |
|
59382-2
|
Aspergillus versicolor IgG Ab [Mass/volume] in Serum |
|
875-5
|
A,B Ab [Presence] in Serum or Plasma from Blood product unit |
|
876-3
|
A,B Ab [Presence] in Serum or Plasma from Donor |
|
878-9
|
A,B Ag [Presence] on Red Blood Cells from Blood product unit |
|
879-7
|
A,B Ag [Presence] on Red Blood Cells from Donor |
|
880-5
|
A,B Ag [Presence] on Red Blood Cells |
|
91668-4
|
Aspergillus oryzae Ab [Units/volume] in Serum |
|
93847-2
|
Aspergillus oryzae IgE Ab [Units/volume] in Serum |
|
78354-8
|
Arterial-alveolar oxygen Partial pressure ratio |
|
69370-5
|
A1 Ab [Presence] in Cord blood |
|
839-1
|
A1 Ab [Presence] in Serum or Plasma from Blood product unit |
|
840-9
|
A1 Ab [Presence] in Serum or Plasma from Donor |
|
841-7
|
A1 Ab [Presence] in Serum or Plasma |
|
33644-6
|
A1 Ab [Titer] in Serum or Plasma |
|
842-5
|
A1 Ag [Presence] on Red Blood Cells from Blood product unit |
|
843-3
|
A1 Ag [Presence] on Red Blood Cells from Donor |
|
844-1
|
A1 Ag [Presence] on Red Blood Cells |
|
848-2
|
A1 B Ag [Presence] on Red Blood Cells from Blood product unit |
|
849-0
|
A1 B Ag [Presence] on Red Blood Cells from Donor |
|
850-8
|
A1 B Ag [Presence] on Red Blood Cells |
|
48414-7
|
Alpha-1-Microglobulin [Mass/time] in 24 hour Urine |
|
50385-4
|
Alpha-1-Microglobulin.placental [Presence] in Vaginal fluid |
|
48413-9
|
Alpha-1-Microglobulin [Mass/volume] in Serum or Plasma |
|
46723-3
|
Alpha-1-Microglobulin [Mass/volume] in Urine |
|
77163-4
|
Alpha-1-Microglobulin [Moles/volume] in Urine |
|
48415-4
|
Alpha-1-Microglobulin/Creatinine [Mass Ratio] in Urine |
|
2684-9
|
Alpha-1-acid glycoprotein [Mass/volume] in Cerebral spinal fluid |
|
48416-2
|
Alpha-1-acid glycoprotein [Mass/volume] in Body fluid |
|
40601-7
|
Alpha-1-acid glycoprotein [Presence] in Serum or Plasma by Immunoelectrophoresis |
|
2685-6
|
Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma |
|
33781-6
|
Alpha-1-acid glycoprotein [Moles/volume] in Serum or Plasma |
|
40600-9
|
Alpha-1-acid glycoprotein [Presence] in Urine by Immunoelectrophoresis |
|
76688-1
|
Alpha-1-acid glycoprotein/Creatinine [Mass Ratio] in Urine |
|
10461-2
|
Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
|
1824-2
|
Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
|
27915-8
|
Alpha-1-Antichymotrypsin [Units/volume] in Stool |
|
46429-7
|
Alpha 1 antitrypsin [Mass/mass] in 24 hour Stool |
|
74990-3
|
Alpha 1 antitrypsin [Mass/time] in 24 hour Stool |
|
46430-5
|
Alpha 1 antitrypsin [Mass/mass] in 48 hour Stool |
|
46431-3
|
Alpha 1 antitrypsin [Mass/mass] in 72 hour Stool |
|
34697-3
|
Alpha 1 antitrypsin actual/normal in Serum or Plasma |
|
10462-0
|
Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
|
12466-9
|
Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry |
|
18271-7
|
Alpha 1 antitrypsin fecal clearance in 24 hour |
|
12960-1
|
Alpha 1 antitrypsin fecal clearance |
|
29146-8
|
Alpha 1 antitrypsin [Mass/volume] in Body fluid |
|
1826-7
|
Alpha 1 antitrypsin MM [Mass/volume] in Serum or Plasma |
|
1827-5
|
Alpha 1 antitrypsin MS [Mass/volume] in Serum or Plasma |
|
1828-3
|
Alpha 1 antitrypsin MZ [Mass/volume] in Serum or Plasma |
|
6770-2
|
Alpha 1 antitrypsin phenotyping [Identifier] in Serum or Plasma by Immunofixation |
|
32769-2
|
Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma |
|
49244-7
|
Alpha 1 antitrypsin phenotyping [Interpretation] in Serum or Plasma Narrative |
|
6771-0
|
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry |
|
40603-3
|
Alpha 1 antitrypsin [Presence] in Serum or Plasma by Immunoelectrophoresis |
|
1825-9
|
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
|
76481-1
|
Alpha 1 antitrypsin [Moles/volume] in Serum or Plasma |
|
1829-1
|
Alpha 1 antitrypsin SS [Mass/volume] in Serum or Plasma |
|
9407-8
|
Alpha 1 antitrypsin [Mass/volume] in Stool |
|
25303-9
|
Alpha 1 antitrypsin [Mass/mass] in Stool |
|
74997-8
|
Alpha 1 antitrypsin [Mass/mass] in Stool.dried |
|
1830-9
|
Alpha 1 antitrypsin SZ [Mass/volume] in Serum or Plasma |
|
40602-5
|
Alpha 1 antitrypsin [Presence] in Urine by Immunoelectrophoresis |
|
1831-7
|
Alpha 1 antitrypsin ZZ [Mass/volume] in Serum or Plasma |
|
33645-3
|
A2 Ab [Titer] in Serum or Plasma |
|
854-0
|
A2 Ag [Presence] on Red Blood Cells from Blood product unit |
|
855-7
|
A2 Ag [Presence] on Red Blood Cells from Donor |
|
856-5
|
A2 Ag [Presence] on Red Blood Cells |
|
860-7
|
A2 B Ag [Presence] on Red Blood Cells from Blood product unit |
|
861-5
|
A2 B Ag [Presence] on Red Blood Cells from Donor |
|
862-3
|
A2 B Ag [Presence] on Red Blood Cells |
|
42660-1
|
Alpha 2 laminin [Presence] in Tissue by Immune stain |
|
50176-7
|
Alpha-2-Macroglobulin/Protein.total in Serum or Plasma |
|
40605-8
|
Alpha-2-Macroglobulin [Presence] in Serum by Immunoelectrophoresis |
|
1835-8
|
Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma |
|
40604-1
|
Alpha-2-Macroglobulin [Presence] in Urine by Immunoelectrophoresis |
|
29944-6
|
Alpha-2-Macroglobulin [Mass/volume] in Unspecified specimen |
|
50748-3
|
Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine |
|
31151-4
|
Alpha-2-Microglobulin [Mass/volume] in 24 hour Urine |
|
866-4
|
A3 Ag [Presence] on Red Blood Cells from Blood product unit |
|
867-2
|
A3 Ag [Presence] on Red Blood Cells from Donor |
|
868-0
|
A3 Ag [Presence] on Red Blood Cells |
|
872-2
|
A3 B Ag [Presence] on Red Blood Cells from Blood product unit |
|
873-0
|
A3 B Ag [Presence] on Red Blood Cells from Donor |
|
874-8
|
A3 B Ag [Presence] on Red Blood Cells |
|
75110-7
|
Arachidonate (C20:4w6) [Entitic substance] in Red Blood Cells |
|
1847-3
|
Amyloid associated protein [Mass/volume] in Serum |
|
1889-5
|
Arachidonate (C20:4w6) [Mass/volume] in Serum or Plasma |
|
35168-4
|
Arachidonate (C20:4w6) [Moles/volume] in Serum or Plasma |
|
90909-3
|
Arachidonate (C20:4w6)/Eicosapentaenoate (C20:5w3) [Mass Ratio] in Blood |
|
90916-8
|
Arachidonate (C20:4w6)/Fatty acids.C14-C22 in Blood |
|
88994-9
|
Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma |
|
90915-0
|
Arachidonate (C20:4w6)+Linoleate (C18:2w6)/Fatty acids.C14-C22 in Blood |
|
6935-1
|
Alpha aminoadipate [Mass/time] in 24 hour Urine |
|
25846-7
|
Alpha aminoadipate [Moles/volume] in 24 hour Urine |
|
25304-7
|
Alpha aminoadipate [Moles/time] in 24 hour Urine |
|
13384-3
|
Alpha aminoadipate [Mass/volume] in Amniotic fluid |
|
26909-2
|
Alpha aminoadipate [Moles/volume] in Amniotic fluid |
|
13366-0
|
Alpha aminoadipate [Mass/volume] in Cerebral spinal fluid |
|
26587-6
|
Alpha aminoadipate [Moles/volume] in Cerebral spinal fluid |
|
50083-5
|
Alpha aminoadipate [Moles/volume] in DBS |
|
50084-3
|
Alpha aminoadipate [Moles/volume] in Body fluid |
|
1785-5
|
Alpha amino acid nitrogen [Mass/time] in 24 hour Urine |
|
1784-8
|
Alpha amino acid nitrogen [Mass/volume] in Plasma |
|
1791-3
|
Alpha aminoadipate [Presence] in Plasma |
|
1792-1
|
Alpha aminoadipate [Mass/volume] in Plasma |
|
70180-5
|
Alpha aminoadipate [Moles/volume] in Serum or Plasma from Fetus |
|
26600-7
|
Alpha aminoadipate [Moles/volume] in Serum or Plasma |
|
16338-6
|
Alpha aminoadipate [Presence] in Urine |
|
1793-9
|
Alpha aminoadipate [Mass/volume] in Urine |
|
26725-2
|
Alpha aminoadipate [Moles/volume] in Urine |
|
56668-7
|
Alpha aminoadipate/Creatinine [Ratio] in 24 hour Urine |
|
25847-5
|
Alpha aminoadipate/Creatinine [Molar ratio] in 24 hour Urine |
|
13666-3
|
Alpha aminoadipate/Creatinine [Mass Ratio] in Urine |
|
28598-1
|
Alpha aminoadipate/Creatinine [Ratio] in Urine |
|
26601-5
|
Alpha aminoadipate/Creatinine [Molar ratio] in Urine |
|
62256-3
|
Aminoglycoside resistance aacA gene [Presence] by Molecular method |
|
16344-4
|
Alpha aminoisobutyrate [Mass/volume] in Amniotic fluid |
|
16343-6
|
Alpha aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
|
16341-0
|
Alpha aminoisobutyrate [Presence] in Plasma |
|
16342-8
|
Alpha aminoisobutyrate [Mass/volume] in Plasma |
|
79590-6
|
Alpha aminoisobutyrate [Moles/volume] in Serum or Plasma |
|
16339-4
|
Alpha aminoisobutyrate [Presence] in Urine |
|
16340-2
|
Alpha aminoisobutyrate [Mass/volume] in Urine |
|
79623-5
|
Alpha aminoisobutyrate/Creatinine [Molar ratio] in Urine |
|
26794-8
|
Alpha aminobutyrate [Presence] in 24 hour Urine |
|
6870-0
|
Alpha aminobutyrate [Mass/volume] in 24 hour Urine |
|
25848-3
|
Alpha aminobutyrate [Moles/volume] in 24 hour Urine |
|
25305-4
|
Alpha aminobutyrate [Moles/time] in 24 hour Urine |
|
13383-5
|
Alpha aminobutyrate [Mass/volume] in Amniotic fluid |
|
26819-3
|
Alpha aminobutyrate [Moles/volume] in Amniotic fluid |
|
1786-3
|
Alpha aminobutyrate [Mass/volume] in Cerebral spinal fluid |
|
26586-8
|
Alpha aminobutyrate [Moles/volume] in Cerebral spinal fluid |
|
47559-0
|
Alpha aminobutyrate [Moles/volume] in DBS |
|
32223-0
|
Alpha aminobutyrate [Moles/volume] in Body fluid |
|
70181-3
|
Alpha aminobutyrate [Moles/volume] in Serum or Plasma from Fetus |
|
1787-1
|
Alpha aminobutyrate [Presence] in Serum or Plasma |
|
1788-9
|
Alpha aminobutyrate [Mass/volume] in Serum or Plasma |
|
20634-2
|
Alpha aminobutyrate [Moles/volume] in Serum or Plasma |
|
55813-0
|
Alpha aminobutyrate/Amino acids.total in Serum or Plasma |
|
16345-1
|
Alpha aminobutyrate [Presence] in Urine |
|
1790-5
|
Alpha aminobutyrate [Mass/volume] in Urine |
|
27341-7
|
Alpha aminobutyrate [Moles/volume] in Urine |
|
32224-8
|
Alpha aminobutyrate [Moles/volume] in Vitreous fluid |
|
44296-2
|
Alpha aminobutyrate/Creatinine [Mass Ratio] in 24 hour Urine |
|
28609-6
|
Alpha aminobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
25849-1
|
Alpha aminobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13667-1
|
Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine |
|
28590-8
|
Alpha aminobutyrate/Creatinine [Ratio] in Urine |
|
26919-1
|
Alpha aminobutyrate/Creatinine [Molar ratio] in Urine |
|
1740-0
|
Alanine aminopeptidase [Mass/volume] in Serum |
|
33353-4
|
Alanine aminopeptidase [Enzymatic activity/volume] in Urine |
|
77109-7
|
AARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77108-9
|
AARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
92766-5
|
Alpha-aminoadipic semialdehyde+Delta-1-piperideine-6-carboxylate [Moles/volume] in Serum or Plasma |
|
22091-3
|
Avian hemorrhagic enteritis virus Ab [Presence] in Serum |
|
15438-5
|
Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay |
|
93629-4
|
Aorta abdominal Holodiastolic flow reversal by US.doppler |
|
23819-6
|
Antibody coated bacteria [Presence] in Urine by Immunofluorescence |
|
50335-9
|
Alpha-beta crystallin Ag [Presence] in Tissue by Immune stain |
|
10766-4
|
Microscopic observation [Identifier] in Tissue by Alcian blue stain |
|
78772-1
|
Abacavir [Mass/volume] in Amniotic fluid |
|
80118-3
|
Abacavir [Mass/volume] in Cord blood |
|
79134-3
|
Abacavir [Mass/volume] in Cerebral spinal fluid |
|
30287-7
|
Abacavir [Susceptibility] by Genotype method |
|
30273-7
|
Abacavir [Susceptibility] by Phenotype method |
|
29113-8
|
Abacavir [Units/volume] in Serum or Plasma |
|
78773-9
|
Abacavir [Mass/volume] in Serum or Plasma |
|
30303-2
|
Abacavir [Susceptibility] |
|
19724-4
|
Abachi Wood Dust IgE Ab [Units/volume] in Serum |
|
25496-1
|
Abachi Wood Dust IgE Ab RAST class [Presence] in Serum |
|
7060-7
|
Abalone IgE Ab [Units/volume] in Serum |
|
15518-4
|
Abalone IgE Ab RAST class [Presence] in Serum |
|
46225-9
|
ABCA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72506-9
|
ABCB1 gene c.3435C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
91672-6
|
ABCB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74004-3
|
ABCB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51476-0
|
ABCB4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49874-1
|
ABCB4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38891-8
|
ABCC8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38918-9
|
ABCC8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79568-2
|
ABCD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53836-3
|
ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87495-8
|
AB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87494-1
|
AB-CHMINACA hydroxycyclohexyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73553-0
|
Abciximab induced platelet Ab [Interpretation] in Serum or Plasma |
|
73555-5
|
Abciximab induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73554-8
|
Abciximab induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
87493-3
|
AB-FUBINACA oxobutanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
12472-7
|
Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine |
|
26700-5
|
Amino beta guanidinopropionate [Moles/time] in 24 hour Urine |
|
13382-7
|
Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
|
26852-4
|
Amino beta guanidinopropionate [Moles/volume] in Amniotic fluid |
|
13365-2
|
Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
|
27337-5
|
Amino beta guanidinopropionate [Moles/volume] in Cerebral spinal fluid |
|
16355-0
|
Amino beta guanidinopropionate [Presence] in Plasma |
|
13364-5
|
Amino beta guanidinopropionate [Mass/volume] in Plasma |
|
30060-8
|
Amino beta guanidinopropionate [Moles/volume] in Serum or Plasma |
|
16353-5
|
Amino beta guanidinopropionate [Presence] in Urine |
|
12471-9
|
Amino beta guanidinopropionate [Mass/volume] in Urine |
|
39582-2
|
Amino beta guanidinopropionate/Creatinine [Molar ratio] in 24 hour Urine |
|
28591-6
|
Amino beta guanidinopropionate/Creatinine [Ratio] in Urine |
|
27254-2
|
Amino beta guanidinopropionate/Creatinine [Molar ratio] in Urine |
|
77194-9
|
Ankle-brachial index |
|
80298-3
|
Ability to concentrate |
|
80299-1
|
Ability to direct attention |
|
57216-4
|
Ability to hear [CMS Assessment] |
|
75530-6
|
Able to request or review patient chart Abstractor [MSCDM] |
|
30440-2
|
Monocytes Abnormal [#/volume] in Blood |
|
29260-7
|
Monocytes Abnormal [#/volume] in Blood by Manual count |
|
30441-0
|
Monocytes Abnormal/100 leukocytes in Blood |
|
29259-9
|
Monocytes Abnormal/100 leukocytes in Blood by Manual count |
|
23381-7
|
Abnormal Prion Protein [Presence] in Brain by Electron microscopy |
|
37425-6
|
Abnormal Prion Protein [Presence] in Brain by Immunoassay |
|
23379-1
|
Abnormal Prion Protein [Presence] in Brain by Immunoblot |
|
23380-9
|
Abnormal Prion Protein [Presence] in Brain by Immune stain |
|
74036-5
|
Abnormal Prion Protein [Identifier] in Tissue by Immunoblot |
|
74035-7
|
Abnormal Prion Protein [Identifier] in Tissue by Immune stain |
|
39021-1
|
Abnormal Prion Protein [Presence] in Tissue by Immunoassay |
|
39320-7
|
Abnormal Prion Protein [Presence] in Tissue by Immunoblot |
|
39020-3
|
Abnormal Prion Protein [Presence] in Tissue by Immune stain |
|
38528-6
|
Protein.abnormal band [Mass/time] in 24 hour Urine |
|
56154-8
|
Protein.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
|
50408-4
|
Protein.abnormal band/Protein.total in Urine by Electrophoresis |
|
49587-9
|
Protein.abnormal band [Mass/volume] in Serum |
|
73812-0
|
Abnormal conditions of the newborn [US Standard Certificate of Live Birth] |
|
90046-4
|
Spermatozoa.abnormal principal pieces/100 spermatozoa in Semen |
|
67128-9
|
Abnormal leukocytes/100 leukocytes in Unspecified specimen by Flow cytometry (FC) |
|
882-1
|
ABO and Rh group [Type] in Blood |
|
881-3
|
ABO and Rh group [Type] in Blood from Blood product unit |
|
77397-8
|
ABO and Rh group [Type] in Blood by Confirmatory method |
|
14577-1
|
ABO and Rh group [Type] in Blood from Donor |
|
90906-9
|
Father's ABO and Rh group Type |
|
54417-1
|
ABO and Rh group [Type] in Blood from Fetus |
|
90905-1
|
Mother's ABO and Rh group Type |
|
19057-9
|
ABO and Rh group [Type] in Blood from Newborn |
|
44086-7
|
ABO and Rh group [Interpretation] in Blood from Newborn |
|
884-7
|
ABO and Rh group [Type] in Capillary blood |
|
34474-7
|
ABO and Rh group [Type] in Cord blood |
|
93906-6
|
ABO and Rh group [Type] in Blood--during infancy |
|
93932-2
|
ABO and Rh group [Type] in Blood--post hematopoietic stem cell transplant |
|
90039-9
|
ABO and Rh group [Type] in Blood--after transfusion reaction |
|
46268-9
|
ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction |
|
50773-1
|
ABO and Rh group [Type] in Blood from Newborn--after transfusion reaction |
|
883-9
|
ABO group [Type] in Blood |
|
14578-9
|
ABO group [Type] in Blood from Blood product unit |
|
57743-7
|
ABO group [Type] in Blood by Confirmatory method |
|
14579-7
|
ABO group [Type] in Blood from Donor |
|
52793-7
|
Father's ABO group Type |
|
14580-5
|
ABO group [Type] in Blood from Newborn |
|
51892-8
|
ABO group [Type] in Cord blood |
|
93905-8
|
ABO group [Type] in Blood--during infancy |
|
93931-4
|
ABO group [Type] in Blood--post hematopoietic stem cell transplant |
|
46270-5
|
ABO group [Type] in Blood--after transfusion reaction |
|
85504-9
|
Presumptive ABO group [Type] in Saliva (oral fluid) by Molecular genetics method |
|
93265-7
|
Aborted or self-interrupted suicide attempt 3 months |
|
93263-2
|
Aborted or self-interrupted suicide attempt Lifetime |
|
93266-5
|
Aborted or self-interrupted suicide attempts # 3 months |
|
93264-0
|
Aborted or self-interrupted suicide attempts # Lifetime |
|
52027-0
|
Abortion consent Document |
|
11612-9
|
[#] Abortions |
|
11613-7
|
[#] Abortions.induced |
|
11614-5
|
[#] Abortions.spontaneous |
|
10768-0
|
Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |
|
87492-5
|
AB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
92846-5
|
Ambulatory blood pressure monitor study report |
|
54933-7
|
Abrine [Mass/volume] in Urine |
|
82288-2
|
Absolute aerobic exercise intensity |
|
41660-2
|
ABT492 [Susceptibility] by Gradient strip |
|
41659-4
|
ABT492 [Susceptibility] by Disk diffusion (KB) |
|
41658-6
|
ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41726-1
|
ABT492 [Susceptibility] |
|
11698-8
|
Aortic arch Peak systolic flow velocity US.doppler |
|
11671-5
|
Aortic arch Mean blood flow velocity US.doppler |
|
1718-6
|
Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum |
|
77044-6
|
ACAD8 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77043-8
|
ACAD8 gene full mutation analysis in Blood or Tissue by Sequencing |
|
75141-2
|
Acadesine [Moles/volume] in Cerebral spinal fluid |
|
75137-0
|
Acadesine [Moles/volume] in Serum or Plasma |
|
48135-8
|
Acadesine [Presence] in Urine |
|
75151-1
|
Acadesine/Creatinine [Molar ratio] in Urine |
|
32628-0
|
ACADM gene c.985A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
43242-7
|
ACADM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
78360-5
|
Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] myristate substrate |
|
78358-9
|
Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] palmitate substrate |
|
34498-6
|
ACADS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41121-5
|
ACADS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78359-7
|
Acyl CoA dehydrogenases.palmitate substrate/Acyl CoA dehydrogenases.myristate substrate [Enzymatic activity ratio] in Fibroblast |
|
77046-1
|
ACADSB gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77045-3
|
ACADSB gene full mutation analysis in Blood or Tissue by Sequencing |
|
73736-1
|
ACADVL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
73735-3
|
ACADVL gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
74697-4
|
Acamprosate [Mass/volume] in Serum or Plasma |
|
22077-2
|
Acanthamoeba sp Ab [Presence] in Cornea |
|
6618-3
|
Acanthamoeba sp Ab [Presence] in Cornea by Immunofluorescence |
|
22078-0
|
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid |
|
6620-9
|
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6619-1
|
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
7803-0
|
Acanthamoeba sp Ab [Presence] in Serum |
|
87991-6
|
Acanthamoeba sp identified in Contact lens by Organism specific culture |
|
88162-3
|
Acanthamoeba sp identified in Cornea or Conjunctiva by Organism specific culture |
|
87990-8
|
Acanthamoeba sp identified in Cerebral spinal fluid by Organism specific culture |
|
87988-2
|
Acanthamoeba sp DNA [Presence] in Contact lens by NAA with probe detection |
|
88163-1
|
Acanthamoeba sp DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88570-7
|
Acanthamoeba sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
88914-7
|
Acanthamoeba sp DNA [Presence] in Tissue by NAA with probe detection |
|
41429-2
|
Acanthamoeba sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10635-1
|
Acanthamoeba sp identified in Eye by Organism specific culture |
|
10636-9
|
Acanthamoeba sp identified in Eye by Wet preparation |
|
9781-6
|
Acanthamoeba sp identified in Unspecified specimen by Organism specific culture |
|
7789-1
|
Acanthocytes [Presence] in Blood by Light microscopy |
|
91135-4
|
Acanthocytes [Presence] in Urine sediment by Light microscopy |
|
51639-3
|
Acanthocytes/1000 erythrocytes in Blood by Light microscopy |
|
73551-4
|
Acarbose induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73550-6
|
Acarbose induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93768-0
|
Acarboxyprothrombin [Units/volume] in Serum or Plasma |
|
34444-0
|
Acarboxyprothrombin [Mass/volume] in Serum or Plasma |
|
27078-5
|
Carotene.alpha [Moles/volume] in Plasma |
|
56669-5
|
Carotene.alpha [Mass/volume] in Serum |
|
74833-5
|
ACAT1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
20170-7
|
Acceleration 2 by US |
|
20171-5
|
Acceleration/Acceleration 2 by US |
|
19150-2
|
Specimen creatinine acceptable [Presence] in Urine |
|
19152-8
|
Specimen specific gravity acceptable [Presence] in Urine |
|
93446-3
|
Accessibility of home interior |
|
93444-8
|
Accessibility of home entrance |
|
75857-3
|
Access restriction by regulation |
|
89569-8
|
Access to transportation/mobility status [CUBS] |
|
93445-5
|
Accessibility note Patient's home Nurse |
|
77280-6
|
Accession rate [NMMDS] |
|
24043-2
|
Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Fibroblast |
|
24044-0
|
Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Leukocytes |
|
75534-8
|
Accreditation received [NMMDS] |
|
91587-6
|
Accuracy of information from source |
|
1857-2
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
|
12480-0
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
|
56022-7
|
ACE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
59044-8
|
ACE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
51835-7
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid |
|
53581-5
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid |
|
2742-5
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
|
3295-3
|
Acebutolol [Mass/time] in 24 hour Urine |
|
60039-5
|
Acebutolol [Mass/volume] in Blood |
|
4103-8
|
Acebutolol [Mass] of Dose |
|
79135-0
|
Acebutolol [Mass/volume] in Body fluid |
|
80119-1
|
Acebutolol [Mass/mass] in Hair by Confirmatory method |
|
73549-8
|
Acebutolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73548-0
|
Acebutolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60040-3
|
Acebutolol [Mass/volume] in Serum or Plasma |
|
60041-1
|
Acebutolol [Mass/mass] in Tissue |
|
3293-8
|
Acebutolol [Presence] in Urine |
|
3294-6
|
Acebutolol [Mass/volume] in Urine |
|
18188-3
|
Acebutolol [Mass/volume] in Unspecified specimen |
|
55521-9
|
Acebutolol [Moles/volume] in Unspecified specimen |
|
78774-7
|
Acenocoumarol [Mass/volume] in Blood |
|
79152-5
|
Acenocoumarol [Mass/volume] in Body fluid |
|
80120-9
|
Acenocoumarol [Mass/mass] in Hair |
|
35102-3
|
Acenocoumarol [Mass/volume] in Serum or Plasma |
|
78775-4
|
Acenocoumarol [Mass/volume] in Urine |
|
60043-7
|
Acepromazine [Mass/volume] in Blood |
|
4104-6
|
Acepromazine [Mass] of Dose |
|
79136-8
|
Acepromazine [Mass/volume] in Body fluid |
|
78776-2
|
Acepromazine [Mass/mass] in Hair |
|
3296-1
|
Acepromazine [Mass/volume] in Serum or Plasma |
|
60044-5
|
Acepromazine [Mass/volume] in Urine |
|
38584-9
|
Acetaldehyde [Mass/volume] in Air |
|
39531-9
|
Acetaldehyde [Presence] in Blood |
|
1700-4
|
Acetaldehyde [Mass/volume] in Blood |
|
60045-2
|
Acetaldehyde [Mass/volume] in Body fluid |
|
49514-3
|
Acetaldehyde [Presence] in Gastric fluid |
|
60046-0
|
Acetaldehyde [Mass/volume] in Red Blood Cells |
|
35118-9
|
Acetaldehyde [Presence] in Serum or Plasma |
|
1701-2
|
Acetaldehyde [Mass/volume] in Serum or Plasma |
|
60047-8
|
Acetaldehyde [Mass/mass] in Tissue |
|
21048-4
|
Acetaldehyde [Mass/volume] in Urine |
|
38629-2
|
Acetamide [Mass/volume] in Air |
|
51213-7
|
Acetaminophen crystals [#/area] in Urine sediment by Microscopy high power field |
|
43628-7
|
Acetaminophen crystals [Presence] in Urine sediment by Light microscopy |
|
43720-2
|
Acetaminophen+Codeine [Presence] in Serum or Plasma |
|
43719-4
|
Acetaminophen+oxyCODONE [Presence] in Serum or Plasma |
|
43721-0
|
Acetaldehyde+Paraldehyde [Presence] in Serum or Plasma |
|
33277-5
|
Acetaminophen+Phenacetin [Presence] in Urine by Screen method |
|
38658-1
|
Acetate [Mass/volume] in Air |
|
16307-1
|
Acetate [Mass/volume] in Dialysis fluid |
|
3303-5
|
Acetazolamide [Mass/time] in 24 hour Urine |
|
59598-3
|
Acetazolamide [Mass/volume] in Blood |
|
4106-1
|
Acetazolamide [Mass] of Dose |
|
43627-9
|
Acetazolamide [Presence] in Serum or Plasma |
|
16308-9
|
Acetazolamide [Units/volume] in Serum or Plasma |
|
3300-1
|
Acetazolamide [Mass/volume] in Serum or Plasma |
|
55522-7
|
Acetazolamide [Moles/volume] in Serum or Plasma |
|
3301-9
|
Acetazolamide [Presence] in Urine |
|
16309-7
|
Acetazolamide [Units/volume] in Urine |
|
3302-7
|
Acetazolamide [Mass/volume] in Urine |
|
74431-8
|
Acetoacetate [Moles/volume] in Blood |
|
1703-8
|
Acetoacetate [Mass/volume] in Cerebral spinal fluid |
|
50154-4
|
Acetoacetate [Moles/volume] in Cerebral spinal fluid |
|
72415-3
|
Acetoacetate [Moles/volume] in Blood --post meal |
|
72414-6
|
Acetoacetate [Moles/volume] in Blood --pre-meal |
|
1704-6
|
Acetoacetate [Presence] in Serum or Plasma |
|
1705-3
|
Acetoacetate [Mass/volume] in Serum or Plasma |
|
35867-1
|
Acetoacetate [Moles/volume] in Serum or Plasma |
|
27132-0
|
Acetoacetate [Presence] in Urine |
|
1702-0
|
Acetoacetate [Mass/volume] in Urine |
|
33918-4
|
Acetoacetate [Moles/volume] in Urine |
|
13701-8
|
Acetoacetate/Creatinine [Mass Ratio] in Urine |
|
29524-6
|
Acetoacetate/Creatinine [Molar ratio] in Urine |
|
30574-8
|
Acetoacetate+Acetone [Mass/volume] in Serum or Plasma |
|
43626-1
|
Acetohexamide [Presence] in Serum or Plasma |
|
27007-4
|
Acetohexamide [Mass/volume] in Serum or Plasma |
|
27164-3
|
Acetohexamide [Mass/volume] in Urine |
|
48322-2
|
Acetohexamide [Presence] in Unspecified specimen |
|
6943-5
|
Acetohexamide [Mass/volume] in Unspecified specimen |
|
35665-9
|
Acetone [Mass/volume] in Urine collected for unspecified duration |
|
18189-1
|
Acetone [Mass/time] in 24 hour Urine |
|
38585-6
|
Acetone [Mass/volume] in Air |
|
39529-3
|
Acetone [Presence] in Blood |
|
9425-0
|
Acetone [Mass/volume] in Blood |
|
76524-8
|
Acetone [Moles/volume] in Blood |
|
5566-5
|
Acetone [Presence] in Exhaled gas |
|
16310-5
|
Acetone [Presence] in Body fluid |
|
15146-4
|
Acetone [Units/volume] in Body fluid |
|
16311-3
|
Acetone [Mass/volume] in Body fluid |
|
50800-2
|
Acetone [Moles/volume] in Body fluid |
|
40598-5
|
Acetone [Presence] in Gastric fluid |
|
59864-9
|
Acetone [Moles/volume] in Gastric fluid |
|
5567-3
|
Acetone [Presence] in Serum or Plasma |
|
20469-3
|
Acetone [Presence] in Serum or Plasma by Screen method |
|
5568-1
|
Acetone [Mass/volume] in Serum or Plasma |
|
14582-1
|
Acetone [Moles/volume] in Serum or Plasma |
|
21049-2
|
Acetone [Mass/mass] in Tissue |
|
5569-9
|
Acetone [Presence] in Urine |
|
5570-7
|
Acetone [Mass/volume] in Urine |
|
32291-7
|
Acetone [Moles/volume] in Urine |
|
32290-9
|
Acetone [Presence] in Unspecified specimen |
|
32292-5
|
Acetone [Moles/volume] in Unspecified specimen |
|
58803-8
|
Acetone/Creatinine [Mass Ratio] in Urine |
|
38586-4
|
Acetonitrile [Mass/volume] in Air |
|
1706-1
|
Acetonitrile [Mass/volume] in Blood |
|
16312-1
|
Acetonitrile [Mass/volume] in Serum or Plasma |
|
12987-4
|
Acetonitrile [Mass/volume] in Urine |
|
60051-0
|
Acetophenazine [Mass/volume] in Blood |
|
26925-8
|
Acetophenazine [Presence] in Serum or Plasma |
|
10528-8
|
Acetophenazine [Mass/volume] in Serum or Plasma |
|
38659-9
|
Acetophenone [Mass/volume] in Air |
|
74810-3
|
Acetyl fentaNYL [Presence] in Urine by Confirmatory method |
|
74372-4
|
Acetyl fentaNYL [Mass/volume] in Urine |
|
86223-5
|
Acetyl norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
93471-1
|
Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method |
|
50156-9
|
Acetylcarnitine (C2) [Moles/volume] in Amniotic fluid |
|
50155-1
|
Acetylcarnitine (C2) [Moles/volume] in Cerebral spinal fluid |
|
50157-7
|
Acetylcarnitine (C2) [Moles/volume] in DBS |
|
18436-6
|
Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma |
|
30191-1
|
Acetylcarnitine (C2) [Moles/volume] in Serum or Plasma |
|
54345-4
|
Acetylcarnitine (C2) [Moles/volume] in Semen |
|
50158-5
|
Acetylcarnitine (C2) [Moles/volume] in Urine |
|
50159-3
|
Acetylcarnitine (C2)/Creatinine [Molar ratio] in Urine |
|
3304-3
|
Acetyldigitoxin [Mass/volume] in Serum or Plasma |
|
38660-7
|
Acetylene [Mass/volume] in Air |
|
16313-9
|
Acetylene [Mass/volume] in Blood |
|
12899-1
|
Acetylene [Mass/volume] in Serum or Plasma |
|
73058-0
|
Acetylsalicylate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73057-2
|
Acetylsalicylate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7108-4
|
Acetylsalicylate IgE Ab [Units/volume] in Serum |
|
73518-3
|
Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73519-1
|
Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3305-0
|
Acetylsalicylate [Presence] in Serum or Plasma |
|
3306-8
|
Acetylsalicylate [Mass/volume] in Serum or Plasma |
|
74970-5
|
Acetylsalicylate [Mass/volume] in Serum or Plasma --trough |
|
16314-7
|
Acetylsalicylate [Presence] in Urine |
|
1707-9
|
Acetylcholine [Mass/volume] in Serum |
|
30106-9
|
Acetylcholinesterase [Presence] in Amniotic fluid |
|
1708-7
|
Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid |
|
76479-5
|
Acetylcholinesterase [Interpretation] in Amniotic fluid Narrative |
|
30244-8
|
Acetylcholinesterase [Enzymatic activity/volume] in Blood |
|
1709-5
|
Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells |
|
49230-6
|
Acetylcholinesterase [Enzymatic activity/mass] in Red Blood Cells |
|
1710-3
|
Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma |
|
35701-2
|
Acetylcholinesterase [Enzymatic activity/volume] in Unspecified specimen |
|
45295-3
|
Acetylcholinesterase/Cholinesterase [Enzymatic activity ratio] in Amniotic fluid |
|
16347-7
|
Alpha chlordane [Mass/volume] in Blood |
|
11091-6
|
Alpha chlordane [Mass/volume] in Serum or Plasma |
|
16346-9
|
Alpha chlordane [Mass/volume] in Urine |
|
68937-2
|
Acetylcholine receptor Ab [Moles/volume] in Serum by Immunoassay |
|
43625-3
|
Acetylcholine receptor Ab [Presence] in Serum |
|
8058-0
|
Acetylcholine receptor Ab [Units/volume] in Serum |
|
20427-1
|
Acetylcholine receptor Ab [Moles/volume] in Serum |
|
43624-6
|
Acetylcholine receptor binding Ab [Presence] in Serum |
|
11560-0
|
Acetylcholine receptor binding Ab [Units/volume] in Serum |
|
11034-6
|
Acetylcholine receptor binding Ab [Moles/volume] in Serum |
|
5037-7
|
Acetylcholine receptor binding Ab [Titer] in Serum by Immunofluorescence |
|
43623-8
|
Acetylcholine receptor blocking Ab [Presence] in Serum |
|
11561-8
|
Acetylcholine receptor blocking Ab [Units/volume] in Serum |
|
33278-3
|
Acetylcholine receptor blocking Ab [Moles/volume] in Serum |
|
5038-5
|
Acetylcholine receptor blocking Ab [Titer] in Serum by Immunofluorescence |
|
42937-3
|
Acetylcholine receptor blocking Ab/Acetylcholine Ab.total in Serum |
|
11562-6
|
Acetylcholine receptor modulation Ab [Units/volume] in Serum |
|
33279-1
|
Acetylcholine receptor modulation Ab [Moles/volume] in Serum |
|
5039-3
|
Acetylcholine receptor modulation Ab [Titer] in Serum by Immunofluorescence |
|
30192-9
|
Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum |
|
67562-9
|
Achromobacter sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76323-5
|
Aorta acceleration index |
|
21064-1
|
Acid alpha glucosidase [Enzymatic activity/volume] in Amniotic fluid |
|
55827-0
|
Acid alpha glucosidase [Enzymatic activity/volume] in DBS |
|
24050-7
|
Acid alpha glucosidase [Enzymatic activity/mass] in Fibroblast |
|
38475-0
|
Acid alpha glucosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1814-3
|
Acid alpha glucosidase [Enzymatic activity/volume] in Semen |
|
1815-0
|
Acid alpha glucosidase [Enzymatic activity/mass] in Tissue |
|
30315-6
|
Acid alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue |
|
1816-8
|
Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes |
|
24051-5
|
Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes |
|
49540-8
|
Acid citrate dextrose [Volume] in Blood product unit |
|
88152-4
|
Microscopic observation [Identifier] in Cervix by Acid fast stain.Kinyoun |
|
640-3
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun |
|
88631-7
|
Microscopic observation [Presence] in Lower respiratory specimen by Acid fast stain.Kinyoun |
|
645-2
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun |
|
6655-5
|
Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun |
|
650-2
|
Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun |
|
654-4
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun |
|
641-1
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun modified |
|
14353-7
|
Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified |
|
646-0
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun modified |
|
6656-3
|
Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun modified |
|
651-0
|
Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun modified |
|
14354-5
|
Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified |
|
655-1
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun modified |
|
88156-5
|
Microscopic observation [Identifier] in Amniotic fluid by Acid fast stain |
|
88159-9
|
Microscopic observation [Identifier] in Aspirate by Acid fast stain |
|
88231-6
|
Microscopic observation [Identifier] in Bile fluid by Acid fast stain |
|
32699-1
|
Microscopic observation [Identifier] in Blood by Acid fast stain |
|
24002-8
|
Microscopic observation [Identifier] in Bronchial specimen by Acid fast stain |
|
88171-4
|
Microscopic observation [Presence] in Cornea or Conjunctiva by Acid fast stain |
|
32188-5
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain |
|
89582-1
|
Microscopic observation [Identifier] in Cervix by Acid fast stain |
|
32189-3
|
Microscopic observation [Identifier] in Body fluid by Acid fast stain |
|
11476-9
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain |
|
88148-2
|
Microscopic observation [Identifier] in Genital specimen by Acid fast stain |
|
89660-5
|
Microscopic observation [Identifier] in Implanted device by Acid fast stain |
|
88172-2
|
Microscopic observation [Presence] in Isolate by Acid fast stain |
|
89662-1
|
Microscopic observation [Identifier] in Lower respiratory specimen by Acid fast stain |
|
88153-2
|
Microscopic observation [Identifier] in Bone marrow by Acid fast stain |
|
90269-2
|
Microscopic observation [Identifier] in Milk by Acid fast stain |
|
88155-7
|
Microscopic observation [Identifier] in Ocular fluid by Acid fast stain |
|
88145-8
|
Microscopic observation [Identifier] in Pericardial fluid by Acid fast stain |
|
88173-0
|
Microscopic observation [Presence] in Pleural fluid by Acid fast stain |
|
88144-1
|
Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain |
|
88154-0
|
Microscopic observation [Identifier] in Sinus by Acid fast stain |
|
88157-3
|
Microscopic observation [Identifier] in Semen by Acid fast stain |
|
88234-0
|
Microscopic observation [Presence] in Synovial fluid by Acid fast stain |
|
11477-7
|
Microscopic observation [Identifier] in Sputum by Acid fast stain |
|
11478-5
|
Microscopic observation [Identifier] in Stool by Acid fast stain |
|
11479-3
|
Microscopic observation [Identifier] in Tissue by Acid fast stain |
|
89661-3
|
Microscopic observation [Identifier] in Upper respiratory specimen by Acid fast stain |
|
11480-1
|
Microscopic observation [Identifier] in Urine by Acid fast stain |
|
88366-0
|
Microscopic observation [Presence] in Vomitus by Acid fast stain |
|
88151-6
|
Microscopic observation [Identifier] in Wound by Acid fast stain |
|
11545-1
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain |
|
72357-7
|
Microscopic observation [Presence] in Unspecified specimen by Acid fast stain |
|
52126-0
|
Acid glycerol lysis [Time] in Red Blood Cells |
|
13533-5
|
Acid hemolysis [Presence] of Blood |
|
35702-0
|
Acid hemolysis fraction in Blood |
|
18297-2
|
Acid hemolysis [Mass/volume] of Red Blood Cells |
|
21536-8
|
Acid sphingomyelinase [Enzymatic activity/volume] in Blood |
|
62316-5
|
Acid sphingomyelinase [Enzymatic activity/volume] in DBS |
|
24100-0
|
Acid sphingomyelinase [Enzymatic activity/mass] in Fibroblast |
|
24101-8
|
Acid sphingomyelinase [Enzymatic activity/mass] in Leukocytes |
|
88244-9
|
Acinetobacter sp rpsA gene [Presence] by Probe in Positive blood culture |
|
90003-5
|
Acinetobacter sp identified in Unspecified specimen by Organism specific culture |
|
43622-0
|
Aconitate [Presence] in 24 hour Urine |
|
75083-6
|
Aconitate [Moles/volume] in Serum or Plasma |
|
26832-6
|
Aconitate [Presence] in Urine |
|
13702-6
|
Aconitate/Creatinine [Mass Ratio] in Urine |
|
29525-3
|
Aconitate/Creatinine [Molar ratio] in Urine |
|
55905-4
|
Alpha cortol [Mass/volume] in 24 hour Urine |
|
53629-2
|
Alpha cortol [Mass/time] in 24 hour Urine |
|
73869-0
|
Alpha cortol [Moles/volume] in 24 hour Urine |
|
73867-4
|
Alpha cortol [Moles/time] in 24 hour Urine |
|
57627-2
|
Alpha cortol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57628-0
|
Alpha cortol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57623-1
|
Alpha cortol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57624-9
|
Alpha cortol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57625-6
|
Alpha cortol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57626-4
|
Alpha cortol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57621-5
|
Alpha cortol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57622-3
|
Alpha cortol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
73868-2
|
Alpha cortol [Moles/volume] in Urine |
|
53630-0
|
Alpha cortol/Creatinine [Mass Ratio] in 24 hour Urine |
|
53631-8
|
Alpha cortol/Creatinine [Mass Ratio] in Urine |
|
81807-0
|
Alpha cortol/Creatinine [Molar ratio] in Urine |
|
55907-0
|
Alpha cortolone [Mass/volume] in 24 hour Urine |
|
55906-2
|
Alpha cortolone [Mass/time] in 24 hour Urine |
|
73872-4
|
Alpha cortolone [Moles/volume] in 24 hour Urine |
|
73870-8
|
Alpha cortolone [Moles/time] in 24 hour Urine |
|
57635-5
|
Alpha cortolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57636-3
|
Alpha cortolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57631-4
|
Alpha cortolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57632-2
|
Alpha cortolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57633-0
|
Alpha cortolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57634-8
|
Alpha cortolone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57629-8
|
Alpha cortolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57630-6
|
Alpha cortolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
73871-6
|
Alpha cortolone [Moles/volume] in Urine |
|
44430-7
|
Alpha cortolone/Creatinine [Mass Ratio] in Urine |
|
81806-2
|
Alpha cortolone/Creatinine [Molar ratio] in Urine |
|
16315-4
|
Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited |
|
1711-1
|
Acid phosphatase [Enzymatic activity/volume] in Blood |
|
12804-1
|
Acid phosphatase [Enzymatic activity/volume] in Body fluid |
|
12173-1
|
Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
1715-2
|
Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
21391-8
|
Microscopic observation [Identifier] in Bone by Acid phosphatase stain |
|
44835-7
|
Acid phosphatase tartrate resistant [Presence] in Blood |
|
16316-2
|
Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood |
|
44834-0
|
Acid phosphatase tartrate resistant [Presence] in Bone marrow |
|
17837-6
|
Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum |
|
18190-9
|
Acid phosphatase tartrate resistant [Presence] in Unspecified specimen |
|
45160-9
|
Acremonium sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
6066-5
|
Acremonium sp IgE Ab [Units/volume] in Serum |
|
15619-0
|
Acremonium sp IgE Ab RAST class [Presence] in Serum |
|
61207-7
|
Acremonium sp IgE Ab/IgE total in Serum |
|
44829-0
|
Acremonium sp IgG Ab RAST class [Presence] in Serum |
|
56214-0
|
Acremonium sp IgG4 Ab [Mass/volume] in Serum |
|
63177-0
|
Acremonium sp IgG Ab [Mass/volume] in Serum |
|
10555-1
|
Acrosin [Entitic Catalytic Activity] in Spermatozoa |
|
38587-2
|
Acrylaldehyde [Mass/volume] in Air |
|
21051-8
|
Acrylaldehyde [Mass/volume] in Serum or Plasma |
|
38573-2
|
Acrylamide [Mass/volume] in Air |
|
12988-2
|
Acrylamide [Mass/volume] in Blood |
|
16319-6
|
Acrylamide [Mass/volume] in Serum or Plasma |
|
16318-8
|
Acrylamide [Mass/volume] in Urine |
|
38318-2
|
Acrylamide [Mass/volume] in Water |
|
38630-0
|
Acrylate [Mass/volume] in Air |
|
93468-7
|
Acrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
38588-0
|
Acrylonitrile [Mass/volume] in Air |
|
5571-5
|
Acrylonitrile [Mass/volume] in Blood |
|
53237-4
|
Acrylylcarnitine (C3:1) [Moles/volume] in DBS |
|
18437-4
|
Acrylylcarnitine (C3:1) [Mass/volume] in Serum or Plasma |
|
43235-1
|
Acrylylcarnitine (C3:1) [Moles/volume] in Serum or Plasma |
|
77048-7
|
ACSF3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77047-9
|
ACSF3 gene full mutation analysis in Blood or Tissue by Sequencing |
|
61110-3
|
ACSL4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
3184-9
|
Activated clotting time (ACT) of Blood by Coagulation assay |
|
80658-8
|
Activated clotting time (ACT) of Blood induced by Diatomaceous earth |
|
80659-6
|
Activated clotting time (ACT) of Blood induced by Kaolin |
|
57839-3
|
Activated clotting time (ACT) of Platelet poor plasma from Control by Kaolin induced method |
|
82271-8
|
Activity metabolic rate/Standard resting metabolic rate [Relative Energy/Time] adjusted for age+sex+race+BMI 1 minute mean Estimated |
|
48344-6
|
Activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method |
|
44700-3
|
ACTA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46401-6
|
Corticotropin [Mass/volume] in Plasma --1.5 hours post 1 ug/kg CRH IV |
|
58530-7
|
Corticotropin [Moles/volume] in Plasma --1.5 hours post 1 ug/kg CRH IV |
|
16654-6
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1.5 hours post XXX challenge |
|
42597-5
|
Corticotropin [Mass/volume] in Plasma --1.5 hours post XXX challenge |
|
60016-3
|
Corticotropin [Moles/volume] in Plasma --1.5 hours post XXX challenge |
|
58526-5
|
Corticotropin [Mass/volume] in Plasma --1.5 hours post dose glucagon |
|
58527-3
|
Corticotropin [Moles/volume] in Plasma --1.5 hours post dose glucagon |
|
58528-1
|
Corticotropin [Mass/volume] in Plasma --1.5 hours post dose glucose |
|
58529-9
|
Corticotropin [Moles/volume] in Plasma --1.5 hours post dose glucose |
|
1358-1
|
Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV |
|
58531-5
|
Corticotropin [Moles/volume] in Plasma --1.5 hours post dose insulin IV |
|
58532-3
|
Corticotropin [Mass/volume] in Plasma --10 AM specimen |
|
58533-1
|
Corticotropin [Moles/volume] in Plasma --10 AM specimen |
|
58534-9
|
Corticotropin [Mass/volume] in Plasma --10 PM specimen |
|
58535-6
|
Corticotropin [Moles/volume] in Plasma --10 PM specimen |
|
58536-4
|
Corticotropin [Mass/volume] in Plasma --105 minutes post dose insulin IV |
|
58537-2
|
Corticotropin [Moles/volume] in Plasma --105 minutes post dose insulin IV |
|
91708-8
|
Corticotropin [Mass/volume] in Plasma --10 minutes post 1 ug/kg CRH IV |
|
16655-3
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --10 minutes post XXX challenge |
|
48091-3
|
Corticotropin [Mass/volume] in Plasma --12 AM specimen |
|
58542-2
|
Corticotropin [Moles/volume] in Plasma --12 AM specimen |
|
48092-1
|
Corticotropin [Mass/volume] in Plasma --12 PM specimen |
|
58543-0
|
Corticotropin [Moles/volume] in Plasma --12 PM specimen |
|
46400-8
|
Corticotropin [Mass/volume] in Plasma --15 minutes post 1 ug/kg CRH IV |
|
58546-3
|
Corticotropin [Moles/volume] in Plasma --15 minutes post 1 ug/kg CRH IV |
|
16656-1
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --15 minutes post XXX challenge |
|
56504-4
|
Corticotropin [Mass/volume] in Plasma --15 minutes post XXX challenge |
|
58549-7
|
Corticotropin [Moles/volume] in Plasma --15 minutes post XXX challenge |
|
58547-1
|
Corticotropin [Mass/volume] in Plasma --15 minutes post dose insulin IV |
|
58548-9
|
Corticotropin [Moles/volume] in Plasma --15 minutes post dose insulin IV |
|
48093-9
|
Corticotropin [Mass/volume] in Plasma --15 minutes pre 1 ug/kg CRH IV |
|
58550-5
|
Corticotropin [Moles/volume] in Plasma --15 minutes pre 1 ug/kg CRH IV |
|
58551-3
|
Corticotropin [Mass/volume] in Plasma --15 minutes pre dose insulin IV |
|
58552-1
|
Corticotropin [Moles/volume] in Plasma --15 minutes pre dose insulin IV |
|
58569-5
|
Corticotropin [Mass/volume] in Plasma --1 day post dose metyraPONE |
|
58570-3
|
Corticotropin [Moles/volume] in Plasma --1 day post dose metyraPONE |
|
1359-9
|
Corticotropin [Mass/volume] in Plasma --1 hour post 1 ug/kg CRH IV |
|
58553-9
|
Corticotropin [Moles/volume] in Plasma --1 hour post 1 ug/kg CRH IV |
|
50428-2
|
Corticotropin [Mass/volume] in Plasma --1 hour post 100 ug CRH IV |
|
16657-9
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 hour post XXX challenge |
|
42599-1
|
Corticotropin [Mass/volume] in Plasma --1 hour post XXX challenge |
|
58559-6
|
Corticotropin [Moles/volume] in Plasma --1 hour post XXX challenge |
|
58554-7
|
Corticotropin [Mass/volume] in Plasma --1 hour post dose glucagon |
|
58555-4
|
Corticotropin [Moles/volume] in Plasma --1 hour post dose glucagon |
|
58556-2
|
Corticotropin [Mass/volume] in Plasma --1 hour post dose glucose |
|
58557-0
|
Corticotropin [Moles/volume] in Plasma --1 hour post dose glucose |
|
1360-7
|
Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV |
|
58558-8
|
Corticotropin [Moles/volume] in Plasma --1 hour post dose insulin IV |
|
1361-5
|
Corticotropin [Mass/volume] in Plasma --1 minute post 1 ug/kg CRH IV |
|
16658-7
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 minute post XXX challenge |
|
91706-2
|
Corticotropin [Mass/volume] in Plasma --1 minute pre 1 ug/kg CRH IV |
|
58561-2
|
Corticotropin [Mass/volume] in Plasma --2 PM specimen |
|
58562-0
|
Corticotropin [Moles/volume] in Plasma --2 PM specimen |
|
16659-5
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2.5 hours post XXX challenge |
|
58563-8
|
Corticotropin [Mass/volume] in Plasma --2.5 hours post dose glucagon |
|
58564-6
|
Corticotropin [Moles/volume] in Plasma --2.5 hours post dose glucagon |
|
58567-9
|
Corticotropin [Mass/volume] in Plasma --2.5 hours post dose glucose |
|
58568-7
|
Corticotropin [Moles/volume] in Plasma --2.5 hours post dose glucose |
|
58565-3
|
Corticotropin [Mass/volume] in Plasma --2.5 hours post dose insulin IV |
|
58566-1
|
Corticotropin [Moles/volume] in Plasma --2.5 hours post dose insulin IV |
|
50426-6
|
Corticotropin [Mass/volume] in Plasma --20 minutes post 100 ug CRH IV |
|
16660-3
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --20 minutes post XXX challenge |
|
57725-4
|
Corticotropin [Mass/volume] in Plasma --20 minutes post XXX challenge |
|
58607-3
|
Corticotropin [Moles/volume] in Plasma --2 days post dose metyraPONE |
|
46402-4
|
Corticotropin [Mass/volume] in Plasma --2 hours post 1 ug/kg CRH IV |
|
58571-1
|
Corticotropin [Moles/volume] in Plasma --2 hours post 1 ug/kg CRH IV |
|
16661-1
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2 hours post XXX challenge |
|
56506-9
|
Corticotropin [Mass/volume] in Plasma --2 hours post XXX challenge |
|
58578-6
|
Corticotropin [Moles/volume] in Plasma --2 hours post XXX challenge |
|
58572-9
|
Corticotropin [Mass/volume] in Plasma --2 hours post dose glucagon |
|
58573-7
|
Corticotropin [Moles/volume] in Plasma --2 hours post dose glucagon |
|
58574-5
|
Corticotropin [Mass/volume] in Plasma --2 hours post dose glucose |
|
58575-2
|
Corticotropin [Moles/volume] in Plasma --2 hours post dose glucose |
|
58576-0
|
Corticotropin [Mass/volume] in Plasma --2 hours post dose insulin IV |
|
58577-8
|
Corticotropin [Moles/volume] in Plasma --2 hours post dose insulin IV |
|
91709-6
|
Corticotropin [Mass/volume] in Plasma --2 minutes post 1 ug/kg CRH IV |
|
50439-9
|
Corticotropin [Mass/volume] in Plasma --3 AM specimen |
|
50436-5
|
Corticotropin [Mass/volume] in Plasma --3 PM specimen |
|
1362-3
|
Corticotropin [Mass/volume] in Plasma --30 minutes post 1 ug/kg CRH IV |
|
58580-2
|
Corticotropin [Moles/volume] in Plasma --30 minutes post 1 ug/kg CRH IV |
|
16662-9
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --30 minutes post XXX challenge |
|
42596-7
|
Corticotropin [Mass/volume] in Plasma --30 minutes post XXX challenge |
|
58586-9
|
Corticotropin [Moles/volume] in Plasma --30 minutes post XXX challenge |
|
58581-0
|
Corticotropin [Mass/volume] in Plasma --30 minutes post dose glucagon |
|
58582-8
|
Corticotropin [Moles/volume] in Plasma --30 minutes post dose glucagon |
|
58583-6
|
Corticotropin [Mass/volume] in Plasma --30 minutes post dose glucose |
|
58584-4
|
Corticotropin [Moles/volume] in Plasma --30 minutes post dose glucose |
|
1363-1
|
Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV |
|
58585-1
|
Corticotropin [Moles/volume] in Plasma --30 minutes post dose insulin IV |
|
58587-7
|
Corticotropin [Mass/volume] in Plasma --30 minutes pre 1 ug/kg CRH IV |
|
58588-5
|
Corticotropin [Moles/volume] in Plasma --30 minutes pre 1 ug/kg CRH IV |
|
58592-7
|
Corticotropin [Mass/volume] in Plasma --30 minutes pre XXX challenge |
|
58593-5
|
Corticotropin [Moles/volume] in Plasma --30 minutes pre XXX challenge |
|
58589-3
|
Corticotropin [Mass/volume] in Plasma --30 minutes pre dose glucagon |
|
58590-1
|
Corticotropin [Moles/volume] in Plasma --30 minutes pre dose glucagon |
|
58591-9
|
Corticotropin [Moles/volume] in Plasma --30 minutes pre dose insulin IV |
|
16663-7
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --3 hours post XXX challenge |
|
58600-8
|
Corticotropin [Mass/volume] in Plasma --3 hours post XXX challenge |
|
58601-6
|
Corticotropin [Moles/volume] in Plasma --3 hours post XXX challenge |
|
58594-3
|
Corticotropin [Mass/volume] in Plasma --3 hours post dose glucagon |
|
58595-0
|
Corticotropin [Moles/volume] in Plasma --3 hours post dose glucagon |
|
58596-8
|
Corticotropin [Mass/volume] in Plasma --3 hours post dose glucose |
|
58597-6
|
Corticotropin [Moles/volume] in Plasma --3 hours post dose glucose |
|
58598-4
|
Corticotropin [Mass/volume] in Plasma --3 hours post dose insulin IV |
|
58599-2
|
Corticotropin [Moles/volume] in Plasma --3 hours post dose insulin IV |
|
48094-7
|
Corticotropin [Mass/volume] in Plasma --4 AM specimen |
|
58603-2
|
Corticotropin [Moles/volume] in Plasma --4 AM specimen |
|
48095-4
|
Corticotropin [Mass/volume] in Plasma --4 PM specimen |
|
58604-0
|
Corticotropin [Moles/volume] in Plasma --4 PM specimen |
|
50427-4
|
Corticotropin [Mass/volume] in Plasma --40 minutes post 100 ug CRH IV |
|
57330-3
|
Corticotropin [Mass/volume] in Plasma --40 minutes post XXX challenge |
|
1364-9
|
Corticotropin [Mass/volume] in Plasma --45 minutes post 1 ug/kg CRH IV |
|
58605-7
|
Corticotropin [Moles/volume] in Plasma --45 minutes post 1 ug/kg CRH IV |
|
16664-5
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --45 minutes post XXX challenge |
|
56505-1
|
Corticotropin [Mass/volume] in Plasma --45 minutes post XXX challenge |
|
77939-7
|
Corticotropin [Moles/volume] in Plasma --45 minutes post XXX challenge |
|
1365-6
|
Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV |
|
58606-5
|
Corticotropin [Moles/volume] in Plasma --45 minutes post dose insulin IV |
|
1366-4
|
Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV |
|
16665-2
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --5 minutes post XXX challenge |
|
60015-5
|
Corticotropin [Moles/volume] in Plasma --5 minutes post XXX challenge |
|
91705-4
|
Corticotropin [Mass/volume] in Plasma --5 minutes pre 1 ug/kg CRH IV |
|
50440-7
|
Corticotropin [Mass/volume] in Plasma --6 AM specimen |
|
50437-3
|
Corticotropin [Mass/volume] in Plasma --6 PM specimen |
|
58610-7
|
Corticotropin [Moles/volume] in Plasma --6 PM specimen |
|
58612-3
|
Corticotropin [Mass/volume] in Plasma --75 minutes post dose insulin IV |
|
58613-1
|
Corticotropin [Moles/volume] in Plasma --75 minutes post dose insulin IV |
|
48096-2
|
Corticotropin [Mass/volume] in Plasma --8 AM specimen |
|
58615-6
|
Corticotropin [Moles/volume] in Plasma --8 AM specimen |
|
48097-0
|
Corticotropin [Mass/volume] in Plasma --8 PM specimen |
|
58616-4
|
Corticotropin [Moles/volume] in Plasma --8 PM specimen |
|
54237-3
|
Corticotropin [Mass/volume] in Plasma --9 AM 2nd day specimen |
|
50435-7
|
Corticotropin [Mass/volume] in Plasma --9 AM specimen |
|
50438-1
|
Corticotropin [Mass/volume] in Plasma --9 PM specimen |
|
51696-3
|
Corticotropin [Mass/volume] in Plasma --afternoon specimen |
|
10475-2
|
Corticotropin Ag [Presence] in Tissue by Immune stain |
|
56913-7
|
Corticotropin [Mass/volume] in Plasma --morning specimen |
|
16652-0
|
Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) |
|
2140-2
|
Corticotropin [Mass/volume] in Amniotic fluid |
|
14149-9
|
Corticotropin Big Fragment [Mass/volume] in Serum or Plasma |
|
42598-3
|
Corticotropin [Mass/volume] in Plasma --baseline |
|
60014-8
|
Corticotropin [Moles/volume] in Plasma --baseline |
|
16653-8
|
Corticotropin Canine [Mass/volume] in Plasma |
|
47206-8
|
Corticotropin [Mass] of Dose |
|
56914-5
|
Corticotropin [Mass/volume] in Plasma --evening specimen |
|
6016-0
|
Corticotropin IgE Ab [Units/volume] in Serum |
|
15520-0
|
Corticotropin IgE Ab RAST class [Presence] in Serum |
|
56167-0
|
Corticotropin IgG4 Ab [Mass/volume] in Serum |
|
50414-2
|
Corticotropin [Mass/volume] in Plasma --post 1 mg dexamethasone PO overnight |
|
50418-3
|
Corticotropin [Mass/volume] in Plasma --post 2 mg dexamethasone PO overnight |
|
50420-9
|
Corticotropin [Mass/volume] in Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
19242-7
|
Corticotropin [Mass/volume] in Plasma --post XXX challenge |
|
47843-8
|
Corticotropin [Mass/volume] in Plasma --post dose dexamethasone |
|
58618-0
|
Corticotropin [Moles/volume] in Plasma --post dose dexamethasone |
|
6879-1
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) |
|
2141-0
|
Corticotropin [Mass/volume] in Plasma |
|
66732-9
|
Corticotropin [Mass or Moles/volume] in Plasma |
|
14674-6
|
Corticotropin [Moles/volume] in Plasma |
|
50413-4
|
Corticotropin [Mass/volume] in Plasma --pre 1 mg dexamethasone PO overnight |
|
1367-2
|
Corticotropin [Mass/volume] in Plasma --pre 1 ug/kg CRH IV |
|
58619-8
|
Corticotropin [Moles/volume] in Plasma --pre 1 ug/kg CRH IV |
|
50425-8
|
Corticotropin [Mass/volume] in Plasma --pre 100 ug CRH IV |
|
50417-5
|
Corticotropin [Mass/volume] in Plasma --pre 2 mg dexamethasone PO overnight |
|
50419-1
|
Corticotropin [Mass/volume] in Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
|
58629-7
|
Corticotropin [Mass/volume] in Plasma --pre XXX challenge |
|
58630-5
|
Corticotropin [Moles/volume] in Plasma --pre XXX challenge |
|
58620-6
|
Corticotropin [Mass/volume] in Plasma --pre dose dexamethasone |
|
58621-4
|
Corticotropin [Moles/volume] in Plasma --pre dose dexamethasone |
|
58622-2
|
Corticotropin [Mass/volume] in Plasma --pre dose glucagon |
|
58623-0
|
Corticotropin [Moles/volume] in Plasma --pre dose glucagon |
|
58624-8
|
Corticotropin [Mass/volume] in Plasma --pre dose glucose |
|
58625-5
|
Corticotropin [Moles/volume] in Plasma --pre dose glucose |
|
1368-0
|
Corticotropin [Mass/volume] in Plasma --pre dose insulin IV |
|
58626-3
|
Corticotropin [Moles/volume] in Plasma --pre dose insulin IV |
|
58627-1
|
Corticotropin [Mass/volume] in Plasma --pre dose metyraPONE |
|
58628-9
|
Corticotropin [Moles/volume] in Plasma --pre dose metyraPONE |
|
51423-2
|
Corticotropin [Moles/volume] in Plasma --pre or post XXX challenge |
|
50671-7
|
Corticotropin releasing hormone [Mass] of Dose |
|
12283-8
|
Corticotropin releasing hormone [Units/volume] in Serum or Plasma |
|
11213-6
|
Corticotropin releasing hormone [Mass/volume] in Serum or Plasma |
|
37990-9
|
Corticotropin releasing hormone [Moles/volume] in Serum or Plasma |
|
15042-5
|
Corticotropin [Units/volume] in Serum |
|
39564-0
|
Corticotropin [Mass/volume] in Plasma --1st specimen post XXX challenge |
|
58560-4
|
Corticotropin [Moles/volume] in Plasma --1st specimen post XXX challenge |
|
50445-6
|
Corticotropin [Mass/volume] in Plasma --1st specimen |
|
58538-0
|
Corticotropin [Mass/volume] in Plasma --10th specimen post XXX challenge |
|
58539-8
|
Corticotropin [Moles/volume] in Plasma --10th specimen post XXX challenge |
|
58540-6
|
Corticotropin [Mass/volume] in Plasma --11th specimen post XXX challenge |
|
58541-4
|
Corticotropin [Moles/volume] in Plasma --11th specimen post XXX challenge |
|
58544-8
|
Corticotropin [Mass/volume] in Plasma --12th specimen post XXX challenge |
|
58545-5
|
Corticotropin [Moles/volume] in Plasma --12th specimen post XXX challenge |
|
12458-6
|
Corticotropin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
58579-4
|
Corticotropin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
|
50446-4
|
Corticotropin [Mass/volume] in Plasma --2nd specimen |
|
12459-4
|
Corticotropin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
|
58602-4
|
Corticotropin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
|
50447-2
|
Corticotropin [Mass/volume] in Plasma --3rd specimen |
|
12460-2
|
Corticotropin [Mass/volume] in Plasma --4th specimen post XXX challenge |
|
58608-1
|
Corticotropin [Moles/volume] in Plasma --4th specimen post XXX challenge |
|
50448-0
|
Corticotropin [Mass/volume] in Plasma --4th specimen |
|
12461-0
|
Corticotropin [Mass/volume] in Plasma --5th specimen post XXX challenge |
|
58609-9
|
Corticotropin [Moles/volume] in Plasma --5th specimen post XXX challenge |
|
50449-8
|
Corticotropin [Mass/volume] in Plasma --5th specimen |
|
12462-8
|
Corticotropin [Mass/volume] in Plasma --6th specimen post XXX challenge |
|
58611-5
|
Corticotropin [Moles/volume] in Plasma --6th specimen post XXX challenge |
|
50450-6
|
Corticotropin [Mass/volume] in Plasma --6th specimen |
|
12463-6
|
Corticotropin [Mass/volume] in Plasma --7th specimen post XXX challenge |
|
58614-9
|
Corticotropin [Moles/volume] in Plasma --7th specimen post XXX challenge |
|
50451-4
|
Corticotropin [Mass/volume] in Plasma --7th specimen |
|
12464-4
|
Corticotropin [Mass/volume] in Plasma --8th specimen post XXX challenge |
|
58617-2
|
Corticotropin [Moles/volume] in Plasma --8th specimen post XXX challenge |
|
50452-2
|
Corticotropin [Mass/volume] in Plasma --8th specimen |
|
16666-0
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --9th specimen post XXX challenge |
|
58687-5
|
Corticotropin [Moles/volume] in Plasma --9th specimen post XXX challenge |
|
53979-1
|
Actin Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
53980-9
|
Actin Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
10457-0
|
Actin Ag [Presence] in Tissue by Immune stain |
|
34661-9
|
Actin IgG Ab [Units/volume] in Serum or Plasma |
|
29885-1
|
Actinobacillus sp identified in Unspecified specimen by Organism specific culture |
|
43619-6
|
Actinomyces sp Ab [Presence] in Serum |
|
7804-8
|
Actinomyces sp Ab [Units/volume] in Serum |
|
22079-8
|
Actinomyces sp Ab [Titer] in Serum |
|
5040-1
|
Actinomyces sp Ab [Titer] in Serum by Immunofluorescence |
|
90458-1
|
Actinomyces sp identified in Aspirate by Organism specific culture |
|
89634-0
|
Actinomyces sp identified in Implanted device by Organism specific culture |
|
89633-2
|
Actinomyces sp identified in Lower respiratory specimen by Organism specific culture |
|
88922-0
|
Actinomyces sp identified in Tissue by Organism specific culture |
|
9816-0
|
Actinomyces sp identified in Unspecified specimen by Organism specific culture |
|
92036-3
|
Action taken based on risk assessment meeting |
|
92184-1
|
Action taken based on watch record |
|
74569-5
|
Action that prevented the near miss incident from reaching the patient [AHRQ] |
|
57460-8
|
Activated T cells lymphocytes/100 lymphocytes.small in Bronchoalveolar lavage |
|
20631-8
|
Activated T cells lymphocytes/100 lymphocytes.small in Blood |
|
57461-6
|
Activated T cells lymphocytes/100 lymphocytes.small in Bronchial specimen |
|
20632-6
|
Activated T cells lymphocytes/100 lymphocytes.small in Unspecified specimen |
|
86671-5
|
Active diagnoses in the last 7 days [CMS Assessment] |
|
58146-2
|
Active discharge planning in place for resident return to community [CMS Assessment] |
|
93248-3
|
Active suicidal ideation with any methods (not plan) without intent to act 1 month |
|
93297-0
|
Active suicidal ideation with any methods (not plan) without intent to act Lifetime |
|
93249-1
|
Active suicidal ideation with some intent to act, without specific plan 1 month |
|
93296-2
|
Active suicidal ideation with some intent to act, without specific plan Lifetime |
|
93250-9
|
Active suicidal ideation with specific plan and intent 1 month |
|
93295-4
|
Active suicidal ideation with specific plan and intent Lifetime |
|
76446-4
|
Activities and participation ICF code |
|
72095-3
|
Activities of daily living score [HOOS] |
|
72100-1
|
Activities of daily living score [KOOS] |
|
79433-9
|
Activities of daily living score change [HOOS] |
|
79438-8
|
Activities of daily living score change [KOOS] |
|
75246-9
|
Activity [Norton scale] |
|
73786-6
|
Activity [NSRAS] |
|
80626-5
|
Activity at time of death [CDC] |
|
80493-0
|
Activity level [Acceleration] |
|
93283-0
|
Actual lethality/medical damage initial/first suicide attempt type [C-SSRS] |
|
93271-5
|
Actual lethality/medical damage most lethal suicide attempt Lifetime [C-SSRS] |
|
93284-8
|
Actual lethality/medical damage most recent suicide attempt [C-SSRS] |
|
74050-6
|
Actual route of administration - attempted or completed [AHRQ] |
|
93255-8
|
Actual suicide attempt 3 months |
|
93253-3
|
Actual suicide attempt Lifetime |
|
93256-6
|
Actual suicide attempts # 3 months |
|
93254-1
|
Actual suicide attempts # Lifetime |
|
85237-6
|
Acupuncture Consult note |
|
85220-2
|
Acupuncture Note |
|
85221-0
|
Acupuncture Nurse Note |
|
88993-1
|
Acute kidney injury risk [Likelihood] by Calculated by NephroCheck |
|
45267-2
|
Acute leukemia markers [Interpretation] in Unspecified specimen Narrative |
|
49312-2
|
Acute leukemia markers [Interpretation] in Unspecified specimen |
|
54632-5
|
Acute onset mental status change [CAM.CMS] |
|
43395-3
|
Cholesterol in VLDL acylated [Mass/volume] in Serum or Plasma |
|
47961-8
|
ACVRL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
69481-0
|
ACVRL1 gene+ENG gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
53837-1
|
ACVRL1 gene+ENG gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80121-7
|
Acyclovir [Mass/volume] in Cerebral spinal fluid |
|
4107-9
|
Acyclovir [Mass] of Dose |
|
73544-9
|
Acyclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73545-6
|
Acyclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73574-6
|
Acyclovir [Susceptibility] by Genotype method |
|
35104-9
|
Acyclovir [Mass/volume] in Serum or Plasma --peak |
|
9416-9
|
Acyclovir [Mass/volume] in Serum or Plasma |
|
1-8
|
Acyclovir [Susceptibility] |
|
16320-4
|
Acyclovir [Susceptibility] by Serum bactericidal titer |
|
35103-1
|
Acyclovir [Mass/volume] in Serum or Plasma --trough |
|
34228-7
|
Acylcarnitine [Moles/volume] in 24 hour Urine |
|
34227-9
|
Acylcarnitine [Moles/time] in 24 hour Urine |
|
50162-7
|
Acylcarnitine [Moles/volume] in Amniotic fluid |
|
43715-2
|
Acylcarnitine [Presence] in Blood |
|
50163-5
|
Acylcarnitine [Moles/volume] in Cerebral spinal fluid |
|
43717-8
|
Acylcarnitine [Presence] in DBS |
|
58088-6
|
Acylcarnitine newborn screen interpretation |
|
38474-3
|
Acylcarnitine [Moles/volume] in DBS |
|
58093-6
|
Acylcarnitine newborn screening comment-discussion |
|
46252-3
|
Acylcarnitine pattern [Interpretation] in Serum or Plasma |
|
77309-3
|
Acylcarnitine pattern [Interpretation] in Serum or Plasma Narrative |
|
48936-9
|
Acylcarnitine pattern [Interpretation] in Tissue |
|
33472-2
|
Acylcarnitine pattern [Interpretation] in Urine |
|
49242-1
|
Acylcarnitine pattern [Interpretation] in Urine Narrative |
|
50164-3
|
Acylcarnitine pattern [Interpretation] in Unspecified specimen |
|
38552-6
|
Acylcarnitine short chain [Moles/volume] in Serum or Plasma |
|
31991-3
|
Acylcarnitine [Presence] in Serum or Plasma |
|
1717-8
|
Acylcarnitine [Mass/volume] in Serum or Plasma |
|
14282-8
|
Acylcarnitine [Moles/volume] in Serum or Plasma |
|
43716-0
|
Acylcarnitine [Presence] in Urine |
|
9403-7
|
Acylcarnitine [Mass/volume] in Urine |
|
14283-6
|
Acylcarnitine [Moles/volume] in Urine |
|
59249-3
|
Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in DBS |
|
59254-3
|
Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in Serum or Plasma |
|
30193-7
|
Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
43576-8
|
Acylcarnitine/Carnitine.free (C0) [Ratio] in Urine |
|
43186-6
|
Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Urine |
|
17868-1
|
Acylcarnitine/Creatinine [Ratio] in Urine |
|
34229-5
|
Acylcarnitine/Creatinine [Molar ratio] in Urine |
|
32280-0
|
Acylglycines [Presence] in Urine |
|
53718-3
|
Acylglycines [Interpretation] in Urine Narrative |
|
90779-0
|
Adalimumab Ab [Units/volume] in Serum by Immunoassay |
|
86895-0
|
Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
87742-3
|
Adalimumab Ab [Units/volume] in Serum or Plasma |
|
74116-5
|
Adalimumab Ab [Mass/volume] in Serum or Plasma |
|
92765-7
|
Adalimumab neutralizing antibody [Titer] in Serum by Bioassay |
|
86894-3
|
Adalimumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
74117-3
|
Adalimumab [Mass/volume] in Serum or Plasma |
|
87491-7
|
ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87485-9
|
ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87490-9
|
ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87251-5
|
Addiction medicine Administrative note |
|
87252-3
|
Addiction medicine Admission evaluation note |
|
88361-1
|
Addiction medicine Alert |
|
86212-8
|
Addiction medicine Attending Note |
|
87261-4
|
Addiction medicine Case manager Note |
|
87254-9
|
Addiction medicine Consult note |
|
87255-6
|
Addiction medicine Counseling note |
|
87245-7
|
Addiction medicine Custodial care facility Note |
|
87256-4
|
Addiction medicine Discharge summary |
|
87248-1
|
Addiction medicine Education note |
|
87257-2
|
Addiction medicine Group counseling note |
|
87259-8
|
Addiction medicine History and physical note |
|
87246-5
|
Addiction medicine Hospital Note |
|
87260-6
|
Addiction medicine Initial evaluation note |
|
86211-0
|
Addiction medicine Physician Note |
|
87247-3
|
Addiction medicine Medication management note |
|
34857-3
|
Addiction medicine Note |
|
87262-2
|
Addiction medicine Nurse Note |
|
87249-9
|
Addiction medicine Outpatient Note |
|
87244-0
|
Addiction medicine Telephone encounter Note |
|
87253-1
|
Addiction medicine Plan of care note |
|
93892-8
|
Addiction medicine Progress note |
|
87250-7
|
Addiction medicine Referral note |
|
87258-0
|
Addiction medicine Risk assessment and screening note |
|
90760-0
|
Addiction medicine Social worker Note |
|
87263-0
|
Addiction medicine Team Note |
|
87264-8
|
Addiction medicine Therapist Note |
|
75422-6
|
Addiction psychiatry Group counseling note |
|
75423-4
|
Addiction psychiatry Note |
|
46696-1
|
Additional comments [RFC] |
|
74570-3
|
Additional details of event or unsafe condition [AHRQ] |
|
77599-9
|
Additional documentation |
|
81317-0
|
Additional pathological findings [Identifier] in Specimen |
|
44624-5
|
Additional pathological findings in Tumor |
|
92634-5
|
Address type |
|
91892-0
|
Address Volunteer |
|
74292-4
|
Additional cause of injury [NTDS] |
|
30288-5
|
Adefovir [Susceptibility] by Genotype method |
|
30274-5
|
Adefovir [Susceptibility] by Phenotype method |
|
72259-5
|
Adefovir [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
30304-0
|
Adefovir [Susceptibility] |
|
75133-9
|
Adenine [Moles/volume] in Cerebral spinal fluid |
|
4108-7
|
Adenine [Mass] of Dose |
|
1719-4
|
Adenine [Mass/volume] in Serum |
|
75131-3
|
Adenine [Moles/volume] in Serum or Plasma |
|
59203-0
|
Adenine/Creatinine [Molar ratio] in Urine |
|
1722-8
|
Adenosine deaminase [Enzymatic activity/volume] in Blood |
|
47996-4
|
Adenosine deaminase binding protein [Units/volume] in Urine |
|
1723-6
|
Adenosine deaminase binding protein [Mass/volume] in Urine |
|
35703-8
|
Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
79404-0
|
Adenosine deaminase [Enzymatic activity/substance] in Red Blood Cells |
|
50395-3
|
Adenosine deaminase [Enzymatic activity/mass] in Chorionic villus sample |
|
75052-1
|
Adenosine deaminase [Enzymatic activity/volume] in DBS |
|
59023-2
|
Adenosine deaminase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
47548-3
|
Adenosine deaminase [Enzymatic activity/mass] in Fibroblast |
|
9404-5
|
Adenosine deaminase [Enzymatic activity/volume] in Body fluid |
|
49760-2
|
Adenosine deaminase [Enzymatic activity/volume] in Pericardial fluid |
|
35704-6
|
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid |
|
49759-4
|
Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid |
|
47549-1
|
Adenosine deaminase [Enzymatic activity/mass] in Red Blood Cells |
|
47826-3
|
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma |
|
51799-5
|
Adenosine deaminase [Enzymatic activity/volume] in Synovial fluid |
|
50591-7
|
Adenosine deaminase [Enzymatic activity/mass] in Trophoblasts |
|
47550-9
|
Adenosine deaminase [Entitic Catalytic Activity] in Leukocytes |
|
79451-1
|
Adenosine deaminase [Enzymatic activity/mass] in Leukocytes |
|
47827-1
|
Adenosyl homocysteine hydrolase [Enzymatic activity/mass] in Red Blood Cells |
|
80586-1
|
Adenovirus hexon gene [Presence] in Nasopharynx by NAA with probe detection |
|
24126-5
|
Adenovirus type [Identifier] in Unspecified specimen by Neutralization test |
|
9782-4
|
Adenovirus sp identified in Unspecified specimen by Organism specific culture |
|
11035-3
|
Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells |
|
44051-1
|
Adenylate kinase [Enzymatic activity/mass] in Red Blood Cells |
|
1731-9
|
Adenylate kinase [Enzymatic activity/volume] in Serum |
|
78689-7
|
Adenylosuccinate/Creatinine [Molar ratio] in Urine |
|
75294-9
|
Adequacy of breastmilk andor formula |
|
80449-2
|
Adequacy of infant formula intake |
|
89077-2
|
Adequacy of information on+time spent reading ADAPTABLE web site [ADAPTABLE] |
|
79453-7
|
Alcohol dehydrogenase [Enzymatic activity/mass] in Liver |
|
1760-8
|
Alcohol dehydrogenase [Enzymatic activity/volume] in Serum |
|
74155-3
|
ADHD action plan |
|
94039-5
|
ADHD question consistency score |
|
78370-4
|
ADHD diagnostic rating scale interpretation [Vanderbilt ADHD] |
|
78369-6
|
ADHD hyperactive symptoms mean score percent difference [Calculated] |
|
94033-8
|
ADHD hyperactive symptoms severity |
|
78373-8
|
ADHD inattentive symptoms mean score percent difference [Calculated] |
|
94032-0
|
ADHD inattentive symptoms severity |
|
94018-9
|
ADHD screening report |
|
94031-2
|
ADHD type |
|
71799-1
|
Adherence to prescribed medication instructions [Reported] |
|
43609-7
|
Adipate [Presence] in 24 hour Urine |
|
75087-7
|
Adipate [Moles/volume] in Serum or Plasma |
|
26751-8
|
Adipate [Presence] in Urine |
|
1733-5
|
Adipate [Mass/volume] in Urine |
|
49933-5
|
Adipate.unsaturated/Creatinine [Molar ratio] in Urine |
|
13703-4
|
Adipate/Creatinine [Mass Ratio] in Urine |
|
29859-6
|
Adipate/Creatinine [Molar ratio] in Urine |
|
49934-3
|
Adipolactone/Creatinine [Molar ratio] in Urine |
|
47828-9
|
Adiponectin [Mass/volume] in Serum or Plasma |
|
55819-7
|
Adiponectin.high molecular weight [Mass/volume] in Serum or Plasma |
|
50302-9
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Amniotic fluid |
|
50303-7
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Cerebral spinal fluid |
|
50304-5
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS |
|
50166-8
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma |
|
50301-1
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Urine |
|
50305-2
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine |
|
74628-9
|
Adipoylcarnitine (C6-DC) [Moles/volume] in DBS |
|
74593-5
|
Adipoylcarnitine (C6-DC) [Enzymatic activity/mass] in Fibroblast |
|
18450-7
|
Adipoylcarnitine (C6-DC) [Mass/volume] in Serum or Plasma |
|
39002-1
|
Adipoylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma |
|
81769-2
|
Adipoylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine |
|
81168-7
|
Site of adjacent organ or tissue involvement Cancer specimen |
|
85301-0
|
Adjacent structure invaded by tumor [Anatomy] in Breast cancer specimen by Macroscopy |
|
85322-6
|
Adjacent structure invaded by tumor [Anatomy] in Breast cancer specimen by Light microscopy |
|
85275-6
|
Adjacent structure invaded by tumor [Anatomy] in Colorectal cancer specimen by Light microscopy |
|
57267-7
|
ADL or IADL assistance frequency from any caregiver [CMS Assessment] |
|
73831-0
|
Adolescent depression screening assessment |
|
81381-6
|
Administrative information associated with this personal advance care plan [Reported] |
|
51851-4
|
Administrative note |
|
74704-8
|
Administrative or billing system component [AHRQ] |
|
52455-3
|
Admission date |
|
86532-9
|
Admission notification note |
|
78020-5
|
Admission priority [NHCS] |
|
75522-3
|
Admission time |
|
67851-6
|
Admission evaluation note |
|
51849-8
|
Admission history and physical note |
|
85398-6
|
Admitted from Facility |
|
46578-1
|
Admitted to Inpatient facility [CMS Assessment] |
|
57909-4
|
ADNFLE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75136-2
|
Adenosine [Moles/volume] in Cerebral spinal fluid |
|
75142-0
|
Adenosine [Moles/volume] in Serum or Plasma |
|
75160-2
|
Adenosine/Creatinine [Molar ratio] in Urine |
|
90709-7
|
Adolescent medicine Consult note |
|
68611-3
|
Adolescent medicine Diagnostic study note |
|
68612-1
|
Adolescent medicine Discharge summary |
|
68614-7
|
Adolescent medicine History and physical note |
|
68619-6
|
Adolescent medicine Hospital Consult note |
|
68620-4
|
Adolescent medicine Hospital Letter |
|
68615-4
|
Adolescent medicine Note |
|
89878-3
|
Adolescent medicine Outpatient Note |
|
68616-2
|
Adolescent medicine Preoperative evaluation and management note |
|
68617-0
|
Adolescent medicine Progress note |
|
89887-4
|
Adolescent medicine Telehealth Note |
|
68618-8
|
Adolescent medicine Transfer summary note |
|
82871-5
|
Adenosine diphosphate [Entitic substance] in Platelets |
|
1724-4
|
Adenosine diphosphate [Mass/volume] in Serum |
|
14232-3
|
Adrenal Ab [Presence] in Serum |
|
57745-2
|
Adrenal Ab [Presence] in Serum by Immunofluorescence |
|
8059-8
|
Adrenal Ab [Units/volume] in Serum |
|
32661-1
|
Adrenal Ab [Titer] in Serum |
|
5043-5
|
Adrenal Ab [Titer] in Serum by Immunofluorescence |
|
6923-7
|
Adrenal cortex Ab [Units/volume] in Serum by Immunofluorescence |
|
43608-9
|
Adrenal cortex Ab [Presence] in Serum |
|
5044-3
|
Adrenal cortex Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
8060-6
|
Adrenal cortex Ab [Units/volume] in Serum |
|
25499-5
|
Adrenal cortex Ab [Titer] in Serum by Immunofluorescence |
|
74967-1
|
Adrenal cortex IgG Ab [Presence] in Serum by Immunofluorescence |
|
56670-3
|
Adrenal cortex IgG Ab [Units/volume] in Serum |
|
66122-3
|
Adrenal gland Pathology biopsy report |
|
79452-9
|
Adenylosuccinate lyase [Enzymatic activity/substance] in Red Blood Cells |
|
1732-7
|
Adenylosuccinate lyase [Enzymatic activity/volume] in Serum |
|
73832-8
|
Adult depression screening assessment |
|
22765-2
|
Adult fly identified in Unspecified specimen |
|
91687-4
|
Adult self-report long form total score [MFQ] |
|
91686-6
|
Adult self-report long short form total score [MFQ] |
|
59061-2
|
Adulterants [Interpretation] in Urine |
|
61363-8
|
Adenovirus 3+4+7+21 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31709-9
|
Adenovirus 40+41 Ag [Presence] in Stool |
|
6306-5
|
Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay |
|
82209-8
|
Adenovirus 40+41 DNA [Presence] in Stool by NAA with non-probe detection |
|
92690-7
|
Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection |
|
80674-5
|
Adenovirus 40+41fiber protein gene [Presence] in Stool by NAA with probe detection |
|
22793-4
|
Aleutian disease virus Ab [Presence] in Serum |
|
22792-6
|
Aleutian disease virus Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
|
86330-8
|
Adenovirus B(11) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86331-6
|
Adenovirus B(14) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86329-0
|
Adenovirus B(16) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86328-2
|
Adenovirus B(21) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86334-0
|
Adenovirus B(3) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86332-4
|
Adenovirus B(7) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
92136-1
|
Adenovirus B+C+E DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
73755-1
|
Adenovirus B+E DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92828-3
|
Adenovirus B+E DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
73754-4
|
Adenovirus C DNA [Presence] in Nasopharynx by NAA with probe detection |
|
86333-2
|
Adenovirus E(4) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
75320-2
|
Advance directive |
|
75791-4
|
Advance directive - request for antibiotics |
|
75787-2
|
Advance directive - request for intubation |
|
75790-6
|
Advance directive - request for IV fluid and support |
|
75789-8
|
Advance directive - request for life support |
|
75792-2
|
Advance directive - request for resuscitation that differs from cardiopulmonary resuscitation |
|
75788-0
|
Advance directive - request for tube feeding |
|
93442-2
|
Advance directive document format |
|
42348-3
|
Advance directives |
|
53243-2
|
Advanced beneficiary notice |
|
82608-1
|
Advancing care information for population |
|
82813-7
|
Adverse Childhood Experiences [ACE] |
|
93308-5
|
Genetic variation's effect on risk of adverse drug reaction |
|
85893-6
|
Adverse event note |
|
30969-0
|
Adverse event following prior vaccination [Complex] Brother Set |
|
30968-2
|
Adverse event following prior vaccination in patient [Complex] Set |
|
35286-4
|
Adverse event following prior vaccination [Complex] Sibling Set |
|
30970-8
|
Adverse event following prior vaccination [Complex] Sister Set |
|
30967-4
|
Adverse event previously reported VAERS |
|
81426-9
|
Microscopic observation [Identifier] in Venous blood by Acetate esterase stain |
|
81423-6
|
Microscopic observation [Identifier] in Bone marrow by Acetate esterase stain |
|
10765-6
|
Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
|
32818-7
|
Microscopic observation [Identifier] in Unspecified specimen by Acetate esterase stain |
|
30971-6
|
Adverse event VAERS |
|
10429-9
|
AE 1 Ag [Presence] in Tissue by Immune stain |
|
10430-7
|
AE 3 Ag [Presence] in Tissue by Immune stain |
|
7500-2
|
Aedes mosquito triggered histamine release [Units/volume] in Blood |
|
6177-0
|
Aedes mosquito IgE Ab [Units/volume] in Serum |
|
15856-8
|
Aedes mosquito IgE Ab RAST class [Presence] in Serum |
|
61208-5
|
Aedes mosquito IgE Ab/IgE total in Serum |
|
56322-1
|
Aedes mosquito IgG4 Ab [Mass/volume] in Serum |
|
92909-1
|
Aerodigestive medicine Outpatient Note |
|
30122-6
|
Aeromonas sp [Presence] in Unspecified specimen by Organism specific culture |
|
85587-4
|
Aerospace medicine Note |
|
32991-2
|
Aesthetics {Dental arch}.denture.complete Observed |
|
32993-8
|
Aesthetics {Dental arch}.denture.complete - Reported |
|
32992-0
|
Aesthetics {Dental arch}.denture.partial Observed |
|
32994-6
|
Aesthetics {Dental arch}.denture.partial - Reported |
|
73873-2
|
Androstenetriol [Moles/volume] in 24 hour Urine |
|
73874-0
|
Androstenetriol [Moles/time] in 24 hour Urine |
|
73875-7
|
Androstenetriol [Moles/volume] in Urine |
|
81808-8
|
Androstenetriol/Creatinine [Molar ratio] in Urine |
|
43908-3
|
Avian encephalomyelitis virus Ab [Presence] in Cerebral spinal fluid |
|
22090-5
|
Avian encephalomyelitis virus Ab [Presence] in Serum |
|
15436-9
|
Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay |
|
15437-7
|
Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
91649-4
|
Affectionate support score [MOS Social Support Survey] |
|
87584-9
|
Aflatoxin B1 [Mass/mass] in Unspecified specimen |
|
87583-1
|
Aflatoxin B2 [Mass/mass] in Unspecified specimen |
|
23654-7
|
Aflatoxin [Mass/mass] in Feed |
|
87582-3
|
Aflatoxin G1 [Mass/mass] in Unspecified specimen |
|
87581-5
|
Aflatoxin G2 [Mass/mass] in Unspecified specimen |
|
32657-9
|
Aflatoxin IgA Ab [Units/volume] in Serum or Plasma |
|
32659-5
|
Aflatoxin IgE Ab [Units/volume] in Serum or Plasma |
|
32656-1
|
Aflatoxin IgG Ab [Units/volume] in Serum or Plasma |
|
32658-7
|
Aflatoxin IgM Ab [Units/volume] in Serum or Plasma |
|
87580-7
|
Aflatoxin M1 [Mass/mass] in Unspecified specimen |
|
23655-4
|
Aflatoxin [Mass/mass] in Tissue |
|
23653-9
|
Aflatoxin [Mass/volume] in Unspecified specimen |
|
90290-8
|
Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29253-2
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted in Amniotic fluid |
|
23811-3
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma |
|
10459-6
|
Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
|
83074-5
|
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid by Immunoassay |
|
83075-2
|
Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay |
|
43798-8
|
Alpha-1-Fetoprotein [Presence] in Amniotic fluid |
|
19171-8
|
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid |
|
1832-5
|
Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid |
|
15019-3
|
Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
|
54348-8
|
Alpha-1-Fetoprotein [Mass/volume] in Cord blood |
|
59564-5
|
Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid |
|
1833-3
|
Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
|
43998-4
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes in Serum or Plasma |
|
43996-8
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes+weight in Serum or Plasma |
|
44910-8
|
Alpha-1-Fetoprotein [Units/volume] in Body fluid |
|
11207-8
|
Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
|
41273-4
|
Alpha-1-Fetoprotein interpretation in Amniotic fluid |
|
49318-9
|
Alpha-1-Fetoprotein interpretation in Amniotic fluid Narrative |
|
41274-2
|
Alpha-1-Fetoprotein interpretation in Serum or Plasma |
|
49246-2
|
Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative |
|
42332-7
|
Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma |
|
29595-6
|
Alpha-1-Fetoprotein [Multiple of the median] in Amniotic fluid |
|
49585-3
|
Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma |
|
20450-3
|
Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma |
|
50610-5
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted for multiple gestations in Serum or Plasma |
|
19172-6
|
Alpha-1-Fetoprotein [Units/volume] in Pleural fluid |
|
49762-8
|
Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid |
|
19173-4
|
Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid |
|
49761-0
|
Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid |
|
83072-9
|
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay |
|
83073-7
|
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay |
|
31993-9
|
Alpha-1-Fetoprotein [Presence] in Serum or Plasma |
|
19176-7
|
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma |
|
1834-1
|
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
|
19177-5
|
Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma |
|
23812-1
|
Alpha-1-Fetoprotein [Multiple of the median] unadjusted in Serum or Plasma |
|
43997-6
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted for weight in Serum or Plasma |
|
53961-9
|
Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma |
|
53962-7
|
Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma |
|
53960-1
|
Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma |
|
10481-0
|
Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
|
27140-3
|
Follitropin.alpha subunit [Mass/volume] in Serum or Plasma |
|
2288-9
|
Follitropin.alpha subunit [Moles/volume] in Serum or Plasma |
|
92319-3
|
After not smoking for a while, I need to smoke in order to avoid feeling any discomfort [PROMIS] |
|
17839-2
|
Alpha fucosidase [Enzymatic activity/volume] in Blood |
|
79454-5
|
Alpha fucosidase [Enzymatic activity/volume] in DBS |
|
24046-5
|
Alpha fucosidase [Enzymatic activity/mass] in Fibroblast |
|
24045-7
|
Alpha fucosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1812-7
|
Alpha fucosidase [Enzymatic activity/mass] in Tissue |
|
23810-5
|
Alpha fucosidase [Units/volume] in Leukocytes |
|
24047-3
|
Alpha fucosidase [Enzymatic activity/mass] in Leukocytes |
|
33062-1
|
Blood group antigens tested for on Red Blood Cells |
|
77069-3
|
AGA gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
24058-0
|
Aspartylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
|
77068-5
|
AGA gene full mutation analysis in Blood or Tissue by Sequencing |
|
24059-8
|
Aspartylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
|
86449-6
|
Against medical advice note |
|
55908-8
|
Alpha galactosidase A [Enzymatic activity/volume] in DBS |
|
24048-1
|
Alpha galactosidase A [Enzymatic activity/mass] in Fibroblast |
|
1813-5
|
Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma |
|
24049-9
|
Alpha galactosidase A [Enzymatic activity/mass] in Leukocytes |
|
30525-0
|
Age |
|
21612-7
|
Age - Reported |
|
42797-1
|
Age at first pregnancy |
|
39016-1
|
Age at death |
|
42798-9
|
Age at menarche |
|
42802-9
|
Age at menopause |
|
35267-4
|
Age at pathology Dx |
|
92661-8
|
Age when first fed something other than breast milk or formula |
|
79723-3
|
Age at 2nd eye involvement in a patient with initial unilateral retinoblastoma |
|
85700-3
|
Age and setting of exposure to illness verified |
|
79724-1
|
Age at first awareness of night blindness |
|
85934-8
|
Age at cough onset |
|
43993-5
|
Age at delivery |
|
85724-3
|
Age of Mother --at delivery |
|
85698-9
|
Age at time of immunity testing |
|
75272-5
|
Age at event onset |
|
75273-3
|
Age at event onset Family member |
|
30972-4
|
Age at onset of adverse event |
|
85949-6
|
Age at rash onset |
|
77998-3
|
Age at time of case investigation |
|
74500-0
|
Age at time of event [AHRQ] |
|
49546-5
|
Age of Blood specimen |
|
92657-6
|
Age when first fed formula |
|
91532-2
|
Age when first injected non-prescription drug |
|
91385-5
|
Age when first used cocaine or crack |
|
91386-3
|
Age when first used heroin |
|
91384-8
|
Age when first used marijuana |
|
88086-4
|
Age range for infant less than 1 month old |
|
88860-2
|
Age score for risk calculation |
|
92659-2
|
Age when stopped smoking cigarettes completely |
|
29553-5
|
Age calculated |
|
21611-9
|
Age estimated |
|
57900-3
|
Age of Unspecified specimen |
|
87296-0
|
Age--at delivery Father |
|
46496-6
|
Agency patient number [CMS Assessment] |
|
91887-0
|
Agency type |
|
90740-2
|
Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore |
|
81830-2
|
AGL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1846-5
|
Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells |
|
82222-1
|
Amylo-alpha-1,6-glucosidase [Enzymatic activity/mass] in Leukocytes |
|
33215-5
|
Neutrophils.agranular [Presence] in Blood by Light microscopy |
|
33216-3
|
Platelets agranular [Presence] in Blood by Light microscopy |
|
80570-5
|
Agreement |
|
59245-1
|
Alanine glyoxylate aminotransferase [Enzymatic activity/mass] in Tissue |
|
69478-6
|
AGXT gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
69384-6
|
AGXT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
69383-8
|
AGXT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74520-8
|
Complement alternate pathway AH50 actual/normal in Serum by Immunoassay |
|
13087-2
|
Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
|
93460-4
|
AH-7921 [Mass/volume] in Urine by Confirmatory method |
|
93457-0
|
AH-8529 [Mass/volume] in Urine by Confirmatory method |
|
93458-8
|
AH-8533 [Mass/volume] in Urine by Confirmatory method |
|
30206-7
|
Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma |
|
2108-9
|
Choriogonadotropin.alpha subunit [Presence] in Serum or Plasma |
|
27252-6
|
Choriogonadotropin.alpha subunit [Mass/volume] in Serum or Plasma |
|
2109-7
|
Choriogonadotropin.alpha subunit [Moles/volume] in Serum or Plasma |
|
77066-9
|
AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77065-1
|
AHCY gene full mutation analysis in Blood or Tissue by Sequencing |
|
88653-1
|
Acute heart failure within 24 hours prior to procedure |
|
22771-0
|
African horse sickness virus Ab [Presence] in Serum |
|
22768-6
|
African horse sickness virus Ab [Presence] in Serum by Complement fixation |
|
22766-0
|
African horse sickness virus Ab [Presence] in Serum by Immunoassay |
|
22767-8
|
African horse sickness virus Ab [Presence] in Serum by Immunoblot |
|
34885-4
|
African horse sickness virus Ab [Presence] in Serum by Immunofluorescence |
|
31220-7
|
African horse sickness virus Ab [Units/volume] in Serum |
|
22770-2
|
African horse sickness virus Ab [Titer] in Serum |
|
22769-4
|
African horse sickness virus Ab [Titer] in Serum by Neutralization test |
|
22772-8
|
African horse sickness virus Ag [Presence] in Tissue by Immunoassay |
|
31715-6
|
African horse sickness virus Ag [Presence] in Unspecified specimen |
|
22773-6
|
African horse sickness virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
22774-4
|
African horse sickness virus RNA [Presence] in Tissue by NAA with probe detection |
|
22775-1
|
African horse sickness virus serotype [Identifier] in Serum by Neutralization test |
|
22776-9
|
African horse sickness virus serotype [Identifier] in Unspecified specimen by Neutralization test |
|
22083-0
|
Alcelaphine herpesvirus 1 Ab [Presence] in Serum |
|
22787-6
|
Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
20873-6
|
Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
31221-5
|
Alcelaphine herpesvirus 1 Ab [Units/volume] in Serum |
|
22786-8
|
Alcelaphine herpesvirus 1 Ab [Titer] in Serum |
|
22788-4
|
Alcelaphine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
|
31717-2
|
Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen |
|
22789-2
|
Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22790-0
|
Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immune stain |
|
22791-8
|
Alcelaphine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
90320-3
|
Aichivirus C RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
90321-1
|
Aichivirus C RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
75872-2
|
Aids or devices usually used for dressing and grooming, arising, eating, AndOr walking [HAQ] |
|
75879-7
|
Aids or devices usually used for hygiene, reach, grip, AndOr activities [HAQ] |
|
53152-5
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in DBS |
|
53154-1
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in DBS |
|
53153-3
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in DBS |
|
53393-5
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in DBS |
|
34893-8
|
Aino virus Ab [Titer] in Serum |
|
34888-8
|
Aino virus Ab [Titer] in Serum by Neutralization test |
|
75396-2
|
AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75395-4
|
AIP gene full mutation analysis in Blood or Tissue by Sequencing |
|
75915-9
|
Air curtain status Infant microenvironment.incubator |
|
76257-5
|
Air cylinder Pressure |
|
75984-5
|
Air delivered during case [Volume] from Gas delivery system |
|
75985-2
|
Air delivered.total [Volume] in Reporting period from Gas delivery system |
|
76258-3
|
Air pipeline Pressure |
|
57908-6
|
AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
86508-9
|
Airspeed--unladen |
|
89186-1
|
Airway clearance technique performed [Identifier] |
|
92553-7
|
Airway clearance technique plan to perform [Identifier] |
|
71574-8
|
Airway device being confirmed NEMSIS |
|
76004-1
|
Airway occlusion pressure |
|
71576-3
|
Airway device placement confirmation NEMSIS |
|
90867-3
|
Airway problem impacting orthodontic treatment |
|
75946-4
|
Airway resistance |
|
75947-2
|
Airway resistance --during expiration |
|
75948-0
|
Airway resistance --during inspiration |
|
91981-1
|
Airway resistance measured/predicted by Plethysmograph body box |
|
81442-6
|
Airway resistance --post bronchodilation |
|
81443-4
|
Airway resistance --pre bronchodilation |
|
89203-4
|
Airway suction device [Type] |
|
60955-2
|
Airway temperature |
|
75890-4
|
Abbreviated Injury Scale predot code AAAM |
|
75891-2
|
Abbreviated Injury Scale severity score AAAM |
|
76066-0
|
Abbreviated Injury Scale version code AAAM |
|
34894-6
|
Akabane virus Ab [Titer] in Serum |
|
34889-6
|
Akabane virus Ab [Titer] in Serum by Neutralization test |
|
87489-1
|
AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
69802-7
|
Alpha ketoglutarate [Moles/volume] in Cerebral spinal fluid |
|
1817-6
|
Alpha ketoglutarate [Mass/volume] in Serum or Plasma |
|
69803-5
|
Alpha ketoglutarate [Moles/volume] in Serum or Plasma |
|
27271-6
|
Alpha ketoglutarate [Presence] in Urine |
|
13678-8
|
Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine |
|
29507-1
|
Alpha ketoglutarate/Creatinine [Molar ratio] in Urine |
|
42777-3
|
AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74127-2
|
Akt1 phosphate Ag [Presence] in Tissue by Immune stain |
|
70072-4
|
Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid |
|
70073-2
|
Amyloid beta 40 peptide [Mass/volume] in Plasma |
|
33203-1
|
Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid |
|
33200-7
|
Amyloid beta 42 peptide [Mass/volume] in Plasma |
|
10741-7
|
Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
|
1770-7
|
Aliphatic carboxylate, C14-C26.absorption [Mass/volume] in Serum or Plasma |
|
1771-5
|
Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Serum or Plasma |
|
55828-8
|
Aliphatic carboxylate, C14-C26.esters [Presence] in Stool |
|
1772-3
|
Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Stool |
|
10465-3
|
Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
|
10743-3
|
Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
|
10742-5
|
Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
|
10744-1
|
Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
|
10463-8
|
Amyloid A component Ag [Presence] in Tissue by Immune stain |
|
53150-9
|
Alanine+Beta Alanine+Sarcosine [Moles/volume] in DBS |
|
15137-3
|
Alanine+Ethanolamine [Presence] in Serum or Plasma |
|
15142-3
|
Alanine+Ethanolamine [Presence] in Urine |
|
38319-0
|
Alachlor [Mass/volume] in Water |
|
10460-4
|
Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
|
25453-2
|
Lactalbumin alpha IgA Ab [Units/volume] in Serum |
|
25454-0
|
Lactalbumin alpha IgA Ab RAST class [Presence] in Serum |
|
7445-0
|
Lactalbumin alpha IgE Ab [Units/volume] in Serum |
|
15529-1
|
Lactalbumin alpha IgE Ab RAST class [Presence] in Serum |
|
61213-5
|
Lactalbumin alpha IgE Ab/IgE total in Serum |
|
51530-4
|
Lactalbumin alpha IgG Ab [Presence] in Serum |
|
11176-5
|
Lactalbumin alpha IgG Ab [Units/volume] in Serum |
|
21358-7
|
Lactalbumin alpha IgG Ab RAST class [Presence] in Serum |
|
26425-9
|
Lactalbumin alpha IgG4 Ab [Units/volume] in Serum |
|
26426-7
|
Lactalbumin alpha IgG4 Ab RAST class [Presence] in Serum |
|
56301-5
|
Lactalbumin alpha IgG4 Ab [Mass/volume] in Serum |
|
63418-8
|
Lactalbumin alpha IgG Ab [Mass/volume] in Serum |
|
48206-7
|
Lactalbumin alpha triggered leukotriene release [Mass/volume] by Leukocytes |
|
26795-5
|
Alanine [Presence] in 24 hour Urine |
|
1739-2
|
Alanine [Mass/time] in 24 hour Urine |
|
25843-4
|
Alanine [Moles/volume] in 24 hour Urine |
|
25301-3
|
Alanine [Moles/time] in 24 hour Urine |
|
12280-4
|
Alanine [Mass/volume] in Amniotic fluid |
|
27013-2
|
Alanine [Moles/volume] in Amniotic fluid |
|
1735-0
|
Alanine [Mass/volume] in Cerebral spinal fluid |
|
22657-1
|
Alanine [Moles/volume] in Cerebral spinal fluid |
|
47551-7
|
Alanine [Moles/volume] in DBS |
|
32222-2
|
Alanine [Moles/volume] in Body fluid |
|
1736-8
|
Alanine [Presence] in Serum or Plasma |
|
1737-6
|
Alanine [Mass/volume] in Serum or Plasma |
|
20636-7
|
Alanine [Moles/volume] in Serum or Plasma |
|
47554-1
|
Alanine/Amino acids.total in Amniotic fluid |
|
47553-3
|
Alanine/Amino acids.total in Cerebral spinal fluid |
|
47556-6
|
Alanine/Amino acids.total in DBS |
|
47552-5
|
Alanine/Amino acids.total in Hair |
|
47555-8
|
Alanine/Amino acids.total in Serum or Plasma |
|
47557-4
|
Alanine/Amino acids.total in Unspecified specimen |
|
16323-8
|
Alanine [Presence] in Urine |
|
1738-4
|
Alanine [Mass/volume] in Urine |
|
27326-8
|
Alanine [Moles/volume] in Urine |
|
32221-4
|
Alanine [Moles/volume] in Vitreous fluid |
|
22724-9
|
Alanine [Moles/volume] in Unspecified specimen |
|
44291-3
|
Alanine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56671-1
|
Alanine/Creatinine [Ratio] in 24 hour Urine |
|
25844-2
|
Alanine/Creatinine [Molar ratio] in 24 hour Urine |
|
13704-2
|
Alanine/Creatinine [Mass Ratio] in Urine |
|
30068-1
|
Alanine/Creatinine [Ratio] in Urine |
|
22698-5
|
Alanine/Creatinine [Molar ratio] in Urine |
|
88018-7
|
Alanine/Lysine [Mass Ratio] in DBS |
|
79581-5
|
Alanylproline [Moles/volume] in Serum or Plasma |
|
79579-9
|
Alanylproline/Creatinine [Molar ratio] in Urine |
|
59067-9
|
ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82458-1
|
Alaska pollock roe IgE Ab [Units/volume] in Serum |
|
82459-9
|
Alaska pollock roe IgE Ab RAST class [Presence] in Serum |
|
1756-6
|
Albumin in CSF/Albumin in Serum or Plasma |
|
66765-9
|
Albumin in pericardial fld/Albumin in Serum or Plasma |
|
66766-7
|
Albumin in peritoneal fluid/Albumin in Serum or Plasma |
|
75222-0
|
Microscopic observation [Identifier] in Throat by Alberts stain |
|
48669-6
|
Albumin and Immunoglobulin Quotient [Interpretation] in Serum and CSF |
|
17819-4
|
Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
|
77940-5
|
Albumin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
|
49002-9
|
Albumin [Mass/time] in Urine collected for unspecified duration |
|
40051-5
|
Albumin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
40059-8
|
Albumin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
|
40060-6
|
Albumin [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
|
40050-7
|
Albumin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
13986-5
|
Albumin/Protein.total in 24 hour Urine by Electrophoresis |
|
72596-0
|
Albumin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
|
51190-7
|
Albumin [Mass/volume] in 24 hour Urine by Electrophoresis |
|
6941-9
|
Albumin [Mass/time] in 24 hour Urine by Electrophoresis |
|
29946-1
|
Albumin [Presence] in 24 hour Urine by Electrophoresis |
|
21059-1
|
Albumin [Mass/volume] in 24 hour Urine |
|
1755-8
|
Albumin [Mass/time] in 24 hour Urine |
|
40061-4
|
Albumin [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
|
40052-3
|
Albumin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
23806-3
|
Albumin [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
21058-3
|
Albumin [Mass/volume] in Serum or Plasma --2 hours post peritoneal dialysis |
|
40048-1
|
Albumin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
40062-2
|
Albumin [Mass/volume] in Serum or Plasma --3 days post XXX challenge |
|
40053-1
|
Albumin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40049-9
|
Albumin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
40047-3
|
Albumin [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge |
|
40063-0
|
Albumin [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
|
40054-9
|
Albumin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
23807-1
|
Albumin [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
|
40055-6
|
Albumin [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
40057-2
|
Albumin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
40056-4
|
Albumin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
40058-0
|
Albumin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
1745-9
|
Albumin [Mass/volume] in Amniotic fluid |
|
76631-1
|
Albumin [Mass/volume] in Blood by Bromocresol purple (BCP) dye binding method |
|
1757-4
|
Albumin renal clearance in 24 hour Urine and Serum or Plasma |
|
10385-3
|
Albumin concentration given |
|
2861-3
|
Albumin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
43711-1
|
Albumin [Presence] in Cerebral spinal fluid |
|
1746-7
|
Albumin [Mass/volume] in Cerebral spinal fluid |
|
76480-3
|
Albumin [Moles/volume] in Cerebral spinal fluid |
|
40599-3
|
Albumin [Mass/volume] in Peritoneal dialysis fluid |
|
43212-0
|
Albumin [Mass/volume] in Body fluid by Electrophoresis |
|
43713-7
|
Albumin [Presence] in Body fluid |
|
1747-5
|
Albumin [Mass/volume] in Body fluid |
|
13873-5
|
Albumin.glycated/Albumin.total in Serum or Plasma |
|
1758-2
|
Albumin.glycated [Mass/volume] in Serum or Plasma |
|
86921-4
|
Albumin goal [Mass/volume] Serum or Plasma |
|
10386-1
|
Albumin given [Volume] |
|
13974-1
|
Albumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
54464-3
|
Albumin/Protein.total in Dialysis fluid by Electrophoresis |
|
17820-2
|
Albumin/Protein.total in Body fluid by Electrophoresis |
|
35706-1
|
Albumin/Protein.total in Serum or Plasma |
|
13980-8
|
Albumin/Protein.total in Serum or Plasma by Electrophoresis |
|
15124-1
|
Albumin/Protein.total in Synovial fluid by Electrophoresis |
|
13992-3
|
Albumin/Protein.total in Urine by Electrophoresis |
|
72599-4
|
Albumin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
|
72600-0
|
Albumin/Protein.total [Pure mass fraction] in Body fluid by Electrophoresis |
|
72598-6
|
Albumin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
|
72597-8
|
Albumin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
|
51693-0
|
Albumin [Mass/volume] in Pericardial fluid |
|
1748-3
|
Albumin [Mass/volume] in Pleural fluid |
|
40046-5
|
Albumin [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
1749-1
|
Albumin [Mass/volume] in Peritoneal fluid |
|
72646-3
|
Albumin in serum - albumin in pericardial fluid [Mass concentration difference] |
|
61151-7
|
Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method |
|
62235-7
|
Albumin [Moles/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method |
|
61152-5
|
Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method |
|
62234-0
|
Albumin [Moles/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method |
|
2862-1
|
Albumin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
61195-4
|
Albumin [Mass/volume] in Serum or Plasma from Fetus |
|
43712-9
|
Albumin [Presence] in Serum or Plasma |
|
77148-5
|
Albumin [Mass/volume] in Serum, Plasma or Blood by Bromocresol purple (BCP) dye binding method |
|
1751-7
|
Albumin [Mass/volume] in Serum or Plasma |
|
72647-1
|
Albumin in serum - albumin in pleural fluid [Mass concentration difference] |
|
54347-0
|
Albumin [Moles/volume] in Serum or Plasma |
|
63549-0
|
Albumin in serum - albumin in peritoneal fluid [Mass concentration difference] |
|
1750-9
|
Albumin [Mass/volume] in Semen |
|
10558-5
|
Albumin [Moles/volume] in Semen |
|
2863-9
|
Albumin [Mass/volume] in Synovial fluid by Electrophoresis |
|
1752-5
|
Albumin [Mass/volume] in Synovial fluid |
|
54346-2
|
Albumin [Mass/volume] in Stool |
|
50209-6
|
Albumin [Mass/time] in Urine collected for unspecified duration --supine |
|
6942-7
|
Albumin [Mass/volume] in Urine by Electrophoresis |
|
61196-2
|
Albumin [Mass/volume] in Urine from Fetus |
|
1753-3
|
Albumin [Presence] in Urine |
|
50949-7
|
Albumin [Presence] in Urine by Test strip |
|
1754-1
|
Albumin [Mass/volume] in Urine |
|
32293-3
|
Albumin [Mass/volume] in Unspecified specimen |
|
56153-0
|
Albumin in serum/Albumin in Peritoneal fluid |
|
13705-9
|
Albumin/Creatinine [Mass Ratio] in 24 hour Urine |
|
76401-9
|
Albumin/Creatinine [Ratio] in 24 hour Urine |
|
44707-8
|
Albumin/Creatinine [Mass Ratio] in Cerebral spinal fluid |
|
9318-7
|
Albumin/Creatinine [Mass Ratio] in Urine |
|
20621-9
|
Albumin/Creatinine [Presence] in Urine by Test strip |
|
32294-1
|
Albumin/Creatinine [Ratio] in Urine |
|
14585-4
|
Albumin/Creatinine [Molar ratio] in Urine |
|
9406-0
|
Albumin/Globulin [Mass Ratio] in 24 hour Urine |
|
44294-7
|
Albumin/Globulin [Mass Ratio] in 24 hour Urine by Electrophoresis |
|
14432-9
|
Albumin/Globulin [Mass Ratio] in Amniotic fluid |
|
14433-7
|
Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid |
|
68930-7
|
Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid by Electrophoresis |
|
12174-9
|
Albumin/Globulin [Mass Ratio] in Body fluid |
|
88709-1
|
Albumin/Globulin [Mass Ratio] in Body fluid by Electrophoresis |
|
14434-5
|
Albumin/Globulin [Mass Ratio] in Pleural fluid |
|
14435-2
|
Albumin/Globulin [Mass Ratio] in Peritoneal fluid |
|
1759-0
|
Albumin/Globulin [Mass Ratio] in Serum or Plasma |
|
44429-9
|
Albumin/Globulin [Mass Ratio] in Serum or Plasma by Electrophoresis |
|
14436-0
|
Albumin/Globulin [Mass Ratio] in Semen |
|
14437-8
|
Albumin/Globulin [Mass Ratio] in Synovial fluid |
|
9405-2
|
Albumin/Globulin [Mass Ratio] in Urine |
|
44293-9
|
Albumin/Globulin [Mass Ratio] in Urine by Electrophoresis |
|
73543-1
|
Albuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73542-3
|
Albuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9311-2
|
Albuterol [Mass/volume] in Serum or Plasma |
|
29635-0
|
Albuterol [Presence] in Urine |
|
74043-1
|
Alcohol abuse or dependence HL7.VMR-CDS |
|
74013-4
|
Alcoholic drinks per day |
|
76894-5
|
Alcohol makes it easier to talk to people [PROMIS] |
|
74205-6
|
Alcohol use [NTDS] |
|
50022-3
|
Ethanol+Methanol+Isopropyl alcohol+Acetone [Presence] in Serum, Plasma or Blood |
|
48342-0
|
Ethanol+Methanol+Isopropyl alcohol+Acetone [Moles/volume] in Serum or Plasma |
|
44940-5
|
Alcoholic drinks per week - Reported |
|
81833-6
|
ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
53646-6
|
Aldicarb [Presence] in Gastric fluid |
|
80634-9
|
Aldicarb sulfone [Mass/volume] in Urine |
|
87635-9
|
Aldicarb sulfone [Mass/mass] in Unspecified specimen |
|
80635-6
|
Aldicarb sulfoxide [Mass/volume] in Urine |
|
80633-1
|
Aldicarb [Mass/volume] in Urine |
|
87634-2
|
Aldicarb [Mass/mass] in Unspecified specimen |
|
36918-1
|
ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41120-7
|
ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49724-8
|
Aldolase [Enzymatic activity/volume] in Body fluid |
|
44801-9
|
Aldolase [Enzymatic activity/volume] in Pleural fluid |
|
2299-6
|
Aldolase [Enzymatic activity/volume] in Red Blood Cells |
|
72655-4
|
Aldolase [Enzymatic activity/mass] in Red Blood Cells |
|
1761-6
|
Aldolase [Enzymatic activity/volume] in Serum or Plasma |
|
41023-3
|
Aldosterone [Molar amount] in Urine collected for unspecified duration |
|
56578-8
|
Aldosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
56755-2
|
Aldosterone [Mass/volume] in Serum or Plasma --100 minutes post XXX challenge |
|
56558-0
|
Aldosterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
57588-6
|
Aldosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
57589-4
|
Aldosterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
13853-7
|
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 25 mg captopril PO |
|
57586-0
|
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post 25 mg captopril PO |
|
13852-9
|
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
50173-4
|
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
55471-7
|
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
15345-2
|
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57595-1
|
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
56579-6
|
Aldosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
31992-1
|
Aldosterone [Mass/volume] in 24 hour Urine |
|
1765-7
|
Aldosterone [Mass/time] in 24 hour Urine |
|
25845-9
|
Aldosterone [Moles/volume] in 24 hour Urine |
|
14587-0
|
Aldosterone [Moles/time] in 24 hour Urine |
|
13854-5
|
Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
|
57583-7
|
Aldosterone [Moles/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
|
49326-2
|
Aldosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
57587-8
|
Aldosterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
13855-2
|
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
50172-6
|
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
15346-0
|
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
57592-8
|
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
57593-6
|
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
57594-4
|
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
57585-2
|
Aldosterone [Mass/volume] in Serum or Plasma --3 hours post 25 mg captopril PO |
|
57584-5
|
Aldosterone [Moles/volume] in Serum or Plasma --3 hours post 25 mg captopril PO |
|
57590-2
|
Aldosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
57591-0
|
Aldosterone [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
58899-6
|
Aldosterone [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
77609-6
|
Aldosterone [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
56756-0
|
Aldosterone [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
|
1762-4
|
Aldosterone [Mass/volume] in Blood |
|
27988-5
|
Aldosterone [Mass/volume] in Serum or Plasma --baseline |
|
1734-3
|
Aldosterone renal clearance in 24 hour Urine and Serum or Plasma |
|
23808-9
|
Aldosterone free [Mass/time] in 24 hour Urine |
|
57579-5
|
Aldosterone [Mass/volume] in Serum or Plasma --post 25 mg captopril PO |
|
50258-3
|
Aldosterone [Moles/volume] in Serum or Plasma --post 25 mg captopril PO |
|
57580-3
|
Aldosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
|
50169-2
|
Aldosterone [Moles/volume] in Serum or Plasma --post XXX challenge |
|
57582-9
|
Aldosterone [Mass/volume] in Serum or Plasma --pre 25 mg captopril PO |
|
50259-1
|
Aldosterone [Moles/volume] in Serum or Plasma --pre 25 mg captopril PO |
|
57596-9
|
Aldosterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
50171-8
|
Aldosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
57581-1
|
Aldosterone [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
50170-0
|
Aldosterone [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
51422-4
|
Aldosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
92897-8
|
Aldosterone [Mass/volume] in Serum or Plasma by Immunoassay |
|
92896-0
|
Aldosterone [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
1763-2
|
Aldosterone [Mass/volume] in Serum or Plasma |
|
35185-8
|
Aldosterone [Mass or Moles/volume] in Serum or Plasma |
|
14586-2
|
Aldosterone [Moles/volume] in Serum or Plasma |
|
43604-8
|
Aldosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
27849-9
|
Aldosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16147-1
|
Aldosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16148-9
|
Aldosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16149-7
|
Aldosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
16329-5
|
Aldosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16330-3
|
Aldosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
16331-1
|
Aldosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
16332-9
|
Aldosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
1767-3
|
Aldosterone [Mass/volume] in Serum or Plasma --supine |
|
35187-4
|
Aldosterone [Mass or Moles/volume] in Serum or Plasma --supine |
|
15011-0
|
Aldosterone [Moles/volume] in Serum or Plasma --supine |
|
1768-1
|
Aldosterone [Mass/volume] in Serum or Plasma --upright |
|
35188-2
|
Aldosterone [Mass or Moles/volume] in Serum or Plasma --upright |
|
15012-8
|
Aldosterone [Moles/volume] in Serum or Plasma --upright |
|
1764-0
|
Aldosterone [Mass/volume] in Urine |
|
35186-6
|
Aldosterone [Mass or Moles/volume] in Urine |
|
15010-2
|
Aldosterone [Moles/volume] in Urine |
|
44295-4
|
Aldosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
13482-5
|
Aldosterone/Creatinine [Mass Ratio] in Urine |
|
34231-1
|
Aldosterone/Creatinine [Molar ratio] in Urine |
|
30894-0
|
Aldosterone/Renin [Ratio] in Plasma |
|
73853-4
|
Aldosterone-18-glucuronide [Moles/volume] in 24 hour Urine |
|
73854-2
|
Aldosterone-18-glucuronide [Moles/time] in 24 hour Urine |
|
43640-2
|
Aldosterone-18-glucuronide [Units/volume] in Urine |
|
73855-9
|
Aldosterone-18-glucuronide [Moles/volume] in Urine |
|
74729-5
|
Adrenoleukodystrophy protein (ALDP) [Presence] in Fibroblast by Immune stain |
|
38661-5
|
Aldrin [Mass/volume] in Air |
|
16333-7
|
Aldrin [Mass/volume] in Blood |
|
87668-0
|
Aldrin [Mass/mass] in Unspecified specimen |
|
73072-1
|
Alendronate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73071-3
|
Alendronate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73541-5
|
Alendronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73540-7
|
Alendronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
74018-3
|
Alert |
|
74017-5
|
Alert status |
|
7065-6
|
Alfalfa IgE Ab [Units/volume] in Serum |
|
15524-2
|
Alfalfa IgE Ab RAST class [Presence] in Serum |
|
7066-4
|
Alfalfa IgG Ab [Units/volume] in Serum |
|
21061-7
|
Alfalfa IgG Ab RAST class [Presence] in Serum |
|
63194-5
|
Alfalfa IgG Ab [Mass/volume] in Serum |
|
7067-2
|
Alfalfa Pollen IgE Ab [Units/volume] in Serum |
|
80122-5
|
Alfentanil [Mass/volume] in Blood by Confirmatory method |
|
78778-8
|
Alfentanil [Presence] in Blood by Screen method |
|
4109-5
|
Alfentanil [Mass] of Dose |
|
79153-3
|
Alfentanil [Mass/volume] in Body fluid |
|
78777-0
|
Alfentanil [Mass/mass] in Hair |
|
3307-6
|
Alfentanil [Mass/volume] in Serum or Plasma |
|
18383-0
|
Alfentanil [Presence] in Urine |
|
16334-5
|
Alfentanil [Mass/volume] in Urine |
|
86604-6
|
Alfentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
7068-0
|
Algae IgE Ab [Units/volume] in Serum |
|
63176-2
|
Algae IgG Ab [Mass/volume] in Serum |
|
2582-5
|
Lutropin.alpha subunit [Moles/volume] in Serum or Plasma |
|
17840-0
|
Alpha-L-iduronidase [Enzymatic activity/volume] in Blood |
|
55909-6
|
Alpha-L-iduronidase [Enzymatic activity/volume] in DBS |
|
24056-4
|
Alpha-L-iduronidase [Enzymatic activity/mass] in Fibroblast |
|
75053-9
|
Alpha-L-iduronidase [Enzymatic activity/volume] in Serum or Plasma |
|
1699-8
|
Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue |
|
24057-2
|
Alpha-L-iduronidase [Enzymatic activity/mass] in Leukocytes |
|
75113-1
|
Alpha linolenate (C18:3w3) [Entitic substance] in Red Blood Cells |
|
81013-5
|
Alpha linolenate intake 24 hour Estimated |
|
81014-3
|
Alpha linolenate intake 24 hour Measured |
|
35164-3
|
Alpha linolenate (C18:3w3) [Moles/volume] in Serum or Plasma |
|
16335-2
|
Hydrocarbons Aliphatic [Identifier] in Blood |
|
78779-6
|
Alizapride [Mass/volume] in Blood |
|
79154-1
|
Alizapride [Mass/volume] in Body fluid |
|
80123-3
|
Alizapride [Mass/mass] in Hair |
|
80201-7
|
Alizapride [Mass/volume] in Urine |
|
47303-3
|
Anaplastic lymphoma kinase Ag [Presence] in Tissue by Immune stain |
|
78210-2
|
ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78205-2
|
ALK gene rearrangements [Presence] in Blood or Tissue by FISH |
|
11159-1
|
Alkalase IgE Ab [Units/volume] in Serum |
|
15525-9
|
Alkalase IgE Ab RAST class [Presence] in Serum |
|
20680-5
|
Alkaloid identified in Ingesta by Thin layer chromatography (TLC) |
|
20679-7
|
Alkaloid identified in Plant by Thin layer chromatography (TLC) |
|
20678-9
|
Alkaloid identified in Urine by Thin layer chromatography (TLC) |
|
82220-5
|
Alkyl-dihydroxyacetonephosphate synthase [Enzymatic activity/mass] in Fibroblast |
|
54493-2
|
Allantoine [Moles/time] in 24 hour Urine by Electrophoresis |
|
75140-4
|
Allantoine [Moles/volume] in Cerebral spinal fluid |
|
75158-6
|
Allantoine [Moles/volume] in Serum or Plasma |
|
50306-0
|
Allantoine [Moles/volume] in Urine |
|
75155-2
|
Allantoine/Creatinine [Molar ratio] in Urine |
|
48008-7
|
Allele name [Identifier] |
|
92821-8
|
Allelic frequency in Population |
|
82120-7
|
Allelic phase |
|
82121-5
|
Allelic read depth |
|
53034-5
|
Allelic state |
|
19058-7
|
Allergens identified in Serum |
|
20662-3
|
Allergens tested for in Serum |
|
79151-7
|
Known allergies to food or environmental agents |
|
82606-5
|
Allergy or intolerance criticality |
|
83320-2
|
Allergy and Immunology Adverse event note |
|
77429-9
|
Allergy and Immunology Consult note |
|
68625-3
|
Allergy and Immunology Diagnostic study note |
|
68626-1
|
Allergy and Immunology Discharge summary |
|
77430-7
|
Allergy and Immunology Education note |
|
77438-0
|
Allergy and Immunology Flowsheet |
|
68628-7
|
Allergy and Immunology History and physical note |
|
68633-7
|
Allergy and Immunology Hospital Consult note |
|
68634-5
|
Allergy and Immunology Hospital Letter |
|
77431-5
|
Allergy and Immunology Initial evaluation note |
|
68629-5
|
Allergy and Immunology Note |
|
83565-2
|
Allergy and Immunology Nurse Note |
|
83566-0
|
Allergy and Immunology Nurse Outpatient Note |
|
84057-9
|
Allergy and Immunology Outpatient Note |
|
77443-0
|
Allergy and Immunology Plan of care note |
|
68630-3
|
Allergy and Immunology procedure note |
|
68631-1
|
Allergy and Immunology Progress note |
|
77432-3
|
Allergy and Immunology Referral note |
|
89895-7
|
Allergy and Immunology Telehealth Note |
|
68632-9
|
Allergy and Immunology Transfer summary note |
|
21062-5
|
Allobarbital [Mass/volume] in Serum or Plasma |
|
25560-4
|
Allobarbital [Moles/volume] in Serum or Plasma |
|
12502-1
|
Allobarbital [Presence] in Stool |
|
79576-5
|
Allocystathionine [Moles/volume] in Serum or Plasma |
|
79593-0
|
Allocystathionine/Creatinine [Molar ratio] in Urine |
|
59213-9
|
Alloisoleucine [Moles/time] in Urine collected for unspecified duration |
|
50174-2
|
Alloisoleucine [Moles/volume] in Amniotic fluid |
|
22658-9
|
Alloisoleucine [Moles/volume] in Cerebral spinal fluid |
|
50175-9
|
Alloisoleucine [Moles/volume] in Body fluid |
|
74875-6
|
Alloisoleucine [Moles/volume] in DBS --post therapeutic diet |
|
41398-9
|
Alloisoleucine [Presence] in Serum or Plasma |
|
27381-3
|
Alloisoleucine [Units/volume] in Serum or Plasma |
|
23809-7
|
Alloisoleucine [Mass/volume] in Serum or Plasma |
|
22670-4
|
Alloisoleucine [Moles/volume] in Serum or Plasma |
|
59212-1
|
Alloisoleucine [Moles/volume] in Urine |
|
22730-6
|
Alloisoleucine [Moles/volume] in Unspecified specimen |
|
73908-6
|
Alloisoleucine/Creatinine [Ratio] in Urine |
|
22699-3
|
Alloisoleucine/Creatinine [Molar ratio] in Urine |
|
55821-3
|
Allo-pregnanediol [Mass/volume] in 24 hour Urine |
|
55820-5
|
Allo-pregnanediol [Mass/time] in 24 hour Urine |
|
73858-3
|
Allo-pregnanediol [Moles/volume] in 24 hour Urine |
|
73857-5
|
Allo-pregnanediol [Moles/time] in 24 hour Urine |
|
73856-7
|
Allo-pregnanediol [Moles/volume] in Urine |
|
83136-2
|
Allo-pregnanediol/Creatinine [Molar ratio] in Urine |
|
82867-3
|
Allo-pregnanediolone [Moles/volume] in 24 hour Urine |
|
82866-5
|
Allo-pregnanediolone [Moles/time] in 24 hour Urine |
|
82868-1
|
Allo-pregnanediolone [Moles/volume] in Urine |
|
83135-4
|
Allo-pregnanediolone/Creatinine [Molar ratio] in Urine |
|
73070-5
|
Allopurinol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73069-7
|
Allopurinol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
79689-6
|
Allopurinol [Moles/volume] in Cerebral spinal fluid |
|
73538-1
|
Allopurinol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73539-9
|
Allopurinol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9736-0
|
Allopurinol [Mass/volume] in Serum or Plasma |
|
79662-3
|
Allopurinol [Moles/volume] in Serum or Plasma |
|
74928-3
|
Allopurinol [Mass/volume] in Serum or Plasma --trough |
|
79681-3
|
Allopurinol/Creatinine [Molar ratio] in Urine |
|
55825-4
|
Allo-tetrahydrocorticosterone [Mass/volume] in 24 hour Urine |
|
55824-7
|
Allo-tetrahydrocorticosterone [Mass/time] in 24 hour Urine |
|
73860-9
|
Allo-tetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
73861-7
|
Allo-tetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
73859-1
|
Allo-tetrahydrocorticosterone [Moles/volume] in Urine |
|
81805-4
|
Allo-tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
55823-9
|
Allo-tetrahydrodeoxycortisol [Mass/volume] in 24 hour Urine |
|
55822-1
|
Allo-tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine |
|
55826-2
|
Allo-tetrahydrocortisol [Mass/volume] in 24 hour Urine |
|
6869-2
|
Allo-tetrahydrocortisol [Mass/time] in 24 hour Urine |
|
73864-1
|
Allo-tetrahydrocortisol [Moles/volume] in 24 hour Urine |
|
73862-5
|
Allo-tetrahydrocortisol [Moles/time] in 24 hour Urine |
|
73863-3
|
Allo-tetrahydrocortisol [Moles/volume] in Urine |
|
81804-7
|
Allo-tetrahydrocortisol/Creatinine [Molar ratio] in Urine |
|
75774-0
|
Allowance to change advance directive preferences in the future regardless of mental state [Reported] |
|
7690-1
|
Allscale IgE Ab [Units/volume] in Serum |
|
7069-8
|
Allspice IgE Ab [Units/volume] in Serum |
|
15526-7
|
Allspice IgE Ab RAST class [Presence] in Serum |
|
56168-8
|
Allspice IgG4 Ab [Mass/volume] in Serum |
|
63136-6
|
Allspice IgG Ab [Mass/volume] in Serum |
|
16327-9
|
Allyl alcohol [Mass/volume] in Blood |
|
27017-3
|
Allyl alcohol [Presence] in Serum or Plasma |
|
12989-0
|
Allyl alcohol [Mass/volume] in Serum or Plasma |
|
38631-8
|
Allyl chloride [Mass/volume] in Air |
|
4-2
|
Almecillin [Susceptibility] by Disk diffusion (KB) |
|
3-4
|
Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
2-6
|
Almecillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18857-3
|
Almecillin [Susceptibility] |
|
5-9
|
Almecillin [Susceptibility] by Serum bactericidal titer |
|
78780-4
|
Alminoprofen [Mass/volume] in Blood |
|
78806-7
|
Alminoprofen [Mass/volume] in Body fluid |
|
80124-1
|
Alminoprofen [Mass/mass] in Hair |
|
7071-4
|
Almond triggered histamine release [Units/volume] in Blood |
|
6019-4
|
Almond IgE Ab [Units/volume] in Serum |
|
15527-5
|
Almond IgE Ab RAST class [Presence] in Serum |
|
39542-6
|
Almond IgE Ab/IgE total in Serum |
|
7070-6
|
Almond IgG Ab [Units/volume] in Serum |
|
21063-3
|
Almond IgG Ab RAST class [Presence] in Serum |
|
56169-6
|
Almond IgG4 Ab [Mass/volume] in Serum |
|
60348-0
|
Almond IgG Ab [Mass/volume] in Serum |
|
7072-2
|
Almond Tree IgE Ab [Units/volume] in Serum |
|
15528-3
|
Almond Tree IgE Ab RAST class [Presence] in Serum |
|
44606-2
|
ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10464-6
|
Amyloid P component Ag [Presence] in Tissue by Immune stain |
|
54907-1
|
Alkaline phosphatase [Enzymatic activity/volume] in Amniotic fluid |
|
53524-5
|
Alkaline phosphatase.bile/Alkaline phosphatase.total in Serum or Plasma |
|
20426-3
|
Alkaline phosphatase.bile [Enzymatic activity/volume] in Serum or Plasma |
|
1783-0
|
Alkaline phosphatase [Enzymatic activity/volume] in Blood |
|
55971-6
|
Alkaline phosphatase [Enzymatic activity/volume] in Cord blood |
|
15013-6
|
Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma |
|
40797-3
|
Alkaline phosphatase.bone [Presence] in Serum or Plasma |
|
1777-2
|
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
|
17838-4
|
Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
|
74996-0
|
Alkaline phosphatase.bone [Z-score] in Serum or Plasma |
|
59164-4
|
Alkaline phosphatase [Enzymatic activity/volume] in Dialysis fluid |
|
43731-9
|
Alkaline phosphatase.fetal+lung+lymphocyte [Presence] in Serum or Plasma |
|
34568-6
|
Alkaline phosphatase [Presence] in Body fluid |
|
15148-0
|
Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
|
1775-6
|
Alkaline phosphatase [Mass/volume] in Body fluid |
|
42718-7
|
Alkaline phosphatase.heat labile/Alkaline phosphatase.total in Serum or Plasma by Heat stability |
|
32351-9
|
Alkaline phosphatase.heat labile [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
43382-1
|
Alkaline phosphatase.heat stable/Alkaline phosphatase.total in Serum or Plasma by Heat stability |
|
32352-7
|
Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
43710-3
|
Alkaline phosphatase.heat stable [Presence] in Serum or Plasma by Heat stability |
|
53578-1
|
Alkaline phosphatase.intestinal 2/Alkaline phosphatase.total in Serum or Plasma |
|
71365-1
|
Alkaline phosphatase.intestinal 2 [Enzymatic activity/volume] in Serum or Plasma |
|
53579-9
|
Alkaline phosphatase.intestinal 3/Alkaline phosphatase.total in Serum or Plasma |
|
71366-9
|
Alkaline phosphatase.intestinal 3 [Enzymatic activity/volume] in Serum or Plasma |
|
15014-4
|
Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma |
|
40794-0
|
Alkaline phosphatase.intestinal [Presence] in Serum or Plasma |
|
1778-0
|
Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma |
|
43709-5
|
Alkaline phosphatase.intestinal+renal [Presence] in Serum or Plasma |
|
12805-8
|
Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma |
|
16182-8
|
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
33063-9
|
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Levamisole inhibition |
|
14588-8
|
Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma |
|
49243-9
|
Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
15348-6
|
Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma |
|
40796-5
|
Alkaline phosphatase.liver 1 [Presence] in Serum or Plasma |
|
13874-3
|
Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma |
|
15349-4
|
Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma |
|
40795-7
|
Alkaline phosphatase.liver 2 [Presence] in Serum or Plasma |
|
13875-0
|
Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma |
|
15015-1
|
Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma |
|
32135-6
|
Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
43939-8
|
Alkaline phosphatase.liver [Presence] in Serum or Plasma |
|
1779-8
|
Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma |
|
43708-7
|
Alkaline phosphatase.liver+bone [Presence] in Serum or Plasma |
|
12806-6
|
Alkaline phosphatase.lung [Enzymatic activity/volume] in Serum or Plasma |
|
49924-4
|
Alkaline phosphatase.macro/Alkaline phosphatase.total in Serum or Plasma |
|
35707-9
|
Alkaline phosphatase.macrohepatic/Alkaline phosphatase.total in Serum or Plasma |
|
26010-9
|
Alkaline phosphatase.other fractions/Alkaline phosphatase.total in Serum or Plasma |
|
33421-9
|
Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma |
|
71363-6
|
Alkaline phosphatase.placental 2/Alkaline phosphatase.total in Serum or Plasma |
|
71367-7
|
Alkaline phosphatase.placental 2 [Enzymatic activity/volume] in Serum or Plasma |
|
10458-8
|
Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
|
15016-9
|
Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma |
|
59188-3
|
Alkaline phosphatase.placental [Enzymatic activity/volume] in Cerebral spinal fluid |
|
40793-2
|
Alkaline phosphatase.placental [Presence] in Serum or Plasma |
|
1780-6
|
Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma |
|
40410-3
|
Alkaline phosphatase [Enzymatic activity/volume] in Peritoneal fluid |
|
15017-7
|
Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma |
|
1781-4
|
Alkaline phosphatase.regan [Enzymatic activity/volume] in Serum or Plasma |
|
15018-5
|
Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma |
|
1782-2
|
Alkaline phosphatase.renal [Enzymatic activity/volume] in Serum or Plasma |
|
77141-0
|
Alkaline phosphatase [Enzymatic activity/volume] in Serum, Plasma or Blood |
|
6768-6
|
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
29639-2
|
Alkaline phosphatase [Enzymatic activity/mass] in Tissue |
|
16337-8
|
Alkaline phosphatase [Enzymatic activity/volume] in Urine |
|
1776-4
|
Alkaline phosphatase [Mass/volume] in Urine |
|
87667-2
|
Alpha benzene hexachloride [Mass/mass] in Unspecified specimen |
|
60848-9
|
Alpha frequency relative power on EEG |
|
53540-1
|
Alpha globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
|
53539-3
|
Alpha globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
|
90040-7
|
Alpha globin gene cluster and HS-40 region deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
|
42234-5
|
Alpha subunit free [Units/volume] in Serum or Plasma |
|
30316-4
|
Alpha subunit free [Mass/volume] in Serum or Plasma |
|
12728-2
|
Alpha subunit [Units/volume] in Serum or Plasma |
|
30199-4
|
Alpha subunit [Mass/volume] in Serum or Plasma |
|
88985-7
|
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Serum or Plasma |
|
74104-1
|
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Urine by Immunoassay |
|
17811-1
|
Alpha 1 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
|
77340-8
|
Alpha 1 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
|
13984-0
|
Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
72592-9
|
Alpha 1 globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
|
35708-7
|
Alpha 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
|
6794-2
|
Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
|
29945-3
|
Alpha 1 globulin [Presence] in 24 hour Urine by Electrophoresis |
|
2864-7
|
Alpha 1 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
17496-1
|
Alpha 1 globulin [Mass/volume] in Body fluid by Electrophoresis |
|
13972-5
|
Alpha 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
54465-0
|
Alpha 1 globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
17812-9
|
Alpha 1 globulin/Protein.total in Body fluid by Electrophoresis |
|
13978-2
|
Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
15125-8
|
Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis |
|
13990-7
|
Alpha 1 globulin/Protein.total in Urine by Electrophoresis |
|
72595-2
|
Alpha 1 globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
|
72594-5
|
Alpha 1 globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
|
72593-7
|
Alpha 1 globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
|
2865-4
|
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2866-2
|
Alpha 1 globulin [Mass/volume] in Synovial fluid by Electrophoresis |
|
9734-5
|
Alpha 1 globulin [Mass/volume] in Urine by Electrophoresis |
|
27184-1
|
Alpha 1 globulin [Presence] in Urine |
|
22064-0
|
Alpha 1 globulin [Mass/volume] in Urine |
|
17813-7
|
Alpha 2 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
|
77581-7
|
Alpha 2 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
|
13987-3
|
Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
72588-7
|
Alpha 2 globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
|
38189-7
|
Alpha 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
|
6795-9
|
Alpha 2 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
|
29947-9
|
Alpha 2 globulin [Presence] in 24 hour Urine by Electrophoresis |
|
2867-0
|
Alpha 2 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
17497-9
|
Alpha 2 globulin [Mass/volume] in Body fluid by Electrophoresis |
|
13975-8
|
Alpha 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
54466-8
|
Alpha 2 globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
17814-5
|
Alpha 2 globulin/Protein.total in Body fluid by Electrophoresis |
|
13981-6
|
Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
15126-6
|
Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis |
|
13993-1
|
Alpha 2 globulin/Protein.total in Urine by Electrophoresis |
|
72591-1
|
Alpha 2 globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
|
72590-3
|
Alpha 2 globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
|
72589-5
|
Alpha 2 globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
|
2868-8
|
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2869-6
|
Alpha 2 globulin [Mass/volume] in Synovial fluid by Electrophoresis |
|
38190-5
|
Alpha 2 globulin [Mass/volume] in Urine by Electrophoresis |
|
53771-2
|
Alpha 2 globulin [Presence] in Urine by Electrophoresis |
|
6888-2
|
Alpha 2 globulin [Mass/volume] in Urine |
|
79280-4
|
Alpha-aminoadipic semialdehyde [Moles/volume] in Cerebral spinal fluid |
|
79279-6
|
Alpha-aminoadipic semialdehyde [Moles/volume] in Serum or Plasma |
|
79346-3
|
Alpha-aminoadipic semialdehyde/Creatinine [Molar ratio] in Urine |
|
80636-4
|
Alpha-amanitin [Mass/volume] in Urine |
|
73837-7
|
Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum |
|
82022-5
|
Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab RAST class [Presence] in Serum |
|
81031-7
|
Alpha-linoate+Linoleate intake 24 hour Estimated |
|
81128-1
|
Alpha-linoate+Linoleate intake 24 hour Measured |
|
49486-4
|
Alphapinene [Presence] in Blood |
|
60052-8
|
Alphapinene [Mass/volume] in Blood |
|
3311-8
|
Alphaprodine [Mass/time] in 24 hour Urine |
|
4110-3
|
Alphaprodine [Mass] of Dose |
|
3308-4
|
Alphaprodine [Mass/volume] in Serum or Plasma |
|
3309-2
|
Alphaprodine [Presence] in Urine |
|
3310-0
|
Alphaprodine [Mass/volume] in Urine |
|
51663-3
|
Alphavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77085-9
|
ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77084-2
|
ALPL gene full mutation analysis in Blood or Tissue by Sequencing |
|
59607-2
|
ALPRAZolam [Mass/volume] in Blood by Confirmatory method |
|
10977-7
|
ALPRAZolam [Mass/volume] in Blood |
|
77763-1
|
ALPRAZolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
78781-2
|
ALPRAZolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
4111-1
|
ALPRAZolam [Mass] of Dose |
|
59609-8
|
ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method |
|
59608-0
|
ALPRAZolam [Mass/volume] in Body fluid |
|
61073-3
|
ALPRAZolam [Presence] in Gastric fluid |
|
29348-0
|
ALPRAZolam [Mass/volume] in Gastric fluid |
|
26886-2
|
ALPRAZolam [Mass/mass] in Hair |
|
73537-3
|
ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73536-5
|
ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59610-6
|
ALPRAZolam [Mass/mass] in Meconium by Confirmatory method |
|
26911-8
|
ALPRAZolam [Mass/mass] in Meconium |
|
72756-0
|
ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72612-5
|
ALPRAZolam [Presence] in Saliva (oral fluid) |
|
72381-7
|
ALPRAZolam [Mass/volume] in Saliva (oral fluid) |
|
59611-4
|
ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13545-9
|
ALPRAZolam [Presence] in Serum or Plasma |
|
3312-6
|
ALPRAZolam [Mass/volume] in Serum or Plasma |
|
14591-2
|
ALPRAZolam [Moles/volume] in Serum or Plasma |
|
59612-2
|
ALPRAZolam [Mass/mass] in Stool by Confirmatory method |
|
16187-7
|
ALPRAZolam [Mass/volume] in Stool |
|
59614-8
|
ALPRAZolam [Mass/mass] in Tissue by Confirmatory method |
|
59613-0
|
ALPRAZolam [Mass/mass] in Tissue |
|
74985-3
|
ALPRAZolam [Mass/volume] in Serum or Plasma --trough |
|
59615-5
|
ALPRAZolam [Mass/volume] in Urine by Confirmatory method |
|
9351-8
|
ALPRAZolam [Presence] in Urine |
|
16203-2
|
ALPRAZolam [Presence] in Urine by Confirmatory method |
|
94116-1
|
ALPRAZolam [Presence] in Urine by Screen method |
|
3313-4
|
ALPRAZolam [Mass/volume] in Urine |
|
26878-9
|
ALPRAZolam [Mass/volume] in Vitreous fluid |
|
61038-6
|
ALPRAZolam [Presence] in Unspecified specimen |
|
48938-5
|
ALPRAZolam [Mass/volume] in Unspecified specimen |
|
60282-1
|
ALPRAZolam [Moles/volume] in Unspecified specimen |
|
86224-3
|
ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
4112-9
|
Alprenolol [Mass] of Dose |
|
3314-2
|
Alprenolol [Mass/volume] in Serum or Plasma |
|
3315-9
|
Alprenolol [Presence] in Urine |
|
3316-7
|
Alprenolol [Mass/volume] in Urine |
|
77630-2
|
ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44705-2
|
ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44785-4
|
Alanine aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma by No addition of P-5'-P |
|
69551-0
|
Genomic alt allele [ID] |
|
1741-8
|
Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
|
76625-3
|
Alanine aminotransferase [Enzymatic activity/volume] in Blood |
|
50168-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
|
25302-1
|
Alanine aminotransferase [Enzymatic activity/volume] in Body fluid |
|
54492-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Pleural fluid |
|
54491-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
|
16324-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
|
74283-3
|
Alternate residence status [NTDS] |
|
1743-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
|
1744-2
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
|
77144-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood |
|
1742-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
|
48134-1
|
Alanine aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
|
16325-3
|
Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
|
54630-9
|
Altered level of consciousness in last 7 day [CAM.CMS] |
|
7074-8
|
Alternaria sp IgE Ab [Units/volume] in Serum |
|
23813-9
|
Alternaria sp IgE Ab RAST class [Presence] in Serum |
|
34233-7
|
Alternaria sp IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
7075-5
|
Alternaria sp IgG Ab [Units/volume] in Serum |
|
40837-7
|
Alternaria sp IgG Ab [Presence] in Serum |
|
39570-7
|
Alternaria sp IgG Ab [Mass/volume] in Serum |
|
58212-2
|
Alternate state Medicaid billing - RUG group [CMS Assessment] |
|
58213-0
|
Alternate state Medicaid billing - RUG version code [CMS Assessment] |
|
30926-0
|
Aluminum [Mass/volume] in Urine collected for unspecified duration |
|
6929-4
|
Aluminum [Mass/volume] in 24 hour Urine |
|
26707-0
|
Aluminum [Mass/time] in 24 hour Urine |
|
14592-0
|
Aluminum [Moles/volume] in 24 hour Urine |
|
32295-8
|
Aluminum [Moles/time] in 24 hour Urine |
|
38759-7
|
Aluminum [Mass/volume] in Air |
|
82463-1
|
Aluminum [Moles/volume] in Blood |
|
10740-9
|
Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
|
27264-1
|
Aluminum [Mass/volume] in Cerebral spinal fluid |
|
80127-4
|
Aluminum [Moles/volume] in Cerebral spinal fluid |
|
5572-3
|
Aluminum [Mass/volume] in Dialysis fluid |
|
15113-4
|
Aluminum [Moles/volume] in Dialysis fluid |
|
16349-3
|
Aluminum [Mass/volume] in Body fluid |
|
80126-6
|
Aluminum [Moles/volume] in Body fluid |
|
5573-1
|
Aluminum [Mass/mass] in Hair |
|
50801-0
|
Aluminum [Moles/mass] in Hair |
|
38662-3
|
Aluminum oxide [Mass/volume] in Air |
|
5575-6
|
Aluminum [Mass/volume] in Red Blood Cells |
|
47096-3
|
Aluminum [Moles/volume] in Red Blood Cells |
|
5574-9
|
Aluminum [Mass/volume] in Serum or Plasma |
|
14593-8
|
Aluminum [Moles/volume] in Serum or Plasma |
|
80125-8
|
Aluminum [Mass/mass] in Tissue |
|
52892-7
|
Aluminum [Moles/mass] in Tissue |
|
5577-2
|
Aluminum [Mass/volume] in Urine |
|
52915-6
|
Aluminum [Moles/volume] in Urine |
|
9462-3
|
Aluminum [Mass/volume] in Water |
|
78782-0
|
Aluminum [Moles/volume] in Water |
|
87482-6
|
Aluminum [Mass/volume] in Unspecified specimen |
|
87483-4
|
Aluminum [Mass/mass] in Unspecified specimen |
|
29937-0
|
Aluminum/Creatinine [Mass Ratio] in 24 hour Urine |
|
52944-6
|
Aluminum/Creatinine [Molar ratio] in 24 hour Urine |
|
13470-0
|
Aluminum/Creatinine [Mass Ratio] in Urine |
|
52943-8
|
Aluminum/Creatinine [Molar ratio] in Urine |
|
31723-0
|
Avian leukosis virus Ag [Units/volume] in Egg yolk |
|
31724-8
|
Avian leukosis virus Ag [Units/volume] in Serum |
|
15446-8
|
Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay |
|
15445-0
|
Avian leukosis virus Ag [Titer] in Serum by Immunoassay |
|
76165-0
|
Alveolar ventilation [Volume] Respiratory system --on ventilator |
|
885-4
|
Am Ab [Presence] in Serum or Plasma from Blood product unit |
|
886-2
|
Am Ab [Presence] in Serum or Plasma from Donor |
|
887-0
|
Am Ab [Presence] in Serum or Plasma |
|
827-6
|
Am Ag [Presence] on Red Blood Cells from Blood product unit |
|
828-4
|
Am Ag [Presence] on Red Blood Cells from Donor |
|
829-2
|
Am Ag [Presence] on Red Blood Cells |
|
64980-6
|
American house dust mite recombinant (rDer f) 2 IgE Ab [Units/volume] in Serum |
|
73528-2
|
amLODIPine+Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73529-0
|
amLODIPine+Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73925-0
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78783-8
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
72817-0
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72463-3
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72818-8
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73952-4
|
AM-2201 (synthetic cannabinoid) [Presence] in Blood |
|
87488-3
|
AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
82221-3
|
Alpha-methylacyl CoA racemase [Enzymatic activity/mass] in Fibroblast |
|
55910-4
|
Alpha mannosidase [Enzymatic activity/volume] in DBS |
|
24052-3
|
Alpha mannosidase [Enzymatic activity/mass] in Fibroblast |
|
1818-4
|
Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1819-2
|
Alpha mannosidase [Enzymatic activity/mass] in Tissue |
|
24053-1
|
Alpha mannosidase [Enzymatic activity/mass] in Leukocytes |
|
4113-7
|
Amantadine [Mass] of Dose |
|
3317-5
|
Amantadine [Mass/volume] in Serum or Plasma |
|
6-7
|
Amantadine [Susceptibility] |
|
16350-1
|
Amantadine [Susceptibility] by Serum bactericidal titer |
|
23814-7
|
Amantadine [Mass/volume] in Urine |
|
79725-8
|
Amblyopia type |
|
18682-5
|
Ambulance records |
|
15515-0
|
Ambulance transport, Medical reason for transport |
|
52020-5
|
Ambulance transport, Medical reason for unscheduled trip |
|
18814-4
|
Ambulance transport, Reason for scheduled trip |
|
18815-1
|
Ambulance transport, Reason for scheduled trip additional service information (narrative) |
|
83186-7
|
Ambulation |
|
4114-5
|
Amdinocillin [Mass] of Dose |
|
7028-4
|
Amdinocillin [Susceptibility] by Gradient strip |
|
9-1
|
Amdinocillin [Susceptibility] by Disk diffusion (KB) |
|
8-3
|
Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
7-5
|
Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3318-3
|
Amdinocillin [Mass/volume] in Serum or Plasma |
|
18859-9
|
Amdinocillin [Susceptibility] |
|
10-9
|
Amdinocillin [Susceptibility] by Serum bactericidal titer |
|
6038-4
|
American Beech IgE Ab [Units/volume] in Serum |
|
15571-3
|
American Beech IgE Ab RAST class [Presence] in Serum |
|
61263-0
|
American Beech IgE Ab/IgE total in Serum |
|
56171-2
|
American Beech IgG4 Ab [Mass/volume] in Serum |
|
30170-5
|
American Cockroach IgE Ab [Units/volume] in Serum |
|
49079-7
|
American Cockroach IgE Ab RAST class [Presence] in Serum |
|
56173-8
|
American Cockroach IgG4 Ab [Mass/volume] in Serum |
|
6263-8
|
American Sycamore IgE Ab [Units/volume] in Serum |
|
16046-5
|
American Sycamore IgE Ab RAST class [Presence] in Serum |
|
58043-1
|
American Sycamore IgE Ab/IgE total in Serum |
|
24145-5
|
American Sycamore IgG Ab [Units/volume] in Serum |
|
56175-3
|
American Sycamore IgG4 Ab [Mass/volume] in Serum |
|
7201-7
|
American Cheese IgE Ab [Units/volume] in Serum |
|
15622-4
|
American Cheese IgE Ab RAST class [Presence] in Serum |
|
7202-5
|
American Cheese IgG Ab [Units/volume] in Serum |
|
56172-0
|
American Cheese IgG4 Ab [Mass/volume] in Serum |
|
63099-6
|
American Cheese IgG Ab [Mass/volume] in Serum |
|
80883-2
|
American Urological Association Symptom Index [AUASI] |
|
38653-2
|
Amiben [Mass/volume] in Air |
|
49578-8
|
Aminocaproate cutoff [Mass/volume] in Serum or Plasma |
|
49579-6
|
Aminocaproate [Presence] in Serum or Plasma |
|
9312-0
|
Aminocaproate [Mass/volume] in Serum or Plasma |
|
3326-6
|
Aminocaproate [Mass/volume] in Serum or Plasma --trough |
|
60564-2
|
Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
48169-7
|
Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25177-7
|
Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25175-1
|
Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42642-9
|
Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25178-5
|
Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25176-9
|
Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
60565-9
|
Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25179-3
|
Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25174-4
|
Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
17798-0
|
Amikacin [Mass/volume] in Cerebral spinal fluid |
|
4115-2
|
Amikacin [Mass] of Dose |
|
13546-7
|
Amikacin [Mass/volume] in Body fluid |
|
80972-3
|
Amikacin free [Mass/volume] in Serum or Plasma |
|
6975-7
|
Amikacin [Susceptibility] by Gradient strip |
|
13-3
|
Amikacin [Susceptibility] by Disk diffusion (KB) |
|
12-5
|
Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
11-7
|
Amikacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20373-7
|
Amikacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89484-0
|
Amikacin [Susceptibility] by Genotype method |
|
59378-0
|
Amikacin [Mass/volume] in Serum or Plasma --post dialysis |
|
3319-1
|
Amikacin [Mass/volume] in Serum or Plasma --peak |
|
50802-8
|
Amikacin [Moles/volume] in Serum or Plasma --peak |
|
31097-9
|
Amikacin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
|
31099-5
|
Amikacin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
|
3320-9
|
Amikacin [Mass/volume] in Serum or Plasma --random |
|
15098-7
|
Amikacin [Moles/volume] in Serum or Plasma --random |
|
35669-1
|
Amikacin [Mass/volume] in Serum or Plasma |
|
56628-1
|
Amikacin [Moles/volume] in Serum or Plasma |
|
18860-7
|
Amikacin [Susceptibility] |
|
14-1
|
Amikacin [Susceptibility] by Serum bactericidal titer |
|
31098-7
|
Amikacin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
|
3321-7
|
Amikacin [Mass/volume] in Serum or Plasma --trough |
|
50803-6
|
Amikacin [Moles/volume] in Serum or Plasma --trough |
|
3325-8
|
aMILoride [Mass/time] in 24 hour Urine |
|
60053-6
|
aMILoride [Mass/volume] in Blood |
|
4116-0
|
aMILoride [Mass] of Dose |
|
16351-9
|
aMILoride [Units/volume] in Serum or Plasma |
|
3322-5
|
aMILoride [Mass/volume] in Serum or Plasma |
|
3323-3
|
aMILoride [Presence] in Urine |
|
16352-7
|
aMILoride [Units/volume] in Urine |
|
3324-1
|
aMILoride [Mass/volume] in Urine |
|
34397-0
|
Amilsulpride [Mass/volume] in Serum or Plasma |
|
48005-3
|
Amino acid change (pHGVS) |
|
48006-1
|
Amino acid change [Type] |
|
81914-4
|
Essential amino acid intake 24 hour Estimated |
|
81915-1
|
Essential amino acid intake 24 hour Measured |
|
81197-6
|
Amino acid intake 24 hour Estimated |
|
81198-4
|
Amino acid intake 24 hour Measured |
|
53721-7
|
Amino acid marker assessed [Identifier] |
|
81932-6
|
Nonessential amino acid intake 24 hour Estimated |
|
81933-4
|
Nonessential amino acid intake 24 hour Measured |
|
43804-4
|
Amino acid pattern [Interpretation] in Cerebral spinal fluid |
|
49303-1
|
Amino acid pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
56901-2
|
Amino acid pattern [Interpretation] in Body fluid |
|
13500-4
|
Amino acid pattern [Interpretation] in Serum or Plasma |
|
49247-0
|
Amino acid pattern [Interpretation] in Serum or Plasma Narrative |
|
32296-6
|
Amino acid pattern [Interpretation] in Urine |
|
49248-8
|
Amino acid pattern [Interpretation] in Urine Narrative |
|
57793-2
|
Amino acidemia disorder suspected [Identifier] in DBS |
|
46733-2
|
Amino acidemias newborn screen interpretation |
|
57710-6
|
Amino acidemias newborn screening comment-discussion |
|
18191-7
|
Amino acids [Identifier] in 24 hour Urine |
|
32611-6
|
Amino acids [Moles/volume] in Amniotic fluid |
|
27336-7
|
Amino acids [Identifier] in Blood |
|
34616-3
|
Amino acids [Identifier] in Cerebral spinal fluid |
|
32610-8
|
Amino acids [Moles/volume] in Cerebral spinal fluid |
|
32609-0
|
Amino acids [Moles/volume] in Body fluid |
|
55817-1
|
Amino acids [Moles/mass] in Hair |
|
41275-9
|
Amino acids intense band position [Identifier] in Urine |
|
21056-7
|
Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine [Presence] in Urine |
|
21057-5
|
Alanine+Histidine+Leucine+Phenylalanine+Tyrosine [Presence] in Serum or Plasma |
|
15136-5
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
|
15140-7
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
|
15135-7
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
|
15143-1
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
|
15133-2
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
|
15139-9
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
|
12468-5
|
Amino acids [Identifier] in Serum or Plasma |
|
12176-4
|
Amino acids [Moles/volume] in Serum or Plasma |
|
12467-7
|
Amino acids [Identifier] in Urine |
|
32612-4
|
Amino acids [Moles/volume] in Vitreous fluid |
|
12177-2
|
Amino acids/Creatinine [Ratio] in Urine |
|
9408-6
|
Aminobenzoate [Mass/volume] in Serum or Plasma |
|
89490-7
|
Aminoglycoside [Susceptibility] by Genotype method |
|
4117-8
|
Aminopyrine [Mass] of Dose |
|
3327-4
|
Aminopyrine [Mass/volume] in Exhaled gas |
|
3328-2
|
Aminopyrine [Mass/volume] in Serum or Plasma |
|
4118-6
|
Aminosalicylate [Mass] of Dose |
|
3329-0
|
Aminosalicylate [Mass/volume] in Serum or Plasma |
|
73068-9
|
Amiodarone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73067-1
|
Amiodarone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60054-4
|
Amiodarone [Mass/volume] in Blood |
|
4119-4
|
Amiodarone [Mass] of Dose |
|
29207-8
|
Amiodarone [Mass/volume] in Body fluid |
|
79230-9
|
Amiodarone [Mass/mass] in Hair |
|
73534-0
|
Amiodarone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73535-7
|
Amiodarone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
40755-1
|
Amiodarone [Mass/volume] in Serum or Plasma --peak |
|
3330-8
|
Amiodarone [Mass/volume] in Serum or Plasma |
|
15099-5
|
Amiodarone [Moles/volume] in Serum or Plasma |
|
40756-9
|
Amiodarone [Mass/volume] in Serum or Plasma --trough |
|
78784-6
|
Amiodarone [Mass/volume] in Urine |
|
3331-6
|
Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma |
|
80129-0
|
Amisulpride [Mass/volume] in Blood |
|
80130-8
|
Amisulpride [Mass/volume] in Body fluid |
|
80128-2
|
Amisulpride [Mass/mass] in Hair |
|
85384-6
|
Amisulpride [Mass/volume] in Serum or Plasma |
|
80131-6
|
Amisulpride [Mass/volume] in Urine |
|
73066-3
|
Amitriptyline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73065-5
|
Amitriptyline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3336-5
|
Amitriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose |
|
78786-1
|
Amitriptyline [Mass/volume] in Blood |
|
19334-2
|
Amitriptyline cutoff [Mass/volume] in Urine for Confirmatory method |
|
19333-4
|
Amitriptyline cutoff [Mass/volume] in Urine for Screen method |
|
80558-0
|
Amitriptyline [Mass/volume] in DBS |
|
4120-2
|
Amitriptyline [Mass] of Dose |
|
79229-1
|
Amitriptyline [Mass/volume] in Body fluid |
|
40411-1
|
Amitriptyline [Presence] in Gastric fluid |
|
29406-6
|
Amitriptyline [Mass/volume] in Gastric fluid |
|
50805-1
|
Amitriptyline [Moles/volume] in Gastric fluid |
|
78785-3
|
Amitriptyline [Mass/mass] in Hair |
|
73532-4
|
Amitriptyline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73533-2
|
Amitriptyline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16360-0
|
Amitriptyline [Mass/volume] in Serum or Plasma --peak |
|
3332-4
|
Amitriptyline [Presence] in Serum or Plasma |
|
35636-0
|
Amitriptyline [Mass/volume] in Serum or Plasma by Screen method |
|
3333-2
|
Amitriptyline [Mass/volume] in Serum or Plasma |
|
14597-9
|
Amitriptyline [Moles/volume] in Serum or Plasma |
|
16361-8
|
Amitriptyline [Mass/volume] in Serum or Plasma --trough |
|
20515-3
|
Amitriptyline [Mass/volume] in Urine by Confirmatory method |
|
3334-0
|
Amitriptyline [Presence] in Urine |
|
16225-5
|
Amitriptyline [Presence] in Urine by Confirmatory method |
|
19331-8
|
Amitriptyline [Presence] in Urine by Screen method |
|
16114-1
|
Amitriptyline [Mass/volume] in Urine |
|
50804-4
|
Amitriptyline [Moles/volume] in Urine |
|
60283-9
|
Amitriptyline [Moles/volume] in Unspecified specimen |
|
61407-3
|
Amitriptyline/Creatinine [Mass Ratio] in Urine |
|
19338-3
|
Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method |
|
19337-5
|
Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Screen method |
|
14594-6
|
Amitriptyline+Nortriptyline [Presence] in Gastric fluid |
|
14595-3
|
Amitriptyline+Nortriptyline [Presence] in Serum or Plasma |
|
3335-7
|
Amitriptyline+Nortriptyline [Mass/volume] in Serum or Plasma |
|
14598-7
|
Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma |
|
20516-1
|
Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method |
|
14596-1
|
Amitriptyline+Nortriptyline [Presence] in Urine |
|
19336-7
|
Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method |
|
19335-9
|
Amitriptyline+Nortriptyline [Presence] in Urine by Screen method |
|
10978-5
|
Amitriptyline+Nortriptyline [Mass/volume] in Urine |
|
32048-1
|
Amitriptyline+Nortriptyline [Presence] in Unspecified specimen |
|
77322-6
|
Amitriptyline+Nortriptyline [Moles/volume] in Unspecified specimen |
|
17979-6
|
Anterior mitral valve leaflet A-C interval by US.M-mode |
|
17980-4
|
Anterior mitral valve leaflet A-C slope [Velocity] by US.M-mode |
|
17997-8
|
Anterior mitral valve leaflet D-E excursion [Length] by US.M-mode |
|
18040-6
|
Anterior mitral valve leaflet E-F slope [Velocity] by US.M-mode |
|
18036-4
|
Anterior mitral valve leaflet E point to septal separation [Time] by US.M-mode |
|
42712-0
|
AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42713-8
|
AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method |
|
73064-8
|
amLODIPine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73063-0
|
amLODIPine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78787-9
|
amLODIPine [Mass/volume] in Blood |
|
79228-3
|
amLODIPine [Mass/volume] in Body fluid |
|
80132-4
|
amLODIPine [Mass/mass] in Hair |
|
73531-6
|
amLODIPine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73530-8
|
amLODIPine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
28064-4
|
amLODIPine [Mass/volume] in Serum or Plasma |
|
78788-7
|
amLODIPine [Mass/volume] in Urine |
|
25144-7
|
Ammonium urate crystals [#/area] in Urine sediment by Microscopy high power field |
|
53130-1
|
Ammonium urate crystals [#/area] in Urine sediment by Microscopy low power field |
|
16258-6
|
Ammonium urate crystals [Presence] in Stone by Infrared spectroscopy |
|
33239-5
|
Ammonium urate crystals [Presence] in Urine by Computer assisted method |
|
5766-1
|
Ammonium urate crystals [Presence] in Urine sediment by Light microscopy |
|
38191-3
|
Ammonium urate/Total in Stone |
|
44865-4
|
Ammonium urate [Presence] in Stone |
|
27039-7
|
Ammonia [Mass/volume] in 24 hour Urine |
|
9309-6
|
Ammonia [Mass/time] in 24 hour Urine |
|
25850-9
|
Ammonia [Moles/volume] in 24 hour Urine |
|
25308-8
|
Ammonia [Moles/time] in 24 hour Urine |
|
38589-8
|
Ammonia [Mass/volume] in Air |
|
93684-9
|
Ammonia [Moles/volume] in Arterial blood |
|
32664-5
|
Ammonia [Mass/volume] in Blood |
|
1839-0
|
Ammonia [Moles/volume] in Blood |
|
1840-8
|
Ammonia [Moles/volume] in Cerebral spinal fluid |
|
54349-6
|
Ammonia [Mass/volume] in Dialysis fluid |
|
53081-6
|
Ammonia [Moles/volume] in Dialysis fluid |
|
15149-8
|
Ammonia [Moles/volume] in Body fluid |
|
20683-9
|
Ammonia [Mass/volume] in Ingesta |
|
1843-2
|
Ammonia nitrogen [Mass/time] in 24 hour Urine |
|
87562-5
|
Ammonia nitrogen [Mass/mass] in Feed |
|
22763-7
|
Ammonia [Mass/volume] in Plasma |
|
35254-2
|
Ammonia [Mass or Moles/volume] in Plasma |
|
16362-6
|
Ammonia [Moles/volume] in Plasma |
|
20684-7
|
Ammonia [Mass/volume] in Serum |
|
1841-6
|
Ammonia [Moles/volume] in Serum |
|
16363-4
|
Ammonia [Moles/mass] in Tissue |
|
20682-1
|
Ammonia [Mass/volume] in Urine |
|
1842-4
|
Ammonia [Moles/volume] in Urine |
|
53500-5
|
Ammonia [Moles/volume] in Water |
|
23656-2
|
Ammonia [Mass/volume] in Unspecified specimen |
|
25851-7
|
Ammonia/Creatinine [Molar ratio] in 24 hour Urine |
|
1844-0
|
Ammonium ion [Moles/volume] in Arterial blood |
|
1845-7
|
Ammonium ion [Moles/volume] in Plasma |
|
14599-5
|
Ammonium [Presence] in Stone |
|
72399-9
|
Amobarbital [Mass/volume] in Blood by Confirmatory method |
|
19342-5
|
Amobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19341-7
|
Amobarbital cutoff [Mass/volume] in Urine for Screen method |
|
4121-0
|
Amobarbital [Mass] of Dose |
|
79227-5
|
Amobarbital [Mass/volume] in Body fluid |
|
12485-9
|
Amobarbital [Presence] in Gastric fluid |
|
16364-2
|
Amobarbital [Mass/volume] in Gastric fluid |
|
59866-4
|
Amobarbital [Moles/volume] in Gastric fluid |
|
26920-9
|
Amobarbital [Mass/mass] in Hair |
|
27324-3
|
Amobarbital [Mass/mass] in Meconium |
|
72455-9
|
Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72631-5
|
Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3337-3
|
Amobarbital [Presence] in Serum or Plasma |
|
82973-9
|
Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3338-1
|
Amobarbital [Mass/volume] in Serum or Plasma |
|
25309-6
|
Amobarbital [Moles/volume] in Serum or Plasma |
|
12494-1
|
Amobarbital [Presence] in Stool |
|
27245-0
|
Amobarbital [Mass/mass] in Stool |
|
16239-6
|
Amobarbital [Mass/volume] in Urine by Confirmatory method |
|
3339-9
|
Amobarbital [Presence] in Urine |
|
16190-1
|
Amobarbital [Presence] in Urine by Confirmatory method |
|
19339-1
|
Amobarbital [Presence] in Urine by Screen method |
|
11230-0
|
Amobarbital [Mass/volume] in Urine |
|
59865-6
|
Amobarbital [Moles/volume] in Urine |
|
26687-4
|
Amobarbital [Mass/volume] in Vitreous fluid |
|
32049-9
|
Amobarbital [Presence] in Unspecified specimen |
|
60284-7
|
Amobarbital [Moles/volume] in Unspecified specimen |
|
64128-2
|
Amobarbital/Creatinine [Mass Ratio] in Urine |
|
18305-3
|
Amoeba identified in Aspirate by Iron hematoxylin stain |
|
10641-9
|
Amoeba identified in Aspirate by Immune stain |
|
10642-7
|
Amoeba identified in Aspirate by Wet preparation |
|
10643-5
|
Amoeba identified in Stool by Organism specific culture |
|
87998-1
|
Amoeba identified in Stool by Wet preparation |
|
6594-6
|
Amoeba identified in Unspecified specimen by Organism specific culture |
|
53331-5
|
Crystals.amorphous [#/volume] in Urine by Computer assisted method |
|
53332-3
|
Crystals.amorphous [#/area] in Urine by Computer assisted method |
|
88973-3
|
Crystals.amorphous [#/area] in Urine sediment |
|
55368-5
|
Crystals.amorphous [#/area] in Urine sediment by Microscopy high power field |
|
53329-9
|
Crystals.amorphous [Presence] in Urine by Computer assisted method |
|
60340-7
|
Crystals.amorphous [Presence] in Urine sediment by Light microscopy |
|
13656-4
|
Phosphate crystals amorphous [#/volume] in Urine sediment |
|
55378-4
|
Phosphate crystals amorphous [#/area] in Urine by Computer assisted method |
|
32145-5
|
Phosphate crystals amorphous [#/area] in Urine sediment by Microscopy high power field |
|
40483-0
|
Phosphate crystals amorphous [#/area] in Urine sediment by Microscopy low power field |
|
50236-9
|
Phosphate crystals amorphous [Presence] in Urine by Computer assisted method |
|
12453-7
|
Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy |
|
8246-1
|
Amorphous sediment [Presence] in Urine sediment by Light microscopy |
|
13657-2
|
Urate crystals amorphous [#/volume] in Urine sediment |
|
32150-5
|
Urate crystals amorphous [#/area] in Urine sediment by Microscopy high power field |
|
40484-8
|
Urate crystals amorphous [#/area] in Urine sediment by Microscopy low power field |
|
50239-3
|
Urate crystals amorphous [Presence] in Urine by Computer assisted method |
|
12454-5
|
Urate crystals amorphous [Presence] in Urine sediment by Light microscopy |
|
90017-5
|
Amount of beef, pork, tuna, or salmon eaten the last time you had anything to eat |
|
82767-5
|
Amount dispensed [#] Medication |
|
88763-8
|
Amount of hip pain experienced while at night while in bed in the last week [HOOS] |
|
88765-3
|
Amount of hip pain experienced while bending your hip fully in the last week [HOOS] |
|
82317-9
|
Amount of hip pain experienced while going up or down stairs in the last week [HOOS] |
|
88762-0
|
Amount of hip pain experienced while sitting or lying in the last week [HOOS] |
|
88761-2
|
Amount of hip pain experienced while standing upgright in the last week [HOOS] |
|
88766-1
|
Amount of hip pain experienced while straightening your hip fully in the last week [HOOS] |
|
88760-4
|
Amount of hip pain experienced while walking of a hard surface (asphalt, concrete, etc.) in the last week [HOOS] |
|
82318-7
|
Amount of hip pain experienced while walking on an uneven surface in the last week [HOOS] |
|
88764-6
|
Amount of hip pain experienced while walking on flat surface in the last week [HOOS] |
|
88803-2
|
Amount of knee pain experienced while at night while in bed in the last week [KOOS] |
|
88805-7
|
Amount of knee pain experienced while bending the knee fully in the last week [KOOS] |
|
82328-6
|
Amount of knee pain experienced while going up or down stairs in the last week [KOOS] |
|
88802-4
|
Amount of knee pain experienced while sitting or lying in the last week [KOOS] |
|
82329-4
|
Amount of knee pain experienced while standing upright in the last week [KOOS] |
|
82327-8
|
Amount of knee pain experienced while straightening knee fully in the last week [KOOS] |
|
82326-0
|
Amount of knee pain experienced while twisting AndOr pivoting on your knee in the last week [KOOS] |
|
88804-0
|
Amount of knee pain experienced while walking on flat surface in the last week [KOOS] |
|
80272-8
|
Amount of Stool |
|
4122-8
|
Amoxapine [Mass] of Dose |
|
79231-7
|
Amoxapine [Mass/volume] in Body fluid |
|
59868-0
|
Amoxapine [Moles/volume] in Gastric fluid |
|
78789-5
|
Amoxapine [Mass/mass] in Hair |
|
10529-6
|
Amoxapine metabolite [Mass/volume] in Serum or Plasma |
|
3340-7
|
Amoxapine [Presence] in Serum or Plasma |
|
3341-5
|
Amoxapine [Mass/volume] in Serum or Plasma |
|
14600-1
|
Amoxapine [Moles/volume] in Serum or Plasma |
|
3342-3
|
Amoxapine [Presence] in Urine |
|
3343-1
|
Amoxapine [Mass/volume] in Urine |
|
59867-2
|
Amoxapine [Moles/volume] in Urine |
|
60285-4
|
Amoxapine [Moles/volume] in Unspecified specimen |
|
9625-5
|
Amoxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
|
14601-9
|
Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
|
73062-2
|
Amoxicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73061-4
|
Amoxicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80133-2
|
Amoxicillin [Mass/volume] in Cerebral spinal fluid |
|
4123-6
|
Amoxicillin [Mass] of Dose |
|
6829-6
|
Amoxicillin IgE Ab [Units/volume] in Serum |
|
15532-5
|
Amoxicillin IgE Ab RAST class [Presence] in Serum |
|
42575-1
|
Amoxicillin IgE Ab/IgE total in Serum |
|
73527-4
|
Amoxicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73526-6
|
Amoxicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6976-5
|
Amoxicillin [Susceptibility] by Gradient strip |
|
17-4
|
Amoxicillin [Susceptibility] by Disk diffusion (KB) |
|
16-6
|
Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
15-8
|
Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
48198-6
|
Amoxicillin triggered leukotriene release [Mass/volume] by Leukocytes |
|
3344-9
|
Amoxicillin [Mass/volume] in Serum or Plasma |
|
18861-5
|
Amoxicillin [Susceptibility] |
|
18-2
|
Amoxicillin [Susceptibility] by Serum bactericidal titer |
|
25274-2
|
Amoxicillin [Mass/volume] in Unspecified specimen |
|
73525-8
|
Amoxicillin+Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73524-1
|
Amoxicillin+Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6977-3
|
Amoxicillin+Clavulanate [Susceptibility] by Gradient strip |
|
21-6
|
Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
20-8
|
Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
19-0
|
Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
|
25310-4
|
Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria |
|
18862-3
|
Amoxicillin+Clavulanate [Susceptibility] |
|
22-4
|
Amoxicillin+Clavulanate [Susceptibility] by Serum bactericidal titer |
|
55615-9
|
Amoxicillin+Sulbactam [Susceptibility] by Gradient strip |
|
55616-7
|
Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55614-2
|
Amoxicillin+Sulbactam [Susceptibility] |
|
1725-1
|
Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum |
|
82732-9
|
AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82733-7
|
AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90811-1
|
AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93869-6
|
AMPAR1 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84929-9
|
AMPAR1 Ab [Presence] in Serum by Immunofluorescence |
|
90812-9
|
AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82735-2
|
AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82734-5
|
AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90813-7
|
AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93868-8
|
AMPAR2 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84930-7
|
AMPAR2 Ab [Presence] in Serum by Immunofluorescence |
|
90814-5
|
AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93491-9
|
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82987-9
|
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
93489-3
|
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding assay immunofluorescent assay |
|
82980-4
|
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
93492-7
|
AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93490-1
|
AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
85841-5
|
Beta-lactam resistance AmpC blaACC gene [Presence] by Molecular method |
|
85842-3
|
Beta-lactam resistance AmpC blaACT+blaMIR genes [Presence] by Molecular method |
|
85822-5
|
Beta-lactam resistance AmpC blaCMY+blaMOX genes [Presence] by Molecular method |
|
93699-7
|
Beta-lactam resistance AmpC blaCMY-2 gene [Presence] by Molecular method |
|
93700-3
|
Beta-lactam resistance AmpC blaDHA gene [Presence] by Molecular method |
|
85843-1
|
Beta-lactam resistance AmpC blaFOX gene [Presence] by Molecular method |
|
85046-1
|
AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio [Presence] by ARD gradient strip |
|
40876-5
|
AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
42576-9
|
Amphetamine [Mass/volume] in Blood by Confirmatory method |
|
78364-7
|
Amphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19348-2
|
Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19347-4
|
Amphetamine cutoff [Mass/volume] in Urine for Screen method |
|
80135-7
|
Amphetamine [Mass/volume] in Body fluid by Confirmatory method |
|
78790-3
|
Amphetamine [Presence] in Body fluid by Screen method |
|
80134-0
|
Amphetamine [Mass/mass] in Hair by Confirmatory method |
|
73425-1
|
Amphetamine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73424-4
|
Amphetamine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26959-7
|
Amphetamine [Mass/mass] in Meconium |
|
72758-6
|
Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74680-0
|
Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
29592-3
|
Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
66127-2
|
Amphetamine [Presence] in Serum or Plasma by Confirmatory method |
|
82967-1
|
Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
30112-7
|
Amphetamine [Mass/volume] in Serum or Plasma |
|
26791-4
|
Amphetamine [Mass/mass] in Stool |
|
16234-7
|
Amphetamine [Mass/volume] in Urine by Confirmatory method |
|
19344-1
|
Amphetamine [Presence] in Urine by Confirmatory method |
|
19343-3
|
Amphetamine [Presence] in Urine by Screen method |
|
19346-6
|
Amphetamine [Mass/volume] in Urine |
|
52957-8
|
Amphetamine [Moles/volume] in Urine |
|
58357-5
|
Amphetamine/Creatinine [Mass Ratio] in Urine |
|
75644-5
|
Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method |
|
43860-6
|
Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method |
|
40421-0
|
Amphetamine+Methamphetamine [Presence] in Serum or Plasma |
|
40419-4
|
Amphetamine+Methamphetamine [Presence] in Urine |
|
76492-8
|
Amphetamine+Methamphetamine [Presence] in Urine by Screen method |
|
33280-9
|
Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method |
|
56120-9
|
Amphetamine+Methamphetamine [Mass/volume] in Urine |
|
40420-2
|
Amphetamine+Methamphetamine [Presence] in Unspecified specimen |
|
51690-6
|
Amphetamines [Presence] in Blood by Screen method |
|
19269-0
|
Amphetamines confirm method [Identifier] in Urine |
|
19267-4
|
Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method |
|
19266-6
|
Amphetamines cutoff [Mass/volume] in Urine for Screen method |
|
19059-5
|
Amphetamines cutoff [Mass/volume] in Urine |
|
8140-6
|
Amphetamines [Presence] in Gastric fluid |
|
8141-4
|
Amphetamines [Presence] in Gastric fluid by Confirmatory method |
|
8142-2
|
Amphetamines [Presence] in Gastric fluid by Screen method |
|
8139-8
|
Amphetamines [Mass/volume] in Gastric fluid |
|
40529-0
|
Amphetamines [Presence] in Hair |
|
40798-1
|
Amphetamines [Presence] in Hair by Screen method |
|
9352-6
|
Amphetamines [Mass/mass] in Hair |
|
43934-9
|
Amphetamines [Mass/mass] in Meconium by Confirmatory method |
|
8144-8
|
Amphetamines [Presence] in Meconium |
|
8145-5
|
Amphetamines [Presence] in Meconium by Confirmatory method |
|
8146-3
|
Amphetamines [Presence] in Meconium by Screen method |
|
8143-0
|
Amphetamines [Mass/volume] in Meconium |
|
26895-3
|
Amphetamines [Mass/mass] in Meconium |
|
27105-6
|
Amphetamines [Mass/volume] in Milk |
|
19265-8
|
Amphetamines [Identifier] in Urine by Confirmatory method |
|
74681-8
|
Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40799-9
|
Amphetamines [Presence] in Saliva (oral fluid) by Screen method |
|
19268-2
|
Amphetamines screen method [Identifier] in Urine |
|
3348-0
|
Amphetamines [Presence] in Serum or Plasma |
|
8148-9
|
Amphetamines [Presence] in Serum or Plasma by Confirmatory method |
|
8149-7
|
Amphetamines [Presence] in Serum or Plasma by Screen method |
|
8147-1
|
Amphetamines [Mass/volume] in Serum or Plasma |
|
12350-5
|
Amphetamines [Presence] in Stool |
|
18431-7
|
Amphetamines [Presence] in Stool by Screen method |
|
19262-5
|
Amphetamines tested for in Urine by Screen method Nominal |
|
19263-3
|
Amphetamines tested for in Urine by Screen method Narrative |
|
20410-7
|
Amphetamines [Mass/volume] in Urine by Confirmatory method |
|
3349-8
|
Amphetamines [Presence] in Urine |
|
16369-1
|
Amphetamines [Presence] in Urine by Confirmatory method |
|
14309-9
|
Amphetamines [Presence] in Urine by Confirm method >200 ng/mL |
|
8151-3
|
Amphetamines [Presence] in Urine by SAMHSA confirm method |
|
8152-1
|
Amphetamines [Presence] in Urine by SAMHSA screen method |
|
19261-7
|
Amphetamines [Presence] in Urine by Screen method |
|
14308-1
|
Amphetamines [Presence] in Urine by Screen method >1000 ng/mL |
|
43983-6
|
Amphetamines [Presence] in Urine by Screen method >500 ng/mL |
|
70138-3
|
Amphetamines [Mass/volume] in Urine by Screen method |
|
8150-5
|
Amphetamines [Mass/volume] in Urine |
|
8154-7
|
Amphetamines [Presence] in Unknown substance |
|
8155-4
|
Amphetamines [Presence] in Unknown substance by Confirmatory method |
|
8156-2
|
Amphetamines [Presence] in Unknown substance by Screen method |
|
8153-9
|
Amphetamines [Mass/volume] in Unknown substance |
|
27205-4
|
Amphetamines [Presence] in Vitreous fluid |
|
27263-3
|
Amphetamines [Mass/volume] in Vitreous fluid |
|
29530-3
|
Amphetamines [Presence] in Unspecified specimen |
|
48939-3
|
Amphetamines [Mass/volume] in Unspecified specimen |
|
41464-9
|
Amphetamines/Creatinine [Mass Ratio] in Urine |
|
3352-2
|
Amphetaminil [Mass/time] in 24 hour Urine |
|
4125-1
|
Amphetaminil [Mass] of Dose |
|
3350-6
|
Amphetaminil [Presence] in Urine |
|
3351-4
|
Amphetaminil [Mass/volume] in Urine |
|
90816-0
|
Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
63383-4
|
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
57750-2
|
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
90815-2
|
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
33422-7
|
Amphiphysin Ab [Presence] in Serum |
|
57749-4
|
Amphiphysin Ab [Presence] in Serum by Immunoblot |
|
33423-5
|
Amphiphysin Ab [Units/volume] in Serum |
|
35142-9
|
Amphiphysin Ab [Titer] in Cerebral spinal fluid |
|
56531-7
|
Amphiphysin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
33927-5
|
Amphiphysin Ab [Titer] in Serum |
|
72327-0
|
Amphiphysin IgG Ab [Presence] in Serum by Immunoassay |
|
3353-0
|
Amphotericin B [Mass/volume] in Cerebral spinal fluid |
|
4126-9
|
Amphotericin B [Mass] of Dose |
|
6978-1
|
Amphotericin B [Susceptibility] by Gradient strip |
|
25-7
|
Amphotericin B [Susceptibility] by Disk diffusion (KB) |
|
24-0
|
Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23-2
|
Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC) |
|
40707-2
|
Amphotericin B [Mass/volume] in Serum or Plasma --peak |
|
3354-8
|
Amphotericin B [Mass/volume] in Serum or Plasma |
|
18863-1
|
Amphotericin B [Susceptibility] |
|
26-5
|
Amphotericin B [Susceptibility] by Serum bactericidal titer |
|
40757-7
|
Amphotericin B [Mass/volume] in Serum or Plasma --trough |
|
16370-9
|
Amphotericin B [Mass/volume] in Urine |
|
49859-2
|
Amphotericin B [Mass/volume] in Unspecified specimen |
|
73060-6
|
Ampicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73059-8
|
Ampicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4127-7
|
Ampicillin [Mass] of Dose |
|
6712-4
|
Ampicillin IgE Ab [Units/volume] in Serum |
|
15533-3
|
Ampicillin IgE Ab RAST class [Presence] in Serum |
|
42577-7
|
Ampicillin IgE Ab/IgE total in Serum |
|
34234-5
|
Ampicillin IgG Ab [Units/volume] in Serum |
|
7078-9
|
Ampicillin IgM Ab [Units/volume] in Serum |
|
73523-3
|
Ampicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73522-5
|
Ampicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6979-9
|
Ampicillin [Susceptibility] by Gradient strip |
|
29-9
|
Ampicillin [Susceptibility] by Disk diffusion (KB) |
|
28-1
|
Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
27-3
|
Ampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
48199-4
|
Ampicillin triggered leukotriene release [Mass/volume] by Leukocytes |
|
33562-0
|
Ampicillin [Mass/volume] in Serum or Plasma --peak |
|
43883-8
|
Ampicillin [Presence] in Serum or Plasma |
|
3355-5
|
Ampicillin [Mass/volume] in Serum or Plasma |
|
18864-9
|
Ampicillin [Susceptibility] |
|
30-7
|
Ampicillin [Susceptibility] by Serum bactericidal titer |
|
33919-2
|
Ampicillin [Mass/volume] in Serum or Plasma --trough |
|
43884-6
|
Ampicillin [Presence] in Urine |
|
21066-6
|
Ampicillin [Mass/volume] in Unspecified specimen |
|
87604-5
|
Ampicillin [Mass/mass] in Unspecified specimen |
|
6980-7
|
Ampicillin+Sulbactam [Susceptibility] by Gradient strip |
|
33-1
|
Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
32-3
|
Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
31-5
|
Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC) |
|
20374-5
|
Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria |
|
18865-6
|
Ampicillin+Sulbactam [Susceptibility] |
|
34-9
|
Ampicillin+Sulbactam [Susceptibility] by Serum bactericidal titer |
|
30297-6
|
Amprenavir [Susceptibility] by Genotype method |
|
30296-8
|
Amprenavir [Susceptibility] by Phenotype method |
|
29114-6
|
Amprenavir [Units/volume] in Serum or Plasma |
|
31028-4
|
Amprenavir [Mass/volume] in Serum or Plasma |
|
30299-2
|
Amprenavir [Susceptibility] |
|
49623-2
|
Amprenavir or Fosamprenavir [Susceptibility] by Genotype method |
|
43349-0
|
Avian metapneumovirus A Ab [Presence] in Serum |
|
43318-5
|
Avian metapneumovirus A Ab [Presence] in Serum by Immunofluorescence |
|
43350-8
|
Avian metapneumovirus A Ab [Titer] in Serum |
|
43319-3
|
Avian metapneumovirus A Ab [Titer] in Serum by Immunoassay |
|
22834-6
|
Avian metapneumovirus Ab [Presence] in Serum |
|
43351-6
|
Avian metapneumovirus B Ab [Presence] in Serum |
|
43320-1
|
Avian metapneumovirus B Ab [Presence] in Serum by Immunofluorescence |
|
43352-4
|
Avian metapneumovirus B Ab [Titer] in Serum |
|
43321-9
|
Avian metapneumovirus B Ab [Titer] in Serum by Immunoassay |
|
43353-2
|
Avian metapneumovirus C Ab [Presence] in Serum |
|
43322-7
|
Avian metapneumovirus C Ab [Presence] in Serum by Immunofluorescence |
|
43354-0
|
Avian metapneumovirus C Ab [Titer] in Serum |
|
43323-5
|
Avian metapneumovirus C Ab [Titer] in Serum by Immunoassay |
|
1820-0
|
Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
|
16373-3
|
Amyl ether [Presence] in Blood |
|
16173-7
|
Amyl ether [Mass/volume] in Blood |
|
12535-1
|
Amyl nitrite [Presence] in Blood |
|
16374-1
|
Amyl nitrite [Mass/volume] in Serum or Plasma |
|
33245-2
|
Amylase [Catalytic Activity] in Urine collected for unspecified duration |
|
33599-2
|
Amylase [Enzymatic activity/volume] in Urine collected for unspecified duration |
|
38193-9
|
Amylase [Enzymatic activity/time] in Urine collected for unspecified duration |
|
38991-6
|
Amylase [Enzymatic activity/volume] in 12 hour Urine |
|
17841-8
|
Amylase [Enzymatic activity/time] in 12 hour Urine |
|
59001-8
|
Amylase [Enzymatic activity/time] in 18 hour Urine |
|
30124-2
|
Amylase [Enzymatic activity/time] in 1 hour Urine |
|
43821-8
|
Amylase [Presence] in 24 hour Urine |
|
38992-4
|
Amylase [Units/volume] in 24 hour Urine |
|
25311-2
|
Amylase [Enzymatic activity/volume] in 24 hour Urine |
|
1800-2
|
Amylase [Enzymatic activity/time] in 24 hour Urine |
|
38192-1
|
Amylase [Enzymatic activity/volume] in 2 hour Urine |
|
15350-2
|
Amylase [Enzymatic activity/time] in 2 hour Urine |
|
14392-5
|
Amylase [Enzymatic activity/volume] in Amniotic fluid |
|
76630-3
|
Amylase [Enzymatic activity/volume] in Blood |
|
1801-0
|
Amylase renal clearance in 24 hour Urine and Serum or Plasma |
|
14389-1
|
Amylase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
59039-8
|
Amylase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
14390-9
|
Amylase [Enzymatic activity/volume] in Dialysis fluid |
|
1794-7
|
Amylase [Enzymatic activity/volume] in Duodenal fluid |
|
43816-8
|
Amylase [Presence] in Body fluid |
|
49927-7
|
Amylase in fluid/Amylase in serum |
|
1795-4
|
Amylase [Enzymatic activity/volume] in Body fluid |
|
14391-7
|
Amylase [Enzymatic activity/volume] in Gastric fluid |
|
7073-0
|
Amylase IgE Ab [Units/volume] in Serum |
|
51566-8
|
Amylase IgE Ab RAST class [Presence] in Serum |
|
53134-3
|
Amylase isoenzymes [Interpretation] in Body fluid Narrative |
|
14589-6
|
Amylase isoenzymes [Interpretation] in Serum or Plasma |
|
49251-2
|
Amylase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
48186-1
|
Amylase triggered leukotriene release [Mass/volume] by Leukocytes |
|
54472-6
|
Amylase.macromolecular/Amylase.total in Serum or Plasma |
|
25312-0
|
Amylase.pancreatic/Amylase.total in Serum or Plasma |
|
72571-3
|
Amylase.pancreatic/Amylase.total [Pure catalytic fraction] in Serum or Plasma |
|
88710-9
|
Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
69357-2
|
Amylase [Enzymatic activity/volume] in Serum or Plasma --fasting |
|
48996-3
|
Amylase.pancreatic [Enzymatic activity/volume] in Body fluid |
|
70270-4
|
Amylase.pancreatic [Enzymatic activity/volume] in Pleural fluid |
|
70258-9
|
Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal fluid |
|
1805-1
|
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma |
|
22749-6
|
Amylase.pancreatic [Enzymatic activity/volume] in Urine |
|
69951-2
|
Amylase.pancreatic/Creatinine [Ratio] in Urine |
|
15020-1
|
Amylase.P1/Amylase.total in Serum or Plasma |
|
1802-8
|
Amylase.P1 [Enzymatic activity/volume] in Serum or Plasma |
|
15021-9
|
Amylase.P2/Amylase.total in Serum or Plasma |
|
1803-6
|
Amylase.P2 [Enzymatic activity/volume] in Serum or Plasma |
|
15022-7
|
Amylase.P3/Amylase.total in Serum or Plasma |
|
1804-4
|
Amylase.P3 [Enzymatic activity/volume] in Serum or Plasma |
|
33368-2
|
Amylase [Enzymatic activity/volume] in Pericardial fluid |
|
1796-2
|
Amylase [Enzymatic activity/volume] in Pleural fluid |
|
1797-0
|
Amylase [Enzymatic activity/volume] in Peritoneal fluid |
|
25313-8
|
Amylase.salivary/Amylase.total in Serum or Plasma |
|
72572-1
|
Amylase.salivary/Amylase.total [Pure catalytic fraction] in Serum or Plasma |
|
1809-3
|
Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma |
|
15023-5
|
Amylase S1/Amylase.total in Serum or Plasma |
|
1806-9
|
Amylase S1 [Enzymatic activity/volume] in Serum or Plasma |
|
15024-3
|
Amylase S2/Amylase.total in Serum or Plasma |
|
1807-7
|
Amylase S2 [Enzymatic activity/volume] in Serum or Plasma |
|
15025-0
|
Amylase S3/Amylase.total in Serum or Plasma |
|
1808-5
|
Amylase S3 [Enzymatic activity/volume] in Serum or Plasma |
|
56776-8
|
Amylase S3+S4/Amylase.total in Serum or Plasma |
|
56782-6
|
Amylase S4/Amylase.total in Serum or Plasma |
|
74992-9
|
Amylase [Enzymatic activity/volume] in Saliva (oral fluid) |
|
77146-9
|
Amylase [Enzymatic activity/volume] in Serum, Plasma or Blood |
|
1798-8
|
Amylase [Enzymatic activity/volume] in Serum or Plasma |
|
14388-3
|
Amylase [Enzymatic activity/volume] in Synovial fluid |
|
69360-6
|
Amylase [Enzymatic activity/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
35346-6
|
Amylase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
|
69359-8
|
Amylase [Enzymatic activity/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
35345-8
|
Amylase [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
|
35344-1
|
Amylase [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
|
35343-3
|
Amylase [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
|
35342-5
|
Amylase [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
|
1799-6
|
Amylase [Enzymatic activity/volume] in Urine |
|
32298-2
|
Amylase [Enzymatic activity/volume] in Unspecified specimen |
|
70262-1
|
Amylase in peritoneal fluid/Amylase in serum |
|
1811-9
|
Amylase/Creatinine renal clearance [Ratio] in 24 hour Urine and Serum or Plasma |
|
30077-2
|
Amylase/Creatinine renal clearance [Ratio] in Urine and Serum or Plasma |
|
56902-0
|
Amylase/Creatinine [Ratio] in 24 hour Urine |
|
1810-1
|
Amylase/Creatinine [Mass Ratio] in Serum or Plasma |
|
13706-7
|
Amylase/Creatinine [Mass Ratio] in Urine |
|
34235-2
|
Amylase/Creatinine [Ratio] in Urine |
|
48498-0
|
Amyloid A [Mass/volume] in Serum or Plasma |
|
81773-4
|
Amyloid A [Mass/mass] in Tissue |
|
72341-1
|
Amyloid bodies [Presence] in Prostatic fluid by Light microscopy |
|
82954-9
|
Amyotrophic lateral sclerosis functional rating scale - revised [ALSFRS-R] |
|
82850-9
|
Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82851-7
|
Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
53988-2
|
Atypic speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
53987-4
|
Atypic speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
53994-0
|
Centrosomal nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
53993-2
|
Centrosomal nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
53990-8
|
Chromosomal nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
53989-0
|
Chromosomal nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
53986-6
|
Coarse speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
53985-8
|
Coarse speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
63295-0
|
Nuclear Ab [Presence] in Cerebral spinal fluid by Hep2 substrate |
|
63294-3
|
Nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
53984-1
|
Fine speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
53002-2
|
Fine speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
13066-6
|
Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence |
|
14607-6
|
Nuclear Ab [Presence] in Body fluid |
|
16394-9
|
Nuclear Ab [Presence] in Body fluid by Immunofluorescence |
|
31540-8
|
Nuclear Ab [Units/volume] in Body fluid |
|
17380-7
|
Nuclear Ab.histone reactive [Presence] in Serum |
|
54149-0
|
Homogenous nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
20398-4
|
Homogenous nuclear Ab pattern [Titer] in Serum |
|
53983-3
|
Homogenous nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
85085-9
|
Centrosomal nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85084-2
|
Coarse speckled nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85083-4
|
Homogeneous nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85081-8
|
Multiple nuclear dots nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85082-6
|
Nuclear membrane pores nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85080-0
|
Nucleolar nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85079-2
|
Other nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
53999-9
|
Multiple nuclear dots nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
54000-5
|
Multiple nuclear dots nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
53997-3
|
Nuclear dots nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
53998-1
|
Nuclear dots nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
53996-5
|
Nuclear matrix Ab pattern [Presence] in Serum by Immunofluorescence |
|
53995-7
|
Nuclear matrix Ab pattern [Titer] in Serum by Immunofluorescence |
|
54005-4
|
Nuclear membrane pores nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
54006-2
|
Nuclear membrane pores nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
53992-4
|
Nucleolar nuclear Ab pattern [Presence] in Serum by Immunofluorescence |
|
42212-1
|
Nucleolar nuclear Ab pattern [Titer] in Body fluid |
|
20399-2
|
Nucleolar nuclear Ab pattern [Titer] in Serum |
|
53991-6
|
Nucleolar nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
63569-8
|
Nuclear Ab pattern [Interpretation] in Cerebral spinal fluid by Immunofluorescence |
|
13067-4
|
Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence |
|
49309-8
|
Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence Narrative |
|
63570-6
|
Nuclear Ab pattern [Interpretation] in Pleural fluid by Immunofluorescence |
|
13068-2
|
Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
49311-4
|
Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative |
|
14611-8
|
Nuclear Ab pattern [Interpretation] in Serum |
|
49310-6
|
Nuclear Ab pattern [Interpretation] in Serum Narrative |
|
57448-3
|
Nuclear Ab pattern [Interpretation] in Synovial fluid by Immunofluorescence |
|
68369-8
|
Nuclear Ab [Presence] in Pericardial fluid by Immunofluorescence |
|
31541-6
|
Nuclear Ab [Units/volume] in Pericardial fluid |
|
14608-4
|
Nuclear Ab [Presence] in Pleural fluid |
|
57010-1
|
Nuclear Ab [Presence] in Pleural fluid by Immunoassay |
|
68370-6
|
Nuclear Ab [Presence] in Pleural fluid by Immunofluorescence |
|
31542-4
|
Nuclear Ab [Units/volume] in Pleural fluid |
|
14609-2
|
Nuclear Ab [Presence] in Peritoneal fluid |
|
68371-4
|
Nuclear Ab [Presence] in Peritoneal fluid by Immunofluorescence |
|
31543-2
|
Nuclear Ab [Units/volume] in Peritoneal fluid |
|
42213-9
|
Rim nuclear Ab pattern [Titer] in Body fluid |
|
20400-8
|
Rim nuclear Ab pattern [Titer] in Serum |
|
5047-6
|
Nuclear Ab [Units/volume] in Serum by Immunoassay |
|
44752-4
|
Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney |
|
9423-5
|
Nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8061-4
|
Nuclear Ab [Presence] in Serum |
|
59069-5
|
Nuclear Ab [Presence] in Serum by Hep2 substrate |
|
47383-5
|
Nuclear Ab [Presence] in Serum by Immunoassay |
|
42254-3
|
Nuclear Ab [Presence] in Serum by Immunofluorescence |
|
44751-6
|
Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney |
|
16392-3
|
Nuclear Ab [Presence] in Serum by Rodent substrate |
|
16393-1
|
Nuclear Ab [Units/volume] in Serum by Rodent substrate |
|
27200-5
|
Nuclear Ab [Units/volume] in Serum |
|
14610-0
|
Nuclear Ab [Presence] in Synovial fluid |
|
68372-2
|
Nuclear Ab [Presence] in Synovial fluid by Immunofluorescence |
|
31544-0
|
Nuclear Ab [Units/volume] in Synovial fluid |
|
42214-7
|
Speckled nuclear Ab pattern [Titer] in Body fluid |
|
20401-6
|
Speckled nuclear Ab pattern [Titer] in Serum |
|
63297-6
|
Nuclear Ab [Titer] in Cerebral spinal fluid by Hep2 substrate |
|
63296-8
|
Nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
14613-4
|
Nuclear Ab [Titer] in Body fluid |
|
68376-3
|
Nuclear Ab [Titer] in Body fluid by Immunofluorescence |
|
14612-6
|
Nuclear Ab [Titer] in Pericardial fluid |
|
68373-0
|
Nuclear Ab [Titer] in Pericardial fluid by Immunofluorescence |
|
14614-2
|
Nuclear Ab [Titer] in Pleural fluid |
|
68374-8
|
Nuclear Ab [Titer] in Pleural fluid by Immunofluorescence |
|
14615-9
|
Nuclear Ab [Titer] in Peritoneal fluid |
|
68375-5
|
Nuclear Ab [Titer] in Peritoneal fluid by Immunofluorescence |
|
29953-7
|
Nuclear Ab [Titer] in Serum |
|
33253-6
|
Nuclear Ab [Titer] in Serum by Hep2 substrate |
|
40655-3
|
Nuclear Ab [Titer] in Serum by Immunoassay |
|
5048-4
|
Nuclear Ab [Titer] in Serum by Immunofluorescence |
|
21423-9
|
Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver |
|
14616-7
|
Nuclear Ab [Titer] in Synovial fluid |
|
6822-1
|
Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence |
|
33915-0
|
Anabasine [Mass/volume] in Urine |
|
46095-6
|
Anabolic steroids [Moles/volume] in Serum or Plasma |
|
9409-4
|
Anabolic steroids [Identifier] in Urine |
|
43977-8
|
Anabolic steroids [Presence] in Urine |
|
24091-1
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
|
1837-4
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma |
|
1838-2
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue |
|
2644-3
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Urine |
|
24092-9
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
|
79455-2
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in DBS |
|
24054-9
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Fibroblast |
|
11037-9
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma |
|
24055-6
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Leukocytes |
|
78792-9
|
Anakinra [Mass/volume] in Serum or Plasma |
|
44035-4
|
Analgesics Non-narcotic [Presence] in Serum or Plasma |
|
44036-2
|
Analgesics Non-narcotic [Presence] in Urine |
|
34175-0
|
Analgesics [Identifier] in Serum or Plasma |
|
90999-4
|
Analysis of emergency department visits |
|
90998-6
|
Analysis of information sources |
|
91095-0
|
Analysis of pharmaceutical needs in a region Narrative |
|
53416-4
|
Alpha naphthylesterase [Enzymatic activity/volume] in Blood |
|
53417-2
|
Alpha naphthylesterase [Enzymatic activity/volume] in Bone marrow |
|
1821-8
|
Alpha naphthylesterase [Enzymatic activity/volume] in Serum |
|
74152-0
|
Anaphylaxis action plan |
|
22800-7
|
Anaplasma sp identified in Blood by Modified Giemsa stain |
|
22799-1
|
Anaplasma sp identified in Tissue by Modified Giemsa stain |
|
48981-5
|
Anaplasma sp [Presence] in Unspecified specimen by Light microscopy |
|
49122-5
|
Anaplasma sp identified in Unspecified specimen by Sequencing |
|
20228-3
|
Anatomic part Laterality |
|
63568-0
|
Neutrophil cytoplasmic Ab pattern [Interpretation] in Cerebral spinal fluid by Immunofluorescence |
|
63567-2
|
Neutrophil cytoplasmic Ab pattern [Interpretation] in Body fluid by Immunofluorescence |
|
21419-7
|
Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
49308-0
|
Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative |
|
45151-8
|
Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay |
|
5262-1
|
Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence |
|
17351-8
|
Neutrophil cytoplasmic Ab [Presence] in Serum |
|
35279-9
|
Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence |
|
5128-4
|
Neutrophil cytoplasmic Ab [Units/volume] in Serum |
|
17352-6
|
Neutrophil cytoplasmic Ab [Interpretation] in Serum |
|
63293-5
|
Neutrophil cytoplasmic Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63292-7
|
Neutrophil cytoplasmic Ab [Titer] in Body fluid by Immunofluorescence |
|
21023-7
|
Neutrophil cytoplasmic Ab [Titer] in Serum |
|
51924-9
|
Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
|
17354-2
|
Neutrophil cytoplasmic IgA Ab [Presence] in Serum |
|
18329-3
|
Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum |
|
17355-9
|
Neutrophil cytoplasmic IgG Ab [Presence] in Serum |
|
18330-1
|
Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum |
|
29967-7
|
Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence |
|
17356-7
|
Neutrophil cytoplasmic IgM Ab [Presence] in Serum |
|
18331-9
|
Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum |
|
7079-7
|
Anchovy IgE Ab [Units/volume] in Serum |
|
15534-1
|
Anchovy IgE Ab RAST class [Presence] in Serum |
|
7080-5
|
Anchovy IgG Ab [Units/volume] in Serum |
|
5045-0
|
Ancylostoma sp Ab [Units/volume] in Serum |
|
24125-7
|
Androgen free Index in Serum or Plasma |
|
58919-2
|
Androstenedione [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
13856-0
|
Androstenedione [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
|
13857-8
|
Androstenedione [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
49327-0
|
Androstenedione [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
32588-6
|
Androstenedione [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
56528-3
|
Androstenedione [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
9310-4
|
Androstenedione [Mass/time] in 24 hour Urine |
|
34239-4
|
Androstenedione [Moles/volume] in 24 hour Urine |
|
15028-4
|
Androstenedione [Moles/time] in 24 hour Urine |
|
32587-8
|
Androstenedione [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
13858-6
|
Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
56498-9
|
Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
77608-8
|
Androstenedione [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
1851-5
|
Androstenedione [Mass/volume] in Amniotic fluid |
|
93731-8
|
Androstenedione [Moles/volume] in Amniotic fluid |
|
1852-3
|
Androstenedione [Mass/volume] in Capillary blood |
|
24407-9
|
Androstenedione [Mass/volume] in Serum or Plasma --baseline |
|
32299-0
|
Androstenedione [Moles/volume] in Serum or Plasma --baseline |
|
53343-0
|
Androstenedione [Mass/volume] in DBS |
|
53344-8
|
Androstenedione [Moles/volume] in DBS |
|
47560-8
|
Androstenedione [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
72489-8
|
Androstenedione [Moles/volume] in Saliva (oral fluid) |
|
43817-6
|
Androstenedione [Presence] in Serum or Plasma |
|
1854-9
|
Androstenedione [Mass/volume] in Serum or Plasma |
|
35190-8
|
Androstenedione [Mass or Moles/volume] in Serum or Plasma |
|
14603-5
|
Androstenedione [Moles/volume] in Serum or Plasma |
|
1853-1
|
Androstenedione [Mass/volume] in Semen |
|
43603-0
|
Androstenedione [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
16378-2
|
Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16379-0
|
Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16380-8
|
Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16381-6
|
Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
16382-4
|
Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16383-2
|
Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
16384-0
|
Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
16385-7
|
Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
1855-6
|
Androstenedione [Mass/volume] in Urine |
|
15027-6
|
Androstenedione [Moles/volume] in Urine |
|
34240-2
|
Androstenedione/Creatinine [Molar ratio] in Urine |
|
23815-4
|
Androstanediol [Mass/time] in 24 hour Urine |
|
9640-4
|
Androstanediol [Mass/volume] in Serum or Plasma |
|
15026-8
|
Androstanediol [Moles/volume] in Serum or Plasma |
|
1850-7
|
Androstanediol [Mass/volume] in Urine |
|
59389-7
|
Androstanolone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
57578-7
|
Androstanolone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
58917-6
|
Androstanolone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57577-9
|
Androstanolone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
58918-4
|
Androstanolone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
13882-6
|
Androstanolone Free/Androstanolone.total in Serum or Plasma |
|
14047-5
|
Androstanolone Free [Mass/volume] in Serum or Plasma |
|
57576-1
|
Androstanolone [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
43826-7
|
Androstanolone [Presence] in Serum or Plasma |
|
1848-1
|
Androstanolone [Mass/volume] in Serum or Plasma |
|
35189-0
|
Androstanolone [Mass or Moles/volume] in Serum or Plasma |
|
15057-3
|
Androstanolone [Moles/volume] in Serum or Plasma |
|
1849-9
|
Androstanolone [Mass/volume] in Semen |
|
60251-6
|
Androstanolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
60250-8
|
Androstanolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
60249-0
|
Androstanolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
60248-2
|
Androstanolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
60247-4
|
Androstanolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
60246-6
|
Androstanolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
60245-8
|
Androstanolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
60244-1
|
Androstanolone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
56033-4
|
Androstenediol [Mass/time] in 24 hour Urine |
|
34237-8
|
Androstenediol [Moles/volume] in 24 hour Urine |
|
25314-6
|
Androstenediol [Moles/time] in 24 hour Urine |
|
55851-0
|
Androstenediol [Moles/volume] in Serum or Plasma |
|
34236-0
|
Androstenediol [Moles/volume] in Urine |
|
34238-6
|
Androstenediol/Creatinine [Molar ratio] in Urine |
|
56487-2
|
Androsterone [Mass/volume] in 24 hour Urine |
|
6705-8
|
Androsterone [Mass/time] in 24 hour Urine |
|
34241-0
|
Androsterone [Moles/volume] in 24 hour Urine |
|
15030-0
|
Androsterone [Moles/time] in 24 hour Urine |
|
57643-9
|
Androsterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57644-7
|
Androsterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57639-7
|
Androsterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57640-5
|
Androsterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
57641-3
|
Androsterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57642-1
|
Androsterone [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57637-1
|
Androsterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57638-9
|
Androsterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
1856-4
|
Androsterone [Mass/volume] in Serum or Plasma |
|
15029-2
|
Androsterone [Moles/volume] in Serum or Plasma |
|
27110-6
|
Androsterone [Mass/volume] in Urine |
|
12479-2
|
Androsterone [Mass/time] in Urine |
|
34242-8
|
Androsterone [Moles/volume] in Urine |
|
44297-0
|
Androsterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
30509-4
|
Androsterone/Creatinine [Mass Ratio] in Urine |
|
34243-6
|
Androsterone/Creatinine [Molar ratio] in Urine |
|
89874-2
|
Anesthesia duration |
|
61359-6
|
Anesthesia consent Document |
|
11485-0
|
Anesthesia records |
|
77401-8
|
Anesthesiology Admission history and physical note |
|
83680-9
|
Anesthesiology Attending Note |
|
83681-7
|
Anesthesiology Attending Preoperative evaluation and management note |
|
78495-9
|
Anesthesiology Checklist |
|
77403-4
|
Anesthesiology Consult note |
|
77404-2
|
Anesthesiology Education note |
|
84058-7
|
Anesthesiology Flowsheet |
|
84059-5
|
Anesthesiology Hospital Note |
|
34123-0
|
Anesthesiology Hospital Preoperative evaluation and management note |
|
34750-0
|
Anesthesiology Note |
|
83567-8
|
Anesthesiology Nurse Note |
|
34749-2
|
Anesthesiology Outpatient Consult note |
|
84060-3
|
Anesthesiology Outpatient Note |
|
84063-7
|
Anesthesiology Telephone encounter Note |
|
84061-1
|
Anesthesiology Postoperative evaluation and management note |
|
34751-8
|
Anesthesiology Preoperative evaluation and management note |
|
84062-9
|
Anesthesiology procedure note |
|
89811-4
|
Anesthesiology Progress note |
|
85849-8
|
Anesthesiology Recovery room Discharge summary |
|
77405-9
|
Anesthesiology Referral note |
|
77436-4
|
Anesthesiology Summary note |
|
89794-2
|
Anesthesiology Team Conference note |
|
77406-7
|
Anesthesiology Transfer summary note |
|
76059-5
|
Anesthetic agent.XXX Airway adaptor |
|
60874-5
|
Anesthetic agent.XXX Airway adaptor --during inspiration |
|
60873-7
|
Anesthetic agent.XXX Airway adaptor --at end expiration |
|
77660-9
|
Aneuploid cell population 2 in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77658-3
|
Aneuploid cell population in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77659-1
|
Aneuploid cell population in S phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77661-7
|
Aneuploid cell population 2 in S phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77664-1
|
Aneuploid G1 phase cell population 2 peak channel [#] in Cells.XXX by Flow cytometry (FC) |
|
77663-3
|
Aneuploid G1 phase cell population peak channel [#] in Cells.XXX by Flow cytometry (FC) |
|
30915-3
|
Aneuploid cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
31114-2
|
Aneuploid cell population 1/100 cells in Unspecified specimen |
|
31115-9
|
Aneuploid cell population 2/100 cells in Unspecified specimen |
|
1921-6
|
Atrial natriuretic factor [Mass/volume] in Arterial blood |
|
11208-6
|
Atrial natriuretic factor [Mass/volume] in Plasma |
|
33783-2
|
Atrial natriuretic factor [Moles/volume] in Plasma |
|
77632-8
|
ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85130-3
|
Anger-Affect Survey - age 18+ - T-score [NIH Toolbox] |
|
78980-0
|
Angioplasty balloon product name |
|
1858-0
|
Angiotensin I [Mass/volume] in Plasma |
|
15031-8
|
Angiotensin I [Moles/volume] in Plasma |
|
1859-8
|
Angiotensin II [Mass/volume] in Cerebral spinal fluid |
|
1860-6
|
Angiotensin II [Mass/volume] in Plasma |
|
15032-6
|
Angiotensin II [Moles/volume] in Plasma |
|
70074-0
|
Angiotensin II [Mass/volume] in Plasma --supine |
|
25562-0
|
Angiotensin II [Moles/volume] in Plasma --supine |
|
51836-5
|
Angiotensin II [Mass/volume] in Plasma --upright |
|
25563-8
|
Angiotensin II [Moles/volume] in Plasma --upright |
|
1861-4
|
Angiotensinogen [Mass/volume] in Plasma |
|
47087-2
|
Angiotensinogen [Moles/volume] in Plasma |
|
54916-2
|
Angler IgE Ab [Units/volume] in Serum |
|
77162-6
|
Anidulafungin [Susceptibility] by Gradient strip |
|
55343-8
|
Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58420-1
|
Anidulafungin [Mass/volume] in Serum or Plasma |
|
57095-2
|
Anidulafungin [Susceptibility] |
|
3359-7
|
Anileridine [Moles/volume] in 24 hour Urine |
|
4128-5
|
Anileridine [Mass] of Dose |
|
3356-3
|
Anileridine [Mass/volume] in Serum or Plasma |
|
55523-5
|
Anileridine [Moles/volume] in Serum or Plasma |
|
3357-1
|
Anileridine [Presence] in Urine |
|
38567-4
|
Aniline [Mass/volume] in Air |
|
35584-2
|
Aniline [Mass/volume] in Blood |
|
1862-2
|
Aniline [Mass/volume] in Serum or Plasma |
|
35590-9
|
Aniline [Mass/volume] in Urine |
|
38736-5
|
Animal hair+Epithelium [Mass/volume] in Air |
|
41276-7
|
Anion gap in Blood |
|
47561-6
|
Anion gap in Body fluid |
|
33037-3
|
Anion gap in Serum or Plasma |
|
42485-3
|
Anion gap in Vitreous fluid |
|
94002-3
|
Anion gap 3 in Serum or Plasma --1 hour post dose vasopressin |
|
94011-4
|
Anion gap 3 in Serum or Plasma --2 hours post dose vasopressin |
|
10466-1
|
Anion gap 3 in Serum or Plasma |
|
73581-1
|
Anion gap 4 in Arterial blood |
|
73577-9
|
Anion gap 4 in Arterial cord blood |
|
73576-1
|
Anion gap 4 in Venous cord blood |
|
73580-3
|
Anion gap 4 in Capillary blood |
|
73579-5
|
Anion gap 4 in Mixed venous blood |
|
73582-9
|
Anion gap 4 in Blood |
|
73578-7
|
Anion gap 4 in Venous blood |
|
77341-6
|
Anion gap 4 in Serum, Plasma or Blood |
|
1863-0
|
Anion gap 4 in Serum or Plasma |
|
64985-5
|
Anisakis recombinant (rAni s) 1 IgE Ab [Units/volume] in Serum |
|
64986-3
|
Anisakis recombinant (rAni s) 3 IgE Ab [Units/volume] in Serum |
|
10919-9
|
Anisakis IgE Ab [Units/volume] in Serum |
|
15535-8
|
Anisakis IgE Ab RAST class [Presence] in Serum |
|
7081-3
|
Anise IgE Ab [Units/volume] in Serum |
|
15536-6
|
Anise IgE Ab RAST class [Presence] in Serum |
|
58468-0
|
Anise IgG4 Ab [Mass/volume] in Serum |
|
51582-5
|
Anisochromasia [Presence] in Blood by Light microscopy |
|
38892-6
|
Anisocytosis [Presence] in Blood |
|
15150-6
|
Anisocytosis [Presence] in Blood by Automated count |
|
702-1
|
Anisocytosis [Presence] in Blood by Light microscopy |
|
50638-6
|
Annatto seed IgE Ab [Units/volume] in Serum |
|
60454-6
|
Annatto seed IgE Ab RAST class [Presence] in Serum |
|
49458-3
|
Annexin 1 Ag [Presence] in Tissue by Immune stain |
|
44431-5
|
Annexin V IgG Ab [Units/volume] in Serum or Plasma |
|
44432-3
|
Annexin V IgM Ab [Units/volume] in Serum or Plasma |
|
48767-8
|
Annotation comment [Interpretation] Narrative |
|
7355-1
|
Annual blue grass IgE Ab [Units/volume] in Serum |
|
84064-5
|
Annual evaluation note |
|
66449-0
|
Annual mercury recombinant (rMer a) 1 IgE Ab [Units/volume] in Serum |
|
7687-7
|
Annual Saltbush IgE Ab [Units/volume] in Serum |
|
21515-2
|
Annual Saltbush IgE Ab RAST class [Presence] in Serum |
|
74550-5
|
Anonymous reporter [AHRQ] |
|
77711-0
|
Patient has anorexia, nausea or vomiting in the past week [UPDRS] |
|
28028-9
|
Anoscopy Study observation Narrative |
|
28029-7
|
Anoscopy Study observation |
|
6871-8
|
Anserine [Mass/time] in 24 hour Urine |
|
25858-2
|
Anserine [Moles/volume] in 24 hour Urine |
|
25320-3
|
Anserine [Moles/time] in 24 hour Urine |
|
13386-8
|
Anserine [Mass/volume] in Amniotic fluid |
|
26787-2
|
Anserine [Moles/volume] in Amniotic fluid |
|
1864-8
|
Anserine [Mass/volume] in Cerebral spinal fluid |
|
26588-4
|
Anserine [Moles/volume] in Cerebral spinal fluid |
|
1865-5
|
Anserine [Presence] in Serum or Plasma |
|
1866-3
|
Anserine [Mass/volume] in Serum or Plasma |
|
26599-1
|
Anserine [Moles/volume] in Serum or Plasma |
|
43906-7
|
Anserine [Presence] in Urine |
|
1867-1
|
Anserine [Mass/volume] in Urine |
|
27047-0
|
Anserine [Moles/volume] in Urine |
|
56903-8
|
Anserine/Creatinine [Ratio] in 24 hour Urine |
|
25859-0
|
Anserine/Creatinine [Molar ratio] in 24 hour Urine |
|
13707-5
|
Anserine/Creatinine [Mass Ratio] in Urine |
|
28596-5
|
Anserine/Creatinine [Ratio] in Urine |
|
26576-9
|
Anserine/Creatinine [Molar ratio] in Urine |
|
80102-7
|
Anterior chamber angle Left eye |
|
80101-9
|
Anterior chamber angle Right eye |
|
85311-9
|
Extent of anterior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
|
57055-6
|
Antepartum summary note |
|
53478-4
|
Anthranilate [Moles/time] in 24 hour Urine |
|
53468-5
|
Anthranilate [Moles/volume] in Serum or Plasma |
|
53498-2
|
Anthranilate [Moles/volume] in Urine |
|
53513-8
|
Anthranilate/Creatinine [Molar ratio] in Urine |
|
48041-8
|
Anthraquinone cutoff [Mass/mass] in Stool |
|
4129-3
|
Anthraquinone [Mass] of Dose |
|
3363-9
|
Anthraquinone [Mass/volume] in Serum or Plasma |
|
9417-7
|
Anthraquinone [Mass/mass] in Stool |
|
43929-9
|
Anthraquinone [Mass/volume] in Urine |
|
71471-7
|
Antibiotic administered Medication |
|
48611-8
|
Antibiotic tested [Identifier] against isolate |
|
74559-6
|
Anticipated duration of harm to the patient [AHRQ] |
|
85062-8
|
Anticoagulant given [Identifier] --preoperative |
|
89063-2
|
Type of anticoagulant medication used |
|
32665-2
|
Anticonvulsants [Identifier] in Serum or Plasma |
|
16388-1
|
Anticonvulsants [Identifier] in Urine |
|
38194-7
|
Antidepressants [Identifier] in Gastric fluid |
|
16389-9
|
Antidepressants [Identifier] in Serum or Plasma |
|
32136-4
|
Antidepressants [Presence] in Urine |
|
16390-7
|
Antidiuretics [Identifier] in Urine |
|
905-0
|
Blood group antigens absent [Identifier] in Blood product unit |
|
18276-6
|
Blood group antigens absent [Identifier] on Red Blood Cells from Donor |
|
906-8
|
Blood group antigens present [Identifier] in Blood |
|
74753-5
|
Blood group antigens present [Identifier] in Blood by IAT |
|
74754-3
|
Blood group antigens present [Identifier] in Blood by Immediate spin |
|
907-6
|
Blood group antigens present [Identifier] in Blood product unit |
|
18275-8
|
Blood group antigens present [Identifier] on Red Blood Cells from Donor |
|
80136-5
|
Antihistamines [Presence] in Blood by Screen method |
|
80137-3
|
Antihistamines [Presence] in Body fluid by Screen method |
|
38195-4
|
Antihistamines [Presence] in Gastric fluid |
|
75812-8
|
Antihistamines [Interpretation] in Serum or Plasma or Urine Qualitative by Screen method |
|
80197-7
|
Antihistamines [Presence] in Serum or Plasma by Screen method |
|
12332-3
|
Antihistamines [Identifier] in Urine |
|
18335-0
|
Antihistamines [Presence] in Urine by Confirmatory method |
|
35699-8
|
Anti-hyperglycemics [Identifier] in Serum or Plasma by Screen method |
|
30910-4
|
Antimicrobials [Presence] in Urine |
|
43876-2
|
Antimony [Presence] in 24 hour Urine |
|
21071-6
|
Antimony [Mass/volume] in 24 hour Urine |
|
14097-0
|
Antimony [Mass/time] in 24 hour Urine |
|
50808-5
|
Antimony [Moles/volume] in 24 hour Urine |
|
50806-9
|
Antimony [Moles/time] in 24 hour Urine |
|
5578-0
|
Antimony [Mass/volume] in Blood |
|
50809-3
|
Antimony [Moles/volume] in Blood |
|
51191-5
|
Antimony [Mass/volume] in Body fluid |
|
80140-7
|
Antimony [Moles/volume] in Body fluid |
|
26765-8
|
Antimony [Presence] in Hair |
|
5579-8
|
Antimony [Mass/mass] in Hair |
|
50810-1
|
Antimony [Moles/mass] in Hair |
|
27137-9
|
Antimony [Mass/mass] in Red Blood Cells |
|
50811-9
|
Antimony [Moles/volume] in Red Blood Cells |
|
12702-7
|
Antimony [Presence] in Serum or Plasma |
|
5580-6
|
Antimony [Mass/volume] in Serum or Plasma |
|
25321-1
|
Antimony [Moles/volume] in Serum or Plasma |
|
80138-1
|
Antimony [Mass/mass] in Tissue |
|
80139-9
|
Antimony [Moles/mass] in Tissue |
|
16391-5
|
Antimony [Presence] in Urine |
|
5581-4
|
Antimony [Mass/volume] in Urine |
|
50807-7
|
Antimony [Moles/volume] in Urine |
|
38308-3
|
Antimony [Mass/volume] in Water |
|
87563-3
|
Antimony [Mass/mass] in Unspecified specimen |
|
29941-2
|
Antimony/Creatinine [Mass Ratio] in 24 hour Urine |
|
52942-0
|
Antimony/Creatinine [Molar ratio] in 24 hour Urine |
|
13823-0
|
Antimony/Creatinine [Mass Ratio] in Urine |
|
52941-2
|
Antimony/Creatinine [Molar ratio] in Urine |
|
55219-0
|
Antioxidants [Moles/volume] in Serum or Plasma |
|
88296-9
|
Antipsychotic medications since admission/entry or reentry or the prior OBRA assessment, whichever is more recent [CMS Assessment] |
|
75811-0
|
Antipsychotics [Interpretation] in Blood or Urine Qualitative by Screen method |
|
12344-8
|
Antipsychotics [Identifier] in Serum or Plasma |
|
16395-6
|
Antipsychotics [Identifier] in Urine |
|
75242-8
|
Antipsychotics [Presence] in Urine by Screen method |
|
3365-4
|
Antipyrine renal clearance in 24 hour Urine and Serum or Plasma |
|
4130-1
|
Antipyrine [Mass] of Dose |
|
3364-7
|
Antipyrine [Mass/volume] in Serum or Plasma |
|
72331-2
|
Anucleated bodies/100 round cells in Prostatic fluid by Manual count |
|
72329-6
|
Anucleated bodies/100 round cells in Semen by Manual count |
|
51583-3
|
Anulocytes [Presence] in Blood by Light microscopy |
|
82872-3
|
AnWj Ab [Presence] in Serum or Plasma |
|
94024-7
|
Anxiety score |
|
71755-3
|
Anxiety score [M3] |
|
94017-1
|
Anxiety screening report |
|
94025-4
|
Anxiety severity |
|
89558-1
|
Anxiety symptoms score [CUBS] |
|
54852-9
|
Any fracture related to a fall in the 6 months prior to admission [CMS Assessment] |
|
78176-5
|
Aorta root Diameter by US 2D |
|
79954-4
|
Aorta root Diameter at end systole (by US 2D)/Body surface area |
|
79953-6
|
Aorta root Diameter at end systole by US 2D |
|
18167-7
|
Aorta root Mean flow velocity during systole by US.doppler |
|
17992-9
|
Aorta root Cardiac output by US.doppler |
|
18163-6
|
Aorta root Maximum blood flow velocity during systole by US.doppler |
|
18168-5
|
Aorta root Blood velocity-time integral by US.doppler |
|
20178-0
|
Aorta root Crossection [Area] by US 2D |
|
20177-2
|
Aorta root Crossection [Area] by US.calculated |
|
59474-7
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Acridine orange stain |
|
6658-9
|
Microscopic observation [Identifier] in Tissue by Acridine orange stain |
|
657-7
|
Microscopic observation [Identifier] in Unspecified specimen by Acridine orange stain |
|
18015-8
|
Aorta root annulo-aortic junction Diameter by US |
|
82339-3
|
Aorta.sinotubular junction Diameter by US 2D |
|
82338-5
|
Aorta.sinotubular junction Diameter by US.M-mode |
|
79955-1
|
Aorta.sinotubular junction Diameter at end systole by US 2D |
|
59600-7
|
Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method |
|
59599-1
|
Alpha hydroxyalprazolam [Mass/volume] in Blood |
|
77762-3
|
Alpha hydroxyalprazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19330-0
|
Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19329-2
|
Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method |
|
59602-3
|
Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59601-5
|
Alpha hydroxyalprazolam [Mass/volume] in Body fluid |
|
61072-5
|
Alpha hydroxyalprazolam [Presence] in Gastric fluid |
|
94115-3
|
Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method |
|
26887-0
|
Alpha hydroxyalprazolam [Mass/mass] in Hair |
|
59603-1
|
Alpha hydroxyalprazolam [Mass/mass] in Meconium by Confirmatory method |
|
26910-0
|
Alpha hydroxyalprazolam [Mass/mass] in Meconium |
|
59604-9
|
Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61035-2
|
Alpha hydroxyalprazolam [Presence] in Serum or Plasma |
|
27921-6
|
Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma |
|
27439-9
|
Alpha hydroxyalprazolam [Mass/mass] in Stool |
|
59606-4
|
Alpha hydroxyalprazolam [Mass/mass] in Tissue by Confirmatory method |
|
59605-6
|
Alpha hydroxyalprazolam [Mass/mass] in Tissue |
|
16348-5
|
Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
|
61036-0
|
Alpha hydroxyalprazolam [Presence] in Urine |
|
19326-8
|
Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method |
|
19325-0
|
Alpha hydroxyalprazolam [Presence] in Urine by Screen method |
|
19328-4
|
Alpha hydroxyalprazolam [Mass/volume] in Urine |
|
61037-8
|
Alpha hydroxyalprazolam [Presence] in Unspecified specimen |
|
48937-7
|
Alpha hydroxyalprazolam [Mass/volume] in Unspecified specimen |
|
58363-3
|
Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine |
|
69842-3
|
Alpha hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
|
1677-4
|
Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
69843-1
|
Alpha hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
26797-1
|
Alpha hydroxybutyrate [Presence] in Urine |
|
13671-3
|
Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
|
29858-8
|
Alpha hydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
73564-7
|
Alpha hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method |
|
53816-5
|
Alpha hydroxytriazolam [Mass/volume] in Serum |
|
49876-6
|
Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
|
94105-4
|
Alpha hydroxytriazolam [Presence] in Urine by Screen method |
|
60677-2
|
Alpha hydroxytriazolam [Mass/volume] in Urine |
|
86605-3
|
Alpha hydroxytriazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
11694-7
|
Aorta ascending Peak systolic flow velocity US.doppler |
|
11667-3
|
Aorta ascending Mean blood flow velocity US.doppler |
|
60981-8
|
Aorta blood pressure |
|
60982-6
|
Aorta Diastolic blood pressure |
|
60983-4
|
Aorta Mean blood pressure |
|
60984-2
|
Aorta Systolic blood pressure |
|
29460-3
|
Aorta Maximum coarctation flow [Velocity] by US.doppler |
|
11696-2
|
Aorta descending Peak systolic flow velocity US.doppler |
|
11669-9
|
Aorta descending Mean blood flow velocity US.doppler |
|
18010-9
|
Aorta Diameter by US |
|
17995-2
|
Aorta Maximum coarctation pressure gradient by US.doppler |
|
18014-1
|
Aorta isthmus Diameter by US |
|
83161-0
|
AP postural sway score [NIH Toolbox] --eyes closed and on foam surface |
|
83177-6
|
AP postural sway score [NIH Toolbox] --eyes closed and on solid surface |
|
83178-4
|
AP postural sway score [NIH Toolbox] --eyes open and on foam surface |
|
83160-2
|
AP postural sway score [NIH Toolbox] --eyes open and on solid surface |
|
83179-2
|
AP postural sway score [NIH Toolbox] --eyes open and in tandem stance and on solid surface |
|
73073-9
|
Acetaminophen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73074-7
|
Acetaminophen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
31089-6
|
Acetaminophen [Presence] in Bile fluid |
|
88059-1
|
Acetaminophen [Presence] in Blood by Screen method |
|
60048-6
|
Acetaminophen [Mass/volume] in Blood |
|
4105-3
|
Acetaminophen [Mass] of Dose |
|
18265-9
|
Acetaminophen [Presence] in Body fluid |
|
60049-4
|
Acetaminophen [Mass/volume] in Body fluid |
|
80964-0
|
Acetaminophen free [Mass/volume] in Serum or Plasma |
|
29389-4
|
Acetaminophen [Presence] in Gastric fluid |
|
35700-4
|
Acetaminophen [Mass/volume] in Gastric fluid |
|
47095-5
|
Acetaminophen [Moles/volume] in Gastric fluid |
|
6711-6
|
Acetaminophen IgE Ab [Units/volume] in Serum |
|
73546-4
|
Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73547-2
|
Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48277-8
|
Acetaminophen triggered leukotriene release [Mass/volume] by Leukocytes |
|
3297-9
|
Acetaminophen [Presence] in Serum or Plasma |
|
35595-8
|
Acetaminophen [Mass/volume] in Serum or Plasma by Screen method |
|
70198-7
|
Acetaminophen [Moles/volume] in Serum or Plasma by Screen method |
|
3298-7
|
Acetaminophen [Mass/volume] in Serum or Plasma |
|
14581-3
|
Acetaminophen [Moles/volume] in Serum or Plasma |
|
60050-2
|
Acetaminophen [Mass/mass] in Tissue |
|
3299-5
|
Acetaminophen [Presence] in Urine |
|
59384-8
|
Acetaminophen [Presence] in Urine by Screen method |
|
16282-6
|
Acetaminophen [Units/volume] in Urine |
|
13622-6
|
Acetaminophen [Mass/volume] in Urine |
|
39456-9
|
Acetaminophen [Moles/volume] in Urine |
|
29529-5
|
Acetaminophen [Presence] in Unspecified specimen |
|
12442-0
|
Acetaminophen [Mass/volume] in Unspecified specimen |
|
22736-3
|
Acetaminophen [Moles/volume] in Unspecified specimen |
|
72819-6
|
Acetaminophen/Creatinine [Mass Ratio] in Urine |
|
75071-1
|
Acetaminophen/Creatinine [Molar ratio] in Urine |
|
93972-8
|
Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma |
|
66503-4
|
APC gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
20990-8
|
APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21618-4
|
APC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21617-6
|
APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method |
|
13589-7
|
Activated protein C resistance [Presence] in Blood by NAA with probe detection |
|
13590-5
|
Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
|
52750-7
|
Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assay |
|
48591-2
|
Activated protein C resistance [Interpretation] in Platelet poor plasma |
|
9273-4
|
2 minute Apgar Score |
|
25505-9
|
Pituitary glycoprotein hormone.alpha subunit [Units/volume] in Serum |
|
14170-5
|
Pituitary glycoprotein hormone.alpha subunit [Mass/volume] in Serum |
|
52119-5
|
Apheresis available [#] in Blood product unit |
|
84887-9
|
Apical lymph node involvement of Colorectal cancer |
|
74214-8
|
Apixaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
74218-9
|
Apixaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
72608-3
|
Apixaban [Mass/volume] in Serum or Plasma |
|
74368-2
|
Apelin [Mass/volume] in Serum or Plasma |
|
37982-6
|
Avian paramyxovirus [Presence] in Unspecified specimen by Organism specific culture |
|
22097-0
|
Avian paramyxovirus 1 Ab [Presence] in Serum |
|
22829-6
|
Avian paramyxovirus 1 Ab [Presence] in Serum by Hemagglutination inhibition |
|
15447-6
|
Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay |
|
31242-1
|
Avian paramyxovirus 1 Ab [Units/volume] in Serum |
|
22098-8
|
Avian paramyxovirus 1 Ab [Titer] in Serum |
|
22830-4
|
Avian paramyxovirus 1 Ab [Titer] in Serum by Agglutination |
|
15448-4
|
Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition |
|
23661-2
|
Avian paramyxovirus 1 Ab [Titer] in Serum by Immunoassay |
|
31725-5
|
Avian paramyxovirus 1 Ag [Presence] in Unspecified specimen |
|
22831-2
|
Avian paramyxovirus 1 Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
|
44267-3
|
Avian paramyxovirus 1 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34486-1
|
Avian paramyxovirus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
34488-7
|
Avian paramyxovirus 1 subtype [Identifier] in Isolate by NAA with probe detection |
|
22832-0
|
Avian paramyxovirus 1 identified in Unspecified specimen by Bioassay |
|
22833-8
|
Avian paramyxovirus 1 [Units/volume] in Unspecified specimen by Bioassay |
|
31243-9
|
Avian paramyxovirus 2 Ab [Units/volume] in Serum |
|
22099-6
|
Avian paramyxovirus 2 Ab [Titer] in Serum |
|
15449-2
|
Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
22100-2
|
Avian paramyxovirus 3 Ab [Titer] in Serum |
|
15450-0
|
Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43345-8
|
Avian paramyxovirus 6 Ab [Titer] in Serum |
|
43314-4
|
Avian paramyxovirus 6 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43346-6
|
Avian paramyxovirus 7 Ab [Titer] in Serum |
|
43315-1
|
Avian paramyxovirus 7 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43347-4
|
Avian paramyxovirus 8 Ab [Titer] in Serum |
|
43316-9
|
Avian paramyxovirus 8 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43348-2
|
Avian paramyxovirus 9 Ab [Titer] in Serum |
|
43317-7
|
Avian paramyxovirus 9 Ab [Titer] in Serum by Hemagglutination inhibition |
|
76166-8
|
Apnea duration setting Ventilator alarm |
|
60821-6
|
Apnea duration |
|
69990-0
|
Apnea hypopnea index 24 hour |
|
90562-0
|
Apnea index |
|
59842-5
|
Apnea interval Ventilator alarm |
|
1883-8
|
Apolipoprotein A [Mass/volume] in Serum or Plasma |
|
1869-7
|
Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
|
76483-7
|
Apolipoprotein A-I [Moles/volume] in Serum or Plasma |
|
13462-7
|
Apolipoprotein A-I/Apolipoprotein B [Mass Ratio] in Serum or Plasma |
|
56035-9
|
Apolipoprotein A-I/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
|
1870-5
|
Apolipoprotein A-II [Mass/volume] in Serum or Plasma |
|
1878-8
|
Apolipoprotein A-III [Mass/volume] in Serum or Plasma |
|
1884-6
|
Apolipoprotein B [Mass/volume] in Serum or Plasma |
|
76482-9
|
Apolipoprotein B [Moles/volume] in Serum or Plasma |
|
9340-1
|
Apolipoprotein B/Apolipoprotein A-I [Percentile] |
|
1874-7
|
Apolipoprotein B/Apolipoprotein A-I [Mass Ratio] in Serum or Plasma |
|
56036-7
|
Apolipoprotein B/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
|
1871-3
|
Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
|
1872-1
|
Apolipoprotein B-150 [Mass/volume] in Serum or Plasma |
|
1873-9
|
Apolipoprotein B-48 [Mass/volume] in Serum or Plasma |
|
1885-3
|
Apolipoprotein C [Mass/volume] in Serum or Plasma |
|
1875-4
|
Apolipoprotein C-I [Mass/volume] in Serum or Plasma |
|
1876-2
|
Apolipoprotein C-II [Mass/volume] in Serum or Plasma |
|
1877-0
|
Apolipoprotein C-III [Mass/volume] in Serum or Plasma |
|
90419-3
|
Apolipoprotein CIII-0/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma |
|
90421-9
|
Apolipoprotein CIII-1/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma |
|
34438-2
|
Apolipoprotein E phenotyping [Identifier] in Blood |
|
43835-8
|
Apolipoprotein E [Presence] in Serum or Plasma |
|
1886-1
|
Apolipoprotein E [Mass/volume] in Serum or Plasma |
|
48619-1
|
Apolipoprotein E1 [Presence] in Blood |
|
15351-0
|
Apolipoprotein E2 [Presence] in Blood |
|
1879-6
|
Apolipoprotein E2 [Mass/volume] in Serum or Plasma |
|
15352-8
|
Apolipoprotein E3 [Presence] in Blood |
|
15353-6
|
Apolipoprotein E4 [Presence] in Blood |
|
1881-2
|
Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
|
1882-0
|
Apolipoprotein LPQ [Mass/volume] in Serum or Plasma |
|
93420-8
|
APOA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
89323-0
|
APOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
73748-6
|
APOB gene p.Arg3500Gln and p.Arg3500Trp [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
56752-9
|
APOB gene+LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
68467-0
|
APOB+LDLR+PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42315-2
|
APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34731-0
|
APOE gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method |
|
34732-8
|
APOE gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method |
|
21619-2
|
APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72157-1
|
Apo-transcobalamin II [Moles/volume] in Serum |
|
92636-0
|
APOL1 inferred genotype [Identifier] in Plasma from Donor |
|
72158-9
|
Apo-transcobalamin I [Moles/volume] in Serum |
|
49459-1
|
Alzheimer precursor protein Ag [Presence] in Tissue by Immune stain |
|
75390-5
|
APP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
52032-0
|
Appeal denial letter |
|
80269-4
|
Appearance of Abdomen |
|
1887-9
|
Appearance of Amniotic fluid |
|
38196-2
|
Appearance of Blood |
|
32803-9
|
Appearance of Bronchial specimen |
|
10333-3
|
Appearance of Cerebral spinal fluid |
|
40606-6
|
Appearance of Peritoneal dialysis fluid |
|
57835-1
|
Appearance of Dialysis fluid |
|
9335-1
|
Appearance of Body fluid |
|
29606-1
|
Appearance of Gastric fluid |
|
46273-9
|
Appearance of Serum--after transfusion reaction |
|
46272-1
|
Appearance of Urine--after transfusion reaction |
|
14617-5
|
Appearance of Pericardial fluid |
|
14619-1
|
Appearance of Plasma |
|
14620-9
|
Appearance of Pleural fluid |
|
14621-7
|
Appearance of Peritoneal fluid |
|
16400-4
|
Appearance of Seminal plasma |
|
11158-3
|
Appearance of Serum |
|
29605-3
|
Appearance of Synovial fluid |
|
33455-7
|
Appearance of Sputum |
|
11135-1
|
Appearance of Spun Cerebral spinal fluid |
|
52812-5
|
Appearance of Spun Dialysis fluid |
|
11134-4
|
Appearance of Spun Body fluid |
|
52820-8
|
Appearance of Spun Pericardial fluid |
|
52813-3
|
Appearance of Spun Pleural fluid |
|
52814-1
|
Appearance of Spun Peritoneal fluid |
|
41280-9
|
Appearance of Spun Synovial fluid |
|
68455-5
|
Appearance of Spun Vitreous fluid |
|
29636-8
|
Appearance of Stool |
|
14618-3
|
Appearance of Stone |
|
76675-8
|
Appearance of Cerebral spinal fluid--1st tube |
|
76676-6
|
Appearance of Cerebral spinal fluid--2nd tube |
|
76677-4
|
Appearance of Cerebral spinal fluid--3rd tube |
|
76678-2
|
Appearance of Cerebral spinal fluid--4th tube |
|
5767-9
|
Appearance of Urine |
|
68436-5
|
Appearance of Vitreous fluid |
|
72371-8
|
Appearance of Wound base |
|
72290-0
|
Appearance of Exudate from wound |
|
33511-7
|
Appearance of Unspecified specimen |
|
64961-6
|
Apple recombinant (rMal d) 1 IgE Ab [Units/volume] in Serum |
|
82000-1
|
Apple recombinant (rMal d) 1 IgE Ab RAST class [Presence] in Serum |
|
81791-6
|
Apple recombinant (rMal d) 3 IgE Ab [Units/volume] in Serum |
|
82460-7
|
Apple recombinant (rMal d) 3 IgE Ab RAST class [Presence] in Serum |
|
79171-5
|
Apple recombinant (rMal d) 4 IgE Ab [Units/volume] in Serum |
|
7089-6
|
Apple triggered histamine release [Units/volume] in Serum |
|
6021-0
|
Apple IgE Ab [Units/volume] in Serum |
|
15539-0
|
Apple IgE Ab RAST class [Presence] in Serum |
|
43596-6
|
Apple IgE Ab/IgE total in Serum |
|
7088-8
|
Apple IgG Ab [Units/volume] in Serum |
|
21072-4
|
Apple IgG Ab RAST class [Presence] in Serum |
|
56176-1
|
Apple IgG4 Ab [Mass/volume] in Serum |
|
60349-8
|
Apple IgG Ab [Mass/volume] in Serum |
|
7090-4
|
Apple Tree IgE Ab [Units/volume] in Serum |
|
15540-8
|
Apple Tree IgE Ab RAST class [Presence] in Serum |
|
75532-2
|
Applicable accrediting agency for unit [NMMDS] |
|
75536-3
|
Applicable certification agency for unit [NMMDS] |
|
75537-1
|
Applicable licensing agency for unit [NMMDS] |
|
79537-7
|
Applied cognitive items number [Activity Measure for Post-Acute Care] |
|
79535-1
|
Applied cognitive score [AM-PAC] |
|
79536-9
|
Applied cognitive score standard error [AM-PAC] |
|
93449-7
|
Appointment of legal guardian |
|
93752-4
|
Atypical porcine pestivirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
93751-6
|
Atypical porcine pestivirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
73653-8
|
Apramycin [Susceptibility] by Disk diffusion (KB) |
|
73652-0
|
Apramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23659-6
|
Apramycin [Susceptibility] |
|
86465-2
|
AST to platelet ratio index in Serum and Blood by calculation |
|
7091-2
|
Apricot IgE Ab [Units/volume] in Serum |
|
15541-6
|
Apricot IgE Ab RAST class [Presence] in Serum |
|
7092-0
|
Apricot IgG Ab [Units/volume] in Serum |
|
21073-2
|
Apricot IgG Ab RAST class [Presence] in Serum |
|
56177-9
|
Apricot IgG4 Ab [Mass/volume] in Serum |
|
60350-6
|
Apricot IgG Ab [Mass/volume] in Serum |
|
19352-4
|
Aprobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19351-6
|
Aprobarbital cutoff [Mass/volume] in Urine for Screen method |
|
10530-4
|
Aprobarbital [Mass/volume] in Serum or Plasma |
|
20517-9
|
Aprobarbital [Mass/volume] in Urine by Confirmatory method |
|
12313-3
|
Aprobarbital [Presence] in Urine |
|
19350-8
|
Aprobarbital [Presence] in Urine by Confirmatory method |
|
19349-0
|
Aprobarbital [Presence] in Urine by Screen method |
|
14183-8
|
Aprobarbital [Mass/volume] in Urine |
|
43975-2
|
Aprobarbital [Presence] in Unspecified specimen |
|
50165-0
|
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells |
|
79450-3
|
Adenine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells |
|
50394-6
|
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample |
|
1720-2
|
Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
74358-3
|
Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Serum or Plasma |
|
50590-9
|
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Trophoblasts |
|
76464-7
|
American Physical Therapy Association registry panel |
|
75507-4
|
aPTT.lupus sensitive W excess phospholipid percent correction |
|
40103-4
|
aPTT in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challenge |
|
40109-1
|
aPTT in Platelet poor plasma by Coagulation assay --12 hours post XXX challenge |
|
40111-7
|
aPTT in Platelet poor plasma by Coagulation assay --18 hours post XXX challenge |
|
40110-9
|
aPTT in Platelet poor plasma by Coagulation assay --1 day post XXX challenge |
|
44950-4
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
30323-0
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
33888-9
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
|
49844-4
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
|
40102-6
|
aPTT in Platelet poor plasma by Coagulation assay --1 hour post XXX challenge |
|
30321-4
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1 hour post incubation |
|
38276-2
|
aPTT in Pooled Platelet poor plasma by Coagulation assay --1 hour post incubation |
|
30322-2
|
aPTT.factor substitution in Platelet poor plasma --1 hour post incubation |
|
5947-7
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
|
5950-1
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
|
33891-3
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
|
33890-5
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
|
33889-7
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
|
49843-6
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
|
40104-2
|
aPTT in Platelet poor plasma by Coagulation assay --2 hours post XXX challenge |
|
38517-9
|
aPTT.factor substitution in Platelet poor plasma --2 hours post incubation |
|
40099-4
|
aPTT in Platelet poor plasma by Coagulation assay --2 hours pre XXX challenge |
|
34189-1
|
aPTT.factor substitution in Platelet poor plasma --30M post incubation with normal plasma |
|
40101-8
|
aPTT in Platelet poor plasma by Coagulation assay --30 minutes post XXX challenge |
|
40105-9
|
aPTT in Platelet poor plasma by Coagulation assay --3 hours post XXX challenge |
|
40106-7
|
aPTT in Platelet poor plasma by Coagulation assay --4 hours post XXX challenge |
|
55203-4
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --5 minutes post incubation after addition of normal plasma |
|
55202-6
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --5 minutes post incubation after addition of normal plasma |
|
40107-5
|
aPTT in Platelet poor plasma by Coagulation assay --6 hours post XXX challenge |
|
40108-3
|
aPTT in Platelet poor plasma by Coagulation assay --8 hours post XXX challenge |
|
63561-5
|
aPTT actual/normal in Platelet poor plasma by Coagulation assay |
|
48590-4
|
aPTT in Platelet poor plasma by Coagulation assay --after addition of APC |
|
3173-2
|
aPTT in Blood by Coagulation assay |
|
16631-4
|
aPTT in Blood by Coagulation 1:1 saline |
|
49058-1
|
aPTT in Blood drawn from CRRT circuit by Coagulation assay |
|
40100-0
|
aPTT in Platelet poor plasma by Coagulation assay --baseline |
|
12185-5
|
aPTT in Control Blood by Coagulation assay |
|
16630-6
|
aPTT in Control Blood by Coagulation 1:1 saline |
|
13488-2
|
aPTT in Control Platelet poor plasma by Coagulation assay |
|
3282-1
|
aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay |
|
91119-8
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma |
|
33892-1
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
|
15361-9
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
|
34683-3
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor IX depleted plasma |
|
54207-6
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma |
|
54208-4
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma+APC |
|
34687-4
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XI depleted plasma |
|
34688-2
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XII depleted plasma |
|
34684-1
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XIII depleted plasma |
|
5949-3
|
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
5946-9
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
57763-5
|
Activated partial thromboplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma/pre addition of normal plasma |
|
15362-7
|
aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay |
|
5899-0
|
aPTT normal/actual in Platelet poor plasma by Coagulation assay |
|
49845-1
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 1H post incubation separate tubes |
|
67566-0
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 2H post incubation separate tubes |
|
52123-7
|
aPTT in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
50754-1
|
aPTT in Pooled Platelet poor plasma by Coagulation assay |
|
14979-9
|
aPTT in Platelet poor plasma by Coagulation assay |
|
43734-3
|
aPTT in Platelet poor plasma by Coagulation 1:1 saline |
|
61191-3
|
aPTT in Platelet poor plasma from Fetus by Coagulation assay |
|
52766-3
|
aPTT in Platelet poor plasma by Coagulation assay -- after addition of protein C activator + Factor V depleted plasma/aPTT |
|
75884-7
|
aPTT.lupus sensitive/aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio) |
|
13058-3
|
aPTT in Platelet poor plasma by Coagulation assay --2nd specimen |
|
13059-1
|
aPTT in Platelet poor plasma by Coagulation assay --3rd specimen |
|
13060-9
|
aPTT in Platelet poor plasma by Coagulation assay --4th specimen |
|
52751-5
|
aPTT.factor sensitive in Platelet poor plasma by Coagulation assay |
|
50760-8
|
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
59806-0
|
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
|
93237-6
|
aPTT.lupus sensitive.excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
93236-8
|
aPTT.lupus sensitive.excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
34572-8
|
aPTT.lupus sensitive in Control Platelet poor plasma by Coagulation assay |
|
34573-6
|
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:2 addition of normal plasma |
|
52134-4
|
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 4:1 addition of normal plasma |
|
67097-6
|
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
53570-8
|
aPTT.lupus insensitive in Platelet poor plasma by Coagulation assay |
|
93235-0
|
aPTT.lupus sensitive in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
52755-6
|
aPTT.lupus sensitive [Presence] in Platelet poor plasma by Coagulation assay |
|
52767-1
|
Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay -- after addition of protein C activator/Activated partial thromboplastin time (aPTT) |
|
41119-9
|
APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40434-3
|
APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
86196-3
|
Alpha pyrrolidinovalerophenone [Mass/volume] in Urine by Confirmatory method |
|
90817-8
|
Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
61430-5
|
Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
46718-3
|
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid |
|
90818-6
|
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
68548-7
|
Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
43752-5
|
Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
43638-6
|
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma |
|
63439-4
|
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
61117-8
|
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immune stain |
|
90819-4
|
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
86240-9
|
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Flow cytometry (FC) |
|
88056-7
|
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
86241-7
|
Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Flow cytometry (FC) |
|
44794-6
|
Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
49457-5
|
Androgen receptor Ag [Presence] in Tissue by Immune stain |
|
21754-7
|
AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
35359-9
|
AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41118-1
|
AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79281-2
|
Arabinose/Creatinine [Molar ratio] in Urine |
|
47829-7
|
Arabitol/Creatinine [Molar ratio] in Urine |
|
75108-1
|
Arachidate (C20:0) [Entitic substance] in Red Blood Cells |
|
16811-2
|
Arachidate (C20:0) [Mass/volume] in Serum or Plasma |
|
35169-2
|
Arachidate (C20:0) [Moles/volume] in Serum or Plasma |
|
54173-0
|
Arbekacin [Susceptibility] by Disk diffusion (KB) |
|
53818-1
|
Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32373-3
|
Arbekacin [Susceptibility] |
|
44074-3
|
Arbovirus Ab [Interpretation] in Serum by Immunofluorescence |
|
36899-3
|
Arbovirus Ab [Identifier] in Unspecified specimen |
|
36895-1
|
Arbovirus Ab [Identifier] in Unspecified specimen by Immunofluorescence |
|
50034-8
|
Arbovirus Ab [Identifier] in Unspecified specimen by Neutralization test |
|
6309-9
|
Arbovirus identified in Blood by Organism specific culture |
|
53802-5
|
Arbovirus IgG Ab [Interpretation] in Serum by Immunofluorescence Narrative |
|
43905-9
|
Arbovirus IgG Ab [Presence] in Serum |
|
40584-5
|
Arbovirus IgM Ab [Presence] in Serum |
|
74033-2
|
Arbovirus IgM Ab [Presence] in Serum by Immunofluorescence |
|
31223-1
|
Arbovirus NOS Ab [Units/volume] in Serum |
|
43092-6
|
Arbovirus NOS Ab [Titer] in Serum |
|
26014-1
|
Arbovirus NOS Ab [Titer] in Serum by Complement fixation |
|
74031-6
|
Arbovirus identified in Serum by Immunofluorescence |
|
6310-7
|
Arbovirus identified in Unspecified specimen by Organism specific culture |
|
44955-3
|
Archive facility identification number NPI Cancer |
|
79770-4
|
Arden ratio Left retina by EOG |
|
79769-6
|
Arden ratio Right retina by EOG |
|
85469-5
|
Are current services involved with this client well-coordinated - visual analog rating [ePCAM] |
|
83341-8
|
Are current services involved with this client well-coordinated [PCAM] |
|
93070-1
|
Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby [NuPDQ] |
|
93027-1
|
Are you a refugee |
|
91730-2
|
Are you able to carry a 50 lb (25 kg) bag of sand 25 yards (25 m) [PROMIS] |
|
79013-9
|
Are you able to carry a bag of groceries for a short distance [PROMIS] |
|
78081-7
|
Are you able to carry a heavy object (over 10 pounds or 5 kg) [PROMIS] |
|
91735-1
|
Are you able to carry a large baby (15 lbs or 7 kg) out of the house to a car or taxi [PROMIS] |
|
79039-4
|
Are you able to carry a shopping bag [PROMIS] |
|
91756-7
|
Are you able to carry a suitcase up a flight of stairs [PROMIS] |
|
91755-9
|
Are you able to carry household items, such as heavy boxes or furniture, up a flight of stairs [PROMIS] |
|
78053-6
|
Are you able to carry two bags filled with groceries 100 yards (100 m) [PROMIS] |
|
79000-6
|
Are you able to clean up after a meal [PROMIS] |
|
91732-8
|
Are you able to climb a 6-foot (2 m) ladder [PROMIS] |
|
89682-9
|
Are you able to climb several flights of stairs [PROMIS] |
|
91748-4
|
Are you able to climb the stairs of a 10-story building without stopping [PROMIS] |
|
91746-8
|
Are you able to come to a complete stop while running [PROMIS] |
|
91749-2
|
Are you able to complete 10 sit-ups without stopping [PROMIS] |
|
91724-5
|
Are you able to complete 5 push-ups without stopping [PROMIS] |
|
91609-8
|
Are you able to continuously swing a baseball bat or tennis racket back and forth for 5 minutes [PROMIS] |
|
79052-7
|
Are you able to cut your toenails [PROMIS] |
|
91726-0
|
Are you able to dance energetically for 1 hour [PROMIS] |
|
78999-0
|
Are you able to dial a number on a phone with large buttons [PROMIS] |
|
79002-2
|
Are you able to dial a number on the keypad of a cell phone [PROMIS] |
|
91754-2
|
Are you able to dig a 2-foot (1/2 m) deep hole in the dirt with a shovel [PROMIS] |
|
91753-4
|
Are you able to do a pull-up [PROMIS] |
|
79017-0
|
Are you able to do an exercise of your choice for 20 minutes several times a week [PROMIS] |
|
79010-5
|
Are you able to do chores such as vacuuming carpet or mopping floors [PROMIS] |
|
79024-6
|
Are you able to do housework like vacuuming or sweeping floors [PROMIS] |
|
79018-8
|
Are you able to do strenuous tasks around the house like cleaning the bathroom or scrubbing floors [PROMIS] |
|
89683-7
|
Are you able to do two hours of physical labor [PROMIS] |
|
79038-6
|
Are you able to do vigorous activities, such as playing sports [PROMIS] |
|
79025-3
|
Are you able to do yard work like raking leaves or sweeping the driveway [PROMIS] |
|
79040-2
|
Are you able to dress yourself [PROMIS] |
|
78048-6
|
Are you able to dress yourself, including tying shoelaces and buttoning your clothes [PROMIS] |
|
79059-2
|
Are you able to exercise regularly [PROMIS] |
|
79009-7
|
Are you able to fasten and unfasten a seatbelt [PROMIS] |
|
79050-1
|
Are you able to fasten buttons on a shirt or blouse [PROMIS] |
|
79053-5
|
Are you able to fold clean laundry [PROMIS] |
|
79054-3
|
Are you able to get into a vehicle [PROMIS] |
|
79028-7
|
Are you able to get items in and out of a wallet [PROMIS] |
|
78050-2
|
Are you able to get up from the floor from lying on your back without help [PROMIS] |
|
78998-2
|
Are you able to go OUTSIDE the home, for example to shop or visit a doctor's office [PROMIS] |
|
79011-3
|
Are you able to go up and down stairs [PROMIS] |
|
91725-2
|
Are you able to hand wash and wax a car for 2 hours without stopping to rest [PROMIS] |
|
79005-5
|
Are you able to hike a couple of miles on uneven surfaces, including hills [PROMIS] |
|
91751-8
|
Are you able to hit the backboard with a basketball from the free throw line 13 ft or 4 m [PROMIS] |
|
79051-9
|
Are you able to hold a card or letter in order to read it [PROMIS] |
|
91740-1
|
Are you able to jump 2 feet (60 cm) high [PROMIS] |
|
91742-7
|
Are you able to jump over a puddle that is 3 feet (1 m) wide [PROMIS] |
|
91743-5
|
Are you able to jump over an object that is 1 foot (30 cm) tall [PROMIS] |
|
91744-3
|
Are you able to jump rope for 10M without stopping [PROMIS] |
|
78054-4
|
Are you able to lift 10 pounds (5 kg) above your shoulder [PROMIS] |
|
91752-6
|
Are you able to lift a heavy object (20 lbs or 10 kg) above your head [PROMIS] |
|
91610-6
|
Are you able to lift a heavy painting or picture to hang on your wall above eye-level [PROMIS] |
|
91734-4
|
Are you able to lift and load one 50-pound (25 kg) bag of sand into a car [PROMIS] |
|
78056-9
|
Are you able to lift one pound (0.5 kg) to shoulder level without bending your elbow [PROMIS] |
|
79012-1
|
Are you able to lift small objects (such as a can of soup) above your shoulder [PROMIS] |
|
91745-0
|
Are you able to make sharp turns while running fast [PROMIS] |
|
79037-8
|
Are you able to move about in a dark room or hallway without falling [PROMIS] |
|
79033-7
|
Are you able to move about the house [PROMIS] |
|
79036-0
|
Are you able to move around on a slippery surface outdoors [PROMIS] |
|
79048-5
|
Are you able to move from the street to the sidewalk without a curb cut [PROMIS] |
|
79035-2
|
Are you able to move wet clothes from the washer to the dryer [PROMIS] |
|
79061-8
|
Are you able to open a tight or new jar [PROMIS] |
|
79007-1
|
Are you able to open and squeeze a new tube of toothpaste [PROMIS] |
|
91741-9
|
Are you able to paint the walls of a room with a brush or roller for 2hours without stopping to rest [PROMIS] |
|
91608-0
|
Are you able to pass a 20-pound (10 kg) turkey or ham to other people at the table [PROMIS] |
|
79020-4
|
Are you able to pour liquid from a container into a cup [PROMIS] |
|
79022-0
|
Are you able to prepare simple meals for yourself or for others [PROMIS] |
|
91729-4
|
Are you able to pull a sled or a wagon with two children (total 100 lbs or 50 kg) for 100 yards (100 m) [PROMIS] |
|
79015-4
|
Are you able to pull a sweater or t-shirt over your head [PROMIS] |
|
78082-5
|
Are you able to pull heavy objects (10 pounds or 5 kg) towards yourself [PROMIS] |
|
79004-8
|
Are you able to pull up covers while lying in bed [PROMIS] |
|
91731-0
|
Are you able to push an empty refrigerator forward 1 yard (1 m) [PROMIS] |
|
79027-9
|
Are you able to push the buttons on a television remote control [PROMIS] |
|
79014-7
|
Are you able to put on socks [PROMIS] |
|
91736-9
|
Are you able to put your hands flat on the floor with both feet flat on the ground [PROMIS] |
|
91723-7
|
Are you able to rake leaves or sweep for 1 hour without stopping to rest [PROMIS] |
|
79023-8
|
Are you able to reach above your head [PROMIS] |
|
78055-1
|
Are you able to reach and get down a 5 pound (2 kg) object from above your head [PROMIS] |
|
75909-2
|
Are you able to reach and get down an object (such as a can of soup) from above your head [PROMIS] |
|
79060-0
|
Are you able to receive a call on a cell phone [PROMIS] |
|
91750-0
|
Are you able to remove a heavy suitcase (50 lbs or 25 kg) from an overhead bin on an airplane or bus [PROMIS] |
|
79003-0
|
Are you able to roll onto your stomach while lying in bed [PROMIS] |
|
91733-6
|
Are you able to row a boat for 30 minutes without stopping to rest [PROMIS] |
|
78061-9
|
Are you able to run 100 yards (100 m) [PROMIS] |
|
78051-0
|
Are you able to run at a fast pace for two miles (3 km) [PROMIS] |
|
78058-5
|
Are you able to run five miles (8 km) [PROMIS] |
|
91757-5
|
Are you able to run on even ground [PROMIS] |
|
89684-5
|
Are you able to run on uneven ground [PROMIS] |
|
78049-4
|
Are you able to run or jog for two miles (3 km) [PROMIS] |
|
78062-7
|
Are you able to run ten miles (16 km) [PROMIS] |
|
78066-8
|
Are you able to sit on and get up from the toilet [PROMIS] |
|
79019-6
|
Are you able to stand on a moving escalator [PROMIS] |
|
91738-5
|
Are you able to stand on one foot with your eyes closed for 30 seconds [PROMIS] |
|
91728-6
|
Are you able to stand up from a push-up position five times quickly [PROMIS] |
|
79045-1
|
Are you able to stand upright briefly without support [PROMIS] |
|
91727-8
|
Are you able to swim laps for 30 minutes at a moderate pace [PROMIS] |
|
79026-1
|
Are you able to take a letter out of an envelope [PROMIS] |
|
79030-3
|
Are you able to take a shower [PROMIS] |
|
79046-9
|
Are you able to transfer from a bed to a chair or a wheelchair [PROMIS] |
|
79029-5
|
Are you able to turn a key to unlock a door [PROMIS] |
|
79021-2
|
Are you able to turn pages in a book [PROMIS] |
|
79031-1
|
Are you able to turn sink faucets on and off [PROMIS] |
|
79032-9
|
Are you able to type a few sentences on a computer keyboard [PROMIS] |
|
79049-3
|
Are you able to use a moving escalator safely [PROMIS] |
|
79034-5
|
Are you able to use a regular computer mouse [PROMIS] |
|
78057-7
|
Are you able to walk a block (about 100 m) on flat ground [PROMIS] |
|
91739-3
|
Are you able to walk across a balance beam [PROMIS] |
|
91747-6
|
Are you able to walk briskly for 20 minutes without stopping to rest [PROMIS] |
|
91737-7
|
Are you able to walk in a straight line putting one foot in front of the other (heel to toe) for 5 yards (5 m) [PROMIS] |
|
79006-3
|
Are you able to walk more than a mile [PROMIS] |
|
79041-0
|
Are you able to wash and dry your feet [PROMIS] |
|
79042-8
|
Are you able to wash dishes and utensils by hand [PROMIS] |
|
75251-9
|
Are you blind or do you have difficulty seeing [HHS.ACA Section 4302.ONC] |
|
93676-5
|
Are you concerned about someone in your home using drugs or alcohol [WellRx] |
|
89174-7
|
Are you concerned that you have a memory or other thinking problem [ECog] |
|
75250-1
|
Are you deaf or do you have difficulty hearing [HHS.ACA Section 4302.ONC] |
|
93078-4
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby [NuPDQ] |
|
93062-8
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy [NuPDQ] |
|
93060-2
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy [NuPDQ] |
|
93082-6
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes [NuPDQ] |
|
93074-3
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery [NuPDQ] |
|
93072-7
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care [NuPDQ] |
|
93061-0
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy [NuPDQ] |
|
93066-9
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches [NuMoM2b] |
|
93065-1
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet [NuMoM2b] |
|
93064-4
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting [NuMoM2b] |
|
93076-8
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches [NuPDQ] |
|
93073-5
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby [NuPDQ] |
|
93059-4
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy [NuPDQ] |
|
93067-7
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy [NuPDQ] |
|
93080-0
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery [NuPDQ] |
|
93069-3
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken [NuPDQ] |
|
93075-0
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early [NuPDQ] |
|
93063-6
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby [NuPDQ] |
|
93081-8
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes [NuPDQ] |
|
93068-5
|
Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy [NuPDQ] |
|
93669-0
|
Are you homeless or worried that you might be in the future [WellRx] |
|
71060-8
|
Are you satisfied with the effects of this treatment so far [FACIT] |
|
89437-8
|
Are you short of breath on washing or dressing [Rose Dyspnea Scale] |
|
93673-2
|
Are you unemployed or without regular income [WellRx] |
|
93033-9
|
Are you worried about losing your housing [PRAPARE] |
|
89260-4
|
Area of wound |
|
41621-4
|
Arenavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
46782-9
|
Argininemia newborn screen interpretation |
|
73520-9
|
Argatroban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73521-7
|
Argatroban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68981-0
|
Argatroban [Units/volume] in Platelet poor plasma by Chromogenic method |
|
55363-6
|
Argatroban [Mass/volume] in Platelet poor plasma |
|
10770-6
|
Microscopic observation [Identifier] in Tissue by Argentaffin stain |
|
1890-3
|
Arginase [Enzymatic activity/volume] in Red Blood Cells |
|
79456-0
|
Arginase [Enzymatic activity/mass] in Red Blood Cells |
|
77620-3
|
Arginase-1 [Mass/volume] in Serum by Immunoassay |
|
1895-2
|
Arginine [Mass/time] in 24 hour Urine |
|
25860-8
|
Arginine [Moles/volume] in 24 hour Urine |
|
25322-9
|
Arginine [Moles/time] in 24 hour Urine |
|
13387-6
|
Arginine [Mass/volume] in Amniotic fluid |
|
26985-2
|
Arginine [Moles/volume] in Amniotic fluid |
|
41168-6
|
Arginine [Presence] in Blood |
|
1891-1
|
Arginine [Mass/volume] in Cerebral spinal fluid |
|
22656-3
|
Arginine [Moles/volume] in Cerebral spinal fluid |
|
43927-3
|
Arginine [Presence] in DBS |
|
47562-4
|
Arginine [Moles/volume] in DBS |
|
47208-4
|
Arginine [Mass] of Dose |
|
32225-5
|
Arginine [Moles/volume] in Body fluid |
|
55911-2
|
Arginine [Moles/mass] in Hair |
|
81015-0
|
Arginine intake 24 hour Estimated |
|
81016-8
|
Arginine intake 24 hour Measured |
|
74876-4
|
Arginine [Moles/volume] in DBS --post therapeutic diet |
|
1892-9
|
Arginine [Presence] in Serum or Plasma |
|
27974-5
|
Arginine [Units/volume] in Serum or Plasma |
|
1893-7
|
Arginine [Mass/volume] in Serum or Plasma |
|
20637-5
|
Arginine [Moles/volume] in Serum or Plasma |
|
47566-5
|
Arginine/Amino acids.total in Amniotic fluid |
|
47565-7
|
Arginine/Amino acids.total in Cerebral spinal fluid |
|
47567-3
|
Arginine/Amino acids.total in DBS |
|
47564-0
|
Arginine/Amino acids.total in Hair |
|
47563-2
|
Arginine/Amino acids.total in Serum or Plasma |
|
47568-1
|
Arginine/Amino acids.total in Unspecified specimen |
|
16401-2
|
Arginine [Presence] in Urine |
|
1894-5
|
Arginine [Mass/volume] in Urine |
|
27296-3
|
Arginine [Moles/volume] in Urine |
|
32226-3
|
Arginine [Moles/volume] in Vitreous fluid |
|
22727-2
|
Arginine [Moles/volume] in Unspecified specimen |
|
44299-6
|
Arginine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56672-9
|
Arginine/Creatinine [Ratio] in 24 hour Urine |
|
25861-6
|
Arginine/Creatinine [Molar ratio] in 24 hour Urine |
|
13708-3
|
Arginine/Creatinine [Mass Ratio] in Urine |
|
30062-4
|
Arginine/Creatinine [Ratio] in Urine |
|
22697-7
|
Arginine/Creatinine [Molar ratio] in Urine |
|
75214-7
|
Arginine/Ornithine [Molar ratio] in DBS |
|
53398-4
|
Arginine/Phenylalanine [Molar ratio] in DBS |
|
32228-9
|
Argininosuccinate [Moles/volume] in Amniotic fluid |
|
40838-5
|
Argininosuccinate [Moles/volume] in Cerebral spinal fluid |
|
53062-6
|
Argininosuccinate [Moles/volume] in DBS |
|
53067-5
|
Argininosuccinate [Moles/volume] in Body fluid |
|
74877-2
|
Argininosuccinate [Moles/volume] in DBS --post therapeutic diet |
|
43907-5
|
Argininosuccinate [Presence] in Serum or Plasma |
|
1896-0
|
Argininosuccinate [Mass/volume] in Serum or Plasma |
|
32227-1
|
Argininosuccinate [Moles/volume] in Serum or Plasma |
|
27134-6
|
Argininosuccinate [Presence] in Urine |
|
1897-8
|
Argininosuccinate [Mass/volume] in Urine |
|
74484-7
|
Argininosuccinate [Moles/volume] in Urine |
|
53200-2
|
Argininosuccinate/Arginine [Molar ratio] in DBS |
|
13709-1
|
Argininosuccinate/Creatinine [Mass Ratio] in Urine |
|
32229-7
|
Argininosuccinate/Creatinine [Ratio] in Urine |
|
29878-6
|
Argininosuccinate/Creatinine [Molar ratio] in Urine |
|
60915-6
|
Argon [VFr/PPres] Airway adaptor --during expiration |
|
76129-6
|
Argon [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60916-4
|
Argon [VFr/PPres] Airway adaptor --during inspiration |
|
76128-8
|
Argon [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60918-0
|
Argon [VFr/PPres] Airway adaptor --at end expiration |
|
29020-5
|
Argon laser coagulation treatment comment [Interpretation] Left eye Narrative |
|
29015-5
|
Argon laser coagulation treatment comment [Interpretation] Right eye Narrative |
|
29030-4
|
Argon laser trabeculoplasty treatment comment [Interpretation] Left eye Narrative |
|
29025-4
|
Argon laser trabeculoplasty treatment comment [Interpretation] Right eye |
|
60914-9
|
Argon [VFr/PPres] Airway adaptor |
|
76127-0
|
Argon [VFr/PPres] Gas delivery system |
|
78794-5
|
ARIPiprazole [Mass/volume] in Blood |
|
77760-7
|
ARIPiprazole cutoff [Mass/volume] in Urine for Confirmatory method |
|
79226-7
|
ARIPiprazole [Mass/volume] in Body fluid |
|
78793-7
|
ARIPiprazole [Mass/mass] in Hair |
|
89985-6
|
ARIPiprazole [Presence] in Serum or Plasma by Screen method |
|
38893-4
|
ARIPiprazole [Mass/volume] in Serum or Plasma |
|
48354-5
|
ARIPiprazole [Moles/volume] in Serum or Plasma |
|
74931-7
|
ARIPiprazole [Mass/volume] in Serum or Plasma --trough |
|
77761-5
|
ARIPiprazole [Mass/volume] in Urine by Confirmatory method |
|
89978-1
|
ARIPiprazole [Presence] in Urine by Screen method |
|
87781-1
|
ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
7095-3
|
Arizona Ash IgE Ab [Units/volume] in Serum |
|
15545-7
|
Arizona Ash IgE Ab RAST class [Presence] in Serum |
|
65778-3
|
Arizona Cypress native (nCup a) 1 IgE Ab [Units/volume] in Serum |
|
82030-8
|
Arizona Cypress native (nCup a) 1 IgE Ab RAST class [Presence] in Serum |
|
11168-2
|
Arizona Cypress IgE Ab [Units/volume] in Serum |
|
15671-1
|
Arizona Cypress IgE Ab RAST class [Presence] in Serum |
|
61253-1
|
Arizona Cypress IgE Ab/IgE total in Serum |
|
16402-0
|
Aromatic solvents [Identifier] in Blood |
|
74132-2
|
Aromatic solvents [Presence] in Blood |
|
40700-7
|
Aromatic solvents [Identifier] in Serum or Plasma |
|
74643-8
|
Aromatic solvents [Presence] in Urine |
|
76281-5
|
Type of arrhythmia on EKG |
|
88095-5
|
Time of arrival of first responder |
|
72151-4
|
Arrived at clinic with partner [RHEA] |
|
7093-8
|
Arrowroot IgE Ab [Units/volume] in Serum |
|
15542-4
|
Arrowroot IgE Ab RAST class [Presence] in Serum |
|
10769-8
|
Microscopic observation [Identifier] in Tissue by Alizarin red S stain |
|
76035-5
|
ARSA gene full mutation analysis in Blood or Tissue by Sequencing |
|
49706-5
|
ARSA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35453-0
|
ARSA gene PD allele [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
18405-1
|
Arsenate [Mass/volume] in Urine |
|
30924-5
|
Arsenic [Mass/volume] in Urine collected for unspecified duration |
|
13958-4
|
Arsenic [Presence] in 24 hour Urine |
|
21074-0
|
Arsenic [Mass/volume] in 24 hour Urine |
|
5587-1
|
Arsenic [Mass/time] in 24 hour Urine |
|
34245-1
|
Arsenic [Moles/volume] in 24 hour Urine |
|
34244-4
|
Arsenic [Moles/time] in 24 hour Urine |
|
38569-0
|
Arsenic [Mass/volume] in Air |
|
5582-2
|
Arsenic [Presence] in Blood |
|
5583-0
|
Arsenic [Mass/volume] in Blood |
|
15114-2
|
Arsenic [Moles/volume] in Blood |
|
40701-5
|
Arsenic [Mass/volume] in Dialysis fluid |
|
9489-6
|
Arsenic [Mass/volume] in Body fluid |
|
80141-5
|
Arsenic [Moles/volume] in Body fluid |
|
43825-9
|
Arsenic [Presence] in Gastric fluid |
|
20687-0
|
Arsenic [Mass/volume] in Gastric fluid |
|
5584-8
|
Arsenic [Mass/mass] in Hair |
|
46096-4
|
Arsenic [Moles/mass] in Hair |
|
8157-0
|
Arsenic [Mass/mass] in Nail |
|
50813-5
|
Arsenic [Moles/mass] in Nail |
|
43181-7
|
Arsenic organic [Mass/volume] in 24 hour Urine |
|
53839-7
|
Arsenic organic [Mass/time] in 24 hour Urine |
|
53778-7
|
Arsenic organic [Mass/volume] in Urine |
|
50816-8
|
Arsenic organic [Moles/volume] in Urine |
|
27127-0
|
Arsenic [Mass/mass] in Red Blood Cells |
|
50812-7
|
Arsenic [Moles/volume] in Red Blood Cells |
|
16403-8
|
Arsenic [Presence] in Serum or Plasma |
|
5585-5
|
Arsenic [Mass/volume] in Serum or Plasma |
|
25323-7
|
Arsenic [Moles/volume] in Serum or Plasma |
|
43809-3
|
Arsenic [Presence] in Tissue |
|
8158-8
|
Arsenic [Mass/mass] in Tissue |
|
78795-2
|
Arsenic [Moles/mass] in Tissue |
|
18406-9
|
Arsenic trioxide [Mass/volume] in Urine |
|
16404-6
|
Arsenic [Presence] in Urine |
|
5586-3
|
Arsenic [Mass/volume] in Urine |
|
29914-9
|
Arsenic [Mass/time] in Urine |
|
15115-9
|
Arsenic [Moles/volume] in Urine |
|
9463-1
|
Arsenic [Mass/volume] in Water |
|
43815-0
|
Arsenic [Presence] in Unspecified specimen |
|
87481-8
|
Arsenic [Mass/volume] in Unspecified specimen |
|
9366-6
|
Arsenic [Mass/mass] in Unspecified specimen |
|
53779-5
|
Arsenic.methylated [Mass/volume] in Urine |
|
13824-8
|
Arsenic/Creatinine [Mass Ratio] in 24 hour Urine |
|
50817-6
|
Arsenic/Creatinine [Molar ratio] in 24 hour Urine |
|
13463-5
|
Arsenic/Creatinine [Mass Ratio] in Urine |
|
56652-1
|
Arsenic/Creatinine [Ratio] in Urine |
|
25324-5
|
Arsenic/Creatinine [Molar ratio] in Urine |
|
60835-6
|
Arterial blood temperature |
|
72047-4
|
Arteriovenous fistula status [ESRD] |
|
72035-9
|
Arteriovenous graft assessed frequency |
|
72037-5
|
Arteriovenous graft assessed frequency [US.doppler] |
|
72038-3
|
Arteriovenous graft assessed using doppler [US.doppler] |
|
72036-7
|
Arteriovenous graft assessed using intra-access flow |
|
72046-6
|
Arteriovenous graft status |
|
85794-6
|
Arthralgia/arthritis [Presence] in Mother |
|
85407-5
|
Arthritis conditions recorded [CMS Assessment] |
|
18742-7
|
Arthroscopy study |
|
56778-4
|
Articaine IgE Ab [Units/volume] in Serum |
|
7094-6
|
Artichoke IgE Ab [Units/volume] in Serum |
|
15543-2
|
Artichoke IgE Ab RAST class [Presence] in Serum |
|
30162-2
|
Artichoke IgG Ab [Units/volume] in Serum |
|
56178-7
|
Artichoke IgG4 Ab [Mass/volume] in Serum |
|
60351-4
|
Artichoke IgG Ab [Mass/volume] in Serum |
|
42578-5
|
Artifact [Presence] in Urine sediment by Light microscopy |
|
50187-4
|
Arterial-mixed venous oxygen saturation difference |
|
50188-2
|
Arterial-venous oxygen saturation difference |
|
22820-5
|
Avian orthoreovirus Ag [Presence] in Unspecified specimen |
|
38537-7
|
ARX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
1900-0
|
Arylamidase [Enzymatic activity/volume] in Serum |
|
16405-3
|
Arylamidase [Presence] in Urine |
|
16406-1
|
Arylamidase [Enzymatic activity/volume] in Urine |
|
42726-0
|
Cerebroside sulfatase [Enzymatic activity/volume] in 24 hour Urine |
|
9341-9
|
Cerebroside sulfatase [Mass/time] in 24 hour Urine |
|
24077-0
|
Cerebroside sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2059-4
|
Cerebroside sulfatase [Presence] in Serum or Plasma |
|
24076-2
|
Cerebroside sulfatase [Enzymatic activity/volume] in Serum or Plasma |
|
2060-2
|
Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
|
2061-0
|
Cerebroside sulfatase [Enzymatic activity/volume] in Urine |
|
2062-8
|
Cerebroside sulfatase [Presence] in Leukocytes |
|
2063-6
|
Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes |
|
24078-8
|
Cerebroside sulfatase [Enzymatic activity/mass] in Leukocytes |
|
2645-0
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic fluid |
|
79463-6
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in DBS |
|
24093-7
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2646-8
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum |
|
2647-6
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue |
|
21413-0
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine |
|
2648-4
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes |
|
24094-5
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
93852-2
|
N-Acetylgalactosamine-4-Sulfatase/N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity ratio] in Urine |
|
76025-6
|
Arylsulfatase C [Enzymatic activity/mass] in Fibroblast |
|
59244-4
|
Arylsulfatase C [Enzymatic activity/mass] in Leukocytes |
|
55912-0
|
Arylsulfatase [Enzymatic activity/volume] in DBS |
|
1901-8
|
Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma |
|
71917-9
|
As a result of any emotional problems, have you accomplished less than you would like in the past 4 weeks [Veterans RAND] |
|
71918-7
|
As a result of any emotional problems, have you cut down the amount of time you spent on work or other activities in the past 4 weeks [Veterans RAND] |
|
71916-1
|
As a result of any emotional problems, you didn't do work or other activities as carefully as usual in the past 4 weeks [Veterans RAND] |
|
71921-1
|
As a result of your physical health, have you accomplished less than you would like in the past 4 weeks [Veterans RAND] |
|
71922-9
|
As a result of your physical health, have you cut down the amount of time you spent on work or other activities in the past 4 weeks [Veterans RAND] |
|
71919-5
|
As a result of your physical health, have you had difficulty performing the work or other activities - for example, it took extra effort in the past 4 weeks [Veterans RAND] |
|
71920-3
|
As a result of your physical health, were you limited in the kind of work in the past 4 weeks [Veterans RAND] |
|
18004-2
|
Atrial septum Defect diameter by US |
|
48024-4
|
AS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50623-8
|
AS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
71155-6
|
As soon as I start eating, I feel like stopping in the past 7 days [FACIT] |
|
71257-0
|
As soon as my child starts eating, s-he feels like stopping in the past 7 days [FACIT] |
|
35466-2
|
AS+PWS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41117-3
|
AS+PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
36915-7
|
AS+PWS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
53435-4
|
Argininosuccinate lyase [Enzymatic activity/mass] in Chorionic villus sample |
|
47570-7
|
Argininosuccinate lyase [Enzymatic activity/mass] in Fibroblast |
|
53439-6
|
Argininosuccinate lyase [Enzymatic activity/mass] in Liver from Fetus |
|
47569-9
|
Argininosuccinate lyase [Enzymatic activity/mass] in Liver |
|
32627-2
|
Argininosuccinate lyase [Enzymatic activity/mass] in Red Blood Cells |
|
1898-6
|
Argininosuccinate lyase [Enzymatic activity/volume] in Serum |
|
47831-3
|
Argininosuccinate synthase [Enzymatic activity/mass] in Amniotic fluid cells |
|
47830-5
|
Argininosuccinate synthase [Enzymatic activity/mass] in Chorionic villus sample |
|
47571-5
|
Argininosuccinate synthase [Enzymatic activity/mass] in Fibroblast |
|
53440-4
|
Argininosuccinate synthase [Enzymatic activity/mass] in Liver from Fetus |
|
1899-4
|
Argininosuccinate synthase [Enzymatic activity/mass] in Tissue |
|
38568-2
|
Asbestos [Mass/volume] in Air |
|
16407-9
|
Asbestos identified in Sputum by Light microscopy |
|
38309-1
|
Asbestos [Mass/volume] in Water |
|
26671-8
|
Ascaris sp Ab [Presence] in Serum |
|
31224-9
|
Ascaris sp Ab [Units/volume] in Serum |
|
43091-8
|
Ascaris sp Ab [Titer] in Serum |
|
27924-0
|
Ascaris sp Ab [Titer] in Serum by Immunoassay |
|
6022-8
|
Ascaris sp IgE Ab [Units/volume] in Serum |
|
25325-2
|
Ascaris sp IgE Ab [Units/volume] in Serum by Immunoassay |
|
15544-0
|
Ascaris sp IgE Ab RAST class [Presence] in Serum |
|
61220-0
|
Ascaris sp IgE Ab/IgE total in Serum |
|
74815-2
|
Ascaris sp IgG Ab [Presence] in Serum by Immunoassay |
|
44437-2
|
Ascaris sp IgG Ab [Units/volume] in Serum |
|
43910-9
|
Ascaris sp IgM Ab [Presence] in Serum |
|
91665-0
|
Ascorbate oxidase IgE Ab [Units/volume] in Serum |
|
91666-8
|
Ascorbate oxidase IgE Ab RAST class [Presence] in Serum |
|
22778-5
|
African swine fever virus Ab [Presence] in Body fluid |
|
22777-7
|
African swine fever virus Ab [Presence] in Body fluid by Immunoassay |
|
22779-3
|
African swine fever virus Ab [Presence] in Serum |
|
22780-1
|
African swine fever virus Ab [Presence] in Serum by Immunoassay |
|
23592-9
|
African swine fever virus Ab [Presence] in Serum by Immune stain |
|
22782-7
|
African swine fever virus Ag [Presence] in Tissue by Agglutination |
|
22783-5
|
African swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
|
31716-4
|
African swine fever virus Ag [Presence] in Unspecified specimen |
|
22781-9
|
African swine fever virus Ag [Presence] in Unspecified specimen by Agglutination |
|
22784-3
|
African swine fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
73693-4
|
African swine fever virus DNA [Cycle Threshold #] in Tissue by NAA with probe detection |
|
22785-0
|
African swine fever virus DNA [Presence] in Tissue by NAA with probe detection |
|
56532-5
|
Asialoglycoprotein receptor Ab [Units/volume] in Serum by Immunoassay |
|
55220-8
|
Asialoglycoprotein receptor Ab [Units/volume] in Serum |
|
50639-4
|
Asian ladybug IgE Ab [Units/volume] in Serum |
|
53155-8
|
Asparagine+Ornithine [Moles/volume] in DBS |
|
53396-8
|
Asparagine+Ornithine/Phenylalanine [Molar ratio] in DBS |
|
53395-0
|
Asparagine+Ornithine/Serine [Molar ratio] in DBS |
|
29208-6
|
Streptolysin O Ab [Units/volume] in Body fluid |
|
25788-1
|
Streptolysin O Ab [Units/volume] in Serum by Latex agglutination |
|
9788-1
|
Streptolysin O Ab [Presence] in Serum |
|
45228-4
|
Streptolysin O Ab [Mass/volume] in Serum |
|
5370-2
|
Streptolysin O Ab [Units/volume] in Serum or Plasma |
|
17657-8
|
Streptolysin O Ab [Units/volume] in Synovial fluid |
|
30149-9
|
Streptolysin O Ab [Units/volume] in Serum --1st specimen |
|
30150-7
|
Streptolysin O Ab [Units/volume] in Serum --2nd specimen |
|
22568-0
|
Streptolysin O Ab [Titer] in Serum |
|
5371-0
|
Streptolysin O Ab [Titer] in Serum by Latex agglutination |
|
21081-5
|
ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46990-8
|
ASPA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21623-4
|
ASPA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
35341-7
|
ASPA gene p.Ala305Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
21622-6
|
ASPA gene p.Glu285Ala [Presence] in Blood or Tissue by Molecular genetics method |
|
35340-9
|
ASPA gene p.Tyr231Ter [Presence] in Blood or Tissue by Molecular genetics method |
|
1910-9
|
Asparagine [Mass/time] in 24 hour Urine |
|
25862-4
|
Asparagine [Moles/volume] in 24 hour Urine |
|
25326-0
|
Asparagine [Moles/time] in 24 hour Urine |
|
13388-4
|
Asparagine [Mass/volume] in Amniotic fluid |
|
27089-2
|
Asparagine [Moles/volume] in Amniotic fluid |
|
1906-7
|
Asparagine [Mass/volume] in Cerebral spinal fluid |
|
26603-1
|
Asparagine [Moles/volume] in Cerebral spinal fluid |
|
47572-3
|
Asparagine [Moles/volume] in DBS |
|
32230-5
|
Asparagine [Moles/volume] in Body fluid |
|
1907-5
|
Asparagine [Presence] in Serum or Plasma |
|
27995-0
|
Asparagine [Units/volume] in Serum or Plasma |
|
1908-3
|
Asparagine [Mass/volume] in Serum or Plasma |
|
20638-3
|
Asparagine [Moles/volume] in Serum or Plasma |
|
53505-4
|
Asparagine/Amino acids.total in Serum or Plasma |
|
16410-3
|
Asparagine [Presence] in Urine |
|
1909-1
|
Asparagine [Mass/volume] in Urine |
|
27317-7
|
Asparagine [Moles/volume] in Urine |
|
44301-0
|
Asparagine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56643-0
|
Asparagine/Creatinine [Ratio] in 24 hour Urine |
|
25863-2
|
Asparagine/Creatinine [Molar ratio] in 24 hour Urine |
|
13710-9
|
Asparagine/Creatinine [Mass Ratio] in Urine |
|
28603-9
|
Asparagine/Creatinine [Ratio] in Urine |
|
26577-7
|
Asparagine/Creatinine [Molar ratio] in Urine |
|
7099-5
|
Asparagus IgE Ab [Units/volume] in Serum |
|
15547-3
|
Asparagus IgE Ab RAST class [Presence] in Serum |
|
7100-1
|
Asparagus IgG Ab [Units/volume] in Serum |
|
21082-3
|
Asparagus IgG Ab RAST class [Presence] in Serum |
|
56179-5
|
Asparagus IgG4 Ab [Mass/volume] in Serum |
|
60362-1
|
Asparagus IgG Ab [Mass/volume] in Serum |
|
1915-8
|
Aspartate [Mass/time] in 24 hour Urine |
|
25864-0
|
Aspartate [Moles/volume] in 24 hour Urine |
|
25327-8
|
Aspartate [Moles/time] in 24 hour Urine |
|
13389-2
|
Aspartate [Mass/volume] in Amniotic fluid |
|
27256-7
|
Aspartate [Moles/volume] in Amniotic fluid |
|
1911-7
|
Aspartate [Mass/volume] in Cerebral spinal fluid |
|
22655-5
|
Aspartate [Moles/volume] in Cerebral spinal fluid |
|
47573-1
|
Aspartate [Moles/volume] in DBS |
|
32232-1
|
Aspartate [Moles/volume] in Body fluid |
|
55913-8
|
Aspartate [Moles/mass] in Hair |
|
1912-5
|
Aspartate [Presence] in Serum or Plasma |
|
1913-3
|
Aspartate [Mass/volume] in Serum or Plasma |
|
20639-1
|
Aspartate [Moles/volume] in Serum or Plasma |
|
47576-4
|
Aspartate/Amino acids.total in Amniotic fluid |
|
47575-6
|
Aspartate/Amino acids.total in Cerebral spinal fluid |
|
47578-0
|
Aspartate/Amino acids.total in DBS |
|
47574-9
|
Aspartate/Amino acids.total in Hair |
|
47577-2
|
Aspartate/Amino acids.total in Serum or Plasma |
|
16411-1
|
Aspartate [Presence] in Urine |
|
1914-1
|
Aspartate [Mass/volume] in Urine |
|
26680-9
|
Aspartate [Moles/volume] in Urine |
|
32231-3
|
Aspartate [Moles/volume] in Vitreous fluid |
|
22723-1
|
Aspartate [Moles/volume] in Unspecified specimen |
|
44302-8
|
Aspartate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56640-6
|
Aspartate/Creatinine [Ratio] in 24 hour Urine |
|
25865-7
|
Aspartate/Creatinine [Molar ratio] in 24 hour Urine |
|
13711-7
|
Aspartate/Creatinine [Mass Ratio] in Urine |
|
30061-6
|
Aspartate/Creatinine [Ratio] in Urine |
|
22691-0
|
Aspartate/Creatinine [Molar ratio] in Urine |
|
79585-6
|
Aspartylglycine [Moles/volume] in Serum or Plasma |
|
79625-0
|
Aspartylglycine/Creatinine [Molar ratio] in Urine |
|
79589-8
|
Aspartylglycosamine [Moles/volume] in Serum or Plasma |
|
79636-7
|
Aspartylglycosamine/Creatinine [Molar ratio] in Urine |
|
7101-9
|
Aspen IgE Ab [Units/volume] in Serum |
|
15548-1
|
Aspen IgE Ab RAST class [Presence] in Serum |
|
7102-7
|
Aspen IgG Ab [Units/volume] in Serum |
|
63205-9
|
Aspen IgG Ab [Mass/volume] in Serum |
|
18426-7
|
Aspergillus sp Ab [Presence] in Cerebral spinal fluid |
|
49730-5
|
Aspergillus sp Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
31233-0
|
Aspergillus sp Ab [Units/volume] in Cerebral spinal fluid |
|
42766-6
|
Aspergillus sp Ab [Interpretation] in Serum by Immune diffusion (ID) Narrative |
|
7808-9
|
Aspergillus sp Ab [Presence] in Serum |
|
43870-5
|
Aspergillus sp Ab [Presence] in Serum by Complement fixation |
|
5052-6
|
Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
7807-1
|
Aspergillus sp Ab [Units/volume] in Serum |
|
23956-6
|
Aspergillus sp Ab [Titer] in Cerebral spinal fluid |
|
23953-3
|
Aspergillus sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43088-4
|
Aspergillus sp Ab [Titer] in Pleural fluid |
|
42488-7
|
Aspergillus sp Ab [Titer] in Pleural fluid by Complement fixation |
|
22087-1
|
Aspergillus sp Ab [Titer] in Serum |
|
5053-4
|
Aspergillus sp Ab [Titer] in Serum by Complement fixation |
|
58808-7
|
Aspergillus sp Ab [Titer] in Serum by Hemagglutination |
|
23660-4
|
Aspergillus sp Ab [Titer] in Serum by Immunoassay |
|
33266-8
|
Aspergillus sp Ab [Titer] in Urine |
|
48335-4
|
Aspergillus sp Ag [Presence] in Tissue by Immune stain |
|
76071-0
|
Aspergillus sp DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
90340-1
|
Aspergillus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
90339-3
|
Aspergillus sp DNA [Presence] in Tissue by NAA with probe detection |
|
49863-4
|
Aspergillus sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43871-3
|
Aspergillus sp IgA Ab [Presence] in Serum |
|
9491-2
|
Aspergillus sp IgA Ab [Units/volume] in Serum |
|
7106-8
|
Aspergillus sp IgE Ab [Units/volume] in Serum |
|
43862-2
|
Aspergillus sp IgE Ab RAST class [Presence] in Serum |
|
61222-6
|
Aspergillus sp IgE Ab/IgE total in Serum |
|
7107-6
|
Aspergillus sp IgG Ab [Units/volume] in Serum |
|
43872-1
|
Aspergillus sp IgG Ab [Presence] in Serum |
|
33267-6
|
Aspergillus sp IgG Ab [Presence] in Urine |
|
43873-9
|
Aspergillus sp IgM Ab [Presence] in Serum |
|
9492-0
|
Aspergillus sp IgM Ab [Units/volume] in Serum |
|
20688-8
|
Aspergillus sp identified in Litter by Organism specific culture |
|
75007-5
|
Aspergillus restrictus native (nAsp r) 1 IgE Ab [Units/volume] in Serum |
|
43979-4
|
Aspergillus sp identified in Unspecified specimen by Organism specific culture |
|
38761-3
|
Asphalt [Mass/volume] in Air |
|
89072-3
|
Aspirin dose--post enrollment in ADAPTABLE study [ADAPTABLE] |
|
89081-4
|
Aspirin dose--pre enrollment in ADAPTABLE study Dose [ADAPTABLE] |
|
89074-9
|
Aspirin usage--post enrollment in ADAPTABLE study [ADAPTABLE] |
|
89076-4
|
Aspirin usage--pre enrollment in ADAPTABLE study [ADAPTABLE] |
|
81820-3
|
ASS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87538-5
|
Assessed for readiness for SBT by day 2 of stay [CMS Assessment] |
|
90522-4
|
Assessment for state payment [CMS Assessment] |
|
90037-3
|
Assessment of global health - 0-10 (0.5 increments) numeric rating [Reported] |
|
52456-1
|
Assessment reference date |
|
54593-9
|
Assessment reference date - observation end date [CMS Assessment] |
|
74710-5
|
Asset tag number |
|
75255-0
|
Assistance needed [HHS.ACA Section 4302.ONC] |
|
92554-5
|
Assistive technology plan to provide [Identifier] |
|
89185-3
|
Assistive technology provided [Identifier] |
|
43372-2
|
Figure associated with report or note |
|
92835-8
|
Associated nevus [Presence] in Skin melanoma |
|
44786-2
|
Aspartate aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma |
|
1917-4
|
Aspartate aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
|
1918-2
|
Aspartate aminotransferase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
14414-7
|
Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
|
43822-6
|
Aspartate aminotransferase [Presence] in Body fluid |
|
1919-0
|
Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid |
|
14412-1
|
Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid |
|
48136-6
|
Aspartate aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
|
54500-4
|
Aspartate aminotransferase.macromolecular/Aspartate aminotransferase.total in Serum or Plasma |
|
14409-7
|
Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid |
|
14410-5
|
Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
|
16412-9
|
Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
|
27344-1
|
Aspartate aminotransferase [Presence] in Serum or Plasma |
|
30239-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
|
88112-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
|
1920-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
|
14411-3
|
Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid |
|
14413-9
|
Aspartate aminotransferase [Enzymatic activity/volume] in Urine |
|
1916-6
|
Aspartate aminotransferase/Alanine aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
|
60055-1
|
Astemizole [Mass/volume] in Body fluid |
|
11231-8
|
Astemizole [Mass/volume] in Serum or Plasma |
|
60056-9
|
Astemizole [Mass/mass] in Tissue |
|
69981-9
|
Asthma action plan |
|
82674-3
|
Asthma Control Test [ACT] |
|
55404-8
|
Asthma spells per week |
|
82210-6
|
Astrovirus subtypes 1-8 RNA [Presence] in Stool by NAA with non-probe detection |
|
90869-9
|
Asymmetry of lower face |
|
49456-7
|
Alpha synuclein Ag [Presence] in Tissue by Immune stain |
|
71563-1
|
At any time in your life have you felt unusually excited, revved up or high [M3] |
|
71564-9
|
At any time in your life have you needed less sleep than usual [M3] |
|
71562-3
|
At any time in your life, have you felt unusually irritable or angry [M3] |
|
71561-5
|
At any time in your life, have you had more energy than usual [M3] |
|
27811-9
|
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method |
|
27812-7
|
Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3175-7
|
Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
1868-9
|
Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3177-3
|
Antithrombin Ag [Moles/volume] in Platelet poor plasma by Immunoassay |
|
43869-7
|
Antithrombin Ag [Presence] in Platelet poor plasma by Immunoassay |
|
3174-0
|
Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
91120-6
|
Antithrombin in Platelet poor plasma by Chromo.no addition of heparin |
|
3176-5
|
Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method |
|
20991-6
|
Antithrombin [Interpretation] in Platelet poor plasma |
|
65318-8
|
At sup(a) Ab [Presence] in Serum or Plasma |
|
74722-0
|
At the time of the event, the device was placed within the patient's tissue [AHRQ] |
|
79966-8
|
Ascending thoracic aorta Diameter during systole by US 2D |
|
18012-5
|
Ascending thoracic aorta Diameter by US |
|
78796-0
|
Atazanavir [Mass/volume] in Amniotic fluid |
|
80143-1
|
Atazanavir [Mass/volume] in Cord blood |
|
80142-3
|
Atazanavir [Mass/volume] in Cerebral spinal fluid by Confirmatory method |
|
41403-7
|
Atazanavir [Susceptibility] by Genotype method |
|
49668-7
|
Atazanavir [Susceptibility] by Phenotype method |
|
41470-6
|
Atazanavir [Mass/volume] in Serum or Plasma |
|
41993-7
|
Atazanavir [Susceptibility] |
|
78797-8
|
Atazanavir [Mass/volume] in Serum or Plasma --trough |
|
49618-2
|
Atazanavir+Ritonavir [Susceptibility] by Genotype method |
|
57907-8
|
Atazanavir+Ritonavir [Susceptibility] by Phenotype method |
|
73056-4
|
Atenolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73055-6
|
Atenolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3362-1
|
Atenolol [Mass/time] in 24 hour Urine |
|
78799-4
|
Atenolol [Mass/volume] in Blood |
|
4132-7
|
Atenolol [Mass] of Dose |
|
79223-4
|
Atenolol [Mass/volume] in Body fluid |
|
78798-6
|
Atenolol [Mass/mass] in Hair |
|
73516-7
|
Atenolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73517-5
|
Atenolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3366-2
|
Atenolol [Mass/volume] in Serum or Plasma |
|
3360-5
|
Atenolol [Presence] in Urine |
|
3361-3
|
Atenolol [Mass/volume] in Urine |
|
57855-9
|
Atenolol [Moles/volume] in Unspecified specimen |
|
1822-6
|
Alpha thymosin [Mass/volume] in Serum |
|
21624-2
|
ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21625-9
|
ATM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
49631-5
|
ATN1 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49632-3
|
ATN1 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21756-2
|
ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
74513-3
|
Alpha tocopherol [Entitic substance] in Red Blood Cells |
|
1823-4
|
Alpha tocopherol [Mass/volume] in Serum or Plasma |
|
14590-4
|
Alpha tocopherol [Moles/volume] in Serum or Plasma |
|
20681-3
|
Alpha tocopherol [Mass/mass] in Tissue |
|
73515-9
|
Atomoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73514-2
|
Atomoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
90748-5
|
Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
35667-5
|
Atomoxetine [Mass/volume] in Serum or Plasma |
|
87761-3
|
Atomoxetine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73054-9
|
Atorvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73053-1
|
Atorvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73513-4
|
Atorvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73512-6
|
Atorvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55618-3
|
Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73684-3
|
Atovaquone [Mass/volume] in Serum or Plasma |
|
1721-0
|
Adenosine triphosphate [Mass/volume] in Blood |
|
46701-9
|
Adenosine triphosphate [Moles/volume] in Red Blood Cells |
|
10557-7
|
Adenosine triphosphate [Moles/volume] in Semen |
|
35135-3
|
Adenosine triphosphate/Adenosine diphosphate [Mass Ratio] in Blood |
|
73675-1
|
Adenosine triphosphate/Adenosine diphosphate [Entitic molar ratio] in Platelets |
|
69364-8
|
ATP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
68947-1
|
ATP1A2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
77073-5
|
ATP5A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77072-7
|
ATP5A1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
34659-3
|
ATP7A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41116-5
|
ATP7A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21630-9
|
ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
21627-5
|
ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method |
|
21628-3
|
ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method |
|
21629-1
|
ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method |
|
75382-2
|
ATP7B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
21626-7
|
ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51756-5
|
ATP7B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21631-7
|
ATP7B gene p.Gly1267Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
21632-5
|
ATP7B gene p.His1070Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
21633-3
|
ATP7B gene p.His714Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
21634-1
|
ATP7B gene p.Asn915Ser [Presence] in Blood or Tissue by Molecular genetics method |
|
21635-8
|
ATP7B gene p.Arg778Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
1729-3
|
Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells |
|
1730-1
|
Adenosine triphosphatase [Enzymatic activity/volume] in Semen |
|
48282-8
|
Atracurium triggered leukotriene release [Mass/volume] by Leukocytes |
|
78801-8
|
Atropine [Mass/volume] in Blood |
|
4133-5
|
Atropine [Mass] of Dose |
|
78800-0
|
Atropine [Mass/mass] in Hair |
|
56698-4
|
Atropine IgE Ab [Units/volume] in Serum |
|
3367-0
|
Atropine [Mass/volume] in Serum or Plasma |
|
55524-3
|
Atropine [Moles/volume] in Serum or Plasma |
|
14184-6
|
Atropine [Presence] in Urine |
|
10840-7
|
Atropine [Mass/volume] in Urine |
|
53841-3
|
ATRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
83824-3
|
Attending Admission evaluation note |
|
28655-9
|
Attending Discharge summary |
|
83818-5
|
Attending Emergency department Note |
|
85723-5
|
Mother attended a family planning clinic prior to conception |
|
83819-3
|
Attending History and physical note |
|
83822-7
|
Attending Hospital Note |
|
83816-9
|
Attending Intensive care unit Admission evaluation note |
|
83817-7
|
Attending Intensive care unit Note |
|
28654-2
|
Attending Initial evaluation note |
|
83823-5
|
Attending Long term care facility Note |
|
75471-3
|
Attending Note |
|
83821-9
|
Attending Outpatient Note |
|
34134-7
|
Attending Outpatient Supervisory note |
|
83815-1
|
Attending Surgical operation note |
|
83820-1
|
Attending Preoperative evaluation and management note |
|
18733-6
|
Attending Progress note |
|
94072-6
|
Attended school today |
|
68468-8
|
Attending physician NPI Provider |
|
87222-6
|
Attestation date [CMS Assessment] |
|
87219-2
|
Attesting individual first name Provider [CMS Assessment] |
|
87220-0
|
Attesting individual last name Provider [CMS Assessment] |
|
87221-8
|
Attesting individual title Provider [CMS Assessment] |
|
3074-2
|
Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma |
|
34939-9
|
Tumor necrosis factor.alpha [Moles/volume] in Serum or Plasma |
|
29641-8
|
Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence |
|
17358-3
|
Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum |
|
53012-1
|
Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence |
|
29642-6
|
Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence |
|
40548-0
|
Mononuclear cells atypical [#/volume] in Blood by Manual count |
|
69003-2
|
Mononuclear cells atypical/100 leukocytes in Blood by Manual count |
|
66133-0
|
Mononuclear cells atypical/100 leukocytes in Body fluid by Manual count |
|
821-9
|
Au sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
822-7
|
Au sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
823-5
|
Au sup(a) Ab [Presence] in Serum or Plasma |
|
824-3
|
Au sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
825-0
|
Au sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
826-8
|
Au sup(a) Ag [Presence] on Red Blood Cells |
|
82870-7
|
Au sup(b) Ab [Presence] in Serum or Plasma |
|
93908-2
|
Au sup(b) Ag [Presence] on Red Blood Cells |
|
84065-2
|
Audiology Administrative note |
|
75424-2
|
Audiology Consult note |
|
68635-2
|
Audiology Diagnostic study note |
|
77423-2
|
Audiology Education note |
|
77439-8
|
Audiology Flowsheet |
|
68637-8
|
Audiology History and physical note |
|
68639-4
|
Audiology Hospital Consult note |
|
68640-2
|
Audiology Hospital Diagnostic study note |
|
77424-0
|
Audiology Initial evaluation note |
|
88362-9
|
Audiology Medical equipment or product note |
|
68636-0
|
Audiology Note |
|
84066-0
|
Audiology Telephone encounter Note |
|
77444-8
|
Audiology Plan of care note |
|
68638-6
|
Audiology Preoperative evaluation and management note |
|
77425-7
|
Audiology procedure note |
|
77426-5
|
Audiology Progress note |
|
77427-3
|
Audiology Referral note |
|
28615-3
|
Audiology study |
|
11281-3
|
Auer rods [Presence] in Blood by Light microscopy |
|
87243-2
|
Microscopic observation [Presence] in Unspecified specimen by Auramine fluorochrome stain |
|
44945-4
|
Australian cervix cytology code [Interpretation] of Unspecified specimen |
|
6032-7
|
Australian pine IgE Ab [Units/volume] in Serum |
|
31078-9
|
Australian pine IgE Ab RAST class [Presence] in Serum |
|
50351-6
|
Australian pine IgE Ab/IgE total in Serum |
|
56183-7
|
Australian pine IgG4 Ab [Mass/volume] in Serum |
|
15939-2
|
Austrian Pine IgE Ab RAST class [Presence] in Serum |
|
71525-0
|
Authorized batch submitting organization Agency [ESRD] |
|
74154-6
|
Autism action plan |
|
54148-2
|
Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) Hep2 substrate Narrative |
|
54147-4
|
Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) rat liver+stomach+kidney substrate Narrative |
|
10388-7
|
Autologous whole blood given [Volume] |
|
51886-0
|
Autologous whole blood units given [#] |
|
10387-9
|
Autologous erythrocytes given [Volume] |
|
52065-0
|
Automobile liability attachment |
|
74498-7
|
Autopsy or histological placental examination results were used [US Standard Report of Fetal Death] |
|
85699-7
|
Autopsy was performed |
|
18743-5
|
Autopsy report |
|
85691-4
|
Autopsy result Narrative |
|
73768-4
|
Autopsy was performed [US Standard Report of Fetal Death] |
|
20174-9
|
Aortic valve Acceleration slope by US |
|
17981-2
|
Aortic valve Acceleration by US.doppler |
|
18016-6
|
Aortic valve annulus Diameter by US |
|
79940-3
|
Aortic valve annulus Diameter at end systole by US 2D |
|
17984-6
|
Aortic valve area method |
|
17996-0
|
Aortic valve Maximum cusp separation [Length] by US |
|
20175-6
|
Aortic valve Deceleration slope [Velocity] by US |
|
20176-4
|
Aortic valve Deceleration [Time] by US |
|
11795-2
|
Aortic valve Diameter by US |
|
20172-3
|
Aortic valve Regurgitant blood flow velocity at end diastole by US.doppler |
|
18041-4
|
Aortic valve Ejection time by US.doppler |
|
79957-7
|
Aortic valve Effective orifice area during systole (by US.doppler+Calculated by continuity Vmax)/Body surface area |
|
79959-3
|
Aortic valve Effective orifice area during systole (by US.doppler+Calculated by continuity VTI)/Body surface area |
|
79956-9
|
Aortic valve Effective orifice area during systole by US.doppler+Calculated by continuity Vmax |
|
79958-5
|
Aortic valve Effective orifice area during systole by US.doppler+Calculated by continuity VTI |
|
79960-1
|
Aortic valve Effective regurgitant orifice area during diastole by US.doppler+Calculated by PISA method |
|
77910-8
|
Aortic valve Effective regurgitant orifice area by US.doppler+Calculated by volumetric method |
|
77909-0
|
Aortic valve Effective regurgitant orifice area by US.doppler+Calculated by PISA method |
|
79963-5
|
Aortic valve Maximum gradient during systole [Pressure Difference] by US.doppler+Calculated by simplified Bernoulli |
|
18061-2
|
Aortic valve Maximum pressure gradient dur systole by US.doppler derived full Bernoulli |
|
18062-0
|
Aortic valve Maximum pressure gradient dur systole by US.doppler+Calculated by simplified Bernoulli |
|
20249-9
|
Aortic valve Maximum regurgitant pressure gradient by US+Calculated |
|
79949-4
|
Aortic valve Maximum regurgitant blood flow velocity during diastole by US.doppler continuous wave |
|
79961-9
|
Aortic valve Mean flow velocity during systole by US.doppler |
|
18066-1
|
Aortic valve Mean systole pressure gradient by US.doppler derived full Bernoulli |
|
79962-7
|
Aortic valve Mean systole pressure gradient by US.doppler+Calculated by simplified Bernoulli |
|
78177-3
|
Aortic valve Mean regurgitant pressure gradient during diastole by US.doppler+Calculated by simplified Bernoulli |
|
80246-2
|
Atrioventricular nodal artery [Presence] on Angiogram |
|
18089-3
|
Aortic valve Orifice area by US |
|
29487-6
|
Aortic valve Orifice area by US.2D+Measured by planimetry |
|
18090-1
|
Aortic valve Orifice area by US.continuity |
|
18093-5
|
Aortic valve Orifice area by US.continuity.Vmax+Area |
|
18094-3
|
Aortic valve Orifice area by US.continuity.Vmax+Diameter |
|
18091-9
|
Aortic valve Orifice area by US.continuity.VTI+Area |
|
18092-7
|
Aortic valve Orifice area by US.continuity.VTI+Diameter |
|
81392-3
|
Aortic valve Orifice area/Body surface area [Area/Area] by US.2D+Measured by planimetry |
|
79947-8
|
Aortic valve Pressure half time during diastole by US.doppler continuous wave |
|
18104-0
|
Aortic valve Pressure half time by US.doppler |
|
79945-2
|
Aortic valve PISA radius during diastole [Length] by US.2D+doppler |
|
79946-0
|
Aortic valve PISA velocity during diastole by US.doppler |
|
18108-1
|
Aortic valve Prosthetic valve type by US |
|
18112-3
|
Aortic valve Regurgitation degree by US.doppler |
|
20173-1
|
Aortic valve Maximum regurgitant blood flow velocity during diastole by US.doppler |
|
93631-0
|
Aortic valve Regurgitant blood velocity-time integral by US.doppler |
|
18003-4
|
Aortic valve Regurgitant deceleration time slope by US.doppler |
|
79942-9
|
Aortic valve Regurgitant fraction by US.doppler |
|
93630-2
|
Aortic valve Regurgitant fraction by US.doppler+Calculated by PISA method |
|
79943-7
|
Aortic valve Regurgitant jet area/Left ventricular outflow tract area by US.2D+Measured by planimetry |
|
17998-6
|
Aortic valve Regurgitant jet deceleration [Time] by US.doppler |
|
79944-5
|
Aortic valve Regurgitant jet width/Left ventricular outflow tract width by US.2D+doppler |
|
18105-7
|
Aortic valve Regurgitant blood flow pressure half-time by US.doppler |
|
79941-1
|
Aortic valve Regurgitant blood flow rate during diastole by US.doppler+Calculated by PISA method |
|
79950-2
|
Aortic valve Regurgitant blood flow volume during diastole by US.doppler+Calculated by continuity VTI |
|
79951-0
|
Aortic valve Regurgitant blood flow volume during diastole by US.doppler+Calculated by PISA method |
|
77912-4
|
Aortic valve Stenosis degree by US |
|
77908-2
|
Aortic valve Vena contracta diameter by US.doppler |
|
79948-6
|
Aortic valve Vena contracta diameter during diastole by US.2D+doppler |
|
20183-0
|
Aortic valve Maximum blood flow velocity by US.doppler --at stenosis |
|
79964-3
|
Aortic valve Maximum blood flow velocity during systole by US.doppler |
|
11706-9
|
Aortic valve Peak systolic flow by US.doppler |
|
79952-8
|
Aortic valve Velocity-time integral during diastole by US.doppler continuous wave |
|
18169-3
|
Aortic valve Blood velocity-time integral by US.doppler |
|
79965-0
|
Aortic valve Velocity-time integral during systole by US.doppler |
|
93347-3
|
Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal |
|
93348-1
|
Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal |
|
77710-2
|
Average proportion of waking day the patient is off in the past week [UPDRS] |
|
77562-7
|
Average distance required to gather essential resources for a patient encounter in a Report Period [NMMDS] |
|
77555-1
|
Average distance to access a patient in a Report Period [NMMDS] |
|
77271-5
|
Average number of nursing staff by job position in a reporting period [NMMDS] |
|
77559-3
|
Average time required to gather essential resources for a patient encounter in a Report Period [NMMDS] |
|
77552-8
|
Average time to access a patient in a Report Period [NMMDS] |
|
55619-1
|
Avilamycin [Susceptibility] by Gradient strip |
|
35754-1
|
Avilamycin [Susceptibility] by Disk diffusion (KB) |
|
35755-8
|
Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35756-6
|
Avilamycin [Susceptibility] |
|
6033-5
|
Avocado IgE Ab [Units/volume] in Serum |
|
15551-5
|
Avocado IgE Ab RAST class [Presence] in Serum |
|
61294-5
|
Avocado IgE Ab/IgE total in Serum |
|
7109-2
|
Avocado IgG Ab [Units/volume] in Serum |
|
56184-5
|
Avocado IgG4 Ab [Mass/volume] in Serum |
|
60398-5
|
Avocado IgG Ab [Mass/volume] in Serum |
|
22102-8
|
Avian reovirus Ab [Presence] in Serum |
|
15453-4
|
Avian reovirus Ab [Presence] in Serum by Immunoassay |
|
15452-6
|
Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) |
|
43324-3
|
Avian reovirus Ab [Presence] in Serum by Immunofluorescence |
|
80236-3
|
A-wave amplitude [Pressure] Left atrium Cardiac catheterization |
|
80232-2
|
A-wave amplitude [Pressure] Pulmonary artery wedge Cardiac catheterization |
|
80234-8
|
A-wave amplitude [Pressure] Right atrium Cardiac catheterization |
|
79774-6
|
a-wave amplitude Left retina dark-adapted by ERG |
|
79776-1
|
a-wave amplitude Left retina light-adapted by ERG |
|
79773-8
|
a-wave amplitude Right retina dark-adapted by ERG |
|
79775-3
|
a-wave amplitude Right retina light-adapted by ERG |
|
79778-7
|
a-wave implicit time Left retina dark-adapted by ERG |
|
79780-3
|
a-wave implicit time Left retina light-adapted by ERG |
|
79777-9
|
a-wave implicit time Right retina dark-adapted by ERG |
|
79779-5
|
a-wave implicit time Right retina light-adapted by ERG |
|
76151-0
|
Airway pressure backup setting Ventilator |
|
76154-4
|
Airway pressure delta --on ventilator |
|
76152-8
|
Airway pressure delta setting Ventilator |
|
908-4
|
Ax Ab [Presence] in Serum or Plasma from Blood product unit |
|
909-2
|
Ax Ab [Presence] in Serum or Plasma from Donor |
|
910-0
|
Ax Ab [Presence] in Serum or Plasma |
|
836-7
|
Ax Ag [Presence] on Red Blood Cells from Blood product unit |
|
837-5
|
Ax Ag [Presence] on Red Blood Cells from Donor |
|
838-3
|
Ax Ag [Presence] on Red Blood Cells |
|
75734-4
|
AXIN2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
75733-6
|
AXIN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
8607-4
|
Axis [Interpretation] by EKG |
|
9866-5
|
Axis [Interpretation] Narrative by EKG |
|
79830-6
|
Axis Left eye by Objective refraction --W cycloplegia |
|
79843-9
|
Axis Left eye by Subjective refraction --W cycloplegia |
|
79829-8
|
Axis Right eye by Objective refraction --W cycloplegia |
|
79842-1
|
Axis Right eye by Subjective refraction --W cycloplegia |
|
79832-2
|
Axis Left eye by Objective refraction --WO cycloplegia |
|
79845-4
|
Axis Left eye by Subjective refraction --WO cycloplegia |
|
79831-4
|
Axis Right eye by Objective refraction --WO cycloplegia |
|
79844-7
|
Axis Right eye by Subjective refraction --WO cycloplegia |
|
86421-5
|
XR Abdomen and RF Gastrointestinal tract upper W air contrast PO and W barium contrast PO |
|
86424-9
|
XR Abdomen and RF Gastrointestinal tract upper W barium contrast PO |
|
86423-1
|
XR Abdomen and RF Gastrointestinal tract upper W contrast PO |
|
86422-3
|
XR Abdomen and RF Gastrointestinal tract upper W water soluble contrast PO |
|
27236-9
|
Azatadine [Mass/volume] in Serum or Plasma |
|
16418-6
|
Azatadine [Presence] in Urine |
|
27276-5
|
Azatadine [Mass/volume] in Urine |
|
43924-0
|
azaTHIOprine [Presence] in Serum or Plasma |
|
16419-4
|
azaTHIOprine [Mass/volume] in Serum or Plasma |
|
79495-8
|
Azelate [Moles/volume] in Serum or Plasma |
|
13712-5
|
Azelate/Creatinine [Mass Ratio] in Urine |
|
29526-1
|
Azelate/Creatinine [Molar ratio] in Urine |
|
38570-8
|
Azinphos-methyl [Mass/volume] in Air |
|
43902-6
|
Azinphos-methyl [Presence] in Blood |
|
23822-0
|
Azinphos-methyl [Mass/volume] in Blood |
|
43903-4
|
Azinphos-methyl [Presence] in Serum or Plasma |
|
35490-2
|
Azinphos-methyl [Mass/volume] in Serum or Plasma |
|
43904-2
|
Azinphos-methyl [Presence] in Urine |
|
21088-0
|
Azinphos-methyl [Mass/volume] in Urine |
|
16421-0
|
Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
56747-9
|
Azithromycin IgE Ab [Units/volume] in Serum |
|
73511-8
|
Azithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73510-0
|
Azithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6981-5
|
Azithromycin [Susceptibility] by Gradient strip |
|
37-2
|
Azithromycin [Susceptibility] by Disk diffusion (KB) |
|
36-4
|
Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35-6
|
Azithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23612-5
|
Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89480-8
|
Azithromycin [Susceptibility] by Genotype method |
|
16420-2
|
Azithromycin [Mass/volume] in Serum or Plasma |
|
18866-4
|
Azithromycin [Susceptibility] |
|
38-0
|
Azithromycin [Susceptibility] by Serum bactericidal titer |
|
25233-8
|
Azithromycin [Mass/volume] in Unspecified specimen |
|
4134-3
|
Azlocillin [Mass] of Dose |
|
41661-0
|
Azlocillin [Susceptibility] by Gradient strip |
|
41-4
|
Azlocillin [Susceptibility] by Disk diffusion (KB) |
|
40-6
|
Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
39-8
|
Azlocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3368-8
|
Azlocillin [Mass/volume] in Serum or Plasma |
|
18867-2
|
Azlocillin [Susceptibility] |
|
42-2
|
Azlocillin [Susceptibility] by Serum bactericidal titer |
|
16422-8
|
Azlocillin [Mass/volume] in Urine |
|
4135-0
|
Aztreonam [Mass] of Dose |
|
73509-2
|
Aztreonam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73508-4
|
Aztreonam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6982-3
|
Aztreonam [Susceptibility] by Gradient strip |
|
45-5
|
Aztreonam [Susceptibility] by Disk diffusion (KB) |
|
44-8
|
Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
43-0
|
Aztreonam [Susceptibility] by Minimum lethal concentration (MLC) |
|
3369-6
|
Aztreonam [Mass/volume] in Serum or Plasma |
|
18868-0
|
Aztreonam [Susceptibility] |
|
46-3
|
Aztreonam [Susceptibility] by Serum bactericidal titer |
|
16423-6
|
Aztreonam [Mass/volume] in Urine |
|
25234-6
|
Aztreonam [Mass/volume] in Unspecified specimen |
|
41664-4
|
Aztreonam+Clavulanate [Susceptibility] by Gradient strip |
|
41663-6
|
Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41662-8
|
Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41727-9
|
Aztreonam+Clavulanate [Susceptibility] |
|
10772-2
|
Microscopic observation [Identifier] in Tissue by Azure-eosin stain |
|
54015-3
|
Azurocidin Ab [Presence] in Serum |
|
69371-3
|
B Ab [Presence] in Cord blood |
|
911-8
|
B Ab [Presence] in Serum or Plasma from Blood product unit |
|
912-6
|
B Ab [Presence] in Serum or Plasma from Donor |
|
913-4
|
B Ab [Presence] in Serum or Plasma |
|
30201-8
|
B Ab [Titer] in Serum or Plasma |
|
34464-8
|
B Ab [Titer] in Serum or Plasma by Antihuman globulin |
|
34465-5
|
B Ab [Titer] in Serum or Plasma by Immediate spin |
|
49196-9
|
Brucella abortus Ab [Presence] in Cerebral spinal fluid |
|
51832-4
|
Brucella abortus Ab [Presence] in Cerebral spinal fluid by Acidified buffered plate agglutination |
|
48967-4
|
Brucella abortus Ab [Presence] in Cerebral spinal fluid by Card agglutination |
|
22146-5
|
Brucella abortus Ab [Presence] in Milk |
|
71714-0
|
Brucella abortus Ab [Presence] in Milk by Heat-inactivation ring test |
|
20725-8
|
Brucella abortus Ab [Presence] in Milk by Ring agglutination |
|
20720-9
|
Brucella abortus Ab [Presence] in Milk by Serial ring agglutination |
|
22921-1
|
Brucella abortus Ab [Units/volume] in Serum by Agglutination |
|
19243-5
|
Brucella abortus Ab [Units/volume] in Serum by Immunoassay |
|
22147-3
|
Brucella abortus Ab [Presence] in Serum |
|
20727-4
|
Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination |
|
20726-6
|
Brucella abortus Ab [Presence] in Serum by Card agglutination |
|
20728-2
|
Brucella abortus Ab [Presence] in Serum by Complement fixation |
|
20731-6
|
Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST |
|
20730-8
|
Brucella abortus Ab [Presence] in Serum by Immunoassay |
|
22920-3
|
Brucella abortus Ab [Presence] in Serum by Immunofluorescence |
|
5066-6
|
Brucella abortus Ab [Presence] in Serum by Latex agglutination |
|
20723-3
|
Brucella abortus Ab [Presence] in Serum by Rapid agglutination |
|
11586-5
|
Brucella abortus Ab [Units/volume] in Serum |
|
22148-1
|
Brucella abortus Ab [Presence] in Semen |
|
20721-7
|
Brucella abortus Ab [Presence] in Semen by Agglutination |
|
33945-7
|
Brucella abortus Ab [Titer] in Cerebral spinal fluid |
|
63435-2
|
Brucella abortus Ab [Titer] in Cerebral spinal fluid by Antihuman globulin |
|
22150-7
|
Brucella abortus Ab [Titer] in Serum |
|
6324-8
|
Brucella abortus Ab [Titer] in Serum by Agglutination |
|
63437-8
|
Brucella abortus Ab [Titer] in Serum by Antihuman globulin |
|
6325-5
|
Brucella abortus Ab [Titer] in Serum by Complement fixation |
|
5067-4
|
Brucella abortus Ab [Titer] in Serum by Latex agglutination |
|
20729-0
|
Brucella abortus Ab [Titer] in Serum by Plate agglutination |
|
20722-5
|
Brucella abortus Ab [Titer] in Serum by Rivanol agglutination |
|
20719-1
|
Brucella abortus Ab [Titer] in Serum by Tube agglutination |
|
22149-9
|
Brucella abortus Ab [Presence] in Whey |
|
20724-1
|
Brucella abortus Ab [Presence] in Whey by Ring agglutination |
|
22927-8
|
Brucella abortus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6910-4
|
Brucella abortus IgA Ab [Units/volume] in Serum |
|
16486-3
|
Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum |
|
42592-6
|
Brucella abortus IgG Ab [Presence] in Cerebral spinal fluid |
|
13212-6
|
Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
16487-1
|
Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination |
|
16488-9
|
Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation |
|
43843-2
|
Brucella abortus IgG Ab [Units/volume] in Serum by Immunoassay |
|
44818-3
|
Brucella abortus IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
38243-2
|
Brucella abortus IgG Ab [Presence] in Serum |
|
6911-2
|
Brucella abortus IgG Ab [Units/volume] in Serum |
|
23963-2
|
Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid |
|
23986-3
|
Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
16119-0
|
Brucella abortus IgG Ab [Titer] in Serum |
|
80151-4
|
Brucella abortus IgG Ab [Titer] in Serum by Agglutination |
|
44458-8
|
Brucella abortus IgG+IgM Ab [Units/volume] in Serum |
|
22925-2
|
Brucella abortus IgG1 Ab [Presence] in Milk |
|
22923-7
|
Brucella abortus IgG1 Ab [Presence] in Milk by Immunoassay |
|
22924-5
|
Brucella abortus IgG1 Ab [Presence] in Serum |
|
22922-9
|
Brucella abortus IgG1 Ab [Presence] in Serum by Immunoassay |
|
71715-7
|
Brucella abortus IgG1 and IgG2 Ab [Presence] in Serum by Immunoassay |
|
13213-4
|
Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
6326-3
|
Brucella abortus IgM Ab [Units/volume] in Serum by Immunoassay |
|
44815-9
|
Brucella abortus IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
38244-0
|
Brucella abortus IgM Ab [Presence] in Serum |
|
22151-5
|
Brucella abortus IgM Ab [Units/volume] in Serum |
|
23964-0
|
Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid |
|
23987-1
|
Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
16120-8
|
Brucella abortus IgM Ab [Titer] in Serum |
|
22926-0
|
Brucella abortus rRNA [Presence] in Unspecified specimen by Probe |
|
92811-9
|
Borrelia afzelii+burgdorferi+garinii IgG Ab index [Units/volume] in Serum and CSF by Immunoassay |
|
92812-7
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
92813-5
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
87276-2
|
Borrelia afzelii+burgdorferi+garinii IgG band pattern [Interpretation] in Serum by Line blot |
|
92810-1
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Serum by Immunoassay |
|
92814-3
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Immunoassay |
|
87275-4
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Line blot |
|
87278-8
|
Borrelia afzelii+burgdorferi+garinii IgM band pattern [Interpretation] in Serum by Line blot |
|
87277-0
|
Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Line blot |
|
48360-2
|
Borrelia afzelii IgG Ab [Presence] in Serum by Immunoblot |
|
914-2
|
B Ag [Presence] on Red Blood Cells from Blood product unit |
|
915-9
|
B Ag [Presence] on Red Blood Cells from Donor |
|
916-7
|
B Ag [Presence] on Red Blood Cells |
|
5055-9
|
Bacillus anthracis Ab [Units/volume] in Serum by Hemagglutination |
|
11467-8
|
Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot |
|
22860-1
|
Bacillus anthracis Ab [Presence] in Serum |
|
22862-7
|
Bacillus anthracis Ab [Presence] in Serum by Agglutination |
|
22864-3
|
Bacillus anthracis Ab [Presence] in Serum by Complement fixation |
|
22863-5
|
Bacillus anthracis Ab [Presence] in Serum by Immunoassay |
|
22861-9
|
Bacillus anthracis Ab [Presence] in Serum by Immune diffusion (ID) |
|
7814-7
|
Bacillus anthracis Ab [Units/volume] in Serum |
|
22859-3
|
Bacillus anthracis Ab [Titer] in Serum |
|
22865-0
|
Bacillus anthracis Ab [Titer] in Serum by Immune diffusion (ID) |
|
11468-6
|
Bacillus anthracis Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
|
22109-3
|
Bacillus anthracis Ab [Units/volume] in Unspecified specimen |
|
33697-4
|
Bacillus anthracis Ag [Presence] in Isolate by Immunofluorescence |
|
22866-8
|
Bacillus anthracis Ag [Presence] in Tissue by Immunofluorescence |
|
31726-3
|
Bacillus anthracis Ag [Presence] in Unspecified specimen |
|
22867-6
|
Bacillus anthracis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
51976-9
|
Bacillus anthracis capsule Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
44269-9
|
Bacillus anthracis cell wall Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41622-2
|
Bacillus anthracis DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41623-0
|
Bacillus anthracis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33698-2
|
Bacillus anthracis [Presence] in Isolate by Phage lysis |
|
44270-7
|
Bacillus anthracis spore Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
11469-4
|
Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture |
|
87241-6
|
Bacillus atrophaeus [Presence] in Laboratory device by Culture |
|
22114-3
|
Bordetella avium Ab [Presence] in Serum |
|
15458-3
|
Bordetella avium Ab [Presence] in Serum by Immunoassay |
|
31265-2
|
Bordetella avium Ab [Units/volume] in Serum |
|
22115-0
|
Bordetella avium Ab [Titer] in Serum |
|
15457-5
|
Bordetella avium Ab [Titer] in Serum by Agglutination |
|
49210-8
|
Bartonella bacilliformis IgG Ab [Titer] in Body fluid |
|
48878-3
|
Bartonella bacilliformis IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49212-4
|
Bartonella bacilliformis IgG Ab [Titer] in Serum |
|
48842-9
|
Bartonella bacilliformis IgG Ab [Titer] in Serum by Immunofluorescence |
|
49209-0
|
Bartonella bacilliformis IgM Ab [Titer] in Body fluid |
|
48879-1
|
Bartonella bacilliformis IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49211-6
|
Bartonella bacilliformis IgM Ab [Titer] in Serum |
|
48843-7
|
Bartonella bacilliformis IgM Ab [Titer] in Serum by Immunofluorescence |
|
22844-5
|
Babesia bigemina Ab [Presence] in Serum |
|
23662-0
|
Babesia bigemina Ab [Presence] in Serum by Complement fixation |
|
22846-0
|
Babesia bigemina Ab [Presence] in Serum by Immunoassay |
|
22845-2
|
Babesia bigemina Ab [Presence] in Serum by Immunofluorescence |
|
22847-8
|
Babesia bovis Ab [Presence] in Serum |
|
23663-8
|
Babesia bovis Ab [Presence] in Serum by Complement fixation |
|
22848-6
|
Babesia bovis Ab [Presence] in Serum by Immunoassay |
|
22849-4
|
Babesia bovis Ab [Presence] in Serum by Immunofluorescence |
|
22886-6
|
Bordetella bronchiseptica Ab [Presence] in Serum |
|
22887-4
|
Bordetella bronchiseptica Ab [Presence] in Serum by Agglutination |
|
31735-4
|
Bordetella bronchiseptica Ag [Presence] in Unspecified specimen |
|
22888-2
|
Bordetella bronchiseptica Ag [Presence] in Unspecified specimen by Agglutination |
|
45271-4
|
Bordetella bronchiseptica DNA [Presence] in Nasopharynx by NAA with probe detection |
|
45294-6
|
Bordetella bronchiseptica DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
90893-9
|
Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection |
|
51744-1
|
Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum by Immunoassay |
|
53362-0
|
Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum |
|
51743-3
|
Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum by Immunoassay |
|
51746-6
|
Borrelia burgdorferi 49736 IgG Ab [Presence] in Serum by Immunoblot |
|
53363-8
|
Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum |
|
51742-5
|
Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum by Immunoassay |
|
53364-6
|
Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum |
|
6318-0
|
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44453-9
|
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoblot |
|
22118-4
|
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid |
|
16475-6
|
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
45189-8
|
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
22119-2
|
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid |
|
6319-8
|
Borrelia burgdorferi Ab [Units/volume] in Body fluid by Immunoassay |
|
16477-2
|
Borrelia burgdorferi Ab [Presence] in Body fluid |
|
16476-4
|
Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay |
|
22120-0
|
Borrelia burgdorferi Ab [Units/volume] in Body fluid |
|
23833-7
|
Borrelia burgdorferi Ab index [Presence] in Serum and CSF |
|
12781-1
|
Borrelia burgdorferi Ab band pattern [Interpretation] in Serum by Immunoblot |
|
5060-9
|
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay |
|
44452-1
|
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoblot |
|
11006-4
|
Borrelia burgdorferi Ab [Presence] in Serum |
|
26006-7
|
Borrelia burgdorferi Ab [Presence] in Serum by Hemagglutination |
|
20449-5
|
Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay |
|
23676-0
|
Borrelia burgdorferi Ab [Presence] in Serum by Immunofluorescence |
|
22121-8
|
Borrelia burgdorferi Ab [Units/volume] in Serum |
|
9586-9
|
Borrelia burgdorferi Ab [Interpretation] in Serum |
|
44020-6
|
Borrelia burgdorferi Ab [Presence] in Synovial fluid by Immunoblot |
|
44454-7
|
Borrelia burgdorferi Ab [Units/volume] in Synovial fluid |
|
44455-4
|
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
44456-2
|
Borrelia burgdorferi Ab [Units/volume] in Serum --1st specimen |
|
30128-3
|
Borrelia burgdorferi Ab [Units/volume] in Serum --2nd specimen |
|
33932-5
|
Borrelia burgdorferi Ab [Titer] in Cerebral spinal fluid |
|
22122-6
|
Borrelia burgdorferi Ab [Titer] in Serum |
|
43842-4
|
Borrelia burgdorferi Ab [Titer] in Serum by Immunoassay |
|
5061-7
|
Borrelia burgdorferi Ab [Titer] in Serum by Immunofluorescence |
|
31155-5
|
Borrelia burgdorferi Ab [Units/volume] in Unspecified specimen by Immunoassay |
|
43077-7
|
Borrelia burgdorferi Ab [Units/volume] in Unspecified specimen |
|
6322-2
|
Borrelia burgdorferi Ag [Units/volume] in Serum |
|
29952-9
|
Borrelia burgdorferi Ag [Mass/volume] in Urine by Immunoassay |
|
11007-2
|
Borrelia burgdorferi Ag [Units/volume] in Urine |
|
31738-8
|
Borrelia burgdorferi Ag [Presence] in Unspecified specimen |
|
23977-2
|
Borrelia burgdorferi Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
38174-9
|
Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43074-4
|
Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid |
|
38173-1
|
Borrelia burgdorferi C6 Ab [Units/volume] in Serum by Immunoassay |
|
57916-9
|
Borrelia burgdorferi C6 Ab [Presence] in Serum |
|
43075-1
|
Borrelia burgdorferi C6 Ab [Units/volume] in Serum |
|
32667-8
|
Borrelia burgdorferi DNA [Presence] in Blood by NAA with probe detection |
|
10846-4
|
Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
|
32668-6
|
Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
11551-9
|
Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification |
|
42589-2
|
Borrelia burgdorferi DNA [Presence] in Body fluid by NAA with probe detection |
|
10847-2
|
Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
|
32669-4
|
Borrelia burgdorferi DNA [Presence] in Synovial fluid by NAA with probe detection |
|
42236-0
|
Borrelia burgdorferi DNA [Presence] in Tick by NAA with probe detection |
|
35638-6
|
Borrelia burgdorferi DNA [Presence] in Tissue by NAA with probe detection |
|
21120-1
|
Borrelia burgdorferi DNA [Presence] in Urine by NAA with probe detection |
|
19052-0
|
Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification |
|
4991-6
|
Borrelia burgdorferi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
51745-8
|
Borrelia burgdorferi G39/40 IgG Ab [Presence] in Serum by Immunoblot |
|
53730-8
|
Borrelia burgdorferi G39/40 IgG Ab [Units/volume] in Serum or Plasma |
|
22123-4
|
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid |
|
16479-8
|
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
18202-2
|
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
45165-8
|
Borrelia burgdorferi IgA Ab [Units/volume] in Serum by Immunofluorescence |
|
22124-2
|
Borrelia burgdorferi IgA Ab [Presence] in Serum |
|
16478-0
|
Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay |
|
18201-4
|
Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot |
|
46174-9
|
Borrelia burgdorferi IgA Ab [Units/volume] in Serum |
|
51747-4
|
Borrelia burgdorferi IgA and IgG and IgM [Interpretation] in Serum by Immunoassay |
|
14077-2
|
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
13204-3
|
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22125-9
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid |
|
83080-2
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13202-7
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
79709-2
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
22126-7
|
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid |
|
16481-4
|
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
23980-6
|
Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot |
|
22127-5
|
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid |
|
47304-1
|
Borrelia burgdorferi IgG Ab index [Units/volume] in Serum and CSF |
|
23979-8
|
Borrelia burgdorferi IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
|
23981-4
|
Borrelia burgdorferi IgG band pattern [Interpretation] in Body fluid by Immunoblot |
|
13502-0
|
Borrelia burgdorferi IgG band pattern [Interpretation] in Serum by Immunoblot |
|
5062-5
|
Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay |
|
22128-3
|
Borrelia burgdorferi IgG Ab [Presence] in Serum |
|
6320-6
|
Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoblot |
|
7817-0
|
Borrelia burgdorferi IgG Ab [Units/volume] in Serum |
|
16480-6
|
Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
79708-4
|
Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
22129-1
|
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid |
|
21118-5
|
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoassay |
|
13206-8
|
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
23966-5
|
Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid |
|
23978-0
|
Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22130-9
|
Borrelia burgdorferi IgG Ab [Titer] in Serum |
|
5063-3
|
Borrelia burgdorferi IgG Ab [Titer] in Serum by Immunofluorescence |
|
31268-6
|
Borrelia burgdorferi IgG Ab [Presence] in Unspecified specimen |
|
29898-4
|
Borrelia burgdorferi IgG Ab [Presence] in Unspecified specimen by Immunoblot |
|
41279-1
|
Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum |
|
42767-4
|
Borrelia burgdorferi IgG and IgM [Interpretation] in Cerebral spinal fluid |
|
46248-1
|
Borrelia burgdorferi IgG and IgM [Interpretation] in Serum by Immunoassay |
|
62342-1
|
Borrelia burgdorferi IgG and IgM [Interpretation] in Serum by Immunoblot |
|
22131-7
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
|
83081-0
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
18203-0
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot |
|
34148-7
|
Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum |
|
14078-0
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43573-5
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoblot |
|
13205-0
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22132-5
|
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid |
|
13203-5
|
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
22133-3
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid |
|
16482-2
|
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
31269-4
|
Borrelia burgdorferi IgM Ab [Presence] in Body fluid |
|
23982-2
|
Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot |
|
22134-1
|
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid |
|
48651-4
|
Borrelia burgdorferi IgM Ab index [Units/volume] in Body fluid |
|
23985-5
|
Borrelia burgdorferi IgM band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
|
23983-0
|
Borrelia burgdorferi IgM band pattern [Interpretation] in Body fluid by Immunoblot |
|
13503-8
|
Borrelia burgdorferi IgM band pattern [Interpretation] in Serum by Immunoblot |
|
5064-1
|
Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay |
|
22135-8
|
Borrelia burgdorferi IgM Ab [Presence] in Serum |
|
6321-4
|
Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunoblot |
|
30526-8
|
Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunofluorescence |
|
7818-8
|
Borrelia burgdorferi IgM Ab [Units/volume] in Serum |
|
40612-4
|
Borrelia burgdorferi IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
22136-6
|
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid |
|
21119-3
|
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoassay |
|
13207-6
|
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot |
|
43076-9
|
Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid |
|
23984-8
|
Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22137-4
|
Borrelia burgdorferi IgM Ab [Titer] in Serum |
|
5065-8
|
Borrelia burgdorferi IgM Ab [Titer] in Serum by Immunofluorescence |
|
11550-1
|
Borrelia burgdorferi [Presence] in Unspecified specimen by Organism specific culture |
|
49991-3
|
Borrelia burgdorferi 18/20kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49992-1
|
Borrelia burgdorferi 18/20kD IgG Ab [Presence] in Serum by Immunoblot |
|
49993-9
|
Borrelia burgdorferi 18/20kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49994-7
|
Borrelia burgdorferi 18/20kD IgM Ab [Presence] in Serum by Immunoblot |
|
12866-0
|
Borrelia burgdorferi 18kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12883-5
|
Borrelia burgdorferi 18kD Ab [Presence] in Body fluid by Immunoblot |
|
27985-1
|
Borrelia burgdorferi 18kD Ab [Presence] in Serum by Immunoblot |
|
48500-3
|
Borrelia burgdorferi 18kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9588-5
|
Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot |
|
42237-8
|
Borrelia burgdorferi 18kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
28058-6
|
Borrelia burgdorferi 21kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
30014-5
|
Borrelia burgdorferi 21kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
27992-7
|
Borrelia burgdorferi 23kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
42238-6
|
Borrelia burgdorferi 23kD Ab [Presence] in Serum by Immunoblot |
|
28057-8
|
Borrelia burgdorferi 23kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9589-3
|
Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot |
|
30013-7
|
Borrelia burgdorferi 23kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
28062-8
|
Borrelia burgdorferi 23kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9598-4
|
Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot |
|
30021-0
|
Borrelia burgdorferi 23kD IgM Ab [Presence] in Synovial fluid by Immunoblot |
|
12864-5
|
Borrelia burgdorferi 25kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12888-4
|
Borrelia burgdorferi 25kD Ab [Presence] in Body fluid by Immunoblot |
|
12879-3
|
Borrelia burgdorferi 25kD Ab [Presence] in Serum by Immunoblot |
|
32666-0
|
Borrelia burgdorferi 25kD IgM Ab [Presence] in Serum by Immunoblot |
|
27986-9
|
Borrelia burgdorferi 28kD Ab [Presence] in Serum by Immunoblot |
|
28056-0
|
Borrelia burgdorferi 28kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9590-1
|
Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot |
|
30012-9
|
Borrelia burgdorferi 28kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
12865-2
|
Borrelia burgdorferi 29kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12882-7
|
Borrelia burgdorferi 29kD Ab [Presence] in Body fluid by Immunoblot |
|
12878-5
|
Borrelia burgdorferi 29kD Ab [Presence] in Serum by Immunoblot |
|
12869-4
|
Borrelia burgdorferi 30kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12889-2
|
Borrelia burgdorferi 30kD Ab [Presence] in Body fluid by Immunoblot |
|
12892-6
|
Borrelia burgdorferi 30kD Ab [Presence] in Serum by Immunoblot |
|
28053-7
|
Borrelia burgdorferi 30kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9591-9
|
Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot |
|
30018-6
|
Borrelia burgdorferi 30kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
49973-1
|
Borrelia burgdorferi 31kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
44946-2
|
Borrelia burgdorferi 31kD IgG Ab [Presence] in Serum by Immunoblot |
|
49974-9
|
Borrelia burgdorferi 31kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
44947-0
|
Borrelia burgdorferi 31kD IgM Ab [Presence] in Serum by Immunoblot |
|
49975-6
|
Borrelia burgdorferi 34kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
44949-6
|
Borrelia burgdorferi 34kD IgG Ab [Presence] in Serum by Immunoblot |
|
49976-4
|
Borrelia burgdorferi 34kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
44948-8
|
Borrelia burgdorferi 34kD IgM Ab [Presence] in Serum by Immunoblot |
|
49978-0
|
Borrelia burgdorferi 35kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49977-2
|
Borrelia burgdorferi 35kD IgG Ab [Presence] in Serum by Immunoblot |
|
49980-6
|
Borrelia burgdorferi 35kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49979-8
|
Borrelia burgdorferi 35kD IgM Ab [Presence] in Serum by Immunoblot |
|
49982-2
|
Borrelia burgdorferi 37kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49981-4
|
Borrelia burgdorferi 37kD IgG Ab [Presence] in Serum by Immunoblot |
|
49984-8
|
Borrelia burgdorferi 37kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49983-0
|
Borrelia burgdorferi 37kD IgM Ab [Presence] in Serum by Immunoblot |
|
12860-3
|
Borrelia burgdorferi 39kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12884-3
|
Borrelia burgdorferi 39kD Ab [Presence] in Body fluid by Immunoblot |
|
28002-4
|
Borrelia burgdorferi 39kD Ab [Presence] in Serum by Immunoblot |
|
28036-2
|
Borrelia burgdorferi 39kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9592-7
|
Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot |
|
42239-4
|
Borrelia burgdorferi 39kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
28037-0
|
Borrelia burgdorferi 39kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9599-2
|
Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot |
|
30020-2
|
Borrelia burgdorferi 39kD IgM Ab [Presence] in Synovial fluid by Immunoblot |
|
12863-7
|
Borrelia burgdorferi 41kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12887-6
|
Borrelia burgdorferi 41kD Ab [Presence] in Body fluid by Immunoblot |
|
12891-8
|
Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot |
|
28040-4
|
Borrelia burgdorferi 41kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9593-5
|
Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot |
|
30015-2
|
Borrelia burgdorferi 41kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
28043-8
|
Borrelia burgdorferi 41kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9587-7
|
Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot |
|
30019-4
|
Borrelia burgdorferi 41kD IgM Ab [Presence] in Synovial fluid by Immunoblot |
|
12890-0
|
Borrelia burgdorferi 45kD Ab [Presence] in Serum by Immunoblot |
|
28055-2
|
Borrelia burgdorferi 45kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9594-3
|
Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot |
|
30011-1
|
Borrelia burgdorferi 45kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
12868-6
|
Borrelia burgdorferi 47kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12881-9
|
Borrelia burgdorferi 47kD Ab [Presence] in Body fluid by Immunoblot |
|
12877-7
|
Borrelia burgdorferi 47kD Ab [Presence] in Serum by Immunoblot |
|
12867-8
|
Borrelia burgdorferi 58kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12880-1
|
Borrelia burgdorferi 58kD Ab [Presence] in Body fluid by Immunoblot |
|
12896-7
|
Borrelia burgdorferi 58kD Ab [Presence] in Serum by Immunoblot |
|
28048-7
|
Borrelia burgdorferi 58kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9595-0
|
Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot |
|
30017-8
|
Borrelia burgdorferi 58kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
12862-9
|
Borrelia burgdorferi 66kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12886-8
|
Borrelia burgdorferi 66kD Ab [Presence] in Body fluid by Immunoblot |
|
27982-8
|
Borrelia burgdorferi 66kD Ab [Presence] in Serum by Immunoblot |
|
28039-6
|
Borrelia burgdorferi 66kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9596-8
|
Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot |
|
30016-0
|
Borrelia burgdorferi 66kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
21116-9
|
Borrelia burgdorferi 66kD IgM Ab [Presence] in Serum by Immunoblot |
|
49995-4
|
Borrelia burgdorferi 83/93kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49996-2
|
Borrelia burgdorferi 83/93kD IgG Ab [Presence] in Serum by Immunoblot |
|
49998-8
|
Borrelia burgdorferi 83/93kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
49997-0
|
Borrelia burgdorferi 83/93kD IgM Ab [Presence] in Serum by Immunoblot |
|
12861-1
|
Borrelia burgdorferi 88kD Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
12885-0
|
Borrelia burgdorferi 88kD Ab [Presence] in Body fluid by Immunoblot |
|
12873-6
|
Borrelia burgdorferi 88kD Ab [Presence] in Serum by Immunoblot |
|
12874-4
|
Borrelia burgdorferi 93kD Ab [Presence] in Serum by Immunoblot |
|
28054-5
|
Borrelia burgdorferi 93kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
9597-6
|
Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot |
|
30010-3
|
Borrelia burgdorferi 93kD IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
21117-7
|
Borrelia burgdorferi 93kD IgM Ab [Presence] in Serum by Immunoblot |
|
22104-4
|
Babesia caballi Ab [Presence] in Serum |
|
20689-6
|
Babesia caballi Ab [Presence] in Serum by Complement fixation |
|
22850-2
|
Babesia caballi Ab [Presence] in Serum by Immunoassay |
|
22851-0
|
Babesia caballi Ab [Presence] in Serum by Immunofluorescence |
|
22853-6
|
Babesia caballi rRNA [Presence] in Blood by Probe |
|
6327-1
|
Brucella canis Ab [Units/volume] in Serum by Immunoassay |
|
22928-6
|
Brucella canis Ab [Presence] in Serum |
|
22930-2
|
Brucella canis Ab [Presence] in Serum by Agglutination |
|
22929-4
|
Brucella canis Ab [Presence] in Serum by Immune diffusion (ID) |
|
23681-0
|
Brucella canis Ab [Presence] in Serum by Immunofluorescence |
|
24410-3
|
Brucella canis Ab [Presence] in Serum by Plate agglutination |
|
11587-3
|
Brucella canis Ab [Units/volume] in Serum |
|
22152-3
|
Brucella canis Ab [Titer] in Serum |
|
43087-6
|
Babesia canis Ab [Titer] in Serum |
|
23682-8
|
Brucella canis Ab [Titer] in Serum by Agglutination |
|
23683-6
|
Brucella canis Ab [Titer] in Serum by Immunofluorescence |
|
23664-6
|
Babesia canis Ab [Titer] in Serum by Immunofluorescence |
|
5068-2
|
Brucella canis Ab [Titer] in Serum by Latex agglutination |
|
24408-7
|
Babesia canis [Presence] in Blood by Giemsa stain |
|
13214-2
|
Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
9495-3
|
Brucella canis IgG Ab [Units/volume] in Serum by Immunoassay |
|
38245-7
|
Brucella canis IgG Ab [Presence] in Serum |
|
22153-1
|
Brucella canis IgG Ab [Units/volume] in Serum |
|
43072-8
|
Brucella canis IgG Ab [Titer] in Cerebral spinal fluid |
|
30092-1
|
Brucella canis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22154-9
|
Brucella canis IgG Ab [Titer] in Serum |
|
14079-8
|
Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence |
|
44077-6
|
Brucella canis IgG and IgM [Interpretation] in Serum |
|
13215-9
|
Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
9496-1
|
Brucella canis IgM Ab [Units/volume] in Serum by Immunoassay |
|
38246-5
|
Brucella canis IgM Ab [Presence] in Serum |
|
22155-6
|
Brucella canis IgM Ab [Units/volume] in Serum |
|
43071-0
|
Brucella canis IgM Ab [Titer] in Cerebral spinal fluid |
|
30093-9
|
Brucella canis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22156-4
|
Brucella canis IgM Ab [Titer] in Serum |
|
14080-6
|
Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence |
|
10431-5
|
B-cell Ag [Presence] in Tissue by Immune stain |
|
48390-9
|
B cell crossmatch [Presence] in Blood from Donor |
|
46715-9
|
B cell crossmatch [Presence] in Blood |
|
38357-0
|
B cell crossmatch [Interpretation] |
|
20692-0
|
Bacillus cereus [Presence] in Food by Culture FDA method |
|
92788-9
|
Bacillus cereus group DNA [Presence] by NAA with probe detection in Positive blood culture |
|
77495-0
|
Bacillus cereus [Presence] in Unspecified specimen by Organism specific culture |
|
6049-1
|
Botrytis cinerea IgE Ab [Units/volume] in Serum |
|
15584-6
|
Botrytis cinerea IgE Ab RAST class [Presence] in Serum |
|
61231-7
|
Botrytis cinerea IgE Ab/IgE total in Serum |
|
30022-8
|
Botrytis cinerea IgG Ab [Units/volume] in Serum |
|
42591-8
|
Botrytis cinerea IgG Ab [Mass/volume] in Serum |
|
7149-8
|
Bipolanis curvularia IgE Ab [Units/volume] in Serum |
|
81653-8
|
Blastomyces dermatitidis drk1 and Histoplasma capsulatum gapdh genes [Identifier] in Unspecified specimen by NAA with probe detection |
|
18197-4
|
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid |
|
43900-0
|
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
51741-7
|
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
13201-9
|
Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid |
|
31259-5
|
Blastomyces dermatitidis Ab [Presence] in Body fluid |
|
27386-2
|
Blastomyces dermatitidis Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
44451-3
|
Blastomyces dermatitidis Ab [Units/volume] in Serum by Complement fixation |
|
7816-2
|
Blastomyces dermatitidis Ab [Presence] in Serum |
|
16470-7
|
Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation |
|
5058-3
|
Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID) |
|
16471-5
|
Blastomyces dermatitidis Ab [Units/volume] in Serum |
|
23959-0
|
Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid |
|
23976-4
|
Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43084-3
|
Blastomyces dermatitidis Ab [Titer] in Pleural fluid |
|
42490-3
|
Blastomyces dermatitidis Ab [Titer] in Pleural fluid by Complement fixation |
|
22112-7
|
Blastomyces dermatitidis Ab [Titer] in Serum |
|
5057-5
|
Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation |
|
51787-0
|
Blastomyces dermatitidis Ab [Titer] in Serum by Immune diffusion (ID) |
|
54455-1
|
Blastomyces dermatitidis Ag [Units/volume] in Body fluid |
|
31731-3
|
Blastomyces dermatitidis Ag [Presence] in Serum |
|
6313-1
|
Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay |
|
41746-9
|
Blastomyces dermatitidis Ag [Presence] in Urine by Immunoassay |
|
18198-2
|
Blastomyces dermatitidis IgE Ab [Presence] in Serum |
|
46160-8
|
Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid |
|
43864-8
|
Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
18199-0
|
Blastomyces dermatitidis IgG Ab [Presence] in Serum |
|
43865-5
|
Blastomyces dermatitidis IgG Ab [Presence] in Serum by Immunoassay |
|
9494-6
|
Blastomyces dermatitidis IgG Ab [Units/volume] in Serum |
|
18200-6
|
Blastomyces dermatitidis IgM Ab [Presence] in Serum |
|
38443-8
|
Blastomyces dermatitidis IgM Ab [Presence] in Serum by Immunoassay |
|
16472-3
|
Blastomyces dermatitidis rRNA [Presence] in Serum by Probe |
|
4990-8
|
Blastomyces dermatitidis rRNA [Presence] in Unspecified specimen by Probe |
|
14197-8
|
Blastomyces dermatitidis exoantigen [Identifier] in Isolate |
|
88450-2
|
Babesia divergens+MO-1 strain 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
|
22855-1
|
Babesia divergens Ab [Presence] in Serum |
|
23665-3
|
Babesia divergens Ab [Presence] in Serum by Complement fixation |
|
22854-4
|
Babesia divergens Ab [Presence] in Serum by Immunofluorescence |
|
43086-8
|
Babesia divergens Ab [Titer] in Serum |
|
41413-6
|
Babesia divergens Ab [Titer] in Serum by Immunofluorescence |
|
88451-0
|
Babesia duncani 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
|
26622-1
|
Babesia duncani Ab [Presence] in Serum |
|
43085-0
|
Babesia duncani Ab [Titer] in Serum |
|
41415-1
|
Babesia duncani Ab [Titer] in Serum by Immunofluorescence |
|
93776-3
|
Babesia duncani IgG Ab [Titer] in Serum by Immunofluorescence |
|
26678-3
|
Bartonella elizabethae Ab [Presence] in Serum |
|
49206-6
|
Bartonella elizabethae IgG Ab [Titer] in Body fluid |
|
48880-9
|
Bartonella elizabethae IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49208-2
|
Bartonella elizabethae IgG Ab [Titer] in Serum |
|
48844-5
|
Bartonella elizabethae IgG Ab [Titer] in Serum by Immunofluorescence |
|
49205-8
|
Bartonella elizabethae IgM Ab [Titer] in Body fluid |
|
48881-7
|
Bartonella elizabethae IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49207-4
|
Bartonella elizabethae IgM Ab [Titer] in Serum |
|
48845-2
|
Bartonella elizabethae IgM Ab [Titer] in Serum by Immunofluorescence |
|
31727-1
|
Bacteroides fragilis Ag [Presence] in Unspecified specimen |
|
544-7
|
Bacteroides fragilis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
93405-9
|
Bacteroides fragilis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70020-3
|
Bacteroides fragilis DNA [Presence] in Blood by NAA with probe detection |
|
26766-6
|
Bacteroides fragilis IgG Ab [Units/volume] in Serum |
|
27905-9
|
Bacteroides fragilis IgM Ab [Units/volume] in Serum |
|
82471-4
|
Borrelia garinii+afzelii oppA1 gene [Presence] in Blood by NAA with non-probe detection |
|
82472-2
|
Borrelia garinii+afzelii oppA1 gene [Presence] in Unspecified specimen by NAA with non-probe detection |
|
34251-9
|
Borrelia garinii IgG Ab [Presence] in Serum by Immunoblot |
|
34252-7
|
Borrelia garinii IgM Ab [Presence] in Serum by Immunoblot |
|
80451-8
|
Beta glucan intake 24 hour Estimated |
|
80452-6
|
Beta glucan intake 24 hour Measured |
|
87283-8
|
Brachyspira hampsonii DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
44442-2
|
Bartonella henselae Ab [Units/volume] in Serum by Immunoassay |
|
26676-7
|
Bartonella henselae Ab [Presence] in Serum |
|
35269-0
|
Bartonella henselae Ab [Presence] in Serum by Immunofluorescence |
|
31249-6
|
Bartonella henselae Ab [Units/volume] in Serum |
|
23668-7
|
Bartonella henselae Ab [Titer] in Serum |
|
34433-3
|
Bartonella henselae Ab [Titer] in Serum by Flow cytometry (FC) |
|
91864-9
|
Bartonella henselae DNA [Presence] in Aspirate by NAA with probe detection |
|
16276-8
|
Bartonella henselae DNA [Presence] in Blood by NAA with probe detection |
|
89645-6
|
Bartonella henselae DNA [Presence] in Implanted device by NAA with probe detection |
|
33985-3
|
Bartonella henselae DNA [Presence] in Tissue by NAA with probe detection |
|
33986-1
|
Bartonella henselae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16174-5
|
Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid |
|
31250-4
|
Bartonella henselae IgG Ab [Units/volume] in Cerebral spinal fluid |
|
7815-4
|
Bartonella henselae IgG Ab [Units/volume] in Serum by Immunoassay |
|
48721-5
|
Bartonella henselae IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
32575-3
|
Bartonella henselae IgG Ab [Presence] in Serum |
|
5326-4
|
Bartonella henselae IgG Ab [Units/volume] in Serum |
|
23957-4
|
Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid |
|
23954-1
|
Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49203-3
|
Bartonella henselae IgG Ab [Titer] in Body fluid |
|
48883-3
|
Bartonella henselae IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
22110-1
|
Bartonella henselae IgG Ab [Titer] in Serum |
|
6954-2
|
Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence |
|
16175-2
|
Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid |
|
31251-2
|
Bartonella henselae IgM Ab [Units/volume] in Cerebral spinal fluid |
|
6312-3
|
Bartonella henselae IgM Ab [Units/volume] in Serum by Immunoassay |
|
32576-1
|
Bartonella henselae IgM Ab [Presence] in Serum |
|
5327-2
|
Bartonella henselae IgM Ab [Units/volume] in Serum |
|
23962-4
|
Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid |
|
23955-8
|
Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49204-1
|
Bartonella henselae IgM Ab [Titer] in Body fluid |
|
48882-5
|
Bartonella henselae IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
22111-9
|
Bartonella henselae IgM Ab [Titer] in Serum |
|
6955-9
|
Bartonella henselae IgM Ab [Titer] in Serum by Immunofluorescence |
|
26631-2
|
Borrelia hermsii Ab [Presence] in Serum |
|
13208-4
|
Borrelia hermsii IgG Ab [Units/volume] in Serum |
|
22138-2
|
Borrelia hermsii IgG Ab [Titer] in Serum |
|
21121-9
|
Borrelia hermsii IgG Ab [Titer] in Serum by Immunofluorescence |
|
60522-0
|
Borrelia hermsii IgG+IgM Ab [Presence] in Serum |
|
13209-2
|
Borrelia hermsii IgM Ab [Units/volume] in Serum |
|
22139-0
|
Borrelia hermsii IgM Ab [Titer] in Serum |
|
21122-7
|
Borrelia hermsii IgM Ab [Titer] in Serum by Immunofluorescence |
|
16483-0
|
Borrelia hermsii [Presence] in Unspecified specimen by Organism specific culture |
|
86326-6
|
Bordetella holmesii hIS1001 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
88576-4
|
Bordetella holmesii hIS1001 DNA [Presence] in Nasopharynx by NAA with probe detection |
|
80599-4
|
Bordetella holmesii fumC gene [Presence] in Nasopharynx by NAA with probe detection |
|
91840-9
|
Bordetella holmesii DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91867-2
|
Bordetella holmesii DNA [Presence] in Throat by NAA with probe detection |
|
91817-7
|
Bordetella holmesii DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
62427-0
|
Bordetella holmesii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70292-8
|
Blastocystis hominis DNA [Presence] in Stool by NAA with probe detection |
|
87282-0
|
Brachyspira hyodysenteriae DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87284-6
|
Brachyspira hyodysenteriae DNA [Presence] in Isolate by NAA with probe detection |
|
87411-5
|
Brachyspira hyodysenteriae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80612-5
|
B IgG Ab [Presence] in Serum or Plasma |
|
50764-0
|
B IgG Ab [Titer] in Serum or Plasma |
|
50763-2
|
B IgM Ab [Titer] in Serum or Plasma |
|
11130-2
|
B lymphocytes [#/volume] in Blood |
|
42759-1
|
B lymphocytes [#/volume] in Bone marrow |
|
7819-6
|
Brugia malayi Ab [Presence] in Serum |
|
6606-8
|
Brugia malayi Ab [Presence] in Serum by Immunoassay |
|
22956-7
|
Burkholderia mallei Ab [Presence] in Serum |
|
22959-1
|
Burkholderia mallei Ab [Presence] in Serum by Complement fixation |
|
22958-3
|
Burkholderia mallei Ab [Presence] in Serum by Immunoassay |
|
70854-5
|
Burkholderia mallei Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
70853-7
|
Burkholderia mallei DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22960-9
|
Burkholderia mallei reaction [Appearance] -1D post 0.1 mL mallein intradermal- |
|
22961-7
|
Burkholderia mallei reaction [Appearance] -2D post 0.1 mL mallein intradermal- |
|
70850-3
|
Burkholderia mallei [Presence] in Unspecified specimen by Organism specific culture |
|
41432-6
|
Balamuthia mandrillaris DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82473-0
|
Borrelia mayonii oppA1 gene [Presence] in Blood by NAA with non-probe detection |
|
82474-8
|
Borrelia mayonii oppA1 gene [Presence] in Unspecified specimen by NAA with non-probe detection |
|
31728-9
|
Bacteroides melaninogenicus Ag [Presence] in Unspecified specimen |
|
545-4
|
Bacteroides melaninogenicus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22934-4
|
Brucella melitensis Ab [Units/volume] in Serum by Complement fixation |
|
16489-7
|
Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination |
|
22931-0
|
Brucella melitensis Ab [Presence] in Serum |
|
22933-6
|
Brucella melitensis Ab [Presence] in Serum by Agglutination |
|
22935-1
|
Brucella melitensis Ab [Presence] in Serum by Complement fixation |
|
22932-8
|
Brucella melitensis Ab [Presence] in Serum by Immunoassay |
|
11588-1
|
Brucella melitensis Ab [Units/volume] in Serum |
|
22157-2
|
Brucella melitensis Ab [Titer] in Serum |
|
5069-0
|
Brucella melitensis Ab [Titer] in Serum by Latex agglutination |
|
22936-9
|
Brucella melitensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
57670-2
|
Brucella melitensis IgG Ab [Units/volume] in Serum by Immunoassay |
|
57671-0
|
Brucella melitensis IgM Ab [Units/volume] in Serum by Immunoassay |
|
88452-8
|
Babesia microti 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
|
6311-5
|
Babesia microti Ab [Units/volume] in Serum by Immunoassay |
|
43918-2
|
Babesia microti Ab [Presence] in Serum |
|
7812-1
|
Babesia microti Ab [Units/volume] in Serum |
|
16427-7
|
Babesia microti Ab [Titer] in Serum |
|
41414-4
|
Babesia microti Ab [Titer] in Serum by Immunofluorescence |
|
10347-3
|
Babesia microti identified in Blood by Light microscopy |
|
21089-8
|
Babesia microti DNA [Presence] in Blood by NAA with probe detection |
|
47396-7
|
Babesia microti DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43893-7
|
Babesia microti IgG Ab [Presence] in Serum |
|
82747-7
|
Babesia microti IgG Ab [Presence] in Serum by Immunoblot |
|
31244-7
|
Babesia microti IgG Ab [Units/volume] in Serum |
|
47071-6
|
Babesia microti IgG Ab [Titer] in Cerebral spinal fluid |
|
16117-4
|
Babesia microti IgG Ab [Titer] in Serum |
|
60521-2
|
Babesia microti IgG+IgM Ab [Presence] in Serum |
|
88700-0
|
Babesia microti IgG and IgM [Interpretation] in Serum |
|
27965-3
|
Babesia microti IgM Ab [Presence] in Serum |
|
31245-4
|
Babesia microti IgM Ab [Units/volume] in Serum |
|
47073-2
|
Babesia microti IgM Ab [Titer] in Cerebral spinal fluid |
|
16118-2
|
Babesia microti IgM Ab [Titer] in Serum |
|
82475-5
|
Borrelia miyamotoi glpQ gene [Presence] in Blood by NAA with non-probe detection |
|
82476-3
|
Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
82780-8
|
Borrelia miyamotoi flaB gene [Presence] in Tick by NAA with probe detection |
|
82781-6
|
Borrelia miyamotoi flaB gene [Presence] in Unspecified specimen by NAA with probe detection |
|
93873-8
|
Borrelia miyamotoi IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
93871-2
|
Borrelia miyamotoi IgG+IgM Ab [Interpretation] in Serum or Plasma |
|
93874-6
|
Borrelia miyamotoi IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
22937-7
|
Brucella ovis Ab [Units/volume] in Serum by Complement fixation |
|
22158-0
|
Brucella ovis Ab [Presence] in Serum |
|
22938-5
|
Brucella ovis Ab [Presence] in Serum by Agglutination |
|
20733-2
|
Brucella ovis Ab [Presence] in Serum by Complement fixation |
|
20732-4
|
Brucella ovis Ab [Presence] in Serum by Immunoassay |
|
22940-1
|
Brucella ovis Ab [Presence] in Serum by Immune diffusion (ID) |
|
22939-3
|
Brucella ovis Ab [Units/volume] in Serum |
|
23684-4
|
Brucella ovis Ab [Titer] in Serum |
|
86327-4
|
Bordetella parapertussis IS1001 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
92855-6
|
Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
87621-9
|
Bordetella parapertussis IS1001 DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92856-4
|
Bordetella parapertussis IS1001 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
44019-8
|
Bordetella parapertussis Ab [Presence] in Body fluid |
|
51825-8
|
Bordetella parapertussis Ab [Units/volume] in Serum by Immunoassay |
|
10348-1
|
Bordetella parapertussis Ab [Presence] in Serum |
|
16473-1
|
Bordetella parapertussis Ab [Units/volume] in Serum |
|
38197-0
|
Bordetella parapertussis Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31736-2
|
Bordetella parapertussis Ag [Presence] in Unspecified specimen |
|
13916-2
|
Bordetella parapertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
42588-4
|
Bordetella parapertussis DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92129-6
|
Bordetella parapertussis DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91868-0
|
Bordetella parapertussis DNA [Presence] in Throat by NAA with probe detection |
|
91816-9
|
Bordetella parapertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29723-4
|
Bordetella parapertussis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
69948-8
|
Bordetella parapertussis IgG Ab [Presence] in Serum by Immunoassay |
|
53361-2
|
Bordetella parapertussis IgG Ab [Titer] in Serum |
|
51837-3
|
Bordetella parapertussis IgG Ab [Titer] in Serum by Immunofluorescence |
|
56636-4
|
Bordetella parapertussis IgM Ab [Titer] in Serum by Immunofluorescence |
|
43879-6
|
Bordetella parapertussis [Presence] in Nasopharynx by Organism specific culture |
|
43925-7
|
Bordetella parapertussis [Presence] in Unspecified specimen by Organism specific culture |
|
85799-5
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
16474-9
|
Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation |
|
5059-1
|
Bordetella pertussis Ab [Units/volume] in Serum by Immunoassay |
|
31998-8
|
Bordetella pertussis Ab [Presence] in Serum |
|
11585-7
|
Bordetella pertussis Ab [Units/volume] in Serum |
|
22116-8
|
Bordetella pertussis Ab [Titer] in Serum |
|
6315-6
|
Bordetella pertussis Ab [Titer] in Serum by Agglutination |
|
6316-4
|
Bordetella pertussis Ab [Titer] in Serum by Complement fixation |
|
22117-6
|
Bordetella pertussis Ab [Titer] in Unspecified specimen |
|
6314-9
|
Bordetella pertussis Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
20992-4
|
Bordetella pertussis Ab [Presence] in Unspecified specimen |
|
43381-3
|
Bordetella pertussis Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
31266-0
|
Bordetella pertussis Ab [Units/volume] in Unspecified specimen |
|
43909-1
|
Bordetella pertussis Ag [Presence] in Nasopharynx |
|
38198-8
|
Bordetella pertussis Ag [Presence] in Nasopharynx by Immunofluorescence |
|
43891-1
|
Bordetella pertussis Ag [Presence] in Sputum by Immunofluorescence |
|
31737-0
|
Bordetella pertussis Ag [Presence] in Unspecified specimen |
|
550-4
|
Bordetella pertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
43913-3
|
Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92128-8
|
Bordetella pertussis DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91869-8
|
Bordetella pertussis DNA [Presence] in Throat by NAA with probe detection |
|
91815-1
|
Bordetella pertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
23826-1
|
Bordetella pertussis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
24034-1
|
Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum by Immunoassay |
|
43880-4
|
Bordetella pertussis filamentous hemagglutinin IgA Ab [Presence] in Serum |
|
23827-9
|
Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum |
|
24033-3
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunoassay |
|
46253-1
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
43881-2
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Presence] in Serum |
|
23828-7
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum |
|
24035-8
|
Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum by Immunoassay |
|
43882-0
|
Bordetella pertussis filamentous hemagglutinin IgM Ab [Presence] in Serum |
|
23829-5
|
Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum |
|
44046-1
|
Bordetella pertussis Higashi-Hama Ab [Units/volume] in Serum |
|
42328-5
|
Bordetella pertussis IgA Ab [Units/volume] in Serum by Immunoassay |
|
29672-3
|
Bordetella pertussis IgA Ab [Presence] in Serum |
|
29657-4
|
Bordetella pertussis IgA Ab [Presence] in Serum by Immunoassay |
|
69366-3
|
Bordetella pertussis IgA Ab [Presence] in Serum by Immunoblot |
|
9362-5
|
Bordetella pertussis IgA Ab [Units/volume] in Serum |
|
42330-1
|
Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay |
|
29674-9
|
Bordetella pertussis IgG Ab [Presence] in Serum |
|
29659-0
|
Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay |
|
69367-1
|
Bordetella pertussis IgG Ab [Presence] in Serum by Immunoblot |
|
9363-3
|
Bordetella pertussis IgG Ab [Units/volume] in Serum |
|
25331-0
|
Bordetella pertussis IgG Ab [Titer] in Serum |
|
25352-6
|
Bordetella pertussis IgG Ab [Titer] in Serum by Immunofluorescence |
|
42329-3
|
Bordetella pertussis IgM Ab [Units/volume] in Serum by Immunoassay |
|
29673-1
|
Bordetella pertussis IgM Ab [Presence] in Serum |
|
29658-2
|
Bordetella pertussis IgM Ab [Presence] in Serum by Immunoassay |
|
69368-9
|
Bordetella pertussis IgM Ab [Presence] in Serum by Immunoblot |
|
9364-1
|
Bordetella pertussis IgM Ab [Units/volume] in Serum |
|
25332-8
|
Bordetella pertussis IgM Ab [Titer] in Serum |
|
25353-4
|
Bordetella pertussis IgM Ab [Titer] in Serum by Immunofluorescence |
|
48741-3
|
Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture |
|
43896-0
|
Bordetella pertussis [Presence] in Pleural fluid by Organism specific culture |
|
31267-8
|
Bordetella pertussis secretory IgA Ab [Presence] in Unspecified specimen |
|
24130-7
|
Bordetella pertussis secretory IgA Ab [Presence] in Unspecified specimen by Immunoassay |
|
43890-3
|
Bordetella pertussis [Presence] in Sputum by Organism specific culture |
|
548-8
|
Bordetella pertussis [Presence] in Throat by Organism specific culture |
|
549-6
|
Bordetella pertussis [Presence] in Unspecified specimen by Organism specific culture |
|
44047-9
|
Bordetella pertussis Yamaguchi Ab [Presence] in Serum |
|
74766-7
|
Bordetella pertussis.pertussis toxin 100 IgG Ab [Presence] in Serum by Line blot |
|
24128-1
|
Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum by Immunoassay |
|
74765-9
|
Bordetella pertussis.pertussis toxin IgA Ab [Presence] in Serum by Line blot |
|
23830-3
|
Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum |
|
24127-3
|
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunoassay |
|
46254-9
|
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
85684-9
|
Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Immunoassay |
|
69755-7
|
Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Line blot |
|
23831-1
|
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum |
|
33268-4
|
Bordetella pertussis.pertussis toxin IgG Ab [Mass/volume] in Serum |
|
24129-9
|
Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum by Immunoassay |
|
23832-9
|
Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum |
|
82179-3
|
Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection |
|
80600-0
|
Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with probe detection |
|
92857-2
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
85360-6
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92858-0
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
69753-2
|
Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgA Ab [Presence] in Serum by Line blot |
|
69754-0
|
Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgG Ab [Presence] in Serum by Line blot |
|
86325-8
|
Bordetella pertussis+parapertussis ptxS1 gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
80601-8
|
Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Nasopharynx by NAA with probe detection |
|
87401-6
|
Brachyspira pilosicoli DNA [Presence] in Isolate by NAA with probe detection |
|
87285-3
|
Brachyspira pilosicoli DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5287-8
|
Burkholderia pseudomallei Ab [Units/volume] in Serum by Hemagglutination |
|
11604-6
|
Burkholderia pseudomallei Ab [Units/volume] in Serum |
|
70855-2
|
Burkholderia pseudomallei Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
70852-9
|
Burkholderia pseudomallei DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
7988-9
|
Burkholderia pseudomallei IgG Ab [Units/volume] in Serum |
|
23965-7
|
Burkholderia pseudomallei IgG Ab [Titer] in Serum |
|
23988-9
|
Burkholderia pseudomallei IgG Ab [Titer] in Serum by Immunofluorescence |
|
43070-2
|
Burkholderia pseudomallei IgG Ab [Titer] in Unspecified specimen |
|
30090-5
|
Burkholderia pseudomallei IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
31276-9
|
Burkholderia pseudomallei IgG Ab [Units/volume] in Unspecified specimen |
|
7989-7
|
Burkholderia pseudomallei IgM Ab [Units/volume] in Serum |
|
23973-1
|
Burkholderia pseudomallei IgM Ab [Titer] in Serum |
|
23989-7
|
Burkholderia pseudomallei IgM Ab [Titer] in Serum by Immunofluorescence |
|
43069-4
|
Burkholderia pseudomallei IgM Ab [Titer] in Unspecified specimen |
|
30091-3
|
Burkholderia pseudomallei IgM Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
31277-7
|
Burkholderia pseudomallei IgM Ab [Units/volume] in Unspecified specimen |
|
70851-1
|
Burkholderia pseudomallei [Presence] in Unspecified specimen by Organism specific culture |
|
26677-5
|
Bartonella quintana Ab [Presence] in Serum |
|
91863-1
|
Bartonella quintana DNA [Presence] in Aspirate by NAA with probe detection |
|
16277-6
|
Bartonella quintana DNA [Presence] in Blood by NAA with probe detection |
|
89646-4
|
Bartonella quintana DNA [Presence] in Implanted device by NAA with probe detection |
|
89592-0
|
Bartonella quintana DNA [Presence] in Tissue by NAA with probe detection |
|
57910-2
|
Bartonella quintana DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17544-8
|
Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid |
|
16176-0
|
Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51816-7
|
Bartonella quintana IgG Ab [Units/volume] in Serum by Immunoassay |
|
32577-9
|
Bartonella quintana IgG Ab [Presence] in Serum |
|
8009-3
|
Bartonella quintana IgG Ab [Units/volume] in Serum |
|
48713-2
|
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
51451-3
|
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma |
|
23961-6
|
Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid |
|
23974-9
|
Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49202-5
|
Bartonella quintana IgG Ab [Titer] in Body fluid |
|
48884-1
|
Bartonella quintana IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9360-9
|
Bartonella quintana IgG Ab [Titer] in Serum |
|
44827-4
|
Bartonella quintana IgG Ab [Titer] in Serum by Immunofluorescence |
|
17545-5
|
Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid |
|
16177-8
|
Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51821-7
|
Bartonella quintana IgM Ab [Units/volume] in Serum by Immunoassay |
|
44823-3
|
Bartonella quintana IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
32578-7
|
Bartonella quintana IgM Ab [Presence] in Serum |
|
8010-1
|
Bartonella quintana IgM Ab [Units/volume] in Serum |
|
23960-8
|
Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid |
|
23975-6
|
Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49201-7
|
Bartonella quintana IgM Ab [Titer] in Body fluid |
|
48885-8
|
Bartonella quintana IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9361-7
|
Bartonella quintana IgM Ab [Titer] in Serum |
|
44825-8
|
Bartonella quintana IgM Ab [Titer] in Serum by Immunofluorescence |
|
17546-3
|
Bartonella quintana rRNA [Presence] in Unspecified specimen by Probe |
|
92787-1
|
Bacillus subtilis group DNA [Presence] by NAA with probe detection in Positive blood culture |
|
30023-6
|
Bacillus subtilis IgE Ab [Units/volume] in Serum |
|
22953-4
|
Brucella suis Ab [Units/volume] in Serum by Complement fixation |
|
16490-5
|
Brucella suis Ab [Units/volume] in Serum by Latex agglutination |
|
22951-8
|
Brucella suis Ab [Presence] in Serum |
|
22952-6
|
Brucella suis Ab [Presence] in Serum by Immunoassay |
|
22950-0
|
Brucella suis Ab [Presence] in Serum by Plate agglutination |
|
11589-9
|
Brucella suis Ab [Units/volume] in Serum |
|
22160-6
|
Brucella suis Ab [Titer] in Serum |
|
5071-6
|
Brucella suis Ab [Titer] in Serum by Latex agglutination |
|
71717-3
|
Brucella suis Ab [Titer] in Serum by Plate agglutination |
|
71716-5
|
Brucella suis Ab [Titer] in Serum by Tube agglutination |
|
22955-9
|
Brucella suis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22954-2
|
Brucella suis rRNA [Presence] in Unspecified specimen by Probe |
|
64979-8
|
Blomia tropicalis recombinant (rBlo t) 5 IgE Ab [Units/volume] in Serum |
|
10921-5
|
Blomia tropicalis IgE Ab [Units/volume] in Serum |
|
15581-2
|
Blomia tropicalis IgE Ab RAST class [Presence] in Serum |
|
48361-0
|
Borrelia valaisiana IgG Ab [Presence] in Serum by Immunoblot |
|
917-5
|
B variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
|
918-3
|
B variant subtype Ab [Presence] in Serum or Plasma from Donor |
|
919-1
|
B variant subtype Ab [Presence] in Serum or Plasma |
|
49197-7
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid |
|
48887-4
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49199-3
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum |
|
48847-8
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum by Immunofluorescence |
|
49198-5
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid |
|
48886-6
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49200-9
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum |
|
48846-0
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum by Immunofluorescence |
|
53588-0
|
Beta globulin+Gamma globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
|
53046-9
|
Beta globulin+Gamma globulin [Mass/volume] in Body fluid by Electrophoresis |
|
53051-9
|
Beta globulin+Gamma globulin/Protein.total in Body fluid by Electrophoresis |
|
44914-0
|
Beta globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
44913-2
|
Beta globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
73809-6
|
B cell+T cell crossmatch [Interpretation] Qualitative by Complement dependent cytotoxicity |
|
73808-8
|
B cell+T cell crossmatch [Interpretation] Qualitative by Flow cytometry (FC) |
|
73807-0
|
B cell+T cell crossmatch.autologous [Interpretation] Qualitative by Complement dependent cytotoxicity |
|
5272-0
|
Parvovirus B19 Ab [Units/volume] in Serum by Immunoassay |
|
7982-2
|
Parvovirus B19 Ab [Units/volume] in Serum |
|
49427-8
|
Parvovirus B19 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49428-6
|
Parvovirus B19 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49431-0
|
Parvovirus B19 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49430-2
|
Parvovirus B19 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49429-4
|
Parvovirus B19 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49434-4
|
Parvovirus B19 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49435-1
|
Parvovirus B19 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
91797-1
|
Parvovirus B19 DNA [#/volume] (viral load) in Upper respiratory specimen by NAA with probe detection |
|
49433-6
|
Parvovirus B19 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49432-8
|
Parvovirus B19 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
50349-0
|
Parvovirus B19 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
50348-2
|
Parvovirus B19 DNA [Presence] in Blood by NAA with probe detection |
|
50346-6
|
Parvovirus B19 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
50344-1
|
Parvovirus B19 DNA [Presence] in Body fluid by NAA with probe detection |
|
50347-4
|
Parvovirus B19 DNA [Presence] in Bone marrow by NAA with probe detection |
|
75541-3
|
Parvovirus B19 DNA [log units/volume] (viral load) in Plasma from Donor by NAA with probe detection |
|
75543-9
|
Parvovirus B19 DNA [Presence] in Plasma from Donor by NAA with probe detection |
|
9572-9
|
Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection |
|
74420-1
|
Parvovirus B19 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
74419-3
|
Parvovirus B19 DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
69355-6
|
Parvovirus B19 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
91796-3
|
Parvovirus B19 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
50345-8
|
Parvovirus B19 DNA [Presence] in Urine by NAA with probe detection |
|
9571-1
|
Parvovirus B19 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32793-2
|
Parvovirus B19 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
32838-5
|
Parvovirus B19 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
58757-6
|
Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31557-2
|
Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
53885-0
|
Parvovirus B19 IgG Ab [Units/volume] in Body fluid |
|
5273-8
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay |
|
29675-6
|
Parvovirus B19 IgG Ab [Presence] in Serum |
|
29660-8
|
Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay |
|
40657-9
|
Parvovirus B19 IgG Ab [Presence] in Serum by Immunofluorescence |
|
7983-0
|
Parvovirus B19 IgG Ab [Units/volume] in Serum |
|
32826-0
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
32836-9
|
Parvovirus B19 IgG Ab [Units/volume] in Serum --1st specimen |
|
32792-4
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
32837-7
|
Parvovirus B19 IgG Ab [Units/volume] in Serum --2nd specimen |
|
27095-9
|
Parvovirus B19 IgG Ab [Titer] in Cerebral spinal fluid |
|
25630-5
|
Parvovirus B19 IgG Ab [Titer] in Serum |
|
25729-5
|
Parvovirus B19 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17422-7
|
Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum |
|
58737-8
|
Parvovirus B19 IgG and IgM [Interpretation] in Serum |
|
32796-5
|
Parvovirus B19 IgM Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
32840-1
|
Parvovirus B19 IgM Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
58756-8
|
Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31558-0
|
Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
53886-8
|
Parvovirus B19 IgM Ab [Units/volume] in Body fluid |
|
5274-6
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay |
|
7981-4
|
Parvovirus B19 IgM Ab [Presence] in Serum |
|
40658-7
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay |
|
6517-7
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoblot |
|
40659-5
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7984-8
|
Parvovirus B19 IgM Ab [Units/volume] in Serum |
|
32794-0
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
41129-8
|
Parvovirus B19 IgM Ab [Units/volume] in Serum --1st specimen |
|
32795-7
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
32839-3
|
Parvovirus B19 IgM Ab [Units/volume] in Serum --2nd specimen |
|
27115-5
|
Parvovirus B19 IgM Ab [Titer] in Cerebral spinal fluid |
|
25631-3
|
Parvovirus B19 IgM Ab [Titer] in Serum |
|
25730-3
|
Parvovirus B19 IgM Ab [Titer] in Serum by Immunofluorescence |
|
5030-2
|
Parvovirus B19 RNA [Presence] in Blood by NAA with probe detection |
|
5031-0
|
Parvovirus B19 RNA [Presence] in Tissue by NAA with probe detection |
|
5032-8
|
Parvovirus B19 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
56538-2
|
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by Immunoassay |
|
31256-1
|
Beta 2 glycoprotein 1 Ab [Presence] in Serum |
|
27817-6
|
Beta 2 glycoprotein 1 Ab [Presence] in Serum by Immunoassay |
|
40456-6
|
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum |
|
43915-8
|
Beta 2 glycoprotein 1 IgA Ab [Presence] in Serum |
|
21108-6
|
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum |
|
44447-1
|
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
43914-1
|
Beta 2 glycoprotein 1 IgG Ab [Presence] in Serum |
|
16135-6
|
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
|
44448-9
|
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
43916-6
|
Beta 2 glycoprotein 1 IgM Ab [Presence] in Serum |
|
16136-4
|
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
|
44449-7
|
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
1880-4
|
Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma |
|
54356-1
|
Beta-2-Microglobulin [Mass/volume] in 24 hour Urine |
|
10873-8
|
Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
|
50824-2
|
Beta-2-Microglobulin [Moles/volume] in 24 hour Urine |
|
56662-0
|
Beta-2-Microglobulin [Moles/time] in 24 hour Urine |
|
43919-0
|
Beta-2-Microglobulin [Presence] in Cerebral spinal fluid |
|
54355-3
|
Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum |
|
1951-3
|
Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid |
|
32301-4
|
Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid |
|
88711-7
|
Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid |
|
49081-3
|
Beta-2-Microglobulin [Mass/volume] in Dialysis fluid |
|
48166-3
|
Beta-2-Microglobulin [Mass/volume] in Body fluid |
|
39458-5
|
Beta-2-Microglobulin [Moles/volume] in Body fluid |
|
87708-4
|
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis |
|
59218-8
|
Beta-2-Microglobulin [Mass/volume] in Pleural fluid |
|
59217-0
|
Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid |
|
43818-4
|
Beta-2-Microglobulin [Presence] in Serum |
|
83076-0
|
Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay |
|
83078-6
|
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay |
|
1952-1
|
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
|
76484-5
|
Beta-2-Microglobulin [Moles/volume] in Serum or Plasma |
|
14626-6
|
Beta-2-Microglobulin [Moles/volume] in Serum |
|
56786-7
|
Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum |
|
83079-4
|
Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay |
|
83077-8
|
Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay |
|
43819-2
|
Beta-2-Microglobulin [Presence] in Urine |
|
1953-9
|
Beta-2-Microglobulin [Mass/volume] in Urine |
|
32302-2
|
Beta-2-Microglobulin [Moles/volume] in Urine |
|
44303-6
|
Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine |
|
93729-2
|
Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine |
|
13485-8
|
Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
|
59177-6
|
Beta-2-Microglobulin/Creatinine [Ratio] in Urine |
|
39773-7
|
Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine |
|
40610-8
|
Beta-2 transferrin [Presence] in Cerebral spinal fluid |
|
53559-1
|
Beta-2 transferrin [Mass/volume] in Cerebral spinal fluid |
|
13876-8
|
Beta-2 transferrin [Presence] in Body fluid |
|
51831-6
|
Beta-2 transferrin [Mass/volume] in Body fluid |
|
43867-1
|
Beta-2 transferrin [Presence] in Serum |
|
43858-0
|
Beta-2 transferrin [Presence] in Unspecified specimen |
|
10467-9
|
Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
|
89321-4
|
Buprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method |
|
91027-3
|
Buprenorphine-3-glucuronide [Presence] in Urine by Screen method |
|
28592-4
|
Beta aminoadipate/Creatinine [Ratio] in Urine |
|
27997-6
|
Beta aminoadipate/Creatinine [Molar ratio] in Urine |
|
89342-0
|
Babesia sp 18S rRNA [Presence] in Blood by NAA with probe detection |
|
43926-5
|
Babesia sp Ab [Presence] in Serum |
|
7813-9
|
Babesia sp Ab [Units/volume] in Serum |
|
22106-9
|
Babesia sp Ab [Titer] in Serum |
|
23666-1
|
Babesia sp Ab [Titer] in Serum by Complement fixation |
|
5054-2
|
Babesia sp Ab [Titer] in Serum by Immunofluorescence |
|
10647-6
|
Babesia sp identified in Blood by Thick film |
|
10648-4
|
Babesia sp identified in Blood by Thin film |
|
88233-2
|
Babesia sp DNA [Presence] in Blood by NAA with probe detection |
|
22857-7
|
Babesia sp DNA [Presence] in Tissue by NAA with probe detection |
|
42641-1
|
Babesia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
42581-9
|
Babesia sp IgG Ab [Presence] in Serum |
|
31246-2
|
Babesia sp IgG Ab [Units/volume] in Serum |
|
22107-7
|
Babesia sp IgG Ab [Titer] in Serum |
|
9584-4
|
Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
16425-1
|
Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
42580-1
|
Babesia sp IgM Ab [Presence] in Serum |
|
22108-5
|
Babesia sp IgM Ab [Units/volume] in Serum |
|
16426-9
|
Babesia sp IgM Ab [Titer] in Serum |
|
9585-1
|
Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
82748-5
|
Erythrocytes.Babesia sp infected/100 erythrocytes in Blood |
|
22856-9
|
Babesia sp rRNA [Presence] in Tissue by Probe |
|
22858-5
|
Babesia sp identified in Tissue by Giemsa stain |
|
67867-2
|
Babesia sp identified in Unspecified specimen |
|
55620-9
|
Bacampicillin [Susceptibility] by Gradient strip |
|
49-7
|
Bacampicillin [Susceptibility] by Disk diffusion (KB) |
|
48-9
|
Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
47-1
|
Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18869-8
|
Bacampicillin [Susceptibility] |
|
50-5
|
Bacampicillin [Susceptibility] by Serum bactericidal titer |
|
88339-7
|
Bacilliform bacteria [Presence] in Ear by Light microscopy |
|
6983-1
|
Bacitracin [Susceptibility] by Gradient strip |
|
10868-8
|
Bacitracin [Susceptibility] by Disk diffusion (KB) |
|
6827-0
|
Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
16428-5
|
Bacitracin [Mass/volume] in Serum or Plasma |
|
18870-6
|
Bacitracin [Susceptibility] |
|
87603-7
|
Bacitracin zinc [Mass/mass] in Unspecified specimen |
|
71529-2
|
Back up NPI Dialysis facility [ESRD] |
|
18280-8
|
Background stain [Presence] in Blood by Light microscopy |
|
74391-4
|
Baclofen [Mass/volume] in Blood |
|
79224-2
|
Baclofen [Mass/volume] in Body fluid |
|
78802-6
|
Baclofen [Mass/mass] in Hair |
|
43897-8
|
Baclofen [Presence] in Serum or Plasma |
|
9353-4
|
Baclofen [Mass/volume] in Serum or Plasma |
|
75227-9
|
Baclofen [Mass/volume] in Urine |
|
74377-3
|
Baclofen [Mass/volume] in Unknown substance |
|
74390-6
|
Baclofen [Mass/mass] in Unspecified specimen |
|
80614-1
|
Baclofen [Moles/volume] in Unspecified specimen |
|
87773-8
|
Baclofen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
76603-0
|
Bacterial 16S rRNA [#/volume] in XXX.body fluid by NAA with probe detection |
|
76575-0
|
Bacterial 16S rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76590-9
|
Bacterial 16S rRNA [#/mass] in XXX.tissue by NAA with probe detection |
|
89314-9
|
Bacterial 23S rRNA gene azithromycin resistance mutation [Presence] by Molecular method |
|
73733-8
|
Bacteria biotype [Type] in Isolate |
|
20695-3
|
Bacteria [#/volume] in Mother's milk |
|
51480-2
|
Bacteria [#/volume] in Urine by Automated count |
|
33218-9
|
Bacteria [#/area] in Urine sediment by Automated count |
|
5769-5
|
Bacteria [#/area] in Urine sediment by Microscopy high power field |
|
13315-7
|
Bacteria identified in 24 hour Urine by Culture |
|
595-9
|
Bacteria identified in Abscess by Aerobe culture |
|
75357-4
|
Bacteria identified in Abscess by Anaerobe+Aerobe culture |
|
87929-6
|
Bacteria identified in Amniotic fluid by Aerobe culture |
|
87933-8
|
Bacteria identified in Amniotic fluid by Anaerobe culture |
|
596-7
|
Bacteria identified in Amniotic fluid by Culture |
|
52966-9
|
Bacteria identified in Anal by Culture |
|
68985-1
|
Bacteria antigenic formula [Identifier] in Isolate |
|
45038-7
|
Bacteria producing arginine decarboxylase [Presence] in Isolate |
|
597-5
|
Bacteria identified in Aspirate by Aerobe culture |
|
598-3
|
Bacteria identified in Aspirate by Anaerobe culture |
|
43411-8
|
Bacteria identified in Aspirate by Culture |
|
43441-5
|
Bacteria identified in Bronchoalveolar lavage by Aerobe culture |
|
88683-8
|
Bacteria identified in Bronchoalveolar lavage by Anaerobe culture |
|
74355-9
|
Bacteria identified in Bartholin cyst by Aerobe culture |
|
90270-0
|
Bacteria identified in Bile fluid by Aerobe culture |
|
87934-6
|
Bacteria identified in Bile fluid by Anaerobe culture |
|
53911-4
|
Bacteria identified in Bile fluid by Culture |
|
45337-3
|
Bacterial biochemical profile [Identifier] in Isolate by Culture |
|
17928-3
|
Bacteria identified in Blood by Aerobe culture |
|
45275-5
|
Bacteria identified in Blood by Aerobe culture 25 degree C incubation |
|
17929-1
|
Bacteria # 2 identified in Blood by Aerobe culture |
|
17930-9
|
Bacteria # 3 identified in Blood by Aerobe culture |
|
17931-7
|
Bacteria # 4 identified in Blood by Aerobe culture |
|
17932-5
|
Bacteria # 5 identified in Blood by Aerobe culture |
|
17933-3
|
Bacteria # 6 identified in Blood by Aerobe culture |
|
17934-1
|
Bacteria identified in Blood by Anaerobe culture |
|
45276-3
|
Bacteria identified in Blood by Anaerobe culture 25 degree C incubation |
|
17935-8
|
Bacteria # 2 identified in Blood by Anaerobe culture |
|
17936-6
|
Bacteria # 3 identified in Blood by Anaerobe culture |
|
600-7
|
Bacteria identified in Blood by Culture |
|
48727-2
|
Bacteria # 2 identified in Blood by Culture |
|
48724-9
|
Bacteria # 3 identified in Blood by Culture |
|
87954-4
|
Bacteria identified in Cord blood by Aerobe culture |
|
87955-1
|
Bacteria identified in Cord blood by Anaerobe culture |
|
602-3
|
Bacteria identified in Bone by Aerobe culture |
|
17873-1
|
Bacteria # 2 identified in Bone by Aerobe culture |
|
17874-9
|
Bacteria # 3 identified in Bone by Aerobe culture |
|
17875-6
|
Bacteria # 4 identified in Bone by Aerobe culture |
|
17876-4
|
Bacteria # 5 identified in Bone by Aerobe culture |
|
17877-2
|
Bacteria # 6 identified in Bone by Aerobe culture |
|
75358-2
|
Bacteria identified in Bone by Anaerobe+Aerobe culture |
|
74348-4
|
Bacteria identified in Bone from Donor by Aerobe culture |
|
599-1
|
Bacteria identified in Blood product unit by Aerobe culture |
|
87935-3
|
Bacteria identified in Blood product unit by Anaerobe culture |
|
68366-4
|
Bacteria identified in Blood product unit by Culture |
|
76693-1
|
Bacteria identified in Blood product unit.autologous by Culture |
|
43442-3
|
Bacteria identified in Bronchial brush by Aerobe culture |
|
32810-4
|
Bacteria identified in Bronchial specimen |
|
604-9
|
Bacteria identified in Bronchial specimen by Aerobe culture |
|
17878-0
|
Bacteria # 2 identified in Bronchial specimen by Aerobe culture |
|
17879-8
|
Bacteria # 3 identified in Bronchial specimen by Aerobe culture |
|
17880-6
|
Bacteria # 4 identified in Bronchial specimen by Aerobe culture |
|
17881-4
|
Bacteria # 5 identified in Bronchial specimen by Aerobe culture |
|
17882-2
|
Bacteria # 6 identified in Bronchial specimen by Aerobe culture |
|
87930-4
|
Bacteria identified in Burn by Aerobe culture |
|
87936-1
|
Bacteria identified in Burn by Anaerobe culture |
|
603-1
|
Bacteria identified in Burn by Culture |
|
17937-4
|
Bacteria # 2 identified in Burn by Culture |
|
17938-2
|
Bacteria # 3 identified in Burn by Culture |
|
17939-0
|
Bacteria # 4 identified in Burn by Culture |
|
17940-8
|
Bacteria # 5 identified in Burn by Culture |
|
17941-6
|
Bacteria # 6 identified in Burn by Culture |
|
605-6
|
Bacteria identified in Cannula specimen by Aerobe culture |
|
45034-6
|
Bacteria producing catalase [Presence] in Isolate |
|
90274-2
|
Bacteria identified in Catheter tip by Aerobe culture |
|
90273-4
|
Bacteria identified in Catheter tip by Anaerobe culture |
|
19128-8
|
Bacteria identified in Catheter tip by Culture |
|
56714-9
|
Bacteria identified in Contact lens by Culture |
|
73670-2
|
Bacteria producing coagulase and protein A [Presence] in Isolate by Latex agglutination |
|
88142-5
|
Bacteria identified in Cornea or Conjunctiva by Aerobe culture |
|
60257-3
|
Bacteria identified in Cornea by Culture |
|
88236-5
|
Bacteria identified in Cerebral spinal fluid by Aerobe culture |
|
87937-9
|
Bacteria identified in Cerebral spinal fluid by Anaerobe culture |
|
606-4
|
Bacteria identified in Cerebral spinal fluid by Culture |
|
75518-1
|
Bacteria identified in Cerebral spinal fluid by Latex agglutination |
|
41602-4
|
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy |
|
14475-8
|
Bacteria identified in Cervix by Aerobe culture |
|
12281-2
|
Bacteria identified in Cervix by Anaerobe culture |
|
43410-0
|
Bacteria identified in Cervix by Culture |
|
44022-2
|
Bacteria [Presence] in Cervix by Wet preparation |
|
17909-3
|
Bacteria identified in Wound deep by Aerobe culture |
|
17910-1
|
Bacteria # 2 identified in Wound deep by Aerobe culture |
|
17911-9
|
Bacteria # 3 identified in Wound deep by Aerobe culture |
|
17912-7
|
Bacteria # 4 identified in Wound deep by Aerobe culture |
|
17913-5
|
Bacteria # 5 identified in Wound deep by Aerobe culture |
|
17914-3
|
Bacteria # 6 identified in Wound deep by Aerobe culture |
|
17925-9
|
Bacteria identified in Wound deep by Anaerobe culture |
|
17926-7
|
Bacteria # 2 identified in Wound deep by Anaerobe culture |
|
17927-5
|
Bacteria # 3 identified in Wound deep by Anaerobe culture |
|
43407-6
|
Bacteria identified in Wound deep by Culture |
|
90280-9
|
Bacteria identified in Peritoneal dialysis fluid by Aerobe culture |
|
90277-5
|
Bacteria identified in Peritoneal dialysis fluid by Anaerobe culture |
|
60032-0
|
Bacteria identified in Peritoneal dialysis fluid by Culture |
|
9822-8
|
Bacteria identified in Dialysis fluid by Culture |
|
73669-4
|
Bacteria producing DNAse [Presence] in Isolate |
|
607-2
|
Bacteria identified in Drain by Aerobe culture |
|
53617-7
|
Bacteria identified in Duodenal fluid by Aerobe culture |
|
53614-4
|
Bacteria # 2 identified in Duodenal fluid by Aerobe culture |
|
53615-1
|
Bacteria # 3 identified in Duodenal fluid by Aerobe culture |
|
53616-9
|
Bacteria # 4 identified in Duodenal fluid by Aerobe culture |
|
608-0
|
Bacteria identified in Ear by Aerobe culture |
|
20694-6
|
Bacteria identified in Embryo by Aerobe culture |
|
53908-0
|
Bacteria identified in Esophageal brushing by Culture |
|
609-8
|
Bacteria identified in Eye by Aerobe culture |
|
74816-0
|
Bacteria identified in Eye by Anaerobe+Aerobe culture |
|
44039-6
|
Bacteria [Presence] in Eye by Light microscopy |
|
610-6
|
Bacteria identified in Body fluid by Aerobe culture |
|
17951-5
|
Bacteria # 2 identified in Body fluid by Aerobe culture |
|
17952-3
|
Bacteria # 3 identified in Body fluid by Aerobe culture |
|
17953-1
|
Bacteria # 4 identified in Body fluid by Aerobe culture |
|
17954-9
|
Bacteria # 5 identified in Body fluid by Aerobe culture |
|
17955-6
|
Bacteria # 6 identified in Body fluid by Aerobe culture |
|
17956-4
|
Bacteria identified in Body fluid by Anaerobe culture |
|
17957-2
|
Bacteria # 2 identified in Body fluid by Anaerobe culture |
|
17958-0
|
Bacteria # 3 identified in Body fluid by Anaerobe culture |
|
611-4
|
Bacteria identified in Body fluid by Culture |
|
41599-2
|
Bacteria [Presence] in Body fluid by Light microscopy |
|
6459-2
|
Bacteria identified in Food by Culture |
|
52967-7
|
Bacteria identified in Gastric fluid by Culture |
|
10352-3
|
Bacteria identified in Genital specimen by Aerobe culture |
|
17883-0
|
Bacteria # 2 identified in Genital specimen by Aerobe culture |
|
17884-8
|
Bacteria # 3 identified in Genital specimen by Aerobe culture |
|
17885-5
|
Bacteria # 4 identified in Genital specimen by Aerobe culture |
|
17886-3
|
Bacteria # 5 identified in Genital specimen by Aerobe culture |
|
17887-1
|
Bacteria # 6 identified in Genital specimen by Aerobe culture |
|
47293-6
|
Bacteria # 7 identified in Genital specimen by Aerobe culture |
|
91865-6
|
Bacteria identified in Genital specimen by Anaerobe culture |
|
75269-1
|
Bacteria identified in Genital specimen by Anaerobe+Aerobe culture |
|
12178-0
|
Bacteria [Presence] in Genital specimen by Wet preparation |
|
45336-5
|
Bacteria producing hemolysis [Presence] in Isolate |
|
73667-8
|
Bacteria producing hippuricase [Presence] in Isolate |
|
45335-7
|
Bacteria Identification [Presence] in Isolate by Culture |
|
87931-2
|
Bacteria identified in Implanted device by Aerobe culture |
|
87938-7
|
Bacteria identified in Implanted device by Anaerobe culture |
|
78356-3
|
Bacteria identified in Implanted device by Culture |
|
45044-5
|
Bacteria producing indole [Presence] in Isolate |
|
42803-7
|
Bacteria identified in Isolate |
|
32367-5
|
Bacteria identified in Isolate by Aerobe culture |
|
20878-5
|
Bacteria identified in Isolate by Anaerobe culture |
|
20877-7
|
Bacteria identified in Isolate by Animal inoculation |
|
43409-2
|
Bacteria identified in Isolate by Culture |
|
75756-7
|
Bacteria identified in Isolate by MS.MALDI-TOF |
|
42661-9
|
Bacteria identified in Isolate by Pulsed-Field Gel Electrophoresis (PFGE) |
|
612-2
|
Bacterial strain [Type] in Isolate by Bacteria subtyping |
|
616-3
|
Bacteria identified in Line specimen by IV Line culture |
|
17942-4
|
Bacteria # 2 identified in Line specimen by IV Line culture |
|
17943-2
|
Bacteria # 3 identified in Line specimen by IV Line culture |
|
17944-0
|
Bacteria # 4 identified in Line specimen by IV Line culture |
|
17945-7
|
Bacteria # 5 identified in Line specimen by IV Line culture |
|
17946-5
|
Bacteria # 6 identified in Line specimen by IV Line culture |
|
20693-8
|
Bacteria identified in Litter by Aerobe culture |
|
89643-1
|
Bacteria identified in Lower respiratory specimen by Aerobe culture |
|
89644-9
|
Bacteria identified in Lower respiratory specimen by Anaerobe culture |
|
79425-5
|
Bacteria identified in Lower respiratory specimen by Cystic fibrosis respiratory culture |
|
19126-2
|
Bacteria identified in Bone marrow by Aerobe culture |
|
75359-0
|
Bacteria identified in Bone marrow by Anaerobe+Aerobe culture |
|
60258-1
|
Bacteria identified in Bone marrow by Culture |
|
20879-3
|
Bacteria identified in Milk by Aerobe culture |
|
91866-4
|
Bacteria identified in Mouth by Aerobe culture |
|
73960-7
|
Bacteria identified in Mouth by Culture |
|
10353-1
|
Bacteria identified in Nose by Aerobe culture |
|
17888-9
|
Bacteria # 2 identified in Nose by Aerobe culture |
|
17889-7
|
Bacteria # 3 identified in Nose by Aerobe culture |
|
17890-5
|
Bacteria # 4 identified in Nose by Aerobe culture |
|
17891-3
|
Bacteria # 5 identified in Nose by Aerobe culture |
|
17892-1
|
Bacteria # 6 identified in Nose by Aerobe culture |
|
17921-8
|
Bacteria # 2 identified in Nose by Anaerobe culture |
|
17922-6
|
Bacteria # 3 identified in Nose by Anaerobe culture |
|
18192-5
|
Bacteria [Presence] in Nose by Light microscopy |
|
43426-6
|
Bacteria identified in Nasopharynx by Aerobe culture |
|
43214-6
|
Bacteria identified in Nasopharynx by Culture |
|
88141-7
|
Bacteria identified in Ocular fluid by Aerobe culture |
|
88139-1
|
Bacteria identified in Ocular fluid by Anaerobe culture |
|
45036-1
|
Bacteria producing oxidase [Presence] in Isolate |
|
90271-8
|
Bacteria identified in Pericardial fluid by Aerobe culture |
|
87939-5
|
Bacteria identified in Pericardial fluid by Anaerobe culture |
|
56715-6
|
Bacteria identified in Pericardial fluid by Culture |
|
41598-4
|
Bacteria [Presence] in Pericardial fluid by Light microscopy |
|
14478-2
|
Bacteria identified in Penis by Aerobe culture |
|
617-1
|
Bacteria identified in Placenta by Aerobe culture |
|
87941-1
|
Bacteria identified in Placenta by Anaerobe culture |
|
17279-1
|
Bacteria identified in Pleural fluid by Aerobe culture |
|
87942-9
|
Bacteria identified in Pleural fluid by Anaerobe culture |
|
618-9
|
Bacteria identified in Pleural fluid by Culture |
|
41603-2
|
Bacteria [Presence] in Pleural fluid by Light microscopy |
|
91063-8
|
Bacteria identified in Platelets from Blood product unit by Aerobe culture |
|
91062-0
|
Bacteria identified in Platelets from Blood product unit by Anaerobe culture |
|
72340-3
|
Bacteria [Presence] in Prostatic fluid by Light microscopy |
|
90281-7
|
Bacteria identified in Peritoneal fluid by Aerobe culture |
|
87940-3
|
Bacteria identified in Peritoneal fluid by Anaerobe culture |
|
619-7
|
Bacteria identified in Peritoneal fluid by Culture |
|
17959-8
|
Bacteria # 2 identified in Peritoneal fluid by Culture |
|
17960-6
|
Bacteria # 3 identified in Peritoneal fluid by Culture |
|
17961-4
|
Bacteria # 4 identified in Peritoneal fluid by Culture |
|
17962-2
|
Bacteria # 5 identified in Peritoneal fluid by Culture |
|
17963-0
|
Bacteria # 6 identified in Peritoneal fluid by Culture |
|
41601-6
|
Bacteria [Presence] in Peritoneal fluid by Light microscopy |
|
17915-0
|
Bacteria identified in Wound shallow by Aerobe culture |
|
17916-8
|
Bacteria # 2 identified in Wound shallow by Aerobe culture |
|
17917-6
|
Bacteria # 3 identified in Wound shallow by Aerobe culture |
|
17918-4
|
Bacteria # 4 identified in Wound shallow by Aerobe culture |
|
17919-2
|
Bacteria # 5 identified in Wound shallow by Aerobe culture |
|
17920-0
|
Bacteria # 6 identified in Wound shallow by Aerobe culture |
|
47294-4
|
Bacteria # 7 identified in Wound shallow by Aerobe culture |
|
47295-1
|
Bacteria # 8 identified in Wound shallow by Aerobe culture |
|
87932-0
|
Bacteria identified in Sinus by Aerobe culture |
|
87943-7
|
Bacteria identified in Sinus by Anaerobe culture |
|
43307-8
|
Bacteria identified in Sinus by Culture |
|
620-5
|
Bacteria identified in Skin by Aerobe culture |
|
13314-0
|
Bacteria identified in Semen |
|
90279-1
|
Bacteria identified in Semen by Aerobe culture |
|
90276-7
|
Bacteria identified in Semen by Anaerobe culture |
|
53558-3
|
Bacteria identified in Semen by Culture |
|
14124-2
|
Bacteria [Presence] in Semen by Light microscopy |
|
90278-3
|
Bacteria identified in Synovial fluid by Aerobe culture |
|
87944-5
|
Bacteria identified in Synovial fluid by Anaerobe culture |
|
621-3
|
Bacteria identified in Synovial fluid by Culture |
|
11101-3
|
Bacteria [#/area] in Synovial fluid by Microscopy high power field |
|
41600-8
|
Bacteria [Presence] in Synovial fluid by Light microscopy |
|
73668-6
|
Bacteria soluble by bile [Presence] in Isolate |
|
622-1
|
Bacteria identified in Sputum by Aerobe culture |
|
17893-9
|
Bacteria # 2 identified in Sputum by Aerobe culture |
|
17894-7
|
Bacteria # 3 identified in Sputum by Aerobe culture |
|
17895-4
|
Bacteria # 4 identified in Sputum by Aerobe culture |
|
17896-2
|
Bacteria # 5 identified in Sputum by Aerobe culture |
|
17897-0
|
Bacteria # 6 identified in Sputum by Aerobe culture |
|
19127-0
|
Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture |
|
623-9
|
Bacteria identified in Sputum by Cystic fibrosis respiratory culture |
|
6460-0
|
Bacteria identified in Sputum by Culture |
|
624-7
|
Bacteria identified in Sputum by Respiratory culture |
|
52973-5
|
Bacteria identified in Sputum tracheal aspirate by Culture |
|
6461-8
|
Bacteria identified in Stool by Anaerobe culture |
|
625-4
|
Bacteria identified in Stool by Culture |
|
17964-8
|
Bacteria # 2 identified in Stool by Culture |
|
17965-5
|
Bacteria # 3 identified in Stool by Culture |
|
17966-3
|
Bacteria # 4 identified in Stool by Culture |
|
17967-1
|
Bacteria # 5 identified in Stool by Culture |
|
17968-9
|
Bacteria # 6 identified in Stool by Culture |
|
17898-8
|
Bacteria identified in Throat by Aerobe culture |
|
17899-6
|
Bacteria # 2 identified in Throat by Aerobe culture |
|
17900-2
|
Bacteria # 3 identified in Throat by Aerobe culture |
|
17901-0
|
Bacteria # 4 identified in Throat by Aerobe culture |
|
17902-8
|
Bacteria # 5 identified in Throat by Aerobe culture |
|
17903-6
|
Bacteria # 6 identified in Throat by Aerobe culture |
|
626-2
|
Bacteria identified in Throat by Culture |
|
627-0
|
Bacteria identified in Tissue by Aerobe culture |
|
17904-4
|
Bacteria # 2 identified in Tissue by Aerobe culture |
|
17905-1
|
Bacteria # 3 identified in Tissue by Aerobe culture |
|
17906-9
|
Bacteria # 4 identified in Tissue by Aerobe culture |
|
17907-7
|
Bacteria # 5 identified in Tissue by Aerobe culture |
|
17908-5
|
Bacteria # 6 identified in Tissue by Aerobe culture |
|
628-8
|
Bacteria identified in Tissue by Anaerobe culture |
|
17923-4
|
Bacteria # 2 identified in Tissue by Anaerobe culture |
|
17924-2
|
Bacteria # 3 identified in Tissue by Anaerobe culture |
|
59051-3
|
Bacteria # 4 identified in Tissue by Anaerobe culture |
|
20474-3
|
Bacteria identified in Tissue by Biopsy culture |
|
43408-4
|
Bacteria identified in Tissue by Culture |
|
58940-8
|
Bacteria identified in Total parental nutrition by Culture |
|
91819-3
|
Bacteria identified in Upper respiratory specimen by Aerobe culture |
|
91818-5
|
Bacteria identified in Upper respiratory specimen by Anaerobe culture |
|
630-4
|
Bacteria identified in Urine by Culture |
|
17970-5
|
Bacteria # 2 identified in Urine by Culture |
|
17971-3
|
Bacteria # 3 identified in Urine by Culture |
|
17972-1
|
Bacteria # 4 identified in Urine by Culture |
|
17973-9
|
Bacteria # 5 identified in Urine by Culture |
|
17974-7
|
Bacteria # 6 identified in Urine by Culture |
|
44847-2
|
Bacteria # 7 identified in Urine by Culture |
|
44849-8
|
Bacteria # 8 identified in Urine by Culture |
|
87829-8
|
Bacteria [Presence] in Urine |
|
50221-1
|
Bacteria [Presence] in Urine by Automated |
|
45037-9
|
Bacteria producing urease [Presence] in Isolate |
|
25145-4
|
Bacteria [Presence] in Urine sediment by Light microscopy |
|
14477-4
|
Bacteria identified in Urethra by Aerobe culture |
|
10354-9
|
Bacteria identified in Urethra by Culture |
|
631-2
|
Bacteria identified in Unknown substance by Aerobe culture |
|
77193-1
|
Bacteria identified in Uterus by Culture |
|
11261-5
|
Bacteria identified in Vaginal fluid by Aerobe culture |
|
44023-0
|
Bacteria [Presence] in Vaginal fluid by Wet preparation |
|
44243-4
|
Bacteria [#/area] in Vaginal fluid by Wet preparation |
|
74356-7
|
Bacteria identified in Ventriculoperitoneal (VP) shunt by Culture |
|
14093-9
|
Bacteria identified in Water by Culture |
|
632-0
|
Bacteria identified in Wound by Aerobe culture |
|
633-8
|
Bacteria identified in Wound by Anaerobe culture |
|
6462-6
|
Bacteria identified in Wound by Culture |
|
45046-0
|
Bacteria producing X and V factors [Presence] in Isolate |
|
23667-9
|
Bacteria identified in Unspecified specimen |
|
634-6
|
Bacteria identified in Unspecified specimen by Aerobe culture |
|
48567-2
|
Bacteria # 3 identified in Unspecified specimen by Aerobe culture |
|
48568-0
|
Bacteria # 7 identified in Unspecified specimen by Aerobe culture |
|
48569-8
|
Bacteria # 8 identified in Unspecified specimen by Aerobe culture |
|
635-3
|
Bacteria identified in Unspecified specimen by Anaerobe culture |
|
44843-1
|
Bacteria # 2 identified in Unspecified specimen by Anaerobe culture |
|
44853-0
|
Bacteria # 3 identified in Unspecified specimen by Anaerobe culture |
|
44856-3
|
Bacteria # 4 identified in Unspecified specimen by Anaerobe culture |
|
44857-1
|
Bacteria # 5 identified in Unspecified specimen by Anaerobe culture |
|
44858-9
|
Bacteria # 6 identified in Unspecified specimen by Anaerobe culture |
|
44859-7
|
Bacteria # 7 identified in Unspecified specimen by Anaerobe culture |
|
21020-3
|
Bacteria identified in Unspecified specimen by Anaerobe+Aerobe culture |
|
636-1
|
Bacteria identified in Unspecified specimen by Sterile body fluid culture |
|
6463-4
|
Bacteria identified in Unspecified specimen by Culture |
|
44841-5
|
Bacteria # 2 identified in Unspecified specimen by Culture |
|
44842-3
|
Bacteria # 3 identified in Unspecified specimen by Culture |
|
44844-9
|
Bacteria # 4 identified in Unspecified specimen by Culture |
|
44845-6
|
Bacteria # 5 identified in Unspecified specimen by Culture |
|
44846-4
|
Bacteria # 6 identified in Unspecified specimen by Culture |
|
44848-0
|
Bacteria # 7 identified in Unspecified specimen by Culture |
|
44850-6
|
Bacteria # 8 identified in Unspecified specimen by Culture |
|
14325-5
|
Bacteria identified in Unspecified specimen by Environmental culture |
|
44038-8
|
Bacteria [Presence] in Unspecified specimen |
|
32763-5
|
Bacteria [Presence] in Unspecified specimen by Wet preparation |
|
32355-0
|
Bacteria identified in Unspecified specimen by Respiratory culture |
|
48561-5
|
Bacteria # 2 identified in Unspecified specimen by Respiratory culture |
|
48562-3
|
Bacteria # 3 identified in Unspecified specimen by Respiratory culture |
|
48563-1
|
Bacteria # 4 identified in Unspecified specimen by Respiratory culture |
|
48564-9
|
Bacteria # 5 identified in Unspecified specimen by Respiratory culture |
|
48565-6
|
Bacteria # 6 identified in Unspecified specimen by Respiratory culture |
|
48566-4
|
Bacteria # 7 identified in Unspecified specimen by Respiratory culture |
|
73834-4
|
Bacteria.carbapenem resistant identified in Anal by Organism specific culture |
|
73835-1
|
Bacteria.extended spectrum beta lactamase resistant identified in Anal by Organism specific culture |
|
73836-9
|
Bacteria.fluoroquinolone resistant identified in Anal by Organism specific culture |
|
94057-7
|
Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method |
|
52107-0
|
Bacterial capsule [Identifier] in Unspecified specimen by Light microscopy |
|
53128-5
|
Bacterial casts [#/area] in Urine sediment by Microscopy low power field |
|
33784-0
|
Bacterial casts [Presence] in Urine sediment by Light microscopy |
|
94064-3
|
Bacterial eis gene drug resistance mutation [Identifier] by Molecular method |
|
94058-5
|
Bacterial embB gene drug resistance mutation [Identifier] by Molecular method |
|
94056-9
|
Bacterial fabG1 gene drug resistance mutation [Identifier] by Molecular method |
|
94061-9
|
Bacterial gidB gene drug resistance mutation [Identifier] by Molecular method |
|
94060-1
|
Bacterial gyrA gene drug resistance mutation [Identifier] by Molecular method |
|
94055-1
|
Bacterial inhA gene drug resistance mutation [Identifier] by Molecular method |
|
94054-4
|
Bacterial katG gene drug resistance mutation [Identifier] by Molecular method |
|
94059-3
|
Bacterial pncA gene drug resistance mutation [Identifier] by Molecular method |
|
94065-0
|
Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method |
|
94063-5
|
Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular method |
|
94062-7
|
Bacterial rrs gene drug resistance mutation [Identifier] by Molecular method |
|
66885-5
|
Bacterial 16S rRNA sequencing [Identifier] in Unspecified specimen |
|
41477-1
|
Bacterial sialidase [Presence] in Unspecified specimen |
|
91895-3
|
Bacterial strain [Type] in Isolate by Sequencing |
|
69568-4
|
Bacterial vaginosis [Interpretation] in Vaginal fluid Qualitative |
|
45035-3
|
Bacterial virulence [Presence] in Unspecified specimen by Mouse bioassay |
|
90246-0
|
Bacterial whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
20675-5
|
Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence |
|
20676-3
|
Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence |
|
90418-5
|
BAFF-R cells/100 CD19 cells in Blood |
|
7111-8
|
Bahia grass triggered histamine release [Units/volume] in Blood |
|
6034-3
|
Bahia grass IgE Ab [Units/volume] in Serum |
|
15737-0
|
Bahia grass IgE Ab RAST class [Presence] in Serum |
|
50354-0
|
Bahia grass IgE Ab/IgE total in Serum |
|
13181-3
|
Bahia grass IgG Ab [Units/volume] in Serum |
|
56185-2
|
Bahia grass IgG4 Ab [Mass/volume] in Serum |
|
63156-4
|
Bahia grass IgG Ab [Mass/volume] in Serum |
|
9320-3
|
Beta aminoisobutyrate [Mass/time] in 24 hour Urine |
|
25870-7
|
Beta aminoisobutyrate [Moles/volume] in 24 hour Urine |
|
25348-4
|
Beta aminoisobutyrate [Moles/time] in 24 hour Urine |
|
13385-0
|
Beta aminoisobutyrate [Mass/volume] in Amniotic fluid |
|
27217-9
|
Beta aminoisobutyrate [Moles/volume] in Amniotic fluid |
|
13367-8
|
Beta aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
|
26590-0
|
Beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
53064-2
|
Beta aminoisobutyrate [Moles/volume] in DBS |
|
53463-6
|
Beta aminoisobutyrate [Moles/volume] in Body fluid |
|
1934-9
|
Beta aminoisobutyrate [Presence] in Plasma |
|
1935-6
|
Beta aminoisobutyrate [Mass/volume] in Plasma |
|
26605-6
|
Beta aminoisobutyrate [Moles/volume] in Serum or Plasma |
|
16453-3
|
Beta aminoisobutyrate [Presence] in Urine |
|
1936-4
|
Beta aminoisobutyrate [Mass/volume] in Urine |
|
26973-8
|
Beta aminoisobutyrate [Moles/volume] in Urine |
|
56673-7
|
Beta aminoisobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
25871-5
|
Beta aminoisobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13681-2
|
Beta aminoisobutyrate/Creatinine [Mass Ratio] in Urine |
|
28602-1
|
Beta aminoisobutyrate/Creatinine [Ratio] in Urine |
|
25086-0
|
Beta aminoisobutyrate/Creatinine [Molar ratio] in Urine |
|
15132-4
|
Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma |
|
15141-5
|
Beta aminoisobutyrate+Proline [Presence] in Urine |
|
53024-6
|
Baker's yeast Ab [Presence] in Serum |
|
56785-9
|
Baker's yeast Ab [Units/volume] in Serum |
|
68936-4
|
Baker's yeast Ab [Units/volume] in Serum by Immunoassay |
|
56761-0
|
Baker's yeast Ab [Titer] in Serum by Immunofluorescence |
|
7784-2
|
Baker's yeast triggered histamine release [Units/volume] in Blood |
|
63330-5
|
Baker's yeast IgA Ab [Units/volume] in Body fluid by Immunoassay |
|
57415-2
|
Baker's yeast IgA Ab [Presence] in Serum by Immunoassay |
|
63331-3
|
Baker's yeast IgA Ab [Presence] in Serum by Immunofluorescence |
|
31032-6
|
Baker's yeast IgA Ab [Units/volume] in Serum |
|
47320-7
|
Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay |
|
43189-0
|
Baker's yeast IgA Ab [Titer] in Serum |
|
6287-7
|
Baker's yeast IgE Ab [Units/volume] in Serum |
|
16096-0
|
Baker's yeast IgE Ab RAST class [Presence] in Serum |
|
41202-3
|
Baker's yeast IgE Ab/IgE total in Serum |
|
63332-1
|
Baker's yeast IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
81421-0
|
Baker's yeast IgG Ab [Presence] in Serum by Immunoassay |
|
63333-9
|
Baker's yeast IgG Ab [Presence] in Serum by Immunofluorescence |
|
6713-2
|
Baker's yeast IgG Ab [Units/volume] in Serum |
|
47321-5
|
Baker's yeast IgG Ab [Units/volume] in Serum by Immunoassay |
|
21607-7
|
Baker's yeast IgG Ab RAST class [Presence] in Serum |
|
56449-2
|
Baker's yeast IgG4 Ab [Mass/volume] in Serum |
|
35538-8
|
Baker's yeast IgG Ab [Mass/volume] in Serum |
|
48208-3
|
Baker's yeast triggered leukotriene release [Mass/volume] by Leukocytes |
|
84422-5
|
Standing Balance Test - scale score age adjusted [NIH Toolbox] |
|
84423-3
|
Standing Balance Test - scale score fully adjusted [NIH Toolbox] |
|
84421-7
|
Standing Balance Test - unadjusted scale score [NIH Toolbox] |
|
79642-5
|
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79638-3
|
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Serum or Plasma Narrative |
|
79598-9
|
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Urine Narrative |
|
6872-6
|
Beta alanine [Mass/time] in 24 hour Urine |
|
25868-1
|
Beta alanine [Moles/volume] in 24 hour Urine |
|
25346-8
|
Beta alanine [Moles/time] in 24 hour Urine |
|
13390-0
|
Beta alanine [Mass/volume] in Amniotic fluid |
|
27058-7
|
Beta alanine [Moles/volume] in Amniotic fluid |
|
13368-6
|
Beta alanine [Mass/volume] in Cerebral spinal fluid |
|
26589-2
|
Beta alanine [Moles/volume] in Cerebral spinal fluid |
|
53063-4
|
Beta alanine [Moles/volume] in DBS |
|
53068-3
|
Beta alanine [Moles/volume] in Body fluid |
|
1931-5
|
Beta alanine [Presence] in Serum or Plasma |
|
1932-3
|
Beta alanine [Mass/volume] in Serum or Plasma |
|
26604-9
|
Beta alanine [Moles/volume] in Serum or Plasma |
|
16452-5
|
Beta alanine [Presence] in Urine |
|
1933-1
|
Beta alanine [Mass/volume] in Urine |
|
26968-8
|
Beta alanine [Moles/volume] in Urine |
|
56674-5
|
Beta alanine/Creatinine [Ratio] in 24 hour Urine |
|
25869-9
|
Beta alanine/Creatinine [Molar ratio] in 24 hour Urine |
|
13714-1
|
Beta alanine/Creatinine [Mass Ratio] in Urine |
|
28588-2
|
Beta alanine/Creatinine [Ratio] in Urine |
|
26578-5
|
Beta alanine/Creatinine [Molar ratio] in Urine |
|
7272-8
|
Bald Cypress IgE Ab [Units/volume] in Serum |
|
15672-9
|
Bald Cypress IgE Ab RAST class [Presence] in Serum |
|
93741-7
|
Balm IgE Ab [Units/volume] in Serum |
|
50634-5
|
Balsam poplar IgE Ab [Units/volume] in Serum |
|
55621-7
|
Bambermycins [Susceptibility] by Gradient strip |
|
35803-6
|
Bambermycins [Susceptibility] by Disk diffusion (KB) |
|
35804-4
|
Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35805-1
|
Bambermycins [Susceptibility] |
|
87602-9
|
Bambermycins [Mass/mass] in Unspecified specimen |
|
10920-7
|
Bamboo shoot IgE Ab [Units/volume] in Serum |
|
15553-1
|
Bamboo shoot IgE Ab RAST class [Presence] in Serum |
|
28068-5
|
Beta aminobutyrate [Moles/volume] in Amniotic fluid |
|
39457-7
|
Beta aminobutyrate [Moles/volume] in Serum or Plasma |
|
7113-4
|
Banana triggered histamine release [Units/volume] in Blood |
|
6035-0
|
Banana IgE Ab [Units/volume] in Serum |
|
15554-9
|
Banana IgE Ab RAST class [Presence] in Serum |
|
61287-9
|
Banana IgE Ab/IgE total in Serum |
|
7112-6
|
Banana IgG Ab [Units/volume] in Serum |
|
21090-6
|
Banana IgG Ab RAST class [Presence] in Serum |
|
56186-0
|
Banana IgG4 Ab [Mass/volume] in Serum |
|
60352-2
|
Banana IgG Ab [Mass/volume] in Serum |
|
26652-8
|
Banzi virus Ab [Presence] in Serum |
|
38628-4
|
Benzo alpha pyrene [Mass/volume] in Air |
|
38320-8
|
Benzo alpha pyrene [Mass/volume] in Water |
|
78804-2
|
Barbital [Mass/volume] in Blood |
|
19356-5
|
Barbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19355-7
|
Barbital cutoff [Mass/volume] in Urine for Screen method |
|
4136-8
|
Barbital [Mass] of Dose |
|
79225-9
|
Barbital [Mass/volume] in Body fluid |
|
52950-3
|
Barbital [Presence] in Gastric fluid |
|
78803-4
|
Barbital [Mass/mass] in Hair |
|
14623-3
|
Barbital [Presence] in Serum or Plasma |
|
3370-4
|
Barbital [Mass/volume] in Serum or Plasma |
|
32050-7
|
Barbital [Moles/volume] in Serum or Plasma |
|
12495-8
|
Barbital [Presence] in Stool |
|
20518-7
|
Barbital [Mass/volume] in Urine by Confirmatory method |
|
12360-4
|
Barbital [Presence] in Urine |
|
19354-0
|
Barbital [Presence] in Urine by Confirmatory method |
|
19353-2
|
Barbital [Presence] in Urine by Screen method |
|
3371-2
|
Barbital [Mass/volume] in Urine |
|
32051-5
|
Barbital [Presence] in Unspecified specimen |
|
3372-0
|
Barbiturate screen absent [Identifier] in Urine |
|
3374-6
|
Barbiturate screen present [Identifier] in Urine |
|
42582-7
|
Barbiturates [Mass/volume] in Blood by Confirmatory method |
|
19278-1
|
Barbiturates confirm method [Identifier] in Urine |
|
19276-5
|
Barbiturates cutoff [Mass/volume] in Urine for Confirmatory method |
|
19275-7
|
Barbiturates cutoff [Mass/volume] in Urine for Screen method |
|
4137-6
|
Barbiturates [Mass] of Dose |
|
91028-1
|
Barbiturates [Presence] in Body fluid by Screen method |
|
14624-1
|
Barbiturates [Presence] in Gastric fluid |
|
61096-4
|
Barbiturates [Presence] in Gastric fluid by Screen method |
|
9427-6
|
Barbiturates [Mass/volume] in Gastric fluid |
|
40413-7
|
Barbiturates [Presence] in Hair |
|
91047-1
|
Barbiturates [Presence] in Hair by Screen method |
|
11092-4
|
Barbiturates [Mass/mass] in Hair |
|
40412-9
|
Barbiturates [Presence] in Meconium |
|
38439-6
|
Barbiturates [Presence] in Meconium by Confirmatory method |
|
34578-5
|
Barbiturates [Presence] in Meconium by Screen method |
|
11022-1
|
Barbiturates [Mass/volume] in Meconium |
|
29161-7
|
Barbiturates [Mass/mass] in Meconium |
|
19274-0
|
Barbiturates positive [Identifier] in Urine by Confirmatory method |
|
21091-4
|
Barbiturates present [Identifier] in Serum or Plasma by Screen method |
|
72451-8
|
Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method |
|
72627-3
|
Barbiturates [Presence] in Saliva (oral fluid) by Screen method |
|
74168-6
|
Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method |
|
19277-3
|
Barbiturates screen method [Identifier] in Urine |
|
20421-4
|
Barbiturates [Presence] in Serum or Plasma by Screen method |
|
30249-7
|
Barbiturates [Mass/volume] in Serum or Plasma by Screen method |
|
3376-1
|
Barbiturates [Presence] in Serum, Plasma or Blood |
|
10338-2
|
Barbiturates [Mass/volume] in Serum or Plasma |
|
15100-1
|
Barbiturates [Moles/volume] in Serum or Plasma |
|
12358-8
|
Barbiturates [Presence] in Stool |
|
19271-6
|
Barbiturates tested for in Urine by Screen method Nominal |
|
19272-4
|
Barbiturates tested for in Urine by Screen method Narrative |
|
20411-5
|
Barbiturates [Mass/volume] in Urine by Confirmatory method |
|
3377-9
|
Barbiturates [Presence] in Urine |
|
16429-3
|
Barbiturates [Presence] in Urine by Confirmatory method |
|
19270-8
|
Barbiturates [Presence] in Urine by Screen method |
|
70155-7
|
Barbiturates [Presence] in Urine by Screen method >200 ng/mL |
|
70139-1
|
Barbiturates [Presence] in Urine by Screen method >300 ng/mL |
|
20664-9
|
Barbiturates [Mass/volume] in Urine by Screen method |
|
16430-1
|
Barbiturates [Units/volume] in Urine |
|
9426-8
|
Barbiturates [Mass/volume] in Urine |
|
52956-0
|
Barbiturates [Moles/volume] in Urine |
|
27224-5
|
Barbiturates [Presence] in Vitreous fluid |
|
10363-0
|
Barbiturates [Presence] in Unspecified specimen |
|
61067-5
|
Barbiturates [Presence] in Unspecified specimen by Screen method |
|
43827-5
|
Barbiturates [Mass/volume] in Unspecified specimen |
|
53735-7
|
Barbiturates.other [Mass/volume] in Urine |
|
41468-0
|
Barbiturates/Creatinine [Mass Ratio] in Urine |
|
85517-1
|
Bariatric surgery Consult note |
|
85514-8
|
Bariatric surgery Discharge summary |
|
85522-1
|
Bariatric surgery Initial evaluation note |
|
85516-3
|
Bariatric surgery Note |
|
85515-5
|
Bariatric surgery Progress note |
|
43901-8
|
Barium [Presence] in 24 hour Urine |
|
29985-9
|
Barium [Mass/volume] in 24 hour Urine |
|
18194-1
|
Barium [Mass/time] in 24 hour Urine |
|
50819-2
|
Barium [Moles/time] in 24 hour Urine |
|
38571-6
|
Barium [Mass/volume] in Air |
|
16432-7
|
Barium [Mass/volume] in Blood |
|
78890-1
|
Barium [Moles/volume] in Blood |
|
51192-3
|
Barium [Mass/volume] in Body fluid |
|
80209-0
|
Barium [Moles/volume] in Body fluid |
|
76653-5
|
Barium [Mass/mass] in Hair |
|
50818-4
|
Barium [Moles/mass] in Hair |
|
5588-9
|
Barium [Presence] in Serum or Plasma |
|
5589-7
|
Barium [Mass/volume] in Serum or Plasma |
|
78807-5
|
Barium [Moles/volume] in Serum or Plasma |
|
78805-9
|
Barium [Moles/mass] in Tissue |
|
16431-9
|
Barium [Presence] in Urine |
|
5590-5
|
Barium [Mass/volume] in Urine |
|
72924-4
|
Barium [Moles/volume] in Urine |
|
9464-9
|
Barium [Mass/volume] in Water |
|
87619-3
|
Barium [Mass/mass] in Unspecified specimen |
|
29986-7
|
Barium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52937-0
|
Barium/Creatinine [Molar ratio] in 24 hour Urine |
|
13826-3
|
Barium/Creatinine [Mass Ratio] in Urine |
|
52938-8
|
Barium/Creatinine [Molar ratio] in Urine |
|
7115-9
|
Barley triggered histamine release [Units/volume] in Blood |
|
6037-6
|
Barley IgE Ab [Units/volume] in Serum |
|
15555-6
|
Barley IgE Ab RAST class [Presence] in Serum |
|
61273-9
|
Barley IgE Ab/IgE total in Serum |
|
7114-2
|
Barley IgG Ab [Units/volume] in Serum |
|
21092-2
|
Barley IgG Ab RAST class [Presence] in Serum |
|
56187-8
|
Barley IgG4 Ab [Mass/volume] in Serum |
|
51917-3
|
Barley IgG Ab [Mass/volume] in Serum |
|
48221-6
|
Barley triggered leukotriene release [Mass/volume] by Leukocytes |
|
7116-7
|
Barley Pollen IgE Ab [Units/volume] in Serum |
|
15556-4
|
Barley Pollen IgE Ab RAST class [Presence] in Serum |
|
46721-7
|
Barley smut IgE Ab [Units/volume] in Serum |
|
16070-5
|
Barley smut IgE Ab RAST class [Presence] in Serum |
|
14104-4
|
Barley smut+Wheat smut IgE Ab [Units/volume] in Serum |
|
21589-7
|
Barley smut+Wheat smut IgE Ab RAST class [Presence] in Serum |
|
13330-6
|
Barr bodies [Presence] in Cervix by Light microscopy |
|
83342-6
|
Barriers to action [PCAM] |
|
44941-3
|
Barriers to self management |
|
75371-5
|
Bartlett score of Sputum Qualitative by Light microscopy |
|
43866-3
|
Bartonella sp Ab [Presence] in Serum |
|
13325-6
|
Bartonella sp identified in Blood by Light microscopy |
|
91862-3
|
Bartonella sp DNA [Presence] in Aspirate by NAA with probe detection |
|
16275-0
|
Bartonella sp DNA [Presence] in Blood by NAA with probe detection |
|
89647-2
|
Bartonella sp DNA [Presence] in Implanted device by NAA with probe detection |
|
89593-8
|
Bartonella sp DNA [Presence] in Tissue by NAA with probe detection |
|
48864-3
|
Bartonella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44443-0
|
Bartonella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
43920-8
|
Bartonella sp IgG Ab [Presence] in Serum |
|
46158-2
|
Bartonella sp IgG Ab [Units/volume] in Serum |
|
43425-8
|
Bartonella sp IgG Ab [Titer] in Cerebral spinal fluid |
|
44444-8
|
Bartonella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
43921-6
|
Bartonella sp IgM Ab [Presence] in Serum |
|
46159-0
|
Bartonella sp IgM Ab [Units/volume] in Serum |
|
43424-1
|
Bartonella sp IgM Ab [Titer] in Cerebral spinal fluid |
|
38354-7
|
Bartonella sp identified in Unspecified specimen by Organism specific culture |
|
49123-3
|
Bartonella sp identified in Unspecified specimen by Sequencing |
|
1922-4
|
Base deficit in Arterial blood |
|
30317-2
|
Base deficit in Arterial cord blood |
|
59154-5
|
Base deficit in Cord blood |
|
28637-7
|
Base deficit in Venous cord blood |
|
1923-2
|
Base deficit in Capillary blood |
|
53116-0
|
Base deficit in Mixed venous blood |
|
30318-0
|
Base deficit in Blood |
|
1924-0
|
Base deficit in Venous blood |
|
72721-4
|
Base excess.100% oxygenated [Moles/volume] standard in Arterial blood by calculation |
|
72720-6
|
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation |
|
72722-2
|
Base excess.100% oxygenated [Moles/volume] standard in Mixed venous blood by calculation |
|
72723-0
|
Base excess.100% oxygenated [Moles/volume] standard in Venous blood by calculation |
|
11555-0
|
Base excess in Blood by calculation |
|
1925-7
|
Base excess in Arterial blood by calculation |
|
1926-5
|
Base excess in Capillary blood by calculation |
|
50820-0
|
Base excess in Capillary blood from Fetus by calculation |
|
32300-6
|
Base excess in Cord blood by calculation |
|
28638-5
|
Base excess in Arterial cord blood by calculation |
|
28639-3
|
Base excess in Venous cord blood by calculation |
|
19234-4
|
Base excess in Mixed venous blood by calculation |
|
1927-3
|
Base excess in Venous blood by calculation |
|
60840-6
|
Base excess in Extracellular fluid by calculation |
|
53085-7
|
Base excess in Nonbiological fluid by calculation |
|
19235-1
|
Base excess standard in Arterial blood by calculation |
|
19236-9
|
Base excess standard in Capillary blood by calculation |
|
19238-5
|
Base excess standard in Mixed venous blood by calculation |
|
19237-7
|
Base excess standard in Venous blood by calculation |
|
62382-7
|
Base pair end coordinate [#] |
|
62381-9
|
Base pair start coordinate [#] |
|
79531-0
|
Basic mobility items number [Activity Measure for Post-Acute Care] |
|
79529-4
|
Basic mobility score [AM-PAC] |
|
79530-2
|
Basic mobility score standard error [AM-PAC] |
|
7118-3
|
Basil IgE Ab [Units/volume] in Serum |
|
15557-2
|
Basil IgE Ab RAST class [Presence] in Serum |
|
61288-7
|
Basil IgE Ab/IgE total in Serum |
|
7119-1
|
Basil IgG Ab [Units/volume] in Serum |
|
56188-6
|
Basil IgG4 Ab [Mass/volume] in Serum |
|
63124-2
|
Basil IgG Ab [Mass/volume] in Serum |
|
82309-6
|
Basis for allelic phase [Type] |
|
11104-7
|
Normoblasts Basophilic/100 cells in Bone marrow by Manual count |
|
703-9
|
Basophilic stippling [Presence] in Blood by Light microscopy |
|
45381-1
|
Basophilic stippling coarse [Presence] in Blood by Light microscopy |
|
45380-3
|
Basophilic stippling fine [Presence] in Blood by Light microscopy |
|
32349-3
|
Basophils+Eosinophils+Monocytes [#/volume] in Blood |
|
32154-7
|
Basophils+Eosinophils+Monocytes [#/volume] in Blood by Automated count |
|
32350-1
|
Basophils+Eosinophils+Monocytes/100 leukocytes in Blood |
|
32155-4
|
Basophils+Eosinophils+Monocytes/100 leukocytes in Blood by Automated count |
|
26444-0
|
Basophils [#/volume] in Blood |
|
704-7
|
Basophils [#/volume] in Blood by Automated count |
|
66142-1
|
Basophils [#/volume] in Blood from Fetus by Manual count |
|
705-4
|
Basophils [#/volume] in Blood by Manual count |
|
74406-0
|
Basophils [#/volume] in Cord blood |
|
35072-8
|
Basophils [#/volume] in Cerebral spinal fluid |
|
35071-0
|
Basophils [#/volume] in Body fluid |
|
40571-2
|
Basophils [#/volume] in Body fluid by Manual count |
|
68393-8
|
Basophils [#/volume] in Pericardial fluid by Manual count |
|
35075-1
|
Basophils [#/volume] in Pleural fluid |
|
68394-6
|
Basophils [#/volume] in Pleural fluid by Manual count |
|
35073-6
|
Basophils [#/volume] in Peritoneal fluid |
|
68392-0
|
Basophils [#/volume] in Peritoneal fluid by Manual count |
|
35074-4
|
Basophils [#/volume] in Synovial fluid |
|
68395-3
|
Basophils [#/volume] in Synovial fluid by Manual count |
|
68397-9
|
Basophils [#/volume] in Vitreous fluid by Manual count |
|
34579-3
|
Basophils [#/area] in Peritoneal fluid by Microscopy high power field |
|
50658-4
|
Basophils.band form/100 leukocytes in Bone marrow |
|
55771-0
|
Basophils [#] in Cerebral spinal fluid by Manual count |
|
44040-4
|
Basophils [Presence] in Cerebral spinal fluid by Light microscopy |
|
76406-8
|
Basophils [#] in Body fluid by Manual count |
|
44018-0
|
Basophils [Presence] in Body fluid by Light microscopy |
|
11105-4
|
Basophils/100 cells in Bone marrow by Manual count |
|
71680-3
|
Basophils/Leukocytes [Pure number fraction] in Blood by Automated count |
|
71675-3
|
Basophils/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71595-3
|
Basophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
|
71662-1
|
Basophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71647-2
|
Basophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
71602-7
|
Basophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71612-6
|
Basophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71631-6
|
Basophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71621-7
|
Basophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
44048-7
|
Basophils [Presence] in Nose by Light microscopy |
|
44042-0
|
Basophils [Presence] in Pericardial fluid by Light microscopy |
|
44043-8
|
Basophils [Presence] in Pleural fluid by Light microscopy |
|
44044-6
|
Basophils [Presence] in Peritoneal fluid by Light microscopy |
|
44041-2
|
Basophils [Presence] in Synovial fluid by Light microscopy |
|
38184-8
|
Basophils/100 leukocytes in Amniotic fluid by Manual count |
|
30180-4
|
Basophils/100 leukocytes in Blood |
|
706-2
|
Basophils/100 leukocytes in Blood by Automated count |
|
74462-3
|
Basophils/100 leukocytes in Blood from Fetus |
|
707-0
|
Basophils/100 leukocytes in Blood by Manual count |
|
74407-8
|
Basophils/100 leukocytes in Cord blood |
|
30373-5
|
Basophils/100 leukocytes in Bronchial specimen |
|
14625-8
|
Basophils/100 leukocytes in Bronchial specimen by Manual count |
|
30374-3
|
Basophils/100 leukocytes in Cerebral spinal fluid |
|
13519-4
|
Basophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
40540-7
|
Basophils/100 leukocytes in Peritoneal dialysis fluid by Manual count |
|
53516-1
|
Basophils/100 leukocytes in Dialysis fluid by Manual count |
|
28543-7
|
Basophils/100 leukocytes in Body fluid |
|
12179-8
|
Basophils/100 leukocytes in Body fluid by Manual count |
|
13595-4
|
Basophils/100 leukocytes in Nose |
|
31994-7
|
Basophils/100 leukocytes in Pericardial fluid by Manual count |
|
35070-2
|
Basophils/100 leukocytes in Pleural fluid |
|
31995-4
|
Basophils/100 leukocytes in Pleural fluid by Manual count |
|
35069-4
|
Basophils/100 leukocytes in Peritoneal fluid |
|
31996-2
|
Basophils/100 leukocytes in Peritoneal fluid by Manual count |
|
17833-5
|
Basophils/100 leukocytes in Synovial fluid |
|
57836-9
|
Basophils/100 leukocytes in Synovial fluid by Manual count |
|
30375-0
|
Basophils/100 leukocytes in Sputum |
|
21094-8
|
Basophils/100 leukocytes in Sputum by Manual count |
|
68396-1
|
Basophils/100 leukocytes in Vitreous fluid by Manual count |
|
26445-7
|
Basophils/100 leukocytes in Unspecified specimen |
|
23823-8
|
Basophils/100 leukocytes in Unspecified specimen by Manual count |
|
69913-2
|
Basophils+Mast cells/100 leukocytes in Cerebral spinal fluid |
|
69910-8
|
Basophils+Mast cells/100 leukocytes in Body fluid |
|
69916-5
|
Basophils+Mast cells/100 leukocytes in Synovial fluid |
|
7120-9
|
Bass, Black IgE Ab [Units/volume] in Serum |
|
15558-0
|
Bass, Black IgE Ab RAST class [Presence] in Serum |
|
61285-3
|
Bass, Black IgE Ab/IgE total in Serum |
|
56192-8
|
Bass, Black IgG4 Ab [Mass/volume] in Serum |
|
63142-4
|
Bass, Black IgG Ab [Mass/volume] in Serum |
|
7121-7
|
Bassiai IgE Ab [Units/volume] in Serum |
|
7122-5
|
Basswood IgE Ab [Units/volume] in Serum |
|
83181-8
|
Bathing |
|
57243-8
|
Bathing - functional ability [CMS Assessment] |
|
45608-7
|
Bathing - self-performance during 7 day assessment period [CMS Assessment] |
|
45609-5
|
Bathing - support provided during 7 day assessment period [CMS Assessment] |
|
7123-3
|
Bayberry IgE Ab [Units/volume] in Serum |
|
15560-6
|
Bayberry IgE Ab RAST class [Presence] in Serum |
|
7124-1
|
Bayberry Pollen IgE Ab [Units/volume] in Serum |
|
7125-8
|
Bayleaf IgE Ab [Units/volume] in Serum |
|
15561-4
|
Bayleaf IgE Ab RAST class [Presence] in Serum |
|
7126-6
|
Bayleaf IgG Ab [Units/volume] in Serum |
|
56189-4
|
Bayleaf IgG4 Ab [Mass/volume] in Serum |
|
63128-3
|
Bayleaf IgG Ab [Mass/volume] in Serum |
|
74843-4
|
Baylisascaris sp IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
74844-2
|
Baylisascaris sp IgG Ab [Presence] in Serum by Immunoassay |
|
87484-2
|
BB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
41743-6
|
BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81822-9
|
BBS10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48598-7
|
BBS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53632-6
|
Breast Cancer Ag 225 [Presence] in Tissue by Immune stain |
|
49460-9
|
Beta catenin Ag [Presence] in Tissue by Immune stain |
|
38664-9
|
Bis(2-Chloroethyl) ether [Mass/volume] in Air |
|
80723-0
|
B-cell CD27 and IgD subsets [Interpretation] in Blood Narrative |
|
79571-6
|
BCHE gene full mutation analysis in Blood or Tissue by Sequencing |
|
56883-2
|
BCHE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
33359-1
|
Branched chain keto-acid dehydrogenase complex [Identifier] in Blood |
|
38479-2
|
Branched chain keto-acid dehydrogenase complex [Presence] in DBS |
|
81842-7
|
BCKDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53633-4
|
BCL1 Ag [Presence] in Tissue by Immune stain |
|
50307-8
|
BCL10 Ag [Presence] in Tissue by Immune stain |
|
33054-8
|
BCL2 Ag [Presence] in Tissue by Immune stain |
|
32757-7
|
BCL2 cells/100 cells in Unspecified specimen |
|
78225-0
|
BCL2 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
21095-5
|
BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
78218-5
|
BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH |
|
47009-6
|
BCL6 Ag [Presence] in Tissue by Immune stain |
|
78208-6
|
BCL6 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
21746-3
|
BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
78203-7
|
BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH |
|
51012-3
|
BCLXL cells/100 cells in Unspecified specimen |
|
38637-5
|
Bis(Chloromethyl) Ether [Mass/volume] in Air |
|
73878-1
|
Beta cortolone [Moles/volume] in 24 hour Urine |
|
73877-3
|
Beta cortolone [Moles/time] in 24 hour Urine |
|
73876-5
|
Beta cortolone [Moles/volume] in Urine |
|
50336-7
|
Beta cortolone/Cortisol [Mass Ratio] in Urine |
|
44450-5
|
Beta cortolone/Creatinine [Mass Ratio] in Urine |
|
81803-9
|
Beta cortolone/Creatinine [Molar ratio] in Urine |
|
55135-8
|
BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49490-6
|
BCR-ABL1 b2a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
|
49491-4
|
BCR-ABL1 b3a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
|
49496-3
|
BCR-ABL1 e1a1 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
|
47397-5
|
BCS1L gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
20779-5
|
Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
|
77233-5
|
Percentage of body fat by Bioelectrical impedance analysis |
|
91371-5
|
Body temperature - Brain |
|
50400-1
|
Body temperature --after transfusion reaction |
|
75539-7
|
Body temperature - Temporal artery |
|
11767-1
|
Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age |
|
11769-7
|
Body weight percentile range Categorization by comparison with standards |
|
13512-9
|
Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain |
|
10778-9
|
Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
|
42583-5
|
Bean string IgE Ab RAST class [Presence] in Serum |
|
7139-9
|
Bean string IgG Ab [Units/volume] in Serum |
|
26662-7
|
Bebaru virus Ab [Presence] in Serum |
|
75253-5
|
Because of a physical, mental, or emotional condition, do you have difficulty doing errands such as visiting a doctor's office or shopping [HHS.ACA Section 4302.ONC] |
|
89211-7
|
Beck Depression Inventory Fast Screen [BDI] |
|
89208-3
|
Beck Depression Inventory Fast Screen total score [BDI] |
|
89210-9
|
Beck Depression Inventory II [BDI] |
|
89209-1
|
Beck Depression Inventory II total score [BDI] |
|
41744-4
|
Beclomethasone dipropionate [Mass/volume] in Serum or Plasma |
|
46945-2
|
Beclomethasone dipropionate [Mass/volume] in Urine |
|
88310-8
|
Bed alarm used during 7 day assessment period [CMS Assessment] |
|
92195-7
|
Bed category [#] Facility |
|
92194-0
|
Bed category Facility |
|
92203-9
|
Bed category panel Facility |
|
45588-1
|
Bed mobility - self-performance during 7 day assessment period [CMS Assessment] |
|
45589-9
|
Bed mobility - support provided during 7 day assessment period [CMS Assessment] |
|
75917-5
|
Bed state Infant microenvironment.incubator |
|
80409-6
|
Bed type |
|
92193-2
|
Bed type [#] Facility |
|
75916-7
|
Bed type Infant microenvironment |
|
92204-7
|
Bed type panel Facility |
|
88703-4
|
Bedaquiline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88704-2
|
Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria |
|
80637-2
|
Bedaquiline [Mass/volume] in Serum or Plasma |
|
89415-4
|
Bed-to-chair transfer - functional ability [CMS Assessment] |
|
83210-5
|
Bed-to-chair transfer - functional ability during 3 day assessment period [CMS Assessment] |
|
89414-7
|
Bed-to-chair transfer - functional goal [CMS Assessment] |
|
83209-7
|
Bed-to-chair transfer - functional goal during 3 day assessment period [CMS Assessment] |
|
7143-1
|
Beef triggered histamine release [Units/volume] in Blood |
|
6039-2
|
Beef IgE Ab [Units/volume] in Serum |
|
15572-1
|
Beef IgE Ab RAST class [Presence] in Serum |
|
61331-5
|
Beef IgE Ab/IgE total in Serum |
|
6714-0
|
Beef IgG Ab [Units/volume] in Serum |
|
21106-0
|
Beef IgG Ab RAST class [Presence] in Serum |
|
56438-5
|
Beef IgG4 Ab [Mass/volume] in Serum |
|
35529-7
|
Beef IgG Ab [Mass/volume] in Serum |
|
48211-7
|
Beef triggered leukotriene release [Mass/volume] by Leukocytes |
|
80450-0
|
Beer intake 24 hour Measured |
|
19728-5
|
Beet IgE Ab [Units/volume] in Serum |
|
15573-9
|
Beet IgE Ab RAST class [Presence] in Serum |
|
7145-6
|
Beet IgG Ab [Units/volume] in Serum |
|
42584-3
|
Beet IgG Ab [Mass/volume] in Serum |
|
82147-0
|
Before age 18, how often did a parent or adult in your home ever hit, beat, kick, or physically hurt you in any way--before 18 years old [ACE.BRFSS] |
|
54676-2
|
Being short-tempered, easily annoyed in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54675-4
|
Being short-tempered, easily annoyed in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
91921-7
|
Being tired kept my child from having fun in past 7 days [PROMIS.PARENTPROXY] |
|
71383-4
|
Being tired made it hard for me to play or go out with my friends as much as I'd like in the past 7 days [FACIT] |
|
78077-5
|
Being tired made it hard for me to remember things in past 7 days [PROMIS.PEDS] |
|
91915-9
|
Being tired made it hard for my child to keep up with schoolwork in past 7 days [PROMIS.PARENTPROXY] |
|
91926-6
|
Being tired made it hard for my child to play or go out with friends as much as he/she would like in past 7 days [PROMIS.PARENTPROXY] |
|
71338-8
|
Being tired made me mad-angry in the past 7 days [FACIT] |
|
71337-0
|
Being tired made me sad in the past 7 days [FACIT] |
|
7586-1
|
Bell Pepper IgE Ab [Units/volume] in Serum |
|
23926-9
|
Bell Pepper IgE Ab RAST class [Presence] in Serum |
|
7587-9
|
Bell Pepper IgG Ab [Units/volume] in Serum |
|
73506-8
|
Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73507-6
|
Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
82331-0
|
Bending to floor/pick up an object [KOOS] |
|
9684-2
|
Bendiocarb [Mass/volume] in Serum or Plasma |
|
42585-0
|
Bendiocarb [Presence] in Urine |
|
21107-8
|
Bendiocarb [Mass/volume] in Urine |
|
43922-4
|
Beta endorphin [Presence] in Serum or Plasma |
|
1937-2
|
Beta endorphin [Mass/volume] in Serum or Plasma |
|
41019-1
|
Beta endorphin [Moles/volume] in Serum or Plasma |
|
3380-3
|
Bendroflumethiazide [Mass/time] in 24 hour Urine |
|
4138-4
|
Bendroflumethiazide [Mass] of Dose |
|
3378-7
|
Bendroflumethiazide [Presence] in Urine |
|
16437-6
|
Bendroflumethiazide [Units/volume] in Urine |
|
3379-5
|
Bendroflumethiazide [Mass/volume] in Urine |
|
78968-5
|
Benperidol [Mass/volume] in Serum or Plasma |
|
47201-9
|
Bentiromide [Mass] of Dose |
|
27012-4
|
Benzaldehyde [Presence] in Serum or Plasma |
|
16438-4
|
Benzaldehyde [Presence] in Urine |
|
38627-6
|
Benzene [Mass/volume] in Air |
|
16439-2
|
Benzene [Presence] in Blood |
|
9330-2
|
Benzene [Mass/volume] in Blood |
|
16440-0
|
Benzene ring IgE Ab [Units/volume] in Serum |
|
16441-8
|
Benzene ring IgG Ab [Units/volume] in Serum |
|
16442-6
|
Benzene ring IgM Ab [Units/volume] in Serum |
|
5591-3
|
Benzene [Presence] in Serum or Plasma |
|
5592-1
|
Benzene [Mass/volume] in Serum or Plasma |
|
43917-4
|
Benzene [Presence] in Urine |
|
9465-6
|
Benzene [Mass/volume] in Urine |
|
38339-8
|
Benzene [Mass/volume] in Water |
|
3384-5
|
Benzfetamine [Mass/time] in 24 hour Urine |
|
3381-1
|
Benzfetamine [Mass/volume] in Blood |
|
4139-2
|
Benzfetamine [Mass] of Dose |
|
27004-1
|
Benzfetamine [Mass/mass] in Meconium |
|
26993-6
|
Benzfetamine [Mass/volume] in Milk |
|
29600-4
|
Benzfetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
26773-2
|
Benzfetamine [Mass/mass] in Stool |
|
3382-9
|
Benzfetamine [Presence] in Urine |
|
3383-7
|
Benzfetamine [Mass/volume] in Urine |
|
27346-6
|
Benzfetamine [Mass/volume] in Vitreous fluid |
|
38572-4
|
Benzidine [Mass/volume] in Air |
|
18321-0
|
Benzidine [Mass/volume] in Serum or Plasma |
|
10909-0
|
Benzidine [Mass/volume] in Urine |
|
1930-7
|
Benzoate [Mass/volume] in Serum or Plasma |
|
75065-3
|
Benzoate [Moles/volume] in Serum or Plasma |
|
13713-3
|
Benzoate/Creatinine [Mass Ratio] in Urine |
|
28587-4
|
Benzoate/Creatinine [Ratio] in Urine |
|
25090-2
|
Benzoate/Creatinine [Molar ratio] in Urine |
|
42586-8
|
Benzodiazepines [Mass/volume] in Blood by Confirmatory method |
|
42662-7
|
Benzodiazepines [Presence] in Blood |
|
19286-4
|
Benzodiazepines confirm method [Identifier] in Urine |
|
19284-9
|
Benzodiazepines cutoff [Mass/volume] in Urine for Confirmatory method |
|
19283-1
|
Benzodiazepines cutoff [Mass/volume] in Urine for Screen method |
|
19064-5
|
Benzodiazepines cutoff [Mass/volume] in Urine |
|
79222-6
|
Benzodiazepines [Presence] in Body fluid by Screen method |
|
29209-4
|
Benzodiazepines [Mass/volume] in Body fluid |
|
12364-6
|
Benzodiazepines [Presence] in Gastric fluid |
|
33560-4
|
Benzodiazepines [Mass/volume] in Gastric fluid |
|
40415-2
|
Benzodiazepines [Presence] in Hair |
|
13933-7
|
Benzodiazepines [Mass/mass] in Hair |
|
40414-5
|
Benzodiazepines [Presence] in Meconium |
|
38441-2
|
Benzodiazepines [Presence] in Meconium by Confirmatory method |
|
31081-3
|
Benzodiazepines [Presence] in Meconium by Screen method |
|
11023-9
|
Benzodiazepines [Mass/volume] in Meconium |
|
29160-9
|
Benzodiazepines [Mass/mass] in Meconium |
|
42235-2
|
Benzodiazepine metabolites [Presence] in Urine by Screen method |
|
3385-2
|
Benzodiazepines negative [Identifier] in Urine |
|
3387-8
|
Benzodiazepines positive [Identifier] in Urine |
|
19282-3
|
Benzodiazepines positive [Identifier] in Urine by Confirmatory method |
|
72616-6
|
Benzodiazepines [Presence] in Saliva (oral fluid) |
|
72456-7
|
Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method |
|
72633-1
|
Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method |
|
72757-8
|
Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method |
|
19285-6
|
Benzodiazepines screen method [Identifier] in Urine |
|
46977-5
|
Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3389-4
|
Benzodiazepines [Presence] in Serum or Plasma |
|
46976-7
|
Benzodiazepines [Presence] in Serum or Plasma by Screen method |
|
78808-3
|
Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL |
|
30250-5
|
Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method |
|
11024-7
|
Benzodiazepines [Mass/volume] in Serum or Plasma |
|
32052-3
|
Benzodiazepines [Moles/volume] in Serum or Plasma |
|
12359-6
|
Benzodiazepines [Presence] in Stool |
|
27063-7
|
Benzodiazepines [Mass/mass] in Stool |
|
19279-9
|
Benzodiazepines tested for in Urine by Screen method Nominal |
|
19280-7
|
Benzodiazepines tested for in Urine by Screen method Narrative |
|
91036-4
|
Benzodiazepines [Presence] in Tissue by Screen method |
|
20412-3
|
Benzodiazepines [Mass/volume] in Urine by Confirmatory method |
|
3390-2
|
Benzodiazepines [Presence] in Urine |
|
16195-0
|
Benzodiazepines [Presence] in Urine by Confirmatory method |
|
14316-4
|
Benzodiazepines [Presence] in Urine by Screen method |
|
70141-7
|
Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL |
|
70142-5
|
Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL |
|
70140-9
|
Benzodiazepines [Mass/volume] in Urine by Screen method |
|
9428-4
|
Benzodiazepines [Mass/volume] in Urine |
|
52955-2
|
Benzodiazepines [Moles/volume] in Urine |
|
27197-3
|
Benzodiazepines [Presence] in Vitreous fluid |
|
48940-1
|
Benzodiazepines [Mass/volume] in Unspecified specimen by Confirmatory method |
|
43828-3
|
Benzodiazepines [Presence] in Unspecified specimen |
|
48941-9
|
Benzodiazepines [Mass/volume] in Unspecified specimen |
|
53736-5
|
Benzodiazepines.other [Mass/volume] in Urine |
|
41467-2
|
Benzodiazepines/Creatinine [Mass Ratio] in Urine |
|
16443-4
|
Benzonatate [Mass/volume] in Serum |
|
16444-2
|
Benzophenone [Mass/volume] in Serum or Plasma |
|
38633-4
|
Benzotrichloride [Mass/volume] in Air |
|
53613-6
|
Benzoylcarnitine (BzCn) [Moles/volume] in DBS |
|
18445-7
|
Benzoylcarnitine (BzCn) [Mass/volume] in Serum or Plasma |
|
39615-0
|
Benzoylcarnitine (BzCn) [Moles/volume] in Serum or Plasma |
|
43863-0
|
Benzthiazide [Presence] in 24 hour Urine |
|
3401-7
|
Benzthiazide [Mass/time] in 24 hour Urine |
|
4141-8
|
Benzthiazide [Mass] of Dose |
|
16449-1
|
Benzthiazide [Mass/volume] in Serum or Plasma |
|
3399-3
|
Benzthiazide [Presence] in Urine |
|
3400-9
|
Benzthiazide [Mass/volume] in Urine |
|
59871-4
|
Benztropine [Moles/volume] in Gastric fluid |
|
73504-3
|
Benztropine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73505-0
|
Benztropine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
43857-2
|
Benztropine [Presence] in Serum or Plasma |
|
9384-9
|
Benztropine [Mass/volume] in Serum or Plasma |
|
59869-8
|
Benztropine [Moles/volume] in Serum or Plasma |
|
43265-8
|
Benztropine [Presence] in Urine |
|
9354-2
|
Benztropine [Mass/volume] in Urine |
|
59870-6
|
Benztropine [Moles/volume] in Urine |
|
60287-0
|
Benztropine [Moles/volume] in Unspecified specimen |
|
16328-7
|
Benzyl alcohol [Presence] in Blood |
|
12304-2
|
Benzyl alcohol [Presence] in Serum or Plasma |
|
38634-2
|
Benzyl chloride [Mass/volume] in Air |
|
16450-9
|
Benzylhydrazine [Mass/volume] in Serum or Plasma |
|
59285-7
|
Benzylpiperazine [Mass/volume] in Blood |
|
79137-6
|
Benzylpiperazine [Mass/volume] in Body fluid |
|
78809-1
|
Benzylpiperazine [Mass/mass] in Hair |
|
59286-5
|
Benzylpiperazine [Mass/volume] in Serum or Plasma |
|
59135-4
|
Benzylpiperazine [Mass/volume] in Urine by Confirmatory method |
|
64233-0
|
Benzylpiperazine [Presence] in Urine by Confirmatory method |
|
59287-3
|
Benzylpiperazine [Mass/volume] in Urine |
|
47010-4
|
Ber-EP4 Ag [Presence] in Tissue by Immune stain |
|
15339-5
|
Berlin Beetle IgE Ab [Units/volume] in Serum |
|
15575-4
|
Berlin Beetle IgE Ab RAST class [Presence] in Serum |
|
65775-9
|
Bermuda grass native (nCyn d) 1 IgE Ab [Units/volume] in Serum |
|
82005-0
|
Bermuda grass native (nCyn d) 1 IgE Ab RAST class [Presence] in Serum |
|
7354-4
|
Bermuda grass triggered histamine release [Units/volume] in Blood |
|
6041-8
|
Bermuda grass IgE Ab [Units/volume] in Serum |
|
15738-8
|
Bermuda grass IgE Ab RAST class [Presence] in Serum |
|
61255-6
|
Bermuda grass IgE Ab/IgE total in Serum |
|
7353-6
|
Bermuda grass IgG Ab [Units/volume] in Serum |
|
56190-2
|
Bermuda grass IgG4 Ab [Mass/volume] in Serum |
|
63152-3
|
Bermuda grass IgG Ab [Mass/volume] in Serum |
|
48264-6
|
Bermuda grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
7704-0
|
Bermuda grass smut IgE Ab [Units/volume] in Serum |
|
16022-6
|
Bermuda grass smut IgE Ab RAST class [Presence] in Serum |
|
58034-0
|
Bermuda grass smut IgE Ab/IgE total in Serum |
|
7148-0
|
Berry IgE Ab [Units/volume] in Serum |
|
29927-1
|
Beryllium [Mass/volume] in 24 hour Urine |
|
5596-2
|
Beryllium [Mass/time] in 24 hour Urine |
|
50822-6
|
Beryllium [Moles/time] in 24 hour Urine |
|
38574-0
|
Beryllium [Mass/volume] in Air |
|
8159-6
|
Beryllium [Mass/volume] in Blood |
|
80210-8
|
Beryllium [Mass/volume] in Body fluid |
|
80211-6
|
Beryllium [Moles/volume] in Body fluid |
|
76654-3
|
Beryllium [Mass/mass] in Hair |
|
50823-4
|
Beryllium [Moles/mass] in Hair |
|
8160-4
|
Beryllium [Mass/volume] in Saliva (oral fluid) |
|
5593-9
|
Beryllium [Presence] in Serum or Plasma |
|
5594-7
|
Beryllium [Mass/volume] in Serum or Plasma |
|
52899-2
|
Beryllium [Moles/volume] in Serum or Plasma |
|
16178-6
|
Beryllium [Mass/mass] in Tissue |
|
78810-9
|
Beryllium [Moles/mass] in Tissue |
|
16451-7
|
Beryllium [Presence] in Urine |
|
5595-4
|
Beryllium [Mass/volume] in Urine |
|
50821-8
|
Beryllium [Moles/volume] in Urine |
|
38310-9
|
Beryllium [Mass/volume] in Water |
|
43885-3
|
Beryllium [Presence] in Unspecified specimen |
|
29920-6
|
Beryllium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52936-2
|
Beryllium/Creatinine [Molar ratio] in 24 hour Urine |
|
13827-1
|
Beryllium/Creatinine [Mass Ratio] in Urine |
|
52935-4
|
Beryllium/Creatinine [Molar ratio] in Urine |
|
73651-2
|
Besifloxacin [Susceptibility] by Disk diffusion (KB) |
|
73628-0
|
Besifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73606-6
|
Besifloxacin [Susceptibility] |
|
74705-5
|
Best characterization of health information technology (HIT) device [AHRQ] |
|
74072-0
|
Best characterization of medication or other substance event [AHRQ] |
|
74067-0
|
Best description for incorrect strength or concentration [AHRQ] |
|
74070-4
|
Best description for the incorrect dose [AHRQ] |
|
74068-8
|
Best description for the incorrect rate [AHRQ] |
|
74069-6
|
Best description for the incorrect timing [AHRQ] |
|
74724-6
|
Best description of the event or unsafe condition [AHRQ] |
|
94073-4
|
Best thing about your day |
|
80213-2
|
Beta blockers [Presence] in Blood by Screen method |
|
80215-7
|
Beta blockers [Presence] in Body fluid by Screen method |
|
80212-4
|
Beta blockers [Presence] in Hair by Screen method |
|
80214-0
|
Beta blockers [Presence] in Serum or Plasma by Screen method |
|
12328-1
|
Beta blockers [Identifier] in Urine |
|
53634-2
|
Beta cortol [Mass/time] in 24 hour Urine |
|
53635-9
|
Beta cortol/Creatinine [Mass Ratio] in 24 hour Urine |
|
53636-7
|
Beta cortol/Creatinine [Mass Ratio] in Urine |
|
56042-5
|
Beta defensin [Mass/mass] in Stool.dried |
|
56041-7
|
Beta defensin [Mass/mass] in Stool.wet |
|
49554-9
|
Beta F1 Ag [Presence] in Tissue by Immune stain |
|
60849-7
|
Beta frequency relative power on EEG |
|
53589-8
|
Beta globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
|
53587-2
|
Beta globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
|
11038-7
|
Beta+gamma tocopherol [Mass/volume] in Serum or Plasma |
|
77342-4
|
Beta 1 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
|
32734-6
|
Beta 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
|
55914-6
|
Beta 1 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
32738-7
|
Beta 1 globulin [Mass/volume] in Body fluid by Electrophoresis |
|
32728-8
|
Beta 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
32740-3
|
Beta 1 globulin/Protein.total in Body fluid by Electrophoresis |
|
32732-0
|
Beta 1 globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
32736-1
|
Beta 1 globulin/Protein.total in Urine by Electrophoresis |
|
32730-4
|
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
54353-8
|
Beta 1 globulin [Mass/volume] in Urine by Electrophoresis |
|
57837-7
|
Beta-1 transferrin [Presence] in Body fluid |
|
32735-3
|
Beta 2 globulin [Mass/time] in 24 hour Urine by Electrophoresis |
|
55915-3
|
Beta 2 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
32739-5
|
Beta 2 globulin [Mass/volume] in Body fluid by Electrophoresis |
|
32729-6
|
Beta 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
32741-1
|
Beta 2 globulin/Protein.total in Body fluid by Electrophoresis |
|
32733-8
|
Beta 2 globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
32737-9
|
Beta 2 globulin/Protein.total in Urine by Electrophoresis |
|
32731-2
|
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
54354-6
|
Beta 2 globulin [Mass/volume] in Urine by Electrophoresis |
|
44912-4
|
Beta 2 globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
54357-9
|
Beta 2 globulin+Gamma globulin/Protein.total in Urine by Electrophoresis |
|
44911-6
|
Beta 2 globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
80638-0
|
Beta-amanitin [Mass/volume] in Urine |
|
41745-1
|
Betamethasone [Mass/volume] in Serum or Plasma |
|
46946-0
|
Betamethasone [Mass/volume] in Urine |
|
48493-1
|
Beta-trace protein [Mass/volume] in Cerebral spinal fluid |
|
72660-4
|
Beta-trace protein [Mass/volume] in Ear fluid |
|
57733-8
|
Beta-trace protein [Mass/volume] in Body fluid |
|
60224-3
|
Beta-trace protein [Mass/volume] in Nasal fluid |
|
48499-8
|
Beta-trace protein [Mass/volume] in Serum or Plasma |
|
79582-3
|
Beta-ureidoisobutyrate [Moles/volume] in Serum or Plasma |
|
79647-4
|
Beta-ureidoisobutyrate/Creatinine [Molar ratio] in Urine |
|
81199-2
|
Beta-ureidopropionase [Enzymatic activity/mass] in Liver |
|
16458-2
|
Bethanechol [Mass/volume] in Serum or Plasma |
|
10773-0
|
Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |
|
1938-0
|
Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells |
|
1939-8
|
Beta fructofuranosidase [Enzymatic activity/volume] in Serum |
|
46427-1
|
Beta fructofuranosidase [Enzymatic activity/mass] in Tissue |
|
10482-8
|
Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
|
26874-8
|
Follitropin.beta subunit [Mass/volume] in Serum or Plasma |
|
2289-7
|
Follitropin.beta subunit [Moles/volume] in Serum or Plasma |
|
81120-8
|
Barmah forest virus Ab [Titer] in Serum |
|
31247-0
|
Barmah forest virus IgG Ab [Presence] in Serum |
|
24121-6
|
Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay |
|
31248-8
|
Barmah forest virus IgM Ab [Presence] in Serum |
|
24118-2
|
Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay |
|
81688-4
|
Barmah forest virus RNA [Presence] in Blood by NAA with probe detection |
|
57902-9
|
Bg sup(a) Ab [Presence] in Serum or Plasma |
|
57903-7
|
Bg sup(a) Ab [Titer] in Serum or Plasma |
|
57904-5
|
Bg sup(a) Ag [Presence] on Red Blood Cells |
|
85485-1
|
Bg sup(b) Ag [Presence] on Red Blood Cells |
|
85486-9
|
Bg sup(c) Ag [Presence] on Red Blood Cells |
|
74124-9
|
Blood group 8 (BG8) Ag [Presence] in Tissue by Immune stain |
|
34192-5
|
Beta galactosidase [Presence] in Amniotic fluid cells |
|
38185-5
|
Beta galactosidase [Presence] in Blood |
|
16454-1
|
Beta galactosidase [Enzymatic activity/volume] in Blood |
|
55916-1
|
Beta galactosidase [Enzymatic activity/volume] in DBS |
|
24060-6
|
Beta galactosidase [Enzymatic activity/mass] in Fibroblast |
|
11178-1
|
Beta galactosidase IgE Ab [Units/volume] in Serum |
|
21359-5
|
Beta galactosidase IgE Ab RAST class [Presence] in Serum |
|
1940-6
|
Beta galactosidase [Enzymatic activity/volume] in Red Blood Cells |
|
1941-4
|
Beta galactosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1942-2
|
Beta galactosidase [Enzymatic activity/mass] in Tissue |
|
30319-8
|
Beta galactosidase [Enzymatic activity/mass] in Small intestine Tissue |
|
33653-7
|
Beta galactosidase [Entitic Catalytic Activity] in Leukocytes |
|
12915-5
|
Beta galactosidase [Enzymatic activity/volume] in Leukocytes |
|
24061-4
|
Beta galactosidase [Enzymatic activity/mass] in Leukocytes |
|
17815-2
|
Beta globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
|
34183-4
|
Beta globulin/Protein.total in 24 hour Urine |
|
13988-1
|
Beta globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
72584-6
|
Beta globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
|
38186-3
|
Beta globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
|
29951-1
|
Beta globulin [Presence] in 24 hour Urine |
|
6889-0
|
Beta globulin [Mass/volume] in 24 hour Urine |
|
9829-3
|
Beta globulin [Mass/time] in 24 hour Urine |
|
2870-4
|
Beta globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
17498-7
|
Beta globulin [Mass/volume] in Body fluid by Electrophoresis |
|
13976-6
|
Beta globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
54358-7
|
Beta globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
17816-0
|
Beta globulin/Protein.total in Body fluid by Electrophoresis |
|
13982-4
|
Beta globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
15127-4
|
Beta globulin/Protein.total in Synovial fluid by Electrophoresis |
|
13994-9
|
Beta globulin/Protein.total in Urine by Electrophoresis |
|
72587-9
|
Beta globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
|
72586-1
|
Beta globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
|
72585-3
|
Beta globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
|
2871-2
|
Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
43836-6
|
Beta globulin [Presence] in Serum or Plasma by Electrophoresis |
|
2872-0
|
Beta globulin [Mass/volume] in Synovial fluid by Electrophoresis |
|
9744-4
|
Beta globulin [Mass/volume] in Urine by Electrophoresis |
|
53772-0
|
Beta globulin [Presence] in Urine by Electrophoresis |
|
25830-1
|
Beta glucosidase activator [Interpretation] in Fibroblast |
|
49319-7
|
Beta glucosidase activator [Interpretation] in Fibroblast Narrative |
|
11209-4
|
Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
79457-8
|
Beta glucuronidase [Enzymatic activity/volume] in DBS |
|
24064-8
|
Beta glucuronidase [Enzymatic activity/mass] in Fibroblast |
|
13962-6
|
Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
|
14284-4
|
Beta glucuronidase [Moles/volume] in Serum or Plasma |
|
1944-8
|
Beta glucuronidase [Enzymatic activity/mass] in Tissue |
|
1945-5
|
Beta glucuronidase [Enzymatic activity/volume] in Urine |
|
24065-5
|
Beta glucuronidase [Enzymatic activity/mass] in Leukocytes |
|
34191-7
|
Beta glucuronidase [Enzymatic activity/volume] in Unspecified specimen |
|
56497-1
|
Choriogonadotropin.beta subunit [Units] in 24 hour Urine |
|
2113-9
|
Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine |
|
23841-0
|
Choriogonadotropin.beta subunit [Multiple of the median] adjusted in Serum or Plasma |
|
47024-5
|
Choriogonadotropin.beta subunit Ag [Presence] in Tissue by Immune stain |
|
19174-2
|
Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid |
|
19175-9
|
Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid |
|
43800-2
|
Choriogonadotropin.beta subunit [Presence] in Cerebral spinal fluid |
|
14041-8
|
Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
|
29154-2
|
Choriogonadotropin.beta subunit [Units/volume] in Body fluid |
|
19178-3
|
Choriogonadotropin.beta subunit free [Units/volume] in Amniotic fluid |
|
19179-1
|
Choriogonadotropin.beta subunit free [Moles/volume] in Amniotic fluid |
|
55866-8
|
Choriogonadotropin.beta subunit free [Mass/volume] in Cerebral spinal fluid |
|
47601-0
|
Choriogonadotropin.beta subunit free [Units/volume] in Body fluid |
|
55867-6
|
Choriogonadotropin.beta subunit free [Mass/volume] in Body fluid |
|
44003-2
|
Choriogonadotropin.beta subunit free [Multiple of the median] in Amniotic fluid |
|
45293-8
|
Choriogonadotropin.beta subunit.free multiple of the median [Percentile] |
|
32122-4
|
Choriogonadotropin.beta subunit free [Multiple of the median] in Serum or Plasma |
|
19180-9
|
Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma |
|
25373-2
|
Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma |
|
2115-4
|
Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma |
|
55868-4
|
Choriogonadotropin.beta subunit [Multiple of the median] in Serum or Plasma |
|
66762-6
|
Choriogonadotropin.beta subunit [Units/volume] in Pleural fluid |
|
2110-5
|
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma |
|
2112-1
|
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine |
|
66763-4
|
Choriogonadotropin.beta subunit [Units/volume] in Peritoneal fluid |
|
20415-6
|
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS |
|
21198-7
|
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
|
55869-2
|
Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma |
|
2111-3
|
Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
|
23840-2
|
Choriogonadotropin.beta subunit [Multiple of the median] unadjusted in Serum or Plasma |
|
2114-7
|
Choriogonadotropin.beta subunit [Moles/volume] in Urine |
|
43799-6
|
Choriogonadotropin.beta subunit [Presence] in Unspecified specimen |
|
44701-1
|
BHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11267-2
|
Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture |
|
73666-0
|
Streptococcus.beta-hemolytic [Type] in Isolate by Latex agglutination |
|
546-2
|
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture |
|
547-0
|
Streptococcus.beta-hemolytic [Presence] in Unspecified specimen by Organism specific culture |
|
78948-7
|
Brinkman index |
|
41667-7
|
Biapenem [Susceptibility] by Gradient strip |
|
41666-9
|
Biapenem [Susceptibility] by Disk diffusion (KB) |
|
41665-1
|
Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41728-7
|
Biapenem [Susceptibility] |
|
76272-4
|
Bias flow setting Ventilator |
|
76271-6
|
Bias flow Ventilator |
|
90080-3
|
Bictegravir [Susceptibility] by Genotype method |
|
10774-8
|
Microscopic observation [Identifier] in Tissue by Bielschowsky stain |
|
20696-1
|
Bifidobacterium sp [#/volume] in Milk by Organism specific culture |
|
72693-5
|
Insulin-like growth factor-II.high molecular weight [Mass/volume] in Serum or Plasma |
|
74515-8
|
Bile acid [Moles/mass] in 24 hour Stool |
|
72679-4
|
Bile acid [Moles/time] in 24 hour Stool |
|
27931-5
|
Bile acid [Moles/volume] in Serum --2 hours post meal |
|
93336-6
|
Bile acid [Moles/time] in 48 hour Stool |
|
43888-7
|
Bile acid [Presence] in Bile fluid |
|
16464-0
|
Bile acid [Units/volume] in Exhaled gas |
|
1966-1
|
Bile acid [Mass/volume] in Exhaled gas |
|
34640-3
|
Bile acid [Mass/volume] in Body fluid |
|
50825-9
|
Bile acid [Moles/volume] in Body fluid |
|
35562-8
|
Bile acid [Moles/volume] in Serum --fasting |
|
75038-0
|
Bile acid pattern [Interpretation] in Serum or Plasma Narrative |
|
33473-0
|
Bile acid pattern [Interpretation] in Urine |
|
49254-6
|
Bile acid pattern [Interpretation] in Urine Narrative |
|
43877-0
|
Bile acid [Presence] in Serum |
|
1967-9
|
Bile acid [Mass/volume] in Serum |
|
14628-2
|
Bile acid [Moles/volume] in Serum or Plasma |
|
72491-4
|
Bile acid [Moles/volume] in Stool |
|
43889-5
|
Bile acid [Presence] in Urine |
|
16465-7
|
Bile acid [Mass/volume] in Urine |
|
73722-1
|
Bile acid [Moles/volume] in Urine |
|
80164-7
|
Bile alcohols pattern [Interpretation] in Urine Narrative |
|
80162-1
|
Bile alcohols [Interpretation] in Urine Qualitative |
|
44034-7
|
Bile canalicular Ab [Presence] in Serum |
|
44016-4
|
Bile [Presence] in Body fluid |
|
1965-3
|
Bile [Presence] in Stool |
|
10745-8
|
Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
|
44764-9
|
Biliary anastomosis procedure |
|
59166-9
|
Bilirubin.total [Moles/time] in 24 hour Stool |
|
44033-9
|
Bilirubin.total [Presence] in 24 hour Urine by Test strip |
|
13877-6
|
Bilirubin.total [Presence] in Amniotic fluid |
|
43887-9
|
Bilirubin.total [Presence] in Amniotic fluid by Spectrophotometry direct |
|
27198-1
|
Bilirubin.total [Units/volume] in Amniotic fluid by Spectrophotometry direct |
|
12476-8
|
Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct |
|
47225-8
|
Bilirubin.total [Interpretation] in Amniotic fluid |
|
1972-9
|
Bilirubin.total [Mass/volume] in Amniotic fluid |
|
72925-1
|
Bilirubin.total [Moles/volume] in Amniotic fluid |
|
59827-6
|
Bilirubin.total [Mass/volume] in Arterial blood |
|
89872-6
|
Bilirubin.total [Moles/volume] in Arterial blood |
|
48624-1
|
Bilirubin.total [Mass/volume] in Cord blood |
|
47994-9
|
Bilirubin.total [Moles/volume] in Cord blood |
|
42719-5
|
Bilirubin.total [Mass/volume] in Blood |
|
54363-7
|
Bilirubin.total [Moles/volume] in Blood |
|
59828-4
|
Bilirubin.total [Mass/volume] in Venous blood |
|
89871-8
|
Bilirubin.total [Moles/volume] in Venous blood |
|
1969-5
|
Bilirubin.total renal clearance in 24 hour Urine and Serum or Plasma |
|
53083-2
|
Bilirubin.conjugated [Moles/volume] in Dialysis fluid |
|
33458-1
|
Bilirubin.conjugated [Mass/volume] in Body fluid |
|
39462-7
|
Bilirubin.conjugated [Moles/volume] in Body fluid |
|
34442-4
|
Bilirubin.conjugated/Bilirubin.total in Serum or Plasma |
|
78441-3
|
Bilirubin.conjugated [Moles/volume] in Peritoneal fluid |
|
15152-2
|
Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
|
29760-6
|
Bilirubin.conjugated [Moles/volume] in Serum or Plasma |
|
33898-8
|
Bilirubin.conjugated+indirect [Mass/volume] in Serum or Plasma |
|
33899-6
|
Bilirubin.conjugated+indirect [Moles/volume] in Serum or Plasma |
|
25146-2
|
Bilirubin crystals [#/area] in Urine sediment by Microscopy high power field |
|
38442-0
|
Bilirubin crystals [#/area] in Urine sediment by Microscopy low power field |
|
33236-1
|
Bilirubin crystals [Presence] in Urine by Computer assisted method |
|
5771-1
|
Bilirubin crystals [Presence] in Urine sediment by Light microscopy |
|
53415-6
|
Bilirubin.total [Presence] in Cerebral spinal fluid |
|
1973-7
|
Bilirubin.total [Mass/volume] in Cerebral spinal fluid |
|
74906-9
|
Bilirubin.total [Moles/volume] in Cerebral spinal fluid |
|
1970-3
|
Bilirubin.delta [Mass/volume] in Serum or Plasma |
|
22665-4
|
Bilirubin.delta [Moles/volume] in Serum or Plasma |
|
14420-4
|
Bilirubin.total [Mass/volume] in Dialysis fluid |
|
54362-9
|
Bilirubin.total [Moles/volume] in Dialysis fluid |
|
48623-3
|
Bilirubin.direct [Mass/volume] in Cord blood |
|
14152-3
|
Bilirubin.direct [Mass/volume] in Body fluid |
|
25564-6
|
Bilirubin.direct [Moles/volume] in Body fluid |
|
35672-5
|
Bilirubin.direct/Bilirubin.total in Serum or Plasma |
|
56905-3
|
Bilirubin.direct [Mass/volume] in Pleural fluid |
|
56906-1
|
Bilirubin.direct [Mass/volume] in Peritoneal fluid |
|
43820-0
|
Bilirubin.direct [Presence] in Serum or Plasma |
|
1968-7
|
Bilirubin.direct [Mass/volume] in Serum or Plasma |
|
35191-6
|
Bilirubin.direct [Mass or Moles/volume] in Serum or Plasma |
|
14629-0
|
Bilirubin.direct [Moles/volume] in Serum or Plasma |
|
43824-2
|
Bilirubin.total [Presence] in Body fluid |
|
1974-5
|
Bilirubin.total [Mass/volume] in Body fluid |
|
35193-2
|
Bilirubin.total [Mass or Moles/volume] in Body fluid |
|
29767-1
|
Bilirubin.total [Moles/volume] in Body fluid |
|
14424-6
|
Bilirubin.total [Mass/volume] in Gastric fluid |
|
64082-1
|
Bilirubin.indirect [Mass/volume] in Cord blood |
|
29210-2
|
Bilirubin.indirect [Mass/volume] in Body fluid |
|
39463-5
|
Bilirubin.indirect [Moles/volume] in Body fluid |
|
78442-1
|
Bilirubin.indirect [Moles/volume] in Peritoneal fluid |
|
1971-1
|
Bilirubin.indirect [Mass/volume] in Serum or Plasma |
|
35192-4
|
Bilirubin.indirect [Mass or Moles/volume] in Serum or Plasma |
|
14630-8
|
Bilirubin.indirect [Moles/volume] in Serum or Plasma |
|
74434-2
|
Bilirubin.total/Total in Stone by Infrared spectroscopy |
|
49763-6
|
Bilirubin.total [Mass/volume] in Pericardial fluid |
|
14421-2
|
Bilirubin.total [Mass/volume] in Pleural fluid |
|
77452-1
|
Bilirubin [Presence] in Peritoneal fluid |
|
14422-0
|
Bilirubin.total [Mass/volume] in Peritoneal fluid |
|
39461-9
|
Bilirubin.total [Moles/volume] in Peritoneal fluid |
|
77137-8
|
Bilirubin.total [Moles/volume] in Serum, Plasma or Blood |
|
1975-2
|
Bilirubin.total [Mass/volume] in Serum or Plasma |
|
35194-0
|
Bilirubin.total [Mass or Moles/volume] in Serum or Plasma |
|
14631-6
|
Bilirubin.total [Moles/volume] in Serum or Plasma |
|
58941-6
|
Bilirubin [Mass/volume] in Skin |
|
72898-0
|
Bilirubin [Moles/volume] in Skin |
|
14423-8
|
Bilirubin.total [Mass/volume] in Synovial fluid |
|
1976-0
|
Bilirubin.total [Presence] in Stool |
|
1977-8
|
Bilirubin.total [Presence] in Urine |
|
58450-8
|
Bilirubin [Presence] in Urine by Confirmatory method |
|
5770-3
|
Bilirubin.total [Presence] in Urine by Test strip |
|
50551-1
|
Bilirubin.total [Presence] in Urine by Automated test strip |
|
53327-3
|
Bilirubin.total [Mass/volume] in Urine by Automated test strip |
|
68367-2
|
Bilirubin.total [Moles/volume] in Urine by Automated test strip |
|
20505-4
|
Bilirubin.total [Mass/volume] in Urine by Test strip |
|
41016-7
|
Bilirubin.total [Moles/volume] in Urine by Test strip |
|
1978-6
|
Bilirubin.total [Mass/volume] in Urine |
|
70199-5
|
Bilirubin.total [Moles/volume] in Urine |
|
33870-7
|
Bilirubin.total [Presence] in Unspecified specimen |
|
32303-0
|
Bilirubin.total [Moles/volume] in Unspecified specimen |
|
50041-3
|
Bilirubin+Urobilinogen [Presence] in Urine |
|
44075-0
|
Bilirubin casts [Presence] in Urine sediment by Light microscopy |
|
72261-1
|
Bilirubin excess [Moles/volume] in Serum and CSF |
|
43428-2
|
Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain |
|
77988-4
|
Binational reporting criteria [CDC.PHIN] |
|
75520-7
|
Biobank specimens are stored and available for research |
|
23669-5
|
Biochanin A [Mass/volume] in Serum or Plasma |
|
20697-9
|
Amines.biogenic [Mass/mass] in Feed |
|
74074-6
|
Biological product of Medication [AHRQ] |
|
92555-2
|
Biophysical agent plan to use |
|
89184-6
|
Biophysical agent used |
|
34681-7
|
Biopsy [Interpretation] in Muscle Narrative |
|
15211-6
|
Biopsy [Interpretation] in Thyroid Narrative |
|
52121-1
|
Biopsy [Interpretation] in Unspecified specimen Narrative |
|
1979-4
|
Biopterin [Mass/volume] in 24 hour Urine |
|
47581-4
|
Biopterin [Moles/volume] in Cerebral spinal fluid |
|
59247-7
|
Tetrahydrobiopterin [Moles/volume] in Cerebral spinal fluid |
|
33877-2
|
Tetrahydrobiopterin/Biopterin in Urine |
|
75039-8
|
Biopterin [Moles/volume] in Serum or Plasma |
|
34170-1
|
Biopterin [Moles/volume] in Urine |
|
79282-0
|
Biopterin/Biopterin+Neopterin [Molar ratio] in Urine |
|
47582-2
|
Biopterin/Creatinine [Molar ratio] in Urine |
|
46761-3
|
Biotinidase deficiency newborn screen interpretation |
|
57699-1
|
Biotinidase deficiency newborn screening comment-discussion |
|
31997-0
|
Biotin [Presence] in Blood |
|
1980-2
|
Biotin [Mass/volume] in Serum or Plasma |
|
34398-8
|
Biotin [Moles/volume] in Serum or Plasma |
|
1981-0
|
Biotinidase [Presence] in Blood |
|
38478-4
|
Biotinidase [Presence] in DBS |
|
75217-0
|
Biotinidase [Enzymatic activity/volume] in DBS |
|
54457-7
|
Biotinidase [Enzymatic activity/volume] in Serum or Plasma from Normal control |
|
32619-9
|
Biotinidase [Presence] in Serum or Plasma |
|
1982-8
|
Biotinidase [Enzymatic activity/volume] in Serum or Plasma |
|
80370-0
|
Biotinidase [Enzymatic activity/mass] in Serum or Plasma |
|
75162-8
|
Biphasic positive airway pressure (BIPAP) activity Ventilator |
|
58959-8
|
BIPAP AndOr CPAP setting Ventilator |
|
16322-0
|
Biperiden [Mass/volume] in Serum or Plasma |
|
38635-9
|
Biphenyl [Mass/volume] in Air |
|
71758-7
|
Bipolar score [M3] |
|
94019-7
|
Bipolar screening report |
|
94026-2
|
Bipolar disorder type |
|
87286-1
|
Birth attendant [Extended Identifier] |
|
73764-3
|
Birth attendant title Provider [US Standard Certificate of Live Birth] |
|
71230-7
|
Birth certificate |
|
80903-8
|
Birth certificate ID |
|
87287-9
|
Birth certifier [Extended Identifier] |
|
86651-7
|
Birth control method at exit Reported --at exit |
|
86649-1
|
Birth control method at intake Reported --at intake |
|
86652-5
|
How birth control method was provided |
|
21112-8
|
Birth date |
|
75092-7
|
Birth date of Fetus |
|
82157-9
|
Birth date Provider |
|
78034-6
|
Procedure that confirmed birth defect diagnosis |
|
77963-7
|
Birth defects diagnosis Narrative |
|
85580-9
|
Birth defects Hospital Registry report |
|
75609-8
|
Birth defects Outpatient Registry report |
|
62331-4
|
Birth hospital facility address |
|
62329-8
|
Birth hospital facility ID |
|
62330-6
|
Birth hospital facility name |
|
62332-2
|
Birth hospital facility phone number |
|
73771-8
|
Birth order |
|
87297-8
|
Birth registration date |
|
57715-5
|
Birth time |
|
80904-6
|
Birth year |
|
11636-8
|
[#] Births.live |
|
11637-6
|
[#] Births.preterm |
|
11638-4
|
[#] Births.still living |
|
11639-2
|
[#] Births.term |
|
11640-0
|
[#] Births total |
|
48042-6
|
Bisacodyl cutoff [Mass/mass] in Stool |
|
4142-6
|
Bisacodyl [Mass] of Dose |
|
49515-0
|
Bisacodyl [Mass/volume] in Stool |
|
10889-4
|
Bisacodyl [Mass/mass] in Stool |
|
43912-5
|
Bisacodyl [Presence] in Urine |
|
27180-9
|
Bisacodyl [Mass/volume] in Urine |
|
43878-8
|
Bismuth [Presence] in 24 hour Urine |
|
21113-6
|
Bismuth [Mass/volume] in 24 hour Urine |
|
29918-0
|
Bismuth [Mass/time] in 24 hour Urine |
|
52887-7
|
Bismuth [Moles/time] in 24 hour Urine |
|
16467-3
|
Bismuth [Presence] in Blood |
|
8161-2
|
Bismuth [Mass/volume] in Blood |
|
81429-3
|
Bismuth [Moles/volume] in Blood |
|
9493-8
|
Bismuth [Mass/volume] in Body fluid |
|
60057-7
|
Bismuth [Mass/mass] in Hair |
|
50826-7
|
Bismuth [Moles/mass] in Hair |
|
60058-5
|
Bismuth [Mass/volume] in Red Blood Cells |
|
43894-5
|
Bismuth [Presence] in Serum or Plasma |
|
5597-0
|
Bismuth [Mass/volume] in Serum or Plasma |
|
25351-8
|
Bismuth [Moles/volume] in Serum or Plasma |
|
60059-3
|
Bismuth [Mass/mass] in Tissue |
|
16468-1
|
Bismuth [Presence] in Urine |
|
5598-8
|
Bismuth [Mass/volume] in Urine |
|
52898-4
|
Bismuth [Moles/volume] in Urine |
|
43886-1
|
Bismuth [Presence] in Unspecified specimen |
|
29940-4
|
Bismuth/Creatinine [Mass Ratio] in 24 hour Urine |
|
52906-5
|
Bismuth/Creatinine [Molar ratio] in 24 hour Urine |
|
16469-9
|
Bismuth/Creatinine [Mass Ratio] in Urine |
|
52907-3
|
Bismuth/Creatinine [Molar ratio] in Urine |
|
75918-3
|
Bispectral index Cerebral cortex Electroencephalogram (EEG) |
|
59288-1
|
Bisphenol A [Mass/volume] in Urine |
|
10371-3
|
Bite cells [Presence] in Blood by Light microscopy |
|
50714-5
|
Bitter dock IgE Ab [Units/volume] in Serum |
|
73503-5
|
Bivalirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73502-7
|
Bivalirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
43584-2
|
Bizarre cells [Presence] in Blood by Light microscopy |
|
60455-3
|
Bizarre platelets [Presence] in Blood by Light microscopy |
|
31152-2
|
Immunoglobulin light chains [Presence] in 24 hour Urine |
|
17793-1
|
Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
|
46084-0
|
Immunoglobulin light chains [Mass/time] in 24 hour Urine |
|
51406-7
|
Immunoglobulin light chains.free [Mass/time] in 24 hour Urine |
|
56125-8
|
Immunoglobulin light chains.free [Presence] in Serum |
|
55897-3
|
Immunoglobulin light chains.free [Presence] in Serum by Immunoelectrophoresis |
|
55898-1
|
Immunoglobulin light chains.free [Presence] in Serum by Immunofixation |
|
14977-3
|
Immunoglobulin light chains.free [Type] in Urine |
|
55899-9
|
Immunoglobulin light chains.free [Presence] in Urine by Electrophoresis |
|
55900-5
|
Immunoglobulin light chains.free [Presence] in Urine by Immunofixation |
|
11219-3
|
Immunoglobulin light chains [Presence] in Serum |
|
1928-1
|
Immunoglobulin light chains [Presence] in Urine |
|
14795-9
|
Immunoglobulin light chains [Interpretation] in Urine |
|
49270-2
|
Immunoglobulin light chains [Interpretation] in Urine Narrative |
|
1929-9
|
Immunoglobulin light chains [Mass/volume] in Urine |
|
79235-8
|
Butylone cutoff [Mass/volume] in Urine for Confirmatory method |
|
79234-1
|
Butylone [Mass/volume] in Urine by Confirmatory method |
|
79244-0
|
Ethylone cutoff [Mass/volume] in Urine for Confirmatory method |
|
79243-2
|
Ethylone [Mass/volume] in Urine by Confirmatory method |
|
26645-2
|
BK virus Ab [Presence] in Serum |
|
49346-0
|
BK virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49345-2
|
BK virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49344-5
|
BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49343-7
|
BK virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
41479-7
|
BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49342-9
|
BK virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
41480-5
|
BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
48309-9
|
BK virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
63475-8
|
BK virus DNA [Presence] in Blood |
|
46970-0
|
BK virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
32284-2
|
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
44805-0
|
BK virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
32362-6
|
BK virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
32285-9
|
BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection |
|
90924-2
|
BK virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
|
33978-8
|
BK virus DNA [Presence] in Urine by NAA with probe detection |
|
42587-6
|
BK virus DNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
43201-3
|
BK virus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
47251-4
|
BK virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62466-8
|
BK virus IgG Ab [Presence] in Serum or Plasma |
|
72484-9
|
BK virus subtype in Blood by NAA with probe detection |
|
72483-1
|
BK virus subtype in Serum or Plasma by NAA with probe detection |
|
72482-3
|
BK virus subtype in Tissue by NAA with probe detection |
|
72412-0
|
BK virus subtype in Urine by NAA with probe detection |
|
72413-8
|
BK virus subtype in Unspecified specimen by NAA with probe detection |
|
90440-9
|
BK virus + JC virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
64967-3
|
Black Alder recombinant (rAln g) 1 IgE Ab [Units/volume] in Serum |
|
7083-9
|
Black Ant triggered histamine release [Units/volume] in Blood |
|
6044-2
|
Black Ant IgE Ab [Units/volume] in Serum |
|
21067-4
|
Black Ant IgE Ab RAST class [Presence] in Serum |
|
7082-1
|
Black Ant IgG Ab [Units/volume] in Serum |
|
21077-3
|
Black Ash IgE Ab [Units/volume] in Serum |
|
21096-3
|
Black Bean IgE Ab [Units/volume] in Serum |
|
21097-1
|
Black Bean IgE Ab RAST class [Presence] in Serum |
|
18417-6
|
Black Bean IgG Ab [Units/volume] in Serum |
|
7254-6
|
Black Cottonwood IgE Ab [Units/volume] in Serum |
|
15954-1
|
Black Cottonwood IgE Ab RAST class [Presence] in Serum |
|
15341-1
|
Black Fly IgE Ab [Units/volume] in Serum |
|
15716-4
|
Black Fly IgE Ab RAST class [Presence] in Serum |
|
7086-2
|
Black Imported Fire Ant IgE Ab [Units/volume] in Serum |
|
7473-2
|
Black Locust IgE Ab [Units/volume] in Serum |
|
15823-8
|
Black Locust IgE Ab RAST class [Presence] in Serum |
|
7528-3
|
Black Oak IgE Ab [Units/volume] in Serum |
|
7589-5
|
Black Pepper triggered histamine release [Units/volume] in Blood |
|
6045-9
|
Black Pepper IgE Ab [Units/volume] in Serum |
|
15925-1
|
Black Pepper IgE Ab RAST class [Presence] in Serum |
|
50364-9
|
Black Pepper IgE Ab/IgE total in Serum |
|
7588-7
|
Black Pepper IgG Ab [Units/volume] in Serum |
|
21449-4
|
Black Pepper IgG Ab RAST class [Presence] in Serum |
|
56450-0
|
Black Pepper IgG4 Ab [Mass/volume] in Serum |
|
60392-8
|
Black Pepper IgG Ab [Mass/volume] in Serum |
|
7763-6
|
Black Walnut IgE Ab [Units/volume] in Serum |
|
16075-4
|
Black Walnut IgE Ab RAST class [Presence] in Serum |
|
24136-4
|
Black Walnut IgG Ab [Units/volume] in Serum |
|
6046-7
|
Black Walnut Pollen IgE Ab [Units/volume] in Serum |
|
16076-2
|
Black Walnut Pollen IgE Ab RAST class [Presence] in Serum |
|
7764-4
|
Black Western Walnut IgE Ab [Units/volume] in Serum |
|
6862-7
|
Black Willow IgE Ab [Units/volume] in Serum |
|
16092-9
|
Black Willow IgE Ab RAST class [Presence] in Serum |
|
56193-6
|
Black Willow IgG4 Ab [Mass/volume] in Serum |
|
7151-4
|
Blackberry IgE Ab [Units/volume] in Serum |
|
15580-4
|
Blackberry IgE Ab RAST class [Presence] in Serum |
|
45227-6
|
Blackberry IgE Ab/IgE total in Serum |
|
56194-4
|
Blackberry IgG4 Ab [Mass/volume] in Serum |
|
63112-7
|
Blackberry IgG Ab [Mass/volume] in Serum |
|
7571-3
|
Black-eye pea IgE Ab [Units/volume] in Serum |
|
15914-5
|
Black-eye pea IgE Ab RAST class [Presence] in Serum |
|
7572-1
|
Black-eye pea IgG Ab [Units/volume] in Serum |
|
56195-1
|
Black-eye pea IgG4 Ab [Mass/volume] in Serum |
|
63100-2
|
Black-eye pea IgG Ab [Mass/volume] in Serum |
|
11177-3
|
Lactalbumin beta IgE Ab [Units/volume] in Serum |
|
15576-2
|
Lactalbumin beta IgE Ab RAST class [Presence] in Serum |
|
6984-9
|
Beta lactamase.extended spectrum [Susceptibility] |
|
20423-0
|
Beta lactamase organism identified in Isolate |
|
6985-6
|
Beta lactamase.usual [Susceptibility] |
|
41397-1
|
Beta lactoglobulin IgE Ab [Units/volume] in Serum |
|
15577-0
|
Beta lactoglobulin IgE Ab RAST class [Presence] in Serum |
|
57914-4
|
Beta lactoglobulin IgE Ab/IgE total in Serum |
|
51531-2
|
Beta lactoglobulin IgG Ab [Presence] in Serum |
|
11160-9
|
Beta lactoglobulin IgG Ab [Units/volume] in Serum |
|
21109-4
|
Beta lactoglobulin IgG Ab RAST class [Presence] in Serum |
|
56302-3
|
Beta lactoglobulin IgG4 Ab [Mass/volume] in Serum |
|
63090-5
|
Beta lactoglobulin IgG Ab [Mass/volume] in Serum |
|
48205-9
|
Beta lactoglobulin triggered leukotriene release [Mass/volume] by Leukocytes |
|
6042-6
|
Beta lactoglobulin MF77 IgE Ab [Units/volume] in Serum |
|
88250-6
|
Cephalosporin resistance blaCTX-M gene [Presence] by Molecular method |
|
85835-7
|
Beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 Group genes [Presence] by Molecular method |
|
86624-4
|
Bladder and bowel appliances used in last 7 days [CMS Assessment] |
|
11278-9
|
Bladder cells [#/area] in Urine sediment by Microscopy high power field |
|
58456-5
|
Bladder cells [Presence] in Urine sediment by Light microscopy |
|
83238-6
|
Bladder continence during 3 day assessment period [CMS Assessment] |
|
84906-7
|
Bladder neck involvement of Prostate tumor |
|
66125-6
|
Urinary bladder Pathology biopsy report |
|
76278-1
|
Bladder temperature via Foley |
|
28551-0
|
Bladder tumor Ag [Units/volume] in Urine by Immunoassay |
|
31729-7
|
Bladder tumor Ag [Presence] in Urine |
|
28078-4
|
Bladder tumor Ag [Presence] in Urine by Immunoassay |
|
80386-6
|
Bladder tumor Ag [Presence] in Urine by Rapid immunoassay |
|
31730-5
|
Bladder tumor Ag [Units/volume] in Urine |
|
85823-3
|
Carbapenem resistance blaGES gene [Presence] by Molecular method |
|
85833-2
|
Carbapenem resistance blaGIM gene [Presence] by Molecular method |
|
88245-6
|
Carbapenem resistance blaIMP gene [Presence] by Probe in Positive blood culture |
|
85824-1
|
Carbapenem resistance blaIMP gene [Presence] by NAA with probe detection |
|
85498-4
|
Carbapenem resistance blaIMP gene [Presence] by Molecular method |
|
85499-2
|
Carbapenem resistance blaKPC gene [Presence] by NAA with probe detection |
|
85788-8
|
Carbapenem resistance blaKPC gene [Presence] by NAA with non-probe detection in Positive blood culture |
|
88246-4
|
Carbapenem resistance blaKPC gene [Presence] by Probe in Positive blood culture |
|
49617-4
|
Carbapenem resistance blaKPC gene [Presence] by Molecular method |
|
85500-7
|
Carbapenem resistance blaNDM gene [Presence] by NAA with probe detection |
|
88247-2
|
Carbapenem resistance blaNDM gene [Presence] by Probe in Positive blood culture |
|
73982-1
|
Carbapenem resistance blaNDM gene [Presence] by Molecular method |
|
88248-0
|
Carbapenem resistance blaOXA gene [Presence] by Probe in Positive blood culture |
|
86712-7
|
Carbapenem resistance blaOXA gene [Presence] by Molecular method |
|
86713-5
|
Carbapenem resistance blaOXA-134-like gene [Presence] by Molecular method |
|
93390-3
|
Carbapenem resistance blaOXA-23-like+blaOXA-48-like genes [Presence] in Isolate or Specimen by Molecular genetics method |
|
85825-8
|
Carbapenem resistance blaOXA-23-like gene [Presence] by Molecular method |
|
85826-6
|
Carbapenem resistance blaOXA-24-like gene [Presence] by Molecular method |
|
85503-1
|
Carbapenem resistance blaOXA-48 gene [Presence] by Molecular method |
|
86220-1
|
Carbapenem resistance blaOXA-48 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
85827-4
|
Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method |
|
86714-3
|
Carbapenem resistance blaOXA-51-like gene [Presence] by Molecular method |
|
85828-2
|
Carbapenem resistance blaOXA-58-like gene [Presence] by Molecular method |
|
85829-0
|
Carbapenem resistance blaSPM gene [Presence] by Molecular method |
|
93432-3
|
Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay |
|
93431-5
|
Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
93430-7
|
Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
93429-9
|
Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay |
|
30376-8
|
Blasts [#/volume] in Blood |
|
66134-8
|
Blasts [#/volume] in Blood from Fetus by Manual count |
|
708-8
|
Blasts [#/volume] in Blood by Manual count |
|
74395-5
|
Blasts [#/volume] in Cord blood |
|
35068-6
|
Blasts [#/volume] in Cerebral spinal fluid |
|
35067-8
|
Blasts [#/volume] in Body fluid |
|
40570-4
|
Blasts [#/volume] in Body fluid by Manual count |
|
35066-0
|
Blasts [#/volume] in Pleural fluid |
|
35065-2
|
Blasts [#/volume] in Peritoneal fluid |
|
35064-5
|
Blasts [#/volume] in Synovial fluid |
|
74233-8
|
Blasts assessment in Bone marrow Narrative |
|
15154-8
|
Blasts [Presence] in Blood by Automated count |
|
44017-2
|
Blasts [Presence] in Blood by Light microscopy |
|
56470-8
|
Blasts [#] in Cerebral spinal fluid by Manual count |
|
76403-5
|
Blasts [#] in Body fluid by Manual count |
|
74851-7
|
Blasts/100 cells in Lymph node by Manual count |
|
11150-0
|
Blasts/100 cells in Bone marrow |
|
61126-9
|
Blasts/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
71669-6
|
Blasts/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71656-3
|
Blasts/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71644-9
|
Blasts/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
26446-5
|
Blasts/100 leukocytes in Blood |
|
74460-7
|
Blasts/100 leukocytes in Blood from Fetus |
|
709-6
|
Blasts/100 leukocytes in Blood by Manual count |
|
74455-7
|
Blasts/100 leukocytes in Cord blood |
|
26447-3
|
Blasts/100 leukocytes in Cerebral spinal fluid |
|
13521-0
|
Blasts/100 leukocytes in Cerebral spinal fluid by Manual count |
|
26448-1
|
Blasts/100 leukocytes in Body fluid |
|
13522-8
|
Blasts/100 leukocytes in Body fluid by Manual count |
|
33412-8
|
Blasts/100 leukocytes in Pericardial fluid |
|
33373-2
|
Blasts/100 leukocytes in Pleural fluid |
|
33372-4
|
Blasts/100 leukocytes in Peritoneal fluid |
|
33374-0
|
Blasts/100 leukocytes in Synovial fluid |
|
88249-8
|
Carbapenem resistance blaVIM gene [Presence] by Probe in Positive blood culture |
|
85830-8
|
Carbapenem resistance blaVIM gene [Presence] by NAA with probe detection |
|
85501-5
|
Carbapenem resistance blaVIM gene [Presence] by Molecular method |
|
80736-2
|
Blood banking and transfusion medicine Consult note |
|
84067-8
|
Blood banking and transfusion medicine Note |
|
83620-5
|
Blood banking and transfusion medicine Nurse Note |
|
89797-5
|
Blood banking and transfusion medicine Telephone encounter Note |
|
89796-7
|
Blood banking and transfusion medicine procedure note |
|
89795-9
|
Blood banking and transfusion medicine Progress note |
|
923-3
|
Blood collection bag lot [Identifier] |
|
82756-8
|
Date of blood donation |
|
74859-0
|
Ethanol [Mass/volume] in Blood Estimated from serum or plasma level |
|
20355-4
|
Peak blood flow 2 by US.doppler |
|
20356-2
|
Mean blood flow 2 by US.doppler |
|
76283-1
|
Blood flow rate Pulmonary capillaries |
|
15330-4
|
Penile cavernosal artery End diastolic blood flow--baseline by US.doppler |
|
15331-2
|
Penile cavernosal artery End diastolic blood flow--post XXX challenge by US.doppler |
|
19071-0
|
Blood removed from patient [Volume] |
|
902-7
|
Blood group antibody screen.autologous [Presence] in Serum or Plasma by Prewarmed |
|
893-8
|
Blood group antibody screen.autologous [Interpretation] in Serum or Plasma |
|
14576-3
|
Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review |
|
14575-5
|
Blood group antibody investigation [Interpretation] in Plasma or RBC |
|
34478-8
|
Blood group antibodies identified in Blood by Chromogenic method |
|
69369-7
|
Blood group antibody screen [Presence] in Cord blood |
|
891-2
|
Blood group antibody screen.cell I [Presence] in Serum or Plasma |
|
898-7
|
Blood group antibody screen.cell I [Presence] in Serum or Plasma by Prewarmed |
|
894-6
|
Blood group antibody screen.cell II [Presence] in Serum or Plasma |
|
899-5
|
Blood group antibody screen.cell II [Presence] in Serum or Plasma by Prewarmed |
|
892-0
|
Blood group antibody screen.cell III [Presence] in Serum or Plasma |
|
900-1
|
Blood group antibody screen.cell III [Presence] in Serum or Plasma by Prewarmed |
|
895-3
|
Blood group antibody screen.cells I+II+III [Presence] in Serum or Plasma |
|
901-9
|
Blood group antibody screen.cells I+II+III [Presence] in Serum or Plasma by Prewarmed |
|
46271-3
|
Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction |
|
18273-3
|
Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit |
|
18274-1
|
Blood group antibody screen [Presence] in Serum or Plasma from Donor |
|
890-4
|
Blood group antibody screen [Presence] in Serum or Plasma |
|
896-1
|
Blood group antibody screen [Presence] in Serum or Plasma by Cold absorption |
|
897-9
|
Blood group antibody screen [Presence] in Serum or Plasma by Elution |
|
75263-4
|
Blood group antibody screen [Presence] in Serum or Plasma by GEL |
|
75264-2
|
Blood group antibody screen [Presence] in Serum or Plasma by Low ionic strength saline (LISS) |
|
75265-9
|
Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method |
|
14606-8
|
Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed |
|
903-5
|
Blood group antibody screen [Presence] in Serum or Plasma by RESt absorption |
|
32638-9
|
Blood group antibody screen [Presence] in Serum or Plasma by Saline method |
|
904-3
|
Blood group antibody screen [Presence] in Serum or Plasma by Warm absorption |
|
15343-7
|
Blood group antibody screen [Titer] in Serum or Plasma |
|
30008-7
|
Blood group antibody screen [Titer] in Serum or Plasma by Albumin technique |
|
49057-3
|
Blood group antibody score |
|
50401-9
|
Blood group antibody titered [Identifier] in Serum or Plasma |
|
81661-1
|
Blood loss [Volume] Measured |
|
924-1
|
Blood product dispensed [Volume] |
|
925-8
|
Blood product disposition [Type] |
|
928-2
|
Blood product reaction [Type] |
|
929-0
|
Blood product release time |
|
930-8
|
Blood product reservation [Date and time] |
|
931-6
|
Blood product source [Type] |
|
10390-3
|
Blood product special preparation [Type] |
|
933-2
|
Blood product type |
|
710-4
|
Blood smear finding positive [Identifier] in Blood by Light microscopy |
|
5909-7
|
Blood smear finding [Identifier] in Blood by Light microscopy |
|
82312-0
|
Blood transfusion andor organ transplant 12 months |
|
936-5
|
Blood product unit [Identifier] |
|
33867-3
|
Blood velocity/Blood velocity 2 by US |
|
30899-9
|
Blood volume by Scintigraphy |
|
49499-7
|
Blood.dried/Total of Stone |
|
47227-4
|
Blood.dried [Presence] of Stone Qualitative |
|
72325-4
|
Arterial blood Functional shunt volume adjusted to patient's actual temperature |
|
72326-2
|
Arterial blood Functional shunt volume |
|
72324-7
|
Arterial blood and Mixed venous blood Functional shunt volume adjusted to patient's actual temperature |
|
10775-5
|
Microscopic observation [Identifier] in Tissue by Bleach stain |
|
81225-5
|
Bleeding risk [CCC] |
|
11067-6
|
Bleeding time |
|
3178-1
|
Bleeding time by Duke method |
|
3179-9
|
Bleeding time by Ivy method |
|
26823-5
|
Lutropin.beta subunit [Mass/volume] in Serum or Plasma |
|
2583-3
|
Lutropin.beta subunit [Moles/volume] in Serum or Plasma |
|
43899-4
|
Beta lipotropin [Presence] in Serum or Plasma |
|
1949-7
|
Beta lipotropin [Mass/volume] in Serum or Plasma |
|
10372-1
|
Blister cells [Presence] in Blood by Light microscopy |
|
32640-5
|
BLM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46991-6
|
BLM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48331-3
|
BLM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
81178-6
|
Tissue block description and site Narrative |
|
85346-5
|
Tissue blocks examined [#] in Specimen |
|
85326-7
|
Tissue blocks positive for DCIS [#] in Breast cancer specimen by Light microscopy |
|
20467-7
|
Blood bank alert |
|
19066-0
|
Blood bank comment |
|
33720-4
|
Blood bank consult |
|
41914-3
|
Type of Blood coagulation device |
|
41916-8
|
Blood coagulation device Vendor model code |
|
41917-6
|
Blood coagulation device Vendor serial number |
|
41918-4
|
Blood coagulation device Vendor software version |
|
41915-0
|
Blood coagulation device Vendor name |
|
52041-1
|
Blood glucose monitor attachment |
|
92552-9
|
Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue from Donor by Molecular genetics method |
|
92514-9
|
Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue by Molecular genetics method |
|
43739-2
|
Blood group Ag [Interpretation] on Red Blood Cells from Blood product unit |
|
889-6
|
Blood group antibodies identified in Blood product unit |
|
888-8
|
Blood group antibodies identified in Serum or Plasma |
|
14604-3
|
Blood group antibodies identified in Serum or Plasma from Blood product unit |
|
34480-4
|
Blood group antibodies identified in Serum or Plasma by Cold incubation |
|
34479-6
|
Blood group antibodies identified in Serum or Plasma by Cold absorption |
|
14605-0
|
Blood group antibodies identified in Serum or Plasma from Donor |
|
34477-0
|
Blood group antibodies identified in Serum or Plasma by Elution |
|
34481-2
|
Blood group antibodies identified in Serum or Plasma by Warm incubation |
|
34482-0
|
Blood group antibodies identified in Serum or Plasma by Warm absorption |
|
72076-3
|
Blood pressure home reading |
|
72273-6
|
Blood product ordered [Volume] in Blood product unit |
|
79569-0
|
Blood product given [Type] |
|
80726-3
|
Blood sampling performed Cardiac catheterization |
|
60834-9
|
Blood temperature |
|
89067-3
|
Type of blood thinning medication used |
|
53963-5
|
Blood [Presence] in Urine by Visual |
|
6047-5
|
Bloodworm IgE Ab [Units/volume] in Serum |
|
15582-0
|
Bloodworm IgE Ab RAST class [Presence] in Serum |
|
7203-3
|
Blue Cheese IgE Ab [Units/volume] in Serum |
|
25368-2
|
Blue Cheese IgE Ab RAST class [Presence] in Serum |
|
7520-0
|
Blue mussel triggered histamine release [Units/volume] in Blood |
|
6048-3
|
Blue mussel IgE Ab [Units/volume] in Serum |
|
15869-1
|
Blue mussel IgE Ab RAST class [Presence] in Serum |
|
39596-2
|
Blue mussel IgE Ab/IgE total in Serum |
|
7519-2
|
Blue mussel IgG Ab [Units/volume] in Serum |
|
56327-0
|
Blue mussel IgG4 Ab [Mass/volume] in Serum |
|
63085-5
|
Blue mussel IgG Ab [Mass/volume] in Serum |
|
21538-4
|
Blue Spruce IgE Ab RAST class [Presence] in Serum |
|
19729-3
|
Blue vetch IgE Ab [Units/volume] in Serum |
|
25815-2
|
Blue vetch IgE Ab RAST class [Presence] in Serum |
|
7154-8
|
Blueberry triggered histamine release [Units/volume] in Blood |
|
7152-2
|
Blueberry IgE Ab [Units/volume] in Serum |
|
15583-8
|
Blueberry IgE Ab RAST class [Presence] in Serum |
|
39609-3
|
Blueberry IgE Ab/IgE total in Serum |
|
7153-0
|
Blueberry IgG Ab [Units/volume] in Serum |
|
21115-1
|
Blueberry IgG Ab RAST class [Presence] in Serum |
|
56196-9
|
Blueberry IgG4 Ab [Mass/volume] in Serum |
|
58035-7
|
Blueberry IgG Ab [Mass/volume] in Serum |
|
22915-3
|
Bovine leukemia virus Ab [Presence] in Milk |
|
22916-1
|
Bovine leukemia virus Ab [Presence] in Milk by Immunoassay |
|
22144-0
|
Bovine leukemia virus Ab [Presence] in Serum |
|
15460-9
|
Bovine leukemia virus Ab [Presence] in Serum by Immunoassay |
|
15461-7
|
Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31274-4
|
Bovine leukemia virus Ab [Units/volume] in Serum |
|
43073-6
|
Bovine leukemia virus Ab [Titer] in Serum |
|
23677-8
|
Bovine leukemia virus Ab [Titer] in Serum by Complement fixation |
|
22917-9
|
Bovine leukemia virus Ag [Presence] in Unspecified specimen |
|
23593-7
|
Bovine leukemia virus [Presence] in Blood by Organism specific culture |
|
22918-7
|
Bovine leukemia virus RNA [Presence] in Blood by NAA with probe detection |
|
22919-5
|
Bovine leukemia virus RNA [Presence] in Tissue by NAA with probe detection |
|
63566-4
|
Basement membrane Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
9329-4
|
Basement membrane Ab [Units/volume] in Serum by Immunoassay |
|
16434-3
|
Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
|
16433-5
|
Basement membrane Ab [Presence] in Serum |
|
5056-7
|
Basement membrane Ab [Presence] in Serum by Immunofluorescence |
|
31252-0
|
Basement membrane Ab [Units/volume] in Serum |
|
10862-1
|
Basement membrane Ab [Titer] in Serum |
|
57737-9
|
Basement membrane Ab [Titer] in Serum by Immunofluorescence |
|
80261-1
|
Bowel movement frequency |
|
31253-8
|
Basement membrane IgA Ab [Presence] in Serum |
|
29995-8
|
Basement membrane IgA Ab [Presence] in Serum by Immunofluorescence |
|
44445-5
|
Basement membrane IgA Ab [Units/volume] in Serum |
|
29997-4
|
Basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
|
44446-3
|
Basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
21093-0
|
Basement membrane IgG Ab [Interpretation] in Serum by Immunofluorescence |
|
31255-3
|
Basement membrane IgG Ab [Presence] in Serum |
|
43814-3
|
Basement membrane IgG Ab [Presence] in Serum by Immunoassay |
|
29994-1
|
Basement membrane IgG Ab [Presence] in Serum by Immunofluorescence |
|
31254-6
|
Basement membrane IgG Ab [Units/volume] in Serum |
|
43875-4
|
Basement membrane IgM Ab [Presence] in Serum |
|
80263-7
|
Bowel movement regularity |
|
80262-9
|
Bowel movement usual time of day |
|
47398-3
|
Beta mannosidase actual/normal in Leukocytes |
|
24067-1
|
Beta mannosidase [Enzymatic activity/mass] in Fibroblast |
|
24066-3
|
Beta mannosidase [Enzymatic activity/volume] in Serum or Plasma |
|
24068-9
|
Beta mannosidase [Enzymatic activity/mass] in Leukocytes |
|
89270-3
|
Body mass index (BMI) [Ratio] Estimated |
|
75735-1
|
BMPR1A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
87756-3
|
BMPR1A and SMAD4 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
50042-1
|
Basal metabolic rate index |
|
1950-5
|
Beta melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
|
38440-4
|
Basement membrane zone Ab [Presence] in Serum |
|
38410-7
|
Basement membrane zone Ab [Titer] in Serum |
|
57738-7
|
Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay |
|
45188-0
|
Basement membrane zone BP180 Ab [Units/volume] in Serum |
|
53842-1
|
Basement membrane zone BP180 IgG Ab [Units/volume] in Serum or Plasma |
|
57911-0
|
Basement membrane zone BP230 Ab [Units/volume] in Serum or Plasma |
|
53807-4
|
Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
53843-9
|
Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma |
|
45178-1
|
Basement membrane zone IgG Ab [Presence] in Serum by Immunofluorescence |
|
2643-5
|
N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum |
|
33354-2
|
N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine |
|
48995-5
|
N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine |
|
29542-8
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Amniotic fluid cells |
|
79458-6
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in DBS |
|
24074-7
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Fibroblast |
|
18344-2
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets |
|
1954-7
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum or Plasma |
|
1955-4
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue |
|
12913-0
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes |
|
24075-4
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Leukocytes |
|
33655-2
|
Beta-N-acetylhexosaminidase [Moles/volume] in Leukocytes |
|
40460-8
|
Phenytoin.bound [Mass/volume] in Serum or Plasma |
|
42637-9
|
Natriuretic peptide B [Mass/volume] in Blood |
|
30934-4
|
Natriuretic peptide B [Mass/volume] in Serum or Plasma |
|
35257-5
|
Natriuretic peptide B [Mass or Moles/volume] in Serum or Plasma |
|
47092-2
|
Natriuretic peptide B [Moles/volume] in Serum or Plasma |
|
53637-5
|
BOB1 Ag [Presence] in Tissue by Immune stain |
|
72859-2
|
Boceprevir [Susceptibility] by Genotype method |
|
10776-3
|
Microscopic observation [Identifier] in Tissue by Bodian stain |
|
94131-0
|
Body disposition facility address |
|
94130-2
|
Body disposition facility name [Identifier] |
|
80905-3
|
Body disposition method |
|
73708-0
|
Body fat [Mass] Calculated |
|
14725-6
|
[Type] of Body fluid |
|
76444-9
|
Body function ICF code |
|
39108-6
|
Body hair distribution [Interpretation] |
|
89269-5
|
Body height Measured --at birth |
|
83845-8
|
Body height Father |
|
3137-7
|
Body height Measured |
|
83846-6
|
Body height Mother |
|
92999-2
|
Body height --sitting |
|
91370-7
|
Body height --used for drug calculation |
|
83844-1
|
Body height method |
|
73964-9
|
Body muscle mass Calculated |
|
73965-6
|
Body muscle mass/Body weight Measured |
|
74727-9
|
Body condition score Jefferies |
|
76445-6
|
Body structure ICF code |
|
61008-9
|
Body surface temperature |
|
90734-5
|
Body weight change goal |
|
93473-7
|
Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method |
|
57336-0
|
Beta hydroxybutyrate [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
43898-6
|
Beta hydroxybutyrate [Presence] in 24 hour Urine |
|
66441-7
|
Beta hydroxybutyrate [Moles/volume] in Blood by Test strip |
|
1946-3
|
Beta hydroxybutyrate [Mass/volume] in Cerebral spinal fluid |
|
16455-8
|
Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
|
1681-6
|
Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood |
|
1682-4
|
Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
72416-1
|
Beta hydroxybutyrate [Moles/volume] in Blood --post meal |
|
72417-9
|
Beta hydroxybutyrate [Moles/volume] in Blood --pre-meal |
|
43923-2
|
Beta hydroxybutyrate [Presence] in Serum or Plasma |
|
29512-1
|
Beta hydroxybutyrate [Mass/volume] in Serum or Plasma |
|
35255-9
|
Beta hydroxybutyrate [Mass or Moles/volume] in Serum or Plasma |
|
6873-4
|
Beta hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
29622-8
|
Beta hydroxybutyrate [Presence] in Urine |
|
1947-1
|
Beta hydroxybutyrate [Mass/volume] in Urine |
|
16456-6
|
Beta hydroxybutyrate [Moles/volume] in Urine |
|
58685-9
|
Beta hydroxybutyrate [Moles/volume] in Vitreous fluid |
|
50099-1
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood |
|
50100-7
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Cerebral spinal fluid |
|
72419-5
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --post meal |
|
72418-7
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --pre-meal |
|
13684-6
|
Beta hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
|
29509-7
|
Beta hydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
72603-4
|
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood |
|
72602-6
|
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood --post meal |
|
72601-8
|
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood --pre-meal |
|
41269-2
|
Beta hydroxybutyrate + Gamma aminobutyrate [Moles/volume] in Serum or Plasma |
|
22905-4
|
Bovine herpesvirus 1 Ab [Presence] in Milk |
|
22903-9
|
Bovine herpesvirus 1 Ab [Presence] in Milk by Immunoassay |
|
22142-4
|
Bovine herpesvirus 1 Ab [Presence] in Serum |
|
30034-3
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Complement fixation |
|
20845-4
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Immunoassay |
|
22902-1
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
|
22901-3
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
22904-7
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
31273-6
|
Bovine herpesvirus 1 Ab [Units/volume] in Serum |
|
22143-2
|
Bovine herpesvirus 1 Ab [Titer] in Serum |
|
15459-1
|
Bovine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
|
31744-6
|
Bovine herpesvirus 1 Ag [Presence] in Genital specimen |
|
22911-2
|
Bovine herpesvirus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
|
31745-3
|
Bovine herpesvirus 1 Ag [Presence] in Nose |
|
22907-0
|
Bovine herpesvirus 1 Ag [Presence] in Nose by Immunofluorescence |
|
20846-2
|
Bovine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
22912-0
|
Bovine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
|
22908-8
|
Bovine herpesvirus 1 Ag [Units/volume] in Unspecified specimen by Neutralization test |
|
31746-1
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen |
|
22906-2
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunoassay |
|
22910-4
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22909-6
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immune stain |
|
31747-9
|
Bovine herpesvirus 1 Ag [Units/volume] in Unspecified specimen |
|
22913-8
|
Bovine herpesvirus 1 DNA [Presence] in Semen by NAA with probe detection |
|
22914-6
|
Bovine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
31748-7
|
Bovine herpesvirus 2 Ag [Presence] in Exudate |
|
20847-0
|
Bovine herpesvirus 2 Ag [Presence] in Exudate by Immunofluorescence |
|
20848-8
|
Bovine herpesvirus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
31749-5
|
Bovine herpesvirus 4 Ag [Presence] in Body fluid |
|
20849-6
|
Bovine herpesvirus 4 Ag [Presence] in Body fluid by Immunofluorescence |
|
20850-4
|
Bovine herpesvirus 4 Ag [Presence] in Tissue by Immunofluorescence |
|
20851-2
|
Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence |
|
3404-1
|
Bolasterone [Mass/time] in 24 hour Urine |
|
4143-4
|
Bolasterone [Mass] of Dose |
|
3402-5
|
Bolasterone [Presence] in Urine |
|
3403-3
|
Bolasterone [Mass/volume] in Urine |
|
43859-8
|
Bolasterone [Presence] in Unspecified specimen |
|
5601-0
|
Boldenone [Mass/time] in 24 hour Urine |
|
5599-6
|
Boldenone [Presence] in Urine |
|
5600-2
|
Boldenone [Mass/volume] in Urine |
|
44024-8
|
Boldenone [Presence] in Unspecified specimen |
|
85738-3
|
Bombay phenotype [Presence] on Red Blood Cells from Blood product unit |
|
85739-1
|
Bombay phenotype [Presence] on Red Blood Cells from Donor |
|
85737-5
|
Bombay phenotype [Presence] on Red Blood Cells |
|
15354-4
|
Bombesin Ag [Presence] in Tissue by Immune stain |
|
10874-6
|
Bombesin [Mass/volume] in Plasma |
|
58478-9
|
Bombus sp IgG Ab [Mass/volume] in Serum |
|
93187-3
|
Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel |
|
85150-1
|
Bone age method |
|
87480-0
|
Bone ash/Bone.total in Bone |
|
48807-2
|
Bone marrow aspiration report |
|
66108-2
|
Bone Pathology biopsy report |
|
85272-3
|
Bleeding on probing Tooth |
|
5603-6
|
Borate [Mass/time] in 24 hour Urine |
|
43892-9
|
Borate [Presence] in Blood |
|
5602-8
|
Borate [Mass/volume] in Serum or Plasma |
|
10910-8
|
Borate [Mass/volume] in Urine |
|
9367-4
|
Borate [Mass/volume] in Unspecified specimen |
|
22875-9
|
Border disease virus Ab [Units/volume] in Serum by Immunoassay |
|
22876-7
|
Border disease virus Ab [Units/volume] in Serum |
|
22877-5
|
Border disease virus Ab [Titer] in Serum |
|
22878-3
|
Border disease virus Ab [Titer] in Serum by Neutralization test |
|
31733-9
|
Border disease virus Ag [Presence] in Blood |
|
22882-5
|
Border disease virus Ag [Presence] in Blood by Immunoassay |
|
20704-3
|
Border disease virus Ag [Presence] in Blood by Immunofluorescence |
|
22881-7
|
Border disease virus Ag [Presence] in Tissue by Immunoassay |
|
20703-5
|
Border disease virus Ag [Presence] in Tissue by Immunofluorescence |
|
31734-7
|
Border disease virus Ag [Presence] in Unspecified specimen |
|
22879-1
|
Border disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22880-9
|
Border disease virus Ag [Presence] in Unspecified specimen by Immune stain |
|
22885-8
|
Border disease virus RNA [Presence] in Blood by NAA with probe detection |
|
22883-3
|
Border disease virus RNA [Presence] in Tissue from Fetus by NAA with probe detection |
|
22884-1
|
Border disease virus RNA [Presence] in Tissue by NAA with probe detection |
|
91839-1
|
Bordetella sp Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
91870-6
|
Bordetella sp Ag [Presence] in Throat by Immunofluorescence |
|
91814-4
|
Bordetella sp Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
|
43360-7
|
Bordetella sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
91838-3
|
Bordetella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection |
|
88583-0
|
Bordetella sp DNA [Identifier] in Nasopharynx by NAA with probe detection |
|
91871-4
|
Bordetella sp DNA [Identifier] in Throat by NAA with probe detection |
|
91813-6
|
Bordetella sp DNA [Identifier] in Upper respiratory specimen by NAA with probe detection |
|
62428-8
|
Bordetella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
63431-1
|
Bordetella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91775-7
|
Bordetella sp identified in Lower respiratory specimen by Organism specific culture |
|
88582-2
|
Bordetella sp identified in Nasopharynx by Organism specific culture |
|
91872-2
|
Bordetella sp identified in Throat by Organism specific culture |
|
91777-3
|
Bordetella sp identified in Upper respiratory specimen by Organism specific culture |
|
6317-2
|
Bordetella sp identified in Unspecified specimen by Organism specific culture |
|
49112-6
|
Borna disease virus Ab [Units/volume] in Serum |
|
29926-3
|
Boron [Mass/volume] in 24 hour Urine |
|
29921-4
|
Boron [Mass/time] in 24 hour Urine |
|
50829-1
|
Boron [Moles/time] in 24 hour Urine |
|
5604-4
|
Boron [Mass/volume] in Blood |
|
5605-1
|
Boron [Mass/volume] in Body fluid |
|
50827-5
|
Boron [Moles/volume] in Body fluid |
|
77178-2
|
Boron [Mass/mass] in Hair |
|
50828-3
|
Boron [Moles/mass] in Hair |
|
81944-1
|
Boron intake 24 hour Estimated |
|
81945-8
|
Boron intake 24 hour Measured |
|
38638-3
|
Boron oxide [Mass/volume] in Air |
|
5606-9
|
Boron [Mass/volume] in Red Blood Cells |
|
5607-7
|
Boron [Mass/volume] in Serum or Plasma |
|
52914-9
|
Boron [Moles/volume] in Serum or Plasma |
|
60060-1
|
Boron [Mass/mass] in Tissue |
|
38639-1
|
Boron trifluoride [Mass/volume] in Air |
|
9331-0
|
Boron [Mass/volume] in Urine |
|
50830-9
|
Boron [Moles/volume] in Urine |
|
9368-2
|
Boron [Mass/volume] in Unspecified specimen |
|
87479-2
|
Boron [Mass/mass] in Unspecified specimen |
|
29922-2
|
Boron/Creatinine [Mass Ratio] in 24 hour Urine |
|
50831-7
|
Boron/Creatinine [Molar ratio] in 24 hour Urine |
|
50832-5
|
Boron/Creatinine [Molar ratio] in Urine |
|
44457-0
|
Borrelia sp Ab [Units/volume] in Serum |
|
42590-0
|
Borrelia sp Ab [Titer] in Serum |
|
31739-6
|
Borrelia sp Ag [Presence] in Unspecified specimen |
|
24036-6
|
Borrelia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
87945-2
|
Borrelia sp identified in Cerebral spinal fluid by Organism specific culture |
|
88581-4
|
Borrelia sp DNA [Identifier] in Cerebral spinal fluid by NAA with probe detection |
|
90042-3
|
Borrelia sp DNA [Presence] in Tick by NAA with probe detection |
|
87947-8
|
Borrelia sp DNA identified in Tissue by NAA with probe detection |
|
49615-8
|
Borrelia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
87946-0
|
Borrelia sp identified in Tissue by Organism specific culture |
|
6323-0
|
Borrelia sp identified in Unspecified specimen by Organism specific culture |
|
92658-4
|
Had both ovaries removed |
|
86482-7
|
Bothered by fatigue over the past 2 weeks [KCCQ] |
|
86484-3
|
Bothered by shortness of breath over the past 2 weeks [KCCQ] |
|
86480-1
|
Bothered by swelling in your feet, ankles or legs over the past 2 weeks [KCCQ] |
|
25565-3
|
Bougainvillea IgE Ab [Units/volume] in Serum |
|
25566-1
|
Bougainvillea IgE Ab RAST class [Presence] in Serum |
|
81288-3
|
Precision of boundaries Nominal |
|
31750-3
|
Bovine inner ear Ag [Presence] in Serum or Plasma |
|
12852-0
|
Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot |
|
16102-6
|
Bovine Gelatin IgE Ab [Units/volume] in Serum |
|
21297-7
|
Bovine Gelatin IgE Ab RAST class [Presence] in Serum |
|
90742-8
|
Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
|
83242-8
|
Bowel continence during 3 day assessment period [CMS Assessment] |
|
54771-1
|
Bowel continence in last 7 days [CMS Assessment] |
|
11783-8
|
Bowel Diameter US |
|
80260-3
|
Bowel elimination pattern |
|
46587-2
|
Bowel incontinence frequency [CMS Assessment] |
|
80266-0
|
Bowel sounds by Auscultation |
|
80267-8
|
Bowel sounds quality by Auscultation |
|
54772-9
|
Bowel toileting program currently being used [CMS Assessment] |
|
7155-5
|
Boxelder IgE Ab [Units/volume] in Serum |
|
15585-3
|
Boxelder IgE Ab RAST class [Presence] in Serum |
|
61206-9
|
Boxelder IgE Ab/IgE total in Serum |
|
7156-3
|
Boxelder IgG Ab [Units/volume] in Serum |
|
56315-5
|
Boxelder IgG4 Ab [Mass/volume] in Serum |
|
16484-8
|
Boysenberry IgE Ab [Units/volume] in Serum |
|
76533-9
|
Blood pressure by Noninvasive |
|
41901-0
|
Type of Blood pressure device |
|
76532-1
|
Blood pressure device Cuff pressure |
|
76539-6
|
Blood pressure device Cuff pressure.diastolic |
|
76537-0
|
Blood pressure device Cuff pressure.mean |
|
76538-8
|
Blood pressure device Cuff pressure.systolic |
|
41902-8
|
Blood pressure device Vendor model code |
|
41903-6
|
Blood pressure device Vendor software version |
|
75995-1
|
Diastolic blood pressure by Continuous non-invasive monitoring |
|
76535-4
|
Diastolic blood pressure by Noninvasive |
|
86909-9
|
Diastolic blood pressure goal |
|
20184-8
|
Diastolic blood pressure by US |
|
89281-0
|
Diastolic blood pressure--during anesthesia |
|
89267-9
|
Diastolic blood pressure--lying in L-lateral position |
|
87736-5
|
Diastolic blood pressure--post exercise |
|
87740-7
|
Diastolic blood pressure--W exercise |
|
82663-6
|
End diastolic blood pressure Left ventricle --post procedure |
|
20185-5
|
End systolic blood pressure by US |
|
75996-9
|
Mean blood pressure by Continuous non-invasive monitoring |
|
76536-2
|
Mean blood pressure by Noninvasive |
|
24371-7
|
Peak systolic blood pressure --during aorta stenosis maximum velocity measurement |
|
24370-9
|
Peak systolic blood pressure --during mitral regurgitation maximum velocity measurement |
|
24372-5
|
Peak systolic blood pressure --during right ventricular septal defect maximum velocity measurement |
|
20186-3
|
Peak systolic blood pressure by US |
|
75997-7
|
Systolic blood pressure by Continuous non-invasive monitoring |
|
76534-7
|
Systolic blood pressure by Noninvasive |
|
86908-1
|
Systolic blood pressure goal |
|
45372-0
|
Blood pressure systolic and diastolic--post phlebotomy |
|
50402-7
|
Blood pressure systolic and diastolic--after transfusion |
|
50403-5
|
Blood pressure systolic and diastolic--before transfusion |
|
89280-2
|
Systolic blood pressure--during anesthesia |
|
89268-7
|
Systolic blood pressure--lying in L-lateral position |
|
87741-5
|
Systolic blood pressure--post exercise |
|
87739-9
|
Systolic blood pressure--W exercise |
|
75161-0
|
Bilevel positive airway pressure (BPAP) activity Ventilator |
|
58960-6
|
Pressure.bilevel positive airway Ventilator |
|
72663-8
|
Bisphosphoglycerate mutase [Enzymatic activity/mass] in Red Blood Cells |
|
63214-1
|
Bactericidal permeability increasing protein Ab [Presence] in Body fluid by Immunoassay |
|
63213-3
|
Bactericidal permeability increasing protein Ab [Units/volume] in Serum by Immunoassay |
|
53013-9
|
Bactericidal permeability increasing protein Ab [Presence] in Serum |
|
58771-7
|
Bactericidal permeability increasing protein Ab [Units/volume] in Serum |
|
33573-7
|
Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum by Immunoassay |
|
33603-2
|
Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum |
|
23678-6
|
Bovine parainfluenza virus 3 Ag [Presence] in Tissue by Immunofluorescence |
|
38720-9
|
Beta-propiolactone [Mass/volume] in Air |
|
20708-4
|
Bovine papular stomatitis virus Ag [Presence] in Tissue by Immunofluorescence |
|
935-7
|
Blood product unit expiration [Date and time] |
|
934-0
|
Blood product unit ID [#] |
|
52113-8
|
Blood product unit 1 expiration [Date and time] |
|
52112-0
|
Blood product unit 2 expiration [Date and time] |
|
52111-2
|
Blood product unit 3 expiration [Date and time] |
|
52110-4
|
Blood product unit 4 expiration [Date and time] |
|
20934-6
|
Bovine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
|
10433-1
|
BR-2 Ag [Presence] in Tissue by Immune stain |
|
83389-7
|
Brachial artery Blood pressure |
|
87400-8
|
Brachyspira sp Ag [Presence] in Tissue by Immune stain |
|
87398-4
|
Brachyspira sp DNA [Presence] in Isolate by NAA with probe detection |
|
87413-1
|
Brachyspira sp [Type] in Isolate by Sequencing |
|
87412-3
|
Brachyspira sp nox gene [Nucleotide sequence] in Isolate by Sequencing |
|
24409-5
|
Brachyspira sp identified in Unspecified specimen by Organism specific culture |
|
1983-6
|
Bradykinin [Mass/volume] in Serum or Plasma |
|
58483-9
|
BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53844-7
|
BRAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85511-4
|
BRAF gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
|
83061-2
|
BRAF gene [VCF] in Cancer specimen by Sequencing |
|
93690-6
|
BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal |
|
85101-4
|
BRAF gene p.Val600Glu [Presence] in Bone marrow by Molecular genetics method |
|
58415-1
|
BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method |
|
89861-9
|
BRAF gene p.Val600Lys [Presence] in Tissue by Molecular genetics method |
|
81705-6
|
BRAF protein [Presence] in Cancer specimen by Immune stain |
|
85299-6
|
BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain |
|
87627-6
|
Brain injury Consult note |
|
87628-4
|
Brain injury Note |
|
87629-2
|
Brain injury Plan of care note |
|
66109-0
|
Brain Pathology biopsy report |
|
82873-1
|
Brallobarbital [Mass/volume] in Serum or Plasma |
|
46495-8
|
Branch number Agency [CMS Assessment] |
|
74059-7
|
Brand name - RxNorm RXCUI of Medication |
|
92281-5
|
Brand name of cigarettes smoked most often 30 days |
|
74060-5
|
Brand name of Medication |
|
77371-3
|
Brassicasterol [Moles/volume] in Serum or Plasma |
|
7670-3
|
Brazilian Rubber Tree IgE Ab [Units/volume] in Serum |
|
64963-2
|
Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum |
|
81984-7
|
Brazil Nut recombinant (rBer e) 1 IgE Ab RAST class [Presence] in Serum |
|
7158-9
|
Brazil Nut triggered histamine release [Units/volume] in Blood |
|
6050-9
|
Brazil Nut IgE Ab [Units/volume] in Serum |
|
15586-1
|
Brazil Nut IgE Ab RAST class [Presence] in Serum |
|
39592-1
|
Brazil Nut IgE Ab/IgE total in Serum |
|
7157-1
|
Brazil Nut IgG Ab [Units/volume] in Serum |
|
56198-5
|
Brazil Nut IgG4 Ab [Mass/volume] in Serum |
|
63081-4
|
Brazil Nut IgG Ab [Mass/volume] in Serum |
|
42778-1
|
BRCA1 Ag [Presence] in Tissue by Immune stain |
|
21637-4
|
BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method |
|
21638-2
|
BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method |
|
79207-7
|
BRCA1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
21636-6
|
BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21639-0
|
BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
50995-0
|
BRCA1+BRCA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
59041-4
|
BRCA1+BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
42779-9
|
BRCA2 Ag [Presence] in Tissue by Immune stain |
|
21640-8
|
BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method |
|
79208-5
|
BRCA2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
38530-2
|
BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38531-0
|
BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
80482-3
|
Breast milk feeding attempts 24 hour |
|
80485-6
|
Breast milk intake adequacy |
|
80483-1
|
Breast milk intake volume 24 hour Estimated |
|
80484-9
|
Breast milk intake volume 24 hour Measured |
|
53755-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.25 hours post XXX challenge |
|
60235-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.25 hours post dose lactose PO |
|
93982-7
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate |
|
50002-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post XXX challenge |
|
60228-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose fructose PO |
|
16985-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose glucose |
|
56936-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hour post dose lactulose |
|
33493-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO |
|
53752-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.75 hours post XXX challenge |
|
60234-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.75 hours post dose lactose PO |
|
88439-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose fructose PO |
|
88440-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose lactose PO |
|
93986-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate |
|
53750-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post XXX challenge |
|
48613-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose lactose PO |
|
93983-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate |
|
50001-7
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post XXX challenge |
|
60229-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose fructose PO |
|
16986-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose glucose |
|
56932-7
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactulose |
|
33492-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO |
|
53753-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.25 hours post XXX challenge |
|
60233-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.25 hours post dose lactose PO |
|
50013-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post XXX challenge |
|
60226-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose fructose PO |
|
16987-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose glucose |
|
56934-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hour post dose lactulose |
|
33495-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO |
|
53751-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.75 hours post XXX challenge |
|
60232-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.75 hours post dose lactose PO |
|
88441-1
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20M post dose fructose PO |
|
88446-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20 minutes post dose lactose PO |
|
93981-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate |
|
50003-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post XXX challenge |
|
60227-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose fructose PO |
|
16988-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose glucose |
|
56933-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hour post dose lactulose |
|
33494-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO |
|
50613-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post XXX challenge |
|
16989-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post dose glucose |
|
56935-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hour post dose lactose |
|
93985-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate |
|
50000-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post XXX challenge |
|
60230-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose fructose PO |
|
56937-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose glucose |
|
56938-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactulose |
|
33491-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
|
50004-1
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post XXX challenge |
|
60225-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose fructose PO |
|
16990-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose glucose |
|
33496-1
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO |
|
57018-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactulose |
|
50614-7
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post XXX challenge |
|
16991-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post dose glucose |
|
88443-7
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40M post dose fructose PO |
|
88442-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40 minutes post dose lactose PO |
|
93984-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate |
|
53754-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post XXX challenge |
|
48612-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose lactose PO |
|
50606-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post XXX challenge |
|
16992-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post dose glucose |
|
50616-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post XXX challenge |
|
16993-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post dose glucose |
|
88444-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose fructose PO |
|
88445-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose lactose PO |
|
50615-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post XXX challenge |
|
16994-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post dose glucose |
|
50617-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post XXX challenge |
|
16995-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post dose glucose |
|
46433-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 10 g lactulose PO |
|
2437-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g glucose PO |
|
46432-1
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g lactose PO |
|
93988-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate |
|
33471-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post XXX challenge |
|
16997-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose glucose |
|
93987-6
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate |
|
50605-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre XXX challenge |
|
60231-8
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose fructose PO |
|
16996-1
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose glucose |
|
56931-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactulose |
|
33490-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO |
|
33502-6
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO |
|
33505-9
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO |
|
33506-7
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO |
|
33503-4
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO |
|
33501-8
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
|
33489-6
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO |
|
33504-2
|
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO |
|
93885-2
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate |
|
33500-0
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO |
|
93889-4
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate |
|
93886-0
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate |
|
33499-5
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO |
|
33481-3
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO |
|
93884-5
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate |
|
33480-5
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO |
|
93888-6
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate |
|
33498-7
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO |
|
33482-1
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO |
|
93887-8
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate |
|
93891-0
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate |
|
93890-2
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate |
|
33497-9
|
Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO |
|
74210-6
|
Breath rate was assisted by respiratory device by [NTDS] |
|
72072-2
|
Breath sounds |
|
80319-7
|
Breath sounds by Auscultation |
|
76198-1
|
Breaths.sigh delivered 1 minute Ventilator |
|
76528-9
|
Breath rate spontaneous |
|
92839-0
|
Breslow thickness [Length] in Skin melanoma |
|
10531-2
|
Bretylium [Mass/volume] in Serum or Plasma |
|
7785-9
|
Brewer's yeast triggered histamine release [Units/volume] in Blood |
|
6051-7
|
Brewer's yeast IgE Ab [Units/volume] in Serum |
|
16098-6
|
Brewer's yeast IgE Ab RAST class [Presence] in Serum |
|
6715-7
|
Brewer's yeast IgG Ab [Units/volume] in Serum |
|
21608-5
|
Brewer's yeast IgG Ab RAST class [Presence] in Serum |
|
56199-3
|
Brewer's yeast IgG4 Ab [Mass/volume] in Serum |
|
60413-2
|
Brewer's yeast IgG Ab [Mass/volume] in Serum |
|
82152-0
|
BRFSS ACE Module [ACE.BRFSS] |
|
53965-0
|
Brickdust deposit [Presence] in Urine by Visual |
|
80906-1
|
Bridged race [CDC] |
|
54614-3
|
Brief Interview for Mental Status - summary score [BIMS] |
|
54605-1
|
Brief Interview for Mental Status (BIMS) should be conducted [CMS Assessment] |
|
52491-8
|
Brief interview for mental status [BIMS] |
|
48303-2
|
Brilliant black BN triggered leukotriene release [Mass/volume] by Leukocytes |
|
29776-2
|
Microscopic observation [Identifier] in Blood by Brilliant cresyl blue |
|
88894-1
|
Brivaracetam [Mass/volume] in Serum or Plasma |
|
53284-6
|
Broad casts [#/volume] in Urine by Computer assisted method |
|
53290-3
|
Broad casts [#/area] in Urine by Computer assisted method |
|
88972-5
|
Broad casts [#/area] in Urine sediment |
|
18487-9
|
Broad casts [#/area] in Urine sediment by Microscopy low power field |
|
50222-9
|
Broad casts [Presence] in Urine by Computer assisted method |
|
31999-6
|
Broad casts [Presence] in Urine sediment by Light microscopy |
|
44382-0
|
Hyaline casts.broad [Presence] in Urine sediment by Light microscopy |
|
41174-4
|
Waxy Casts Broad [Presence] in Urine sediment by Light microscopy |
|
6052-5
|
Broccoli IgE Ab [Units/volume] in Serum |
|
15587-9
|
Broccoli IgE Ab RAST class [Presence] in Serum |
|
61234-1
|
Broccoli IgE Ab/IgE total in Serum |
|
7159-7
|
Broccoli IgG Ab [Units/volume] in Serum |
|
21124-3
|
Broccoli IgG Ab RAST class [Presence] in Serum |
|
56200-9
|
Broccoli IgG4 Ab [Mass/volume] in Serum |
|
60356-3
|
Broccoli IgG Ab [Mass/volume] in Serum |
|
40705-6
|
Brodifacoum [Mass/volume] in Blood |
|
12426-3
|
Brodifacoum [Mass/volume] in Serum or Plasma |
|
74111-6
|
Brodifacoum [Presence] in Unspecified specimen by Screen method |
|
87612-8
|
Brodifacoum [Mass/mass] in Unspecified specimen |
|
74112-4
|
Bromadiolone [Presence] in Unspecified specimen by Screen method |
|
87611-0
|
Bromadiolone [Mass/mass] in Unspecified specimen |
|
19367-2
|
Bromazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19366-4
|
Bromazepam cutoff [Mass/volume] in Urine for Screen method |
|
4144-2
|
Bromazepam [Mass] of Dose |
|
59873-0
|
Bromazepam [Moles/volume] in Gastric fluid |
|
3405-8
|
Bromazepam [Mass/volume] in Serum or Plasma |
|
32124-0
|
Bromazepam [Moles/volume] in Serum or Plasma |
|
20520-3
|
Bromazepam [Mass/volume] in Urine by Confirmatory method |
|
19365-6
|
Bromazepam [Presence] in Urine by Confirmatory method |
|
19364-9
|
Bromazepam [Presence] in Urine by Screen method |
|
3406-6
|
Bromazepam [Mass/volume] in Urine |
|
59872-2
|
Bromazepam [Moles/volume] in Urine |
|
60288-8
|
Bromazepam [Moles/volume] in Unspecified specimen |
|
6053-3
|
Brome IgE Ab [Units/volume] in Serum |
|
15740-4
|
Brome IgE Ab RAST class [Presence] in Serum |
|
61235-8
|
Brome IgE Ab/IgE total in Serum |
|
24144-8
|
Brome IgG Ab [Units/volume] in Serum |
|
40847-6
|
Brome IgG4 Ab [Mass/volume] in Serum |
|
10923-1
|
Bromelin IgE Ab [Units/volume] in Serum |
|
15588-7
|
Bromelin IgE Ab RAST class [Presence] in Serum |
|
58984-6
|
Bromelin MUXF3 IgE Ab [Units/volume] in Serum |
|
82026-6
|
Bromelin MUXF3 IgE Ab RAST class [Presence] in Serum |
|
38444-6
|
Bromide [Presence] in 24 hour Urine |
|
42725-2
|
Bromide [Mass/volume] in Blood |
|
25171-0
|
Bromide [Moles/volume] in Blood |
|
20718-3
|
Bromide [Mass/volume] in Ocular fluid |
|
1984-4
|
Bromide [Mass/volume] in Serum or Plasma |
|
15034-2
|
Bromide [Moles/volume] in Serum or Plasma |
|
1985-1
|
Bromide [Mass/volume] in Urine |
|
43169-2
|
Bromide [Moles/volume] in Urine |
|
23680-2
|
Bromide [Mass/volume] in Unspecified specimen |
|
56655-4
|
Bromide/Creatinine [Ratio] in Urine |
|
38640-9
|
Bromine [Mass/volume] in Air |
|
11232-6
|
Bromocriptine [Mass/volume] in Serum or Plasma |
|
30516-9
|
Bromodiphenhydramine [Mass/volume] in Serum or Plasma |
|
16485-5
|
Bromodiphenhydramine [Mass/volume] in Urine |
|
38575-7
|
Bromoform [Mass/volume] in Air |
|
14260-4
|
Bromoform [Mass/volume] in Blood |
|
35105-6
|
Bromperidol [Mass/volume] in Serum or Plasma |
|
82917-6
|
Bromperidol [Mass/volume] in Serum or Plasma --trough |
|
4145-9
|
Brompheniramine [Mass] of Dose |
|
59875-5
|
Brompheniramine [Moles/volume] in Gastric fluid |
|
75758-3
|
Brompheniramine [Presence] in Serum or Plasma or Urine by Screen method |
|
3407-4
|
Brompheniramine [Presence] in Serum or Plasma |
|
11233-4
|
Brompheniramine [Mass/volume] in Serum or Plasma |
|
55526-8
|
Brompheniramine [Moles/volume] in Serum or Plasma |
|
3408-2
|
Brompheniramine [Presence] in Urine |
|
27284-9
|
Brompheniramine [Mass/volume] in Urine |
|
59874-8
|
Brompheniramine [Moles/volume] in Urine |
|
60289-6
|
Brompheniramine [Moles/volume] in Unspecified specimen |
|
1371-4
|
Bromsulphthalein [Mass/volume] in Serum or Plasma |
|
18744-3
|
Bronchoscopy study |
|
10777-1
|
Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |
|
47305-8
|
BRST 2 Ag [Presence] in Tissue by Immune stain |
|
76545-3
|
Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna |
|
76544-6
|
Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna |
|
66110-8
|
Breast Pathology biopsy report |
|
31751-1
|
Bovine respiratory syncytial virus Ag [Presence] in Lung |
|
20944-5
|
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunoassay |
|
20945-2
|
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunofluorescence |
|
20943-7
|
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immune stain |
|
23679-4
|
Bovine respiratory syncytial virus Ag [Presence] in Unspecified specimen |
|
30202-6
|
Brucella sp Ab [Presence] in Serum |
|
40614-0
|
Brucella sp Ab [Presence] in Serum by Agglutination |
|
86455-3
|
Brucella sp Ab [Presence] in Serum by Acidified buffered plate agglutination |
|
86456-1
|
Brucella sp Ab [Presence] in Serum by Card agglutination |
|
40613-2
|
Brucella sp Ab [Presence] in Serum by Complement fixation |
|
86457-9
|
Brucella sp Ab [Presence] in Serum by Fluorescent polarization assay |
|
10349-9
|
Brucella sp Ab [Units/volume] in Serum |
|
30129-1
|
Brucella sp Ab [Presence] in Serum --1st specimen |
|
29250-8
|
Brucella sp Ab [Titer] in Serum --1st specimen |
|
30130-9
|
Brucella sp Ab [Presence] in Serum --2nd specimen |
|
29251-6
|
Brucella sp Ab [Titer] in Serum --2nd specimen |
|
58806-1
|
Brucella sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
|
22159-8
|
Brucella sp Ab [Titer] in Serum |
|
19053-8
|
Brucella sp Ab [Titer] in Serum by Agglutination |
|
91876-3
|
Brucella sp Ab [Titer] in Serum by Immunocapture agglutination |
|
6328-9
|
Brucella sp Ab [Titer] in Serum by Immunofluorescence |
|
86459-5
|
Brucella sp Ab [Titer] in Serum by Plate agglutination |
|
86458-7
|
Brucella sp Ab [Titer] in Serum by Rivanol agglutination |
|
51671-6
|
Brucella sp Ab [Titer] in Serum by Tube agglutination |
|
31754-5
|
Brucella sp Ag [Presence] in Placenta |
|
22943-5
|
Brucella sp Ag [Presence] in Placenta by Immunofluorescence |
|
22949-2
|
Brucella sp Ag [Presence] in Placenta by Immune stain |
|
22946-8
|
Brucella sp Ag [Presence] in Tissue from Fetus by Immunofluorescence |
|
22948-4
|
Brucella sp Ag [Presence] in Tissue from Fetus by Immune stain |
|
22945-0
|
Brucella sp Ag [Presence] in Tissue by Immune stain |
|
31753-7
|
Brucella sp Ag [Presence] in Vaginal fluid |
|
22947-6
|
Brucella sp Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
22944-3
|
Brucella sp Ag [Presence] in Vaginal fluid by Immune stain |
|
44271-5
|
Brucella sp Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
47001-3
|
Brucella sp Ag [Presence] in Unspecified specimen by Agglutination |
|
41624-8
|
Brucella sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
551-2
|
Brucella sp identified in Blood by Organism specific culture |
|
63465-9
|
Brucella sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
53604-5
|
Brucella sp DNA [Identifier] in Serum by NAA with probe detection |
|
41625-5
|
Brucella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41626-3
|
Brucella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
13211-8
|
Brucella sp IgA Ab [Units/volume] in Serum |
|
56630-7
|
Brucella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
24396-4
|
Brucella sp IgG Ab [Presence] in Serum |
|
24387-3
|
Brucella sp IgG Ab [Presence] in Serum by Immunoassay |
|
13210-0
|
Brucella sp IgG Ab [Units/volume] in Serum |
|
72308-0
|
Brucella sp IgG Ab [Titer] in Serum --1st specimen |
|
72307-2
|
Brucella sp IgG Ab [Titer] in Serum --2nd specimen |
|
38247-3
|
Brucella sp IgG Ab [Titer] in Serum |
|
66485-4
|
Brucella sp IgG and IgM [Interpretation] in Serum |
|
56631-5
|
Brucella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
24397-2
|
Brucella sp IgM Ab [Presence] in Serum |
|
24388-1
|
Brucella sp IgM Ab [Presence] in Serum by Immunoassay |
|
5070-8
|
Brucella sp IgM Ab [Units/volume] in Serum |
|
38248-1
|
Brucella sp IgM Ab [Titer] in Serum |
|
24003-6
|
Brucella sp identified in Bone marrow by Organism specific culture |
|
20735-7
|
Brucella sp identified in Milk by Organism specific culture |
|
23594-5
|
Brucella sp identified in Semen by Organism specific culture |
|
20734-0
|
Brucella sp identified in Tissue by Organism specific culture |
|
552-0
|
Brucella sp identified in Unspecified specimen by Organism specific culture |
|
44797-9
|
Brucella sp [Presence] in Unspecified specimen by Organism specific culture |
|
31275-1
|
Brush border Ab [Presence] in Serum |
|
16491-3
|
Brush border Ab [Presence] in Serum by Immunofluorescence |
|
5072-4
|
Brush border Ab [Units/volume] in Serum |
|
21125-0
|
Brush border Ab [Titer] in Serum by Immunofluorescence |
|
7160-5
|
Brussel Sprouts IgE Ab [Units/volume] in Serum |
|
15589-5
|
Brussel Sprouts IgE Ab RAST class [Presence] in Serum |
|
7161-3
|
Brussel Sprouts IgG Ab [Units/volume] in Serum |
|
21126-8
|
Brussel Sprouts IgG Ab RAST class [Presence] in Serum |
|
56201-7
|
Brussel Sprouts IgG4 Ab [Mass/volume] in Serum |
|
60357-1
|
Brussel Sprouts IgG Ab [Mass/volume] in Serum |
|
20950-2
|
Bovine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
|
80268-6
|
Bowel sounds quadrant of Abdomen |
|
10922-3
|
Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum |
|
15590-3
|
Bovine serum albumin (BSA) IgE Ab RAST class [Presence] in Serum |
|
48228-1
|
Bovine serum albumin (BSA) triggered leukotriene release [Mass/volume] by Leukocytes |
|
75741-9
|
Beta sitosterol [Mass/volume] in Serum or Plasma |
|
74907-7
|
Beta sitosterol [Moles/volume] in Serum or Plasma |
|
53845-4
|
BTD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75708-8
|
Bruton tyrosine kinase [Interpretation] in B cells+monocytes by Flow cytometry (FC) Narrative |
|
69479-4
|
BTK gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
35295-5
|
BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
31257-9
|
Beta tubulin IgG Ab [Units/volume] in Serum |
|
14233-1
|
Beta tubulin IgG Ab [Titer] in Serum |
|
82737-8
|
Beta tubulin IgG Ab [Titer] in Serum by Immunoassay |
|
44739-1
|
Beta tubulin IgM Ab [Presence] in Serum |
|
31258-7
|
Beta tubulin IgM Ab [Units/volume] in Serum |
|
14234-9
|
Beta tubulin IgM Ab [Titer] in Serum |
|
22113-5
|
Bluetongue virus Ab [Presence] in Serum |
|
20699-5
|
Bluetongue virus Ab [Presence] in Serum by Complement fixation |
|
15456-7
|
Bluetongue virus Ab [Presence] in Serum by Immunoassay |
|
15455-9
|
Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
22868-4
|
Bluetongue virus Ab [Presence] in Serum by Neutralization test |
|
22872-6
|
Bluetongue virus Ag [Presence] in Blood |
|
20701-9
|
Bluetongue virus Ag [Presence] in Tissue by Immunofluorescence |
|
31732-1
|
Bluetongue virus Ag [Presence] in Unspecified specimen |
|
22870-0
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
22869-2
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22873-4
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Immune stain |
|
22871-8
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
20700-1
|
Bluetongue virus RNA [Presence] in Tissue by NAA with probe detection |
|
20698-7
|
Bluetongue virus serotype [Identifier] in Isolate |
|
22874-2
|
Bluetongue virus serotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
20702-7
|
Bluetongue virus [Presence] in Unspecified specimen by Organism specific culture |
|
31260-3
|
Bluetongue virus 10 Ab [Units/volume] in Serum |
|
43082-7
|
Bluetongue virus 10 Ab [Titer] in Serum |
|
23671-1
|
Bluetongue virus 10 Ab [Titer] in Serum by Neutralization test |
|
31261-1
|
Bluetongue virus 11 Ab [Units/volume] in Serum |
|
43081-9
|
Bluetongue virus 11 Ab [Titer] in Serum |
|
23672-9
|
Bluetongue virus 11 Ab [Titer] in Serum by Neutralization test |
|
31262-9
|
Bluetongue virus 13 Ab [Units/volume] in Serum |
|
43080-1
|
Bluetongue virus 13 Ab [Titer] in Serum |
|
23673-7
|
Bluetongue virus 13 Ab [Titer] in Serum by Neutralization test |
|
31263-7
|
Bluetongue virus 17 Ab [Units/volume] in Serum |
|
43079-3
|
Bluetongue virus 17 Ab [Titer] in Serum |
|
23674-5
|
Bluetongue virus 17 Ab [Titer] in Serum by Neutralization test |
|
31264-5
|
Bluetongue virus 2 Ab [Units/volume] in Serum |
|
43078-5
|
Bluetongue virus 2 Ab [Titer] in Serum |
|
23675-2
|
Bluetongue virus 2 Ab [Titer] in Serum by Neutralization test |
|
34399-6
|
Buccal mucosa Ab [Titer] in Serum by Immunofluorescence |
|
65773-4
|
Buckwheat native (nFag e) 2 IgE Ab [Units/volume] in Serum |
|
6054-1
|
Buckwheat IgE Ab [Units/volume] in Serum |
|
15591-1
|
Buckwheat IgE Ab RAST class [Presence] in Serum |
|
61262-2
|
Buckwheat IgE Ab/IgE total in Serum |
|
7162-1
|
Buckwheat IgG Ab [Units/volume] in Serum |
|
56202-5
|
Buckwheat IgG4 Ab [Mass/volume] in Serum |
|
63078-0
|
Buckwheat IgG Ab [Mass/volume] in Serum |
|
73501-9
|
Budesonide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73500-1
|
Budesonide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41747-7
|
Budesonide [Mass/volume] in Serum or Plasma |
|
46947-8
|
Budesonide [Mass/volume] in Urine |
|
6304-0
|
Budgerigar droppings IgE Ab [Units/volume] in Serum |
|
15904-6
|
Budgerigar droppings IgE Ab RAST class [Presence] in Serum |
|
61236-6
|
Budgerigar droppings IgE Ab/IgE total in Serum |
|
51545-2
|
Budgerigar droppings IgG Ab [Presence] in Serum |
|
57917-7
|
Budgerigar droppings IgG Ab [Units/volume] in Serum |
|
55589-6
|
Budgerigar feather IgE Ab [Presence] in Serum |
|
6030-1
|
Budgerigar feather IgE Ab [Units/volume] in Serum |
|
15592-9
|
Budgerigar feather IgE Ab RAST class [Presence] in Serum |
|
61237-4
|
Budgerigar feather IgE Ab/IgE total in Serum |
|
51858-9
|
Budgerigar serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
|
78385-2
|
Budgerigar serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
|
6031-9
|
Budgerigar serum proteins IgE Ab [Units/volume] in Serum |
|
15906-1
|
Budgerigar serum proteins IgE Ab RAST class [Presence] in Serum |
|
87743-1
|
Bufencarb [Mass/mass] in Unspecified specimen |
|
16493-9
|
Bufotenine [Units/volume] in Serum or Plasma |
|
12433-9
|
Bufotenine [Mass/volume] in Serum or Plasma |
|
16492-1
|
Bufotenine [Units/volume] in Urine |
|
5608-5
|
Bufotenine [Mass/volume] in Urine |
|
6056-6
|
Bumble Bee IgE Ab [Units/volume] in Serum |
|
15593-7
|
Bumble Bee IgE Ab RAST class [Presence] in Serum |
|
57915-1
|
Bumble Bee IgE Ab/IgE total in Serum |
|
3411-6
|
Bumetanide [Mass/time] in 24 hour Urine |
|
4146-7
|
Bumetanide [Mass] of Dose |
|
73499-6
|
Bumetanide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73498-8
|
Bumetanide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9355-9
|
Bumetanide [Mass/volume] in Serum or Plasma |
|
3409-0
|
Bumetanide [Presence] in Urine |
|
16494-7
|
Bumetanide [Units/volume] in Urine |
|
3410-8
|
Bumetanide [Mass/volume] in Urine |
|
94003-1
|
Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
93975-1
|
Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour specimen |
|
94012-2
|
Urea nitrogen [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
12966-8
|
Urea nitrogen [Mass/volume] in Serum or Plasma --2 hour specimen |
|
12965-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma --70 minute specimen |
|
12961-9
|
Urea nitrogen [Mass/volume] in Arterial blood |
|
6299-2
|
Urea nitrogen [Mass/volume] in Blood |
|
12963-5
|
Urea nitrogen [Mass/volume] in Peripheral blood |
|
59570-2
|
Urea nitrogen [Moles/volume] in Blood |
|
12962-7
|
Urea nitrogen [Mass/volume] in Venous blood |
|
12964-3
|
Urea nitrogen [Mass/volume] in Blood --baseline |
|
17759-2
|
Urea nitrogen [Mass/volume] in Arterial blood --post dialysis |
|
48639-9
|
Urea nitrogen [Mass/volume] in Peripheral blood --post dialysis |
|
48629-0
|
Urea nitrogen [Mass/volume] in Venous blood --post dialysis |
|
11064-3
|
Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
|
49071-4
|
Urea nitrogen [Mass ratio] in Serum or Plasma--post dialysis/pre dialysis |
|
72270-2
|
Urea nitrogen [Mass/volume] in Serum or Plasma --pre contrast |
|
17760-0
|
Urea nitrogen [Mass/volume] in Venous blood --pre dialysis |
|
11065-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
|
3094-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma |
|
35234-4
|
Urea nitrogen [Mass or Moles/volume] in Serum or Plasma |
|
14937-7
|
Urea nitrogen [Moles/volume] in Serum or Plasma |
|
44734-2
|
Urea nitrogen/Creatinine [Mass Ratio] in Blood |
|
3097-3
|
Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma |
|
56699-2
|
Bupivacaine IgE Ab [Units/volume] in Serum |
|
3412-4
|
Bupivacaine [Mass/volume] in Serum or Plasma |
|
32053-1
|
Bupivacaine [Moles/volume] in Serum or Plasma |
|
74382-3
|
Bupivacaine [Mass/volume] in Unknown substance |
|
87786-0
|
Bupivacaine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
3416-5
|
Buprenorphine [Mass/time] in 24 hour Urine |
|
79138-4
|
Buprenorphine [Presence] in Blood by Confirmatory method |
|
79139-2
|
Buprenorphine [Presence] in Blood by Screen method |
|
78811-7
|
Buprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
77764-9
|
Buprenorphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
77787-0
|
Buprenorphine cutoff [Mass/volume] in Urine for Screen method |
|
4147-5
|
Buprenorphine [Mass] of Dose |
|
82372-4
|
Buprenorphine [Presence] in Gastric fluid by Screen method |
|
75367-3
|
Buprenorphine [Mass/mass] in Meconium by Confirmatory method |
|
77205-3
|
Buprenorphine [Presence] in Meconium by Screen method |
|
72762-8
|
Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
77204-6
|
Buprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
73942-5
|
Buprenorphine [Presence] in Saliva (oral fluid) by Screen method |
|
53846-2
|
Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
82369-0
|
Buprenorphine [Presence] in Serum or Plasma by Screen method |
|
16495-4
|
Buprenorphine [Units/volume] in Serum or Plasma |
|
75368-1
|
Buprenorphine [Mass/volume] in Serum, Plasma or Blood |
|
3413-2
|
Buprenorphine [Mass/volume] in Serum or Plasma |
|
49752-9
|
Buprenorphine [Mass/volume] in Urine by Confirmatory method |
|
3414-0
|
Buprenorphine [Presence] in Urine |
|
16208-1
|
Buprenorphine [Presence] in Urine by Confirmatory method |
|
93494-3
|
Buprenorphine [Presence] in Urine by Screen method |
|
16496-2
|
Buprenorphine [Units/volume] in Urine |
|
3415-7
|
Buprenorphine [Mass/volume] in Urine |
|
82373-2
|
Buprenorphine [Presence] in Unspecified specimen by Screen method |
|
58360-9
|
Buprenorphine/Creatinine [Mass Ratio] in Urine |
|
77201-2
|
Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
38373-7
|
Buprenorphine+Norbuprenorphine [Presence] in Urine |
|
58359-1
|
Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method |
|
73052-3
|
Bupropion induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73051-5
|
Bupropion induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60061-9
|
Bupropion [Mass/volume] in Blood |
|
78812-5
|
Bupropion cutoff [Mass/volume] in Urine for Confirmatory method |
|
60062-7
|
Bupropion [Mass/volume] in Body fluid |
|
73496-2
|
Bupropion induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73497-0
|
Bupropion induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6706-6
|
Bupropion [Mass/volume] in Serum or Plasma |
|
55527-6
|
Bupropion [Moles/volume] in Serum or Plasma |
|
60063-5
|
Bupropion [Mass/mass] in Tissue |
|
59169-3
|
Bupropion [Presence] in Urine |
|
60064-3
|
Bupropion [Mass/volume] in Urine |
|
41627-1
|
Burkholderia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41629-7
|
Burkholderia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41628-9
|
Burkholderia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88580-6
|
Burkholderia sp identified in Lower respiratory specimen by Organism specific culture |
|
44798-7
|
Burkholderia sp identified in Unspecified specimen by Organism specific culture |
|
44800-1
|
Burkholderia sp [Presence] in Unspecified specimen by Organism specific culture |
|
90012-6
|
Burn management Consult note |
|
93150-1
|
Burn management procedure note |
|
90014-2
|
Burn management Progress note |
|
41281-7
|
Burr cells [#/volume] in Cerebral spinal fluid by Manual count |
|
7790-9
|
Burr cells [Presence] in Blood by Light microscopy |
|
53972-6
|
Burr cells [Presence] in Urine sediment by Light microscopy |
|
48709-0
|
Burr cells/100 erythrocytes in Cerebral spinal fluid by Manual count |
|
7164-7
|
Burrobrush IgE Ab [Units/volume] in Serum |
|
15594-5
|
Burrobrush IgE Ab RAST class [Presence] in Serum |
|
83366-5
|
Burst rate Cerebral cortex Electroencephalogram (EEG) |
|
7166-2
|
Burweed IgE Ab [Units/volume] in Serum |
|
7484-9
|
Burweed marshelder IgE Ab [Units/volume] in Serum |
|
15595-2
|
Burweed marshelder IgE Ab RAST class [Presence] in Serum |
|
7485-6
|
Burweed marshelder IgG Ab [Units/volume] in Serum |
|
71530-0
|
Business name Dialysis facility [ESRD] |
|
73495-4
|
Buspirone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73494-7
|
Buspirone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9356-7
|
Buspirone [Mass/volume] in Serum or Plasma |
|
74943-2
|
Buspirone [Mass/volume] in Serum or Plasma --trough |
|
60471-0
|
Buspirone [Mass/volume] in Urine |
|
93435-6
|
Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion |
|
93434-9
|
Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion |
|
93433-1
|
Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion |
|
93475-2
|
Busulfan clearance from plasma over study |
|
93477-8
|
Busulfan given [Mass] in unspecified time Dose |
|
93436-4
|
Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion |
|
93476-0
|
Busulfan [Area under the curve] in Plasma |
|
15363-5
|
Busulfan [Mass/volume] in Serum or Plasma |
|
22666-2
|
Busulfan [Moles/volume] in Serum or Plasma |
|
73683-5
|
Busulfan [Mass/volume] in Serum or Plasma --trough |
|
75645-2
|
Butabarbital [Mass/volume] in Blood by Confirmatory method |
|
19372-2
|
Butabarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19371-4
|
Butabarbital cutoff [Mass/volume] in Urine for Screen method |
|
4148-3
|
Butabarbital [Mass] of Dose |
|
12486-7
|
Butabarbital [Presence] in Gastric fluid |
|
16497-0
|
Butabarbital [Mass/volume] in Gastric fluid |
|
26923-3
|
Butabarbital [Mass/mass] in Hair |
|
27061-1
|
Butabarbital [Mass/mass] in Meconium |
|
18384-8
|
Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3417-3
|
Butabarbital [Presence] in Serum or Plasma |
|
82972-1
|
Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3418-1
|
Butabarbital [Mass/volume] in Serum or Plasma |
|
25357-5
|
Butabarbital [Moles/volume] in Serum or Plasma |
|
12496-6
|
Butabarbital [Presence] in Stool |
|
26733-6
|
Butabarbital [Mass/mass] in Stool |
|
16236-2
|
Butabarbital [Mass/volume] in Urine by Confirmatory method |
|
3419-9
|
Butabarbital [Presence] in Urine |
|
16191-9
|
Butabarbital [Presence] in Urine by Confirmatory method |
|
19368-0
|
Butabarbital [Presence] in Urine by Screen method |
|
19370-6
|
Butabarbital [Mass/volume] in Urine |
|
26689-0
|
Butabarbital [Mass/volume] in Vitreous fluid |
|
32054-9
|
Butabarbital [Presence] in Unspecified specimen |
|
73493-9
|
Butalbital+Acetylsalicylate+Caffeine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73492-1
|
Butalbital+Acetylsalicylate+Caffeine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72398-1
|
Butalbital [Mass/volume] in Blood by Confirmatory method |
|
19376-3
|
Butalbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19375-5
|
Butalbital cutoff [Mass/volume] in Urine for Screen method |
|
4149-1
|
Butalbital [Mass] of Dose |
|
12487-5
|
Butalbital [Presence] in Gastric fluid |
|
16498-8
|
Butalbital [Units/volume] in Gastric fluid |
|
27912-5
|
Butalbital [Mass/mass] in Hair |
|
27962-0
|
Butalbital [Mass/mass] in Meconium |
|
72454-2
|
Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72632-3
|
Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3420-7
|
Butalbital [Presence] in Serum or Plasma |
|
35598-2
|
Butalbital [Mass/volume] in Serum or Plasma by Screen method |
|
82971-3
|
Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
6895-7
|
Butalbital [Mass/volume] in Serum or Plasma |
|
32055-6
|
Butalbital [Moles/volume] in Serum or Plasma |
|
12497-4
|
Butalbital [Presence] in Stool |
|
27246-8
|
Butalbital [Mass/mass] in Stool |
|
16237-0
|
Butalbital [Mass/volume] in Urine by Confirmatory method |
|
3421-5
|
Butalbital [Presence] in Urine |
|
18385-5
|
Butalbital [Presence] in Urine by Confirmatory method |
|
19373-0
|
Butalbital [Presence] in Urine by Screen method |
|
11071-8
|
Butalbital [Mass/volume] in Urine |
|
32056-4
|
Butalbital [Moles/volume] in Urine |
|
27927-3
|
Butalbital [Mass/volume] in Vitreous fluid |
|
32057-2
|
Butalbital [Presence] in Unspecified specimen |
|
64139-9
|
Butalbital/Creatinine [Mass Ratio] in Urine |
|
38576-5
|
Butane [Mass/volume] in Air |
|
9497-9
|
Butane [Mass/volume] in Blood |
|
13934-5
|
Butanol [Mass/volume] in Blood |
|
9685-9
|
Butanol [Mass/volume] in Unspecified specimen |
|
55622-5
|
Butirosin [Susceptibility] by Gradient strip |
|
53-9
|
Butirosin [Susceptibility] by Disk diffusion (KB) |
|
52-1
|
Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
51-3
|
Butirosin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18871-4
|
Butirosin [Susceptibility] |
|
54-7
|
Butirosin [Susceptibility] by Serum bactericidal titer |
|
19380-5
|
Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method |
|
19379-7
|
Butorphanol cutoff [Mass/volume] in Urine for Screen method |
|
9313-8
|
Butorphanol [Mass/volume] in Body fluid |
|
12394-3
|
Butorphanol [Mass/volume] in Serum or Plasma |
|
16499-6
|
Butorphanol [Mass/volume] in Urine by Confirmatory method |
|
12333-1
|
Butorphanol [Presence] in Urine |
|
19378-9
|
Butorphanol [Presence] in Urine by Confirmatory method |
|
19377-1
|
Butorphanol [Presence] in Urine by Screen method |
|
12395-0
|
Butorphanol [Mass/volume] in Urine |
|
13547-5
|
Butriptyline [Presence] in Serum or Plasma |
|
7167-0
|
Butterfly IgE Ab [Units/volume] in Serum |
|
7168-8
|
Buttermilk triggered histamine release [Units/volume] in Blood |
|
14268-7
|
Butyl acetate [Mass/volume] in Blood |
|
12536-9
|
Butyl nitrate [Presence] in Blood |
|
16500-1
|
Butyrate (C4) [Mass/volume] in Stool |
|
27169-2
|
Butyrate (C4) [Mass/mass] in Stool |
|
53166-5
|
Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS |
|
51413-3
|
Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
|
53167-3
|
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
53168-1
|
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
53169-9
|
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
53060-0
|
Butyrylcarnitine (C4) [Moles/volume] in Amniotic fluid |
|
53070-9
|
Butyrylcarnitine (C4) [Moles/volume] in Cerebral spinal fluid |
|
53065-9
|
Butyrylcarnitine (C4) [Moles/volume] in DBS |
|
74596-8
|
Butyrylcarnitine (C4) [Enzymatic activity/mass] in Fibroblast |
|
18439-0
|
Butyrylcarnitine (C4) [Mass/volume] in Serum or Plasma |
|
35655-0
|
Butyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
|
53106-1
|
Butyrylcarnitine (C4) [Moles/volume] in Urine |
|
53111-1
|
Butyrylcarnitine (C4)/Creatinine [Molar ratio] in Urine |
|
93467-9
|
Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
27892-9
|
Butyrylglycine/Creatinine [Mass Ratio] in Urine |
|
24437-6
|
Butyrylglycine/Creatinine [Molar ratio] in Urine |
|
92702-0
|
Lactobacillus crispatus+jensenii + Gardnerella vaginalis + Atopobium vaginae + Bacterial Vaginosis Associated Bacteria-2 + Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
43391-2
|
Bacterial vaginosis score |
|
69564-3
|
Bacterial vaginosis score in Vaginal fluid Qualitative by NAA with probe detection |
|
46730-8
|
Bacterial vaginosis whiff test [Presence] in Vaginal fluid |
|
69566-8
|
Bacterial vaginosis associated bacterium 2 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
22889-0
|
Bovine diarrhea virus Ab [Presence] in Milk |
|
22890-8
|
Bovine diarrhea virus Ab [Presence] in Milk by Immunoassay |
|
22895-7
|
Bovine diarrhea virus Ab [Presence] in Serum |
|
22894-0
|
Bovine diarrhea virus Ab [Presence] in Serum by Immunoassay |
|
22893-2
|
Bovine diarrhea virus Ab [Presence] in Serum by Neutralization test |
|
31272-8
|
Bovine diarrhea virus Ab [Units/volume] in Serum |
|
22891-6
|
Bovine diarrhea virus Ab [Titer] in Serum |
|
22892-4
|
Bovine diarrhea virus Ab [Titer] in Serum by Neutralization test |
|
31740-4
|
Bovine diarrhea virus Ag [Presence] in Blood |
|
22896-5
|
Bovine diarrhea virus Ag [Presence] in Blood by Immunoassay |
|
20713-4
|
Bovine diarrhea virus Ag [Presence] in Blood by Immunofluorescence |
|
31741-2
|
Bovine diarrhea virus Ag [Presence] in Nose |
|
20711-8
|
Bovine diarrhea virus Ag [Presence] in Nose by Immunofluorescence |
|
20715-9
|
Bovine diarrhea virus Ag [Presence] in Serum by Immune stain |
|
31742-0
|
Bovine diarrhea virus Ag [Presence] in Stool |
|
20714-2
|
Bovine diarrhea virus Ag [Presence] in Stool by Immunofluorescence |
|
20712-6
|
Bovine diarrhea virus Ag [Presence] in Tissue by Immunofluorescence |
|
31743-8
|
Bovine diarrhea virus Ag [Presence] in Unspecified specimen |
|
22898-1
|
Bovine diarrhea virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22897-3
|
Bovine diarrhea virus Ag [Presence] in Unspecified specimen by Immune stain |
|
20710-0
|
Bovine diarrhea virus RNA [Presence] in Serum by NAA with probe detection |
|
20709-2
|
Bovine diarrhea virus RNA [Presence] in Tissue by NAA with probe detection |
|
22899-9
|
Bovine diarrhea virus RNA [Presence] in Tissue by Probe |
|
22900-5
|
Bovine diarrhea virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20716-7
|
Bovine diarrhea virus [Presence] in Serum by Organism specific culture |
|
31270-2
|
Bovine diarrhea virus 1 Ab [Units/volume] in Serum |
|
22140-8
|
Bovine diarrhea virus 1 Ab [Titer] in Serum |
|
15462-5
|
Bovine diarrhea virus 1 Ab [Titer] in Serum by Neutralization test |
|
31271-0
|
Bovine diarrhea virus 2 Ab [Units/volume] in Serum |
|
22141-6
|
Bovine diarrhea virus 2 Ab [Titer] in Serum |
|
15463-3
|
Bovine diarrhea virus 2 Ab [Titer] in Serum by Neutralization test |
|
20717-5
|
Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
79782-9
|
b-wave amplitude Left retina dark-adapted by ERG |
|
79784-5
|
b-wave amplitude Left retina light-adapted by ERG |
|
79781-1
|
b-wave amplitude Right retina dark-adapted by ERG |
|
79783-7
|
b-wave amplitude Right retina light-adapted by ERG |
|
79785-2
|
b-wave implicit time Left retina dark-adapted by ERG |
|
79788-6
|
b-wave implicit time Left retina light-adapted by ERG |
|
79786-0
|
b-wave implicit time Right retina dark-adapted by ERG |
|
79787-8
|
b-wave implicit time Right retina light-adapted by ERG |
|
52117-9
|
Bx Ab [Presence] in Serum or Plasma |
|
88091-4
|
Bystander observed collapse |
|
42856-5
|
Benzoylecgonine [Mass/volume] in Blood by Confirmatory method |
|
72407-0
|
Benzoylecgonine [Presence] in Blood by Screen method |
|
77791-2
|
Benzoylecgonine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19358-1
|
Benzoylecgonine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19357-3
|
Benzoylecgonine cutoff [Mass/volume] in Urine for Screen method |
|
19065-2
|
Benzoylecgonine cutoff [Mass/volume] in Urine |
|
4140-0
|
Benzoylecgonine [Mass] of Dose |
|
8183-6
|
Benzoylecgonine [Presence] in Gastric fluid |
|
8184-4
|
Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method |
|
8185-1
|
Benzoylecgonine [Presence] in Gastric fluid by Screen method |
|
8182-8
|
Benzoylecgonine [Mass/volume] in Gastric fluid |
|
5938-6
|
Benzoylecgonine [Presence] in Hair |
|
5936-0
|
Benzoylecgonine [Mass/mass] in Hair |
|
69010-7
|
Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method |
|
8187-7
|
Benzoylecgonine [Presence] in Meconium |
|
8188-5
|
Benzoylecgonine [Presence] in Meconium by Confirmatory method |
|
8189-3
|
Benzoylecgonine [Presence] in Meconium by Screen method |
|
8186-9
|
Benzoylecgonine [Mass/volume] in Meconium |
|
27026-4
|
Benzoylecgonine [Mass/mass] in Meconium |
|
87809-0
|
Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74679-2
|
Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
57301-4
|
Benzoylecgonine [Mass/volume] in Saliva (oral fluid) |
|
59616-3
|
Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3391-0
|
Benzoylecgonine [Presence] in Serum or Plasma |
|
16446-7
|
Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
|
3392-8
|
Benzoylecgonine [Mass/volume] in Serum or Plasma |
|
55525-0
|
Benzoylecgonine [Moles/volume] in Serum or Plasma |
|
12352-1
|
Benzoylecgonine [Presence] in Stool |
|
27248-4
|
Benzoylecgonine [Mass/mass] in Stool |
|
16226-3
|
Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
|
3393-6
|
Benzoylecgonine [Presence] in Urine |
|
14315-6
|
Benzoylecgonine [Presence] in Urine by Confirmatory method |
|
8192-7
|
Benzoylecgonine [Presence] in Urine by SAMHSA confirm method |
|
8193-5
|
Benzoylecgonine [Presence] in Urine by SAMHSA screen method |
|
14314-9
|
Benzoylecgonine [Presence] in Urine by Screen method |
|
43984-4
|
Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL |
|
43985-1
|
Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL |
|
70146-6
|
Benzoylecgonine [Mass/volume] in Urine by Screen method |
|
3394-4
|
Benzoylecgonine [Mass/volume] in Urine |
|
27358-1
|
Benzoylecgonine [Mass/volume] in Vitreous fluid |
|
40609-0
|
Benzoylecgonine [Presence] in Unspecified specimen |
|
43230-2
|
Benzoylecgonine [Mass/volume] in Unspecified specimen |
|
77320-0
|
Benzoylecgonine [Moles/volume] in Unspecified specimen |
|
13479-1
|
Benzoylecgonine/Creatinine [Mass Ratio] in Urine |
|
943-1
|
C Ab [Presence] in Serum or Plasma from Blood product unit |
|
944-9
|
C Ab [Presence] in Serum or Plasma from Donor |
|
945-6
|
C Ab [Presence] in Serum or Plasma |
|
34196-6
|
C Ab [Titer] in Serum or Plasma |
|
92785-5
|
Cutibacterium acnes DNA [Presence] by NAA with probe detection in Positive blood culture |
|
93938-9
|
C Ag [Presence] on Red Blood Cells --during infancy |
|
92551-1
|
C Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92513-1
|
C Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93928-0
|
C Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93921-5
|
C Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
946-4
|
C Ag [Presence] on Red Blood Cells from Blood product unit |
|
947-2
|
C Ag [Presence] on Red Blood Cells from Donor |
|
948-0
|
C Ag [Presence] on Red Blood Cells |
|
93946-2
|
C Ag [Presence] in Cord red blood cells |
|
33461-5
|
Candida albicans Ab [Presence] in Cerebral spinal fluid |
|
33406-0
|
Candida albicans Ab [Units/volume] in Serum by Complement fixation |
|
16537-3
|
Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
|
22162-2
|
Candida albicans Ab [Presence] in Serum |
|
5074-0
|
Candida albicans Ab [Presence] in Serum by Immune diffusion (ID) |
|
22163-0
|
Candida albicans Ab [Units/volume] in Serum |
|
42859-9
|
Candida albicans Ab [Titer] in Serum |
|
68948-9
|
Candida albicans Ab [Titer] in Serum by Immunofluorescence |
|
31758-6
|
Candida albicans Ag [Presence] in Serum |
|
6337-0
|
Candida albicans Ag [Presence] in Serum by Immune diffusion (ID) |
|
31759-4
|
Candida albicans Ag [Units/volume] in Serum |
|
5075-7
|
Candida albicans Ag [Titer] in Serum by Latex agglutination |
|
7173-8
|
Candida albicans triggered histamine release [Units/volume] in Blood |
|
85781-3
|
Candida albicans DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92790-5
|
Candida albicans DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70022-9
|
Candida albicans DNA [Presence] in Blood by NAA with probe detection |
|
90806-1
|
Candida albicans DNA [Presence] in Serum by NAA with probe detection |
|
69562-7
|
Candida albicans DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
56151-4
|
Candida albicans IgA Ab [Units/volume] in Serum |
|
6059-0
|
Candida albicans IgE Ab [Units/volume] in Serum |
|
15599-4
|
Candida albicans IgE Ab RAST class [Presence] in Serum |
|
61238-2
|
Candida albicans IgE Ab/IgE total in Serum |
|
7172-0
|
Candida albicans IgG Ab [Units/volume] in Serum |
|
51539-5
|
Candida albicans IgG Ab [Presence] in Serum |
|
26413-5
|
Candida albicans IgG4 Ab [Units/volume] in Serum |
|
26414-3
|
Candida albicans IgG4 Ab RAST class [Presence] in Serum |
|
56204-1
|
Candida albicans IgG4 Ab [Mass/volume] in Serum |
|
35530-5
|
Candida albicans IgG Ab [Mass/volume] in Serum |
|
56150-6
|
Candida albicans IgM Ab [Units/volume] in Serum |
|
13216-7
|
Candida albicans immune complex [Units/volume] in Serum or Plasma |
|
76608-9
|
Candida albicans its gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76580-0
|
Candida albicans its gene [Presence] in XXX.swab by NAA with probe detection |
|
76595-8
|
Candida albicans its gene [#/mass] in XXX.tissue by NAA with probe detection |
|
48240-6
|
Candida albicans triggered leukotriene release [Mass/volume] by Leukocytes |
|
11166-6
|
Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum |
|
15638-0
|
Chortoglyphus arcuatus IgE Ab RAST class [Presence] in Serum |
|
92791-3
|
Candida auris DNA [Presence] by NAA with probe detection in Positive blood culture |
|
87620-1
|
Candida auris ITS2 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
90002-7
|
Candida auris [Presence] in Unspecified specimen by Organism specific culture |
|
80518-4
|
Clostridium baratii toxin F bont gene [Presence] in Unspecified specimen by NAA with probe detection |
|
33695-8
|
Clostridium botulinum [Presence] in Isolate by Organism specific culture |
|
87948-6
|
Clostridium botulinum [Presence] in Stool by Organism specific culture |
|
34664-3
|
Clostridium botulinum toxin A Ab [Presence] in Serum |
|
33709-7
|
Clostridium botulinum toxin A [Presence] in Unspecified specimen |
|
41630-5
|
Clostridium botulinum toxin A [Presence] in Unspecified specimen by Immunofluorescence |
|
33701-4
|
Clostridium botulinum toxin A [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33712-1
|
Clostridium botulinum toxin A+B+E [Presence] in Unspecified specimen |
|
33704-8
|
Clostridium botulinum toxin A+B+E [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
38989-0
|
Clostridium botulinum toxin A+B+E+F+G [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33713-9
|
Clostridium botulinum toxin B [Presence] in Unspecified specimen |
|
41632-1
|
Clostridium botulinum toxin B [Presence] in Unspecified specimen by Immunofluorescence |
|
33705-5
|
Clostridium botulinum toxin B [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33710-5
|
Clostridium botulinum toxin E [Presence] in Unspecified specimen |
|
41634-7
|
Clostridium botulinum toxin E [Presence] in Unspecified specimen by Immunofluorescence |
|
33702-2
|
Clostridium botulinum toxin E [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33711-3
|
Clostridium botulinum toxin F [Presence] in Unspecified specimen |
|
41635-4
|
Clostridium botulinum toxin F [Presence] in Unspecified specimen by Immunofluorescence |
|
33703-0
|
Clostridium botulinum toxin F [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
46705-0
|
Clostridium botulinum toxin gene [Identifier] in Unspecified specimen by NAA with probe detection |
|
20705-0
|
Clostridium botulinum toxin [Identifier] in Serum by Animal inoculation |
|
88589-7
|
Clostridium botulinum toxin [Identifier] in Serum by Mouse bioassay neutralization |
|
88578-0
|
Clostridium botulinum toxin [Identifier] in Stool by Mouse bioassay neutralization |
|
11470-2
|
Clostridium botulinum toxin [Units/volume] in Stool |
|
44796-1
|
Clostridium botulinum toxin [Identifier] in Unspecified specimen |
|
20706-8
|
Clostridium botulinum toxin [Identifier] in Unspecified specimen by Animal inoculation |
|
44274-9
|
Clostridium botulinum toxin [Identifier] in Unspecified specimen by Immunoassay |
|
33708-9
|
Clostridium botulinum toxin [Presence] in Unspecified specimen |
|
45039-5
|
Clostridium botulinum toxin [Presence] in Unspecified specimen by Immunoassay |
|
33696-6
|
Clostridium botulinum toxin [Presence] in Unspecified specimen by Mouse bioassay |
|
33694-1
|
Clostridium botulinum [Presence] in Unspecified specimen by Organism specific culture |
|
41631-3
|
Clostridium botulinum toxin A botA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
41633-9
|
Clostridium botulinum toxin B botB gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81644-7
|
Clostridium botulinum toxin C botC gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81645-4
|
Clostridium botulinum toxin D botD gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81646-2
|
Clostridium botulinum toxin E botE gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81647-0
|
Clostridium botulinum toxin F botF gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81648-8
|
Clostridium botulinum toxin G botG gene [Presence] in Unspecified specimen by NAA with probe detection |
|
23020-1
|
Coxiella burnetii Ab [Presence] in Serum |
|
23017-7
|
Coxiella burnetii Ab [Presence] in Serum by Complement fixation |
|
23019-3
|
Coxiella burnetii Ab [Presence] in Serum by Immunoassay |
|
23018-5
|
Coxiella burnetii Ab [Presence] in Serum by Immunofluorescence |
|
7828-7
|
Coxiella burnetii Ab [Units/volume] in Serum |
|
44021-4
|
Coxiella burnetii Ab [Interpretation] in Serum |
|
32566-2
|
Coxiella burnetii Ab [Titer] in Cerebral spinal fluid |
|
22211-7
|
Coxiella burnetii Ab [Titer] in Serum |
|
5100-3
|
Coxiella burnetii Ab [Titer] in Serum by Complement fixation |
|
31783-4
|
Coxiella burnetii Ag [Presence] in Placenta |
|
23022-7
|
Coxiella burnetii Ag [Presence] in Placenta by Immunofluorescence |
|
23021-9
|
Coxiella burnetii Ag [Presence] in Tissue by Immunoassay |
|
31784-2
|
Coxiella burnetii Ag [Presence] in Unspecified specimen |
|
23023-5
|
Coxiella burnetii Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
90443-3
|
Coxiella burnetii aroE gene [Presence] in Serum, Plasma or Blood by NAA with non-probe detection |
|
90442-5
|
Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection |
|
88177-1
|
Coxiella burnetii DNA [Presence] in Blood by NAA with probe detection |
|
89649-8
|
Coxiella burnetii DNA [Presence] in Implanted device by NAA with probe detection |
|
60261-5
|
Coxiella burnetii DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
88178-9
|
Coxiella burnetii DNA [Presence] in Tissue by NAA with probe detection |
|
23024-3
|
Coxiella burnetii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
30212-5
|
Coxiella burnetii IgG Ab [Presence] in Serum |
|
56915-2
|
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence |
|
16677-7
|
Coxiella burnetii IgG Ab [Units/volume] in Serum |
|
57681-9
|
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen |
|
56920-2
|
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
57682-7
|
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
|
56919-4
|
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
25335-1
|
Coxiella burnetii IgG Ab [Titer] in Serum |
|
25384-9
|
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence |
|
30213-3
|
Coxiella burnetii IgM Ab [Presence] in Serum |
|
56917-8
|
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence |
|
16678-5
|
Coxiella burnetii IgM Ab [Units/volume] in Serum |
|
57673-6
|
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --1st specimen |
|
56918-6
|
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
56916-0
|
Coxiella burnetii IgM Ab [Units/volume] in Serum by Immunofluorescence --2nd specimen |
|
57674-4
|
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
|
25336-9
|
Coxiella burnetii IgM Ab [Titer] in Serum |
|
25385-6
|
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence |
|
44006-5
|
Coxiella burnetii phase 1 and 2 IgG and IgM [Interpretation] in Serum |
|
31311-4
|
Coxiella burnetii phase 1 Ab [Units/volume] in Serum |
|
43050-4
|
Coxiella burnetii phase 1 Ab [Titer] in Serum |
|
29774-7
|
Coxiella burnetii phase 1 Ab [Titer] in Serum by Complement fixation |
|
27951-3
|
Coxiella burnetii phase 1 Ab [Titer] in Serum by Immunofluorescence |
|
31312-2
|
Coxiella burnetii phase 1 IgA Ab [Units/volume] in Serum |
|
49187-8
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid |
|
48889-0
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid by Immunofluorescence |
|
9706-3
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum |
|
48848-6
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum by Immunofluorescence |
|
51810-0
|
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
32644-7
|
Coxiella burnetii phase 1 IgG Ab [Presence] in Serum |
|
48720-7
|
Coxiella burnetii phase 1 IgG Ab [Presence] in Serum by Immunofluorescence |
|
7829-5
|
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum |
|
49186-0
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid |
|
48888-2
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9708-9
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum |
|
34716-1
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
51811-8
|
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
42897-9
|
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
32645-4
|
Coxiella burnetii phase 1 IgM Ab [Presence] in Serum |
|
63455-0
|
Coxiella burnetii phase 1 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7831-1
|
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum |
|
49185-2
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid |
|
48890-8
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9710-5
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum |
|
47075-7
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31313-0
|
Coxiella burnetii phase 2 Ab [Units/volume] in Serum |
|
38389-3
|
Coxiella burnetii phase 2 Ab [Titer] in Serum |
|
29772-1
|
Coxiella burnetii phase 2 Ab [Titer] in Serum by Complement fixation |
|
27945-5
|
Coxiella burnetii phase 2 Ab [Titer] in Serum by Immunofluorescence |
|
31316-3
|
Coxiella burnetii phase 2 IgA Ab [Units/volume] in Serum |
|
49184-5
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid |
|
48891-6
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid by Immunofluorescence |
|
9707-1
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum |
|
48849-4
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum by Immunofluorescence |
|
58762-6
|
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
51812-6
|
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
31314-8
|
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum |
|
29777-0
|
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay |
|
48719-9
|
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunofluorescence |
|
7830-3
|
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum |
|
58761-8
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49183-7
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid |
|
48893-2
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9709-7
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum |
|
34717-9
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
51813-4
|
Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
31315-5
|
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum |
|
29773-9
|
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunoassay |
|
43928-1
|
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7832-9
|
Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum |
|
49182-9
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid |
|
48892-4
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9711-3
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum |
|
44814-2
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
23016-9
|
Coxiella burnetii [Presence] in Placenta by Light microscopy |
|
44799-5
|
Coxiella burnetii [Presence] in Unspecified specimen by Organism specific culture |
|
44275-6
|
Coxiella burnetii [Presence] in Unspecified specimen by Light microscopy |
|
49124-1
|
Coxiella burnetii identified in Unspecified specimen by Sequencing |
|
41435-9
|
Cyclospora carcopitheci DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82206-4
|
Cyclospora cayetanensis DNA [Presence] in Stool by NAA with non-probe detection |
|
41436-7
|
Cyclospora cayetanensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10850-6
|
Cyclospora cayetanensis [Presence] in Unspecified specimen |
|
20760-5
|
Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence |
|
56729-7
|
Cladosporium cladosporioides IgE Ab [Units/volume] in Serum |
|
51543-7
|
Cladosporium cladosporioides IgG Ab [Presence] in Serum |
|
25598-4
|
Cladosporium cladosporioides IgG Ab [Units/volume] in Serum |
|
26018-2
|
Cladosporium cladosporioides IgG Ab RAST class [Presence] in Serum |
|
35557-8
|
Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum |
|
16528-2
|
Campylobacter coli rRNA [Units/volume] in Serum by Probe |
|
6329-7
|
Campylobacter coli rRNA [Presence] in Unspecified specimen by Probe |
|
80684-4
|
Campylobacter coli+jejuni+lari 16S rRNA [Presence] in Stool by NAA with probe detection |
|
82196-7
|
Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with non-probe detection |
|
81656-1
|
Campylobacter coli+jejuni tuf gene [Presence] in Stool by NAA with probe detection |
|
79382-8
|
Campylobacter coli+jejuni+lari fusA gene [Presence] in Stool by NAA with probe detection |
|
41437-5
|
Cyclospora colobi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31336-1
|
Cryptostroma corticale Ab [Presence] in Serum |
|
24499-6
|
Cryptostroma corticale Ab [Presence] in Serum by Immune diffusion (ID) |
|
6839-5
|
Cryptostroma corticale IgE Ab [Units/volume] in Serum |
|
82197-5
|
Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with non-probe detection |
|
80685-1
|
Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection |
|
31308-0
|
Clostridioides difficile Ab [Units/volume] in Serum |
|
9365-8
|
Clostridioides difficile Ab [Titer] in Serum |
|
87755-5
|
Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection |
|
61367-9
|
Clostridioides difficile DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
79177-2
|
Clostridioides difficile glutamate dehydrogenase and toxins A+B [Presence] in Stool by Rapid immunoassay |
|
57901-1
|
Clostridioides difficile glutamate dehydrogenase [Presence] in Stool |
|
83087-7
|
Clostridioides difficile glutamate dehydrogenase [Presence] in Stool by Immunoassay |
|
26697-3
|
Clostridioides difficile IgA Ab [Units/volume] in Serum |
|
26702-1
|
Clostridioides difficile IgG Ab [Units/volume] in Serum |
|
26694-0
|
Clostridioides difficile IgM Ab [Units/volume] in Serum |
|
34712-0
|
Clostridioides difficile [Presence] in Stool |
|
20762-1
|
Clostridioides difficile [Presence] in Stool by Aerobe culture |
|
20761-3
|
Clostridioides difficile [Presence] in Stool by Agglutination |
|
562-9
|
Clostridioides difficile [Presence] in Stool by Organism specific culture |
|
6359-4
|
Clostridioides difficile toxin A [Units/volume] in Stool by Immunoassay |
|
13957-6
|
Clostridioides difficile toxin A [Presence] in Stool by Immunoassay |
|
6360-2
|
Clostridioides difficile toxin A [Units/volume] in Unspecified specimen by Immunoassay |
|
6361-0
|
Clostridioides difficile toxin A+B [Units/volume] in Serum by Immunoassay |
|
6363-6
|
Clostridioides difficile toxin A+B [Units/volume] in Stool by Immunoassay |
|
34713-8
|
Clostridioides difficile toxin A+B [Presence] in Stool |
|
6362-8
|
Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay |
|
34468-9
|
Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay |
|
6364-4
|
Clostridioides difficile toxin A+B [Units/volume] in Unspecified specimen by Immunoassay |
|
43055-3
|
Clostridioides difficile toxin Ab [Titer] in Serum |
|
33947-3
|
Clostridioides difficile toxin Ab [Titer] in Serum by Neutralization test |
|
6365-1
|
Clostridioides difficile toxin B [Units/volume] in Stool by Immunoassay |
|
10895-1
|
Clostridioides difficile toxin B [Presence] in Stool |
|
46131-9
|
Clostridioides difficile toxin B [Presence] in Stool by Cytotoxin tissue culture assay |
|
74822-8
|
Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection |
|
6366-9
|
Clostridioides difficile toxin B [Units/volume] in Unspecified specimen by Immunoassay |
|
54067-4
|
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection |
|
563-7
|
Clostridioides difficile [Presence] in Unspecified specimen by Organism specific culture |
|
47298-5
|
Corynebacterium diphtheriae Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
5116-9
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay |
|
32620-7
|
Corynebacterium diphtheriae Ab [Presence] in Serum |
|
5115-1
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum |
|
32569-6
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum --1st specimen |
|
31014-4
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum --2nd specimen |
|
35348-2
|
Corynebacterium diphtheriae Ab [Titer] in Serum |
|
67561-1
|
Corynebacterium diphtheriae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58787-3
|
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay |
|
45166-6
|
Corynebacterium diphtheriae IgG Ab [Presence] in Serum |
|
13227-4
|
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
|
26630-4
|
Corynebacterium diphtheriae toxin Ab [Presence] in Serum |
|
34625-4
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum |
|
47297-7
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
47429-6
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --1st specimen |
|
48655-5
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
49188-6
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --2nd specimen |
|
48654-8
|
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum by Immunoassay |
|
89642-3
|
Corynebacterium diphtheriae toxin IgG Ab [Presence] in Serum by Immunoassay |
|
49189-4
|
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum |
|
88584-8
|
Corynebacterium diphtheriae [Presence] in Upper respiratory specimen by Organism specific culture |
|
16676-9
|
Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture |
|
92792-1
|
Candida dubliniensis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92793-9
|
Candida famata DNA [Presence] by NAA with probe detection in Positive blood culture |
|
22962-5
|
Campylobacter fetus Ab [Presence] in Genital mucus |
|
22963-3
|
Campylobacter fetus Ab [Presence] in Genital mucus by Agglutination |
|
69576-7
|
Campylobacter fetus Ab [Presence] in Serum |
|
31278-5
|
Campylobacter fetus Ab [Units/volume] in Serum |
|
25333-6
|
Campylobacter fetus Ab [Titer] in Serum |
|
25363-3
|
Campylobacter fetus Ab [Titer] in Serum by Complement fixation |
|
31755-2
|
Campylobacter fetus Ag [Presence] in Genital fluid |
|
22964-1
|
Campylobacter fetus Ag [Presence] in Genital fluid by Immunofluorescence |
|
22966-6
|
Campylobacter fetus Ag [Presence] in Tissue by Immunofluorescence |
|
31756-0
|
Campylobacter fetus Ag [Presence] in Unspecified specimen |
|
22965-8
|
Campylobacter fetus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22967-4
|
Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus |
|
22968-2
|
Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus by Agglutination |
|
22970-8
|
Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus |
|
22969-0
|
Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus by Immunoassay |
|
82181-9
|
Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
85782-1
|
Candida glabrata DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92794-7
|
Candida glabrata DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70026-0
|
Candida glabrata DNA [Presence] in Blood by NAA with probe detection |
|
90807-9
|
Candida glabrata DNA [Presence] in Serum by NAA with probe detection |
|
69563-5
|
Candida glabrata DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
7200-9
|
Chaetomium globosum IgE Ab [Units/volume] in Serum |
|
15620-8
|
Chaetomium globosum IgE Ab RAST class [Presence] in Serum |
|
61242-4
|
Chaetomium globosum IgE Ab/IgE total in Serum |
|
18420-0
|
Chaetomium globosum IgG Ab [Units/volume] in Serum |
|
63178-8
|
Chaetomium globosum IgG Ab [Mass/volume] in Serum |
|
92795-4
|
Candida guilliermondii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
64978-0
|
Cladosporium herbarum recombinant (rCla h) 8 IgE Ab [Units/volume] in Serum |
|
44460-4
|
Cladosporium herbarum Ab [Presence] in Serum by Immune diffusion (ID) |
|
16618-1
|
Cladosporium herbarum Ab [Units/volume] in Serum |
|
7231-4
|
Cladosporium herbarum triggered histamine release [Units/volume] in Blood |
|
6075-6
|
Cladosporium herbarum IgE Ab [Units/volume] in Serum |
|
15642-2
|
Cladosporium herbarum IgE Ab RAST class [Presence] in Serum |
|
61249-9
|
Cladosporium herbarum IgE Ab/IgE total in Serum |
|
51538-7
|
Cladosporium herbarum IgG Ab [Presence] in Serum |
|
7230-6
|
Cladosporium herbarum IgG Ab [Units/volume] in Serum |
|
42893-8
|
Cladosporium herbarum IgG Ab [Mass/volume] in Serum |
|
26417-6
|
Cladosporium herbarum IgG4 Ab [Units/volume] in Serum |
|
26418-4
|
Cladosporium herbarum IgG4 Ab RAST class [Presence] in Serum |
|
56224-9
|
Cladosporium herbarum IgG4 Ab [Mass/volume] in Serum |
|
28552-8
|
Cladosporium herbarum IgM Ab [Units/volume] in Serum |
|
48242-2
|
Cladosporium herbarum triggered leukotriene release [Mass/volume] by Leukocytes |
|
41433-4
|
Cryptosporidium hominis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22204-2
|
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid |
|
30209-1
|
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
21209-2
|
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
16634-8
|
Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid |
|
31309-8
|
Coccidioides immitis Ab [Presence] in Body fluid |
|
31048-2
|
Coccidioides immitis Ab [Presence] in Body fluid by Complement fixation |
|
5094-8
|
Coccidioides immitis Ab [Units/volume] in Serum by Immunoassay |
|
22205-9
|
Coccidioides immitis Ab [Presence] in Serum |
|
20768-8
|
Coccidioides immitis Ab [Presence] in Serum by Complement fixation |
|
40712-2
|
Coccidioides immitis Ab [Presence] in Serum by Immunoassay |
|
5095-5
|
Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID) |
|
22206-7
|
Coccidioides immitis Ab [Units/volume] in Serum |
|
22207-5
|
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid |
|
13917-0
|
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
51452-1
|
Coccidioides immitis Ab [Titer] in Body fluid |
|
48392-5
|
Coccidioides immitis Ab [Titer] in Body fluid by Complement fixation |
|
43053-8
|
Coccidioides immitis Ab [Titer] in Pleural fluid |
|
42494-5
|
Coccidioides immitis Ab [Titer] in Pleural fluid by Complement fixation |
|
22208-3
|
Coccidioides immitis Ab [Titer] in Serum |
|
5096-3
|
Coccidioides immitis Ab [Titer] in Serum by Complement fixation |
|
26980-3
|
Coccidioides immitis Ab [Titer] in Serum by Immune diffusion (ID) |
|
6368-5
|
Coccidioides immitis Ab [Titer] in Serum by Latex agglutination |
|
38385-1
|
Coccidioides immitis Ag [Presence] in Cerebral spinal fluid |
|
31782-6
|
Coccidioides immitis Ag [Presence] in Isolate |
|
14205-9
|
Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) |
|
62455-1
|
Coccidioides sp F Ab [Presence] in Serum by Immune diffusion (ID) |
|
16636-3
|
Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid |
|
16635-5
|
Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay |
|
9705-5
|
Coccidioides immitis IgA Ab [Units/volume] in Serum |
|
16637-1
|
Coccidioides immitis IgE Ab [Units/volume] in Serum |
|
30207-5
|
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid |
|
57946-6
|
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
16638-9
|
Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
22209-1
|
Coccidioides immitis IgG Ab [Presence] in Serum |
|
13947-7
|
Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
|
62459-3
|
Coccidioides immitis IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
7826-1
|
Coccidioides immitis IgG Ab [Units/volume] in Serum |
|
43380-5
|
Coccidioides immitis IgG Ab [Units/volume] in Unspecified specimen |
|
30208-3
|
Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid |
|
16639-7
|
Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
48393-3
|
Coccidioides immitis IgM Ab [Units/volume] in Body fluid |
|
22210-9
|
Coccidioides immitis IgM Ab [Presence] in Serum |
|
13948-5
|
Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
|
62458-5
|
Coccidioides immitis IgM Ab [Presence] in Serum by Immune diffusion (ID) |
|
7827-9
|
Coccidioides immitis IgM Ab [Units/volume] in Serum |
|
33534-9
|
Coccidioides immitis IgM Ab [Presence] in Unspecified specimen |
|
33510-9
|
Coccidioides immitis IgM Ab [Presence] in Unspecified specimen by Immunoassay |
|
20767-0
|
Coccidioides immitis [Presence] in Isolate |
|
4994-0
|
Coccidioides immitis rRNA [Presence] in Unspecified specimen by Probe |
|
14206-7
|
Coccidioides immitis exoantigen [Identifier] in Isolate |
|
75710-4
|
Coccidioides immitis+posadasii IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
26818-5
|
Campylobacter jejuni Ab [Units/volume] in Serum by Immunoassay |
|
69575-9
|
Campylobacter jejuni Ab [Presence] in Serum by Complement fixation |
|
31279-3
|
Campylobacter jejuni Ab [Units/volume] in Serum |
|
9655-2
|
Campylobacter jejuni Ab [Titer] in Serum |
|
25364-1
|
Campylobacter jejuni Ab [Titer] in Serum by Complement fixation |
|
61368-7
|
Campylobacter jejuni DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82875-6
|
Campylobacter jejuni IgA Ab [Titer] in Serum |
|
45325-8
|
Campylobacter jejuni IgG Ab [Titer] in Serum |
|
58789-9
|
Campylobacter jejuni IgG Ab [Titer] in Serum by Immunofluorescence |
|
45134-4
|
Campylobacter jejuni IgM Ab [Titer] in Serum |
|
58788-1
|
Campylobacter jejuni IgM Ab [Titer] in Serum by Immunofluorescence |
|
16529-0
|
Campylobacter jejuni rRNA [Units/volume] in Serum by Probe |
|
16530-8
|
Campylobacter jejuni rRNA [Presence] in Serum by Probe |
|
6333-9
|
Campylobacter jejuni rRNA [Presence] in Unspecified specimen by Probe |
|
57768-4
|
Campylobacter jejuni+Campylobacter coli Ag [Presence] in Stool |
|
92796-2
|
Candida kefyr DNA [Presence] by NAA with probe detection in Positive blood culture |
|
85783-9
|
Candida krusei DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92797-0
|
Candida krusei DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70025-2
|
Candida krusei DNA [Presence] in Blood by NAA with probe detection |
|
90808-7
|
Candida krusei DNA [Presence] in Serum by NAA with probe detection |
|
72389-0
|
Candida krusei DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
16531-6
|
Campylobacter lari rRNA [Units/volume] in Serum by Probe |
|
16532-4
|
Campylobacter lari rRNA [Presence] in Serum by Probe |
|
6334-7
|
Campylobacter lari rRNA [Presence] in Unspecified specimen by Probe |
|
949-8
|
C little e Ab [Presence] in Serum or Plasma from Blood product unit |
|
950-6
|
C little e Ab [Presence] in Serum or Plasma from Donor |
|
951-4
|
C little e Ab [Presence] in Serum or Plasma |
|
952-2
|
C little e Ag [Presence] on Red Blood Cells from Blood product unit |
|
953-0
|
C little e Ag [Presence] on Red Blood Cells from Donor |
|
954-8
|
C little e Ag [Presence] on Red Blood Cells |
|
6094-7
|
Curvularia lunata IgE Ab [Units/volume] in Serum |
|
15669-5
|
Curvularia lunata IgE Ab RAST class [Presence] in Serum |
|
39598-8
|
Curvularia lunata IgE Ab/IgE total in Serum |
|
18409-3
|
Curvularia lunata IgG Ab [Units/volume] in Serum |
|
63162-2
|
Curvularia lunata IgG Ab [Mass/volume] in Serum |
|
92798-8
|
Candida lusitaniae DNA [Presence] by NAA with probe detection in Positive blood culture |
|
72390-8
|
Candida lusitaniae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
7842-8
|
Cryptococcus neoformans Ab [Units/volume] in Serum |
|
22237-2
|
Cryptococcus neoformans Ab [Titer] in Serum |
|
6369-3
|
Cryptococcus neoformans Ab [Titer] in Serum by Agglutination |
|
92802-8
|
Cryptococcus neoformans DNA [Presence] by NAA with probe detection in Positive blood culture |
|
49098-7
|
Cryptococcus neoformans rRNA [Units/volume] in Unspecified specimen by NAA with probe detection |
|
4995-7
|
Cryptococcus neoformans rRNA [Presence] in Unspecified specimen by Probe |
|
38377-8
|
Cryptococcus neoformans [Presence] in Unspecified specimen by Organism specific culture |
|
20763-9
|
Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence |
|
41438-3
|
Cyclospora papionis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85784-7
|
Candida parapsilosis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92799-6
|
Candida parapsilosis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70024-5
|
Candida parapsilosis DNA [Presence] in Blood by NAA with probe detection |
|
90809-5
|
Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection |
|
72495-5
|
Candida parapsilosis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
41487-0
|
Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
|
91677-5
|
Cryptosporidium parvum Ag [Presence] in Stool by Rapid immunoassay |
|
41434-2
|
Cryptosporidium parvum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40958-1
|
Cryptosporidium parvum identified in Stool |
|
80681-0
|
Cryptosporidium parvum+hominis oocyst wall protein COWP gene [Presence] in Stool by NAA with probe detection |
|
92688-1
|
Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection |
|
57651-2
|
C peptide [Moles/volume] in Serum or Plasma --1.3 hours post XXX challenge |
|
13040-1
|
C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
38423-0
|
C peptide [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
58494-6
|
C peptide [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
47583-0
|
C peptide [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
57894-8
|
C peptide [Moles/volume] in Serum or Plasma --100 minutes post XXX challenge |
|
13859-4
|
C peptide [Mass/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV |
|
58495-3
|
C peptide [Moles/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV |
|
56582-0
|
C peptide [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
47584-8
|
C peptide [Moles/volume] in Serum or Plasma --10 minutes post dose glucose |
|
57645-4
|
C peptide [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge |
|
56584-6
|
C peptide [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge |
|
13860-2
|
C peptide [Mass/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV |
|
58499-5
|
C peptide [Moles/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV |
|
38249-9
|
C peptide [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
77610-4
|
C peptide [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
58500-0
|
C peptide [Mass/volume] in Serum or Plasma --15 minutes post dose glucose |
|
47585-5
|
C peptide [Moles/volume] in Serum or Plasma --15 minutes post dose glucose |
|
58501-8
|
C peptide [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
58502-6
|
C peptide [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
57646-2
|
C peptide [Moles/volume] in Serum or Plasma --190 minutes post XXX challenge |
|
13039-3
|
C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
38422-2
|
C peptide [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
58503-4
|
C peptide [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
|
47586-3
|
C peptide [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
|
57649-6
|
C peptide [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge |
|
47587-1
|
C peptide [Moles/volume] in Serum or Plasma --1 minute post dose glucose |
|
13042-7
|
C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
38425-5
|
C peptide [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
58505-9
|
C peptide [Mass/volume] in Serum or Plasma --2.5 hours post dose glucose |
|
58506-7
|
C peptide [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose |
|
27408-4
|
C peptide [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
55920-3
|
C peptide [Mass/volume] in 24 hour Urine |
|
27944-8
|
C peptide [Mass/time] in 24 hour Urine |
|
25872-3
|
C peptide [Moles/volume] in 24 hour Urine |
|
25358-3
|
C peptide [Moles/time] in 24 hour Urine |
|
13041-9
|
C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
38424-8
|
C peptide [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
58686-7
|
C peptide [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
|
47588-9
|
C peptide [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
|
58507-5
|
C peptide [Moles/volume] in Serum or Plasma --2 minutes post 1 mg glucagon IV |
|
57647-0
|
C peptide [Moles/volume] in Serum or Plasma --3.3 hours post XXX challenge |
|
58508-3
|
C peptide [Mass/volume] in Serum or Plasma --3.5 hours post dose glucose |
|
58509-1
|
C peptide [Moles/volume] in Serum or Plasma --3.5 hours post dose glucose |
|
13038-5
|
C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
38421-4
|
C peptide [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
58510-9
|
C peptide [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
|
47589-7
|
C peptide [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
|
13043-5
|
C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
38426-3
|
C peptide [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
58511-7
|
C peptide [Mass/volume] in Serum or Plasma --3 hours post dose glucose |
|
47590-5
|
C peptide [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
|
47591-3
|
C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose |
|
58512-5
|
C peptide [Mass/volume] in Serum or Plasma --4.5 hours post dose glucose |
|
58513-3
|
C peptide [Moles/volume] in Serum or Plasma --4.5 hours post dose glucose |
|
27421-7
|
C peptide [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
56583-8
|
C peptide [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
77612-0
|
C peptide [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
58514-1
|
C peptide [Mass/volume] in Serum or Plasma --45 minutes post dose glucose |
|
58515-8
|
C peptide [Moles/volume] in Serum or Plasma --45 minutes post dose glucose |
|
27839-0
|
C peptide [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
77611-2
|
C peptide [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
58516-6
|
C peptide [Mass/volume] in Serum or Plasma --4 hours post dose glucose |
|
58517-4
|
C peptide [Moles/volume] in Serum or Plasma --4 hours post dose glucose |
|
47832-1
|
C peptide [Moles/volume] in Serum or Plasma --4 minutes post 1 mg glucagon |
|
13044-3
|
C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
77652-6
|
C peptide [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
58518-2
|
C peptide [Mass/volume] in Serum or Plasma --5 hours post dose glucose |
|
58519-0
|
C peptide [Moles/volume] in Serum or Plasma --5 hours post dose glucose |
|
13861-0
|
C peptide [Mass/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV |
|
58520-8
|
C peptide [Moles/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV |
|
58841-8
|
C peptide [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
47592-1
|
C peptide [Moles/volume] in Serum or Plasma --5 minutes post dose glucose |
|
57648-8
|
C peptide [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge |
|
47593-9
|
C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose |
|
13045-0
|
C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
56516-8
|
C peptide [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge |
|
47833-9
|
C peptide [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon |
|
57650-4
|
C peptide [Moles/volume] in Serum or Plasma --70 minutes pre XXX challenge |
|
77651-8
|
C peptide [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
47834-7
|
C peptide [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon |
|
57376-6
|
C peptide [Mass/volume] in Serum or Plasma --baseline |
|
58896-2
|
C peptide [Mass/volume] in Serum or Plasma --post XXX challenge |
|
13037-7
|
C peptide [Mass/volume] in Serum or Plasma --fasting |
|
42180-0
|
C peptide [Moles/volume] in Serum or Plasma --fasting |
|
55918-7
|
C peptide [Mass/volume] in Serum or Plasma --post meal |
|
55919-5
|
C peptide [Moles/volume] in Serum or Plasma --post meal |
|
47594-7
|
C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon |
|
58522-4
|
C peptide [Mass/volume] in Serum or Plasma --pre dose glucose |
|
47595-4
|
C peptide [Moles/volume] in Serum or Plasma --pre dose glucose |
|
1986-9
|
C peptide [Mass/volume] in Serum or Plasma |
|
35195-7
|
C peptide [Mass or Moles/volume] in Serum or Plasma |
|
14633-2
|
C peptide [Moles/volume] in Serum or Plasma |
|
58504-2
|
C peptide [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25574-5
|
C peptide [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50461-3
|
C peptide [Moles/volume] in Serum or Plasma --1st specimen |
|
58496-1
|
C peptide [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
25568-7
|
C peptide [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
58497-9
|
C peptide [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
25569-5
|
C peptide [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
58498-7
|
C peptide [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
25570-3
|
C peptide [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
25571-1
|
C peptide [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
25572-9
|
C peptide [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
25573-7
|
C peptide [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge |
|
13032-8
|
C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25575-2
|
C peptide [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
58816-0
|
C peptide [Mass/volume] in Serum or Plasma --2nd specimen |
|
50462-1
|
C peptide [Moles/volume] in Serum or Plasma --2nd specimen |
|
13033-6
|
C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25576-0
|
C peptide [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50463-9
|
C peptide [Moles/volume] in Serum or Plasma --3rd specimen |
|
13034-4
|
C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25577-8
|
C peptide [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50464-7
|
C peptide [Moles/volume] in Serum or Plasma --4th specimen |
|
13035-1
|
C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25578-6
|
C peptide [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50465-4
|
C peptide [Moles/volume] in Serum or Plasma --5th specimen |
|
13036-9
|
C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
25579-4
|
C peptide [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50466-2
|
C peptide [Moles/volume] in Serum or Plasma --6th specimen |
|
16501-9
|
C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25580-2
|
C peptide [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50467-0
|
C peptide [Moles/volume] in Serum or Plasma --7th specimen |
|
16502-7
|
C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25581-0
|
C peptide [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50468-8
|
C peptide [Moles/volume] in Serum or Plasma --8th specimen |
|
58521-6
|
C peptide [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
25582-8
|
C peptide [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
1987-7
|
C peptide [Mass/volume] in Urine |
|
34253-5
|
C peptide [Moles/volume] in Urine |
|
13715-8
|
C peptide/Creatinine [Mass Ratio] in 24 hour Urine |
|
44459-6
|
C peptide/Creatinine [Mass Ratio] in Urine --2nd specimen post XXX challenge |
|
13716-6
|
C peptide/Creatinine [Mass Ratio] in Urine |
|
25091-0
|
C peptide/Creatinine [Molar ratio] in Urine |
|
87313-3
|
Clostridium perfringens iota toxin DNA [Presence] in Isolate by NAA with probe detection |
|
87304-2
|
Clostridium perfringens cpa gene [Presence] in Isolate by NAA with probe detection |
|
87397-6
|
Clostridium perfringens cpb gene [Presence] in Isolate by NAA with probe detection |
|
87305-9
|
Clostridium perfringens cpb2 gene [Presence] in Isolate by NAA with probe detection |
|
87306-7
|
Clostridium perfringens cpe gene [Presence] in Isolate by NAA with probe detection |
|
20799-3
|
Clostridium perfringens enterotoxin [Presence] in Body fluid |
|
20800-9
|
Clostridium perfringens enterotoxin [Presence] in Small intestine Fixed |
|
87307-5
|
Clostridium perfringens etx gene [Presence] in Isolate by NAA with probe detection |
|
20798-5
|
Clostridium perfringens enterotoxin [Presence] in Tissue |
|
32369-1
|
Clostridium perfringens enterotoxin [Identifier] in Unspecified specimen |
|
20764-7
|
Clostridium perfringens genotype [Identifier] in Isolate |
|
26767-4
|
Clostridium perfringens IgG Ab [Units/volume] in Serum |
|
26768-2
|
Clostridium perfringens IgM Ab [Units/volume] in Serum |
|
46706-8
|
Clostridium perfringens toxin gene [Identifier] in Unspecified specimen by NAA with probe detection |
|
77496-8
|
Clostridium perfringens [Presence] in Unspecified specimen by Organism specific culture |
|
33943-2
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
43216-1
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Throat by NAA with probe detection |
|
35639-4
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Tissue by NAA with probe detection |
|
24402-0
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Unspecified specimen by Probe with amplification |
|
47052-6
|
Chlamydophila pneumoniae Ab [Units/volume] in Serum by Immunofluorescence |
|
30205-9
|
Chlamydophila pneumoniae Ab [Presence] in Serum |
|
5078-1
|
Chlamydophila pneumoniae Ab [Units/volume] in Serum |
|
44980-1
|
Chlamydophila pneumoniae Ab [Presence] in Serum --1st specimen |
|
44979-3
|
Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen |
|
11254-0
|
Chlamydophila pneumoniae Ab [Titer] in Serum |
|
43845-7
|
Chlamydophila pneumoniae Ab [Titer] in Serum by Immunofluorescence |
|
10651-8
|
Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
|
31778-4
|
Chlamydophila pneumoniae Ag [Presence] in Unspecified specimen |
|
29722-6
|
Chlamydophila pneumoniae Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88546-7
|
Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection |
|
92986-9
|
Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88547-5
|
Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82178-5
|
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88718-2
|
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92133-8
|
Chlamydophila pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
10652-6
|
Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
|
92577-6
|
Chlamydophila pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
34645-2
|
Chlamydophila pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31299-1
|
Chlamydophila pneumoniae IgA Ab [Units/volume] in Cerebral spinal fluid |
|
44982-7
|
Chlamydophila pneumoniae IgA Ab [Presence] in Serum |
|
31300-7
|
Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum |
|
22169-7
|
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid |
|
16581-1
|
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22170-5
|
Chlamydophila pneumoniae IgA Ab [Titer] in Serum |
|
6912-0
|
Chlamydophila pneumoniae IgA Ab [Titer] in Serum by Immunofluorescence |
|
50612-1
|
Chlamydophila pneumoniae IgA and IgG and IgM [Interpretation] in Serum |
|
58758-4
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31301-5
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51806-8
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
44981-9
|
Chlamydophila pneumoniae IgG Ab [Presence] in Serum |
|
89641-5
|
Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay |
|
31302-3
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum |
|
22171-3
|
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
|
16582-9
|
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22172-1
|
Chlamydophila pneumoniae IgG Ab [Titer] in Serum |
|
6913-8
|
Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence |
|
44080-0
|
Chlamydophila pneumoniae IgG and IgM [Interpretation] in Serum |
|
31303-1
|
Chlamydophila pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51807-6
|
Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
|
24004-4
|
Chlamydophila pneumoniae IgM Ab [Presence] in Serum |
|
89640-7
|
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay |
|
43844-0
|
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence |
|
31304-9
|
Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum |
|
22173-9
|
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
|
16583-7
|
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22174-7
|
Chlamydophila pneumoniae IgM Ab [Titer] in Serum |
|
6914-6
|
Chlamydophila pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence |
|
7821-2
|
Chlamydophila pneumoniae rRNA [Presence] in Serum by NAA with probe detection |
|
16585-2
|
Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by Probe |
|
16584-5
|
Chlamydophila pneumoniae rRNA [Presence] in Sputum by Probe |
|
34707-0
|
Chlamydophila pneumoniae rRNA [Presence] in Unspecified specimen by Probe |
|
21184-7
|
Chlamydophila pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
|
22175-4
|
Chlamydophila psittaci Ab [Presence] in Serum |
|
22994-8
|
Chlamydophila psittaci Ab [Presence] in Serum by Agglutination |
|
20754-8
|
Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation |
|
22996-3
|
Chlamydophila psittaci Ab [Presence] in Serum by Immunoassay |
|
22995-5
|
Chlamydophila psittaci Ab [Presence] in Serum by Immune diffusion (ID) |
|
7822-0
|
Chlamydophila psittaci Ab [Units/volume] in Serum |
|
22176-2
|
Chlamydophila psittaci Ab [Titer] in Serum |
|
5079-9
|
Chlamydophila psittaci Ab [Titer] in Serum by Complement fixation |
|
14198-6
|
Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence |
|
23000-3
|
Chlamydophila psittaci Ag [Presence] in Exudate by Immune stain |
|
31779-2
|
Chlamydophila psittaci Ag [Presence] in Genital specimen |
|
6338-8
|
Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunoassay |
|
6339-6
|
Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunofluorescence |
|
22999-7
|
Chlamydophila psittaci Ag [Presence] in Stool by Immune stain |
|
20753-0
|
Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence |
|
22998-9
|
Chlamydophila psittaci Ag [Presence] in Tissue by Immune stain |
|
31780-0
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen |
|
6340-4
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immunoassay |
|
6341-2
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22997-1
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immune stain |
|
59065-3
|
Chlamydophila psittaci [Presence] in Bronchial brush by Organism specific culture |
|
23001-1
|
Chlamydophila psittaci DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31305-6
|
Chlamydophila psittaci IgA Ab [Units/volume] in Cerebral spinal fluid |
|
44978-5
|
Chlamydophila psittaci IgA Ab [Presence] in Serum |
|
31306-4
|
Chlamydophila psittaci IgA Ab [Units/volume] in Serum |
|
22177-0
|
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid |
|
16586-0
|
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22178-8
|
Chlamydophila psittaci IgA Ab [Titer] in Serum |
|
6915-3
|
Chlamydophila psittaci IgA Ab [Titer] in Serum by Immunofluorescence |
|
44081-8
|
Chlamydophila psittaci IgA and IgG and IgM [Interpretation] in Serum |
|
31307-2
|
Chlamydophila psittaci IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51808-4
|
Chlamydophila psittaci IgG Ab [Units/volume] in Serum by Immunoassay |
|
43868-9
|
Chlamydophila psittaci IgG Ab [Presence] in Serum |
|
5080-7
|
Chlamydophila psittaci IgG Ab [Units/volume] in Serum |
|
22179-6
|
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid |
|
16587-8
|
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22180-4
|
Chlamydophila psittaci IgG Ab [Titer] in Serum |
|
6916-1
|
Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence |
|
16588-6
|
Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51809-2
|
Chlamydophila psittaci IgM Ab [Units/volume] in Serum by Immunoassay |
|
44977-7
|
Chlamydophila psittaci IgM Ab [Presence] in Serum |
|
5081-5
|
Chlamydophila psittaci IgM Ab [Units/volume] in Serum |
|
43057-9
|
Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid |
|
27404-3
|
Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22181-2
|
Chlamydophila psittaci IgM Ab [Titer] in Serum |
|
6917-9
|
Chlamydophila psittaci IgM Ab [Titer] in Serum by Immunofluorescence |
|
22993-0
|
Chlamydophila psittaci [Presence] in Placenta by Electron microscopy |
|
20752-2
|
Chlamydophila psittaci [Presence] in Unspecified specimen by Organism specific culture |
|
22992-2
|
Chlamydophila psittaci [Presence] in Unspecified specimen by Giemsa stain |
|
23012-8
|
Cowdria ruminantium Ab [Presence] in Serum |
|
23011-0
|
Cowdria ruminantium Ab [Presence] in Serum by Immunoassay |
|
23013-6
|
Cowdria ruminantium Ab [Presence] in Serum by Immunoblot |
|
23010-2
|
Cowdria ruminantium Ab [Presence] in Serum by Immunofluorescence |
|
23009-4
|
Cowdria ruminantium [Presence] in Brain by Giemsa stain |
|
23014-4
|
Cowdria ruminantium DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23015-1
|
Cowdria ruminantium rRNA [Presence] in Unspecified specimen by Probe |
|
93402-6
|
Cronobacter sakazakii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
20765-4
|
Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence |
|
7498-9
|
Chrysonilia sitophila IgE Ab [Units/volume] in Serum |
|
15855-0
|
Chrysonilia sitophila IgE Ab RAST class [Presence] in Serum |
|
20766-2
|
Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence |
|
42198-2
|
Curvularia specifera IgE Ab [Units/volume] in Serum |
|
15670-3
|
Curvularia specifera IgE Ab RAST class [Presence] in Serum |
|
33281-7
|
Curvularia specifera IgG Ab RAST class [Presence] in Serum |
|
7415-3
|
Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum |
|
7267-8
|
Cryptococcus terreus IgE Ab [Units/volume] in Serum |
|
15666-1
|
Cryptococcus terreus IgE Ab RAST class [Presence] in Serum |
|
40711-4
|
Clostridium tetani Ab [Units/volume] in Serum by Immunoassay |
|
5093-0
|
Clostridium tetani Ab [Presence] in Serum |
|
5092-2
|
Clostridium tetani Ab [Units/volume] in Serum |
|
16626-4
|
Clostridium tetani Ab [Units/volume] in Serum --1st specimen |
|
16627-2
|
Clostridium tetani Ab [Units/volume] in Serum --2nd specimen |
|
6367-7
|
Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay |
|
33469-8
|
Clostridium tetani IgG Ab [Presence] in Serum |
|
22203-4
|
Clostridium tetani IgG Ab [Units/volume] in Serum |
|
47296-9
|
Clostridium tetani toxoid Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
41483-9
|
Clostridium tetani toxoid Ab [Units/volume] in Serum by Immunoassay |
|
26643-7
|
Clostridium tetani toxoid Ab [Presence] in Serum |
|
32775-9
|
Clostridium tetani toxoid Ab [Units/volume] in Serum |
|
19760-8
|
Clostridium tetani toxoid IgE Ab [Units/volume] in Serum |
|
25536-4
|
Clostridium tetani toxoid IgE Ab RAST class [Presence] in Serum |
|
58770-9
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
53935-3
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
48653-0
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
49191-0
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --1st specimen |
|
48652-2
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
49192-8
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen |
|
45130-2
|
Chlamydia trachomatis Ab [Presence] in Body fluid |
|
45007-2
|
Chlamydia trachomatis Ab [Units/volume] in Serum by Immunoassay |
|
30204-2
|
Chlamydia trachomatis Ab [Presence] in Serum |
|
45008-0
|
Chlamydia trachomatis Ab [Presence] in Serum by Complement fixation |
|
45009-8
|
Chlamydia trachomatis Ab [Presence] in Serum by Immunofluorescence |
|
7824-6
|
Chlamydia trachomatis Ab [Units/volume] in Serum |
|
44998-3
|
Chlamydia trachomatis Ab [Presence] in Serum --1st specimen |
|
44997-5
|
Chlamydia trachomatis Ab [Units/volume] in Serum --2nd specimen |
|
22187-9
|
Chlamydia trachomatis Ab [Titer] in Serum |
|
5087-2
|
Chlamydia trachomatis Ab [Titer] in Serum by Complement fixation |
|
5088-0
|
Chlamydia trachomatis Ab [Titer] in Serum by Immunofluorescence |
|
34710-4
|
Chlamydia trachomatis Ag [Presence] in Anal |
|
91861-5
|
Chlamydia trachomatis Ag [Presence] in Aspirate by Immunofluorescence |
|
31768-5
|
Chlamydia trachomatis Ag [Presence] in Blood |
|
14468-3
|
Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay |
|
14507-8
|
Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence |
|
31769-3
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen |
|
6350-3
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunoassay |
|
6351-1
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
31770-1
|
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid |
|
14469-1
|
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
14508-6
|
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31771-9
|
Chlamydia trachomatis Ag [Presence] in Cervix |
|
14470-9
|
Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay |
|
14509-4
|
Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence |
|
47234-0
|
Chlamydia trachomatis Ag [Presence] in Body fluid |
|
45091-6
|
Chlamydia trachomatis Ag [Presence] in Genital specimen |
|
91860-7
|
Chlamydia trachomatis Ag [Presence] in Genital specimen by Immunofluorescence |
|
34709-6
|
Chlamydia trachomatis Ag [Presence] in Nasopharynx |
|
45092-4
|
Chlamydia trachomatis Ag [Presence] in Nasopharynx by Immunoassay |
|
31774-3
|
Chlamydia trachomatis Ag [Presence] in Stool |
|
6352-9
|
Chlamydia trachomatis Ag [Presence] in Stool by Immunofluorescence |
|
91873-0
|
Chlamydia trachomatis Ag [Presence] in Throat by Immunofluorescence |
|
6353-7
|
Chlamydia trachomatis Ag [Presence] in Tissue by Immunofluorescence |
|
31775-0
|
Chlamydia trachomatis Ag [Presence] in Urine sediment |
|
14474-1
|
Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay |
|
14513-6
|
Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence |
|
31776-8
|
Chlamydia trachomatis Ag [Presence] in Urethra |
|
14472-5
|
Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay |
|
14511-0
|
Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence |
|
31772-7
|
Chlamydia trachomatis Ag [Presence] in Vaginal fluid |
|
14471-7
|
Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay |
|
14510-2
|
Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31777-6
|
Chlamydia trachomatis Ag [Presence] in Unspecified specimen |
|
6354-5
|
Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunoassay |
|
6355-2
|
Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
45093-2
|
Chlamydia trachomatis [Presence] in Anal by Organism specific culture |
|
13217-5
|
Chlamydia trachomatis B Ab [Units/volume] in Serum |
|
32005-1
|
Chlamydia trachomatis B Ab [Titer] in Serum |
|
27368-0
|
Chlamydia trachomatis B Ab [Titer] in Serum by Immunofluorescence |
|
44996-7
|
Chlamydia trachomatis B IgA Ab [Presence] in Serum |
|
31294-2
|
Chlamydia trachomatis B IgA Ab [Units/volume] in Serum |
|
22194-5
|
Chlamydia trachomatis B IgA Ab [Titer] in Serum |
|
14199-4
|
Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence |
|
44995-9
|
Chlamydia trachomatis B IgG Ab [Presence] in Serum |
|
16597-7
|
Chlamydia trachomatis B IgG Ab [Units/volume] in Serum |
|
22195-2
|
Chlamydia trachomatis B IgG Ab [Titer] in Serum |
|
14200-0
|
Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence |
|
44994-2
|
Chlamydia trachomatis B IgM Ab [Presence] in Serum |
|
31295-9
|
Chlamydia trachomatis B IgM Ab [Units/volume] in Serum |
|
22196-0
|
Chlamydia trachomatis B IgM Ab [Titer] in Serum |
|
14201-8
|
Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence |
|
14461-8
|
Chlamydia trachomatis [Presence] in Blood by Organism specific culture |
|
13218-3
|
Chlamydia trachomatis C Ab [Units/volume] in Serum |
|
32006-9
|
Chlamydia trachomatis C Ab [Titer] in Serum |
|
27370-6
|
Chlamydia trachomatis C Ab [Titer] in Serum by Immunofluorescence |
|
44993-4
|
Chlamydia trachomatis C IgA Ab [Presence] in Serum |
|
22197-8
|
Chlamydia trachomatis C IgA Ab [Titer] in Serum |
|
14202-6
|
Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence |
|
44992-6
|
Chlamydia trachomatis C IgG Ab [Presence] in Serum |
|
16598-5
|
Chlamydia trachomatis C IgG Ab [Units/volume] in Serum |
|
22198-6
|
Chlamydia trachomatis C IgG Ab [Titer] in Serum |
|
14203-4
|
Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence |
|
44991-8
|
Chlamydia trachomatis C IgM Ab [Presence] in Serum |
|
13220-9
|
Chlamydia trachomatis C IgM Ab [Units/volume] in Serum |
|
22199-4
|
Chlamydia trachomatis C IgM Ab [Titer] in Serum |
|
14204-2
|
Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence |
|
45094-0
|
Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture |
|
14462-6
|
Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture |
|
14463-4
|
Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
|
26663-5
|
Chlamydia trachomatis D Ab [Presence] in Serum |
|
46176-4
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum |
|
43356-5
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum by Immunofluorescence |
|
46177-2
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum |
|
43355-7
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum by Immunofluorescence |
|
46178-0
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum |
|
43357-3
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum by Immunofluorescence |
|
44990-0
|
Chlamydia trachomatis D+K IgA Ab [Presence] in Serum |
|
31296-7
|
Chlamydia trachomatis D+K IgA Ab [Units/volume] in Serum |
|
43060-3
|
Chlamydia trachomatis D+K IgA Ab [Titer] in Serum |
|
28557-7
|
Chlamydia trachomatis D+K IgA Ab [Titer] in Serum by Immunofluorescence |
|
44989-2
|
Chlamydia trachomatis D+K IgG Ab [Presence] in Serum |
|
31297-5
|
Chlamydia trachomatis D+K IgG Ab [Units/volume] in Serum |
|
43059-5
|
Chlamydia trachomatis D+K IgG Ab [Titer] in Serum |
|
28556-9
|
Chlamydia trachomatis D+K IgG Ab [Titer] in Serum by Immunofluorescence |
|
44988-4
|
Chlamydia trachomatis D+K IgM Ab [Presence] in Serum |
|
31298-3
|
Chlamydia trachomatis D+K IgM Ab [Units/volume] in Serum |
|
43058-7
|
Chlamydia trachomatis D+K IgM Ab [Titer] in Serum |
|
28558-5
|
Chlamydia trachomatis D+K IgM Ab [Titer] in Serum by Immunofluorescence |
|
45090-8
|
Chlamydia trachomatis DNA [Presence] in Anal by NAA with probe detection |
|
16599-3
|
Chlamydia trachomatis DNA [Presence] in Blood by NAA with probe detection |
|
21189-6
|
Chlamydia trachomatis DNA [Presence] in Cervical mucus by NAA with probe detection |
|
21187-0
|
Chlamydia trachomatis DNA [Presence] in Conjunctival specimen by NAA with probe detection |
|
21190-4
|
Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection |
|
6356-0
|
Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection |
|
45086-6
|
Chlamydia trachomatis DNA [Presence] in Nasopharynx by NAA with probe detection |
|
80363-5
|
Chlamydia trachomatis DNA [Presence] in Rectum by NAA with probe detection |
|
51578-3
|
Chlamydia trachomatis DNA [Presence] in Semen by NAA with probe detection |
|
88221-7
|
Chlamydia trachomatis DNA [Presence] in Throat by NAA with probe detection |
|
87949-4
|
Chlamydia trachomatis DNA [Presence] in Tissue by NAA with probe detection |
|
6357-8
|
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection |
|
21191-2
|
Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection |
|
45084-1
|
Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
50311-0
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
47212-6
|
Chlamydia trachomatis DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49096-1
|
Chlamydia trachomatis DNA [Units/volume] in Unspecified specimen by NAA with probe detection |
|
21613-5
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43404-3
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
26664-3
|
Chlamydia trachomatis E Ab [Presence] in Serum |
|
26665-0
|
Chlamydia trachomatis F Ab [Presence] in Serum |
|
13219-1
|
Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
|
32007-7
|
Chlamydia trachomatis G+F+K Ab [Titer] in Serum |
|
27371-4
|
Chlamydia trachomatis G+F+K Ab [Titer] in Serum by Immunofluorescence |
|
44987-6
|
Chlamydia trachomatis G+F+K IgA Ab [Presence] in Serum |
|
22200-0
|
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum |
|
18490-3
|
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence |
|
22201-8
|
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum |
|
18491-1
|
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence |
|
44986-8
|
Chlamydia trachomatis G+F+K IgM Ab [Presence] in Serum |
|
13221-7
|
Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum |
|
22202-6
|
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum |
|
18492-9
|
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence |
|
45095-7
|
Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture |
|
26666-8
|
Chlamydia trachomatis H Ab [Presence] in Serum |
|
26667-6
|
Chlamydia trachomatis I Ab [Presence] in Serum |
|
33605-7
|
Chlamydia trachomatis I Ab [Titer] in Serum |
|
33575-2
|
Chlamydia trachomatis I Ab [Titer] in Serum by Immunofluorescence |
|
33604-0
|
Chlamydia trachomatis I IgM Ab [Titer] in Serum |
|
33574-5
|
Chlamydia trachomatis I IgM Ab [Titer] in Serum by Immunofluorescence |
|
45004-9
|
Chlamydia trachomatis IgA Ab [Presence] in Cerebral spinal fluid |
|
45006-4
|
Chlamydia trachomatis IgA Ab [Units/volume] in Serum by Immunoassay |
|
45005-6
|
Chlamydia trachomatis IgA Ab [Presence] in Serum |
|
31293-4
|
Chlamydia trachomatis IgA Ab [Units/volume] in Serum |
|
22188-7
|
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid |
|
16594-4
|
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22189-5
|
Chlamydia trachomatis IgA Ab [Titer] in Serum |
|
6918-7
|
Chlamydia trachomatis IgA Ab [Titer] in Serum by Immunofluorescence |
|
44079-2
|
Chlamydia trachomatis IgA and IgG and IgM [Interpretation] in Serum |
|
16595-1
|
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
45002-3
|
Chlamydia trachomatis IgG Ab [Presence] in Cerebral spinal fluid |
|
22190-3
|
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
26715-3
|
Chlamydia trachomatis IgG Ab [Units/volume] in Serum by Immunoassay |
|
43848-1
|
Chlamydia trachomatis IgG Ab [Presence] in Serum |
|
45135-1
|
Chlamydia trachomatis IgG Ab [Presence] in Serum by Immunoassay |
|
5089-8
|
Chlamydia trachomatis IgG Ab [Units/volume] in Serum |
|
43062-9
|
Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid |
|
27185-8
|
Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22191-1
|
Chlamydia trachomatis IgG Ab [Titer] in Serum |
|
45003-1
|
Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunoassay |
|
6919-5
|
Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence |
|
16596-9
|
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
44999-1
|
Chlamydia trachomatis IgM Ab [Presence] in Cerebral spinal fluid |
|
22192-9
|
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
45001-5
|
Chlamydia trachomatis IgM Ab [Units/volume] in Serum by Immunoassay |
|
41157-9
|
Chlamydia trachomatis IgM Ab [Presence] in Serum |
|
40710-6
|
Chlamydia trachomatis IgM Ab [Presence] in Serum by Immunoassay |
|
5090-6
|
Chlamydia trachomatis IgM Ab [Units/volume] in Serum |
|
43061-1
|
Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid |
|
27167-6
|
Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22193-7
|
Chlamydia trachomatis IgM Ab [Titer] in Serum |
|
45000-7
|
Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunoassay |
|
6920-3
|
Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence |
|
26668-4
|
Chlamydia trachomatis L1 Ab [Presence] in Serum |
|
90361-7
|
Chlamydia trachomatis L1 IgA Ab [Titer] in Serum by Immunoassay |
|
90362-5
|
Chlamydia trachomatis L1 IgG Ab [Titer] in Serum by Immunoassay |
|
90363-3
|
Chlamydia trachomatis L1 IgM Ab [Titer] in Serum by Immunoassay |
|
26626-2
|
Chlamydia trachomatis L2 Ab [Presence] in Serum |
|
47211-8
|
Chlamydia trachomatis L2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44985-0
|
Chlamydia trachomatis L2 IgA Ab [Presence] in Serum |
|
40855-9
|
Chlamydia trachomatis L2 IgA Ab [Titer] in Serum |
|
43174-2
|
Chlamydia trachomatis L2 IgA Ab [Titer] in Serum by Immunofluorescence |
|
51734-2
|
Chlamydia trachomatis L2 IgA and IgG and IgM [Interpretation] in Serum |
|
44984-3
|
Chlamydia trachomatis L2 IgG Ab [Presence] in Serum |
|
40854-2
|
Chlamydia trachomatis L2 IgG Ab [Titer] in Serum |
|
43173-4
|
Chlamydia trachomatis L2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
44983-5
|
Chlamydia trachomatis L2 IgM Ab [Presence] in Serum |
|
40856-7
|
Chlamydia trachomatis L2 IgM Ab [Titer] in Serum |
|
43175-9
|
Chlamydia trachomatis L2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
45096-5
|
Chlamydia trachomatis [Presence] in Nasopharynx by Organism specific culture |
|
80367-6
|
Chlamydia trachomatis [Presence] in Rectum by Organism specific culture |
|
57287-5
|
Chlamydia trachomatis rRNA [Presence] in Anal by NAA with probe detection |
|
45089-0
|
Chlamydia trachomatis rRNA [Presence] in Anal by Probe |
|
38469-3
|
Chlamydia trachomatis rRNA [Presence] in Blood by Probe |
|
21188-8
|
Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by Probe |
|
50387-0
|
Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection |
|
45078-3
|
Chlamydia trachomatis rRNA [Presence] in Cervix by Probe |
|
23838-6
|
Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe |
|
16600-9
|
Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe |
|
57288-3
|
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by NAA with probe detection |
|
45085-8
|
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe |
|
80364-3
|
Chlamydia trachomatis rRNA [Presence] in Rectum by NAA with probe detection |
|
82306-2
|
Chlamydia trachomatis rRNA [Presence] in Throat by NAA with probe detection |
|
42931-6
|
Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection |
|
16601-7
|
Chlamydia trachomatis rRNA [Presence] in Urine by Probe |
|
53925-4
|
Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection |
|
21192-0
|
Chlamydia trachomatis rRNA [Presence] in Urethra by Probe |
|
53926-2
|
Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
45080-9
|
Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe |
|
50411-8
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
43304-5
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
4993-2
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe |
|
89648-0
|
Chlamydia trachomatis [Presence] in Throat by Organism specific culture |
|
87950-2
|
Chlamydia trachomatis [Presence] in Tissue by Organism specific culture |
|
14467-5
|
Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture |
|
14465-9
|
Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
|
14464-2
|
Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
|
6349-5
|
Chlamydia trachomatis [Presence] in Unspecified specimen by Organism specific culture |
|
45068-4
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection |
|
44807-6
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
|
44806-8
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
|
36903-3
|
Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
43405-0
|
Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by Probe with signal amplification |
|
36902-5
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43406-8
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
45072-6
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anal by Probe |
|
80361-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
|
45067-6
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe |
|
45069-2
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe |
|
80365-0
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Rectum by NAA with probe detection |
|
45073-4
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Tissue by Probe |
|
80360-1
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
|
45074-2
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe |
|
45075-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe |
|
80362-7
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
45070-0
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe |
|
47362-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
45076-7
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe |
|
85785-4
|
Candida tropicalis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92800-2
|
Candida tropicalis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70023-7
|
Candida tropicalis DNA [Presence] in Blood by NAA with probe detection |
|
90810-3
|
Candida tropicalis DNA [Presence] in Serum by NAA with probe detection |
|
72391-6
|
Candida tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
92801-0
|
Cryptococcus gattii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
53236-6
|
Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS |
|
66951-5
|
Complement C1.functional [Units/volume] in Serum |
|
53900-7
|
C10orf2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77075-0
|
C12orf65 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77074-3
|
C12orf65 gene full mutation analysis in Blood or Tissue by Sequencing |
|
93882-9
|
N-Palmitoylsphingosine [Moles/volume] in Plasma |
|
93879-5
|
N-Palmitoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
|
93881-1
|
N-Stearoylsphingosine [Moles/volume] in Plasma |
|
93878-7
|
N-Stearoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
|
48494-9
|
Complement C1 esterase inhibitor actual/normal in Serum or Plasma |
|
51795-3
|
Complement C1 esterase inhibitor bound Ab [Mass/volume] in Serum or Plasma |
|
18210-5
|
Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma |
|
18211-3
|
Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma |
|
36906-6
|
Complement C1 esterase inhibitor [Mass/volume] in Body fluid |
|
18212-1
|
Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma |
|
18213-9
|
Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma |
|
34619-7
|
Complement C1 esterase inhibitor.functional [Mass/volume] in Body fluid |
|
15161-3
|
Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma |
|
4476-8
|
Complement C1 esterase inhibitor.functional [Mass/volume] in Serum or Plasma |
|
10634-4
|
Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
|
82876-4
|
Complement C1 esterase inhibitor [Units/volume] in Serum or Plasma by Chromogenic method |
|
4477-6
|
Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma |
|
53020-4
|
Complement C1q Ab [Presence] in Serum |
|
44702-9
|
Complement C1q Ab [Units/volume] in Serum |
|
6297-6
|
Complement C1q Ag [Units/volume] in Serum |
|
13172-2
|
Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay |
|
4479-2
|
Complement C1q Ag [Moles/volume] in Serum or Plasma |
|
15162-1
|
Complement C1q [Mass/volume] in Body fluid |
|
4478-4
|
Complement C1q [Mass/volume] in Serum or Plasma |
|
87722-5
|
Complement C1q.functional [Units/volume] in Serum or Plasma |
|
33911-9
|
Complement C1r actual/normal in Serum or Plasma |
|
4481-8
|
Complement C1r [Mass/volume] in Serum or Plasma |
|
4482-6
|
Complement C1r2+C1s2 [Units/volume] in Serum or Plasma |
|
4513-8
|
Complement C1r2+C1s2 [Mass/volume] in Serum or Plasma |
|
33912-7
|
Complement C1s actual/normal in Serum or Plasma |
|
4483-4
|
Complement C1s [Mass/volume] in Serum or Plasma |
|
15163-9
|
Complement C2 [Mass/volume] in Body fluid |
|
40747-8
|
Complement C2 [Presence] in Serum or Plasma |
|
33408-6
|
Complement C2 [Units/volume] in Serum or Plasma |
|
4484-2
|
Complement C2 [Mass/volume] in Serum or Plasma |
|
93977-7
|
Complement C2.functional [Units/volume] in Serum or Plasma |
|
93880-3
|
N-Nervonoylsphingosine [Moles/volume] in Plasma |
|
93877-9
|
N-Nervonoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
|
79283-8
|
C29 dicarboxylate [Moles/volume] in Serum or Plasma |
|
60277-1
|
Complement C3 Ag [Presence] in Tissue by Immunofluorescence |
|
10434-9
|
Complement C3 Ag [Presence] in Tissue by Immune stain |
|
6801-5
|
Complement C3 [Mass/volume] in Body fluid |
|
4486-7
|
Complement C3 fragment [Presence] in Red Blood Cells |
|
4487-5
|
Complement C3 fragment [Mass/volume] in Red Blood Cells |
|
38387-7
|
C3 nephritic factor [Presence] in Serum or Plasma |
|
23844-4
|
C3 nephritic factor [Units/volume] in Serum or Plasma |
|
13086-4
|
C3 nephritic factor [Mass/volume] in Serum or Plasma |
|
43575-0
|
Complement C3 [Mass/volume] in Pericardial fluid |
|
43579-2
|
Complement C3 [Mass/volume] in Pleural fluid |
|
43578-4
|
Complement C3 [Mass/volume] in Peritoneal fluid |
|
38388-5
|
Complement C3 [Presence] in Serum or Plasma |
|
4485-9
|
Complement C3 [Mass/volume] in Serum or Plasma |
|
15164-7
|
Complement C3 [Mass/volume] in Synovial fluid |
|
87723-3
|
Complement C3.functional [Units/volume] in Serum or Plasma |
|
44714-4
|
Complement C3/Protein [Mass Ratio] in Synovial fluid |
|
75211-3
|
Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS |
|
4488-3
|
Complement C3a [Mass/volume] in Serum or Plasma |
|
14195-2
|
Complement C3b Inactive [Mass/volume] in Plasma |
|
4489-1
|
Complement C3b [Mass/volume] in Serum or Plasma |
|
4490-9
|
Complement C3b-C4b receptor [Entitic number] in Red Blood Cells |
|
6296-8
|
Complement C3b-C4b receptor [Presence] in Red Blood Cells |
|
48420-4
|
Complement C3c [Mass/volume] in Body fluid |
|
4491-7
|
Complement C3c [Mass/volume] in Serum or Plasma |
|
4492-5
|
Complement C3d [Entitic number] in Red Blood Cells |
|
6295-0
|
Complement C3d [Presence] in Red Blood Cells |
|
34401-0
|
Complement C3d [Mass/volume] in Serum or Plasma |
|
4500-5
|
Complement C4 CH50 [Mass/volume] in Cerebral spinal fluid |
|
6908-8
|
Complement C4 [Mass/volume] in Body fluid |
|
93866-2
|
C4 nephritic factor [Presence] in Serum or Plasma |
|
13085-6
|
C4 nephritic factor [Mass/volume] in Serum or Plasma |
|
43580-0
|
Complement C4 [Mass/volume] in Pericardial fluid |
|
43582-6
|
Complement C4 [Mass/volume] in Pleural fluid |
|
43581-8
|
Complement C4 [Mass/volume] in Peritoneal fluid |
|
48731-4
|
Complement C4 [Presence] in Serum or Plasma |
|
26931-6
|
Complement C4 [Units/volume] in Serum or Plasma |
|
4498-2
|
Complement C4 [Mass/volume] in Serum or Plasma |
|
76496-9
|
Complement C4 [Moles/volume] in Serum or Plasma |
|
15165-4
|
Complement C4 [Mass/volume] in Synovial fluid |
|
93978-5
|
Complement C4.functional [Units/volume] in Serum or Plasma |
|
44715-1
|
Complement C4/Protein [Mass Ratio] in Synovial fluid |
|
4501-3
|
Complement C4a [Mass/volume] in Plasma |
|
38522-9
|
Complement C4b binding protein actual/normal in Serum or Plasma |
|
4502-1
|
Complement C4b binding protein [Units/volume] in Serum or Plasma |
|
4503-9
|
Complement C4b binding protein [Mass/volume] in Serum or Plasma |
|
49461-7
|
C4d Ag [Presence] in Tissue by Immune stain |
|
4504-7
|
Complement C4d [Entitic number] in Red Blood Cells |
|
39565-7
|
Complement C4d [Mass/volume] in Plasma by Immunoassay |
|
21217-5
|
Complement C4d [Mass/volume] in Plasma |
|
6293-5
|
Complement C4d [Presence] in Red Blood Cells |
|
67709-6
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
|
74629-7
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
81778-3
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
|
15166-2
|
Complement C5 [Mass/volume] in Body fluid |
|
58683-4
|
Complement C5 [Presence] in Serum or Plasma |
|
4505-4
|
Complement C5 [Mass/volume] in Serum or Plasma |
|
60472-8
|
Complement C5.functional [Units/volume] in Serum or Plasma |
|
4506-2
|
Complement C5a [Mass/volume] in Plasma |
|
10435-6
|
C5B-9 Ag [Presence] in Tissue by Immune stain |
|
15167-0
|
Complement C6 [Mass/volume] in Body fluid |
|
4507-0
|
Complement C6 [Mass/volume] in Serum or Plasma |
|
60459-5
|
Complement C6.functional [Units/volume] in Serum or Plasma |
|
89310-7
|
Codeine-6-glucuronide [Presence] in Urine by Screen method |
|
26996-9
|
Complement C7 [Units/volume] in Serum or Plasma |
|
4508-8
|
Complement C7 [Mass/volume] in Serum or Plasma |
|
87724-1
|
Complement C7.functional [Units/volume] in Serum or Plasma |
|
50997-6
|
Complement C8.functional [Units/volume] in Serum or Plasma |
|
4509-6
|
Complement C8 [Mass/volume] in Serum or Plasma |
|
4510-4
|
Complement C9 [Mass/volume] in Serum or Plasma |
|
87727-4
|
Complement C9.functional [Units/volume] in Serum or Plasma |
|
81847-6
|
C9orf72 gene GGGGCC repeat analysis in Amniotic fluid by Molecular genetics method |
|
81846-8
|
C9orf72 gene GGGGCC repeat analysis in Blood or Tissue by Molecular genetics method |
|
77635-1
|
C9orf72 gene GGGGCC repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
79157-4
|
Cold agglutinin [Titer] in Serum by 22 degree C incubation --1 hour post incubation |
|
79158-2
|
Cold agglutinin [Titer] in Serum by 4 deg C incubation --1 hour post incubation |
|
79156-6
|
Cold agglutinin [Titer] in Serum by 37 degree C incubation --1 hour post incubation |
|
81310-5
|
Carbonic anhydrase 2 Ab [Presence] in Serum by Immunoassay |
|
79159-0
|
Cold agglutinin [Titer] in Serum by 4 deg C incubation --24 hour post incubation |
|
34471-3
|
Calcium bilirubinate crystals [Presence] in Bile fluid by Light microscopy |
|
16261-0
|
Calcium bilirubinate crystals [Presence] in Stone by Infrared spectroscopy |
|
54439-5
|
Calcium bilirubinate/Total in Stone |
|
53302-6
|
Calcium carbonate crystals [#/volume] in Urine by Computer assisted method |
|
53312-5
|
Calcium carbonate crystals [#/area] in Urine by Computer assisted method |
|
25147-0
|
Calcium carbonate crystals [#/area] in Urine sediment by Microscopy high power field |
|
45389-4
|
Calcium carbonate crystals [#/area] in Urine sediment by Microscopy low power field |
|
5772-9
|
Calcium carbonate crystals [Presence] in Synovial fluid by Light microscopy |
|
16267-7
|
Calcium carbonate crystals [Presence] in Stone by Infrared spectroscopy |
|
33241-1
|
Calcium carbonate crystals [Presence] in Urine by Computer assisted method |
|
5773-7
|
Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy |
|
32156-2
|
Calcium carbonate/Total in Stone |
|
85278-0
|
Distance of carcinoma from closest surgical margin when all margins are uninvolved [Length] in Cancer specimen by Light microscopy |
|
85277-2
|
Distance of carcinoma from closest mucosal margin when all mucosal margins are uninvolved [Length] in Colorectal cancer specimen by Light microscopy |
|
42673-4
|
Calcium hydrogen phosphate dihydrate [Saturation Fraction] in 24 hour Urine |
|
40999-5
|
Calcium hydrogen phosphate dihydrate [Mass/time] in 24 hour Urine |
|
59276-6
|
Calcium hydrogen phosphate dihydrate crystals [Presence] in Stone by X-ray diffraction |
|
12512-0
|
Calcium hydrogen phosphate dihydrate crystals [Presence] in Urine sediment by Light microscopy |
|
40998-7
|
Calcium hydrogen phosphate dihydrate/Total in Stone |
|
49875-8
|
California juniper IgE Ab [Units/volume] in Serum |
|
54161-5
|
Cytoplasmic Ab pattern.PL-7+PL-12 [Presence] in Serum by Immunofluorescence |
|
54162-3
|
Cytoplasmic Ab pattern.PL-7+PL-12 [Titer] in Serum by Immunofluorescence |
|
53299-4
|
Calcium phosphate crystals [#/volume] in Urine by Computer assisted method |
|
53309-1
|
Calcium phosphate crystals [#/area] in Urine by Computer assisted method |
|
25149-6
|
Calcium phosphate crystals [#/area] in Urine sediment by Microscopy high power field |
|
45388-6
|
Calcium phosphate crystals [#/area] in Urine sediment by Microscopy low power field |
|
16268-5
|
Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy |
|
33235-3
|
Calcium phosphate crystals [Presence] in Urine by Computer assisted method |
|
5775-2
|
Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy |
|
55178-8
|
Calcium phosphate crystals [Presence] in Unspecified specimen by Light microscopy |
|
32137-2
|
Calcium phosphate/Total in Stone |
|
70665-5
|
Cold agglutinin [Presence] in Serum by 18 degree C incubation |
|
70666-3
|
Cold agglutinin [Presence] in Serum by 22 degree C incubation |
|
70667-1
|
Cold agglutinin [Presence] in Serum by 28 degree C incubation |
|
32672-8
|
Cold agglutinin [Presence] in Serum or Plasma |
|
5097-1
|
Cold agglutinin [Presence] in Serum or Plasma by Agglutination |
|
25150-4
|
Calcium sulfate crystals [#/area] in Urine sediment by Microscopy high power field |
|
5776-0
|
Calcium sulfate crystals [Presence] in Urine sediment by Light microscopy |
|
14658-9
|
Cold agglutinin [Titer] in Serum or Plasma |
|
30900-5
|
Cold agglutinin [Titer] in Serum or Plasma by Adult RBC Agglutination |
|
5098-9
|
Cold agglutinin [Titer] in Serum or Plasma by Agglutination |
|
30901-3
|
Cold agglutinin [Titer] in Serum or Plasma by Cord RBC agglutination |
|
77211-1
|
Carbonic anhydrase 6 IgA Ab [Units/volume] in Serum by Immunoassay |
|
77212-9
|
Carbonic anhydrase 6 IgG Ab [Units/volume] in Serum by Immunoassay |
|
77213-7
|
Carbonic anhydrase 6 IgM Ab [Units/volume] in Serum by Immunoassay |
|
7169-6
|
Cabbage IgE Ab [Units/volume] in Serum |
|
15596-0
|
Cabbage IgE Ab RAST class [Presence] in Serum |
|
61233-3
|
Cabbage IgE Ab/IgE total in Serum |
|
7170-4
|
Cabbage IgG Ab [Units/volume] in Serum |
|
21127-6
|
Cabbage IgG Ab RAST class [Presence] in Serum |
|
56203-3
|
Cabbage IgG4 Ab [Mass/volume] in Serum |
|
60358-9
|
Cabbage IgG Ab [Mass/volume] in Serum |
|
11280-5
|
Cabot rings [Presence] in Blood by Light microscopy |
|
49649-7
|
CACNA1A gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49650-5
|
CACNA1A gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21755-4
|
CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
44420-8
|
CACNA1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21641-6
|
CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21645-7
|
CACNA1S gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21642-4
|
CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method |
|
21643-2
|
CACNA1S gene p.Arg1239His [Presence] in Blood or Tissue by Molecular genetics method |
|
21644-0
|
CACNA1S gene p.Arg528His [Presence] in Blood or Tissue by Molecular genetics method |
|
57918-5
|
CACNA1S+SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53847-0
|
CACT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
30925-2
|
Cadmium [Mass/volume] in Urine collected for unspecified duration |
|
21130-0
|
Cadmium [Mass/volume] in 24 hour Urine |
|
5612-7
|
Cadmium [Mass/time] in 24 hour Urine |
|
34254-3
|
Cadmium [Moles/volume] in 24 hour Urine |
|
32304-8
|
Cadmium [Moles/time] in 24 hour Urine |
|
51902-5
|
Cadmium [Mass/volume] in Air |
|
5609-3
|
Cadmium [Mass/volume] in Blood |
|
15117-5
|
Cadmium [Moles/volume] in Blood |
|
9686-7
|
Cadmium [Mass/volume] in Cerebral spinal fluid |
|
51193-1
|
Cadmium [Mass/volume] in Body fluid |
|
5610-1
|
Cadmium [Mass/mass] in Hair |
|
50833-3
|
Cadmium [Moles/mass] in Hair |
|
21128-4
|
Cadmium [Mass/mass] in Nail |
|
12505-4
|
Cadmium [Mass/volume] in Red Blood Cells |
|
27117-1
|
Cadmium [Mass/mass] in Red Blood Cells |
|
50834-1
|
Cadmium [Moles/volume] in Red Blood Cells |
|
21129-2
|
Cadmium [Mass/volume] in Serum or Plasma |
|
25359-1
|
Cadmium [Moles/volume] in Serum or Plasma |
|
20737-3
|
Cadmium [Mass/mass] in Tissue |
|
5611-9
|
Cadmium [Mass/volume] in Urine |
|
25360-9
|
Cadmium [Moles/volume] in Urine |
|
34255-0
|
Cadmium [Moles/time] in Urine |
|
9466-4
|
Cadmium [Mass/volume] in Water |
|
9687-5
|
Cadmium [Mass/volume] in Unspecified specimen |
|
87478-4
|
Cadmium [Mass/mass] in Unspecified specimen |
|
13828-9
|
Cadmium/Creatinine [Mass Ratio] in 24 hour Urine |
|
50835-8
|
Cadmium/Creatinine [Molar ratio] in 24 hour Urine |
|
13471-8
|
Cadmium/Creatinine [Mass Ratio] in Urine |
|
56651-3
|
Cadmium/Creatinine [Ratio] in Urine |
|
22696-9
|
Cadmium/Creatinine [Molar ratio] in Urine |
|
23686-9
|
Canine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
|
31282-7
|
Canine adenovirus 1 Ab [Presence] in Serum |
|
23685-1
|
Canine adenovirus 1 Ab [Presence] in Serum by Neutralization test |
|
11017-1
|
Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
|
10780-5
|
Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
|
32814-6
|
Microscopic observation [Identifier] in Unspecified specimen by Chloracetate esterase stain |
|
22972-4
|
Caprine arthritis encephalitis virus Ab [Presence] in Milk |
|
22973-2
|
Caprine arthritis encephalitis virus Ab [Presence] in Milk by Immunoassay |
|
22164-8
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum |
|
22974-0
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Agglutination |
|
15464-1
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
15465-8
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23708-1
|
Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen |
|
22976-5
|
Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22975-7
|
Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen by Immune stain |
|
22978-1
|
Caprine arthritis encephalitis virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22977-3
|
Caprine arthritis encephalitis virus DNA [Presence] in Unspecified specimen by Polyacrylamide gel electrophoresis (PAGE) |
|
22971-6
|
Caprine arthritis encephalitis virus [Presence] in Unspecified specimen by Electron microscopy |
|
18204-8
|
Caffeine renal clearance in 24 hour Urine and Serum or Plasma |
|
4150-9
|
Caffeine [Mass] of Dose |
|
29211-0
|
Caffeine [Mass/volume] in Body fluid |
|
40416-0
|
Caffeine [Presence] in Gastric fluid |
|
80489-8
|
Caffeine intake 24 hour Estimated |
|
80490-6
|
Caffeine intake 24 hour Measured |
|
59811-0
|
Caffeine [Moles/volume] in Serum --peak |
|
3422-3
|
Caffeine [Mass/volume] in Serum or Plasma |
|
25361-7
|
Caffeine [Moles/volume] in Serum or Plasma |
|
74919-2
|
Caffeine [Mass/volume] in Serum or Plasma --trough |
|
59810-2
|
Caffeine [Moles/volume] in Serum --trough |
|
3423-1
|
Caffeine [Presence] in Urine |
|
3424-9
|
Caffeine [Mass/volume] in Urine |
|
43829-1
|
Caffeine [Presence] in Unspecified specimen |
|
60290-4
|
Caffeine [Moles/volume] in Unspecified specimen |
|
80994-7
|
Coronary angiography performed |
|
89001-2
|
CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
46758-9
|
Congenital adrenal hyperplasia newborn screen interpretation |
|
57706-4
|
Congenital adrenal hyperplasia newborn screening comment-discussion |
|
16266-9
|
Calcium hydrogen phosphate crystals [Presence] in Stone by Infrared spectroscopy |
|
41158-7
|
Canine herpesvirus Ab [Presence] in Serum |
|
23697-6
|
Canine herpesvirus Ab [Presence] in Serum by Neutralization test |
|
23698-4
|
Canine herpesvirus Ag [Presence] in Tissue by Immunofluorescence |
|
59472-1
|
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE) |
|
53138-4
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Arterial blood |
|
54366-0
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Cord blood |
|
53139-2
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood |
|
47598-8
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood |
|
59473-9
|
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Venous blood by Ion-selective membrane electrode (ISE) |
|
53140-0
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Venous blood |
|
53087-3
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Nonbiological fluid |
|
50838-2
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Body fluid |
|
57333-7
|
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
19072-8
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma |
|
49936-8
|
Calcium.ionized/Calcium.total corrected for albumin in Blood |
|
49935-0
|
Calcium.ionized/Calcium.total corrected for albumin in Serum or Plasma |
|
47596-2
|
Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) |
|
59470-5
|
Calcium.ionized [Mass/volume] in Arterial blood |
|
34581-9
|
Calcium.ionized [Moles/volume] in Arterial blood |
|
54367-8
|
Calcium.ionized [Moles/volume] in Cord blood |
|
83064-6
|
Calcium.ionized [Moles/volume] in Blood drawn from CRRT circuit |
|
41644-6
|
Calcium.ionized [Moles/volume] in Capillary blood |
|
38230-9
|
Calcium.ionized [Mass/volume] in Blood |
|
41646-1
|
Calcium.ionized [Moles/volume] in Mixed venous blood |
|
1994-3
|
Calcium.ionized [Moles/volume] in Blood |
|
59471-3
|
Calcium.ionized [Mass/volume] in Venous blood |
|
41645-3
|
Calcium.ionized [Moles/volume] in Venous blood |
|
46093-1
|
Calcium.ionized [Moles/volume] in Dialysis fluid |
|
53088-1
|
Calcium.ionized [Moles/volume] in Nonbiological fluid by Ion-selective membrane electrode (ISE) |
|
50837-4
|
Calcium.ionized [Moles/volume] in Body fluid |
|
13959-2
|
Calcium.ionized [Moles/volume] in Serum or Plasma by calculation |
|
17864-0
|
Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
12180-6
|
Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
17863-2
|
Calcium.ionized [Mass/volume] in Serum or Plasma |
|
42567-8
|
Calcium.ionized [Mass or Moles/volume] in Serum or Plasma |
|
1995-0
|
Calcium.ionized [Moles/volume] in Serum or Plasma |
|
16512-6
|
Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16513-4
|
Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16514-2
|
Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16515-9
|
Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
16516-7
|
Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16517-5
|
Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
7489-8
|
Cajeput tree triggered histamine release [Units/volume] in Blood |
|
6171-3
|
Cajeput tree IgE Ab [Units/volume] in Serum |
|
15841-0
|
Cajeput tree IgE Ab RAST class [Presence] in Serum |
|
61284-6
|
Cajeput tree IgE Ab/IgE total in Serum |
|
56319-7
|
Cajeput tree IgG4 Ab [Mass/volume] in Serum |
|
49591-1
|
Calcidiol and Calciferol [Interpretation] in Serum or Plasma Narrative |
|
60493-4
|
Calcidiol+Calciferol [Moles/volume] in Serum or Plasma |
|
1991-9
|
Calciferol binding proteins [Mass/volume] in Serum |
|
16504-3
|
Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge |
|
21131-8
|
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 0.5 ug/kg pentagastrin IV |
|
1373-0
|
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
|
16505-0
|
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
77614-6
|
Calcitonin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
50180-9
|
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
|
56534-1
|
Calcitonin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
21132-6
|
Calcitonin [Mass/volume] in Serum or Plasma --1 minute post 0.5 ug/kg pentagastrin IV |
|
58891-3
|
Calcitonin [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
|
77613-8
|
Calcitonin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
|
50183-3
|
Calcitonin [Mass/volume] in Serum or Plasma --1 minute post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
|
21133-4
|
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post 0.5 ug/kg pentagastrin IV |
|
56511-9
|
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
77667-4
|
Calcitonin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
50182-5
|
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
|
77669-0
|
Calcitonin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
1374-8
|
Calcitonin [Mass/volume] in Serum or Plasma --3 hours post 15 mg/kg calcium gluconate IV |
|
16506-8
|
Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
21134-2
|
Calcitonin [Mass/volume] in Serum or Plasma --3 minutes post 0.5 ug/kg pentagastrin IV |
|
1375-5
|
Calcitonin [Mass/volume] in Serum or Plasma --4 hours post 15 mg/kg calcium gluconate IV |
|
16507-6
|
Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
1376-3
|
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 0.5 ug/kg pentagastrin IV |
|
1377-1
|
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
|
16508-4
|
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
77668-2
|
Calcitonin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
50181-7
|
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
|
46413-1
|
Calcitonin [Mass/volume] in Serum or Plasma --7 minutes post 0.5 ug/kg pentagastrin IV |
|
1372-2
|
Calcitonin [Mass/volume] in Serum or Plasma --90 seconds post 0.5 ug/kg pentagastrin IV |
|
13924-6
|
Calcitonin Ab [Presence] in Serum |
|
10468-7
|
Calcitonin Ag [Presence] in Tissue by Immune stain |
|
58892-1
|
Calcitonin [Mass/volume] in Serum or Plasma --baseline |
|
47369-4
|
Calcitonin [Mass/volume] in Body fluid |
|
75709-6
|
Calcitonin [Mass/volume] in Lymph node fine needle aspirate |
|
59569-4
|
Calcitonin [Moles/volume] in Serum or Plasma --post XXX challenge |
|
1378-9
|
Calcitonin [Mass/volume] in Serum or Plasma --pre 0.5 ug/kg pentagastrin IV |
|
1379-7
|
Calcitonin [Mass/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
|
50184-1
|
Calcitonin [Mass/volume] in Serum or Plasma --pre 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV |
|
51430-7
|
Calcitonin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
|
1992-7
|
Calcitonin [Mass/volume] in Serum or Plasma |
|
15035-9
|
Calcitonin [Moles/volume] in Serum or Plasma |
|
33788-1
|
Calcitonin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50469-6
|
Calcitonin [Mass/volume] in Serum or Plasma --1st specimen |
|
33787-3
|
Calcitonin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
12506-2
|
Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50470-4
|
Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen |
|
12507-0
|
Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50471-2
|
Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen |
|
12508-8
|
Calcitonin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50472-0
|
Calcitonin [Mass/volume] in Serum or Plasma --4th specimen |
|
12509-6
|
Calcitonin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50473-8
|
Calcitonin [Mass/volume] in Serum or Plasma --5th specimen |
|
12510-4
|
Calcitonin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50474-6
|
Calcitonin [Mass/volume] in Serum or Plasma --6th specimen |
|
16509-2
|
Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50475-3
|
Calcitonin [Mass/volume] in Serum or Plasma --7th specimen |
|
16510-0
|
Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50476-1
|
Calcitonin [Mass/volume] in Serum or Plasma --8th specimen |
|
16511-8
|
Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
32541-5
|
Calcium [Molar amount] in Urine collected for unspecified duration |
|
35675-8
|
Calcium [Mass/volume] in Urine collected for unspecified duration |
|
71790-0
|
Calcium [Moles/volume] in Urine collected for unspecified duration |
|
40069-7
|
Calcium [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
40230-5
|
Calcium [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
1381-3
|
Calcium [Moles/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
|
16519-1
|
Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
40078-8
|
Calcium [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
|
40239-6
|
Calcium [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
|
57335-2
|
Calcium [Mass/volume] in 12 hour Urine |
|
18186-7
|
Calcium [Mass/time] in 12 hour Urine |
|
51610-4
|
Calcium [Moles/time] in 12 hour Urine |
|
40079-6
|
Calcium [Mass/volume] in Serum or Plasma --13 hours post XXX challenge |
|
40240-4
|
Calcium [Moles/volume] in Serum or Plasma --13 hours post XXX challenge |
|
40080-4
|
Calcium [Mass/volume] in Serum or Plasma --14 hours post XXX challenge |
|
40241-2
|
Calcium [Moles/volume] in Serum or Plasma --14 hours post XXX challenge |
|
40066-3
|
Calcium [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
40225-5
|
Calcium [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
40081-2
|
Calcium [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
|
40242-0
|
Calcium [Moles/volume] in Serum or Plasma --16 hours post XXX challenge |
|
59000-0
|
Calcium [Mass/time] in 18 hour Urine |
|
40083-8
|
Calcium [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
|
40244-6
|
Calcium [Moles/volume] in Serum or Plasma --1 day post XXX challenge |
|
16270-1
|
Calcium [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
40229-7
|
Calcium [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
53124-4
|
Calcium [Moles/time] in 1 hour Urine |
|
40070-5
|
Calcium [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
40232-1
|
Calcium [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
40082-0
|
Calcium [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
|
40243-8
|
Calcium [Moles/volume] in Serum or Plasma --20 hours post XXX challenge |
|
27172-6
|
Calcium [Mass/mass] in 24 hour Stool |
|
2001-6
|
Calcium [Moles/volume] in 24 hour Stool |
|
18488-7
|
Calcium [Mass/volume] in 24 hour Urine |
|
6874-2
|
Calcium [Mass/time] in 24 hour Urine |
|
35248-4
|
Calcium [Mass or Moles/volume] in 24 hour Urine |
|
25362-5
|
Calcium [Moles/volume] in 24 hour Urine |
|
14637-3
|
Calcium [Moles/time] in 24 hour Urine |
|
40085-3
|
Calcium [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
|
40246-1
|
Calcium [Moles/volume] in Serum or Plasma --2 days post XXX challenge |
|
16272-7
|
Calcium [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
40231-3
|
Calcium [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
57334-5
|
Calcium [Mass/volume] in 2 hour Urine |
|
16518-3
|
Calcium [Mass/time] in 2 hour Urine |
|
16271-9
|
Calcium [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
40227-1
|
Calcium [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
40084-6
|
Calcium [Mass/volume] in Serum or Plasma --36 hours post XXX challenge |
|
40245-3
|
Calcium [Moles/volume] in Serum or Plasma --36 hours post XXX challenge |
|
40086-1
|
Calcium [Mass/volume] in Serum or Plasma --3 days post XXX challenge |
|
40247-9
|
Calcium [Moles/volume] in Serum or Plasma --3 days post XXX challenge |
|
40071-3
|
Calcium [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40233-9
|
Calcium [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40068-9
|
Calcium [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
40228-9
|
Calcium [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
40065-5
|
Calcium [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge |
|
40224-8
|
Calcium [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge |
|
40072-1
|
Calcium [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
40234-7
|
Calcium [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
12511-2
|
Calcium [Mass/volume] in 4 hour Urine |
|
27091-8
|
Calcium [Mass/time] in 4 hour Urine |
|
25584-4
|
Calcium [Moles/volume] in Urine --5 hours post 500 mg calcium PO |
|
40073-9
|
Calcium [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
40235-4
|
Calcium [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
1382-1
|
Calcium [Moles/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
|
16523-3
|
Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
40075-4
|
Calcium [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
40236-2
|
Calcium [Moles/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
40074-7
|
Calcium [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
16524-1
|
Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
|
40076-2
|
Calcium [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
40237-0
|
Calcium [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
40077-0
|
Calcium [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
40238-8
|
Calcium [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
|
46099-8
|
Calcium [Mass/volume] corrected for albumin in Serum or Plasma |
|
29265-6
|
Calcium [Moles/volume] corrected for albumin in Serum or Plasma |
|
49764-4
|
Calcium [Mass/volume] in Amniotic fluid |
|
14415-4
|
Calcium [Moles/volume] in Amniotic fluid |
|
27182-5
|
Calcium [Presence] in Blood |
|
54365-2
|
Calcium [Moles/volume] in Cord blood |
|
42593-4
|
Calcium [Moles/volume] in Capillary blood |
|
49765-1
|
Calcium [Mass/volume] in Blood |
|
1996-8
|
Calcium [Moles/volume] in Blood |
|
42857-3
|
Calcium [Moles/volume] in Venous blood |
|
40067-1
|
Calcium [Mass/volume] in Serum or Plasma --baseline |
|
40226-3
|
Calcium [Moles/volume] in Serum or Plasma --baseline |
|
1993-5
|
Calcium renal clearance in 24 hour Urine and Serum or Plasma |
|
1997-6
|
Calcium [Moles/volume] in Cerebral spinal fluid |
|
38643-3
|
Calcium cyanamide [Mass/volume] in Air |
|
58781-6
|
Calcium [Mass/volume] in Peritoneal dialysis fluid |
|
49005-2
|
Calcium [Moles/volume] in Peritoneal dialysis fluid |
|
27373-0
|
Calcium [Mass/volume] in Dialysis fluid |
|
1998-4
|
Calcium [Moles/volume] in Dialysis fluid |
|
57919-3
|
Calcium [Mass/volume] in Nonbiological fluid |
|
54364-5
|
Calcium [Moles/volume] in Nonbiological fluid |
|
15155-5
|
Calcium [Mass/volume] in Body fluid |
|
12181-4
|
Calcium [Moles/volume] in Body fluid |
|
14419-6
|
Calcium [Moles/volume] in Gastric fluid |
|
86915-6
|
Calcium goal [Mass/volume] Serum or Plasma |
|
50836-6
|
Calcium [Moles/mass] in Hair |
|
81137-2
|
Calcium intake 24 hour Estimated |
|
80975-6
|
Calcium intake 24 hour Measured |
|
35264-1
|
Calcium intake 24 hour |
|
63550-8
|
Calcium magnesium phosphate/Total in Stone |
|
87477-6
|
Calcium in Unspecified specimen |
|
74909-3
|
Calcium oxalate dihydrate/Total in Stone |
|
49500-2
|
Calcium oxalate dihydrate/Total in Stone by Infrared spectroscopy |
|
2005-7
|
Calcium [Moles/time] in 2 hour Urine --12 hours fasting |
|
1384-7
|
Calcium [Moles/volume] in Blood --post calcium infusion |
|
51950-4
|
Calcium [Mass/volume] in Serum or Plasma --post dialysis |
|
59148-7
|
Calcium [Moles/volume] in Serum or Plasma --post dialysis |
|
14416-2
|
Calcium [Moles/volume] in Pleural fluid |
|
1383-9
|
Calcium [Moles/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
|
25873-1
|
Calcium [Moles/volume] in Urine --pre 500 mg calcium PO |
|
40064-8
|
Calcium [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
40223-0
|
Calcium [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
14417-0
|
Calcium [Moles/volume] in Peritoneal fluid |
|
16273-5
|
Calcium [Mass/mass] in Red Blood Cells |
|
25583-6
|
Calcium [Moles/volume] in Red Blood Cells |
|
74516-6
|
Calcium [Moles/volume] in Saliva (oral fluid) |
|
17861-6
|
Calcium [Mass/volume] in Serum or Plasma |
|
35246-8
|
Calcium [Mass or Moles/volume] in Serum or Plasma |
|
2000-8
|
Calcium [Moles/volume] in Serum or Plasma |
|
69425-7
|
Calcium [Mass/volume] in Semen |
|
1999-2
|
Calcium [Moles/volume] in Semen |
|
14418-8
|
Calcium [Moles/volume] in Synovial fluid |
|
27909-1
|
Calcium [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
33790-7
|
Calcium [Moles/volume] in Urine --1st specimen post XXX challenge |
|
33789-9
|
Calcium [Moles/volume] in Urine --10th specimen post XXX challenge |
|
27916-6
|
Calcium [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16520-9
|
Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge |
|
27919-0
|
Calcium [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16521-7
|
Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge |
|
27935-6
|
Calcium [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16522-5
|
Calcium [Moles/volume] in Urine --4th specimen post XXX challenge |
|
27933-1
|
Calcium [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
33791-5
|
Calcium [Moles/volume] in Urine --5th specimen post XXX challenge |
|
27910-9
|
Calcium [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
33792-3
|
Calcium [Moles/volume] in Urine --6th specimen post XXX challenge |
|
27913-3
|
Calcium [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
33793-1
|
Calcium [Moles/volume] in Urine --7th specimen post XXX challenge |
|
33794-9
|
Calcium [Moles/volume] in Urine --8th specimen post XXX challenge |
|
33795-6
|
Calcium [Moles/volume] in Urine --9th specimen post XXX challenge |
|
2002-4
|
Calcium [Moles/volume] in Stool |
|
14636-5
|
Calcium [Presence] in Stone |
|
10746-6
|
Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
|
47597-0
|
Calcium [Moles/volume] corrected for total protein in Blood |
|
34907-6
|
Calcium [Mass/volume] corrected for total protein in Serum or Plasma |
|
35258-3
|
Calcium [Mass or Moles/volume] corrected for total protein in Serum or Plasma |
|
18281-6
|
Calcium [Moles/volume] corrected for total protein in Serum or Plasma |
|
30527-6
|
Calcium [Mass/volume] in Total parental nutrition |
|
53100-4
|
Calcium [Moles/volume] in Total parental nutrition |
|
29276-3
|
Calcium [Presence] in Urine |
|
17862-4
|
Calcium [Mass/volume] in Urine |
|
35247-6
|
Calcium [Mass or Moles/volume] in Urine |
|
2004-0
|
Calcium [Moles/volume] in Urine |
|
9467-2
|
Calcium [Mass/volume] in Water |
|
38250-7
|
Calcium [Mass/volume] in Unspecified specimen |
|
53455-2
|
Calcium [Mass/mass] in Unspecified specimen |
|
32305-5
|
Calcium [Moles/volume] in Unspecified specimen |
|
53502-1
|
Calcium [Moles/mass] in Unspecified specimen |
|
13444-5
|
Calcium/Albumin [Mass Ratio] in Serum or Plasma |
|
13717-4
|
Calcium/Creatinine [Mass Ratio] in 24 hour Urine |
|
50839-0
|
Calcium/Creatinine [Molar ratio] in 24 hour Urine |
|
27037-1
|
Calcium/Creatinine [Mass Ratio] in 2 hour Urine |
|
9321-1
|
Calcium/Creatinine [Mass Ratio] in Urine |
|
24518-3
|
Calcium/Creatinine [Molar ratio] in Urine |
|
13448-6
|
Calcium/Osmolality [Mass Ratio] in Serum or Plasma |
|
49937-6
|
Calcium/Oxalate [Molar ratio] in Urine |
|
1380-5
|
Calcium/Phosphate parathyroid-challenge test [Mass Ratio] in Serum |
|
16525-8
|
Calcium/Phosphate [Mass Ratio] in Serum or Plasma |
|
16526-6
|
Calcium/Protein [Mass Ratio] in Serum or Plasma |
|
16527-4
|
Calcium/Sodium [Mass Ratio] in Serum or Plasma |
|
6468-3
|
Microscopic observation [Identifier] in Sputum by Calcofluor white |
|
6472-5
|
Microscopic observation [Identifier] in Tissue by Calcofluor white |
|
658-5
|
Microscopic observation [Identifier] in Unspecified specimen by Calcofluor white |
|
50308-6
|
Caldesmon Ag [Presence] in Tissue by Immune stain |
|
38916-3
|
Calicivirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10649-2
|
Calicivirus [Identifier] in Stool by Electron microscopy |
|
7529-1
|
California Black Oak IgE Ab [Units/volume] in Serum |
|
15876-6
|
California Black Oak IgE Ab RAST class [Presence] in Serum |
|
7532-5
|
California Live Oak IgE Ab [Units/volume] in Serum |
|
7511-9
|
California Mugwort IgE Ab [Units/volume] in Serum |
|
7683-6
|
California Sagebrush IgE Ab [Units/volume] in Serum |
|
21508-7
|
California Sagebrush IgE Ab RAST class [Presence] in Serum |
|
6274-5
|
California Walnut IgE Ab [Units/volume] in Serum |
|
33982-0
|
California Walnut Pollen IgE Ab [Units/volume] in Serum |
|
16078-8
|
California Walnut Pollen IgE Ab RAST class [Presence] in Serum |
|
39085-6
|
California Walnut Pollen IgE Ab/IgE total in Serum |
|
75302-0
|
Calorie intake 24 hour |
|
75298-0
|
Calorie intake 24 hour Estimated |
|
80494-8
|
Calorie intake 24 hour Measured |
|
55424-6
|
Calories burned in unspecified time Pedometer |
|
93819-1
|
Calories burned in unspecified time --during activity |
|
93821-7
|
Calories burned in unspecified time --during aerobic activity |
|
93824-1
|
Calories burned in unspecified time --during cycling |
|
93825-8
|
Calories burned in unspecified time --during running |
|
93823-3
|
Calories burned in unspecified time --during swimming |
|
93826-6
|
Calories burned in unspecified time --during walking |
|
93820-9
|
Calories burned in unspecified time --during weight training |
|
55421-2
|
Calories burned Machine estimate |
|
93822-5
|
Calories burned in unspecified time --while playing a sport |
|
49462-5
|
Calponin Ag [Presence] in Tissue by Immune stain |
|
93771-4
|
Calprotectin [Mass/volume] in Synovial fluid |
|
82874-9
|
Calprotectin [Mass/volume] in Stool |
|
38445-3
|
Calprotectin [Mass/mass] in Stool |
|
82538-0
|
CALR gene exon 9 full mutation analysis in Blood or Tissue by Sequencing |
|
77174-1
|
CALR gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47011-2
|
Calretinin Ag [Presence] in Tissue by Immune stain |
|
82736-0
|
Calcium-calmodulin-dependent protein kinase II activity actual/normal in Serum |
|
49869-1
|
Camel dander IgE Ab [Units/volume] in Serum |
|
1727-7
|
Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
|
34230-3
|
Adenosine monophosphate.cyclic [Moles/volume] in 24 hour Urine |
|
14584-7
|
Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine |
|
45013-0
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --2 hours post XXX challenge |
|
45016-3
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --4 hours post XXX challenge |
|
45014-8
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --6 hours post XXX challenge |
|
45015-5
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --baseline |
|
21052-6
|
Adenosine monophosphate.cyclic.nephrogenous [Moles/volume] in Urine and Serum or Plasma |
|
44428-1
|
Adenosine monophosphate.cyclic.nephrogenous/Creatinine [Molar ratio] in Urine |
|
1726-9
|
Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
|
25498-7
|
Adenosine monophosphate.cyclic [Moles/volume] in Serum or Plasma |
|
47264-7
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --1st specimen post XXX challenge |
|
47250-6
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --2nd specimen post XXX challenge |
|
47263-9
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --3rd specimen post XXX challenge |
|
47265-4
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --4th specimen post XXX challenge |
|
47266-2
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --5th specimen post XXX challenge |
|
47267-0
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine --6th specimen post XXX challenge |
|
6868-4
|
Adenosine monophosphate.cyclic [Mass/volume] in Urine |
|
22712-4
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine |
|
25972-1
|
Adenosine monophosphate.cyclic/Creatinine [Molar ratio] in 24 hour Urine |
|
45019-7
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2 hours post XXX challenge |
|
45020-5
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4 hours post XXX challenge |
|
45018-9
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6 hours post XXX challenge |
|
45017-1
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --baseline |
|
1728-5
|
Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma |
|
49886-5
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --1st specimen post XXX challenge |
|
47269-6
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2nd specimen post XXX challenge |
|
47270-4
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --3rd specimen post XXX challenge |
|
47271-2
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4th specimen post XXX challenge |
|
47272-0
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --5th specimen post XXX challenge |
|
47268-8
|
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6th specimen post XXX challenge |
|
18361-6
|
Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine |
|
75738-5
|
Campesterol [Mass/volume] in Serum or Plasma |
|
58464-9
|
Campesterol [Moles/volume] in Serum or Plasma |
|
9369-0
|
Camphor [Mass/volume] in Blood |
|
34620-5
|
Camphor [Mass/volume] in Body fluid |
|
71429-5
|
Campylobacter sp DNA.diarrheagenic [Presence] in Stool by NAA with probe detection |
|
26619-7
|
Campylobacter sp Ab [Presence] in Serum |
|
6330-5
|
Campylobacter sp identified in Blood by Organism specific culture |
|
49614-1
|
Campylobacter sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
20739-9
|
Campylobacter sp identified in Body fluid by Organism specific culture |
|
43068-6
|
Campylobacter sp IgA Ab [Presence] in Serum |
|
40616-5
|
Campylobacter sp IgA Ab [Presence] in Serum by Immunoassay |
|
41159-5
|
Campylobacter sp IgG Ab [Presence] in Serum |
|
40617-3
|
Campylobacter sp IgG Ab [Presence] in Serum by Immunoassay |
|
20738-1
|
Campylobacter sp identified in Isolate by Organism specific culture |
|
16534-0
|
Campylobacter sp rRNA [Presence] in Serum by Probe |
|
4992-4
|
Campylobacter sp rRNA [Presence] in Unspecified specimen by Probe |
|
6331-3
|
Campylobacter sp identified in Stool by Organism specific culture |
|
82302-1
|
Campylobacter sp [Presence] in Stool by Culture |
|
20740-7
|
Campylobacter sp identified in Tissue by Organism specific culture |
|
6332-1
|
Campylobacter sp identified in Unspecified specimen by Organism specific culture |
|
7356-9
|
Canadian blue grass IgE Ab [Units/volume] in Serum |
|
15739-6
|
Canadian blue grass IgE Ab RAST class [Presence] in Serum |
|
79106-1
|
Can correctly draw all the numbers to indicate the hours of a clock [GPCOG] |
|
79107-9
|
Can correctly draw hands to show 10M past eleven o'clock [GPCOG] |
|
85467-9
|
Can engage in healthcare discussions - visual analog rating [ePCAM] |
|
83338-4
|
Can engage in healthcare discussions [PCAM] |
|
77532-0
|
Can pronounce abstemious [AmNART] |
|
77498-4
|
Can pronounce ache [AmNART] |
|
77499-2
|
Can pronounce aisle [AmNART] |
|
77523-9
|
Can pronounce algae [AmNART] |
|
77527-0
|
Can pronounce apropos [AmNART] |
|
77539-5
|
Can pronounce beautify [AmNART] |
|
77515-5
|
Can pronounce blatant [AmNART] |
|
77505-6
|
Can pronounce bouquet [AmNART] |
|
77531-2
|
Can pronounce cabal [AmNART] |
|
77500-7
|
Can pronounce capon [AmNART] |
|
77506-4
|
Can pronounce caprice [AmNART] |
|
77522-1
|
Can pronounce cellist [AmNART] |
|
77525-4
|
Can pronounce chamois [AmNART] |
|
77521-3
|
Can pronounce chassis [AmNART] |
|
77502-3
|
Can pronounce chord [AmNART] |
|
77533-8
|
Can pronounce détente [AmNART] |
|
77501-5
|
Can pronounce debt [AmNART] |
|
77504-9
|
Can pronounce deny [AmNART] |
|
77509-8
|
Can pronounce depot [AmNART] |
|
77538-7
|
Can pronounce epitome [AmNART] |
|
77530-4
|
Can pronounce façade [AmNART] |
|
77514-8
|
Can pronounce fetal [AmNART] |
|
77507-2
|
Can pronounce gauge [AmNART] |
|
77503-1
|
Can pronounce heir [AmNART] |
|
77517-1
|
Can pronounce hiatus [AmNART] |
|
77540-3
|
Can pronounce hyperbole [AmNART] |
|
77541-1
|
Can pronounce imbroglio [AmNART] |
|
77519-7
|
Can pronounce meringue [AmNART] |
|
77511-4
|
Can pronounce naïve [AmNART] |
|
77510-6
|
Can pronounce nausea [AmNART] |
|
77535-3
|
Can pronounce papyrus [AmNART] |
|
77516-3
|
Can pronounce placebo [AmNART] |
|
77537-9
|
Can pronounce prelate [AmNART] |
|
77513-0
|
Can pronounce pugilist [AmNART] |
|
77536-1
|
Can pronounce quadruped [AmNART] |
|
77534-6
|
Can pronounce scion [AmNART] |
|
77520-5
|
Can pronounce sieve [AmNART] |
|
77518-9
|
Can pronounce smile [AmNART] |
|
77512-2
|
Can pronounce subtle [AmNART] |
|
77524-7
|
Can pronounce superfluous [AmNART] |
|
77542-9
|
Can pronounce syncope [AmNART] |
|
77526-2
|
Can pronounce thyme [AmNART] |
|
77528-8
|
Can pronounce virulent [AmNART] |
|
77508-0
|
Can pronounce worsted [AmNART] |
|
77529-6
|
Can pronounce zealot [AmNART] |
|
79105-3
|
Can provide correct date [GPCOG] |
|
79111-1
|
Can recall 42 [GPCOG] |
|
79110-3
|
Can recall Brown [GPCOG] |
|
79109-5
|
Can recall John [GPCOG] |
|
79113-7
|
Can recall Kensington [GPCOG] |
|
79112-9
|
Can recall West [GPCOG] |
|
79108-7
|
Can report something that happened in the news recently [GPCOG] |
|
88793-5
|
Can you bend your knee fully during the last week [KOOS] |
|
76718-6
|
Can you find companionship when you want it [PROMIS] |
|
88794-3
|
Can you straighten your knee fully during the last week [KOOS] |
|
78997-4
|
Can you walk 25 feet on a level surface (with or without support) [PROMIS] |
|
75910-0
|
Canadian triage and acuity scale [CTAS] |
|
16535-7
|
Canary droppings IgE Ab [Units/volume] in Serum |
|
23834-5
|
Canary droppings IgE Ab RAST class [Presence] in Serum |
|
81784-1
|
Canary droppings IgG Ab [Mass/volume] in Serum |
|
55590-4
|
Canary feather IgE Ab [Presence] in Serum |
|
7171-2
|
Canary feather IgE Ab [Units/volume] in Serum |
|
15598-6
|
Canary feather IgE Ab RAST class [Presence] in Serum |
|
51547-8
|
Canary feather IgG Ab [Presence] in Serum |
|
58916-8
|
Canary feather IgG Ab [Mass/volume] in Serum |
|
6058-2
|
Canary grass IgE Ab [Units/volume] in Serum |
|
15988-9
|
Canary grass IgE Ab RAST class [Presence] in Serum |
|
50356-5
|
Canary grass IgE Ab/IgE total in Serum |
|
31280-1
|
Canary serum proteins Ab [Presence] in Serum |
|
24497-0
|
Canary serum proteins Ab [Presence] in Serum by Immune diffusion (ID) |
|
16536-5
|
Canary serum proteins Ab [Units/volume] in Serum |
|
9729-5
|
Canary serum proteins IgE Ab [Units/volume] in Serum |
|
26048-9
|
Canary serum proteins IgE Ab RAST class [Presence] in Serum |
|
37992-5
|
Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay |
|
30538-3
|
Neutrophil cytoplasmic Ab.classic [Presence] in Serum |
|
17353-4
|
Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence |
|
8084-6
|
Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum |
|
32708-0
|
Neutrophil cytoplasmic Ab.classic [Titer] in Serum |
|
14277-8
|
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
|
13127-6
|
Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
|
50775-6
|
Cancer Ag 125 [Units/volume] in Cerebral spinal fluid |
|
59040-6
|
Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid |
|
15156-3
|
Cancer Ag 125 [Units/volume] in Body fluid by Dilution |
|
11210-2
|
Cancer Ag 125 [Units/volume] in Body fluid |
|
68923-2
|
Cancer Ag 125 [Units/volume] in Pericardial fluid |
|
19165-0
|
Cancer Ag 125 [Units/volume] in Pleural fluid |
|
40618-1
|
Cancer Ag 125 [Units/volume] in Peritoneal fluid |
|
15157-1
|
Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution |
|
83082-8
|
Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay |
|
2006-5
|
Cancer Ag 125 [Presence] in Serum or Plasma |
|
10334-1
|
Cancer Ag 125 [Units/volume] in Serum or Plasma |
|
48677-9
|
Cancer Ag 125 [Presence] in Tissue by Immune stain |
|
50776-4
|
Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid |
|
29153-4
|
Cancer Ag 15-3 [Units/volume] in Body fluid |
|
50777-2
|
Cancer Ag 15-3 [Units/volume] in Pericardial fluid |
|
19186-6
|
Cancer Ag 15-3 [Units/volume] in Pleural fluid |
|
50778-0
|
Cancer Ag 15-3 [Units/volume] in Peritoneal fluid |
|
83083-6
|
Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay |
|
2007-3
|
Cancer Ag 15-3 [Presence] in Serum or Plasma |
|
6875-9
|
Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
|
50779-8
|
Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid |
|
26924-1
|
Cancer Ag 19-9 [Units/volume] in Body fluid |
|
50780-6
|
Cancer Ag 19-9 [Units/volume] in Pericardial fluid |
|
19163-5
|
Cancer Ag 19-9 [Units/volume] in Pleural fluid |
|
50781-4
|
Cancer Ag 19-9 [Units/volume] in Peritoneal fluid |
|
83084-4
|
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay |
|
2009-9
|
Cancer Ag 19-9 [Presence] in Serum or Plasma |
|
24108-3
|
Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
|
2011-5
|
Cancer Ag 242 [Presence] in Serum or Plasma |
|
50782-2
|
Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid |
|
19187-4
|
Cancer Ag 27-29 [Units/volume] in Pleural fluid |
|
2012-3
|
Cancer Ag 27-29 [Presence] in Serum or Plasma |
|
17842-6
|
Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
|
2013-1
|
Cancer Ag 50 [Presence] in Serum or Plasma |
|
34256-8
|
Cancer Ag 50 [Units/volume] in Serum or Plasma |
|
19190-8
|
Cancer Ag 549 [Units/volume] in Pleural fluid |
|
2014-9
|
Cancer Ag 549 [Presence] in Serum or Plasma |
|
19189-0
|
Cancer Ag 549 [Units/volume] in Serum or Plasma |
|
68925-7
|
Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid |
|
34161-0
|
Cancer Ag 72-4 [Units/volume] in Body fluid |
|
68926-5
|
Cancer Ag 72-4 [Units/volume] in Pericardial fluid |
|
19164-3
|
Cancer Ag 72-4 [Units/volume] in Pleural fluid |
|
68924-0
|
Cancer Ag 72-4 [Units/volume] in Peritoneal fluid |
|
2015-6
|
Cancer Ag 72-4 [Presence] in Serum or Plasma |
|
17843-4
|
Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
|
47012-0
|
Cancer Ag 72-4 [Presence] in Tissue by Immune stain |
|
75692-4
|
Cancer detection basis |
|
72135-7
|
Cancer diagnosis Narrative |
|
72134-0
|
Cancer event report |
|
73977-1
|
Cancer related large scale gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81167-9
|
Cancer treatment --preoperative |
|
73491-3
|
Candesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73490-5
|
Candesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26636-1
|
Candida sp Ab [Presence] in Serum |
|
35270-8
|
Candida sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
43067-8
|
Candida sp Ab [Titer] in Serum |
|
40501-9
|
Candida sp Ab [Titer] in Serum by Latex agglutination |
|
16539-9
|
Candida sp Ag [Presence] in Serum |
|
35271-6
|
Candida sp Ag [Presence] in Serum by Latex agglutination |
|
31760-2
|
Candida sp Ag [Units/volume] in Serum |
|
27440-7
|
Candida sp Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
48336-2
|
Candida sp Ag [Presence] in Tissue by Immune stain |
|
9501-8
|
Candida sp Ag [Titer] in Serum |
|
10650-0
|
Candida sp DNA [Presence] in Blood by Probe with amplification |
|
62460-1
|
Candida sp DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
92699-8
|
Candida sp DNA [Presence] in Vaginal fluid by Probe |
|
54142-5
|
Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
91081-0
|
Candida sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16538-1
|
Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
|
27417-5
|
Candida sp IgA Ab [Units/volume] in Serum by Immunoassay |
|
34582-7
|
Candida sp IgA Ab [Presence] in Serum |
|
9498-7
|
Candida sp IgA Ab [Units/volume] in Serum |
|
34583-5
|
Candida sp IgG Ab [Presence] in Serum |
|
7174-6
|
Candida sp IgG Ab [Units/volume] in Serum |
|
40825-2
|
Candida sp IgG Ab [Titer] in Serum |
|
27391-2
|
Candida sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
34584-3
|
Candida sp IgM Ab [Presence] in Serum |
|
9500-0
|
Candida sp IgM Ab [Units/volume] in Serum |
|
88717-4
|
Candida sp identified in Isolate |
|
73962-3
|
Candida sp rRNA [Identifier] by FISH in Positive blood culture |
|
47000-5
|
Candida sp rRNA [Presence] in Vaginal fluid by Probe |
|
553-8
|
Candida sp identified in Saliva (oral fluid) by Organism specific culture |
|
554-6
|
Candida sp identified in Stool by Organism specific culture |
|
33038-1
|
Candida sp identified in Vaginal fluid by Cyto stain |
|
555-3
|
Candida sp identified in Unspecified specimen by Organism specific culture |
|
23699-2
|
Canine parainfluenza virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
78814-1
|
Cannabicyclohexanol cutoff [Mass/volume] in Urine for Confirmatory method |
|
78813-3
|
Cannabicyclohexanol [Mass/volume] in Urine by Confirmatory method |
|
82964-8
|
Cannabidiol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
16243-8
|
Cannabinoids [Mass/volume] in Blood by Confirmatory method |
|
42630-4
|
Cannabinoids [Presence] in Blood |
|
42491-1
|
Cannabinoids [Presence] in Blood by Screen method |
|
19294-8
|
Cannabinoids confirm method [Identifier] in Urine |
|
19292-2
|
Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method |
|
19291-4
|
Cannabinoids cutoff [Mass/volume] in Urine for Screen method |
|
19073-6
|
Cannabinoids cutoff [Mass/volume] in Urine |
|
50338-3
|
Cannabinoids [Mass/volume] in Dialysis fluid |
|
91041-4
|
Cannabinoids [Presence] in Body fluid by Screen method |
|
59573-6
|
Cannabinoids [Presence] in Gastric fluid |
|
33561-2
|
Cannabinoids [Mass/volume] in Gastric fluid |
|
26764-1
|
Cannabinoids [Presence] in Hair |
|
40800-5
|
Cannabinoids [Presence] in Hair by Screen method |
|
59160-2
|
Cannabinoids [Mass/mass] in Hair |
|
33282-5
|
Cannabinoids [Mass/mass] in Meconium by Confirmatory method |
|
50406-8
|
Cannabinoids [Presence] in Meconium by Confirmatory method |
|
31080-5
|
Cannabinoids [Presence] in Meconium by Screen method |
|
27024-9
|
Cannabinoids [Mass/mass] in Meconium |
|
19290-6
|
Cannabinoids positive [Identifier] in Urine by Confirmatory method |
|
40801-3
|
Cannabinoids [Presence] in Saliva (oral fluid) by Screen method |
|
19293-0
|
Cannabinoids screen method [Identifier] in Urine |
|
16542-3
|
Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3425-6
|
Cannabinoids [Presence] in Serum or Plasma |
|
8171-1
|
Cannabinoids [Presence] in Serum or Plasma by Confirmatory method |
|
8172-9
|
Cannabinoids [Presence] in Serum or Plasma by Screen method |
|
74157-9
|
Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method |
|
8170-3
|
Cannabinoids [Mass/volume] in Serum or Plasma |
|
26856-5
|
Cannabinoids [Mass/mass] in Stool |
|
73943-3
|
Cannabinoids synthetic [Presence] in Blood |
|
67126-3
|
Cannabinoids synthetic [Presence] in Urine by Confirmatory method |
|
72379-1
|
Cannabinoids synthetic [Presence] in Unspecified specimen by Screen method |
|
19287-2
|
Cannabinoids tested for in Urine by Screen method Nominal |
|
19288-0
|
Cannabinoids tested for in Urine by Screen method Narrative |
|
91048-9
|
Cannabinoids [Presence] in Tissue by Screen method |
|
20413-1
|
Cannabinoids [Mass/volume] in Urine by Confirmatory method |
|
3427-2
|
Cannabinoids [Presence] in Urine |
|
19289-8
|
Cannabinoids [Presence] in Urine by Confirmatory method |
|
18282-4
|
Cannabinoids [Presence] in Urine by Screen method |
|
70144-1
|
Cannabinoids [Presence] in Urine by Screen method >20 ng/mL |
|
70145-8
|
Cannabinoids [Presence] in Urine by Screen method >50 ng/mL |
|
70143-3
|
Cannabinoids [Mass/volume] in Urine by Screen method |
|
26760-9
|
Cannabinoids [Units/volume] in Urine |
|
42860-7
|
Cannabinoids [Mass/volume] in Urine |
|
52954-5
|
Cannabinoids [Moles/volume] in Urine |
|
16543-1
|
Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
|
8177-8
|
Cannabinoids [Presence] in Unknown substance |
|
8178-6
|
Cannabinoids [Presence] in Unknown substance by Confirmatory method |
|
8179-4
|
Cannabinoids [Presence] in Unknown substance by Screen method |
|
8176-0
|
Cannabinoids [Mass/volume] in Unknown substance |
|
27086-8
|
Cannabinoids [Presence] in Vitreous fluid |
|
48943-5
|
Cannabinoids [Presence] in Unspecified specimen by Confirmatory method |
|
48942-7
|
Cannabinoids [Mass/volume] in Unspecified specimen |
|
26747-6
|
Cannabinoids/Creatinine [Mass Ratio] in Urine |
|
87379-4
|
Cannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3430-6
|
Canrenone [Mass/time] in 24 hour Urine |
|
4151-7
|
Canrenone [Mass] of Dose |
|
21135-9
|
Canrenone [Mass/volume] in Serum or Plasma |
|
3428-0
|
Canrenone [Presence] in Urine |
|
16544-9
|
Canrenone [Units/volume] in Urine |
|
3429-8
|
Canrenone [Mass/volume] in Urine |
|
57874-0
|
Cantaloupe triggered histamine release [Units/volume] in Blood |
|
57883-1
|
Cantaloupe IgE Ab [Units/volume] in Serum |
|
57881-5
|
Cantaloupe IgE Ab RAST class [Presence] in Serum |
|
57879-9
|
Cantaloupe IgG Ab [Units/volume] in Serum |
|
57877-3
|
Cantaloupe IgG Ab RAST class [Presence] in Serum |
|
57875-7
|
Cantaloupe IgG4 Ab [Mass/volume] in Serum |
|
60359-7
|
Cantaloupe IgG Ab [Mass/volume] in Serum |
|
7645-5
|
Canyon Ragweed IgE Ab [Units/volume] in Serum |
|
81623-1
|
Calcium oxalate [Energy Difference] in 24 hour Urine |
|
38251-5
|
Calcium oxalate [Mass/time] in 24 hour Urine |
|
53296-0
|
Calcium oxalate crystals [#/volume] in Urine by Computer assisted method |
|
53306-7
|
Calcium oxalate crystals [#/area] in Urine by Computer assisted method |
|
25148-8
|
Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field |
|
53131-9
|
Calcium oxalate crystals [#/area] in Urine sediment by Microscopy low power field |
|
33234-6
|
Calcium oxalate crystals [Presence] in Urine by Computer assisted method |
|
5774-5
|
Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy |
|
34736-9
|
Calcium oxalate index in 24 hour Urine |
|
32157-0
|
Calcium oxalate/Total in Stone |
|
38520-3
|
Capillary fragility [Presence] |
|
44963-7
|
Capillary refill [Time] of Nail bed |
|
86507-1
|
Capital of Assyria |
|
45191-4
|
CAPN3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41748-5
|
CAPN3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
25210-6
|
Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25211-4
|
Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
48170-5
|
Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25212-2
|
Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
61355-4
|
Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55623-3
|
Capreomycin [Susceptibility] by Gradient strip |
|
57-0
|
Capreomycin [Susceptibility] by Disk diffusion (KB) |
|
56-2
|
Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55-4
|
Capreomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23607-5
|
Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89483-2
|
Capreomycin [Susceptibility] by Genotype method |
|
16545-6
|
Capreomycin [Mass/volume] in Serum or Plasma |
|
18872-2
|
Capreomycin [Susceptibility] |
|
58-8
|
Capreomycin [Susceptibility] by Serum bactericidal titer |
|
22166-3
|
Caprine parapoxvirus Ab [Presence] in Serum |
|
20777-9
|
Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation |
|
22167-1
|
Caprine parapoxvirus Ab [Presence] in Tissue |
|
20776-1
|
Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence |
|
22982-3
|
Capripox virus Ab [Presence] in Serum |
|
22983-1
|
Capripox virus Ab [Presence] in Serum by Immunoblot |
|
22984-9
|
Capripox virus Ab [Presence] in Serum by Neutralization test |
|
22990-6
|
Capripox virus Ag [Presence] in Tissue by Immunoassay |
|
22987-2
|
Capripox virus Ag [Presence] in Tissue by Immune stain |
|
31762-8
|
Capripox virus Ag [Presence] in Unspecified specimen |
|
22988-0
|
Capripox virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
22986-4
|
Capripox virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
22989-8
|
Capripox virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22991-4
|
Capripox virus DNA [Presence] in Unspecified specimen by RFLP |
|
22981-5
|
Capripox virus [Presence] in Tissue by Animal inoculation |
|
38644-1
|
Caprolactam [Mass/volume] in Air |
|
38645-8
|
Captan [Mass/volume] in Air |
|
73489-7
|
Captopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73488-9
|
Captopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16546-4
|
Captopril [Mass/volume] in Serum or Plasma |
|
31281-9
|
Cancer associated retinopathy Ab [Presence] in Serum |
|
25834-3
|
Cancer associated retinopathy Ab [Presence] in Serum by Immunoblot |
|
89413-9
|
Car transfer - functional ability [CMS Assessment] |
|
83206-3
|
Car transfer - functional ability during 3 day assessment period [CMS Assessment] |
|
89412-1
|
Car transfer - functional goal [CMS Assessment] |
|
83205-5
|
Car transfer - functional goal during 3 day assessment period [CMS Assessment] |
|
11163-3
|
Carageenan IgE Ab [Units/volume] in Serum |
|
21137-5
|
Carageenan IgE Ab RAST class [Presence] in Serum |
|
7178-7
|
Caraway IgE Ab [Units/volume] in Serum |
|
15602-6
|
Caraway IgE Ab RAST class [Presence] in Serum |
|
32159-6
|
Carbonated calcium phosphate/Total in Stone |
|
38254-9
|
Carbonated calcium phosphate [Presence] in Stone |
|
75288-1
|
Carbohydrate need [Mass/time] 24 hour Estimated |
|
87790-2
|
Carbadox [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87791-0
|
Carbadox [Susceptibility] |
|
87601-1
|
Carbadox [Mass/mass] in Unspecified specimen |
|
9789-9
|
Carbamate pesticides [Type] in Serum or Plasma |
|
16547-2
|
Carbamate pesticides [Type] in Urine |
|
28047-9
|
Carbamate pesticides [Mass/volume] in Urine |
|
20749-8
|
Carbamates [Presence] in Feed by Screen method |
|
20745-6
|
Carbamates [Presence] in Gastric fluid by Screen method |
|
20747-2
|
Carbamates [Presence] in Ingesta by Screen method |
|
20748-0
|
Carbamates [Presence] in Tissue by Screen method |
|
20746-4
|
Carbamates [Presence] in Unspecified specimen by Screen method |
|
73050-7
|
carBAMazepine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73049-9
|
carBAMazepine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
29148-4
|
carBAMazepine.bound [Mass/volume] in Serum or Plasma |
|
41472-2
|
carBAMazepine [Mass/volume] in DBS |
|
4152-5
|
carBAMazepine [Mass] of Dose |
|
29147-6
|
carBAMazepine 10,11-Epoxide.bound [Mass/volume] in Serum or Plasma |
|
41473-0
|
carBAMazepine 10,11-Epoxide [Mass/volume] in DBS |
|
14056-6
|
carBAMazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma |
|
47097-1
|
carBAMazepine 10,11-epoxide free [Moles/volume] in Serum or Plasma |
|
9415-1
|
carBAMazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma |
|
18270-9
|
carBAMazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma |
|
29212-8
|
carBAMazepine [Mass/volume] in Body fluid |
|
32852-6
|
carBAMazepine free/carBAMazepine.total in Serum or Plasma |
|
14057-4
|
carBAMazepine free [Mass/volume] in Saliva (oral fluid) |
|
3433-0
|
carBAMazepine free [Mass/volume] in Serum or Plasma |
|
32058-0
|
carBAMazepine free [Moles/volume] in Serum or Plasma |
|
74974-7
|
carBAMazepine free [Mass/volume] in Serum or Plasma --trough |
|
59876-3
|
carBAMazepine [Presence] in Gastric fluid |
|
73486-3
|
carBAMazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73487-1
|
carBAMazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3431-4
|
carBAMazepine [Presence] in Serum or Plasma |
|
35599-0
|
carBAMazepine [Mass/volume] in Serum or Plasma by Screen method |
|
3432-2
|
carBAMazepine [Mass/volume] in Serum or Plasma |
|
35237-7
|
carBAMazepine [Mass or Moles/volume] in Serum or Plasma |
|
14639-9
|
carBAMazepine [Moles/volume] in Serum or Plasma |
|
74973-9
|
carBAMazepine [Mass/volume] in Serum or Plasma --trough |
|
12363-8
|
carBAMazepine [Presence] in Urine |
|
16548-0
|
carBAMazepine [Mass/volume] in Urine |
|
60291-2
|
carBAMazepine [Presence] in Unspecified specimen |
|
89249-7
|
Carbapenem resistance gene identified event index case |
|
88462-7
|
Carbapenem [Susceptibility] |
|
74676-8
|
Carbapenemase [Type] in Isolate by Carba NP |
|
86930-5
|
Carbapenemase [Presence] in Isolate |
|
38738-1
|
Carbaryl [Mass/volume] in Air |
|
53644-1
|
Carbaryl [Presence] in Gastric fluid |
|
9688-3
|
Carbaryl [Mass/volume] in Serum or Plasma |
|
42861-5
|
Carbaryl [Presence] in Urine |
|
21138-3
|
Carbaryl [Mass/volume] in Urine |
|
87744-9
|
Carbaryl [Mass/mass] in Unspecified specimen |
|
4153-3
|
Carbenicillin [Mass] of Dose |
|
41668-5
|
Carbenicillin [Susceptibility] by Gradient strip |
|
61-2
|
Carbenicillin [Susceptibility] by Disk diffusion (KB) |
|
60-4
|
Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
59-6
|
Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3434-8
|
Carbenicillin [Mass/volume] in Serum or Plasma |
|
18873-0
|
Carbenicillin [Susceptibility] |
|
62-0
|
Carbenicillin [Susceptibility] by Serum bactericidal titer |
|
73485-5
|
Carbidopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73484-8
|
Carbidopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9328-6
|
Carbidopa [Mass/volume] in Serum or Plasma |
|
30517-7
|
Carbinoxamine [Mass/volume] in Serum or Plasma |
|
16549-8
|
Carbinoxamine [Presence] in Urine |
|
27282-3
|
Carbinoxamine [Mass/volume] in Urine |
|
9689-1
|
Carbofuran [Mass/volume] in Serum or Plasma |
|
42862-3
|
Carbofuran [Presence] in Urine |
|
21139-1
|
Carbofuran [Mass/volume] in Urine |
|
38321-6
|
Carbofuran [Mass/volume] in Water |
|
87656-5
|
Carbofuran [Mass/mass] in Unspecified specimen |
|
75296-4
|
Carbohydrate intake 24 hour Estimated |
|
81953-2
|
Carbohydrate intake 24 hour Measured |
|
59015-8
|
Carbohydrates [Mass/mass] in Stool by Infrared spectroscopy |
|
55221-6
|
Carbohydrates [Presence] in Stool |
|
16550-6
|
Carbohydrates [Identifier] in Urine |
|
34466-3
|
Carbohydrates [Presence] in Unspecified specimen |
|
38577-3
|
Carbon disulfide [Mass/volume] in Air |
|
29277-1
|
Carbon disulfide [Presence] in Blood |
|
29290-4
|
Carbon disulfide [Mass/volume] in Blood |
|
23836-0
|
Carbon disulfide [Mass/volume] in Serum or Plasma |
|
18205-5
|
Carbon disulfide [Presence] in Urine |
|
23835-2
|
Carbon disulfide [Mass/volume] in Urine |
|
43166-8
|
Carbon.organic [Mass/volume] in Unspecified specimen |
|
38578-1
|
Carbon tetrachloride [Mass/volume] in Air |
|
9332-8
|
Carbon tetrachloride [Mass/volume] in Blood |
|
54936-0
|
Carbon tetrachloride [Mass/volume] in Serum or Plasma |
|
38322-4
|
Carbon tetrachloride [Mass/volume] in Water |
|
2033-9
|
Carbonate [Mass/volume] in Arterial blood |
|
2034-7
|
Carbonate [Mass/volume] in Venous blood |
|
2036-2
|
Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells |
|
2035-4
|
Carbonate [Mass/volume] in Plasma |
|
14641-5
|
Carbonate [Presence] in Stone |
|
38652-4
|
Carbonyl sulfide [Mass/volume] in Air |
|
30024-4
|
Carbophenothion [Mass/volume] in Serum or Plasma |
|
21140-9
|
Carbophenothion [Mass/volume] in Urine |
|
9502-6
|
Carbophenothion [Mass/volume] in Unspecified specimen |
|
87745-6
|
Carbophenothion [Mass/mass] in Unspecified specimen |
|
53447-9
|
Carboxymefloquine [Mass/volume] in Serum or Plasma |
|
42492-9
|
Carboxy tetrahydrocannabinol [Presence] in Blood |
|
26995-1
|
Carboxy tetrahydrocannabinol [Mass/volume] in Blood |
|
19384-7
|
Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method |
|
19383-9
|
Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method |
|
61062-6
|
Carboxy tetrahydrocannabinol [Presence] in Gastric fluid |
|
29326-6
|
Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid |
|
69007-3
|
Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method |
|
57924-3
|
Carboxy tetrahydrocannabinol [Presence] in Meconium |
|
31136-5
|
Carboxy tetrahydrocannabinol [Mass/mass] in Meconium |
|
72764-4
|
Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74678-4
|
Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method |
|
47386-8
|
Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method |
|
26743-5
|
Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma |
|
49746-1
|
Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method |
|
16150-5
|
Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
|
26732-8
|
Carboxy tetrahydrocannabinol [Mass/mass] in Stool |
|
20521-1
|
Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
3435-5
|
Carboxy tetrahydrocannabinol [Presence] in Urine |
|
19382-1
|
Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
|
19381-3
|
Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method |
|
3436-3
|
Carboxy tetrahydrocannabinol [Mass/volume] in Urine |
|
27213-8
|
Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid |
|
61063-4
|
Carboxy tetrahydrocannabinol [Presence] in Unspecified specimen |
|
48944-3
|
Carboxy tetrahydrocannabinol [Mass/volume] in Unspecified specimen |
|
19055-3
|
Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
|
75651-0
|
Tetrahydrocannabivarin [Mass/volume] in Urine |
|
4154-1
|
Carbromal [Mass] of Dose |
|
60523-8
|
Carbromal [Mass/volume] in Serum or Plasma |
|
18160-2
|
Cardiac echo imaging device Class |
|
18067-9
|
Cardiac echo imaging device Image quality by US |
|
18176-8
|
Cardiac echo imaging device Vendor model number |
|
18177-6
|
Cardiac echo imaging device Vendor serial number |
|
85474-5
|
Cardiac implantable loop monitor study report |
|
78977-6
|
Cardiologist name Provider |
|
15279-3
|
Cardamon IgE Ab [Units/volume] in Serum |
|
21141-7
|
Cardamon IgE Ab RAST class [Presence] in Serum |
|
80986-3
|
Cardiac arrest within 24 hours prior to procedure |
|
77152-7
|
Cardiac arrest event outcome NEMSIS |
|
80243-9
|
Cardiac catheterization access site |
|
18745-0
|
Cardiac catheterization study |
|
88435-3
|
Cardiac compression start time |
|
18107-3
|
Cardiac echo study Procedure stress method |
|
18106-5
|
Cardiac echo study Procedure |
|
18159-4
|
Cardiac echo study Transducer site |
|
44970-2
|
Cardiac monitor interpretation Narrative |
|
78936-2
|
Cardiac procedure complication [Presence] |
|
78938-8
|
Cardiac procedure complication Narrative |
|
78937-0
|
Cardiac procedure complication Type |
|
18836-7
|
Cardiac stress study Procedure |
|
76645-1
|
Cardiac stress test EKG study Type |
|
89823-9
|
Cardiac surgery Team Conference note |
|
80574-7
|
Cardiac surgery Admission history and physical note |
|
80573-9
|
Cardiac surgery Checklist |
|
89798-3
|
Cardiac surgery Conference note |
|
80575-4
|
Cardiac surgery Consult note |
|
80576-2
|
Cardiac surgery Education note |
|
80572-1
|
Cardiac surgery Flowsheet |
|
82826-9
|
Cardiac surgery Initial evaluation note |
|
80579-6
|
Cardiac surgery Surgical operation note |
|
89824-7
|
Cardiac surgery Telephone encounter Note |
|
80789-1
|
Cardiac surgery Plan of care note |
|
80578-8
|
Cardiac surgery Preoperative evaluation and management note |
|
89822-1
|
Cardiac surgery procedure note |
|
80577-0
|
Cardiac surgery Referral note |
|
80580-4
|
Cardiac surgery Transfer summary note |
|
68484-5
|
Cardiology Attending Hospital Progress note |
|
83516-5
|
Cardiology Attending Intensive care unit Admission evaluation note |
|
83517-3
|
Cardiology Attending Intensive care unit Note |
|
83518-1
|
Cardiology Attending Note |
|
83519-9
|
Cardiology Attending Outpatient Note |
|
34135-4
|
Cardiology Attending Outpatient Supervisory note |
|
83520-7
|
Cardiology Case manager Note |
|
83527-2
|
Cardiology Fellow Note |
|
83528-0
|
Cardiology Fellow Outpatient Note |
|
68483-7
|
Cardiology Medical student Hospital Admission evaluation note |
|
68486-0
|
Cardiology Medical student Hospital Consult note |
|
68485-2
|
Cardiology Medical student Hospital Progress note |
|
83530-6
|
Cardiology Nurse practitioner Note |
|
83531-4
|
Cardiology Nurse Note |
|
83532-2
|
Cardiology Nurse Outpatient Note |
|
83533-0
|
Cardiology Nurse procedure note |
|
83538-9
|
Cardiology Resident Note |
|
78497-5
|
Cardiopulmonary Admission history and physical note |
|
78448-8
|
Cardiopulmonary Checklist |
|
78498-3
|
Cardiopulmonary Consult note |
|
78499-1
|
Cardiopulmonary Education note |
|
78500-6
|
Cardiopulmonary Flowsheet |
|
82828-5
|
Cardiopulmonary Initial evaluation note |
|
78501-4
|
Cardiopulmonary Referral note |
|
78502-2
|
Cardiopulmonary Transfer summary note |
|
80987-1
|
Cardiogenic shock within 24 hours prior to procedure |
|
3180-7
|
Cardiolipin Ab [Units/volume] in Serum by Immunoassay |
|
29860-4
|
Cardiolipin Ab [Presence] in Serum |
|
46125-1
|
Cardiolipin Ab [Presence] in Serum by Immunoassay |
|
8062-2
|
Cardiolipin Ab [Units/volume] in Serum |
|
42729-4
|
Cardiolipin IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42730-2
|
Cardiolipin IgA Ab B2GP1 independent [Multiple of the median] in Serum |
|
5076-5
|
Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay |
|
30470-9
|
Cardiolipin IgA Ab [Presence] in Serum |
|
43361-5
|
Cardiolipin IgA Ab [Mass/volume] in Serum |
|
8063-0
|
Cardiolipin IgA Ab [Units/volume] in Serum or Plasma |
|
20669-8
|
Cardiolipin IgA Ab [Titer] in Serum |
|
42731-0
|
Cardiolipin IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42732-8
|
Cardiolipin IgG Ab B2GP1 independent [Multiple of the median] in Serum |
|
55772-8
|
Cardiolipin IgG Ab [Multiple of the median] in Serum |
|
3181-5
|
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay |
|
27183-3
|
Cardiolipin IgG Ab [Presence] in Serum |
|
24385-7
|
Cardiolipin IgG Ab [Presence] in Serum by Immunoassay |
|
20424-8
|
Cardiolipin IgG Ab [Interpretation] in Serum |
|
43362-3
|
Cardiolipin IgG Ab [Mass/volume] in Serum |
|
8065-5
|
Cardiolipin IgG Ab [Units/volume] in Serum or Plasma |
|
20484-2
|
Cardiolipin IgG Ab [Titer] in Serum |
|
42733-6
|
Cardiolipin IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42734-4
|
Cardiolipin IgM Ab B2GP1 independent [Multiple of the median] in Serum |
|
55773-6
|
Cardiolipin IgM Ab [Multiple of the median] in Serum |
|
3182-3
|
Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay |
|
24386-5
|
Cardiolipin IgM Ab [Presence] in Serum by Immunoassay |
|
20425-5
|
Cardiolipin IgM Ab [Interpretation] in Serum |
|
43363-1
|
Cardiolipin IgM Ab [Mass/volume] in Serum |
|
8067-1
|
Cardiolipin IgM Ab [Units/volume] in Serum or Plasma |
|
20485-9
|
Cardiolipin IgM Ab [Titer] in Serum |
|
2040-4
|
Cardiolipin [Mass/volume] in Serum |
|
83521-5
|
Cardiology Clinical nurse specialist Note |
|
34099-2
|
Cardiology Consult note |
|
75425-9
|
Cardiology Diagnostic study note |
|
77408-3
|
Cardiology Discharge instructions |
|
77409-1
|
Cardiology Discharge summary |
|
77411-7
|
Cardiology Education note |
|
77437-2
|
Cardiology Flowsheet |
|
77412-5
|
Cardiology History and physical note |
|
68471-2
|
Cardiology Hospital Admission evaluation note |
|
34094-3
|
Cardiology Hospital Admission history and physical note |
|
77410-9
|
Cardiology Hospital Discharge teaching note |
|
68472-0
|
Cardiology Hospital Progress note |
|
83522-3
|
Cardiology Intensive care unit Admission evaluation note |
|
83523-1
|
Cardiology Intensive care unit Discharge summary |
|
83524-9
|
Cardiology Intensive care unit Note |
|
83525-6
|
Cardiology Intensive care unit procedure note |
|
83526-4
|
Cardiology Intensive care unit Transfer summary note |
|
77413-3
|
Cardiology Initial evaluation note |
|
34896-1
|
Cardiology Interventional procedure note |
|
34752-6
|
Cardiology Note |
|
83534-8
|
Cardiology Observation unit Note |
|
34753-4
|
Cardiology Outpatient Note |
|
34124-8
|
Cardiology Outpatient Progress note |
|
83535-5
|
Cardiology Surgical operation note |
|
83536-3
|
Cardiology Physician assistant Note |
|
83540-5
|
Cardiology Telephone encounter Note |
|
77442-2
|
Cardiology Plan of care note |
|
85938-9
|
Cardiology Postoperative evaluation and management note |
|
83537-1
|
Cardiology Preoperative evaluation and management note |
|
75426-7
|
Cardiology procedure note |
|
78710-1
|
Cardiology Progress note |
|
83529-8
|
Cardiology Patient's home Note |
|
57170-3
|
Cardiology Referral note |
|
83539-7
|
Cardiology Risk assessment and screening note |
|
86208-6
|
Cardiology Telehealth Note |
|
77414-1
|
Cardiology Transfer summary note |
|
83541-3
|
Cardiology Transplant candidate evaluation note |
|
84068-6
|
Cardiothoracic surgery Admission evaluation note |
|
78508-9
|
Cardiothoracic surgery Admission history and physical note |
|
83656-9
|
Cardiothoracic surgery Attending Admission evaluation note |
|
64073-0
|
Cardiothoracic surgery Attending Hospital Note |
|
68481-1
|
Cardiothoracic surgery Attending Hospital Progress note |
|
83657-7
|
Cardiothoracic surgery Attending Note |
|
78543-6
|
Cardiothoracic surgery Checklist |
|
34849-0
|
Cardiothoracic surgery Consult note |
|
78596-4
|
Cardiothoracic surgery Education note |
|
78626-9
|
Cardiothoracic surgery Flowsheet |
|
85850-6
|
Cardiothoracic surgery History and physical note |
|
64060-7
|
Cardiothoracic surgery Hospital Admission evaluation note |
|
64061-5
|
Cardiothoracic surgery Hospital Progress note |
|
82829-3
|
Cardiothoracic surgery Initial evaluation note |
|
64074-8
|
Cardiothoracic surgery Medical student Hospital Admission evaluation note |
|
64076-3
|
Cardiothoracic surgery Medical student Hospital Consult note |
|
64075-5
|
Cardiothoracic surgery Medical student Hospital Progress note |
|
85436-4
|
Cardiothoracic surgery Note |
|
34850-8
|
Cardiothoracic surgery Outpatient Note |
|
78679-8
|
Cardiothoracic surgery Surgical operation note |
|
85889-4
|
Cardiothoracic surgery Telephone encounter Note |
|
80749-5
|
Cardiothoracic surgery Plan of care note |
|
85853-0
|
Cardiothoracic surgery Postoperative evaluation and management note |
|
78730-9
|
Cardiothoracic surgery Preoperative evaluation and management note |
|
85854-8
|
Cardiothoracic surgery procedure note |
|
57167-9
|
Cardiothoracic surgery Referral note |
|
78681-4
|
Cardiothoracic surgery Transfer summary note |
|
85891-0
|
Cardiothoracic surgery Fellow Note |
|
85851-4
|
Cardiothoracic surgery Interdisciplinary Note |
|
85852-2
|
Cardiothoracic surgery Nurse Note |
|
85900-9
|
Cardiothoracic surgery Resident Note |
|
87212-7
|
Care area triggered [CMS Assessment] |
|
57124-0
|
Care capacity # [Estimate] |
|
91983-7
|
Care management note |
|
57125-7
|
Care provided # |
|
78022-1
|
Care setting Facility [NHCS] |
|
86744-0
|
Care team |
|
76440-7
|
Care transfer location APTA |
|
6060-8
|
Careless Weed IgE Ab [Units/volume] in Serum |
|
15603-4
|
Careless Weed IgE Ab RAST class [Presence] in Serum |
|
56205-8
|
Careless Weed IgG4 Ab [Mass/volume] in Serum |
|
32962-3
|
Caries risk Dentition |
|
78815-8
|
Carisoprodol [Mass/volume] in Blood by Confirmatory method |
|
4155-8
|
Carisoprodol [Mass] of Dose |
|
73483-0
|
Carisoprodol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73482-2
|
Carisoprodol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72761-0
|
Carisoprodol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
3437-1
|
Carisoprodol [Mass/volume] in Serum or Plasma |
|
58427-6
|
Carisoprodol [Mass/volume] in Urine by Confirmatory method |
|
21142-5
|
Carisoprodol [Presence] in Urine |
|
58426-8
|
Carisoprodol [Presence] in Urine by Confirmatory method |
|
10979-3
|
Carisoprodol [Mass/volume] in Urine |
|
57856-7
|
Carisoprodol [Moles/volume] in Unspecified specimen |
|
58371-6
|
Carisoprodol/Creatinine [Mass Ratio] in Urine |
|
78816-6
|
Carisoprodol+Meprobamate [Presence] in Blood by Confirmatory method |
|
79140-0
|
Carisoprodol+Meprobamate [Presence] in Blood by Screen method |
|
79256-4
|
Carisoprodol+Meprobamate cutoff [Mass/volume] in Urine for Screen method |
|
34666-8
|
Carisoprodol+Meprobamate [Mass/volume] in Serum or Plasma |
|
75228-7
|
Carisoprodol+Meprobamate [Mass/volume] in Urine by Confirmatory method |
|
58370-8
|
Carisoprodol+Meprobamate [Presence] in Urine by Screen method |
|
74672-7
|
Carisoprodol+Meprobamate [Mass/volume] in Urine |
|
10779-7
|
Microscopic observation [Identifier] in Tissue by Carmine stain.Best |
|
53624-3
|
Carnitine esters [Moles/volume] in DBS |
|
10876-1
|
Carnitine esters [Mass/volume] in Serum or Plasma |
|
19074-4
|
Carnitine esters [Moles/volume] in Serum or Plasma |
|
24450-9
|
Carnitine esters [Moles/mass] in Tissue |
|
26753-4
|
Carnitine esters [Units/volume] in Urine |
|
10875-3
|
Carnitine esters [Mass/volume] in Urine |
|
24449-1
|
Carnitine esters [Moles/volume] in Urine |
|
45192-2
|
Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS |
|
40869-0
|
Carnitine esters/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
54442-9
|
Carnitine esters/Carnitine.free (C0) [Molar ratio] in Urine |
|
14153-1
|
Carnitine esters/Creatinine [Mass Ratio] in Urine |
|
28589-0
|
Carnitine esters/Creatinine [Ratio] in Urine |
|
25141-3
|
Carnitine esters/Creatinine [Molar ratio] in Urine |
|
48430-3
|
Carnitine [Molar amount] in unspecified time Semen |
|
34257-6
|
Carnitine [Moles/volume] in 24 hour Urine |
|
24448-3
|
Carnitine [Moles/time] in 24 hour Urine |
|
2041-2
|
Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
|
34521-5
|
Carnitine acyltransferase [Enzymatic activity/mass] in Tissue |
|
16556-3
|
Carnitine [Mass/volume] in Amniotic fluid |
|
53053-5
|
Carnitine [Moles/volume] in Amniotic fluid |
|
79340-6
|
Carnitine biosynthesis intermediates pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79339-8
|
Carnitine biosynthesis intermediates pattern newborn screen interpretation |
|
79341-4
|
Carnitine biosynthesis intermediates pattern [Interpretation] in Serum or Plasma Narrative |
|
79342-2
|
Carnitine biosynthesis intermediates pattern [Interpretation] in Urine Narrative |
|
16555-5
|
Carnitine [Mass/volume] in Cerebral spinal fluid |
|
53071-7
|
Carnitine [Moles/volume] in Cerebral spinal fluid |
|
38480-0
|
Carnitine [Moles/volume] in DBS |
|
55200-0
|
Carnitine [Moles/volume] in Body fluid |
|
34258-4
|
Carnitine free (C0) [Moles/volume] in 24 hour Urine |
|
34259-2
|
Carnitine free (C0) [Moles/time] in 24 hour Urine |
|
53054-3
|
Carnitine free (C0) [Moles/volume] in Amniotic fluid |
|
53072-5
|
Carnitine free (C0) [Moles/volume] in Cerebral spinal fluid |
|
38481-8
|
Carnitine free (C0) [Moles/volume] in DBS |
|
74878-0
|
Carnitine free (C0) [Moles/volume] in DBS --post therapeutic diet |
|
2042-0
|
Carnitine free (C0) [Presence] in Serum or Plasma |
|
2043-8
|
Carnitine free (C0) [Mass/volume] in Serum or Plasma |
|
14286-9
|
Carnitine free (C0) [Moles/volume] in Serum or Plasma |
|
53112-9
|
Carnitine free (C0)/Carnitine.total in Amniotic fluid |
|
53096-4
|
Carnitine free (C0)/Carnitine.total in Cerebral spinal fluid |
|
53095-6
|
Carnitine free (C0)/Carnitine.total in DBS |
|
32281-8
|
Carnitine free (C0)/Carnitine.total in Serum or Plasma |
|
32613-2
|
Carnitine free (C0)/Carnitine.total in Urine |
|
69422-4
|
Carnitine free (C0) [Moles/volume] in Semen |
|
18363-2
|
Carnitine free (C0) [Units/mass] in Tissue |
|
24452-5
|
Carnitine free (C0) [Moles/mass] in Tissue |
|
26757-5
|
Carnitine free (C0) [Units/volume] in Urine |
|
10877-9
|
Carnitine free (C0) [Mass/volume] in Urine |
|
14285-1
|
Carnitine free (C0) [Moles/volume] in Urine |
|
53233-3
|
Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
53235-8
|
Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS |
|
59206-3
|
Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Serum or Plasma |
|
53234-1
|
Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS |
|
13718-2
|
Carnitine free (C0)/Creatinine [Mass Ratio] in Urine |
|
17867-3
|
Carnitine free (C0)/Creatinine [Ratio] in Urine |
|
22704-1
|
Carnitine free (C0)/Creatinine [Molar ratio] in Urine |
|
2045-3
|
Carnitine [Presence] in Serum or Plasma |
|
2046-1
|
Carnitine [Mass/volume] in Serum or Plasma |
|
14288-5
|
Carnitine [Moles/volume] in Serum or Plasma |
|
2044-6
|
Carnitine [Mass/volume] in Semen |
|
10561-9
|
Carnitine [Moles/volume] in Semen |
|
26788-0
|
Carnitine [Units/mass] in Tissue |
|
16553-0
|
Carnitine [Mass/mass] in Tissue |
|
24451-7
|
Carnitine [Moles/mass] in Tissue |
|
46774-6
|
Carnitine uptake deficiency newborn screen interpretation |
|
2047-9
|
Carnitine [Mass/volume] in Urine |
|
14287-7
|
Carnitine [Moles/volume] in Urine |
|
44710-2
|
Carnitine/Acylcarnitine [Molar ratio] in Serum or Plasma |
|
2048-7
|
Carnitine/Creatinine [Mass Ratio] in Serum or Plasma |
|
13719-0
|
Carnitine/Creatinine [Mass Ratio] in Urine |
|
17866-5
|
Carnitine/Creatinine [Ratio] in Urine |
|
22695-1
|
Carnitine/Creatinine [Molar ratio] in Urine |
|
12474-3
|
Carnosine [Mass/volume] in 24 hour Urine |
|
25874-9
|
Carnosine [Moles/volume] in 24 hour Urine |
|
25365-8
|
Carnosine [Moles/time] in 24 hour Urine |
|
13391-8
|
Carnosine [Mass/volume] in Amniotic fluid |
|
26750-0
|
Carnosine [Moles/volume] in Amniotic fluid |
|
53817-3
|
Carnosine [Presence] in Cerebral spinal fluid |
|
13369-4
|
Carnosine [Mass/volume] in Cerebral spinal fluid |
|
26591-8
|
Carnosine [Moles/volume] in Cerebral spinal fluid |
|
2049-5
|
Carnosine [Presence] in Serum or Plasma |
|
2050-3
|
Carnosine [Mass/volume] in Serum or Plasma |
|
26606-4
|
Carnosine [Moles/volume] in Serum or Plasma |
|
16557-1
|
Carnosine [Presence] in Urine |
|
2051-1
|
Carnosine [Mass/volume] in Urine |
|
27294-8
|
Carnosine [Moles/volume] in Urine |
|
44304-4
|
Carnosine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56675-2
|
Carnosine/Creatinine [Ratio] in 24 hour Urine |
|
25875-6
|
Carnosine/Creatinine [Molar ratio] in 24 hour Urine |
|
13720-8
|
Carnosine/Creatinine [Mass Ratio] in Urine |
|
28597-3
|
Carnosine/Creatinine [Ratio] in Urine |
|
26580-1
|
Carnosine/Creatinine [Molar ratio] in Urine |
|
7179-5
|
Carob IgE Ab [Units/volume] in Serum |
|
15604-2
|
Carob IgE Ab RAST class [Presence] in Serum |
|
2052-9
|
Carotene [Mass/volume] in Blood |
|
1370-6
|
Carotene [Mass/volume] in Serum --post 15000 U carotene QDx3 for 3 day poly |
|
2053-7
|
Carotene [Mass/volume] in Serum |
|
14642-3
|
Carotene [Moles/volume] in Serum |
|
66445-8
|
Carp recombinant (rCyp c) 1 IgE Ab [Units/volume] in Serum |
|
81985-4
|
Carp recombinant (rCyp c) 1 IgE Ab RAST class [Presence] in Serum |
|
21143-3
|
Carp IgE Ab [Units/volume] in Serum |
|
21144-1
|
Carp IgE Ab RAST class [Presence] in Serum |
|
66446-6
|
Carrot recombinant (rDau c) 1 IgE Ab [Units/volume] in Serum |
|
7181-1
|
Carrot triggered histamine release [Units/volume] in Blood |
|
6061-6
|
Carrot IgE Ab [Units/volume] in Serum |
|
15605-9
|
Carrot IgE Ab RAST class [Presence] in Serum |
|
42900-1
|
Carrot IgE Ab/IgE total in Serum |
|
7180-3
|
Carrot IgG Ab [Units/volume] in Serum |
|
21145-8
|
Carrot IgG Ab RAST class [Presence] in Serum |
|
56206-6
|
Carrot IgG4 Ab [Mass/volume] in Serum |
|
60360-5
|
Carrot IgG Ab [Mass/volume] in Serum |
|
48210-9
|
Carrot triggered leukotriene release [Mass/volume] by Leukocytes |
|
51694-8
|
Carumonam [Susceptibility] |
|
73481-4
|
Carvedilol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73480-6
|
Carvedilol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
24474-9
|
Cancer associated serum Ag [Units/volume] in Serum |
|
73479-8
|
Casanthranol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73478-0
|
Casanthranol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
77990-0
|
Case class status [CDC.PHIN] |
|
77979-3
|
Case investigation start date |
|
77980-1
|
Case is associated with a known outbreak |
|
85222-8
|
Case manager Consult note |
|
85172-5
|
Case manager Custodial care facility Note |
|
85223-6
|
Case manager Discharge summary |
|
64065-6
|
Case manager Hospital Initial evaluation note |
|
85224-4
|
Case manager Long term care facility Note |
|
46210-1
|
Case manager Note |
|
85225-1
|
Case manager Outpatient Note |
|
85227-7
|
Case manager Telephone encounter Note |
|
85228-5
|
Case manager Plan of care note |
|
34125-5
|
Case manager Patient's home Progress note |
|
85226-9
|
Case manager Referral note |
|
77999-1
|
Case notification comment |
|
77981-9
|
Case outbreak name |
|
75218-8
|
Case report |
|
18418-4
|
Casein IgA Ab [Units/volume] in Serum |
|
6062-4
|
Casein IgE Ab [Units/volume] in Serum |
|
15606-7
|
Casein IgE Ab RAST class [Presence] in Serum |
|
61241-6
|
Casein IgE Ab/IgE total in Serum |
|
51532-0
|
Casein IgG Ab [Presence] in Serum |
|
7182-9
|
Casein IgG Ab [Units/volume] in Serum |
|
21146-6
|
Casein IgG Ab RAST class [Presence] in Serum |
|
26415-0
|
Casein IgG4 Ab [Units/volume] in Serum |
|
26416-8
|
Casein IgG4 Ab RAST class [Presence] in Serum |
|
56207-4
|
Casein IgG4 Ab [Mass/volume] in Serum |
|
53829-8
|
Casein IgG Ab [Mass/volume] in Serum |
|
81019-2
|
Casein intake 24 hour Estimated |
|
81020-0
|
Casein intake 24 hour Measured |
|
48204-2
|
Casein triggered leukotriene release [Mass/volume] by Leukocytes |
|
91000-0
|
Cases [#] Reporting Period |
|
64962-4
|
Cashew nut recombinant (rAna o) 2 IgE Ab [Units/volume] in Serum |
|
82539-8
|
Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum |
|
82540-6
|
Cashew nut recombinant (rAna o) 3 IgE Ab RAST class [Presence] in Serum |
|
6718-1
|
Cashew nut IgE Ab [Units/volume] in Serum |
|
15607-5
|
Cashew nut IgE Ab RAST class [Presence] in Serum |
|
38437-0
|
Cashew nut IgE Ab/IgE total in Serum |
|
7183-7
|
Cashew nut IgG Ab [Units/volume] in Serum |
|
56208-2
|
Cashew nut IgG4 Ab [Mass/volume] in Serum |
|
63109-3
|
Cashew nut IgG Ab [Mass/volume] in Serum |
|
73477-2
|
Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73476-4
|
Caspofungin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
54185-4
|
Caspofungin [Susceptibility] by Gradient strip |
|
54175-5
|
Caspofungin [Susceptibility] by Disk diffusion (KB) |
|
54176-3
|
Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58419-3
|
Caspofungin [Mass/volume] in Serum or Plasma |
|
32378-2
|
Caspofungin [Susceptibility] |
|
90820-2
|
Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90821-0
|
Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82986-1
|
Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82979-6
|
Contactin-associated protein 2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
82534-9
|
CASR gene full mutation analysis in Blood or Tissue by Sequencing |
|
45190-6
|
CASR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41854-1
|
Castor Bean DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6063-2
|
Castor Bean IgE Ab [Units/volume] in Serum |
|
15562-2
|
Castor Bean IgE Ab RAST class [Presence] in Serum |
|
56209-0
|
Castor Bean IgG4 Ab [Mass/volume] in Serum |
|
63160-6
|
Castor Bean IgG Ab [Mass/volume] in Serum |
|
51483-6
|
Casts [#/volume] in Urine by Automated count |
|
43755-8
|
Casts [#/area] in Urine sediment by Automated count |
|
9439-1
|
Casts [#/area] in Urine sediment by Microscopy high power field |
|
9842-6
|
Casts [#/area] in Urine sediment by Microscopy low power field |
|
53323-2
|
Casts type not specified [#/volume] in Urine by Computer assisted method |
|
53335-6
|
Casts type not specified [#/area] in Urine by Computer assisted method |
|
53280-4
|
Casts type not specified [Presence] in Urine by Computer assisted method |
|
87827-2
|
Casts [Presence] in Urine |
|
53320-8
|
Casts [Presence] in Urine by Automated |
|
58436-7
|
Casts [Type] in Urine sediment by Light microscopy |
|
24124-0
|
Casts [Presence] in Urine sediment by Light microscopy |
|
91563-7
|
Casualties [#] Reporting Period |
|
64975-6
|
Cat recombinant (rFel d) 1 IgE Ab [Units/volume] in Serum |
|
81980-5
|
Cat recombinant (rFel d) 1 IgE Ab RAST class [Presence] in Serum |
|
64976-4
|
Cat recombinant (rFel d) 4 IgE Ab [Units/volume] in Serum |
|
81979-7
|
Cat recombinant (rFel d) 4 IgE Ab RAST class [Presence] in Serum |
|
78384-5
|
Cat dander native (nFel d) 1 IgE Ab [Units/volume] in Serum |
|
7185-2
|
Cat dander triggered histamine release [Units/volume] in Blood |
|
6833-8
|
Cat dander IgE Ab [Units/volume] in Serum |
|
15609-1
|
Cat dander IgE Ab RAST class [Presence] in Serum |
|
38255-6
|
Cat dander IgE Ab/IgE total in Serum |
|
7184-5
|
Cat dander IgG Ab [Units/volume] in Serum |
|
56210-8
|
Cat dander IgG4 Ab [Mass/volume] in Serum |
|
63076-4
|
Cat dander IgG Ab [Mass/volume] in Serum |
|
48230-7
|
Cat dander triggered leukotriene release [Mass/volume] by Leukocytes |
|
19732-7
|
Cat serum albumin IgE Ab [Units/volume] in Serum |
|
25585-1
|
Cat serum albumin IgE Ab RAST class [Presence] in Serum |
|
54368-6
|
Catalase [Enzymatic activity/volume] in Plasma |
|
2054-5
|
Catalase [Enzymatic activity/volume] in Red Blood Cells |
|
49221-5
|
Catalase [Enzymatic activity/mass] in Red Blood Cells |
|
55829-6
|
Catalase [Enzymatic activity/mass] in Tissue |
|
41114-0
|
CATCH22 syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34517-3
|
CATCH22 syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
36912-4
|
CATCH22 syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
38646-6
|
Catechol [Mass/volume] in Air |
|
75070-3
|
Catechol [Moles/volume] in Serum or Plasma |
|
75091-9
|
Catechol/Creatinine [Molar ratio] in Urine |
|
79392-7
|
Catecholamine metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79407-3
|
Catecholamine metabolites pattern [Interpretation] in Serum or Plasma Narrative |
|
75086-9
|
Catecholamine metabolites pattern [Interpretation] in Urine Narrative |
|
30487-3
|
Catecholamines [Mass/volume] in Plasma --1 hour post XXX challenge |
|
32161-2
|
Catecholamines [Presence] in 24 hour Urine |
|
32000-2
|
Catecholamines [Mass/volume] in 24 hour Urine |
|
2058-6
|
Catecholamines [Mass/time] in 24 hour Urine |
|
34260-0
|
Catecholamines [Moles/volume] in 24 hour Urine |
|
15036-7
|
Catecholamines [Moles/time] in 24 hour Urine |
|
16558-9
|
Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge |
|
16559-7
|
Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge |
|
27971-1
|
Catecholamines [Mass/volume] in Plasma --4 hours post XXX challenge |
|
38446-1
|
Catecholamines [Mass/time] in 72 hour Urine |
|
2055-2
|
Catecholamines [Mass/volume] in Blood |
|
30486-5
|
Catecholamines [Mass/volume] in Plasma --baseline |
|
55830-4
|
Catecholamines [Moles/volume] in Cerebral spinal fluid |
|
55831-2
|
Catecholamines [Moles/volume] in Body fluid |
|
44838-1
|
Catecholamines [Interpretation] in Plasma |
|
49257-9
|
Catecholamines [Interpretation] in Plasma Narrative |
|
2056-0
|
Catecholamines [Mass/volume] in Plasma |
|
59787-2
|
Catecholamines [Moles/volume] in Plasma |
|
12522-9
|
Catecholamines [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
12516-1
|
Catecholamines [Mass/volume] in Urine --2nd specimen post XXX challenge |
|
12523-7
|
Catecholamines [Mass/volume] in Plasma --3rd specimen post XXX challenge |
|
12517-9
|
Catecholamines [Mass/volume] in Urine --3rd specimen post XXX challenge |
|
12524-5
|
Catecholamines [Mass/volume] in Plasma --4th specimen post XXX challenge |
|
12518-7
|
Catecholamines [Mass/volume] in Urine --4th specimen post XXX challenge |
|
16560-5
|
Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge |
|
12519-5
|
Catecholamines [Mass/volume] in Urine --5th specimen post XXX challenge |
|
16561-3
|
Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge |
|
12520-3
|
Catecholamines [Mass/volume] in Urine --6th specimen post XXX challenge |
|
18206-3
|
Catecholamines [Mass/volume] in Plasma --7th specimen post XXX challenge |
|
47173-0
|
Catecholamines [Moles/volume] in Plasma --7th specimen post XXX challenge |
|
12521-1
|
Catecholamines [Mass/volume] in Urine --7th specimen post XXX challenge |
|
44078-4
|
Catecholamines [Interpretation] in Urine |
|
49256-1
|
Catecholamines [Interpretation] in Urine Narrative |
|
2057-8
|
Catecholamines [Mass/volume] in Urine |
|
34261-8
|
Catecholamines [Moles/volume] in Urine |
|
43247-6
|
Catecholamines/Creatinine [Mass Ratio] in 24 hour Urine |
|
9641-2
|
Catecholamines/Creatinine [Mass Ratio] in Urine |
|
34262-6
|
Catecholamines/Creatinine [Molar ratio] in Urine |
|
74552-1
|
Categories associated with patient safety event or unsafe condition [AHRQ] |
|
7188-6
|
Catfish triggered histamine release [Units/volume] in Blood |
|
7187-8
|
Catfish IgE Ab [Units/volume] in Serum |
|
15611-7
|
Catfish IgE Ab RAST class [Presence] in Serum |
|
33283-3
|
Catfish IgG Ab RAST class [Presence] in Serum |
|
56211-6
|
Catfish IgG4 Ab [Mass/volume] in Serum |
|
63143-2
|
Catfish IgG Ab [Mass/volume] in Serum |
|
78978-4
|
Catheterization device Guiding catheter product name |
|
78945-3
|
Catheterization device Guiding catheter size |
|
78979-2
|
Catheterization device Guide wire product name |
|
16562-1
|
Cathartic laxatives [Identifier] in Urine |
|
78958-6
|
Cathepsin A [Enzymatic activity/mass] in Leukocytes |
|
16563-9
|
Cathepsin D in Serum or Plasma |
|
30080-6
|
Cathepsin D [Presence] in Tissue by Immune stain |
|
9794-9
|
Cathepsin D [Moles/mass] in Tissue |
|
63215-8
|
Cathepsin G Ab [Units/volume] in Serum by Immunoassay |
|
54016-1
|
Cathepsin G Ab [Presence] in Serum |
|
55832-0
|
Cathepsin K [Moles/volume] in Serum or Plasma |
|
55833-8
|
Cathepsin L [Mass/volume] in Serum or Plasma |
|
55834-6
|
Cathepsin S [Mass/volume] in Serum or Plasma |
|
3440-5
|
Cathine [Mass/time] in 24 hour Urine |
|
4156-6
|
Cathine [Mass] of Dose |
|
43933-1
|
Cathine [Mass/mass] in Meconium |
|
59724-5
|
Cathine [Mass/volume] in Serum or Plasma |
|
3438-9
|
Cathine [Presence] in Urine |
|
3439-7
|
Cathine [Mass/volume] in Urine |
|
78817-4
|
Cathinone [Mass/volume] in Urine by Confirmatory method |
|
79141-8
|
Cathinone [Presence] in Urine by Screen method |
|
7189-4
|
Cattail IgE Ab [Units/volume] in Serum |
|
7191-0
|
Cauliflower triggered histamine release [Units/volume] in Blood |
|
6835-3
|
Cauliflower IgE Ab [Units/volume] in Serum |
|
15612-5
|
Cauliflower IgE Ab RAST class [Presence] in Serum |
|
61232-5
|
Cauliflower IgE Ab/IgE total in Serum |
|
7190-2
|
Cauliflower IgG Ab [Units/volume] in Serum |
|
21147-4
|
Cauliflower IgG Ab RAST class [Presence] in Serum |
|
56212-4
|
Cauliflower IgG4 Ab [Mass/volume] in Serum |
|
60361-3
|
Cauliflower IgG Ab [Mass/volume] in Serum |
|
79378-6
|
Cause of death |
|
80356-9
|
Cause of death entity axis code [Automated] |
|
80357-7
|
Cause of death record axis code [Automated] |
|
82791-5
|
Cause of death sequence |
|
80358-5
|
Cause of death.underlying [Automated] |
|
80359-3
|
Cause of death.underlying [Manual] |
|
86802-6
|
Cause of death and related information Document |
|
91094-3
|
Cause of fatalities Narrative |
|
44782-1
|
Cause of graft failure |
|
94075-9
|
Cause of sick feeling |
|
22168-9
|
Chicken anemia virus Ab [Presence] in Serum |
|
20751-4
|
Chicken anemia virus Ab [Presence] in Serum by Immunoassay |
|
43325-0
|
Chicken anemia virus Ab [Presence] in Serum by Immunofluorescence |
|
20750-6
|
Chicken anemia virus Ab [Presence] in Serum by Neutralization test |
|
55296-8
|
CAV3 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
77195-6
|
Cardio-ankle vascular index Calculated |
|
50675-8
|
Calcium-phosphorus product [(Mass/volume)*2] in Serum or Plasma |
|
13454-4
|
Calcium-phosphorus product [(Moles/volume)*2] in Serum or Plasma |
|
11188-0
|
Cayenne IgE Ab [Units/volume] in Serum |
|
15926-9
|
Cayenne IgE Ab RAST class [Presence] in Serum |
|
7590-3
|
Cayenne IgG Ab [Units/volume] in Serum |
|
21450-2
|
Cayenne IgG Ab RAST class [Presence] in Serum |
|
63082-2
|
Cayenne IgG Ab [Mass/volume] in Serum |
|
50979-4
|
CBir1 Ab [Units/volume] in Serum by Immunoassay |
|
40872-4
|
CBS gene c.833T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40873-2
|
CBS gene c.919G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
82223-9
|
Cystathionine beta synthase [Enzymatic activity/mass] in Fibroblast |
|
21646-5
|
CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21649-9
|
CBS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
20566-6
|
Colony count [#/volume] in Catheter tip by Culture |
|
30121-8
|
Colony count [#/volume] in Dialysis fluid |
|
77344-0
|
Colony count [#/volume] in Implanted device by Culture |
|
20773-8
|
Colony count [#/volume] in Milk by Culture Standard Plate Count |
|
19090-0
|
Colony count [#/volume] in Urine |
|
49223-1
|
Colony count [#/volume] in Unspecified specimen by Visual count |
|
19091-8
|
Colony count [#] in Urine by Visual count |
|
38436-2
|
Colony count [#/mass] in Unspecified specimen by Visual count |
|
565-2
|
Colony count [#] in Unspecified specimen Qualitative by Visual count |
|
564-5
|
Colony count [#] in Unspecified specimen by Visual count |
|
20774-6
|
Colony count [Units/volume] in Unspecified specimen by Visual count |
|
20775-3
|
Colony count [Units/volume] in Unspecified specimen by Viability count FDA method |
|
74518-2
|
Clara cell protein 16 [Mass/volume] in Serum |
|
73700-7
|
CCHD newborn screening interpretation |
|
73697-5
|
CCHD newborn screening protocol used [Type] |
|
73698-3
|
Reason CCHD oxygen saturation screening not performed |
|
2081-8
|
Cholecystokinin [Mass/volume] in Plasma |
|
81786-6
|
Chemokine (C-C motif) ligand 17 [Mass/volume] in Serum by Immunoassay |
|
74512-5
|
Chemokine (C-C motif) ligand 18 [Mass/volume] in Serum |
|
77415-8
|
Critical care medicine Admission history and physical note |
|
64069-8
|
Critical care medicine Attending Hospital Note |
|
68473-8
|
Critical care medicine Attending Hospital Progress note |
|
78496-7
|
Critical care medicine Consult note |
|
77416-6
|
Critical care medicine Discharge instructions |
|
77417-4
|
Critical care medicine Discharge summary |
|
77418-2
|
Critical care medicine Discharge teaching note |
|
77419-0
|
Critical care medicine Education note |
|
77440-6
|
Critical care medicine Flowsheet |
|
77420-8
|
Critical care medicine History and physical note |
|
64058-1
|
Critical care medicine Hospital Admission evaluation note |
|
64059-9
|
Critical care medicine Hospital Progress note |
|
77421-6
|
Critical care medicine Initial evaluation note |
|
64070-6
|
Critical care medicine Medical student Hospital Admission evaluation note |
|
64072-2
|
Critical care medicine Medical student Hospital Consult note |
|
64071-4
|
Critical care medicine Medical student Hospital Progress note |
|
34754-2
|
Critical care medicine Note |
|
78380-3
|
Critical care medicine Surgical operation note |
|
77445-5
|
Critical care medicine Plan of care note |
|
77422-4
|
Critical care medicine procedure note |
|
57178-6
|
Critical care medicine Referral note |
|
34755-9
|
Critical care medicine Transfer summary note |
|
78209-4
|
CCND1 gene duplication [Interpretation] in Blood or Tissue by FISH Narrative |
|
78204-5
|
CCND1 gene duplication [Presence] in Blood or Tissue by FISH |
|
42780-7
|
CCND1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21744-8
|
CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
32218-0
|
Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay |
|
53028-7
|
Cyclic citrullinated peptide Ab [Presence] in Serum |
|
53027-9
|
Cyclic citrullinated peptide Ab [Units/volume] in Serum |
|
82576-0
|
Cyclic citrullinated peptide IgA Ab [Units/volume] in Serum or Plasma |
|
63375-0
|
Cyclic citrullinated peptide IgA+IgG Ab [Presence] in Serum |
|
57093-7
|
Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
63217-4
|
Cyclic citrullinated peptide IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
42898-7
|
Cyclic citrullinated peptide IgG Ab [Presence] in Serum |
|
33935-8
|
Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma |
|
70246-4
|
CCR2 gene p.Val64Ile [Presence] in Blood or Tissue by Molecular genetics method |
|
70247-2
|
CCR5 gene c.794_825del [Presence] in Blood or Tissue by Molecular genetics method |
|
21207-6
|
CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
|
21651-5
|
CCR5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
31283-5
|
Canine coronavirus Ab [Presence] in Serum |
|
23687-7
|
Canine coronavirus Ab [Presence] in Serum by Immunofluorescence |
|
23688-5
|
Canine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
|
49463-3
|
CD1 Ag [Presence] in Tissue by Immune stain |
|
51016-4
|
CD1 blasts [Units/volume] in Blood |
|
51181-6
|
CD1 blasts [Units/volume] in Bone marrow |
|
51014-9
|
CD1 blasts/100 blasts in Blood |
|
51013-1
|
CD1 blasts/100 blasts in Bone marrow |
|
51015-6
|
CD1 blasts/100 blasts in Unspecified specimen |
|
51017-2
|
CD1 blasts [Units/volume] in Unspecified specimen |
|
21010-4
|
CD1 cells [#/volume] in Blood |
|
8106-7
|
CD1 cells/100 cells in Blood |
|
20586-4
|
CD1 cells/100 cells in Unspecified specimen |
|
14961-7
|
CD10 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
40551-4
|
CD10 Ag [Presence] in Tissue by Immune stain |
|
51020-6
|
CD10 blasts [Units/volume] in Blood |
|
51182-4
|
CD10 blasts [Units/volume] in Bone marrow |
|
13837-0
|
CD10 blasts/100 blasts in Blood |
|
51018-0
|
CD10 blasts/100 blasts in Bone marrow |
|
51019-8
|
CD10 blasts/100 blasts in Unspecified specimen |
|
51021-4
|
CD10 blasts [Units/volume] in Unspecified specimen |
|
9554-7
|
CD10 cells [#/volume] in Blood |
|
8107-5
|
CD10 cells/100 cells in Blood |
|
51215-2
|
CD10 cells/100 cells in Cerebral spinal fluid |
|
51217-8
|
CD10 cells/100 cells in Body fluid |
|
51216-0
|
CD10 cells/100 cells in Bone marrow |
|
51214-5
|
CD10 cells/100 cells in Tissue |
|
20587-2
|
CD10 cells/100 cells in Unspecified specimen |
|
60435-5
|
CD10+CD19+ cells [#/volume] in Blood |
|
32502-7
|
CD10+CD19+ cells/100 cells in Blood |
|
51218-6
|
CD10+CD19+ cells/100 cells in Cerebral spinal fluid |
|
51219-4
|
CD10+CD19+ cells/100 cells in Body fluid |
|
32500-1
|
CD10+CD19+ cells/100 cells in Bone marrow |
|
32501-9
|
CD10+CD19+ cells/100 cells in Tissue |
|
32521-7
|
CD10+CD19+ cells/100 cells in Unspecified specimen |
|
33596-8
|
CD10+CD20+ cells [#/volume] in Blood |
|
17097-7
|
CD10+CD20+ cells/100 cells in Blood |
|
42608-0
|
CD10+CD20+ cells/100 cells in Bone marrow |
|
34151-1
|
CD10+CD25+ cells [#/volume] in Blood |
|
57427-7
|
CD10+FMC7+ cells/100 cells in Body fluid |
|
33592-7
|
CD10+HLA-DR+ cells [#/volume] in Blood |
|
17098-5
|
CD100 cells/100 cells in Blood |
|
17099-3
|
CD102 cells/100 cells in Blood |
|
17100-9
|
CD103 cells/100 cells in Blood |
|
51220-2
|
CD103 cells/100 cells in Cerebral spinal fluid |
|
42864-9
|
CD103 cells/100 cells in Body fluid |
|
51221-0
|
CD103 cells/100 cells in Bone marrow |
|
40861-7
|
CD103 cells/100 cells in Tissue |
|
26556-1
|
CD103 cells/100 cells in Unspecified specimen |
|
17101-7
|
CD104 cells/100 cells in Blood |
|
17102-5
|
CD105 cells/100 cells in Blood |
|
51223-6
|
CD105 cells/100 cells in Cerebral spinal fluid |
|
51225-1
|
CD105 cells/100 cells in Body fluid |
|
51224-4
|
CD105 cells/100 cells in Bone marrow |
|
51222-8
|
CD105 cells/100 cells in Tissue |
|
17103-3
|
CD106 cells/100 cells in Blood |
|
17104-1
|
CD107a cells/100 cells in Blood |
|
17105-8
|
CD107b cells/100 cells in Blood |
|
18283-2
|
CD11 cells/100 cells in Blood |
|
34634-6
|
CD11+CD18+ cells [#/volume] in Leukocytes |
|
42930-8
|
CD11+CD18+ cells [Presence] in Blood |
|
9840-0
|
CD11+CD20+ cells [#/volume] in Leukocytes |
|
17106-6
|
CD115 cells/100 cells in Blood |
|
51184-0
|
CD117 Ag [Presence] in Blood by Immune stain |
|
51183-2
|
CD117 Ag [Presence] in Bone marrow by Immune stain |
|
40552-2
|
CD117 Ag [Presence] in Tissue by Immune stain |
|
51185-7
|
CD117 Ag [Presence] in Unspecified specimen by Immune stain |
|
51029-7
|
CD117 blasts [Units/volume] in Blood |
|
51028-9
|
CD117 blasts [Units/volume] in Bone marrow |
|
51026-3
|
CD117 blasts/100 blasts in Blood |
|
51025-5
|
CD117 blasts/100 blasts in Bone marrow |
|
51027-1
|
CD117 blasts/100 blasts in Unspecified specimen |
|
51030-5
|
CD117 blasts [Units/volume] in Unspecified specimen |
|
51443-0
|
CD117 cells [Units/volume] in Blood |
|
17107-4
|
CD117 cells/100 cells in Blood |
|
51226-9
|
CD117 cells/100 cells in Cerebral spinal fluid |
|
42867-2
|
CD117 cells/100 cells in Body fluid |
|
42866-4
|
CD117 cells/100 cells in Bone marrow |
|
42865-6
|
CD117 cells/100 cells in Tissue |
|
32742-9
|
CD117 cells/100 cells in Unspecified specimen |
|
17108-2
|
CD118 cells/100 cells in Blood |
|
51035-4
|
CD11a blasts [Units/volume] in Blood |
|
51034-7
|
CD11a blasts [Units/volume] in Bone marrow |
|
51032-1
|
CD11a blasts/100 blasts in Blood |
|
51031-3
|
CD11a blasts/100 blasts in Bone marrow |
|
51033-9
|
CD11a blasts/100 blasts in Unspecified specimen |
|
51036-2
|
CD11a blasts [Units/volume] in Unspecified specimen |
|
17109-0
|
CD11a cells/100 cells in Blood |
|
57393-1
|
CD11a cells/100 cells in Body fluid |
|
77944-7
|
CD11a cells/100 cells in Unspecified specimen |
|
51038-8
|
CD11b blasts/100 blasts in Blood |
|
51037-0
|
CD11b blasts/100 blasts in Bone marrow |
|
51039-6
|
CD11b blasts/100 blasts in Unspecified specimen |
|
29341-5
|
CD11b cells [#/volume] in Blood |
|
17110-8
|
CD11b cells/100 cells in Blood |
|
51228-5
|
CD11b cells/100 cells in Cerebral spinal fluid |
|
51230-1
|
CD11b cells/100 cells in Body fluid |
|
51229-3
|
CD11b cells/100 cells in Bone marrow |
|
51227-7
|
CD11b cells/100 cells in Tissue |
|
32758-5
|
CD11b cells/100 cells in Unspecified specimen |
|
38510-4
|
CD11b+CD11c+ cells/100 cells in Unspecified specimen |
|
26557-9
|
CD11b+CD56+ cells/100 cells in Unspecified specimen |
|
38231-7
|
CD11b+HLA-DR+ cells/100 cells in Blood |
|
10445-5
|
CD11c Ag [Presence] in Tissue by Immune stain |
|
51041-2
|
CD11c blasts/100 blasts in Blood |
|
51040-4
|
CD11c blasts/100 blasts in Bone marrow |
|
51042-0
|
CD11c blasts/100 blasts in Unspecified specimen |
|
9555-4
|
CD11c cells [#/volume] in Blood |
|
8109-1
|
CD11c cells/100 cells in Blood |
|
51231-9
|
CD11c cells/100 cells in Cerebral spinal fluid |
|
51232-7
|
CD11c cells/100 cells in Body fluid |
|
33202-3
|
CD11c cells/100 cells in Bone marrow |
|
33201-5
|
CD11c cells/100 cells in Tissue |
|
21154-0
|
CD11c cells/100 cells in Unspecified specimen |
|
59145-3
|
CD11c+CD103+ cells [#/volume] in Blood |
|
59136-2
|
CD11c+CD103+ cells/100 cells in Bone marrow |
|
51234-3
|
CD11c+CD19+ cells/100 cells in Blood |
|
51233-5
|
CD11c+CD19+ cells/100 cells in Cerebral spinal fluid |
|
40888-0
|
CD11c+CD19+ cells/100 cells in Body fluid |
|
42868-0
|
CD11c+CD19+ cells/100 cells in Bone marrow |
|
40887-2
|
CD11c+CD19+ cells/100 cells in Tissue |
|
47022-9
|
CD11c+CD19+ cells/100 cells in Unspecified specimen |
|
8108-3
|
CD11c+CD20+ cells/100 cells in Blood |
|
59146-1
|
CD11c+CD25+ cells [#/volume] in Blood |
|
26558-7
|
CD11c+CD25+ cells/100 cells in Unspecified specimen |
|
59141-2
|
CD11c-CD103+ cells/100 cells in Blood |
|
31129-0
|
CD11c-CD20+ cells [#/volume] in Blood |
|
31128-2
|
CD11c-CD20+ cells/100 cells in Blood |
|
59142-0
|
CD11c-CD25+ cells/100 cells in Blood |
|
17111-6
|
CD12 cells/100 cells in Blood |
|
17112-4
|
CD120A cells/100 cells in Blood |
|
17113-2
|
CD120B cells/100 cells in Blood |
|
29633-5
|
CD122 Ag [Presence] in Tissue by Immune stain |
|
46968-4
|
CD122 cells [#/volume] in Blood |
|
17114-0
|
CD122 cells/100 cells in Blood |
|
49473-2
|
CD123 Ag [Presence] in Tissue by Immune stain |
|
51047-9
|
CD123 blasts [Units/volume] in Blood |
|
51046-1
|
CD123 blasts [Units/volume] in Bone marrow |
|
51044-6
|
CD123 blasts/100 blasts in Blood |
|
51043-8
|
CD123 blasts/100 blasts in Bone marrow |
|
51045-3
|
CD123 blasts/100 blasts in Unspecified specimen |
|
51048-7
|
CD123 blasts [Units/volume] in Unspecified specimen |
|
51053-7
|
CD126 blasts [Units/volume] in Blood |
|
51052-9
|
CD126 blasts [Units/volume] in Bone marrow |
|
51050-3
|
CD126 blasts/100 blasts in Blood |
|
51049-5
|
CD126 blasts/100 blasts in Bone marrow |
|
51051-1
|
CD126 blasts/100 blasts in Unspecified specimen |
|
51054-5
|
CD126 blasts [Units/volume] in Unspecified specimen |
|
17115-7
|
CD126 cells/100 cells in Blood |
|
51059-4
|
CD127 blasts [Units/volume] in Blood |
|
51058-6
|
CD127 blasts [Units/volume] in Bone marrow |
|
51056-0
|
CD127 blasts/100 blasts in Blood |
|
51055-2
|
CD127 blasts/100 blasts in Bone marrow |
|
51057-8
|
CD127 blasts/100 blasts in Unspecified specimen |
|
51060-2
|
CD127 blasts [Units/volume] in Unspecified specimen |
|
17116-5
|
CD128 cells/100 cells in Blood |
|
14962-5
|
CD13 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
49464-1
|
CD13 Ag [Presence] in Tissue by Immune stain |
|
51067-7
|
CD13 blasts [Units/volume] in Blood |
|
51066-9
|
CD13 blasts [Units/volume] in Bone marrow |
|
13838-8
|
CD13 blasts/100 blasts in Blood |
|
51064-4
|
CD13 blasts/100 blasts in Bone marrow |
|
51065-1
|
CD13 blasts/100 blasts in Unspecified specimen |
|
51068-5
|
CD13 blasts [Units/volume] in Unspecified specimen |
|
21011-2
|
CD13 cells [#/volume] in Blood |
|
8110-9
|
CD13 cells/100 cells in Blood |
|
51236-8
|
CD13 cells/100 cells in Cerebral spinal fluid |
|
51238-4
|
CD13 cells/100 cells in Body fluid |
|
51237-6
|
CD13 cells/100 cells in Bone marrow |
|
51235-0
|
CD13 cells/100 cells in Tissue |
|
20588-0
|
CD13 cells/100 cells in Unspecified specimen |
|
38232-5
|
CD13+CD16+ cells/100 cells in Blood |
|
33582-8
|
CD13+CD33+ cells [#/volume] in Blood |
|
32503-5
|
CD13+CD33+ cells/100 cells in Blood |
|
51239-2
|
CD13+CD33+ cells/100 cells in Cerebral spinal fluid |
|
51240-0
|
CD13+CD33+ cells/100 cells in Body fluid |
|
32504-3
|
CD13+CD33+ cells/100 cells in Bone marrow |
|
32505-0
|
CD13+CD33+ cells/100 cells in Tissue |
|
32522-5
|
CD13+CD33+ cells/100 cells in Unspecified specimen |
|
51245-9
|
CD13+CD33+HLA-DR+ cells/100 cells in Blood |
|
51242-6
|
CD13+CD33+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
|
51244-2
|
CD13+CD33+HLA-DR+ cells/100 cells in Body fluid |
|
51243-4
|
CD13+CD33+HLA-DR+ cells/100 cells in Bone marrow |
|
51241-8
|
CD13+CD33+HLA-DR+ cells/100 cells in Tissue |
|
59140-4
|
CD13+CD34+ cells/100 cells in Bone marrow |
|
42622-1
|
CD13+CD56+ cells/100 cells in Bone marrow |
|
56890-7
|
CD13+HLA-DR+ cells/100 cells in Aspirate |
|
56892-3
|
CD13+HLA-DR+ cells/100 cells in Blood |
|
56894-9
|
CD13+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
|
56893-1
|
CD13+HLA-DR+ cells/100 cells in Body fluid |
|
56895-6
|
CD13+HLA-DR+ cells/100 cells in Bone marrow |
|
56889-9
|
CD13+HLA-DR+ cells/100 cells in Tissue |
|
56891-5
|
CD13+HLA-DR+ cells/100 cells in Unspecified specimen |
|
51073-5
|
CD135 blasts [Units/volume] in Blood |
|
51072-7
|
CD135 blasts [Units/volume] in Bone marrow |
|
51070-1
|
CD135 blasts/100 blasts in Blood |
|
51069-3
|
CD135 blasts/100 blasts in Bone marrow |
|
51071-9
|
CD135 blasts/100 blasts in Unspecified specimen |
|
51074-3
|
CD135 blasts [Units/volume] in Unspecified specimen |
|
50309-4
|
CD138 Ag [Presence] in Tissue by Immune stain |
|
50972-9
|
CD138 cells [#/volume] in Blood |
|
42869-8
|
CD138 cells/100 cells in Blood |
|
51246-7
|
CD138 cells/100 cells in Cerebral spinal fluid |
|
42871-4
|
CD138 cells/100 cells in Body fluid |
|
42870-6
|
CD138 cells/100 cells in Bone marrow |
|
42872-2
|
CD138 cells/100 cells in Tissue |
|
32743-7
|
CD138 cells/100 cells in Unspecified specimen |
|
55365-1
|
CD138+Kappa+ Cells/100 cells in Blood |
|
55366-9
|
CD138+Lambda+ Cells/100 cells in Blood |
|
14963-3
|
CD14 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
49465-8
|
CD14 Ag [Presence] in Tissue by Immune stain |
|
51078-4
|
CD14 blasts [Units/volume] in Blood |
|
51077-6
|
CD14 blasts [Units/volume] in Bone marrow |
|
13839-6
|
CD14 blasts/100 blasts in Blood |
|
51075-0
|
CD14 blasts/100 blasts in Bone marrow |
|
51076-8
|
CD14 blasts/100 blasts in Unspecified specimen |
|
51079-2
|
CD14 blasts [Units/volume] in Unspecified specimen |
|
27011-6
|
CD14 cells [#/volume] in Blood |
|
32772-6
|
CD14 cells [Presence] in Blood |
|
8111-7
|
CD14 cells/100 cells in Blood |
|
51247-5
|
CD14 cells/100 cells in Cerebral spinal fluid |
|
51248-3
|
CD14 cells/100 cells in Body fluid |
|
32507-6
|
CD14 cells/100 cells in Bone marrow |
|
32506-8
|
CD14 cells/100 cells in Tissue |
|
20589-8
|
CD14 cells/100 cells in Unspecified specimen |
|
27876-2
|
CD14+CD11b+ cells/100 cells in Blood |
|
24468-1
|
CD14+CD16+CD59+ cells [Presence] in Serum |
|
27878-8
|
CD14+HLA-DR+ cells/100 cells in Blood |
|
90736-0
|
CD14-FLAER- cells/100 cells.CD33 in Blood |
|
51187-3
|
CD15 Ag [Presence] in Blood by Immune stain |
|
51186-5
|
CD15 Ag [Presence] in Bone marrow by Immune stain |
|
10436-4
|
CD15 Ag [Presence] in Tissue by Immune stain |
|
51188-1
|
CD15 Ag [Presence] in Unspecified specimen by Immune stain |
|
51084-2
|
CD15 blasts [Units/volume] in Blood |
|
51083-4
|
CD15 blasts [Units/volume] in Bone marrow |
|
51081-8
|
CD15 blasts/100 blasts in Blood |
|
51080-0
|
CD15 blasts/100 blasts in Bone marrow |
|
51082-6
|
CD15 blasts/100 blasts in Unspecified specimen |
|
51085-9
|
CD15 blasts [Units/volume] in Unspecified specimen |
|
21012-0
|
CD15 cells [#/volume] in Blood |
|
50783-0
|
CD15 cells actual/normal in Blood |
|
17117-3
|
CD15 cells/100 cells in Blood |
|
51250-9
|
CD15 cells/100 cells in Cerebral spinal fluid |
|
51252-5
|
CD15 cells/100 cells in Body fluid |
|
51251-7
|
CD15 cells/100 cells in Bone marrow |
|
51249-1
|
CD15 cells/100 cells in Tissue |
|
20590-6
|
CD15 cells/100 cells in Unspecified specimen |
|
57736-1
|
CD154 cells/100 cells in Body fluid |
|
35653-5
|
CD158 cells [#/volume] in Blood |
|
38894-2
|
CD158 cells [#/volume] in Unspecified specimen |
|
73975-5
|
CD158a cells/100 cells in Unspecified specimen |
|
73976-3
|
CD158b cells/100 cells in Unspecified specimen |
|
10437-2
|
CD16 Ag [Presence] in Tissue by Immune stain |
|
51087-5
|
CD16 blasts/100 blasts in Blood |
|
51086-7
|
CD16 blasts/100 blasts in Bone marrow |
|
51088-3
|
CD16 blasts/100 blasts in Unspecified specimen |
|
26571-0
|
CD16 cells [#/volume] in Blood |
|
50784-8
|
CD16 cells actual/normal in Blood |
|
8115-8
|
CD16 cells/100 cells in Blood |
|
17828-5
|
CD16 cells/100 cells in Body fluid |
|
26560-3
|
CD16 cells/100 cells in Unspecified specimen |
|
20402-4
|
CD16+CD56+ cells [#/volume] in Blood |
|
26561-1
|
CD16+CD56+ cells [#/volume] in Unspecified specimen |
|
18267-5
|
CD16+CD56+ cells/100 cells in Blood |
|
51254-1
|
CD16+CD56+ cells/100 cells in Cerebral spinal fluid |
|
18268-3
|
CD16+CD56+ cells/100 cells in Body fluid |
|
51255-8
|
CD16+CD56+ cells/100 cells in Bone marrow |
|
51253-3
|
CD16+CD56+ cells/100 cells in Tissue |
|
20620-1
|
CD16+CD56+ cells/100 cells in Unspecified specimen |
|
8113-3
|
CD16+CD57- cells/100 cells in Blood |
|
20591-4
|
CD16+CD57- cells/100 cells in Unspecified specimen |
|
9680-0
|
CD16+CD57+ cells/100 cells in Blood |
|
51257-4
|
CD16+CD57+ cells/100 cells in Cerebral spinal fluid |
|
51259-0
|
CD16+CD57+ cells/100 cells in Body fluid |
|
51258-2
|
CD16+CD57+ cells/100 cells in Bone marrow |
|
51256-6
|
CD16+CD57+ cells/100 cells in Tissue |
|
49474-0
|
CD163 Ag [Presence] in Tissue by Immune stain |
|
17118-1
|
CD16B cells/100 cells in Blood |
|
51261-6
|
CD16B cells/100 cells in Cerebral spinal fluid |
|
51263-2
|
CD16B cells/100 cells in Body fluid |
|
51262-4
|
CD16B cells/100 cells in Bone marrow |
|
51260-8
|
CD16B cells/100 cells in Tissue |
|
14108-5
|
CD16C+CD56+ cells [#/volume] in Blood |
|
14109-3
|
CD16C+CD56+ cells/100 cells in Blood |
|
17119-9
|
CD16-CD34+ cells/100 cells in Blood |
|
8114-1
|
CD16-CD57+ cells/100 cells in Blood |
|
17120-7
|
CD17 cells/100 cells in Blood |
|
51099-0
|
CD179a blasts [Units/volume] in Blood |
|
51098-2
|
CD179a blasts [Units/volume] in Bone marrow |
|
51096-6
|
CD179a blasts/100 blasts in Blood |
|
51095-8
|
CD179a blasts/100 blasts in Bone marrow |
|
51097-4
|
CD179a blasts/100 blasts in Unspecified specimen |
|
51100-6
|
CD179a blasts [Units/volume] in Unspecified specimen |
|
50785-5
|
CD18 cells actual/normal in Blood |
|
17121-5
|
CD18 cells/100 cells in Blood |
|
57417-8
|
CD18 cells/100 cells in Body fluid |
|
42874-8
|
CD18 cells/100 cells in Bone marrow |
|
42873-0
|
CD18 cells/100 cells in Tissue |
|
38170-7
|
CD18 cells/100 cells in Unspecified specimen |
|
14964-1
|
CD19 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
40553-0
|
CD19 Ag [Presence] in Tissue by Immune stain |
|
51104-8
|
CD19 blasts [Units/volume] in Blood |
|
51103-0
|
CD19 blasts [Units/volume] in Bone marrow |
|
13840-4
|
CD19 blasts/100 blasts in Blood |
|
51101-4
|
CD19 blasts/100 blasts in Bone marrow |
|
51102-2
|
CD19 blasts/100 blasts in Unspecified specimen |
|
51105-5
|
CD19 blasts [Units/volume] in Unspecified specimen |
|
8116-6
|
CD19 cells [#/volume] in Blood |
|
43972-9
|
CD19 cells [#/volume] in Cerebral spinal fluid |
|
32524-1
|
CD19 cells [#/volume] in Bone marrow |
|
20592-2
|
CD19 cells [#/volume] in Unspecified specimen |
|
8117-4
|
CD19 cells/100 cells in Blood |
|
32755-1
|
CD19 cells/100 cells in Bronchial specimen |
|
51265-7
|
CD19 cells/100 cells in Cerebral spinal fluid |
|
17829-3
|
CD19 cells/100 cells in Body fluid |
|
32525-8
|
CD19 cells/100 cells in Bone marrow |
|
51264-0
|
CD19 cells/100 cells in Tissue |
|
20593-0
|
CD19 cells/100 cells in Unspecified specimen |
|
89354-5
|
CD19+21- cells [#/volume] in Blood |
|
60434-8
|
CD19+CD103+ cells [#/volume] in Blood |
|
40885-6
|
CD19+CD103+ cells/100 cells in Blood |
|
40886-4
|
CD19+CD103+ cells/100 cells in Body fluid |
|
40883-1
|
CD19+CD103+ cells/100 cells in Bone marrow |
|
40884-9
|
CD19+CD103+ cells/100 cells in Tissue |
|
57397-2
|
CD19+CD20+ cells/100 cells in Body fluid |
|
27893-7
|
CD19+CD23+ cells/100 cells in Blood |
|
57399-8
|
CD19+CD23+ cells/100 cells in Body fluid |
|
47023-7
|
CD19+CD23+ cells/100 cells in Unspecified specimen |
|
60436-3
|
CD19+CD25+ cells [#/volume] in Blood |
|
89353-7
|
CD19+CD27+ cells [#/volume] in Blood |
|
43273-2
|
CD19+CD27+IgD+ cells/100 cells in Blood or Tissue |
|
89351-1
|
CD19+CD27+IgD+IgM+ cells [#/volume] in Blood |
|
89349-5
|
CD19+CD27+IgD-IgM- cells [#/volume] in Blood |
|
89347-9
|
CD19+CD27+IgD-IgM+ cells [#/volume] in Blood |
|
38511-2
|
CD19+CD33+ cells/100 cells in Blood |
|
57394-9
|
CD19+CD34+ cells/100 cells in Body fluid |
|
59139-6
|
CD19+CD34+ cells/100 cells in Bone marrow |
|
59147-9
|
CD19+CD38+ cells [#/volume] in Blood |
|
51444-8
|
CD19+CD38+ cells [Units/volume] in Blood |
|
59143-8
|
CD19+CD38+ cells/100 cells in Blood |
|
57395-6
|
CD19+CD38+ cells/100 cells in Body fluid |
|
26562-9
|
CD19+CD38+ cells/100 cells in Unspecified specimen |
|
89343-8
|
CD19+CD38+IgM- cells [#/volume] in Blood |
|
89357-8
|
CD19+CD38+IgM+ cells [#/volume] in Blood |
|
51337-4
|
CD19+CD43+ cells/100 cells in Blood |
|
51334-1
|
CD19+CD43+ cells/100 cells in Cerebral spinal fluid |
|
51336-6
|
CD19+CD43+ cells/100 cells in Body fluid |
|
51335-8
|
CD19+CD43+ cells/100 cells in Bone marrow |
|
51333-3
|
CD19+CD43+ cells/100 cells in Tissue |
|
57396-4
|
CD19+CD56+ cells/100 cells in Body fluid |
|
51356-4
|
CD19+CD58+ cells/100 cells in Blood |
|
51353-1
|
CD19+CD58+ cells/100 cells in Cerebral spinal fluid |
|
51355-6
|
CD19+CD58+ cells/100 cells in Body fluid |
|
51354-9
|
CD19+CD58+ cells/100 cells in Bone marrow |
|
51352-3
|
CD19+CD58+ cells/100 cells in Tissue |
|
49842-8
|
CD19+IgA+ cells/100 cells in Unspecified specimen |
|
49835-2
|
CD19+IgD+ cells/100 cells in Unspecified specimen |
|
49840-2
|
CD19+IgG+ cells/100 cells in Unspecified specimen |
|
89345-3
|
CD19+IgM+ cells [#/volume] in Blood |
|
49841-0
|
CD19+IgM+ cells/100 cells in Unspecified specimen |
|
50664-2
|
CD19+Kappa+ cells [#/volume] in Blood |
|
17122-3
|
CD19+Kappa+ cells/100 cells in Blood |
|
57432-7
|
CD19+Kappa+ cells/100 cells in Body fluid |
|
26565-2
|
CD19+Kappa+ cells/100 cells in Unspecified specimen |
|
50665-9
|
CD19+Lambda+ cells [#/volume] in Blood |
|
17123-1
|
CD19+Lambda+ cells/100 cells in Blood |
|
57433-5
|
CD19+Lambda+ cells/100 cells in Body fluid |
|
26566-0
|
CD19+Lambda+ cells/100 cells in Unspecified specimen |
|
18284-0
|
CD198 cells/100 cells in Blood |
|
47013-8
|
CD1a Ag [Presence] in Tissue by Immune stain |
|
51107-1
|
CD1a blasts/100 blasts in Blood |
|
51106-3
|
CD1a blasts/100 blasts in Bone marrow |
|
51108-9
|
CD1a blasts/100 blasts in Unspecified specimen |
|
20476-8
|
CD1a cells/100 cells in Blood |
|
56773-5
|
CD1a cells/100 cells in Bronchial specimen |
|
52875-2
|
CD1a cells/100 cells in Cerebral spinal fluid |
|
52873-7
|
CD1a cells/100 cells in Body fluid |
|
52874-5
|
CD1a cells/100 cells in Bone marrow |
|
52876-0
|
CD1a cells/100 cells in Tissue |
|
26563-7
|
CD1a cells/100 cells in Unspecified specimen |
|
43274-0
|
CD1c+CD22+ cells/100 cells in Unspecified specimen |
|
14965-8
|
CD2 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
49466-6
|
CD2 Ag [Presence] in Tissue by Immune stain |
|
51113-9
|
CD2 blasts [Units/volume] in Blood |
|
51112-1
|
CD2 blasts [Units/volume] in Bone marrow |
|
13841-2
|
CD2 blasts/100 blasts in Blood |
|
51110-5
|
CD2 blasts/100 blasts in Bone marrow |
|
51111-3
|
CD2 blasts/100 blasts in Unspecified specimen |
|
51114-7
|
CD2 blasts [Units/volume] in Unspecified specimen |
|
9557-0
|
CD2 cells [#/volume] in Blood |
|
43949-7
|
CD2 cells [#/volume] in Cerebral spinal fluid |
|
43950-5
|
CD2 cells [#/volume] in Body fluid |
|
32526-6
|
CD2 cells [#/volume] in Bone marrow |
|
43951-3
|
CD2 cells [#/volume] in Tissue |
|
32512-6
|
CD2 cells [#/volume] in Unspecified specimen |
|
8118-2
|
CD2 cells/100 cells in Blood |
|
17827-7
|
CD2 cells/100 cells in Body fluid |
|
32527-4
|
CD2 cells/100 cells in Bone marrow |
|
20594-8
|
CD2 cells/100 cells in Unspecified specimen |
|
17124-9
|
CD2+CD20+ cells/100 cells in Blood |
|
26921-7
|
CD2+CD26+ cells [#/volume] in Blood |
|
13331-4
|
CD2+CD26+ cells/100 cells in Blood |
|
38513-8
|
CD2+CD3+ cells [#/volume] in Unspecified specimen |
|
38512-0
|
CD2+CD3+ cells/100 cells in Unspecified specimen |
|
33586-9
|
CD2+CD7+ cells [#/volume] in Blood |
|
26572-8
|
CD2+CD7+ cells/100 cells in Blood |
|
14966-6
|
CD20 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
10438-0
|
CD20 Ag [Presence] in Tissue by Immune stain |
|
13842-0
|
CD20 blasts/100 blasts in Blood |
|
51115-4
|
CD20 blasts/100 blasts in Bone marrow |
|
51116-2
|
CD20 blasts/100 blasts in Unspecified specimen |
|
9558-8
|
CD20 cells [#/volume] in Blood |
|
74837-6
|
CD20 cells [#/volume] in Unspecified specimen |
|
8119-0
|
CD20 cells/100 cells in Blood |
|
57418-6
|
CD20 cells/100 cells in Body fluid |
|
20595-5
|
CD20 cells/100 cells in Unspecified specimen |
|
42735-1
|
CD20+CD117+ cells/100 cells in Blood |
|
42736-9
|
CD20+CD23+ cells/100 cells in Blood |
|
31127-4
|
CD20+CD25- cells [#/volume] in Blood |
|
31126-6
|
CD20+CD25- cells/100 cells in Blood |
|
31125-8
|
CD20+CD25+ cells [#/volume] in Blood |
|
31124-1
|
CD20+CD25+ cells/100 cells in Blood |
|
45193-0
|
CD20+CD52+ cells/100 cells in Blood |
|
44071-9
|
CD20+CD52+ cells/100 cells in Cerebral spinal fluid |
|
44072-7
|
CD20+CD52+ cells/100 cells in Body fluid |
|
44070-1
|
CD20+CD52+ cells/100 cells in Bone marrow |
|
44073-5
|
CD20+CD52+ cells/100 cells in Tissue |
|
44066-9
|
CD20+FMC7+ cells [#/volume] in Cerebral spinal fluid |
|
44067-7
|
CD20+FMC7+ cells [#/volume] in Body fluid |
|
44065-1
|
CD20+FMC7+ cells [#/volume] in Bone marrow |
|
44068-5
|
CD20+FMC7+ cells [#/volume] in Tissue |
|
44069-3
|
CD20+FMC7+ cells [#/volume] in Unspecified specimen |
|
44062-8
|
CD20+FMC7+ cells/100 cells in Cerebral spinal fluid |
|
44063-6
|
CD20+FMC7+ cells/100 cells in Body fluid |
|
44061-0
|
CD20+FMC7+ cells/100 cells in Bone marrow |
|
44064-4
|
CD20+FMC7+ cells/100 cells in Tissue |
|
47014-6
|
CD21 Ag [Presence] in Tissue by Immune stain |
|
51117-0
|
CD21 blasts/100 blasts in Unspecified specimen |
|
25164-5
|
CD21 cells [#/volume] in Blood |
|
8120-8
|
CD21 cells/100 cells in Blood |
|
57419-4
|
CD21 cells/100 cells in Body fluid |
|
38419-8
|
CD21 cells/100 cells in Unspecified specimen |
|
89356-0
|
CD21 cells/100 CD19 cells in Blood |
|
89355-2
|
CD21- cells/100 CD19 cells in Blood |
|
49467-4
|
CD22 Ag [Presence] in Tissue by Immune stain |
|
51128-7
|
CD22 blasts [Units/volume] in Blood |
|
51127-9
|
CD22 blasts [Units/volume] in Bone marrow |
|
51125-3
|
CD22 blasts/100 blasts in Blood |
|
51124-6
|
CD22 blasts/100 blasts in Bone marrow |
|
51126-1
|
CD22 blasts/100 blasts in Unspecified specimen |
|
51129-5
|
CD22 blasts [Units/volume] in Unspecified specimen |
|
21013-8
|
CD22 cells [#/volume] in Blood |
|
14017-8
|
CD22 cells/100 cells in Blood |
|
42875-5
|
CD22 cells/100 cells in Body fluid |
|
20596-3
|
CD22 cells/100 cells in Unspecified specimen |
|
20503-9
|
CD22+CD11c+ cells/100 cells in Blood |
|
17125-6
|
CD22+CD19+ cells/100 cells in Blood |
|
57398-0
|
CD22+CD19+ cells/100 cells in Body fluid |
|
10479-4
|
CD227 Ag [Presence] in Tissue by Immune stain |
|
31120-9
|
CD227 cells [#/volume] in Blood |
|
31119-1
|
CD227 cells/100 cells in Blood |
|
29617-8
|
CD23 Ag [Presence] in Tissue by Immune stain |
|
51131-1
|
CD23 blasts/100 blasts in Blood |
|
51130-3
|
CD23 blasts/100 blasts in Bone marrow |
|
51132-9
|
CD23 blasts/100 blasts in Unspecified specimen |
|
25165-2
|
CD23 cells [#/volume] in Blood |
|
14018-6
|
CD23 cells/100 cells in Blood |
|
51267-3
|
CD23 cells/100 cells in Cerebral spinal fluid |
|
51269-9
|
CD23 cells/100 cells in Body fluid |
|
51268-1
|
CD23 cells/100 cells in Bone marrow |
|
51266-5
|
CD23 cells/100 cells in Tissue |
|
19078-5
|
CD23 cells/100 cells in Unspecified specimen |
|
33601-6
|
CD23+CD38+ cells [#/volume] in Blood |
|
50317-7
|
CD235a Ag [Presence] in Tissue by Immune stain |
|
31122-5
|
CD235a cells [#/volume] in Blood |
|
33209-8
|
CD235a cells/100 cells in Aspirate |
|
17221-3
|
CD235a cells/100 cells in Blood |
|
57430-1
|
CD235a cells/100 cells in Body fluid |
|
33208-0
|
CD235a cells/100 cells in Bone marrow |
|
33206-4
|
CD235a cells/100 cells in Pleural fluid |
|
33205-6
|
CD235a cells/100 cells in Peritoneal fluid |
|
33207-2
|
CD235a cells/100 cells in Tissue |
|
32750-2
|
CD235a cells/100 cells in Unspecified specimen |
|
51133-7
|
CD24 blasts/100 blasts in Unspecified specimen |
|
21014-6
|
CD24 cells [#/volume] in Blood |
|
32773-4
|
CD24 cells [Presence] in Blood |
|
17126-4
|
CD24 cells/100 cells in Blood |
|
20597-1
|
CD24 cells/100 cells in Unspecified specimen |
|
90737-8
|
CD24-FLAER- cells/100 CD15 cells in Blood |
|
29596-4
|
CD25 Ag [Presence] in Tissue by Immune stain |
|
51135-2
|
CD25 blasts/100 blasts in Blood |
|
51134-5
|
CD25 blasts/100 blasts in Bone marrow |
|
51136-0
|
CD25 blasts/100 blasts in Unspecified specimen |
|
31123-3
|
CD25 cells [#/volume] in Blood |
|
74842-6
|
CD25 cells [#/volume] in Unspecified specimen |
|
8121-6
|
CD25 cells/100 cells in Blood |
|
51270-7
|
CD25 cells/100 cells in Cerebral spinal fluid |
|
51271-5
|
CD25 cells/100 cells in Body fluid |
|
32493-9
|
CD25 cells/100 cells in Bone marrow |
|
32494-7
|
CD25 cells/100 cells in Tissue |
|
32495-4
|
CD25 cells/100 cells in Unspecified specimen |
|
89431-1
|
CD25 cells/100 CD4 cells in Blood |
|
59031-5
|
CD25+C69+ cells/100 cells in Blood |
|
80700-8
|
CD25+CD127- (regulatory T) cells/100 CD3+CD4+ cells in Blood |
|
49025-0
|
CD25+CD127Low cells/CD4 cells [# Ratio] in Unspecified specimen |
|
14112-7
|
CD25+CD19+ cells/100 cells in Blood |
|
51272-3
|
CD25+CD19+ cells/100 cells in Cerebral spinal fluid |
|
40890-6
|
CD25+CD19+ cells/100 cells in Body fluid |
|
42876-3
|
CD25+CD19+ cells/100 cells in Bone marrow |
|
40889-8
|
CD25+CD19+ cells/100 cells in Tissue |
|
89319-8
|
CD25+CD45RA+CD127Low+ cells/100 CD4 cells in Blood |
|
89320-6
|
CD25+CD45RO+CD127Low+ cells/100 CD4 cells in Blood |
|
89318-0
|
CD25-CD127+ cells/100 CD4 cells in Blood |
|
17127-2
|
CD26 cells/100 cells in Blood |
|
49468-2
|
CD27 Ag [Presence] in Tissue by Immune stain |
|
17128-0
|
CD27 cells/100 cells in Blood |
|
57420-2
|
CD27 cells/100 cells in Body fluid |
|
89358-6
|
CD27 cells/100 CD19 cells in Blood |
|
80701-6
|
CD27- cells/100 CD3+CD8+ cells in Blood |
|
80702-4
|
CD27+CD45RA- cells/100 CD3+CD4+ cells in Blood |
|
80703-2
|
CD27+CD45RA- cells/100 CD3+CD8+ cells in Blood |
|
80704-0
|
CD27+CD45RA+ cells/100 CD3+CD4+ cells in Blood |
|
80705-7
|
CD27+CD45RA+ cells/100 CD3+CD8+ cells in Blood |
|
89338-8
|
CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD4+ cells in Blood |
|
89335-4
|
CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD8+ cells in Blood |
|
89340-4
|
CD27+CD62L+ cells/100 CD3+CD4+ cells in Blood |
|
89339-6
|
CD27+CD62L+ cells/100 CD3+CD8+ cells in Blood |
|
80706-5
|
CD27+IgD- cells/100 CD19+CD20+ cells in Blood |
|
80707-3
|
CD27+IgD+ cells/100 CD19+CD20+ cells in Blood |
|
89352-9
|
CD27+IgD+IgM+ cells/100 CD19 cells in Blood |
|
89350-3
|
CD27+IgD-IgM- cells/100 CD19 cells in Blood |
|
89348-7
|
CD27+IgD-IgM+ cells/100 CD19 cells in Blood |
|
80708-1
|
CD27-CD45RA- cells/100 CD3+CD4+ cells in Blood |
|
80709-9
|
CD27-CD45RA+ cells/100 CD3+CD4+ cells in Blood |
|
89337-0
|
CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD4+ cells in Blood |
|
89334-7
|
CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD8+ cells in Blood |
|
80710-7
|
CD27-IgD+ cells/100 CD19+CD20+ cells in Blood |
|
17129-8
|
CD28 cells/100 cells in Blood |
|
42619-7
|
CD28 cells/100 cells in Bone marrow |
|
89333-9
|
CD28+HLA DR+ cells/100 CD3+CD4+ cells in Blood |
|
89332-1
|
CD28+HLA DR+ cells/100 CD3+CD8+ cells in Blood |
|
17130-6
|
CD29 cells/100 cells in Blood |
|
10439-8
|
CD3 Ag [Presence] in Tissue by Immune stain |
|
51147-7
|
CD3 blasts [Units/volume] in Blood |
|
51146-9
|
CD3 blasts [Units/volume] in Bone marrow |
|
51144-4
|
CD3 blasts/100 blasts in Blood |
|
51143-6
|
CD3 blasts/100 blasts in Bone marrow |
|
51145-1
|
CD3 blasts/100 blasts in Unspecified specimen |
|
51148-5
|
CD3 blasts [Units/volume] in Unspecified specimen |
|
8122-4
|
CD3 cells [#/volume] in Blood |
|
63449-3
|
CD3 cells [#/volume] in Cerebral spinal fluid |
|
32528-2
|
CD3 cells [#/volume] in Bone marrow |
|
20598-9
|
CD3 cells [#/volume] in Unspecified specimen |
|
8124-0
|
CD3 cells/100 cells in Blood |
|
32752-8
|
CD3 cells/100 cells in Bronchial specimen |
|
42193-3
|
CD3 cells/100 cells in Cerebral spinal fluid |
|
17826-9
|
CD3 cells/100 cells in Body fluid |
|
32529-0
|
CD3 cells/100 cells in Bone marrow |
|
51273-1
|
CD3 cells/100 cells in Tissue |
|
20599-7
|
CD3 cells/100 cells in Unspecified specimen |
|
43275-7
|
CD3 cells/CD4 cells [# Ratio] in Unspecified specimen |
|
90304-7
|
CD3 cells/100 lymphocytes in Blood |
|
34929-0
|
CD3+CD4+CD45RO+CD45RA- cells/100 cells in Blood |
|
34930-8
|
CD3+CD4+CD45RO+CD45RA+ cells/100 cells in Blood |
|
34931-6
|
CD3+CD4+CD45RO-CD45RA- cells/100 cells in Blood |
|
34932-4
|
CD3+CD4+CD45RO-CD45RA+ cells/100 cells in Blood |
|
34933-2
|
CD3+CD8+CD45RO+CD45RA- cells/100 cells in Blood |
|
34934-0
|
CD3+CD8+CD45RO+CD45RA+ cells/100 cells in Blood |
|
34935-7
|
CD3+CD8+CD45RO-CD45RA- cells/100 cells in Blood |
|
34936-5
|
CD3+CD8+CD45RO-CD45RA+ cells/100 cells in Blood |
|
17133-0
|
CD3+CD16+ cells/100 cells in Blood |
|
51275-6
|
CD3+CD16+ cells/100 cells in Cerebral spinal fluid |
|
51277-2
|
CD3+CD16+ cells/100 cells in Body fluid |
|
51276-4
|
CD3+CD16+ cells/100 cells in Bone marrow |
|
51274-9
|
CD3+CD16+ cells/100 cells in Tissue |
|
51150-1
|
CD3+CD16+CD56+ blasts/100 blasts in Blood |
|
51149-3
|
CD3+CD16+CD56+ blasts/100 blasts in Bone marrow |
|
51151-9
|
CD3+CD16+CD56+ blasts/100 blasts in Unspecified specimen |
|
42188-3
|
CD3+CD16+CD56+ cells [#/volume] in Blood |
|
91674-2
|
CD3+CD16+CD56+ cells [#/volume] in Bone marrow |
|
42189-1
|
CD3+CD16+CD56+ cells/100 cells in Blood |
|
91673-4
|
CD3+CD16+CD56+ cells/100 cells in Bone marrow |
|
74485-4
|
CD3 and CD20 Ag [Identifier] in Tissue by Immune stain |
|
26997-7
|
CD3+CD25+ cells [#/volume] in Blood |
|
32530-8
|
CD3+CD25+ cells [#/volume] in Bone marrow |
|
43969-5
|
CD3+CD25+ cells [#/volume] in Tissue |
|
32513-4
|
CD3+CD25+ cells [#/volume] in Unspecified specimen |
|
13333-0
|
CD3+CD25+ cells/100 cells in Blood |
|
43967-9
|
CD3+CD25+ cells/100 cells in Cerebral spinal fluid |
|
43856-4
|
CD3+CD25+ cells/100 cells in Body fluid |
|
32531-6
|
CD3+CD25+ cells/100 cells in Bone marrow |
|
13341-3
|
CD3+CD25+ cells/100 cells in Tissue |
|
32514-2
|
CD3+CD25+ cells/100 cells in Unspecified specimen |
|
13848-7
|
CD3+CD26+ cells [#/volume] in Blood |
|
13342-1
|
CD3+CD26+ cells/100 cells in Blood |
|
13340-5
|
CD3+CD38+ cells/100 cells in Blood |
|
24467-3
|
CD3+CD4+ (T4 helper) cells [#/volume] in Blood |
|
92736-8
|
CD3+CD4+ (T4 helper) cells [#/volume] in Blood by Rapid immunoassay |
|
63450-1
|
CD3+CD4+ (T4 helper) cells [#/volume] in Cerebral spinal fluid |
|
32532-4
|
CD3+CD4+ (T4 helper) cells [#/volume] in Bone marrow |
|
40898-9
|
CD3+CD4+ (T4 helper) cells [#/volume] in Tissue |
|
32515-9
|
CD3+CD4+ (T4 helper) cells [#/volume] in Unspecified specimen |
|
8123-2
|
CD3+CD4+ (T4 helper) cells/100 cells in Blood |
|
40623-1
|
CD3+CD4+ (T4 helper) cells/100 cells in Bronchial specimen |
|
43970-3
|
CD3+CD4+ (T4 helper) cells/100 cells in Cerebral spinal fluid |
|
17822-8
|
CD3+CD4+ (T4 helper) cells/100 cells in Body fluid |
|
32533-2
|
CD3+CD4+ (T4 helper) cells/100 cells in Bone marrow |
|
51300-2
|
CD3+CD4+ (T4 helper) cells/100 cells in Tissue |
|
32516-7
|
CD3+CD4+ (T4 helper) cells/100 cells in Unspecified specimen |
|
54218-3
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood |
|
32756-9
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Bronchial specimen |
|
18266-7
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Body fluid |
|
32537-3
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Bone marrow |
|
40900-3
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Tissue |
|
20607-8
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Unspecified specimen |
|
89329-7
|
CD3+CD4+CD27+CD45RO+CD62L+ cells [#/volume] in Blood |
|
89331-3
|
CD3+CD4+CD27+CD62L+ cells [#/volume] in Blood |
|
89328-9
|
CD3+CD4+CD27-CD45RO+CD62L- cells [#/volume] in Blood |
|
89326-3
|
CD3+CD4+CD28+HLA DR+ cells [#/volume] in Blood |
|
85792-0
|
CD3+CD4+CD45RO+ cells [#/volume] in Blood |
|
85791-2
|
CD3+CD4+CD45RO+ cells/100 CD3 cells in Blood |
|
79187-1
|
Cells.CD3+CD4+CD8+ (Double positive) [#/volume] in Blood |
|
79186-3
|
Cells.CD3+CD4+CD8+ (Double positive)/100 cells in Blood |
|
89312-3
|
CD3+CD45+ cells [#/volume] in Blood |
|
56907-9
|
CD3+CD45+ cells/100 cells in Blood |
|
51755-7
|
CD3+CD4-CD8-CD45+ cells/100 cells in Blood |
|
63447-7
|
CD3+CD5- cells [#/volume] in Cerebral spinal fluid |
|
63446-9
|
CD3+CD5- cells/100 cells in Cerebral spinal fluid |
|
68945-5
|
CD3+CD5+ cells [#/volume] in Cerebral spinal fluid |
|
63448-5
|
CD3+CD5+ cells/100 cells in Cerebral spinal fluid |
|
26858-1
|
CD3+CD56+ cells [#/volume] in Blood |
|
40897-1
|
CD3+CD56+ cells [#/volume] in Body fluid |
|
40895-5
|
CD3+CD56+ cells [#/volume] in Bone marrow |
|
40896-3
|
CD3+CD56+ cells [#/volume] in Tissue |
|
17135-5
|
CD3+CD56+ cells/100 cells in Blood |
|
51279-8
|
CD3+CD56+ cells/100 cells in Cerebral spinal fluid |
|
51281-4
|
CD3+CD56+ cells/100 cells in Body fluid |
|
51280-6
|
CD3+CD56+ cells/100 cells in Bone marrow |
|
51278-0
|
CD3+CD56+ cells/100 cells in Tissue |
|
50640-2
|
CD3+CD57+ cells [#/volume] in Blood |
|
51286-3
|
CD3+CD57+ cells/100 cells in Blood |
|
51283-0
|
CD3+CD57+ cells/100 cells in Cerebral spinal fluid |
|
51285-5
|
CD3+CD57+ cells/100 cells in Body fluid |
|
51284-8
|
CD3+CD57+ cells/100 cells in Bone marrow |
|
51282-2
|
CD3+CD57+ cells/100 cells in Tissue |
|
38233-3
|
CD3+CD62L+ cells [#/volume] in Blood |
|
38234-1
|
CD3+CD62L+ cells/100 cells in Blood |
|
17131-4
|
CD3+CD69+ cells/100 cells in Blood |
|
32564-7
|
CD3+CD7+ cells/100 cells in Blood |
|
14135-8
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood |
|
63451-9
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Cerebral spinal fluid |
|
32534-0
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Bone marrow |
|
40899-7
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Tissue |
|
32517-5
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Unspecified specimen |
|
8101-8
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood |
|
40624-9
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Bronchial specimen |
|
43971-1
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Cerebral spinal fluid |
|
17824-4
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Body fluid |
|
32535-7
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Bone marrow |
|
32518-3
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Unspecified specimen |
|
89330-5
|
CD3+CD8+CD27+CD62L+ cells [#/volume] in Blood |
|
89327-1
|
CD3+CD8+CD27-CD45RO+CD62L- cells [#/volume] in Blood |
|
89325-5
|
CD3+CD8+CD28+HLA DR+ cells [#/volume] in Blood |
|
56908-7
|
CD3+CD8+CD45+ cells/100 cells in Blood |
|
85790-4
|
CD3+CD8+CD45RO+ cells [#/volume] in Blood |
|
85789-6
|
CD3+CD8+CD45RO+ cells/100 CD3 cells in Blood |
|
50641-0
|
CD3+CD8+CD57+ cells [#/volume] in Blood |
|
60456-1
|
CD3+CD8+CD57+ cells/100 cells in Blood |
|
17136-3
|
CD3+DR+ cells/100 cells in Blood |
|
26568-6
|
CD3+HLA-DR+ cells [#/volume] in Blood |
|
43958-8
|
CD3+HLA-DR+ cells [#/volume] in Cerebral spinal fluid |
|
43959-6
|
CD3+HLA-DR+ cells [#/volume] in Body fluid |
|
43957-0
|
CD3+HLA-DR+ cells [#/volume] in Bone marrow |
|
43960-4
|
CD3+HLA-DR+ cells [#/volume] in Tissue |
|
43961-2
|
CD3+HLA-DR+ cells [#/volume] in Unspecified specimen |
|
18408-5
|
CD3+HLA-DR+ cells/100 cells in Blood |
|
43968-7
|
CD3+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
|
57740-3
|
CD3+HLA-DR+ cells/100 cells in Body fluid |
|
30320-6
|
CD3+IL2R1+ cells [#/volume] in Blood |
|
17132-2
|
CD3+IL2R1+ cells/100 cells in Blood |
|
34963-9
|
CD3+TCR alpha beta+ cells [#/volume] in Blood |
|
34962-1
|
CD3+TCR alpha beta+ cells/100 cells in Blood |
|
57409-5
|
CD3+TCR alpha beta+ cells/100 cells in Body fluid |
|
33029-0
|
CD3+TCR cells/100 cells in Blood |
|
38235-8
|
CD3+TCR gamma delta+ cells [#/volume] in Blood |
|
57429-3
|
CD3+TCR gamma delta+ cells/100 cells in Body fluid |
|
38236-6
|
CD3+TCR gamma delta+ cells/100 cells in Unspecified specimen |
|
10432-3
|
CD30 Ag [Presence] in Tissue by Immune stain |
|
51153-5
|
CD30 blasts/100 blasts in Blood |
|
51152-7
|
CD30 blasts/100 blasts in Bone marrow |
|
51154-3
|
CD30 blasts/100 blasts in Unspecified specimen |
|
31074-8
|
CD30 cells [#/volume] in Blood |
|
26564-5
|
CD30 cells [#/volume] in Unspecified specimen |
|
17137-1
|
CD30 cells/100 cells in Blood |
|
51288-9
|
CD30 cells/100 cells in Cerebral spinal fluid |
|
51290-5
|
CD30 cells/100 cells in Body fluid |
|
51289-7
|
CD30 cells/100 cells in Bone marrow |
|
51287-1
|
CD30 cells/100 cells in Tissue |
|
20600-3
|
CD30 cells/100 cells in Unspecified specimen |
|
47015-3
|
CD31 Ag [Presence] in Tissue by Immune stain |
|
17138-9
|
CD31 cells/100 cells in Blood |
|
17139-7
|
CD32 cells/100 cells in Blood |
|
14967-4
|
CD33 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
49469-0
|
CD33 Ag [Presence] in Tissue by Immune stain |
|
51158-4
|
CD33 blasts [Units/volume] in Blood |
|
51157-6
|
CD33 blasts [Units/volume] in Bone marrow |
|
13843-8
|
CD33 blasts/100 blasts in Blood |
|
51155-0
|
CD33 blasts/100 blasts in Bone marrow |
|
51156-8
|
CD33 blasts/100 blasts in Unspecified specimen |
|
51159-2
|
CD33 blasts [Units/volume] in Unspecified specimen |
|
21015-3
|
CD33 cells [#/volume] in Blood |
|
8102-6
|
CD33 cells/100 cells in Blood |
|
51292-1
|
CD33 cells/100 cells in Cerebral spinal fluid |
|
51294-7
|
CD33 cells/100 cells in Body fluid |
|
51293-9
|
CD33 cells/100 cells in Bone marrow |
|
51291-3
|
CD33 cells/100 cells in Tissue |
|
20601-1
|
CD33 cells/100 cells in Unspecified specimen |
|
27877-0
|
CD33+CD11b+ cells/100 cells in Blood |
|
51160-0
|
CD33+CD34+ blasts/100 blasts in Unspecified specimen |
|
38514-6
|
CD33+CD34+ cells/100 cells in Blood |
|
56896-4
|
CD33+CD34+ cells/100 cells in Bone marrow |
|
20477-6
|
CD33+CD44+ cells/100 cells in Blood |
|
27879-6
|
CD33+HLA-DR+ cells/100 cells in Blood |
|
10441-4
|
CD34 Ag [Presence] in Tissue by Immune stain |
|
51165-9
|
CD34 blasts [Units/volume] in Blood |
|
51164-2
|
CD34 blasts [Units/volume] in Bone marrow |
|
13844-6
|
CD34 blasts/100 blasts in Blood |
|
51162-6
|
CD34 blasts/100 blasts in Bone marrow |
|
51163-4
|
CD34 blasts/100 blasts in Unspecified specimen |
|
51166-7
|
CD34 blasts [Units/volume] in Unspecified specimen |
|
14136-6
|
CD34 cells [#/volume] in Blood |
|
33030-8
|
CD34 cells [#/volume] in Blood from Blood product unit |
|
58939-0
|
CD34 cells [#/volume] in Body fluid |
|
74838-4
|
CD34 cells [#/volume] in Unspecified specimen |
|
8125-7
|
CD34 cells/100 cells in Blood |
|
33023-3
|
CD34 cells/100 cells in Blood from Blood product unit |
|
57421-0
|
CD34 cells/100 cells in Body fluid |
|
57400-4
|
CD34 cells/100 cells in Bone marrow |
|
20602-9
|
CD34 cells/100 cells in Unspecified specimen |
|
78002-3
|
CD34 dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass |
|
51171-7
|
CD34+CD117+ blasts [Units/volume] in Blood |
|
51170-9
|
CD34+CD117+ blasts [Units/volume] in Bone marrow |
|
51168-3
|
CD34+CD117+ blasts/100 blasts in Blood |
|
51167-5
|
CD34+CD117+ blasts/100 blasts in Bone marrow |
|
51169-1
|
CD34+CD117+ blasts/100 blasts in Unspecified specimen |
|
51172-5
|
CD34+CD117+ blasts [Units/volume] in Unspecified specimen |
|
17140-5
|
CD34+DR+ cells/100 cells in Blood |
|
74494-6
|
CD34 and Coagulation factor XIII Ag [Identifier] in Tissue by Immune stain |
|
49470-8
|
CD35 Ag [Presence] in Tissue by Immune stain |
|
13346-2
|
CD35 cells/100 cells in Blood |
|
51177-4
|
CD36 blasts [Units/volume] in Blood |
|
51176-6
|
CD36 blasts [Units/volume] in Bone marrow |
|
51174-1
|
CD36 blasts/100 blasts in Blood |
|
51173-3
|
CD36 blasts/100 blasts in Bone marrow |
|
51175-8
|
CD36 blasts/100 blasts in Unspecified specimen |
|
51178-2
|
CD36 blasts [Units/volume] in Unspecified specimen |
|
17141-3
|
CD36 cells/100 cells in Blood |
|
51295-4
|
CD36 cells/100 cells in Cerebral spinal fluid |
|
49681-0
|
CD36 cells/100 cells in Body fluid |
|
49679-4
|
CD36 cells/100 cells in Bone marrow |
|
49680-2
|
CD36 cells/100 cells in Tissue |
|
51180-8
|
CD36+CD235a+ blasts/100 blasts in Blood |
|
51179-0
|
CD36+CD235a+ blasts/100 blasts in Bone marrow |
|
17142-1
|
CD37 cells/100 cells in Blood |
|
56127-4
|
CD38 Ag [Presence] in Tissue by Immune stain |
|
26728-6
|
CD38 cells [#/volume] in Blood |
|
8126-5
|
CD38 cells/100 cells in Blood |
|
51297-0
|
CD38 cells/100 cells in Cerebral spinal fluid |
|
51299-6
|
CD38 cells/100 cells in Body fluid |
|
51298-8
|
CD38 cells/100 cells in Bone marrow |
|
51296-2
|
CD38 cells/100 cells in Tissue |
|
20603-7
|
CD38 cells/100 cells in Unspecified specimen |
|
50723-6
|
CD38+ Lambda+ cells [#/volume] in Blood |
|
42818-5
|
CD38+ Lambda+ cells/100 cells in Blood |
|
50973-7
|
CD38+CD138+ cells [#/volume] in Blood |
|
50974-5
|
CD38+CD138+ cells/100 cells in Blood |
|
26559-5
|
CD38+CD56+ cells/100 cells in Unspecified specimen |
|
80711-5
|
CD38+HLA-DR+ cells/100 CD3+CD4+ cells in Blood |
|
80712-3
|
CD38+HLA-DR+ cells/100 CD3+CD8+ cells in Blood |
|
89344-6
|
CD38+IgM- cells/100 CD19 cells in Blood |
|
89341-2
|
CD38+IgM+ cells/100 CD19 cells in Blood |
|
42817-7
|
CD38+Kappa+ cells/100 cells in Blood |
|
17143-9
|
CD39 cells/100 cells in Blood |
|
15193-6
|
CD3-CD16+ cells [#/volume] in Blood |
|
42877-1
|
CD3-CD16+ cells [#/volume] in Body fluid |
|
42878-9
|
CD3-CD16+ cells [#/volume] in Bone marrow |
|
42879-7
|
CD3-CD16+ cells [#/volume] in Tissue |
|
15194-4
|
CD3-CD16+ cells/100 cells in Blood |
|
40894-8
|
CD3-CD16+ cells/100 cells in Body fluid |
|
40892-2
|
CD3-CD16+ cells/100 cells in Bone marrow |
|
40893-0
|
CD3-CD16+ cells/100 cells in Tissue |
|
9728-7
|
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood |
|
32536-5
|
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Bone marrow |
|
56775-0
|
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Tissue |
|
20604-5
|
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Unspecified specimen |
|
8112-5
|
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood |
|
32508-4
|
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Bone marrow |
|
32509-2
|
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Tissue |
|
32519-1
|
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Unspecified specimen |
|
51010-7
|
CD3-CD16+CD56+CD244+ cells/100 cells in Blood |
|
51009-9
|
CD3-CD16+CD56+CD244+ cells/100 cells in Bone marrow |
|
51011-5
|
CD3-CD16+CD56+CD244+ cells/100 cells in Unspecified specimen |
|
15195-1
|
CD3-CD19+ cells [#/volume] in Blood |
|
15196-9
|
CD3-CD19+ cells/100 cells in Blood |
|
38171-5
|
CD3-CD19+ cells/100 cells in Unspecified specimen |
|
74839-2
|
CD3-CD4+ cells/100 cells in Unspecified specimen |
|
89313-1
|
CD3-CD45+ cells [#/volume] in Blood |
|
89311-5
|
CD3-CD45+ cells/100 cells in Blood |
|
53936-1
|
CD3-CD56+ cells [#/volume] in Blood |
|
55090-5
|
CD3-CD56+ cells/100 cells in Blood |
|
56897-2
|
CD3-CD56+ cells/100 cells in Cerebral spinal fluid |
|
56029-2
|
CD3-CD56+ cells/100 cells in Body fluid |
|
56028-4
|
CD3-CD56+ cells/100 cells in Bone marrow |
|
40880-7
|
CD3-CD56+ cells/100 cells in Tissue |
|
73902-9
|
CD3-CD57+ cells [#/volume] in Blood by Flow cytometry (FC) |
|
40891-4
|
CD3-CD57+ cells [#/volume] in Body fluid |
|
42880-5
|
CD3-CD57+ cells [#/volume] in Bone marrow |
|
42881-3
|
CD3-CD57+ cells [#/volume] in Tissue |
|
40882-3
|
CD3-CD57+ cells/100 cells in Body fluid |
|
40881-5
|
CD3-CD57+ cells/100 cells in Bone marrow |
|
42882-1
|
CD3-CD57+ cells/100 cells in Tissue |
|
73903-7
|
CD3-CD57+ cells/100 leukocytes in Blood by Flow cytometry (FC) |
|
73904-5
|
CD3-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) |
|
17191-8
|
CD3-CD7+cells/100 cells in Blood |
|
63452-7
|
CD3-CD7+cells/100 cells in Tissue |
|
73899-7
|
CD3- CD8- CD57+ Cells [#/volume] in Blood by Flow cytometry (FC) |
|
73900-3
|
CD3- CD8- CD57+ Cells/100 leukocytes in Blood by Flow cytometry (FC) |
|
73901-1
|
CD3- CD8- CD57+ Cells/100 lymphocytes in Blood by Flow cytometry (FC) |
|
47016-1
|
CD4 Ag [Presence] in Tissue by Immune stain |
|
53940-3
|
CD4 stimulated ATP immune response [Presence] in Blood |
|
53939-5
|
CD4 stimulated ATP immune response [Mass/volume] in Blood |
|
80223-1
|
CD4 cells/100 lymphocytes in Unspecified specimen |
|
26982-9
|
CD4+CD25+ cells [#/volume] in Blood |
|
13332-2
|
CD4+CD25+ cells/100 cells in Blood |
|
34622-1
|
CD4+CD25+ cells/100 cells in Unspecified specimen |
|
89315-6
|
CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood |
|
89316-4
|
CD4+CD25+CD45RO+CD127Low+ cells [#/volume] in Blood |
|
89317-2
|
CD4+CD25-CD127+ cells [#/volume] in Blood |
|
60457-9
|
CD4+ CD26- Cells [#/volume] in Blood |
|
38237-4
|
CD4+CD28+ cells [#/volume] in Blood |
|
38238-2
|
CD4+CD28+ cells/100 cells in Blood |
|
26569-4
|
CD4+CD29+ cells [#/volume] in Blood |
|
13335-5
|
CD4+CD29+ cells/100 cells in Blood |
|
26570-2
|
CD4+CD45+ cells [#/volume] in Blood |
|
26573-6
|
CD4+CD45+ cells/100 cells in Blood |
|
43944-8
|
CD4+CD45+ cells/100 cells in Bone marrow |
|
43947-1
|
CD4+CD45+ cells/100 cells in Tissue |
|
26759-1
|
CD4+CD45RA+ cells [#/volume] in Blood |
|
13336-3
|
CD4+CD45RA+ cells/100 cells in Blood |
|
43963-8
|
CD4+CD45RA+ cells/100 cells in Cerebral spinal fluid |
|
43964-6
|
CD4+CD45RA+ cells/100 cells in Body fluid |
|
43962-0
|
CD4+CD45RA+ cells/100 cells in Bone marrow |
|
43965-3
|
CD4+CD45RA+ cells/100 cells in Tissue |
|
43966-1
|
CD4+CD45RA+ cells/100 cells in Unspecified specimen |
|
17153-8
|
CD4+CD45RA+ cells/CD8 Cells [# Ratio] in Blood |
|
44057-8
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Cerebral spinal fluid |
|
44058-6
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Body fluid |
|
44056-0
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Bone marrow |
|
44059-4
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Tissue |
|
44060-2
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Unspecified specimen |
|
34475-4
|
CD4+CD45RO+ cells [#/volume] in Blood |
|
43953-9
|
CD4+CD45RO+ cells [#/volume] in Cerebral spinal fluid |
|
43954-7
|
CD4+CD45RO+ cells [#/volume] in Body fluid |
|
43952-1
|
CD4+CD45RO+ cells [#/volume] in Bone marrow |
|
43955-4
|
CD4+CD45RO+ cells [#/volume] in Tissue |
|
43956-2
|
CD4+CD45RO+ cells [#/volume] in Unspecified specimen |
|
41994-5
|
CD4+CD45RO+ cells/100 cells in Blood |
|
43946-3
|
CD4+CD45RO+ cells/100 cells in Cerebral spinal fluid |
|
43945-5
|
CD4+CD45RO+ cells/100 cells in Body fluid |
|
43948-9
|
CD4+CD45RO+ cells/100 cells in Unspecified specimen |
|
58920-0
|
CD4+CD45RO+ cells/CD3+CD4+ (T4 helper) cells [# Ratio] in Blood |
|
17144-7
|
CD4+CD69+ cells/100 cells in Blood |
|
51306-9
|
CD4+CD7- cells/100 cells in Blood |
|
51303-6
|
CD4+CD7- cells/100 cells in Cerebral spinal fluid |
|
51305-1
|
CD4+CD7- cells/100 cells in Body fluid |
|
51304-4
|
CD4+CD7- cells/100 cells in Bone marrow |
|
51302-8
|
CD4+CD7- cells/100 cells in Tissue |
|
42737-7
|
CD4+CD7+ cells/100 cells in Blood |
|
51311-9
|
CD4+CD7-CD26- cells/100 cells in Blood |
|
51308-5
|
CD4+CD7-CD26- cells/100 cells in Cerebral spinal fluid |
|
51310-1
|
CD4+CD7-CD26- cells/100 cells in Body fluid |
|
51309-3
|
CD4+CD7-CD26- cells/100 cells in Bone marrow |
|
51307-7
|
CD4+CD7-CD26- cells/100 cells in Tissue |
|
51316-8
|
CD4+CD7-CD49D- cells/100 cells in Blood |
|
51313-5
|
CD4+CD7-CD49D- cells/100 cells in Cerebral spinal fluid |
|
51315-0
|
CD4+CD7-CD49D- cells/100 cells in Body fluid |
|
51314-3
|
CD4+CD7-CD49D- cells/100 cells in Bone marrow |
|
51312-7
|
CD4+CD7-CD49D- cells/100 cells in Tissue |
|
17146-2
|
CD4+CD8+ cells/100 cells in Blood |
|
57401-2
|
CD4+CD8+ cells/100 cells in Body fluid |
|
38239-0
|
CD4+CD95+ cells [#/volume] in Blood |
|
38240-8
|
CD4+CD95+ cells/100 cells in Blood |
|
26983-7
|
CD4+HLA-DR+ cells [#/volume] in Blood |
|
13343-9
|
CD4+HLA-DR+ cells/100 cells in Blood |
|
46967-6
|
CD40 cells [#/volume] in Blood |
|
17147-0
|
CD40 cells/100 cells in Blood |
|
57422-8
|
CD40 cells/100 cells in Body fluid |
|
42932-4
|
CD40 cells/100 cells in Unspecified specimen |
|
21016-1
|
CD41 cells [#/volume] in Blood |
|
17148-8
|
CD41 cells/100 cells in Blood |
|
51318-4
|
CD41 cells/100 cells in Cerebral spinal fluid |
|
51320-0
|
CD41 cells/100 cells in Body fluid |
|
51319-2
|
CD41 cells/100 cells in Bone marrow |
|
51317-6
|
CD41 cells/100 cells in Tissue |
|
20608-6
|
CD41 cells/100 cells in Unspecified specimen |
|
51445-5
|
CD41a cells [Units/volume] in Blood |
|
17825-1
|
CD41a cells/100 cells in Blood |
|
33775-8
|
CD41a cells/100 cells in Unspecified specimen |
|
49475-7
|
CD41-Bf Ag [Presence] in Tissue by Immune stain |
|
29350-6
|
CD42 cells [#/volume] in Blood |
|
19122-1
|
CD42 cells/100 cells in Blood |
|
51322-6
|
CD42 cells/100 cells in Cerebral spinal fluid |
|
51324-2
|
CD42 cells/100 cells in Body fluid |
|
51323-4
|
CD42 cells/100 cells in Bone marrow |
|
51321-8
|
CD42 cells/100 cells in Tissue |
|
20609-4
|
CD42 cells/100 cells in Unspecified specimen |
|
17149-6
|
CD42a cells/100 cells in Blood |
|
57402-0
|
CD42a cells/100 cells in Body fluid |
|
17150-4
|
CD42b cells/100 cells in Blood |
|
51326-7
|
CD42b cells/100 cells in Cerebral spinal fluid |
|
51328-3
|
CD42b cells/100 cells in Body fluid |
|
51327-5
|
CD42b cells/100 cells in Bone marrow |
|
51325-9
|
CD42b cells/100 cells in Tissue |
|
77946-2
|
CD42b cells/100 cells in Unspecified specimen |
|
17151-2
|
CD42c cells/100 cells in Blood |
|
17152-0
|
CD42d cells/100 cells in Blood |
|
10443-0
|
CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
|
17154-6
|
CD43 cells/100 cells in Blood |
|
51330-9
|
CD43 cells/100 cells in Cerebral spinal fluid |
|
51332-5
|
CD43 cells/100 cells in Body fluid |
|
51331-7
|
CD43 cells/100 cells in Bone marrow |
|
51329-1
|
CD43 cells/100 cells in Tissue |
|
19079-3
|
CD43 cells/100 cells in Unspecified specimen |
|
17155-3
|
CD44 cells/100 cells in Blood |
|
17156-1
|
CD44R cells/100 cells in Blood |
|
40554-8
|
CD45 Ag [Presence] in Tissue by Immune stain |
|
27071-0
|
CD45 (Lymphs) cells [#/volume] in Blood |
|
8130-7
|
CD45 (Lymphs) cells/100 cells in Blood |
|
51339-0
|
CD45 (Lymphs) cells/100 cells in Cerebral spinal fluid |
|
17823-6
|
CD45 (Lymphs) cells/100 cells in Body fluid |
|
51340-8
|
CD45 (Lymphs) cells/100 cells in Bone marrow |
|
51338-2
|
CD45 (Lymphs) cells/100 cells in Tissue |
|
20610-2
|
CD45 (Lymphs) cells/100 cells in Unspecified specimen |
|
33034-0
|
CD45 negative events [#] in Unspecified specimen |
|
33033-2
|
CD45 positive events [#] in Unspecified specimen |
|
59030-7
|
CD45+CD103+ Cells/100 cells in Tissue |
|
8103-4
|
CD45+CD14+ cells/100 cells in Blood |
|
17157-9
|
CD45RA cells/100 cells in Blood |
|
57403-8
|
CD45RA cells/100 cells in Body fluid |
|
89360-2
|
CD45RA cells/100 CD4 cells in Blood |
|
53638-3
|
CD45RB Ag [Presence] in Tissue by Immune stain |
|
17158-7
|
CD45RB cells/100 cells in Blood |
|
29594-9
|
CD45RO Ag [Presence] in Tissue by Immune stain |
|
17159-5
|
CD45RO cells/100 cells in Blood |
|
57404-6
|
CD45RO cells/100 cells in Body fluid |
|
89336-2
|
CD45RO cells/100 CD3+CD8+ cells in Blood |
|
89362-8
|
CD45RO cells/100 CD4 cells in Blood |
|
17160-3
|
CD46 cells/100 cells in Blood |
|
17161-1
|
CD47 cells/100 cells in Blood |
|
17162-9
|
CD48 cells/100 cells in Blood |
|
17163-7
|
CD49a cells/100 cells in Blood |
|
17164-5
|
CD49b cells/100 cells in Blood |
|
17165-2
|
CD49c cells/100 cells in Blood |
|
17166-0
|
CD49d cells/100 cells in Blood |
|
17167-8
|
CD49e cells/100 cells in Blood |
|
17168-6
|
CD49f cells/100 cells in Blood |
|
80699-2
|
CD4-CD8-/100 CD3+TCR alpha beta+ cells in Blood |
|
14968-2
|
CD5 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
29603-8
|
CD5 Ag [Presence] in Tissue by Immune stain |
|
13845-3
|
CD5 blasts/100 blasts in Blood |
|
9559-6
|
CD5 cells [#/volume] in Blood |
|
8132-3
|
CD5 cells/100 cells in Blood |
|
57423-6
|
CD5 cells/100 cells in Body fluid |
|
35640-2
|
CD5 cells/100 cells in Bone marrow |
|
20611-0
|
CD5 cells/100 cells in Unspecified specimen |
|
9561-2
|
CD5+CD19+ cells [#/volume] in Blood |
|
8131-5
|
CD5+CD19+ cells/100 cells in Blood |
|
51341-6
|
CD5+CD19+ cells/100 cells in Cerebral spinal fluid |
|
51342-4
|
CD5+CD19+ cells/100 cells in Body fluid |
|
32510-0
|
CD5+CD19+ cells/100 cells in Bone marrow |
|
32511-8
|
CD5+CD19+ cells/100 cells in Tissue |
|
32523-3
|
CD5+CD19+ cells/100 cells in Unspecified specimen |
|
55364-4
|
CD5+CD19+CD38+ cells/100 cells in Blood |
|
17169-4
|
CD5+CD2- cells/100 cells in Blood |
|
33595-0
|
CD5+CD20+ cells [#/volume] in Blood |
|
9771-7
|
CD5+CD20+ cells [#/volume] in Leukocytes |
|
8104-2
|
CD5+CD20+ cells/100 cells in Blood |
|
60437-1
|
CD5+CD23+ cells [#/volume] in Blood |
|
59144-6
|
CD5+CD23+ cells/100 cells in Blood |
|
59137-0
|
CD5+CD23+ cells/100 cells in Bone marrow |
|
13850-3
|
CD5+CD25+ cells [#/volume] in Blood |
|
13851-1
|
CD5+CD25+ cells/100 cells in Blood |
|
8105-9
|
CD5+CD8+ cells/100 cells in Blood |
|
56899-8
|
CD5+FMC7+ cells/100 cells in Bone marrow |
|
56898-0
|
CD5+FMC7+ cells/100 cells in Tissue |
|
17170-2
|
CD50 cells/100 cells in Blood |
|
17171-0
|
CD51 cells/100 cells in Blood |
|
53639-1
|
CD52 Ag [Presence] in Tissue by Immune stain |
|
17172-8
|
CD52 cells/100 cells in Blood |
|
42885-4
|
CD52 cells/100 cells in Body fluid |
|
42886-2
|
CD52 cells/100 cells in Bone marrow |
|
42883-9
|
CD52 cells/100 cells in Tissue |
|
42884-7
|
CD52 cells/100 cells in Unspecified specimen |
|
17173-6
|
CD53 cells/100 cells in Blood |
|
17174-4
|
CD54 cells/100 cells in Blood |
|
59035-6
|
CD54 cells/100 cells in Body fluid |
|
44007-3
|
CD55 and CD59 RBC [Interpretation] in Blood |
|
33250-2
|
CD55 cells [Presence] in Blood |
|
17175-1
|
CD55 cells/100 cells in Blood |
|
51343-2
|
CD55 cells/100 cells in Cerebral spinal fluid |
|
43935-6
|
CD55 cells/100 cells in Body fluid |
|
51344-0
|
CD55 cells/100 cells in Bone marrow |
|
43936-4
|
CD55 cells/100 cells in Tissue |
|
32744-5
|
CD55 cells/100 cells in Unspecified specimen |
|
53832-2
|
CD55 deficient RBC/100 erythrocytes in Blood |
|
53830-6
|
CD55 deficient Granulocytes/100 cells in Blood |
|
49599-4
|
CD55 Granulocytes [Presence] in Blood |
|
26615-5
|
CD55 RBC [Presence] in Blood |
|
46080-8
|
CD55 RBC/100 erythrocytes in Blood |
|
57762-7
|
CD55+CD59 cells [Presence] in Blood by Agglutination |
|
53769-6
|
CD55+CD59 deficient RBC actual/normal in Blood |
|
56145-6
|
CD55+CD59 deficient RBC+Granulocytes [Interpretation] in Blood Narrative |
|
53768-8
|
CD55+CD59 RBC actual/normal in Blood |
|
10442-2
|
CD56 Ag [Presence] in Tissue by Immune stain |
|
14113-5
|
CD56 cells [#/volume] in Blood |
|
74840-0
|
CD56 cells [#/volume] in Unspecified specimen |
|
8133-1
|
CD56 cells/100 cells in Blood |
|
57424-4
|
CD56 cells/100 cells in Body fluid |
|
21166-4
|
CD56 cells/100 cells in Unspecified specimen |
|
33652-9
|
CD56 cells/CD38 Cells [# Ratio] in Blood |
|
57437-6
|
CD56+CD138+ cells/100 cells in Body fluid |
|
51349-9
|
CD56+CD57+ cells/100 cells in Blood |
|
51346-5
|
CD56+CD57+ cells/100 cells in Cerebral spinal fluid |
|
51348-1
|
CD56+CD57+ cells/100 cells in Body fluid |
|
51347-3
|
CD56+CD57+ cells/100 cells in Bone marrow |
|
51345-7
|
CD56+CD57+ cells/100 cells in Tissue |
|
57438-4
|
CD56-CD138+ cells/100 cells in Body fluid |
|
10444-8
|
CD57 Ag [Presence] in Tissue by Immune stain |
|
21017-9
|
CD57 cells [#/volume] in Blood |
|
8134-9
|
CD57 cells/100 cells in Blood |
|
51350-7
|
CD57 cells/100 cells in Cerebral spinal fluid |
|
51351-5
|
CD57 cells/100 cells in Body fluid |
|
32497-0
|
CD57 cells/100 cells in Bone marrow |
|
32496-2
|
CD57 cells/100 cells in Tissue |
|
32498-8
|
CD57 cells/100 cells in Unspecified specimen |
|
17176-9
|
CD58 cells/100 cells in Blood |
|
33664-4
|
CD59 cells [Presence] in Blood |
|
17177-7
|
CD59 cells/100 cells in Blood |
|
51357-2
|
CD59 cells/100 cells in Cerebral spinal fluid |
|
43938-0
|
CD59 cells/100 cells in Body fluid |
|
51358-0
|
CD59 cells/100 cells in Bone marrow |
|
43937-2
|
CD59 cells/100 cells in Tissue |
|
32601-7
|
CD59 cells/100 cells in Unspecified specimen |
|
33663-6
|
CD59 deficient cells/100 cells in Blood |
|
53831-4
|
CD59 deficient Granulocytes/100 cells in Blood |
|
60554-3
|
CD59 deficient monocytes/100 cells in Blood |
|
49550-7
|
CD59 Deficient leukocytes/100 cells in Blood |
|
49625-7
|
CD59 Granulocytes [Interpretation] in Blood Qualitative |
|
26616-3
|
CD59 RBC [Presence] in Blood |
|
49031-8
|
CD59 RBC/100 erythrocytes in Blood |
|
17178-5
|
CD6 cells/100 cells in Blood |
|
21018-7
|
CD61 cells [#/volume] in Blood |
|
20478-4
|
CD61 cells/100 cells in Blood |
|
51360-6
|
CD61 cells/100 cells in Cerebral spinal fluid |
|
51362-2
|
CD61 cells/100 cells in Body fluid |
|
51361-4
|
CD61 cells/100 cells in Bone marrow |
|
51359-8
|
CD61 cells/100 cells in Tissue |
|
21167-2
|
CD61 cells/100 cells in Unspecified specimen |
|
32855-9
|
CD62 cells/100 cells in Unspecified specimen |
|
17179-3
|
CD62E cells/100 cells in Blood |
|
32745-2
|
CD62E cells/100 cells in Unspecified specimen |
|
17180-1
|
CD62L cells/100 cells in Blood |
|
17181-9
|
CD62P cells/100 cells in Blood |
|
32746-0
|
CD62P cells/100 cells in Unspecified specimen |
|
75023-2
|
CD63 (Activated) Basophils/100 basophils in Blood by Flow cytometry (FC) |
|
17182-7
|
CD63 cells/100 cells in Blood |
|
93353-1
|
CD64 Ag [Entitic number] on Neutrophil by Flow cytometry (FC) |
|
51446-3
|
CD64 cells [Units/volume] in Blood |
|
17183-5
|
CD64 cells/100 cells in Blood |
|
51364-8
|
CD64 cells/100 cells in Cerebral spinal fluid |
|
51366-3
|
CD64 cells/100 cells in Body fluid |
|
51365-5
|
CD64 cells/100 cells in Bone marrow |
|
51363-0
|
CD64 cells/100 cells in Tissue |
|
32747-8
|
CD64 cells/100 cells in Unspecified specimen |
|
51400-0
|
CD65w cells/100 cells in Blood |
|
51397-8
|
CD65w cells/100 cells in Cerebral spinal fluid |
|
51399-4
|
CD65w cells/100 cells in Body fluid |
|
51398-6
|
CD65w cells/100 cells in Bone marrow |
|
51396-0
|
CD65w cells/100 cells in Tissue |
|
17184-3
|
CD66a cells/100 cells in Blood |
|
17185-0
|
CD66b cells/100 cells in Blood |
|
17186-8
|
CD66c cells/100 cells in Blood |
|
17187-6
|
CD66d cells/100 cells in Blood |
|
40555-5
|
CD66e Ag [Presence] in Tissue by Immune stain |
|
17188-4
|
CD66e cells/100 cells in Blood |
|
47017-9
|
CD68 Ag [Presence] in Tissue by Immune stain |
|
17189-2
|
CD68 cells/100 cells in Blood |
|
46966-8
|
CD69 cells [#/volume] in Blood |
|
17190-0
|
CD69 cells/100 cells in Blood |
|
14969-0
|
CD7 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
50310-2
|
CD7 Ag [Presence] in Tissue by Immune stain |
|
13846-1
|
CD7 blasts/100 blasts in Blood |
|
9563-8
|
CD7 cells [#/volume] in Blood |
|
8135-6
|
CD7 cells/100 cells in Blood |
|
57425-1
|
CD7 cells/100 cells in Body fluid |
|
35641-0
|
CD7 cells/100 cells in Bone marrow |
|
20612-8
|
CD7 cells/100 cells in Unspecified specimen |
|
59138-8
|
CD7+CD34+ cells/100 cells in Bone marrow |
|
42738-5
|
CD7+CD8+ cells/100 cells in Blood |
|
29340-7
|
CD71 cells [#/volume] in Blood |
|
8136-4
|
CD71 cells/100 cells in Blood |
|
57426-9
|
CD71 cells/100 cells in Body fluid |
|
21169-8
|
CD71 cells/100 cells in Unspecified specimen |
|
17192-6
|
CD72 cells/100 cells in Blood |
|
17193-4
|
CD73 cells/100 cells in Blood |
|
17194-2
|
CD74 cells/100 cells in Blood |
|
17195-9
|
CD77 cells/100 cells in Blood |
|
62252-2
|
CD79 cells/100 cells in Blood |
|
61178-0
|
CD79 cells/100 cells in Unspecified specimen |
|
47018-7
|
CD79a Ag [Presence] in Tissue by Immune stain |
|
51447-1
|
CD79a cells [Units/volume] in Blood |
|
17196-7
|
CD79a cells/100 cells in Blood |
|
51368-9
|
CD79a cells/100 cells in Body fluid |
|
51367-1
|
CD79a cells/100 cells in Bone marrow |
|
42933-2
|
CD79a cells/100 cells in Unspecified specimen |
|
17197-5
|
CD79b cells/100 cells in Blood |
|
51369-7
|
CD79b cells/100 cells in Cerebral spinal fluid |
|
42888-8
|
CD79b cells/100 cells in Body fluid |
|
42889-6
|
CD79b cells/100 cells in Bone marrow |
|
42887-0
|
CD79b cells/100 cells in Tissue |
|
33991-1
|
CD79b cells/100 cells in Unspecified specimen |
|
32499-6
|
CD7-CD13+CD33+ cells/100 cells in Blood |
|
32520-9
|
CD7-CD13+CD33+ cells/100 cells in Unspecified specimen |
|
47019-5
|
CD8 Ag [Presence] in Tissue by Immune stain |
|
80222-3
|
CD8 cells/100 lymphocytes in Unspecified specimen |
|
27023-1
|
CD8+CD11b+ cells [#/volume] in Blood |
|
13345-4
|
CD8+CD11b+ cells/100 cells in Blood |
|
18349-1
|
CD8+CD25+ cells [#/volume] in Blood |
|
13334-8
|
CD8+CD25+ cells/100 cells in Blood |
|
16106-7
|
CD8+CD28+ cells [#/volume] in Blood |
|
17198-3
|
CD8+CD28+ cells/100 cells in Blood |
|
77942-1
|
CD8+CD3- cells/100 cells in Unspecified specimen |
|
21374-4
|
CD8+CD38+ cells [#/volume] in Blood |
|
13344-7
|
CD8+CD38+ cells/100 cells in Blood |
|
82743-6
|
CD8+CD45RA+ cells [#/volume] in Blood |
|
57407-9
|
CD8+CD45RA+ cells/100 cells in Body fluid |
|
82744-4
|
CD8+CD45RA+ cells/100 CD8 cells in Blood |
|
57408-7
|
CD8+CD45RO+ cells/100 cells in Body fluid |
|
13339-7
|
CD8+CD56+ cells/100 cells in Blood |
|
57405-3
|
CD8+CD56+ cells/100 cells in Body fluid |
|
18350-9
|
CD8+CD57+ cells [#/volume] in Blood |
|
13338-9
|
CD8+CD57+ cells/100 cells in Blood |
|
57406-1
|
CD8+CD57+ cells/100 cells in Body fluid |
|
74841-8
|
CD8+CD57+ cells/100 cells in Unspecified specimen |
|
38241-6
|
CD8+CD95+ cells [#/volume] in Blood |
|
38242-4
|
CD8+CD95+ cells/100 cells in Blood |
|
16107-5
|
CD8+HLA-DR+ cells [#/volume] in Blood |
|
13337-1
|
CD8+HLA-DR+ cells/100 cells in Blood |
|
51371-3
|
CD8+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
|
51373-9
|
CD8+HLA-DR+ cells/100 cells in Body fluid |
|
51372-1
|
CD8+HLA-DR+ cells/100 cells in Bone marrow |
|
51370-5
|
CD8+HLA-DR+ cells/100 cells in Tissue |
|
17199-1
|
CD80 cells/100 cells in Blood |
|
51405-9
|
CD81 cells/100 cells in Blood |
|
51402-6
|
CD81 cells/100 cells in Cerebral spinal fluid |
|
51404-2
|
CD81 cells/100 cells in Body fluid |
|
51403-4
|
CD81 cells/100 cells in Bone marrow |
|
51401-8
|
CD81 cells/100 cells in Tissue |
|
17200-7
|
CD82 cells/100 cells in Blood |
|
17201-5
|
CD83 cells/100 cells in Blood |
|
42934-0
|
CD83 cells/100 cells in Unspecified specimen |
|
17202-3
|
CD85 cells/100 cells in Blood |
|
17203-1
|
CD86 cells/100 cells in Blood |
|
17204-9
|
CD87 cells/100 cells in Blood |
|
17205-6
|
CD88 cells/100 cells in Blood |
|
61122-8
|
CD8-CD57+ cells [#/volume] in Blood |
|
61121-0
|
CD8-CD57+ cells/100 cells in Blood |
|
73898-9
|
CD8-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) |
|
17206-4
|
CD9 cells/100 cells in Blood |
|
51375-4
|
CD9 cells/100 cells in Cerebral spinal fluid |
|
51377-0
|
CD9 cells/100 cells in Body fluid |
|
51376-2
|
CD9 cells/100 cells in Bone marrow |
|
51374-7
|
CD9 cells/100 cells in Tissue |
|
77947-0
|
CD9 cells/100 cells in Unspecified specimen |
|
42628-8
|
CD9+CD41+ cells/100 cells in Blood |
|
32748-6
|
CD90 cells/100 cells in Unspecified specimen |
|
17207-2
|
CD91 cells/100 cells in Blood |
|
17208-0
|
CD93 cells/100 cells in Blood |
|
17209-8
|
CD94 cells/100 cells in Blood |
|
17210-6
|
CD95 cells/100 cells in Blood |
|
17211-4
|
CD96 cells/100 cells in Blood |
|
17212-2
|
CD97 cells/100 cells in Blood |
|
17213-0
|
CD98 cells/100 cells in Blood |
|
47020-3
|
CD99 Ag [Presence] in Tissue by Immune stain |
|
17214-8
|
CD99 cells/100 cells in Blood |
|
18285-7
|
CDA cells/100 cells in Blood |
|
93337-4
|
Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool |
|
2065-1
|
Chenodeoxycholate [Mass/volume] in Serum |
|
30519-3
|
Chenodeoxycholate [Moles/volume] in Serum or Plasma |
|
2067-7
|
Chenodeoxycholylglycine.conjugated [Mass/volume] in Serum |
|
2066-9
|
Chenodeoxycholylglycine [Mass/volume] in Serum |
|
21652-3
|
CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21653-1
|
CDH1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
77132-9
|
CDHR1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77131-1
|
CDHR1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
48978-1
|
CDKL5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75388-9
|
CDKN1B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75389-7
|
CDKN1B gene full mutation analysis in Blood or Tissue by Sequencing |
|
21614-3
|
CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
89037-6
|
CDKN2A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
57927-6
|
CDKN2A+CDK4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21615-0
|
CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
35301-1
|
Transferrin.carbohydrate deficient.asialo [Presence] in Cerebral spinal fluid |
|
44731-8
|
Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.disialo [Mass Ratio] in Serum or Plasma |
|
35475-3
|
Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
|
21572-3
|
Transferrin.carbohydrate deficient.asialo/Transferrin.total in Serum or Plasma |
|
35469-6
|
Transferrin.carbohydrate deficient.disialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
|
21573-1
|
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma |
|
91671-8
|
Transferrin.carbohydrate deficient.disialo/Transferrin.total standardized per IFCC-RMP for CDT in Serum or Plasma |
|
53943-7
|
Bacterial cytolethal distending toxin cdt gene [Presence] in Unspecified specimen by NAA with probe detection |
|
44732-6
|
Transferrin.carbohydrate deficient.monosialo/Transferrin.carbohydrate deficient.disialo [Mass Ratio] in Serum or Plasma |
|
21574-9
|
Transferrin.carbohydrate deficient.monosialo/Transferrin.total in Serum or Plasma |
|
33614-9
|
Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma |
|
21575-6
|
Transferrin.carbohydrate deficient.pentasialo/Transferrin.total in Serum or Plasma |
|
76613-9
|
Transferrin.carbohydrate deficient.pentasialo+hexasialo/Transferrin.total in Serum or Plasma |
|
13999-8
|
Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma |
|
12949-4
|
Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma |
|
21576-4
|
Transferrin.carbohydrate deficient.tetrasialo/Transferrin.total in Serum or Plasma |
|
90420-1
|
Transferrin.carbohydrate deficient.trisialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
|
21577-2
|
Transferrin.carbohydrate deficient.trisialo/Transferrin.total in Serum or Plasma |
|
48495-6
|
Transferrin.carbohydrate deficient/Transferrin.total in Serum or Plasma |
|
87418-0
|
Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay |
|
87419-8
|
Cytolethal distending toxin B+Vinculin Ab [Interpretation] in Serum Qualitative by Immunoassay |
|
31285-0
|
Canine distemper virus Ab [Presence] in Serum |
|
23689-3
|
Canine distemper virus Ab [Presence] in Serum by Immunofluorescence |
|
31284-3
|
Canine distemper virus Ab [Units/volume] in Serum |
|
23690-1
|
Canine distemper virus Ab [Titer] in Serum |
|
23696-8
|
Canine distemper virus Ag [Presence] in Conjunctival specimen |
|
20742-3
|
Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
23695-0
|
Canine distemper virus Ag [Presence] in Tissue by Immunofluorescence |
|
43066-0
|
Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid |
|
26903-5
|
Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
23692-7
|
Canine distemper virus IgG Ab [Titer] in Serum |
|
23691-9
|
Canine distemper virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
43065-2
|
Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid |
|
26890-4
|
Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
23694-3
|
Canine distemper virus IgM Ab [Titer] in Serum |
|
23693-5
|
Canine distemper virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
47021-1
|
CDX2 Ag [Presence] in Tissue by Immune stain |
|
93912-4
|
CE Ag [Presence] on Red Blood Cells |
|
81144-8
|
Cerium [Mass/volume] in Blood |
|
33675-0
|
Microscopic observation [Identifier] in Unspecified specimen by Esterase stain.combined |
|
2037-0
|
Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid |
|
12515-3
|
Carcinoembryonic Ag [Mass/volume] in Body fluid |
|
40621-5
|
Carcinoembryonic Ag [Mass/volume] in Pericardial fluid |
|
19168-4
|
Carcinoembryonic Ag [Units/volume] in Pleural fluid |
|
19169-2
|
Carcinoembryonic Ag [Mass/volume] in Pleural fluid |
|
19170-0
|
Carcinoembryonic Ag [Moles/volume] in Pleural fluid |
|
40622-3
|
Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid |
|
83085-1
|
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
19166-8
|
Carcinoembryonic Ag [Units/volume] in Serum or Plasma |
|
2039-6
|
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
|
19167-6
|
Carcinoembryonic Ag [Moles/volume] in Serum or Plasma |
|
10560-1
|
Carcinoembryonic Ag [Units/volume] in Semen |
|
2038-8
|
Carcinoembryonic Ag [Mass/volume] in Semen |
|
10469-5
|
Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
|
75009-1
|
CEBPA gene full mutation analysis in Blood or Tissue by Molecular genetics method |
|
75032-3
|
CEBPA gene full mutation analysis in Bone marrow by Molecular genetics method |
|
64012-8
|
CEBPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7192-8
|
Cedar dust IgE Ab [Units/volume] in Serum |
|
78701-0
|
Cedar elm IgE Ab [Units/volume] in Serum |
|
82027-4
|
Cedar elm IgE Ab RAST class [Presence] in Serum |
|
26049-7
|
Cedar IgE Ab [Units/volume] in Serum |
|
26050-5
|
Cedar IgE Ab RAST class [Presence] in Serum |
|
42863-1
|
Cedar IgE Ab/IgE total in Serum |
|
55627-4
|
Cefacetrile [Susceptibility] by Gradient strip |
|
55626-6
|
Cefacetrile [Susceptibility] by Disk diffusion (KB) |
|
55624-1
|
Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55625-8
|
Cefacetrile [Susceptibility] |
|
19733-5
|
Cefaclor IgE Ab [Units/volume] in Serum |
|
21150-8
|
Cefaclor IgE Ab RAST class [Presence] in Serum |
|
34263-4
|
Cefaclor IgG Ab [Units/volume] in Serum |
|
6986-4
|
Cefaclor [Susceptibility] by Gradient strip |
|
85-1
|
Cefaclor [Susceptibility] by Disk diffusion (KB) |
|
84-4
|
Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
83-6
|
Cefaclor [Susceptibility] by Minimum lethal concentration (MLC) |
|
16564-7
|
Cefaclor [Mass/volume] in Serum or Plasma |
|
18874-8
|
Cefaclor [Susceptibility] |
|
86-9
|
Cefaclor [Susceptibility] by Serum bactericidal titer |
|
73475-6
|
Cefadroxil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73474-9
|
Cefadroxil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55628-2
|
Cefadroxil [Susceptibility] by Gradient strip |
|
65-3
|
Cefadroxil [Susceptibility] by Disk diffusion (KB) |
|
64-6
|
Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
63-8
|
Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC) |
|
16565-4
|
Cefadroxil [Mass/volume] in Serum or Plasma |
|
18875-5
|
Cefadroxil [Susceptibility] |
|
66-1
|
Cefadroxil [Susceptibility] by Serum bactericidal titer |
|
4157-4
|
Cefamandole [Mass] of Dose |
|
41669-3
|
Cefamandole [Susceptibility] by Gradient strip |
|
69-5
|
Cefamandole [Susceptibility] by Disk diffusion (KB) |
|
68-7
|
Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
67-9
|
Cefamandole [Susceptibility] by Minimum lethal concentration (MLC) |
|
48269-5
|
Cefamandole triggered leukotriene release [Mass/volume] by Leukocytes |
|
3441-3
|
Cefamandole [Mass/volume] in Serum or Plasma |
|
18876-3
|
Cefamandole [Susceptibility] |
|
70-3
|
Cefamandole [Susceptibility] by Serum bactericidal titer |
|
55637-3
|
Cefamandole+Sulbactam [Susceptibility] by Gradient strip |
|
55636-5
|
Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55634-0
|
Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55635-7
|
Cefamandole+Sulbactam [Susceptibility] |
|
55639-9
|
Cefatrizine [Susceptibility] by Gradient strip |
|
73-7
|
Cefatrizine [Susceptibility] by Disk diffusion (KB) |
|
72-9
|
Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
71-1
|
Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18877-1
|
Cefatrizine [Susceptibility] |
|
74-5
|
Cefatrizine [Susceptibility] by Serum bactericidal titer |
|
73048-1
|
ceFAZolin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73047-3
|
ceFAZolin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4159-0
|
ceFAZolin [Mass] of Dose |
|
80962-4
|
ceFAZolin free [Mass/volume] in Serum or Plasma |
|
73472-3
|
ceFAZolin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73473-1
|
ceFAZolin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41670-1
|
ceFAZolin [Susceptibility] by Gradient strip |
|
77-8
|
ceFAZolin [Susceptibility] by Disk diffusion (KB) |
|
76-0
|
ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
75-2
|
ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC) |
|
85422-4
|
ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC) |
|
48270-3
|
ceFAZolin triggered leukotriene release [Mass/volume] by Leukocytes |
|
3443-9
|
ceFAZolin [Mass/volume] in Serum or Plasma |
|
18878-9
|
ceFAZolin [Susceptibility] |
|
78-6
|
ceFAZolin [Susceptibility] by Serum bactericidal titer |
|
16566-2
|
ceFAZolin [Mass/volume] in Urine |
|
25235-3
|
ceFAZolin [Mass/volume] in Unspecified specimen |
|
76143-7
|
Cefcapene [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35757-4
|
Cefdinir [Susceptibility] by Gradient strip |
|
35758-2
|
Cefdinir [Susceptibility] by Disk diffusion (KB) |
|
23637-2
|
Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23636-4
|
Cefdinir [Susceptibility] |
|
35760-8
|
Cefditoren [Susceptibility] by Gradient strip |
|
35759-0
|
Cefditoren [Susceptibility] by Disk diffusion (KB) |
|
35761-6
|
Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35762-4
|
Cefditoren [Susceptibility] |
|
73046-5
|
Cefepime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73045-7
|
Cefepime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73471-5
|
Cefepime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73470-7
|
Cefepime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6987-2
|
Cefepime [Susceptibility] by Gradient strip |
|
8272-7
|
Cefepime [Susceptibility] by Disk diffusion (KB) |
|
6644-9
|
Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6643-1
|
Cefepime [Susceptibility] by Minimum lethal concentration (MLC) |
|
50631-1
|
Cefepime [Susceptibility] by Method for Slow-growing mycobacteria |
|
31143-1
|
Cefepime [Susceptibility] for meningitis by Gradient strip |
|
58412-8
|
Cefepime [Susceptibility] for meningitis by Disk diffusion (KB) |
|
31142-3
|
Cefepime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
38363-8
|
Cefepime [Mass/volume] in Serum or Plasma |
|
18879-7
|
Cefepime [Susceptibility] |
|
8273-5
|
Cefepime [Susceptibility] by Serum bactericidal titer |
|
35763-2
|
Cefepime+Clavulanate [Susceptibility] by Gradient strip |
|
42350-9
|
Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
42351-7
|
Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
42353-3
|
Cefepime+Clavulanate [Susceptibility] |
|
55640-7
|
Cefetamet [Susceptibility] by Gradient strip |
|
35764-0
|
Cefetamet [Susceptibility] by Disk diffusion (KB) |
|
35765-7
|
Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32377-4
|
Cefetamet [Susceptibility] |
|
35766-5
|
Cefixime [Susceptibility] by Gradient strip |
|
81-0
|
Cefixime [Susceptibility] by Disk diffusion (KB) |
|
80-2
|
Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
79-4
|
Cefixime [Susceptibility] by Minimum lethal concentration (MLC) |
|
16567-0
|
Cefixime [Mass/volume] in Serum or Plasma |
|
18880-5
|
Cefixime [Susceptibility] |
|
82-8
|
Cefixime [Susceptibility] by Serum bactericidal titer |
|
25236-1
|
Cefixime [Mass/volume] in Unspecified specimen |
|
55641-5
|
Cefmenoxime [Susceptibility] by Gradient strip |
|
54174-8
|
Cefmenoxime [Susceptibility] by Disk diffusion (KB) |
|
54203-5
|
Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32375-8
|
Cefmenoxime [Susceptibility] |
|
25222-1
|
Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
11575-8
|
Cefmetazole [Susceptibility] by Gradient strip |
|
89-3
|
Cefmetazole [Susceptibility] by Disk diffusion (KB) |
|
88-5
|
Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87-7
|
Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18881-3
|
Cefmetazole [Susceptibility] |
|
90-1
|
Cefmetazole [Susceptibility] by Serum bactericidal titer |
|
54908-9
|
Cefminox [Susceptibility] |
|
6988-0
|
Cefodizime [Susceptibility] by Gradient strip |
|
93-5
|
Cefodizime [Susceptibility] by Disk diffusion (KB) |
|
92-7
|
Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
91-9
|
Cefodizime [Susceptibility] by Minimum lethal concentration (MLC) |
|
18882-1
|
Cefodizime [Susceptibility] |
|
94-3
|
Cefodizime [Susceptibility] by Serum bactericidal titer |
|
4160-8
|
Cefonicid [Mass] of Dose |
|
55642-3
|
Cefonicid [Susceptibility] by Gradient strip |
|
97-6
|
Cefonicid [Susceptibility] by Disk diffusion (KB) |
|
96-8
|
Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
95-0
|
Cefonicid [Susceptibility] by Minimum lethal concentration (MLC) |
|
3444-7
|
Cefonicid [Mass/volume] in Serum or Plasma |
|
18883-9
|
Cefonicid [Susceptibility] |
|
98-4
|
Cefonicid [Susceptibility] by Serum bactericidal titer |
|
25237-9
|
Cefonicid [Mass/volume] in Unspecified specimen |
|
4161-6
|
Cefoperazone [Mass] of Dose |
|
35767-3
|
Cefoperazone [Susceptibility] by Gradient strip |
|
101-6
|
Cefoperazone [Susceptibility] by Disk diffusion (KB) |
|
100-8
|
Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
99-2
|
Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC) |
|
3445-4
|
Cefoperazone [Mass/volume] in Serum or Plasma |
|
18884-7
|
Cefoperazone [Susceptibility] |
|
102-4
|
Cefoperazone [Susceptibility] by Serum bactericidal titer |
|
35768-1
|
Cefoperazone+Sulbactam [Susceptibility] by Gradient strip |
|
54168-0
|
Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54167-2
|
Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54166-4
|
Cefoperazone+Sulbactam [Susceptibility] |
|
55643-1
|
Ceforanide [Susceptibility] by Gradient strip |
|
105-7
|
Ceforanide [Susceptibility] by Disk diffusion (KB) |
|
104-0
|
Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
103-2
|
Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
|
18885-4
|
Ceforanide [Susceptibility] |
|
106-5
|
Ceforanide [Susceptibility] by Serum bactericidal titer |
|
4162-4
|
Cefotaxime [Mass] of Dose |
|
80961-6
|
Cefotaxime free [Mass/volume] in Serum or Plasma |
|
6989-8
|
Cefotaxime [Susceptibility] by Gradient strip |
|
109-9
|
Cefotaxime [Susceptibility] by Disk diffusion (KB) |
|
108-1
|
Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
107-3
|
Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
|
50632-9
|
Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria |
|
31139-9
|
Cefotaxime [Susceptibility] for meningitis by Gradient strip |
|
55189-5
|
Cefotaxime [Susceptibility] for meningitis by Disk diffusion (KB) |
|
31138-1
|
Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
3446-2
|
Cefotaxime [Mass/volume] in Serum or Plasma |
|
18886-2
|
Cefotaxime [Susceptibility] |
|
52128-6
|
Cefotaxime [Susceptibility] for meningitis |
|
110-7
|
Cefotaxime [Susceptibility] by Serum bactericidal titer |
|
25238-7
|
Cefotaxime [Mass/volume] in Unspecified specimen |
|
41671-9
|
Cefotaxime+Clavulanate [Susceptibility] by Gradient strip |
|
35769-9
|
Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
35770-7
|
Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35771-5
|
Cefotaxime+Clavulanate [Susceptibility] |
|
55644-9
|
Cefotaxime+Sulbactam [Susceptibility] by Gradient strip |
|
54193-8
|
Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54192-0
|
Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54191-2
|
Cefotaxime+Sulbactam [Susceptibility] |
|
4163-2
|
cefoTEtan [Mass] of Dose |
|
6990-6
|
cefoTEtan [Susceptibility] by Gradient strip |
|
113-1
|
cefoTEtan [Susceptibility] by Disk diffusion (KB) |
|
112-3
|
cefoTEtan [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
111-5
|
cefoTEtan [Susceptibility] by Minimum lethal concentration (MLC) |
|
3447-0
|
cefoTEtan [Mass/volume] in Serum or Plasma |
|
18887-0
|
cefoTEtan [Susceptibility] |
|
114-9
|
cefoTEtan [Susceptibility] by Serum bactericidal titer |
|
25239-5
|
cefoTEtan [Mass/volume] in Unspecified specimen |
|
41674-3
|
cefoTEtan+Clavulanate [Susceptibility] by Gradient strip |
|
41673-5
|
cefoTEtan+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41672-7
|
cefoTEtan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41729-5
|
cefoTEtan+Clavulanate [Susceptibility] |
|
55740-5
|
Cefotiam hexetil [Susceptibility] by Gradient strip |
|
55739-7
|
Cefotiam hexetil [Susceptibility] by Disk diffusion (KB) |
|
55737-1
|
Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55738-9
|
Cefotiam hexetil [Susceptibility] |
|
55645-6
|
Cefotiam [Susceptibility] by Gradient strip |
|
35772-3
|
Cefotiam [Susceptibility] by Disk diffusion (KB) |
|
35773-1
|
Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32374-1
|
Cefotiam [Susceptibility] |
|
76147-8
|
Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87792-8
|
Cefovecin [Susceptibility] |
|
25220-5
|
cefOXitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4164-0
|
cefOXitin [Mass] of Dose |
|
18241-0
|
cefOXitin IgE Ab [Units/volume] in Serum |
|
6991-4
|
cefOXitin [Susceptibility] by Gradient strip |
|
117-2
|
cefOXitin [Susceptibility] by Disk diffusion (KB) |
|
116-4
|
cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
115-6
|
cefOXitin [Susceptibility] by Minimum lethal concentration (MLC) |
|
25366-6
|
cefOXitin [Susceptibility] by Method for Slow-growing mycobacteria |
|
3448-8
|
cefOXitin [Mass/volume] in Serum or Plasma |
|
18888-8
|
cefOXitin [Susceptibility] |
|
118-0
|
cefOXitin [Susceptibility] by Serum bactericidal titer |
|
25240-3
|
cefOXitin [Mass/volume] in Unspecified specimen |
|
41677-6
|
cefOXitin+Clavulanate [Susceptibility] by Gradient strip |
|
41676-8
|
cefOXitin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41675-0
|
cefOXitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41730-3
|
cefOXitin+Clavulanate [Susceptibility] |
|
53820-7
|
Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6992-2
|
Cefpirome [Susceptibility] by Gradient strip |
|
8276-8
|
Cefpirome [Susceptibility] by Disk diffusion (KB) |
|
8275-0
|
Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
8274-3
|
Cefpirome [Susceptibility] by Minimum lethal concentration (MLC) |
|
18889-6
|
Cefpirome [Susceptibility] |
|
6650-6
|
Cefpirome [Susceptibility] by Serum bactericidal titer |
|
90849-1
|
Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
6993-0
|
Cefpodoxime [Susceptibility] by Gradient strip |
|
121-4
|
Cefpodoxime [Susceptibility] by Disk diffusion (KB) |
|
120-6
|
Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
119-8
|
Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) |
|
18890-4
|
Cefpodoxime [Susceptibility] |
|
122-2
|
Cefpodoxime [Susceptibility] by Serum bactericidal titer |
|
25241-1
|
Cefpodoxime [Mass/volume] in Unspecified specimen |
|
41678-4
|
Cefpodoxime+Clavulanate [Susceptibility] by Gradient strip |
|
41680-0
|
Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41679-2
|
Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41731-1
|
Cefpodoxime+Clavulanate [Susceptibility] |
|
6994-8
|
Cefprozil [Susceptibility] by Gradient strip |
|
125-5
|
Cefprozil [Susceptibility] by Disk diffusion (KB) |
|
124-8
|
Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
123-0
|
Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) |
|
18891-2
|
Cefprozil [Susceptibility] |
|
126-3
|
Cefprozil [Susceptibility] by Serum bactericidal titer |
|
4165-7
|
Cefsulodin [Mass] of Dose |
|
55647-2
|
Cefsulodin [Susceptibility] by Gradient strip |
|
129-7
|
Cefsulodin [Susceptibility] by Disk diffusion (KB) |
|
128-9
|
Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
127-1
|
Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) |
|
131-3
|
Cefsulodin [Mass/volume] in Serum or Plasma |
|
18892-0
|
Cefsulodin [Susceptibility] |
|
130-5
|
Cefsulodin [Susceptibility] by Serum bactericidal titer |
|
25242-9
|
Cefsulodin [Mass/volume] in Unspecified specimen |
|
74170-2
|
Ceftaroline [Susceptibility] by Gradient strip |
|
73650-4
|
Ceftaroline [Susceptibility] by Disk diffusion (KB) |
|
73627-2
|
Ceftaroline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73605-8
|
Ceftaroline [Susceptibility] |
|
73649-6
|
Ceftaroline+Avibactam [Susceptibility] by Disk diffusion (KB) |
|
73626-4
|
Ceftaroline+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73604-1
|
Ceftaroline+Avibactam [Susceptibility] |
|
73044-0
|
cefTAZidime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73043-2
|
cefTAZidime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
90850-9
|
cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4166-5
|
cefTAZidime [Mass] of Dose |
|
80960-8
|
cefTAZidime free [Mass/volume] in Serum or Plasma |
|
73468-1
|
cefTAZidime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73469-9
|
cefTAZidime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6995-5
|
cefTAZidime [Susceptibility] by Gradient strip |
|
134-7
|
cefTAZidime [Susceptibility] by Disk diffusion (KB) |
|
133-9
|
cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
132-1
|
cefTAZidime [Susceptibility] by Minimum lethal concentration (MLC) |
|
58705-5
|
cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteria |
|
3449-6
|
cefTAZidime [Mass/volume] in Serum or Plasma |
|
18893-8
|
cefTAZidime [Susceptibility] |
|
135-4
|
cefTAZidime [Susceptibility] by Serum bactericidal titer |
|
21151-6
|
cefTAZidime [Mass/volume] in Unspecified specimen |
|
87734-0
|
cefTAZidime+Avibactam [Susceptibility] by Gradient strip |
|
73648-8
|
cefTAZidime+Avibactam [Susceptibility] by Disk diffusion (KB) |
|
73625-6
|
cefTAZidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73603-3
|
cefTAZidime+Avibactam [Susceptibility] |
|
42352-5
|
cefTAZidime+Clavulanate [Susceptibility] by Gradient strip |
|
35774-9
|
cefTAZidime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
35775-6
|
cefTAZidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35776-4
|
cefTAZidime+Clavulanate [Susceptibility] |
|
55651-4
|
cefTAZidime+Sulbactam [Susceptibility] by Gradient strip |
|
55650-6
|
cefTAZidime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55648-0
|
cefTAZidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55649-8
|
cefTAZidime+Sulbactam [Susceptibility] |
|
76144-5
|
Cefteram [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6996-3
|
Ceftibuten [Susceptibility] by Gradient strip |
|
35777-2
|
Ceftibuten [Susceptibility] by Disk diffusion (KB) |
|
35778-0
|
Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35779-8
|
Ceftibuten [Susceptibility] |
|
55652-2
|
Ceftiofur [Susceptibility] by Gradient strip |
|
35780-6
|
Ceftiofur [Susceptibility] by Disk diffusion (KB) |
|
35781-4
|
Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23709-9
|
Ceftiofur [Susceptibility] |
|
4167-3
|
Ceftizoxime [Mass] of Dose |
|
73466-5
|
Ceftizoxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73467-3
|
Ceftizoxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6997-1
|
Ceftizoxime [Susceptibility] by Gradient strip |
|
138-8
|
Ceftizoxime [Susceptibility] by Disk diffusion (KB) |
|
137-0
|
Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
136-2
|
Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) |
|
20378-6
|
Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria |
|
3450-4
|
Ceftizoxime [Mass/volume] in Serum or Plasma |
|
18894-6
|
Ceftizoxime [Susceptibility] |
|
139-6
|
Ceftizoxime [Susceptibility] by Serum bactericidal titer |
|
25243-7
|
Ceftizoxime [Mass/volume] in Unspecified specimen |
|
85052-9
|
Ceftobiprole [Susceptibility] by Gradient strip |
|
43269-0
|
Ceftobiprole [Susceptibility] by Disk diffusion (KB) |
|
43271-6
|
Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
43270-8
|
Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC) |
|
43272-4
|
Ceftobiprole [Susceptibility] |
|
87735-7
|
Ceftolozane+Tazobactam [Susceptibility] by Gradient strip |
|
73647-0
|
Ceftolozane+Tazobactam [Susceptibility] by Disk diffusion (KB) |
|
73624-9
|
Ceftolozane+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73602-5
|
Ceftolozane+Tazobactam [Susceptibility] |
|
73042-4
|
cefTRIAXone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73041-6
|
cefTRIAXone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4168-1
|
cefTRIAXone [Mass] of Dose |
|
80957-4
|
cefTRIAXone free [Mass/volume] in Serum or Plasma |
|
16569-6
|
cefTRIAXone IgE Ab [Mass/volume] in Serum |
|
73464-0
|
cefTRIAXone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73465-7
|
cefTRIAXone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6998-9
|
cefTRIAXone [Susceptibility] by Gradient strip |
|
142-0
|
cefTRIAXone [Susceptibility] by Disk diffusion (KB) |
|
141-2
|
cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
140-4
|
cefTRIAXone [Susceptibility] by Minimum lethal concentration (MLC) |
|
25367-4
|
cefTRIAXone [Susceptibility] by Method for Slow-growing mycobacteria |
|
31141-5
|
cefTRIAXone [Susceptibility] for meningitis by Gradient strip |
|
55190-3
|
cefTRIAXone [Susceptibility] for meningitis by Disk diffusion (KB) |
|
31140-7
|
cefTRIAXone [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
3451-2
|
cefTRIAXone [Mass/volume] in Serum or Plasma |
|
18895-3
|
cefTRIAXone [Susceptibility] |
|
50633-7
|
cefTRIAXone [Susceptibility] for meningitis |
|
143-8
|
cefTRIAXone [Susceptibility] by Serum bactericidal titer |
|
25244-5
|
cefTRIAXone [Mass/volume] in Unspecified specimen |
|
41683-4
|
cefTRIAXone+Clavulanate [Susceptibility] by Gradient strip |
|
41682-6
|
cefTRIAXone+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41681-8
|
cefTRIAXone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41732-9
|
cefTRIAXone+Clavulanate [Susceptibility] |
|
16568-8
|
Cefuroxime IgE Ab [Units/volume] in Serum |
|
73462-4
|
Cefuroxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73463-2
|
Cefuroxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55654-8
|
Cefuroxime [Susceptibility] by Gradient strip |
|
74699-0
|
Cefuroxime [Susceptibility] by Disk diffusion (KB) |
|
51774-8
|
Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
48197-8
|
Cefuroxime triggered leukotriene release [Mass/volume] by Leukocytes |
|
55653-0
|
Cefuroxime Oral [Susceptibility] by Gradient strip |
|
35782-2
|
Cefuroxime Oral [Susceptibility] by Disk diffusion (KB) |
|
20460-2
|
Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35783-0
|
Cefuroxime Oral [Susceptibility] |
|
4169-9
|
Cefuroxime Parenteral [Mass] of Dose |
|
6999-7
|
Cefuroxime Parenteral [Susceptibility] by Gradient strip |
|
146-1
|
Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) |
|
145-3
|
Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
144-6
|
Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) |
|
3452-0
|
Cefuroxime Parenteral [Mass/volume] in Serum or Plasma |
|
18896-1
|
Cefuroxime Parenteral [Susceptibility] |
|
147-9
|
Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer |
|
25245-2
|
Cefuroxime Parenteral [Mass/volume] in Unspecified specimen |
|
80608-3
|
Cefuroxime [Mass/volume] in Serum or Plasma |
|
51724-3
|
Cefuroxime [Susceptibility] |
|
80617-4
|
Cefuroxime free [Mass/volume] in Serum or Plasma |
|
73040-8
|
Celecoxib induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73039-0
|
Celecoxib induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73461-6
|
Celecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73460-8
|
Celecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
28066-9
|
Celecoxib [Mass/volume] in Serum or Plasma |
|
64960-8
|
Celery recombinant (rApi g) 1 IgE Ab [Units/volume] in Serum |
|
91123-0
|
Celery recombinant (rApi g) 1 IgE Ab RAST class [Presence] in Serum |
|
7198-5
|
Celery triggered histamine release [Units/volume] in Blood |
|
6065-7
|
Celery IgE Ab [Units/volume] in Serum |
|
15618-2
|
Celery IgE Ab RAST class [Presence] in Serum |
|
61218-4
|
Celery IgE Ab/IgE total in Serum |
|
7197-7
|
Celery IgG Ab [Units/volume] in Serum |
|
21152-4
|
Celery IgG Ab RAST class [Presence] in Serum |
|
56213-2
|
Celery IgG4 Ab [Mass/volume] in Serum |
|
60363-9
|
Celery IgG Ab [Mass/volume] in Serum |
|
48203-4
|
Celery triggered leukotriene release [Mass/volume] by Leukocytes |
|
33255-1
|
Cell Fractions/Differential [Interpretation] in Blood |
|
20998-1
|
Cell Fractions/Differential [Interpretation] in Cerebral spinal fluid |
|
20999-9
|
Cell Fractions/Differential [Interpretation] in Body fluid |
|
56119-1
|
Cellular material [Mass/mass] of Stone by Estimated |
|
62368-6
|
Cell phase [Type] |
|
32760-1
|
Cell type in Unspecified specimen |
|
88053-4
|
Cells.CD4-CD8-CD45R+TCR alpha beta+ [#/volume] in Blood by Flow cytometry (FC) |
|
4469-3
|
Cellano Ag [Presence] on Red Blood Cells |
|
10562-7
|
Cells [#/volume] in Cervical mucus |
|
58469-8
|
Cells [#/volume] in Body fluid |
|
12182-2
|
Cells [#/volume] in Body fluid by Manual count |
|
32162-0
|
Cells [#/volume] in Pleural fluid by Manual count |
|
32163-8
|
Cells [#/volume] in Peritoneal fluid by Manual count |
|
32164-6
|
Cells [#/volume] in Synovial fluid by Manual count |
|
62360-3
|
Cells analyzed [#] |
|
64092-0
|
Cells analyzed [#] in Amniotic fluid by Molecular genetics method |
|
64086-2
|
Cells analyzed [#] in Chorionic villus sample by Molecular genetics method |
|
79887-6
|
Cells [#] Left anterior chamber Slit lamp biomicroscopy |
|
79886-8
|
Cells [#] Right anterior chamber Slit lamp biomicroscopy |
|
62361-1
|
Cells counted [#] |
|
64095-3
|
Cells counted [#] in Amniotic fluid by Molecular genetics method |
|
64089-6
|
Cells counted [#] in Chorionic villus sample by Molecular genetics method |
|
19077-7
|
Cells identified in Body fluid |
|
32858-3
|
IgG cells/100 cells in Unspecified specimen |
|
64091-2
|
Cells karyotyped.total [#] in Amniotic fluid |
|
55199-4
|
Cells karyotyped.total [#] in Blood or Tissue |
|
64085-4
|
Cells karyotyped.total [#] in Chorionic villus sample |
|
10563-5
|
Cells other than spermatozoa [#/volume] in Semen |
|
58438-3
|
Cells [Type] in Urine sediment by Light microscopy |
|
93356-4
|
Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method |
|
84915-8
|
Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH |
|
84914-1
|
Cells.chromosome region 13q14 deletion/Cells counted in Blood or Tissue by FISH |
|
84916-6
|
Cells.chromosome region 17p13.1 deletion/Cells counted in Blood or Tissue by FISH |
|
78211-0
|
Cells.4q12 chromosome region rearrangements/Cells counted in Blood or Tissue by FISH |
|
84920-8
|
Cells.chromosome region 5q31 deletion/Cells counted in Blood or Tissue by FISH |
|
84912-5
|
Cells.chromosome region 5q31 deletion/Cells counted in Bone marrow by FISH |
|
84921-6
|
Cells.chromosome region 7q31 deletion/Cells counted in Blood or Tissue by FISH |
|
78212-8
|
Cells.9q34 chromosome region deletion/Cells counted in Blood or Tissue by FISH |
|
78233-4
|
Cells.ALK gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78232-6
|
Cells.BCL2 gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78213-6
|
Cells.BCL6 gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78214-4
|
Cells.CCND1 gene duplication/Cells counted in Blood or Tissue by FISH |
|
73974-8
|
CD158e cells/100 cells in Unspecified specimen |
|
84913-3
|
Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISH |
|
86239-1
|
Cells.chromosome 3 monosomy/Cells counted in Cancer specimen by FISH |
|
84922-4
|
Cells.chromosome 7 monosomy/Cells counted in Blood or Tissue by FISH |
|
88052-6
|
Cells.CD4-CD8-CD45R+TCR alpha beta+/100 CD3 cells in Blood by Flow cytometry (FC) |
|
78917-2
|
Cells.FGFR1 gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78236-7
|
Cells.IGH gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78234-2
|
Cells.MLL gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78343-1
|
Cells.MYB gene deletion/Cells counted in Blood or Tissue by FISH |
|
78229-2
|
Cells.MYC gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78235-9
|
Cells.PDGFRB gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
83053-9
|
Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain |
|
78230-0
|
Cells.RARA gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
78231-8
|
Cells.TRA+TRD gene rearrangements/Cells counted in Blood or Tissue by FISH |
|
74232-0
|
Cellularity assessment in Bone marrow Narrative |
|
67127-1
|
Cellularity assessment [Interpretation] in Unspecified specimen by Flow cytometry (FC) Narrative |
|
82390-6
|
Centromere protein A Ab [Units/volume] in Serum by Line blot |
|
81714-8
|
Centromere protein A Ab [Presence] in Serum by Line blot |
|
72318-9
|
Centromere protein A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
76185-8
|
Central apnea duration Respiratory system |
|
79826-4
|
Central corneal thickness Left cornea Pachymetry |
|
79825-6
|
Central corneal thickness Right cornea Pachymetry |
|
78199-7
|
Cardiovascular system.central US Study diagnosis |
|
89207-5
|
Center for Epidemiologic Studies Depression Scale-Revised [CESD-R] |
|
89205-9
|
Center for Epidemiologic Studies Depression Scale-Revised total score [CESD-R] |
|
90564-6
|
Central apnea hypopnea index |
|
70003-9
|
Central apnea index 24 hour |
|
54150-8
|
Centriole Ab [Presence] in Serum by Immunofluorescence |
|
54151-6
|
Centriole Ab [Titer] in Serum by Immunofluorescence |
|
63530-0
|
Centromere Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63526-8
|
Centromere Ab [Presence] in Body fluid |
|
63527-6
|
Centromere Ab [Presence] in Body fluid by Immunoassay |
|
63528-4
|
Centromere Ab [Presence] in Body fluid by Immunofluorescence |
|
17830-1
|
Centromere Ab [Units/volume] in Body fluid |
|
16137-2
|
Centromere Ab [Presence] in Serum |
|
57739-5
|
Centromere Ab [Presence] in Serum by Immunoblot |
|
16570-4
|
Centromere Ab [Presence] in Serum by Immunofluorescence |
|
8068-9
|
Centromere Ab [Units/volume] in Serum |
|
63531-8
|
Centromere Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
42197-4
|
Centromere Ab [Titer] in Body fluid |
|
63529-2
|
Centromere Ab [Titer] in Body fluid by Immunofluorescence |
|
42196-6
|
Centromere Ab [Titer] in Serum |
|
5077-3
|
Centromere Ab [Titer] in Serum by Immunofluorescence |
|
63533-4
|
Centromere protein B Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89542-5
|
Centromere protein B Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63532-6
|
Centromere protein B Ab [Presence] in Body fluid by Immunoassay |
|
82391-4
|
Centromere protein B Ab [Units/volume] in Serum by Line blot |
|
53981-7
|
Centromere protein B Ab [Presence] in Serum |
|
56734-7
|
Centromere protein B Ab [Presence] in Serum by Immunoblot |
|
53982-5
|
Centromere protein B Ab [Units/volume] in Serum |
|
82913-5
|
Centromere protein B IgG Ab [Presence] in Serum by Line blot |
|
54001-3
|
Centromere protein F Ab [Presence] in Serum by Immunofluorescence |
|
54002-1
|
Centromere protein F Ab [Titer] in Serum by Immunofluorescence |
|
35272-4
|
Centromere IgG Ab [Presence] in Serum |
|
31290-0
|
Centromere IgG Ab [Units/volume] in Serum |
|
29966-9
|
Centromere IgG Ab [Titer] in Serum by Immunofluorescence |
|
16571-2
|
Cephadrine [Mass/volume] in Serum or Plasma |
|
21173-0
|
Cephaeline [Mass/volume] in Serum or Plasma |
|
21174-8
|
Cephaeline [Mass/volume] in Urine |
|
4170-7
|
Cephalexin [Mass] of Dose |
|
56695-0
|
Cephalexin IgE Ab [Units/volume] in Serum |
|
73458-2
|
Cephalexin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73459-0
|
Cephalexin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35784-8
|
Cephalexin [Susceptibility] by Gradient strip |
|
150-3
|
Cephalexin [Susceptibility] by Disk diffusion (KB) |
|
149-5
|
Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
148-7
|
Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3453-8
|
Cephalexin [Mass/volume] in Serum or Plasma |
|
18897-9
|
Cephalexin [Susceptibility] |
|
151-1
|
Cephalexin [Susceptibility] by Serum bactericidal titer |
|
21175-5
|
Cephalexin [Mass/volume] in Unspecified specimen |
|
55629-0
|
Cephaloglycin [Susceptibility] by Gradient strip |
|
154-5
|
Cephaloglycin [Susceptibility] by Disk diffusion (KB) |
|
153-7
|
Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
152-9
|
Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18898-7
|
Cephaloglycin [Susceptibility] |
|
155-2
|
Cephaloglycin [Susceptibility] by Serum bactericidal titer |
|
41684-2
|
Cephaloridine [Susceptibility] by Gradient strip |
|
158-6
|
Cephaloridine [Susceptibility] by Disk diffusion (KB) |
|
157-8
|
Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
156-0
|
Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) |
|
16572-0
|
Cephaloridine [Mass/volume] in Serum or Plasma |
|
18899-5
|
Cephaloridine [Susceptibility] |
|
159-4
|
Cephaloridine [Susceptibility] by Serum bactericidal titer |
|
7199-3
|
Cephalosporine mold IgE Ab [Units/volume] in Serum |
|
47384-3
|
Cephalosporine mold IgE Ab RAST class [Presence] in Serum |
|
18419-2
|
Cephalosporine mold IgG Ab [Units/volume] in Serum |
|
48196-0
|
Cephalosporin C triggered leukotriene release [Mass/volume] by Leukocytes |
|
50033-0
|
Cephalosporin IgE Ab [Units/volume] in Serum |
|
4171-5
|
Cephalothin [Mass] of Dose |
|
7000-3
|
Cephalothin [Susceptibility] by Gradient strip |
|
162-8
|
Cephalothin [Susceptibility] by Disk diffusion (KB) |
|
161-0
|
Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
160-2
|
Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3454-6
|
Cephalothin [Mass/volume] in Serum or Plasma |
|
18900-1
|
Cephalothin [Susceptibility] |
|
163-6
|
Cephalothin [Susceptibility] by Serum bactericidal titer |
|
25246-0
|
Cephalothin [Mass/volume] in Unspecified specimen |
|
55633-2
|
Cephalothin+Sulbactam [Susceptibility] by Gradient strip |
|
55632-4
|
Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55630-8
|
Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55631-6
|
Cephalothin+Sulbactam [Susceptibility] |
|
55638-1
|
Cephapirin [Susceptibility] by Gradient strip |
|
166-9
|
Cephapirin [Susceptibility] by Disk diffusion (KB) |
|
165-1
|
Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
164-4
|
Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) |
|
10980-1
|
Cephapirin [Mass/volume] in Serum or Plasma |
|
18901-9
|
Cephapirin [Susceptibility] |
|
167-7
|
Cephapirin [Susceptibility] by Serum bactericidal titer |
|
55646-4
|
Cephradine [Susceptibility] by Gradient strip |
|
170-1
|
Cephradine [Susceptibility] by Disk diffusion (KB) |
|
169-3
|
Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
168-5
|
Cephradine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18902-7
|
Cephradine [Susceptibility] |
|
171-9
|
Cephradine [Susceptibility] by Serum bactericidal titer |
|
76150-2
|
Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
93876-1
|
Ceramide risk score in Plasma by calculation |
|
34680-9
|
Ceramide trihexoside [Presence] in Urine |
|
93770-6
|
Ceramide trihexoside [Molar ratio] in Urine |
|
11998-2
|
Cerebral artery anterior Pulsatility index US.doppler |
|
12134-3
|
Cerebral artery anterior Systolic flow/Diastolic flow US.doppler |
|
11700-2
|
Cerebral artery anterior Peak systolic flow velocity US.doppler |
|
11673-1
|
Cerebral artery anterior Mean blood flow velocity US.doppler |
|
11655-8
|
Cerebral artery anterior Minimal flow velocity US.doppler |
|
12000-6
|
Cerebral artery middle Pulsatility index US.doppler |
|
12014-7
|
Cerebral artery middle Resistivity index US.doppler |
|
12136-8
|
Cerebral artery middle Systolic flow/Diastolic flow US.doppler |
|
11702-8
|
Cerebral artery middle Peak systolic flow velocity US.doppler |
|
11674-9
|
Cerebral artery middle Mean blood flow velocity US.doppler |
|
11657-4
|
Cerebral artery middle Minimal flow velocity US.doppler |
|
87514-6
|
Cerebral monitor |
|
61017-0
|
Cerebral perfusion pressure |
|
49321-3
|
Cerebroside sulfatase activator [Interpretation] in Fibroblast Narrative |
|
25833-5
|
Cerebroside sulfatase activator [Interpretation] in Fibroblast |
|
21176-3
|
Cerebroventricular lining cells [Presence] in Cerebral spinal fluid by Light microscopy |
|
77130-3
|
CERKL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77129-5
|
CERKL gene full mutation analysis in Blood or Tissue by Sequencing |
|
89013-7
|
Certified first responder was on site when EMS unit arrived |
|
80571-3
|
Certificate |
|
71580-5
|
Certification NEMSIS |
|
75535-5
|
Certification received [NMMDS] |
|
71522-7
|
Certified program Dialysis facility [ESRD] |
|
87405-7
|
Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
87404-0
|
Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
40455-8
|
Ceruloplasmin actual/normal in Serum or Plasma |
|
53073-3
|
Ceruloplasmin [Moles/volume] in Cerebral spinal fluid |
|
46716-7
|
Ceruloplasmin [Mass/volume] in DBS |
|
29213-6
|
Ceruloplasmin [Mass/volume] in Body fluid |
|
2064-4
|
Ceruloplasmin [Mass/volume] in Serum or Plasma |
|
47600-2
|
Ceruloplasmin [Moles/volume] in Serum or Plasma |
|
88341-3
|
Cerumen [Presence] in Ear |
|
11961-0
|
Cervix [Length] US |
|
65753-6
|
Cervix Pathology biopsy report |
|
79164-0
|
CES1 gene c.428G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
29982-6
|
Cesium [Mass/volume] in 24 hour Urine |
|
29983-4
|
Cesium [Mass/time] in 24 hour Urine |
|
5614-3
|
Cesium [Mass/volume] in Blood |
|
5615-0
|
Cesium [Mass/mass] in Hair |
|
5617-6
|
Cesium [Mass/volume] in Red Blood Cells |
|
5616-8
|
Cesium [Mass/volume] in Serum or Plasma |
|
5618-4
|
Cesium [Mass/volume] in Urine |
|
29984-2
|
Cesium/Creatinine [Mass Ratio] in 24 hour Urine |
|
82541-4
|
Cetuximab IgE Ab [Units/volume] in Serum |
|
82542-2
|
Cetuximab IgE Ab RAST class [Presence] in Serum |
|
43132-0
|
California encephalitis virus Ab [Units/volume] in Serum Qualitative |
|
35696-4
|
California encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
43931-5
|
California encephalitis virus Ab [Titer] in Serum |
|
49195-1
|
California encephalitis virus IgG Ab [Units/volume] in Serum |
|
49194-4
|
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
49138-1
|
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
35694-9
|
California encephalitis virus IgG Ab [Titer] in Serum |
|
49140-7
|
California encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
88456-9
|
California encephalitis virus IgG+IgM Ab [Interpretation] in Serum Qualitative by Immunofluorescence |
|
49193-6
|
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
49139-9
|
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
35695-6
|
California encephalitis virus IgM Ab [Titer] in Serum |
|
49141-5
|
California encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
66754-3
|
Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase |
|
74148-8
|
Cystic fibrosis action plan |
|
46769-6
|
Cystic fibrosis newborn screen interpretation |
|
57707-2
|
Cystic fibrosis newborn screening comment-discussion |
|
85820-9
|
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase |
|
66758-4
|
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60M post maximum clot amplitude |
|
85819-1
|
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase |
|
6659-7
|
Microscopic observation [Identifier] in Tissue by Carbol-fuchsin stain |
|
659-3
|
Microscopic observation [Identifier] in Unspecified specimen by Carbol-fuchsin stain |
|
75606-4
|
Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75605-6
|
Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
51779-7
|
CFH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
52768-9
|
Clot formation [Time] in Blood by Thromboelastography |
|
66753-5
|
Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase |
|
52770-5
|
Clot formation.extrinsic coagulation system activated [Time] in Blood by Rotational TEG |
|
52769-7
|
Clot formation.extrinsic coagulation system activated.fibrinolysis suppressed [Time] in Blood by Rotational TEG |
|
52772-1
|
Clot formation.intrinsic coagulation system activated.heparin insensitive [Time] in Blood by Rotational TEG |
|
52771-3
|
Clot formation.intrinsic coagulation system activated [Time] in Blood by Rotational TEG |
|
82794-9
|
Spontaneous clot formation [Time] in Platelet poor plasma |
|
42938-1
|
CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
|
42939-9
|
CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
|
38449-5
|
CFTR gene c.1078delT [Presence] in Blood or Tissue by Molecular genetics method |
|
38450-3
|
CFTR gene c.2184delA [Presence] in Blood or Tissue by Molecular genetics method |
|
38451-1
|
CFTR gene c.2789+5G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
38452-9
|
CFTR gene c.3120+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
34706-2
|
CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method |
|
38453-7
|
CFTR gene c.3659delC [Presence] in Blood or Tissue by Molecular genetics method |
|
38456-0
|
CFTR gene c.3849+10kbC>T [Presence] in Blood or Tissue by Molecular genetics method |
|
70244-9
|
CFTR gene c.394delTT [Presence] in Blood or Tissue by Molecular genetics method |
|
38455-2
|
CFTR gene c.621+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
38447-9
|
CFTR gene c.711+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
69480-2
|
CFTR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
90256-9
|
CFTR gene full mutation analysis in Blood or Tissue by Sequencing |
|
53789-4
|
CFTR gene.p.IVS8 polyT 7T/9T [presence] in Blood or Tissue by Molecular genetics method |
|
43370-6
|
CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method |
|
46989-0
|
CFTR gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
34718-7
|
CFTR gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
38404-0
|
CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21654-9
|
CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77017-2
|
CFTR gene mutation analysis [interpretation] in Blood or Tissue Qualitative by MS.MALDI |
|
78382-9
|
CFTR gene mutations found [Identifier] in Blood or Tissue by MS.MALDI-TOF Nominal |
|
54083-1
|
CFTR gene mutations found [Identifier] in DBS Nominal |
|
21656-4
|
CFTR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
38448-7
|
CFTR gene p.Ala455Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
57930-0
|
CFTR gene p.Asp1152His [Presence] in Blood or Tissue by Molecular genetics method |
|
21655-6
|
CFTR gene.p.Phe508del [Presence] in Blood or Tissue by Molecular genetics method |
|
38454-5
|
CFTR gene p.Gly85Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
34729-4
|
CFTR gene.p.Arg117His+5T variant [Presence] in Blood or Tissue by Molecular genetics method |
|
57931-8
|
CFTR+PRSS1+SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10472-9
|
Chromogranin Ag [Presence] in Tissue by Immune stain |
|
10471-1
|
Chromogranin A Ag [Presence] in Tissue by Immune stain |
|
59227-9
|
Chromogranin A [Units/volume] in Cerebral spinal fluid |
|
59241-0
|
Chromogranin A [Units/volume] in Body fluid |
|
53047-7
|
Chromogranin A [Mass/volume] in Body fluid |
|
59220-4
|
Chromogranin A [Units/volume] in Pleural fluid |
|
59226-1
|
Chromogranin A [Units/volume] in Peritoneal fluid |
|
30169-7
|
Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay |
|
9811-1
|
Chromogranin A [Mass/volume] in Serum or Plasma |
|
25587-7
|
Chromogranin A [Moles/volume] in Serum or Plasma |
|
2402-6
|
Guanosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
|
46762-1
|
Congenital hypothyroidism newborn screen interpretation |
|
57705-6
|
Congenital hypothyroidism newborn screening comment-discussion |
|
58054-8
|
Ch sup(a) Ab [Presence] in Serum or Plasma |
|
58053-0
|
Ch sup(a) Ag [Presence] on Red Blood Cells |
|
14076-4
|
Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) |
|
13088-0
|
Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
|
74521-6
|
Complement total hemolytic CH50 actual/normal in Serum by Immunoassay |
|
48496-4
|
Complement total hemolytic CH50 actual/normal in Serum or Plasma |
|
21218-3
|
Complement total hemolytic CH50 [Units/volume] in Cerebral spinal fluid |
|
4511-2
|
Complement total hemolytic CH50 [Units/volume] in Body fluid |
|
4532-8
|
Complement total hemolytic CH50 [Units/volume] in Serum or Plasma |
|
30131-7
|
Complement total hemolytic CH50 [Mass/volume] in Serum or Plasma |
|
48071-5
|
Complement total hemolytic CH50 [Titer] in Serum or Plasma |
|
88311-6
|
Chair alarm used during 7 day assessment period [CMS Assessment] |
|
15334-6
|
Challenge |
|
6057-4
|
Chamomile IgE Ab [Units/volume] in Serum |
|
15621-6
|
Chamomile IgE Ab RAST class [Presence] in Serum |
|
54696-0
|
Change in behavioral or other symptoms in last 7 days [CMS Assessment] |
|
86478-5
|
Change in symptoms of heart failure compared with 2 weeks ago [KCCQ] |
|
71789-2
|
Change in systolic blood pressure |
|
75274-1
|
Characteristics of residence |
|
9374-0
|
Character of Cerebral spinal fluid |
|
13359-5
|
Character of Semen |
|
14271-1
|
Character of Synovial fluid |
|
19244-3
|
Character of Urine |
|
73813-8
|
Characteristics of labor and delivery [US Standard Certificate of Live Birth] |
|
49967-3
|
Charcoal [Presence] in Urine sediment by Light microscopy |
|
53242-4
|
Charge ticket or encounter form |
|
86209-4
|
Community health care Case manager Note |
|
88643-2
|
Community health care Nurse Adult day care center Note |
|
85902-5
|
Community health care Nurse Note |
|
90752-7
|
Community health care Social worker Note |
|
76141-1
|
Reticulocyte corpuscular hemoglobin concentration mean [Mass/volume] in Blood |
|
93201-2
|
Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method |
|
56469-0
|
Cardiac heart disease risk [Ratio] in Serum or Plasma |
|
42240-2
|
CHD7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76686-5
|
Reticulocyte cellular hemoglobin distribution width [Entitic mass] in Blood by calculation |
|
72569-7
|
Cholinesterase [Pure catalytic fraction] in Serum or Plasma --dibucaine/Cholinesterase |
|
80566-3
|
Checklist |
|
7205-8
|
Cheese cheddar type triggered histamine release [Units/volume] in Blood |
|
6067-3
|
Cheese cheddar type IgE Ab [Units/volume] in Serum |
|
15623-2
|
Cheese cheddar type IgE Ab RAST class [Presence] in Serum |
|
57932-6
|
Cheese cheddar type IgE Ab/IgE total in Serum |
|
7204-1
|
Cheese cheddar type IgG Ab [Units/volume] in Serum |
|
21178-9
|
Cheese cheddar type IgG Ab RAST class [Presence] in Serum |
|
56215-7
|
Cheese cheddar type IgG4 Ab [Mass/volume] in Serum |
|
63092-1
|
Cheese cheddar type IgG Ab [Mass/volume] in Serum |
|
75224-6
|
Chediak-Higashi cells [Presence] in Blood |
|
7497-1
|
Cheese mold type triggered histamine release [Units/volume] in Blood |
|
6068-1
|
Cheese mold type IgE Ab [Units/volume] in Serum |
|
15854-3
|
Cheese mold type IgE Ab RAST class [Presence] in Serum |
|
57933-4
|
Cheese mold type IgE Ab/IgE total in Serum |
|
7496-3
|
Cheese mold type IgG Ab [Units/volume] in Serum |
|
56216-5
|
Cheese mold type IgG4 Ab [Mass/volume] in Serum |
|
60364-7
|
Cheese mold type IgG Ab [Mass/volume] in Serum |
|
72518-4
|
CHEK2 gene c.470C>T and 1100delC [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
89038-4
|
CHEK2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
81191-9
|
Chemical pathology Consult note |
|
88060-9
|
Chemotherapy infusion start time |
|
88061-7
|
Chemotherapy infusion stop time |
|
88063-3
|
Chemotherapy infusion start date |
|
88062-5
|
Chemotherapy infusion stop date |
|
11486-8
|
Chemotherapy records |
|
79170-7
|
Cherry recombinant (rPru av) 1 IgE Ab [Units/volume] in Serum |
|
79169-9
|
Cherry recombinant (rPru av) 3 IgE Ab [Units/volume] in Serum |
|
79168-1
|
Cherry recombinant (rPru av) 4 IgE Ab [Units/volume] in Serum |
|
7218-1
|
Cherry triggered histamine release [Units/volume] in Blood |
|
6719-9
|
Cherry IgE Ab [Units/volume] in Serum |
|
15628-1
|
Cherry IgE Ab RAST class [Presence] in Serum |
|
61306-7
|
Cherry IgE Ab/IgE total in Serum |
|
7217-3
|
Cherry IgG Ab [Units/volume] in Serum |
|
21181-3
|
Cherry IgG Ab RAST class [Presence] in Serum |
|
56191-0
|
Cherry IgG4 Ab [Mass/volume] in Serum |
|
60365-4
|
Cherry IgG Ab [Mass/volume] in Serum |
|
6259-6
|
Chestnut IgE Ab [Units/volume] in Serum |
|
15629-9
|
Chestnut IgE Ab RAST class [Presence] in Serum |
|
57925-0
|
Chestnut IgE Ab/IgE total in Serum |
|
56396-5
|
Chestnut IgG4 Ab [Mass/volume] in Serum |
|
63132-5
|
Chestnut IgG Ab [Mass/volume] in Serum |
|
6069-9
|
Chestnut Pollen IgE Ab [Units/volume] in Serum |
|
15632-3
|
Chestnut Pollen IgE Ab RAST class [Presence] in Serum |
|
7221-5
|
Chewing gum IgE Ab [Units/volume] in Serum |
|
56144-9
|
CHIC2 gene 4q12 deletion in Blood or Tissue by FISH |
|
41749-3
|
CHIC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7573-9
|
Chick Pea IgE Ab [Units/volume] in Serum |
|
15915-2
|
Chick Pea IgE Ab RAST class [Presence] in Serum |
|
61244-0
|
Chick Pea IgE Ab/IgE total in Serum |
|
56217-3
|
Chick Pea IgG4 Ab [Mass/volume] in Serum |
|
63135-8
|
Chick Pea IgG Ab [Mass/volume] in Serum |
|
7223-1
|
Chicken triggered histamine release [Units/volume] in Blood |
|
65785-8
|
Chicken CSA serum albumin native (nGal d) 5 IgE Ab [Units/volume] in Serum |
|
56694-3
|
Chicken droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
19734-3
|
Chicken droppings IgE Ab [Units/volume] in Serum |
|
25586-9
|
Chicken droppings IgE Ab RAST class [Presence] in Serum |
|
58911-9
|
Chicken droppings IgG Ab [Mass/volume] in Serum |
|
55591-2
|
Chicken feather IgE Ab [Presence] in Serum |
|
6070-7
|
Chicken feather IgE Ab [Units/volume] in Serum |
|
15633-1
|
Chicken feather IgE Ab RAST class [Presence] in Serum |
|
61337-2
|
Chicken feather IgE Ab/IgE total in Serum |
|
51546-0
|
Chicken feather IgG Ab [Presence] in Serum |
|
7224-9
|
Chicken feather IgG Ab [Units/volume] in Serum |
|
56437-7
|
Chicken feather IgG4 Ab [Mass/volume] in Serum |
|
81783-3
|
Chicken feather IgG Ab [Mass/volume] in Serum |
|
40879-9
|
Chicken IgE Ab [Units/volume] in Serum |
|
38465-1
|
Chicken IgE Ab/IgE total in Serum |
|
7222-3
|
Chicken IgG Ab [Units/volume] in Serum |
|
21182-1
|
Chicken IgG Ab RAST class [Presence] in Serum |
|
56218-1
|
Chicken IgG4 Ab [Mass/volume] in Serum |
|
35532-1
|
Chicken IgG Ab [Mass/volume] in Serum |
|
6071-5
|
Chicken meat IgE Ab [Units/volume] in Serum |
|
15634-9
|
Chicken meat IgE Ab RAST class [Presence] in Serum |
|
40843-5
|
Chicken meat IgE Ab/IgE total in Serum |
|
21183-9
|
Chicken meat IgG Ab RAST class [Presence] in Serum |
|
31291-8
|
Chicken serum Ab [Presence] in Serum |
|
24498-8
|
Chicken serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
6836-1
|
Chicken serum proteins IgE Ab [Units/volume] in Serum |
|
23837-8
|
Chicken serum proteins IgE Ab RAST class [Presence] in Serum |
|
38466-9
|
Chicken serum proteins IgG Ab [Presence] in Serum |
|
7225-6
|
Chicory IgE Ab [Units/volume] in Serum |
|
15635-6
|
Chicory IgE Ab RAST class [Presence] in Serum |
|
56219-9
|
Chicory IgG4 Ab [Mass/volume] in Serum |
|
63144-0
|
Chicory IgG Ab [Mass/volume] in Serum |
|
71588-8
|
Chief complaint [Location] NEMSIS |
|
46239-0
|
Chief complaint+Reason for visit Narrative |
|
90115-7
|
Chief of staff email address |
|
90113-2
|
Chief of staff name |
|
90114-0
|
Chief of staff phone number |
|
26623-9
|
Chikungunya virus Ab [Presence] in Serum |
|
74821-0
|
Chikungunya virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
43064-5
|
Chikungunya virus Ab [Titer] in Serum |
|
40505-0
|
Chikungunya virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
82297-3
|
Chikungunya virus structural proteins (E1+E2) IgG Ab [Presence] in Serum by Immunoassay |
|
83068-7
|
Chikungunya virus structural proteins (E1+E2) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
83067-9
|
Chikungunya virus structural proteins (E1+E2) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
93979-3
|
Chikungunya virus IgG Ab [Presence] in Serum |
|
88630-9
|
Chikungunya virus IgG Ab [Presence] in Serum by Immunoassay |
|
56129-0
|
Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
56128-2
|
Chikungunya virus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
57934-2
|
Chikungunya virus IgM Ab [Presence] in Serum |
|
88629-1
|
Chikungunya virus IgM Ab [Presence] in Serum by Immunoassay |
|
56131-6
|
Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
56130-8
|
Chikungunya virus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
81153-9
|
Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81152-1
|
Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Serum by NAA with probe detection |
|
86514-7
|
Chikungunya virus RNA [Presence] in Amniotic fluid by NAA with probe detection |
|
85583-3
|
Chikungunya virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
60260-7
|
Chikungunya virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
86515-4
|
Chikungunya virus RNA [Presence] in Urine by NAA with probe detection |
|
51664-1
|
Chikungunya virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85582-5
|
Chikungunya virus RNA+Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
85519-7
|
Child and adolescent psychology Consult note |
|
85520-5
|
Child and adolescent psychology Discharge summary |
|
85518-9
|
Child and adolescent psychology Initial evaluation note |
|
89568-0
|
Child care availability status [CUBS] |
|
68696-4
|
Neurology with special qualifications in child neurology Diagnostic study note |
|
68697-2
|
Neurology with special qualifications in child neurology Discharge summary |
|
68699-8
|
Neurology with special qualifications in child neurology History and physical note |
|
68705-3
|
Neurology with special qualifications in child neurology Hospital Consult note |
|
68706-1
|
Neurology with special qualifications in child neurology Hospital Diagnostic study note |
|
68707-9
|
Neurology with special qualifications in child neurology Hospital Letter |
|
68700-4
|
Neurology with special qualifications in child neurology Note |
|
68701-2
|
Neurology with special qualifications in child neurology Preoperative evaluation and management note |
|
68702-0
|
Neurology with special qualifications in child neurology procedure note |
|
68703-8
|
Neurology with special qualifications in child neurology Progress note |
|
68704-6
|
Neurology with special qualifications in child neurology Transfer summary note |
|
68641-0
|
Child and adolescent psychiatry Diagnostic study note |
|
68642-8
|
Child and adolescent psychiatry Discharge summary |
|
77441-4
|
Child and adolescent psychiatry Flowsheet |
|
68644-4
|
Child and adolescent psychiatry History and physical note |
|
68648-5
|
Child and adolescent psychiatry Hospital Consult note |
|
68649-3
|
Child and adolescent psychiatry Hospital Letter |
|
68645-1
|
Child and adolescent psychiatry Note |
|
77446-3
|
Child and adolescent psychiatry Plan of care note |
|
68646-9
|
Child and adolescent psychiatry Progress note |
|
68647-7
|
Child and adolescent psychiatry Transfer summary note |
|
7593-7
|
Chili Pepper triggered histamine release [Units/volume] in Blood |
|
7591-1
|
Chili Pepper IgE Ab [Units/volume] in Serum |
|
15927-7
|
Chili Pepper IgE Ab RAST class [Presence] in Serum |
|
7592-9
|
Chili Pepper IgG Ab [Units/volume] in Serum |
|
21451-0
|
Chili Pepper IgG Ab RAST class [Presence] in Serum |
|
56220-7
|
Chili Pepper IgG4 Ab [Mass/volume] in Serum |
|
60366-2
|
Chili Pepper IgG Ab [Mass/volume] in Serum |
|
50032-2
|
China aster IgE Ab [Units/volume] in Serum |
|
30987-2
|
Chinchilla epithelium IgE Ab [Units/volume] in Serum |
|
51551-0
|
Chinchilla epithelium IgE Ab RAST class [Presence] in Serum |
|
11165-8
|
Chinchilla IgE Ab [Units/volume] in Serum |
|
15636-4
|
Chinchilla IgE Ab RAST class [Presence] in Serum |
|
7302-3
|
Chinese Elm IgE Ab [Units/volume] in Serum |
|
15698-4
|
Chinese Elm IgE Ab RAST class [Presence] in Serum |
|
56221-5
|
Chinese Elm IgG4 Ab [Mass/volume] in Serum |
|
7226-4
|
Chinese Tallow Tree IgE Ab [Units/volume] in Serum |
|
84071-0
|
Chiropractic medicine Consult note |
|
28581-7
|
Chiropractic medicine Initial evaluation note |
|
84072-8
|
Chiropractic medicine Telephone encounter Note |
|
28580-9
|
Chiropractic medicine Progress note |
|
53594-8
|
Chitobioside IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
55836-1
|
Chitotriosidase [Enzymatic activity/volume] in DBS |
|
38355-4
|
Chitotriosidase [Enzymatic activity/volume] in Serum or Plasma |
|
80371-8
|
Chitotriosidase [Enzymatic activity/mass] in Serum or Plasma |
|
93740-9
|
Chives IgE Ab [Units/volume] in Serum |
|
45011-4
|
Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
38468-5
|
Chlamydia sp Ab [Presence] in Cerebral spinal fluid |
|
31292-6
|
Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid |
|
16590-2
|
Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
|
5082-3
|
Chlamydia sp Ab [Units/volume] in Serum by Immunoassay |
|
16589-4
|
Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
|
45012-2
|
Chlamydia sp Ab [Presence] in Serum |
|
75757-5
|
Chlamydia sp Ab [Presence] in Serum by Complement fixation |
|
7823-8
|
Chlamydia sp Ab [Units/volume] in Serum |
|
23967-3
|
Chlamydia sp Ab [Titer] in Cerebral spinal fluid |
|
23990-5
|
Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
27273-2
|
Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22182-0
|
Chlamydia sp Ab [Titer] in Serum |
|
5083-1
|
Chlamydia sp Ab [Titer] in Serum by Complement fixation |
|
5084-9
|
Chlamydia sp Ab [Titer] in Serum by Immunofluorescence |
|
45105-4
|
Chlamydia sp Ag [Presence] in Anal |
|
45104-7
|
Chlamydia sp Ag [Presence] in Anal by Immunoassay |
|
45103-9
|
Chlamydia sp Ag [Presence] in Anal by Immunofluorescence |
|
31763-6
|
Chlamydia sp Ag [Presence] in Conjunctival specimen |
|
6343-8
|
Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunoassay |
|
6344-6
|
Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
45107-0
|
Chlamydia sp Ag [Presence] in Cervix |
|
45106-2
|
Chlamydia sp Ag [Presence] in Cervix by Immunoassay |
|
45108-8
|
Chlamydia sp Ag [Presence] in Cervix by Immunofluorescence |
|
31764-4
|
Chlamydia sp Ag [Presence] in Body fluid |
|
20755-5
|
Chlamydia sp Ag [Presence] in Body fluid by Immunoassay |
|
45109-6
|
Chlamydia sp Ag [Presence] in Body fluid by Immunofluorescence |
|
31765-1
|
Chlamydia sp Ag [Presence] in Genital specimen |
|
6345-3
|
Chlamydia sp Ag [Presence] in Genital specimen by Immunoassay |
|
6346-1
|
Chlamydia sp Ag [Presence] in Genital specimen by Immunofluorescence |
|
45133-6
|
Chlamydia sp Ag [Presence] in Nasopharynx |
|
45132-8
|
Chlamydia sp Ag [Presence] in Nasopharynx by Immunoassay |
|
45131-0
|
Chlamydia sp Ag [Presence] in Nasopharynx by Immunofluorescence |
|
32003-6
|
Chlamydia sp Ag [Presence] in Peritoneal fluid by Immunoassay |
|
31766-9
|
Chlamydia sp Ag [Presence] in Stool |
|
20756-3
|
Chlamydia sp Ag [Presence] in Stool by Immunoassay |
|
20757-1
|
Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence |
|
16593-6
|
Chlamydia sp Ag [Presence] in Urine |
|
32004-4
|
Chlamydia sp Ag [Presence] in Urine by Immunoassay |
|
45112-0
|
Chlamydia sp Ag [Presence] in Urine by Immunofluorescence |
|
45114-6
|
Chlamydia sp Ag [Presence] in Urethra |
|
45113-8
|
Chlamydia sp Ag [Presence] in Urethra by Immunoassay |
|
45115-3
|
Chlamydia sp Ag [Presence] in Urethra by Immunofluorescence |
|
32671-0
|
Chlamydia sp Ag [Presence] in Vaginal fluid |
|
32001-0
|
Chlamydia sp Ag [Presence] in Vaginal fluid by Immunoassay |
|
31767-7
|
Chlamydia sp Ag [Presence] in Unspecified specimen |
|
6347-9
|
Chlamydia sp Ag [Presence] in Unspecified specimen by Immunoassay |
|
561-1
|
Chlamydia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
45097-3
|
Chlamydia sp identified in Anal by Organism specific culture |
|
24005-1
|
Chlamydia sp identified in Bronchial specimen by Organism specific culture |
|
556-1
|
Chlamydia sp identified in Conjunctival specimen by Organism specific culture |
|
45098-1
|
Chlamydia sp identified in Cervix by Organism specific culture |
|
35711-1
|
Chlamydia sp DNA [Presence] in Anal by NAA with probe detection |
|
35710-3
|
Chlamydia sp DNA [Presence] in Conjunctival specimen by NAA with probe detection |
|
35713-7
|
Chlamydia sp DNA [Presence] in Cervix by NAA with probe detection |
|
32774-2
|
Chlamydia sp DNA [Presence] in Genital specimen by NAA with probe detection |
|
35412-6
|
Chlamydia sp DNA [Presence] in Nose by NAA with probe detection |
|
35722-8
|
Chlamydia sp DNA [Presence] in Serum by NAA with probe detection |
|
35724-4
|
Chlamydia sp DNA [Presence] in Throat by NAA with probe detection |
|
34708-8
|
Chlamydia sp DNA [Presence] in Urine by NAA with probe detection |
|
35727-7
|
Chlamydia sp DNA [Presence] in Urethra by NAA with probe detection |
|
35716-0
|
Chlamydia sp DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
35729-3
|
Chlamydia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
45099-9
|
Chlamydia sp identified in Body fluid by Organism specific culture |
|
557-9
|
Chlamydia sp identified in Genital specimen by Organism specific culture |
|
29677-2
|
Chlamydia sp IgA Ab [Presence] in Serum |
|
29664-0
|
Chlamydia sp IgA Ab [Presence] in Serum by Immunoassay |
|
25369-0
|
Chlamydia sp IgA Ab [Units/volume] in Serum |
|
43063-7
|
Chlamydia sp IgA Ab [Titer] in Serum |
|
34264-2
|
Chlamydia sp IgA Ab [Titer] in Serum by Immunofluorescence |
|
16591-0
|
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
45010-6
|
Chlamydia sp IgG Ab [Presence] in Cerebral spinal fluid |
|
22183-8
|
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
38467-7
|
Chlamydia sp IgG Ab [Presence] in Body fluid |
|
33410-2
|
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
21185-4
|
Chlamydia sp IgG Ab [Presence] in Serum |
|
56909-5
|
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay |
|
5085-6
|
Chlamydia sp IgG Ab [Units/volume] in Serum |
|
56910-3
|
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57679-3
|
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --1st specimen |
|
24238-8
|
Chlamydia sp IgG Ab [Units/volume] in Serum --1st specimen |
|
56911-1
|
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
57680-1
|
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --2nd specimen |
|
24239-6
|
Chlamydia sp IgG Ab [Units/volume] in Serum --2nd specimen |
|
22184-6
|
Chlamydia sp IgG Ab [Titer] in Serum |
|
10848-0
|
Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
16592-8
|
Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22185-3
|
Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid |
|
21186-2
|
Chlamydia sp IgM Ab [Presence] in Serum |
|
5086-4
|
Chlamydia sp IgM Ab [Units/volume] in Serum |
|
22186-1
|
Chlamydia sp IgM Ab [Titer] in Serum |
|
10849-8
|
Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
45101-3
|
Chlamydia sp identified in Nasopharynx by Organism specific culture |
|
35721-0
|
Chlamydia sp rRNA [Presence] in Anal by Probe |
|
35712-9
|
Chlamydia sp rRNA [Presence] in Conjunctival specimen by Probe |
|
35714-5
|
Chlamydia sp rRNA [Presence] in Cervix by Probe |
|
35715-2
|
Chlamydia sp rRNA [Presence] in Genital specimen by Probe |
|
35718-6
|
Chlamydia sp rRNA [Presence] in Nose by Probe |
|
35736-8
|
Chlamydia sp rRNA [Presence] in Nasopharynx by Probe |
|
35723-6
|
Chlamydia sp rRNA [Presence] in Serum by Probe |
|
35725-1
|
Chlamydia sp rRNA [Presence] in Throat by Probe |
|
35726-9
|
Chlamydia sp rRNA [Presence] in Urine by Probe |
|
35728-5
|
Chlamydia sp rRNA [Presence] in Urethra by Probe |
|
35717-8
|
Chlamydia sp rRNA [Presence] in Vaginal fluid by Probe |
|
35730-1
|
Chlamydia sp rRNA [Presence] in Unspecified specimen by Probe |
|
6348-7
|
Chlamydia sp identified in Sputum by Organism specific culture |
|
558-7
|
Chlamydia sp identified in Throat by Organism specific culture |
|
559-5
|
Chlamydia sp identified in Urethra by Organism specific culture |
|
45100-5
|
Chlamydia sp identified in Vaginal fluid by Organism specific culture |
|
560-3
|
Chlamydia sp identified in Unspecified specimen by Organism specific culture |
|
46179-8
|
Chlamydophila sp Ab [Presence] in Serum |
|
43847-3
|
Chlamydophila sp Ab [Presence] in Serum by Immunofluorescence |
|
43846-5
|
Chlamydophila sp Ab [Interpretation] in Serum |
|
12993-2
|
Hydrocarbons.chlorinated [Identifier] in Blood |
|
24422-8
|
Hydrocarbons.chlorinated [Identifier] in Unspecified specimen |
|
4071-7
|
Chloral hydrate [Mass/volume] in Blood |
|
4172-3
|
Chloral hydrate [Mass] of Dose |
|
59878-9
|
Chloral hydrate [Moles/volume] in Gastric fluid |
|
35119-7
|
Chloral hydrate [Presence] in Serum or Plasma |
|
3042-9
|
Chloral hydrate [Mass/volume] in Serum or Plasma |
|
55528-4
|
Chloral hydrate [Moles/volume] in Serum or Plasma |
|
17738-6
|
Chloral hydrate [Presence] in Urine |
|
17739-4
|
Chloral hydrate [Presence] in Urine by Confirmatory method |
|
4072-5
|
Chloral hydrate [Mass/volume] in Urine |
|
59877-1
|
Chloral hydrate [Moles/volume] in Urine |
|
60292-0
|
Chloral hydrate [Moles/volume] in Unspecified specimen |
|
44305-1
|
Chloral hydrate/Creatinine [Mass Ratio] in Urine |
|
6072-3
|
Chloramin T IgE Ab [Units/volume] in Serum |
|
15637-2
|
Chloramin T IgE Ab RAST class [Presence] in Serum |
|
48187-9
|
Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes |
|
9468-0
|
Chloramines [Mass/volume] in Water |
|
4173-1
|
Chloramphenicol [Mass] of Dose |
|
29214-4
|
Chloramphenicol [Mass/volume] in Body fluid |
|
29347-2
|
Chloramphenicol [Mass/volume] in Gastric fluid |
|
7001-1
|
Chloramphenicol [Susceptibility] by Gradient strip |
|
174-3
|
Chloramphenicol [Susceptibility] by Disk diffusion (KB) |
|
173-5
|
Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
172-7
|
Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) |
|
16603-3
|
Chloramphenicol [Mass/volume] in Serum or Plasma --peak |
|
3455-3
|
Chloramphenicol [Mass/volume] in Serum or Plasma |
|
15101-9
|
Chloramphenicol [Moles/volume] in Serum or Plasma |
|
18903-5
|
Chloramphenicol [Susceptibility] |
|
175-0
|
Chloramphenicol [Susceptibility] by Serum bactericidal titer |
|
16604-1
|
Chloramphenicol [Mass/volume] in Serum or Plasma --trough |
|
29346-4
|
Chloramphenicol [Mass/volume] in Urine |
|
25247-8
|
Chloramphenicol [Mass/volume] in Unspecified specimen |
|
12297-8
|
Chlorate [Presence] in Blood |
|
38579-9
|
Chlordane [Mass/volume] in Air |
|
9807-9
|
Chlordane [Mass/volume] in Serum or Plasma |
|
38341-4
|
Chlordane [Mass/volume] in Water |
|
87746-4
|
Chlordane [Mass/mass] in Unspecified specimen |
|
12305-9
|
Chlordecone [Presence] in Blood |
|
13638-2
|
Chlordecone [Mass/volume] in Blood |
|
13639-0
|
Chlordecone [Mass/volume] in Serum or Plasma |
|
59618-9
|
chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method |
|
59617-1
|
chlordiazePOXIDE [Mass/volume] in Blood |
|
19388-8
|
chlordiazePOXIDE cutoff [Mass/volume] in Urine for Confirmatory method |
|
19387-0
|
chlordiazePOXIDE cutoff [Mass/volume] in Urine for Screen method |
|
4175-6
|
chlordiazePOXIDE [Mass] of Dose |
|
59620-5
|
chlordiazePOXIDE [Mass/volume] in Body fluid by Confirmatory method |
|
59619-7
|
chlordiazePOXIDE [Mass/volume] in Body fluid |
|
52949-5
|
chlordiazePOXIDE [Presence] in Gastric fluid |
|
29380-3
|
chlordiazePOXIDE [Mass/volume] in Gastric fluid |
|
59880-5
|
chlordiazePOXIDE [Moles/volume] in Gastric fluid |
|
26790-6
|
chlordiazePOXIDE [Mass/mass] in Hair |
|
73457-4
|
chlordiazePOXIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73456-6
|
chlordiazePOXIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59621-3
|
chlordiazePOXIDE [Mass/mass] in Meconium by Confirmatory method |
|
26938-1
|
chlordiazePOXIDE [Mass/mass] in Meconium |
|
87808-2
|
chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59622-1
|
chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3456-1
|
chlordiazePOXIDE [Presence] in Serum or Plasma |
|
35600-6
|
chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method |
|
3457-9
|
chlordiazePOXIDE [Mass/volume] in Serum or Plasma |
|
32059-8
|
chlordiazePOXIDE [Moles/volume] in Serum or Plasma |
|
59623-9
|
chlordiazePOXIDE [Mass/mass] in Stool by Confirmatory method |
|
16185-1
|
chlordiazePOXIDE [Mass/volume] in Stool |
|
27418-3
|
chlordiazePOXIDE [Mass/mass] in Stool |
|
59625-4
|
chlordiazePOXIDE [Mass/mass] in Tissue by Confirmatory method |
|
59624-7
|
chlordiazePOXIDE [Mass/mass] in Tissue |
|
20522-9
|
chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method |
|
3458-7
|
chlordiazePOXIDE [Presence] in Urine |
|
19386-2
|
chlordiazePOXIDE [Presence] in Urine by Confirmatory method |
|
19385-4
|
chlordiazePOXIDE [Presence] in Urine by Screen method |
|
3459-5
|
chlordiazePOXIDE [Mass/volume] in Urine |
|
59879-7
|
chlordiazePOXIDE [Moles/volume] in Urine |
|
26900-1
|
chlordiazePOXIDE [Mass/volume] in Vitreous fluid |
|
48945-0
|
chlordiazePOXIDE [Mass/volume] in Unspecified specimen |
|
60293-8
|
chlordiazePOXIDE [Moles/volume] in Unspecified specimen |
|
66128-0
|
chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine |
|
33060-5
|
chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma |
|
21193-8
|
chlordiazePOXIDE+Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
|
66717-0
|
Chlorhexidine IgE Ab [Units/volume] in Serum |
|
66716-2
|
Chlorhexidine IgE Ab RAST class [Presence] in Serum |
|
32542-3
|
Chloride [Molar amount] in Urine collected for unspecified duration |
|
35676-6
|
Chloride [Moles/volume] in Urine collected for unspecified duration |
|
57340-2
|
Chloride [Moles/volume] in 12 hour Urine |
|
57342-8
|
Chloride [Moles/time] in 12 hour Urine |
|
58999-4
|
Chloride [Moles/time] in 18 hour Urine |
|
94000-7
|
Chloride [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
55837-9
|
Chloride [Moles/volume] in 24 hour Stool |
|
9742-8
|
Chloride [Moles/time] in 24 hour Stool |
|
51695-5
|
Chloride [Mass/time] in 24 hour Urine |
|
21194-6
|
Chloride [Moles/volume] in 24 hour Urine |
|
2079-2
|
Chloride [Moles/time] in 24 hour Urine |
|
94009-8
|
Chloride [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
57341-0
|
Chloride [Moles/volume] in 2 hour Urine |
|
2068-5
|
Chloride [Moles/volume] in Amniotic fluid |
|
41650-3
|
Chloride [Moles/volume] in Arterial blood |
|
51590-8
|
Chloride [Moles/volume] in Capillary blood |
|
2069-3
|
Chloride [Moles/volume] in Blood |
|
41649-5
|
Chloride [Moles/volume] in Venous blood |
|
2070-1
|
Chloride [Moles/volume] in Cerebral spinal fluid |
|
39467-6
|
Chloride [Moles/volume] in Peritoneal dialysis fluid |
|
2071-9
|
Chloride [Moles/volume] in Dialysis fluid |
|
54370-2
|
Chloride [Mass/volume] in Body fluid |
|
2072-7
|
Chloride [Moles/volume] in Body fluid |
|
59178-4
|
Chloride [Moles/volume] in Gastric fluid |
|
39357-9
|
Cholinesterase.chloride inhibited/Cholinesterase in Serum or Plasma |
|
72570-5
|
Cholinesterase.chloride inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
|
81080-4
|
Chloride intake 24 hour Estimated |
|
80983-0
|
Chloride intake 24 hour Measured |
|
60217-7
|
Chloride [Moles/volume] in Mother's milk |
|
54369-4
|
Chloride [Moles/volume] in Serum or Plasma --post dialysis |
|
53627-6
|
Chloride [Moles/volume] in Pleural fluid |
|
33366-6
|
Chloride [Moles/volume] in Peritoneal fluid |
|
2073-5
|
Chloride [Moles/volume] in Red Blood Cells |
|
2074-3
|
Chloride [Moles/volume] in Saliva (oral fluid) |
|
77138-6
|
Chloride [Moles/volume] in Serum, Plasma or Blood |
|
2075-0
|
Chloride [Moles/volume] in Serum or Plasma |
|
15158-9
|
Chloride [Moles/volume] in Stool |
|
2076-8
|
Chloride [Moles/mass] in Stool |
|
56448-4
|
Chloride [Moles/volume] in Sweat by Screen method |
|
2077-6
|
Chloride [Moles/volume] in Sweat |
|
53099-8
|
Chloride [Moles/volume] in Total parental nutrition |
|
26762-5
|
Chloride [Units/volume] in Urine |
|
2078-4
|
Chloride [Moles/volume] in Urine |
|
12898-3
|
Chloride [Moles/volume] in Vitreous fluid |
|
54494-0
|
Chloride [Mass/volume] in Water |
|
12530-2
|
Chloride [Moles/volume] in Water |
|
87475-0
|
Chloride [Mass/volume] in Unspecified specimen |
|
87476-8
|
Chloride [Mass/mass] in Unspecified specimen |
|
32307-1
|
Chloride [Moles/volume] in Unspecified specimen |
|
13721-6
|
Chloride/Creatinine [Mass Ratio] in 24 hour Urine |
|
53640-9
|
Chloride/Creatinine [Ratio] in 24 hour Urine |
|
43221-1
|
Chloride/Creatinine [Ratio] in Urine |
|
34265-9
|
Chloride/Creatinine [Molar ratio] in Urine |
|
74674-3
|
Chlorinated solvents [Presence] in Urine |
|
38647-4
|
Chlorine [Mass/volume] in Air |
|
16606-6
|
Chlorine [Mass/volume] in Dialysis fluid |
|
43158-5
|
Chlorine.free [Mass/volume] in Water |
|
16607-4
|
Chlorine [Mass/volume] in Water |
|
3461-1
|
Chlormerodrin [Mass/volume] in 24 hour Urine |
|
4176-4
|
Chlormerodrin [Mass] of Dose |
|
3460-3
|
Chlormerodrin [Presence] in Urine |
|
3462-9
|
Chlormerodrin [Mass/volume] in Urine |
|
12427-1
|
Chlormezanone [Mass/volume] in Serum or Plasma |
|
38654-0
|
Chloroacetate [Mass/volume] in Air |
|
53821-5
|
Chloroamphetamine [Mass/volume] in Serum |
|
38648-2
|
Chlorobenzene [Mass/volume] in Air |
|
8180-2
|
Chlorobenzene [Mass/volume] in Blood |
|
9505-9
|
Chlorobenzene [Mass/volume] in Serum or Plasma |
|
29902-4
|
Chlorobenzene [Mass/volume] in Urine |
|
38343-0
|
Chlorobenzene [Mass/volume] in Water |
|
38656-5
|
Chlorobenzilate [Mass/volume] in Air |
|
16605-8
|
Chlorocycline [Mass/volume] in Urine |
|
38694-6
|
Chloroethane [Mass/volume] in Air |
|
9506-7
|
Chloroethane [Mass/volume] in Blood |
|
38649-0
|
Chloroform [Mass/volume] in Air |
|
9333-6
|
Chloroform [Mass/volume] in Blood |
|
54937-8
|
Chloroform [Mass/volume] in Serum or Plasma |
|
38706-8
|
Chloromethane [Mass/volume] in Air |
|
9507-5
|
Chloromethane [Mass/volume] in Blood |
|
87610-2
|
Chlorophacinone [Mass/mass] in Unspecified specimen |
|
4182-2
|
Chloroquine [Mass] of Dose |
|
3463-7
|
Chloroquine [Mass/volume] in Serum or Plasma |
|
32060-6
|
Chloroquine [Moles/volume] in Serum or Plasma |
|
4177-2
|
Chlorothiazide [Mass] of Dose |
|
18386-3
|
Chlorothiazide [Presence] in Serum or Plasma |
|
3464-5
|
Chlorothiazide [Mass/volume] in Serum or Plasma |
|
9508-3
|
Chlorothiazide [Presence] in Urine |
|
9648-7
|
Chlorothiazide [Mass/volume] in Urine |
|
19394-6
|
Chlorpheniramine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19393-8
|
Chlorpheniramine cutoff [Mass/volume] in Urine for Screen method |
|
4178-0
|
Chlorpheniramine [Mass] of Dose |
|
59883-9
|
Chlorpheniramine [Moles/volume] in Gastric fluid |
|
75759-1
|
Chlorpheniramine [Presence] in Serum or Plasma or Urine by Screen method |
|
3465-2
|
Chlorpheniramine [Presence] in Serum or Plasma |
|
3466-0
|
Chlorpheniramine [Mass/volume] in Serum or Plasma |
|
59881-3
|
Chlorpheniramine [Moles/volume] in Serum or Plasma |
|
19391-2
|
Chlorpheniramine [Mass/volume] in Urine by Confirmatory method |
|
3467-8
|
Chlorpheniramine [Presence] in Urine |
|
16209-9
|
Chlorpheniramine [Presence] in Urine by Confirmatory method |
|
19389-6
|
Chlorpheniramine [Presence] in Urine by Screen method |
|
16608-2
|
Chlorpheniramine [Units/volume] in Urine |
|
19392-0
|
Chlorpheniramine [Mass/volume] in Urine |
|
59882-1
|
Chlorpheniramine [Moles/volume] in Urine |
|
57857-5
|
Chlorpheniramine [Moles/volume] in Unspecified specimen |
|
16609-0
|
Chlorphentermine [Units/volume] in Blood |
|
3468-6
|
Chlorphentermine [Mass/volume] in Blood |
|
26716-1
|
Chlorphentermine [Mass/mass] in Meconium |
|
27171-8
|
Chlorphentermine [Mass/volume] in Milk |
|
29602-0
|
Chlorphentermine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
27307-8
|
Chlorphentermine [Mass/mass] in Stool |
|
3469-4
|
Chlorphentermine [Presence] in Urine |
|
16610-8
|
Chlorphentermine [Units/volume] in Urine |
|
3470-2
|
Chlorphentermine [Mass/volume] in Urine |
|
27253-4
|
Chlorphentermine [Mass/volume] in Vitreous fluid |
|
19398-7
|
chlorproMAZINE cutoff [Mass/volume] in Urine for Confirmatory method |
|
19397-9
|
chlorproMAZINE cutoff [Mass/volume] in Urine for Screen method |
|
4179-8
|
chlorproMAZINE [Mass] of Dose |
|
14644-9
|
chlorproMAZINE [Presence] in Gastric fluid |
|
29386-0
|
chlorproMAZINE [Mass/volume] in Gastric fluid |
|
59885-4
|
chlorproMAZINE [Moles/volume] in Gastric fluid |
|
73454-1
|
chlorproMAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73455-8
|
chlorproMAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13548-3
|
chlorproMAZINE [Presence] in Serum or Plasma |
|
35601-4
|
chlorproMAZINE [Mass/volume] in Serum or Plasma by Screen method |
|
3471-0
|
chlorproMAZINE [Mass/volume] in Serum or Plasma |
|
14645-6
|
chlorproMAZINE [Moles/volume] in Serum or Plasma |
|
20523-7
|
chlorproMAZINE [Mass/volume] in Urine by Confirmatory method |
|
3472-8
|
chlorproMAZINE [Presence] in Urine |
|
19396-1
|
chlorproMAZINE [Presence] in Urine by Confirmatory method |
|
19395-3
|
chlorproMAZINE [Presence] in Urine by Screen method |
|
3473-6
|
chlorproMAZINE [Mass/volume] in Urine |
|
59884-7
|
chlorproMAZINE [Moles/volume] in Urine |
|
32061-4
|
chlorproMAZINE [Presence] in Unspecified specimen |
|
60294-6
|
chlorproMAZINE [Moles/volume] in Unspecified specimen |
|
38470-1
|
Chlorpropamide [Mass/volume] in 24 hour Urine |
|
4180-6
|
Chlorpropamide [Mass] of Dose |
|
73453-3
|
Chlorpropamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73452-5
|
Chlorpropamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48329-7
|
Chlorpropamide [Presence] in Serum or Plasma |
|
3474-4
|
Chlorpropamide [Mass/volume] in Serum or Plasma |
|
32062-2
|
Chlorpropamide [Moles/volume] in Serum or Plasma |
|
12329-9
|
Chlorpropamide [Presence] in Urine |
|
12396-8
|
Chlorpropamide [Mass/volume] in Urine |
|
48324-8
|
Chlorpropamide [Presence] in Unspecified specimen |
|
47392-6
|
Chlorpropamide [Mass/volume] in Unspecified specimen |
|
3475-1
|
Chlorprothixene [Mass/volume] in Blood |
|
4181-4
|
Chlorprothixene [Mass] of Dose |
|
3476-9
|
Chlorprothixene [Mass/volume] in Serum or Plasma |
|
48353-7
|
Chlorprothixene [Moles/volume] in Serum or Plasma |
|
3477-7
|
Chlorprothixene [Mass/volume] in Urine |
|
9371-6
|
Chlorpyrifos [Mass/volume] in Blood |
|
35489-4
|
Chlorpyrifos [Mass/volume] in Serum or Plasma |
|
16611-6
|
Chlorpyrifos [Mass/volume] in Urine |
|
87747-2
|
Chlorpyrifos [Mass/mass] in Unspecified specimen |
|
55655-5
|
Chlortetracycline [Susceptibility] by Gradient strip |
|
178-4
|
Chlortetracycline [Susceptibility] by Disk diffusion (KB) |
|
177-6
|
Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
176-8
|
Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18904-3
|
Chlortetracycline [Susceptibility] |
|
179-2
|
Chlortetracycline [Susceptibility] by Serum bactericidal titer |
|
87600-3
|
Chlortetracycline [Mass/mass] in Unspecified specimen |
|
3480-1
|
Chlorthalidone [Mass/time] in 24 hour Urine |
|
4183-0
|
Chlorthalidone [Mass] of Dose |
|
73451-7
|
Chlorthalidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73450-9
|
Chlorthalidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16612-4
|
Chlorthalidone [Mass/volume] in Serum or Plasma |
|
3478-5
|
Chlorthalidone [Presence] in Urine |
|
3479-3
|
Chlorthalidone [Mass/volume] in Urine |
|
12425-5
|
Chlorzoxazone [Mass/volume] in Serum or Plasma |
|
21195-3
|
Chlorzoxazone [Mass/volume] in Urine |
|
25609-9
|
Cochineal extract IgE Ab [Units/volume] in Serum |
|
25610-7
|
Cochineal extract IgE Ab RAST class [Presence] in Serum |
|
61336-4
|
Cochineal extract IgE Ab/IgE total in Serum |
|
7227-2
|
Chocolate triggered histamine release [Units/volume] in Blood |
|
6073-1
|
Chocolate IgE Ab [Units/volume] in Serum |
|
25370-8
|
Chocolate IgE Ab RAST class [Presence] in Serum |
|
57935-9
|
Chocolate IgE Ab/IgE total in Serum |
|
6720-7
|
Chocolate IgG Ab [Units/volume] in Serum |
|
21196-1
|
Chocolate IgG Ab RAST class [Presence] in Serum |
|
56222-3
|
Chocolate IgG4 Ab [Mass/volume] in Serum |
|
35554-5
|
Chocolate IgG Ab [Mass/volume] in Serum |
|
70263-9
|
Cholesterol in pericardial fluid/Cholesterol in serum |
|
70268-8
|
Cholesterol in pleural fluid/Cholesterol in serum |
|
70261-3
|
Cholesterol in peritoneal fluid/Cholesterol in serum |
|
90364-1
|
Cholesterol.in LDL.small dense [Mass/volume] in Serum by Immunoassay |
|
92756-6
|
Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in Blood |
|
92757-4
|
Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in DBS |
|
92755-8
|
Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in Serum or Plasma |
|
2080-0
|
Cholate [Mass/volume] in Serum |
|
30518-5
|
Cholate [Moles/volume] in Serum or Plasma |
|
4470-1
|
Choleglobin/Hemoglobin.total in Blood |
|
14438-6
|
Cholesterol [Mass/volume] in Amniotic fluid |
|
5932-9
|
Cholesterol [Presence] in Blood by Test strip |
|
55367-7
|
Cholesterol crystals [#/area] in Urine by Computer assisted method |
|
25153-8
|
Cholesterol crystals [#/area] in Urine sediment by Microscopy high power field |
|
77964-5
|
Cholesterol crystals [#/area] in Urine sediment by Microscopy low power field |
|
34472-1
|
Cholesterol crystals [Presence] in Bile fluid by Light microscopy |
|
16614-0
|
Cholesterol crystals [Presence] in Body fluid by Light microscopy |
|
16613-2
|
Cholesterol crystals [Presence] in Stone by Infrared spectroscopy |
|
93504-9
|
Cholesterol crystals [Presence] in Stone by X-ray diffraction |
|
50223-7
|
Cholesterol crystals [Presence] in Urine by Computer assisted method |
|
5777-8
|
Cholesterol crystals [Presence] in Urine sediment by Light microscopy |
|
14439-4
|
Cholesterol [Mass/volume] in Cerebral spinal fluid |
|
59038-0
|
Cholesterol [Mass/volume] in Peritoneal dialysis fluid |
|
53082-4
|
Cholesterol [Moles/volume] in Dialysis fluid |
|
73958-1
|
Cholesterol esterase [Enzymatic activity/volume] in DBS |
|
24079-6
|
Cholesterol esterase [Enzymatic activity/mass] in Fibroblast |
|
2083-4
|
Cholesterol esterase [Enzymatic activity/volume] in Serum |
|
59248-5
|
Cholesterol esterase [Enzymatic activity/mass] in Tissue |
|
74359-1
|
Cholesterol ester transfer protein actual/normal in Serum or Plasma |
|
55839-5
|
Cholesterol ester transfer protein [Units/volume] in Serum or Plasma |
|
24080-4
|
Cholesterol esterase [Enzymatic activity/mass] in Leukocytes |
|
21197-9
|
Cholesterol esters/Cholesterol.total in Serum or Plasma |
|
2084-2
|
Cholesterol esters [Mass/volume] in Serum or Plasma |
|
55840-3
|
Cholesterol esters [Moles/volume] in Serum or Plasma |
|
12183-0
|
Cholesterol [Mass/volume] in Body fluid |
|
29765-5
|
Cholesterol [Moles/volume] in Body fluid |
|
35389-6
|
Cholesterol.in chylomicrons [Presence] in Serum or Plasma |
|
34467-1
|
Cholesterol.in chylomicrons [Mass/volume] in Serum or Plasma |
|
54438-7
|
Cholesterol/Total in Stone |
|
56912-9
|
Cholesterol [Mass/volume] in Pericardial fluid |
|
78518-8
|
Cholesterol [Moles/volume] in Pericardial fluid |
|
9618-0
|
Cholesterol [Mass/volume] in Pleural fluid |
|
39468-4
|
Cholesterol [Moles/volume] in Pleural fluid |
|
9342-7
|
Cholesterol [Percentile] |
|
14441-0
|
Cholesterol [Mass/volume] in Peritoneal fluid |
|
54371-0
|
Cholesterol [Moles/volume] in Peritoneal fluid |
|
48620-9
|
Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate |
|
2093-3
|
Cholesterol [Mass/volume] in Serum or Plasma |
|
35200-5
|
Cholesterol [Mass or Moles/volume] in Serum or Plasma |
|
14647-2
|
Cholesterol [Moles/volume] in Serum or Plasma |
|
14442-8
|
Cholesterol [Mass/volume] in Semen |
|
14443-6
|
Cholesterol [Mass/volume] in Synovial fluid |
|
51591-6
|
Cholesterol [Moles/volume] in Synovial fluid |
|
14154-9
|
Cholesterol sulfate [Mass/volume] in Serum |
|
74517-4
|
Cholesterol sulfate [Moles/volume] in Serum or Plasma |
|
14444-4
|
Cholesterol [Mass/volume] in Urine |
|
32308-9
|
Cholesterol [Moles/volume] in Unspecified specimen |
|
48089-7
|
Cholesterol/Apolipoprotein B [Molar ratio] in Serum or Plasma |
|
9322-9
|
Cholesterol.total/Cholesterol in HDL [Percentile] |
|
9830-1
|
Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
|
32309-7
|
Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
16615-7
|
Cholesterol.total/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
|
55838-7
|
Cholesterol/Phospholipid [Molar ratio] in Serum or Plasma |
|
2096-6
|
Cholesterol/Triglyceride [Mass Ratio] in Serum or Plasma |
|
2082-6
|
Cholestanol [Mass/volume] in Serum or Plasma |
|
74432-6
|
Cholestanol [Moles/volume] in Serum or Plasma |
|
74433-4
|
Cholestanol/Cholesterol in Serum or Plasma |
|
81021-8
|
Cholesterol intake 24 hour Estimated |
|
81022-6
|
Cholesterol intake 24 hour Measured |
|
2097-4
|
Cholinesterase [Enzymatic activity/volume] in Amniotic fluid |
|
11154-2
|
Cholinesterase [Enzymatic activity/volume] in Blood |
|
20758-9
|
Cholinesterase [Enzymatic activity/mass] in Brain |
|
77367-1
|
Cholinesterase [Enzymatic activity/volume] in Serum or Plasma by calculation --Dibucaine |
|
39354-6
|
Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase |
|
89363-6
|
Cholinesterase [Enzymatic activity/volume] in Body fluid |
|
49851-9
|
Cholinesterase [Enzymatic activity/volume] in Peritoneal fluid |
|
2099-0
|
Cholinesterase [Enzymatic activity/volume] in Red Blood Cells |
|
49231-4
|
Cholinesterase [Enzymatic activity/mass] in Red Blood Cells |
|
34711-2
|
Cholinesterase [Presence] in Serum or Plasma |
|
2098-2
|
Cholinesterase [Enzymatic activity/volume] in Serum or Plasma |
|
2101-4
|
Cholylglycine.conjugated [Mass/volume] in Serum |
|
2100-6
|
Cholylglycine [Mass/volume] in Serum |
|
18364-0
|
Chondroitin sulfate [Mass/volume] in Serum |
|
24464-0
|
Chondroitin sulfate [Presence] in Urine |
|
2102-2
|
Chondroitin sulfate [Mass/volume] in Urine |
|
2103-0
|
Choriomammotropin [Mass/volume] in Amniotic fluid |
|
2104-8
|
Choriomammotropin [Mass/volume] in Serum |
|
92568-5
|
Fetal Chorion [Type] |
|
93801-9
|
Chromosome 1 polysomy [Presence] in Tissue by FISH |
|
35292-2
|
Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
81850-0
|
Chromosome region 11p15 methylation and deletion+duplication in Amniotic fluid by Molecular genetics method |
|
81851-8
|
Chromosome region 11p15 methylation and deletion+duplication in Blood or Tissue by Molecular genetics method |
|
57038-2
|
Chromosome 12 aneuploidy in Amniotic fluid by FISH Nominal |
|
93804-3
|
Chromosome 12 copy number/nucleus in Tissue by FISH |
|
21770-3
|
Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
42635-3
|
Chromosome 12p tetrasomy [Presence] in Fixed tissue by Molecular genetics method |
|
57454-1
|
Chromosome 13 aneuploidy in Amniotic fluid by FISH Nominal |
|
57037-4
|
Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by Molecular genetics method Nominal |
|
57317-0
|
Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by FISH Nominal |
|
57030-9
|
Chromosome 13+18+21+X+Y aneuploidy in Blood by Molecular genetics method Nominal |
|
57318-8
|
Chromosome 13+18+21+X+Y aneuploidy in Blood or Tissue by FISH Nominal |
|
57029-1
|
Fetal chromosome 13+18+21+X+Y aneuploidy in Tissue by Molecular genetics method Nominal |
|
81749-4
|
Chromosome region 13q14 deletion in Bone marrow by FISH |
|
35123-9
|
Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
81853-4
|
Chromosome 15 and 16 and 22 aneuploidy in Blood or Tissue by Molecular genetics method |
|
34503-3
|
Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
82238-7
|
Chromosome region 15q11-13 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
|
82240-3
|
Chromosome region 16p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
82239-5
|
Chromosome region 16p13.3 deletion in Blood or Tissue by FISH |
|
74861-6
|
Chromosome 17 copy number/nucleus in Tissue by FISH |
|
82241-1
|
Chromosome region 17p11.2 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
81751-0
|
Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH |
|
81746-0
|
Chromosome region 17p13.1 deletion in Blood or Tissue by FISH |
|
82242-9
|
Chromosome region 17p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
82243-7
|
Chromosome region 17p13.3 deletion in Blood or Tissue by FISH |
|
57453-3
|
Chromosome 18 aneuploidy in Amniotic fluid by FISH Nominal |
|
93803-5
|
Chromosome 19 polysomy [Presence] in Tissue by FISH |
|
82244-5
|
Chromosome region 1p36 deletion in Blood or Tissue by FISH |
|
81752-8
|
Chromosome region 1q21 duplication in Bone marrow by FISH |
|
93799-5
|
Chromosome 2 copy number/nucleus in Tissue by FISH |
|
84919-0
|
Chromosome 21 aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
|
21771-1
|
Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
43306-0
|
Chromosome 21 trisomy [Percentile] by Cytogenetics |
|
82245-2
|
Chromosome region 22q11.2 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
|
82246-0
|
Chromosome region 22q11.2 deletion and duplication mutation analysis in Blood or Tissue by FISH |
|
78238-3
|
Chromosome 3 copy number/nucleus in Blood or Tissue by FISH |
|
82251-0
|
Chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in Urine by FISH |
|
81747-8
|
Chromosome region 6q22 rearrangements in Tissue by FISH |
|
92905-9
|
Chromosome 7 copy number/nucleus in Blood or Tissue by FISH |
|
21772-9
|
Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
34496-0
|
Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
82247-8
|
Chromosome region 7q11.23 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
82248-6
|
Chromosome region 7q11.23 deletion in Blood or Tissue by FISH |
|
81852-6
|
Chromosome region 7q11.23 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
|
78237-5
|
Chromosome 8 copy number/nucleus in Blood or Tissue by FISH |
|
21773-7
|
Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
36907-4
|
Chromosome 8 trisomy [Percentile] by Cytogenetics |
|
82249-4
|
Chromosome region 8q23.3-24.13 deletion in Blood or Tissue by FISH |
|
21774-5
|
Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
82597-6
|
Chromosome painting analysis in Blood or Tissue by FISH |
|
75394-7
|
Chromosome uniparental disomy [Identifier] in Amniotic fluid or Chorionic villus sample by Molecular genetics method Narrative |
|
36917-3
|
Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
87436-2
|
Chromosome X and Y aneuploidy in Blood or Tissue by FISH |
|
73822-9
|
Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal |
|
84918-2
|
Chromosome X aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
|
84917-4
|
Chromosome Y aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
|
81748-6
|
Chromosome region Yp11.3 deletion AndOr rearrangement in Blood or Tissue by FISH |
|
86611-1
|
Chromosome analysis in Amniotic fluid or Chorionic villus sample by Microarray |
|
94087-4
|
Chromosome analysis in Blood or Tissue by Microarray |
|
55192-9
|
Chromosome analysis.interphase [Interpretation] in Amniotic fluid by FISH Narrative |
|
50684-0
|
Chromosome analysis.interphase [Interpretation] in Blood by FISH Narrative |
|
57802-1
|
Chromosome analysis.interphase [Interpretation] in Blood or Marrow by FISH Narrative |
|
55193-7
|
Chromosome analysis.interphase [Interpretation] in Chorionic villus sample by FISH Narrative |
|
50659-2
|
Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative |
|
59050-5
|
Chromosome analysis.interphase [Interpretation] in Unspecified specimen by FISH Narrative |
|
64090-4
|
Chromosome analysis overall interpretation in Unspecified specimen Qualitative by Molecular genetics method |
|
62357-9
|
Chromosome analysis overall interpretation Qualitative |
|
62356-1
|
Chromosome analysis result in ISCN expression |
|
62380-1
|
Chromosome band involved end |
|
62379-3
|
Chromosome band involved start |
|
62359-5
|
Chromosome banding method - |
|
57781-7
|
Chromosome breakage [Identifier] in Blood by Diepoxybutane Narrative |
|
34742-7
|
Chromosome breakage [Units/volume] in Blood by Diepoxybutane |
|
34730-2
|
Chromosome breakage [Interpretation] in Unspecified specimen |
|
62378-5
|
Chromosome copy number change [Type] |
|
33064-7
|
Chromate [Mass/volume] in Urine |
|
68380-5
|
Chromatin Ab [Presence] in Serum or Plasma |
|
51775-5
|
Chromatin Ab [Units/volume] in Serum or Plasma |
|
32580-3
|
Chromatin IgG Ab [Units/volume] in Serum or Plasma |
|
30923-7
|
Chromium [Mass/volume] in Urine collected for unspecified duration |
|
21201-9
|
Chromium [Mass/volume] in 24 hour Urine |
|
5624-2
|
Chromium [Mass/time] in 24 hour Urine |
|
47099-7
|
Chromium [Moles/volume] in 24 hour Urine |
|
40417-8
|
Chromium [Moles/time] in 24 hour Urine |
|
51903-3
|
Chromium [Mass/volume] in Air |
|
5619-2
|
Chromium [Mass/volume] in Blood |
|
15118-3
|
Chromium [Moles/volume] in Blood |
|
57939-1
|
Chromium [Mass/volume] in Cerebral spinal fluid |
|
21199-5
|
Chromium [Mass/volume] in Body fluid |
|
47098-9
|
Chromium [Moles/volume] in Body fluid |
|
5620-0
|
Chromium [Mass/mass] in Hair |
|
50842-4
|
Chromium [Moles/mass] in Hair |
|
81023-4
|
Chromium intake 24 hour Estimated |
|
81024-2
|
Chromium intake 24 hour Measured |
|
21200-1
|
Chromium [Mass/mass] in Nail |
|
5621-8
|
Chromium [Mass/volume] in Red Blood Cells |
|
50841-6
|
Chromium [Moles/volume] in Red Blood Cells |
|
8181-0
|
Chromium [Mass/volume] in Saliva (oral fluid) |
|
5622-6
|
Chromium [Mass/volume] in Serum or Plasma |
|
25374-0
|
Chromium [Moles/volume] in Serum or Plasma |
|
20759-7
|
Chromium [Mass/mass] in Tissue |
|
52891-9
|
Chromium [Moles/mass] in Tissue |
|
51977-7
|
Chromium [Presence] in Urine |
|
5623-4
|
Chromium [Mass/volume] in Urine |
|
42219-6
|
Chromium [Moles/volume] in Urine |
|
9469-8
|
Chromium [Mass/volume] in Water |
|
9690-9
|
Chromium [Mass/volume] in Unspecified specimen |
|
87474-3
|
Chromium [Mass/mass] in Unspecified specimen |
|
29919-8
|
Chromium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52934-7
|
Chromium/Creatinine [Molar ratio] in 24 hour Urine |
|
13464-3
|
Chromium/Creatinine [Mass Ratio] in Urine |
|
56650-5
|
Chromium/Creatinine [Ratio] in Urine |
|
42220-4
|
Chromium/Creatinine [Molar ratio] in Urine |
|
48000-4
|
Chromosome [Identifier] in Blood or Tissue by Molecular genetics method |
|
48297-6
|
Chromotrope 2B triggered leukotriene release [Mass/volume] by Leukocytes |
|
45266-4
|
Chronic leukemia markers [Interpretation] in Unspecified specimen Narrative |
|
49313-0
|
Chronic leukemia markers [Interpretation] in Unspecified specimen |
|
63369-3
|
Chronic urticaria index in Serum |
|
33049-8
|
Hypertonic cryohemolysis of Red Blood Cells |
|
10925-6
|
Chub Mackerel IgE Ab [Units/volume] in Serum |
|
15828-7
|
Chub Mackerel IgE Ab RAST class [Presence] in Serum |
|
56439-3
|
Chub Mackerel IgG4 Ab [Mass/volume] in Serum |
|
63086-3
|
Chub Mackerel IgG Ab [Mass/volume] in Serum |
|
82599-2
|
Chum salmon roe IgE Ab [Units/volume] in Serum |
|
82600-8
|
Chum salmon roe IgE Ab RAST class [Presence] in Serum |
|
10781-3
|
Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |
|
33009-2
|
Chylomicrons [Presence] in Body fluid |
|
49131-6
|
Chylomicrons/total Lipoprotein in Serum or Plasma |
|
33375-7
|
Chylomicrons [Presence] in Pleural fluid |
|
9617-2
|
Chylomicrons [Mass/volume] in Pleural fluid |
|
2121-2
|
Chylomicrons [Presence] in Serum or Plasma |
|
2120-4
|
Chylomicrons [Mass/volume] in Serum or Plasma |
|
14648-0
|
Chylomicrons [Moles/volume] in Serum or Plasma |
|
6074-9
|
Chymopapain IgE Ab [Units/volume] in Serum |
|
15640-6
|
Chymopapain IgE Ab RAST class [Presence] in Serum |
|
56451-8
|
Chymopapain IgG4 Ab [Mass/volume] in Serum |
|
2122-0
|
Chymopapain [Mass/volume] in Serum |
|
5091-4
|
Chymotrypsin Ab [Units/volume] in Serum |
|
10473-7
|
Chymotrypsin Ag [Presence] in Tissue by Immune stain |
|
2123-8
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid |
|
2124-6
|
Chymotrypsin [Mass/volume] in Serum or Plasma |
|
35339-1
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
|
35338-3
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
|
35337-5
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
|
35336-7
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
|
35335-9
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
|
49766-9
|
Chymotrypsin [Presence] in Stool |
|
25375-7
|
Chymotrypsin [Enzymatic activity/mass] in Stool |
|
2125-3
|
Chymotrypsin [Mass/mass] in Stool |
|
15037-5
|
Chymotrypsin [Moles/mass] in Stool |
|
66760-0
|
Coagulation index in Blood by Thromboelastography |
|
44419-0
|
CIAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72856-8
|
Cidofovir [Susceptibility] by Genotype method |
|
72855-0
|
Cidofovir [Susceptibility] by Phenotype method |
|
33628-9
|
Cidofovir [Susceptibility] |
|
81257-8
|
CIGAR [ID] |
|
92275-7
|
Cigarettes smoked per day --during pregnancy |
|
87298-6
|
Cigarettes smoked per day by Mother--1st trimester |
|
87299-4
|
Cigarettes smoked per day by Mother--2nd trimester |
|
35477-9
|
Ciliated columnar lining cells/100 leukocytes [# Ratio] in Body fluid |
|
16650-4
|
Cilantro IgE Ab [Units/volume] in Serum |
|
21220-9
|
Cilantro IgE Ab RAST class [Presence] in Serum |
|
4184-8
|
Cilastatin [Mass] of Dose |
|
73448-3
|
Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73449-1
|
Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53790-2
|
CILD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
63488-1
|
Epithelial cells.ciliated [Presence] in Bronchoalveolar lavage |
|
70123-5
|
Epithelial cells.ciliated [Presence] in Body fluid |
|
4185-5
|
Cimetidine [Mass] of Dose |
|
14649-8
|
Cimetidine [Presence] in Gastric fluid |
|
73447-5
|
Cimetidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73446-7
|
Cimetidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3481-9
|
Cimetidine [Presence] in Serum or Plasma |
|
3482-7
|
Cimetidine [Mass/volume] in Serum or Plasma |
|
3483-5
|
Cimetidine [Presence] in Urine |
|
32063-0
|
Cimetidine [Presence] in Unspecified specimen |
|
6837-9
|
Cinnamon IgE Ab [Units/volume] in Serum |
|
15641-4
|
Cinnamon IgE Ab RAST class [Presence] in Serum |
|
61245-7
|
Cinnamon IgE Ab/IgE total in Serum |
|
7229-8
|
Cinnamon IgG Ab [Units/volume] in Serum |
|
21202-7
|
Cinnamon IgG Ab RAST class [Presence] in Serum |
|
56223-1
|
Cinnamon IgG4 Ab [Mass/volume] in Serum |
|
60367-0
|
Cinnamon IgG Ab [Mass/volume] in Serum |
|
55656-3
|
Cinoxacin [Susceptibility] by Gradient strip |
|
182-6
|
Cinoxacin [Susceptibility] by Disk diffusion (KB) |
|
181-8
|
Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
180-0
|
Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18905-0
|
Cinoxacin [Susceptibility] |
|
183-4
|
Cinoxacin [Susceptibility] by Serum bactericidal titer |
|
73038-2
|
Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73037-4
|
Ciprofloxacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55194-5
|
Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25180-1
|
Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25181-9
|
Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25189-2
|
Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25188-4
|
Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
34636-1
|
Ciprofloxacin [Mass/volume] in Cerebral spinal fluid |
|
4186-3
|
Ciprofloxacin [Mass] of Dose |
|
56702-4
|
Ciprofloxacin IgE Ab [Units/volume] in Serum |
|
73445-9
|
Ciprofloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73444-2
|
Ciprofloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7002-9
|
Ciprofloxacin [Susceptibility] by Gradient strip |
|
186-7
|
Ciprofloxacin [Susceptibility] by Disk diffusion (KB) |
|
185-9
|
Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
184-2
|
Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20377-8
|
Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
48272-9
|
Ciprofloxacin triggered leukotriene release [Mass/volume] by Leukocytes |
|
14031-9
|
Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
|
3484-3
|
Ciprofloxacin [Mass/volume] in Serum or Plasma |
|
18906-8
|
Ciprofloxacin [Susceptibility] |
|
187-5
|
Ciprofloxacin [Susceptibility] by Serum bactericidal titer |
|
14032-7
|
Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
|
25248-6
|
Ciprofloxacin [Mass/volume] in Unspecified specimen |
|
89056-6
|
Circulatory assistive device(s) used [Identifier] --during surgery |
|
89055-8
|
Circulatory assistive device(s) used [Identifier] --postoperative |
|
89054-1
|
Circulatory assistive device(s) used [Identifier] --preoperative |
|
66749-3
|
Circulatory assist status [Identifier] |
|
20201-0
|
Circulatory system [Identifier] |
|
20167-3
|
Circulatory system Acceleration slope by US.doppler |
|
20168-1
|
Circulatory system Acceleration by US.doppler |
|
11653-3
|
Circulatory system End diastolic blood flow velocity US.doppler |
|
20217-6
|
Circulatory system Deceleration [Time] by US |
|
11692-1
|
Circulatory system Maximum blood flow velocity mean US.doppler |
|
11726-7
|
Circulatory system Peak systolic flow velocity US.doppler |
|
20352-1
|
Circulatory system Mean blood flow velocity by US.doppler |
|
11665-7
|
Circulatory system Minimal flow velocity US.doppler |
|
74702-2
|
Circumstances involving the health information technology device in the event or unsafe condition [AHRQ] |
|
81341-0
|
Circumstances that activate healthcare agent's powers [Reported] |
|
38293-7
|
cis-1,2-Dichloroethylene [Mass/volume] in Water |
|
79700-1
|
cis-11,14-Eicosadienoate (cis 11,14 C20:2w6) [Moles/volume] in Serum or Plasma |
|
79696-1
|
cis-11-Eicosenoate (cis 11 C20:1w9) [Entitic substance] in Red Blood Cells |
|
79699-5
|
cis-11-Eicosenoate (cis 11 C20:1w9) [Moles/volume] in Serum or Plasma |
|
79702-7
|
cis-13-Eicosenoate (cis 13 C20:1w7) [Entitic substance] in Red Blood Cells |
|
79703-5
|
cis-13-Eicosenoate (cis 13 C20:1w7) [Moles/volume] in Serum or Plasma |
|
18451-5
|
cis-4-Decenoylcarnitine (Cis 4 C10:1) [Mass/volume] in Serum or Plasma |
|
27069-4
|
Cisapride [Mass/volume] in Serum or Plasma |
|
4187-1
|
CISplatin [Mass] of Dose |
|
3485-0
|
CISplatin [Mass/volume] in Serum or Plasma |
|
34629-6
|
CISplatin [Mass/volume] in Urine |
|
48367-7
|
cis-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
|
46734-0
|
Citrullinemias/Arginosuccinic aciduria newborn screen interpretation |
|
73036-6
|
Citalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73035-8
|
Citalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78818-2
|
Citalopram cutoff [Mass/volume] in Urine for Confirmatory method |
|
80560-6
|
Citalopram [Mass/volume] in DBS |
|
59887-0
|
Citalopram [Moles/volume] in Gastric fluid |
|
73443-4
|
Citalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73442-6
|
Citalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
34635-3
|
Citalopram [Mass/volume] in Serum or Plasma |
|
25589-3
|
Citalopram [Moles/volume] in Serum or Plasma |
|
59170-1
|
Citalopram [Presence] in Urine |
|
92645-1
|
Citalopram [Presence] in Urine by Confirmatory method |
|
59886-2
|
Citalopram [Moles/volume] in Urine |
|
60295-3
|
Citalopram [Moles/volume] in Unspecified specimen |
|
77765-6
|
Citalopram+Escitalopram [Mass/volume] in Urine by Confirmatory method |
|
89991-4
|
Citalopram+Escitalopram [Presence] in Urine by Screen method |
|
75608-0
|
Citation [Bibliographic Citation] in Reference lab test Narrative |
|
41022-5
|
Citrate [Molar amount] in Urine collected for unspecified duration |
|
57337-8
|
Citrate [Mass/volume] in 12 hour Urine |
|
57339-4
|
Citrate [Mass/time] in 12 hour Urine |
|
21203-5
|
Citrate [Mass/volume] in 24 hour Urine |
|
6687-8
|
Citrate [Mass/time] in 24 hour Urine |
|
25876-4
|
Citrate [Moles/volume] in 24 hour Urine |
|
14650-6
|
Citrate [Moles/time] in 24 hour Urine |
|
57338-6
|
Citrate [Mass/volume] in 2 hour Urine |
|
2127-9
|
Citrate [Mass/volume] in Serum or Plasma |
|
15038-3
|
Citrate [Moles/volume] in Serum or Plasma |
|
2126-1
|
Citrate [Mass/volume] in Semen |
|
10567-6
|
Citrate [Moles/volume] in Semen |
|
47841-2
|
Citrate synthase [Enzymatic activity/mass] in Amniotic fluid cells |
|
49938-4
|
Citrate synthase [Enzymatic activity/mass] in Amniotic fluid |
|
53515-3
|
Citrate synthase [Enzymatic activity/mass] in Control Fibroblast |
|
47603-6
|
Citrate synthase [Enzymatic activity/mass] in Fibroblast |
|
35495-1
|
Citrate synthase [Enzymatic activity/mass] in Tissue |
|
53444-6
|
Citrate synthase [Enzymatic activity/mass] in Control Leukocytes |
|
47602-8
|
Citrate synthase [Enzymatic activity/mass] in Leukocytes |
|
27133-8
|
Citrate [Presence] in Urine |
|
2128-7
|
Citrate [Mass/volume] in Urine |
|
34266-7
|
Citrate [Moles/volume] in Urine |
|
51792-0
|
Citrate/Creatinine [Mass Ratio] in Urine collected for unspecified duration |
|
44306-9
|
Citrate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13722-4
|
Citrate/Creatinine [Mass Ratio] in Urine |
|
29527-9
|
Citrate/Creatinine [Molar ratio] in Urine |
|
93403-4
|
Citrobacter sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
88254-8
|
Citrobacter sp ompA+mrkC genes [Presence] by Probe in Positive blood culture |
|
6876-7
|
Citrulline [Mass/time] in 24 hour Urine |
|
25877-2
|
Citrulline [Moles/volume] in 24 hour Urine |
|
25376-5
|
Citrulline [Moles/time] in 24 hour Urine |
|
13392-6
|
Citrulline [Mass/volume] in Amniotic fluid |
|
26745-0
|
Citrulline [Moles/volume] in Amniotic fluid |
|
9511-7
|
Citrulline [Mass/volume] in Cerebral spinal fluid |
|
22654-8
|
Citrulline [Moles/volume] in Cerebral spinal fluid |
|
42892-0
|
Citrulline [Moles/volume] in DBS |
|
32235-4
|
Citrulline [Moles/volume] in Body fluid |
|
2129-5
|
Citrulline [Presence] in Serum or Plasma |
|
2130-3
|
Citrulline [Mass/volume] in Serum or Plasma |
|
20640-9
|
Citrulline [Moles/volume] in Serum or Plasma |
|
53506-2
|
Citrulline/Amino acids.total in Plasma |
|
49629-9
|
Citrulline [Presence] in Urine |
|
2131-1
|
Citrulline [Mass/volume] in Urine |
|
27056-1
|
Citrulline [Moles/volume] in Urine |
|
32234-7
|
Citrulline [Moles/volume] in Vitreous fluid |
|
22722-3
|
Citrulline [Moles/volume] in Unspecified specimen |
|
54092-2
|
Citrulline/Arginine [Molar ratio] in DBS |
|
44307-7
|
Citrulline/Creatinine [Mass Ratio] in 24 hour Urine |
|
56676-0
|
Citrulline/Creatinine [Ratio] in 24 hour Urine |
|
25878-0
|
Citrulline/Creatinine [Molar ratio] in 24 hour Urine |
|
13723-2
|
Citrulline/Creatinine [Mass Ratio] in Urine |
|
30161-4
|
Citrulline/Creatinine [Ratio] in Urine |
|
22694-4
|
Citrulline/Creatinine [Molar ratio] in Urine |
|
53157-4
|
Citrulline/Phenylalanine [Molar ratio] in DBS |
|
53399-2
|
Citrulline/Tyrosine [Molar ratio] in DBS |
|
51528-8
|
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Presence] in Serum by Multidisk |
|
82068-8
|
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Units/volume] in Serum by Multidisk |
|
82067-0
|
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
77986-8
|
City of exposure to illness |
|
50314-4
|
Cytokeratin 19 Ag [Presence] in Tissue by Immune stain |
|
68928-1
|
Cytokeratin 19 [Mass/volume] in Cerebral spinal fluid |
|
48163-0
|
Cytokeratin 19 [Mass/volume] in Body fluid |
|
68929-9
|
Cytokeratin 19 [Mass/volume] in Pericardial fluid |
|
19183-3
|
Cytokeratin 19 [Units/volume] in Pleural fluid |
|
68938-0
|
Cytokeratin 19 [Mass/volume] in Pleural fluid |
|
68927-3
|
Cytokeratin 19 [Mass/volume] in Peritoneal fluid |
|
19182-5
|
Cytokeratin 19 [Units/volume] in Serum or Plasma |
|
25390-6
|
Cytokeratin 19 [Mass/volume] in Serum or Plasma |
|
56787-5
|
Cytokeratin 19 [Units/volume] in Urine |
|
40558-9
|
Cytokeratin 20 Ag [Presence] in Tissue by Immune stain |
|
47025-2
|
Cytokeratin 5/6 Ag [Presence] in Tissue by Immune stain |
|
40559-7
|
Cytokeratin 7 Ag [Presence] in Tissue by Immune stain |
|
40560-5
|
Cytokeratin AE1/AE3 Ag [Presence] in Tissue by Immune stain |
|
2156-8
|
Creatine kinase [Enzymatic activity/volume] in Amniotic fluid |
|
9642-0
|
Creatine kinase.BB/Creatine kinase.total in Serum or Plasma |
|
15048-2
|
Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
72565-5
|
Creatine kinase.BB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
|
51505-6
|
Creatine kinase.BB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
|
2152-7
|
Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
50756-6
|
Creatine kinase [Mass/volume] in Blood |
|
40561-3
|
Cytokeratin Cam5.2 Ag [Presence] in Tissue by Immune stain |
|
2151-9
|
Creatine kinase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
53433-9
|
Creatine kinase [Enzymatic activity/volume] in Dialysis fluid |
|
34160-2
|
Creatine kinase [Presence] in Body fluid |
|
16688-4
|
Creatine kinase [Enzymatic activity/volume] in Body fluid |
|
47026-0
|
Cytoketatin HMW Ag [Presence] in Tissue by Immune stain |
|
49258-7
|
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
|
14680-3
|
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis |
|
49259-5
|
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
5912-1
|
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma |
|
59149-5
|
Creatine kinase.macromolecular [Presence] in Serum or Plasma |
|
2153-5
|
Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
|
26019-0
|
Creatine Kinase.macromolecular type 1/Creatine kinase.total in Serum or Plasma |
|
26020-8
|
Creatine Kinase.macromolecular type 2/Creatine kinase.total in Serum or Plasma |
|
49551-5
|
Creatine kinase.MB [Mass/volume] in Blood |
|
20569-0
|
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma |
|
12189-7
|
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation |
|
12187-1
|
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
72564-8
|
Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by calculation |
|
72563-0
|
Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
|
51506-4
|
Creatine kinase.MB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
|
2154-3
|
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
83092-7
|
Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay |
|
38482-6
|
Creatine kinase.MB [Presence] in Serum or Plasma |
|
32673-6
|
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma |
|
13969-1
|
Creatine kinase.MB [Mass/volume] in Serum or Plasma |
|
49136-5
|
Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma |
|
49129-0
|
Creatine kinase.MiMi/Creatine kinase.total in Serum or Plasma |
|
9643-8
|
Creatine kinase.MM/Creatine kinase.total in Serum or Plasma |
|
15049-0
|
Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
72562-2
|
Creatine kinase.MM/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
|
51507-2
|
Creatine kinase.MM [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
|
2155-0
|
Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
2157-6
|
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
|
50757-4
|
Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Blood |
|
2158-4
|
Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma |
|
50315-1
|
Cytokeratin 5 Ag [Presence] in Tissue by Immune stain |
|
74486-2
|
Cytokeratin 5 and p63 and Cytokeratin AE1 Ag [Identifier] in Tissue by Immune stain |
|
74491-2
|
Cytokeratin 7 and Thyroid transcription factor 1 Ag [Identifier] in Tissue by Immune stain |
|
33547-1
|
Creatine Kinase aberrant band/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
72561-4
|
Creatine Kinase aberrant band/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis |
|
86906-5
|
Chronic kidney disease education topic(s) discussed during this visit |
|
11102-1
|
Charcot-leyden crystals [type] in Unspecified specimen by Trichrome stain |
|
35304-5
|
CLA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
43691-5
|
Cladosporium sp IgE Ab [Presence] in Serum |
|
53760-5
|
Cladosporium sp IgE Ab [Units/volume] in Serum |
|
43056-1
|
Cladosporium sp IgG Ab [Presence] in Serum |
|
34267-5
|
Cladosporium sp IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
57942-5
|
Cladosporium sp IgG4 Ab [Mass/volume] in Serum |
|
7233-0
|
Clam triggered histamine release [Units/volume] in Blood |
|
6076-4
|
Clam IgE Ab [Units/volume] in Serum |
|
15643-0
|
Clam IgE Ab RAST class [Presence] in Serum |
|
39090-6
|
Clam IgE Ab/IgE total in Serum |
|
7232-2
|
Clam IgG Ab [Units/volume] in Serum |
|
21204-3
|
Clam IgG Ab RAST class [Presence] in Serum |
|
56225-6
|
Clam IgG4 Ab [Mass/volume] in Serum |
|
60368-8
|
Clam IgG Ab [Mass/volume] in Serum |
|
43987-7
|
Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25191-8
|
Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43990-1
|
Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25192-6
|
Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43991-9
|
Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25190-0
|
Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
34638-7
|
Clarithromycin [Mass/volume] in Cerebral spinal fluid |
|
80559-8
|
Clarithromycin [Mass/volume] in DBS |
|
56710-7
|
Clarithromycin IgE Ab [Units/volume] in Serum |
|
73441-8
|
Clarithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73440-0
|
Clarithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7003-7
|
Clarithromycin [Susceptibility] by Gradient strip |
|
190-9
|
Clarithromycin [Susceptibility] by Disk diffusion (KB) |
|
189-1
|
Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
188-3
|
Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20375-2
|
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89485-7
|
Clarithromycin [Susceptibility] by Genotype method |
|
16619-9
|
Clarithromycin [Mass/volume] in Serum or Plasma |
|
18907-6
|
Clarithromycin [Susceptibility] |
|
191-7
|
Clarithromycin [Susceptibility] by Serum bactericidal titer |
|
25253-6
|
Clarithromycin [Mass/volume] in Unspecified specimen |
|
16620-7
|
Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
49736-2
|
Clarity of Cerebral spinal fluid |
|
94127-8
|
Clarity of Body fluid |
|
61193-9
|
Clarity of Pleural fluid from Fetus |
|
10568-4
|
Clarity of Semen |
|
32167-9
|
Clarity of Urine |
|
50552-9
|
Clarity in Urine by Refractometry automated |
|
33515-8
|
Clarity of Unspecified specimen |
|
4188-9
|
Clavulanate [Mass] of Dose |
|
49328-8
|
Clavulanate IgE Ab [Units/volume] in Serum |
|
73439-2
|
Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73438-4
|
Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41685-9
|
Clavulanate [Susceptibility] by Gradient strip |
|
41686-7
|
Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41687-5
|
Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41733-7
|
Clavulanate [Susceptibility] |
|
48599-5
|
CLCN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60537-8
|
CLCN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19787-1
|
Cleaning method Endoscopy device |
|
30418-8
|
Lymphocytes clefted [#/volume] in Blood |
|
30181-2
|
Lymphocytes clefted [#/volume] in Blood by Manual count |
|
74184-3
|
Lymphocytes clefted [Presence] in Blood |
|
74750-1
|
Lymphocytes clefted [Presence] in Blood or Tissue by Light microscopy |
|
30419-6
|
Lymphocytes clefted/100 leukocytes in Blood |
|
15197-7
|
Lymphocytes clefted/100 leukocytes in Blood by Manual count |
|
93036-2
|
Cleft and Craniofacial Outpatient Note |
|
57943-3
|
Clenbuterol [Presence] in Urine |
|
46228-3
|
Clenbuterol [Mass/volume] in Urine |
|
71803-1
|
Client status |
|
86476-9
|
Climbing a flight of stairs without stopping was limited by heart failure over the past 2 weeks [KCCQ] |
|
82949-9
|
Climbing stairs [ALSFRS-R] |
|
74477-1
|
Clinical document Kind of document from LOINC Document Ontology |
|
74479-7
|
Clinical document Role from LOINC Document Ontology |
|
74476-3
|
Clinical document Setting from LOINC Document Ontology |
|
74480-5
|
Clinical document Subject matter domain from LOINC Document Ontology |
|
74478-9
|
Clinical document Type of service from LOINC Document Ontology |
|
43139-5
|
Clinical finding absent [Identifier] Population Narrative Investigation |
|
43136-1
|
Clinical finding absent [Identifier] Population Investigation |
|
43137-9
|
Clinical finding present [Identifier] Population Investigation |
|
43140-3
|
Clinical finding present [Identifier] Population Narrative Investigation |
|
85229-3
|
Clinical nurse specialist Note |
|
81192-7
|
Clinical pathology Consult note |
|
90013-4
|
Clinical pathology Initial evaluation note |
|
90371-6
|
Clinical pathology Note |
|
90015-9
|
Clinical pathology Telephone encounter Note |
|
90010-0
|
Clinical pathology procedure note |
|
90011-8
|
Clinical pathology Progress note |
|
81196-8
|
Clinical pharmacology Consult note |
|
89826-2
|
Clinical pharmacology procedure note |
|
7004-5
|
Clinafloxacin [Susceptibility] by Gradient strip |
|
35785-5
|
Clinafloxacin [Susceptibility] by Disk diffusion (KB) |
|
35786-3
|
Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32376-6
|
Clinafloxacin [Susceptibility] |
|
73034-1
|
Clindamycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73033-3
|
Clindamycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4189-7
|
Clindamycin [Mass] of Dose |
|
42894-6
|
Clindamycin IgE Ab [Units/volume] in Serum |
|
73437-6
|
Clindamycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73436-8
|
Clindamycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7005-2
|
Clindamycin [Susceptibility] by Gradient strip |
|
194-1
|
Clindamycin [Susceptibility] by Disk diffusion (KB) |
|
193-3
|
Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
192-5
|
Clindamycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
16621-5
|
Clindamycin [Mass/volume] in Serum or Plasma --peak |
|
3486-8
|
Clindamycin [Mass/volume] in Serum or Plasma |
|
18908-4
|
Clindamycin [Susceptibility] |
|
195-8
|
Clindamycin [Susceptibility] by Serum bactericidal titer |
|
16622-3
|
Clindamycin [Mass/volume] in Serum or Plasma --trough |
|
25249-4
|
Clindamycin [Mass/volume] in Unspecified specimen |
|
55658-9
|
Clindamycin.high potency [Susceptibility] by Gradient strip |
|
55659-7
|
Clindamycin.high potency [Susceptibility] by Disk diffusion (KB) |
|
55660-5
|
Clindamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55657-1
|
Clindamycin.high potency [Susceptibility] |
|
42720-3
|
Clindamycin.induced [Susceptibility] by Disk diffusion (KB) |
|
61188-9
|
Clindamycin.induced [Susceptibility] |
|
68651-9
|
Clinical biochemical genetics Hospital Consult note |
|
68650-1
|
Clinical biochemical genetics Note |
|
59462-2
|
Clinical biochemist review of results |
|
89261-2
|
Clinical course |
|
69965-2
|
Clinical cytogeneticist review of results |
|
48672-0
|
Clinical cytogeneticist [Identifier] in Unspecified specimen |
|
82607-3
|
Clinical data [Date and Time Range] |
|
74056-3
|
Clinical drug component - RxNorm RXCUI of Medication |
|
75321-0
|
Clinical finding |
|
75312-9
|
Clinical finding Family member |
|
78254-0
|
Clinical genetics Consult note |
|
89993-0
|
Clinical genetics Counseling note |
|
68652-7
|
Clinical genetics Diagnostic study note |
|
68653-5
|
Clinical genetics Discharge summary |
|
78276-3
|
Clinical genetics Education note |
|
78304-3
|
Clinical genetics Flowsheet |
|
68655-0
|
Clinical genetics History and physical note |
|
68661-8
|
Clinical genetics Hospital Consult note |
|
68662-6
|
Clinical genetics Hospital Letter |
|
78311-8
|
Clinical genetics Initial evaluation note |
|
68656-8
|
Clinical genetics Note |
|
89877-5
|
Clinical genetics Outpatient Note |
|
80748-7
|
Clinical genetics Plan of care note |
|
68657-6
|
Clinical genetics Preoperative evaluation and management note |
|
68658-4
|
Clinical genetics procedure note |
|
68659-2
|
Clinical genetics Progress note |
|
78330-8
|
Clinical genetics Referral note |
|
89893-2
|
Clinical genetics Telehealth Note |
|
68660-0
|
Clinical genetics Transfer summary note |
|
80664-6
|
Clinical neurophysiology Consult note |
|
82824-4
|
Clinical neurophysiology Surgical operation note |
|
89809-8
|
Clinical neurophysiology Telephone encounter Note |
|
80670-3
|
Clinical neurophysiology procedure note |
|
80665-3
|
Clinical neurophysiology Progress note |
|
90009-2
|
Clinical pathology Team Conference note |
|
82609-9
|
Clinical practice improvement activity for population |
|
89189-5
|
Clinical presentation status |
|
86795-2
|
Clinical record documents a request that questions regarding possible return to the community be asked only on comprehensive assessments [CMS Assessment] |
|
58411-0
|
Clinical research drug XXX [Mass/volume] in Plasma |
|
58439-1
|
Clinical research drug XXX [Mass/volume] in Urine |
|
71476-6
|
Clinical sepsis symptoms present [ESRD] |
|
90004-3
|
Clinical significance of updated information |
|
75193-3
|
Clinical signs of congenital syphilis [CDC.CS] |
|
72188-6
|
Clinical summary score [KCCQ] |
|
83008-3
|
ClinVar version [ID] |
|
41113-2
|
Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35506-5
|
Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35864-8
|
Chronic lymphocytic leukemia gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
70243-1
|
CLN3 gene exon 7+8 deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
81819-5
|
CLN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81839-3
|
CLN8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
59627-0
|
cloBAZam [Mass/volume] in Blood by Confirmatory method |
|
59626-2
|
cloBAZam [Mass/volume] in Blood |
|
4190-5
|
cloBAZam [Mass] of Dose |
|
59629-6
|
cloBAZam [Mass/volume] in Body fluid by Confirmatory method |
|
59628-8
|
cloBAZam [Mass/volume] in Body fluid |
|
52948-7
|
cloBAZam [Presence] in Gastric fluid |
|
52964-4
|
cloBAZam [Moles/volume] in Gastric fluid |
|
59631-2
|
cloBAZam [Mass/mass] in Meconium by Confirmatory method |
|
59630-4
|
cloBAZam [Mass/mass] in Meconium |
|
59632-0
|
cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3487-6
|
cloBAZam [Mass/volume] in Serum or Plasma |
|
14651-4
|
cloBAZam [Moles/volume] in Serum or Plasma |
|
59634-6
|
cloBAZam [Mass/mass] in Tissue by Confirmatory method |
|
59633-8
|
cloBAZam [Mass/mass] in Tissue |
|
59635-3
|
cloBAZam [Mass/volume] in Urine by Confirmatory method |
|
52959-4
|
cloBAZam [Presence] in Urine |
|
94114-6
|
cloBAZam [Presence] in Urine by Screen method |
|
12374-5
|
cloBAZam [Mass/volume] in Urine |
|
59888-8
|
cloBAZam [Moles/volume] in Urine |
|
60296-1
|
cloBAZam [Moles/volume] in Unspecified specimen |
|
55346-1
|
cloBAZam+Norclobazam [Moles/volume] in Serum or Plasma |
|
4191-3
|
Clobenzorex [Mass] of Dose |
|
3488-4
|
Clobenzorex [Presence] in Urine |
|
3489-2
|
Clobenzorex [Mass/volume] in Urine |
|
43988-5
|
Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43989-3
|
Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43986-9
|
Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55662-1
|
Clofazimine [Susceptibility] by Gradient strip |
|
55661-3
|
Clofazimine [Susceptibility] by Disk diffusion (KB) |
|
16623-1
|
Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20376-0
|
Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria |
|
23627-3
|
Clofazimine [Susceptibility] |
|
4192-1
|
Clofibrate [Mass] of Dose |
|
3490-0
|
Clofibrate [Mass/volume] in Serum or Plasma |
|
90975-4
|
Clomethiazole [Mass/volume] in Serum or Plasma |
|
78819-0
|
Clomipramine cutoff [Mass/volume] in Urine for Confirmatory method |
|
4193-9
|
Clomipramine [Mass] of Dose |
|
59889-6
|
Clomipramine [Moles/volume] in Gastric fluid |
|
16624-9
|
Clomipramine [Units/volume] in Milk |
|
16625-6
|
Clomipramine [Mass/volume] in Milk |
|
13549-1
|
Clomipramine [Presence] in Serum or Plasma |
|
35602-2
|
Clomipramine [Mass/volume] in Serum or Plasma by Screen method |
|
3491-8
|
Clomipramine [Mass/volume] in Serum or Plasma |
|
14652-2
|
Clomipramine [Moles/volume] in Serum or Plasma |
|
74958-0
|
Clomipramine [Mass/volume] in Serum or Plasma --trough |
|
45144-3
|
Clomipramine [Presence] in Urine |
|
3492-6
|
Clomipramine [Mass/volume] in Urine |
|
14653-0
|
Clomipramine [Moles/volume] in Urine |
|
60297-9
|
Clomipramine [Moles/volume] in Unspecified specimen |
|
3493-4
|
Clomipramine+Norclomipramine [Mass/volume] in Serum or Plasma |
|
14654-8
|
Clomipramine+Norclomipramine [Moles/volume] in Serum or Plasma |
|
74945-7
|
Clomipramine+Norclomipramine [Mass/volume] in Serum or Plasma --trough |
|
91606-4
|
Clomipramine+Norclomipramine [Mass/volume] in Urine |
|
59637-9
|
clonazePAM [Mass/volume] in Blood by Confirmatory method |
|
59636-1
|
clonazePAM [Mass/volume] in Blood |
|
77766-4
|
clonazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19404-3
|
clonazePAM cutoff [Mass/volume] in Urine for Confirmatory method |
|
19403-5
|
clonazePAM cutoff [Mass/volume] in Urine for Screen method |
|
4194-7
|
clonazePAM [Mass] of Dose |
|
59639-5
|
clonazePAM [Mass/volume] in Body fluid by Confirmatory method |
|
59638-7
|
clonazePAM [Mass/volume] in Body fluid |
|
52965-1
|
clonazePAM [Presence] in Gastric fluid |
|
29399-3
|
clonazePAM [Mass/volume] in Gastric fluid |
|
73434-3
|
clonazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73435-0
|
clonazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
76349-0
|
clonazePAM [Mass/mass] in Meconium by Confirmatory method |
|
72755-2
|
clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59640-3
|
clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13550-9
|
clonazePAM [Presence] in Serum or Plasma |
|
35603-0
|
clonazePAM [Mass/volume] in Serum or Plasma by Screen method |
|
70205-0
|
clonazePAM [Moles/volume] in Serum or Plasma by Screen method |
|
3494-2
|
clonazePAM [Mass/volume] in Serum or Plasma |
|
14655-5
|
clonazePAM [Moles/volume] in Serum or Plasma |
|
59642-9
|
clonazePAM [Mass/mass] in Tissue by Confirmatory method |
|
59641-1
|
clonazePAM [Mass/mass] in Tissue |
|
82934-1
|
clonazePAM [Mass/volume] in Serum or Plasma --trough |
|
16229-7
|
clonazePAM [Mass/volume] in Urine by Confirmatory method |
|
19245-0
|
clonazePAM [Presence] in Urine |
|
16204-0
|
clonazePAM [Presence] in Urine by Confirmatory method |
|
19399-5
|
clonazePAM [Presence] in Urine by Screen method |
|
19402-7
|
clonazePAM [Mass/volume] in Urine |
|
50843-2
|
clonazePAM [Moles/volume] in Urine |
|
61039-4
|
clonazePAM [Presence] in Unspecified specimen |
|
86225-0
|
clonazePAM/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73032-5
|
cloNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73031-7
|
cloNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4195-4
|
cloNIDine [Mass] of Dose |
|
73433-5
|
cloNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73432-7
|
cloNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3495-9
|
cloNIDine [Mass/volume] in Serum or Plasma |
|
52960-2
|
cloNIDine [Presence] in Urine |
|
10981-9
|
cloNIDine [Mass/volume] in Urine |
|
74373-2
|
cloNIDine [Mass/volume] in Unknown substance |
|
4196-2
|
Clopenthixol [Mass] of Dose |
|
3496-7
|
Clopenthixol [Mass/volume] in Serum or Plasma |
|
55529-2
|
Clopenthixol [Moles/volume] in Serum or Plasma |
|
3497-5
|
Clopenthixol [Mass/volume] in Urine |
|
73030-9
|
Clopidogrel induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73029-1
|
Clopidogrel induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73430-1
|
Clopidogrel induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73431-9
|
Clopidogrel induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4174-9
|
Clorazepate [Mass] of Dose |
|
13551-7
|
Clorazepate [Presence] in Serum or Plasma |
|
3498-3
|
Clorazepate [Mass/volume] in Serum or Plasma |
|
32064-8
|
Clorazepate [Moles/volume] in Serum or Plasma |
|
74366-6
|
Clorazepate [Mass/volume] in Serum or Plasma --trough |
|
12314-1
|
Clorazepate [Presence] in Urine |
|
3501-4
|
Clorprenaline [Mass/time] in 24 hour Urine |
|
4197-0
|
Clorprenaline [Mass] of Dose |
|
3499-1
|
Clorprenaline [Presence] in Urine |
|
3500-6
|
Clorprenaline [Mass/volume] in Urine |
|
85276-4
|
Closest surgical margin when all margins are uninvolved [Type] in Colorectal cancer specimen by Light microscopy |
|
90857-4
|
Closed-spaced teeth [#] |
|
33738-6
|
Closest margin |
|
71515-1
|
Closing time Dialysis facility [ESRD] |
|
3504-8
|
Clostebol [Mass/time] in 24 hour Urine |
|
4198-8
|
Clostebol [Mass] of Dose |
|
3502-2
|
Clostebol [Presence] in Urine |
|
3503-0
|
Clostebol [Mass/volume] in Urine |
|
49836-0
|
Platelet function (closure time) [Interpretation] in Blood Narrative |
|
24472-3
|
Platelet function (closure time) collagen+ADP induced [Time] in Blood |
|
24471-5
|
Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood |
|
66748-5
|
Clot angle in Blood by Thromboelastography |
|
66750-1
|
Clot angle in Blood by Thromboelastography --after addition of heparinase |
|
82792-3
|
Clot density in Platelet poor plasma |
|
82798-0
|
Clot formation lag time in Platelet poor plasma |
|
85818-3
|
Clot formation+Clotting time of Blood by Thromboelastography |
|
82795-6
|
Clot growth mean [Velocity] Platelet poor plasma |
|
82797-2
|
Initial clot growth [Velocity] in Platelet poor plasma |
|
82796-4
|
Stationary clot growth mean [Velocity] Platelet poor plasma |
|
66745-1
|
Clot Lysis [Length fraction] in Blood by Thromboelastography --30 minutes post maximum clot amplitude |
|
33524-0
|
Clot Lysis [Time] in Control Platelet poor plasma by Coagulation assay |
|
66757-6
|
Clot lysis estimate [Percentile] by Thromboelastography |
|
3244-1
|
Clot Lysis [Time] in Platelet poor plasma by Coagulation assay |
|
40454-1
|
Clot Lysis [Presence] in Platelet poor plasma by Coagulation assay |
|
3245-8
|
Clot Retraction [Time] in Blood by Coagulation assay |
|
49008-6
|
Clot Retraction [Volume Fraction] in Blood |
|
82793-1
|
Clot size [Length] in Platelet poor plasma --30 minutes post incubation |
|
91129-7
|
Clot strength ADP induced [Length fraction] in Blood by Resonance TEG |
|
91128-9
|
Clot strength ADP receptor inhibited [Length fraction] in Blood by calculation |
|
66751-9
|
Clot strength in Blood by Thromboelastography |
|
66752-7
|
Clot strength in Blood by Thromboelastography --after addition of heparinase |
|
41293-2
|
Clotted specimen |
|
55663-9
|
Clotrimazole [Susceptibility] by Gradient strip |
|
54177-1
|
Clotrimazole [Susceptibility] by Disk diffusion (KB) |
|
10653-4
|
Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
10654-2
|
Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18909-2
|
Clotrimazole [Susceptibility] |
|
66747-7
|
Clotting time of Blood by Heparin protamine titration |
|
3183-1
|
Clotting time of Blood by Lee White method |
|
52789-5
|
Clotting time of Blood by Thromboelastography |
|
81638-9
|
Clotting time of Capillary blood by Sukharev method |
|
66756-8
|
Clotting time of Blood by Thromboelastography --after addition of heparinase |
|
7234-8
|
Clove IgE Ab [Units/volume] in Serum |
|
15644-8
|
Clove IgE Ab RAST class [Presence] in Serum |
|
7235-5
|
Clove IgG Ab [Units/volume] in Serum |
|
21205-0
|
Clove IgG Ab RAST class [Presence] in Serum |
|
56440-1
|
Clove IgG4 Ab [Mass/volume] in Serum |
|
60369-6
|
Clove IgG Ab [Mass/volume] in Serum |
|
7236-3
|
Clover IgE Ab [Units/volume] in Serum |
|
15645-5
|
Clover IgE Ab RAST class [Presence] in Serum |
|
56696-8
|
Cloxacillin IgE Ab [Units/volume] in Serum |
|
55664-7
|
Cloxacillin [Susceptibility] by Gradient strip |
|
198-2
|
Cloxacillin [Susceptibility] by Disk diffusion (KB) |
|
197-4
|
Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
196-6
|
Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
16628-0
|
Cloxacillin [Mass/volume] in Serum or Plasma |
|
18910-0
|
Cloxacillin [Susceptibility] |
|
199-0
|
Cloxacillin [Susceptibility] by Serum bactericidal titer |
|
25250-2
|
Cloxacillin [Mass/volume] in Unspecified specimen |
|
77788-8
|
cloZAPine cutoff [Mass/volume] in Urine for Confirmatory method |
|
80556-4
|
cloZAPine [Mass/volume] in DBS |
|
32608-2
|
cloZAPine [Mass] of Dose |
|
59890-4
|
cloZAPine [Moles/volume] in Gastric fluid |
|
29371-2
|
cloZAPine [Mass/volume] in Serum or Plasma --peak |
|
13552-5
|
cloZAPine [Presence] in Serum or Plasma |
|
6896-5
|
cloZAPine [Mass/volume] in Serum or Plasma |
|
14656-3
|
cloZAPine [Moles/volume] in Serum or Plasma |
|
29370-4
|
cloZAPine [Mass/volume] in Serum or Plasma --trough |
|
77961-1
|
cloZAPine [Mass/volume] in Urine by Confirmatory method |
|
32065-5
|
cloZAPine [Presence] in Urine |
|
50844-0
|
cloZAPine [Moles/volume] in Urine |
|
32066-3
|
cloZAPine [Presence] in Unspecified specimen |
|
60298-7
|
cloZAPine [Moles/volume] in Unspecified specimen |
|
12375-2
|
cloZAPine+Norclozapine [Mass/volume] in Serum or Plasma |
|
14657-1
|
cloZAPine+Norclozapine [Moles/volume] in Serum or Plasma |
|
77749-0
|
CLRN1 gene c.144T>G [Presence] in Blood or Tissue by Molecular genetics method |
|
44241-8
|
Clue cells [#/area] in Vaginal fluid by Microscopy low power field |
|
20502-1
|
Clue cells [Presence] in Vaginal fluid by Wet preparation |
|
32764-3
|
Clue cells [Presence] in Unspecified specimen by Wet preparation |
|
50312-8
|
Clusterin Ag [Presence] in Tissue by Immune stain |
|
38650-8
|
Chloromethyl methyl ether [Mass/volume] in Air |
|
28736-7
|
Comment N [Interpretation] Left eye Narrative Phoropter |
|
74144-7
|
Complex medical conditions action plan |
|
69417-4
|
CMS certification number (CCN) for Facility |
|
4464-4
|
Cervical Mucus Penetration Test [Interpretation] in Semen |
|
49305-6
|
Cervical Mucus Penetration Test [Interpretation] in Semen Narrative |
|
49504-4
|
CMT demyelinating gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50994-3
|
CMT demyelinating gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41112-4
|
CMT axonal gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35464-7
|
CMT axonal gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38529-4
|
CMTX2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
16713-0
|
Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid |
|
16712-2
|
Cytomegalovirus Ab [Units/volume] in Body fluid |
|
52976-8
|
Cytomegalovirus Ab [Units/volume] in Serum by Complement fixation |
|
47363-7
|
Cytomegalovirus Ab [Presence] in Serum from Donor by Hemagglutination |
|
16714-8
|
Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination |
|
15377-5
|
Cytomegalovirus Ab [Presence] in Serum by Latex agglutination |
|
47430-4
|
Cytomegalovirus Ab [Presence] in Serum or Plasma from Donor |
|
5122-7
|
Cytomegalovirus Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
22239-8
|
Cytomegalovirus Ab [Presence] in Serum or Plasma |
|
59838-3
|
Cytomegalovirus Ab [Presence] in Serum or Plasma by Latex agglutination |
|
7851-9
|
Cytomegalovirus Ab [Units/volume] in Serum or Plasma |
|
22240-6
|
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid |
|
9514-1
|
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
9513-3
|
Cytomegalovirus Ab [Titer] in Serum by Complement fixation |
|
22241-4
|
Cytomegalovirus Ab [Titer] in Serum or Plasma |
|
32170-3
|
Cytomegalovirus Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
5121-9
|
Cytomegalovirus Ab [Titer] in Serum or Plasma by Latex agglutination |
|
77388-7
|
Cytomegalovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
16718-9
|
Cytomegalovirus Ag [Presence] in Blood |
|
89583-9
|
Cytomegalovirus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
67805-2
|
Cytomegalovirus Ag [Presence] in Isolate by Immunofluorescence |
|
88566-5
|
Cytomegalovirus Ag [Presence] in Bone marrow by Immunofluorescence |
|
31795-8
|
Cytomegalovirus Ag [Presence] in Serum or Plasma |
|
6376-8
|
Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunoassay |
|
6377-6
|
Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunofluorescence |
|
86517-0
|
Cytomegalovirus Ag [Presence] in Tissue by Immunofluorescence |
|
10660-9
|
Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
|
31796-6
|
Cytomegalovirus Ag [Presence] in Urine |
|
16717-1
|
Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
|
31797-4
|
Cytomegalovirus Ag [Presence] in Unspecified specimen |
|
6379-2
|
Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunoassay |
|
6381-8
|
Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
42336-8
|
Cytomegalovirus Ag [#/area] in Unspecified specimen |
|
34201-4
|
Cytomegalovirus [Presence] in Amniotic fluid by Organism specific culture |
|
88624-2
|
Cytomegalovirus [Presence] in Amniotic fluid by Shell vial culture |
|
43706-1
|
Cytomegalovirus [Presence] in Anal by Shell vial culture |
|
5835-4
|
Cytomegalovirus [Presence] in Blood by Organism specific culture |
|
43703-8
|
Cytomegalovirus [Presence] in Blood by Shell vial culture |
|
32675-1
|
Cytomegalovirus [Presence] in Bronchial specimen by Organism specific culture |
|
88623-4
|
Cytomegalovirus [Presence] in Cerebral spinal fluid by Organism specific culture |
|
43702-0
|
Cytomegalovirus [Presence] in Cerebral spinal fluid by Shell vial culture |
|
49348-6
|
Cytomegalovirus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49349-4
|
Cytomegalovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
29604-6
|
Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
39003-9
|
Cytomegalovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
88545-9
|
Cytomegalovirus DNA [#/volume] (viral load) in DBS by NAA with probe detection |
|
49350-2
|
Cytomegalovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
88130-0
|
Cytomegalovirus DNA [#/volume] (viral load) in Ocular fluid by NAA with probe detection |
|
30247-1
|
Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49351-0
|
Cytomegalovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
54163-1
|
Cytomegalovirus DNA [#/volume] (viral load) in Urine by Probe and target amplification method detection limit = 200 copies/ml |
|
49347-8
|
Cytomegalovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
33006-8
|
Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34719-5
|
Cytomegalovirus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
29590-7
|
Cytomegalovirus DNA [Mass/volume] (viral load) in Blood by Probe |
|
4996-5
|
Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection |
|
28008-1
|
Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification |
|
35401-9
|
Cytomegalovirus DNA [Presence] in Bronchial specimen by NAA with probe detection |
|
82189-2
|
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
30326-3
|
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
88535-0
|
Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection |
|
88558-2
|
Cytomegalovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88567-3
|
Cytomegalovirus DNA [Presence] in Bone marrow by NAA with probe detection |
|
88131-8
|
Cytomegalovirus DNA [Presence] in Ocular fluid by NAA with probe detection |
|
72493-0
|
Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection |
|
72494-8
|
Cytomegalovirus DNA [log units/volume] (viral load) in Plasma by NAA with probe detection |
|
83065-3
|
Cytomegalovirus DNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
|
54206-8
|
Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
30246-3
|
Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
4998-1
|
Cytomegalovirus DNA [Presence] in Tissue by NAA with probe detection |
|
4997-3
|
Cytomegalovirus DNA [Presence] in Tissue by Probe |
|
4999-9
|
Cytomegalovirus DNA [Presence] in Urine by NAA with probe detection |
|
34720-3
|
Cytomegalovirus DNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
53763-9
|
Cytomegalovirus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
24041-6
|
Cytomegalovirus DNA [Units/volume] (viral load) in Unspecified specimen by Probe with signal amplification |
|
5000-5
|
Cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33616-4
|
Cytomegalovirus early Ag [Presence] in Urine |
|
60541-0
|
Cytomegalovirus early Ag [Presence] in Unspecified specimen |
|
43704-6
|
Cytomegalovirus [Presence] in Body fluid by Shell vial culture |
|
40444-2
|
CMV gene mutations detected [Identifier] |
|
72605-9
|
Cytomegalovirus glycoprotein genotype in Unspecified specimen by NAA with probe detection |
|
54164-9
|
Cytomegalovirus immediate-early Ag [Presence] in Blood |
|
10391-1
|
Cytomegalovirus immune globulin given [Volume] |
|
45286-2
|
Cytomegalovirus IgA Ab [Presence] in Body fluid |
|
32791-6
|
Cytomegalovirus IgG Ab [Ratio] in Serum or Plasma by Immunoassay --1st specimen/2nd specimen |
|
32835-1
|
Cytomegalovirus IgG Ab [Ratio] in Serum or Plasma --1st specimen/2nd specimen |
|
52984-2
|
Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay |
|
78445-4
|
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay |
|
45326-6
|
Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma |
|
6921-1
|
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
42495-2
|
Cytomegalovirus IgG Ab [Presence] in Cerebral spinal fluid |
|
22243-0
|
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
50018-1
|
Cytomegalovirus IgG Ab [Presence] in Body fluid |
|
47307-4
|
Cytomegalovirus IgG Ab index [Units/volume] in Serum and CSF |
|
87726-6
|
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
|
5124-3
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
16715-5
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
22244-8
|
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma |
|
13949-3
|
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
7852-7
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma |
|
20475-0
|
Cytomegalovirus IgG Ab [Interpretation] in Serum or Plasma |
|
13225-8
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --1st specimen |
|
16716-3
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay --2nd specimen |
|
22247-1
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --2nd specimen |
|
22245-5
|
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid |
|
11008-0
|
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22246-3
|
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma |
|
5125-0
|
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
44817-5
|
Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43045-4
|
Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid |
|
42899-5
|
Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13226-6
|
Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
33285-8
|
Cytomegalovirus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
41155-3
|
Cytomegalovirus IgM Ab [Units/volume] in Body fluid |
|
87725-8
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
|
5126-8
|
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30325-5
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma |
|
24119-0
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
49539-0
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
7853-5
|
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma |
|
22248-9
|
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid |
|
21237-3
|
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22249-7
|
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma |
|
5127-6
|
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
16719-7
|
Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation |
|
91783-1
|
Cytomegalovirus [Presence] in Lower respiratory specimen by Organism specific culture |
|
81328-7
|
Cytomegalovirus [Presence] in Lower respiratory specimen by Shell vial culture |
|
88564-0
|
Cytomegalovirus [Presence] in Bone marrow by Organism specific culture |
|
43705-3
|
Cytomegalovirus [Presence] in Bone marrow by Shell vial culture |
|
88625-9
|
Cytomegalovirus [Presence] in Ocular fluid by Organism specific culture |
|
88622-6
|
Cytomegalovirus [Presence] in Ocular fluid by Shell vial culture |
|
78001-5
|
Cytomegalovirus pp65 Ag/100000 PMN cells in Blood by Immunofluorescence |
|
5836-2
|
Cytomegalovirus [Presence] in Tissue by Organism specific culture |
|
43707-9
|
Cytomegalovirus [Presence] in Tissue by Shell vial culture |
|
33631-3
|
Cytomegalovirus UL54 gene mutations detected [Identifier] |
|
33632-1
|
Cytomegalovirus UL54+UL97 gene mutations detected [Identifier] |
|
72833-7
|
Cytomegalovirus UL97 gene mutations detected [Identifier] |
|
5837-0
|
Cytomegalovirus [Presence] in Urine by Organism specific culture |
|
43700-4
|
Cytomegalovirus [Presence] in Urine by Shell vial culture |
|
5838-8
|
Cytomegalovirus [Presence] in Unspecified specimen by Organism specific culture |
|
43701-2
|
Cytomegalovirus [Presence] in Unspecified specimen by Shell vial culture |
|
80301-5
|
Olfactory nerve (CNI) exam |
|
80302-3
|
Oculomotor+trochlear+abducens nerves (CN III+IV+VI) exam |
|
80306-4
|
Glossopharyngeal nerve (CN IX) exam |
|
80303-1
|
Trigeminal nerve (CN V) exam |
|
80304-9
|
Facial nerve (CN VII) exam |
|
80305-6
|
Vestibulocochlear nerve (CN VIII) exam |
|
80307-2
|
Vagus nerve (CN X) exam |
|
80308-0
|
Accessory nerve (CN XI) exam |
|
80309-8
|
Hypoglossal nerve (CN XII) exam |
|
94097-3
|
Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
81883-1
|
CNBP gene CCTG repeat analysis in Blood or Tissue by Molecular genetics method |
|
40871-6
|
CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81827-8
|
CNGB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85497-6
|
cloZAPine N-oxide [Mass/volume] in Serum or Plasma |
|
31757-8
|
Canarypox virus Ag [Presence] in Serum |
|
20741-5
|
Canarypox virus Ag [Presence] in Serum by Immunofluorescence |
|
47956-8
|
CNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
94136-9
|
Controlled substance agreement |
|
82753-5
|
County of travel [Location] |
|
93045-3
|
Carbon monoxide [Mass/volume] in Air |
|
52109-6
|
Co sup(a) Ab [Presence] in Serum or Plasma |
|
92550-3
|
Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92512-3
|
Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
58055-5
|
Co sup(a) Ag [Presence] on Red Blood Cells |
|
52108-8
|
Co sup(b) Ab [Presence] in Serum or Plasma |
|
92549-5
|
Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92511-5
|
Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
58056-3
|
Co sup(b) Ag [Presence] on Red Blood Cells |
|
77987-6
|
County of exposure to illness [Location] |
|
35685-7
|
Carbon dioxide [Moles/volume] in Urine collected for unspecified duration |
|
34728-6
|
Carbon dioxide, total [Moles/volume] in Blood by calculation |
|
41647-9
|
Carbon dioxide, total [Moles/volume] in Arterial blood by calculation |
|
2026-3
|
Carbon dioxide, total [Moles/volume] in Arterial blood |
|
51781-3
|
Carbon dioxide, total [Moles/volume] in Capillary blood by calculation |
|
57921-9
|
Carbon dioxide, total [Moles/volume] in Arterial cord blood by calculation |
|
39466-8
|
Carbon dioxide, total [Moles/volume] in Arterial cord blood |
|
34520-7
|
Carbon dioxide, total [Moles/volume] in Cord blood |
|
57923-5
|
Carbon dioxide, total [Moles/volume] in Venous cord blood by calculation |
|
39465-0
|
Carbon dioxide, total [Moles/volume] in Venous cord blood |
|
16551-4
|
Carbon dioxide, total [Moles/volume] in Capillary blood |
|
57920-1
|
Carbon dioxide, total [Moles/volume] in Mixed venous blood by calculation |
|
19223-7
|
Carbon dioxide, total [Moles/volume] in Mixed venous blood |
|
20565-8
|
Carbon dioxide, total [Moles/volume] in Blood |
|
48391-7
|
Carbon dioxide, total [Moles/volume] in Venous blood by calculation |
|
2027-1
|
Carbon dioxide, total [Moles/volume] in Venous blood |
|
13540-0
|
Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid |
|
39464-3
|
Carbon dioxide, total [Moles/volume] in Peritoneal dialysis fluid |
|
14640-7
|
Carbon dioxide, total [Moles/volume] in Dialysis fluid |
|
60809-1
|
Carbon dioxide [VFr/PPres] in Airway adaptor --during expiration |
|
76095-9
|
Carbon dioxide [VFr/PPres] in Gas delivery system.expiratory limb --during expiration |
|
60924-8
|
Carbon dioxide [VFr/PPres] in Airway adaptor --during inspiration |
|
76096-7
|
Carbon dioxide [VFr/PPres] in Gas delivery system.inspiratory limb --during inspiration |
|
60808-3
|
Carbon dioxide [VFr/PPres] in Airway adaptor --at end expiration |
|
53089-9
|
Carbon dioxide, total [Moles/volume] in Nonbiological fluid by calculation |
|
53090-7
|
Carbon dioxide, total [Moles/volume] in Nonbiological fluid |
|
11211-0
|
Carbon dioxide, total [Moles/volume] in Body fluid |
|
60789-5
|
Carbon dioxide gas delivered during case [Volume] from Gas delivery system |
|
60790-3
|
Carbon dioxide gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
74684-2
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma --post dialysis |
|
76265-8
|
Carbon dioxide production (VCO2)/Body surface area in Respiratory system |
|
76266-6
|
Carbon dioxide production (VCO2)/Ideal body weight in Respiratory system |
|
57922-7
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma by calculation |
|
77143-6
|
Carbon dioxide, total [Moles/volume] in Serum, Plasma or Blood |
|
2028-9
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma |
|
60786-1
|
Gas delivery system inspiratory Carbon dioxide setting [VFr/PPres] |
|
14040-0
|
Carbon dioxide, total [Moles/volume] in Stool |
|
13538-4
|
Carbon dioxide, total [Moles/volume] in Urine |
|
60926-3
|
Carbon dioxide [VFr/PPres] in Airway adaptor |
|
62264-7
|
Carbon dioxide [VFr/PPres] in Gas delivery system |
|
38253-1
|
Carbon dioxide, total [Moles/volume] in Unspecified specimen |
|
15160-5
|
Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma Narrative |
|
80627-3
|
Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma |
|
70016-1
|
Staphylococcus sp.coagulase negative DNA [Presence] in Blood by NAA with probe detection |
|
63574-8
|
Staphylococcus sp.coagulase negative DNA [Presence] in Isolate by NAA with probe detection |
|
18313-7
|
Coagulation of Semen by Visual observation |
|
69049-5
|
Coagulation specialist review of results |
|
33227-0
|
Coarse Granular Casts [#/area] in Urine sediment by Automated count |
|
33226-2
|
Coarse Granular Casts [#/area] in Urine sediment by Microscopy high power field |
|
33393-0
|
Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field |
|
32175-2
|
Coarse Granular Casts [Presence] in Urine sediment by Light microscopy |
|
7478-1
|
Coastal Maple IgE Ab [Units/volume] in Serum |
|
15833-7
|
Coastal Maple IgE Ab RAST class [Presence] in Serum |
|
61205-1
|
Coastal Maple IgE Ab/IgE total in Serum |
|
15877-4
|
Coastal Oak IgE Ab RAST class [Presence] in Serum |
|
21208-4
|
Cobalt [Mass/volume] in 24 hour Urine |
|
29916-4
|
Cobalt [Mass/time] in 24 hour Urine |
|
34269-1
|
Cobalt [Moles/volume] in 24 hour Urine |
|
25379-9
|
Cobalt [Moles/time] in 24 hour Urine |
|
5625-9
|
Cobalt [Mass/volume] in Blood |
|
15119-1
|
Cobalt [Moles/volume] in Blood |
|
57944-1
|
Cobalt [Mass/volume] in Cerebral spinal fluid |
|
51194-9
|
Cobalt [Mass/volume] in Body fluid |
|
5626-7
|
Cobalt [Mass/mass] in Hair |
|
50845-7
|
Cobalt [Moles/mass] in Hair |
|
81127-3
|
Cobalt intake 24 hour Estimated |
|
81126-5
|
Cobalt intake 24 hour Measured |
|
60065-0
|
Cobalt [Mass/mass] in Nail |
|
60066-8
|
Cobalt [Mass/volume] in Red Blood Cells |
|
50847-3
|
Cobalt [Moles/volume] in Red Blood Cells |
|
5627-5
|
Cobalt [Mass/volume] in Serum or Plasma |
|
25378-1
|
Cobalt [Moles/volume] in Serum or Plasma |
|
23842-8
|
Cobalt [Mass/volume] in Synovial fluid |
|
60067-6
|
Cobalt [Mass/mass] in Tissue |
|
50846-5
|
Cobalt [Moles/mass] in Tissue |
|
5628-3
|
Cobalt [Mass/volume] in Urine |
|
34268-3
|
Cobalt [Moles/volume] in Urine |
|
9691-7
|
Cobalt [Mass/volume] in Unspecified specimen |
|
87473-5
|
Cobalt [Mass/mass] in Unspecified specimen |
|
29934-7
|
Cobalt/Creatinine [Mass Ratio] in 24 hour Urine |
|
52933-9
|
Cobalt/Creatinine [Molar ratio] in 24 hour Urine |
|
13468-4
|
Cobalt/Creatinine [Mass Ratio] in Urine |
|
34270-9
|
Cobalt/Creatinine [Molar ratio] in Urine |
|
82723-8
|
Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method |
|
74670-1
|
Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method |
|
31135-7
|
Cocaethylene [Mass/volume] in Bile fluid |
|
19410-0
|
Cocaethylene cutoff [Mass/volume] in Urine for Confirmatory method |
|
19409-2
|
Cocaethylene cutoff [Mass/volume] in Urine for Screen method |
|
29324-1
|
Cocaethylene [Mass/volume] in Gastric fluid |
|
49072-2
|
Cocaethylene [Presence] in Hair |
|
16171-1
|
Cocaethylene [Mass/mass] in Hair |
|
69011-5
|
Cocaethylene [Mass/mass] in Meconium by Confirmatory method |
|
57945-8
|
Cocaethylene [Presence] in Meconium |
|
26815-1
|
Cocaethylene [Mass/mass] in Meconium |
|
59643-7
|
Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13553-3
|
Cocaethylene [Presence] in Serum or Plasma |
|
27226-0
|
Cocaethylene [Mass/volume] in Serum or Plasma |
|
55530-0
|
Cocaethylene [Moles/volume] in Serum or Plasma |
|
27295-5
|
Cocaethylene [Mass/mass] in Stool |
|
16632-2
|
Cocaethylene [Mass/volume] in Urine by Confirmatory method |
|
19406-8
|
Cocaethylene [Presence] in Urine by Confirmatory method |
|
19405-0
|
Cocaethylene [Presence] in Urine by Screen method |
|
19408-4
|
Cocaethylene [Mass/volume] in Urine |
|
29325-8
|
Cocaethylene [Mass/volume] in Vitreous fluid |
|
48946-8
|
Cocaethylene [Mass/volume] in Unspecified specimen |
|
86606-1
|
Cocaethylene/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
31137-3
|
Cocaine [Mass/volume] in Bile fluid |
|
72405-4
|
Cocaine [Mass/volume] in Blood by Confirmatory method |
|
16633-0
|
Cocaine [Presence] in Blood |
|
41036-5
|
Cocaine [Presence] in Blood by Confirmatory method |
|
77790-4
|
Cocaine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19363-1
|
Cocaine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19362-3
|
Cocaine cutoff [Mass/volume] in Urine for Screen method |
|
38384-4
|
Cocaine [Presence] in Gastric fluid |
|
29323-3
|
Cocaine [Mass/volume] in Gastric fluid |
|
41021-7
|
Cocaine [Presence] in Hair |
|
34715-3
|
Cocaine [Presence] in Hair by Screen method |
|
27114-8
|
Cocaine [Mass/mass] in Hair |
|
69009-9
|
Cocaine [Mass/mass] in Meconium by Confirmatory method |
|
40527-4
|
Cocaine [Presence] in Meconium |
|
41037-3
|
Cocaine [Presence] in Meconium by Confirmatory method |
|
26956-3
|
Cocaine [Mass/mass] in Meconium |
|
53743-1
|
Cocaine metabolites.other [Mass/volume] in Urine |
|
72737-0
|
Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74671-9
|
Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40802-1
|
Cocaine [Presence] in Saliva (oral fluid) by Screen method |
|
74169-4
|
Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method |
|
59644-5
|
Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3395-1
|
Cocaine [Presence] in Serum or Plasma |
|
8190-1
|
Cocaine [Presence] in Serum or Plasma by Confirmatory method |
|
8191-9
|
Cocaine [Presence] in Serum or Plasma by Screen method |
|
16447-5
|
Cocaine [Units/volume] in Serum or Plasma |
|
3396-9
|
Cocaine [Mass/volume] in Serum or Plasma |
|
26758-3
|
Cocaine [Mass/mass] in Stool |
|
20519-5
|
Cocaine [Mass/volume] in Urine by Confirmatory method |
|
3397-7
|
Cocaine [Presence] in Urine |
|
19360-7
|
Cocaine [Presence] in Urine by Confirmatory method |
|
19359-9
|
Cocaine [Presence] in Urine by Screen method |
|
16448-3
|
Cocaine [Units/volume] in Urine |
|
3398-5
|
Cocaine [Mass/volume] in Urine |
|
52953-7
|
Cocaine [Moles/volume] in Urine |
|
8195-0
|
Cocaine [Presence] in Unknown substance |
|
8196-8
|
Cocaine [Presence] in Unknown substance by Confirmatory method |
|
8197-6
|
Cocaine [Presence] in Unknown substance by Screen method |
|
8194-3
|
Cocaine [Mass/volume] in Unknown substance |
|
27204-7
|
Cocaine [Mass/volume] in Vitreous fluid |
|
40625-6
|
Cocaine [Presence] in Unspecified specimen |
|
48947-6
|
Cocaine [Presence] in Unspecified specimen by Confirmatory method |
|
18208-9
|
Cocaine [Mass/volume] in Unspecified specimen |
|
57898-9
|
Cocaine [Moles/volume] in Unspecified specimen |
|
86607-9
|
Cocaine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
91038-0
|
Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method |
|
91029-9
|
Cocaine+Benzoylecgonine [Presence] in Meconium by Screen method |
|
49747-9
|
Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method |
|
73823-7
|
Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method |
|
91049-7
|
Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method |
|
47400-7
|
Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method |
|
42241-0
|
Cocaine+Benzoylecgonine [Presence] in Urine by Screen method |
|
88338-9
|
Coccal bacteria [Presence] in Ear by Light microscopy |
|
10655-9
|
Coccidia identified in Duodenal fluid by Acid fast stain |
|
10656-7
|
Coccidia identified in Stool by Acid fast stain |
|
24412-9
|
Coccidia identified in Small intestine Tissue by Giemsa stain |
|
49190-2
|
Coccidioides sp Ab [Presence] in Body fluid |
|
48394-1
|
Coccidioides sp Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
43224-5
|
Coccidioides sp Ab [Units/volume] in Serum by Complement fixation |
|
26625-4
|
Coccidioides sp Ab [Presence] in Serum |
|
33379-9
|
Coccidioides sp Ab [Presence] in Serum by Complement fixation |
|
33416-9
|
Coccidioides sp Ab [Presence] in Serum by Immunoassay |
|
43974-5
|
Coccidioides sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
49712-3
|
Coccidioides sp Ab [Presence] in Serum by Latex agglutination |
|
33381-5
|
Coccidioides sp Ab [Units/volume] in Serum |
|
33402-9
|
Coccidioides sp Ab [Titer] in Serum |
|
33380-7
|
Coccidioides sp Ab [Titer] in Serum by Complement fixation |
|
51788-8
|
Coccidioides sp Ab [Titer] in Serum by Immune diffusion (ID) |
|
43052-0
|
Coccidioides sp Ab [Presence] in Unspecified specimen |
|
31153-0
|
Coccidioides sp Ab [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
93224-4
|
Coccidioides sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay |
|
93225-1
|
Coccidioides sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
93226-9
|
Coccidioides sp Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
93227-7
|
Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay |
|
46181-4
|
Coccidioides sp IgA Ab [Presence] in Serum |
|
44811-8
|
Coccidioides sp IgA Ab [Presence] in Serum by Immunoassay |
|
93837-3
|
Coccidioides sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
46182-2
|
Coccidioides sp IgG Ab [Presence] in Serum |
|
43849-9
|
Coccidioides sp IgG Ab [Presence] in Serum by Immunoassay |
|
27009-0
|
Coccidioides sp IgG Ab [Units/volume] in Serum |
|
93836-5
|
Coccidioides sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
41156-1
|
Coccidioides sp IgG Ab [Presence] in Unspecified specimen |
|
31154-8
|
Coccidioides sp IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
93834-0
|
Coccidioides sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
46183-0
|
Coccidioides sp IgM Ab [Presence] in Serum |
|
43850-7
|
Coccidioides sp IgM Ab [Presence] in Serum by Immunoassay |
|
93835-7
|
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
90448-2
|
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma |
|
53367-9
|
Coccidioides sp IgM Ab [Presence] in Unspecified specimen |
|
51477-8
|
Coccidioides sp IgM Ab [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
48589-6
|
Coccidioides sp rRNA [Presence] in Isolate by NAA with probe detection |
|
48588-8
|
Coccidioides sp rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62457-7
|
Coccidioides sp TP Ab [Presence] in Serum by Immune diffusion (ID) |
|
30210-9
|
Coccidioides reaction wheal [Diameter] --2 days post 0.1 mL coccidioidin intradermal |
|
16640-5
|
Coccidioides reaction wheal [Diameter] |
|
41750-1
|
COCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
31310-6
|
Cockatiel droppings Ab [Presence] in Serum |
|
23843-6
|
Cockatiel droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
16641-3
|
Cockatiel droppings Ab [Units/volume] in Serum |
|
6838-7
|
Cockatiel droppings IgE Ab [Units/volume] in Serum |
|
21210-0
|
Cockatiel droppings IgE Ab RAST class [Presence] in Serum |
|
61348-9
|
Cockatiel droppings IgE Ab/IgE total in Serum |
|
39539-2
|
Cockatiel droppings IgG Ab [Presence] in Serum |
|
16642-1
|
Cockatiel droppings IgG Ab [Units/volume] in Serum |
|
55592-0
|
Cockatiel feather IgE Ab [Presence] in Serum |
|
11167-4
|
Cockatiel feather IgE Ab [Units/volume] in Serum |
|
21211-8
|
Cockatiel feather IgE Ab RAST class [Presence] in Serum |
|
61349-7
|
Cockatiel feather IgE Ab/IgE total in Serum |
|
18324-4
|
Cockatiel serum IgE Ab [Units/volume] in Serum |
|
16643-9
|
Cockatoo droppings Ab [Units/volume] in Serum |
|
7237-1
|
Cockatoo IgE Ab [Units/volume] in Serum |
|
7239-7
|
Cocklebur triggered histamine release [Units/volume] in Blood |
|
6077-2
|
Cocklebur IgE Ab [Units/volume] in Serum |
|
15646-3
|
Cocklebur IgE Ab RAST class [Presence] in Serum |
|
61326-5
|
Cocklebur IgE Ab/IgE total in Serum |
|
7238-9
|
Cocklebur IgG Ab [Units/volume] in Serum |
|
56226-4
|
Cocklebur IgG4 Ab [Mass/volume] in Serum |
|
63188-7
|
Cocklebur IgG Ab [Mass/volume] in Serum |
|
65793-2
|
Cockroach native (nBla g) 7 IgE Ab [Units/volume] in Serum |
|
7366-8
|
Cocksfoot triggered histamine release [Units/volume] in Blood |
|
6195-2
|
Cocksfoot IgE Ab [Units/volume] in Serum |
|
15746-1
|
Cocksfoot IgE Ab RAST class [Presence] in Serum |
|
61256-4
|
Cocksfoot IgE Ab/IgE total in Serum |
|
7365-0
|
Cocksfoot IgG Ab [Units/volume] in Serum |
|
56339-5
|
Cocksfoot IgG4 Ab [Mass/volume] in Serum |
|
48263-8
|
Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes |
|
10942-1
|
Cockspur IgE Ab [Units/volume] in Serum |
|
15851-9
|
Cockspur IgE Ab RAST class [Presence] in Serum |
|
6080-6
|
Cocoa IgE Ab [Units/volume] in Serum |
|
15597-8
|
Cocoa IgE Ab RAST class [Presence] in Serum |
|
61319-0
|
Cocoa IgE Ab/IgE total in Serum |
|
7241-3
|
Coconut triggered histamine release [Units/volume] in Blood |
|
6081-4
|
Coconut IgE Ab [Units/volume] in Serum |
|
15649-7
|
Coconut IgE Ab RAST class [Presence] in Serum |
|
39593-9
|
Coconut IgE Ab/IgE total in Serum |
|
7240-5
|
Coconut IgG Ab [Units/volume] in Serum |
|
21212-6
|
Coconut IgG Ab RAST class [Presence] in Serum |
|
56227-2
|
Coconut IgG4 Ab [Mass/volume] in Serum |
|
63084-8
|
Coconut IgG Ab [Mass/volume] in Serum |
|
47516-0
|
Cocal virus Ab [Titer] in Serum |
|
45123-7
|
Cocal virus Ab [Titer] in Serum by Neutralization test |
|
45121-1
|
Cocal virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45122-9
|
Cocal virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
38274-7
|
Columbid circovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16263-6
|
Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
|
59278-2
|
Calcium oxalate dihydrate crystals [Presence] in Stone by X-ray diffraction |
|
38993-2
|
Calcium oxalate dihydrate crystals [Presence] in Urine sediment |
|
86799-4
|
Coded cause of death - recommended CDA R1 sections |
|
92022-3
|
Coded initiating cause or condition of fetal death |
|
92023-1
|
Coded other significant causes or conditions of fetal death |
|
86800-0
|
Coded race and ethnicity - recommended CDA R1 sections |
|
41038-1
|
Codeine [Mass/volume] in Blood |
|
77767-2
|
Codeine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19414-2
|
Codeine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19413-4
|
Codeine cutoff [Mass/volume] in Urine for Screen method |
|
4199-6
|
Codeine [Mass] of Dose |
|
16644-7
|
Codeine Free [Presence] in Serum or Plasma by Confirmatory method |
|
46262-2
|
Codeine Free [Presence] in Serum or Plasma by Screen method |
|
12784-5
|
Codeine Free [Mass/volume] in Serum or Plasma |
|
27311-0
|
Codeine Free [Mass/mass] in Stool |
|
51739-1
|
Codeine Free [Mass/volume] in Urine |
|
14261-2
|
Codeine [Presence] in Gastric fluid |
|
29372-0
|
Codeine [Mass/volume] in Gastric fluid |
|
26720-3
|
Codeine [Mass/mass] in Hair |
|
49871-7
|
Codeine IgE Ab [Units/volume] in Serum |
|
81970-6
|
Codeine IgE Ab RAST class [Presence] in Serum |
|
68542-0
|
Codeine [Mass/mass] in Meconium by Confirmatory method |
|
29278-9
|
Codeine [Presence] in Meconium |
|
15364-3
|
Codeine [Mass/volume] in Meconium |
|
26865-6
|
Codeine [Mass/mass] in Meconium |
|
72759-4
|
Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74675-0
|
Codeine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
57304-8
|
Codeine [Mass/volume] in Saliva (oral fluid) |
|
3505-5
|
Codeine [Presence] in Serum or Plasma |
|
86226-8
|
Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3506-3
|
Codeine [Mass/volume] in Serum or Plasma |
|
15102-7
|
Codeine [Moles/volume] in Serum or Plasma |
|
16250-3
|
Codeine [Mass/volume] in Urine by Confirmatory method |
|
70206-8
|
Codeine [Moles/volume] in Urine by Confirmatory method |
|
3507-1
|
Codeine [Presence] in Urine |
|
16197-6
|
Codeine [Presence] in Urine by Confirmatory method |
|
13641-6
|
Codeine [Presence] in Urine by SAMHSA confirm method |
|
19411-8
|
Codeine [Presence] in Urine by Screen method |
|
3508-9
|
Codeine [Mass/volume] in Urine |
|
40626-4
|
Codeine [Presence] in Unspecified specimen |
|
58391-4
|
Codeine/Creatinine [Mass Ratio] in Urine |
|
63473-3
|
Codfish recombinant (rGad c) 1 IgE Ab [Units/volume] in Serum |
|
64037-5
|
Codfish recombinant (rGad c) 1 IgE Ab RAST class [Presence] in Serum |
|
7242-1
|
Codfish triggered histamine release [Units/volume] in Blood |
|
6082-2
|
Codfish IgE Ab [Units/volume] in Serum |
|
15650-5
|
Codfish IgE Ab RAST class [Presence] in Serum |
|
39081-5
|
Codfish IgE Ab/IgE total in Serum |
|
6721-5
|
Codfish IgG Ab [Units/volume] in Serum |
|
21213-4
|
Codfish IgG Ab RAST class [Presence] in Serum |
|
61268-9
|
Codfish IgG Ab/IgE total in Serum |
|
56228-0
|
Codfish IgG4 Ab [Mass/volume] in Serum |
|
49099-5
|
Codfish IgG Ab [Mass/volume] in Serum |
|
48224-0
|
Codfish triggered leukotriene release [Mass/volume] by Leukocytes |
|
91586-8
|
Coding system [Identifier] in Reference lab test |
|
92732-7
|
Codon AndOr region with poor sequence quality [Identifier] in Isolate or Specimen by Sequencing Nominal |
|
7243-9
|
Coffee bean IgE Ab [Units/volume] in Serum |
|
57947-4
|
Coffee bean IgE Ab RAST class [Presence] in Serum |
|
6083-0
|
Coffee IgE Ab [Units/volume] in Serum |
|
15651-3
|
Coffee IgE Ab RAST class [Presence] in Serum |
|
61250-7
|
Coffee IgE Ab/IgE total in Serum |
|
6722-3
|
Coffee IgG Ab [Units/volume] in Serum |
|
21214-2
|
Coffee IgG Ab RAST class [Presence] in Serum |
|
56229-8
|
Coffee IgG4 Ab [Mass/volume] in Serum |
|
35533-9
|
Coffee IgG Ab [Mass/volume] in Serum |
|
75275-8
|
Cognitive function [Interpretation] |
|
46589-8
|
Cognitive functioning [CMS Assessment] |
|
54624-2
|
Cognitive skills for daily decision making in last 7 days [CMS Assessment] |
|
46473-5
|
Cognitive, behavioral, and psychiatric symptoms demonstrated at least one time per week [CMS Assessment] |
|
86904-0
|
Carboxyhemoglobin/Hemoglobin.total in Arterial blood by Pulse oximetry |
|
32160-4
|
Carboxyhemoglobin [Presence] in Blood by Screen method |
|
31157-1
|
Carboxyhemoglobin [Mass/volume] in Blood |
|
20563-3
|
Carboxyhemoglobin/Hemoglobin.total in Blood |
|
2030-5
|
Carboxyhemoglobin/Hemoglobin.total in Arterial blood |
|
2031-3
|
Carboxyhemoglobin/Hemoglobin.total in Capillary blood |
|
63523-5
|
Carboxyhemoglobin/Hemoglobin.total in Arterial cord blood |
|
63524-3
|
Carboxyhemoglobin/Hemoglobin.total in Venous cord blood |
|
41648-7
|
Carboxyhemoglobin/Hemoglobin.total in Mixed venous blood |
|
2032-1
|
Carboxyhemoglobin/Hemoglobin.total in Venous blood |
|
71890-8
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Blood |
|
71889-0
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
|
71888-2
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood |
|
71887-4
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial cord blood |
|
71886-6
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous cord blood |
|
71885-8
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood |
|
71884-1
|
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood |
|
91558-7
|
Coinfection type |
|
78248-2
|
Colon and rectal surgery Admission history and physical note |
|
83658-5
|
Colon and rectal surgery Attending Note |
|
78505-5
|
Colon and rectal surgery Checklist |
|
78250-8
|
Colon and rectal surgery Consult note |
|
78271-4
|
Colon and rectal surgery Education note |
|
83735-1
|
Colon and rectal surgery Fellow Note |
|
78300-1
|
Colon and rectal surgery Flowsheet |
|
82827-7
|
Colon and rectal surgery Initial evaluation note |
|
84073-6
|
Colon and rectal surgery Note |
|
83542-1
|
Colon and rectal surgery Nurse practitioner Note |
|
83600-7
|
Colon and rectal surgery Nurse Note |
|
78381-1
|
Colon and rectal surgery Surgical operation note |
|
80744-6
|
Colon and rectal surgery Plan of care note |
|
78313-4
|
Colon and rectal surgery Preoperative evaluation and management note |
|
84074-4
|
Colon and rectal surgery procedure note |
|
78329-0
|
Colon and rectal surgery Referral note |
|
83753-4
|
Colon and rectal surgery Resident Note |
|
78340-7
|
Colon and rectal surgery Transfer summary note |
|
53851-2
|
COL10A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35354-0
|
COL1A1+COL1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21657-2
|
COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21658-0
|
COL2A1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
53852-0
|
COL2A1 gene+COL11A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41751-9
|
COL3A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43097-5
|
COL3A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53853-8
|
COL4A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41111-6
|
COL5A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38534-4
|
COL5A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49854-3
|
COL5A1 gene+COL5A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7244-7
|
Cola IgE Ab [Units/volume] in Serum |
|
15652-1
|
Cola IgE Ab RAST class [Presence] in Serum |
|
7245-4
|
Cola IgG Ab [Units/volume] in Serum |
|
7246-2
|
Cola nut triggered histamine release [Units/volume] in Blood |
|
33010-0
|
Colby Cheese IgE Ab [Units/volume] in Serum |
|
33011-8
|
Colby Cheese IgE Ab RAST class [Presence] in Serum |
|
60068-4
|
Colchicine [Mass/volume] in Blood |
|
73428-5
|
Colchicine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73429-3
|
Colchicine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12397-6
|
Colchicine [Mass/volume] in Serum or Plasma |
|
40706-4
|
Colchicine [Mass/volume] in Urine |
|
44778-9
|
Cold ischemic time {Organ} |
|
20770-4
|
Coliform bacteria [#/volume] by Viability count |
|
20769-6
|
Coliform bacteria [#/volume] in Water by Viability count |
|
34890-4
|
Coliform bacteria [#/volume] in Unspecified specimen by Viability count |
|
20772-0
|
Coliform colony count [#/volume] in Milk |
|
20771-2
|
Coliform bacteria [#/mass] in Egg by Viability count |
|
86324-1
|
Coliform bacteria [#/mass] in Food by Viability count |
|
14081-4
|
Coliform bacteria [Presence] in Water |
|
39018-7
|
Coliform bacteria [#/mass] in Unspecified specimen by Viability count |
|
55665-4
|
Colistimethate by Gradient strip |
|
202-2
|
Colistimethate by Disk diffusion (KB) |
|
201-4
|
Colistimethate by Minimum inhibitory concentration (MIC) |
|
200-6
|
Colistimethate by Minimum lethal concentration (MLC) |
|
18911-8
|
Colistimethate |
|
203-0
|
Colistimethate [Susceptibility] by Serum bactericidal titer |
|
33333-6
|
Colistin [Susceptibility] by Gradient strip |
|
206-3
|
Colistin [Susceptibility] by Disk diffusion (KB) |
|
205-5
|
Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
204-8
|
Colistin [Susceptibility] by Minimum lethal concentration (MLC) |
|
86221-9
|
Colistin resistance mcr-1 gene [Presence] by Molecular method |
|
93701-1
|
Colistin resistance mcr-2 gene [Presence] by Molecular method |
|
16645-4
|
Colistin [Mass/volume] in Serum or Plasma |
|
18912-6
|
Colistin [Susceptibility] |
|
207-1
|
Colistin [Susceptibility] by Serum bactericidal titer |
|
29493-4
|
Colistin [Mass/volume] in Unspecified specimen |
|
16647-0
|
Collagen Ab [Units/volume] in Serum |
|
12735-7
|
Collagen Ab [Units/volume] in Urine |
|
57948-2
|
Collagen crosslinked C-telopeptide [Mass/volume] in 24 hour Urine |
|
53052-7
|
Collagen crosslinked C-telopeptide [Mass/time] in 24 hour Urine |
|
41171-0
|
Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma |
|
53092-3
|
Collagen crosslinked C-telopeptide [Moles/volume] in Serum or Plasma |
|
48586-2
|
Collagen crosslinked C-telopeptide [Mass/volume] in Urine |
|
74994-5
|
Collagen crosslinked C-telopeptide [Z-score] in Serum or Plasma |
|
48587-0
|
Collagen crosslinked C-telopeptide/Creatinine [Ratio] in Urine |
|
35334-2
|
Collagen crosslinked N-telopeptide [Moles/volume] in 24 hour Urine |
|
21215-9
|
Collagen crosslinked N-telopeptide [Moles/volume] in Serum |
|
34271-7
|
Collagen crosslinked N-telopeptide [Mass/volume] in Urine |
|
27939-8
|
Collagen crosslinked N-telopeptide [Moles/volume] in Urine |
|
44308-5
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine by Immunoassay |
|
21216-7
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine |
|
44712-8
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine by Immunoassay |
|
34272-5
|
Collagen crosslinked N-telopeptide/Creatinine [Ratio] in Urine |
|
14115-0
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
|
44713-6
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Unspecified specimen by Immunoassay |
|
10749-0
|
Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
|
48383-4
|
Collagen.bovine type 1 Ab [Units/volume] in Serum |
|
48384-2
|
Collagen.bovine type 2 Ab [Units/volume] in Serum |
|
48385-9
|
Collagen.injectable Ab [Units/volume] in Serum |
|
10747-4
|
Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
|
10748-2
|
Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
|
48376-8
|
Collagen type 1 Ab [Units/volume] in Serum |
|
13878-4
|
Collagen type 1 IgG Ab [Units/volume] in Serum |
|
35643-6
|
Collagen type 2 Ab [Presence] in Serum by Immunoassay |
|
34605-6
|
Collagen type 2 Ab [Units/volume] in Serum |
|
13879-2
|
Collagen type 2 IgG Ab [Units/volume] in Serum |
|
10474-5
|
Collagen type 4 Ag [Presence] in Tissue by Immune stain |
|
13880-0
|
Collagen type 4 IgG Ab [Units/volume] in Serum |
|
2133-7
|
Collagenase [Enzymatic activity/volume] in Serum |
|
94096-5
|
Collagen type VII IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
58734-5
|
Collection date of Amniotic fluid |
|
51953-8
|
Collection date of Blood |
|
41393-0
|
Collection date of Body fluid |
|
61100-4
|
Collection date of Stool--2nd specimen |
|
61099-8
|
Collection date of Stool--3rd specimen |
|
41394-8
|
Collection date of Stool |
|
41395-5
|
Collection date of Urine |
|
33882-2
|
Collection date of Unspecified specimen |
|
47842-0
|
Collection duration of Dialysis fluid |
|
24454-1
|
Collection duration of Gastric fluid |
|
13363-7
|
Collection duration of Stool |
|
13362-9
|
Collection duration of Urine |
|
30211-7
|
Collection duration of Unspecified specimen |
|
19086-8
|
Collection of urine specimen end date |
|
51905-8
|
Collection of air specimen end time |
|
19087-6
|
Collection of urine specimen end time |
|
50220-3
|
Collection interval from baseline of Unspecified specimen |
|
19088-4
|
Collection of urine specimen start date |
|
51906-6
|
Collection of air specimen start time |
|
19089-2
|
Collection of urine specimen start time |
|
29264-9
|
Collection time of Blood |
|
49488-0
|
Collection time of Body fluid |
|
34595-9
|
Collection time of Gastric fluid |
|
13358-7
|
Collection time of Semen |
|
49972-3
|
Collection time of Blood--2nd specimen |
|
49971-5
|
Collection time of Blood--3rd specimen |
|
49970-7
|
Collection time of Blood--4th specimen |
|
53749-8
|
Collection time of Blood--5th specimen |
|
60458-7
|
Collection time of Blood--6th specimen |
|
74751-9
|
Collection time of Urine |
|
49049-0
|
Collection time of Unspecified specimen |
|
68963-8
|
Collection date and time of Unspecified specimen |
|
33724-6
|
Collection method - |
|
79566-6
|
Collection method - DBS |
|
34696-5
|
Collection method - Semen |
|
53903-1
|
Collection method - Specimen |
|
79729-0
|
Coloboma location [Anatomy] Left eye |
|
79728-2
|
Coloboma location [Anatomy] Right eye |
|
34400-2
|
Colon Ab [Titer] in Serum by Immunofluorescence |
|
11791-1
|
Colon lumen Diameter US |
|
62362-9
|
Colonies counted [#] |
|
64096-1
|
Colonies counted [#] in Amniotic fluid by Molecular genetics method |
|
28022-2
|
Colonoscopy Study observation Narrative |
|
28023-0
|
Colonoscopy Study observation |
|
18746-8
|
Colonoscopy study |
|
28033-9
|
Colonoscopy.thru stoma Study observation Narrative |
|
28034-7
|
Colonoscopy.thru stoma Study observation |
|
38386-9
|
Color of Amniotic fluid |
|
32802-1
|
Color of Bronchial specimen |
|
10335-8
|
Color of Cerebral spinal fluid |
|
80661-2
|
Color of Peritoneal dialysis fluid |
|
51617-9
|
Color of Dialysis fluid |
|
6824-7
|
Color of Body fluid |
|
14132-5
|
Color of Gastric fluid |
|
86242-5
|
Color of Nasal fluid |
|
14661-3
|
Color of Pericardial fluid |
|
14662-1
|
Color of Pleural fluid |
|
61192-1
|
Color of Pleural fluid from Fetus |
|
14660-5
|
Color of Peritoneal fluid |
|
10569-2
|
Color of Semen |
|
14664-7
|
Color of Synovial fluid |
|
86243-3
|
Color of Sputum |
|
32168-7
|
Color of Spun Cerebral spinal fluid |
|
53733-2
|
Color of Spun Body fluid |
|
9397-1
|
Color of Stool |
|
9796-4
|
Color of Stone |
|
76679-0
|
Color of Cerebral spinal fluid--1st tube |
|
76680-8
|
Color of Cerebral spinal fluid--2nd tube |
|
76681-6
|
Color of Cerebral spinal fluid--3rd tube |
|
76682-4
|
Color of Cerebral spinal fluid--4th tube |
|
5778-6
|
Color of Urine |
|
50553-7
|
Color of Urine by Auto |
|
79732-4
|
Type of Color vision exam method |
|
79731-6
|
Color vision Left eye |
|
79730-8
|
Color vision Right eye |
|
68971-1
|
Color of Vitreous fluid |
|
72289-2
|
Color of Exudate from wound |
|
33512-5
|
Color of Unspecified specimen |
|
29757-2
|
Colposcopy study |
|
32823-7
|
Columnar cells/100 cells in Bronchial specimen |
|
6084-8
|
Colza IgE Ab [Units/volume] in Serum |
|
16264-4
|
Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy |
|
38252-3
|
Calcium oxalate monohydrate/Total in Stone |
|
49501-0
|
Calcium oxalate monohydrate/Total in Stone by Infrared spectroscopy |
|
85629-4
|
Comatose during 3 day assessment period [CMS Assessment] |
|
54597-0
|
Comatose in last 7 days [CMS Assessment] |
|
87511-2
|
Combat zone AndOr hazardous duty work dates |
|
73568-8
|
Communication of critical results [Description] Document |
|
88640-8
|
Community health care Adult day care center Consult note |
|
88641-6
|
Community health care Adult day care center Discharge summary |
|
88642-4
|
Community health care Adult day care center Note |
|
85899-3
|
Community health care Consult note |
|
82825-1
|
Community health care Initial evaluation note |
|
80418-7
|
Community health care Medical equipment or product list |
|
85901-7
|
Community health care Note |
|
85903-3
|
Community health care Telephone encounter Note |
|
80419-5
|
Community health care Referral note |
|
80422-9
|
Community health care Report |
|
80417-9
|
Community health care Risk assessment and screening note |
|
80423-7
|
Community health care Safety issue assessment note |
|
28988-4
|
Comment [Interpretation] Left eye Narrative Ophthalmometer |
|
28978-5
|
Comment [Interpretation] Right eye Narrative Ophthalmometer |
|
28817-5
|
Comment [Interpretation] LM glasses lens - left |
|
28816-7
|
Comment [Interpretation] LM glasses lens - right |
|
6175-4
|
Common Millet IgE Ab [Units/volume] in Serum |
|
15849-3
|
Common Millet IgE Ab RAST class [Presence] in Serum |
|
7494-8
|
Common Millet IgG Ab [Units/volume] in Serum |
|
56321-3
|
Common Millet IgG4 Ab [Mass/volume] in Serum |
|
63087-1
|
Common Millet IgG Ab [Mass/volume] in Serum |
|
7604-2
|
Common Pigweed IgE Ab [Units/volume] in Serum |
|
15936-8
|
Common Pigweed IgE Ab RAST class [Presence] in Serum |
|
50363-1
|
Common Pigweed IgE Ab/IgE total in Serum |
|
65782-5
|
Common ragweed native (nAmb a) 1 IgE Ab [Units/volume] in Serum |
|
81965-6
|
Common ragweed native (nAmb a) 1 IgE Ab RAST class [Presence] in Serum |
|
7652-1
|
Common Ragweed triggered histamine release [Units/volume] in Blood |
|
6085-5
|
Common Ragweed IgE Ab [Units/volume] in Serum |
|
15975-6
|
Common Ragweed IgE Ab RAST class [Presence] in Serum |
|
61214-3
|
Common Ragweed IgE Ab/IgE total in Serum |
|
7646-3
|
Common Ragweed IgG Ab [Units/volume] in Serum |
|
56371-8
|
Common Ragweed IgG4 Ab [Mass/volume] in Serum |
|
63206-7
|
Common Ragweed IgG Ab [Mass/volume] in Serum |
|
48256-2
|
Common Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
6855-1
|
Common Reed IgE Ab [Units/volume] in Serum |
|
15989-7
|
Common Reed IgE Ab RAST class [Presence] in Serum |
|
56230-6
|
Common Reed IgG4 Ab [Mass/volume] in Serum |
|
66714-7
|
Common wasp recombinant (rVes v) 1 IgE Ab [Units/volume] in Serum |
|
66715-4
|
Common wasp recombinant (rVes v) 1 IgE Ab RAST class [Presence] in Serum |
|
60240-9
|
Common wasp recombinant (rVes v) 5 IgE Ab [Units/volume] in Serum |
|
60239-1
|
Common wasp recombinant (rVes v) 5 IgE Ab RAST class [Presence] in Serum |
|
91878-9
|
Mode of communication |
|
75618-9
|
Comorbid condition |
|
83243-6
|
Comorbidities and coexisting conditions [CMS Assessment] |
|
74291-6
|
Comorbidities relevant to trauma care [NTDS] |
|
74522-4
|
Complement lectin pathway actual/normal in Serum by Immunoassay |
|
4471-9
|
Complement Activity Cell Surface Induced [Units/volume] in Serum or Plasma |
|
15168-8
|
Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay |
|
15169-6
|
Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
|
15170-4
|
Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay |
|
4514-6
|
Complement decay accelerating factor [Entitic number] in Red Blood Cells |
|
6292-7
|
Complement decay accelerating factor [Presence] in Red Blood Cells |
|
15178-7
|
Complement factor B [Mass/volume] in Body fluid |
|
2269-9
|
Complement factor B [Mass/volume] in Serum or Plasma |
|
4516-1
|
Complement factor Ba [Mass/volume] in Serum or Plasma |
|
4517-9
|
Complement factor Bb [Mass/volume] in Serum or Plasma |
|
4518-7
|
Complement factor D [Mass/volume] in Serum or Plasma |
|
4519-5
|
Complement factor H [Mass/volume] in Serum or Plasma |
|
4520-3
|
Complement factor I [Mass/volume] in Serum or Plasma |
|
4521-1
|
Complement factor P [Mass/volume] in Plasma |
|
58462-3
|
Complement functional activity [Units/volume] in Serum or Plasma by Immunoassay |
|
34095-0
|
Comprehensive history and physical note |
|
4524-5
|
Complement membrane attack complex (C5b-C6-C7-C8-C9n) [Mass/volume] in Plasma |
|
47306-6
|
Cartilage oligomeric matrix protein [Units/volume] in Serum by Immunoassay |
|
81262-8
|
Complex variant HGVS name |
|
81260-2
|
Complex genetic variant [ID] |
|
81261-0
|
Complex variant name Nominal |
|
81263-6
|
Complex variant type |
|
13946-9
|
Complement+Immunoglobulin [Presence] in Red Blood Cells |
|
4533-6
|
Complement+Immunoglobulin [Units/volume] in Red Blood Cells |
|
89101-0
|
Compared to 10 years ago, has there been any change in balancing the checkbook without error [ECog.Partner] |
|
89173-9
|
Compared to 10 years ago, has there been any change in balancing the checkbook without error [ECog] |
|
89119-2
|
Compared to 10 years ago, has there been any change in communicating thoughts in a conversation [ECog.Partner] |
|
89172-1
|
Compared to 10 years ago, has there been any change in communicating thoughts in a conversation [ECog] |
|
89093-9
|
Compared to 10 years ago, has there been any change in cooking or working and talking at the same time [ECog.Partner] |
|
89171-3
|
Compared to 10 years ago, has there been any change in cooking or working and talking at the same time [ECog] |
|
89115-0
|
Compared to 10 years ago, has there been any change in describing a program he or she has watched on TV [ECog.Partner] |
|
89170-5
|
Compared to 10 years ago, has there been any change in describing a program I have watched on TV [ECog] |
|
89104-4
|
Compared to 10 years ago, has there been any change in developing a schedule in advance of anticipated events [ECog.Partner] |
|
89169-7
|
Compared to 10 years ago, has there been any change in developing a schedule in advance of anticipated events [ECog] |
|
89130-9
|
Compared to 10 years ago, has there been any change in finding his or her way around a familiar neighborhood [ECog.Partner] |
|
89108-5
|
Compared to 10 years ago, has there been any change in finding his or her way around a familiar store [ECog.Partner] |
|
89107-7
|
Compared to 10 years ago, has there been any change in finding his or her way around a house visited many times [ECog.Partner] |
|
89168-9
|
Compared to 10 years ago, has there been any change in finding my car in a parking lot [ECog] |
|
89167-1
|
Compared to 10 years ago, has there been any change in finding my way around a familiar neighborhood [ECog] |
|
89166-3
|
Compared to 10 years ago, has there been any change in finding my way around a familiar store [ECog] |
|
89165-5
|
Compared to 10 years ago, has there been any change in finding my way around a house visited many times [ECog] |
|
89164-8
|
Compared to 10 years ago, has there been any change in finding my way back to a meeting spot in the mall or other location [ECog] |
|
89111-9
|
Compared to 10 years ago, has there been any change in finding one's car in a parking lot [ECog.Partner] |
|
89120-0
|
Compared to 10 years ago, has there been any change in finding the right words to use in a conversation [ECog.Partner] |
|
89163-0
|
Compared to 10 years ago, has there been any change in finding the right words to use in a conversation [ECog] |
|
89110-1
|
Compared to 10 years ago, has there been any change in finding the way back to a meeting spot in the mall or other location [ECog.Partner] |
|
89113-5
|
Compared to 10 years ago, has there been any change in following a map to find a new location [ECog.Partner] |
|
89162-2
|
Compared to 10 years ago, has there been any change in following a map to find a new location [ECog] |
|
89118-4
|
Compared to 10 years ago, has there been any change in following a story in a book or on TV [ECog.Partner] |
|
89161-4
|
Compared to 10 years ago, has there been any change in following a story in a book or on TV [ECog] |
|
89122-6
|
Compared to 10 years ago, has there been any change in forgetting the names of objects [ECog.Partner] |
|
89160-6
|
Compared to 10 years ago, has there been any change in forgetting the names of objects [ECog] |
|
89100-2
|
Compared to 10 years ago, has there been any change in keeping financial records organized [ECog.Partner] |
|
89159-8
|
Compared to 10 years ago, has there been any change in keeping financial records organized [ECog] |
|
89102-8
|
Compared to 10 years ago, has there been any change in keeping living and work space organized [ECog.Partner] |
|
89158-0
|
Compared to 10 years ago, has there been any change in keeping living and work space organized [ECog] |
|
89098-8
|
Compared to 10 years ago, has there been any change in keeping mail and papers organized [ECog.Partner] |
|
89157-2
|
Compared to 10 years ago, has there been any change in keeping mail and papers organized [ECog] |
|
89156-4
|
Compared to 10 years ago, has there been any change in planning a sequence of stops on a shopping trip [ECog] |
|
89106-9
|
Compared to 10 years ago, has there been any change in planning the sequence of stops on a shopping trip [ECog.Partner] |
|
89099-6
|
Compared to 10 years ago, has there been any change in prioritizing tasks by importance [ECog.Partner] |
|
89155-6
|
Compared to 10 years ago, has there been any change in prioritizing tasks by importance [ECog] |
|
89112-7
|
Compared to 10 years ago, has there been any change in reading a map and helping with directions when someone else is driving [ECog.Partner] |
|
89154-9
|
Compared to 10 years ago, has there been any change in reading a map and helping with directions when someone else is driving [ECog] |
|
89128-3
|
Compared to 10 years ago, has there been any change in recalling conversations a few days later [ECog.Partner] |
|
89153-1
|
Compared to 10 years ago, has there been any change in recalling conversations a few days later [ECog] |
|
89129-1
|
Compared to 10 years ago, has there been any change in remembering a few shopping items without a list [ECog.Partner] |
|
89152-3
|
Compared to 10 years ago, has there been any change in remembering a few shopping items without a list [ECog] |
|
89123-4
|
Compared to 10 years ago, has there been any change in remembering appointments, meetings, or engagements [ECog.Partner] |
|
89151-5
|
Compared to 10 years ago, has there been any change in remembering appointments, meetings, or engagements [ECog] |
|
89124-2
|
Compared to 10 years ago, has there been any change in remembering he or she has already told someone something [ECog.Partner] |
|
89150-7
|
Compared to 10 years ago, has there been any change in remembering I have already told someone something [ECog] |
|
89125-9
|
Compared to 10 years ago, has there been any change in remembering the current date or day of the week [ECog.Partner] |
|
89149-9
|
Compared to 10 years ago, has there been any change in remembering the current date or day of the week [ECog] |
|
89116-8
|
Compared to 10 years ago, has there been any change in remembering the meaning of common words [ECog.Partner] |
|
89148-1
|
Compared to 10 years ago, has there been any change in remembering the meaning of common words [ECog] |
|
89109-3
|
Compared to 10 years ago, has there been any change in remembering things that happened recently (such as recent outings, events in the news) [ECog.Partner] |
|
89147-3
|
Compared to 10 years ago, has there been any change in remembering things that happened recently (such as recent outings, events in the news) [ECog] |
|
89127-5
|
Compared to 10 years ago, has there been any change in remembering where he or she has placed objects [ECog.Partner] |
|
89146-5
|
Compared to 10 years ago, has there been any change in remembering where I have placed objects [ECog] |
|
89126-7
|
Compared to 10 years ago, has there been any change in repeating stories AndOr questions [ECog.Partner] |
|
89145-7
|
Compared to 10 years ago, has there been any change in repeating stories AndOr questions [ECog] |
|
89095-4
|
Compared to 10 years ago, has there been any change in returning to a task after being interrupted [ECog.Partner] |
|
89144-0
|
Compared to 10 years ago, has there been any change in returning to a task after being interrupted [ECog] |
|
89143-2
|
Compared to 10 years ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e. bring a coat or umbrella) [ECog] |
|
89105-1
|
Compared to 10 years ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e.bring a coat or umbrella) [ECog.Partner] |
|
89094-7
|
Compared to 10 years ago, has there been any change in the ability to concentrate on a task without being distracted by external things in the environment [ECog.Partner] |
|
89142-4
|
Compared to 10 years ago, has there been any change in the ability to concentrate on a task without being distracted by external things in the environment [ECog] |
|
89096-2
|
Compared to 10 years ago, has there been any change in the ability to do two things at once [ECog.Partner] |
|
89141-6
|
Compared to 10 years ago, has there been any change in the ability to do two things at once [ECog] |
|
89103-6
|
Compared to 10 years ago, has there been any change in thinking ahead [ECog.Partner] |
|
89140-8
|
Compared to 10 years ago, has there been any change in thinking ahead [ECog] |
|
89092-1
|
Compared to 10 years ago, has there been any change in thinking things through before acting [ECog.Partner] |
|
89139-0
|
Compared to 10 years ago, has there been any change in thinking things through before acting [ECog] |
|
89114-3
|
Compared to 10 years ago, has there been any change in understanding spoken directions or instructions [ECog.Partner] |
|
89138-2
|
Compared to 10 years ago, has there been any change in understanding spoken directions or instructions [ECog] |
|
89117-6
|
Compared to 10 years ago, has there been any change in understanding the point of what other people are trying to say [ECog.Partner] |
|
89137-4
|
Compared to 10 years ago, has there been any change in understanding the point of what other people are trying to say [ECog] |
|
89097-0
|
Compared to 10 years ago, has there been any change in using an organized strategy to manage a medication schedule involving multiple medications [ECog.Partner] |
|
89136-6
|
Compared to 10 years ago, has there been any change in using an organized strategy to manage a medication schedule involving multiple medications [ECog] |
|
89121-8
|
Compared to 10 years ago, has there been any change in verbally giving instructions to others [ECog.Partner] |
|
89135-8
|
Compared to 10 years ago, has there been any change in verbally giving instructions to others [ECog] |
|
79119-4
|
Compared to a few years ago, does he or she have more trouble recalling conversations a few days later [GPCOG] |
|
79118-6
|
Compared to a few years ago, does the patient have more trouble remembering things that have happened recently than she or he used to [GPCOG] |
|
79123-6
|
Compared to a few years ago, does the patient need more assistance with transport (either private or public) [GPCOG] |
|
79122-8
|
Compared to a few years ago, is the patient less able to manage his or her medication independently [GPCOG] |
|
79121-0
|
Compared to a few years ago, is the patient less able to manage money and financial affairs (e.g. paying bills, budgeting) [GPCOG] |
|
79120-2
|
Compared to a few years ago, when speaking, does the patient have more difficulty in finding the right word or tend to use the wrong words more often [GPCOG] |
|
71897-3
|
Compared to one year ago, how would you rate your emotional problems, such as feeling anxious,depressed or irritable, now [Veterans RAND] |
|
71898-1
|
Compared to one year ago, how would you rate your physical health in general now [Veterans RAND] |
|
71056-6
|
Compared to what you expected, how do you rate the effectiveness of the treatment so far [FACIT] |
|
71057-4
|
Compared to what you expected, how do you rate the side effects of treatment so far [FACIT] |
|
8598-5
|
Comparison study [Date and time] by EKG |
|
8599-3
|
Comparison study [Interpretation] by EKG |
|
18843-3
|
EKG Comparison study (narrative) |
|
93126-1
|
Comparison with previous results |
|
81348-5
|
Compensation for healthcare agent [Reported] |
|
75322-8
|
Complaint |
|
75313-7
|
Complaint Family member |
|
72114-2
|
Complaint NEMSIS |
|
57949-0
|
Complement C4c [Mass/volume] in Serum or Plasma |
|
81025-9
|
Complex carbohydrate intake 24 hour Estimated |
|
81026-7
|
Complex carbohydrate intake 24 hour Measured |
|
33667-7
|
Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma |
|
60828-1
|
Compliance.static Lung |
|
74284-1
|
Type of complication [NTDS] |
|
19817-6
|
Complications |
|
85419-0
|
Complications during rehabilitation stay [CMS Assessment] |
|
9795-6
|
Composition in Stone |
|
74511-7
|
COMT gene c.1947G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
93411-7
|
COMT gene product metabolic activity interpretation in Blood or Tissue by Molecular genetics method |
|
58807-9
|
Conalbumin native (nGal d) 3 IgE Ab [Units/volume] in Serum |
|
81981-3
|
Conalbumin native (nGal d) 3 IgE Ab RAST class [Presence] in Serum |
|
25615-6
|
Conalbumin IgE Ab [Units/volume] in Serum |
|
25616-4
|
Conalbumin IgE Ab RAST class [Presence] in Serum |
|
90803-8
|
Post-challenge peak - baseline concentration increment [Mass concentration difference] in Serum or Plasma by calculation |
|
82232-0
|
Concentration [NDI] |
|
33067-0
|
Conception date |
|
53662-3
|
Conception method |
|
75323-6
|
Condition |
|
75315-2
|
Condition Family member |
|
45349-8
|
Condition of tick [Identifier] |
|
89251-3
|
Condition present on admission |
|
89914-6
|
Condition triggering EOC response activation |
|
89915-3
|
Condition triggering EOC response termination |
|
86469-4
|
Conditions prior to medical or treatment regimen change or inpatient stay that took place within past 14 days [CMS Assessment] |
|
46465-1
|
Conditions prior to medical or treatment regimen change or inpatient stay within past 14 days [OASIS] |
|
86527-9
|
Conditions related to intellectual disability and developmental disability status [CMS Assessment] |
|
57719-7
|
Conditions tested for in this newborn screening study [Identifier] in DBS |
|
8608-2
|
Conduction [Interpretation] by EKG |
|
9868-1
|
Conduction [Interpretation] Narrative by EKG |
|
34098-4
|
Conference note |
|
85060-2
|
Confidence in cause of death |
|
85059-4
|
Confidence in date of death |
|
75506-6
|
aPTT.lupus sensitive W excess phospholipid (LA confirm) |
|
33930-9
|
aPTT W excess hexagonal phospholipid (StaClot LA confirm) |
|
75508-2
|
aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm) |
|
47040-1
|
Consultation 2nd opinion |
|
57838-5
|
dRVVT W excess phospholipid (LA confirm) |
|
75883-9
|
dRVVT W excess hexagonal phospholipid (STA-StaClot confirm) |
|
68916-6
|
dRVVT W excess phospholipid actual/normal (normalized LA confirm) |
|
91102-4
|
People with confirmed negative lab results [#] Population |
|
91100-8
|
People with confirmed positive lab results [#] Population |
|
72177-9
|
Congenital anomalies noted [RHEA] |
|
73780-9
|
Congenital anomalies of the newborn [US Standard Certificate of Live Birth] |
|
85677-3
|
Congenital rubella syndrome case classification |
|
10750-8
|
Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
|
58351-8
|
Connective tissue growth factor [Mass/volume] in Urine |
|
58352-6
|
Connective tissue growth factor [Moles/volume] in Urine |
|
82252-8
|
Constitutive heterochromatin analysis in Blood or Tissue by Banding |
|
90353-4
|
Conscious sedation procedure note |
|
59284-0
|
Consent Document |
|
81347-7
|
Consent for healthcare agent to deviate from stated goals, preferences and priorities [Reported] |
|
90407-8
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had singing or humming [PROMIS] |
|
90384-9
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another [PROMIS] |
|
90400-3
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another [PROMIS] |
|
90399-7
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another [PROMIS] |
|
90402-9
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when dining out [PROMIS] |
|
90376-5
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when dressing yourself without help [PROMIS] |
|
90401-1
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when getting in or out of a car [PROMIS] |
|
90383-1
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when lifting something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) [PROMIS] |
|
90397-1
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) [PROMIS] |
|
90396-3
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when lifting something weighing less than 5 lbs (about 2 kg, like a houseplant) [PROMIS] |
|
90398-9
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase) [PROMIS] |
|
90403-7
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when low-intensity leisure activity (gardening, etc.) [PROMIS] |
|
90382-3
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when making a bed [PROMIS] |
|
90404-5
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when moderate-intensity leisure activity (bicycling on level terrain, etc.) [PROMIS] |
|
90379-9
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when preparing meals [PROMIS] |
|
90388-0
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when putting on socks or stockings [PROMIS] |
|
90395-5
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when scrubbing the floor or counter [PROMIS] |
|
90389-8
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when standing for at least 5 minutes [PROMIS] |
|
90381-5
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when sweeping or mopping [PROMIS] |
|
90386-4
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when taking a bath without help [PROMIS] |
|
90387-2
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when taking a shower [PROMIS] |
|
90408-6
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when talking while walking [PROMIS] |
|
90385-6
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping [PROMIS] |
|
90405-2
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking (faster than your usual speed) for 50 steps without stopping [PROMIS] |
|
90406-0
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping [PROMIS] |
|
90391-4
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping [PROMIS] |
|
90390-6
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking 10 steps/paces on flat ground at a normal speed without stopping [PROMIS] |
|
90377-3
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking 50 steps/paces on flat ground at a normal speed without stopping [PROMIS] |
|
90393-0
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking up 10 stairs (1 flight) without stopping [PROMIS] |
|
90378-1
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking up 20 stairs (2 flights) without stopping [PROMIS] |
|
90394-8
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking up 30 stairs (3 flights) without stopping [PROMIS] |
|
90392-2
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking up 5 stairs without stopping [PROMIS] |
|
90380-7
|
Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when washing dishes [PROMIS] |
|
10570-0
|
Consistency of Cervical mucus |
|
74411-0
|
Consistency of Lymph node |
|
11029-6
|
Consistency of Stool |
|
9797-2
|
Consistency of Stone |
|
72082-1
|
Constant dialysate sodium prescribed [ESRD] |
|
54773-7
|
Constipation present in last 7 days [CMS Assessment] |
|
11488-4
|
Consult note |
|
18763-3
|
Consultant Initial evaluation note |
|
28569-2
|
Consultant Progress note |
|
76276-5
|
Continuous flow setting Ventilator |
|
76273-2
|
Continuous flow Ventilator |
|
89058-2
|
Contact email address |
|
89060-8
|
Contact Phone number |
|
80407-0
|
Contamination/radiation/contagion status |
|
79828-0
|
Contrast sensitivity [Log Inverse Percent] of Left eye by Pelli-Robson eye chart |
|
79827-2
|
Contrast sensitivity [Log Inverse Percent] of Right eye by Pelli-Robson eye chart |
|
86654-1
|
Contraceptive counseling was provided |
|
93122-0
|
Contraindicated vaccine type [Identifier] |
|
78975-0
|
Type of Contrast given |
|
74566-1
|
Contributing factors for event [AHRQ] |
|
74567-9
|
Contributing factors for event were known [AHRQ] |
|
93289-7
|
Controllability of most severe suicidal ideation 1 month [C-SSRS] |
|
93290-5
|
Controllability of most severe suicidal ideation Lifetime [C-SSRS] |
|
93738-3
|
Cooked cauliflower IgE Ab [Units/volume] in Serum |
|
12186-3
|
Colloid oncotic pressure [Partial pressure] in Plasma |
|
30920-3
|
Copper [Mass/volume] in Urine collected for unspecified duration |
|
21219-1
|
Copper [Mass/volume] in 24 hour Urine |
|
5633-3
|
Copper [Mass/time] in 24 hour Urine |
|
25879-8
|
Copper [Moles/volume] in 24 hour Urine |
|
14666-2
|
Copper [Moles/time] in 24 hour Urine |
|
12556-7
|
Copper [Mass/volume] in Blood |
|
47100-3
|
Copper [Moles/volume] in Blood |
|
57347-7
|
Copper [Mass/volume] in Dialysis fluid |
|
93728-4
|
Copper [Moles/volume] in Dialysis fluid |
|
16648-8
|
Copper [Mass/volume] in Body fluid |
|
47101-1
|
Copper [Moles/volume] in Body fluid |
|
5629-1
|
Copper [Mass/mass] in Hair |
|
47103-7
|
Copper [Moles/mass] in Hair |
|
81027-5
|
Copper intake 24 hour Estimated |
|
81028-3
|
Copper intake 24 hour Measured |
|
56126-6
|
Copper [Mass/mass] in Liver |
|
5630-9
|
Copper [Mass/volume] in Red Blood Cells |
|
27124-7
|
Copper [Mass/mass] in Red Blood Cells |
|
47102-9
|
Copper [Moles/volume] in Red Blood Cells |
|
5631-7
|
Copper [Mass/volume] in Serum or Plasma |
|
14665-4
|
Copper [Moles/volume] in Serum or Plasma |
|
10751-6
|
Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
|
8198-4
|
Copper [Mass/mass] in Tissue |
|
52912-3
|
Copper [Moles/mass] in Tissue |
|
5632-5
|
Copper [Mass/volume] in Urine |
|
34273-3
|
Copper [Moles/volume] in Urine |
|
9470-6
|
Copper [Mass/volume] in Water |
|
20778-7
|
Copper [Mass/volume] in Unspecified specimen |
|
87472-7
|
Copper [Mass/mass] in Unspecified specimen |
|
22744-7
|
Copper [Moles/volume] in Unspecified specimen |
|
29942-0
|
Copper/Creatinine [Mass Ratio] in 24 hour Urine |
|
52932-1
|
Copper/Creatinine [Molar ratio] in 24 hour Urine |
|
13829-7
|
Copper/Creatinine [Mass Ratio] in Urine |
|
25880-6
|
Copper/Creatinine [Molar ratio] in Urine |
|
9382-3
|
Coproporphyrin [Mass/time] in unspecified time Stool |
|
51417-4
|
Coproporphyrin/Porphyrins.total in 24 hour Urine |
|
72574-7
|
Coproporphyrin/Porphyrins.total [Pure substance fraction] in 24 hour Urine |
|
14156-4
|
Coproporphyrin [Mass/mass] in 24 hour Stool |
|
2135-2
|
Coproporphyrin [Mass/time] in 24 hour Stool |
|
15040-9
|
Coproporphyrin [Moles/time] in 24 hour Stool |
|
13960-0
|
Coproporphyrin [Presence] in 24 hour Urine |
|
20623-5
|
Coproporphyrin [Mass/volume] in 24 hour Urine |
|
2137-8
|
Coproporphyrin [Mass/time] in 24 hour Urine |
|
25881-4
|
Coproporphyrin [Moles/volume] in 24 hour Urine |
|
15041-7
|
Coproporphyrin [Moles/time] in 24 hour Urine |
|
18257-6
|
Coproporphyrin [Mass/volume] in Blood |
|
2134-5
|
Coproporphyrin [Moles/volume] in Red Blood Cells |
|
14157-2
|
Coproporphyrin [Mass/volume] in Serum or Plasma |
|
22661-3
|
Coproporphyrin [Moles/volume] in Serum or Plasma |
|
40627-2
|
Coproporphyrin [Mass/mass] in Stool |
|
29266-4
|
Coproporphyrin [Moles/mass] in Stool |
|
2136-0
|
Coproporphyrin [Presence] in Urine |
|
11212-8
|
Coproporphyrin [Mass/volume] in Urine |
|
12809-0
|
Coproporphyrin [Mass/time] in Urine |
|
25167-8
|
Coproporphyrin [Moles/volume] in Urine |
|
48634-0
|
Coproporphyrin/Creatinine [Mass Ratio] in 24 hour Urine |
|
32008-5
|
Coproporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
|
38162-4
|
Coproporphyrin/Creatinine [Mass Ratio] in Urine |
|
48395-8
|
Coproporphyrin/Creatinine [Molar ratio] in Urine |
|
34402-8
|
Coproporphyrin/Hemoglobin [Mass Ratio] in Red Blood Cells |
|
23845-1
|
Coproporphyrin 1 [Mass/time] in 24 hour Stool |
|
47253-0
|
Coproporphyrin 1 [Mass/volume] in 24 hour Urine |
|
6877-5
|
Coproporphyrin 1 [Mass/time] in 24 hour Urine |
|
40792-4
|
Coproporphyrin 1 [Moles/time] in 24 hour Urine |
|
14667-0
|
Coproporphyrin 1 [Moles/volume] in Serum or Plasma |
|
75024-0
|
Coproporphyrin 1/Porphyrins.total in Stool |
|
14670-4
|
Coproporphyrin 1/Porphyrins.total in Urine |
|
26977-9
|
Coproporphyrin 1 [Presence] in Stool |
|
14668-8
|
Coproporphyrin 1 [Moles/volume] in Stool |
|
45305-0
|
Coproporphyrin 1 [Moles/mass] in Stool |
|
9343-5
|
Coproporphyrin 1 [Mass/volume] in Urine |
|
14669-6
|
Coproporphyrin 1 [Moles/volume] in Urine |
|
9344-3
|
Coproporphyrin 1/Coproporphyrin.total [Mass Ratio] in 24 hour Urine |
|
59820-1
|
Coproporphyrin 1/Creatinine [Molar ratio] in 24 hour Urine |
|
48305-7
|
Coproporphyrin 1/Creatinine [Mass Ratio] in Urine |
|
45313-4
|
Coproporphyrin 1/Creatinine [Molar ratio] in Urine |
|
23846-9
|
Coproporphyrin 3 [Mass/time] in 24 hour Stool |
|
47254-8
|
Coproporphyrin 3 [Mass/volume] in 24 hour Urine |
|
6878-3
|
Coproporphyrin 3 [Mass/time] in 24 hour Urine |
|
40791-6
|
Coproporphyrin 3 [Moles/time] in 24 hour Urine |
|
14671-2
|
Coproporphyrin 3 [Moles/volume] in Serum or Plasma |
|
75025-7
|
Coproporphyrin 3/Porphyrins.total in Stool |
|
14672-0
|
Coproporphyrin 3 [Moles/volume] in Stool |
|
45306-8
|
Coproporphyrin 3 [Moles/mass] in Stool |
|
9345-0
|
Coproporphyrin 3 [Mass/volume] in Urine |
|
14673-8
|
Coproporphyrin 3 [Moles/volume] in Urine |
|
75000-0
|
Coproporphyrin 3/Coproporphyrin.total in 24 hour Urine |
|
75001-8
|
Coproporphyrin 3/Coproporphyrin.total in Stool |
|
33618-0
|
Coproporphyrin 3/Coproporphyrin 1 [Mass Ratio] in 24 hour Stool |
|
39793-5
|
Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in 24 hour Urine |
|
45314-2
|
Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in Urine |
|
59821-9
|
Coproporphyrin 3/Creatinine [Molar ratio] in 24 hour Urine |
|
48306-5
|
Coproporphyrin 3/Creatinine [Mass Ratio] in Urine |
|
45315-9
|
Coproporphyrin 3/Creatinine [Molar ratio] in Urine |
|
16649-6
|
Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells |
|
2138-6
|
Coproporphyrinogen oxidase [Enzymatic activity/volume] in Serum |
|
74586-9
|
Coenzyme Q cytochrome C reductase (Complex III) [Enzymatic activity/mass] in Tissue |
|
74585-1
|
Coenzyme Q cytochrome C reductase (Complex III)/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
80924-4
|
Coronary Bifurcated lesion end coordinates |
|
80923-6
|
Coronary Bifurcated lesion end segment |
|
80925-1
|
Coronary Bifurcated lesion end segment position |
|
80920-2
|
Coronary Lesion end coordinates |
|
80919-4
|
Coronary Lesion end segment |
|
80921-0
|
Coronary Lesion end segment position |
|
80922-8
|
Coronary Lesion located at vessel bifurcation |
|
80917-8
|
Coronary Lesion start coordinates |
|
80918-6
|
Coronary Lesion start segment position |
|
80916-0
|
Coronary Lesion start segment |
|
81435-0
|
Coronary Lesion treatment duration |
|
81437-6
|
Coronary Lesion treatment sequence |
|
78946-1
|
Coronary stent diameter |
|
80930-1
|
Coronary stent end coordinates |
|
80931-9
|
Coronary stent end segment position |
|
80927-7
|
Coronary stent end segment |
|
80240-5
|
Coronary stent expansion pressure |
|
80241-3
|
Coronary stent expansion time |
|
78947-9
|
Coronary stent length |
|
81438-4
|
Coronary stent number |
|
78981-8
|
Coronary stent product name |
|
80929-3
|
Coronary stent start coordinates |
|
80928-5
|
Coronary stent start segment position |
|
80926-9
|
Coronary stent start segment |
|
19736-8
|
Coralbumin IgE Ab [Units/volume] in Serum |
|
7247-0
|
Corn triggered histamine release [Units/volume] in Blood |
|
6087-1
|
Corn IgE Ab [Units/volume] in Serum |
|
15653-9
|
Corn IgE Ab RAST class [Presence] in Serum |
|
61327-3
|
Corn IgE Ab/IgE total in Serum |
|
6723-1
|
Corn IgG Ab [Units/volume] in Serum |
|
21221-7
|
Corn IgG Ab RAST class [Presence] in Serum |
|
56231-4
|
Corn IgG4 Ab [Mass/volume] in Serum |
|
35534-7
|
Corn IgG Ab [Mass/volume] in Serum |
|
7703-2
|
Corn smut IgE Ab [Units/volume] in Serum |
|
56232-2
|
Corn smut IgG4 Ab [Mass/volume] in Serum |
|
79814-0
|
Corneal curvature [Inverse Length] Left cornea by Keratometry |
|
79813-2
|
Corneal curvature [Inverse Length] Right cornea by Keratometry |
|
7249-6
|
Cornish hen triggered histamine release [Units/volume] in Blood |
|
76640-2
|
Coronary artery catheterization Study report |
|
5099-7
|
Coronavirus Ab [Units/volume] in Serum |
|
71496-4
|
Corporate organization code Dialysis facility [ESRD] |
|
77543-7
|
Correct responses count # [AmNART] |
|
58200-7
|
Correction number [CMS Assessment] |
|
54604-4
|
Corrective lenses used in last 7 days [CMS Assessment] |
|
58524-0
|
Corticosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
55841-1
|
Corticosterone [Mass/volume] in 24 hour Urine |
|
14042-6
|
Corticosterone [Mass/time] in 24 hour Urine |
|
55843-7
|
Corticosterone [Moles/volume] in 24 hour Urine |
|
55842-9
|
Corticosterone [Moles/time] in 24 hour Urine |
|
58523-2
|
Corticosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
16651-2
|
Corticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
|
58525-7
|
Corticosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
2139-4
|
Corticosterone [Mass/volume] in Serum or Plasma |
|
25381-5
|
Corticosterone [Moles/volume] in Serum or Plasma |
|
58631-3
|
Cortisol [Mass/volume] in Saliva (oral fluid) --1.5 hours post 1 ug/kg CRH IV |
|
58632-1
|
Cortisol [Moles/volume] in Saliva (oral fluid) --1.5 hours post 1 ug/kg CRH IV |
|
46398-4
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV |
|
47604-4
|
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV |
|
9615-6
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 250 ug corticotropin IM |
|
29363-9
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
32314-7
|
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
1398-7
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
40315-4
|
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus |
|
1397-9
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
|
58633-9
|
Cortisol [Mass/volume] in Serum or Plasma --10 AM specimen |
|
58634-7
|
Cortisol [Moles/volume] in Serum or Plasma --10 AM specimen |
|
58635-4
|
Cortisol [Mass/volume] in Serum or Plasma --10 PM specimen |
|
58636-2
|
Cortisol [Moles/volume] in Serum or Plasma --10 PM specimen |
|
77936-3
|
Cortisol [Moles/volume] in Serum or Plasma --10.5 hours post XXX challenge |
|
24393-1
|
Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight |
|
77935-5
|
Cortisol [Moles/volume] in Serum or Plasma --10 hours post XXX challenge |
|
93481-0
|
Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV |
|
16669-4
|
Cortisol [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
77925-6
|
Cortisol [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
21222-5
|
Cortisol [Mass/volume] in Serum or Plasma --11 PM specimen |
|
58642-0
|
Cortisol [Mass/volume] in Saliva (oral fluid) --12 AM specimen |
|
58643-8
|
Cortisol [Moles/volume] in Saliva (oral fluid) --12 AM specimen |
|
48098-8
|
Cortisol [Mass/volume] in Serum or Plasma --12 AM specimen |
|
45047-8
|
Cortisol [Moles/volume] in Serum or Plasma --12 AM specimen |
|
58644-6
|
Cortisol [Mass/volume] in Saliva (oral fluid) --12 PM specimen |
|
58645-3
|
Cortisol [Moles/volume] in Saliva (oral fluid) --12 PM specimen |
|
48099-6
|
Cortisol [Mass/volume] in Serum or Plasma --12 PM specimen |
|
45048-6
|
Cortisol [Moles/volume] in Serum or Plasma --12 PM specimen |
|
77937-1
|
Cortisol [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
|
58648-7
|
Cortisol [Mass/volume] in Saliva (oral fluid) --15 minutes post 1 ug/kg CRH IV |
|
58649-5
|
Cortisol [Moles/volume] in Saliva (oral fluid) --15 minutes post 1 ug/kg CRH IV |
|
46397-6
|
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV |
|
47605-1
|
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV |
|
9612-3
|
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
|
43217-9
|
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose corticotropin IM |
|
16670-2
|
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
40274-3
|
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
50752-5
|
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV |
|
40311-3
|
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
58650-3
|
Cortisol [Mass/volume] in Saliva (oral fluid) --15 minutes pre 1 ug/kg CRH IV |
|
58651-1
|
Cortisol [Moles/volume] in Saliva (oral fluid) --15 minutes pre 1 ug/kg CRH IV |
|
48100-2
|
Cortisol [Mass/volume] in Serum or Plasma --15 minutes pre 1 ug/kg CRH IV |
|
48101-0
|
Cortisol [Moles/volume] in Serum or Plasma --15 minutes pre 1 ug/kg CRH IV |
|
24394-9
|
Cortisol [Moles/volume] in Serum or Plasma --17 hours post 1 mg dexamethasone PO overnight |
|
1408-4
|
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 40 ug corticotropin IM BID 3 day |
|
58652-9
|
Cortisol [Mass/volume] in Saliva (oral fluid) --1 hour post 1 ug/kg CRH IV |
|
58653-7
|
Cortisol [Moles/volume] in Saliva (oral fluid) --1 hour post 1 ug/kg CRH IV |
|
1400-1
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
|
47606-9
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
|
50424-1
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 100 ug CRH IV |
|
1403-5
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
49968-1
|
Cortisol [Molar concentration difference] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
24391-5
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
|
1401-9
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM rapid |
|
1402-7
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid |
|
34476-2
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
20995-7
|
Cortisol [Interpretation] in Serum or Plasma--1 hour post dose corticotropin |
|
26528-0
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
26536-3
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
12567-4
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
59804-5
|
Cortisol [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge |
|
32311-3
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
1404-3
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
40314-7
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
1399-5
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
1406-8
|
Cortisol [Mass/volume] in Serum or Plasma --1 minute post 1 ug/kg CRH IV |
|
16671-0
|
Cortisol [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
|
77607-0
|
Cortisol [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
|
93482-8
|
Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV |
|
58655-2
|
Cortisol [Mass/volume] in Serum or Plasma --2 PM specimen |
|
58656-0
|
Cortisol [Moles/volume] in Serum or Plasma --2 PM specimen |
|
12569-0
|
Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
55472-5
|
Cortisol [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
50422-5
|
Cortisol [Mass/volume] in Serum or Plasma --20 minutes post 100 ug CRH IV |
|
12568-2
|
Cortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
55348-7
|
Cortisol [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
50442-3
|
Cortisol [Mass/volume] in Serum or Plasma --20 minutes post dose insulin IV |
|
24395-6
|
Cortisol [Moles/volume] in Serum or Plasma --24 hours post 1 mg dexamethasone PO overnight |
|
1407-6
|
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1409-2
|
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug corticotropin IM |
|
1410-0
|
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
14677-9
|
Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
26529-8
|
Cortisol [Mass/volume] in Serum or Plasma --24 hours post dose corticotropin |
|
54211-8
|
Cortisol [Moles/volume] in Serum or Plasma --24 hours post dose dexamethasone |
|
78047-8
|
Cortisol [Moles/volume] in Serum or Plasma --24 hour post XXX challenge |
|
83089-3
|
Cortisol [Mass/volume] in 24 hour Urine by Immunoassay |
|
83091-9
|
Cortisol [Moles/volume] in 24 hour Urine by Immunoassay |
|
20622-7
|
Cortisol [Mass/volume] in 24 hour Urine |
|
14158-0
|
Cortisol [Mass/time] in 24 hour Urine |
|
50848-1
|
Cortisol [Moles/volume] in 24 hour Urine |
|
32310-5
|
Cortisol [Moles/time] in 24 hour Urine |
|
1412-6
|
Cortisol [Mass/volume] in Serum or Plasma --26 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1411-8
|
Cortisol [Mass/volume] in Serum or Plasma --26 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
1426-6
|
Cortisol [Mass/volume] in Serum or Plasma --48 hours post 40 ug corticotropin IM BID 3 day |
|
1413-4
|
Cortisol [Mass/volume] in Serum or Plasma --2 days post 500 ug corticotropin IM |
|
58657-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) --2 hours post 1 ug/kg CRH IV |
|
58658-6
|
Cortisol [Moles/volume] in Saliva (oral fluid) --2 hours post 1 ug/kg CRH IV |
|
46399-2
|
Cortisol [Mass/volume] in Serum or Plasma --2 hours post 1 ug/kg CRH IV |
|
58659-4
|
Cortisol [Moles/volume] in Serum or Plasma --2 hours post 1 ug/kg CRH IV |
|
9613-1
|
Cortisol [Mass/volume] in Serum or Plasma --2 hours post 250 ug corticotropin IM |
|
21224-1
|
Cortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
32312-1
|
Cortisol [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
46403-2
|
Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV |
|
40316-2
|
Cortisol [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
93483-6
|
Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV |
|
50433-2
|
Cortisol [Mass/volume] in Serum or Plasma --3 AM specimen |
|
50430-8
|
Cortisol [Mass/volume] in Serum or Plasma --3 PM specimen |
|
77929-8
|
Cortisol [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
1415-9
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
|
47607-7
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
|
1418-3
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
49969-9
|
Cortisol [Molar concentration difference] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
24390-7
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
|
1416-7
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM rapid |
|
1417-5
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid |
|
26530-6
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
26535-5
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
12566-6
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
59803-7
|
Cortisol [Molar concentration difference] in Serum or Plasma --30 minutes post XXX challenge |
|
32313-9
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
1419-1
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
40312-1
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
1414-2
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
58661-0
|
Cortisol [Mass/volume] in Saliva (oral fluid) --30 minutes pre 1 ug/kg CRH IV |
|
58662-8
|
Cortisol [Moles/volume] in Saliva (oral fluid) --30 minutes pre 1 ug/kg CRH IV |
|
58663-6
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre 1 ug/kg CRH IV |
|
58664-4
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes pre 1 ug/kg CRH IV |
|
50441-5
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre dose insulin IV |
|
1421-7
|
Cortisol [Mass/volume] in Serum or Plasma --32 hours post 40 ug corticotropin IM BID 3 day |
|
26531-4
|
Cortisol [Mass/volume] in Serum or Plasma --32 hours post dose corticotropin |
|
1422-5
|
Cortisol [Mass/volume] in Serum or Plasma --3 days post 500 ug corticotropin IM |
|
54212-6
|
Cortisol [Moles/volume] in Serum or Plasma --3 days post dose dexamethasone |
|
21225-8
|
Cortisol [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
55473-3
|
Cortisol [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40317-0
|
Cortisol [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
77926-4
|
Cortisol [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
58666-9
|
Cortisol [Mass/volume] in Saliva (oral fluid) --4 AM specimen |
|
58667-7
|
Cortisol [Moles/volume] in Saliva (oral fluid) --4 AM specimen |
|
48102-8
|
Cortisol [Mass/volume] in Serum or Plasma --4 AM specimen |
|
48103-6
|
Cortisol [Moles/volume] in Serum or Plasma --4 AM specimen |
|
58668-5
|
Cortisol [Mass/volume] in Saliva (oral fluid) --4 PM specimen |
|
58669-3
|
Cortisol [Moles/volume] in Saliva (oral fluid) --4 PM specimen |
|
21226-6
|
Cortisol [Mass/volume] in Serum or Plasma --4 PM specimen |
|
45049-4
|
Cortisol [Moles/volume] in Serum or Plasma --4 PM specimen |
|
50423-3
|
Cortisol [Mass/volume] in Serum or Plasma --40 minutes post 100 ug CRH IV |
|
16672-8
|
Cortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
60013-0
|
Cortisol [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
58670-1
|
Cortisol [Mass/volume] in Saliva (oral fluid) --45 minutes post 1 ug/kg CRH IV |
|
58671-9
|
Cortisol [Moles/volume] in Saliva (oral fluid) --45 minutes post 1 ug/kg CRH IV |
|
1423-3
|
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV |
|
58672-7
|
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV |
|
9614-9
|
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM |
|
56585-3
|
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
40275-0
|
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
1424-1
|
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
40313-9
|
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus |
|
1425-8
|
Cortisol [Mass/volume] in Serum or Plasma --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1427-4
|
Cortisol [Mass/volume] in Serum or Plasma --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
26532-2
|
Cortisol [Mass/volume] in Serum or Plasma --48 hours post dose corticotropin |
|
54213-4
|
Cortisol [Moles/volume] in Serum or Plasma --4 days post dose corticotropin |
|
77930-6
|
Cortisol [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
1429-0
|
Cortisol [Mass/volume] in Serum or Plasma --50 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1428-2
|
Cortisol [Mass/volume] in Serum or Plasma --50 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
16673-6
|
Cortisol [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
|
1430-8
|
Cortisol [Mass/volume] in Serum or Plasma --56 hours post 40 ug corticotropin IM BID 3 day |
|
26533-0
|
Cortisol [Mass/volume] in Serum or Plasma --56 hours post dose corticotropin |
|
54214-2
|
Cortisol [Moles/volume] in Serum or Plasma --5 days post dose dexamethasone |
|
59153-7
|
Cortisol [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
54215-9
|
Cortisol [Moles/volume] in Serum or Plasma --5 hours post dose corticotropin |
|
1431-6
|
Cortisol [Mass/volume] in Serum or Plasma --5 minutes post 1 ug/kg CRH IV |
|
77927-2
|
Cortisol [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
93484-4
|
Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV |
|
50434-0
|
Cortisol [Mass/volume] in Serum or Plasma --6 AM specimen |
|
50431-6
|
Cortisol [Mass/volume] in Serum or Plasma --6 PM specimen |
|
77931-4
|
Cortisol [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
|
16674-4
|
Cortisol [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
|
1432-4
|
Cortisol [Mass/volume] in Serum or Plasma --72 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1433-2
|
Cortisol [Mass/volume] in Serum or Plasma --72 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
77928-0
|
Cortisol [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
58674-3
|
Cortisol [Mass/volume] in Saliva (oral fluid) --8 AM specimen |
|
58675-0
|
Cortisol [Moles/volume] in Saliva (oral fluid) --8 AM specimen |
|
48104-4
|
Cortisol [Mass/volume] in Serum or Plasma --8 AM specimen |
|
45050-2
|
Cortisol [Moles/volume] in Serum or Plasma --8 AM specimen |
|
58676-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) --8 PM specimen |
|
58677-6
|
Cortisol [Moles/volume] in Saliva (oral fluid) --8 PM specimen |
|
48105-1
|
Cortisol [Mass/volume] in Serum or Plasma --8 PM specimen |
|
45051-0
|
Cortisol [Moles/volume] in Serum or Plasma --8 PM specimen |
|
16675-1
|
Cortisol [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge |
|
1434-0
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 1 mg dexamethasone PO overnight |
|
1435-7
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
25626-3
|
Cortisol [Moles/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1436-5
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyraPONE PO |
|
1438-1
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 40 ug corticotropin IM BID 3 day |
|
1437-3
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
46416-4
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 8 mg dexamethasone PO overnight high dose |
|
26534-8
|
Cortisol [Mass/volume] in Serum or Plasma --8 hours post dose corticotropin |
|
77932-2
|
Cortisol [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
|
54236-5
|
Cortisol [Mass/volume] in Serum or Plasma --9 AM 2nd day specimen |
|
50429-0
|
Cortisol [Mass/volume] in Serum or Plasma --9 AM specimen |
|
50432-4
|
Cortisol [Mass/volume] in Serum or Plasma --9 PM specimen |
|
1439-9
|
Cortisol [Mass/volume] in Serum or Plasma --9.5 hours post 8 mg dexamethasone PO overnight high dose |
|
77934-8
|
Cortisol [Moles/volume] in Serum or Plasma --9.5 hours post XXX challenge |
|
1440-7
|
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight |
|
1441-5
|
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 3 g metyraPONE PO overnight |
|
1442-3
|
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 8 mg dexamethasone PO overnight high dose |
|
77933-0
|
Cortisol [Moles/volume] in Serum or Plasma --9 hours post XXX challenge |
|
66733-7
|
Cortisol [Mass or Moles/volume] in Serum or Plasma --afternoon specimen |
|
9813-7
|
Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen |
|
66735-2
|
Cortisol [Mass or Moles/volume] in Serum or Plasma --AM peak specimen |
|
14679-5
|
Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
|
51495-0
|
Cortisol [Mass/volume] in Saliva (oral fluid) --baseline |
|
43215-3
|
Cortisol [Mass/volume] in Serum or Plasma --baseline |
|
32315-4
|
Cortisol [Moles/volume] in Serum or Plasma --baseline |
|
33257-7
|
Cortisol [Mass/volume] in Cerebral spinal fluid |
|
53345-5
|
Cortisol [Mass/volume] in DBS |
|
53346-3
|
Cortisol [Moles/volume] in DBS |
|
14043-4
|
Cortisol Free [Mass/time] in 12 hour Urine |
|
1389-6
|
Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
|
60681-4
|
Cortisol Free [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
26525-6
|
Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post dose corticotropin |
|
34909-2
|
Cortisol Free [Mass/volume] in 24 hour Urine by HPLC |
|
35261-7
|
Cortisol Free [Mass or Moles/volume] in 24 hour Urine by HPLC |
|
25883-0
|
Cortisol Free [Moles/volume] in 24 hour Urine by HPLC |
|
25885-5
|
Cortisol Free [Moles/time] in 24 hour Urine by HPLC |
|
55845-2
|
Cortisol Free [Mass/volume] in 24 hour Urine by Radioimmunoassay (RIA) |
|
55844-5
|
Cortisol Free [Mass/time] in 24 hour Urine by Radioimmunoassay (RIA) |
|
25882-2
|
Cortisol Free [Moles/volume] in 24 hour Urine by Radioimmunoassay (RIA) |
|
25884-8
|
Cortisol Free [Moles/time] in 24 hour Urine by Radioimmunoassay (RIA) |
|
33346-8
|
Cortisol Free [Mass/volume] in 24 hour Urine |
|
2147-7
|
Cortisol Free [Mass/time] in 24 hour Urine |
|
75516-5
|
Cortisol Free [Moles/volume] in 24 hour Urine |
|
14676-1
|
Cortisol Free [Moles/time] in 24 hour Urine |
|
1390-4
|
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
|
60680-6
|
Cortisol Free [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
1392-0
|
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1391-2
|
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
26526-4
|
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post dose corticotropin |
|
16667-8
|
Cortisol Free [Mass/time] in 48 hour Urine |
|
1393-8
|
Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
|
26527-2
|
Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post dose corticotropin |
|
16668-6
|
Cortisol Free [Mass/time] in 72 hour Urine |
|
57824-5
|
Cortisol Free [Mass/volume] in Serum or Plasma --AM peak specimen |
|
57825-2
|
Cortisol Free [Mass/volume] in Serum or Plasma --PM trough specimen |
|
1396-1
|
Cortisol Free [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1394-6
|
Cortisol Free [Mass/volume] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
|
1395-3
|
Cortisol Free [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
|
18365-7
|
Cortisol Free [Mass/volume] in Saliva (oral fluid) |
|
2145-1
|
Cortisol Free [Mass/volume] in Serum or Plasma |
|
15044-1
|
Cortisol Free [Moles/volume] in Serum or Plasma |
|
11040-3
|
Cortisol Free [Mass/volume] in Urine |
|
30173-9
|
Cortisol Free [Moles/volume] in Urine |
|
49029-2
|
Cortisol Free/Cortisone free [Mass Ratio] in Urine |
|
71805-6
|
Cortisol Free/Cortisone free [Molar ratio] in Urine |
|
32009-3
|
Cortisol Free/Creatinine [Mass Ratio] in 24 hour Urine |
|
30171-3
|
Cortisol Free/Creatinine [Molar ratio] in 24 hour Urine |
|
44309-3
|
Cortisol Free/Creatinine [Mass Ratio] in Urine |
|
30172-1
|
Cortisol Free/Creatinine [Molar ratio] in Urine |
|
65364-2
|
Cortisol Free/Cortisol.total in Serum or Plasma |
|
78988-3
|
Cortisol [Moles/mass] in Hair |
|
47844-6
|
Cortisol [Mass/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight |
|
47845-3
|
Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight |
|
47846-1
|
Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
47847-9
|
Cortisol [Moles/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
50416-7
|
Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO overnight |
|
47848-7
|
Cortisol [Mass/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
47849-5
|
Cortisol [Moles/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
59273-3
|
Cortisol [Mass/volume] in Serum or Plasma --post 6 mg dexamethasone PO overnight |
|
47850-3
|
Cortisol [Mass/volume] in Serum or Plasma --post dose corticotropin |
|
12570-8
|
Cortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
|
55138-2
|
Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone PO overnight |
|
47851-1
|
Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone |
|
44917-3
|
Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone |
|
9812-9
|
Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen |
|
14678-7
|
Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
|
1445-6
|
Cortisol [Mass/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight |
|
24392-3
|
Cortisol [Moles/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight |
|
58678-4
|
Cortisol [Mass/volume] in Saliva (oral fluid) --pre 1 ug/kg CRH IV |
|
58679-2
|
Cortisol [Moles/volume] in Saliva (oral fluid) --pre 1 ug/kg CRH IV |
|
1443-1
|
Cortisol [Mass/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
|
47609-3
|
Cortisol [Moles/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
|
50421-7
|
Cortisol [Mass/volume] in Serum or Plasma --pre 100 ug CRH IV |
|
1444-9
|
Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
1450-6
|
Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
|
58680-0
|
Cortisol [Moles/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
|
50415-9
|
Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO overnight |
|
10332-5
|
Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
24389-9
|
Cortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
|
1446-4
|
Cortisol [Mass/volume] in Serum or Plasma --pre 3 g metyraPONE PO overnight |
|
1447-2
|
Cortisol [Mass/volume] in Serum or Plasma --pre 40 ug corticotropin IM 3 day |
|
1448-0
|
Cortisol [Mass/volume] in Serum or Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
|
1449-8
|
Cortisol [Mass/volume] in Serum or Plasma --pre 8 mg dexamethasone PO overnight high dose |
|
41407-8
|
Cortisol [Mass/volume] in Serum or Plasma --pre dose corticotropin |
|
47608-5
|
Cortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
29358-9
|
Cortisol [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
44916-5
|
Cortisol [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
40928-4
|
Cortisol [Mass/volume] in Serum or Plasma --pre dose dexamethasone |
|
45296-1
|
Cortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
1451-4
|
Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV |
|
40310-5
|
Cortisol [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
34065-3
|
Cortisol [Moles/volume] in Serum or Plasma --pre or post dose corticotropin |
|
51424-0
|
Cortisol [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
38551-8
|
Cortisol [Mass/volume] in Serum or Plasma --pre or post dose dexamethasone |
|
26828-4
|
Cortisol [Units/volume] in Saliva (oral fluid) |
|
2142-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) |
|
51844-9
|
Cortisol [Moles/volume] in Saliva (oral fluid) |
|
83088-5
|
Cortisol [Mass/volume] in Serum or Plasma by Immunoassay |
|
83090-1
|
Cortisol [Moles/volume] in Serum or Plasma by Immunoassay |
|
2143-6
|
Cortisol [Mass/volume] in Serum or Plasma |
|
35202-1
|
Cortisol [Mass or Moles/volume] in Serum or Plasma |
|
14675-3
|
Cortisol [Moles/volume] in Serum or Plasma |
|
51494-3
|
Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen post XXX challenge |
|
58654-5
|
Cortisol [Moles/volume] in Saliva (oral fluid) --1st specimen post XXX challenge |
|
21223-3
|
Cortisol [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25618-0
|
Cortisol [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
28045-3
|
Cortisol [Presence] in Saliva (oral fluid) --1st specimen |
|
57687-6
|
Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen |
|
50453-0
|
Cortisol [Mass/volume] in Serum or Plasma --1st specimen |
|
58637-0
|
Cortisol [Mass/volume] in Saliva (oral fluid) --10th specimen post XXX challenge |
|
58638-8
|
Cortisol [Moles/volume] in Saliva (oral fluid) --10th specimen post XXX challenge |
|
12565-8
|
Cortisol [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
58639-6
|
Cortisol [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
57690-0
|
Cortisol [Mass/volume] in Saliva (oral fluid) --10th specimen |
|
57465-7
|
Cortisol [Mass/volume] in Serum or Plasma --10th specimen |
|
58640-4
|
Cortisol [Mass/volume] in Saliva (oral fluid) --11th specimen post XXX challenge |
|
58641-2
|
Cortisol [Moles/volume] in Saliva (oral fluid) --11th specimen post XXX challenge |
|
58688-3
|
Cortisol [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
58689-1
|
Cortisol [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
57684-3
|
Cortisol [Mass/volume] in Saliva (oral fluid) --11th specimen |
|
57464-0
|
Cortisol [Mass/volume] in Serum or Plasma --11th specimen |
|
58646-1
|
Cortisol [Mass/volume] in Saliva (oral fluid) --12th specimen post XXX challenge |
|
58647-9
|
Cortisol [Moles/volume] in Saliva (oral fluid) --12th specimen post XXX challenge |
|
58690-9
|
Cortisol [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
58691-7
|
Cortisol [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
57686-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) --12th specimen |
|
57463-2
|
Cortisol [Mass/volume] in Serum or Plasma --12th specimen |
|
58830-1
|
Cortisol [Mass/volume] in Serum or Plasma --13th specimen |
|
58828-5
|
Cortisol [Mass/volume] in Serum or Plasma --14th specimen |
|
58829-3
|
Cortisol [Mass/volume] in Serum or Plasma --15th specimen |
|
58827-7
|
Cortisol [Mass/volume] in Serum or Plasma --16th specimen |
|
58826-9
|
Cortisol [Mass/volume] in Serum or Plasma --17th specimen |
|
58825-1
|
Cortisol [Mass/volume] in Serum or Plasma --18th specimen |
|
58824-4
|
Cortisol [Mass/volume] in Serum or Plasma --19th specimen |
|
51493-5
|
Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge |
|
58660-2
|
Cortisol [Moles/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge |
|
12557-5
|
Cortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25619-8
|
Cortisol [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
28046-1
|
Cortisol [Presence] in Saliva (oral fluid) --2nd specimen |
|
57685-0
|
Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen |
|
50454-8
|
Cortisol [Mass/volume] in Serum or Plasma --2nd specimen |
|
58823-6
|
Cortisol [Mass/volume] in Serum or Plasma --20th specimen |
|
58819-4
|
Cortisol [Mass/volume] in Serum or Plasma --21st specimen |
|
58822-8
|
Cortisol [Mass/volume] in Serum or Plasma --22nd specimen |
|
58821-0
|
Cortisol [Mass/volume] in Serum or Plasma --23rd specimen |
|
58820-2
|
Cortisol [Mass/volume] in Serum or Plasma --24th specimen |
|
51492-7
|
Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge |
|
58665-1
|
Cortisol [Moles/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge |
|
12558-3
|
Cortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25621-4
|
Cortisol [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
57688-4
|
Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen |
|
50455-5
|
Cortisol [Mass/volume] in Serum or Plasma --3rd specimen |
|
51491-9
|
Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen post XXX challenge |
|
58673-5
|
Cortisol [Moles/volume] in Saliva (oral fluid) --4th specimen post XXX challenge |
|
12559-1
|
Cortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25622-2
|
Cortisol [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
57689-2
|
Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen |
|
50456-3
|
Cortisol [Mass/volume] in Serum or Plasma --4th specimen |
|
51490-1
|
Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen post XXX challenge |
|
58692-5
|
Cortisol [Moles/volume] in Saliva (oral fluid) --5th specimen post XXX challenge |
|
12560-9
|
Cortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25623-0
|
Cortisol [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
57692-6
|
Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen |
|
50457-1
|
Cortisol [Mass/volume] in Serum or Plasma --5th specimen |
|
51488-5
|
Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen post XXX challenge |
|
58693-3
|
Cortisol [Moles/volume] in Saliva (oral fluid) --6th specimen post XXX challenge |
|
12561-7
|
Cortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
25624-8
|
Cortisol [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
57693-4
|
Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen |
|
50458-9
|
Cortisol [Mass/volume] in Serum or Plasma --6th specimen |
|
51489-3
|
Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen post XXX challenge |
|
58694-1
|
Cortisol [Moles/volume] in Saliva (oral fluid) --7th specimen post XXX challenge |
|
12562-5
|
Cortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25625-5
|
Cortisol [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
57694-2
|
Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen |
|
50459-7
|
Cortisol [Mass/volume] in Serum or Plasma --7th specimen |
|
58695-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) --8th specimen post XXX challenge |
|
58696-6
|
Cortisol [Moles/volume] in Saliva (oral fluid) --8th specimen post XXX challenge |
|
12563-3
|
Cortisol [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25627-1
|
Cortisol [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
57695-9
|
Cortisol [Mass/volume] in Saliva (oral fluid) --8th specimen |
|
50460-5
|
Cortisol [Mass/volume] in Serum or Plasma --8th specimen |
|
58697-4
|
Cortisol [Mass/volume] in Saliva (oral fluid) --9th specimen post XXX challenge |
|
58698-2
|
Cortisol [Moles/volume] in Saliva (oral fluid) --9th specimen post XXX challenge |
|
12564-1
|
Cortisol [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
25628-9
|
Cortisol [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
57691-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) --9th specimen |
|
57466-5
|
Cortisol [Mass/volume] in Serum or Plasma --9th specimen |
|
28550-2
|
Cortisol [Presence] in Urine |
|
2144-4
|
Cortisol [Mass/volume] in Urine |
|
15043-3
|
Cortisol [Moles/volume] in Urine |
|
72392-4
|
Cortisol/Cortisone [Mass Ratio] in Serum or Plasma |
|
44310-1
|
Cortisol/Creatinine [Mass Ratio] in 24 hour Urine |
|
11155-9
|
Cortisol/Creatinine [Mass Ratio] in Urine |
|
30072-3
|
Cortisone [Mass/volume] in 24 hour Urine by HPLC |
|
14044-2
|
Cortisone [Mass/time] in 24 hour Urine |
|
71892-4
|
Cortisone [Moles/volume] in Saliva (oral fluid) --AM peak specimen |
|
73880-7
|
Cortisone free [Moles/volume] in 24 hour Urine |
|
71894-0
|
Cortisone free [Moles/time] in 24 hour Urine |
|
76475-3
|
Cortisone free [Moles/volume] in Serum or Plasma |
|
53777-9
|
Cortisone free [Mass/volume] in Urine |
|
73881-5
|
Cortisone free [Moles/volume] in Urine |
|
71893-2
|
Cortisone [Moles/volume] in Saliva (oral fluid) --PM trough specimen |
|
74360-9
|
Cortisone [Moles/volume] in Saliva (oral fluid) |
|
14159-8
|
Cortisone [Mass/volume] in Serum or Plasma |
|
25382-3
|
Cortisone [Moles/volume] in Serum or Plasma |
|
30511-0
|
Cortisone/Creatinine [Mass Ratio] in Urine |
|
92786-3
|
Corynebacterium sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
90066-2
|
Corynebacterium sp identified in Isolate by Organism specific culture |
|
24102-6
|
Corynebacterium toxin [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
81256-0
|
COSMIC [ID] |
|
82119-9
|
COSMIC structural variant [Identifier] |
|
83007-5
|
COSMIC version [ID] |
|
19092-6
|
Cotinine cutoff [Mass/volume] in Urine |
|
59892-0
|
Cotinine [Moles/volume] in Gastric fluid |
|
40355-0
|
Cotinine [Presence] in Hair |
|
10364-8
|
Cotinine [Mass/mass] in Hair |
|
40418-6
|
Cotinine [Presence] in Meconium |
|
74371-6
|
Cotinine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74370-8
|
Cotinine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
63044-2
|
Cotinine [Presence] in Saliva (oral fluid) by Screen method |
|
43196-5
|
Cotinine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61128-5
|
Cotinine [Presence] in Serum or Plasma |
|
59645-2
|
Cotinine [Presence] in Serum or Plasma by Screen method |
|
10365-5
|
Cotinine [Mass/volume] in Serum or Plasma |
|
59891-2
|
Cotinine [Moles/volume] in Serum or Plasma |
|
92643-6
|
Cotinine [Mass/volume] in Urine by Confirmatory method |
|
12293-7
|
Cotinine [Presence] in Urine |
|
35642-8
|
Cotinine [Presence] in Urine by Confirmatory method |
|
59646-0
|
Cotinine [Presence] in Urine by Screen method |
|
72786-7
|
Cotinine [Mass/volume] in Urine by Screen method |
|
10366-3
|
Cotinine [Mass/volume] in Urine |
|
33796-4
|
Cotinine [Moles/volume] in Urine |
|
9372-4
|
Cotinine [Mass/volume] in Unspecified specimen |
|
60299-5
|
Cotinine [Moles/volume] in Unspecified specimen |
|
44311-9
|
Cotinine/Creatinine [Mass Ratio] in Urine |
|
7206-6
|
Cottage Cheese IgE Ab [Units/volume] in Serum |
|
15624-0
|
Cottage Cheese IgE Ab RAST class [Presence] in Serum |
|
7207-4
|
Cottage Cheese IgG Ab [Units/volume] in Serum |
|
19737-6
|
Cotton fibers IgE Ab [Units/volume] in Serum |
|
15656-2
|
Cotton fibers IgE Ab RAST class [Presence] in Serum |
|
7250-4
|
Cotton gin dust IgE Ab [Units/volume] in Serum |
|
7252-0
|
Cotton linters triggered histamine release [Units/volume] in Blood |
|
7251-2
|
Cotton linters IgE Ab [Units/volume] in Serum |
|
21227-4
|
Cotton linters IgE Ab RAST class [Presence] in Serum |
|
6089-7
|
Cottonseed IgE Ab [Units/volume] in Serum |
|
15658-8
|
Cottonseed IgE Ab RAST class [Presence] in Serum |
|
61340-6
|
Cottonseed IgE Ab/IgE total in Serum |
|
7253-8
|
Cottonseed IgG Ab [Units/volume] in Serum |
|
21228-2
|
Cottonseed IgG Ab RAST class [Presence] in Serum |
|
56452-6
|
Cottonseed IgG4 Ab [Mass/volume] in Serum |
|
63097-0
|
Cottonseed IgG Ab [Mass/volume] in Serum |
|
6090-5
|
Cottonwood IgE Ab [Units/volume] in Serum |
|
15659-6
|
Cottonwood IgE Ab RAST class [Presence] in Serum |
|
61304-2
|
Cottonwood IgE Ab/IgE total in Serum |
|
13184-7
|
Cottonwood IgG Ab [Units/volume] in Serum |
|
58021-7
|
Cottonwood IgG Ab RAST class [Presence] in Serum or Plasma |
|
56233-0
|
Cottonwood IgG4 Ab [Mass/volume] in Serum |
|
63183-8
|
Cottonwood IgG Ab [Mass/volume] in Serum |
|
85933-0
|
Cough duration |
|
76879-6
|
Could you get a friend or family member to help fix something at home if you need it [PROMIS] |
|
76877-0
|
Could you get a friend or family member to help move furniture around your home if you need it [PROMIS] |
|
76881-2
|
Could you get a friend or family member to help you if you have financial problems [PROMIS] |
|
76880-4
|
Could you get a friend or family member to help you with your finances if you need it [PROMIS] |
|
74113-2
|
Coumafuryl [Presence] in Unspecified specimen by Screen method |
|
30025-1
|
Coumaphos [Mass/volume] in Serum or Plasma |
|
21229-0
|
Coumaphos [Mass/volume] in Urine |
|
87748-0
|
Coumaphos [Mass/mass] in Unspecified specimen |
|
74114-0
|
Coumatetralyl [Presence] in Unspecified specimen by Screen method |
|
86655-8
|
Counseling to achieve pregnancy was provided |
|
47042-7
|
Counseling note |
|
91096-8
|
Countermeasure description Narrative |
|
91097-6
|
Countermeasure implementation progress |
|
91098-4
|
Countermeasure name |
|
92841-6
|
Countermeasure report |
|
77984-3
|
Country of exposure to illness [Location] |
|
91514-0
|
Country where healthcare received outside U.S. [Location] |
|
78746-5
|
Country of birth [Location] |
|
77983-5
|
Country of usual residence [Location] |
|
87721-7
|
County of residence [Location] |
|
25038-1
|
Courtesy consultation Unspecified body region Document |
|
87520-3
|
Coverage type |
|
6091-3
|
Cow dander IgE Ab [Units/volume] in Serum |
|
15661-2
|
Cow dander IgE Ab RAST class [Presence] in Serum |
|
39551-7
|
Cow dander IgE Ab/IgE total in Serum |
|
56453-4
|
Cow dander IgG4 Ab [Mass/volume] in Serum |
|
7257-9
|
Cow epithelium IgE Ab [Units/volume] in Serum |
|
15662-0
|
Cow epithelium IgE Ab RAST class [Presence] in Serum |
|
45195-5
|
Cow epithelium+Cow dander IgE Ab [Units/volume] in Serum |
|
30087-1
|
Cow hair+Cow dander IgE Ab [Units/volume] in Serum |
|
57035-8
|
Cow milk Ab [Presence] in Serum by Immune diffusion (ID) |
|
7259-5
|
Cow milk triggered histamine release [Units/volume] in Blood |
|
10940-5
|
Cow milk boiled IgE Ab [Units/volume] in Serum |
|
15847-7
|
Cow milk boiled IgE Ab RAST class [Presence] in Serum |
|
7258-7
|
Cow milk IgE Ab [Units/volume] in Serum |
|
25383-1
|
Cow milk IgE Ab RAST class [Presence] in Serum |
|
61332-3
|
Cow milk IgE Ab/IgE total in Serum |
|
6729-8
|
Cow milk IgG Ab [Units/volume] in Serum |
|
21230-8
|
Cow milk IgG Ab RAST class [Presence] in Serum |
|
56234-8
|
Cow milk IgG4 Ab [Mass/volume] in Serum |
|
35539-6
|
Cow milk IgG Ab [Mass/volume] in Serum |
|
48225-7
|
Cow milk triggered leukotriene release [Mass/volume] by Leukocytes |
|
7774-3
|
Cow whey IgE Ab [Units/volume] in Serum |
|
16089-5
|
Cow whey IgE Ab RAST class [Presence] in Serum |
|
57950-8
|
Cow whey IgE Ab/IgE total in Serum |
|
56419-5
|
Cow whey IgG4 Ab [Mass/volume] in Serum |
|
59058-8
|
Cow whey IgG Ab [Mass/volume] in Serum |
|
43744-2
|
COX10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49476-5
|
Cyclooxygenase 2 Ag [Presence] in Tissue by Immune stain |
|
32592-8
|
Cryoprecipitate poor plasma units available [#] |
|
54412-2
|
Cryoprecipitate poor plasma units given [#] |
|
69987-6
|
Continuous positive airway pressure 24 hour maximum Respiratory system |
|
69985-0
|
Continuous positive airway pressure 24 hour mean Respiratory system |
|
70000-5
|
Continuous positive airway pressure 24 hour median Respiratory system |
|
52042-9
|
Continuous positive airway pressure (CPAP) attachment |
|
35410-0
|
Continuous positive airway pressure Respiratory system |
|
40994-6
|
CPEO syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22979-9
|
Caprine herpesvirus 1 Ab [Presence] in Serum |
|
22980-7
|
Caprine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
89425-3
|
CPR flowsheet |
|
63368-5
|
Carbapenem resistance genes [Identifier] by NAA with probe detection |
|
88103-7
|
CPR was being given on arrival at destination |
|
88669-7
|
CPR guidance provided by dispatch prior to EMS arrival |
|
89426-1
|
CPR note |
|
88438-7
|
CPR start time |
|
88101-1
|
CPR stop time |
|
80737-0
|
Calculated panel reactive antibody - Serum |
|
2017-2
|
Carbamoyl phosphate synthetase (ammonia) [Enzymatic activity/mass] in Tissue |
|
2016-4
|
Carbamoyl phosphate synthetase [Enzymatic activity/volume] in Serum |
|
32233-9
|
Carbamoyl phosphate synthetase [Enzymatic activity/mass] in Tissue |
|
53854-6
|
CPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76448-0
|
CPT billing code |
|
76430-8
|
CPT units [#] |
|
46775-3
|
Carnitine palmitoyltransferase 1 deficiency newborn screen interpretation |
|
53437-0
|
Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Fibroblast |
|
53441-2
|
Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Leukocytes |
|
74780-8
|
CPT1A gene c.1436C>T [Presence] in DBS by Molecular genetics method |
|
53434-7
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Amniotic fluid cells |
|
53436-2
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Chorionic villus sample |
|
53514-6
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Fibroblast |
|
53438-8
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Fibroblast |
|
49678-6
|
CPT2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40877-3
|
CPT2 gene p.Pro50His+Ser113Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
40878-1
|
CPT2 gene p.Gln413FSer+Gly549Asp [Presence] in Blood or Tissue by Molecular genetics method |
|
49684-4
|
CPT2 gene p.Arg503Cys [Presence] in Blood by Molecular genetics method |
|
49686-9
|
CPT2 gene p.Arg631Cys [Presence] in Blood by Molecular genetics method |
|
53443-8
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Leukocytes |
|
53442-0
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Leukocytes |
|
46776-1
|
CPT2/CACT newborn screen interpretation |
|
53445-3
|
Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Fibroblast |
|
53446-1
|
Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Red Blood Cells |
|
23701-6
|
Canine parvovirus Ab [Presence] in Serum |
|
24411-1
|
Canine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
|
23700-8
|
Canine parvovirus Ab [Presence] in Serum by Immunofluorescence |
|
31286-8
|
Canine parvovirus Ab [Units/volume] in Serum |
|
31287-6
|
Canine parvovirus Ab [Presence] in Stool |
|
28607-0
|
Canine parvovirus Ab [Presence] in Stool by Hemagglutination inhibition |
|
23702-4
|
Canine parvovirus Ab [Titer] in Serum |
|
31761-0
|
Canine parvovirus Ag [Presence] in Stool |
|
23793-3
|
Canine parvovirus Ag [Presence] in Stool by Immunoassay |
|
23706-5
|
Canine parvovirus Ag [Presence] in Stool by Immunofluorescence |
|
23705-7
|
Canine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
|
23707-3
|
Canine parvovirus DNA [Presence] in Stool by Probe |
|
31288-4
|
Canine parvovirus IgG Ab [Units/volume] in Serum |
|
23703-2
|
Canine parvovirus IgG Ab [Titer] in Serum |
|
31289-2
|
Canine parvovirus IgM Ab [Units/volume] in Serum |
|
23704-0
|
Canine parvovirus IgM Ab [Titer] in Serum |
|
57951-6
|
CPVT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79293-7
|
Creatine and guanidinoacetate pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79291-1
|
Creatine and guanidinoacetate pattern [Interpretation] in Serum or Plasma Narrative |
|
10782-1
|
Microscopic observation [Identifier] in Tissue by Congo red stain |
|
79292-9
|
Creatine, guanidinoacetate and creatinine pattern [Interpretation] in Urine Narrative |
|
7261-1
|
Crab triggered histamine release [Units/volume] in Blood |
|
6092-1
|
Crab IgE Ab [Units/volume] in Serum |
|
15663-8
|
Crab IgE Ab RAST class [Presence] in Serum |
|
39545-9
|
Crab IgE Ab/IgE total in Serum |
|
7260-3
|
Crab IgG Ab [Units/volume] in Serum |
|
21231-6
|
Crab IgG Ab RAST class [Presence] in Serum |
|
56235-5
|
Crab IgG4 Ab [Mass/volume] in Serum |
|
60370-4
|
Crab IgG Ab [Mass/volume] in Serum |
|
48215-8
|
Crab triggered leukotriene release [Mass/volume] by Leukocytes |
|
7264-5
|
Cranberry triggered histamine release [Units/volume] in Blood |
|
7262-9
|
Cranberry IgE Ab [Units/volume] in Serum |
|
15664-6
|
Cranberry IgE Ab RAST class [Presence] in Serum |
|
61323-2
|
Cranberry IgE Ab/IgE total in Serum |
|
7263-7
|
Cranberry IgG Ab [Units/volume] in Serum |
|
56236-3
|
Cranberry IgG4 Ab [Mass/volume] in Serum |
|
63104-4
|
Cranberry IgG Ab [Mass/volume] in Serum |
|
90865-7
|
Craniofacial anomalies impacting orthodontic care |
|
92318-5
|
Cravings for a cigarette make it difficult for me to quit [PROMIS] |
|
7265-2
|
Crawfish IgE Ab [Units/volume] in Serum |
|
15665-3
|
Crawfish IgE Ab RAST class [Presence] in Serum |
|
61223-4
|
Crawfish IgE Ab/IgE total in Serum |
|
56237-1
|
Crawfish IgG4 Ab [Mass/volume] in Serum |
|
63137-4
|
Crawfish IgG Ab [Mass/volume] in Serum |
|
77924-9
|
Enterobacteriaceae.carbapenem resistant [Presence] in Anorectal or stool specimen by Organism specific culture |
|
7208-2
|
Cream Cheese triggered histamine release [Units/volume] in Blood |
|
11164-1
|
Cream Cheese IgE Ab [Units/volume] in Serum |
|
21179-7
|
Cream Cheese IgE Ab RAST class [Presence] in Serum |
|
44784-7
|
Creatinine [Mass/volume] (Maximum value during study) in Serum or Plasma |
|
48790-0
|
Creatinine [Mass/time] in unspecified time Peritoneal dialysis fluid |
|
32543-1
|
Creatinine [Molar amount] in Urine collected for unspecified duration |
|
72821-2
|
Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration |
|
35674-1
|
Creatinine [Mass/volume] in Urine collected for unspecified duration |
|
55593-8
|
Creatinine [Moles/volume] in Urine collected for unspecified duration |
|
40251-1
|
Creatinine [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
40267-7
|
Creatinine [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
39985-7
|
Creatinine [Mass/volume] in Urine --1.5 hours post XXX challenge |
|
40136-4
|
Creatinine [Moles/volume] in Urine --1.5 hours post XXX challenge |
|
39956-8
|
Creatinine [Mass/volume] in Serum or Plasma --1.5 hours pre XXX challenge |
|
40113-3
|
Creatinine [Moles/volume] in Serum or Plasma --1.5 hours pre XXX challenge |
|
39979-0
|
Creatinine [Mass/volume] in Urine --1.5 hours pre XXX challenge |
|
40130-7
|
Creatinine [Moles/volume] in Urine --1.5 hours pre XXX challenge |
|
39970-9
|
Creatinine [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
|
40122-4
|
Creatinine [Moles/volume] in Serum or Plasma --10 hours post XXX challenge |
|
39971-7
|
Creatinine [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
|
40123-2
|
Creatinine [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
|
12194-7
|
Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
|
57346-9
|
Creatinine [Mass/volume] in 12 hour Urine |
|
12589-8
|
Creatinine [Mass/time] in 12 hour Urine |
|
53499-0
|
Creatinine [Moles/volume] in 12 hour Urine |
|
51592-4
|
Creatinine [Moles/time] in 12 hour Urine |
|
39972-5
|
Creatinine [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
|
40124-0
|
Creatinine [Moles/volume] in Serum or Plasma --16 hours post XXX challenge |
|
39973-3
|
Creatinine [Mass/volume] in Serum or Plasma --18 hours post XXX challenge |
|
40125-7
|
Creatinine [Moles/volume] in Serum or Plasma --18 hours post XXX challenge |
|
58998-6
|
Creatinine [Mass/time] in 18 hour Urine |
|
1452-2
|
Creatinine [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
|
40258-6
|
Creatinine [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
|
40273-5
|
Creatinine [Moles/volume] in Serum or Plasma --1 day post XXX challenge |
|
39996-4
|
Creatinine [Mass/volume] in Urine --1 day post XXX challenge |
|
40147-1
|
Creatinine [Moles/volume] in Urine --1 day post XXX challenge |
|
40250-3
|
Creatinine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
40266-9
|
Creatinine [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
39984-0
|
Creatinine [Mass/volume] in Urine --1 hour post XXX challenge |
|
40135-6
|
Creatinine [Moles/volume] in Urine --1 hour post XXX challenge |
|
93999-1
|
Creatinine [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
39957-6
|
Creatinine [Mass/volume] in Serum or Plasma --1 hour pre XXX challenge |
|
40114-1
|
Creatinine [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge |
|
39980-8
|
Creatinine [Mass/volume] in Urine --1 hour pre XXX challenge |
|
40131-5
|
Creatinine [Moles/volume] in Urine --1 hour pre XXX challenge |
|
53120-2
|
Creatinine [Moles/time] in 1 hour Urine |
|
40253-7
|
Creatinine [Mass/volume] in Serum or Plasma --2.25 hours post XXX challenge |
|
39978-2
|
Creatinine [Mass/volume] in Urine --2.25 hours pre XXX challenge |
|
40254-5
|
Creatinine [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
40269-3
|
Creatinine [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
39987-3
|
Creatinine [Mass/volume] in Urine --2.5 hours post XXX challenge |
|
40138-0
|
Creatinine [Moles/volume] in Urine --2.5 hours post XXX challenge |
|
57726-2
|
Creatinine [Mass/volume] in 24 hour Peritoneal dialysis fluid |
|
39471-8
|
Creatinine [Moles/volume] in 24 hour Peritoneal dialysis fluid |
|
39472-6
|
Creatinine [Moles/volume] in 24 hour Dialysis fluid |
|
40356-8
|
Creatinine [Moles/time] in 24 hour Dialysis fluid |
|
31101-9
|
Creatinine [Mass/time] in 24 hour Body fluid |
|
40357-6
|
Creatinine [Moles/time] in 24 hour Body fluid |
|
48626-6
|
Creatinine [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
|
12574-0
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
|
60518-8
|
Creatinine [Moles/time] in 24 hour Stool |
|
20624-3
|
Creatinine [Mass/volume] in 24 hour Urine |
|
2162-6
|
Creatinine [Mass/time] in 24 hour Urine |
|
35251-8
|
Creatinine [Mass or Moles/volume] in 24 hour Urine |
|
35262-5
|
Creatinine [Mass or Moles] in 24 hour Urine |
|
25886-3
|
Creatinine [Moles/volume] in 24 hour Urine |
|
14684-5
|
Creatinine [Moles/time] in 24 hour Urine |
|
1453-0
|
Creatinine [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
|
39974-1
|
Creatinine [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
|
40126-5
|
Creatinine [Moles/volume] in Serum or Plasma --2 days post XXX challenge |
|
12572-4
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
78532-9
|
Creatinine [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
40252-9
|
Creatinine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
40268-5
|
Creatinine [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
39986-5
|
Creatinine [Mass/volume] in Urine --2 hours post XXX challenge |
|
40137-2
|
Creatinine [Moles/volume] in Urine --2 hours post XXX challenge |
|
12192-1
|
Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
94008-0
|
Creatinine [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
46086-5
|
Creatinine [Moles/volume] in Dialysis fluid --2 hour specimen |
|
16188-5
|
Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen |
|
57344-4
|
Creatinine [Mass/volume] in 2 hour Urine |
|
12585-6
|
Creatinine [Mass/time] in 2 hour Urine |
|
33798-0
|
Creatinine [Moles/time] in 2 hour Urine |
|
39961-8
|
Creatinine [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
40118-2
|
Creatinine [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
39989-9
|
Creatinine [Mass/volume] in Urine --3.5 hours post XXX challenge |
|
40140-6
|
Creatinine [Moles/volume] in Urine --3.5 hours post XXX challenge |
|
39962-6
|
Creatinine [Mass/volume] in Serum or Plasma --3.75 hours post XXX challenge |
|
40249-5
|
Creatinine [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
40265-1
|
Creatinine [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
39983-2
|
Creatinine [Mass/volume] in Urine --30 minutes post XXX challenge |
|
40134-9
|
Creatinine [Moles/volume] in Urine --30 minutes post XXX challenge |
|
39959-2
|
Creatinine [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
40116-6
|
Creatinine [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
39981-6
|
Creatinine [Mass/volume] in Urine --30 minutes pre XXX challenge |
|
40132-3
|
Creatinine [Moles/volume] in Urine --30 minutes pre XXX challenge |
|
40255-2
|
Creatinine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40270-1
|
Creatinine [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
39988-1
|
Creatinine [Mass/volume] in Urine --3 hours post XXX challenge |
|
40139-8
|
Creatinine [Moles/volume] in Urine --3 hours post XXX challenge |
|
39964-2
|
Creatinine [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
|
39991-5
|
Creatinine [Mass/volume] in Urine --4.5 hours post XXX challenge |
|
40142-2
|
Creatinine [Moles/volume] in Urine --4.5 hours post XXX challenge |
|
39960-0
|
Creatinine [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
40117-4
|
Creatinine [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
39958-4
|
Creatinine [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge |
|
40115-8
|
Creatinine [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge |
|
1455-5
|
Creatinine [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1454-8
|
Creatinine [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
16689-2
|
Creatinine [Mass/time] in 48 hour Urine |
|
39975-8
|
Creatinine [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
|
40127-3
|
Creatinine [Moles/volume] in Serum or Plasma --4 days post XXX challenge |
|
12573-2
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
78533-7
|
Creatinine [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
39963-4
|
Creatinine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
40119-0
|
Creatinine [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
39990-7
|
Creatinine [Mass/volume] in Urine --4 hours post XXX challenge |
|
40141-4
|
Creatinine [Moles/volume] in Urine --4 hours post XXX challenge |
|
12193-9
|
Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
|
46219-2
|
Creatinine [Moles/volume] in Dialysis fluid --4 hour specimen |
|
16189-3
|
Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen |
|
12586-4
|
Creatinine [Mass/time] in 4 hour Urine |
|
39965-9
|
Creatinine [Mass/volume] in Serum or Plasma --5.25 hours post XXX challenge |
|
39966-7
|
Creatinine [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
|
39993-1
|
Creatinine [Mass/volume] in Urine --5.5 hours post XXX challenge |
|
40144-8
|
Creatinine [Moles/volume] in Urine --5.5 hours post XXX challenge |
|
40256-0
|
Creatinine [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
40271-9
|
Creatinine [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
39992-3
|
Creatinine [Mass/volume] in Urine --5 hours post XXX challenge |
|
40143-0
|
Creatinine [Moles/volume] in Urine --5 hours post XXX challenge |
|
93733-4
|
Creatinine [Mass/time] in 5 hour Urine |
|
93735-9
|
Creatinine [Moles/volume] in 5 hour Urine |
|
93734-2
|
Creatinine [Moles/time] in 5 hour Urine |
|
39967-5
|
Creatinine [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
40257-8
|
Creatinine [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
40272-7
|
Creatinine [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
|
39994-9
|
Creatinine [Mass/volume] in Urine --6 hours post XXX challenge |
|
40145-5
|
Creatinine [Moles/volume] in Urine --6 hours post XXX challenge |
|
12587-2
|
Creatinine [Mass/time] in 6 hour Urine |
|
1456-3
|
Creatinine [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
|
16690-0
|
Creatinine [Mass/time] in 72 hour Urine |
|
39473-4
|
Creatinine [Moles/volume] in 72 hour Urine |
|
39976-6
|
Creatinine [Mass/volume] in Serum or Plasma --7 days post XXX challenge |
|
40128-1
|
Creatinine [Moles/volume] in Serum or Plasma --7 days post XXX challenge |
|
39968-3
|
Creatinine [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
40120-8
|
Creatinine [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
|
39995-6
|
Creatinine [Mass/volume] in Urine --8 hours post XXX challenge |
|
40146-3
|
Creatinine [Moles/volume] in Urine --8 hours post XXX challenge |
|
12588-0
|
Creatinine [Mass/time] in 8 hour Urine |
|
39969-1
|
Creatinine [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
|
40121-6
|
Creatinine [Moles/volume] in Serum or Plasma --9 hours post XXX challenge |
|
2159-2
|
Creatinine [Mass/volume] in Amniotic fluid |
|
15050-8
|
Creatinine [Moles/volume] in Amniotic fluid |
|
21232-4
|
Creatinine [Mass/volume] in Arterial blood |
|
38483-4
|
Creatinine [Mass/volume] in Blood |
|
59826-8
|
Creatinine [Moles/volume] in Blood |
|
12575-7
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --baseline |
|
40248-7
|
Creatinine [Mass/volume] in Serum or Plasma --baseline |
|
40264-4
|
Creatinine [Moles/volume] in Serum or Plasma --baseline |
|
39982-4
|
Creatinine [Mass/volume] in Urine --baseline |
|
40133-1
|
Creatinine [Moles/volume] in Urine --baseline |
|
33558-8
|
Creatinine renal clearance in Urine and Serum or Plasma collected for unspecified duration |
|
2163-4
|
Creatinine renal clearance in 12 hour Urine and Serum or Plasma |
|
2164-2
|
Creatinine renal clearance in 24 hour Urine and Serum or Plasma |
|
26752-6
|
Creatinine renal clearance in 2 hour Urine and Serum or Plasma |
|
13441-1
|
Creatinine renal clearance in 4 hour Urine and Serum or Plasma |
|
13442-9
|
Creatinine renal clearance in 6 hour Urine and Serum or Plasma |
|
13443-7
|
Creatinine renal clearance in 8 hour Urine and Serum or Plasma |
|
48788-4
|
Creatinine peritoneal dialysis clearance |
|
13451-0
|
Creatinine dialysis fluid clearance |
|
35591-7
|
Creatinine renal clearance predicted by Cockcroft-Gault formula |
|
35593-3
|
Creatinine renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
|
13450-2
|
Creatinine renal clearance/1.73 sq M in 12 hour Urine and Serum or Plasma |
|
12195-4
|
Creatinine renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma |
|
35594-1
|
Creatinine renal clearance/1.73 sq M in 2 hour Urine and Serum or Plasma |
|
13446-0
|
Creatinine renal clearance/1.73 sq M in 4 hour Urine and Serum or Plasma |
|
13447-8
|
Creatinine renal clearance/1.73 sq M in 6 hour Urine and Serum or Plasma |
|
13449-4
|
Creatinine renal clearance/1.73 sq M in 8 hour Urine and Serum or Plasma |
|
48789-2
|
Creatinine peritoneal dialysis clearance/1.73 sq M |
|
50379-7
|
Creatinine dialysis fluid clearance/1.73 sq M |
|
50380-5
|
Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula |
|
50381-3
|
Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula |
|
35592-5
|
Creatinine renal clearance/1.73 sq M.predicted by Cockcroft-Gault formula, BSA formula |
|
14398-2
|
Creatinine [Mass/volume] in Cerebral spinal fluid |
|
39802-4
|
Creatinine in dialysis fluid/Creatinine in serum or plasma |
|
49004-5
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid |
|
14681-1
|
Creatinine [Moles/volume] in Peritoneal dialysis fluid |
|
5919-6
|
Creatinine [Mass/volume] in Dialysis fluid |
|
35242-7
|
Creatinine [Mass or Moles/volume] in Dialysis fluid |
|
15051-6
|
Creatinine [Moles/volume] in Dialysis fluid |
|
12190-5
|
Creatinine [Mass/volume] in Body fluid |
|
25386-4
|
Creatinine [Moles/volume] in Body fluid |
|
14402-2
|
Creatinine [Mass/volume] in Gastric fluid |
|
57345-1
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --overnight |
|
46220-0
|
Creatinine [Moles/volume] in Dialysis fluid --overnight |
|
79263-0
|
Creatinine [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
|
62425-4
|
Creatinine [Moles/volume] in Serum or Plasma --post XXX challenge |
|
11041-1
|
Creatinine [Mass/volume] in Serum or Plasma --post dialysis |
|
51620-3
|
Creatinine [Moles/volume] in Serum or Plasma --post dialysis |
|
70264-7
|
Creatinine in pleural fluid/Creatinine in serum |
|
14399-0
|
Creatinine [Mass/volume] in Pleural fluid |
|
54375-1
|
Creatinine [Moles/volume] in Pleural fluid |
|
1459-7
|
Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
|
1457-1
|
Creatinine [Mass/volume] in 24 hour Urine --pre 40 ug corticotropin IM 3 day |
|
1458-9
|
Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
|
39955-0
|
Creatinine [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
40112-5
|
Creatinine [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
39977-4
|
Creatinine [Mass/volume] in Urine --pre XXX challenge |
|
40129-9
|
Creatinine [Moles/volume] in Urine --pre XXX challenge |
|
72271-0
|
Creatinine [Mass/volume] in Serum or Plasma --pre contrast |
|
48630-8
|
Creatinine [Mass/volume] in Peritoneal fluid --pre dialysis |
|
11042-9
|
Creatinine [Mass/volume] in Serum or Plasma --pre dialysis |
|
51619-5
|
Creatinine [Moles/volume] in Serum or Plasma --pre dialysis |
|
70266-2
|
Creatinine in peritoneal fluid/Creatinine in serum |
|
12191-3
|
Creatinine [Mass/volume] in Peritoneal fluid |
|
39474-2
|
Creatinine [Moles/volume] in Peritoneal fluid |
|
77140-2
|
Creatinine [Moles/volume] in Serum, Plasma or Blood |
|
2160-0
|
Creatinine [Mass/volume] in Serum or Plasma |
|
35203-9
|
Creatinine [Mass or Moles/volume] in Serum or Plasma |
|
14682-9
|
Creatinine [Moles/volume] in Serum or Plasma |
|
14401-4
|
Creatinine [Mass/volume] in Synovial fluid |
|
12576-5
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
|
47257-1
|
Creatinine [Mass/volume] in Urine --1st specimen post XXX challenge |
|
12577-3
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
|
47256-3
|
Creatinine [Mass/volume] in Urine --2nd specimen post XXX challenge |
|
58951-5
|
Creatinine [Mass/volume] in Urine --2nd specimen |
|
12578-1
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
|
47258-9
|
Creatinine [Mass/volume] in Urine --3rd specimen post XXX challenge |
|
12579-9
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
|
47259-7
|
Creatinine [Mass/volume] in Urine --4th specimen post XXX challenge |
|
12580-7
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
|
47273-8
|
Creatinine [Mass/volume] in Urine --5th specimen post XXX challenge |
|
12581-5
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
|
47261-3
|
Creatinine [Mass/volume] in Urine --6th specimen post XXX challenge |
|
12582-3
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
|
12583-1
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
|
47610-1
|
Creatinine [Moles/volume] in Stool |
|
30004-6
|
Creatinine [Mass/volume] in Urine by Test strip |
|
30002-0
|
Creatinine [Moles/volume] in Urine by Test strip |
|
20511-2
|
Creatinine [Interpretation] in Urine |
|
2161-8
|
Creatinine [Mass/volume] in Urine |
|
35204-7
|
Creatinine [Mass or Moles/volume] in Urine |
|
14683-7
|
Creatinine [Moles/volume] in Urine |
|
12584-9
|
Creatinine [Mass/volume] in Vitreous fluid |
|
75363-2
|
Creatinine [Moles/volume] in Vitreous fluid |
|
22726-4
|
Creatinine [Moles/volume] in Unspecified specimen |
|
35654-3
|
Creatinine/Body weight [Mass/kg/time] in 24 hour Urine |
|
54374-4
|
Creatinine/Body weight [Moles/kg/time] in 24 hour Urine |
|
44716-9
|
Creatinine/Calcium [Mass Ratio] in Urine |
|
16285-9
|
Creatinine/Protein [Mass Ratio] in Urine |
|
31045-8
|
Creatinine/Urea nitrogen [Mass Ratio] in Serum or Plasma |
|
33797-2
|
Creatine [Moles/time] in 12 hour Urine |
|
49097-9
|
Creatine [Mass/volume] in 24 hour Urine |
|
2150-1
|
Creatine [Mass/time] in 24 hour Urine |
|
34274-1
|
Creatine [Moles/volume] in 24 hour Urine |
|
15047-4
|
Creatine [Moles/time] in 24 hour Urine |
|
53055-0
|
Creatine [Moles/volume] in Amniotic fluid |
|
53074-1
|
Creatine [Moles/volume] in Cerebral spinal fluid |
|
2148-5
|
Creatine [Mass/volume] in Serum or Plasma |
|
15045-8
|
Creatine [Moles/volume] in Serum or Plasma |
|
2149-3
|
Creatine [Mass/volume] in Urine |
|
15046-6
|
Creatine [Moles/volume] in Urine |
|
16687-6
|
Creatine [Mass/volume] in Vitreous fluid |
|
13484-1
|
Creatine/Creatinine [Mass Ratio] in Urine |
|
34275-8
|
Creatine/Creatinine [Molar ratio] in Urine |
|
70957-6
|
Creatinine clearance corrected for body surface area using standard methods [ESRD] |
|
59834-2
|
Creatinine reduction ratio in Serum or Plasma |
|
30975-7
|
Creator report number [Identifier] Form VAERS |
|
23849-3
|
Creosol [Mass/volume] in Serum or Plasma |
|
23850-1
|
Creosol [Mass/volume] in Urine |
|
9512-5
|
Creosol [Presence] in Unspecified specimen |
|
23848-5
|
Creosol [Mass/volume] in Unspecified specimen |
|
38580-7
|
Cresols [Mass/volume] in Air |
|
16691-8
|
Cresols [Identifier] in Unspecified specimen |
|
71581-3
|
Crew member response role NEMSIS |
|
7266-0
|
Cricket IgE Ab [Units/volume] in Serum |
|
88191-2
|
Crimean-Congo hemorrhagic fever virus IgG Ab [Presence] in Serum by Immunoassay |
|
88190-4
|
Crimean-Congo hemorrhagic fever virus IgM Ab [Presence] in Serum by Immunoassay |
|
88192-0
|
Crimean-Congo hemorrhagic fever virus RNA [Presence] in Serum by NAA with probe detection |
|
82823-6
|
Criminal household member--before 18 years old [ACE] |
|
78709-3
|
Crisis intervention note |
|
29751-5
|
Critical care records |
|
91602-3
|
Critical information requirements related to the emergency response activation Reporting Period |
|
72702-4
|
Criticism had a devastating effect on me in last week [BSL-23] |
|
3513-9
|
Cropropamide [Mass/time] in 24 hour Urine |
|
4201-0
|
Cropropamide [Mass] of Dose |
|
3511-3
|
Cropropamide [Presence] in Urine |
|
3512-1
|
Cropropamide [Mass/volume] in Urine |
|
90856-6
|
Crossbite teeth [#] |
|
3516-2
|
Crotethamide [Mass/time] in 24 hour Urine |
|
4202-8
|
Crotethamide [Mass] of Dose |
|
3514-7
|
Crotethamide [Presence] in Urine |
|
3515-4
|
Crotethamide [Mass/volume] in Urine |
|
18440-8
|
Crotonylcarnitine (C4:1) [Mass/volume] in Serum or Plasma |
|
87749-8
|
Crotoxyphos [Mass/mass] in Unspecified specimen |
|
90860-8
|
Crowded teeth [#] |
|
71426-1
|
C reactive protein [Mass/volume] in Blood by High sensitivity method |
|
48421-2
|
C reactive protein [Mass/volume] in Capillary blood |
|
59182-6
|
C reactive protein [Mass/volume] in Cerebral spinal fluid by High sensitivity method |
|
45062-7
|
C reactive protein [Mass/volume] in Cerebral spinal fluid |
|
16503-5
|
C reactive protein [Mass/volume] in Body fluid |
|
35648-5
|
C reactive protein [Quintile] in Serum or Plasma by High sensitivity method |
|
30522-7
|
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method |
|
76486-0
|
C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method |
|
11039-5
|
C reactive protein [Presence] in Serum or Plasma |
|
1988-5
|
C reactive protein [Mass/volume] in Serum or Plasma |
|
76485-2
|
C reactive protein [Moles/volume] in Serum or Plasma |
|
14634-0
|
C reactive protein [Titer] in Serum or Plasma |
|
79411-5
|
Creatine transport protein [Enzymatic activity/mass] in Fibroblast by Creatine uptake assay |
|
87636-7
|
Crufomate [Mass/mass] in Unspecified specimen |
|
15174-6
|
Cryocrit of Serum by Spun Westergren |
|
2165-9
|
Cryofibrinogen [Mass/volume] in Blood |
|
11043-7
|
Cryofibrinogen [Presence] in Plasma |
|
12197-0
|
Cryofibrinogen [Presence] in Plasma by 1 day cold incubation |
|
46265-5
|
Cryofibrinogen [Presence] in Plasma by 1 week cold incubation |
|
43401-9
|
Cryofibrinogen [Presence] in Plasma by 1 week 37 degree C incubation |
|
12198-8
|
Cryofibrinogen [Presence] in Plasma by 2 day cold incubation |
|
12199-6
|
Cryofibrinogen [Presence] in Plasma by 3 day cold incubation |
|
29744-0
|
Cryofibrinogen [Presence] in Plasma by 3 day 37 degree C incubation |
|
29743-2
|
Cryofibrinogen [Presence] in Plasma by 3 day RT incubation |
|
12196-2
|
Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation |
|
2166-7
|
Cryoglobulin [Mass/volume] in Blood |
|
44082-6
|
Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum |
|
49260-3
|
Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum Narrative |
|
55846-0
|
Cryoglobulin.IgA.monoclonal [Presence] in Serum |
|
40580-3
|
Cryoglobulin.IgA [Mass/volume] in Serum by Cold incubation |
|
40628-0
|
Cryoglobulin.IgA [Mass/volume] in Serum by 37 degree C incubation |
|
81311-3
|
Cryoglobulin.IgA [Presence] in Serum |
|
15171-2
|
Cryoglobulin.IgA [Units/volume] in Serum |
|
33650-3
|
Cryoglobulin.IgA [Mass/volume] in Serum |
|
55847-8
|
Cryoglobulin.IgG.monoclonal [Presence] in Serum |
|
40579-5
|
Cryoglobulin.IgG [Mass/volume] in Serum by Cold incubation |
|
40582-9
|
Cryoglobulin.IgG [Mass/volume] in Serum by 37 degree C incubation |
|
55848-6
|
Cryoglobulin.IgG [Presence] in Serum |
|
15172-0
|
Cryoglobulin.IgG [Units/volume] in Serum |
|
33649-5
|
Cryoglobulin.IgG [Mass/volume] in Serum |
|
55849-4
|
Cryoglobulin.IgM.monoclonal [Presence] in Serum |
|
40578-7
|
Cryoglobulin.IgM [Mass/volume] in Serum by Cold incubation |
|
40581-1
|
Cryoglobulin.IgM [Mass/volume] in Serum by 37 degree C incubation |
|
81312-1
|
Cryoglobulin.IgM [Presence] in Serum |
|
15173-8
|
Cryoglobulin.IgM [Units/volume] in Serum |
|
33651-1
|
Cryoglobulin.IgM [Mass/volume] in Serum |
|
33648-7
|
Cryoglobulin Rheumatoid Factor [Units/volume] in Serum |
|
5117-7
|
Cryoglobulin [Presence] in Serum |
|
12201-0
|
Cryoglobulin [Presence] in Serum by 1 day cold incubation |
|
12207-7
|
Cryoglobulin [Presence] in Serum by 1 week cold incubation |
|
12202-8
|
Cryoglobulin [Presence] in Serum by 2 day cold incubation |
|
12203-6
|
Cryoglobulin [Presence] in Serum by 3 day cold incubation |
|
29746-5
|
Cryoglobulin [Presence] in Serum by 3 day 37 degree C incubation |
|
29745-7
|
Cryoglobulin [Presence] in Serum by 3 day RT incubation |
|
12204-4
|
Cryoglobulin [Presence] in Serum by 4 day cold incubation |
|
12200-2
|
Cryoglobulin [Presence] in Serum by 4 hour cold incubation |
|
12205-1
|
Cryoglobulin [Presence] in Serum by 5 day cold incubation |
|
12206-9
|
Cryoglobulin [Presence] in Serum by 6 day cold incubation |
|
70970-9
|
Cryoglobulin [Presence] in Serum by Hypotonic dilution |
|
48614-2
|
Cryoglobulin [Presence] in Serum by Immune diffusion (ID) |
|
78989-1
|
Cryoglobulin [Mass/volume] in Serum |
|
2167-5
|
Cryoglobulin [Presence] in Serum or Plasma |
|
2168-3
|
Cryoglobulin [Mass/volume] in Serum or Plasma |
|
24038-2
|
Cryoglobulin type [Identifier] in Serum by Electrophoresis |
|
48638-1
|
Cryoglobulin type [Identifier] in Serum by Immunofixation |
|
71834-6
|
Cryoglobulin/Serum.total [Pure volume fraction] in Serum by Spun Westergren |
|
81313-9
|
Cryoglobulin.complement C3 [Presence] in Serum |
|
14299-2
|
Cryoprecipitate units available [#] |
|
51882-9
|
Cryoprecipitate units given [#] |
|
10392-9
|
Cryoprecipitate given [Volume] |
|
49261-1
|
Cryoproteins [Interpretation] in Serum by Electrophoresis agarose gel Narrative |
|
15176-1
|
Cryoproteins identified in Serum or Plasma |
|
15175-3
|
Cryoproteins [Interpretation] in Serum or Plasma by Electrophoresis agarose gel |
|
90338-5
|
Cryptococcus sp rRNA gene [Presence] in Blood by NAA with probe detection |
|
90337-7
|
Cryptococcus sp rRNA gene [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81649-6
|
Cryptococcus sp rRNA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
70907-1
|
Cryptococcus sp rRNA gene [Identifier] in Unspecified specimen by Sequencing |
|
7843-6
|
Cryptococcus sp Ab [Presence] in Serum |
|
6370-1
|
Cryptococcus sp Ab [Presence] in Serum by Immunofluorescence |
|
31335-3
|
Cryptococcus sp Ab [Units/volume] in Serum |
|
16123-2
|
Cryptococcus sp Ab [Titer] in Cerebral spinal fluid |
|
16124-0
|
Cryptococcus sp Ab [Titer] in Serum |
|
31788-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid |
|
29896-8
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
70911-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay |
|
46964-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31789-1
|
Cryptococcus sp Ag [Units/volume] in Cerebral spinal fluid |
|
16692-6
|
Cryptococcus sp Ag [Presence] in Body fluid |
|
31790-9
|
Cryptococcus sp Ag [Presence] in Serum |
|
29903-2
|
Cryptococcus sp Ag [Presence] in Serum by Immunoassay |
|
70910-5
|
Cryptococcus sp Ag [Presence] in Serum by Rapid immunoassay |
|
30324-8
|
Cryptococcus sp Ag [Presence] in Serum by Latex agglutination |
|
31791-7
|
Cryptococcus sp Ag [Units/volume] in Serum |
|
70908-9
|
Cryptococcus sp Ag [Presence] in Tissue by Immunofluorescence |
|
70909-7
|
Cryptococcus sp Ag [Presence] in Tissue by Immune stain |
|
32674-4
|
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid |
|
9817-8
|
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay |
|
9819-4
|
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Latex agglutination |
|
40768-4
|
Cryptococcus sp Ag [Titer] in Serum |
|
9818-6
|
Cryptococcus sp Ag [Titer] in Serum by Immunoassay |
|
9820-2
|
Cryptococcus sp Ag [Titer] in Serum by Latex agglutination |
|
93766-4
|
Cryptococcus sp Ag [Titer] in Urine by Rapid immunoassay |
|
11473-6
|
Cryptococcus sp Ag [Titer] in Unspecified specimen |
|
43229-4
|
Cryptococcus sp Ag [Titer] in Unspecified specimen by Latex agglutination |
|
16693-4
|
Cryptococcus sp Ag [Presence] in Urine |
|
29533-7
|
Cryptococcus sp Ag [Presence] in Unspecified specimen |
|
43228-6
|
Cryptococcus sp Ag [Presence] in Unspecified specimen by Latex agglutination |
|
31792-5
|
Cryptococcus sp Ag [Units/volume] in Unspecified specimen |
|
38376-0
|
Cryptococcus sp identified in Unspecified specimen by Organism specific culture |
|
21233-2
|
Cryptosporidium sp Ag [Presence] in Stool |
|
6371-9
|
Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
|
39534-3
|
Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence |
|
31793-3
|
Cryptosporidium sp Ag [Units/volume] in Stool |
|
6372-7
|
Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence |
|
31794-1
|
Cryptosporidium sp Ag [Presence] in Unspecified specimen |
|
566-0
|
Cryptosporidium sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
82205-6
|
Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection |
|
88928-7
|
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection |
|
88927-9
|
Cryptosporidium sp DNA [Presence] in Tissue by NAA with probe detection |
|
60545-1
|
Cryptosporidium sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27907-5
|
Cryptosporidium sp [Identifier] in Stool by Organism specific culture |
|
20781-1
|
Cryptosporidium sp [Presence] in Stool by Acid fast stain |
|
20780-3
|
Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain |
|
41488-8
|
Cryptosporidium sp [Presence] in Unspecified specimen by Acid fast stain |
|
85093-3
|
Crystal casts [Presence] in Urine sediment by Light microscopy |
|
51482-8
|
Crystals [#/volume] in Urine by Automated count |
|
75236-0
|
Crystals [#/area] in Body fluid by Light microscopy |
|
53322-4
|
Crystals [#/area] in Urine sediment by Automated count |
|
38459-4
|
Crystals [#/area] in Urine sediment by Microscopy high power field |
|
38397-6
|
Crystals [type] in Amniotic fluid by Light microscopy |
|
5779-4
|
Crystals [type] in Bile fluid by Light microscopy |
|
5780-2
|
Crystals [type] in Duodenal fluid by Light microscopy |
|
6825-4
|
Crystals [type] in Body fluid by Light microscopy |
|
38398-4
|
Crystals [type] in Pericardial fluid by Light microscopy |
|
6826-2
|
Crystals [type] in Pleural fluid by Light microscopy |
|
38399-2
|
Crystals [type] in Peritoneal fluid by Light microscopy |
|
5781-0
|
Crystals [type] in Synovial fluid by Light microscopy |
|
38458-6
|
Crystals [Presence] in Synovial fluid by Light microscopy |
|
47611-9
|
Crystals [type] in Tissue by Light microscopy |
|
87828-0
|
Crystals [Presence] in Urine |
|
53319-0
|
Crystals [Presence] in Urine by Automated |
|
5782-8
|
Crystals [type] in Urine sediment by Light microscopy |
|
49755-2
|
Crystals [Presence] in Urine sediment by Light microscopy |
|
42764-1
|
Crystals [type] in Vitreous fluid by Light microscopy |
|
58057-1
|
Cs sup(a) Ab [Presence] in Serum or Plasma |
|
58058-9
|
Cs sup(a) Ag [Presence] in Serum or Plasma |
|
32190-1
|
Microscopic observation [Identifier] in Cerebral spinal fluid |
|
75195-8
|
CSF Venereal Disease Research Laboratory test was performed and test findings [CDC.CS] |
|
92674-1
|
CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
23004-5
|
Classical swine fever virus Ab [Presence] in Serum |
|
23002-9
|
Classical swine fever virus Ab [Presence] in Serum by Immunoassay |
|
23003-7
|
Classical swine fever virus Ab [Presence] in Serum by Neutralization test |
|
46180-6
|
Classical swine fever virus Ab [Titer] in Serum |
|
43326-8
|
Classical swine fever virus Ab [Titer] in Serum by Neutralization test |
|
23005-2
|
Classical swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
|
23007-8
|
Classical swine fever virus Ag [Presence] in Tissue by Immune stain |
|
31781-8
|
Classical swine fever virus Ag [Presence] in Unspecified specimen |
|
23006-0
|
Classical swine fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
43327-6
|
Classical swine fever virus Ag [Presence] in Unspecified specimen by Immune stain |
|
58440-9
|
Classical swine fever virus E2 Ab [Units/volume] in Serum by Immunoassay |
|
44273-1
|
Classical swine fever virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23008-6
|
Classical swine fever virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
34463-0
|
California serogroup RNA [Presence] in Blood by NAA with probe detection |
|
34462-2
|
California serogroup RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
55143-2
|
California serogroup RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37986-7
|
California serogroup RNA [Presence] in Unspecified specimen by Probe |
|
41110-8
|
CSTB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34698-1
|
CSTB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85040-4
|
CT Unspecified body region 3D printed model |
|
41806-1
|
CT Abdomen |
|
35948-9
|
CT Abdominal Aorta |
|
36143-6
|
CT Abdominal Aorta W contrast IV |
|
36431-5
|
CT Abdominal Aorta WO contrast |
|
36271-5
|
CT Abdominal Aorta WO and W contrast IV |
|
36086-7
|
CT Abdomen limited |
|
36095-8
|
CT Abdomen limited W contrast IV |
|
36103-0
|
CT Abdomen limited WO contrast |
|
36102-2
|
CT Abdomen limited WO and W contrast IV |
|
79066-7
|
CT Abdomen 3D post processing WO contrast |
|
79103-8
|
CT Abdomen W contrast IV |
|
46330-7
|
CT Abdomen W reduced contrast volume IV |
|
87863-7
|
CT Abdomen WO and CT Chest and Abdomen W contrast IV |
|
87862-9
|
CT Abdomen WO and CT Abdomen and Pelvis W contrast IV |
|
87864-5
|
CT Abdomen WO and CT Chest and Abdomen and Pelvis W contrast IV |
|
36424-0
|
CT Abdomen WO contrast |
|
36267-3
|
CT Abdomen WO and W contrast IV |
|
46318-2
|
CT Abdomen WO and W reduced contrast volume IV |
|
87854-6
|
CT Abdomen and Pelvis and CT angiogram Abdominal aorta W contrast IV |
|
87853-8
|
CT Abdomen and Pelvis and CT angiogram Abdominal aorta WO and W contrast IV |
|
87865-2
|
CT Abdomen and Pelvis WO and CT Chest and Abdomen and Pelvis W contrast IV |
|
88319-9
|
CT Abdomen and Pelvis and Lower extremity - bilateral W contrast IV |
|
44115-4
|
CT Abdomen and Pelvis |
|
79065-9
|
CT Abdomen and Pelvis 3D post processing WO contrast |
|
36813-4
|
CT Abdomen and Pelvis W contrast IV |
|
36952-0
|
CT Abdomen and Pelvis WO contrast |
|
42274-1
|
CT Abdomen and Pelvis WO and W contrast IV |
|
36930-6
|
CT Adrenal gland |
|
36943-9
|
CT Adrenal gland W contrast IV |
|
36953-8
|
CT Adrenal gland WO contrast |
|
36950-4
|
CT Adrenal gland WO and W contrast IV |
|
79067-5
|
CT Airway WO contrast |
|
35940-6
|
CT Ankle |
|
36135-2
|
CT Ankle W contrast IV |
|
36425-7
|
CT Ankle WO contrast |
|
36268-1
|
CT Ankle WO and W contrast IV |
|
35941-4
|
CT Ankle - bilateral |
|
69087-5
|
CT Ankle - bilateral WO contrast |
|
35942-2
|
CT Ankle - left |
|
69102-2
|
CT Ankle - left Arthrogram |
|
36137-8
|
CT Ankle - left W contrast IV |
|
36426-5
|
CT Ankle - left WO contrast |
|
36269-9
|
CT Ankle - left WO and W contrast IV |
|
35944-8
|
CT Ankle - right |
|
69109-7
|
CT Ankle - right Arthrogram |
|
36139-4
|
CT Ankle - right W contrast IV |
|
36428-1
|
CT Ankle - right WO contrast |
|
36270-7
|
CT Ankle - right WO and W contrast IV |
|
35952-1
|
CT Appendix |
|
36145-1
|
CT Appendix W contrast IV |
|
36434-9
|
CT Appendix WO contrast |
|
79085-7
|
CT Biliary ducts WO and W contrast IV |
|
79094-9
|
CT Urinary bladder W contrast intra bladder |
|
69095-8
|
CT Urinary bladder W contrast IV |
|
44229-3
|
CT Bone |
|
35891-1
|
CT guidance for percutaneous biopsy of Bone |
|
36054-5
|
CT Brachial plexus |
|
89835-3
|
CT Brachial plexus W contrast IV |
|
89836-1
|
CT Brachial plexus WO contrast |
|
44119-6
|
CT Breast - bilateral WO contrast |
|
89833-8
|
CT Unspecified body region by reconstruction |
|
86984-2
|
CT Cervical and thoracic and lumbar spine W contrast IV |
|
86987-5
|
CT Cervical and thoracic and lumbar spine WO contrast |
|
87870-2
|
CT Cervical spine to Coccyx WO and W contrast IV |
|
87922-1
|
CT Cervical and thoracic spine W contrast IT |
|
86985-9
|
CT Cervical and thoracic spine W contrast IV |
|
83304-6
|
CT Cervical and thoracic spine WO contrast |
|
86959-4
|
CT Cervical and thoracic spine WO and W contrast IV |
|
24734-6
|
CT Cerebral cisterns W contrast IT |
|
24627-2
|
CT Chest |
|
88322-3
|
CT Chest W contrast IV and CT angiogram Pulmonary arteries for pulmonary embolus W contrast IV |
|
36089-1
|
CT Chest limited |
|
69096-6
|
CT Chest limited W contrast IV |
|
47366-0
|
CT Chest limited WO contrast |
|
79096-4
|
CT Chest 3D post processing WO contrast |
|
87279-6
|
CT Chest for screening |
|
79068-3
|
CT Chest for screening W contrast IV |
|
79086-5
|
CT Chest for screening WO contrast |
|
24628-0
|
CT Chest W contrast IV |
|
89860-1
|
CT Chest W inspiration and expiration |
|
46327-3
|
CT Chest W reduced contrast volume IV |
|
87847-0
|
CT Chest WO and CT angiogram Coronary arteries W contrast IV |
|
29252-4
|
CT Chest WO contrast |
|
30598-7
|
CT Chest WO and W contrast IV |
|
46317-4
|
CT Chest WO and W reduced contrast volume IV |
|
79097-2
|
CT Chest and Abdomen 3D post processing WO contrast |
|
42275-8
|
CT Chest and Abdomen W contrast IV |
|
42276-6
|
CT Chest and Abdomen WO contrast |
|
42277-4
|
CT Chest and Abdomen WO and W contrast IV |
|
87869-4
|
CT Chest and Abdomen and Pelvis |
|
79098-0
|
CT Chest and Abdomen and Pelvis 3D post processing WO contrast |
|
72254-6
|
CT Chest and Abdomen and Pelvis W contrast IV |
|
72253-8
|
CT Chest and Abdomen and Pelvis WO contrast |
|
72252-0
|
CT Chest and Abdomen and Pelvis WO and W contrast IV |
|
35960-4
|
CT Clavicle |
|
82685-9
|
CT Clavicle W contrast IV |
|
82687-5
|
CT Clavicle WO contrast |
|
82684-2
|
CT Clavicle WO and W contrast IV |
|
89834-6
|
CT Clavicle - bilateral WO contrast |
|
87871-0
|
CT Clavicle - left |
|
82716-2
|
CT Clavicle - left W contrast IV |
|
82682-6
|
CT Clavicle - left WO contrast |
|
87872-8
|
CT Clavicle - right |
|
82686-7
|
CT Clavicle - right W contrast IV |
|
82683-4
|
CT Clavicle - right WO contrast |
|
79069-1
|
CT Colon and Rectum for screening WO contrast IV and W air contrast PR |
|
79101-2
|
CT Colon and Rectum for screening W air contrast PR |
|
60515-4
|
CT Colon and Rectum W air contrast PR |
|
72531-7
|
CT Colon and Rectum W contrast IV and W air contrast PR |
|
79071-7
|
CT Colon and Rectum WO contrast IV and W air contrast PR |
|
82688-3
|
CT Colon and Rectum WO and W contrast IV and W air contrast PR |
|
24932-6
|
CT Cervical spine |
|
79078-2
|
CT Cervical spine by reconstruction W contrast IV |
|
79079-0
|
CT Cervical spine by reconstruction WO contrast |
|
36099-0
|
CT Cervical spine limited W contrast IV |
|
36109-7
|
CT Cervical spine limited WO contrast |
|
37496-7
|
CT Cervical spine W contrast intradisc |
|
24934-2
|
CT Cervical spine W contrast IT |
|
24933-4
|
CT Cervical spine W contrast IV |
|
30592-0
|
CT Cervical spine WO contrast |
|
36401-8
|
CT Cervical spine WO and W contrast IV |
|
83293-1
|
CT Spine Cervical and Spine Lumbar W contrast IV |
|
83305-3
|
CT Spine Cervical and Spine Lumbar WO contrast |
|
83297-2
|
CT Spine Cervical and Spine Lumbar WO and W contrast IV |
|
44005-7
|
Chlamydia trachomatis D and K IgA and IgG and IgM [Interpretation] in Serum |
|
35962-0
|
CT Elbow |
|
36157-6
|
CT Elbow W contrast IV |
|
36443-0
|
CT Elbow WO contrast |
|
36285-5
|
CT Elbow WO and W contrast IV |
|
35965-3
|
CT Elbow - bilateral |
|
36444-8
|
CT Elbow - bilateral WO contrast |
|
35966-1
|
CT Elbow - left |
|
69103-0
|
CT Elbow - left Arthrogram |
|
36159-2
|
CT Elbow - left W contrast IV |
|
36445-5
|
CT Elbow - left WO contrast |
|
36286-3
|
CT Elbow - left WO and W contrast IV |
|
35968-7
|
CT Elbow - right |
|
69110-5
|
CT Elbow - right Arthrogram |
|
36161-8
|
CT Elbow - right W contrast IV |
|
36447-1
|
CT Elbow - right WO contrast |
|
36287-1
|
CT Elbow - right WO and W contrast IV |
|
35969-5
|
CT Esophagus |
|
24690-0
|
CT Extremity |
|
36090-9
|
CT Extremity limited |
|
24691-8
|
CT Extremity W contrast IV |
|
42278-2
|
CT Extremity WO contrast |
|
42268-3
|
CT Extremity WO and W contrast IV |
|
26224-6
|
CT Extremity - bilateral |
|
26184-2
|
CT Extremity - bilateral W contrast IV |
|
26226-1
|
CT Extremity - left |
|
26185-9
|
CT Extremity - left W contrast IV |
|
69104-8
|
CT Extremity - left WO contrast |
|
26231-1
|
CT Extremity - right |
|
26186-7
|
CT Extremity - right W contrast IV |
|
69111-3
|
CT Extremity - right WO contrast |
|
24696-7
|
CT Facial bones |
|
24697-5
|
CT Facial bones W contrast IV |
|
72249-6
|
CT Facial bones WO contrast |
|
82133-0
|
CT Face and Neck WO contrast |
|
82132-2
|
CT Face and Neck WO and W contrast IV |
|
87895-9
|
CT Finger WO contrast |
|
87888-4
|
CT Finger second - left WO contrast |
|
87892-6
|
CT Finger second - right WO contrast |
|
87893-4
|
CT Finger third - right WO contrast |
|
87887-6
|
CT Finger fourth - left W contrast IV |
|
87891-8
|
CT Finger fourth - right WO contrast |
|
87886-8
|
CT Finger fifth - left WO contrast |
|
87890-0
|
CT Finger fifth - right WO contrast |
|
89850-2
|
CT Finger - left WO contrast |
|
89849-4
|
CT Finger - right WO contrast |
|
35991-9
|
CT Foot |
|
36178-2
|
CT Foot W contrast IV |
|
36466-1
|
CT Foot WO contrast |
|
36341-6
|
CT Foot WO and W contrast IV |
|
35993-5
|
CT Foot - bilateral |
|
86973-5
|
CT Foot - bilateral W contrast IV |
|
86967-7
|
CT Foot - bilateral WO contrast |
|
35994-3
|
CT Foot - left |
|
36181-6
|
CT Foot - left W contrast IV |
|
36468-7
|
CT Foot - left WO contrast |
|
36343-2
|
CT Foot - left WO and W contrast IV |
|
35996-8
|
CT Foot - right |
|
36183-2
|
CT Foot - right W contrast IV |
|
36470-3
|
CT Foot - right WO contrast |
|
36345-7
|
CT Foot - right WO and W contrast IV |
|
37221-9
|
CT Unspecified body region for fistula |
|
35997-6
|
CT Forearm |
|
36185-7
|
CT Forearm W contrast IV |
|
36472-9
|
CT Forearm WO contrast |
|
36347-3
|
CT Forearm WO and W contrast IV |
|
35998-4
|
CT Forearm - bilateral |
|
35999-2
|
CT Forearm - left |
|
36187-3
|
CT Forearm - left W contrast IV |
|
36473-7
|
CT Forearm - left WO contrast |
|
36348-1
|
CT Forearm - left WO and W contrast IV |
|
36000-8
|
CT Forearm - right |
|
36189-9
|
CT Forearm - right W contrast IV |
|
36475-2
|
CT Forearm - right WO contrast |
|
36350-7
|
CT Forearm - right WO and W contrast IV |
|
35924-0
|
CT Guidance for drainage and placement of drainage catheter of Chest-- WO contrast |
|
35923-2
|
CT Guidance for drainage and placement of drainage catheter of Chest-- W contrast IV |
|
46291-1
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO and W contrast IV |
|
42287-3
|
CT Guidance for drainage and placement of drainage catheter of Retroperitoneum |
|
43502-4
|
CT Guidance for drainage of abscess and placement of drainage catheter of Subphrenic space |
|
35884-6
|
CT Guidance for drainage of abscess and placement of drainage catheter of Abdomen |
|
92924-0
|
CT Guidance for aspiration of Abdomen |
|
30601-9
|
CT Guidance for biopsy of Abdomen |
|
89620-9
|
CT Guidance for biopsy of Abdomen-- W contrast IV |
|
69083-4
|
CT Guidance for biopsy of Abdomen-- WO contrast |
|
37210-2
|
CT Guidance for aspiration of cyst of Abdomen |
|
35913-3
|
CT Guidance for drainage and placement of drainage catheter of Abdomen |
|
89613-4
|
CT Guidance for drainage and placement of drainage catheter of Abdomen-- WO contrast |
|
89615-9
|
CT Guidance for drainage and placement of drainage catheter of Abdomen-- W contrast IV |
|
30602-7
|
CT Guidance for fine needle aspiration of Abdomen |
|
35930-7
|
CT Guidance for nerve block of Abdomen |
|
52790-3
|
CT Guidance for percutaneous replacement of drainage tube of Abdomen |
|
58747-7
|
CT Guidance for ablation of tissue of Unspecified body region |
|
30578-9
|
CT Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
|
36767-2
|
CT Guidance for biopsy of Adrenal gland |
|
44108-9
|
CT Guidance for fine needle aspiration of Adrenal gland |
|
89699-3
|
CT Guidance for injection of Ankle - left |
|
89698-5
|
CT Guidance for injection of Ankle - right |
|
35914-1
|
CT Guidance for drainage and placement of drainage catheter of Anus |
|
42280-8
|
CT Guidance for drainage of abscess and placement of drainage catheter of Appendix |
|
35915-8
|
CT Guidance for drainage and placement of drainage catheter of Appendix |
|
25042-3
|
CT Guidance for aspiration or biopsy of Unspecified body region |
|
25041-5
|
CT Guidance for aspiration or biopsy of Unspecified body region-- W contrast IV |
|
36770-6
|
CT Guidance for drainage and placement of drainage catheter of Biliary ducts and Gallbladder |
|
43567-7
|
CT Guidance for deep biopsy of Bone |
|
37211-0
|
CT Guidance for biopsy of Bone marrow |
|
89930-2
|
CT Guidance for radiofrequency ablation of Bone |
|
42265-9
|
CT Guidance for superficial biopsy of Bone |
|
35893-7
|
CT Guidance for biopsy of Breast |
|
44110-5
|
CT Guidance for needle localization of Breast |
|
44118-8
|
CT Guidance for needle localization of Breast-- WO and W contrast IV |
|
35886-1
|
CT Guidance for fluid aspiration of Breast |
|
35928-1
|
CT Guidance for localization of Breast - left |
|
35929-9
|
CT Guidance for localization of Breast - right |
|
25044-9
|
CT Guidance for biopsy of Unspecified body region |
|
42260-0
|
CT Guidance for biopsy of Unspecified body region-- W contrast IV |
|
46290-3
|
CT Guidance for biopsy of Unspecified body region-- WO contrast |
|
46289-5
|
CT Guidance for biopsy of Unspecified body region-- WO and W contrast IV |
|
92921-6
|
CT Guidance for 1 level injection of Cervical and thoracic spine |
|
46365-3
|
CT Guidance for ablation of tissue of Celiac plexus |
|
24623-1
|
CT Guidance for nerve block of Celiac plexus |
|
42281-6
|
CT Guidance for drainage of abscess and placement of drainage catheter of Chest |
|
35895-2
|
CT Guidance for biopsy of Chest |
|
35909-1
|
CT Guidance for biopsy of Chest-- W contrast IV |
|
35911-7
|
CT Guidance for biopsy of Chest-- WO contrast |
|
35910-9
|
CT Guidance for biopsy of Chest-- WO and W contrast IV |
|
35916-6
|
CT Guidance for drainage and placement of drainage catheter of Chest |
|
88317-3
|
CT Guidance for fluid aspiration of Chest |
|
37492-6
|
CT Guidance for biopsy of Chest Pleura |
|
35938-0
|
CT Guidance for placement of tube in Chest |
|
35904-2
|
CT Guidance for biopsy of Cervical spine |
|
75748-4
|
CT Guidance for fluid aspiration of Cervical spine Intervertebral disc |
|
37493-4
|
CT Guidance for injection of Cervical spine Intervertebral disc |
|
42021-6
|
CT Guidance for needle localization of Cervical spine |
|
70921-2
|
CT Guidance for nerve block of Cervical spine |
|
92925-7
|
CT Guidance for injection of Spine cervical and thoracic epidural space |
|
35887-9
|
CT Guidance for aspiration of cyst of Unspecified body region |
|
46281-2
|
CT Guidance for aspiration or injection of cyst of Unspecified body region |
|
87916-3
|
CT Guidance for injection of cyst of Unspecified body region |
|
89932-8
|
CT Guidance for deep placement of needle of Unspecified body region |
|
35922-4
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region |
|
46292-9
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- W contrast IV |
|
46293-7
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO contrast |
|
37212-8
|
CT Guidance for biopsy of Epididymis |
|
30580-5
|
CT Guidance for fine needle aspiration of Unspecified body region |
|
90307-0
|
CT Guidance for injection of Foot joint - right |
|
35917-4
|
CT Guidance for drainage and placement of drainage catheter of Gallbladder |
|
35892-9
|
CT Guidance for biopsy of Head |
|
36928-0
|
CT Guidance for stereotactic biopsy of Head |
|
24585-2
|
CT Guidance for stereotactic biopsy of Head-- W contrast IV |
|
36929-8
|
CT Guidance for stereotactic biopsy of Head-- WO contrast |
|
89955-9
|
CT Guidance for arthrocentesis of Hip - bilateral |
|
89956-7
|
CT Guidance for arthrocentesis of Hip - left |
|
89701-7
|
CT Guidance for injection of Hip - left |
|
89957-5
|
CT Guidance for arthrocentesis of Hip - right |
|
89700-9
|
CT Guidance for injection of Hip - right |
|
42136-2
|
CT Guidance for biopsy of Heart |
|
89929-4
|
CT Guidance for fluid aspiration of Intervertebral disc |
|
89628-2
|
CT Guidance for aspiration of cyst of Ileum - left |
|
89627-4
|
CT Guidance for aspiration of cyst of Ileum - right |
|
24769-2
|
CT Guidance for injection of Joint space |
|
44102-2
|
CT Guidance for procedure of Joint space |
|
30607-6
|
CT Guidance for biopsy of Kidney - bilateral |
|
89604-3
|
CT Guidance for aspiration of cyst of Kidney - bilateral |
|
30608-4
|
CT Guidance for fine needle aspiration of Kidney - bilateral |
|
44228-5
|
CT Guidance for ablation of tissue of Kidney |
|
42285-7
|
CT Guidance for drainage of abscess and placement of drainage catheter of Kidney |
|
92923-2
|
CT Guidance for aspiration of Kidney |
|
42279-0
|
CT Guidance for biopsy of Kidney |
|
89621-7
|
CT Guidance for biopsy of Kidney-- W contrast IV |
|
89614-2
|
CT Guidance for biopsy of Kidney-- WO contrast |
|
89625-8
|
CT Guidance for aspiration of cyst of Kidney |
|
89617-5
|
CT Guidance for aspiration of cyst of Kidney-- W contrast IV |
|
89618-3
|
CT Guidance for aspiration of cyst of Kidney-- WO contrast |
|
35918-2
|
CT Guidance for drainage and placement of drainage catheter of Kidney |
|
43757-4
|
CT Guidance for fine needle aspiration of Kidney |
|
36769-8
|
CT Guidance for exchange of nephrostomy tube of Kidney |
|
36772-2
|
CT Guidance for placement of nephrostomy tube in Kidney |
|
89606-8
|
CT Guidance for ablation of tissue of Kidney - left |
|
89961-7
|
CT Guidance for drainage of abscess and placement of drainage catheter of Kidney - left |
|
92918-2
|
CT Guidance for aspiration of Kidney - left |
|
88325-6
|
CT Guidance for biopsy of Kidney - left |
|
89602-7
|
CT Guidance for aspiration of cyst of Kidney - left |
|
89605-0
|
CT Guidance for ablation of tissue of Kidney - right |
|
89960-9
|
CT Guidance for drainage of abscess and placement of drainage catheter of Kidney - right |
|
92917-4
|
CT Guidance for aspiration of Kidney - right |
|
88323-1
|
CT Guidance for biopsy of Kidney - right |
|
89603-5
|
CT Guidance for aspiration of cyst of Kidney - right |
|
89706-6
|
CT Guidance for injection of Knee - bilateral |
|
82676-8
|
CT Guidance for arthrocentesis of Knee - left |
|
89708-2
|
CT Guidance for injection of Knee - left |
|
82715-4
|
CT Guidance for arthrocentesis of Knee - right |
|
89707-4
|
CT Guidance for injection of Knee - right |
|
35896-0
|
CT Guidance for biopsy of Lower extremity |
|
90317-9
|
CT Guidance for drainage and placement of drainage catheter of Lower extremity - left |
|
90318-7
|
CT Guidance for drainage and placement of drainage catheter of Lower extremity - right |
|
44101-4
|
CT Guidance for ablation of tissue of Liver |
|
42282-4
|
CT Guidance for drainage of abscess and placement of drainage catheter of Liver |
|
24812-0
|
CT Guidance for biopsy of Liver |
|
69092-5
|
CT Guidance for biopsy of Liver-- WO contrast |
|
24813-8
|
CT Guidance for core needle biopsy of Liver |
|
35919-0
|
CT Guidance for drainage and placement of drainage catheter of Liver |
|
30603-5
|
CT Guidance for fine needle aspiration of Liver |
|
24811-2
|
CT Guidance for fluid aspiration of Liver |
|
35901-8
|
CT Guidance for biopsy of Lymph node |
|
35920-8
|
CT Guidance for drainage of Lymph node |
|
44103-0
|
CT Guidance for fine needle aspiration of Lymph node |
|
35905-9
|
CT Guidance for biopsy of Lumbar spine |
|
89928-6
|
CT Guidance for fluid aspiration of Lumbar spine Intervertebral disc |
|
90335-1
|
CT Guidance for injection of Lumbar Spine Facet Joint |
|
92922-4
|
CT Guidance for intrathecal injection of Lumbar spine |
|
42020-8
|
CT Guidance for needle localization of Lumbar spine |
|
35932-3
|
CT Guidance for nerve block of Lumbar spine |
|
35934-9
|
CT Guidance for percutaneous vertebroplasty of Lumbar spine |
|
92928-1
|
CT Guidance for injection of Spine lumbar and Sacrum epidural space |
|
92920-8
|
CT Guidance for 1 level injection of Spine Lumbar and Sacrum |
|
92919-0
|
CT Guidance for 2 levels injection of Spine Lumbar and Sacrum |
|
24823-7
|
CT Guidance for biopsy of Lung |
|
30595-3
|
CT Guidance for fine needle aspiration of Lung |
|
24822-9
|
CT Guidance for fluid aspiration of Lung |
|
89962-5
|
CT Guidance for radiofrequency ablation of Lung |
|
89720-7
|
CT Guidance for drainage of abscess and placement of drainage catheter of Lung - left |
|
88324-9
|
CT Guidance for biopsy of Lung - left |
|
89629-0
|
CT Guidance for aspiration of cyst of Lung - left |
|
90319-5
|
CT Guidance for drainage and placement of drainage catheter of Lung - left |
|
89608-4
|
CT Guidance for fluid aspiration of Lung - left |
|
89719-9
|
CT Guidance for drainage of abscess and placement of drainage catheter of Lung - right |
|
88526-9
|
CT Guidance for biopsy of Lung - right |
|
89630-8
|
CT Guidance for aspiration of cyst of Lung - right |
|
90309-6
|
CT Guidance for drainage and placement of drainage catheter of Lung - right |
|
89607-6
|
CT Guidance for fluid aspiration of Lung - right |
|
36927-2
|
CT Guidance for biopsy of Maxillofacial region |
|
37213-6
|
CT Guidance for biopsy of Mediastinum |
|
44104-8
|
CT Guidance for fine needle aspiration of Mediastinum |
|
36768-0
|
CT Guidance for percutaneous biopsy of Muscle |
|
44109-7
|
CT Guidance for deep biopsy of Muscle |
|
44105-5
|
CT Guidance for fine needle aspiration of Muscle |
|
90336-9
|
CT Guidance for injection of Muscle |
|
89828-8
|
CT Guidance for superficial biopsy of Muscle |
|
24838-5
|
CT Guidance for biopsy of Neck |
|
24837-7
|
CT Guidance for fluid aspiration of Neck |
|
39026-0
|
CT Guidance for needle localization of Unspecified body region |
|
82681-8
|
CT Guidance for biopsy of Oral tissue |
|
30604-3
|
CT Guidance for biopsy of Pancreas |
|
89619-1
|
CT Guidance for biopsy of Pancreas-- W contrast IV |
|
89616-7
|
CT Guidance for aspiration of cyst of Pancreas-- WO contrast |
|
42283-2
|
CT Guidance for drainage and placement of drainage catheter of Pancreas |
|
30605-0
|
CT Guidance for fine needle aspiration of Pancreas |
|
24856-7
|
CT Guidance for fluid aspiration of Pancreas |
|
89697-7
|
CT Guidance for drainage of pseudocyst and placement of drainage catheter of Pancreas |
|
43444-9
|
CT Guidance for percutaneous drainage of abscess and placement of drainage catheter of Unspecified body region |
|
90311-2
|
CT Guidance for percutaneous replacement of drainage tube of Unspecified body region |
|
92567-7
|
CT Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region |
|
25043-1
|
CT Guidance for fluid aspiration of Unspecified body region |
|
89695-1
|
CT Guidance for drainage and placement of drainage catheter of Pelvis-- WO contrast |
|
89696-9
|
CT Guidance for drainage and placement of drainage catheter of Pelvis-- W contrast IV |
|
42286-5
|
CT Guidance for drainage of abscess and placement of drainage catheter of Pelvis |
|
24864-1
|
CT Guidance for biopsy of Pelvis |
|
69093-3
|
CT Guidance for biopsy of Pelvis-- W contrast IV |
|
69094-1
|
CT Guidance for biopsy of Pelvis-- WO contrast |
|
89958-3
|
CT Guidance for cryoablation of Pelvis |
|
35921-6
|
CT Guidance for drainage and placement of drainage catheter of Pelvis |
|
30606-8
|
CT Guidance for fine needle aspiration of Pelvis |
|
35931-5
|
CT Guidance for nerve block of Pelvis |
|
52791-1
|
CT Guidance for percutaneous replacement of drainage tube of Pelvis |
|
24863-3
|
CT Guidance for fluid aspiration of Pelvis |
|
89859-3
|
CT Guidance for transrectal drainage of abscess of Pelvis |
|
89609-2
|
CT Guidance for fluid aspiration of Pericardial space |
|
89931-0
|
CT Guidance for drainage and placement of drainage catheter of Perirectal region |
|
89854-4
|
CT Guidance for drainage of abscess and placement of drainage catheter of Perirenal space - left |
|
89855-1
|
CT Guidance for drainage of abscess and placement of drainage catheter of Perirenal space - right |
|
89624-1
|
CT Guidance for drainage of abscess and placement of drainage catheter of Peritoneal space |
|
89623-3
|
CT Guidance for drainage and placement of drainage catheter of Peritoneal space |
|
89610-0
|
CT Guidance for placement of catheter in Peritoneal space |
|
89622-5
|
CT Guidance for fluid aspiration of Peritoneal space |
|
42284-0
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space |
|
37491-8
|
CT Guidance for fluid aspiration of Pleural space |
|
75746-8
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space - bilateral |
|
90050-6
|
CT Guidance for placement of chest tube in Pleural space - bilateral |
|
92569-3
|
CT Guidance for drainage and placement of chest tube of Pleural space - bilateral |
|
75752-6
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space - left |
|
90049-8
|
CT Guidance for placement of chest tube in Pleural space - left |
|
90313-8
|
CT Guidance for drainage and placement of chest tube of Pleural space - left |
|
89612-6
|
CT Guidance for fluid aspiration of Pleural space - left |
|
75818-5
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space - right |
|
90051-4
|
CT Guidance for placement of chest tube in Pleural space - right |
|
92571-9
|
CT Guidance for drainage and placement of chest tube of Pleural space - right |
|
89611-8
|
CT Guidance for fluid aspiration of Pleural space - right |
|
89858-5
|
CT Guidance for biopsy of Pleura - left |
|
89857-7
|
CT Guidance for biopsy of Pleura - right |
|
35903-4
|
CT Guidance for biopsy of Prostate |
|
44106-3
|
CT Guidance for FNA of Prostate |
|
25053-0
|
CT Guidance for radiosurgery of Unspecified body region |
|
25054-8
|
CT Guidance for radiosurgery of Unspecified body region-- W contrast IV |
|
89721-5
|
CT Guidance for drainage of abscess and placement of drainage catheter of Retroperitoneum |
|
90314-6
|
CT Guidance for drainage and placement of drainage catheter of Retroperitoneum-- W contrast IV |
|
90310-4
|
CT Guidance for drainage and placement of drainage catheter of Retroperitoneum-- WO contrast |
|
92916-6
|
CT Guidance for aspiration of Retroperitoneum |
|
44117-0
|
CT Guidance for biopsy of Retroperitoneum |
|
89830-4
|
CT Guidance for biopsy of Retroperitoneum-- W contrast IV |
|
89829-6
|
CT Guidance for biopsy of Retroperitoneum-- WO contrast |
|
44107-1
|
CT Guidance for fine needle aspiration of Retroperitoneum |
|
79072-5
|
CT Guidance for radiation treatment of Unspecified body region |
|
35937-2
|
CT Guidance for placement of radiation therapy fields in Unspecified body region |
|
30581-3
|
CT Guidance for radiation treatment of Unspecified body region-- W contrast IV |
|
30582-1
|
CT Guidance for radiation treatment of Unspecified body region-- WO contrast |
|
92926-5
|
CT Guidance for radiation treatment of Unspecified body region-- WO and W contrast IV |
|
35898-6
|
CT Guidance for biopsy of Salivary gland |
|
89702-5
|
CT Guidance for injection of Shoulder - bilateral |
|
89954-2
|
CT Guidance for arthrocentesis of Shoulder - left |
|
89703-3
|
CT Guidance for injection of Shoulder - left |
|
89953-4
|
CT Guidance for arthrocentesis of Shoulder - right |
|
89704-1
|
CT Guidance for injection of Shoulder - right |
|
24901-1
|
CT Guidance for injection of Sacroiliac Joint |
|
26319-4
|
CT Guidance for injection of Sacroiliac joint - bilateral |
|
26320-2
|
CT Guidance for injection of Sacroiliac joint - left |
|
89952-6
|
CT Guidance for arthrocentesis of Sacroiliac joint - right |
|
26321-0
|
CT Guidance for injection of Sacroiliac joint - right |
|
89959-1
|
CT Guidance for biopsy of Soft tissue |
|
90315-3
|
CT Guidance for deep biopsy of Soft tissue |
|
90316-1
|
CT Guidance for superficial biopsy of Soft tissue |
|
88316-5
|
CT Guidance for biopsy of Spinal cord |
|
24986-2
|
CT Guidance for biopsy of Spine |
|
30579-7
|
CT Guidance for injection of Spine facet joint |
|
89711-6
|
CT Guidance for 1 level injection of Spine facet joint |
|
89710-8
|
CT Guidance for 2 levels injection of Spine facet joint |
|
89709-0
|
CT Guidance for greater than 2 levels for injection of Spine facet joint |
|
42688-2
|
CT Guidance for nerve block of Spine |
|
35933-1
|
CT Guidance for percutaneous vertebroplasty of Spine |
|
30609-2
|
CT Guidance for biopsy of Spleen |
|
30610-0
|
CT Guidance for fine needle aspiration of Spleen |
|
89839-5
|
CT Guidance for biopsy of Sternum |
|
88321-5
|
CT Guidance for stereotactic localization of Unspecified body region |
|
89718-1
|
CT Guidance for stereotactic localization of Unspecified body region-- W contrast IV |
|
89856-9
|
CT Guidance for stereotactic localization of Unspecified body region-- WO contrast |
|
89717-3
|
CT Guidance for stereotactic localization of Unspecified body region-- WO and W contrast IV |
|
89831-2
|
CT Guidance for drainage and placement of drainage catheter of Subphrenic space |
|
90372-4
|
CT Guidance for injection of Tendon |
|
90373-2
|
CT Guidance for injection of Tendon or ligament |
|
35908-3
|
CT Guidance for biopsy of Thyroid gland |
|
89832-0
|
CT Guidance for deep biopsy of Tissue |
|
37214-4
|
CT Guidance for superficial biopsy of Tissue |
|
35906-7
|
CT Guidance for biopsy of Thoracic spine |
|
90334-4
|
CT Guidance for injection of Spine Thoracic Facet Joint |
|
90308-8
|
CT Guidance for needle localization of Thoracic spine |
|
70922-0
|
CT Guidance for nerve block of Thoracic spine |
|
35935-6
|
CT Guidance for percutaneous vertebroplasty of Thoracic spine |
|
35897-8
|
CT Guidance for biopsy of Upper extremity |
|
42701-3
|
CT Guidance for localization of placenta of Uterus |
|
89705-8
|
CT Guidance for injection of Wrist - left |
|
36002-4
|
CT Hand |
|
36191-5
|
CT Hand W contrast IV |
|
36477-8
|
CT Hand WO contrast |
|
36352-3
|
CT Hand WO and W contrast IV |
|
36004-0
|
CT Hand - bilateral |
|
86968-5
|
CT Hand - bilateral W contrast IV |
|
36005-7
|
CT Hand - left |
|
36193-1
|
CT Hand - left W contrast IV |
|
36478-6
|
CT Hand - left WO contrast |
|
36353-1
|
CT Hand - left WO and W contrast IV |
|
36007-3
|
CT Hand - right |
|
36195-6
|
CT Hand - right W contrast IV |
|
36480-2
|
CT Hand - right WO contrast |
|
36355-6
|
CT Hand - right WO and W contrast IV |
|
24725-4
|
CT Head |
|
88327-2
|
CT Head W contrast IV and CT angiogram Head and neck vessels W contrast IV |
|
36087-5
|
CT Head limited |
|
36104-8
|
CT Head limited WO contrast |
|
83296-4
|
CT Head W contrast IV and CT Orbit - bilateral WO and W contrast IV |
|
24727-0
|
CT Head W contrast IV |
|
46328-1
|
CT Head W reduced contrast volume IV |
|
30799-1
|
CT Head WO contrast |
|
82804-6
|
CT Head WO and W contrast IV and CT Neck W contrast IV |
|
82742-8
|
CT Head WO and W contrast IV and CT Orbit - bilateral W contrast IV |
|
82802-0
|
CT Head WO and W contrast IV and CT Sinuses W contrast IV |
|
82803-8
|
CT Head WO and W contrast IV and CT Temporal bone W contrast IV |
|
24726-2
|
CT Head WO and W contrast IV |
|
46316-6
|
CT Head WO and W reduced contrast volume IV |
|
90352-6
|
CT Head and CT Brain for perfusion and CT angiogram Head vessels WO and W contrast IV |
|
92025-6
|
CT Head and Cervical spine W contrast IV |
|
82690-9
|
CT Head and Cervical spine WO contrast |
|
93603-9
|
CT Head and Cervical spine WO and W contrast IV |
|
83307-9
|
CT Head and Mandible WO contrast |
|
87908-0
|
CT Head and Maxillofacial region W contrast IV |
|
83306-1
|
CT Head and Maxillofacial region WO contrast |
|
87911-4
|
CT Head and Maxillofacial region WO and W contrast IV |
|
86991-7
|
CT Head and Maxillofacial region and Cervical spine WO contrast |
|
82691-7
|
CT Head and Neck W contrast IV |
|
82692-5
|
CT Head and Neck WO contrast |
|
86972-7
|
CT Head and Neck WO and W contrast IV |
|
86989-1
|
CT Head and Orbit - bilateral W contrast IV |
|
86990-9
|
CT Head and Orbit - bilateral WO contrast |
|
89845-2
|
CT Head and Orbit - bilateral WO and W contrast IV |
|
87897-5
|
CT Head and Pituitary and Sella turcica W contrast IV |
|
86978-4
|
CT Head and Sinuses W contrast IV |
|
86992-5
|
CT Head and Sinuses WO contrast |
|
87910-6
|
CT Head and Sinuses WO and W contrast IV |
|
86977-6
|
CT Head and Temporal bone W contrast IV |
|
83302-0
|
CT Head and Temporal bone WO contrast |
|
89844-5
|
CT Head and Temporal bone WO and W contrast IV |
|
77448-9
|
CT Hindfoot and Midfoot |
|
77456-2
|
CT Hindfoot and Midfoot W contrast IV |
|
77458-8
|
CT Hindfoot and Midfoot WO contrast |
|
77457-0
|
CT Hindfoot and Midfoot WO and W contrast IV |
|
77466-1
|
CT Hindfoot - left and Midfoot - left W contrast IV |
|
77470-3
|
CT Hindfoot - left and Midfoot - left WO contrast |
|
77468-7
|
CT Hindfoot - left and Midfoot - left WO and W contrast IV |
|
77467-9
|
CT Hindfoot - right and Midfoot - right W contrast IV |
|
77471-1
|
CT Hindfoot - right and Midfoot - right WO contrast |
|
77469-5
|
CT Hindfoot - right and Midfoot - right WO and W contrast IV |
|
36014-9
|
CT Hip |
|
36092-5
|
CT Hip limited |
|
36200-4
|
CT Hip W contrast IV |
|
36484-4
|
CT Hip WO contrast |
|
36359-8
|
CT Hip WO and W contrast IV |
|
36016-4
|
CT Hip - bilateral |
|
36201-2
|
CT Hip - bilateral W contrast IV |
|
36485-1
|
CT Hip - bilateral WO contrast |
|
36360-6
|
CT Hip - bilateral WO and W contrast IV |
|
36018-0
|
CT Hip - left |
|
69105-5
|
CT Hip - left Arthrogram |
|
36203-8
|
CT Hip - left W contrast IV |
|
36487-7
|
CT Hip - left WO contrast |
|
36362-2
|
CT Hip - left WO and W contrast IV |
|
36021-4
|
CT Hip - right |
|
69112-1
|
CT Hip - right Arthrogram |
|
36205-3
|
CT Hip - right W contrast IV |
|
36489-3
|
CT Hip - right WO contrast |
|
36364-8
|
CT Hip - right WO and W contrast IV |
|
58744-4
|
CT Heart |
|
86956-0
|
CT Heart WO contrast IV and CT Heart for left ventricular function W contrast IV |
|
36934-8
|
CT Heart for calcium scoring |
|
36935-5
|
CT Heart for calcium scoring W contrast IV |
|
79088-1
|
CT Heart for congenital disease W contrast IV |
|
86975-0
|
CT Heart for left ventricular function W contrast IV |
|
79089-9
|
CT Heart W contrast IV |
|
89927-8
|
CT Heart and aortic root WO contrast for calcium scoring + CTA W contrast IV |
|
83289-9
|
CT for calcium scoring WO contrast and CTA W contrast IV Heart and coronary arteries |
|
79087-3
|
CT Heart and Coronary arteries for calcium scoring WO contrast |
|
35958-8
|
CT Internal auditory canal |
|
30583-9
|
CT Internal auditory canal W contrast IV |
|
46325-7
|
CT Internal auditory canal W reduced contrast volume IV |
|
30584-7
|
CT Internal auditory canal WO contrast |
|
36282-2
|
CT Internal auditory canal WO and W contrast IV |
|
46314-1
|
CT Internal auditory canal WO and W reduced contrast volume IV |
|
35957-0
|
CT Internal auditory canal - left |
|
38767-0
|
CT Internal auditory canal - right |
|
36811-8
|
CT Joint Arthrogram |
|
43767-3
|
CT Kidney - bilateral |
|
43766-5
|
CT Kidney - bilateral W contrast IV |
|
36503-1
|
CT Kidney - bilateral WO contrast |
|
36377-0
|
CT Kidney - bilateral WO and W contrast IV |
|
79074-1
|
CT Kidney and Ureter and Urinary bladder 3D post processing WO and W contrast IV |
|
87866-0
|
CT Kidney and Ureter and Urinary bladder WO and W contrast IV |
|
46322-4
|
CT Kidney W contrast IV |
|
43770-7
|
CT Kidney WO contrast |
|
43768-1
|
CT Kidney WO and W contrast IV |
|
69113-9
|
CT Kidney - right |
|
36037-0
|
CT Knee |
|
36124-6
|
CT Knee Arthrogram |
|
36222-8
|
CT Knee W contrast IV |
|
36505-6
|
CT Knee WO contrast |
|
36379-6
|
CT Knee WO and W contrast IV |
|
36040-4
|
CT Knee - bilateral |
|
87878-5
|
CT Knee - bilateral Arthrogram |
|
69088-3
|
CT Knee - bilateral W contrast IV |
|
69089-1
|
CT Knee - bilateral WO contrast |
|
36041-2
|
CT Knee - left |
|
69106-3
|
CT Knee - left Arthrogram |
|
36225-1
|
CT Knee - left W contrast IV |
|
36507-2
|
CT Knee - left WO contrast |
|
36380-4
|
CT Knee - left WO and W contrast IV |
|
36043-8
|
CT Knee - right |
|
69114-7
|
CT Knee - right Arthrogram |
|
36227-7
|
CT Knee - right W contrast IV |
|
36509-8
|
CT Knee - right WO contrast |
|
36381-2
|
CT Knee - right WO and W contrast IV |
|
90365-8
|
Chlamydia trachomatis L1 Ab.IgG+IgA+IgM Interpretation in Serum by Immunoassay |
|
36229-3
|
CT Larynx W contrast IV |
|
36511-4
|
CT Larynx WO contrast |
|
35971-1
|
CT Lower extremity |
|
37238-3
|
CT Lower Extremity Joint Arthrogram |
|
89716-5
|
CT Lower extremity joint - left Arthrogram |
|
89715-7
|
CT Lower extremity joint - right Arthrogram |
|
36106-3
|
CT Lower extremity limited WO contrast |
|
30624-1
|
CT Lower extremity W contrast IV |
|
30625-8
|
CT Lower extremity WO contrast |
|
36288-9
|
CT Lower extremity WO and W contrast IV |
|
35973-7
|
CT Lower extremity - bilateral |
|
50755-8
|
CT Lower extremity - bilateral W contrast IV |
|
36449-7
|
CT Lower extremity - bilateral WO contrast |
|
82694-1
|
CT Lower extremity - bilateral WO and W contrast IV |
|
35976-0
|
CT Lower extremity - left |
|
36164-2
|
CT Lower extremity - left W contrast IV |
|
36452-1
|
CT Lower extremity - left WO contrast |
|
36290-5
|
CT Lower extremity - left WO and W contrast IV |
|
35979-4
|
CT Lower extremity - right |
|
36166-7
|
CT Lower extremity - right W contrast IV |
|
36454-7
|
CT Lower extremity - right WO contrast |
|
36292-1
|
CT Lower extremity - right WO and W contrast IV |
|
24814-6
|
CT Liver |
|
46393-5
|
CT Liver W Xe-133 IH |
|
24815-3
|
CT Liver W contrast IV |
|
30611-8
|
CT Liver WO contrast |
|
30612-6
|
CT Liver WO and W contrast IV |
|
36074-3
|
CT Lower leg |
|
36258-2
|
CT Lower leg W contrast IV |
|
36537-9
|
CT Lower leg WO contrast |
|
36408-3
|
CT Lower leg WO and W contrast IV |
|
87879-3
|
CT Lower leg - bilateral WO contrast |
|
87882-7
|
CT Lower leg - left |
|
36260-8
|
CT Lower leg - left W contrast IV |
|
36538-7
|
CT Lower leg - left WO contrast |
|
36409-1
|
CT Lower leg - left WO and W contrast IV |
|
36262-4
|
CT Lower leg - right W contrast IV |
|
36540-3
|
CT Lower leg - right WO contrast |
|
36411-7
|
CT Lower leg - right WO and W contrast IV |
|
37232-6
|
CT Spine lumbosacral junction |
|
37288-8
|
CT Spine lumbosacral junction WO contrast |
|
24963-1
|
CT Lumbar spine |
|
87867-8
|
CT Lumbar spine by reconstruction |
|
79080-8
|
CT Lumbar spine by reconstruction W contrast IV |
|
79081-6
|
CT Lumbar spine by reconstruction WO contrast |
|
87868-6
|
CT Lumbar spine by reconstruction WO and W contrast IV |
|
36110-5
|
CT Lumbar spine limited WO contrast |
|
37509-7
|
CT Lumbar spine W contrast intradisc |
|
24965-6
|
CT Lumbar spine W contrast IT |
|
24964-9
|
CT Lumbar spine W contrast IV |
|
30620-9
|
CT Lumbar spine WO contrast |
|
44114-7
|
CT Lumbar spine WO and W contrast IT |
|
36402-6
|
CT Lumbar spine WO and W contrast IV |
|
82696-6
|
CT Spine Lumbar and Sacrum W contrast IV |
|
82697-4
|
CT Spine Lumbar and Sacrum WO contrast |
|
89827-0
|
CT Spine Lumbar and Sacrum WO and W contrast IV |
|
25039-9
|
CT Unspecified body region limited |
|
89840-3
|
CT Lumbosacral plexus WO contrast |
|
37439-7
|
CT Lung parenchyma |
|
37440-5
|
CT Lung parenchyma W contrast IV |
|
37441-3
|
CT Lung parenchyma WO contrast |
|
87873-6
|
CT Lung parenchyma WO and W contrast IV |
|
36047-9
|
CT Mandible |
|
44116-2
|
CT Mandible limited |
|
36232-7
|
CT Mandible W contrast IV |
|
36512-2
|
CT Mandible WO contrast |
|
36383-8
|
CT Mandible WO and W contrast IV |
|
87900-7
|
CT Mastoid W contrast IV |
|
46298-6
|
CT Mastoid - bilateral |
|
36049-5
|
CT Maxilla and Mandible |
|
36050-3
|
CT Maxilla |
|
41808-7
|
CT Maxillofacial region |
|
36937-1
|
CT Maxillofacial region limited |
|
36938-9
|
CT Maxillofacial region limited WO contrast |
|
30801-5
|
CT Maxillofacial region W contrast IV |
|
46326-5
|
CT Maxillofacial region W reduced contrast volume IV |
|
30802-3
|
CT Maxillofacial region WO contrast |
|
30803-1
|
CT Maxillofacial region WO and W contrast IV |
|
46315-8
|
CT Maxillofacial region WO and W reduced contrast volume IV |
|
87906-4
|
CT Maxillofacial region - right W contrast IV |
|
87874-4
|
CT Mediastinum W contrast IV |
|
89848-6
|
CT Midfoot - right WO and W contrast IV |
|
89846-0
|
CT Midfoot - left and Forefoot - left WO and W contrast IV |
|
89847-8
|
CT Midfoot - right and Forefoot - right |
|
48446-9
|
CT Nasopharynx W contrast IV |
|
48443-6
|
CT Nasopharynx WO and W contrast IV |
|
24835-1
|
CT Nasopharynx and Neck |
|
24836-9
|
CT Nasopharynx and Neck W contrast IV |
|
30585-4
|
CT Nasopharynx and Neck WO contrast |
|
36051-1
|
CT Neck |
|
88320-7
|
CT Neck W contrast IV and CT angiogram Head and neck vessels W contrast IV |
|
36235-0
|
CT Neck W contrast IV |
|
36514-8
|
CT Neck WO contrast |
|
30586-2
|
CT Neck WO and W contrast IV |
|
86986-7
|
CT Neck and Chest W contrast IV |
|
87877-7
|
CT Neck and Chest WO contrast |
|
86958-6
|
CT Neck and Chest WO and W contrast IV |
|
89283-6
|
CT Neck+Chest+Abdomen+Pelvis W contrast IV |
|
83295-6
|
CT Neck and Superior mediastinum W contrast IV |
|
83308-7
|
CT Neck and Superior mediastinum WO contrast |
|
83301-2
|
CT Neck and Superior mediastinum WO and W contrast IV |
|
41807-9
|
CT Orbit |
|
48449-3
|
CT Orbit W contrast IV |
|
46331-5
|
CT Orbit WO contrast |
|
48451-9
|
CT Orbit WO and W contrast IV |
|
46320-8
|
CT Orbit and Face W contrast IV |
|
86988-3
|
CT Orbit and Face WO contrast |
|
24848-4
|
CT Orbit - bilateral |
|
24850-0
|
CT Orbit - bilateral W contrast IV |
|
30587-0
|
CT Orbit - bilateral WO contrast |
|
24849-2
|
CT Orbit - bilateral WO and W contrast IV |
|
79093-1
|
CT Unspecified body region 3D post processing |
|
72251-2
|
CT Pulmonary arteries for pulmonary embolus |
|
24857-5
|
CT Pancreas |
|
24858-3
|
CT Pancreas W contrast IV |
|
30613-4
|
CT Pancreas WO contrast |
|
30614-2
|
CT Pancreas WO and W contrast IV |
|
87918-9
|
CT Parathyroid gland WO and W contrast IV |
|
37223-5
|
CT Parotid gland |
|
37240-9
|
CT Parotid gland W contrast IV |
|
37280-5
|
CT Parotid gland WO contrast |
|
46311-7
|
CT Parotid gland WO and W contrast IV |
|
24865-8
|
CT Pelvis |
|
86979-2
|
CT Pelvis and Hip - bilateral WO contrast |
|
87919-7
|
CT Pelvis bones |
|
87920-5
|
CT Pelvis bones W contrast IV |
|
87917-1
|
CT Pelvis bones WO contrast |
|
87914-8
|
CT Pelvis bones WO and W contrast IV |
|
87913-0
|
CT Pelvis by reconstruction |
|
79075-8
|
CT Pelvis by reconstruction W contrast IV |
|
79076-6
|
CT Pelvis by reconstruction WO contrast |
|
36098-2
|
CT Pelvis limited W contrast IV |
|
36108-9
|
CT Pelvis limited WO contrast |
|
79099-8
|
CT Pelvis 3D post processing WO contrast |
|
39046-8
|
CT Pelvis limited for pelvimetry WO contrast |
|
24866-6
|
CT Pelvis W contrast IV |
|
46329-9
|
CT Pelvis W reduced contrast volume IV |
|
30615-9
|
CT Pelvis WO contrast |
|
30616-7
|
CT Pelvis WO and W contrast IV |
|
46313-3
|
CT Pelvis WO and W reduced contrast volume IV |
|
82693-3
|
CT Pelvis and Lower extremity W contrast IV |
|
82695-8
|
CT Pelvis and Lower extremity - bilateral W contrast IV |
|
89925-2
|
CT Pelvis and Lower extremity - bilateral WO and W contrast IV |
|
24877-3
|
CT Petrous part of temporal bone |
|
24878-1
|
CT Petrous part of temporal bone W contrast IV |
|
30589-6
|
CT Petrous part of temporal bone WO contrast |
|
36835-7
|
CT Petrous part of temporal bone WO and W contrast IV |
|
36932-2
|
CT Pituitary and Sella turcica |
|
30590-4
|
CT Pituitary and Sella turcica W contrast IV |
|
30591-2
|
CT Pituitary and Sella turcica WO contrast |
|
24904-5
|
CT Pituitary and Sella turcica WO and W contrast IV |
|
91719-5
|
CT Unspecified body region Post mortem |
|
36055-2
|
CT Posterior fossa |
|
36242-6
|
CT Posterior fossa W contrast IV |
|
36517-1
|
CT Posterior fossa WO contrast |
|
36387-9
|
CT Posterior fossa WO and W contrast IV |
|
36057-8
|
CT Prostate |
|
43445-6
|
CT Pulmonary system |
|
42394-7
|
CT Pulmonary system W Xe-133 IH |
|
24566-2
|
CT Retroperitoneum |
|
42291-5
|
CT Retroperitoneum WO contrast |
|
48743-9
|
CT Retroperitoneum WO and W contrast IV |
|
82698-2
|
CT Ribs - left W contrast IV |
|
82699-0
|
CT Ribs - left WO contrast |
|
82717-0
|
CT Ribs - left WO and W contrast IV |
|
82700-6
|
CT Ribs - right W contrast IV |
|
82701-4
|
CT Ribs - right WO contrast |
|
82702-2
|
CT Ribs - right WO and W contrast IV |
|
36058-6
|
CT Sacrum |
|
36245-9
|
CT Sacrum W contrast IV |
|
36520-5
|
CT Sacrum WO contrast |
|
36390-3
|
CT Sacrum WO and W contrast IV |
|
69116-2
|
CT Sacrum and Coccyx |
|
82704-8
|
CT Sacrum and Coccyx W contrast IV |
|
86970-1
|
CT Sacrum and Coccyx WO contrast |
|
82703-0
|
CT Sacrum and Coccyx WO and W contrast IV |
|
36941-3
|
CT Salivary gland W contrast intra salivary duct |
|
86966-9
|
CT Salivary gland WO contrast |
|
86957-8
|
CT Salivary gland WO and W contrast IV |
|
82689-1
|
CT Small bowel W contrast PO and WO and W contrast IV |
|
72250-4
|
CT Small bowel W contrast PO and W contrast IV |
|
30600-1
|
CT Small bowel W positive contrast via enteroclysis tube |
|
37225-0
|
CT Sternoclavicular Joint |
|
37242-5
|
CT Sternoclavicular Joint W contrast IV |
|
37282-1
|
CT Sternoclavicular Joint WO contrast |
|
37266-4
|
CT Sternoclavicular Joint WO and W contrast IV |
|
69117-0
|
CT Scapula |
|
83292-3
|
CT Scapula W contrast |
|
69118-8
|
CT Scapula WO contrast |
|
83300-4
|
CT Scapula - bilateral WO and W contrast IV |
|
82705-5
|
CT Scapula - left WO contrast |
|
82707-1
|
CT Scapula - left WO and W contrast IV |
|
82706-3
|
CT Scapula - right WO contrast |
|
82718-8
|
CT Scapula - right WO and W contrast IV |
|
36062-8
|
CT Shoulder |
|
36128-7
|
CT Shoulder Arthrogram |
|
36250-9
|
CT Shoulder W contrast IV |
|
36524-7
|
CT Shoulder WO contrast |
|
36395-2
|
CT Shoulder WO and W contrast IV |
|
36063-6
|
CT Shoulder - bilateral |
|
87884-3
|
CT Shoulder - bilateral Arthrogram |
|
86969-3
|
CT Shoulder - bilateral W contrast IV |
|
69090-9
|
CT Shoulder - bilateral WO contrast |
|
36064-4
|
CT Shoulder - left |
|
38828-0
|
CT Shoulder - left Arthrogram |
|
36252-5
|
CT Shoulder - left W contrast IV |
|
36526-2
|
CT Shoulder - left WO contrast |
|
36396-0
|
CT Shoulder - left WO and W contrast IV |
|
36066-9
|
CT Shoulder - right |
|
36131-1
|
CT Shoulder - right Arthrogram |
|
36253-3
|
CT Shoulder - right W contrast IV |
|
36527-0
|
CT Shoulder - right WO contrast |
|
36397-8
|
CT Shoulder - right WO and W contrast IV |
|
30619-1
|
CT Sacroiliac Joint |
|
36123-8
|
CT Sacroiliac Joint Arthrogram |
|
36217-8
|
CT Sacroiliac Joint W contrast IV |
|
36501-5
|
CT Sacroiliac Joint WO contrast |
|
36375-4
|
CT Sacroiliac Joint WO and W contrast IV |
|
37237-5
|
CT Sinus tract W contrast intra sinus tract |
|
30588-8
|
CT Sinuses |
|
24913-6
|
CT Sinuses limited |
|
46304-2
|
CT Sinuses limited WO contrast |
|
36255-8
|
CT Sinuses W contrast IV |
|
36529-6
|
CT Sinuses WO contrast |
|
36398-6
|
CT Sinuses WO and W contrast IV |
|
83309-5
|
CT Sinuses and Mandible WO contrast |
|
87912-2
|
CT Sinuses and Orbit WO contrast |
|
37495-9
|
CT Skull base |
|
44112-1
|
CT Skull base WO contrast |
|
44111-3
|
CT Skull base WO and W contrast IV |
|
28566-8
|
CT Spine |
|
39322-3
|
CT Spine W contrast intradisc |
|
47985-7
|
CT Spine W contrast IT |
|
24987-0
|
CT Spine W contrast IV |
|
36530-4
|
CT Spine WO contrast |
|
48442-8
|
CT Spine WO and W contrast IT |
|
36399-4
|
CT Spine WO and W contrast IV |
|
24988-8
|
CT Spleen |
|
30622-5
|
CT Spleen W contrast IV |
|
30621-7
|
CT Spleen WO contrast |
|
24989-6
|
CT Spleen WO and W contrast IV |
|
36071-9
|
CT Sternum |
|
36257-4
|
CT Sternum W contrast IV |
|
36534-6
|
CT Sternum WO contrast |
|
36405-9
|
CT Sternum WO and W contrast IV |
|
83294-9
|
CT Thoracic and lumbar spine W contrast IV |
|
83310-3
|
CT Thoracic and lumbar spine WO contrast |
|
86974-3
|
CT Thoracic and lumbar spine WO and W contrast IV |
|
24544-9
|
CT Thoracic Aorta |
|
35945-5
|
CT Thoracic and abdominal aorta |
|
36142-8
|
CT Thoracic and abdominal aorta W contrast IV |
|
36430-7
|
CT Thoracic and abdominal aorta WO contrast |
|
87861-1
|
CT Thoracic and abdominal aorta WO and W contrast IV |
|
24545-6
|
CT Thoracic Aorta W contrast IV |
|
87860-3
|
CT Thoracic Aorta WO contrast |
|
87859-5
|
CT Thoracic Aorta WO and W contrast IV |
|
79095-6
|
CT Teeth |
|
87896-7
|
CT Teeth W contrast IV |
|
87899-1
|
CT Teeth.mandible WO contrast |
|
87898-3
|
CT Teeth.maxilla WO contrast |
|
36773-0
|
CT Temporal bone |
|
79083-2
|
CT Temporal bone by reconstruction W contrast IV |
|
79084-0
|
CT Temporal bone by reconstruction WO contrast |
|
36815-9
|
CT Temporal bone W contrast IV |
|
36866-2
|
CT Temporal bone WO contrast |
|
36837-3
|
CT Temporal bone WO and W contrast IV |
|
87902-3
|
CT Temporal bone - bilateral W contrast IV |
|
87903-1
|
CT Temporal bone - bilateral WO contrast |
|
87901-5
|
CT Temporal bone - bilateral WO and W contrast IV |
|
38835-5
|
CT Temporal bone - left W contrast IV |
|
36867-0
|
CT Temporal bone - left WO contrast |
|
89837-9
|
CT Temporal bone - left WO and W contrast IV |
|
36816-7
|
CT Temporal bone - right W contrast IV |
|
36868-8
|
CT Temporal bone - right WO contrast |
|
89838-7
|
CT Temporal bone - right WO and W contrast IV |
|
35984-4
|
CT Thigh |
|
36172-5
|
CT Thigh W contrast IV |
|
36460-4
|
CT Thigh WO contrast |
|
36338-2
|
CT Thigh WO and W contrast IV |
|
87880-1
|
CT Thigh - bilateral W contrast IV |
|
87881-9
|
CT Thigh - bilateral WO contrast |
|
35987-7
|
CT Thigh - left |
|
36174-1
|
CT Thigh - left W contrast IV |
|
36462-0
|
CT Thigh - left WO contrast |
|
36339-0
|
CT Thigh - left WO and W contrast IV |
|
35989-3
|
CT Thigh - right |
|
36176-6
|
CT Thigh - right W contrast IV |
|
36464-6
|
CT Thigh - right WO contrast |
|
36340-8
|
CT Thigh - right WO and W contrast IV |
|
83291-5
|
CT Thumb WO contrast |
|
87889-2
|
CT Thumb - left WO contrast |
|
87894-2
|
CT Thumb - right WO contrast |
|
87876-9
|
CT Thymus gland |
|
36955-3
|
CT Thyroid gland WO contrast |
|
37226-8
|
CT Temporomandibular joint |
|
87909-8
|
CT Temporomandibular joint Arthrogram |
|
37243-3
|
CT Temporomandibular joint W contrast IV |
|
37283-9
|
CT Temporomandibular joint WO contrast |
|
37267-2
|
CT Temporomandibular joint WO and W contrast IV |
|
87904-9
|
CT Temporomandibular joint - bilateral WO contrast |
|
37246-6
|
CT Temporomandibular joint - left W contrast IV |
|
37248-2
|
CT Temporomandibular joint - right W contrast IV |
|
83303-8
|
CT Toe WO contrast |
|
87921-3
|
CT Trachea WO contrast |
|
24978-9
|
CT Thoracic spine |
|
87875-1
|
CT Thoracic spine by reconstruction |
|
79082-4
|
CT Thoracic spine by reconstruction W contrast IV |
|
79091-5
|
CT Thoracic spine by reconstruction WO contrast |
|
70931-1
|
CT Thoracic spine W contrast intradisc |
|
30596-1
|
CT Thoracic spine W contrast IT |
|
24979-7
|
CT Thoracic spine W contrast IV |
|
30597-9
|
CT Thoracic spine WO contrast |
|
44113-9
|
CT Thoracic spine WO and W contrast IT |
|
36403-4
|
CT Thoracic spine WO and W contrast IV |
|
35981-0
|
CT Upper extremity |
|
89714-0
|
CT Upper extremity joint - left Arthrogram |
|
89713-2
|
CT Upper extremity joint - right Arthrogram |
|
36097-4
|
CT Upper extremity limited W contrast IV |
|
30626-6
|
CT Upper extremity W contrast IV |
|
30627-4
|
CT Upper extremity WO contrast |
|
36334-1
|
CT Upper extremity WO and W contrast IV |
|
36168-3
|
CT Upper extremity - bilateral W contrast IV |
|
36456-2
|
CT Upper extremity - bilateral WO contrast |
|
87883-5
|
CT Upper extremity - bilateral WO and W contrast IV |
|
35982-8
|
CT Upper extremity - left |
|
36169-1
|
CT Upper extremity - left W contrast IV |
|
36457-0
|
CT Upper extremity - left WO contrast |
|
36335-8
|
CT Upper extremity - left WO and W contrast IV |
|
35983-6
|
CT Upper extremity - right |
|
36170-9
|
CT Upper extremity - right W contrast IV |
|
36458-8
|
CT Upper extremity - right WO contrast |
|
36336-6
|
CT Upper extremity - right WO and W contrast IV |
|
25045-6
|
CT Unspecified body region |
|
36023-0
|
CT Upper arm |
|
36207-9
|
CT Upper arm W contrast IV |
|
36491-9
|
CT Upper arm WO contrast |
|
36366-3
|
CT Upper arm WO and W contrast IV |
|
36026-3
|
CT Upper arm - bilateral |
|
87885-0
|
CT Upper arm - bilateral WO contrast |
|
36027-1
|
CT Upper arm - left |
|
36209-5
|
CT Upper arm - left W contrast IV |
|
36492-7
|
CT Upper arm - left WO contrast |
|
36367-1
|
CT Upper arm - left WO and W contrast IV |
|
36029-7
|
CT Upper arm - right |
|
36211-1
|
CT Upper arm - right W contrast IV |
|
36494-3
|
CT Upper arm - right WO contrast |
|
36369-7
|
CT Upper arm - right WO and W contrast IV |
|
36264-0
|
CT Uterus W contrast IV |
|
53626-8
|
CT Cerebral atrophic index |
|
46305-9
|
CT Whole body |
|
46306-7
|
CT Whole body W contrast IV |
|
88326-4
|
CT Head WO contrast and CT Brain for perfusion W contrast IV and CT angiogram Head vessels W contrast IV |
|
88315-7
|
CT Head WO contrast and CT Brain for perfusion W contrast IV and CT angiogram Head and neck vessels W contrast IV |
|
37428-0
|
CT Wrist |
|
37447-0
|
CT Wrist W contrast IV |
|
37459-5
|
CT Wrist WO contrast |
|
37457-9
|
CT Wrist WO and W contrast IV |
|
37430-6
|
CT Wrist - bilateral |
|
69091-7
|
CT Wrist - bilateral W contrast IV |
|
37461-1
|
CT Wrist - bilateral WO contrast |
|
37431-4
|
CT Wrist - left |
|
69107-1
|
CT Wrist - left Arthrogram |
|
37450-4
|
CT Wrist - left W contrast IV |
|
37463-7
|
CT Wrist - left WO contrast |
|
37458-7
|
CT Wrist - left WO and W contrast IV |
|
37433-0
|
CT Wrist - right |
|
69115-4
|
CT Wrist - right Arthrogram |
|
37452-0
|
CT Wrist - right W contrast IV |
|
37465-2
|
CT Wrist - right WO contrast |
|
38802-5
|
CT Wrist - right WO and W contrast IV |
|
89852-8
|
CT Unspecified body region limited W contrast IV |
|
89853-6
|
CT Unspecified body region limited WO contrast |
|
25046-4
|
CT Unspecified body region W anesthesia |
|
25047-2
|
CT Unspecified body region W conscious sedation |
|
24753-6
|
CT Unspecified body region W contrast IV |
|
43525-5
|
CT Unspecified body region WO contrast |
|
79090-7
|
CT densitometry Lumbar spine WO contrast |
|
79092-3
|
CT densitometry Thoracic spine WO contrast |
|
52773-9
|
Clotting time.extrinsic coagulation system activated of Blood by Rotational TEG |
|
52774-7
|
Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed of Blood by Rotational TEG |
|
52775-4
|
Clotting time.intrinsic coagulation system activated.heparin insensitive of Blood by Rotational TEG |
|
52776-2
|
Clotting time.intrinsic coagulation system activated of Blood by Rotational TEG |
|
24728-8
|
CT perfusion Head |
|
42377-2
|
CT perfusion Head W Xe-133 IH+WO and W contrast IV |
|
39142-5
|
CT perfusion Head W contrast IV |
|
24729-6
|
CT perfusion Head WO and W contrast IV |
|
78973-5
|
CT scanogram Lower extremity - bilateral for leg measurement WO contrast |
|
78037-9
|
CTA Abdominal Aorta and Bilateral Runoff Vessels W contrast IV |
|
82677-6
|
CTA Abdominal Aorta W contrast IV |
|
82678-4
|
CTA Abdominal Aorta WO and W contrast IV |
|
78031-2
|
CTA Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV |
|
77311-9
|
CTA Abdominal aorta and Bilateral vessels for endograft |
|
36828-2
|
CTA Abdominal vessels W contrast IV |
|
30805-6
|
CTA Abdominal vessels WO and W contrast IV |
|
82679-2
|
CTA Abdominal vessels and Pelvis vessels WO and W contrast IV |
|
87838-9
|
CTA Abdominal veins and Pelvis veins W contrast IV |
|
87280-4
|
CTA Abdominal veins and Pelvis veins and Lower extremity veins - bilateral W contrast IV |
|
89626-6
|
CTA Abdominal, Pelvis and Lower extremity vessels W contrast IV |
|
69908-2
|
CTA Abdominal and Pelvic vessels W contrast IV |
|
36144-4
|
CTA Aortic arch W contrast IV |
|
87837-1
|
CTA Aortic valve W contrast IV |
|
87840-5
|
CTA Coronary arteries and Pulmonary arteries W contrast IV |
|
88318-1
|
CTA Coronary arteries and Pulmonary veins W contrast IV |
|
87841-3
|
CTA Coronary arteries and Thoracic aorta W contrast IV |
|
36146-9
|
CTA Carotid artery W contrast IV |
|
83299-8
|
CT Chest and Abdomen and Pelvis WO and W contrast IV and CTA Thoracic and abdominal aorta WO and W contrast IV |
|
86981-8
|
CTA Chest vessels |
|
36266-5
|
CTA Chest vessels W contrast IV |
|
69084-2
|
CTA Chest vessels WO contrast |
|
30804-9
|
CTA Chest vessels WO and W contrast IV |
|
86982-6
|
CTA Chest and abdominal vessels W contrast IV |
|
86971-9
|
CTA Chest and abdominal vessels WO and W contrast IV |
|
86983-4
|
CTA Chest vessels and Abdominal vessels and Pelvis vessels W contrast IV |
|
83298-0
|
CTA Chest vessels and Abdominal vessels and Pelvis vessels WO and W contrast IV |
|
87856-1
|
CTA Circle of Willis and Carotid arteries W contrast IV |
|
87855-3
|
CTA Circle of Willis and Carotid arteries WO and W contrast IV |
|
75671-8
|
CTA Circle of Willis WO and W contrast IV |
|
87842-1
|
CTA Coronary arteries and Pulmonary arteries and Thoracic aorta W contrast IV |
|
87858-7
|
CTA Deep inferior epigastric artery W contrast IV |
|
87850-4
|
CTA Deep inferior epigastric artery WO and W contrast IV |
|
36814-2
|
CTA Head Arteries W contrast IV |
|
36830-8
|
CTA Head vessels W contrast IV |
|
42293-1
|
CTA Head vessels WO contrast |
|
30593-8
|
CTA Head vessels WO and W contrast IV |
|
37498-3
|
CTA Head vessels and Neck vessels W contrast IV |
|
82680-0
|
CTA Head vessels and Neck vessels WO and W contrast IV |
|
36809-2
|
CTA Hepatic artery W contrast IA |
|
87836-3
|
CTA Hepatic vessels WO and W contrast IV |
|
79073-3
|
CTA Heart and Coronary arteries W contrast IV |
|
86980-0
|
CTA Heart and Coronary arteries WO and W contrast IV |
|
87845-4
|
CTA Lower extremity vessels |
|
36831-6
|
CTA Lower extremity vessels W contrast IV |
|
30807-2
|
CTA Lower extremity vessels WO and W contrast IV |
|
82711-3
|
CTA Lower extremity vessels - bilateral |
|
86965-1
|
CTA Lower extremity vessels - bilateral W contrast IV |
|
82708-9
|
CTA Lower extremity vessels - bilateral WO and W contrast IV |
|
82712-1
|
CTA Lower extremity vessels - left |
|
86964-4
|
CTA Lower extremity vessels - left W contrast IV |
|
46308-3
|
CTA Lower extremity vessels - left WO and W contrast IV |
|
82710-5
|
CTA Lower extremity vessels - right |
|
86963-6
|
CTA Lower extremity vessels - right W contrast IV |
|
46307-5
|
CTA Lower extremity vessels - right WO and W contrast IV |
|
87281-2
|
CTA Lower extremity veins - bilateral W contrast IV |
|
36824-1
|
CTA Lower extremity veins - left W contrast IV |
|
36825-8
|
CTA Lower extremity veins - right W contrast IV |
|
87851-2
|
CTA Mesenteric vessels W contrast IV |
|
87852-0
|
CTA Mesenteric vessels WO and W contrast IV |
|
36234-3
|
CTA Neck vessels W contrast IV |
|
30594-6
|
CTA Neck vessels WO and W contrast IV |
|
79077-4
|
CTA Pulmonary arteries for pulmonary embolus W contrast IV |
|
36147-7
|
CTA Pulmonary arteries W contrast IV |
|
87849-6
|
CTA Pulmonary arteries - bilateral and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis |
|
87848-8
|
CTA Pulmonary arteries - bilateral and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis W contrast IV |
|
83290-7
|
CTA Pulmonary arteries - bilateral and Pelvis veins and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis W contrast IV |
|
42294-9
|
CTA Pelvis vessels W contrast IV |
|
30623-3
|
CTA Pelvis vessels WO and W contrast IV |
|
87844-7
|
CTA Pelvis veins |
|
87843-9
|
CTA Pelvis veins and Lower extremity veins - bilateral |
|
87839-7
|
CTA Pulmonary veins W contrast IV |
|
36833-2
|
CTA Renal vessels W contrast IV |
|
87846-2
|
CTA Renal vessels WO and W contrast IV |
|
77451-3
|
CTA Thoracic and Abdominal Aorta and Bilateral Vessels for endograft |
|
78038-7
|
CTA Thoracic and Abdominal Aorta and Bilateral Runoff Vessels W contrast IV |
|
78032-0
|
CTA Thoracic and Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV |
|
82709-7
|
CTA Thoracic Aorta |
|
36141-0
|
CTA Thoracic and abdominal aorta W contrast IV |
|
87857-9
|
CTA Thoracic and abdominal aorta WO and W contrast IV |
|
69119-6
|
CTA Thoracic Aorta WO contrast |
|
42295-6
|
CTA Upper extremity vessels W contrast IV |
|
36421-6
|
CTA Upper extremity vessels WO and W contrast IV |
|
86962-8
|
CTA Upper extremity vessels - bilateral W contrast IV |
|
89841-1
|
CTA Upper extremity vessels - bilateral WO and W contrast IV |
|
82713-9
|
CTA Upper extremity vessels - left |
|
86961-0
|
CTA Upper extremity vessels - left W contrast IV |
|
46312-5
|
CTA Upper extremity vessels - left WO and W contrast IV |
|
82714-7
|
CTA Upper extremity vessels - right |
|
86960-2
|
CTA Upper extremity vessels - right W contrast IV |
|
46309-1
|
CTA Upper extremity vessels - right WO and W contrast IV |
|
89722-3
|
CTA Upper extremity veins - left W contrast IV |
|
89723-1
|
CTA Upper extremity veins - right W contrast IV |
|
36834-0
|
CTA Vessel W contrast IV |
|
89851-0
|
CTA Unspecified body region limited |
|
67568-6
|
Circulating tumor cells.breast [#/volume] in Blood |
|
68124-7
|
Circulating tumor cells.colon [#/volume] in Blood |
|
68123-9
|
Circulating tumor cells.prostate [#/volume] in Blood |
|
26653-6
|
Colorado tick fever virus Ab [Presence] in Serum |
|
42614-8
|
Colorado tick fever virus Ab [Titer] in Cerebral spinal fluid |
|
34623-9
|
Colorado tick fever virus Ab [Titer] in Serum |
|
53368-7
|
Colorado tick fever virus Ab [Presence] in Unspecified specimen |
|
50035-5
|
Colorado tick fever virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
43051-2
|
Colorado tick fever virus IgG Ab [Presence] in Serum |
|
42895-3
|
Colorado tick fever virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
13292-8
|
Colorado tick fever virus IgG Ab [Units/volume] in Serum |
|
16121-6
|
Colorado tick fever virus IgG Ab [Titer] in Serum |
|
61200-2
|
Colorado tick fever virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
57773-4
|
Colorado tick fever virus IgG and IgM [Interpretation] in Serum Narrative |
|
13293-6
|
Colorado tick fever virus IgM Ab [Units/volume] in Serum |
|
16122-4
|
Colorado tick fever virus IgM Ab [Titer] in Serum |
|
42896-1
|
Colorado tick fever virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
21659-8
|
CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21660-6
|
CTNNB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
81815-3
|
CTNS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
31337-9
|
Cytotoxic percent reactive Ab [Presence] in Serum |
|
4535-1
|
Cytotoxic percent reactive Ab [Presence] in Serum by Quick method |
|
78987-5
|
Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay |
|
81836-9
|
CTSK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7269-4
|
Cucumber triggered histamine release [Units/volume] in Blood |
|
6724-9
|
Cucumber IgE Ab [Units/volume] in Serum |
|
15667-9
|
Cucumber IgE Ab RAST class [Presence] in Serum |
|
61329-9
|
Cucumber IgE Ab/IgE total in Serum |
|
7268-6
|
Cucumber IgG Ab [Units/volume] in Serum |
|
21234-0
|
Cucumber IgG Ab RAST class [Presence] in Serum |
|
56238-9
|
Cucumber IgG4 Ab [Mass/volume] in Serum |
|
60371-2
|
Cucumber IgG Ab [Mass/volume] in Serum |
|
46755-5
|
Carnitine uptake defect/CPT1 deficiency newborn screen interpretation |
|
54909-7
|
Culex mosquito IgE Ab [Units/volume] in Serum |
|
20430-5
|
Culture medium [Type] in Isolate |
|
7248-8
|
Cultivated Corn IgE Ab [Units/volume] in Serum |
|
15654-7
|
Cultivated Corn IgE Ab RAST class [Presence] in Serum |
|
6088-9
|
Cultivated Cotton IgE Ab [Units/volume] in Serum |
|
15655-4
|
Cultivated Cotton IgE Ab RAST class [Presence] in Serum |
|
6236-4
|
Cultivated Rye IgE Ab [Units/volume] in Serum |
|
15997-0
|
Cultivated Rye IgE Ab RAST class [Presence] in Serum |
|
58025-8
|
Cultivated Rye IgE Ab/IgE total in Serum |
|
56381-7
|
Cultivated Rye IgG4 Ab [Mass/volume] in Serum |
|
63154-9
|
Cultivated Rye IgG Ab [Mass/volume] in Serum |
|
48258-8
|
Cultivated Rye triggered leukotriene release [Mass/volume] by Leukocytes |
|
6277-8
|
Cultivated Wheat IgE Ab [Units/volume] in Serum |
|
16086-1
|
Cultivated Wheat IgE Ab RAST class [Presence] in Serum |
|
56418-7
|
Cultivated Wheat IgG4 Ab [Mass/volume] in Serum |
|
63155-6
|
Cultivated Wheat IgG Ab [Mass/volume] in Serum |
|
38581-5
|
Cumene [Mass/volume] in Air |
|
16694-2
|
Cumene [Presence] in Blood |
|
12430-5
|
Cumene [Mass/volume] in Serum or Plasma |
|
30507-8
|
Cumene [Mass/volume] in Urine |
|
16101-8
|
Cumin IgE Ab [Units/volume] in Serum |
|
21235-7
|
Cumin IgE Ab RAST class [Presence] in Serum |
|
56454-2
|
Cumin IgG4 Ab [Mass/volume] in Serum |
|
63123-4
|
Cumin IgG Ab [Mass/volume] in Serum |
|
91007-5
|
Cumulative cases [#] |
|
71484-0
|
Cup-disc ratio Left optic nerve by Ophthalmoscopy |
|
71485-7
|
Cup-disc ratio Right optic nerve by Ophthalmoscopy |
|
76450-6
|
Current severity of limitation |
|
92662-6
|
Current age or age at death of Family member |
|
92417-5
|
Current level of confidence Friends and family will come to see me when I am sick [PROMIS] |
|
92445-6
|
Current level of confidence I can actively participate in decisions about my treatment [PROMIS] |
|
92416-7
|
Current level of confidence I can ask for help when I don't understand something [PROMIS] |
|
92415-9
|
Current level of confidence I can attend social events without being embarrassed [PROMIS] |
|
92355-7
|
Current level of confidence I can avoid becoming angry [PROMIS] |
|
92354-0
|
Current level of confidence I can avoid feeling discouraged [PROMIS] |
|
92353-2
|
Current level of confidence I can avoid feeling helpless [PROMIS] |
|
92352-4
|
Current level of confidence I can avoid upsetting thoughts [PROMIS] |
|
92477-9
|
Current level of confidence I can be physically active, despite my symptoms [PROMIS] |
|
92351-6
|
Current level of confidence I can bounce back from disappointment [PROMIS] |
|
92390-4
|
Current level of confidence I can climb one flight of stairs (with or without rails) [PROMIS] |
|
92414-2
|
Current level of confidence I can communicate well with my doctors and nurses [PROMIS] |
|
92389-6
|
Current level of confidence I can concentrate on something difficult [PROMIS] |
|
92444-9
|
Current level of confidence I can continue my treatment when I am not feeling well [PROMIS] |
|
92443-1
|
Current level of confidence I can continue my treatment when traveling [PROMIS] |
|
92476-1
|
Current level of confidence I can control my symptoms by taking my medications [PROMIS] |
|
92475-3
|
Current level of confidence I can control my symptoms by using methods other than taking medication (for example: relaxation exercises, distraction) [PROMIS] |
|
92474-6
|
Current level of confidence I can do something to prevent my symptoms from worsening [PROMIS] |
|
92473-8
|
Current level of confidence I can do something to reduce my symptoms when they worsen [PROMIS] |
|
92388-8
|
Current level of confidence I can dress myself in the way I want to be dressed (including buttoning clothes and putting on shoes) [PROMIS] |
|
92387-0
|
Current level of confidence I can drive a car [PROMIS] |
|
92386-2
|
Current level of confidence I can eat without help from anyone [PROMIS] |
|
92385-4
|
Current level of confidence I can engage in hobbies or recreational activities [PROMIS] |
|
92472-0
|
Current level of confidence I can enjoy things, despite my symptoms [PROMIS] |
|
92384-7
|
Current level of confidence I can exercise at a moderate level for 10 minutes (for example: walking briskly, biking, swimming, aerobics) [PROMIS] |
|
92383-9
|
Current level of confidence I can exercise at a vigorous level for 10 minutes (for example: running, jogging) [PROMIS] |
|
92442-3
|
Current level of confidence I can figure out what treatment I need when my symptoms change [PROMIS] |
|
92441-5
|
Current level of confidence I can find information to learn more about my treatment [PROMIS] |
|
92382-1
|
Current level of confidence I can find new ways to manage daily activities when the old way doesn't work [PROMIS] |
|
92471-2
|
Current level of confidence I can find the information I need to manage my symptoms [PROMIS] |
|
92350-8
|
Current level of confidence I can find ways to manage stress [PROMIS] |
|
92440-7
|
Current level of confidence I can fit my medication schedule into my daily routine [PROMIS] |
|
92349-0
|
Current level of confidence I can focus on something else to decrease anxiety [PROMIS] |
|
92439-9
|
Current level of confidence I can follow a full treatment plan (including medication, diet, physical activity) [PROMIS] |
|
92438-1
|
Current level of confidence I can follow directions when my doctor changes my medications [PROMIS] |
|
92381-3
|
Current level of confidence I can get around in an unfamiliar environment [PROMIS] |
|
92413-4
|
Current level of confidence I can get emotional support when I need it [PROMIS] |
|
92437-3
|
Current level of confidence I can get help when I am not sure how to take my medicine [PROMIS] |
|
92380-5
|
Current level of confidence I can get in and out of a chair [PROMIS] |
|
92379-7
|
Current level of confidence I can get in and out of bed without falling [PROMIS] |
|
92378-9
|
Current level of confidence I can get to the bathroom in time [PROMIS] |
|
92377-1
|
Current level of confidence I can go outside in challenging weather for me [PROMIS] |
|
92376-3
|
Current level of confidence I can go shopping and run errands [PROMIS] |
|
92348-2
|
Current level of confidence I can handle negative feelings [PROMIS] |
|
92347-4
|
Current level of confidence I can handle the stress of going for treatment of my medical conditions [PROMIS] |
|
92346-6
|
Current level of confidence I can handle upsetting situations [PROMIS] |
|
92345-8
|
Current level of confidence I can hear about symptoms and side effects without getting discouraged [PROMIS] |
|
92344-1
|
Current level of confidence I can keep anxiety from becoming overwhelming [PROMIS] |
|
92375-5
|
Current level of confidence I can keep doing my usual activities at work [PROMIS] |
|
92343-3
|
Current level of confidence I can keep emotional distress from interfering with things I want to do [PROMIS] |
|
92412-6
|
Current level of confidence I can keep in touch with friends and family [PROMIS] |
|
92470-4
|
Current level of confidence I can keep my symptoms from interfering with my personal care [PROMIS] |
|
92469-6
|
Current level of confidence I can keep my symptoms from interfering with my recreational activities [PROMIS] |
|
92468-8
|
Current level of confidence I can keep my symptoms from interfering with my sleep [PROMIS] |
|
92467-0
|
Current level of confidence I can keep my symptoms from interfering with relationships with friends and family [PROMIS] |
|
92466-2
|
Current level of confidence I can keep my symptoms from interfering with the work I need to do [PROMIS] |
|
92374-8
|
Current level of confidence I can lift and carry groceries [PROMIS] |
|
92436-5
|
Current level of confidence I can list my medications, including the doses and schedule [PROMIS] |
|
92465-4
|
Current level of confidence I can live a normal life, despite my symptoms [PROMIS] |
|
92373-0
|
Current level of confidence I can maintain a regular exercise program [PROMIS] |
|
92372-2
|
Current level of confidence I can maintain my finances (for example: write checks, pay bills) [PROMIS] |
|
92464-7
|
Current level of confidence I can maintain my sense of humor, despite my symptoms [PROMIS] |
|
92411-8
|
Current level of confidence I can maintain my usual social activities [PROMIS] |
|
92463-9
|
Current level of confidence I can make a moderate reduction in my symptoms [PROMIS] |
|
92342-5
|
Current level of confidence I can manage anxiety about injuring myself or others (for example: falling, dropping a child, a driving accident) [PROMIS] |
|
92341-7
|
Current level of confidence I can manage my anger when others don't understand what I am going through [PROMIS] |
|
92340-9
|
Current level of confidence I can manage my anger when others make insensitive comments about my health problems [PROMIS] |
|
92339-1
|
Current level of confidence I can manage my anxiety about telling others I have health problems [PROMIS] |
|
92371-4
|
Current level of confidence I can manage my clothes when I need to use the toilet [PROMIS] |
|
92338-3
|
Current level of confidence I can manage my frustration [PROMIS] |
|
92435-7
|
Current level of confidence I can manage my medication without help [PROMIS] |
|
92462-1
|
Current level of confidence I can manage my symptoms as well as other people with symptoms like mine [PROMIS] |
|
92461-3
|
Current level of confidence I can manage my symptoms during my daily activities [PROMIS] |
|
92460-5
|
Current level of confidence I can manage my symptoms in a public place [PROMIS] |
|
92459-7
|
Current level of confidence I can manage my symptoms when I am at home [PROMIS] |
|
92458-9
|
Current level of confidence I can manage my symptoms when I am in an unfamiliar place [PROMIS] |
|
92457-1
|
Current level of confidence I can manage my symptoms when I am tired [PROMIS] |
|
92337-5
|
Current level of confidence I can manage the loss of my ability to do things that are important to me (for example: parenting, work, hobbies, attend school) [PROMIS] |
|
92456-3
|
Current level of confidence I can manage unexpected or new symptoms [PROMIS] |
|
92370-6
|
Current level of confidence I can perform my daily activities even if someone is rushing me [PROMIS] |
|
92369-8
|
Current level of confidence I can perform my household chores [PROMIS] |
|
92368-0
|
Current level of confidence I can prepare my own meals (for example: plan and cook full meals by myself) [PROMIS] |
|
92336-7
|
Current level of confidence I can prevent my illness from making me feel discouraged [PROMIS] |
|
92367-2
|
Current level of confidence I can recognize risks (for example: handling hot liquids, walking on uneven ground) and take steps to prevent accidents [PROMIS] |
|
92455-5
|
Current level of confidence I can recognize when my symptoms change [PROMIS] |
|
92454-8
|
Current level of confidence I can reduce my symptoms to my satisfaction [PROMIS] |
|
92410-0
|
Current level of confidence I can refuse help when I don't need it [PROMIS] |
|
92335-9
|
Current level of confidence I can relax my body to reduce my anxiety [PROMIS] |
|
92453-0
|
Current level of confidence I can rely on my judgment to manage my symptoms, even when others disagree with me [PROMIS] |
|
92434-0
|
Current level of confidence I can remember to refill my prescriptions before they run out [PROMIS] |
|
92433-2
|
Current level of confidence I can remember to take my medication as prescribed [PROMIS] |
|
92432-4
|
Current level of confidence I can remember to take my medications when there is no one to remind me [PROMIS] |
|
92366-4
|
Current level of confidence I can stand for 5 minutes (for example: waiting in a line, waiting for a bus) [PROMIS] |
|
92409-2
|
Current level of confidence I can stay involved in community or religious activities [PROMIS] |
|
92334-2
|
Current level of confidence I can stay positive when I feel like I am the only one going through this [PROMIS] |
|
92452-2
|
Current level of confidence I can still accomplish most of my goals in life, despite my symptoms [PROMIS] |
|
92365-6
|
Current level of confidence I can take a bath or shower [PROMIS] |
|
92364-9
|
Current level of confidence I can take care of my personal hygiene without help from anyone (for example: brush my teeth, comb my hair, shave, apply makeup) [PROMIS] |
|
92363-1
|
Current level of confidence I can take care of others (for example: cook for others, help them dress, watch children) [PROMIS] |
|
92431-6
|
Current level of confidence I can take my medication when I am working or away from home [PROMIS] |
|
92430-8
|
Current level of confidence I can take my medication when there is a change in my usual day (unexpected things happen) [PROMIS] |
|
92362-3
|
Current level of confidence I can take my medications in the right doses and at the right times [PROMIS] |
|
92429-0
|
Current level of confidence I can take my medicine even if it causes mild side effects [PROMIS] |
|
92428-2
|
Current level of confidence I can take several medications on different schedules [PROMIS] |
|
92408-4
|
Current level of confidence I can talk about my health problems with someone [PROMIS] |
|
92407-6
|
Current level of confidence I can talk to others about my condition without being embarrassed [PROMIS] |
|
92406-8
|
Current level of confidence I can tell others about my health problems [PROMIS] |
|
92361-5
|
Current level of confidence I can travel to a new destination alone [PROMIS] |
|
92427-4
|
Current level of confidence I can travel to my local pharmacy to fill my prescriptions [PROMIS] |
|
92360-7
|
Current level of confidence I can use a computer (for example: use keyboard, see screen, login) [PROMIS] |
|
92333-4
|
Current level of confidence I can use a strategy (for example: humor, leaving a situation) to keep from getting upset [PROMIS] |
|
92359-9
|
Current level of confidence I can use a telephone to schedule an appointment [PROMIS] |
|
92426-6
|
Current level of confidence I can use my own judgment regarding treatment alternatives (including not having treatment) [PROMIS] |
|
92358-1
|
Current level of confidence I can use public transportation [PROMIS] |
|
92332-6
|
Current level of confidence I can use relaxation to deal with worries [PROMIS] |
|
92425-8
|
Current level of confidence I can use technology to help me manage my medication and treatments (for example: to get information, avoid side-effects, schedule reminders) [PROMIS] |
|
92357-3
|
Current level of confidence I can walk a block (about 300 feet or 100 meters) on flat ground [PROMIS] |
|
92356-5
|
Current level of confidence I can walk around inside my house [PROMIS] |
|
92424-1
|
Current level of confidence I can work with my doctor to choose the treatment that seems right for me [PROMIS] |
|
92451-4
|
Current level of confidence I can work with my doctor to manage my symptoms [PROMIS] |
|
92405-0
|
Current level of confidence I have someone to help me plan and make decisions related to my illness [PROMIS] |
|
92404-3
|
Current level of confidence I have someone who helps me understand medical information [PROMIS] |
|
92403-5
|
Current level of confidence I have someone who will go out and do things with me [PROMIS] |
|
92423-3
|
Current level of confidence I know what to do if I forget to take my medication(s) [PROMIS] |
|
92422-5
|
Current level of confidence I know what to do when my medication refill looks different than usual [PROMIS] |
|
92450-6
|
Current level of confidence I know what to do when my symptoms worsen [PROMIS] |
|
92421-7
|
Current level of confidence I know when and how to take my medications [PROMIS] |
|
92402-7
|
Current level of confidence I know when to stop talking about my condition [PROMIS] |
|
92420-9
|
Current level of confidence I understand the difference between my symptoms and medication side effects [PROMIS] |
|
92401-9
|
Current level of confidence If I need help, I can find someone to take me to the doctor's office [PROMIS] |
|
92400-1
|
Current level of confidence If I need help, I have someone to help me manage my daily activities [PROMIS] |
|
92399-5
|
Current level of confidence If I need help, I have someone to help with my financial affairs [PROMIS] |
|
92398-7
|
Current level of confidence My doctors and nurses listen to my needs [PROMIS] |
|
92397-9
|
Current level of confidence People are accepting of my condition [PROMIS] |
|
92396-1
|
Current level of confidence People are concerned about my health [PROMIS] |
|
92395-3
|
Current level of confidence People understand when I need help and when I don't need help [PROMIS] |
|
92331-8
|
Current level of confidence when I'm feeling down, I can find ways to make myself feel better [PROMIS] |
|
57199-2
|
Current payment sources for home care [CMS Assessment] |
|
91603-1
|
Summary of current situation related to public health emergency Narrative |
|
64234-8
|
Current smoker |
|
54769-5
|
Current toileting program or trial [CMS Assessment] |
|
7270-2
|
Curry IgE Ab [Units/volume] in Serum |
|
15668-7
|
Curry IgE Ab RAST class [Presence] in Serum |
|
41849-1
|
Curry IgG Ab [Units/volume] in Serum |
|
56239-7
|
Curry IgG4 Ab [Mass/volume] in Serum |
|
63129-1
|
Curry IgG Ab [Mass/volume] in Serum |
|
7271-0
|
Curvularia sp IgE Ab [Units/volume] in Serum |
|
85177-4
|
Custodial care facility Administrative note |
|
85173-3
|
Custodial care facility Admission evaluation note |
|
85174-1
|
Custodial care facility Consult note |
|
85175-8
|
Custodial care facility Counseling note |
|
85176-6
|
Custodial care facility Discharge summary |
|
85171-7
|
Custodial care facility Education note |
|
85178-2
|
Custodial care facility Group counseling note |
|
85179-0
|
Custodial care facility History and physical note |
|
75429-1
|
Custodial care facility Note |
|
85182-4
|
Custodial care facility Plan of care note |
|
85180-8
|
Custodial care facility Risk assessment and screening note |
|
85181-6
|
Custodial care facility Transfer summary note |
|
82945-7
|
Cutting food and handling utensils (patients with gastrostomy) [ALSFRS-R] |
|
82944-0
|
Cutting food and handling utensils (patients without gastrostomy) [ALSFRS-R] |
|
13232-4
|
Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid |
|
16679-3
|
Coxsackievirus A Ab [Units/volume] in Serum |
|
40762-7
|
Coxsackievirus A Ab [Titer] in Serum --1st specimen |
|
40760-1
|
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40761-9
|
Coxsackievirus A Ab [Titer] in Serum --2nd specimen |
|
40758-5
|
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid |
|
63434-5
|
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
51978-5
|
Coxsackievirus A Ab [Titer] in Serum |
|
86516-2
|
Coxsackievirus A Ab [Titer] in Serum by Complement fixation |
|
16680-1
|
Coxsackievirus A IgG Ab [Units/volume] in Serum |
|
16681-9
|
Coxsackievirus A IgM Ab [Units/volume] in Serum |
|
40759-3
|
Coxsackievirus A IgM Ab [Titer] in Serum --1st specimen |
|
13297-7
|
Coxsackievirus A1 Ab [Units/volume] in Serum |
|
13295-1
|
Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid |
|
31317-1
|
Coxsackievirus A10 Ab [Units/volume] in Body fluid |
|
30214-1
|
Coxsackievirus A10 Ab [Presence] in Serum |
|
11590-7
|
Coxsackievirus A10 Ab [Units/volume] in Serum |
|
24300-6
|
Coxsackievirus A10 Ab [Titer] in Serum --1st specimen |
|
24226-3
|
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24301-4
|
Coxsackievirus A10 Ab [Titer] in Serum --2nd specimen |
|
24227-1
|
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22212-5
|
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid |
|
9751-9
|
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43049-6
|
Coxsackievirus A10 Ab [Titer] in Body fluid |
|
31051-6
|
Coxsackievirus A10 Ab [Titer] in Body fluid by Complement fixation |
|
22213-3
|
Coxsackievirus A10 Ab [Titer] in Serum |
|
9750-1
|
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation |
|
13235-7
|
Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid |
|
31318-9
|
Coxsackievirus A16 Ab [Units/volume] in Body fluid |
|
30215-8
|
Coxsackievirus A16 Ab [Presence] in Serum |
|
7833-7
|
Coxsackievirus A16 Ab [Units/volume] in Serum |
|
24302-2
|
Coxsackievirus A16 Ab [Titer] in Serum --1st specimen |
|
24228-9
|
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24303-0
|
Coxsackievirus A16 Ab [Titer] in Serum --2nd specimen |
|
24229-7
|
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22214-1
|
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid |
|
9752-7
|
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43046-2
|
Coxsackievirus A16 Ab [Titer] in Body fluid |
|
31052-4
|
Coxsackievirus A16 Ab [Titer] in Body fluid by Complement fixation |
|
22215-8
|
Coxsackievirus A16 Ab [Titer] in Serum |
|
6688-6
|
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation |
|
59583-5
|
Coxsackievirus A16 IgG Ab [Titer] in Serum by Immunofluorescence |
|
59580-1
|
Coxsackievirus A16 IgM Ab [Titer] in Serum by Immunofluorescence |
|
13233-2
|
Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid |
|
30216-6
|
Coxsackievirus A2 Ab [Presence] in Serum |
|
11591-5
|
Coxsackievirus A2 Ab [Units/volume] in Serum |
|
16682-7
|
Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid |
|
22216-6
|
Coxsackievirus A2 Ab [Titer] in Serum |
|
9753-5
|
Coxsackievirus A2 Ab [Titer] in Serum by Complement fixation |
|
11599-8
|
Coxsackievirus A21 Ab [Units/volume] in Serum |
|
22217-4
|
Coxsackievirus A21 Ab [Titer] in Serum |
|
6956-7
|
Coxsackievirus A21 Ab [Titer] in Serum by Complement fixation |
|
59582-7
|
Coxsackievirus A24 IgG Ab [Titer] in Serum by Immunofluorescence |
|
59579-3
|
Coxsackievirus A24 IgM Ab [Titer] in Serum by Immunofluorescence |
|
42623-9
|
Coxsackievirus A3 Ab [Titer] in Serum |
|
13234-0
|
Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid |
|
30217-4
|
Coxsackievirus A4 Ab [Presence] in Serum |
|
11593-1
|
Coxsackievirus A4 Ab [Units/volume] in Serum |
|
16683-5
|
Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid |
|
22218-2
|
Coxsackievirus A4 Ab [Titer] in Serum |
|
9754-3
|
Coxsackievirus A4 Ab [Titer] in Serum by Complement fixation |
|
35413-4
|
Coxsackievirus A4+A16 Ab [Titer] in Serum |
|
42603-1
|
Coxsackievirus A6 Ab [Titer] in Serum |
|
31319-7
|
Coxsackievirus A7 Ab [Units/volume] in Cerebral spinal fluid |
|
31320-5
|
Coxsackievirus A7 Ab [Units/volume] in Body fluid |
|
30218-2
|
Coxsackievirus A7 Ab [Presence] in Serum |
|
7834-5
|
Coxsackievirus A7 Ab [Units/volume] in Serum |
|
24304-8
|
Coxsackievirus A7 Ab [Titer] in Serum --1st specimen |
|
24230-5
|
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24305-5
|
Coxsackievirus A7 Ab [Titer] in Serum --2nd specimen |
|
24231-3
|
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22219-0
|
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid |
|
9756-8
|
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43047-0
|
Coxsackievirus A7 Ab [Titer] in Body fluid |
|
31049-0
|
Coxsackievirus A7 Ab [Titer] in Body fluid by Complement fixation |
|
22220-8
|
Coxsackievirus A7 Ab [Titer] in Serum |
|
9755-0
|
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation |
|
5101-1
|
Coxsackievirus A7 Ab [Titer] in Serum by Neutralization test |
|
59584-3
|
Coxsackievirus A7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
59581-9
|
Coxsackievirus A7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
27947-1
|
Coxsackievirus A7 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
33392-2
|
Coxsackievirus A8 Ab [Presence] in Serum |
|
33391-4
|
Coxsackievirus A8 Ab [Units/volume] in Serum |
|
31321-3
|
Coxsackievirus A9 Ab [Units/volume] in Cerebral spinal fluid |
|
31322-1
|
Coxsackievirus A9 Ab [Units/volume] in Body fluid |
|
30219-0
|
Coxsackievirus A9 Ab [Presence] in Serum |
|
7835-2
|
Coxsackievirus A9 Ab [Units/volume] in Serum |
|
24306-3
|
Coxsackievirus A9 Ab [Titer] in Serum --1st specimen |
|
24232-1
|
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24307-1
|
Coxsackievirus A9 Ab [Titer] in Serum --2nd specimen |
|
24233-9
|
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22221-6
|
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid |
|
9758-4
|
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43048-8
|
Coxsackievirus A9 Ab [Titer] in Body fluid |
|
31050-8
|
Coxsackievirus A9 Ab [Titer] in Body fluid by Complement fixation |
|
22222-4
|
Coxsackievirus A9 Ab [Titer] in Serum |
|
9757-6
|
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation |
|
5102-9
|
Coxsackievirus A9 Ab [Titer] in Serum by Neutralization test |
|
56621-6
|
Coxsackievirus A9 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
58792-3
|
Coxsackievirus A9 IgG Ab [Titer] in Serum by Immunofluorescence |
|
58791-5
|
Coxsackievirus A9 IgM Ab [Titer] in Serum by Immunofluorescence |
|
27969-5
|
Coxsackievirus A9 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
51453-9
|
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum |
|
50691-5
|
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum by Complement fixation |
|
30132-5
|
Coxsackievirus Ab [Presence] in Serum --1st specimen |
|
30133-3
|
Coxsackievirus Ab [Presence] in Serum --2nd specimen |
|
80285-0
|
Cardiovascular physiologic assessment [Interpretation] |
|
16684-3
|
Coxsackievirus B Ab [Units/volume] in Serum |
|
40765-0
|
Coxsackievirus B Ab [Titer] in Cerebral spinal fluid |
|
34437-4
|
Coxsackievirus B Ab [Titer] in Serum |
|
20996-5
|
Coxsackievirus B1+B2+B3+B4+B5+B6 Ab [Interpretation] in Serum |
|
51817-5
|
Coxsackievirus B IgG Ab [Units/volume] in Serum by Immunoassay |
|
16685-0
|
Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test |
|
22223-2
|
Coxsackievirus B IgG Ab [Units/volume] in Serum |
|
40767-6
|
Coxsackievirus B IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40764-3
|
Coxsackievirus B IgG Ab [Titer] in Serum --2nd specimen |
|
58780-8
|
Coxsackievirus B IgG Ab [Titer] in Serum |
|
51818-3
|
Coxsackievirus B IgM Ab [Units/volume] in Serum by Immunoassay |
|
16686-8
|
Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test |
|
22224-0
|
Coxsackievirus B IgM Ab [Units/volume] in Serum |
|
40766-8
|
Coxsackievirus B IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
|
40763-5
|
Coxsackievirus B IgM Ab [Titer] in Serum --1st specimen |
|
58790-7
|
Coxsackievirus B IgM Ab [Titer] in Serum by Immunofluorescence |
|
27908-3
|
Coxsackievirus B1 Ab [Presence] in Cerebral spinal fluid |
|
31323-9
|
Coxsackievirus B1 Ab [Units/volume] in Cerebral spinal fluid |
|
45292-0
|
Coxsackievirus B1 Ab [Presence] in Body fluid |
|
31324-7
|
Coxsackievirus B1 Ab [Units/volume] in Body fluid |
|
30220-8
|
Coxsackievirus B1 Ab [Presence] in Serum |
|
7836-0
|
Coxsackievirus B1 Ab [Units/volume] in Serum |
|
24251-1
|
Coxsackievirus B1 Ab [Titer] in Serum --1st specimen |
|
24177-8
|
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24179-4
|
Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24252-9
|
Coxsackievirus B1 Ab [Titer] in Serum --2nd specimen |
|
24178-6
|
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24180-2
|
Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22225-7
|
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid |
|
9759-2
|
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29230-0
|
Coxsackievirus B1 Ab [Titer] in Body fluid |
|
31053-2
|
Coxsackievirus B1 Ab [Titer] in Body fluid by Complement fixation |
|
22226-5
|
Coxsackievirus B1 Ab [Titer] in Serum |
|
5104-5
|
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation |
|
5103-7
|
Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test |
|
27903-4
|
Coxsackievirus B2 Ab [Presence] in Cerebral spinal fluid |
|
31325-4
|
Coxsackievirus B2 Ab [Units/volume] in Cerebral spinal fluid |
|
45291-2
|
Coxsackievirus B2 Ab [Presence] in Body fluid |
|
31326-2
|
Coxsackievirus B2 Ab [Units/volume] in Body fluid |
|
30221-6
|
Coxsackievirus B2 Ab [Presence] in Serum |
|
7837-8
|
Coxsackievirus B2 Ab [Units/volume] in Serum |
|
24255-2
|
Coxsackievirus B2 Ab [Titer] in Serum --1st specimen |
|
24181-0
|
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24183-6
|
Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24256-0
|
Coxsackievirus B2 Ab [Titer] in Serum --2nd specimen |
|
24182-8
|
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24184-4
|
Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22227-3
|
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid |
|
9760-0
|
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29231-8
|
Coxsackievirus B2 Ab [Titer] in Body fluid |
|
31054-0
|
Coxsackievirus B2 Ab [Titer] in Body fluid by Complement fixation |
|
22228-1
|
Coxsackievirus B2 Ab [Titer] in Serum |
|
5106-0
|
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation |
|
5105-2
|
Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test |
|
27917-4
|
Coxsackievirus B3 Ab [Presence] in Cerebral spinal fluid |
|
31327-0
|
Coxsackievirus B3 Ab [Units/volume] in Cerebral spinal fluid |
|
45290-4
|
Coxsackievirus B3 Ab [Presence] in Body fluid |
|
31328-8
|
Coxsackievirus B3 Ab [Units/volume] in Body fluid |
|
30222-4
|
Coxsackievirus B3 Ab [Presence] in Serum |
|
7838-6
|
Coxsackievirus B3 Ab [Units/volume] in Serum |
|
24259-4
|
Coxsackievirus B3 Ab [Titer] in Serum --1st specimen |
|
24185-1
|
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24187-7
|
Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24260-2
|
Coxsackievirus B3 Ab [Titer] in Serum --2nd specimen |
|
24186-9
|
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24188-5
|
Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22229-9
|
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid |
|
9761-8
|
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29232-6
|
Coxsackievirus B3 Ab [Titer] in Body fluid |
|
31055-7
|
Coxsackievirus B3 Ab [Titer] in Body fluid by Complement fixation |
|
22230-7
|
Coxsackievirus B3 Ab [Titer] in Serum |
|
5108-6
|
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation |
|
5107-8
|
Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test |
|
27918-2
|
Coxsackievirus B4 Ab [Presence] in Cerebral spinal fluid |
|
31329-6
|
Coxsackievirus B4 Ab [Units/volume] in Cerebral spinal fluid |
|
45289-6
|
Coxsackievirus B4 Ab [Presence] in Body fluid |
|
31330-4
|
Coxsackievirus B4 Ab [Units/volume] in Body fluid |
|
30223-2
|
Coxsackievirus B4 Ab [Presence] in Serum |
|
7839-4
|
Coxsackievirus B4 Ab [Units/volume] in Serum |
|
24263-6
|
Coxsackievirus B4 Ab [Titer] in Serum --1st specimen |
|
24189-3
|
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24191-9
|
Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24264-4
|
Coxsackievirus B4 Ab [Titer] in Serum --2nd specimen |
|
24190-1
|
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24192-7
|
Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22231-5
|
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid |
|
9762-6
|
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29233-4
|
Coxsackievirus B4 Ab [Titer] in Body fluid |
|
31056-5
|
Coxsackievirus B4 Ab [Titer] in Body fluid by Complement fixation |
|
22232-3
|
Coxsackievirus B4 Ab [Titer] in Serum |
|
5110-2
|
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation |
|
5109-4
|
Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test |
|
31331-2
|
Coxsackievirus B5 Ab [Units/volume] in Cerebral spinal fluid |
|
45288-8
|
Coxsackievirus B5 Ab [Presence] in Body fluid |
|
31332-0
|
Coxsackievirus B5 Ab [Units/volume] in Body fluid |
|
30224-0
|
Coxsackievirus B5 Ab [Presence] in Serum |
|
7840-2
|
Coxsackievirus B5 Ab [Units/volume] in Serum |
|
24267-7
|
Coxsackievirus B5 Ab [Titer] in Serum --1st specimen |
|
24193-5
|
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24195-0
|
Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24268-5
|
Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen |
|
24194-3
|
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24196-8
|
Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22233-1
|
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid |
|
9763-4
|
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29234-2
|
Coxsackievirus B5 Ab [Titer] in Body fluid |
|
31057-3
|
Coxsackievirus B5 Ab [Titer] in Body fluid by Complement fixation |
|
22234-9
|
Coxsackievirus B5 Ab [Titer] in Serum |
|
5112-8
|
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation |
|
5111-0
|
Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test |
|
27960-4
|
Coxsackievirus B5 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
31333-8
|
Coxsackievirus B6 Ab [Units/volume] in Cerebral spinal fluid |
|
45287-0
|
Coxsackievirus B6 Ab [Presence] in Body fluid |
|
31334-6
|
Coxsackievirus B6 Ab [Units/volume] in Body fluid |
|
30225-7
|
Coxsackievirus B6 Ab [Presence] in Serum |
|
7841-0
|
Coxsackievirus B6 Ab [Units/volume] in Serum |
|
24271-9
|
Coxsackievirus B6 Ab [Titer] in Serum --1st specimen |
|
24197-6
|
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24199-2
|
Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24272-7
|
Coxsackievirus B6 Ab [Titer] in Serum --2nd specimen |
|
24198-4
|
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24200-8
|
Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22235-6
|
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid |
|
9764-2
|
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29235-9
|
Coxsackievirus B6 Ab [Titer] in Body fluid |
|
31058-1
|
Coxsackievirus B6 Ab [Titer] in Body fluid by Complement fixation |
|
22236-4
|
Coxsackievirus B6 Ab [Titer] in Serum |
|
5114-4
|
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation |
|
5113-6
|
Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test |
|
27954-7
|
Coxsackievirus B6 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
70013-8
|
Coxsackievirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
70012-0
|
Coxsackievirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
13509-5
|
Microscopic observation [Identifier] in Blood by Crystal violet stain |
|
48722-3
|
Microscopic observation [Identifier] in Body fluid by Crystal violet stain |
|
10783-9
|
Microscopic observation [Identifier] in Tissue by Crystal violet stain |
|
90822-8
|
CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
57451-7
|
CV2 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
63216-6
|
CV2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
52970-1
|
CV2 Ab [Units/volume] in Cerebral spinal fluid |
|
34690-8
|
CV2 Ab [Presence] in Serum or Plasma |
|
47402-3
|
CV2 Ab [Presence] in Serum or Plasma by Immunoblot |
|
72504-4
|
CV2 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
51797-9
|
CV2 Ab [Units/volume] in Serum or Plasma |
|
56530-9
|
CV2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
51697-1
|
CV2 Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
53707-6
|
CV2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
47401-5
|
CV2 IgG Ab [Presence] in Serum by Immunoblot |
|
43103-1
|
CV2 IgG Ab [Units/volume] in Serum |
|
35385-4
|
CV2 IgG Ab [Titer] in Cerebral spinal fluid |
|
35386-2
|
CV2 IgG Ab [Titer] in Serum |
|
78925-5
|
History of cerebrovascular accident |
|
80696-8
|
2-Chlorovinyl arsonous acid [Mass/volume] in Urine |
|
79423-0
|
Cardiovascular disease 10Y risk [Likelihood] ACC-AHA Pooled Cohort by Goff 2013 |
|
60985-9
|
Central venous pressure (CVP) |
|
60986-7
|
Central venous pressure (CVP) Diastolic |
|
60987-5
|
Central venous pressure (CVP) Systolic |
|
22161-4
|
Cache valley virus Ab [Presence] in Serum |
|
20736-5
|
Cache valley virus Ab [Presence] in Serum by Neutralization test |
|
46175-6
|
Cache valley virus Ab [Titer] in Serum |
|
44272-3
|
Cache valley virus Ab [Titer] in Serum by Neutralization test |
|
34447-3
|
Cache valley virus RNA [Presence] in Blood by NAA with probe detection |
|
34448-1
|
Cache valley virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
55142-4
|
Cache valley virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11788-7
|
Cervical canal Diameter Probe insertion.Hagar |
|
11789-5
|
Cervical canal Diameter Probe insertion.Pratt |
|
11784-6
|
Cervical canal external os Diameter palpation |
|
11785-3
|
Cervical canal external os Diameter US |
|
11786-1
|
Cervical canal internal os Diameter palpation |
|
11787-9
|
Cervical canal internal os Diameter US |
|
11958-6
|
Cervical canal [Length] palpation |
|
11959-4
|
Cervical canal [Length] US |
|
76498-5
|
Cervical cells.overexpressing HPV E6+E7 mRNA/cervical cells by Flow cytometry (FC) |
|
11960-2
|
Cervix externally palpable surface [Length] palpation |
|
10564-3
|
Cervical mucus [Volume] |
|
955-5
|
Cw Ab [Presence] in Serum or Plasma from Blood product unit |
|
956-3
|
Cw Ab [Presence] in Serum or Plasma from Donor |
|
957-1
|
Cw Ab [Presence] in Serum or Plasma |
|
55321-4
|
Cw Ab [Titer] in Serum or Plasma |
|
958-9
|
Cw Ag [Presence] on Red Blood Cells from Blood product unit |
|
959-7
|
Cw Ag [Presence] on Red Blood Cells from Donor |
|
960-5
|
Cw Ag [Presence] on Red Blood Cells |
|
961-3
|
Cx Ab [Presence] in Serum or Plasma from Blood product unit |
|
962-1
|
Cx Ab [Presence] in Serum or Plasma from Donor |
|
963-9
|
Cx Ab [Presence] in Serum or Plasma |
|
964-7
|
Cx Ag [Presence] on Red Blood Cells from Blood product unit |
|
965-4
|
Cx Ag [Presence] on Red Blood Cells from Donor |
|
966-2
|
Cx Ag [Presence] on Red Blood Cells |
|
74917-6
|
CXCL13 Ag [Mass/volume] in Cerebral spinal fluid |
|
49477-3
|
CXCL13 Ag [Presence] in Tissue by Immune stain |
|
49478-1
|
CXCR5 Ag [Presence] in Tissue by Immune stain |
|
13511-1
|
Cyanide ascorbate screen [Presence] in Blood |
|
43183-3
|
Cyanide [Mass/volume] in Blood by Confirmatory method |
|
46698-7
|
Cyanide [Presence] in Blood |
|
5634-1
|
Cyanide [Mass/volume] in Blood |
|
59186-7
|
Cyanide [Moles/volume] in Blood |
|
29357-1
|
Cyanide [Mass/volume] in Gastric fluid |
|
20783-7
|
Cyanide [Units/mass] in Plant Qualitative |
|
20782-9
|
Cyanide [Mass/mass] in Plant |
|
5635-8
|
Cyanide [Mass/volume] in Serum or Plasma |
|
25387-2
|
Cyanide [Moles/volume] in Serum or Plasma |
|
5636-6
|
Cyanide [Mass/mass] in Tissue |
|
59824-3
|
Cyanide [Presence] in Urine |
|
5637-4
|
Cyanide [Mass/volume] in Urine |
|
38338-0
|
Cyanide [Mass/volume] in Water |
|
20784-5
|
Cyanide [Mass/volume] in Unspecified specimen |
|
87618-5
|
Cyanide [Mass/mass] in Unspecified specimen |
|
77321-8
|
Cyanide [Moles/volume] in Unspecified specimen |
|
4534-4
|
Cyanmethemoglobin/Hemoglobin.total in Blood |
|
10658-3
|
Cyanobacterium identified in Water by Light microscopy |
|
4203-6
|
Cyanocobalamin.PO [Mass] of Dose |
|
2182-4
|
Cytochrome B reductase [Enzymatic activity/volume] in Amniotic fluid |
|
51603-9
|
Cytochrome B5 reductase [Presence] in Red Blood Cells |
|
32703-1
|
Cytochrome B5 reductase [Enzymatic activity/mass] in Red Blood Cells |
|
2653-4
|
Cytochrome B5 reductase [Mass/volume] in Red Blood Cells |
|
2183-2
|
Cytochrome B5 reductase [Enzymatic activity/volume] in Serum |
|
48729-8
|
CYBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
90743-6
|
CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method |
|
48734-8
|
CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
54382-7
|
Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid cells |
|
54384-3
|
Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid |
|
54383-5
|
Cytochrome C oxidase [Enzymatic activity/mass] in Fibroblast |
|
2184-0
|
Cytochrome C oxidase [Enzymatic activity/volume] in Plasma |
|
2185-7
|
Cytochrome C oxidase [Enzymatic activity/volume] in Platelets |
|
18366-5
|
Cytochrome C oxidase [Enzymatic activity/mass] in Tissue |
|
2186-5
|
Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes |
|
82877-2
|
Cytochrome C oxidase [Enzymatic activity/mass] in Leukocytes |
|
74584-4
|
Cytochrome C oxidase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
51023-0
|
Cytoplasmic CD117 blasts/100 cells in Blood |
|
51022-2
|
Cytoplasmic CD117 blasts/100 cells in Bone marrow |
|
51024-8
|
Cytoplasmic CD117 blasts/100 cells in Unspecified specimen |
|
51062-8
|
Cytoplasmic CD13 blasts/100 blasts in Blood |
|
51061-0
|
Cytoplasmic CD13 blasts/100 blasts in Bone marrow |
|
51063-6
|
Cytoplasmic CD13 blasts/100 blasts in Unspecified specimen |
|
51093-3
|
Cytoplasmic CD179a blasts [Units/volume] in Blood |
|
51092-5
|
Cytoplasmic CD179a blasts [Units/volume] in Bone marrow |
|
51090-9
|
Cytoplasmic CD179a blasts/100 blasts in Blood |
|
51089-1
|
Cytoplasmic CD179a blasts/100 blasts in Bone marrow |
|
51091-7
|
Cytoplasmic CD179a blasts/100 blasts in Unspecified specimen |
|
51094-1
|
Cytoplasmic CD179a blasts [Units/volume] in Unspecified specimen |
|
51109-7
|
Cytoplasmic CD2 blasts/100 blasts in Unspecified specimen |
|
51122-0
|
Cytoplasmic CD22 blasts [Units/volume] in Blood |
|
51121-2
|
Cytoplasmic CD22 blasts [Units/volume] in Bone marrow |
|
51119-6
|
Cytoplasmic CD22 blasts/100 blasts in Blood |
|
51118-8
|
Cytoplasmic CD22 blasts/100 blasts in Bone marrow |
|
51120-4
|
Cytoplasmic CD22 blasts/100 blasts in Unspecified specimen |
|
51123-8
|
Cytoplasmic CD22 blasts [Units/volume] in Unspecified specimen |
|
52877-8
|
Cytoplasmic CD22 cells/100 cells in Blood |
|
52880-2
|
Cytoplasmic CD22 cells/100 cells in Cerebral spinal fluid |
|
52878-6
|
Cytoplasmic CD22 cells/100 cells in Body fluid |
|
52879-4
|
Cytoplasmic CD22 cells/100 cells in Bone marrow |
|
52881-0
|
Cytoplasmic CD22 cells/100 cells in Tissue |
|
32856-7
|
Cytoplasmic CD22 cells/100 cells in Unspecified specimen |
|
51141-0
|
Cytoplasmic CD3 blasts [Units/volume] in Blood |
|
51140-2
|
Cytoplasmic CD3 blasts [Units/volume] in Bone marrow |
|
51138-6
|
Cytoplasmic CD3 blasts/100 blasts in Blood |
|
51137-8
|
Cytoplasmic CD3 blasts/100 blasts in Bone marrow |
|
51139-4
|
Cytoplasmic CD3 blasts/100 blasts in Unspecified specimen |
|
51142-8
|
Cytoplasmic CD3 blasts [Units/volume] in Unspecified specimen |
|
17216-3
|
Cytoplasmic CD3 cells/100 cells in Blood |
|
52884-4
|
Cytoplasmic CD3 cells/100 cells in Cerebral spinal fluid |
|
52882-8
|
Cytoplasmic CD3 cells/100 cells in Body fluid |
|
52883-6
|
Cytoplasmic CD3 cells/100 cells in Bone marrow |
|
52885-1
|
Cytoplasmic CD3 cells/100 cells in Tissue |
|
32857-5
|
Cytoplasmic CD3 cells/100 cells in Unspecified specimen |
|
51161-8
|
Cytoplasmic CD34 blasts/100 blasts in Unspecified specimen |
|
17217-1
|
Cytoplasmic CD79 cells/100 cells in Blood |
|
52991-7
|
Cytoplasmic CD79a cells/100 cells in Blood |
|
52994-1
|
Cytoplasmic CD79a cells/100 cells in Cerebral spinal fluid |
|
52992-5
|
Cytoplasmic CD79a cells/100 cells in Body fluid |
|
52993-3
|
Cytoplasmic CD79a cells/100 cells in Bone marrow |
|
52995-8
|
Cytoplasmic CD79a cells/100 cells in Tissue |
|
4204-4
|
Cyclacillin [Mass] of Dose |
|
55666-2
|
Cyclacillin [Susceptibility] by Gradient strip |
|
210-5
|
Cyclacillin [Susceptibility] by Disk diffusion (KB) |
|
209-7
|
Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
208-9
|
Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3517-0
|
Cyclacillin [Mass/volume] in Serum or Plasma |
|
18913-4
|
Cyclacillin [Susceptibility] |
|
211-3
|
Cyclacillin [Susceptibility] by Serum bactericidal titer |
|
93818-3
|
Cycling distance unspecified time |
|
88423-9
|
Cycle physical activity.active transportation domain [IPAQ] |
|
83383-0
|
Cycle volume setting Nebulizer |
|
83372-3
|
Cycles setting [#] Nebulizer |
|
83371-5
|
Cycles.remaining [#] Nebulizer |
|
32749-4
|
Cyclin D1 cells/100 cells in Unspecified specimen |
|
4205-1
|
Cyclizine [Mass] of Dose |
|
3518-8
|
Cyclizine [Mass/volume] in Serum or Plasma |
|
78820-8
|
Cyclobenzaprine cutoff [Mass/volume] in Urine for Confirmatory method |
|
13554-1
|
Cyclobenzaprine [Presence] in Serum or Plasma |
|
35604-8
|
Cyclobenzaprine [Mass/volume] in Serum or Plasma by Screen method |
|
6797-5
|
Cyclobenzaprine [Mass/volume] in Serum or Plasma |
|
55531-8
|
Cyclobenzaprine [Moles/volume] in Serum or Plasma |
|
61410-7
|
Cyclobenzaprine [Mass/volume] in Urine by Confirmatory method |
|
14060-8
|
Cyclobenzaprine [Presence] in Urine |
|
61409-9
|
Cyclobenzaprine [Presence] in Urine by Confirmatory method |
|
14061-6
|
Cyclobenzaprine [Mass/volume] in Urine |
|
61408-1
|
Cyclobenzaprine/Creatinine [Mass Ratio] in Urine |
|
53448-7
|
Cycloguanil [Mass/volume] in Serum or Plasma |
|
16697-5
|
Cyclohexane [Presence] in Blood |
|
12306-7
|
Cyclohexane [Mass/volume] in Blood |
|
16698-3
|
Cyclohexanol [Mass/volume] in Blood |
|
16699-1
|
Cyclohexanol [Mass/volume] in Urine |
|
16700-7
|
Cyclohexanol/Creatinine [Mass Ratio] in Urine |
|
12995-7
|
Cyclohexanone [Mass/volume] in Blood |
|
23851-9
|
Cyclohexanone [Mass/volume] in Serum or Plasma |
|
21236-5
|
Cyclohexanone [Mass/volume] in Urine |
|
38314-1
|
Cyclohexanone [Mass/volume] in Water |
|
53449-5
|
Cyclophosphamide [Mass/volume] in Serum or Plasma |
|
53453-7
|
Cyclophosphamide [Mass/volume] in Urine |
|
16701-5
|
Cyclopropane [Presence] in Blood |
|
12312-5
|
Cyclopropane [Mass/volume] in Blood |
|
25207-2
|
cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25208-0
|
cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25209-8
|
cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4206-9
|
cycloSERINE [Mass] of Dose |
|
55667-0
|
cycloSERINE [Susceptibility] by Gradient strip |
|
214-7
|
cycloSERINE [Susceptibility] by Disk diffusion (KB) |
|
213-9
|
cycloSERINE [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
212-1
|
cycloSERINE [Susceptibility] by Minimum lethal concentration (MLC) |
|
23608-3
|
cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria |
|
3519-6
|
cycloSERINE [Mass/volume] in Serum or Plasma |
|
18914-2
|
cycloSERINE [Susceptibility] |
|
215-4
|
cycloSERINE [Susceptibility] by Serum bactericidal titer |
|
16702-3
|
cycloSERINE [Mass/volume] in Urine |
|
25251-0
|
cycloSERINE [Mass/volume] in Unspecified specimen |
|
38403-2
|
Cyclospora sp Ag [Presence] in Stool by Immunoassay |
|
10659-1
|
Cyclospora sp identified in Stool by Acid fast stain |
|
50313-6
|
Cyclospora sp identified in Stool by Safranin stain |
|
3523-8
|
cycloSPORINE [Mass/volume] in Blood --12 hours post dose |
|
3524-6
|
cycloSPORINE [Mass/volume] in Serum --12 hours post dose |
|
77169-1
|
cycloSPORINE [Mass/volume] in Blood --1 hour post dose |
|
3525-3
|
cycloSPORINE [Mass/volume] in Blood --24 hours post dose |
|
3526-1
|
cycloSPORINE [Mass/volume] in Serum --24 hours post dose |
|
32997-9
|
cycloSPORINE [Mass/volume] in Blood --2 hours post dose |
|
77167-5
|
cycloSPORINE [Mass/volume] in Blood --3 hours post dose |
|
77168-3
|
cycloSPORINE [Mass/volume] in Blood --4 hours post dose |
|
14978-1
|
cycloSPORINE [Mass/volume] in Blood by Immunoassay |
|
78920-6
|
cycloSPORINE [Moles/volume] in Blood by Immunoassay |
|
55805-6
|
cycloSPORINE [Mass/volume] in Blood by LC/MS/MS |
|
3520-4
|
cycloSPORINE [Mass/volume] in Blood |
|
80561-4
|
cycloSPORINE [Mass/volume] in DBS |
|
4207-7
|
cycloSPORINE [Mass] of Dose |
|
17807-9
|
cycloSPORINE [Mass/volume] in Body fluid |
|
73427-7
|
cycloSPORINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73426-9
|
cycloSPORINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
33955-6
|
cycloSPORINE.monoclonal [Mass/volume] in Blood |
|
34426-7
|
cycloSPORINE.monoclonal [Mass/volume] in Serum or Plasma |
|
53573-2
|
cycloSPORINE [Mass/volume] in Blood --post dose |
|
53834-8
|
cycloSPORINE [Mass/volume] in Blood --peak |
|
16703-1
|
cycloSPORINE [Mass/volume] in Plasma |
|
33956-4
|
cycloSPORINE.polyclonal [Mass/volume] in Blood |
|
3521-2
|
cycloSPORINE [Mass/volume] in Serum |
|
15103-5
|
cycloSPORINE [Moles/volume] in Serum |
|
48597-9
|
cycloSPORINE [Mass/volume] in Blood by Immunoassay --trough |
|
53828-0
|
cycloSPORINE [Mass/volume] in Blood --trough |
|
3522-0
|
cycloSPORINE+Metabolites [Mass/volume] in Blood |
|
12345-5
|
Cyclothiazide [Presence] in Urine |
|
17219-7
|
Cytoplasmic Ig cells/100 cells in Blood |
|
38515-3
|
Cytoplasmic Ig mu cells [#/volume] in Blood |
|
17218-9
|
Cytoplasmic Ig mu cells/100 cells in Blood |
|
79834-8
|
Cylinder Left eye by Objective refraction --W cycloplegia |
|
79847-0
|
Cylinder Left eye by Subjective refraction --W cycloplegia |
|
79833-0
|
Cylinder Right eye by Objective refraction --W cycloplegia |
|
79846-2
|
Cylinder Right eye by Subjective refraction --W cycloplegia |
|
79836-3
|
Cylinder Left eye by Objective refraction --WO cycloplegia |
|
79849-6
|
Cylinder Left eye by Subjective refraction --WO cycloplegia |
|
79835-5
|
Cylinder Right eye by Objective refraction --WO cycloplegia |
|
79848-8
|
Cylinder Right eye by Subjective refraction --WO cycloplegia |
|
77056-0
|
CYP11B1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77055-2
|
CYP11B1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
57308-9
|
CYP11B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57311-3
|
CYP11B1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
77058-6
|
CYP17A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77057-8
|
CYP17A1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
75713-8
|
CYP1A2 gene c.125C>G [Presence] in Blood or Tissue by Molecular genetics method |
|
75722-9
|
CYP1A2 gene c.-163C>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75723-7
|
CYP1A2 gene c.2385G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75714-6
|
CYP1A2 gene c.-2467delT [Presence] in Blood or Tissue by Molecular genetics method |
|
75715-3
|
CYP1A2 gene c.2473G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75716-1
|
CYP1A2 gene c.2499A>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75717-9
|
CYP1A2 gene c.3497G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75718-7
|
CYP1A2 gene c.3533G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75719-5
|
CYP1A2 gene c.-3860G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75720-3
|
CYP1A2 gene c.5090C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75721-1
|
CYP1A2 gene c.5166G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75724-5
|
CYP1A2 gene c.558C>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75725-2
|
CYP1A2 gene c.-729C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
72884-0
|
CYP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80687-7
|
CYP1A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81854-2
|
CYP21A2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
48781-9
|
CYP21A2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
30005-3
|
CYP21A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34651-0
|
CYP21A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
56780-0
|
CYP21A2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
79720-9
|
CYP2B6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
72882-4
|
CYP2B6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72511-9
|
CYP2B6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
66737-8
|
CYP2C19 gene c.1A>G(*4) [Presence] in Blood or Tissue by Molecular genetics method |
|
66738-6
|
CYP2C19 gene c.358T>C(*8) [Presence] in Blood or Tissue by Molecular genetics method |
|
66740-2
|
CYP2C19 gene c.636G>A(*3) [Presence] in Blood or Tissue by Molecular genetics method |
|
66741-0
|
CYP2C19 gene c.681G>A(*2) [Presence] in Blood or Tissue by Molecular genetics method |
|
66742-8
|
CYP2C19 gene c.806C>T(*17) [Presence] in Blood or Tissue by Molecular genetics method |
|
66739-4
|
CYP2C19 gene c.395G>A(*6) [Presence] in Blood or Tissue by Molecular genetics method |
|
66743-6
|
CYP2C19 gene c.IVS5+2T>A(*7) [Presence] in Blood or Tissue by Molecular genetics method |
|
79714-2
|
CYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
66489-6
|
CYP2C19 gene targeted mutation analysis in Blood by Molecular genetics method |
|
57132-3
|
CYP2C19 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78972-7
|
CYP2C8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
54451-0
|
CYP2C9 and VKORC1 [Interpretation] in Blood or Tissue by Molecular genetics method Narrative |
|
56164-7
|
CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal |
|
56165-4
|
CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal |
|
46724-1
|
CYP2C9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80686-9
|
CYP2C9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79716-7
|
CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
73682-7
|
CYP2D6 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
73681-9
|
CYP2D6 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21662-2
|
CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method |
|
21661-4
|
CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79715-9
|
CYP2D6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
47403-1
|
CYP2D6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40425-1
|
CYP2D6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21664-8
|
CYP2D6 gene p.Gly169Ter [Presence] in Blood or Tissue by Molecular genetics method |
|
72883-2
|
CYP2E1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81146-3
|
CYP3A4 and CYP3A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74003-5
|
CYP3A4 gene c.-392A>G (*1B) [Presence] in Blood or Tissue by Molecular genetics method |
|
74007-6
|
CYP3A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81139-8
|
CYP3A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79717-5
|
CYP3A5 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
81140-6
|
CYP3A5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72697-6
|
CYP3A5 gene c.6986A>G(*3) [Presence] in Blood or Tissue by Molecular genetics method |
|
91669-2
|
CYP3A7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
93197-2
|
CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
79721-7
|
CYP4F2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
16704-9
|
Cyproheptadine [Mass/volume] in Serum or Plasma |
|
34631-2
|
Cyproheptadine [Mass/volume] in Urine |
|
16711-4
|
Cystine+Homocystine [Presence] in Urine |
|
2180-8
|
Cystine+Cysteine [Mass/volume] in Serum or Plasma |
|
10969-4
|
Cystine+Homocysteine [Presence] in Urine |
|
27349-0
|
Cystathionine [Presence] in 24 hour Urine |
|
6880-9
|
Cystathionine [Mass/time] in 24 hour Urine |
|
25887-1
|
Cystathionine [Moles/volume] in 24 hour Urine |
|
25388-0
|
Cystathionine [Moles/time] in 24 hour Urine |
|
13393-4
|
Cystathionine [Mass/volume] in Amniotic fluid |
|
30070-7
|
Cystathionine [Moles/volume] in Amniotic fluid |
|
13370-2
|
Cystathionine [Mass/volume] in Cerebral spinal fluid |
|
26592-6
|
Cystathionine [Moles/volume] in Cerebral spinal fluid |
|
53066-7
|
Cystathionine [Moles/volume] in DBS |
|
53069-1
|
Cystathionine [Moles/volume] in Body fluid |
|
2172-5
|
Cystathionine [Presence] in Serum or Plasma |
|
2173-3
|
Cystathionine [Mass/volume] in Serum or Plasma |
|
26607-2
|
Cystathionine [Moles/volume] in Serum or Plasma |
|
16705-6
|
Cystathionine [Presence] in Urine |
|
2174-1
|
Cystathionine [Mass/volume] in Urine |
|
26964-7
|
Cystathionine [Moles/volume] in Urine |
|
32236-2
|
Cystathionine [Moles/volume] in Vitreous fluid |
|
25888-9
|
Cystathionine/Creatinine [Molar ratio] in 24 hour Urine |
|
13724-0
|
Cystathionine/Creatinine [Mass Ratio] in Urine |
|
28599-9
|
Cystathionine/Creatinine [Ratio] in Urine |
|
25092-8
|
Cystathionine/Creatinine [Molar ratio] in Urine |
|
54380-1
|
Cystatin C [Mass/volume] in 24 hour Urine |
|
54381-9
|
Cystatin C [Mass/time] in 24 hour Urine |
|
33863-2
|
Cystatin C [Mass/volume] in Serum or Plasma |
|
47612-7
|
Cystatin C [Mass/volume] in Urine |
|
54379-3
|
Cystatin C/Creatinine [Ratio] in Urine |
|
25889-7
|
Cysteate [Moles/volume] in 24 hour Urine |
|
25820-2
|
Cysteate [Moles/time] in 24 hour Urine |
|
79606-0
|
Cysteate [Moles/volume] in Serum or Plasma |
|
34276-6
|
Cysteate [Moles/volume] in Urine |
|
25890-5
|
Cysteate/Creatinine [Molar ratio] in 24 hour Urine |
|
79599-7
|
Cysteate/Creatinine [Molar ratio] in Urine |
|
38484-2
|
Cysteine [Mass/time] in 24 hour Urine |
|
25891-3
|
Cysteine [Moles/volume] in 24 hour Urine |
|
25892-1
|
Cysteine [Moles/time] in 24 hour Urine |
|
20641-7
|
Cysteine [Moles/volume] in Serum or Plasma |
|
34277-4
|
Cysteine [Moles/volume] in Urine |
|
25893-9
|
Cysteine/Creatinine [Molar ratio] in 24 hour Urine |
|
26843-3
|
Cystine [Presence] in 24 hour Urine |
|
32169-5
|
Cystine [Mass/volume] in 24 hour Urine |
|
2179-0
|
Cystine [Mass/time] in 24 hour Urine |
|
34278-2
|
Cystine [Moles/volume] in 24 hour Urine |
|
13966-7
|
Cystine [Moles/time] in 24 hour Urine |
|
13394-2
|
Cystine [Mass/volume] in Amniotic fluid |
|
27027-2
|
Cystine [Moles/volume] in Amniotic fluid |
|
2175-8
|
Cystine [Presence] in Blood |
|
53303-4
|
Cystine crystals [#/volume] in Urine by Computer assisted method |
|
53313-3
|
Cystine crystals [#/area] in Urine by Computer assisted method |
|
25155-3
|
Cystine crystals [#/area] in Urine sediment by Microscopy high power field |
|
45387-8
|
Cystine crystals [#/area] in Urine sediment by Microscopy low power field |
|
12469-3
|
Cystine crystals [type] in Stone by Light microscopy |
|
16710-6
|
Cystine crystals [Presence] in Stone by Infrared spectroscopy |
|
59277-4
|
Cystine crystals [Presence] in Stone by X-ray diffraction |
|
33240-3
|
Cystine crystals [Presence] in Urine by Computer assisted method |
|
5784-4
|
Cystine crystals [Presence] in Urine sediment by Light microscopy |
|
13371-0
|
Cystine [Mass/volume] in Cerebral spinal fluid |
|
22653-0
|
Cystine [Moles/volume] in Cerebral spinal fluid |
|
53080-8
|
Cystine [Moles/mass] in Chorionic villus sample |
|
32237-0
|
Cystine [Moles/volume] in Body fluid |
|
40870-8
|
Cystine Free [Presence] in Serum or Plasma |
|
34624-7
|
Cystine Free [Moles/volume] in Serum or Plasma |
|
32138-0
|
Cystine/Total in Stone |
|
2176-6
|
Cystine [Presence] in Serum or Plasma |
|
27350-8
|
Cystine [Units/volume] in Serum or Plasma |
|
2177-4
|
Cystine [Mass/volume] in Serum or Plasma |
|
22672-0
|
Cystine [Moles/volume] in Serum or Plasma |
|
14686-0
|
Cystine [Presence] in Stone |
|
9644-6
|
Cystine [Presence] in Urine |
|
16709-8
|
Cystine [Units/volume] in Urine |
|
2178-2
|
Cystine [Mass/volume] in Urine |
|
26962-1
|
Cystine [Moles/volume] in Urine |
|
32238-8
|
Cystine [Moles/volume] in Vitreous fluid |
|
33872-3
|
Cystine [Moles/mass] in Leukocytes |
|
22728-0
|
Cystine [Moles/volume] in Unspecified specimen |
|
44312-7
|
Cystine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56677-8
|
Cystine/Creatinine [Ratio] in 24 hour Urine |
|
25894-7
|
Cystine/Creatinine [Molar ratio] in 24 hour Urine |
|
13725-7
|
Cystine/Creatinine [Mass Ratio] in Urine |
|
30065-7
|
Cystine/Creatinine [Ratio] in Urine |
|
22687-8
|
Cystine/Creatinine [Molar ratio] in Urine |
|
2181-6
|
Cystinyl aminopeptidase [Enzymatic activity/volume] in Serum |
|
53450-3
|
Cytarabine [Mass/volume] in Serum or Plasma |
|
79671-4
|
Cytidine [Moles/volume] in Cerebral spinal fluid |
|
79675-5
|
Cytidine [Moles/volume] in Serum or Plasma |
|
79684-7
|
Cytidine/Creatinine [Molar ratio] in Urine |
|
31196-9
|
Microscopic observation [Identifier] in Abdomen fine needle aspirate by Cyto stain |
|
18498-6
|
Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
|
50971-1
|
Cytology report of Bronchial brush Cyto stain |
|
42210-5
|
Microscopic observation [Identifier] in Bronchial specimen by Cyto stain |
|
18501-7
|
Microscopic observation [Identifier] in Buccal smear by Cyto stain |
|
42209-7
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain |
|
10524-7
|
Microscopic observation [Identifier] in Cervix by Cyto stain |
|
19765-7
|
Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
19766-5
|
Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative |
|
18502-5
|
Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
|
49050-8
|
Microscopic observation [Identifier] in Endocervical brush by Cyto stain |
|
55604-3
|
Microscopic observation [Identifier] in Endometrium by Cyto stain |
|
43417-5
|
Microscopic observation [Identifier] in Esophageal brushing by Cyto stain |
|
11068-4
|
Microscopic observation [Identifier] in Body fluid by Cyto stain |
|
11069-2
|
Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
|
31188-6
|
Microscopic observation [Identifier] in Kidney fine needle aspirate by Cyto stain |
|
31192-8
|
Microscopic observation [Identifier] in Liver fine needle aspirate by Cyto stain |
|
31187-8
|
Microscopic observation [Identifier] in Lymph node fine needle aspirate by Cyto stain |
|
48001-2
|
Cytogenetic (chromosome) location |
|
31199-3
|
Microscopic observation [Identifier] in Lung fine needle aspirate by Cyto stain |
|
31189-4
|
Microscopic observation [Identifier] in Neck mass fine needle aspirate by Cyto stain |
|
18499-4
|
Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
|
31193-6
|
Microscopic observation [Identifier] in Pancreas fine needle aspirate by Cyto stain |
|
31198-5
|
Microscopic observation [Identifier] in Parotid fine needle aspirate by Cyto stain |
|
55601-9
|
Microscopic observation [Identifier] in Pericardial fluid by Cyto stain |
|
31197-7
|
Microscopic observation [Identifier] in Pelvis fine needle aspirate by Cyto stain |
|
55602-7
|
Microscopic observation [Identifier] in Pleural fluid by Cyto stain |
|
31191-0
|
Microscopic observation [Identifier] in Prostate fine needle aspirate by Cyto stain |
|
55600-1
|
Microscopic observation [Identifier] in Peritoneal fluid by Cyto stain |
|
31190-2
|
Microscopic observation [Identifier] in Salivary gland fine needle aspirate by Cyto stain |
|
55603-5
|
Microscopic observation [Identifier] in Synovial fluid by Cyto stain |
|
31195-1
|
Microscopic observation [Identifier] in Soft tissue fine needle aspirate by Cyto stain |
|
10526-2
|
Microscopic observation [Identifier] in Sputum by Cyto stain |
|
74225-4
|
Cytochemical stains in Bone marrow Narrative |
|
31194-4
|
Microscopic observation [Identifier] in Submandibular fine needle aspirate by Cyto stain |
|
18503-3
|
Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
|
18497-8
|
Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
|
10527-0
|
Microscopic observation [Identifier] in Tissue by Cyto stain |
|
11070-0
|
Microscopic observation [Identifier] in Urine by Cyto stain |
|
10525-4
|
Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
|
55228-1
|
Cytogenetics study |
|
50789-7
|
Cytokeratin cells [#/volume] in Blood |
|
50788-9
|
Cytokeratin cells/100 cells in Blood |
|
40860-9
|
Cytokines [Presence] in Serum or Plasma |
|
45196-3
|
Cytokines [Presence] in Unspecified specimen |
|
19767-3
|
Cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
|
59256-8
|
Cytologist who read Cyto stain of Unspecified specimen |
|
50007-4
|
Cytology report of Bronchoalveolar lavage Cyto stain |
|
47530-1
|
Cytology report of Breast ductal lavage Cyto stain |
|
47521-0
|
Cytology report of Breast fine needle aspirate Cyto stain |
|
19774-9
|
Cytology study comment Cervical or vaginal smear or scraping Cyto stain |
|
47528-5
|
Cytology report of Cervical or vaginal smear or scraping Cyto stain |
|
47527-7
|
Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep |
|
33717-0
|
Cytology Cervical or vaginal smear or scraping study |
|
47523-6
|
Cytology report of Body fluid Cyto stain |
|
47522-8
|
Cytology report of Nipple discharge Cyto stain |
|
47520-2
|
Cytology report of Sputum Cyto stain |
|
47524-4
|
Cytology report of Thyroid fine needle aspirate Cyto stain |
|
47529-3
|
Cytology report of Tissue Other stain |
|
33718-8
|
Cytology report of Tissue fine needle aspirate Cyto stain |
|
47525-1
|
Cytology report of Urine Cyto stain |
|
47526-9
|
Cytology report of Unspecified specimen Cyto stain |
|
54239-9
|
Cytopathic effect [Presence] in Unspecified specimen |
|
55171-3
|
Cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
55170-5
|
Cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
|
79683-9
|
Cytosine [Moles/volume] in Cerebral spinal fluid |
|
79655-7
|
Cytosine [Moles/volume] in Serum or Plasma |
|
79658-1
|
Cytosine/Creatinine [Molar ratio] in Urine |
|
34404-4
|
Cytoskeleton Ab [Titer] in Serum by Immunofluorescence |
|
35478-7
|
Cytosol aminopeptidase [Enzymatic activity/time] in 24 hour Urine |
|
2187-3
|
Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
|
2188-1
|
Cytosol aminopeptidase [Presence] in Urine |
|
2189-9
|
Cytosol aminopeptidase [Enzymatic activity/volume] in Urine |
|
973-8
|
D Ab [Presence] in Serum or Plasma from Blood product unit |
|
974-6
|
D Ab [Presence] in Serum or Plasma from Donor |
|
975-3
|
D Ab [Presence] in Serum or Plasma |
|
52115-3
|
D Ab [Presence] in Serum or Plasma by Antihuman globulin |
|
1304-5
|
D Ab [Titer] in Serum or Plasma |
|
1305-2
|
D Ag [Presence] in Blood |
|
93940-5
|
D Ag [Presence] on Red Blood Cells --during infancy |
|
93930-6
|
D Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
976-1
|
D Ag [Presence] on Red Blood Cells from Blood product unit |
|
977-9
|
D Ag [Presence] on Red Blood Cells from Donor |
|
978-7
|
D Ag [Presence] on Red Blood Cells |
|
93948-8
|
D Ag [Presence] in Cord red blood cells |
|
23026-8
|
Dermatophilus congolensis Ab [Presence] in Serum |
|
23027-6
|
Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay |
|
31800-6
|
Dermatophilus congolensis Ag [Presence] in Exudate |
|
23598-6
|
Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence |
|
23028-4
|
Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence |
|
23596-0
|
Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain |
|
23595-2
|
Dermatophilus congolensis [Presence] in Exudate by Giemsa stain |
|
23597-8
|
Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain |
|
23025-0
|
Dermatophilus congolensis [Presence] in Skin by Giemsa stain |
|
42499-4
|
Fibrin D-dimer [Presence] in Cerebral spinal fluid |
|
91556-1
|
Fibrin D-dimer DDU [Mass/volume] in Blood by Immunoassay |
|
42727-8
|
Fibrin D-dimer DDU [Mass/volume] in Cerebral spinal fluid by Latex agglutination |
|
48058-2
|
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay |
|
48066-5
|
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma |
|
71427-9
|
Fibrin D-dimer FEU [Mass/volume] in Blood by Immunoassay |
|
48067-3
|
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay |
|
48065-7
|
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma |
|
3246-6
|
Fibrin D-dimer [Units/volume] in Platelet poor plasma by Immunoassay |
|
15179-5
|
Fibrin D-dimer [Presence] in Platelet poor plasma |
|
29280-5
|
Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination |
|
7799-0
|
Fibrin D-dimer [Units/volume] in Platelet poor plasma |
|
38898-3
|
Fibrin D-dimer [Titer] in Platelet poor plasma |
|
65790-8
|
American house dust mite native (nDer f) 1 IgE Ab [Units/volume] in Serum |
|
78374-6
|
American house dust mite native (nDer f) 2 IgE Ab [Units/volume] in Serum |
|
44461-2
|
American house dust mite Ab [Presence] in Serum by Immune diffusion (ID) |
|
7277-7
|
American house dust mite triggered histamine release [Units/volume] in Blood |
|
6095-4
|
American house dust mite IgE Ab [Units/volume] in Serum |
|
15680-2
|
American house dust mite IgE Ab RAST class [Presence] in Serum |
|
16741-1
|
American house dust mite IgG Ab [Presence] in Blood |
|
51534-6
|
American house dust mite IgG Ab [Presence] in Serum |
|
7276-9
|
American house dust mite IgG Ab [Units/volume] in Serum |
|
26419-2
|
American house dust mite IgG4 Ab [Units/volume] in Serum |
|
26420-0
|
American house dust mite IgG4 Ab RAST class [Presence] in Serum |
|
56241-3
|
American house dust mite IgG4 Ab [Mass/volume] in Serum |
|
63075-6
|
American house dust mite IgG Ab [Mass/volume] in Serum |
|
48235-6
|
American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes |
|
70295-1
|
Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection |
|
30040-0
|
Dirofilaria immitis Ab [Units/volume] in Serum |
|
30044-2
|
Dirofilaria immitis Ab [Titer] in Serum |
|
23029-2
|
Dirofilaria immitis Ag [Presence] in Blood |
|
31801-4
|
Dirofilaria immitis Ag [Presence] in Serum |
|
23710-7
|
Dirofilaria immitis Ag [Presence] in Serum by Immunoassay |
|
93085-9
|
Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay |
|
14036-8
|
Dermatophagoides microceras IgE Ab [Units/volume] in Serum |
|
15681-0
|
Dermatophagoides microceras IgE Ab RAST class [Presence] in Serum |
|
61257-2
|
Dermatophagoides microceras IgE Ab/IgE total in Serum |
|
63456-8
|
European house dust mite native (nDer p) 1 IgE Ab [Units/volume] in Serum |
|
81972-2
|
European house dust mite native (nDer p) 1 IgE Ab RAST class [Presence] in Serum |
|
81792-4
|
Dermatophagoides pteronyssinus native (nDer p) 2 IgE Ab [Units/volume] in Serum |
|
63463-4
|
European house dust mite recombinant (rDer p) 10 IgE Ab [Units/volume] in Serum |
|
81974-8
|
European house dust mite recombinant (rDer p) 10 IgE Ab RAST class [Presence] in Serum |
|
63457-6
|
European house dust mite recombinant (rDer p) 2 IgE Ab [Units/volume] in Serum |
|
81973-0
|
European house dust mite recombinant (rDer p) 2 IgE Ab RAST class [Presence] in Serum |
|
7279-3
|
European house dust mite triggered histamine release [Units/volume] in Blood |
|
6096-2
|
European house dust mite IgE Ab [Units/volume] in Serum |
|
15682-8
|
European house dust mite IgE Ab RAST class [Presence] in Serum |
|
61258-0
|
European house dust mite IgE Ab/IgE total in Serum |
|
16742-9
|
European house dust mite IgG Ab [Presence] in Blood |
|
51533-8
|
European house dust mite IgG Ab [Presence] in Serum |
|
7278-5
|
European house dust mite IgG Ab [Units/volume] in Serum |
|
26421-8
|
European house dust mite IgG4 Ab [Units/volume] in Serum |
|
26422-6
|
European house dust mite IgG4 Ab RAST class [Presence] in Serum |
|
56242-1
|
European house dust mite IgG4 Ab [Mass/volume] in Serum |
|
81772-6
|
European house dust mite IgG Ab [Mass/volume] in Serum |
|
48236-4
|
European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes |
|
88708-3
|
Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgE Ab [Units/volume] in Serum |
|
93950-4
|
D variant Ag [Presence] on Red Blood Cells |
|
90056-3
|
Date and time lab result reported |
|
91008-3
|
Date and time of fatality assessment |
|
90091-0
|
Date and time of incident management system activation |
|
91022-4
|
Date and time of risk assessment |
|
91583-5
|
Date and time of public health emergency |
|
90089-4
|
Date and time report was released |
|
91877-1
|
Date and time report was received |
|
91880-5
|
Date and time of risk assessment meeting |
|
91584-3
|
Date and time rumor record was released |
|
90063-9
|
Date and time task assigned |
|
80249-6
|
First diagonal artery [Presence] on Angiogram |
|
80250-4
|
Additional first diagonal artery [Presence] on Angiogram |
|
80251-2
|
Second diagonal artery [Presence] on Angiogram |
|
73909-4
|
D2-40 Ag [Presence] in Tissue by Immune stain |
|
80252-0
|
Additional second diagonal artery [Presence] on Angiogram |
|
85061-0
|
Door-to-balloon time Heart |
|
79302-6
|
D- and L-2-hydroxyglutarate pattern [Interpretation] in Amniotic fluid Narrative |
|
79299-4
|
D- and L-2-hydroxyglutarate pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79301-8
|
D- and L-2-hydroxyglutarate pattern newborn screen interpretation |
|
79300-0
|
D- and L-2-hydroxyglutarate pattern [Interpretation] in Serum or Plasma Narrative |
|
79303-4
|
D- and L-2-hydroxyglutarate pattern [Interpretation] in Urine Narrative |
|
79307-5
|
D-2-hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
79304-2
|
D-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
79306-7
|
D-2-hydroxyglutarate [Moles/volume] in DBS |
|
79305-9
|
D-2-hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
80100-1
|
D-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine |
|
6699-3
|
Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine |
|
18214-7
|
Delta 5-Pregnanetriol [Mass/volume] in Urine |
|
11704-4
|
Ductus arteriosus Peak systolic flow velocity US.doppler |
|
11676-4
|
Ductus arteriosus Mean blood flow velocity US.doppler |
|
68980-2
|
Dabigatran [Units/volume] in Platelet poor plasma by Chromogenic method |
|
74220-5
|
Dabigatran [Mass/volume] in Platelet poor plasma by Coagulation assay |
|
74263-5
|
Dabigatran [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
72625-7
|
Dabigatran [Mass/volume] in Serum or Plasma |
|
82379-9
|
Daclatasvir [Susceptibility] by Genotype method |
|
7791-7
|
Dacrocytes [Presence] in Blood by Light microscopy |
|
7273-6
|
Dahlia IgE Ab [Units/volume] in Serum |
|
85462-0
|
Daily activities impact on well-being - visual analog rating [ePCAM] |
|
83323-6
|
Daily activities impact on well-being [PCAM] |
|
79534-4
|
Daily activity items number [Activity Measure for Post-Acute Care] |
|
79532-8
|
Daily activity score [AM-PAC] |
|
79533-6
|
Daily activity score standard error [AM-PAC] |
|
78708-5
|
Daily or end of shift signout note |
|
80461-7
|
Dairy servings 24 hour Estimated |
|
80462-5
|
Dairy servings 24 hour Measured |
|
7274-4
|
Daisy IgE Ab [Units/volume] in Serum |
|
15674-5
|
Daisy IgE Ab RAST class [Presence] in Serum |
|
26974-6
|
Delta aminolevulinate [Mass/volume] in 24 hour Urine |
|
2200-4
|
Delta aminolevulinate [Mass/time] in 24 hour Urine |
|
25896-2
|
Delta aminolevulinate [Moles/volume] in 24 hour Urine |
|
14689-4
|
Delta aminolevulinate [Moles/time] in 24 hour Urine |
|
2198-0
|
Delta aminolevulinate [Mass/volume] in Plasma |
|
2199-8
|
Delta aminolevulinate [Mass/volume] in Serum |
|
79646-6
|
Delta aminolevulinate [Moles/volume] in Serum or Plasma |
|
47088-0
|
Delta aminolevulinate [Moles/volume] in Serum |
|
11215-1
|
Delta aminolevulinate [Mass/volume] in Urine |
|
12475-0
|
Delta aminolevulinate [Mass/time] in Urine |
|
34284-0
|
Delta aminolevulinate [Moles/volume] in Urine |
|
44313-5
|
Delta aminolevulinate/Creatinine [Mass Ratio] in 24 hour Urine |
|
25897-0
|
Delta aminolevulinate/Creatinine [Molar ratio] in 24 hour Urine |
|
13728-1
|
Delta aminolevulinate/Creatinine [Mass Ratio] in Urine |
|
56658-8
|
Delta aminolevulinate/Creatinine [Ratio] in Urine |
|
39782-8
|
Delta aminolevulinate/Creatinine [Molar ratio] in Urine |
|
18215-4
|
Delta alanine [Mass/volume] in Urine |
|
41690-9
|
Dalbavancin [Susceptibility] by Gradient strip |
|
41688-3
|
Dalbavancin [Susceptibility] by Disk diffusion (KB) |
|
41689-1
|
Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41734-5
|
Dalbavancin [Susceptibility] |
|
19442-3
|
Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19441-5
|
Diamorphine cutoff [Mass/volume] in Urine for Screen method |
|
4216-8
|
Diamorphine [Mass] of Dose |
|
80555-6
|
Diamorphine [Mass/mass] in Hair |
|
16756-9
|
Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
18387-1
|
Diamorphine [Mass/volume] in Serum or Plasma |
|
16755-1
|
Diamorphine [Mass/volume] in Urine by Confirmatory method |
|
3546-9
|
Diamorphine [Presence] in Urine |
|
16198-4
|
Diamorphine [Presence] in Urine by Confirmatory method |
|
19439-9
|
Diamorphine [Presence] in Urine by Screen method |
|
3547-7
|
Diamorphine [Mass/volume] in Urine |
|
12326-5
|
Diamorphine [Presence] in Unknown substance |
|
16754-4
|
Diamorphine [Mass/volume] in Unknown substance |
|
19422-5
|
Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19421-7
|
Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
31025-0
|
Dextroamphetamine/Amphetamines.total in Urine |
|
9814-5
|
Dextroamphetamine [Mass/volume] in Serum or Plasma |
|
20525-2
|
Dextroamphetamine [Mass/volume] in Urine by Confirmatory method |
|
19420-9
|
Dextroamphetamine [Presence] in Urine by Confirmatory method |
|
19419-1
|
Dextroamphetamine [Presence] in Urine by Screen method |
|
15366-8
|
Dextroamphetamine [Mass/volume] in Urine |
|
32642-1
|
Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma |
|
13497-3
|
Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine |
|
73688-4
|
Danazol [Presence] in Urine by Screen method |
|
6097-0
|
Dandelion IgE Ab [Units/volume] in Serum |
|
15676-0
|
Dandelion IgE Ab RAST class [Presence] in Serum |
|
61318-2
|
Dandelion IgE Ab/IgE total in Serum |
|
56243-9
|
Dandelion IgG4 Ab [Mass/volume] in Serum |
|
73646-2
|
Danofloxacin [Susceptibility] by Disk diffusion (KB) |
|
73623-1
|
Danofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73601-7
|
Danofloxacin [Susceptibility] |
|
60069-2
|
Dantrolene [Mass/volume] in Blood |
|
9746-9
|
Dantrolene [Mass/volume] in Serum or Plasma |
|
4208-5
|
Dantron [Mass] of Dose |
|
42665-0
|
Dantron [Mass/mass] in Stool |
|
3527-9
|
Dantron [Mass/volume] in Urine |
|
68967-9
|
Dantu Ab [Presence] in Serum or Plasma |
|
10931-4
|
Daphnia (fish feed) IgE Ab [Units/volume] in Serum |
|
15677-8
|
Daphnia (fish feed) IgE Ab RAST class [Presence] in Serum |
|
41691-7
|
DAPTOmycin [Susceptibility] by Gradient strip |
|
35787-1
|
DAPTOmycin [Susceptibility] by Disk diffusion (KB) |
|
35788-9
|
DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35789-7
|
DAPTOmycin [Susceptibility] |
|
20885-0
|
Microscopic observation [Identifier] in Gastric fluid by Dark field examination |
|
20884-3
|
Microscopic observation [Identifier] in Stool by Dark field examination |
|
6607-6
|
Microscopic observation [Identifier] in Tissue by Dark field examination |
|
20883-5
|
Microscopic observation [Identifier] in Urine by Dark field examination |
|
660-1
|
Microscopic observation [Identifier] in Unspecified specimen by Dark field examination |
|
93120-4
|
Dark-mediated rod adaptation time Left eye |
|
93119-6
|
Dark-mediated rod adaptation time Right eye |
|
75192-5
|
Darkfield exam, DFA, or special stain was performed and test findings [CDC.CS] |
|
55091-3
|
Darunavir [Susceptibility] by Genotype method |
|
49666-1
|
Darunavir [Susceptibility] by Phenotype method |
|
57954-0
|
Darunavir [Mass/volume] in Serum or Plasma |
|
49630-7
|
Darunavir+Ritonavir [Susceptibility] by Genotype method |
|
57955-7
|
Darunavir+Ritonavir [Susceptibility] by Phenotype method |
|
54409-8
|
Direct antiglobulin test.complement C3+C4 specific reagent [Presence] on Red Blood Cells |
|
58956-4
|
Direct antiglobulin test.complement C3b+C4d specific reagent [Presence] on Red Blood Cells |
|
56471-6
|
Direct antiglobulin test.complement C3c specific reagent [Presence] on Red Blood Cells |
|
55774-4
|
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells |
|
54410-6
|
Direct antiglobulin test.complement C3 specific reagent [Presence] on Red Blood Cells |
|
1004-1
|
Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
|
53744-9
|
Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells by 5 minute RT incubation |
|
55775-1
|
Direct antiglobulin test.IgA specific reagent [Presence] on Red Blood Cells |
|
90907-7
|
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells --after transfusion reaction |
|
55776-9
|
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells |
|
52114-6
|
Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells |
|
1006-6
|
Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
|
55777-7
|
Direct antiglobulin test.IgM specific reagent [Presence] on Red Blood Cells |
|
51007-3
|
Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --after transfusion |
|
46274-7
|
Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --after transfusion reaction |
|
1007-4
|
Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
|
51871-2
|
Direct antiglobulin test.poly specific reagent [presence] on Cord red blood cells |
|
51006-5
|
Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells |
|
77544-5
|
Data collected |
|
71479-0
|
Date access infection confirmed [ESRD] |
|
90120-7
|
Date and time of event response status |
|
90118-1
|
Date and time of scheduled task |
|
80616-6
|
Date and time pronounced dead [US Standard Certificate of Death] |
|
91559-5
|
Date of arrival at travel destination |
|
72053-2
|
Date arteriovenous fistula creation [ESRD] |
|
72048-2
|
Date arteriovenous fistula usable |
|
89068-1
|
Date aspirin discontinued |
|
46501-3
|
Date assessment information completed [CMS Assessment] |
|
53665-6
|
Date of best overall gestational age estimate |
|
87288-7
|
Date of birth certification |
|
72052-4
|
Date catheter placement |
|
72051-6
|
Date catheter removal |
|
72054-0
|
Date change of dialysis access type [ESRD] |
|
71505-2
|
Date changed ownership Dialysis facility [ESRD] |
|
71504-5
|
Date closed Dialysis facility [ESRD] |
|
72049-0
|
Date dialysis session [ESRD] |
|
79218-4
|
Date education program completed by Patient |
|
79216-8
|
Date education program assigned to Patient |
|
79219-2
|
Date education program expires for Patient |
|
79217-6
|
Date education program started by Patient |
|
47241-5
|
Date determined medically eligible and ready to start HIV treatment |
|
47240-7
|
Date determined medically eligible to start HIV treatment |
|
90102-5
|
Date of emergency response plan release |
|
90106-6
|
Date emergency operations center standard operating procedure issued |
|
90107-4
|
Date emergency operations center standard operating procedure released |
|
71464-2
|
Date first prescribed Medication |
|
30947-6
|
Date form completed |
|
71506-0
|
Date initially certified by medicare Dialysis facility [ESRD] |
|
29742-4
|
Date last dose |
|
72074-8
|
Date last formal post dialysis weight [ESRD] |
|
91381-4
|
Date medication started - Reported |
|
91382-2
|
Date medication stopped - Reported |
|
71742-1
|
Date most recent record submitted Facility [ESRD] |
|
45354-8
|
Date next dose |
|
91103-2
|
Date next report due |
|
45353-0
|
Date of analysis of unspecified specimen |
|
75711-2
|
Date of autopsy |
|
71472-5
|
Date of blood culture |
|
88878-4
|
Date of condition abatement |
|
85585-8
|
Date of condition onset |
|
85932-2
|
Date of cough onset |
|
81954-0
|
Date of death [Date] |
|
53719-1
|
Date of death - Canada |
|
91560-3
|
Date of departure from travel destination |
|
72078-9
|
Date of echocardiogram |
|
50786-3
|
Date of entry |
|
81266-9
|
Date of fever onset |
|
85729-2
|
Date of fever onset in Mother |
|
75188-3
|
Date of first reactive non-treponemal test |
|
75191-7
|
Date of first reactive treponemal test |
|
77994-2
|
Date of first report to Centers for Disease Control and Prevention [CDC.PHIN] |
|
77995-9
|
Date of first report to public health department |
|
76423-3
|
Date of first visit |
|
80395-7
|
Date of gestational age estimate |
|
71474-1
|
Date of infection hospitalization [ESRD] |
|
71463-4
|
Date of infection onset [ESRD] |
|
77970-2
|
Date of initial report |
|
93301-0
|
Date of initial/first suicide attempt |
|
75329-3
|
Date of intrauterine device insertion |
|
88298-5
|
Date of last attempted gradual dose reduction [CMS Assessment] |
|
80265-2
|
Date of last bowel movement |
|
85734-2
|
Date of last evaluation |
|
55400-6
|
Date of last eye examination |
|
46581-5
|
Date of last home visit [CMS Assessment] |
|
93275-6
|
Date of most lethal suicide attempt |
|
93302-8
|
Date of most recent suicide attempt |
|
76425-8
|
Date of onset - Reported |
|
70952-7
|
Date of peritoneal dialysis adequacy measurement [ESRD] |
|
57201-6
|
Date of Physician-ordered Start of Care (Resumption of Care) [CMS Assessment] |
|
58123-1
|
Date of Pressure injury.oldest non-epithelialized stage 2 [CMS Assessment] |
|
60432-2
|
Date of previous PAP smear |
|
80989-7
|
Date of procedure |
|
81268-5
|
Date of rash onset |
|
85732-6
|
Date of rash onset in Mother |
|
57202-4
|
Date of Referral |
|
85931-4
|
Date of salivary gland swelling onset |
|
45351-4
|
Date of skin test |
|
87290-3
|
Date of Social Security Number request |
|
72081-3
|
Date of sodium education [ESRD] |
|
75361-6
|
Date of total hysterectomy |
|
45376-1
|
Date of transfusion reaction |
|
71503-7
|
Date opened Dialysis facility [ESRD] |
|
31035-9
|
Date of other vaccinations given within 4 weeks prior to the date of vaccine causing adverse event |
|
7275-1
|
Date Palm Pollen IgE Ab [Units/volume] in Serum |
|
15678-6
|
Date Palm Pollen IgE Ab RAST class [Presence] in Serum |
|
71523-5
|
Date personnel record submitted Dialysis facility [ESRD] |
|
88300-9
|
Date physician documented GDR as clinically contraindicated [CMS Assessment] |
|
71465-9
|
Date prescription changed Medication |
|
71466-7
|
Date prescription stopped Medication |
|
58052-2
|
Date pressure injury.oldest non-epithelialized stage 2 first identified [CMS Assessment] |
|
82758-4
|
Date of previous diagnosis |
|
60431-4
|
Date of previous biopsy |
|
53663-1
|
Date of prior gestational age estimate |
|
88030-2
|
Date quit smokeless tobacco |
|
74010-0
|
Date quit tobacco smoking |
|
92189-0
|
Date range for emergency response plan |
|
90087-8
|
Date range of report |
|
30976-5
|
Date received Form |
|
74015-9
|
Date recorded |
|
56155-5
|
Date reference lab test results received |
|
49548-1
|
Date reference lab test sent |
|
87510-4
|
Date of retirement |
|
45355-5
|
Date Rh immune globulin given |
|
82765-9
|
Date prescription dispensed Medication |
|
70158-1
|
Date sections completed Provider |
|
85674-0
|
Date of serology test in Mother --pre pregnancy |
|
45352-2
|
Date skin test interpreted |
|
89264-6
|
Date specimen was sent to public health laboratory |
|
85930-6
|
Date specimen sent to CDC |
|
65838-5
|
Date submitted |
|
75360-8
|
Date of supracervical hysterectomy |
|
90060-5
|
Date task due |
|
72187-8
|
Date tetanus vaccine given [RHEA] |
|
86771-3
|
Date therapy regimen resumed [CMS Assessment] |
|
45348-0
|
Date tick acquired |
|
45347-2
|
Date tick attached |
|
45346-4
|
Date tick removed |
|
52116-1
|
Date blood unit received |
|
88879-2
|
Date vaccination indication expires |
|
30946-8
|
Date.vaccination contraindication/precaution effective |
|
30980-7
|
Date vaccine due |
|
88877-6
|
Date vaccination indication effective |
|
29769-7
|
Date vaccine information statement presented |
|
29768-9
|
Date vaccine information statement published |
|
30944-3
|
Date of vaccination temporary contraindication/precaution expiration |
|
45285-4
|
Date and time of Dose |
|
80331-2
|
Date and time of last void |
|
93857-1
|
Date and time of obstetric delivery |
|
19788-9
|
Date and time of cleaning Endoscopy device |
|
81956-5
|
Date and time of death [TimeStamp] |
|
80992-1
|
Date and time of surgery |
|
30952-6
|
Date and time of vaccination |
|
30953-4
|
Date and time of onset of vaccination adverse event |
|
49542-4
|
Date and time of pheresis procedure |
|
80410-4
|
Date and time of transfer departure |
|
31002-9
|
Dates IgE Ab [Units/volume] in Serum |
|
43375-5
|
Dates IgE Ab RAST class [Presence] in Serum |
|
56244-7
|
Dates IgG4 Ab [Mass/volume] in Serum |
|
63130-9
|
Dates IgG Ab [Mass/volume] in Serum |
|
71745-4
|
Day closed Facility |
|
77293-9
|
Days per week of moderate to vigorous physical activity |
|
82766-7
|
Days' supply dispensed [#] Medication |
|
82776-6
|
Days' supply prescribed [#] Medication |
|
47027-8
|
DBA44 Ag [Presence] in Tissue by Immune stain |
|
38583-1
|
1,2-Dibromo-3-Chloropropane [Mass/volume] in Air |
|
38288-7
|
1,2-Dibromo-3-Chloropropane [Mass/volume] in Water |
|
1000-9
|
DBG Ab [Presence] in Serum or Plasma from Blood product unit |
|
1001-7
|
DBG Ab [Presence] in Serum or Plasma from Donor |
|
1002-5
|
DBG Ab [Presence] in Serum or Plasma |
|
997-7
|
DBG Ag [Presence] on Red Blood Cells from Blood product unit |
|
998-5
|
DBG Ag [Presence] on Red Blood Cells from Donor |
|
999-3
|
DBG Ag [Presence] on Red Blood Cells |
|
81255-2
|
dbSNP [ID] |
|
82115-7
|
dbSNP version [ID] |
|
86463-7
|
DBT Breast - bilateral |
|
72139-9
|
DBT Breast - bilateral diagnostic |
|
91519-9
|
DBT Breast - bilateral diagnostic for implant |
|
72142-3
|
DBT Breast - bilateral screening |
|
91522-3
|
DBT Breast - bilateral screen for implant |
|
72138-1
|
DBT Breast - left diagnostic |
|
91518-1
|
DBT Breast - left diagnostic for implant |
|
72141-5
|
DBT Breast - left screening |
|
91521-5
|
DBT Breast - left screen for implant |
|
72137-3
|
DBT Breast - right diagnostic |
|
91517-3
|
DBT Breast - right diagnostic for implant |
|
72140-7
|
DBT Breast - right screening |
|
91520-7
|
DBT Breast - right screen for implant |
|
86462-9
|
DBT Breast - unilateral |
|
16766-8
|
Dichloroethane [Presence] in Blood |
|
12307-5
|
Dichloroethane [Mass/volume] in Blood |
|
38316-6
|
Dichloroethane [Mass/volume] in Water |
|
16762-7
|
Dichlorobenzene [Mass/volume] in Blood |
|
38315-8
|
Dichlorobenzene [Mass/volume] in Water |
|
84454-8
|
Dimensional Change Card Sort Test - computed score [NIH Toolbox] |
|
84456-3
|
Dimensional Change Card Sort Test - raw score [NIH Toolbox] |
|
84457-1
|
Dimensional Change Card Sort Test - unadjusted scale score [NIH Toolbox] |
|
84452-2
|
Dimensional Change Card Sort Test - national percentile [NIH Toolbox] |
|
84432-4
|
Dimensional Change Card Sort Test [NIH Toolbox] |
|
84453-0
|
Dimensional Change Card Sort Test - scale score age adjusted [NIH Toolbox] |
|
84455-5
|
Dimensional Change Card Sort Test - scale score fully adjusted [NIH Toolbox] |
|
12996-5
|
Dichlorodifluoroethane [Mass/volume] in Blood |
|
13935-2
|
Dichlorodifluoromethane [Mass/volume] in Blood |
|
85302-8
|
Growth pattern of DCIS [Type] in Breast cancer specimen by Light microscopy |
|
85336-6
|
DCIS intraductal extension in Breast cancer specimen Qualitative by Light microscopy |
|
85340-8
|
DCIS necrosis [Type] in Breast cancer specimen by Light microscopy |
|
85333-3
|
DCIS.additional dimension 1 [Length] in Breast cancer specimen by Light microscopy |
|
85335-8
|
DCIS.additional dimension 2 [Length] in Breast cancer specimen by Light microscopy |
|
85317-6
|
DCIS.max dimension [Length] in Breast cancer specimen by Light microscopy |
|
44673-2
|
DCIS.uninvolved margin distance.closest in Breast tumor |
|
44675-7
|
DCIS.uninvolved margin.closest in Breast tumor |
|
38610-2
|
Methylene chloride [Mass/volume] in Air |
|
12998-1
|
Methylene chloride [Mass/volume] in Blood |
|
56625-7
|
Methylene chloride [Moles/volume] in Blood |
|
38295-2
|
Methylene chloride [Mass/volume] in Water |
|
38739-9
|
1,3-Dichloropropene [Mass/volume] in Air |
|
48969-0
|
DCX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38740-7
|
Dimethylcarbamoyl chloride [Mass/volume] in Air |
|
17695-8
|
Tetrachlorodiphenylethane [Mass/volume] in Blood |
|
40817-9
|
Tetrachlorodiphenylethane [Presence] in Serum or Plasma |
|
14257-0
|
Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma |
|
14256-2
|
Tetrachlorodiphenylethane [Mass/mass] in Tissue |
|
17696-6
|
Tetrachlorodiphenylethane [Mass/volume] in Urine |
|
13732-3
|
Dodecanedioate/Creatinine [Mass Ratio] in Urine |
|
25097-7
|
Dodecanedioate/Creatinine [Molar ratio] in Urine |
|
38669-8
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Air |
|
16764-3
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Blood |
|
11093-2
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma |
|
14262-0
|
Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue |
|
16763-5
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Urine |
|
87640-9
|
Dichlorodiphenyldichloroethylene [Mass/mass] in Unspecified specimen |
|
9747-7
|
Dapsone [Mass/volume] in Serum or Plasma |
|
51698-9
|
Dapsone [Susceptibility] |
|
53643-3
|
Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid |
|
16765-0
|
Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
|
26953-0
|
Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma |
|
11094-0
|
Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
|
14263-8
|
Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue |
|
87639-1
|
Dichlorodiphenyltrichloroethane [Mass/mass] in Unspecified specimen |
|
86807-5
|
Death administrative information Document |
|
81356-8
|
Death arrangements [Reported] |
|
64297-5
|
Death certificate |
|
74734-5
|
Death certifier details |
|
86804-2
|
Cause of death classification and related information Document |
|
74499-5
|
Death pronouncer details |
|
80911-1
|
Death pronouncer Provider [Extended Identifier] |
|
80907-9
|
Death registration date |
|
42672-6
|
Debris [Presence] in Semen |
|
13726-5
|
Decadienediate/Creatinine [Mass Ratio] in Urine |
|
25093-6
|
Decadienediate/Creatinine [Molar ratio] in Urine |
|
53459-4
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Amniotic fluid |
|
53464-4
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Cerebral spinal fluid |
|
53180-6
|
Decadienoylcarnitine (C10:2) [Moles/volume] in DBS |
|
74610-7
|
Decadienoylcarnitine (C10:2) [Enzymatic activity/mass] in Fibroblast |
|
53471-9
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Serum or Plasma |
|
53492-5
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Urine |
|
53508-8
|
Decadienoylcarnitine (C10:2)/Creatinine [Molar ratio] in Urine |
|
75116-4
|
Decanoate (C10:0) [Entitic substance] in Red Blood Cells |
|
35146-0
|
Decanoate (C10:0) [Moles/volume] in Serum or Plasma |
|
47613-5
|
Decanoate (C10:0)/Creatinine [Molar ratio] in Urine |
|
53056-8
|
Decanoylcarnitine (C10) [Moles/volume] in Amniotic fluid |
|
53075-8
|
Decanoylcarnitine (C10) [Moles/volume] in Cerebral spinal fluid |
|
45197-1
|
Decanoylcarnitine (C10) [Moles/volume] in DBS |
|
74612-3
|
Decanoylcarnitine (C10) [Enzymatic activity/mass] in Fibroblast |
|
18452-3
|
Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma |
|
30327-1
|
Decanoylcarnitine (C10) [Moles/volume] in Serum or Plasma |
|
53102-0
|
Decanoylcarnitine (C10) [Moles/volume] in Urine |
|
53504-7
|
Decanoylcarnitine (C10)/Creatinine [Molar ratio] in Urine |
|
53208-5
|
Decatrienoylcarnitine (C10:3) [Moles/volume] in DBS |
|
74524-0
|
Decatrienoylcarnitine (C10:3) [Moles/volume] in Serum or Plasma |
|
20219-2
|
Deceleration 2 [Velocity] by US |
|
20216-8
|
Deceleration slope [Velocity] by US |
|
20218-4
|
Deceleration [Velocity] by US |
|
20215-0
|
Maximum deceleration [Velocity] by US |
|
20220-0
|
Deceleration/Deceleration 2 by US |
|
79509-6
|
Decenedioate [Moles/volume] in Serum or Plasma |
|
13727-3
|
Decenedioate/Creatinine [Mass Ratio] in Urine |
|
25094-4
|
Decenedioate/Creatinine [Molar ratio] in Urine |
|
78350-6
|
Decenoate (C10:1) [Entitic substance] in Red Blood Cells |
|
35147-8
|
Decenoate (C10:1) [Moles/volume] in Serum or Plasma |
|
47614-3
|
Decenoate (C10:1)/Creatinine [Molar ratio] in Urine |
|
53057-6
|
Decenoylcarnitine (C10:1) [Moles/volume] in Amniotic fluid |
|
53076-6
|
Decenoylcarnitine (C10:1) [Moles/volume] in Cerebral spinal fluid |
|
45198-9
|
Decenoylcarnitine (C10:1) [Moles/volume] in DBS |
|
74611-5
|
Decenoylcarnitine (C10:1) [Enzymatic activity/mass] in Fibroblast |
|
30328-9
|
Decenoylcarnitine (C10:1) [Moles/volume] in Serum or Plasma |
|
53103-8
|
Decenoylcarnitine (C10:1) [Moles/volume] in Urine |
|
53108-7
|
Decenoylcarnitine (C10:1)/Creatinine [Molar ratio] in Urine |
|
16720-5
|
Dechlorane [Presence] in Blood |
|
16151-3
|
Dechlorane [Presence] in Serum or Plasma |
|
87645-8
|
Dechlorane [Mass/mass] in Unspecified specimen |
|
77224-4
|
Decision making required level [NMMDS] |
|
75775-7
|
Decision to inform doctors and nurses about the role religion, faith, or spirituality play in my life [Reported] |
|
72275-1
|
Dedication to Excellence and Inspiration to all |
|
87540-1
|
Deemed medically ready for SBT by day 2 of stay [CMS Assessment] |
|
93831-6
|
Deep sleep duration |
|
33759-2
|
Deepest extent of invasion [Type] in Specimen |
|
84883-8
|
Deepest extent of tumor invasion [Type] in Colorectal cancer specimen |
|
10926-4
|
Deer epithelium IgE Ab [Units/volume] in Serum |
|
15679-4
|
Deer epithelium IgE Ab RAST class [Presence] in Serum |
|
7319-7
|
Deer Fly IgE Ab [Units/volume] in Serum |
|
56245-4
|
Deer Fly IgG4 Ab [Mass/volume] in Serum |
|
11169-0
|
Deer hair IgE Ab [Units/volume] in Serum |
|
21238-1
|
Deer hair IgE Ab RAST class [Presence] in Serum |
|
81249-5
|
Default genomic reference sequence coding system [Type] |
|
81248-7
|
Default transcript reference sequence coding system [Type] |
|
88662-2
|
Defibrillator type |
|
88773-7
|
Degree of difficulty experienced due to your hip while ascending stairs in the last week [HOOS] |
|
82320-3
|
Degree of difficulty experienced due to your hip while bending to floor AndOr pick up an object in the last week [HOOS] |
|
88780-2
|
Degree of difficulty experienced due to your hip while descending stairs in the last week [HOOS] |
|
88775-2
|
Degree of difficulty experienced due to your hip while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last week [HOOS] |
|
88774-5
|
Degree of difficulty experienced due to your hip while doing light domestic duties (cooking, dusting, etc) in the last week [HOOS] |
|
88777-8
|
Degree of difficulty experienced due to your hip while getting in or out of bath in the last week [HOOS] |
|
88770-3
|
Degree of difficulty experienced due to your hip while getting in or out of car in the last week [HOOS] |
|
88776-0
|
Degree of difficulty experienced due to your hip while getting on or off toilet in the last week [HOOS] |
|
88769-5
|
Degree of difficulty experienced due to your hip while going shopping in the last week [HOOS] |
|
82321-1
|
Degree of difficulty experienced due to your hip while lying in bed (turning over, maintaining hip position) in the last week [HOOS] |
|
88768-7
|
Degree of difficulty experienced due to your hip while putting on socks or stockings in the last week [HOOS] |
|
88779-4
|
Degree of difficulty experienced due to your hip while rising from bed in the last week [HOOS] |
|
82319-5
|
Degree of difficulty experienced due to your hip while rising from sitting in the last week [HOOS] |
|
88749-7
|
Degree of difficulty experienced due to your hip while running during the last week [HOOS] |
|
82322-9
|
Degree of difficulty experienced due to your hip while sitting in the last week [HOOS] |
|
88750-5
|
Degree of difficulty experienced due to your hip while squatting during the last week [HOOS] |
|
88772-9
|
Degree of difficulty experienced due to your hip while standing in the last week [HOOS] |
|
88778-6
|
Degree of difficulty experienced due to your hip while taking off socks or stockings in the last week [HOOS] |
|
88748-9
|
Degree of difficulty experienced due to your hip while twisting or pivoting on loaded leg during the last week [HOOS] |
|
88771-1
|
Degree of difficulty experienced due to your hip while walking on a flat surface in the last week [HOOS] |
|
88747-1
|
Degree of difficulty experienced due to your hip while walking on uneven surface during the last week [HOOS] |
|
88812-3
|
Degree of difficulty experienced due to your knee while ascending stairs in the last week [KOOS] |
|
88821-4
|
Degree of difficulty experienced due to your knee while descending stairs in the last week [KOOS] |
|
88814-9
|
Degree of difficulty experienced due to your knee while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last week [KOOS] |
|
88813-1
|
Degree of difficulty experienced due to your knee while doing light domestic duties (cooking, dusting, etc) in the last week [KOOS] |
|
88817-2
|
Degree of difficulty experienced due to your knee while getting in or out of bath in the last week [KOOS] |
|
88809-9
|
Degree of difficulty experienced due to your knee while getting in or out of car in the last week [KOOS] |
|
88815-6
|
Degree of difficulty experienced due to your knee while getting on or off toilet in the last week [KOOS] |
|
88808-1
|
Degree of difficulty experienced due to your knee while going shopping in the last week [KOOS] |
|
88789-3
|
Degree of difficulty experienced due to your knee while jumping during the last week [KOOS] |
|
88787-7
|
Degree of difficulty experienced due to your knee while kneeling during the last week [KOOS] |
|
88818-0
|
Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last week [KOOS] |
|
88807-3
|
Degree of difficulty experienced due to your knee while putting on socks or stockings in the last week [KOOS] |
|
88820-6
|
Degree of difficulty experienced due to your knee while rising from bed in the last week [KOOS] |
|
82330-2
|
Degree of difficulty experienced due to your knee while rising from sitting in the last week [KOOS] |
|
88790-1
|
Degree of difficulty experienced due to your knee while running during the last week [KOOS] |
|
88816-4
|
Degree of difficulty experienced due to your knee while sitting in the last week [KOOS] |
|
88791-9
|
Degree of difficulty experienced due to your knee while squatting during the last week [KOOS] |
|
88811-5
|
Degree of difficulty experienced due to your knee while standing in the last week [KOOS] |
|
88819-8
|
Degree of difficulty experienced due to your knee while taking off socks or stockings in the last week [KOOS] |
|
88788-5
|
Degree of difficulty experienced due to your knee while twisting or pivoting on your injured knee during the last week [KOOS] |
|
88810-7
|
Degree of difficulty experienced due to your knee while walking on a flat surface in the last week [KOOS] |
|
38636-7
|
Di(2-Ethylhexyl) phthalate [Mass/volume] in Air |
|
38297-8
|
Di(2-Ethylhexyl) phthalate [Mass/volume] in Water |
|
77882-9
|
Dehydroaripiprazole cutoff [Mass/volume] in Urine for Confirmatory method |
|
88714-1
|
Dehydroaripiprazole [Mass/volume] in Serum or Plasma by Confirmatory method |
|
77884-5
|
Dehydroaripiprazole [Mass/volume] in Urine by Confirmatory method |
|
31013-6
|
Dehydrochlormethyltestosterone [Mass/volume] in Urine |
|
53211-9
|
Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in DBS |
|
74525-7
|
Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in Serum or Plasma |
|
53209-3
|
Dehydrosuberylcarnitine (C8:1-DC) [Moles/volume] in DBS |
|
72728-9
|
Del(13)(q14) [Identifier] in Blood or Tissue by FISH Nominal |
|
72824-6
|
Del(17)(p13) [Identifier] in Blood or Tissue by FISH Nominal |
|
70289-4
|
Del(1)(p32p32)(STIL,TAL1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
42715-3
|
Del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93851-4
|
Delamanid [Susceptibility] |
|
30290-1
|
Delavirdine [Susceptibility] by Genotype method |
|
30276-0
|
Delavirdine [Susceptibility] by Phenotype method |
|
29115-3
|
Delavirdine [Units/volume] in Serum or Plasma |
|
27082-7
|
Delavirdine [Mass/volume] in Serum or Plasma |
|
30305-7
|
Delavirdine [Susceptibility] |
|
83006-7
|
Deletion-duplication overall interpretation |
|
11778-8
|
Delivery date Estimated |
|
53692-0
|
Delivery date Estimated from conception date |
|
11779-6
|
Delivery date Estimated from last menstrual period |
|
11780-4
|
Delivery date Estimated from ovulation date |
|
90368-2
|
Delivery date Estimated from physical exam |
|
53694-6
|
Delivery date Estimated from prior gestational age assessment |
|
11781-2
|
Delivery date US composite estimate |
|
72150-6
|
Delivery location |
|
72149-8
|
Delivery method [RHEA] |
|
76021-5
|
Delta aPTT [Time] in Platelet poor plasma by Coagulation assay |
|
76020-7
|
Delta dRVVT [Time] in Platelet poor plasma by Coagulation assay |
|
60850-5
|
Delta frequency relative power on EEG |
|
11170-8
|
Dematiaceae IgE Ab [Units/volume] in Serum |
|
7006-0
|
Demeclocycline [Susceptibility] by Gradient strip |
|
218-8
|
Demeclocycline [Susceptibility] by Disk diffusion (KB) |
|
217-0
|
Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
216-2
|
Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
10982-7
|
Demeclocycline [Mass/volume] in Serum or Plasma |
|
18915-9
|
Demeclocycline [Susceptibility] |
|
219-6
|
Demeclocycline [Susceptibility] by Serum bactericidal titer |
|
29494-2
|
Demeclocycline [Mass/volume] in Unspecified specimen |
|
74208-0
|
Demographic information + History of occupation Document |
|
13556-6
|
Demoxepam [Presence] in Serum or Plasma |
|
12377-8
|
Demoxepam [Mass/volume] in Serum or Plasma |
|
32966-4
|
Dental prognosis {Procedure} Best estimate |
|
32965-6
|
Dental prognosis {Tooth} Best estimate |
|
32964-9
|
Dental prognosis Best estimate |
|
32874-0
|
Dental treatment anatomical site access Head |
|
90864-0
|
Dental abnormalities impacting orthodontic care |
|
86706-9
|
Dental problems during 7 day assessment period [CMS Assessment] |
|
83829-2
|
Dentistry Administrative note |
|
90786-5
|
Dentistry Attending Note |
|
34756-7
|
Dentistry Consult note |
|
78259-9
|
Dentistry Diagnostic study note |
|
29761-4
|
Dentistry Discharge summary |
|
83834-2
|
Dentistry Emergency department Note |
|
78275-5
|
Dentistry Education note |
|
78301-9
|
Dentistry Flowsheet |
|
83830-0
|
Dentistry History and physical note |
|
83831-8
|
Dentistry Hospital Note |
|
34127-1
|
Dentistry Hygienist Outpatient Progress note |
|
28572-6
|
Dentistry Initial evaluation note |
|
83832-6
|
Dentistry Long term care facility Note |
|
28618-7
|
Dentistry Note |
|
83601-5
|
Dentistry Nurse Long term care facility Note |
|
34128-9
|
Dentistry Outpatient Progress note |
|
28583-3
|
Dentist Operation note |
|
83838-3
|
Dentistry Telephone encounter Note |
|
80743-8
|
Dentistry Plan of care note |
|
83833-4
|
Dentistry Postoperative evaluation and management note |
|
83828-4
|
Dentistry Preoperative evaluation and management note |
|
28577-5
|
Dentistry procedure note |
|
28617-9
|
Dentistry Progress note |
|
57134-9
|
Dentistry Referral note |
|
90787-3
|
Dentistry Resident Note |
|
83835-9
|
Dentistry Risk assessment and screening note |
|
83836-7
|
Dentistry Summary note |
|
83837-5
|
Dentistry Technician Note |
|
83839-1
|
Dentistry Transplant candidate evaluation note |
|
81151-3
|
Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81150-5
|
Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Serum by NAA with probe detection |
|
77958-7
|
Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Cerebral spinal fluid by NAA with probe detection |
|
88203-5
|
Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Serum or Blood by NAA with probe detection |
|
82384-9
|
Dengue virus 1+3 RNA [Presence] in Serum by NAA with probe detection |
|
82383-1
|
Dengue virus 2+4 RNA [Presence] in Serum by NAA with probe detection |
|
16740-3
|
Dengue virus Ab [Presence] in Serum |
|
40748-6
|
Dengue virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
7859-2
|
Dengue virus Ab [Units/volume] in Serum |
|
33606-5
|
Dengue virus Ab [Titer] in Serum |
|
40515-9
|
Dengue virus Ab [Titer] in Serum by Complement fixation |
|
55369-3
|
Dengue virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
33578-6
|
Dengue virus Ab [Titer] in Serum by Immunofluorescence |
|
55438-6
|
Dengue virus Ab [Titer] in Serum by Neutralization test |
|
31343-7
|
Dengue virus Ab [Presence] in Unspecified specimen |
|
50036-3
|
Dengue virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
31342-9
|
Dengue virus Ab [Units/volume] in Unspecified specimen |
|
31798-2
|
Dengue virus Ag [Presence] in Serum |
|
6384-2
|
Dengue virus Ag [Presence] in Serum by Immunofluorescence |
|
31799-0
|
Dengue virus Ag [Presence] in Unspecified specimen |
|
6385-9
|
Dengue virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
6386-7
|
Dengue virus DNA [Presence] in Serum by Probe |
|
6387-5
|
Dengue virus DNA [Presence] in Unspecified specimen by Probe |
|
23991-3
|
Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
29676-4
|
Dengue virus IgG Ab [Presence] in Serum |
|
23958-2
|
Dengue virus IgG Ab [Units/volume] in Serum |
|
29661-6
|
Dengue virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
6811-4
|
Dengue virus IgG Ab [Titer] in Serum |
|
51785-4
|
Dengue virus IgG and IgM [Interpretation] in Serum |
|
75223-8
|
Dengue virus IgG and IgM [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
|
34721-1
|
Dengue virus IgM Ab [Presence] in Cerebral spinal fluid |
|
23992-1
|
Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25338-5
|
Dengue virus IgM Ab [Presence] in Serum |
|
25392-2
|
Dengue virus IgM Ab [Presence] in Serum by Immunoblot |
|
23968-1
|
Dengue virus IgM Ab [Units/volume] in Serum |
|
29663-2
|
Dengue virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
6812-2
|
Dengue virus IgM Ab [Titer] in Serum |
|
91064-6
|
Dengue virus NS1 Ag [Presence] in Serum or Plasma by Immunoassay |
|
75377-2
|
Dengue virus NS1 Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
85584-1
|
Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
22250-5
|
Dengue virus 1 Ab [Presence] in Serum |
|
7854-3
|
Dengue virus 1 Ab [Presence] in Serum by Immunoassay |
|
31338-7
|
Dengue virus 1 Ab [Units/volume] in Serum |
|
16736-1
|
Dengue virus 1 Ab [Titer] in Serum |
|
86860-4
|
Dengue virus 1 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86865-3
|
Dengue virus 1 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60262-3
|
Dengue virus 1 RNA [Presence] in Serum by NAA with probe detection |
|
87440-4
|
Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay |
|
88189-6
|
Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with probe detection |
|
7855-0
|
Dengue virus 1+2+3+4 RNA [Presence] in Serum by NAA with probe detection |
|
88188-8
|
Dengue virus 1+2+3+4 RNA [Presence] in Urine by NAA with probe detection |
|
87438-8
|
Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen by Immunoassay |
|
22251-3
|
Dengue virus 2 Ab [Presence] in Serum |
|
7856-8
|
Dengue virus 2 Ab [Presence] in Serum by Immunoassay |
|
31339-5
|
Dengue virus 2 Ab [Units/volume] in Serum |
|
16737-9
|
Dengue virus 2 Ab [Titer] in Serum |
|
86858-8
|
Dengue virus 2 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86864-6
|
Dengue virus 2 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60420-7
|
Dengue virus 2 RNA [Presence] in Serum by NAA with probe detection |
|
22252-1
|
Dengue virus 3 Ab [Presence] in Serum |
|
7857-6
|
Dengue virus 3 Ab [Presence] in Serum by Immunoassay |
|
31340-3
|
Dengue virus 3 Ab [Units/volume] in Serum |
|
16738-7
|
Dengue virus 3 Ab [Titer] in Serum |
|
86859-6
|
Dengue virus 3 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86863-8
|
Dengue virus 3 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60419-9
|
Dengue virus 3 RNA [Presence] in Serum by NAA with probe detection |
|
22253-9
|
Dengue virus 4 Ab [Presence] in Serum |
|
7858-4
|
Dengue virus 4 Ab [Presence] in Serum by Immunoassay |
|
31341-1
|
Dengue virus 4 Ab [Units/volume] in Serum |
|
16739-5
|
Dengue virus 4 Ab [Titer] in Serum |
|
86861-2
|
Dengue virus 4 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86862-0
|
Dengue virus 4 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60418-1
|
Dengue virus 4 RNA [Presence] in Serum by NAA with probe detection |
|
75124-8
|
Deoxyadenosine [Moles/volume] in Cerebral spinal fluid |
|
75122-2
|
Deoxyadenosine [Moles/volume] in Serum or Plasma |
|
59199-0
|
Deoxyadenosine/Creatinine [Molar ratio] in Urine |
|
75149-5
|
Deoxyguanosine [Moles/volume] in Cerebral spinal fluid |
|
75134-7
|
Deoxyguanosine [Moles/volume] in Serum or Plasma |
|
59201-4
|
Deoxyguanosine/Creatinine [Molar ratio] in Urine |
|
75157-8
|
Deoxyinosine [Moles/volume] in Cerebral spinal fluid |
|
75127-1
|
Deoxyinosine [Moles/volume] in Serum or Plasma |
|
59202-2
|
Deoxyinosine/Creatinine [Molar ratio] in Urine |
|
75143-8
|
Deoxyuridine [Moles/volume] in Cerebral spinal fluid |
|
47957-6
|
Deoxyuridine [Moles/volume] in Serum or Plasma |
|
59193-3
|
Deoxyuridine/Creatinine [Molar ratio] in Urine |
|
43267-4
|
Uranium depleted cutoff [Mass/volume] in Urine |
|
41164-5
|
Uranium depleted [Presence] in Urine |
|
41285-8
|
Uranium depleted/Creatinine [Mass Ratio] in 24 hour Urine |
|
41166-0
|
Uranium depleted/Creatinine [Mass Ratio] in Urine |
|
77688-0
|
Depression scale [UPDRS] |
|
94022-1
|
Depression score |
|
71757-9
|
Depression score [M3] |
|
94016-3
|
Depression screening report |
|
94023-9
|
Depression severity |
|
89557-3
|
Depression symptoms score [CUBS] |
|
86668-1
|
Depth of deep margin involved by invasive melanoma [Length] in Skin melanoma by Light microscopy |
|
44662-5
|
Depth of invasion by tumor cannot be determined comment in Skin melanoma Narrative |
|
44661-7
|
Depth of invasion by tumor [Length] in Skin melanoma |
|
57228-9
|
Depth Pressure injury.largest stage 3 or 4 [CMS Assessment] |
|
85345-7
|
Dermal lymph-vascular invasion in Cancer specimen Qualitative by Light microscopy |
|
90233-8
|
Dermatan sulfate [Moles/volume] in DBS |
|
2203-8
|
Dermatan sulfate [Mass/volume] in Serum or Plasma |
|
47615-0
|
Dermatan sulfate [Presence] in Urine |
|
2204-6
|
Dermatan sulfate [Mass/volume] in Urine |
|
84076-9
|
Dermatology Administrative note |
|
83682-5
|
Dermatology Attending Note |
|
34758-3
|
Dermatology Consult note |
|
78260-7
|
Dermatology Diagnostic study note |
|
78269-8
|
Dermatology Education note |
|
78294-6
|
Dermatology Flowsheet |
|
84077-7
|
Dermatology History and physical note |
|
68551-1
|
Dermatology Hospital Consult note |
|
84078-5
|
Dermatology Hospital Note |
|
78334-0
|
Dermatology Initial evaluation note |
|
34759-1
|
Dermatology Note |
|
83543-9
|
Dermatology Nurse practitioner Note |
|
83568-6
|
Dermatology Nurse Note |
|
83569-4
|
Dermatology Nurse Outpatient Note |
|
84080-1
|
Dermatology Outpatient Note |
|
84081-9
|
Dermatology Outpatient procedure note |
|
84079-3
|
Dermatology Surgical operation note |
|
84082-7
|
Dermatology Telephone encounter Note |
|
80751-1
|
Dermatology Plan of care note |
|
85887-8
|
Dermatology Postoperative evaluation and management note |
|
68550-3
|
Dermatology Preoperative evaluation and management note |
|
78314-2
|
Dermatology procedure note |
|
78326-6
|
Dermatology Progress note |
|
57135-6
|
Dermatology Referral note |
|
83754-2
|
Dermatology Resident Note |
|
84083-5
|
Dermatology Transfer summary note |
|
41271-8
|
Dermatophagoides sp IgE Ab [Units/volume] in Serum |
|
43276-5
|
Dermatophagoides sp IgE Ab RAST class [Presence] in Serum |
|
70027-8
|
Dermatophytes chitin synthase 1 chs1 gene [Presence] in Nail by NAA with probe detection |
|
62265-4
|
Desflurane [VFr/PPres] Airway adaptor --during expiration |
|
60746-5
|
Desflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60805-9
|
Desflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60747-3
|
Desflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60877-8
|
Desflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60744-0
|
Gas delivery system inspiratory Desflurane setting [VFr/PPres] |
|
60876-0
|
Desflurane [VFr/PPres] Airway adaptor |
|
60853-9
|
Desflurane [VFr/PPres] Gas delivery system |
|
80605-9
|
Desacetylrifampicin [Mass/volume] in DBS |
|
80604-2
|
Desacetylrifampicin [Mass/volume] in Serum or Plasma |
|
47404-9
|
N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method |
|
59647-8
|
N-desalkylflurazepam [Mass/volume] in Blood |
|
19619-6
|
N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19618-8
|
N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method |
|
59649-4
|
N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59648-6
|
N-desalkylflurazepam [Mass/volume] in Body fluid |
|
61098-0
|
N-desalkylflurazepam [Presence] in Gastric fluid |
|
26841-7
|
N-desalkylflurazepam [Mass/mass] in Hair |
|
59650-2
|
N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method |
|
26866-4
|
N-desalkylflurazepam [Mass/mass] in Meconium |
|
46980-9
|
N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13568-1
|
N-desalkylflurazepam [Presence] in Serum or Plasma |
|
35605-5
|
N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method |
|
9652-9
|
N-desalkylflurazepam [Mass/volume] in Serum or Plasma |
|
14690-2
|
N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
|
59651-0
|
N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method |
|
12603-7
|
N-desalkylflurazepam [Presence] in Stool |
|
27436-5
|
N-desalkylflurazepam [Mass/mass] in Stool |
|
59653-6
|
N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method |
|
59652-8
|
N-desalkylflurazepam [Mass/mass] in Tissue |
|
16230-5
|
N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method |
|
61040-2
|
N-desalkylflurazepam [Presence] in Urine |
|
19615-4
|
N-desalkylflurazepam [Presence] in Urine by Confirmatory method |
|
19614-7
|
N-desalkylflurazepam [Presence] in Urine by Screen method |
|
19617-0
|
N-desalkylflurazepam [Mass/volume] in Urine |
|
27194-0
|
N-desalkylflurazepam [Mass/volume] in Vitreous fluid |
|
61041-0
|
N-desalkylflurazepam [Presence] in Unspecified specimen |
|
77325-9
|
N-desalkylflurazepam [Moles/volume] in Unspecified specimen |
|
64129-0
|
N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine |
|
21239-9
|
Desalkylhalazepam [Mass/volume] in Serum or Plasma |
|
79506-2
|
Desaminotyrosine [Moles/volume] in Serum or Plasma |
|
79517-9
|
Desaminotyrosine/Creatinine [Molar ratio] in Urine |
|
51195-6
|
Desbutylbupivacaine [Mass/volume] in Serum or Plasma |
|
74554-7
|
Description of patient safety event or unsafe condition [AHRQ] |
|
87728-2
|
Description of swab specimen Narrative |
|
7647-1
|
Desert Ragweed IgE Ab [Units/volume] in Serum |
|
15976-4
|
Desert Ragweed IgE Ab RAST class [Presence] in Serum |
|
4211-9
|
Desethylamiodarone [Mass] of Dose |
|
6774-4
|
Desethylamiodarone [Mass/volume] in Serum or Plasma |
|
25393-0
|
Desethylamiodarone [Moles/volume] in Serum or Plasma |
|
59356-6
|
Desethylvardenafil [Mass/volume] in Blood |
|
59358-2
|
Desethylvardenafil [Mass/volume] in Serum or Plasma |
|
59360-8
|
Desethylvardenafil [Mass/volume] in Urine |
|
60748-1
|
Desflurane gas delivered during case [Volume] from Gas delivery system |
|
61022-0
|
Desflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76012-4
|
Desflurane liquid delivered during case [Volume] from Gas delivery system |
|
76013-2
|
Desflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
60741-6
|
Desflurane target [VFr/PPres] Airway adaptor --at end expiration |
|
78821-6
|
Desipramine cutoff [Mass/volume] in Urine for Confirmatory method |
|
4212-7
|
Desipramine [Mass] of Dose |
|
40358-4
|
Desipramine [Presence] in Gastric fluid |
|
29409-0
|
Desipramine [Mass/volume] in Gastric fluid |
|
59893-8
|
Desipramine [Moles/volume] in Gastric fluid |
|
3532-9
|
Desipramine [Presence] in Serum or Plasma |
|
35606-3
|
Desipramine [Mass/volume] in Serum or Plasma by Screen method |
|
3531-1
|
Desipramine [Mass/volume] in Serum or Plasma |
|
14691-0
|
Desipramine [Moles/volume] in Serum or Plasma |
|
3535-2
|
Desipramine [Mass/volume] in Serum or Plasma --trough |
|
61413-1
|
Desipramine [Mass/volume] in Urine by Confirmatory method |
|
3533-7
|
Desipramine [Presence] in Urine |
|
61412-3
|
Desipramine [Presence] in Urine by Confirmatory method |
|
3534-5
|
Desipramine [Mass/volume] in Urine |
|
14692-8
|
Desipramine [Moles/volume] in Urine |
|
60300-1
|
Desipramine [Moles/volume] in Unspecified specimen |
|
61411-5
|
Desipramine/Creatinine [Mass Ratio] in Urine |
|
59299-8
|
Desloratadine [Mass/volume] in Blood |
|
59300-4
|
Desloratadine [Mass/volume] in Serum or Plasma |
|
59301-2
|
Desloratadine [Mass/volume] in Urine |
|
72457-5
|
Desmin Ab [Presence] in Serum or Plasma by Immunoblot |
|
10476-0
|
Desmin Ag [Presence] in Tissue by Immune stain |
|
57411-1
|
Desmoglein 1 Ab [Units/volume] in Serum by Immunoassay |
|
63218-2
|
Desmoglein 1 Ab [Presence] in Serum by Immunoassay |
|
43311-0
|
Desmoglein 1 Ab [Units/volume] in Serum |
|
57412-9
|
Desmoglein 3 Ab [Units/volume] in Serum by Immunoassay |
|
63219-0
|
Desmoglein 3 Ab [Presence] in Serum by Immunoassay |
|
43312-8
|
Desmoglein 3 Ab [Units/volume] in Serum |
|
92836-6
|
Desmoplastic melanoma [Identifier] in Skin melanoma |
|
82975-4
|
Desmosome IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
71368-5
|
Desmosome IgG Ab [Titer] in Serum by Immunofluorescence |
|
75739-3
|
Desmosterol [Mass/volume] in Serum or Plasma |
|
74905-1
|
Desmosterol [Moles/volume] in Serum or Plasma |
|
74817-8
|
Desomorphine [Mass/volume] in Urine by Confirmatory method |
|
74818-6
|
Desomorphine [Presence] in Urine by Screen method |
|
57956-5
|
Desoxymethyltestosterone [Presence] in Urine |
|
11072-6
|
Despropionylfentanyl [Mass/volume] in Serum or Plasma |
|
11073-4
|
Despropionylfentanyl [Mass/volume] in Urine |
|
86708-5
|
Determination of pressure injury risk in last 7 days [CMS Assessment] |
|
93287-1
|
Deterrents of most severe suicidal ideation 1 month [C-SSRS] |
|
93288-9
|
Deterrents of most severe suicidal ideation Lifetime [C-SSRS] |
|
23852-7
|
Deuteroporphyrin [Mass/time] in unspecified time Stool |
|
75026-5
|
Deuteroporphyrin/Porphyrins.total in Stool |
|
14696-9
|
Deuteroporphyrin [Moles/volume] in Stool |
|
45307-6
|
Deuteroporphyrin [Moles/mass] in Stool |
|
89250-5
|
Device or anatomic structure visible in wound |
|
90710-5
|
Developmental-behavioral pediatrics Consult note |
|
93957-9
|
Developmental-behavioral pediatrics Diagnostic study note |
|
68663-4
|
Developmental-behavioral pediatrics Discharge summary |
|
68665-9
|
Developmental-behavioral pediatrics History and physical note |
|
68670-9
|
Developmental-behavioral pediatrics Hospital Consult note |
|
68671-7
|
Developmental-behavioral pediatrics Hospital Letter |
|
68666-7
|
Developmental-behavioral pediatrics Note |
|
89881-7
|
Developmental-behavioral pediatrics Outpatient Note |
|
68667-5
|
Developmental-behavioral pediatrics procedure note |
|
68668-3
|
Developmental-behavioral pediatrics Progress note |
|
89896-5
|
Developmental-behavioral pediatrics Telehealth Note |
|
68669-1
|
Developmental-behavioral pediatrics Transfer summary note |
|
91604-9
|
Device count |
|
44615-3
|
Device error code [Identifier] |
|
74718-8
|
Type of device identifier [AHRQ] |
|
74709-7
|
Device intended for single use was involved in the event or unsafe condition [AHRQ] |
|
74708-9
|
Device intended for single use was reused in the event or unsafe condition [AHRQ] |
|
74723-8
|
Device involved in patient safety event or unsafe condition [AHRQ] |
|
74720-4
|
Device name |
|
81002-8
|
Devices used during Cardiac catheterization |
|
77665-8
|
Dexamethasone [Mass] of Dose |
|
56712-3
|
Dexamethasone IgE Ab [Units/volume] in Serum |
|
14062-4
|
Dexamethasone [Mass/volume] in Serum or Plasma |
|
46948-6
|
Dexamethasone [Mass/volume] in Urine |
|
16751-0
|
Dezocine [Mass/volume] in Blood |
|
16750-2
|
Dezocine [Mass/volume] in Serum or Plasma |
|
14063-2
|
Dezocine [Presence] in Urine |
|
18216-2
|
Dezocine [Presence] in Urine by Confirmatory method |
|
77122-0
|
DFNB31 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77121-2
|
DFNB31 gene full mutation analysis in Blood or Tissue by Sequencing |
|
94098-1
|
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
82998-6
|
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Line blot |
|
75095-0
|
Docosahexaenoate (C22:6w3) [Entitic substance] in Red Blood Cells |
|
81037-4
|
Docosahexaenoate (DHA) intake 24 hour Estimated |
|
81038-2
|
Docosahexaenoate (DHA) intake 24 hour Measured |
|
35174-2
|
Docosahexaenoate (C22:6w3) [Moles/volume] in Serum or Plasma |
|
54386-8
|
Dehydroascorbate [Moles/volume] in Serum or Plasma |
|
90914-3
|
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood |
|
88995-6
|
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma |
|
54385-0
|
Dehydroascorbate/Ascorbate in Serum or Plasma |
|
24081-2
|
Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast |
|
14067-3
|
Dihydrocodeine [Mass/volume] in Blood |
|
19451-4
|
Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19450-6
|
Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method |
|
16775-9
|
Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method |
|
12785-2
|
Dihydrocodeine Free [Mass/volume] in Serum or Plasma |
|
74811-1
|
Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
86227-6
|
Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
42901-9
|
Dihydrocodeine [Mass/volume] in Serum or Plasma |
|
19448-0
|
Dihydrocodeine [Mass/volume] in Urine by Confirmatory method |
|
14066-5
|
Dihydrocodeine [Presence] in Urine |
|
16211-5
|
Dihydrocodeine [Presence] in Urine by Confirmatory method |
|
19446-4
|
Dihydrocodeine [Presence] in Urine by Screen method |
|
19449-8
|
Dihydrocodeine [Mass/volume] in Urine |
|
64131-6
|
Dihydrocodeine/Creatinine [Mass Ratio] in Urine |
|
27035-5
|
Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium |
|
28072-7
|
Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool |
|
46703-5
|
Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method |
|
46704-3
|
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method |
|
49750-3
|
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma |
|
51955-3
|
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine |
|
46257-2
|
Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method |
|
51765-6
|
Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma |
|
51448-9
|
Dihydrocodeine+Hydrocodol [Mass/volume] in Urine |
|
55195-2
|
DHCR7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
56589-5
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
13862-8
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
|
56586-1
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
13863-6
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
55475-8
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
56510-1
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
55815-5
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine |
|
13612-7
|
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine |
|
25895-4
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in 24 hour Urine |
|
25391-4
|
Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine |
|
57789-0
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57790-8
|
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57785-8
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57786-6
|
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
56590-3
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
13864-4
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
56587-9
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
31020-1
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Amniotic fluid |
|
16734-6
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --baseline |
|
55474-1
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma --baseline |
|
16735-3
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --post XXX challenge |
|
47852-9
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin |
|
57787-4
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57788-2
|
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57783-3
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57784-1
|
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
30029-3
|
Dehydroepiandrosterone (DHEA) [Units/volume] in Saliva (oral fluid) |
|
49716-4
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Saliva (oral fluid) |
|
74361-7
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Saliva (oral fluid) |
|
2193-1
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma |
|
35206-2
|
Dehydroepiandrosterone (DHEA) [Mass or Moles/volume] in Serum or Plasma |
|
15054-0
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
|
49887-3
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
12590-6
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12591-4
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12592-2
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12593-0
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12594-8
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16732-0
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
59840-9
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
16733-8
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
2194-9
|
Dehydroepiandrosterone (DHEA) [Presence] in Urine |
|
2195-6
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Urine |
|
34279-0
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Urine |
|
29879-4
|
Dehydroepiandrosterone (DHEA)/Creatinine [Mass Ratio] in 24 hour Urine |
|
34283-2
|
Dehydroepiandrosterone (DHEA)/Creatinine [Molar ratio] in Urine |
|
82878-0
|
Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82879-8
|
Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
49888-1
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
56508-5
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
2192-3
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine |
|
34281-6
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in 24 hour Urine |
|
15053-2
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine |
|
56507-7
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
56591-1
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
56588-7
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
2190-7
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid |
|
56552-3
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --baseline |
|
49889-9
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --pre dose corticotropin |
|
16721-3
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) |
|
2191-5
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma |
|
35205-4
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass or Moles/volume] in Serum or Plasma |
|
14688-6
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
|
59983-7
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
16722-1
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
16723-9
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16724-7
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16725-4
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16726-2
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
16727-0
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16728-8
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
16729-6
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
16730-4
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
34280-8
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Urine |
|
76347-4
|
Dehydroepiandrosterone sulfate (DHEA-S)/Cortisol [Molar ratio] in Serum or Plasma |
|
34282-4
|
Dehydroepiandrosterone sulfate (DHEA-S)/Creatinine [Molar ratio] in Urine |
|
72497-1
|
Dihydropteridine reductase [Enzymatic activity/mass] in DBS |
|
79459-4
|
Dihydropteridine reductase [Enzymatic activity/mass] in Red Blood Cells |
|
2212-9
|
Dihydropteridine reductase [Enzymatic activity/volume] in Serum |
|
23034-2
|
Duck hepatitis virus 1 Ab [Presence] in Serum |
|
23033-4
|
Duck hepatitis virus 1 Ab [Presence] in Serum by Neutralization test |
|
31803-0
|
Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen |
|
23035-9
|
Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen by Neutralization test |
|
23036-7
|
Duck hepatitis virus 2 Ab [Presence] in Serum |
|
23037-5
|
Duck hepatitis virus 2 Ab [Presence] in Serum by Neutralization test |
|
31804-8
|
Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen |
|
23038-3
|
Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen by Neutralization test |
|
23039-1
|
Duck hepatitis virus 3 Ab [Presence] in Serum |
|
23040-9
|
Duck hepatitis virus 3 Ab [Presence] in Serum by Neutralization test |
|
31805-5
|
Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen |
|
23041-7
|
Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
979-5
|
Di sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
980-3
|
Di sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
981-1
|
Di sup(a) Ab [Presence] in Serum or Plasma |
|
92548-7
|
Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92510-7
|
Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
982-9
|
Di sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
983-7
|
Di sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
984-5
|
Di sup(a) Ag [Presence] on Red Blood Cells |
|
985-2
|
Di sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
986-0
|
Di sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
987-8
|
Di sup(b) Ab [Presence] in Serum or Plasma |
|
92547-9
|
Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92509-9
|
Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
988-6
|
Di sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
989-4
|
Di sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
990-2
|
Di sup(b) Ag [Presence] on Red Blood Cells |
|
71490-7
|
Diabetic retinopathy severity level Left eye by Ophthalmoscopy |
|
71491-5
|
Diabetic retinopathy severity level Right eye by Ophthalmoscopy |
|
92663-4
|
Problem related to diabetes Family member |
|
33248-6
|
Diabetes status [Identifier] |
|
74150-4
|
Diabetes Type I action plan |
|
74151-2
|
Diabetes Type II action plan |
|
92655-0
|
Age diabetes-related problem occurred for Family member |
|
84084-3
|
Diabetology Case manager Note |
|
34760-9
|
Diabetology Consult note |
|
34897-9
|
Diabetology Education note |
|
84085-0
|
Diabetology Group counseling note |
|
84087-6
|
Diabetology Hospital Note |
|
84086-8
|
Diabetology Initial evaluation note |
|
84088-4
|
Diabetology Medication management note |
|
34861-5
|
Diabetology Note |
|
83570-2
|
Diabetology Nurse Consult note |
|
83571-0
|
Diabetology Nurse Note |
|
83572-8
|
Diabetology Nurse Outpatient Note |
|
84089-2
|
Diabetology Outpatient Group counseling note |
|
84090-0
|
Diabetology Outpatient Initial evaluation note |
|
34110-7
|
Diabetology Outpatient Note |
|
84091-8
|
Diabetology Outpatient Risk assessment and screening note |
|
84093-4
|
Diabetology Telephone encounter Note |
|
84094-2
|
Diabetology Plan of care note |
|
57136-4
|
Diabetology Referral note |
|
84092-6
|
Diabetology Risk assessment and screening note |
|
89890-8
|
Diabetology Telehealth Note |
|
70004-7
|
Diagnostic study note |
|
67714-6
|
Diagnosing provider phone number |
|
85418-2
|
Diagnosis for interruption or death [CMS Assessment] |
|
18748-4
|
Diagnostic imaging study |
|
62365-2
|
Diagnostic impression [Interpretation] in Unspecified specimen Narrative |
|
80562-2
|
Diagram |
|
88239-9
|
Dialysis unit visit as part of chronic kidney disease education |
|
87233-3
|
Dialysis Consult note |
|
87235-8
|
Dialysis Discharge summary |
|
87234-1
|
Dialysis Education note |
|
87238-2
|
Dialysis Note |
|
87237-4
|
Dialysis Plan of care note |
|
87236-6
|
Dialysis Summary note |
|
72050-8
|
Dialysis access [ESRD] |
|
72044-1
|
Dialysis access physical exam frequency |
|
42605-6
|
Peritoneal dialysis bag number |
|
87265-5
|
Dialysis Interdisciplinary Plan of care note |
|
87267-1
|
Dialysis Physician Note |
|
70958-4
|
Dialysis method [ESRD] |
|
87266-3
|
Dialysis Nurse Note |
|
71497-2
|
Dialysis organization affiliation Dialysis facility [ESRD] |
|
29749-9
|
Dialysis records |
|
65836-9
|
Dialysis services offered Facility |
|
71533-4
|
Dialysis shifts Dialysis facility # [ESRD] |
|
20166-5
|
Diameter by US 2D |
|
52729-1
|
Diameter transverse Pressure injury.largest stage 3 or 4 [CMS Assessment] |
|
52728-3
|
Diameter.any.max Pressure injury.largest stage 3 or 4 [CMS Assessment] |
|
60438-9
|
Diamine oxidase [Units/volume] in Serum or Plasma |
|
81669-4
|
Diaper count |
|
59655-1
|
diazePAM [Mass/volume] in Blood by Confirmatory method |
|
59654-4
|
diazePAM [Mass/volume] in Blood |
|
79251-5
|
diazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19445-6
|
diazePAM cutoff [Mass/volume] in Urine for Confirmatory method |
|
19444-9
|
diazePAM cutoff [Mass/volume] in Urine for Screen method |
|
4217-6
|
diazePAM [Mass] of Dose |
|
59657-7
|
diazePAM [Mass/volume] in Body fluid by Confirmatory method |
|
59656-9
|
diazePAM [Mass/volume] in Body fluid |
|
52946-1
|
diazePAM [Presence] in Gastric fluid |
|
29384-5
|
diazePAM [Mass/volume] in Gastric fluid |
|
26837-5
|
diazePAM [Mass/mass] in Hair |
|
73423-6
|
diazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73422-8
|
diazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59658-5
|
diazePAM [Mass/mass] in Meconium by Confirmatory method |
|
26935-7
|
diazePAM [Mass/mass] in Meconium |
|
72610-9
|
diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72611-7
|
diazePAM [Presence] in Saliva (oral fluid) |
|
26784-9
|
diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3549-3
|
diazePAM [Presence] in Serum or Plasma |
|
35607-1
|
diazePAM [Mass/volume] in Serum or Plasma by Screen method |
|
3548-5
|
diazePAM [Mass/volume] in Serum or Plasma |
|
14697-7
|
diazePAM [Moles/volume] in Serum or Plasma |
|
59659-3
|
diazePAM [Mass/mass] in Stool by Confirmatory method |
|
12378-6
|
diazePAM [Presence] in Stool |
|
27275-7
|
diazePAM [Mass/mass] in Stool |
|
59661-9
|
diazePAM [Mass/mass] in Tissue by Confirmatory method |
|
59660-1
|
diazePAM [Mass/mass] in Tissue |
|
3552-7
|
diazePAM [Mass/volume] in Serum or Plasma --trough |
|
16227-1
|
diazePAM [Mass/volume] in Urine by Confirmatory method |
|
3550-1
|
diazePAM [Presence] in Urine |
|
18388-9
|
diazePAM [Presence] in Urine by Confirmatory method |
|
19443-1
|
diazePAM [Presence] in Urine by Screen method |
|
3551-9
|
diazePAM [Mass/volume] in Urine |
|
27192-4
|
diazePAM [Mass/volume] in Vitreous fluid |
|
61074-1
|
diazePAM [Presence] in Unspecified specimen |
|
48948-4
|
diazePAM [Mass/volume] in Unspecified specimen |
|
77323-4
|
diazePAM [Moles/volume] in Unspecified specimen |
|
64130-8
|
diazePAM/Creatinine [Mass Ratio] in Urine |
|
16757-7
|
diazePAM+Nordiazepam [Mass/volume] in Serum or Plasma |
|
50849-9
|
diazePAM+Nordiazepam [Moles/volume] in Serum or Plasma |
|
21241-5
|
diazePAM+Nordiazepam [Mass/volume] in Urine |
|
5638-2
|
Diazinon [Mass/volume] in Blood |
|
35488-6
|
Diazinon [Mass/volume] in Serum or Plasma |
|
35479-5
|
Diazinon [Mass/volume] in Urine |
|
87666-4
|
Diazinon [Mass/mass] in Unspecified specimen |
|
38657-3
|
Diazomethane [Mass/volume] in Air |
|
10534-6
|
Diazoxide [Mass/volume] in Serum or Plasma |
|
55672-0
|
Dibekacin [Susceptibility] by Gradient strip |
|
55671-2
|
Dibekacin [Susceptibility] by Disk diffusion (KB) |
|
55669-6
|
Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55670-4
|
Dibekacin [Susceptibility] |
|
3553-5
|
Dibenzepin [Mass/volume] in Blood |
|
4218-4
|
Dibenzepin [Mass] of Dose |
|
38760-5
|
Dibenzofuran [Mass/volume] in Air |
|
72827-9
|
dic(9;20)(p11-13;q11)(wcp9+,wcp20+) [Identifier] in Blood or Tissue by FISH Nominal |
|
16758-5
|
Dicamba [Mass/volume] in Serum or Plasma |
|
16759-3
|
Dicamba [Mass/volume] in Urine |
|
2206-1
|
Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum |
|
2207-9
|
Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine |
|
55854-4
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Amniotic fluid |
|
55853-6
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Cerebral spinal fluid |
|
53214-3
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS |
|
55855-1
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Serum or Plasma |
|
55856-9
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Urine |
|
55852-8
|
Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine [Molar ratio] in Urine |
|
53213-5
|
Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS |
|
74528-1
|
Dicarboxyeicosanoylcarnitine (C20-DC) [Moles/volume] in Serum or Plasma |
|
82585-1
|
Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in DBS |
|
74529-9
|
Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in Serum or Plasma |
|
82584-4
|
Dicarboxyhexenoylcarnitine (C6:1-DC)/Creatinine [Molar ratio] in Urine |
|
69771-4
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Amniotic fluid |
|
69770-6
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Cerebral spinal fluid |
|
53219-2
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS |
|
18466-3
|
Dicarboxyoleylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma |
|
59207-1
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Serum or Plasma |
|
69773-0
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Urine |
|
69769-8
|
Dicarboxyoleylcarnitine (C18:1-DC)/Creatinine [Molar ratio] in Urine |
|
53217-6
|
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in DBS |
|
74530-7
|
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in Serum or Plasma |
|
54478-3
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Amniotic fluid |
|
54477-5
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Cerebral spinal fluid |
|
53218-4
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS |
|
74598-4
|
Dicarboxypalmitoylcarnitine (C16-DC) [Enzymatic activity/mass] in Fibroblast |
|
55872-6
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Serum or Plasma |
|
54480-9
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Urine |
|
54459-3
|
Dicarboxypalmitoylcarnitine (C16-DC)/Creatinine [Molar ratio] in Urine |
|
54483-3
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Amniotic fluid |
|
54482-5
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Cerebral spinal fluid |
|
53220-0
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS |
|
55949-2
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Serum or Plasma |
|
54485-8
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Urine |
|
54481-7
|
Dicarboxystearoylcarnitine (C18-DC)/Creatinine [Molar ratio] in Urine |
|
53216-8
|
Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS |
|
74531-5
|
Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in Serum or Plasma |
|
70175-5
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Amniotic fluid |
|
70174-8
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Cerebral spinal fluid |
|
53215-0
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS |
|
70176-3
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Serum or Plasma |
|
70177-1
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Urine |
|
69795-3
|
Dicarboxytetradecenoylcarnitine (C14:1-DC)/Creatinine [Molar ratio] in Urine |
|
38663-1
|
Dichlorobenzidine [Mass/volume] in Air |
|
10911-6
|
Dichlorobenzidine [Mass/volume] in Urine |
|
3557-6
|
Dichlorphenamide [Mass/time] in 24 hour Urine |
|
4220-0
|
Dichlorphenamide [Mass] of Dose |
|
3555-0
|
Dichlorphenamide [Presence] in Urine |
|
3556-8
|
Dichlorphenamide [Mass/volume] in Urine |
|
38591-4
|
Dichlorvos [Mass/volume] in Air |
|
60070-0
|
Dichlorvos [Mass/volume] in Blood |
|
30026-9
|
Dichlorvos [Mass/volume] in Serum or Plasma |
|
16768-4
|
Dichlorvos [Mass/volume] in Urine |
|
87750-6
|
Dichlorvos [Mass/mass] in Unspecified specimen |
|
59662-7
|
Diclofenac [Mass/volume] in Blood |
|
56701-6
|
Diclofenac IgE Ab [Units/volume] in Serum |
|
48274-5
|
Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes |
|
9515-8
|
Diclofenac [Mass/volume] in Serum or Plasma |
|
59663-5
|
Diclofenac [Mass/volume] in Urine |
|
87782-9
|
Diclofenac/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
55668-8
|
Dicloxacillin [Susceptibility] by Gradient strip |
|
222-0
|
Dicloxacillin [Susceptibility] by Disk diffusion (KB) |
|
221-2
|
Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
220-4
|
Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
10984-3
|
Dicloxacillin [Mass/volume] in Serum or Plasma |
|
18916-7
|
Dicloxacillin [Susceptibility] |
|
223-8
|
Dicloxacillin [Susceptibility] by Serum bactericidal titer |
|
16769-2
|
Dicloxacillin [Mass/volume] in Urine |
|
25252-8
|
Dicloxacillin [Mass/volume] in Unspecified specimen |
|
3558-4
|
Dicoumarol [Mass/volume] in Serum or Plasma |
|
16770-0
|
Dicoumarol [Mass/volume] in Urine |
|
87609-4
|
Dicoumarol [Mass/mass] in Unspecified specimen |
|
73421-0
|
Dicyclomine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73420-2
|
Dicyclomine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16771-8
|
Dicyclomine [Mass/volume] in Serum or Plasma |
|
72075-5
|
Did patient provide the home blood pressure values to the dialysis unit [ESRD] |
|
72080-5
|
Did prescribed dialysate sodium concentration exceed 138 mEq/L for any dialysis session during the Mo [ESRD] |
|
85630-2
|
Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity during 3 day assessment period [CAM.CMS] |
|
71481-6
|
Did the death of this person involve injury of any kind |
|
71477-4
|
Did the infection require hospitalization [ESRD] |
|
85631-0
|
Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said during 3 day assessment period [CAM.CMS] |
|
83274-1
|
Did the patient have major surgery during the 100 days prior to admission [CMS Assessment] |
|
90542-2
|
Did the resident have a major surgical procedure during the prior inpatient hospital stay that requires active care during the SNF stay [CMS Assessment] |
|
71083-0
|
Did the treatment staff discuss how your health and treatment may affect you emotionally [FACIT] |
|
71081-4
|
Did the treatment staff discuss how your health and treatment may affect your normal daily activities [FACIT] |
|
71080-6
|
Did the treatment staff discuss how your health and treatment may affect your normal work - including housework [FACIT] |
|
71082-2
|
Did the treatment staff discuss how your health and treatment may affect your personal relationships [FACIT] |
|
71100-2
|
Did the treatment staff respect your privacy [FACIT] |
|
76900-0
|
Did you drink any type of alcoholic beverage in past 30D [PROMIS] |
|
71912-0
|
Did you feel full of pep during the past 4 weeks [Veterans RAND] |
|
71099-6
|
Did you feel that the treatment staff answered your questions honestly [FACIT] |
|
71078-0
|
Did you feel that the treatment staff worked together towards the same goal [FACIT] |
|
71904-7
|
Did you feel tired during the past 4 weeks [Veterans RAND] |
|
71906-2
|
Did you feel worn out during the past 4 weeks [Veterans RAND] |
|
71085-5
|
Did you feel your doctors had experience treating your illness [FACIT] |
|
71086-3
|
Did you feel your doctor-s knew about the latest medical developments for your illness [FACIT] |
|
71073-1
|
Did you get to say the things that were important to you [FACIT] |
|
71908-8
|
Did you have a lot of energy during the past 4 weeks [Veterans RAND] |
|
71071-5
|
Did you have an opportunity to ask questions [FACIT] |
|
71101-0
|
Did you have confidence in your doctor-s [FACIT] |
|
71092-1
|
Did you have enough information to make decisions about your health care [FACIT] |
|
71091-3
|
Did you have enough time to make decisions about your health care [FACIT] |
|
82144-7
|
Did you live with anyone who served time or was sentenced to serve time in a prison, jail, or other correctional facility--before 18 years old [ACE.BRFSS] |
|
82143-9
|
Did you live with anyone who used illegal street drugs or who abused prescription medications--before 18 years old [ACE.BRFSS] |
|
82142-1
|
Did you live with anyone who was a problem drinker or alcoholic--before 18 years old [ACE.BRFSS] |
|
82141-3
|
Did you live with anyone who was depressed, mentally ill, or suicidal--before 18 years old [ACE.BRFSS] |
|
93668-2
|
Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2 months [WellRx] |
|
71102-8
|
Did you trust your doctor-s suggestions for treatment [FACIT] |
|
71089-7
|
Did your doctor-s discuss other treatments, example, alternative medicine or new for treatments [FACIT] |
|
71069-9
|
Did your doctor-s explain the possible benefits of your treatment [FACIT] |
|
71070-7
|
Did your doctor-s explain the possible side effects or risks of your treatment [FACIT] |
|
71068-1
|
Did your doctor-s give explanations that you could understand [FACIT] |
|
71058-2
|
Did your doctor-s help you evaluate the effects of your treatment so far [FACIT] |
|
71093-9
|
Did your doctor-s seem to respect your opinions [FACIT] |
|
71074-9
|
Did your doctor-s seem to understand what was important to you [FACIT] |
|
71077-2
|
Did your doctor-s seem to understand your needs [FACIT] |
|
71075-6
|
Did your doctor-s show genuine concern for you [FACIT] |
|
85598-1
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by causing swelling in your ankles or legs [MLHFQ] |
|
85611-2
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by costing you money for medical care [MLHFQ] |
|
85612-0
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by giving you side effects from treatments [MLHFQ] |
|
85616-1
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making it difficult for you to concentrate or remember things [MLHFQ] |
|
85614-6
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you feel a loss of self-control in your life [MLHFQ] |
|
85617-9
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you feel depressed [MLHFQ] |
|
85613-8
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you feel you are a burden to your family or friends [MLHFQ] |
|
85608-8
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you short of breath [MLHFQ] |
|
85619-5
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you sit or lie down to rest during the day [MLHFQ] |
|
85610-4
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you stay in a hospital [MLHFQ] |
|
85620-3
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you tired, fatigued or low on energy [MLHFQ] |
|
85615-3
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you worry [MLHFQ] |
|
85601-3
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your going places away from home difficult? [MLHFQ] |
|
85605-4
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your recreational pastimes, sports or hobbies difficult [MLHFQ] |
|
85603-9
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your relating to or doing things with your friends or family difficult [MLHFQ] |
|
85606-2
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your sexual activities difficult [MLHFQ] |
|
85602-1
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your sleeping well at night difficult [MLHFQ] |
|
85599-9
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your walking about or climbing stairs difficult [MLHFQ] |
|
85600-5
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your working around the house or yard difficult [MLHFQ] |
|
85604-7
|
Did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your working to earn a living difficult [MLHFQ] |
|
85607-0
|
Did your heart failure prevent you from living as you wanted during the past month (4weeks) by making you eat less of the foods you like [MLHFQ] |
|
71095-4
|
Did your nurses give explanations that you could understand [FACIT] |
|
71097-0
|
Did your nurse-s seem to understand your needs [FACIT] |
|
71096-2
|
Did your nurses show genuine concern for you [FACIT] |
|
30284-4
|
Didanosine [Susceptibility] by Genotype method |
|
30270-3
|
Didanosine [Susceptibility] by Phenotype method |
|
29116-1
|
Didanosine [Units/volume] in Serum or Plasma |
|
48307-3
|
Didanosine [Mass/volume] in Serum or Plasma |
|
30300-8
|
Didanosine [Susceptibility] |
|
74095-1
|
Didesmethylcitalopram [Mass/volume] in Serum or Plasma |
|
26042-2
|
Didesmethylcitalopram [Moles/volume] in Serum or Plasma |
|
16773-4
|
Dieldrin [Mass/volume] in Blood |
|
11095-7
|
Dieldrin [Mass/volume] in Serum or Plasma |
|
16772-6
|
Dieldrin [Mass/volume] in Urine |
|
87665-6
|
Dieldrin [Mass/mass] in Unspecified specimen |
|
77243-4
|
Dietary behavior |
|
38665-6
|
Diethanolamine [Mass/volume] in Air |
|
27001-7
|
Diethyl ether [Presence] in Blood |
|
13936-0
|
Diethyl ether [Mass/volume] in Blood |
|
2208-7
|
Diethyl ether [Mass/volume] in Serum or Plasma |
|
21243-1
|
Diethyl ether [Mass/volume] in Urine |
|
57860-9
|
Diethylamine [Moles/volume] in Unspecified specimen |
|
41474-8
|
Diethylcarbamazepine [Mass/volume] in DBS |
|
16774-2
|
Diethylcarbamazepine [Mass/volume] in Serum or Plasma |
|
34436-6
|
Diethylene glycol [Mass/volume] in Serum or Plasma |
|
3347-2
|
Diethylpropion [Mass/time] in 24 hour Urine |
|
4124-4
|
Diethylpropion [Mass] of Dose |
|
90444-1
|
Diethylpropion [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
16366-7
|
Diethylpropion [Mass/volume] in Serum or Plasma |
|
55532-6
|
Diethylpropion [Moles/volume] in Serum or Plasma |
|
3345-6
|
Diethylpropion [Presence] in Urine |
|
16210-7
|
Diethylpropion [Presence] in Urine by Confirmatory method |
|
3346-4
|
Diethylpropion [Mass/volume] in Urine |
|
14064-0
|
Diethylstilbestrol [Mass/volume] in Serum or Plasma |
|
38666-4
|
Diethylsulfate [Mass/volume] in Air |
|
57957-3
|
Difenacoum [Mass/volume] in Serum or Plasma |
|
74115-7
|
Difenacoum [Presence] in Unspecified specimen by Screen method |
|
87608-6
|
Difenacoum [Mass/mass] in Unspecified specimen |
|
87607-8
|
Difethialone [Mass/mass] in Unspecified specimen |
|
69578-3
|
Diffusion capacity.carbon monoxide/Alveolar volume adjusted for hemoglobin |
|
82620-6
|
Diffusion capacity/Alveolar volume --post bronchodilation |
|
82619-8
|
Diffusion capacity/Alveolar volume --pre bronchodilation |
|
93783-9
|
Diffuse large B-cell lymphoma cell of origin [Type] in Tissue |
|
93781-3
|
Diffuse large B-cell lymphoma.activated B-cell subtype [Likelihood] in Tissue |
|
92238-5
|
Differential diagnosis |
|
49024-3
|
Differential cell count method - Blood |
|
89212-5
|
Reason for difficult intubation |
|
71124-2
|
Difficult times have strengthened my faith or spiritual beliefs in the past 7 days [FACIT] |
|
93118-8
|
Difficulties in pregnancy total score [NuMoM2b] |
|
88754-7
|
Difficulties spreading legs wide apart during the last week [HOOS] |
|
88753-9
|
Difficulties to stride out when walking during the last week [HOOS] |
|
35790-5
|
Difloxacin [Susceptibility] by Disk diffusion (KB) |
|
35791-3
|
Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35792-1
|
Difloxacin [Susceptibility] |
|
14065-7
|
Diflunisal [Mass/volume] in Serum or Plasma |
|
3561-8
|
Digitoxin>6h post dose [Mass/volume] in Serum or Plasma |
|
4221-8
|
Digitoxin [Mass] of Dose |
|
29215-1
|
Digitoxin [Mass/volume] in Body fluid |
|
3559-2
|
Digitoxin [Mass/volume] in Serum or Plasma |
|
15104-3
|
Digitoxin [Moles/volume] in Serum or Plasma |
|
3560-0
|
Digitoxin [Mass/volume] in Urine |
|
4222-6
|
Digoxin [Mass] of Dose |
|
29216-9
|
Digoxin [Mass/volume] in Body fluid |
|
3562-6
|
Digoxin Free [Mass/volume] in Serum or Plasma |
|
32067-1
|
Digoxin Free [Moles/volume] in Serum or Plasma |
|
73418-6
|
Digoxin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73419-4
|
Digoxin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
83093-5
|
Digoxin [Mass/volume] in Serum or Plasma by Immunoassay |
|
83094-3
|
Digoxin [Moles/volume] in Serum or Plasma by Immunoassay |
|
10535-3
|
Digoxin [Mass/volume] in Serum or Plasma |
|
35244-3
|
Digoxin [Mass or Moles/volume] in Serum or Plasma |
|
14698-5
|
Digoxin [Moles/volume] in Serum or Plasma |
|
3563-4
|
Digoxin>12 hours post dose [Mass/volume] in Serum or Plasma |
|
48370-1
|
Dihomogammalinolenate (C20:3n-6) [Moles/volume] in Serum or Plasma |
|
2209-5
|
Dihydrofolate [Mass/volume] in Serum |
|
79661-5
|
Dihydroorotate [Moles/volume] in Cerebral spinal fluid |
|
79654-0
|
Dihydroorotate [Moles/volume] in Serum or Plasma |
|
79653-2
|
Dihydroorotate [Moles/volume] in Urine |
|
78694-7
|
Dihydroorotate/Creatinine [Molar ratio] in Urine |
|
79651-6
|
Dihydrothymine [Moles/volume] in Cerebral spinal fluid |
|
79669-8
|
Dihydrothymine [Moles/volume] in Serum or Plasma |
|
78693-9
|
Dihydrothymine/Creatinine [Molar ratio] in Urine |
|
13015-3
|
Diisobutylketone [Mass/volume] in Blood |
|
21245-6
|
Diisobutylketone [Mass/volume] in Urine |
|
7280-1
|
Dill IgE Ab [Units/volume] in Serum |
|
15683-6
|
Dill IgE Ab RAST class [Presence] in Serum |
|
7281-9
|
Dill IgG Ab [Units/volume] in Serum |
|
56246-2
|
Dill IgG4 Ab [Mass/volume] in Serum |
|
63127-5
|
Dill IgG Ab [Mass/volume] in Serum |
|
73416-0
|
dilTIAZem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73417-8
|
dilTIAZem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6898-1
|
dilTIAZem [Mass/volume] in Serum or Plasma |
|
55533-4
|
dilTIAZem [Moles/volume] in Serum or Plasma |
|
58417-7
|
dilTIAZem [Presence] in Urine |
|
16776-7
|
dilTIAZem [Mass/volume] in Urine |
|
12391-9
|
Dimenhydrinate [Mass/volume] in Serum or Plasma |
|
39475-9
|
Dimenhydrinate [Moles/volume] in Serum or Plasma |
|
12365-3
|
Dimenhydrinate [Presence] in Urine |
|
84894-5
|
Dimension [Length] of Specimen |
|
3566-7
|
Dimetamphetamine [Mass/time] in 24 hour Urine |
|
19455-5
|
Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19454-8
|
Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
20526-0
|
Dimetamphetamine [Mass/volume] in Urine by Confirmatory method |
|
3564-2
|
Dimetamphetamine [Presence] in Urine |
|
19453-0
|
Dimetamphetamine [Presence] in Urine by Confirmatory method |
|
19452-2
|
Dimetamphetamine [Presence] in Urine by Screen method |
|
3565-9
|
Dimetamphetamine [Mass/volume] in Urine |
|
30027-7
|
Dimethoate [Mass/volume] in Serum or Plasma |
|
21246-4
|
Dimethoate [Mass/volume] in Urine |
|
87664-9
|
Dimethoate [Mass/mass] in Unspecified specimen |
|
38689-6
|
Dimethyl sulfate [Mass/volume] in Air |
|
38668-0
|
Dimethylaniline [Mass/volume] in Air |
|
38673-0
|
Dimethylphthalate [Mass/volume] in Air |
|
3567-5
|
Dimethyltryptamine [Mass/volume] in Serum or Plasma |
|
12292-9
|
Dimethyltryptamine [Presence] in Urine |
|
3568-3
|
Dimethyltryptamine [Mass/volume] in Urine |
|
53977-5
|
Dimagnesium phosphate crystals [Presence] in Urine sediment by Light microscopy |
|
2214-5
|
Dinitrobenzene [Mass/volume] in Urine |
|
16778-3
|
Dinitrophenol [Presence] in Serum or Plasma |
|
16779-1
|
Dinitrophenol [Mass/volume] in Urine |
|
10661-7
|
Dinoflagellate identified in Water by Light microscopy |
|
59331-9
|
Dinorsibutramine [Mass/volume] in Blood |
|
59334-3
|
Dinorsibutramine [Mass/volume] in Serum or Plasma |
|
59337-6
|
Dinorsibutramine [Mass/volume] in Urine |
|
38298-6
|
Dinoseb [Mass/volume] in Water |
|
16463-2
|
Bile acid.dihydroxy [Mass/volume] in Serum or Plasma |
|
38187-1
|
Bile acid.dihydroxy [Moles/volume] in Serum or Plasma |
|
54387-6
|
Dihydroxycholestanoate [Moles/volume] in Body fluid |
|
53479-2
|
Dihydroxycholestanoate [Moles/volume] in Serum or Plasma |
|
54388-4
|
Dihydroxycholestanoate [Moles/volume] in Urine |
|
38619-3
|
Dioxin [Mass/volume] in Air |
|
27316-9
|
Dioxin [Presence] in Serum or Plasma |
|
23854-3
|
Dioxin [Mass/volume] in Serum or Plasma |
|
38299-4
|
Dioxin [Mass/volume] in Water |
|
87606-0
|
Diphacinone [Mass/mass] in Unspecified specimen |
|
4224-2
|
Diphenhydramine [Mass] of Dose |
|
61075-8
|
Diphenhydramine [Presence] in Gastric fluid |
|
73415-2
|
Diphenhydramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73414-5
|
Diphenhydramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3569-1
|
Diphenhydramine [Presence] in Serum or Plasma |
|
35608-9
|
Diphenhydramine [Mass/volume] in Serum or Plasma by Screen method |
|
3570-9
|
Diphenhydramine [Mass/volume] in Serum or Plasma |
|
39476-7
|
Diphenhydramine [Moles/volume] in Serum or Plasma |
|
92641-0
|
Diphenhydramine [Mass/volume] in Urine by Confirmatory method |
|
3571-7
|
Diphenhydramine [Presence] in Urine |
|
92647-7
|
Diphenhydramine [Presence] in Urine by Confirmatory method |
|
3572-5
|
Diphenhydramine [Mass/volume] in Urine |
|
29531-1
|
Diphenhydramine [Presence] in Unspecified specimen |
|
14699-3
|
Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid |
|
14700-9
|
Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma |
|
14701-7
|
Diphenhydramine+Dimenhydrinate [Presence] in Urine |
|
32068-9
|
Diphenhydramine+Dimenhydrinate [Presence] in Unspecified specimen |
|
73413-7
|
Diphenoxylate and Atropine (Lomatil) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73412-9
|
Diphenoxylate and Atropine (Lomatil) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12398-4
|
Diphenoxylate [Mass/volume] in Serum or Plasma |
|
33335-1
|
Diphenylmethoxyacetate [Presence] in Urine by Screen method |
|
47853-7
|
Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells |
|
14483-2
|
Diphtheria identified in Bronchial specimen by Organism specific culture |
|
6596-1
|
Diphtheria identified in Isolate by Organism specific culture |
|
14481-6
|
Diphtheria identified in Nose by Organism specific culture |
|
14482-4
|
Diphtheria identified in Skin by Organism specific culture |
|
14480-8
|
Diphtheria identified in Sputum by Organism specific culture |
|
14479-0
|
Diphtheria identified in Throat by Organism specific culture |
|
567-8
|
Diphtheria identified in Unspecified specimen by Organism specific culture |
|
3575-8
|
Dipipanone [Mass/time] in 24 hour Urine |
|
4227-5
|
Dipipanone [Mass] of Dose |
|
3573-3
|
Dipipanone [Presence] in Urine |
|
3574-1
|
Dipipanone [Mass/volume] in Urine |
|
77657-5
|
Diploid cells in G1 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77654-2
|
Diploid cells in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77656-7
|
Diploid cells in S phase/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77655-9
|
Diploid cells/100 cells in Cells.XXX by Flow cytometry (FC) |
|
77662-5
|
Diploid G1 phase cell population peak channel [#] in Cells.XXX by Flow cytometry (FC) |
|
73411-1
|
Dipyridamole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73410-3
|
Dipyridamole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10536-1
|
Dipyridamole [Mass/volume] in Serum or Plasma |
|
9748-5
|
Dipyridamole [Mass/volume] in Unspecified specimen |
|
48783-5
|
Dipyrone IgE Ab [Units/volume] in Serum |
|
48782-7
|
Dipyrone IgE Ab RAST class [Presence] in Serum |
|
48280-2
|
Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes |
|
12339-8
|
Diquat [Presence] in Urine |
|
38300-0
|
Diquat [Mass/volume] in Water |
|
87416-4
|
Diagnostic imaging report - recommended DICOM PS3.20 sections |
|
77286-3
|
Direct care staff [NMMDS] |
|
45613-7
|
Direct care staff believe resident is capable of increased independence in at least some ADLs [CMS Assessment] |
|
7007-8
|
Dirithromycin [Susceptibility] by Gradient strip |
|
35793-9
|
Dirithromycin [Susceptibility] by Disk diffusion (KB) |
|
35794-7
|
Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35795-4
|
Dirithromycin [Susceptibility] |
|
2024-8
|
Carbon dioxide dissolved [Moles/volume] in Plasma |
|
2025-5
|
Carbon dioxide dissolved [Moles/volume] in Red Blood Cells |
|
85216-0
|
Disability examination note |
|
89571-4
|
Disability status [CUBS] |
|
89435-2
|
Disabled from walking by any condition other than heart or lung disease [Rose Dyspnea Scale] |
|
57779-1
|
Disaccharidases [Interpretation] in Small intestine Tissue Narrative |
|
7282-7
|
Discase IgE Ab [Units/volume] in Serum |
|
89242-2
|
Discharge checklist |
|
52525-3
|
Discharge date |
|
55128-3
|
Discharge disposition |
|
75528-0
|
Discharge disposition [MSCDM] |
|
78375-3
|
Discharge diagnosis Narrative |
|
74213-0
|
Discharge instructions |
|
85417-4
|
Discharge living arrangement [CMS Assessment] |
|
75311-1
|
Discharge medications Narrative |
|
86531-1
|
Discharge notification note |
|
18842-5
|
Discharge summary |
|
78039-5
|
Discharge teaching note |
|
75523-1
|
Discharge time |
|
71440-2
|
Discharge type [CMS Assessment] |
|
46582-3
|
Discharge, transfer, death date [CMS Assessment] |
|
93034-7
|
Discharged from the U.S. Armed Forces |
|
87518-7
|
Discharged to caregiver other than caregiver at admission due to suspected abuse |
|
46500-5
|
Discipline of Person Completing Assessment Provider [CMS Assessment] |
|
57657-9
|
Disconnect sensitivity setting Ventilator alarm |
|
78045-2
|
Disease analysis overall interpretation Blood or Tissue Narrative |
|
78044-5
|
Disease assessed [Identifier] Blood or Tissue |
|
74224-7
|
Disease category [Interpretation] in Bone marrow |
|
74023-3
|
Disease of interest in family member |
|
91541-3
|
Disease outcome [Type] |
|
90775-8
|
Disease severity level [Reported] |
|
88859-4
|
Disease stage score for risk calculation |
|
86534-5
|
Disease staging note |
|
77989-2
|
Disease transmission mode |
|
74044-9
|
Disease of interest was cause of death in family member HL7-VMR-CDS |
|
75505-8
|
Diseases with serologic evidence of immunity |
|
4228-3
|
Disopyramide [Mass] of Dose |
|
29217-7
|
Disopyramide [Mass/volume] in Body fluid |
|
29401-7
|
Disopyramide [Mass/volume] in Gastric fluid |
|
59898-7
|
Disopyramide [Moles/volume] in Gastric fluid |
|
13558-2
|
Disopyramide [Presence] in Serum or Plasma |
|
3576-6
|
Disopyramide [Mass/volume] in Serum or Plasma |
|
14702-5
|
Disopyramide [Moles/volume] in Serum or Plasma |
|
12366-1
|
Disopyramide [Presence] in Urine |
|
16780-9
|
Disopyramide [Mass/volume] in Urine |
|
59897-9
|
Disopyramide [Moles/volume] in Urine |
|
60301-9
|
Disopyramide [Moles/volume] in Unspecified specimen |
|
80640-6
|
Disopyramide+Nordisopyramide [Mass/volume] in Serum or Plasma |
|
93415-8
|
Disorganized thinking in last 3 days [CMS Assessment] |
|
54629-1
|
Disorganized thinking in last 7 days [CAM.CMS] |
|
88072-4
|
Dispatch center [Identifier] EMS system |
|
81707-2
|
Dissection technique [Type] in Tissue |
|
43165-0
|
Dissolved solids [Mass/volume] in Water |
|
80478-1
|
Distilled alcohol intake 24 hour Measured |
|
85304-4
|
Distance of carcinoma from anterior margin [Length] in Breast cancer specimen by Light microscopy |
|
85305-1
|
Distance of carcinoma from inferior margin [Length] in Breast cancer specimen by Light microscopy |
|
85306-9
|
Distance of carcinoma from lateral margin [Length] in Breast cancer specimen by Light microscopy |
|
85307-7
|
Distance of carcinoma from medial margin [Length] in Breast cancer specimen by Light microscopy |
|
85308-5
|
Distance of carcinoma from posterior margin [Length] in Breast cancer specimen by Light microscopy |
|
85309-3
|
Distance of carcinoma from superior margin [Length] in Breast cancer specimen by Light microscopy |
|
33748-5
|
Distance from anal verge |
|
44685-6
|
Distance of invasive melanoma to closest deep margin [Length] in Skin melanoma |
|
44683-1
|
Distance of invasive melanoma to closest lateral margin [Length] in Skin melanoma |
|
84890-3
|
Distant metastases confirmed by histology [Presence] in Cancer specimen |
|
33752-7
|
Distance of carcinoma from closest lateral margin [Length] in Specimen |
|
33755-0
|
Distance of carcinoma from deep margin [Length] in Specimen |
|
44684-9
|
Distance of melanoma in situ to closest lateral margin |
|
80087-0
|
Right ventricular outflow tract distal Diameter at end diastole by US.2D.PSAX |
|
84884-6
|
Distal AndOr proximal margin involvement [Presence] in Colorectal cancer specimen |
|
28735-9
|
Distance comment [Interpretation] Left eye Narrative Phoropter |
|
28734-2
|
Distance comment [Interpretation] Right eye Narrative Phoropter |
|
77560-1
|
Distance required to gather essential resources for a patient encounter [NMMDS] |
|
77561-9
|
Distance required to gather essential resources for all patient encounters in a Report Period [NMMDS] |
|
77553-6
|
Distance to access a patient [NMMDS] |
|
77554-4
|
Distance to access all patients in a Report Period [NMMDS] |
|
81184-4
|
Distance of tumor from circumferential resection margin [Length] by Microscopy |
|
81176-0
|
Distance of tumor from circumferential resection margin [Length] in Specimen by Macroscopy |
|
90548-9
|
Distinct calendar days of therapy during assessment period # [CMS Assessment] |
|
86769-7
|
Distinct calendar days of therapy in last 7 days [CMS Assessment] |
|
91350-9
|
Distress subscore [STarT Back] |
|
4229-1
|
Disulfiram [Mass] of Dose |
|
3577-4
|
Disulfiram [Mass/volume] in Serum or Plasma |
|
16781-7
|
Disulfiram [Presence] in Urine |
|
9357-5
|
Disulfiram [Mass/volume] in Urine |
|
87663-1
|
Disulfoton [Mass/mass] in Unspecified specimen |
|
32010-1
|
Diuretics [Identifier] in Serum or Plasma by Screen method |
|
12288-7
|
Diuretics [Identifier] in Urine |
|
75369-9
|
Diuretics [Interpretation] in Urine Qualitative by Screen method |
|
32676-9
|
Diuretics [Mass/volume] in Urine |
|
88677-0
|
German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set |
|
18286-5
|
Donath Landsteiner Ab [Presence] in Blood |
|
18287-3
|
Donath Landsteiner Ab [Presence] in Control Serum and RBC |
|
48817-1
|
Donath Landsteiner Ab [Titer] in Control Serum |
|
18288-1
|
Donath Landsteiner Ab [Titer] in Control Serum and RBC |
|
2210-3
|
Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue |
|
2211-1
|
Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue |
|
75040-6
|
D-Lactate [Moles/volume] in Cerebral spinal fluid |
|
25905-1
|
D-Lactate [Moles/volume] in Serum or Plasma --Pre excercise |
|
14045-9
|
D-Lactate [Moles/volume] in Serum or Plasma |
|
25899-6
|
D-Lactate [Moles/volume] in Serum or Plasma --1st specimen post excercise |
|
25900-2
|
D-Lactate [Moles/volume] in Serum or Plasma --2nd specimen post excercise |
|
25901-0
|
D-Lactate [Moles/volume] in Serum or Plasma --3rd specimen post excercise |
|
25902-8
|
D-Lactate [Moles/volume] in Serum or Plasma --4th specimen post excercise |
|
25903-6
|
D-Lactate [Moles/volume] in Serum or Plasma --5th specimen post excercise |
|
25904-4
|
D-Lactate [Moles/volume] in Serum or Plasma --6th specimen post excercise |
|
74436-7
|
D-Lactate [Moles/mass] in Stool |
|
14046-7
|
D-Lactate [Moles/volume] in Urine |
|
44314-3
|
D-Lactate/Creatinine [Molar ratio] in Urine |
|
77750-8
|
DLD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93790-4
|
Delafloxacin [Susceptibility] by Gradient strip |
|
90447-4
|
Delafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88885-9
|
Delafloxacin [Susceptibility] |
|
74626-3
|
1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast |
|
74627-1
|
1,1-Dimethoxyhexadecane (DMA 16:0) [Moles/mass] in Red Blood Cells |
|
74624-8
|
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Fibroblast |
|
74625-5
|
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Molar ratio] in Red Blood Cells |
|
74618-0
|
1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/mass] in Fibroblast |
|
74619-8
|
1,1-Dimethoxyoctadecane (DMA 18:0) [Moles/mass] in Red Blood Cells |
|
74616-4
|
1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in Fibroblast |
|
74617-2
|
1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Molar ratio] in Red Blood Cells |
|
74622-2
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast |
|
74623-0
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells |
|
74620-6
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast |
|
74621-4
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells |
|
79343-0
|
Dimethylacetals pattern [Interpretation] in Red Blood Cells Narrative |
|
16777-5
|
Dimethylacetamide [Presence] in Urine |
|
12372-9
|
Dimethylacetamide [Mass/volume] in Urine |
|
73916-9
|
1,3-Dimethylamylamine [Mass/volume] in Urine by Confirmatory method |
|
73915-1
|
1,3-Dimethylamylamine [Presence] in Urine by Screen method |
|
38755-5
|
Dimethylbenzene [Mass/volume] in Air |
|
29296-1
|
Dimethylbenzene [Presence] in Blood |
|
13940-2
|
Dimethylbenzene [Mass/volume] in Blood |
|
5759-6
|
Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
17772-5
|
Dimethylbenzene [Mass/volume] in Urine |
|
13832-1
|
Dimethylbenzene/Creatinine [Mass Ratio] in Urine |
|
75383-0
|
DMD gene deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by MLPA |
|
75385-5
|
DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
50626-1
|
DMD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21247-2
|
DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22075-6
|
DMD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
19428-2
|
Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19427-4
|
Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
31026-8
|
Dextromethamphetamine/Amphetamines.total in Urine |
|
19425-8
|
Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method |
|
58925-9
|
Dextromethamphetamine [Presence] in Urine |
|
19424-1
|
Dextromethamphetamine [Presence] in Urine by Confirmatory method |
|
19423-3
|
Dextromethamphetamine [Presence] in Urine by Screen method |
|
12477-6
|
Dextromethamphetamine [Mass/volume] in Urine |
|
32643-9
|
Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma |
|
13498-1
|
Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine |
|
4214-3
|
Dextromethorphan [Mass] of Dose |
|
52947-9
|
Dextromethorphan [Presence] in Gastric fluid |
|
59896-1
|
Dextromethorphan [Moles/volume] in Gastric fluid |
|
16247-9
|
Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3538-6
|
Dextromethorphan [Presence] in Serum or Plasma |
|
27413-4
|
Dextromethorphan [Units/volume] in Serum or Plasma |
|
13623-4
|
Dextromethorphan [Mass/volume] in Serum or Plasma |
|
59894-6
|
Dextromethorphan [Moles/volume] in Serum or Plasma |
|
92642-8
|
Dextromethorphan [Mass/volume] in Urine by Confirmatory method |
|
3539-4
|
Dextromethorphan [Presence] in Urine |
|
92646-9
|
Dextromethorphan [Presence] in Urine by Confirmatory method |
|
21240-7
|
Dextromethorphan [Mass/volume] in Urine |
|
59895-3
|
Dextromethorphan [Moles/volume] in Urine |
|
40359-2
|
Dextromethorphan [Presence] in Unspecified specimen |
|
57859-1
|
Dextromethorphan [Moles/volume] in Unspecified specimen |
|
27076-9
|
Dextromethorphan+Levorphanol [Presence] in Urine |
|
38592-2
|
Dimethylformamide [Mass/volume] in Air |
|
23853-5
|
Dimethylformamide/Creatinine [Mass Ratio] in Urine |
|
38688-8
|
1,1-Dimethylhydrazine [Mass/volume] in Air |
|
2213-7
|
Dimethadione [Mass/volume] in Serum or Plasma |
|
4215-0
|
Dextromoramide [Mass] of Dose |
|
16747-8
|
Dextromoramide [Presence] in Serum or Plasma |
|
3540-2
|
Dextromoramide [Presence] in Urine |
|
3541-0
|
Dextromoramide [Mass/volume] in Urine |
|
49837-8
|
Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic fluid |
|
35375-5
|
DMPK gene allele 1 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
35751-7
|
DMPK gene allele 1 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
35374-8
|
DMPK gene allele 2 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
35750-9
|
DMPK gene allele 2 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
81855-9
|
DMPK gene CTG repeat analysis in Blood or Tissue by Molecular genetics method |
|
21757-0
|
DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
34727-8
|
DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35749-1
|
DMPK phenotype [Type] in Blood or Tissue by Molecular genetics method |
|
12337-2
|
Dimethylsulfoxide [Presence] in Serum or Plasma |
|
14098-8
|
Dimethylsulfoxide [Mass/volume] in Serum or Plasma |
|
48004-6
|
DNA change (c.HGVS) |
|
48019-4
|
DNA change type |
|
34973-8
|
DNA index 2 in Serum or Plasma by Flow cytometry (FC) |
|
34976-1
|
DNA index 2 in Unspecified specimen by Flow cytometry (FC) |
|
34974-6
|
DNA index 3 in Serum or Plasma by Flow cytometry (FC) |
|
34972-0
|
DNA index 3 in Unspecified specimen by Flow cytometry (FC) |
|
60253-2
|
DNA index 4 in Unspecified specimen by Flow cytometry (FC) |
|
59562-9
|
DNA index by Automated image cytometry |
|
34975-3
|
DNA index in Serum or Plasma by Flow cytometry (FC) |
|
30912-0
|
DNA index in Unspecified specimen by Flow cytometry (FC) |
|
53035-2
|
DNA marker assessed [Identifier] |
|
30911-2
|
DNA ploidy [Identifier] in Unspecified specimen by Flow cytometry (FC) Nominal |
|
30917-9
|
DNA ploidy [Interpretation] in Unspecified specimen by Flow cytometry (FC) Narrative |
|
81293-3
|
Description of ranges of DNA sequences examined |
|
47999-8
|
DNA region name [Identifier] |
|
51959-5
|
Range(s) of DNA sequence examined |
|
69545-2
|
DNA region of interest start [Identifier] |
|
69546-0
|
DNA region of interest stop [Identifier] |
|
47998-0
|
DNA sequence variation display name [Text] Narrative |
|
48003-8
|
DNA sequence variation identifier [Identifier] |
|
53855-3
|
DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
5129-2
|
Deoxyribonuclease Ab [Units/volume] in Serum |
|
13091-4
|
Deoxyribonucleoprotein Ab [Units/volume] in Serum |
|
9308-8
|
2,4-Dinitrophenylhydrazine reacting substances [Presence] in Urine |
|
84095-9
|
Do not resuscitate |
|
81351-9
|
Do Not Resuscitate, Do Not Attempt Resuscitation, or Allow Natural Death order is in place [Reported] |
|
85468-7
|
Do other services need to be involved to help this client - visual analog rating [ePCAM] |
|
83340-0
|
Do other services need to be involved to help this client [PCAM] |
|
991-0
|
Do sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
992-8
|
Do sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
993-6
|
Do sup(a) Ab [Presence] in Serum or Plasma |
|
92546-1
|
Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92508-1
|
Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
994-4
|
Do sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
995-1
|
Do sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
996-9
|
Do sup(a) Ag [Presence] on Red Blood Cells |
|
58059-7
|
Do sup(b) Ab [Presence] in Serum or Plasma |
|
92545-3
|
Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92507-3
|
Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
58060-5
|
Do sup(b) Ag [Presence] on Red Blood Cells |
|
76511-5
|
Do you belong to any clubs or organizations such as church groups unions, fraternal or athletic groups, or school groups [NHANES III] |
|
88381-9
|
Do you currently have a job or do any unpaid work outside your home [IPAQ] |
|
88755-4
|
Do you feel grinding, hear clicking or any other type of noise from your hip during the last week [HOOS] |
|
88796-8
|
Do you feel grinding, hear clicking or any other type of noise when your knee moves during the last week [KOOS] |
|
93026-3
|
Do you feel physically and emotionally safe where you currently live [PRAPARE] |
|
76542-0
|
Do you feel stress - tense, restless, nervous, or anxious, or unable to sleep at night because your mind is troubled all the time - these days [OSQ] |
|
93682-3
|
Do you feel unsafe in your daily life [WellRx] |
|
71059-0
|
Do you feel you received the treatment that was right for you [FACIT] |
|
76863-0
|
Do you get invitations to go out and do things with other people [PROMIS] |
|
89439-4
|
Do you get short of breath walking with other people of your own age on level ground [Rose Dyspnea Scale] |
|
75254-3
|
Do you have difficulty communicating, reading, or do you have limited proficiency in English [HHS.ACA Section 4302.ONC] |
|
75252-7
|
Do you have difficulty walking or climbing stairs [HHS.ACA Section 4302.ONC] |
|
76876-2
|
Do you have someone to bring you to an appointment if you need it [PROMIS] |
|
76862-2
|
Do you have someone to call if you are bored [PROMIS] |
|
76717-8
|
Do you have someone to go with you to an event [PROMIS] |
|
76753-3
|
Do you have someone to help with your daily chores if you are sick [PROMIS] |
|
76754-1
|
Do you have someone to help you clean up around the home if you need it [PROMIS] |
|
76858-0
|
Do you have someone to help you get your mind off things if you need it [PROMIS] |
|
76750-9
|
Do you have someone to help you if you are confined to bed [PROMIS] |
|
76716-0
|
Do you have someone to keep you company at home [PROMIS] |
|
76878-8
|
Do you have someone to pick up a prescription if you need it [PROMIS] |
|
76752-5
|
Do you have someone to prepare your meals if you are unable to do it yourself [PROMIS] |
|
76755-8
|
Do you have someone to run errands if you need it [PROMIS] |
|
76756-6
|
Do you have someone to take over all of your responsibilities at home if you need it [PROMIS] |
|
76751-7
|
Do you have someone to take you to the doctor if you need it [PROMIS] |
|
76713-7
|
Do you have someone with whom to have fun [PROMIS] |
|
76714-5
|
Do you have someone with whom to relax [PROMIS] |
|
76860-6
|
Do you have someone with whom you can celebrate holidays [PROMIS] |
|
76861-4
|
Do you have someone with whom you can celebrate special occasions [PROMIS] |
|
76715-2
|
Do you have someone with whom you can do something enjoyable [PROMIS] |
|
76859-8
|
Do you have someone you can call when you want to chat [PROMIS] |
|
88797-6
|
Do you have swelling in your knee during the last week [KOOS] |
|
89438-6
|
Do you have to stop for breath when walking at your own pace on level ground [Rose Dyspnea Scale] |
|
93671-6
|
Do you have trouble finding or paying for transportation [WellRx] |
|
93670-8
|
Do you have trouble paying for your gas or electricity bills [WellRx] |
|
93672-4
|
Do you need daycare, or better daycare, for your kids [WellRx] |
|
93674-0
|
Do you need help finding a better job [WellRx] |
|
93675-7
|
Do you need help getting more education [WellRx] |
|
93677-3
|
Do you need help with legal issues [WellRx] |
|
75855-7
|
Do you sometimes drink alcoholic beverages [Reported] |
|
21248-0
|
Dobutamine [Mass/volume] in Serum or Plasma |
|
2201-2
|
Deoxycholate [Mass/volume] in Serum |
|
30520-1
|
Deoxycholate [Moles/volume] in Serum or Plasma |
|
2202-0
|
Deoxycholylglycine [Mass/volume] in Serum |
|
79697-9
|
Docosadienoate (C22:2w6) [Entitic substance] in Red Blood Cells |
|
79698-7
|
Docosadienoate (C22:2w6) [Moles/volume] in Serum or Plasma |
|
78348-0
|
Docosapentaenate (C22:5w6) [Entitic substance] in Red Blood Cells |
|
35181-7
|
Docosapentaenate (C22:5w6) [Moles/volume] in Serum or Plasma |
|
48371-9
|
Docosapentaenoate (C22:5 n-3) [Moles/volume] in Serum or Plasma |
|
75112-3
|
Docosatetraenoate (C22:4w6) [Entitic substance] in Red Blood Cells |
|
35182-5
|
Docosatetraenoate (C22:4w6) [Moles/volume] in Serum or Plasma |
|
81765-0
|
Docosatrienoate (C22:3w9) [Entitic substance] in Red Blood Cells |
|
81764-3
|
Docosatrienoate (C22:3w9) [Moles/volume] in Serum or Plasma |
|
78345-6
|
Docosenoate (C22:1) [Entitic substance] in Red Blood Cells |
|
35160-1
|
Docosenoate (C22:1) [Moles/volume] in Serum or Plasma |
|
53109-5
|
Docosenoate (C22:1)/Creatinine [Molar ratio] in Urine |
|
85694-8
|
Documentation of previous rubella immunity testing |
|
92446-4
|
Document key words |
|
91886-2
|
Document name [Identifier] |
|
92447-2
|
Document synopsis |
|
92183-3
|
Document type |
|
69764-9
|
Document type ID |
|
74561-2
|
Documented rescue interventions [AHRQ] |
|
73409-5
|
Docusate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73408-7
|
Docusate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53058-4
|
Dodecanoylcarnitine (C12) [Moles/volume] in Amniotic fluid |
|
53078-2
|
Dodecanoylcarnitine (C12) [Moles/volume] in Cerebral spinal fluid |
|
45199-7
|
Dodecanoylcarnitine (C12) [Moles/volume] in DBS |
|
74608-1
|
Dodecanoylcarnitine (C12) [Enzymatic activity/mass] in Fibroblast |
|
18455-6
|
Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma |
|
30331-3
|
Dodecanoylcarnitine (C12) [Moles/volume] in Serum or Plasma |
|
54389-2
|
Dodecanoylcarnitine (C12) [Moles/volume] in Urine |
|
53510-4
|
Dodecanoylcarnitine (C12)/Creatinine [Molar ratio] in Urine |
|
49939-2
|
Dodecenedioate/Creatinine [Molar ratio] in Urine |
|
53059-2
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Amniotic fluid |
|
53079-0
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Cerebral spinal fluid |
|
45200-3
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS |
|
74607-3
|
Dodecenoylcarnitine (C12:1) [Enzymatic activity/mass] in Fibroblast |
|
18454-9
|
Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma |
|
30332-1
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Serum or Plasma |
|
53104-6
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Urine |
|
53511-2
|
Dodecenoylcarnitine (C12:1)/Creatinine [Molar ratio] in Urine |
|
53542-7
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Amniotic fluid |
|
53545-0
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Cerebral spinal fluid |
|
53543-5
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in DBS |
|
53546-8
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Serum or Plasma |
|
53549-2
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Urine |
|
53552-6
|
Dodeicosanoylcarnitine (C22)/Creatinine [Molar ratio] in Urine |
|
83271-7
|
Does the patient use a wheelchair or scooter during 3 day assessment period [CMS Assessment] |
|
89411-3
|
Does the patient use a wheelchair/scooter [CMS Assessment] |
|
83270-9
|
Does the patient walk - admission performance during 3 day assessment period [CMS Assessment] |
|
83278-2
|
Does the patient walk - discharge performance during 3 day assessment period [CMS Assessment] |
|
71923-7
|
Does your health now limit you in bathing or dressing yourself [Veterans RAND] |
|
71927-8
|
Does your health now limit you in bending, kneeling, stooping [Veterans RAND] |
|
71928-6
|
Does your health now limit you in climbing one flight of stairs [Veterans RAND] |
|
71929-4
|
Does your health now limit you in climbing several flights of stairs [Veterans RAND] |
|
91760-9
|
Does your health now limit you in dancing for half an hour [PROMIS] |
|
89685-2
|
Does your health now limit you in doing housework or jobs around the house [PROMIS] |
|
89686-0
|
Does your health now limit you in doing recreational activities which require little exertion (e.g., card playing, knitting, etc.) [PROMIS] |
|
91758-3
|
Does your health now limit you in doing yard work like raking leaves, weeding, or pushing a lawn mower [PROMIS] |
|
89681-1
|
Does your health now limit you in exercising regularly [PROMIS] |
|
78052-8
|
Does your health now limit you in hiking a couple of miles (3 km) on uneven surfaces, including hills [PROMIS] |
|
71930-2
|
Does your health now limit you in lifting or carrying groceries [Veterans RAND] |
|
71931-0
|
Does your health now limit you in moderate activities, such as moving a table, pushing a vacuum cleaner, bowling or playing golf [Veterans RAND] |
|
91607-2
|
Does your health now limit you in opening a previously opened jar [PROMIS] |
|
89687-8
|
Does your health now limit you in pursuing your hobbies or other leisure activities [PROMIS] |
|
91759-1
|
Does your health now limit you in taking part in any sports (swimming, bowling, and so forth) [PROMIS] |
|
89688-6
|
Does your health now limit you in traveling out of town for an overnight stay [PROMIS] |
|
71932-8
|
Does your health now limit you in vigorous activities, such as running, lifting heavy objects, participating in strenuous sports [Veterans RAND] |
|
78064-3
|
Does your health now limit you in walking more than a mile (1.6 km) [PROMIS] |
|
71926-0
|
Does your health now limit you in walking more than a mile [Veterans RAND] |
|
71924-5
|
Does your health now limit you in walking one block [Veterans RAND] |
|
71925-2
|
Does your health now limit you in walking several blocks [Veterans RAND] |
|
88795-0
|
Does your knee catch or hang up when moving during the last week [KOOS] |
|
58773-3
|
Dog recombinant (rCan f) 1 IgE Ab [Units/volume] in Serum |
|
81975-5
|
Dog recombinant (rCan f) 1 IgE Ab RAST class [Presence] in Serum |
|
58772-5
|
Dog recombinant (rCan f) 2 IgE Ab [Units/volume] in Serum |
|
81976-3
|
Dog recombinant (rCan f) 2 IgE Ab RAST class [Presence] in Serum |
|
82543-0
|
Dog recombinant (rCan f) 4 IgE Ab [Units/volume] in Serum |
|
82544-8
|
Dog recombinant (rCan f) 4 IgE Ab RAST class [Presence] in Serum |
|
64973-1
|
Dog recombinant 5 IgE Ab [Units/volume] in Serum |
|
81977-1
|
Dog recombinant 5 IgE Ab RAST class [Presence] in Serum |
|
6098-8
|
Dog dander IgE Ab [Units/volume] in Serum |
|
15685-1
|
Dog dander IgE Ab RAST class [Presence] in Serum |
|
61333-1
|
Dog dander IgE Ab/IgE total in Serum |
|
7284-3
|
Dog dander IgG Ab [Units/volume] in Serum |
|
56248-8
|
Dog dander IgG4 Ab [Mass/volume] in Serum |
|
63077-2
|
Dog dander IgG Ab [Mass/volume] in Serum |
|
56713-1
|
Dog dander+Dog epithelium IgE Ab [Units/volume] in Serum |
|
41272-6
|
Dog dander+Dog epithelium IgE Ab RAST class [Presence] in Serum |
|
7286-8
|
Dog epithelium triggered histamine release [Units/volume] in Blood |
|
6099-6
|
Dog epithelium IgE Ab [Units/volume] in Serum |
|
15686-9
|
Dog epithelium IgE Ab RAST class [Presence] in Serum |
|
61334-9
|
Dog epithelium IgE Ab/IgE total in Serum |
|
7285-0
|
Dog epithelium IgG Ab [Units/volume] in Serum |
|
56247-0
|
Dog epithelium IgG4 Ab [Mass/volume] in Serum |
|
48229-9
|
Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes |
|
7287-6
|
Dog Fennel IgE Ab [Units/volume] in Serum |
|
15705-7
|
Dog Fennel IgE Ab RAST class [Presence] in Serum |
|
75008-3
|
Dog native (nCan f) 1 IgE Ab [Units/volume] in Serum |
|
19738-4
|
Dog serum albumin IgE Ab [Units/volume] in Serum |
|
25395-5
|
Dog serum albumin IgE Ab RAST class [Presence] in Serum |
|
73912-8
|
DOG1 Ag [Presence] in Tissue by Immune stain |
|
7288-4
|
Dogwood pollen IgE Ab [Units/volume] in Serum |
|
39533-5
|
Deoxyhemoglobin [Mass/volume] in Blood |
|
4536-9
|
Deoxyhemoglobin/Hemoglobin.total in Blood |
|
19225-2
|
Deoxyhemoglobin/Hemoglobin.total in Arterial blood |
|
19226-0
|
Deoxyhemoglobin/Hemoglobin.total in Capillary blood |
|
19228-6
|
Deoxyhemoglobin/Hemoglobin.total in Mixed venous blood |
|
19227-8
|
Deoxyhemoglobin/Hemoglobin.total in Venous blood |
|
71854-4
|
Deoxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
|
7792-5
|
Dohle body [Presence] in Blood by Light microscopy |
|
86475-1
|
Doing yardwork, housework or carrying groceries was limited by heart failure over the past 2 weeks [KCCQ] |
|
12606-0
|
Dolichol [Mass/volume] in Serum or Plasma |
|
21249-8
|
Dolichol [Mass/volume] in Urine |
|
72857-6
|
Dolutegravir [Susceptibility] by Genotype method |
|
44658-3
|
Dominant nodule additional dimension 1 in Prostate tumor |
|
44659-1
|
Dominant nodule additional dimension 2 in Prostate tumor |
|
44657-5
|
Dominant nodule.maximum.dimension in Prostate tumor |
|
82820-2
|
Domestic violence--before 18 years old [ACE] |
|
84898-6
|
Dominant nodule plane [Anatomy] in Prostate tumor |
|
84897-8
|
Dominant nodule quadrant [Anatomy] in Prostate tumor |
|
51418-2
|
Domperidone [Moles/volume] in Body fluid |
|
51442-2
|
Domperidone [Moles/volume] in Serum or Plasma |
|
87566-6
|
Deoxynivalenol [Mass/mass] in Unspecified specimen |
|
53948-6
|
Donated egg [Presence] |
|
92047-0
|
Donated item by Donor |
|
73406-1
|
Donepezil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73407-9
|
Donepezil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51979-3
|
Donepezil [Mass/volume] in Serum or Plasma |
|
90768-3
|
Donor blood study report |
|
92046-2
|
Donor contact information panel |
|
85593-2
|
Type of donor kidney |
|
92045-4
|
Name of Donor |
|
88858-6
|
Donor type score for risk calculation |
|
88857-8
|
Donor-recipient gender combination score for risk calculation |
|
24534-0
|
US.doppler Abdominal vessels |
|
43572-7
|
US.doppler Abdominal vessels limited |
|
80896-4
|
US.doppler Aorta and Iliac artery - bilateral |
|
80897-2
|
US.doppler Aorta and Iliac artery - bilateral limited |
|
39523-6
|
US.doppler Artery |
|
39039-3
|
US.doppler Brachiocephalic artery |
|
69397-8
|
US.doppler Breast vessels |
|
42146-1
|
US.doppler Carotid arteries |
|
80850-1
|
US.doppler Carotid arteries limited |
|
43765-7
|
US.doppler Carotid arteries - bilateral |
|
39427-0
|
US.doppler Carotid arteries - left |
|
39437-9
|
US.doppler Carotid arteries -right |
|
80851-9
|
US.doppler Cerebral artery middle Fetal for pregnancy |
|
39042-7
|
US.doppler Extremity artery |
|
72830-3
|
US.doppler Extremity arteries - bilateral for physiologic artery study |
|
72831-1
|
US.doppler Extremity arteries - bilateral for physiologic artery study limited |
|
72832-9
|
US.doppler Extremity arteries - bilateral for physiologic artery study at rest and with exercise |
|
39031-0
|
US.doppler Extremity artery - bilateral |
|
39428-8
|
US.doppler Extremity artery - left |
|
39439-5
|
US.doppler Extremity artery - right |
|
39449-4
|
US.doppler Extremity vein |
|
39418-9
|
US.doppler Extremity vein - bilateral |
|
46301-8
|
US.doppler Extremity vein - bilateral limited |
|
39429-6
|
US.doppler Extremity vein - left |
|
39440-3
|
US.doppler Extremity vein - right |
|
69283-0
|
US.doppler Extremity veins - bilateral |
|
43771-5
|
US.doppler Extremity vessels |
|
39424-7
|
US.doppler Extremity vessels limited |
|
39495-7
|
US.doppler Extremity vessels - bilateral |
|
69398-6
|
US.doppler Extremity vessels - left |
|
39503-8
|
US.doppler Extremity vessels - right |
|
39498-1
|
US.doppler Femoral vessels - left |
|
39504-6
|
US.doppler Femoral vessels - right |
|
49508-5
|
Fetal Narrative [Interpretation] Study observation general US.doppler |
|
80864-2
|
US.doppler for pregnancy |
|
80863-4
|
US.doppler for transplanted kidney |
|
42477-0
|
US.doppler for transplanted kidney vessels |
|
46362-0
|
US.doppler Foot vessels |
|
46382-8
|
US.doppler Hand vessels |
|
80857-6
|
US.doppler Head |
|
80856-8
|
US.doppler Head limited |
|
24733-8
|
US.doppler Head vessels |
|
39044-3
|
US.doppler Head vessels limited |
|
30880-9
|
US.doppler Head vessels and Neck vessels |
|
80859-2
|
US.doppler Heart |
|
81161-2
|
US.doppler Heart for blood flow |
|
39425-4
|
US.doppler Iliac artery |
|
43776-4
|
US.doppler Iliac artery limited |
|
42147-9
|
US.doppler Iliac graft |
|
42150-3
|
US.doppler Iliac graft limited |
|
39497-3
|
US.doppler Iliac vessels |
|
39434-6
|
US.doppler Lower extremity artery |
|
38042-8
|
US.doppler Lower extremity artery limited |
|
93604-7
|
US.doppler Lower extremity arteries+veins - bilateral |
|
39421-3
|
US.doppler Lower extremity artery - bilateral |
|
39499-9
|
US.doppler Lower extremity artery - left |
|
39505-3
|
US.doppler Lower extremity artery - right |
|
30881-7
|
US.doppler Lower extremity vein |
|
39420-5
|
US.doppler Lower extremity vein - bilateral |
|
44174-1
|
US.doppler Lower extremity vessels |
|
39422-1
|
US.doppler Lower extremity vessels - bilateral |
|
39431-2
|
US.doppler Lower extremity vessels - left |
|
39430-4
|
US.doppler Lower extremity vessels - left limited |
|
39442-9
|
US.doppler Lower extremity vessels - right |
|
39441-1
|
US.doppler Lower extremity vessels - right limited |
|
42461-4
|
US.doppler Lower extremity vessel - left for graft |
|
42462-2
|
US.doppler Lower extremity vessel - right for graft |
|
39432-0
|
US.doppler Lower extremity vein - left |
|
39443-7
|
US.doppler Lower extremity vein - right |
|
69282-2
|
US.doppler Unspecified body region limited |
|
44175-8
|
US.doppler Neck vessels |
|
39502-0
|
US.doppler Ovarian vessels |
|
24870-8
|
US.doppler Pelvis vessels |
|
42152-9
|
US.doppler Pelvis vessels limited |
|
80873-3
|
US.doppler Penis limited |
|
80874-1
|
US.doppler Penis vessels |
|
69284-8
|
US.doppler Portal vein and Hepatic vein |
|
39435-3
|
US.doppler Renal artery |
|
39426-2
|
US.doppler Renal vessels |
|
39436-1
|
US.doppler Renal vessels limited |
|
39419-7
|
US.doppler Renal vessels - bilateral |
|
48742-1
|
US.doppler Scrotum and testicle |
|
44235-0
|
US.doppler Superior mesenteric vessels |
|
46388-5
|
US.doppler Thoracic and abdominal aorta |
|
39446-0
|
US.doppler Testicular vessels |
|
39447-8
|
US.doppler Upper extremity artery |
|
38143-4
|
US.doppler Upper extremity artery limited |
|
39423-9
|
US.doppler Upper extremity artery - bilateral |
|
46302-6
|
US.doppler Upper extremity artery - bilateral limited |
|
39500-4
|
US.doppler Upper extremity artery - left |
|
39506-1
|
US.doppler Upper extremity artery - right |
|
30882-5
|
US.doppler Upper extremity vein |
|
39496-5
|
US.doppler Upper extremity vein - bilateral |
|
39448-6
|
US.doppler Upper extremity vessels |
|
46385-1
|
US.doppler Upper extremity vessel for graft |
|
46303-4
|
US.doppler Upper extremity vessels limited |
|
46379-4
|
US.doppler Upper extremity vessels - bilateral |
|
44236-8
|
US.doppler Upper extremity vessel - bilateral for graft |
|
44237-6
|
US.doppler Upper extremity vessel - bilateral for graft limited |
|
39433-8
|
US.doppler Upper extremity vessels - left |
|
39444-5
|
US.doppler Upper extremity vessels - right |
|
42475-4
|
US.doppler Upper extremity vessel - left for graft |
|
42476-2
|
US.doppler Upper extremity vessel - right for graft |
|
39501-2
|
US.doppler Upper extremity vein - left |
|
39507-9
|
US.doppler Upper extremity vein - right |
|
69285-5
|
US.doppler Umbilical artery Fetal |
|
80878-2
|
US.doppler Umbilical artery Fetal for pregnancy |
|
39508-7
|
US.doppler Umbilical vessels Fetal |
|
93241-8
|
US.doppler Unspecified body region |
|
80872-5
|
US.doppler Uterus and Fallopian tubes W saline IU |
|
39525-1
|
US.doppler Vein |
|
39524-4
|
US.doppler Vein limited |
|
39445-2
|
US.doppler Vessels |
|
27443-1
|
Dopamine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
27212-0
|
Dopamine [Mass/volume] in 24 hour Urine |
|
2218-6
|
Dopamine [Mass/time] in 24 hour Urine |
|
25906-9
|
Dopamine [Moles/volume] in 24 hour Urine |
|
15059-9
|
Dopamine [Moles/time] in 24 hour Urine |
|
27348-2
|
Dopamine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
27363-1
|
Dopamine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
27380-5
|
Dopamine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
2219-4
|
Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma |
|
74904-4
|
Dopamine [Moles/volume] in Cerebral spinal fluid |
|
2216-0
|
Dopamine [Mass/volume] in Serum or Plasma |
|
14703-3
|
Dopamine [Moles/volume] in Serum or Plasma |
|
13432-0
|
Dopamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16784-1
|
Dopamine [Mass/volume] in Urine --2nd specimen post XXX challenge |
|
13433-8
|
Dopamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16785-8
|
Dopamine [Mass/volume] in Urine --3rd specimen post XXX challenge |
|
13434-6
|
Dopamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16786-6
|
Dopamine [Mass/volume] in Urine --4th specimen post XXX challenge |
|
13435-3
|
Dopamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
16787-4
|
Dopamine [Mass/volume] in Urine --5th specimen post XXX challenge |
|
13436-1
|
Dopamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16788-2
|
Dopamine [Mass/volume] in Urine --6th specimen post XXX challenge |
|
13437-9
|
Dopamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
16789-0
|
Dopamine [Mass/volume] in Urine --7th specimen post XXX challenge |
|
72816-2
|
Dopamine [Mass/volume] in Urine by Confirmatory method |
|
2217-8
|
Dopamine [Mass/volume] in Urine |
|
15058-1
|
Dopamine [Moles/volume] in Urine |
|
33873-1
|
Dopamine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
44316-8
|
Dopamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
44918-1
|
Dopamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13733-1
|
Dopamine/Creatinine [Mass Ratio] in Urine |
|
24524-1
|
Dopamine/Creatinine [Molar ratio] in Urine |
|
91897-9
|
Doravirine [Susceptibility] by Genotype method |
|
58711-3
|
Doripenem [Susceptibility] by Gradient strip |
|
72893-1
|
Doripenem [Susceptibility] by Disk diffusion (KB) |
|
56031-8
|
Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
60535-2
|
Doripenem [Susceptibility] |
|
30973-2
|
Dose number |
|
84301-1
|
Dose adjusted after temporary treatment stop |
|
83847-4
|
Dose changed since previous visit |
|
84296-3
|
Dose form changed since previous visit |
|
74055-5
|
Dose form of Medication |
|
52809-1
|
Dose form Current medication |
|
74054-8
|
Dose form - RxNorm RXCUI of Medication |
|
84297-1
|
Dose(s) missed since previous visit |
|
76300-3
|
Doses.delivered [#] in Reporting period Infusion pump |
|
76301-1
|
Doses.requested [#] Reporting Period |
|
29652-5
|
Dothiepin [Mass/volume] in Serum or Plasma |
|
29653-3
|
Dothiepin [Moles/volume] in Serum or Plasma |
|
35120-5
|
Dothiepin sulfoxide [Mass/volume] in Serum or Plasma |
|
82914-3
|
Dothiepin [Mass/volume] in Serum or Plasma --trough |
|
80641-4
|
Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma |
|
79413-1
|
Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma --trough |
|
7310-6
|
Douglas Fir IgE Ab [Units/volume] in Serum |
|
15711-5
|
Douglas Fir IgE Ab RAST class [Presence] in Serum |
|
56249-6
|
Douglas Fir IgG4 Ab [Mass/volume] in Serum |
|
73779-1
|
Down syndrome karyotype status [US Standard Certificate of Live Birth] |
|
10985-0
|
Doxapram [Mass/volume] in Serum or Plasma |
|
73404-6
|
Doxazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73405-3
|
Doxazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78822-4
|
Doxepin cutoff [Mass/volume] in Urine for Confirmatory method |
|
4230-9
|
Doxepin [Mass] of Dose |
|
14704-1
|
Doxepin [Presence] in Gastric fluid |
|
29410-8
|
Doxepin [Mass/volume] in Gastric fluid |
|
47104-5
|
Doxepin [Moles/volume] in Gastric fluid |
|
3578-2
|
Doxepin [Presence] in Serum or Plasma |
|
35609-7
|
Doxepin [Mass/volume] in Serum or Plasma by Screen method |
|
3579-0
|
Doxepin [Mass/volume] in Serum or Plasma |
|
14705-8
|
Doxepin [Moles/volume] in Serum or Plasma |
|
16115-8
|
Doxepin [Mass/mass] in Tissue |
|
3584-0
|
Doxepin [Mass/volume] in Serum or Plasma --trough |
|
61416-4
|
Doxepin [Mass/volume] in Urine by Confirmatory method |
|
3580-8
|
Doxepin [Presence] in Urine |
|
61415-6
|
Doxepin [Presence] in Urine by Confirmatory method |
|
3581-6
|
Doxepin [Mass/volume] in Urine |
|
14706-6
|
Doxepin [Moles/volume] in Urine |
|
40629-8
|
Doxepin [Presence] in Unspecified specimen |
|
60302-7
|
Doxepin [Moles/volume] in Unspecified specimen |
|
61414-9
|
Doxepin/Creatinine [Mass Ratio] in Urine |
|
3583-2
|
Doxepin+Metabolites [Mass/volume] in Serum or Plasma |
|
19247-6
|
Doxepin+Metabolites [Mass/volume] in Urine |
|
3582-4
|
Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
|
14707-4
|
Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
|
13624-2
|
DOXOrubicin [Mass/volume] in Serum or Plasma |
|
25223-9
|
Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
56706-5
|
Doxycycline IgE Ab [Units/volume] in Serum |
|
73402-0
|
Doxycycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73403-8
|
Doxycycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7008-6
|
Doxycycline [Susceptibility] by Gradient strip |
|
226-1
|
Doxycycline [Susceptibility] by Disk diffusion (KB) |
|
225-3
|
Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
224-6
|
Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
20379-4
|
Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
10986-8
|
Doxycycline [Mass/volume] in Serum or Plasma |
|
18917-5
|
Doxycycline [Susceptibility] |
|
227-9
|
Doxycycline [Susceptibility] by Serum bactericidal titer |
|
26902-7
|
Doxycycline [Units/volume] in Unspecified specimen |
|
21250-6
|
Doxycycline [Mass/volume] in Unspecified specimen |
|
4231-7
|
Doxylamine [Mass] of Dose |
|
75761-7
|
Doxylamine [Presence] in Serum or Plasma or Urine by Screen method |
|
3585-7
|
Doxylamine [Presence] in Serum or Plasma |
|
16791-6
|
Doxylamine [Mass/volume] in Serum or Plasma |
|
55534-2
|
Doxylamine [Moles/volume] in Serum or Plasma |
|
3586-5
|
Doxylamine [Presence] in Urine |
|
16792-4
|
Doxylamine [Mass/volume] in Urine |
|
78347-2
|
Docosapentaenate (C22:5w3) [Entitic substance] in Red Blood Cells |
|
35180-9
|
Docosapentaenate (C22:5w3) [Moles/volume] in Serum or Plasma |
|
90913-5
|
Docosapentaenate (C22:5w3)/Fatty acids.C14-C22 in Blood |
|
94123-7
|
Pulmonary artery End diastolic blood pressure by Cardiac catheterization |
|
6937-7
|
Deoxypyridinoline [Mass/time] in 24 hour Urine |
|
25898-8
|
Deoxypyridinoline [Moles/volume] in 24 hour Urine |
|
15055-7
|
Deoxypyridinoline [Moles/time] in 24 hour Urine |
|
6936-9
|
Deoxypyridinoline [Mass/time] in 2 hour Urine |
|
13881-8
|
Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
|
11216-9
|
Deoxypyridinoline [Mass/volume] in Urine |
|
27424-1
|
Deoxypyridinoline [Moles/volume] in Urine |
|
35646-9
|
Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
13730-7
|
Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
|
24456-6
|
Deoxypyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
|
13731-5
|
Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
|
25096-9
|
Deoxypyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
|
13729-9
|
Deoxypyridinoline/Creatinine [Mass Ratio] in Urine |
|
25095-1
|
Deoxypyridinoline/Creatinine [Molar ratio] in Urine |
|
58954-9
|
Deoxypyridinoline/Pyridinoline [Molar ratio] in Urine |
|
11044-5
|
Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells |
|
38691-2
|
1,2-Diphenylhydrazine [Mass/volume] in Air |
|
2215-2
|
Dipalmitoylphosphatidylcholine [Mass/volume] in Serum |
|
90823-6
|
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90824-4
|
Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82989-5
|
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82976-2
|
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
13555-8
|
D-pseudoephedrine [Presence] in Serum or Plasma |
|
9798-0
|
Depth of Stone |
|
45284-7
|
DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93199-8
|
DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79719-1
|
DPYD gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
57958-1
|
DPYD2A gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
81664-5
|
Drain number [Identifier] |
|
72291-8
|
Drainage amount from device of Exudate from wound |
|
82739-4
|
Dopamine receptor D1 IgG Ab [Titer] in Serum by Immunoassay |
|
82738-6
|
Dopamine receptor D2 IgG Ab [Titer] in Serum by Immunoassay |
|
46599-7
|
Dress lower body - functional ability [CMS Assessment] |
|
46597-1
|
Dress upper body - functional ability [CMS Assessment] |
|
83182-6
|
Dressing |
|
45600-4
|
Dressing - self-performance during 7 day assessment period [CMS Assessment] |
|
45601-2
|
Dressing - support provided during 7 day assessment period [CMS Assessment] |
|
82946-5
|
Dressing and hygiene [ALSFRS-R] |
|
72285-0
|
Dressing purpose for Wound |
|
77695-5
|
Dressing scale [UPDRS] |
|
86473-6
|
Dressing yourself was limited by heart failure over the past 2 weeks [KCCQ] |
|
76950-5
|
Drinking can be harmful to physical health [PROMIS] |
|
76971-1
|
Drinking created problems between me and others in past 30D [PROMIS] |
|
81032-5
|
Days per week alcoholic drinks consumed |
|
76895-2
|
Drinking eases physical pain [PROMIS] |
|
76897-8
|
Drinking improves a person's mood [PROMIS] |
|
76945-5
|
Drinking is harmful to mental health [PROMIS] |
|
53245-7
|
Driver license |
|
82234-6
|
Driving [NDI] |
|
56704-0
|
Droperidol IgE Ab [Units/volume] in Serum |
|
16144-8
|
Droperidol [Presence] in Serum or Plasma |
|
57959-9
|
Drostanolone [Presence] in Urine |
|
73075-4
|
Drug induced neutrophil Ab [Interpretation] in Serum or Plasma by Flow cytometry (FC) Narrative |
|
82664-4
|
Drug Abuse Screening Test [DAST] |
|
82666-9
|
Drug Abuse Screening Test-10 [DAST-10] |
|
93153-5
|
Drug classes of medications taken |
|
93154-3
|
Drug classes that have an indication documented [CMS Assessment] |
|
53975-9
|
Drug crystals [Presence] in Urine sediment by Light microscopy |
|
51964-5
|
Drug efficacy analysis overall interpretation |
|
51961-1
|
Genetic variation's effect on drug efficacy |
|
80238-9
|
Drug given for spasm stress test [Identifier] |
|
13063-3
|
Drug induced platelet Ab [Units/volume] in Serum |
|
73552-2
|
Drug induced platelet Ab [Interpretation] in Serum or Plasma Narrative |
|
53040-2
|
Genetic variation's effect on drug metabolism |
|
57255-2
|
Drug regimen review identified potential medication issues [CMS Assessment] |
|
88870-1
|
Drug regimen review identified potential medication issues in the last 3 days [CMS Assessment] |
|
54247-2
|
Drug screen comment [Interpretation] in Urine |
|
55428-7
|
Drug test kit name [Identifier] in Urine |
|
74204-9
|
Drug use [NTDS] |
|
89495-6
|
Drug use by Mother --during pregnancy |
|
15401-3
|
Drugs identified in Blood by Screen method |
|
34601-5
|
Drugs identified in Body fluid |
|
12287-9
|
Drugs identified in Gastric fluid by Screen method |
|
27034-8
|
Drugs identified in Hair by Screen method |
|
64126-6
|
Drugs identified in Meconium by Confirmatory method |
|
32797-3
|
Drugs identified in Meconium by Screen method |
|
42326-9
|
Drugs identified in Mother's milk by Screen method |
|
58738-6
|
Drugs of abuse [Interpretation] in Meconium |
|
20785-2
|
Drugs identified in Serum or Plasma by Screen method |
|
27208-8
|
Drugs identified in Stool by Screen method |
|
20786-0
|
Drugs identified in Tissue by Screen method |
|
41270-0
|
Drugs identified in Urine |
|
40464-0
|
Drugs identified in Urine by Confirmatory method |
|
12286-1
|
Drugs identified in Urine by Screen method |
|
16793-2
|
Drugs identified in Unknown substance by Screen method |
|
12289-5
|
Drugs identified in Vitreous fluid by Screen method |
|
40585-2
|
Drugs identified in Unspecified specimen by Confirmatory method |
|
20787-8
|
Drugs identified in Unspecified specimen by Screen method |
|
75511-6
|
dRVVT W excess phospholipid percent correction |
|
59788-0
|
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
59789-8
|
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
|
15360-1
|
dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay |
|
93239-2
|
dRVVT excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
93238-4
|
dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
52756-4
|
dRVVT excess phospholipid [Presence] in Platelet poor plasma by Coagulation assay |
|
53221-8
|
dRVVT in Control Platelet poor plasma by Coagulation assay |
|
93240-0
|
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma and heparin neutralization |
|
34569-4
|
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:2 addition of normal plasma |
|
52133-6
|
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 4:1 addition of normal plasma |
|
43397-9
|
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
93234-3
|
dRVVT in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
50410-0
|
dRVVT/dRVVT W excess phospholipid (screen to confirm ratio) |
|
6661-3
|
Microscopic observation [Identifier] in Tissue by Dry mount |
|
661-9
|
Microscopic observation [Identifier] in Unspecified specimen by Dry mount |
|
77149-3
|
Dry weight/Total of 24 hour Stool |
|
18382-2
|
Dry weight [Mass/time] of 24 hour Stool |
|
3171-6
|
Dry weight [Mass/time] of 72 hour Stool |
|
72079-7
|
Dry weight order present [ESRD] |
|
74200-7
|
Days in intensive care unit |
|
72281-9
|
Days in therapeutic INR range/Days INR result determined [Ratio] |
|
74201-5
|
Days on ventilator |
|
63410-5
|
DNA double strand Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63408-9
|
DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63409-7
|
DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
48308-1
|
DNA double strand Ab [Units/volume] in Body fluid by Farr method |
|
53148-3
|
DNA double strand Ab [Presence] in Body fluid |
|
15177-9
|
DNA double strand Ab [Units/volume] in Body fluid |
|
63222-4
|
DNA double strand Ab [Units/volume] in Pleural fluid by Immunoassay |
|
63221-6
|
DNA double strand Ab [Presence] in Pleural fluid by Immunofluorescence |
|
47299-3
|
DNA double strand Ab [Units/volume] in Serum by Farr method |
|
32677-7
|
DNA double strand Ab [Units/volume] in Serum by Immunoassay |
|
54910-5
|
DNA double strand Ab [Units/volume] in Serum by Immunofluorescence |
|
31348-6
|
DNA double strand Ab [Presence] in Serum |
|
6457-6
|
DNA double strand Ab [Presence] in Serum by Immunofluorescence (IF) Crithidia luciliae |
|
12277-0
|
DNA double strand Ab [Presence] in Serum by Farr method |
|
5131-8
|
DNA double strand Ab [Presence] in Serum by Immunofluorescence |
|
81716-3
|
DNA double strand Ab [Presence] in Serum by Line blot |
|
42200-6
|
DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
37993-3
|
DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA) |
|
5130-0
|
DNA double strand Ab [Units/volume] in Serum |
|
63220-8
|
DNA double strand Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63223-2
|
DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence |
|
11013-0
|
DNA double strand Ab [Titer] in Serum |
|
34187-5
|
DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
|
63229-9
|
DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63228-1
|
DNA double strand IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63535-9
|
DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid |
|
63385-9
|
DNA double strand IgG Ab [Units/volume] in Body fluid by Flow cytometry (FC) |
|
63226-5
|
DNA double strand IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
63224-0
|
DNA double strand IgG Ab [Presence] in Body fluid by Immunoassay |
|
63225-7
|
DNA double strand IgG Ab [Presence] in Body fluid by Immunofluorescence |
|
63534-2
|
DNA double strand IgG Ab [Units/volume] in Body fluid |
|
68956-2
|
DNA double strand IgG Ab [Units/volume] in Pericardial fluid by Immunoassay |
|
63386-7
|
DNA double strand IgG Ab [Units/volume] in Pleural fluid by Flow cytometry (FC) |
|
63231-5
|
DNA double strand IgG Ab [Units/volume] in Pleural fluid by Immunoassay |
|
68388-8
|
DNA double strand IgG Ab [Units/volume] in Peritoneal fluid by Immunoassay |
|
63379-2
|
DNA double strand IgG Ab [Presence] in Serum |
|
58465-6
|
DNA double strand IgG Ab [Presence] in Serum by Immunoassay |
|
33800-4
|
DNA double strand IgG Ab [Units/volume] in Serum |
|
33799-8
|
DNA double strand IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
68389-6
|
DNA double strand IgG Ab [Units/volume] in Synovial fluid by Immunoassay |
|
63230-7
|
DNA double strand IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63227-3
|
DNA double strand IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
63381-8
|
DNA double strand IgG Ab [Titer] in Serum |
|
58466-4
|
DNA double strand IgG Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
|
63234-9
|
DNA double strand IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63233-1
|
DNA double strand IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
63232-3
|
DNA double strand IgM Ab [Presence] in Body fluid by Immunofluorescence |
|
63235-6
|
DNA double strand IgM Ab [Units/volume] in Pleural fluid by Immunoassay |
|
63237-2
|
DNA double strand IgM Ab [Units/volume] in Serum by Immunoassay |
|
63236-4
|
DNA double strand IgM Ab [Presence] in Serum by Immunofluorescence |
|
72496-3
|
DNA double strand [Mass/volume] in Unspecified specimen |
|
79648-2
|
D-serine [Moles/volume] in Cerebral spinal fluid |
|
79610-2
|
D-serine [Moles/volume] in Serum or Plasma |
|
79596-3
|
D-serine/Creatinine [Molar ratio] in Urine |
|
80993-9
|
Date and time of first balloon inflation Heart Cardiac catheterization |
|
18013-3
|
Descending thoracic aorta Diameter by US |
|
30936-9
|
Corynebacterium diphtheriae+Clostridium tetani+Bordetella pertussis dose count in combination vaccine |
|
82640-4
|
Difference in time to end-systole between lateral and septal wall Left ventricle SPECT --resting |
|
82632-1
|
Difference in time to end-systole between lateral and septal wall Left ventricle SPECT --W stress |
|
13970-9
|
Delta tocopherol [Mass/volume] in Serum or Plasma |
|
34031-5
|
Denture base evaluation {Dental arch} |
|
34032-3
|
Denture teeth evaluation {Dental arch} |
|
91548-8
|
Duke Treadmill Score risk level |
|
970-4
|
Du Ag [Presence] on Red Blood Cells from Blood product unit |
|
971-2
|
Du Ag [Presence] on Red Blood Cells from Donor |
|
54425-4
|
Du Ag [Presence] on Red Blood Cells from Fetus |
|
972-0
|
Du Ag [Presence] on Red Blood Cells |
|
74690-9
|
Du Ag [Presence] in Cord red blood cells |
|
65319-6
|
Du sup(a) Ab [Presence] in Serum or Plasma |
|
55594-6
|
Duck feather IgE Ab [Presence] in Serum |
|
6100-2
|
Duck feather IgE Ab [Units/volume] in Serum |
|
15687-7
|
Duck feather IgE Ab RAST class [Presence] in Serum |
|
7289-2
|
Duck feather IgG Ab [Units/volume] in Serum |
|
56250-4
|
Duck feather IgG4 Ab [Mass/volume] in Serum |
|
81785-8
|
Duck feather IgG Ab [Mass/volume] in Serum |
|
6101-0
|
Duck meat IgE Ab [Units/volume] in Serum |
|
25396-3
|
Duck meat IgE Ab RAST class [Presence] in Serum |
|
56251-2
|
Duck meat IgG4 Ab [Mass/volume] in Serum |
|
63101-0
|
Duck meat IgG Ab [Mass/volume] in Serum |
|
13309-0
|
Duffy group Ag [Type] on Red Blood Cells |
|
91549-6
|
Duke Treadmill Score |
|
78824-0
|
DULoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
|
46227-5
|
DULoxetine [Mass/volume] in Serum or Plasma |
|
72814-7
|
DULoxetine [Mass/volume] in Urine by Confirmatory method |
|
75229-5
|
DULoxetine [Presence] in Urine |
|
78823-2
|
DULoxetine [Presence] in Urine by Confirmatory method |
|
72815-4
|
DULoxetine/Creatinine [Mass Ratio] in Urine |
|
81173-7
|
Duodenum [Length] in Specimen |
|
85725-0
|
Duration in the U.S. of Mother |
|
93252-5
|
Duration of most severe suicidal ideation 1 month [C-SSRS] |
|
93251-7
|
Duration of most severe suicidal ideation Lifetime [C-SSRS] |
|
82310-4
|
Duration of stay outside the U.S. |
|
77589-0
|
During the last 7 days, how much time did you usually spend sitting on a weekday [IPAQ] |
|
88411-4
|
During the last 7 days, how much time did you usually spend sitting on a weekend day [IPAQ] |
|
88391-8
|
During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go from place to place [IPAQ] |
|
88398-3
|
During the last 7 days, on how many days did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10 minutes at a time [IPAQ] |
|
88400-7
|
During the last 7 days, on how many days did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10 minutes at a time [IPAQ] |
|
88407-2
|
During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10 minutes at a time [IPAQ] |
|
88384-3
|
During the last 7 days, on how many days did you do moderate physical activities like carrying light loads as part of your work, not including walking, greater than 10 minutes at a time [IPAQ] |
|
77585-8
|
During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10 minutes at a time [IPAQ] |
|
88405-6
|
During the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10 minutes at a time [IPAQ] |
|
88396-7
|
During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10 minutes at a time [IPAQ] |
|
77583-3
|
During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling for at least 10 minutes at a time [IPAQ] |
|
88382-7
|
During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time [IPAQ] |
|
88389-2
|
During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car, or tram [IPAQ] |
|
77587-4
|
During the last 7 days, on how many days did you walk for at least 10 minutes at a time [IPAQ] |
|
88386-8
|
During the last 7 days, on how many days did you walk for at least 10 minutes at a time as a part of your work, not counting any walking you did to travel to or from work [IPAQ] |
|
88393-4
|
During the last 7 days, on how many days did you walk for at least 10 minutes at a time to go from place to place [IPAQ] |
|
75702-1
|
During the past 2 weeks, has your physical and emotional health limited your social activities with family, friends, neighbors or groups [COOP.WONCA] |
|
75703-9
|
During the past 2 weeks, how much bodily pain have you generally had [COOP.WONCA] |
|
75701-3
|
During the past 2 weeks, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health [COOP.WONCA] |
|
75700-5
|
During the past 2 weeks, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue [COOP.WONCA] |
|
75705-4
|
During the past 2 weeks, how would you rate your health in general [COOP.WONCA] |
|
75706-2
|
During the past 2 weeks, was someone available to help you if you needed and wanted help [COOP.WONCA] |
|
75699-9
|
During the past 2 weeks, what was the hardest physical activity you could do for at least 2 minutes [COOP.WONCA] |
|
77572-6
|
During the past 24 hours, how has pain interfered with your enjoyment of life [BPI Short Form] |
|
77566-8
|
During the past 24 hours, how has pain interfered with your general activity [BPI Short Form] |
|
77567-6
|
During the past 24 hours, how has pain interfered with your mood [BPI Short Form] |
|
77569-2
|
During the past 24 hours, how has pain interfered with your normal work [BPI Short Form] |
|
77570-0
|
During the past 24 hours, how has pain interfered with your relations with other people [BPI Short Form] |
|
77571-8
|
During the past 24 hours, how has pain interfered with your sleep [BPI Short Form] |
|
77568-4
|
During the past 24 hours, how has pain interfered with your walking ability [BPI Short Form] |
|
93111-3
|
During the past 4 weeks, because of my health situation I feel uncertain about the future [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93110-5
|
During the past 4 weeks, because of my health situation I have little trust in my own body [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93108-9
|
During the past 4 weeks, because of my health situation I have problems in my work with fatigue/lack of energy [Quality of Working Life Questionnaire for Cancer Survivors] |
|
75806-0
|
During the past 4 weeks, has your physical and emotional health limited your social activities with family, friends, neighbors or groups [COOP] |
|
75805-2
|
During the past 4 weeks, how much bodily pain have you generally had [COOP] |
|
75807-8
|
During the past 4 weeks, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health [COOP] |
|
75808-6
|
During the past 4 weeks, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue [COOP] |
|
71903-9
|
During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities - like visiting with friends, relatives, etc. [Veterans RAND] |
|
75803-7
|
During the past 4 weeks, how would you rate your health in general [COOP] |
|
93107-1
|
During the past 4 weeks, I am content with my current income [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93100-6
|
During the past 4 weeks, I am content with my work [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93106-3
|
During the past 4 weeks, I am content with the fringe benefits provided by my employer [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93109-7
|
During the past 4 weeks, I am limited in my work [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93094-1
|
During the past 4 weeks, I am self-confident in my work [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93095-8
|
During the past 4 weeks, I am suited to my work [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93092-5
|
During the past 4 weeks, I consider my work important [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93105-5
|
During the past 4 weeks, I consider that employees with health problems are treated well in my organization [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93091-7
|
During the past 4 weeks, I consider that my work gives me a goal in life [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93093-3
|
During the past 4 weeks, I do my work well [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93097-4
|
During the past 4 weeks, I feel powerless in my work [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93098-2
|
During the past 4 weeks, I feel there is a positive atmosphere in my working environment [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93102-2
|
During the past 4 weeks, I feel valuable to my colleagues [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93096-6
|
During the past 4 weeks, I have control over the work I do [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93101-4
|
During the past 4 weeks, I have good relations with my colleagues [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93104-8
|
During the past 4 weeks, I have good relations with my immediate superior [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93099-0
|
During the past 4 weeks, I have the feeling I am taken seriously by people in my working environment [Quality of Working Life Questionnaire for Cancer Survivors] |
|
93090-9
|
During the past 4 weeks, I think it is good to work [Quality of Working Life Questionnaire for Cancer Survivors] |
|
71913-8
|
During the past 4 weeks, much did pain interfere with your normal work - including both work outside the home and house work [Veterans RAND] |
|
93103-0
|
During the past 4 weeks, my immediate superior understands my health situation and possible health problems [Quality of Working Life Questionnaire for Cancer Survivors] |
|
71915-3
|
During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors or groups [Veterans RAND] |
|
75802-9
|
During the past 4 weeks, was someone available to help you if you needed and wanted help [COOP] |
|
75809-4
|
During the past 4 weeks, what was the hardest physical activity you could do for at least 2 minutes [COOP] |
|
93089-1
|
During the past 4 weeks, working gives me structure in my life [Quality of Working Life Questionnaire for Cancer Survivors] |
|
90720-4
|
During the past month, how often did you drink coffee or tea that had sugar or honey added to it |
|
90719-6
|
During the past month, how often did you drink regular soda or pop that contains sugar |
|
90721-2
|
During the past month, how often did you eat a green leafy or lettuce salad, with or without other vegetables |
|
90727-9
|
During the past month, how often did you eat any kind of cheese |
|
90722-0
|
During the past month, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes |
|
90723-8
|
During the past month, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad |
|
90725-3
|
During the past month, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet |
|
90718-8
|
During the past month, how often did you eat hot or cold cereals |
|
90729-5
|
During the past month, how often did you eat ice cream or other frozen desserts |
|
90726-1
|
During the past month, how often did you eat pizza |
|
90728-7
|
During the past month, how often did you eat red meat, such as beef, pork, ham, or sausage |
|
90724-6
|
During the past month, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans |
|
15231-4
|
Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk |
|
30186-1
|
Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Units/volume] in Serum by Multidisk |
|
23795-8
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Presence] in Serum by Multidisk |
|
37987-5
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Units/volume] in Serum by Multidisk |
|
24506-8
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
56291-8
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgG4 Ab [Mass/volume] in Serum |
|
22254-7
|
Duck enteritis virus Ab [Presence] in Serum |
|
43328-4
|
Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence |
|
20788-6
|
Duck enteritis virus Ab [Presence] in Serum by Neutralization test |
|
20852-0
|
Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence |
|
31802-2
|
Duck enteritis virus Ag [Presence] in Unspecified specimen |
|
23032-6
|
Duck enteritis virus Ag [Presence] in Unspecified specimen by Agglutination |
|
23031-8
|
Duck enteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
23030-0
|
Duck enteritis virus [Presence] in Tissue by Electron microscopy |
|
29308-4
|
Diagnosis |
|
29548-5
|
Diagnosis Narrative |
|
19809-3
|
Diagnosis Abdomen |
|
19807-7
|
Diagnosis Biliary duct and Pancreatic duct |
|
19810-1
|
Diagnosis Endoscopy Procedure |
|
19811-9
|
Diagnosis Endoscopy Procedure Narrative |
|
75314-5
|
Diagnosis Family member |
|
52797-8
|
Diagnosis ICD code [Identifier] |
|
76514-9
|
Fetal Narrative Study observation general Diagnostic imaging |
|
47048-4
|
Diagnostic interventional study report Interventional radiology |
|
19808-5
|
Diagnosis Gastrointestinal tract lower |
|
44833-2
|
Preliminary diagnosis |
|
78026-2
|
Diagnosis present on admission |
|
19806-9
|
Diagnosis Gastrointestinal tract upper |
|
81885-6
|
Secondary diagnosis |
|
46383-6
|
DXA Bone [Mass/Area] Bone density |
|
83051-3
|
DXA Cervical and thoracic and lumbar spine Views for vertebral fracture |
|
24701-5
|
DXA Femur [Mass/Area] Bone density |
|
38263-0
|
DXA Femur [T-score] Bone density |
|
80934-3
|
DXA Femur [Z-score] Bone density |
|
80954-1
|
DXA Femur - left [Mass/Area] Bone density |
|
80948-3
|
DXA Femur - left [T-score] Bone density |
|
80940-0
|
DXA Femur - left [Z-score] Bone density |
|
80953-3
|
DXA Femur - right [Mass/Area] Bone density |
|
80947-5
|
DXA Femur - right [T-score] Bone density |
|
80939-2
|
DXA Femur - right [Z-score] Bone density |
|
38262-2
|
DXA Calcaneus [Mass/Area] Bone density |
|
38266-3
|
DXA Calcaneus [T-score] Bone density |
|
80956-6
|
DXA Calcaneus - left [Mass/Area] Bone density |
|
80950-9
|
DXA Calcaneus - left [T-score] Bone density |
|
80942-6
|
DXA Calcaneus - left [Z-score] Bone density |
|
80955-8
|
DXA Calcaneus - right [Mass/Area] Bone density |
|
80949-1
|
DXA Calcaneus - right [T-score] Bone density |
|
80941-8
|
DXA Calcaneus - right [Z-score] Bone density |
|
38261-4
|
DXA Hip [Mass/Area] Bone density |
|
38264-8
|
DXA Hip [T-score] Bone density |
|
80933-5
|
DXA Hip [Z-score] Bone density |
|
46278-8
|
DXA Hip - left [Mass/Area] Bone density |
|
80946-7
|
DXA Hip - left [T-score] Bone density |
|
80938-4
|
DXA Hip - left [Z-score] Bone density |
|
46279-6
|
DXA Hip - right [Mass/Area] Bone density |
|
80945-9
|
DXA Hip - right [T-score] Bone density |
|
80937-6
|
DXA Hip - right [Z-score] Bone density |
|
85385-3
|
DXA Humerus [Mass/Area] Bone density |
|
85390-3
|
DXA Humerus [T-score] Bone density |
|
85391-1
|
DXA Humerus [Z-score] Bone density |
|
85386-1
|
DXA Humerus - left [Mass/Area] Bone density |
|
85389-5
|
DXA Humerus - left [T-score] Bone density |
|
85393-7
|
DXA Humerus - left [Z-score] Bone density |
|
85387-9
|
DXA Humerus - right [Mass/Area] Bone density |
|
85388-7
|
DXA Humerus - right [T-score] Bone density |
|
85392-9
|
DXA Humerus - right [Z-score] Bone density |
|
24966-4
|
DXA Lumbar spine [Mass/Area] Bone density |
|
38267-1
|
DXA Lumbar spine [T-score] Bone density |
|
85394-5
|
DXA Lumbar spine [Z-score] Bone density |
|
24890-6
|
DXA Radius and Ulna [Mass/Area] Bone density |
|
38265-5
|
DXA Radius and Ulna [T-score] Bone density |
|
80932-7
|
DXA Radius and Ulna [Z-score] Bone density |
|
80952-5
|
DXA Radius and Ulna - left [Mass/Area] Bone density |
|
80944-2
|
DXA Radius and Ulna - left [T-score] Bone density |
|
80936-8
|
DXA Radius and Ulna - left [Z-score] Bone density |
|
80951-7
|
DXA Radius and Ulna - right [Mass/Area] Bone density |
|
80943-4
|
DXA Radius and Ulna - right [T-score] Bone density |
|
80935-0
|
DXA Radius and Ulna - right [Z-score] Bone density |
|
83012-5
|
DXA Skeletal system.axial Views for bone density |
|
83014-1
|
DXA Skeletal system.axial Views for bone density and vertebral fracture |
|
83013-3
|
DXA Skeletal system.peripheral Views for bone density |
|
38268-9
|
DXA Skeletal system Views for bone density |
|
73566-2
|
Dextrorphan [Mass/volume] in Urine |
|
14068-1
|
Triamterene+hydroCHLOROthiazide [Mass/volume] in Serum or Plasma |
|
4232-5
|
Dyphylline [Mass] of Dose |
|
3587-3
|
Dyphylline [Mass/volume] in Serum or Plasma |
|
46992-4
|
DYS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32653-8
|
DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
43745-9
|
DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
51589-0
|
Dyserythropoiesis [Presence] in Blood by Light microscopy |
|
53856-1
|
DYSF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35124-7
|
Dysferlin [Presence] in Leukocytes |
|
77704-5
|
Dyskinesia disability in the past week [UPDRS] |
|
77703-7
|
Dyskinesia duration per day in the past week [UPDRS] |
|
77705-2
|
Dyskinesia pain in the past week [UPDRS] |
|
33666-9
|
Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy |
|
58444-1
|
Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy |
|
53967-6
|
Erythrocytes.dysmorphic/100 erythrocytes in Urine sediment by Light microscopy |
|
82950-7
|
Dyspnea [ALSFRS-R] |
|
1016-5
|
E Ab [Presence] in Serum or Plasma from Blood product unit |
|
1017-3
|
E Ab [Presence] in Serum or Plasma from Donor |
|
1018-1
|
E Ab [Presence] in Serum or Plasma |
|
34602-3
|
E Ab [Titer] in Serum or Plasma |
|
93937-1
|
E Ag [Presence] on Red Blood Cells --during infancy |
|
92544-6
|
E Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92506-5
|
E Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93927-2
|
E Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93920-7
|
E Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1019-9
|
E Ag [Presence] on Red Blood Cells from Blood product unit |
|
1020-7
|
E Ag [Presence] on Red Blood Cells from Donor |
|
1021-5
|
E Ag [Presence] on Red Blood Cells |
|
93945-4
|
E Ag [Presence] in Cord red blood cells |
|
41443-3
|
Enterocytozoon bieneusi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
7874-1
|
Ehrlichia canis Ab [Presence] in Serum |
|
6400-6
|
Ehrlichia canis Ab [Presence] in Serum by Immunoassay |
|
23054-0
|
Ehrlichia canis Ab [Presence] in Serum by Immunofluorescence |
|
31361-9
|
Ehrlichia canis Ab [Units/volume] in Serum |
|
23711-5
|
Ehrlichia canis Ab [Titer] in Serum |
|
87560-9
|
Ehrlichia canis+ewingii groEL gene [Presence] in Blood by NAA with non-probe detection |
|
87559-1
|
Ehrlichia chaffeensis groEL gene [Presence] in Blood by NAA with non-probe detection |
|
32172-9
|
Ehrlichia chaffeensis Ab [Presence] in Serum |
|
13195-3
|
Ehrlichia chaffeensis Ab [Units/volume] in Serum |
|
41752-7
|
Ehrlichia chaffeensis Ab [Titer] in Serum |
|
68949-7
|
Ehrlichia chaffeensis Ab [Titer] in Serum by Immunofluorescence |
|
54035-1
|
Ehrlichia chaffeensis Ag [Presence] in Tissue by Immune stain |
|
27994-3
|
Ehrlichia chaffeensis DNA [Presence] in Blood by NAA with probe detection |
|
24042-4
|
Ehrlichia chaffeensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32678-5
|
Ehrlichia chaffeensis IgG Ab [Presence] in Cerebral spinal fluid |
|
7875-8
|
Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum by Immunoassay |
|
22283-6
|
Ehrlichia chaffeensis IgG Ab [Presence] in Serum |
|
6401-4
|
Ehrlichia chaffeensis IgG Ab [Presence] in Serum by Immunoassay |
|
22284-4
|
Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum |
|
49180-3
|
Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid |
|
48894-0
|
Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9783-2
|
Ehrlichia chaffeensis IgG Ab [Titer] in Serum |
|
47405-6
|
Ehrlichia chaffeensis IgG Ab [Titer] in Serum by Immunofluorescence |
|
51760-7
|
Ehrlichia chaffeensis IgG+IgM Ab [Presence] in Serum or Plasma |
|
32679-3
|
Ehrlichia chaffeensis IgM Ab [Presence] in Cerebral spinal fluid |
|
7876-6
|
Ehrlichia chaffeensis IgM Ab [Presence] in Serum |
|
6402-2
|
Ehrlichia chaffeensis IgM Ab [Presence] in Serum by Immunoassay |
|
31362-7
|
Ehrlichia chaffeensis IgM Ab [Units/volume] in Serum |
|
49179-5
|
Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid |
|
48895-7
|
Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9784-0
|
Ehrlichia chaffeensis IgM Ab [Titer] in Serum |
|
48850-2
|
Ehrlichia chaffeensis IgM Ab [Titer] in Serum by Immunofluorescence |
|
92985-1
|
Enterobacter cloacae complex DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85772-2
|
Enterobacter cloacae complex DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93404-2
|
Enterobacter cloacae complex DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92984-4
|
Enterobacter cloacae complex DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
87317-4
|
Escherichia coli [#/volume] in Water by Viability count |
|
53945-2
|
Escherichia coli adherence pattern [Identifier] in Isolate by Hep2 substrate |
|
92983-6
|
Escherichia coli DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85773-0
|
Escherichia coli DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93401-8
|
Escherichia coli DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92982-8
|
Escherichia coli DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61398-4
|
Escherichia coli DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53944-5
|
Escherichia coli enteroinvasive [Presence] in Isolate |
|
13318-1
|
Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
|
16832-8
|
Escherichia coli enterotoxic identified in Stool by Organism specific culture |
|
20813-2
|
Escherichia coli F41 [Presence] in Isolate by Agglutination |
|
20814-0
|
Escherichia coli F41 [Presence] in Small intestine Tissue by Immunofluorescence |
|
50028-0
|
Escherichia coli IgE Ab [Units/volume] in Serum |
|
26800-3
|
Escherichia coli IgG Ab [Units/volume] in Serum |
|
26789-8
|
Escherichia coli IgM Ab [Units/volume] in Serum |
|
31824-6
|
Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid |
|
14324-8
|
Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
43431-6
|
Escherichia coli K1 Ag [Presence] in Serum |
|
43432-4
|
Escherichia coli K1 Ag [Presence] in Urine |
|
31825-3
|
Escherichia coli K1 Ag [Presence] in Unspecified specimen |
|
16833-6
|
Escherichia coli K1 Ag [Presence] in Unspecified specimen by Immunoassay |
|
16834-4
|
Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
82182-7
|
Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
87373-7
|
Escherichia coli K88 DNA [Presence] in Isolate by NAA with probe detection |
|
20816-5
|
Escherichia coli K88 [Presence] in Isolate by Agglutination |
|
20815-7
|
Escherichia coli K88 [Presence] in Small intestine Tissue by Agglutination |
|
20817-3
|
Escherichia coli K88 [Presence] in Small intestine Tissue by Immunofluorescence |
|
87374-5
|
Escherichia coli K99 DNA [Presence] in Isolate by NAA with probe detection |
|
20819-9
|
Escherichia coli K99 [Presence] in Isolate by Agglutination |
|
20821-5
|
Escherichia coli K99 [Presence] in Stool by Agglutination |
|
20818-1
|
Escherichia coli K99 [Presence] in Small intestine Tissue by Agglutination |
|
20822-3
|
Escherichia coli K99 [Presence] in Small intestine Tissue by Immunofluorescence |
|
13329-8
|
Escherichia coli labile toxin [Presence] in Unspecified specimen |
|
45162-5
|
Escherichia coli O157 Ag [Presence] in Isolate by Latex agglutination |
|
44087-5
|
Escherichia coli O157 Ag [Presence] in Unspecified specimen |
|
82204-9
|
Escherichia coli O157 DNA [Presence] in Stool by NAA with non-probe detection |
|
53955-1
|
Escherichia coli O157 identified in Isolate by Organism specific culture |
|
82303-9
|
Escherichia coli O157 [Presence] in Stool by Culture |
|
39019-5
|
Escherichia coli O157:H7 Ag [Presence] in Raw milk by Immunoassay |
|
32777-5
|
Escherichia coli O157:H7 Ag [Presence] in Stool |
|
44088-3
|
Escherichia coli O157:H7 DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
38990-8
|
Escherichia coli O157:H7 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35879-6
|
Escherichia coli O157:H7 IgG Ab [Units/volume] in Serum |
|
35878-8
|
Escherichia coli O157:H7 IgM Ab [Units/volume] in Serum |
|
44090-9
|
Escherichia coli O157:H7 [Presence] in Isolate by Organism specific culture |
|
20823-1
|
Escherichia coli O157:H7 [Presence] in Raw milk by Organism specific culture |
|
10851-4
|
Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
|
44089-1
|
Escherichia coli O157:H7 [Identifier] in Unspecified specimen by Organism specific culture |
|
20789-4
|
Escherichia coli serotype [Identifier] in Isolate |
|
82299-9
|
Escherichia coli shiga-like toxin 1+2 [Presence] in Stool by Immunoassay |
|
16835-1
|
Escherichia coli shiga-like toxin identified in Stool by Organism specific culture |
|
21262-1
|
Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay |
|
53946-0
|
Escherichia coli shiga-like toxin identified in Unspecified specimen |
|
28035-4
|
Escherichia coli shiga-like toxin [Units/volume] in Unspecified specimen by Immunoassay |
|
51940-5
|
Escherichia coli shiga-like toxin 1 [Presence] in Stool by Immunoassay |
|
64013-6
|
Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay |
|
51939-7
|
Escherichia coli shiga-like toxin 2 [Presence] in Stool by Immunoassay |
|
16836-9
|
Escherichia coli verotoxic identified in Stool by Organism specific culture |
|
16283-4
|
Escherichia coli verotoxin [Presence] in Unspecified specimen |
|
31381-7
|
Escherichia coli verotoxin 1 Ab [Units/volume] in Stool |
|
22608-4
|
Escherichia coli verotoxin 1 Ab [Titer] in Stool |
|
6575-5
|
Escherichia coli verotoxin 1 Ab [Titer] in Stool by Neutralization test |
|
6574-8
|
Escherichia coli verotoxin 1 [Presence] in Stool |
|
31382-5
|
Escherichia coli verotoxin 2 Ab [Units/volume] in Stool |
|
22609-2
|
Escherichia coli verotoxin 2 Ab [Titer] in Stool |
|
6577-1
|
Escherichia coli verotoxin 2 Ab [Titer] in Stool by Neutralization test |
|
6576-3
|
Escherichia coli verotoxin 2 [Presence] in Stool |
|
20811-6
|
Escherichia coli [Presence] in Unspecified specimen by Culture FDA method |
|
20812-4
|
Escherichia coli 987P [Presence] in Small intestine Tissue by Immunofluorescence |
|
20801-7
|
Encephalitozoon cuniculi Ab [Presence] in Serum |
|
41439-1
|
Encephalitozoon cuniculi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41442-5
|
Entamoeba dispar DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48865-0
|
Ehrlichia ewingii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76612-1
|
Enterococcus faecalis cpn60 gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76584-2
|
Enterococcus faecalis cpn60 gene [Presence] in XXX.swab by NAA with probe detection |
|
76599-0
|
Enterococcus faecalis cpn60 gene [#/mass] in XXX.tissue by NAA with probe detection |
|
92783-0
|
Enterococcus faecalis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
61362-0
|
Enterococcus faecalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88256-3
|
Enterococcus faecalis hsp60 gene [Presence] by Probe in Positive blood culture |
|
73963-1
|
Enterococcus faecalis and other enterococcus sp rRNA [Identifier] by FISH in Positive blood culture |
|
92782-2
|
Enterococcus faecium DNA [Presence] by NAA with probe detection in Positive blood culture |
|
61397-6
|
Enterococcus faecium DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88257-1
|
Enterococcus faecium hsp60 gene [Presence] by Probe in Positive blood culture |
|
76607-1
|
Enterococcus faecium sodA gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76579-2
|
Enterococcus faecium sodA gene [Presence] in XXX.swab by NAA with probe detection |
|
76594-1
|
Enterococcus faecium sodA gene [#/mass] in XXX.tissue by NAA with probe detection |
|
7307-2
|
Epidermophyton floccosum IgE Ab [Units/volume] in Serum |
|
15701-6
|
Epidermophyton floccosum IgE Ab RAST class [Presence] in Serum |
|
63175-4
|
Epidermophyton floccosum IgG Ab [Mass/volume] in Serum |
|
43602-2
|
Echinococcus granulosus Ab [Units/volume] in Serum by Immunoassay |
|
26673-4
|
Echinococcus granulosus Ab [Presence] in Serum |
|
35416-7
|
Echinococcus granulosus Ab [Presence] in Serum by Immunoblot |
|
46184-8
|
Echinococcus granulosus Ab [Units/volume] in Serum |
|
49181-1
|
Echinococcus granulosus Ab [Titer] in Serum |
|
88921-2
|
Echinococcus granulosus Ab [Titer] in Serum by Complement fixation |
|
48359-4
|
Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination |
|
23855-0
|
Echinococcus granulosus IgE Ab [Units/volume] in Serum |
|
21251-4
|
Echinococcus granulosus IgE Ab RAST class [Presence] in Serum |
|
47308-2
|
Echinococcus granulosus IgG Ab [Units/volume] in Serum by Immunoassay |
|
22264-6
|
Echinococcus granulosus IgG Ab [Presence] in Serum |
|
21252-2
|
Echinococcus granulosus IgG Ab [Presence] in Serum by Immunoblot |
|
47431-2
|
Echinococcus granulosus IgG Ab [Units/volume] in Serum |
|
41440-9
|
Encephalitozoon hellem DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70293-6
|
Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47406-4
|
Entamoeba histolytica Ab [Presence] in Cerebral spinal fluid |
|
16818-7
|
Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid |
|
16820-3
|
Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation |
|
5151-6
|
Entamoeba histolytica Ab [Units/volume] in Serum by Hemagglutination |
|
5150-8
|
Entamoeba histolytica Ab [Units/volume] in Serum by Immunoassay |
|
9421-9
|
Entamoeba histolytica Ab [Units/volume] in Serum by Immune diffusion (ID) |
|
16819-5
|
Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence |
|
22285-1
|
Entamoeba histolytica Ab [Presence] in Serum |
|
90297-3
|
Entamoeba histolytica Ab [Presence] in Serum by Immunoassay |
|
16817-9
|
Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) |
|
56921-0
|
Entamoeba histolytica Ab [Presence] in Serum by Immunofluorescence |
|
7880-8
|
Entamoeba histolytica Ab [Units/volume] in Serum |
|
22286-9
|
Entamoeba histolytica Ab [Titer] in Serum |
|
9420-1
|
Entamoeba histolytica Ab [Titer] in Serum by Complement fixation |
|
21259-7
|
Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination |
|
25400-3
|
Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence |
|
6397-4
|
Entamoeba histolytica Ag [Units/volume] in Serum by Immunoassay |
|
31810-5
|
Entamoeba histolytica Ag [Units/volume] in Serum |
|
6398-2
|
Entamoeba histolytica Ag [Units/volume] in Stool by Immunoassay |
|
29905-7
|
Entamoeba histolytica Ag [Presence] in Stool by Immunoassay |
|
31811-3
|
Entamoeba histolytica Ag [Units/volume] in Stool |
|
6399-0
|
Entamoeba histolytica Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
31812-1
|
Entamoeba histolytica Ag [Units/volume] in Unspecified specimen |
|
91766-6
|
Entamoeba histolytica DNA [Presence] in Aspirate by NAA with probe detection |
|
82207-2
|
Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection |
|
92689-9
|
Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection |
|
6396-6
|
Entamoeba histolytica DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27090-0
|
Entamoeba histolytica IgA Ab [Presence] in Saliva (oral fluid) |
|
9521-6
|
Entamoeba histolytica IgA Ab [Units/volume] in Serum by Immunoassay |
|
22287-7
|
Entamoeba histolytica IgA Ab [Units/volume] in Serum |
|
9522-4
|
Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay |
|
56922-8
|
Entamoeba histolytica IgG Ab [Presence] in Serum by Immunoassay |
|
22288-5
|
Entamoeba histolytica IgG Ab [Units/volume] in Serum |
|
9523-2
|
Entamoeba histolytica IgM Ab [Units/volume] in Serum by Immunoassay |
|
22289-3
|
Entamoeba histolytica IgM Ab [Units/volume] in Serum |
|
14125-9
|
Entamoeba histolytica [Presence] in Stool by Trichrome stain |
|
80682-8
|
Entamoeba histolytica 18S rRNA [Presence] in Stool by NAA with probe detection |
|
41441-7
|
Encephalitozoon intestinalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
66447-4
|
Euroglyphus maynei recombinant (rEur m) 2 IgE Ab [Units/volume] in Serum |
|
6114-3
|
Euroglyphus maynei IgE Ab [Units/volume] in Serum |
|
15704-0
|
Euroglyphus maynei IgE Ab RAST class [Presence] in Serum |
|
87561-7
|
Ehrlichia muris eauclairensis groEL gene [Presence] in Blood by NAA with non-probe detection |
|
6111-9
|
Epicoccum purpurascens IgE Ab [Units/volume] in Serum |
|
15700-8
|
Epicoccum purpurascens IgE Ab RAST class [Presence] in Serum |
|
39599-6
|
Epicoccum purpurascens IgE Ab/IgE total in Serum |
|
18410-1
|
Epicoccum purpurascens IgG Ab [Units/volume] in Serum |
|
42904-3
|
Epicoccum purpurascens IgG Ab [Mass/volume] in Serum |
|
87367-9
|
Erysipelothrix rhusiopathiae Ab/Positive control in Serum by Immunoassay |
|
86725-9
|
Erysipelothrix rhusiopathiae Ag [Presence] in Tissue by Immune stain |
|
86726-7
|
Erysipelothrix rhusiopathiae DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86724-2
|
Erysipelothrix rhusiopathiae [Presence] in Unspecified specimen by Organism specific culture |
|
23056-5
|
Ehrlichia risticii Ab [Presence] in Serum |
|
23055-7
|
Ehrlichia risticii Ab [Presence] in Serum by Immunofluorescence |
|
46185-5
|
Ehrlichia risticii Ab [Titer] in Serum |
|
43331-8
|
Ehrlichia risticii Ab [Titer] in Serum by Immunofluorescence |
|
72505-1
|
Exserohilum rostratum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
28071-9
|
E selectin [Mass/volume] in Blood |
|
33801-2
|
E selectin [Mass/volume] in Serum or Plasma |
|
1010-8
|
E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1011-6
|
E sup(w) Ab [Presence] in Serum or Plasma from Donor |
|
1012-4
|
E sup(w) Ab [Presence] in Serum or Plasma |
|
1013-2
|
E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1014-0
|
E sup(w) Ag [Presence] on Red Blood Cells from Donor |
|
1015-7
|
E sup(w) Ag [Presence] on Red Blood Cells |
|
86728-3
|
Erysipelothrix tonsillarum DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
6676-1
|
Enterobius vermicularis [Presence] in Anal by Pinworm exam |
|
77345-7
|
Enterobius vermicularis [Presence] in Anal by Pinworm exam --2nd specimen |
|
77346-5
|
Enterobius vermicularis [Presence] in Anal by Pinworm exam --3rd specimen |
|
675-9
|
Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam |
|
93400-0
|
Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA [Presence] by NAA with probe detection in Positive blood culture |
|
34856-5
|
Evaluation and management of anticoagulation note |
|
34859-9
|
Evaluation and management of hyperlipidemia note |
|
34860-7
|
Evaluation and management of hypertension note |
|
70005-4
|
Evaluation and management of smoking cessation note |
|
89427-9
|
Evaluation and management consent Document |
|
89553-2
|
Evaluation and management of radiation exposure note |
|
81194-3
|
Evaluation and management of workers compensation note |
|
81195-0
|
Evaluation and management of workers compensation form |
|
35121-3
|
E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma |
|
55149-9
|
BCR-ABL1 e1a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
|
31814-7
|
Equine adenovirus Ag [Presence] in Lung |
|
20677-1
|
Equine adenovirus Ag [Presence] in Lung by Immunofluorescence |
|
44276-4
|
Equine adenovirus Ag [Titer] in Serum by Neutralization test |
|
87319-0
|
Escherichia coli enteroaggregative astA gene [Presence] in Isolate by NAA with probe detection |
|
80349-4
|
Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection |
|
76011-6
|
Ear temperature |
|
88336-3
|
Microscopic observation [Interpretation] of Ear specimen Narrative |
|
77975-1
|
Earliest date of diagnosis |
|
77972-8
|
Earliest date reported to county |
|
77973-6
|
Earliest date reported to state |
|
30981-5
|
Earliest date to give |
|
77706-0
|
Early morning dystonia in the past week [UPDRS] |
|
7397-3
|
Eastern Hemlock IgE Ab [Units/volume] in Serum |
|
15770-1
|
Eastern Hemlock IgE Ab RAST class [Presence] in Serum |
|
6282-8
|
Eastern White Pine IgE Ab [Units/volume] in Serum |
|
15947-5
|
Eastern White Pine IgE Ab RAST class [Presence] in Serum |
|
61299-4
|
Eastern White Pine IgE Ab/IgE total in Serum |
|
56427-8
|
Eastern White Pine IgG4 Ab [Mass/volume] in Serum |
|
7463-3
|
Easter lily IgE Ab [Units/volume] in Serum |
|
15817-0
|
Easter lily IgE Ab RAST class [Presence] in Serum |
|
89410-5
|
Eating - functional ability [CMS Assessment] |
|
83232-9
|
Eating - functional ability during 3 day assessment period [CMS Assessment] |
|
89409-7
|
Eating - functional goal [CMS Assessment] |
|
83231-1
|
Eating - functional goal during 3 day assessment period [CMS Assessment] |
|
45602-0
|
Eating - self-performance during 7 day assessment period [CMS Assessment] |
|
45603-8
|
Eating - support provided during 7 day assessment period [CMS Assessment] |
|
89563-1
|
Eating disorder symptoms score [CUBS] |
|
92912-5
|
Eating disorders Consult note |
|
93958-7
|
Eating disorders Diagnostic study note |
|
92911-7
|
Eating disorders Outpatient Note |
|
23073-0
|
Equine arteritis virus Ab [Presence] in Serum |
|
23070-6
|
Equine arteritis virus Ab [Presence] in Serum by Immunoassay |
|
23068-0
|
Equine arteritis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23072-2
|
Equine arteritis virus Ab [Presence] in Serum by Immunofluorescence |
|
23071-4
|
Equine arteritis virus Ab [Presence] in Serum by Neutralization test |
|
31376-7
|
Equine arteritis virus Ab [Units/volume] in Serum |
|
22299-2
|
Equine arteritis virus Ab [Titer] in Serum |
|
23069-8
|
Equine arteritis virus Ab [Titer] in Serum by Complement fixation |
|
15473-2
|
Equine arteritis virus Ab [Titer] in Serum by Neutralization test |
|
23077-1
|
Equine arteritis virus Ag [Presence] in Tissue by Immunofluorescence |
|
23078-9
|
Equine arteritis virus Ag [Presence] in Tissue by Immune stain |
|
31815-4
|
Equine arteritis virus Ag [Presence] in Unspecified specimen |
|
23074-8
|
Equine arteritis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23075-5
|
Equine arteritis virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23076-3
|
Equine arteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
20807-4
|
Equine arteritis virus [Presence] in Blood by Organism specific culture |
|
23079-7
|
Equine arteritis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11581-6
|
Ebola virus Ab [Units/volume] in Serum |
|
22263-8
|
Ebola virus Ab [Titer] in Serum |
|
7862-6
|
Ebola virus Ab [Titer] in Serum by Immunofluorescence |
|
71768-6
|
Ebola virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
41637-0
|
Ebola virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
71770-2
|
Ebola virus IgG Ab [Presence] in Serum by Immunoassay |
|
71767-8
|
Ebola virus IgG Ab [Titer] in Serum by Immunoassay |
|
71712-4
|
Ebola virus IgM Ab [Presence] in Serum by Immunoassay |
|
71711-6
|
Ebola virus IgM Ab [Titer] in Serum by Immunoassay |
|
86518-8
|
Ebola virus RNA [Presence] in Blood by NAA with probe detection |
|
41636-2
|
Ebola virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
49178-7
|
Epstein Barr virus Ab [Presence] in Serum |
|
48723-1
|
Epstein Barr virus Ab [Presence] in Serum by Immunofluorescence |
|
13238-1
|
Epstein Barr virus Ab [Units/volume] in Serum |
|
49069-8
|
Epstein Barr virus Ab [Titer] in Serum |
|
84871-3
|
Epstein Barr virus capsid p18 IgG Ab [Presence] in Serum by Rapid immunoassay |
|
49355-1
|
Epstein Barr virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49354-4
|
Epstein Barr virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
36923-1
|
Epstein Barr virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
34593-4
|
Epstein Barr virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49353-6
|
Epstein Barr virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
47982-4
|
Epstein Barr virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49356-9
|
Epstein Barr virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49352-8
|
Epstein Barr virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
32585-2
|
Epstein Barr virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
93840-7
|
Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
93841-5
|
Epstein Barr virus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
|
5002-1
|
Epstein Barr virus DNA [Presence] in Blood by NAA with probe detection |
|
23858-4
|
Epstein Barr virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
59805-2
|
Epstein Barr virus DNA [Presence] in Body fluid by NAA with probe detection |
|
35397-9
|
Epstein Barr virus DNA [Presence] in Bone marrow by NAA with probe detection |
|
35398-7
|
Epstein Barr virus DNA [Presence] in Mouth by NAA with probe detection |
|
43730-1
|
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
5004-7
|
Epstein Barr virus DNA [Presence] in Tissue by NAA with probe detection |
|
5003-9
|
Epstein Barr virus DNA [Presence] in Tissue by Probe |
|
53774-6
|
Epstein Barr virus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5005-4
|
Epstein Barr virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
18427-5
|
Epstein Barr virus early Ab [Presence] in Body fluid |
|
16823-7
|
Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay |
|
7882-4
|
Epstein Barr virus early Ab [Presence] in Serum |
|
5153-2
|
Epstein Barr virus early Ab [Presence] in Serum by Immunoassay |
|
5154-0
|
Epstein Barr virus early Ab [Presence] in Serum by Immunofluorescence |
|
22293-5
|
Epstein Barr virus early Ab [Units/volume] in Serum |
|
42497-8
|
Epstein Barr virus early Ab [Titer] in Cerebral spinal fluid |
|
22294-3
|
Epstein Barr virus early Ab [Titer] in Serum |
|
14083-0
|
Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
|
47435-3
|
Epstein Barr virus early IgA Ab [Titer] in Serum |
|
47072-4
|
Epstein Barr virus early IgA Ab [Titer] in Serum by Immunofluorescence |
|
31371-8
|
Epstein Barr virus early IgG Ab [Units/volume] in Cerebral spinal fluid |
|
22295-0
|
Epstein Barr virus early IgG Ab [Presence] in Serum |
|
40752-8
|
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay |
|
6814-8
|
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunofluorescence |
|
24007-7
|
Epstein Barr virus early IgG Ab [Units/volume] in Serum |
|
23972-3
|
Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid |
|
23996-2
|
Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47436-1
|
Epstein Barr virus early IgG Ab [Titer] in Body fluid |
|
47068-2
|
Epstein Barr virus early IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
23971-5
|
Epstein Barr virus early IgG Ab [Titer] in Serum |
|
23995-4
|
Epstein Barr virus early IgG Ab [Titer] in Serum by Immunofluorescence |
|
56598-6
|
Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay |
|
51454-7
|
Epstein Barr virus early diffuse Ab [Presence] in Cerebral spinal fluid |
|
47434-6
|
Epstein Barr virus early diffuse Ab [Presence] in Serum |
|
13236-5
|
Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence |
|
94102-1
|
Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
59183-4
|
Epstein Barr virus early diffuse IgG Ab [Presence] in Serum |
|
50969-5
|
Epstein Barr virus early diffuse IgG Ab [Units/volume] in Serum |
|
47437-9
|
Epstein Barr virus early restricted Ab [Presence] in Serum |
|
13237-3
|
Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence |
|
33479-7
|
Epstein Barr virus early restricted Ab [Titer] in Serum |
|
84872-1
|
Epstein Barr virus nuclear 1 IgG Ab [Presence] in Serum by Rapid immunoassay |
|
66493-8
|
Epstein Barr virus nuclear 1 IgG Ab [Units/volume] in Serum |
|
72206-6
|
Epstein Barr virus nuclear 1 IgG and IgM [Color Ratio] in Serum or Plasma by Rapid immunoassay |
|
16824-5
|
Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid |
|
93712-8
|
Epstein Barr virus nuclear Ab [Presence] in Serum from Donor by Immunoassay |
|
22296-8
|
Epstein Barr virus nuclear Ab [Presence] in Serum |
|
20432-1
|
Epstein Barr virus nuclear Ab [Presence] in Serum by Immunofluorescence |
|
31372-6
|
Epstein Barr virus nuclear Ab [Units/volume] in Serum |
|
30138-2
|
Epstein Barr virus nuclear Ab [Presence] in Serum --2nd specimen |
|
42498-6
|
Epstein Barr virus nuclear Ab [Titer] in Cerebral spinal fluid |
|
22297-6
|
Epstein Barr virus nuclear Ab [Titer] in Serum |
|
21260-5
|
Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence |
|
18428-3
|
Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid |
|
31373-4
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Cerebral spinal fluid |
|
16825-2
|
Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid |
|
30083-0
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
40753-6
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
7883-2
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
|
5156-5
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
5155-7
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
|
31374-2
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum |
|
23970-7
|
Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid |
|
23994-7
|
Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22298-4
|
Epstein Barr virus nuclear IgG Ab [Titer] in Serum |
|
12212-7
|
Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
7884-0
|
Epstein Barr virus nuclear IgM Ab [Presence] in Serum |
|
6815-5
|
Epstein Barr virus nuclear IgM Ab [Presence] in Serum by Immunoassay |
|
31375-9
|
Epstein Barr virus nuclear IgM Ab [Units/volume] in Serum |
|
26705-4
|
Epstein Barr virus nuclear IgM Ab [Titer] in Serum |
|
49564-8
|
Epstein Barr virus band pattern [Interpretation] in Unspecified specimen by Immunoblot Narrative |
|
33395-5
|
Epstein Barr virus capsid Ab [Presence] in Serum |
|
31369-2
|
Epstein Barr virus capsid IgA Ab [Units/volume] in Serum |
|
34639-5
|
Epstein Barr virus capsid IgA Ab [Titer] in Cerebral spinal fluid |
|
22290-1
|
Epstein Barr virus capsid IgA Ab [Titer] in Serum |
|
9633-9
|
Epstein Barr virus capsid IgA Ab [Titer] in Serum by Immunofluorescence |
|
32830-2
|
Epstein Barr virus capsid IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
32845-0
|
Epstein Barr virus capsid IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
81119-0
|
Epstein Barr virus capsid IgG Ab avidity [Ratio] in Serum by Immunoassay |
|
69949-6
|
Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay |
|
58760-0
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
16827-8
|
Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid |
|
16826-0
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid |
|
93713-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
5157-3
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay |
|
30339-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum |
|
24114-1
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay |
|
40750-2
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence |
|
7885-7
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum |
|
32828-6
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
32843-5
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --1st specimen |
|
32829-4
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
30136-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum --2nd specimen |
|
32844-3
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --2nd specimen |
|
22291-9
|
Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid |
|
11009-8
|
Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47432-0
|
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid |
|
47064-1
|
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
20490-9
|
Epstein Barr virus capsid IgG Ab [Titer] in Serum |
|
5158-1
|
Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence |
|
56599-4
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31370-0
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid |
|
93714-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum from Donor by Immunoassay |
|
5159-9
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay |
|
30340-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum |
|
24115-8
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay |
|
40751-0
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunofluorescence |
|
7886-5
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum |
|
30137-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum --2nd specimen |
|
22292-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid |
|
11010-6
|
Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47433-8
|
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid |
|
47066-6
|
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
20491-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Serum |
|
5160-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence |
|
83095-0
|
Epstein Barr virus capsid+early IgG Ab [Presence] in Serum by Immunoassay |
|
68466-2
|
Epstein-Barr virus-encoded RNA 1 [Presence] in Tissue by Probe |
|
48673-8
|
EBV-LMP Ag [Presence] in Tissue by Immune stain |
|
87402-4
|
Escherichia coli aidA-I gene [Presence] in Isolate by NAA with probe detection |
|
87318-2
|
Escherichia coli eaeA gene [Presence] in Isolate by NAA with probe detection |
|
87951-0
|
Escherichia coli eaeA gene [Presence] in Stool by NAA with probe detection |
|
63423-8
|
Escherichia coli eaeA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
87370-3
|
Escherichia coli fasA gene [Presence] in Isolate by NAA with probe detection |
|
87371-1
|
Escherichia coli fedF gene [Presence] in Isolate by NAA with probe detection |
|
87372-9
|
Escherichia coli FimF41a gene [Presence] in Isolate by NAA with probe detection |
|
80676-0
|
Escherichia coli O157 rfbE gene [Presence] in Stool by NAA with probe detection |
|
88258-9
|
Escherichia coli oppA gene [Presence] by Probe in Positive blood culture |
|
87375-2
|
Escherichia coli paa gene [Presence] in Isolate by NAA with probe detection |
|
81285-9
|
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes [Identifier] in Stool by NAA with probe detection |
|
87376-0
|
Escherichia coli Stx1 toxin stx1 gene [Presence] in Isolate by NAA with probe detection |
|
79386-9
|
Escherichia coli Stx1 toxin stx1 gene [Presence] in Stool by NAA with probe detection |
|
63427-9
|
Escherichia coli Stx1 toxin stx1 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
53947-8
|
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 and H7 flagellar fliC genes [Identifier] in Unspecified specimen by NAA with probe detection |
|
82203-1
|
Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with non-probe detection |
|
80679-4
|
Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with probe detection |
|
87377-8
|
Escherichia coli Stx2 toxin stx2 gene [Presence] in Isolate by NAA with probe detection |
|
79387-7
|
Escherichia coli Stx2 toxin stx2 gene [Presence] in Stool by NAA with probe detection |
|
63428-7
|
Escherichia coli Stx2 toxin stx2 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
87380-2
|
Escherichia coli Stx2e toxin stx2e gene [Presence] in Isolate by NAA with probe detection |
|
29540-2
|
E-cadherin [Presence] in Tissue by Immune stain |
|
71577-1
|
ECG interpretation method NEMSIS |
|
71575-5
|
ECG NEMSIS |
|
42496-0
|
Echinococcus sp Ab [Presence] in Cerebral spinal fluid |
|
6390-9
|
Echinococcus sp Ab [Units/volume] in Serum by Complement fixation |
|
25398-9
|
Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
|
5135-9
|
Echinococcus sp Ab [Units/volume] in Serum by Hemagglutination |
|
6391-7
|
Echinococcus sp Ab [Units/volume] in Serum by Immunoassay |
|
25339-3
|
Echinococcus sp Ab [Presence] in Serum |
|
40749-4
|
Echinococcus sp Ab [Presence] in Serum by Complement fixation |
|
26007-5
|
Echinococcus sp Ab [Presence] in Serum by Hemagglutination |
|
25397-1
|
Echinococcus sp Ab [Presence] in Serum by Immunoassay |
|
41416-9
|
Echinococcus sp Ab [Presence] in Serum by Immunoblot |
|
7863-4
|
Echinococcus sp Ab [Units/volume] in Serum |
|
25867-3
|
Echinococcus sp Ab [Titer] in Serum |
|
26008-3
|
Echinococcus sp Ab [Titer] in Serum by Hemagglutination |
|
31809-7
|
Echinococcus sp Ag [Presence] in Stool |
|
23053-2
|
Echinococcus sp Ag [Presence] in Stool by Immunoassay |
|
6103-6
|
Echinococcus sp IgE Ab [Units/volume] in Serum |
|
15688-5
|
Echinococcus sp IgE Ab RAST class [Presence] in Serum |
|
9656-0
|
Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
14082-2
|
Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot |
|
32171-1
|
Echinococcus sp IgG Ab [Presence] in Serum |
|
22265-3
|
Echinococcus sp IgG Ab [Units/volume] in Serum |
|
52982-6
|
Echinococcus sp IgG1 Ab [Units/volume] in Serum by Immunoassay |
|
53369-5
|
Echinococcus sp IgG1 Ab [Units/volume] in Serum |
|
52983-4
|
Echinococcus sp IgG4 Ab [Units/volume] in Serum by Immunoassay |
|
55165-5
|
Echinococcus sp IgG4 Ab [Presence] in Serum |
|
53370-3
|
Echinococcus sp IgG4 Ab [Units/volume] in Serum |
|
9657-8
|
Echinococcus sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
16794-0
|
Echinococcus sp IgM Ab [Units/volume] in Serum |
|
89262-0
|
ECOG Performance Status [Interpretation] |
|
89247-1
|
ECOG Performance Status score |
|
73961-5
|
Escherichia coli and Klebsiella pneumoniae and Pseudomonas aeruginosa rRNA [Identifier] by FISH in Positive blood culture |
|
55673-8
|
Econazole [Susceptibility] by Gradient strip |
|
54178-9
|
Econazole [Susceptibility] by Disk diffusion (KB) |
|
25637-0
|
Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25595-0
|
Econazole [Susceptibility] |
|
57089-5
|
Eosinophil cationic protein (ECP) [Mass/volume] in Nasal fluid |
|
25638-8
|
Eosinophil cationic protein (ECP) [Mass/volume] in Serum |
|
55347-9
|
Ecarin clotting time (ECT) in Blood by Coagulation assay |
|
60242-5
|
Ecarin clotting time (ECT) in Platelet poor plasma by Coagulation assay |
|
33065-4
|
[#] Ectopic pregnancy |
|
90240-3
|
Eculizumab [Mass/volume] in Serum |
|
16796-5
|
Echovirus Ab [Units/volume] in Serum by Complement fixation |
|
53582-3
|
Echovirus Ab [Units/volume] in Serum by Immunoassay |
|
16795-7
|
Echovirus Ab [Units/volume] in Serum |
|
20666-4
|
Echovirus Ab [Interpretation] in Serum |
|
30134-1
|
Echovirus Ab [Presence] in Serum --1st specimen |
|
30135-8
|
Echovirus Ab [Presence] in Serum --2nd specimen |
|
58759-2
|
Echovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
59397-0
|
Echovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
59401-0
|
Echovirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
56622-4
|
Echovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
53371-1
|
Echovirus IgG Ab [Titer] in Serum |
|
51840-7
|
Echovirus IgG Ab [Titer] in Serum by Immunofluorescence |
|
59396-2
|
Echovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
53583-1
|
Echovirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
56623-2
|
Echovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
53372-9
|
Echovirus IgM Ab [Titer] in Serum |
|
51841-5
|
Echovirus IgM Ab [Titer] in Serum by Immunofluorescence |
|
22282-8
|
Echovirus NOS Ab [Titer] in Serum |
|
5149-0
|
Echovirus NOS Ab [Titer] in Serum by Complement fixation |
|
5148-2
|
Echovirus NOS Ab [Titer] in Serum by Neutralization test |
|
29666-5
|
Echovirus+Coxsackievirus IgA Ab [Presence] in Serum |
|
29645-9
|
Echovirus+Coxsackievirus IgA Ab [Presence] in Serum by Immunoassay |
|
61364-6
|
Echovirus+Coxsackievirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16797-3
|
Echovirus 1 Ab [Units/volume] in Serum by Complement fixation |
|
7864-2
|
Echovirus 1 Ab [Units/volume] in Serum |
|
22266-1
|
Echovirus 1 Ab [Titer] in Serum |
|
5137-5
|
Echovirus 1 Ab [Titer] in Serum by Complement fixation |
|
5136-7
|
Echovirus 1 Ab [Titer] in Serum by Neutralization test |
|
45283-9
|
Echovirus 11 Ab [Presence] in Body fluid |
|
31350-2
|
Echovirus 11 Ab [Presence] in Serum |
|
30333-9
|
Echovirus 11 Ab [Presence] in Serum by Complement fixation |
|
7865-9
|
Echovirus 11 Ab [Units/volume] in Serum |
|
22267-9
|
Echovirus 11 Ab [Titer] in Cerebral spinal fluid |
|
9516-6
|
Echovirus 11 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43043-9
|
Echovirus 11 Ab [Titer] in Body fluid |
|
31061-5
|
Echovirus 11 Ab [Titer] in Body fluid by Complement fixation |
|
22268-7
|
Echovirus 11 Ab [Titer] in Serum |
|
6708-2
|
Echovirus 11 Ab [Titer] in Serum by Complement fixation |
|
41489-6
|
Echovirus 11 Ab [Titer] in Serum by Neutralization test |
|
27934-9
|
Echovirus 11 RNA [Presence] in Cerebral spinal fluid by Probe |
|
16798-1
|
Echovirus 14 Ab [Units/volume] in Serum |
|
22269-5
|
Echovirus 14 Ab [Titer] in Serum |
|
24008-5
|
Echovirus 14 Ab [Titer] in Serum by Complement fixation |
|
20665-6
|
Echovirus 14 Ab [Titer] in Serum by Neutralization test |
|
11594-9
|
Echovirus 16 Ab [Units/volume] in Serum |
|
22271-1
|
Echovirus 16 Ab [Titer] in Serum |
|
6813-0
|
Echovirus 16 Ab [Titer] in Serum by Complement fixation |
|
41490-4
|
Echovirus 16 Ab [Titer] in Serum by Neutralization test |
|
11595-6
|
Echovirus 18 Ab [Units/volume] in Serum |
|
22272-9
|
Echovirus 18 Ab [Titer] in Serum |
|
9517-4
|
Echovirus 18 Ab [Titer] in Serum by Complement fixation |
|
16800-5
|
Echovirus 19 Ab [Units/volume] in Serum by Complement fixation |
|
7866-7
|
Echovirus 19 Ab [Units/volume] in Serum |
|
22273-7
|
Echovirus 19 Ab [Titer] in Serum |
|
5139-1
|
Echovirus 19 Ab [Titer] in Serum by Complement fixation |
|
5138-3
|
Echovirus 19 Ab [Titer] in Serum by Neutralization test |
|
54443-7
|
Echovirus 2 Ab [Titer] in Serum |
|
16801-3
|
Echovirus 3 Ab [Units/volume] in Serum by Complement fixation |
|
7867-5
|
Echovirus 3 Ab [Units/volume] in Serum |
|
22274-5
|
Echovirus 3 Ab [Titer] in Serum |
|
5141-7
|
Echovirus 3 Ab [Titer] in Serum by Complement fixation |
|
5140-9
|
Echovirus 3 Ab [Titer] in Serum by Neutralization test |
|
31351-0
|
Echovirus 30 Ab [Units/volume] in Cerebral spinal fluid |
|
45282-1
|
Echovirus 30 Ab [Presence] in Body fluid |
|
31352-8
|
Echovirus 30 Ab [Units/volume] in Body fluid |
|
6393-3
|
Echovirus 30 Ab [Units/volume] in Serum by Neutralization test |
|
31353-6
|
Echovirus 30 Ab [Presence] in Serum |
|
30334-7
|
Echovirus 30 Ab [Presence] in Serum by Complement fixation |
|
16802-1
|
Echovirus 30 Ab [Units/volume] in Serum |
|
22275-2
|
Echovirus 30 Ab [Titer] in Cerebral spinal fluid |
|
9518-2
|
Echovirus 30 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43040-5
|
Echovirus 30 Ab [Titer] in Body fluid |
|
31062-3
|
Echovirus 30 Ab [Titer] in Body fluid by Complement fixation |
|
7868-3
|
Echovirus 30 Ab [Titer] in Serum |
|
6392-5
|
Echovirus 30 Ab [Titer] in Serum by Complement fixation |
|
41491-2
|
Echovirus 30 Ab [Titer] in Serum by Neutralization test |
|
27928-1
|
Echovirus 30 RNA [Presence] in Cerebral spinal fluid by Probe |
|
34724-5
|
Echovirus 4 Ab [Presence] in Cerebral spinal fluid |
|
31354-4
|
Echovirus 4 Ab [Units/volume] in Cerebral spinal fluid |
|
31355-1
|
Echovirus 4 Ab [Units/volume] in Body fluid |
|
16803-9
|
Echovirus 4 Ab [Units/volume] in Serum by Complement fixation |
|
31356-9
|
Echovirus 4 Ab [Presence] in Serum |
|
30335-4
|
Echovirus 4 Ab [Presence] in Serum by Complement fixation |
|
7869-1
|
Echovirus 4 Ab [Units/volume] in Serum |
|
22276-0
|
Echovirus 4 Ab [Titer] in Cerebral spinal fluid |
|
9519-0
|
Echovirus 4 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43042-1
|
Echovirus 4 Ab [Titer] in Body fluid |
|
31059-9
|
Echovirus 4 Ab [Titer] in Body fluid by Complement fixation |
|
22277-8
|
Echovirus 4 Ab [Titer] in Serum |
|
5143-3
|
Echovirus 4 Ab [Titer] in Serum by Complement fixation |
|
5142-5
|
Echovirus 4 Ab [Titer] in Serum by Neutralization test |
|
27922-4
|
Echovirus 4 RNA [Presence] in Cerebral spinal fluid |
|
6395-8
|
Echovirus 40 Ab [Units/volume] in Serum by Neutralization test |
|
16804-7
|
Echovirus 40 Ab [Units/volume] in Serum |
|
7870-9
|
Echovirus 40 Ab [Titer] in Serum |
|
6394-1
|
Echovirus 40 Ab [Titer] in Serum by Complement fixation |
|
50977-8
|
Echovirus 5 Ab [Titer] in Serum |
|
16805-4
|
Echovirus 6 Ab [Units/volume] in Serum by Complement fixation |
|
43121-3
|
Echovirus 6 Ab [Presence] in Serum |
|
7871-7
|
Echovirus 6 Ab [Units/volume] in Serum |
|
22278-6
|
Echovirus 6 Ab [Titer] in Serum |
|
5145-8
|
Echovirus 6 Ab [Titer] in Serum by Complement fixation |
|
5144-1
|
Echovirus 6 Ab [Titer] in Serum by Neutralization test |
|
16806-2
|
Echovirus 6+18+30 Ab [Units/volume] in Serum |
|
34725-2
|
Echovirus 7 Ab [Presence] in Cerebral spinal fluid |
|
18333-5
|
Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid |
|
45281-3
|
Echovirus 7 Ab [Presence] in Body fluid |
|
31357-7
|
Echovirus 7 Ab [Presence] in Serum |
|
30336-2
|
Echovirus 7 Ab [Presence] in Serum by Complement fixation |
|
11601-2
|
Echovirus 7 Ab [Units/volume] in Serum |
|
23969-9
|
Echovirus 7 Ab [Titer] in Cerebral spinal fluid |
|
23993-9
|
Echovirus 7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22279-4
|
Echovirus 7 Ab [Titer] in Serum |
|
6922-9
|
Echovirus 7 Ab [Titer] in Serum by Complement fixation |
|
41492-0
|
Echovirus 7 Ab [Titer] in Serum by Neutralization test |
|
54444-5
|
Echovirus 8 Ab [Titer] in Serum |
|
31358-5
|
Echovirus 9 Ab [Units/volume] in Cerebral spinal fluid |
|
45280-5
|
Echovirus 9 Ab [Presence] in Body fluid |
|
31359-3
|
Echovirus 9 Ab [Units/volume] in Body fluid |
|
16807-0
|
Echovirus 9 Ab [Units/volume] in Serum by Complement fixation |
|
31360-1
|
Echovirus 9 Ab [Presence] in Serum |
|
30337-0
|
Echovirus 9 Ab [Presence] in Serum by Complement fixation |
|
7872-5
|
Echovirus 9 Ab [Units/volume] in Serum |
|
22280-2
|
Echovirus 9 Ab [Titer] in Cerebral spinal fluid |
|
9520-8
|
Echovirus 9 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43041-3
|
Echovirus 9 Ab [Titer] in Body fluid |
|
31060-7
|
Echovirus 9 Ab [Titer] in Body fluid by Complement fixation |
|
22281-0
|
Echovirus 9 Ab [Titer] in Serum |
|
5147-4
|
Echovirus 9 Ab [Titer] in Serum by Complement fixation |
|
5146-6
|
Echovirus 9 Ab [Titer] in Serum by Neutralization test |
|
78249-0
|
Emergency department Admission history and physical note |
|
78447-0
|
Emergency department Checklist |
|
51846-4
|
Emergency department Consult note |
|
74285-8
|
ED discharge disposition [NTDS] |
|
78024-7
|
ED discharge disposition [NHCS] |
|
60280-5
|
Emergency department Discharge instructions |
|
59258-4
|
Emergency department Discharge summary |
|
78265-6
|
Emergency department Discharge teaching note |
|
11300-1
|
ED diagnosis |
|
78273-0
|
Emergency department Education note |
|
75613-0
|
ED episode of care |
|
78303-5
|
Emergency department Flowsheet |
|
78307-6
|
Emergency department History and physical note |
|
78337-3
|
Emergency department Initial evaluation note |
|
34111-5
|
Emergency department Note |
|
88647-3
|
Emergency department Parenteral therapy note |
|
80746-1
|
Emergency department Plan of care note |
|
78316-7
|
Emergency department procedure note |
|
11313-4
|
ED procedure result observation [Interpretation] |
|
15507-7
|
Emergency department Progress note |
|
78341-5
|
Emergency department Transfer summary note |
|
54094-8
|
Emergency department Triage note |
|
80110-0
|
Emergency department Visit notification note |
|
91021-6
|
Emergency department visits [#] Reporting Period |
|
74211-4
|
Emergency department+Hospital Summary of episode note |
|
38595-5
|
Ethylene dibromide [Mass/volume] in Air |
|
38304-2
|
Ethylene dibromide [Mass/volume] in Water |
|
79250-7
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
77754-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Confirmatory method |
|
77752-4
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Screen method |
|
61076-6
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid |
|
80557-2
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Hair |
|
73562-1
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method |
|
72385-8
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72386-6
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method |
|
41860-8
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma |
|
60071-8
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma |
|
58429-2
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method |
|
41858-2
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine |
|
58428-4
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method |
|
93495-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method |
|
50542-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine |
|
41859-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Unspecified specimen |
|
58390-6
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine |
|
44966-0
|
Edema |
|
72071-4
|
Edema present |
|
44972-8
|
Edema site |
|
72304-9
|
Edge of wound description |
|
92012-4
|
Edit flags section |
|
82468-0
|
Edoxaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
93200-4
|
Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method |
|
34895-3
|
Education note |
|
79215-0
|
Education program online access code |
|
79213-5
|
Type of education program assigned to patient |
|
79214-3
|
Education program [URI] |
|
22255-4
|
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
20794-4
|
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
20792-8
|
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
22256-2
|
Eastern equine encephalitis virus Ab [Presence] in Serum |
|
23043-3
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Agglutination |
|
20793-6
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
|
20790-2
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
20791-0
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
|
23044-1
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
|
5134-2
|
Eastern equine encephalitis virus Ab [Units/volume] in Serum |
|
24287-5
|
Eastern equine encephalitis virus Ab [Titer] in Serum --1st specimen |
|
24213-1
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24288-3
|
Eastern equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
|
24214-9
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
34723-7
|
Eastern equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
22257-0
|
Eastern equine encephalitis virus Ab [Titer] in Serum |
|
43329-2
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23042-5
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
13918-8
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
|
20795-1
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
31806-3
|
Eastern equine encephalitis virus Ag [Presence] in Brain |
|
23047-4
|
Eastern equine encephalitis virus Ag [Presence] in Brain by Complement fixation |
|
31807-1
|
Eastern equine encephalitis virus Ag [Presence] in Serum |
|
6388-3
|
Eastern equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
|
6389-1
|
Eastern equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
|
31808-9
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen |
|
23049-0
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23048-2
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23050-8
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
29836-4
|
Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid |
|
29798-6
|
Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13228-2
|
Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
62431-2
|
Eastern equine encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29848-9
|
Eastern equine encephalitis virus IgG Ab [Presence] in Serum |
|
52822-4
|
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
29811-7
|
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
7860-0
|
Eastern equine encephalitis virus IgG Ab [Units/volume] in Serum |
|
22258-8
|
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
10897-7
|
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22259-6
|
Eastern equine encephalitis virus IgG Ab [Titer] in Serum |
|
10896-9
|
Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
29824-0
|
Eastern equine encephalitis virus IgG Ab [Presence] in Unspecified specimen |
|
29785-3
|
Eastern equine encephalitis virus IgG Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
38764-7
|
Eastern equine encephalitis virus IgG Ab [Units/volume] in Unspecified specimen |
|
49065-6
|
Eastern equine encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
|
24006-9
|
Eastern equine encephalitis virus IgG and IgM [Interpretation] in Serum |
|
43044-7
|
Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
42004-2
|
Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13229-0
|
Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
62430-4
|
Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
62429-6
|
Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence |
|
23046-6
|
Eastern equine encephalitis virus IgM Ab [Presence] in Serum |
|
23045-8
|
Eastern equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
7861-8
|
Eastern equine encephalitis virus IgM Ab [Units/volume] in Serum |
|
22260-4
|
Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
10899-3
|
Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22261-2
|
Eastern equine encephalitis virus IgM Ab [Titer] in Serum |
|
43330-0
|
Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunoassay |
|
10898-5
|
Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
43096-7
|
Eastern equine encephalitis virus IgM Ab [Presence] in Unspecified specimen |
|
38763-9
|
Eastern equine encephalitis virus IgM Ab [Units/volume] in Unspecified specimen |
|
34449-9
|
Eastern equine encephalitis virus RNA [Presence] in Blood by NAA with probe detection |
|
34450-7
|
Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
26825-0
|
Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
|
23051-6
|
Eastern equine encephalitis virus RNA [Presence] in Tissue by NAA with probe detection |
|
23052-4
|
Eastern equine encephalitis virus RNA [Presence] in Tissue by Probe |
|
50547-9
|
Eastern equine encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37983-4
|
Eastern equine encephalitis virus RNA [Presence] in Unspecified specimen by Probe |
|
11523-8
|
EEG study report |
|
6105-1
|
Eel IgE Ab [Units/volume] in Serum |
|
29534-5
|
Eel IgE Ab RAST class [Presence] in Serum |
|
56252-0
|
Eel IgG4 Ab [Mass/volume] in Serum |
|
63122-6
|
Eel IgG Ab [Mass/volume] in Serum |
|
2273-1
|
Fatty acids.esterified [Mass/volume] in Blood |
|
17078-7
|
Fatty acids.esterified [Mass/volume] in Serum or Plasma |
|
30291-9
|
Efavirenz [Susceptibility] by Genotype method |
|
30277-8
|
Efavirenz [Susceptibility] by Phenotype method |
|
51908-2
|
Efavirenz [Mass/volume] in Serum or Plasma --peak |
|
29117-9
|
Efavirenz [Units/volume] in Serum or Plasma |
|
33928-3
|
Efavirenz [Mass/volume] in Serum or Plasma |
|
30306-5
|
Efavirenz [Susceptibility] |
|
51907-4
|
Efavirenz [Mass/volume] in Serum or Plasma --trough |
|
11867-9
|
Effacement Cervix |
|
33144-7
|
Fetal Body weight estimated on US by Tokyo 1987 method |
|
11775-4
|
Fetal body weight estimation formula Narrative [Bibliographic Citation] Citation |
|
11868-7
|
Fetal body weight estimation formula Narrative [Equation] Equation |
|
11728-3
|
Fetal Body weight estimated from Abdominal circumference on US |
|
11756-4
|
Fetal Body weight estimated from Abdominal circumference on US by Campbell 1975 method |
|
11757-2
|
Fetal Body weight estimated from Abdominal circumference on US by Vintzileos 1987 method |
|
11758-0
|
Fetal Body weight estimated from Abdominal circumference on US by Warsof 1977 method |
|
11729-1
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US |
|
11737-4
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Eik-Nes 1982 method |
|
11738-2
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Hadlock 1984 method |
|
11739-0
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Shepard 1982 method |
|
11740-8
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Thurnau 1983 method |
|
11741-6
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Warsof 1977 method |
|
11742-4
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Weinberger 1984 method |
|
11730-9
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US |
|
11734-1
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1984 method |
|
11735-8
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1985 method |
|
11736-6
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Woo 1985 method |
|
11731-7
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US |
|
11732-5
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Hadlock 1985 method |
|
11733-3
|
Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Roberts 1985 method |
|
11743-2
|
Fetal Body weight estimated from Abdominal circumference and Femur length on US |
|
11750-7
|
Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1984 method |
|
11751-5
|
Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1985 method |
|
11752-3
|
Fetal Body weight estimated from Abdominal circumference and Femur length on US by Woo 1985 method |
|
11744-0
|
Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US |
|
11745-7
|
Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1984 method |
|
11746-5
|
Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1985 method |
|
11747-3
|
Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Ott 1986 method |
|
11748-1
|
Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Vintzileos 1987 method |
|
11749-9
|
Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Weiner 1985 method |
|
11753-1
|
Fetal Body weight estimated from Abdominal circumference and Head circumference on US |
|
11754-9
|
Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Hadlock 1984 method |
|
11755-6
|
Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Jordaan 1983 method |
|
11759-8
|
Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US |
|
11762-2
|
Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Rose 1987 method |
|
11763-0
|
Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Vintzileos 1987 method |
|
11760-6
|
Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US |
|
11761-4
|
Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US by Rose 1987 method |
|
11764-8
|
Fetal Body weight estimated from Abdominal diameter and Femur length on US |
|
11765-5
|
Fetal Body weight estimated from Abdominal diameter and Femur length on US by Rose 1987 method |
|
33140-5
|
Fetal Body weight estimated from Biparietal diameter and Fetal trunk area and Femur length on US by Osaka 1990 method |
|
33139-7
|
Fetal Body weight estimated from Biparietal diameter and Transverse thoracic diameter on US by Hansmann 1986 method |
|
33162-9
|
Fetal Body weight US+Estimated from Hadlock 1991 |
|
28014-9
|
EGD Study observation Narrative |
|
28015-6
|
EGD Study observation |
|
35588-3
|
Ethylene glycol dinitrate [Mass/volume] in Blood |
|
14049-1
|
Epidermal growth factor [Mass/volume] in Serum or Plasma |
|
39004-7
|
Epidermal growth factor receptor Ag [Presence] in Tissue |
|
32581-1
|
Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain |
|
55765-2
|
EGFR gene c.2156G>C+2155G>A+2155G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
55768-6
|
EGFR gene c.2303G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
85383-8
|
EGFR gene c.2369C>T actual/normal in Plasma cell-free DNA by Molecular genetics method |
|
55769-4
|
EGFR gene c.2369C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
55766-0
|
EGFR gene c.2573T>G [Presence] in Blood or Tissue by Molecular genetics method |
|
55767-8
|
EGFR gene c.2582T>A [Presence] in Blood or Tissue by Molecular genetics method |
|
55764-5
|
EGFR gene exon 19 deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
55770-2
|
EGFR gene exon 20 insertion [Presence] in Blood or Tissue by Molecular genetics method |
|
21665-5
|
EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21666-3
|
EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
42782-3
|
Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain |
|
13659-8
|
Epidermal growth factor receptor [Mass/mass] in Tissue |
|
14050-9
|
Epidermal growth factor receptor [Moles/mass] in Tissue |
|
68327-6
|
Egg donor age |
|
80402-1
|
Egg source [Type] |
|
7290-0
|
Egg white triggered histamine release [Units/volume] in Blood |
|
6106-9
|
Egg white IgE Ab [Units/volume] in Serum |
|
15689-3
|
Egg white IgE Ab RAST class [Presence] in Serum |
|
61338-0
|
Egg white IgE Ab/IgE total in Serum |
|
51536-1
|
Egg white IgG Ab [Presence] in Serum |
|
6725-6
|
Egg white IgG Ab [Units/volume] in Serum |
|
21253-0
|
Egg white IgG Ab RAST class [Presence] in Serum |
|
26423-4
|
Egg white IgG4 Ab [Units/volume] in Serum |
|
26424-2
|
Egg white IgG4 Ab RAST class [Presence] in Serum |
|
56253-8
|
Egg white IgG4 Ab [Mass/volume] in Serum |
|
35535-4
|
Egg white IgG Ab [Mass/volume] in Serum |
|
48226-5
|
Egg white triggered leukotriene release [Mass/volume] by Leukocytes |
|
7295-9
|
Egg yolk triggered histamine release [Units/volume] in Blood |
|
6107-7
|
Egg yolk IgE Ab [Units/volume] in Serum |
|
15691-9
|
Egg yolk IgE Ab RAST class [Presence] in Serum |
|
61339-8
|
Egg yolk IgE Ab/IgE total in Serum |
|
7294-2
|
Egg yolk IgG Ab [Units/volume] in Serum |
|
21254-8
|
Egg yolk IgG Ab RAST class [Presence] in Serum |
|
56254-6
|
Egg yolk IgG4 Ab [Mass/volume] in Serum |
|
35536-2
|
Egg yolk IgG Ab [Mass/volume] in Serum |
|
48207-5
|
Egg yolk triggered leukotriene release [Mass/volume] by Leukocytes |
|
7296-7
|
Eggplant IgE Ab [Units/volume] in Serum |
|
15692-7
|
Eggplant IgE Ab RAST class [Presence] in Serum |
|
7297-5
|
Eggplant IgG Ab [Units/volume] in Serum |
|
21255-5
|
Eggplant IgG Ab RAST class [Presence] in Serum |
|
56256-1
|
Eggplant IgG4 Ab [Mass/volume] in Serum |
|
60372-0
|
Eggplant IgG Ab [Mass/volume] in Serum |
|
34722-9
|
EGR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34506-6
|
EGR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
20803-3
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum |
|
23060-7
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Complement fixation |
|
23059-9
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
|
15466-6
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
20802-5
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Neutralization test |
|
23062-3
|
Epizootic hemorrhagic disease virus Ag [Presence] in Blood |
|
20804-1
|
Epizootic hemorrhagic disease virus Ag [Presence] in Blood by Immunofluorescence |
|
31813-9
|
Epizootic hemorrhagic disease virus Ag [Presence] in Lung |
|
20805-8
|
Epizootic hemorrhagic disease virus Ag [Units/mass] in Lung Qualitative by Immunofluorescence |
|
23061-5
|
Epizootic hemorrhagic disease virus Ag [Presence] in Unspecified specimen |
|
23063-1
|
Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum |
|
23064-9
|
Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum by Immune diffusion (ID) |
|
23065-6
|
Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum |
|
23066-4
|
Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum by Immune diffusion (ID) |
|
23067-2
|
Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection |
|
91898-7
|
Epizootic hemorrhagic disease virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
63424-6
|
Bacterial enterohemolysin ehlyA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
7879-0
|
Ehrlichia sp Ab [Presence] in Serum |
|
6405-5
|
Ehrlichia sp Ab [Presence] in Serum by Immunoassay |
|
43039-7
|
Ehrlichia sp Ab [Titer] in Serum |
|
34285-7
|
Ehrlichia sp Ab [Titer] in Serum by Complement fixation |
|
48866-8
|
Ehrlichia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
13196-1
|
Ehrlichia sp IgG Ab [Presence] in Serum |
|
32011-9
|
Ehrlichia sp IgG Ab [Titer] in Serum |
|
13197-9
|
Ehrlichia sp IgM Ab [Presence] in Serum |
|
32012-7
|
Ehrlichia sp IgM Ab [Titer] in Serum |
|
48873-4
|
Ehrlichia sp identified in Unspecified specimen by Organism specific culture |
|
48982-3
|
Ehrlichia sp [Presence] in Unspecified specimen by Light microscopy |
|
49125-8
|
Ehrlichia sp identified in Unspecified specimen by Sequencing |
|
31377-5
|
Equine herpesvirus 1 Ab [Units/volume] in Serum |
|
46186-3
|
Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid |
|
43332-6
|
Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
22300-8
|
Equine herpesvirus 1 Ab [Titer] in Serum |
|
15467-4
|
Equine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
|
20854-6
|
Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
23081-3
|
Equine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
|
31816-2
|
Equine herpesvirus 1 Ag [Presence] in Tracheal swab |
|
20853-8
|
Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence |
|
31817-0
|
Equine herpesvirus 1 Ag [Presence] in Unspecified specimen |
|
23080-5
|
Equine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23082-1
|
Equine herpesvirus 1 DNA [Presence] in Nose by NAA with probe detection |
|
23084-7
|
Equine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
23083-9
|
Equine herpesvirus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23087-0
|
Equine herpesvirus 1+4 Ab [Presence] in Serum |
|
23085-4
|
Equine herpesvirus 1+4 Ab [Presence] in Serum by Neutralization test |
|
31378-3
|
Equine herpesvirus 1+4 Ab [Units/volume] in Serum |
|
23088-8
|
Equine herpesvirus 1+4 Ab [Titer] in Serum |
|
23090-4
|
Equine herpesvirus 1+4 Ab [Titer] in Serum by Complement fixation |
|
23086-2
|
Equine herpesvirus 1+4 Ab [Titer] in Serum by Immunoassay |
|
23089-6
|
Equine herpesvirus 1+4 Ab [Titer] in Serum by Neutralization test |
|
31818-8
|
Equine herpesvirus 1+4 Ag [Presence] in Body fluid |
|
23091-2
|
Equine herpesvirus 1+4 Ag [Presence] in Body fluid by Immunofluorescence |
|
46187-1
|
Equine herpesvirus 2 Ab [Titer] in Serum |
|
43333-4
|
Equine herpesvirus 2 Ab [Titer] in Serum by Neutralization test |
|
46188-9
|
Equine herpesvirus 3 Ab [Titer] in Serum |
|
43334-2
|
Equine herpesvirus 3 Ab [Titer] in Serum by Neutralization test |
|
31819-6
|
Equine herpesvirus 4 Ag [Presence] in Unspecified specimen |
|
23092-0
|
Equine herpesvirus 4 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23093-8
|
Equine herpesvirus 4 DNA [Presence] in Nose by NAA with probe detection |
|
23094-6
|
Equine herpesvirus 4 DNA [Presence] in Tissue by NAA with probe detection |
|
23095-3
|
Equine herpesvirus 4 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22301-6
|
Equine infectious anemia virus Ab [Presence] in Serum |
|
23097-9
|
Equine infectious anemia virus Ab [Presence] in Serum by Immunoassay |
|
23096-1
|
Equine infectious anemia virus Ab [Presence] in Serum by Immunoblot |
|
15468-2
|
Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31820-4
|
Equine infectious anemia virus Ag [Presence] in Unspecified specimen |
|
23099-5
|
Equine infectious anemia virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23098-7
|
Equine infectious anemia virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
79705-0
|
Eicosadienoate (C20:2w6) [Entitic substance] in Red Blood Cells |
|
79694-6
|
Eicosadienoate (C20:2w6) [Moles/volume] in Serum or Plasma |
|
53461-0
|
Eicosanoylcarnitine (C20) [Moles/volume] in Amniotic fluid |
|
53466-9
|
Eicosanoylcarnitine (C20) [Moles/volume] in Cerebral spinal fluid |
|
53462-8
|
Eicosanoylcarnitine (C20) [Moles/volume] in DBS |
|
53473-5
|
Eicosanoylcarnitine (C20) [Moles/volume] in Serum or Plasma |
|
53494-1
|
Eicosanoylcarnitine (C20) [Moles/volume] in Urine |
|
53512-0
|
Eicosanoylcarnitine (C20)/Creatinine [Molar ratio] in Urine |
|
81029-1
|
Eicosapentaenoate intake 24 hour Estimated |
|
81030-9
|
Eicosapentaenoate intake 24 hour Measured |
|
81766-8
|
Eicosatrienoate (C20:3w3) [Entitic substance] in Serum or Plasma |
|
81767-6
|
Eicosatrienoate (C20:3w3) [Moles/volume] in Serum or Plasma |
|
23101-9
|
Equine influenza virus A1 Ab [Presence] in Serum |
|
23100-1
|
Equine influenza virus A1 Ab [Presence] in Serum by Complement fixation |
|
31379-1
|
Equine influenza virus A1 Ab [Units/volume] in Serum |
|
22302-4
|
Equine influenza virus A1 Ab [Titer] in Serum |
|
15469-0
|
Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition |
|
23102-7
|
Equine influenza virus A1 Ag [Titer] in Unspecified specimen by Hemagglutination inhibition |
|
31821-2
|
Equine influenza virus A1 Ag [Units/volume] in Unspecified specimen |
|
15470-8
|
Equine influenza virus A2 Ab [Presence] in Serum |
|
23103-5
|
Equine influenza virus A2 Ab [Presence] in Serum by Complement fixation |
|
31380-9
|
Equine influenza virus A2 Ab [Units/volume] in Serum |
|
22303-2
|
Equine influenza virus A2 Ab [Titer] in Serum |
|
15471-6
|
Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
23104-3
|
Equine influenza virus A2 Ag [Titer] in Unspecified specimen by Hemagglutination inhibition |
|
31822-0
|
Equine influenza virus A2 Ag [Units/volume] in Unspecified specimen |
|
31823-8
|
Equine influenza virus Ag [Presence] in Nose |
|
15472-4
|
Equine influenza virus Ag [Presence] in Nose by Immunoassay |
|
45149-2
|
Ej Ab [Presence] in Serum |
|
82392-2
|
Ej Ab [Presence] in Serum by Line blot |
|
48647-2
|
Ej Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) |
|
8600-9
|
Type of EKG device |
|
9860-8
|
EKG device Institution inventory number |
|
9863-2
|
EKG device Vendor model number |
|
9865-7
|
EKG device Vendor serial number |
|
8601-7
|
EKG impression |
|
18844-1
|
EKG impression Narrative |
|
44967-8
|
Electrocardiograph lead |
|
8605-8
|
Type of EKG leads |
|
11524-6
|
EKG study |
|
8612-4
|
EKG Study overall |
|
38895-9
|
ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
63387-5
|
Elastase Ab [Presence] in Body fluid by Immunoassay |
|
56620-8
|
Elastase Ab [Units/volume] in Serum by Immunoassay |
|
54017-9
|
Elastase Ab [Presence] in Serum |
|
85086-7
|
Elastase IgG Ab [Presence] in Serum by Immunoassay |
|
2223-6
|
Elastase.leukocyte [Enzymatic activity/volume] in Plasma |
|
33864-0
|
Elastase.leukocyte [Mass/volume] in Plasma |
|
2220-2
|
Elastase.pancreatic Free [Enzymatic activity/volume] in Serum |
|
2221-0
|
Elastase.pancreatic [Enzymatic activity/volume] in Serum |
|
14048-3
|
Elastase.pancreatic [Mass/volume] in Serum |
|
42902-7
|
Elastase.pancreatic [Presence] in Stool |
|
25907-7
|
Elastase.pancreatic [Mass/mass] in Stool |
|
2222-8
|
Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum |
|
82376-5
|
Elbasvir [Susceptibility] by Genotype method |
|
41353-4
|
Elbow - left Extension Active Range of Motion Quantitative |
|
41354-2
|
Elbow - left Extension Passive Range of Motion Quantitative |
|
41351-8
|
Elbow - left Flexion Active Range of Motion Quantitative |
|
41352-6
|
Elbow - left Flexion Passive Range of Motion Quantitative |
|
41357-5
|
Elbow - right Extension Active Range of Motion Quantitative |
|
41358-3
|
Elbow - right Extension Passive Range of Motion Quantitative |
|
41355-9
|
Elbow - right Flexion Active Range of Motion Quantitative |
|
41356-7
|
Elbow - right Flexion Passive Range of Motion Quantitative |
|
6108-5
|
Elder IgE Ab [Units/volume] in Serum |
|
15694-3
|
Elder IgE Ab RAST class [Presence] in Serum |
|
7298-3
|
Elder IgG Ab [Units/volume] in Serum |
|
87444-6
|
Electrical conductivity [Fluid Conductance] of Water |
|
75921-7
|
Electrical potential Cerebral cortex Electroencephalogram (EEG) |
|
60852-1
|
Electrical potential Muscle on EMG |
|
81226-3
|
Electrolyte imbalance [CCC] |
|
19096-7
|
Electrolytes - single valence [Interpretation] in 24 hour Urine Narrative |
|
18749-2
|
Electromyogram study |
|
75745-0
|
Electronic Health Record (EHR) Implementation Stage [NMMDS] |
|
74703-0
|
Electronic health record system component [AHRQ] |
|
85886-0
|
Clinical cardiac electrophysiology Consult note |
|
85940-5
|
Clinical cardiac electrophysiology Postoperative evaluation and management note |
|
85939-7
|
Clinical cardiac electrophysiology Preoperative evaluation and management note |
|
18750-0
|
Electrophysiology study |
|
93971-0
|
Elevation climbed [Length/Time] 24 hour |
|
53247-3
|
Eligibility acknowledgement |
|
10927-2
|
Elk or Moose Meat IgE Ab [Units/volume] in Serum |
|
15696-8
|
Elk or Moose Meat IgE Ab RAST class [Presence] in Serum |
|
11274-8
|
Elliptocytes [Presence] in Blood by Light microscopy |
|
48970-8
|
ELN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35461-3
|
ELN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
36919-9
|
ELN gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
72526-7
|
Elvitegravir [Susceptibility] by Genotype method |
|
88986-5
|
Elvitegravir [Mass/volume] in Serum or Plasma |
|
80411-2
|
Emergency management incident location |
|
80393-2
|
Emergency management incident name |
|
80394-0
|
Emergency management incident type |
|
20882-7
|
Microscopic observation [Identifier] in Stool by Electron microscopy negative stain |
|
8250-3
|
Microscopic observation [Identifier] in Stool by Electron microscopy |
|
20881-9
|
Microscopic observation [Identifier] in Tissue by Electron microscopy thin sectiion |
|
50668-3
|
Microscopic observation in Unspecified specimen by Electron microscopy Narrative |
|
34166-9
|
Microscopic observation [Identifier] in Unspecified specimen by Electron microscopy |
|
33048-0
|
Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC) |
|
90097-7
|
Email address of person responsible for generating report |
|
91893-8
|
Email address Volunteer |
|
10478-6
|
Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
|
31364-3
|
Encephalomyocarditis virus Ab [Units/volume] in Serum |
|
29889-3
|
Encephalomyocarditis virus Ab [Titer] in Serum |
|
29886-9
|
Encephalomyocarditis virus Ab [Titer] in Serum by Neutralization test |
|
93754-0
|
Encephalomyocarditis virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87315-8
|
Encephalomyocarditis virus RNA [Presence] in Tissue by NAA with probe detection |
|
87314-1
|
Encephalomyocarditis virus [Presence] in Tissue by Organism specific culture |
|
80193-6
|
Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method |
|
80196-9
|
Ecgonine methyl ester [Presence] in Blood by Screen method |
|
80194-4
|
Ecgonine methyl ester [Mass/volume] in Body fluid by Confirmatory method |
|
30109-3
|
Ecgonine methyl ester [Mass/volume] in Gastric fluid |
|
78825-7
|
Ecgonine methyl ester [Mass/mass] in Hair |
|
30108-5
|
Ecgonine methyl ester [Mass/mass] in Meconium |
|
80195-1
|
Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method |
|
45320-9
|
Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method |
|
30107-7
|
Ecgonine methyl ester [Mass/volume] in Serum or Plasma |
|
50592-5
|
Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method |
|
80144-9
|
Ecgonine methyl ester [Presence] in Urine by Screen method |
|
30110-1
|
Ecgonine methyl ester [Mass/volume] in Vitreous fluid |
|
92188-2
|
Emergency activation decision |
|
92190-8
|
Emergency response improvement activity |
|
91882-1
|
Emergency response plan objective |
|
91884-7
|
Emergency response plan problem analysis Narrative |
|
91885-4
|
Emergency response plan success analysis |
|
90099-3
|
Emergency response report Document |
|
91883-9
|
Emergency response plan target outcome |
|
56796-6
|
Emergency contact information panel |
|
56863-4
|
Emergency contact Phone number |
|
89916-1
|
Emergency management plan approved date |
|
89918-7
|
Emergency management plan approver name |
|
89917-9
|
Emergency management plan estimated fulfillment date |
|
89911-2
|
Emergency management plan name |
|
89912-0
|
Emergency management plan purpose |
|
68552-9
|
Emergency medicine Emergency department Admission evaluation note |
|
78302-7
|
Emergency medicine Emergency department Flowsheet |
|
80741-2
|
Emergency medicine Emergency department Plan of care note |
|
34878-9
|
Emergency medicine Note |
|
84096-7
|
Emergency medicine Telephone encounter Note |
|
89883-3
|
Emergency medicine Telehealth Note |
|
92840-8
|
Emergency operations standard operating procedure Document |
|
90116-5
|
Emergency response plan Document |
|
90103-3
|
Emergency response plan identifier |
|
75636-1
|
Emergency severity index [ESI] |
|
91890-4
|
Emergency supply category |
|
57276-8
|
Emergent care utilized [CMS Assessment] |
|
94070-0
|
Emesis count 24 hour |
|
94069-2
|
Emesis occurred |
|
4233-3
|
Emetine [Mass] of Dose |
|
16812-0
|
Emetine [Presence] in Serum or Plasma |
|
16813-8
|
Emetine [Units/volume] in Serum or Plasma |
|
12399-2
|
Emetine [Mass/volume] in Serum or Plasma |
|
3588-1
|
Emetine [Presence] in Urine |
|
12400-8
|
Emetine [Mass/volume] in Urine |
|
89843-7
|
Unicode Emoji skin tone modifier |
|
82814-5
|
Emotional abuse--before 18 years old [ACE] |
|
82817-8
|
Emotional neglect--before 18 years old [ACE] |
|
85609-6
|
Emotional score [MLHFQ] |
|
85034-7
|
Emotional Support Survey - fixed length form - ages 18+ - raw score [NIH Toolbox] |
|
85036-2
|
Emotional Support Survey - national percentile [NIH Toolbox] |
|
85035-4
|
Emotional Support Survey - scale score age adjusted [NIH Toolbox] |
|
85028-9
|
Emotional Support Survey - scale score fully adjusted [NIH Toolbox] |
|
85027-1
|
Emotional Support Survey - unadjusted scale score [NIH Toolbox] |
|
85031-3
|
Emotional Support Survey version 2.0 - ages 8-17 - T-score [NIH Toolbox] |
|
91647-8
|
Emotional/informational support score [MOS Social Support Survey] |
|
19465-4
|
Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19464-7
|
Ethylmorphine cutoff [Mass/volume] in Urine for Screen method |
|
4247-3
|
Ethylmorphine [Mass] of Dose |
|
20527-8
|
Ethylmorphine [Mass/volume] in Urine by Confirmatory method |
|
3618-6
|
Ethylmorphine [Presence] in Urine |
|
19463-9
|
Ethylmorphine [Presence] in Urine by Confirmatory method |
|
19462-1
|
Ethylmorphine [Presence] in Urine by Screen method |
|
16851-8
|
Ethylmorphine [Units/volume] in Urine |
|
3619-4
|
Ethylmorphine [Mass/volume] in Urine |
|
52071-8
|
Employee assistance program attachment |
|
80429-4
|
Employer address |
|
80431-0
|
Employer city |
|
80437-7
|
Employer country [Location] |
|
80427-8
|
Employer name [Identifier] |
|
80435-1
|
Employer postal code [Location] |
|
80433-6
|
Employer state |
|
91570-2
|
Employment net income in past 30 days |
|
89564-9
|
Employment status [CUBS] |
|
85152-7
|
Employment status of family member |
|
85104-8
|
Compensation and sector employment type |
|
80467-4
|
Empty calorie servings 24 hour Estimated |
|
80468-2
|
Empty calorie servings 24 hour Measured |
|
89011-1
|
EMS assistant name |
|
89012-9
|
EMS assistant qualification |
|
88088-0
|
EMS transport destination name [Identifier] of Facility |
|
71578-9
|
EMS transport destination NEMSIS |
|
77156-8
|
EMS unit Level of care capability |
|
88073-2
|
EMS physician vehicle arrived before the paramedics |
|
89010-3
|
EMS physician name |
|
88066-6
|
EMS physician qualification |
|
88075-7
|
EMS personnel drove themselves to scene |
|
77157-6
|
EMS Response mode descriptors NEMSIS |
|
77153-5
|
EMS Transport mode descriptors NEMSIS |
|
88067-4
|
EMS unit on scene |
|
41402-9
|
Emtricitabine [Susceptibility] by Genotype method |
|
49669-5
|
Emtricitabine [Susceptibility] by Phenotype method |
|
63389-1
|
Extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63239-8
|
Extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63388-3
|
Extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63238-0
|
Extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
29954-5
|
Extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
14722-3
|
Extractable nuclear Ab [Presence] in Serum |
|
63391-7
|
Extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
57431-9
|
Extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
63390-9
|
Extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
30342-0
|
Extractable nuclear Ab [Units/volume] in Serum |
|
44083-4
|
Extractable nuclear Ab [Interpretation] in Serum |
|
63394-1
|
Jo-1 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
51749-0
|
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid |
|
63267-9
|
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89529-2
|
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63393-3
|
Jo-1 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63536-7
|
Jo-1 extractable nuclear Ab [Presence] in Body fluid |
|
63266-1
|
Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63265-3
|
Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
35333-4
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
17032-4
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8076-2
|
Jo-1 extractable nuclear Ab [Presence] in Serum |
|
5234-0
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56731-3
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5235-7
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17031-6
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
11565-9
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum |
|
14235-6
|
Jo-1 extractable nuclear Ab [Titer] in Serum |
|
44332-5
|
Jo-1 extractable nuclear IgG Ab [Presence] in Serum |
|
82918-4
|
Jo-1 extractable nuclear IgG Ab [Presence] in Serum by Line blot |
|
33571-1
|
Jo-1 extractable nuclear IgG Ab [Units/volume] in Serum |
|
63306-5
|
PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89537-5
|
PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63305-7
|
PCNA extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
8088-7
|
PCNA extractable nuclear Ab [Presence] in Serum |
|
5275-3
|
PCNA extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56733-9
|
PCNA extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5276-1
|
PCNA extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
47074-0
|
PCNA extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
53006-3
|
PCNA extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
|
82841-8
|
PCNA extractable nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
63308-1
|
PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89536-7
|
PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63307-3
|
PM-SCL extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
33635-4
|
PM-SCL extractable nuclear Ab [Mass/volume] in Serum by Immune diffusion (ID) |
|
31563-0
|
PM-SCL extractable nuclear Ab [Presence] in Serum |
|
56721-4
|
PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
53007-1
|
PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
31562-2
|
PM-SCL extractable nuclear Ab [Units/volume] in Serum |
|
53008-9
|
PM-SCL extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
|
49055-7
|
Ribonucleoprotein extractable nuclear 52kD Ab [Presence] in Serum |
|
68377-1
|
Ribonucleoprotein extractable nuclear 63kD Ab [Presence] in Serum or Plasma |
|
63399-0
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63319-8
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89535-9
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63398-2
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63540-9
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
|
63318-0
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63317-2
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
51928-0
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
17536-4
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8091-1
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
|
5301-7
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56723-0
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5302-5
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17535-6
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
29374-6
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
|
41025-8
|
Ribonucleoprotein extractable nuclear Ab [Mass/volume] in Serum |
|
9399-7
|
Ribonucleoprotein extractable nuclear Ab [Titer] in Serum |
|
29958-6
|
Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
23929-3
|
Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
|
31588-7
|
Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
|
63400-6
|
SCL-70 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63337-0
|
SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89533-4
|
SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63336-2
|
SCL-70 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63542-5
|
SCL-70 extractable nuclear Ab [Presence] in Body fluid |
|
63335-4
|
SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63334-7
|
SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
26975-3
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
89502-9
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Line blot |
|
8092-9
|
SCL-70 extractable nuclear Ab [Presence] in Serum |
|
5348-8
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56693-5
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5349-6
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17569-5
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
27416-7
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum |
|
63338-8
|
SCL-70 extractable nuclear Ab [Titer] in Serum by Immunoassay |
|
32715-5
|
SCL-70 extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
47322-3
|
SCL-70 extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
21518-6
|
SCL-70 extractable nuclear IgG Ab [Presence] in Serum |
|
17570-3
|
SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
26023-2
|
Extractable nuclear Ab identified in Serum |
|
63406-3
|
Smith extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63354-5
|
Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89531-8
|
Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63405-5
|
Smith extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63546-6
|
Smith extractable nuclear Ab [Presence] in Body fluid |
|
63353-7
|
Smith extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63352-9
|
Smith extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
43182-5
|
Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
17592-7
|
Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
31627-3
|
Smith extractable nuclear Ab [Presence] in Serum |
|
5355-3
|
Smith extractable nuclear Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
|
5356-1
|
Smith extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56730-5
|
Smith extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5357-9
|
Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17591-9
|
Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
11090-8
|
Smith extractable nuclear Ab [Units/volume] in Serum |
|
9722-0
|
Smith extractable nuclear Ab [Titer] in Serum |
|
17590-1
|
Smith extractable nuclear Ab [Titer] in Serum by Immunoassay |
|
17589-3
|
Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
33564-6
|
Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33565-3
|
Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
21523-6
|
Smith extractable nuclear IgG Ab [Presence] in Serum |
|
18323-6
|
Smith extractable nuclear IgG Ab [Units/volume] in Serum |
|
63547-4
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
|
14030-1
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
31628-1
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
|
26880-5
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
89501-1
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Line blot |
|
27048-8
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
|
30556-5
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
|
33567-9
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33568-7
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
33460-7
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
|
21522-8
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
|
26703-9
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Titer] in Serum by Immunoassay |
|
63548-2
|
Smith extractable nuclear B Ab [Units/volume] in Serum by Immunoassay |
|
54030-2
|
Smith extractable nuclear B Ab [Presence] in Serum |
|
88882-6
|
Smith extractable nuclear B Ab [Presence] in Serum by Line blot |
|
54031-0
|
Smith extractable nuclear D Ab [Presence] in Serum |
|
88881-8
|
Smith extractable nuclear D Ab [Presence] in Serum by Line blot |
|
82938-2
|
Smith extractable nuclear D IgG Ab [Units/volume] in Serum |
|
63341-2
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89532-6
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63543-3
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid |
|
63339-6
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid by Immunoassay |
|
56549-9
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Immunoassay |
|
53016-2
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum |
|
63342-0
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoassay |
|
63445-1
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoblot |
|
53017-0
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum |
|
63340-4
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Titer] in Body fluid by Immunoassay |
|
70257-1
|
Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Units/volume] in Serum by Immunoassay |
|
82933-3
|
Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Presence] in Serum by Line blot |
|
63544-1
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid |
|
63343-8
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid by Immunoassay |
|
53018-8
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum |
|
63411-3
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoassay |
|
59014-1
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoblot |
|
53019-6
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum |
|
63344-6
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Titer] in Body fluid by Immunoassay |
|
63401-4
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63402-2
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89527-6
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63348-7
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63345-3
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Flow cytometry (FC) |
|
63347-9
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63346-1
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
33569-5
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
33566-1
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoblot |
|
17584-4
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8093-7
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum |
|
5351-2
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56724-8
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5352-0
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17583-6
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
17792-3
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
|
32716-3
|
Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum |
|
29948-7
|
Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
29964-4
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33583-6
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
31625-7
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum |
|
17585-1
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
33610-7
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum |
|
32041-6
|
Sjogrens syndrome-A extractable nuclear Ab+Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
|
63404-8
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63351-1
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89526-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63403-0
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63545-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid |
|
63350-3
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63349-5
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
45142-7
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
33570-3
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoblot |
|
17587-7
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8094-5
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum |
|
5353-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56725-5
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5354-6
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17586-9
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
17791-5
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
|
29949-5
|
Sjogrens syndrome-B extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
29965-1
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33598-4
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
31626-5
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum |
|
17588-5
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
33613-1
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum |
|
31693-5
|
Unidentified extractable nuclear Ab [Presence] in Serum |
|
20435-4
|
Unidentified extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
73028-3
|
Enalapril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73027-5
|
Enalapril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73401-2
|
Enalapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73400-4
|
Enalapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4234-1
|
Encainide [Mass] of Dose |
|
3589-9
|
Encainide [Mass/volume] in Serum or Plasma |
|
89601-9
|
Proof of encounter certificate |
|
75519-9
|
Encounter identifier |
|
80412-0
|
Encounter location |
|
89009-5
|
Encounter location [Type] |
|
54596-2
|
End date of most recent Medicare stay [CMS Assessment] |
|
55028-5
|
End date of occupational therapy [CMS Assessment] |
|
55030-1
|
End date of physical therapy [CMS Assessment] |
|
55026-9
|
End date of speech language pathology and audiology services [CMS Assessment] |
|
67876-3
|
End stage renal disease (ESRD) co-morbidities ICD code |
|
7304-9
|
Endive IgE Ab [Units/volume] in Serum |
|
15699-2
|
Endive IgE Ab RAST class [Presence] in Serum |
|
7305-6
|
Endive IgG Ab [Units/volume] in Serum |
|
21258-9
|
Endive IgG Ab RAST class [Presence] in Serum |
|
83683-3
|
Endocrinology Attending Note |
|
83736-9
|
Endocrinology Fellow Note |
|
83544-7
|
Endocrinology Nurse practitioner Note |
|
83573-6
|
Endocrinology Nurse Outpatient Note |
|
83755-9
|
Endocrinology Resident Note |
|
89799-1
|
Endocrinology Team Conference note |
|
46735-7
|
Endocrine disorders newborn screen interpretation |
|
69053-7
|
Endocrinologist review of results |
|
34879-7
|
Endocrinology Consult note |
|
78257-3
|
Endocrinology Diagnostic study note |
|
78278-9
|
Endocrinology Education note |
|
78295-3
|
Endocrinology Flowsheet |
|
84097-5
|
Endocrinology History and physical note |
|
84098-3
|
Endocrinology Hospital Note |
|
78312-6
|
Endocrinology Initial evaluation note |
|
34898-7
|
Endocrinology Note |
|
84099-1
|
Endocrinology Outpatient Note |
|
84100-7
|
Endocrinology Telephone encounter Note |
|
80747-9
|
Endocrinology Plan of care note |
|
78321-7
|
Endocrinology procedure note |
|
78327-4
|
Endocrinology Progress note |
|
57137-2
|
Endocrinology Referral note |
|
89891-6
|
Endocrinology Telehealth Note |
|
12145-9
|
Endometrium Thickness US |
|
16815-3
|
Endomysium Ab [Units/volume] in Serum by Immunofluorescence |
|
31365-0
|
Endomysium Ab [Presence] in Serum |
|
16814-6
|
Endomysium Ab [Presence] in Serum by Immunofluorescence |
|
13092-2
|
Endomysium Ab [Units/volume] in Serum |
|
14708-2
|
Endomysium Ab [Titer] in Serum |
|
25399-7
|
Endomysium Ab [Titer] in Serum by Immunofluorescence |
|
10362-2
|
Endomysium IgA Ab [Presence] in Serum |
|
46126-9
|
Endomysium IgA Ab [Presence] in Serum by Immunofluorescence |
|
31366-8
|
Endomysium IgA Ab [Units/volume] in Serum |
|
10863-9
|
Endomysium IgA Ab [Titer] in Serum |
|
27038-9
|
Endomysium IgA Ab [Titer] in Serum by Immunofluorescence |
|
39554-1
|
Endomysium IgG Ab [Presence] in Serum |
|
45136-9
|
Endomysium IgG Ab [Units/volume] in Serum |
|
49726-3
|
Endomysium IgG Ab [Titer] in Serum |
|
51699-7
|
Endomysium IgG Ab [Titer] in Serum by Immunofluorescence |
|
20796-9
|
Endophyte identified in Plant |
|
19783-0
|
Type of Endoscopy device |
|
19784-8
|
Endoscopy device Institution inventory number |
|
19804-4
|
Endoscopy procedure Study observation |
|
19805-1
|
Endoscopy procedure Study observation Narrative |
|
18751-8
|
Endoscopy study |
|
87661-5
|
Endosulfan I [Mass/mass] in Unspecified specimen |
|
87751-4
|
Endosulfan II [Mass/mass] in Unspecified specimen |
|
38301-8
|
Endothall [Mass/volume] in Water |
|
58933-3
|
Endothelial cell Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
58460-7
|
Endothelial cell Ab [Titer] in Serum or Plasma |
|
49867-5
|
Endothelin I [Mass/volume] in Serum or Plasma |
|
12737-3
|
Endothelin [Units/volume] in Serum or Plasma |
|
26769-0
|
Endothelin [Mass/volume] in Serum or Plasma |
|
74098-5
|
Endothelin [Moles/volume] in Serum or Plasma |
|
20797-7
|
Endotoxin identified in Unspecified specimen |
|
59345-9
|
Endoxifen [Mass/volume] in Blood |
|
59349-1
|
Endoxifen [Mass/volume] in Serum or Plasma |
|
23856-8
|
Endrin [Mass/volume] in Serum or Plasma |
|
38302-6
|
Endrin [Mass/volume] in Water |
|
87660-7
|
Endrin [Mass/mass] in Unspecified specimen |
|
77150-1
|
Energy content [Energy/mass] in 24 hour Stool.dried |
|
74532-3
|
Energy content [Energy/mass] of 24 hour Stool.wet |
|
75990-2
|
Energy expended Reporting Period by Indirect calorimetry |
|
14264-6
|
Enflurane [Mass/volume] in Blood |
|
61019-6
|
Enflurane [VFr/PPres] Airway adaptor --during expiration |
|
60754-9
|
Enflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60885-1
|
Enflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60855-4
|
Enflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60884-4
|
Enflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60752-3
|
Gas delivery system inspiratory Enflurane setting [VFr/PPres] |
|
62266-2
|
Enflurane [VFr/PPres] Airway adaptor |
|
60854-7
|
Enflurane [VFr/PPres] Gas delivery system |
|
60755-6
|
Enflurane gas delivered during case [Volume] from Gas delivery system |
|
61023-8
|
Enflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76014-0
|
Enflurane liquid delivered during case [Volume] from Gas delivery system |
|
76015-7
|
Enflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
72858-4
|
Enfuvirtide [Susceptibility] by Genotype method |
|
82719-6
|
Enfuvirtide [Susceptibility] by Phenotype method |
|
69482-8
|
ENG gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77625-2
|
ENG gene full mutation analysis in Blood or Tissue by Sequencing |
|
7766-9
|
English Walnut Pollen IgE Ab [Units/volume] in Serum |
|
16077-0
|
English Walnut Pollen IgE Ab RAST class [Presence] in Serum |
|
7616-6
|
English plantain triggered histamine release [Units/volume] in Blood |
|
6110-1
|
English plantain IgE Ab [Units/volume] in Serum |
|
15952-5
|
English plantain IgE Ab RAST class [Presence] in Serum |
|
61301-8
|
English plantain IgE Ab/IgE total in Serum |
|
13189-6
|
English plantain IgG Ab [Units/volume] in Serum |
|
56257-9
|
English plantain IgG4 Ab [Mass/volume] in Serum |
|
63209-1
|
English plantain IgG Ab [Mass/volume] in Serum |
|
48253-9
|
English plantain triggered leukotriene release [Mass/volume] by Leukocytes |
|
64972-3
|
English plantain recombinant (rPla l) 1 IgE Ab [Units/volume] in Serum |
|
81969-8
|
English plantain recombinant (rPla l) 1 IgE Ab RAST class [Presence] in Serum |
|
65766-8
|
English Walnut native (nJug r) 1 IgE Ab [Units/volume] in Serum |
|
65767-6
|
English Walnut native (nJug r) 2 IgE Ab [Units/volume] in Serum |
|
65768-4
|
English Walnut native (nJug r) 3 IgE Ab [Units/volume] in Serum |
|
81790-8
|
English walnut recombinant (rJug r) 1 IgE Ab [Units/volume] in Serum |
|
82546-3
|
English walnut recombinant (rJug r) 1 IgE Ab RAST class [Presence] in Serum |
|
81789-0
|
English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum |
|
82545-5
|
English walnut recombinant (rJug r) 3 IgE Ab RAST class [Presence] in Serum |
|
7765-1
|
English Walnut IgE Ab [Units/volume] in Serum |
|
21600-2
|
English Walnut IgE Ab RAST class [Presence] in Serum |
|
61279-6
|
English Walnut IgE Ab/IgE total in Serum |
|
13179-7
|
English Walnut IgG Ab [Units/volume] in Serum |
|
45345-6
|
Tick engorgement [presence] |
|
77601-3
|
Enhanced note |
|
86488-4
|
Enjoyment of life limited by heart failure over the past 2 weeks [KCCQ] |
|
11045-2
|
Enolase [Enzymatic activity/volume] in Red Blood Cells |
|
2224-4
|
Enolase [Enzymatic activity/volume] in Serum |
|
4235-8
|
Enoxacin [Mass] of Dose |
|
41692-5
|
Enoxacin [Susceptibility] by Gradient strip |
|
230-3
|
Enoxacin [Susceptibility] by Disk diffusion (KB) |
|
229-5
|
Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
228-7
|
Enoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3590-7
|
Enoxacin [Mass/volume] in Serum or Plasma |
|
18918-3
|
Enoxacin [Susceptibility] |
|
231-1
|
Enoxacin [Susceptibility] by Serum bactericidal titer |
|
16816-1
|
Enoxacin [Mass/volume] in Urine |
|
35796-2
|
Enrofloxacin [Susceptibility] by Gradient strip |
|
35797-0
|
Enrofloxacin [Susceptibility] by Disk diffusion (KB) |
|
35798-8
|
Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23712-3
|
Enrofloxacin [Susceptibility] |
|
75531-4
|
Enrollment basis |
|
26655-1
|
Entamoeba sp Ab [Presence] in Serum |
|
91765-8
|
Entamoeba sp DNA [Identifier] in Aspirate by Sequencing |
|
90298-1
|
Entamoeba sp DNA [Identifier] in Stool by Sequencing |
|
70294-4
|
Entamoeba sp DNA [Identifier] in Unspecified specimen by Sequencing |
|
56791-7
|
Entecavir [Susceptibility] by Genotype method |
|
80448-4
|
Enteral tube flush volume 24 hour |
|
80476-5
|
Enteral tube nutritional formula concentration [Energy/volume] |
|
89069-9
|
Enteric coated aspirin tablet |
|
76632-9
|
Enterovirus sp [Presence] in Isolate by Immunofluorescence |
|
85771-4
|
Enterobacteriaceae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
88255-5
|
Enterobacter sp gyrB+metB genes [Presence] by Probe in Positive blood culture |
|
90067-0
|
Enterobacteriaceae identified in Isolate by Organism specific culture |
|
85775-5
|
Enterococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92784-8
|
Enterococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
71718-1
|
Enterococcus sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27902-6
|
Enterococcus sp IgG Ab [Units/volume] in Serum |
|
27077-7
|
Enterococcus sp IgM Ab [Units/volume] in Serum |
|
5001-3
|
Enterococcus sp rRNA [Presence] in Unspecified specimen by Probe |
|
69031-3
|
Enterocyte IgA Ab [Presence] in Serum |
|
69030-5
|
Enterocyte IgG Ab [Presence] in Serum |
|
69032-1
|
Enterocyte IgM Ab [Presence] in Serum |
|
2226-9
|
Enteroglucagon [Mass/volume] in Serum |
|
2227-7
|
Enteropeptidase [Enzymatic activity/volume] in Plasma |
|
28018-0
|
Enteroscopy Study observation Narrative |
|
28019-8
|
Enteroscopy Study observation |
|
28020-6
|
Enteroscopy through stoma Study observation Narrative |
|
28021-4
|
Enteroscopy through stoma Study observation |
|
76370-6
|
Entry level nursing degree Provider [NMMDS] |
|
54590-5
|
Entry type [CMS Assessment] |
|
58108-2
|
Entry/discharge reporting [CMS Assessment] |
|
80352-8
|
Environment temperature during transport |
|
89551-6
|
Environmental health Consult note |
|
89552-4
|
Environmental health Note |
|
91599-1
|
Emergency operations center activation level |
|
81892-2
|
Episode of care primary diagnosis |
|
81891-4
|
Episode of care secondary diagnosis |
|
90105-8
|
Emergency operations center standard operating procedure identifier |
|
90104-1
|
Emergency operations center standard operating procedure name |
|
78030-4
|
Episode of care Type |
|
26449-9
|
Eosinophils [#/volume] in Blood |
|
711-2
|
Eosinophils [#/volume] in Blood by Automated count |
|
66141-3
|
Eosinophils [#/volume] in Blood from Fetus by Manual count |
|
712-0
|
Eosinophils [#/volume] in Blood by Manual count |
|
74404-5
|
Eosinophils [#/volume] in Cord blood |
|
34958-9
|
Eosinophils [#/volume] in Cerebral spinal fluid |
|
34957-1
|
Eosinophils [#/volume] in Cerebral spinal fluid by Manual count |
|
35063-7
|
Eosinophils [#/volume] in Body fluid |
|
40569-6
|
Eosinophils [#/volume] in Body fluid by Manual count |
|
67829-2
|
Eosinophils [#/volume] in Pericardial fluid |
|
68398-7
|
Eosinophils [#/volume] in Pericardial fluid by Manual count |
|
35062-9
|
Eosinophils [#/volume] in Pleural fluid |
|
67835-9
|
Eosinophils [#/volume] in Pleural fluid from Fetus |
|
68400-1
|
Eosinophils [#/volume] in Pleural fluid by Manual count |
|
35061-1
|
Eosinophils [#/volume] in Peritoneal fluid |
|
68399-5
|
Eosinophils [#/volume] in Peritoneal fluid by Manual count |
|
35060-3
|
Eosinophils [#/volume] in Synovial fluid |
|
68401-9
|
Eosinophils [#/volume] in Synovial fluid by Manual count |
|
68402-7
|
Eosinophils [#/volume] in Vitreous fluid by Manual count |
|
34726-0
|
Eosinophils [#/area] in Peritoneal fluid by Microscopy high power field |
|
5785-1
|
Eosinophils [#/area] in Urine sediment by Microscopy high power field |
|
50373-0
|
Eosinophils.band form/100 cells in Bone marrow by Manual count |
|
32173-7
|
Eosinophils [Presence] in Blood by Wright stain |
|
55778-5
|
Eosinophils [#] in Cerebral spinal fluid by Manual count |
|
76407-6
|
Eosinophils [#] in Body fluid by Manual count |
|
60520-4
|
Eosinophils [Presence] in Body fluid by Light microscopy |
|
11152-6
|
Eosinophils/100 cells in Bone marrow |
|
11106-2
|
Eosinophils/100 cells in Bone marrow by Manual count |
|
71679-5
|
Eosinophils/Leukocytes [Pure number fraction] in Blood by Automated count |
|
71674-6
|
Eosinophils/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71596-1
|
Eosinophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
|
71661-3
|
Eosinophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71646-4
|
Eosinophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
71603-5
|
Eosinophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71613-4
|
Eosinophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71632-4
|
Eosinophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71622-5
|
Eosinophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
50340-9
|
Eosinophils [Presence] in Nose by Hansel stain |
|
29992-5
|
Eosinophils [Presence] in Nose by Wright stain |
|
50341-7
|
Eosinophils [Presence] in Sputum by Hansel stain |
|
29993-3
|
Eosinophils [Presence] in Sputum by Wright stain |
|
45379-5
|
Eosinophils [Presence] in Stool by Light microscopy |
|
48049-1
|
Eosinophils [Presence] in Stool by Wright stain |
|
25156-1
|
Eosinophils [Presence] in Urine sediment by Light microscopy |
|
49839-4
|
Eosinophils [Presence] in Urine sediment by Wright stain |
|
48710-8
|
Eosinophils [Presence] in Unspecified specimen by Light microscopy |
|
20472-7
|
Eosinophils [Presence] in Unspecified specimen by Wright stain |
|
26450-7
|
Eosinophils/100 leukocytes in Blood |
|
713-8
|
Eosinophils/100 leukocytes in Blood by Automated count |
|
714-6
|
Eosinophils/100 leukocytes in Blood by Manual count |
|
74405-2
|
Eosinophils/100 leukocytes in Cord blood |
|
30377-6
|
Eosinophils/100 leukocytes in Bronchial specimen |
|
56771-9
|
Eosinophils/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
|
14709-0
|
Eosinophils/100 leukocytes in Bronchial specimen by Manual count |
|
26451-5
|
Eosinophils/100 leukocytes in Cerebral spinal fluid |
|
12208-5
|
Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
40539-9
|
Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count |
|
57840-1
|
Eosinophils/100 leukocytes in Dialysis fluid by Manual count |
|
26452-3
|
Eosinophils/100 leukocytes in Body fluid |
|
12209-3
|
Eosinophils/100 leukocytes in Body fluid by Manual count |
|
30378-4
|
Eosinophils/100 leukocytes in Nose |
|
9727-9
|
Eosinophils/100 leukocytes in Nose by Manual count |
|
32013-5
|
Eosinophils/100 leukocytes in Pericardial fluid by Manual count |
|
30379-2
|
Eosinophils/100 leukocytes in Pleural fluid |
|
14344-6
|
Eosinophils/100 leukocytes in Pleural fluid by Manual count |
|
30380-0
|
Eosinophils/100 leukocytes in Peritoneal fluid |
|
14343-8
|
Eosinophils/100 leukocytes in Peritoneal fluid by Manual count |
|
17834-3
|
Eosinophils/100 leukocytes in Synovial fluid |
|
57391-5
|
Eosinophils/100 leukocytes in Synovial fluid by Manual count |
|
30381-8
|
Eosinophils/100 leukocytes in Sputum |
|
10327-5
|
Eosinophils/100 leukocytes in Sputum by Manual count |
|
30382-6
|
Eosinophils/100 leukocytes in Stool |
|
14326-3
|
Eosinophils/100 leukocytes in Stool by Manual count |
|
32014-3
|
Eosinophils/100 leukocytes in Urine by Manual count |
|
12210-1
|
Eosinophils/100 leukocytes in Urine sediment by Manual count |
|
68403-5
|
Eosinophils/100 leukocytes in Vitreous fluid by Manual count |
|
32593-6
|
Eosinophils/100 leukocytes in Unspecified specimen |
|
75097-6
|
Eicosapentaenoate (C20:5w3) [Entitic substance] in Red Blood Cells |
|
35173-4
|
Eicosapentaenoate (C20:5w3) [Moles/volume] in Serum or Plasma |
|
88996-4
|
Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
|
90912-7
|
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C22 in Blood |
|
88997-2
|
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma |
|
90908-5
|
Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 risk [Interpretation] in Blood Qualitative |
|
90911-9
|
Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood |
|
90291-6
|
EpCAM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
79418-0
|
EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
85454-7
|
ePCAM Social Complexity [ePCAM] |
|
84903-4
|
Extraprostatic extension extent [Type] of Prostate tumor |
|
80348-6
|
Escherichia coli enteropathogenic eae gene [Presence] in Stool by NAA with non-probe detection |
|
50342-5
|
Ependymal+Choroid plexus cells/100 leukocytes [Ratio] in Cerebral spinal fluid |
|
51909-0
|
Ependymal cells/100 cells in Cerebral spinal fluid |
|
24413-7
|
Eperythrozoon sp [Presence] in Blood by Giemsa stain |
|
4236-6
|
ePHEDrine [Mass] of Dose |
|
47105-2
|
ePHEDrine [Presence] in Gastric fluid |
|
47106-0
|
ePHEDrine [Presence] in Serum or Plasma |
|
90445-8
|
ePHEDrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3591-5
|
ePHEDrine [Mass/volume] in Serum or Plasma |
|
55535-9
|
ePHEDrine [Moles/volume] in Serum or Plasma |
|
59134-7
|
ePHEDrine [Mass/volume] in Urine by Confirmatory method |
|
3592-3
|
ePHEDrine [Presence] in Urine |
|
3593-1
|
ePHEDrine [Mass/volume] in Urine |
|
14710-8
|
ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid |
|
26727-8
|
ePHEDrine+Pseudoephedrine [Mass/mass] in Meconium |
|
29612-9
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3594-9
|
ePHEDrine+Pseudoephedrine [Presence] in Serum or Plasma |
|
3595-6
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma |
|
26771-6
|
ePHEDrine+Pseudoephedrine [Mass/mass] in Stool |
|
58707-1
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Urine by Confirmatory method |
|
3596-4
|
ePHEDrine+Pseudoephedrine [Presence] in Urine |
|
26785-6
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Urine |
|
27412-6
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid |
|
32069-7
|
ePHEDrine+Pseudoephedrine [Presence] in Unspecified specimen |
|
23058-1
|
Ephemeral fever virus Ab [Presence] in Serum |
|
23057-3
|
Ephemeral fever virus Ab [Presence] in Serum by Neutralization test |
|
30383-4
|
Epithelial cells [#/volume] in Urine |
|
87926-2
|
Epithelial cells [#/volume] in Urine by Automated |
|
24123-2
|
Epithelial cells [#/volume] in Urine by Manual count |
|
58766-7
|
Epithelial cells [#/area] in Semen by Microscopy high power field |
|
33342-7
|
Epithelial cells [#/area] in Urine sediment by Automated count |
|
5787-7
|
Epithelial cells [#/area] in Urine sediment by Microscopy high power field |
|
46133-5
|
Epithelial cells [#/area] in Urine sediment by Microscopy low power field |
|
53541-9
|
Epithelial cells [Presence] in Blood by Light microscopy |
|
35652-7
|
Epithelial cells/100 cells in Body fluid |
|
16822-9
|
Epithelial cells [Presence] in Nose by Light microscopy |
|
12452-9
|
Epithelial cells [Presence] in Semen by Light microscopy |
|
14103-6
|
Epithelial cells [Presence] in Stool by Light microscopy |
|
87830-6
|
Epithelial cells [Presence] in Urine |
|
20453-7
|
Epithelial cells [Presence] in Urine sediment by Light microscopy |
|
12211-9
|
Epithelial cells [Presence] in Vaginal fluid by Wet preparation |
|
72161-3
|
Epithelial cells [Presence] in Unspecified specimen by Gram stain |
|
32762-7
|
Epithelial cells [Presence] in Unspecified specimen by Wet preparation |
|
74354-2
|
Epithelial cells/100 leukocytes in Sputum |
|
2229-3
|
Epiandrosterone [Mass/volume] in Serum or Plasma |
|
38594-8
|
Epichlorohydrin [Mass/volume] in Air |
|
12999-9
|
Epichlorohydrin [Mass/volume] in Serum or Plasma |
|
38303-4
|
Epichlorohydrin [Mass/volume] in Water |
|
24147-1
|
Epidermal Allergen Mix A (Chicken feather+Duck feather+Goose feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
31005-2
|
Epidermal Allergen Mix B (Budgerigar feather+Canary feather+Parrot feather+Finch feather) IgE Ab [Presence] in Serum by Multidisk |
|
23798-2
|
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
|
30185-3
|
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
|
24483-0
|
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15213-2
|
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk |
|
82047-2
|
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82046-4
|
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15215-7
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk |
|
72279-3
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
24495-4
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
61203-6
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab/IgE total in Serum by Multidisk |
|
56259-5
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG4 Ab [Mass/volume] in Serum |
|
38361-2
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG Ab [Mass/volume] in Serum by Multidisk |
|
15216-5
|
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
|
73713-0
|
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
82049-8
|
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
23799-0
|
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
|
31161-3
|
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
24488-9
|
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
56781-8
|
Epidermal Allergen Mix C (Canary feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
|
91010-9
|
Epidemiological investigation report Document |
|
15214-0
|
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk |
|
71370-1
|
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82048-0
|
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
45382-9
|
Epidermis Ab [Presence] in Serum |
|
31368-4
|
Epidermis Ab [Units/volume] in Serum |
|
23857-6
|
Epidermis Ab [Interpretation] in Tissue by Immunofluorescence |
|
8069-7
|
Epidermis Ab [Titer] in Serum |
|
5152-4
|
Epidermis Ab [Titer] in Serum by Immunofluorescence |
|
18217-0
|
Epidermis IgA Ab [Presence] in Tissue |
|
18218-8
|
Epidermis IgM Ab [Presence] in Tissue |
|
85884-5
|
Epilepsy Consult note |
|
85883-7
|
Epilepsy Note |
|
1461-3
|
EPINEPHrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
|
47136-7
|
EPINEPHrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
|
32015-0
|
EPINEPHrine [Mass/volume] in 24 hour Urine |
|
2232-7
|
EPINEPHrine [Mass/time] in 24 hour Urine |
|
25908-5
|
EPINEPHrine [Moles/volume] in 24 hour Urine |
|
14712-4
|
EPINEPHrine [Moles/time] in 24 hour Urine |
|
1462-1
|
EPINEPHrine [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
|
47137-5
|
EPINEPHrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
|
12529-4
|
EPINEPHrine [Mass/volume] in Plasma --2 hours post XXX challenge |
|
47138-3
|
EPINEPHrine [Moles/volume] in Plasma --2 hours post XXX challenge |
|
1463-9
|
EPINEPHrine [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
|
47141-7
|
EPINEPHrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
|
16821-1
|
EPINEPHrine [Mass/volume] in Plasma --4 hours post XXX challenge |
|
47144-1
|
EPINEPHrine [Moles/volume] in Plasma --4 hours post XXX challenge |
|
2230-1
|
EPINEPHrine [Mass/volume] in Plasma |
|
14711-6
|
EPINEPHrine [Moles/volume] in Plasma |
|
1464-7
|
EPINEPHrine [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
|
47153-2
|
EPINEPHrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO |
|
51425-7
|
EPINEPHrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
13420-5
|
EPINEPHrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
47139-1
|
EPINEPHrine [Moles/volume] in Plasma --2nd specimen post XXX challenge |
|
18219-6
|
EPINEPHrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
|
47140-9
|
EPINEPHrine [Moles/volume] in Urine --2nd specimen post XXX challenge |
|
13421-3
|
EPINEPHrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
|
47142-5
|
EPINEPHrine [Moles/volume] in Plasma --3rd specimen post XXX challenge |
|
18220-4
|
EPINEPHrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
|
47143-3
|
EPINEPHrine [Moles/volume] in Urine --3rd specimen post XXX challenge |
|
13422-1
|
EPINEPHrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
|
47146-6
|
EPINEPHrine [Moles/volume] in Plasma --4th specimen post XXX challenge |
|
18221-2
|
EPINEPHrine [Mass/volume] in Urine --4th specimen post XXX challenge |
|
47145-8
|
EPINEPHrine [Moles/volume] in Urine --4th specimen post XXX challenge |
|
13423-9
|
EPINEPHrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
|
47147-4
|
EPINEPHrine [Moles/volume] in Plasma --5th specimen post XXX challenge |
|
18222-0
|
EPINEPHrine [Mass/volume] in Urine --5th specimen post XXX challenge |
|
47148-2
|
EPINEPHrine [Moles/volume] in Urine --5th specimen post XXX challenge |
|
13424-7
|
EPINEPHrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
|
47149-0
|
EPINEPHrine [Moles/volume] in Plasma --6th specimen post XXX challenge |
|
18223-8
|
EPINEPHrine [Mass/volume] in Urine --6th specimen post XXX challenge |
|
47150-8
|
EPINEPHrine [Moles/volume] in Urine --6th specimen post XXX challenge |
|
13425-4
|
EPINEPHrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
|
47151-6
|
EPINEPHrine [Moles/volume] in Plasma --7th specimen post XXX challenge |
|
18224-6
|
EPINEPHrine [Mass/volume] in Urine --7th specimen post XXX challenge |
|
47152-4
|
EPINEPHrine [Moles/volume] in Urine --7th specimen post XXX challenge |
|
1465-4
|
EPINEPHrine [Mass/volume] in Plasma --supine |
|
11046-0
|
EPINEPHrine [Mass/volume] in Urine |
|
24521-7
|
EPINEPHrine [Moles/volume] in Urine |
|
33874-9
|
EPINEPHrine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
43248-4
|
EPINEPHrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
25909-3
|
EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine |
|
13734-9
|
EPINEPHrine/Creatinine [Mass Ratio] in Urine |
|
24522-5
|
EPINEPHrine/Creatinine [Molar ratio] in Urine |
|
44837-3
|
Epinephrine+Norepinephrine [Mass/volume] in 24 hour Urine |
|
16111-7
|
Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine |
|
49552-3
|
Epinephrine+Norepinephrine [Mass/volume] in Urine |
|
13735-6
|
Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine |
|
78377-9
|
Epipregnanolone [Moles/volume] in 24 hour Urine |
|
78376-1
|
Epipregnanolone [Moles/time] in 24 hour Urine |
|
78379-5
|
Epipregnanolone [Moles/volume] in Urine |
|
81775-9
|
Epipregnanolone/Creatinine [Molar ratio] in Urine |
|
85915-7
|
Episode of care includes influenza vaccination season [CMS Assessment] |
|
76432-4
|
Episode of care unique identifier |
|
57203-2
|
Episode Timing [CMS Assessment] |
|
89252-1
|
Episode of Wound |
|
2233-5
|
Epitestosterone [Mass/volume] in Serum or Plasma |
|
2234-3
|
Epitestosterone [Presence] in Urine |
|
2235-0
|
Epitestosterone [Mass/volume] in Urine |
|
53287-9
|
Epithelial casts [#/volume] in Urine by Computer assisted method |
|
53291-1
|
Epithelial casts [#/area] in Urine by Computer assisted method |
|
88977-4
|
Epithelial casts [#/area] in Urine sediment |
|
45386-0
|
Epithelial casts [#/area] in Urine sediment by Microscopy high power field |
|
5786-9
|
Epithelial casts [#/area] in Urine sediment by Microscopy low power field |
|
50224-5
|
Epithelial casts [Presence] in Urine by Computer assisted method |
|
25157-9
|
Epithelial casts [Presence] in Urine sediment by Light microscopy |
|
39080-7
|
EPM2A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
30028-5
|
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Serum or Plasma |
|
21267-0
|
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Urine |
|
87752-2
|
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/mass] in Unspecified specimen |
|
77350-7
|
Erythropoietin (EPO) Ab [Presence] in Serum |
|
23634-9
|
Erythropoietin (EPO) given [Units/volume] of Dose |
|
23635-6
|
Erythropoietin (EPO) given [Units/mass] of Dose |
|
73399-8
|
Erythropoietin (EPO) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73398-0
|
Erythropoietin (EPO) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
15061-5
|
Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
|
2237-6
|
Erythropoietin (EPO) [Mass/volume] in Serum or Plasma |
|
14714-0
|
Erythropoietin (EPO) [Moles/volume] in Serum or Plasma |
|
73397-2
|
Eptifibatide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73396-4
|
Eptifibatide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
92192-4
|
Equipment type available |
|
85337-4
|
Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain |
|
40556-3
|
Estrogen receptor Ag [Presence] in Tissue by Immune stain |
|
85310-1
|
Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
|
16112-5
|
Estrogen receptor [Interpretation] in Tissue |
|
14130-9
|
Estrogen receptor [Moles/mass] in Tissue |
|
85329-1
|
Cells.estrogen receptor/100 cells in Breast cancer specimen by Immune stain |
|
14228-1
|
Cells.estrogen receptor/100 cells in Tissue by Immune stain |
|
10480-2
|
Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
|
93767-2
|
Eravacycline [Susceptibility] by Gradient strip |
|
85423-2
|
Eravacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
42783-1
|
ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
69572-6
|
ERCC1 Ag [Presence] in Tissue by Immune stain |
|
28016-4
|
ERCP Study observation Narrative |
|
28017-2
|
ERCP Study observation |
|
79800-9
|
ERG ISCEV standard protocol followed |
|
79791-0
|
ERG Reference electrode [Location] |
|
79794-4
|
ERG study standard procedure followed |
|
87579-9
|
Ergocornine [Mass/mass] in Unspecified specimen |
|
87578-1
|
Ergocristine [Mass/mass] in Unspecified specimen |
|
87577-3
|
Ergocryptine [Mass/mass] in Unspecified specimen |
|
74700-6
|
Ergonomics or human AndOr device interface issue [AHRQ] |
|
87576-5
|
Ergosine [Mass/mass] in Unspecified specimen |
|
15411-2
|
Ergosterol [Mass/volume] in Serum or Plasma |
|
20809-0
|
Ergot alkaloid [Mass/mass] in Feed |
|
20808-2
|
Ergot alkaloid [Mass/volume] in Unspecified specimen |
|
9773-3
|
Ergotamine [Mass/volume] in Serum or Plasma |
|
87575-7
|
Ergotamine [Mass/mass] in Unspecified specimen |
|
87574-0
|
Ergovaline [Mass/mass] in Unspecified specimen |
|
62258-9
|
Erythromyin+clindamycin resistance ermA + ermC genes [Presence] by Molecular method |
|
35800-2
|
Ertapenem [Susceptibility] by Gradient strip |
|
35799-6
|
Ertapenem [Susceptibility] by Disk diffusion (KB) |
|
35801-0
|
Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35802-8
|
Ertapenem [Susceptibility] |
|
86727-5
|
Erysipelothrix sp strain 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
93758-1
|
Erysipelothrix sp [Presence] in Tissue by Immune stain |
|
48107-7
|
Erythritol/Creatinine [Molar ratio] in Urine |
|
16830-2
|
Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
11576-6
|
Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip |
|
238-6
|
Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) |
|
237-8
|
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
236-0
|
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18920-9
|
Erythromycin+Sulfisoxazole [Susceptibility] |
|
239-4
|
Erythromycin+Sulfisoxazole [Susceptibility] by Serum bactericidal titer |
|
48139-0
|
Erythro-4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine |
|
48140-8
|
Erythro-4-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
34691-6
|
Erythroamino alcohol [Mass/volume] in Serum or Plasma |
|
5161-5
|
Erythrocyte Ab [Units/volume] in Serum |
|
51638-5
|
Erythrocyte aggregates [Presence] in Blood by Light microscopy |
|
86285-4
|
Erythrocyte deformability [Interpretation] in Red Blood Cells Narrative |
|
53610-2
|
Erythroid cells [#/volume] in Blood or Marrow |
|
40689-2
|
Erythroid cells/100 cells in Bone marrow by Manual count |
|
25224-7
|
Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4237-4
|
Erythromycin [Mass] of Dose |
|
11171-6
|
Erythromycin IgE Ab [Units/volume] in Serum |
|
21261-3
|
Erythromycin IgE Ab RAST class [Presence] in Serum |
|
61260-6
|
Erythromycin IgE Ab/IgE total in Serum |
|
73395-6
|
Erythromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73394-9
|
Erythromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7009-4
|
Erythromycin [Susceptibility] by Gradient strip |
|
234-5
|
Erythromycin [Susceptibility] by Disk diffusion (KB) |
|
233-7
|
Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
232-9
|
Erythromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20380-2
|
Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
3597-2
|
Erythromycin [Mass/volume] in Serum or Plasma |
|
18919-1
|
Erythromycin [Susceptibility] |
|
235-2
|
Erythromycin [Susceptibility] by Serum bactericidal titer |
|
12298-6
|
Erythromycin [Presence] in Urine |
|
16829-4
|
Erythromycin [Mass/volume] in Urine |
|
25275-9
|
Erythromycin [Mass/volume] in Unspecified specimen |
|
74231-2
|
Erythropoiesis assessment in Bone marrow Narrative |
|
71467-5
|
Erythropoiesis-stimulating agent prescribed Medication |
|
48300-8
|
Erythrosine triggered leukotriene release [Mass/volume] by Leukocytes |
|
85831-6
|
Beta-lactam resistance ESBL blaBEL gene [Presence] by Molecular method |
|
85832-4
|
Beta-lactam resistance ESBL blaCTX-M-1 Group gene [Presence] by Molecular method |
|
85844-9
|
Beta-lactam resistance ESBL blaCTX-M-2 Group gene [Presence] by Molecular method |
|
85834-0
|
Beta-lactam resistance ESBL blaCTX-M-9 Group gene [Presence] by Molecular method |
|
85836-5
|
Beta-lactam resistance ESBL blaGES gene [Presence] by Molecular method |
|
85837-3
|
Beta-lactam resistance ESBL blaPER gene [Presence] by Molecular method |
|
85838-1
|
Beta-lactam resistance ESBL blaSHV gene [Presence] by Molecular method |
|
85839-9
|
Beta-lactam resistance ESBL blaTEM gene [Presence] by Molecular method |
|
85840-7
|
Beta-lactam resistance ESBL blaVEB gene [Presence] by Molecular method |
|
85043-8
|
ESBL by cefepime to cefepime-clavulanate IC ratio [Presence] by ARD gradient strip |
|
85049-5
|
ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient strip |
|
85050-3
|
ESBL by cefTAZidime to cefTAZidime-clavulanate IC ratio [Presence] by ARD gradient strip |
|
11200-3
|
Escargot IgE Ab [Units/volume] in Serum |
|
16024-2
|
Escargot IgE Ab RAST class [Presence] in Serum |
|
39549-1
|
Escargot IgE Ab/IgE total in Serum |
|
73026-7
|
Escitalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73025-9
|
Escitalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73393-1
|
Escitalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73392-3
|
Escitalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
34405-1
|
Escitalopram [Mass/volume] in Serum or Plasma |
|
73692-6
|
Escitalopram [Mass/volume] in Urine |
|
82880-6
|
Escitalopram+norescitalopram [Mass/volume] in Serum or Plasma |
|
92937-2
|
Eslicarbazepine [Mass/volume] in Serum or Plasma |
|
73391-5
|
Esomeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73390-7
|
Esomeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60836-4
|
Esophageal temperature |
|
28012-3
|
Esophagoscopy Study observation Narrative |
|
28013-1
|
Esophagoscopy Study observation |
|
81172-9
|
Esophagus [Length] in Specimen |
|
30341-2
|
Erythrocyte sedimentation rate |
|
43402-7
|
Erythrocyte sedimentation rate by 15 minute reading |
|
82477-1
|
Erythrocyte sedimentation rate by Photometric method |
|
4537-7
|
Erythrocyte sedimentation rate by Westergren method |
|
18184-2
|
Erythrocyte sedimentation rate by 2H Westergren method |
|
4538-5
|
Erythrocyte sedimentation rate by Wintrobe method |
|
82266-8
|
Estimated Activity metabolic rate/Measured RMR [Relative energy/Time] |
|
82269-2
|
Estimated Activity metabolic rate/Population RMR [Relative energy/Time] |
|
82274-2
|
Estimated metabolic rate/Predicted RMR [Relative energy/Time] |
|
82262-7
|
Estimated activity metabolic rate/Standard RMR [Relative energy/Time] |
|
90117-3
|
Estimated date of next emergency response plan release |
|
7308-0
|
Esterase IgE Ab [Units/volume] in Serum |
|
27353-2
|
Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin |
|
53553-4
|
Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin |
|
59665-0
|
Estazolam [Mass/volume] in Blood by Confirmatory method |
|
59664-3
|
Estazolam [Mass/volume] in Blood |
|
4238-2
|
Estazolam [Mass] of Dose |
|
59667-6
|
Estazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59666-8
|
Estazolam [Mass/volume] in Body fluid |
|
26914-2
|
Estazolam [Mass/mass] in Meconium |
|
59668-4
|
Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
14069-9
|
Estazolam [Mass/volume] in Serum or Plasma |
|
59669-2
|
Estazolam [Mass/mass] in Stool by Confirmatory method |
|
27285-6
|
Estazolam [Mass/mass] in Stool |
|
59671-8
|
Estazolam [Mass/mass] in Tissue by Confirmatory method |
|
59670-0
|
Estazolam [Mass/mass] in Tissue |
|
59672-6
|
Estazolam [Mass/volume] in Urine by Confirmatory method |
|
3598-0
|
Estazolam [Mass/volume] in Urine |
|
26683-3
|
Estazolam [Mass/volume] in Vitreous fluid |
|
48949-2
|
Estazolam [Mass/volume] in Unspecified specimen |
|
88087-2
|
Estimated BMI greater than 40 |
|
73811-2
|
Estimated timing of fetal death [US Standard Report of Fetal Death] |
|
47616-8
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
56750-3
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
21263-9
|
Estradiol (E2) [Mass/time] in 24 hour Urine |
|
34287-3
|
Estradiol (E2) [Moles/volume] in 24 hour Urine |
|
25401-1
|
Estradiol (E2) [Moles/time] in 24 hour Urine |
|
90891-3
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
56749-5
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
12596-3
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
58854-1
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
|
55477-4
|
Estradiol (E2) [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
17844-2
|
Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma |
|
31176-1
|
Estradiol (E2) [Mass/volume] in Amniotic fluid |
|
13883-4
|
Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma |
|
13884-2
|
Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
|
58485-4
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --baseline |
|
24414-5
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --baseline |
|
55476-6
|
Estradiol (E2) [Moles/volume] in Serum or Plasma --baseline |
|
55857-7
|
Estradiol (E2) [Mass/volume] in Body fluid |
|
55858-5
|
Estradiol (E2) [Moles/volume] in Body fluid |
|
14960-9
|
Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma |
|
2240-0
|
Estradiol (E2) Free [Mass/volume] in Serum or Plasma |
|
2241-8
|
Estradiol (E2) Free [Moles/mass] in Tissue |
|
85068-5
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose dexamethasone |
|
85065-1
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose follitropin |
|
85067-7
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose gonadotropin releasing hormone |
|
85066-9
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose lutropin |
|
47617-6
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --pre dose corticotropin |
|
2238-4
|
Estradiol (E2) [Mass/volume] in Saliva (oral fluid) |
|
35384-7
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method |
|
72873-3
|
Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method |
|
83096-8
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by Immunoassay |
|
83097-6
|
Estradiol (E2) [Moles/volume] in Serum or Plasma by Immunoassay |
|
2243-4
|
Estradiol (E2) [Mass/volume] in Serum or Plasma |
|
35207-0
|
Estradiol (E2) [Mass or Moles/volume] in Serum or Plasma |
|
14715-7
|
Estradiol (E2) [Moles/volume] in Serum or Plasma |
|
2239-2
|
Estradiol (E2) [Mass/volume] in Semen |
|
58492-0
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --1st specimen post XXX challenge |
|
51499-2
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
58491-2
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --2nd specimen post XXX challenge |
|
51501-5
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
58490-4
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --3rd specimen post XXX challenge |
|
51498-4
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
58817-8
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen |
|
58489-6
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --4th specimen post XXX challenge |
|
51496-8
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
58488-8
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --5th specimen post XXX challenge |
|
51497-6
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
58487-0
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --6th specimen post XXX challenge |
|
51502-3
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
58486-2
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --7th specimen post XXX challenge |
|
51500-7
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
58484-7
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --8th specimen post XXX challenge |
|
2245-9
|
Estradiol (E2) [Moles/mass] in Tissue |
|
12595-5
|
Estradiol (E2) [Mass/volume] in Urine |
|
34286-5
|
Estradiol (E2) [Moles/volume] in Urine |
|
13736-4
|
Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine |
|
34291-5
|
Estradiol (E2)/Creatinine [Molar ratio] in Urine |
|
43802-8
|
Estriol (E3) [Mass/volume] in 24 hour Urine |
|
2253-3
|
Estriol (E3) [Mass/time] in 24 hour Urine |
|
34292-3
|
Estriol (E3) [Moles/volume] in 24 hour Urine |
|
14718-1
|
Estriol (E3) [Moles/time] in 24 hour Urine |
|
43803-6
|
Estriol (E3) [Multiple of the median] adjusted in Serum or Plasma |
|
2248-3
|
Estriol (E3) [Mass/volume] in Amniotic fluid |
|
2247-5
|
Estriol (E3).conjugated [Mass/volume] in Serum or Plasma |
|
15063-1
|
Estriol (E3).conjugated [Moles/volume] in Serum or Plasma |
|
16838-5
|
Estriol (E3) [Mass/volume] in Body fluid |
|
32353-5
|
Estriol (E3) [Multiple of the median] in Serum or Plasma |
|
27225-2
|
Estriol (E3) [Mass/volume] in Saliva (oral fluid) |
|
2251-7
|
Estriol (E3) [Mass/volume] in Serum or Plasma |
|
14716-5
|
Estriol (E3) [Moles/volume] in Serum or Plasma |
|
2252-5
|
Estriol (E3) [Mass/volume] in Urine |
|
14717-3
|
Estriol (E3) [Moles/volume] in Urine |
|
13737-2
|
Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine |
|
30510-2
|
Estriol (E3)/Creatinine [Mass Ratio] in Urine |
|
34293-1
|
Estriol (E3)/Creatinine [Molar ratio] in Urine |
|
2256-6
|
Estrogen [Mass/time] in 24 hour Urine |
|
34294-9
|
Estrogen [Moles/volume] in 24 hour Urine |
|
25402-9
|
Estrogen [Moles/time] in 24 hour Urine |
|
14051-7
|
Estrogen binding protein [Mass/volume] in Serum or Plasma |
|
53765-4
|
Estrogen [Mass/volume] in Serum or Plasma by calculation |
|
2254-1
|
Estrogen [Mass/volume] in Serum or Plasma |
|
70207-6
|
Estrogen [Moles/volume] in Serum or Plasma |
|
12597-1
|
Estrogen [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
58818-6
|
Estrogen [Mass/volume] in Serum or Plasma --2nd specimen |
|
2255-8
|
Estrogen [Mass/volume] in Urine |
|
34295-6
|
Estrogen [Moles/volume] in Urine |
|
13738-0
|
Estrogen/Creatinine [Mass Ratio] in 24 hour Urine |
|
34296-4
|
Estrogen/Creatinine [Molar ratio] in Urine |
|
6776-9
|
Estrone (E1) [Mass/time] in 24 hour Urine |
|
34297-2
|
Estrone (E1) [Moles/volume] in 24 hour Urine |
|
34298-0
|
Estrone (E1) [Moles/time] in 24 hour Urine |
|
31177-9
|
Estrone (E1) [Mass/volume] in Amniotic fluid |
|
14971-6
|
Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma |
|
14970-8
|
Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma |
|
27998-4
|
Estrone (E1) [Mass/volume] in Saliva (oral fluid) |
|
2258-2
|
Estrone (E1) [Mass/volume] in Serum or Plasma |
|
35208-8
|
Estrone (E1) [Mass or Moles/volume] in Serum or Plasma |
|
22663-9
|
Estrone (E1) [Moles/volume] in Serum or Plasma |
|
2257-4
|
Estrone (E1) [Mass/volume] in Semen |
|
15355-1
|
Estrone sulfate [Mass/volume] in Serum or Plasma |
|
2259-0
|
Estrone (E1) [Mass/volume] in Urine |
|
25403-7
|
Estrone (E1) [Moles/volume] in Urine |
|
13739-8
|
Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine |
|
34299-8
|
Estrone (E1)/Creatinine [Molar ratio] in Urine |
|
89042-6
|
Eszopiclone [Mass/volume] in Urine |
|
3601-2
|
Etafedrine [Mass/time] in 24 hour Urine |
|
4239-0
|
Etafedrine [Mass] of Dose |
|
3599-8
|
Etafedrine [Presence] in Urine |
|
3600-4
|
Etafedrine [Mass/volume] in Urine |
|
3604-6
|
Etamivan [Mass/time] in 24 hour Urine |
|
4240-8
|
Etamivan [Mass] of Dose |
|
3602-0
|
Etamivan [Presence] in Urine |
|
3603-8
|
Etamivan [Mass/volume] in Urine |
|
82469-8
|
Etanercept Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
82470-6
|
Etanercept [Mass/volume] in Serum or Plasma by Immunoassay |
|
80677-8
|
Escherichia coli enterotoxigenic eltA+estB genes [Presence] in Stool by NAA with probe detection |
|
87320-8
|
Escherichia coli enterotoxigenic heat-labile toxin DNA [Presence] in Isolate by NAA with probe detection |
|
80351-0
|
Escherichia coli enterotoxigenic ltA+st1a+st1b genes [Presence] in Stool by NAA with non-probe detection |
|
87321-6
|
Escherichia coli enterotoxigenic sta gene [Presence] in Isolate by NAA with probe detection |
|
87322-4
|
Escherichia coli enterotoxigenic stb gene [Presence] in Isolate by NAA with probe detection |
|
74758-4
|
Ethyl sulfate+Ethyl glucuronide [Presence] in Urine by Confirmatory method |
|
93706-0
|
Ethyl sulfate+Ethyl glucuronide [Mass/volume] in Urine by Screen method |
|
4241-6
|
Ethacrynate [Mass] of Dose |
|
16840-1
|
Ethacrynate [Mass/volume] in Serum or Plasma |
|
3605-3
|
Ethacrynate [Presence] in Urine |
|
3606-1
|
Ethacrynate [Mass/volume] in Urine |
|
25195-9
|
Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55674-6
|
Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25230-4
|
Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25194-2
|
Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25187-6
|
Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
56025-0
|
Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4242-4
|
Ethambutol [Mass] of Dose |
|
7010-2
|
Ethambutol [Susceptibility] by Gradient strip |
|
242-8
|
Ethambutol [Susceptibility] by Disk diffusion (KB) |
|
241-0
|
Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
240-2
|
Ethambutol [Susceptibility] by Minimum lethal concentration (MLC) |
|
20381-0
|
Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria |
|
89491-5
|
Ethambutol [Susceptibility] by Genotype method |
|
25404-5
|
Ethambutol [Presence] in Serum or Plasma |
|
3607-9
|
Ethambutol [Mass/volume] in Serum or Plasma |
|
18921-7
|
Ethambutol [Susceptibility] |
|
243-6
|
Ethambutol [Susceptibility] by Serum bactericidal titer |
|
16841-9
|
Ethambutol+rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55154-9
|
Ethambutol+rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria |
|
13007-0
|
Ethane [Mass/volume] in Blood |
|
35664-2
|
Ethanol [Mass/volume] in Urine collected for unspecified duration |
|
56478-1
|
Ethanol [Mass/volume] in Blood by Gas chromatography |
|
5639-0
|
Ethanol [Presence] in Blood |
|
5640-8
|
Ethanol [Mass/volume] in Blood |
|
15120-9
|
Ethanol [Moles/volume] in Blood |
|
77768-0
|
Ethanol cutoff [Mass/volume] in Urine for Confirmatory method |
|
5641-6
|
Ethanol [Mass/volume] in Exhaled gas |
|
16843-5
|
Ethanol [Mass/volume] in Body fluid |
|
40530-8
|
Ethanol [Presence] in Gastric fluid |
|
61095-6
|
Ethanol [Presence] in Gastric fluid by Screen method |
|
10367-1
|
Ethanol [Mass/volume] in Gastric fluid |
|
47107-8
|
Ethanol [Moles/volume] in Gastric fluid |
|
15402-1
|
Ethanol [Presence] in Meconium |
|
74673-5
|
Ethanol [Presence] in Saliva (oral fluid) by Confirmatory method |
|
50343-3
|
Ethanol [Presence] in Saliva (oral fluid) by Screen method |
|
34882-1
|
Ethanol [Mass/volume] in Saliva (oral fluid) |
|
14336-2
|
Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography |
|
5642-4
|
Ethanol [Presence] in Serum or Plasma |
|
20470-1
|
Ethanol [Presence] in Serum or Plasma by Screen method |
|
5643-2
|
Ethanol [Mass/volume] in Serum or Plasma |
|
35240-1
|
Ethanol [Mass or Moles/volume] in Serum or Plasma |
|
14719-9
|
Ethanol [Moles/volume] in Serum or Plasma |
|
23861-8
|
Ethanol [Mass/mass] in Tissue |
|
46983-3
|
Ethanol [Mass/volume] in Urine by Confirmatory method |
|
5644-0
|
Ethanol [Presence] in Urine |
|
34180-0
|
Ethanol [Presence] in Urine by Confirmatory method |
|
42242-8
|
Ethanol [Presence] in Urine by Screen method |
|
5645-7
|
Ethanol [Mass/volume] in Urine |
|
22745-4
|
Ethanol [Moles/volume] in Urine |
|
16842-7
|
Ethanol [Mass/volume] in Unknown substance |
|
12465-1
|
Ethanol [Mass/volume] in Vitreous fluid |
|
61066-7
|
Ethanol [Presence] in Unspecified specimen by Screen method |
|
32070-5
|
Ethanol [Moles/volume] in Unspecified specimen |
|
58356-7
|
Ethanol/Creatinine [Mass Ratio] in Urine |
|
26803-7
|
Ethanolamine [Presence] in 24 hour Urine |
|
6881-7
|
Ethanolamine [Mass/time] in 24 hour Urine |
|
25910-1
|
Ethanolamine [Moles/volume] in 24 hour Urine |
|
25405-2
|
Ethanolamine [Moles/time] in 24 hour Urine |
|
32239-6
|
Ethanolamine [Moles/volume] in Amniotic fluid |
|
13613-5
|
Ethanolamine [Mass/volume] in Cerebral spinal fluid |
|
26593-4
|
Ethanolamine [Moles/volume] in Cerebral spinal fluid |
|
2263-2
|
Ethanolamine [Mass/volume] in Serum or Plasma |
|
26608-0
|
Ethanolamine [Moles/volume] in Serum or Plasma |
|
49633-1
|
Ethanolamine [Presence] in Urine |
|
2264-0
|
Ethanolamine [Mass/volume] in Urine |
|
34300-4
|
Ethanolamine [Moles/volume] in Urine |
|
56678-6
|
Ethanolamine/Creatinine [Ratio] in 24 hour Urine |
|
25911-9
|
Ethanolamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13740-6
|
Ethanolamine/Creatinine [Mass Ratio] in Urine |
|
28605-4
|
Ethanolamine/Creatinine [Ratio] in Urine |
|
25098-5
|
Ethanolamine/Creatinine [Molar ratio] in Urine |
|
31090-4
|
Ethchlorvynol [Presence] in Bile fluid |
|
3608-7
|
Ethchlorvynol [Mass/volume] in Blood |
|
4243-2
|
Ethchlorvynol [Mass] of Dose |
|
29373-8
|
Ethchlorvynol [Presence] in Gastric fluid |
|
3609-5
|
Ethchlorvynol [Presence] in Serum or Plasma |
|
3610-3
|
Ethchlorvynol [Mass/volume] in Serum or Plasma |
|
32071-3
|
Ethchlorvynol [Moles/volume] in Serum or Plasma |
|
3611-1
|
Ethchlorvynol [Presence] in Urine |
|
3612-9
|
Ethchlorvynol [Mass/volume] in Urine |
|
29611-1
|
Ethchlorvynol [Presence] in Unspecified specimen |
|
86451-2
|
Ethics Consult note |
|
86452-0
|
Ethics Note |
|
89800-7
|
Ethics Telephone encounter Note |
|
89801-5
|
Ethics Team Conference note |
|
16844-3
|
Ethinamate [Presence] in Serum or Plasma by Confirmatory method |
|
12401-6
|
Ethinamate [Mass/volume] in Serum or Plasma |
|
12299-4
|
Ethinamate [Presence] in Urine |
|
32651-2
|
Ethion [Mass/volume] in Serum or Plasma |
|
21266-2
|
Ethion [Mass/volume] in Urine |
|
25231-2
|
Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25183-5
|
Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25198-3
|
Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25196-7
|
Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7011-0
|
Ethionamide [Susceptibility] by Gradient strip |
|
41693-3
|
Ethionamide [Susceptibility] by Disk diffusion (KB) |
|
16099-4
|
Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20382-8
|
Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
16845-0
|
Ethionamide [Mass/volume] in Serum or Plasma |
|
18922-5
|
Ethionamide [Susceptibility] |
|
57953-2
|
Ethisterone [Presence] in Urine |
|
42784-9
|
Ethnic background Stated |
|
74694-1
|
Ethnicity [AHRQ] |
|
80908-7
|
Ethnicity [CDC] |
|
3615-2
|
Ethoheptazine [Mass/time] in 24 hour Urine |
|
4244-0
|
Ethoheptazine [Mass] of Dose |
|
16847-6
|
Ethoheptazine [Presence] in Serum or Plasma |
|
16848-4
|
Ethoheptazine [Mass/volume] in Serum or Plasma |
|
3613-7
|
Ethoheptazine [Presence] in Urine |
|
3614-5
|
Ethoheptazine [Mass/volume] in Urine |
|
87644-1
|
Ethoprop [Mass/mass] in Unspecified specimen |
|
4245-7
|
Ethosuximide [Mass] of Dose |
|
29218-5
|
Ethosuximide [Mass/volume] in Body fluid |
|
40769-2
|
Ethosuximide [Mass/volume] in Serum or Plasma --peak |
|
3616-0
|
Ethosuximide [Mass/volume] in Serum or Plasma |
|
14720-7
|
Ethosuximide [Moles/volume] in Serum or Plasma |
|
40770-0
|
Ethosuximide [Mass/volume] in Serum or Plasma --trough |
|
4246-5
|
Ethotoin [Mass] of Dose |
|
3617-8
|
Ethotoin [Mass/volume] in Serum or Plasma |
|
13937-8
|
Ethyl acetate [Mass/volume] in Blood |
|
13027-8
|
Ethyl acetate [Mass/volume] in Serum or Plasma |
|
78826-5
|
Ethyl acetate [Mass/volume] in Urine |
|
38693-8
|
Ethyl acrylate [Mass/volume] in Air |
|
8199-2
|
Ethyl benzene [Mass/volume] in Blood |
|
54938-6
|
Ethyl benzene [Mass/volume] in Serum or Plasma |
|
16849-2
|
Ethyl benzene [Mass/volume] in Urine |
|
38336-4
|
Ethyl benzene [Mass/volume] in Water |
|
38641-7
|
Ethyl bromide [Mass/volume] in Air |
|
77769-8
|
Ethyl glucuronide cutoff [Mass/volume] in Urine for Confirmatory method |
|
79239-0
|
Ethyl glucuronide cutoff [Mass/volume] in Urine for Screen method |
|
89000-4
|
Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method |
|
58378-1
|
Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method |
|
55349-5
|
Ethyl glucuronide [Presence] in Urine |
|
58377-3
|
Ethyl glucuronide [Presence] in Urine by Confirmatory method |
|
58375-7
|
Ethyl glucuronide [Presence] in Urine by Screen method |
|
45324-1
|
Ethyl glucuronide [Mass/volume] in Urine |
|
58376-5
|
Ethyl glucuronide/Creatinine [Mass Ratio] in Urine |
|
77885-2
|
Ethyl sulfate cutoff [Mass/volume] in Urine for Confirmatory method |
|
86228-4
|
Ethyl sulfate [Presence] in Saliva (oral fluid) |
|
82508-3
|
Ethyl sulfate [Mass/volume] in Saliva (oral fluid) |
|
58425-0
|
Ethyl sulfate [Mass/volume] in Urine by Confirmatory method |
|
74683-4
|
Ethyl sulfate [Presence] in Urine by Confirmatory method |
|
58424-3
|
Ethyl sulfate [Presence] in Urine by Screen method |
|
60676-4
|
Ethyl sulfate [Mass/volume] in Urine |
|
58423-5
|
Ethyl sulfate/Creatinine [Mass Ratio] in Urine |
|
19461-3
|
Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19460-5
|
Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
19458-9
|
Ethylamphetamine [Mass/volume] in Urine by Confirmatory method |
|
16212-3
|
Ethylamphetamine [Presence] in Urine by Confirmatory method |
|
19456-3
|
Ethylamphetamine [Presence] in Urine by Screen method |
|
19459-7
|
Ethylamphetamine [Mass/volume] in Urine |
|
12340-6
|
Ethylene [Presence] in Blood |
|
38596-3
|
Ethylene glycol [Mass/volume] in Air |
|
75646-0
|
Ethylene glycol [Presence] in Gastric fluid |
|
31082-1
|
Ethylene glycol [Mass/volume] in Gastric fluid |
|
59899-5
|
Ethylene glycol [Moles/volume] in Gastric fluid |
|
23713-1
|
Ethylene glycol [Presence] in Serum or Plasma |
|
5646-5
|
Ethylene glycol [Mass/volume] in Serum, Plasma or Blood |
|
14721-5
|
Ethylene glycol [Moles/volume] in Serum or Plasma |
|
29279-7
|
Ethylene glycol [Presence] in Urine |
|
5647-3
|
Ethylene glycol [Mass/volume] in Urine |
|
22678-7
|
Ethylene glycol [Moles/volume] in Urine |
|
87617-7
|
Ethylene glycol [Mass/mass] in Unspecified specimen |
|
22734-8
|
Ethylene glycol [Moles/volume] in Unspecified specimen |
|
38696-1
|
Ethylene oxide [Mass/volume] in Air |
|
16850-0
|
Ethylene oxide [Mass/volume] in Blood |
|
6112-7
|
Ethylene oxide IgE Ab [Units/volume] in Serum |
|
15702-4
|
Ethylene oxide IgE Ab RAST class [Presence] in Serum |
|
38697-9
|
Ethylene thiourea [Mass/volume] in Air |
|
38698-7
|
Ethyleneimine [Mass/volume] in Air |
|
31015-1
|
Ethylestrenol [Mass/volume] in Urine |
|
82502-6
|
Ethylmalonate [Moles/volume] in DBS |
|
79476-8
|
Ethylmalonate [Moles/volume] in Serum or Plasma |
|
30472-5
|
Ethylmalonate [Presence] in Urine |
|
2265-7
|
Ethylmalonate [Mass/volume] in Urine |
|
44354-9
|
Ethylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13741-4
|
Ethylmalonate/Creatinine [Mass Ratio] in Urine |
|
25099-3
|
Ethylmalonate/Creatinine [Molar ratio] in Urine |
|
3623-6
|
Etilefrine [Mass/time] in 24 hour Urine |
|
4249-9
|
Etilefrine [Mass] of Dose |
|
3621-0
|
Etilefrine [Presence] in Urine |
|
3622-8
|
Etilefrine [Mass/volume] in Urine |
|
56488-0
|
Etiocholanolone [Mass/volume] in 24 hour Urine |
|
2268-1
|
Etiocholanolone [Mass/time] in 24 hour Urine |
|
34302-0
|
Etiocholanolone [Moles/volume] in 24 hour Urine |
|
15065-6
|
Etiocholanolone [Moles/time] in 24 hour Urine |
|
13614-3
|
Etiocholanolone [Mass/volume] in Serum or Plasma |
|
80157-1
|
Etiocholanolone [Moles/volume] in Serum or Plasma |
|
2266-5
|
Etiocholanolone [Presence] in Urine |
|
2267-3
|
Etiocholanolone [Mass/volume] in Urine |
|
34301-2
|
Etiocholanolone [Moles/volume] in Urine |
|
82882-2
|
Etiocholanolone/Androsterone [Molar ratio] in 24 hour Urine |
|
82881-4
|
Etiocholanolone/Androsterone [Molar ratio] in Urine |
|
44355-6
|
Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
30508-6
|
Etiocholanolone/Creatinine [Mass Ratio] in Urine |
|
34303-8
|
Etiocholanolone/Creatinine [Molar ratio] in Urine |
|
91011-7
|
Etiology of a public health emergency |
|
16852-6
|
Etodolac [Mass/volume] in Serum or Plasma |
|
52749-9
|
Etravirine [Susceptibility] by Genotype method |
|
72558-0
|
Etravirine [Susceptibility] by Phenotype method |
|
57961-5
|
Etravirine [Mass/volume] in Serum or Plasma |
|
79562-5
|
Endotracheal tube Diameter |
|
2228-5
|
Enterotoxin [Mass/volume] in Serum |
|
30916-1
|
Euploid+Aneuploid cells/100 cells in Unspecified specimen |
|
31116-7
|
Euploid+Aneuploid cells population 1/100 cells in Unspecified specimen |
|
31117-5
|
Euploid+Aneuploid cells population 2/100 cells in Unspecified specimen |
|
60238-3
|
European Ash IgE Ab [Units/volume] in Serum |
|
60237-5
|
European Ash IgE Ab RAST class [Presence] in Serum |
|
15342-9
|
European Hornet IgE Ab [Units/volume] in Serum |
|
24510-0
|
European Hornet IgE Ab RAST class [Presence] in Serum |
|
61325-7
|
European Hornet IgE Ab/IgE total in Serum |
|
56999-6
|
European Hornet IgG4 Ab [Units/volume] in Serum |
|
56600-0
|
European Hornet IgG Ab [Mass/volume] in Serum |
|
48182-0
|
European Hornet triggered leukotriene release [Mass/volume] by Leukocytes |
|
58804-6
|
European paper wasp IgE Ab [Units/volume] in Serum |
|
82008-4
|
European paper wasp IgE Ab RAST class [Presence] in Serum |
|
86191-4
|
Eutylone [Mass/volume] in Urine by Confirmatory method |
|
60429-8
|
Enterovirus 71 RNA [Presence] in Isolate by NAA with probe detection |
|
62861-0
|
Enterovirus 71 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31367-6
|
Enterovirus NOS Ab [Units/volume] in Serum |
|
42903-5
|
Enterovirus NOS Ab [Titer] in Cerebral spinal fluid |
|
43038-9
|
Enterovirus NOS Ab [Titer] in Serum |
|
26022-4
|
Enterovirus NOS Ab [Titer] in Serum by Complement fixation |
|
70065-8
|
Enterovirus Ag [Presence] in Stool by Immunoassay |
|
86323-3
|
Enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
5839-6
|
Enterovirus identified in Cerebral spinal fluid by Organism specific culture |
|
43699-8
|
Enterovirus identified in Cerebral spinal fluid by Shell vial culture |
|
76072-8
|
Enterovirus D68 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70010-4
|
Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
70011-2
|
Enterovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
70008-8
|
Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
35100-7
|
Enterovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
70009-6
|
Enterovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
5840-4
|
Enterovirus identified in Isolate by Immunofluorescence |
|
5841-2
|
Enterovirus identified in Isolate by Neutralization test |
|
88537-6
|
Enterovirus identified in Pericardial fluid by Organism specific culture |
|
62463-5
|
Enterovirus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
62464-3
|
Enterovirus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
53256-4
|
Enterovirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88540-0
|
Enterovirus RNA [Presence] in Aspirate by NAA with probe detection |
|
91067-9
|
Enterovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82194-2
|
Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
29558-4
|
Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
27952-1
|
Enterovirus RNA [Presence] in Cerebral spinal fluid by Probe |
|
74424-3
|
Enterovirus RNA [Cycle Threshold #] in Stool by NAA with probe detection |
|
74423-5
|
Enterovirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87960-1
|
Enterovirus RNA [Presence] in Body fluid by NAA with probe detection |
|
60263-1
|
Enterovirus RNA [Presence] in Isolate by NAA with probe detection |
|
91066-1
|
Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
7881-6
|
Enterovirus RNA [Presence] in Nose by NAA with probe detection |
|
76074-4
|
Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88538-4
|
Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
49847-7
|
Enterovirus RNA [Presence] in Serum by NAA with probe detection |
|
91068-7
|
Enterovirus RNA [Presence] in Stool by NAA with probe detection |
|
35396-1
|
Enterovirus RNA [Presence] in Tissue by NAA with probe detection |
|
91769-0
|
Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
91069-5
|
Enterovirus RNA [Presence] in Urine by NAA with probe detection |
|
93856-3
|
Enterovirus RNA [Presence] in Unspecified specimen by NAA with non-probe detection |
|
29591-5
|
Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5842-0
|
Enterovirus identified in Stool by Organism specific culture |
|
60528-7
|
Enterovirus subtype in Unspecified specimen by NAA with probe detection |
|
91770-8
|
Enterovirus identified in Upper respiratory specimen by Organism specific culture |
|
5843-8
|
Enterovirus identified in Unspecified specimen by Organism specific culture |
|
43364-9
|
Enterovirus identified in Unspecified specimen by Immunofluorescence |
|
86322-5
|
Enterovirus [Presence] in Unspecified specimen by Organism specific culture |
|
43698-0
|
Enterovirus identified in Unspecified specimen by Shell vial culture |
|
68457-1
|
Enterovirus and Parechovirus A RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
92132-0
|
Enterovirus A+B+C RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
72267-8
|
Evaluation of mental and physical incapacity certificate |
|
51848-0
|
Evaluation note |
|
51847-2
|
Evaluation + Plan note |
|
75846-6
|
Evaluator global assessment of disease activity - 0-10 (0.5 increments) numeric rating [Observed] |
|
71125-9
|
Even during difficult times, I know that things will be okay in the past 7 days [FACIT] |
|
92234-4
|
Even when I feel good, smoking helps me feel better [PROMIS] |
|
74079-5
|
Event [AHRQ] |
|
89792-6
|
Event activation or deactivation |
|
89793-4
|
Event description |
|
74555-4
|
Event discovery date and time |
|
89913-8
|
Event identifier |
|
91013-3
|
Event impact level |
|
91026-5
|
Event Inter-agency communication documentation |
|
90096-9
|
Event managing group at co-lead department or agency Organization |
|
90095-1
|
Event managing group at lead department or agency Organization |
|
90121-5
|
Event response description |
|
74721-2
|
Event resulted in the device being removed [AHRQ] |
|
74565-3
|
Event was a National Quality Forum (NQF) serious reportable event [AHRQ] |
|
74568-7
|
Event was associated with a handover [AHRQ] |
|
19099-1
|
Events counted [#] in Unspecified specimen |
|
89079-8
|
Events--during hospitalization [ADAPTABLE] |
|
86646-7
|
Ever had sex - Reported |
|
41695-8
|
Everninomicin [Susceptibility] by Gradient strip |
|
41696-6
|
Everninomicin [Susceptibility] by Disk diffusion (KB) |
|
41694-1
|
Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41735-2
|
Everninomicin [Susceptibility] |
|
50544-6
|
Everolimus [Mass/volume] in Blood |
|
80529-1
|
Everolimus [Mass/volume] in DBS |
|
80652-1
|
Everolimus [Mass] of Dose |
|
77349-9
|
Everolimus [Mass/volume] in Blood by LC/MS/MS --trough |
|
72671-1
|
Everolimus [Mass/volume] in Plasma --trough |
|
78118-7
|
Everyone in my family could be completely trusted in past 4 weeks [PROMIS.PEDS] |
|
78102-1
|
Everyone in my family loved each other in past 4 weeks [PROMIS.PEDS] |
|
78119-5
|
Everyone in my family loved me in past 4 weeks [PROMIS.PEDS] |
|
91321-0
|
Everything bothered me in past 7 days [PROMIS.PEDS] |
|
91358-2
|
Everything bothered my child in past 7 days [PROMIS.PARENTPROXY] |
|
72699-2
|
Everything seemed senseless to me in last week [BSL-23] |
|
87316-6
|
Enterovirus G RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77199-8
|
Evoked potential Study report |
|
93806-8
|
EWSR1 gene rearrangements in Tissue by FISH |
|
81879-9
|
t(11;22)(q24;q12.2)(FLI1,EWSR1) and t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
19797-0
|
Examination extent landmark [Description] Abdomen Narrative Laparoscopy |
|
19793-9
|
Examination extent landmark [Description] Biliary duct Narrative ERCP |
|
19796-2
|
Examination extent landmark Gastrointestinal tract lower Flexible sigmoidoscopy |
|
19794-7
|
Examination extent landmark Pancreatic duct ERCP |
|
19792-1
|
Examination extent landmark Gastrointestinal tract upper EGD |
|
71584-7
|
Exam finding location Abdomen NEMSIS |
|
71589-6
|
Exam finding location Back+Spine NEMSIS |
|
71585-4
|
Exam finding location Extremity NEMSIS |
|
71586-2
|
Exam finding location Eye NEMSIS |
|
71785-0
|
Exam findings communicated to clinician managing diabetic care |
|
11870-3
|
Examination level ultrasound |
|
90047-2
|
Spermatozoa.excess residual cytoplasm/100 spermatozoa in Semen |
|
83312-9
|
Exchanged drugs AndOr money for sex in the past year |
|
85279-8
|
Excised length [Length] of Colon by Macroscopy |
|
73985-4
|
Exercise activity |
|
73986-2
|
Exercise aerobic category |
|
55412-1
|
Exercise distance unspecified time |
|
93849-8
|
Exercise distance in 24 hour |
|
55411-3
|
Exercise duration |
|
74009-2
|
Exercise duration/Exercise frequency |
|
74008-4
|
Exercise intensity |
|
18752-6
|
Exercise stress test study |
|
55408-9
|
Exercise tolerance |
|
57237-0
|
Exertion level causing shortness of breath [CMS Assessment] |
|
34406-9
|
Exocrine pancreas Ab [Titer] in Serum by Immunofluorescence |
|
82982-0
|
Exocrine pancreas IgA+IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
29002-3
|
Exopthalmia comment [Interpretation] Left eye Narrative Exopthalmometer.Hertel |
|
29001-5
|
Exopthalmia comment [Interpretation] Right eye Narrative Exopthalmometer.Hertel |
|
44268-1
|
Avian paramyxovirus 1.exotic RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34485-3
|
Avian paramyxovirus 1.exotic RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76320-1
|
Expiratory airway gas flow |
|
76187-4
|
Expiratory hold time setting Ventilator |
|
76186-6
|
Expiratory hold time Ventilator |
|
76188-2
|
Expiratory pause time Ventilator |
|
76260-9
|
Expiratory pressure Respiratory system airway |
|
60739-0
|
Expiration [Time] Respiratory system |
|
85712-8
|
Expected delivery location |
|
74712-1
|
Expiration date |
|
74066-2
|
Expiration date of Medication [AHRQ] |
|
60792-9
|
Expiratory gas flow Respiratory system airway --on ventilator |
|
76008-2
|
Expired minute Volume during Mechanical ventilation |
|
28953-8
|
Explanation [Interpretation] Contact lens prescription - left |
|
28926-4
|
Explanation [Interpretation] Contact lens prescription - right |
|
52030-4
|
Explanation of benefits |
|
52031-2
|
Explanation of benefits to subscriber |
|
85708-6
|
Mother Directly exposed to a confirmed case |
|
92944-8
|
Exposure source |
|
93046-1
|
Exposure treatment site |
|
54601-0
|
Express ideas and wants in last 7 days [CMS Assessment] |
|
83250-1
|
Expression of ideas and wants during 3 day assessment period [CMS Assessment] |
|
53858-7
|
EXT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38930-4
|
EXT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74560-4
|
Extent of harm to the patient [AHRQ] |
|
73820-3
|
External cephalic version outcome |
|
77598-1
|
Externally defined clinical data elements Document |
|
73706-4
|
Extracellular fluid [Volume] Measured |
|
84889-5
|
Extramural vein invasion [Presence] in Colorectal cancer specimen by Light microscopy |
|
85350-7
|
Extranodal extension of carcinoma [Presence] in Cancer specimen by Light microscopy |
|
44627-8
|
Extraprostatic extension by CAP cancer protocols |
|
84902-6
|
Extraprostatic extension site [Anatomy] of Prostate tumor |
|
26051-3
|
Epithelial cells.extrarenal [#/area] in Urine sediment by Microscopy high power field |
|
15159-7
|
Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma Narrative |
|
83387-1
|
Extrinsic dynamic PEEP Respiratory system |
|
83386-3
|
Extrinsic PEEP Respiratory system |
|
88070-8
|
Time of extubation |
|
89259-6
|
Presence of wound exudate |
|
47955-0
|
EYA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48971-6
|
EYA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
29272-2
|
Eye ultrasound study |
|
29110-4
|
Eye - left US 2D |
|
79727-4
|
Eye.left Can elevate above midline |
|
29109-6
|
Eye - right US 2D |
|
79726-6
|
Eye.right Can elevate above midline |
|
79741-5
|
Eye-related brain MRI findings |
|
75411-9
|
Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection |
|
73389-9
|
Ezetimibe induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73388-1
|
Ezetimibe induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
74134-8
|
Ezogabine [Mass/volume] in Plasma |
|
87763-9
|
Ezogabine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
6120-0
|
Fusarium culmorum IgE Ab [Units/volume] in Serum |
|
15721-4
|
Fusarium culmorum IgE Ab RAST class [Presence] in Serum |
|
7324-7
|
Fusarium culmorum IgG Ab [Units/volume] in Serum |
|
63443-6
|
Fasciola hepatica Ab [Presence] in Serum by Hemagglutination |
|
56923-6
|
Fasciola hepatica Ab [Presence] in Serum by Immunoassay |
|
5162-3
|
Fasciola hepatica Ab [Units/volume] in Serum |
|
43037-1
|
Fasciola hepatica Ab [Titer] in Serum |
|
87996-5
|
Fasciola hepatica Ab [Titer] in Serum by Complement fixation |
|
56924-4
|
Fasciola hepatica Ab [Titer] in Serum by Hemagglutination |
|
27342-5
|
Fasciola hepatica Ab [Titer] in Serum by Immunoassay |
|
6121-8
|
Fusarium moniliforme IgE Ab [Units/volume] in Serum |
|
15722-2
|
Fusarium moniliforme IgE Ab RAST class [Presence] in Serum |
|
39600-2
|
Fusarium moniliforme IgE Ab/IgE total in Serum |
|
7325-4
|
Fusarium moniliforme IgG Ab [Units/volume] in Serum |
|
33286-6
|
Fusarium moniliforme IgG Ab RAST class [Presence] in Serum |
|
35548-7
|
Fusarium moniliforme IgG Ab [Mass/volume] in Serum |
|
7326-2
|
Fusarium oxysporum IgE Ab [Units/volume] in Serum |
|
21281-1
|
Fusarium oxysporum IgE Ab RAST class [Presence] in Serum |
|
18421-8
|
Fusarium oxysporum IgG Ab [Units/volume] in Serum |
|
58958-0
|
Fusarium oxysporum IgG Ab [Mass/volume] in Serum |
|
63374-3
|
Fusarium roseum IgE Ab [Units/volume] in Serum |
|
7327-0
|
Fusarium solani IgE Ab [Units/volume] in Serum |
|
15723-0
|
Fusarium solani IgE Ab RAST class [Presence] in Serum |
|
7328-8
|
Fusarium solani IgG Ab [Units/volume] in Serum |
|
23122-5
|
Francisella tularensis A DNA [Presence] in Tissue by NAA with probe detection |
|
23123-3
|
Francisella tularensis A rRNA [Presence] in Tissue by Probe |
|
53373-7
|
Francisella tularensis Ab [Presence] in Isolate |
|
33715-4
|
Francisella tularensis Ab [Presence] in Isolate by Slide agglutination |
|
7888-1
|
Francisella tularensis Ab [Presence] in Serum |
|
23124-1
|
Francisella tularensis Ab [Presence] in Serum by Immunoassay |
|
5166-4
|
Francisella tularensis Ab [Presence] in Serum by Latex agglutination |
|
45040-3
|
Francisella tularensis Ab [Presence] in Serum by Microagglutination |
|
31396-5
|
Francisella tularensis Ab [Units/volume] in Serum |
|
16875-7
|
Francisella tularensis Ab [Titer] in Serum |
|
23125-8
|
Francisella tularensis Ab [Titer] in Serum by Agglutination |
|
23741-2
|
Francisella tularensis Ab [Titer] in Serum by Complement fixation |
|
5167-2
|
Francisella tularensis Ab [Titer] in Serum by Latex agglutination |
|
33683-4
|
Francisella tularensis Ab [Titer] in Serum by Microagglutination |
|
33684-2
|
Francisella tularensis Ab [Titer] in Serum by Tube agglutination |
|
53374-5
|
Francisella tularensis Ab [Presence] in Unspecified specimen |
|
33714-7
|
Francisella tularensis Ab [Presence] in Unspecified specimen by Slide agglutination |
|
33678-4
|
Francisella tularensis Ag [Presence] in Isolate by Immunofluorescence |
|
31828-7
|
Francisella tularensis Ag [Presence] in Serum |
|
16879-9
|
Francisella tularensis Ag [Presence] in Serum by Immunofluorescence |
|
23127-4
|
Francisella tularensis Ag [Presence] in Tissue by Immunofluorescence |
|
23126-6
|
Francisella tularensis Ag [Presence] in Tissue by Immune stain |
|
31829-5
|
Francisella tularensis Ag [Presence] in Unspecified specimen |
|
6408-9
|
Francisella tularensis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
45041-1
|
Francisella tularensis Ag [Presence] in Unspecified specimen by Slide agglutination |
|
23128-2
|
Francisella tularensis B DNA [Presence] in Tissue by NAA with probe detection |
|
23129-0
|
Francisella tularensis B rRNA [Presence] in Tissue by Probe |
|
33680-0
|
Francisella tularensis DNA [Presence] in Isolate by NAA with probe detection |
|
23130-8
|
Francisella tularensis DNA [Presence] in Tissue by NAA with probe detection |
|
33679-2
|
Francisella tularensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14209-1
|
Francisella tularensis IgA Ab [Presence] in Serum |
|
16876-5
|
Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination |
|
33576-0
|
Francisella tularensis IgA Ab [Titer] in Serum |
|
7889-9
|
Francisella tularensis IgG Ab [Presence] in Serum |
|
93717-7
|
Francisella tularensis IgG Ab [Presence] in Serum by Immunoassay |
|
16877-3
|
Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination |
|
70121-9
|
Francisella tularensis IgG Ab [Units/volume] in Serum or Plasma |
|
33465-6
|
Francisella tularensis IgG Ab [Titer] in Serum |
|
93718-5
|
Francisella tularensis IgG and IgM [Interpretation] in Serum |
|
7890-7
|
Francisella tularensis IgM Ab [Presence] in Serum |
|
93716-9
|
Francisella tularensis IgM Ab [Presence] in Serum by Immunoassay |
|
6407-1
|
Francisella tularensis IgM Ab [Presence] in Serum by Latex agglutination |
|
16878-1
|
Francisella tularensis IgM Ab [Units/volume] in Serum |
|
33466-4
|
Francisella tularensis IgM Ab [Titer] in Serum |
|
33682-6
|
Francisella tularensis [Presence] in Isolate by Cell wall fatty acid analysis |
|
33677-6
|
Francisella tularensis [Presence] in Isolate by Organism specific culture |
|
23131-6
|
Francisella tularensis rRNA [Presence] in Tissue by Probe |
|
46732-4
|
Francisella tularensis subtype [Identifier] in Unspecified specimen by NAA with probe detection |
|
33681-8
|
Francisella tularensis [Presence] in Unspecified specimen by Cell wall fatty acid analysis |
|
33676-8
|
Francisella tularensis [Presence] in Unspecified specimen by Organism specific culture |
|
93399-4
|
Fusobacterium necrophorum DNA [Presence] by NAA with probe detection in Positive blood culture |
|
93396-0
|
Fusobacterium nucleatum DNA [Presence] by NAA with probe detection in Positive blood culture |
|
78027-0
|
Follow-up attempt within 24 hours |
|
92990-1
|
F10 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81813-8
|
F11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
58937-4
|
F12 gene mutations found [Type] in Blood or Tissue by Molecular genetics method |
|
58902-8
|
F12 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
92991-9
|
F13A1 and F13B gene full mutation analysis in Blood or Tissue by Sequencing |
|
50750-9
|
F13A1 gene p.Val34Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
24475-6
|
F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
24476-4
|
F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
24477-2
|
F2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
90782-4
|
F2-Isoprostanes [Mass/volume] in Urine |
|
90783-2
|
F2-Isoprostanes/Creatinine [Mass Ratio] in Urine |
|
91712-0
|
F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
21667-1
|
F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21669-7
|
F5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
93788-8
|
F5 gene HR2 haplotype [Genotype] in Blood by Molecular genetics method Nominal |
|
59047-1
|
F5 gene p.His1299Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
21668-9
|
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
21670-5
|
F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21671-3
|
F7 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21672-1
|
F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21673-9
|
F8 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
82342-7
|
F8 gene intron 1 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
81762-7
|
F8 gene intron 1 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82343-5
|
F8 gene intron 1 and 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
81761-9
|
F8 gene intron 1 and 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
91680-9
|
F8 gene intron 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
91679-1
|
F8 gene intron 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
91681-7
|
F9 gene mutation analysis limited to known familial mutations in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
69483-6
|
F9 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
93811-8
|
F9 gene full mutation analysis in Blood or Tissue by Sequencing |
|
38896-7
|
F9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51772-2
|
F9 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
74918-4
|
Fatty acids [Mass/mass] in 24 hour Stool |
|
74903-6
|
Fatty acids [Mass/time] in 24 hour Stool |
|
75100-8
|
Fatty acids [Entitic substance] in Red Blood Cells |
|
57792-4
|
Fatty acid oxidation conditions suspected [Identifier] in DBS |
|
35574-3
|
Fatty acid oxidation [Identifier] in Fibroblast |
|
42669-2
|
Fatty acids [Presence] in Pleural fluid |
|
2275-6
|
Fatty acids [Mass/volume] in Serum or Plasma |
|
24461-6
|
Fatty acids [Moles/volume] in Serum or Plasma |
|
42668-4
|
Fatty acids [Presence] in Stool |
|
42667-6
|
Fatty acids [Presence] in Urine |
|
62305-8
|
Fabry disease newborn screen interpretation |
|
62306-6
|
Fabry disease newborn screening comment-discussion |
|
65835-1
|
Facility affiliation information |
|
91891-2
|
Facility Bed type |
|
89202-6
|
County location of Facility |
|
75524-9
|
Facility identifier |
|
19825-9
|
Facility location [Identifier] Endoscopy procedure |
|
75529-8
|
Admitted from Facility [MSCDM] |
|
65837-7
|
Facility offers dialysis shift starting at 5:00 pm |
|
65834-4
|
Facility ownership |
|
65651-2
|
Phone number Facility |
|
72176-1
|
Facility recommended for birth [RHEA] |
|
85632-8
|
Facility type [CMS Assessment] |
|
50390-4
|
Coagulation factor II circulating inhibitor [Presence] in Platelet poor plasma |
|
32635-5
|
Coagulation factor II inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
40744-5
|
Factor inhibitor XXX [Presence] in Platelet poor plasma by Coagulation assay |
|
13591-3
|
Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3187-2
|
Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay |
|
88449-4
|
Coagulation factor IX activity actual/normal in Platelet poor plasma by Chromogenic method |
|
3190-6
|
Coagulation factor IX Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3189-8
|
Coagulation factor IX Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
10393-7
|
Factor IX given [Type] |
|
10394-5
|
Factor IX given [Volume] |
|
30086-3
|
Coagulation factor IX inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3185-6
|
Coagulation factor IX inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3188-0
|
Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3186-4
|
Coagulation factor IX activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3193-0
|
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3195-5
|
Coagulation factor V Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3194-8
|
Coagulation factor V Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
81124-0
|
Coagulation factor V inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3191-4
|
Coagulation factor V inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3192-2
|
Coagulation factor V activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
10520-5
|
Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
|
3198-9
|
Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3200-3
|
Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assay |
|
49870-9
|
Coagulation factor VII Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3201-1
|
Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
81123-2
|
Coagulation factor VII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3196-3
|
Coagulation factor VII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3199-7
|
Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3203-7
|
Coagulation factor VII+Acarboxy Ag activity actual/normal in Platelet poor plasma by Immunoassay |
|
3202-9
|
Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
27814-3
|
Coagulation factor VII+Coagulation factor X actual/normal in Platelet poor plasma by Coagulation assay |
|
3197-1
|
Coagulation factor VII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3205-2
|
Coagulation factor VIII Ab [Units/volume] in Platelet poor plasma by Immunoassay |
|
58493-8
|
Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay |
|
3209-4
|
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3211-0
|
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation.2 stage |
|
49865-9
|
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Chromogenic method |
|
38521-1
|
Coagulation factor VIII Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3213-6
|
Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3215-1
|
Coagulation factor VIII Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3214-4
|
Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoelectrophoresis |
|
10521-3
|
Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
|
10395-2
|
Factor VIII given [Type] |
|
51890-2
|
Factor VIII units given [#] |
|
10396-0
|
Factor VIII given [Volume] |
|
93450-5
|
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3206-0
|
Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3207-8
|
Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method |
|
3204-5
|
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3210-2
|
Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3212-8
|
Coagulation factor VIII Activity.Xa activator [Units/volume] in Platelet poor plasma by Chromogenic method |
|
21001-3
|
Coagulation factor VIII [Interpretation] in Unspecified specimen |
|
90919-2
|
Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag Ag in Plasma by Immunoassay |
|
3208-6
|
Coagulation factor VIII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3218-5
|
Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay |
|
33984-6
|
Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method |
|
3221-9
|
Coagulation factor X Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3220-1
|
Coagulation factor X Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
39556-6
|
Coagulation factor X inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3216-9
|
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3219-3
|
Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3223-5
|
Coagulation factor X+Acarboxy Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3222-7
|
Coagulation factor X+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
28657-5
|
Coagulation factor X activated actual/normal in Platelet poor plasma by Chromogenic method |
|
3217-7
|
Coagulation factor X activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3226-8
|
Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3229-2
|
Coagulation factor XI Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3228-4
|
Coagulation factor XI Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
80603-4
|
Coagulation factor XI inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3224-3
|
Coagulation factor XI inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3227-6
|
Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
53222-6
|
Coagulation factor XI activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3232-6
|
Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3235-9
|
Coagulation factor XII Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3234-2
|
Coagulation factor XII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3230-0
|
Coagulation factor XII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3233-4
|
Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3231-8
|
Coagulation factor XII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
27815-0
|
Coagulation factor XIII activity actual/normal in Platelet poor plasma by Chromogenic method |
|
3239-1
|
Coagulation factor XIII Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3238-3
|
Coagulation factor XIII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
10522-1
|
Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
|
3241-7
|
Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay |
|
3240-9
|
Coagulation factor XIII coagulum dissolution [Units/volume] in Platelet poor plasma by Coagulation assay |
|
57760-1
|
Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
50637-8
|
Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method |
|
3236-7
|
Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3237-5
|
Coagulation factor XIII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
81712-2
|
Actin.filamentous Ab [Presence] in Serum by Line blot |
|
57410-3
|
Actin.filamentous Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
54020-3
|
Actin.filamentous Ab [Presence] in Serum or Plasma |
|
63484-0
|
Actin.filamentous Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
54021-1
|
Actin.filamentous Ab [Units/volume] in Serum or Plasma |
|
88674-7
|
Factors related to rescue |
|
53647-4
|
Flavin adenine dinucleotide [Mass/volume] in Blood |
|
78991-7
|
Flavin adenine dinucleotide [Moles/volume] in Blood |
|
2281-4
|
Flavin adenine dinucleotide [Mass/volume] in Serum |
|
78990-9
|
Flavin adenine dinucleotide [Moles/volume] in Serum or Plasma |
|
22089-7
|
Avian adenovirus Ab [Presence] in Serum |
|
15434-4
|
Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
|
47438-7
|
Fowl adenovirus Ab [Presence] in Serum |
|
43335-9
|
Fowl adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
|
43344-1
|
Avian adenovirus 127 Ab [Titer] in Serum |
|
43313-6
|
Avian adenovirus 127 Ab [Titer] in Serum by Hemagglutination inhibition |
|
22088-9
|
Avian adenovirus 2 Ab [Presence] in Serum |
|
15435-1
|
Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
|
20674-8
|
Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) |
|
38928-8
|
FAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38929-6
|
FAH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
91380-6
|
Number of falls in the past 3 months - Reported |
|
54851-1
|
Fall one or more times in the last 2 to 6 months prior to admission [CMS Assessment] |
|
54850-3
|
Fall one or more times in the last month prior to admission [CMS Assessment] |
|
81227-1
|
Fall risk [CCC] |
|
75431-7
|
Fall risk assessment note |
|
73830-2
|
Fall risk assessment |
|
77698-9
|
Fall scale [UPDRS] |
|
52552-7
|
Falls in the past year [CMS Assessment] |
|
6726-4
|
False oat grass IgE Ab [Units/volume] in Serum |
|
15741-2
|
False oat grass IgE Ab RAST class [Presence] in Serum |
|
7648-9
|
False ragweed triggered histamine release [Units/volume] in Blood |
|
6115-0
|
False ragweed IgE Ab [Units/volume] in Serum |
|
15977-2
|
False ragweed IgE Ab RAST class [Presence] in Serum |
|
61267-1
|
False ragweed IgE Ab/IgE total in Serum |
|
13187-0
|
False ragweed IgG Ab [Units/volume] in Serum |
|
56369-2
|
False ragweed IgG4 Ab [Mass/volume] in Serum |
|
63207-5
|
False ragweed IgG Ab [Mass/volume] in Serum |
|
78253-2
|
Family medicine Consult note |
|
78255-7
|
Family medicine Diagnostic study note |
|
78277-1
|
Family medicine Education note |
|
78299-5
|
Family medicine Flowsheet |
|
78338-1
|
Family medicine Initial evaluation note |
|
85437-2
|
Family medicine Note |
|
93898-5
|
Family medicine Telephone encounter Note |
|
80752-9
|
Family medicine Plan of care note |
|
78315-9
|
Family medicine procedure note |
|
78324-1
|
Family medicine Progress note |
|
78332-4
|
Family medicine Referral note |
|
72839-4
|
Famciclovir [Susceptibility] by Genotype method |
|
55146-5
|
Familial long QTS syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44942-1
|
First nations living status from Family |
|
79751-4
|
Family history of Eye problems |
|
80985-5
|
Family history of Premature coronary artery disease |
|
74024-1
|
Family member identifier |
|
71273-7
|
Family or friends try to get my child to eat more in the past 7 days [FACIT] |
|
74556-2
|
Family or guardian was notified [AHRQ] |
|
74027-4
|
Family pedigree identifier |
|
86635-0
|
Family planning report Document |
|
80390-8
|
Family unification code |
|
73387-3
|
Famotidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73386-5
|
Famotidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
23862-6
|
Famotidine [Mass/volume] in Serum or Plasma |
|
87658-1
|
Famphur [Mass/mass] in Unspecified specimen |
|
75922-5
|
Fan speed Infant microenvironment.incubator |
|
43191-6
|
FANCC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32639-7
|
FANCC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
73645-4
|
Faropenem [Susceptibility] by Disk diffusion (KB) |
|
73622-3
|
Faropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73600-9
|
Faropenem [Susceptibility] |
|
77083-4
|
FARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77082-6
|
FARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
60550-1
|
Fascin [Presence] in Tissue by Immune stain |
|
5163-1
|
Fasciola sp Ab [Units/volume] in Serum |
|
25342-7
|
Fasciola sp Ab [Titer] in Serum |
|
25406-0
|
Fasciola sp Ab [Titer] in Serum by Immunofluorescence |
|
25407-8
|
Fasciola sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
25343-5
|
Fasciola sp IgG Ab [Units/volume] in Serum |
|
87527-8
|
Fasting duration |
|
49541-6
|
Fasting status - Reported |
|
53356-2
|
Fat [#/volume] in Urine by Computer assisted method |
|
53359-6
|
Fat [#/area] in Urine by Computer assisted method |
|
34329-3
|
Fat [Mass/mass] in 24 hour Stool |
|
16142-2
|
Fat [Mass/time] in 24 hour Stool |
|
16855-9
|
Fat [Mass/time] in 48 hour Stool |
|
58934-1
|
Fat [Mass/mass] in 72 hour Stool |
|
2271-5
|
Fat [Mass/time] in 72 hour Stool |
|
32545-6
|
Fat [Moles/time] in 72 hour Stool |
|
13356-1
|
Fat [Presence] in Body fluid |
|
75297-2
|
Fat intake 24 hour Estimated |
|
81952-4
|
Fat intake 24 hour Measured |
|
10752-4
|
Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
|
23714-9
|
Fat [Mass/volume] in Milk |
|
75289-9
|
Fat need [Mass/time] 24 hour Estimated |
|
16856-7
|
Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain |
|
13531-9
|
Fat.microscopic observation [Presence] in Sputum by Sudan III stain |
|
2270-7
|
Fat [Presence] in Stool |
|
16853-4
|
Fat [Mass] in Stool |
|
10753-2
|
Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
|
2570-0
|
Fat [Mass/volume] in Stool |
|
63556-5
|
Fat [Mass/mass] in Stool |
|
10754-0
|
Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
|
2272-3
|
Fat [Presence] in Urine |
|
50227-8
|
Fat [Presence] in Urine by Computer assisted method |
|
88978-2
|
Fat [Presence] in Urine sediment |
|
75022-4
|
Fat.microscopic observation [Presence] in Urine sediment by Oil red O stain |
|
29256-5
|
Fat.microscopic observation [Identifier] in Urine sediment by Sudan IV stain |
|
35745-9
|
Fat/Total solids [Mass Ratio] in Stool |
|
91009-1
|
Fatalities [#] |
|
74026-6
|
Father identifier |
|
92013-2
|
Father's administrative information |
|
88120-1
|
Father's Bridged race [CDC] |
|
80909-5
|
Father's last name |
|
88118-5
|
Father's Tabulated ethnicity [CDC] |
|
86481-9
|
Fatigue limited your ability to do what you wanted over the past 2 weeks [KCCQ] |
|
75114-9
|
Fatty acids pattern [Interpretation] in Red Blood Cells Narrative |
|
44084-2
|
Fatty acids pattern [Interpretation] in Serum or Plasma |
|
49262-9
|
Fatty acids pattern [Interpretation] in Serum or Plasma Narrative |
|
62453-6
|
Fatty acids.ethyl esters [Moles/mass] in Hair |
|
60519-6
|
Fatty acids.ethyl esters [Moles/mass] in Meconium |
|
53288-7
|
Fatty casts [#/volume] in Urine by Computer assisted method |
|
33231-2
|
Fatty casts [#/area] in Urine by Computer assisted method |
|
88975-8
|
Fatty casts [#/area] in Urine sediment |
|
67813-6
|
Fatty casts [#/area] in Urine sediment by Microscopy high power field |
|
5789-3
|
Fatty casts [#/area] in Urine sediment by Microscopy low power field |
|
50229-4
|
Fatty casts [Presence] in Urine by Computer assisted method |
|
25159-5
|
Fatty casts [Presence] in Urine sediment by Light microscopy |
|
54930-3
|
Fava bean IgE Ab [Units/volume] in Serum |
|
86506-3
|
Favorite color |
|
71507-8
|
Fax number Dialysis facility [ESRD] |
|
69484-4
|
FBN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77114-7
|
FBN1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
40471-5
|
FBN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49735-4
|
FBN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43310-2
|
FBN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90465-6
|
3-(4-fluorobenzoyl)propionate [Mass/volume] in Urine by Confirmatory method |
|
90466-4
|
3-(4-fluorobenzoyl)propionate [Presence] in Urine by Screen method |
|
55141-6
|
Fc epsilon RI + RII Ab [Units/volume] in Serum |
|
42177-6
|
Fc epsilon RI Ab [Presence] in Serum |
|
5164-9
|
Fc fragment Ab [Units/volume] in Serum |
|
68931-5
|
Catecholamines Free [Mass/volume] in 24 hour Urine |
|
27055-3
|
Catecholamines Free [Mass/time] in 24 hour Urine |
|
14643-1
|
Catecholamines Free [Moles/time] in 24 hour Urine |
|
1385-4
|
Catecholamines Free fractionated [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
|
1386-2
|
Catecholamines Free fractionated [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
|
1387-0
|
Catecholamines Free fractionated [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
|
42493-7
|
Catecholamines Free fractionated [Mass/volume] in Plasma |
|
1388-8
|
Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
|
11133-6
|
Catecholamines Free [Mass/volume] in Urine |
|
23717-2
|
Feline coronavirus Ab [Presence] in Serum |
|
23716-4
|
Feline coronavirus Ab [Presence] in Serum by Immunoassay |
|
31385-8
|
Feline coronavirus Ab [Units/volume] in Serum |
|
23718-0
|
Feline coronavirus Ab [Titer] in Serum |
|
31384-1
|
Feline calicivirus Ab [Units/volume] in Serum |
|
23715-6
|
Feline calicivirus Ab [Titer] in Serum |
|
69761-5
|
FDA package insert Alarms |
|
86445-4
|
FDA package insert Blanket no changes certification of product listing |
|
90374-0
|
FDA package insert Clinical trials experience section |
|
69760-7
|
FDA package insert Compatible accessories |
|
69758-1
|
FDA package insert Diagram of device |
|
69763-1
|
FDA package insert Disposal and waste handling |
|
77292-1
|
FDA package insert eFacility |
|
77291-3
|
FDA package insert Females and males reproductive potential |
|
88829-7
|
FDA package insert Hepatic Impairment subsection |
|
77289-7
|
FDA package insert Identification of suspect product and notification |
|
88830-5
|
FDA package insert Immunogenicity |
|
73815-3
|
FDA package insert Indexing - product concept |
|
82353-4
|
FDA package insert Indexing - risk evaluation and mitigation strategies |
|
77288-9
|
FDA package insert Indexing - warning letter alert |
|
77290-5
|
FDA package insert Lactation |
|
49489-8
|
FDA package insert Microbiology section |
|
90375-7
|
FDA package insert Postmarketing experience section |
|
82351-8
|
FDA package insert Risk evaluation and mitigation strategies |
|
87523-7
|
FDA package insert REMS administrative information |
|
87526-0
|
FDA package insert REMS applicant requirements |
|
82344-3
|
FDA package insert REMS communication plan |
|
85273-1
|
FDA package insert REMS conversion to shared system |
|
82348-4
|
FDA package insert REMS elements |
|
82345-0
|
FDA package insert REMS elements to assure safe use |
|
82349-2
|
FDA package insert REMS goals |
|
82336-9
|
FDA package insert REMS header |
|
82350-0
|
FDA package insert REMS implementation system |
|
82346-8
|
FDA package insert REMS material |
|
82598-4
|
FDA package insert REMS medication guide |
|
87525-2
|
FDA package insert REMS participant requirements |
|
85274-9
|
FDA package insert REMS release |
|
87524-5
|
FDA package insert REMS requirements |
|
82347-6
|
FDA package insert REMS summary |
|
82352-6
|
FDA package insert REMS timetable for submission assessments |
|
88828-9
|
FDA package insert Renal Impairment subsection |
|
69759-9
|
FDA package insert Risks |
|
44425-7
|
FDA package insert Storage and handling section |
|
69762-3
|
FDA package insert Troubleshooting |
|
77647-6
|
FDA product label Animal compounded drug label |
|
86446-2
|
FDA product label Blood establishment registration and product listing change in information |
|
85481-0
|
FDA product label Blood establishment registration and product listing |
|
53409-9
|
FDA product label Bulk ingredient |
|
81203-2
|
FDA product label Bulk ingredient - animal drug |
|
85482-8
|
FDA product label Human cell and tissue establishment registration and product listing |
|
86447-0
|
FDA product label Human cell and tissue establishment registration and product listing change in information |
|
78744-0
|
FDA product label Drug for further processing label |
|
85480-2
|
FDA product label Establishment registration exempt notification |
|
85484-4
|
FDA product label Establishment temporary inactivation notification |
|
71743-9
|
FDA product label Generic drug facility identification submission |
|
69719-3
|
FDA product label Health claim section |
|
75031-5
|
FDA product label Human compounded drug label |
|
86448-8
|
FDA product label Human salvaged drug |
|
72090-4
|
FDA product label Identification of CBER-regulated generic drug facility |
|
77648-4
|
FDA product label Indexing - biologic or drug substance |
|
93723-5
|
FDA product label Indexing - drug interactions |
|
93372-1
|
FDA product label Indexing - national clinical trial number |
|
53407-3
|
FDA product label Licensed blood intermediate/paste label |
|
53408-1
|
FDA product label Licensed minimally manipulated cells label |
|
53406-5
|
FDA product label Licensed vaccine bulk intermediate label |
|
86444-7
|
FDA product label Manufacturing establishment information |
|
55439-4
|
FDA product label Medical device |
|
81204-0
|
FDA product label NDC labeler code inactivation - animal drug |
|
72871-7
|
FDA product label NDC labeler code request - animal drug |
|
53410-7
|
FDA product label No change notification |
|
53405-7
|
FDA product label Non-standardized allergenic label |
|
53414-9
|
FDA product label OTC - Pregnancy or breast feeding section |
|
53413-1
|
FDA product label OTC - Questions section |
|
53411-5
|
FDA product label Out of business notification |
|
68498-5
|
FDA product label Patient medication information section |
|
78745-7
|
FDA product label Recombinant deoxyribonucleic acid construct label |
|
53412-3
|
FDA product label Residue warning section |
|
69718-5
|
FDA product label Statement of identity section |
|
53404-0
|
FDA product label Vaccine label |
|
77573-4
|
FDA product label Withdrawal of wholesale drug distributors and third-party logistics facility report |
|
75030-7
|
FDA product label Wholesale drug distributors and third-party logistics facility registration |
|
89600-1
|
FDA product label FDA-initiated compliance action drug registration and listing inactivation |
|
29263-1
|
Fibrin degradation products [Presence] in Blood by Agglutination |
|
85139-4
|
Fear Survey version 2.0 - ages 8-17 - T-score [NIH Toolbox] |
|
91526-4
|
Fear-Affect Survey - age 18+ - T-score [NIH Toolbox] |
|
85123-8
|
Fear-Over Anxious Survey version 2.0 - parent report - ages 3-7 - T-score [NIH Toolbox] |
|
85120-4
|
Fear-Separation Anxiety Survey version 2.0 - parent report - ages 3-7 - T-score [NIH Toolbox] |
|
57962-3
|
FECH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76470-4
|
Organization federal tax ID |
|
54583-0
|
Federal OBRA reason for assessment [CMS Assessment] |
|
74466-4
|
Feedback to user--post question response |
|
57248-7
|
Feeding - functional ability [CMS Assessment] |
|
34588-4
|
Tick feeding duration |
|
83184-2
|
Feeding or eating |
|
67704-7
|
Feeding types |
|
44258-2
|
Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2 weeks [Reported.PHQ] |
|
54647-3
|
Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54646-5
|
Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
54639-0
|
Feeling down, depressed or hopeless in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54638-2
|
Feeling down, depressed or hopeless in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
44255-8
|
Feeling down, depressed, or hopeless in last 2 weeks [Reported.PHQ] |
|
54660-6
|
Feeling or appearing down, depressed or hopeless in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
54661-4
|
Feeling or appearing down, depressed, or hopeless in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
44254-1
|
Feeling tired or having little energy in last 2 weeks [Reported.PHQ] |
|
54665-5
|
Feeling tired or having little energy in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54643-2
|
Feeling tired or having little energy in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54664-8
|
Feeling tired or having little energy in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
54642-4
|
Feeling tired or having little energy in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
69973-6
|
FEF 25-75% --post bronchodilation |
|
69972-8
|
FEF 25-75% --pre bronchodilation |
|
69971-0
|
FEF 25-75% Predicted |
|
69980-1
|
FEF 50%/FIV 50% --post bronchodilation |
|
69979-3
|
FEF 50%/FIV 50% --pre bronchodilation |
|
31387-4
|
Feline herpesvirus Ab [Units/volume] in Serum |
|
43036-3
|
Feline herpesvirus Ab [Titer] in Serum |
|
23722-2
|
Feline herpesvirus Ab [Titer] in Serum by Neutralization test |
|
31386-6
|
Feline herpesvirus 1 Ab [Presence] in Serum |
|
27383-9
|
Feline herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
23719-8
|
Feline herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
31393-2
|
Feline herpesvirus 1 Ab [Units/volume] in Serum |
|
23738-8
|
Feline herpesvirus 1 Ab [Titer] in Serum |
|
23720-6
|
Feline herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
23721-4
|
Feline herpesvirus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32600-9
|
Felbamate [Mass] of Dose |
|
50611-3
|
Felbamate [Mass/volume] in Serum or Plasma by Confirmatory method |
|
6899-9
|
Felbamate [Mass/volume] in Serum or Plasma |
|
83826-8
|
Fellow Intensive care unit Admission evaluation note |
|
83827-6
|
Fellow Intensive care unit Note |
|
83825-0
|
Fellow Note |
|
86490-0
|
Felt discouraged or down in the dumps because of heart failure over the past 2 weeks [KCCQ] |
|
23734-7
|
Feline leukemia virus Ab [Presence] in Serum |
|
23732-1
|
Feline leukemia virus Ab [Presence] in Serum by Immunoassay |
|
23733-9
|
Feline leukemia virus Ab [Presence] in Serum by Immunofluorescence |
|
31389-0
|
Feline leukemia virus Ab [Units/volume] in Serum |
|
43034-8
|
Feline leukemia virus Ab [Titer] in Serum |
|
23735-4
|
Feline leukemia virus Ab [Titer] in Serum by Neutralization test |
|
23736-2
|
Feline leukemia virus Ag [Presence] in Tissue by Immunofluorescence |
|
23731-3
|
Feline leukemia provirus [Presence] in Unspecified specimen |
|
75993-6
|
Femoral artery Blood pressure |
|
3626-9
|
Fencamfamin [Mass/time] in 24 hour Urine |
|
4250-7
|
Fencamfamin [Mass] of Dose |
|
3624-4
|
Fencamfamin [Presence] in Urine |
|
3625-1
|
Fencamfamin [Mass/volume] in Urine |
|
35487-8
|
Fenchlorphos [Mass/volume] in Serum or Plasma |
|
21268-8
|
Fenchlorphos [Mass/volume] in Urine |
|
87637-5
|
Fenchlorphos [Mass/mass] in Unspecified specimen |
|
16857-5
|
Fenclorvos [Presence] in Blood |
|
3629-3
|
Fenetylline [Mass/time] in 24 hour Urine |
|
4251-5
|
Fenetylline [Mass] of Dose |
|
3627-7
|
Fenetylline [Presence] in Urine |
|
3628-5
|
Fenetylline [Mass/volume] in Urine |
|
4252-3
|
Fenfluramine [Mass] of Dose |
|
3630-1
|
Fenfluramine [Mass/volume] in Serum or Plasma |
|
55350-3
|
Fenfluramine [Presence] in Urine |
|
3631-9
|
Fenfluramine [Mass/volume] in Urine |
|
10928-0
|
Fennel Fresh IgE Ab [Units/volume] in Serum |
|
15706-5
|
Fennel Fresh IgE Ab RAST class [Presence] in Serum |
|
63126-7
|
Fennel Fresh IgG Ab [Mass/volume] in Serum |
|
10929-8
|
Fennel Seed IgE Ab [Units/volume] in Serum |
|
15707-3
|
Fennel Seed IgE Ab RAST class [Presence] in Serum |
|
61265-5
|
Fennel Seed IgE Ab/IgE total in Serum |
|
73024-2
|
Fenofibrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73023-4
|
Fenofibrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73385-7
|
Fenofibrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73384-0
|
Fenofibrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4253-1
|
Fenoprofen [Mass] of Dose |
|
59901-9
|
Fenoprofen [Moles/volume] in Gastric fluid |
|
3632-7
|
Fenoprofen [Mass/volume] in Serum or Plasma |
|
55536-7
|
Fenoprofen [Moles/volume] in Serum or Plasma |
|
59900-1
|
Fenoprofen [Moles/volume] in Urine |
|
60303-5
|
Fenoprofen [Moles/volume] in Unspecified specimen |
|
3635-0
|
Fenproporex [Mass/time] in 24 hour Urine |
|
4254-9
|
Fenproporex [Mass] of Dose |
|
3633-5
|
Fenproporex [Presence] in Urine |
|
3634-3
|
Fenproporex [Mass/volume] in Urine |
|
26867-2
|
fentaNYL [Units/volume] in 24 hour Urine |
|
78766-3
|
fentaNYL [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
73938-3
|
fentaNYL [Mass/volume] in Blood by Confirmatory method |
|
73936-7
|
fentaNYL [Presence] in Blood by Screen method |
|
78827-3
|
fentaNYL cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
79259-8
|
fentaNYL cutoff [Mass/volume] in Urine for Confirmatory method |
|
79260-6
|
fentaNYL cutoff [Mass/volume] in Urine for Screen method |
|
4255-6
|
fentaNYL [Mass] of Dose |
|
16858-3
|
fentaNYL [Mass/volume] in Body fluid |
|
61077-4
|
fentaNYL [Presence] in Gastric fluid |
|
73382-4
|
fentaNYL induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73383-2
|
fentaNYL induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72760-2
|
fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87815-7
|
fentaNYL [Presence] in Saliva (oral fluid) by Screen method |
|
29356-3
|
fentaNYL [Presence] in Serum or Plasma |
|
74136-3
|
fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3636-8
|
fentaNYL [Mass/volume] in Serum or Plasma |
|
55537-5
|
fentaNYL [Moles/volume] in Serum or Plasma |
|
58381-5
|
fentaNYL [Mass/volume] in Urine by Confirmatory method |
|
11235-9
|
fentaNYL [Presence] in Urine |
|
40839-3
|
fentaNYL [Presence] in Urine by Confirmatory method |
|
59673-4
|
fentaNYL [Presence] in Urine by Screen method |
|
3637-6
|
fentaNYL [Mass/volume] in Urine |
|
74383-1
|
fentaNYL [Mass/volume] in Unknown substance |
|
61042-8
|
fentaNYL [Presence] in Unspecified specimen |
|
78828-1
|
fentaNYL [Z-score] in Urine |
|
58380-7
|
fentaNYL/Creatinine [Mass Ratio] in Urine |
|
66130-6
|
fentaNYL+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method |
|
66129-8
|
fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method |
|
58379-9
|
fentaNYL+Norfentanyl [Presence] in Urine by Screen method |
|
32652-0
|
Fenthion [Mass/volume] in Serum or Plasma |
|
21269-6
|
Fenthion [Mass/volume] in Urine |
|
87657-3
|
Fenthion [Mass/mass] in Unspecified specimen |
|
19739-2
|
Fenugreek IgE Ab [Units/volume] in Serum |
|
25408-6
|
Fenugreek IgE Ab RAST class [Presence] in Serum |
|
2892-8
|
Protoporphyrin Free [Mass/volume] in Blood |
|
15093-8
|
Protoporphyrin Free [Moles/volume] in Blood |
|
39775-2
|
Protoporphyrin Free [Moles/volume] in Red Blood Cells |
|
10573-4
|
Ferning [Type] in Cervical mucus |
|
54452-8
|
Ferning [Presence] in Cervical mucus |
|
11172-4
|
Ferret epithelium IgE Ab [Units/volume] in Serum |
|
15708-1
|
Ferret epithelium IgE Ab RAST class [Presence] in Serum |
|
61343-0
|
Ferret epithelium IgE Ab/IgE total in Serum |
|
14724-9
|
Ferritin [Interpretation] in Blood |
|
24373-3
|
Ferritin [Mass/volume] in Blood |
|
53048-5
|
Ferritin [Mass/volume] in Body fluid |
|
86914-9
|
Ferritin goal [Mass/volume] Serum or Plasma |
|
48141-6
|
Ferritin [Entitic mass] in Red Blood Cells |
|
20567-4
|
Ferritin [Mass/volume] in Serum or Plasma by Immunoassay |
|
2276-4
|
Ferritin [Mass/volume] in Serum or Plasma |
|
35209-6
|
Ferritin [Mass or Moles/volume] in Serum or Plasma |
|
14723-1
|
Ferritin [Moles/volume] in Serum or Plasma |
|
2277-2
|
Ferrochelatase [Enzymatic activity/volume] in Serum |
|
89692-8
|
Heart rate 10 minutes mean Fetus |
|
75980-3
|
Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75598-3
|
Fetal 1p36 deletion prior risk [Likelihood] based on general population risk |
|
75599-1
|
Fetal 1p36 deletion prior risk [Likelihood] based on general population risk Narrative |
|
75601-5
|
Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75602-3
|
Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75600-7
|
Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75574-4
|
Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk |
|
75575-1
|
Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk Narrative |
|
88572-3
|
Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75577-7
|
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75578-5
|
Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75576-9
|
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75592-6
|
Fetal 5p deletion prior risk [Likelihood] based on general population risk |
|
75593-4
|
Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative |
|
75595-9
|
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75596-7
|
Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75594-2
|
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
11777-0
|
Fetal Abdomen [Area] Cross section derived by US |
|
33147-0
|
Fetal Abdomen Circumference measured by method of Chitty 1994 (US) |
|
33546-3
|
Fetal Abdomen Circumference derived by method of Chitty 1994 (US) |
|
11980-0
|
Fetal Abdomen Circumference measured by ellipse overlay (US) |
|
11978-4
|
Fetal Abdomen Circumference derived by US |
|
33145-4
|
Fetal Abdomen Circumference estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
33146-2
|
Fetal Abdomen Circumference estimated from gestational age by method of Hadlock 1984 (US) |
|
33148-8
|
Fetal Abdomen Circumference estimated from gestational age by method of Merz 1988 (US) |
|
33149-6
|
Fetal Abdomen Circumference estimated from gestational age by method of Shinozuka 1996 (US) |
|
11979-2
|
Fetal Abdomen Circumference US |
|
11981-8
|
Fetal Abdomen Circumference US.traced |
|
11818-2
|
Fetal Abdomen Diameter.anterior-posterior US |
|
33150-4
|
Fetal Abdomen Diameter product estimated from gestational age by method of Shinozuka 1996 (US) |
|
11849-7
|
Fetal Abdomen Mean diameter Estimated from gestational age |
|
11991-7
|
Fetal Abdomen Mean perimeter Estimated from gestational age |
|
11697-0
|
Fetal Aortic arch Peak systolic flow velocity US.doppler |
|
11670-7
|
Fetal Aortic arch Mean blood flow velocity US.doppler |
|
11817-4
|
Fetal Amniotic fluid space Diameter largest pocket US |
|
11832-3
|
Fetal Amniotic fluid space Maximum diameter largest pocket US |
|
11833-1
|
Fetal Amniotic fluid space Mean diameter largest pocket US |
|
12167-3
|
Fetal Amniotic fluid space [Interpretation] Volume.amniotic fluid US |
|
11627-7
|
Fetal Amniotic fluid index.sum derived by US |
|
11693-9
|
Fetal Aorta ascending Peak systolic flow velocity US.doppler |
|
11666-5
|
Fetal Aorta ascending Mean blood flow velocity US.doppler |
|
11695-4
|
Fetal Aorta descending Peak systolic flow velocity US.doppler |
|
11668-1
|
Fetal Aorta descending Mean blood flow velocity US.doppler |
|
53658-1
|
Fetal Aorta Diameter US |
|
75586-8
|
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk |
|
75587-6
|
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative |
|
75589-2
|
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75590-0
|
Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75588-4
|
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
11794-5
|
Fetal Aortic valve Diameter US |
|
11705-1
|
Fetal Aortic valve Peak systolic flow velocity US.doppler |
|
11766-3
|
Fetal Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age |
|
11768-9
|
Fetal Body weight percentile range Categorization by comparison with standards |
|
11815-8
|
Fetal Urinary bladder Diameter US |
|
12169-9
|
Fetal Urinary bladder Volume.pre void US |
|
12168-1
|
Fetal Urinary bladder Volume post void US |
|
11782-0
|
Fetal Bowel Diameter US |
|
33151-2
|
Fetal Head Diameter.biparietal estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
33198-3
|
Fetal Head Diameter.biparietal estimated from gestational age by method of Hadlock 1984 (US) |
|
33153-8
|
Fetal Head Diameter.biparietal estimated from gestational age by method of Jeanty 1982 (US) |
|
33154-6
|
Fetal Head Diameter.biparietal estimated from gestational age by method of Merz 1988 (US) |
|
33155-3
|
Fetal Head Diameter.biparietal estimated from gestational age by method of Rempen 1991 (US) |
|
33156-1
|
Fetal Head Diameter.biparietal estimated from gestational age by method of Shinozuka 1996 (US) |
|
33556-2
|
Fetal Head Diameter.biparietal outer to inner estimated from gestational age by method of Chitty 1994 (US) |
|
33152-0
|
Fetal Head Diameter.biparietal outer to outer estimated from gestational age by method of Chitty 1994 (US) |
|
11820-8
|
Fetal Head Diameter.biparietal US |
|
11821-6
|
Fetal Head Mean biparietal diameter Estimated from gestational age |
|
11822-4
|
Fetal Head Mean biparietal diameter estimated from Cerebellar diameter (US) |
|
11823-2
|
Fetal Head Diameter.biparietal/Diameter.occipital derived by US |
|
33157-9
|
Fetal Head Diameter.biparietal/Diameter.occipital estimated from gestational age by method of Chitty 1994 (US) |
|
33158-7
|
Fetal Head Diameter.biparietal/Diameter.occipital estimated from gestational age by method of Hadlock 1981 (US) |
|
11630-1
|
Fetal Biophysical profile.amniotic fluid volume US |
|
11631-9
|
Fetal Biophysical profile.body movement US |
|
11632-7
|
Fetal Biophysical profile.breathing movement US |
|
11633-5
|
Fetal Biophysical profile.heart rate reactivity US |
|
11634-3
|
Fetal Biophysical profile.sum Derived |
|
11635-0
|
Fetal Biophysical profile.tone US |
|
11997-4
|
Fetal Cerebral artery anterior Pulsatility index US.doppler |
|
12012-1
|
Fetal Cerebral artery anterior Resistivity index US.doppler |
|
12133-5
|
Fetal Cerebral artery anterior Systolic flow/Diastolic flow US.doppler |
|
11699-6
|
Fetal Cerebral artery anterior Peak systolic flow velocity US.doppler |
|
11672-3
|
Fetal Cerebral artery anterior Mean blood flow velocity US.doppler |
|
11654-1
|
Fetal Cerebral artery anterior Minimal flow velocity US.doppler |
|
11999-0
|
Fetal Cerebral artery middle Pulsatility index US.doppler |
|
12135-0
|
Fetal Cerebral artery middle Systolic flow/Diastolic flow US.doppler |
|
11701-0
|
Fetal Cerebral artery middle Peak systolic flow velocity US.doppler |
|
53659-9
|
Fetal Cerebral artery middle Mean blood flow velocity US.doppler |
|
11656-6
|
Fetal Cerebral artery middle Minimal flow velocity US.doppler |
|
92899-4
|
Fetal Chromosome region 11q23 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
77013-1
|
Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Sequencing |
|
75981-1
|
Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75979-5
|
Fetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75975-3
|
Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
92903-4
|
Fetal Chromosome region 15q11 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
77012-3
|
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Sequencing |
|
75982-9
|
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75978-7
|
Fetal Chromosome 18 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
77011-5
|
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Sequencing |
|
75983-7
|
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75976-1
|
Fetal Chromosome 21 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
92900-0
|
Fetal Chromosome region 4p16 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
92902-6
|
Fetal Chromosome region 8q24 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
75977-9
|
Fetal Chromosome X and Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
73821-1
|
Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
77619-5
|
Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma |
|
76664-2
|
Fetal Chromosome X and Y aneuploidy [interpretation] based on dosage of chromosome-specific cell-free DNA in Maternal plasma |
|
11861-2
|
Fetal Cisterna magna Mean sagittal diameter Estimated from gestational age |
|
11860-4
|
Fetal Cisterna magna Diameter.sagittal US |
|
11962-8
|
Fetal Clavicle diaphysis [Length] US |
|
53677-1
|
Fetal Clavicle.diaphysis - right [Length] US |
|
11790-3
|
Fetal Colon lumen Diameter US |
|
33159-5
|
Fetal Crown Rump length estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
33160-3
|
Fetal Crown Rump length estimated from gestational age by method of Rempen 1991 (US) |
|
33161-1
|
Fetal Crown Rump length estimated from gestational age by method of Shinozuka 1996 (US) |
|
11957-8
|
Fetal Crown Rump length US |
|
11703-6
|
Fetal Ductus arteriosus Peak systolic flow velocity US.doppler |
|
11675-6
|
Fetal Ductus arteriosus Mean blood flow velocity US.doppler |
|
76061-1
|
Other significant causes or conditions of fetal death [US Standard Report of Fetal Death] |
|
46242-4
|
Fetal Document Vital signs measurements |
|
53684-7
|
Fetal Ear - left Maximum length US |
|
53668-0
|
Fetal Ear - right Maximum length US |
|
11792-9
|
Fetal Eye Diameter US |
|
53669-8
|
Fetal Right eye Diameter US |
|
11970-1
|
Fetal Femur diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
|
33165-2
|
Fetal Femur diaphysis [Length] estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
33167-8
|
Fetal Femur diaphysis [Length] estimated from gestational age by method of Chitty 1994 (US) |
|
33166-0
|
Fetal Femur diaphysis [Length] estimated from gestational age by method of Hadlock 1984 (US) |
|
33168-6
|
Fetal Femur diaphysis [Length] estimated from gestational age by method of Jeanty 1982 (US) |
|
33169-4
|
Fetal Femur diaphysis [Length] estimated from gestational age by method of Merz 1988 (US) |
|
33170-2
|
Fetal Femur diaphysis [Length] estimated from gestational age by method of Shinozuka 1996 (US) |
|
11963-6
|
Fetal Femur diaphysis [Length] US |
|
53696-1
|
Fetal Femur.diaphysis - right [Length] US |
|
11971-9
|
Fetal Fibula diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
|
33164-5
|
Fetal Fibula diaphysis [Length] estimated from gestational age by method of Jeanty 1983 (US) |
|
11964-4
|
Fetal Fibula diaphysis [Length] US |
|
53679-7
|
Fetal Fibula.diaphysis - right [Length] US |
|
53701-9
|
Fetal Finger fifth - left Length US |
|
53674-8
|
Fetal Finger fifth - right Length US |
|
11871-1
|
Fetal Femur length/Abdominal circumference derived by US |
|
11872-9
|
Fetal Femur length/Biparietal diameter derived by US |
|
11873-7
|
Fetal Femur length/Head circumference derived by US |
|
11965-1
|
Fetal Foot [Length] US |
|
53681-3
|
Fetal Foot - right [Length] US |
|
53682-1
|
Fetal Third cerebral ventricle Diameter transverse US |
|
53683-9
|
Fetal Head.fourth cerebral ventricle Diameter.anterior-posterior US |
|
11628-5
|
Fetal Head Binocular distance estimated from Biparietal diameter on US |
|
11629-3
|
Fetal Head Binocular distance US |
|
11824-0
|
Fetal Head Diameter.BPD.area-corrected derived by US |
|
11985-9
|
Fetal Head Circumference measured by ellipse overlay (US) |
|
11983-4
|
Fetal Head Circumference derived from occipital-frontal diameter and outer-inner biparietal diameter (US) |
|
11982-6
|
Fetal Head Circumference derived from occipital-frontal diameter and outer-outer transaxial diameter (US) |
|
33172-8
|
Fetal Head Circumference estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
33174-4
|
Fetal Head Circumference estimated from gestational age by method of Chitty 1994 (US) |
|
33173-6
|
Fetal Head Circumference estimated from gestational age by method of Hadlock 1984 (US) |
|
33175-1
|
Fetal Head Circumference estimated from gestational age by method of Jeanty 1982 (US) |
|
33176-9
|
Fetal Head Circumference estimated from gestational age by method of Merz 1988 (US) |
|
11984-2
|
Fetal Head Circumference US |
|
11986-7
|
Fetal Head Circumference US.traced |
|
11852-1
|
Fetal Head Diameter.outer to outer US |
|
12170-7
|
Fetal Head Hemisphere width US |
|
11956-0
|
Fetal Head Lateral ventricular body width/Hemispheric width derived by US |
|
11851-3
|
Fetal Head Diameter.occipito-frontal US |
|
11992-5
|
Fetal Heart position US |
|
11993-3
|
Fetal Narrative Heart position US |
|
11948-7
|
Fetal Heart rate US |
|
11615-2
|
Fetal Heart Activity US |
|
11616-0
|
Fetal Heart Narrative Activity US |
|
53657-3
|
Fetal Heart Circumference US |
|
53656-5
|
Fetal Heart Diameter.anterior-posterior US |
|
53655-7
|
Fetal Heart Diameter transverse US |
|
12009-7
|
Fetal Heart R-R duration US |
|
11972-7
|
Fetal Humerus diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
|
33177-7
|
Fetal Humerus diaphysis [Length] estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
11966-9
|
Fetal Humerus diaphysis [Length] US |
|
53698-7
|
Fetal Humerus diaphysis - right [Length] US |
|
11951-1
|
Fetal [Identifier] Identifier |
|
11949-5
|
Fetal Identification criteria US |
|
11950-3
|
Fetal Narrative Identification criteria US |
|
12149-1
|
Fetal Interventricular septum Thickness diastolic Measured by real time two dimension US |
|
12148-3
|
Fetal Interventricular septum Thickness diastolic US.M-mode+Measured |
|
12153-3
|
Fetal Interventricular septum Thickness.systolic Measured by real time two dimension US |
|
12152-5
|
Fetal Interventricular septum Thickness.systolic US.M-mode+Measured |
|
11831-5
|
Fetal Kidney Mean width Estimated from gestational age |
|
11843-0
|
Fetal Kidney Mean longitudinal diameter Estimated from gestational age |
|
11954-5
|
Fetal Kidney length/Abdominal circumference derived by US |
|
11825-7
|
Fetal Kidney - left Hilum-cortex diameter US |
|
11834-9
|
Fetal Kidney - left Longitudinal diameter US |
|
11853-9
|
Fetal Kidney - left Thickeness US |
|
12162-4
|
Fetal Kidney - left Volume derived by US |
|
11827-3
|
Fetal Kidney - right Hilum-cortex diameter US |
|
11836-4
|
Fetal Kidney - right Longitudinal diameter US |
|
11855-4
|
Fetal Kidney - right Thickeness US |
|
12163-2
|
Fetal Kidney - right Volume derived by US |
|
11617-8
|
Fetal Limbs Activity US |
|
11618-6
|
Fetal Limbs Narrative Activity US |
|
11844-8
|
Fetal Liver Mean longitudinal diameter Estimated from abdominal circumference |
|
11845-5
|
Fetal Liver Mean longitudinal diameter Estimated from gestational age |
|
11838-0
|
Fetal Liver Longitudinal diameter US |
|
53671-4
|
Fetal Lung - left Diameter US |
|
53672-2
|
Fetal Lung - right Diameter US |
|
33197-5
|
Fetal Lateral cerebral ventricles Anterior horn width US |
|
53685-4
|
Fetal Left ventricle Diameter during diastole US |
|
33196-7
|
Fetal Lateral cerebral ventricles Posterior horn width US |
|
12171-5
|
Fetal Lateral cerebral ventricles Transverse width US |
|
12151-7
|
Fetal Left ventricular posterior wall Thickness diastolic Measured by real time two dimension US |
|
12150-9
|
Fetal Left ventricular posterior wall Thickness diastolic US.M-mode+Measured |
|
12155-8
|
Fetal Left ventricular posterior wall Thickness.systolic Measured by real time two dimension US |
|
12154-1
|
Fetal Left ventricular posterior wall Thickness.systolic US.M-mode+Measured |
|
11802-6
|
Fetal Left ventricular outflow tract Diameter US.doppler |
|
11713-5
|
Fetal Left ventricular outflow tract Peak systolic flow velocity US.doppler |
|
11679-8
|
Fetal Left ventricular outflow tract Mean blood flow velocity US.doppler |
|
53680-5
|
Fetal Lateral cerebral ventricle - right Transverse width US |
|
53670-6
|
Fetal Mandible Maximum length US |
|
79212-7
|
Fetal Microdeletions risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing |
|
11719-2
|
Fetal Main pulmonary artery Peak systolic flow velocity US.doppler |
|
11685-5
|
Fetal Main pulmonary artery Mean blood flow velocity US.doppler |
|
75568-6
|
Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative |
|
75566-0
|
Fetal Monosomy X prior risk [Likelihood] Based on maternal age |
|
88571-5
|
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75569-4
|
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75570-2
|
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75567-8
|
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
11796-0
|
Fetal Mitral valve Diameter US |
|
11649-1
|
Fetal Mitral valve E-wave/A-wave US.doppler |
|
11641-8
|
Fetal Mitral valve Peak A wave US.doppler |
|
11645-9
|
Fetal Mitral valve Peak E wave US.doppler |
|
11707-7
|
Fetal Mitral valve Peak systolic flow velocity US.doppler |
|
53697-9
|
Fetal Nasal bone diaphysis [Length] US |
|
49091-2
|
Fetal Neural tube defect risk [Likelihood] Based on maternal age |
|
49035-9
|
Fetal Nuchal fold [Multiple of the median] Thickness US |
|
60477-7
|
Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight |
|
12146-7
|
Fetal Nuchal fold Thickness US |
|
33069-6
|
Fetal nuchal translucency measured by US |
|
33070-4
|
Fetal Orbit - bilateral Diameter.inner orbital US |
|
11806-7
|
Fetal Pulmonary artery Diameter US |
|
11946-1
|
Fetal Placenta Grade US |
|
12147-5
|
Fetal Placenta Thickness US |
|
11874-5
|
Fetal position palpation |
|
11875-2
|
Fetal position US |
|
80109-2
|
Fetal Pregnancy risk factors for prenatal genetic testing |
|
11876-0
|
Fetal presentation palpation |
|
11877-8
|
Fetal presentation US |
|
11798-6
|
Fetal Pulmonic valve Diameter US |
|
11709-3
|
Fetal Pulmonic valve Peak systolic flow velocity US.doppler |
|
11677-2
|
Fetal Pulmonic valve Mean blood flow velocity US.doppler |
|
75580-1
|
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk |
|
75581-9
|
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative |
|
75583-5
|
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75584-3
|
Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75582-7
|
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
11624-4
|
Fetal Quadrant four one Amniotic fluid index derived by US |
|
11626-9
|
Fetal Quadrant two Amniotic fluid index derived by US |
|
11625-1
|
Fetal Quadrant three Amniotic fluid index derived by US |
|
11623-6
|
Fetal Quadrant four Amniotic fluid index derived by US |
|
11973-5
|
Fetal Radius diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
|
33180-1
|
Fetal Radius diaphysis [Length] estimated from gestational age by method of Jeanty 1983 (US) |
|
11967-7
|
Fetal Radius diaphysis [Length] US |
|
53699-5
|
Fetal Radius.diaphysis - right [Length] US |
|
11808-3
|
Fetal Renal pelvis - left Diameter US |
|
11810-9
|
Fetal Renal pelvis - right Diameter US |
|
11619-4
|
Fetal Respiratory Activity US |
|
11620-2
|
Fetal Respiratory Narrative Activity US |
|
77016-4
|
Fetal RhD antigen in Plasma cell-free DNA by MS.MALDI-TOF |
|
53673-0
|
Fetal Right ventricle Diameter during diastole US |
|
11804-2
|
Fetal Right ventricular outflow tract Diameter US |
|
11715-0
|
Fetal Right ventricular outflow tract Peak systolic flow velocity US.doppler |
|
11681-4
|
Fetal Right ventricular outflow tract Mean blood flow velocity US.doppler |
|
11812-5
|
Fetal Small bowel Diameter US |
|
53675-5
|
Fetal Scapula - left Maximum length US |
|
53676-3
|
Fetal Scapula - right Maximum length US |
|
75604-9
|
Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNA |
|
75668-4
|
Fetal sex [Likelihood] in Plasma cell-free DNA by Dosage of chromosome specifi cell free (cf) DNA |
|
75693-2
|
Fetal sex in Plasma cell-free DNA by Dosage of chromosome specific cell free (cf) DNA |
|
11882-8
|
Fetal Sex US |
|
11883-6
|
Fetal Narrative Sex US |
|
33071-2
|
Fetal Spine Length from T6 to L3 US |
|
33068-8
|
Fetal Thoracic area US |
|
33191-8
|
Fetal Thorax Diameter product derived by US |
|
11989-1
|
Fetal Thorax Circumference measured by ellipse overlay (US) |
|
11987-5
|
Fetal Thorax Circumference derived by US |
|
11988-3
|
Fetal Thorax Circumference US |
|
11990-9
|
Fetal Thorax Circumference US.traced |
|
11819-0
|
Fetal Thorax Diameter.anterior-posterior US |
|
11864-6
|
Fetal Thorax Diameter transverse US |
|
11974-3
|
Fetal Tibia diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
|
11968-5
|
Fetal Tibia diaphysis [Length] US |
|
53678-9
|
Fetal Tibia diaphysis - right [Length] US |
|
75572-8
|
Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
11621-0
|
Fetal Trunk Activity US |
|
11622-8
|
Fetal Trunk Narrative Activity US |
|
75550-4
|
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative |
|
75546-2
|
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age |
|
73824-5
|
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
73969-8
|
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75551-2
|
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75552-0
|
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75548-8
|
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75556-1
|
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative |
|
75554-6
|
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age |
|
47223-3
|
Fetal Trisomy 18 risk [Likelihood] Based on maternal age |
|
77015-6
|
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative |
|
73825-2
|
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
73968-0
|
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75557-9
|
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75558-7
|
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75555-3
|
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75560-3
|
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age |
|
75562-9
|
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative |
|
49090-4
|
Fetal Trisomy 21 risk [Likelihood] Based on maternal age |
|
77014-9
|
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative |
|
73966-4
|
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
73970-6
|
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75563-7
|
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75564-5
|
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75561-1
|
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
11800-0
|
Fetal Tricuspid valve Diameter US |
|
11651-7
|
Fetal Tricuspid valve E-wave/A-wave US.doppler |
|
11643-4
|
Fetal Tricuspid valve Peak A wave US.doppler |
|
11647-5
|
Fetal Tricuspid valve Peak E wave US.doppler |
|
11711-9
|
Fetal Tricuspid valve Peak systolic flow velocity US.doppler |
|
11975-0
|
Fetal Ulna diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
|
11969-3
|
Fetal Ulna diaphysis [Length] US |
|
53700-1
|
Fetal Ulna diaphysis - right [Length] US |
|
12003-0
|
Fetal Umbilical artery at fetus Pulsatility index US.doppler |
|
12018-8
|
Fetal Umbilical artery at fetus Resistivity index US.doppler |
|
12139-2
|
Fetal Umbilical artery at fetus Systolic flow/Diastolic flow US.doppler |
|
11721-8
|
Fetal Umbilical artery at fetus Peak systolic flow velocity US.doppler |
|
11687-1
|
Fetal Umbilical artery at fetus Mean blood flow velocity US.doppler |
|
11660-8
|
Fetal Umbilical artery at fetus Minimal flow velocity US.doppler |
|
12005-5
|
Fetal Umbilical artery between fetus and placenta Pulsatility index US.doppler |
|
12020-4
|
Fetal Umbilical artery between fetus and placenta Resistivity index US.doppler |
|
12141-8
|
Fetal Umbilical artery between fetus and placenta Systolic flow/Diastolic flow US.doppler |
|
11723-4
|
Fetal Umbilical artery between fetus and placenta Peak systolic flow velocity US.doppler |
|
11689-7
|
Fetal Umbilical artery between fetus and placenta Mean blood flow US.doppler |
|
11662-4
|
Fetal Umbilical artery between fetus and placenta Minimal flow velocity US.doppler |
|
12004-8
|
Fetal Umbilical artery at placenta Pulsatility index US.doppler |
|
12019-6
|
Fetal Umbilical artery at placenta Resistivity index US.doppler |
|
12140-0
|
Fetal Umbilical artery at placenta Systolic flow/Diastolic flow US.doppler |
|
11722-6
|
Fetal Umbilical artery at placenta Peak systolic flow velocity US.doppler |
|
11688-9
|
Fetal Umbilical artery at placenta Mean blood flow US.doppler |
|
11661-6
|
Fetal Umbilical artery at placenta Minimal flow velocity US.doppler |
|
11952-9
|
Fetal Umbilical cord.placenta Narrative Insertion site US |
|
11814-1
|
Fetal Umbilical vein Diameter US |
|
89087-1
|
Fetal Body weight Estimated |
|
33163-7
|
Fetal weight estimated from gestational age by method of Hansmann 1986 (US) |
|
33141-3
|
Fetal weight estimated by method of Shinozuka formula 1 1996 (US) |
|
33142-1
|
Fetal weight estimated by method of Shinozuka formula 2 1996 (US) |
|
33143-9
|
Fetal weight estimated by method of Shinozuka formula 3 1996 (US) |
|
11727-5
|
Fetal Body weight estimated by US |
|
79211-9
|
Fetal Chromosome X and Y aneuploidy risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing |
|
77020-6
|
Fetal Y chromosome [Interpretation] based on Plasma cell-free DNA by Sequencing |
|
77021-4
|
Fetal Y chromosome [Presence] based on Plasma cell-free DNA by Sequencing |
|
11816-6
|
Fetal Yolk sac Diameter US |
|
12166-5
|
Fetal Yolk sac Volume US |
|
55730-6
|
Fetal blood [Volume] in Blood |
|
75308-7
|
Fetal blood [Volume] in Blood by Flow cytometry (FC) |
|
48555-7
|
Fetal blood [Volume] by Kleihauer-Betke method |
|
33900-2
|
Fetal cell screen [Presence] in Blood by Rosette test |
|
1034-8
|
Fetal cell screen [Interpretation] in Blood |
|
87289-5
|
Date of fetal death registration |
|
73761-9
|
Fetal presentation--at birth [US Standard Certificate of Live Birth] |
|
55729-8
|
Erythrocytes.fetal/100 erythrocytes [Ratio] in Blood by Flow cytometry (FC) |
|
48556-5
|
Erythrocytes.fetal/1000 erythrocytes [Ratio] in Blood by Kleihauer-Betke method |
|
75373-1
|
Erythrocytes.fetal/2000 erythrocytes in Blood by Kleihauer-Betke method |
|
88241-5
|
Fetal remains disposition method |
|
11862-0
|
Fetal Abdomen Diameter transverse US |
|
11866-1
|
Fetal Cerebellum Mean transverse diameter Estimated from gestational age |
|
33181-9
|
Fetal Cerebellum Diameter transverse estimated from gestational age by method of Goldstein 1987 (US) |
|
11863-8
|
Fetal Cerebellum Diameter transverse US |
|
69983-5
|
FEV1 percent change |
|
69984-3
|
FEV1/FVC percent change |
|
69970-2
|
FEV1/FVC --post bronchodilation |
|
81264-4
|
Fever duration |
|
85728-4
|
Fever duration in Mother |
|
85730-0
|
Fever in Mother |
|
73022-6
|
Fexofenadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73021-8
|
Fexofenadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60072-6
|
Fexofenadine [Mass/volume] in Blood |
|
73381-6
|
Fexofenadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73380-8
|
Fexofenadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60073-4
|
Fexofenadine [Mass/volume] in Serum or Plasma |
|
60074-2
|
Fexofenadine [Mass/volume] in Urine |
|
39152-4
|
FFD mammogram Breast Diagnostic |
|
39153-2
|
FFD mammogram Breast Screening |
|
46342-2
|
FFD mammogram Breast Views |
|
39150-8
|
FFD mammogram Breast Views Post Localization |
|
39154-0
|
FFD mammogram Breast - bilateral Diagnostic |
|
42174-3
|
FFD mammogram Breast - bilateral Screening |
|
42169-3
|
FFD mammogram Breast - left Diagnostic |
|
46355-4
|
FFD mammogram Breast - left Screening |
|
42168-5
|
FFD mammogram Breast - right Diagnostic |
|
46354-7
|
FFD mammogram Breast - right Screening |
|
51878-7
|
Fresh frozen plasma units given [#] |
|
1035-5
|
Fresh frozen plasma given [Volume] |
|
54426-2
|
Fresh frozen plasma pediatric units given [#] |
|
80997-0
|
Fractional flow reserve performed |
|
92992-7
|
FGA, FGB, and FGG gene full mutation analysis in Blood or Tissue by Sequencing |
|
58988-7
|
FGB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
59046-3
|
FGB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
41109-0
|
FGD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40426-9
|
FGD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87832-2
|
Fibroblast growth factor 21.intact [Mass/volume] in Serum or Plasma |
|
47855-2
|
Fibroblast growth factor 23.C-terminal [Units/volume] in Plasma |
|
41108-2
|
FGF23 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40427-7
|
FGF23 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46699-5
|
Fibroblast growth factor 23 [Units/volume] in Plasma |
|
53425-5
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --pre XXX challenge |
|
53426-3
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --1st specimen post XXX challenge |
|
53427-1
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --2nd specimen post XXX challenge |
|
53428-9
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --3rd specimen post XXX challenge |
|
53429-7
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --4th specimen post XXX challenge |
|
53430-5
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --5th specimen post XXX challenge |
|
53431-3
|
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --6th specimen post XXX challenge |
|
47854-5
|
Fibroblast growth factor 23.intact [Units/volume] in Plasma |
|
53418-0
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma --pre XXX challenge |
|
54390-0
|
Fibroblast growth factor 23.intact [Mass/volume] in Serum or Plasma |
|
53419-8
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --1st specimen post XXX challenge |
|
53420-6
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --2nd specimen post XXX challenge |
|
53421-4
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --3rd specimen post XXX challenge |
|
53422-2
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --4th specimen post XXX challenge |
|
53423-0
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --5th specimen post XXX challenge |
|
53424-8
|
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --6th specimen post XXX challenge |
|
42785-6
|
FGFR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78916-4
|
FGFR1 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78915-6
|
FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH |
|
38412-3
|
FGFR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21674-7
|
FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21675-4
|
FGFR2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
48972-4
|
FGFR2 gene+FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75391-3
|
FGFR3 gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
38413-1
|
FGFR3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21676-2
|
FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22074-9
|
FGFR3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21677-0
|
FGFR3 gene p.Gly375Cys [Presence] in Blood or Tissue by Molecular genetics method |
|
21678-8
|
FGFR3 gene p.Gly380Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
82137-1
|
FGFR3 gene p.Gly380Arg targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
21679-6
|
FGFR3 gene p.Lys650Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
49872-5
|
FH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81060-6
|
Insoluble fiber intake 24 hour Estimated |
|
81061-4
|
Insoluble fiber intake 24 hour Measured |
|
81133-1
|
Fiber intake 24 hour Estimated |
|
81057-2
|
Fiber intake 24 hour Measured |
|
81058-0
|
Soluble fiber intake 24 hour Estimated |
|
81059-8
|
Soluble fiber intake 24 hour Measured |
|
47407-2
|
Fibers [#/area] in Stool by Light microscopy |
|
78035-3
|
Fibers [Presence] in Body fluid |
|
38897-5
|
Fibers [Presence] in Stool by Light microscopy |
|
78036-1
|
Fibers [Presence] in Urine |
|
82393-0
|
Fibrillarin Ab [Units/volume] in Serum by Line blot |
|
49963-2
|
Fibrillarin Ab [Presence] in Serum |
|
53005-5
|
Fibrillarin Ab [Presence] in Serum by Immunofluorescence |
|
82394-8
|
Fibrillarin Ab [Presence] in Serum by Line blot |
|
51803-5
|
Fibrillarin Ab [Titer] in Serum by Immunofluorescence |
|
82915-0
|
Fibrillarin IgG Ab [Presence] in Serum by Line blot |
|
3248-2
|
Fibrin fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3249-0
|
Fibrin fragments [Identifier] in Platelet poor plasma by Immunoelectrophoresis |
|
93748-2
|
Fibrin monomer [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3250-8
|
Fibrin monomer [Units/volume] in Platelet poor plasma by Latex agglutination |
|
40702-3
|
Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination |
|
3253-2
|
Fibrin.soluble [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3254-0
|
Fibrin.soluble [Units/volume] in Serum by Coagulation assay |
|
32778-3
|
Fibrin strands [Presence] in Blood by Light microscopy |
|
3256-5
|
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
42772-4
|
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Nephelometry |
|
60278-9
|
Fibrinogen Ag [Presence] in Tissue by Immunofluorescence |
|
10523-9
|
Fibrinogen Ag [Presence] in Tissue by Immune stain |
|
31158-9
|
Fibrinogen Ag/Fibrinogen [Mass Ratio] in Platelet poor plasma |
|
3259-9
|
Fibrinogen fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
27990-1
|
Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination |
|
27991-9
|
Fibrinogen fragments [Mass/volume] in Urine by Latex agglutination |
|
56784-2
|
Fibrinogen fragments [Mass/volume] in Urine |
|
48664-7
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derived |
|
30902-1
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturation |
|
16859-1
|
Fibrinogen [Presence] in Platelet poor plasma |
|
21002-1
|
Fibrinogen [Interpretation] in Platelet poor plasma |
|
3255-7
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay |
|
42568-6
|
Fibrinogen [Mass or Moles/volume] in Platelet poor plasma by Coagulation assay |
|
13173-0
|
Fibronectin aggregate IgA Ab [Units/volume] in Serum |
|
14095-4
|
Fibronectin aggregate IgG Ab [Units/volume] in Serum |
|
16867-4
|
Fibronectin aggregate IgG Ab [Mass/volume] in Serum |
|
20404-0
|
Fibronectin.fetal [Presence] in Vaginal fluid |
|
20403-2
|
Fibronectin.fetal [Mass/volume] in Vaginal fluid |
|
48039-2
|
Fibronectin.fetal [Presence] in Unspecified specimen |
|
2280-6
|
Fibronectin [Mass/volume] in Plasma |
|
48794-2
|
Fibrosis stage |
|
6116-8
|
Ficus sp IgE Ab [Units/volume] in Serum |
|
51565-0
|
Ficus sp IgE Ab RAST class [Presence] in Serum |
|
73644-7
|
Fidaxomicin [Susceptibility] by Disk diffusion (KB) |
|
73621-5
|
Fidaxomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73599-3
|
Fidaxomicin [Susceptibility] |
|
11173-2
|
Fig IgE Ab [Units/volume] in Serum |
|
21270-4
|
Fig IgE Ab RAST class [Presence] in Serum |
|
53862-9
|
FIG4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
5790-1
|
Fungi.filamentous [#/area] in Urine sediment by Microscopy high power field |
|
33242-9
|
Fungi.filamentous [Presence] in Urine by Computer assisted method |
|
20457-8
|
Fungi.filamentous [Presence] in Urine sediment by Light microscopy |
|
44245-9
|
Fungi.filamentous [#/area] in Vaginal fluid by Wet preparation |
|
45357-1
|
Erythrocytes.filamented [Presence] in Blood by Light microscopy |
|
5165-6
|
Filaria Ab [Units/volume] in Serum by Hemagglutination |
|
41417-7
|
Filaria Ab [Units/volume] in Serum by Immunoassay |
|
7887-3
|
Filaria Ab [Units/volume] in Serum |
|
25344-3
|
Filaria Ab [Titer] in Serum |
|
25409-4
|
Filaria Ab [Titer] in Serum by Immunofluorescence |
|
42928-2
|
Filaria Ag [Presence] in Serum |
|
40745-2
|
Filaria identified in Blood |
|
10662-5
|
Filaria identified in Blood by Concentration |
|
10663-3
|
Filaria identified in Blood by Thick film |
|
10664-1
|
Filaria identified in Blood by Thin film |
|
88918-8
|
Filaria DNA [Presence] in Blood by NAA with probe detection |
|
88915-4
|
Filaria DNA [Presence] in Tissue by NAA with probe detection |
|
25410-2
|
Filaria IgG Ab [Units/volume] in Serum by Immunoassay |
|
13244-9
|
Filaria IgG Ab [Units/volume] in Serum |
|
49770-1
|
Filaria IgG1 Ab [Units/volume] in Serum by Immunoassay |
|
51455-4
|
Filaria IgG1 Ab [Units/volume] in Serum |
|
49767-7
|
Filaria IgG2 Ab [Units/volume] in Serum by Immunoassay |
|
51456-2
|
Filaria IgG2 Ab [Units/volume] in Serum |
|
49768-5
|
Filaria IgG3 Ab [Units/volume] in Serum by Immunoassay |
|
51457-0
|
Filaria IgG3 Ab [Units/volume] in Serum |
|
49769-3
|
Filaria IgG4 Ab [Units/volume] in Serum by Immunoassay |
|
14208-3
|
Filaria IgG4 Ab [Units/volume] in Serum |
|
13245-6
|
Filaria IgM Ab [Units/volume] in Serum |
|
76699-8
|
Filaria identified in Skin by Light microscopy |
|
31022-7
|
Filaria identified in Unspecified specimen by Concentration |
|
53036-0
|
Filler DNA analysis test identifier [Identifier] |
|
31395-7
|
Filovirus Ab [Units/volume] in Serum |
|
24416-0
|
Filovirus Ab [Titer] in Serum |
|
73643-9
|
Finafloxacin [Susceptibility] by Disk diffusion (KB) |
|
73620-7
|
Finafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73598-5
|
Finafloxacin [Susceptibility] |
|
77941-3
|
Final patient acuity NEMSIS |
|
73762-7
|
Final route and method of delivery [US Standard Certificate of Live Birth] |
|
90853-3
|
Final score [DUKE-AD] |
|
85464-6
|
Financial resources - visual analog rating [ePCAM] |
|
83335-0
|
Financial resources [PCAM] |
|
89178-8
|
Patient's Financial responsibility amount [#] |
|
73379-0
|
Finasteride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73378-2
|
Finasteride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60075-9
|
Finasteride [Mass/volume] in Serum or Plasma |
|
16868-2
|
Finch droppings IgE Ab [Presence] in Serum |
|
23863-4
|
Finch droppings IgE Ab RAST class [Presence] in Serum |
|
39538-4
|
Finch droppings IgG Ab [Presence] in Serum |
|
55595-3
|
Finch feather IgE Ab [Presence] in Serum |
|
13833-9
|
Finch feather IgE Ab [Units/volume] in Serum |
|
15710-7
|
Finch feather IgE Ab RAST class [Presence] in Serum |
|
33225-4
|
Fine Granular Casts [#/area] in Urine sediment by Automated count |
|
33224-7
|
Fine Granular Casts [#/area] in Urine sediment by Microscopy high power field |
|
32680-1
|
Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field |
|
32176-0
|
Fine Granular Casts [Presence] in Urine sediment by Light microscopy |
|
93010-7
|
Finger chase - left |
|
93009-9
|
Finger chase - left+right mean [Score] |
|
93011-5
|
Finger chase - right |
|
60830-7
|
Finger temperature |
|
23728-9
|
Feline infectious peritonitis virus Ab [Presence] in Serum |
|
23726-3
|
Feline infectious peritonitis virus Ab [Presence] in Serum by Immunoassay |
|
23727-1
|
Feline infectious peritonitis virus Ab [Presence] in Serum by Immunofluorescence |
|
23729-7
|
Feline infectious peritonitis virus Ag [Presence] in Tissue by Immunofluorescence |
|
31826-1
|
Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue |
|
23730-5
|
Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
|
7084-7
|
Fire Ant IgG Ab [Units/volume] in Serum |
|
7442-7
|
Firebush IgA Ab [Units/volume] in Serum |
|
6118-4
|
Firebush IgE Ab [Units/volume] in Serum |
|
15712-3
|
Firebush IgE Ab RAST class [Presence] in Serum |
|
42923-3
|
Firebush IgE Ab/IgE total in Serum |
|
56299-1
|
Firebush IgG4 Ab [Mass/volume] in Serum |
|
21271-2
|
Fireweed IgE Ab [Units/volume] in Serum |
|
21272-0
|
Fireweed IgE Ab RAST class [Presence] in Serum |
|
75784-9
|
First alternate healthcare agent [Reported] |
|
54587-1
|
First assessment since the most recent admission/reentry [CMS Assessment] |
|
45392-8
|
First name |
|
79183-0
|
First name of Guardian or legally authorized representative |
|
75189-1
|
First reactive non-treponemal test titer |
|
81369-1
|
First witness |
|
15713-1
|
Fiscus sp IgE Ab RAST class [Presence] in Serum |
|
10930-6
|
Fish Feed IgE Ab [Units/volume] in Serum |
|
19044-7
|
Fish Feed IgE Ab RAST class [Presence] in Serum |
|
7311-4
|
Fish IgE Ab [Units/volume] in Serum |
|
62370-2
|
FISH probe gene name [Identifier] in Laboratory device |
|
62371-0
|
FISH probe locus [Identifier] in Laboratory device |
|
78040-3
|
FISH probe target gene [Identifier] in Laboratory device |
|
78041-1
|
FISH probe target locus [Identifier] in Laboratory device |
|
62372-8
|
FISH probe vendor [Identifier] in Laboratory device |
|
10785-4
|
Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |
|
23724-8
|
Feline immunodeficiency virus Ab [Presence] in Serum |
|
23723-0
|
Feline immunodeficiency virus Ab [Presence] in Serum by Immunoassay |
|
31388-2
|
Feline immunodeficiency virus Ab [Units/volume] in Serum |
|
43035-5
|
Feline immunodeficiency virus Ab [Titer] in Serum |
|
23725-5
|
Feline immunodeficiency virus Ab [Titer] in Serum by Immunofluorescence |
|
15559-8
|
Fivehook Bassia IgE Ab RAST class [Presence] in Serum |
|
77116-2
|
FKBP10 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77115-4
|
FKBP10 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41753-5
|
FKRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53861-1
|
FKTN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35468-8
|
FLAER cells [Presence] in Blood |
|
77948-8
|
FLAER cells/100 cells in Unspecified specimen |
|
84465-4
|
Flanker Inhibitory Control and Attention Test - computed score [NIH Toolbox] |
|
84467-0
|
Flanker Inhibitory Control and Attention Test - raw score [NIH Toolbox] |
|
84468-8
|
Flanker Inhibitory Control and Attention Test - unadjusted scale score [NIH Toolbox] |
|
84433-2
|
Flanker Inhibitory Control and Attention Test [NIH Toolbox] |
|
84463-9
|
Flanker Inhibitory Control and Attention Test - national percentile [NIH Toolbox] |
|
84464-7
|
Flanker Inhibitory Control and Attention Test - scale score age adjusted [NIH Toolbox] |
|
84466-2
|
Flanker Inhibitory Control and Attention Test - scale score fully adjusted [NIH Toolbox] |
|
62384-3
|
Flanking normal region after end |
|
62383-5
|
Flanking normal region before start |
|
79889-2
|
Flare Left anterior chamber Slit lamp biomicroscopy |
|
79888-4
|
Flare Right anterior chamber Slit lamp biomicroscopy |
|
53648-2
|
Flavin mononucleotide [Mass/volume] in Blood |
|
79393-5
|
Flavin mononucleotide [Moles/volume] in Serum or Plasma |
|
71699-3
|
Flavivirus Ag [Presence] in Unspecified specimen by Immune stain |
|
86857-0
|
Flavivirus neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
51665-8
|
Flavivirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
49114-2
|
Flavivirus rRNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
6406-3
|
Flavivirus identified in Unspecified specimen by Organism specific culture |
|
7312-2
|
Flax IgE Ab [Units/volume] in Serum |
|
21273-8
|
Flax IgE Ab RAST class [Presence] in Serum |
|
56261-1
|
Flax IgG4 Ab [Mass/volume] in Serum |
|
63107-7
|
Flax IgG Ab [Mass/volume] in Serum |
|
57963-1
|
FLCN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7315-5
|
Flea triggered histamine release [Units/volume] in Blood |
|
7313-0
|
Flea IgE Ab [Units/volume] in Serum |
|
15714-9
|
Flea IgE Ab RAST class [Presence] in Serum |
|
7314-8
|
Flea IgG Ab [Units/volume] in Serum |
|
56262-9
|
Flea IgG4 Ab [Mass/volume] in Serum |
|
63159-8
|
Flea IgG Ab [Mass/volume] in Serum |
|
48237-2
|
Flea triggered leukotriene release [Mass/volume] by Leukocytes |
|
4256-4
|
Flecainide [Mass] of Dose |
|
29339-9
|
Flecainide [Mass/volume] in Gastric fluid |
|
35111-4
|
Flecainide [Mass/volume] in Serum or Plasma --peak |
|
13559-0
|
Flecainide [Presence] in Serum or Plasma |
|
3638-4
|
Flecainide [Mass/volume] in Serum or Plasma |
|
15105-0
|
Flecainide [Moles/volume] in Serum or Plasma |
|
35110-6
|
Flecainide [Mass/volume] in Serum or Plasma --trough |
|
29338-1
|
Flecainide [Mass/volume] in Urine |
|
7012-8
|
Fleroxacin [Susceptibility] by Gradient strip |
|
35806-9
|
Fleroxacin [Susceptibility] by Disk diffusion (KB) |
|
25411-0
|
Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32372-5
|
Fleroxacin [Susceptibility] |
|
18753-4
|
Flexible sigmoidoscopy study |
|
79798-5
|
Flicker response wave implicit time Left retina light-adapted by ERG |
|
79797-7
|
Flicker response wave implicit time Right retina light-adapted by ERG |
|
79796-9
|
Flicker response wave amplitude Left retina light-adapted by ERG |
|
79795-1
|
Flicker response wave amplitude Right retina light-adapted by ERG |
|
93833-2
|
Flights climbed 24 hour |
|
47226-6
|
Fetal lung maturity [Interpretation] in Amniotic fluid |
|
53863-7
|
FLNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53822-3
|
Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88312-4
|
Floor mat alarm used during 7 day assessment period [CMS Assessment] |
|
35807-7
|
Florfenicol [Susceptibility] by Disk diffusion (KB) |
|
35808-5
|
Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23740-4
|
Florfenicol [Susceptibility] |
|
87599-7
|
Florfenicol [Mass/mass] in Unspecified specimen |
|
7318-9
|
Flounder triggered histamine release [Units/volume] in Blood |
|
7316-3
|
Flounder IgE Ab [Units/volume] in Serum |
|
15715-6
|
Flounder IgE Ab RAST class [Presence] in Serum |
|
61345-5
|
Flounder IgE Ab/IgE total in Serum |
|
7317-1
|
Flounder IgG Ab [Units/volume] in Serum |
|
21274-6
|
Flounder IgG Ab RAST class [Presence] in Serum |
|
56263-7
|
Flounder IgG4 Ab [Mass/volume] in Serum |
|
60373-8
|
Flounder IgG Ab [Mass/volume] in Serum |
|
20226-7
|
Flow [Area] by US+Calculated |
|
69052-9
|
Flow cytometry specialist review of results |
|
33719-6
|
Flow cytometry study |
|
80520-0
|
Flow time by Uroflowmetry |
|
57656-1
|
Flow trigger setting Ventilator |
|
80567-1
|
Flowsheet |
|
80642-2
|
Floxacillin Free [Mass/volume] in Serum or Plasma |
|
246-9
|
Floxacillin [Susceptibility] by Disk diffusion (KB) |
|
245-1
|
Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
244-4
|
Floxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
35112-2
|
Floxacillin [Mass/volume] in Serum or Plasma |
|
18923-3
|
Floxacillin [Susceptibility] |
|
247-7
|
Floxacillin [Susceptibility] by Serum bactericidal titer |
|
89487-3
|
Fluoroquinolone [Susceptibility] by Genotype method |
|
47958-4
|
FLT3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54447-8
|
FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method |
|
79210-1
|
FLT3 gene internal tandem duplication [Presence] in Blood or Tissue by Molecular genetics method |
|
85100-6
|
FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method |
|
92844-0
|
FLT3 gene internal tandem duplication/Normal [Ratio] in Blood or Tissue by Molecular genetics method |
|
92843-2
|
FLT3 gene p.Asp835 mutations [Presence] in Blood or Tissue by Molecular genetics method |
|
72520-0
|
FLT3 gene p.Asp835+Ile836 [Presence] in Blood or Tissue by Molecular genetics method |
|
58131-4
|
Date of influenza vaccination |
|
44010-7
|
Influenza virus A and B Ab [Interpretation] in Body fluid |
|
72366-8
|
Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay |
|
72365-0
|
Influenza virus A and B Ag [Identifier] in Nose by Immunofluorescence |
|
72356-9
|
Influenza virus A and B Ag [Identifier] in Unspecified specimen by Rapid immunoassay |
|
61102-0
|
Influenza virus A and B Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
80204-1
|
Influenza virus A and B identified in Nasopharynx by Shell vial culture |
|
49537-4
|
Influenza virus A and B RNA [Identifier] in Isolate by NAA with probe detection |
|
48509-4
|
Influenza virus A and B RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49012-8
|
Influenza virus A and B identified in Unspecified specimen by Bioassay |
|
57896-3
|
Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method |
|
44876-1
|
Influenza virus A Ab [Presence] in Cerebral spinal fluid |
|
17012-6
|
Influenza virus A Ab [Units/volume] in Cerebral spinal fluid |
|
47443-7
|
Influenza virus A Ab [Presence] in Egg yolk |
|
39295-1
|
Influenza virus A Ab [Presence] in Egg yolk by Immune diffusion (ID) |
|
44557-7
|
Influenza virus A Ab [Presence] in Body fluid |
|
53381-0
|
Influenza virus A Ab [Identifier] in Serum |
|
39536-8
|
Influenza virus A Ab [Units/volume] in Serum by Complement fixation |
|
38273-9
|
Influenza virus A Ab [Units/volume] in Serum by Immunoassay |
|
50696-4
|
Influenza virus A Ab [Identifier] in Serum by Neutralization test |
|
22096-2
|
Influenza virus A Ab [Presence] in Serum |
|
44556-9
|
Influenza virus A Ab [Presence] in Serum by Complement fixation |
|
20862-9
|
Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition |
|
22822-1
|
Influenza virus A Ab [Presence] in Serum by Immunoassay |
|
15444-3
|
Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) |
|
7920-2
|
Influenza virus A Ab [Units/volume] in Serum |
|
47232-4
|
Influenza virus A Ab [Presence] in Serum --1st specimen |
|
24289-1
|
Influenza virus A Ab [Titer] in Serum --1st specimen |
|
24215-6
|
Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen |
|
47233-2
|
Influenza virus A Ab [Presence] in Serum --2nd specimen |
|
24290-9
|
Influenza virus A Ab [Titer] in Serum --2nd specimen |
|
24216-4
|
Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
9531-5
|
Influenza virus A Ab [Titer] in Cerebral spinal fluid |
|
22365-1
|
Influenza virus A Ab [Titer] in Serum |
|
22823-9
|
Influenza virus A Ab [Titer] in Serum by Agglutination |
|
5229-0
|
Influenza virus A Ab [Titer] in Serum by Complement fixation |
|
22824-7
|
Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
|
34153-7
|
Influenza virus A Ab [Units/volume] in Unspecified specimen |
|
90323-7
|
Influenza virus A Ab/Positive control in Serum by Immunoassay |
|
50699-8
|
Influenza virus A.adamantane resistance [Presence] |
|
50698-0
|
Influenza virus A.adamantane resistance [Presence] by Phenotype method |
|
50700-4
|
Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detection |
|
77383-8
|
Influenza virus A Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
44562-7
|
Influenza virus A Ag [Presence] in Bronchial specimen |
|
44559-3
|
Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
50697-2
|
Influenza virus A Ag [Identifier] in Isolate |
|
49529-1
|
Influenza virus A Ag [Presence] in Isolate by Immunofluorescence |
|
88904-8
|
Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44563-5
|
Influenza virus A Ag [Presence] in Nose |
|
44564-3
|
Influenza virus A Ag [Presence] in Nose by Immunoassay |
|
44560-1
|
Influenza virus A Ag [Presence] in Nose by Immunofluorescence |
|
43874-7
|
Influenza virus A Ag [Presence] in Nasopharynx |
|
46082-4
|
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay |
|
80382-5
|
Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay |
|
44558-5
|
Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31858-4
|
Influenza virus A Ag [Presence] in Throat |
|
5860-2
|
Influenza virus A Ag [Presence] in Throat by Immunoassay |
|
5861-0
|
Influenza virus A Ag [Presence] in Throat by Immunofluorescence |
|
86565-9
|
Influenza virus A Ag [Presence] in Tissue by Immunofluorescence |
|
44561-9
|
Influenza virus A Ag [Presence] in Trachea by Immunofluorescence |
|
31859-2
|
Influenza virus A Ag [Presence] in Unspecified specimen |
|
5862-8
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immunoassay |
|
22825-4
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
5863-6
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
85534-6
|
Influenza virus A avian origin nucleoprotein Ab/Negative control in Serum by Immunoassay |
|
6639-9
|
Influenza virus A Bangkok Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7921-0
|
Influenza virus A Bangkok Ab [Units/volume] in Serum |
|
33383-1
|
Influenza virus A Bangkok Ab [Titer] in Cerebral spinal fluid |
|
38381-0
|
Influenza virus A cDNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6635-7
|
Influenza virus A England Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7922-8
|
Influenza virus A England Ab [Units/volume] in Serum |
|
81305-5
|
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
82168-6
|
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
60529-5
|
Influenza virus A H1 2009 pandemic Ab [Titer] in Serum |
|
86317-5
|
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
77028-9
|
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection |
|
55465-9
|
Influenza virus A H1 2009 pandemic RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60494-2
|
Influenza virus A H1 2009 pandemic and Influenza virus A swine origin RNA [Interpretation] in Unspecified specimen Qualitative by NAA with probe detection |
|
47444-5
|
Influenza virus A H1 Ab [Titer] in Serum |
|
39296-9
|
Influenza virus A H1 Ab [Titer] in Serum by Hemagglutination inhibition |
|
50701-2
|
Influenza virus A H1 Ag [Presence] in Isolate by Immunofluorescence |
|
85802-7
|
Influenza virus A H1 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
80589-5
|
Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection |
|
57895-5
|
Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method |
|
74038-1
|
Influenza virus A H1 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49520-0
|
Influenza virus A H1 RNA [Presence] in Isolate by NAA with probe detection |
|
82167-8
|
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
77026-3
|
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92809-3
|
Influenza virus A H1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
49521-8
|
Influenza virus A H1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60538-6
|
Influenza virus A H1+H3+B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47445-2
|
Influenza virus A H10 Ab [Titer] in Serum |
|
39297-7
|
Influenza virus A H10 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47446-0
|
Influenza virus A H11 Ab [Titer] in Serum |
|
39298-5
|
Influenza virus A H11 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47447-8
|
Influenza virus A H12 Ab [Titer] in Serum |
|
39299-3
|
Influenza virus A H12 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47448-6
|
Influenza virus A H13 Ab [Titer] in Serum |
|
39300-9
|
Influenza virus A H13 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47449-4
|
Influenza virus A H14 Ab [Titer] in Serum |
|
39301-7
|
Influenza virus A H14 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47450-2
|
Influenza virus A H15 Ab [Titer] in Serum |
|
39302-5
|
Influenza virus A H15 Ab [Titer] in Serum by Hemagglutination inhibition |
|
51460-4
|
Influenza virus A H16 Ab [Titer] in Serum |
|
49519-2
|
Influenza virus A H16 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47451-0
|
Influenza virus A H2 Ab [Titer] in Serum |
|
39303-3
|
Influenza virus A H2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
57985-4
|
Influenza virus A H2 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47452-8
|
Influenza virus A H3 Ab [Titer] in Serum |
|
39304-1
|
Influenza virus A H3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
49522-6
|
Influenza virus A H3 Ag [Presence] in Isolate by Immunofluorescence |
|
85803-5
|
Influenza virus A H3 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
80590-3
|
Influenza virus A H3 HA gene [Presence] in Nasopharynx by NAA with probe detection |
|
74039-9
|
Influenza virus A H3 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49523-4
|
Influenza virus A H3 RNA [Presence] in Isolate by NAA with probe detection |
|
82169-4
|
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
77027-1
|
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92808-5
|
Influenza virus A H3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
49524-2
|
Influenza virus A H3 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47453-6
|
Influenza virus A H4 Ab [Titer] in Serum |
|
39305-8
|
Influenza virus A H4 Ab [Titer] in Serum by Hemagglutination inhibition |
|
49525-9
|
Influenza virus A H5 Ab [Presence] in Serum |
|
47454-4
|
Influenza virus A H5 Ab [Titer] in Serum |
|
39306-6
|
Influenza virus A H5 Ab [Titer] in Serum by Hemagglutination inhibition |
|
85804-3
|
Influenza virus A H5 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
81320-4
|
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory specimen by Nucleic acid amplification using primer-probe set H5a |
|
81321-2
|
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory specimen by Nucleic acid amplification using primer-probe set H5b |
|
44795-3
|
Influenza virus A H5 Asian RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77605-4
|
Influenza virus A H5 icA RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49526-7
|
Influenza virus A H5 RNA [Presence] in Isolate by NAA with probe detection |
|
44264-0
|
Influenza virus A H5 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
38272-1
|
Influenza virus A H5 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
68986-9
|
Influenza virus A H5a RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
68987-7
|
Influenza virus A H5b RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47455-1
|
Influenza virus A H6 Ab [Titer] in Serum |
|
39307-4
|
Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition |
|
44265-7
|
Influenza virus A H6 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
38271-3
|
Influenza virus A H6 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47456-9
|
Influenza virus A H7 Ab [Titer] in Serum |
|
39308-2
|
Influenza virus A H7 Ab [Titer] in Serum by Hemagglutination inhibition |
|
85805-0
|
Influenza virus A H7 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
81307-1
|
Influenza virus A H7 Eurasia RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
81428-5
|
Influenza virus A H7 Eurasia RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
49527-5
|
Influenza virus A H7 RNA [Presence] in Isolate by NAA with probe detection |
|
44266-5
|
Influenza virus A H7 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
38270-5
|
Influenza virus A H7 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47457-7
|
Influenza virus A H8 Ab [Titer] in Serum |
|
39309-0
|
Influenza virus A H8 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47458-5
|
Influenza virus A H9 Ab [Titer] in Serum |
|
39310-8
|
Influenza virus A H9 Ab [Titer] in Serum by Hemagglutination inhibition |
|
60530-3
|
Influenza virus A H9 RNA [Presence] in Isolate by NAA with probe detection |
|
49528-3
|
Influenza virus A H9 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55133-3
|
Influenza virus A hemagglutinin cDNA [Identifier] in Isolate by NAA with probe detection |
|
39102-9
|
Influenza virus A hemagglutinin cDNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
39025-2
|
Influenza virus A hemagglutinin cDNA [Identifier] in Unspecified specimen by Sequencing |
|
87715-9
|
Influenza virus A HA gene [Nucleotide sequence] in Isolate by Sequencing |
|
59424-2
|
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection |
|
49532-5
|
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by Sequencing |
|
59423-4
|
Influenza virus A hemagglutinin type RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
72767-7
|
Influenza virus A hemagglutinin segment sequence identifier |
|
6634-0
|
Influenza virus A Hong Kong Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7923-6
|
Influenza virus A Hong Kong Ab [Units/volume] in Serum |
|
49074-8
|
Influenza virus A IgA Ab [Mass/volume] in Cerebral spinal fluid |
|
72266-0
|
Influenza virus A IgA Ab [Units/volume] in Serum by Immunoassay |
|
43851-5
|
Influenza virus A IgA Ab [Presence] in Serum |
|
49073-0
|
Influenza virus A IgG Ab [Mass/volume] in Cerebral spinal fluid |
|
47313-2
|
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay |
|
43837-4
|
Influenza virus A IgG Ab [Presence] in Serum |
|
86566-7
|
Influenza virus A IgG Ab [Presence] in Serum by Immunoassay |
|
31437-7
|
Influenza virus A IgG Ab [Units/volume] in Serum |
|
57324-6
|
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57325-3
|
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
9532-3
|
Influenza virus A IgG Ab [Titer] in Serum |
|
49075-5
|
Influenza virus A IgM Ab [Mass/volume] in Cerebral spinal fluid |
|
47312-4
|
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay |
|
43838-2
|
Influenza virus A IgM Ab [Presence] in Serum |
|
86567-5
|
Influenza virus A IgM Ab [Presence] in Serum by Immunoassay |
|
31438-5
|
Influenza virus A IgM Ab [Units/volume] in Serum |
|
57326-1
|
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57327-9
|
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
9533-1
|
Influenza virus A IgM Ab [Titer] in Serum |
|
6642-3
|
Influenza virus A Leningrad Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7924-4
|
Influenza virus A Leningrad Ab [Units/volume] in Serum |
|
87714-2
|
Influenza virus A M gene [Nucleotide sequence] in Isolate by Sequencing |
|
80588-7
|
Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection |
|
6641-5
|
Influenza virus A Mississippi Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7925-1
|
Influenza virus A Mississippi Ab [Units/volume] in Serum |
|
50702-0
|
Influenza virus A matrix protein RNA [Presence] in Isolate by Sequencing |
|
72201-7
|
Influenza virus A matrix protein segment sequence identifier |
|
41142-1
|
Influenza virus A N1 Ab [Presence] in Serum |
|
39311-6
|
Influenza virus A N1 Ab [Presence] in Serum by Neutralization test |
|
56024-3
|
Influenza virus A N1 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
41141-3
|
Influenza virus A N2 Ab [Presence] in Serum |
|
39312-4
|
Influenza virus A N2 Ab [Presence] in Serum by Neutralization test |
|
74040-7
|
Influenza virus A N2 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
41140-5
|
Influenza virus A N3 Ab [Presence] in Serum |
|
39313-2
|
Influenza virus A N3 Ab [Presence] in Serum by Neutralization test |
|
41139-7
|
Influenza virus A N4 Ab [Presence] in Serum |
|
39314-0
|
Influenza virus A N4 Ab [Presence] in Serum by Neutralization test |
|
41138-9
|
Influenza virus A N5 Ab [Presence] in Serum |
|
39315-7
|
Influenza virus A N5 Ab [Presence] in Serum by Neutralization test |
|
41137-1
|
Influenza virus A N6 Ab [Presence] in Serum |
|
39316-5
|
Influenza virus A N6 Ab [Presence] in Serum by Neutralization test |
|
41136-3
|
Influenza virus A N7 Ab [Presence] in Serum |
|
39317-3
|
Influenza virus A N7 Ab [Presence] in Serum by Neutralization test |
|
41135-5
|
Influenza virus A N8 Ab [Presence] in Serum |
|
39318-1
|
Influenza virus A N8 Ab [Presence] in Serum by Neutralization test |
|
41134-8
|
Influenza virus A N9 Ab [Presence] in Serum |
|
39319-9
|
Influenza virus A N9 Ab [Presence] in Serum by Neutralization test |
|
39103-7
|
Influenza virus A neuraminidase cDNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
87716-7
|
Influenza virus A NA gene [Nucleotide sequence] in Isolate by Sequencing |
|
55134-1
|
Influenza virus A neuraminidase RNA [Identifier] in Isolate by NAA with probe detection |
|
61101-2
|
Influenza virus A neuraminidase RNA [Type] in Unspecified specimen by Sequencing |
|
72200-9
|
Influenza virus A neuraminidase segment sequence identifier |
|
50703-8
|
Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method |
|
93762-3
|
Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing |
|
50704-6
|
Influenza virus A nucleoprotein RNA [Presence] in Isolate by Sequencing |
|
50705-3
|
Influenza virus A non-structural protein RNA [Presence] in Isolate by Sequencing |
|
93763-1
|
Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
93761-5
|
Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing |
|
50706-1
|
Influenza virus A polymerase A RNA [Presence] in Isolate by Sequencing |
|
50707-9
|
Influenza virus A polymerase B1 cDNA [Presence] in Isolate by Sequencing |
|
93760-7
|
Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
93759-9
|
Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing |
|
50708-7
|
Influenza virus A polymerase B2 RNA [Presence] in Isolate by Sequencing |
|
6640-7
|
Influenza virus A Phillipines Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7926-9
|
Influenza virus A Phillipines Ab [Units/volume] in Serum |
|
50711-1
|
Influenza virus A polymerase RNA [Identifier] in Isolate by Sequencing |
|
85552-8
|
Influenza virus A porcine origin nucleoprotein IgA Ab/Positive control in Unspecified specimen by Immunoassay |
|
85533-8
|
Influenza virus A porcine origin nucleoprotein IgG Ab/Positive control in Unspecified specimen by Immunoassay |
|
6636-5
|
Influenza virus A Port Chalmers Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7927-7
|
Influenza virus A Port Chalmers Ab [Units/volume] in Serum |
|
53250-7
|
Influenza virus A RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
76077-7
|
Influenza virus A RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
88193-8
|
Influenza virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
86568-3
|
Influenza virus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81308-9
|
Influenza virus A RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
49531-7
|
Influenza virus A RNA [Presence] in Isolate by NAA with probe detection |
|
92977-8
|
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88599-6
|
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82166-0
|
Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76078-5
|
Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88600-2
|
Influenza virus A RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
92142-9
|
Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
85535-3
|
Influenza virus A RNA TCID50 [#/volume] in Unspecified specimen |
|
86569-1
|
Influenza virus A RNA [Presence] in Tissue by NAA with probe detection |
|
85477-8
|
Influenza virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
44263-2
|
Influenza virus A RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34487-9
|
Influenza virus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88187-0
|
Influenza virus A subtype [Identifier] in Cornea or Conjunctiva by NAA with probe detection |
|
91072-9
|
Influenza virus A subtype [Identifier] in Lower respiratory specimen by NAA with probe detection |
|
91771-6
|
Influenza virus A subtype [Identifier] in Upper respiratory specimen by NAA with probe detection |
|
22828-8
|
Influenza virus A subtype [Identifier] in Unspecified specimen by Immune diffusion (ID) |
|
22827-0
|
Influenza virus A subtype [Identifier] in Unspecified specimen by NAA with probe detection |
|
88835-4
|
Influenza virus A swine origin RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
55463-4
|
Influenza virus A swine origin RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
55464-2
|
Influenza virus A swine origin RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6638-1
|
Influenza virus A Texas Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7928-5
|
Influenza virus A Texas Ab [Units/volume] in Serum |
|
6637-3
|
Influenza virus A Victoria Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7929-3
|
Influenza virus A Victoria Ab [Units/volume] in Serum |
|
85532-0
|
Influenza virus A whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
22826-2
|
Influenza virus A identified in Unspecified specimen by Bioassay |
|
48310-7
|
Influenza virus A [Presence] in Unspecified specimen by Organism specific culture |
|
45279-7
|
Influenza virus A+B Ab [Presence] in Body fluid |
|
17013-4
|
Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence |
|
44565-0
|
Influenza virus A+B Ab [Presence] in Serum |
|
7930-1
|
Influenza virus A+B Ab [Units/volume] in Serum |
|
22366-9
|
Influenza virus A+B Ab [Titer] in Serum |
|
50693-1
|
Influenza virus A+B Ab [Titer] in Serum by Complement fixation |
|
6434-5
|
Influenza virus A+B Ab [Titer] in Serum by Immunofluorescence |
|
44566-8
|
Influenza virus A+B Ag [Presence] in Bronchial specimen |
|
44567-6
|
Influenza virus A+B Ag [Presence] in Nose |
|
72367-6
|
Influenza virus A+B Ag [Presence] in Nose by Rapid immunoassay |
|
33535-6
|
Influenza virus A+B Ag [Presence] in Nasopharynx |
|
31860-0
|
Influenza virus A+B Ag [Presence] in Throat |
|
6435-2
|
Influenza virus A+B Ag [Presence] in Throat by Immunoassay |
|
6436-0
|
Influenza virus A+B Ag [Presence] in Throat by Immunofluorescence |
|
24015-0
|
Influenza virus A+B Ag [Presence] in Unspecified specimen |
|
6437-8
|
Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunoassay |
|
6438-6
|
Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
57897-1
|
Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method |
|
62462-7
|
Influenza virus A+B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31861-8
|
Influenza virus A+B+C Ag [Presence] in Throat |
|
6439-4
|
Influenza virus A+B+C Ag [Presence] in Throat by Immunoassay |
|
6440-2
|
Influenza virus A+B+C Ag [Presence] in Throat by Immunofluorescence |
|
31862-6
|
Influenza virus A+B+C Ag [Presence] in Unspecified specimen |
|
6441-0
|
Influenza virus A+B+C Ag [Presence] in Unspecified specimen by Immunoassay |
|
6442-8
|
Influenza virus A+B+C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
82461-5
|
Influenza virus A and B and H1 2009 pandemic RNA [Identifier] in Upper respiratory specimen by NAA with probe detection |
|
17014-2
|
Influenza virus B Ab [Units/volume] in Cerebral spinal fluid |
|
44569-2
|
Influenza virus B Ab [Presence] in Body fluid |
|
52974-3
|
Influenza virus B Ab [Units/volume] in Serum by Complement fixation |
|
39537-6
|
Influenza virus B Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
44570-0
|
Influenza virus B Ab [Presence] in Serum |
|
44568-4
|
Influenza virus B Ab [Presence] in Serum by Complement fixation |
|
49533-3
|
Influenza virus B Ab [Presence] in Serum by Immunoassay |
|
7931-9
|
Influenza virus B Ab [Units/volume] in Serum |
|
24291-7
|
Influenza virus B Ab [Titer] in Serum --1st specimen |
|
24217-2
|
Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24292-5
|
Influenza virus B Ab [Titer] in Serum --2nd specimen |
|
24218-0
|
Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
9534-9
|
Influenza virus B Ab [Titer] in Cerebral spinal fluid |
|
22367-7
|
Influenza virus B Ab [Titer] in Serum |
|
5230-8
|
Influenza virus B Ab [Titer] in Serum by Complement fixation |
|
50709-5
|
Influenza virus B Ab [Titer] in Serum by Hemagglutination inhibition |
|
34154-5
|
Influenza virus B Ab [Units/volume] in Unspecified specimen |
|
77384-6
|
Influenza virus B Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
44576-7
|
Influenza virus B Ag [Presence] in Bronchial specimen |
|
44572-6
|
Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
54241-5
|
Influenza virus B Ag [Presence] in Isolate |
|
49534-1
|
Influenza virus B Ag [Presence] in Isolate by Immunofluorescence |
|
88905-5
|
Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44577-5
|
Influenza virus B Ag [Presence] in Nose |
|
44575-9
|
Influenza virus B Ag [Presence] in Nose by Immunoassay |
|
44573-4
|
Influenza virus B Ag [Presence] in Nose by Immunofluorescence |
|
43895-2
|
Influenza virus B Ag [Presence] in Nasopharynx |
|
46083-2
|
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay |
|
80383-3
|
Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay |
|
44571-8
|
Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31863-4
|
Influenza virus B Ag [Presence] in Throat |
|
5864-4
|
Influenza virus B Ag [Presence] in Throat by Immunoassay |
|
5865-1
|
Influenza virus B Ag [Presence] in Throat by Immunofluorescence |
|
88194-6
|
Influenza virus B Ag [Presence] in Tissue by Immunofluorescence |
|
44574-2
|
Influenza virus B Ag [Presence] in Trachea by Immunofluorescence |
|
31864-2
|
Influenza virus B Ag [Presence] in Unspecified specimen |
|
5866-9
|
Influenza virus B Ag [Presence] in Unspecified specimen by Immunoassay |
|
5867-7
|
Influenza virus B Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
49076-3
|
Influenza virus B IgA Ab [Mass/volume] in Cerebral spinal fluid |
|
72265-2
|
Influenza virus B IgA Ab [Units/volume] in Serum by Immunoassay |
|
43852-3
|
Influenza virus B IgA Ab [Presence] in Serum |
|
49077-1
|
Influenza virus B IgG Ab [Mass/volume] in Cerebral spinal fluid |
|
47314-0
|
Influenza virus B IgG Ab [Units/volume] in Serum by Immunoassay |
|
43839-0
|
Influenza virus B IgG Ab [Presence] in Serum |
|
88903-0
|
Influenza virus B IgG Ab [Presence] in Serum by Immunoassay |
|
17015-9
|
Influenza virus B IgG Ab [Units/volume] in Serum |
|
9535-6
|
Influenza virus B IgG Ab [Titer] in Serum |
|
49078-9
|
Influenza virus B IgM Ab [Mass/volume] in Cerebral spinal fluid |
|
47315-7
|
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay |
|
43840-8
|
Influenza virus B IgM Ab [Presence] in Serum |
|
86570-9
|
Influenza virus B IgM Ab [Presence] in Serum by Immunoassay |
|
17016-7
|
Influenza virus B IgM Ab [Units/volume] in Serum |
|
57328-7
|
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57329-5
|
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
9536-4
|
Influenza virus B IgM Ab [Titer] in Serum |
|
74784-0
|
Influenza virus B lineage RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
80591-1
|
Influenza virus B NS gene [Presence] in Nasopharynx by NAA with probe detection |
|
53251-5
|
Influenza virus B RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
76079-3
|
Influenza virus B RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
88195-3
|
Influenza virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
86571-7
|
Influenza virus B RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81309-7
|
Influenza virus B RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
90886-3
|
Influenza virus B RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49535-8
|
Influenza virus B RNA [Presence] in Isolate by NAA with probe detection |
|
49536-6
|
Influenza virus B RNA [Identifier] in Isolate by Sequencing |
|
92976-0
|
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88592-1
|
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82170-2
|
Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76080-1
|
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88596-2
|
Influenza virus B RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
92141-1
|
Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
86572-5
|
Influenza virus B RNA [Presence] in Tissue by NAA with probe detection |
|
85478-6
|
Influenza virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40982-1
|
Influenza virus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85821-7
|
Influenza virus B Victoria lineage Ag [Presence] in Isolate by Hemagglutination inhibition |
|
81327-9
|
Influenza virus B Victoria lineage RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
74785-7
|
Influenza virus B Victoria lineage RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
38382-8
|
Influenza virus B [Presence] in Unspecified specimen by Organism specific culture |
|
86318-3
|
Influenza virus B Yamagata lineage Ag [Presence] in Isolate by Hemagglutination inhibition |
|
85801-9
|
Influenza virus B Yamagata lineage Ag [Titer] in Isolate by Hemagglutination inhibition |
|
81325-3
|
Influenza virus B Yamagata lineage RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
74786-5
|
Influenza virus B Yamagata lineage RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
73020-0
|
Fluconazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73019-2
|
Fluconazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80530-9
|
Fluconazole [Mass/volume] in DBS |
|
73376-6
|
Fluconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73377-4
|
Fluconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7013-6
|
Fluconazole [Susceptibility] by Gradient strip |
|
250-1
|
Fluconazole [Susceptibility] by Disk diffusion (KB) |
|
249-3
|
Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
248-5
|
Fluconazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
10987-6
|
Fluconazole [Mass/volume] in Serum or Plasma |
|
18924-1
|
Fluconazole [Susceptibility] |
|
251-9
|
Fluconazole [Susceptibility] by Serum bactericidal titer |
|
16870-8
|
Fluconazole [Mass/volume] in Urine |
|
25255-1
|
Fluconazole [Mass/volume] in Unspecified specimen |
|
44579-1
|
Influenza virus C Ab [Presence] in Serum |
|
44578-3
|
Influenza virus C Ab [Presence] in Serum by Complement fixation |
|
7932-7
|
Influenza virus C Ab [Units/volume] in Serum |
|
22368-5
|
Influenza virus C Ab [Titer] in Serum |
|
5231-6
|
Influenza virus C Ab [Titer] in Serum by Complement fixation |
|
31865-9
|
Influenza virus C Ag [Presence] in Unspecified specimen |
|
29721-8
|
Influenza virus C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
60267-2
|
Influenza virus C RNA [Presence] in Isolate by NAA with probe detection |
|
62860-2
|
Influenza virus C RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41754-3
|
Fludrocortisone [Mass/volume] in Serum or Plasma |
|
46949-4
|
Fludrocortisone [Mass/volume] in Urine |
|
85526-2
|
Influenza virus D PB2 gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90885-5
|
Influenza virus D RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
79546-8
|
Fluid intake enteral tube nutritional formula [Volume] Measured |
|
75301-2
|
Fluid intake 24 hour Estimated |
|
81951-6
|
Fluid intake 24 hour Measured |
|
80475-7
|
Fluid intake enteral tube nutritional formula composition |
|
80477-3
|
Fluid intake enteral tube nutritional formula volume 24 hour |
|
79548-4
|
Fluid intake total intraoperative [Volume] Measured |
|
61148-3
|
Fluid management note |
|
75291-5
|
Fluid need 24 hour Estimated |
|
79553-4
|
Fluid output emesis [#] |
|
79561-7
|
Fluid output enteral tube [Volume] Measured |
|
79559-1
|
Fluid output gastrointestinal drain [Volume] Measured |
|
79560-9
|
Fluid output gastrointestinal ostomy [Volume] Measured |
|
79557-5
|
Fluid output musculoskeletal drain [Volume] Measured |
|
79556-7
|
Fluid output neurological drain [Volume] Measured |
|
73704-9
|
Fluid output.nasogastric tube Measured |
|
79558-3
|
Fluid output pressure injury [Volume] Measured |
|
79555-9
|
Fluid output total intraoperative [Volume] Measured |
|
79549-2
|
Urine output measured by nephrostomy |
|
80523-4
|
Urine output by Uroflowmetry |
|
55678-7
|
Flumequine [Susceptibility] by Gradient strip |
|
55677-9
|
Flumequine [Susceptibility] by Disk diffusion (KB) |
|
55675-3
|
Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55676-1
|
Flumequine [Susceptibility] |
|
41755-0
|
Flunisolide [Mass/volume] in Serum or Plasma |
|
46950-2
|
Flunisolide [Mass/volume] in Urine |
|
3640-0
|
Flunitrazepam [Mass/volume] in Blood |
|
19469-6
|
Flunitrazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19468-8
|
Flunitrazepam cutoff [Mass/volume] in Urine for Screen method |
|
4258-0
|
Flunitrazepam [Mass] of Dose |
|
61078-2
|
Flunitrazepam [Presence] in Gastric fluid |
|
87812-4
|
Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
50966-1
|
Flunitrazepam [Presence] in Serum, Plasma or Blood |
|
73828-6
|
Flunitrazepam [Mass/volume] in Serum, Plasma or Blood |
|
23864-2
|
Flunitrazepam [Mass/volume] in Serum or Plasma |
|
25412-8
|
Flunitrazepam [Moles/volume] in Serum or Plasma |
|
20528-6
|
Flunitrazepam [Mass/volume] in Urine by Confirmatory method |
|
41020-9
|
Flunitrazepam [Presence] in Urine |
|
19467-0
|
Flunitrazepam [Presence] in Urine by Confirmatory method |
|
19466-2
|
Flunitrazepam [Presence] in Urine by Screen method |
|
3641-8
|
Flunitrazepam [Mass/volume] in Urine |
|
61079-0
|
Flunitrazepam [Presence] in Unspecified specimen |
|
5651-5
|
Fluoride [Mass/time] in 24 hour Urine |
|
25912-7
|
Fluoride [Moles/volume] in 24 hour Urine |
|
25413-6
|
Fluoride [Moles/time] in 24 hour Urine |
|
5648-1
|
Fluoride [Mass/volume] in Blood |
|
25172-8
|
Fluoride [Moles/volume] in Blood |
|
16871-6
|
Fluoride [Units/volume] in Bone |
|
12601-1
|
Fluoride [Mass/volume] in Dialysis fluid |
|
39355-3
|
Cholinesterase.fluoride inhibited/Cholinesterase in Serum or Plasma |
|
72568-9
|
Cholinesterase.fluoride inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
|
81081-2
|
Fluoride intake 24 hour Estimated |
|
80984-8
|
Fluoride intake 24 hour Measured |
|
5649-9
|
Fluoride [Mass/volume] in Serum or Plasma |
|
14726-4
|
Fluoride [Moles/volume] in Serum or Plasma |
|
5650-7
|
Fluoride [Mass/volume] in Urine |
|
34304-6
|
Fluoride [Moles/volume] in Urine |
|
9471-4
|
Fluoride [Mass/volume] in Water |
|
25913-5
|
Fluoride/Creatinine [Molar ratio] in 24 hour Urine |
|
13475-9
|
Fluoride/Creatinine [Mass Ratio] in Urine |
|
56656-2
|
Fluoride/Creatinine [Ratio] in Urine |
|
50850-7
|
Fluoride/Creatinine [Molar ratio] in Urine |
|
80991-3
|
Fluoroscopy [Energy/mass] dose |
|
80990-5
|
Fluoroscopy duration |
|
16872-4
|
Fluorocarbons [Identifier] in Serum or Plasma |
|
41756-8
|
Fluorometholone [Mass/volume] in Serum or Plasma |
|
46951-0
|
Fluorometholone [Mass/volume] in Urine |
|
4259-8
|
Fluorouracil [Mass] of Dose |
|
3642-6
|
Fluorouracil [Mass/volume] in Serum or Plasma |
|
19473-8
|
FLUoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19472-0
|
FLUoxetine cutoff [Mass/volume] in Urine for Screen method |
|
4260-6
|
FLUoxetine [Mass] of Dose |
|
29219-3
|
FLUoxetine [Mass/volume] in Body fluid |
|
14727-2
|
FLUoxetine [Presence] in Gastric fluid |
|
59903-5
|
FLUoxetine [Moles/volume] in Gastric fluid |
|
73375-8
|
FLUoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73374-1
|
FLUoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3643-4
|
FLUoxetine [Presence] in Serum or Plasma |
|
35610-5
|
FLUoxetine [Mass/volume] in Serum or Plasma by Screen method |
|
3644-2
|
FLUoxetine [Mass/volume] in Serum or Plasma |
|
14728-0
|
FLUoxetine [Moles/volume] in Serum or Plasma |
|
74982-0
|
FLUoxetine [Mass/volume] in Serum or Plasma --trough |
|
20529-4
|
FLUoxetine [Mass/volume] in Urine by Confirmatory method |
|
3645-9
|
FLUoxetine [Presence] in Urine |
|
19471-2
|
FLUoxetine [Presence] in Urine by Confirmatory method |
|
19470-4
|
FLUoxetine [Presence] in Urine by Screen method |
|
12439-6
|
FLUoxetine [Mass/volume] in Urine |
|
59902-7
|
FLUoxetine [Moles/volume] in Urine |
|
32072-1
|
FLUoxetine [Presence] in Unspecified specimen |
|
60304-3
|
FLUoxetine [Moles/volume] in Unspecified specimen |
|
72813-9
|
FLUoxetine/Creatinine [Mass Ratio] in Urine |
|
10339-0
|
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
|
74948-1
|
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough |
|
23865-9
|
FLUoxetine+Norfluoxetine [Presence] in Urine |
|
3648-3
|
Fluoxymesterone [Mass/time] in 24 hour Urine |
|
4261-4
|
Fluoxymesterone [Mass] of Dose |
|
3646-7
|
Fluoxymesterone [Presence] in Urine |
|
3647-5
|
Fluoxymesterone [Mass/volume] in Urine |
|
4262-2
|
Flupenthixol [Mass] of Dose |
|
34305-3
|
Flupenthixol [Mass/volume] in Serum or Plasma |
|
55538-3
|
Flupenthixol [Moles/volume] in Serum or Plasma |
|
3649-1
|
Flupenthixol [Mass/volume] in Urine |
|
75766-6
|
fluPHENAZine [Presence] in Blood or Urine by Screen method |
|
4263-0
|
fluPHENAZine [Mass] of Dose |
|
59905-0
|
fluPHENAZine [Moles/volume] in Gastric fluid |
|
38899-1
|
fluPHENAZine [Presence] in Serum or Plasma |
|
3650-9
|
fluPHENAZine [Mass/volume] in Serum or Plasma |
|
39477-5
|
fluPHENAZine [Moles/volume] in Serum or Plasma |
|
74934-1
|
fluPHENAZine [Mass/volume] in Serum or Plasma --trough |
|
14070-7
|
fluPHENAZine [Presence] in Urine |
|
3651-7
|
fluPHENAZine [Mass/volume] in Urine |
|
59904-3
|
fluPHENAZine [Moles/volume] in Urine |
|
60305-0
|
fluPHENAZine [Moles/volume] in Unspecified specimen |
|
59675-9
|
Flurazepam [Mass/volume] in Blood by Confirmatory method |
|
59674-2
|
Flurazepam [Mass/volume] in Blood |
|
19477-9
|
Flurazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19476-1
|
Flurazepam cutoff [Mass/volume] in Urine for Screen method |
|
4264-8
|
Flurazepam [Mass] of Dose |
|
59677-5
|
Flurazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59676-7
|
Flurazepam [Mass/volume] in Body fluid |
|
52963-6
|
Flurazepam [Presence] in Gastric fluid |
|
26774-0
|
Flurazepam [Mass/mass] in Hair |
|
26979-5
|
Flurazepam [Mass/mass] in Meconium |
|
87813-2
|
Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
46979-1
|
Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3652-5
|
Flurazepam [Presence] in Serum or Plasma |
|
35611-3
|
Flurazepam [Mass/volume] in Serum or Plasma by Screen method |
|
3653-3
|
Flurazepam [Mass/volume] in Serum or Plasma |
|
14729-8
|
Flurazepam [Moles/volume] in Serum or Plasma |
|
12605-2
|
Flurazepam [Presence] in Stool |
|
27287-2
|
Flurazepam [Mass/mass] in Stool |
|
59679-1
|
Flurazepam [Mass/mass] in Tissue by Confirmatory method |
|
59678-3
|
Flurazepam [Mass/mass] in Tissue |
|
82916-8
|
Flurazepam [Mass/volume] in Serum or Plasma --trough |
|
16231-3
|
Flurazepam [Mass/volume] in Urine by Confirmatory method |
|
3654-1
|
Flurazepam [Presence] in Urine |
|
19475-3
|
Flurazepam [Presence] in Urine by Confirmatory method |
|
19474-6
|
Flurazepam [Presence] in Urine by Screen method |
|
3655-8
|
Flurazepam [Mass/volume] in Urine |
|
26901-9
|
Flurazepam [Mass/volume] in Vitreous fluid |
|
61080-8
|
Flurazepam [Presence] in Unspecified specimen |
|
48950-0
|
Flurazepam [Mass/volume] in Unspecified specimen |
|
77324-2
|
Flurazepam [Moles/volume] in Unspecified specimen |
|
73826-0
|
Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
14730-6
|
Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
|
12428-9
|
Flurbiprofen [Mass/volume] in Serum or Plasma |
|
55539-1
|
Flurbiprofen [Moles/volume] in Serum or Plasma |
|
79445-3
|
Fluspirilene [Mass/volume] in Serum or Plasma |
|
41757-6
|
Fluticasone propionate [Mass/volume] in Serum or Plasma |
|
46952-8
|
Fluticasone propionate [Mass/volume] in Urine |
|
18233-7
|
Influenza virus Ab [Units/volume] in Cerebral spinal fluid |
|
49518-4
|
Influenza virus Ab [Titer] in Serum |
|
54240-7
|
Influenza virus Ag [Presence] in Unspecified specimen |
|
88200-1
|
Influenza virus identified in Cornea or Conjunctiva by Organism specific culture |
|
54242-3
|
Influenza virus identified in Isolate |
|
88568-1
|
Influenza virus identified in Lower respiratory specimen by Organism specific culture |
|
50713-7
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
|
50712-9
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative |
|
54243-1
|
Influenza virus RNA [Identifier] in Unspecified specimen by Probe |
|
6601-9
|
Influenza virus identified in Sputum by Organism specific culture |
|
6602-7
|
Influenza virus identified in Sputum tracheal aspirate by Organism specific culture |
|
6603-5
|
Influenza virus identified in Throat by Organism specific culture |
|
91772-4
|
Influenza virus identified in Upper respiratory specimen by Organism specific culture |
|
54244-9
|
Influenza virus identified in Unspecified specimen |
|
6604-3
|
Influenza virus identified in Unspecified specimen by Organism specific culture |
|
49538-2
|
Influenza virus identified in Unspecified specimen by Shell vial culture |
|
73372-5
|
Fluvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73373-3
|
Fluvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59907-6
|
fluvoxaMINE [Moles/volume] in Gastric fluid |
|
13560-8
|
fluvoxaMINE [Presence] in Serum or Plasma |
|
35612-1
|
fluvoxaMINE [Mass/volume] in Serum or Plasma by Screen method |
|
10988-4
|
fluvoxaMINE [Mass/volume] in Serum or Plasma |
|
32073-9
|
fluvoxaMINE [Moles/volume] in Serum or Plasma |
|
89990-6
|
fluvoxaMINE [Mass/volume] in Urine by Confirmatory method |
|
32074-7
|
fluvoxaMINE [Presence] in Urine |
|
59906-8
|
fluvoxaMINE [Moles/volume] in Urine |
|
32075-4
|
fluvoxaMINE [Presence] in Unspecified specimen |
|
60306-8
|
fluvoxaMINE [Moles/volume] in Unspecified specimen |
|
23105-0
|
Fly larvae identified in Unspecified specimen |
|
10810-0
|
Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |
|
17220-5
|
FMC7 cells/100 cells in Blood |
|
57428-5
|
FMC7 cells/100 cells in Body fluid |
|
21171-4
|
FMC7 cells/100 cells in Unspecified specimen |
|
23106-8
|
Foot and mouth disease virus Ab [Presence] in Serum |
|
23108-4
|
Foot and mouth disease virus Ab [Presence] in Serum by Immunoassay |
|
23109-2
|
Foot and mouth disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23107-6
|
Foot and mouth disease virus Ab [Presence] in Serum by Neutralization test |
|
31827-9
|
Foot and mouth disease virus Ag [Presence] in Throat |
|
23113-4
|
Foot and mouth disease virus Ag [Presence] in Throat by Complement fixation |
|
23111-8
|
Foot and mouth disease virus Ag [Presence] in Throat by Immunoassay |
|
23112-6
|
Foot and mouth disease virus Ag [Presence] in Tissue by Complement fixation |
|
23110-0
|
Foot and mouth disease virus Ag [Presence] in Tissue by Immunoassay |
|
23114-2
|
Foot and mouth disease virus RNA [Presence] in Tissue by Probe |
|
56023-5
|
Foot and mouth disease virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23117-5
|
Foot and mouth disease virus serotype [Identifier] in Serum by Immunoassay |
|
23118-3
|
Foot and mouth disease virus serotype [Identifier] in Serum by Neutralization test |
|
23119-1
|
Foot and mouth disease virus serotype [Identifier] in Tissue by Complement fixation |
|
23116-7
|
Foot and mouth disease virus serotype [Identifier] in Tissue by Immunoassay |
|
23121-7
|
Foot and mouth disease virus serotype [Identifier] in Tissue by NAA with probe detection |
|
23115-9
|
Foot and mouth disease virus serotype [Identifier] in Unspecified specimen by Complement fixation |
|
23120-9
|
Foot and mouth disease virus serotype [Identifier] in Unspecified specimen by Immunoassay |
|
58748-5
|
Functional MR Brain |
|
80583-8
|
Functional MR Brain for motor function |
|
66874-9
|
FMR1 gene activation in Blood by Molecular genetics method |
|
45322-5
|
FMR1 gene allele 2 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
45321-7
|
FMR1 gene allele 1 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
81856-7
|
FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method |
|
21759-6
|
FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
45327-4
|
FMR1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
41107-4
|
FMR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
36913-2
|
FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
36914-0
|
FMR1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
66875-6
|
FMR1 gene methylation/methylated+unmethylated in Blood by Molecular genetics method |
|
66876-4
|
FMR1 gene premutation/premutation+full mutation in Blood by Molecular genetics method |
|
64081-3
|
FMRP cells/100 lymphocytes in Blood by Immune stain |
|
93007-3
|
Finger-nose-finger - left |
|
93006-5
|
Finger-nose-finger - left+right mean [Score] |
|
93008-1
|
Finger-nose-finger - right |
|
85327-5
|
Foci [#] in Breast cancer specimen by Light microscopy |
|
85320-0
|
Foci [Type] in Breast cancer specimen by Light microscopy |
|
46736-5
|
Fatty acid oxidation defects newborn screen interpretation |
|
57709-8
|
Fatty acid oxidation defects newborn screening comment-discussion |
|
79574-0
|
Folate and tryptophan and metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
27088-4
|
Folate [Presence] in Blood |
|
14903-9
|
Folate [Interpretation] in Blood |
|
2282-2
|
Folate [Mass/volume] in Blood |
|
25415-1
|
Folate [Moles/volume] in Blood |
|
55859-3
|
Folate [Mass/volume] in Cerebral spinal fluid |
|
2283-0
|
Folate [Mass/volume] in Red Blood Cells |
|
14731-4
|
Folate [Moles/volume] in Red Blood Cells |
|
2284-8
|
Folate [Mass/volume] in Serum or Plasma |
|
35210-4
|
Folate [Mass or Moles/volume] in Serum or Plasma |
|
14732-2
|
Folate [Moles/volume] in Serum or Plasma |
|
49264-5
|
Folate+Cyanocobalamin [Interpretation] in Serum or Blood Narrative |
|
14733-0
|
Folate+Cyanocobalamin [Interpretation] in Serum or Blood |
|
42704-7
|
Follicle Diameter baseline US |
|
11793-7
|
Follicle Diameter US |
|
44956-1
|
Following registry NPI [Identifier] Cancer registry |
|
78028-8
|
Follow-up attempt outcome [NHCS] |
|
74217-1
|
Fondaparinux [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
74216-3
|
Fondaparinux [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
49060-7
|
Fondaparinux [Mass/volume] in Serum or Plasma |
|
31172-0
|
Fonofos [Mass/volume] in Blood |
|
35486-0
|
Fonofos [Mass/volume] in Serum or Plasma |
|
21280-3
|
Fonofos [Mass/volume] in Urine |
|
87662-3
|
Fonofos [Mass/mass] in Unspecified specimen |
|
82547-1
|
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Presence] in Serum by Multidisk |
|
82549-7
|
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Units/volume] in Serum by Multidisk |
|
82548-9
|
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
71374-3
|
Food Allergen Mix 51 (Carrot+Tomato+Mustard+Potato+Garlic) IgE Ab [Units/volume] in Serum by Multidisk |
|
15220-7
|
Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
15223-1
|
Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk |
|
23794-1
|
Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
24496-2
|
Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
24149-7
|
Food Allergen Mix D (Cauliflower+Cabbage+Brussel sprouts+Broccoli) IgG Ab [Units/volume] in Serum by Multidisk |
|
15222-3
|
Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
75006-7
|
Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
15221-5
|
Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
15226-4
|
Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk |
|
15247-0
|
Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk |
|
15217-3
|
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
|
46708-4
|
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk |
|
82050-6
|
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15241-3
|
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
|
82052-2
|
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82051-4
|
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15242-1
|
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
46711-8
|
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
82095-1
|
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15243-9
|
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk |
|
82054-8
|
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Units/volume] in Serum by Multidisk |
|
82053-0
|
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15244-7
|
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk |
|
69931-4
|
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Units/volume] in Serum by Multidisk |
|
82055-5
|
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15245-4
|
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
|
75005-9
|
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk |
|
82056-3
|
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15246-2
|
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
|
69958-7
|
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
|
82057-1
|
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
31006-0
|
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Presence] in Serum by Multidisk |
|
82059-7
|
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Units/volume] in Serum by Multidisk |
|
82058-9
|
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
34392-1
|
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Presence] in Serum by Multidisk |
|
46714-2
|
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
|
82096-9
|
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15248-8
|
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk |
|
73711-4
|
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Units/volume] in Serum by Multidisk |
|
82060-5
|
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15249-6
|
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
|
73717-1
|
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk |
|
82061-3
|
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15218-1
|
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
|
46712-6
|
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Units/volume] in Serum by Multidisk |
|
24487-1
|
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15250-4
|
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
46713-4
|
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
24482-2
|
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15251-2
|
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
|
82098-5
|
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
|
82097-7
|
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15252-0
|
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk |
|
46707-6
|
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk |
|
82099-3
|
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
31007-8
|
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
|
46710-0
|
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82062-1
|
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
31008-6
|
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Presence] in Serum by Multidisk |
|
50655-0
|
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Units/volume] in Serum by Multidisk |
|
82063-9
|
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
31009-4
|
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Multidisk |
|
50657-6
|
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
82004-3
|
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab RAST class [Presence] in Serum |
|
82580-2
|
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Presence] in Serum by Multidisk |
|
82582-8
|
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
82581-0
|
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
34394-7
|
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Presence] in Serum by Multidisk |
|
50651-9
|
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Units/volume] in Serum by Multidisk |
|
82064-7
|
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
34395-4
|
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
50656-8
|
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82065-4
|
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
34393-9
|
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Presence] in Serum by Multidisk |
|
50652-7
|
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk |
|
82066-2
|
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15219-9
|
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
52972-7
|
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
82069-6
|
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
50026-4
|
Food Allergen Mix 30 (Peanut+White bean+Soybean+Lentil+ Peas) IgE Ab [Units/volume] in Serum by Multidisk |
|
82577-8
|
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Presence] in Serum by Multidisk |
|
82579-4
|
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Units/volume] in Serum by Multidisk |
|
82578-6
|
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82550-5
|
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Presence] in Serum by Multidisk |
|
82552-1
|
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Units/volume] in Serum by Multidisk |
|
82551-3
|
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
63199-4
|
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk |
|
56331-2
|
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG4 Ab [Mass/volume] in Serum |
|
63151-5
|
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum by Multidisk |
|
23801-4
|
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
30187-9
|
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
24484-8
|
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82553-9
|
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
82555-4
|
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
82554-7
|
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15253-8
|
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk |
|
47302-5
|
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
82070-4
|
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
31010-2
|
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Presence] in Serum by Multidisk |
|
73712-2
|
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Units/volume] in Serum by Multidisk |
|
82071-2
|
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15224-9
|
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk |
|
73714-8
|
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Units/volume] in Serum by Multidisk |
|
82072-0
|
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15225-6
|
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk |
|
82074-6
|
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Units/volume] in Serum by Multidisk |
|
82073-8
|
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15227-2
|
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk |
|
51828-2
|
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Units/volume] in Serum |
|
82076-1
|
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82557-0
|
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
82559-6
|
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Units/volume] in Serum |
|
82558-8
|
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82560-4
|
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
|
82562-0
|
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk |
|
82561-2
|
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82563-8
|
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Presence] in Serum by Multidisk |
|
82565-3
|
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk |
|
82564-6
|
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15254-6
|
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk |
|
82078-7
|
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Units/volume] in Serum by Multidisk |
|
82077-9
|
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15255-3
|
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk |
|
82080-3
|
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Units/volume] in Serum by Multidisk |
|
82079-5
|
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
75004-2
|
Food Allergen Mix fp73 (Beef+Chicken+Pork+Lamb) IgE Ab [Units/volume] in Serum by Multidisk |
|
24163-8
|
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Presence] in Serum by Multidisk |
|
69922-3
|
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Units/volume] in Serum by Multidisk |
|
82075-3
|
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
75002-6
|
Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk |
|
75003-4
|
Food Allergen Mix 7A (Peanut+Cow milk+Egg white+Soybean+Wheat+Rice) IgE Ab [Units/volume] in Serum by Multidisk |
|
48294-3
|
Food colorant mix I triggered leukotriene release [Mass/volume] by Leukocytes |
|
48295-0
|
Food colorant mix II triggered leukotriene release [Mass/volume] by Leukocytes |
|
88124-3
|
Food insecurity risk [HVS] |
|
89567-2
|
Food insecurity status [CUBS] |
|
86954-5
|
Foreign material [Presence] in Food |
|
69438-0
|
Forensic medicine Referral note |
|
80568-9
|
Form |
|
70157-3
|
Form sections completed Provider |
|
57219-8
|
Formal pain assessment using standardized tool [CMS Assessment] |
|
38700-1
|
Formaldehyde [Mass/volume] in Air |
|
7322-1
|
Formaldehyde triggered histamine release [Units/volume] in Blood |
|
5652-3
|
Formaldehyde [Mass/volume] in Blood |
|
43159-3
|
Formaldehyde [Mass/volume] in Nonbiological fluid |
|
6119-2
|
Formaldehyde IgE Ab [Units/volume] in Serum |
|
15718-0
|
Formaldehyde IgE Ab RAST class [Presence] in Serum |
|
13180-5
|
Formaldehyde IgG Ab [Units/volume] in Serum |
|
13190-4
|
Formaldehyde IgM Ab [Units/volume] in Serum or Plasma |
|
48189-5
|
Formaldehyde triggered leukotriene release [Mass/volume] by Leukocytes |
|
5653-1
|
Formaldehyde [Mass/volume] in Urine |
|
2291-3
|
Formate [Mass/volume] in Blood |
|
72904-6
|
Formate [Moles/volume] in Blood |
|
79538-5
|
Formate [Moles/volume] in Serum or Plasma by Confirmatory method |
|
2292-1
|
Formate [Mass/volume] in Serum or Plasma |
|
14052-5
|
Formate [Mass/volume] in Urine |
|
79449-5
|
Formate [Moles/volume] in Urine |
|
42905-0
|
Formate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13742-2
|
Formate/Creatinine [Mass Ratio] in Urine |
|
25100-9
|
Formate/Creatinine [Molar ratio] in Urine |
|
16874-0
|
Formate+Formaldehyde [Mass/volume] in Blood |
|
57964-9
|
Formebolone metabolite [Presence] in Urine |
|
53165-7
|
Formiminoglutamate [Moles/volume] in DBS |
|
79628-4
|
Formiminoglutamate [Moles/volume] in Serum or Plasma |
|
79620-1
|
Formiminoglutamate/Creatinine [Molar ratio] in Urine |
|
24418-6
|
Formononetin [Mass/volume] in Serum or Plasma |
|
48020-2
|
Forward primer [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal |
|
43736-8
|
Fosamprenavir [Susceptibility] by Genotype method |
|
42500-9
|
Fosamprenavir [Susceptibility] by Phenotype method |
|
51409-1
|
Fosamprenavir+Ritonavir [Susceptibility] by Genotype method |
|
57965-6
|
Fosamprenavir+Ritonavir [Susceptibility] by Phenotype method |
|
42317-8
|
Foscarnet [Susceptibility] by Genotype method |
|
72834-5
|
Foscarnet [Susceptibility] by Phenotype method |
|
256-8
|
Foscarnet [Susceptibility] |
|
54912-1
|
Fosfomycin IgE Ab [Units/volume] in Serum |
|
35809-3
|
Fosfomycin [Susceptibility] by Gradient strip |
|
35810-1
|
Fosfomycin [Susceptibility] by Disk diffusion (KB) |
|
25653-7
|
Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25596-8
|
Fosfomycin [Susceptibility] |
|
73371-7
|
Fosinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73370-9
|
Fosinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
47408-0
|
Fosphenytoin [Mass/volume] in Serum or Plasma |
|
75615-5
|
Four level triage system [NAMCS] |
|
79817-3
|
Foveal thickness Left retina by OCT |
|
79816-5
|
Foveal thickness Right retina by OCT |
|
19740-0
|
Fox epithelium IgE Ab [Units/volume] in Serum |
|
51552-8
|
Fox epithelium IgE Ab RAST class [Presence] in Serum |
|
14037-6
|
Fox IgE Ab [Units/volume] in Serum |
|
15719-8
|
Fox IgE Ab RAST class [Presence] in Serum |
|
93807-6
|
FOXO1 gene rearrangements in Tissue by FISH |
|
49479-9
|
FOXP3 Ag [Presence] in Tissue by Immune stain |
|
11186-4
|
Foxtail Millet IgE Ab [Units/volume] in Serum |
|
15850-1
|
Foxtail Millet IgE Ab RAST class [Presence] in Serum |
|
33059-7
|
Fluorescence polarization [Presence] in Amniotic fluid |
|
16861-7
|
Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3264-9
|
Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16860-9
|
Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunoassay |
|
2279-8
|
Fibrinopeptide A [Mass/volume] in Peritoneal fluid |
|
38523-7
|
Fibrinopeptide A [Mass/volume] in Urine |
|
16862-5
|
Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3265-6
|
Fibrinopeptide B Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16863-3
|
Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3260-7
|
Fibrinopeptide B beta (1-14) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16864-1
|
Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3261-5
|
Fibrinopeptide B beta (1-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16865-8
|
Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3262-3
|
Fibrinopeptide B beta (15-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16866-6
|
Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3263-1
|
Fibrinopeptide B beta (43-47) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
2278-0
|
Fibrinopeptide B [Mass/volume] in Serum |
|
31390-8
|
Feline panleukopenia virus Ab [Units/volume] in Serum |
|
23737-0
|
Feline panleukopenia virus Ab [Titer] in Serum |
|
24415-2
|
Feline panleukopenia virus Ag [Presence] in Tissue by Immunofluorescence |
|
31391-6
|
Feline panleukopenia virus IgG Ab [Units/volume] in Serum |
|
27332-6
|
Feline panleukopenia virus IgG Ab [Titer] in Serum |
|
31392-4
|
Feline panleukopenia virus IgM Ab [Units/volume] in Serum |
|
27329-2
|
Feline panleukopenia virus IgM Ab [Titer] in Serum |
|
59010-9
|
Fractional excretion of potassium [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
|
49135-7
|
Fractional excretion of sodium [Ratio] in Urine and Serum or Plasma |
|
50057-9
|
Fractional excretion of phosphate [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
|
56925-1
|
Fractional excretion of phosphate [Ratio] in 24 hour Urine and Serum or Plasma |
|
59009-1
|
Fractional excretion of urea [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
|
80958-2
|
Fractional excretion of magnesium [Ratio] in Urine and Serum or Plasma |
|
90264-3
|
Fracture Risk Assessment [FRAX] |
|
64417-9
|
Fragile X protein (FMRP) [Interpretation] in Blood |
|
40746-0
|
Fragments [Presence] in Blood by Automated count |
|
10373-9
|
Fragments [Presence] in Blood by Light microscopy |
|
55679-5
|
Framycetin [Susceptibility] by Gradient strip |
|
259-2
|
Framycetin [Susceptibility] by Disk diffusion (KB) |
|
258-4
|
Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
257-6
|
Framycetin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18926-6
|
Framycetin [Susceptibility] |
|
260-0
|
Framycetin [Susceptibility] by Serum bactericidal titer |
|
88223-3
|
Francisella sp DNA [Presence] in Aspirate by NAA with probe detection |
|
91837-5
|
Francisella sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
80979-8
|
Frataxin [Mass/volume] in Blood |
|
80980-6
|
Frataxin [Mass/volume] in DBS |
|
21760-4
|
FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
81457-4
|
Functional residual capacity --post bronchodilation |
|
81456-6
|
Functional residual capacity --pre bronchodilation |
|
77372-1
|
3-Methoxytyramine.free [Moles/volume] in Serum or Plasma |
|
87499-0
|
3-Methoxytyramine.free [Molar ratio] in Urine |
|
87498-2
|
3-Methoxytyramine.free/Creatinine [Molar ratio] in 24 hour Urine |
|
20824-9
|
Freezing point of Milk |
|
85271-5
|
Frenum involvement site Oral cavity |
|
82290-8
|
Frequency of moderate to vigorous aerobic physical activity |
|
90733-7
|
Frequency of anabolic steroids used to improve muscle mass or strength in past year |
|
82293-2
|
Frequency of bone-strengthening physical activity |
|
90731-1
|
Frequency of creatine used to improve muscle mass or strength in past year |
|
90732-9
|
Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past year |
|
91569-4
|
Frequency of medicine or drug injection with needle during time period with highest use 12 months |
|
82291-6
|
Frequency of muscle-strengthening physical activity |
|
91571-0
|
Frequency of drug injection in past 12 months |
|
82777-4
|
Frequency prescribed Medication |
|
46592-2
|
Frequency of behavior problems [CMS Assessment] |
|
58118-1
|
Frequency of indicator of pain or possible pain in last 5 days [CMS Assessment] |
|
93599-9
|
Frequency of most severe suicidal ideation 1 month [C-SSRS.PCI] |
|
93291-3
|
Frequency of most severe suicidal ideation 1 month [C-SSRS] |
|
93600-5
|
Frequency of most severe suicidal ideation Lifetime [C-SSRS.PCI] |
|
93292-1
|
Frequency of most severe suicidal ideation Lifetime [C-SSRS] |
|
57220-6
|
Frequency of pain interfering with activity or movement [CMS Assessment] |
|
75923-3
|
Fresh gas.air flow Gas delivery system |
|
83367-3
|
Gas delivery system Fresh gas.air flow setting [Flow] |
|
75924-1
|
Fresh gas.nitrous oxide flow Gas delivery system |
|
83369-9
|
Gas delivery system Fresh gas.nitrous oxide flow setting [Flow] |
|
75925-8
|
Fresh gas.oxygen flow Gas delivery system |
|
83370-7
|
Gas delivery system Fresh gas.oxygen flow setting [Flow] |
|
84964-6
|
Friendship Survey - age 18+ - T-score [NIH Toolbox] |
|
84962-0
|
Friendship Survey - national percentile [NIH Toolbox] |
|
84963-8
|
Friendship Survey - scale score age adjusted [NIH Toolbox] |
|
84968-7
|
Friendship Survey - scale score fully adjusted [NIH Toolbox] |
|
84969-5
|
Friendship Survey - unadjusted scale score [NIH Toolbox] |
|
84966-1
|
Friendship Survey version 2.0 - ages 8-17 - T-score [NIH Toolbox] |
|
54428-8
|
Frozen packed erythrocytes given [Volume] |
|
51870-4
|
Frozen erythrocytes given [Volume] |
|
54420-5
|
Frozen erythrocytes newborn units given [#] |
|
54422-1
|
Frozen erythrocytes pediatric units given [#] |
|
2293-9
|
Fructokinase [Enzymatic activity/volume] in Serum |
|
33805-3
|
Fructosamine [Mass/volume] in Serum or Plasma |
|
15069-8
|
Fructosamine [Moles/volume] in Serum or Plasma |
|
53550-0
|
Fructosamine/Protein [Ratio] in Serum or Plasma |
|
48432-9
|
Fructose [Molar amount] in unspecified time Semen |
|
2297-0
|
Fructose [Mass/time] in 24 hour Urine |
|
34307-9
|
Fructose [Moles/volume] in 24 hour Urine |
|
15070-6
|
Fructose [Moles/time] in 24 hour Urine |
|
34194-1
|
Fructose [Mass/volume] in Body fluid |
|
74804-6
|
Fructose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
|
81055-6
|
Fructose intake 24 hour Estimated |
|
81056-4
|
Fructose intake 24 hour Measured |
|
74792-3
|
Fructose.PO [Mass] in Dose |
|
2296-2
|
Fructose [Mass/volume] in Serum |
|
56624-0
|
Fructose [Moles/volume] in Serum |
|
13943-6
|
Fructose [Presence] in Semen |
|
2295-4
|
Fructose [Mass/volume] in Semen |
|
10574-2
|
Fructose [Moles/volume] in Semen |
|
51593-2
|
Fructose [Presence] in Stool |
|
32240-4
|
Fructose [Presence] in Urine |
|
49772-7
|
Fructose [Mass/volume] in Urine |
|
34308-7
|
Fructose [Moles/volume] in Urine |
|
34309-5
|
Fructose/Creatinine [Molar ratio] in Urine |
|
7323-9
|
Fruit IgE Ab [Units/volume] in Serum |
|
80457-5
|
Fruit servings 24 hour Estimated |
|
80458-3
|
Fruit servings 24 hour Measured |
|
25640-4
|
Follitropin [Units/volume] in Serum or Plasma --1.5 hours post 100 ug lutenizing releasing hormone IV |
|
21279-5
|
Follitropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
57098-6
|
Follitropin [Units/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
|
1467-0
|
Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
|
1468-8
|
Follitropin [Mass/volume] in Serum or Plasma --105 minutes post 100 ug lutenizing releasing hormone IV |
|
16873-2
|
Follitropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge |
|
56592-9
|
Follitropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
12661-5
|
Follitropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
57097-8
|
Follitropin [Units/volume] in Serum or Plasma --10 minutes pre dose gonadotropin releasing hormone |
|
47618-4
|
Follitropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV |
|
1469-6
|
Follitropin [Mass/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV |
|
27887-9
|
Follitropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
21275-3
|
Follitropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone |
|
40360-0
|
Follitropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
48108-5
|
Follitropin [Units/volume] in Serum or Plasma --15 minutes pre 100 ug lutenizing releasing hormone IV |
|
25641-2
|
Follitropin [Units/volume] in Serum or Plasma --1 hour post 100 ug lutenizing releasing hormone IV |
|
1470-4
|
Follitropin [Mass/volume] in Serum or Plasma --1 hour post 100 ug lutenizing releasing hormone IV |
|
21276-1
|
Follitropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57099-4
|
Follitropin [Units/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
|
1471-2
|
Follitropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
|
40361-8
|
Follitropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
47619-2
|
Follitropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug lutenizing releasing hormone IV |
|
32586-0
|
Follitropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
12662-3
|
Follitropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
57101-8
|
Follitropin [Units/volume] in Serum or Plasma --20 minutes post dose gonadotropin releasing hormone |
|
40362-6
|
Follitropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
|
15068-0
|
Follitropin [Units] in 24 hour Urine |
|
34306-1
|
Follitropin [Units/volume] in 24 hour Urine by 2nd IRP |
|
27203-9
|
Follitropin [Units/volume] in 24 hour Urine |
|
2287-1
|
Follitropin [Mass/time] in 24 hour Urine |
|
14734-8
|
Follitropin [Moles/time] in 24 hour Urine |
|
25643-8
|
Follitropin [Units/volume] in Serum or Plasma --2 hours post 100 ug lutenizing releasing hormone IV |
|
1472-0
|
Follitropin [Mass/volume] in Serum or Plasma --2 hours post 100 ug lutenizing releasing hormone IV |
|
53147-5
|
Follitropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
21277-9
|
Follitropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
|
40363-4
|
Follitropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
25645-3
|
Follitropin [Units/volume] in Serum or Plasma --30 minutes post 100 ug lutenizing releasing hormone IV |
|
1473-8
|
Follitropin [Mass/volume] in Serum or Plasma --30 minutes post 100 ug lutenizing releasing hormone IV |
|
32316-2
|
Follitropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
57100-0
|
Follitropin [Units/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
|
1474-6
|
Follitropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
|
40364-2
|
Follitropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
56593-7
|
Follitropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
|
12660-7
|
Follitropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
27886-1
|
Follitropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
12663-1
|
Follitropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
1475-3
|
Follitropin [Mass/volume] in Serum or Plasma --45 minutes post 100 ug lutenizing releasing hormone IV |
|
53146-7
|
Follitropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
21278-7
|
Follitropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone |
|
55478-2
|
Follitropin [Units/volume] in Serum or Plasma --4 hours post XXX challenge |
|
1476-1
|
Follitropin [Mass/volume] in Serum or Plasma --75 minutes post 100 ug lutenizing releasing hormone IV |
|
47028-6
|
Follitropin Ag [Presence] in Tissue by Immune stain |
|
32317-0
|
Follitropin [Units/volume] in Serum or Plasma --baseline |
|
1477-9
|
Follitropin [Mass/volume] in Serum or Plasma --baseline |
|
14291-9
|
Follitropin [Moles/volume] in Serum or Plasma --baseline |
|
48570-6
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 10 |
|
48571-4
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 11 |
|
48572-2
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 21 |
|
48573-0
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 3 |
|
70255-5
|
Follitropin IgA Ab [Units/volume] in Serum by Immunoassay |
|
70254-8
|
Follitropin IgG Ab [Units/volume] in Serum by Immunoassay |
|
47856-0
|
Follitropin [Units/volume] in Serum or Plasma --pre 100 ug lutenizing releasing hormone IV |
|
58947-3
|
Follitropin [Units/volume] in Serum or Plasma --pre XXX challenge |
|
1478-7
|
Follitropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
|
40365-9
|
Follitropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
|
65350-1
|
Follitropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
|
83098-4
|
Follitropin [Units/volume] in Serum or Plasma by Immunoassay |
|
20433-9
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP |
|
15067-2
|
Follitropin [Units/volume] in Serum or Plasma |
|
27942-2
|
Follitropin [Mass/volume] in Serum or Plasma |
|
2286-3
|
Follitropin [Moles/volume] in Serum or Plasma |
|
2285-5
|
Follitropin [Moles/volume] in Semen |
|
25642-0
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --1st specimen post XXX challenge |
|
55611-8
|
Follitropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
24417-8
|
Follitropin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50477-9
|
Follitropin [Units/volume] in Serum or Plasma --1st specimen |
|
25644-6
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --2nd specimen post XXX challenge |
|
55610-0
|
Follitropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12664-9
|
Follitropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50478-7
|
Follitropin [Units/volume] in Serum or Plasma --2nd specimen |
|
25646-1
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --3rd specimen post XXX challenge |
|
27865-5
|
Follitropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12665-6
|
Follitropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50479-5
|
Follitropin [Units/volume] in Serum or Plasma --3rd specimen |
|
25647-9
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --4th specimen post XXX challenge |
|
27870-5
|
Follitropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12666-4
|
Follitropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50480-3
|
Follitropin [Units/volume] in Serum or Plasma --4th specimen |
|
25648-7
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --5th specimen post XXX challenge |
|
27868-9
|
Follitropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12667-2
|
Follitropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50481-1
|
Follitropin [Units/volume] in Serum or Plasma --5th specimen |
|
25649-5
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --6th specimen post XXX challenge |
|
27880-4
|
Follitropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
12668-0
|
Follitropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50482-9
|
Follitropin [Units/volume] in Serum or Plasma --6th specimen |
|
25650-3
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --7th specimen post XXX challenge |
|
55612-6
|
Follitropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
12669-8
|
Follitropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50483-7
|
Follitropin [Units/volume] in Serum or Plasma --7th specimen |
|
25651-1
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --8th specimen post XXX challenge |
|
27869-7
|
Follitropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
12670-6
|
Follitropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50484-5
|
Follitropin [Units/volume] in Serum or Plasma --8th specimen |
|
25652-9
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --9th specimen post XXX challenge |
|
27864-8
|
Follitropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
12671-4
|
Follitropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
25639-6
|
Follitropin [Units/volume] in Urine by 2nd IRP |
|
44356-4
|
Follitropin/Creatinine [Mass Ratio] in 24 hour Urine |
|
29155-9
|
Follitropin/Creatinine [Ratio] in 24 hour Urine |
|
13489-0
|
Follitropin/Creatinine [Mass Ratio] in Urine |
|
2290-5
|
Follitropin/Lutropin [Molar ratio] in Serum or Plasma |
|
70041-9
|
FSHB gene c.-211G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
41105-8
|
FSHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35353-2
|
FSHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80715-6
|
FSHR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50211-2
|
Functional shunt volume |
|
28026-3
|
Flexible sigmoidoscopy Study observation Narrative |
|
28027-1
|
Flexible sigmoidoscopy Study observation |
|
3251-6
|
Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutination |
|
30226-5
|
Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma |
|
3252-4
|
Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutination |
|
29991-7
|
Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutination |
|
30009-5
|
Fibrin+Fibrinogen fragments [Mass/volume] in Serum |
|
48592-0
|
Fibrin+Fibrinogen fragments [Titer] in Platelet poor plasma by Latex agglutination |
|
13054-2
|
Fibrin+Fibrinogen fragments [Units/volume] in Urine |
|
31394-0
|
Feline syncytial virus Ab [Units/volume] in Serum |
|
23739-6
|
Feline syncytial virus Ab [Titer] in Serum |
|
83164-4
|
Additional feet past last 10 foot mark [NIH Toolbox] --2M post trial start |
|
32215-6
|
Thyroxine (T4) free index in Serum or Plasma by calculation |
|
57129-9
|
Full newborn screening summary report for display or printing |
|
77258-2
|
Full time equivalent hours of actual nursing staff [NMMDS] |
|
77260-8
|
Full time equivalent hours of budgeted nursing staff [NMMDS] |
|
74581-0
|
Fumarase [Enzymatic activity/mass] in Fibroblast |
|
2302-8
|
Fumarase [Enzymatic activity/volume] in Serum |
|
74580-2
|
Fumarase [Enzymatic activity/mass] in Tissue |
|
75081-0
|
Fumarate [Moles/volume] in Serum or Plasma |
|
26799-7
|
Fumarate [Presence] in Urine |
|
2303-6
|
Fumarate [Mass/volume] in Urine |
|
13743-0
|
Fumarate/Creatinine [Mass Ratio] in Urine |
|
25101-7
|
Fumarate/Creatinine [Molar ratio] in Urine |
|
2304-4
|
Fumarylacetoacetate [Mass/volume] in Serum |
|
87573-2
|
Fumonisin B1 [Mass/mass] in Unspecified specimen |
|
87572-4
|
Fumonisin B2 [Mass/mass] in Unspecified specimen |
|
87571-6
|
Fumonisin B3 [Mass/mass] in Unspecified specimen |
|
20825-6
|
Fumonisin [Mass/mass] in Feed |
|
23742-0
|
Fumonisin [Mass/volume] in Unspecified specimen |
|
77160-0
|
Functional outcome score GOSE |
|
75316-0
|
Functional performance Family member |
|
88020-3
|
Functional capacity NYHA |
|
85073-5
|
Functional cognition [CMS Assessment] |
|
75276-6
|
Functional status [Interpretation] |
|
47420-5
|
Functional status assessment note |
|
44781-3
|
Functional status of graft |
|
89183-8
|
Functional training performed [Identifier] |
|
92556-0
|
Functional training plan to perform [Identifier] |
|
30963-3
|
Funds vaccine purchased with VAERS |
|
79822-3
|
Fundus hypopigmentation Retinal pigment epithelium by Ophthalmoscopy |
|
94133-6
|
Funeral facility address |
|
94132-8
|
Funeral facility name [Identifier] |
|
94135-1
|
Funeral service licensee identifier Facility |
|
91084-4
|
Fungal 18s rRNA gene [Presence] in Dermatologic specimen by NAA with probe detection |
|
91083-6
|
Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection |
|
91085-1
|
Fungal 18s rRNA gene [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91082-8
|
Fungal 18s rRNA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
91088-5
|
Fungal BT2 gene [Presence] in Dermatologic specimen by NAA with probe detection |
|
91087-7
|
Fungal BT2 gene [Presence] in Isolate by NAA with probe detection |
|
91089-3
|
Fungal BT2 gene [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91086-9
|
Fungal BT2 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
91092-7
|
Fungal ITS region [Presence] in Dermatologic specimen by NAA with probe detection |
|
91091-9
|
Fungal ITS region [Presence] in Isolate by NAA with probe detection |
|
91093-5
|
Fungal ITS region [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91090-1
|
Fungal ITS region [Presence] in Unspecified specimen by NAA with probe detection |
|
613-0
|
Fungal strain [Type] in Isolate by Fungus subtyping |
|
76692-3
|
Fungus identified [#/volume] in Mouth by Culture |
|
568-6
|
Fungus identified in Aspirate by Culture |
|
88686-1
|
Fungus identified in Bronchoalveolar lavage by Culture |
|
601-5
|
Fungus identified in Blood by Culture |
|
24009-3
|
Fungus identified in Bronchial specimen by Culture |
|
32809-6
|
Fungus identified in Bronchial specimen by Fungus stain |
|
55318-0
|
Fungus [Presence] in Bronchial specimen by KOH preparation |
|
87981-7
|
Fungus identified in Burn by Culture |
|
19101-5
|
Fungus colony count [#/volume] in Unspecified specimen by Culture |
|
10665-8
|
Fungus colony count [#/volume] in Unspecified specimen by Environmental culture |
|
88143-3
|
Fungus identified in Cornea or Conjunctiva by Culture |
|
569-4
|
Fungus identified in Cerebral spinal fluid by Culture |
|
87978-3
|
Fungus identified in Peritoneal dialysis fluid by Culture |
|
570-2
|
Fungus identified in Body fluid by Culture |
|
33039-9
|
Fungus identified in Body fluid by Fungus stain |
|
87445-3
|
Fungus [Presence] in Food by Culture |
|
41026-6
|
Fungus identified in Genital specimen by Culture |
|
571-0
|
Fungus identified in Hair by Culture |
|
87976-7
|
Fungus identified in Implanted device by Culture |
|
42804-5
|
Fungus identified in Isolate |
|
15378-3
|
Fungus identified in Isolate by Culture |
|
89656-3
|
Fungus identified in Lower respiratory specimen by Culture |
|
572-8
|
Fungus identified in Bone marrow by Culture |
|
88687-9
|
Fungus identified in Mouth by Culture |
|
573-6
|
Fungus identified in Nail by Culture |
|
55306-5
|
Fungus [Presence] in Nail by KOH preparation |
|
76073-6
|
Fungus identified in Nose by Culture |
|
87977-5
|
Fungus identified in Pericardial fluid by Culture |
|
87979-1
|
Fungus identified in Pleural fluid by Culture |
|
574-4
|
Fungus identified in Peritoneal fluid by Culture |
|
87980-9
|
Fungus identified in Sinus by Culture |
|
575-1
|
Fungus identified in Skin by Culture |
|
55303-2
|
Fungus [Presence] in Skin by KOH preparation |
|
576-9
|
Fungus identified in Synovial fluid by Culture |
|
577-7
|
Fungus identified in Sputum by Culture |
|
55304-0
|
Fungus [Presence] in Sputum by KOH preparation |
|
6409-7
|
Fungus identified in Sputum tracheal aspirate by Culture |
|
27414-2
|
Fungus identified in Stool by Culture |
|
578-5
|
Fungus identified in Tissue by Culture |
|
10666-6
|
Fungus identified in Tissue by Fontana-Masson stain |
|
10755-7
|
Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
|
48411-3
|
Fungus identified in Tissue by Immune stain |
|
91812-8
|
Fungus identified in Upper respiratory specimen by Culture |
|
40435-0
|
Fungus identified in Urine by Culture |
|
55307-3
|
Fungus [Presence] in Vaginal fluid by KOH preparation |
|
579-3
|
Fungus identified in Wound by Culture |
|
42805-2
|
Fungus identified in Unspecified specimen |
|
10667-4
|
Fungus identified in Unspecified specimen by Animal inoculation |
|
580-1
|
Fungus identified in Unspecified specimen by Culture |
|
17947-3
|
Fungus # 2 identified in Unspecified specimen by Culture |
|
17948-1
|
Fungus # 3 identified in Unspecified specimen by Culture |
|
17949-9
|
Fungus # 4 identified in Unspecified specimen by Culture |
|
44840-7
|
Fungus # 5 identified in Unspecified specimen by Culture |
|
47291-0
|
Fungus # 6 identified in Unspecified specimen by Culture |
|
47292-8
|
Fungus # 7 identified in Unspecified specimen by Culture |
|
50766-5
|
Fungus # 8 identified in Unspecified specimen by Culture |
|
10668-2
|
Fungus identified in Unspecified specimen by Environmental culture |
|
10669-0
|
Fungus identified in Unspecified specimen by Sticky tape for environmental fungus |
|
21003-9
|
Fungus identified in Unspecified specimen by Fungus stain |
|
39575-6
|
Fungus.microscopic observation [Identifier] in Unspecified specimen by Periodic acid-Schiff stain |
|
51723-5
|
Fungus [Presence] in Unspecified specimen by Organism specific culture |
|
55305-7
|
Fungus [Presence] in Unspecified specimen by KOH preparation |
|
93470-3
|
Furanylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
57966-4
|
Furazabol metabolite [Presence] in Urine |
|
46229-1
|
Furazabol [Mass/volume] in Urine |
|
87794-4
|
Furazolidone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
69574-2
|
Furazolidone [Susceptibility] |
|
85270-7
|
Furcation site Tooth |
|
3658-2
|
Furfenorex [Mass/time] in 24 hour Urine |
|
4265-5
|
Furfenorex [Mass] of Dose |
|
3656-6
|
Furfenorex [Presence] in Urine |
|
3657-4
|
Furfenorex [Mass/volume] in Urine |
|
35589-1
|
Furoate/Creatinine [Mass Ratio] in Urine |
|
73018-4
|
Furosemide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73017-6
|
Furosemide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3662-4
|
Furosemide [Mass/time] in 24 hour Urine |
|
4266-3
|
Furosemide [Mass] of Dose |
|
47108-6
|
Furosemide [Presence] in Gastric fluid |
|
73369-1
|
Furosemide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73368-3
|
Furosemide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3659-0
|
Furosemide [Mass/volume] in Serum or Plasma |
|
55540-9
|
Furosemide [Moles/volume] in Serum or Plasma |
|
3660-8
|
Furosemide [Presence] in Urine |
|
3661-6
|
Furosemide [Mass/volume] in Urine |
|
79492-5
|
Furoylglycine [Moles/volume] in Serum or Plasma |
|
79500-5
|
Furoylglycine/Creatinine [Molar ratio] in Urine |
|
77634-4
|
FUS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
92803-6
|
Fusarium sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
43692-3
|
Fusarium sp IgE Ab RAST class [Presence] in Serum |
|
7015-1
|
Fusidate [Susceptibility] by Gradient strip |
|
263-4
|
Fusidate [Susceptibility] by Disk diffusion (KB) |
|
262-6
|
Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
261-8
|
Fusidate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18927-4
|
Fusidate [Susceptibility] |
|
264-2
|
Fusidate [Susceptibility] by Serum bactericidal titer |
|
69982-7
|
FVC percent change Respiratory system |
|
77726-8
|
Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by FVIII dosing |
|
77725-0
|
Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by vWF dosing |
|
33187-6
|
Fetal body weight growth percentile by method of Arbuckle 1993 female singleton (US) |
|
33188-4
|
Fetal body weight growth percentile by method of Arbuckle 1993 female twins (US) |
|
33186-8
|
Fetal body weight growth percentile by method of Arbuckle 1993 male singleton (US) |
|
33199-1
|
Fetal body weight growth percentile by method of Arbuckle 1993 male twins (US) |
|
80415-3
|
Fetal Body weight growth percentile US+Estimated from Hadlock 1991 |
|
33185-0
|
Fetal body weight growth percentile estimated from gestational age by method of Alexander 1996 (US) |
|
33189-2
|
Fetal body weight growth percentile estimated from gestational age by method of Brenner 1976 (US) |
|
33190-0
|
Fetal body weight growth percentile estimated from gestational age by method of Hadlock 1985 (US) |
|
33184-3
|
Fetal body weight growth percentile estimated from gestational age by method of Williams 1982 (US) |
|
22101-0
|
Avian pox virus Ab [Presence] in Serum |
|
22837-9
|
Avian pox virus Ab [Presence] in Serum by Agglutination |
|
22841-1
|
Avian pox virus Ab [Presence] in Serum by Immunoassay |
|
15451-8
|
Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
22838-7
|
Avian pox virus Ab [Presence] in Serum by Immunofluorescence |
|
22840-3
|
Avian pox virus Ab [Presence] in Serum by Immune stain |
|
22839-5
|
Avian pox virus Ab [Presence] in Serum by Neutralization test |
|
22842-9
|
Avian pox virus DNA [Presence] in Tissue by NAA with probe detection |
|
22843-7
|
Avian pox virus DNA [Presence] in Tissue by Probe |
|
22836-1
|
Avian pox virus [Presence] in Tissue by Electron microscopy |
|
49634-9
|
FXN gene allele 1.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49635-6
|
FXN gene allele 2.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
75392-1
|
FXN gene GAA repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
21762-0
|
FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
41106-6
|
FXN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35298-9
|
FXN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1022-3
|
Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1023-1
|
Fy sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1024-9
|
Fy sup(a) Ab [Presence] in Serum or Plasma |
|
33977-0
|
Fy sup(a) Ab [Titer] in Serum or Plasma |
|
92543-8
|
Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92505-7
|
Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1025-6
|
Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1026-4
|
Fy sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1027-2
|
Fy sup(a) Ag [Presence] on Red Blood Cells |
|
1028-0
|
Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1029-8
|
Fy sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1030-6
|
Fy sup(b) Ab [Presence] in Serum or Plasma |
|
55322-2
|
Fy sup(b) Ab [Titer] in Serum or Plasma |
|
92542-0
|
Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92504-0
|
Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1031-4
|
Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1032-2
|
Fy sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1033-0
|
Fy sup(b) Ag [Presence] on Red Blood Cells |
|
65320-4
|
Fy3 Ab [Presence] in Serum or Plasma |
|
93910-8
|
Fy3 Ag [Presence] on Red Blood Cells |
|
1036-3
|
G Ab [Presence] in Serum or Plasma from Blood product unit |
|
1037-1
|
G Ab [Presence] in Serum or Plasma from Donor |
|
1038-9
|
G Ab [Presence] in Serum or Plasma |
|
1039-7
|
G Ag [Presence] on Red Blood Cells from Blood product unit |
|
1040-5
|
G Ag [Presence] on Red Blood Cells from Donor |
|
1041-3
|
G Ag [Presence] on Red Blood Cells |
|
7333-8
|
Geotrichum candidum IgE Ab [Units/volume] in Serum |
|
15726-3
|
Geotrichum candidum IgE Ab RAST class [Presence] in Serum |
|
6126-7
|
Glycyphagus domesticus IgE Ab [Units/volume] in Serum |
|
15730-5
|
Glycyphagus domesticus IgE Ab RAST class [Presence] in Serum |
|
56264-5
|
Glycyphagus domesticus IgG4 Ab [Mass/volume] in Serum |
|
48231-5
|
Glycyphagus domesticus triggered leukotriene release [Mass/volume] by Leukocytes |
|
63564-9
|
Giardia lamblia Ag and Cryptosporidium parvum Ag and Entamoeba histolytica/dispar Ag [Identifier] in Stool |
|
80683-6
|
Giardia lamblia 18S rRNA [Presence] in Stool by NAA with probe detection |
|
5169-8
|
Giardia lamblia Ab [Units/volume] in Serum |
|
22304-0
|
Giardia lamblia Ab [Titer] in Serum |
|
9524-0
|
Giardia lamblia Ab [Titer] in Serum by Immunofluorescence |
|
34470-5
|
Giardia lamblia Ag [Presence] in Bile fluid |
|
31831-1
|
Giardia lamblia Ag [Presence] in Stool --2nd specimen |
|
21302-5
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay --2nd specimen |
|
31832-9
|
Giardia lamblia Ag [Presence] in Stool --3rd specimen |
|
21303-3
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay --3rd specimen |
|
31830-3
|
Giardia lamblia Ag [Presence] in Stool |
|
6412-1
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay |
|
91676-7
|
Giardia lamblia Ag [Presence] in Stool by Rapid immunoassay |
|
14210-9
|
Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
|
16899-7
|
Giardia lamblia Ag [Presence] in Unspecified specimen |
|
6413-9
|
Giardia lamblia Ag [Presence] in Unspecified specimen by Immunoassay |
|
23744-6
|
Giardia lamblia Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
82208-0
|
Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection |
|
92687-3
|
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection |
|
60544-4
|
Giardia lamblia DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
9658-6
|
Giardia lamblia IgA Ab [Units/volume] in Serum |
|
22305-7
|
Giardia lamblia IgA Ab [Titer] in Serum |
|
21300-9
|
Giardia lamblia IgA Ab [Titer] in Serum by Immunofluorescence |
|
51761-5
|
Giardia lamblia IgA and IgG and IgM [Interpretation] in Serum or Plasma |
|
41154-6
|
Giardia lamblia IgG Ab [Presence] in Serum |
|
40713-0
|
Giardia lamblia IgG Ab [Presence] in Serum by Immunoassay |
|
7891-5
|
Giardia lamblia IgG Ab [Units/volume] in Serum |
|
22306-5
|
Giardia lamblia IgG Ab [Titer] in Serum |
|
6411-3
|
Giardia lamblia IgG Ab [Titer] in Serum by Immunofluorescence |
|
41153-8
|
Giardia lamblia IgM Ab [Presence] in Serum |
|
40714-8
|
Giardia lamblia IgM Ab [Presence] in Serum by Immunoassay |
|
7892-3
|
Giardia lamblia IgM Ab [Units/volume] in Serum |
|
22307-3
|
Giardia lamblia IgM Ab [Titer] in Serum |
|
21301-7
|
Giardia lamblia IgM Ab [Titer] in Serum by Immunofluorescence |
|
10670-8
|
Giardia lamblia [Presence] in Stool by Organism specific culture |
|
48064-0
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool |
|
48063-2
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
|
48062-4
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence |
|
49233-0
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes |
|
51912-4
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool --2nd specimen |
|
51911-6
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool --3rd specimen |
|
48060-8
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool |
|
48059-0
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
|
48061-6
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence |
|
49232-2
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Rapid, less than 30 minutes |
|
16898-9
|
Giardia lamblia 65 Ag [Presence] in Stool |
|
87242-4
|
Geobacillus stearothermophilus [Presence] in Laboratory device by Culture |
|
74668-5
|
Gardnerella vaginalis DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
92698-0
|
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe |
|
54143-3
|
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
69936-3
|
Gardnerella vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
21284-5
|
Gardnerella vaginalis [Presence] in Genital specimen by Organism specific culture |
|
6410-5
|
Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe |
|
90275-9
|
Gardnerella vaginalis [Presence] in Vaginal fluid by Organism specific culture |
|
43398-7
|
Gardnerella vaginalis+Prevotella sp morphotypes [Presence] in Vaginal fluid by Light microscopy |
|
36909-0
|
G0+G1 phase cells/100 cells in Blood |
|
35692-3
|
G0+G1 phase cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
53966-8
|
Erythrocytes.dysmorphic G1/100 erythrocytes in Urine sediment by Light microscopy |
|
31118-3
|
G2+M phase cells/100 cells in Unspecified specimen |
|
32779-1
|
Glucose-6-Phosphatase [Enzymatic activity/volume] in Red Blood Cells |
|
2354-9
|
Glucose-6-Phosphatase [Enzymatic activity/volume] in Serum |
|
2355-6
|
Glucose-6-Phosphatase [Enzymatic activity/mass] in Tissue |
|
49862-6
|
G6PC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49502-8
|
Glucose-6-Phosphate dehydrogenase [Entitic Catalytic Activity] in Blood |
|
71593-8
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/substance] in Red Blood Cells |
|
33287-4
|
Glucose-6-Phosphate dehydrogenase [Presence] in DBS |
|
58089-4
|
Glucose-6-Phosphate dehydrogenase newborn screen interpretation |
|
21680-4
|
G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21681-2
|
G6PD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
58090-2
|
Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion |
|
42319-4
|
Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells |
|
49266-0
|
Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells Narrative |
|
49925-1
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by Glock and McLean |
|
2356-4
|
Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells |
|
49926-9
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by WHO method |
|
2357-2
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
32546-4
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
|
2358-0
|
Glucose-6-Phosphate dehydrogenase [Presence] in Serum |
|
2359-8
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
|
18228-7
|
Glucose-6-Phosphate dehydrogenase [Presence] in Tissue |
|
2360-6
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Leukocytes |
|
74469-8
|
Glucose-6-Phosphate dehydrogenase/Pyruvate kinase [Ratio] in Blood |
|
18185-9
|
Gestational age |
|
49052-4
|
Gestational age in days |
|
49051-6
|
Gestational age in weeks |
|
85719-3
|
Gestational age in weeks--at cessation of pregnancy |
|
81270-1
|
Gestational age in weeks--at onset of illness |
|
46739-9
|
Glutaric acidemia type 1 newborn screen interpretation |
|
46777-9
|
Glutaric acidemia 2/Ethylmalonic Encephalopathy newborn screen interpretation |
|
11884-4
|
Gestational age Estimated |
|
11776-2
|
Gestational age estimation formula Narrative [Bibliographic Citation] Citation |
|
11869-5
|
Gestational age estimation formula Narrative [Equation] Equation |
|
53693-8
|
Gestational age Estimated from conception date |
|
33542-2
|
Gestational age Estimated from FL.Merz 1988 |
|
11885-1
|
Gestational age Estimated from last menstrual period |
|
11886-9
|
Gestational age Estimated from ovulation date |
|
90367-4
|
Gestational age Estimated from physical exam |
|
53695-3
|
Gestational age Estimated from prior assessment |
|
11887-7
|
Gestational age Estimated from selected delivery date |
|
53691-2
|
Gestational age Estimated from patient reported estimated date of conception |
|
11889-3
|
Gestational age estimated from Abdominal circumference on US |
|
33072-0
|
Gestational age estimated from Abdominal circumference on US by Australian Society of Ultrasound Medicine 2000 method |
|
11890-1
|
Gestational age estimated from Abdominal circumference on US by Campbell 1975 method |
|
11891-9
|
Gestational age estimated from Abdominal circumference on US by Hadlock 1982 method |
|
11892-7
|
Gestational age estimated from Abdominal circumference on US by Hadlock 1984 method |
|
33073-8
|
Gestational age estimated from Abdominal circumference on US by Hansmann 1985 method |
|
33537-2
|
Gestational age estimated from Abdominal circumference on US by Jeanty 1982 method |
|
11893-5
|
Gestational age estimated from Abdominal circumference on US by Jeanty 1984 method |
|
33074-6
|
Gestational age estimated from Abdominal circumference on US by Lessoway 1998 method |
|
33075-3
|
Gestational age estimated from Abdominal circumference on US by Merz 1988 method |
|
33076-1
|
Gestational age estimated from Abdominal circumference on US by Shinozuka 1996 method |
|
33077-9
|
Gestational age estimated from Anterior-posterior diameter of the abdomen by method of Lessoway 1998 (US) |
|
11894-3
|
Gestational age estimated from area corrected Biparietal circumference (US) |
|
33078-7
|
Gestational age estimated from AXT by method of Shinozuka 1996 (US) |
|
11895-0
|
Gestational age estimated from Binocular distance on US |
|
33545-5
|
Gestational age estimated from Binocular distance on US by Jeanty 1982 method |
|
11896-8
|
Gestational age estimated from Binocular distance on US by Jeanty 1984 method |
|
11897-6
|
Gestational age estimated from Biparietal circumference (US) |
|
11898-4
|
Gestational age estimated from Biparietal diameter on US |
|
33079-5
|
Gestational age estimated from Biparietal diameter on US by Australian Society of Ultrasound Medicine 1989 method |
|
11899-2
|
Gestational age estimated from Biparietal diameter on US by Campbell 1975 method |
|
11900-8
|
Gestational age estimated from Biparietal diameter on US by Doubilet 1993 method |
|
11901-6
|
Gestational age estimated from Biparietal diameter on US by Hadlock 1982 method |
|
11902-4
|
Gestational age estimated from Biparietal diameter on US by Hadlock 1984 method |
|
11903-2
|
Gestational age estimated from Biparietal diameter on US by Hansmann 1985 method |
|
33538-0
|
Gestational age estimated from Biparietal diameter on US by Hansmann 1986 method |
|
11904-0
|
Gestational age estimated from Biparietal diameter on US by Hobbins 1983 method |
|
33539-8
|
Gestational age estimated from Biparietal diameter on US by Jeanty 1982 method |
|
11905-7
|
Gestational age estimated from Biparietal diameter on US by Jeanty 1984 method |
|
11906-5
|
Gestational age estimated from Biparietal diameter on US by Kurtz 1980 method |
|
33080-3
|
Gestational age estimated from Biparietal diameter on US by Lessoway 1998 method |
|
33081-1
|
Gestational age estimated from Biparietal diameter on US by Merz 1988 method |
|
33082-9
|
Gestational age estimated from Biparietal diameter on US by Osaka 1989 method |
|
33083-7
|
Gestational age estimated from Biparietal diameter on US by Rempen 1991 method |
|
11907-3
|
Gestational age estimated from Biparietal diameter on US by Sabbagha 1978 method |
|
33084-5
|
Gestational age estimated from Biparietal diameter on US by Shinozuka 1996 method |
|
33085-2
|
Gestational age estimated from Biparietal diameter on US by Tokyo 1986 method |
|
11908-1
|
Gestational age estimated from Cerebellar diameter by method of Goldstein 1987 (US) |
|
33088-6
|
Gestational age estimated from clavicle length by method of Yarkoni 1985 (US) |
|
11909-9
|
Gestational age estimated from Crown rump length on US |
|
33090-2
|
Gestational age estimated from Crown rump length on US by Australian Society of Ultrasound Medicine 2000 method |
|
33089-4
|
Gestational age estimated from Crown rump length on US by Australian Society of Ultrasound Medicine 1991 method |
|
33091-0
|
Gestational age estimated from Crown rump length on US by Daya 1993 method |
|
11910-7
|
Gestational age estimated from Crown rump length on US by Hadlock 1992 method |
|
11911-5
|
Gestational age estimated from Crown rump length on US by Hansmann 1985 method |
|
33540-6
|
Gestational age estimated from Crown rump length on US by Hansmann 1986 method |
|
33092-8
|
Gestational age estimated from Crown rump length on US by Jeanty 1982 method |
|
11912-3
|
Gestational age estimated from Crown rump length on US by Jeanty 1984 method |
|
11913-1
|
Gestational age estimated from Crown rump length on US by Nelson 1981 method |
|
33093-6
|
Gestational age estimated from Crown rump length on US by Osaka 1989 method |
|
33094-4
|
Gestational age estimated from Crown rump length on US by Rempen 1991 method |
|
11914-9
|
Gestational age estimated from Crown rump length on US by Robinson 1975 method |
|
33095-1
|
Gestational age estimated from Crown rump length on US by Shinozuka 1996 method |
|
33096-9
|
Gestational age estimated from Crown rump length on US by Tokyo 1986 method |
|
11915-6
|
Gestational age estimated from Crown rump length on US by Yeh 1988 method |
|
11916-4
|
Gestational age estimated from Fibula length (US) |
|
33097-7
|
Gestational age estimated from Fibula length by method of Jeanty 1983 (US) |
|
11917-2
|
Gestational age estimated from Fibula length by method of Jeanty 1984 (US) |
|
11918-0
|
Gestational age estimated from Fibula length by method of Merz 1987 (US) |
|
11919-8
|
Gestational age estimated from Femur length on US |
|
33098-5
|
Gestational age estimated from Femur length on US by Chitty 1997 method |
|
11920-6
|
Gestational age estimated from Femur length on US by Hadlock 1984 method |
|
11921-4
|
Gestational age estimated from Femur length on US by Hansmann 1985 method |
|
33541-4
|
Gestational age estimated from Femur length on US by Hansmann 1986 method |
|
11922-2
|
Gestational age estimated from Femur length on US by Hohler 1982 method |
|
33099-3
|
Gestational age estimated from Femur length on US by Jeanty 1982 method |
|
11923-0
|
Gestational age estimated from Femur length on US by Jeanty 1984 method |
|
33100-9
|
Gestational age estimated from Femur length on US by Lessoway 1998 method |
|
11926-3
|
Gestational age estimated from Foot length on US by Mercer 1987 method |
|
11924-8
|
Gestational age estimated from Femur length on US by Merz 1987 method |
|
11925-5
|
Gestational age estimated from Femur length on US by Obrien 1982 method |
|
33101-7
|
Gestational age estimated from Femur length on US by Osaka 1989 method |
|
33102-5
|
Gestational age estimated from Femur length on US by Shinozuka 1996 method |
|
33103-3
|
Gestational age estimated from Femur length on US by Tokyo 1986 method |
|
33138-9
|
Gestational age estimated from Fetal trunk area by method of Osaka 1989 (US) |
|
11927-1
|
Gestational age estimated from Gestational sac diameter on US |
|
33104-1
|
Gestational age estimated from Gestational sac diameter on US by Daya 1991 method |
|
33106-6
|
Gestational age estimated from Gestational sac diameter on US by Hansmann 1982 method |
|
11928-9
|
Gestational age estimated from Gestational sac diameter on US by Hellman 1969 method |
|
11929-7
|
Gestational age estimated from Gestational sac diameter on US by Rempen 1991 method |
|
33108-2
|
Gestational age estimated from Gestational sac diameter on US by Tokyo 1986 method |
|
33105-8
|
Gestational age estimated from Gestational sac length on US by Hansmann 1979 method |
|
33107-4
|
Gestational age estimated from Gestational sac length on US by Nyberg 1992 method |
|
11930-5
|
Gestational age estimated from Head circumference on US |
|
33111-6
|
Gestational age estimated from Head circumference derived on US by Chitty 1997 method |
|
33110-8
|
Gestational age estimated from Head circumference measured on US by Chitty 1997 method |
|
33109-0
|
Gestational age estimated from Head circumference on US by Australian Society of Ultrasound Medicine 2000 method |
|
11931-3
|
Gestational age estimated from Head circumference on US by Hadlock 1982 method |
|
11932-1
|
Gestational age estimated from Head circumference on US by Hadlock 1984 method |
|
33112-4
|
Gestational age estimated from Head circumference on US by Hansmann 1985 method |
|
33543-0
|
Gestational age estimated from Head circumference on US by Hansmann 1986 method |
|
11933-9
|
Gestational age estimated from Head circumference on US by Hoffbauer 1979 method |
|
11934-7
|
Gestational age estimated from Head circumference on US by Jeanty 1984 method |
|
33113-2
|
Gestational age estimated from Head circumference on US by Jeanty 1982 method |
|
33114-0
|
Gestational age estimated from Head circumference on US by Lessoway 1998 method |
|
33115-7
|
Gestational age estimated from Head circumference on US by Merz 1988 method |
|
11935-4
|
Gestational age estimated from Humerus length on US |
|
33116-5
|
Gestational age estimated from Humerus length on US by Australian Society of Ultrasound Medicine 2000 method |
|
11936-2
|
Gestational age estimated from Humerus length on US by Jeanty 1984 method |
|
11937-0
|
Gestational age estimated from Humerus length on US by Merz 1987 method |
|
33117-3
|
Gestational age estimated from Humerus length on US by Osaka 1989 method |
|
33122-3
|
Gestational age estimated from Inter ocular distance on US by Mayden 1982 method |
|
33123-1
|
Gestational age estimated from Inter ocular distance on US by Trout 1994 method |
|
33118-1
|
Gestational age estimated from length of vertebra by method of Tokyo 1986 (US) |
|
33119-9
|
Gestational age estimated from Occipital-frontal diameter on US by Australian Society of Ultrasound Medicine 2000 method |
|
33544-8
|
Gestational age estimated from Occipital-frontal diameter on US by Hansmann 1985 method |
|
33120-7
|
Gestational age estimated from Occipital-frontal diameter on US by Hansmann 1986 method |
|
33121-5
|
Gestational age estimated from Occipital-frontal diameter on US by Lessoway 1998 method |
|
33086-0
|
Gestational age estimated from Outer-Inner Biparietal diameter on US by Chitty 1997 method |
|
33087-8
|
Gestational age estimated from Outer-Outer Biparietal diameter on US by Chitty 1997 method |
|
33124-9
|
Gestational age estimated from Outer orbital distance on US by Mayden 1982 method |
|
33125-6
|
Gestational age estimated from Outer orbital distance on US by Trout 1994 method |
|
11938-8
|
Gestational age estimated from Radius length (US) |
|
33126-4
|
Gestational age estimated from Radius length by method of Jeanty 1983 (US) |
|
11939-6
|
Gestational age estimated from Radius length by method of Merz 1987 (US) |
|
33127-2
|
Gestational age estimated from Spine length by method of Tokyo 1989 (US) |
|
33128-0
|
Gestational age estimated from Transverse abdominal diameter on US by Eriksen 1985 method |
|
33129-8
|
Gestational age estimated from Transverse abdominal diameter on US by Hansmann 1979 method |
|
33130-6
|
Gestational age estimated from Transverse abdominal diameter on US by Tokyo 1986 method |
|
33131-4
|
Gestational age estimated from Thoracic circumference on US by Chitkara 1987 method |
|
33135-5
|
Gestational age estimated from Thoracic circumference on US by Nimrod 1986 method |
|
33132-2
|
Gestational age estimated from Transverse cerebral diameter on US by Chitty 1994 method |
|
33133-0
|
Gestational age estimated from Transverse cerebral diameter on US by Goldstein 1987 method |
|
33134-8
|
Gestational age estimated from Transverse cerebral diameter on US by Hill 1990 method |
|
11940-4
|
Gestational age estimated from Tibia length on US |
|
11941-2
|
Gestational age estimated from Tibia length on US by Jeanty 1984 method |
|
11942-0
|
Gestational age estimated from Tibia length on US by Merz 1987 method |
|
33136-3
|
Gestational age estimated from Transverse abdominal diameter on US by Hansmann 1985 method |
|
33137-1
|
Gestational age estimated from Transverse abdominal diameter on US by Lessoway 1998 method |
|
11943-8
|
Gestational age estimated from Ulna length (US) |
|
11944-6
|
Gestational age estimated from Ulna length by method of Jeanty 1984 (US) |
|
11945-3
|
Gestational age estimated from Ulna length by method of Merz 1987 (US) |
|
21299-3
|
Gestational age method |
|
33901-0
|
Gestational age of fetus by Amniocentesis |
|
11888-5
|
Gestational age US composite estimate |
|
76516-4
|
Gestational age--at birth |
|
27914-1
|
Gamma aminoadipate [Moles/time] in 24 hour Urine |
|
76034-8
|
GAA gene full mutation analysis in Blood or Tissue by Sequencing |
|
53864-5
|
GAA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
26804-5
|
Gamma aminobutyrate [Presence] in 24 hour Urine |
|
6882-5
|
Gamma aminobutyrate [Mass/time] in 24 hour Urine |
|
25914-3
|
Gamma aminobutyrate [Moles/volume] in 24 hour Urine |
|
25427-6
|
Gamma aminobutyrate [Moles/time] in 24 hour Urine |
|
16887-2
|
Gamma aminobutyrate [Mass/volume] in Amniotic fluid |
|
26861-5
|
Gamma aminobutyrate [Moles/volume] in Amniotic fluid |
|
72422-9
|
Gamma aminobutyrate [Moles/volume] in Blood from Fetus |
|
13615-0
|
Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid |
|
26594-2
|
Gamma aminobutyrate [Moles/volume] in Cerebral spinal fluid |
|
50146-0
|
Gamma aminobutyrate [Moles/volume] in DBS |
|
50147-8
|
Gamma aminobutyrate [Moles/volume] in Body fluid |
|
2317-6
|
Gamma aminobutyrate [Presence] in Serum or Plasma |
|
2318-4
|
Gamma aminobutyrate [Mass/volume] in Serum or Plasma |
|
26609-8
|
Gamma aminobutyrate [Moles/volume] in Serum or Plasma |
|
16882-3
|
Gamma aminobutyrate [Presence] in Urine |
|
2319-2
|
Gamma aminobutyrate [Mass/volume] in Urine |
|
27911-7
|
Gamma aminobutyrate [Moles/volume] in Urine |
|
72420-3
|
Gamma aminobutyrate.free [Moles/volume] in Cerebral spinal fluid |
|
56679-4
|
Gamma aminobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
25915-0
|
Gamma aminobutyrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13695-2
|
Gamma aminobutyrate/Creatinine [Mass Ratio] in Urine |
|
28593-2
|
Gamma aminobutyrate/Creatinine [Ratio] in Urine |
|
26581-9
|
Gamma aminobutyrate/Creatinine [Molar ratio] in Urine |
|
90825-1
|
GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93867-0
|
GABABR Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84931-5
|
GABABR Ab [Presence] in Serum by Immunofluorescence |
|
90826-9
|
GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93426-5
|
GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82984-6
|
GABABR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
93428-1
|
GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding assay immunofluorescent assay |
|
82977-0
|
GABABR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
93425-7
|
GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93427-3
|
GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
73016-8
|
Gabapentin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73015-0
|
Gabapentin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
32589-4
|
Gabapentin [Mass] of Dose |
|
73367-5
|
Gabapentin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73366-7
|
Gabapentin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
87496-6
|
Gabapentin [Presence] in Serum, Plasma or Blood by Screen method |
|
9738-6
|
Gabapentin [Mass/volume] in Serum, Plasma or Blood |
|
25425-0
|
Gabapentin [Moles/volume] in Serum or Plasma |
|
93121-2
|
Gabapentin [Presence] in Tissue by Screen method |
|
74964-8
|
Gabapentin [Mass/volume] in Serum or Plasma --trough |
|
72810-5
|
Gabapentin [Mass/volume] in Urine by Confirmatory method |
|
68439-9
|
Gabapentin [Presence] in Urine |
|
92648-5
|
Gabapentin [Presence] in Urine by Confirmatory method |
|
59680-9
|
Gabapentin [Mass/volume] in Urine |
|
72811-3
|
Gabapentin/Creatinine [Mass Ratio] in Urine |
|
82658-6
|
Glutamate decarboxylase Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82660-2
|
Glutamate decarboxylase Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90829-3
|
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
42501-7
|
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid |
|
53708-4
|
Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid |
|
56540-8
|
Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay |
|
81725-4
|
Glutamate decarboxylase 65 Ab [Presence] in Serum by Line blot |
|
13926-1
|
Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
|
58451-6
|
Glutamate decarboxylase 65 Ab [Mass/volume] in Serum |
|
72523-4
|
Glutamate decarboxylase 65 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
30347-9
|
Glutamate decarboxylase 65 Ab [Moles/volume] in Serum |
|
83004-2
|
Glutamate decarboxylase 65 IgG Ab [Presence] in Serum or Plasma by Line blot |
|
8201-6
|
Gadolinium [Mass/time] in 24 hour Urine |
|
76650-1
|
Gadolinium [Mass/mass] in Hair |
|
80912-9
|
Gadolinium [Mass/volume] in Serum or Plasma |
|
80643-0
|
Gadolinium [Mass/mass] in Tissue |
|
8200-8
|
Gadolinium [Mass/volume] in Urine |
|
93854-8
|
Gadolinium/Creatinine [Mass Ratio] in Urine |
|
74632-1
|
Glycosaminoglycans [Presence] in 24 hour Urine |
|
49268-6
|
Glycosaminoglycans pattern [Interpretation] in Urine Narrative |
|
33474-8
|
Glycosaminoglycans pattern [Interpretation] in Urine |
|
2398-6
|
Glycosaminoglycans [Presence] in Urine |
|
2399-4
|
Glycosaminoglycans [Mass/volume] in Urine |
|
44366-3
|
Glycosaminoglycans/Creatinine [Mass Ratio] in 24 hour Urine |
|
74631-3
|
Glycosaminoglycans/Creatinine [Ratio] in 24 hour Urine |
|
32799-9
|
Glycosaminoglycans/Creatinine [Mass Ratio] in Urine |
|
46132-7
|
Glycosaminoglycans/Creatinine [Ratio] in Urine |
|
44367-1
|
Glycosaminoglycans/Creatinine [Molar ratio] in Urine |
|
23224-9
|
Mareks disease virus Ab [Presence] in Serum |
|
23225-6
|
Mareks disease virus Ab [Presence] in Serum by Immunoassay |
|
23228-0
|
Mareks disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23226-4
|
Mareks disease virus Ab [Presence] in Serum by Immunofluorescence |
|
23227-2
|
Mareks disease virus Ab [Presence] in Serum by Neutralization test |
|
31873-3
|
Mareks disease virus Ag [Presence] in Feather |
|
23230-6
|
Mareks disease virus Ag [Presence] in Feather by Immune diffusion (ID) |
|
31874-1
|
Mareks disease virus Ag [Presence] in Unspecified specimen |
|
23229-8
|
Mareks disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23231-4
|
Mareks disease virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23601-8
|
Mareks disease virus serotype [Identifier] in Tissue by Organism specific culture |
|
52045-2
|
Gait trainers attachment |
|
93015-6
|
Gait and turn and tandem gait assessment |
|
40842-7
|
Galactose 1 phosphate [Mass/volume] in DBS |
|
74879-8
|
Galactose 1 phosphate [Mass/volume] in DBS --post therapeutic diet |
|
2312-7
|
Galactose 1 phosphate [Mass/volume] in Red Blood Cells |
|
33360-9
|
Galactose 1 phosphate [Mass/mass] in Red Blood Cells |
|
38485-9
|
Galactose 1 phosphate [Moles/mass] in Red Blood Cells |
|
20576-5
|
Galactose 1 phosphate uridyl transferase [Presence] in Blood |
|
10970-2
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
|
79460-2
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/substance] in Red Blood Cells |
|
33288-2
|
Galactose 1 phosphate uridyl transferase [Presence] in DBS |
|
42906-8
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS |
|
75094-3
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS --post therapeutic diet |
|
33780-8
|
Galactose 1 phosphate uridyl transferase phenotype [Type] in Blood |
|
2313-5
|
Galactose 1 phosphate uridyl transferase [Presence] in Red Blood Cells |
|
2314-3
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
|
24082-0
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Red Blood Cells |
|
74902-8
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Leukocytes |
|
49333-8
|
Galactitol [Moles/volume] in Amniotic fluid |
|
49773-5
|
Galactitol [Moles/volume] in Serum or Plasma |
|
57967-2
|
Galactitol [Presence] in Urine |
|
47857-8
|
Galactitol/Creatinine [Molar ratio] in Urine |
|
2305-1
|
Galactokinase [Enzymatic activity/volume] in Red Blood Cells |
|
81143-0
|
Galactokinase [Enzymatic activity/mass] in Red Blood Cells |
|
74437-5
|
Galactokinase [Enzymatic activity/mass] in Leukocytes |
|
88555-8
|
Galactomannan Ag [Presence] in Bronchoalveolar lavage |
|
76075-1
|
Galactomannan Ag [Units/volume] in Bronchoalveolar lavage |
|
53865-2
|
Galactomannan Ag [Units/volume] in Cerebral spinal fluid |
|
44357-2
|
Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
44099-0
|
Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay |
|
35383-9
|
Galactomannan Ag [Units/volume] in Serum or Plasma |
|
62467-6
|
Galactomannan Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
35671-7
|
Galactomannan Ag [Units/volume] in Unspecified specimen |
|
80189-4
|
Galactosamine [Moles/volume] in Serum or Plasma |
|
80095-3
|
Galactosamine/Creatinine [Molar ratio] in Urine |
|
1480-3
|
Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO |
|
34310-3
|
Galactose [Moles/volume] in 24 hour Urine |
|
15071-4
|
Galactose [Moles/time] in 24 hour Urine |
|
1481-1
|
Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO |
|
1482-9
|
Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO |
|
1479-5
|
Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO |
|
2306-9
|
Galactose [Presence] in Blood |
|
2307-7
|
Galactose [Mass/volume] in Blood |
|
2311-9
|
Galactose renal clearance in 24 hour Urine and Serum or Plasma |
|
54084-9
|
Galactose [Mass/volume] in DBS |
|
54085-6
|
Galactose [Moles/volume] in DBS |
|
81053-1
|
Galactose intake 24 hour Estimated |
|
81054-9
|
Galactose intake 24 hour Measured |
|
1483-7
|
Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO |
|
75093-5
|
Galactose [Mass/volume] in DBS --post therapeutic diet |
|
4267-1
|
Galactose.PO [Mass] of Dose |
|
49219-9
|
Galactose [Mass/volume] in Red Blood Cells |
|
2308-5
|
Galactose [Mass/volume] in Serum or Plasma |
|
25426-8
|
Galactose [Moles/volume] in Serum or Plasma |
|
51594-0
|
Galactose [Presence] in Stool |
|
2309-3
|
Galactose [Presence] in Urine |
|
2310-1
|
Galactose [Mass/volume] in Urine |
|
34311-1
|
Galactose [Moles/volume] in Urine |
|
13744-8
|
Galactose/Creatinine [Mass Ratio] in Urine |
|
25102-5
|
Galactose/Creatinine [Molar ratio] in Urine |
|
46737-3
|
Galactosemias newborn screen interpretation |
|
57704-9
|
Galactosemias newborn screening comment-discussion |
|
53580-7
|
Galactosylceramidase [Enzymatic activity/mass] in Amniotic fluid cells |
|
62310-8
|
Galactosylceramidase [Enzymatic activity/volume] in DBS |
|
87738-1
|
GALC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
24083-8
|
Galactosylceramidase [Enzymatic activity/mass] in Fibroblast |
|
81843-5
|
GALC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
2315-0
|
Galactosylceramidase [Enzymatic activity/mass] in Tissue |
|
24084-6
|
Galactosylceramidase [Enzymatic activity/mass] in Leukocytes |
|
46773-8
|
Galactose epimerase deficiency newborn screen interpretation |
|
50316-9
|
Galectin 3 Ag [Presence] in Tissue by Immune stain |
|
83099-2
|
Galectin 3 [Mass/volume] in Serum or Plasma by Immunoassay |
|
62419-7
|
Galectin 3 [Mass/volume] in Serum or Plasma |
|
2316-8
|
Galactosylgalactosylglucosylceramidase [Enzymatic activity/mass] in Tissue |
|
80158-9
|
Galactosylhydroxylysine/Creatinine [Molar ratio] in Urine |
|
46772-0
|
Galactokinase deficiency newborn screen interpretation |
|
5168-0
|
Gall canaliculi Ab [Units/volume] in Serum |
|
16881-5
|
Gallium [Mass/volume] in Blood |
|
60076-7
|
Gallium [Mass/volume] in Red Blood Cells |
|
12703-5
|
Gallium [Mass/volume] in Serum or Plasma |
|
5654-9
|
Gallium [Mass/volume] in Urine |
|
20827-2
|
Gallotannin [Mass/mass] in Gastric fluid |
|
20828-0
|
Gallotannin [Mass/mass] in Plant |
|
20826-4
|
Gallotannin [Mass/volume] in Serum or Plasma |
|
88019-5
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in DBS |
|
24095-2
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2649-2
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue |
|
93853-0
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in Urine |
|
24096-0
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
34693-2
|
GALOP Ab [Titer] in Serum or Plasma |
|
42202-2
|
GALOP IgM Ab [Titer] in Serum or Plasma |
|
42940-7
|
GALT gene allele 1 [Presence] in Blood by Molecular genetics method |
|
42941-5
|
GALT gene allele 2 [Presence] in Blood by Molecular genetics method |
|
46771-2
|
Classical galactosemia newborn screen interpretation |
|
76037-1
|
GALT gene full mutation analysis in Blood or Tissue by Sequencing |
|
42318-6
|
GALT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
70248-0
|
GALT gene p.Gln188Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
7530-9
|
Gamble Oak IgE Ab [Units/volume] in Serum |
|
15878-2
|
Gamble Oak IgE Ab RAST class [Presence] in Serum |
|
88376-9
|
Gamithromycin [Susceptibility] by Disk diffusion (KB) |
|
88378-5
|
Gamithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
53593-0
|
Gamma 2 globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
|
53592-2
|
Gamma 2 globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
|
49064-9
|
Gamma 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
53457-8
|
Gamma 3 globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
|
53452-9
|
Gamma 3 globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
|
17817-8
|
Gamma globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
|
77343-2
|
Gamma globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration |
|
34184-2
|
Gamma globulin/Protein.total in 24 hour Urine |
|
13989-9
|
Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
72580-4
|
Gamma globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
|
29899-2
|
Gamma globulin [Presence] in 24 hour Urine |
|
6890-8
|
Gamma globulin [Mass/volume] in 24 hour Urine |
|
9831-9
|
Gamma globulin [Mass/time] in 24 hour Urine |
|
53590-6
|
Gamma globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis |
|
53591-4
|
Gamma globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2873-8
|
Gamma globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
17499-5
|
Gamma globulin [Mass/volume] in Body fluid by Electrophoresis |
|
13977-4
|
Gamma globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
54391-8
|
Gamma globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
17818-6
|
Gamma globulin/Protein.total in Body fluid by Electrophoresis |
|
13983-2
|
Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
15128-2
|
Gamma globulin/Protein.total in Synovial fluid by Electrophoresis |
|
13995-6
|
Gamma globulin/Protein.total in Urine by Electrophoresis |
|
72583-8
|
Gamma globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
|
72582-0
|
Gamma globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis |
|
72581-2
|
Gamma globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
|
2874-6
|
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2875-3
|
Gamma globulin [Mass/volume] in Synovial fluid by Electrophoresis |
|
9745-1
|
Gamma globulin [Mass/volume] in Urine by Electrophoresis |
|
53773-8
|
Gamma globulin [Presence] in Urine by Electrophoresis |
|
40632-2
|
Gamma globulin/Beta globulin [Mass Ratio] in Cerebral spinal fluid by Electrophoresis |
|
71776-9
|
Gamma interferon background [Units/volume] in Blood by Immunoassay |
|
74901-0
|
Gamma tocopherol [Entitic substance] in Red Blood Cells |
|
63370-1
|
Gamma tocopherol [Mass/volume] in Serum or Plasma |
|
59205-5
|
Gamma tocopherol [Moles/volume] in Serum or Plasma |
|
80639-8
|
Gamma-amanitin [Mass/volume] in Urine |
|
49265-2
|
Gammopathy [Interpretation] in Serum by Electrophoresis Narrative |
|
14340-4
|
Gammopathy [Interpretation] in Serum or Plasma by Electrophoresis |
|
60077-5
|
Ganciclovir [Mass/volume] in Blood |
|
72854-3
|
Ganciclovir [Susceptibility] by Genotype method |
|
72861-8
|
Ganciclovir [Susceptibility] by Phenotype method |
|
59798-9
|
Ganciclovir [Mass/volume] in Plasma --peak |
|
15367-6
|
Ganciclovir [Mass/volume] in Serum or Plasma |
|
265-9
|
Ganciclovir [Susceptibility] |
|
59799-7
|
Ganciclovir [Mass/volume] in Plasma --trough |
|
60078-3
|
Ganciclovir [Mass/volume] in Urine |
|
25256-9
|
Ganciclovir [Mass/volume] in Unspecified specimen |
|
51701-1
|
Ganglioside IgG Ab [Presence] in Serum by Immunoblot |
|
51702-9
|
Ganglioside IgM Ab [Presence] in Serum by Immunoblot |
|
11048-6
|
Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
2384-6
|
Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
|
88478-3
|
Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4 weeks [SAQ] |
|
35811-9
|
Garenoxacin [Susceptibility] by Disk diffusion (KB) |
|
35812-7
|
Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35813-5
|
Garenoxacin [Susceptibility] |
|
7331-2
|
Garlic triggered histamine release [Units/volume] in Blood |
|
6122-6
|
Garlic IgE Ab [Units/volume] in Serum |
|
15724-8
|
Garlic IgE Ab RAST class [Presence] in Serum |
|
61211-9
|
Garlic IgE Ab/IgE total in Serum |
|
7330-4
|
Garlic IgG Ab [Units/volume] in Serum |
|
21285-2
|
Garlic IgG Ab RAST class [Presence] in Serum |
|
56265-2
|
Garlic IgG4 Ab [Mass/volume] in Serum |
|
60374-6
|
Garlic IgG Ab [Mass/volume] in Serum |
|
5923-8
|
Gastric acid free [Moles/volume] in Gastric fluid |
|
5922-0
|
Gastric acid [Moles/volume] in Gastric fluid |
|
5925-3
|
Gastric acid [Volume] in Gastric fluid |
|
60819-0
|
Gastric mucosal pCO2 |
|
76298-9
|
Gastric pressure |
|
60817-4
|
Gastric-arterial pCO2 gap |
|
60818-2
|
Gastric-end tidal pCO2 gap |
|
21286-0
|
Gastrin [Mass/volume] in Serum or Plasma --1.5 hours post 0.2 U/kg secretin |
|
29396-9
|
Gastrin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
1484-5
|
Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
|
14735-5
|
Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
|
16890-6
|
Gastrin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
77674-0
|
Gastrin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
33584-4
|
Gastrin [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge |
|
1485-2
|
Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
|
14736-3
|
Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
|
16892-2
|
Gastrin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
77675-7
|
Gastrin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
21287-8
|
Gastrin [Mass/volume] in Serum or Plasma --1 hour post 0.2 U/kg secretin |
|
29392-8
|
Gastrin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
77671-6
|
Gastrin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
|
29398-5
|
Gastrin [Mass/volume] in Serum or Plasma --1 minute pre XXX challenge |
|
21288-6
|
Gastrin [Mass/volume] in Serum or Plasma --2.5 hours post 0.2 U/kg secretin |
|
29394-4
|
Gastrin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
1486-0
|
Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
|
14737-1
|
Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
|
16893-0
|
Gastrin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
1487-8
|
Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
|
14738-9
|
Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
|
16894-8
|
Gastrin [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge |
|
21289-4
|
Gastrin [Mass/volume] in Serum or Plasma --2 hours post 0.2 U/kg secretin |
|
29391-0
|
Gastrin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
14739-7
|
Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin |
|
42624-7
|
Gastrin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
21290-2
|
Gastrin [Mass/volume] in Serum or Plasma --3.5 hours post 0.2 U/kg secretin |
|
1488-6
|
Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
|
14740-5
|
Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
|
16895-5
|
Gastrin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
77676-5
|
Gastrin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
29397-7
|
Gastrin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
21291-0
|
Gastrin [Mass/volume] in Serum or Plasma --3 hours post 0.2 U/kg secretin |
|
29393-6
|
Gastrin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
77672-4
|
Gastrin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
21292-8
|
Gastrin [Mass/volume] in Serum or Plasma --40 minutes post 0.2 U/kg secretin |
|
21293-6
|
Gastrin [Mass/volume] in Serum or Plasma --45 minutes post 0.2 U/kg secretin |
|
21294-4
|
Gastrin [Mass/volume] in Serum or Plasma --4 hours post 0.2 U/kg secretin |
|
21295-1
|
Gastrin [Mass/volume] in Serum or Plasma --50 minutes post 0.2 U/kg secretin |
|
1489-4
|
Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
|
14741-3
|
Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
|
16896-3
|
Gastrin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
77673-2
|
Gastrin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
21296-9
|
Gastrin [Mass/volume] in Serum or Plasma --7 minutes post 0.2 U/kg secretin |
|
10483-6
|
Gastrin Ag [Presence] in Tissue by Immune stain |
|
59831-8
|
Gastrin [Mass/volume] in Serum or Plasma --baseline |
|
16161-2
|
Gastrin [Mass/volume] in Serum or Plasma --post XXX challenge |
|
29395-1
|
Gastrin [Mass/volume] in Serum or Plasma --fasting |
|
26024-0
|
Gastrin [Moles/volume] in Serum or Plasma --post meal |
|
1490-2
|
Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
|
14742-1
|
Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
|
77670-8
|
Gastrin [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
51431-5
|
Gastrin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
|
2333-3
|
Gastrin [Mass/volume] in Serum or Plasma |
|
15072-2
|
Gastrin [Moles/volume] in Serum or Plasma |
|
59832-6
|
Gastrin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25654-5
|
Gastrin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50485-2
|
Gastrin [Mass/volume] in Serum or Plasma --1st specimen |
|
16160-4
|
Gastrin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
16891-4
|
Gastrin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
16152-1
|
Gastrin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25655-2
|
Gastrin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50486-0
|
Gastrin [Mass/volume] in Serum or Plasma --2nd specimen |
|
16153-9
|
Gastrin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25656-0
|
Gastrin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50487-8
|
Gastrin [Mass/volume] in Serum or Plasma --3rd specimen |
|
16154-7
|
Gastrin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25657-8
|
Gastrin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50488-6
|
Gastrin [Mass/volume] in Serum or Plasma --4th specimen |
|
16155-4
|
Gastrin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25658-6
|
Gastrin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50489-4
|
Gastrin [Mass/volume] in Serum or Plasma --5th specimen |
|
16156-2
|
Gastrin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
25659-4
|
Gastrin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50490-2
|
Gastrin [Mass/volume] in Serum or Plasma --6th specimen |
|
16157-0
|
Gastrin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25660-2
|
Gastrin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50491-0
|
Gastrin [Mass/volume] in Serum or Plasma --7th specimen |
|
16158-8
|
Gastrin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25661-0
|
Gastrin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50492-8
|
Gastrin [Mass/volume] in Serum or Plasma --8th specimen |
|
16159-6
|
Gastrin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
25662-8
|
Gastrin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
2332-5
|
Gastrin.14 residue fragment [Mass/volume] in Serum or Plasma |
|
2331-7
|
Gastrin.17 residue fragment [Mass/volume] in Serum or Plasma |
|
2330-9
|
Gastrin.34 residue fragment [Mass/volume] in Serum or Plasma |
|
2334-1
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid |
|
42909-2
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --1st specimen |
|
42910-0
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --2nd specimen |
|
42911-8
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --3rd specimen |
|
84101-5
|
Gastroenterology Administrative note |
|
84102-3
|
Gastroenterology Admission evaluation note |
|
83684-1
|
Gastroenterology Attending Note |
|
34136-2
|
Gastroenterology Attending Outpatient Supervisory note |
|
84103-1
|
Gastroenterology Clinical nurse specialist Note |
|
34761-7
|
Gastroenterology Consult note |
|
78256-5
|
Gastroenterology Diagnostic study note |
|
78270-6
|
Gastroenterology Education note |
|
83737-7
|
Gastroenterology Fellow Note |
|
78297-9
|
Gastroenterology Flowsheet |
|
84104-9
|
Gastroenterology History and physical note |
|
84105-6
|
Gastroenterology Hospital Note |
|
78339-9
|
Gastroenterology Initial evaluation note |
|
34899-5
|
Gastroenterology Interventional procedure note |
|
84106-4
|
Gastroenterology Letter |
|
34762-5
|
Gastroenterology Note |
|
83575-1
|
Gastroenterology Nurse Note |
|
83576-9
|
Gastroenterology Nurse Outpatient Note |
|
83577-7
|
Gastroenterology Nurse procedure note |
|
84107-2
|
Gastroenterology Outpatient Note |
|
78241-7
|
Gastroenterology Surgical operation note |
|
84108-0
|
Gastroenterology Telephone encounter Note |
|
80750-3
|
Gastroenterology Plan of care note |
|
85941-3
|
Gastroenterology Postoperative evaluation and management note |
|
85942-1
|
Gastroenterology Preoperative evaluation and management note |
|
78317-5
|
Gastroenterology procedure note |
|
78323-3
|
Gastroenterology Progress note |
|
57138-0
|
Gastroenterology Referral note |
|
83756-7
|
Gastroenterology Resident Note |
|
81422-8
|
GATA1 gene exon 2 targeted mutation analysis in Blood or Tissue by Sequencing |
|
31042-5
|
Gatifloxacin [Susceptibility] by Gradient strip |
|
31040-9
|
Gatifloxacin [Susceptibility] by Disk diffusion (KB) |
|
31036-7
|
Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41494-6
|
Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
31038-3
|
Gatifloxacin [Susceptibility] |
|
22073-1
|
Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21682-0
|
Gaucher 1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
22072-3
|
Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21683-8
|
Gaucher 2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
22071-5
|
Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21684-6
|
Gaucher 3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
62312-4
|
Gaucher disease newborn screen interpretation |
|
62313-2
|
Gaucher disease newborn screening comment-discussion |
|
35686-5
|
GBA gene c.1226A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
35687-3
|
GBA gene c.1297G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
35688-1
|
GBA gene c.1448T>G and 1448T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
35689-9
|
GBA gene c.84insG [Presence] in Blood or Tissue by Molecular genetics method |
|
35690-7
|
GBA gene c.IVS2(+1)G>A and IVS2(+1)G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
41104-1
|
GBA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35693-1
|
GBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46988-2
|
GBA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
35372-2
|
GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method |
|
59394-7
|
Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay |
|
68385-4
|
Glomerular basement membrane Ab [Presence] in Serum |
|
63262-0
|
Glomerular basement membrane Ab [Presence] in Serum by Immunoassay |
|
53260-6
|
Glomerular basement membrane Ab [Presence] in Serum by Immunofluorescence |
|
89514-4
|
Glomerular basement membrane Ab [Presence] in Serum by Line blot |
|
49774-3
|
Glomerular basement membrane Ab [Units/volume] in Serum |
|
51980-1
|
Glomerular basement membrane Ab [Mass/volume] in Serum |
|
53259-8
|
Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence |
|
30343-8
|
Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
|
68386-2
|
Glomerular basement membrane IgG Ab [Presence] in Serum by Immunoassay |
|
58796-4
|
Glomerular basement membrane IgG Ab [Presence] in Serum by Immunofluorescence |
|
31406-2
|
Glomerular basement membrane IgG Ab [Units/volume] in Serum |
|
58795-6
|
Glomerular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
|
89002-0
|
GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
79309-1
|
Gamma butyrobetaine [Moles/volume] in Cerebral spinal fluid |
|
79310-9
|
Gamma butyrobetaine [Moles/volume] in DBS |
|
79308-3
|
Gamma butyrobetaine [Moles/volume] in Serum or Plasma |
|
79311-7
|
Gamma butyrobetaine/Creatinine [Molar ratio] in Urine |
|
79315-8
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid |
|
79314-1
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in DBS |
|
79312-5
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Serum or Plasma |
|
79313-3
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Urine |
|
93334-1
|
Glycocholate [Moles/volume] in Serum or Plasma |
|
93335-8
|
Glycochenodeoxycholate [Moles/volume] in Serum or Plasma |
|
75055-4
|
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
75401-0
|
GCDH gene full mutation analysis in Blood or Tissue by Sequencing |
|
75402-8
|
GCDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
2375-4
|
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Tissue |
|
75054-7
|
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
53866-0
|
GCH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11096-5
|
Gamma chlordane [Mass/volume] in Serum or Plasma |
|
16888-0
|
Gamma chlordane [Mass/volume] in Urine |
|
53732-4
|
GCK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54458-5
|
Granulocyte colony stimulating factor [Mass/volume] in Serum or Plasma |
|
48656-3
|
Ganglioside GD1a Ab [Units/volume] in Serum by Immunoassay |
|
44740-9
|
Ganglioside GD1a Ab [Presence] in Serum |
|
31344-5
|
Ganglioside GD1a Ab [Units/volume] in Serum |
|
58969-7
|
Ganglioside GD1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
57968-0
|
Ganglioside GD1a IgG Ab [Presence] in Serum |
|
82395-5
|
Ganglioside GD1a IgG Ab [Presence] in Serum by Line blot |
|
31397-3
|
Ganglioside GD1a IgG Ab [Units/volume] in Serum |
|
23997-0
|
Ganglioside GD1a IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
21283-7
|
Ganglioside GD1a IgG Ab [Titer] in Serum by Immunoassay |
|
50767-3
|
Ganglioside GD1a IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
|
88724-0
|
Ganglioside GD1a IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
82396-3
|
Ganglioside GD1a IgG+IgM Ab [Presence] in Serum by Line blot |
|
58970-5
|
Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31398-1
|
Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid |
|
57969-8
|
Ganglioside GD1a IgM Ab [Presence] in Serum |
|
82397-1
|
Ganglioside GD1a IgM Ab [Presence] in Serum by Line blot |
|
31399-9
|
Ganglioside GD1a IgM Ab [Units/volume] in Serum |
|
23998-8
|
Ganglioside GD1a IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
21282-9
|
Ganglioside GD1a IgM Ab [Titer] in Serum by Immunoassay |
|
26870-6
|
Ganglioside GD1b Ab [Units/volume] in Serum by Immunoassay |
|
31400-5
|
Ganglioside GD1b Ab [Presence] in Serum |
|
26926-6
|
Ganglioside GD1b Ab [Presence] in Serum by Immunoassay |
|
31345-2
|
Ganglioside GD1b Ab [Units/volume] in Serum |
|
31163-9
|
Ganglioside GD1b Ab [Titer] in Serum |
|
58971-3
|
Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31401-3
|
Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid |
|
56541-6
|
Ganglioside GD1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
43601-4
|
Ganglioside GD1b IgG Ab [Presence] in Serum |
|
56739-6
|
Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoblot |
|
31346-0
|
Ganglioside GD1b IgG Ab [Units/volume] in Serum |
|
23999-6
|
Ganglioside GD1b IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
13662-2
|
Ganglioside GD1b IgG Ab [Titer] in Serum |
|
50768-1
|
Ganglioside GD1b IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
|
88730-7
|
Ganglioside GD1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
82398-9
|
Ganglioside GD1b IgG+IgM Ab [Presence] in Serum by Line blot |
|
56542-4
|
Ganglioside GD1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58977-0
|
Ganglioside GD1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
43600-6
|
Ganglioside GD1b IgM Ab [Presence] in Serum |
|
56740-4
|
Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoblot |
|
31347-8
|
Ganglioside GD1b IgM Ab [Units/volume] in Serum |
|
24000-2
|
Ganglioside GD1b IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
13661-4
|
Ganglioside GD1b IgM Ab [Titer] in Serum |
|
63471-7
|
Ganglioside GD2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
59034-9
|
Ganglioside GD2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
82399-7
|
Ganglioside GD2 IgG Ab [Presence] in Serum by Line blot |
|
82400-3
|
Ganglioside GD2 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58980-4
|
Ganglioside GD2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
82401-1
|
Ganglioside GD2 IgM Ab [Presence] in Serum by Line blot |
|
63472-5
|
Ganglioside GD3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58979-6
|
Ganglioside GD3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
82402-9
|
Ganglioside GD3 IgG Ab [Presence] in Serum by Line blot |
|
63240-6
|
Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89512-8
|
Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58978-8
|
Ganglioside GD3 IgM Ab [Units/volume] in Serum by Immunoassay |
|
82404-5
|
Ganglioside GD3 IgM Ab [Presence] in Serum by Line blot |
|
81857-5
|
GDAP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43277-3
|
GDAP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93333-3
|
Glycodeoxycholate [Moles/volume] in Serum or Plasma |
|
92665-9
|
Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay |
|
91573-6
|
Twelve or more drinks in a day in past 12 months |
|
83034-9
|
XR Pelvis and Hip - bilateral GE 2 views for pediatrics |
|
91574-4
|
Four or more drinks in 2 hours or less in 12 months |
|
91576-9
|
Five or more drinks in a period of 2 hours or less in past 12 months |
|
91575-1
|
Eight or more drinks in a day in past 12 months |
|
65321-2
|
Ge Ab [Presence] in Serum or Plasma |
|
7332-0
|
Gelatin IgE Ab [Units/volume] in Serum |
|
15725-5
|
Gelatin IgE Ab RAST class [Presence] in Serum |
|
61269-7
|
Gelatin IgE Ab/IgE total in Serum |
|
56455-9
|
Gelatin IgG4 Ab [Mass/volume] in Serum |
|
63140-8
|
Gelatin IgG Ab [Mass/volume] in Serum |
|
11236-7
|
Gemfibrozil [Mass/volume] in Serum or Plasma |
|
41697-4
|
Gemifloxacin [Susceptibility] by Gradient strip |
|
35814-3
|
Gemifloxacin [Susceptibility] by Disk diffusion (KB) |
|
35815-0
|
Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35816-8
|
Gemifloxacin [Susceptibility] |
|
81254-5
|
Genomic allele start-end |
|
19762-4
|
General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
|
75603-1
|
Genetic counselor comment on fetal 1p36 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75579-3
|
Genetic counselor comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75597-5
|
Genetic counselor comment on fetal 5p deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75591-8
|
Genetic counselor comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75571-0
|
Genetic counselor comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75585-0
|
Genetic counselor comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75573-6
|
Fetal Genetic counselor comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75553-8
|
Genetic counselor comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75559-5
|
Genetic counselor comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75565-2
|
Genetic counselor comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
69549-4
|
Genetic knowledge reference [Identifier] |
|
69550-2
|
Genetic knowledge reference [Type] |
|
34862-3
|
General medicine Attending Hospital Admission evaluation note |
|
68475-3
|
General medicine Attending Hospital Progress note |
|
34769-0
|
General medicine Attending Note |
|
64054-0
|
General medicine Medical student Hospital Admission evaluation note |
|
64056-5
|
General medicine Medical student Hospital Consult note |
|
64055-7
|
General medicine Medical student Hospital Progress note |
|
34767-4
|
General medicine Medical student Note |
|
34768-2
|
General medicine Nurse Note |
|
93865-4
|
General medicine Team Conference note |
|
82155-3
|
Genomic structural variant copy number |
|
82154-6
|
Genomic structural variant name |
|
87396-8
|
GenBank accession number |
|
76691-5
|
Gender identity |
|
51969-4
|
Genetic analysis report |
|
53039-4
|
Genetic disease analysis overall carrier interpretation |
|
51968-6
|
Discrete variation analysis overall interpretation |
|
51967-8
|
Genetic disease assessed [ID] |
|
53037-8
|
Genetic variation clinical significance [Imp] |
|
48025-1
|
Gene mutations tested for [#] in Blood or Tissue by Molecular genetics method |
|
36908-2
|
Gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
51971-0
|
Gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
48018-6
|
Gene studied [ID] |
|
93366-3
|
Gene studied with no variant found [Identifier] in Blood or Tissue Nominal |
|
41103-3
|
Gene XXX mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35474-6
|
Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48010-3
|
Genechip ID [Identifier] in Blood or Tissue by Molecular genetics method |
|
48009-5
|
Genechip manufacturer ID [Identifier] in Blood or Tissue by Molecular genetics method |
|
48011-1
|
Genechip version [Identifier] in Blood or Tissue by Molecular genetics method |
|
76447-2
|
General health |
|
85024-8
|
General Life Satisfaction Survey - age 18+ - T-score [NIH Toolbox] |
|
85026-3
|
General Life Satisfaction Survey - national percentile [NIH Toolbox] |
|
85074-3
|
General Life Satisfaction Survey - parent report - national percentile [NIH Toolbox] |
|
85075-0
|
General Life Satisfaction Survey - parent report - scale score age adjusted [NIH Toolbox] |
|
85076-8
|
General Life Satisfaction Survey - parent report - scale score fully adjusted [NIH Toolbox] |
|
85077-6
|
General Life Satisfaction Survey - parent report - unadjusted scale score [NIH Toolbox] |
|
85025-5
|
General Life Satisfaction Survey - scale score age adjusted [NIH Toolbox] |
|
85012-3
|
General Life Satisfaction Survey - scale score fully adjusted [NIH Toolbox] |
|
85008-1
|
General Life Satisfaction Survey - unadjusted scale score [NIH Toolbox] |
|
85132-9
|
General Life Satisfaction Survey version 2.0 - ages 13-17 - T-score [NIH Toolbox] |
|
85021-4
|
General Life Satisfaction Survey version 2.0 - ages 8-12 - T-score [NIH Toolbox] |
|
85011-5
|
General Life Satisfaction Survey version 2.0 - parent report - ages 3-12 - T-score [NIH Toolbox] |
|
34763-3
|
General medicine Admission history and physical note |
|
34764-1
|
General medicine Consult note |
|
78262-3
|
General medicine Discharge instructions |
|
78264-9
|
General medicine Discharge summary |
|
78267-2
|
General medicine Discharge teaching note |
|
78272-2
|
General medicine Education note |
|
78298-7
|
General medicine Flowsheet |
|
78308-4
|
General medicine History and physical note |
|
64053-2
|
General medicine Hospital Admission evaluation note |
|
78335-7
|
General medicine Initial evaluation note |
|
34765-8
|
General medicine Note |
|
34101-6
|
General medicine Outpatient Consult note |
|
34766-6
|
General medicine Outpatient Note |
|
34901-9
|
General medicine Outpatient Progress note |
|
80745-3
|
General medicine Plan of care note |
|
78320-9
|
General medicine procedure note |
|
34900-1
|
General medicine Progress note |
|
57139-8
|
General medicine Referral note |
|
34770-8
|
General medicine Transfer summary note |
|
73789-0
|
General physical condition [NSRAS] |
|
91651-0
|
General Well-Being Schedule - 18 item - total score [NHANES] |
|
74173-6
|
Generally speaking, I am very satisfied with interactions with non-physician health care team members [NMMDS] |
|
74174-4
|
Generally speaking, I am very satisfied with interactions with physicians [NMMDS] |
|
74172-8
|
Generally speaking, I am very satisfied with my own level of autonomy [NMMDS] |
|
74175-1
|
Generally speaking, I am very satisfied with nursing administration [NMMDS] |
|
74176-9
|
Generally speaking, I am very satisfied with nursing management [NMMDS] |
|
74181-9
|
Generally speaking, I am very satisfied with this job [NMMDS] |
|
75616-3
|
Generic five level triage system [NAMCS] |
|
74062-1
|
Generic or investigational drug name of Medication |
|
74021-7
|
Genetic risk algorithm |
|
74020-9
|
Genetic risk algorithm sensitivity [Ratio] |
|
75545-4
|
Genetic counselor comment on overall fetal aneuploidy and microdeletion risk [Text] based on Plasma cell-free+WBC DNA |
|
48674-6
|
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal |
|
19102-3
|
Genetic screen in Unspecified specimen by Molecular genetics method Narrative |
|
69548-6
|
Genetic variant assessment |
|
83009-1
|
Genetic variation's effect on high-risk allele |
|
48007-9
|
Genetic variant allelic state [Type] in Blood or Tissue by Molecular genetics method |
|
47997-2
|
Genetic variant clinical significance [Interpretation] in Blood or Tissue by Molecular genetics method |
|
82939-0
|
Genetic variant details in Blood or Tissue by Molecular genetics method Narrative |
|
93364-8
|
Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative |
|
93365-5
|
Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative |
|
46738-1
|
Genetic.Disorders newborn screen interpretation |
|
69047-9
|
Geneticist review of results |
|
23743-8
|
Genistein [Units/volume] in Serum or Plasma |
|
683-3
|
Genital Mycoplasma identified in Genital specimen by Organism specific culture |
|
80335-3
|
Genitourinary assessment [Interpretation] |
|
92822-6
|
Genomic coordinate system [Type] |
|
48013-7
|
Genomic reference sequence [ID] |
|
48002-0
|
Genomic source class [Type] |
|
84413-4
|
Genotype display name |
|
73014-3
|
Gentamicin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73013-5
|
Gentamicin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13561-6
|
Gentamicin [Mass/volume] in Cerebral spinal fluid |
|
4268-9
|
Gentamicin [Mass] of Dose |
|
13562-4
|
Gentamicin [Mass/volume] in Body fluid |
|
80971-5
|
Gentamicin free [Mass/volume] in Serum or Plasma |
|
54913-9
|
Gentamicin IgE Ab [Units/volume] in Serum |
|
73365-9
|
Gentamicin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73364-2
|
Gentamicin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7016-9
|
Gentamicin [Susceptibility] by Gradient strip |
|
268-3
|
Gentamicin [Susceptibility] by Disk diffusion (KB) |
|
267-5
|
Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
266-7
|
Gentamicin [Susceptibility] by Minimum lethal concentration (MLC) |
|
50630-3
|
Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89481-6
|
Gentamicin [Susceptibility] by Genotype method |
|
59379-8
|
Gentamicin [Mass/volume] in Serum or Plasma --post dialysis |
|
39082-3
|
Gentamicin [Mass/volume] in Cerebral spinal fluid --peak |
|
3663-2
|
Gentamicin [Mass/volume] in Serum or Plasma --peak |
|
22746-2
|
Gentamicin [Moles/volume] in Serum or Plasma --peak |
|
31091-2
|
Gentamicin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
|
31093-8
|
Gentamicin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
|
88111-0
|
Gentamicin [Moles/volume] in Serum or Plasma --random post extended interval dosing |
|
3664-0
|
Gentamicin [Mass/volume] in Serum or Plasma --random |
|
15106-8
|
Gentamicin [Moles/volume] in Serum or Plasma --random |
|
35668-3
|
Gentamicin [Mass/volume] in Serum or Plasma |
|
47109-4
|
Gentamicin [Moles/volume] in Serum or Plasma |
|
18928-2
|
Gentamicin [Susceptibility] |
|
35817-6
|
Gentamicin.high potency [Susceptibility] by Gradient strip |
|
7017-7
|
Gentamicin.high potency [Susceptibility] by Disk diffusion (KB) |
|
7018-5
|
Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18929-0
|
Gentamicin.high potency [Susceptibility] |
|
269-1
|
Gentamicin [Susceptibility] by Serum bactericidal titer |
|
31092-0
|
Gentamicin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
|
3665-7
|
Gentamicin [Mass/volume] in Serum or Plasma --trough |
|
22747-0
|
Gentamicin [Moles/volume] in Serum or Plasma --trough |
|
79515-3
|
Gentisate [Moles/volume] in Serum or Plasma |
|
47858-6
|
Gentisate/Creatinine [Molar ratio] in Urine |
|
6123-4
|
Geranium IgE Ab [Units/volume] in Serum |
|
7334-6
|
Gerbil epithelium IgE Ab [Units/volume] in Serum |
|
31079-7
|
Gerbil epithelium IgE Ab RAST class [Presence] in Serum |
|
61341-4
|
Gerbil epithelium IgE Ab/IgE total in Serum |
|
30127-5
|
Gerbil hair IgE Ab [Units/volume] in Serum |
|
30125-9
|
Gerbil hair IgE Ab RAST class [Presence] in Serum |
|
6840-3
|
Gerbil IgE Ab [Units/volume] in Serum |
|
15727-1
|
Gerbil IgE Ab RAST class [Presence] in Serum |
|
84109-8
|
Geriatric medicine Admission evaluation note |
|
80809-7
|
Geriatric medicine Admission history and physical note |
|
84110-6
|
Geriatric medicine Annual evaluation note |
|
83702-1
|
Geriatric medicine Attending Note |
|
84111-4
|
Geriatric medicine Case manager Note |
|
34776-5
|
Geriatric medicine Consult note |
|
80810-5
|
Geriatric medicine Discharge instructions |
|
80811-3
|
Geriatric medicine Discharge summary |
|
80812-1
|
Geriatric medicine Discharge teaching note |
|
67854-0
|
Geriatric medicine Education note |
|
83738-5
|
Geriatric medicine Fellow Note |
|
80817-0
|
Geriatric medicine Flowsheet |
|
84112-2
|
Geriatric medicine Group counseling note |
|
80813-9
|
Geriatric medicine History and physical note |
|
84114-8
|
Geriatric medicine Hospital Note |
|
80814-7
|
Geriatric medicine Initial evaluation note |
|
84124-7
|
Geriatric medicine Interdisciplinary Plan of care note |
|
84115-5
|
Geriatric medicine Long term care facility Consult note |
|
84116-3
|
Geriatric medicine Long term care facility Note |
|
84117-1
|
Geriatric medicine Long term care facility Plan of care note |
|
85445-5
|
Geriatric medicine Note |
|
83545-4
|
Geriatric medicine Nurse practitioner Note |
|
83621-3
|
Geriatric medicine Nurse Consult note |
|
83622-1
|
Geriatric medicine Nurse Note |
|
83623-9
|
Geriatric medicine Nurse Outpatient Note |
|
83624-7
|
Geriatric medicine Nurse Risk assessment and screening note |
|
34902-7
|
Geriatric medicine Outpatient Education note |
|
84118-9
|
Geriatric medicine Outpatient Initial evaluation note |
|
84119-7
|
Geriatric medicine Outpatient Note |
|
84120-5
|
Geriatric medicine Pharmacist Note |
|
84123-9
|
Geriatric medicine Telephone encounter Note |
|
80818-8
|
Geriatric medicine Plan of care note |
|
82355-9
|
Geriatric medicine procedure note |
|
80815-4
|
Geriatric medicine Progress note |
|
84113-0
|
Geriatric medicine Patient's home Note |
|
57171-1
|
Geriatric medicine Referral note |
|
83757-5
|
Geriatric medicine Resident Note |
|
84121-3
|
Geriatric medicine Risk assessment and screening note |
|
68672-5
|
Geriatric medicine Skilled nursing facility Note |
|
84122-1
|
Geriatric medicine Team Note |
|
80816-2
|
Geriatric medicine Transfer summary note |
|
93737-5
|
German turnip IgE Ab [Units/volume] in Serum |
|
60079-1
|
Germanium [Mass/volume] in Blood |
|
76649-3
|
Germanium [Mass/mass] in Hair |
|
50851-5
|
Germanium [Moles/mass] in Hair |
|
60080-9
|
Germanium [Mass/volume] in Red Blood Cells |
|
60081-7
|
Germanium [Mass/volume] in Serum or Plasma |
|
5655-6
|
Germanium [Mass/volume] in Urine |
|
72147-2
|
Gestational age--at birth [RHEA] |
|
58038-1
|
Gestrinone [Presence] in Urine |
|
26644-5
|
Getah virus Ab [Presence] in Serum |
|
10484-4
|
Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
|
93422-4
|
Glial fibrillary acidic protein.alpha IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93424-0
|
Glial fibrillary acidic protein.alpha IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
47959-2
|
GFAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93421-6
|
Glial fibrillary acidic protein IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93423-2
|
Glial fibrillary acidic protein IgG Ab [Titer] in Serum by Immunofluorescence |
|
77089-1
|
GFM1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77088-3
|
GFM1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
48642-3
|
Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
|
48643-1
|
Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
|
88293-6
|
Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
|
50044-7
|
Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
|
70969-1
|
Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
|
88294-4
|
Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
|
76633-7
|
Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood |
|
33914-3
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) |
|
62238-1
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
|
50210-4
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin-based formula |
|
77147-7
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
|
50384-7
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) |
|
69405-9
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood |
|
2320-0
|
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells |
|
2321-8
|
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum |
|
58768-3
|
Gamma glutamyl transferase [Enzymatic activity/time] in 24 hour Urine |
|
2322-6
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid |
|
53432-1
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Dialysis fluid |
|
17858-2
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid |
|
2324-2
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
|
2323-4
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
|
27403-5
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Urine |
|
2325-9
|
Gamma glutamyl transferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
|
49942-6
|
Somatotropin [Units/volume] in Serum or Plasma --1 AM specimen |
|
79204-4
|
Somatotropin [Mass/volume] in Serum or Plasma --1.25 hours post dose arginine+insulin |
|
46407-3
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post 1 g/kg glucose PO |
|
47752-1
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine |
|
40304-8
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine |
|
47885-9
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin |
|
79205-1
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin |
|
47886-7
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose betaxolol+glucagon |
|
79174-9
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
14147-3
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
40300-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine |
|
47749-7
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucagon |
|
55516-9
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon |
|
47750-5
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose PO |
|
55510-2
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
47753-9
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
1627-9
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
47887-5
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose ornithine |
|
47751-3
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH |
|
47888-3
|
Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin |
|
81753-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin |
|
47889-1
|
Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose ornithine |
|
49943-4
|
Somatotropin [Units/volume] in Serum or Plasma --1:30 am specimen |
|
49944-2
|
Somatotropin [Units/volume] in Serum or Plasma --10 PM specimen |
|
56568-9
|
Somatotropin [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge |
|
49945-9
|
Somatotropin [Units/volume] in Serum or Plasma --10:30 PM specimen |
|
46412-3
|
Somatotropin [Mass/volume] in Serum or Plasma --105 minutes post dose arginine |
|
56567-1
|
Somatotropin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
|
27850-7
|
Somatotropin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
12697-9
|
Somatotropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
55506-0
|
Somatotropin [Mass/volume] in Serum or Plasma --10 minutes post exercise |
|
47754-7
|
Somatotropin [Units/volume] in Serum or Plasma --10 minutes post dose TRH |
|
49946-7
|
Somatotropin [Units/volume] in Serum or Plasma --11 PM specimen |
|
56570-5
|
Somatotropin [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge |
|
49947-5
|
Somatotropin [Units/volume] in Serum or Plasma --11:30 PM specimen |
|
68941-4
|
Somatotropin [Mass/volume] in Serum or Plasma --110 minutes post exercise |
|
56569-7
|
Somatotropin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
|
49948-3
|
Somatotropin [Units/volume] in Serum or Plasma --12 PM specimen |
|
49949-1
|
Somatotropin [Units/volume] in Serum or Plasma --12:30 PM specimen |
|
68942-2
|
Somatotropin [Mass/volume] in Serum or Plasma --130 minutes post exercise |
|
47757-0
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine |
|
46409-9
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine |
|
47890-9
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
|
79199-6
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
|
79181-4
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
14142-4
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
12698-7
|
Somatotropin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
68919-0
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post exercise |
|
47758-8
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon |
|
47891-7
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose growth hormone releasing factor |
|
47759-6
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose insulin IV |
|
50753-3
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV |
|
47892-5
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose ornithine |
|
48122-6
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH |
|
40335-2
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
47756-2
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine |
|
46408-1
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes pre dose arginine |
|
48123-4
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine+insulin |
|
82902-8
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
12695-3
|
Somatotropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
48124-2
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose glucagon |
|
48125-9
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose insulin IV |
|
48126-7
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose ornithine |
|
48127-5
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH |
|
56884-0
|
Somatotropin [Mass/volume] in Serum or Plasma --160 minutes post exercise |
|
1628-7
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post 1 g/kg glucose PO |
|
47760-4
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine |
|
40303-0
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine |
|
48128-3
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
|
79203-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
|
47928-7
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose betaxolol+glucagon |
|
79175-6
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
14146-5
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
40299-0
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine |
|
47893-3
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucagon |
|
55517-7
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucagon |
|
47761-2
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucose PO |
|
55508-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
|
47894-1
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose growth hormone releasing factor |
|
47762-0
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
1629-5
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
47895-8
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose ornithine |
|
47896-6
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose propranolol+glucagon |
|
56983-0
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post resting |
|
47897-4
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH |
|
40338-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
49950-9
|
Somatotropin [Units/volume] in Serum or Plasma --2 AM specimen |
|
47898-2
|
Somatotropin [Units/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin |
|
79198-8
|
Somatotropin [Mass/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin |
|
48074-9
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin |
|
79200-2
|
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin |
|
48075-6
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose betaxolol+glucagon |
|
79172-3
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
27369-8
|
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
12701-9
|
Somatotropin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
48076-4
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose glucagon |
|
55515-1
|
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon |
|
47899-0
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose propranolol+glucagon |
|
49951-7
|
Somatotropin [Units/volume] in Serum or Plasma --2:30 am specimen |
|
56572-1
|
Somatotropin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
|
50444-9
|
Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post dose arginine |
|
14143-2
|
Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
12699-5
|
Somatotropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
55514-4
|
Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post exercise |
|
47900-6
|
Somatotropin [Units/volume] in Serum or Plasma --20 minutes post dose TRH |
|
50685-7
|
Somatotropin [Mass/time] in 24 hour Urine |
|
1630-3
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post 1 g/kg glucose PO |
|
47764-6
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine |
|
40305-5
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine |
|
47901-4
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine+insulin |
|
79197-0
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine+insulin |
|
47902-2
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose betaxolol+glucagon |
|
79173-1
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
14144-0
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
40301-4
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine |
|
47903-0
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucagon |
|
55504-5
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucagon |
|
47765-3
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucose PO |
|
55507-8
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
|
47904-8
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose growth hormone releasing factor |
|
47766-1
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose insulin IV |
|
46404-0
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV |
|
47905-5
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose ornithine |
|
47906-3
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose propranolol+glucagon |
|
47907-1
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose TRH |
|
40339-4
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
47908-9
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours pre dose propranolol+glucagon |
|
49952-5
|
Somatotropin [Units/volume] in Serum or Plasma --3 AM specimen |
|
40307-1
|
Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post dose arginine |
|
40297-4
|
Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
49953-3
|
Somatotropin [Units/volume] in Serum or Plasma --3:30 AM specimen |
|
46406-5
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post 1 g/kg glucose PO |
|
47768-7
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine |
|
46410-7
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine |
|
47909-7
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
|
79201-0
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
|
47910-5
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose betaxolol+glucagon |
|
79176-4
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
15347-8
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
25984-6
|
Somatotropin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
55513-6
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine |
|
56526-7
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post exercise |
|
47911-3
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucagon |
|
55512-8
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon |
|
47769-5
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucose PO |
|
55505-2
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
|
47912-1
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose growth hormone releasing factor |
|
47770-3
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
1631-1
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
47913-9
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose ornithine |
|
56981-4
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post resting |
|
47914-7
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH |
|
40336-0
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
46405-7
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes pre 1 g/kg glucose PO |
|
50443-1
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes pre dose arginine |
|
48129-1
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose betaxolol+glucagon |
|
48130-9
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose propranolol+glucagon |
|
48131-7
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose TRH |
|
1632-9
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post 1 g/kg glucose PO |
|
40306-3
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose arginine |
|
47915-4
|
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose betaxolol+glucagon |
|
56500-2
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
56885-7
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post exercise |
|
47916-2
|
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucagon |
|
55511-0
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose glucagon |
|
47771-1
|
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucose PO |
|
47917-0
|
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose propranolol+glucagon |
|
40340-2
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
49954-1
|
Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen |
|
56560-6
|
Somatotropin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
|
49955-8
|
Somatotropin [Units/volume] in Serum or Plasma --4:30 AM specimen |
|
14145-7
|
Somatotropin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
25777-4
|
Somatotropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
47772-9
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine |
|
46411-5
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine |
|
47919-6
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
|
79202-8
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
|
79180-6
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
56499-7
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
12700-1
|
Somatotropin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
55509-4
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose cloNIDine |
|
47920-4
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose glucagon |
|
47921-2
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose growth hormone releasing factor |
|
47773-7
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
1633-7
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
47922-0
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose ornithine |
|
40337-8
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose triple bolus |
|
40308-9
|
Somatotropin [Mass/volume] in Serum or Plasma --4 hours post dose arginine |
|
29151-8
|
Somatotropin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
49956-6
|
Somatotropin [Units/volume] in Serum or Plasma --5 AM specimen |
|
56561-4
|
Somatotropin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
|
49957-4
|
Somatotropin [Units/volume] in Serum or Plasma --5:30 AM specimen |
|
25778-2
|
Somatotropin [Moles/volume] in Serum or Plasma --50 minutes post XXX challenge |
|
1634-5
|
Somatotropin [Mass/volume] in Serum or Plasma --52 hours post 250 ug L-dopa TID 2day PO |
|
17597-6
|
Somatotropin [Mass/volume] in Serum or Plasma --52 hours post XXX challenge |
|
29152-6
|
Somatotropin [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
47924-6
|
Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine |
|
47925-3
|
Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine+insulin |
|
47926-1
|
Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose ornithine |
|
49958-2
|
Somatotropin [Units/volume] in Serum or Plasma --6 AM specimen |
|
56562-2
|
Somatotropin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
56501-0
|
Somatotropin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
56563-0
|
Somatotropin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
79179-8
|
Somatotropin [Units/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
53144-2
|
Somatotropin [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
56502-8
|
Somatotropin [Units/volume] in Serum or Plasma --7 hours post XXX challenge |
|
63444-4
|
Somatotropin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
|
63560-7
|
Somatotropin [Mass/volume] in Serum or Plasma --8.5 hours post XXX challenge |
|
56503-6
|
Somatotropin [Units/volume] in Serum or Plasma --8 hours post XXX challenge |
|
56564-8
|
Somatotropin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
56566-3
|
Somatotropin [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge |
|
68940-6
|
Somatotropin [Mass/volume] in Serum or Plasma --90 minutes post exercise |
|
56982-2
|
Somatotropin [Mass/volume] in Serum or Plasma --90 minutes post resting |
|
56565-5
|
Somatotropin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
|
14253-9
|
Somatotropin Ab [Presence] in Serum or Plasma |
|
5359-5
|
Somatotropin Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
8096-0
|
Somatotropin Ab [Units/volume] in Serum or Plasma |
|
11014-8
|
Somatotropin Ab [Titer] in Serum or Plasma |
|
10513-0
|
Somatotropin Ag [Presence] in Tissue by Immune stain |
|
2962-9
|
Somatotropin [Mass/volume] in Amniotic fluid |
|
12253-1
|
Somatotropin [Mass/volume] in Serum or Plasma --baseline |
|
12694-6
|
Somatotropin [Moles/volume] in Serum or Plasma --post XXX challenge |
|
56571-3
|
Somatotropin [Mass/volume] in Serum or Plasma --post exercise |
|
1635-2
|
Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO |
|
1636-0
|
Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO |
|
47774-5
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine |
|
40302-2
|
Somatotropin [Mass/volume] in Serum or Plasma --pre dose arginine |
|
58948-1
|
Somatotropin [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
12696-1
|
Somatotropin [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
40298-2
|
Somatotropin [Mass/volume] in Serum or Plasma --pre dose cloNIDine |
|
47933-7
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine+insulin |
|
47934-5
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose betaxolol+glucagon |
|
47935-2
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose growth hormone releasing factor |
|
47937-8
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose propranolol+glucagon |
|
47775-2
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose glucagon |
|
47776-0
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose glucose PO |
|
47777-8
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose insulin IV |
|
1637-8
|
Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
|
47936-0
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose ornithine |
|
47778-6
|
Somatotropin [Units/volume] in Serum or Plasma --pre dose TRH |
|
40334-5
|
Somatotropin [Mass/volume] in Serum or Plasma --pre dose triple bolus |
|
34061-2
|
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose arginine |
|
51434-9
|
Somatotropin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
|
34062-0
|
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose cloNIDine |
|
34063-8
|
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucagon |
|
40309-7
|
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucose |
|
34064-6
|
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose insulin |
|
33858-2
|
Somatotropin [Units/volume] in Serum or Plasma |
|
2963-7
|
Somatotropin [Mass/volume] in Serum or Plasma |
|
25529-9
|
Somatotropin [Moles/volume] in Serum or Plasma |
|
47763-8
|
Somatotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
49892-3
|
Somatotropin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25776-6
|
Somatotropin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50493-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1st specimen |
|
47755-4
|
Somatotropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
49895-6
|
Somatotropin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
12693-8
|
Somatotropin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
58856-6
|
Somatotropin [Mass/volume] in Serum or Plasma --10th specimen |
|
27835-8
|
Somatotropin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
25772-5
|
Somatotropin [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
58950-7
|
Somatotropin [Mass/volume] in Serum or Plasma --11th specimen |
|
27836-6
|
Somatotropin [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
25773-3
|
Somatotropin [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
58949-9
|
Somatotropin [Mass/volume] in Serum or Plasma --12th specimen |
|
27837-4
|
Somatotropin [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
25774-1
|
Somatotropin [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
58855-8
|
Somatotropin [Mass/volume] in Serum or Plasma --13th specimen |
|
27838-2
|
Somatotropin [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
25775-8
|
Somatotropin [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
58850-9
|
Somatotropin [Mass/volume] in Serum or Plasma --14th specimen |
|
27359-9
|
Somatotropin [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge |
|
58849-1
|
Somatotropin [Mass/volume] in Serum or Plasma --15th specimen |
|
27840-8
|
Somatotropin [Mass/volume] in Serum or Plasma --16th specimen post XXX challenge |
|
58848-3
|
Somatotropin [Mass/volume] in Serum or Plasma --16th specimen |
|
27841-6
|
Somatotropin [Mass/volume] in Serum or Plasma --17th specimen post XXX challenge |
|
58847-5
|
Somatotropin [Mass/volume] in Serum or Plasma --17th specimen |
|
27385-4
|
Somatotropin [Mass/volume] in Serum or Plasma --18th specimen post XXX challenge |
|
58846-7
|
Somatotropin [Mass/volume] in Serum or Plasma --18th specimen |
|
27842-4
|
Somatotropin [Mass/volume] in Serum or Plasma --19th specimen post XXX challenge |
|
58845-9
|
Somatotropin [Mass/volume] in Serum or Plasma --19th specimen |
|
47767-9
|
Somatotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
27888-7
|
Somatotropin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12685-4
|
Somatotropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50494-4
|
Somatotropin [Mass/volume] in Serum or Plasma --2nd specimen |
|
27843-2
|
Somatotropin [Mass/volume] in Serum or Plasma --20th specimen post XXX challenge |
|
58844-2
|
Somatotropin [Mass/volume] in Serum or Plasma --20th specimen |
|
27844-0
|
Somatotropin [Mass/volume] in Serum or Plasma --21st specimen post XXX challenge |
|
58884-8
|
Somatotropin [Mass/volume] in Serum or Plasma --21st specimen |
|
27366-4
|
Somatotropin [Mass/volume] in Serum or Plasma --22nd specimen post XXX challenge |
|
58883-0
|
Somatotropin [Mass/volume] in Serum or Plasma --22nd specimen |
|
27845-7
|
Somatotropin [Mass/volume] in Serum or Plasma --23rd specimen post XXX challenge |
|
58882-2
|
Somatotropin [Mass/volume] in Serum or Plasma --23rd specimen |
|
27846-5
|
Somatotropin [Mass/volume] in Serum or Plasma --24th specimen post XXX challenge |
|
58843-4
|
Somatotropin [Mass/volume] in Serum or Plasma --24th specimen |
|
27847-3
|
Somatotropin [Mass/volume] in Serum or Plasma --25th specimen post XXX challenge |
|
58842-6
|
Somatotropin [Mass/volume] in Serum or Plasma --25th specimen |
|
58881-4
|
Somatotropin [Mass/volume] in Serum or Plasma --26th specimen |
|
58880-6
|
Somatotropin [Mass/volume] in Serum or Plasma --27th specimen |
|
58879-8
|
Somatotropin [Mass/volume] in Serum or Plasma --28th specimen |
|
58878-0
|
Somatotropin [Mass/volume] in Serum or Plasma --29th specimen |
|
47918-8
|
Somatotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
27889-5
|
Somatotropin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12686-2
|
Somatotropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50495-1
|
Somatotropin [Mass/volume] in Serum or Plasma --3rd specimen |
|
58877-2
|
Somatotropin [Mass/volume] in Serum or Plasma --30th specimen |
|
58876-4
|
Somatotropin [Mass/volume] in Serum or Plasma --31st specimen |
|
58875-6
|
Somatotropin [Mass/volume] in Serum or Plasma --32nd specimen |
|
58874-9
|
Somatotropin [Mass/volume] in Serum or Plasma --33rd specimen |
|
59043-0
|
Somatotropin [Mass/volume] in Serum or Plasma --34th specimen |
|
58873-1
|
Somatotropin [Mass/volume] in Serum or Plasma --35th specimen |
|
58872-3
|
Somatotropin [Mass/volume] in Serum or Plasma --36th specimen |
|
58871-5
|
Somatotropin [Mass/volume] in Serum or Plasma --37th specimen |
|
58870-7
|
Somatotropin [Mass/volume] in Serum or Plasma --38th specimen |
|
58869-9
|
Somatotropin [Mass/volume] in Serum or Plasma --39th specimen |
|
47923-8
|
Somatotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
27881-2
|
Somatotropin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12687-0
|
Somatotropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50496-9
|
Somatotropin [Mass/volume] in Serum or Plasma --4th specimen |
|
58868-1
|
Somatotropin [Mass/volume] in Serum or Plasma --40th specimen |
|
58867-3
|
Somatotropin [Mass/volume] in Serum or Plasma --41st specimen |
|
58866-5
|
Somatotropin [Mass/volume] in Serum or Plasma --42nd specimen |
|
58865-7
|
Somatotropin [Mass/volume] in Serum or Plasma --43rd specimen |
|
58864-0
|
Somatotropin [Mass/volume] in Serum or Plasma --44th specimen |
|
58863-2
|
Somatotropin [Mass/volume] in Serum or Plasma --45th specimen |
|
58862-4
|
Somatotropin [Mass/volume] in Serum or Plasma --46th specimen |
|
58861-6
|
Somatotropin [Mass/volume] in Serum or Plasma --47th specimen |
|
58860-8
|
Somatotropin [Mass/volume] in Serum or Plasma --48th specimen |
|
47927-9
|
Somatotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
27890-3
|
Somatotropin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12688-8
|
Somatotropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50497-7
|
Somatotropin [Mass/volume] in Serum or Plasma --5th specimen |
|
47929-5
|
Somatotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
27328-4
|
Somatotropin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
12689-6
|
Somatotropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50498-5
|
Somatotropin [Mass/volume] in Serum or Plasma --6th specimen |
|
47930-3
|
Somatotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
49893-1
|
Somatotropin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
12690-4
|
Somatotropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50499-3
|
Somatotropin [Mass/volume] in Serum or Plasma --7th specimen |
|
47931-1
|
Somatotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
27829-1
|
Somatotropin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
12691-2
|
Somatotropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50500-8
|
Somatotropin [Mass/volume] in Serum or Plasma --8th specimen |
|
47932-9
|
Somatotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
49894-9
|
Somatotropin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
12692-0
|
Somatotropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
58857-4
|
Somatotropin [Mass/volume] in Serum or Plasma --9th specimen |
|
33859-0
|
Somatotropin/Creatinine [Ratio] in 12 hour Urine |
|
33860-8
|
Somatotropin/Creatinine [Ratio] in 24 hour Urine |
|
44407-5
|
Somatotropin/Creatinine [Mass Ratio] in Urine |
|
90048-0
|
Somatotropin binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
|
11015-5
|
Somatotropin binding protein [Moles/volume] in Serum or Plasma |
|
76474-6
|
Ghrelin [Mass/volume] in Serum or Plasma |
|
12284-6
|
Growth hormone-releasing hormone [Units/volume] in Serum or Plasma |
|
14177-0
|
Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma |
|
80273-6
|
Gastrointestinal assessment [Interpretation] |
|
79390-1
|
Gastrointestinal pathogens identified in Stool by NAA with probe detection |
|
88516-0
|
Gastrointestinal pathogens identified in Unspecified specimen by NAA with probe detection |
|
54911-3
|
Giant grouper IgE Ab [Units/volume] in Serum |
|
82025-8
|
Giant grouper IgE Ab RAST class [Presence] in Serum |
|
50636-0
|
Giant Japanese spider crab IgE Ab [Units/volume] in Serum |
|
5908-9
|
Giant platelets [Presence] in Blood by Light microscopy |
|
32712-2
|
Giant platelets/100 leukocytes [Ratio] in Blood by Manual count |
|
7649-7
|
Giant Ragweed triggered histamine release [Units/volume] in Blood |
|
6124-2
|
Giant Ragweed IgE Ab [Units/volume] in Serum |
|
15978-0
|
Giant Ragweed IgE Ab RAST class [Presence] in Serum |
|
61215-0
|
Giant Ragweed IgE Ab/IgE total in Serum |
|
24151-3
|
Giant Ragweed IgG Ab [Units/volume] in Serum |
|
56370-0
|
Giant Ragweed IgG4 Ab [Mass/volume] in Serum |
|
48255-4
|
Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
27265-8
|
Giardia sp Ag [Presence] in Stool |
|
91761-7
|
Giardia sp Ag [Presence] in Stool by Rapid immunoassay |
|
91767-4
|
Giardia sp DNA [Presence] in Duodenal fluid by NAA with probe detection |
|
91836-7
|
Giardia sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
90299-9
|
Giardia sp DNA [Presence] in Stool by NAA with probe detection |
|
87970-0
|
Microscopic observation [Identifier] in Amniotic fluid by Giemsa stain |
|
88684-6
|
Microscopic observation [Identifier] in Aspirate by Giemsa stain |
|
90261-9
|
Microscopic observation [Identifier] in Bile fluid by Giemsa stain |
|
51714-4
|
Microscopic observation [Identifier] in Blood by Giemsa stain |
|
87965-0
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Giemsa stain |
|
87968-4
|
Microscopic observation [Identifier] in Body fluid by Giemsa stain |
|
91850-8
|
Microscopic observation [Identifier] in Genital specimen by Giemsa stain |
|
88633-3
|
Microscopic observation [Identifier] in Lower respiratory specimen by Giemsa stain |
|
87966-8
|
Microscopic observation [Identifier] in Bone marrow by Giemsa stain |
|
88150-8
|
Microscopic observation [Identifier] in Ocular fluid by Giemsa stain |
|
90267-6
|
Microscopic observation [Identifier] in Pericardial fluid by Giemsa stain |
|
88000-5
|
Microscopic observation [Identifier] in Pleural fluid by Giemsa stain |
|
90268-4
|
Microscopic observation [Identifier] in Peritoneal fluid by Giemsa stain |
|
88235-7
|
Microscopic observation [Identifier] in Synovial fluid by Giemsa stain |
|
6662-1
|
Microscopic observation [Identifier] in Tissue by Giemsa stain |
|
662-7
|
Microscopic observation [Identifier] in Unspecified specimen by Giemsa stain |
|
6663-9
|
Microscopic observation [Identifier] in Tissue by Gimenez stain |
|
663-5
|
Microscopic observation [Identifier] in Unspecified specimen by Gimenez stain |
|
7335-3
|
Ginger IgE Ab [Units/volume] in Serum |
|
15728-9
|
Ginger IgE Ab RAST class [Presence] in Serum |
|
61328-1
|
Ginger IgE Ab/IgE total in Serum |
|
7336-1
|
Ginger IgG Ab [Units/volume] in Serum |
|
21304-1
|
Ginger IgG Ab RAST class [Presence] in Serum |
|
56267-8
|
Ginger IgG4 Ab [Mass/volume] in Serum |
|
60375-3
|
Ginger IgG Ab [Mass/volume] in Serum |
|
2326-7
|
Gastric inhibitory polypeptide [Mass/volume] in Plasma |
|
72178-7
|
Given a mosquito net [RHEA] |
|
72180-3
|
Given iron and folic acid [RHEA] |
|
72179-5
|
Given pyrimethamine sulfadoxine - starting at 4th month [RHEA] |
|
40461-6
|
GJB1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40462-4
|
GJB1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81858-3
|
GJB1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
41102-5
|
GJB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34653-6
|
GJB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82138-9
|
GJB2 gene c.35delG targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
90851-7
|
GJB2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41101-7
|
GJB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35300-3
|
GJB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
71358-6
|
GJB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41100-9
|
GJB6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34504-1
|
GJB6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76036-3
|
GLA gene full mutation analysis in Blood or Tissue by Sequencing |
|
41099-3
|
GLA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34515-7
|
GLA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7337-9
|
Gladiolus IgE Ab [Units/volume] in Serum |
|
85321-8
|
Glandular differentiation [Score] in Breast cancer specimen Qualitative by Nottingham |
|
93331-7
|
Glycolithocholate [Moles/volume] in Serum or Plasma |
|
47860-2
|
Glutamate dehydrogenase [Enzymatic activity/mass] in Chorionic villus sample |
|
2367-1
|
Glutamate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
49940-0
|
Glutamate dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
84904-2
|
Gleason score at positive margin in Prostate tumor Qualitative |
|
35266-6
|
Gleason score in Specimen Qualitative |
|
44641-9
|
Gleason pattern.primary in Prostate tumor |
|
44642-7
|
Gleason pattern.secondary in Prostate tumor |
|
44643-5
|
Gleason pattern.tertiary in Prostate tumor |
|
92733-5
|
Glecaprevir [Susceptibility] by Genotype method |
|
79405-7
|
1,4-Alpha glucan branching enzyme [Enzymatic activity/mass] in Fibroblast |
|
1650-1
|
1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes |
|
16900-3
|
Gliadin Ab [Units/volume] in Saliva (oral fluid) |
|
53025-3
|
Gliadin Ab [Presence] in Serum |
|
7893-1
|
Gliadin Ab [Units/volume] in Serum |
|
20495-8
|
Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
|
16901-1
|
Gliadin IgA Ab [Presence] in Serum |
|
6924-5
|
Gliadin IgA Ab [Units/volume] in Serum |
|
63260-4
|
Gliadin IgA Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
20496-6
|
Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
|
16902-9
|
Gliadin IgG Ab [Presence] in Serum |
|
5170-6
|
Gliadin IgG Ab [Units/volume] in Serum |
|
63261-2
|
Gliadin IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
8070-5
|
Gliadin IgM Ab [Units/volume] in Serum |
|
63453-5
|
Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay |
|
47393-4
|
Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay |
|
58709-7
|
Gliadin peptide IgA Ab [Units/volume] in Serum |
|
63459-2
|
Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay |
|
47394-2
|
Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay |
|
58710-5
|
Gliadin peptide IgG Ab [Units/volume] in Serum |
|
63420-4
|
Gliadin peptide+tissue transglutaminase IgA+IgG Ab [Presence] in Serum by Immunoassay |
|
10756-5
|
Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
|
90828-5
|
Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
90827-7
|
Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
88726-5
|
Glial nuclear type 1 Ab [Units/volume] in Serum by Line blot |
|
84927-3
|
Glial nuclear type 1 Ab [Presence] in Serum by Immunofluorescence |
|
82444-1
|
Glial nuclear type 1 Ab [Presence] in Serum by Line blot |
|
53714-2
|
Glial nuclear type 1 Ab [Titer] in Cerebral spinal fluid |
|
53709-2
|
Glial nuclear type 1 Ab [Titer] in Serum |
|
83001-8
|
Glial nuclear type 1 IgG Ab [Presence] in Serum or Plasma by Line blot |
|
74094-4
|
Gliclazide [Mass/volume] in Serum or Plasma |
|
73363-4
|
Glimepride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73362-6
|
Glimepride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48325-5
|
Glimepride [Presence] in Serum or Plasma |
|
40465-7
|
Glimepride [Mass/volume] in Serum or Plasma |
|
73691-8
|
Glimepride [Mass/volume] in Urine |
|
75119-8
|
Gamma Linolenate (C18:3w6) [Entitic substance] in Red Blood Cells |
|
35163-5
|
Gamma Linolenate (C18:3w6) [Moles/volume] in Serum or Plasma |
|
73360-0
|
Glipizide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73361-8
|
Glipizide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48326-3
|
Glipizide [Presence] in Serum or Plasma |
|
10539-5
|
Glipizide [Mass/volume] in Serum or Plasma |
|
47204-3
|
Glipizide [Presence] in Urine |
|
27025-6
|
Glipizide [Mass/volume] in Urine |
|
48319-8
|
Glipizide [Presence] in Unspecified specimen |
|
6944-3
|
Glipizide [Mass/volume] in Unspecified specimen |
|
74093-6
|
Gliquidone [Mass/volume] in Serum or Plasma |
|
92753-3
|
Globotriaosylsphingosine [Moles/volume] in Blood |
|
92754-1
|
Globotriaosylsphingosine [Moles/volume] in DBS |
|
90234-6
|
Globotriaosylsphingosine [Mass/volume] in Serum |
|
14341-2
|
Globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
15356-9
|
Globulin [Mass/time] in 24 hour Urine |
|
14425-3
|
Globulin [Mass/volume] in Amniotic fluid |
|
14426-1
|
Globulin [Mass/volume] in Cerebral spinal fluid |
|
12217-6
|
Globulin [Mass/volume] in Body fluid |
|
13536-8
|
Globulin [Mass/volume] in Plasma |
|
14427-9
|
Globulin [Mass/volume] in Pleural fluid |
|
14428-7
|
Globulin [Mass/volume] in Peritoneal fluid |
|
10834-0
|
Globulin [Mass/volume] in Serum by calculation |
|
2336-6
|
Globulin [Mass/volume] in Serum |
|
14429-5
|
Globulin [Mass/volume] in Semen |
|
14430-3
|
Globulin [Mass/volume] in Synovial fluid |
|
18320-2
|
Globulin [Mass/volume] in Urine by calculation |
|
49047-4
|
Globulin [Mass/volume] in Urine by Electrophoresis |
|
14431-1
|
Globulin [Mass/volume] in Urine |
|
47960-0
|
GLRA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44361-4
|
Glutamate+Glutamine/Creatinine [Mass Ratio] in Urine |
|
44360-6
|
Glutamate+Glutamine/Creatinine [Molar ratio] in Urine |
|
15134-0
|
Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
|
15144-9
|
Glutamate+Glutamine+Threonine [Presence] in Urine |
|
10485-1
|
Glucagon Ag [Presence] in Tissue by Immune stain |
|
2337-4
|
Glucagon [Mass/volume] in Amniotic fluid |
|
47209-2
|
Glucagon [Mass] of Dose |
|
65344-4
|
Glucagon [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
2338-2
|
Glucagon [Mass/volume] in Serum or Plasma |
|
66734-5
|
Glucagon [Mass or Moles/volume] in Serum or Plasma |
|
15073-0
|
Glucagon [Moles/volume] in Serum or Plasma |
|
65345-1
|
Glucagon [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
59057-0
|
Glucagon [Mass/volume] in Serum or Plasma --1st specimen fasting |
|
65346-9
|
Glucagon [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
59056-2
|
Glucagon [Mass/volume] in Serum or Plasma --2nd specimen fasting |
|
65347-7
|
Glucagon [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
59055-4
|
Glucagon [Mass/volume] in Serum or Plasma --3rd specimen fasting |
|
65348-5
|
Glucagon [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
59054-7
|
Glucagon [Mass/volume] in Serum or Plasma --4th specimen fasting |
|
65349-3
|
Glucagon [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
59053-9
|
Glucagon [Mass/volume] in Serum or Plasma --5th specimen fasting |
|
59578-5
|
Glucagon [Mass/volume] in Serum or Plasma --6th specimen fasting |
|
59577-7
|
Glucagon [Mass/volume] in Serum or Plasma --7th specimen fasting |
|
81322-0
|
Glucan 1,4 alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue |
|
92751-7
|
Glucopsychosine [Moles/volume] in Blood |
|
92752-5
|
Glucopsychosine [Moles/volume] in DBS |
|
92750-9
|
Glucopsychosine [Moles/volume] in Serum or Plasma |
|
80093-8
|
Glucosamine [Moles/volume] in Serum or Plasma |
|
80098-7
|
Glucosamine/Creatinine [Molar ratio] in Urine |
|
35662-6
|
Glucose [Mass/volume] in Urine collected for unspecified duration |
|
74351-8
|
Glucose [Moles/volume] in Urine collected for unspecified duration |
|
30265-3
|
Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose glucose |
|
54266-2
|
Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose insulin IV |
|
1492-8
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV |
|
1494-4
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO |
|
1495-1
|
Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO |
|
6762-9
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
|
14751-2
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
|
6761-1
|
Glucose [Presence] in Urine by Test strip --1.5 hours post 50 g lactose PO |
|
1496-9
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
|
55351-1
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
|
6763-7
|
Glucose [Presence] in Urine by Test strip --1.5 hours post 75 g glucose PO |
|
53487-5
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose betaxolol |
|
40003-6
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
59793-0
|
Glucose [Molar concentration difference] in Serum or Plasma --1.5 hours post XXX challenge |
|
25679-2
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
92669-1
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine |
|
51767-2
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose fructose PO |
|
20440-4
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
14752-0
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
26553-8
|
Glucose [Presence] in Urine by Test strip --1.5 hours post dose glucose |
|
25678-4
|
Glucose [Mass/volume] in Urine --1.5 hours post dose glucose |
|
1497-7
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
54267-0
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
26779-9
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose lactose PO |
|
40278-4
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO |
|
80959-0
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post meal |
|
44919-9
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post meal |
|
54277-9
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hour post dose ornithine alpha-ketoglutarate |
|
75405-1
|
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus |
|
1493-6
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
|
30266-1
|
Glucose [Moles/volume] in Serum or Plasma --1.6 hours post dose glucose |
|
16165-3
|
Glucose [Mass/volume] in Serum or Plasma --10 AM specimen |
|
48991-4
|
Glucose [Mass/volume] in Serum or Plasma --10 PM specimen |
|
40259-4
|
Glucose [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge |
|
40260-2
|
Glucose [Mass/volume] in Serum or Plasma --10.75 hours post XXX challenge |
|
40174-5
|
Glucose [Moles/volume] in Serum or Plasma --10.75 hours post XXX challenge |
|
40004-4
|
Glucose [Mass/volume] in Serum or Plasma --100 minutes post XXX challenge |
|
21308-2
|
Glucose [Mass/volume] in Serum or Plasma --105 minutes post XXX challenge |
|
40286-7
|
Glucose [Moles/volume] in Serum or Plasma --105 minutes post dose glucose |
|
12645-8
|
Glucose [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
|
40173-7
|
Glucose [Moles/volume] in Serum or Plasma --10 hours post XXX challenge |
|
21307-4
|
Glucose [Mass/time] in 10 hour Urine |
|
1498-5
|
Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV |
|
12654-0
|
Glucose [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
40154-7
|
Glucose [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
92819-2
|
Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucagon |
|
54401-5
|
Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucagon |
|
48984-9
|
Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucose |
|
32359-2
|
Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucose |
|
12651-6
|
Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge |
|
40151-3
|
Glucose [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge |
|
54248-0
|
Glucose [Moles/volume] in Serum or Plasma --10 minutes pre dose glucagon |
|
16166-1
|
Glucose [Mass/volume] in Serum or Plasma --11 AM specimen |
|
59812-8
|
Glucose [Moles/volume] in Serum or Plasma --11 AM specimen |
|
40008-5
|
Glucose [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge |
|
40175-2
|
Glucose [Moles/volume] in Serum or Plasma --11.5 hours post XXX challenge |
|
40005-1
|
Glucose [Mass/volume] in Serum or Plasma --110 minutes post XXX challenge |
|
26817-7
|
Glucose [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
|
77681-5
|
Glucose [Moles/volume] in Serum or Plasma --11 hour post XXX challenge |
|
48992-2
|
Glucose [Mass/volume] in Serum or Plasma --12 AM specimen |
|
45052-8
|
Glucose [Moles/volume] in Serum or Plasma --12 AM specimen |
|
48988-0
|
Glucose [Mass/volume] in Serum or Plasma --12 PM specimen |
|
45054-4
|
Glucose [Moles/volume] in Serum or Plasma --12 PM specimen |
|
40009-3
|
Glucose [Mass/volume] in Serum or Plasma --12.5 hours post XXX challenge |
|
40177-8
|
Glucose [Moles/volume] in Serum or Plasma --12.5 hours post XXX challenge |
|
18354-1
|
Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO |
|
12647-4
|
Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
|
40176-0
|
Glucose [Moles/volume] in Serum or Plasma --12 hours post XXX challenge |
|
12220-0
|
Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
|
74687-5
|
Glucose [Moles/volume] in 12 hour Urine |
|
74686-7
|
Glucose [Moles/time] in 12 hour Urine |
|
40028-3
|
Glucose [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge |
|
40204-0
|
Glucose [Moles/volume] in Serum or Plasma --12 minutes post XXX challenge |
|
40011-9
|
Glucose [Mass/volume] in Serum or Plasma --13.5 hours post XXX challenge |
|
40179-4
|
Glucose [Moles/volume] in Serum or Plasma --13.5 hours post XXX challenge |
|
40010-1
|
Glucose [Mass/volume] in Serum or Plasma --13 hours post XXX challenge |
|
40178-6
|
Glucose [Moles/volume] in Serum or Plasma --13 hours post XXX challenge |
|
40261-0
|
Glucose [Mass/volume] in Serum or Plasma --13 minutes pre XXX challenge |
|
40195-0
|
Glucose [Moles/volume] in Serum or Plasma --13 minutes pre XXX challenge |
|
40012-7
|
Glucose [Mass/volume] in Serum or Plasma --14 hours post XXX challenge |
|
40180-2
|
Glucose [Moles/volume] in Serum or Plasma --14 hours post XXX challenge |
|
40029-1
|
Glucose [Mass/volume] in Serum or Plasma --14 minutes post XXX challenge |
|
40205-7
|
Glucose [Moles/volume] in Serum or Plasma --14 minutes post XXX challenge |
|
40013-5
|
Glucose [Mass/volume] in Serum or Plasma --15.5 hours post XXX challenge |
|
40181-0
|
Glucose [Moles/volume] in Serum or Plasma --15.5 hours post XXX challenge |
|
50751-7
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post 0.1 U/kg insulin |
|
11142-7
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post 100 g glucose PO |
|
10832-4
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
|
74084-5
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
|
79193-9
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
|
12639-1
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
40155-4
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
54249-8
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucagon |
|
25663-6
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucose |
|
54260-5
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose insulin IV |
|
12648-2
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose lactose PO |
|
72896-4
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO |
|
54271-2
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose ornithine alpha-ketoglutarate |
|
40319-6
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
53481-8
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose betaxolol |
|
39999-8
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
40150-5
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
54250-6
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucagon |
|
48109-3
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucose |
|
54261-3
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose insulin IV |
|
54272-0
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose ornithine alpha-ketoglutarate |
|
40014-3
|
Glucose [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
|
40182-8
|
Glucose [Moles/volume] in Serum or Plasma --16 hours post XXX challenge |
|
40030-9
|
Glucose [Mass/volume] in Serum or Plasma --16 minutes post XXX challenge |
|
40206-5
|
Glucose [Moles/volume] in Serum or Plasma --16 minutes post XXX challenge |
|
40015-0
|
Glucose [Mass/volume] in Serum or Plasma --17.5 hours post XXX challenge |
|
40183-6
|
Glucose [Moles/volume] in Serum or Plasma --17.5 hours post XXX challenge |
|
40017-6
|
Glucose [Mass/volume] in Serum or Plasma --18.5 hours post XXX challenge |
|
40185-1
|
Glucose [Moles/volume] in Serum or Plasma --18.5 hours post XXX challenge |
|
40016-8
|
Glucose [Mass/volume] in Serum or Plasma --18 hours post XXX challenge |
|
40184-4
|
Glucose [Moles/volume] in Serum or Plasma --18 hours post XXX challenge |
|
58997-8
|
Glucose [Mass/time] in 18 hour Urine |
|
40018-4
|
Glucose [Mass/volume] in Serum or Plasma --19.5 hours post XXX challenge |
|
40186-9
|
Glucose [Moles/volume] in Serum or Plasma --19.5 hours post XXX challenge |
|
40031-7
|
Glucose [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge |
|
40207-3
|
Glucose [Moles/volume] in Serum or Plasma --19 minutes post XXX challenge |
|
40024-2
|
Glucose [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
|
40192-7
|
Glucose [Moles/volume] in Serum or Plasma --1 day post XXX challenge |
|
1499-3
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
|
30344-6
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 1.2 g/kg lactose PO |
|
1501-6
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
14753-8
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
1503-2
|
Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
|
1504-0
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
|
14754-6
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
|
1505-7
|
Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO |
|
1506-5
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
|
14755-3
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
|
6747-0
|
Glucose [Presence] in Urine by Test strip --1 hour post 50 g lactose PO |
|
1507-3
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
51597-3
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
6748-8
|
Glucose [Presence] in Urine by Test strip --1 hour post 75 g glucose PO |
|
1509-9
|
Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO |
|
79196-2
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
|
53486-7
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose betaxolol |
|
12646-6
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
59792-2
|
Glucose [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge |
|
25665-1
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
92668-3
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine |
|
48605-0
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose fructose PO |
|
19104-9
|
Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose |
|
20438-8
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
|
14756-1
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
|
26546-2
|
Glucose [Presence] in Urine by Test strip --1 hour post dose glucose |
|
25664-4
|
Glucose [Mass/volume] in Urine --1 hour post dose glucose |
|
1510-7
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
54265-4
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
26778-1
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose lactose PO |
|
40277-6
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO |
|
42611-4
|
Glucose [Mass/volume] in Urine --1 hour post dose lactose PO |
|
10449-7
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
|
40287-5
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post meal |
|
56124-1
|
Glucose [Mass/volume] in Urine --1 hour post meal |
|
54276-1
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose ornithine alpha-ketoglutarate |
|
40322-0
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
1500-8
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
1512-3
|
Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV |
|
57350-1
|
Glucose [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
|
16167-9
|
Glucose [Mass/volume] in Serum or Plasma --2 PM specimen |
|
56751-1
|
Glucose [Mass/volume] in Serum or Plasma --2.17 hours post XXX challenge |
|
30267-9
|
Glucose [Moles/volume] in Serum or Plasma --2.3 hours post dose glucose |
|
9375-7
|
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 100 g glucose PO |
|
13865-1
|
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
|
45298-7
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
|
6749-6
|
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
|
55381-8
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
|
10966-0
|
Glucose [Presence] in Urine by Test strip --2.5 hours post 75 g glucose PO |
|
53480-0
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose betaxolol |
|
29332-4
|
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
40161-2
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
51766-4
|
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose fructose PO |
|
26554-6
|
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose glucose |
|
25666-9
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose |
|
26537-1
|
Glucose [Presence] in Urine by Test strip --2.5 hours post dose glucose |
|
54259-7
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose insulin IV |
|
72895-6
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose lactose PO |
|
54270-4
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hour post dose ornithine alpha-ketoglutarate |
|
30251-3
|
Glucose [Moles/volume] in Serum or Plasma --2.6 hours post dose glucose |
|
40020-0
|
Glucose [Mass/volume] in Serum or Plasma --20.5 hours post XXX challenge |
|
40188-5
|
Glucose [Moles/volume] in Serum or Plasma --20.5 hours post XXX challenge |
|
40019-2
|
Glucose [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
|
40187-7
|
Glucose [Moles/volume] in Serum or Plasma --20 hours post XXX challenge |
|
1513-1
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV |
|
53928-8
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes post 50 g lactose PO |
|
69943-9
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post 50 g lactose PO |
|
12655-7
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
40156-2
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
92818-4
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucagon |
|
54251-4
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucagon |
|
48985-6
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucose |
|
30263-8
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucose |
|
69941-3
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose lactose PO |
|
48983-1
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge |
|
40194-3
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge |
|
40021-8
|
Glucose [Mass/volume] in Serum or Plasma --21.5 hours post XXX challenge |
|
40189-3
|
Glucose [Moles/volume] in Serum or Plasma --21.5 hours post XXX challenge |
|
40022-6
|
Glucose [Mass/volume] in Serum or Plasma --22 hours post XXX challenge |
|
40190-1
|
Glucose [Moles/volume] in Serum or Plasma --22 hours post XXX challenge |
|
40032-5
|
Glucose [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge |
|
40208-1
|
Glucose [Moles/volume] in Serum or Plasma --22 minutes post XXX challenge |
|
40023-4
|
Glucose [Mass/volume] in Serum or Plasma --23.5 hours post XXX challenge |
|
40191-9
|
Glucose [Moles/volume] in Serum or Plasma --23.5 hours post XXX challenge |
|
12629-2
|
Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid |
|
45297-9
|
Glucose [Moles/volume] in 24 hour Dialysis fluid |
|
40366-7
|
Glucose [Moles/time] in 24 hour Body fluid |
|
48787-6
|
Glucose [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
|
55860-1
|
Glucose [Mass/time] in 24 hour Stool |
|
32174-5
|
Glucose [Presence] in 24 hour Urine |
|
21305-8
|
Glucose [Mass/volume] in 24 hour Urine |
|
2351-5
|
Glucose [Mass/time] in 24 hour Urine |
|
25916-8
|
Glucose [Moles/volume] in 24 hour Urine |
|
15077-1
|
Glucose [Moles/time] in 24 hour Urine |
|
40037-4
|
Glucose [Mass/volume] in Serum or Plasma --25 hours post XXX challenge |
|
40214-9
|
Glucose [Moles/volume] in Serum or Plasma --25 hours post XXX challenge |
|
40033-3
|
Glucose [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge |
|
40209-9
|
Glucose [Moles/volume] in Serum or Plasma --25 minutes post XXX challenge |
|
40038-2
|
Glucose [Mass/volume] in Serum or Plasma --26 hours post XXX challenge |
|
40215-6
|
Glucose [Moles/volume] in Serum or Plasma --26 hours post XXX challenge |
|
40039-0
|
Glucose [Mass/volume] in Serum or Plasma --27 hours post XXX challenge |
|
40216-4
|
Glucose [Moles/volume] in Serum or Plasma --27 hours post XXX challenge |
|
40034-1
|
Glucose [Mass/volume] in Serum or Plasma --27 minutes post XXX challenge |
|
40210-7
|
Glucose [Moles/volume] in Serum or Plasma --27 minutes post XXX challenge |
|
40040-8
|
Glucose [Mass/volume] in Serum or Plasma --28 hours post XXX challenge |
|
40217-2
|
Glucose [Moles/volume] in Serum or Plasma --28 hours post XXX challenge |
|
40041-6
|
Glucose [Mass/volume] in Serum or Plasma --29 hours post XXX challenge |
|
40218-0
|
Glucose [Moles/volume] in Serum or Plasma --29 hours post XXX challenge |
|
40045-7
|
Glucose [Mass/volume] in Serum or Plasma --2 days post XXX challenge |
|
40222-2
|
Glucose [Moles/volume] in Serum or Plasma --2 days post XXX challenge |
|
12608-6
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
78534-5
|
Glucose [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
30345-3
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 1.2 g/kg lactose PO |
|
1514-9
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
14757-9
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
1516-4
|
Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO |
|
41024-1
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g glucose PO |
|
1517-2
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
|
14758-7
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
|
6750-4
|
Glucose [Presence] in Urine by Test strip --2 hours post 50 g lactose PO |
|
1518-0
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
14995-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
6751-2
|
Glucose [Presence] in Urine by Test strip --2 hours post 75 g glucose PO |
|
1520-6
|
Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
|
53476-8
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose betaxolol |
|
12610-2
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
59794-8
|
Glucose [Molar concentration difference] in Serum or Plasma --2 hours post XXX challenge |
|
25668-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
92670-9
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine |
|
51769-8
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose fructose PO |
|
49134-0
|
Glucose [Mass/volume] in Blood --2 hours post dose glucose |
|
20436-2
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
|
14759-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
|
26547-0
|
Glucose [Presence] in Urine by Test strip --2 hours post dose glucose |
|
25667-7
|
Glucose [Mass/volume] in Urine --2 hours post dose glucose |
|
54258-9
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose insulin IV |
|
26780-7
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose lactose PO |
|
40279-2
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO |
|
42613-0
|
Glucose [Mass/volume] in Urine --2 hours post dose lactose PO |
|
14760-3
|
Glucose [Moles/volume] in Capillary blood --2 hours post meal |
|
6689-4
|
Glucose [Mass/volume] in Blood --2 hours post meal |
|
43278-1
|
Glucose [Mass/volume] in Milk --2 hours post meal |
|
77677-3
|
Glucose [Moles/volume] in Serum, Plasma or Blood --2 hours post meal |
|
1521-4
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
|
14761-1
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
|
54269-6
|
Glucose [Moles/volume] in Serum or Plasma --2 hour post dose ornithine alpha-ketoglutarate |
|
12218-4
|
Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
40323-8
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
12612-8
|
Glucose [Mass/volume] in Dialysis fluid --2 hour specimen |
|
46221-8
|
Glucose [Moles/volume] in Dialysis fluid --2 hour specimen |
|
12652-4
|
Glucose [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
40198-4
|
Glucose [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
54252-2
|
Glucose [Moles/volume] in Serum or Plasma --2 minutes post dose glucagon |
|
48993-0
|
Glucose [Mass/volume] in Serum or Plasma --3 AM specimen |
|
16168-7
|
Glucose [Mass/volume] in Serum or Plasma --3 PM specimen |
|
59815-1
|
Glucose [Moles/volume] in Serum or Plasma --3 PM specimen |
|
30252-1
|
Glucose [Moles/volume] in Serum or Plasma --3.3 hours post dose glucose |
|
9376-5
|
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post 100 g glucose PO |
|
6752-0
|
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO |
|
10967-8
|
Glucose [Presence] in Urine by Test strip --3.5 hours post 75 g glucose PO |
|
29329-0
|
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
40211-5
|
Glucose [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
26555-3
|
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose glucose |
|
25669-3
|
Glucose [Moles/volume] in Serum or Plasma --3.5 hours post dose glucose |
|
26538-9
|
Glucose [Presence] in Urine by Test strip --3.5 hours post dose glucose |
|
12650-8
|
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose lactose PO |
|
30253-9
|
Glucose [Moles/volume] in Serum or Plasma --3.6 hours post dose glucose |
|
40042-4
|
Glucose [Mass/volume] in Serum or Plasma --30 hours post XXX challenge |
|
40219-8
|
Glucose [Moles/volume] in Serum or Plasma --30 hours post XXX challenge |
|
1522-2
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.5 g/kg glucose IV |
|
1524-8
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin |
|
33024-1
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 1.2 g/kg lactose PO |
|
1525-5
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 100 g glucose PO |
|
1491-0
|
Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO |
|
1526-3
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
|
14762-9
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
|
6753-8
|
Glucose [Presence] in Urine by Test strip --30 minutes post 50 g lactose PO |
|
1527-1
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
|
32319-6
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
|
6754-6
|
Glucose [Presence] in Urine by Test strip --30 minutes post 75 g glucose PO |
|
79194-7
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
|
53483-4
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose betaxolol |
|
40263-6
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
59791-4
|
Glucose [Molar concentration difference] in Serum or Plasma --30 minutes post XXX challenge |
|
25671-9
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
92667-5
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine |
|
48607-6
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose fructose PO |
|
92817-6
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon |
|
20439-6
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
|
14763-7
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
|
26548-8
|
Glucose [Presence] in Urine by Test strip --30 minutes post dose glucose |
|
25670-1
|
Glucose [Mass/volume] in Urine --30 minutes post dose glucose |
|
1528-9
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
54263-9
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
26777-3
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose lactose PO |
|
40276-8
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO |
|
42615-5
|
Glucose [Mass/volume] in Urine --30 minutes post dose lactose PO |
|
54274-6
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose ornithine alpha-ketoglutarate |
|
40320-4
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
1523-0
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
53484-2
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes pre dose betaxolol |
|
39998-0
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
40149-7
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
40043-2
|
Glucose [Mass/volume] in Serum or Plasma --31 hour post XXX challenge |
|
40220-6
|
Glucose [Moles/volume] in Serum or Plasma --31 hour post XXX challenge |
|
40044-0
|
Glucose [Mass/volume] in Serum or Plasma --36 hours post XXX challenge |
|
40221-4
|
Glucose [Moles/volume] in Serum or Plasma --36 hours post XXX challenge |
|
30346-1
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post 1.2 g/kg lactose PO |
|
1530-5
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
|
14764-5
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
|
1532-1
|
Glucose [Mass/volume] in Urine --3 hours post 100 g glucose PO |
|
13606-9
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO |
|
1533-9
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
|
32320-4
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
|
6755-3
|
Glucose [Presence] in Urine by Test strip --3 hours post 75 g glucose PO |
|
57970-6
|
Glucose [Mass/volume] in Urine --3 hours post 75 g glucose PO |
|
53482-6
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose betaxolol |
|
18342-6
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
59795-5
|
Glucose [Molar concentration difference] in Serum or Plasma --3 hours post XXX challenge |
|
40162-0
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
51768-0
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose fructose PO |
|
19105-6
|
Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose |
|
20437-0
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose |
|
14765-2
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
|
26549-6
|
Glucose [Presence] in Urine by Test strip --3 hours post dose glucose |
|
26540-5
|
Glucose [Mass/volume] in Urine --3 hours post dose glucose |
|
26781-5
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO |
|
40280-0
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose lactose PO |
|
42604-9
|
Glucose [Mass/volume] in Urine --3 hours post dose lactose PO |
|
54273-8
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose ornithine alpha-ketoglutarate |
|
40324-6
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
54262-1
|
Glucose [Moles/volume] in Serum or Plasma --3 hours pre dose insulin IV |
|
1534-7
|
Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV |
|
40025-9
|
Glucose [Mass/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
40199-2
|
Glucose [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
40262-8
|
Glucose [Mass/volume] in Serum or Plasma --3 minutes pre XXX challenge |
|
40197-6
|
Glucose [Moles/volume] in Serum or Plasma --3 minutes pre XXX challenge |
|
53474-3
|
Glucose [Moles/volume] in Serum or Plasma --4 AM specimen |
|
16169-5
|
Glucose [Mass/volume] in Serum or Plasma --4 PM specimen |
|
45055-1
|
Glucose [Moles/volume] in Serum or Plasma --4 PM specimen |
|
9377-3
|
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post 100 g glucose PO |
|
6756-1
|
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO |
|
10968-6
|
Glucose [Presence] in Urine by Test strip --4.5 hours post 75 g glucose PO |
|
40035-8
|
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
|
40212-3
|
Glucose [Moles/volume] in Serum or Plasma --4.5 hours post XXX challenge |
|
25672-7
|
Glucose [Moles/volume] in Serum or Plasma --4.5 hours post dose glucose |
|
1535-4
|
Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV |
|
53929-6
|
Glucose [Mass/volume] in Serum or Plasma --40 minutes post 50 g lactose PO |
|
69944-7
|
Glucose [Moles/volume] in Serum or Plasma --40 minutes post 50 g lactose PO |
|
12657-3
|
Glucose [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
40157-0
|
Glucose [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
30264-6
|
Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose glucose |
|
69942-1
|
Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose lactose PO |
|
11143-5
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post 100 g glucose PO |
|
11032-0
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
|
75637-9
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
|
55352-9
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post 75 g glucose PO |
|
79195-4
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
|
53485-9
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose betaxolol |
|
21309-0
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
25674-3
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
26539-7
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose glucose |
|
25673-5
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose glucose |
|
1536-2
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
54264-7
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
32820-3
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose lactose PO |
|
45299-5
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO |
|
54275-3
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose ornithine alpha-ketoglutarate |
|
40321-2
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus |
|
12609-4
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
78535-2
|
Glucose [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
1537-0
|
Glucose [Mass/volume] in Serum or Plasma --4 hours post 100 g glucose PO |
|
1538-8
|
Glucose [Mass/volume] in Urine --4 hours post 100 g glucose PO |
|
13607-7
|
Glucose [Mass/volume] in Serum or Plasma --4 hours post 50 g lactose PO |
|
1539-6
|
Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
|
32321-2
|
Glucose [Moles/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
|
6757-9
|
Glucose [Presence] in Urine by Test strip --4 hours post 75 g glucose PO |
|
29330-8
|
Glucose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
59796-3
|
Glucose [Molar concentration difference] in Serum or Plasma --4 hours post XXX challenge |
|
40163-8
|
Glucose [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
26541-3
|
Glucose [Mass/volume] in Serum or Plasma --4 hours post dose glucose |
|
14766-0
|
Glucose [Moles/volume] in Serum or Plasma --4 hours post dose glucose |
|
26550-4
|
Glucose [Presence] in Urine by Test strip --4 hours post dose glucose |
|
25675-0
|
Glucose [Mass/volume] in Urine --4 hours post dose glucose |
|
26782-3
|
Glucose [Mass/volume] in Serum or Plasma --4 hours post dose lactose PO |
|
42629-6
|
Glucose [Mass/volume] in Urine --4 hours post dose lactose PO |
|
56160-5
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hours post peritoneal dialysis |
|
12219-2
|
Glucose [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
|
12613-6
|
Glucose [Mass/volume] in Dialysis fluid --4 hour specimen |
|
46222-6
|
Glucose [Moles/volume] in Dialysis fluid --4 hour specimen |
|
12611-0
|
Glucose [Mass/volume] in Serum or Plasma --4 hour specimen |
|
12656-5
|
Glucose [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
|
40200-8
|
Glucose [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge |
|
54253-0
|
Glucose [Moles/volume] in Serum or Plasma --4 minutes post dose glucagon |
|
57971-4
|
Glucose [Mass/volume] in Serum or Plasma --4th specimen post lactose |
|
16170-3
|
Glucose [Mass/volume] in Serum or Plasma --5 PM specimen |
|
9378-1
|
Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 100 g glucose PO |
|
14137-4
|
Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 75 g glucose PO |
|
40036-6
|
Glucose [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
|
40213-1
|
Glucose [Moles/volume] in Serum or Plasma --5.5 hours post XXX challenge |
|
25676-8
|
Glucose [Moles/volume] in Serum or Plasma --5.5 hours post dose glucose |
|
12658-1
|
Glucose [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
|
40158-8
|
Glucose [Moles/volume] in Serum or Plasma --50 minutes post XXX challenge |
|
1540-4
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post 100 g glucose PO |
|
1541-2
|
Glucose [Mass/volume] in Urine --5 hours post 100 g glucose PO |
|
48810-6
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g glucose PO |
|
13866-9
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g lactose PO |
|
1542-0
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
|
32322-0
|
Glucose [Moles/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
|
6758-7
|
Glucose [Presence] in Urine by Test strip --5 hours post 75 g glucose PO |
|
29331-6
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
59797-1
|
Glucose [Molar concentration difference] in Serum or Plasma --5 hours post XXX challenge |
|
40164-6
|
Glucose [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
26543-9
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post dose glucose |
|
14767-8
|
Glucose [Moles/volume] in Serum or Plasma --5 hours post dose glucose |
|
26551-2
|
Glucose [Presence] in Urine by Test strip --5 hours post dose glucose |
|
26542-1
|
Glucose [Mass/volume] in Urine --5 hours post dose glucose |
|
26783-1
|
Glucose [Mass/volume] in Serum or Plasma --5 hours post dose lactose PO |
|
42631-2
|
Glucose [Mass/volume] in Urine --5 hours post dose lactose PO |
|
1543-8
|
Glucose [Mass/volume] in Serum or Plasma --5 minutes post 0.5 g/kg glucose IV |
|
40001-0
|
Glucose [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
40153-9
|
Glucose [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
47859-4
|
Glucose [Moles/volume] in Serum or Plasma --5 minutes post dose glucose |
|
40000-2
|
Glucose [Mass/volume] in Serum or Plasma --5 minutes pre XXX challenge |
|
40152-1
|
Glucose [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge |
|
54254-8
|
Glucose [Moles/volume] in Serum or Plasma --5 minutes pre dose glucagon |
|
57972-2
|
Glucose [Mass/volume] in Serum or Plasma --5th specimen post lactose |
|
48994-8
|
Glucose [Mass/volume] in Serum or Plasma --6 AM specimen |
|
48989-8
|
Glucose [Mass/volume] in Serum or Plasma --6 PM specimen |
|
12640-9
|
Glucose [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
40166-1
|
Glucose [Moles/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
1544-6
|
Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO |
|
1546-1
|
Glucose [Mass/volume] in Urine --6 hours post 100 g glucose PO |
|
18353-3
|
Glucose [Mass/volume] in Serum or Plasma --6 hours post 50 g lactose PO |
|
6760-3
|
Glucose [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO |
|
6759-5
|
Glucose [Presence] in Urine by Test strip --6 hours post 75 g glucose PO |
|
29412-4
|
Glucose [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
40165-3
|
Glucose [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
|
26544-7
|
Glucose [Mass/volume] in Serum or Plasma --6 hours post dose glucose |
|
25677-6
|
Glucose [Moles/volume] in Serum or Plasma --6 hours post dose glucose |
|
26552-0
|
Glucose [Presence] in Urine by Test strip --6 hours post dose glucose |
|
26545-4
|
Glucose [Mass/volume] in Urine --6 hours post dose glucose |
|
42609-8
|
Glucose [Mass/volume] in Urine --6 hours post dose lactose PO |
|
18227-9
|
Glucose [Mass/time] in 6 hour Urine |
|
40026-7
|
Glucose [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge |
|
40201-6
|
Glucose [Moles/volume] in Serum or Plasma --6 minutes post XXX challenge |
|
54255-5
|
Glucose [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon |
|
59813-6
|
Glucose [Moles/volume] in Capillary blood by Glucometer --7 AM specimen |
|
59814-4
|
Glucose [Moles/volume] in Serum or Plasma --7 AM specimen |
|
12642-5
|
Glucose [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
40168-7
|
Glucose [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
12659-9
|
Glucose [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
|
40159-6
|
Glucose [Moles/volume] in Serum or Plasma --70 minutes post XXX challenge |
|
21310-8
|
Glucose [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
40160-4
|
Glucose [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
40285-9
|
Glucose [Moles/volume] in Serum or Plasma --75 minutes post dose glucose |
|
12641-7
|
Glucose [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
|
40167-9
|
Glucose [Moles/volume] in Serum or Plasma --7 hours post XXX challenge |
|
12614-4
|
Glucose [Mass/volume] in Serum or Plasma --7 hours post meal |
|
48986-4
|
Glucose [Mass/volume] in Serum or Plasma --8 AM specimen |
|
45053-6
|
Glucose [Moles/volume] in Serum or Plasma --8 AM specimen |
|
48990-6
|
Glucose [Mass/volume] in Serum or Plasma --8 PM specimen |
|
45056-9
|
Glucose [Moles/volume] in Serum or Plasma --8 PM specimen |
|
40006-9
|
Glucose [Mass/volume] in Serum or Plasma --8.5 hours post XXX challenge |
|
40170-3
|
Glucose [Moles/volume] in Serum or Plasma --8.5 hours post XXX challenge |
|
40002-8
|
Glucose [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge |
|
12643-3
|
Glucose [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
40169-5
|
Glucose [Moles/volume] in Serum or Plasma --8 hours post XXX challenge |
|
21306-6
|
Glucose [Mass/time] in 8 hour Urine |
|
12653-2
|
Glucose [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
|
40202-4
|
Glucose [Moles/volume] in Serum or Plasma --8 minutes post XXX challenge |
|
54256-3
|
Glucose [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon |
|
40196-8
|
Glucose [Moles/volume] in Serum or Plasma --8 minutes pre XXX challenge |
|
40007-7
|
Glucose [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge |
|
40172-9
|
Glucose [Moles/volume] in Serum or Plasma --9.5 hours post XXX challenge |
|
12644-1
|
Glucose [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
|
40171-1
|
Glucose [Moles/volume] in Serum or Plasma --9 hours post XXX challenge |
|
40027-5
|
Glucose [Mass/volume] in Serum or Plasma --9 minutes post XXX challenge |
|
40203-2
|
Glucose [Moles/volume] in Serum or Plasma --9 minutes post XXX challenge |
|
6300-8
|
Glucose [Mass/volume] in Amniotic fluid |
|
2341-6
|
Glucose [Mass/volume] in Blood by Test strip manual |
|
5914-7
|
Glucose [Presence] in Blood by Test strip |
|
2340-8
|
Glucose [Mass/volume] in Blood by Automated test strip |
|
72516-8
|
Glucose [Moles/volume] in Blood by Automated test strip |
|
41651-1
|
Glucose [Mass/volume] in Arterial blood |
|
39481-7
|
Glucose [Moles/volume] in Arterial blood |
|
41653-7
|
Glucose [Mass/volume] in Capillary blood by Glucometer |
|
14743-9
|
Glucose [Moles/volume] in Capillary blood by Glucometer |
|
32016-8
|
Glucose [Mass/volume] in Capillary blood |
|
47995-6
|
Glucose [Moles/volume] in Cord blood |
|
51596-5
|
Glucose [Moles/volume] in Capillary blood |
|
2339-0
|
Glucose [Mass/volume] in Blood |
|
15074-8
|
Glucose [Moles/volume] in Blood |
|
41652-9
|
Glucose [Mass/volume] in Venous blood |
|
39480-9
|
Glucose [Moles/volume] in Venous blood |
|
40858-3
|
Glucose [Mass/volume] in Capillary blood --baseline |
|
61153-3
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --baseline |
|
1547-9
|
Glucose [Mass/volume] in Serum or Plasma --baseline |
|
14768-6
|
Glucose [Moles/volume] in Serum or Plasma --baseline |
|
81637-1
|
Glucose meter to reference method correlation [Ratio] in Serum, Plasma or Blood by calculation |
|
2352-3
|
Glucose in CSF/Glucose plas |
|
2342-4
|
Glucose [Mass/volume] in Cerebral spinal fluid |
|
14744-7
|
Glucose [Moles/volume] in Cerebral spinal fluid |
|
12628-4
|
Glucose [Mass/volume] in Peritoneal dialysis fluid |
|
14746-2
|
Glucose [Moles/volume] in Peritoneal dialysis fluid |
|
2343-2
|
Glucose [Mass/volume] in Dialysis fluid |
|
15075-5
|
Glucose [Moles/volume] in Dialysis fluid |
|
53084-0
|
Glucose [Moles/volume] in Nonbiological fluid |
|
2344-0
|
Glucose [Mass/volume] in Body fluid |
|
14745-4
|
Glucose [Moles/volume] in Body fluid |
|
14386-7
|
Glucose [Mass/volume] in Gastric fluid |
|
74802-0
|
Glucose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
|
47621-8
|
Glucose.IV [Mass] of Dose |
|
93791-2
|
Glucose [Mass/volume] mean in Serum or Plasma |
|
41896-2
|
Type of Glucose meter device |
|
41899-6
|
Glucose meter device Vendor serial number |
|
41900-2
|
Glucose meter device Vendor software version |
|
41897-0
|
Glucose meter device Vendor name |
|
46223-4
|
Glucose [Moles/volume] in Dialysis fluid --overnight |
|
79264-8
|
Glucose [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
|
10450-5
|
Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
|
1554-5
|
Glucose [Mass/volume] in Serum or Plasma --12 hours fasting |
|
1555-2
|
Glucose [Mass/volume] in Urine --12 hours fasting |
|
20441-2
|
Glucose [Mass/volume] in Serum or Plasma --post 50 g glucose |
|
17865-7
|
Glucose [Mass/volume] in Serum or Plasma --8 hours fasting |
|
16914-4
|
Glucose [Mass/volume] in Serum or Plasma --post XXX challenge |
|
53093-1
|
Glucose [Moles/volume] in Serum or Plasma --post XXX challenge |
|
54495-7
|
Glucose [Moles/volume] in Serum or Plasma --post dialysis |
|
41604-0
|
Fasting glucose [Mass/volume] in Capillary blood by Glucometer |
|
14770-2
|
Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
|
1556-0
|
Fasting glucose [Mass/volume] in Capillary blood |
|
76629-5
|
Fasting glucose [Moles/volume] in Blood |
|
1557-8
|
Fasting glucose [Mass/volume] in Venous blood |
|
77145-1
|
Fasting glucose [Moles/volume] in Serum, Plasma or Blood |
|
1558-6
|
Fasting glucose [Mass/volume] in Serum or Plasma |
|
35184-1
|
Fasting glucose [Mass or Moles/volume] in Serum or Plasma |
|
14771-0
|
Fasting glucose [Moles/volume] in Serum or Plasma |
|
16913-6
|
Fasting glucose [Presence] in Urine |
|
6764-5
|
Fasting glucose [Presence] in Urine by Test strip |
|
63382-6
|
Fasting glucose [Mass/volume] in Urine |
|
53114-5
|
Fasting glucose [Moles/volume] in Urine |
|
18296-4
|
Glucose [Interpretation] in Serum or Plasma--post dose glucose |
|
87422-2
|
Glucose [Mass/volume] in Blood --post meal |
|
16915-1
|
Glucose [Mass/volume] in Serum or Plasma --post meal |
|
53094-9
|
Glucose [Moles/volume] in Serum or Plasma --post meal |
|
33405-2
|
Glucose [Mass/volume] in Pericardial fluid |
|
39479-1
|
Glucose [Moles/volume] in Pericardial fluid |
|
2346-5
|
Glucose [Mass/volume] in Pleural fluid |
|
14747-0
|
Glucose [Moles/volume] in Pleural fluid |
|
4269-7
|
Glucose.PO [Mass] of Dose |
|
1548-7
|
Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV |
|
1549-5
|
Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
|
70208-4
|
Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO |
|
1550-3
|
Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
14769-4
|
Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast |
|
25680-0
|
Glucose [Moles/volume] in Serum or Plasma --pre 50 g glucose PO |
|
1551-1
|
Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO |
|
1552-9
|
Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
|
14996-3
|
Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO |
|
53475-0
|
Glucose [Moles/volume] in Serum or Plasma --pre dose betaxolol |
|
39997-2
|
Glucose [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
40148-9
|
Glucose [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
12607-8
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --pre dialysis |
|
48606-8
|
Glucose [Mass/volume] in Serum or Plasma --pre dose fructose PO |
|
54400-7
|
Glucose [Moles/volume] in Serum or Plasma --pre dose glucagon |
|
47622-6
|
Glucose [Moles/volume] in Serum or Plasma --pre dose glucose |
|
1553-7
|
Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV |
|
54257-1
|
Glucose [Moles/volume] in Serum or Plasma --pre dose insulin IV |
|
12638-3
|
Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO |
|
59157-8
|
Glucose [Moles/volume] in Serum or Plasma --pre dose lactose PO |
|
54268-8
|
Glucose [Moles/volume] in Serum or Plasma --pre dose ornithine alpha-ketoglutarate |
|
40318-8
|
Glucose [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
34056-2
|
Glucose [Moles/volume] in Serum or Plasma --pre or post dose arginine |
|
51426-5
|
Glucose [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
34057-0
|
Glucose [Moles/volume] in Serum or Plasma --pre or post dose cloNIDine |
|
34058-8
|
Glucose [Moles/volume] in Serum or Plasma --pre or post dose glucagon |
|
34059-6
|
Glucose [Moles/volume] in Serum or Plasma --pre or post dose glucose |
|
34060-4
|
Glucose [Moles/volume] in Serum or Plasma --pre or post dose insulin |
|
88365-2
|
Glucose [Mass/volume] in Blood --pre-meal |
|
53049-3
|
Glucose [Mass/volume] in Serum or Plasma --pre-meal |
|
40193-5
|
Glucose [Moles/volume] in Serum or Plasma --pre-meal |
|
2347-3
|
Glucose [Mass/volume] in Peritoneal fluid |
|
14748-8
|
Glucose [Moles/volume] in Peritoneal fluid |
|
72650-5
|
Glucose in serum - glucose in pericard fld [Molar concentration difference] |
|
72651-3
|
Glucose in serum - glucose in pleural fluid [Molar concentration difference] |
|
72649-7
|
Glucose in serum - glucose in peritoneal fluid [Molar concentration difference] |
|
72648-9
|
Glucose in serum - glucose in synovial fluid [Molar concentration difference] |
|
74774-1
|
Glucose [Mass/volume] in Serum, Plasma or Blood |
|
77135-2
|
Glucose [Moles/volume] in Serum, Plasma or Blood |
|
2345-7
|
Glucose [Mass/volume] in Serum or Plasma |
|
35211-2
|
Glucose [Mass or Moles/volume] in Serum or Plasma |
|
14749-6
|
Glucose [Moles/volume] in Serum or Plasma |
|
2348-1
|
Glucose [Mass/volume] in Synovial fluid |
|
14750-4
|
Glucose [Moles/volume] in Synovial fluid |
|
12630-0
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
|
12615-1
|
Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
54392-6
|
Glucose [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
16904-5
|
Glucose [Presence] in Urine --1st specimen post XXX challenge |
|
40849-2
|
Glucose [Mass/volume] in Urine by Test strip --1st specimen post XXX challenge |
|
39561-6
|
Glucose [Mass/volume] in Serum or Plasma --1st specimen post dose lactose |
|
50206-2
|
Glucose [Mass/volume] in Serum or Plasma --1st specimen |
|
40874-0
|
Glucose [Mass/volume] in Unspecified specimen --1st specimen |
|
12622-7
|
Glucose [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
54393-4
|
Glucose [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
50208-8
|
Glucose [Mass/volume] in Serum or Plasma --10th specimen |
|
12623-5
|
Glucose [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
54394-2
|
Glucose [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
12624-3
|
Glucose [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
54395-9
|
Glucose [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
12625-0
|
Glucose [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
12626-8
|
Glucose [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
12627-6
|
Glucose [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge |
|
12631-8
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
|
12616-9
|
Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
54396-7
|
Glucose [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
16905-2
|
Glucose [Presence] in Urine --2nd specimen post XXX challenge |
|
40850-0
|
Glucose [Mass/volume] in Urine by Test strip --2nd specimen post XXX challenge |
|
39562-4
|
Glucose [Mass/volume] in Serum or Plasma --2nd specimen post dose lactose |
|
50212-0
|
Glucose [Mass/volume] in Serum or Plasma --2nd specimen |
|
12632-6
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
|
12617-7
|
Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
54397-5
|
Glucose [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
16906-0
|
Glucose [Presence] in Urine --3rd specimen post XXX challenge |
|
45204-5
|
Glucose [Mass/volume] in Urine by Test strip --3rd specimen post XXX challenge |
|
39563-2
|
Glucose [Mass/volume] in Serum or Plasma --3rd specimen post dose lactose |
|
50213-8
|
Glucose [Mass/volume] in Serum or Plasma --3rd specimen |
|
40875-7
|
Glucose [Mass/volume] in Unspecified specimen --3rd specimen |
|
12633-4
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
|
12618-5
|
Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
54398-3
|
Glucose [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
16907-8
|
Glucose [Presence] in Urine --4th specimen post XXX challenge |
|
45205-2
|
Glucose [Mass/volume] in Urine by Test strip --4th specimen post XXX challenge |
|
50214-6
|
Glucose [Mass/volume] in Serum or Plasma --4th specimen |
|
12634-2
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
|
12619-3
|
Glucose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
54496-5
|
Glucose [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
16908-6
|
Glucose [Presence] in Urine --5th specimen post XXX challenge |
|
45206-0
|
Glucose [Mass/volume] in Urine by Test strip --5th specimen post XXX challenge |
|
50215-3
|
Glucose [Mass/volume] in Serum or Plasma --5th specimen |
|
12635-9
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
|
12620-1
|
Glucose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
54497-3
|
Glucose [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
16909-4
|
Glucose [Presence] in Urine --6th specimen post XXX challenge |
|
12649-0
|
Glucose [Mass/volume] in Serum or Plasma --6th specimen post dose lactose |
|
50216-1
|
Glucose [Mass/volume] in Serum or Plasma --6th specimen |
|
12636-7
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
|
26853-2
|
Glucose [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
26695-7
|
Glucose [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
54498-1
|
Glucose [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
16910-2
|
Glucose [Presence] in Urine --7th specimen post XXX challenge |
|
50207-0
|
Glucose [Mass/volume] in Serum or Plasma --7th specimen |
|
12637-5
|
Glucose [Mass/volume] in Peritoneal dialysis fluid --8th specimen post XXX challenge |
|
26854-0
|
Glucose [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
27432-4
|
Glucose [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
54499-9
|
Glucose [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
16911-0
|
Glucose [Presence] in Urine --8th specimen post XXX challenge |
|
50217-9
|
Glucose [Mass/volume] in Serum or Plasma --8th specimen |
|
12621-9
|
Glucose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
54399-1
|
Glucose [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
16912-8
|
Glucose [Presence] in Urine --9th specimen post XXX challenge |
|
50218-7
|
Glucose [Mass/volume] in Serum or Plasma --9th specimen |
|
57797-3
|
Glucose [Mass/volume] in Stool by Post hydrolysis |
|
51595-7
|
Glucose [Presence] in Stool |
|
48036-8
|
Glucose [Mass/volume] in Stool |
|
47620-0
|
Glucose [Moles/volume] in Stool |
|
53868-6
|
Glucose tetrasaccharide/Creatinine [Molar ratio] in Urine |
|
53050-1
|
Glucose [Mass/volume] in Total parental nutrition |
|
76669-1
|
Glucose [Moles/volume] in Cerebral spinal fluid --1st tube |
|
76670-9
|
Glucose [Moles/volume] in Cerebral spinal fluid --2nd tube |
|
76671-7
|
Glucose [Moles/volume] in Cerebral spinal fluid --3rd tube |
|
76672-5
|
Glucose [Moles/volume] in Cerebral spinal fluid --4th tube |
|
2349-9
|
Glucose [Presence] in Urine |
|
25428-4
|
Glucose [Presence] in Urine by Test strip |
|
50555-2
|
Glucose [Presence] in Urine by Automated test strip |
|
53328-1
|
Glucose [Mass/volume] in Urine by Automated test strip |
|
59156-0
|
Glucose [Moles/volume] in Urine by Automated test strip |
|
5792-7
|
Glucose [Mass/volume] in Urine by Test strip |
|
22705-8
|
Glucose [Moles/volume] in Urine by Test strip |
|
2350-7
|
Glucose [Mass/volume] in Urine |
|
35212-0
|
Glucose [Mass or Moles/volume] in Urine |
|
15076-3
|
Glucose [Moles/volume] in Urine |
|
16903-7
|
Glucose [Mass/volume] in Vitreous fluid |
|
39478-3
|
Glucose [Moles/volume] in Vitreous fluid |
|
54486-6
|
Glucose [Mass/volume] in Water |
|
54487-4
|
Glucose [Moles/volume] in Water |
|
32318-8
|
Glucose [Moles/volume] in Unspecified specimen |
|
57004-4
|
Glucose/Creatinine [Mass Ratio] in 24 hour Urine |
|
33352-6
|
Glucose/Creatinine [Mass Ratio] in Urine |
|
40488-9
|
Glucose/Creatinine [Ratio] in Urine |
|
34312-9
|
Glucose/Creatinine [Molar ratio] in Urine |
|
43740-0
|
Glucose/Insulin [Mass Ratio] in Serum or Plasma |
|
62418-9
|
Glucose/Insulin [Ratio] in Serum or Plasma |
|
10577-5
|
Glucosidase [Enzymatic activity/volume] in Seminal plasma |
|
44037-0
|
Glucosylceramidase [Presence] in Blood |
|
55917-9
|
Glucosylceramidase [Enzymatic activity/volume] in DBS |
|
25829-3
|
Glucosylceramidase [Enzymatic activity/mass] in Fibroblast |
|
38477-6
|
Glucosylceramidase [Enzymatic activity/volume] in Serum or Plasma |
|
18195-8
|
Glucosylceramidase [Presence] in Tissue |
|
2361-4
|
Glucosylceramidase [Enzymatic activity/mass] in Tissue |
|
33661-0
|
Glucosylceramidase [Entitic Catalytic Activity] in Leukocytes |
|
1943-0
|
Glucosylceramidase [Enzymatic activity/volume] in Leukocytes |
|
32540-7
|
Glucosylceramidase [Enzymatic activity/mass] in Leukocytes |
|
35303-7
|
Glucosylceramidase [Enzymatic activity/mass] in Unspecified specimen |
|
53183-0
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS |
|
51414-1
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma |
|
53186-3
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
53403-2
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS |
|
53184-8
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
|
53185-5
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
67710-4
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
|
67701-3
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
67711-2
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
30473-3
|
Glutaconate [Presence] in Urine |
|
13745-5
|
Glutaconate/Creatinine [Mass Ratio] in Urine |
|
25103-3
|
Glutaconate/Creatinine [Molar ratio] in Urine |
|
26805-2
|
Glutamate [Presence] in 24 hour Urine |
|
2366-3
|
Glutamate [Mass/time] in 24 hour Urine |
|
25917-6
|
Glutamate [Moles/volume] in 24 hour Urine |
|
25429-2
|
Glutamate [Moles/time] in 24 hour Urine |
|
13395-9
|
Glutamate [Mass/volume] in Amniotic fluid |
|
27104-9
|
Glutamate [Moles/volume] in Amniotic fluid |
|
2362-2
|
Glutamate [Mass/volume] in Cerebral spinal fluid |
|
22652-2
|
Glutamate [Moles/volume] in Cerebral spinal fluid |
|
47623-4
|
Glutamate [Moles/volume] in DBS |
|
32614-0
|
Glutamate [Moles/volume] in Body fluid |
|
55861-9
|
Glutamate [Moles/mass] in Hair |
|
48304-0
|
Glutamate triggered leukotriene release [Mass/volume] by Leukocytes |
|
2363-0
|
Glutamate [Presence] in Serum or Plasma |
|
2364-8
|
Glutamate [Mass/volume] in Serum or Plasma |
|
20642-5
|
Glutamate [Moles/volume] in Serum or Plasma |
|
47626-7
|
Glutamate/Amino acids.total in Amniotic fluid |
|
47625-9
|
Glutamate/Amino acids.total in Cerebral spinal fluid |
|
47628-3
|
Glutamate/Amino acids.total in DBS |
|
47624-2
|
Glutamate/Amino acids.total in Hair |
|
47627-5
|
Glutamate/Amino acids.total in Serum or Plasma |
|
47629-1
|
Glutamate/Amino acids.total in Unspecified specimen |
|
16916-9
|
Glutamate [Presence] in Urine |
|
2365-5
|
Glutamate [Mass/volume] in Urine |
|
30348-7
|
Glutamate [Moles/volume] in Urine |
|
32241-2
|
Glutamate [Moles/volume] in Vitreous fluid |
|
22721-5
|
Glutamate [Moles/volume] in Unspecified specimen |
|
44359-8
|
Glutamate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56644-8
|
Glutamate/Creatinine [Ratio] in 24 hour Urine |
|
25918-4
|
Glutamate/Creatinine [Molar ratio] in 24 hour Urine |
|
13746-3
|
Glutamate/Creatinine [Mass Ratio] in Urine |
|
30059-0
|
Glutamate/Creatinine [Ratio] in Urine |
|
22711-6
|
Glutamate/Creatinine [Molar ratio] in Urine |
|
26806-0
|
Glutamine [Presence] in 24 hour Urine |
|
2374-7
|
Glutamine [Mass/time] in 24 hour Urine |
|
25919-2
|
Glutamine [Moles/volume] in 24 hour Urine |
|
25430-0
|
Glutamine [Moles/time] in 24 hour Urine |
|
13396-7
|
Glutamine [Mass/volume] in Amniotic fluid |
|
26894-6
|
Glutamine [Moles/volume] in Amniotic fluid |
|
2370-5
|
Glutamine [Mass/volume] in Cerebral spinal fluid |
|
22641-5
|
Glutamine [Moles/volume] in Cerebral spinal fluid |
|
47630-9
|
Glutamine [Moles/volume] in DBS |
|
32243-8
|
Glutamine [Moles/volume] in Body fluid |
|
81129-9
|
Glutamine intake 24 hour Estimated |
|
81130-7
|
Glutamine intake 24 hour Measured |
|
2371-3
|
Glutamine [Presence] in Serum or Plasma |
|
2372-1
|
Glutamine [Mass/volume] in Serum or Plasma |
|
20643-3
|
Glutamine [Moles/volume] in Serum or Plasma |
|
16917-7
|
Glutamine [Presence] in Urine |
|
2373-9
|
Glutamine [Mass/volume] in Urine |
|
27043-9
|
Glutamine [Moles/volume] in Urine |
|
32242-0
|
Glutamine [Moles/volume] in Vitreous fluid |
|
22720-7
|
Glutamine [Moles/volume] in Unspecified specimen |
|
44362-2
|
Glutamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56680-2
|
Glutamine/Creatinine [Ratio] in 24 hour Urine |
|
25920-0
|
Glutamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13747-1
|
Glutamine/Creatinine [Mass Ratio] in Urine |
|
30056-6
|
Glutamine/Creatinine [Ratio] in Urine |
|
22710-8
|
Glutamine/Creatinine [Molar ratio] in Urine |
|
58921-8
|
Glutamine+Histidine [Moles/volume] in Cerebral spinal fluid |
|
58930-9
|
Glutamine+Histidine [Moles/volume] in Serum or Plasma |
|
58927-5
|
Glutamine+Histidine/Creatinine [Ratio] in Urine |
|
80096-1
|
Glutamylphenylalanine [Moles/volume] in Serum or Plasma |
|
80094-6
|
Glutamylphenylalanine/Creatinine [Molar ratio] in Urine |
|
33933-3
|
Glutaraldehyde IgE Ab [Units/volume] in Serum |
|
23866-7
|
Glutaraldehyde [Presence] in Urine |
|
54278-7
|
Glutarate [Moles/volume] in Cerebral spinal fluid |
|
82504-2
|
Glutarate [Moles/volume] in DBS |
|
35133-8
|
Glutarate [Mass/volume] in Serum or Plasma |
|
27301-1
|
Glutarate [Moles/volume] in Serum or Plasma |
|
30474-1
|
Glutarate [Presence] in Urine |
|
44363-0
|
Glutarate/Creatinine [Mass Ratio] in 24 hour Urine |
|
44364-8
|
Glutarate/Creatinine [Molar ratio] in 24 hour Urine |
|
13748-9
|
Glutarate/Creatinine [Mass Ratio] in Urine |
|
25104-1
|
Glutarate/Creatinine [Molar ratio] in Urine |
|
54281-1
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Amniotic fluid |
|
54280-3
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Cerebral spinal fluid |
|
45207-8
|
Glutarylcarnitine (C5-DC) [Moles/volume] in DBS |
|
18449-9
|
Glutarylcarnitine (C5-DC) [Mass/volume] in Serum or Plasma |
|
30349-5
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Serum or Plasma |
|
54282-9
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Urine |
|
75225-3
|
Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS |
|
75267-5
|
Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
88013-8
|
Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
|
88016-1
|
Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
88005-4
|
Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
88017-9
|
Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
88026-0
|
Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in Serum or Plasma |
|
75216-2
|
Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS |
|
75266-7
|
Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) [Molar ratio] in DBS |
|
54279-5
|
Glutarylcarnitine (C5-DC)/Creatinine [Molar ratio] in Urine |
|
91685-8
|
Glutathione [Mass/volume] in Blood |
|
65363-4
|
Glutathione [Moles/volume] in Blood |
|
45328-2
|
Glutathione peroxidase [Enzymatic activity/volume] in Blood |
|
2377-0
|
Glutathione peroxidase [Enzymatic activity/volume] in Red Blood Cells |
|
45378-7
|
Glutathione peroxidase [Enzymatic activity/mass] in Red Blood Cells |
|
2376-2
|
Glutathione peroxidase [Enzymatic activity/volume] in Serum or Plasma |
|
2383-8
|
Glutathione [Mass/volume] in Red Blood Cells |
|
16918-5
|
Glutathione [Mass/volume] in Serum or Plasma |
|
57005-1
|
Glutathione [Moles/volume] in Serum or Plasma |
|
2380-4
|
Glutathione synthase [Enzymatic activity/volume] in Red Blood Cells |
|
6125-9
|
Gluten IgE Ab [Units/volume] in Serum |
|
15729-7
|
Gluten IgE Ab RAST class [Presence] in Serum |
|
61270-5
|
Gluten IgE Ab/IgE total in Serum |
|
7338-7
|
Gluten IgG Ab [Units/volume] in Serum |
|
21311-6
|
Gluten IgG Ab RAST class [Presence] in Serum |
|
56268-6
|
Gluten IgG4 Ab [Mass/volume] in Serum |
|
63091-3
|
Gluten IgG Ab [Mass/volume] in Serum |
|
81039-0
|
Gluten intake 24 hour Estimated |
|
81040-8
|
Gluten intake 24 hour Measured |
|
4270-5
|
Glutethimide [Mass] of Dose |
|
29282-1
|
Glutethimide [Presence] in Gastric fluid |
|
29291-2
|
Glutethimide [Mass/volume] in Gastric fluid |
|
47110-2
|
Glutethimide [Moles/volume] in Gastric fluid |
|
13563-2
|
Glutethimide [Presence] in Serum or Plasma |
|
35613-9
|
Glutethimide [Mass/volume] in Serum or Plasma by Screen method |
|
3666-5
|
Glutethimide [Mass/volume] in Serum or Plasma |
|
32076-2
|
Glutethimide [Moles/volume] in Serum or Plasma |
|
3667-3
|
Glutethimide [Presence] in Urine |
|
3668-1
|
Glutethimide [Mass/volume] in Urine |
|
47111-0
|
Glutethimide [Moles/volume] in Urine |
|
32077-0
|
Glutethimide [Presence] in Unspecified specimen |
|
73359-2
|
Glyburide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73358-4
|
Glyburide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48327-1
|
Glyburide [Presence] in Serum or Plasma |
|
10540-3
|
Glyburide [Mass/volume] in Serum or Plasma |
|
32078-8
|
Glyburide [Moles/volume] in Serum or Plasma |
|
27175-9
|
Glyburide [Mass/volume] in Urine |
|
48320-6
|
Glyburide [Presence] in Unspecified specimen |
|
6945-0
|
Glyburide [Mass/volume] in Unspecified specimen |
|
82730-3
|
GlycA [Moles/volume] in Serum or Plasma |
|
2385-3
|
Glycerate [Mass/volume] in Serum |
|
75063-8
|
Glycerate [Moles/volume] in Serum or Plasma |
|
30475-8
|
Glycerate [Presence] in Urine |
|
2386-1
|
Glycerate [Mass/volume] in Urine |
|
13749-7
|
Glycerate/Creatinine [Mass Ratio] in Urine |
|
25105-8
|
Glycerate/Creatinine [Molar ratio] in Urine |
|
54283-7
|
Glycerol [Mass/volume] in Body fluid |
|
54284-5
|
Glycerol [Moles/volume] in Body fluid |
|
2387-9
|
Glycerol [Mass/volume] in Serum or Plasma |
|
45300-1
|
Glycerol [Moles/volume] in Serum or Plasma |
|
54285-2
|
Glycerol [Moles/volume] in Urine |
|
47632-5
|
Glycerol/Creatinine [Molar ratio] in Urine |
|
26807-8
|
Glycine [Presence] in 24 hour Urine |
|
2393-7
|
Glycine [Mass/time] in 24 hour Urine |
|
25921-8
|
Glycine [Moles/volume] in 24 hour Urine |
|
25431-8
|
Glycine [Moles/time] in 24 hour Urine |
|
13397-5
|
Glycine [Mass/volume] in Amniotic fluid |
|
26929-0
|
Glycine [Moles/volume] in Amniotic fluid |
|
73913-6
|
Glycine in CSF/Glycine in plasma |
|
2389-5
|
Glycine [Mass/volume] in Cerebral spinal fluid |
|
22650-6
|
Glycine [Moles/volume] in Cerebral spinal fluid |
|
47633-3
|
Glycine [Moles/volume] in DBS |
|
32245-3
|
Glycine [Moles/volume] in Body fluid |
|
55862-7
|
Glycine [Moles/mass] in Hair |
|
33213-0
|
Glycine in plasma/Glycine in CSF |
|
2390-3
|
Glycine [Presence] in Serum or Plasma |
|
2391-1
|
Glycine [Mass/volume] in Serum or Plasma |
|
20644-1
|
Glycine [Moles/volume] in Serum or Plasma |
|
47637-4
|
Glycine/Amino acids.total in Amniotic fluid |
|
47636-6
|
Glycine/Amino acids.total in Cerebral spinal fluid |
|
47638-2
|
Glycine/Amino acids.total in DBS |
|
47635-8
|
Glycine/Amino acids.total in Hair |
|
47634-1
|
Glycine/Amino acids.total in Serum or Plasma |
|
47639-0
|
Glycine/Amino acids.total in Unspecified specimen |
|
16919-3
|
Glycine [Presence] in Urine |
|
2392-9
|
Glycine [Mass/volume] in Urine |
|
27325-0
|
Glycine [Moles/volume] in Urine |
|
32244-6
|
Glycine [Moles/volume] in Vitreous fluid |
|
22718-1
|
Glycine [Moles/volume] in Unspecified specimen |
|
44365-5
|
Glycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56681-0
|
Glycine/Creatinine [Ratio] in 24 hour Urine |
|
25922-6
|
Glycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13750-5
|
Glycine/Creatinine [Mass Ratio] in Urine |
|
30066-5
|
Glycine/Creatinine [Ratio] in Urine |
|
22709-0
|
Glycine/Creatinine [Molar ratio] in Urine |
|
44832-4
|
Glycogen synthase I/Glycogen synthase.total in Blood |
|
2394-5
|
Glycogen synthase [Enzymatic activity/volume] in Serum |
|
93332-5
|
Glycohyodeoxycholate [Moles/volume] in Serum or Plasma |
|
20829-8
|
Glycol [Mass/mass] in Tissue |
|
20830-6
|
Glycol [Mass/volume] in Urine |
|
73882-3
|
Glycolate [Moles/volume] in 24 hour Urine |
|
73883-1
|
Glycolate [Moles/time] in 24 hour Urine |
|
54286-0
|
Glycolate [Moles/volume] in Cerebral spinal fluid |
|
55863-5
|
Glycolate [Mass/volume] in Body fluid |
|
55864-3
|
Glycolate [Moles/volume] in Body fluid |
|
78749-9
|
Glycolate [Mass/volume] in Serum or Plasma by Gas chromatography |
|
2395-2
|
Glycolate [Mass/volume] in Serum or Plasma |
|
42502-5
|
Glycolate [Moles/volume] in Serum or Plasma |
|
20831-4
|
Glycolate [Mass/mass] in Tissue |
|
26682-5
|
Glycolate [Presence] in Urine |
|
2396-0
|
Glycolate [Mass/volume] in Urine |
|
55865-0
|
Glycolate [Moles/volume] in Urine |
|
13751-3
|
Glycolate/Creatinine [Mass Ratio] in Urine |
|
25106-6
|
Glycolate/Creatinine [Molar ratio] in Urine |
|
16920-1
|
Glycoproteins [Presence] in Serum or Plasma |
|
2397-8
|
Glycoproteins [Presence] in Urine |
|
80097-9
|
Glycyl-4-hydroxyproline [Moles/volume] in Serum or Plasma |
|
80092-0
|
Glycyl-4-hydroxyproline/Creatinine [Molar ratio] in Urine |
|
30476-6
|
Glyoxylate [Presence] in Urine |
|
13752-1
|
Glyoxylate/Creatinine [Mass Ratio] in Urine |
|
25107-4
|
Glyoxylate/Creatinine [Molar ratio] in Urine |
|
38305-9
|
Glyphosate [Mass/volume] in Water |
|
79617-7
|
Glycylproline [Moles/volume] in Serum or Plasma |
|
79594-8
|
Glycylproline/Creatinine [Molar ratio] in Urine |
|
44737-5
|
Asialoganglioside GM1 Ab [Units/volume] in Serum by Immunoassay |
|
43861-4
|
Asialoganglioside GM1 Ab [Presence] in Serum |
|
44736-7
|
Asialoganglioside GM1 Ab [Presence] in Serum by Immunoassay |
|
31225-6
|
Asialoganglioside GM1 Ab [Units/volume] in Serum |
|
21080-7
|
Asialoganglioside GM1 Ab [Titer] in Serum |
|
58968-9
|
Asialoganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44708-6
|
Asialoganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
29961-0
|
Asialoganglioside GM1 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
44738-3
|
Asialoganglioside GM1 IgG Ab [Presence] in Serum |
|
63212-5
|
Asialoganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay |
|
31226-4
|
Asialoganglioside GM1 IgG Ab [Units/volume] in Serum |
|
23951-7
|
Asialoganglioside GM1 IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
13663-0
|
Asialoganglioside GM1 IgG Ab [Titer] in Serum |
|
46969-2
|
Asialoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
|
50769-9
|
Asialoganglioside GM1 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
|
88723-2
|
Asialoganglioside GM1 IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
59027-3
|
Asialoganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44709-4
|
Asialoganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
29962-8
|
Asialoganglioside GM1 IgM Ab [Mass/volume] in Serum by Immunoassay |
|
30200-0
|
Asialoganglioside GM1 IgM Ab [Presence] in Serum |
|
63384-2
|
Asialoganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay |
|
31227-2
|
Asialoganglioside GM1 IgM Ab [Units/volume] in Serum |
|
23952-5
|
Asialoganglioside GM1 IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
10359-8
|
Asialoganglioside GM1 IgM Ab [Titer] in Serum |
|
43179-1
|
Asialoganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay |
|
49636-4
|
Ganglioside GM1 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
48660-5
|
Ganglioside GM1 Ab [Units/volume] in Serum by Immunoassay |
|
31497-1
|
Ganglioside GM1 Ab [Presence] in Serum |
|
17288-2
|
Ganglioside GM1 Ab [Presence] in Serum by Immunofluorescence |
|
31496-3
|
Ganglioside GM1 Ab [Units/volume] in Serum |
|
42203-0
|
Ganglioside GM1 Ab [Titer] in Serum |
|
44749-0
|
Ganglioside GM1 IgA Ab [Presence] in Serum |
|
31498-9
|
Ganglioside GM1 IgA Ab [Units/volume] in Serum |
|
16138-0
|
Ganglioside GM1 IgA Ab [Titer] in Serum |
|
58972-1
|
Ganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63242-2
|
Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89541-7
|
Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63241-4
|
Ganglioside GM1 IgG Ab [Presence] in Body fluid by Immunoassay |
|
51729-2
|
Ganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
29959-4
|
Ganglioside GM1 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
45169-0
|
Ganglioside GM1 IgG Ab [Presence] in Serum |
|
63243-0
|
Ganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay |
|
89521-9
|
Ganglioside GM1 IgG Ab [Presence] in Serum by Line blot |
|
31499-7
|
Ganglioside GM1 IgG Ab [Units/volume] in Serum |
|
6925-2
|
Ganglioside GM1 IgG Ab [Titer] in Serum |
|
43240-1
|
Ganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
|
50770-7
|
Ganglioside GM1 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
|
31501-0
|
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum |
|
63244-8
|
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89519-3
|
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Line blot |
|
31500-2
|
Ganglioside GM1 IgG+IgM Ab [Units/volume] in Serum |
|
59028-1
|
Ganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63246-3
|
Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89540-9
|
Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63245-5
|
Ganglioside GM1 IgM Ab [Presence] in Body fluid by Immunoassay |
|
51703-7
|
Ganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
29960-2
|
Ganglioside GM1 IgM Ab [Mass/volume] in Serum by Immunoassay |
|
44750-8
|
Ganglioside GM1 IgM Ab [Presence] in Serum |
|
63247-1
|
Ganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay |
|
89518-5
|
Ganglioside GM1 IgM Ab [Presence] in Serum by Line blot |
|
31502-8
|
Ganglioside GM1 IgM Ab [Units/volume] in Serum |
|
6926-0
|
Ganglioside GM1 IgM Ab [Titer] in Serum |
|
43241-9
|
Ganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay |
|
31404-7
|
Ganglioside GM1b IgG Ab [Units/volume] in Serum |
|
17853-3
|
Ganglioside GM1b IgG Ab [Titer] in Serum |
|
31405-4
|
Ganglioside GM1b IgM Ab [Units/volume] in Serum |
|
17854-1
|
Ganglioside GM1b IgM Ab [Titer] in Serum |
|
45164-1
|
Asialoganglioside GM2 Ab [Presence] in Serum |
|
34249-3
|
Asialoganglioside GM2 Ab [Units/volume] in Serum |
|
48657-1
|
Ganglioside GM2 Ab [Units/volume] in Serum by Immunoassay |
|
58973-9
|
Ganglioside GM2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56543-2
|
Ganglioside GM2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
63248-9
|
Ganglioside GM2 IgG Ab [Presence] in Serum by Immunoassay |
|
89525-0
|
Ganglioside GM2 IgG Ab [Presence] in Serum by Line blot |
|
50771-5
|
Ganglioside GM2 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
|
88731-5
|
Ganglioside GM2 IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
63249-7
|
Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89517-7
|
Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58974-7
|
Ganglioside GM2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56544-0
|
Ganglioside GM2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
63250-5
|
Ganglioside GM2 IgM Ab [Presence] in Serum by Immunoassay |
|
89524-3
|
Ganglioside GM2 IgM Ab [Presence] in Serum by Line blot |
|
63466-7
|
Ganglioside GM3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
59033-1
|
Ganglioside GM3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
63251-3
|
Ganglioside GM3 IgG Ab [Presence] in Serum by Immunoassay |
|
89522-7
|
Ganglioside GM3 IgG Ab [Presence] in Serum by Line blot |
|
63252-1
|
Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89511-0
|
Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Line blot |
|
63467-5
|
Ganglioside GM3 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58967-1
|
Ganglioside GM3 IgM Ab [Units/volume] in Serum by Immunoassay |
|
63253-9
|
Ganglioside GM3 IgM Ab [Presence] in Serum by Immunoassay |
|
89510-2
|
Ganglioside GM3 IgM Ab [Presence] in Serum by Line blot |
|
63470-9
|
Ganglioside GM4 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58966-3
|
Ganglioside GM4 IgG Ab [Units/volume] in Serum by Immunoassay |
|
82407-8
|
Ganglioside GM4 IgG Ab [Presence] in Serum by Line blot |
|
82408-6
|
Ganglioside GM4 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58965-5
|
Ganglioside GM4 IgM Ab [Units/volume] in Serum by Immunoassay |
|
82409-4
|
Ganglioside GM4 IgM Ab [Presence] in Serum by Line blot |
|
14162-2
|
Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
|
88259-7
|
Gram negative bacteria identified [Interpretation] by Probe in Positive blood culture |
|
92769-9
|
Gram negative bacteria DNA [Presence] by NAA with probe detection in Positive blood culture |
|
41758-4
|
GNAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7339-5
|
Gnat whole body IgE Ab [Units/volume] in Serum |
|
41418-5
|
Gnathostoma sp Ab [Presence] in Serum by Immunoblot |
|
44803-5
|
GNE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77060-2
|
GNMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77059-4
|
GNMT gene full mutation analysis in Blood or Tissue by Sequencing |
|
4271-3
|
Gonadotropin releasing hormone [Mass] of Dose |
|
13660-6
|
Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
|
2581-7
|
Gonadotropin releasing hormone [Moles/volume] in Serum or Plasma |
|
58061-3
|
Go sup(a) Ab [Presence] in Serum or Plasma |
|
81340-2
|
Goals AndOr preferences in order of priority [Reported] |
|
55057-4
|
Goals established during assessment process [CMS Assessment] |
|
81380-8
|
Goals, preferences, and priorities for care experience [Reported] |
|
75773-2
|
Goals, preferences, and priorities for medical treatment [Reported] |
|
81377-4
|
Goals, preferences, and priorities regarding the appointment of healthcare agents [Reported] |
|
81378-2
|
Goals, preferences, and priorities under certain health conditions [Reported] |
|
81379-0
|
Goals, preferences, and priorities upon death [Reported] |
|
6127-5
|
Goat epithelium IgE Ab [Units/volume] in Serum |
|
15731-3
|
Goat epithelium IgE Ab RAST class [Presence] in Serum |
|
7340-3
|
Goat milk IgE Ab [Units/volume] in Serum |
|
15732-1
|
Goat milk IgE Ab RAST class [Presence] in Serum |
|
61335-6
|
Goat milk IgE Ab/IgE total in Serum |
|
7341-1
|
Goat milk IgG Ab [Units/volume] in Serum |
|
56269-4
|
Goat milk IgG4 Ab [Mass/volume] in Serum |
|
63133-3
|
Goat milk IgG Ab [Mass/volume] in Serum |
|
50148-6
|
Gamma hydroxybutyrate [Moles/volume] in Amniotic fluid |
|
28038-8
|
Gamma hydroxybutyrate [Mass/volume] in Blood |
|
74920-0
|
Gamma hydroxybutyrate [Moles/volume] in Blood |
|
72433-6
|
Gamma hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
|
50965-3
|
Gamma hydroxybutyrate cutoff [Mass/volume] in Serum or Plasma |
|
79142-6
|
Gamma hydroxybutyrate [Mass/volume] in Body fluid |
|
68441-5
|
Gamma hydroxybutyrate [Moles/volume] in Gastric fluid |
|
78829-9
|
Gamma hydroxybutyrate [Mass/mass] in Hair |
|
43194-0
|
Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma by Confirmatory method |
|
46085-7
|
Gamma hydroxybutyrate [Presence] in Serum or Plasma |
|
59681-7
|
Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method |
|
73827-8
|
Gamma hydroxybutyrate [Mass/volume] in Serum, Plasma or Blood |
|
28041-2
|
Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma |
|
59209-7
|
Gamma hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
43198-1
|
Gamma hydroxybutyrate [Mass/volume] in Urine by Confirmatory method |
|
29868-7
|
Gamma hydroxybutyrate [Presence] in Urine |
|
57746-0
|
Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method |
|
43197-3
|
Gamma hydroxybutyrate [Presence] in Urine by Screen method |
|
28044-6
|
Gamma hydroxybutyrate [Mass/volume] in Urine |
|
68440-7
|
Gamma hydroxybutyrate [Moles/volume] in Urine |
|
81629-8
|
Gamma hydroxybutyrate [Presence] in Unspecified specimen by Confirmatory method |
|
77733-4
|
Gamma hydroxybutyrate [Presence] in Unspecified specimen by Screen method |
|
68970-3
|
Gamma hydroxybutyrate [Moles/volume] in Unspecified specimen |
|
44358-0
|
Gamma hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
|
47542-6
|
Gamma hydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
30918-7
|
Gold [Mass/volume] in Urine collected for unspecified duration |
|
29987-5
|
Gold [Mass/volume] in 24 hour Urine |
|
5661-4
|
Gold [Mass/time] in 24 hour Urine |
|
50852-3
|
Gold [Moles/volume] in 24 hour Urine |
|
47112-8
|
Gold [Moles/time] in 24 hour Urine |
|
5656-4
|
Gold [Mass/volume] in Blood |
|
5657-2
|
Gold [Mass/volume] in Cerebral spinal fluid |
|
21312-4
|
Gold [Mass/volume] in Body fluid |
|
5658-0
|
Gold [Mass/mass] in Hair |
|
60082-5
|
Gold [Mass/volume] in Red Blood Cells |
|
5659-8
|
Gold [Mass/volume] in Serum or Plasma |
|
14772-8
|
Gold [Moles/volume] in Serum or Plasma |
|
5660-6
|
Gold [Mass/volume] in Urine |
|
32079-6
|
Gold [Moles/volume] in Urine |
|
29988-3
|
Gold/Creatinine [Mass Ratio] in 24 hour Urine |
|
47113-6
|
Gold/Creatinine [Molar ratio] in 24 hour Urine |
|
7343-7
|
Goldenrod triggered histamine release [Units/volume] in Blood |
|
6128-3
|
Goldenrod IgE Ab [Units/volume] in Serum |
|
15733-9
|
Goldenrod IgE Ab RAST class [Presence] in Serum |
|
61316-6
|
Goldenrod IgE Ab/IgE total in Serum |
|
7342-9
|
Goldenrod IgG Ab [Units/volume] in Serum |
|
56271-0
|
Goldenrod IgG4 Ab [Mass/volume] in Serum |
|
63200-0
|
Goldenrod IgG Ab [Mass/volume] in Serum |
|
54007-0
|
Golgi apparatus Ab [Presence] in Serum by Immunofluorescence |
|
54008-8
|
Golgi apparatus Ab [Titer] in Serum by Immunofluorescence |
|
87407-3
|
Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
87406-5
|
Golimumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
10817-5
|
Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |
|
55596-1
|
Goose feather IgE Ab [Presence] in Serum |
|
6129-1
|
Goose feather IgE Ab [Units/volume] in Serum |
|
15734-7
|
Goose feather IgE Ab RAST class [Presence] in Serum |
|
39605-1
|
Goose feather IgE Ab/IgE total in Serum |
|
7344-5
|
Goose feather IgG Ab [Units/volume] in Serum |
|
56272-8
|
Goose feather IgG4 Ab [Mass/volume] in Serum |
|
78366-2
|
Goose feather IgG Ab [Mass/volume] in Serum |
|
6130-9
|
Goose meat IgE Ab [Units/volume] in Serum |
|
64971-5
|
Goosefoot recombinant (rChe a) 1 IgE Ab [Units/volume] in Serum |
|
7450-0
|
Goosefoot triggered histamine release [Units/volume] in Blood |
|
6156-4
|
Goosefoot IgE Ab [Units/volume] in Serum |
|
15805-5
|
Goosefoot IgE Ab RAST class [Presence] in Serum |
|
61243-2
|
Goosefoot IgE Ab/IgE total in Serum |
|
24154-7
|
Goosefoot IgG Ab [Units/volume] in Serum |
|
56303-1
|
Goosefoot IgG4 Ab [Mass/volume] in Serum |
|
63186-1
|
Goosefoot IgG Ab [Mass/volume] in Serum |
|
42183-4
|
Gossypol negative isomer [Mass/volume] in Unspecified specimen |
|
42184-2
|
Gossypol posiitve isomer [Mass/volume] in Unspecified specimen |
|
42182-6
|
Gossypol bound [Mass/volume] in Unspecified specimen |
|
20832-2
|
Gossypol [Mass/mass] in Feed |
|
23746-1
|
Gossypol Free [Mass/volume] in Unspecified specimen |
|
23745-3
|
Gossypol [Mass/volume] in Unspecified specimen |
|
87616-9
|
Gossypol [Mass/mass] in Unspecified specimen |
|
20488-3
|
Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid |
|
14323-0
|
Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
41508-3
|
Streptococcus agalactiae Ag [Presence] in Body fluid |
|
31967-3
|
Streptococcus agalactiae Ag [Presence] in Throat |
|
6551-6
|
Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence |
|
24020-0
|
Streptococcus agalactiae Ag [Presence] in Urine |
|
40784-1
|
Streptococcus agalactiae Ag [Presence] in Vaginal fluid |
|
11266-4
|
Streptococcus agalactiae Ag [Presence] in Unspecified specimen |
|
20459-4
|
Streptococcus agalactiae Ag [Presence] in Unspecified specimen by Latex agglutination |
|
52968-5
|
Streptococcus agalactiae [Presence] in Anal by Organism specific culture |
|
581-9
|
Streptococcus agalactiae [Presence] in Cervix by Organism specific culture |
|
92951-3
|
Streptococcus agalactiae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85767-2
|
Streptococcus agalactiae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92773-1
|
Streptococcus agalactiae DNA [Presence] by NAA with probe detection in Positive blood culture |
|
82186-8
|
Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
91847-4
|
Streptococcus agalactiae DNA [Presence] in Genital specimen by NAA with probe detection |
|
92950-5
|
Streptococcus agalactiae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
90272-6
|
Streptococcus agalactiae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
91875-5
|
Streptococcus agalactiae DNA [Presence] in Vag+Rectum by NAA with probe detection |
|
48683-7
|
Streptococcus agalactiae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
583-5
|
Streptococcus agalactiae [Presence] in Genital lochia by Organism specific culture |
|
582-7
|
Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture |
|
5034-4
|
Streptococcus agalactiae rRNA [Presence] in Unspecified specimen by Probe |
|
585-0
|
Streptococcus agalactiae [Presence] in Throat by Organism specific culture |
|
584-3
|
Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture |
|
72607-5
|
Streptococcus agalactiae [Presence] in Vag+Rectum by Organism specific culture |
|
586-8
|
Streptococcus agalactiae [Presence] in Unspecified specimen by Organism specific culture |
|
88261-3
|
Gram positive bacteria identified [Interpretation] by Probe in Positive blood culture |
|
93389-5
|
Gram positive bacteria DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92789-7
|
Gram positive blood culture panel by NAA with probe detection in Positive blood culture |
|
90070-4
|
Gram positive catalase producing cocci identified in Isolate by Organism specific culture |
|
90071-2
|
Gram positive non-catalase producing cocci identified in Isolate by Organism specific culture |
|
10336-6
|
Gonadotropin peptide [Mass/volume] in Urine |
|
13481-7
|
Gonadotropin peptide/Creatinine [Mass Ratio] in Urine |
|
10578-3
|
Glycerophosphocholine [Moles/volume] in Seminal plasma |
|
34499-4
|
GPC3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41098-5
|
GPC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
11047-8
|
Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
|
44050-3
|
Glucose phosphate isomerase [Enzymatic activity/mass] in Red Blood Cells |
|
2353-1
|
Glucose phosphate isomerase [Enzymatic activity/volume] in Serum |
|
81336-0
|
Patient Goals, preferences, and priorities under certain health conditions |
|
81338-6
|
Patient Goals, preferences, and priorities for care experience |
|
81337-8
|
Patient Goals, preferences, and priorities upon death |
|
48975-7
|
GPR143 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77124-6
|
GPR98 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77123-8
|
GPR98 gene full mutation analysis in Blood or Tissue by Sequencing |
|
46189-7
|
Goose parvovirus Ab [Presence] in Serum |
|
43336-7
|
Goose parvovirus Ab [Presence] in Serum by Immunofluorescence |
|
43337-5
|
Goose parvovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17577-8
|
Ganglioside GQ1a IgM Ab [Presence] in Serum |
|
17578-6
|
Ganglioside GQ1b Ab [Presence] in Serum |
|
31674-5
|
Ganglioside GQ1b Ab [Units/volume] in Serum |
|
31164-7
|
Ganglioside GQ1b Ab [Titer] in Serum |
|
58975-4
|
Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
17580-2
|
Ganglioside GQ1b IgG Ab [Presence] in Cerebral spinal fluid |
|
31676-0
|
Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid |
|
57660-3
|
Ganglioside GQ1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
17579-4
|
Ganglioside GQ1b IgG Ab [Presence] in Serum |
|
63254-7
|
Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoassay |
|
56741-2
|
Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoblot |
|
31678-6
|
Ganglioside GQ1b IgG Ab [Units/volume] in Serum |
|
24001-0
|
Ganglioside GQ1b IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
14254-7
|
Ganglioside GQ1b IgG Ab [Titer] in Serum |
|
50772-3
|
Ganglioside GQ1b IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay |
|
88729-9
|
Ganglioside GQ1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
82410-2
|
Ganglioside GQ1b IgG+IgM Ab [Presence] in Serum by Line blot |
|
58976-2
|
Ganglioside GQ1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56545-7
|
Ganglioside GQ1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
17581-0
|
Ganglioside GQ1b IgM Ab [Presence] in Serum |
|
63255-4
|
Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoassay |
|
56742-0
|
Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoblot |
|
42320-2
|
Glutathione reductase phenotype [Interpretation] in Red Blood Cells |
|
49267-8
|
Glutathione reductase phenotype [Interpretation] in Red Blood Cells Narrative |
|
29281-3
|
Glutathione reductase [Presence] in Red Blood Cells |
|
2378-8
|
Glutathione reductase [Enzymatic activity/volume] in Red Blood Cells |
|
50382-1
|
Glutathione reductase [Enzymatic activity/mass] in Red Blood Cells |
|
45329-0
|
Glutathione reductase [Enzymatic activity/volume] in Serum |
|
73851-8
|
18-Beta glycyrrhetinate [Mass/volume] in 24 hour Urine |
|
73850-0
|
18-Beta glycyrrhetinate [Mass/volume] in Urine |
|
82158-7
|
Graduation state Provider |
|
44649-2
|
Grading system in Breast tumor |
|
88297-7
|
Gradual dose reduction (GDR) attempted [CMS Assessment] |
|
44761-5
|
Graft portion Liver |
|
80455-9
|
Grain servings 24 hour Estimated |
|
80456-7
|
Grain servings 24 hour Measured |
|
7346-0
|
Grain dust IgE Ab [Units/volume] in Serum |
|
21313-2
|
Grain elevator dust IgE Ab RAST class [Presence] in Serum |
|
7345-2
|
Grain IgE Ab [Units/volume] in Serum |
|
7347-8
|
Grain mill dust IgE Ab [Units/volume] in Serum |
|
11174-0
|
Grain weevel IgE Ab [Units/volume] in Serum |
|
16084-6
|
Grain weevel IgE Ab RAST class [Presence] in Serum |
|
90068-8
|
Gram negative bacilli identified in Isolate by Organism specific culture |
|
90069-6
|
Gram positive bacilli identified in Isolate by Organism specific culture |
|
87971-8
|
Microscopic observation [Identifier] in Amniotic fluid by Gram stain |
|
72408-8
|
Microscopic observation [Identifier] in Anal by Gram stain |
|
14358-6
|
Microscopic observation [Identifier] in Aspirate by Gram stain |
|
90262-7
|
Microscopic observation [Identifier] in Bile fluid by Gram stain |
|
87969-2
|
Microscopic observation [Identifier] in Blood by Gram stain |
|
21021-1
|
Microscopic observation [Identifier] in Bronchial specimen by Gram stain |
|
87974-2
|
Microscopic observation [Identifier] in Burn by Gram stain |
|
90282-5
|
Microscopic observation [Identifier] in Catheter tip by Gram stain |
|
87999-9
|
Microscopic observation [Identifier] in Contact lens by Gram stain |
|
88170-6
|
Microscopic observation [Identifier] in Cornea or Conjunctiva by Gram stain |
|
14357-8
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain |
|
6464-2
|
Microscopic observation [Identifier] in Cervix by Gram stain |
|
88001-3
|
Microscopic observation [Identifier] in Peritoneal dialysis fluid by Gram stain |
|
21022-9
|
Microscopic observation [Identifier] in Dialysis fluid by Gram stain |
|
14365-1
|
Microscopic observation [Identifier] in Ear by Gram stain |
|
14364-4
|
Microscopic observation [Identifier] in Eye by Gram stain |
|
27112-2
|
Microscopic observation [Identifier] in Body fluid by Gram stain |
|
48712-4
|
Microscopic observation [Identifier] in Genital specimen by Gram stain |
|
6467-5
|
Microscopic observation [Identifier] in Genital fluid by Gram stain |
|
10856-3
|
Microscopic observation [Identifier] in Genital mucus by Gram stain |
|
89659-7
|
Microscopic observation [Identifier] in Implanted device by Gram stain |
|
87975-9
|
Microscopic observation [Identifier] in Isolate by Gram stain |
|
88632-5
|
Microscopic observation [Identifier] in Lower respiratory specimen by Gram stain |
|
87967-6
|
Microscopic observation [Identifier] in Bone marrow by Gram stain |
|
90263-5
|
Microscopic observation [Identifier] in Milk by Gram stain |
|
32026-7
|
Microscopic observation [Identifier] in Nose by Gram stain |
|
88149-0
|
Microscopic observation [Identifier] in Nasopharynx by Gram stain |
|
88158-1
|
Microscopic observation [Identifier] in Ocular fluid by Gram stain |
|
88147-4
|
Microscopic observation [Identifier] in Pericardial fluid by Gram stain |
|
88146-6
|
Microscopic observation [Identifier] in Placenta by Gram stain |
|
14360-2
|
Microscopic observation [Identifier] in Pleural fluid by Gram stain |
|
14359-4
|
Microscopic observation [Identifier] in Peritoneal fluid by Gram stain |
|
643-7
|
Microscopic observation [Identifier] in Pus by Gram stain |
|
88634-1
|
Microscopic observation [Identifier] in Saliva (oral fluid) by Gram stain |
|
87972-6
|
Microscopic observation [Identifier] in Sinus by Gram stain |
|
90296-5
|
Microscopic observation [Identifier] in Skin by Gram stain |
|
87973-4
|
Microscopic observation [Identifier] in Semen by Gram stain |
|
14363-6
|
Microscopic observation [Identifier] in Synovial fluid by Gram stain |
|
648-6
|
Microscopic observation [Identifier] in Sputum by Gram stain |
|
649-4
|
Microscopic observation [Identifier] in Stool by Gram stain |
|
14362-8
|
Microscopic observation [Identifier] in Throat by Gram stain |
|
6664-7
|
Microscopic observation [Identifier] in Tissue by Gram stain |
|
91808-6
|
Microscopic observation [Identifier] in Upper respiratory specimen by Gram stain |
|
653-6
|
Microscopic observation [Identifier] in Urine by Gram stain |
|
6474-1
|
Microscopic observation [Identifier] in Urethra by Gram stain |
|
14361-0
|
Microscopic observation [Identifier] in Vaginal fluid by Gram stain |
|
88635-8
|
Microscopic observation [Identifier] in Vomitus by Gram stain |
|
10357-2
|
Microscopic observation [Identifier] in Wound by Gram stain |
|
664-3
|
Microscopic observation [Identifier] in Unspecified specimen by Gram stain |
|
272-5
|
Gramicidin D [Susceptibility] by Disk diffusion (KB) |
|
271-7
|
Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
270-9
|
Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC) |
|
18930-8
|
Gramicidin D [Susceptibility] |
|
273-3
|
Gramicidin D [Susceptibility] by Serum bactericidal titer |
|
7360-1
|
Gramma grass (Bouteloua gracilis) IgE Ab [Units/volume] in Serum |
|
15742-0
|
Gramma grass (Bouteloua gracilis) IgE Ab RAST class [Presence] in Serum |
|
53282-0
|
Granular casts [#/volume] in Urine by Computer assisted method |
|
33341-9
|
Granular casts [#/area] in Urine by Computer assisted method |
|
88974-1
|
Granular casts [#/area] in Urine sediment |
|
46134-3
|
Granular casts [#/area] in Urine sediment by Microscopy high power field |
|
5793-5
|
Granular casts [#/area] in Urine sediment by Microscopy low power field |
|
50230-2
|
Granular casts [Presence] in Urine by Computer assisted method |
|
25160-3
|
Granular casts [Presence] in Urine sediment by Light microscopy |
|
30394-1
|
Granulocytes [#/volume] in Blood |
|
20482-6
|
Granulocytes [#/volume] in Blood by Automated count |
|
51588-2
|
Granulocytes [#/volume] in Blood by Manual count |
|
35059-5
|
Granulocytes [#/volume] in Cerebral spinal fluid |
|
74140-5
|
Granulocytes [#/volume] in Peritoneal dialysis fluid |
|
74142-1
|
Granulocytes [#/volume] in Body fluid |
|
32590-2
|
Granulocytes units available [#] |
|
30395-8
|
Granulocytes/100 leukocytes in Blood |
|
19023-1
|
Granulocytes/100 leukocytes in Blood by Automated count |
|
30396-6
|
Granulocytes/100 leukocytes in Bronchial specimen |
|
14773-6
|
Granulocytes/100 leukocytes in Bronchial specimen by Manual count |
|
33963-0
|
Granulocytes/100 leukocytes in Cerebral spinal fluid |
|
74141-3
|
Granulocytes/100 leukocytes in Peritoneal dialysis fluid |
|
74143-9
|
Granulocytes/100 leukocytes in Body fluid |
|
32177-8
|
Granulocytes/100 leukocytes in Vaginal fluid |
|
61124-4
|
Granulocytes/100 leukocytes in Unspecified specimen by Flow cytometry (FC) |
|
67814-4
|
Granulocytic cells/100 cells in Bone marrow by Manual count |
|
50318-5
|
Granzyme B Ag [Presence] in Tissue by Immune stain |
|
6841-1
|
Grape IgE Ab [Units/volume] in Serum |
|
15735-4
|
Grape IgE Ab RAST class [Presence] in Serum |
|
43587-5
|
Grape IgE Ab/IgE total in Serum |
|
7348-6
|
Grape IgG Ab [Units/volume] in Serum |
|
21314-0
|
Grape IgG Ab RAST class [Presence] in Serum |
|
56273-6
|
Grape IgG4 Ab [Mass/volume] in Serum |
|
60376-1
|
Grape IgG Ab [Mass/volume] in Serum |
|
7349-4
|
Grape raisin triggered histamine release [Units/volume] in Blood |
|
7351-0
|
Grapefruit triggered histamine release [Units/volume] in Blood |
|
6131-7
|
Grapefruit IgE Ab [Units/volume] in Serum |
|
15736-2
|
Grapefruit IgE Ab RAST class [Presence] in Serum |
|
61247-3
|
Grapefruit IgE Ab/IgE total in Serum |
|
7350-2
|
Grapefruit IgG Ab [Units/volume] in Serum |
|
21315-7
|
Grapefruit IgG Ab RAST class [Presence] in Serum |
|
56274-4
|
Grapefruit IgG4 Ab [Mass/volume] in Serum |
|
60377-9
|
Grapefruit IgG Ab [Mass/volume] in Serum |
|
31003-7
|
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
|
82101-7
|
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
82100-9
|
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
24515-9
|
Grass Allergen Mix A (Sweet vernal grass+Bermuda grass+Perennial rye grass+Timothy+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
24132-3
|
Grass Allergen Mix B (Sweet vernal grass+Perennial rye grass+Common reed+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
|
15230-6
|
Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
|
23802-2
|
Grass Allergen Mix D (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
|
48266-1
|
Grass Allergen Mix E (Cocksfoot+Meadow Fescue+Velvet grass+Perennial rye grass+Timothy+Kentucky blue grass ) triggered leukotriene release [Mass/volume] by Leukocytes |
|
23803-0
|
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Presence] in Serum by Multidisk |
|
30189-5
|
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
24478-0
|
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
51523-9
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
|
30188-7
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
24486-3
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
61204-4
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab/IgE total in Serum by Multidisk |
|
15229-8
|
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
|
50654-3
|
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
82081-1
|
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15228-0
|
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk |
|
69960-3
|
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Units/volume] in Serum by Multidisk |
|
82082-9
|
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82566-1
|
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Presence] in Serum by Multidisk |
|
82568-7
|
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Units/volume] in Serum by Multidisk |
|
82567-9
|
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82612-3
|
Grass Allergen Mix 7 (Bermuda grass+Meadow fescue+Rye grass+Timothy grass+Cultivated rye) IgE Ab [Units/volume] in Serum by Multidisk |
|
7380-9
|
Grayfish IgE Ab [Units/volume] in Serum |
|
82523-2
|
Grazoprevir [Susceptibility] by Genotype method |
|
7381-7
|
Greasewood IgE Ab [Units/volume] in Serum |
|
21078-1
|
Green Ash IgE Ab [Units/volume] in Serum |
|
21079-9
|
Green Ash IgE Ab RAST class [Presence] in Serum |
|
7128-2
|
Green Bean triggered histamine release [Units/volume] in Blood |
|
6831-2
|
Green Bean IgE Ab [Units/volume] in Serum |
|
15564-8
|
Green Bean IgE Ab RAST class [Presence] in Serum |
|
57912-8
|
Green Bean IgE Ab/IgE total in Serum |
|
7127-4
|
Green Bean IgG Ab [Units/volume] in Serum |
|
21098-9
|
Green Bean IgG Ab RAST class [Presence] in Serum |
|
56275-1
|
Green Bean IgG4 Ab [Mass/volume] in Serum |
|
60353-0
|
Green Bean IgG Ab [Mass/volume] in Serum |
|
6132-5
|
Green Coffee Bean IgE Ab [Units/volume] in Serum |
|
15563-0
|
Green Coffee Bean IgE Ab RAST class [Presence] in Serum |
|
6133-3
|
Green Nimitti IgE Ab [Units/volume] in Serum |
|
15845-1
|
Green Nimitti IgE Ab RAST class [Presence] in Serum |
|
6852-8
|
Green Pepper IgE Ab [Units/volume] in Serum |
|
15928-5
|
Green Pepper IgE Ab RAST class [Presence] in Serum |
|
7594-5
|
Green Pepper IgG Ab [Units/volume] in Serum |
|
21452-8
|
Green Pepper IgG Ab RAST class [Presence] in Serum |
|
56278-5
|
Green Pepper IgG4 Ab [Mass/volume] in Serum |
|
60393-6
|
Green Pepper IgG Ab [Mass/volume] in Serum |
|
21316-5
|
Grepafloxacin [Susceptibility] by Gradient strip |
|
35818-4
|
Grepafloxacin [Susceptibility] by Disk diffusion (KB) |
|
23639-8
|
Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23638-0
|
Grepafloxacin [Susceptibility] |
|
15284-3
|
Grey Alder IgE Ab [Units/volume] in Serum |
|
21060-9
|
Grey Alder IgE Ab RAST class [Presence] in Serum |
|
61212-7
|
Grey Alder IgE Ab/IgE total in Serum |
|
81837-7
|
GRHPR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
10787-0
|
Microscopic observation [Identifier] in Tissue by Gridley stain |
|
10811-8
|
Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |
|
84419-1
|
Grip Strength Test - national percentile Hand.dominant [NIH Toolbox] |
|
83175-0
|
Grip Strength Test - scale score age adjusted Hand.dominant [NIH Toolbox] |
|
84416-7
|
Grip Strength Test - scale score fully adjusted Hand.dominant [NIH Toolbox] |
|
83176-8
|
Grip Strength Test - scale score age adjusted Hand.non-dominant [NIH Toolbox] |
|
84417-5
|
Grip Strength Test - scale score fully adjusted Hand.non-dominant [NIH Toolbox] |
|
83173-5
|
Grip strength Hand - left Dynamometer |
|
83174-3
|
Grip strength Hand - right Dynamometer |
|
83145-3
|
Grip Strength Test [NIH Toolbox] |
|
84418-3
|
Grip Strength Test - unadjusted scale score Hand.dominant [NIH Toolbox] |
|
54202-7
|
Griseofulvin [Susceptibility] by Disk diffusion (KB) |
|
54201-9
|
Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
12402-4
|
Griseofulvin [Mass/volume] in Serum or Plasma |
|
54200-1
|
Griseofulvin [Susceptibility] |
|
81859-1
|
GRN gene full mutation analysis in Blood or Tissue by Sequencing |
|
46595-5
|
Grooming - functional ability [CMS Assessment] |
|
41277-5
|
Gross blood [Presence] of Body fluid Qualitative |
|
41278-3
|
Gross blood [Presence] of Stool Qualitative |
|
79738-1
|
Gross defects Left eye |
|
79737-3
|
Gross defects Right eye |
|
7110-0
|
Groundsel Tree IgE Ab [Units/volume] in Serum |
|
15552-3
|
Groundsel Tree IgE Ab RAST class [Presence] in Serum |
|
47043-5
|
Group counseling note |
|
81180-2
|
Growth pattern [Type] in Tumor |
|
86742-4
|
Growth phase [Type] in Skin melanoma by Light microscopy |
|
2327-5
|
Gastrin releasing polypeptide [Mass/volume] in Cerebral spinal fluid |
|
2328-3
|
Gastrin releasing polypeptide [Moles/volume] in Cerebral spinal fluid |
|
2329-1
|
Gastrin releasing polypeptide [Mass/volume] in Serum or Plasma |
|
93306-9
|
Genetic risk score for coronary heart disease |
|
33171-0
|
Gestational sac Diameter estimated from gestational age by method of Rempen 1991 (US) |
|
11850-5
|
Gestational sac Mean diameter US |
|
48112-7
|
Glutathione.reduced [Units/mass] in Red Blood Cells |
|
2382-0
|
Glutathione.reduced [Mass/volume] in Red Blood Cells |
|
48111-9
|
Glutathione.reduced [Moles/mass] in Red Blood Cells |
|
79600-3
|
Glutathione.reduced [Moles/volume] in Serum or Plasma |
|
79641-7
|
Glutathione.reduced/Creatinine [Molar ratio] in Urine |
|
53642-5
|
Glutathione.reduced/glutathione.oxidized [Molar ratio] in Blood |
|
2381-2
|
Glutathione.oxidized [Mass/volume] in Red Blood Cells |
|
47631-7
|
Glutathione.oxidized [Moles/mass] in Red Blood Cells |
|
79609-4
|
Glutathione.oxidized [Moles/volume] in Serum or Plasma |
|
79637-5
|
Glutathione.oxidized/Creatinine [Molar ratio] in Urine |
|
48110-1
|
Glutathione.oxidized/Glutathione.reduced [Molar ratio] in Red Blood Cells |
|
2379-6
|
Glutathione S-transferase [Enzymatic activity/volume] in Red Blood Cells |
|
59585-0
|
GSTP1 gene+APC gene methylation [Presence] in Tissue by Molecular genetics method |
|
70108-6
|
Glutathione S-transferase T1 Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
63468-3
|
Ganglioside GT1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58964-8
|
Ganglioside GT1a IgG Ab [Units/volume] in Serum by Immunoassay |
|
82411-0
|
Ganglioside GT1a IgG Ab [Presence] in Serum by Line blot |
|
63256-2
|
Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89509-4
|
Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Line blot |
|
58963-0
|
Ganglioside GT1a IgM Ab [Units/volume] in Serum by Immunoassay |
|
82413-6
|
Ganglioside GT1a IgM Ab [Presence] in Serum by Line blot |
|
58459-9
|
Ganglioside GT1b Ab [Presence] in Serum by Immunofluorescence |
|
63469-1
|
Ganglioside GT1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58962-2
|
Ganglioside GT1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
63257-0
|
Ganglioside GT1b IgG Ab [Presence] in Serum by Immunoassay |
|
89523-5
|
Ganglioside GT1b IgG Ab [Presence] in Serum by Line blot |
|
63258-8
|
Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89516-9
|
Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Line blot |
|
58961-4
|
Ganglioside GT1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
63259-6
|
Ganglioside GT1b IgM Ab [Presence] in Serum by Immunoassay |
|
89515-1
|
Ganglioside GT1b IgM Ab [Presence] in Serum by Line blot |
|
49689-3
|
Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 100 g glucose PO |
|
49688-5
|
Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO |
|
21004-7
|
Glucose tolerance [Interpretation] in Serum or Plasma |
|
50667-5
|
Glucose tolerance [Interpretation] in Serum or Plasma Narrative |
|
16923-5
|
guaiFENesin [Mass/volume] in Serum or Plasma |
|
87787-8
|
guaiFENesin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
54288-6
|
Guanidinoacetate [Moles/volume] in Amniotic fluid |
|
54287-8
|
Guanidinoacetate [Moles/volume] in Cerebral spinal fluid |
|
93488-5
|
Guanidinoacetate [Moles/volume] in DBS |
|
33244-5
|
Guanidinoacetate [Moles/volume] in Serum or Plasma |
|
34155-2
|
Guanidinoacetate/Creatinine [Molar ratio] in Urine |
|
79663-1
|
Guanine [Moles/volume] in Cerebral spinal fluid |
|
2400-0
|
Guanine deaminase [Enzymatic activity/volume] in Blood |
|
2401-8
|
Guanine deaminase [Enzymatic activity/volume] in Serum |
|
79690-4
|
Guanine [Moles/volume] in Serum or Plasma |
|
78695-4
|
Guanine/Creatinine [Molar ratio] in Urine |
|
79660-7
|
Guanosine [Moles/volume] in Cerebral spinal fluid |
|
79670-6
|
Guanosine [Moles/volume] in Serum or Plasma |
|
78691-3
|
Guanosine/Creatinine [Molar ratio] in Urine |
|
10933-0
|
Guar gum IgE Ab [Units/volume] in Serum |
|
15757-8
|
Guar gum IgE Ab RAST class [Presence] in Serum |
|
87294-5
|
Guardian or legally authorized representative signature for Social Security Number request |
|
10934-8
|
Guava IgE Ab [Units/volume] in Serum |
|
15758-6
|
Guava IgE Ab RAST class [Presence] in Serum |
|
93330-9
|
Glycoursodeoxycholate [Moles/volume] in Serum or Plasma |
|
88940-2
|
Guidance for repair of aneurysm of Abdominal Aorta |
|
87056-8
|
Guidance for biopsy of Abdomen |
|
87057-6
|
Guidance for placement of fiducial marker in Abdomen |
|
87078-2
|
Guidance for percutaneous drainage and placement of drainage catheter of Abdomen |
|
88943-6
|
Guidance for venous sampling of Adrenal vein |
|
87132-7
|
Guidance for injection of Ankle |
|
87193-9
|
Guidance for initial day infusion of thrombolytic of Artery-- W thrombolytic via catheter |
|
87020-4
|
Guidance for embolization of Artery |
|
88942-8
|
Guidance for repair of endoleak of Artery |
|
86999-0
|
Guidance for additional percutaneous mechanical thrombectomy of Artery |
|
87169-9
|
Guidance for initial mechanical thrombectomy of Artery |
|
87184-8
|
Guidance for percutaneous transluminal angioplasty of arterial anastomosis of Artery |
|
87164-0
|
Guidance for secondary mechanical thrombectomy of Artery |
|
87200-2
|
Guidance for placement of stent in Artery |
|
87001-4
|
Guidance for additional placement of stent of Artery |
|
87201-0
|
Guidance for treatment of AV fistula |
|
88930-3
|
Guidance for dilation of stricture and placement of stent of Biliary ducts-- W contrast IV |
|
87059-2
|
Guidance for biopsy of Biliary ducts |
|
87060-0
|
Guidance for removal of calculus from Biliary ducts |
|
87061-8
|
Guidance for injection of contrast of Biliary ducts |
|
88937-8
|
Guidance for placement of stent in Biliary ducts |
|
87051-9
|
Guidance for dilation of stricture of Biliary ducts |
|
87310-9
|
Guidance for transhepatic exchange of catheter of Biliary ducts |
|
87309-1
|
Guidance for transhepatic placement of catheter of Biliary ducts |
|
87308-3
|
Guidance for transhepatic removal of catheter of Biliary ducts |
|
87044-4
|
Guidance for check of tube of Biliary ducts |
|
87013-9
|
Guidance for percutaneous biopsy of Bone |
|
87010-5
|
Guidance for aspiration of cyst of Bone |
|
87018-8
|
Guidance for deep biopsy of Bone |
|
87014-7
|
Guidance for biopsy of Bone marrow |
|
87008-9
|
Guidance for fluid aspiration of Bone marrow |
|
87176-4
|
Guidance for radiofrequency ablation of Bone |
|
87145-9
|
Guidance for embolization of Brachial artery |
|
87101-2
|
Guidance for percutaneous transluminal angioplasty of Brachiocephalic artery |
|
87062-6
|
Guidance for nerve block of Celiac plexus |
|
87034-5
|
Guidance for exchange of catheter portion only of CV catheter with port of Chest |
|
87149-1
|
Guidance for exchange of chest tube of Chest |
|
87104-6
|
Guidance for injection of CV catheter of Chest |
|
87105-3
|
Guidance for reposition of CV catheter in Chest |
|
87035-2
|
Guidance for exchange of CV catheter with port of Chest |
|
87106-1
|
Guidance for placement of CV catheter with port in Chest |
|
87107-9
|
Guidance for removal of CV catheter with port from Chest |
|
87108-7
|
Guidance for repair of CV catheter with port of Chest |
|
87205-1
|
Guidance for exchange of non-tunneled CV catheter of Chest |
|
87115-2
|
Guidance for repair of non-tunneled CV catheter without port of Chest |
|
87027-9
|
Guidance for biopsy of Chest Pleura |
|
87177-2
|
Guidance for radiofrequency ablation of Chest Pleura |
|
87121-0
|
Guidance for placement of tunneled catheter in Chest Pleura |
|
88243-1
|
Guidance for removal of tunneled catheter from Chest Pleura |
|
87109-5
|
Guidance for placement of Swan-Ganz catheter in Chest |
|
87111-1
|
Guidance for thoracentesis of Chest |
|
87110-3
|
Guidance for thoracentesis and insertion of tube of Chest |
|
87112-9
|
Guidance for exchange of tunneled CV catheter without port of Chest |
|
87113-7
|
Guidance for placement of tunneled CV catheter without port in Chest |
|
87114-5
|
Guidance for removal of tunneled CV catheter without port from Chest |
|
87031-1
|
Guidance for check of peritoneovenous shunt of Chest and Abdomen |
|
87097-2
|
Guidance for placement of peritoneovenous shunt in Chest and Abdomen |
|
87098-0
|
Guidance for removal of peritoneovenous shunt from Chest and Abdomen |
|
87099-8
|
Guidance for revision of peritoneovenous shunt of Chest and Abdomen |
|
87154-1
|
Guidance for diagnostic puncture of Cervical spine |
|
87153-3
|
Guidance for therapeutic puncture and drainage of Cervical spine |
|
87186-3
|
Guidance for mechanical thrombectomy of central venous catheter lumen obstruction |
|
92682-4
|
Guidance for dilation of existing nephrostomy tract and placement of nephrostomy tube at new site of Kidney |
|
87161-6
|
Guidance for injection of Spine epidural space |
|
87130-1
|
Guidance for laser ablation of Extremity vein |
|
87138-4
|
Guidance for additional laser ablation of Extremity vein |
|
87131-9
|
Guidance for greater than 20 stab phlebectomy of Extremity vein |
|
87180-6
|
Guidance for dilation of Fallopian tube |
|
87133-5
|
Guidance for percutaneous transluminal angioplasty of Femoral artery and Popliteal artery |
|
87134-3
|
Guidance for placement of stent in Femoral artery and Popliteal artery |
|
87046-9
|
Guidance for cholangioscopy of Gallbladder |
|
87045-1
|
Guidance for cholangioscopy and removal of calculus of Gallbladder |
|
87047-7
|
Guidance for cholecystostomy of Gallbladder |
|
88935-2
|
Guidance for chemoembolization of Hepatic artery-- W chemotherapy IA+W embolic agent IA |
|
88939-4
|
Guidance for radioembolization for tumor of Hepatic artery-- W Yttrium-90 IA |
|
88242-3
|
Guidance for infusion of non-thrombolytic of Head Arteries |
|
88936-0
|
Guidance for injection of Hepatic artery-- W Tc-99m MAA IA |
|
88931-1
|
Guidance for embolization for tumor of Hepatic artery-- W embolic agent IA |
|
87135-0
|
Guidance for injection of Hip |
|
87117-8
|
Guidance for pericardiocentesis of Heart |
|
87165-7
|
Guidance for placement of endograft in Iliac artery |
|
87150-9
|
Guidance for percutaneous transluminal angioplasty of Iliac artery |
|
87038-6
|
Guidance for additional transluminal angioplasty of Iliac artery |
|
87151-7
|
Guidance for placement of stent in Iliac artery |
|
87037-8
|
Guidance for additional placement of stent of Iliac artery |
|
87004-8
|
Guidance for arthrocentesis of Intermediate joint |
|
87092-3
|
Guidance for placement of venous filter in Inferior vena cava |
|
87093-1
|
Guidance for removal of venous filter from Inferior vena cava |
|
87094-9
|
Guidance for reposition of venous filter in Inferior vena cava |
|
87007-1
|
Guidance for arthrocentesis of Joint |
|
87188-9
|
Guidance for exchange of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87041-0
|
Guidance for percutaneous biopsy of Kidney |
|
87049-3
|
Guidance for cryoablation of Kidney |
|
87040-2
|
Guidance for aspiration of cyst of Kidney |
|
92681-6
|
Guidance for dilation of existing nephrostomy tract of Kidney |
|
87054-3
|
Guidance for exchange of nephrostomy tube of Kidney |
|
87066-7
|
Guidance for percutaneous placement of nephrostomy tube of Kidney |
|
87058-4
|
Guidance for radiofrequency ablation of Kidney |
|
87067-5
|
Guidance for transjugular biopsy of Kidney |
|
87068-3
|
Guidance for transjugular biopsy and venography of Kidney |
|
87136-8
|
Guidance for arthrocentesis of Knee |
|
87137-6
|
Guidance for injection of Knee |
|
87042-8
|
Guidance for percutaneous biopsy of Liver |
|
87050-1
|
Guidance for cryoablation of Liver |
|
87069-1
|
Guidance for hemodynamic evaluation of Liver |
|
87070-9
|
Guidance for microwave ablation of Liver |
|
87071-7
|
Guidance for radiofrequency ablation of Liver |
|
87072-5
|
Guidance for placement of TIPS of Liver |
|
87073-3
|
Guidance for revision of TIPS of Liver |
|
87074-1
|
Guidance for transhepatic revision of tube of Liver |
|
87075-8
|
Guidance for transjugular biopsy of Liver |
|
87076-6
|
Guidance for transjugular biopsy and hemodynamic evaluation of Liver |
|
87077-4
|
Guidance for transjugular biopsy and venography of Liver |
|
87015-4
|
Guidance for biopsy of Lymph node |
|
87012-1
|
Guidance for fluid aspiration of Lymph node |
|
87129-3
|
Guidance for percutaneous transluminal angioplasty of Lower leg |
|
87139-2
|
Guidance for additional transluminal angioplasty of Lower leg |
|
87140-0
|
Guidance for additional placement of stent of Lower leg vessel |
|
87089-9
|
Guidance for kyphoplasty of Lumbar spine |
|
87036-0
|
Guidance for additional level kyphoplasty of Lumbar spine |
|
87090-7
|
Guidance for myelography of Lumbar spine |
|
87088-1
|
Guidance for puncture of Lumbar spine |
|
87091-5
|
Guidance for vertebroplasty of Lumbar spine |
|
87039-4
|
Guidance for additional vertebroplasty of Lumbar spine |
|
87028-7
|
Guidance for biopsy of Lung |
|
87032-9
|
Guidance for cryoablation of Lung |
|
87118-6
|
Guidance for placement of fiducial marker in Lung |
|
87119-4
|
Guidance for microwave ablation of Lung |
|
87120-2
|
Guidance for radiofrequency ablation of Lung |
|
87170-7
|
Guidance for ligation of Lymphatic vessel |
|
87005-5
|
Guidance for arthrocentesis of Major joint |
|
87029-5
|
Guidance for biopsy of Mediastinum |
|
87174-9
|
Guidance for biopsy of Muscle |
|
87183-0
|
Guidance for greater than 2 injections of trigger point of Muscle |
|
86994-1
|
Guidance for 1 or 2 injections of trigger point of Muscle |
|
87030-3
|
Guidance for biopsy of Neck or Chest Soft tissue |
|
87203-6
|
Guidance for transurethral exchange of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87189-7
|
Guidance for transurethral removal of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87187-1
|
Guidance for nerve block of Nerve root |
|
87185-5
|
Guidance for sympathectomy of Nerve |
|
87055-0
|
Guidance for biopsy of Pancreas |
|
87190-5
|
Guidance for percutaneous placement of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87191-3
|
Guidance for removal of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87175-6
|
Guidance for deep drainage and placement of drainage catheter of Pelvis |
|
87081-6
|
Guidance for placement of catheter in Peritoneum |
|
87082-4
|
Guidance for removal of catheter from Peritoneum |
|
87083-2
|
Guidance for reposition of catheter in Peritoneum |
|
87084-0
|
Guidance for removal of foreign body from Peritoneum |
|
87079-0
|
Guidance for paracentesis and insertion of tube of Peritoneum |
|
87080-8
|
Guidance for paracentesis of Peritoneum |
|
87085-7
|
Guidance for placement of port in Peritoneum |
|
87086-5
|
Guidance for removal of port from Peritoneum |
|
87116-0
|
Guidance for placement of chest tube in Pleural space |
|
87033-7
|
Guidance for drainage and placement of chest tube of Pleural space |
|
87206-9
|
Guidance for nerve block of Peripheral nerve |
|
88933-7
|
Guidance for embolization of Portal vein-- W embolic agent IV |
|
87173-1
|
Guidance for biopsy of Prostate |
|
87087-3
|
Guidance for percutaneous transluminal angioplasty of Renal artery |
|
87146-7
|
Guidance for injection of Shoulder |
|
87006-3
|
Guidance for arthrocentesis of Small joint |
|
87016-2
|
Guidance for biopsy of Soft tissue |
|
88932-9
|
Guidance for embolization for tumor of Spinal artery-- W embolic agent IA |
|
87160-8
|
Guidance for injection of Spine facet joint |
|
88934-5
|
Guidance for embolization of Splenic artery-- W embolic agent IA |
|
87052-7
|
Guidance for exchange of G-tube of Stomach |
|
87128-5
|
Guidance for placement of venous filter in Superior vena cava |
|
87126-9
|
Guidance for removal of venous filter from Superior vena cava |
|
87127-7
|
Guidance for reposition of venous filter in Superior vena cava |
|
87100-4
|
Guidance for percutaneous transluminal angioplasty of Thoracic and abdominal aorta |
|
88941-0
|
Guidance for repair of aneurysm of Thoracic Aorta |
|
87158-2
|
Guidance for injection of Tendon |
|
86997-4
|
Guidance for additional day infusion of thrombolytic of Vessel-- W thrombolytic via catheter |
|
87024-6
|
Guidance for additional day infusion of thrombolytic of Chest-- W thrombolytic via chest tube |
|
87102-0
|
Guidance for initial day infusion of thrombolytic of Chest-- W thrombolytic via chest tube |
|
87103-8
|
Guidance for infusion of thrombolytic of Chest-- W thrombolytic via CVC |
|
87155-8
|
Guidance for fine needle aspiration of Thyroid gland |
|
87156-6
|
Guidance for percutaneous biopsy.core needle of Thyroid gland |
|
87159-0
|
Guidance for injection of Temporomandibular joint |
|
87125-1
|
Guidance for nerve block of Thoracic spine intercostal nerve |
|
87122-8
|
Guidance for kyphoplasty of Thoracic spine |
|
87025-3
|
Guidance for additional level kyphoplasty of Thoracic spine |
|
87123-6
|
Guidance for myelography of Thoracic spine |
|
87124-4
|
Guidance for vertebroplasty of Thoracic spine |
|
87026-1
|
Guidance for additional vertebroplasty of Thoracic spine |
|
87142-6
|
Guidance for exchange of CV catheter with port of Upper extremity |
|
87141-8
|
Guidance for placement of CV catheter with port in Upper extremity |
|
87143-4
|
Guidance for exchange of peripherally inserted central catheter of Upper extremity |
|
87144-2
|
Guidance for placement of peripherally-inserted central venous catheter in Upper extremity |
|
87048-5
|
Guidance for conversion of G-tube to GJ-tube of Gastrointestinal tract upper |
|
87064-2
|
Guidance for placement of GJ-tube in Gastrointestinal tract upper |
|
87063-4
|
Guidance for removal of GJ-tube from Gastrointestinal tract upper |
|
87065-9
|
Guidance for placement of G-tube in Gastrointestinal tract upper |
|
87053-5
|
Guidance for exchange of J-tube of Gastrointestinal tract upper |
|
87017-0
|
Guidance for check of drainage catheter for abscess |
|
87023-8
|
Guidance for exchange of drainage catheter for abscess |
|
87198-8
|
Guidance for placement of drainage catheter for abscess |
|
86995-8
|
Guidance for abscess |
|
87171-5
|
Guidance for placement of clip |
|
87172-3
|
Guidance for placement of clip-- preoperative |
|
87199-6
|
Guidance for substance removal of central venous catheter pericatheter obstruction |
|
87009-7
|
Guidance for aspiration of cyst |
|
87019-6
|
Guidance for drainage and placement of drainage catheter |
|
87179-8
|
Guidance for fine needle aspiration |
|
87011-3
|
Guidance for aspiration of ganglion cyst |
|
88349-6
|
Guidance-- during surgery |
|
25072-0
|
Guidance for placement of infusion port |
|
87162-4
|
Guidance for placement of needle |
|
87157-4
|
Guidance for injection of platelet rich plasma |
|
87192-1
|
Guidance for thrombectomy |
|
87167-3
|
Guidance for transcatheter biopsy |
|
87168-1
|
Guidance for transcatheter placement of stent |
|
87182-2
|
Guidance for placement of wire |
|
87002-2
|
Guidance for additional placement of wire |
|
87043-6
|
Guidance for biopsy of Ureter |
|
88938-6
|
Guidance for placement of stent in Ureter |
|
87152-5
|
Guidance for exchange of ureterostomy through ileal conduit of Ureter |
|
87181-4
|
Guidance for embolization of Uterine artery |
|
87021-2
|
Guidance for embolization of Vein |
|
87163-2
|
Guidance for placement of endovascular device in Vein |
|
87000-6
|
Guidance for additional placement of endovascular device of Vein |
|
25027-4
|
Guidance for placement of large bore CV catheter in Vein |
|
86998-2
|
Guidance for additional percutaneous mechanical thrombectomy of Vein |
|
87194-7
|
Guidance for initial mechanical thrombectomy of Vein |
|
87166-5
|
Guidance for percutaneous transluminal angioplasty of Vein |
|
88929-5
|
Guidance for additional transluminal angioplasty of Vein |
|
87312-5
|
Guidance for percutaneous transluminal angioplasty for dialysis of Vein |
|
87195-4
|
Guidance for initial day infusion of thrombolytic of Vein-- W thrombolytic via catheter |
|
87202-8
|
Guidance for venous sampling of Vein |
|
26307-9
|
Guidance for placement of large bore CV catheter in Vein - bilateral |
|
26308-7
|
Guidance for placement of large bore CV catheter in Vein - left |
|
26309-5
|
Guidance for placement of large bore CV catheter in Vein - right |
|
86996-6
|
Guidance for additional augmentation of Spine vertebra |
|
86993-3
|
Guidance for 1 level kyphoplasty of Spine vertebra |
|
87003-0
|
Guidance for additional vertebroplasty of Spine vertebra |
|
87197-0
|
Guidance for retrieval of foreign body of Vessel |
|
87196-2
|
Guidance for infusion of non-thrombolytic of Vessel |
|
87178-0
|
Guidance for final day of infusion of thrombolytic of Vessel-- W thrombolytic via catheter |
|
87311-7
|
Guidance for embolization for tumor, ischemia or infarction of Vessel |
|
87022-0
|
Guidance for embolization of Vessels |
|
87095-6
|
Guidance for percutaneous transluminal angioplasty of Visceral artery |
|
87096-4
|
Guidance for placement of stent in Visceral artery |
|
87147-5
|
Guidance for injection of Wrist |
|
6134-1
|
Guinea pig epithelium IgE Ab [Units/volume] in Serum |
|
15759-4
|
Guinea pig epithelium IgE Ab RAST class [Presence] in Serum |
|
39603-6
|
Guinea pig epithelium IgE Ab/IgE total in Serum |
|
56279-3
|
Guinea pig epithelium IgG4 Ab [Mass/volume] in Serum |
|
7382-5
|
Gum arabic IgE Ab [Units/volume] in Serum |
|
15760-2
|
Gum arabic IgE Ab RAST class [Presence] in Serum |
|
56166-2
|
Gum arabic IgG4 Ab [Mass/volume] in Serum |
|
63145-7
|
Gum arabic IgG Ab [Mass/volume] in Serum |
|
6113-5
|
Gum-Tree IgE Ab [Units/volume] in Serum |
|
15703-2
|
Gum-Tree IgE Ab RAST class [Presence] in Serum |
|
61261-4
|
Gum-Tree IgE Ab/IgE total in Serum |
|
56258-7
|
Gum-Tree IgG4 Ab [Mass/volume] in Serum |
|
65322-0
|
Gy sup(a) Ab [Presence] in Serum or Plasma |
|
89455-0
|
Gynecology Attending Note |
|
89453-5
|
Gynecology Nurse practitioner Note |
|
89451-9
|
Gynecology Nurse Note |
|
89463-4
|
Gynecology Nurse Outpatient Note |
|
80396-5
|
Gynecologic oncology Consult note |
|
85444-8
|
Gynecologic oncology Note |
|
93896-9
|
Gynecologic oncology Telephone encounter Note |
|
89803-1
|
Gynecologic oncology procedure note |
|
89802-3
|
Gynecologic oncology Progress note |
|
93895-1
|
Gynecologic oncology Team Conference note |
|
89441-0
|
Gynecology Resident Note |
|
89473-3
|
Gynecology Administrative note |
|
89215-8
|
Gynecology Admission history and physical note |
|
89445-1
|
Gynecology Checklist |
|
89216-6
|
Gynecology Consult note |
|
89499-8
|
Gynecology Diagnostic study note |
|
89217-4
|
Gynecology Discharge instructions |
|
89218-2
|
Gynecology Discharge summary |
|
89219-0
|
Gynecology Discharge teaching note |
|
89220-8
|
Gynecology Education note |
|
89237-2
|
Gynecology Flowsheet |
|
89221-6
|
Gynecology History and physical note |
|
89447-7
|
Gynecology Hospital Consult note |
|
89449-3
|
Gynecology Hospital Letter |
|
89459-2
|
Gynecology Hospital Note |
|
89222-4
|
Gynecology Initial evaluation note |
|
85937-1
|
Gynecology Note |
|
89461-8
|
Gynecology Outpatient Note |
|
89472-5
|
Gynecology Surgical operation note |
|
89465-9
|
Gynecology Telephone encounter Note |
|
89239-8
|
Gynecology Plan of care note |
|
89467-5
|
Gynecology Postoperative evaluation and management note |
|
89469-1
|
Gynecology Preoperative evaluation and management note |
|
89223-2
|
Gynecology procedure note |
|
89224-0
|
Gynecology Progress note |
|
89225-7
|
Gynecology Referral note |
|
89471-7
|
Gynecology Summary note |
|
89897-3
|
Gynecology Telehealth Note |
|
89226-5
|
Gynecology Transfer summary note |
|
53867-8
|
GYS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1044-7
|
H Ab [Presence] in Serum |
|
1042-1
|
H Ab [Presence] in Serum or Plasma from Blood product unit |
|
1043-9
|
H Ab [Presence] in Serum or Plasma from Donor |
|
91682-5
|
Histoplasma capsulatum Ab [Identifier] in Cerebral spinal fluid by Immune diffusion (ID) |
|
22345-3
|
Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid |
|
21330-6
|
Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
40827-8
|
Histoplasma capsulatum Ab [Presence] in Body fluid |
|
43019-9
|
Histoplasma capsulatum Ab [Presence] in Pleural fluid |
|
42509-0
|
Histoplasma capsulatum Ab [Presence] in Pleural fluid by Immune diffusion (ID) |
|
6426-1
|
Histoplasma capsulatum Ab [Units/volume] in Serum by Immunoassay |
|
22346-1
|
Histoplasma capsulatum Ab [Presence] in Serum |
|
16970-6
|
Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation |
|
44869-6
|
Histoplasma capsulatum Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
|
44522-1
|
Histoplasma capsulatum Ab [Presence] in Serum by Immunoassay |
|
5218-3
|
Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) |
|
6427-9
|
Histoplasma capsulatum Ab [Presence] in Serum by Latex agglutination |
|
7916-0
|
Histoplasma capsulatum Ab [Units/volume] in Serum |
|
90232-0
|
Histoplasma capsulatum Ab [Identifier] in Serum or Plasma by Immune diffusion (ID) |
|
22347-9
|
Histoplasma capsulatum Ab [Titer] in Serum |
|
5219-1
|
Histoplasma capsulatum Ab [Titer] in Serum by Complement fixation |
|
27266-6
|
Histoplasma capsulatum Ab [Titer] in Serum by Immune diffusion (ID) |
|
53930-4
|
Histoplasma capsulatum Ag [Units/volume] in Bronchoalveolar lavage by Immunoassay |
|
53931-2
|
Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
51754-0
|
Histoplasma capsulatum Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
40776-7
|
Histoplasma capsulatum Ag [Presence] in Cerebral spinal fluid |
|
34158-6
|
Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid |
|
57766-8
|
Histoplasma capsulatum Ag [Mass/volume] in Body fluid |
|
6428-7
|
Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay |
|
51753-2
|
Histoplasma capsulatum Ag [Mass/volume] in Serum by Immunoassay |
|
19108-0
|
Histoplasma capsulatum Ag [Presence] in Serum |
|
44525-4
|
Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay |
|
19107-2
|
Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
31855-0
|
Histoplasma capsulatum Ag [Units/volume] in Serum |
|
48338-8
|
Histoplasma capsulatum Ag [Presence] in Tissue by Immune stain |
|
13971-7
|
Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay |
|
35734-3
|
Histoplasma capsulatum Ag [Presence] in Urine |
|
44524-7
|
Histoplasma capsulatum Ag [Presence] in Urine by Immunoassay |
|
44870-4
|
Histoplasma capsulatum Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
31856-8
|
Histoplasma capsulatum Ag [Units/volume] in Urine |
|
48952-6
|
Histoplasma capsulatum Ag [Mass/volume] in Urine |
|
42916-7
|
Histoplasma capsulatum Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
19109-8
|
Histoplasma capsulatum Ag [Presence] in Unspecified specimen |
|
34171-9
|
Histoplasma capsulatum Ag [Units/volume] in Unspecified specimen |
|
51771-4
|
Histoplasma capsulatum DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
88926-1
|
Histoplasma capsulatum DNA [Presence] in Tissue by NAA with probe detection |
|
5015-3
|
Histoplasma capsulatum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23135-7
|
Histoplasma farciminosum Ab [Presence] in Serum |
|
23134-0
|
Histoplasma farciminosum Ab [Presence] in Serum by Hemagglutination |
|
23133-2
|
Histoplasma farciminosum Ab [Presence] in Serum by Immunoassay |
|
23132-4
|
Histoplasma farciminosum Ab [Presence] in Serum by Immunofluorescence |
|
44526-2
|
Histoplasma capsulatum H Ab [Presence] in Cerebral spinal fluid |
|
44808-4
|
Histoplasma capsulatum H Ab band pattern [Interpretation] in Serum by Immunoblot |
|
44527-0
|
Histoplasma capsulatum H Ab [Presence] in Serum |
|
35732-7
|
Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID) |
|
9528-1
|
Histoplasma capsulatum IgA Ab [Units/volume] in Serum by Immunoassay |
|
22348-7
|
Histoplasma capsulatum IgA Ab [Presence] in Serum |
|
16971-4
|
Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) |
|
22349-5
|
Histoplasma capsulatum IgA Ab [Units/volume] in Serum |
|
22350-3
|
Histoplasma capsulatum IgE Ab [Presence] in Serum |
|
16972-2
|
Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) |
|
93839-9
|
Histoplasma capsulatum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
46191-3
|
Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid |
|
44523-9
|
Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
31200-9
|
Histoplasma capsulatum IgG Ab [Presence] in Serum |
|
39588-9
|
Histoplasma capsulatum IgG Ab [Presence] in Serum by Immunoassay |
|
22351-1
|
Histoplasma capsulatum IgG Ab [Units/volume] in Serum |
|
9529-9
|
Histoplasma capsulatum IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
40774-2
|
Histoplasma capsulatum IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40778-3
|
Histoplasma capsulatum IgG Ab [Titer] in Serum --2nd specimen |
|
93838-1
|
Histoplasma capsulatum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
57973-0
|
Histoplasma capsulatum IgM Ab [Presence] in Cerebral spinal fluid |
|
22352-9
|
Histoplasma capsulatum IgM Ab [Presence] in Serum |
|
16973-0
|
Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) |
|
22353-7
|
Histoplasma capsulatum IgM Ab [Units/volume] in Serum |
|
9530-7
|
Histoplasma capsulatum IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
40773-4
|
Histoplasma capsulatum IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
|
40775-9
|
Histoplasma capsulatum IgM Ab [Titer] in Serum --1st specimen |
|
49904-6
|
Histoplasma capsulatum M Ab [Presence] in Cerebral spinal fluid |
|
44809-2
|
Histoplasma capsulatum M Ab band pattern [Interpretation] in Serum by Immunoblot |
|
44528-8
|
Histoplasma capsulatum M Ab [Presence] in Serum |
|
35733-5
|
Histoplasma capsulatum M Ab [Presence] in Serum by Immune diffusion (ID) |
|
12456-0
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid |
|
31425-2
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Cerebral spinal fluid |
|
31426-0
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Body fluid |
|
20497-4
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation |
|
6816-3
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum |
|
30360-2
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Complement fixation |
|
44529-6
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Immune diffusion (ID) |
|
22354-5
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum |
|
43018-1
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid |
|
27220-3
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43017-3
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid |
|
31071-4
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid by Complement fixation |
|
20417-2
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum |
|
20573-2
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation |
|
51789-6
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Immune diffusion (ID) |
|
5016-1
|
Histoplasma capsulatum rRNA [Presence] in Unspecified specimen by Probe |
|
14214-1
|
Histoplasma capsulatum exoantigen [Identifier] in Isolate |
|
12455-2
|
Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid |
|
31427-8
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Cerebral spinal fluid |
|
31428-6
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Body fluid |
|
20498-2
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation |
|
6817-1
|
Histoplasma capsulatum yeast phase Ab [Presence] in Serum |
|
35435-7
|
Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Complement fixation |
|
44530-4
|
Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Immune diffusion (ID) |
|
22355-2
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum |
|
43016-5
|
Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid |
|
27209-6
|
Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43015-7
|
Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid |
|
31070-6
|
Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid by Complement fixation |
|
20418-0
|
Histoplasma capsulatum yeast phase Ab [Titer] in Serum |
|
20574-0
|
Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation |
|
70055-9
|
Hantavirus dobrova IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
70054-2
|
Hantavirus dobrova IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
76076-9
|
Haemophilus ducreyi DNA [Presence] in Genital specimen by NAA with probe detection |
|
29559-2
|
Haemophilus ducreyi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91789-8
|
Haemophilus ducreyi [Presence] in Genital specimen by Organism specific culture |
|
11255-7
|
Haemophilus ducreyi [Presence] in Unspecified specimen by Organism specific culture |
|
24421-0
|
Haemobartonella felis [Presence] in Blood by Light microscopy |
|
85678-1
|
Haemophilus influenzae acs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85683-1
|
Haemophilus influenzae bcs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85679-9
|
Haemophilus influenzae bex gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85682-3
|
Haemophilus influenzae ccs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85681-5
|
Haemophilus influenzae dcs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85680-7
|
Haemophilus influenzae ecs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85627-8
|
Haemophilus influenzae hpd gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
76602-2
|
Haemophilus influenzae lex2 gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76574-3
|
Haemophilus influenzae lex2 gene [Presence] in XXX.swab by NAA with probe detection |
|
76589-1
|
Haemophilus influenzae lex2 gene [#/mass] in XXX.tissue by NAA with probe detection |
|
7393-2
|
Helminthosporium interseminatum IgE Ab [Units/volume] in Serum |
|
63170-5
|
Helminthosporium interseminatum IgG Ab [Mass/volume] in Serum |
|
35747-5
|
Hydrogen ion [Moles/volume] in Arterial blood |
|
50860-6
|
Hydrogen ion [Moles/volume] in Arterial cord blood |
|
50858-0
|
Hydrogen ion [Moles/volume] in Mixed venous cord blood |
|
50862-2
|
Hydrogen ion [Moles/volume] in Cord blood |
|
50859-8
|
Hydrogen ion [Moles/volume] in Venous cord blood |
|
50861-4
|
Hydrogen ion [Moles/volume] in Capillary blood |
|
53143-4
|
Hydrogen ion [Moles/volume] in Mixed venous blood |
|
50863-0
|
Hydrogen ion [Moles/volume] in Blood |
|
50864-8
|
Hydrogen ion [Moles/volume] in Venous blood |
|
50865-5
|
Hydrogen ion [Moles/volume] in Serum or Plasma |
|
35748-3
|
Hydrogen ion [Moles/volume] adjusted to patient's actual temperature in Arterial blood |
|
7394-0
|
Helminthosporium maydis IgE Ab [Units/volume] in Serum |
|
34884-7
|
Haemophilus paragallinarum Ab [Units/volume] in Serum by Immunoassay |
|
41152-0
|
Haemophilus paragallinarum Ab [Units/volume] in Serum |
|
20833-0
|
Haemophilus paragallinarum serotype [Identifier] in Isolate |
|
87364-6
|
Haemophilus parasuis Ab/Positive control in Serum by Immunoassay |
|
86729-1
|
Haemophilus parasuis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90322-9
|
Haemophilus parasuis serotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
88509-5
|
Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular method |
|
5174-8
|
Helicobacter pylori Ab [Units/volume] in Serum by Immunoassay |
|
16929-2
|
Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence |
|
22310-7
|
Helicobacter pylori Ab [Presence] in Serum |
|
6419-6
|
Helicobacter pylori Ab [Presence] in Serum by Immunofluorescence |
|
7900-4
|
Helicobacter pylori Ab [Units/volume] in Serum |
|
16533-2
|
Helicobacter pylori Ab [Titer] in Serum |
|
5175-5
|
Helicobacter pylori Ab [Titer] in Serum by Latex agglutination |
|
31843-6
|
Helicobacter pylori Ag [Presence] in Stool |
|
17780-8
|
Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
|
80373-4
|
Helicobacter pylori Ag [Presence] in Stool by Rapid immunoassay |
|
50320-1
|
Helicobacter pylori Ag [Presence] in Tissue by Immune stain |
|
91061-2
|
Helicobacter pylori DNA [Presence] in Stool by NAA with probe detection |
|
91060-4
|
Helicobacter pylori DNA [Presence] in Tissue by NAA with probe detection |
|
49101-9
|
Helicobacter pylori DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44015-6
|
Helicobacter pylori [Presence] in Gastric fluid by Organism specific culture |
|
6420-4
|
Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay |
|
16125-7
|
Helicobacter pylori IgA Ab [Presence] in Serum |
|
7901-2
|
Helicobacter pylori IgA Ab [Units/volume] in Serum |
|
40820-3
|
Helicobacter pylori IgA Ab [Titer] in Serum |
|
51762-3
|
Helicobacter pylori IgA and IgG and IgM [Interpretation] in Serum or Plasma |
|
26984-5
|
Helicobacter pylori IgG Ab [Units/volume] in Saliva (oral fluid) |
|
5176-3
|
Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay |
|
16126-5
|
Helicobacter pylori IgG Ab [Presence] in Serum |
|
60524-6
|
Helicobacter pylori IgG Ab [Presence] in Serum by Immunoblot |
|
7902-0
|
Helicobacter pylori IgG Ab [Units/volume] in Serum |
|
17859-0
|
Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
5177-1
|
Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay |
|
16127-3
|
Helicobacter pylori IgM Ab [Presence] in Serum |
|
46987-4
|
Helicobacter pylori IgM Ab [Presence] in Serum by Immunoassay |
|
7903-8
|
Helicobacter pylori IgM Ab [Units/volume] in Serum |
|
40821-1
|
Helicobacter pylori IgM Ab [Titer] in Serum |
|
87952-8
|
Helicobacter pylori [Presence] in Stool by Organism specific culture |
|
87953-6
|
Helicobacter pylori [Presence] in Tissue by Organism specific culture |
|
587-6
|
Helicobacter pylori [Presence] in Unspecified specimen by Organism specific culture |
|
70056-7
|
Hantavirus saaremaa IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
70057-5
|
Hantavirus saaremaa IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
11175-7
|
Helminthosporium sativum IgE Ab [Units/volume] in Serum |
|
21324-9
|
Helminthosporium sativum IgE Ab RAST class [Presence] in Serum |
|
70060-9
|
Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
94101-3
|
Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Line blot |
|
94100-5
|
Hantavirus seoul IgM Ab [Presence] in Serum or Plasma by Line blot |
|
31407-0
|
Haemophilus somnus Ab [Units/volume] in Serum |
|
24420-2
|
Haemophilus somnus Ab [Titer] in Serum |
|
34117-2
|
History and physical note |
|
10789-6
|
Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |
|
10790-4
|
Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |
|
6665-4
|
Microscopic observation [Identifier] in Tissue by Hematoxylin and eosin stain |
|
665-0
|
Microscopic observation [Identifier] in Unspecified specimen by Hematoxylin and eosin stain |
|
49100-1
|
H2a-H2b DNA IgG Ab [Presence] in Serum |
|
14231-5
|
H2a-H2b DNA IgG Ab [Units/volume] in Serum |
|
89309-9
|
HYDROmorphone-3-glucuronide [Presence] in Urine by Screen method |
|
82414-4
|
Ha Ab [Units/volume] in Serum by Line blot |
|
82415-1
|
Ha Ab [Presence] in Serum by Line blot |
|
90870-7
|
Habits impacting orthodontic condition |
|
34145-3
|
Human antichimeric Ab [Mass/volume] in Serum |
|
7383-3
|
Hackberry tree IgE Ab [Units/volume] in Serum |
|
15762-8
|
Hackberry tree IgE Ab RAST class [Presence] in Serum |
|
7384-1
|
Haddock IgE Ab [Units/volume] in Serum |
|
15763-6
|
Haddock IgE Ab RAST class [Presence] in Serum |
|
7385-8
|
Haddock IgG Ab [Units/volume] in Serum |
|
21319-9
|
Haddock IgG Ab RAST class [Presence] in Serum |
|
56280-1
|
Haddock IgG4 Ab [Mass/volume] in Serum |
|
60378-7
|
Haddock IgG Ab [Mass/volume] in Serum |
|
34501-7
|
HADHA gene c.1528G>C [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
41097-7
|
HADHA gene c.1528G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
21685-3
|
HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21686-1
|
HADHB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
94040-3
|
Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
88716-6
|
Adenovirus A+B+C+D+E+F DNA [Presence] in Nasopharynx by NAA with probe detection |
|
43617-0
|
Adenovirus Ab [Presence] in Cerebral spinal fluid |
|
13192-0
|
Adenovirus Ab [Units/volume] in Cerebral spinal fluid |
|
31217-3
|
Adenovirus Ab [Units/volume] in Body fluid |
|
44289-7
|
Adenovirus Ab [Units/volume] in Serum by Complement fixation |
|
43616-2
|
Adenovirus Ab [Presence] in Serum |
|
43618-8
|
Adenovirus Ab [Presence] in Serum by Complement fixation |
|
7805-5
|
Adenovirus Ab [Units/volume] in Serum |
|
24249-5
|
Adenovirus Ab [Titer] in Serum --1st specimen |
|
24175-2
|
Adenovirus Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24250-3
|
Adenovirus Ab [Titer] in Serum --2nd specimen |
|
24176-0
|
Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
34576-9
|
Adenovirus Ab [Titer] in Cerebral spinal fluid |
|
23950-9
|
Adenovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29416-5
|
Adenovirus Ab [Titer] in Body fluid |
|
29314-2
|
Adenovirus Ab [Titer] in Body fluid by Complement fixation |
|
22080-6
|
Adenovirus Ab [Titer] in Serum |
|
5041-9
|
Adenovirus Ab [Titer] in Serum by Complement fixation |
|
13913-9
|
Adenovirus Ab [Titer] in Serum by Immunofluorescence |
|
43714-5
|
Adenovirus Ab [Presence] in Unspecified specimen |
|
77382-0
|
Adenovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
43611-3
|
Adenovirus Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
31710-7
|
Adenovirus Ag [Presence] in Conjunctival specimen |
|
5823-0
|
Adenovirus Ag [Presence] in Conjunctival specimen by Immunoassay |
|
5824-8
|
Adenovirus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
87959-3
|
Adenovirus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
43615-4
|
Adenovirus Ag [Presence] in Genital specimen |
|
88603-6
|
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunoassay |
|
91841-7
|
Adenovirus Ag [Presence] in Lower respiratory specimen by Rapid immunoassay |
|
88897-4
|
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
43614-7
|
Adenovirus Ag [Presence] in Nose |
|
43612-1
|
Adenovirus Ag [Presence] in Nose by Immunofluorescence |
|
35705-3
|
Adenovirus Ag [Presence] in Nasopharynx |
|
88602-8
|
Adenovirus Ag [Presence] in Nasopharynx by Immunoassay |
|
43610-5
|
Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31711-5
|
Adenovirus Ag [Presence] in Stool |
|
5825-5
|
Adenovirus Ag [Presence] in Stool by Immunoassay |
|
78529-5
|
Adenovirus Ag [Presence] in Stool by Rapid immunoassay |
|
5826-3
|
Adenovirus Ag [Presence] in Stool by Immunofluorescence |
|
31712-3
|
Adenovirus Ag [Presence] in Throat |
|
5827-1
|
Adenovirus Ag [Presence] in Throat by Immunoassay |
|
5828-9
|
Adenovirus Ag [Presence] in Throat by Immunofluorescence |
|
5829-7
|
Adenovirus Ag [Presence] in Tissue by Immunoassay |
|
5830-5
|
Adenovirus Ag [Presence] in Tissue by Immunofluorescence |
|
43613-9
|
Adenovirus Ag [Presence] in Trachea by Immunofluorescence |
|
91822-7
|
Adenovirus Ag [Presence] in Upper respiratory specimen by Immunoassay |
|
91821-9
|
Adenovirus Ag [Presence] in Upper respiratory specimen by Rapid immunoassay |
|
31713-1
|
Adenovirus Ag [Presence] in Urine |
|
5831-3
|
Adenovirus Ag [Presence] in Urine by Immunoassay |
|
5832-1
|
Adenovirus Ag [Presence] in Urine by Immunofluorescence |
|
31714-9
|
Adenovirus Ag [Presence] in Unspecified specimen |
|
5833-9
|
Adenovirus Ag [Presence] in Unspecified specimen by Immunoassay |
|
5834-7
|
Adenovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88899-0
|
Adenovirus [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
49336-1
|
Adenovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49341-1
|
Adenovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
92854-9
|
Adenovirus DNA [#/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection |
|
49338-7
|
Adenovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
66721-2
|
Adenovirus DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
|
66727-9
|
Adenovirus DNA [#/volume] (viral load) in Genital specimen by NAA with probe detection |
|
49337-9
|
Adenovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49334-6
|
Adenovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
66729-5
|
Adenovirus DNA [#/volume] (viral load) in Skin by NAA with probe detection |
|
49339-5
|
Adenovirus DNA [#/volume] (viral load) in Stool by NAA with probe detection |
|
49335-3
|
Adenovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
48609-2
|
Adenovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49340-3
|
Adenovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88541-8
|
Adenovirus DNA [Presence] in Aspirate by NAA with probe detection |
|
62480-9
|
Adenovirus DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
66725-3
|
Adenovirus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
86511-3
|
Adenovirus DNA [Presence] in Blood by NAA with probe detection |
|
88533-5
|
Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
66730-3
|
Adenovirus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
38375-2
|
Adenovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
66720-4
|
Adenovirus DNA [Log #/volume] (viral load) in Body fluid by NAA with probe detection |
|
66726-1
|
Adenovirus DNA [Log #/volume] (viral load) in Genital specimen by NAA with probe detection |
|
60259-9
|
Adenovirus DNA [Presence] in Isolate by NAA with probe detection |
|
92987-7
|
Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
90463-1
|
Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82160-3
|
Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76070-2
|
Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection |
|
66723-8
|
Adenovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
21055-9
|
Adenovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
66728-7
|
Adenovirus DNA [Log #/volume] (viral load) in Skin by NAA with probe detection |
|
66731-1
|
Adenovirus DNA [Log #/volume] (viral load) in Sputum or Bronchial by NAA with probe detection |
|
66724-6
|
Adenovirus DNA [Log #/volume] (viral load) in Stool by NAA with probe detection |
|
88539-2
|
Adenovirus DNA [Presence] in Stool by NAA with probe detection |
|
66722-0
|
Adenovirus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
|
86510-5
|
Adenovirus DNA [Presence] in Tissue by NAA with probe detection |
|
91820-1
|
Adenovirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
66719-6
|
Adenovirus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
|
86512-1
|
Adenovirus DNA [Presence] in Urine by NAA with probe detection |
|
40976-3
|
Adenovirus DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
64038-3
|
Adenovirus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
39528-5
|
Adenovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40975-5
|
Adenovirus DNA [Identifier] in Unspecified specimen by RFLP |
|
69920-7
|
Adenovirus IgA Ab [Presence] in Serum by Immunoassay |
|
51822-5
|
Adenovirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
41162-9
|
Adenovirus IgG Ab [Presence] in Serum |
|
40977-1
|
Adenovirus IgG Ab [Presence] in Serum by Immunoassay |
|
13914-7
|
Adenovirus IgG Ab [Units/volume] in Serum |
|
21053-4
|
Adenovirus IgG Ab [Titer] in Serum |
|
51823-3
|
Adenovirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
21054-2
|
Adenovirus IgM Ab [Presence] in Serum |
|
86513-9
|
Adenovirus IgM Ab [Presence] in Serum by Immunoassay |
|
5042-7
|
Adenovirus IgM Ab [Units/volume] in Serum |
|
13915-4
|
Adenovirus IgM Ab [Titer] in Serum |
|
88898-2
|
Adenovirus [Presence] in Lower respiratory specimen by Organism specific culture |
|
6307-3
|
Adenovirus rRNA [Presence] in Tissue by Probe |
|
6308-1
|
Adenovirus rRNA [Presence] in Unspecified specimen by Probe |
|
88901-4
|
Adenovirus [Presence] in Stool by Organism specific culture |
|
88900-6
|
Adenovirus [Presence] in Upper respiratory specimen by Organism specific culture |
|
88902-2
|
Adenovirus [Presence] in Urine by Organism specific culture |
|
55095-4
|
Adenovirus [Presence] in Unspecified specimen by Organism specific culture |
|
40831-0
|
Adenovirus+Rotavirus Ag [Presence] in Stool |
|
32134-9
|
Adenovirus+Rotavirus [Identifier] in Stool |
|
90072-0
|
Haemophilus and Neisseria species identified in Isolate by Organism specific culture |
|
16926-8
|
Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid |
|
6610-0
|
Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
16925-0
|
Haemophilus influenzae A Ag [Presence] in Urine |
|
31833-7
|
Haemophilus influenzae A Ag [Presence] in Unspecified specimen |
|
6414-7
|
Haemophilus influenzae A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
29906-5
|
Haemophilus influenzae A DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5178-9
|
Haemophilus influenzae Ab [Units/volume] in Serum by Immunoassay |
|
7894-9
|
Haemophilus influenzae Ab [Units/volume] in Serum |
|
25432-6
|
Haemophilus influenzae Ab [Mass/volume] in Serum |
|
32139-8
|
Haemophilus influenzae Ag [Presence] in Cerebral spinal fluid |
|
40771-8
|
Haemophilus influenzae Ag [Presence] in Urine |
|
13246-4
|
Haemophilus influenzae B Ab [Units/volume] in Serum |
|
22755-3
|
Haemophilus influenzae B Ab [Mass/volume] in Serum |
|
24010-1
|
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid |
|
6611-8
|
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
14321-4
|
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
20486-7
|
Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid |
|
41495-3
|
Haemophilus influenzae B Ag [Presence] in Body fluid |
|
43429-0
|
Haemophilus influenzae B Ag [Presence] in Serum |
|
15379-1
|
Haemophilus influenzae B Ag [Presence] in Urine |
|
31834-5
|
Haemophilus influenzae B Ag [Presence] in Unspecified specimen |
|
6599-5
|
Haemophilus influenzae B Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
21320-7
|
Haemophilus influenzae B Ag [Presence] in Unspecified specimen by Latex agglutination |
|
53607-8
|
Haemophilus influenzae B DNA [Presence] in Blood by NAA with probe detection |
|
29907-3
|
Haemophilus influenzae B DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47309-0
|
Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
11257-3
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
16927-6
|
Haemophilus influenzae B IgG Ab [Units/volume] in Serum |
|
11256-5
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
|
47310-8
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47439-5
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --1st specimen |
|
47311-6
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
31018-5
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --2nd specimen |
|
31835-2
|
Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid |
|
6612-6
|
Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31836-0
|
Haemophilus influenzae C Ag [Presence] in Unspecified specimen |
|
8271-9
|
Haemophilus influenzae C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
31837-8
|
Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid |
|
6613-4
|
Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31838-6
|
Haemophilus influenzae D Ag [Presence] in Unspecified specimen |
|
6416-2
|
Haemophilus influenzae D Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92981-0
|
Haemophilus influenzae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85778-9
|
Haemophilus influenzae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93397-8
|
Haemophilus influenzae DNA [Presence] by NAA with probe detection in Positive blood culture |
|
82183-5
|
Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
92127-0
|
Haemophilus influenzae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
92980-2
|
Haemophilus influenzae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61366-1
|
Haemophilus influenzae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31839-4
|
Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid |
|
6614-2
|
Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31840-2
|
Haemophilus influenzae E Ag [Presence] in Unspecified specimen |
|
6417-0
|
Haemophilus influenzae E Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
31841-0
|
Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid |
|
6615-9
|
Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31842-8
|
Haemophilus influenzae F Ag [Presence] in Unspecified specimen |
|
6418-8
|
Haemophilus influenzae F Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
16924-3
|
Haemophilus influenzae IgG Ab [Units/volume] in Serum |
|
5006-2
|
Haemophilus influenzae rRNA [Presence] in Unspecified specimen by Probe |
|
58473-0
|
Haemophilus influenzae serotype DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
58739-4
|
Haemophilus influenzae serotype [Identifier] in Isolate by Agglutination |
|
49721-4
|
Haemophilus influenzae type [Identifier] in Isolate |
|
69410-9
|
Haemophilus influenzae [Identifier] in Unspecified specimen by Organism specific culture |
|
6600-1
|
Haemophilus sp identified in Unspecified specimen by Organism specific culture |
|
58353-4
|
Human antihuman Ab [Mass/volume] in Plasma |
|
58354-2
|
Human antihuman Ab [Moles/volume] in Plasma |
|
92240-1
|
Healthcare-associated infection flag |
|
86535-2
|
Healthcare associated infection report - recommended CDA R3 set |
|
30397-4
|
Hairy cells [#/volume] in Blood |
|
24107-5
|
Hairy cells [#/volume] in Blood by Manual count |
|
40716-3
|
Hairy cells [Presence] in Blood by Light microscopy |
|
35058-7
|
Hairy cells/100 leukocytes in Blood |
|
24106-7
|
Hairy cells/100 leukocytes in Blood by Manual count |
|
42204-8
|
Hairy cells/100 leukocytes in Bone marrow |
|
19741-8
|
Hake IgE Ab [Units/volume] in Serum |
|
51554-4
|
Hake IgE Ab RAST class [Presence] in Serum |
|
12335-6
|
Halothane [Presence] in Blood |
|
27202-1
|
Halothane [Mass/volume] in Blood |
|
61020-4
|
Halothane [VFr/PPres] Airway adaptor --during expiration |
|
60761-4
|
Halothane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
61021-2
|
Halothane [VFr/PPres] Airway adaptor --during inspiration |
|
60857-0
|
Halothane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60889-3
|
Halothane [VFr/PPres] Airway adaptor --at end expiration |
|
2425-7
|
Histidine ammonia lyase [Enzymatic activity/volume] in Serum |
|
60759-8
|
Gas delivery system inspiratory Halothane setting [VFr/PPres] |
|
62267-0
|
Halothane [VFr/PPres] Airway adaptor |
|
60856-2
|
Halothane [VFr/PPres] Gas delivery system |
|
12379-4
|
Halazepam [Mass/volume] in Serum or Plasma |
|
7387-4
|
Halibut triggered histamine release [Units/volume] in Blood |
|
6842-9
|
Halibut IgE Ab [Units/volume] in Serum |
|
15764-4
|
Halibut IgE Ab RAST class [Presence] in Serum |
|
39595-4
|
Halibut IgE Ab/IgE total in Serum |
|
7386-6
|
Halibut IgG Ab [Units/volume] in Serum |
|
21321-5
|
Halibut IgG Ab RAST class [Presence] in Serum |
|
56281-9
|
Halibut IgG4 Ab [Mass/volume] in Serum |
|
60379-5
|
Halibut IgG Ab [Mass/volume] in Serum |
|
12295-2
|
Hallucinogens [Identifier] in Urine |
|
60762-2
|
Halothane gas delivered during case [Volume] from Gas delivery system |
|
61024-6
|
Halothane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76016-5
|
Halothane liquid delivered during case [Volume] from Gas delivery system |
|
76017-3
|
Halothane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
13003-9
|
Halogenated organic molecules [Identifier] in Blood |
|
12446-1
|
Halogenated organic molecules [Identifier] in Urine |
|
75760-9
|
Haloperidol [Presence] in Blood or Urine by Screen method |
|
19481-1
|
Haloperidol cutoff [Mass/volume] in Urine for Confirmatory method |
|
19480-3
|
Haloperidol cutoff [Mass/volume] in Urine for Screen method |
|
4272-1
|
Haloperidol [Mass] of Dose |
|
73356-8
|
Haloperidol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73357-6
|
Haloperidol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26847-4
|
Haloperidol [Presence] in Serum or Plasma |
|
3669-9
|
Haloperidol [Mass/volume] in Serum or Plasma |
|
14774-4
|
Haloperidol [Moles/volume] in Serum or Plasma |
|
74965-5
|
Haloperidol [Mass/volume] in Serum or Plasma --trough |
|
20530-2
|
Haloperidol [Mass/volume] in Urine by Confirmatory method |
|
3670-7
|
Haloperidol [Presence] in Urine |
|
19479-5
|
Haloperidol [Presence] in Urine by Confirmatory method |
|
19478-7
|
Haloperidol [Presence] in Urine by Screen method |
|
3671-5
|
Haloperidol [Mass/volume] in Urine |
|
7388-2
|
Ham triggered histamine release [Units/volume] in Blood |
|
84125-4
|
Surgery of the hand Admission evaluation note |
|
84126-2
|
Surgery of the hand Consult note |
|
84127-0
|
Surgery of the hand Hospital Note |
|
84128-8
|
Surgery of the hand Note |
|
84129-6
|
Surgery of the hand Outpatient Note |
|
88673-9
|
Handover |
|
82943-2
|
Handwriting [ALSFRS-R] |
|
77693-0
|
Handwriting scale [UPDRS] |
|
10788-8
|
Microscopic observation [Identifier] in Tissue by Hansel stain |
|
42503-3
|
Hantavirus Ab [Presence] in Serum |
|
5046-8
|
Hantavirus Ab [Units/volume] in Serum |
|
60264-9
|
Hantavirus Ab [Titer] in Serum |
|
65762-7
|
Hantavirus Ag [Presence] in Tissue by Immune stain |
|
26620-5
|
Hantavirus IgG Ab [Presence] in Serum |
|
35392-0
|
Hantavirus IgG Ab [Units/volume] in Serum |
|
32131-5
|
Hantavirus IgM Ab [Presence] in Serum |
|
35393-8
|
Hantavirus IgM Ab [Units/volume] in Serum |
|
94099-9
|
Hantavirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
86520-4
|
Hantavirus RNA [Presence] in Blood by NAA with probe detection |
|
86536-0
|
Hantavirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91130-5
|
Hantavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
7899-8
|
Hantavirus RNA [Presence] in Serum by NAA with probe detection |
|
86537-8
|
Hantavirus RNA [Presence] in Tissue by NAA with probe detection |
|
86538-6
|
Hantavirus RNA [Presence] in Urine by NAA with probe detection |
|
84414-2
|
Haplotype name |
|
29220-1
|
Haptoglobin [Mass/volume] in Body fluid |
|
4543-5
|
Haptoglobin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
46127-7
|
Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry |
|
40717-1
|
Haptoglobin [Presence] in Serum or Plasma |
|
4542-7
|
Haptoglobin [Mass/volume] in Serum or Plasma |
|
70209-2
|
Haptoglobin [Moles/volume] in Serum or Plasma |
|
87443-8
|
Hardness [Mass/volume] of Water by Calculation |
|
77105-5
|
HARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77104-8
|
HARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
91388-9
|
Has automobile available for use |
|
92256-7
|
Has infectious disease or illness |
|
93030-5
|
Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living [PRAPARE] |
|
48227-3
|
Human serum albumin triggered leukotriene release [Mass/volume] by Leukocytes |
|
93035-4
|
Has season or migrant farm work been your or your family's main source of income at any point in past 2 years [PRAPARE] |
|
93258-2
|
Has subject engaged in non-suicidal self-injurious behavior 3 months |
|
93257-4
|
Has subject engaged in non-suicidal self-injurious behavior Lifetime |
|
93486-9
|
Has subject engaged in self-injurious behavior, intent unknown 3 months |
|
93487-7
|
Has subject engaged in self-injurious behavior, intent unknown Lifetime |
|
83280-8
|
Has the patient had any falls since admission [CMS Assessment] |
|
54853-7
|
Has the patient had any falls since admission or prior assessment [CMS Assessment] |
|
91387-1
|
Has valid driver license |
|
91621-3
|
Has your daily life been full of things that were interesting to you during the past month [NHANES] |
|
31718-0
|
Astrovirus Ag [Presence] in Stool |
|
7810-5
|
Astrovirus Ag [Presence] in Stool by Immunoassay |
|
7811-3
|
Astrovirus RNA [Presence] in Serum by NAA with probe detection |
|
92691-5
|
Astrovirus RNA [Presence] in Stool by NAA with probe detection |
|
69938-9
|
Astrovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10646-8
|
Astrovirus [Identifier] in Stool by Electron microscopy |
|
7809-7
|
Astrovirus [Presence] in Stool by Electron microscopy |
|
51661-7
|
Hepatitis A virus Ab [Presence] in Body fluid |
|
20575-7
|
Hepatitis A virus Ab [Presence] in Serum |
|
13951-9
|
Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
|
5184-7
|
Hepatitis A virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22312-3
|
Hepatitis A virus Ab [Units/volume] in Serum |
|
5183-9
|
Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
89373-5
|
Hepatitis A virus genotype in Unspecified specimen by NAA with probe detection |
|
5179-7
|
Hepatitis A virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
32018-4
|
Hepatitis A virus IgG Ab [Presence] in Serum |
|
40724-7
|
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay |
|
5180-5
|
Hepatitis A virus IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22313-1
|
Hepatitis A virus IgG Ab [Units/volume] in Serum |
|
51913-2
|
Hepatitis A virus IgG+IgM Ab [Presence] in Serum |
|
78444-7
|
Hepatitis A virus IgG+IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
51660-9
|
Hepatitis A virus IgM Ab [Presence] in Body fluid |
|
5181-3
|
Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
22314-9
|
Hepatitis A virus IgM Ab [Presence] in Serum |
|
5182-1
|
Hepatitis A virus IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22315-6
|
Hepatitis A virus IgM Ab [Units/volume] in Serum |
|
13950-1
|
Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
53776-1
|
Hepatitis A virus IgM and total [Interpretation] in Serum |
|
75542-1
|
Hepatitis A virus RNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection |
|
7904-6
|
Hepatitis A virus RNA [Presence] in Serum by NAA with probe detection |
|
91070-3
|
Hepatitis A virus RNA [Presence] in Stool by NAA with probe detection |
|
75540-5
|
Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection |
|
71905-4
|
Have you been a happy person during the past 4 weeks [Veterans RAND] |
|
71911-2
|
Have you been a very nervous person during the past 4 weeks [Veterans RAND] |
|
91632-0
|
Have you been anxious, worried, or upset during the past month [NHANES] |
|
93678-1
|
Have you been at the emergency department more than twice in the last 6 months [WellRx] |
|
91631-2
|
Have you been bothered by any illness, bodily disorder, pains, or fears about your health during the past month [NHANES] |
|
91627-0
|
Have you been bothered by nervousness or your nerves during the past month [NHANES] |
|
91620-5
|
Have you been feeling emotionally stable and sure of yourself during the past month [NHANES] |
|
91626-2
|
Have you been in firm control of your behavior, thoughts, emotions, or feelings during the past month [NHANES] |
|
91633-8
|
Have you been under or felt you were under any strain, stress, or pressure during the past month [NHANES] |
|
91622-1
|
Have you been waking up fresh and rested during the past month [NHANES] |
|
71909-6
|
Have you felt calm and peaceful during the past 4 weeks [Veterans RAND] |
|
71907-0
|
Have you felt downhearted and blue during the past 4 weeks [Veterans RAND] |
|
91630-4
|
Have you felt down-hearted and blue during the past month [NHANES] |
|
71910-4
|
Have you felt so down in the dumps that nothing could cheer you up during the past 4 weeks [Veterans RAND] |
|
91625-4
|
Have you felt so sad, discouraged, hopeless, or had so many problems that you wondered if anything was worthwhile during the past month [NHANES] |
|
91619-7
|
Have you felt tired, worn out, used-up, or exhausted during the past month [NHANES] |
|
91623-9
|
Have you had any reason to wonder if you were losing your mind, or losing control over the way you act, talk, think, feel, or of your memory during the past month [NHANES] |
|
88758-8
|
Have you modified your life style to avoid activities potentially damaging to your hip [HOOS] |
|
88800-8
|
Have you modified your life style to avoid activities potentially damaging to your knee? [KOOS] |
|
93031-3
|
Have you or any family members you live with been unable to get any of the following when it was really needed in past 1 year [PRAPARE] |
|
93028-9
|
Have you spent more than 2 nights in a row in a jail, prison, detention center, or juvenile correctional facility in past 1 year [PRAPARE] |
|
79125-1
|
Hawkinsin [Moles/volume] in Serum or Plasma |
|
7389-0
|
Hay IgE Ab [Units/volume] in Serum |
|
65765-0
|
Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum |
|
82002-7
|
Hazelnut native (nCor a) 9 IgE Ab RAST class [Presence] in Serum |
|
69421-6
|
Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum |
|
81995-3
|
Hazelnut recombinant (rCor a) 1 IgE Ab RAST class [Presence] in Serum |
|
64968-1
|
Hazelnut recombinant (rCor a) 1.0101 IgE Ab [Units/volume] in Serum |
|
64964-0
|
Hazelnut recombinant (rCor a) 1.0401 IgE Ab [Units/volume] in Serum |
|
81788-2
|
Hazelnut recombinant (rCor a) 14 IgE Ab [Units/volume] in Serum |
|
82569-5
|
Hazelnut recombinant (rCor a) 14 IgE Ab RAST class [Presence] in Serum |
|
58753-5
|
Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum |
|
81993-8
|
Hazelnut recombinant (rCor a) 8 IgE Ab RAST class [Presence] in Serum |
|
7392-4
|
Hazelnut triggered histamine release [Units/volume] in Blood |
|
6136-6
|
Hazelnut IgE Ab [Units/volume] in Serum |
|
15766-9
|
Hazelnut IgE Ab RAST class [Presence] in Serum |
|
39543-4
|
Hazelnut IgE Ab/IgE total in Serum |
|
7391-6
|
Hazelnut IgG Ab [Units/volume] in Serum |
|
35731-9
|
Hazelnut IgG Ab RAST class [Presence] in Serum |
|
56283-5
|
Hazelnut IgG4 Ab [Mass/volume] in Serum |
|
63080-6
|
Hazelnut IgG Ab [Mass/volume] in Serum |
|
48216-6
|
Hazelnut triggered leukotriene release [Mass/volume] by Leukocytes |
|
6137-4
|
Hazelnut Pollen IgE Ab [Units/volume] in Serum |
|
15767-7
|
Hazelnut Pollen IgE Ab RAST class [Presence] in Serum |
|
56282-7
|
Hazelnut Pollen IgG4 Ab [Mass/volume] in Serum |
|
48248-9
|
Hazelnut Pollen triggered leukotriene release [Mass/volume] by Leukocytes |
|
64122-5
|
Hemoglobins that can be presumptively identified based on available controls in DBS |
|
46767-0
|
Hemoglobin S/Beta Thalassemia newborn screen interpretation |
|
46759-7
|
Hb SS, Hb SC, Hb SB thal newborn screen interpretation |
|
87730-8
|
HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
55247-1
|
HBA1 gene c.223G>C [Presence] in Blood by Molecular genetics method |
|
21687-9
|
HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
66502-6
|
HBA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21688-7
|
HBA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
41960-6
|
Type of HbA1c measurement device |
|
41962-2
|
HbA1c measurement device Vendor model code |
|
41963-0
|
HbA1c measurement device Vendor serial number |
|
41964-8
|
HbA1c measurement device Vendor software version |
|
41961-4
|
HbA1c measurement device Vendor name |
|
55251-3
|
HBA2 gene alpha 3.7kb deletion [Presence] in Blood by Molecular genetics method |
|
85091-7
|
HBA2 gene alpha 3.7kb triplication [Presence] in Blood by Molecular genetics method |
|
55236-4
|
HBA2 gene alpha 4.2kb deletion [Presence] in Blood by Molecular genetics method |
|
55237-2
|
HBA2 gene c.427T>C [Presence] in Blood by Molecular genetics method |
|
55238-0
|
HBA2 gene c.429A>T [Presence] in Blood by Molecular genetics method |
|
55246-3
|
HBA2 gene c.84G>C [Presence] in Blood by Molecular genetics method |
|
60540-2
|
HBA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
55249-7
|
HBA2 gene SEA deletion [Presence] in Blood by Molecular genetics method |
|
55250-5
|
HBA2 gene THAI+FIL+MED+alpha 20.5 deletion [Presence] in Blood by Molecular genetics method |
|
55241-4
|
HBB gene c.19G>A [Presence] in Blood by Molecular genetics method |
|
55242-2
|
HBB gene c.20A>T [Presence] in Blood by Molecular genetics method |
|
55245-5
|
HBB gene c.220G>A [Presence] in Blood by Molecular genetics method |
|
55240-6
|
HBB gene c.251G>A [Presence] in Blood by Molecular genetics method |
|
55243-0
|
HBB gene c.364G>C [Presence] in Blood by Molecular genetics method |
|
55239-8
|
HBB gene c.441_442insAC [Presence] in Blood by Molecular genetics method |
|
55248-9
|
HBB gene c.79G>A [Presence] in Blood by Molecular genetics method |
|
90925-9
|
HBB gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Sequencing |
|
79401-6
|
HBB gene full mutation analysis [Identifier] in Blood or Tissue by Sequencing |
|
77627-8
|
HBB gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
21689-5
|
HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50996-8
|
HBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21691-1
|
HBB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21690-3
|
HBB gene p.Glu6Val [Presence] in Blood or Tissue by Molecular genetics method |
|
50319-3
|
HBME-1 Ag [Presence] in Tissue by Immune stain |
|
92135-3
|
Human bocavirus 1+2+3 DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91832-6
|
Human bocavirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
91811-0
|
Human bocavirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
|
48056-6
|
Human bocavirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88593-9
|
Human bocavirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
86559-2
|
Human bocavirus DNA [Presence] in Tissue by NAA with probe detection |
|
88613-5
|
Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
62424-7
|
Human bocavirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
49175-3
|
Human bocavirus IgG Ab [Presence] in Unspecified specimen |
|
48057-4
|
Human bocavirus IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
45159-1
|
Hepatitis B virus and Hepatitis D virus Ab [Interpretation] in Serum Narrative |
|
72849-3
|
Hepatitis B virus codon 169 [Identifier] by Genotype method |
|
49877-4
|
Hepatitis B virus codon 173 [Identifier] by Genotype method |
|
49878-2
|
Hepatitis B virus codon 180 [Identifier] by Genotype method |
|
49879-0
|
Hepatitis B virus codon 181 [Identifier] by Genotype method |
|
72848-5
|
Hepatitis B virus codon 184 [Identifier] by Genotype method |
|
72847-7
|
Hepatitis B virus codon 191 [Identifier] by Genotype method |
|
72846-9
|
Hepatitis B virus codon 194 [Identifier] by Genotype method |
|
72845-1
|
Hepatitis B virus codon 202 [Identifier] by Genotype method |
|
49880-8
|
Hepatitis B virus codon 204 [Identifier] by Genotype method |
|
72844-4
|
Hepatitis B virus codon 214 [Identifier] by Genotype method |
|
72843-6
|
Hepatitis B virus codon 215 [Identifier] by Genotype method |
|
72842-8
|
Hepatitis B virus codon 233 [Identifier] by Genotype method |
|
49881-6
|
Hepatitis B virus codon 236 [Identifier] by Genotype method |
|
72841-0
|
Hepatitis B virus codon 237 [Identifier] by Genotype method |
|
72840-2
|
Hepatitis B virus codon 250 [Identifier] by Genotype method |
|
49882-4
|
Hepatitis B virus codon 80 [Identifier] by Genotype method |
|
72851-9
|
Hepatitis B virus codon 84 [Identifier] by Genotype method |
|
72850-1
|
Hepatitis B virus codon 85 [Identifier] by Genotype method |
|
61161-6
|
Hepatitis B virus codon A181T [Presence] by Genotype method |
|
61160-8
|
Hepatitis B virus codon A181V [Presence] by Genotype method |
|
61163-2
|
Hepatitis B virus codon A194T [Presence] by Genotype method |
|
54210-0
|
Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection |
|
39005-4
|
Hepatitis B virus core Ab [Presence] in Body fluid |
|
21005-4
|
Hepatitis B virus core Ab [Units/volume] in Serum from Donor by Immunoassay |
|
47440-3
|
Hepatitis B virus core Ab [Presence] in Serum from Donor |
|
47358-7
|
Hepatitis B virus core Ab [Presence] in Serum from Donor by Immunoassay |
|
22317-2
|
Hepatitis B virus core Ab [Units/volume] in Serum from Donor |
|
5187-0
|
Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay |
|
16933-4
|
Hepatitis B virus core Ab [Presence] in Serum |
|
5188-8
|
Hepatitis B virus core Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22316-4
|
Hepatitis B virus core Ab [Units/volume] in Serum |
|
13952-7
|
Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
|
75378-0
|
Hepatitis B virus core Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
10673-2
|
Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
|
13919-6
|
Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay |
|
32685-0
|
Hepatitis B virus core IgG Ab [Presence] in Serum |
|
40725-4
|
Hepatitis B virus core IgG Ab [Presence] in Serum by Immunoassay |
|
22318-0
|
Hepatitis B virus core IgG Ab [Units/volume] in Serum |
|
51914-0
|
Hepatitis B virus core IgG+IgM Ab [Presence] in Serum |
|
83100-8
|
Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
51658-3
|
Hepatitis B virus core IgM Ab [Presence] in Body fluid |
|
31204-1
|
Hepatitis B virus core IgM Ab [Presence] in Serum |
|
5186-2
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22319-8
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum |
|
5185-4
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
24113-3
|
Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
49363-5
|
Hepatitis B virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49364-3
|
Hepatitis B virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
20442-0
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum by Probe with signal amplification |
|
47216-7
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 200 copies/ml |
|
48650-6
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 copies/mL |
|
29615-2
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49365-0
|
Hepatitis B virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49362-7
|
Hepatitis B virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5007-0
|
Hepatitis B virus DNA [Presence] in Blood by NAA with probe detection |
|
49357-7
|
Hepatitis B virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49601-8
|
Hepatitis B virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49367-6
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49358-5
|
Hepatitis B virus DNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49602-6
|
Hepatitis B virus DNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49359-3
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection |
|
40459-0
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Serum by Probe with signal amplification |
|
29900-8
|
Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification |
|
23869-1
|
Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe |
|
11258-1
|
Hepatitis B virus DNA [Units/volume] in Serum |
|
32686-8
|
Hepatitis B virus DNA [Mass/volume] in Serum |
|
42595-9
|
Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
48398-2
|
Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
45161-7
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
29610-3
|
Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
49368-4
|
Hepatitis B virus DNA [Units/volume] (viral load) in Tissue by NAA with probe detection |
|
49606-7
|
Hepatitis B virus DNA [log units/volume] (viral load) in Tissue by NAA with probe detection |
|
49361-9
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
|
5008-8
|
Hepatitis B virus DNA [Presence] in Tissue by NAA with probe detection |
|
49360-1
|
Hepatitis B virus DNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49600-0
|
Hepatitis B virus DNA [log units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49366-8
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5009-6
|
Hepatitis B virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16934-2
|
Hepatitis B virus polymerase DNA [Presence] in Blood by NAA with probe detection |
|
30937-7
|
Hepatitis B virus dose count in combination vaccine |
|
39006-2
|
Hepatitis B virus e Ab [Presence] in Body fluid |
|
5189-6
|
Hepatitis B virus e Ab [Units/volume] in Serum by Immunoassay |
|
22320-6
|
Hepatitis B virus e Ab [Presence] in Serum |
|
5190-4
|
Hepatitis B virus e Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22321-4
|
Hepatitis B virus e Ab [Units/volume] in Serum |
|
13953-5
|
Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
|
75407-7
|
Hepatitis B virus e Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
5191-2
|
Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay |
|
31844-4
|
Hepatitis B virus e Ag [Presence] in Serum |
|
5192-0
|
Hepatitis B virus e Ag [Presence] in Serum by Radioimmunoassay (RIA) |
|
31845-1
|
Hepatitis B virus e Ag [Units/volume] in Serum |
|
13954-3
|
Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
|
75408-5
|
Hepatitis B virus e Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
32178-6
|
Hepatitis B virus e Ag [Titer] in Serum |
|
39007-0
|
Hepatitis B virus e Ag [Presence] in Unspecified specimen |
|
41151-2
|
Hepatitis B virus e IgG Ab [Presence] in Serum |
|
33463-1
|
Hepatitis B virus e IgG Ab [Presence] in Serum by Immunoassay |
|
32366-7
|
Hepatitis B virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
|
61169-9
|
Hepatitis B virus codon I233V [Presence] by Genotype method |
|
10397-8
|
Hepatitis B immune globulin given [Volume] |
|
61154-1
|
Hepatitis B virus codon L180M [Presence] by Genotype method |
|
61173-1
|
Hepatitis B virus codon L80I [Presence] by Genotype method |
|
61155-8
|
Hepatitis B virus codon L80V [Presence] by Genotype method |
|
61158-2
|
Hepatitis B virus codon M204I [Presence] by Genotype method |
|
61159-0
|
Hepatitis B virus codon M204S [Presence] by Genotype method |
|
61157-4
|
Hepatitis B virus codon M204V [Presence] by Genotype method |
|
61171-5
|
Hepatitis B virus codon M250I [Presence] by Genotype method |
|
61172-3
|
Hepatitis B virus codon M250L [Presence] by Genotype method |
|
61170-7
|
Hepatitis B virus codon M250V [Presence] by Genotype method |
|
61162-4
|
Hepatitis B virus codon N236T [Presence] by Genotype method |
|
33633-9
|
Hepatitis B virus precore TAG [Presence] in Serum by NAA with probe detection |
|
6421-2
|
Hepatitis B virus rRNA [Presence] in Unspecified specimen by Probe |
|
42322-8
|
Hepatitis B virus S+pol gene [Identifier] in Serum or Plasma by NAA with probe detection |
|
61167-3
|
Hepatitis B virus codon S202C [Presence] by Genotype method |
|
61166-5
|
Hepatitis B virus codon S202G [Presence] by Genotype method |
|
61168-1
|
Hepatitis B virus codon S202I [Presence] by Genotype method |
|
33629-7
|
Hepatitis B virus sequencing [Identifier] in Serum by NAA with probe detection |
|
42504-1
|
Hepatitis B virus surface Ab [Presence] in Cerebral spinal fluid |
|
49495-5
|
Hepatitis B virus surface Ab actual/Negative control in Serum or Plasma |
|
58405-2
|
Hepatitis B virus surface Ab Signal/Cutoff in Serum |
|
21006-2
|
Hepatitis B virus surface Ab [Units/volume] in Serum from Donor by Immunoassay |
|
22323-0
|
Hepatitis B virus surface Ab [Units/volume] in Serum from Donor |
|
22322-2
|
Hepatitis B virus surface Ab [Presence] in Serum |
|
10900-9
|
Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
|
39535-0
|
Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA) |
|
5194-6
|
Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
16935-9
|
Hepatitis B virus surface Ab [Units/volume] in Serum |
|
5193-8
|
Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
75409-3
|
Hepatitis B virus surface Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
32019-2
|
Hepatitis B virus surface Ab [Titer] in Serum |
|
50967-9
|
Hepatitis B virus surface Ag [Presence] in Blood from Donor by Neutralization test |
|
42505-8
|
Hepatitis B virus surface Ag [Presence] in Cerebral spinal fluid |
|
51659-1
|
Hepatitis B virus surface Ag [Presence] in Body fluid |
|
47364-5
|
Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay |
|
5195-3
|
Hepatitis B virus surface Ag [Presence] in Serum |
|
5197-9
|
Hepatitis B virus surface Ag [Presence] in Serum by Radioimmunoassay (RIA) |
|
58452-4
|
Hepatitis B virus surface Ag [Units/volume] in Serum |
|
70154-0
|
Hepatitis B virus surface Ag in Serum or Plasma by Confirmatory method |
|
63557-3
|
Hepatitis B virus surface Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
65633-0
|
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Confirmatory method |
|
5196-1
|
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay |
|
7905-3
|
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test |
|
75410-1
|
Hepatitis B virus surface Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
10674-0
|
Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
|
10675-7
|
Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
|
49177-9
|
Hepatitis B virus surface IgG Ab [Presence] in Serum |
|
48070-7
|
Hepatitis B virus surface IgG Ab [Presence] in Serum by Immunoassay |
|
61165-7
|
Hepatitis B virus codon T184I [Presence] by Genotype method |
|
61164-0
|
Hepatitis B virus codon T184S [Presence] by Genotype method |
|
61156-6
|
Hepatitis B virus codon V173L [Presence] by Genotype method |
|
43279-9
|
Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection |
|
50627-9
|
HC gene rearrangements in Blood or Tissue by Molecular genetics method Narrative |
|
21747-1
|
HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
34600-7
|
HC gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
60575-8
|
HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
|
11947-9
|
Head circumference/Abdominal circumference derived by US |
|
80416-1
|
Head circumference/Abdominal circumference US+Estimated from Campbell 1977 |
|
80414-6
|
Head circumference/Abdominal circumference US+Estimated from Campbell 1991 |
|
38598-9
|
Hexachlorobenzene [Mass/volume] in Air |
|
9474-8
|
Hexachlorobenzene [Mass/volume] in Serum or Plasma |
|
38342-2
|
Hexachlorobenzene [Mass/volume] in Water |
|
87653-2
|
Hexachlorobenzene [Mass/mass] in Unspecified specimen |
|
38599-7
|
Hexachlorobutadiene [Mass/volume] in Air |
|
28077-6
|
Hexachlorobutadiene [Presence] in Serum or Plasma |
|
38600-3
|
Hexachloroethane [Mass/volume] in Air |
|
16966-4
|
Hexachloroethane [Mass/volume] in Blood |
|
44002-4
|
Choriogonadotropin [Multiple of the median] adjusted in Amniotic fluid |
|
32166-1
|
Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma |
|
10470-3
|
Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
|
44000-8
|
Choriogonadotropin [Units/volume] in Amniotic fluid |
|
55870-0
|
Choriogonadotropin [Units/volume] in Cord blood |
|
44001-6
|
Choriogonadotropin [Units/volume] in Cerebral spinal fluid |
|
12184-8
|
Choriogonadotropin [Presence] in Body fluid |
|
42891-2
|
Choriogonadotropin [Units/volume] in Body fluid |
|
43999-2
|
Choriogonadotropin [Multiple of the median] in Amniotic fluid |
|
20465-1
|
Choriogonadotropin [Multiple of the median] in Serum or Plasma |
|
80385-8
|
Choriogonadotropin (pregnancy test) [Presence] in Serum by Rapid immunoassay |
|
2118-8
|
Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
|
2106-3
|
Choriogonadotropin (pregnancy test) [Presence] in Urine |
|
80384-1
|
Choriogonadotropin (pregnancy test) [Presence] in Urine by Rapid immunoassay |
|
44839-9
|
Choriogonadotropin [Presence] in Control Serum |
|
83086-9
|
Choriogonadotropin [Units/volume] in Serum or Plasma by Immunoassay |
|
19080-1
|
Choriogonadotropin [Units/volume] in Serum or Plasma |
|
20994-0
|
Choriogonadotropin [Interpretation] in Serum or Plasma |
|
34670-0
|
Choriogonadotropin [Mass/volume] in Serum or Plasma |
|
2119-6
|
Choriogonadotropin [Moles/volume] in Serum or Plasma |
|
10565-0
|
Choriogonadotropin [Units/volume] in Semen |
|
2105-5
|
Choriogonadotropin [Moles/volume] in Semen |
|
25372-4
|
Choriogonadotropin [Units/volume] in Urine |
|
2107-1
|
Choriogonadotropin [Moles/volume] in Urine |
|
53959-3
|
Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma |
|
53957-7
|
Choriogonadotropin.tumor marker [Mass/volume] in Serum or Plasma |
|
53958-5
|
Choriogonadotropin.tumor marker [Moles/volume] in Serum or Plasma |
|
60492-6
|
Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81860-9
|
Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Sequencing |
|
80613-3
|
Bicarbonate [Moles/volume] in Urine collected for unspecified duration |
|
94001-5
|
Bicarbonate [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
47580-6
|
Bicarbonate [Moles/volume] in 24 hour Urine |
|
47579-8
|
Bicarbonate [Moles/time] in 24 hour Urine |
|
94010-6
|
Bicarbonate [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
16462-4
|
Bicarbonate [Moles/volume] in Amniotic fluid |
|
1960-4
|
Bicarbonate [Moles/volume] in Arterial blood |
|
28640-1
|
Bicarbonate [Moles/volume] in Arterial cord blood |
|
14151-5
|
Bicarbonate [Moles/volume] in Cord blood |
|
28641-9
|
Bicarbonate [Moles/volume] in Venous cord blood |
|
1961-2
|
Bicarbonate [Moles/volume] in Capillary blood |
|
19229-4
|
Bicarbonate [Moles/volume] in Mixed venous blood |
|
1959-6
|
Bicarbonate [Moles/volume] in Blood |
|
14627-4
|
Bicarbonate [Moles/volume] in Venous blood |
|
16460-8
|
Bicarbonate [Moles/volume] in Cerebral spinal fluid |
|
12514-6
|
Bicarbonate [Moles/volume] in Dialysis fluid |
|
53086-5
|
Bicarbonate [Moles/volume] in Nonbiological fluid |
|
16459-0
|
Bicarbonate [Moles/volume] in Body fluid |
|
86920-6
|
Bicarbonate goal [Moles/volume] Blood |
|
54359-5
|
Bicarbonate [Moles/volume] in Plasma --post dialysis |
|
48631-6
|
Bicarbonate [Moles/volume] in Serum --post dialysis |
|
1962-0
|
Bicarbonate [Moles/volume] in Plasma |
|
54361-1
|
Bicarbonate [Moles/volume] in Pleural fluid |
|
54360-3
|
Bicarbonate [Moles/volume] in Peritoneal fluid |
|
16461-6
|
Bicarbonate [Moles/volume] in Red Blood Cells |
|
1963-8
|
Bicarbonate [Moles/volume] in Serum or Plasma |
|
19230-2
|
Bicarbonate [Moles/volume] standard in Arterial blood |
|
39460-1
|
Bicarbonate [Moles/volume] standard in Arterial cord blood |
|
39459-3
|
Bicarbonate [Moles/volume] standard in Venous cord blood |
|
19231-0
|
Bicarbonate [Moles/volume] standard in Capillary blood |
|
19233-6
|
Bicarbonate [Moles/volume] standard in Mixed venous blood |
|
19232-8
|
Bicarbonate [Moles/volume] standard in Venous blood |
|
69964-5
|
Bicarbonate [Moles/volume] standard in Plasma |
|
1964-6
|
Bicarbonate [Moles/volume] in Urine |
|
12513-8
|
Bicarbonate [Moles/volume] in Water |
|
22735-5
|
Bicarbonate [Moles/volume] in Unspecified specimen |
|
41004-3
|
Human coronavirus 229E Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41013-4
|
Human coronavirus 229E IgG Ab [Presence] in Serum |
|
41002-7
|
Human coronavirus 229E IgG Ab [Presence] in Serum by Immunoassay |
|
88607-7
|
Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection |
|
88609-3
|
Human coronavirus 229E RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88608-5
|
Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82163-7
|
Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88610-1
|
Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41003-5
|
Human coronavirus 229E RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88891-7
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88719-0
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92146-0
|
Human coronavirus 229E+NL63 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
77008-1
|
Human coronavirus 229E+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
41453-2
|
Human coronavirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88611-9
|
Human coronavirus HKU1 RNA [Presence] in Aspirate by NAA with probe detection |
|
88612-7
|
Human coronavirus HKU1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88594-7
|
Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82161-1
|
Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88604-4
|
Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
62423-9
|
Human coronavirus HKU1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
92147-8
|
Human coronavirus HKU1+OC43 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
41014-2
|
Human coronavirus NL63 IgG Ab [Presence] in Serum |
|
41006-8
|
Human coronavirus NL63 IgG Ab [Presence] in Serum by Immunoassay |
|
88615-0
|
Human coronavirus NL63 RNA [Presence] in Aspirate by NAA with probe detection |
|
88617-6
|
Human coronavirus NL63 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88616-8
|
Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82162-9
|
Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88618-4
|
Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41005-0
|
Human coronavirus NL63 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41007-6
|
Human coronavirus OC43 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41015-9
|
Human coronavirus OC43 IgG Ab [Presence] in Serum |
|
41008-4
|
Human coronavirus OC43 IgG Ab [Presence] in Serum by Immunoassay |
|
88619-2
|
Human coronavirus OC43 RNA [Presence] in Aspirate by NAA with probe detection |
|
88621-8
|
Human coronavirus OC43 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88605-1
|
Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82164-5
|
Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88626-7
|
Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41009-2
|
Human coronavirus OC43 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88614-3
|
Human coronavirus RNA [Presence] in Aspirate by NAA with probe detection |
|
88628-3
|
Human coronavirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
92979-4
|
Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88620-0
|
Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
60265-6
|
Human coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
88627-5
|
Human coronavirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41000-1
|
Human coronavirus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41001-9
|
Human coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41454-0
|
Human coronavirus identified in Unspecified specimen |
|
2408-3
|
Hexachlorophene [Mass/volume] in Blood |
|
86558-4
|
Healthcare personnel influenza vaccination summary report Document |
|
20570-8
|
Hematocrit [Volume Fraction] of Blood |
|
4544-3
|
Hematocrit [Volume Fraction] of Blood by Automated count |
|
48703-3
|
Hematocrit [Volume Fraction] of Blood by Estimated |
|
62241-5
|
Hematocrit [Volume Fraction] of Blood from Fetus by Automated count |
|
31100-1
|
Hematocrit [Volume Fraction] of Blood by Impedance |
|
4545-0
|
Hematocrit [Volume Fraction] of Blood by Centrifugation |
|
32354-3
|
Hematocrit [Volume Fraction] of Arterial blood |
|
42908-4
|
Hematocrit [Volume Fraction] of Capillary blood |
|
11151-8
|
Hematocrit [Volume Fraction] of Cord blood |
|
11271-4
|
Hematocrit [Volume Fraction] of Cord blood by Automated count |
|
41655-2
|
Hematocrit [Volume Fraction] of Mixed venous blood |
|
41654-5
|
Hematocrit [Volume Fraction] of Venous blood |
|
30398-2
|
Hematocrit [Volume Fraction] of Cerebral spinal fluid |
|
13508-7
|
Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
|
47640-8
|
Hematocrit [Volume Fraction] of Dialysis fluid |
|
11153-4
|
Hematocrit [Volume Fraction] of Body fluid |
|
55781-9
|
Hematocrit [Volume Fraction] of Bone marrow |
|
70169-8
|
Hematocrit [Volume Fraction] of Pleural fluid |
|
70168-0
|
Hematocrit [Volume Fraction] of Synovial fluid |
|
43416-7
|
Hematocrit [Volume Fraction] of Stem cell product |
|
17809-5
|
Hematocrit [Volume Fraction] of Urine |
|
71833-8
|
Hematocrit [Pure volume fraction] of Blood by Automated count |
|
71832-0
|
Hematocrit [Pure volume fraction] of Arterial blood |
|
71831-2
|
Hematocrit [Pure volume fraction] of Capillary blood |
|
71830-4
|
Hematocrit [Pure volume fraction] of Mixed venous blood |
|
71829-6
|
Hematocrit [Pure volume fraction] of Venous blood |
|
71828-8
|
Hematocrit [Pure volume fraction] of Body fluid |
|
16931-8
|
Hematocrit/Hemoglobin [Ratio] of Blood by Automated count |
|
42506-6
|
Hepatitis C virus Ab [Presence] in Cerebral spinal fluid |
|
51657-5
|
Hepatitis C virus Ab [Presence] in Body fluid |
|
39008-8
|
Hepatitis C virus Ab [Presence] in Body fluid by Immunoblot |
|
75886-2
|
HCV antibody screening - Meaningful Use set |
|
24011-9
|
Hepatitis C virus Ab band pattern [Interpretation] in Serum by Immunoblot |
|
75887-0
|
HCV antibody RIBA tests - Meaningful Use set by Immunoblot |
|
51656-7
|
Hepatitis C virus Ab Signal/Cutoff in Body fluid |
|
48159-8
|
Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay |
|
47441-1
|
Hepatitis C virus Ab [Presence] in Serum from Donor |
|
47365-2
|
Hepatitis C virus Ab [Presence] in Serum from Donor by Immunoassay |
|
5198-7
|
Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay |
|
16128-1
|
Hepatitis C virus Ab [Presence] in Serum |
|
5199-5
|
Hepatitis C virus Ab [Presence] in Serum by Immunoblot |
|
22327-1
|
Hepatitis C virus Ab [Units/volume] in Serum |
|
13955-0
|
Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
|
72376-7
|
Hepatitis C virus Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
56926-9
|
Hepatitis C virus c1 Ab [Presence] in Serum by Immunoblot |
|
44831-6
|
Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum |
|
51649-2
|
Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum by Immunoblot |
|
56927-7
|
Hepatitis C virus c2 Ab [Presence] in Serum by Immunoblot |
|
44813-4
|
Hepatitis C virus c22p Ab [Presence] in Serum by Immunoblot |
|
22329-7
|
Hepatitis C virus c33c Ab [Presence] in Serum |
|
9610-7
|
Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot |
|
81116-6
|
Hepatitis C virus core Ab+Ag [Presence] in Serum |
|
49846-9
|
Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor |
|
54914-7
|
Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay |
|
79189-7
|
Hepatitis C virus core Ag [Presence] in Serum or Plasma by Immunoassay |
|
56928-5
|
Hepatitis C virus E2 Ab [Presence] in Serum by Immunoblot |
|
82381-5
|
Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier] |
|
82380-7
|
Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier] |
|
82512-5
|
Hepatitis C virus genotype 1 [Type] in Serum or Plasma by NAA with probe detection |
|
82514-1
|
Hepatitis C virus genotype 3 NS5a gene mutations detected [Identifier] |
|
82513-3
|
Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detection |
|
48574-8
|
Hepatitis C virus genotype [Identifier] in Blood by NAA with probe detection |
|
32286-7
|
Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
|
92731-9
|
Hepatitis C virus genotype in Serum or Plasma by Sequencing |
|
49607-5
|
Hepatitis C virus genotype [Identifier] in Tissue by NAA with probe detection |
|
48575-5
|
Hepatitis C virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
34162-8
|
Hepatitis C virus IgG band pattern [Interpretation] in Serum by Immunoblot |
|
57006-9
|
Hepatitis C virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
16129-9
|
Hepatitis C virus IgG Ab [Presence] in Serum |
|
33462-3
|
Hepatitis C virus IgG Ab [Presence] in Serum by Immunoblot |
|
16936-7
|
Hepatitis C virus IgG Ab [Units/volume] in Serum |
|
40726-2
|
Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
89359-4
|
Hepatitis C virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
51824-1
|
Hepatitis C virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
53376-0
|
Hepatitis C virus IgM Ab [Units/volume] in Serum |
|
56929-3
|
Hepatitis C virus NS3 Ab [Presence] in Serum by Immunoblot |
|
73654-6
|
Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method |
|
56930-1
|
Hepatitis C virus NS4 Ab [Presence] in Serum by Immunoblot |
|
23871-7
|
Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot |
|
73655-3
|
Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method |
|
49369-2
|
Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49370-0
|
Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
20416-4
|
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
20571-6
|
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
49371-8
|
Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49380-9
|
Hepatitis C virus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5010-4
|
Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection |
|
49377-5
|
Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49603-4
|
Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49373-4
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
51655-9
|
Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection |
|
49378-3
|
Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49604-2
|
Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49374-2
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection |
|
75888-8
|
HCV RNA screening tests - Meaningful Use set |
|
34703-9
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL |
|
34704-7
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL |
|
49758-6
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL |
|
11011-4
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
38180-6
|
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
47252-2
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
10676-5
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
|
29609-5
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
42617-1
|
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
42003-4
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
11259-9
|
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
49379-1
|
Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection |
|
49608-3
|
Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection |
|
49375-9
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
|
5011-2
|
Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection |
|
49376-7
|
Hepatitis C virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49605-9
|
Hepatitis C virus RNA [log units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49372-6
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5012-0
|
Hepatitis C virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48576-3
|
Hepatitis C virus RNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
22328-9
|
Hepatitis C virus superoxide dismutase Ab [Presence] in Serum |
|
11077-5
|
Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot |
|
23870-9
|
Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot |
|
22324-8
|
Hepatitis C virus 100-3 Ab [Presence] in Serum |
|
9608-1
|
Hepatitis C virus 100-3 Ab [Presence] in Serum by Immunoblot |
|
22325-5
|
Hepatitis C virus 22-3 Ab [Presence] in Serum |
|
9609-9
|
Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot |
|
22326-3
|
Hepatitis C virus 5-1-1 Ab [Presence] in Serum |
|
11076-7
|
Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot |
|
46741-5
|
Homocystinuria and/or other hypermethioninemias newborn screen interpretation |
|
55878-3
|
Homocysteine [Moles/volume] in 24 hour Urine |
|
32690-0
|
Homocysteine [Moles/time] in 24 hour Urine |
|
72501-0
|
Homocyst(e)ine [Moles/volume] in Serum or Plasma --6 hours post dose methionine |
|
72502-8
|
Homocyst(e)ine [Molar concentration difference] in Serum or Plasma --6 hours post dose methionine - post CFst |
|
54300-9
|
Homocysteine [Moles/volume] in Amniotic fluid |
|
44375-4
|
Homocysteine [Presence] in Blood |
|
49727-1
|
Homocysteine [Moles/volume] in Cerebral spinal fluid |
|
44376-2
|
Homocysteine [Presence] in DBS |
|
54301-7
|
Homocysteine [Moles/volume] in DBS |
|
55877-5
|
Homocysteine [Moles/volume] in Body fluid |
|
81934-2
|
Homocysteine intake 24 hour Estimated |
|
81935-9
|
Homocysteine intake 24 hour Measured |
|
58859-0
|
Homocyst(e)ine [Moles/volume] in Serum or Plasma --post XXX challenge |
|
72500-2
|
Homocyst(e)ine [Moles/volume] in Serum or Plasma --fasting |
|
44374-7
|
Homocysteine [Presence] in Serum or Plasma |
|
2428-1
|
Homocysteine [Mass/volume] in Serum or Plasma |
|
13965-9
|
Homocysteine [Moles/volume] in Serum or Plasma |
|
44373-9
|
Homocysteine [Presence] in Urine |
|
12470-1
|
Homocysteine [Mass/volume] in Urine |
|
32020-0
|
Homocysteine [Moles/volume] in Urine |
|
48115-0
|
Homocysteine.free/Creatinine [Molar ratio] in Urine |
|
44377-0
|
Homocysteine/Creatinine [Molar ratio] in 24 hour Urine |
|
13758-8
|
Homocysteine/Creatinine [Mass Ratio] in Urine |
|
26582-7
|
Homocysteine/Creatinine [Molar ratio] in Urine |
|
93329-1
|
Hyodeoxycholate [Moles/volume] in Serum or Plasma |
|
86222-7
|
Lipoprotein.alpha 3 [Moles/volume] in Serum |
|
26822-7
|
Lipoprotein.alpha [Presence] in Body fluid |
|
17082-9
|
Lipoprotein.alpha [Mass/volume] in Body fluid |
|
15121-7
|
Lipoprotein.alpha/total Lipoprotein in Serum or Plasma |
|
19250-0
|
Lipoprotein.alpha [Mass/volume] in Pleural fluid |
|
14813-0
|
Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis |
|
17845-9
|
Lipoprotein.alpha [Presence] in Serum or Plasma |
|
62253-0
|
Lipoprotein.alpha [Entitic length] in Serum or Plasma |
|
2573-4
|
Lipoprotein.alpha [Mass/volume] in Serum or Plasma |
|
49748-7
|
Lipoprotein.alpha [Moles/volume] in Serum or Plasma |
|
92711-1
|
Lipoprotein.alpha.subparticle.small [Moles/volume] in Serum |
|
47221-7
|
Cholesterol in HDL 1+2 [Mass/volume] in Serum or Plasma |
|
50409-2
|
Cholesterol in HDL 2+3 [Mass/volume] in Serum or Plasma |
|
26016-6
|
Cholesterol in HDL 2 [Mass/volume] in Serum or Plasma ultracentrifugate |
|
9832-7
|
Cholesterol in HDL 2 [Mass/volume] in Serum or Plasma |
|
26015-8
|
Cholesterol in HDL 2 [Moles/volume] in Serum or Plasma |
|
9833-5
|
Cholesterol in HDL 3 [Mass/volume] in Serum or Plasma |
|
35243-5
|
Cholesterol in HDL 3 [Mass or Moles/volume] in Serum or Plasma |
|
26017-4
|
Cholesterol in HDL 3 [Moles/volume] in Serum or Plasma |
|
47220-9
|
Cholesterol in HDL 4+5 [Mass/volume] in Serum or Plasma |
|
54467-6
|
Cholesterol in HDL 2a/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
|
57936-7
|
Cholesterol in HDL 2a [Mass/volume] in Serum or Plasma |
|
56132-4
|
Cholesterol in HDL 2a [Moles/volume] in Serum or Plasma |
|
54468-4
|
Cholesterol in HDL 2b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
|
56133-2
|
Cholesterol in HDL 2b [Moles/volume] in Serum or Plasma |
|
54469-2
|
Cholesterol in HDL 3a/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
|
57937-5
|
Cholesterol in HDL 3a [Mass/volume] in Serum or Plasma |
|
54470-0
|
Cholesterol in HDL 3b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
|
54471-8
|
Cholesterol in HDL 3c/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
|
53135-0
|
Cholesterol in HDL [Moles/volume] in Dialysis fluid |
|
54372-8
|
Cholesterol in HDL [Mass/volume] in Body fluid |
|
50840-8
|
Cholesterol in HDL [Moles/volume] in Body fluid |
|
2095-8
|
Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
|
12772-0
|
Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis |
|
49130-8
|
Cholesterol in HDL [Mass/volume] in Serum or Plasma by Electrophoresis |
|
27340-9
|
Cholesterol in HDL [Presence] in Serum or Plasma |
|
12771-2
|
Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis |
|
18263-4
|
Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate |
|
2085-9
|
Cholesterol in HDL [Mass/volume] in Serum or Plasma |
|
35197-3
|
Cholesterol in HDL [Mass or Moles/volume] in Serum or Plasma |
|
14646-4
|
Cholesterol in HDL [Moles/volume] in Serum or Plasma |
|
70200-1
|
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma |
|
48090-5
|
Cholesterol in HDL/Cholesterol in HDL+VLDL [Molar ratio] in Serum or Plasma |
|
16616-5
|
Cholesterol in HDL/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
|
1051-2
|
Hemolytic disease of newborn screen [Interpretation] in Blood |
|
49315-5
|
Hemolytic disease of newborn screen [Interpretation] in Blood Narrative |
|
51654-2
|
Hepatitis D virus Ab [Presence] in Body fluid |
|
5200-1
|
Hepatitis D virus Ab [Units/volume] in Serum by Immunoassay |
|
13248-0
|
Hepatitis D virus Ab [Presence] in Serum |
|
40727-0
|
Hepatitis D virus Ab [Presence] in Serum by Immunoassay |
|
5201-9
|
Hepatitis D virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22330-5
|
Hepatitis D virus Ab [Units/volume] in Serum |
|
44755-7
|
Hepatitis D virus Ag [Units/volume] in Serum by Immunoassay |
|
33464-9
|
Hepatitis D virus Ag [Presence] in Serum |
|
44754-0
|
Hepatitis D virus Ag [Presence] in Serum by Immunoassay |
|
43281-5
|
Hepatitis D virus Ag [Mass/volume] in Serum |
|
43280-7
|
Hepatitis D virus Ag [Mass/volume] in Urine |
|
72606-7
|
Hepatitis D virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
49775-0
|
Hepatitis D virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
35283-1
|
Hepatitis D virus IgG Ab [Presence] in Serum |
|
35273-2
|
Hepatitis D virus IgG Ab [Presence] in Serum by Immunoassay |
|
51458-8
|
Hepatitis D virus IgG Ab [Units/volume] in Serum |
|
44826-6
|
Hepatitis D virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
34597-5
|
Hepatitis D virus IgM Ab [Presence] in Serum |
|
44938-9
|
Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay |
|
9525-7
|
Hepatitis D virus IgM Ab [Units/volume] in Serum |
|
80426-0
|
Hepatitis D virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
85512-2
|
Hepatitis D virus RNA [Units/volume] (viral load) in Serum by NAA with probe detection |
|
85513-0
|
Hepatitis D virus RNA [log units/volume] (viral load) in Serum by NAA with probe detection |
|
7906-1
|
Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection |
|
46423-0
|
Hemoglobin distribution width [Mass/volume] in Blood |
|
76139-5
|
Reticulocyte hemoglobin distribution width [Mass/volume] in Blood by calculation |
|
65323-8
|
He Ab [Presence] in Serum or Plasma |
|
76119-7
|
Helium gas delivered during case [Volume] from Gas delivery system |
|
76122-1
|
Helium gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
55180-4
|
Human epididymis protein 4 [Moles/volume] in Serum or Plasma |
|
79766-2
|
Head posture for nystagmus null-point |
|
82231-2
|
Headaches [NDI] |
|
85447-1
|
Health and well-being domain risk level [ePCAM] |
|
85446-3
|
Health and well-being total [ePCAM] |
|
75310-3
|
Health concerns Document |
|
74735-2
|
Health data repository [Identifier] |
|
74706-3
|
Health information technology (HIT) device was involved [AHRQ] |
|
64290-0
|
Health insurance card |
|
69322-6
|
Health insurance plan benefits comment |
|
64291-8
|
Health insurance-related form |
|
85451-3
|
Health literacy and communication domain risk level [ePCAM] |
|
85450-5
|
Health literacy and communication total [ePCAM] |
|
88093-0
|
Health status prior to emergency incident |
|
81335-2
|
Patient Healthcare agent |
|
81343-6
|
Healthcare agent advisor [Reported] |
|
81342-8
|
Healthcare agent appointment intended to be valid in any jurisdiction [Reported] |
|
81344-4
|
Healthcare agent authority to inspect and disclose mental and physical health information [Reported] |
|
81345-1
|
Healthcare agent authority to inspect and disclose specially protected health information [Reported] |
|
90366-6
|
Received healthcare outside the U.S. in the past |
|
74571-1
|
Healthcare professional type [AHRQ] |
|
54599-6
|
Hearing aid used during 7 day assessment period [CMS Assessment] |
|
46770-4
|
Hearing loss newborn screening interpretation |
|
57700-7
|
Hearing loss newborn screening comment/discussion |
|
89016-0
|
Hearing threshold Ear - left --1000 Hz |
|
89017-8
|
Hearing threshold Ear - right --1000 Hz |
|
91373-1
|
Hearing threshold Ear - left --1500 Hz |
|
91372-3
|
Hearing threshold Ear - right --1500 Hz |
|
89018-6
|
Hearing threshold Ear - left --2000 Hz |
|
89019-4
|
Hearing threshold Ear - right --2000 Hz |
|
91375-6
|
Hearing threshold Ear - left --250 Hz |
|
91374-9
|
Hearing threshold Ear - right --250 Hz |
|
89020-2
|
Hearing threshold Ear - left --3000 Hz |
|
89021-0
|
Hearing threshold Ear - right --3000 Hz |
|
89022-8
|
Hearing threshold Ear - left --4000 Hz |
|
89023-6
|
Hearing threshold Ear - right --4000 Hz |
|
89024-4
|
Hearing threshold Ear - left --500 Hz |
|
89025-1
|
Hearing threshold Ear - right --500 Hz |
|
91377-2
|
Hearing threshold Ear - left --5000 Hz |
|
91376-4
|
Hearing threshold Ear - right --5000 Hz |
|
89026-9
|
Hearing threshold Ear - left --6000 Hz |
|
89027-7
|
Hearing threshold Ear - right --6000 Hz |
|
91379-8
|
Hearing threshold Ear - left --750 Hz |
|
91378-0
|
Hearing threshold Ear - right --750 Hz |
|
89028-5
|
Hearing threshold Ear - left --8000 Hz |
|
89029-3
|
Hearing threshold Ear - right --8000 Hz |
|
93309-3
|
Hearing.ability to hear during 3 day assessment period [CMS Assessment] |
|
54598-8
|
Hearing.ability to hear in last 7 days [CMS Assessment] |
|
74146-2
|
Heart disease action plan |
|
90771-7
|
Heart failure Consult note |
|
57240-4
|
Heart failure follow-up [CMS Assessment] |
|
90770-9
|
Heart failure Initial evaluation note |
|
90773-3
|
Heart failure Telephone encounter Note |
|
90769-1
|
Heart failure Plan of care note |
|
90772-5
|
Heart failure Progress note |
|
90774-1
|
Heart failure Team Conference note |
|
55426-1
|
Heart rate unspecified time maximum by Pedometer |
|
55425-3
|
Heart rate unspecified time mean by Pedometer |
|
73795-7
|
Heart rate Blood Postductal Pulse oximetry |
|
73799-9
|
Heart rate Blood Preductal Pulse oximetry |
|
76476-1
|
Heart rate by Transthoracic impedance |
|
89278-6
|
Heart rate --during anesthesia |
|
89271-1
|
Heart rate --during apnea |
|
55422-0
|
Heart rate Encounter maximum |
|
76477-9
|
Heart rate by Noninvasive |
|
89282-8
|
Heart rate --post bronchodilation |
|
44969-4
|
Heart rate rhythm palpation |
|
89299-2
|
Heart rate special circumstances |
|
89273-7
|
Heart rate --W exercise |
|
89291-9
|
Heart rate --W pain |
|
76282-3
|
Heart rate.beat-to-beat by EKG |
|
80276-9
|
Heart sounds |
|
79102-0
|
Heart transplant acute cellular rejection risk [Score] in Mononuclear cells Calculated by AlloMap |
|
71122-6
|
Heat worsens my symptoms in the past 7 days [FACIT] |
|
75927-4
|
Heater power Infant microenvironment |
|
75926-6
|
Heater type Infant microenvironment |
|
74186-8
|
Health insurance funding was provided |
|
32591-0
|
Heavy metals [Presence] in 24 hour Urine |
|
5664-8
|
Heavy metals negative [Identifier] in Urine by Screen method |
|
5663-0
|
Heavy metals positive [Identifier] in Urine by Screen method |
|
31148-0
|
Heavy metals [Identifier] in Tissue |
|
40772-6
|
Heavy metals [Presence] in Urine |
|
5662-2
|
Heavy metals [Presence] in Urine by Reinsch |
|
23747-9
|
Heavy metals [Presence] in Unspecified specimen |
|
74254-4
|
HEDIS 2014-2018 Value Set - Rh |
|
74255-1
|
HEDIS 2014-2018 Value Set - Rubella Antibody |
|
74262-7
|
HEDIS 2014-2018 Value Set - Toxoplasma Antibody |
|
74256-9
|
HEDIS 2014-2019 Value Set - Serum Creatinine |
|
75867-2
|
HEDIS 2015-2018 Value Set - Cholesterol Tests Other Than LDL |
|
75863-1
|
HEDIS 2015-2018 Value Set - Digoxin Level |
|
75864-9
|
HEDIS 2015-2018 Value Set - Glucose Tests |
|
75865-6
|
HEDIS 2015-2018 Value Set - PSA Test Exclusion |
|
75866-4
|
HEDIS 2015-2018 Value Set - PSA Tests |
|
75862-3
|
HEDIS 2015-2020 Value Set - HbA1C Tests |
|
75861-5
|
HEDIS 2015-2020 Value Set - LDL-C Tests |
|
79540-1
|
HEDIS 2016-2018 Value Set - PHQ-9 Total Score |
|
79539-3
|
HEDIS 2016-2018 Value Set - Urine Protein Tests |
|
79543-5
|
HEDIS 2016-2019 Value Set - ABO and Rh |
|
79541-9
|
HEDIS 2016-2020 Value Set - Lead Tests |
|
82957-2
|
HEDIS 2017, 2018 Value Set - Chlamydia Tests |
|
82958-0
|
HEDIS 2017, 2018 Value Set - Cytomegalovirus Antibody |
|
82960-6
|
HEDIS 2017, 2018 Value Set - Group A Strep Tests |
|
82963-0
|
HEDIS 2017, 2018 Value Set - HPV Vaccine Administered |
|
82961-4
|
HEDIS 2017, 2018 Value Set - Pregnancy Test Exclusion |
|
82962-2
|
HEDIS 2017, 2018 Value Set - Serum Potassium |
|
82956-4
|
HEDIS 2017-2020 Value Set - FIT-DNA |
|
82959-8
|
HEDIS 2017-2020 Value Set - FOBT |
|
87624-3
|
HEDIS 2018 Alcohol Screening |
|
87623-5
|
HEDIS 2018 Value Set - Depression Screen |
|
87625-0
|
HEDIS 2018 Value Sets |
|
90777-4
|
HEDIS 2019 Value Set - Cytomegalovirus Antibody |
|
90765-9
|
HEDIS 2019 Value Set - Rh |
|
90776-6
|
HEDIS 2019 Value Set - Rubella Antibody |
|
90764-2
|
HEDIS 2019 Value Set - Toxoplasma Antibody |
|
90766-7
|
HEDIS 2019 Value Sets |
|
90763-4
|
HEDIS 2019-2020 Value Set - Chlamydia Tests |
|
90997-8
|
HEDIS 2019-2020 Value Set - Group A Strep Tests |
|
93003-2
|
Heel-shin slide - left |
|
93002-4
|
Heel-shin slide - left+right mean [Score] |
|
93004-0
|
Heel-shin slide - right |
|
15298-3
|
Urinary bladder Height by US |
|
41910-1
|
Type of Height device |
|
41912-7
|
Height device Vendor model code |
|
41913-5
|
Height device Vendor serial number |
|
41911-9
|
Height device Vendor name |
|
15286-8
|
Kidney - left Height by US |
|
15289-2
|
Kidney - right Height by US |
|
15301-5
|
Prostate Height by US |
|
88077-3
|
Height range of fall |
|
15292-6
|
Testis - left Height by US |
|
15295-9
|
Testis - right Height by US |
|
48068-1
|
Heinz bodies [Presence] in Blood |
|
716-1
|
Heinz bodies [Presence] in Blood by Light microscopy |
|
40718-9
|
Heinz bodies/100 erythrocytes in Blood |
|
33057-1
|
Heinz bodies/100 erythrocytes in Blood by Light microscopy |
|
60813-3
|
Helium [VFr/PPres] Airway adaptor --during expiration |
|
76097-5
|
Helium [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60934-7
|
Helium [VFr/PPres] Airway adaptor --during inspiration |
|
76098-3
|
Helium [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60812-5
|
Helium [VFr/PPres] Airway adaptor --at end expiration |
|
60932-1
|
Helium [VFr/PPres] Airway adaptor |
|
76110-6
|
Helium [VFr/PPres] Gas delivery system |
|
10374-7
|
Helmet cells [Presence] in Blood by Light microscopy |
|
7395-7
|
Helminthosporium sp IgE Ab [Units/volume] in Serum |
|
15768-5
|
Helminthosporium sp IgE Ab RAST class [Presence] in Serum |
|
7396-5
|
Helminthosporium sp IgG Ab [Units/volume] in Serum |
|
33289-0
|
Helminthosporium sp IgG Ab RAST class [Presence] in Serum |
|
42907-6
|
Helminthosporium sp IgG Ab [Mass/volume] in Serum |
|
75873-0
|
Help from another person is usually needed for dressing and grooming, arising, eating, AndOr walking [HAQ] |
|
75878-9
|
Help from another person usually needed for hygiene, reach, gripping and opening things, AndOr errands and chores [HAQ] |
|
10757-3
|
Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
|
59466-3
|
Hematologist review of results |
|
78251-6
|
Hematology Consult note |
|
85442-2
|
Hematology Discharge summary |
|
78274-8
|
Hematology Education note |
|
78291-2
|
Hematology Flowsheet |
|
78310-0
|
Hematology Initial evaluation note |
|
85443-0
|
Hematology Note |
|
89804-9
|
Hematology Telephone encounter Note |
|
80740-4
|
Hematology Plan of care note |
|
78319-1
|
Hematology procedure note |
|
78328-2
|
Hematology Progress note |
|
93894-4
|
Hematology Team Conference note |
|
89031-9
|
Hematology Telehealth Consult note |
|
33626-3
|
Hematoporphyrin [Mass/time] in 24 hour Stool |
|
50045-4
|
Hemicystine [Moles/volume] in Amniotic fluid |
|
50177-5
|
Hemicystine [Moles/volume] in Cerebral spinal fluid |
|
50047-0
|
Hemicystine [Moles/volume] in DBS |
|
50046-2
|
Hemicystine [Moles/volume] in Serum or Plasma |
|
50050-4
|
Hemicystine/Amino acids.total in Amniotic fluid |
|
50052-0
|
Hemicystine/Amino acids.total in DBS |
|
50049-6
|
Hemicystine/Amino acids.total in Hair |
|
50051-2
|
Hemicystine/Amino acids.total in Serum or Plasma |
|
50053-8
|
Hemicystine/Amino acids.total in Unspecified specimen |
|
50048-8
|
Hemicystine [Moles/volume] in Unspecified specimen |
|
50054-6
|
Hemicystine/Creatinine [Molar ratio] in Urine |
|
14563-1
|
Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen |
|
57905-2
|
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --1st specimen |
|
42913-4
|
Hemoglobin.gastrointestinal [Presence] in Unspecified specimen --1st specimen |
|
14564-9
|
Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen |
|
56490-6
|
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --2nd specimen |
|
42912-6
|
Hemoglobin.gastrointestinal [Presence] in Unspecified specimen --2nd specimen |
|
14565-6
|
Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen |
|
56491-4
|
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --3rd specimen |
|
12503-9
|
Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen |
|
12504-7
|
Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen |
|
27401-9
|
Hemoglobin.gastrointestinal [Presence] in Stool --6th specimen |
|
27925-7
|
Hemoglobin.gastrointestinal [Presence] in Stool --7th specimen |
|
27926-5
|
Hemoglobin.gastrointestinal [Presence] in Stool --8th specimen |
|
50017-3
|
Hemoglobin.gastrointestinal [Presence] in Sputum or Gastric fluid |
|
58453-2
|
Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay |
|
2335-8
|
Hemoglobin.gastrointestinal [Presence] in Stool |
|
29771-3
|
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay |
|
80372-6
|
Hemoglobin.gastrointestinal [Presence] in Stool by Rapid immunoassay |
|
27396-1
|
Hemoglobin.gastrointestinal [Mass/mass] in Stool |
|
48047-5
|
Hemoglobin.gastrointestinal [Presence] in Vomitus |
|
46740-7
|
Hemoglobin disorders newborn screen interpretation |
|
57703-1
|
Hemoglobin disorders newborn screening comment-discussion |
|
92540-4
|
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92502-4
|
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
46766-2
|
Hemoglobin SC disease newborn screen interpretation |
|
71592-0
|
Hemoglobinopathies conditions suspected [Identifier] in DBS |
|
4640-9
|
Hemolysin cold [Mass/volume] in Plasma |
|
4641-7
|
Hemolysin warm [Mass/volume] in Plasma |
|
46424-8
|
Hemolysis index of Serum or Plasma |
|
83685-8
|
Hematology+Medical oncology Attending Consult note |
|
83686-6
|
Hematology+Medical oncology Attending Note |
|
84138-7
|
Hematology+Medical oncology Conference note |
|
34779-9
|
Hematology+Medical oncology Consult note |
|
85588-2
|
Hematology+Medical oncology Diagnostic study note |
|
84139-5
|
Hematology+Medical oncology Discharge summary |
|
86215-1
|
Hematology+Medical oncology Disease staging note |
|
84140-3
|
Hematology+Medical oncology Education note |
|
83739-3
|
Hematology+Medical oncology Fellow Note |
|
84141-1
|
Hematology+Medical oncology Group counseling note |
|
84142-9
|
Hematology+Medical oncology Hospital Consult note |
|
68555-2
|
Hematology+Medical oncology Hospital Letter |
|
84143-7
|
Hematology+Medical oncology Hospital Note |
|
68553-7
|
Hematology+Medical oncology Initial evaluation note |
|
84144-5
|
Hematology+Medical oncology Medication management note |
|
34780-7
|
Hematology+Medical oncology Note |
|
83546-2
|
Hematology+Medical oncology Nurse practitioner Note |
|
83578-5
|
Hematology+Medical oncology Nurse Consult note |
|
83579-3
|
Hematology+Medical oncology Nurse Note |
|
83580-1
|
Hematology+Medical oncology Nurse Outpatient Note |
|
84145-2
|
Hematology+Medical oncology Outpatient Consult note |
|
84146-0
|
Hematology+Medical oncology Outpatient Note |
|
78242-5
|
Hematology+Medical oncology Surgical operation note |
|
88648-1
|
Hematology+Medical oncology Parenteral therapy note |
|
84137-9
|
Hematology+Medical oncology Pharmacist Note |
|
84150-2
|
Hematology+Medical oncology Telephone encounter Note |
|
84151-0
|
Hematology+Medical oncology Plan of care note |
|
84147-8
|
Hematology+Medical oncology procedure note |
|
68554-5
|
Hematology+Medical oncology Progress note |
|
57172-9
|
Hematology+Medical oncology Referral note |
|
83758-3
|
Hematology+Medical oncology Resident Note |
|
84148-6
|
Hematology+Medical oncology Risk assessment and screening note |
|
84149-4
|
Hematology+Medical oncology Team Note |
|
89884-1
|
Hematology+Medical oncology Telehealth Note |
|
40633-0
|
Hemopexin [Presence] in Serum |
|
2403-4
|
Hemopexin [Mass/volume] in Serum |
|
2404-2
|
Hemopexin [Mass/volume] in Urine |
|
4643-3
|
Hemosiderin [Mass/volume] in Serum |
|
40722-1
|
Hemosiderin [Presence] in Sputum |
|
10762-3
|
Microscopic observation [Identifier] in Blood by Hemosiderin stain |
|
4644-1
|
Hemosiderin [Presence] in Urine |
|
17783-2
|
Hemosiderin [Presence] in Urine by Light microscopy |
|
4645-8
|
Hemosiderin [Mass/volume] in Urine |
|
33923-4
|
Hemosiderin [Presence] in Unspecified specimen |
|
7399-9
|
Hemp fiber IgE Ab [Units/volume] in Serum |
|
7398-1
|
Hemp IgE Ab [Units/volume] in Serum |
|
81639-7
|
Heparin dose response slope in Blood by Coagulation assay |
|
29474-4
|
Hepatic vein Maximum A wave reversal by US.doppler |
|
29482-7
|
Hepatic vein Maximum A wave reversal by US.doppler --expiration |
|
29478-5
|
Hepatic vein Maximum A wave reversal by US.doppler --inspiration |
|
93619-5
|
Hepatic vein Systolic flow reversal by US.doppler |
|
29472-8
|
Hepatic vein Maximum blood flow velocity during diastole by US.doppler |
|
29480-1
|
Hepatic vein Maximum blood flow velocity during diastole by US.doppler --expiration |
|
29476-9
|
Hepatic vein Maximum blood flow velocity during diastole by US.doppler --inspiration |
|
29471-0
|
Hepatic vein Maximum blood flow velocity during systole by US.doppler |
|
29479-3
|
Hepatic vein Maximum blood flow velocity during systole by US.doppler --expiration |
|
29475-1
|
Hepatic vein Maximum blood flow velocity during systole by US.doppler --inspiration |
|
29473-6
|
Hepatic vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler |
|
29483-5
|
Hepatic vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived |
|
29481-9
|
Hepatic vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler --expiration |
|
29485-0
|
Hepatic vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived --expiration |
|
29477-7
|
Hepatic vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler --inspiration |
|
29484-3
|
Hepatic vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived --inspiration |
|
90235-3
|
Heparan sulfate [Moles/volume] in DBS |
|
18229-5
|
Heparan sulfate [Presence] in Serum or Plasma |
|
93725-0
|
Heparan sulfate [Mass/volume] in Serum or Plasma |
|
2405-9
|
Heparan sulfate [Presence] in Urine |
|
2406-7
|
Heparan sulfate [Mass/volume] in Urine |
|
24085-3
|
Heparan-N-sulfatase [Enzymatic activity/mass] in Fibroblast |
|
24086-1
|
Heparan-N-sulfatase [Enzymatic activity/mass] in Leukocytes |
|
55253-9
|
Heparin 10000 U/mL given [Volume] |
|
55254-7
|
Heparin 5000 U/mL given [Volume] |
|
40723-9
|
Heparin Ab [Presence] in Platelet poor plasma by Platelet aggregation |
|
31159-7
|
Heparin anti Xa [Units/volume] in Nonbiological fluid |
|
33987-9
|
Heparin cofactor II actual/normal in Platelet poor plasma by Chromogenic method |
|
3268-0
|
Heparin cofactor II Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
47285-2
|
Heparin cofactor II Ag [Units/volume] in Platelet poor plasma |
|
58957-2
|
Heparin given [Type] |
|
48388-3
|
Heparin IgE Ab [Units/volume] in Serum |
|
66759-2
|
Heparin neutralization [Presence] in Blood by Thromboelastography |
|
3269-8
|
Heparin neutralization [Presence] in Platelet poor plasma |
|
42679-1
|
Heparin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
13055-9
|
Heparin [Units/volume] in Platelet poor plasma |
|
66744-4
|
Heparin/Body weight [Mass/mass] in Blood |
|
28652-6
|
Heparinoid [Units/volume] in Platelet poor plasma by Chromogenic method |
|
44772-2
|
Hepatic artery anatomy |
|
49061-5
|
Hepatic iron index |
|
72056-5
|
Hepatitis B vaccination received |
|
83581-9
|
Hepatology Nurse Note |
|
50321-9
|
Hepatocyte Ag [Presence] in Tissue by Immune stain |
|
84152-8
|
Hepatology Consult note |
|
84153-6
|
Hepatology Counseling note |
|
84154-4
|
Hepatology Education note |
|
87268-9
|
Hepatology Immunization note |
|
84155-1
|
Hepatology Initial evaluation note |
|
84156-9
|
Hepatology Note |
|
84157-7
|
Hepatology Outpatient Note |
|
84159-3
|
Hepatology Telephone encounter Note |
|
84158-5
|
Hepatology procedure note |
|
84160-1
|
Hepatology Transplant candidate evaluation note |
|
71386-7
|
Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma |
|
40367-5
|
Heptacarboxylate [Moles/time] in 24 hour Urine |
|
14776-9
|
Heptacarboxylate [Moles/volume] in Plasma |
|
14777-7
|
Heptacarboxylate [Moles/volume] in Stool |
|
45308-4
|
Heptacarboxylate [Moles/mass] in Stool |
|
14778-5
|
Heptacarboxylate [Moles/volume] in Urine |
|
49225-6
|
Heptacarboxylate/Creatinine [Molar ratio] in 24 hour Urine |
|
38175-6
|
Heptacarboxylate/Creatinine [Molar ratio] in Urine |
|
38597-1
|
Heptachlor [Mass/volume] in Air |
|
87655-7
|
Heptachlor epoxide [Mass/mass] in Unspecified specimen |
|
9472-2
|
Heptachlor [Mass/volume] in Serum or Plasma |
|
16939-1
|
Heptachlor [Mass/volume] in Urine |
|
38306-7
|
Heptachlor [Mass/volume] in Water |
|
87654-0
|
Heptachlor [Mass/mass] in Unspecified specimen |
|
9473-0
|
Heptachlorepoxide [Mass/volume] in Serum or Plasma |
|
16940-9
|
Heptachlorepoxide [Mass/volume] in Urine |
|
38307-5
|
Heptachlorepoxide [Mass/volume] in Water |
|
9380-7
|
Heptacarboxylporphyrin [Mass/time] in unspecified time Stool |
|
48632-4
|
Heptacarboxylporphyrin [Mass/time] in 24 hour Stool |
|
41997-8
|
Heptacarboxylporphyrin [Mass/volume] in 24 hour Urine |
|
24462-4
|
Heptacarboxylporphyrin [Mass/time] in 24 hour Urine |
|
25923-4
|
Heptacarboxylporphyrin [Moles/volume] in 24 hour Urine |
|
25434-2
|
Heptacarboxylporphyrin [Moles/time] in 24 hour Urine |
|
45209-4
|
Heptacarboxylporphyrin [Moles/volume] in DBS |
|
23872-5
|
Heptacarboxylporphyrin I [Mass/time] in unspecified time Stool |
|
49900-4
|
Heptacarboxylporphyrin I [Mass/time] in 24 hour Stool |
|
93505-6
|
Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine |
|
93708-6
|
Heptacarboxylporphyrin I/Creatinine [Molar ratio] in Urine |
|
49918-6
|
Heptacarboxylporphyrin II [Mass/time] in unspecified time Stool |
|
9446-6
|
Heptacarboxylporphyrin [Mass/volume] in Red Blood Cells |
|
9447-4
|
Heptacarboxylporphyrin [Mass/volume] in Serum or Plasma |
|
76773-1
|
Heptacarboxylporphyrin [Moles/volume] in Serum or Plasma |
|
16938-3
|
Heptacarboxylporphyrin [Mass/volume] in Stool |
|
34313-7
|
Heptacarboxylporphyrin [Mass/mass] in Stool |
|
50853-1
|
Heptacarboxylporphyrin [Moles/mass] in Stool |
|
30528-4
|
Heptacarboxylporphyrin [Presence] in Urine |
|
2407-5
|
Heptacarboxylporphyrin [Mass/volume] in Urine |
|
34314-5
|
Heptacarboxylporphyrin [Moles/volume] in Urine |
|
32179-4
|
Heptacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
|
38163-2
|
Heptacarboxylporphyrin/Creatinine [Mass Ratio] in Urine |
|
50628-7
|
Heptacarboxylporphyrin/Creatinine [Molar ratio] in Urine |
|
23873-3
|
Heptacarboxylporphyrin III [Mass/time] in unspecified time Stool |
|
49901-2
|
Heptacarboxylporphyrin III [Mass/time] in 24 hour Stool |
|
93506-4
|
Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine |
|
74088-6
|
Heptacarboxylporphyrin III [Moles/mass] in Stool |
|
74091-0
|
Heptacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
|
48113-5
|
Heptadecenoate/Creatinine [Molar ratio] in Urine |
|
3674-9
|
Heptaminol [Mass/time] in 24 hour Urine |
|
4273-9
|
Heptaminol [Mass] of Dose |
|
3672-3
|
Heptaminol [Presence] in Urine |
|
3673-1
|
Heptaminol [Mass/volume] in Urine |
|
17360-9
|
Heptane [Mass/volume] in Blood |
|
54292-8
|
Heptanoylcarnitine (C7) [Moles/volume] in Amniotic fluid |
|
54291-0
|
Heptanoylcarnitine (C7) [Moles/volume] in Cerebral spinal fluid |
|
53204-4
|
Heptanoylcarnitine (C7) [Moles/volume] in DBS |
|
55871-8
|
Heptanoylcarnitine (C7) [Moles/volume] in Serum or Plasma |
|
54293-6
|
Heptanoylcarnitine (C7) [Moles/volume] in Urine |
|
54290-2
|
Heptanoylcarnitine (C7)/Creatinine [Molar ratio] in Urine |
|
18474-7
|
HER2 Ag [Presence] in Tissue by Immune stain |
|
85318-4
|
HER2 [Presence] in Breast cancer specimen by FISH |
|
85319-2
|
HER2 [Presence] in Breast cancer specimen by Immune stain |
|
49683-6
|
HER2 gene copy number/Chromosome 17 copy number in Tissue by FISH |
|
74860-8
|
HER2 gene copy number/nucleus in Tissue by FISH |
|
42914-2
|
HER2 [Mass/volume] in Serum by Immunoassay |
|
51981-9
|
HER2 [Presence] in Serum by Immunoassay |
|
32996-1
|
HER2 [Mass/volume] in Serum |
|
72382-5
|
HER2 [Units/volume] in Tissue by Immunoassay |
|
31150-6
|
HER2 [Presence] in Tissue by FISH |
|
72383-3
|
HER2 [Presence] in Tissue by Immunoassay |
|
48676-1
|
HER2 [Interpretation] in Tissue |
|
85328-3
|
Cells.HER2 uniform intense membrane staining/100 cells in Breast cancer specimen by Immune stain |
|
42786-4
|
HER3 Ag [Presence] in Tissue by Immune stain |
|
42787-2
|
HER4 Ag [Presence] in Tissue by Immune stain |
|
20837-1
|
Herbicide [Identifier] in Feed |
|
20842-1
|
Herbicide [Presence] in Feed by Screen method |
|
20838-9
|
Herbicide [Presence] in Gastric fluid by Screen method |
|
20835-5
|
Herbicide [Identifier] in Ingesta |
|
20840-5
|
Herbicide [Presence] in Ingesta by Screen method |
|
20836-3
|
Herbicide [Identifier] in Tissue |
|
20841-3
|
Herbicide [Presence] in Tissue by Screen method |
|
16941-7
|
Herbicide [Identifier] in Unspecified specimen |
|
20839-7
|
Herbicide [Presence] in Unspecified specimen by Screen method |
|
6139-0
|
Herring IgE Ab [Units/volume] in Serum |
|
15772-7
|
Herring IgE Ab RAST class [Presence] in Serum |
|
7401-3
|
Herring IgG Ab [Units/volume] in Serum |
|
56284-3
|
Herring IgG4 Ab [Mass/volume] in Serum |
|
63111-9
|
Herring IgG Ab [Mass/volume] in Serum |
|
276-6
|
Hetacillin [Susceptibility] by Disk diffusion (KB) |
|
275-8
|
Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
274-1
|
Hetacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18931-6
|
Hetacillin [Susceptibility] |
|
277-4
|
Hetacillin [Susceptibility] by Serum bactericidal titer |
|
22344-6
|
Heterophile Ab after absorption [Titer] in Serum |
|
5216-7
|
Heterophile Ab after absorption [Titer] in Serum by Latex agglutination |
|
7914-5
|
Heterophile Ab after beef cell absorption [Titer] in Serum |
|
69420-8
|
Heterophile Ab [Presence] in Blood by Immunoassay |
|
7915-2
|
Heterophile Ab after guinea pig cell absorption [Titer] in Serum |
|
43282-3
|
Heterophile Ab [Presence] in Control Serum |
|
31418-7
|
Heterophile Ab [Presence] in Serum |
|
5213-4
|
Heterophile Ab [Presence] in Serum by Latex agglutination |
|
12221-8
|
Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination |
|
11610-3
|
Heterophile Ab [Units/volume] in Serum |
|
6425-3
|
Heterophile Ab [Presence] in Serum or Plasma by Immunoassay |
|
31419-5
|
Heterophile Ab [Presence] in Synovial fluid |
|
16962-3
|
Heterophile Ab [Presence] in Synovial fluid by Latex agglutination |
|
43020-7
|
Heterophile Ab [Titer] in Serum |
|
6424-6
|
Heterophile Ab [Titer] in Serum by Agglutination |
|
5215-9
|
Heterophile Ab [Titer] in Serum by Latex agglutination |
|
30157-2
|
Heterophils/100 leukocytes in Blood |
|
28632-8
|
Heterophoria study |
|
74858-2
|
Hepatitis E virus genotypes 1+2+3+4 RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
51653-4
|
Hepatitis E virus Ab [Presence] in Body fluid |
|
49776-8
|
Hepatitis E virus Ab [Units/volume] in Serum by Immunoassay |
|
13294-4
|
Hepatitis E virus Ab [Presence] in Serum |
|
58936-6
|
Hepatitis E virus Ab [Presence] in Serum by Immunoassay |
|
51459-6
|
Hepatitis E virus Ab [Units/volume] in Serum |
|
60430-6
|
Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection |
|
14211-7
|
Hepatitis E virus IgG Ab [Presence] in Serum |
|
49693-5
|
Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay |
|
56513-5
|
Hepatitis E virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
14212-5
|
Hepatitis E virus IgM Ab [Presence] in Serum |
|
51798-7
|
Hepatitis E virus IgM Ab [Units/volume] in Serum |
|
83128-9
|
Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
69577-5
|
Hepatitis E virus RNA [Presence] in Blood by NAA with probe detection |
|
69961-1
|
Hepatitis E virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
78750-7
|
Hepatitis E virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
90460-7
|
Hepatitis E virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
91071-1
|
Hepatitis E virus RNA [Presence] in Stool by NAA with probe detection |
|
81689-2
|
Hendra virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
38701-9
|
Hexachlorocyclopentadiene [Mass/volume] in Air |
|
38337-2
|
Hexachlorocyclopentadiene [Mass/volume] in Water |
|
35381-3
|
HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
35473-8
|
HEXA gene 7.6kb deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
35472-0
|
HEXA gene c.1277insTATC [Presence] in Blood or Tissue by Molecular genetics method |
|
35380-5
|
HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
76033-0
|
HEXA gene full mutation analysis in Blood or Tissue by Sequencing |
|
32632-2
|
HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51773-0
|
HEXA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38900-7
|
HEXA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
35382-1
|
HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method |
|
40368-3
|
Hexacarboxylate [Moles/time] in 24 hour Urine |
|
14779-3
|
Hexacarboxylate [Moles/volume] in Plasma |
|
14780-1
|
Hexacarboxylate [Moles/volume] in Stool |
|
45309-2
|
Hexacarboxylate [Moles/mass] in Stool |
|
14781-9
|
Hexacarboxylate [Moles/volume] in Urine |
|
45316-7
|
Hexacarboxylate/Creatinine [Molar ratio] in Urine |
|
39574-9
|
Hexacarboxylporphyrin [Mass/time] in 24 hour Stool |
|
43115-5
|
Hexacarboxylporphyrin [Presence] in 24 hour Urine |
|
41998-6
|
Hexacarboxylporphyrin [Mass/volume] in 24 hour Urine |
|
9527-3
|
Hexacarboxylporphyrin [Mass/time] in 24 hour Urine |
|
25924-2
|
Hexacarboxylporphyrin [Moles/volume] in 24 hour Urine |
|
25438-3
|
Hexacarboxylporphyrin [Moles/time] in 24 hour Urine |
|
16963-1
|
Hexacarboxylporphyrin [Mass/volume] in Blood |
|
23874-1
|
Hexacarboxylporphyrin I [Mass/time] in unspecified time Stool |
|
93507-2
|
Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine |
|
93709-4
|
Hexacarboxylporphyrin I/Creatinine [Molar ratio] in Urine |
|
9450-8
|
Hexacarboxylporphyrin [Mass/volume] in Red Blood Cells |
|
74988-7
|
Hexacarboxylporphyrin [Moles/volume] in Red Blood Cells |
|
9451-6
|
Hexacarboxylporphyrin [Mass/volume] in Serum or Plasma |
|
59790-6
|
Hexacarboxylporphyrin [Moles/volume] in Serum or Plasma |
|
16964-9
|
Hexacarboxylporphyrin [Mass/volume] in Stool |
|
50855-6
|
Hexacarboxylporphyrin [Moles/mass] in Stool |
|
30529-2
|
Hexacarboxylporphyrin [Presence] in Urine |
|
27400-1
|
Hexacarboxylporphyrin [Mass/volume] in Urine |
|
48621-7
|
Hexacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
|
38164-0
|
Hexacarboxylporphyrin/Creatinine [Mass Ratio] in Urine |
|
23875-8
|
Hexacarboxylporphyrin III [Mass/time] in unspecified time Stool |
|
93508-0
|
Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine |
|
74087-8
|
Hexacarboxylporphyrin III [Moles/mass] in Stool |
|
74090-2
|
Hexacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
|
34315-2
|
Hexacarboxylporphyrins [Mass/mass] in Stool |
|
78353-0
|
Hexadecadienoate (C16:2) [Entitic substance] in Red Blood Cells |
|
35154-4
|
Hexadecadienoate (C16:2) [Moles/volume] in Serum or Plasma |
|
38365-3
|
Hexadecadienoate (C16:2)/Creatinine [Mass Ratio] in Urine |
|
50332-6
|
Hexadecanedioate/Creatinine [Mass Ratio] in Urine |
|
48114-3
|
Hexadecanedioate/Creatinine [Molar ratio] in Urine |
|
78346-4
|
Hexadecenoate (C16:1w9) [Entitic substance] in Red Blood Cells |
|
35155-1
|
Hexadecenoate (C16:1w9) [Moles/volume] in Serum or Plasma |
|
47642-4
|
Hexadecenoate (C16:1w9)/Creatinine [Molar ratio] in Urine |
|
38601-1
|
Hexane [Mass/volume] in Air |
|
9475-5
|
Hexane [Mass/volume] in Blood |
|
75372-3
|
Hexane [Mass/volume] in Serum or Plasma by Screen method |
|
38317-4
|
Hexane [Mass/volume] in Water |
|
85087-5
|
Hexanoate (C6:0) [Moles/volume] in Serum or Plasma |
|
54297-7
|
Hexanoylcarnitine (C6) [Moles/volume] in Amniotic fluid |
|
54296-9
|
Hexanoylcarnitine (C6) [Moles/volume] in Cerebral spinal fluid |
|
45211-0
|
Hexanoylcarnitine (C6) [Moles/volume] in DBS |
|
74594-3
|
Hexanoylcarnitine (C6) [Enzymatic activity/mass] in Fibroblast |
|
18443-2
|
Hexanoylcarnitine (C6) [Mass/volume] in Serum or Plasma |
|
30358-6
|
Hexanoylcarnitine (C6) [Moles/volume] in Serum or Plasma |
|
54298-5
|
Hexanoylcarnitine (C6) [Moles/volume] in Urine |
|
54295-1
|
Hexanoylcarnitine (C6)/Creatinine [Molar ratio] in Urine |
|
79473-5
|
Hexanoylglycine [Moles/volume] in Serum or Plasma |
|
30477-4
|
Hexanoylglycine [Presence] in Urine |
|
9476-3
|
Hexanoylglycine [Moles/volume] in Urine |
|
44368-9
|
Hexanoylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
49902-0
|
Hexanoylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13753-9
|
Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
|
24438-4
|
Hexanoylglycine/Creatinine [Molar ratio] in Urine |
|
76029-8
|
HEXB gene full mutation analysis in Blood or Tissue by Sequencing |
|
53203-6
|
Hexenoylcarnitine (C6:1) [Moles/volume] in DBS |
|
74540-6
|
Hexenoylcarnitine (C6:1) [Moles/volume] in Serum or Plasma |
|
12493-3
|
Hexobarbital [Mass/volume] in Serum or Plasma |
|
27165-0
|
Hexobarbital [Mass/volume] in Urine |
|
44369-7
|
Hexokinase [Presence] in Plasma |
|
2409-1
|
Hexokinase [Enzymatic activity/volume] in Plasma |
|
2410-9
|
Hexokinase [Enzymatic activity/volume] in Red Blood Cells |
|
49216-5
|
Hexokinase [Enzymatic activity/mass] in Red Blood Cells |
|
2411-7
|
Hexokinase 1/Hexokinase.total in Red Blood Cells |
|
16967-2
|
Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
|
2412-5
|
Hexokinase 3/Hexokinase.total in Red Blood Cells |
|
16968-0
|
Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
|
21328-0
|
Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood |
|
49253-8
|
Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood Narrative |
|
49320-5
|
Beta-N-acetylhexosaminidase.A activator [Interpretation] in Fibroblast Narrative |
|
25832-7
|
Beta-N-acetylhexosaminidase.A activator [Interpretation] in Fibroblast |
|
29543-6
|
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Amniotic fluid cells |
|
12914-8
|
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Serum or Plasma |
|
23825-3
|
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Leukocytes |
|
80425-2
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in DBS |
|
25831-9
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Fibroblast |
|
1956-2
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma |
|
18196-6
|
Beta-N-acetylhexosaminidase.A [Presence] in Tissue |
|
16457-4
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes |
|
50759-0
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Leukocytes |
|
33657-8
|
Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes |
|
21110-2
|
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Blood |
|
24070-5
|
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Fibroblast |
|
21111-0
|
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Serum or Plasma |
|
24071-3
|
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Leukocytes |
|
24072-1
|
Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Fibroblast |
|
1957-0
|
Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum or Plasma |
|
24073-9
|
Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Leukocytes |
|
33656-0
|
Beta-N-acetylhexosaminidase.B [Moles/volume] in Leukocytes |
|
1958-8
|
Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum |
|
90717-0
|
Heart failure+Transplant cardiology Consult note |
|
93959-5
|
Heart failure+Transplant cardiology Diagnostic study note |
|
68622-0
|
Heart failure+Transplant cardiology History and physical note |
|
68624-6
|
Heart failure+Transplant cardiology Hospital Letter |
|
93956-1
|
Heart failure+Transplant cardiology Letter |
|
68621-2
|
Heart failure+Transplant cardiology Note |
|
68623-8
|
Heart failure+Transplant cardiology Preoperative evaluation and management note |
|
48578-9
|
HFE gene c.187G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
21694-5
|
HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34519-9
|
HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21697-8
|
HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21695-2
|
HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method |
|
21696-0
|
HFE gene p.His63Asp [Presence] in Blood or Tissue by Molecular genetics method |
|
38380-2
|
HFE gene.p.Ser65Cys [Presence] in Blood or Tissue by Molecular genetics method |
|
63392-5
|
Herpes gestationis Ab [Titer] in Serum by Immunofluorescence |
|
45179-9
|
Herpes gestationis IgG Ab complement fixing [Presence] in Serum by Immunofluorescence |
|
45177-3
|
Herpes gestationis IgG Ab non-complement fixing [Presence] in Serum by Immunofluorescence |
|
80657-0
|
Hemoglobin Q/Hemoglobin.total in Blood |
|
10346-5
|
Hemoglobin A [Units/volume] in Blood by Electrophoresis |
|
45208-6
|
Hemoglobin A [Presence] in Blood by Electrophoresis |
|
4546-8
|
Hemoglobin A/Hemoglobin.total in Blood |
|
20572-4
|
Hemoglobin A/Hemoglobin.total in Blood by Electrophoresis |
|
42244-4
|
Hemoglobin A/Hemoglobin.total in Blood by HPLC |
|
54072-4
|
Hemoglobin A/Hemoglobin.total in DBS |
|
71876-7
|
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood |
|
71878-3
|
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
|
71877-5
|
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
12711-8
|
Hemoglobin A region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4547-6
|
Hemoglobin A1/Hemoglobin.total in Blood |
|
51196-4
|
Hemoglobin A1/Hemoglobin.total in Blood by Electrophoresis |
|
41995-2
|
Hemoglobin A1c [Mass/volume] in Blood |
|
86910-7
|
Hemoglobin A1c/Hemoglobin.total goal Blood |
|
4548-4
|
Hemoglobin A1c/Hemoglobin.total in Blood |
|
17855-8
|
Hemoglobin A1c/Hemoglobin.total in Blood by calculation |
|
4549-2
|
Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis |
|
17856-6
|
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
|
62388-4
|
Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol |
|
71875-9
|
Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood |
|
59261-8
|
Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol |
|
4550-0
|
Hemoglobin A2 [Moles/volume] in Blood by Chromatography column |
|
28559-3
|
Hemoglobin A2 [Presence] in Blood |
|
27345-8
|
Hemoglobin A2 [Presence] in Blood by Electrophoresis |
|
4551-8
|
Hemoglobin A2/Hemoglobin.total in Blood |
|
34660-1
|
Hemoglobin A2/Hemoglobin.total in Blood by Chromatography column |
|
4552-6
|
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis |
|
4553-4
|
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3) |
|
4554-2
|
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
|
42245-1
|
Hemoglobin A2/Hemoglobin.total in Blood by HPLC |
|
71872-6
|
Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood |
|
71874-2
|
Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
|
71873-4
|
Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
35127-0
|
Hemoglobin A2.prime/Hemoglobin.total in Blood |
|
51615-3
|
Hemoglobin A2+C/Hemoglobin.total in Blood |
|
55370-1
|
Hemoglobin A2+C+E+O/Hemoglobin.total in Blood |
|
51616-1
|
Hemoglobin A2+E/Hemoglobin.total in Blood |
|
55371-9
|
Hemoglobin A2+E+O/Hemoglobin.total in Blood |
|
24470-7
|
Hemoglobin A2+XXX/Hemoglobin.total in Blood by Electrophoresis |
|
4555-9
|
Hemoglobin A3/Hemoglobin.total in Blood |
|
16932-6
|
Hemoglobin A3/Hemoglobin.total in Blood by Electrophoresis |
|
4556-7
|
Hemoglobin Abruzzo [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4557-5
|
Hemoglobin Abruzzo [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
10486-9
|
Hemoglobin Ag [Presence] in Tissue by Immune stain |
|
4558-3
|
Hemoglobin Barts [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4559-1
|
Hemoglobin Barts [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
55783-5
|
Hemoglobin Barts [Presence] in Blood by HPLC |
|
31156-3
|
Hemoglobin Barts/Hemoglobin.total in Blood |
|
54069-0
|
Hemoglobin Barts/Hemoglobin.total in DBS |
|
71871-8
|
Hemoglobin Barts/Hemoglobin.total [Pure mass fraction] in Blood |
|
4560-9
|
Hemoglobin Bethesda [Presence] in Blood |
|
54289-4
|
Hemoglobin [Mass/volume] in Blood from Blood product unit |
|
20509-6
|
Hemoglobin [Mass/volume] in Blood by calculation |
|
61180-6
|
Hemoglobin [Mass/volume] in Blood from Fetus |
|
55782-7
|
Hemoglobin [Mass/volume] in Blood by Oximetry |
|
717-9
|
Hemoglobin [Presence] in Blood |
|
14775-1
|
Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
|
30313-1
|
Hemoglobin [Mass/volume] in Arterial blood |
|
75928-2
|
Hemoglobin [Moles/volume] in Arterial blood |
|
30352-9
|
Hemoglobin [Mass/volume] in Capillary blood |
|
33026-6
|
Hemoglobin [Mass/volume] in Arterial cord blood by calculation |
|
30354-5
|
Hemoglobin [Mass/volume] in Arterial cord blood |
|
40719-7
|
Hemoglobin [Mass/volume] in Cord blood |
|
33025-8
|
Hemoglobin [Mass/volume] in Venous cord blood by calculation |
|
30353-7
|
Hemoglobin [Mass/volume] in Venous cord blood |
|
718-7
|
Hemoglobin [Mass/volume] in Blood |
|
76768-1
|
Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry |
|
30351-1
|
Hemoglobin [Mass/volume] in Mixed venous blood |
|
59260-0
|
Hemoglobin [Moles/volume] in Blood |
|
76769-9
|
Hemoglobin [Mass/volume] in Venous blood by Oximetry |
|
30350-3
|
Hemoglobin [Mass/volume] in Venous blood |
|
93846-4
|
Hemoglobin [Moles/volume] in Venous blood |
|
40720-5
|
Hemoglobin C [Presence] in Blood |
|
40545-6
|
Hemoglobin C [Presence] in Blood by Electrophoresis |
|
48707-4
|
Hemoglobin C crystals [Presence] in Red Blood Cells by Light microscopy |
|
4563-3
|
Hemoglobin C/Hemoglobin.total in Blood |
|
32681-9
|
Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis |
|
4561-7
|
Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3) |
|
4562-5
|
Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
|
44920-7
|
Hemoglobin C/Hemoglobin.total in Blood by HPLC |
|
54073-2
|
Hemoglobin C/Hemoglobin.total in DBS |
|
71870-0
|
Hemoglobin C/Hemoglobin.total [Pure mass fraction] in Blood |
|
71869-2
|
Hemoglobin C/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
12713-4
|
Hemoglobin C+E+O+A2 region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
34174-3
|
Hemoglobin casts [Presence] in Urine sediment by Light microscopy |
|
4564-1
|
Hemoglobin C - Harlem [Presence] in Blood |
|
54209-2
|
Hemoglobin C - Harlem/Hemoglobin.total in Blood |
|
4565-8
|
Hemoglobin Chesapeake [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4566-6
|
Hemoglobin Chesapeake [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
48035-0
|
Hemoglobin [Presence] in Cerebral spinal fluid |
|
719-5
|
Hemoglobin [Mass/volume] in Cerebral spinal fluid |
|
4567-4
|
Hemoglobin Constant Spring [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4568-2
|
Hemoglobin Constant Spring [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
55372-7
|
Hemoglobin Constant Spring/Hemoglobin.total in Blood |
|
4569-0
|
Hemoglobin D/Hemoglobin.total in Blood |
|
44921-5
|
Hemoglobin D/Hemoglobin.total in Blood by HPLC |
|
54070-8
|
Hemoglobin D/Hemoglobin.total in DBS |
|
71868-4
|
Hemoglobin D/Hemoglobin.total [Pure mass fraction] in Blood |
|
71867-6
|
Hemoglobin D/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
55373-5
|
Hemoglobin D+G/Hemoglobin.total in Blood |
|
4572-4
|
Hemoglobin Denver [Presence] in Blood |
|
4571-6
|
Hemoglobin D - Punjab [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4570-8
|
Hemoglobin D - Punjab [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
40546-4
|
Hemoglobin E [Presence] in Blood by Electrophoresis |
|
4575-7
|
Hemoglobin E/Hemoglobin.total in Blood |
|
4573-2
|
Hemoglobin E/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3) |
|
4574-0
|
Hemoglobin E/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
|
44922-3
|
Hemoglobin E/Hemoglobin.total in Blood by HPLC |
|
54071-6
|
Hemoglobin E/Hemoglobin.total in DBS |
|
71866-8
|
Hemoglobin E/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
73895-5
|
Hemoglobin [Entitic substance] in Reticulocytes by Automated count |
|
28067-7
|
Hemoglobin F [Presence] in Amniotic fluid |
|
9749-3
|
Hemoglobin F [Units/volume] in Blood by Electrophoresis |
|
40549-8
|
Hemoglobin F [Mass/volume] in Blood by Electrophoresis |
|
4579-9
|
Hemoglobin F [Presence] in Blood |
|
4632-6
|
Hemoglobin F [Presence] in Blood by Alkali denaturation |
|
32140-6
|
Hemoglobin F [Presence] in Blood by Kleihauer-Betke method |
|
53857-9
|
Hemoglobin F [Mass/volume] in Blood |
|
14276-0
|
Hemoglobin F distribution [Interpretation] in Blood by Kleihauer-Betke method |
|
18277-4
|
Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method |
|
18278-2
|
Hemoglobin F [Presence] in Meconium by Apt-Downey method |
|
5913-9
|
Hemoglobin F/Hemoglobin.total in Amniotic fluid |
|
4576-5
|
Hemoglobin F/Hemoglobin.total in Blood |
|
32682-7
|
Hemoglobin F/Hemoglobin.total in Blood by Electrophoresis |
|
38524-5
|
Hemoglobin F/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9) |
|
42246-9
|
Hemoglobin F/Hemoglobin.total in Blood by HPLC |
|
4633-4
|
Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method |
|
18291-5
|
Hemoglobin F/Hemoglobin.total in Blood from Newborn |
|
54074-0
|
Hemoglobin F/Hemoglobin.total in DBS |
|
71865-0
|
Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
|
71864-3
|
Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
71863-5
|
Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by Kleihauer-Betke method |
|
4631-8
|
Hemoglobin F [Presence] in Stool by Apt-Downey method |
|
28006-5
|
Hemoglobin F [Presence] in Vomitus |
|
30074-9
|
Hemoglobin F [Presence] in Unspecified specimen |
|
40721-3
|
Hemoglobin F [Presence] in Unspecified specimen by Apt-Downey method |
|
4580-7
|
Hemoglobin F1/Hemoglobin.total in Blood |
|
33517-4
|
Hemoglobin [Presence] in Body fluid |
|
33509-1
|
Hemoglobin [Mass/volume] in Body fluid |
|
78748-1
|
Hemoglobin pattern [Interpretation] in Blood by Capillary electrophoresis (CE) |
|
13515-2
|
Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar Narrative |
|
49323-9
|
Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar |
|
50791-3
|
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis acid (pH 6.0) |
|
13514-5
|
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative |
|
49316-3
|
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis |
|
42247-7
|
Hemoglobin pattern [Interpretation] in Blood by HPLC Narrative |
|
49322-1
|
Hemoglobin pattern [Interpretation] in Blood by HPLC |
|
12710-0
|
Hemoglobin pattern [Interpretation] in Blood |
|
49317-1
|
Hemoglobin pattern [Interpretation] in Blood Narrative |
|
54103-7
|
Hemoglobin pattern in DBS by Electrophoresis |
|
54104-5
|
Hemoglobin pattern in DBS by HPLC |
|
54105-2
|
Hemoglobin pattern in DBS by Isoelectric focusing |
|
49000-3
|
Free Hemoglobin [Presence] in Cerebral spinal fluid |
|
89364-4
|
Free Hemoglobin [Mass/volume] in Body fluid |
|
48711-6
|
Free Hemoglobin [Mass/volume] in Plasma --after transfusion reaction |
|
720-3
|
Free Hemoglobin [Presence] in Plasma |
|
721-1
|
Free Hemoglobin [Mass/volume] in Plasma |
|
25433-4
|
Free Hemoglobin [Moles/volume] in Plasma |
|
4635-9
|
Free Hemoglobin [Mass/volume] in Serum |
|
33411-0
|
Free Hemoglobin [Presence] in Urine |
|
4636-7
|
Free Hemoglobin [Mass/volume] in Urine |
|
4578-1
|
Hemoglobin F - Texas [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4577-3
|
Hemoglobin F - Texas [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
53223-4
|
Hemoglobin G/Hemoglobin.total in Blood |
|
4582-3
|
Hemoglobin G - Coushatta [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4581-5
|
Hemoglobin G - Coushatta [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
33593-5
|
Hemoglobin G - Coushatta/Hemoglobin.total in Blood |
|
4583-1
|
Hemoglobin G - Georgia [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4584-9
|
Hemoglobin G - Georgia [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
86912-3
|
Hemoglobin goal [Mass/volume] Blood |
|
4585-6
|
Hemoglobin G - Philadelphia [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4586-4
|
Hemoglobin G - Philadelphia [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
80655-4
|
Hemoglobin G - Philadelphia/Hemoglobin.total in Blood |
|
40550-6
|
Hemoglobin H [Mass/volume] in Blood by Electrophoresis |
|
40547-2
|
Hemoglobin H [Presence] in Blood |
|
17871-5
|
Hemoglobin H [Presence] in Blood by Heat denaturation |
|
59185-9
|
Hemoglobin H inclusion bodies [Presence] in Blood |
|
4588-0
|
Hemoglobin H/Hemoglobin.total in Blood |
|
4587-2
|
Hemoglobin H/Hemoglobin.total in Blood by Electrophoresis |
|
71862-7
|
Hemoglobin H/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
|
4589-8
|
Hemoglobin Hasharon [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4590-6
|
Hemoglobin Hasharon [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
50765-7
|
Hemoglobin Hasharon/Hemoglobin.total in Blood by Electrophoresis |
|
4591-4
|
Hemoglobin Hope [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4592-2
|
Hemoglobin Hope [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
80656-2
|
Hemoglobin Hope/Hemoglobin.total in Blood |
|
4593-0
|
Hemoglobin I [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4594-8
|
Hemoglobin I [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
51613-8
|
Hemoglobin J/Hemoglobin.total in Blood |
|
4595-5
|
Hemoglobin J - Baltimore [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4596-3
|
Hemoglobin J - Baltimore [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4597-1
|
Hemoglobin J - Capetown [Presence] in Blood |
|
4598-9
|
Hemoglobin J - Oxford [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4599-7
|
Hemoglobin J - Oxford [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4600-3
|
Hemoglobin Kansas [Presence] in Blood |
|
4601-1
|
Hemoglobin Kempsey [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4602-9
|
Hemoglobin Kempsey [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4603-7
|
Hemoglobin Koln [Presence] in Blood |
|
4604-5
|
Hemoglobin Lepore [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4605-2
|
Hemoglobin Lepore [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
35125-4
|
Hemoglobin Lepore/Hemoglobin.total in Blood |
|
71861-9
|
Hemoglobin Lepore/Hemoglobin.total [Pure mass fraction] in Blood |
|
53224-2
|
Hemoglobin M [Presence] in Blood |
|
51614-6
|
Hemoglobin M/Hemoglobin.total in Blood |
|
71860-1
|
Hemoglobin M/Hemoglobin.total [Pure mass fraction] in Blood |
|
4611-0
|
Hemoglobin Malmo [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4612-8
|
Hemoglobin Malmo [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4606-0
|
Hemoglobin M - Boston [Presence] in Blood |
|
4607-8
|
Hemoglobin M - Hyde Park [Presence] in Blood |
|
4608-6
|
Hemoglobin M - Iwate [Presence] in Blood |
|
4609-4
|
Hemoglobin M - Milwaukee [Presence] in Blood |
|
4610-2
|
Hemoglobin M - Saskatoon [Presence] in Blood |
|
55374-3
|
Hemoglobin N+I/Hemoglobin.total in Blood |
|
4613-6
|
Hemoglobin N - Baltimore [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4614-4
|
Hemoglobin N - Baltimore [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4615-1
|
Hemoglobin N - Seattle [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4616-9
|
Hemoglobin N - Seattle [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
4617-7
|
Hemoglobin O - Arab [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4618-5
|
Hemoglobin O - Arab [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
35126-2
|
Hemoglobin O - Arab/Hemoglobin.total in Blood |
|
54068-2
|
Hemoglobin O - Arab/Hemoglobin.total in DBS |
|
73984-7
|
Hemoglobin.other [Type] in Blood |
|
48343-8
|
Hemoglobin.other/Hemoglobin.total in Blood |
|
32017-6
|
Hemoglobin.other/Hemoglobin.total in Blood by Electrophoresis |
|
42248-5
|
Hemoglobin.other/Hemoglobin.total in Blood by HPLC |
|
71855-1
|
Hemoglobin.other/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
|
71856-9
|
Hemoglobin.other/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
69950-4
|
Hemoglobin [Mass/volume] in Pericardial fluid |
|
35183-3
|
Hemoglobin [Mass or Moles/volume] in Plasma |
|
722-9
|
Hemoglobin [Mass/volume] in Pleural fluid |
|
48725-6
|
Hemoglobin [Mass/volume] in Blood --pre therapeutic phlebotomy |
|
723-7
|
Hemoglobin [Mass/volume] in Peritoneal fluid |
|
4619-3
|
Hemoglobin Ranier [Presence] in Blood |
|
42810-2
|
Hemoglobin [Entitic mass] in Reticulocytes |
|
71694-4
|
Hemoglobin [Entitic mass] in Reticulocytes by Automated count |
|
34663-5
|
Hemoglobin S [Presence] in Amniotic fluid |
|
4621-9
|
Hemoglobin S [Presence] in Blood |
|
4622-7
|
Hemoglobin S [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4623-5
|
Hemoglobin S [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
6864-3
|
Hemoglobin S [Presence] in Blood by Solubility test |
|
4625-0
|
Hemoglobin S/Hemoglobin.total in Blood |
|
32683-5
|
Hemoglobin S/Hemoglobin.total in Blood by Electrophoresis |
|
44923-1
|
Hemoglobin S/Hemoglobin.total in Blood by HPLC |
|
56476-5
|
Hemoglobin S/Hemoglobin.total in DBS |
|
71857-7
|
Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood |
|
71859-3
|
Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis |
|
71858-5
|
Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
12712-6
|
Hemoglobin S+D+G region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
724-5
|
Hemoglobin [Mass/volume] in Synovial fluid |
|
34743-5
|
Stable Hemoglobin [Presence] in Blood by Isopropanol stability |
|
4638-3
|
Thermolabile hemoglobin/Hemoglobin.total in Red Blood Cells |
|
53117-8
|
Thermolabile hemoglobin [Presence] in Red Blood Cells |
|
4639-1
|
Unstable Hemoglobin [Presence] in Red Blood Cells |
|
41619-8
|
Unstable Hemoglobin [Presence] in Red Blood Cells by Isopropanol stability |
|
725-2
|
Hemoglobin [Presence] in Urine |
|
5794-3
|
Hemoglobin [Presence] in Urine by Test strip |
|
57751-0
|
Hemoglobin [Presence] in Urine by Automated test strip |
|
50559-4
|
Hemoglobin [Mass/volume] in Urine by Automated test strip |
|
49137-3
|
Hemoglobin [Mass/volume] in Urine by Test strip |
|
726-0
|
Hemoglobin [Mass/volume] in Urine |
|
24469-9
|
Hemoglobin XXX/Hemoglobin.total in Blood by Electrophoresis |
|
34618-9
|
Hemoglobin [Presence] in Unspecified specimen |
|
4626-8
|
Hemoglobin Yakima [Presence] in Blood |
|
4627-6
|
Hemoglobin Yoshizuka [Presence] in Blood |
|
4628-4
|
Hemoglobin Ypsilanti [Presence] in Blood |
|
4629-2
|
Hemoglobin Zurich [Presence] in Blood by Electrophoresis acid (pH 6.3) |
|
4630-0
|
Hemoglobin Zurich [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
|
43981-0
|
Choriogonadotropin.intact [Multiple of the median] adjusted in Serum or Plasma |
|
43801-0
|
Choriogonadotropin.intact [Units/volume] in Amniotic fluid |
|
48625-8
|
Choriogonadotropin.intact [Presence] in Body fluid |
|
43982-8
|
Choriogonadotropin.intact [Multiple of the median] in Serum or Plasma |
|
2116-2
|
Choriogonadotropin.intact [Presence] in Serum or Plasma |
|
30243-0
|
Choriogonadotropin.intact [Units/volume] in Serum or Plasma |
|
2117-0
|
Choriogonadotropin.intact [Moles/volume] in Serum or Plasma |
|
16617-3
|
Choriogonadotropin.intact [Moles/volume] in Semen |
|
45194-8
|
Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma |
|
93769-8
|
Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma |
|
81826-0
|
HGD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79394-3
|
Hepatocyte growth factor [Mass/volume] in Serum or Plasma |
|
77173-3
|
Hepatocyte growth factor receptor Ag [Presence] in Tissue by Immune stain |
|
49777-6
|
Hepatitis G virus Ab [Units/volume] in Serum |
|
55166-3
|
Hepatitis G virus E2 Ab [Presence] in Serum |
|
16937-5
|
Hepatitis G virus RNA [Presence] in Serum by NAA with probe detection |
|
81303-0
|
HGVS version [ID] |
|
19742-6
|
Hexahydrophthalic anhydride (HHPA) IgE Ab [Units/volume] in Serum |
|
26026-5
|
Hexahydrophthalic anhydride (HHPA) IgE Ab RAST class [Presence] in Serum |
|
62481-7
|
Herpes virus 6A DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
62483-3
|
Herpes virus 6A DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
62485-8
|
Herpes virus 6A DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62482-5
|
Herpes virus 6B DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
62484-1
|
Herpes virus 6B DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
62486-6
|
Herpes virus 6B DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20445-3
|
Herpes virus identified in Unspecified specimen by Organism specific culture |
|
43695-6
|
Herpes virus identified in Unspecified specimen by Shell vial culture |
|
51704-5
|
Herpes virus 6 Ab [Units/volume] in Serum by Immunoassay |
|
44519-7
|
Herpes virus 6 Ab [Presence] in Serum |
|
53378-6
|
Herpes virus 6 Ab [Units/volume] in Serum |
|
49387-4
|
Herpes virus 6 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49391-6
|
Herpes virus 6 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49388-2
|
Herpes virus 6 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49389-0
|
Herpes virus 6 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49392-4
|
Herpes virus 6 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49390-8
|
Herpes virus 6 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49393-2
|
Herpes virus 6 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
38349-7
|
Herpes virus 6 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
33941-6
|
Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection |
|
82192-6
|
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
33942-4
|
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
86543-6
|
Herpes virus 6 DNA [Presence] in Bone marrow by NAA with probe detection |
|
43244-3
|
Herpes virus 6 DNA [Presence] in Serum by NAA with probe detection |
|
47410-6
|
Herpes virus 6 DNA [Identifier] in Serum or Plasma by NAA with probe detection |
|
33940-8
|
Herpes virus 6 DNA [Presence] in Tissue by NAA with probe detection |
|
38348-9
|
Herpes virus 6 DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
38350-5
|
Herpes virus 6 DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
29495-9
|
Herpes virus 6 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44520-5
|
Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid |
|
31414-6
|
Herpes virus 6 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
41148-8
|
Herpes virus 6 IgG Ab [Presence] in Serum |
|
40730-4
|
Herpes virus 6 IgG Ab [Presence] in Serum by Immunoassay |
|
44521-3
|
Herpes virus 6 IgG Ab [Presence] in Serum by Immunofluorescence |
|
5211-8
|
Herpes virus 6 IgG Ab [Units/volume] in Serum |
|
43024-9
|
Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid |
|
27168-4
|
Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
41496-1
|
Herpes virus 6 IgG Ab [Titer] in Serum |
|
34179-2
|
Herpes virus 6 IgG Ab [Titer] in Serum by Immunoassay |
|
25416-9
|
Herpes virus 6 IgG Ab [Titer] in Serum by Immunofluorescence |
|
13250-6
|
Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum |
|
51730-0
|
Herpes virus 6 IgG and IgM [Interpretation] in Serum Narrative |
|
42915-9
|
Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid |
|
31415-3
|
Herpes virus 6 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
41147-0
|
Herpes virus 6 IgM Ab [Presence] in Serum |
|
40731-2
|
Herpes virus 6 IgM Ab [Presence] in Serum by Immunoassay |
|
5212-6
|
Herpes virus 6 IgM Ab [Units/volume] in Serum |
|
43025-6
|
Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid |
|
27159-3
|
Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
32182-8
|
Herpes virus 6 IgM Ab [Titer] in Serum |
|
25417-7
|
Herpes virus 6 IgM Ab [Titer] in Serum by Immunofluorescence |
|
49395-7
|
Herpes virus 7 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49398-1
|
Herpes virus 7 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49400-5
|
Herpes virus 7 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49396-5
|
Herpes virus 7 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49397-3
|
Herpes virus 7 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49401-3
|
Herpes virus 7 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49394-0
|
Herpes virus 7 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49399-9
|
Herpes virus 7 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86544-4
|
Herpes virus 7 DNA [Presence] in Blood by NAA with probe detection |
|
44423-2
|
Herpes virus 7 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31416-1
|
Herpes virus 7 IgG Ab [Units/volume] in Serum |
|
43023-1
|
Herpes virus 7 IgG Ab [Titer] in Serum |
|
26972-0
|
Herpes virus 7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
31417-9
|
Herpes virus 7 IgM Ab [Units/volume] in Serum |
|
43022-3
|
Herpes virus 7 IgM Ab [Titer] in Serum |
|
27177-5
|
Herpes virus 7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
39083-1
|
Herpes virus 8 Ab [Presence] in Serum |
|
49409-6
|
Herpes virus 8 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49406-2
|
Herpes virus 8 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49407-0
|
Herpes virus 8 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49408-8
|
Herpes virus 8 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49404-7
|
Herpes virus 8 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49402-1
|
Herpes virus 8 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49405-4
|
Herpes virus 8 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49403-9
|
Herpes virus 8 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86545-1
|
Herpes virus 8 DNA [Presence] in Blood by NAA with probe detection |
|
49102-7
|
Herpes virus 8 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
32364-2
|
Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
86546-9
|
Herpes virus 8 DNA [Presence] in Tissue by NAA with probe detection |
|
51826-6
|
Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunoassay |
|
42508-2
|
Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
41146-2
|
Herpes virus 8 IgG Ab [Presence] in Serum |
|
40834-4
|
Herpes virus 8 IgG Ab [Presence] in Serum by Immunofluorescence |
|
43021-5
|
Herpes virus 8 IgG Ab [Units/volume] in Serum |
|
68950-5
|
Herpes virus 8 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47442-9
|
Herpes virus 8 IgG Ab [Titer] in Serum |
|
47050-0
|
Herpes virus 8 IgG Ab [Titer] in Serum by Immunofluorescence |
|
49176-1
|
Herpes virus 8 IgM Ab [Titer] in Serum |
|
48358-6
|
Herpes virus 8 IgM Ab [Titer] in Serum by Immunofluorescence |
|
49480-7
|
Herpes virus 8 latent nuclear Ag [Presence] in Tissue by Immune stain |
|
30938-5
|
Haemophilus influenzae B dose count in combination vaccine |
|
82216-3
|
3-Hydroxyisobutyrate dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
82217-1
|
3-Hydroxyisobutyryl-CoA hydrolase [Enzymatic activity/mass] in Fibroblast |
|
81905-2
|
High biological value protein intake 24 hour Estimated |
|
81906-0
|
High biological value protein intake 24 hour Measured |
|
76190-8
|
High pressure hold time setting Ventilator |
|
76191-6
|
High pressure hold time Ventilator |
|
82589-3
|
Highest level of education |
|
80913-7
|
Highest level of education [US Standard Certificate of Death] |
|
87300-0
|
Highest level of education Father |
|
76378-9
|
Highest level of education in a non-nursing degree Provider [NMMDS] |
|
76374-8
|
Highest level of education in a nursing degree Provider [NMMDS] |
|
57712-2
|
Highest level of education Mother |
|
76505-7
|
Highest pressure ulcer stage NPUAP |
|
90266-8
|
Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment |
|
41323-7
|
Hip - left Abduction Active Range of Motion Quantitative |
|
41324-5
|
Hip - left Abduction Passive Range of Motion Quantitative |
|
41325-2
|
Hip - left Adduction Active Range of Motion Quantitative |
|
41326-0
|
Hip - left Adduction Passive Range of Motion Quantitative |
|
41321-1
|
Hip - left Extension Active Range of Motion Quantitative |
|
41322-9
|
Hip - left Extension Passive Range of Motion Quantitative |
|
41329-4
|
Hip - left External rotation Active Range of Motion Quantitative |
|
41330-2
|
Hip - left External rotation Passive Range of Motion Quantitative |
|
41319-5
|
Hip - left Flexion Active Range of Motion Quantitative |
|
41320-3
|
Hip - left Flexion Passive Range of Motion Quantitative |
|
41327-8
|
Hip - left Internal rotation Active Range of Motion Quantitative |
|
41328-6
|
Hip - left Internal rotation Passive Range of Motion Quantitative |
|
2413-3
|
Hippuran renal clearance in 24 hour Urine and Serum or Plasma |
|
2414-1
|
Hippurate [Mass/time] in 24 hour Urine |
|
25161-1
|
Hippurate crystals [#/area] in Urine sediment by Microscopy high power field |
|
45385-2
|
Hippurate crystals [#/area] in Urine sediment by Microscopy low power field |
|
5795-0
|
Hippurate crystals [Presence] in Urine sediment by Light microscopy |
|
4274-7
|
Hippurate [Mass] of Dose |
|
75069-5
|
Hippurate [Moles/volume] in Serum or Plasma |
|
26833-4
|
Hippurate [Presence] in Urine |
|
6709-0
|
Hippurate [Mass/volume] in Urine |
|
44370-5
|
Hippurate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56649-7
|
Hippurate/Creatinine [Ratio] in 24 hour Urine |
|
49903-8
|
Hippurate/Creatinine [Molar ratio] in 24 hour Urine |
|
13754-7
|
Hippurate/Creatinine [Mass Ratio] in Urine |
|
29528-7
|
Hippurate/Creatinine [Molar ratio] in Urine |
|
41335-1
|
Hip - right Abduction Active Range of Motion Quantitative |
|
41336-9
|
Hip - right Abduction Passive Range of Motion Quantitative |
|
41337-7
|
Hip - right Adduction Active Range of Motion Quantitative |
|
41338-5
|
Hip - right Adduction Passive Range of Motion Quantitative |
|
41333-6
|
Hip - right Extension Active Range of Motion Quantitative |
|
41334-4
|
Hip - right Extension Passive Range of Motion Quantitative |
|
41341-9
|
Hip - right External rotation Active Range of Motion Quantitative |
|
41342-7
|
Hip - right External rotation Passive Range of Motion Quantitative |
|
41331-0
|
Hip - right Flexion Active Range of Motion Quantitative |
|
41332-8
|
Hip - right Flexion Passive Range of Motion Quantitative |
|
41339-3
|
Hip - right Internal rotation Active Range of Motion Quantitative |
|
41340-1
|
Hip - right Internal rotation Passive Range of Motion Quantitative |
|
50746-7
|
Hirudin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
55353-7
|
Hirudin [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
9410-2
|
Histamine [Mass/time] in 24 hour Urine |
|
34317-8
|
Histamine [Moles/volume] in 24 hour Urine |
|
25439-1
|
Histamine [Moles/time] in 24 hour Urine |
|
50857-2
|
Histamine [Moles/volume] in 3 hour Urine |
|
2415-8
|
Histamine [Mass/volume] in Blood |
|
46436-2
|
Histamine [Moles/volume] in Blood |
|
7408-8
|
Histamine extract triggered histamine release [Units/volume] in Blood |
|
2416-6
|
Histamine [Mass/volume] in Serum or Plasma |
|
35260-9
|
Histamine [Mass or Moles/volume] in Serum or Plasma |
|
34316-0
|
Histamine [Moles/volume] in Serum or Plasma |
|
2417-4
|
Histamine [Mass/volume] in Urine |
|
33290-8
|
Histamine [Moles/volume] in Urine |
|
13756-2
|
Histamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
25925-9
|
Histamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13755-4
|
Histamine/Creatinine [Mass Ratio] in Urine |
|
43577-6
|
Histamine/Creatinine [Ratio] in Urine |
|
44371-3
|
Histamine/Creatinine [Molar ratio] in Urine |
|
26808-6
|
Histidine [Presence] in 24 hour Urine |
|
2424-0
|
Histidine [Mass/time] in 24 hour Urine |
|
25926-7
|
Histidine [Moles/volume] in 24 hour Urine |
|
25440-9
|
Histidine [Moles/time] in 24 hour Urine |
|
13398-3
|
Histidine [Mass/volume] in Amniotic fluid |
|
27111-4
|
Histidine [Moles/volume] in Amniotic fluid |
|
2418-2
|
Histidine [Presence] in Blood |
|
2419-0
|
Histidine [Mass/volume] in Blood |
|
9453-2
|
Histidine [Moles/volume] in Cerebral spinal fluid |
|
47643-2
|
Histidine [Moles/volume] in DBS |
|
32246-1
|
Histidine [Moles/volume] in Body fluid |
|
55874-2
|
Histidine [Moles/mass] in Hair |
|
81916-9
|
Histidine intake 24 hour Estimated |
|
81917-7
|
Histidine intake 24 hour Measured |
|
2421-6
|
Histidine [Presence] in Serum or Plasma |
|
27972-9
|
Histidine [Units/volume] in Serum or Plasma |
|
2420-8
|
Histidine [Mass/volume] in Serum or Plasma |
|
20645-8
|
Histidine [Moles/volume] in Serum or Plasma |
|
47646-5
|
Histidine/Amino acids.total in Amniotic fluid |
|
47645-7
|
Histidine/Amino acids.total in Cerebral spinal fluid |
|
47648-1
|
Histidine/Amino acids.total in DBS |
|
47644-0
|
Histidine/Amino acids.total in Hair |
|
47647-3
|
Histidine/Amino acids.total in Serum or Plasma |
|
47649-9
|
Histidine/Amino acids.total in Unspecified specimen |
|
2422-4
|
Histidine [Presence] in Urine |
|
2423-2
|
Histidine [Mass/volume] in Urine |
|
27904-2
|
Histidine [Moles/volume] in Urine |
|
32247-9
|
Histidine [Moles/volume] in Vitreous fluid |
|
22717-3
|
Histidine [Moles/volume] in Unspecified specimen |
|
44372-1
|
Histidine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56683-6
|
Histidine/Creatinine [Ratio] in 24 hour Urine |
|
25927-5
|
Histidine/Creatinine [Molar ratio] in 24 hour Urine |
|
13757-0
|
Histidine/Creatinine [Mass Ratio] in Urine |
|
30047-5
|
Histidine/Creatinine [Ratio] in Urine |
|
22703-3
|
Histidine/Creatinine [Molar ratio] in Urine |
|
35056-1
|
Histiocytes [#/volume] in Cerebral spinal fluid |
|
35057-9
|
Histiocytes [#/volume] in Body fluid |
|
26027-3
|
Histiocytes [#/area] in Urine sediment by Microscopy high power field |
|
44721-9
|
Histiocytes [Presence] in Blood by Light microscopy |
|
44722-7
|
Histiocytes [Presence] in Body fluid by Light microscopy |
|
44723-5
|
Histiocytes [Presence] in Bone marrow by Light microscopy |
|
20504-7
|
Histiocytes/100 cells in Cerebral spinal fluid |
|
20493-3
|
Histiocytes/100 cells in Body fluid by Light microscopy |
|
74453-2
|
Histiocytes/100 cells in Bone marrow |
|
40523-3
|
Histiocytes/100 cells in Pericardial fluid by Manual count |
|
40519-1
|
Histiocytes/100 cells in Pleural fluid by Manual count |
|
40516-7
|
Histiocytes/100 cells in Peritoneal fluid by Manual count |
|
40489-7
|
Histiocytes/100 cells in Synovial fluid by Manual count |
|
13596-2
|
Histiocytes [Presence] in Nose by Light microscopy |
|
38994-0
|
Histiocytes [Presence] in Urine sediment by Light microscopy |
|
35055-3
|
Histiocytes/100 leukocytes in Body fluid |
|
44648-4
|
Histologic grade [Score] in Breast cancer specimen Qualitative by Nottingham |
|
44638-5
|
Histologic type in Breast tumor |
|
84882-0
|
Histologic type in Colorectal cancer specimen by WHO classification |
|
44640-1
|
Histologic type in Skin melanoma |
|
44639-3
|
Histologic type in Prostate tumor |
|
81179-4
|
Histologic type of Stomach cancer by Lauren classification |
|
81190-1
|
Histologic type of Stomach cancer by WHO Classification |
|
73767-6
|
Histological placental examination was performed [US Standard Report of Fetal Death] |
|
33732-9
|
Histology grade [Identifier] in Cancer specimen |
|
33731-1
|
Histology type in Cancer specimen Narrative |
|
63264-6
|
Histone Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89530-0
|
Histone Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63263-8
|
Histone Ab [Presence] in Body fluid by Immunoassay |
|
43231-0
|
Histone Ab [Units/volume] in Serum by Immunoassay |
|
8071-3
|
Histone Ab [Presence] in Serum |
|
58765-9
|
Histone Ab [Presence] in Serum by Immunoassay |
|
56717-2
|
Histone Ab [Presence] in Serum by Immunoblot |
|
5217-5
|
Histone Ab [Presence] in Serum by Immunofluorescence |
|
30359-4
|
Histone Ab [Units/volume] in Serum |
|
16969-8
|
Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence |
|
31424-5
|
Histone H2a+H2b Ab [Presence] in Serum |
|
18231-1
|
Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence |
|
18230-3
|
Histone H2a+H2b Ab [Units/volume] in Serum |
|
29996-6
|
Histone IgG Ab [Units/volume] in Serum by Immunoassay |
|
35284-9
|
Histone IgG Ab [Presence] in Serum |
|
35274-0
|
Histone IgG Ab [Presence] in Serum by Immunoassay |
|
31423-7
|
Histone IgG Ab [Units/volume] in Serum |
|
74065-4
|
History of allergies or sensitivities to the medication or substance administered was documented [AHRQ] |
|
89078-0
|
History of hospitalization--post enrollment in ADAPTABLE study [ADAPTABLE] |
|
33345-0
|
Histrelin [Mass/volume] in Urine |
|
69918-1
|
Thrombin time.high dose in Platelet poor plasma by Coagulation assay |
|
43185-8
|
HIV 1 and 2 Ab band pattern [Interpretation] in Serum by Immunoblot |
|
42768-2
|
HIV 1 and 2 Ab [Interpretation] in Serum Narrative |
|
69668-2
|
HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay |
|
80203-3
|
HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
|
77685-6
|
HIV 1 and 2 IgG Ab [Identifier] in Serum or Plasma by Immunoblot |
|
35564-4
|
HIV 1 p31+p32 Ab [Presence] in Serum by Immunoblot |
|
35565-1
|
HIV 1 p40 Ab [Presence] in Serum by Immunoblot |
|
74854-1
|
HIV 1 proviral DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
78007-2
|
HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection |
|
78009-8
|
HIV 1 proviral DNA [Entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection |
|
44871-2
|
HIV 1 proviral DNA [Presence] in Blood by NAA with probe detection |
|
9837-6
|
HIV 1 proviral DNA [Presence] in Blood by Probe with amplification |
|
88212-6
|
HIV 1 proviral DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
48023-6
|
HIV 1 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
77368-9
|
HIV 1 proviral DNA [Presence] in Semen by NAA with probe detection |
|
78010-6
|
HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection |
|
78008-0
|
HIV 1 proviral DNA [Entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection |
|
74855-8
|
HIV 1 proviral DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74853-3
|
HIV 1 proviral DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80695-0
|
HIV 1 proviral DNA genotype in Mononuclear cells from whole blood |
|
83326-9
|
HIV 1 RNA genotype and phenotype in Isolate |
|
83325-1
|
HIV 1 RNA genotype in Isolate |
|
88542-6
|
HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
90903-6
|
HIV 1 RNA integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
83327-7
|
HIV 1 RNA phenotype in Isolate |
|
88543-4
|
HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
90904-4
|
HIV 1 RNA protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
80689-3
|
HIV 1 RNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Plasma by Sequencing |
|
90901-0
|
HIV 1 RNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
81122-4
|
HIV 1 RNA reverse transcriptase and protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
88544-2
|
HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
90902-8
|
HIV 1 RNA reverse transcriptase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
79380-2
|
HIV 1 RNA+proviral DNA [Presence] in Blood by NAA with probe detection |
|
79379-4
|
HIV 1 RNA+proviral DNA [Presence] in Plasma by NAA with probe detection |
|
87962-7
|
HIV 1 subtype identified in Cerebral spinal fluid by NAA with probe detection |
|
73658-7
|
HIV 1 subtype in Unspecified specimen by NAA with probe detection |
|
58900-2
|
HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
56888-1
|
HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
|
75666-8
|
HIV 1+2 Ab and HIV1 p24 Ag [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
|
38998-1
|
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection |
|
53825-6
|
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
59052-1
|
HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
57975-5
|
HIV 1+O+2 Ab [Presence] in Body fluid |
|
48345-3
|
HIV 1+O+2 Ab [Presence] in Serum or Plasma |
|
48346-1
|
HIV 1+O+2 Ab [Units/volume] in Serum or Plasma |
|
47029-4
|
HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
31073-0
|
HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot |
|
51786-2
|
HIV 2 Ab Signal/Cutoff in Serum or Plasma by Immunoassay |
|
7919-4
|
HIV 2 Ab [Presence] in Serum |
|
5225-8
|
HIV 2 Ab [Presence] in Serum by Immunoblot |
|
22358-6
|
HIV 2 Ab [Units/volume] in Serum |
|
5224-1
|
HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30361-0
|
HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay |
|
81641-3
|
HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
21335-5
|
HIV 2 gp120 Ab [Presence] in Serum by Immunoblot |
|
57976-3
|
HIV 2 gp140 Ab [Presence] in Serum by Immunoblot |
|
33807-9
|
HIV 2 IgG Ab [Presence] in Serum |
|
33806-1
|
HIV 2 IgG Ab [Presence] in Serum by Immunoblot |
|
57977-1
|
HIV 2 p16 Ab [Presence] in Serum by Immunoblot |
|
45212-8
|
HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot |
|
57978-9
|
HIV 2 p34 Ab [Presence] in Serum by Immunoblot |
|
25841-8
|
HIV 2 proviral DNA [Presence] in Blood by NAA with probe detection |
|
34699-9
|
HIV 2 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
25842-6
|
HIV 2 proviral DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86547-7
|
HIV 2 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
86548-5
|
HIV 2 RNA [#/volume] (viral load) in Plasma by NAA with probe detection |
|
86549-3
|
HIV 2 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
69354-9
|
HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
81652-0
|
HIV 2 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
69353-1
|
HIV 2 RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
73659-5
|
HIV 2 subtype in Unspecified specimen by NAA with probe detection |
|
6429-5
|
HIV identified in Blood by Organism specific culture |
|
48558-1
|
HIV genotype [Susceptibility] |
|
49573-9
|
HIV genotype [Susceptibility] in Isolate by Genotype method Narrative |
|
85380-4
|
HIV immunoassay testing algorithm interpretation in Serum, Plasma or Blood |
|
45176-5
|
HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] |
|
45175-7
|
HIV nucleoside reverse transcriptase gene mutations detected [Identifier] |
|
45182-3
|
HIV phenotype [Susceptibility] |
|
33630-5
|
HIV protease gene mutations detected [Identifier] |
|
9836-8
|
HIV proviral DNA [Presence] in Blood by Probe with amplification |
|
86664-0
|
HIV Referral note |
|
72181-1
|
HIV results shared with partner [RHEA] |
|
30554-0
|
HIV reverse transcriptase gene mutations detected [Identifier] |
|
53798-5
|
HIV reverse transcriptase+protease gene mutations detected [Identifier] |
|
34700-5
|
HIV reverse transcriptase+protease gene mutations tested for |
|
6430-3
|
HIV identified in Semen by Organism specific culture |
|
74264-3
|
HIV Summary registry report |
|
6431-1
|
HIV identified in Unspecified specimen by Organism specific culture |
|
41145-4
|
HIV 1 Ab [Presence] in Capillary blood |
|
33866-5
|
HIV 1 Ab [Presence] in Capillary blood by Immunoassay |
|
16974-8
|
HIV 1 Ab [Presence] in Cerebral spinal fluid |
|
57974-8
|
HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
42627-0
|
HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29327-4
|
HIV 1 Ab [Presence] in Body fluid |
|
34591-8
|
HIV 1 Ab [Presence] in Body fluid by Immunoassay |
|
34592-6
|
HIV 1 Ab [Presence] in Body fluid by Immunoblot |
|
13499-9
|
HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot |
|
35438-1
|
HIV 1 Ab [Units/volume] in Saliva (oral fluid) by Immunoassay |
|
41144-7
|
HIV 1 Ab [Presence] in Saliva (oral fluid) |
|
35437-3
|
HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoassay |
|
35439-9
|
HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
41143-9
|
HIV 1 Ab [Units/volume] in Saliva (oral fluid) |
|
21007-0
|
HIV 1 Ab [Presence] in Serum from Donor |
|
43599-0
|
HIV 1 Ab [Units/volume] in Serum by Immunofluorescence |
|
7917-8
|
HIV 1 Ab [Presence] in Serum |
|
14092-1
|
HIV 1 Ab [Presence] in Serum by Immunofluorescence |
|
22356-0
|
HIV 1 Ab [Units/volume] in Serum |
|
5220-9
|
HIV 1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29893-5
|
HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay |
|
5221-7
|
HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot |
|
68961-2
|
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
86233-4
|
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunoblot |
|
85686-4
|
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunofluorescence |
|
32571-2
|
HIV 1 Ab [Presence] in Urine by Immunoblot |
|
53379-4
|
HIV 1 Ab [Presence] in Unspecified specimen |
|
89374-3
|
HIV 1 Ab [Presence] in Unspecified specimen by Immunoassay |
|
49905-3
|
HIV 1 Ab [Presence] in Unspecified specimen by Rapid immunoassay |
|
16977-1
|
HIV 1 Ag [Presence] in Cerebral spinal fluid |
|
44531-2
|
HIV 1 Ag [Presence] in Serum from Donor |
|
24012-7
|
HIV 1 Ag [Presence] in Serum |
|
16976-3
|
HIV 1 Ag [Units/volume] in Serum |
|
5222-5
|
HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay |
|
12893-4
|
HIV 1 gp105 Ab [Presence] in Serum by Immunoblot |
|
35441-5
|
HIV 1 gp120 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
44532-0
|
HIV 1 gp120 Ab [Presence] in Serum |
|
9661-0
|
HIV 1 gp120 Ab [Presence] in Serum by Immunoblot |
|
43013-2
|
HIV 1 gp120+gp160 Ab [Presence] in Serum |
|
14126-7
|
HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot |
|
40439-2
|
HIV 1 gp120+gp160 Ab [Presence] in Serum or Plasma by Immunoassay |
|
35440-7
|
HIV 1 gp160 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
9660-2
|
HIV 1 gp160 Ab [Presence] in Serum by Immunoblot |
|
12870-2
|
HIV 1 gp34 Ab [Presence] in Serum by Immunoblot |
|
35452-2
|
HIV 1 gp40 Ab [Presence] in Serum by Immunoblot |
|
35446-4
|
HIV 1 gp41 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
43012-4
|
HIV 1 gp41 Ab [Presence] in Serum |
|
9662-8
|
HIV 1 gp41 Ab [Presence] in Serum by Immunoblot |
|
40438-4
|
HIV 1 gp41 Ab [Presence] in Serum or Plasma by Immunoassay |
|
19110-6
|
HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot |
|
31430-2
|
HIV 1 IgG Ab [Presence] in Cerebral spinal fluid |
|
28004-0
|
HIV 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
28052-9
|
HIV 1 IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
|
16975-5
|
HIV 1 IgG Ab [Presence] in Serum |
|
40732-0
|
HIV 1 IgG Ab [Presence] in Serum by Immunoblot |
|
61199-6
|
HIV 1 integrase gene mutations detected [Identifier] |
|
12872-8
|
HIV 1 p15 Ab [Presence] in Serum by Immunoblot |
|
16132-3
|
HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot |
|
35449-8
|
HIV 1 p17 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
9663-6
|
HIV 1 p17 Ab [Presence] in Serum by Immunoblot |
|
32842-7
|
HIV 1 p17+p18 Ab [Presence] in Serum |
|
32827-8
|
HIV 1 p17+p18 Ab [Presence] in Serum by Immunoblot |
|
35450-6
|
HIV 1 p18 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
12859-5
|
HIV 1 p18 Ab [Presence] in Serum by Immunoblot |
|
12855-3
|
HIV 1 p23 Ab [Presence] in Serum by Immunoblot |
|
35448-0
|
HIV 1 p24 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
43011-6
|
HIV 1 p24 Ab [Presence] in Serum |
|
9664-4
|
HIV 1 p24 Ab [Presence] in Serum by Immunoblot |
|
16978-9
|
HIV 1 p24 Ab [Units/volume] in Serum |
|
40437-6
|
HIV 1 p24 Ab [Presence] in Serum or Plasma by Immunoassay |
|
21331-4
|
HIV 1 p24 Ab [Titer] in Serum by Immunoblot |
|
49718-0
|
HIV 1 p24 Ag [Presence] in Cerebral spinal fluid |
|
16979-7
|
HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid |
|
9821-0
|
HIV 1 p24 Ag [Presence] in Serum |
|
9665-1
|
HIV 1 p24 Ag [Units/volume] in Serum |
|
44872-0
|
HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay |
|
53601-1
|
HIV 1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
42339-2
|
HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
18396-2
|
HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
|
33660-2
|
HIV 1 p24 Ag [Presence] in Serum or Plasma by Neutralization test |
|
12871-0
|
HIV 1 p26 Ab [Presence] in Serum by Immunoblot |
|
12857-9
|
HIV 1 p28 Ab [Presence] in Serum by Immunoblot |
|
35447-2
|
HIV 1 p31 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
9666-9
|
HIV 1 p31 Ab [Presence] in Serum by Immunoblot |
|
12858-7
|
HIV 1 p32 Ab [Presence] in Serum by Immunoblot |
|
31072-2
|
HIV 1 p41 Ab [Presence] in Serum by Immunoblot |
|
21332-2
|
HIV 1 p41 Ab [Titer] in Serum by Immunoblot |
|
35445-6
|
HIV 1 p51 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
9667-7
|
HIV 1 p51 Ab [Presence] in Serum by Immunoblot |
|
12876-9
|
HIV 1 p53 Ab [Presence] in Serum by Immunoblot |
|
35444-9
|
HIV 1 p55 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
9668-5
|
HIV 1 p55 Ab [Presence] in Serum by Immunoblot |
|
12895-9
|
HIV 1 p58 Ab [Presence] in Serum by Immunoblot |
|
12875-1
|
HIV 1 p64 Ab [Presence] in Serum by Immunoblot |
|
35443-1
|
HIV 1 p65 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
12856-1
|
HIV 1 p65 Ab [Presence] in Serum by Immunoblot |
|
33508-3
|
HIV 1 p65+p66 Ab [Presence] in Serum by Immunoblot |
|
35442-3
|
HIV 1 p66 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
9669-3
|
HIV 1 p66 Ab [Presence] in Serum by Immunoblot |
|
12894-2
|
HIV 1 p68 Ab [Presence] in Serum by Immunoblot |
|
80693-5
|
HIV 1 proviral DNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
|
80694-3
|
HIV 1 proviral DNA genotype [Interpretation] in Mononuclear cells from whole blood Narrative |
|
90900-2
|
HIV 1 proviral DNA integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
|
80691-9
|
HIV 1 proviral DNA integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
|
90899-6
|
HIV 1 proviral DNA reverse transcriptase and protease gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
|
80692-7
|
HIV 1 proviral DNA reverse transcriptase and protease gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
|
90898-8
|
HIV 1 proviral DNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
|
80690-1
|
HIV 1 proviral DNA tropism [Identifier] in Blood mononuclear cells |
|
41498-7
|
HIV 1 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
70241-5
|
HIV 1 RNA [#/volume] (viral load) in Plasma by Probe and target amplification method detection limit = 20 copies/mL |
|
59419-2
|
HIV 1 RNA [#/volume] (viral load) in Plasma by Probe with signal amplification |
|
21333-0
|
HIV 1 RNA [#/volume] in Serum |
|
48551-6
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 400 copies/mL |
|
48511-0
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL |
|
20447-9
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
21008-8
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe |
|
41513-3
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 400 copies/mL |
|
41515-8
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 75 copies/mL |
|
25836-8
|
HIV 1 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5017-9
|
HIV 1 RNA [Presence] in Blood by NAA with probe detection |
|
41497-9
|
HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
42917-5
|
HIV 1 RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
23876-6
|
HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification |
|
29539-4
|
HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification |
|
24013-5
|
HIV 1 RNA [Interpretation] in Serum |
|
47359-5
|
HIV 1 RNA [Presence] in Serum or Plasma from Donor by Probe with amplification |
|
51780-5
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 0.5 log copies/mL |
|
48510-2
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/mL |
|
48552-4
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 2.6 log copies/mL |
|
62469-2
|
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
29541-0
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
41516-6
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 1.9 log copies/mL |
|
41514-1
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 2.6 log copies/mL |
|
10351-5
|
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
|
25835-0
|
HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
77369-7
|
HIV 1 RNA [Presence] in Semen by NAA with probe detection |
|
87963-5
|
HIV 1 RNA tropism [Identifier] in Cerebral spinal fluid |
|
50790-5
|
HIV 1 RNA tropism [Identifier] |
|
80688-5
|
HIV 1 RNA tropism [Identifier] in Plasma |
|
57182-8
|
HIV 1 RNA tropism [Identifier] in Plasma Narrative |
|
49890-7
|
HIV 1 RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5018-7
|
HIV 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44607-0
|
HIV 1 [Interpretation] in Serum or Plasma by Immunoassay |
|
49483-1
|
HIV 1 [Interpretation] in Serum or Plasma by Immunoassay Narrative |
|
53923-9
|
HIV 1 tropism [Identifier] in Blood Narrative |
|
32602-5
|
HIV 1+2 Ab [Presence] in Cerebral spinal fluid |
|
44533-8
|
HIV 1+2 Ab [Presence] in Serum from Donor |
|
7918-6
|
HIV 1+2 Ab [Presence] in Serum |
|
44873-8
|
HIV 1+2 Ab [Presence] in Serum by Immunoblot |
|
22357-8
|
HIV 1+2 Ab [Units/volume] in Serum |
|
5223-3
|
HIV 1+2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
31201-7
|
HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay |
|
80387-4
|
HIV 1+2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
43010-8
|
HIV 1+2 Ab [Presence] in Unspecified specimen |
|
42600-7
|
HIV 1+2 Ab [Presence] in Unspecified specimen by Immunoassay |
|
49580-4
|
HIV 1+2 Ab [Presence] in Unspecified specimen by Rapid immunoassay |
|
73906-0
|
HIV 1+2 IgG Ab [Presence] in Blood by Rapid immunoassay |
|
54086-4
|
HIV 1+2 IgG Ab [Presence] in DBS |
|
43009-0
|
HIV 1+2 IgG Ab [Presence] in Serum |
|
40733-8
|
HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
73905-2
|
HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Rapid immunoassay |
|
43008-2
|
HIV 1+2 IgM Ab [Units/volume] in Serum |
|
41290-8
|
HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
85361-4
|
HIV 1+2 RNA [Presence] in Blood by NAA with probe detection |
|
85368-9
|
HIV 1+2 RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
74856-6
|
HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
88453-6
|
HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection |
|
21334-8
|
HIV 2 gp105 Ab [Presence] in Serum by Immunoblot |
|
10901-7
|
HIV 2 gp125 Ab [Presence] in Serum by Immunoblot |
|
21336-3
|
HIV 2 gp15 Ab [Presence] in Serum by Immunoblot |
|
21337-1
|
HIV 2 gp34 Ab [Presence] in Serum by Immunoblot |
|
10902-5
|
HIV 2 gp36 Ab [Presence] in Serum by Immunoblot |
|
11078-3
|
HIV 2 gp80 Ab [Presence] in Serum by Immunoblot |
|
62456-9
|
HIV 2 p15 Ab [Presence] in Serum by Immunoblot |
|
11079-1
|
HIV 2 p26 Ab [Presence] in Serum by Immunoblot |
|
21338-9
|
HIV 2 p31 Ab [Presence] in Serum by Immunoblot |
|
13920-4
|
HIV 2 p41 Ab [Presence] in Serum by Immunoblot |
|
11080-9
|
HIV 2 p53 Ab [Presence] in Serum by Immunoblot |
|
21339-7
|
HIV 2 p55 Ab [Presence] in Serum by Immunoblot |
|
11081-7
|
HIV 2 p56 Ab [Presence] in Serum by Immunoblot |
|
21340-5
|
HIV 2 p58 Ab [Presence] in Serum by Immunoblot |
|
11082-5
|
HIV 2 p68 Ab [Presence] in Serum by Immunoblot |
|
31420-3
|
Highlands J virus Ab [Units/volume] in Cerebral spinal fluid |
|
31421-1
|
Highlands J virus Ab [Units/volume] in Serum |
|
29835-6
|
Highlands J virus Ab [Titer] in Cerebral spinal fluid |
|
29797-8
|
Highlands J virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
29847-1
|
Highlands J virus Ab [Titer] in Serum |
|
29810-9
|
Highlands J virus Ab [Titer] in Serum by Neutralization test |
|
29823-2
|
Highlands J virus Ab [Titer] in Unspecified specimen |
|
29784-6
|
Highlands J virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
31422-9
|
Highlands J virus Ab [Units/volume] in Unspecified specimen |
|
51643-5
|
Reticulocytes.high light scatter [#/volume] in Blood |
|
51642-7
|
Reticulocytes.high light scatter/Reticulocytes.total in Blood |
|
34960-5
|
HLA Ab [Identifier] |
|
45153-4
|
HLA Ab in Serum |
|
35471-2
|
HLA Ab [Presence] |
|
50968-7
|
HLA Ab [Type] in Serum |
|
44534-6
|
HLA Ab [Presence] in Serum |
|
41618-0
|
HLA Ab [Presence] in Serum by Flow cytometry (FC) |
|
48501-1
|
HLA Ab [Presence] in Serum by Immunoassay |
|
40734-6
|
HLA Ab [Units/volume] in Serum |
|
4693-8
|
HLA Ag absent [Identifier] |
|
4694-6
|
HLA Ag present [Identifier] |
|
4692-0
|
HLA Ag [Units/mass] in Tissue |
|
42675-9
|
HLA Ag [Interpretation] |
|
77640-1
|
HLA class I and II IgG Ab in Serum or Plasma by Immunoassay [interpretation] Narrative |
|
59586-8
|
HLA IgG Ab [Presence] in Serum by Immunofluorescence |
|
13298-5
|
HLA-A [Type] |
|
57290-9
|
HLA-A [Type] by High resolution |
|
77641-9
|
HLA-A IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
38548-4
|
HLA-A locus [Type] |
|
78014-8
|
HLA-A [Type] by Low resolution |
|
45025-4
|
HLA-A SBT [Type] by High resolution |
|
79712-6
|
HLA-A*31:01 [Presence] in Blood or Tissue |
|
13300-9
|
HLA-A+B [Type] |
|
13301-7
|
HLA-A+B+Bw [Type] |
|
51937-1
|
HLA-A+B+Bw+DR [Type] |
|
51938-9
|
HLA-A+B+Bw+DR [Type] in Donor |
|
13303-3
|
HLA-A+B+C (class I) [Type] |
|
46994-0
|
HLA-A+B+C (class I) Ab in Serum |
|
49555-6
|
HLA-A+B+C (class I) Ag [Presence] in Tissue by Immune stain |
|
72328-8
|
HLA-A+B+C (class I) IgG Ab [Presence] in Serum by Flow cytometry (FC) |
|
72322-1
|
HLA-A+B+C (class I) IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
53767-0
|
HLA-A+B+C SBT [Interpretation] by High resolution |
|
4717-5
|
HLA-A1 [Presence] in Donor |
|
4718-3
|
HLA-A1 [Presence] |
|
4713-4
|
HLA-A10 [Presence] in Donor |
|
4714-2
|
HLA-A10 [Presence] |
|
4715-9
|
HLA-A11 [Presence] in Donor |
|
4716-7
|
HLA-A11 [Presence] |
|
4695-3
|
HLA-A19 [Presence] in Donor |
|
4696-1
|
HLA-A19 [Presence] |
|
4730-8
|
HLA-A2 [Presence] in Donor |
|
4731-6
|
HLA-A2 [Presence] |
|
45026-2
|
HLA-A2 SBT [Type] by High resolution |
|
4719-1
|
HLA-A23(9) [Presence] in Donor |
|
4720-9
|
HLA-A23(9) [Presence] |
|
4721-7
|
HLA-A24(9) [Presence] in Donor |
|
18394-7
|
HLA-A24(9) [Presence] |
|
4722-5
|
HLA-A25(10) [Presence] in Donor |
|
4723-3
|
HLA-A25(10) [Presence] |
|
4724-1
|
HLA-A26(10) [Presence] in Donor |
|
4725-8
|
HLA-A26(10) [Presence] |
|
4726-6
|
HLA-A28 [Presence] in Donor |
|
4727-4
|
HLA-A28 [Presence] |
|
44724-3
|
HLA-A29 [Presence] |
|
4728-2
|
HLA-A29(19) [Presence] in Donor |
|
4729-0
|
HLA-A29(19) [Presence] |
|
4738-1
|
HLA-A3 [Presence] in Donor |
|
4739-9
|
HLA-A3 [Presence] |
|
4732-4
|
HLA-A30(19) [Presence] in Donor |
|
4733-2
|
HLA-A30(19) [Presence] |
|
4734-0
|
HLA-A31(19) [Presence] in Donor |
|
4735-7
|
HLA-A31(19) [Presence] |
|
4736-5
|
HLA-A32(19) [Presence] in Donor |
|
4737-3
|
HLA-A32(19) [Presence] |
|
4697-9
|
HLA-A33(19) [Presence] in Donor |
|
4698-7
|
HLA-A33(19) [Presence] |
|
4699-5
|
HLA-A34(10) [Presence] in Donor |
|
4700-1
|
HLA-A34(10) [Presence] |
|
4701-9
|
HLA-A36 [Presence] in Donor |
|
4702-7
|
HLA-A36 [Presence] |
|
4703-5
|
HLA-A43 [Presence] in Donor |
|
4704-3
|
HLA-A43 [Presence] |
|
4705-0
|
HLA-A66(10) [Presence] in Donor |
|
4706-8
|
HLA-A66(10) [Presence] |
|
4707-6
|
HLA-A68(28) [Presence] in Donor |
|
4708-4
|
HLA-A68(28) [Presence] |
|
4709-2
|
HLA-A69(28) [Presence] in Donor |
|
4710-0
|
HLA-A69(28) [Presence] |
|
4711-8
|
HLA-A74(19) [Presence] in Donor |
|
4712-6
|
HLA-A74(19) [Presence] |
|
4740-7
|
HLA-A9 [Presence] in Donor |
|
4741-5
|
HLA-A9 [Presence] |
|
13299-3
|
HLA-B [Type] |
|
57291-7
|
HLA-B [Type] by High resolution |
|
77642-7
|
HLA-B IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
38546-8
|
HLA-B locus [Type] |
|
78015-5
|
HLA-B [Type] by Low resolution |
|
51650-0
|
HLA-B [Interpretation] by NAA with probe detection |
|
45028-8
|
HLA-B SBT [Type] by High resolution |
|
58039-9
|
HLA-B SBT [Type] in Bone marrow by High resolution |
|
4754-8
|
HLA-B w4 [Presence] in Donor |
|
4755-5
|
HLA-B w4 [Presence] |
|
53937-9
|
HLA-B w4+w6 [Type] in Leukocytes |
|
4788-6
|
HLA-B w6 [Presence] in Donor |
|
4789-4
|
HLA-B w6 [Presence] |
|
57979-7
|
HLA-B*15:02 [Presence] |
|
46236-6
|
HLA-B*51 [Type] in Leukocytes |
|
50956-2
|
HLA-B*57:01 [Presence] |
|
42358-2
|
HLA-B*57:01 [Presence] in Unspecified specimen |
|
79711-8
|
HLA-B*58:01 [Presence] in Blood or Tissue |
|
44725-0
|
HLA-B1 [Presence] |
|
4804-1
|
HLA-B12 [Presence] in Donor |
|
4805-8
|
HLA-B12 [Presence] |
|
4806-6
|
HLA-B13 [Presence] in Donor |
|
4807-4
|
HLA-B13 [Presence] |
|
4808-2
|
HLA-B14 [Presence] in Donor |
|
4809-0
|
HLA-B14 [Presence] |
|
4810-8
|
HLA-B15 [Presence] in Donor |
|
4811-6
|
HLA-B15 [Presence] |
|
4812-4
|
HLA-B16 [Presence] in Donor |
|
4813-2
|
HLA-B16 [Presence] |
|
4814-0
|
HLA-B17 [Presence] in Donor |
|
4815-7
|
HLA-B17 [Presence] |
|
4816-5
|
HLA-B18 [Presence] in Donor |
|
4817-3
|
HLA-B18 [Presence] |
|
4818-1
|
HLA-B21 [Presence] in Donor |
|
4819-9
|
HLA-B21 [Presence] |
|
4742-3
|
HLA-B22 [Presence] in Donor |
|
4743-1
|
HLA-B22 [Presence] |
|
55431-1
|
HLA-B27 cells [#/volume] in Blood |
|
4820-7
|
HLA-B27 [Presence] in Donor |
|
4821-5
|
HLA-B27 [Presence] |
|
26028-1
|
HLA-B27 [Presence] by Flow cytometry (FC) |
|
26043-0
|
HLA-B27 [Presence] by NAA with probe detection |
|
13911-3
|
HLA-B27 related Ag [Presence] |
|
4822-3
|
HLA-B35 [Presence] in Donor |
|
4823-1
|
HLA-B35 [Presence] |
|
4824-9
|
HLA-B37 [Presence] in Donor |
|
4825-6
|
HLA-B37 [Presence] |
|
4826-4
|
HLA-B38(16) [Presence] in Donor |
|
4827-2
|
HLA-B38(16) [Presence] |
|
4828-0
|
HLA-B39(16) [Presence] in Donor |
|
4829-8
|
HLA-B39(16) [Presence] |
|
4830-6
|
HLA-B40 [Presence] in Donor |
|
4831-4
|
HLA-B40 [Presence] |
|
4744-9
|
HLA-B41 [Presence] in Donor |
|
4745-6
|
HLA-B41 [Presence] |
|
4746-4
|
HLA-B42 [Presence] in Donor |
|
4747-2
|
HLA-B42 [Presence] |
|
4832-2
|
HLA-B44(12) [Presence] in Donor |
|
4833-0
|
HLA-B44(12) [Presence] |
|
4834-8
|
HLA-B45(12) [Presence] in Donor |
|
4835-5
|
HLA-B45(12) [Presence] |
|
4748-0
|
HLA-B46 [Presence] in Donor |
|
4749-8
|
HLA-B46 [Presence] |
|
4750-6
|
HLA-B47 [Presence] in Donor |
|
4751-4
|
HLA-B47 [Presence] |
|
4752-2
|
HLA-B48 [Presence] in Donor |
|
4753-0
|
HLA-B48 [Presence] |
|
4836-3
|
HLA-B49(21) [Presence] in Donor |
|
4837-1
|
HLA-B49(21) [Presence] |
|
4840-5
|
HLA-B5 [Presence] in Donor |
|
4841-3
|
HLA-B5 [Presence] |
|
4756-3
|
HLA-B50(21) [Presence] in Donor |
|
4757-1
|
HLA-B50(21) [Presence] |
|
44726-8
|
HLA-B51 [Presence] |
|
4838-9
|
HLA-B51(5) [Presence] in Donor |
|
4839-7
|
HLA-B51(5) [Presence] |
|
4758-9
|
HLA-B52(5) [Presence] in Donor |
|
4759-7
|
HLA-B52(5) [Presence] |
|
4760-5
|
HLA-B53 [Presence] in Donor |
|
4761-3
|
HLA-B53 [Presence] |
|
4762-1
|
HLA-B54(22) [Presence] in Donor |
|
4763-9
|
HLA-B54(22) [Presence] |
|
4764-7
|
HLA-B55(22) [Presence] in Donor |
|
4765-4
|
HLA-B55(22) [Presence] |
|
4766-2
|
HLA-B56(22) [Presence] in Donor |
|
4767-0
|
HLA-B56(22) [Presence] |
|
4768-8
|
HLA-B57(17) [Presence] in Donor |
|
4769-6
|
HLA-B57(17) [Presence] |
|
4770-4
|
HLA-B58(17) [Presence] in Donor |
|
4771-2
|
HLA-B58(17) [Presence] |
|
4772-0
|
HLA-B59 [Presence] in Donor |
|
4773-8
|
HLA-B59 [Presence] |
|
53586-4
|
HLA-B6 [Presence] |
|
4774-6
|
HLA-B60(40) [Presence] in Donor |
|
4775-3
|
HLA-B60(40) [Presence] |
|
4776-1
|
HLA-B61(40) [Presence] in Donor |
|
4777-9
|
HLA-B61(40) [Presence] |
|
4778-7
|
HLA-B62(15) [Presence] in Donor |
|
4779-5
|
HLA-B62(15) [Presence] |
|
4780-3
|
HLA-B63(15) [Presence] in Donor |
|
4781-1
|
HLA-B63(15) [Presence] |
|
4782-9
|
HLA-B64(14) [Presence] in Donor |
|
4783-7
|
HLA-B64(14) [Presence] |
|
4784-5
|
HLA-B65(14) [Presence] in Donor |
|
4785-2
|
HLA-B65(14) [Presence] |
|
4786-0
|
HLA-B67 [Presence] in Donor |
|
4787-8
|
HLA-B67 [Presence] |
|
4842-1
|
HLA-B7 [Presence] in Donor |
|
4843-9
|
HLA-B7 [Presence] |
|
4790-2
|
HLA-B70 [Presence] in Donor |
|
4791-0
|
HLA-B70 [Presence] |
|
4792-8
|
HLA-B71(70) [Presence] in Donor |
|
4793-6
|
HLA-B71(70) [Presence] |
|
4794-4
|
HLA-B72(70) [Presence] in Donor |
|
4795-1
|
HLA-B72(70) [Presence] |
|
4796-9
|
HLA-B73 [Presence] in Donor |
|
4797-7
|
HLA-B73 [Presence] |
|
4798-5
|
HLA-B75(15) [Presence] in Donor |
|
4799-3
|
HLA-B75(15) [Presence] |
|
4800-9
|
HLA-B76(15) [Presence] in Donor |
|
4801-7
|
HLA-B76(15) [Presence] |
|
4802-5
|
HLA-B77(15) [Presence] in Donor |
|
4803-3
|
HLA-B77(15) [Presence] |
|
4844-7
|
HLA-B8 [Presence] in Donor |
|
4845-4
|
HLA-B8 [Presence] |
|
13302-5
|
HLA-C [Type] |
|
77636-9
|
HLA-C [Type] by High resolution typing |
|
77643-5
|
HLA-C IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
45031-2
|
HLA-C SBT [Type] by High resolution |
|
42664-3
|
HLA-Cw [Type] |
|
57297-4
|
HLA-Cw [Type] by High resolution |
|
42663-5
|
HLA-Cw locus [Type] |
|
4850-4
|
HLA-Cw1 [Presence] in Donor |
|
4851-2
|
HLA-Cw1 [Presence] |
|
4846-2
|
HLA-Cw10(w3) [Presence] in Donor |
|
4847-0
|
HLA-Cw10(w3) [Presence] |
|
4848-8
|
HLA-Cw11 [Presence] in Donor |
|
4849-6
|
HLA-Cw11 [Presence] |
|
4852-0
|
HLA-Cw2 [Presence] in Donor |
|
4853-8
|
HLA-Cw2 [Presence] |
|
4854-6
|
HLA-Cw3 [Presence] in Donor |
|
4855-3
|
HLA-Cw3 [Presence] |
|
4856-1
|
HLA-Cw4 [Presence] in Donor |
|
4857-9
|
HLA-Cw4 [Presence] |
|
4858-7
|
HLA-Cw5 [Presence] in Donor |
|
4859-5
|
HLA-Cw5 [Presence] |
|
4860-3
|
HLA-Cw6 [Presence] in Donor |
|
4861-1
|
HLA-Cw6 [Presence] |
|
4862-9
|
HLA-Cw7 [Presence] in Donor |
|
4863-7
|
HLA-Cw7 [Presence] |
|
4864-5
|
HLA-Cw8 [Presence] in Donor |
|
4865-2
|
HLA-Cw8 [Presence] |
|
4866-0
|
HLA-Cw9(w3) [Presence] in Donor |
|
4867-8
|
HLA-Cw9(w3) [Presence] |
|
12285-3
|
HLA-DP [Type] |
|
77644-3
|
HLA-DP IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
50019-9
|
HLA-DP+DQ+DR (class II) [Type] |
|
46995-7
|
HLA-DP+DQ+DR (class II) Ab in Serum |
|
72323-9
|
HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Flow cytometry (FC) |
|
72321-3
|
HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Immunoassay |
|
44727-6
|
HLA-DP2 [Presence] |
|
59018-2
|
HLA-DPA1 [Type] by High resolution |
|
59017-4
|
HLA-DPB1 [Type] by High resolution |
|
4920-5
|
HLA-DPw1 [Presence] in Donor |
|
4921-3
|
HLA-DPw1 [Presence] |
|
4922-1
|
HLA-DPw2 [Presence] in Donor |
|
4923-9
|
HLA-DPw2 [Presence] |
|
4924-7
|
HLA-DPw3 [Presence] in Donor |
|
4925-4
|
HLA-DPw3 [Presence] |
|
4926-2
|
HLA-DPw4 [Presence] in Donor |
|
4927-0
|
HLA-DPw4 [Presence] |
|
4928-8
|
HLA-DPw5 [Presence] in Donor |
|
4929-6
|
HLA-DPw5 [Presence] |
|
4930-4
|
HLA-DPw6 [Presence] in Donor |
|
4931-2
|
HLA-DPw6 [Presence] |
|
13305-8
|
HLA-DQ [Type] |
|
13307-4
|
HLA-DQ alpha [Type] |
|
60536-0
|
HLA-DQ beta [Type] |
|
77645-0
|
HLA-DQ IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
34143-8
|
HLA-DQ locus 2 [Type] |
|
4932-0
|
HLA-DQ1 [Presence] in Donor |
|
4933-8
|
HLA-DQ1 [Presence] |
|
43689-9
|
HLA-DQ2 and HLA-DQ8 [Interpretation] |
|
4934-6
|
HLA-DQ2 [Presence] in Donor |
|
4935-3
|
HLA-DQ2 [Presence] |
|
4936-1
|
HLA-DQ3 [Presence] in Donor |
|
4937-9
|
HLA-DQ3 [Presence] |
|
4938-7
|
HLA-DQ4 [Presence] in Donor |
|
4939-5
|
HLA-DQ4 [Presence] |
|
4940-3
|
HLA-DQ5(1) [Presence] in Donor |
|
4941-1
|
HLA-DQ5(1) [Presence] |
|
9419-3
|
HLA-DQ6 [Presence] |
|
4942-9
|
HLA-DQ6(1) [Presence] in Donor |
|
4943-7
|
HLA-DQ6(1) [Presence] |
|
4944-5
|
HLA-DQ7(3) [Presence] in Donor |
|
4945-2
|
HLA-DQ7(3) [Presence] |
|
41283-3
|
HLA-DQ8 [Presence] |
|
4946-0
|
HLA-DQ8(3) [Presence] in Donor |
|
4947-8
|
HLA-DQ8(3) [Presence] |
|
4948-6
|
HLA-DQ9(3) [Presence] in Donor |
|
4949-4
|
HLA-DQ9(3) [Presence] |
|
59019-0
|
HLA-DQA1 [Type] by High resolution |
|
44728-4
|
HLA-DQA1 [Presence] |
|
53737-3
|
HLA-DQA1*01:02 [Presence] |
|
58928-3
|
HLA-DQA1*03:01 [Presence] |
|
57090-3
|
HLA-DQA1*05:01 [Presence] |
|
53938-7
|
HLA-DQB1 [Type] |
|
57299-0
|
HLA-DQB1 [Type] by High resolution |
|
78017-1
|
HLA-DQB1 [Type] by Low resolution |
|
43291-4
|
HLA-DQB1 [Presence] |
|
45029-6
|
HLA-DQB1 SBT [Type] by High resolution |
|
57091-1
|
HLA-DQB1*02:01 [Presence] |
|
58929-1
|
HLA-DQB1*03:02 [Presence] |
|
63558-1
|
HLA-DQB1*06:02 [Presence] |
|
53738-1
|
HLA-DQB1*2 [Presence] |
|
53739-9
|
HLA-DQB1*9 [Presence] |
|
13304-1
|
HLA-DR [Type] |
|
93351-5
|
HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) |
|
42323-6
|
HLA-DR Ag [Type] in Tissue |
|
13306-6
|
HLA-DR beta [Type] |
|
22756-1
|
HLA-DR [Units/volume] in Cerebral spinal fluid |
|
77646-8
|
HLA-DR IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
21341-3
|
HLA-DR locus [Type] |
|
21342-1
|
HLA-DR locus 2 [Type] |
|
32621-5
|
HLA-DR [Presence] |
|
5557-4
|
HLA-DR [Units/volume] in Leukocytes |
|
33617-2
|
HLA-DR+ cells [#/volume] in Blood |
|
31113-4
|
HLA-DR+ cells/100 cells in Blood |
|
51379-6
|
HLA-DR+ cells/100 cells in Cerebral spinal fluid |
|
51381-2
|
HLA-DR+ cells/100 cells in Body fluid |
|
51380-4
|
HLA-DR+ cells/100 cells in Bone marrow |
|
51378-8
|
HLA-DR+ cells/100 cells in Tissue |
|
32751-0
|
HLA-DR+ cells/100 cells in Unspecified specimen |
|
21343-9
|
HLA-DR+DQ [Type] |
|
4976-7
|
HLA-DR1 [Presence] in Donor |
|
4977-5
|
HLA-DR1 [Presence] |
|
4950-2
|
HLA-DR10 [Presence] in Donor |
|
4951-0
|
HLA-DR10 [Presence] |
|
4952-8
|
HLA-DR11(5) [Presence] in Donor |
|
4953-6
|
HLA-DR11(5) [Presence] |
|
4954-4
|
HLA-DR12(5) [Presence] in Donor |
|
4955-1
|
HLA-DR12(5) [Presence] |
|
4956-9
|
HLA-DR13(6) [Presence] in Donor |
|
4957-7
|
HLA-DR13(6) [Presence] |
|
4958-5
|
HLA-DR14(6) [Presence] in Donor |
|
4959-3
|
HLA-DR14(6) [Presence] |
|
6803-1
|
HLA-DR15 [Presence] |
|
4960-1
|
HLA-DR15(2) [Presence] in Donor |
|
4961-9
|
HLA-DR15(2) [Presence] |
|
18413-5
|
HLA-DR16 [Presence] |
|
4962-7
|
HLA-DR16(2) [Presence] in Donor |
|
4963-5
|
HLA-DR16(2) [Presence] |
|
4964-3
|
HLA-DR17(3) [Presence] in Donor |
|
4965-0
|
HLA-DR17(3) [Presence] |
|
4966-8
|
HLA-DR18(3) [Presence] in Donor |
|
4967-6
|
HLA-DR18(3) [Presence] |
|
4978-3
|
HLA-DR2 [Presence] in Donor |
|
4979-1
|
HLA-DR2 [Presence] |
|
4980-9
|
HLA-DR3 [Presence] in Donor |
|
4981-7
|
HLA-DR3 [Presence] |
|
4982-5
|
HLA-DR4 [Presence] in Donor |
|
4983-3
|
HLA-DR4 [Presence] |
|
4984-1
|
HLA-DR5 [Presence] in Donor |
|
4985-8
|
HLA-DR5 [Presence] |
|
4968-4
|
HLA-DR52 [Presence] in Donor |
|
4969-2
|
HLA-DR52 [Presence] |
|
4970-0
|
HLA-DR53 [Presence] in Donor |
|
4971-8
|
HLA-DR53 [Presence] |
|
4972-6
|
HLA-DR6 [Presence] in Donor |
|
4973-4
|
HLA-DR6 [Presence] |
|
4986-6
|
HLA-DR7 [Presence] in Donor |
|
4987-4
|
HLA-DR7 [Presence] |
|
4974-2
|
HLA-DR8 [Presence] in Donor |
|
4975-9
|
HLA-DR8 [Presence] |
|
4988-2
|
HLA-DR9 [Presence] in Donor |
|
4989-0
|
HLA-DR9 [Presence] |
|
78016-3
|
HLA-DRB [Type] by Low resolution |
|
57298-2
|
HLA-DRB1 [Type] |
|
57293-3
|
HLA-DRB1 [Type] by High resolution |
|
43290-6
|
HLA-DRB1 [Presence] |
|
45030-4
|
HLA-DRB1 SBT [Type] by High resolution |
|
53758-9
|
HLA-DRB1 SBT [Type] in Unspecified specimen by High resolution |
|
59029-9
|
HLA-DRB1*15:01 [Presence] |
|
53740-7
|
HLA-DRB1*17 [Presence] |
|
53741-5
|
HLA-DRB1*7 [Presence] |
|
59022-4
|
HLA-DRB3 [Type] |
|
57294-1
|
HLA-DRB3 [Type] by High resolution |
|
43379-7
|
HLA-DRB3 [Presence] |
|
59021-6
|
HLA-DRB4 [Type] |
|
57295-8
|
HLA-DRB4 [Type] by High resolution |
|
59020-8
|
HLA-DRB5 [Type] |
|
57296-6
|
HLA-DRB5 [Type] by High resolution |
|
4888-4
|
HLA-Dw1 [Presence] in Donor |
|
4889-2
|
HLA-Dw1 [Presence] |
|
4868-6
|
HLA-Dw10 [Presence] in Donor |
|
4869-4
|
HLA-Dw10 [Presence] |
|
4870-2
|
HLA-Dw11(w7) [Presence] in Donor |
|
4871-0
|
HLA-Dw11(w7) [Presence] |
|
4872-8
|
HLA-Dw12 [Presence] in Donor |
|
4873-6
|
HLA-Dw12 [Presence] |
|
4874-4
|
HLA-Dw13 [Presence] in Donor |
|
4875-1
|
HLA-Dw13 [Presence] |
|
4876-9
|
HLA-Dw14 [Presence] in Donor |
|
4877-7
|
HLA-Dw14 [Presence] |
|
4878-5
|
HLA-Dw15 [Presence] in Donor |
|
4879-3
|
HLA-Dw15 [Presence] |
|
4880-1
|
HLA-Dw16 [Presence] in Donor |
|
4881-9
|
HLA-Dw16 [Presence] |
|
4882-7
|
HLA-Dw17(w7) [Presence] in Donor |
|
4883-5
|
HLA-Dw17(w7) [Presence] |
|
4884-3
|
HLA-Dw18(w6) [Presence] in Donor |
|
4885-0
|
HLA-Dw18(w6) [Presence] |
|
4886-8
|
HLA-Dw19(w6) [Presence] in Donor |
|
4887-6
|
HLA-Dw19(w6) [Presence] |
|
4904-9
|
HLA-Dw2 [Presence] in Donor |
|
4905-6
|
HLA-Dw2 [Presence] |
|
4890-0
|
HLA-Dw20 [Presence] in Donor |
|
4891-8
|
HLA-Dw20 [Presence] |
|
4892-6
|
HLA-Dw21 [Presence] in Donor |
|
4893-4
|
HLA-Dw21 [Presence] |
|
4894-2
|
HLA-Dw22 [Presence] in Donor |
|
4895-9
|
HLA-Dw22 [Presence] |
|
4896-7
|
HLA-Dw23 [Presence] in Donor |
|
4897-5
|
HLA-Dw23 [Presence] |
|
4898-3
|
HLA-Dw24 [Presence] in Donor |
|
4899-1
|
HLA-Dw24 [Presence] |
|
4900-7
|
HLA-Dw25 [Presence] in Donor |
|
4901-5
|
HLA-Dw25 [Presence] |
|
4902-3
|
HLA-Dw26 [Presence] in Donor |
|
4903-1
|
HLA-Dw26 [Presence] |
|
4906-4
|
HLA-Dw3 [Presence] in Donor |
|
4907-2
|
HLA-Dw3 [Presence] |
|
4908-0
|
HLA-Dw4 [Presence] in Donor |
|
4909-8
|
HLA-Dw4 [Presence] |
|
4910-6
|
HLA-Dw5 [Presence] in Donor |
|
4911-4
|
HLA-Dw5 [Presence] |
|
4912-2
|
HLA-Dw6 [Presence] in Donor |
|
4913-0
|
HLA-Dw6 [Presence] |
|
4914-8
|
HLA-Dw7 [Presence] in Donor |
|
4915-5
|
HLA-Dw7 [Presence] |
|
4916-3
|
HLA-Dw8 [Presence] in Donor |
|
4917-1
|
HLA-Dw8 [Presence] |
|
4918-9
|
HLA-Dw9 [Presence] in Donor |
|
4919-7
|
HLA-Dw9 [Presence] |
|
43729-3
|
Lipoprotein.alpha.subparticle.large [Moles/volume] in Serum or Plasma |
|
10487-7
|
HMB-45 Ag [Presence] in Tissue by Immune stain |
|
38702-7
|
Hexamethylene diisocyanate [Mass/volume] in Air |
|
74295-7
|
Hydroxymethylglutaryl CoA lyase deficiency newborn screen interpretation |
|
2444-8
|
Hydroxymethylglutaryl CoA lyase [Enzymatic activity/volume] in Serum |
|
82388-0
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum by Line blot |
|
82389-8
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Presence] in Serum by Line blot |
|
93493-5
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay |
|
82990-3
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Presence] in Serum or Plasma by Line blot |
|
38703-5
|
Hexamethylphosphoramide [Mass/volume] in Air |
|
79523-7
|
3-(3-Hydroxyphenyl)propanoate [Moles/volume] in Serum or Plasma |
|
79482-6
|
3-(3-Hydroxyphenyl)propanoate/Creatinine [Molar ratio] in Urine |
|
67820-1
|
Human metapneumovirus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80587-9
|
Human metapneumovirus A+B L+N genes [Presence] in Nasopharynx by NAA with probe detection |
|
91831-8
|
Human metapneumovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
88222-5
|
Human metapneumovirus Ag [Presence] in Nasopharynx by Immunofluorescence |
|
91810-2
|
Human metapneumovirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
|
60425-6
|
Human metapneumovirus Ag [Presence] in Unspecified specimen |
|
40979-7
|
Human metapneumovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
67821-9
|
Human metapneumovirus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88532-7
|
Human metapneumovirus identified in Cornea or Conjunctiva by Organism specific culture |
|
41011-8
|
Human metapneumovirus IgG Ab [Presence] in Serum |
|
40980-5
|
Human metapneumovirus IgG Ab [Presence] in Serum by Immunoassay |
|
89652-2
|
Human metapneumovirus identified in Lower respiratory specimen by Organism specific culture |
|
53249-9
|
Human metapneumovirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88534-3
|
Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60266-4
|
Human metapneumovirus RNA [Presence] in Isolate by NAA with probe detection |
|
92978-6
|
Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
89651-4
|
Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82165-2
|
Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
77024-8
|
Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92134-6
|
Human metapneumovirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91809-4
|
Human metapneumovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40978-9
|
Human metapneumovirus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
38917-1
|
Human metapneumovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91778-1
|
Human metapneumovirus identified in Upper respiratory specimen by Organism specific culture |
|
6135-8
|
Hamster epithelium IgE Ab [Units/volume] in Serum |
|
15765-1
|
Hamster epithelium IgE Ab RAST class [Presence] in Serum |
|
39602-8
|
Hamster epithelium IgE Ab/IgE total in Serum |
|
56270-2
|
Hamster epithelium IgG4 Ab [Mass/volume] in Serum |
|
3278-9
|
Kininogen HMW actual/normal in Platelet poor plasma by Immunoassay |
|
52754-9
|
Kininogen HMW activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3277-1
|
Kininogen HMW [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3276-3
|
Kininogen HMW [Units/volume] in Platelet poor plasma by Coagulation assay |
|
72921-0
|
HNA 1 genotype in Blood |
|
72915-2
|
HNA 1a/1b Ab [Presence] in Serum by Immunoassay |
|
72922-8
|
HNA 1a/1a Ab [Presence] in Serum by Immunoassay |
|
72916-0
|
HNA 1b/1b Ab [Presence] in Serum by Immunoassay |
|
72914-5
|
HNA 1c Ab [Presence] in Serum by Immunoassay |
|
72920-2
|
HNA 1c genotype [Presence] in Blood |
|
72913-7
|
HNA 2 Ab [Presence] in Serum by Immunoassay |
|
72919-4
|
HNA 3 genotype in Blood |
|
72918-6
|
HNA 4 genotype in Blood |
|
72912-9
|
HNA 4a/4a Ab [Presence] in Serum by Immunoassay |
|
72910-3
|
HNA 4a/4b Ab [Presence] in Serum by Immunoassay |
|
72911-1
|
HNA 4b/4b Ab [Presence] in Serum by Immunoassay |
|
72917-8
|
HNA 5 genotype in Blood |
|
75397-0
|
HNF1A gene full mutation analysis in Blood or Tissue by Sequencing |
|
75398-8
|
HNF1B gene full mutation analysis in Blood or Tissue by Sequencing |
|
75399-6
|
HNF4A gene full mutation analysis in Blood or Tissue by Sequencing |
|
80663-8
|
4-Hydroxy 3-Nitrophenylacetate (HNPAA) [Mass/volume] in Urine |
|
35379-7
|
HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35378-9
|
HNPCC genes mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
93842-3
|
HOGA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
83152-9
|
Able to hold position for 50 seconds - trial 1 [NIH Toolbox] --eyes closed and on foam surface |
|
83148-7
|
Able to hold position for 50 seconds - trial 1 [NIH Toolbox] --eyes closed and on solid surface |
|
83150-3
|
Able to hold position for 50 seconds - trial 1 [NIH Toolbox] --eyes open and on foam surface |
|
83146-1
|
Able to hold position for 50 seconds - trial 1 [NIH Toolbox] --eyes open and on solid surface |
|
83154-5
|
Able to hold position for 50 seconds - trial 1 [NIH Toolbox] --eyes open and in tandem stance and on solid surface |
|
83153-7
|
Able to hold position for 50 seconds - trial 2 [NIH Toolbox] --eyes closed and on foam surface |
|
83149-5
|
Able to hold position for 50 seconds - trial 2 [NIH Toolbox] --eyes closed and on solid surface |
|
83151-1
|
Able to hold position for 50 seconds - trial 2 [NIH Toolbox] --eyes open and on foam surface |
|
83147-9
|
Able to hold position for 50 seconds - trial 2 [NIH Toolbox] --eyes open and on solid surface |
|
83155-2
|
Able to hold position for 50 seconds - trial 2 [NIH Toolbox] --eyes open and in tandem stance and on solid surface |
|
91553-8
|
Duration that patient was able to hold balance position [NIH Toolbox] |
|
58982-0
|
Holm oak IgE Ab [Units/volume] in Serum |
|
72160-5
|
Holo-transcobalamin II [Moles/volume] in Serum |
|
18754-2
|
Holter monitor study |
|
47214-2
|
Homeostasis model assessment |
|
44962-9
|
Homans sign of Lower extremity - left |
|
44961-1
|
Homans sign of Lower extremity - right |
|
93448-9
|
Home accessibility evaluation status |
|
93441-4
|
Home accessibility modification date |
|
93447-1
|
Home accessibility modification responsible party |
|
85461-2
|
Home environment safety and stability - visual analog rating [ePCAM] |
|
83322-8
|
Home environment safety and stability [PCAM] |
|
52035-3
|
Home health claims |
|
52036-1
|
Home health prior authorization |
|
2426-5
|
Homocarnosine [Mass/volume] in Cerebral spinal fluid |
|
75638-7
|
Homocarnosine [Moles/volume] in Cerebral spinal fluid |
|
79602-9
|
Homocarnosine [Moles/volume] in Serum or Plasma |
|
79632-6
|
Homocarnosine/Creatinine [Molar ratio] in Urine |
|
54299-3
|
Homocitrulline [Moles/volume] in Amniotic fluid |
|
55875-9
|
Homocitrulline [Moles/volume] in Cerebral spinal fluid |
|
53158-2
|
Homocitrulline [Moles/volume] in DBS |
|
55876-7
|
Homocitrulline [Moles/volume] in Serum or Plasma |
|
2427-3
|
Homocitrulline [Mass/volume] in Urine |
|
74483-9
|
Homocitrulline [Moles/volume] in Urine |
|
32248-7
|
Homocitrulline/Creatinine [Ratio] in Urine |
|
79592-2
|
Homocitrulline/Creatinine [Molar ratio] in Urine |
|
33937-4
|
Homocystine Free [Moles/volume] in Serum or Plasma |
|
33936-6
|
Homocystine Free [Moles/volume] in Urine |
|
79704-3
|
Homo-gamma Linolenate (C20:3w6) [Entitic substance] in Red Blood Cells |
|
35171-8
|
Homo-gamma Linolenate (C20:3w6) [Moles/volume] in Serum or Plasma |
|
51800-1
|
Homogentisate [Mass/volume] in 24 hour Urine |
|
51705-2
|
Homogentisate [Mass/time] in 24 hour Urine |
|
2432-3
|
Homogentisate [Presence] in Urine |
|
2433-1
|
Homogentisate [Mass/volume] in Urine |
|
75085-1
|
Homogentisate/Creatinine [Molar ratio] in 24 hour Urine |
|
47650-7
|
Homogentisate/Creatinine [Molar ratio] in Urine |
|
65791-6
|
Honey bee native (nApi m) 4 IgE Ab [Units/volume] in Serum |
|
82613-1
|
Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum |
|
82614-9
|
Honey bee recombinant (rApi m) 10 IgE Ab RAST class [Presence] in Serum |
|
6844-5
|
Honey bee IgE Ab [Units/volume] in Serum |
|
15570-5
|
Honey bee IgE Ab RAST class [Presence] in Serum |
|
40997-9
|
Honey bee IgE Ab/IgE total in Serum |
|
6727-2
|
Honey bee IgG Ab [Units/volume] in Serum |
|
44298-8
|
Honey bee IgG Ab RAST class [Presence] in Serum |
|
26407-7
|
Honey bee IgG4 Ab [Units/volume] in Serum |
|
26408-5
|
Honey bee IgG4 Ab RAST class [Presence] in Serum |
|
56286-8
|
Honey bee IgG4 Ab [Mass/volume] in Serum |
|
49739-6
|
Honey bee IgG Ab [Mass/volume] in Serum |
|
48185-3
|
Honey bee triggered leukotriene release [Mass/volume] by Leukocytes |
|
7412-0
|
Honey IgE Ab [Units/volume] in Serum |
|
15777-6
|
Honey IgE Ab RAST class [Presence] in Serum |
|
7411-2
|
Honey IgG Ab [Units/volume] in Serum |
|
56285-0
|
Honey IgG4 Ab [Mass/volume] in Serum |
|
63119-2
|
Honey IgG Ab [Mass/volume] in Serum |
|
7413-8
|
Honeysuckle IgE Ab [Units/volume] in Serum |
|
15778-4
|
Honeysuckle IgE Ab RAST class [Presence] in Serum |
|
6141-6
|
Hop IgE Ab [Units/volume] in Serum |
|
15779-2
|
Hop IgE Ab RAST class [Presence] in Serum |
|
61275-4
|
Hop IgE Ab/IgE total in Serum |
|
7414-6
|
Hop IgG Ab [Units/volume] in Serum |
|
56288-4
|
Hop IgG4 Ab [Mass/volume] in Serum |
|
63138-2
|
Hop IgG Ab [Mass/volume] in Serum |
|
79739-9
|
Horizontal diameter Left cornea |
|
79740-7
|
Horizontal diameter Right cornea |
|
60516-2
|
Hormone treatment |
|
7416-1
|
Horn beam IgE Ab [Units/volume] in Serum |
|
15780-0
|
Horn beam IgE Ab RAST class [Presence] in Serum |
|
15781-8
|
Hornet IgE Ab RAST class [Presence] in Serum |
|
6142-4
|
Hornet venom IgE Ab [Units/volume] in Serum |
|
50982-8
|
Horowitz index in Blood |
|
50984-4
|
Horowitz index in Arterial blood |
|
50983-6
|
Horowitz index in Capillary blood |
|
50985-1
|
Horowitz index in Mixed venous blood |
|
50986-9
|
Horowitz index in Venous blood |
|
50987-7
|
Horowitz index adjusted to patients actual temperature in Blood |
|
50989-3
|
Horowitz index adjusted to patients actual temperature in Arterial blood |
|
50988-5
|
Horowitz index adjusted to patients actual temperature in Capillary blood |
|
50990-1
|
Horowitz index adjusted to patients actual temperature in Mixed venous blood |
|
50991-9
|
Horowitz index adjusted to patients actual temperature in Venous blood |
|
64974-9
|
Horse recombinant (rEqu c) 1 IgE Ab [Units/volume] in Serum |
|
81978-9
|
Horse recombinant (rEqu c) 1 IgE Ab RAST class [Presence] in Serum |
|
15281-9
|
Horse Bot Fly IgE Ab [Units/volume] in Serum |
|
25414-4
|
Horse Bot Fly IgE Ab RAST class [Presence] in Serum |
|
58467-2
|
Horse Bot Fly IgG4 Ab [Mass/volume] in Serum |
|
30983-1
|
Horse Chestnut IgE Ab [Presence] in Serum |
|
7220-7
|
Horse Chestnut IgE Ab [Units/volume] in Serum |
|
15630-7
|
Horse Chestnut IgE Ab RAST class [Presence] in Serum |
|
7418-7
|
Horse dander triggered histamine release [Units/volume] in Blood |
|
6143-2
|
Horse dander IgE Ab [Units/volume] in Serum |
|
15784-2
|
Horse dander IgE Ab RAST class [Presence] in Serum |
|
39550-9
|
Horse dander IgE Ab/IgE total in Serum |
|
56456-7
|
Horse dander IgG4 Ab [Mass/volume] in Serum |
|
7419-5
|
Horse epithelium IgE Ab [Units/volume] in Serum |
|
15785-9
|
Horse epithelium IgE Ab RAST class [Presence] in Serum |
|
6144-0
|
Horse Fly IgE Ab [Units/volume] in Serum |
|
15717-2
|
Horse Fly IgE Ab RAST class [Presence] in Serum |
|
7320-5
|
Horse Fly IgG Ab [Units/volume] in Serum |
|
56467-4
|
Horse Fly IgG4 Ab [Mass/volume] in Serum |
|
30088-9
|
Horse hair+Horse dander IgE Ab [Units/volume] in Serum |
|
44379-6
|
Horse hair+Horse dander IgE Ab RAST class [Presence] in Serum |
|
19743-4
|
Horse meat IgE Ab [Units/volume] in Serum |
|
25442-5
|
Horse meat IgE Ab RAST class [Presence] in Serum |
|
65788-2
|
Horse serum albumin native (nEqu c) 3 IgE Ab [Units/volume] in Serum |
|
10935-5
|
Horse serum proteins IgE Ab [Units/volume] in Serum |
|
15786-7
|
Horse serum proteins IgE Ab RAST class [Presence] in Serum |
|
65792-4
|
Horseradish native (nArm r) HRP IgE Ab [Units/volume] in Serum |
|
7420-3
|
Horseradish IgE Ab [Units/volume] in Serum |
|
15787-5
|
Horseradish IgE Ab RAST class [Presence] in Serum |
|
41847-5
|
Horseradish IgG Ab [Units/volume] in Serum |
|
56289-2
|
Horseradish IgG4 Ab [Mass/volume] in Serum |
|
63147-3
|
Horseradish IgG Ab [Mass/volume] in Serum |
|
79429-7
|
Hospital Admission notification note |
|
67852-4
|
Hospital Admission evaluation note |
|
47039-3
|
Hospital Admission history and physical note |
|
78976-8
|
Hospital admission ischemic heart disease diagnosis |
|
47041-9
|
Hospital Consultation 2nd opinion |
|
34104-0
|
Hospital Consult note |
|
74290-8
|
Hospital discharge disposition [NTDS] |
|
8653-8
|
Hospital Discharge instructions |
|
79430-5
|
Hospital Discharge notification note |
|
34105-7
|
Hospital Discharge summary |
|
64142-3
|
Hospital Evaluation and management of smoking cessation note |
|
34114-9
|
Hospital Group counseling note |
|
11492-6
|
Provider-unspecifed, History and physical note |
|
47044-3
|
Hospital Initial evaluation note |
|
68609-7
|
Hospital Letter |
|
85471-1
|
Hospital Medication management note |
|
34112-3
|
Hospital Note |
|
68610-5
|
Hospital Postoperative evaluation and management note |
|
34130-5
|
Hospital Progress note |
|
78033-8
|
Hospital stay duration |
|
92273-2
|
Hospital stay duration for Newborn |
|
85184-0
|
Hospital Transfer summary note |
|
8646-2
|
Hospital admission diagnosis |
|
46241-6
|
Hospital admission diagnosis Narrative - Reported |
|
18841-7
|
Hospital consultations Document |
|
77155-0
|
Hospital designation capability NEMSIS |
|
78023-9
|
Hospital discharge disposition [NHCS] |
|
38999-9
|
Hospital discharge DRG [Interpretation] |
|
11535-2
|
Hospital discharge Dx Narrative |
|
8651-2
|
Hospital discharge Dx |
|
77154-3
|
Hospital inpatient destination |
|
74286-6
|
Transport mode to hospital [NTDS] |
|
44959-5
|
Hospital.reporting NPI [Identifier] Cancer |
|
71520-1
|
Hospitalized due to presumptive diagnosis [ESRD] |
|
93680-7
|
Hospitalized in the last 6 months |
|
71590-4
|
Hospitalized or emergency room [ESRD] |
|
55420-4
|
Hours after meal [Time] |
|
6018-6
|
House dust Allergopharma IgE Ab [Units/volume] in Serum |
|
7421-1
|
House dust AP IgE Ab [Units/volume] in Serum |
|
7422-9
|
House dust AP IgG Ab [Units/volume] in Serum |
|
7423-7
|
House dust triggered histamine release [Units/volume] in Blood |
|
6040-0
|
House dust Bencard IgE Ab [Units/volume] in Serum |
|
82006-8
|
House dust Bencard IgE Ab RAST class [Presence] in Serum |
|
9828-5
|
House dust Greer IgE Ab [Units/volume] in Serum |
|
15789-1
|
House dust Greer IgE Ab RAST class [Presence] in Serum |
|
61274-7
|
House dust Greer IgE Ab/IgE total in Serum |
|
7424-5
|
House dust Greer IgG Ab [Units/volume] in Serum |
|
21344-7
|
House dust Greer IgG Ab RAST class [Presence] in Serum |
|
56290-0
|
House dust Greer IgG4 Ab [Mass/volume] in Serum |
|
63157-2
|
House dust Greer IgG Ab [Mass/volume] in Serum |
|
9444-1
|
House dust Hausstaub IgE Ab [Units/volume] in Serum |
|
15790-9
|
House dust Hausstaub IgE Ab RAST class [Presence] in Serum |
|
7425-2
|
House dust Hollister Stier IgE Ab [Units/volume] in Serum |
|
15791-7
|
House dust Hollister Stier IgE Ab RAST class [Presence] in Serum |
|
7426-0
|
House dust Hollister Stier IgG Ab [Units/volume] in Serum |
|
44380-4
|
House dust Hollister Stier IgG Ab RAST class [Presence] in Serum |
|
63158-0
|
House dust Hollister Stier IgG Ab [Mass/volume] in Serum |
|
6145-7
|
House dust IgE Ab [Units/volume] in Serum |
|
15788-3
|
House dust IgE Ab RAST class [Presence] in Serum |
|
7321-3
|
Housefly triggered histamine release [Units/volume] in Blood |
|
49715-6
|
Housefly IgE Ab [Units/volume] in Serum |
|
86639-2
|
Household size [#] |
|
82821-0
|
Household substance abuse--before 18 years old [ACE] |
|
71802-3
|
Housing status |
|
89565-6
|
Housing status [CUBS] |
|
91618-9
|
How concerned or worried about your health have you been during the past month [NHANES] |
|
91615-5
|
How depressed or cheerful have you been during the past month [NHANES] |
|
71106-9
|
How do you rate the care you received [FACIT] |
|
71063-2
|
How do you rate this treatment overall [FACIT] |
|
91624-7
|
How happy, satisfied, or pleased have you been with your personal life during the past month [NHANES] |
|
76513-1
|
How hard is it for you to pay for the very basics like food, housing, medical care, and heating [CARDIA] |
|
75707-0
|
How have things been going for you during the past 2 weeks [COOP.WONCA] |
|
75801-1
|
How have things been going for you during the past 4 weeks [COOP] |
|
91628-8
|
How have you been feeling in general during the past month [NHANES] |
|
54704-2
|
How important it is to be able to use the phone in private while in this facility [CMS Assessment] |
|
54708-3
|
How important it is to be around animals such as pets while in this facility [CMS Assessment] |
|
54700-0
|
How important it is to choose between a tub bath, shower, bed bath, or sponge bath while in this facility [CMS Assessment] |
|
54698-6
|
How important it is to choose what clothes to wear while in this facility [CMS Assessment] |
|
54702-6
|
How important it is to choose your own bedtime while in this facility [CMS Assessment] |
|
54710-9
|
How important it is to do things with groups of people while in this facility [CMS Assessment] |
|
54711-7
|
How important it is to do your favorite activities while in this facility [CMS Assessment] |
|
54712-5
|
How important it is to go outside to get fresh air when the weather is good while in this facility [CMS Assessment] |
|
54705-9
|
How important it is to have a place to lock your things to keep them safe while in this facility [CMS Assessment] |
|
54706-7
|
How important it is to have books, newspapers, and magazines to read while in this facility [CMS Assessment] |
|
54701-8
|
How important it is to have snacks available between meals while in this facility [CMS Assessment] |
|
54703-4
|
How important it is to have your family or a close friend involved in discussions about your care while in this facility [CMS Assessment] |
|
54709-1
|
How important it is to keep up with the news while in this facility [CMS Assessment] |
|
54707-5
|
How important it is to listen to music you like while in this facility [CMS Assessment] |
|
54713-3
|
How important it is to participate in religious services or practices while in this facility [CMS Assessment] |
|
54699-4
|
How important it is to take care of your personal belongings or things while in this facility [CMS Assessment] |
|
75261-8
|
How intense was your average pain in the past 7 days [PROMIS] |
|
75262-6
|
How intense was your pain at its worse in the past 7 days [PROMIS] |
|
91221-2
|
How many days did you exercise or play so hard that you felt tired in past 7 days [PROMIS.PEDS] |
|
91223-8
|
How many days did you exercise or play so hard that your body got tired in past 7 days [PROMIS.PEDS] |
|
91222-0
|
How many days did you exercise or play so hard that your muscles burned in past 7 days [PROMIS.PEDS] |
|
91219-6
|
How many days did you exercise really hard for 10 minutes or more in past 7 days [PROMIS.PEDS] |
|
91226-1
|
How many days did you exercise so much that you breathed hard in past 7 days [PROMIS.PEDS] |
|
91225-3
|
How many days did you play sports for 10 minutes or more in past 7 days [PROMIS.PEDS] |
|
91217-0
|
How many days did you run for 10 minutes or more in past 7 days [PROMIS.PEDS] |
|
91209-7
|
How many days did your child exercise or play so hard that he or she felt tired in past 7 days [PROMIS.PARENTPROXY] |
|
91211-3
|
How many days did your child exercise or play so hard that his or her body got tired in past 7 days [PROMIS.PARENTPROXY] |
|
91210-5
|
How many days did your child exercise or play so hard that his or her muscles burned in past 7 days [PROMIS.PARENTPROXY] |
|
91207-1
|
How many days did your child exercise really hard for 10 minutes or more in past 7 days [PROMIS.PARENTPROXY] |
|
91214-7
|
How many days did your child exercise so much that he or she breathed hard in past 7 days [PROMIS.PARENTPROXY] |
|
91213-9
|
How many days did your child play sports for 10 minutes or more in past 7 days [PROMIS.PARENTPROXY] |
|
91205-5
|
How many days did your child run for 10 minutes or more in past 7 days [PROMIS.PARENTPROXY] |
|
75902-7
|
How many days in the past week did your child miss taking one or more medications # [SAMHSA] |
|
89555-7
|
How many days per week did you engage in moderate to strenuous physical activity in the last 30 days |
|
91206-3
|
How many days was your child physically active for 10 minutes or more in past 7 days [PROMIS.PARENTPROXY] |
|
91212-1
|
How many days was your child so physically active that he or she sweated in past 7 days [PROMIS.PARENTPROXY] |
|
91337-6
|
How many days was your child strong enough to carry heavy things with his or her hands in past 7 days [PROMIS.PARENTPROXY] |
|
91328-5
|
How many days was your child strong enough to carry his or her school books in past 7 days [PROMIS.PARENTPROXY] |
|
91327-7
|
How many days was your child strong enough to get down on the floor in past 7 days [PROMIS.PARENTPROXY] |
|
91332-7
|
How many days was your child strong enough to get out of bed and stand without help in past 7 days [PROMIS.PARENTPROXY] |
|
91336-8
|
How many days was your child strong enough to go up and down stairs in past 7 days [PROMIS.PARENTPROXY] |
|
91333-5
|
How many days was your child strong enough to hold a full plate or tray of food in past 7 days [PROMIS.PARENTPROXY] |
|
91331-9
|
How many days was your child strong enough to jump up and down in past 7 days [PROMIS.PARENTPROXY] |
|
91326-9
|
How many days was your child strong enough to lift heavy things over his or her head in past 7 days [PROMIS.PARENTPROXY] |
|
91334-3
|
How many days was your child strong enough to open a heavy door in past 7 days [PROMIS.PARENTPROXY] |
|
91329-3
|
How many days was your child strong enough to open a jar by himself or herself in past 7 days [PROMIS.PARENTPROXY] |
|
91330-1
|
How many days was your child strong enough to pour a drink from a full pitcher or carton in past 7 days [PROMIS.PARENTPROXY] |
|
91335-0
|
How many days was your child strong enough to reach above his or her head to get heavy things in past 7 days [PROMIS.PARENTPROXY] |
|
91218-8
|
How many days were you physically active for 10 minutes or more in past 7 days [PROMIS.PEDS] |
|
91224-6
|
How many days were you so physically active that you sweated in past 7 days [PROMIS.PEDS] |
|
91500-9
|
How many days were you strong enough to carry heavy things with your hands in past 7 days [PROMIS.PEDS] |
|
91501-7
|
How many days were you strong enough to carry your school books in past 7 days [PROMIS.PEDS] |
|
91502-5
|
How many days were you strong enough to get down on the floor in past 7 days [PROMIS.PEDS] |
|
91503-3
|
How many days were you strong enough to get out of bed and stand without help in past 7 days [PROMIS.PEDS] |
|
91504-1
|
How many days were you strong enough to go up and down stairs in past 7 days [PROMIS.PEDS] |
|
91505-8
|
How many days were you strong enough to hold a full plate or tray of food in past 7 days [PROMIS.PEDS] |
|
91506-6
|
How many days were you strong enough to jump up and down in past 7 days [PROMIS.PEDS] |
|
91507-4
|
How many days were you strong enough to lift heavy things over your head in past 7 days [PROMIS.PEDS] |
|
91508-2
|
How many days were you strong enough to open a heavy door in past 7 days [PROMIS.PEDS] |
|
91509-0
|
How many days were you strong enough to open a jar by yourself in past 7 days [PROMIS.PEDS] |
|
91510-8
|
How many days were you strong enough to pour a drink from a full pitcher or carton in past 7 days [PROMIS.PEDS] |
|
91511-6
|
How many days were you strong enough to reach above your head to get heavy things in past 7 days [PROMIS.PEDS] |
|
80890-7
|
How many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning over the past month [AUASI] |
|
88476-7
|
How many times have you had chest pain, chest tightness or angina over the past 4 weeks [SAQ] |
|
88475-9
|
How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina over the past 4 weeks [SAQ] |
|
88757-0
|
How much are you troubled with lack of confidence in your hip [HOOS] |
|
88799-2
|
How much are you troubled with lack of confidence in your knee? [KOOS] |
|
71914-6
|
How much bodily pain have you had during the past 4 weeks [Veterans RAND] |
|
89671-2
|
How much did pain interfere with your ability to pay attention in past 7 days [PROMIS] |
|
89673-8
|
How much did you worry about pain in past 7 days [PROMIS] |
|
79056-8
|
How much difficulty do you currently have applying spreads to breads using a knife [PROMIS] |
|
79016-2
|
How much difficulty do you currently have cleaning yourself after a bowel movement [PROMIS] |
|
79055-0
|
How much difficulty do you currently have getting into and out of a truck, bus, shuttle van or sport utility vehicle [PROMIS] |
|
79001-4
|
How much difficulty do you currently have opening previously opened jars [PROMIS] |
|
79057-6
|
How much difficulty do you currently have playing cards or Bingo or other light recreational activities [PROMIS] |
|
79008-9
|
How much difficulty do you currently have pulling up and fastening your pants after a bowel movement [PROMIS] |
|
79058-4
|
How much difficulty do you currently have removing wrappings from small objects [PROMIS] |
|
79043-6
|
How much difficulty do you currently have sitting down on a low, soft couch [PROMIS] |
|
79044-4
|
How much difficulty do you currently have standing up from a low, soft couch [PROMIS] |
|
91616-3
|
How much energy, pep, and vitality have you felt during the past month [NHANES] |
|
77240-0
|
How much formula does the patient drink per day |
|
88469-2
|
How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4 weeks [SAQ] |
|
82669-3
|
How much of the time did your asthma keep you from getting as much done at work, school or at home in the past 4 weeks [ACT] |
|
93156-8
|
How much of the time has pain made it hard for you to sleep at night over the past 5 days [CMS Assessment] |
|
77586-6
|
How much time did you usually spend doing moderate physical activities on one of those days [IPAQ] |
|
77584-1
|
How much time did you usually spend doing vigorous physical activities on one of those days [IPAQ] |
|
88385-0
|
How much time did you usually spend on one of those days doing moderate physical activities as part of your work during the last 7 days [IPAQ] |
|
88399-1
|
How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard during the last 7 days [IPAQ] |
|
88408-0
|
How much time did you usually spend on one of those days doing moderate physical activities in your leisure time during the last 7 days [IPAQ] |
|
88401-5
|
How much time did you usually spend on one of those days doing moderate physical activities inside your home during the last 7 days [IPAQ] |
|
88383-5
|
How much time did you usually spend on one of those days doing vigorous physical activities as part of your work during the last 7 days [IPAQ] |
|
88397-5
|
How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard during the last 7 days [IPAQ] |
|
88406-4
|
How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time during the last 7 days [IPAQ] |
|
88392-6
|
How much time did you usually spend on one of those days to bicycle from place to place during the last 7 days [IPAQ] |
|
88390-0
|
How much time did you usually spend on one of those days traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7 days [IPAQ] |
|
88387-6
|
How much time did you usually spend on one of those days walking as part of your work during the last 7 days [IPAQ] |
|
88394-2
|
How much time did you usually spend on one of those days walking from place to place during the last 7 days [IPAQ] |
|
88404-9
|
How much time did you usually spend on one of those days walking in your leisure time during the last 7 days [IPAQ] |
|
77588-2
|
How much time did you usually spend walking on one of those days [IPAQ] |
|
88759-6
|
How often are you aware of your hip problem [HOOS] |
|
88801-6
|
How often are you aware of your knee problem? [KOOS] |
|
82148-8
|
How often did a parent or adult in your home ever swear at you, insult you, or put you down--before 18 years old [ACE.BRFSS] |
|
82149-6
|
How often did anyone at least 5 years older than you or an adult, ever touch you sexually--before 18 years old [ACE.BRFSS] |
|
82151-2
|
How often did anyone at least 5 years older than you or an adult, force you to have sex--before 18 years old [ACE.BRFSS] |
|
82150-4
|
How often did anyone at least 5 years older than you or an adult, try to make you touch sexually--before 18 years old [ACE.BRFSS] |
|
89672-0
|
How often did pain make it hard for you to walk more than 5 minutes at a time in past 7 days [PROMIS] |
|
82671-9
|
How often did your asthma symptoms (wheezing, coughing, shortness of breath, chest tightness or pain) wake you up at night or earlier than usual in the morning during the past 4 weeks [ACT] |
|
82146-2
|
How often did your parents or adults in your home ever slap, hit, kick, punch or beat each other up--before 18 years old [ACE.BRFSS] |
|
76510-7
|
How often do you attend church or religious services [NHANES] |
|
88806-5
|
How often do you experience knee pain [KOOS] |
|
93159-2
|
How often do you feel lonely or isolated from those around you [CMS Assessment] |
|
75416-8
|
How often do you feel really sad [PROMIS.PEDS] |
|
76509-9
|
How often do you get together with friends or relatives [NHANES III] |
|
75415-0
|
How often do you have fun with friends [PROMIS.PEDS] |
|
93157-6
|
How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy [SILS] |
|
93029-7
|
How often do you see or talk to people that you care about and feel close to [PRAPARE] |
|
75414-3
|
How often do your parents listen to your ideas [PROMIS.PEDS] |
|
75904-3
|
How often does your child feel really sad [PROMIS.PARENTPROXY] |
|
75896-1
|
How often does your child feel that you listen to his or her ideas [PROMIS.PARENTPROXY] |
|
75897-9
|
How often does your child have fun with friends [PROMIS.PARENTPROXY] |
|
77316-8
|
How often have you added cereal to your baby's bottle of formula or pumped (or expressed) breast milk in the past 2 weeks [IFPS-II] |
|
80887-3
|
How often have you found it difficult to postpone urination over the past month [AUASI] |
|
80886-5
|
How often have you found you stopped and started again several times when you urinated over the past month [AUASI] |
|
80884-0
|
How often have you had a sensation of not emptying your bladder completely after you finished urinating over the past month [AUASI] |
|
80888-1
|
How often have you had a weak urinary stream in the last month [AUASI] |
|
88037-7
|
How often have you had five or more drinks in one day during the past year [Reported] |
|
75889-6
|
How often have you had four or more drinks in one day during the past year [Reported] |
|
82670-1
|
How often have you had shortness of breath during the past 4 weeks [ACT] |
|
80889-9
|
How often have you had to push or strain to begin urination over the past month [AUASI] |
|
80885-7
|
How often have you had to urinate again less than two hours after you finished urinating over the past month [AUASI] |
|
93158-4
|
How often have you limited your day-to-day activities because of pain over the past 5 days [CMS Assessment] |
|
93160-0
|
How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5 days [CMS Assessment] |
|
82672-7
|
How often have you used your rescue inhaler or nebulizer medication (such as albuterol) during the past 4 weeks [ACT] |
|
77234-3
|
How often in the past 12 months would you say the patient was worried or stressed about having enough money to buy nutritious meals [BRFSS] |
|
91637-9
|
How often is the following kind of support available to you if you need it - someone to confide in or talk to about yourself or your problems [MOS Social Support Survey] |
|
91661-9
|
How often is the following kind of support available to you if you need it - someone to do something enjoyable with [MOS Social Support Survey] |
|
91659-3
|
How often is the following kind of support available to you if you need it - someone to do things with to help get your mind off things [MOS Social Support Survey] |
|
91657-7
|
How often is the following kind of support available to you if you need it - someone to get together with for relaxation [MOS Social Support Survey] |
|
91635-3
|
How often is the following kind of support available to you if you need it - someone to give you good advice about a crisis [MOS Social Support Survey] |
|
91655-1
|
How often is the following kind of support available to you if you need it - someone to give you information to help you understand a situation [MOS Social Support Survey] |
|
91654-4
|
How often is the following kind of support available to you if you need it - someone to have a good time with [MOS Social Support Survey] |
|
91639-5
|
How often is the following kind of support available to you if you need it - someone to help with daily chores if you were sick [MOS Social Support Survey] |
|
91652-8
|
How often is the following kind of support available to you if you need it - someone to help you if you were confined to bed [MOS Social Support Survey] |
|
91641-1
|
How often is the following kind of support available to you if you need it - someone to love and make you feel wanted [MOS Social Support Survey] |
|
91658-5
|
How often is the following kind of support available to you if you need it - someone to prepare your meals if you were unable to do it yourself [MOS Social Support Survey] |
|
91640-3
|
How often is the following kind of support available to you if you need it - someone to share your most private worries and fears with [MOS Social Support Survey] |
|
91653-6
|
How often is the following kind of support available to you if you need it - someone to take you to the doctor if you needed it [MOS Social Support Survey] |
|
91660-1
|
How often is the following kind of support available to you if you need it - someone to turn to for suggestions about how to deal with a personal problem [MOS Social Support Survey] |
|
91656-9
|
How often is the following kind of support available to you if you need it - someone who hugs you [MOS Social Support Survey] |
|
91636-1
|
How often is the following kind of support available to you if you need it - someone who shows you love and affection [MOS Social Support Survey] |
|
91662-7
|
How often is the following kind of support available to you if you need it - someone who understands your problems [MOS Social Support Survey] |
|
91638-7
|
How often is the following kind of support available to you if you need it - someone whose advice you really want [MOS Social Support Survey] |
|
91634-6
|
How often is the following kind of support available to you if you need it - someone you can count on to listen to you when you need to talk [MOS Social Support Survey] |
|
88767-9
|
How often is your hip painful [HOOS] |
|
72042-5
|
How often was arterial pre-pump pressure measured [ESRD] |
|
72039-1
|
How often was static venous pressure measured |
|
91617-1
|
How relaxed or tense have you been during the past month [NHANES] |
|
88752-1
|
How severe is your hip joint stiffness after first wakening in the morning during the last week [HOOS] |
|
88751-3
|
How severe is your hip stiffness after sitting, lying or resting later in the day during the last week [HOOS] |
|
82325-2
|
How severe is your knee stiffness after first wakening in the morning during the last week [KOOS] |
|
88792-7
|
How severe is your knee stiffness after sitting, lying or resting later in the day during the last week [KOOS] |
|
92182-5
|
How short of breath did you get carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another over past 7 days [PROMIS] |
|
70979-0
|
How short of breath did you get carrying something weighing 10-20 lbs, about 4.5-9kg, like a large bag of groceries, from one room to another in the past 7 days [FACIT] |
|
92181-7
|
How short of breath did you get carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another over past 7 days [PROMIS] |
|
70997-2
|
How short of breath did you get carrying something weighing 5-10 lbs, about 2-4.5 kg, like a basket of clothes, from one room to another in the past 7 days [FACIT] |
|
92180-9
|
How short of breath did you get carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another over past 7 days [PROMIS] |
|
70996-4
|
How short of breath did you get carrying something weighing less than 5 lbs, about 2 kg, like a houseplant, from one room to another in the past 7 days [FACIT] |
|
70999-8
|
How short of breath did you get dining out in the past 7 days [FACIT] |
|
92179-1
|
How short of breath did you get dining out over past 7 days [PROMIS] |
|
70971-7
|
How short of breath did you get dressing yourself without help in the past 7 days [FACIT] |
|
92178-3
|
How short of breath did you get dressing yourself without help over past 7 days [PROMIS] |
|
70998-0
|
How short of breath did you get getting in or out of a car in the past 7 days [FACIT] |
|
92177-5
|
How short of breath did you get getting in or out of a car over past 7 days [PROMIS] |
|
92176-7
|
How short of breath did you get lifting something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) over past 7 days [PROMIS] |
|
70978-2
|
How short of breath did you get lifting something weighing 10-20 lbs, about 4.5-9kg , like a large bag of groceries, in the past 7 days [FACIT] |
|
92175-9
|
How short of breath did you get lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) over past 7 days [PROMIS] |
|
70994-9
|
How short of breath did you get lifting something weighing 5-10 lbs, about 2-4.5 kg, like a basket of clothes in the past 7 days [FACIT] |
|
92174-2
|
How short of breath did you get lifting something weighing less than 5 lbs (about 2 kg, like a houseplant) over past 7 days [PROMIS] |
|
70993-1
|
How short of breath did you get lifting something weighing less than 5 lbs, about 2 kg, like a houseplant, in the past 7 days [FACIT] |
|
92173-4
|
How short of breath did you get lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase) over past 7 days [PROMIS] |
|
70995-6
|
How short of breath did you get lifting something weighing more than 20 lbs, about 9 kg, like a medium-sized suitcase in the past 7 days [FACIT] |
|
71000-4
|
How short of breath did you get low-intensity leisure activity - gardening, etc, in the past 7 days [FACIT] |
|
92172-6
|
How short of breath did you get low-intensity leisure activity (gardening, etc.) over past 7 days [PROMIS] |
|
70977-4
|
How short of breath did you get making a bed in the past 7 days [FACIT] |
|
92171-8
|
How short of breath did you get making a bed over past 7 days [PROMIS] |
|
71001-2
|
How short of breath did you get moderate-intensity leisure activity - bicycling on level terrain, etc, in the past 7 days [FACIT] |
|
92170-0
|
How short of breath did you get moderate-intensity leisure activity (bicycling on level terrain, etc.) over past 7 days [PROMIS] |
|
70974-1
|
How short of breath did you get preparing meals in the past 7 days [FACIT] |
|
92169-2
|
How short of breath did you get preparing meals over past 7 days [PROMIS] |
|
70986-5
|
How short of breath did you get putting on socks or stockings in the past 7 days [FACIT] |
|
92168-4
|
How short of breath did you get putting on socks or stockings over past 7 days [PROMIS] |
|
71006-1
|
How short of breath did you get scrubbing the floor or counter in the past 7 days [FACIT] |
|
92167-6
|
How short of breath did you get scrubbing the floor or counter over past 7 days [PROMIS] |
|
71004-6
|
How short of breath did you get singing or humming in the past 7 days [FACIT] |
|
92166-8
|
How short of breath did you get singing or humming over past 7 days [PROMIS] |
|
70987-3
|
How short of breath did you get standing for at least 5 minutes in the past 7 days [FACIT] |
|
92165-0
|
How short of breath did you get standing for at least 5 minutes over past 7 days [PROMIS] |
|
70976-6
|
How short of breath did you get sweeping or mopping in the past 7 days [FACIT] |
|
92164-3
|
How short of breath did you get sweeping or mopping over past 7 days [PROMIS] |
|
70984-0
|
How short of breath did you get taking a bath without help in the past 7 days [FACIT] |
|
92163-5
|
How short of breath did you get taking a bath without help over past 7 days [PROMIS] |
|
70985-7
|
How short of breath did you get taking a shower in the past 7 days [FACIT] |
|
92162-7
|
How short of breath did you get taking a shower over past 7 days [PROMIS] |
|
71005-3
|
How short of breath did you get talking while walking in the past 7 days [FACIT] |
|
92161-9
|
How short of breath did you get talking while walking over past 7 days [PROMIS] |
|
92160-1
|
How short of breath did you get walking (faster than your usual speed) for .5 mile (almost 1 km) without stopping over past 7 days [PROMIS] |
|
92159-3
|
How short of breath did you get walking (faster than your usual speed) for 50 steps without stopping over past 7 days [PROMIS] |
|
92158-5
|
How short of breath did you get walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping over past 7 days [PROMIS] |
|
92157-7
|
How short of breath did you get walking .5 mile (almost 1 km) on flat ground at a normal speed without stopping over past 7 days [PROMIS] |
|
70988-1
|
How short of breath did you get walking 10 steps - paces on flat ground at a normal speed without stopping in the past 7 days [FACIT] |
|
92156-9
|
How short of breath did you get walking 10 steps or paces on flat ground at a normal speed without stopping over past 7 days [PROMIS] |
|
92155-1
|
How short of breath did you get walking 50 steps or paces on flat ground at a normal speed without stopping over past 7 days [PROMIS] |
|
70972-5
|
How short of breath did you get walking 50 steps-paces on flat ground at a normal speed without stopping in the past 7 days [FACIT] |
|
70980-8
|
How short of breath did you get walking faster than your usual speed for half a mile, almost 1 km, without stopping in the past 7 days [FACIT] |
|
70989-9
|
How short of breath did you get walking half a mile, almost 1 km, on flat ground at a normal speed, without stopping in the past 7 days [FACIT] |
|
92154-4
|
How short of breath did you get walking up 10 stairs (1 flight) without stopping over past 7 days [PROMIS] |
|
70991-5
|
How short of breath did you get walking up 10 stairs, 1 flight, without stopping in the past 7 days [FACIT] |
|
70973-3
|
How short of breath did you get walking up 20 stairs - 2 flights - without stopping in the past 7 days [FACIT] |
|
92153-6
|
How short of breath did you get walking up 20 stairs (2 flights) without stopping over past 7 days [PROMIS] |
|
92152-8
|
How short of breath did you get walking up 30 stairs (3 flights) without stopping over past 7 days [PROMIS] |
|
70992-3
|
How short of breath did you get walking up 30 stairs, 3 flights, without stopping in the past 7 days [FACIT] |
|
70990-7
|
How short of breath did you get walking up 5 stairs without stopping in the past 7 days [FACIT] |
|
92151-0
|
How short of breath did you get walking up 5 stairs without stopping over past 7 days [PROMIS] |
|
71002-0
|
How short of breath did you get walking, faster than your usual speed, for 50 steps without stopping in the past 7 days [FACIT] |
|
71003-8
|
How short of breath did you get walking, faster than your usual speed, for at least 1 mile, a little more than 1.5 km, without stopping in the past 7 days [FACIT] |
|
70975-8
|
How short of breath did you get washing dishes in the past 7 days [FACIT] |
|
92150-2
|
How short of breath did you get washing dishes over past 7 days [PROMIS] |
|
86489-2
|
How would you feel if you had to spend the rest of your life with your heart failure the way it is right now [KCCQ] |
|
82673-5
|
How would you rate your asthma control during the past 4 weeks [ACT] |
|
75704-7
|
How would you rate your overall health now compared to 2 weeks ago [COOP.WONCA] |
|
75804-5
|
How would you rate your overall health now compared to 4 weeks ago [COOP] |
|
7793-3
|
Howell-Jolly bodies [Presence] in Blood by Light microscopy |
|
56157-1
|
HOXB13 gene/IL17BR gene [Ratio] in Tissue by Molecular genetics method |
|
22070-7
|
HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21693-7
|
HP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
53950-2
|
HPA 1a/1a+Gp IIb/IIIa [Presence] in Blood |
|
57096-0
|
HPA 1a/1a+HPA 3a/3a [Presence] in Blood |
|
53949-4
|
HPA 1a/1a+HPA 3b/3b [Presence] in Blood |
|
53952-8
|
HPA 1b/1b+Gp IIb/IIa [Presence] in Blood |
|
53951-0
|
HPA 1b/1b+HPA 3a/3a [Presence] in Blood |
|
53953-6
|
HPA 5a/5a+Gp Ia/IIa [Presence] in Blood |
|
53954-4
|
HPA 5a/5b+Gp Ia/IIa [Presence] in Blood |
|
50599-0
|
HPA-1 [Type] in Blood |
|
50598-2
|
HPA-15 [Type] in Blood |
|
50596-6
|
HPA-1a [Type] in Blood |
|
50597-4
|
HPA-2 [Type] in Blood |
|
50600-6
|
HPA-3 [Type] in Blood |
|
50601-4
|
HPA-4 [Type] in Blood |
|
50602-2
|
HPA-5 [Type] in Blood |
|
50603-0
|
HPA-6 [Type] in Blood |
|
71691-0
|
Hematopoietic progenitor cells [#/volume] in Blood by Automated count |
|
77062-8
|
HPD gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77061-0
|
HPD gene full mutation analysis in Blood or Tissue by Sequencing |
|
49562-2
|
Holoprosencephaly gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
55244-8
|
HPFH-6 gene [Presence] in Blood by Molecular genetics method |
|
70014-6
|
Parainfluenza virus 1+2+3+4 IgA Ab [Presence] in Serum by Immunoassay |
|
93747-4
|
Parainfluenza virus 1+2+3+4 IgG Ab [Presence] in Serum by Immunoassay |
|
70017-9
|
Parainfluenza virus 1+2+3+4 IgM Ab [Presence] in Serum by Immunoassay |
|
92883-8
|
Parainfluenza virus 1+2+3+4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88890-9
|
Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92884-6
|
Parainfluenza virus 1+2+3+4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
31555-6
|
Parainfluenza virus Ab [Units/volume] in Serum |
|
42982-9
|
Parainfluenza virus Ab [Titer] in Serum |
|
49713-1
|
Parainfluenza virus Ab [Titer] in Serum by Complement fixation |
|
26855-7
|
Parainfluenza virus Ab [Titer] in Serum by Immunofluorescence |
|
43366-4
|
Parainfluenza virus Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
31929-3
|
Parainfluenza virus Ag [Presence] in Unspecified specimen |
|
13327-2
|
Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88531-9
|
Parainfluenza virus identified in Cornea or Conjunctiva by Organism specific culture |
|
89653-0
|
Parainfluenza virus identified in Lower respiratory specimen by Organism specific culture |
|
21442-9
|
Parainfluenza virus identified in Nose by Organism specific culture |
|
88529-3
|
Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
92963-8
|
Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88562-4
|
Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91798-9
|
Parainfluenza virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
61365-3
|
Parainfluenza virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
89654-8
|
Parainfluenza virus identified in Upper respiratory specimen by Organism specific culture |
|
40436-8
|
Parainfluenza virus identified in Unspecified specimen by Organism specific culture |
|
31548-1
|
Parainfluenza virus 1 Ab [Units/volume] in Body fluid |
|
7978-0
|
Parainfluenza virus 1 Ab [Units/volume] in Serum |
|
24293-3
|
Parainfluenza virus 1 Ab [Titer] in Serum --1st specimen |
|
24219-8
|
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
42984-5
|
Parainfluenza virus 1 Ab [Titer] in Serum --2nd specimen |
|
25297-3
|
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
46199-6
|
Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid |
|
43203-9
|
Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29417-3
|
Parainfluenza virus 1 Ab [Titer] in Body fluid |
|
29366-2
|
Parainfluenza virus 1 Ab [Titer] in Body fluid by Complement fixation |
|
22437-8
|
Parainfluenza virus 1 Ab [Titer] in Serum |
|
5268-8
|
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation |
|
77385-3
|
Parainfluenza virus 1 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
67808-6
|
Parainfluenza virus 1 Ag [Presence] in Isolate by Immunofluorescence |
|
88906-3
|
Parainfluenza virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
38396-8
|
Parainfluenza virus 1 Ag [Presence] in Nose by Immunofluorescence |
|
38395-0
|
Parainfluenza virus 1 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31923-6
|
Parainfluenza virus 1 Ag [Presence] in Throat |
|
5868-5
|
Parainfluenza virus 1 Ag [Presence] in Throat by Immunofluorescence |
|
31924-4
|
Parainfluenza virus 1 Ag [Presence] in Unspecified specimen |
|
5869-3
|
Parainfluenza virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
80592-9
|
Parainfluenza virus 1 F gene [Presence] in Nasopharynx by NAA with probe detection |
|
15389-0
|
Parainfluenza virus 1 IgG Ab [Presence] in Serum |
|
40983-9
|
Parainfluenza virus 1 IgG Ab [Presence] in Serum by Immunoassay |
|
38182-2
|
Parainfluenza virus 1 IgG Ab [Units/volume] in Serum |
|
15390-8
|
Parainfluenza virus 1 IgM Ab [Presence] in Serum |
|
31549-9
|
Parainfluenza virus 1 IgM Ab [Units/volume] in Serum |
|
15391-6
|
Parainfluenza virus 1 IgM Ab [Titer] in Serum |
|
53252-3
|
Parainfluenza virus 1 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88208-4
|
Parainfluenza virus 1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60269-8
|
Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection |
|
88563-2
|
Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82171-0
|
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76084-3
|
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92140-3
|
Parainfluenza virus 1 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91802-9
|
Parainfluenza virus 1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29908-1
|
Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55097-0
|
Parainfluenza virus 1 [Presence] in Unspecified specimen by Organism specific culture |
|
38400-8
|
Parainfluenza virus 1+2+3 Ab [Presence] in Serum |
|
51466-1
|
Parainfluenza virus 1+2+3 Ab [Titer] in Serum |
|
50692-3
|
Parainfluenza virus 1+2+3 Ab [Titer] in Serum by Complement fixation |
|
17414-4
|
Parainfluenza virus 1+2+3 Ag [Presence] in Unspecified specimen |
|
60254-0
|
Parainfluenza virus 1+2+3 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43204-7
|
Parainfluenza virus 2 Ab [Units/volume] in Cerebral spinal fluid |
|
31550-7
|
Parainfluenza virus 2 Ab [Units/volume] in Body fluid |
|
7979-8
|
Parainfluenza virus 2 Ab [Units/volume] in Serum |
|
24294-1
|
Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen |
|
24220-6
|
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24295-8
|
Parainfluenza virus 2 Ab [Titer] in Serum --2nd specimen |
|
24221-4
|
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
29359-7
|
Parainfluenza virus 2 Ab [Titer] in Body fluid |
|
29367-0
|
Parainfluenza virus 2 Ab [Titer] in Body fluid by Complement fixation |
|
22438-6
|
Parainfluenza virus 2 Ab [Titer] in Serum |
|
5269-6
|
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation |
|
77386-1
|
Parainfluenza virus 2 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
67809-4
|
Parainfluenza virus 2 Ag [Presence] in Isolate by Immunofluorescence |
|
88907-1
|
Parainfluenza virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
77391-1
|
Parainfluenza virus 2 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31925-1
|
Parainfluenza virus 2 Ag [Presence] in Throat |
|
5870-1
|
Parainfluenza virus 2 Ag [Presence] in Throat by Immunofluorescence |
|
31926-9
|
Parainfluenza virus 2 Ag [Presence] in Unspecified specimen |
|
5871-9
|
Parainfluenza virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41405-2
|
Parainfluenza virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
15392-4
|
Parainfluenza virus 2 IgG Ab [Presence] in Serum |
|
40984-7
|
Parainfluenza virus 2 IgG Ab [Presence] in Serum by Immunoassay |
|
38183-0
|
Parainfluenza virus 2 IgG Ab [Units/volume] in Serum |
|
29667-3
|
Parainfluenza virus 2 IgM Ab [Presence] in Serum |
|
29646-7
|
Parainfluenza virus 2 IgM Ab [Presence] in Serum by Immunoassay |
|
31551-5
|
Parainfluenza virus 2 IgM Ab [Units/volume] in Serum |
|
15393-2
|
Parainfluenza virus 2 IgM Ab [Titer] in Serum |
|
80593-7
|
Parainfluenza virus 2 L gene [Presence] in Nasopharynx by NAA with probe detection |
|
53253-1
|
Parainfluenza virus 2 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88209-2
|
Parainfluenza virus 2 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60417-3
|
Parainfluenza virus 2 RNA [Presence] in Isolate by NAA with probe detection |
|
88559-0
|
Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82172-8
|
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76085-0
|
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92139-5
|
Parainfluenza virus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91801-1
|
Parainfluenza virus 2 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29909-9
|
Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55098-8
|
Parainfluenza virus 2 [Presence] in Unspecified specimen by Organism specific culture |
|
46200-2
|
Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid |
|
43205-4
|
Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
31552-3
|
Parainfluenza virus 3 Ab [Units/volume] in Body fluid |
|
7980-6
|
Parainfluenza virus 3 Ab [Units/volume] in Serum |
|
24296-6
|
Parainfluenza virus 3 Ab [Titer] in Serum --1st specimen |
|
24222-2
|
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24297-4
|
Parainfluenza virus 3 Ab [Titer] in Serum --2nd specimen |
|
24223-0
|
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
29414-0
|
Parainfluenza virus 3 Ab [Titer] in Body fluid |
|
29368-8
|
Parainfluenza virus 3 Ab [Titer] in Body fluid by Complement fixation |
|
22439-4
|
Parainfluenza virus 3 Ab [Titer] in Serum |
|
5270-4
|
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation |
|
15493-0
|
Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
77387-9
|
Parainfluenza virus 3 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
67810-2
|
Parainfluenza virus 3 Ag [Presence] in Isolate by Immunofluorescence |
|
88908-9
|
Parainfluenza virus 3 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
77392-9
|
Parainfluenza virus 3 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31927-7
|
Parainfluenza virus 3 Ag [Presence] in Throat |
|
5872-7
|
Parainfluenza virus 3 Ag [Presence] in Throat by Immunofluorescence |
|
31928-5
|
Parainfluenza virus 3 Ag [Presence] in Unspecified specimen |
|
5873-5
|
Parainfluenza virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
15394-0
|
Parainfluenza virus 3 IgG Ab [Presence] in Serum |
|
40985-4
|
Parainfluenza virus 3 IgG Ab [Presence] in Serum by Immunoassay |
|
31553-1
|
Parainfluenza virus 3 IgG Ab [Units/volume] in Serum |
|
11262-3
|
Parainfluenza virus 3 IgG Ab [Titer] in Serum |
|
15395-7
|
Parainfluenza virus 3 IgM Ab [Presence] in Serum |
|
31554-9
|
Parainfluenza virus 3 IgM Ab [Units/volume] in Serum |
|
11263-1
|
Parainfluenza virus 3 IgM Ab [Titer] in Serum |
|
80594-5
|
Parainfluenza virus 3 NP gene [Presence] in Nasopharynx by NAA with probe detection |
|
53254-9
|
Parainfluenza virus 3 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88210-0
|
Parainfluenza virus 3 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60416-5
|
Parainfluenza virus 3 RNA [Presence] in Isolate by NAA with probe detection |
|
88560-8
|
Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82173-6
|
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76086-8
|
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92138-7
|
Parainfluenza virus 3 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91800-3
|
Parainfluenza virus 3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29910-7
|
Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55099-6
|
Parainfluenza virus 3 [Presence] in Unspecified specimen by Organism specific culture |
|
67811-0
|
Parainfluenza virus 4 Ag [Presence] in Isolate by Immunofluorescence |
|
60424-9
|
Parainfluenza virus 4 Ag [Presence] in Unspecified specimen |
|
40986-2
|
Parainfluenza virus 4 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
42983-7
|
Parainfluenza virus 4 IgG Ab [Presence] in Serum |
|
41990-3
|
Parainfluenza virus 4 IgG Ab [Presence] in Serum by Immunoassay |
|
80595-2
|
Parainfluenza virus 4 P gene [Presence] in Nasopharynx by NAA with probe detection |
|
88530-1
|
Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60415-7
|
Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection |
|
88561-6
|
Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82174-4
|
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76087-6
|
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92137-9
|
Parainfluenza virus 4 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91799-7
|
Parainfluenza virus 4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41010-0
|
Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
67818-5
|
Parainfluenza virus 4a RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
67819-3
|
Parainfluenza virus 4b RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17415-1
|
Parainfluenza virus A Ab [Units/volume] in Serum |
|
47861-0
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells |
|
79461-0
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells |
|
55896-5
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample |
|
47652-3
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Placenta |
|
2454-7
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
2455-4
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Tissue |
|
55892-4
|
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Amniotic fluid cells |
|
55895-7
|
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Chorionic villus sample |
|
55894-0
|
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Placenta |
|
55893-2
|
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Red Blood Cells |
|
53869-4
|
HPRT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53870-2
|
HPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82456-5
|
Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
|
7975-6
|
Human papilloma virus Ab [Presence] in Genital specimen |
|
6510-2
|
Human papilloma virus Ab [Presence] in Genital specimen by Immunoassay |
|
6511-0
|
Human papilloma virus Ab [Presence] in Genital specimen by Immunoblot |
|
22434-5
|
Human papilloma virus Ab [Presence] in Tissue |
|
6512-8
|
Human papilloma virus Ab [Presence] in Tissue by Immunoassay |
|
6513-6
|
Human papilloma virus Ab [Presence] in Tissue by Immunoblot |
|
14499-8
|
Human papilloma virus Ag [Presence] in Cervix |
|
12222-6
|
Human papilloma virus Ag [Presence] in Genital specimen |
|
14501-1
|
Human papilloma virus Ag [Presence] in Penis |
|
10705-2
|
Human papilloma virus Ag [Presence] in Tissue by Immune stain |
|
14502-9
|
Human papilloma virus Ag [Presence] in Urethra |
|
14500-3
|
Human papilloma virus Ag [Presence] in Vaginal fluid |
|
11083-3
|
Human papilloma virus identified in Cervix |
|
44550-2
|
Human papilloma virus DNA [Presence] in Cervix by Probe |
|
38372-9
|
Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
91852-4
|
Human papilloma virus DNA [Presence] in Genital specimen by NAA with probe detection |
|
86564-2
|
Human papilloma virus DNA [Presence] in Tissue by NAA with probe detection |
|
44551-0
|
Human papilloma virus DNA [Presence] in Tissue by Probe |
|
44545-2
|
Human papilloma virus DNA [Presence] in Urethra by Probe |
|
44548-6
|
Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification |
|
44546-0
|
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe |
|
44549-4
|
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
49891-5
|
Human papilloma virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16280-0
|
Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with amplification |
|
44547-8
|
Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
74763-4
|
Human papilloma virus E6+E7 mRNA [Presence] in Anal by NAA with probe detection |
|
69358-0
|
HPV E6+E7 mRNA cells/cells [Presence] in Cervix by Flow cytometry (FC) |
|
69002-4
|
Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
|
91851-6
|
Human papilloma virus genotype [Identifier] in Genital specimen by NAA with probe detection |
|
91073-7
|
Human papilloma virus genotype [Identifier] in Tissue by NAA with probe detection |
|
48560-7
|
Human papilloma virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
73959-9
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe |
|
73732-0
|
Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA [Presence] in Genital specimen by NAA with probe detection |
|
77394-5
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal by NAA with probe detection |
|
75696-5
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
|
71431-1
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
|
91853-2
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86563-4
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Tissue by NAA with probe detection |
|
77375-4
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
56140-7
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Anal by Probe with signal amplification |
|
30167-1
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
91855-7
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86561-8
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Tissue by NAA with probe detection |
|
49896-4
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32047-3
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA [Presence] in Tissue by Probe |
|
43210-4
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by NAA with probe detection |
|
43209-6
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by Probe with signal amplification |
|
82675-0
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
|
59420-0
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
21440-3
|
Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe |
|
13321-5
|
Human papilloma virus IgG Ab [Presence] in Serum |
|
13322-3
|
Human papilloma virus IgM Ab [Presence] in Serum |
|
43211-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe |
|
50642-8
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe with signal amplification |
|
21441-1
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe |
|
42481-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification |
|
55298-4
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Urethra by Probe with signal amplification |
|
55299-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
6514-4
|
Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection |
|
6515-1
|
Human papilloma virus rRNA [Presence] in Tissue by NAA with probe detection |
|
6516-9
|
Human papilloma virus rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11481-9
|
Human papilloma virus identified in Unspecified specimen |
|
17398-9
|
Human papilloma virus 11 Ag [Presence] in Unspecified specimen |
|
74779-0
|
Human papilloma virus 11 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74778-2
|
Human papilloma virus 11 DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
61394-3
|
Human papilloma virus 11 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17399-7
|
Human papilloma virus 16 Ag [Presence] in Unspecified specimen |
|
70061-7
|
Human papilloma virus 16 and 18 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77396-0
|
Human papilloma virus 16 DNA [Presence] in Anorectal by NAA with probe detection |
|
75664-3
|
Human papilloma virus 16 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
|
77399-4
|
Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection |
|
59263-4
|
Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification |
|
91856-5
|
Human papilloma virus 16 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86560-0
|
Human papilloma virus 16 DNA [Presence] in Tissue by NAA with probe detection |
|
61372-9
|
Human papilloma virus 16 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14503-7
|
Human papilloma virus 16+18 Ag [Presence] in Cervix |
|
12223-4
|
Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
|
14505-2
|
Human papilloma virus 16+18 Ag [Presence] in Penis |
|
14506-0
|
Human papilloma virus 16+18 Ag [Presence] in Urethra |
|
14504-5
|
Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid |
|
17400-3
|
Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen |
|
18478-8
|
Human papilloma virus 16+18 DNA [Presence] in Tissue by Probe |
|
93777-1
|
Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe |
|
82354-2
|
Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection |
|
77380-4
|
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Anorectal |
|
77379-6
|
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix |
|
77377-0
|
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Unspecified specimen |
|
17401-1
|
Human papilloma virus 18 Ag [Presence] in Unspecified specimen |
|
77395-2
|
Human papilloma virus 18 DNA [Presence] in Anorectal by NAA with probe detection |
|
75695-7
|
Human papilloma virus 18 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
|
77400-0
|
Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection |
|
59264-2
|
Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification |
|
91854-0
|
Human papilloma virus 18 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86562-6
|
Human papilloma virus 18 DNA [Presence] in Tissue by NAA with probe detection |
|
61373-7
|
Human papilloma virus 18 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
75694-0
|
Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
|
61374-5
|
Human papilloma virus 26 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17402-9
|
Human papilloma virus 31 Ag [Presence] in Unspecified specimen |
|
61375-2
|
Human papilloma virus 31 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44543-7
|
Human papilloma virus 31+33 Ag [Presence] in Unspecified specimen |
|
81439-2
|
Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe |
|
43170-0
|
Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe with signal amplification |
|
17403-7
|
Human papilloma virus 31+33+35 Ag [Presence] in Unspecified specimen |
|
18479-6
|
Human papilloma virus 31+35+51 DNA [Presence] in Tissue by Probe |
|
17404-5
|
Human papilloma virus 33 Ag [Presence] in Unspecified specimen |
|
61376-0
|
Human papilloma virus 33 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44544-5
|
Human papilloma virus 35 Ag [Presence] in Unspecified specimen |
|
61377-8
|
Human papilloma virus 35 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61378-6
|
Human papilloma virus 39 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17405-2
|
Human papilloma virus 42 Ag [Presence] in Unspecified specimen |
|
61395-0
|
Human papilloma virus 42 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17406-0
|
Human papilloma virus 43 Ag [Presence] in Unspecified specimen |
|
17407-8
|
Human papilloma virus 44 Ag [Presence] in Unspecified specimen |
|
61379-4
|
Human papilloma virus 44 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17408-6
|
Human papilloma virus 45 Ag [Presence] in Unspecified specimen |
|
61380-2
|
Human papilloma virus 45 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17409-4
|
Human papilloma virus 5 Ag [Presence] in Unspecified specimen |
|
17410-2
|
Human papilloma virus 51 Ag [Presence] in Unspecified specimen |
|
61381-0
|
Human papilloma virus 51 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61382-8
|
Human papilloma virus 52 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61383-6
|
Human papilloma virus 53 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61396-8
|
Human papilloma virus 56 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61384-4
|
Human papilloma virus 58 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61385-1
|
Human papilloma virus 59 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17411-0
|
Human papilloma virus 6 Ag [Presence] in Unspecified specimen |
|
74777-4
|
Human papilloma virus 6 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74776-6
|
Human papilloma virus 6 DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
61393-5
|
Human papilloma virus 6 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17412-8
|
Human papilloma virus 6+11 Ag [Presence] in Unspecified specimen |
|
18480-4
|
Human papilloma virus 6+11 DNA [Presence] in Tissue by Probe |
|
93778-9
|
Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe |
|
61386-9
|
Human papilloma virus 66 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61387-7
|
Human papilloma virus 67 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61388-5
|
Human papilloma virus 68 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61389-3
|
Human papilloma virus 69 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61390-1
|
Human papilloma virus 70 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61391-9
|
Human papilloma virus 73 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61392-7
|
Human papilloma virus 82 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
21698-6
|
HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53871-0
|
HRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53623-5
|
HRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
21699-4
|
HRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
18025-7
|
Heart Diameter anterior-posterior systole/Aortic root diameter by US |
|
93633-6
|
Heart Left ventricular outflow tract/Maximum blood flow aortic valve by US.doppler |
|
93632-8
|
Heart Left ventricular outflow tract/Aortic valve VTI by US.doppler |
|
80278-5
|
Heart Murmur grade |
|
80280-1
|
Heart Murmur pitch |
|
80279-3
|
Heart Murmur quality |
|
80281-9
|
Heart Murmur timing |
|
41919-2
|
Heart rate device Vendor software version |
|
20189-7
|
Ventricular Cardiac index by US.cubed.calculated |
|
20223-4
|
Ventricular Ejection time 2 by US |
|
20221-8
|
Ventricular Ejection time by US.doppler |
|
20222-6
|
Ventricular Ejection time by US |
|
20209-3
|
Ventricular Cardiac output by US.2D+Calculated by modified Simpson method |
|
88856-0
|
Hematopoietic stem cell transplantation risk score EBMT |
|
88862-8
|
Hematopoietic stem cell transplantation risk score interpretation EBMT |
|
81814-6
|
HSD17B4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
68934-9
|
Heat shock protein 60 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
80353-6
|
Herpes simplex virus 1 genome DNA polymerase region B+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection |
|
44009-9
|
Herpes simplex virus 1 and 2 IgG Ab [Interpretation] in Serum by Immunoassay |
|
44008-1
|
Herpes simplex virus 1 and 2 IgM Ab [Interpretation] in Serum |
|
80355-1
|
Herpes simplex virus 2 genome glycoprotein B 3' end region+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection |
|
44506-4
|
Herpes simplex virus Ab [Presence] in Cerebral spinal fluid |
|
31413-8
|
Herpes simplex virus Ab [Units/volume] in Cerebral spinal fluid |
|
46190-5
|
Herpes simplex virus Ab [Presence] in Body fluid |
|
44504-9
|
Herpes simplex virus Ab [Presence] in Body fluid by Immunofluorescence |
|
52977-6
|
Herpes simplex virus Ab [Units/volume] in Serum by Complement fixation |
|
5202-7
|
Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay |
|
5203-5
|
Herpes simplex virus Ab [Units/volume] in Serum by Latex agglutination |
|
22339-6
|
Herpes simplex virus Ab [Presence] in Serum |
|
16942-5
|
Herpes simplex virus Ab [Presence] in Serum by Immunoblot |
|
7907-9
|
Herpes simplex virus Ab [Units/volume] in Serum |
|
22340-4
|
Herpes simplex virus Ab [Titer] in Cerebral spinal fluid |
|
9454-0
|
Herpes simplex virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22341-2
|
Herpes simplex virus Ab [Titer] in Serum |
|
5204-3
|
Herpes simplex virus Ab [Titer] in Serum by Complement fixation |
|
44513-0
|
Herpes simplex virus Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
88681-2
|
Herpes simplex virus Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
|
47229-0
|
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid |
|
44514-8
|
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
88680-4
|
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
44508-0
|
Herpes simplex virus Ag [Presence] in Cervix |
|
44515-5
|
Herpes simplex virus Ag [Presence] in Cervix by Immunoassay |
|
44516-3
|
Herpes simplex virus Ag [Presence] in Cervix by Immunofluorescence |
|
44511-4
|
Herpes simplex virus Ag [Presence] in Eye |
|
31852-7
|
Herpes simplex virus Ag [Presence] in Genital specimen |
|
5850-3
|
Herpes simplex virus Ag [Presence] in Genital specimen by Immunoassay |
|
5851-1
|
Herpes simplex virus Ag [Presence] in Genital specimen by Immunofluorescence |
|
91833-4
|
Herpes simplex virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44512-2
|
Herpes simplex virus Ag [Presence] in Nose |
|
44509-8
|
Herpes simplex virus Ag [Presence] in Penis |
|
31853-5
|
Herpes simplex virus Ag [Presence] in Serum |
|
29957-8
|
Herpes simplex virus Ag [Presence] in Serum by Immunoblot |
|
31854-3
|
Herpes simplex virus Ag [Presence] in Skin |
|
5852-9
|
Herpes simplex virus Ag [Presence] in Skin by Immunoassay |
|
5853-7
|
Herpes simplex virus Ag [Presence] in Skin by Immunofluorescence |
|
44510-6
|
Herpes simplex virus Ag [Presence] in Vaginal fluid |
|
16945-8
|
Herpes simplex virus Ag [Presence] in Unspecified specimen |
|
5854-5
|
Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
5855-2
|
Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
35417-5
|
Herpes simplex virus identified in Anal by Organism specific culture |
|
91773-2
|
Herpes simplex virus identified in Aspirate by Organism specific culture |
|
35418-3
|
Herpes simplex virus identified in Bronchial specimen by Organism specific culture |
|
88127-6
|
Herpes simplex virus identified in Cornea or Conjunctiva by Organism specific culture |
|
35419-1
|
Herpes simplex virus identified in Cerebral spinal fluid by Organism specific culture |
|
10680-7
|
Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
|
43696-4
|
Herpes simplex virus identified in Cerebral spinal fluid by Shell vial culture |
|
35420-9
|
Herpes simplex virus identified in Cervix by Organism specific culture |
|
44517-1
|
Herpes simplex virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
90450-8
|
Herpes simplex virus DNA [Presence] in Aspirate by NAA with probe detection |
|
34451-5
|
Herpes simplex virus DNA [Presence] in Blood by NAA with probe detection |
|
88138-3
|
Herpes simplex virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
5013-8
|
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91857-3
|
Herpes simplex virus DNA [Presence] in Genital specimen by NAA with probe detection |
|
89584-7
|
Herpes simplex virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
44518-9
|
Herpes simplex virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
86542-8
|
Herpes simplex virus DNA [Presence] in Tissue by NAA with probe detection |
|
72838-6
|
Herpes simplex virus DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
5014-6
|
Herpes simplex virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35421-7
|
Herpes simplex virus identified in Ear by Organism specific culture |
|
32689-2
|
Herpes simplex virus identified in Eye by Organism specific culture |
|
35422-5
|
Herpes simplex virus identified in Body fluid by Organism specific culture |
|
5856-0
|
Herpes simplex virus identified in Genital specimen by Organism specific culture |
|
47230-8
|
Herpes simplex virus glycoprotein G IgG Ab [Presence] in Serum |
|
9659-4
|
Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44505-6
|
Herpes simplex virus IgG Ab [Presence] in Cerebral spinal fluid |
|
16943-3
|
Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
53533-6
|
Herpes simplex virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
52981-8
|
Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
20446-1
|
Herpes simplex virus IgG Ab [Interpretation] in Serum by Immunoassay |
|
19106-4
|
Herpes simplex virus IgG Ab [Presence] in Serum |
|
40728-8
|
Herpes simplex virus IgG Ab [Presence] in Serum by Immunoassay |
|
9422-7
|
Herpes simplex virus IgG Ab [Units/volume] in Serum |
|
22342-0
|
Herpes simplex virus IgG Ab [Interpretation] in Serum |
|
53377-8
|
Herpes simplex virus IgG Ab [Titer] in Serum |
|
51915-7
|
Herpes simplex virus IgG Ab [Titer] in Serum by Immunoassay |
|
53538-5
|
Herpes simplex virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
53560-9
|
Herpes simplex virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25435-9
|
Herpes simplex virus IgM Ab [Presence] in Serum |
|
40729-6
|
Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay |
|
44507-2
|
Herpes simplex virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
16944-1
|
Herpes simplex virus IgM Ab [Units/volume] in Serum |
|
22343-8
|
Herpes simplex virus IgM Ab [Titer] in Serum |
|
10350-7
|
Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
|
14213-3
|
Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
5857-8
|
Herpes simplex virus identified in Isolate by Immunofluorescence |
|
88606-9
|
Herpes simplex virus identified in Lower respiratory specimen by Organism specific culture |
|
35451-4
|
Herpes simplex virus identified in Nasopharynx by Organism specific culture |
|
35424-1
|
Herpes simplex virus identified in Penis by Organism specific culture |
|
35425-8
|
Herpes simplex virus identified in Placenta by Organism specific culture |
|
35426-6
|
Herpes simplex virus identified in Pleural fluid by Organism specific culture |
|
35427-4
|
Herpes simplex virus identified in Peritoneal fluid by Organism specific culture |
|
5858-6
|
Herpes simplex virus identified in Skin by Organism specific culture |
|
35428-2
|
Herpes simplex virus identified in Synovial fluid by Organism specific culture |
|
35429-0
|
Herpes simplex virus identified in Stool by Organism specific culture |
|
35430-8
|
Herpes simplex virus identified in Throat by Organism specific culture |
|
35431-6
|
Herpes simplex virus identified in Tissue by Organism specific culture |
|
10681-5
|
Herpes simplex virus identified in Tissue by Electron microscopy |
|
35432-4
|
Herpes simplex virus identified in Urine by Organism specific culture |
|
35433-2
|
Herpes simplex virus identified in Urethra by Organism specific culture |
|
35423-3
|
Herpes simplex virus identified in Vaginal fluid by Organism specific culture |
|
35434-0
|
Herpes simplex virus identified in Wound by Organism specific culture |
|
5859-4
|
Herpes simplex virus identified in Unspecified specimen by Organism specific culture |
|
43697-2
|
Herpes simplex virus identified in Unspecified specimen by Shell vial culture |
|
33027-4
|
Herpes simplex virus+Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62454-4
|
Herpes simplex virus and Varicella zoster virus identified in Unspecified specimen by Organism specific culture |
|
41033-2
|
Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22331-3
|
Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid |
|
16947-4
|
Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
31410-4
|
Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid |
|
44469-5
|
Herpes simplex virus 1 Ab [Presence] in Body fluid |
|
29237-5
|
Herpes simplex virus 1 Ab [Units/volume] in Body fluid |
|
5205-0
|
Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunoassay |
|
13324-9
|
Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence |
|
43111-4
|
Herpes simplex virus 1 Ab [Presence] in Serum |
|
7908-7
|
Herpes simplex virus 1 Ab [Units/volume] in Serum |
|
32180-2
|
Herpes simplex virus 1 Ab [Units/volume] in Synovial fluid |
|
43032-2
|
Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid |
|
25838-4
|
Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
43031-4
|
Herpes simplex virus 1 Ab [Titer] in Serum |
|
25837-6
|
Herpes simplex virus 1 Ab [Titer] in Serum by Immunofluorescence |
|
44470-3
|
Herpes simplex virus 1 Ag [Presence] in Anal |
|
88678-8
|
Herpes simplex virus 1 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
|
89586-2
|
Herpes simplex virus 1 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
44471-1
|
Herpes simplex virus 1 Ag [Presence] in Cervix |
|
44472-9
|
Herpes simplex virus 1 Ag [Presence] in Eye |
|
31846-9
|
Herpes simplex virus 1 Ag [Presence] in Genital specimen |
|
5844-6
|
Herpes simplex virus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
|
91835-9
|
Herpes simplex virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44473-7
|
Herpes simplex virus 1 Ag [Presence] in Penis |
|
31847-7
|
Herpes simplex virus 1 Ag [Presence] in Skin |
|
5845-3
|
Herpes simplex virus 1 Ag [Presence] in Skin by Immunofluorescence |
|
44474-5
|
Herpes simplex virus 1 Ag [Presence] in Throat |
|
44475-2
|
Herpes simplex virus 1 Ag [Presence] in Tissue |
|
88201-9
|
Herpes simplex virus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
10677-3
|
Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
|
44476-0
|
Herpes simplex virus 1 Ag [Presence] in Urethra |
|
44477-8
|
Herpes simplex virus 1 Ag [Presence] in Vaginal fluid |
|
31848-5
|
Herpes simplex virus 1 Ag [Presence] in Unspecified specimen |
|
5846-1
|
Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
44468-7
|
Herpes simplex virus 1 [Presence] in Anal by Organism specific culture |
|
44467-9
|
Herpes simplex virus 1 [Presence] in Cervix by Organism specific culture |
|
62472-6
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
62473-4
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49985-5
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49987-1
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49986-3
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
|
62470-0
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
50660-0
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
62471-8
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
50661-8
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
60461-1
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
44478-6
|
Herpes simplex virus 1 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
92872-1
|
Herpes simplex virus 1 DNA [Presence] in Anogenital by NAA with probe detection |
|
90451-6
|
Herpes simplex virus 1 DNA [Presence] in Aspirate by NAA with probe detection |
|
93439-8
|
Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection |
|
92870-5
|
Herpes simplex virus 1 DNA [Presence] in Blood by NAA with probe detection |
|
88128-4
|
Herpes simplex virus 1 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82190-0
|
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
16952-4
|
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91859-9
|
Herpes simplex virus 1 DNA [Presence] in Genital specimen by NAA with probe detection |
|
89585-4
|
Herpes simplex virus 1 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
16953-2
|
Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
92871-3
|
Herpes simplex virus 1 DNA [Presence] in Skin by NAA with probe detection |
|
86539-4
|
Herpes simplex virus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
90452-4
|
Herpes simplex virus 1 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
16130-7
|
Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44465-3
|
Herpes simplex virus 1 [Presence] in Genital specimen by Organism specific culture |
|
48399-0
|
Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid |
|
42337-6
|
Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Serum |
|
32831-0
|
Herpes simplex virus 1 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
32846-8
|
Herpes simplex virus 1 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
58786-5
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
42507-4
|
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid |
|
28001-6
|
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
16948-2
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
31066-4
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Body fluid |
|
5206-8
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
17850-9
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum |
|
33291-6
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot |
|
7909-5
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum |
|
51916-5
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
16949-0
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen |
|
16950-8
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen |
|
22333-9
|
Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid |
|
14086-3
|
Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
73559-7
|
Herpes simplex virus 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
58784-0
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
69921-5
|
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
88457-7
|
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13251-4
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
31068-0
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Body fluid |
|
5207-6
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
32687-6
|
Herpes simplex virus 1 IgM Ab [Presence] in Serum |
|
40466-5
|
Herpes simplex virus 1 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7910-3
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Serum |
|
22334-7
|
Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid |
|
14087-1
|
Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
21326-4
|
Herpes simplex virus 1 IgM Ab [Titer] in Serum |
|
50758-2
|
Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
14084-8
|
Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
|
44464-6
|
Herpes simplex virus 1 [Presence] in Skin by Organism specific culture |
|
44466-1
|
Herpes simplex virus 1 [Presence] in Throat by Organism specific culture |
|
44463-8
|
Herpes simplex virus 1 [Presence] in Vaginal fluid by Organism specific culture |
|
16291-7
|
Herpes simplex virus 1 [Presence] in Unspecified specimen by Organism specific culture |
|
44479-4
|
Herpes simplex virus 1+2 Ab [Presence] in Cerebral spinal fluid |
|
35875-4
|
Herpes simplex virus 1+2 Ab [Units/volume] in Cerebral spinal fluid |
|
13505-3
|
Herpes simplex virus 1+2 Ab pattern [Interpretation] in Serum |
|
44480-2
|
Herpes simplex virus 1+2 Ab [Presence] in Serum |
|
43033-0
|
Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid |
|
33292-4
|
Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
48400-6
|
Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immunofluorescence |
|
10678-1
|
Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
|
49385-8
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49386-6
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
34655-1
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49384-1
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
47409-8
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49382-5
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49383-3
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49381-7
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
58414-4
|
Herpes simplex virus 1+2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
32141-4
|
Herpes simplex virus 1+2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
44868-8
|
Herpes simplex virus 1+2 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
20444-6
|
Herpes simplex virus 1+2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44481-0
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid |
|
33293-2
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
13249-8
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
44482-8
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Body fluid |
|
27948-9
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
36921-5
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum |
|
90461-5
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoassay |
|
49848-5
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot |
|
31411-2
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum |
|
34613-0
|
Herpes simplex virus 1+2 IgG Ab [Titer] in Serum |
|
41150-4
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid |
|
33294-0
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63432-9
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
44483-6
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Body fluid |
|
41399-7
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
41149-6
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum |
|
90464-9
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunoassay |
|
30355-2
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunofluorescence |
|
43030-6
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum |
|
39571-5
|
Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid |
|
49731-3
|
Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
34152-9
|
Herpes simplex virus 1+2 IgM Ab [Titer] in Serum |
|
41034-0
|
Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
44493-5
|
Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid |
|
44492-7
|
Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
27087-6
|
Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid |
|
44491-9
|
Herpes simplex virus 2 Ab [Presence] in Body fluid |
|
29236-7
|
Herpes simplex virus 2 Ab [Units/volume] in Body fluid |
|
13501-2
|
Herpes simplex virus 2 Ab pattern [Interpretation] in Serum |
|
5208-4
|
Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunoassay |
|
13323-1
|
Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence |
|
16954-0
|
Herpes simplex virus 2 Ab [Presence] in Serum |
|
48784-3
|
Herpes simplex virus 2 Ab [Presence] in Serum by Immunoassay |
|
7911-1
|
Herpes simplex virus 2 Ab [Units/volume] in Serum |
|
32181-0
|
Herpes simplex virus 2 Ab [Units/volume] in Synovial fluid |
|
43029-8
|
Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid |
|
25840-0
|
Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
43028-0
|
Herpes simplex virus 2 Ab [Titer] in Serum |
|
25839-2
|
Herpes simplex virus 2 Ab [Titer] in Serum by Immunofluorescence |
|
44498-4
|
Herpes simplex virus 2 Ag [Presence] in Anal |
|
88679-6
|
Herpes simplex virus 2 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
|
89588-8
|
Herpes simplex virus 2 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
44500-7
|
Herpes simplex virus 2 Ag [Presence] in Cervix |
|
44495-0
|
Herpes simplex virus 2 Ag [Presence] in Eye |
|
31849-3
|
Herpes simplex virus 2 Ag [Presence] in Genital specimen |
|
5847-9
|
Herpes simplex virus 2 Ag [Presence] in Genital specimen by Immunofluorescence |
|
91834-2
|
Herpes simplex virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44496-8
|
Herpes simplex virus 2 Ag [Presence] in Penis |
|
31850-1
|
Herpes simplex virus 2 Ag [Presence] in Skin |
|
5848-7
|
Herpes simplex virus 2 Ag [Presence] in Skin by Immunofluorescence |
|
44501-5
|
Herpes simplex virus 2 Ag [Presence] in Throat |
|
44502-3
|
Herpes simplex virus 2 Ag [Presence] in Tissue |
|
86540-2
|
Herpes simplex virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
10679-9
|
Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
|
44499-2
|
Herpes simplex virus 2 Ag [Presence] in Urethra |
|
44497-6
|
Herpes simplex virus 2 Ag [Presence] in Vaginal fluid |
|
31851-9
|
Herpes simplex virus 2 Ag [Presence] in Unspecified specimen |
|
5849-5
|
Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
44490-1
|
Herpes simplex virus 2 [Presence] in Anal by Organism specific culture |
|
44489-3
|
Herpes simplex virus 2 [Presence] in Cervix by Organism specific culture |
|
62476-7
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
62477-5
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49988-9
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49990-5
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49989-7
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
|
62474-2
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
50662-6
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
62475-9
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
50663-4
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
60462-9
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
44503-1
|
Herpes simplex virus 2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
92875-4
|
Herpes simplex virus 2 DNA [Presence] in Anogenital by NAA with probe detection |
|
90453-2
|
Herpes simplex virus 2 DNA [Presence] in Aspirate by NAA with probe detection |
|
93438-0
|
Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection |
|
92873-9
|
Herpes simplex virus 2 DNA [Presence] in Blood by NAA with probe detection |
|
88133-4
|
Herpes simplex virus 2 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82191-8
|
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
16960-7
|
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91858-1
|
Herpes simplex virus 2 DNA [Presence] in Genital specimen by NAA with probe detection |
|
89587-0
|
Herpes simplex virus 2 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
16959-9
|
Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
92874-7
|
Herpes simplex virus 2 DNA [Presence] in Skin by NAA with probe detection |
|
86541-0
|
Herpes simplex virus 2 DNA [Presence] in Tissue by NAA with probe detection |
|
90454-0
|
Herpes simplex virus 2 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
16131-5
|
Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44487-7
|
Herpes simplex virus 2 [Presence] in Genital specimen by Organism specific culture |
|
48401-4
|
Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid |
|
42338-4
|
Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Serum |
|
32790-8
|
Herpes simplex virus 2 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
32834-4
|
Herpes simplex virus 2 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
58785-7
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
27315-1
|
Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid |
|
16956-5
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
31067-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Body fluid |
|
5209-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
17851-7
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum |
|
16955-7
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot |
|
7912-9
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum |
|
43180-9
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
16957-3
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen |
|
57321-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
16958-1
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen |
|
22337-0
|
Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid |
|
14089-7
|
Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
24014-3
|
Herpes simplex virus 2 IgG Ab [Titer] in Serum |
|
58783-2
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43026-4
|
Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid |
|
42606-4
|
Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13252-2
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
31412-0
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Body fluid |
|
5210-0
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
32688-4
|
Herpes simplex virus 2 IgM Ab [Presence] in Serum |
|
44494-3
|
Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunoassay |
|
45210-2
|
Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7913-7
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Serum |
|
22338-8
|
Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid |
|
14090-5
|
Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
43027-2
|
Herpes simplex virus 2 IgM Ab [Titer] in Body fluid |
|
31069-8
|
Herpes simplex virus 2 IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
21327-2
|
Herpes simplex virus 2 IgM Ab [Titer] in Serum |
|
26927-4
|
Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
14085-5
|
Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence |
|
44486-9
|
Herpes simplex virus 2 [Presence] in Skin by Organism specific culture |
|
44488-5
|
Herpes simplex virus 2 [Presence] in Throat by Organism specific culture |
|
44485-1
|
Herpes simplex virus 2 [Presence] in Vaginal fluid by Organism specific culture |
|
44484-4
|
Herpes simplex virus 2 [Presence] in Unspecified specimen by Organism specific culture |
|
53849-6
|
HTC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53850-4
|
HTC2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
73012-7
|
hydroCHLOROthiazide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73011-9
|
hydroCHLOROthiazide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
44384-6
|
hydroCHLOROthiazide [Presence] in 24 hour Urine |
|
3678-0
|
hydroCHLOROthiazide [Mass/time] in 24 hour Urine |
|
4275-4
|
hydroCHLOROthiazide [Mass] of Dose |
|
73353-5
|
hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73352-7
|
hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
44552-8
|
hydroCHLOROthiazide [Presence] in Serum or Plasma |
|
3675-6
|
hydroCHLOROthiazide [Mass/volume] in Serum or Plasma |
|
55541-7
|
hydroCHLOROthiazide [Moles/volume] in Serum or Plasma |
|
3676-4
|
hydroCHLOROthiazide [Presence] in Urine |
|
3677-2
|
hydroCHLOROthiazide [Mass/volume] in Urine |
|
73351-9
|
hydroCHLOROthiazide+Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73350-1
|
hydroCHLOROthiazide+Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
18298-0
|
High titer low avidity Ab [Presence] in Serum or Plasma |
|
93743-3
|
HTLV I and II IgG band [Type] in Cerebral spinal fluid by Line blot |
|
40822-9
|
HTLV I Ab [Presence] in Cerebral spinal fluid |
|
44535-3
|
HTLV I Ab [Presence] in Serum from Donor |
|
67815-1
|
HTLV I Ab [Units/volume] in Serum by Immunoassay |
|
22359-4
|
HTLV I Ab [Presence] in Serum |
|
11260-7
|
HTLV I Ab [Presence] in Serum by Immunoassay |
|
6432-9
|
HTLV I Ab [Presence] in Serum by Immunoblot |
|
11609-5
|
HTLV I Ab [Units/volume] in Serum |
|
44537-9
|
HTLV I DNA [Presence] in Blood by NAA with probe detection |
|
44536-1
|
HTLV I DNA [Presence] in Blood by Probe |
|
32021-8
|
HTLV I DNA [Presence] in Serum by NAA with probe detection |
|
16981-3
|
HTLV I DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14215-8
|
HTLV I g46 Ab [Presence] in Serum |
|
44810-0
|
HTLV I gp21e Ab [Presence] in Serum |
|
77746-6
|
HTLV I gp46-I Ab [Presence] in Serum or Plasma by Immunoblot |
|
22360-2
|
HTLV I IgG Ab [Presence] in Serum |
|
6433-7
|
HTLV I IgG Ab [Presence] in Serum by Immunoassay |
|
14217-4
|
HTLV I p19 Ab [Presence] in Serum |
|
39589-7
|
HTLV I p19 Ab [Units/volume] in Serum |
|
77745-8
|
HTLV I p19-I Ab [Presence] in Serum or Plasma by Immunoblot |
|
14218-2
|
HTLV I p24 Ab [Presence] in Serum |
|
14219-0
|
HTLV I p26 Ab [Presence] in Serum |
|
14220-8
|
HTLV I p28 Ab [Presence] in Serum |
|
14221-6
|
HTLV I p32 Ab [Presence] in Serum |
|
14222-4
|
HTLV I p36 Ab [Presence] in Serum |
|
42340-0
|
HTLV I p42 Ab [Presence] in Serum by Immunoblot |
|
14223-2
|
HTLV I p53 Ab [Presence] in Serum |
|
14224-0
|
HTLV I rgp21 Ab [Presence] in Serum |
|
48160-6
|
HTLV I rgp21 Ab [Presence] in Serum by Immunoblot |
|
63460-0
|
HTLV I+II Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
22361-0
|
HTLV I+II Ab [Presence] in Cerebral spinal fluid |
|
21345-4
|
HTLV I+II Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
13247-2
|
HTLV I+II Ab [Units/volume] in Cerebral spinal fluid |
|
21346-2
|
HTLV I+II Ab band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
|
93742-5
|
HTLV I and II Ab band pattern [Interpretation] in Cerebral spinal fluid by Line blot |
|
21347-0
|
HTLV I+II Ab band pattern [Interpretation] in Serum by Immunoblot |
|
33665-1
|
HTLV I+II Ab band pattern [Interpretation] in Serum by Radioimmunoprecipitation assay (RIPA) |
|
77744-1
|
HTLV I and II Ab band pattern [Interpretation] in Serum or Plasma |
|
44538-7
|
HTLV I+II Ab [Presence] in Serum from Donor |
|
5226-6
|
HTLV I+II Ab [Units/volume] in Serum by Immunoassay |
|
22362-8
|
HTLV I+II Ab [Presence] in Serum |
|
29901-6
|
HTLV I+II Ab [Presence] in Serum by Immunoassay |
|
16982-1
|
HTLV I+II Ab [Presence] in Serum by Immunoblot |
|
22363-6
|
HTLV I+II Ab [Units/volume] in Serum |
|
42769-0
|
HTLV I+II Ab [Interpretation] in Serum Narrative |
|
43007-4
|
HTLV I+II Ab [Titer] in Serum |
|
34318-6
|
HTLV I+II Ab [Titer] in Serum by Complement fixation |
|
30159-8
|
HTLV I+II DNA [Presence] in Blood by NAA with probe detection |
|
43296-3
|
HTLV I+II gp46 Ab [Presence] in Serum |
|
14019-4
|
HTLV I+II gp46 Ab [Presence] in Serum or Plasma by Immunoblot |
|
93745-8
|
HTLV I+II IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
|
31431-0
|
HTLV I+II IgG Ab [Presence] in Serum |
|
21348-8
|
HTLV I+II IgG Ab [Presence] in Serum by Immunoassay |
|
40735-3
|
HTLV I+II IgG Ab [Presence] in Serum by Immunoblot |
|
43299-7
|
HTLV I+II p19 Ab [Presence] in Serum |
|
39590-5
|
HTLV I+II p19 Ab [Units/volume] in Serum |
|
14020-2
|
HTLV I+II p19 Ab [Presence] in Serum or Plasma by Immunoblot |
|
44580-9
|
HTLV I+II p21 env Ab [Presence] in Serum by Immunoblot |
|
43300-3
|
HTLV I+II p24 Ab [Presence] in Serum |
|
14021-0
|
HTLV I+II p24 Ab [Presence] in Serum or Plasma by Immunoblot |
|
43294-8
|
HTLV I+II p26 Ab [Presence] in Serum |
|
14022-8
|
HTLV I+II p26 Ab [Presence] in Serum by Immunoblot |
|
43293-0
|
HTLV I+II p28 Ab [Presence] in Serum |
|
14023-6
|
HTLV I+II p28 Ab [Presence] in Serum by Immunoblot |
|
43297-1
|
HTLV I+II p32 Ab [Presence] in Serum |
|
14024-4
|
HTLV I+II p32 Ab [Presence] in Serum by Immunoblot |
|
43301-1
|
HTLV I+II p36 Ab [Presence] in Serum |
|
14025-1
|
HTLV I+II p36 Ab [Presence] in Serum by Immunoblot |
|
44581-7
|
HTLV I+II p38 tax Ab [Presence] in Serum by Immunoblot |
|
43295-5
|
HTLV I+II p53 Ab [Presence] in Serum |
|
14026-9
|
HTLV I+II p53 Ab [Presence] in Serum by Immunoblot |
|
43298-9
|
HTLV I+II rgp21 Ab [Presence] in Serum |
|
14027-7
|
HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot |
|
86550-1
|
HTLV I+II RNA [Presence] in Blood by NAA with probe detection |
|
44874-6
|
HTLV I+II RNA [Presence] in Serum by NAA with probe detection |
|
5019-5
|
HTLV I+II RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40823-7
|
HTLV II Ab [Presence] in Cerebral spinal fluid |
|
26656-9
|
HTLV II Ab [Presence] in Serum |
|
44539-5
|
HTLV II Ab [Presence] in Serum by Immunoassay |
|
44542-9
|
HTLV II DNA [Presence] in Blood by NAA with probe detection |
|
44541-1
|
HTLV II DNA [Presence] in Blood by Probe |
|
16980-5
|
HTLV II DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14225-7
|
HTLV II g46 Ab [Presence] in Serum |
|
77747-4
|
HTLV II gp46-II Ab [Presence] in Serum or Plasma by Immunoblot |
|
46192-1
|
HTLV II IgG Ab [Presence] in Serum |
|
44540-3
|
HTLV II IgG Ab [Presence] in Serum by Immunoassay |
|
61112-9
|
HTLV [Type] in Serum or Plasma |
|
14216-6
|
HTLV 1 gp46 Ab [Presence] in Serum |
|
13289-4
|
Hantavirus hantaan Ab [Units/volume] in Serum |
|
7895-6
|
Hantavirus hantaan IgG Ab [Units/volume] in Serum |
|
70052-6
|
Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
7896-4
|
Hantavirus hantaan IgM Ab [Units/volume] in Serum |
|
70053-4
|
Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
75731-0
|
HTR2A gene c.102T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
75729-4
|
HTR2A gene c.1354C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75726-0
|
HTR2A gene c.-1438G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
93190-7
|
HTR2A gene c.614-2211T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
75728-6
|
HTR2A gene c.74C>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75727-8
|
HTR2A gene c.IVS2+54538A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
46726-6
|
HTR2A gene+HTR2C gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
93192-3
|
HTR2C gene c.551-3008C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
75732-8
|
HTR2C gene c.-759C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
93191-5
|
HTR2C gene c.-759C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
75730-2
|
HTR2C gene c.796G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
49637-2
|
HTT gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49638-0
|
HTT gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
75393-9
|
HTT gene CAG repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
21763-8
|
HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
53782-9
|
HTT gene CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
42321-0
|
HTT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50621-2
|
HTT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11089-0
|
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid |
|
17341-9
|
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
81728-8
|
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
14240-6
|
Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid |
|
19137-9
|
Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot |
|
33600-8
|
Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
11088-2
|
Neuronal nuclear Ab [Presence] in Serum |
|
35278-1
|
Neuronal nuclear Ab [Presence] in Serum by Immunoblot |
|
49738-8
|
Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence |
|
31535-8
|
Neuronal nuclear Ab [Units/volume] in Serum |
|
16139-8
|
Neuronal nuclear Ab [Titer] in Cerebral spinal fluid |
|
15398-1
|
Neuronal nuclear Ab [Titer] in Serum |
|
59390-5
|
Neuronal nuclear Ab [Titer] in Serum by Immunofluorescence |
|
33590-1
|
Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid |
|
33591-9
|
Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
15399-9
|
Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
48405-5
|
Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
|
31536-6
|
Neuronal nuclear IgG Ab [Units/volume] in Serum |
|
44770-6
|
Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
44769-8
|
Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
44768-0
|
Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31537-4
|
Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid |
|
33615-6
|
Neuronal nuclear type 1 Ab [Presence] in Serum |
|
41769-1
|
Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot |
|
12854-6
|
Neuronal nuclear type 1 Ab [Units/volume] in Serum |
|
53711-8
|
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid |
|
24403-8
|
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot |
|
24400-4
|
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
13997-2
|
Neuronal nuclear type 1 Ab [Titer] in Serum |
|
54921-2
|
Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
17343-5
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid |
|
63291-9
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
56959-0
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
89538-3
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Line blot |
|
31538-2
|
Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid |
|
17344-3
|
Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence |
|
31539-0
|
Neuronal nuclear type 2 Ab [Presence] in Serum |
|
33008-4
|
Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot |
|
43187-4
|
Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence |
|
17342-7
|
Neuronal nuclear type 2 Ab [Units/volume] in Serum |
|
53712-6
|
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid |
|
24404-6
|
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot |
|
24401-2
|
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
13998-0
|
Neuronal nuclear type 2 Ab [Titer] in Serum |
|
43188-2
|
Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence |
|
69954-6
|
Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Immunoassay |
|
90838-4
|
Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
90836-8
|
Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
43102-3
|
Neuronal nuclear type 3 Ab [Presence] in Serum |
|
35144-5
|
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid |
|
90837-6
|
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
33924-2
|
Neuronal nuclear type 3 Ab [Titer] in Serum |
|
82417-7
|
Human upstream binding factor Ab [Units/volume] in Serum by Line blot |
|
54003-9
|
Human upstream binding factor Ab [Presence] in Serum by Immunofluorescence |
|
82418-5
|
Human upstream binding factor Ab [Presence] in Serum by Line blot |
|
54004-7
|
Human upstream binding factor Ab [Titer] in Serum by Immunofluorescence |
|
69956-1
|
Human upstream binding factor IgG Ab [Presence] in Serum by Immunoassay |
|
89003-8
|
HuD Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
62373-6
|
Human reference assembly release, UCSC version [Identifier] |
|
50006-6
|
Human antimouse Ab [Presence] in Serum |
|
13164-9
|
Human antimouse Ab [Units/volume] in Serum |
|
14975-7
|
Human antimouse Ab [Mass/volume] in Serum |
|
42205-5
|
Human antimouse IgG Ab [Mass/volume] in Serum |
|
62374-4
|
Human reference sequence assembly version |
|
81326-1
|
Human RNase P RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
86316-7
|
Human RNase P RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
68993-5
|
Human RNase P RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
57652-0
|
Humidifier heated wire temperature differential setting Ventilator airway circuit |
|
88121-9
|
Hunger Vital Sign [HVS] |
|
86477-7
|
Hurrying or jogging (as if to catch a bus) was limited by heart failure over the past 2 weeks [KCCQ] |
|
44908-2
|
Homovanillate and Creatinine [Interpretation] in Urine |
|
49269-4
|
Homovanillate and Creatinine [Interpretation] in Urine Narrative |
|
59587-6
|
Homovanillate [Mass/volume] in Urine collected for unspecified duration |
|
53595-5
|
Homovanillate [Mass/volume] in 24 hour Urine |
|
2436-4
|
Homovanillate [Mass/time] in 24 hour Urine |
|
25930-9
|
Homovanillate [Moles/volume] in 24 hour Urine |
|
14783-5
|
Homovanillate [Moles/time] in 24 hour Urine |
|
2434-9
|
Homovanillate [Mass/volume] in Cerebral spinal fluid |
|
40846-8
|
Homovanillate [Moles/volume] in Cerebral spinal fluid |
|
2435-6
|
Homovanillate [Mass/volume] in Serum |
|
55880-9
|
Homovanillate [Moles/volume] in Serum |
|
27267-4
|
Homovanillate [Presence] in Urine |
|
11144-3
|
Homovanillate [Mass/volume] in Urine |
|
12715-9
|
Homovanillate [Mass/time] in Urine |
|
14782-7
|
Homovanillate [Moles/volume] in Urine |
|
51994-2
|
Homovanillate/Creatinine [Mass Ratio] in Urine collected for unspecified duration |
|
13760-4
|
Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine |
|
25931-7
|
Homovanillate/Creatinine [Molar ratio] in 24 hour Urine |
|
11146-8
|
Homovanillate/Creatinine [Mass Ratio] in Urine |
|
22708-2
|
Homovanillate/Creatinine [Molar ratio] in Urine |
|
74165-2
|
History of employment status NIOSH |
|
46264-8
|
History of medical device use |
|
44939-7
|
History of Adverse drug reaction Narrative |
|
88654-9
|
History of Coronary artery bypass graft surgery |
|
46240-8
|
History of Hospitalizations+Outpatient visits Narrative |
|
88655-6
|
History of Hyperlipidemia |
|
78924-8
|
History of Hyperuricemia |
|
90871-5
|
History of Medical conditions impacting orthodontic condition |
|
49053-2
|
History of Neural tube defect Narrative |
|
53827-2
|
History of Neural tube defect Qualitative |
|
86188-0
|
History of Occupation industry |
|
74164-5
|
History of Usual occupation and industry Narrative |
|
87729-0
|
History of Occupational hazard |
|
88656-4
|
History of Percutaneous coronary intervention |
|
91390-5
|
History of Preadolescent sexual abuse |
|
79753-0
|
History of Problem(s) affecting Left eye |
|
79752-2
|
History of Problem(s) affecting Right eye |
|
89062-4
|
History of Severe bleeding related to aspirin use |
|
80286-8
|
History of Surgical procedures of cardiovascular system |
|
80274-4
|
History of Surgical procedures of gastrointestinal system |
|
80336-1
|
History of Surgical procedures of genitourinary system |
|
80329-6
|
History of Surgical procedures of musculoskeletal system |
|
80315-5
|
History of Surgical procedures of neurological system |
|
50715-2
|
History of Trisomy 21 Narrative |
|
53826-4
|
History of Trisomy 21 Qualitative |
|
21843-8
|
History of Usual occupation |
|
88038-5
|
Hy Ab [Presence] in Serum or Plasma |
|
92541-2
|
Hy Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92503-2
|
Hy Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
35302-9
|
HYAL1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51484-4
|
Hyaline casts [#/volume] in Urine by Automated count |
|
88966-7
|
Hyaline casts [#/area] in Urine sediment |
|
33223-9
|
Hyaline casts [#/area] in Urine sediment by Automated count |
|
46135-0
|
Hyaline casts [#/area] in Urine sediment by Microscopy high power field |
|
5796-8
|
Hyaline casts [#/area] in Urine sediment by Microscopy low power field |
|
50231-0
|
Hyaline casts [Presence] in Urine by Automated |
|
25162-9
|
Hyaline casts [Presence] in Urine sediment by Light microscopy |
|
29240-9
|
Hyaluronate [Mass/volume] in Body fluid |
|
44383-8
|
Hyaluronate [Presence] in Pleural fluid |
|
51706-0
|
Hyaluronate [Mass/volume] in Pleural fluid |
|
56601-8
|
Hyaluronate [Mass/volume] in Peritoneal fluid |
|
12736-5
|
Hyaluronate [Mass/volume] in Serum or Plasma |
|
79167-3
|
Honey bee recombinant (rApi m) 2 IgE Ab [Units/volume] in Serum |
|
87717-5
|
Honey bee recombinant (rApi m) 2 IgE Ab RAST class [Presence] in Serum |
|
32622-3
|
Hyaluronidase Ab [Presence] in Serum |
|
31435-1
|
Hyaluronidase Ab [Units/volume] in Serum |
|
10903-3
|
Hyaluronidase Ab [Titer] in Serum |
|
59252-7
|
Homocysteine cysteine disulfide [Moles/volume] in Cerebral spinal fluid |
|
32615-7
|
Homocysteine cysteine disulfide [Moles/volume] in Serum or Plasma |
|
59253-5
|
Homocysteine cysteine disulfide [Moles/volume] in Urine |
|
32616-5
|
Homocysteine cysteine disulfide/Creatinine [Ratio] in Urine |
|
79649-0
|
Homocysteine cysteine disulfide/Creatinine [Molar ratio] in Urine |
|
79496-6
|
Hydantoin-5-propionate [Moles/volume] in Serum or Plasma |
|
79481-8
|
Hydantoin-5-propionate/Creatinine [Molar ratio] in Urine |
|
18306-1
|
Hydatid cyst identified in Aspirate by Iron hematoxylin stain |
|
10683-1
|
Hydatid cyst identified in Aspirate by Immune stain |
|
10684-9
|
Hydatid cyst identified in Liver by Wet preparation |
|
10685-6
|
Hydatid cyst identified in Lung tissue by Wet preparation |
|
11474-4
|
Hydatid cyst identified in Unspecified specimen by Wet preparation |
|
81676-9
|
Hydration status |
|
73355-0
|
hydrALAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73354-3
|
hydrALAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12336-4
|
hydrALAZINE [Presence] in Serum or Plasma |
|
11237-5
|
hydrALAZINE [Mass/volume] in Serum or Plasma |
|
16983-9
|
hydrALAZINE [Presence] in Urine |
|
34632-0
|
hydrALAZINE [Mass/volume] in Urine |
|
27160-1
|
Hydrastine [Presence] in Serum or Plasma |
|
16984-7
|
Hydrastine [Presence] in Urine |
|
38602-9
|
Hydrazine [Mass/volume] in Air |
|
35582-6
|
Hydrazine [Mass/volume] in Blood |
|
35583-4
|
Hydrazine/Creatinine [Mass Ratio] in Urine |
|
78769-7
|
HYDROcodone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
79261-4
|
HYDROcodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19485-2
|
HYDROcodone cutoff [Mass/volume] in Urine for Confirmatory method |
|
19484-5
|
HYDROcodone cutoff [Mass/volume] in Urine for Screen method |
|
4276-2
|
HYDROcodone [Mass] of Dose |
|
73939-1
|
HYDROcodone Free [Mass/volume] in Blood |
|
46261-4
|
HYDROcodone Free [Presence] in Serum or Plasma |
|
12786-0
|
HYDROcodone Free [Mass/volume] in Serum or Plasma |
|
27312-8
|
HYDROcodone Free [Mass/mass] in Stool |
|
51738-3
|
HYDROcodone Free [Mass/volume] in Urine |
|
27357-3
|
HYDROcodone Free [Mass/volume] in Vitreous fluid |
|
40634-8
|
HYDROcodone [Presence] in Gastric fluid |
|
26719-5
|
HYDROcodone [Mass/mass] in Hair |
|
73349-3
|
HYDROcodone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73348-5
|
HYDROcodone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68544-6
|
HYDROcodone [Mass/mass] in Meconium by Confirmatory method |
|
57981-3
|
HYDROcodone [Presence] in Meconium |
|
26863-1
|
HYDROcodone [Mass/mass] in Meconium |
|
72753-7
|
HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74644-6
|
HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3679-8
|
HYDROcodone [Presence] in Serum or Plasma |
|
86229-2
|
HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3680-6
|
HYDROcodone [Mass/volume] in Serum or Plasma |
|
16252-9
|
HYDROcodone [Mass/volume] in Urine by Confirmatory method |
|
12308-3
|
HYDROcodone [Presence] in Urine |
|
19483-7
|
HYDROcodone [Presence] in Urine by Confirmatory method |
|
19482-9
|
HYDROcodone [Presence] in Urine by Screen method |
|
3681-4
|
HYDROcodone [Mass/volume] in Urine |
|
32080-4
|
HYDROcodone [Presence] in Unspecified specimen |
|
57861-7
|
HYDROcodone [Moles/volume] in Unspecified specimen |
|
78830-7
|
HYDROcodone [Z-score] in Urine |
|
58393-0
|
HYDROcodone/Creatinine [Mass Ratio] in Urine |
|
73347-7
|
HYDROcodone+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73346-9
|
HYDROcodone+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73345-1
|
HYDROcodone+Chlorpheniramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73344-4
|
HYDROcodone+Chlorpheniramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9411-0
|
Hydrocorticosterone [Mass/time] in 24 hour Urine |
|
18232-9
|
Hydrocorticosterone [Presence] in Urine |
|
73342-8
|
Hydrocortisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73343-6
|
Hydrocortisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
57862-5
|
Hydrocortisone [Moles/volume] in Unspecified specimen |
|
44385-3
|
Hydroflumethiazide [Presence] in 24 hour Urine |
|
42918-3
|
Hydroflumethiazide [Mass/volume] in Serum or Plasma |
|
40469-9
|
Hydroflumethiazide [Presence] in Urine |
|
9649-5
|
Hydroflumethiazide [Mass/volume] in Urine |
|
38743-1
|
Hydrogen chloride [Mass/volume] in Air |
|
38744-9
|
Hydrogen fluoride [Mass/volume] in Air |
|
38603-7
|
Hydrogen sulfide [Mass/volume] in Air |
|
29283-9
|
Hydrogen sulfide [Presence] in Blood |
|
29292-0
|
Hydrogen sulfide [Mass/volume] in Blood |
|
77770-6
|
HYDROmorphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19488-6
|
HYDROmorphone cutoff [Mass/volume] in Urine for Confirmatory method |
|
19487-8
|
HYDROmorphone cutoff [Mass/volume] in Urine for Screen method |
|
4223-4
|
HYDROmorphone [Mass] of Dose |
|
73940-9
|
HYDROmorphone Free [Mass/volume] in Blood |
|
46260-6
|
HYDROmorphone Free [Presence] in Serum or Plasma by Screen method |
|
12787-8
|
HYDROmorphone Free [Mass/volume] in Serum or Plasma |
|
27314-4
|
HYDROmorphone Free [Mass/mass] in Stool |
|
46971-8
|
HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method |
|
51737-5
|
HYDROmorphone Free [Mass/volume] in Urine |
|
27196-5
|
HYDROmorphone Free [Mass/volume] in Vitreous fluid |
|
40369-1
|
HYDROmorphone [Presence] in Gastric fluid |
|
26718-7
|
HYDROmorphone [Mass/mass] in Hair |
|
73341-0
|
HYDROmorphone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73340-2
|
HYDROmorphone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68541-2
|
HYDROmorphone [Mass/mass] in Meconium by Confirmatory method |
|
57982-1
|
HYDROmorphone [Presence] in Meconium |
|
26862-3
|
HYDROmorphone [Mass/mass] in Meconium |
|
72733-9
|
HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74645-3
|
HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3682-2
|
HYDROmorphone [Presence] in Serum or Plasma |
|
86230-0
|
HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3683-0
|
HYDROmorphone [Mass/volume] in Serum or Plasma |
|
16998-7
|
HYDROmorphone [Mass/volume] in Urine by Confirmatory method |
|
9834-3
|
HYDROmorphone [Presence] in Urine |
|
18473-9
|
HYDROmorphone [Presence] in Urine by Confirmatory method |
|
19486-0
|
HYDROmorphone [Presence] in Urine by Screen method |
|
9835-0
|
HYDROmorphone [Mass/volume] in Urine |
|
74380-7
|
HYDROmorphone [Mass/volume] in Unknown substance |
|
32081-2
|
HYDROmorphone [Presence] in Unspecified specimen |
|
57863-3
|
HYDROmorphone [Moles/volume] in Unspecified specimen |
|
58394-8
|
HYDROmorphone/Creatinine [Mass Ratio] in Urine |
|
38604-5
|
Hydroquinone [Mass/volume] in Air |
|
16999-5
|
Hydroquinone [Mass/volume] in Urine |
|
81622-3
|
Hydroxyapatite [Energy Difference] in 24 hour Urine |
|
4280-4
|
hydrOXYzine [Mass] of Dose |
|
59909-2
|
hydrOXYzine [Moles/volume] in Gastric fluid |
|
73339-4
|
hydrOXYzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73338-6
|
hydrOXYzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3686-3
|
hydrOXYzine [Mass/volume] in Serum or Plasma |
|
55544-1
|
hydrOXYzine [Moles/volume] in Serum or Plasma |
|
12324-0
|
hydrOXYzine [Presence] in Urine |
|
11240-9
|
hydrOXYzine [Mass/volume] in Urine |
|
59908-4
|
hydrOXYzine [Moles/volume] in Urine |
|
60307-6
|
hydrOXYzine [Moles/volume] in Unspecified specimen |
|
77696-3
|
Hygiene scale [UPDRS] |
|
78959-4
|
Hyocholate [Moles/volume] in Serum or Plasma |
|
60087-4
|
Hyoscyamine [Mass/volume] in Blood |
|
11241-7
|
Hyoscyamine [Mass/volume] in Serum or Plasma |
|
60088-2
|
Hyoscyamine [Mass/volume] in Urine |
|
35746-7
|
Hyperchromia [Presence] in Blood by Automated count |
|
33249-4
|
Hyperchromia [Presence] in Blood by Light microscopy |
|
30914-6
|
Hyperdiploid cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
8609-0
|
Hypertrophy [Interpretation] by EKG |
|
9869-9
|
Hypertrophy [Interpretation] Narrative by EKG |
|
44387-9
|
Hypnotics [Presence] in Gastric fluid by Screen method |
|
33040-7
|
Hypnotics [Presence] in Serum or Plasma by Screen method |
|
33041-5
|
Hypnotics [Presence] in Urine by Screen method |
|
30400-6
|
Hypochromia [Presence] in Blood |
|
15180-3
|
Hypochromia [Presence] in Blood by Automated count |
|
728-6
|
Hypochromia [Presence] in Blood by Light microscopy |
|
40654-6
|
Neutrophils.hypogranulated [Presence] in Blood by Light microscopy |
|
90561-2
|
Hypopnea index |
|
75123-0
|
Hypoxanthine [Moles/volume] in Cerebral spinal fluid |
|
2452-1
|
Hypoxanthine [Mass/volume] in Body fluid |
|
2453-9
|
Hypoxanthine [Mass/volume] in Serum |
|
75135-4
|
Hypoxanthine [Moles/volume] in Serum or Plasma |
|
17004-3
|
Hypoxanthine [Mass/volume] in Urine |
|
38366-1
|
Hypoxanthine/Creatinine [Molar ratio] in Urine |
|
52028-8
|
Hysterectomy consent Document |
|
73759-3
|
Hysterotomy or hysterectomy was performed at delivery [US Standard Report of Fetal Death] |
|
14983-1
|
I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
|
14984-9
|
I (intermediate) subtype [Presence] on Red Blood Cells from Donor |
|
14985-6
|
I (intermediate) subtype [Presence] on Red Blood Cells |
|
1058-7
|
I Ab [Presence] in Serum or Plasma from Blood product unit |
|
1059-5
|
I Ab [Presence] in Serum or Plasma from Donor |
|
1060-3
|
I Ab [Presence] in Serum or Plasma |
|
34603-1
|
I Ab [Titer] in Serum or Plasma |
|
10398-6
|
I Ag [Presence] on Red Blood Cells from Blood product unit |
|
10399-4
|
I Ag [Presence] on Red Blood Cells from Donor |
|
10400-0
|
I Ag [Presence] on Red Blood Cells |
|
71437-8
|
I am able to feel like a man in the past 7 days [FACIT] |
|
71040-0
|
I am able to forgive others for any harm they have ever caused me in the past 7 days [FACIT] |
|
71438-6
|
I am able to have and maintain an erection in the past 7 days [FACIT] |
|
87699-5
|
I am able to help this person maintain lifestyle changes (like eating right or exercising) for her/his condition Caregiver [PAM] |
|
71020-2
|
I am able to make decisions in the past 7 days [FACIT] |
|
71022-8
|
I am able to openly discuss my concerns with the people closest to me in the past 7 days [FACIT] |
|
71029-3
|
I am able to reach down deep into myself for comfort in the past 7 days [FACIT] |
|
71156-4
|
I am afraid to eat because it may make me sick in the past 7 days [FACIT] |
|
71901-3
|
I am as healthy as anyone I know [Veterans RAND] |
|
71303-2
|
I am bothered by being shorter than other people in the past 4 weeks [FACIT] |
|
71305-7
|
I am bothered by being unable to hear well in the past 4 weeks [FACIT] |
|
71304-0
|
I am bothered by being unable to see well in the past 4 weeks [FACIT] |
|
71306-5
|
I am bothered by headaches in the past 4 weeks [FACIT] |
|
71111-9
|
I am bothered by muscle pains in the past 7 days [FACIT] |
|
71123-4
|
I am bothered by muscle spasms in the past 7 days [FACIT] |
|
71137-4
|
I am concerned about what the future holds for me in the past 7 days [FACIT] |
|
87687-0
|
I am confident I can figure out solutions when new problems arise with my child's health Parent [PAM] |
|
86934-7
|
I am confident I can figure out solutions when new problems arise with my health [PAM] |
|
87701-9
|
I am confident I can figure out solutions when new situations or problems arise with this person's health Caregiver [PAM] |
|
87678-9
|
I am confident I can help prevent or reduce problems associated with my child's health Parent [PAM] |
|
86943-8
|
I am confident I can help prevent or reduce problems associated with my health [PAM] |
|
87702-7
|
I am confident I can help this person with lifestyle changes, like diet and exercise, even during times of stress Caregiver [PAM] |
|
87695-3
|
I am confident I can tell a doctor the concerns that I have about this person's health even when he or she does not ask Caregiver [PAM] |
|
86932-1
|
I am confident that I can follow through on medical treatments I may need to do at home [PAM] |
|
87682-1
|
I am confident that I can follow through on medical treatments I need to do for my child at home Parent [PAM] |
|
87696-1
|
I am confident that I can follow through on medical treatments I need to do for this person at home Caregiver [PAM] |
|
87688-8
|
I am confident that I can help my child maintain lifestyle changes, like eating right and exercising, even during times of stress Parent [PAM] |
|
86939-6
|
I am confident that I can maintain lifestyle changes, like eating right and exercising, even during times of stress [PAM] |
|
87692-0
|
I am confident that I can take actions that will help prevent or minimize some symptoms or problems associated with this person's health Caregiver [PAM] |
|
87681-3
|
I am confident that I can tell a doctor concerns I have abou my child's health even when he or she does not ask Parent [PAM] |
|
86940-4
|
I am confident that I can tell a doctor concerns I have even when he or she does not ask [PAM] |
|
87694-6
|
I am confident that I can tell when this person needs to get medical care and when I can handle the problem myself Caregiver [PAM] |
|
86941-2
|
I am confident that I can tell whether I need to go to the doctor or whether I can take care of a health problem myself [PAM] |
|
87680-5
|
I am confident that I can tell whether I need to go to the doctor or whether I can take care of my child's health problem myself Parent [PAM] |
|
71013-7
|
I am constipated in the past 7 days [FACIT] |
|
90026-6
|
I am dependent on other people's assistance for my treatment [PsoSat] |
|
71114-3
|
I am depressed about my condition in the past 7 days [FACIT] |
|
71138-2
|
I am embarrassed by my illness in the past 7 days [FACIT] |
|
71117-6
|
I am frustrated by my condition in the past 7 days [FACIT] |
|
74179-3
|
I am generally satisfied with the kind of work I do in this job [NMMDS] |
|
76809-3
|
I am happy with how much I do for my family [PROMIS] |
|
76816-8
|
I am happy with how much I do for my friends [PROMIS] |
|
71555-7
|
I am jumpy or feel startled easily in the last 2 weeks or more [M3] |
|
71820-5
|
I am jumpy or feel startled easily since I took my last screen [M3] |
|
76835-8
|
I am limited in doing my work (include work at home) [PROMIS] |
|
71553-2
|
I am nervous or shaky in social situations in the last 2 weeks or more [M3] |
|
71818-9
|
I am nervous or shaky in social situations since I took my last screen [M3] |
|
76782-2
|
I am satisfied with how much work I can do (include work at home) [PROMIS] |
|
76778-0
|
I am satisfied with how often I go out for entertainment [PROMIS] |
|
76786-3
|
I am satisfied with my ability to do all of the community activities that are really important to me [PROMIS] |
|
76830-9
|
I am satisfied with my ability to do all of the group activities that are really important to me [PROMIS] |
|
76829-1
|
I am satisfied with my ability to do all of the leisure activities that are really important to me [PROMIS] |
|
76820-0
|
I am satisfied with my ability to do household chores and tasks [PROMIS] |
|
76810-1
|
I am satisfied with my ability to do leisure activities [PROMIS] |
|
76811-9
|
I am satisfied with my ability to do leisure activities with others [PROMIS] |
|
76823-4
|
I am satisfied with my ability to do regular personal and household responsibilities [PROMIS] |
|
76824-2
|
I am satisfied with my ability to do regular personal responsibilities [PROMIS] |
|
76738-4
|
I am satisfied with my ability to do the work that is really important to me (include work at home) [PROMIS] |
|
76825-9
|
I am satisfied with my ability to do things for fun at home (like reading, listening to music, etc.) [PROMIS] |
|
76739-2
|
I am satisfied with my ability to do things for fun outside my home [PROMIS] |
|
76740-0
|
I am satisfied with my ability to do things for fun with others [PROMIS] |
|
76737-6
|
I am satisfied with my ability to do things for my family [PROMIS] |
|
76807-7
|
I am satisfied with my ability to do things for my friends [PROMIS] |
|
76814-3
|
I am satisfied with my ability to engage in activities with friends [PROMIS] |
|
76822-6
|
I am satisfied with my ability to keep in touch with others [PROMIS] |
|
76777-2
|
I am satisfied with my ability to maintain friendships [PROMIS] |
|
76742-6
|
I am satisfied with my ability to meet the needs of my family [PROMIS] |
|
76743-4
|
I am satisfied with my ability to meet the needs of my friends [PROMIS] |
|
76826-7
|
I am satisfied with my ability to meet the needs of those who depend on me [PROMIS] |
|
76785-5
|
I am satisfied with my ability to participate in family activities [PROMIS] |
|
76744-2
|
I am satisfied with my ability to perform my daily routines [PROMIS] |
|
76827-5
|
I am satisfied with my ability to run errands [PROMIS] |
|
76828-3
|
I am satisfied with my ability to run errands for others [PROMIS] |
|
76779-8
|
I am satisfied with my ability to socialize with friends [PROMIS] |
|
76812-7
|
I am satisfied with my ability to work (include work at home) [PROMIS] |
|
76813-5
|
I am satisfied with my current level of activities with my friends [PROMIS] |
|
76776-4
|
I am satisfied with my current level of family activities [PROMIS] |
|
76784-8
|
I am satisfied with my current level of social activity [PROMIS] |
|
71436-0
|
I am satisfied with my present level of comfort in the past 7 days [FACIT] |
|
76780-6
|
I am satisfied with the amount of time I spend doing leisure activities [PROMIS] |
|
76781-4
|
I am satisfied with the amount of time I spend doing leisure activities with others [PROMIS] |
|
76819-2
|
I am satisfied with the amount of time I spend doing things for my family [PROMIS] |
|
76808-5
|
I am satisfied with the amount of time I spend doing work (include work at home) [PROMIS] |
|
76818-4
|
I am satisfied with the amount of time I spend performing my daily routines [PROMIS] |
|
76817-6
|
I am satisfied with the amount of time I spend visiting friends [PROMIS] |
|
76775-6
|
I am satisfied with the extent of my social activities outside my home [PROMIS] |
|
76821-8
|
I am satisfied with the extent of my social activities with groups of people [PROMIS] |
|
90020-9
|
I am satisfied with the treatment [PsoSat] |
|
92217-9
|
I am tempted to smoke when I am anxious [PROMIS] |
|
92216-1
|
I am tempted to smoke when I feel depressed [PROMIS] |
|
92317-7
|
I am tempted to smoke when I realize I haven't smoked for a while [PROMIS] |
|
71134-1
|
I am unhappy with my appearance in the past 7 days [FACIT] |
|
71189-5
|
I am worried about how thin I am in the past 7 days [FACIT] |
|
71556-5
|
I avoid places that strongly remind me of a bad experience in the last 2 weeks or more [M3] |
|
71821-3
|
I avoid places that strongly remind me of a bad experience since I took my last screen [M3] |
|
76903-4
|
I became drunk or intoxicated in past 30D [PROMIS] |
|
78110-4
|
I believed in helping my family, no matter what in past 4 weeks [PROMIS.PEDS] |
|
44330-9
|
Isospora belli [Presence] in Stool |
|
26704-7
|
Isospora belli [Presence] in Stool by Immunofluorescence |
|
10853-0
|
Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
|
76992-7
|
I calmed down when I drank in past 30D [PROMIS] |
|
76745-9
|
I can get helpful advice from others when dealing with a problem [PROMIS] |
|
71572-2
|
I can't concentrate or focus in the last 2 weeks more [M3] |
|
71826-2
|
I can't concentrate or focus since I took my last screen [M3] |
|
71558-1
|
I can't get certain things out of my mind in the last 2 weeks or more [M3] |
|
71823-9
|
I can't get certain things out of my mind since I took my last screen [M3] |
|
78072-6
|
I could comb my hair by myself in past 7 days [PROMIS.PEDS] |
|
78090-8
|
I could depend on my family in past 4 weeks [PROMIS.PEDS] |
|
71162-2
|
I could do my usual things at home in the past 7 days [FACIT] |
|
78074-2
|
I could jump up and down in past 7 days [PROMIS.PEDS] |
|
91428-3
|
I could not stay still for long in past 7 days [PROMIS.PEDS] |
|
78069-2
|
I could pick up coins from a table in past 7 days [PROMIS.PEDS] |
|
78071-8
|
I could put beads on a string in past 7 days [PROMIS.PEDS] |
|
76998-4
|
I could relax when I drank in past 30D [PROMIS] |
|
78113-8
|
I could rely on my family in past 4 weeks [PROMIS.PEDS] |
|
78095-7
|
I could talk to someone in my family about my problems in past 4 weeks [PROMIS.PEDS] |
|
78117-9
|
I could talk to someone in my family if I needed to in past 4 weeks [PROMIS.PEDS] |
|
78094-0
|
I could talk to someone in my family if something was bothering me in past 4 weeks [PROMIS.PEDS] |
|
78073-4
|
I could thread a needle in past 7 days [PROMIS.PEDS] |
|
78098-1
|
I could trust others in my family in past 4 weeks [PROMIS.PEDS] |
|
78070-0
|
I could wash my hair by myself in past 7 days [PROMIS.PEDS] |
|
92316-9
|
I crave cigarettes at certain times of day [PROMIS] |
|
72711-5
|
I didn't believe in my right to live in last week [BSL-23] |
|
72712-3
|
I didn't trust other people in last week [BSL-23] |
|
76974-5
|
I disappointed others when I drank in past 30D [PROMIS] |
|
72681-0
|
I displayed high-risk behavior by knowingly driving too fast, running around on the roofs of high buildings, balancing on bridges, etc. in last week [BSL-SUPP] |
|
76931-5
|
I drank at the end of a busy day in past 30D [PROMIS] |
|
76928-1
|
I drank because I deserved it in past 30D [PROMIS] |
|
76930-7
|
I drank because I felt tense in past 30D [PROMIS] |
|
76923-2
|
I drank because I had nothing to do in past 30D [PROMIS] |
|
76936-4
|
I drank because I had physical pain in past 30D [PROMIS] |
|
76925-7
|
I drank because I was angry with myself in past 30D [PROMIS] |
|
76929-9
|
I drank because I was annoyed in past 30D [PROMIS] |
|
76937-2
|
I drank because I was bored in past 30D [PROMIS] |
|
76935-6
|
I drank because I was depressed in past 30D [PROMIS] |
|
76927-3
|
I drank because I was irritable in past 30D [PROMIS] |
|
76934-9
|
I drank because I was lonely in past 30D [PROMIS] |
|
76932-3
|
I drank because I was nervous in past 30D [PROMIS] |
|
76933-1
|
I drank because I was sad in past 30D [PROMIS] |
|
76926-5
|
I drank because someone made me angry in past 30D [PROMIS] |
|
76906-7
|
I drank heavily at a single sitting in past 30D [PROMIS] |
|
76912-5
|
I drank more than planned in past 30D [PROMIS] |
|
76908-3
|
I drank throughout the day in past 30D [PROMIS] |
|
76907-5
|
I drank too much in past 30D [PROMIS] |
|
76924-0
|
I drank when I arrived at home in past 30D [PROMIS] |
|
76922-4
|
I drank when I was alone in past 30D [PROMIS] |
|
92315-1
|
I drop everything to go out and buy cigarettes [PROMIS] |
|
71152-3
|
I eat as much as I want in the past 7 days [FACIT] |
|
71153-1
|
I eat enough food for me to do whatever I need to do in the past 7 days [FACIT] |
|
92233-6
|
I enjoy the sensations of a long, slow exhalation of smoke [PROMIS] |
|
92328-4
|
I enjoy the social aspect of smoking with other smokers [PROMIS] |
|
76995-0
|
I enjoyed life when I drank in past 30D [PROMIS] |
|
71900-5
|
I expect my health to get worse [Veterans RAND] |
|
72709-9
|
I experienced stressful inner tension in last week [BSL-23] |
|
92327-6
|
I feel a bond with other smokers [PROMIS] |
|
71044-2
|
I feel a sense of appreciation for the beauty of nature in the past 7 days [FACIT] |
|
71030-1
|
I feel a sense of harmony within myself in the past 7 days [FACIT] |
|
71028-5
|
I feel a sense of purpose in my life in the past 7 days [FACIT] |
|
92232-8
|
I feel better after smoking a cigarette [PROMIS] |
|
76865-5
|
I feel close to my friends [PROMIS] |
|
76873-9
|
I feel close to my partner (or the person who is my main support) [PROMIS] |
|
71045-9
|
I feel compassion for others in the difficulties they are facing in the past 7 days [FACIT] |
|
71036-8
|
I feel connected to a higher power, or God, in the past 7 days [FACIT] |
|
71037-6
|
I feel connected to other people in the past 7 days [FACIT] |
|
76759-0
|
I feel detached from other people [PROMIS] |
|
71557-3
|
I feel dull, numb, or detached in the last 2 weeks or more [M3] |
|
71822-1
|
I feel dull, numb, or detached since I took my last screen [M3] |
|
92296-3
|
I feel embarrassed when I smoke [PROMIS] |
|
71041-8
|
I feel forgiven for any harm I may have ever caused in the past 7 days [FACIT] |
|
76783-0
|
I feel good about my ability to do things for my family [PROMIS] |
|
76741-8
|
I feel good about my ability to do things for my friends [PROMIS] |
|
71285-1
|
I feel happy in the past 4 weeks [FACIT] |
|
71169-7
|
I feel happy in the past 7 days [FACIT] |
|
71019-4
|
I feel hopeful in the past 7 days [FACIT] |
|
71559-9
|
I feel I must repeat certain acts or rituals in the last 2 weeks or more [M3] |
|
71824-7
|
I feel I must repeat certain acts or rituals since I took my last screen [M3] |
|
76757-4
|
I feel isolated even when I am not alone [PROMIS] |
|
76763-2
|
I feel isolated from others [PROMIS] |
|
76761-6
|
I feel left out [PROMIS] |
|
71120-0
|
I feel left out of things in the past 7 days [FACIT] |
|
71012-9
|
I feel like a burden to my family in the past 7 days [FACIT] |
|
76760-8
|
I feel like a stranger to those around me [PROMIS] |
|
71160-6
|
I feel like I am getting better in the past 7 days [FACIT] |
|
92326-8
|
I feel like part of a group when I'm around other smokers [PROMIS] |
|
76853-1
|
I feel limited in my ability to visit friends [PROMIS] |
|
76845-7
|
I feel limited in the amount of time I have for my family [PROMIS] |
|
76857-2
|
I feel limited in the amount of time I have to visit friends [PROMIS] |
|
71301-6
|
I feel lonely in the past 4 weeks [FACIT] |
|
71185-3
|
I feel lonely in the past 7 days [FACIT] |
|
71039-2
|
I feel love for others in the past 7 days [FACIT] |
|
71038-4
|
I feel loved in the past 7 days [FACIT] |
|
71024-4
|
I feel peaceful in the past 7 days [FACIT] |
|
71541-7
|
I feel sad, down in the dumps or unhappy in the last 2 weeks or more [M3] |
|
71806-4
|
I feel sad, down in the dumps or unhappy since I took my last screen [M3] |
|
71549-0
|
I feel tense, anxious or can't sit still in the last 2 weeks or more [M3] |
|
71814-8
|
I feel tense, anxious or can't sit still since I took my last screen [M3] |
|
76887-9
|
I feel that I am alone in my interests and ideas [PROMIS] |
|
76886-1
|
I feel that I am no longer close to anyone [PROMIS] |
|
71011-1
|
I feel that my family appreciates me in the past 7 days [FACIT] |
|
76764-0
|
I feel that people are around me but not with me [PROMIS] |
|
76758-2
|
I feel that people avoid talking to me [PROMIS] |
|
76762-4
|
I feel that people barely know me [PROMIS] |
|
76885-3
|
I feel that some of my family members avoid me [PROMIS] |
|
76884-6
|
I feel that some of my friends avoid me [PROMIS] |
|
71560-7
|
I feel the need to check and recheck things in the last 2 weeks or more [M3] |
|
71825-4
|
I feel the need to check and recheck things since I took my last screen [M3] |
|
76870-5
|
I feel there are people who really understand me [PROMIS] |
|
71543-3
|
I feel tired - have no energy in the last 2 weeks or more [M3] |
|
71808-0
|
I feel tired - have no energy since I took my last screen [M3] |
|
71113-5
|
I feel trapped by my condition in the past 7 days [FACIT] |
|
71016-0
|
I feel useful in the past 7 days [FACIT] |
|
71115-0
|
I feel useless in the past 7 days [FACIT] |
|
71336-2
|
I feel weak in the past 7 days [FACIT] |
|
71550-8
|
I feel worried or fearful in the last 2 weeks or more [M3] |
|
71815-5
|
I feel worried or fearful since I took my last screen [M3] |
|
76990-1
|
I felt a sense of control when I drank in past 30D [PROMIS] |
|
78109-6
|
I felt a sense of togetherness with my family in past 4 weeks [PROMIS.PEDS] |
|
91232-9
|
I felt active in past 7 days [PROMIS.PEDS] |
|
76953-9
|
I felt angry when I drank in past 30D [PROMIS] |
|
76963-8
|
I felt anxious when I drank in past 30D [PROMIS] |
|
91255-0
|
I felt appreciated in past 7 days [PROMIS.PEDS] |
|
91429-1
|
I felt as if I needed to move my legs a lot in past 7 days [PROMIS.PEDS] |
|
72691-9
|
I felt as if I was far away from myself in last week [BSL-23] |
|
76987-7
|
I felt at ease when I drank in past 30D [PROMIS] |
|
91238-6
|
I felt blissful in past 7 days [PROMIS.PEDS] |
|
91353-3
|
I felt calm in past 7 days [PROMIS.PEDS] |
|
91260-0
|
I felt carefree in past 7 days [PROMIS.PEDS] |
|
91250-1
|
I felt cheerful in past 7 days [PROMIS.PEDS] |
|
76985-1
|
I felt comfortable around others when I drank in past 30D [PROMIS] |
|
91258-4
|
I felt comfortable in past 7 days [PROMIS.PEDS] |
|
91323-6
|
I felt concerned about what was going on in my life in past 7 days [PROMIS.PEDS] |
|
76996-8
|
I felt confident when I drank in past 30D [PROMIS] |
|
91264-2
|
I felt content in past 7 days [PROMIS.PEDS] |
|
76993-5
|
I felt creative when I drank in past 30D [PROMIS] |
|
91246-9
|
I felt delighted in past 7 days [PROMIS.PEDS] |
|
72714-9
|
I felt disgust in last week [BSL-23] |
|
72692-7
|
I felt disgusted by myself in last week [BSL-23] |
|
91430-9
|
I felt dizzy in past 7 days [PROMIS.PEDS] |
|
76977-8
|
I felt dizzy when I drank in past 30D [PROMIS] |
|
91236-0
|
I felt energetic in past 7 days [PROMIS.PEDS] |
|
91237-8
|
I felt enthusiastic in past 7 days [PROMIS.PEDS] |
|
78101-3
|
I felt everyone in my family loved me in past 4 weeks [PROMIS.PEDS] |
|
91257-6
|
I felt fulfilled in past 7 days [PROMIS.PEDS] |
|
91231-1
|
I felt full of pep in past 7 days [PROMIS.PEDS] |
|
76988-5
|
I felt good about myself when I drank in past 30D [PROMIS] |
|
91239-4
|
I felt good in past 7 days [PROMIS.PEDS] |
|
91263-4
|
I felt grateful in past 7 days [PROMIS.PEDS] |
|
91251-9
|
I felt great in past 7 days [PROMIS.PEDS] |
|
76960-4
|
I felt guilty when I drank in past 30D [PROMIS] |
|
91249-3
|
I felt happy in past 7 days [PROMIS.PEDS] |
|
76989-3
|
I felt happy when I drank in past 30D [PROMIS] |
|
91229-5
|
I felt healthy in past 7 days [PROMIS.PEDS] |
|
72716-4
|
I felt helpless in last week [BSL-23] |
|
78106-2
|
I felt I had a strong relationship with my family in past 4 weeks [PROMIS.PEDS] |
|
91308-7
|
I felt I had too much going on in past 7 days [PROMIS.PEDS] |
|
76919-0
|
I felt I needed help for my drinking in past 30D [PROMIS] |
|
78105-4
|
I felt I really belonged in my family in past 4 weeks [PROMIS.PEDS] |
|
78084-1
|
I felt important in my family in past 4 weeks [PROMIS.PEDS] |
|
89663-9
|
I felt irritable in past 7 days [PROMIS] |
|
91247-7
|
I felt joyful in past 7 days [PROMIS.PEDS] |
|
89666-2
|
I felt like crying in past 7 days [PROMIS] |
|
76991-9
|
I felt like I could do anything when I drank in past 30D [PROMIS] |
|
89668-8
|
I felt like I needed help for my depression in past 7 days [PROMIS] |
|
91316-0
|
I felt like my thinking was slower than usual in past 7 days [PROMIS.PEDS] |
|
89664-7
|
I felt lonely even when I was with other people in past 7 days [PROMIS] |
|
78103-9
|
I felt loved by my family in past 4 weeks [PROMIS.PEDS] |
|
78085-8
|
I felt my family believed in me in past 4 weeks [PROMIS.PEDS] |
|
76954-7
|
I felt nervous when I drank in past 30D [PROMIS] |
|
76994-3
|
I felt outgoing when I drank in past 30D [PROMIS] |
|
91318-6
|
I felt overwhelmed in past 7 days [PROMIS.PEDS] |
|
91266-7
|
I felt peaceful in past 7 days [PROMIS.PEDS] |
|
91252-7
|
I felt pleased in past 7 days [PROMIS.PEDS] |
|
91261-8
|
I felt positive in past 7 days [PROMIS.PEDS] |
|
91254-3
|
I felt proud in past 7 days [PROMIS.PEDS] |
|
78114-6
|
I felt really important to my family in past 4 weeks [PROMIS.PEDS] |
|
78083-3
|
I felt really respected by my family in past 4 weeks [PROMIS.PEDS] |
|
91233-7
|
I felt refreshed in past 7 days [PROMIS.PEDS] |
|
91259-2
|
I felt relaxed in past 7 days [PROMIS.PEDS] |
|
76986-9
|
I felt relaxed when I drank in past 30D [PROMIS] |
|
91256-8
|
I felt respected in past 7 days [PROMIS.PEDS] |
|
78079-1
|
I felt sad for no reason in past 7 days [PROMIS.PEDS] |
|
76970-3
|
I felt sad when I drank in past 30D [PROMIS] |
|
91265-9
|
I felt satisfied in past 7 days [PROMIS.PEDS] |
|
91314-5
|
I felt so upset that I could not remember what happened or what I did in past 7 days [PROMIS.PEDS] |
|
91431-7
|
I felt some food coming up into my throat in past 7 days [PROMIS.PEDS] |
|
91230-3
|
I felt strong in past 7 days [PROMIS.PEDS] |
|
91262-6
|
I felt thankful in past 7 days [PROMIS.PEDS] |
|
78097-3
|
I felt that I could trust the people in my family in past 4 weeks [PROMIS.PEDS] |
|
78112-0
|
I felt that I had similar values and beliefs as others in my family in past 4 weeks [PROMIS.PEDS] |
|
76914-1
|
I felt that I should cut down on my drinking in past 30D [PROMIS] |
|
78120-3
|
I felt that my family loved me in past 4 weeks [PROMIS.PEDS] |
|
78116-1
|
I felt that my family really respected me in past 4 weeks [PROMIS.PEDS] |
|
78089-0
|
I felt that my family understood me in past 4 weeks [PROMIS.PEDS] |
|
91319-4
|
I felt that my problems kept piling up in past 7 days [PROMIS.PEDS] |
|
78078-3
|
I felt tired even when I had not done anything in past 7 days [PROMIS.PEDS] |
|
78168-2
|
I felt too nervous to be with a group of kids my age in past 7 days [PROMIS.PEDS] |
|
78088-2
|
I felt totally accepted by my family in past 4 weeks [PROMIS.PEDS] |
|
91309-5
|
I felt unable to manage things in my life in past 7 days [PROMIS.PEDS] |
|
91310-3
|
I felt unable to react to something that bothered me in past 7 days [PROMIS.PEDS] |
|
91315-2
|
I felt unable to remember answers, even for questions I knew the answer to in past 7 days [PROMIS.PEDS] |
|
91320-2
|
I felt under pressure in past 7 days [PROMIS.PEDS] |
|
89667-0
|
I felt unloved in past 7 days [PROMIS] |
|
78107-0
|
I felt very close to my family in past 4 weeks [PROMIS.PEDS] |
|
72701-6
|
I felt vulnerable in last week [BSL-23] |
|
91234-5
|
I felt wide awake in past 7 days [PROMIS.PEDS] |
|
72690-1
|
I felt worthless in the last week [BSL-23] |
|
92314-4
|
I find myself reaching for cigarettes without thinking about it [PROMIS] |
|
71032-7
|
I find strength in my faith or spiritual beliefs in the past 7 days [FACIT] |
|
76882-0
|
I find that friends or relatives have difficulty talking with me about my health [PROMIS] |
|
76902-6
|
I finished several drinks fast to get a quick effect in past 30D [PROMIS] |
|
76999-2
|
I fit in better when I drank in past 30D [PROMIS] |
|
90197-5
|
I forget things easily in past 4 weeks - frequency [PROMIS.PEDS] |
|
90198-3
|
I forget things easily in past 4 weeks - severity [PROMIS.PEDS] |
|
71310-7
|
I forget things easily in the past 4 weeks [FACIT] |
|
90203-1
|
I forget to bring things to and from school that I need for homework in past 4 weeks - frequency [PROMIS.PEDS] |
|
90204-9
|
I forget to bring things to and from school that I need for homework in past 4 weeks - severity [PROMIS.PEDS] |
|
90205-6
|
I forget what I am going to say in past 4 weeks - frequency [PROMIS.PEDS] |
|
90206-4
|
I forget what I am going to say in past 4 weeks - severity [PROMIS.PEDS] |
|
90185-0
|
I forget what my parents or teachers ask me to do in past 4 weeks [PROMIS.PEDS] |
|
91317-8
|
I forgot things in past 7 days [PROMIS.PEDS] |
|
92313-6
|
I frequently crave cigarettes [PROMIS] |
|
92312-8
|
I get a real gnawing hunger for a cigarette when l haven't smoked in a while [PROMIS] |
|
76866-3
|
I get emotional support from my family [PROMIS] |
|
71283-6
|
I get ill easily in the past 4 weeks [FACIT] |
|
71167-1
|
I get ill easily in the past 7 days [FACIT] |
|
76869-7
|
I get love and affection [PROMIS] |
|
71293-5
|
I get nervous - frightened easily in the past 4 weeks [FACIT] |
|
71177-0
|
I get nervous - frightened easily in the past 7 days [FACIT] |
|
76872-1
|
I get support from my friends [PROMIS] |
|
71281-0
|
I get tired easily in the past 4 weeks [FACIT] |
|
92295-5
|
I get upset when I think about my smoking [PROMIS] |
|
76730-1
|
I get useful advice about important things in life [PROMIS] |
|
78093-2
|
I got all the help I needed from my family in past 4 weeks [PROMIS.PEDS] |
|
76957-0
|
I got confused when I drank in past 30D [PROMIS] |
|
72641-4
|
I got drunk in last week [BSL-SUPP] |
|
76968-7
|
I got in an argument when I drank in past 30D [PROMIS] |
|
76962-0
|
I got sick when I drank in past 30D [PROMIS] |
|
78091-6
|
I got the support I needed from my family in past 4 weeks [PROMIS.PEDS] |
|
71382-6
|
I got upset by being too tired to do things I wanted to do in the past 7 days [FACIT] |
|
42324-4
|
I group phenotype [Identifier] in Blood |
|
91432-5
|
I had a bad stomach ache in past 7 days [PROMIS.PEDS] |
|
78174-0
|
I had a bad temper in past 7 days [PROMIS.PEDS] |
|
76978-6
|
I had a hangover after I drank in past 30D [PROMIS] |
|
76961-2
|
I had a headache after I drank in past 30D [PROMIS] |
|
91433-3
|
I had a headache in past 7 days [PROMIS.PEDS] |
|
91235-2
|
I had a lot of energy in past 7 days [PROMIS.PEDS] |
|
76913-3
|
I had an urge to continue drinking once I started in past 30D [PROMIS] |
|
76918-2
|
I had cravings for alcohol in past 30D [PROMIS] |
|
72683-6
|
I had episodes of binge eating in the last week [BSL-SUPP] |
|
72708-1
|
I had images that I was very much afraid of in last week [BSL-23] |
|
89665-4
|
I had mood swings in past 7 days [PROMIS] |
|
77001-6
|
I had more desire for sex when I drank in past 30D [PROMIS] |
|
77000-8
|
I had more fun when I drank in past 30D [PROMIS] |
|
91253-5
|
I had much to be proud about in past 7 days [PROMIS.PEDS] |
|
72638-0
|
I had outbreaks of uncontrolled anger or physically attacked others in last week [BSL-SUPP] |
|
91434-1
|
I had pain that really bothered me in past 7 days [PROMIS.PEDS] |
|
89934-4
|
I had so much pain I had to stop what I was doing in past 7 days [PROMIS.PEDS] |
|
91435-8
|
I had trouble breathing, even when I was not exercising or playing hard in past 7 days [PROMIS.PEDS] |
|
91313-7
|
I had trouble concentrating in past 7 days [PROMIS.PEDS] |
|
76915-8
|
I had trouble controlling my drinking in past 30D [PROMIS] |
|
91369-9
|
I had trouble controlling my thoughts in past 7 days [PROMIS.PEDS] |
|
71380-0
|
I had trouble finishing things because I was too tired in the past 7 days [FACIT] |
|
76980-2
|
I had trouble getting things done after I drank in past 30D [PROMIS] |
|
76956-2
|
I had trouble keeping appointments after I drank in past 30D [PROMIS] |
|
71379-2
|
I had trouble starting things because I was too tired in the past 7 days [FACIT] |
|
76920-8
|
I had trouble stopping drinking when I wanted to in past 30D [PROMIS] |
|
76982-8
|
I had trouble trusting other people when I drank in past 30D [PROMIS] |
|
72637-2
|
I had uncontrollable sexual encounters of which I was later ashamed or which made me angry in last week [BSL-SUPP] |
|
89678-7
|
I had unpleasant thoughts that wouldn't leave my mind in past 7 days [PROMIS] |
|
76917-4
|
I had urges to drink in past 30D [PROMIS] |
|
91248-5
|
I had very strong happy feelings in past 7 days [PROMIS.PEDS] |
|
72707-3
|
I hated myself in last week [BSL-23] |
|
75413-5
|
I have a good life [NIH Toolbox] |
|
90201-5
|
I have a hard time keeping track of my homework in past 4 weeks - frequency [PROMIS.PEDS] |
|
90202-3
|
I have a hard time keeping track of my homework in past 4 weeks - severity [PROMIS.PEDS] |
|
71025-1
|
I have a reason for living in the past 7 days [FACIT] |
|
71435-2
|
I have aches and pains that bother me in the past 7 days [FACIT] |
|
71551-6
|
I have attacks of anxiety or panic in the last 2 weeks or more [M3] |
|
71816-3
|
I have attacks of anxiety or panic since I took my last screen [M3] |
|
88854-5
|
I have been able to add and subtract numbers in my head without difficulty in past 7 days [PROMIS] |
|
81493-9
|
I have been able to bring to mind words that I wanted to use while talking to someone in past 7 days [PROMIS] |
|
81502-7
|
I have been able to concentrate in past 7 days [PROMIS] |
|
81520-9
|
I have been able to focus my attention in past 7 days [PROMIS] |
|
81503-5
|
I have been able to form thoughts clearly in past 7 days [PROMIS] |
|
81505-0
|
I have been able to get my point across when talking with someone in past 7 days [PROMIS] |
|
81515-9
|
I have been able to handle many tasks at once without losing track of what I was doing in past 7 days [PROMIS] |
|
87685-4
|
I have been able to help my child maintain (keep up with) lifestyle changes, like eating right or exercising Parent [PAM] |
|
81501-9
|
I have been able to keep track of what I am doing, even if I am interrupted in past 7 days [PROMIS] |
|
71344-6
|
I have been able to laugh and see the funny side of things in the past 7 days [EPDS] |
|
81523-3
|
I have been able to learn new things easily, like telephone numbers or instructions in past 7 days [PROMIS] |
|
86936-2
|
I have been able to maintain (keep up with) lifestyle changes, like eating right or exercising [PAM] |
|
81521-7
|
I have been able to mentally focus in past 7 days [PROMIS] |
|
81517-5
|
I have been able to multi-task as easily as usual without extra effort in past 7 days [PROMIS] |
|
81495-4
|
I have been able to pay attention and keep track of what I am doing without extra effort in past 7 days [PROMIS] |
|
71021-0
|
I have been able to reconcile, make peace, with other people in the past 7 days [FACIT] |
|
81504-3
|
I have been able to remember telephone numbers in past 7 days [PROMIS] |
|
81506-8
|
I have been able to remember the name of a familiar object in past 7 days [PROMIS] |
|
81522-5
|
I have been able to remember the name of a familiar person in past 7 days [PROMIS] |
|
81508-4
|
I have been able to remember things as easily as usual without extra effort in past 7 days [PROMIS] |
|
81494-7
|
I have been able to remember to do things, like take medicine or buy something I needed in past 7 days [PROMIS] |
|
88853-7
|
I have been able to remember where I put things, like my keys or my wallet in past 7 days [PROMIS] |
|
81500-1
|
I have been able to shift back and forth between two activities that require thinking in past 7 days [PROMIS] |
|
81507-6
|
I have been able to think as clearly as usual without extra effort in past 7 days [PROMIS] |
|
81496-2
|
I have been able to think clearly in past 7 days [PROMIS] |
|
81518-3
|
I have been able to think clearly without extra effort in past 7 days [PROMIS] |
|
71347-9
|
I have been anxious or worried for no good reason in the past 7 days [EPDS] |
|
71548-2
|
I have been eating more in the last 2 weeks or more [M3] |
|
71813-0
|
I have been eating more since I took my last screen [M3] |
|
71546-6
|
I have been sleeping too much in the last 2 weeks or more [M3] |
|
71811-4
|
I have been sleeping too much since I took my last screen [M3] |
|
71352-9
|
I have been so unhappy that I have been crying in the past 7 days [EPDS] |
|
71350-3
|
I have been so unhappy that I have had difficulty sleeping in the past 7 days [EPDS] |
|
71158-0
|
I have been throwing up in the past 7 days [FACIT] |
|
81487-1
|
I have been upset about my problems with memory, concentration, or making mental mistakes in past 7 days [PROMIS] |
|
71346-1
|
I have blamed myself unnecessarily when things went wrong in the past 7 days [EPDS] |
|
71050-9
|
I have confidence in my pharmacist-s in the past 7 days [FACIT] |
|
71545-8
|
I have difficulty sleeping in the last 2 weeks or more [M3] |
|
71810-6
|
I have difficulty sleeping since I took my last screen [M3] |
|
91343-4
|
I have dressed more slowly than usual because of back pain in the last 2 weeks [STarT Back] |
|
71161-4
|
I have energy or strength in the past 7 days [FACIT] |
|
71010-3
|
I have family members who will take on my responsibilities in the past 7 days [FACIT] |
|
71351-1
|
I have felt sad or miserable in the past 7 days [EPDS] |
|
71348-7
|
I have felt scared or panicky for no very good reason in the past 7 days [EPDS] |
|
81475-6
|
I have forgotten names of people soon after being introduced in past 7 days [PROMIS] |
|
81491-3
|
I have had difficulty multi-tasking in past 7 days [PROMIS] |
|
81482-2
|
I have had more problems conversing with others in past 7 days [PROMIS] |
|
91341-8
|
I have had pain in the shoulder or neck at some time in the last 2 weeks [STarT Back] |
|
71544-1
|
I have had thoughts of suicide in the last 2 weeks or more [M3] |
|
71809-8
|
I have had thoughts of suicide since I took my last screen [M3] |
|
81483-0
|
I have had to use written lists more often than usual so I would not forget things in past 7 days [PROMIS] |
|
81481-4
|
I have had to work harder than usual to express myself clearly in past 7 days [PROMIS] |
|
81479-8
|
I have had to work harder than usual to keep track of what I was doing in past 7 days [PROMIS] |
|
81474-9
|
I have had to work really hard to pay attention or I would make a mistake in past 7 days [PROMIS] |
|
81463-2
|
I have had trouble adding or subtracting numbers in my head in past 7 days [PROMIS] |
|
81465-7
|
I have had trouble concentrating in past 7 days [PROMIS] |
|
81466-5
|
I have had trouble finding my way to a familiar place in past 7 days [PROMIS] |
|
90412-8
|
I have had trouble finding the right words to express myself in past 7 days [PROMIS] |
|
81460-8
|
I have had trouble forming thoughts in past 7 days [PROMIS] |
|
81484-8
|
I have had trouble keeping track of what I was doing when interrupted in past 7 days [PROMIS] |
|
81470-7
|
I have had trouble recalling the name of an object while talking to someone in past 7 days [PROMIS] |
|
81469-9
|
I have had trouble remembering new information, like phone numbers or simple instructions in past 7 days [PROMIS] |
|
81467-3
|
I have had trouble remembering where I put things, like my keys or my wallet in past 7 days [PROMIS] |
|
81468-1
|
I have had trouble remembering whether I did things I was supposed to do, like taking a medicine or buying something I needed in past 7 days [PROMIS] |
|
81485-5
|
I have had trouble shifting back and forth between different activities that require thinking in past 7 days [PROMIS] |
|
81471-5
|
I have had trouble speaking fluently in past 7 days [PROMIS] |
|
81486-3
|
I have hidden my problems with memory, concentration, or making mental mistakes so that others would not notice in past 7 days [PROMIS] |
|
71345-3
|
I have looked forward with enjoyment to things in the past 7 days [EPDS] |
|
71547-4
|
I have lost some appetite in the last 2 weeks or more [M3] |
|
71812-2
|
I have lost some appetite since I took my last screen [M3] |
|
81464-0
|
I have made mistakes when writing down phone numbers in past 7 days [PROMIS] |
|
81473-1
|
I have needed medical instructions repeated because I could not keep them straight in past 7 days [PROMIS] |
|
71554-0
|
I have nightmares or flashbacks in the last 2 weeks or more [M3] |
|
71819-7
|
I have nightmares or flashbacks since I took my last screen [M3] |
|
91342-6
|
I have only walked short distances because of my back pain in the last 2 weeks [STarT Back] |
|
71159-8
|
I have pain in my stomach in the past 7 days [FACIT] |
|
71018-6
|
I have peace of mind in the past 7 days [FACIT] |
|
76746-7
|
I have people I can turn to for help with my problems [PROMIS] |
|
76868-9
|
I have people who care about what happens to me [PROMIS] |
|
76864-8
|
I have people who I can talk to about my health [PROMIS] |
|
76724-4
|
I have someone I trust to talk with about my feelings [PROMIS] |
|
76726-9
|
I have someone I trust to talk with about my problems [PROMIS] |
|
76720-2
|
I have someone to confide in or talk to about myself or my problems [PROMIS] |
|
76727-7
|
I have someone to give me good advice about a crisis if I need it [PROMIS] |
|
76729-3
|
I have someone to give me information if I need it [PROMIS] |
|
76875-4
|
I have someone to talk with about money matters [PROMIS] |
|
76725-1
|
I have someone to talk with when I have a bad day [PROMIS] |
|
76728-5
|
I have someone to turn to for suggestions about how to deal with a problem [PROMIS] |
|
76723-6
|
I have someone who makes me feel appreciated [PROMIS] |
|
76867-1
|
I have someone who makes me feel needed [PROMIS] |
|
76722-8
|
I have someone who understands my problems [PROMIS] |
|
76719-4
|
I have someone who will listen to me when I need to talk [PROMIS] |
|
76721-0
|
I have someone with whom to share my most private worries and fears [PROMIS] |
|
71014-5
|
I have swelling in parts of my body in the past 7 days [FACIT] |
|
76844-0
|
I have to do my work for shorter periods of time than usual (include work at home) [PROMIS] |
|
76711-1
|
I have to limit my regular activities with friends [PROMIS] |
|
76706-1
|
I have to limit my regular family activities [PROMIS] |
|
76833-3
|
I have to limit social activities at home [PROMIS] |
|
76836-6
|
I have to limit social activities outside my home [PROMIS] |
|
76843-2
|
I have to limit social activities with groups of people [PROMIS] |
|
76707-9
|
I have to limit the things I do for fun with others [PROMIS] |
|
71312-3
|
I have to read things several times so I can understand them in the past 4 weeks [FACIT] |
|
90191-8
|
I have to read things several times to understand them in past 4 weeks - frequency [PROMIS.PEDS] |
|
90192-6
|
I have to read things several times to understand them in past 4 weeks - severity [PROMIS.PEDS] |
|
71110-1
|
I have to take my condition into account when making plans in the past 7 days [FACIT] |
|
90209-8
|
I have to use written lists more often than other people my age so I will not forget things in past 4 weeks - frequency [PROMIS.PEDS] |
|
90210-6
|
I have to use written lists more often than other people my age so I will not forget things in past 4 weeks - severity [PROMIS.PEDS] |
|
90215-5
|
I have to work really hard to pay attention or I make mistakes in past 4 weeks - frequency [PROMIS.PEDS] |
|
90216-3
|
I have to work really hard to pay attention or I make mistakes in past 4 weeks - severity [PROMIS.PEDS] |
|
76839-0
|
I have trouble accomplishing my usual work (include work at home) [PROMIS] |
|
75417-6
|
I have trouble doing all of my regular leisure activities with others [PROMIS] |
|
89084-8
|
I have trouble doing all of my regular leisure activities with others in the past 7 days [ADAPTABLE] |
|
76709-5
|
I have trouble doing all of my usual work (include work at home) [PROMIS] |
|
76846-5
|
I have trouble doing all of the activities with friends that are really important to me [PROMIS] |
|
76851-5
|
I have trouble doing all of the activities with friends that I feel I should do [PROMIS] |
|
76712-9
|
I have trouble doing all of the activities with friends that I want to do [PROMIS] |
|
76841-6
|
I have trouble doing all of the family activities that are really important to me [PROMIS] |
|
76840-8
|
I have trouble doing all of the family activities that I feel I should do [PROMIS] |
|
76708-7
|
I have trouble doing all of the family activities that I want to do [PROMIS] |
|
76852-3
|
I have trouble doing all of the work that I feel I should do (include work at home) [PROMIS] |
|
76710-3
|
I have trouble doing all of the work that is really important to me (include work at home) [PROMIS] |
|
76847-3
|
I have trouble doing all the leisure activities with others that I want to do [PROMIS] |
|
76838-2
|
I have trouble doing everything for my family that I feel I should do [PROMIS] |
|
76856-4
|
I have trouble doing everything for my friends that I feel I should do [PROMIS] |
|
76850-7
|
I have trouble doing everything for my friends that I want to do [PROMIS] |
|
76842-4
|
I have trouble doing everything for work that I want to do (include work at home) [PROMIS] |
|
76831-7
|
I have trouble doing my regular daily work around the house [PROMIS] |
|
71027-7
|
I have trouble feeling peace of mind in the past 7 days [FACIT] |
|
71109-3
|
I have trouble getting around in public places in the past 7 days [FACIT] |
|
71279-4
|
I have trouble getting myself dressed in the past 4 weeks [FACIT] |
|
71164-8
|
I have trouble getting myself dressed in the past 7 days [FACIT] |
|
76854-9
|
I have trouble keeping in touch with others [PROMIS] |
|
90183-5
|
I have trouble keeping track of what I am doing if I get interrupted in past 4 weeks [PROMIS.PEDS] |
|
76848-1
|
I have trouble keeping up with my family responsibilities [PROMIS] |
|
76855-6
|
I have trouble keeping up with my work responsibilities (include work at home) [PROMIS] |
|
71140-8
|
I have trouble learning new tasks or directions in the past 7 days [FACIT] |
|
76834-1
|
I have trouble meeting the needs of my family [PROMIS] |
|
76832-5
|
I have trouble meeting the needs of my friends [PROMIS] |
|
76837-4
|
I have trouble participating in recreational activities with others [PROMIS] |
|
90213-0
|
I have trouble paying attention to the teacher in past 4 weeks - frequency [PROMIS.PEDS] |
|
90214-8
|
I have trouble paying attention to the teacher in past 4 weeks - severity [PROMIS.PEDS] |
|
90182-7
|
I have trouble recalling the names of things in past 4 weeks [PROMIS.PEDS] |
|
90189-2
|
I have trouble remembering the date or day of the week in past 4 weeks [PROMIS.PEDS] |
|
90176-9
|
I have trouble remembering the names of people I have just met in past 4 weeks [PROMIS.PEDS] |
|
90187-6
|
I have trouble remembering the names of people I know in past 4 weeks [PROMIS.PEDS] |
|
90211-4
|
I have trouble remembering to do things like school projects or chores in past 4 weeks - frequency [PROMIS.PEDS] |
|
90212-2
|
I have trouble remembering to do things like school projects or chores in past 4 weeks - severity [PROMIS.PEDS] |
|
90175-1
|
I have trouble remembering where I put things, like my watch or my homework in past 4 weeks [PROMIS.PEDS] |
|
71280-2
|
I have trouble running like other people in the past 4 weeks [FACIT] |
|
71165-5
|
I have trouble running like other people in the past 7 days [FACIT] |
|
76345-8
|
I have trouble starting things because I am tired during the past 7 days [PROMIS] |
|
76849-9
|
I have trouble taking care of my regular personal responsibilities [PROMIS] |
|
71284-4
|
I have trouble writing with a pen or pencil in the past 4 weeks [FACIT] |
|
71168-9
|
I have trouble writing with a pen or pencil in the past 7 days [FACIT] |
|
81472-3
|
I have walked into a room and forgotten what I meant to get or do there in past 7 days [PROMIS] |
|
72686-9
|
I hurt myself by cutting, burning, strangling, headbanging etc. in last week [BSL-SUPP] |
|
72682-8
|
I induced vomiting in lthe last week [BSL-SUPP] |
|
78096-5
|
I knew my family would help me if I needed it in past 4 weeks [PROMIS.PEDS] |
|
78100-5
|
I knew that my family would be there if I needed them in past 4 weeks [PROMIS.PEDS] |
|
78092-4
|
I knew what I could expect from others in my family in past 4 weeks [PROMIS.PEDS] |
|
87686-2
|
I know how to prevent problems with my child's health Parent [PAM] |
|
86935-4
|
I know how to prevent problems with my health [PAM] |
|
87700-1
|
I know how to prevent problems with this person's health Caregiver [PAM] |
|
71034-3
|
I know that whatever happens with my illness things will be okay in the past 7 days [FACIT] |
|
87698-7
|
I know the different medical treatment options available for this person's health Caregiver [PAM] |
|
87679-7
|
I know what each of my child's prescribed medications do Parent [PAM] |
|
86942-0
|
I know what each of my prescribed medications do [PAM] |
|
87693-8
|
I know what each of this person's prescribed medications do Caregiver [PAM] |
|
87684-7
|
I know what treatments are available for my child's health problems Parent [PAM] |
|
86937-0
|
I know what treatments are available for my health problems [PAM] |
|
91243-6
|
I laughed a lot in past 7 days [PROMIS.PEDS] |
|
76973-7
|
I lied about my drinking in past 30D [PROMIS] |
|
76888-7
|
I like being alone [PROMIS] |
|
92231-0
|
I like the way a cigarette makes me feel physically [PROMIS] |
|
92294-8
|
I look ridiculous while smoking [PROMIS] |
|
76976-0
|
I looked sloppy when I drank in past 30D [PROMIS] |
|
71163-0
|
I lose balance or fall down easily in the past 7 days [FACIT] |
|
71278-6
|
I lose my balance or fall down easily in the past 4 weeks [FACIT] |
|
92230-2
|
I love the feel of inhaling the smoke into my mouth [PROMIS] |
|
71009-5
|
I maintain contact with my friends in the past 7 days [FACIT] |
|
71017-8
|
I make each day count in the past 7 days [FACIT] |
|
71308-1
|
I need to work harder than other people to get my school work done in the past 4 weeks [FACIT] |
|
71385-9
|
I needed help doing my usual things at home in the past 7 days [FACIT] |
|
78164-1
|
I needed help walking when I was in pain in past 7 days [PROMIS.PEDS] |
|
78075-9
|
I needed to sleep during the day in past 7 days [PROMIS.PEDS] |
|
71381-8
|
I needed to sleep during the day in the past 7 days [FACIT] |
|
71191-1
|
I often feel that other children are better than me in the past 4 weeks [FACIT] |
|
71233-1
|
I often feel that other children are better than me in the past 7 days [FACIT] |
|
71289-3
|
I often feel that other people are better than me in the past 4 weeks [FACIT] |
|
71173-9
|
I often feel that other people are better than me in the past 7 days [FACIT] |
|
71291-9
|
I often switch from good moods to bad moods in the past 4 weeks [FACIT] |
|
71175-4
|
I often switch from good moods to bad moods in the past 7 days [FACIT] |
|
74180-1
|
I rarely think of quitting this job [NMMDS] |
|
90193-4
|
I react slower than most people my age when I play games in past 4 weeks - frequency [PROMIS.PEDS] |
|
90194-2
|
I react slower than most people my age when I play games in past 4 weeks - severity [PROMIS.PEDS] |
|
92215-3
|
I rely on smoking to deal with stress [PROMIS] |
|
76972-9
|
I said or did embarrassing things when I drank in past 30D [PROMIS] |
|
71902-1
|
I seem to get sick a lot easier than other people [Veterans RAND] |
|
76997-6
|
I slept better after I drank in past 30D [PROMIS] |
|
91244-4
|
I smiled a lot in past 7 days [PROMIS.PEDS] |
|
92229-4
|
I smoke because it is self-satisfying [PROMIS] |
|
92228-6
|
I smoke because smoking feels good [PROMIS] |
|
92311-0
|
I smoke even when I am so ill that I am in bed most of the day [PROMIS] |
|
92310-2
|
I smoke more before going into a situation where smoking is not allowed [PROMIS] |
|
92227-8
|
I smoke to get a sense of pleasure [PROMIS] |
|
76905-9
|
I spent a whole weekend drinking in past 30D [PROMIS] |
|
76901-8
|
I spent too much time drinking in past 30D [PROMIS] |
|
72705-7
|
I suffered from shame in last week [BSL-23] |
|
72703-2
|
I suffered from voices and noises from inside or outside my head in last week [BSL-23] |
|
71192-9
|
I think I have fewer friends than other children in the past 7 days [FACIT] |
|
71299-2
|
I think I have fewer friends than others in the past 4 weeks [FACIT] |
|
71183-8
|
I think I have fewer friends than others in the past 7 days [FACIT] |
|
72713-1
|
I thought of hurting myself in last week [BSL-23] |
|
91436-6
|
I threw up in past 7 days [PROMIS.PEDS] |
|
72685-1
|
I told other people that I was going to kill myself in the last week [BSL-SUPP] |
|
72640-6
|
I took drugs in last week [BSL-SUPP] |
|
72639-8
|
I took medication that had not been prescribed or if had been prescribed, I took more than the prescribed dose in last week [BSL-SUPP] |
|
76958-8
|
I took risks when I drank in past 30D [PROMIS] |
|
72684-4
|
I tried to commit suicide in last week [BSL-SUPP] |
|
87683-9
|
I understand my child's health problems and what causes them Parent [PAM] |
|
86945-3
|
I understand my health problems and what causes them [PAM] |
|
87697-9
|
I understand the nature and causes of this person's health Caregiver [PAM] |
|
76910-9
|
I used alcohol and other drugs together to get high in past 30D [PROMIS] |
|
76979-4
|
I used poor judgment when I drank in past 30D [PROMIS] |
|
90186-8
|
I walk into a room and forget what I wanted to get or do in past 4 weeks [PROMIS.PEDS] |
|
78165-8
|
I walked carefully when I was in pain in past 7 days [PROMIS.PEDS] |
|
78172-4
|
I wanted to be alone because I was so angry in past 7 days [PROMIS.PEDS] |
|
78111-2
|
I wanted to help my family however I could in past 4 weeks [PROMIS.PEDS] |
|
72706-5
|
I wanted to punish myself in last week [BSL-23] |
|
76984-4
|
I was able to express myself better when I drank in past 30D [PROMIS] |
|
72715-6
|
I was absent-minded and unable to remember what I was actually doing in last week [BSL-23] |
|
72698-4
|
I was afraid of losing control in last week [BSL-23] |
|
78171-6
|
I was angry when things didn't go my way in past 7 days [PROMIS.PEDS] |
|
76964-6
|
I was clumsy when I drank in past 30D [PROMIS] |
|
76959-6
|
I was critical of myself when I drank in past 30D [PROMIS] |
|
76967-9
|
I was criticized about my drinking in past 30D [PROMIS] |
|
91241-0
|
I was in a good mood in past 7 days [PROMIS.PEDS] |
|
91240-2
|
I was in good spirits in past 7 days [PROMIS.PEDS] |
|
76981-0
|
I was inconsiderate when I drank in past 30D [PROMIS] |
|
72710-7
|
I was lonely in last week [BSL-23] |
|
76969-5
|
I was loud when I drank in past 30D [PROMIS] |
|
91242-8
|
I was merry in past 7 days [PROMIS.PEDS] |
|
91311-1
|
I was slow to react to things in past 7 days [PROMIS.PEDS] |
|
78173-2
|
I was so mad I did not want to talk to people in past 7 days [PROMIS.PEDS] |
|
91437-4
|
I was sweaty, even when I was not exercising or playing hard in past 7 days [PROMIS.PEDS] |
|
78076-7
|
I was too tired to eat in past 7 days [PROMIS.PEDS] |
|
71384-2
|
I was too tired to eat in the past 7 days [FACIT] |
|
76965-3
|
I was unreliable after I drank in past 30D [PROMIS] |
|
90021-7
|
I wish for a better treatment [PsoSat] |
|
89922-9
|
I worried about dying in past 7 days [PROMIS] |
|
78169-0
|
I worried that something might happen to my parents or guardians in past 7 days [PROMIS.PEDS] |
|
76952-1
|
I worried when I drank in past 30D [PROMIS] |
|
71295-0
|
I worry about being able to date because of my illness history in the past 4 weeks [FACIT] |
|
71296-8
|
I worry about being able to go to college because of my illness history in the past 4 weeks [FACIT] |
|
71180-4
|
I worry about being able to go to college because of my illness in the past 7 days [FACIT] |
|
71179-6
|
I worry about being able to have a girlfriend or boyfriend because of my illness in the past 7 days [FACIT] |
|
71290-1
|
I worry about being sick again in the past 4 weeks [FACIT] |
|
71552-4
|
I worry about dying or losing control in the last 2 weeks or more [M3] |
|
71817-1
|
I worry about dying or losing control since I took my last screen [M3] |
|
71181-2
|
I worry about getting a job because of my illness in the past 7 days [FACIT] |
|
71297-6
|
I worry about getting a job to support myself because of my illness history in the past 4 weeks [FACIT] |
|
71174-7
|
I worry about getting another cancer-tumor in the past 7 days [FACIT] |
|
71294-3
|
I worry about having a good life in the future in the past 4 weeks [FACIT] |
|
71178-8
|
I worry about having a good life in the future in the past 7 days [FACIT] |
|
71136-6
|
I worry about spreading my infection in the past 7 days [FACIT] |
|
92271-6
|
I worry that smoking will lower my quality of life [PROMIS] |
|
71292-7
|
I worry when I go back to the hospital or clinic in the past 4 weeks [FACIT] |
|
71176-2
|
I worry when I go back to the hospital or clinic in the past 7 days [FACIT] |
|
71302-4
|
I would rather do something by myself than with other people in the past 4 weeks [FACIT] |
|
71186-1
|
I would rather do something by myself than with other people in the past 7 days [FACIT] |
|
71194-5
|
I would rather play alone than with other children in the past 7 days [FACIT] |
|
80998-8
|
Intra-aortic balloon pump used |
|
13128-4
|
Immunosuppressive acidic protein [Units/volume] in Serum or Plasma |
|
14164-8
|
Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma |
|
1003-3
|
Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
|
1005-8
|
Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
|
50958-8
|
Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma --after transfusion |
|
1008-2
|
Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma |
|
50012-4
|
Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method |
|
50959-6
|
Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma |
|
56886-5
|
Indirect antiglobulin test.unspecified reagent [Titer] in Serum or Plasma |
|
35040-5
|
Lymphocytes Immunoblastic [#/volume] in Blood |
|
33832-7
|
Lymphocytes Immunoblastic [#/volume] in Blood by Manual count |
|
74357-5
|
Lymphocytes Immunoblastic [Presence] in Blood by Light microscopy |
|
34920-9
|
Lymphocytes Immunoblastic/100 leukocytes in Blood |
|
33833-5
|
Lymphocytes Immunoblastic/100 leukocytes in Blood by Manual count |
|
59060-4
|
Inflammatory bowel disease Ab 7 [Interpretation] in Serum |
|
74149-6
|
Inflammatory bowel disease action plan |
|
22364-4
|
Infectious bursal disease virus Ab [Presence] in Serum |
|
15475-7
|
Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
|
15474-0
|
Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31436-9
|
Infectious bursal disease virus Ab [Units/volume] in Serum |
|
23139-9
|
Infectious bursal disease virus Ab [Titer] in Serum |
|
23140-7
|
Infectious bursal disease virus Ab [Titer] in Serum by Immune diffusion (ID) |
|
23141-5
|
Infectious bursal disease virus Ab [Titer] in Serum by Neutralization test |
|
23143-1
|
Infectious bursal disease virus Ag [Presence] in Bursa of Fabricius by Immune diffusion (ID) |
|
31857-6
|
Infectious bursal disease virus Ag [Presence] in Unspecified specimen |
|
23142-3
|
Infectious bursal disease virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
74297-3
|
Isobutyryl-CoA dehydrogenase deficiency newborn screen interpretation |
|
73010-1
|
Ibuprofen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73009-3
|
Ibuprofen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
38431-3
|
Ibuprofen [Mass/volume] in Serum or Plasma --1.5 hours post dose |
|
38430-5
|
Ibuprofen [Mass/volume] in Serum or Plasma --1 hour post dose |
|
38433-9
|
Ibuprofen [Mass/volume] in Serum or Plasma --2.5 hours post dose |
|
38432-1
|
Ibuprofen [Mass/volume] in Serum or Plasma --2 hours post dose |
|
38429-7
|
Ibuprofen [Mass/volume] in Serum or Plasma --30 minutes post dose |
|
38434-7
|
Ibuprofen [Mass/volume] in Serum or Plasma --3 hours post dose |
|
4281-2
|
Ibuprofen [Mass] of Dose |
|
59911-8
|
Ibuprofen [Moles/volume] in Gastric fluid |
|
49868-3
|
Ibuprofen IgE Ab [Units/volume] in Serum |
|
73336-0
|
Ibuprofen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73337-8
|
Ibuprofen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48275-2
|
Ibuprofen triggered leukotriene release [Mass/volume] by Leukocytes |
|
38428-9
|
Ibuprofen [Mass/volume] in Serum or Plasma --pre dose |
|
13564-0
|
Ibuprofen [Presence] in Serum or Plasma |
|
35614-7
|
Ibuprofen [Mass/volume] in Serum or Plasma by Screen method |
|
3687-1
|
Ibuprofen [Mass/volume] in Serum or Plasma |
|
32082-0
|
Ibuprofen [Moles/volume] in Serum or Plasma |
|
14071-5
|
Ibuprofen [Presence] in Urine |
|
73997-9
|
Ibuprofen [Mass/volume] in Urine |
|
59910-0
|
Ibuprofen [Moles/volume] in Urine |
|
60308-4
|
Ibuprofen [Moles/volume] in Unspecified specimen |
|
31236-3
|
Infectious bronchitis virus Ab [Units/volume] in Serum |
|
22801-5
|
Infectious bronchitis virus Ab [Titer] in Serum |
|
22802-3
|
Infectious bronchitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
22803-1
|
Infectious bronchitis virus Ab [Titer] in Serum by Immunoassay |
|
22804-9
|
Infectious bronchitis virus Ab [Titer] in Serum by Neutralization test |
|
22806-4
|
Infectious bronchitis virus Ag [Presence] in Tissue by Immune stain |
|
31719-8
|
Infectious bronchitis virus Ag [Presence] in Unspecified specimen |
|
22807-2
|
Infectious bronchitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22805-6
|
Infectious bronchitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
31237-1
|
Infectious bronchitis virus Ark-99 Ab [Units/volume] in Serum |
|
22092-1
|
Infectious bronchitis virus Ark-99 Ab [Titer] in Serum |
|
15439-3
|
Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition |
|
31238-9
|
Infectious bronchitis virus Conn-42 Ab [Units/volume] in Serum |
|
22093-9
|
Infectious bronchitis virus Conn-42 Ab [Titer] in Serum |
|
15441-9
|
Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition |
|
20861-1
|
Infectious bronchitis virus genotype [Identifier] in Isolate by NAA with probe detection |
|
20858-7
|
Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
|
46193-9
|
Infectious bronchitis virus JMK Ab [Titer] in Serum |
|
43338-3
|
Infectious bronchitis virus JMK Ab [Titer] in Serum by Hemagglutination inhibition |
|
31239-7
|
Infectious bronchitis virus Mass-41 Ab [Units/volume] in Serum |
|
22094-7
|
Infectious bronchitis virus Mass-41 Ab [Titer] in Serum |
|
15440-1
|
Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition |
|
22810-6
|
Infectious bronchitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22809-8
|
Infectious bronchitis virus RNA [Presence] in Unspecified specimen by Probe |
|
20859-5
|
Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test |
|
20860-3
|
Infectious bronchitis virus [Presence] in Tissue by Organism specific culture |
|
22808-0
|
Infectious bronchitis virus [Presence] in Unspecified specimen by Electron microscopy |
|
43303-7
|
Immune Complex C3d [Units/volume] in Serum or Plasma |
|
47217-5
|
Immune Complex C3d [Mass/volume] in Serum or Plasma |
|
38457-8
|
Immune complex.C3d+IgG [Units/volume] in Serum or Plasma |
|
84173-4
|
Interventional cardiology Consult note |
|
23879-0
|
Immune complex [Units/volume] in Body fluid by C1q binding assay |
|
23882-4
|
Immune complex [Units/volume] in Body fluid by Conglutinin assay |
|
23881-6
|
Immune complex [Mass/volume] in Body fluid by Polyethylene glycol (PEG) assay |
|
23880-8
|
Immune complex [Units/volume] in Body fluid by Raji cell assay |
|
18269-1
|
Immune complex [Units/volume] in Body fluid |
|
33953-1
|
Immune complex IgA [Mass/volume] in Serum or Plasma |
|
33960-6
|
Immune complex IgE [Units/volume] in Serum or Plasma |
|
48997-1
|
Immune complex.IgG [Mass/volume] in Body fluid by C1q binding assay |
|
42639-5
|
Immune complex.IgG [Units/volume] in Serum or Plasma by C1q binding assay |
|
48419-6
|
Immune complex.IgG [Mass/volume] in Serum or Plasma by C1q binding assay |
|
33954-9
|
Immune complex.IgG [Mass/volume] in Serum or Plasma |
|
42601-5
|
Immune complex.IgG [Units/volume] in Synovial fluid by C1q binding assay |
|
33952-3
|
Immune complex.IgM [Mass/volume] in Serum or Plasma |
|
84174-2
|
Interventional cardiology Note |
|
84175-9
|
Interventional cardiology Surgical operation note |
|
84176-7
|
Interventional cardiology Postoperative evaluation and management note |
|
84177-5
|
Interventional cardiology Preoperative evaluation and management note |
|
27831-7
|
Immune complex [Units/volume] in Serum or Plasma by C1q binding assay |
|
14275-2
|
Immune complex [Units/volume] in Serum or Plasma by C3b binding assay |
|
45158-3
|
Immune complex [Units/volume] in Serum or Plasma by C3d binding assay |
|
13170-6
|
Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
|
52971-9
|
Immune complex [Mass/volume] in Serum or Plasma by Immunoassay |
|
13171-4
|
Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
|
13631-7
|
Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
|
44393-7
|
Immune complex [Presence] in Serum or Plasma |
|
44391-1
|
Immune complex [Presence] in Serum or Plasma by C1q binding assay |
|
44392-9
|
Immune complex [Presence] in Serum or Plasma by Raji cell assay |
|
10864-7
|
Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
|
5228-2
|
Immune complex [Units/volume] in Serum or Plasma |
|
49778-4
|
Immune complex [Mass/volume] in Serum or Plasma |
|
44674-0
|
Invasive carcinoma uninvolved margin closest in Breast tumor |
|
44672-4
|
Invasive carcinoma uninvolved margin distance closest [Length] in Breast tumor |
|
93455-4
|
IC-26 [Mass/volume] in Urine by Confirmatory method |
|
4522-9
|
Complement iC3 [Mass/volume] in Plasma |
|
4523-7
|
Complement iC3b receptors [Entitic number] in Leukocytes |
|
6291-9
|
Complement iC3b receptors [Presence] in Leukocytes |
|
77339-0
|
Indocyanine green [Mass/volume] in Plasma --15 minutes post dose indocyanine green |
|
77338-2
|
Indocyanine green [Mass/volume] in Plasma --1 minute post dose indocyanine green |
|
73642-1
|
Iclaprim [Susceptibility] by Disk diffusion (KB) |
|
73619-9
|
Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73597-7
|
Iclaprim [Susceptibility] |
|
60956-0
|
Intracranial pressure (ICP) |
|
60957-8
|
Intracranial pressure (ICP) Diastolic |
|
35101-5
|
Intrathecal pressure |
|
60958-6
|
Intracranial pressure (ICP) Mean |
|
60959-4
|
Intracranial pressure (ICP) Systolic |
|
79744-9
|
International classification of retinoblastoma Intraocular retinoblastoma classification at initial diagnosis Left eye |
|
79743-1
|
International classification of retinoblastoma Intraocular retinoblastoma classification at initial diagnosis Right eye |
|
79746-4
|
International classification of retinoblastoma Intraocular retinoblastoma classification at final disease stage Left eye |
|
79745-6
|
International classification of retinoblastoma Intraocular retinoblastoma classification at final disease stage Right eye |
|
17021-7
|
Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
|
10865-4
|
Intercellular substance Ab [Presence] in Serum |
|
17020-9
|
Intercellular substance Ab [Presence] in Serum by Immunofluorescence |
|
31441-9
|
Intercellular substance Ab [Units/volume] in Serum |
|
9424-3
|
Intercellular substance Ab [Titer] in Serum |
|
51708-6
|
Intercellular substance Ab [Titer] in Serum by Immunofluorescence |
|
42936-5
|
Intercellular substance IgA Ab [Presence] in Serum by Immunofluorescence |
|
21352-0
|
Intercellular substance IgG Ab [Interpretation] in Serum by Immunofluorescence |
|
93233-5
|
Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence |
|
92040-5
|
Information communication technology description |
|
92039-7
|
Information communication technology name |
|
92038-9
|
Information communication technology type |
|
46426-3
|
Icteric index of Serum or Plasma |
|
84075-1
|
Intensive care unit Admission evaluation note |
|
34100-8
|
Intensive care unit Consult note |
|
75432-5
|
Intensive care unit Note |
|
34126-3
|
Intensive care unit Progress note |
|
76698-0
|
Identifier assigning authority |
|
82786-5
|
Identifier Clinical trial protocol |
|
44877-9
|
Insulin dependent diabetes mellitus [Presence] |
|
50064-5
|
Ideal body weight |
|
82761-8
|
Identified based on transfusion investigation post blood product donation |
|
54096-3
|
Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative |
|
92719-4
|
Lipoprotein.broad beta.subparticle.large [Moles/volume] in Serum |
|
35865-5
|
Lipoprotein.intermediate density [Presence] in Serum or Plasma |
|
92718-6
|
Lipoprotein.broad beta.subparticle.small [Moles/volume] in Serum |
|
56134-0
|
Cholesterol in IDL 1 [Moles/volume] in Serum or Plasma |
|
56135-7
|
Cholesterol in IDL 2 [Moles/volume] in Serum or Plasma |
|
2087-5
|
Cholesterol in IDL [Mass/volume] in Serum or Plasma |
|
70201-9
|
Cholesterol in IDL [Moles/volume] in Serum or Plasma |
|
50194-0
|
Cholesterol in IDL+Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma |
|
70202-7
|
Cholesterol in IDL+Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma |
|
76030-6
|
IDS gene full mutation analysis in Blood or Tissue by Sequencing |
|
76028-0
|
IDUA gene full mutation analysis in Blood or Tissue by Sequencing |
|
57983-9
|
IDUA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79462-8
|
Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS |
|
24088-7
|
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
24087-9
|
Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma |
|
2456-2
|
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue |
|
24089-5
|
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
56539-0
|
Intrinsic factor Ab [Units/volume] in Serum by Immunoassay |
|
30530-0
|
Intrinsic factor Ab [Presence] in Serum |
|
24383-2
|
Intrinsic factor Ab [Presence] in Serum by Immunoassay |
|
89508-6
|
Intrinsic factor Ab [Presence] in Serum by Line blot |
|
5233-2
|
Intrinsic factor Ab [Presence] in Serum by Radioimmunoassay (RIA) |
|
11564-2
|
Intrinsic factor Ab [Units/volume] in Serum |
|
31444-3
|
Intrinsic factor blocking Ab [Presence] in Serum |
|
9537-2
|
Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA) |
|
31443-5
|
Intrinsic factor blocking Ab [Units/volume] in Serum |
|
2489-3
|
Intrinsic factor blocking Ab [Titer] in Serum |
|
26892-0
|
Intrinsic factor blocking IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
31445-0
|
Intrinsic factor blocking IgG Ab [Units/volume] in Serum |
|
73760-1
|
If cesarean, a trial of labor was attempted [US Standard Certificate of Live Birth] |
|
92325-0
|
If I quit smoking I will be less welcome around my friends who smoke [PROMIS] |
|
92293-0
|
If I quit smoking I will be more attractive to others [PROMIS] |
|
92292-2
|
If I quit smoking I will be more in control of my life [PROMIS] |
|
92270-8
|
If I quit smoking I will breathe easier [PROMIS] |
|
92269-0
|
If I quit smoking I will feel more energetic [PROMIS] |
|
92291-4
|
If I quit smoking my friends will respect me more [PROMIS] |
|
60221-9
|
Intrinsic factor IgG Ab [Units/volume] in Serum |
|
2488-5
|
Intrinsic factor [Mass/volume] in Serum |
|
35347-4
|
Microscopic observation [Identifier] in Unspecified specimen by Immunofluorescence |
|
88473-4
|
If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this [SAQ] |
|
79047-7
|
If you need to, are you physically able to rush for a short distance, such as to cross a street [PROMIS] |
|
81090-3
|
If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] |
|
77052-9
|
IFITM5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77051-1
|
IFITM5 gene full mutation analysis in Blood or Tissue by Sequencing |
|
4649-0
|
Interferon [Units/volume] in Serum |
|
49329-6
|
Interferon alpha Ab [Presence] in Serum or Plasma by Immunoassay |
|
44320-0
|
Interferon alpha [Presence] in Serum or Plasma |
|
12731-6
|
Interferon alpha [Units/volume] in Serum or Plasma |
|
33820-2
|
Interferon alpha [Mass/volume] in Serum or Plasma |
|
29647-5
|
Interferon beta Ab [Presence] in Serum or Plasma |
|
34607-2
|
Interferon beta Ab [Units/volume] in Serum or Plasma |
|
35139-5
|
Interferon beta Ab [Titer] in Serum or Plasma |
|
59181-8
|
Interferon beta given [Type] |
|
27871-3
|
Interferon beta IgG Ab [Units/volume] in Serum or Plasma |
|
12730-8
|
Interferon beta [Units/volume] in Serum or Plasma |
|
61113-7
|
Immunoglobulin gene rearrangements in Blood or Tissue by Molecular genetics method Narrative |
|
30140-8
|
IgA [Presence] in 24 hour Urine by Immunoelectrophoresis |
|
44388-7
|
IgA [Presence] in 24 hour Urine by Immunofixation |
|
26871-4
|
IgA [Mass/volume] in 24 hour Urine |
|
58763-4
|
IgA [Mass/time] in 24 hour Urine |
|
44584-1
|
IgA Ab [Presence] in Serum or Plasma |
|
44583-3
|
IgA Ab [Presence] in Serum or Plasma by Hemagglutination inhibition |
|
49907-9
|
IgA Ag [Presence] in Tissue by Immunofluorescence |
|
10488-5
|
IgA Ag [Presence] in Tissue by Immune stain |
|
24431-9
|
IgA.canine [Mass/volume] in Serum by Immune diffusion (ID) |
|
21349-6
|
IgA [Presence] in Cerebral spinal fluid by Immunofixation |
|
42206-3
|
IgA in CSF/IgA in serum |
|
2457-0
|
IgA [Mass/volume] in Cerebral spinal fluid |
|
15181-1
|
IgA [Mass/volume] in Body fluid |
|
10489-3
|
IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
|
44585-8
|
IgA IgG Ab [Presence] in Serum or Plasma |
|
13312-4
|
IgA IgG Ab [Units/volume] in Serum or Plasma |
|
44586-6
|
IgA IgM Ab [Presence] in Serum or Plasma |
|
74864-0
|
IgA.kappa [Mass/volume] in Serum or Plasma |
|
74869-9
|
IgA.kappa/IgA.lambda [Mass Ratio] in Serum or Plasma |
|
74865-7
|
IgA.lambda [Mass/volume] in Serum or Plasma |
|
54900-6
|
IgA [Mass/volume] in Peritoneal fluid |
|
6938-5
|
IgA [Mass/volume] in Saliva (oral fluid) |
|
55902-1
|
IgA [Mass/volume] in Serum by Electrophoresis |
|
44389-5
|
IgA [Presence] in Serum |
|
15182-9
|
IgA [Presence] in Serum by Immunoelectrophoresis |
|
18299-8
|
IgA [Presence] in Serum by Immunofixation |
|
38487-5
|
IgA [Units/volume] in Serum |
|
2458-8
|
IgA [Mass/volume] in Serum or Plasma |
|
76487-8
|
IgA [Moles/volume] in Serum or Plasma |
|
44582-5
|
IgA [Presence] in Skin by Immunofluorescence |
|
6778-5
|
IgA [Mass/volume] in Urine by Electrophoresis |
|
6779-3
|
IgA [Mass/volume] in Urine by Immunoassay |
|
25444-1
|
IgA [Presence] in Urine by Immunoelectrophoresis |
|
18300-4
|
IgA [Presence] in Urine by Immunofixation |
|
56121-7
|
IgA [Mass/volume] in Urine |
|
68973-7
|
IgA.intrathecally synthesized/IgA.total in Cerebral spinal fluid |
|
48665-4
|
IgA.intrathecally synthesized [Mass/volume] in Serum and CSF |
|
17005-0
|
IgA subclass 1 [Mass/volume] in Cerebral spinal fluid |
|
9336-9
|
IgA subclass 1/IgA.total in Serum |
|
6886-6
|
IgA subclass 1 [Mass/volume] in Serum |
|
17006-8
|
IgA subclass 2 [Mass/volume] in Cerebral spinal fluid |
|
6939-3
|
IgA subclass 2 [Mass/volume] in Serum |
|
29863-8
|
IgD Ag [Presence] in Tissue by Immune stain |
|
42511-6
|
IgD [Mass/volume] in Cerebral spinal fluid |
|
44592-4
|
IgD [Presence] in Serum |
|
30081-4
|
IgD [Presence] in Serum by Immunofixation |
|
56688-5
|
IgD [Units/volume] in Serum |
|
2460-4
|
IgD [Mass/volume] in Serum |
|
44591-6
|
IgD [Presence] in Urine by Immunofixation |
|
42510-8
|
IgD [Mass/volume] in Urine |
|
51651-8
|
IgE Ab [Presence] in Serum or Plasma |
|
10490-1
|
IgE Ag [Presence] in Tissue by Immune stain |
|
14001-2
|
IgE [Units/volume] in Cord blood |
|
42513-2
|
IgE [Units/volume] in Cerebral spinal fluid |
|
57092-9
|
IgE [Units/volume] in Nasal fluid |
|
44594-0
|
IgE [Presence] in Serum |
|
30082-2
|
IgE [Presence] in Serum by Immunofixation |
|
2462-0
|
IgE [Mass/volume] in Serum |
|
83102-4
|
IgE [Units/volume] in Serum or Plasma by Immunoassay |
|
76488-6
|
IgE [Mass/volume] in Serum or Plasma by Immunoassay |
|
19113-0
|
IgE [Units/volume] in Serum or Plasma |
|
14292-7
|
IgE [Moles/volume] in Serum |
|
93732-6
|
IgE [Units/volume] in Tear |
|
44593-2
|
IgE [Presence] in Urine by Immunofixation |
|
42512-4
|
IgE [Units/volume] in Urine |
|
45167-4
|
IgE [Mass/volume] in Unspecified specimen |
|
54216-7
|
Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
|
12722-5
|
Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma |
|
69945-4
|
Insulin-like growth factor binding protein 1 [Presence] in Vaginal fluid |
|
12723-3
|
Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma |
|
57668-6
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
59008-3
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
33654-5
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57669-4
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
33658-6
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
58832-7
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
38491-7
|
Insulin-like growth factor binding protein 3.acid labile [Mass/volume] in Serum or Plasma |
|
60003-1
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --baseline |
|
2483-6
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
|
33808-7
|
Insulin-like growth factor binding protein 3 [Moles/volume] in Serum or Plasma |
|
60004-9
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
60002-3
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
60001-5
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
60000-7
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
59999-3
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
59998-5
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
59997-7
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
59996-9
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
48628-2
|
Insulin-like growth factor binding protein 3 [Presence] in Urine |
|
25528-1
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma |
|
57986-2
|
Insulin-like growth factor [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25763-4
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25758-4
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
25759-2
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
25760-0
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
25761-8
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
25762-6
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
25764-2
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25765-9
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25766-7
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25767-5
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25768-3
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
25769-1
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25770-9
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25771-7
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
12911-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
56618-2
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
56523-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
12910-6
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
77678-1
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
56619-0
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
17019-1
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
12909-8
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
77679-9
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
56524-2
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
13896-6
|
Insulin-like growth factor-I [Units/volume] in Blood |
|
32023-4
|
Insulin-like growth factor-I [Mass/volume] in Blood |
|
49850-1
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --baseline |
|
38492-5
|
Insulin-like growth factor-I [Units/volume] in Serum or Plasma |
|
2484-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
|
35213-8
|
Insulin-like growth factor-I [Mass or Moles/volume] in Serum or Plasma |
|
29775-4
|
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma |
|
60012-2
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
60011-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
60010-6
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
60009-8
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
60008-0
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
60007-2
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
60006-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
60005-6
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
73561-3
|
Insulin-like growth factor-I [Z-score] in Serum or Plasma |
|
2485-1
|
Insulin-like growth factor-II [Mass/volume] in Serum or Plasma |
|
42788-0
|
Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain |
|
30141-6
|
IgG [Presence] in 24 hour Urine by Immunoelectrophoresis |
|
44595-7
|
IgG [Presence] in 24 hour Urine by Immunofixation |
|
47083-1
|
IgG [Mass/volume] in 24 hour Urine |
|
55923-7
|
IgG [Mass/time] in 24 hour Urine |
|
44596-5
|
IgG Ag [Presence] in Skin by Immunofluorescence |
|
10491-9
|
IgG Ag [Presence] in Tissue by Immune stain |
|
56122-5
|
IgG [Mass/volume] in Cord blood |
|
20855-3
|
IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID) |
|
24432-7
|
IgG.canine [Mass/volume] in Serum by Immune diffusion (ID) |
|
21350-4
|
IgG [Presence] in Cerebral spinal fluid by Immunofixation |
|
42207-1
|
IgG in CSF/IgG in serum |
|
2464-6
|
IgG [Mass/volume] in Cerebral spinal fluid |
|
76489-4
|
IgG [Moles/volume] in Cerebral spinal fluid |
|
20857-9
|
IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID) |
|
20856-1
|
IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID) |
|
24433-5
|
IgG.equine [Mass/volume] in Serum |
|
55975-7
|
IgG [Mass/volume] in Body fluid by Immune diffusion (ID) |
|
15183-7
|
IgG [Mass/volume] in Body fluid |
|
10492-7
|
IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
|
74862-4
|
IgG.kappa [Mass/volume] in Serum or Plasma |
|
74868-1
|
IgG.kappa/IgG.lambda [Mass Ratio] in Serum or Plasma |
|
74863-2
|
IgG.lambda [Mass/volume] in Serum or Plasma |
|
14339-6
|
IgG/Protein.total in Cerebral spinal fluid |
|
54901-4
|
IgG [Mass/volume] in Peritoneal fluid |
|
55922-9
|
IgG [Mass/volume] in Serum by Electrophoresis |
|
55974-0
|
IgG [Mass/volume] in Serum by Immune diffusion (ID) |
|
17007-6
|
IgG [Presence] in Serum |
|
15184-5
|
IgG [Presence] in Serum by Immunoelectrophoresis |
|
18301-2
|
IgG [Presence] in Serum by Immunofixation |
|
38488-3
|
IgG [Units/volume] in Serum |
|
2465-3
|
IgG [Mass/volume] in Serum or Plasma |
|
77177-4
|
IgG [Moles/volume] in Serum or Plasma |
|
14116-8
|
IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
|
13456-9
|
IgG synthesis rate [Units/volume] in Serum and CSF |
|
6780-1
|
IgG [Mass/volume] in Urine by Electrophoresis |
|
6781-9
|
IgG [Mass/volume] in Urine by Immunoassay |
|
25445-8
|
IgG [Presence] in Urine by Immunoelectrophoresis |
|
18302-0
|
IgG [Presence] in Urine by Immunofixation |
|
33415-1
|
IgG [Mass/volume] in Urine |
|
76490-2
|
IgG [Moles/volume] in Urine |
|
48666-2
|
IgG.intrathecally synthesized [Mass/volume] in Serum and CSF |
|
68974-5
|
IgG.intrathecally synthesized/IgG.total in Cerebral spinal fluid |
|
14117-6
|
IgG clearance/Albumin clearance [Ratio] in Serum and CSF |
|
78961-0
|
IgG clearance/Albumin clearance [Ratio] in Urine and Serum or Plasma |
|
2470-3
|
IgG/Albumin [Mass Ratio] in Cerebral spinal fluid |
|
6782-7
|
IgG/Albumin [Mass Ratio] in Serum |
|
17008-4
|
IgG/Beta tubulin [Mass Ratio] in Serum |
|
33948-1
|
IgG/Creatinine [Mass Ratio] in Urine |
|
78962-8
|
IgG clearance/Transferrin clearance [Ratio] in Urine and Serum or Plasma |
|
88184-7
|
IgG+IgM.porcine [Presence] in Pleural fluid from Fetus by Immune diffusion (ID) |
|
88185-4
|
IgG+IgM.porcine [Presence] in Serum from Fetus by Immune diffusion (ID) |
|
2466-1
|
IgG subclass 1 [Mass/volume] in Serum |
|
2467-9
|
IgG subclass 2 [Mass/volume] in Serum |
|
2468-7
|
IgG subclass 3 [Mass/volume] in Serum |
|
49471-6
|
IgG subclass 4 Ag [Presence] in Tissue by Immune stain |
|
2469-5
|
IgG subclass 4 [Mass/volume] in Serum |
|
78228-4
|
IGH gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78221-9
|
IGH gene rearrangements [Presence] in Blood or Tissue by FISH |
|
30142-4
|
IgM [Presence] in 24 hour Urine by Immunoelectrophoresis |
|
44600-5
|
IgM [Presence] in 24 hour Urine by Immunofixation |
|
26958-9
|
IgM [Mass/volume] in 24 hour Urine |
|
58764-2
|
IgM [Mass/time] in 24 hour Urine |
|
47231-6
|
IgM Ab [Presence] in Serum or Plasma |
|
13313-2
|
IgM IgM Ab [Units/volume] in Serum or Plasma |
|
44875-3
|
IgM Ag [Presence] in Skin by Immunofluorescence |
|
10493-5
|
IgM Ag [Presence] in Tissue by Immune stain |
|
14002-0
|
IgM [Units/volume] in Cord blood |
|
50992-7
|
IgM [Mass/volume] in Cord blood |
|
24434-3
|
IgM.canine [Mass/volume] in Serum by Immune diffusion (ID) |
|
89346-1
|
IgM cells/100 CD19 cells in Blood |
|
21351-2
|
IgM [Presence] in Cerebral spinal fluid by Immunofixation |
|
42208-9
|
IgM in CSF/IgM in serum |
|
2471-1
|
IgM [Mass/volume] in Cerebral spinal fluid |
|
15185-2
|
IgM [Mass/volume] in Body fluid |
|
10494-3
|
IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
|
74866-5
|
IgM.kappa [Mass/volume] in Serum or Plasma |
|
74870-7
|
IgM.kappa/IgM.lambda [Mass Ratio] in Serum or Plasma |
|
74867-3
|
IgM.lambda [Mass/volume] in Serum or Plasma |
|
54902-2
|
IgM [Mass/volume] in Peritoneal fluid |
|
55925-2
|
IgM [Mass/volume] in Serum by Electrophoresis |
|
17009-2
|
IgM [Presence] in Serum |
|
15186-0
|
IgM [Presence] in Serum by Immunoelectrophoresis |
|
18303-8
|
IgM [Presence] in Serum by Immunofixation |
|
2472-9
|
IgM [Mass/volume] in Serum or Plasma |
|
76491-0
|
IgM [Moles/volume] in Serum or Plasma |
|
6783-5
|
IgM [Mass/volume] in Urine by Electrophoresis |
|
6784-3
|
IgM [Mass/volume] in Urine by Immunoassay |
|
25446-6
|
IgM [Presence] in Urine by Immunoelectrophoresis |
|
18304-6
|
IgM [Presence] in Urine by Immunofixation |
|
56123-3
|
IgM [Mass/volume] in Urine |
|
48667-0
|
IgM.intrathecally synthesized [Mass/volume] in Serum and CSF |
|
68975-2
|
IgM.intrathecally synthesized/IgM.total in Cerebral spinal fluid |
|
79406-5
|
IgM clearance/Albumin clearance [Ratio] in Serum and CSF |
|
60485-0
|
Interferon gamma [Mass/volume] in Body fluid |
|
74279-1
|
Gamma interferon negative control spot count [#] in Blood |
|
82509-1
|
Gamma interferon.negative control [Units/volume] in Blood |
|
12729-0
|
Interferon gamma [Units/volume] in Serum or Plasma |
|
27415-9
|
Interferon gamma [Mass/volume] in Serum or Plasma |
|
48670-4
|
IgVH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
58078-7
|
IH Ab [Presence] in Serum or Plasma |
|
32811-2
|
Microscopic observation [Identifier] in Bronchial specimen by Iron hematoxylin stain |
|
14841-1
|
Microscopic observation [Identifier] in Unspecified specimen by Iron hematoxylin stain |
|
74223-9
|
Immunohistochemical stains in Bone marrow Narrative |
|
57753-6
|
IKBKG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57757-7
|
IKBKG gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
4650-8
|
Interleukin 1 [Units/volume] in Serum or Plasma |
|
34407-7
|
Interleukin 1 [Mass/volume] in Serum or Plasma |
|
17022-5
|
Interleukin 1+2 [Units/volume] in Serum or Plasma |
|
49909-5
|
Interleukin 10 [Mass/volume] in Cerebral spinal fluid |
|
49733-9
|
Interleukin 10 [Mass/volume] in Body fluid |
|
26848-2
|
Interleukin 10 [Mass/volume] in Serum or Plasma |
|
47317-3
|
Interleukin 12 [Mass/volume] in Body fluid by Immunoassay |
|
12732-4
|
Interleukin 12 [Units/volume] in Serum or Plasma |
|
41760-0
|
Interleukin 12 [Mass/volume] in Serum or Plasma |
|
70089-8
|
Interleukin 13 [Mass/volume] in Cerebral spinal fluid |
|
70090-6
|
Interleukin 13 [Mass/volume] in Body fluid |
|
33822-8
|
Interleukin 13 [Mass/volume] in Serum or Plasma |
|
82334-4
|
Interleukin 17A [Mass/volume] in Serum or Plasma |
|
33823-6
|
Interleukin 18 [Mass/volume] in Serum or Plasma |
|
70075-7
|
Interleukin 1 alpha [Mass/volume] in Cerebral spinal fluid |
|
70076-5
|
Interleukin 1 alpha [Mass/volume] in Body fluid |
|
33821-0
|
Interleukin 1 alpha [Mass/volume] in Serum or Plasma |
|
49717-2
|
Interleukin 1 beta [Mass/volume] in Body fluid |
|
13629-1
|
Interleukin 1 beta [Mass/volume] in Serum or Plasma |
|
70077-3
|
Interleukin 2 [Mass/volume] in Cerebral spinal fluid |
|
70078-1
|
Interleukin 2 [Mass/volume] in Body fluid |
|
4651-6
|
Interleukin 2 [Units/volume] in Serum or Plasma |
|
33939-0
|
Interleukin 2 [Mass/volume] in Serum or Plasma |
|
60279-7
|
IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method |
|
43171-8
|
Interleukin 2 receptor [Units/volume] in Serum or Plasma |
|
24458-2
|
Interleukin 2 receptor [Mass/volume] in Serum or Plasma |
|
23884-0
|
Interleukin 2 receptor [Presence] in Tissue by Immunocytochemical assay |
|
38352-1
|
Interleukin 2 receptor [Units/volume] in Unspecified specimen |
|
55926-0
|
Interleukin 1 receptor alpha chain [Mass/volume] in Serum or Plasma |
|
70080-7
|
Interleukin 3 [Mass/volume] in Cerebral spinal fluid |
|
70081-5
|
Interleukin 3 [Mass/volume] in Body fluid |
|
4652-4
|
Interleukin 3 [Units/volume] in Serum or Plasma |
|
70079-9
|
Interleukin 3 [Mass/volume] in Serum or Plasma |
|
70083-1
|
Interleukin 4 [Mass/volume] in Cerebral spinal fluid |
|
70082-3
|
Interleukin 4 [Mass/volume] in Body fluid |
|
4653-2
|
Interleukin 4 [Units/volume] in Serum or Plasma |
|
27161-9
|
Interleukin 4 [Mass/volume] in Serum or Plasma |
|
70084-9
|
Interleukin 5 [Mass/volume] in Cerebral spinal fluid |
|
70085-6
|
Interleukin 5 [Mass/volume] in Body fluid |
|
44321-8
|
Interleukin 5 [Presence] in Serum or Plasma |
|
4654-0
|
Interleukin 5 [Units/volume] in Serum or Plasma |
|
33938-2
|
Interleukin 5 [Mass/volume] in Serum or Plasma |
|
49919-4
|
Interleukin 6 [Mass/volume] in Cerebral spinal fluid |
|
49732-1
|
Interleukin 6 [Mass/volume] in Body fluid |
|
44322-6
|
Interleukin 6 [Presence] in Serum or Plasma |
|
4655-7
|
Interleukin 6 [Units/volume] in Serum or Plasma |
|
26881-3
|
Interleukin 6 [Mass/volume] in Serum or Plasma |
|
70087-2
|
Interleukin 7 [Mass/volume] in Cerebral spinal fluid |
|
70088-0
|
Interleukin 7 [Mass/volume] in Body fluid |
|
4656-5
|
Interleukin 7 [Units/volume] in Serum or Plasma |
|
70086-4
|
Interleukin 7 [Mass/volume] in Serum or Plasma |
|
49714-9
|
Interleukin 8 [Mass/volume] in Body fluid |
|
33211-4
|
Interleukin 8 [Mass/volume] in Serum or Plasma |
|
45214-4
|
Isoleucine+Leucine [Moles/volume] in DBS |
|
15131-6
|
Isoleucine+Leucine [Presence] in Serum or Plasma |
|
72899-8
|
Isoleucine+Leucine [Moles/volume] in Serum or Plasma |
|
15138-1
|
Isoleucine+Leucine [Presence] in Urine |
|
30965-8
|
Illness at time of vaccination |
|
77977-7
|
Illness duration |
|
77976-9
|
Illness or injury end date |
|
59289-9
|
Iloperidone [Mass/volume] in Blood |
|
59290-7
|
Iloperidone [Mass/volume] in Serum or Plasma |
|
22095-4
|
Avian infectious laryngotracheitis virus Ab [Presence] in Serum |
|
15442-7
|
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay |
|
15443-5
|
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31240-5
|
Avian infectious laryngotracheitis virus Ab [Units/volume] in Serum |
|
22815-5
|
Avian infectious laryngotracheitis virus Ab [Titer] in Serum |
|
22813-0
|
Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Immunofluorescence |
|
22814-8
|
Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Neutralization test |
|
31720-6
|
Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue |
|
20844-7
|
Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue by Immunofluorescence |
|
31721-4
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea |
|
22818-9
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunoassay |
|
22817-1
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immune diffusion (ID) |
|
20843-9
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence |
|
31722-2
|
Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen |
|
22819-7
|
Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
22816-3
|
Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
22811-4
|
Avian infectious laryngotracheitis virus [Presence] in Unspecified specimen by Electron microscopy |
|
44690-6
|
Invasive melanoma.location relative to closest uninvolved deep margin in Skin melanoma |
|
44686-4
|
Invasive melanoma.location relative to closest uninvolved lateral margin in Skin melanoma |
|
44691-4
|
Invasive melanoma.location relative to involved deep margin in Skin melanoma |
|
44688-0
|
Invasive melanoma.location relative to involved lateral margin in Skin melanoma |
|
44681-5
|
Invasive melanoma.uninvolved margin.closest in Skin melanoma |
|
75239-4
|
Albumin.ischemia modified [Units/volume] in Serum |
|
19816-8
|
Images taken Endoscopy procedure |
|
57844-3
|
Imatinib mesylate [Mass/volume] in Serum or Plasma |
|
93232-7
|
Imipenem+Relebactam [Susceptibility] by Gradient strip |
|
85424-0
|
Imipenem+Relebactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25221-3
|
Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4282-0
|
Imipenem [Mass] of Dose |
|
73334-5
|
Imipenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73335-2
|
Imipenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7019-3
|
Imipenem [Susceptibility] by Gradient strip |
|
280-8
|
Imipenem [Susceptibility] by Disk diffusion (KB) |
|
279-0
|
Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
278-2
|
Imipenem [Susceptibility] by Minimum lethal concentration (MLC) |
|
23613-3
|
Imipenem [Susceptibility] by Method for Slow-growing mycobacteria |
|
17010-0
|
Imipenem [Mass/volume] in Serum or Plasma |
|
18932-4
|
Imipenem [Susceptibility] |
|
281-6
|
Imipenem [Susceptibility] by Serum bactericidal titer |
|
27331-8
|
Imipenem [Units/volume] in Unspecified specimen |
|
25257-7
|
Imipenem [Mass/volume] in Unspecified specimen |
|
35819-2
|
Imipenem+EDTA [Susceptibility] by Gradient strip |
|
54172-2
|
Imipenem+EDTA [Susceptibility] by Disk diffusion (KB) |
|
54171-4
|
Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54170-6
|
Imipenem+EDTA [Susceptibility] |
|
78835-6
|
Imipramine cutoff [Mass/volume] in Urine for Confirmatory method |
|
4283-8
|
Imipramine [Mass] of Dose |
|
40370-9
|
Imipramine [Presence] in Gastric fluid |
|
29408-2
|
Imipramine [Mass/volume] in Gastric fluid |
|
59913-4
|
Imipramine [Moles/volume] in Gastric fluid |
|
3689-7
|
Imipramine [Presence] in Serum or Plasma |
|
3690-5
|
Imipramine [Mass/volume] in Serum or Plasma |
|
15107-6
|
Imipramine [Moles/volume] in Serum or Plasma |
|
3693-9
|
Imipramine [Mass/volume] in Serum or Plasma --trough |
|
61419-8
|
Imipramine [Mass/volume] in Urine by Confirmatory method |
|
3691-3
|
Imipramine [Presence] in Urine |
|
61418-0
|
Imipramine [Presence] in Urine by Confirmatory method |
|
3692-1
|
Imipramine [Mass/volume] in Urine |
|
59912-6
|
Imipramine [Moles/volume] in Urine |
|
44390-3
|
Imipramine [Presence] in Unspecified specimen |
|
6946-8
|
Imipramine [Mass/volume] in Unspecified specimen |
|
60309-2
|
Imipramine [Moles/volume] in Unspecified specimen |
|
61417-2
|
Imipramine/Creatinine [Mass Ratio] in Urine |
|
14791-8
|
Imipramine+Desipramine [Presence] in Gastric fluid |
|
14792-6
|
Imipramine+Desipramine [Presence] in Serum or Plasma |
|
9627-1
|
Imipramine+Desipramine [Mass/volume] in Serum or Plasma |
|
14794-2
|
Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
|
78362-1
|
Imipramine+Desipramine [Mass/volume] in Serum or Plasma --trough |
|
14793-4
|
Imipramine+Desipramine [Presence] in Urine |
|
32083-8
|
Imipramine+Desipramine [Presence] in Unspecified specimen |
|
77333-3
|
Imipramine+Desipramine [Moles/volume] in Unspecified specimen |
|
44682-3
|
Invasive melanoma in situ.uninvolved margin.closest in Skin melanoma |
|
34910-0
|
Immature basophils [#/volume] in Blood |
|
33785-7
|
Immature basophils [#/volume] in Blood by Manual count |
|
34911-8
|
Immature basophils/100 leukocytes in Blood |
|
33786-5
|
Immature basophils/100 leukocytes in Blood by Manual count |
|
34912-6
|
Immature eosinophils [#/volume] in Blood |
|
33802-0
|
Immature eosinophils [#/volume] in Blood by Manual count |
|
34913-4
|
Immature eosinophils/100 leukocytes in Blood |
|
33803-8
|
Immature eosinophils/100 leukocytes in Blood by Manual count |
|
10576-7
|
Germ cells.immature [#/volume] in Semen |
|
51584-1
|
Immature granulocytes [#/volume] in Blood |
|
53115-2
|
Immature granulocytes [#/volume] in Blood by Automated count |
|
40715-5
|
Immature granulocytes [Presence] in Blood |
|
34165-1
|
Immature granulocytes [Presence] in Blood by Automated count |
|
38518-7
|
Immature granulocytes/100 leukocytes in Blood |
|
71695-1
|
Immature granulocytes/100 leukocytes in Blood by Automated count |
|
74459-9
|
Immature granulocytes/100 leukocytes in Blood from Fetus |
|
69006-5
|
Immature granulocytes/100 leukocytes in Cerebral spinal fluid |
|
69004-0
|
Immature granulocytes/100 leukocytes in Body fluid |
|
69017-2
|
Immature granulocytes/100 leukocytes in Synovial fluid |
|
75652-8
|
Immature lymphocytes [Presence] in Blood |
|
76142-9
|
Immature lymphocytes [Presence] in Blood by Manual count |
|
27906-7
|
Immature lymphocytes/100 leukocytes in Amniotic fluid |
|
34924-1
|
Immature monocytes [#/volume] in Blood |
|
33841-8
|
Immature monocytes [#/volume] in Blood by Manual count |
|
74138-9
|
Immature monocytes [Presence] in Blood |
|
34925-8
|
Immature monocytes/100 leukocytes in Blood |
|
33842-6
|
Immature monocytes/100 leukocytes in Blood by Manual count |
|
58355-9
|
Plasma cells immature [#/volume] in Blood |
|
33850-9
|
Plasma cells immature [#/volume] in Bone marrow by Manual count |
|
58350-0
|
Plasma cells immature/100 cells in Blood |
|
11117-9
|
Plasma cells immature/100 cells in Bone marrow by Manual count |
|
51636-9
|
Immature reticulocytes [#/volume] in Blood |
|
33516-6
|
Immature reticulocytes/Reticulocytes.total in Blood |
|
62250-6
|
Immature reticulocytes/Reticulocytes.total in Blood from Fetus by Automated count |
|
74393-0
|
Immature reticulocytes/100 erythrocytes in Cord blood by Automated count |
|
55432-9
|
Immature cells [#/volume] in Blood |
|
55433-7
|
Immature cells/100 leukocytes in Blood |
|
55435-2
|
Mononuclear cells immature [#/volume] in Blood by Manual count |
|
55377-6
|
Mononuclear cells immature/100 leukocytes in Blood by Manual count |
|
77965-2
|
Immediate national notifiable condition |
|
89089-7
|
Immigration status |
|
54220-9
|
Immune response markers [Interpretation] in Unspecified specimen Narrative |
|
55229-9
|
Immune stain study |
|
87273-9
|
Immunization note |
|
31044-1
|
Immunization reaction |
|
82593-5
|
Immunization summary report |
|
82757-6
|
Immunodeficiency |
|
45265-6
|
Immunodeficiency markers [Interpretation] in Unspecified specimen Narrative |
|
49314-8
|
Immunodeficiency markers [Interpretation] in Unspecified specimen |
|
69048-7
|
Immunologist review of results |
|
92915-8
|
Immunology Consult note |
|
93960-3
|
Immunology Diagnostic study note |
|
92914-1
|
Immunology Outpatient Note |
|
92913-3
|
Immunology Telehealth Note |
|
55230-7
|
Immunophenotyping study |
|
52047-8
|
Immunosuppressive drug attachment |
|
73333-7
|
Imipenem+Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73332-9
|
Imipenem+Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80644-8
|
Isopropyl methylphosphonate [Mass/volume] in Blood |
|
54098-9
|
Isopropyl methylphosphonate [Mass/volume] in Urine |
|
85845-6
|
Impairment group [CMS Assessment] |
|
87529-4
|
Most important functional area |
|
87530-2
|
Most important health event to avoid |
|
87528-6
|
Most important health goal |
|
87532-8
|
Most important mental health issue to address |
|
87531-0
|
Most important symptom to manage |
|
85058-6
|
Imputed values for date of death |
|
76911-7
|
In a typical week in past 30D, I drank... [PROMIS] |
|
76508-1
|
In a typical week, how many times do you talk on the telephone with family, friends, or neighbors [NHANES III] |
|
94043-7
|
In caring for me, my doctor considers all the factors that affect my health [PCPCM] |
|
88756-2
|
In general, how much difficulty do you have with your hip [HOOS] |
|
88798-4
|
In general, how much difficulty do you have with your knee? [KOOS] |
|
75900-1
|
In general, how would you rate your child's mental health, including mood and ability to think [PROMIS.PARENTPROXY] |
|
75908-4
|
In general, how would you rate your child's physical health [PROMIS.PARENTPROXY] |
|
75898-7
|
In general, would you say your child's health is [PROMIS.PARENTPROXY] |
|
75907-6
|
In general, would you say your child's quality of life is [PROMIS.PARENTPROXY] |
|
58063-9
|
In sup (b) Ab [Presence] in Serum or Plasma |
|
58062-1
|
In sup (b) Ag [Presence] on Red Blood Cells |
|
77317-6
|
In the past week, how many times were dinners prepared at home and eaten together |
|
78371-2
|
ADHD inattentive symptoms mean score [Calculated] |
|
93416-6
|
Inattention in last 3 days [CMS Assessment] |
|
54628-3
|
Inattention in last 7 days [CAM.CMS] |
|
83165-1
|
Remainder of inches past last 10 foot mark [NIH Toolbox] --2M post trial start |
|
90111-6
|
Incident commander email address |
|
90108-2
|
Incident commander name |
|
90110-8
|
Incident commander phone number |
|
90109-0
|
Incident commander qualification |
|
74563-8
|
Incident preventability [AHRQ] |
|
53033-7
|
Include all data of the selected type that represents observations made two years or less before the starting date of service |
|
89566-4
|
Income status [CUBS] |
|
81668-6
|
Incontinent voids [#] Urinary tract |
|
75248-5
|
Incontinence [Norton scale] |
|
74071-2
|
Incorrect action [AHRQ] |
|
77546-0
|
Incorrect responses count # [AmNART] |
|
74557-0
|
Increased length of stay due to incident [AHRQ] |
|
638-7
|
Microscopic observation [Identifier] in Cerebral spinal fluid by India ink prep |
|
6666-2
|
Microscopic observation [Identifier] in Tissue by India ink prep |
|
666-8
|
Microscopic observation [Identifier] in Unspecified specimen by India ink prep |
|
43598-2
|
Indicans [Presence] in 24 hour Urine |
|
6887-4
|
Indicans [Mass/time] in 24 hour Urine |
|
47089-8
|
Indicans [Moles/time] in 24 hour Urine |
|
2474-5
|
Indicans [Presence] in Urine |
|
26699-9
|
Indicans [Units/volume] in Urine |
|
2475-2
|
Indicans [Mass/volume] in Urine |
|
47090-6
|
Indicans/Creatinine [Molar ratio] in 24 hour Urine |
|
50866-3
|
Indicans/Creatinine [Molar ratio] in Urine |
|
89045-9
|
Indicate the patient's primary medical condition category [CMS Assessment] |
|
85633-6
|
Indicate the patient's primary medical condition category during 3 day assessment period [CMS Assessment] |
|
83272-5
|
Indicate the type of wheelchair or scooter used during 3 day assessment period [CMS Assessment] |
|
89408-9
|
Indicate the type of wheelchair/scooter used [CMS Assessment] |
|
54669-7
|
Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54668-9
|
Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
76541-2
|
Indication ICD code [Identifier] |
|
19778-0
|
Indications description Narrative Endoscopy |
|
19777-2
|
Indications Endoscopy |
|
86673-1
|
Indicators of pain or possible pain in the last 5 days [CMS Assessment] |
|
48302-4
|
Indigo carmine triggered leukotriene release [Mass/volume] by Leukocytes |
|
30292-7
|
Indinavir [Susceptibility] by Genotype method |
|
30278-6
|
Indinavir [Susceptibility] by Phenotype method |
|
29118-7
|
Indinavir [Units/volume] in Serum or Plasma |
|
31033-4
|
Indinavir [Mass/volume] in Serum or Plasma |
|
30307-3
|
Indinavir [Susceptibility] |
|
51918-1
|
Indinavir [Mass/volume] in Serum or Plasma --trough |
|
49619-0
|
Indinavir+Ritonavir [Susceptibility] by Genotype method |
|
57984-7
|
Indinavir+Ritonavir [Susceptibility] by Phenotype method |
|
5665-5
|
Indium [Mass/volume] in Blood |
|
60089-0
|
Indium [Mass/volume] in Red Blood Cells |
|
60090-8
|
Indium [Mass/volume] in Serum or Plasma |
|
5666-3
|
Indium [Mass/volume] in Urine |
|
9429-2
|
Indium [Mass/volume] in Unspecified specimen |
|
74282-5
|
Individual counseling note |
|
51970-2
|
Individual allele identifier [Identifier] |
|
2476-0
|
Indolamine [Mass/volume] in Serum |
|
2477-8
|
Indole [Mass/volume] in Serum |
|
75067-9
|
Indole-3-Acetate [Moles/volume] in Serum or Plasma |
|
48142-4
|
Indole-3-Acetate/Creatinine [Molar ratio] in Urine |
|
4284-6
|
Indomethacin [Mass] of Dose |
|
59915-9
|
Indomethacin [Moles/volume] in Gastric fluid |
|
48276-0
|
Indomethacin triggered leukotriene release [Mass/volume] by Leukocytes |
|
3694-7
|
Indomethacin [Mass/volume] in Serum or Plasma |
|
55545-8
|
Indomethacin [Moles/volume] in Serum or Plasma |
|
59914-2
|
Indomethacin [Moles/volume] in Urine |
|
60310-0
|
Indomethacin [Moles/volume] in Unspecified specimen |
|
85071-9
|
Indoor mobility (Ambulation) [CMS Assessment] |
|
85657-5
|
Occupation industry CDC Census code |
|
76305-2
|
Infusion dose.programmed [Mass] Infusion pump |
|
76306-0
|
Infusion dose.remaining [Mass] Infusion pump |
|
57713-0
|
Infant factors that affect newborn screening interpretation |
|
80474-0
|
Infant formula intake 24 hour Estimated |
|
80469-0
|
Infant formula intake 24 hour Measured |
|
85312-7
|
Extent of inferior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
|
76326-8
|
Infusion pump Alarm state |
|
76327-6
|
Infusion pump Alarm trigger |
|
76328-4
|
Infusion pump Alert priority |
|
76324-3
|
Infusion pump Alert type |
|
76325-0
|
Infusion pump Communication status |
|
76329-2
|
Infusion pump Pump mode |
|
76330-0
|
Infusion pump Pump mode.current |
|
76331-8
|
Infusion pump Pump mode.set |
|
76319-3
|
Infusion pump Pump status |
|
76332-6
|
Infusion pump Reason pump stopped infusing |
|
76316-9
|
Infusion pump Volume.remaining |
|
76317-7
|
Infusion pump Volume.start |
|
76307-8
|
Infusion time.programmed Infusion pump |
|
76309-4
|
Infusion time.remaining Infusion pump Based on container volume |
|
76308-6
|
Infusion time.remaining Infusion pump |
|
76310-2
|
Infusion volume.programmed Procedure Infusion pump |
|
76311-0
|
Infusion volume.remaining Infusion pump |
|
76302-9
|
Infused volume.segment Procedure |
|
76303-7
|
Infused volume.single container |
|
76304-5
|
Infused volume.total Reporting Period Infusion pump |
|
73792-4
|
Infant activity during postductal oxygen saturation measurement |
|
73796-5
|
Infant activity during preductal oxygen saturation measurement |
|
80488-0
|
Infant formula feedings 24 hour |
|
73756-9
|
Infant is being breastfed at discharge [US Standard Certificate of Live Birth] |
|
73757-7
|
Infant living at time of report [US Standard Certificate of Live Birth] |
|
32395-6
|
Infant monitor type |
|
73758-5
|
Infant was transferred within 24 hours of delivery [US Standard Certificate of Live Birth] |
|
31442-7
|
Interferon.beta 1 Ab [Units/volume] in Serum or Plasma |
|
31021-9
|
Interferon.beta 1 Ab [Titer] in Serum or Plasma by Neutralization test |
|
60551-9
|
Interferon.beta 1a Ab [Titer] in Serum or Plasma |
|
60552-7
|
Interferon.beta 1b Ab [Titer] in Serum or Plasma |
|
83740-1
|
Infectious disease Fellow Note |
|
83626-2
|
Infectious disease Nurse Note |
|
83627-0
|
Infectious disease Nurse Outpatient Note |
|
83759-1
|
Infectious disease Resident Note |
|
71473-3
|
Infected dialysis site [ESRD] |
|
73769-2
|
Infections present AndOr treated during this pregnancy for fetal death [US Standard Report of Fetal Death] |
|
72519-2
|
Infections present AndOr treated during this pregnancy for live birth [US Standard Certificate of Live Birth] |
|
88357-9
|
Infectious disease Alert |
|
83783-1
|
Infectious disease Attending Note |
|
34781-5
|
Infectious disease Consult note |
|
84166-8
|
Infectious disease Counseling note |
|
78258-1
|
Infectious disease Diagnostic study note |
|
78281-3
|
Infectious disease Education note |
|
78293-8
|
Infectious disease Flowsheet |
|
84167-6
|
Infectious disease Group counseling note |
|
84168-4
|
Infectious disease Hospital Note |
|
78333-2
|
Infectious disease Initial evaluation note |
|
34782-3
|
Infectious disease Note |
|
84169-2
|
Infectious disease Outpatient Note |
|
84171-8
|
Infectious disease Telephone encounter Note |
|
80739-6
|
Infectious disease Plan of care note |
|
78318-3
|
Infectious disease procedure note |
|
78325-8
|
Infectious disease Progress note |
|
57141-4
|
Infectious disease Referral note |
|
84170-0
|
Infectious disease Risk assessment and screening note |
|
89892-4
|
Infectious disease Telehealth Note |
|
85264-0
|
Infectious disease Transplant candidate evaluation note |
|
57702-3
|
Infectious diseases newborn screen interpretation |
|
57701-5
|
Infectious diseases newborn screening comment-discussion |
|
92239-3
|
Infectious pathogen carried [Identifier] |
|
76295-5
|
Inflation phase duration [Time] Ventilator |
|
76224-5
|
Inflation trigger pressure setting Ventilator |
|
76223-7
|
Inflation trigger pressure Ventilator |
|
76196-5
|
Inflation trigger flow setting Ventilator |
|
76194-0
|
Inflation trigger flow Ventilator |
|
44696-3
|
Inflammation type in Prostate tumor |
|
90780-8
|
inFLIXimab Ab [Units/volume] in Serum by Immunoassay |
|
86897-6
|
inFLIXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
72623-2
|
inFLIXimab Ab [Mass/volume] in Serum or Plasma |
|
86896-8
|
inFLIXimab [Mass/volume] in Serum or Plasma by Immunoassay |
|
39803-2
|
inFLIXimab [Mass/volume] in Serum or Plasma |
|
86598-0
|
Influenza season [DateRange] |
|
57208-1
|
Influenza vaccination received in Reporting Period [CMS Assessment] |
|
86551-9
|
Influenza vaccine cycle |
|
72058-1
|
Influenza virus vaccination received |
|
55019-4
|
Influenza virus vaccine received in facility [CMS Assessment] |
|
84893-7
|
Supporting information about local extention AndOr metastasis for staging Tumor Narrative |
|
90872-3
|
Supplemental information about orthodontic condition Oral cavity Document |
|
75521-5
|
Information source for data [PCORnet] |
|
86798-6
|
Information source for preference on return to community queries [CMS Assessment] |
|
55058-2
|
Information source for resident's overall goal [CMS Assessment] |
|
75778-1
|
Information to tell doctors if I have a severe, irreversible brain injury or illness and can't dress, feed, or bathe myself, or communicate my medical wishes, but can be kept alive [Reported] |
|
75777-3
|
Information to tell doctors if my health deteriorates due to a terminal illness and I am unable to interact meaningfully with family, friends, or surroundings [Reported] |
|
19826-7
|
Informed consent obtained |
|
74061-3
|
Ingredient - RxNorm RXCUI of Medication |
|
74077-9
|
Ingredients for compounded preparations Medication |
|
65806-2
|
Inhalation challenge test report Document --W methacholine inhaled |
|
90881-4
|
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk |
|
71375-0
|
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
82556-2
|
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
82114-0
|
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum |
|
71376-8
|
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum by Multidisk |
|
82113-2
|
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab RAST class [Presence] in Serum |
|
37989-1
|
Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Presence] in Serum by Multidisk |
|
71373-5
|
Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Units/volume] in Serum by Multidisk |
|
71835-3
|
Inhaled oxygen [Pure volume fraction] Inhaled gas |
|
79742-3
|
Inheritance pattern based on family history |
|
36904-1
|
Inhibin A [Multiple of the median] adjusted in Serum or Plasma |
|
35738-4
|
Inhibin A [Multiple of the median] in Serum or Plasma |
|
27014-0
|
Inhibin A [Presence] in Serum or Plasma |
|
23883-2
|
Inhibin A [Mass/volume] in Serum or Plasma |
|
36905-8
|
Inhibin A [Multiple of the median] unadjusted in Serum or Plasma |
|
42514-0
|
Inhibin Ag [Presence] in Tissue by Immune stain |
|
56940-0
|
Inhibin B [Mass/volume] in Serum or Plasma by Immunoassay |
|
39532-7
|
Inhibin B [Presence] in Serum or Plasma |
|
30521-9
|
Inhibin B [Units/volume] in Serum or Plasma |
|
34319-4
|
Inhibin B [Mass/volume] in Serum or Plasma |
|
27174-2
|
Inhibin [Units/volume] in Serum or Plasma |
|
2478-6
|
Inhibin [Mass/volume] in Serum or Plasma |
|
88082-3
|
Initial case report processing information Document |
|
28636-9
|
Initial evaluation note |
|
79734-0
|
Initial unilateral retinoblastoma that later developed into bilateral disease |
|
76060-3
|
Initiating cause or condition of fetal death [US Standard Report of Fetal Death] |
|
83313-7
|
Injection drug use in the past year |
|
55731-4
|
Inject Rh immune globulin [Mass] |
|
10404-2
|
Inject Rh immune globulin [Volume] |
|
10403-4
|
Inject immune serum globulin [Volume] |
|
10405-9
|
Inject varicella zoster virus immune globulin [Volume] |
|
57259-4
|
Injectable medication management - prior ability [CMS Assessment] |
|
60837-2
|
Injectate temperature |
|
88105-2
|
Injured body site |
|
74209-8
|
Injury event summary Document |
|
74496-1
|
Injury location ICD code |
|
88126-8
|
Injury severity |
|
43694-9
|
Inner Ear 68kD Ab [Presence] in Body fluid |
|
47316-5
|
Inner Ear 68kD Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
34585-0
|
Inner Ear 68kD Ab [Presence] in Serum or Plasma |
|
43597-4
|
Inner Ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot |
|
51707-8
|
Inner Ear 68kD Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
41992-9
|
Arsenic.inorganic [Mass/volume] in 24 hour Urine |
|
53838-9
|
Arsenic.inorganic [Mass/time] in 24 hour Urine |
|
50815-0
|
Arsenic.inorganic [Moles/time] in 24 hour Urine |
|
12481-8
|
Arsenic.inorganic [Mass/volume] in Urine |
|
50814-3
|
Arsenic.inorganic [Moles/volume] in Urine |
|
44300-2
|
Arsenic.inorganic/Creatinine [Mass Ratio] in 24 hour Urine |
|
52940-4
|
Arsenic.inorganic/Creatinine [Molar ratio] in 24 hour Urine |
|
13825-5
|
Arsenic.inorganic/Creatinine [Mass Ratio] in Urine |
|
52939-6
|
Arsenic.inorganic/Creatinine [Molar ratio] in Urine |
|
44324-2
|
Iodine.inorganic [Presence] in Serum or Plasma |
|
17024-1
|
Iodine.inorganic [Mass/volume] in Serum or Plasma |
|
62489-0
|
Sulfate.inorganic [Moles/time] in 24 hour Urine |
|
2976-9
|
Sulfate.inorganic [Mass/volume] in Serum or Plasma |
|
75154-5
|
Inosine [Moles/volume] in Cerebral spinal fluid |
|
2479-4
|
Inosine [Mass/volume] in Serum |
|
75150-3
|
Inosine [Moles/volume] in Serum or Plasma |
|
59210-5
|
Inosine/Creatinine [Molar ratio] in Urine |
|
2480-2
|
Inositol Free [Mass/volume] in Serum |
|
76135-3
|
Inositol Free/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
74890-5
|
Inositol Free/Creatinine [Molar ratio] in Urine |
|
57204-0
|
Inpatient discharge facility within the past 14 days [CMS Assessment] |
|
87414-9
|
Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.5 [CMS Assessment] |
|
85397-8
|
Inpatient rehabilitation facility admission [CMS Assessment] |
|
46504-7
|
Inpatient stay within last 14 days - ICD code [CMS Assessment] |
|
34714-6
|
INR in Blood by Coagulation assay |
|
46418-0
|
INR in Capillary blood by Coagulation assay |
|
92891-1
|
INR goal in Platelet poor plasma by Coagulation assay |
|
52129-4
|
INR in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
6301-6
|
INR in Platelet poor plasma by Coagulation assay |
|
61189-7
|
INR in Platelet poor plasma from Fetus by Coagulation assay |
|
38875-1
|
INR in Platelet poor plasma or blood by Coagulation assay |
|
75387-1
|
INS gene full mutation analysis in Blood or Tissue by Sequencing |
|
89061-6
|
Insurance group number [Identifier] |
|
93792-0
|
Insulin sensitivity index in Serum or Plasma by calculation |
|
10644-3
|
Arthropod identified in Unspecified specimen |
|
14787-6
|
Arthropod identified in Unspecified specimen by Permanent mount |
|
19795-4
|
Insertion depth Gastrointestinal tract lower Flexible sigmoidoscopy |
|
19791-3
|
Insertion depth Gastrointestinal tract upper EGD |
|
76275-7
|
Inspiratory flow setting Ventilator |
|
76264-1
|
Inspiratory gas flow Respiratory system airway |
|
81449-1
|
Inspiratory gas flow.max Respiratory system airway --post bronchodilation |
|
81448-3
|
Inspiratory gas flow.max Respiratory system airway --pre bronchodilation |
|
76210-4
|
Inspiratory hold time setting Ventilator |
|
76211-2
|
Inspiratory hold time Ventilator |
|
76226-0
|
Inspiratory pause time setting Ventilator |
|
76227-8
|
Inspiratory pause time Ventilator |
|
60740-8
|
Inspiration [Time] Respiratory system |
|
75932-4
|
Inspiratory time percent |
|
76334-2
|
Inspiratory time setting Ventilator |
|
75931-6
|
Inspiration/Expiration time Ratio |
|
12044-4
|
Cervix Study observation Inspection |
|
76009-0
|
Inspired minute Volume during Mechanical ventilation |
|
44960-3
|
Institution data source NPI Registry message |
|
44958-7
|
Institution referred from NPI Cancer registry |
|
44957-9
|
Institution referred to NPI Cancer registry |
|
77282-2
|
Instability rate [NMMDS] |
|
69730-0
|
Instructions |
|
76662-6
|
Instructions [Text] Medication Narrative |
|
92557-8
|
Instructions plan to provide [Identifier] |
|
89187-9
|
Instructions provided [Identifier] |
|
84972-9
|
Instrumental Support Survey - age 18+ - T-score [NIH Toolbox] |
|
84970-3
|
Instrumental Support Survey - national percentile [NIH Toolbox] |
|
84971-1
|
Instrumental Support Survey - scale score age adjusted [NIH Toolbox] |
|
84974-5
|
Instrumental Support Survey - scale score fully adjusted [NIH Toolbox] |
|
84975-2
|
Instrumental Support Survey - unadjusted scale score [NIH Toolbox] |
|
68464-7
|
Insulin [Units/volume] in Serum or Plasma --1.25 hours post XXX challenge |
|
30256-2
|
Insulin [Units/volume] in Serum or Plasma --1.3 hours post XXX challenge |
|
27834-1
|
Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
|
13608-5
|
Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
|
27330-0
|
Insulin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
40290-9
|
Insulin [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
55489-9
|
Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucagon |
|
55483-2
|
Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose IV |
|
47658-0
|
Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
1559-4
|
Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose tolbutamide IV |
|
30257-0
|
Insulin [Units/volume] in Serum or Plasma --1.6 hours post XXX challenge |
|
68465-4
|
Insulin [Units/volume] in Serum or Plasma --1.75 hours post XXX challenge |
|
12754-8
|
Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
|
32360-0
|
Insulin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
17017-5
|
Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
55383-4
|
Insulin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
47653-1
|
Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon |
|
55484-0
|
Insulin [Moles/volume] in Serum or Plasma --10 minutes post dose glucose IV |
|
47654-9
|
Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose |
|
48116-8
|
Insulin [Units/volume] in Serum or Plasma --10 minutes pre dose glucose |
|
55481-6
|
Insulin [Moles/volume] in Serum or Plasma --10 minutes pre dose glucose |
|
12755-5
|
Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
|
12756-3
|
Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
|
56581-2
|
Insulin [Units/volume] in Serum or Plasma --12 minutes post XXX challenge |
|
30254-7
|
Insulin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
12762-1
|
Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
55385-9
|
Insulin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
47655-6
|
Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon |
|
55499-8
|
Insulin [Moles/volume] in Serum or Plasma --15 minutes post dose glucose IV |
|
12758-9
|
Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
56690-1
|
Insulin [Mass/volume] in Serum or Plasma --16 hours post XXX challenge |
|
12763-9
|
Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge |
|
56692-7
|
Insulin [Mass/volume] in Serum or Plasma --1 day post XXX challenge |
|
27830-9
|
Insulin [Units/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
1561-0
|
Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
72902-0
|
Insulin [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
27379-7
|
Insulin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
40289-1
|
Insulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
55488-1
|
Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucagon |
|
55485-7
|
Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucose IV |
|
47657-2
|
Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose |
|
1560-2
|
Insulin [Mass/volume] in Serum or Plasma --1 hour post dose tolbutamide IV |
|
55392-5
|
Insulin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
|
55486-5
|
Insulin [Moles/volume] in Serum or Plasma --1 minute post dose glucose IV |
|
47656-4
|
Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose |
|
30258-8
|
Insulin [Units/volume] in Serum or Plasma --2.3 hours post XXX challenge |
|
13609-3
|
Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
|
27863-0
|
Insulin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
40292-5
|
Insulin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
55487-3
|
Insulin [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose IV |
|
47660-6
|
Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose |
|
1562-8
|
Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose tolbutamide IV |
|
30259-6
|
Insulin [Units/volume] in Serum or Plasma --2.6 hours post XXX challenge |
|
56691-9
|
Insulin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
|
27372-2
|
Insulin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
17018-3
|
Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
55434-5
|
Insulin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
47661-4
|
Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose |
|
12764-7
|
Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge |
|
56788-3
|
Insulin [Units/volume] in Serum or Plasma --28 hours post XXX challenge |
|
56946-7
|
Insulin [Units/volume] in Serum or Plasma --2 days post XXX challenge |
|
27860-6
|
Insulin [Units/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
1564-4
|
Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
72901-2
|
Insulin [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
27826-7
|
Insulin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
40291-7
|
Insulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
55491-5
|
Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucagon |
|
55496-4
|
Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucose IV |
|
47659-8
|
Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose |
|
1563-6
|
Insulin [Mass/volume] in Serum or Plasma --2 hours post dose tolbutamide IV |
|
12759-7
|
Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
55386-7
|
Insulin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
30260-4
|
Insulin [Units/volume] in Serum or Plasma --3.3 hours post XXX challenge |
|
30261-2
|
Insulin [Units/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
12747-2
|
Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
|
30262-0
|
Insulin [Units/volume] in Serum or Plasma --3.6 hours post XXX challenge |
|
30362-8
|
Insulin [Units/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
|
9307-0
|
Insulin [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
|
27827-5
|
Insulin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
40288-3
|
Insulin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
55500-3
|
Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucagon |
|
55492-3
|
Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucose IV |
|
47663-0
|
Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose |
|
1565-1
|
Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose tolbutamide IV |
|
12757-1
|
Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
56789-1
|
Insulin [Units/volume] in Serum or Plasma --32 hours post XXX challenge |
|
56790-9
|
Insulin [Units/volume] in Serum or Plasma --36 hours post XXX challenge |
|
56944-2
|
Insulin [Units/volume] in Serum or Plasma --3 days post XXX challenge |
|
27861-4
|
Insulin [Units/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
|
1567-7
|
Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
|
72900-4
|
Insulin [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
|
27828-3
|
Insulin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40293-3
|
Insulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
47662-2
|
Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose |
|
1566-9
|
Insulin [Mass/volume] in Serum or Plasma --3 hours post dose tolbutamide IV |
|
55493-1
|
Insulin [Moles/volume] in Serum or Plasma --3 hours post dose glucose IV |
|
55384-2
|
Insulin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
55497-2
|
Insulin [Moles/volume] in Serum or Plasma --3 minutes post dose glucose IV |
|
47664-8
|
Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose |
|
72604-2
|
Insulin [Units/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO |
|
12748-0
|
Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
|
56949-1
|
Insulin [Units/volume] in Serum or Plasma --40 hours post XXX challenge |
|
27444-9
|
Insulin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
12765-4
|
Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
56948-3
|
Insulin [Units/volume] in Serum or Plasma --44 hour post XXX challenge |
|
30255-4
|
Insulin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
12766-2
|
Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
55387-5
|
Insulin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
55490-7
|
Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucagon |
|
55495-6
|
Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucose IV |
|
27862-2
|
Insulin [Units/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
|
1568-5
|
Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
|
29378-7
|
Insulin [Units/volume] in Serum or Plasma --4 hours post XXX challenge |
|
55388-3
|
Insulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
55482-4
|
Insulin [Moles/volume] in Serum or Plasma --4 hours post dose glucose IV |
|
12760-5
|
Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
|
55391-7
|
Insulin [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge |
|
12749-8
|
Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
|
12767-0
|
Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
|
57007-7
|
Insulin [Units/volume] in Serum or Plasma --52 hours post XXX challenge |
|
56945-9
|
Insulin [Units/volume] in Serum or Plasma --56 hours post XXX challenge |
|
1569-3
|
Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
|
27852-3
|
Insulin [Units/volume] in Serum or Plasma --5 hours post XXX challenge |
|
55389-1
|
Insulin [Moles/volume] in Serum or Plasma --5 hours post XXX challenge |
|
57353-5
|
Insulin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
55382-6
|
Insulin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
55494-9
|
Insulin [Moles/volume] in Serum or Plasma --5 minutes post dose glucose IV |
|
47665-5
|
Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose |
|
47666-3
|
Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose |
|
55480-8
|
Insulin [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose |
|
56947-5
|
Insulin [Units/volume] in Serum or Plasma --60 hour post XXX challenge |
|
56942-6
|
Insulin [Units/volume] in Serum or Plasma --64 hour post XXX challenge |
|
56943-4
|
Insulin [Units/volume] in Serum or Plasma --68 hour post XXX challenge |
|
27872-1
|
Insulin [Units/volume] in Serum or Plasma --6 hours post 75 g glucose PO |
|
9339-3
|
Insulin [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO |
|
29379-5
|
Insulin [Units/volume] in Serum or Plasma --6 hours post XXX challenge |
|
55390-9
|
Insulin [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
|
56492-2
|
Insulin [Units/volume] in Serum or Plasma --6 minutes post XXX challenge |
|
47667-1
|
Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon |
|
12751-4
|
Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
25696-6
|
Insulin [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
12768-8
|
Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
|
27833-3
|
Insulin [Units/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
|
10833-2
|
Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
|
12750-6
|
Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
|
55479-0
|
Insulin [Moles/volume] in Serum or Plasma --7 minutes post dose glucose IV |
|
55498-0
|
Insulin [Moles/volume] in Serum or Plasma --7 minutes pre dose glucose |
|
56941-8
|
Insulin [Units/volume] in Serum or Plasma --8 hours post XXX challenge |
|
12752-2
|
Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
12761-3
|
Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
|
12753-0
|
Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
|
56546-5
|
Insulin Ab [Units/volume] in Serum by Immunoassay |
|
2481-0
|
Insulin Ab [Presence] in Serum |
|
5232-4
|
Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
8072-1
|
Insulin Ab [Units/volume] in Serum |
|
2482-8
|
Insulin Ab [Mass/volume] in Serum |
|
60463-7
|
Insulin Ab [Moles/volume] in Serum |
|
11087-4
|
Insulin Ab [Titer] in Serum |
|
10495-0
|
Insulin Ag [Presence] in Tissue by Immune stain |
|
44319-2
|
Insulin.bound [Presence] in Serum or Plasma |
|
34156-0
|
Insulin.bound [Units/volume] in Serum or Plasma |
|
44397-8
|
Insulin bovine Ab [Presence] in Serum |
|
8073-9
|
Insulin bovine Ab [Units/volume] in Serum |
|
38489-1
|
Insulin bovine Ab [Titer] in Serum |
|
6147-3
|
Insulin bovine IgE Ab [Units/volume] in Serum |
|
15792-5
|
Insulin bovine IgE Ab RAST class [Presence] in Serum |
|
56197-7
|
Insulin bovine IgG4 Ab [Mass/volume] in Serum |
|
56482-3
|
Insulin [Units/volume] in Serum or Plasma --baseline |
|
1570-1
|
Insulin [Mass/volume] in Serum or Plasma --baseline |
|
14293-5
|
Insulin [Moles/volume] in Serum or Plasma --baseline |
|
41936-6
|
Type of Insulin delivery device |
|
41983-8
|
Insulin delivery device Vendor model code |
|
41937-4
|
Insulin delivery device Vendor serial number |
|
41977-0
|
Insulin delivery device Vendor software version |
|
29238-3
|
Insulin [Units/volume] in Body fluid |
|
50867-1
|
Insulin [Moles/volume] in Body fluid |
|
6901-3
|
Insulin Free [Units/volume] in Serum or Plasma |
|
43942-2
|
Insulin Free [Mass/volume] in Serum or Plasma |
|
25447-4
|
Insulin Free [Moles/volume] in Serum or Plasma |
|
44462-0
|
Insulin Free+Bound [Presence] in Serum or Plasma |
|
44317-6
|
Insulin human Ab [Presence] in Serum |
|
8074-7
|
Insulin human Ab [Units/volume] in Serum |
|
6148-1
|
Insulin human IgE Ab [Units/volume] in Serum |
|
15793-3
|
Insulin human IgE Ab RAST class [Presence] in Serum |
|
56292-6
|
Insulin human IgG4 Ab [Mass/volume] in Serum |
|
56533-3
|
Insulin IgG Ab [Units/volume] in Serum |
|
89324-8
|
Insulin intact [Units/volume] in Serum by LC/MS/MS |
|
4285-3
|
Insulin Lente [Mass] of Dose |
|
93793-8
|
Insulin [Units/volume] mean in Serum or Plasma |
|
4286-1
|
Insulin NPH [Mass] of Dose |
|
30363-6
|
Insulin [Units/volume] in Serum or Plasma --12 hours fasting |
|
1573-5
|
Insulin [Mass/volume] in Serum or Plasma --12 hours fasting |
|
27873-9
|
Insulin [Units/volume] in Serum or Plasma --fasting |
|
59179-2
|
Insulin [Moles/volume] in Serum or Plasma --fasting |
|
47862-8
|
Insulin [Units/volume] in Serum or Plasma --post meal |
|
93727-6
|
Insulin [Moles/volume] in Serum or Plasma --post meal |
|
44318-4
|
Insulin porcine Ab [Presence] in Serum |
|
8075-4
|
Insulin porcine Ab [Units/volume] in Serum |
|
38490-9
|
Insulin porcine Ab [Titer] in Serum |
|
6149-9
|
Insulin porcine IgE Ab [Units/volume] in Serum |
|
15794-1
|
Insulin porcine IgE Ab RAST class [Presence] in Serum |
|
61276-2
|
Insulin porcine IgE Ab/IgE total in Serum |
|
56363-5
|
Insulin porcine IgG4 Ab [Mass/volume] in Serum |
|
42919-1
|
Insulin [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
|
1572-7
|
Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
|
49897-2
|
Insulin [Units/volume] in Serum or Plasma --pre XXX challenge |
|
12738-1
|
Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
47669-7
|
Insulin [Units/volume] in Serum or Plasma --pre dose glucagon |
|
47668-9
|
Insulin [Units/volume] in Serum or Plasma --pre dose glucose |
|
1571-9
|
Insulin [Mass/volume] in Serum or Plasma --pre dose tolbutamide IV |
|
51427-3
|
Insulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
40294-1
|
Insulin [Moles/volume] in Serum or Plasma --pre or post dose glucose |
|
47670-5
|
Insulin [Units/volume] in Serum or Plasma --pre-meal |
|
13633-3
|
Insulin receptor Ab [Presence] in Serum |
|
31439-3
|
Insulin receptor Ab [Units/volume] in Serum |
|
13632-5
|
Insulin receptor Ab [Titer] in Serum |
|
4287-9
|
Insulin regular [Mass] of Dose |
|
92845-7
|
Insulin resistance score in Serum by Calculated.CardioIQ |
|
4288-7
|
Insulin semilente [Mass] of Dose |
|
44396-0
|
Insulin [Presence] in Serum or Plasma |
|
20448-7
|
Insulin [Units/volume] in Serum or Plasma |
|
3695-4
|
Insulin [Mass/volume] in Serum or Plasma |
|
14796-7
|
Insulin [Moles/volume] in Serum or Plasma |
|
33815-2
|
Insulin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25691-7
|
Insulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50501-6
|
Insulin [Units/volume] in Serum or Plasma --1st specimen |
|
33809-5
|
Insulin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
25685-9
|
Insulin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
33810-3
|
Insulin [Units/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
25686-7
|
Insulin [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
33811-1
|
Insulin [Units/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
25687-5
|
Insulin [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
33812-9
|
Insulin [Units/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
25688-3
|
Insulin [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge |
|
33813-7
|
Insulin [Units/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
25689-1
|
Insulin [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge |
|
33814-5
|
Insulin [Units/volume] in Serum or Plasma --15th specimen post XXX challenge |
|
25690-9
|
Insulin [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge |
|
33816-0
|
Insulin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12739-9
|
Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25692-5
|
Insulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50502-4
|
Insulin [Units/volume] in Serum or Plasma --2nd specimen |
|
33817-8
|
Insulin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12740-7
|
Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25693-3
|
Insulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50503-2
|
Insulin [Units/volume] in Serum or Plasma --3rd specimen |
|
27832-5
|
Insulin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12741-5
|
Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25694-1
|
Insulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50504-0
|
Insulin [Units/volume] in Serum or Plasma --4th specimen |
|
27874-7
|
Insulin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12742-3
|
Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25695-8
|
Insulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50505-7
|
Insulin [Units/volume] in Serum or Plasma --5th specimen |
|
27875-4
|
Insulin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
12743-1
|
Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50506-5
|
Insulin [Units/volume] in Serum or Plasma --6th specimen |
|
27867-1
|
Insulin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
12744-9
|
Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25697-4
|
Insulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50507-3
|
Insulin [Units/volume] in Serum or Plasma --7th specimen |
|
33818-6
|
Insulin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
12745-6
|
Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25698-2
|
Insulin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50508-1
|
Insulin [Units/volume] in Serum or Plasma --8th specimen |
|
33819-4
|
Insulin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
12746-4
|
Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
25699-0
|
Insulin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
89908-8
|
Insulin was taken in last 8H 8 hour |
|
4289-5
|
Insulin ultralente [Mass] of Dose |
|
18234-5
|
Insulin [Presence] in Unknown substance |
|
55070-7
|
Insurance billing |
|
55071-5
|
Insurance case mix - RUG group |
|
55072-3
|
Insurance case mix - RUG version code |
|
90101-7
|
Internal control result |
|
89182-0
|
Integumentary repair and protection technique used [Identifier] |
|
92558-6
|
Integumentary repair and protection technique plan to use [Identifier] |
|
49586-1
|
First and Second trimester integrated maternal screen [Interpretation] |
|
75365-7
|
First and Second trimester integrated maternal screen [Interpretation] Narrative |
|
91986-0
|
Integrative medicine Consult note |
|
93961-1
|
Integrative medicine Diagnostic study note |
|
91985-2
|
Integrative medicine Outpatient Note |
|
71453-5
|
Intellectual disability and developmental disability with no organic condition [MDSv3] |
|
71452-7
|
Intellectual disability and developmental disability with organic condition [MDSv3] |
|
77686-4
|
Intellectual impairment scale [UPDRS] |
|
74051-4
|
Intended route of administration [AHRQ] |
|
92945-5
|
Intent of carbon monoxide exposure |
|
2487-7
|
Inter alpha trypsin inhibitor [Mass/volume] in Serum |
|
90090-2
|
Inter-agency communication document type |
|
31440-1
|
Intercalated disk Ab [Units/volume] in Serum |
|
14096-2
|
Intercalated disk Ab [Titer] in Serum by Immunofluorescence |
|
70951-9
|
Interdialytic time [ESRD] |
|
75433-3
|
Interdisciplinary Education note |
|
84172-6
|
Interdisciplinary Hospital Plan of care note |
|
84186-6
|
Interdisciplinary Long term care facility Note |
|
84187-4
|
Interdisciplinary Long term care facility Plan of care note |
|
34794-8
|
Interdisciplinary Note |
|
84361-5
|
Interdisciplinary Outpatient Note |
|
81200-8
|
Interdisciplinary Plan of care note |
|
84163-5
|
Interdisciplinary Patient's home Note |
|
84164-3
|
Interdisciplinary Patient's home Plan of care note |
|
83951-4
|
Interdisciplinary Risk assessment and screening note |
|
53796-9
|
Interferon drug given [Identifier] |
|
7533-3
|
Interior Live Oak IgE Ab [Units/volume] in Serum |
|
75526-4
|
Internal identifier for Provider |
|
85250-9
|
Internal medicine Admission evaluation note |
|
85233-5
|
Internal medicine Attending Admission evaluation note |
|
85218-6
|
Internal medicine Attending Hospital Note |
|
85235-0
|
Internal medicine Attending Intensive care unit Note |
|
75472-1
|
Internal medicine Attending Note |
|
85238-4
|
Internal medicine Consult note |
|
85183-2
|
Internal medicine Custodial care facility Note |
|
85243-4
|
Internal medicine Discharge summary |
|
85244-2
|
Internal medicine Education note |
|
85245-9
|
Internal medicine History and physical note |
|
75434-1
|
Internal medicine Hospital Note |
|
85239-2
|
Internal medicine Intensive care unit Admission evaluation note |
|
85240-0
|
Internal medicine Intensive care unit Discharge summary |
|
85241-8
|
Internal medicine Intensive care unit Note |
|
85242-6
|
Internal medicine Intensive care unit procedure note |
|
85219-4
|
Internal medicine Intensive care unit Transfer summary note |
|
85254-1
|
Internal medicine Interdisciplinary Plan of care note |
|
85266-5
|
Internal medicine Interdisciplinary Note |
|
85246-7
|
Internal medicine Intern Admission evaluation note |
|
85247-5
|
Internal medicine Long term care facility Note |
|
85234-3
|
Internal medicine Attending Intensive care unit Admission evaluation note |
|
75435-8
|
Internal medicine Note |
|
85248-3
|
Internal medicine Nurse practitioner Note |
|
85249-1
|
Internal medicine Nurse Note |
|
75436-6
|
Internal medicine Outpatient Note |
|
88649-9
|
Internal medicine Parenteral therapy note |
|
85265-7
|
Internal medicine Pharmacist Medication management note |
|
85252-5
|
Internal medicine Telephone encounter Note |
|
85236-8
|
Internal medicine procedure note |
|
85251-7
|
Internal medicine Resident Admission evaluation note |
|
75478-8
|
Internal medicine Resident Note |
|
85253-3
|
Internal medicine Transfer summary note |
|
80976-4
|
International Prostate Symptom Score [IPSS] |
|
44774-8
|
Interposition graft {Blood vessel} |
|
57457-4
|
Immunoelectrophoresis for 24 hour Urine |
|
33042-3
|
Immunofixation for 24 hour Urine |
|
49277-7
|
Immunofixation for 24 hour Urine Narrative |
|
40685-0
|
Immunoelectrophoresis for Cerebral spinal fluid |
|
49272-8
|
Immunoelectrophoresis for Cerebral spinal fluid Narrative |
|
13174-8
|
Immunofixation for Cerebral spinal fluid |
|
49271-0
|
Immunofixation for Cerebral spinal fluid Narrative |
|
32821-1
|
Immunofixation for Body fluid |
|
49273-6
|
Immunofixation for Body fluid Narrative |
|
13169-8
|
Immunoelectrophoresis for Serum or Plasma |
|
49274-4
|
Immunoelectrophoresis for Serum or Plasma Narrative |
|
49275-1
|
Immunofixation for Serum or Plasma Narrative |
|
25700-6
|
Immunofixation for Serum or Plasma |
|
34440-8
|
Immunoelectrophoresis for Urine |
|
49278-5
|
Immunoelectrophoresis for Urine Narrative |
|
13440-3
|
Immunofixation for Urine |
|
49276-9
|
Immunofixation for Urine Narrative |
|
54588-9
|
Interpreter needed |
|
74188-4
|
interRAI Acute Care (AC) Hospital Document |
|
74197-5
|
interRAI Contact Assessment (CA) Document |
|
74194-2
|
interRAI Community Health Assessment (CHA) Document |
|
74191-8
|
interRAI Community Health Assessment - Assisted Living Supplement (CHA-AL) Document |
|
74190-0
|
interRAI Community Health Assessment - Deafblind Supplement (CHA-Db) Document |
|
74193-4
|
interRAI Community Health Assessment - Functional Supplement (CHA-FS) Document |
|
74192-6
|
interRAI Community Health Assessment - Mental Health Supplement (CHA-MH) Document |
|
74187-6
|
interRAI Emergency Screener for Psychiatry (ESP) Document |
|
74196-7
|
interRAI Home Care (HC) Document |
|
74195-9
|
interRAI Long Term Care Facility (LTCF) Document |
|
74189-2
|
interRAI Palliative Care (PC) Document |
|
93261-6
|
Interrupted suicide attempt 3 months |
|
93259-0
|
Interrupted suicide attempt Lifetime |
|
93262-4
|
Interrupted suicide attempts # 3 months |
|
93260-8
|
Interrupted suicide attempts # Lifetime |
|
34121-4
|
Interventional procedure note |
|
77600-5
|
Interval note |
|
91714-6
|
Date of interview |
|
54697-8
|
Interview for daily and activity preferences should be conducted [CMS Assessment] |
|
69955-3
|
Intestinal goblet cell Ab [Presence] in Serum by Immunoassay |
|
58461-5
|
Intestinal goblet cell Ab [Titer] in Serum |
|
88068-2
|
Cause of intoxication |
|
46214-3
|
Intracardiac ablation study |
|
73705-6
|
Intracellular fluid [Volume] Estimated |
|
88344-7
|
Intracellular bacteria [Presence] in Ear by Light microscopy |
|
82662-8
|
Intrachamber diastolic pressure Left ventricle --post procedure |
|
82661-0
|
Intrachamber systolic pressure Left ventricle --post procedure |
|
60738-2
|
Intraluminal [Pressure] Esophagus |
|
76280-7
|
Intramucosal gastric pH |
|
84888-7
|
Intramural vein invasion [Presence] in Colorectal cancer specimen by Light microscopy |
|
79893-4
|
Intraocular pressure Left eye |
|
79892-6
|
Intraocular pressure Right eye |
|
85281-4
|
Intratumoral lymphocytic response in Cancer specimen Qualitative by Light microscopy |
|
79547-6
|
Intravascular lipids fluid intake [Volume] Measured |
|
72066-4
|
Intravenous iron prescribed [ESRD] |
|
82721-2
|
Intravenous lipid emulsion [Mass/volume] in Serum by Nephelometry |
|
76246-8
|
Intrinsic dynamic PEEP Respiratory system |
|
88071-6
|
Time of intubation |
|
2491-9
|
Inulin renal clearance in 24 hour Urine and Serum or Plasma |
|
72159-7
|
Inulin renal clearance/1.73 sq M in 4 hour Urine and Serum or Plasma |
|
40588-6
|
Inulin [Mass/volume] in Control Serum |
|
2490-1
|
Inulin [Mass/volume] in Serum or Plasma |
|
44636-9
|
Invasive component size additional dimension 1 [Length] in Breast tumor |
|
44637-7
|
Invasive component size additional dimension 2 [Length] in Breast tumor |
|
44635-1
|
Invasive component size.maximum dimension [Length] in Breast tumor |
|
77034-7
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Tissue by FISH |
|
70291-0
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75010-9
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72210-8
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
70156-5
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue |
|
72209-0
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
79206-9
|
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Blood or Tissue by FISH |
|
88744-8
|
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
77041-2
|
inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript in Blood or Tissue by FISH |
|
76212-0
|
Invasive Blood pressure |
|
76213-8
|
Invasive Diastolic blood pressure |
|
76214-6
|
Invasive Mean blood pressure |
|
87539-3
|
Invasive mechanical ventilation support upon admission [CMS Assessment] |
|
86851-3
|
Invasive mechanical ventilator liberation status at discharge [CMS Assessment] |
|
76215-3
|
Invasive Systolic blood pressure |
|
80323-9
|
Involuntary movements |
|
89570-6
|
Involvement with criminal justice [CUBS] |
|
74049-8
|
Periodontal condition involves frenum |
|
59697-3
|
Iodide [Mass/volume] in Serum or Plasma |
|
51001-6
|
Iodide [Mass/volume] in Urine |
|
44790-4
|
Iodide [Mass/volume] in Unspecified specimen |
|
53872-8
|
Iodine [Mass/volume] in Urine collected for unspecified duration |
|
26842-5
|
Iodine [Mass/volume] in 24 hour Urine |
|
2492-7
|
Iodine [Mass/time] in 24 hour Urine |
|
25936-6
|
Iodine [Moles/volume] in 24 hour Urine |
|
25449-0
|
Iodine [Moles/time] in 24 hour Urine |
|
11220-1
|
Iodine Free [Mass/time] in 24 hour Urine |
|
18367-3
|
Iodine Free [Mass/volume] in Serum or Plasma |
|
2493-5
|
Iodine Free [Mass/volume] in Urine |
|
76657-6
|
Iodine [Mass/mass] in Hair |
|
50868-9
|
Iodine [Moles/mass] in Hair |
|
81003-6
|
Iodine intake 24 hour Estimated |
|
81004-4
|
Iodine intake 24 hour Measured |
|
20865-2
|
Iodine [Mass/mass] in Liver |
|
20864-5
|
Iodine [Mass/volume] in Milk |
|
44323-4
|
Iodine [Presence] in Serum or Plasma |
|
2494-3
|
Iodine [Mass/volume] in Serum or Plasma |
|
25448-2
|
Iodine [Moles/volume] in Serum or Plasma |
|
2495-0
|
Iodine [Mass/volume] in Urine |
|
34320-2
|
Iodine [Moles/volume] in Urine |
|
20863-7
|
Iodine [Mass/volume] in Water |
|
55928-6
|
Iodine/Creatinine [Mass Ratio] in Urine |
|
34321-0
|
Iodine/Creatinine [Molar ratio] in Urine |
|
7428-6
|
Iodinebush IgE Ab [Units/volume] in Serum |
|
15795-8
|
Iodinebush IgE Ab RAST class [Presence] in Serum |
|
2496-8
|
Iodohippuran renal clearance in 24 hour Urine and Serum or Plasma |
|
50055-3
|
Iohexol renal clearance in Urine and Serum or Plasma |
|
93974-4
|
Iohexol [Mass/volume] in Serum or Plasma |
|
93973-6
|
Iohexol [Mass/volume] in Urine |
|
90994-5
|
Iothalamate renal clearance |
|
90995-2
|
Iothalamate renal clearance/Body surface area |
|
93980-1
|
Iothalamate [Mass/volume] in Serum or Plasma |
|
93855-5
|
Iothalamate [Mass/volume] in Urine |
|
73331-1
|
Ipratropium induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73330-3
|
Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
33555-4
|
Inactivated poliovirus vaccine dose count in combination vaccine |
|
72555-6
|
Interventional radiology Consult note |
|
89805-6
|
Interventional radiology Initial evaluation note |
|
84178-3
|
Interventional radiology Note |
|
83582-7
|
Interventional radiology Nurse Note |
|
89806-4
|
Interventional radiology Telephone encounter Note |
|
75238-6
|
Interventional radiology procedure note |
|
72556-4
|
Interventional radiology Progress note |
|
83760-9
|
Interventional radiology Resident Note |
|
73329-5
|
Irbesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73328-7
|
Irbesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73327-9
|
Irbesartan+hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73326-1
|
Irbesartan+hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53873-6
|
IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54915-4
|
Iroko IgE Ab [Units/volume] in Serum |
|
30919-5
|
Iron [Mass/volume] in Urine collected for unspecified duration |
|
30030-1
|
Iron [Mass/volume] in 24 hour Urine |
|
2499-2
|
Iron [Mass/time] in 24 hour Urine |
|
35256-7
|
Iron [Mass or Moles/volume] in 24 hour Urine |
|
25937-4
|
Iron [Moles/volume] in 24 hour Urine |
|
14799-1
|
Iron [Moles/time] in 24 hour Urine |
|
92742-6
|
Iron.microscopic observation [Identifier] in Bronchoalveolar lavage by Potassium ferrocyanide stain |
|
34615-5
|
Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain |
|
10758-1
|
Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
|
2503-1
|
Iron.chelated [Mass/volume] in Urine |
|
57988-8
|
Iron [Mass/volume] in Cerebral spinal fluid |
|
44327-5
|
Iron [Presence] in Body fluid |
|
44867-0
|
Iron.microscopic observation [Presence] in Body fluid by Other stain |
|
51197-2
|
Iron [Mass/volume] in Body fluid |
|
29764-8
|
Iron [Moles/volume] in Body fluid |
|
44325-9
|
Iron [Presence] in Hair |
|
2497-6
|
Iron [Mass/mass] in Hair |
|
50869-7
|
Iron [Moles/mass] in Hair |
|
81082-0
|
Iron intake 24 hour Estimated |
|
81083-8
|
Iron intake 24 hour Measured |
|
57028-3
|
Iron [Mass/mass] in Liver |
|
13513-7
|
Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
|
53454-5
|
Iron [Mass/volume] in Urine --post dose deferoxamine |
|
53495-8
|
Iron [Moles/volume] in Urine --post dose deferoxamine |
|
72067-2
|
Iron prescription current [ESRD] |
|
86913-1
|
Iron saturation goal Serum or Plasma |
|
2502-3
|
Iron saturation [Mass Fraction] in Serum or Plasma |
|
14801-5
|
Iron saturation [Molar fraction] in Serum or Plasma |
|
44326-7
|
Iron [Presence] in Serum or Plasma |
|
14797-5
|
Iron [Interpretation] in Serum or Plasma |
|
2498-4
|
Iron [Mass/volume] in Serum or Plasma |
|
35214-6
|
Iron [Mass or Moles/volume] in Serum or Plasma |
|
14798-3
|
Iron [Moles/volume] in Serum or Plasma |
|
50198-1
|
Iron [Mass/volume] in Serum or Plasma --1st specimen |
|
50199-9
|
Iron [Mass/volume] in Serum or Plasma --2nd specimen |
|
50200-5
|
Iron [Mass/volume] in Serum or Plasma --3rd specimen |
|
50201-3
|
Iron [Mass/volume] in Serum or Plasma --4th specimen |
|
50202-1
|
Iron [Mass/volume] in Serum or Plasma --5th specimen |
|
50203-9
|
Iron [Mass/volume] in Serum or Plasma --6th specimen |
|
50204-7
|
Iron [Mass/volume] in Serum or Plasma --7th specimen |
|
50205-4
|
Iron [Mass/volume] in Serum or Plasma --8th specimen |
|
10759-9
|
Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
|
34612-2
|
Iron [Mass/volume] in Stool |
|
10760-7
|
Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
|
10761-5
|
Iron.microscopic observation [Identifier] in Tissue by Other stain |
|
15357-7
|
Iron [Mass/mass] in Tissue |
|
38414-9
|
Iron [Moles/mass] in Tissue |
|
2504-9
|
Iron [Mass/volume] in Urine |
|
33824-4
|
Iron [Moles/volume] in Urine |
|
17025-8
|
Iron [Mass/volume] in Water |
|
53501-3
|
Iron [Moles/volume] in Water |
|
87471-9
|
Iron [Mass/volume] in Unspecified specimen |
|
53456-0
|
Iron [Mass/mass] in Unspecified specimen |
|
53503-9
|
Iron [Moles/mass] in Unspecified specimen |
|
57014-3
|
Iron/Creatinine [Mass Ratio] in 24 hour Urine |
|
53149-1
|
Iron/Creatinine [Molar ratio] in 24 hour Urine |
|
27411-8
|
Iron/Creatinine [Mass Ratio] in Urine |
|
34322-8
|
Iron/Creatinine [Molar ratio] in Urine |
|
2505-6
|
Iron/Iron binding capacity.total [Mass Ratio] in Serum or Plasma |
|
39778-6
|
Iron/Iron binding capacity.total [Molar ratio] in Serum or Plasma |
|
13452-8
|
Iron/Transferrin [Mass Ratio] in Serum or Plasma |
|
60517-0
|
Iron/Transferrin [Ratio] in Serum or Plasma |
|
10375-4
|
Irregularly contracted cells [Presence] in Blood by Light microscopy |
|
93683-1
|
Is anyone in your home threatening or abusing you [WellRx] |
|
92277-3
|
Is your baby living with you |
|
76749-1
|
Is someone available to help you if you need it [PROMIS] |
|
77318-4
|
Is the patient breastfed |
|
77239-2
|
Is the patient fed something other than breast milk or formula |
|
77241-8
|
Is the patient having any problems breastfeeding |
|
87541-9
|
Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay? [CMS Assessment] |
|
85634-4
|
Is there evidence of an acute change in mental status from the patient's baseline during 3 day assessment period [CAM.CMS] |
|
85381-2
|
Isavuconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88887-5
|
Isavuconazole [Susceptibility] |
|
64093-8
|
ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method |
|
64087-0
|
ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method |
|
62358-7
|
ISCN band level [#] Qualitative |
|
55680-3
|
Isepamicin [Susceptibility] by Gradient strip |
|
35820-0
|
Isepamicin [Susceptibility] by Disk diffusion (KB) |
|
35821-8
|
Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32381-6
|
Isepamicin [Susceptibility] |
|
10401-8
|
Immune serum globulin given [Type] |
|
10402-6
|
Immune serum globulin given [Volume] |
|
56718-0
|
Islet cell 512 Ab [Units/volume] in Serum by Immunoassay |
|
31209-0
|
Islet cell 512 Ab [Units/volume] in Serum |
|
81155-4
|
Islet cell 512 Ab [Moles/volume] in Serum |
|
32636-3
|
Islet cell 512 Ab [Titer] in Serum |
|
70253-0
|
Islet cell 512 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
70252-2
|
Islet cell 512 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
12992-4
|
Isobutane [Mass/volume] in Blood |
|
9431-8
|
Isobutanol [Mass/volume] in Blood |
|
9692-5
|
Isobutanol [Mass/volume] in Unspecified specimen |
|
14265-3
|
Isobutyl acetate [Mass/volume] in Blood |
|
9432-6
|
Isobutyl acetate [Mass/volume] in Unspecified specimen |
|
9430-0
|
Isobutylcarbinol [Mass/volume] in Blood |
|
45213-6
|
Isobutyrylcarnitine (C4) [Moles/volume] in DBS |
|
43243-5
|
Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
|
29873-7
|
Isobutyrylglycine [Presence] in Urine |
|
54304-1
|
Isobutyrylglycine [Moles/volume] in Urine |
|
38360-4
|
Isobutyrylglycine/Creatinine [Mass Ratio] in Urine |
|
24439-2
|
Isobutyrylglycine/Creatinine [Molar ratio] in Urine |
|
12551-8
|
Isocarboxazid [Mass/volume] in Serum or Plasma |
|
44328-3
|
Isocitrate [Presence] in 24 hour Urine |
|
2506-4
|
Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
75090-1
|
Isocitrate [Moles/volume] in Serum or Plasma |
|
27269-0
|
Isocitrate [Presence] in Urine |
|
49910-3
|
Isocitrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13764-6
|
Isocitrate/Creatinine [Mass Ratio] in Urine |
|
25111-6
|
Isocitrate/Creatinine [Molar ratio] in Urine |
|
55684-5
|
Isoconazole [Susceptibility] by Gradient strip |
|
55683-7
|
Isoconazole [Susceptibility] by Disk diffusion (KB) |
|
55681-1
|
Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55682-9
|
Isoconazole [Susceptibility] |
|
33625-5
|
Isocoproporphyrin [Mass/time] in 24 hour Stool |
|
74085-2
|
Isocoproporphyrin [Moles/mass] in Stool |
|
7429-4
|
Isocyanate HDI IgE Ab [Units/volume] in Serum |
|
15796-6
|
Isocyanate HDI IgE Ab RAST class [Presence] in Serum |
|
61277-0
|
Isocyanate HDI IgE Ab/IgE total in Serum |
|
61141-8
|
Isocyanate HDI IgG Ab [Mass/volume] in Serum |
|
17026-6
|
Isocyanate IgE Ab [Units/volume] in Serum |
|
17027-4
|
Isocyanate IgG Ab [Units/volume] in Serum |
|
17028-2
|
Isocyanate IgM Ab [Units/volume] in Serum |
|
38745-6
|
Isocyanate MDI [Mass/volume] in Air |
|
7430-2
|
Isocyanate MDI IgE Ab [Units/volume] in Serum |
|
15797-4
|
Isocyanate MDI IgE Ab RAST class [Presence] in Serum |
|
61140-0
|
Isocyanate MDI IgG Ab [Mass/volume] in Serum |
|
7431-0
|
Isocyanate TDI IgE Ab [Units/volume] in Serum |
|
15798-2
|
Isocyanate TDI IgE Ab RAST class [Presence] in Serum |
|
61278-8
|
Isocyanate TDI IgE Ab/IgE total in Serum |
|
61139-2
|
Isocyanate TDI IgG Ab [Mass/volume] in Serum |
|
60766-3
|
Gas delivery system inspiratory Isoflurane setting [VFr/PPres] |
|
87652-4
|
Isofenphos [Mass/mass] in Unspecified specimen |
|
9433-4
|
Isoflurane [Mass/volume] in Blood |
|
62269-6
|
Isoflurane [VFr/PPres] Airway adaptor --during expiration |
|
60768-9
|
Isoflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
62270-4
|
Isoflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60859-6
|
Isoflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60895-0
|
Isoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60769-7
|
Isoflurane gas delivered during case [Volume] from Gas delivery system |
|
61025-3
|
Isoflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76130-4
|
Isoflurane liquid delivered during case [Volume] from Gas delivery system |
|
76131-2
|
Isoflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
62268-8
|
Isoflurane [VFr/PPres] Airway adaptor |
|
60858-8
|
Isoflurane [VFr/PPres] Gas delivery system |
|
23885-7
|
Isoheptacarboxylporphyrin [Mass/time] in unspecified time Stool |
|
23886-5
|
Isohexacarboxylporphyrin [Mass/time] in unspecified time Stool |
|
71511-0
|
Isolation stations Dialysis facility # [ESRD] |
|
2510-6
|
Isoleucine [Mass/time] in 24 hour Urine |
|
25938-2
|
Isoleucine [Moles/volume] in 24 hour Urine |
|
25450-8
|
Isoleucine [Moles/time] in 24 hour Urine |
|
13402-3
|
Isoleucine [Mass/volume] in Amniotic fluid |
|
26730-2
|
Isoleucine [Moles/volume] in Amniotic fluid |
|
9743-6
|
Isoleucine [Mass/volume] in Cerebral spinal fluid |
|
22659-7
|
Isoleucine [Moles/volume] in Cerebral spinal fluid |
|
47671-3
|
Isoleucine [Moles/volume] in DBS |
|
32251-1
|
Isoleucine [Moles/volume] in Body fluid |
|
55929-4
|
Isoleucine [Moles/mass] in Hair |
|
81041-6
|
Isoleucine intake 24 hour Estimated |
|
81042-4
|
Isoleucine intake 24 hour Measured |
|
74881-4
|
Isoleucine [Moles/volume] in DBS --post therapeutic diet |
|
2507-2
|
Isoleucine [Presence] in Serum or Plasma |
|
2508-0
|
Isoleucine [Mass/volume] in Serum or Plasma |
|
20648-2
|
Isoleucine [Moles/volume] in Serum or Plasma |
|
47674-7
|
Isoleucine/Amino acids.total in Amniotic fluid |
|
47673-9
|
Isoleucine/Amino acids.total in Cerebral spinal fluid |
|
47676-2
|
Isoleucine/Amino acids.total in DBS |
|
47672-1
|
Isoleucine/Amino acids.total in Hair |
|
47675-4
|
Isoleucine/Amino acids.total in Serum or Plasma |
|
47677-0
|
Isoleucine/Amino acids.total in Unspecified specimen |
|
17029-0
|
Isoleucine [Presence] in Urine |
|
2509-8
|
Isoleucine [Mass/volume] in Urine |
|
26965-4
|
Isoleucine [Moles/volume] in Urine |
|
32252-9
|
Isoleucine [Moles/volume] in Vitreous fluid |
|
22714-0
|
Isoleucine [Moles/volume] in Unspecified specimen |
|
44329-1
|
Isoleucine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56689-3
|
Isoleucine/Creatinine [Ratio] in 24 hour Urine |
|
25939-0
|
Isoleucine/Creatinine [Molar ratio] in 24 hour Urine |
|
13765-3
|
Isoleucine/Creatinine [Mass Ratio] in Urine |
|
30052-5
|
Isoleucine/Creatinine [Ratio] in Urine |
|
22706-6
|
Isoleucine/Creatinine [Molar ratio] in Urine |
|
29640-0
|
Isomaltase [Enzymatic activity/mass] in Tissue |
|
74954-9
|
Isomaltase [Enzymatic activity/mass] in Small intestine Tissue |
|
25217-1
|
Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25218-9
|
Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
29315-9
|
Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25219-7
|
Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55685-2
|
Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
45215-1
|
Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42651-0
|
Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4290-3
|
Isoniazid [Mass] of Dose |
|
7020-1
|
Isoniazid [Susceptibility] by Gradient strip |
|
288-1
|
Isoniazid [Susceptibility] by Disk diffusion (KB) |
|
287-3
|
Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
286-5
|
Isoniazid [Susceptibility] by Minimum lethal concentration (MLC) |
|
20383-6
|
Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria |
|
89488-1
|
Isoniazid [Susceptibility] by Genotype method |
|
26756-7
|
Isoniazid [Units/volume] in Serum or Plasma |
|
3697-0
|
Isoniazid [Mass/volume] in Serum or Plasma |
|
25451-6
|
Isoniazid [Moles/volume] in Serum or Plasma |
|
18934-0
|
Isoniazid [Susceptibility] |
|
289-9
|
Isoniazid [Susceptibility] by Serum bactericidal titer |
|
40371-7
|
Isoniazid [Presence] in Urine |
|
38762-1
|
Iso-octane [Mass/volume] in Air |
|
23887-3
|
Isopentacarboxylporphyrin [Mass/time] in unspecified time Stool |
|
38704-3
|
Isophorone [Mass/volume] in Air |
|
39530-1
|
Isopropanol [Presence] in Blood |
|
5667-1
|
Isopropanol [Mass/volume] in Blood |
|
50870-5
|
Isopropanol [Moles/volume] in Body fluid |
|
40372-5
|
Isopropanol [Presence] in Gastric fluid |
|
23888-1
|
Isopropanol [Mass/volume] in Gastric fluid |
|
59916-7
|
Isopropanol [Moles/volume] in Gastric fluid |
|
15403-9
|
Isopropanol [Presence] in Meconium |
|
5668-9
|
Isopropanol [Presence] in Serum or Plasma |
|
20471-9
|
Isopropanol [Presence] in Serum or Plasma by Screen method |
|
5669-7
|
Isopropanol [Mass/volume] in Serum or Plasma |
|
14802-3
|
Isopropanol [Moles/volume] in Serum or Plasma |
|
9435-9
|
Isopropanol [Mass/mass] in Tissue |
|
5670-5
|
Isopropanol [Presence] in Urine |
|
9434-2
|
Isopropanol [Mass/volume] in Urine |
|
32085-3
|
Isopropanol [Moles/volume] in Urine |
|
32084-6
|
Isopropanol [Moles/volume] in Unspecified specimen |
|
17030-8
|
Isopropyl ether [Presence] in Blood |
|
12371-1
|
Isopropyl ether [Mass/volume] in Blood |
|
49920-2
|
Isopropyl ether [Presence] in Serum or Plasma |
|
73325-3
|
Isosorbide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73324-6
|
Isosorbide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78006-4
|
Isotopic Glomerular filtration rate/1.73 sq M [Volume Rate/Area] in Urine and Serum or Plasma |
|
87378-6
|
Isotopic Tubular extraction rate/1.73 sq M [Volume Rate/Area] in Serum or Blood |
|
73323-8
|
ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73322-0
|
ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6947-6
|
ISOtretinoin [Mass/volume] in Serum or Plasma |
|
33622-2
|
Isotricarboxylporphyrin [Mass/time] in 24 hour Stool |
|
54306-6
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Amniotic fluid |
|
54305-8
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Cerebral spinal fluid |
|
45216-9
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS |
|
30531-8
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Serum or Plasma |
|
54307-4
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Urine |
|
53238-2
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88007-0
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
53239-0
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
53240-8
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
53401-6
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
54931-1
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Creatinine [Molar ratio] in Urine |
|
42920-9
|
Isovalerylcarnitine (C5) [Moles/volume] in DBS |
|
18441-6
|
Isovalerylcarnitine (C5) [Mass/volume] in Serum or Plasma |
|
39009-6
|
Isovalerylcarnitine (C5) [Moles/volume] in Serum or Plasma |
|
54308-2
|
Isovalerylglycine [Moles/volume] in Cerebral spinal fluid |
|
55930-2
|
Isovalerylglycine [Moles/volume] in Plasma |
|
29874-5
|
Isovalerylglycine [Presence] in Urine |
|
10879-5
|
Isovalerylglycine [Mass/volume] in Urine |
|
44331-7
|
Isovalerylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
49911-1
|
Isovalerylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13766-1
|
Isovalerylglycine/Creatinine [Mass Ratio] in Urine |
|
24440-0
|
Isovalerylglycine/Creatinine [Molar ratio] in Urine |
|
48117-6
|
Isovalerylglycine/Urea [Molar ratio] in Plasma |
|
79316-6
|
Isoxanthopterin [Moles/volume] in Serum or Plasma |
|
6150-7
|
Ispaghula laxative IgE Ab [Units/volume] in Serum |
|
15799-0
|
Ispaghula laxative IgE Ab RAST class [Presence] in Serum |
|
74470-6
|
Injury severity score (ISS) body region [NTDS] |
|
74471-4
|
Injury severity score Calculated |
|
88076-5
|
Injury severity score NACA |
|
81478-0
|
It has seemed like my brain was not working as well as usual in past 7 days [PROMIS] |
|
90188-4
|
It is hard for me to add or subtract numbers in my head in past 4 weeks [PROMIS.PEDS] |
|
90199-1
|
It is hard for me to concentrate in school in past 4 weeks - frequency [PROMIS.PEDS] |
|
90200-7
|
It is hard for me to concentrate in school in past 4 weeks - severity [PROMIS.PEDS] |
|
71311-5
|
It is hard for me to concentrate in school in the past 4 weeks [FACIT] |
|
90184-3
|
It is hard for me to do more than one thing at a time in past 4 weeks [PROMIS.PEDS] |
|
90174-4
|
It is hard for me to find my way to a place that I have visited several times before in past 4 weeks [PROMIS.PEDS] |
|
90195-9
|
It is hard for me to find the right words to say what I mean in past 4 weeks - frequency [PROMIS.PEDS] |
|
90196-7
|
It is hard for me to find the right words to say what I mean in past 4 weeks - severity [PROMIS.PEDS] |
|
71314-9
|
It is hard for me to find the right words to say what I mean in the past 4 weeks [FACIT] |
|
90178-5
|
It is hard for me to learn new things in past 4 weeks [PROMIS.PEDS] |
|
90181-9
|
It is hard for me to pay attention to one thing for more than 5-10 minutes in past 4 weeks [PROMIS.PEDS] |
|
90180-1
|
It is hard for me to pay attention to something boring I have to do in past 4 weeks [PROMIS.PEDS] |
|
90177-7
|
It is hard for me to take notes in class in past 4 weeks [PROMIS.PEDS] |
|
90179-3
|
It is hard for me to understand pictures that show how to make something in past 4 weeks [PROMIS.PEDS] |
|
71331-3
|
It is hard for my child to concentrate in school in the past 4 weeks [FACIT] |
|
90141-3
|
It is hard for your child to add or subtract numbers in his or her head in past 4 weeks [PROMIS.PARENTPROXY] |
|
90152-0
|
It is hard for your child to concentrate in school in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90153-8
|
It is hard for your child to concentrate in school in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90137-1
|
It is hard for your child to do more than one thing at a time in past 4 weeks [PROMIS.PARENTPROXY] |
|
90127-2
|
It is hard for your child to find his or her way to a place that he or she has visited several times before in past 4 weeks [PROMIS.PARENTPROXY] |
|
90148-8
|
It is hard for your child to find the right words to say what he or she means in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90149-6
|
It is hard for your child to find the right words to say what he or she means in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90131-4
|
It is hard for your child to learn new things in past 4 weeks [PROMIS.PARENTPROXY] |
|
90134-8
|
It is hard for your child to pay attention to one thing for more than 5-10 minutes in past 4 weeks [PROMIS.PARENTPROXY] |
|
90133-0
|
It is hard for your child to pay attention to something boring he or she has to do in past 4 weeks [PROMIS.PARENTPROXY] |
|
90130-6
|
It is hard for your child to take notes in class in past 4 weeks [PROMIS.PARENTPROXY] |
|
90132-2
|
It is hard for your child to understand pictures that show how to make something in past 4 weeks [PROMIS.PARENTPROXY] |
|
92309-4
|
It is hard to ignore urges to smoke [PROMIS] |
|
71135-8
|
It is hard to tell other people about my infection in the past 7 days [FACIT] |
|
90207-2
|
It takes me longer than other people to get my school work done in past 4 weeks - frequency [PROMIS.PEDS] |
|
90208-0
|
It takes me longer than other people to get my school work done in past 4 weeks - severity [PROMIS.PEDS] |
|
92268-2
|
It takes me longer to recover from a cold because I smoke [PROMIS] |
|
90160-3
|
It takes your child longer than other people to get his or her school work done in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90161-1
|
It takes your child longer than other people to get his or her school work done in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
76916-6
|
It was difficult for me to stop drinking after one or two drinks in past 30D [PROMIS] |
|
76921-6
|
It was difficult to get the thought of drinking out of my mind in past 30D [PROMIS] |
|
77002-4
|
It was easier to talk to people when I drank in past 30D [PROMIS] |
|
78108-8
|
It was easy to be close to everyone in my family in past 4 weeks [PROMIS.PEDS] |
|
78162-5
|
It was hard for me to be away from home because I had pain in past 7 days [PROMIS.PEDS] |
|
72717-2
|
It was hard for me to concentrate in last week [BSL-23] |
|
91394-7
|
It was hard for my child to do school work because he or she felt sad in past 7 days [PROMIS.PARENTPROXY] |
|
89946-8
|
It was hard for my child to get along with other people when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91925-8
|
It was hard for my child to get out of bed in the morning because he/she was too tired in past 7 days [PROMIS.PARENTPROXY] |
|
91395-4
|
It was hard for my child to have fun in past 7 days [PROMIS.PARENTPROXY] |
|
89941-9
|
It was hard for my child to have fun when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
89940-1
|
It was hard for my child to pay attention when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91408-5
|
It was hard for my child to play sports or exercise because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
91409-3
|
It was hard for my child to play with pets because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
91996-9
|
It was hard for my child to relax in past 7 days [PROMIS.PARENTPROXY] |
|
89945-0
|
It was hard for my child to remember things when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
89939-3
|
It was hard for my child to run when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
89948-4
|
It was hard for my child to stay standing when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91410-1
|
It was hard for my child to take a deep breath because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
89937-7
|
It was hard for my child to walk one block when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
78167-4
|
It was hard to do things with my family because I had pain in past 7 days [PROMIS.PEDS] |
|
78163-3
|
It was hard to have fun with friends because I was in pain in past 7 days [PROMIS.PEDS] |
|
43208-8
|
Invasive trophoblast Ag [Multiple of the median] in Serum or Plasma |
|
43207-0
|
Invasive trophoblast Ag [Presence] in Serum or Plasma |
|
40583-7
|
Invasive trophoblast Ag [Mass/volume] in Serum or Plasma |
|
15340-3
|
Italian Cedar IgE Ab [Units/volume] in Serum |
|
15613-3
|
Italian Cedar IgE Ab RAST class [Presence] in Serum |
|
6151-5
|
Italian Cypress IgE Ab [Units/volume] in Serum |
|
15673-7
|
Italian Cypress IgE Ab RAST class [Presence] in Serum |
|
61254-9
|
Italian Cypress IgE Ab/IgE total in Serum |
|
56293-4
|
Italian Cypress IgG4 Ab [Mass/volume] in Serum |
|
94093-2
|
Itemized bill |
|
48026-9
|
ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
58987-9
|
ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
59045-5
|
ITGB3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
91137-0
|
ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method |
|
91138-8
|
ITPA gene g.9381A>C [Type] in Serum or Plasma by Molecular genetics method |
|
80424-5
|
Inosine triphosphate pyrophosphatase [Enzymatic activity/substance] in Red Blood Cells |
|
80531-7
|
Itraconazole [Mass/volume] in DBS |
|
7021-9
|
Itraconazole [Susceptibility] by Gradient strip |
|
54179-7
|
Itraconazole [Susceptibility] by Disk diffusion (KB) |
|
25452-4
|
Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32184-4
|
Itraconazole [Mass/volume] in Serum or Plasma --peak |
|
10989-2
|
Itraconazole [Mass/volume] in Serum or Plasma |
|
32603-3
|
Itraconazole [Susceptibility] |
|
32185-1
|
Itraconazole [Mass/volume] in Serum or Plasma --trough |
|
25258-5
|
Itraconazole [Mass/volume] in Unspecified specimen |
|
27081-9
|
Itraconazole+Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
|
81665-2
|
IV number [Identifier] |
|
9870-7
|
Intraventricular conduction [Interpretation] Narrative by EKG |
|
9871-5
|
Intraventricular conduction [Interpretation] by EKG |
|
78974-3
|
IV contrast given [Identifier] |
|
80242-1
|
IV contrast given [Volume] |
|
71587-0
|
IV site NEMSIS |
|
74294-0
|
Isovaleric acidemia newborn screen interpretation |
|
46742-3
|
Isovaleric Acidemia/2-Methylbutyric Acidemia newborn screen interpretation |
|
94121-1
|
Inferior vena cava Blood pressure by US |
|
93634-4
|
Inferior vena cava Collapse by US |
|
29459-5
|
Inferior vena cava Diameter by US --expiration |
|
29429-8
|
Inferior vena cava Diameter by US --inspiration |
|
18006-7
|
Inferior vena cava Diameter by US |
|
79967-6
|
Inferior vena cava Diameter at end expiration by US 2D |
|
18050-5
|
Inferior vena cava Fractional collapse by US --inspiration |
|
81844-3
|
IVD gene full mutation analysis in Blood or Tissue by Sequencing |
|
82518-2
|
IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47224-1
|
In vitro fertilization pregnancy |
|
20368-7
|
Interventricular septal defect Maximum blood flow velocity by US.doppler |
|
79969-2
|
Interventricular septum Thickness at end diastole by US 2D |
|
79968-4
|
Interventricular septum Thickness at end diastole by US.M-mode |
|
79971-8
|
Interventricular septum Thickness at end systole by US 2D |
|
79970-0
|
Interventricular septum Thickness at end systole by US.M-mode |
|
18054-7
|
Interventricular septum Fractional thickness; fractional change by US 2D |
|
29430-6
|
Interventricular septum Thickness during diastole by US 2D |
|
29431-4
|
Interventricular septum Thickness during diastole by US.M-mode |
|
18154-5
|
Interventricular septum Thickness during diastole by US |
|
29432-2
|
Interventricular septum Thickness during systole by US 2D |
|
29433-0
|
Interventricular septum Thickness during systole by US.M-mode |
|
18158-6
|
Interventricular septum Thickness during systole by US |
|
79972-6
|
Interventricular septum Time to peak displacement during systole by US.M-mode+ECG |
|
80996-2
|
Intravascular ultrasound performed |
|
9877-2
|
J point depression in lead AVF |
|
9878-0
|
J point depression in lead AVL |
|
9879-8
|
J point depression in lead AVR |
|
9880-6
|
J point depression in lead I |
|
9881-4
|
J point depression in lead II |
|
9882-2
|
J point depression in lead III |
|
9883-0
|
J point depression in lead V1 |
|
9884-8
|
J point depression in lead V2 |
|
9885-5
|
J point depression in lead V3 |
|
9886-3
|
J point depression in lead V4 |
|
9887-1
|
J point depression in lead V5 |
|
9888-9
|
J point depression in lead V6 |
|
18544-7
|
ST amplitude.J point+20 ms Lead AVF |
|
18545-4
|
ST amplitude.J point+20 ms Lead AVL |
|
18546-2
|
ST amplitude.J point+20 ms Lead AVR |
|
18547-0
|
ST amplitude.J point+20 ms Lead I |
|
18548-8
|
ST amplitude.J point+20 ms Lead II |
|
18549-6
|
ST amplitude.J point+20 ms Lead III |
|
18550-4
|
ST amplitude.J point+20 ms Lead V1 |
|
18551-2
|
ST amplitude.J point+20 ms Lead V2 |
|
18552-0
|
ST amplitude.J point+20 ms Lead V3 |
|
18553-8
|
ST amplitude.J point+20 ms Lead V4 |
|
18554-6
|
ST amplitude.J point+20 ms Lead V5 |
|
18555-3
|
ST amplitude.J point+20 ms Lead V6 |
|
18556-1
|
ST amplitude.J point+60 ms Lead AVF |
|
18557-9
|
ST amplitude.J point+60 ms Lead AVL |
|
18558-7
|
ST amplitude.J point+60 ms Lead AVR |
|
18559-5
|
ST amplitude.J point+60 ms Lead I |
|
18560-3
|
ST amplitude.J point+60 ms Lead II |
|
18561-1
|
ST amplitude.J point+60 ms Lead III |
|
18562-9
|
ST amplitude.J point+60 ms Lead V1 |
|
18563-7
|
ST amplitude.J point+60 ms Lead V2 |
|
18564-5
|
ST amplitude.J point+60 ms Lead V3 |
|
18565-2
|
ST amplitude.J point+60 ms Lead V4 |
|
18566-0
|
ST amplitude.J point+60 ms Lead V5 |
|
18567-8
|
ST amplitude.J point+60 ms Lead V6 |
|
18568-6
|
ST amplitude.J point+80 ms Lead AVF |
|
18569-4
|
ST amplitude.J point+80 ms Lead AVL |
|
18570-2
|
ST amplitude.J point+80 ms Lead AVR |
|
18571-0
|
ST amplitude.J point+80 ms Lead I |
|
18572-8
|
ST amplitude.J point+80 ms Lead II |
|
18573-6
|
ST amplitude.J point+80 ms Lead III |
|
18574-4
|
ST amplitude.J point+80 ms Lead V1 |
|
18575-1
|
ST amplitude.J point+80 ms Lead V2 |
|
18576-9
|
ST amplitude.J point+80 ms Lead V3 |
|
18577-7
|
ST amplitude.J point+80 ms Lead V4 |
|
18578-5
|
ST amplitude.J point+80 ms Lead V5 |
|
18579-3
|
ST amplitude.J point+80 ms Lead V6 |
|
19744-2
|
Jackfruit IgE Ab [Units/volume] in Serum |
|
25701-4
|
Jackfruit IgE Ab RAST class [Presence] in Serum |
|
82253-6
|
JAG1 gene deletion in Blood or Tissue by FISH |
|
47962-6
|
JAG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
55300-8
|
JAK2 gene exon 12 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80186-0
|
JAK2 gene exon 12 targeted mutation analysis in Bone marrow by Molecular genetics method |
|
63421-2
|
JAK2 gene exon 12 mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
55301-6
|
JAK2 gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80187-8
|
JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80188-6
|
JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method |
|
48726-4
|
JAK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43399-5
|
JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method |
|
72333-8
|
JAK2 gene p.Val617Phe [Presence] in Bone marrow by Molecular genetics method |
|
53761-3
|
JAK2 gene.p.Val617Phe mutant/Normal in Blood or Tissue by Molecular genetics method |
|
85039-6
|
JAK2 gene.p.Val617Phe mutant/Normal in Bone marrow by Molecular genetics method |
|
47963-4
|
JAK3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11189-8
|
Jalepeno Pepper IgE Ab [Units/volume] in Serum |
|
21453-6
|
Jalepeno Pepper IgE Ab RAST class [Presence] in Serum |
|
65777-5
|
Japanese Cedar native (nCry j) 1 IgE Ab [Units/volume] in Serum |
|
14035-0
|
Japanese Cedar IgE Ab [Units/volume] in Serum |
|
15614-1
|
Japanese Cedar IgE Ab RAST class [Presence] in Serum |
|
61251-5
|
Japanese Cedar IgE Ab/IgE total in Serum |
|
48245-5
|
Japanese Cedar triggered leukotriene release [Mass/volume] by Leukocytes |
|
40788-2
|
Japanese cypress IgE Ab [Units/volume] in Serum |
|
81961-5
|
Japanese cypress IgE Ab RAST class [Presence] in Serum |
|
40789-0
|
Japanese hop IgE Ab [Units/volume] in Serum |
|
44381-2
|
Japanese hop IgE Ab RAST class [Presence] in Serum |
|
79750-6
|
Jaw winking [Presence] Left eye |
|
79749-8
|
Jaw winking [Presence] Right eye |
|
70173-0
|
JC virus Ab [Presence] in Serum or Plasma by Immunoassay |
|
49416-1
|
JC virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49414-6
|
JC virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49410-4
|
JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49415-3
|
JC virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49413-8
|
JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49417-9
|
JC virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49411-2
|
JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49412-0
|
JC virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49547-3
|
JC virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
86573-3
|
JC virus DNA [Presence] in Blood by NAA with probe detection |
|
49545-7
|
JC virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
33295-7
|
JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
32363-4
|
JC virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
34586-8
|
JC virus DNA [Presence] in Tissue by NAA with probe detection |
|
35661-8
|
JC virus DNA [Presence] in Urine by NAA with probe detection |
|
42921-7
|
JC virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
26642-9
|
Jamestown canyon virus Ab [Presence] in Serum |
|
74823-6
|
Jamestown canyon virus Ab [Presence] in Serum by Immunoassay |
|
31446-8
|
Jamestown canyon virus Ab [Units/volume] in Serum |
|
43006-6
|
Jamestown canyon virus Ab [Titer] in Serum |
|
40507-6
|
Jamestown canyon virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
40506-8
|
Jamestown canyon virus Ab [Titer] in Serum by Immunofluorescence |
|
29562-6
|
Jamestown canyon virus Ab [Titer] in Serum by Neutralization test |
|
41133-0
|
Jamestown canyon virus Ab [Presence] in Unspecified specimen |
|
30175-4
|
Jamestown canyon virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
29801-8
|
Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
29839-8
|
Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
29814-1
|
Jamestown canyon virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
29851-3
|
Jamestown canyon virus IgG Ab [Units/volume] in Serum |
|
43005-8
|
Jamestown canyon virus IgG Ab [Titer] in Serum |
|
29561-8
|
Jamestown canyon virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
43004-1
|
Jamestown canyon virus IgG Ab [Titer] in Unspecified specimen |
|
30174-7
|
Jamestown canyon virus IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
29788-7
|
Jamestown canyon virus IgG Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
|
29827-3
|
Jamestown canyon virus IgG Ab [Units/volume] in Unspecified specimen |
|
29799-4
|
Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
29838-0
|
Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid |
|
29800-0
|
Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29837-2
|
Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
29812-5
|
Jamestown canyon virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
29850-5
|
Jamestown canyon virus IgM Ab [Presence] in Serum |
|
29813-3
|
Jamestown canyon virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
29849-7
|
Jamestown canyon virus IgM Ab [Units/volume] in Serum |
|
62946-9
|
Jamestown canyon virus IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
43003-3
|
Jamestown canyon virus IgM Ab [Titer] in Serum |
|
40508-4
|
Jamestown canyon virus IgM Ab [Titer] in Serum by Neutralization test |
|
29786-1
|
Jamestown canyon virus IgM Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
|
29826-5
|
Jamestown canyon virus IgM Ab [Presence] in Unspecified specimen |
|
29787-9
|
Jamestown canyon virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
29825-7
|
Jamestown canyon virus IgM Ab [Units/volume] in Unspecified specimen |
|
34452-3
|
Jamestown canyon virus RNA [Presence] in Blood by NAA with probe detection |
|
34453-1
|
Jamestown canyon virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
42515-7
|
Jamestown canyon virus RNA [Presence] in Urine by NAA with probe detection |
|
53874-4
|
Jamestown canyon virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
7531-7
|
Jerusalem oak IgE Ab [Units/volume] in Serum |
|
15879-0
|
Jerusalem oak IgE Ab RAST class [Presence] in Serum |
|
22369-3
|
Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
7933-5
|
Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
7935-0
|
Japanese encephalitis virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
22370-1
|
Japanese encephalitis virus Ab [Presence] in Serum |
|
23146-4
|
Japanese encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
7934-3
|
Japanese encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
11608-7
|
Japanese encephalitis virus Ab [Units/volume] in Serum |
|
49912-9
|
Japanese encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
23147-2
|
Japanese encephalitis virus Ab [Titer] in Serum |
|
23145-6
|
Japanese encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23144-9
|
Japanese encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
31866-7
|
Japanese encephalitis virus Ag [Presence] in Unspecified specimen |
|
23149-8
|
Japanese encephalitis virus Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
|
23148-0
|
Japanese encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
63563-1
|
Japanese encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63562-3
|
Japanese encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
60532-9
|
Japanese encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
60531-1
|
Japanese encephalitis virus IgM Ab [Titer] in Serum |
|
7936-8
|
Japanese encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
|
51666-6
|
Japanese encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80205-8
|
Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
80206-6
|
Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
1067-8
|
Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1068-6
|
Jk sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1069-4
|
Jk sup(a) Ab [Presence] in Serum or Plasma |
|
55323-0
|
Jk sup(a) Ab [Titer] in Serum or Plasma |
|
92539-6
|
Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92501-6
|
Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1070-2
|
Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1071-0
|
Jk sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1072-8
|
Jk sup(a) Ag [Presence] on Red Blood Cells |
|
1073-6
|
Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1074-4
|
Jk sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1075-1
|
Jk sup(b) Ab [Presence] in Serum or Plasma |
|
55324-8
|
Jk sup(b) Ab [Titer] in Serum or Plasma |
|
92538-8
|
Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92500-8
|
Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1076-9
|
Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1077-7
|
Jk sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1078-5
|
Jk sup(b) Ag [Presence] on Red Blood Cells |
|
65324-6
|
Jk3 Ab [Presence] in Serum or Plasma |
|
93909-0
|
Jk3 Ag [Presence] on Red Blood Cells |
|
58079-5
|
JMH Ab [Presence] in Serum or Plasma |
|
92537-0
|
Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92499-3
|
Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
7361-9
|
Johnson grass triggered histamine release [Units/volume] in Blood |
|
6152-3
|
Johnson grass IgE Ab [Units/volume] in Serum |
|
15743-8
|
Johnson grass IgE Ab RAST class [Presence] in Serum |
|
39091-4
|
Johnson grass IgE Ab/IgE total in Serum |
|
24138-0
|
Johnson grass IgG Ab [Units/volume] in Serum |
|
56294-2
|
Johnson grass IgG4 Ab [Mass/volume] in Serum |
|
63153-1
|
Johnson grass IgG Ab [Mass/volume] in Serum |
|
7705-7
|
Johnson grass smut IgE Ab [Units/volume] in Serum |
|
16023-4
|
Johnson grass smut IgE Ab RAST class [Presence] in Serum |
|
7706-5
|
Johnson grass smut IgG Ab [Units/volume] in Serum |
|
63179-6
|
Johnson grass smut IgG Ab [Mass/volume] in Serum |
|
10792-0
|
Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |
|
41699-0
|
Josamycine [Susceptibility] by Gradient strip |
|
41698-2
|
Josamycine [Susceptibility] by Disk diffusion (KB) |
|
25702-2
|
Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25597-6
|
Josamycine [Susceptibility] |
|
58065-4
|
Jr sup(a) Ab [Presence] in Serum or Plasma |
|
58064-7
|
Jr sup(a) Ag [Presence] on Red Blood Cells |
|
1079-3
|
Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1080-1
|
Js sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1081-9
|
Js sup(a) Ab [Presence] in Serum or Plasma |
|
55325-5
|
Js sup(a) Ab [Titer] in Serum or Plasma |
|
92536-2
|
Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92498-5
|
Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1082-7
|
Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1083-5
|
Js sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1084-3
|
Js sup(a) Ag [Presence] on Red Blood Cells |
|
1085-0
|
Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1086-8
|
Js sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1087-6
|
Js sup(b) Ab [Presence] in Serum or Plasma |
|
55597-9
|
Js sup(b) Ab [Titer] in Serum or Plasma |
|
92535-4
|
Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92497-7
|
Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1088-4
|
Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1089-2
|
Js sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1090-0
|
Js sup(b) Ag [Presence] on Red Blood Cells |
|
44965-2
|
Jugular vein distention --head raised 30 degrees |
|
25703-0
|
Jujube IgE Ab [Units/volume] in Serum |
|
25704-8
|
Jujube IgE Ab RAST class [Presence] in Serum |
|
54920-4
|
Jumper ant IgE Ab [Units/volume] in Serum |
|
7433-6
|
Juniper triggered histamine release [Units/volume] in Blood |
|
7432-8
|
Juniper IgE Ab [Units/volume] in Serum |
|
15800-6
|
Juniper IgE Ab RAST class [Presence] in Serum |
|
22371-9
|
Junin virus Ab [Presence] in Serum |
|
7937-6
|
Junin virus Ab [Presence] in Serum by Immunoassay |
|
11607-9
|
Junin virus Ab [Units/volume] in Serum |
|
77969-4
|
Jurisdiction code |
|
86801-8
|
Jurisdiction death information - recommended CDA R1 sections |
|
86806-7
|
Jurisdiction death registration Document |
|
92010-8
|
Jurisdiction fetal death report Document |
|
92011-6
|
Jurisdiction live birth report Document |
|
77982-7
|
Jurisdiction where disease acquired |
|
7436-9
|
Jute IgE Ab [Units/volume] in Serum |
|
73920-1
|
JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood |
|
72459-1
|
JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method |
|
78836-4
|
JWH-018 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
73949-0
|
JWH-018 (synthetic cannabinoid) [Presence] in Blood |
|
72808-9
|
JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72809-7
|
JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73923-5
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78837-2
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
72782-6
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72461-7
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72783-4
|
JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
72780-0
|
JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72781-8
|
JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73914-4
|
JWH-018 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method |
|
73921-9
|
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72460-9
|
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73926-8
|
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78838-0
|
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
72464-1
|
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73953-2
|
JWH-073 (synthetic cannabinoid) [Presence] in Blood |
|
73927-6
|
JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78839-8
|
JWH-073 butanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
72778-4
|
JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72465-8
|
JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72779-2
|
JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
72875-8
|
JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72874-1
|
JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
72806-3
|
JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72807-1
|
JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73918-5
|
JWH-073 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method |
|
78840-6
|
JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
77771-4
|
JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
73956-5
|
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78842-2
|
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78841-4
|
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72474-0
|
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73948-2
|
JWH-122 (synthetic cannabinoid) [Presence] in Blood |
|
73924-3
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78844-8
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78843-0
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72462-5
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
78846-3
|
JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78845-5
|
JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
73946-6
|
JWH-200 (synthetic cannabinoid) [Presence] in Blood |
|
78849-7
|
JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78848-9
|
JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
78847-1
|
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
72804-8
|
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72805-5
|
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73917-7
|
JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73929-2
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72802-2
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72467-4
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72803-0
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73928-4
|
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78850-5
|
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
72466-6
|
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73950-8
|
JWH-250 (synthetic cannabinoid) [Presence] in Blood |
|
73954-0
|
JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72473-2
|
JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73947-4
|
JWH-398 (synthetic cannabinoid) [Presence] in Blood |
|
1091-8
|
K Ab [Presence] in Serum or Plasma from Blood product unit |
|
1092-6
|
K Ab [Presence] in Serum or Plasma from Donor |
|
1093-4
|
K Ab [Presence] in Serum or Plasma |
|
34738-5
|
K Ab [Titer] in Serum or Plasma |
|
92975-2
|
Klebsiella aerogenes DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
92974-5
|
Klebsiella aerogenes DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
93934-8
|
K Ag [Presence] on Red Blood Cells --during infancy |
|
92534-7
|
K Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92496-9
|
K Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93924-9
|
K Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93917-3
|
K Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1094-2
|
K Ag [Presence] on Red Blood Cells from Blood product unit |
|
1095-9
|
K Ag [Presence] on Red Blood Cells from Donor |
|
1096-7
|
K Ag [Presence] on Red Blood Cells |
|
93942-1
|
K Ag [Presence] in Cord red blood cells |
|
32158-8
|
Klebsiella granulomatis [Presence] in Genital specimen by Light microscopy |
|
6595-3
|
Klebsiella granulomatis [Presence] in Isolate by Organism specific culture |
|
91059-6
|
Kingella kingae DNA [Presence] in Blood by NAA with probe detection |
|
91058-8
|
Kingella kingae DNA [Presence] in Synovial fluid by NAA with probe detection |
|
65809-6
|
Kingella kingae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48291-9
|
Potassium metabisulfite triggered leukotriene release [Mass/volume] by Leukocytes |
|
92973-7
|
Klebsiella oxytoca DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85774-8
|
Klebsiella oxytoca DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93398-6
|
Klebsiella oxytoca DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70019-5
|
Klebsiella oxytoca DNA [Presence] in Blood by NAA with probe detection |
|
92972-9
|
Klebsiella oxytoca DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
88263-9
|
Klebsiella oxytoca ompA gene [Presence] by Probe in Positive blood culture |
|
92971-1
|
Klebsiella pneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85761-5
|
Klebsiella pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93395-2
|
Klebsiella pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92970-3
|
Klebsiella pneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61399-2
|
Klebsiella pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88264-7
|
Klebsiella pneumoniae yggE gene [Presence] by Probe in Positive blood culture |
|
61361-2
|
Klebsiella aerogenes DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
4657-3
|
Kallikrein [Enzymatic activity/volume] in Plasma |
|
4658-1
|
Kallikrein Tissue type [Units/volume] in Plasma |
|
24153-9
|
Kamut flour IgG Ab [Units/volume] in Serum |
|
49080-5
|
Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
88002-1
|
Kanamycin 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
88705-9
|
Kanamycin 3.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25214-8
|
Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25182-7
|
Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25213-0
|
Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4291-1
|
Kanamycin [Mass] of Dose |
|
7023-5
|
Kanamycin.high potency [Susceptibility] by Disk diffusion (KB) |
|
7024-3
|
Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18936-5
|
Kanamycin.high potency [Susceptibility] |
|
7022-7
|
Kanamycin [Susceptibility] by Gradient strip |
|
292-3
|
Kanamycin [Susceptibility] by Disk diffusion (KB) |
|
291-5
|
Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
290-7
|
Kanamycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23609-1
|
Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89482-4
|
Kanamycin [Susceptibility] by Genotype method |
|
3698-8
|
Kanamycin [Mass/volume] in Serum or Plasma --peak |
|
3699-6
|
Kanamycin [Mass/volume] in Serum or Plasma --random |
|
47395-9
|
Kanamycin [Mass/volume] in Serum or Plasma |
|
18935-7
|
Kanamycin [Susceptibility] |
|
293-1
|
Kanamycin [Susceptibility] by Serum bactericidal titer |
|
3700-2
|
Kanamycin [Mass/volume] in Serum or Plasma --trough |
|
23889-9
|
Kanamycin [Mass/volume] in Unspecified specimen |
|
7438-5
|
Kapok triggered histamine release [Units/volume] in Blood |
|
7437-7
|
Kapok IgE Ab [Units/volume] in Serum |
|
15801-4
|
Kapok IgE Ab RAST class [Presence] in Serum |
|
10497-6
|
Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
|
44394-5
|
Kappa light chains [Presence] in 24 hour Urine |
|
88304-1
|
Kappa light chains [Presence] in 24 hour Urine by Immunofixation |
|
15188-6
|
Kappa light chains [Mass/volume] in 24 hour Urine |
|
25682-6
|
Kappa light chains [Mass/time] in 24 hour Urine |
|
10496-8
|
Kappa light chains Ag [Presence] in Tissue by Immune stain |
|
44605-4
|
Kappa light chains [Presence] in Cerebral spinal fluid by Immunofixation |
|
48771-0
|
Kappa light chains [Mass/volume] in Cerebral spinal fluid |
|
88301-7
|
Kappa light chains.free [Presence] in 24 hour Urine by Immunofixation |
|
43940-6
|
Kappa light chains.free [Mass/volume] in 24 hour Urine |
|
38177-2
|
Kappa light chains.free [Mass/time] in 24 hour Urine |
|
48774-4
|
Kappa light chains.free [Mass/volume] in Cerebral spinal fluid |
|
80515-0
|
Kappa light chains.free [Mass/volume] in Serum by Nephelometry |
|
44555-1
|
Kappa light chains.free [Presence] in Serum by Immunofixation |
|
36916-5
|
Kappa light chains.free [Mass/volume] in Serum |
|
40637-1
|
Kappa light chains.free [Presence] in Urine |
|
44604-7
|
Kappa light chains.free [Presence] in Urine by Immunofixation |
|
12777-9
|
Kappa light chains.free [Units/volume] in Urine |
|
38176-4
|
Kappa light chains.free [Mass/volume] in Urine |
|
48777-7
|
Kappa light chains.free/Albumin in Serum and CSF |
|
49553-1
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in 24 hour Urine |
|
48776-9
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Cerebral spinal fluid |
|
48378-4
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum |
|
80517-6
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry |
|
41759-2
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Urine |
|
21748-9
|
Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
6785-0
|
Kappa light chains [Presence] in Serum by Electrophoresis |
|
6787-6
|
Kappa light chains [Presence] in Serum by Immunoassay |
|
25681-8
|
Kappa light chains [Presence] in Serum by Immunoelectrophoresis |
|
40635-5
|
Kappa light chains [Presence] in Serum by Immunofixation |
|
11050-2
|
Kappa light chains [Mass/volume] in Serum or Plasma |
|
6786-8
|
Kappa light chains [Presence] in Urine by Electrophoresis |
|
40636-3
|
Kappa light chains [Presence] in Urine by Immunofixation |
|
27365-6
|
Kappa light chains [Mass/volume] in Urine |
|
49908-7
|
Kappa light chains/Lambda light chains [Mass Ratio] in 24 hour Urine |
|
48773-6
|
Kappa light chains/Lambda light chains [Mass Ratio] in Cerebral spinal fluid |
|
15189-4
|
Kappa light chains/Lambda light chains [Mass Ratio] in Serum |
|
6788-4
|
Kappa light chains/Lambda light chains [Mass Ratio] in Serum by Immunoassay |
|
33559-6
|
Kappa light chains/Lambda light chains [Mass Ratio] in Urine |
|
7439-3
|
Karaya gum IgE Ab [Units/volume] in Serum |
|
21354-6
|
Karaya gum IgE Ab RAST class [Presence] in Serum |
|
56295-9
|
Karaya gum IgG4 Ab [Mass/volume] in Serum |
|
63146-5
|
Karaya gum IgG Ab [Mass/volume] in Serum |
|
77111-3
|
KARS gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77110-5
|
KARS gene full mutation analysis in Blood or Tissue by Sequencing |
|
33773-3
|
Karyotype [Identifier] in Amniotic fluid Nominal |
|
64094-6
|
Karyotype [Identifier] in Amniotic fluid Narrative |
|
29770-5
|
Karyotype [Identifier] in Blood or Tissue Nominal |
|
50619-6
|
Karyotype [Identifier] in Blood or Tissue Narrative |
|
59267-5
|
Karyotype [Identifier] in Blood or Tissue by FISH Narrative |
|
48818-9
|
Karyotype [Identifier] in Blood or Tissue by High resolution Nominal |
|
48820-5
|
Karyotype [Identifier] in Cord blood Nominal |
|
33774-1
|
Karyotype [Identifier] in Chorionic villus sample Nominal |
|
64088-8
|
Karyotype [Identifier] in Chorionic villus sample Narrative |
|
81861-7
|
Karyotype in Bone marrow |
|
33893-9
|
Karyotype [Identifier] in Bone marrow Nominal |
|
81862-5
|
Karyotype in Blood or Tissue --post mitogen stimulation |
|
77164-2
|
Karyotype [Identifier] in Products of Conception Nominal |
|
48819-7
|
Karyotype [Identifier] in Tissue from Fetus Nominal |
|
38471-9
|
Karyotype [Identifier] in Urine Nominal |
|
56030-0
|
Karyotype [Identifier] in Urine by FISH Narrative |
|
35129-6
|
Karyotype [Identifier] in Unspecified specimen Nominal |
|
53726-6
|
KCNC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81863-3
|
KCNH2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75400-2
|
KCNJ11 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81864-1
|
KCNQ1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
43746-7
|
KCNQ1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44608-8
|
KCNQ1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
48580-5
|
KCNQ1OT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49707-3
|
KCNQ2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48054-1
|
Kaolin activated time [Units/volume] in Blood |
|
13053-4
|
Kaolin activated time [Units/volume] in Platelet poor plasma |
|
34656-9
|
KEL gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
41096-9
|
KEL gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
13310-8
|
Kell group Ag [Type] on Red Blood Cells |
|
33004-3
|
Kelp or Seaweed IgE Ab [Units/volume] in Serum |
|
33005-0
|
Kelp or Seaweed IgE Ab RAST class [Presence] in Serum |
|
7358-5
|
Kentucky blue grass triggered histamine release [Units/volume] in Blood |
|
6153-1
|
Kentucky blue grass IgE Ab [Units/volume] in Serum |
|
15744-6
|
Kentucky blue grass IgE Ab RAST class [Presence] in Serum |
|
61303-4
|
Kentucky blue grass IgE Ab/IgE total in Serum |
|
24148-9
|
Kentucky blue grass IgG Ab [Units/volume] in Serum |
|
56296-7
|
Kentucky blue grass IgG4 Ab [Mass/volume] in Serum |
|
49719-8
|
Kentucky blue grass IgG Ab [Mass/volume] in Serum |
|
48259-6
|
Kentucky blue grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
2511-4
|
Keratan sulfate [Mass/volume] in Blood |
|
90236-1
|
Keratan sulfate [Moles/volume] in DBS |
|
93724-3
|
Keratan sulfate [Mass/volume] in Serum or Plasma |
|
24463-2
|
Keratan sulfate [Presence] in Urine |
|
2512-2
|
Keratan sulfate [Mass/volume] in Urine |
|
92806-9
|
Keratan sulfate/Creatinine [Ratio] in Urine |
|
63268-7
|
Keratin Ab [Presence] in Serum by Immunofluorescence |
|
34409-3
|
Keratin Ab [Titer] in Serum by Immunofluorescence |
|
10498-4
|
Keratin Ag [Presence] in Tissue by Immune stain |
|
19500-8
|
Ketamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19501-6
|
Ketamine cutoff [Mass/volume] in Urine for Screen method |
|
4292-9
|
Ketamine [Mass] of Dose |
|
61081-6
|
Ketamine [Presence] in Gastric fluid |
|
42922-5
|
Ketamine [Presence] in Serum or Plasma |
|
3701-0
|
Ketamine [Mass/volume] in Serum or Plasma |
|
20537-7
|
Ketamine [Mass/volume] in Urine by Confirmatory method |
|
12327-3
|
Ketamine [Presence] in Urine |
|
17033-2
|
Ketamine [Presence] in Urine by Confirmatory method |
|
19499-3
|
Ketamine [Mass/volume] in Urine by Screen method |
|
11052-8
|
Ketamine [Mass/volume] in Urine |
|
61043-6
|
Ketamine [Presence] in Unspecified specimen |
|
72801-4
|
Ketamine/Creatinine [Mass Ratio] in Urine |
|
4293-7
|
Ketobemidone [Mass] of Dose |
|
3702-8
|
Ketobemidone [Presence] in Urine |
|
3703-6
|
Ketobemidone [Mass/volume] in Urine |
|
60091-6
|
Ketoconazole [Mass/volume] in Blood |
|
7025-0
|
Ketoconazole [Susceptibility] by Gradient strip |
|
296-4
|
Ketoconazole [Susceptibility] by Disk diffusion (KB) |
|
295-6
|
Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
294-9
|
Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
10990-0
|
Ketoconazole [Mass/volume] in Serum or Plasma |
|
18937-3
|
Ketoconazole [Susceptibility] |
|
297-2
|
Ketoconazole [Susceptibility] by Serum bactericidal titer |
|
60092-4
|
Ketoconazole [Mass/volume] in Urine |
|
25259-3
|
Ketoconazole [Mass/volume] in Unspecified specimen |
|
18235-2
|
Ketone solvents [Identifier] in Blood |
|
21357-9
|
Ketones [Presence] in Urine --1.5 hours post XXX challenge |
|
25705-5
|
Ketones [Presence] in Urine --1 hour post 50 g glucose PO |
|
27062-9
|
Ketones [Presence] in Urine --1 hour post XXX challenge |
|
27040-5
|
Ketones [Presence] in Urine by Test strip --1 hour post XXX challenge |
|
12449-5
|
Ketones [Mass/volume] in Urine by Test strip --1 hour post XXX challenge |
|
63371-9
|
Ketones [Presence] in Urine by Test strip --1 hour post dose glucose |
|
21355-3
|
Ketones [Presence] in Urine --2.5 hours post XXX challenge |
|
33043-1
|
Ketones [Presence] in 24 hour Urine |
|
27065-2
|
Ketones [Presence] in Urine --2 hours post XXX challenge |
|
27028-0
|
Ketones [Presence] in Urine by Test strip --2 hours post XXX challenge |
|
12450-3
|
Ketones [Mass/volume] in Urine by Test strip --2 hours post XXX challenge |
|
25706-3
|
Ketones [Mass/volume] in Urine by Test strip --2 hours post dose glucose |
|
21356-1
|
Ketones [Presence] in Urine --3.5 hours post XXX challenge |
|
14138-2
|
Ketones [Presence] in Urine --30 minutes post XXX challenge |
|
27066-0
|
Ketones [Presence] in Urine --3 hours post XXX challenge |
|
26884-7
|
Ketones [Presence] in Urine by Test strip --3 hours post XXX challenge |
|
12451-1
|
Ketones [Mass/volume] in Urine by Test strip --3 hours post XXX challenge |
|
63372-7
|
Ketones [Presence] in Urine by Test strip --3 hours post dose glucose |
|
14139-0
|
Ketones [Presence] in Urine --4 hours post XXX challenge |
|
63373-5
|
Ketones [Presence] in Urine by Test strip --4 hours post dose glucose |
|
25707-1
|
Ketones [Mass/volume] in Urine by Test strip --4 hours post dose glucose |
|
14140-8
|
Ketones [Presence] in Urine --5 hours post XXX challenge |
|
14141-6
|
Ketones [Presence] in Urine --6 hours post XXX challenge |
|
68955-4
|
Ketones [Presence] in Blood by Tablet |
|
53061-8
|
Ketones [Moles/volume] in Blood |
|
12448-7
|
Ketones [Mass/volume] in Urine by Test strip --fasting |
|
2513-0
|
Ketones [Presence] in Serum or Plasma |
|
32547-2
|
Ketones [Moles/volume] in Serum or Plasma by Test strip |
|
33058-9
|
Ketones [Mass/volume] in Serum or Plasma |
|
38493-3
|
Ketones [Titer] in Serum or Plasma |
|
33903-6
|
Ketones [Presence] in Urine |
|
2514-8
|
Ketones [Presence] in Urine by Test strip |
|
57734-6
|
Ketones [Presence] in Urine by Automated test strip |
|
50557-8
|
Ketones [Mass/volume] in Urine by Automated test strip |
|
59158-6
|
Ketones [Moles/volume] in Urine by Automated test strip |
|
5797-6
|
Ketones [Mass/volume] in Urine by Test strip |
|
22702-5
|
Ketones [Moles/volume] in Urine by Test strip |
|
49779-2
|
Ketones [Mass/volume] in Urine |
|
40641-3
|
Ketones [Presence] in Vitreous fluid |
|
32323-8
|
Ketones [Moles/volume] in Unspecified specimen |
|
60093-2
|
Ketoprofen [Mass/volume] in Blood |
|
59918-3
|
Ketoprofen [Moles/volume] in Gastric fluid |
|
17034-0
|
Ketoprofen [Mass/volume] in Serum or Plasma |
|
55546-6
|
Ketoprofen [Moles/volume] in Serum or Plasma |
|
60094-0
|
Ketoprofen [Mass/volume] in Urine |
|
59917-5
|
Ketoprofen [Moles/volume] in Urine |
|
60311-8
|
Ketoprofen [Moles/volume] in Unspecified specimen |
|
87783-7
|
Ketoprofen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73321-2
|
Ketorolac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73320-4
|
Ketorolac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17035-7
|
Ketorolac [Mass/volume] in Serum or Plasma |
|
91565-2
|
Key words related to public health emergency |
|
54160-7
|
Ki Ab [Presence] in Serum |
|
33055-5
|
Ki-67 nuclear Ag [Presence] in Tissue by Immune stain |
|
85330-9
|
Cells.Ki-67 nuclear Ag/100 cells in Breast cancer specimen by Immune stain |
|
29593-1
|
Cells.Ki-67 nuclear Ag/100 cells in Tissue by Immune stain |
|
53898-3
|
KIAA0196 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85624-5
|
Kidney failure 2-year risk [Likelihood] by KFRE |
|
85625-2
|
Kidney failure 5-year risk [Likelihood] by KFRE |
|
65757-7
|
Kidney Pathology biopsy report |
|
11826-5
|
Kidney - left Hilum-cortex diameter US |
|
11835-6
|
Kidney - left Longitudinal diameter US |
|
11854-7
|
Kidney - left Thickeness US |
|
11828-1
|
Kidney - right Hilum-cortex diameter US |
|
11837-2
|
Kidney - right Longitudinal diameter US |
|
11856-2
|
Kidney - right Thickeness US |
|
92932-3
|
KIF6 gene.c.2155T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
34783-1
|
Kinesiotherapy Consult note |
|
84179-1
|
Kinesiotherapy Discharge summary |
|
84180-9
|
Kinesiotherapy Education note |
|
84182-5
|
Kinesiotherapy Initial evaluation note |
|
84183-3
|
Kinesiotherapy Long term care facility Plan of care note |
|
34784-9
|
Kinesiotherapy Note |
|
84184-1
|
Kinesiotherapy Outpatient Note |
|
84185-8
|
Kinesiotherapy Plan of care note |
|
84181-7
|
Kinesiotherapy Patient's home Note |
|
57142-2
|
Kinesiotherapy Referral note |
|
14842-9
|
Microscopic observation [Identifier] in Unspecified specimen by Kinyoun iron hematoxylin stain |
|
64413-8
|
KIR gene allele 2DL1 [Presence] in Blood or Tissue by Molecular genetics method |
|
64414-6
|
KIR gene allele 2DL2 [Presence] in Blood or Tissue by Molecular genetics method |
|
64415-3
|
KIR gene allele 2DL3 [Presence] in Blood or Tissue by Molecular genetics method |
|
64416-1
|
KIR gene allele 2DL4 [Presence] in Blood or Tissue by Molecular genetics method |
|
64419-5
|
KIR gene allele 2DL5 [Presence] in Blood or Tissue by Molecular genetics method |
|
64430-2
|
KIR gene allele 2DP1 [Presence] in Blood or Tissue by Molecular genetics method |
|
64420-3
|
KIR gene allele 2DS1 [Presence] in Blood or Tissue by Molecular genetics method |
|
64421-1
|
KIR gene allele 2DS2 [Presence] in Blood or Tissue by Molecular genetics method |
|
64422-9
|
KIR gene allele 2DS3 [Presence] in Blood or Tissue by Molecular genetics method |
|
64425-2
|
KIR gene allele 2DS5 [Presence] in Blood or Tissue by Molecular genetics method |
|
64426-0
|
KIR gene allele 3DL1 [Presence] in Blood or Tissue by Molecular genetics method |
|
64427-8
|
KIR gene allele 3DL2 [Presence] in Blood or Tissue by Molecular genetics method |
|
64428-6
|
KIR gene allele 3DL3 [Presence] in Blood or Tissue by Molecular genetics method |
|
64429-4
|
KIR gene allele 3DS1 [Presence] in Blood or Tissue by Molecular genetics method |
|
64424-5
|
KIR2DS4 gene deletion variant [Presence] in Blood or Tissue by Molecular genetics method |
|
64423-7
|
KIR2DS4 gene full variant [Presence] in Blood or Tissue by Molecular genetics method |
|
64432-8
|
KIR3DP1 gene deletion variant [Presence] in Blood or Tissue by Molecular genetics method |
|
64431-0
|
KIR3DP1 gene full variant [Presence] in Blood or Tissue by Molecular genetics method |
|
88519-4
|
KIT gene c.2447A>T [Presence] in Blood or Tissue by Molecular genetics method |
|
77171-7
|
KIT gene exon 11 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
87732-4
|
KIT gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87731-6
|
KIT gene exon 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87733-2
|
KIT gene exon 8 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77172-5
|
KIT gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
55201-8
|
KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
65795-7
|
Kiwi native (nAct d) 1 IgE Ab [Units/volume] in Serum |
|
82001-9
|
Kiwi native (nAct d) 1 IgE Ab RAST class [Presence] in Serum |
|
65796-5
|
Kiwi native (nAct d) 2 IgE Ab [Units/volume] in Serum |
|
65764-3
|
Kiwi native (nAct d) 5 IgE Ab [Units/volume] in Serum |
|
64959-0
|
Kiwi recombinant (rAct d) 8 IgE Ab [Units/volume] in Serum |
|
81996-1
|
Kiwi recombinant (rAct d) 8 IgE Ab RAST class [Presence] in Serum |
|
7441-9
|
Kiwifruit triggered histamine release [Units/volume] in Blood |
|
6154-9
|
Kiwifruit IgE Ab [Units/volume] in Serum |
|
15802-2
|
Kiwifruit IgE Ab RAST class [Presence] in Serum |
|
45186-4
|
Kiwifruit IgE Ab/IgE total in Serum |
|
7440-1
|
Kiwifruit IgG Ab [Units/volume] in Serum |
|
33296-5
|
Kiwifruit IgG Ab RAST class [Presence] in Serum |
|
56298-3
|
Kiwifruit IgG4 Ab [Mass/volume] in Serum |
|
63093-9
|
Kiwifruit IgG Ab [Mass/volume] in Serum |
|
76611-3
|
Klebsiella pneumoniae phoE gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76583-4
|
Klebsiella pneumoniae phoE gene [Presence] in XXX.swab by NAA with probe detection |
|
76598-2
|
Klebsiella pneumoniae phoE gene [#/mass] in XXX.tissue by NAA with probe detection |
|
93369-7
|
Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay |
|
73745-2
|
Keyhole limpet hemocyanin IgA Ab [Mass/volume] in Serum |
|
73746-0
|
Keyhole limpet hemocyanin IgG Ab [Mass/volume] in Serum |
|
73747-8
|
Keyhole limpet hemocyanin IgM Ab [Mass/volume] in Serum |
|
21700-0
|
Kallmann syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21701-8
|
Kallmann syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
58068-8
|
Kn sup (b) Ab [Presence] in Serum or Plasma |
|
58069-6
|
Kn sup (b) Ag [Presence] on Red Blood Cells |
|
58067-0
|
Kn sup(a) Ab [Presence] in Serum or Plasma |
|
58066-2
|
Kn sup(a) Ag [Presence] on Red Blood Cells |
|
90255-1
|
Satisfaction with knee AndOr hip replacement result |
|
41345-0
|
Knee - left Extension Active Range of Motion Quantitative |
|
41346-8
|
Knee - left Extension Passive Range of Motion Quantitative |
|
41343-5
|
Knee - left Flexion Active Range of Motion Quantitative |
|
41344-3
|
Knee - left Flexion Passive Range of Motion Quantitative |
|
41349-2
|
Knee - right Extension Active Range of Motion Quantitative |
|
41350-0
|
Knee - right Extension Passive Range of Motion Quantitative |
|
41347-6
|
Knee - right Flexion Active Range of Motion Quantitative |
|
41348-4
|
Knee - right Flexion Passive Range of Motion Quantitative |
|
77222-8
|
Knowledge required level [NMMDS] |
|
88096-3
|
Known bacterial drug resistant infection |
|
88636-6
|
Known exposure [Identifier] |
|
89496-4
|
Maternal Known exposure --during pregnancy |
|
7362-7
|
Koehlers grass IgE Ab [Units/volume] in Serum |
|
15745-3
|
Koehlers grass IgE Ab RAST class [Presence] in Serum |
|
73694-2
|
Microscopic observation [Identifier] in Blood by KOH preparation |
|
639-5
|
Microscopic observation [Identifier] in Cerebral spinal fluid by KOH preparation |
|
14355-2
|
Microscopic observation [Identifier] in Cervix by KOH preparation |
|
68383-9
|
Microscopic observation [Identifier] in Body fluid by KOH preparation |
|
10688-0
|
Microscopic observation [Identifier] in Hair by KOH preparation |
|
88685-3
|
Microscopic observation [Identifier] in Lower respiratory specimen by KOH preparation |
|
10689-8
|
Microscopic observation [Identifier] in Nail by KOH preparation |
|
644-5
|
Microscopic observation [Identifier] in Skin by KOH preparation |
|
17281-7
|
Microscopic observation [Identifier] in Sputum by KOH preparation |
|
6667-0
|
Microscopic observation [Identifier] in Tissue by KOH preparation |
|
68958-8
|
Microscopic observation [Identifier] in Urine by KOH preparation |
|
14356-0
|
Microscopic observation [Identifier] in Vaginal fluid by KOH preparation |
|
667-6
|
Microscopic observation [Identifier] in Unspecified specimen by KOH preparation |
|
1097-5
|
Kp sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1098-3
|
Kp sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1099-1
|
Kp sup(a) Ab [Presence] in Serum or Plasma |
|
55326-3
|
Kp sup(a) Ab [Titer] in Serum or Plasma |
|
92533-9
|
Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92495-1
|
Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1100-7
|
Kp sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1101-5
|
Kp sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1102-3
|
Kp sup(a) Ag [Presence] on Red Blood Cells |
|
1103-1
|
Kp sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1104-9
|
Kp sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1105-6
|
Kp sup(b) Ab [Presence] in Serum or Plasma |
|
55327-1
|
Kp sup(b) Ab [Titer] in Serum or Plasma |
|
92532-1
|
Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92494-4
|
Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1106-4
|
Kp sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1107-2
|
Kp sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1108-0
|
Kp sup(b) Ag [Presence] on Red Blood Cells |
|
89245-5
|
Karnofsky Performance Status [Interpretation] |
|
89243-0
|
Karnofsky Performance Status score |
|
62308-2
|
Krabbe disease newborn screen interpretation |
|
62309-0
|
Krabbe disease newborn screening comment-discussion |
|
81420-2
|
KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82535-6
|
KRAS gene full mutation analysis in Blood or Tissue by Sequencing |
|
21702-6
|
KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75974-6
|
KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85509-8
|
KRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
|
53620-1
|
KRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
21703-4
|
KRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
83059-6
|
KRAS gene [VCF] in Cancer specimen by Sequencing |
|
57990-4
|
KRIT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82421-9
|
Ks Ab [Units/volume] in Serum by Line blot |
|
82422-7
|
Ks Ab [Presence] in Serum by Line blot |
|
70965-9
|
Kt/V.Hemodialysis [Daugirdas II] |
|
71342-0
|
Kt/V.Hemodialysis [Derived] |
|
70966-7
|
Kt/V.Hemodialysis [UKM] |
|
70963-4
|
Kt/V.Peritoneal Dialysis [Hume] |
|
71341-2
|
Kt/V.Peritoneal Dialysis [Percent of body weight] |
|
70964-2
|
Kt/V.Peritoneal Dialysis [Watson] |
|
63269-5
|
Ku Ab [Presence] in Body fluid by Immunoassay |
|
18484-6
|
Ku Ab [Presence] in Serum |
|
69556-9
|
Ku Ab [Presence] in Serum by Immunoblot |
|
65325-3
|
Ku Ab [Presence] in Serum or Plasma |
|
59403-6
|
Ku Ab [Titer] in Serum by Immunofluorescence |
|
82919-2
|
Ku IgG Ab [Presence] in Serum by Line blot |
|
29043-7
|
KW impression code Left eye |
|
29040-3
|
KW impression code Right eye |
|
29044-5
|
KW impression comment Left eye Narrative |
|
29041-1
|
KW impression comment Right eye Narrative |
|
53489-1
|
Kynurenate [Moles/time] in 24 hour Urine |
|
53469-3
|
Kynurenate [Moles/volume] in Serum or Plasma |
|
2515-5
|
Kynurenate [Mass/volume] in Urine |
|
53101-2
|
Kynurenate [Moles/volume] in Urine |
|
53107-9
|
Kynurenate/Creatinine [Molar ratio] in Urine |
|
53491-7
|
Kynurenin [Moles/time] in 24 hour Urine |
|
74942-4
|
Kynurenin [Moles/volume] in Cerebral spinal fluid |
|
53470-1
|
Kynurenin [Moles/volume] in Serum or Plasma |
|
53490-9
|
Kynurenin [Moles/volume] in Urine |
|
53507-0
|
Kynurenin/Creatinine [Molar ratio] in Urine |
|
20866-0
|
Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture |
|
81098-6
|
Leptospira borgpetersenii sv Arborea Ab [Titer] in Serum by Agglutination |
|
86730-9
|
Leptospira borgpetersenii sv Hardjo-bovis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23167-0
|
Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum |
|
23168-8
|
Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination |
|
42996-9
|
Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum |
|
40643-9
|
Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum by Agglutination |
|
23193-6
|
Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum |
|
23194-4
|
Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum by Agglutination |
|
31476-5
|
Leptospira borgpetersenii sv Sejroe Ab [Units/volume] in Serum |
|
25866-5
|
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum |
|
40644-7
|
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Agglutination |
|
25940-8
|
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Complement fixation |
|
23208-2
|
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum |
|
23209-0
|
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination |
|
42995-1
|
Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum |
|
40645-4
|
Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum by Agglutination |
|
26633-8
|
Legionella bozemaniae Ab [Presence] in Serum |
|
26637-9
|
Leishmania brasilensis Ab [Presence] in Serum |
|
43000-9
|
Leishmania brasilensis Ab [Titer] in Serum |
|
41419-3
|
Leishmania brasilensis Ab [Titer] in Serum by Immunofluorescence |
|
35404-3
|
Leishmania brasilensis IgG Ab [Presence] in Serum |
|
13258-9
|
Leishmania brasilensis IgG Ab [Units/volume] in Serum |
|
15380-9
|
Leishmania brasilensis IgG Ab [Titer] in Serum |
|
44821-7
|
Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence |
|
35405-0
|
Leishmania brasilensis IgM Ab [Presence] in Serum |
|
13259-7
|
Leishmania brasilensis IgM Ab [Units/volume] in Serum |
|
15381-7
|
Leishmania brasilensis IgM Ab [Titer] in Serum |
|
44820-9
|
Leishmania brasilensis IgM Ab [Titer] in Serum by Immunofluorescence |
|
43266-6
|
Leishmania chagasi K39 Ab [Presence] in Serum |
|
64981-4
|
Lepidoglyphus destructor recombinant (rLep d) 2 IgE Ab [Units/volume] in Serum |
|
6160-6
|
Lepidoglyphus destructor IgE Ab [Units/volume] in Serum |
|
15814-7
|
Lepidoglyphus destructor IgE Ab RAST class [Presence] in Serum |
|
57993-8
|
Lepidoglyphus destructor IgE Ab/IgE total in Serum |
|
56300-7
|
Lepidoglyphus destructor IgG4 Ab [Mass/volume] in Serum |
|
48233-1
|
Lepidoglyphus destructor triggered leukotriene release [Mass/volume] by Leukocytes |
|
26638-7
|
Leishmania donovani Ab [Presence] in Serum |
|
31475-7
|
Leishmania donovani Ab [Units/volume] in Serum |
|
25633-9
|
Leishmania donovani Ab [Titer] in Serum |
|
25708-9
|
Leishmania donovani Ab [Titer] in Serum by Immunofluorescence |
|
23150-6
|
Leishmania donovani Ag [Presence] in Tissue by Immune stain |
|
35402-7
|
Leishmania donovani IgG Ab [Presence] in Serum |
|
13256-3
|
Leishmania donovani IgG Ab [Units/volume] in Serum |
|
15382-5
|
Leishmania donovani IgG Ab [Titer] in Serum |
|
44824-1
|
Leishmania donovani IgG Ab [Titer] in Serum by Immunofluorescence |
|
50999-2
|
Leishmania donovani IgG and IgM [Interpretation] in Serum |
|
35403-5
|
Leishmania donovani IgM Ab [Presence] in Serum |
|
13257-1
|
Leishmania donovani IgM Ab [Units/volume] in Serum |
|
15383-3
|
Leishmania donovani IgM Ab [Titer] in Serum |
|
44819-1
|
Leishmania donovani IgM Ab [Titer] in Serum by Immunofluorescence |
|
26632-0
|
Legionella dumoffii Ab [Presence] in Serum |
|
26634-6
|
Legionella gormanii Ab [Presence] in Serum |
|
80208-2
|
Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
80207-4
|
Leishmania infantum+donovani IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
7960-8
|
Leptospira interrogans Ab [Units/volume] in Serum by Hemagglutination |
|
23187-8
|
Leptospira interrogans Ab [Presence] in Serum |
|
23188-6
|
Leptospira interrogans Ab [Presence] in Serum by Agglutination |
|
23186-0
|
Leptospira interrogans Ab [Presence] in Serum by Immunoassay |
|
11606-1
|
Leptospira interrogans Ab [Units/volume] in Serum |
|
56952-5
|
Leptospira interrogans Ab [Titer] in Serum by Agglutination |
|
6605-0
|
Leptospira interrogans Ag [Presence] in Tissue by Immunofluorescence |
|
31871-7
|
Leptospira interrogans Ag [Presence] in Unspecified specimen |
|
6452-7
|
Leptospira interrogans Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23164-7
|
Leptospira interrogans sv Australis Ab [Presence] in Serum |
|
23163-9
|
Leptospira interrogans sv Australis Ab [Presence] in Serum by Agglutination |
|
59370-7
|
Leptospira interrogans sv Australis Ab [Titer] in Serum by Agglutination |
|
23166-2
|
Leptospira interrogans sv Autumnalis Ab [Presence] in Serum |
|
23165-4
|
Leptospira interrogans sv Autumnalis Ab [Presence] in Serum by Agglutination |
|
59371-5
|
Leptospira interrogans sv Autumnalis Ab [Titer] in Serum by Agglutination |
|
59372-3
|
Leptospira interrogans sv Ballum Ab [Titer] in Serum by Agglutination |
|
23170-4
|
Leptospira interrogans sv Bataviae Ab [Presence] in Serum |
|
23169-6
|
Leptospira interrogans sv Bataviae Ab [Presence] in Serum by Agglutination |
|
59368-1
|
Leptospira interrogans sv Bataviae Ab [Titer] in Serum by Agglutination |
|
23172-0
|
Leptospira interrogans sv Bratislava Ab [Presence] in Serum |
|
23171-2
|
Leptospira interrogans sv Bratislava Ab [Presence] in Serum by Agglutination |
|
31477-3
|
Leptospira interrogans sv Bratislava Ab [Units/volume] in Serum |
|
22400-6
|
Leptospira interrogans sv Bratislava Ab [Titer] in Serum |
|
15476-5
|
Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
|
29695-4
|
Leptospira interrogans sv Bulgarica Ab [Presence] in Serum |
|
29725-9
|
Leptospira interrogans sv Bulgarica Ab [Presence] in Serum by Agglutination |
|
81099-4
|
Leptospira interrogans sv Bulgarica Ab [Titer] in Serum by Agglutination |
|
23173-8
|
Leptospira interrogans sv Canicola Ab [Presence] in Serum |
|
23174-6
|
Leptospira interrogans sv Canicola Ab [Presence] in Serum by Agglutination |
|
31478-1
|
Leptospira interrogans sv Canicola Ab [Units/volume] in Serum |
|
22401-4
|
Leptospira interrogans sv Canicola Ab [Titer] in Serum |
|
15477-3
|
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
|
25709-7
|
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Complement fixation |
|
29694-7
|
Leptospira interrogans sv Celledoni Ab [Presence] in Serum |
|
29724-2
|
Leptospira interrogans sv Celledoni Ab [Presence] in Serum by Agglutination |
|
81100-0
|
Leptospira interrogans sv Celledoni Ab [Titer] in Serum by Agglutination |
|
23175-3
|
Leptospira interrogans sv Copenhageni Ab [Presence] in Serum |
|
23176-1
|
Leptospira interrogans sv Copenhageni Ab [Presence] in Serum by Agglutination |
|
81101-8
|
Leptospira interrogans sv Copenhageni Ab [Titer] in Serum by Agglutination |
|
29696-2
|
Leptospira interrogans sv Cynopteri Ab [Presence] in Serum |
|
29726-7
|
Leptospira interrogans sv Cynopteri Ab [Presence] in Serum by Agglutination |
|
81102-6
|
Leptospira interrogans sv Cynopteri Ab [Titer] in Serum by Agglutination |
|
29697-0
|
Leptospira interrogans sv Djasiman Ab [Presence] in Serum |
|
29727-5
|
Leptospira interrogans sv Djasiman Ab [Presence] in Serum by Agglutination |
|
23177-9
|
Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum |
|
23178-7
|
Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum by Agglutination |
|
31479-9
|
Leptospira interrogans sv Grippotyphosa Ab [Units/volume] in Serum |
|
22402-2
|
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum |
|
15478-1
|
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
|
25710-5
|
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Complement fixation |
|
23181-1
|
Leptospira interrogans sv Hardjo Ab [Presence] in Serum |
|
23180-3
|
Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Agglutination |
|
23179-5
|
Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Immunoassay |
|
31480-7
|
Leptospira interrogans sv Hardjo Ab [Units/volume] in Serum |
|
22403-0
|
Leptospira interrogans sv Hardjo Ab [Titer] in Serum |
|
15479-9
|
Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
|
23183-7
|
Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum |
|
23182-9
|
Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum by Agglutination |
|
59369-9
|
Leptospira interrogans sv Hebdomadis Ab [Titer] in Serum by Agglutination |
|
23185-2
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum |
|
23184-5
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum by Agglutination |
|
31481-5
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Units/volume] in Serum |
|
22404-8
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum |
|
15480-7
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
|
25711-3
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Complement fixation |
|
46196-2
|
Leptospira interrogans IgG Ab [Titer] in Serum |
|
45330-8
|
Leptospira interrogans IgG Ab [Titer] in Serum by Immunofluorescence |
|
56953-3
|
Leptospira interrogans IgM Ab [Presence] in Serum by Immunoassay |
|
29698-8
|
Leptospira interrogans sv Javanica Ab [Presence] in Serum |
|
29728-3
|
Leptospira interrogans sv Javanica Ab [Presence] in Serum by Agglutination |
|
59422-6
|
Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination |
|
29739-0
|
Leptospira interrogans sv Kremastos Ab [Presence] in Serum |
|
29733-3
|
Leptospira interrogans sv Kremastos Ab [Presence] in Serum by Agglutination |
|
81103-4
|
Leptospira interrogans sv Kremastos Ab [Titer] in Serum by Agglutination |
|
59363-2
|
Leptospira interrogans sv Manhao Ab [Titer] in Serum by Agglutination |
|
29741-6
|
Leptospira interrogans sv Medanensis Ab [Presence] in Serum |
|
29735-8
|
Leptospira interrogans sv Medanensis Ab [Presence] in Serum by Agglutination |
|
81104-2
|
Leptospira interrogans sv Medanensis Ab [Titer] in Serum by Agglutination |
|
59365-7
|
Leptospira interrogans sv Mini Ab [Titer] in Serum by Agglutination |
|
23189-4
|
Leptospira interrogans sv Mitis Ab [Presence] in Serum |
|
23190-2
|
Leptospira interrogans sv Mitis Ab [Presence] in Serum by Agglutination |
|
29699-6
|
Leptospira interrogans sv Panama Ab [Presence] in Serum |
|
29729-1
|
Leptospira interrogans sv Panama Ab [Presence] in Serum by Agglutination |
|
81105-9
|
Leptospira interrogans sv Panama Ab [Titer] in Serum by Agglutination |
|
23191-0
|
Leptospira interrogans sv Pomona Ab [Presence] in Serum |
|
23192-8
|
Leptospira interrogans sv Pomona Ab [Presence] in Serum by Agglutination |
|
31482-3
|
Leptospira interrogans sv Pomona Ab [Units/volume] in Serum |
|
22405-5
|
Leptospira interrogans sv Pomona Ab [Titer] in Serum |
|
15481-5
|
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
|
25712-1
|
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation |
|
59364-0
|
Leptospira interrogans sv Pyrogenes Ab [Titer] in Serum by Agglutination |
|
29738-2
|
Leptospira interrogans sv Robinsoni Ab [Presence] in Serum |
|
29732-5
|
Leptospira interrogans sv Robinsoni Ab [Presence] in Serum by Agglutination |
|
81106-7
|
Leptospira interrogans sv Robinsoni Ab [Titer] in Serum by Agglutination |
|
59366-5
|
Leptospira interrogans sv Sejroe Ab [Titer] in Serum by Agglutination |
|
29700-2
|
Leptospira interrogans sv Shermani Ab [Presence] in Serum |
|
29730-9
|
Leptospira interrogans sv Shermani Ab [Presence] in Serum by Agglutination |
|
81107-5
|
Leptospira interrogans sv Shermani Ab [Titer] in Serum by Agglutination |
|
29740-8
|
Leptospira interrogans sv Szwajizak Ab [Presence] in Serum |
|
29734-1
|
Leptospira interrogans sv Szwajizak Ab [Presence] in Serum by Agglutination |
|
81108-3
|
Leptospira interrogans sv Szwajizak Ab [Titer] in Serum by Agglutination |
|
59367-3
|
Leptospira interrogans sv Tarassovi Ab [Titer] in Serum by Agglutination |
|
29701-0
|
Leptospira interrogans sv Zanoni Ab [Presence] in Serum |
|
29731-7
|
Leptospira interrogans sv Zanoni Ab [Presence] in Serum by Agglutination |
|
81109-1
|
Leptospira interrogans sv Zanoni Ab [Titer] in Serum by Agglutination |
|
86929-7
|
Lawsonia intracellularis Ab/Negative control in Serum by Immunoassay |
|
86925-5
|
Lawsonia intracellularis Ab [Presence] in Serum by Immunoassay |
|
86705-1
|
Lawsonia intracellularis Ab [Titer] in Serum by Immunoassay |
|
86203-7
|
Lawsonia intracellularis Ag [Presence] in Tissue by Immune stain |
|
86709-3
|
Lawsonia intracellularis RNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
86704-4
|
Lawsonia intracellularis RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87369-5
|
Lawsonia intracellularis VNTR pattern [Type] in Unspecified specimen by Molecular genetics method |
|
53584-9
|
Loa loa DNA [Presence] in Blood by NAA with probe detection |
|
81690-0
|
Legionella longbeachae 1 and 2 DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
26674-2
|
Legionella longbeachae 1 Ab [Presence] in Serum |
|
17053-0
|
Legionella longbeachae 1 IgG Ab [Presence] in Serum |
|
17054-8
|
Legionella longbeachae 1 IgM Ab [Presence] in Serum |
|
13255-5
|
Legionella longbeachae 1+2 Ab [Presence] in Serum |
|
32694-2
|
Legionella longbeachae 1+2 Ab [Titer] in Serum |
|
26675-9
|
Legionella longbeachae 2 Ab [Presence] in Serum |
|
17055-5
|
Legionella longbeachae 2 IgG Ab [Presence] in Serum |
|
17056-3
|
Legionella longbeachae 2 IgM Ab [Presence] in Serum |
|
48718-1
|
Leishmania mexicana IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
35406-8
|
Leishmania mexicana IgG Ab [Presence] in Serum |
|
13260-5
|
Leishmania mexicana IgG Ab [Units/volume] in Serum |
|
15384-1
|
Leishmania mexicana IgG Ab [Titer] in Serum |
|
48314-9
|
Leishmania mexicana IgG Ab [Titer] in Serum by Immunofluorescence |
|
48717-3
|
Leishmania mexicana IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
35407-6
|
Leishmania mexicana IgM Ab [Presence] in Serum |
|
13261-3
|
Leishmania mexicana IgM Ab [Units/volume] in Serum |
|
15385-8
|
Leishmania mexicana IgM Ab [Titer] in Serum |
|
48315-6
|
Leishmania mexicana IgM Ab [Titer] in Serum by Immunofluorescence |
|
26635-3
|
Legionella micdadei Ab [Presence] in Serum |
|
67563-7
|
Legionella micdadei DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5240-7
|
Listeria monocytogenes Ab [Units/volume] in Serum |
|
22406-3
|
Listeria monocytogenes Ab [Titer] in Serum |
|
6456-8
|
Listeria monocytogenes Ab [Titer] in Serum by Complement fixation |
|
85763-1
|
Listeria monocytogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92780-6
|
Listeria monocytogenes DNA [Presence] by NAA with probe detection in Positive blood culture |
|
89596-1
|
Listeria monocytogenes DNA [Presence] in Blood by NAA with probe detection |
|
82184-3
|
Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
61369-5
|
Listeria monocytogenes DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
51820-9
|
Listeria monocytogenes IgG Ab [Units/volume] in Serum by Immunoassay |
|
26698-1
|
Listeria monocytogenes IgG Ab [Units/volume] in Serum |
|
68944-8
|
Listeria monocytogenes IgG Ab [Titer] in Serum by Agglutination |
|
5021-1
|
Listeria monocytogenes rRNA [Presence] in Unspecified specimen by Probe |
|
41167-8
|
Listeria monocytogenes H Ab [Titer] in Serum |
|
41029-0
|
Listeria monocytogenes H1 Ab [Titer] in Serum |
|
41028-2
|
Listeria monocytogenes O1 Ab [Titer] in Serum |
|
41030-8
|
Listeria monocytogenes O4b Ab [Titer] in Serum |
|
45138-5
|
Listeria monocytogenes O4b IgG Ab [Titer] in Serum |
|
45139-3
|
Listeria monocytogenes O4b IgM Ab [Titer] in Serum |
|
57992-0
|
Legionella pneumophila 1+3+4+5+6+8 Ab [Presence] in Serum |
|
43853-1
|
Legionella pneumophila 1+3+4+5+6+8 IgM Ab [Presence] in Serum |
|
47459-3
|
Legionella pneumophila 10 IgG Ab [Titer] in Serum |
|
47082-3
|
Legionella pneumophila 10 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47460-1
|
Legionella pneumophila 10 IgM Ab [Titer] in Serum |
|
47054-2
|
Legionella pneumophila 10 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47461-9
|
Legionella pneumophila 11 IgG Ab [Titer] in Serum |
|
47055-9
|
Legionella pneumophila 11 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47462-7
|
Legionella pneumophila 11 IgM Ab [Titer] in Serum |
|
47056-7
|
Legionella pneumophila 11 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47463-5
|
Legionella pneumophila 12 IgG Ab [Titer] in Serum |
|
47057-5
|
Legionella pneumophila 12 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47464-3
|
Legionella pneumophila 12 IgM Ab [Titer] in Serum |
|
47058-3
|
Legionella pneumophila 12 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47465-0
|
Legionella pneumophila 13 IgG Ab [Titer] in Serum |
|
47059-1
|
Legionella pneumophila 13 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47466-8
|
Legionella pneumophila 13 IgM Ab [Titer] in Serum |
|
47060-9
|
Legionella pneumophila 13 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47467-6
|
Legionella pneumophila 14 IgG Ab [Titer] in Serum |
|
47061-7
|
Legionella pneumophila 14 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47468-4
|
Legionella pneumophila 14 IgM Ab [Titer] in Serum |
|
47062-5
|
Legionella pneumophila 14 IgM Ab [Titer] in Serum by Immunofluorescence |
|
53742-3
|
Legionella pneumophila 2+3+4+5+6+8 Ab [Presence] in Serum |
|
46195-4
|
Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum |
|
43192-4
|
Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum by Immunofluorescence |
|
54205-0
|
Legionella pneumophila 7+8+9+10+11+12+13+14 Ab [Titer] in Serum |
|
30046-7
|
Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay |
|
7947-5
|
Legionella pneumophila Ab [Presence] in Serum |
|
5236-5
|
Legionella pneumophila Ab [Presence] in Serum by Immunofluorescence |
|
31471-6
|
Legionella pneumophila Ab [Units/volume] in Serum |
|
24277-6
|
Legionella pneumophila Ab [Titer] in Serum --1st specimen |
|
24203-2
|
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24278-4
|
Legionella pneumophila Ab [Titer] in Serum --2nd specimen |
|
24204-0
|
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22396-6
|
Legionella pneumophila Ab [Titer] in Serum |
|
5237-3
|
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence |
|
89594-6
|
Legionella pneumophila Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
31869-1
|
Legionella pneumophila Ag [Presence] in Sputum |
|
6445-1
|
Legionella pneumophila Ag [Presence] in Sputum by Immunofluorescence |
|
6446-9
|
Legionella pneumophila Ag [Presence] in Sputum by Latex agglutination |
|
89595-3
|
Legionella pneumophila Ag [Presence] in Tissue by Immunofluorescence |
|
31870-9
|
Legionella pneumophila Ag [Presence] in Urine |
|
6447-7
|
Legionella pneumophila Ag [Presence] in Urine by Immunoassay |
|
17059-7
|
Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence |
|
17058-9
|
Legionella pneumophila Ag [Presence] in Urine by Latex agglutination |
|
6448-5
|
Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
17057-1
|
Legionella pneumophila Ag [Presence] in Unspecified specimen |
|
588-4
|
Legionella pneumophila Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
6449-3
|
Legionella pneumophila Ag [Presence] in Unspecified specimen by Latex agglutination |
|
13254-8
|
Legionella pneumophila atypical Ab [Presence] in Serum |
|
31473-2
|
Legionella pneumophila atypical Ab [Units/volume] in Serum |
|
32695-9
|
Legionella pneumophila atypical Ab [Titer] in Serum |
|
27966-1
|
Legionella pneumophila atypical Ab [Titer] in Serum by Immunofluorescence |
|
18237-8
|
Legionella pneumophila atypical IgM Ab [Presence] in Serum |
|
92969-5
|
Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88590-5
|
Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
92145-2
|
Legionella pneumophila DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
88577-2
|
Legionella pneumophila DNA [Presence] in Tissue by NAA with probe detection |
|
21363-7
|
Legionella pneumophila DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82920-0
|
Legionella pneumophila IgA Ab [Units/volume] in Serum by Immunoassay |
|
29955-2
|
Legionella pneumophila IgG Ab [Units/volume] in Serum by Immunoassay |
|
49913-7
|
Legionella pneumophila IgG Ab [Presence] in Serum |
|
56514-3
|
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence |
|
30085-5
|
Legionella pneumophila IgG Ab [Units/volume] in Serum |
|
57675-1
|
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen |
|
57008-5
|
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
57676-9
|
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
|
56950-9
|
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22397-4
|
Legionella pneumophila IgG Ab [Titer] in Serum |
|
21362-9
|
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence |
|
51814-2
|
Legionella pneumophila IgM Ab [Units/volume] in Serum by Immunoassay |
|
31472-4
|
Legionella pneumophila IgM Ab [Units/volume] in Serum |
|
22398-2
|
Legionella pneumophila IgM Ab [Titer] in Serum |
|
16133-1
|
Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence |
|
32696-7
|
Legionella pneumophila 1+2+3+4+5+6 Ab [Titer] in Serum |
|
53770-4
|
Legionella pneumophila 1+2+3+4+5+6 IgG Ab [Titer] in Serum |
|
49914-5
|
Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum |
|
53784-5
|
Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Titer] in Serum |
|
40840-1
|
Legionella pneumophila 1 Ab [Presence] in Serum |
|
31454-2
|
Legionella pneumophila 1 Ab [Units/volume] in Serum |
|
17060-5
|
Legionella pneumophila 1 Ab [Titer] in Serum |
|
7948-3
|
Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence |
|
31868-3
|
Legionella pneumophila 1 Ag [Presence] in Urine |
|
41499-5
|
Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay |
|
77684-9
|
Legionella pneumophila 1 Ag [Presence] in Urine by Rapid immunoassay |
|
9543-0
|
Legionella pneumophila 1 Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
58799-8
|
Legionella pneumophila 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
35394-6
|
Legionella pneumophila 1 IgG Ab [Presence] in Serum |
|
31455-9
|
Legionella pneumophila 1 IgG Ab [Units/volume] in Serum |
|
22381-8
|
Legionella pneumophila 1 IgG Ab [Titer] in Serum |
|
9541-4
|
Legionella pneumophila 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
31456-7
|
Legionella pneumophila 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
35395-3
|
Legionella pneumophila 1 IgM Ab [Presence] in Serum |
|
17061-3
|
Legionella pneumophila 1 IgM Ab [Units/volume] in Serum |
|
43002-5
|
Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid |
|
31075-5
|
Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22382-6
|
Legionella pneumophila 1 IgM Ab [Titer] in Serum |
|
9542-2
|
Legionella pneumophila 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31457-5
|
Legionella pneumophila 2 Ab [Units/volume] in Serum |
|
17062-1
|
Legionella pneumophila 2 Ab [Titer] in Serum |
|
7949-1
|
Legionella pneumophila 2 Ab [Titer] in Serum by Immunofluorescence |
|
31458-3
|
Legionella pneumophila 2 IgG Ab [Units/volume] in Serum |
|
22383-4
|
Legionella pneumophila 2 IgG Ab [Titer] in Serum |
|
9544-8
|
Legionella pneumophila 2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
58798-0
|
Legionella pneumophila 2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
17063-9
|
Legionella pneumophila 2 IgM Ab [Units/volume] in Serum |
|
22384-2
|
Legionella pneumophila 2 IgM Ab [Titer] in Serum |
|
9545-5
|
Legionella pneumophila 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31459-1
|
Legionella pneumophila 3 Ab [Units/volume] in Serum |
|
17064-7
|
Legionella pneumophila 3 Ab [Titer] in Serum |
|
7950-9
|
Legionella pneumophila 3 Ab [Titer] in Serum by Immunofluorescence |
|
31460-9
|
Legionella pneumophila 3 IgG Ab [Units/volume] in Serum |
|
22385-9
|
Legionella pneumophila 3 IgG Ab [Titer] in Serum |
|
9546-3
|
Legionella pneumophila 3 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17065-4
|
Legionella pneumophila 3 IgM Ab [Units/volume] in Serum |
|
22386-7
|
Legionella pneumophila 3 IgM Ab [Titer] in Serum |
|
9547-1
|
Legionella pneumophila 3 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31461-7
|
Legionella pneumophila 4 Ab [Units/volume] in Serum |
|
17066-2
|
Legionella pneumophila 4 Ab [Titer] in Serum |
|
7951-7
|
Legionella pneumophila 4 Ab [Titer] in Serum by Immunofluorescence |
|
31462-5
|
Legionella pneumophila 4 IgG Ab [Units/volume] in Serum |
|
22387-5
|
Legionella pneumophila 4 IgG Ab [Titer] in Serum |
|
9548-9
|
Legionella pneumophila 4 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17067-0
|
Legionella pneumophila 4 IgM Ab [Units/volume] in Serum |
|
22388-3
|
Legionella pneumophila 4 IgM Ab [Titer] in Serum |
|
9549-7
|
Legionella pneumophila 4 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31463-3
|
Legionella pneumophila 5 Ab [Units/volume] in Serum |
|
17068-8
|
Legionella pneumophila 5 Ab [Titer] in Serum |
|
7952-5
|
Legionella pneumophila 5 Ab [Titer] in Serum by Immunofluorescence |
|
31464-1
|
Legionella pneumophila 5 IgG Ab [Units/volume] in Serum |
|
22389-1
|
Legionella pneumophila 5 IgG Ab [Titer] in Serum |
|
9550-5
|
Legionella pneumophila 5 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17069-6
|
Legionella pneumophila 5 IgM Ab [Units/volume] in Serum |
|
22390-9
|
Legionella pneumophila 5 IgM Ab [Titer] in Serum |
|
9551-3
|
Legionella pneumophila 5 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31465-8
|
Legionella pneumophila 6 Ab [Units/volume] in Serum |
|
17070-4
|
Legionella pneumophila 6 Ab [Titer] in Serum |
|
7953-3
|
Legionella pneumophila 6 Ab [Titer] in Serum by Immunofluorescence |
|
31466-6
|
Legionella pneumophila 6 IgG Ab [Units/volume] in Serum |
|
22391-7
|
Legionella pneumophila 6 IgG Ab [Titer] in Serum |
|
9552-1
|
Legionella pneumophila 6 IgG Ab [Titer] in Serum by Immunofluorescence |
|
31467-4
|
Legionella pneumophila 6 IgM Ab [Units/volume] in Serum |
|
22392-5
|
Legionella pneumophila 6 IgM Ab [Titer] in Serum |
|
9553-9
|
Legionella pneumophila 6 IgM Ab [Titer] in Serum by Immunofluorescence |
|
17071-2
|
Legionella pneumophila 7 Ab [Presence] in Serum |
|
31468-2
|
Legionella pneumophila 7 Ab [Units/volume] in Serum |
|
22393-3
|
Legionella pneumophila 7 Ab [Titer] in Serum |
|
7954-1
|
Legionella pneumophila 7 Ab [Titer] in Serum by Immunofluorescence |
|
47469-2
|
Legionella pneumophila 7 IgG Ab [Titer] in Serum |
|
47076-5
|
Legionella pneumophila 7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47470-0
|
Legionella pneumophila 7 IgM Ab [Titer] in Serum |
|
47077-3
|
Legionella pneumophila 7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
17072-0
|
Legionella pneumophila 8 Ab [Presence] in Serum |
|
31469-0
|
Legionella pneumophila 8 Ab [Units/volume] in Serum |
|
22394-1
|
Legionella pneumophila 8 Ab [Titer] in Serum |
|
7955-8
|
Legionella pneumophila 8 Ab [Titer] in Serum by Immunofluorescence |
|
47471-8
|
Legionella pneumophila 8 IgG Ab [Titer] in Serum |
|
47078-1
|
Legionella pneumophila 8 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47472-6
|
Legionella pneumophila 8 IgM Ab [Titer] in Serum |
|
47079-9
|
Legionella pneumophila 8 IgM Ab [Titer] in Serum by Immunofluorescence |
|
17073-8
|
Legionella pneumophila 9 Ab [Presence] in Serum |
|
31470-8
|
Legionella pneumophila 9 Ab [Units/volume] in Serum |
|
22395-8
|
Legionella pneumophila 9 Ab [Titer] in Serum |
|
7956-6
|
Legionella pneumophila 9 Ab [Titer] in Serum by Immunofluorescence |
|
47473-4
|
Legionella pneumophila 9 IgG Ab [Titer] in Serum |
|
47080-7
|
Legionella pneumophila 9 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47474-2
|
Legionella pneumophila 9 IgM Ab [Titer] in Serum |
|
47081-5
|
Legionella pneumophila 9 IgM Ab [Titer] in Serum by Immunofluorescence |
|
73671-0
|
Legionella pneumophila serogroup [Type] in Isolate by Agglutination |
|
26639-5
|
Leishmania tropica Ab [Presence] in Serum |
|
42998-5
|
Leishmania tropica Ab [Titer] in Serum |
|
41420-1
|
Leishmania tropica Ab [Titer] in Serum by Immunofluorescence |
|
48715-7
|
Leishmania tropica IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
35408-4
|
Leishmania tropica IgG Ab [Presence] in Serum |
|
13262-1
|
Leishmania tropica IgG Ab [Units/volume] in Serum |
|
15386-6
|
Leishmania tropica IgG Ab [Titer] in Serum |
|
48316-4
|
Leishmania tropica IgG Ab [Titer] in Serum by Immunofluorescence |
|
51000-8
|
Leishmania tropica IgG and IgM [Interpretation] in Serum Narrative |
|
48714-0
|
Leishmania tropica IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
35409-2
|
Leishmania tropica IgM Ab [Presence] in Serum |
|
13263-9
|
Leishmania tropica IgM Ab [Units/volume] in Serum |
|
15387-4
|
Leishmania tropica IgM Ab [Titer] in Serum |
|
48317-2
|
Leishmania tropica IgM Ab [Titer] in Serum by Immunofluorescence |
|
81110-9
|
Leptospira weilii serovar Topaz Ab [Titer] in Serum by Agglutination |
|
57056-4
|
Labor and delivery admission history and physical note |
|
57057-2
|
Labor and delivery summary note |
|
40477-2
|
L1CAM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41095-1
|
L1CAM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79319-0
|
L-2-hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
79317-4
|
L-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
79332-3
|
L-2-hydroxyglutarate [Moles/volume] in DBS |
|
79318-2
|
L-2-hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
80099-5
|
L-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine |
|
75514-0
|
Lupus anticoagulant two screening tests W Reflex [interpretation] |
|
75882-1
|
Lupus anticoagulant three screening tests W Reflex [interpretation] |
|
17985-3
|
Left atrial AP dimension.left atrium/AP dimension.aorta root by US |
|
17977-0
|
Left atrial Area by US.2D.A4C |
|
29468-6
|
Left atrial Diameter anterior-posterior systole by US 2D |
|
18024-0
|
Left atrial Diameter anterior-posterior systole by US.M-mode |
|
79973-4
|
Left atrial Area at end systole by US.2D.A2C+Measured by planimetry |
|
79974-2
|
Left atrial Area at end systole by US.2D.A4C+Measured by planimetry |
|
79979-1
|
Left atrial Length at end systole by US.2D.A2C |
|
79980-9
|
Left atrial Length at end systole by US.2D.A4C |
|
79976-7
|
Left atrial Minor axis at end systole (by US 2D)/Body surface area |
|
79978-3
|
Left atrial Minor axis at end systole (by US.M-mode)/Body surface area |
|
79975-9
|
Left atrial Minor axis at end systole [Length] by US 2D |
|
79977-5
|
Left atrial Minor axis at end systole [Length] by US.M-mode |
|
79982-5
|
Left atrial End-systolic volume (by US.2D+Calculated by biplane area-length method)/Body surface area |
|
79984-1
|
Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area |
|
79985-8
|
Left atrial End-systolic volume by US.2D.A2C+Calculated by single plane method of disks |
|
93640-1
|
Left atrial End-systolic volume by US.2D.A2C+Calc by single plane area-length method |
|
79986-6
|
Left atrial End-systolic volume by US.2D.A4C+Calculated by single plane method of disks |
|
93641-9
|
Left atrial End-systolic volume by US.2D.A4C+Calc by single plane area-length method |
|
79981-7
|
Left atrial End-systolic volume by US.2D+Calculated by biplane area-length method |
|
79983-3
|
Left atrial End-systolic volume by US.2D+Calculated by biplane method of disks |
|
77905-8
|
Left atrial End-systolic volume by US.2D+Calculated by area-length method |
|
77904-1
|
Left atrial End-systolic volume by US.2D+Calculated by modified Simpson method |
|
93638-5
|
Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A2C+Calculated by single plane method of disks |
|
93636-9
|
Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A2C+Calc by single plane area-length method |
|
93639-3
|
Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A4C+Calculated by single plane method of disks |
|
93637-7
|
Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A4C+Calc by single plane area-length method |
|
77907-4
|
Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D+Calculated by area-length method |
|
77906-6
|
Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D+Calculated by modified Simpson method |
|
29469-4
|
Left atrial Major axis diameter anterior-posterior systole by US 2D |
|
17259-3
|
Methadone.long acting metabolite [Mass/volume] in Serum or Plasma |
|
33527-3
|
Methadone.long acting metabolite [Mass/volume] in Urine |
|
43308-6
|
Lupus anticoagulant neutralization buffer [Time] in Platelet poor plasma by Coagulation assay |
|
50376-3
|
Lupus anticoagulant neutralization dilute phospholipid actual/normal in Platelet poor plasma by Coagulation assay |
|
53748-0
|
Lupus anticoagulant neutralization dilute phospholipid [Time] in Platelet poor plasma |
|
15191-0
|
Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
|
57181-0
|
Lupus anticoagulant neutralization dilute phospholipid/Lupus anticoagulant neutralization.high phospholipid [Ratio] in Platelet poor plasma by Coagulation assay |
|
34570-2
|
Lupus anticoagulant neutralization high phospholipid.factor substitution [Time] in Platelet poor plasma by Coagulation assay --immediately after 1:2 addition of normal plasma |
|
55786-8
|
Lupus anticoagulant neutralization high phospholipid.factor substitution [Time] in Platelet poor plasma by Coagulation assay --immediately after 1:2 addition of platelet lysate |
|
55785-0
|
Lupus anticoagulant neutralization high phospholipid.factor substitution [Time] in Platelet poor plasma by Coagulation assay --immediately after 1:2 addition of saline |
|
3283-9
|
Lupus anticoagulant neutralization high phospholipid [Time] in Platelet poor plasma by Coagulation assay |
|
3284-7
|
Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay |
|
40647-0
|
Lupus anticoagulant neutralization platelet [Presence] in Platelet poor plasma by Coagulation assay |
|
3281-3
|
Lupus anticoagulant [Interpretation] in Platelet poor plasma |
|
60988-3
|
Left atrial pressure |
|
75933-2
|
Left atrial pressure Diastolic |
|
60989-1
|
Left atrial pressure Systolic |
|
29467-8
|
Left atrial Superior-Inferior [Length] by US.2D.A4C |
|
3019-7
|
Thyrotropin.long acting [Presence] in Serum or Plasma |
|
30151-5
|
Thyrotropin.long acting [Units/volume] in Serum or Plasma |
|
29486-8
|
Left atrial appendage Maximum emptying [Velocity] by US.doppler |
|
81213-1
|
Laboratory communication about newborn screening Narrative |
|
89581-3
|
Laboratory device 99th percentile URL |
|
89580-5
|
Laboratory device Coefficient of variation at 99th percentile URL |
|
87706-8
|
Laboratory device Detection limit |
|
43157-7
|
Laboratory device Vendor serial number |
|
72486-4
|
Laboratory director name in Provider |
|
92236-9
|
Lab observation result status |
|
92237-7
|
Lab observation sub-type |
|
82785-7
|
Lab order date |
|
82768-3
|
Lab order priority [Type] |
|
92235-1
|
Lab order result status |
|
82772-5
|
Lab result date reported |
|
82773-3
|
Lab result time reported |
|
82771-7
|
Lab test location performed [Type] |
|
85069-3
|
Lab test method [Type] |
|
90946-5
|
Date of laboratory phone call to provider to communicate test result |
|
3707-7
|
Labetalol [Mass/time] in 24 hour Urine |
|
4295-2
|
Labetalol [Mass] of Dose |
|
17040-7
|
Labetalol [Presence] in Serum or Plasma |
|
3704-4
|
Labetalol [Mass/volume] in Serum or Plasma |
|
55547-4
|
Labetalol [Moles/volume] in Serum or Plasma |
|
3705-1
|
Labetalol [Presence] in Urine |
|
3706-9
|
Labetalol [Mass/volume] in Urine |
|
90863-2
|
Labio-lingual spread [Length] Mouth Measured |
|
15508-5
|
Labor and delivery records |
|
32396-4
|
Labor duration |
|
77202-0
|
Laboratory comment [Text] in Report Narrative |
|
11502-2
|
Laboratory report |
|
57015-0
|
Lactulose.PO [Mass] of Dose |
|
59296-4
|
Lacosamide [Mass/volume] in Blood |
|
59297-2
|
Lacosamide [Mass/volume] in Serum or Plasma |
|
59298-0
|
Lacosamide [Mass/volume] in Urine |
|
7446-8
|
Lactalbumin triggered histamine release [Units/volume] in Blood |
|
57991-2
|
Lactalbumin IgE Ab/IgE total in Serum |
|
7444-3
|
Lactalbumin IgG Ab [Units/volume] in Serum |
|
81315-4
|
Lactase [Enzymatic activity/mass] in Small intestine Tissue |
|
57365-9
|
Lactate [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
57357-6
|
Lactate [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
59011-7
|
Lactate [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
59012-5
|
Lactate [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
27946-3
|
Lactate [Mass/volume] in Blood --1 hour post XXX challenge |
|
57364-2
|
Lactate [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57356-8
|
Lactate [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
|
59005-9
|
Lactate [Moles/volume] in Serum or Plasma --1 minute post XXX challenge |
|
57360-0
|
Lactate [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
2526-2
|
Lactate [Mass/time] in 24 hour Urine |
|
34323-6
|
Lactate [Moles/volume] in 24 hour Urine |
|
15078-9
|
Lactate [Moles/time] in 24 hour Urine |
|
27955-4
|
Lactate [Mass/volume] in Blood --2 hours post XXX challenge |
|
57358-4
|
Lactate [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
57362-6
|
Lactate [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
59013-3
|
Lactate [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
27961-2
|
Lactate [Mass/volume] in Blood --3 hours post XXX challenge |
|
57359-2
|
Lactate [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
57361-8
|
Lactate [Mass/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
59006-7
|
Lactate [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge |
|
57728-8
|
Lactate [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
27949-7
|
Lactate [Mass/volume] in Blood --4 hours post XXX challenge |
|
57363-4
|
Lactate [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
59007-5
|
Lactate [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
57729-6
|
Lactate [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge |
|
30242-2
|
Lactate [Mass/volume] in Arterial blood |
|
2518-9
|
Lactate [Moles/volume] in Arterial blood |
|
75366-5
|
Lactate [Moles/volume] in Capillary blood from Fetus by Test strip |
|
51829-0
|
Lactate [Mass/volume] in Capillary blood |
|
55932-8
|
Lactate [Moles/volume] in Cord blood |
|
19239-3
|
Lactate [Moles/volume] in Capillary blood |
|
59032-3
|
Lactate [Mass/volume] in Blood |
|
19240-1
|
Lactate [Moles/volume] in Mixed venous blood |
|
32693-4
|
Lactate [Moles/volume] in Blood |
|
30241-4
|
Lactate [Mass/volume] in Venous blood |
|
2519-7
|
Lactate [Moles/volume] in Venous blood |
|
59004-2
|
Lactate [Moles/volume] in Serum or Plasma --baseline |
|
27941-4
|
Lactate [Mass/volume] in Cerebral spinal fluid |
|
2520-5
|
Lactate [Moles/volume] in Cerebral spinal fluid |
|
55931-0
|
Lactate [Moles/volume] in Dialysis fluid |
|
29246-6
|
Lactate [Mass/volume] in Body fluid |
|
14165-5
|
Lactate [Moles/volume] in Body fluid |
|
2521-3
|
Lactate [Presence] in Gastric fluid |
|
68911-7
|
Lactate [Mass/volume] in Serum or Plasma --post exercise |
|
59849-0
|
Lactate [Moles/volume] in Serum or Plasma --post exercise |
|
27976-0
|
Lactate [Mass/volume] in Blood --fasting |
|
32132-3
|
Lactate [Moles/volume] in Arterial plasma |
|
32133-1
|
Lactate [Moles/volume] in Plasma venous |
|
2522-1
|
Lactate [Moles/volume] in Pleural fluid |
|
57366-7
|
Lactate [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
51428-1
|
Lactate [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
2523-9
|
Lactate [Moles/volume] in Peritoneal fluid |
|
14118-4
|
Lactate [Mass/volume] in Serum or Plasma |
|
35245-0
|
Lactate [Mass or Moles/volume] in Serum or Plasma |
|
2524-7
|
Lactate [Moles/volume] in Serum or Plasma |
|
2525-4
|
Lactate [Moles/volume] in Synovial fluid |
|
74896-2
|
Lactate [Moles/mass] in Stool |
|
29875-2
|
Lactate [Presence] in Urine |
|
34324-4
|
Lactate [Moles/volume] in Urine |
|
44333-3
|
Lactate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13767-9
|
Lactate/Creatinine [Mass Ratio] in Urine |
|
25112-4
|
Lactate/Creatinine [Molar ratio] in Urine |
|
59048-9
|
Lactate/Pyruvate [Mass Ratio] in Blood |
|
2550-2
|
Lactate/Pyruvate [Molar ratio] in Blood |
|
54309-0
|
Lactate/Pyruvate [Molar ratio] in Cerebral spinal fluid |
|
90073-8
|
Lactobacillales identified in Isolate by Organism specific culture |
|
92781-4
|
Lactobacillus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
74669-3
|
Lactobacillus sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
27900-0
|
Lactobacillus sp IgG Ab [Units/volume] in Serum |
|
27901-8
|
Lactobacillus sp IgM Ab [Units/volume] in Serum |
|
43400-1
|
Lactobacillus sp morphotypes [Presence] in Vaginal fluid by Light microscopy |
|
59003-4
|
Lactoferrin Ab [Units/volume] in Serum by Immunoassay |
|
54018-7
|
Lactoferrin Ab [Presence] in Serum |
|
26029-9
|
Lactoferrin bovine IgE Ab [Units/volume] in Serum |
|
26030-7
|
Lactoferrin bovine IgE Ab RAST class [Presence] in Serum |
|
2551-0
|
Lactoferrin [Mass/volume] in Serum |
|
63376-8
|
Lactoferrin [Presence] in Stool |
|
40703-1
|
Lactoferrin [Presence] in Stool by Immunoassay |
|
6443-6
|
Lactoferrin [Presence] in Stool by Latex agglutination |
|
42924-1
|
Lactoferrin [Mass/volume] in Stool |
|
6444-4
|
Lactoferrin [Presence] in Unspecified specimen by Latex agglutination |
|
25455-7
|
Lactoglobulin IgA Ab [Units/volume] in Serum |
|
25456-5
|
Lactoglobulin IgA Ab RAST class [Presence] in Serum |
|
17042-3
|
Lactoglobulin IgE Ab [Units/volume] in Serum |
|
25457-3
|
Lactoglobulin IgE Ab RAST class [Presence] in Serum |
|
7447-6
|
Lactoglobulin IgG Ab [Units/volume] in Serum |
|
26427-5
|
Lactoglobulin IgG4 Ab [Units/volume] in Serum |
|
26434-1
|
Lactoglobulin IgG4 Ab RAST class [Presence] in Serum |
|
51700-3
|
Microscopic observation [Identifier] in Unspecified specimen by Lactophenol blue |
|
40283-4
|
Lactose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO |
|
78515-4
|
Lactose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO |
|
1582-6
|
Lactose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
|
40282-6
|
Lactose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO |
|
2554-4
|
Lactose [Mass/time] in 24 hour Urine |
|
1583-4
|
Lactose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
|
40284-2
|
Lactose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO |
|
1584-2
|
Lactose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
|
40281-8
|
Lactose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO |
|
19249-2
|
Lactose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO |
|
41606-5
|
Lactose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO |
|
78516-2
|
Lactose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO |
|
74803-8
|
Lactose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
|
56879-0
|
Lactose IgE Ab [Units/volume] in Serum |
|
81051-5
|
Lactose intake 24 hour Estimated |
|
81052-3
|
Lactose intake 24 hour Measured |
|
74349-2
|
Lactose [Moles/volume] in Serum or Plasma --fasting |
|
14806-4
|
Lactose.PO [Mass] of Dose |
|
1585-9
|
Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
41605-7
|
Lactose [Mass/volume] in Serum or Plasma --pre fast |
|
2552-8
|
Lactose [Mass/volume] in Serum or Plasma |
|
51598-1
|
Lactose [Presence] in Stool |
|
69553-6
|
Lactose tolerance [Interpretation] in Serum or Plasma Narrative |
|
2553-6
|
Lactose [Presence] in Urine |
|
17043-1
|
Lactose [Mass/volume] in Urine |
|
74438-3
|
Lactose/Creatinine [Molar ratio] in Urine |
|
74791-5
|
Lactulose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
|
76136-1
|
Lactulose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
|
74900-2
|
Lactulose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
74899-6
|
Lactulose/Mannitol [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
79521-1
|
Lactyl lactate [Moles/volume] in Serum or Plasma |
|
79487-5
|
Lactyl lactate/Creatinine [Molar ratio] in Urine |
|
31448-4
|
La Crosse virus Ab [Units/volume] in Cerebral spinal fluid |
|
44748-2
|
La Crosse virus Ab [Units/volume] in Serum by Immunoassay |
|
44746-6
|
La Crosse virus Ab [Units/volume] in Serum by Immunofluorescence |
|
44747-4
|
La Crosse virus Ab [Presence] in Serum |
|
40736-1
|
La Crosse virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
44745-8
|
La Crosse virus Ab [Presence] in Serum by Immunoassay |
|
44744-1
|
La Crosse virus Ab [Presence] in Serum by Immunofluorescence |
|
5073-2
|
La Crosse virus Ab [Units/volume] in Serum |
|
24016-8
|
La Crosse virus Ab [Interpretation] in Serum |
|
24283-4
|
La Crosse virus Ab [Titer] in Serum --1st specimen |
|
24209-9
|
La Crosse virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24284-2
|
La Crosse virus Ab [Titer] in Serum --2nd specimen |
|
24210-7
|
La Crosse virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
17037-3
|
La Crosse virus Ab [Titer] in Cerebral spinal fluid |
|
9538-0
|
La Crosse virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
35709-5
|
La Crosse virus Ab [Titer] in Body fluid |
|
17036-5
|
La Crosse virus Ab [Titer] in Serum |
|
35697-2
|
La Crosse virus Ab [Titer] in Serum by Complement fixation |
|
29563-4
|
La Crosse virus Ab [Titer] in Serum by Neutralization test |
|
31449-2
|
La Crosse virus Ab [Presence] in Unspecified specimen |
|
30176-2
|
La Crosse virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
29840-6
|
La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid |
|
29802-6
|
La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31450-0
|
La Crosse virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
62433-8
|
La Crosse virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
48716-5
|
La Crosse virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
29852-1
|
La Crosse virus IgG Ab [Presence] in Serum |
|
52823-2
|
La Crosse virus IgG Ab [Presence] in Serum by Immunoassay |
|
29815-8
|
La Crosse virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
7940-0
|
La Crosse virus IgG Ab [Units/volume] in Serum |
|
22373-5
|
La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid |
|
9539-8
|
La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
17038-1
|
La Crosse virus IgG Ab [Titer] in Serum |
|
10904-1
|
La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
29828-1
|
La Crosse virus IgG Ab [Presence] in Unspecified specimen |
|
29789-5
|
La Crosse virus IgG Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
49067-2
|
La Crosse virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
|
49142-3
|
La Crosse virus IgG and IgM [Interpretation] in Serum |
|
29841-4
|
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid |
|
52825-7
|
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
29803-4
|
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31451-8
|
La Crosse virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
62432-0
|
La Crosse virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
29853-9
|
La Crosse virus IgM Ab [Presence] in Serum |
|
52824-0
|
La Crosse virus IgM Ab [Presence] in Serum by Immunoassay |
|
29816-6
|
La Crosse virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
7941-8
|
La Crosse virus IgM Ab [Units/volume] in Serum |
|
22375-0
|
La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid |
|
9540-6
|
La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
17039-9
|
La Crosse virus IgM Ab [Titer] in Serum |
|
44822-5
|
La Crosse virus IgM Ab [Titer] in Serum by Immunoassay |
|
10905-8
|
La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
29829-9
|
La Crosse virus IgM Ab [Presence] in Unspecified specimen |
|
29790-3
|
La Crosse virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
34454-9
|
La Crosse virus RNA [Presence] in Blood by NAA with probe detection |
|
34455-6
|
La Crosse virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
69767-2
|
La Crosse virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76614-7
|
Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate |
|
76615-4
|
Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-palmitate substrate |
|
76622-0
|
Lysosomal acid lipase [Interpretation] in Fibroblast Narrative |
|
33643-8
|
Limulus amebocyte lysate test [Units/volume] in Nonbiological fluid |
|
82883-0
|
Lysosomal acid lipase [Enzymatic activity/mass] in Leukocytes by 4-MU-palmitate substrate |
|
38535-1
|
LAMA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41094-4
|
LAMA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82517-4
|
LAMA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7449-2
|
Lamb triggered histamine release [Units/volume] in Blood |
|
6155-6
|
Lamb IgE Ab [Units/volume] in Serum |
|
15803-0
|
Lamb IgE Ab RAST class [Presence] in Serum |
|
39552-5
|
Lamb IgE Ab/IgE total in Serum |
|
7448-4
|
Lamb IgG Ab [Units/volume] in Serum |
|
21360-3
|
Lamb IgG Ab RAST class [Presence] in Serum |
|
56457-5
|
Lamb IgG4 Ab [Mass/volume] in Serum |
|
60380-3
|
Lamb IgG Ab [Mass/volume] in Serum |
|
81831-0
|
LAMB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
10500-7
|
Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
|
44395-2
|
Lambda light chains [Presence] in 24 hour Urine |
|
88303-3
|
Lambda light chains [Presence] in 24 hour Urine by Immunofixation |
|
15187-8
|
Lambda light chains [Mass/volume] in 24 hour Urine |
|
25684-2
|
Lambda light chains [Mass/time] in 24 hour Urine |
|
10499-2
|
Lambda light chains Ag [Presence] in Tissue by Immune stain |
|
48772-8
|
Lambda light chains [Mass/volume] in Cerebral spinal fluid |
|
88302-5
|
Lambda light chains.free [Presence] in 24 hour Urine by Immunofixation |
|
53574-0
|
Lambda light chains.free [Mass/volume] in 24 hour Urine |
|
38169-9
|
Lambda light chains.free [Mass/time] in 24 hour Urine |
|
48775-1
|
Lambda light chains.free [Mass/volume] in Cerebral spinal fluid |
|
80516-8
|
Lambda light chains.free [Mass/volume] in Serum by Nephelometry |
|
50978-6
|
Lambda light chains.free [Presence] in Serum by Immunofixation |
|
33944-0
|
Lambda light chains.free [Mass/volume] in Serum or Plasma |
|
40640-5
|
Lambda light chains.free [Presence] in Urine |
|
56481-5
|
Lambda light chains.free [Presence] in Urine by Immunofixation |
|
12778-7
|
Lambda light chains.free [Units/volume] in Urine |
|
38178-0
|
Lambda light chains.free [Mass/volume] in Urine |
|
21749-7
|
Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
6789-2
|
Lambda light chains [Presence] in Serum by Electrophoresis |
|
6791-8
|
Lambda light chains [Presence] in Serum by Immunoassay |
|
25683-4
|
Lambda light chains [Presence] in Serum by Immunoelectrophoresis |
|
40639-7
|
Lambda light chains [Presence] in Serum by Immunofixation |
|
11051-0
|
Lambda light chains [Mass/volume] in Serum or Plasma |
|
6790-0
|
Lambda light chains [Presence] in Urine by Electrophoresis |
|
40638-9
|
Lambda light chains [Presence] in Urine by Immunofixation |
|
27394-6
|
Lambda light chains [Mass/volume] in Urine |
|
82516-6
|
LAMC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19114-8
|
Lamellar bodies [#/volume] in Amniotic fluid |
|
17044-9
|
Lamellar bodies [Presence] in Amniotic fluid |
|
54027-8
|
Lamin Ab [Presence] in Serum by Immunofluorescence |
|
54028-6
|
Lamin Ab [Titer] in Serum by Immunofluorescence |
|
53596-3
|
Laminaribioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30283-6
|
lamiVUDine [Susceptibility] by Genotype method |
|
30269-5
|
lamiVUDine [Susceptibility] by Phenotype method |
|
29119-5
|
lamiVUDine [Units/volume] in Serum or Plasma |
|
49226-4
|
lamiVUDine [Mass/volume] in Serum or Plasma |
|
30298-4
|
lamiVUDine [Susceptibility] |
|
49620-8
|
lamiVUDine or Emtricitabine [Susceptibility] by Genotype method |
|
59920-9
|
lamoTRIgine [Moles/volume] in Gastric fluid |
|
51982-7
|
lamoTRIgine [Presence] in Serum or Plasma |
|
41761-8
|
lamoTRIgine [Mass/volume] in Serum or Plasma by Screen method |
|
6948-4
|
lamoTRIgine [Mass/volume] in Serum or Plasma |
|
25458-1
|
lamoTRIgine [Moles/volume] in Serum or Plasma |
|
74944-0
|
lamoTRIgine [Mass/volume] in Serum or Plasma --trough |
|
59919-1
|
lamoTRIgine [Moles/volume] in Urine |
|
60312-6
|
lamoTRIgine [Moles/volume] in Unspecified specimen |
|
87772-0
|
lamoTRIgine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
31016-9
|
Levoamphetamine/Amphetamines.total in Urine |
|
65326-1
|
LAN Ab [Presence] in Serum or Plasma |
|
68964-6
|
LAN Ag [Presence] on Red Blood Cells |
|
74898-8
|
Lanosterol [Moles/volume] in Serum or Plasma |
|
73008-5
|
Lansoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73007-7
|
Lansoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73319-6
|
Lansoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73318-8
|
Lansoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13944-4
|
Leukocyte phosphatase [Enzymatic activity/volume] in Control Leukocytes by Light microscopy |
|
55804-9
|
Leukocyte phosphatase [Presence] in Leukocytes |
|
15112-6
|
Leukocyte phosphatase [Units/volume] in Leukocytes |
|
4659-9
|
Leukocyte phosphatase [Enzymatic activity/volume] in Leukocytes |
|
26845-8
|
Sialate.lipid bound [Mass/volume] in Serum or Plasma |
|
26031-5
|
Sialate.lipid bound [Moles/volume] in Serum or Plasma |
|
88012-0
|
Sialate.lipid bound/Creatinine [Molar ratio] in Urine |
|
87598-9
|
Lasalocid [Mass/mass] in Unspecified specimen |
|
72153-0
|
Last born child vital status [RHEA] |
|
74014-2
|
Last drank alcohol [Date and time] |
|
45394-4
|
Last name |
|
79184-8
|
Last name of Guardian or legally authorized representative |
|
31867-5
|
Lassa virus Ag [Presence] in Serum |
|
7946-7
|
Lassa virus Ag [Presence] in Serum by Immunoassay |
|
22377-6
|
Lassa virus IgG Ab [Presence] in Serum |
|
7942-6
|
Lassa virus IgG Ab [Presence] in Serum by Immunoassay |
|
31452-6
|
Lassa virus IgG Ab [Units/volume] in Serum |
|
22378-4
|
Lassa virus IgG Ab [Titer] in Serum |
|
71710-8
|
Lassa virus IgG Ab [Titer] in Serum by Immunoassay |
|
7943-4
|
Lassa virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
22379-2
|
Lassa virus IgM Ab [Presence] in Serum |
|
7944-2
|
Lassa virus IgM Ab [Presence] in Serum by Immunoassay |
|
31453-4
|
Lassa virus IgM Ab [Units/volume] in Serum |
|
22380-0
|
Lassa virus IgM Ab [Titer] in Serum |
|
71709-0
|
Lassa virus IgM Ab [Titer] in Serum by Immunoassay |
|
7945-9
|
Lassa virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
85313-5
|
Extent of lateral margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
|
50646-9
|
Latex recombinant (rHev b) 1 IgE Ab [Units/volume] in Serum |
|
82010-0
|
Latex recombinant (rHev b) 1 IgE Ab RAST class [Presence] in Serum |
|
82601-6
|
Latex recombinant (rHev b) 10 IgE Ab [Units/volume] in Serum |
|
82602-4
|
Latex recombinant (rHev b) 10 IgE Ab RAST class [Presence] in Serum |
|
50647-7
|
Latex recombinant (rHev b) 11 IgE Ab [Units/volume] in Serum |
|
82017-5
|
Latex recombinant (rHev b) 11 IgE Ab RAST class [Presence] in Serum |
|
82603-2
|
Latex recombinant (rHev b) 2 IgE Ab [Units/volume] in Serum |
|
82604-0
|
Latex recombinant (rHev b) 2 IgE Ab RAST class [Presence] in Serum |
|
56595-2
|
Latex recombinant (rHev b) 3 IgE Ab [Units/volume] in Serum |
|
82011-8
|
Latex recombinant (rHev b) 3 IgE Ab RAST class [Presence] in Serum |
|
56596-0
|
Latex recombinant (rHev b) 5 IgE Ab [Units/volume] in Serum |
|
82012-6
|
Latex recombinant (rHev b) 5 IgE Ab RAST class [Presence] in Serum |
|
66448-2
|
Latex recombinant (rHev b) 6 IgE Ab [Units/volume] in Serum |
|
50648-5
|
Latex recombinant (rHev b) 6.01 IgE Ab [Units/volume] in Serum |
|
82013-4
|
Latex recombinant (rHev b) 6.01 IgE Ab RAST class [Presence] in Serum |
|
50649-3
|
Latex recombinant (rHev b) 6.02 IgE Ab [Units/volume] in Serum |
|
82014-2
|
Latex recombinant (rHev b) 6.02 IgE Ab RAST class [Presence] in Serum |
|
56597-8
|
Latex recombinant (rHev b) 8 IgE Ab [Units/volume] in Serum |
|
82015-9
|
Latex recombinant (rHev b) 8 IgE Ab RAST class [Presence] in Serum |
|
59395-4
|
Latex recombinant (rHev b) 9 IgE Ab [Units/volume] in Serum |
|
82016-7
|
Latex recombinant (rHev b) 9 IgE Ab RAST class [Presence] in Serum |
|
75740-1
|
Lathosterol [Mass/volume] in Serum or Plasma |
|
77373-9
|
Lathosterol [Moles/volume] in Serum or Plasma |
|
91588-4
|
Latitude Event |
|
75099-2
|
Laurate (C12:0) [Entitic substance] in Red Blood Cells |
|
35150-2
|
Laurate (C12:0) [Moles/volume] in Serum or Plasma |
|
78349-8
|
Lauroleate (C12:1) [Entitic substance] in Red Blood Cells |
|
35151-0
|
Lauroleate (C12:1) [Moles/volume] in Serum or Plasma |
|
48429-5
|
Lavender IgE Ab [Units/volume] in Serum |
|
21361-1
|
Laxatives present [Identifier] in Stool by Screen method |
|
50993-5
|
Laxatives [Mass/mass] in Stool |
|
17051-4
|
Laxatives [Identifier] in Urine |
|
88054-2
|
Lipopolysaccharide binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
|
60491-8
|
LCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
10446-3
|
Leukocyte common Ag [Presence] in Tissue by Immune stain |
|
77134-5
|
LCA5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77133-7
|
LCA5 gene full mutation analysis in Blood or Tissue by Sequencing |
|
74362-5
|
Lecithin cholesterol acyltransferase actual/normal in Serum or Plasma |
|
2555-1
|
Lecithin cholesterol acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
|
17079-5
|
Fatty acids.long chain [Identifier] in Serum or Plasma |
|
46754-8
|
Long Chain Hydroxy Acyl Dehydrogenase/Trifunctional Protein Deficiencies newborn screen interpretation |
|
85338-2
|
LCIS [Presence] in Breast cancer specimen by Light microscopy |
|
31491-4
|
Lymphocytic choriomeningitis virus Ab [Units/volume] in Cerebral spinal fluid |
|
11605-3
|
Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum |
|
17228-8
|
Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid |
|
9564-6
|
Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22408-9
|
Lymphocytic choriomeningitis virus Ab [Titer] in Serum |
|
5241-5
|
Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Complement fixation |
|
6458-4
|
Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Immunofluorescence |
|
45219-3
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Cerebral spinal fluid |
|
31492-2
|
Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
45278-9
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Body fluid |
|
45218-5
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum |
|
88206-8
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
31493-0
|
Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Serum |
|
22409-7
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
9766-7
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22410-5
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum |
|
40500-1
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunoassay |
|
9765-9
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
93787-0
|
Lymphocytic choriomeningitis virus IgG+IgM Ab [Presence] in Cerebral spinal fluid |
|
45221-9
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
31494-8
|
Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
45277-1
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Body fluid |
|
45220-1
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum |
|
88205-0
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
31495-5
|
Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Serum |
|
17229-6
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
9768-3
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22411-3
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum |
|
40499-6
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunoassay |
|
9767-5
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
88207-6
|
Lymphocytic choriomeningitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
51667-4
|
Lymphocytic choriomeningitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58938-2
|
LCT gene mutations found [Type] in Blood or Tissue by Molecular genetics method |
|
58924-2
|
LCT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
80254-6
|
Mid and distal left circumflex artery [Presence] on Angiogram |
|
47678-8
|
Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine |
|
47863-6
|
Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine |
|
2527-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
|
60024-7
|
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction |
|
60023-9
|
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction |
|
2528-8
|
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
81430-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal dialysis fluid by Lactate to pyruvate reaction |
|
5921-2
|
Lactate dehydrogenase [Enzymatic activity/volume] in Dialysis fluid |
|
14803-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
|
60017-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction |
|
2529-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid |
|
14403-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
|
49279-3
|
Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
5910-5
|
Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma |
|
60019-7
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction |
|
60018-9
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction |
|
53933-8
|
Lactate dehydrogenase in pericardial fluid/Lactate dehydrogenase in serum |
|
33367-4
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid |
|
60022-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction |
|
60021-3
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction |
|
49930-1
|
Lactate dehydrogenase in pleural fluid/Lactate dehydrogenase in serum |
|
2530-4
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid |
|
68387-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction |
|
60020-5
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction |
|
53934-6
|
Lactate dehydrogenase in peritoneal fluid/Lactate dehydrogenase in serum |
|
2531-2
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid |
|
11053-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
14804-9
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
|
14805-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
|
2532-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
57664-5
|
Lactate dehydrogenase [Enzymatic activity/volume] in Semen |
|
68453-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction |
|
68452-2
|
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction |
|
2533-8
|
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid |
|
17041-5
|
Lactate dehydrogenase [Presence] in Urine |
|
2534-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Urine |
|
32324-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Unspecified specimen |
|
75639-5
|
Lactate dehydrogenase in body fluid/Lactate dehydrogenase in serum |
|
53561-7
|
Lactate dehydrogenase/Creatinine [Ratio] in Urine |
|
51510-6
|
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
|
51508-0
|
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
|
51509-8
|
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
|
2536-1
|
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
|
13886-7
|
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
2535-3
|
Lactate dehydrogenase 1 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
|
2537-9
|
Lactate dehydrogenase 1 [Enzymatic activity/volume] in Serum or Plasma |
|
14119-2
|
Lactate dehydrogenase 1/Lactate dehydrogenase 2 [Enzymatic activity ratio] in Serum or Plasma |
|
51511-4
|
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
|
51512-2
|
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
|
51513-0
|
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
|
2539-5
|
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
|
13887-5
|
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
2538-7
|
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
|
19248-4
|
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
2540-3
|
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma |
|
51516-3
|
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
|
51514-8
|
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
|
51515-5
|
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
|
2542-9
|
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
|
13888-3
|
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
2541-1
|
Lactate dehydrogenase 3 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
|
2543-7
|
Lactate dehydrogenase 3 [Enzymatic activity/volume] in Serum or Plasma |
|
51519-7
|
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
|
51518-9
|
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
|
51517-1
|
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
|
2545-2
|
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
|
13889-1
|
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
2544-5
|
Lactate dehydrogenase 4 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
|
2546-0
|
Lactate dehydrogenase 4 [Enzymatic activity/volume] in Serum or Plasma |
|
51522-1
|
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis |
|
51521-3
|
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis |
|
51520-5
|
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis |
|
2548-6
|
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
|
13890-9
|
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
2547-8
|
Lactate dehydrogenase 5 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation |
|
2549-4
|
Lactate dehydrogenase 5 [Enzymatic activity/volume] in Serum or Plasma |
|
53806-6
|
LDL apheresis procedure [Identifier] |
|
53805-8
|
LDL apheresis procedure [Type] |
|
26821-9
|
Lipoprotein.beta [Presence] in Body fluid |
|
17083-7
|
Lipoprotein.beta [Mass/volume] in Body fluid |
|
47215-9
|
Lipoprotein.beta.subparticle.intermediate [Entitic length] in Serum or Plasma |
|
92717-8
|
Lipoprotein.beta.subparticle.large-a [Moles/volume] in Serum |
|
92716-0
|
Lipoprotein.beta.subparticle.large-b [Moles/volume] in Serum |
|
33413-6
|
Lipoprotein.beta/total Lipoprotein in Pleural fluid |
|
15122-5
|
Lipoprotein.beta/total Lipoprotein in Serum or Plasma |
|
9620-6
|
Lipoprotein.beta [Mass/volume] in Pleural fluid |
|
35505-7
|
Lipoprotein.beta.subparticle [Type] in Serum or Plasma |
|
9346-8
|
Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation |
|
14815-5
|
Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation |
|
14814-8
|
Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis |
|
17846-7
|
Lipoprotein.beta [Presence] in Serum or Plasma |
|
17782-4
|
Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma |
|
2574-2
|
Lipoprotein.beta [Mass/volume] in Serum or Plasma |
|
54434-6
|
Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma |
|
43727-7
|
Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma |
|
92715-2
|
Lipoprotein.beta.subparticle.very small-a [Moles/volume] in Serum |
|
92714-5
|
Lipoprotein.beta.subparticle.very small-b [Moles/volume] in Serum |
|
92713-7
|
Lipoprotein.beta.subparticle.very small-c [Moles/volume] in Serum |
|
92712-9
|
Lipoprotein.beta.subparticle.very small-d [Moles/volume] in Serum |
|
68935-6
|
LDL.oxidized Ab [Units/volume] in Serum by Immunoassay |
|
48143-2
|
LDL.oxidized Ab [Units/volume] in Serum |
|
54238-1
|
LDL.oxidized [Units/volume] in Serum or Plasma |
|
44717-7
|
Lipoprotein.beta/Lipoprotein.alpha [Mass Ratio] in Serum or Plasma |
|
43392-0
|
LDL 1 [Mass/volume] in Serum or Plasma |
|
56136-5
|
LDL 1 [Moles/volume] in Serum or Plasma |
|
91105-7
|
Cholesterol in LDL 1 [Mass/volume] in Serum or Plasma |
|
91112-3
|
Cholesterol in LDL 1 [Moles/volume] in Serum or Plasma |
|
46984-1
|
LDL 2 [Mass/volume] in Serum or Plasma |
|
56137-3
|
LDL 2 [Moles/volume] in Serum or Plasma |
|
91106-5
|
Cholesterol in LDL 2 [Mass/volume] in Serum or Plasma |
|
91113-1
|
Cholesterol in LDL 2 [Moles/volume] in Serum or Plasma |
|
46985-8
|
LDL 3 [Mass/volume] in Serum or Plasma |
|
56138-1
|
LDL 3 [Moles/volume] in Serum or Plasma |
|
91107-3
|
Cholesterol in LDL 3 [Mass/volume] in Serum or Plasma |
|
91114-9
|
Cholesterol in LDL 3 [Moles/volume] in Serum or Plasma |
|
43393-8
|
LDL 4 [Mass/volume] in Serum or Plasma |
|
56139-9
|
LDL 4 [Moles/volume] in Serum or Plasma |
|
91108-1
|
Cholesterol in LDL 4 [Mass/volume] in Serum or Plasma |
|
91115-6
|
Cholesterol in LDL 4 [Moles/volume] in Serum or Plasma |
|
57938-3
|
LDL 5 [Mass/volume] in Serum or Plasma |
|
91109-9
|
Cholesterol in LDL 5 [Mass/volume] in Serum or Plasma |
|
91116-4
|
Cholesterol in LDL 5 [Moles/volume] in Serum or Plasma |
|
49026-8
|
LDL 6 [Mass/volume] in Serum or Plasma |
|
91110-7
|
Cholesterol in LDL 6 [Mass/volume] in Serum or Plasma |
|
91117-2
|
Cholesterol in LDL 6 [Moles/volume] in Serum or Plasma |
|
49027-6
|
LDL 7 [Mass/volume] in Serum or Plasma |
|
91111-5
|
Cholesterol in LDL 7 [Mass/volume] in Serum or Plasma |
|
91118-0
|
Cholesterol in LDL 7 [Moles/volume] in Serum or Plasma |
|
48635-7
|
Cholesterol in LDL pattern A [Presence] in Serum or Plasma |
|
48637-3
|
Cholesterol in LDL pattern BI [Presence] in Serum or Plasma by Electrophoresis |
|
48636-5
|
Cholesterol in LDL pattern BII [Presence] in Serum or Plasma by Electrophoresis |
|
53133-5
|
Cholesterol in LDL [Moles/volume] in Body fluid |
|
86911-5
|
Cholesterol in LDL goal [Mass/volume] Serum or Plasma |
|
50193-2
|
Cholesterol in LDL.narrow density [Mass/volume] in Serum or Plasma |
|
14155-6
|
Cholesterol in LDL [Percentile] |
|
47213-4
|
Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma |
|
13459-3
|
Cholesterol in LDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
|
13457-7
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation |
|
39469-2
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation |
|
18262-6
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
|
69419-0
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay |
|
12773-8
|
Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis |
|
49132-4
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis |
|
18261-8
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate |
|
2089-1
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma |
|
35198-1
|
Cholesterol in LDL [Mass or Moles/volume] in Serum or Plasma |
|
22748-8
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma |
|
44711-0
|
Cholesterol in LDL/Apolipoprotein B [Mass Ratio] in Serum or Plasma |
|
11054-4
|
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
|
44915-7
|
Cholesterol in LDL/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
43394-6
|
Cholesterol in LDL acylated [Mass/volume] in Serum or Plasma |
|
55440-2
|
Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP |
|
69486-9
|
LDLR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
69485-1
|
LDLR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
90258-5
|
LDLR gene full mutation analysis in Blood or Tissue by Sequencing |
|
56159-7
|
LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53077-4
|
Levodopa [Moles/volume] in Cerebral spinal fluid |
|
35131-2
|
L-dopa decarboxylase [Enzymatic activity/volume] in Plasma |
|
73309-7
|
Levodopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73308-9
|
Levodopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51983-5
|
Levodopa [Presence] in Serum or Plasma |
|
9385-6
|
Levodopa [Mass/volume] in Serum or Plasma |
|
34328-5
|
Levodopa [Moles/volume] in Serum or Plasma |
|
79577-3
|
Levodopa/Creatinine [Molar ratio] in Urine |
|
53477-6
|
Levodopa/Tyrosine [Molar ratio] in Serum or Plasma |
|
1125-4
|
Le Ab [Presence] in Serum or Plasma from Blood product unit |
|
1126-2
|
Le Ab [Presence] in Serum or Plasma from Donor |
|
13507-9
|
Lupus erythematosus cells [Presence] in Blood |
|
30084-8
|
Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay |
|
31490-6
|
Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum |
|
18239-4
|
Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination |
|
17092-8
|
Lupus erythematosus factor [Presence] in Serum by Latex agglutination |
|
1110-6
|
Le sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1111-4
|
Le sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1112-2
|
Le sup(a) Ab [Presence] in Serum or Plasma |
|
55328-9
|
Le sup(a) Ab [Titer] in Serum or Plasma |
|
1113-0
|
Le sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1114-8
|
Le sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1115-5
|
Le sup(a) Ag [Presence] on Red Blood Cells |
|
1116-3
|
Le sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1117-1
|
Le sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1118-9
|
Le sup(b) Ab [Presence] in Serum or Plasma |
|
55329-7
|
Le sup(b) Ab [Titer] in Serum or Plasma |
|
1119-7
|
Le sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1120-5
|
Le sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1121-3
|
Le sup(b) Ag [Presence] on Red Blood Cells |
|
1122-1
|
Le sup(x) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1123-9
|
Le sup(x) Ab [Presence] in Serum or Plasma from Donor |
|
1124-7
|
Le sup(x) Ab [Presence] in Serum or Plasma |
|
30931-0
|
Lead [Mass/volume] in Urine collected for unspecified duration |
|
14333-9
|
Lead [Presence] in 24 hour Urine |
|
20625-0
|
Lead [Mass/volume] in 24 hour Urine |
|
5677-0
|
Lead [Mass/time] in 24 hour Urine |
|
34325-1
|
Lead [Moles/volume] in 24 hour Urine |
|
14809-8
|
Lead [Moles/time] in 24 hour Urine |
|
31083-9
|
Lead [Mass/time] in 8 hour Urine |
|
17052-2
|
Lead [Presence] in Blood |
|
10368-9
|
Lead [Mass/volume] in Capillary blood |
|
5671-3
|
Lead [Mass/volume] in Blood |
|
14807-2
|
Lead [Moles/volume] in Blood |
|
77307-7
|
Lead [Mass/volume] in Venous blood |
|
20867-8
|
Lead [Mass/mass] in Bone |
|
79266-3
|
Lead [Mass/mass] in Dentin |
|
91025-7
|
Lead department or agency name Organization |
|
5933-7
|
Lead [Mass/volume] in Dialysis fluid |
|
88675-4
|
EMS physician responsible for management at scene |
|
9436-7
|
Lead [Mass/volume] in Body fluid |
|
5673-9
|
Lead [Mass/mass] in Hair |
|
50871-3
|
Lead [Moles/mass] in Hair |
|
27232-8
|
Lead [Mass/volume] in Milk |
|
8202-4
|
Lead [Mass/mass] in Nail |
|
55393-3
|
Lead [Moles/mass] in Nail |
|
1586-7
|
Lead [Mass/volume] in Urine --post EDTA therapy |
|
47154-0
|
Lead [Moles/volume] in Urine --post EDTA therapy |
|
5674-7
|
Lead [Mass/volume] in Red Blood Cells |
|
27129-6
|
Lead [Mass/mass] in Red Blood Cells |
|
32325-3
|
Lead [Moles/volume] in Red Blood Cells |
|
10912-4
|
Lead [Mass/volume] in Serum or Plasma |
|
25459-9
|
Lead [Moles/volume] in Serum or Plasma |
|
40451-7
|
Lead [Presence] in Stool |
|
18236-0
|
Lead [Presence] in Tissue |
|
12770-4
|
Lead [Mass/mass] in Tissue |
|
52890-1
|
Lead [Moles/mass] in Tissue |
|
5675-4
|
Lead [Presence] in Urine |
|
5676-2
|
Lead [Mass/volume] in Urine |
|
14808-0
|
Lead [Moles/volume] in Urine |
|
9477-1
|
Lead [Mass/volume] in Water |
|
23749-5
|
Lead [Mass/volume] in Unspecified specimen |
|
23890-7
|
Lead [Mass/mass] in Unspecified specimen |
|
29943-8
|
Lead/Creatinine [Mass Ratio] in 24 hour Urine |
|
52931-3
|
Lead/Creatinine [Molar ratio] in 24 hour Urine |
|
13466-8
|
Lead/Creatinine [Mass Ratio] in Urine |
|
34327-7
|
Lead/Creatinine [Molar ratio] in Urine |
|
69996-7
|
Leak 24 hour mean Positive airway pressure device |
|
70001-3
|
Leak 24 hour median Positive airway pressure device |
|
69997-5
|
Leak.95% 24 hour maximum Positive airway pressure device |
|
91557-9
|
Lean body weight |
|
88334-8
|
Lean body weight Calculated |
|
27233-6
|
Lecithin [Units/volume] in Amniotic fluid |
|
49577-0
|
Lecithin/Surfactant.total in Amniotic fluid |
|
2556-9
|
Lecithin phosphorus [Mass/volume] in Amniotic fluid |
|
2783-9
|
Lecithin [Mass/volume] in Plasma |
|
72339-5
|
Lecithin [Presence] in Prostatic fluid by Light microscopy |
|
2557-7
|
Lecithin/Sphingomyelin [Mass Ratio] in Amniotic fluid |
|
14976-5
|
Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
|
82377-3
|
Ledipasvir [Susceptibility] by Genotype method |
|
56746-1
|
Leeks IgE Ab [Units/volume] in Serum |
|
85425-7
|
Lefamulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
38901-5
|
Leflunomide [Mass/volume] in Serum or Plasma |
|
79987-4
|
Left pulmonary artery Diameter at end systole by US 2D |
|
72070-6
|
Left ventricular hypertrophy |
|
72083-9
|
Left ventricular hypertrophy change [ESRD] |
|
77997-5
|
Legacy case identifier [CDC.PHIN] |
|
64299-1
|
Legal document |
|
78506-3
|
Legal letter |
|
38392-7
|
Legionella sp Ab [Presence] in Serum |
|
7957-4
|
Legionella sp Ab [Units/volume] in Serum |
|
30143-2
|
Legionella sp Ab [Presence] in Serum --1st specimen |
|
30144-0
|
Legionella sp Ab [Presence] in Serum --2nd specimen |
|
51920-7
|
Legionella sp Ab [Titer] in Serum --2nd specimen |
|
43001-7
|
Legionella sp Ab [Titer] in Cerebral spinal fluid |
|
42516-5
|
Legionella sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22399-0
|
Legionella sp Ab [Titer] in Serum |
|
6450-1
|
Legionella sp Ab [Titer] in Serum by Immunofluorescence |
|
73833-6
|
Legionella sp Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
38460-2
|
Legionella sp Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
38461-0
|
Legionella sp Ag [Presence] in Pleural fluid by Immunofluorescence |
|
38462-8
|
Legionella sp Ag [Presence] in Sputum by Immunofluorescence |
|
32781-7
|
Legionella sp Ag [Presence] in Urine |
|
38463-6
|
Legionella sp Ag [Presence] in Urine by Immunofluorescence |
|
26621-3
|
Legionella sp Ag [Presence] in Unspecified specimen |
|
39541-8
|
Legionella sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
589-2
|
Legionella sp identified in Bronchial specimen by Organism specific culture |
|
88588-9
|
Legionella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection |
|
88587-1
|
Legionella sp DNA [Identifier] in Tissue by NAA with probe detection |
|
49616-6
|
Legionella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49915-2
|
Legionella sp IgG Ab [Presence] in Serum |
|
81118-2
|
Legionella sp IgM Ab [Presence] in Serum |
|
31474-0
|
Legionella sp IgM Ab [Units/volume] in Serum |
|
39559-0
|
Legionella sp IgM Ab [Titer] in Serum |
|
28612-0
|
Legionella sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
71377-6
|
Legionella sp [Identifier] in Isolate by Agglutination |
|
88585-5
|
Legionella sp identified in Lower respiratory specimen by Organism specific culture |
|
13253-0
|
Legionella non-pneumophila Ab [Presence] in Serum |
|
46194-7
|
Legionella non-pneumophila Ab [Titer] in Serum |
|
43193-2
|
Legionella non-pneumophila Ab [Titer] in Serum by Immunofluorescence |
|
38393-5
|
Legionella sp identified in Pleural fluid by Organism specific culture |
|
26627-0
|
Legionella polyvalent A Ab [Presence] in Serum |
|
26628-8
|
Legionella polyvalent B Ab [Presence] in Serum |
|
26629-6
|
Legionella polyvalent C Ab [Presence] in Serum |
|
5020-3
|
Legionella sp rRNA [Presence] in Unspecified specimen by Probe |
|
590-0
|
Legionella sp identified in Sputum by Organism specific culture |
|
87956-9
|
Legionella sp identified in Tissue by Organism specific culture |
|
38394-3
|
Legionella sp identified in Urine by Organism specific culture |
|
87957-7
|
Legionella sp identified in Water by Organism specific culture |
|
593-4
|
Legionella sp identified in Unspecified specimen by Organism specific culture |
|
15810-5
|
Legume IgE Ab RAST class [Presence] in Serum |
|
42999-3
|
Leishmania sp Ab [Presence] in Cerebral spinal fluid |
|
42517-3
|
Leishmania sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
51711-0
|
Leishmania sp Ab [Presence] in Body fluid |
|
7958-2
|
Leishmania sp Ab [Presence] in Serum |
|
23157-1
|
Leishmania sp Ab [Presence] in Serum by Agglutination |
|
6623-3
|
Leishmania sp Ab [Presence] in Serum by Complement fixation |
|
6622-5
|
Leishmania sp Ab [Presence] in Serum by Hemagglutination |
|
23153-0
|
Leishmania sp Ab [Presence] in Serum by Immunoassay |
|
23155-5
|
Leishmania sp Ab [Presence] in Serum by Immunoelectrophoresis |
|
6621-7
|
Leishmania sp Ab [Presence] in Serum by Immunofluorescence |
|
5238-1
|
Leishmania sp Ab [Units/volume] in Serum |
|
23152-2
|
Leishmania sp Ab [Titer] in Serum |
|
23154-8
|
Leishmania sp Ab [Titer] in Serum by Hemagglutination |
|
23156-3
|
Leishmania sp Ab [Titer] in Serum by Immunofluorescence |
|
87987-4
|
Leishmania sp identified in Blood by Organism specific culture |
|
49780-0
|
Leishmania sp DNA [Presence] in Blood by NAA with probe detection |
|
88917-0
|
Leishmania sp DNA [Identifier] in Bone marrow by NAA with probe detection |
|
88916-2
|
Leishmania sp DNA [Identifier] in Tissue by NAA with probe detection |
|
23159-7
|
Leishmania sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
40853-4
|
Leishmania sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
56951-7
|
Leishmania sp IgG Ab [Presence] in Serum by Immunofluorescence |
|
40852-6
|
Leishmania sp IgG Ab [Units/volume] in Serum |
|
34608-0
|
Leishmania sp IgG Ab [Titer] in Serum |
|
52985-9
|
Leishmania sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
39577-2
|
Leishmania sp IgM Ab [Titer] in Serum |
|
88682-0
|
Leishmania sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
87986-6
|
Leishmania sp identified in Bone marrow by Organism specific culture |
|
23158-9
|
Leishmania sp rRNA [Identifier] in Unspecified specimen by Probe |
|
53625-0
|
Leishmania sp identified in Tissue |
|
10687-2
|
Leishmania sp identified in Tissue by Organism specific culture |
|
23161-3
|
Leishmania sp identified in Tissue by Electrophoresis |
|
10686-4
|
Leishmania sp identified in Tissue by Giemsa stain |
|
23160-5
|
Leishmania sp identified in Tissue by Immunofluorescence |
|
23162-1
|
Leishmania sp identified in Tissue by Polyacrylamide gel electrophoresis (PAGE) |
|
51710-2
|
Leishmania sp identified in Unspecified specimen by Organism specific culture |
|
51709-4
|
Leishmania sp identified in Unspecified specimen by Giemsa stain |
|
7456-7
|
Lemon triggered histamine release [Units/volume] in Blood |
|
6159-8
|
Lemon IgE Ab [Units/volume] in Serum |
|
15811-3
|
Lemon IgE Ab RAST class [Presence] in Serum |
|
61246-5
|
Lemon IgE Ab/IgE total in Serum |
|
7455-9
|
Lemon IgG Ab [Units/volume] in Serum |
|
21364-5
|
Lemon IgG Ab RAST class [Presence] in Serum |
|
56304-9
|
Lemon IgG4 Ab [Mass/volume] in Serum |
|
60381-1
|
Lemon IgG Ab [Mass/volume] in Serum |
|
15300-7
|
Urinary bladder Length by US |
|
12704-3
|
Length of Hair |
|
15288-4
|
Kidney - left Length by US |
|
15291-8
|
Kidney - right Length by US |
|
45358-9
|
Length of calorie fast |
|
45359-7
|
Length of time post dose |
|
44619-5
|
Length of tissue core(s) |
|
86901-6
|
Length Pressure injury.largest stage 3 or 4 [CMS Assessment] |
|
15303-1
|
Prostate Length by US |
|
9799-8
|
Length of Stone |
|
15294-2
|
Testis - left Length by US |
|
15297-5
|
Testis - right Length by US |
|
6239-8
|
Lenscale IgE Ab [Units/volume] in Serum |
|
15812-1
|
Lenscale IgE Ab RAST class [Presence] in Serum |
|
61224-2
|
Lenscale IgE Ab/IgE total in Serum |
|
56305-6
|
Lenscale IgG4 Ab [Mass/volume] in Serum |
|
7458-3
|
Lentils IgE Ab [Units/volume] in Serum |
|
15813-9
|
Lentils IgE Ab RAST class [Presence] in Serum |
|
7459-1
|
Lentils IgG Ab [Units/volume] in Serum |
|
56306-4
|
Lentils IgG4 Ab [Mass/volume] in Serum |
|
63118-4
|
Lentils IgG Ab [Mass/volume] in Serum |
|
73317-0
|
Lepirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73316-2
|
Lepirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
21365-2
|
Leptin [Mass/volume] in Serum or Plasma |
|
23196-9
|
Leptospira sp Ab [Presence] in Serum |
|
23197-7
|
Leptospira sp Ab [Presence] in Serum by Agglutination |
|
23195-1
|
Leptospira sp Ab [Presence] in Serum by Immunoassay |
|
31483-1
|
Leptospira sp Ab [Units/volume] in Serum |
|
32604-1
|
Leptospira sp Ab [Titer] in Serum --1st specimen |
|
32605-8
|
Leptospira sp Ab [Titer] in Serum --2nd specimen |
|
42994-4
|
Leptospira sp Ab [Titer] in Cerebral spinal fluid |
|
42518-1
|
Leptospira sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
|
7959-0
|
Leptospira sp Ab [Titer] in Serum |
|
23198-5
|
Leptospira sp Ab [Titer] in Serum by Agglutination |
|
5239-9
|
Leptospira sp Ab [Titer] in Serum by Latex agglutination |
|
23203-3
|
Leptospira sp Ag [Presence] in Tissue by Immunofluorescence |
|
23204-1
|
Leptospira sp Ag [Presence] in Tissue by Immune stain |
|
31872-5
|
Leptospira sp Ag [Presence] in Urine |
|
23750-3
|
Leptospira sp Ag [Presence] in Urine by Immunofluorescence |
|
6453-5
|
Leptospira sp identified in Blood by Organism specific culture |
|
6454-3
|
Leptospira sp identified in Cerebral spinal fluid by Organism specific culture |
|
52989-1
|
Leptospira sp DNA [Presence] in Blood by NAA with probe detection |
|
52988-3
|
Leptospira sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
86731-7
|
Leptospira sp DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23205-8
|
Leptospira sp DNA [Presence] in Body fluid by NAA with probe detection |
|
23206-6
|
Leptospira sp DNA [Presence] in Tissue by NAA with probe detection |
|
52990-9
|
Leptospira sp DNA [Presence] in Urine by NAA with probe detection |
|
35491-0
|
Leptospira sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27093-4
|
Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31484-9
|
Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51815-9
|
Leptospira sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
23200-9
|
Leptospira sp IgG Ab [Presence] in Serum |
|
23199-3
|
Leptospira sp IgG Ab [Presence] in Serum by Immunoassay |
|
31485-6
|
Leptospira sp IgG Ab [Units/volume] in Serum |
|
13264-7
|
Leptospira sp IgG Ab [Titer] in Serum |
|
27384-7
|
Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31486-4
|
Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51819-1
|
Leptospira sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
23202-5
|
Leptospira sp IgM Ab [Presence] in Serum |
|
23201-7
|
Leptospira sp IgM Ab [Presence] in Serum by Immunoassay |
|
31487-2
|
Leptospira sp IgM Ab [Units/volume] in Serum |
|
13265-4
|
Leptospira sp IgM Ab [Titer] in Serum |
|
71378-4
|
Leptospira sp [Identifier] in Isolate by Agglutination |
|
86732-5
|
Leptospira sp identified [Type] in Isolate by Sequencing |
|
23600-0
|
Leptospira sp identified in Milk by Organism specific culture |
|
23207-4
|
Leptospira subtype [Identifier] in Unspecified specimen |
|
23599-4
|
Leptospira sp identified in Tissue by Organism specific culture |
|
20869-4
|
Leptospira sp [Presence] in Tissue by Organism specific culture |
|
20868-6
|
Leptospira sp [Presence] in Tissue by Immunofluorescence |
|
6455-0
|
Leptospira sp identified in Urine by Organism specific culture |
|
594-2
|
Leptospira sp identified in Unspecified specimen by Organism specific culture |
|
44698-9
|
Lesion size additional dimension 1 in Skin |
|
44697-1
|
Lesion size.maximum dimension in Skin |
|
51852-2
|
Letter |
|
7461-7
|
Lettuce triggered histamine release [Units/volume] in Blood |
|
6161-4
|
Lettuce IgE Ab [Units/volume] in Serum |
|
15815-4
|
Lettuce IgE Ab RAST class [Presence] in Serum |
|
61280-4
|
Lettuce IgE Ab/IgE total in Serum |
|
7460-9
|
Lettuce IgG Ab [Units/volume] in Serum |
|
21366-0
|
Lettuce IgG Ab RAST class [Presence] in Serum |
|
56307-2
|
Lettuce IgG4 Ab [Mass/volume] in Serum |
|
51919-9
|
Lettuce IgG Ab [Mass/volume] in Serum |
|
57996-1
|
Leucine+Isoleucine [Mass/volume] in DBS |
|
32783-3
|
Leucine+Isoleucine+Valine [Identifier] in Serum or Plasma |
|
2562-7
|
Leucine [Mass/time] in 24 hour Urine |
|
25941-6
|
Leucine [Moles/volume] in 24 hour Urine |
|
25460-7
|
Leucine [Moles/time] in 24 hour Urine |
|
17074-6
|
Leucine [Units/volume] in Amniotic fluid |
|
13403-1
|
Leucine [Mass/volume] in Amniotic fluid |
|
26710-4
|
Leucine [Moles/volume] in Amniotic fluid |
|
29284-7
|
Leucine [Presence] in Blood |
|
29293-8
|
Leucine [Mass/volume] in Blood |
|
53300-0
|
Leucine crystals [#/volume] in Urine by Computer assisted method |
|
53310-9
|
Leucine crystals [#/area] in Urine by Computer assisted method |
|
88967-5
|
Leucine crystals [#/area] in Urine sediment |
|
25163-7
|
Leucine crystals [#/area] in Urine sediment by Microscopy high power field |
|
45384-5
|
Leucine crystals [#/area] in Urine sediment by Microscopy low power field |
|
50232-8
|
Leucine crystals [Presence] in Urine by Computer assisted method |
|
5798-4
|
Leucine crystals [Presence] in Urine sediment by Light microscopy |
|
9412-8
|
Leucine [Moles/volume] in Cerebral spinal fluid |
|
47679-6
|
Leucine [Moles/volume] in DBS |
|
32254-5
|
Leucine [Moles/volume] in Body fluid |
|
55933-6
|
Leucine [Moles/mass] in Hair |
|
81043-2
|
Leucine intake 24 hour Estimated |
|
81044-0
|
Leucine intake 24 hour Measured |
|
74882-2
|
Leucine [Moles/volume] in DBS --post therapeutic diet |
|
2559-3
|
Leucine [Presence] in Serum or Plasma |
|
2560-1
|
Leucine [Mass/volume] in Serum or Plasma |
|
20649-0
|
Leucine [Moles/volume] in Serum or Plasma |
|
47682-0
|
Leucine/Amino acids.total in Amniotic fluid |
|
47681-2
|
Leucine/Amino acids.total in Cerebral spinal fluid |
|
47684-6
|
Leucine/Amino acids.total in DBS |
|
47680-4
|
Leucine/Amino acids.total in Hair |
|
47683-8
|
Leucine/Amino acids.total in Serum or Plasma |
|
47685-3
|
Leucine/Amino acids.total in Unspecified specimen |
|
49834-5
|
Leucine [Presence] in Urine |
|
2561-9
|
Leucine [Mass/volume] in Urine |
|
27323-5
|
Leucine [Moles/volume] in Urine |
|
32253-7
|
Leucine [Moles/volume] in Vitreous fluid |
|
22719-9
|
Leucine [Moles/volume] in Unspecified specimen |
|
57994-6
|
Leucine/Alanine [Mass Ratio] in DBS |
|
44334-1
|
Leucine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56954-1
|
Leucine/Creatinine [Ratio] in 24 hour Urine |
|
25942-4
|
Leucine/Creatinine [Molar ratio] in 24 hour Urine |
|
13768-7
|
Leucine/Creatinine [Mass Ratio] in Urine |
|
30053-3
|
Leucine/Creatinine [Ratio] in Urine |
|
22693-6
|
Leucine/Creatinine [Molar ratio] in Urine |
|
57995-3
|
Leucine/Phenylalanine [Mass Ratio] in DBS |
|
75268-3
|
Leucine/Phenylalanine [Molar ratio] in DBS |
|
12726-6
|
Leucine-enkephalin [Units/volume] in Serum or Plasma |
|
49493-0
|
Leukemia markers [Interpretation] in Blood Narrative |
|
49492-2
|
Leukemia markers [Interpretation] in Cerebral spinal fluid Narrative |
|
49494-8
|
Leukemia markers [Interpretation] in Pleural fluid Narrative |
|
74347-6
|
Leukocyte aggregates [Presence] in Blood by Light microscopy |
|
75196-6
|
Leukocyte count or protein test was performed on CSF and test findings [CDC.CS] |
|
59262-6
|
Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip |
|
77563-5
|
Leukocyte esterase [Presence] in Body fluid by Automated test strip |
|
5799-2
|
Leukocyte esterase [Presence] in Urine by Test strip |
|
60026-2
|
Leukocyte esterase [Presence] in Urine by Automated test strip |
|
27297-1
|
Leukocyte esterase [Units/volume] in Urine |
|
2563-5
|
Leukocyte esterase [Enzymatic activity/volume] in Leukocytes |
|
73315-4
|
Leuprolide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73314-7
|
Leuprolide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73313-9
|
Levalbuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73312-1
|
Levalbuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59291-5
|
Levamisole [Mass/volume] in Blood |
|
59292-3
|
Levamisole [Mass/volume] in Body fluid |
|
59293-1
|
Levamisole [Mass/volume] in Serum or Plasma |
|
59294-9
|
Levamisole [Mass/mass] in Tissue |
|
59295-6
|
Levamisole [Mass/volume] in Urine |
|
71441-0
|
Level II Preadmission Screening and Resident Review (PASRR) [CMS Assessment] |
|
80294-2
|
Level of arousal |
|
80391-6
|
Level of care [Type] |
|
80288-4
|
Level of consciousness |
|
85646-8
|
Level of consciousness - Alert (normal) during 3 day assessment [CAM.CMS] |
|
85655-9
|
Level of consciousness - Vigilant or lethargic or stupor or coma during 3 day assessment [CAM.CMS] |
|
93044-6
|
Level of evidence |
|
72349-4
|
Level of fatigue on average over the past month [Reported] |
|
73006-9
|
levETIRAcetam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73005-1
|
levETIRAcetam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73311-3
|
levETIRAcetam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73310-5
|
levETIRAcetam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
30471-7
|
levETIRAcetam [Mass/volume] in Serum or Plasma |
|
48347-9
|
levETIRAcetam [Moles/volume] in Serum or Plasma |
|
42249-3
|
levETIRAcetam [Presence] in Urine by Screen method |
|
38159-0
|
levETIRAcetam [Mass/volume] in Urine |
|
87765-4
|
levETIRAcetam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
4294-5
|
Levodopa.PO [Mass] of Dose |
|
73004-4
|
levoFLOXacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73003-6
|
levoFLOXacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
76040-5
|
levoFLOXacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
48173-9
|
levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
76041-3
|
levoFLOXacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
76042-1
|
levoFLOXacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
73307-1
|
levoFLOXacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73306-3
|
levoFLOXacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7026-8
|
levoFLOXacin [Susceptibility] by Gradient strip |
|
21367-8
|
levoFLOXacin [Susceptibility] by Disk diffusion (KB) |
|
20396-8
|
levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
53716-7
|
levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
30532-6
|
levoFLOXacin [Mass/volume] in Serum or Plasma --peak |
|
21368-6
|
levoFLOXacin [Mass/volume] in Serum or Plasma |
|
20629-2
|
levoFLOXacin [Susceptibility] |
|
30533-4
|
levoFLOXacin [Mass/volume] in Serum or Plasma --trough |
|
3713-5
|
Levorphanol [Mass/time] in 24 hour Urine |
|
19519-8
|
Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method |
|
19518-0
|
Levorphanol cutoff [Mass/volume] in Urine for Screen method |
|
4298-6
|
Levorphanol [Mass] of Dose |
|
3710-1
|
Levorphanol [Mass/volume] in Serum or Plasma |
|
20540-1
|
Levorphanol [Mass/volume] in Urine by Confirmatory method |
|
3711-9
|
Levorphanol [Presence] in Urine |
|
16213-1
|
Levorphanol [Presence] in Urine by Confirmatory method |
|
19516-4
|
Levorphanol [Presence] in Urine by Screen method |
|
3712-7
|
Levorphanol [Mass/volume] in Urine |
|
90804-6
|
Levothyroxine absorption in Serum or Plasma by calculation |
|
79484-2
|
Levulinate [Moles/volume] in Serum or Plasma |
|
79504-7
|
Levulinate/Creatinine [Molar ratio] in Urine |
|
93782-1
|
Large B-cell lymphoma [Type] in Tissue |
|
93779-7
|
Large B-cell lymphoma and cell of origin [Type] in Tissue |
|
35082-7
|
Large granular lymphocytes [#/volume] in Blood |
|
59808-6
|
Large granular lymphocytes [Presence] in Blood |
|
30420-4
|
Large granular lymphocytes/100 leukocytes in Blood |
|
60439-7
|
Large granular lymphocytes/100 leukocytes in Blood by Flow cytometry (FC) |
|
11275-5
|
Large granular lymphocytes/100 leukocytes in Blood by Manual count |
|
34167-7
|
Platelets Large [Presence] in Blood by Automated count |
|
32146-3
|
Platelets Large [Presence] in Blood by Light microscopy |
|
48386-7
|
Platelets Large/Platelets in Blood by Automated count |
|
90830-1
|
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90831-9
|
Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82985-3
|
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82978-8
|
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
25717-0
|
Lutropin [Units/volume] in Serum or Plasma --1.5 hours post 100 ug lutenizing releasing hormone IV |
|
27885-3
|
Lutropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
57103-4
|
Lutropin [Units/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
|
1588-3
|
Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
|
17094-4
|
Lutropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge |
|
56493-0
|
Lutropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
12672-2
|
Lutropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
57107-5
|
Lutropin [Units/volume] in Serum or Plasma --10 minutes pre dose gonadotropin releasing hormone |
|
47687-9
|
Lutropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV |
|
27883-8
|
Lutropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
46414-9
|
Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone |
|
40373-3
|
Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
48118-4
|
Lutropin [Units/volume] in Serum or Plasma --15 minutes pre 100 ug lutenizing releasing hormone IV |
|
12674-8
|
Lutropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
25718-8
|
Lutropin [Units/volume] in Serum or Plasma --1 hour post 100 ug lutenizing releasing hormone IV |
|
32327-9
|
Lutropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
32606-6
|
Lutropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57104-2
|
Lutropin [Units/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
|
1592-5
|
Lutropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
|
40374-1
|
Lutropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
47864-4
|
Lutropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug lutenizing releasing hormone IV |
|
32995-3
|
Lutropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
12675-5
|
Lutropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
57106-7
|
Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose gonadotropin releasing hormone |
|
40375-8
|
Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
|
15080-5
|
Lutropin [Units] in 24 hour Urine |
|
34333-5
|
Lutropin [Units/volume] in 24 hour Urine by 1st IRP |
|
29156-7
|
Lutropin [Units/volume] in 24 hour Urine |
|
6692-8
|
Lutropin [Moles/time] in 24 hour Urine |
|
25719-6
|
Lutropin [Units/volume] in Serum or Plasma --2 hours post 100 ug lutenizing releasing hormone IV |
|
56494-8
|
Lutropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
57102-6
|
Lutropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
|
1594-1
|
Lutropin [Mass/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
|
40376-6
|
Lutropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
25720-4
|
Lutropin [Units/volume] in Serum or Plasma --30 minutes post 100 ug lutenizing releasing hormone IV |
|
32326-1
|
Lutropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
32599-3
|
Lutropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
57105-9
|
Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
|
1596-6
|
Lutropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
|
40377-4
|
Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
56495-5
|
Lutropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
|
12673-0
|
Lutropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
27884-6
|
Lutropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
12676-3
|
Lutropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
53145-9
|
Lutropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
46415-6
|
Lutropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone |
|
55501-1
|
Lutropin [Units/volume] in Serum or Plasma --4 hours post XXX challenge |
|
17095-1
|
Lutropin [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
10502-3
|
Lutropin Ag [Presence] in Tissue by Immune stain |
|
32328-7
|
Lutropin [Units/volume] in Serum or Plasma --baseline |
|
1599-0
|
Lutropin [Mass/volume] in Serum or Plasma --baseline |
|
48581-3
|
Lutropin [Units/volume] in Serum or Plasma --on cycle day 11 |
|
48583-9
|
Lutropin [Units/volume] in Serum or Plasma --on cycle day 21 |
|
48582-1
|
Lutropin [Units/volume] in Serum or Plasma --on cycle day 3 |
|
47688-7
|
Lutropin [Units/volume] in Serum or Plasma --pre 100 ug lutenizing releasing hormone IV |
|
58946-5
|
Lutropin [Units/volume] in Serum or Plasma --pre XXX challenge |
|
1600-6
|
Lutropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
|
40378-2
|
Lutropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
|
34055-4
|
Lutropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
|
83103-2
|
Lutropin [Units/volume] in Serum or Plasma by Immunoassay |
|
20419-8
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP |
|
10501-5
|
Lutropin [Units/volume] in Serum or Plasma |
|
2579-1
|
Lutropin [Moles/volume] in Serum or Plasma |
|
2578-3
|
Lutropin [Moles/volume] in Semen |
|
25943-2
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --1st specimen post XXX challenge |
|
33827-7
|
Lutropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50509-9
|
Lutropin [Units/volume] in Serum or Plasma --1st specimen |
|
33826-9
|
Lutropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
25944-0
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --2nd specimen post XXX challenge |
|
27848-1
|
Lutropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12677-1
|
Lutropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50510-7
|
Lutropin [Units/volume] in Serum or Plasma --2nd specimen |
|
25945-7
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --3rd specimen post XXX challenge |
|
27851-5
|
Lutropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12678-9
|
Lutropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50511-5
|
Lutropin [Units/volume] in Serum or Plasma --3rd specimen |
|
25946-5
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --4th specimen post XXX challenge |
|
27853-1
|
Lutropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12679-7
|
Lutropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50512-3
|
Lutropin [Units/volume] in Serum or Plasma --4th specimen |
|
25947-3
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --5th specimen post XXX challenge |
|
27854-9
|
Lutropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12680-5
|
Lutropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50513-1
|
Lutropin [Units/volume] in Serum or Plasma --5th specimen |
|
25948-1
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --6th specimen post XXX challenge |
|
27855-6
|
Lutropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
12681-3
|
Lutropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50514-9
|
Lutropin [Units/volume] in Serum or Plasma --6th specimen |
|
25949-9
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --7th specimen post XXX challenge |
|
27858-0
|
Lutropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
12682-1
|
Lutropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50515-6
|
Lutropin [Units/volume] in Serum or Plasma --7th specimen |
|
25950-7
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --8th specimen post XXX challenge |
|
33828-5
|
Lutropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
12683-9
|
Lutropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50516-4
|
Lutropin [Units/volume] in Serum or Plasma --8th specimen |
|
25951-5
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --9th specimen post XXX challenge |
|
33829-3
|
Lutropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
12684-7
|
Lutropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
25716-2
|
Lutropin [Units/volume] in Urine by 1st IRP |
|
15079-7
|
Lutropin [Units/volume] in Urine |
|
2580-9
|
Lutropin [Moles/volume] in Urine |
|
29157-5
|
Lutropin/Creatinine [Ratio] in 24 hour Urine |
|
13490-8
|
Lutropin/Creatinine [Mass Ratio] in Urine |
|
34334-3
|
Lutropin/Creatinine [Ratio] in Urine |
|
34434-1
|
Lutropin/Follitropin [Ratio] in Serum or Plasma |
|
79612-8
|
L-homoarginine [Moles/volume] in Serum or Plasma |
|
79587-2
|
L-homoarginine/Creatinine [Molar ratio] in Urine |
|
79631-8
|
L-homoserine [Moles/volume] in Serum or Plasma |
|
79644-1
|
L-homoserine/Creatinine [Molar ratio] in Urine |
|
35358-1
|
LHON syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41093-6
|
LHON syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76367-2
|
Licensed nursing personnel [#] by age range [NMMDS] |
|
76357-3
|
Licensed nursing personnel [#] by employment position [NMMDS] |
|
76391-2
|
Licensed nursing personnel [#] by employment specialty [NMMDS] |
|
76371-4
|
Licensed nursing personnel [#] by entry level nursing degree [NMMDS] |
|
76379-7
|
Licensed nursing personnel [#] by highest level of education in a non-nursing degree [NMMDS] |
|
76375-5
|
Licensed nursing personnel [#] by highest level of education in a nursing degree [NMMDS] |
|
76387-0
|
Licensed nursing personnel [#] by nursing certification [NMMDS] |
|
76383-9
|
Licensed nursing personnel [#] by primary nursing license type [NMMDS] |
|
76363-1
|
Licensed nursing personnel [#] by race or ethnicity [NMMDS] |
|
76360-7
|
Licensed nursing personnel [#] by sex [NMMDS] |
|
76353-2
|
Licensed nursing staff # [NMMDS] |
|
76392-0
|
Licensed nursing staff [NMMDS] |
|
76358-1
|
Licensed nursing staff by employment position/Licensed nursing staff [NMMDS] |
|
76368-0
|
Licensed nursing staff.age range/Licensed nursing staff [NMMDS] |
|
76372-2
|
Licensed nursing staff.entry level nursing degree/Licensed nursing staff [NMMDS] |
|
76380-5
|
Licensed nursing staff.highest level of education in a non-nursing degree/Licensed nursing staff [NMMDS] |
|
76376-3
|
Licensed nursing staff.highest level of education in a nursing degree/Licensed nursing staff [NMMDS] |
|
76388-8
|
Licensed nursing staff.nursing certification/Licensed nursing staff [NMMDS] |
|
76384-7
|
Licensed nursing staff.primary nursing license type/Licensed nursing staff [NMMDS] |
|
76364-9
|
Licensed nursing staff.race or ethnicity/Licensed nursing staff [NMMDS] |
|
76361-5
|
Licensed nursing staff.sex/Licensed nursing staff [NMMDS] |
|
75538-9
|
Licensing received [NMMDS] |
|
7462-5
|
Licorice IgE Ab [Units/volume] in Serum |
|
21369-4
|
Licorice IgE Ab RAST class [Presence] in Serum |
|
2516-3
|
L-iditol dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
|
2517-1
|
L-iditol dehydrogenase [Enzymatic activity/volume] in Serum |
|
3717-6
|
Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose |
|
4299-4
|
Lidocaine [Mass] of Dose |
|
17076-1
|
Lidocaine [Mass/volume] in Body fluid |
|
41850-9
|
Lidocaine IgE Ab [Units/volume] in Serum |
|
73305-5
|
Lidocaine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73304-8
|
Lidocaine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48194-5
|
Lidocaine triggered leukotriene release [Mass/volume] by Leukocytes |
|
3715-0
|
Lidocaine [Presence] in Serum or Plasma |
|
35615-4
|
Lidocaine [Mass/volume] in Serum or Plasma by Screen method |
|
3714-3
|
Lidocaine [Mass/volume] in Serum or Plasma |
|
14812-2
|
Lidocaine [Moles/volume] in Serum or Plasma |
|
3716-8
|
Lidocaine [Presence] in Urine |
|
17075-3
|
Lidocaine [Mass/volume] in Urine |
|
32086-1
|
Lidocaine [Presence] in Unspecified specimen |
|
75327-7
|
Life expectancy [Time] Estimated |
|
54846-1
|
Life expectancy of less than 6 months [CMS Assessment] |
|
87516-1
|
Life support was discontinued |
|
85458-8
|
Lifestyle behaviors impacting physical or mental well-being - visual analog rating [ePCAM] |
|
83332-7
|
Lifestyle behaviors impacting physical or mental well-being [PCAM] |
|
93307-7
|
Lifetime risk for developing coronary heart disease based on genetic risk score |
|
87759-7
|
Lifetime risk for developing genetic disease assessed Lifetime |
|
89559-9
|
Lifetime suicide risk score [CUBS] |
|
74011-8
|
Lifetime tobacco use |
|
82229-6
|
Lifting [NDI] |
|
88477-5
|
Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4 weeks [SAQ] |
|
93830-8
|
Light sleep duration |
|
6162-2
|
Lilac IgE Ab [Units/volume] in Serum |
|
15816-2
|
Lilac IgE Ab RAST class [Presence] in Serum |
|
50964-6
|
Liley Zone [Presence] in Amniotic fluid by Spectrophotometry |
|
7131-6
|
Lima Bean IgE Ab [Units/volume] in Serum |
|
15566-3
|
Lima Bean IgE Ab RAST class [Presence] in Serum |
|
7132-4
|
Lima Bean IgG Ab [Units/volume] in Serum |
|
56308-0
|
Lima Bean IgG4 Ab [Mass/volume] in Serum |
|
63106-9
|
Lima Bean IgG Ab [Mass/volume] in Serum |
|
7464-1
|
Lime IgE Ab [Units/volume] in Serum |
|
15818-8
|
Lime IgE Ab RAST class [Presence] in Serum |
|
57941-7
|
Lime IgE Ab/IgE total in Serum |
|
7465-8
|
Lime IgG Ab [Units/volume] in Serum |
|
21370-2
|
Lime IgG Ab RAST class [Presence] in Serum |
|
56309-8
|
Lime IgG4 Ab [Mass/volume] in Serum |
|
60382-9
|
Lime IgG Ab [Mass/volume] in Serum |
|
6163-0
|
Lime Tree (Citrus aurantifolia tree) IgE Ab [Units/volume] in Serum |
|
81346-9
|
Limitations placed on healthcare agent [Reported] |
|
54832-1
|
Limited activities because of pain in last 5 days [CMS Assessment] |
|
19798-8
|
Limitations of examination Endoscopy procedure |
|
19799-6
|
Limitations of examination [Description] Endoscopy procedure Narrative |
|
41700-6
|
Lincomycin [Susceptibility] by Gradient strip |
|
300-4
|
Lincomycin [Susceptibility] by Disk diffusion (KB) |
|
299-8
|
Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
298-0
|
Lincomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18938-1
|
Lincomycin [Susceptibility] |
|
301-2
|
Lincomycin [Susceptibility] by Serum bactericidal titer |
|
87597-1
|
Lincomycin [Mass/mass] in Unspecified specimen |
|
38605-2
|
Lindane [Mass/volume] in Air |
|
16965-6
|
Lindane [Mass/volume] in Blood |
|
11097-3
|
Lindane [Mass/volume] in Serum or Plasma |
|
13643-2
|
Lindane [Mass/volume] in Urine |
|
38323-2
|
Lindane [Mass/volume] in Water |
|
87649-0
|
Lindane [Mass/mass] in Unspecified specimen |
|
11179-9
|
Linden IgE Ab [Units/volume] in Serum |
|
15819-6
|
Linden IgE Ab RAST class [Presence] in Serum |
|
77738-3
|
Line Flush [Type] |
|
7466-6
|
Linen IgE Ab [Units/volume] in Serum |
|
88706-7
|
Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
80609-1
|
Linezolid [Mass/volume] in DBS |
|
73302-2
|
Linezolid induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73303-0
|
Linezolid induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
33332-8
|
Linezolid [Susceptibility] by Gradient strip |
|
29255-7
|
Linezolid [Susceptibility] by Disk diffusion (KB) |
|
29254-0
|
Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41500-0
|
Linezolid [Susceptibility] by Method for Slow-growing mycobacteria |
|
34202-2
|
Linezolid [Mass/volume] in Serum or Plasma |
|
29258-1
|
Linezolid [Susceptibility] |
|
75117-2
|
Linoleate (C18:2w6) [Entitic substance] in Red Blood Cells |
|
2564-3
|
Linoleate (C18:2w6) [Mass/volume] in Serum or Plasma |
|
35165-0
|
Linoleate (C18:2w6) [Moles/volume] in Serum or Plasma |
|
47686-1
|
Linoleate (C18:2w6)/Creatinine [Molar ratio] in Urine |
|
90917-6
|
Linoleate (C18:2w6)/Fatty acids.C14-C22 in Blood |
|
54312-4
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Amniotic fluid |
|
54311-6
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Cerebral spinal fluid |
|
45217-7
|
Linoleoylcarnitine (C18:2) [Moles/volume] in DBS |
|
18462-2
|
Linoleoylcarnitine (C18:2) [Mass/volume] in Serum or Plasma |
|
30534-2
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Serum or Plasma |
|
54313-2
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Urine |
|
54310-8
|
Linoleoylcarnitine (C18:2)/Creatinine [Molar ratio] in Urine |
|
55294-3
|
Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB) |
|
55293-5
|
Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55292-7
|
Linopristin+Flopristin [Susceptibility] |
|
25992-9
|
Lipase [Enzymatic activity/volume] in 24 hour Urine |
|
25543-0
|
Lipase [Enzymatic activity/time] in 24 hour Urine |
|
3039-5
|
Lipase [Enzymatic activity/volume] in Amniotic fluid |
|
88712-5
|
Lipase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
55934-4
|
Lipase [Enzymatic activity/volume] in Dialysis fluid |
|
15212-4
|
Lipase [Enzymatic activity/volume] in Body fluid |
|
47418-9
|
Lipase [Enzymatic activity/volume] in Pleural fluid |
|
32722-1
|
Lipase [Enzymatic activity/volume] in Peritoneal fluid |
|
3040-3
|
Lipase [Enzymatic activity/volume] in Serum or Plasma |
|
35364-9
|
Lipase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
|
35316-9
|
Lipase [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
|
35315-1
|
Lipase [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
|
35314-4
|
Lipase [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
|
35313-6
|
Lipase [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
|
10888-6
|
Lipase [Enzymatic activity/volume] in Urine |
|
46425-5
|
Lipemic index of Serum or Plasma |
|
49062-3
|
Lipid risk factors [Finding] |
|
5800-8
|
Lipids [#/area] in Urine sediment by Microscopy high power field |
|
12912-2
|
Lipids [Mass/volume] in Body fluid |
|
2569-2
|
Lipids [Mass/volume] in Serum |
|
7467-4
|
Lipolase IgE Ab [Units/volume] in Serum |
|
82018-3
|
Lipolase IgE Ab RAST class [Presence] in Serum |
|
70034-4
|
Lipophages/100 leukocytes in Cerebral spinal fluid by Manual count |
|
54441-1
|
Lipoprotein goals |
|
51002-4
|
Lipoprotein midband A [Mass/volume] in Serum or Plasma |
|
51003-2
|
Lipoprotein midband B [Mass/volume] in Serum or Plasma |
|
51004-0
|
Lipoprotein midband C [Mass/volume] in Serum or Plasma |
|
10580-9
|
Liquefaction [Time] in Semen |
|
73002-8
|
Lisinopril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73001-0
|
Lisinopril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73301-4
|
Lisinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73300-6
|
Lisinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
84474-6
|
List Sorting Working Memory Test - raw score [NIH Toolbox] |
|
84475-3
|
List Sorting Working Memory Test - unadjusted scale score [NIH Toolbox] |
|
84471-2
|
List Sorting Working Memory Test - national percentile [NIH Toolbox] |
|
84472-0
|
List Sorting Working Memory Test - scale score age adjusted [NIH Toolbox] |
|
84473-8
|
List Sorting Working Memory Test - scale score fully adjusted [NIH Toolbox] |
|
84434-0
|
List Sorting Working Memory Test [NIH Toolbox] |
|
31488-0
|
Listeria sp Ab [Units/volume] in Cerebral spinal fluid |
|
23210-8
|
Listeria sp Ab [Presence] in Serum |
|
23211-6
|
Listeria sp Ab [Presence] in Serum by Agglutination |
|
26907-6
|
Listeria sp Ab [Titer] in Cerebral spinal fluid |
|
51461-2
|
Listeria sp Ab [Titer] in Serum |
|
49711-5
|
Listeria sp Ab [Titer] in Serum by Complement fixation |
|
20871-0
|
Listeria sp [Presence] in Cheese by Organism specific culture |
|
92767-3
|
Listeria sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
90100-9
|
Listeria sp identified in Isolate by Organism specific culture |
|
20870-2
|
Listeria sp [Presence] in Milk by Organism specific culture |
|
88265-4
|
Listeria sp tuf gene [Presence] by Probe in Positive blood culture |
|
6609-2
|
Listeria sp identified in Unspecified specimen by Organism specific culture |
|
38902-3
|
LITAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38919-7
|
LITAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
25714-7
|
Litchi IgE Ab [Units/volume] in Serum |
|
25715-4
|
Litchi IgE Ab RAST class [Presence] in Serum |
|
34330-1
|
Lithium [Moles/volume] in 24 hour Urine |
|
18477-0
|
Lithium [Moles/time] in 24 hour Urine |
|
25461-5
|
Lithium [Moles/volume] in Blood |
|
3722-6
|
Lithium renal clearance in 24 hour Urine and Serum or Plasma |
|
4300-0
|
Lithium [Mass] of Dose |
|
17086-0
|
Lithium [Mass/volume] in Body fluid |
|
80970-7
|
Lithium free [Moles/volume] in Serum or Plasma |
|
56032-6
|
Lithium [Moles/volume] in Gastric fluid |
|
3718-4
|
Lithium [Mass/mass] in Hair |
|
50872-1
|
Lithium [Moles/mass] in Hair |
|
9815-2
|
Lithium [Mass/volume] in Red Blood Cells |
|
25462-3
|
Lithium [Moles/volume] in Red Blood Cells |
|
15369-2
|
Lithium.saliva/Lithium.serum |
|
9358-3
|
Lithium [Mass/volume] in Saliva (oral fluid) |
|
43176-7
|
Lithium [Moles/volume] in Saliva (oral fluid) |
|
3720-0
|
Lithium [Presence] in Serum or Plasma |
|
13455-1
|
Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood |
|
3719-2
|
Lithium [Mass/volume] in Serum or Plasma |
|
14334-7
|
Lithium [Moles/volume] in Serum or Plasma |
|
18238-6
|
Lithium [Mass/mass] in Tissue |
|
3723-4
|
Lithium [Mass/volume] in Serum or Plasma --trough |
|
74806-1
|
Lithium [Moles/volume] in Serum or Plasma --trough |
|
3721-8
|
Lithium [Mass/volume] in Urine |
|
25463-1
|
Lithium [Moles/volume] in Urine |
|
34331-9
|
Lithium/Creatinine [Molar ratio] in Urine |
|
2577-5
|
Lithocholate [Mass/volume] in Serum |
|
74897-0
|
Lithocholate [Moles/volume] in Serum or Plasma |
|
1154-4
|
little c Ab [Presence] in Serum or Plasma from Blood product unit |
|
1155-1
|
little c Ab [Presence] in Serum or Plasma from Donor |
|
1156-9
|
little c Ab [Presence] in Serum or Plasma |
|
24384-0
|
little c Ab [Units/volume] in Serum or Plasma |
|
55332-1
|
little c Ab [Titer] in Serum or Plasma |
|
93936-3
|
little c Ag [Presence] on Red Blood Cells --during infancy |
|
92529-7
|
little c Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92491-0
|
little c Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93926-4
|
little c Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93919-9
|
little c Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1157-7
|
little c Ag [Presence] on Red Blood Cells from Blood product unit |
|
1158-5
|
little c Ag [Presence] on Red Blood Cells from Donor |
|
1159-3
|
little c Ag [Presence] on Red Blood Cells |
|
93944-7
|
little c Ag [Presence] in Cord red blood cells |
|
65331-1
|
little cE Ab [Presence] in Serum or Plasma |
|
93911-6
|
little cE Ag [Presence] on Red Blood Cells |
|
1160-1
|
little e Ab [Presence] in Serum or Plasma from Blood product unit |
|
1161-9
|
little e Ab [Presence] in Serum or Plasma from Donor |
|
1162-7
|
little e Ab [Presence] in Serum or Plasma |
|
34157-8
|
little e Ab [Titer] in Serum or Plasma |
|
93935-5
|
little e Ag [Presence] on Red Blood Cells --during infancy |
|
92528-9
|
little e Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92490-2
|
little e Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93925-6
|
little e Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93918-1
|
little e Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1163-5
|
little e Ag [Presence] on Red Blood Cells from Blood product unit |
|
1164-3
|
little e Ag [Presence] on Red Blood Cells from Donor |
|
1165-0
|
little e Ag [Presence] on Red Blood Cells |
|
93943-9
|
little e Ag [Presence] in Cord red blood cells |
|
1166-8
|
little f Ab [Presence] in Serum or Plasma from Blood product unit |
|
1167-6
|
little f Ab [Presence] in Serum or Plasma from Donor |
|
1168-4
|
little f Ab [Presence] in Serum or Plasma |
|
55333-9
|
little f Ab [Titer] in Serum or Plasma |
|
1169-2
|
little f Ag [Presence] on Red Blood Cells from Blood product unit |
|
1170-0
|
little f Ag [Presence] on Red Blood Cells from Donor |
|
1171-8
|
little f Ag [Presence] on Red Blood Cells |
|
1184-1
|
little i Ab [Presence] in Serum or Plasma from Blood product unit |
|
1185-8
|
little i Ab [Presence] in Serum or Plasma from Donor |
|
1186-6
|
little i Ab [Presence] in Serum or Plasma |
|
15344-5
|
little i Ab [Titer] in Serum or Plasma |
|
10406-7
|
little i Ag [Presence] on Red Blood Cells from Blood product unit |
|
10407-5
|
little i Ag [Presence] on Red Blood Cells from Donor |
|
10408-3
|
little i Ag [Presence] on Red Blood Cells |
|
14986-4
|
little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
|
14987-2
|
little i-1 subtype [Presence] on Red Blood Cells from Donor |
|
14988-0
|
little i-1 subtype [Presence] on Red Blood Cells |
|
14989-8
|
little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
|
14990-6
|
little i-2 subtype [Presence] on Red Blood Cells from Donor |
|
14991-4
|
little i-2 subtype [Presence] on Red Blood Cells |
|
44250-9
|
Little interest or pleasure in doing things in last 2 weeks [Reported.PHQ] |
|
54659-8
|
Little interest or pleasure in doing things in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54637-4
|
Little interest or pleasure in doing things in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54658-0
|
Little interest or pleasure in doing things in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
54636-6
|
Little interest or pleasure in doing things in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
1190-8
|
little k Ab [Presence] in Serum or Plasma from Blood product unit |
|
1191-6
|
little k Ab [Presence] in Serum or Plasma from Donor |
|
1192-4
|
little k Ab [Presence] in Serum or Plasma |
|
55334-7
|
little k Ab [Titer] in Serum or Plasma |
|
92527-1
|
little k Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92489-4
|
little k Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1193-2
|
little k Ag [Presence] on Red Blood Cells from Blood product unit |
|
1194-0
|
little k Ag [Presence] on Red Blood Cells from Donor |
|
1195-7
|
little k Ag [Presence] on Red Blood Cells |
|
88041-9
|
little p phenotype [Presence] on Red Blood Cells from Blood product unit |
|
88042-7
|
little p phenotype [Presence] on Red Blood Cells from Donor |
|
88039-3
|
little p phenotype [Presence] on Red Blood Cells |
|
1208-8
|
little s Ab [Presence] in Serum or Plasma from Blood product unit |
|
1209-6
|
little s Ab [Presence] in Serum or Plasma from Donor |
|
1210-4
|
little s Ab [Presence] in Serum or Plasma |
|
55335-4
|
little s Ab [Titer] in Serum or Plasma |
|
92526-3
|
little s Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92488-6
|
little s Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1211-2
|
little s Ag [Presence] on Red Blood Cells from Blood product unit |
|
1212-0
|
little s Ag [Presence] on Red Blood Cells from Donor |
|
1213-8
|
little s Ag [Presence] on Red Blood Cells |
|
90370-8
|
LIVD mapping data set |
|
92278-1
|
Lived with someone who smoked regularly inside the home during childhood |
|
7144-9
|
Liver beef triggered histamine release [Units/volume] in Blood |
|
15820-4
|
Liver beef IgE Ab RAST class [Presence] in Serum |
|
7469-0
|
Liver calf IgE Ab [Units/volume] in Serum |
|
90292-4
|
Liver cancer antibodies and AFP [Interpretation] in Serum or Plasma Qualitative |
|
13175-5
|
Liver cytosol Ab [Presence] in Serum |
|
57748-6
|
Liver cytosol Ab [Presence] in Serum by Immunoassay |
|
56719-8
|
Liver cytosol Ab [Presence] in Serum by Immunoblot |
|
34621-3
|
Liver cytosol Ab [Units/volume] in Serum |
|
63395-8
|
Liver cytosol Ab [Titer] in Serum by Immunofluorescence |
|
82921-8
|
Liver cytosol IgG Ab [Presence] in Serum by Line blot |
|
78894-3
|
Liver fibrosis score in Serum or Plasma Calculated by HepaScore |
|
88055-9
|
Liver fibrosis score in Serum or Plasma by Calculated by ELF |
|
77616-1
|
Liver fibrosis score in Serum or Plasma Calculated by FibroMeter |
|
48795-9
|
Fibrosis score |
|
88447-8
|
Liver fibrosis interpretation in Serum Qualitative |
|
7468-2
|
Liver IgE Ab [Units/volume] in Serum |
|
11839-8
|
Liver Longitudinal diameter US |
|
65752-8
|
Liver Pathology biopsy report |
|
93696-3
|
Liver steatosis grade in Serum or Plasma Qualitative |
|
93697-1
|
Liver steatosis interpretation in Serum or Plasma Qualitative |
|
93695-5
|
Liver steatosis score in Serum or Plasma |
|
85950-4
|
Living situation and availability of assistance [CMS Assessment] |
|
14272-9
|
Liver kidney microsomal Ab [Presence] in Serum |
|
56760-2
|
Liver kidney microsomal Ab [Presence] in Serum by Immunoblot |
|
53030-3
|
Liver kidney microsomal Ab [Presence] in Serum by Immunofluorescence |
|
11566-7
|
Liver kidney microsomal Ab [Units/volume] in Serum |
|
9838-4
|
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence |
|
82842-6
|
Liver kidney microsomal IgG Ab [Presence] in Serum by Immunofluorescence |
|
50629-5
|
Liver kidney microsomal IgG Ab [Titer] in Serum |
|
46982-5
|
Liver kidney microsomal IgG Ab [Titer] in Serum by Immunofluorescence |
|
63272-9
|
Liver kidney microsomal 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63270-3
|
Liver kidney microsomal 1 Ab [Presence] in Body fluid by Immunofluorescence |
|
30535-9
|
Liver kidney microsomal 1 Ab [Presence] in Serum |
|
59072-9
|
Liver kidney microsomal 1 Ab [Presence] in Serum by Immunoblot |
|
58907-7
|
Liver kidney microsomal 1 Ab [Presence] in Serum by Immunofluorescence |
|
32220-6
|
Liver kidney microsomal 1 Ab [Units/volume] in Serum |
|
63273-7
|
Liver kidney microsomal 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63271-1
|
Liver kidney microsomal 1 Ab [Titer] in Body fluid by Immunofluorescence |
|
57434-3
|
Liver kidney microsomal 1 Ab [Titer] in Serum by Immunofluorescence |
|
47318-1
|
Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
43234-4
|
Liver kidney microsomal 1 IgG Ab [Presence] in Serum |
|
69952-0
|
Liver kidney microsomal 1 IgG Ab [Presence] in Serum by Immunoassay |
|
43202-1
|
Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum |
|
63274-5
|
Liver kidney microsomal 2 Ab [Presence] in Serum by Immunofluorescence |
|
63275-2
|
Liver kidney microsomal 2 Ab [Titer] in Serum by Immunofluorescence |
|
7470-8
|
Llama fur IgE Ab [Units/volume] in Serum |
|
79633-4
|
L-leucyl-L-proline [Moles/volume] in Serum or Plasma |
|
79626-8
|
L-leucyl-L-proline/Creatinine [Molar ratio] in Urine |
|
19515-6
|
Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19514-9
|
Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
15404-7
|
Levomethamphetamine/Amphetamines.total in Urine |
|
19512-3
|
Levomethamphetamine [Mass/volume] in Urine by Confirmatory method |
|
19511-5
|
Levomethamphetamine [Presence] in Urine by Confirmatory method |
|
19510-7
|
Levomethamphetamine [Presence] in Urine by Screen method |
|
12478-4
|
Levomethamphetamine [Mass/volume] in Urine |
|
35297-1
|
LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49705-7
|
LMNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
3144-3
|
Last menstrual period duration |
|
33066-2
|
Last menstrual period Estimated from EDD |
|
45274-8
|
Low molecular weight heparin induced platelet Ab [Presence] in Serum |
|
3272-2
|
LMW Heparin [Mass/time] in 24 hour Urine |
|
3271-4
|
LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3270-6
|
LMW Heparin [Units/volume] in Platelet poor plasma by Coagulation assay |
|
32684-3
|
LMW Heparin [Units/volume] in Platelet poor plasma |
|
3279-7
|
Kininogen LMW [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3280-5
|
Kininogen LMW [Mass/volume] in Serum by Immunoassay |
|
53875-1
|
LMX1B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
92833-3
|
Lymph nodes examined [#] in Cancer specimen by Light microscopy |
|
76397-9
|
Lymph node involvement |
|
85343-2
|
Lymph nodes with macrometastases [#] in Cancer specimen by Light microscopy |
|
92831-7
|
Lymph nodes with metastasis [#] in Cancer specimen |
|
85351-5
|
Lymph node metastatic deposit.max dimension [Length] in Cancer specimen by Light microscopy |
|
85344-0
|
Lymph nodes with micrometastases [#] in Cancer specimen by Light microscopy |
|
85342-4
|
Lymph node site of origin [Anatomy] in Cancer specimen |
|
66112-4
|
Lymph node Pathology biopsy report |
|
85349-9
|
Lymph node response to neoadjuvant therapy in Cancer specimen by CAP cancer protocols |
|
85352-3
|
Lymph nodes with isolated tumor cells [#] in Cancer specimen by Light microscopy |
|
7608-3
|
Loblolly Pine IgE Ab [Units/volume] in Serum |
|
15940-0
|
Loblolly Pine IgE Ab RAST class [Presence] in Serum |
|
6165-5
|
Lobster IgE Ab [Units/volume] in Serum |
|
15821-2
|
Lobster IgE Ab RAST class [Presence] in Serum |
|
39546-7
|
Lobster IgE Ab/IgE total in Serum |
|
7471-6
|
Lobster IgG Ab [Units/volume] in Serum |
|
21371-0
|
Lobster IgG Ab RAST class [Presence] in Serum |
|
56310-6
|
Lobster IgG4 Ab [Mass/volume] in Serum |
|
60383-7
|
Lobster IgG Ab [Mass/volume] in Serum |
|
80342-9
|
Location of breath sounds by Auscultation |
|
92829-1
|
Location of metastasis within sentinel lymph node [Anatomy] in Cancer specimen |
|
86666-5
|
Location within lymph node [Anatomy] in Skin melanoma by Light microscopy |
|
69580-9
|
Local assigning authority [Identifier] in Isolate |
|
69579-1
|
Local PFGE event description in Isolate |
|
68988-5
|
Local PFGE pattern [Identifier] in Isolate |
|
71521-9
|
Location Dialysis facility [ESRD] |
|
71480-8
|
Location of death [ESRD] |
|
74553-9
|
Location of patient safety event or unsafe condition - Narrative [AHRQ] |
|
74573-7
|
Location of patient safety event or unsafe condition - Nominal [AHRQ] |
|
81355-0
|
Location of prescribed anticipatory medication [Reported] |
|
90119-9
|
Location of task |
|
57247-9
|
Locomotion - functional ability [CMS Assessment] |
|
45598-0
|
Locomotion off unit - self-performance during 7 day assessment period [CMS Assessment] |
|
45599-8
|
Locomotion off unit - support provided during 7 day assessment period [CMS Assessment] |
|
45596-4
|
Locomotion on unit - self-performance during 7 day assessment period [CMS Assessment] |
|
45597-2
|
Locomotion on unit - support provided during 7 day assessment period [CMS Assessment] |
|
7472-4
|
Locust tree IgE Ab [Units/volume] in Serum |
|
56311-4
|
Locust tree IgG4 Ab [Mass/volume] in Serum |
|
21461-9
|
Lodgepole Pine+Pondersosa Pine IgE Ab [Units/volume] in Serum |
|
21462-7
|
Lodgepole Pine+Pondersosa Pine IgE Ab RAST class [Presence] in Serum |
|
6672-0
|
Microscopic observation [Identifier] in Tissue by Methylene blue stain.Loeffler |
|
671-8
|
Microscopic observation [Identifier] in Unspecified specimen by Methylene blue stain.Loeffler |
|
41701-4
|
Lomefloxacin [Susceptibility] by Gradient strip |
|
304-6
|
Lomefloxacin [Susceptibility] by Disk diffusion (KB) |
|
303-8
|
Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
302-0
|
Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18939-9
|
Lomefloxacin [Susceptibility] |
|
305-3
|
Lomefloxacin [Susceptibility] by Serum bactericidal titer |
|
65781-7
|
London Plane native (nPla a) 2 IgE Ab [Units/volume] in Serum |
|
64969-9
|
London Plane recombinant (rPla a) 1 IgE Ab [Units/volume] in Serum |
|
81963-1
|
London Plane recombinant (rPla a) 1 IgE Ab RAST class [Presence] in Serum |
|
64970-7
|
London Plane recombinant (rPla a) 3 IgE Ab [Units/volume] in Serum |
|
15285-0
|
London Plane IgE Ab [Units/volume] in Serum |
|
30126-7
|
London Plane IgE Ab RAST class [Presence] in Serum |
|
61302-6
|
London Plane IgE Ab/IgE total in Serum |
|
84978-6
|
Loneliness Survey - age 18+ - T-score [NIH Toolbox] |
|
84976-0
|
Loneliness Survey - national percentile [NIH Toolbox] |
|
84977-8
|
Loneliness Survey - scale score age adjusted [NIH Toolbox] |
|
84982-8
|
Loneliness Survey - scale score fully adjusted [NIH Toolbox] |
|
84983-6
|
Loneliness Survey - unadjusted scale score [NIH Toolbox] |
|
84980-2
|
Loneliness Survey version 2.0 - ages 8-17 - T-score [NIH Toolbox] |
|
75194-1
|
Long bone x-rays were performed and consistent with congenital syphilis [CDC.CS] |
|
10955-3
|
Long Leaf Pine IgE Ab [Units/volume] in Serum |
|
15941-8
|
Long Leaf Pine IgE Ab RAST class [Presence] in Serum |
|
91589-2
|
Longitude Event |
|
87509-6
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00 [CMS Assessment] |
|
87506-2
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00 [CMS Assessment] |
|
87507-0
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00 [CMS Assessment] |
|
87508-8
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00 [CMS Assessment] |
|
87505-4
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 4.00 [CMS Assessment] |
|
54617-6
|
Long-term memory OK in last 7 days [CMS Assessment] |
|
60095-7
|
Loperamide [Mass/volume] in Blood |
|
73299-0
|
Loperamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73298-2
|
Loperamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17087-8
|
Loperamide [Mass/volume] in Serum or Plasma |
|
60096-5
|
Loperamide [Mass/volume] in Urine |
|
41031-6
|
Lopinavir [Susceptibility] by Genotype method |
|
34643-7
|
Lopinavir [Susceptibility] by Phenotype method |
|
31179-5
|
Lopinavir [Mass/volume] in Serum or Plasma |
|
51921-5
|
Lopinavir [Mass/volume] in Serum or Plasma --trough |
|
42000-0
|
Lopinavir+Ritonavir [Susceptibility] by Genotype method |
|
57997-9
|
Lopinavir+Ritonavir [Susceptibility] by Phenotype method |
|
7027-6
|
Loracarbef [Susceptibility] by Gradient strip |
|
308-7
|
Loracarbef [Susceptibility] by Disk diffusion (KB) |
|
307-9
|
Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
306-1
|
Loracarbef [Susceptibility] by Minimum lethal concentration (MLC) |
|
18940-7
|
Loracarbef [Susceptibility] |
|
309-5
|
Loracarbef [Susceptibility] by Serum bactericidal titer |
|
73000-2
|
Loratadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72999-6
|
Loratadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60097-3
|
Loratadine [Mass/volume] in Blood |
|
73297-4
|
Loratadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73296-6
|
Loratadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27070-2
|
Loratadine [Mass/volume] in Serum or Plasma |
|
60098-1
|
Loratadine [Mass/volume] in Urine |
|
59700-5
|
LORazepam [Mass/volume] in Blood by Confirmatory method |
|
59699-9
|
LORazepam [Mass/volume] in Blood |
|
79254-9
|
LORazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19523-0
|
LORazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19522-2
|
LORazepam cutoff [Mass/volume] in Urine for Screen method |
|
4301-8
|
LORazepam [Mass] of Dose |
|
59702-1
|
LORazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59701-3
|
LORazepam [Mass/volume] in Body fluid |
|
52945-3
|
LORazepam [Presence] in Gastric fluid |
|
29344-9
|
LORazepam [Mass/volume] in Gastric fluid |
|
47114-4
|
LORazepam [Moles/volume] in Gastric fluid |
|
94109-6
|
LORazepam glucuronide [Presence] in Urine by Screen method |
|
26838-3
|
LORazepam [Mass/mass] in Hair |
|
73295-8
|
LORazepam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73294-1
|
LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26934-0
|
LORazepam [Mass/mass] in Meconium |
|
72754-5
|
LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72380-9
|
LORazepam [Mass/volume] in Saliva (oral fluid) |
|
59703-9
|
LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13565-7
|
LORazepam [Presence] in Serum or Plasma |
|
35616-2
|
LORazepam [Mass/volume] in Serum or Plasma by Screen method |
|
3724-2
|
LORazepam [Mass/volume] in Serum or Plasma |
|
14817-1
|
LORazepam [Moles/volume] in Serum or Plasma |
|
12380-2
|
LORazepam [Presence] in Stool |
|
27237-7
|
LORazepam [Mass/mass] in Stool |
|
59704-7
|
LORazepam [Mass/mass] in Tissue |
|
74980-4
|
LORazepam [Mass/volume] in Serum or Plasma --trough |
|
17088-6
|
LORazepam [Mass/volume] in Urine by Confirmatory method |
|
18187-5
|
LORazepam [Presence] in Urine |
|
16205-7
|
LORazepam [Presence] in Urine by Confirmatory method |
|
19520-6
|
LORazepam [Presence] in Urine by Screen method |
|
3725-9
|
LORazepam [Mass/volume] in Urine |
|
47115-1
|
LORazepam [Moles/volume] in Urine |
|
26851-6
|
LORazepam [Mass/volume] in Vitreous fluid |
|
61044-4
|
LORazepam [Presence] in Unspecified specimen |
|
48955-9
|
LORazepam [Mass/volume] in Unspecified specimen |
|
77326-7
|
LORazepam [Moles/volume] in Unspecified specimen |
|
58366-6
|
LORazepam/Creatinine [Mass Ratio] in Urine |
|
17089-4
|
Lorcainide [Mass/volume] in Serum or Plasma |
|
19527-1
|
Lormetazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19526-3
|
Lormetazepam cutoff [Mass/volume] in Urine for Screen method |
|
4302-6
|
Lormetazepam [Mass] of Dose |
|
34332-7
|
Lormetazepam [Mass/volume] in Serum or Plasma |
|
20541-9
|
Lormetazepam [Mass/volume] in Urine by Confirmatory method |
|
19525-5
|
Lormetazepam [Presence] in Urine by Confirmatory method |
|
19524-8
|
Lormetazepam [Presence] in Urine by Screen method |
|
3726-7
|
Lormetazepam [Mass/volume] in Urine |
|
72998-8
|
Losartan induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72997-0
|
Losartan induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73292-5
|
Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73293-3
|
Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51895-1
|
Lot number of Blood product unit |
|
51784-7
|
Lot number of Rh immune globulin |
|
30959-1
|
Lot number [Identifier] Vaccine |
|
74714-7
|
Lot or batch number |
|
15278-5
|
Lovage IgE Ab [Units/volume] in Serum |
|
29861-2
|
Lovage IgE Ab RAST class [Presence] in Serum |
|
73291-7
|
Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73290-9
|
Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
76229-4
|
Low pressure hold time setting Ventilator |
|
76228-6
|
Low pressure hold time Ventilator |
|
89407-1
|
Lower body dressing - functional ability [CMS Assessment] |
|
83222-0
|
Lower body dressing - functional ability during 3 day assessment period [CMS Assessment] |
|
89406-3
|
Lower body dressing - functional goal [CMS Assessment] |
|
83221-2
|
Lower body dressing - functional goal during 3 day assessment period [CMS Assessment] |
|
92998-4
|
Lower segment [Length] |
|
60099-9
|
Loxapine [Mass/volume] in Blood |
|
4303-4
|
Loxapine [Mass] of Dose |
|
3727-5
|
Loxapine [Presence] in Serum or Plasma |
|
3728-3
|
Loxapine [Mass/volume] in Serum or Plasma |
|
32087-9
|
Loxapine [Moles/volume] in Serum or Plasma |
|
89972-4
|
Loxapine [Mass/volume] in Urine by Confirmatory method |
|
3729-1
|
Loxapine [Presence] in Urine |
|
60100-5
|
Loxapine [Mass/volume] in Urine |
|
6691-0
|
Loxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
|
17090-2
|
Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
|
54414-8
|
Leukocyte-poor plateletpheresis units given [#] |
|
20510-4
|
Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis |
|
49280-1
|
Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
|
17085-2
|
Lipoproteins [Presence] in Serum or Plasma |
|
5911-3
|
Lipoprotein fractions [Interpretation] in Serum or Plasma |
|
49281-9
|
Lipoprotein fractions [Interpretation] in Serum or Plasma Narrative |
|
2576-7
|
Lipoproteins [Mass/volume] in Serum or Plasma |
|
92930-7
|
LPA gene.c.3947+467T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
92931-5
|
LPA gene.c.5673A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
35387-0
|
Cholesterol. in Lipoprotein (a) [Presence] in Serum or Plasma |
|
35388-8
|
Cholesterol. in Lipoprotein (a) [Mass/volume] in Serum or Plasma |
|
60344-9
|
Lipoprotein a/total Lipoprotein in Serum or Plasma |
|
10835-7
|
Lipoprotein a [Mass/volume] in Serum or Plasma |
|
43583-4
|
Lipoprotein a [Moles/volume] in Serum or Plasma |
|
35361-5
|
Triglyceride in Lipoprotein a [Presence] in Serum or Plasma |
|
35360-7
|
Triglyceride in Lipoprotein a [Mass/volume] in Serum or Plasma |
|
80256-1
|
Posterior descending branch from left circumflex artery [Presence] on Angiogram |
|
62255-5
|
Lipoprotein insulin resistance score in Serum or Plasma |
|
2572-6
|
Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma |
|
80255-3
|
Posterolateral from left circumflex artery [Presence] on Angiogram |
|
84188-2
|
Licensed practical nurse Long term care facility Note |
|
75437-4
|
Licensed practical nurse Note |
|
84189-0
|
Licensed practical nurse Outpatient Note |
|
86951-1
|
Lipoprotein associated phospholipase A2 [Enzymatic activity/volume] in Serum or Plasma |
|
39804-0
|
Lipoprotein associated phospholipase A2 [Mass/volume] in Serum or Plasma |
|
58721-2
|
Lymphocyte proliferation stimulated by 0.5 ug concanavalin A actual/normal in Blood |
|
45360-5
|
Lymphocyte proliferation stimulated by 0.125 ug pokeweed mitogen in Blood |
|
45361-3
|
Lymphocyte proliferation stimulated by 0.25 ug pokeweed mitogen in Blood |
|
58731-1
|
Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin actual/normal in Blood |
|
45369-6
|
Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin in Blood |
|
38277-0
|
Lymphocyte proliferation stimulated by 0.5 ug/mL Candida albicans [Units/volume] in Blood |
|
58726-1
|
Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen actual/normal in Blood |
|
45362-1
|
Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen in Blood |
|
61351-3
|
Lymphocyte proliferation stimulated by 0.6 ug pokeweed mitogen in Blood |
|
49676-0
|
Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --5 days post incubation |
|
49677-8
|
Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --7 day post incubation |
|
58730-3
|
Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin actual/normal in Blood |
|
45363-9
|
Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin in Blood |
|
58725-3
|
Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen actual/normal in Blood |
|
45364-7
|
Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen [Units/volume] in Blood |
|
38278-8
|
Lymphocyte proliferation stimulated by 1.0 ug/mL Candida albicans [Units/volume] in Blood |
|
58718-8
|
Lymphocyte proliferation stimulated by 10 ug concanavalin A actual/normal in Blood |
|
45365-4
|
Lymphocyte proliferation stimulated by 10 ug concanavalin A in Blood |
|
61353-9
|
Lymphocyte proliferation stimulated by 10 ug phytohemagglutinin in Blood |
|
58723-8
|
Lymphocyte proliferation stimulated by 10 ug pokeweed mitogen actual/normal in Blood |
|
49674-5
|
Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Blood --5 days post incubation |
|
49917-8
|
Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Leukocytes --6 days post incubation |
|
49675-2
|
Lymphocyte proliferation stimulated by 10 umol beryllium [Units/volume] in Blood --7 day post incubation |
|
48661-3
|
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --5 days post incubation |
|
50178-3
|
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --6 days post incubation |
|
49673-7
|
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --7 day post incubation |
|
38284-6
|
Lymphocyte proliferation stimulated by 19.3 ug/mL tetanus toxoid [Units/volume] in Blood |
|
58720-4
|
Lymphocyte proliferation stimulated by 2.0 ug concanavalin A actual/normal in Blood |
|
45366-2
|
Lymphocyte proliferation stimulated by 2.0 ug phytohemagglutinin in Blood |
|
38281-2
|
Lymphocyte proliferation stimulated by 2.41 ug/mL tetanus toxoid [Units/volume] in Blood |
|
61350-5
|
Lymphocyte proliferation stimulated by 2.5 ug concanavalin A in Blood |
|
58729-5
|
Lymphocyte proliferation stimulated by 2.5 ug phytohemagglutin actual/normal in Blood |
|
61352-1
|
Lymphocyte proliferation stimulated by 2.5 ug pokeweed mitogen in Blood |
|
38279-6
|
Lymphocyte proliferation stimulated by 2.5 ug/mL Candida albicans [Units/volume] in Blood |
|
45367-0
|
Lymphocyte proliferation stimulated by 20 ug concanavalin A in Blood |
|
38282-0
|
Lymphocyte proliferation stimulated by 4.83 ug/mL tetanus toxoid [Units/volume] in Blood |
|
61354-7
|
Lymphocyte proliferation stimulated by 40 ug phytohemagglutinin in Blood |
|
58719-6
|
Lymphocyte proliferation stimulated by 5 ug concanavalin A actual/normal in Blood |
|
45368-8
|
Lymphocyte proliferation stimulated by 5 ug concanavalin A in Blood |
|
58728-7
|
Lymphocyte proliferation stimulated by 5 ug phytohemagglutin actual/normal in Blood |
|
58724-6
|
Lymphocyte proliferation stimulated by 5 ug pokeweed mitogen actual/normal in Blood |
|
38280-4
|
Lymphocyte proliferation stimulated by 5.0 ug/mL Candida albicans [Units/volume] in Blood |
|
38283-8
|
Lymphocyte proliferation stimulated by 9.67 ug/mL tetanus toxoid [Units/volume] in Blood |
|
81758-5
|
Lymphocyte proliferation.anti-CD28.maximum/CD3 in Blood by Flow cytometry (FC) |
|
81759-3
|
Lymphocyte proliferation.anti-CD28.maximum/CD45 in Blood by Flow cytometry (FC) |
|
81756-9
|
Lymphocyte proliferation.anti-CD3.maximum/CD3 in Blood by Flow cytometry (FC) |
|
81760-1
|
Lymphocyte proliferation.anti-CD3.maximum/CD45 in Blood by Flow cytometry (FC) |
|
33931-7
|
Lymphocyte proliferation stimulated by Borrelia burgdorferi [Ratio] in Blood |
|
33639-6
|
Lymphocyte proliferation stimulated by Candida albicans [Units/volume] in Blood |
|
58717-0
|
Lymphocyte proliferation stimulated by concanavalin A [Interpretation] in Blood |
|
49921-0
|
Lymphocyte proliferation stimulated by concanavalin A in Blood |
|
69015-6
|
Lymphocyte proliferation.Candida albicans.maximum/CD3 in Blood by Flow cytometry (FC) |
|
69014-9
|
Lymphocyte proliferation.Candida albicans.maximum/CD45 in Blood by Flow cytometry (FC) |
|
81757-7
|
Lymphocyte proliferation.Interleukin 2.maximum/CD3 in Blood by Flow cytometry (FC) |
|
81755-1
|
Lymphocyte proliferation.Interleukin 2.maximum/CD45 in Blood by Flow cytometry (FC) |
|
57741-1
|
Lymphocyte proliferation stimulated by OKT3 in Blood |
|
49682-8
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood --3 days post incubation |
|
58727-9
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Interpretation] in Blood Narrative |
|
33638-8
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Mass/volume] in Blood |
|
49922-8
|
Lymphocyte proliferation stimulated by phytohemagglutinin in Blood |
|
48662-1
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood |
|
69013-1
|
Lymphocyte proliferation.phytohemagglutinin.maximum/CD3 in Blood by Flow cytometry (FC) |
|
69038-8
|
Lymphocyte proliferation.phytohemagglutinin.maximum/CD45 in Blood by Flow cytometry (FC) |
|
58722-0
|
Lymphocyte proliferation stimulated by pokeweed mitogen [Interpretation] in Blood |
|
49923-6
|
Lymphocyte proliferation stimulated by pokeweed mitogen in Blood |
|
69037-0
|
Lymphocyte proliferation.pokeweed mitogen.maximum/CD19 in Blood by Flow cytometry (FC) |
|
69020-6
|
Lymphocyte proliferation stimulated by pokeweed mitogen/CD3 in Blood by Flow cytometry (FC) |
|
69019-8
|
Lymphocyte proliferation stimulated by pokeweed mitogen/CD45 in Blood by Flow cytometry (FC) |
|
49884-0
|
Lymphocyte proliferation stimulated by tetanus toxoid [Ratio] in Blood --7 day post incubation |
|
33640-4
|
Lymphocyte proliferation stimulated by tetanus toxoid [Units/volume] in Blood |
|
69029-7
|
Lymphocyte proliferation.tetanus toxoid.maximum/CD3 in Blood by Flow cytometry (FC) |
|
69016-4
|
Lymphocyte proliferation.tetanus toxoid.maximum/CD45 in Blood by Flow cytometry (FC) |
|
33641-2
|
Lymphocyte proliferation stimulated by tuberculin [Units/volume] in Blood |
|
42178-4
|
Lipoprotein.X [Presence] in Serum or Plasma |
|
53876-9
|
LRRK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82139-7
|
LRRK2 gene Arg1441Gly and Gly2019Ser targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19531-3
|
Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method |
|
19530-5
|
Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method |
|
62301-7
|
Lysosomal storage disorders newborn screen interpretation |
|
61094-9
|
Lysergate diethylamide [Presence] in Gastric fluid |
|
73726-2
|
Lysergate diethylamide [Presence] in Hair |
|
73730-4
|
Lysergate diethylamide [Presence] in Meconium |
|
62303-3
|
Lysosomal storage disorders newborn screening comment-discussion |
|
3730-9
|
Lysergate diethylamide [Presence] in Serum or Plasma |
|
5678-8
|
Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
3731-7
|
Lysergate diethylamide [Mass/volume] in Serum or Plasma |
|
62302-5
|
Lysosomal storage disorders suspected [Identifier] in DBS |
|
20542-7
|
Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method |
|
3732-5
|
Lysergate diethylamide [Presence] in Urine |
|
16214-9
|
Lysergate diethylamide [Presence] in Urine by Confirmatory method |
|
19528-9
|
Lysergate diethylamide [Presence] in Urine by Screen method |
|
33350-0
|
Lysergate diethylamide [Mass/volume] in Urine by Screen method |
|
5679-6
|
Lysergate diethylamide [Mass/volume] in Urine |
|
61065-9
|
Lysergate diethylamide [Presence] in Unspecified specimen |
|
23216-5
|
Lumpy skin disease virus Ab [Presence] in Serum |
|
23214-0
|
Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot |
|
23215-7
|
Lumpy skin disease virus Ab [Presence] in Serum by Neutralization test |
|
31489-8
|
Lumpy skin disease virus Ab [Units/volume] in Serum |
|
23217-3
|
Lumpy skin disease virus Ab [Titer] in Serum |
|
23213-2
|
Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence |
|
23218-1
|
Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay |
|
23220-7
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen |
|
23219-9
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23222-3
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
23221-5
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23223-1
|
Lumpy skin disease virus DNA [Presence] in Unspecified specimen by RFLP |
|
23212-4
|
Lumpy skin disease virus [Presence] in Tissue by Electron microscopy |
|
79601-1
|
L-serine [Moles/volume] in Cerebral spinal fluid |
|
79618-5
|
L-serine [Moles/volume] in Serum or Plasma |
|
79645-8
|
L-serine/Creatinine [Molar ratio] in Urine |
|
92748-3
|
Lyso-sphingomyelin [Moles/volume] in Blood |
|
92749-1
|
Lyso-sphingomyelin [Moles/volume] in DBS |
|
92747-5
|
Lyso-sphingomyelin [Moles/volume] in Serum or Plasma |
|
44762-3
|
Liver transplant anastomosis site Hepatic artery |
|
44773-0
|
Liver transplant anastomosis site Hepatic artery from Graft |
|
44775-5
|
Liver transplant anastomosis site Portal vein from Graft |
|
63425-3
|
Bacterial heat-labile enterotoxin LT gene [Presence] in Unspecified specimen by NAA with probe detection |
|
85189-9
|
Long term care facility Admission evaluation note |
|
85190-7
|
Long term care facility Annual evaluation note |
|
85191-5
|
Long term care facility Conference note |
|
51854-8
|
Long term care facility Consult note |
|
85192-3
|
Long term care facility Discharge summary |
|
85193-1
|
Long term care facility Education note |
|
85194-9
|
Long term care facility Fall risk assessment note |
|
85195-6
|
Long term care facility Group counseling note |
|
85196-4
|
Long term care facility History and physical note |
|
85185-7
|
Long term care facility Initial evaluation note |
|
75438-2
|
Long term care facility Note |
|
85186-5
|
Long term care facility Plan of care note |
|
85199-8
|
Long term care facility Referral note |
|
85188-1
|
Long term care facility Respite note |
|
85880-3
|
Long term care facility Restraint note |
|
85197-2
|
Long term care facility Risk assessment and screening note |
|
85187-3
|
Long term care facility Transfer summary note |
|
86640-0
|
Limited English proficiency |
|
33344-3
|
Leukotriene E4 [Mass/volume] in Urine |
|
33343-5
|
Leukotriene E4/Creatinine [Mass Ratio] in Urine |
|
7451-8
|
Latex ALK triggered histamine release [Units/volume] in Blood |
|
7452-6
|
Latex Bencard triggered histamine release [Units/volume] in Blood |
|
17047-2
|
Latex Bencard IgE Ab [Units/volume] in Serum |
|
17049-8
|
Latex glove extract ammoniated IgE Ab [Units/volume] in Blood |
|
6845-2
|
Latex glove extract ammoniated IgE Ab [Units/volume] in Serum |
|
15808-9
|
Latex glove extract ammoniated IgE Ab RAST class [Presence] in Serum |
|
17050-6
|
Latex glove extract buffered IgE Ab [Units/volume] in Blood |
|
6846-0
|
Latex glove extract buffered IgE Ab [Units/volume] in Serum |
|
15809-7
|
Latex glove extract buffered IgE Ab RAST class [Presence] in Serum |
|
17048-0
|
Latex glove extract IgE Ab [Units/volume] in Blood |
|
6728-0
|
Latex glove extract IgE Ab [Units/volume] in Serum |
|
15807-1
|
Latex glove extract IgE Ab RAST class [Presence] in Serum |
|
7453-4
|
Latex Greer triggered histamine release [Units/volume] in Blood |
|
17045-6
|
Latex IgE Ab [Units/volume] in Blood |
|
6158-0
|
Latex IgE Ab [Units/volume] in Serum |
|
15806-3
|
Latex IgE Ab RAST class [Presence] in Serum |
|
48402-2
|
Latex IgE Ab/IgE total in Serum |
|
17046-4
|
Latex IgG Ab [Units/volume] in Serum |
|
56441-9
|
Latex IgG4 Ab [Mass/volume] in Serum |
|
63161-4
|
Latex IgG Ab [Mass/volume] in Serum |
|
48188-7
|
Latex triggered leukotriene release [Mass/volume] by Leukocytes |
|
7454-2
|
Latex Stallerg triggered histamine release [Units/volume] in Blood |
|
65327-9
|
Lu 14 Ab [Presence] in Serum or Plasma |
|
93907-4
|
Lu 20 Ag [Presence] on Red Blood Cells |
|
1133-8
|
Lu sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1134-6
|
Lu sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1135-3
|
Lu sup(a) Ab [Presence] in Serum or Plasma |
|
55330-5
|
Lu sup(a) Ab [Titer] in Serum or Plasma |
|
92531-3
|
Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92493-6
|
Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1136-1
|
Lu sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1137-9
|
Lu sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1138-7
|
Lu sup(a) Ag [Presence] on Red Blood Cells |
|
1139-5
|
Lu sup(ab) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1140-3
|
Lu sup(ab) Ab [Presence] in Serum or Plasma from Donor |
|
1141-1
|
Lu sup(ab) Ab [Presence] in Serum or Plasma |
|
1142-9
|
Lu sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1143-7
|
Lu sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1144-5
|
Lu sup(b) Ab [Presence] in Serum or Plasma |
|
55331-3
|
Lu sup(b) Ab [Titer] in Serum or Plasma |
|
92530-5
|
Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92492-8
|
Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1145-2
|
Lu sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1146-0
|
Lu sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1147-8
|
Lu sup(b) Ag [Presence] on Red Blood Cells |
|
26462-2
|
Large unstained cells [#/volume] in Blood |
|
17789-9
|
Large unstained cells [#/volume] in Blood by Automated count |
|
26463-0
|
Large unstained cells/100 leukocytes in Blood |
|
17788-1
|
Large unstained cells/100 leukocytes in Blood by Automated count |
|
74458-1
|
Large unstained cells/100 leukocytes in Blood from Fetus by Automated count |
|
74396-3
|
Large unstained cells/100 leukocytes in Cord blood by Automated count |
|
17091-0
|
Lumpfish roe IgE Ab [Units/volume] in Serum |
|
89041-8
|
Lung cancer antibody [Interpretation] in Serum or Plasma by Immunoassay |
|
66107-4
|
Lung Pathology biopsy report |
|
11180-7
|
Lupin IgE Ab [Units/volume] in Serum |
|
15824-6
|
Lupin IgE Ab RAST class [Presence] in Serum |
|
50650-1
|
Lupin seed IgE Ab [Units/volume] in Serum |
|
68972-9
|
Lupin seed IgE Ab RAST class [Presence] in Serum |
|
93437-2
|
Lurasidone [Mass/volume] in Serum or Plasma |
|
78884-4
|
Lurasidone [Mass/volume] in Urine by Confirmatory method |
|
48701-7
|
Lutenizing releasing hormone [Mass] of Dose |
|
78953-7
|
Left ventricular apex Segmental wall motion by Cardiac angiogram |
|
78198-9
|
Heart ventricle Left apex Segmental wall motion by US |
|
17986-1
|
Left ventricular Maximum Apical 2 chamber.diastole [Volume] by US 2D modified |
|
17987-9
|
Left ventricular Apical 2 chamber.systole.minimum [Volume] by US 2D modified |
|
17989-5
|
Left ventricular Maximum Apical 4 chamber.diastole [Volume] by US 2D modified |
|
17990-3
|
Left ventricular Apical 4 chamber.systole.minimum [Volume] by US 2D modified |
|
17991-1
|
Left ventricular Cardiac echo volume method |
|
55406-3
|
Left ventricular Cardiac ejection fraction method |
|
75919-1
|
Left ventricular Cardiac index |
|
20193-9
|
Left ventricular Cardiac index 2 chamber by US.modified.single-plane.calculated |
|
20194-7
|
Left ventricular Cardiac index 4 chamber by US.modified.single-plane.calculated |
|
24525-8
|
Left ventricular Cardiac index by US |
|
20190-5
|
Left ventricular Cardiac index by US 2D left ventricular outflow tract area calculated |
|
20191-3
|
Left ventricular Cardiac index by US 2D modified biplane ellipse calculated |
|
20195-4
|
Left ventricular Cardiac index by US 2D mitral valve calculated |
|
20187-1
|
Left ventricular Cardiac index by US.2D+Calculated by biplane ellipse method |
|
20188-9
|
Left ventricular Cardiac index by US.2D+Calculated by bullet method |
|
20197-0
|
Left ventricular Cardiac index by US.2D+Calculated by single-plane ellipse method |
|
20192-1
|
Left ventricular Cardiac index by US.modified Simpson.calculated |
|
20198-8
|
Left ventricular Cardiac index by US+Calculated by Teichholz method |
|
18083-6
|
Left ventricular Internal diameter minor axis diastole by US 2D |
|
29437-1
|
Left ventricular Internal diameter minor axis diastole by US.M-mode |
|
29436-3
|
Left ventricular Internal diameter minor axis diastole by US |
|
18085-1
|
Left ventricular Internal diameter minor axis systole by US 2D |
|
29439-7
|
Left ventricular Internal diameter minor axis systole by US.M-mode |
|
29438-9
|
Left ventricular Internal diameter minor axis systole by US |
|
18033-1
|
Left ventricular Diastole-systole [Volume] by US |
|
80048-2
|
Left ventricular Dyssynchrony index during systole by US.tissue doppler |
|
80005-2
|
Left ventricular Area at end diastole by US.2D.SAX at PM+Measured by planimetry |
|
80006-0
|
Left ventricular Epicardial area at end diastole by US.2D.SAX at PM+Measured by planimetry |
|
79994-0
|
Left ventricular Length at end diastole by US.2D.A4C |
|
80010-2
|
Left ventricular Minor axis at end diastole (by US 2D)/Body surface area |
|
80009-4
|
Left ventricular Minor axis at end diastole (by US.M-mode)/Body surface area |
|
80007-8
|
Left ventricular Minor axis at end diastole [Length] by US 2D |
|
18081-0
|
Left ventricular Minor axis at end diastole [Length] by US.2D.A4C |
|
80008-6
|
Left ventricular Minor axis at end diastole [Length] by US.M-mode |
|
80017-7
|
Left ventricular Myocardial mass at end diastole (by US.2D+Calculated by area-length method)/Body surface area |
|
80018-5
|
Left ventricular Myocardial mass at end diastole (by US.2D+Calculated by area-length method)/Height exp 2.7 |
|
80020-1
|
Left ventricular Myocardial mass at end diastole (by US.2D+Calculated by dimension method)/Body surface area |
|
80021-9
|
Left ventricular Myocardial mass at end diastole (by US.2D+Calculated by dimension method)/Height exp 2.7 |
|
80027-6
|
Left ventricular Myocardial mass at end diastole (by US.2D+Calculated by truncated ellipsoid method)/Height exp 2.7 |
|
80026-8
|
Left ventricular Myocardial mass at end diastole (by US.2D+Calculated by truncated ellipsoid method)/Body surface area |
|
80023-5
|
Left ventricular Myocardial mass at end diastole (by US.M-mode+Calculated by dimension method)/Body surface area |
|
80024-3
|
Left ventricular Myocardial mass at end diastole (by US.M-mode+Calculated by dimension method)/Height exp 2.7 |
|
80016-9
|
Left ventricular Myocardial mass at end diastole by US.2D+Calculated by area-length method |
|
80019-3
|
Left ventricular Myocardial mass at end diastole by US.2D+Calculated by dimension method |
|
80025-0
|
Left ventricular Myocardial mass at end diastole by US.2D+Calculated by truncated ellipsoid method |
|
80022-7
|
Left ventricular Myocardial mass at end diastole by US.M-mode+Calculated by dimension method |
|
93663-3
|
Left ventricular Sphericity index.end diastole by US |
|
75988-6
|
Left ventricular End diastolic volume |
|
79997-3
|
Left ventricular End-diastolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area |
|
76551-1
|
Left ventricular End-diastolic volume by US.2D+Calculated by Gibson method |
|
76549-5
|
Left ventricular End-diastolic volume by US.2D+Calculated by Teichholz method |
|
79995-7
|
Left ventricular End-diastolic volume by US.3D.segmentation |
|
79998-1
|
Left ventricular End-diastolic volume by US.2D.A2C+Calculated by single plane method of disks |
|
93660-9
|
Left ventricular End-diastolic volume by US.2D.A2C+Calc by single plane area-length method |
|
79999-9
|
Left ventricular End-diastolic volume by US.2D.A4C+Calculated by single plane method of disks |
|
93661-7
|
Left ventricular End-diastolic volume by US.2D.A4C+Calc by single plane area-length method |
|
93662-5
|
Left ventricular End-diastolic volume by US.2D+Calculated by biplane area-length method |
|
79996-5
|
Left ventricular End-diastolic volume by US.2D+Calculated by biplane method of disks |
|
18026-5
|
Left ventricular End-diastolic volume by US |
|
18029-9
|
Left ventricular End-diastolic volume by US 2D modified |
|
20236-6
|
Left ventricular End-diastolic volume by US 2D modified biplane ellipse calculated |
|
18028-1
|
Left ventricular End-diastolic volume by US.2D+Calculated by biplane ellipse method |
|
20234-1
|
Left ventricular End-diastolic volume by US.2D+Calculated by bullet method |
|
76548-7
|
Left ventricular End-diastolic volume by US.2D+Calculated by cube method |
|
20237-4
|
Left ventricular End-diastolic volume by US.2D+Calculated by modified Simpson method |
|
18027-3
|
Left ventricular End-diastolic volume by US.2D+Calculated by single-plane ellipse method |
|
20235-8
|
Left ventricular End-diastolic volume by US.cubed.calculated |
|
76547-9
|
Left ventricular End-diastolic volume by US.M-mode+Calculated by cube method |
|
76550-3
|
Left ventricular End-diastolic volume by US.M-mode+Calculated by Gibson method |
|
20238-2
|
Left ventricular End-diastolic volume by US.M-mode+Calculated by Teichholz method |
|
77891-0
|
Left ventricular Ejection fraction by US.2D+Calculated by Teichholz method |
|
79990-8
|
Left ventricular Ejection fraction by US.3D.segmentation |
|
79992-4
|
Left ventricular Ejection fraction by US.2D.A2C+Calculated by single plane method of disks |
|
93644-3
|
Left ventricular Ejection fraction by US.2D.A2C+Calc by single plane area-length method |
|
79993-2
|
Left ventricular Ejection fraction by US.2D.A4C+Calculated by single plane method of disks |
|
93645-0
|
Left ventricular Ejection fraction by US.2D.A4C+Calc by single plane area-length method |
|
93646-8
|
Left ventricular Ejection fraction by US.2D+Calculated by biplane area-length method |
|
79991-6
|
Left ventricular Ejection fraction by US.2D+Calculated by biplane method of disks |
|
18043-0
|
Left ventricular Ejection fraction by US |
|
18046-3
|
Left ventricular Ejection fraction by US 2D modified |
|
18047-1
|
Left ventricular Ejection fraction by US 2D modified biplane |
|
18048-9
|
Left ventricular Ejection fraction by US 2D modified single-plane |
|
18045-5
|
Left ventricular Ejection fraction by US.2D+Calculated by biplane ellipse method |
|
77890-2
|
Left ventricular Ejection fraction by US.2D+Calculated by cube method |
|
77892-8
|
Left ventricular Ejection fraction by US.2D+Calculated by modified Simpson method |
|
18044-8
|
Left ventricular Ejection fraction by US.2D+Calculated by single-plane ellipse method |
|
77889-4
|
Left ventricular Ejection fraction by US.M-mode+Calculated by cube method |
|
18049-7
|
Left ventricular Ejection fraction by US.M-mode+Calculated by Teichholz method |
|
60974-3
|
Left ventricular Ejection Time |
|
20224-2
|
Left ventricular Ejection time/Ejection time 2 by US.calculated |
|
80014-4
|
Left ventricular Minor axis at end systole (by US 2D)/Body surface area |
|
80013-6
|
Left ventricular Minor axis at end systole (by US.M-mode)/Body surface area |
|
80011-0
|
Left ventricular Minor axis at end systole [Length] by US 2D |
|
18082-8
|
Left ventricular Minor axis at end systole.apical 4 chamber [Length] by US.M-mode |
|
80012-8
|
Left ventricular Minor axis at end systole [Length] by US.M-mode |
|
75989-4
|
Left ventricular End systolic volume |
|
80002-9
|
Left ventricular End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area |
|
76556-0
|
Left ventricular End-systolic volume by US.2D+Calculated by Gibson method |
|
76554-5
|
Left ventricular End-systolic volume by US.2D+Calculated by Teichholz method |
|
80000-3
|
Left ventricular End-systolic volume by US.3D.segmentation |
|
80003-7
|
Left ventricular End-systolic volume by US.2D.A2C+Calculated by single plane method of disks |
|
93657-5
|
Left ventricular End-systolic volume by US.2D.A2C+Calc by single plane area-length method |
|
80004-5
|
Left ventricular End-systolic volume by US.2D.A4C+Calculated by single plane method of disks |
|
93658-3
|
Left ventricular End-systolic volume by US.2D.A4C+Calc by single plane area-length method |
|
93659-1
|
Left ventricular End-systolic volume by US.2D+Calculated by biplane area-length method |
|
80001-1
|
Left ventricular End-systolic volume by US.2D+Calculated by biplane method of disks |
|
18148-7
|
Left ventricular End-systolic volume by US |
|
18151-1
|
Left ventricular End-systolic volume by US 2D modified |
|
24529-0
|
Left ventricular End-systolic volume by US 2D modified biplane |
|
18150-3
|
Left ventricular End-systolic volume by US.2D+Calculated by biplane ellipse method |
|
76553-7
|
Left ventricular End-systolic volume by US.2D+Calculated by cube method |
|
76557-8
|
Left ventricular End-systolic volume by US.2D+Calculated by modified Simpson method |
|
18149-5
|
Left ventricular End-systolic volume by US.2D+Calculated by single-plane ellipse method |
|
76552-9
|
Left ventricular End-systolic volume by US.M-mode+Calculated by cube method |
|
76555-2
|
Left ventricular End-systolic volume by US.M-mode+Calculated by Gibson method |
|
24530-8
|
Left ventricular End-systolic volume by US.M-mode+Calculated by Teichholz method |
|
29465-2
|
Left ventricular End-systolic volume by US.Teichholz.calculated |
|
29434-8
|
Left ventricular Fractional shortening minor axis by US 2D |
|
29435-5
|
Left ventricular Fractional shortening minor axis by US.M-mode |
|
18051-3
|
Left ventricular Fractional shortening minor axis by US |
|
78954-5
|
Left ventricular inferior Segmental wall motion by Cardiac angiogram |
|
18071-1
|
Left ventricular Isovolumic relaxation time by US.doppler |
|
80015-1
|
Left ventricular Isovolumic relaxation time by US.tissue doppler |
|
18077-8
|
Left ventricular Major axis apical diastole [Length] by US 2D |
|
18076-0
|
Left ventricular Major axis apical systole [Length] by US 2D |
|
18072-9
|
Left ventricular Major axis diastole [Length] by US.2D.A2C |
|
18074-5
|
Left ventricular Major axis diastole [Length] by US.2D.A4C |
|
18073-7
|
Left ventricular Major axis during systole [Length] by US.2D.A2C |
|
18075-2
|
Left ventricular Major axis during systole [Length] by US.2D.A4C |
|
81415-2
|
Left ventricular Maximum apical rotation [Angle] by US 2D |
|
93615-3
|
Left ventricular Maximum area strain by US 3D |
|
93608-8
|
Left ventricular Maximum atrial contraction strain rate by US 3D |
|
81416-0
|
Left ventricular Maximum basal rotation [Angle] by US 2D |
|
93609-6
|
Left ventricular Maximum circumferential atrial contraction strain rate by US 3D |
|
81401-2
|
Left ventricular Maximum circumferential strain by US 2D |
|
93616-1
|
Left ventricular Maximum circumferential strain by US 3D |
|
81413-7
|
Left ventricular Maximum circumferential strain rate during diastole by US 2D |
|
81409-5
|
Left ventricular Maximum circumferential strain rate during early diastole by US 2D |
|
93611-2
|
Left ventricular Maximum circumferential strain rate during early diastole by US 3D |
|
81405-3
|
Left ventricular Maximum circumferential strain rate during systole by US 2D |
|
93613-8
|
Left ventricular Maximum circumferential strain rate during systole by US 3D |
|
93610-4
|
Left ventricular Maximum longitudinal atrial contraction strain rate by US 3D |
|
81399-8
|
Left ventricular Maximum longitudinal strain by US 2D |
|
93617-9
|
Left ventricular Maximum longitudinal strain by US 3D |
|
81411-1
|
Left ventricular Maximum longitudinal strain rate during diastole by US 2D |
|
81407-9
|
Left ventricular Maximum longitudinal strain rate during early diastole by US 2D |
|
93612-0
|
Left ventricular Maximum longitudinal strain rate during early diastole by US 3D |
|
81403-8
|
Left ventricular Maximum longitudinal strain rate during systole by US 2D |
|
93614-6
|
Left ventricular Maximum longitudinal strain rate during systole by US 3D |
|
81408-7
|
Left ventricular Maximum radial strain rate during early diastole by US 2D |
|
81400-4
|
Left ventricular Maximum radial strain by US 2D |
|
81412-9
|
Left ventricular Maximum radial strain rate during diastole by US 2D |
|
81404-6
|
Left ventricular Maximum radial strain rate during systole by US 2D |
|
81402-0
|
Left ventricular Maximum strain by US 3D |
|
81406-1
|
Left ventricular Maximum strain rate by US 2D |
|
81414-5
|
Left ventricular Maximum strain rate during diastole by US 3D |
|
81410-3
|
Left ventricular Maximum strain rate during early diastole by US 3D |
|
82596-8
|
Left ventricular Maximum strain rate during systole by US 3D |
|
81417-8
|
Left ventricular Maximum torsion [Angle] by US 2D |
|
81418-6
|
Left ventricular Maximum twist rate by US 2D |
|
81419-4
|
Left ventricular Maximum untwist rate by US 2D |
|
12027-9
|
Left ventricle [Length] Minor axis during systole Measured by real time two dimension US |
|
12025-3
|
Left ventricle [Length] Minor axis.diastole Measured by real time two dimension US |
|
12024-6
|
Left ventricle [Length] Minor axis.diastole US.M-mode+Measured |
|
18135-4
|
Left ventricular Minor axis.mitral level.diastole [Area] by US 2D |
|
18136-2
|
Left ventricular Minor axis.mitral level.systole [Area] by US 2D |
|
18137-0
|
Left ventricular Minor axis.papillary level.diastole [Area] by US 2D |
|
18138-8
|
Left ventricular Minor axis.papillary level.systole [Area] by US 2D |
|
81393-1
|
Left ventricular Myocardial performance index (Tei) by US.doppler |
|
77895-1
|
Left ventricular Myocardial mass by US.2D+Calculated by Devereux method |
|
18088-5
|
Left ventricular Myocardial mass by US.M-mode |
|
18087-7
|
Left ventricular Myocardial mass by US |
|
24528-2
|
Left ventricular Myocardial mass by US 2D modified biplane |
|
24527-4
|
Left ventricular Myocardial mass by US 2D modified single-plane |
|
77896-9
|
Left ventricular Myocardial mass by US.2D+Calculated by area-length method |
|
77894-4
|
Left ventricular Myocardial mass by US.2D+Calculated by truncated ellipsoid method |
|
77893-6
|
Left ventricular Myocardial mass by US.M-mode+Calculated by cube method |
|
81095-2
|
Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.2D+Calculated by Devereux method |
|
77897-7
|
Left ventricular Myocardial mass/Body surface area [Mass/Area] by US 2D |
|
77900-9
|
Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.2D+Calculated by area-length method |
|
77899-3
|
Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.2D+Calculated by truncated ellipsoid method |
|
77898-5
|
Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.M-mode+Calculated by cube method |
|
77920-7
|
Left ventricular Myocardial mass/Height exp 2.7 [Mass/Area] by US 2D |
|
77922-3
|
Left ventricular Myocardial mass/Height exp 2.7 [Mass/Area] by US.2D+Calculated by area-length method |
|
77923-1
|
Left ventricular Myocardial mass/Height exp 2.7 [Mass/Area] by US.2D+Calculated by truncated ellipsoid method |
|
77921-5
|
Left ventricular Myocardial mass/Height exp 2.7 [Mass/Area] by US.M-mode+Calculated by cube method |
|
76571-9
|
Left ventricular Cardiac output by US.2D+Calculated by Gibson method |
|
76569-3
|
Left ventricular Cardiac output by US.2D+Calculated by Teichholz method |
|
81390-7
|
Left ventricular Cardiac output by US 3D |
|
20211-9
|
Left ventricular Cardiac output.4 chamber by US 2D modified single-plane calculated |
|
93650-0
|
Left ventricular Cardiac output by US.2D.A2C+Calculated by single plane method of disks |
|
93647-6
|
Left ventricular Cardiac output by US.2D.A2C+Calc by single plane area-length method |
|
93651-8
|
Left ventricular Cardiac output by US.2D.A4C+Calculated by single plane method of disks |
|
93648-4
|
Left ventricular Cardiac output by US.2D.A4C+Calc by single plane area-length method |
|
93649-2
|
Left ventricular Cardiac output by US.2D+Calculated by biplane area-length method |
|
76519-8
|
Left ventricular Cardiac output by Continuous |
|
24526-6
|
Left ventricular Cardiac output by US |
|
20207-7
|
Left ventricular Cardiac output by US 2D left ventricular outflow tract calculated |
|
20208-5
|
Left ventricular Cardiac output by US 2D modified biplane calculated |
|
20204-4
|
Left ventricular Cardiac output by US.2D+Calculated by biplane ellipse method |
|
20205-1
|
Left ventricular Cardiac output by US.2D+Calculated by bullet method |
|
76565-1
|
Left ventricular Cardiac output by US.2D+Calculated |
|
76567-7
|
Left ventricular Cardiac output by US.2D+Calculated by cube method |
|
20212-7
|
Left ventricular Cardiac output by US.2D+Calculated by single-plane ellipse method |
|
20206-9
|
Left ventricular Cardiac output by US.cubed.calculated |
|
76564-4
|
Left ventricular Cardiac output by US.M-mode+Calculated |
|
76566-9
|
Left ventricular Cardiac output by US.M-mode+Calculated by cube method |
|
76570-1
|
Left ventricular Cardiac output by US.M-mode+Calculated by Gibson method |
|
76568-5
|
Left ventricular Cardiac output by US.M-mode+Calculated by Teichholz method |
|
20213-5
|
Left ventricular Cardiac output by US+Calculated by Teichholz method |
|
20210-1
|
Left ventricular Cardiac output.2 chamber by US 2D modified single-plane calculated |
|
20332-3
|
Left ventricular Cardiac output/Heart rate 4 chamber by US 2D modified single-plane calculated |
|
20239-0
|
Left ventricular Apical plane diastole [Area] by US 2D |
|
20241-6
|
Left ventricular Apical plane systole [Area] by US 2D |
|
18099-2
|
Left ventricular Plane.diastole [Area] by US.2D.A2C |
|
18101-6
|
Left ventricular Plane.diastole [Area] by US.2D.A4C |
|
18100-8
|
Left ventricular Plane.systole [Area] by US.2D.A2C |
|
18102-4
|
Left ventricular Plane.systole [Area] by US.2D.A4C |
|
60973-5
|
Left ventricular Pre ejection Time |
|
79989-0
|
Left ventricular Pre ejection time by US.doppler |
|
18068-7
|
Left ventricular Pre ejection time by US |
|
12026-1
|
Left ventricle [Length] Short axis during systole US.M-mode+Measured |
|
18116-4
|
Left ventricular Segmental wall appearance by US |
|
20316-6
|
Left ventricular Stroke volume index 2 chamber by US 2D modified single-plane ellipse calculated |
|
20317-4
|
Left ventricular Stroke volume index 4 chamber by US 2D modified single-plane ellipse calculated |
|
20331-5
|
Left ventricular Stroke volume 2 chamber by US 2D modified single-plane calculated |
|
76563-6
|
Left ventricular Stroke volume by US.2D+Calculated by Gibson method |
|
76561-0
|
Left ventricular Stroke volume by US.2D+Calculated by Teichholz method |
|
80035-9
|
Left ventricular Stroke volume by US.3D.segmentation |
|
93655-9
|
Left ventricular Stroke volume by US.2D.A2C+Calculated by single plane method of disks |
|
93652-6
|
Left ventricular Stroke volume by US.2D.A2C+Calc by single plane area-length method |
|
93656-7
|
Left ventricular Stroke volume by US.2D.A4C+Calculated by single plane method of disks |
|
93653-4
|
Left ventricular Stroke volume by US.2D.A4C+Calc by single plane area-length method |
|
93654-2
|
Left ventricular Stroke volume by US.2D+Calculated by biplane area-length method |
|
20324-0
|
Left ventricular Stroke volume by US 2D aortic root calculated |
|
20328-1
|
Left ventricular Stroke volume by US 2D left ventricular outflow tract area calculated |
|
20329-9
|
Left ventricular Stroke volume by US 2D modified biplane ellipse calculated |
|
20333-1
|
Left ventricular Stroke volume by US 2D mitral valve flow area calculated |
|
20325-7
|
Left ventricular Stroke volume by US.2D+Calculated by biplane ellipse method |
|
20326-5
|
Left ventricular Stroke volume by US.2D+Calculated by bullet method |
|
20323-2
|
Left ventricular Stroke volume by US.2D+Calculated |
|
76559-4
|
Left ventricular Stroke volume by US.2D+Calculated by cube method |
|
20330-7
|
Left ventricular Stroke volume by US.2D+Calculated by modified Simpson method |
|
20335-6
|
Left ventricular Stroke volume by US.2D+Calculated by single-plane ellipse method |
|
20327-3
|
Left ventricular Stroke volume by US.cubed.calculated |
|
76558-6
|
Left ventricular Stroke volume by US.M-mode+Calculated by cube method |
|
76562-8
|
Left ventricular Stroke volume by US.M-mode+Calculated by Gibson method |
|
76560-2
|
Left ventricular Stroke volume by US.M-mode+Calculated by Teichholz method |
|
20336-4
|
Left ventricular Stroke volume by US.Teichholz.calculated |
|
76297-1
|
Left ventricular Stroke volume index |
|
20309-1
|
Left ventricular Stroke volume index by US 2D aortic root calculated |
|
20313-3
|
Left ventricular Stroke volume index by US 2D left ventricular outflow tract area calculated |
|
20314-1
|
Left ventricular Stroke volume index by US 2D modified biplane ellipse calculated |
|
20318-2
|
Left ventricular Stroke volume index by US 2D mitral valve calculated |
|
20319-0
|
Left ventricular Stroke volume index by US 2D pulmonic valve flow area calculated |
|
20322-4
|
Left ventricular Stroke volume index by US 2D tricuspid valve calculated |
|
20310-9
|
Left ventricular Stroke volume index by US.2D+Calculated by biplane ellipse method |
|
20311-7
|
Left ventricular Stroke volume index by US.2D+Calculated by bullet method |
|
20308-3
|
Left ventricular Stroke volume index by US.2D+Calculated |
|
20320-8
|
Left ventricular Stroke volume index by US.2D+Calculated by single-plane ellipse method |
|
20312-5
|
Left ventricular Stroke volume index by US.cubed.calculated |
|
20315-8
|
Left ventricular Stroke volume index by US.modified Simpson.calculated |
|
20321-6
|
Left ventricular Stroke volume index by US.Teichholz |
|
18118-0
|
Left ventricular Segmental wall motion Narrative by US |
|
18117-2
|
Left ventricular Segmental wall motion by US score |
|
29440-5
|
Left ventricular Thickness septal wall/Thickness posterior wall by US 2D |
|
29441-3
|
Left ventricular Thickness septal wall/Thickness posterior wall by US.M-mode |
|
18155-2
|
Left ventricular Thickness septal wall/Thickness posterior wall by US |
|
18178-4
|
Left ventricular Wall motion index by US |
|
18179-2
|
Left ventricular Wall segment [Identifier] by US |
|
76527-1
|
Left ventricular Work/Body surface area [Energy/Area] by Non-invasive impedance cardiography (NI-ICG) |
|
18119-8
|
Left ventricular apical anterior Segmental wall motion by US |
|
18128-9
|
Left ventricular lateral apical Segmental wall motion by US |
|
18120-6
|
Left ventricular apical septum Segmental wall motion by US |
|
78194-8
|
Heart.ventricle.left.basal anterior lateral Segmental wall motion by US |
|
18122-2
|
Left ventricular basal anterior septum Segmental wall motion by US |
|
80037-5
|
Left ventricular basal anterior septum Time to max tissue velocity during systole by US.tissue doppler |
|
78951-1
|
Left ventricular basal anterior Segmental wall motion by Cardiac angiogram |
|
18121-4
|
Left ventricular basal anterior Segmental wall motion by US |
|
80036-7
|
Left ventricular basal anterior Time to max tissue velocity during systole by US.tissue doppler |
|
78193-0
|
Heart ventricle Left basal inferior lateral Segmental wall motion by US |
|
78192-2
|
Heart ventricle Left basal inferior septum Segmental wall motion by US |
|
18123-0
|
Left ventricular basal inferior Segmental wall motion by US |
|
80038-3
|
Left ventricular basal inferior Time to max tissue velocity during systole by US.tissue doppler |
|
18124-8
|
Left ventricular basal lateral Segmental wall motion by US |
|
80039-1
|
Left ventricular basal lateral Time to max tissue velocity during systole by US.tissue doppler |
|
78955-2
|
Left ventricular basal posterior Segmental wall motion by Cardiac angiogram |
|
18125-5
|
Left ventricular basal posterior Segmental wall motion by US |
|
80040-9
|
Left ventricular basal posterior Time to max tissue velocity during systole by US.tissue doppler |
|
18126-3
|
Left ventricular basal septum Segmental wall motion by US |
|
80041-7
|
Left ventricular basal septum Time to max tissue velocity during systole by US.tissue doppler |
|
20240-8
|
Left ventricular epicardium Short axis papillary level diastole [Area] by US 2D |
|
20242-4
|
Left ventricular epicardium Short axis papillary level systole [Area] by US 2D |
|
18127-1
|
Left ventricular inferior apical Segmental wall motion by US |
|
78952-9
|
Left ventricular lateral anterior Segmental wall motion by Cardiac angiogram |
|
78957-8
|
Left ventricular lateral posterior Segmental wall motion by Cardiac angiogram |
|
78197-1
|
Heart ventricle Left mid anterior lateral Segmental wall motion by US |
|
18130-5
|
Left ventricular mid anterior septum Segmental wall motion by US |
|
80043-3
|
Left ventricular mid anterior septum Time to max tissue velocity during systole by US.tissue doppler |
|
18129-7
|
Left ventricular mid anterior Segmental wall motion by US |
|
80042-5
|
Left ventricular mid anterior Time to max tissue velocity during systole by US.tissue doppler |
|
78196-3
|
Heart ventricle Left mid inferior lateral Segmental wall motion by US |
|
78195-5
|
Heart ventricle Left mid inferior septum Segmental wall motion by US |
|
18131-3
|
Left ventricular mid inferior Segmental wall motion by US |
|
80044-1
|
Left ventricular mid inferior Time to max tissue velocity during systole by US.tissue doppler |
|
18132-1
|
Left ventricular mid lateral Segmental wall motion by US |
|
80045-8
|
Left ventricular mid lateral Time to max tissue velocity during systole by US.tissue doppler |
|
18133-9
|
Left ventricular mid posterior Segmental wall motion by US |
|
80046-6
|
Left ventricular mid posterior Time to max tissue velocity during systole by US.tissue doppler |
|
18134-7
|
Left ventricular mid septum Segmental wall motion by US |
|
80047-4
|
Left ventricular mid septum Time to max tissue velocity during systole by US.tissue doppler |
|
80995-4
|
Left ventriculography performed |
|
11803-4
|
Left ventricular outflow tract Diameter US.doppler |
|
18018-2
|
Left ventricular outflow tract Diameter by US |
|
80028-4
|
Left ventricular outflow tract Diameter at end diastole by US 2D |
|
81391-5
|
Left ventricular outflow tract Ejection time by US.doppler |
|
18064-6
|
Left ventricular outflow tract Maximum pressure gradient dur systole by US.doppler |
|
20233-3
|
Left ventricular outflow tract Mean systole pressure gradient by US.doppler |
|
18103-2
|
Left ventricular outflow tract Planimetry parasternal short axis [Area] by US 2D |
|
20245-7
|
Left ventricular outflow tract Region crossection [Area] by US+Calculated |
|
80029-2
|
Left ventricular outflow tract Maximum blood flow velocity during systole by US.doppler |
|
20232-5
|
Left ventricular outflow tract Mean blood flow velocity by US.doppler |
|
18170-1
|
Left ventricular outflow tract Blood velocity-time integral by US.doppler |
|
80030-0
|
Left ventricular outflow tract Velocity-time integral during systole by US.doppler |
|
80032-6
|
Left ventricular posterior wall Thickness at end diastole by US 2D |
|
80031-8
|
Left ventricular posterior wall Thickness at end diastole by US.M-mode |
|
80034-2
|
Left ventricular posterior wall Thickness at end systole by US 2D |
|
80033-4
|
Left ventricular posterior wall Thickness at end systole by US.M-mode |
|
29446-2
|
Left ventricular posterior wall Thickening.fractional change by US 2D |
|
29447-0
|
Left ventricular posterior wall Thickening.fractional change by US.M-mode |
|
18053-9
|
Left ventricular posterior wall Thickening.fractional change by US |
|
29442-1
|
Left ventricular posterior wall Thickness during diastole by US 2D |
|
29443-9
|
Left ventricular posterior wall Thickness during diastole by US.M-mode |
|
18152-9
|
Left ventricular posterior wall Thickness during diastole by US |
|
29444-7
|
Left ventricular posterior wall Thickness during systole by US 2D |
|
29445-4
|
Left ventricular posterior wall Thickness during systole by US.M-mode |
|
18156-0
|
Left ventricular posterior wall Thickness during systole by US |
|
79988-2
|
Left ventricular posterior wall Time to peak displacement during systole by US.M-mode+ECG |
|
1214-6
|
LW Ab [Presence] in Serum or Plasma from Blood product unit |
|
1215-3
|
LW Ab [Presence] in Serum or Plasma from Donor |
|
1216-1
|
LW Ab [Presence] in Serum or Plasma |
|
1217-9
|
LW Ag [Presence] on Red Blood Cells from Blood product unit |
|
1218-7
|
LW Ag [Presence] on Red Blood Cells from Donor |
|
1219-5
|
LW Ag [Presence] on Red Blood Cells |
|
65328-7
|
LW sup(a) Ab [Presence] in Serum or Plasma |
|
92525-5
|
LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92487-8
|
LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
92524-8
|
LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92486-0
|
LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
27075-1
|
Lycopene [Moles/volume] in Plasma |
|
11181-5
|
Lycopodium spp IgE Ab [Units/volume] in Serum |
|
15825-3
|
Lycopodium spp IgE Ab RAST class [Presence] in Serum |
|
85926-4
|
Lying to sitting on side of bed - functional ability [CMS Assessment] |
|
83214-7
|
Lying to sitting on side of bed - functional ability during 3 day assessment period [CMS Assessment] |
|
85927-2
|
Lying to sitting on side of bed - functional goal [CMS Assessment] |
|
83213-9
|
Lying to sitting on side of bed - functional goal during 3 day assessment period [CMS Assessment] |
|
312-9
|
Lymecycline [Susceptibility] by Disk diffusion (KB) |
|
311-1
|
Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
310-3
|
Lymecycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18941-5
|
Lymecycline [Susceptibility] |
|
313-7
|
Lymecycline [Susceptibility] by Serum bactericidal titer |
|
30412-1
|
Abnormal lymphocytes [#/volume] in Blood |
|
29262-3
|
Abnormal lymphocytes [#/volume] in Blood by Manual count |
|
35047-0
|
Abnormal lymphocytes [#/volume] in Cerebral spinal fluid |
|
35046-2
|
Abnormal lymphocytes [#/volume] in Body fluid |
|
35048-8
|
Abnormal lymphocytes [#/volume] in Synovial fluid |
|
78355-5
|
Abnormal lymphocytes [Presence] in Blood by Manual count |
|
30413-9
|
Abnormal lymphocytes/100 leukocytes in Blood |
|
29261-5
|
Abnormal lymphocytes/100 leukocytes in Blood by Manual count |
|
30414-7
|
Abnormal lymphocytes/100 leukocytes in Cerebral spinal fluid |
|
21372-8
|
Abnormal lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
35077-7
|
Abnormal lymphocytes/100 leukocytes in Body fluid |
|
33548-9
|
Abnormal lymphocytes/100 leukocytes in Body fluid by Manual count |
|
30415-4
|
Abnormal lymphocytes/100 leukocytes in Synovial fluid |
|
21373-6
|
Abnormal lymphocytes/100 leukocytes in Synovial fluid by Manual count |
|
68406-8
|
Abnormal lymphocytes/100 leukocytes in Vitreous fluid by Manual count |
|
84896-0
|
Lymph node(s) [Presence] in Specimen |
|
65761-9
|
Lymphocyte subset interpretation in Blood by Flow cytometry (FC) |
|
93953-8
|
Villous lymphocytes [Presence] in Blood by Light microscopy |
|
33739-4
|
Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols |
|
85727-6
|
Lymphadenopathy in Mother |
|
52048-6
|
Lymphedema pump attachment |
|
35050-4
|
Lymphoblasts [#/volume] in Blood |
|
33830-1
|
Lymphoblasts [#/volume] in Blood by Manual count |
|
74850-9
|
Lymphoblasts/100 cells in Lymph node by Manual count |
|
34922-5
|
Lymphoblasts/100 leukocytes in Blood |
|
33831-9
|
Lymphoblasts/100 leukocytes in Blood by Manual count |
|
50724-4
|
Lymphoblasts/100 leukocytes in Bone marrow by Manual count |
|
33642-0
|
Lymphocyte Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
53810-8
|
Lymphocyte proliferation [Interpretation] in Blood |
|
74952-3
|
Lymphocyte proliferation [Interpretation] in Blood Narrative |
|
26474-7
|
Lymphocytes [#/volume] in Blood |
|
731-0
|
Lymphocytes [#/volume] in Blood by Automated count |
|
30364-4
|
Lymphocytes [#/volume] in Blood by Flow cytometry (FC) |
|
66140-5
|
Lymphocytes [#/volume] in Blood from Fetus by Manual count |
|
732-8
|
Lymphocytes [#/volume] in Blood by Manual count |
|
74401-1
|
Lymphocytes [#/volume] in Cord blood |
|
26475-4
|
Lymphocytes [#/volume] in Cerebral spinal fluid |
|
14106-9
|
Lymphocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
26476-2
|
Lymphocytes [#/volume] in Body fluid |
|
6744-7
|
Lymphocytes [#/volume] in Body fluid by Manual count |
|
67827-6
|
Lymphocytes [#/volume] in Pericardial fluid |
|
68404-3
|
Lymphocytes [#/volume] in Pericardial fluid by Manual count |
|
35098-3
|
Lymphocytes [#/volume] in Pleural fluid |
|
67833-4
|
Lymphocytes [#/volume] in Pleural fluid from Fetus |
|
68405-0
|
Lymphocytes [#/volume] in Pleural fluid by Manual count |
|
35097-5
|
Lymphocytes [#/volume] in Peritoneal fluid |
|
51627-8
|
Lymphocytes [#/volume] in Peritoneal fluid by Manual count |
|
35049-6
|
Lymphocytes [#/volume] in Synovial fluid |
|
32697-5
|
Lymphocytes [#/volume] in Synovial fluid by Manual count |
|
68407-6
|
Lymphocytes [#/volume] in Vitreous fluid by Manual count |
|
20585-6
|
Lymphocytes [#/volume] in Unspecified specimen by Automated count |
|
40470-7
|
Lymphocytes [#/area] in Semen by Microscopy high power field |
|
72219-9
|
Lymphocytes [#/area] in Urine sediment by Microscopy high power field |
|
55787-6
|
Lymphocytes [#] in Cerebral spinal fluid by Manual count |
|
76409-2
|
Lymphocytes [#] in Body fluid by Manual count |
|
74848-3
|
Lymphocytes/100 cells in Lymph node by Manual count |
|
11108-8
|
Lymphocytes/100 cells in Bone marrow by Manual count |
|
71678-7
|
Lymphocytes/Leukocytes [Pure number fraction] in Blood by Automated count |
|
71673-8
|
Lymphocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71597-9
|
Lymphocytes/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
|
71660-5
|
Lymphocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71649-8
|
Lymphocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
71605-0
|
Lymphocytes/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71615-9
|
Lymphocytes/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71634-0
|
Lymphocytes/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71624-1
|
Lymphocytes/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
38903-1
|
Lymphocytes [Presence] in Stool by Light microscopy |
|
61118-6
|
Lymphocytes.cytoplasmic IgG/100 lymphocytes in Body fluid |
|
61119-4
|
Lymphocytes.cytoplasmic IgM/100 lymphocytes in Body fluid |
|
26478-8
|
Lymphocytes/100 leukocytes in Blood |
|
736-9
|
Lymphocytes/100 leukocytes in Blood by Automated count |
|
30365-1
|
Lymphocytes/100 leukocytes in Blood by Flow cytometry (FC) |
|
74461-5
|
Lymphocytes/100 leukocytes in Blood from Fetus |
|
737-7
|
Lymphocytes/100 leukocytes in Blood by Manual count |
|
74402-9
|
Lymphocytes/100 leukocytes in Cord blood |
|
30421-2
|
Lymphocytes/100 leukocytes in Bronchial specimen |
|
56769-3
|
Lymphocytes/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
|
14819-7
|
Lymphocytes/100 leukocytes in Bronchial specimen by Manual count |
|
26479-6
|
Lymphocytes/100 leukocytes in Cerebral spinal fluid |
|
10328-3
|
Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
40538-1
|
Lymphocytes/100 leukocytes in Peritoneal dialysis fluid by Manual count |
|
59463-0
|
Lymphocytes/100 leukocytes in Dialysis fluid |
|
66761-8
|
Lymphocytes/100 leukocytes in Dialysis fluid by Manual count |
|
11031-2
|
Lymphocytes/100 leukocytes in Body fluid |
|
13941-0
|
Lymphocytes/100 leukocytes in Body fluid by Manual count |
|
26480-4
|
Lymphocytes/100 leukocytes in Pericardial fluid |
|
14818-9
|
Lymphocytes/100 leukocytes in Pericardial fluid by Manual count |
|
26481-2
|
Lymphocytes/100 leukocytes in Pleural fluid |
|
14820-5
|
Lymphocytes/100 leukocytes in Pleural fluid by Manual count |
|
26482-0
|
Lymphocytes/100 leukocytes in Peritoneal fluid |
|
14821-3
|
Lymphocytes/100 leukocytes in Peritoneal fluid by Manual count |
|
26483-8
|
Lymphocytes/100 leukocytes in Synovial fluid |
|
17227-0
|
Lymphocytes/100 leukocytes in Synovial fluid by Automated count |
|
14822-1
|
Lymphocytes/100 leukocytes in Synovial fluid by Manual count |
|
27936-4
|
Lymphocytes/100 leukocytes in Sputum |
|
56774-3
|
Lymphocytes/100 leukocytes in Tissue |
|
72364-3
|
Lymphocytes/100 leukocytes in Vitreous fluid by Manual count |
|
20619-3
|
Lymphocytes/100 leukocytes in Unspecified specimen by Automated count |
|
61123-6
|
Lymphocytes/100 leukocytes in Unspecified specimen by Flow cytometry (FC) |
|
54222-5
|
Lymphoma - acute screen markers [Interpretation] in Unspecified specimen Narrative |
|
54223-3
|
Lymphoma - CLL screen markers [Interpretation] in Unspecified specimen Narrative |
|
54224-1
|
Lymphoma - T-cell markers [Interpretation] in Unspecified specimen Narrative |
|
30422-0
|
Lymphoma cells [#/volume] in Blood |
|
24105-9
|
Lymphoma cells [#/volume] in Blood by Manual count |
|
59809-4
|
Lymphoma cells [Presence] in Blood |
|
30423-8
|
Lymphoma cells/100 leukocytes in Blood |
|
24104-2
|
Lymphoma cells/100 leukocytes in Blood by Manual count |
|
54221-7
|
Lymphoma markers [Interpretation] in Unspecified specimen Narrative |
|
74230-4
|
Lymphocytes assessment in Bone marrow Narrative |
|
17215-5
|
CV lymphocytes/100 lymphocytes in Blood |
|
17222-1
|
HLE lymphocytes/100 lymphocytes in Blood |
|
30118-4
|
IgA lymphocytes [#/volume] in Leukocytes |
|
9440-9
|
IgA lymphocytes/100 lymphocytes in Leukocytes |
|
26567-8
|
IgA lymphocytes/100 lymphocytes in Unspecified specimen |
|
30120-0
|
IgD lymphocytes [#/volume] in Leukocytes |
|
9441-7
|
IgD lymphocytes/100 lymphocytes in Leukocytes |
|
20615-1
|
IgD lymphocytes/100 lymphocytes in Unspecified specimen |
|
30113-5
|
IgG lymphocytes [#/volume] in Leukocytes |
|
32563-9
|
IgG lymphocytes/100 lymphocytes in Cerebral spinal fluid |
|
9442-5
|
IgG lymphocytes/100 lymphocytes in Leukocytes |
|
32562-1
|
IgG lymphocytes/100 lymphocytes in Unspecified specimen |
|
30119-2
|
IgM lymphocytes [#/volume] in Leukocytes |
|
9443-3
|
IgM lymphocytes/100 lymphocytes in Leukocytes |
|
20616-9
|
IgM lymphocytes/100 lymphocytes in Unspecified specimen |
|
30115-0
|
Kappa lymphocytes [#/volume] in Blood |
|
21375-1
|
Kappa lymphocytes/Lymphocytes.lambda [# Ratio] in Blood |
|
17096-9
|
Kappa lymphocytes/100 lymphocytes in Blood |
|
46238-2
|
Kappa lymphocytes/100 lymphocytes in Body fluid |
|
46237-4
|
Kappa lymphocytes/100 lymphocytes in Bone marrow |
|
20617-7
|
Kappa lymphocytes/100 lymphocytes in Unspecified specimen |
|
30114-3
|
Lambda lymphocytes [#/volume] in Blood |
|
17224-7
|
Lambda lymphocytes/100 lymphocytes in Blood |
|
20618-5
|
Lambda lymphocytes/100 lymphocytes in Unspecified specimen |
|
17225-4
|
SMIg lymphocytes/100 lymphocytes in Blood |
|
60473-6
|
Lymphocytes.vacuolated [Presence] in Blood by Light microscopy |
|
35081-9
|
Lymphocytes+Monocytes [#/volume] in Blood |
|
4662-3
|
Lymphocytes+Monocytes/100 leukocytes in Blood |
|
2587-4
|
Lysine [Mass/time] in 24 hour Urine |
|
25952-3
|
Lysine [Moles/volume] in 24 hour Urine |
|
25464-9
|
Lysine [Moles/time] in 24 hour Urine |
|
48273-7
|
Lysine acetylsalicylate triggered leukotriene release [Mass/volume] by Leukocytes |
|
13404-9
|
Lysine [Mass/volume] in Amniotic fluid |
|
27107-2
|
Lysine [Moles/volume] in Amniotic fluid |
|
13375-1
|
Lysine [Mass/volume] in Cerebral spinal fluid |
|
22651-4
|
Lysine [Moles/volume] in Cerebral spinal fluid |
|
47689-5
|
Lysine [Moles/volume] in DBS |
|
32256-0
|
Lysine [Moles/volume] in Body fluid |
|
55935-1
|
Lysine [Moles/mass] in Hair |
|
81920-1
|
Lysine intake 24 hour Estimated |
|
81921-9
|
Lysine intake 24 hour Measured |
|
2584-1
|
Lysine [Presence] in Serum or Plasma |
|
27333-4
|
Lysine [Units/volume] in Serum or Plasma |
|
2585-8
|
Lysine [Mass/volume] in Serum or Plasma |
|
20650-8
|
Lysine [Moles/volume] in Serum or Plasma |
|
47692-9
|
Lysine/Amino acids.total in Amniotic fluid |
|
47691-1
|
Lysine/Amino acids.total in Cerebral spinal fluid |
|
47694-5
|
Lysine/Amino acids.total in DBS |
|
47690-3
|
Lysine/Amino acids.total in Hair |
|
47693-7
|
Lysine/Amino acids.total in Serum or Plasma |
|
47695-2
|
Lysine/Amino acids.total in Unspecified specimen |
|
17230-4
|
Lysine [Presence] in Urine |
|
2586-6
|
Lysine [Mass/volume] in Urine |
|
27304-5
|
Lysine [Moles/volume] in Urine |
|
32255-2
|
Lysine [Moles/volume] in Vitreous fluid |
|
22713-2
|
Lysine [Moles/volume] in Unspecified specimen |
|
44335-8
|
Lysine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56955-8
|
Lysine/Creatinine [Ratio] in 24 hour Urine |
|
25953-1
|
Lysine/Creatinine [Molar ratio] in 24 hour Urine |
|
13769-5
|
Lysine/Creatinine [Mass Ratio] in Urine |
|
30048-3
|
Lysine/Creatinine [Ratio] in Urine |
|
22679-5
|
Lysine/Creatinine [Molar ratio] in Urine |
|
82740-2
|
Lysoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
|
2588-2
|
Lysolecithin acyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
75736-9
|
Lysophosphatidylcholine(16:0) [Moles/volume] in Plasma |
|
75737-7
|
Lysophosphatidylcholine(18:0) [Moles/volume] in Plasma |
|
90920-0
|
Lysophosphatidylcholine(20:0) [Mass/volume] in DBS |
|
90921-8
|
Lysophosphatidylcholine(22:0) [Mass/volume] in DBS |
|
90922-6
|
Lysophosphatidylcholine(24:0) [Mass/volume] in DBS |
|
79320-8
|
Lysophosphatidylcholine(26:0) [Moles/volume] in Cerebral spinal fluid |
|
79567-4
|
Lysophosphatidylcholine(26:0) [Moles/volume] in DBS by LC/MS/MS |
|
90923-4
|
Lysophosphatidylcholine(26:0) [Mass/volume] in DBS |
|
79321-6
|
Lysophosphatidylcholine(26:0) [Moles/volume] in DBS |
|
79322-4
|
Lysophosphatidylcholine(26:0) [Moles/volume] in Serum or Plasma |
|
17231-2
|
Lysosomal enzymes [Identifier] in Plasma |
|
48311-5
|
Lysosomal enzymes screen [Identifier] in Blood |
|
14294-3
|
Lysosomal enzymes screen [Identifier] in Plasma and Urine |
|
54009-6
|
Lysosome Ab [Presence] in Serum by Immunofluorescence |
|
54010-4
|
Lysosome Ab [Titer] in Serum by Immunofluorescence |
|
56038-3
|
Lysozyme [Units] in 24 hour Urine |
|
34335-0
|
Lysozyme [Mass/volume] in 24 hour Urine |
|
2590-8
|
Lysozyme [Mass/time] in 24 hour Urine |
|
75640-3
|
Lysozyme [Moles/volume] in 24 hour Urine |
|
54019-5
|
Lysozyme Ab [Presence] in Serum |
|
10503-1
|
Lysozyme Ag [Presence] in Tissue by Immune stain |
|
55936-9
|
Lysozyme [Mass/volume] in Cerebral spinal fluid |
|
29956-0
|
Lysozyme [Mass/volume] in Body fluid |
|
11182-3
|
Lysozyme IgE Ab [Units/volume] in Serum |
|
15826-1
|
Lysozyme IgE Ab RAST class [Presence] in Serum |
|
54917-0
|
Lysozyme [Mass/volume] in Pleural fluid |
|
4665-6
|
Lysozyme [Enzymatic activity/volume] in Serum or Plasma |
|
2589-0
|
Lysozyme [Mass/volume] in Serum or Plasma |
|
6289-3
|
Lysozyme [Moles/volume] in Serum or Plasma |
|
27186-6
|
Lysozyme [Presence] in Stool |
|
17232-0
|
Lysozyme [Enzymatic activity/volume] in Tear |
|
56039-1
|
Lysozyme [Units/volume] in Urine |
|
10971-0
|
Lysozyme [Mass/volume] in Urine |
|
34336-8
|
Lysozyme/Creatinine [Ratio] in Urine |
|
1226-0
|
M Ab [Presence] in Serum or Plasma from Blood product unit |
|
1227-8
|
M Ab [Presence] in Serum or Plasma from Donor |
|
1228-6
|
M Ab [Presence] in Serum or Plasma |
|
34604-9
|
M Ab [Titer] in Serum or Plasma |
|
77735-9
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [Presence] by Molecular method |
|
77734-2
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene [Presence] by Molecular method |
|
77736-7
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) gene [Interpretation] by Molecular method |
|
92523-0
|
M Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92485-2
|
M Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1229-4
|
M Ag [Presence] on Red Blood Cells from Blood product unit |
|
1230-2
|
M Ag [Presence] on Red Blood Cells from Donor |
|
1231-0
|
M Ag [Presence] on Red Blood Cells |
|
23251-2
|
Mycoplasma agalactiae Ab [Presence] in Serum |
|
23249-6
|
Mycoplasma agalactiae Ab [Presence] in Serum by Complement fixation |
|
23250-4
|
Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay |
|
23248-8
|
Mycoplasma agalactiae Ab [Presence] in Serum by Neutralization test |
|
23252-0
|
Mycoplasma agalactiae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23253-8
|
Mycoplasma arginini Ab [Presence] in Serum |
|
23254-6
|
Mycoplasma arginini Ab [Presence] in Serum by Complement fixation |
|
82387-2
|
Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood |
|
23234-8
|
Mycobacterium avium ss avium Ab [Presence] in Blood |
|
23235-5
|
Mycobacterium avium ss avium Ab [Presence] in Blood by Agglutination |
|
23236-3
|
Mycobacterium avium ss avium rRNA [Presence] in Tissue by Probe |
|
5023-7
|
Mycobacterium avium ss avium rRNA [Presence] in Unspecified specimen by Probe |
|
23238-9
|
Mycobacterium avium ss avium serotype [Identifier] in Unspecified specimen |
|
23237-1
|
Mycobacterium avium ss avium identified in Unspecified specimen by Bioassay |
|
71719-9
|
Mycobacterium avium complex DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20463-6
|
Mycobacterium avium complex rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5022-9
|
Mycobacterium avium complex rRNA [Presence] in Unspecified specimen by Probe |
|
70671-3
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Milk by Immunoassay |
|
35268-2
|
Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum by Immunoassay |
|
22421-2
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum |
|
20894-2
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Complement fixation |
|
15483-1
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
|
15482-3
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
|
41130-6
|
Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum |
|
23246-2
|
Mycobacterium avium ss paratuberculosis DNA [Presence] in Stool by NAA with probe detection |
|
23245-4
|
Mycobacterium avium ss paratuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20893-4
|
Mycobacterium avium ss paratuberculosis [Presence] in Stool by Organism specific culture |
|
23243-9
|
Mycobacterium avium ss paratuberculosis [Presence] in Stool by Acid fast stain.Ziehl-Neelsen |
|
20892-6
|
Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Organism specific culture |
|
23244-7
|
Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Acid fast stain.Ziehl-Neelsen |
|
24427-7
|
Mycobacterium avium ss paratuberculosis [Presence] in Unspecified specimen by Organism specific culture |
|
85581-7
|
Mycobacterium avium and Mycobacterium intracellulare DNA [Identifier] in Sputum or Bronchial by NAA with probe detection |
|
53702-7
|
Mycobacterium bovis tuberculin stimulated gamma interferon-Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood |
|
23239-7
|
Mycobacterium bovis Ab [Presence] in Serum |
|
23240-5
|
Mycobacterium bovis Ab [Presence] in Serum by Immunoassay |
|
23242-1
|
Mycobacterium bovis Ag [Presence] in Blood |
|
23241-3
|
Mycobacterium bovis Ag [Presence] in Tissue by Immune stain |
|
53704-3
|
Mycobacterium bovis tuberculin stimulated gamma interferon-control stimulated gamma interferon [Units/volume] in Blood |
|
82511-7
|
Mycobacterium bovis tuberculin stimulated gamma interferon [Units/volume] in Blood |
|
82510-9
|
Mycobacterium bovis tuberculin stimulated gamma interferon [Interpretation] in Blood Qualitative |
|
23259-5
|
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum |
|
23258-7
|
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Complement fixation |
|
23257-9
|
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Immunoassay |
|
31508-5
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood |
|
23264-5
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood by Agglutination |
|
31510-1
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum |
|
23260-3
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Agglutination |
|
23266-0
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Complement fixation |
|
23263-7
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Immunoassay |
|
31509-3
|
Mycoplasma capricolum ss capripneumonia Ab [Units/volume] in Serum |
|
23262-9
|
Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum |
|
23265-2
|
Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum by Complement fixation |
|
23270-2
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Tissue |
|
23269-4
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen |
|
23268-6
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23267-8
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen by Neutralization test |
|
23272-8
|
Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23271-0
|
Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Unspecified specimen by Probe |
|
76601-4
|
Moraxella catarrhalis g1b gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76573-5
|
Moraxella catarrhalis g1b gene [Presence] in XXX.swab by NAA with probe detection |
|
76588-3
|
Moraxella catarrhalis g1b gene [#/mass] in XXX.tissue by NAA with probe detection |
|
92966-1
|
Moraxella catarrhalis DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
92144-5
|
Moraxella catarrhalis DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
92965-3
|
Moraxella catarrhalis DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
17299-9
|
Mycoplasma fermentans Ab [Presence] in Serum |
|
34150-3
|
Mycoplasma fermentans DNA [Presence] in Blood by NAA with probe detection |
|
85553-6
|
Mycoplasma flocculare 16S rRNA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
10949-6
|
Malassezia furfur IgE Ab [Units/volume] in Serum |
|
15950-9
|
Malassezia furfur IgE Ab RAST class [Presence] in Serum |
|
22422-0
|
Mycoplasma gallisepticum Ab [Presence] in Serum |
|
15484-9
|
Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
|
23273-6
|
Mycoplasma gallisepticum Ab [Presence] in Serum by Hemagglutination |
|
15485-6
|
Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
|
31511-9
|
Mycoplasma gallisepticum Ab [Units/volume] in Serum |
|
23275-1
|
Mycoplasma gallisepticum Ab [Titer] in Serum |
|
23274-4
|
Mycoplasma gallisepticum Ab [Titer] in Serum by Hemagglutination |
|
20895-9
|
Mycoplasma gallisepticum Ag [Presence] in Tissue by Immune stain |
|
31901-2
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen |
|
23276-9
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23277-7
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Immune stain |
|
23278-5
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Neutralization test |
|
23279-3
|
Mycoplasma gallisepticum DNA [Presence] in Nose or Trachea by NAA with probe detection |
|
15486-4
|
Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by Probe |
|
88229-0
|
Mycoplasma genitalium DNA [Presence] in Anorectal by NAA with probe detection |
|
89597-9
|
Mycoplasma genitalium DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88227-4
|
Mycoplasma genitalium DNA [Presence] in Cervix by NAA with probe detection |
|
91849-0
|
Mycoplasma genitalium DNA [Presence] in Genital specimen by NAA with probe detection |
|
91828-4
|
Mycoplasma genitalium DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88230-8
|
Mycoplasma genitalium DNA [Presence] in Throat by NAA with probe detection |
|
88226-6
|
Mycoplasma genitalium DNA [Presence] in Urine by NAA with probe detection |
|
91874-8
|
Mycoplasma genitalium DNA [Presence] in Urethra by NAA with probe detection |
|
88228-2
|
Mycoplasma genitalium DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
69935-5
|
Mycoplasma genitalium DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
45116-1
|
Mycobacterium gordonae rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5024-5
|
Mycobacterium gordonae rRNA [Presence] in Unspecified specimen by Probe |
|
17301-3
|
Mycoplasma hominis Ab [Presence] in Serum |
|
31512-7
|
Mycoplasma hominis Ab [Units/volume] in Serum |
|
22423-8
|
Mycoplasma hominis Ab [Titer] in Serum |
|
17300-5
|
Mycoplasma hominis Ab [Titer] in Serum by Complement fixation |
|
42621-3
|
Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection |
|
89598-7
|
Mycoplasma hominis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
91848-2
|
Mycoplasma hominis DNA [Presence] in Genital specimen by NAA with probe detection |
|
91827-6
|
Mycoplasma hominis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
68546-1
|
Mycoplasma hominis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
15388-2
|
Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture |
|
80218-1
|
Mycoplasma hyopneumoniae Ab sample/Buffer control in Serum by Immunoassay |
|
80219-9
|
Mycoplasma hyopneumoniae Ab sample/Positive control in Serum by Immunoassay |
|
31513-5
|
Mycoplasma hyopneumoniae Ab [Presence] in Serum |
|
24428-5
|
Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunoassay |
|
23753-7
|
Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunofluorescence |
|
80217-3
|
Mycoplasma hyopneumoniae Ag [Presence] in Fixed tissue by Immune stain |
|
85536-1
|
Mycoplasma hyopneumoniae DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
80244-7
|
Mycoplasma hyopneumoniae DNA (Cycle Threshold #) in Unspecified specimen by Probe and target amplification method |
|
90324-5
|
Mycoplasma hyopneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85685-6
|
Mycoplasma hyopneumoniae P146 gene [Nucleotide sequence] in Unspecified specimen by Sequencing |
|
85527-0
|
Mycoplasma hyopneumoniae P146 gene sequence and phylogenetic analysis in Unspecified specimen Document |
|
85538-7
|
Mycoplasma hyorhinis 16S rRNA gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
93756-5
|
Mycoplasma hyorhinis IgG Ab/Positive control in Serum by Immunoassay |
|
85537-9
|
Mycoplasma hyosynoviae 16S rRNA gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
5025-2
|
Mycobacterium intracellulare rRNA [Presence] in Unspecified specimen by Probe |
|
45117-9
|
Mycobacterium kansasii rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5026-0
|
Mycobacterium kansasii rRNA [Presence] in Unspecified specimen by Probe |
|
91805-2
|
Mycobacterium leprae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
72868-3
|
Mycobacterium leprae folP1 gene dapsone resistance mutation [Presence] by Molecular method |
|
72869-1
|
Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
72863-4
|
Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
72870-9
|
Mycobacterium leprae rpoB gene rifAMPin resistance mutation [Presence] by Molecular method |
|
22424-6
|
Mycoplasma meleagridis Ab [Presence] in Serum |
|
15488-0
|
Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
|
23280-1
|
Mycoplasma meleagridis Ab [Presence] in Serum by Hemagglutination |
|
15487-2
|
Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
|
23282-7
|
Mycoplasma mycoides ss capri Ab [Presence] in Serum |
|
23281-9
|
Mycoplasma mycoides ss capri Ab [Presence] in Serum by Complement fixation |
|
31514-3
|
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum |
|
23283-5
|
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Complement fixation |
|
23284-3
|
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Immunoassay |
|
23285-0
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum |
|
23289-2
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Agglutination |
|
23288-4
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Complement fixation |
|
23287-6
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoassay |
|
23286-8
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoblot |
|
23292-6
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Tissue by Immune stain |
|
31902-0
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen |
|
23290-0
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
23291-8
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23293-4
|
Mycoplasma mycoides ss mycoides small colony DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47965-9
|
Mycoplasma penetrans DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
63173-9
|
Mycogone perniciosa IgG Ab [Mass/volume] in Serum |
|
7506-9
|
Mucor plumbeus IgE Ab [Units/volume] in Serum |
|
63172-1
|
Mucor plumbeus IgG Ab [Mass/volume] in Serum |
|
17303-9
|
Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid |
|
39012-0
|
Mycoplasma pneumoniae Ab [Presence] in Body fluid |
|
52987-5
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum by Complement fixation |
|
5252-2
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
|
17302-1
|
Mycoplasma pneumoniae Ab [Presence] in Serum |
|
5253-0
|
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay |
|
7969-9
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum |
|
13268-8
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen |
|
24310-5
|
Mycoplasma pneumoniae Ab [Titer] in Serum --1st specimen |
|
24236-2
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --1st specimen |
|
13269-6
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen |
|
24311-3
|
Mycoplasma pneumoniae Ab [Titer] in Serum --2nd specimen |
|
24237-0
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
42993-6
|
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid |
|
28548-6
|
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
27318-5
|
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22425-3
|
Mycoplasma pneumoniae Ab [Titer] in Serum |
|
91896-1
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Agglutination |
|
5254-8
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation |
|
31202-5
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Immunofluorescence |
|
60533-7
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Latex agglutination |
|
53255-6
|
Mycoplasma pneumoniae DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
49104-3
|
Mycoplasma pneumoniae DNA [Units/volume] in Blood by NAA with probe detection |
|
92964-6
|
Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88579-8
|
Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82177-7
|
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88720-8
|
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92126-2
|
Mycoplasma pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91804-5
|
Mycoplasma pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29257-3
|
Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31515-0
|
Mycoplasma pneumoniae IgA Ab [Presence] in Serum |
|
26684-1
|
Mycoplasma pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
|
13270-4
|
Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum |
|
18243-6
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
|
5255-5
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
46198-8
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum |
|
45224-3
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay |
|
7970-7
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum |
|
56958-2
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57677-7
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --1st specimen |
|
24234-7
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
|
57009-3
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
57678-5
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --2nd specimen |
|
24235-4
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
|
42992-8
|
Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
|
26947-2
|
Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
42526-4
|
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid |
|
42989-4
|
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid by Immunofluorescence |
|
22426-1
|
Mycoplasma pneumoniae IgG Ab [Titer] in Serum |
|
6481-6
|
Mycoplasma pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence |
|
17304-7
|
Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum |
|
58782-4
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31516-8
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid |
|
5256-3
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
|
21406-4
|
Mycoplasma pneumoniae IgM Ab [Presence] in Serum |
|
5257-1
|
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay |
|
58708-9
|
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence |
|
8078-8
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum |
|
42991-0
|
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
|
26946-4
|
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
42990-2
|
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid |
|
42525-6
|
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid by Immunofluorescence |
|
22427-9
|
Mycoplasma pneumoniae IgM Ab [Titer] in Serum |
|
5258-9
|
Mycoplasma pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence |
|
6482-4
|
Mycoplasma pneumoniae rRNA [Presence] in Sputum by Probe |
|
6483-2
|
Mycoplasma pneumoniae rRNA [Presence] in Unspecified specimen by Probe |
|
19054-6
|
Mycoplasma pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
|
56766-9
|
Protein.monoclonal band 1/Protein.total in Serum or Plasma by Electrophoresis |
|
51435-6
|
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis |
|
66481-3
|
Protein.monoclonal band 2 [Mass/time] in Urine collected for unspecified duration |
|
51438-0
|
Protein.monoclonal band 2 [Mass/volume] in 24 hour Urine by Electrophoresis |
|
74637-0
|
Protein.monoclonal band 2 [Mass/time] in 24 hour Urine by Electrophoresis |
|
44932-2
|
Protein.monoclonal band 2/Protein.total in Serum or Plasma by Electrophoresis |
|
59800-3
|
Protein.monoclonal band 2/Protein.total in Urine by Electrophoresis |
|
35559-4
|
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis |
|
51437-2
|
Protein.monoclonal band 2 [Mass/volume] in Urine by Electrophoresis |
|
87834-8
|
Protein.monoclonal band 2 [Mass/volume] in Urine by Immunofixation |
|
35561-0
|
Protein.monoclonal band 2 [Mass/volume] in Urine |
|
42484-6
|
Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis |
|
72577-0
|
Protein.monoclonal/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis |
|
51436-4
|
Protein.monoclonal [Mass/volume] in 24 hour Urine by Electrophoresis |
|
42482-0
|
Protein.monoclonal [Mass/time] in 24 hour Urine by Electrophoresis |
|
51439-8
|
Protein.monoclonal band 3 [Mass/volume] in 24 hour Urine by Electrophoresis |
|
74636-2
|
Protein.monoclonal band 3 [Mass/time] in 24 hour Urine by Electrophoresis |
|
50792-1
|
Protein.monoclonal band 3/Protein.total in Serum or Plasma by Electrophoresis |
|
59801-1
|
Protein.monoclonal band 3/Protein.total in Urine by Electrophoresis |
|
50796-2
|
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis |
|
51440-6
|
Protein.monoclonal band 3 [Mass/volume] in Urine by Electrophoresis |
|
87833-0
|
Protein.monoclonal band 3 [Mass/volume] in Urine by Immunofixation |
|
75517-3
|
Protein.monoclonal band 4 [Mass/time] in 24 hour Urine by Electrophoresis |
|
50793-9
|
Protein.monoclonal band 4/Protein.total in Serum or Plasma by Electrophoresis |
|
59802-9
|
Protein.monoclonal band 4/Protein.total in Urine by Electrophoresis |
|
50797-0
|
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis |
|
59563-7
|
Protein.monoclonal band 4 [Mass/volume] in Urine by Electrophoresis |
|
56768-5
|
Protein.monoclonal.beta/Protein.total in Urine by Electrophoresis |
|
56767-7
|
Protein.monoclonal.beta [Mass/volume] in Urine by Electrophoresis |
|
90990-3
|
Protein.monoclonal isotype [Identifier] in Serum or Plasma by MS.MALDI-TOF |
|
33647-9
|
Protein.monoclonal/Protein.total in Serum or Plasma by Electrophoresis |
|
42483-8
|
Protein.monoclonal/Protein.total in Urine by Electrophoresis |
|
32629-8
|
Protein.monoclonal/Protein.total in Unspecified specimen by Immunofixation |
|
33018-3
|
Protein.monoclonal [Units/volume] in Serum or Plasma by Electrophoresis |
|
33358-3
|
Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis |
|
40661-1
|
Protein.monoclonal [Mass/volume] in Urine by Electrophoresis |
|
87835-5
|
Protein.monoclonal [Mass/volume] in Urine by Immunofixation |
|
48627-4
|
Protein.monoclonal [Units/volume] in Urine |
|
35560-2
|
Protein.monoclonal [Mass/volume] in Urine |
|
33879-8
|
Protein.monoclonal [Mass/volume] in Unspecified specimen by Immunofixation |
|
23296-7
|
Mycoplasma putrefaciens Ab [Presence] in Serum |
|
23295-9
|
Mycoplasma putrefaciens Ab [Presence] in Serum by Complement fixation |
|
23294-2
|
Mycoplasma putrefaciens Ab [Presence] in Serum by Immunoassay |
|
7508-5
|
Mucor racemosus triggered histamine release [Units/volume] in Blood |
|
6182-0
|
Mucor racemosus IgE Ab [Units/volume] in Serum |
|
15862-6
|
Mucor racemosus IgE Ab RAST class [Presence] in Serum |
|
7507-7
|
Mucor racemosus IgG Ab [Units/volume] in Serum |
|
33297-3
|
Mucor racemosus IgG Ab RAST class [Presence] in Serum |
|
56324-7
|
Mucor racemosus IgG4 Ab [Mass/volume] in Serum |
|
35549-5
|
Mucor racemosus IgG Ab [Mass/volume] in Serum |
|
22429-5
|
Mycoplasma synoviae Ab [Presence] in Serum |
|
15490-6
|
Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
|
23302-3
|
Mycoplasma synoviae Ab [Presence] in Serum by Hemagglutination |
|
15489-8
|
Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
|
31518-4
|
Mycoplasma synoviae Ab [Units/volume] in Serum |
|
42988-6
|
Mycoplasma synoviae Ab [Titer] in Serum |
|
23755-2
|
Mycoplasma synoviae Ab [Titer] in Serum by Hemagglutination |
|
15491-4
|
Mycoplasma synoviae rRNA [Presence] in Serum by Probe |
|
55224-0
|
Mycobacterium tuberculosis A60 Ab [Presence] in Serum by Immunoassay |
|
55223-2
|
Mycobacterium tuberculosis A60 IgM Ab [Presence] in Serum by Immunoassay |
|
88874-3
|
Mycobacterium tuberculosis complex DNA [Presence] in Isolate or Specimen by Molecular genetics method |
|
85362-2
|
Mycobacterium tuberculosis complex DNA [Presence] in Sputum or Bronchial by NAA with probe detection |
|
38379-4
|
Mycobacterium tuberculosis complex DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
42717-9
|
Mycobacterium tuberculosis complex genotype [Identifier] in Isolate |
|
83066-1
|
Mycobacterium tuberculosis complex immunogenic protein MPB64 [Presence] in Isolate by Immunoassay |
|
48174-7
|
Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17296-5
|
Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by Probe |
|
53257-2
|
Mycobacterium tuberculosis DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
91763-3
|
Mycobacterium tuberculosis DNA [Presence] in Aspirate by NAA with probe detection |
|
78357-1
|
Mycobacterium tuberculosis DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
90283-3
|
Mycobacterium tuberculosis DNA [Presence] in Bile fluid by NAA with probe detection |
|
16278-4
|
Mycobacterium tuberculosis DNA [Presence] in Blood by NAA with probe detection |
|
14557-3
|
Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by NAA with probe detection |
|
88165-6
|
Mycobacterium tuberculosis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
14561-5
|
Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
58931-7
|
Mycobacterium tuberculosis DNA [Presence] in Body fluid by NAA with probe detection |
|
14558-1
|
Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by NAA with probe detection |
|
89635-7
|
Mycobacterium tuberculosis DNA [Presence] in Implanted device by NAA with probe detection |
|
91829-2
|
Mycobacterium tuberculosis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88166-4
|
Mycobacterium tuberculosis DNA [Presence] in Ocular fluid by NAA with probe detection |
|
14559-9
|
Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection |
|
14562-3
|
Mycobacterium tuberculosis DNA [Presence] in Semen by NAA with probe detection |
|
14556-5
|
Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection |
|
14560-7
|
Mycobacterium tuberculosis DNA [Presence] in Urine by NAA with probe detection |
|
13956-8
|
Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35352-4
|
Mycobacterium tuberculosis genotype [Identifier] in Isolate |
|
71773-6
|
Mycobacterium tuberculosis stimulated gamma interferon [Interpretation] in Blood Qualitative |
|
64084-7
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood |
|
46217-6
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood |
|
88517-8
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood |
|
74277-5
|
Mycobacterium tuberculosis stimulated gamma interferon CFP10 Ag spot count [#] in Blood |
|
74278-3
|
Mycobacterium tuberculosis stimulated gamma interferon ESAT-6 Ag spot count [#] in Blood |
|
54146-6
|
Mycobacterium tuberculosis IgG Ab [Units/volume] in Serum by Immunoassay |
|
46246-5
|
Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation [Identifier] by Molecular method |
|
5027-8
|
Mycobacterium tuberculosis rRNA [Presence] in Unspecified specimen by Probe |
|
45323-3
|
Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood |
|
39017-9
|
Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon in Blood |
|
46216-8
|
Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon [Units/volume] in Control Blood |
|
88518-6
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood |
|
93394-5
|
Morganella morganii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
46779-5
|
Medium/Short chain acyl-CoA dehydrogenase deficiency newborn screen interpretation |
|
82889-7
|
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine |
|
82890-5
|
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate/Creatinine [Molar ratio] in Urine |
|
54939-4
|
Meta methylhippurate+Para methylhippurate [Mass/volume] in Serum or Plasma |
|
12541-9
|
Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine |
|
1244-3
|
M1 Ab [Presence] in Serum or Plasma from Blood product unit |
|
1245-0
|
M1 Ab [Presence] in Serum or Plasma from Donor |
|
1246-8
|
M1 Ab [Presence] in Serum or Plasma |
|
1247-6
|
M1 Ag [Presence] on Red Blood Cells from Blood product unit |
|
1248-4
|
M1 Ag [Presence] on Red Blood Cells from Donor |
|
1249-2
|
M1 Ag [Presence] on Red Blood Cells |
|
81727-0
|
Mitochondria M2-3E Ab [Presence] in Serum by Line blot |
|
72320-5
|
Mitochondria M2-3E IgG Ab [Presence] in Serum by Immunoassay |
|
10447-1
|
M-5 Ag [Presence] in Tissue by Immune stain |
|
76027-2
|
Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Fibroblast |
|
78963-6
|
Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Leukocytes |
|
91126-3
|
Maximum amplitude activator F induced [Length] in Blood by Resonance TEG |
|
91127-1
|
Maximum amplitude ADP induced [Length] in Blood by Resonance TEG |
|
91125-5
|
Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG --after addition of heparinase |
|
90833-5
|
Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
57452-5
|
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
90832-7
|
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
54918-8
|
Ma+Ta Ab [Units/volume] in Serum by Immunoassay |
|
35458-9
|
Ma+Ta Ab [Presence] in Serum |
|
56720-6
|
Ma+Ta Ab [Presence] in Serum by Immunoblot |
|
82423-5
|
Ma+Ta Ab [Presence] in Serum by Line blot |
|
56529-1
|
Ma+Ta Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
51712-8
|
Ma+Ta Ab [Titer] in Serum by Immunofluorescence |
|
82983-8
|
Ma+Ta IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
69559-3
|
Ma1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
69558-5
|
Ma1 Ab [Presence] in Serum by Immunoblot |
|
87487-5
|
MAB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
11183-1
|
Macadamia IgE Ab [Units/volume] in Serum |
|
21376-9
|
Macadamia IgE Ab RAST class [Presence] in Serum |
|
61283-8
|
Macadamia IgE Ab/IgE total in Serum |
|
6669-6
|
Microscopic observation [Identifier] in Tissue by Macchiavello stain |
|
669-2
|
Microscopic observation [Identifier] in Unspecified specimen by Macchiavello stain |
|
15280-1
|
Mace IgE Ab [Units/volume] in Serum |
|
51553-6
|
Mace IgE Ab RAST class [Presence] in Serum |
|
7475-7
|
Mackerel triggered histamine release [Units/volume] in Blood |
|
7474-0
|
Mackerel IgE Ab [Units/volume] in Serum |
|
15827-9
|
Mackerel IgE Ab RAST class [Presence] in Serum |
|
33726-1
|
Macroscopic tumor configuration |
|
26011-7
|
Macroamylase/Amylase.total in Serum or Plasma |
|
55204-2
|
Macroamylase [Presence] in Pleural fluid |
|
15358-5
|
Macroamylase [Presence] in Serum or Plasma |
|
2591-6
|
Macroamylase [Enzymatic activity/volume] in Serum or Plasma |
|
51629-4
|
Macroblasts/100 cells in Bone marrow by Manual count |
|
30424-6
|
Macrocytes [Presence] in Blood |
|
15198-5
|
Macrocytes [Presence] in Blood by Automated count |
|
738-5
|
Macrocytes [Presence] in Blood by Light microscopy |
|
10376-2
|
Oval macrocytes [Presence] in Blood by Light microscopy |
|
53970-0
|
Macrocytes [Presence] in Urine sediment by Light microscopy |
|
2592-4
|
Macroglobulin [Mass/volume] in Serum or Plasma |
|
35038-9
|
Macrophages [#/volume] in Cerebral spinal fluid |
|
35036-3
|
Macrophages [#/volume] in Body fluid |
|
67828-4
|
Macrophages [#/volume] in Pericardial fluid |
|
68408-4
|
Macrophages [#/volume] in Pericardial fluid by Manual count |
|
67834-2
|
Macrophages [#/volume] in Pleural fluid from Fetus |
|
68410-0
|
Macrophages [#/volume] in Pleural fluid by Manual count |
|
68409-2
|
Macrophages [#/volume] in Peritoneal fluid by Manual count |
|
35037-1
|
Macrophages [#/volume] in Synovial fluid |
|
68411-8
|
Macrophages [#/volume] in Synovial fluid by Manual count |
|
68413-4
|
Macrophages [#/volume] in Vitreous fluid by Manual count |
|
72220-7
|
Macrophages [#/area] in Urine sediment by Microscopy high power field |
|
63552-4
|
Macrophages/100 cells in Bone marrow by Manual count |
|
71594-6
|
Macrophages/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
|
71651-4
|
Macrophages/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71641-5
|
Macrophages/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
71600-1
|
Macrophages/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71609-2
|
Macrophages/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71628-2
|
Macrophages/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71618-3
|
Macrophages/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
30425-3
|
Macrophages/100 leukocytes in Bronchial specimen |
|
56772-7
|
Macrophages/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
|
14823-9
|
Macrophages/100 leukocytes in Bronchial specimen by Manual count |
|
30426-1
|
Macrophages/100 leukocytes in Cerebral spinal fluid |
|
12229-1
|
Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
|
51621-1
|
Macrophages/100 leukocytes in Dialysis fluid by Manual count |
|
30427-9
|
Macrophages/100 leukocytes in Body fluid |
|
12230-9
|
Macrophages/100 leukocytes in Body fluid by Manual count |
|
40524-1
|
Macrophages/100 leukocytes in Pericardial fluid by Manual count |
|
40520-9
|
Macrophages/100 leukocytes in Pleural fluid by Manual count |
|
40517-5
|
Macrophages/100 leukocytes in Peritoneal fluid by Manual count |
|
33376-5
|
Macrophages/100 leukocytes in Synovial fluid |
|
40490-5
|
Macrophages/100 leukocytes in Synovial fluid by Manual count |
|
68412-6
|
Macrophages/100 leukocytes in Vitreous fluid by Manual count |
|
51580-9
|
Macrophages/100 leukocytes in Bone marrow by Manual count |
|
72680-2
|
Macroprolactin [Presence] in Serum or Plasma |
|
74953-1
|
Macroprolactin [Units/volume] in Serum or Plasma |
|
38926-2
|
Macroprolactin [Mass/volume] in Serum or Plasma |
|
51441-4
|
Macroprolactin/Prolactin [Mass] in Serum or Plasma |
|
72575-4
|
Macroprolactin/Prolactin [Pure mass fraction] in Serum or Plasma |
|
48389-1
|
Macroprolactin/Prolactin [Moles] in Serum or Plasma |
|
87928-8
|
Macroscopic observation [Interpretation] in Stool Narrative |
|
74574-5
|
Macroscopic observation [Interpretation] in Unspecified specimen Narrative |
|
71488-1
|
Macular edema Left eye by Ophthalmoscopy |
|
71489-9
|
Macular edema Right eye by Ophthalmoscopy |
|
85733-4
|
Maculopapular rash in Mother |
|
14072-3
|
Monoacetyldapsone [Mass/volume] in Serum or Plasma |
|
13461-9
|
Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma |
|
86466-0
|
Maestro of scalable information infrastructure |
|
20391-9
|
Mafenide [Susceptibility] |
|
63290-1
|
Myelin associated glycoprotein Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31519-2
|
Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid |
|
12897-5
|
Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
63289-3
|
Myelin associated glycoprotein Ab [Units/volume] in Body fluid by Immunoassay |
|
63288-5
|
Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoassay |
|
63396-6
|
Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoblot |
|
17308-8
|
Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot |
|
45170-8
|
Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunofluorescence |
|
31521-8
|
Myelin associated glycoprotein Ab [Presence] in Serum |
|
26775-7
|
Myelin associated glycoprotein Ab [Presence] in Serum by Immunoassay |
|
13119-3
|
Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot |
|
17310-4
|
Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence |
|
31520-0
|
Myelin associated glycoprotein Ab [Units/volume] in Serum |
|
33394-8
|
Myelin associated glycoprotein Ab [Titer] in Serum |
|
17311-2
|
Myelin associated glycoprotein IgA Ab [Units/volume] in Serum |
|
17313-8
|
Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
17312-0
|
Myelin associated glycoprotein IgG Ab [Units/volume] in Serum |
|
33602-4
|
Myelin associated glycoprotein IgG Ab [Titer] in Serum |
|
90835-0
|
Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
27030-6
|
Myelin associated glycoprotein IgM Ab [Units/volume] in Cerebral spinal fluid |
|
17314-6
|
Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay |
|
31522-6
|
Myelin associated glycoprotein IgM Ab [Presence] in Serum |
|
31023-5
|
Myelin associated glycoprotein IgM Ab [Presence] in Serum by Immunoblot |
|
21411-4
|
Myelin associated glycoprotein IgM Ab [Units/volume] in Serum |
|
91001-8
|
Myelin associated glycoprotein IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
21410-6
|
Myelin associated glycoprotein IgM Ab [Titer] in Serum |
|
39087-2
|
Myelin associated glycoprotein IgM Ab [Titer] in Serum by Immunoassay |
|
42211-3
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside Ab [Titer] in Serum |
|
23907-9
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Units/volume] in Serum |
|
90848-3
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
13664-8
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
|
43190-8
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum by Immunoassay |
|
89004-6
|
MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30922-9
|
Magnesium [Mass/volume] in Urine collected for unspecified duration |
|
57367-5
|
Magnesium [Mass/volume] in 12 hour Urine |
|
57368-3
|
Magnesium [Mass/time] in 12 hour Urine |
|
74696-6
|
Magnesium [Moles/volume] in 12 hour Urine |
|
58995-2
|
Magnesium [Mass/time] in 18 hour Urine |
|
23891-5
|
Magnesium [Moles/volume] in 24 hour Stool |
|
27255-9
|
Magnesium [Moles/mass] in 24 hour Stool |
|
23892-3
|
Magnesium [Moles/time] in 24 hour Stool |
|
32024-2
|
Magnesium [Mass/volume] in 24 hour Urine |
|
24447-5
|
Magnesium [Mass/time] in 24 hour Urine |
|
35252-6
|
Magnesium [Mass or Moles/volume] in 24 hour Urine |
|
25954-9
|
Magnesium [Moles/volume] in 24 hour Urine |
|
2599-9
|
Magnesium [Moles/time] in 24 hour Urine |
|
18368-1
|
Magnesium [Moles/time] in 2 hour Urine |
|
18369-9
|
Magnesium [Moles/time] in 4 hour Urine |
|
65362-6
|
Magnesium [Moles/volume] corrected for albumin in Serum or Plasma |
|
27210-4
|
Magnesium [Presence] in Blood |
|
21377-7
|
Magnesium [Mass/volume] in Blood |
|
2593-2
|
Magnesium [Moles/volume] in Blood |
|
29364-7
|
Magnesium [Mass/volume] in Cerebral spinal fluid |
|
2594-0
|
Magnesium [Moles/volume] in Cerebral spinal fluid |
|
48045-9
|
Magnesium cutoff [Mass/mass] in Stool |
|
49007-8
|
Magnesium [Moles/volume] in Peritoneal dialysis fluid |
|
42616-3
|
Magnesium [Mass/volume] in Dialysis fluid |
|
2595-7
|
Magnesium [Moles/volume] in Dialysis fluid |
|
57998-7
|
Magnesium [Mass/volume] in Nonbiological fluid |
|
29365-4
|
Magnesium [Mass/volume] in Body fluid |
|
2596-5
|
Magnesium [Moles/volume] in Body fluid |
|
16172-9
|
Magnesium [Mass/mass] in Hair |
|
17237-9
|
Magnesium [Moles/mass] in Hair |
|
81005-1
|
Magnesium intake 24 hour Estimated |
|
81006-9
|
Magnesium intake 24 hour Measured |
|
20872-8
|
Magnesium [Mass/volume] in Ocular fluid |
|
55937-7
|
Magnesium [Moles/volume] in Serum or Plasma --post dialysis |
|
26746-8
|
Magnesium [Mass/volume] in Red Blood Cells |
|
27122-1
|
Magnesium [Mass/mass] in Red Blood Cells |
|
2597-3
|
Magnesium [Moles/volume] in Red Blood Cells |
|
17234-6
|
Magnesium.plasma/Magnesium.RBC [Molar ratio] in Blood |
|
19123-9
|
Magnesium [Mass/volume] in Serum or Plasma |
|
35249-2
|
Magnesium [Mass or Moles/volume] in Serum or Plasma |
|
2601-3
|
Magnesium [Moles/volume] in Serum or Plasma |
|
54919-6
|
Magnesium [Mass/volume] in Semen |
|
29911-5
|
Magnesium [Mass/volume] in Stool |
|
10880-3
|
Magnesium [Mass/mass] in Stool |
|
29912-3
|
Magnesium [Mass/time] in Stool |
|
17236-1
|
Magnesium [Moles/volume] in Stool |
|
26708-8
|
Magnesium [Moles/mass] in Stool |
|
14824-7
|
Magnesium [Presence] in Stone |
|
52911-5
|
Magnesium [Moles/mass] in Tissue |
|
30536-7
|
Magnesium [Mass/volume] in Total parental nutrition |
|
55938-5
|
Magnesium [Moles/volume] in Total parental nutrition |
|
19124-7
|
Magnesium [Mass/volume] in Urine |
|
35250-0
|
Magnesium [Mass or Moles/volume] in Urine |
|
2598-1
|
Magnesium [Moles/volume] in Urine |
|
9478-9
|
Magnesium [Mass/volume] in Water |
|
17235-3
|
Magnesium [Moles/volume] in Leukocytes |
|
87469-3
|
Magnesium [Mass/volume] in Unspecified specimen |
|
87470-1
|
Magnesium [Mass/mass] in Unspecified specimen |
|
32329-5
|
Magnesium [Moles/volume] in Unspecified specimen |
|
44336-6
|
Magnesium/Creatinine [Mass Ratio] in 24 hour Urine |
|
50873-9
|
Magnesium/Creatinine [Molar ratio] in 24 hour Urine |
|
13474-2
|
Magnesium/Creatinine [Mass Ratio] in Urine |
|
56956-6
|
Magnesium/Creatinine [Ratio] in Urine |
|
33950-7
|
Magnesium/Creatinine [Molar ratio] in Urine |
|
50185-8
|
Magnolia IgE Ab [Units/volume] in Serum |
|
82570-3
|
Mahi mahi IgE Ab [Units/volume] in Serum |
|
82571-1
|
Mahi mahi IgE Ab RAST class [Presence] in Serum |
|
50029-8
|
Mahogany wood dust IgE Ab [Units/volume] in Serum |
|
33962-2
|
Melanoma inhibitory activity protein [Mass/volume] in Serum or Plasma |
|
80049-0
|
Main pulmonary artery Diameter at end systole by US 2D |
|
1252-6
|
Major crossmatch [Interpretation] --post immediate spin |
|
46275-4
|
Major crossmatch [Interpretation] --after transfusion reaction |
|
1254-2
|
Major crossmatch.re-crossmatch [Interpretation] |
|
53799-3
|
Major crossmatch [Interpretation] by Electronic |
|
1251-8
|
Major crossmatch [Interpretation] by Immediate spin |
|
38168-1
|
Major crossmatch [Interpretation] by Low ionic strength saline (LISS) |
|
38167-3
|
Major crossmatch [Interpretation] by Polyethylene glycol (PEG) method |
|
1253-4
|
Major crossmatch [Interpretation] by Prewarmed |
|
1250-0
|
Major crossmatch [Interpretation] |
|
13010-4
|
Methyl amyl ketone [Mass/volume] in Blood |
|
31184-5
|
Methyl amyl ketone [Mass/volume] in Urine |
|
46781-1
|
Malonic acidemia newborn screen interpretation |
|
33699-0
|
Microscopic observation [Identifier] in Unspecified specimen by Malachite green stain |
|
23893-1
|
Malaoxon [Mass/volume] in Blood |
|
11098-1
|
Malaoxon [Mass/volume] in Serum or Plasma |
|
32700-7
|
Microscopic observation [Identifier] in Blood by Malaria smear |
|
6670-4
|
Microscopic observation [Identifier] in Tissue by Malaria smear |
|
33271-8
|
Microscopic observation [Identifier] in Blood by Malaria thin smear |
|
88342-1
|
Malassezia sp [Presence] in Ear by Light microscopy |
|
51857-1
|
Malassezia sp IgE Ab [Units/volume] in Serum |
|
51864-7
|
Malassezia sp IgE Ab RAST class [Presence] in Serum |
|
2602-1
|
Malate dehydrogenase [Enzymatic activity/volume] in Serum |
|
75068-7
|
Malate [Moles/volume] in Serum or Plasma |
|
13770-3
|
Malate/Creatinine [Mass Ratio] in Urine |
|
25113-2
|
Malate/Creatinine [Molar ratio] in Urine |
|
5680-4
|
Malathion [Mass/volume] in Serum or Plasma |
|
21378-5
|
Malathion [Mass/volume] in Urine |
|
87648-2
|
Malathion [Mass/mass] in Unspecified specimen |
|
85473-7
|
Male sexual partner in last 12 months |
|
38606-0
|
Maleic anhydride [Mass/volume] in Air |
|
19746-7
|
Maleic anhydride IgE Ab [Units/volume] in Serum |
|
25465-6
|
Maleic anhydride IgE Ab RAST class [Presence] in Serum |
|
34914-2
|
Malignant cells [#/volume] in Blood |
|
33836-8
|
Malignant cells [#/volume] in Blood by Manual count |
|
44890-2
|
Malignant cells [#/volume] in Cerebral spinal fluid |
|
44883-7
|
Malignant cells [#/volume] in Cerebral spinal fluid by Manual count |
|
44891-0
|
Malignant cells [#/volume] in Pericardial fluid |
|
44886-0
|
Malignant cells [#/volume] in Pericardial fluid by Manual count |
|
44889-4
|
Malignant cells [#/volume] in Pleural fluid |
|
44884-5
|
Malignant cells [#/volume] in Pleural fluid by Manual count |
|
44882-9
|
Malignant cells [#/volume] in Peritoneal fluid |
|
44887-8
|
Malignant cells [#/volume] in Peritoneal fluid by Manual count |
|
44888-6
|
Malignant cells [#/volume] in Synovial fluid |
|
44885-2
|
Malignant cells [#/volume] in Synovial fluid by Manual count |
|
74783-2
|
Malignant cells [Presence] in Body fluid by Light microscopy |
|
81284-2
|
Malignant cells/100 cells in Bronchoalveolar lavage by Manual count |
|
44892-8
|
Malignant cells/100 cells in Cerebral spinal fluid |
|
44894-4
|
Malignant cells/100 cells in Cerebral spinal fluid by Manual count |
|
51624-5
|
Malignant cells/100 cells in Dialysis fluid by Manual count |
|
69005-7
|
Malignant cells/100 cells in Body fluid |
|
51625-2
|
Malignant cells/100 cells in Body fluid by Manual count |
|
44901-7
|
Malignant cells/100 cells in Liver by Manual count |
|
44903-3
|
Malignant cells/100 cells in Bone marrow |
|
44900-9
|
Malignant cells/100 cells in Bone marrow by Manual count |
|
44904-1
|
Malignant cells/100 cells in Pericardial fluid |
|
44897-7
|
Malignant cells/100 cells in Pericardial fluid by Manual count |
|
44902-5
|
Malignant cells/100 cells in Pleural fluid |
|
44895-1
|
Malignant cells/100 cells in Pleural fluid by Manual count |
|
44905-8
|
Malignant cells/100 cells in Peritoneal fluid |
|
44898-5
|
Malignant cells/100 cells in Peritoneal fluid by Manual count |
|
44893-6
|
Malignant cells/100 cells in Synovial fluid |
|
44896-9
|
Malignant cells/100 cells in Synovial fluid by Manual count |
|
44899-3
|
Malignant cells/100 cells in Urine by Manual count |
|
34915-9
|
Malignant cells/100 leukocytes in Blood |
|
33837-6
|
Malignant cells/100 leukocytes in Blood by Manual count |
|
32025-9
|
Malignin Ab [Presence] in Serum |
|
17238-7
|
Malignin Ab [Units/volume] in Serum |
|
10791-2
|
Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |
|
90862-4
|
Malocclusion index Teeth and gum Calculated |
|
90873-1
|
Malocclusion severity assessment |
|
2603-9
|
Malonate [Mass/volume] in Serum |
|
75061-2
|
Malonate [Moles/volume] in Serum or Plasma |
|
30478-2
|
Malonate [Presence] in Urine |
|
45168-2
|
Malonate [Mass/volume] in Urine |
|
51843-1
|
Malonate/Creatinine [Mass Ratio] in Urine |
|
47696-0
|
Malonate/Creatinine [Molar ratio] in Urine |
|
72258-7
|
Malondialdehyde [Entitic substance] in Platelets |
|
47865-1
|
Malondialdehyde [Moles/volume] in Plasma |
|
55939-3
|
Malondialdehyde [Moles/mass] in Red Blood Cells |
|
50550-3
|
Malondialdehyde.free [Moles/volume] in Plasma |
|
67708-8
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
|
74630-5
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma |
|
75213-9
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
81779-1
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine |
|
54461-9
|
Malonylcarnitine (C3-DC) [Moles/volume] in Amniotic fluid |
|
54460-1
|
Malonylcarnitine (C3-DC) [Moles/volume] in Cerebral spinal fluid |
|
54462-7
|
Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
|
55940-1
|
Malonylcarnitine (C3-DC) [Moles/volume] in Serum or Plasma |
|
54463-5
|
Malonylcarnitine (C3-DC) [Moles/volume] in Urine |
|
75212-1
|
Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
54314-0
|
Malonylcarnitine (C3-DC)/Creatinine [Molar ratio] in Urine |
|
6166-3
|
Malt IgE Ab [Units/volume] in Serum |
|
15831-1
|
Malt IgE Ab RAST class [Presence] in Serum |
|
7476-5
|
Malt IgG Ab [Units/volume] in Serum |
|
21379-3
|
Malt IgG Ab RAST class [Presence] in Serum |
|
56312-2
|
Malt IgG4 Ab [Mass/volume] in Serum |
|
51922-3
|
Malt IgG Ab [Mass/volume] in Serum |
|
66950-7
|
MALT1 18q21 gene rearrangements in Blood or Tissue by FISH |
|
91122-2
|
Maltose binding protein IgE Ab [Units/volume] in Serum |
|
91121-4
|
Maltose binding protein IgE Ab RAST class [Presence] in Serum |
|
57848-4
|
Maltose [Presence] in Urine |
|
74895-4
|
Maltose/Creatinine [Molar ratio] in Urine |
|
73944-1
|
MAM-2201 (synthetic cannabinoid) [Presence] in Blood |
|
73919-3
|
MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72470-8
|
MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
74034-0
|
MAML2 11q21 gene rearrangements in Tissue by FISH |
|
49472-4
|
Mammaglobin Ag [Presence] in Tissue by Immune stain |
|
81825-2
|
MAN2B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
57284-2
|
Management of injectable medications - ability [CMS Assessment] |
|
57285-9
|
Management of oral medications - ability [CMS Assessment] |
|
77287-1
|
Management, administrative, AndOr support staff [NMMDS] |
|
71498-0
|
Manager Dialysis facility [ESRD] |
|
7731-3
|
Mandarin IgE Ab [Units/volume] in Serum |
|
16047-3
|
Mandarin IgE Ab RAST class [Presence] in Serum |
|
7732-1
|
Mandarin IgG Ab [Units/volume] in Serum |
|
21552-5
|
Mandarin IgG Ab RAST class [Presence] in Serum |
|
56400-5
|
Mandarin IgG4 Ab [Mass/volume] in Serum |
|
60408-2
|
Mandarin IgG Ab [Mass/volume] in Serum |
|
80564-8
|
Mandatory reporting form |
|
75072-9
|
Mandelate [Moles/volume] in Serum or Plasma |
|
27929-9
|
Mandelate [Presence] in Urine |
|
13000-5
|
Mandelate [Mass/volume] in Urine |
|
13001-3
|
Mandelate/Creatinine [Mass Ratio] in Urine |
|
47697-8
|
Mandelate/Creatinine [Molar ratio] in Urine |
|
30932-8
|
Manganese [Mass/volume] in Urine collected for unspecified duration |
|
21382-7
|
Manganese [Mass/volume] in 24 hour Urine |
|
8203-2
|
Manganese [Mass/time] in 24 hour Urine |
|
42222-0
|
Manganese [Moles/time] in 24 hour Urine |
|
5681-2
|
Manganese [Mass/volume] in Blood |
|
25466-4
|
Manganese [Moles/volume] in Blood |
|
57999-5
|
Manganese [Mass/volume] in Cerebral spinal fluid |
|
20875-1
|
Manganese [Mass/mass] in Feed |
|
51198-0
|
Manganese [Mass/volume] in Body fluid |
|
47116-9
|
Manganese [Moles/volume] in Gastric fluid |
|
17244-5
|
Manganese [Mass/mass] in Hair |
|
50874-7
|
Manganese [Moles/mass] in Hair |
|
81007-7
|
Manganese intake 24 hour Estimated |
|
81008-5
|
Manganese intake 24 hour Measured |
|
5682-0
|
Manganese [Mass/volume] in Red Blood Cells |
|
50875-4
|
Manganese [Moles/volume] in Red Blood Cells |
|
5683-8
|
Manganese [Mass/volume] in Serum or Plasma |
|
25467-2
|
Manganese [Moles/volume] in Serum or Plasma |
|
20874-4
|
Manganese [Mass/mass] in Tissue |
|
5684-6
|
Manganese [Mass/volume] in Urine |
|
42221-2
|
Manganese [Moles/volume] in Urine |
|
13645-7
|
Manganese [Mass/volume] in Water |
|
87467-7
|
Manganese [Mass/volume] in Unspecified specimen |
|
87468-5
|
Manganese [Mass/mass] in Unspecified specimen |
|
29935-4
|
Manganese/Creatinine [Mass Ratio] in 24 hour Urine |
|
52930-5
|
Manganese/Creatinine [Molar ratio] in 24 hour Urine |
|
27367-2
|
Manganese/Creatinine [Mass Ratio] in Urine |
|
42223-8
|
Manganese/Creatinine [Molar ratio] in Urine |
|
6167-1
|
Mango IgE Ab [Units/volume] in Serum |
|
15832-9
|
Mango IgE Ab RAST class [Presence] in Serum |
|
24155-4
|
Mango IgG Ab [Units/volume] in Serum |
|
56313-0
|
Mango IgG4 Ab [Mass/volume] in Serum |
|
63096-2
|
Mango IgG Ab [Mass/volume] in Serum |
|
7477-3
|
Mango Pollen IgE Ab [Units/volume] in Serum |
|
2604-7
|
Mannitol renal clearance in 24 hour Urine and Serum or Plasma |
|
74894-7
|
Mannitol [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
|
33838-4
|
Mannitol [Moles/volume] in Serum or Plasma |
|
55941-9
|
Mannitol [Mass/volume] in Urine |
|
47698-6
|
Mannitol/Creatinine [Molar ratio] in Urine |
|
53597-1
|
Mannobioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
48144-0
|
Mannose [Presence] in Urine |
|
74893-9
|
Mannose/Creatinine [Molar ratio] in Urine |
|
30152-3
|
Mannose-binding protein [Mass/volume] in Serum |
|
51393-7
|
Manometry Study observation Narrative |
|
58445-8
|
Manual differential comment [Interpretation] in Blood Narrative |
|
75654-4
|
Manual differential comment [Interpretation] in Cerebral spinal fluid Narrative |
|
75653-6
|
Manual differential comment [Interpretation] in Body fluid Narrative |
|
50957-0
|
Manual differential performed [Presence] in Blood |
|
92559-4
|
Manual therapy technique plan to use [Identifier] |
|
89181-2
|
Manual therapy technique used [Identifier] |
|
52049-4
|
Manual wheelchair attachment |
|
74719-6
|
Manufacturer name |
|
74058-9
|
Manufacturer name of Medication |
|
30957-5
|
Manufacturer name [Identifier] Vaccine |
|
82884-8
|
MAOA gene upstream VNTR repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
23339-5
|
Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL avian tuberculin intradermal |
|
23340-3
|
Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL johnin intradermal |
|
60495-9
|
MAP2K1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60496-7
|
MAP2K2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
42789-8
|
Mitogen-Activated protein kinase 14 Ag [Presence] in Tissue by Immune stain |
|
42791-4
|
Mitogen-Activated protein kinase 3 Ag [Presence] in Tissue by Immune stain |
|
42792-2
|
Mitogen-Activated protein kinase 8 Ag [Presence] in Tissue by Immune stain |
|
42793-0
|
Mitogen-Activated protein kinase 9 Ag [Presence] in Tissue by Immune stain |
|
6168-9
|
Maple IgE Ab [Units/volume] in Serum |
|
23894-9
|
Maple IgE Ab RAST class [Presence] in Serum |
|
7482-3
|
Maple sugar IgE Ab [Units/volume] in Serum |
|
15836-0
|
Maple sugar IgE Ab RAST class [Presence] in Serum |
|
58000-1
|
Maple sugar IgE Ab/IgE total in Serum |
|
7483-1
|
Maple syrup IgE Ab [Units/volume] in Serum |
|
24514-2
|
Maple syrup IgE Ab RAST class [Presence] in Serum |
|
24156-2
|
Maple syrup IgG Ab [Units/volume] in Serum |
|
56314-8
|
Maple syrup IgG4 Ab [Mass/volume] in Serum |
|
63148-1
|
Maple syrup IgG Ab [Mass/volume] in Serum |
|
4304-2
|
Maprotiline [Mass] of Dose |
|
40379-0
|
Maprotiline [Presence] in Gastric fluid |
|
29405-8
|
Maprotiline [Mass/volume] in Gastric fluid |
|
47117-7
|
Maprotiline [Moles/volume] in Gastric fluid |
|
3734-1
|
Maprotiline [Presence] in Serum or Plasma |
|
3735-8
|
Maprotiline [Mass/volume] in Serum or Plasma |
|
14825-4
|
Maprotiline [Moles/volume] in Serum or Plasma |
|
74962-2
|
Maprotiline [Mass/volume] in Serum or Plasma --trough |
|
3737-4
|
Maprotiline [Presence] in Urine |
|
3738-2
|
Maprotiline [Mass/volume] in Urine |
|
47118-5
|
Maprotiline [Moles/volume] in Urine |
|
60313-4
|
Maprotiline [Moles/volume] in Unspecified specimen |
|
80645-5
|
Maprotiline+normaprotiline [Mass/volume] in Serum or Plasma |
|
41092-8
|
MAPT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40478-0
|
MAPT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
63438-6
|
MAPT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
80565-5
|
Medication administration record |
|
82254-4
|
Marker and derivative chromosome analysis in Amniotic fluid or Chorionic villus sample Document by Cytogenetics |
|
82255-1
|
Marker and derivative chromosome analysis in Blood or Tissue Document by Cytogenetics |
|
33721-2
|
Bone marrow Pathology biopsy report |
|
66119-9
|
Bone marrow Pathology biopsy report Narrative |
|
88987-3
|
Maraviroc [Mass/volume] in Serum or Plasma |
|
73641-3
|
Marbofloxacin [Susceptibility] by Disk diffusion (KB) |
|
73618-1
|
Marbofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73596-9
|
Marbofloxacin [Susceptibility] |
|
10936-3
|
Mare milk IgE Ab [Units/volume] in Serum |
|
15837-8
|
Mare milk IgE Ab RAST class [Presence] in Serum |
|
85334-1
|
Surgical margin DCIS involvement [Presence] in Breast cancer specimen by Light microscopy |
|
84885-3
|
Surgical margin tumor involvement.circumferential [Presence] in Colorectal cancer specimen |
|
85291-3
|
Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy |
|
86743-2
|
Surgical margin tumor involvement.deep [Presence] in Skin melanoma by Light microscopy |
|
85292-1
|
Surgical margin tumor involvement.distant [Presence] in Colorectal cancer specimen by Light microscopy |
|
85293-9
|
Surgical margin tumor involvement.mesenteric [Presence] in Colorectal cancer specimen by Light microscopy |
|
85294-7
|
Surgical margin tumor involvement.mucosal [Identifier] in Colorectal cancer specimen by Light microscopy |
|
85295-4
|
Surgical margin tumor involvement.proximal [Presence] in Colorectal cancer specimen by Light microscopy |
|
85290-5
|
Surgical margin tumor involvement [Presence] in Colorectal cancer specimen by Light microscopy |
|
44671-6
|
Margin involvement by CAP cancer protocols |
|
44670-8
|
Margin involvement in Prostate tumor by CAP cancer protocols |
|
44669-0
|
Margin involvement in Breast tumor |
|
84905-9
|
Margin involvement [Type] in Prostate tumor |
|
44677-3
|
Margin(s) involved by DCIS in Breast tumor |
|
44676-5
|
Margin(s) involved by invasive carcinoma in Breast tumor |
|
44678-1
|
Margin(s) involved by invasive carcinoma in Prostate tumor |
|
44679-9
|
Margin(s) involved by invasive melanoma in Skin melanoma |
|
44680-7
|
Margin(s) involved by melanoma in situ |
|
72853-5
|
Maribavir [Susceptibility] by Genotype method |
|
45404-1
|
Marital status |
|
85431-5
|
Marital status of Contact |
|
10937-1
|
Marjoram IgE Ab [Units/volume] in Serum |
|
15838-6
|
Marjoram IgE Ab RAST class [Presence] in Serum |
|
81687-6
|
Marked operative site |
|
74834-3
|
MARS2 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
6232-3
|
Marsh Elder IgE Ab [Units/volume] in Serum |
|
15693-5
|
Marsh Elder IgE Ab RAST class [Presence] in Serum |
|
39084-9
|
Marsh Elder IgE Ab/IgE total in Serum |
|
24141-4
|
Marsh Elder IgG Ab [Units/volume] in Serum |
|
56316-3
|
Marsh Elder IgG4 Ab [Mass/volume] in Serum |
|
63190-3
|
Marsh Elder IgG Ab [Mass/volume] in Serum |
|
17509-1
|
Marsh Ragweed IgE Ab [Units/volume] in Serum |
|
71708-2
|
Marburg virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
71769-4
|
Marburg virus IgG Ab [Presence] in Serum by Immunoassay |
|
71707-4
|
Marburg virus IgG Ab [Titer] in Serum by Immunoassay |
|
71771-0
|
Marburg virus IgM Ab [Presence] in Serum by Immunoassay |
|
71706-6
|
Marburg virus IgM Ab [Titer] in Serum by Immunoassay |
|
86574-1
|
Marburg virus RNA [Presence] in Blood by NAA with probe detection |
|
41638-8
|
Marburg virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
79397-6
|
Mastic tree (Pistacia lentiscus) IgE Ab [Units/volume] in Serum |
|
11109-6
|
Mast cells/100 cells in Bone marrow by Manual count |
|
82751-9
|
Maternal Babesiosis during pregnancy Qualitative |
|
67706-2
|
Maternal factors that affect newborn screening interpretation |
|
51635-1
|
Reticulocytes.mature [#/volume] in Blood |
|
34419-2
|
Reticulocytes.mature/Reticulocytes.total in Blood |
|
2625-2
|
Methionine adenosyltransferase [Enzymatic activity/volume] in Serum |
|
35457-1
|
Maternal cell contamination [Identifier] in Amniotic fluid Nominal |
|
40704-9
|
Maternal cell contamination [Identifier] in Blood Nominal |
|
59266-7
|
Maternal cell contamination [Identifier] in Unspecified specimen Nominal |
|
80673-7
|
Maternal and fetal medicine Consult note |
|
85439-8
|
Maternal and fetal medicine Note |
|
89808-0
|
Maternal and fetal medicine Telephone encounter Note |
|
89807-2
|
Maternal and fetal medicine Telephone encounter Progress note |
|
89951-8
|
Maternal and fetal medicine procedure note |
|
93897-7
|
Maternal and fetal medicine Progress note |
|
73781-7
|
Maternal morbidity [US Standard Certificate of Live Birth] |
|
92016-5
|
Maternal pregnancy risk factors Document |
|
79192-1
|
Maternal pregnancy information Narrative |
|
92017-3
|
Maternal pregnancy summary Document |
|
32399-8
|
Maternal risk factors |
|
44623-7
|
Matted nodes by CAP cancer protocols |
|
7486-4
|
Mattress dust IgE Ab [Units/volume] in Serum |
|
23895-6
|
Mattress dust IgE Ab RAST class [Presence] in Serum |
|
81265-1
|
Maximum body temperature during illness |
|
88667-1
|
Maximum defibrillation dose [Energy] |
|
76249-2
|
Maximum expiratory pressure Respiratory system airway |
|
81447-5
|
Maximum expiratory pressure Respiratory system --post bronchodilation |
|
81446-7
|
Maximum expiratory pressure Respiratory system --pre bronchodilation |
|
76092-6
|
Maximum gradient during systole [Pressure] Aortic valve |
|
81445-9
|
Maximum inspiratory pressure Respiratory system --post bronchodilation |
|
81444-2
|
Maximum inspiratory pressure Respiratory system --pre bronchodilation |
|
82634-7
|
Maximum phase [Angle] Left ventricle SPECT --resting |
|
82626-3
|
Maximum phase [Angle] Left ventricle SPECT --W stress |
|
20248-1
|
Maximum pressure gradient 2 by US+Calculated |
|
11185-6
|
Maxatase IgE Ab [Units/volume] in Serum |
|
15839-4
|
Maxatase IgE Ab RAST class [Presence] in Serum |
|
7488-0
|
Mayfly triggered histamine release [Units/volume] in Blood |
|
7487-2
|
Mayfly IgE Ab [Units/volume] in Serum |
|
12341-4
|
Mazindol [Presence] in Serum or Plasma |
|
85053-7
|
MBL by imipenem to imipenem-EDTA IC ratio [Presence] by ARD gradient strip |
|
85047-9
|
MBL by meropenem to meropenem-EDTA IC ratio [Presence] by ARD gradient strip |
|
76068-6
|
MBL2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47319-9
|
Myelin basic protein Ab [Units/volume] in Serum by Immunoassay |
|
27360-7
|
Myelin basic protein Ab [Units/volume] in Serum |
|
17315-3
|
Myelin basic protein Ab [Mass/volume] in Serum |
|
8082-0
|
Myelin basic protein Ab [Titer] in Serum |
|
5259-7
|
Myelin basic protein Ab [Titer] in Serum by Immunofluorescence |
|
10504-9
|
Myelin basic protein Ag [Presence] in Tissue by Immune stain |
|
26940-7
|
Myelin basic protein [Units/volume] in Cerebral spinal fluid |
|
2638-5
|
Myelin basic protein [Mass/volume] in Cerebral spinal fluid |
|
14237-2
|
Myelin basic protein IgA Ab [Units/volume] in Serum |
|
14238-0
|
Myelin basic protein IgG Ab [Units/volume] in Serum |
|
14239-8
|
Myelin basic protein IgM Ab [Units/volume] in Serum |
|
56661-2
|
Myelin basic protein [Mass/volume] in Serum |
|
44703-7
|
MC4R gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19188-2
|
Mucin-like carcinoma associated Ag [Units/volume] in Pleural fluid |
|
12776-1
|
Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma |
|
46778-7
|
MCAD newborn screen interpretation |
|
74892-1
|
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
74891-3
|
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
46752-2
|
Medium chain acyl dehydrogenase Deficiency/Glutaric Acidemia type 2 newborn screen interpretation |
|
58070-4
|
McC sup(a) Ab [Presence] in Serum or Plasma |
|
65329-5
|
McC sup(c) Ab [Presence] in Serum or Plasma |
|
73701-5
|
Multiple carboxylase deficiency (MCD) newborn screen interpretation |
|
30386-7
|
Erythrocyte mean corpuscular diameter [Length] |
|
784-9
|
Erythrocyte mean corpuscular diameter [Length] by Automated count |
|
66453-2
|
McD sup(d) Ab [Presence] in Serum or Plasma |
|
52778-8
|
Maximum clot firmness [Length] in Blood by Thromboelastography |
|
66755-0
|
Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinase |
|
52783-8
|
Maximum clot firmness.extrinsic coagulation system activated [Length] in Blood by Rotational TEG |
|
52779-6
|
Maximum clot firmness.extrinsic coagulation system activated.fibrinolysis suppressed [Length] in Blood by Rotational TEG |
|
52782-0
|
Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive [Length] in Blood by Rotational TEG |
|
52781-2
|
Maximum clot firmness.intrinsic coagulation system activated [Length] in Blood by Rotational TEG |
|
52780-4
|
Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited [Length] in Blood by Rotational TEG |
|
62243-1
|
MCH [Entitic mass] in Blood from Fetus by Automated count |
|
47278-7
|
MCH [Entitic mass] in Cord blood |
|
59468-9
|
MCH [Entitic substance] |
|
28539-5
|
MCH [Entitic mass] |
|
785-6
|
MCH [Entitic mass] by Automated count |
|
62246-4
|
MCHC [Mass/volume] in Blood from Fetus by Automated count |
|
47279-5
|
MCHC [Mass/volume] in Cord blood |
|
786-4
|
MCHC [Mass/volume] by Automated count |
|
28540-3
|
MCHC [Mass/volume] |
|
59467-1
|
MCHC [Moles/volume] |
|
2631-0
|
Methylmalonyl CoA mutase [Enzymatic activity/volume] in Serum |
|
72872-5
|
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34658-5
|
MCOLN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46965-0
|
MCOLN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48330-5
|
MCOLN1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
4525-2
|
Complement membrane C3b-C4b cofactor protein [Entitic number] in Leukocytes |
|
6290-1
|
Complement membrane C3b-C4b cofactor protein [Presence] in Leukocytes |
|
78852-1
|
M-chlorophenylpiperazine [Mass/volume] in Blood |
|
78853-9
|
M-chlorophenylpiperazine [Mass/volume] in Body fluid |
|
78851-3
|
M-chlorophenylpiperazine [Mass/mass] in Hair |
|
35467-0
|
M-chlorophenylpiperazine [Presence] in Serum or Plasma |
|
78854-7
|
M-chlorophenylpiperazine [Mass/volume] in Serum or Plasma |
|
92640-2
|
M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method |
|
75230-3
|
M-chlorophenylpiperazine [Presence] in Urine |
|
78855-4
|
M-chlorophenylpiperazine [Mass/volume] in Urine |
|
38671-4
|
M-cresol [Mass/volume] in Air |
|
93413-3
|
Mechanical circulatory support Consultation note |
|
81902-9
|
Medium chain triglyceride intake 24 hour Estimated |
|
81903-7
|
Medium chain triglyceride intake 24 hour Measured |
|
62242-3
|
MCV [Entitic volume] in Blood from Fetus by Automated count |
|
47282-9
|
MCV [Entitic volume] in Cord blood |
|
11272-2
|
MCV [Entitic volume] in Cord blood by Automated count |
|
30428-7
|
MCV [Entitic volume] |
|
787-2
|
MCV [Entitic volume] by Automated count |
|
74147-0
|
Muscular Dystrophy action plan |
|
83804-5
|
Physician Administrative note |
|
83805-2
|
Physician Admission evaluation note |
|
83803-7
|
Physician Custodial care facility Note |
|
83802-9
|
Physician Discharge instructions |
|
11490-0
|
Physician Discharge summary |
|
28568-4
|
Physician Emergency department Note |
|
28626-0
|
Physician History and physical note |
|
34106-5
|
Physician Hospital Discharge summary |
|
83800-3
|
Physician Hospital Note |
|
68474-6
|
Physician Hospital Restraint note |
|
18736-9
|
Physician Initial evaluation note |
|
75475-4
|
Physician Letter |
|
83793-0
|
Physician Long term care facility Note |
|
86210-2
|
Physician Medical clearance note |
|
75476-2
|
Physician Note |
|
34116-4
|
Physician Nursing facility History and physical note |
|
83798-9
|
Physician Outpatient Note |
|
28573-4
|
Physician, Operation note |
|
83795-5
|
Physician Telephone encounter Note |
|
11505-5
|
Physician procedure note |
|
83801-1
|
Physician Patient's home Note |
|
83797-1
|
Physician Referral note |
|
85873-8
|
Physician Restraint note |
|
88090-6
|
Physician specialty |
|
83796-3
|
Physician Summary of death note |
|
28616-1
|
Physician Transfer note |
|
83799-7
|
Physician Transplant candidate evaluation note |
|
83794-8
|
Physician Urgent care center Note |
|
18359-0
|
Methylenedioxyamphetamine [Mass/volume] in Blood |
|
79257-2
|
Methylenedioxyamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
20546-8
|
Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19567-7
|
Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
40531-6
|
Methylenedioxyamphetamine [Presence] in Gastric fluid |
|
80534-1
|
Methylenedioxyamphetamine [Mass/mass] in Hair |
|
69023-0
|
Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
27244-3
|
Methylenedioxyamphetamine [Mass/mass] in Meconium |
|
26742-7
|
Methylenedioxyamphetamine [Mass/volume] in Milk |
|
72736-2
|
Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74648-7
|
Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
29598-0
|
Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61045-1
|
Methylenedioxyamphetamine [Presence] in Serum or Plasma |
|
74647-9
|
Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood |
|
59837-5
|
Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma |
|
55551-6
|
Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma |
|
26792-2
|
Methylenedioxyamphetamine [Mass/mass] in Stool |
|
20545-0
|
Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method |
|
42253-5
|
Methylenedioxyamphetamine [Presence] in Urine |
|
19566-9
|
Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method |
|
19565-1
|
Methylenedioxyamphetamine [Presence] in Urine by Screen method |
|
18355-8
|
Methylenedioxyamphetamine [Mass/volume] in Urine |
|
27189-0
|
Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid |
|
61046-9
|
Methylenedioxyamphetamine [Presence] in Unspecified specimen |
|
64138-1
|
Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine |
|
88725-7
|
MDA5 Ab [Units/volume] in Serum by Line blot |
|
82424-3
|
MDA5 Ab [Presence] in Serum by Line blot |
|
82994-5
|
MDA5 IgG Ab [Presence] in Serum by Line blot |
|
48974-0
|
MDCR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80536-6
|
Methylenedioxyethylamphetamine [Mass/volume] in Blood |
|
79248-1
|
Methylenedioxyethylamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
77772-2
|
Methylenedioxyethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
61082-4
|
Methylenedioxyethylamphetamine [Presence] in Gastric fluid |
|
80535-8
|
Methylenedioxyethylamphetamine [Mass/mass] in Hair |
|
69024-8
|
Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
27080-1
|
Methylenedioxyethylamphetamine [Mass/mass] in Meconium |
|
27074-4
|
Methylenedioxyethylamphetamine [Mass/volume] in Milk |
|
74649-5
|
Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74650-3
|
Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
29599-8
|
Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61047-7
|
Methylenedioxyethylamphetamine [Presence] in Serum or Plasma |
|
82965-5
|
Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
33016-7
|
Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma |
|
27079-3
|
Methylenedioxyethylamphetamine [Mass/mass] in Stool |
|
45143-5
|
Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method |
|
61048-5
|
Methylenedioxyethylamphetamine [Presence] in Urine |
|
59844-1
|
Methylenedioxyethylamphetamine [Presence] in Urine by Screen method |
|
27085-0
|
Methylenedioxyethylamphetamine [Mass/volume] in Urine |
|
27299-7
|
Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid |
|
61049-3
|
Methylenedioxyethylamphetamine [Presence] in Unspecified specimen |
|
64127-4
|
Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine |
|
48268-7
|
Minor determinant mixture triggered leukotriene release [Mass/volume] by Leukocytes |
|
93808-4
|
MDM2 gene amplification in Tissue by FISH |
|
93809-2
|
MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH |
|
93805-0
|
MDM2 gene copy number/nucleus in Tissue by FISH |
|
18357-4
|
Methylenedioxymethamphetamine [Mass/volume] in Blood |
|
79247-3
|
Methylenedioxymethamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19572-7
|
Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19571-9
|
Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
61083-2
|
Methylenedioxymethamphetamine [Presence] in Gastric fluid |
|
80537-4
|
Methylenedioxymethamphetamine [Mass/mass] in Hair |
|
69025-5
|
Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
74651-1
|
Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74653-7
|
Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
87810-8
|
Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method |
|
29619-4
|
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
40493-9
|
Methylenedioxymethamphetamine [Presence] in Serum or Plasma |
|
74652-9
|
Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood |
|
18356-6
|
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma |
|
26793-0
|
Methylenedioxymethamphetamine [Mass/mass] in Stool |
|
18358-2
|
Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
|
14267-9
|
Methylenedioxymethamphetamine [Presence] in Urine |
|
19569-3
|
Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method |
|
19568-5
|
Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
|
19570-1
|
Methylenedioxymethamphetamine [Mass/volume] in Urine |
|
27188-2
|
Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid |
|
40481-4
|
Methylenedioxymethamphetamine [Presence] in Unspecified specimen |
|
44424-0
|
Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine |
|
75648-6
|
Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood |
|
73971-4
|
Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative |
|
90747-7
|
MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method |
|
79238-2
|
Methylenedioxypyrovalerone cutoff [Mass/volume] in Urine for Confirmatory method |
|
72797-4
|
Methylenedioxypyrovalerone [Mass/volume] in Urine by Confirmatory method |
|
73687-6
|
Methylenedioxypyrovalerone [Presence] in Urine by Screen method |
|
72798-2
|
Methylenedioxypyrovalerone/Creatinine [Mass Ratio] in Urine |
|
32859-1
|
Multiple drug resistance cells/100 cells in Unspecified specimen |
|
78702-8
|
Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture |
|
40684-3
|
Acinetobacter sp multidrug resistant identified in Unspecified specimen by Organism specific culture |
|
42775-7
|
Multiple drug resistant organism identified in Sputum |
|
42773-2
|
Multiple drug resistant organism identified in Urine |
|
42774-0
|
Multiple drug resistant organism identified in Wound |
|
82639-6
|
Maximum difference in time to end-systole Left ventricle SPECT --resting |
|
82631-3
|
Maximum difference in time to end-systole Left ventricle SPECT --W stress |
|
88880-0
|
Monocyte distribution width [Entitic volume] in Blood by Automated |
|
38608-6
|
Methyl bromide [Mass/volume] in Air |
|
9790-7
|
Methyl bromide [Mass/volume] in Serum or Plasma |
|
17270-0
|
Methylacrylate [Mass/volume] in Serum or Plasma |
|
75106-5
|
Mead acid (C20:3w9) [Entitic substance] in Red Blood Cells |
|
35172-6
|
Mead acid (C20:3w9) [Moles/volume] in Serum or Plasma |
|
7359-3
|
Meadow Fescue triggered histamine release [Units/volume] in Blood |
|
6169-7
|
Meadow Fescue IgE Ab [Units/volume] in Serum |
|
15709-9
|
Meadow Fescue IgE Ab RAST class [Presence] in Serum |
|
61264-8
|
Meadow Fescue IgE Ab/IgE total in Serum |
|
7364-3
|
Meadow Fescue IgG Ab [Units/volume] in Serum |
|
56317-1
|
Meadow Fescue IgG4 Ab [Mass/volume] in Serum |
|
49720-6
|
Meadow Fescue IgG Ab [Mass/volume] in Serum |
|
48262-0
|
Meadow Fescue triggered leukotriene release [Mass/volume] by Leukocytes |
|
6170-5
|
Meadow Foxtail IgE Ab [Units/volume] in Serum |
|
15720-6
|
Meadow Foxtail IgE Ab RAST class [Presence] in Serum |
|
56318-9
|
Meadow Foxtail IgG4 Ab [Mass/volume] in Serum |
|
81662-9
|
Percentage of meal eaten |
|
80491-4
|
Meals 24 hour Estimated |
|
80492-2
|
Meals 24 hour Measured |
|
19747-5
|
Mealworm IgE Ab [Units/volume] in Serum |
|
25554-7
|
Mealworm IgE Ab RAST class [Presence] in Serum |
|
87458-6
|
Mean diameter [Length] of Feed particles |
|
60843-0
|
Mean dominant power frequency on EEG |
|
86684-8
|
Mean fluid intake per day by IV or tube feeding during entire 7 days [CMS Assessment] |
|
86683-0
|
Mean fluid intake per day by IV or tube feeding in last 7 days - while a resident [CMS Assessment] |
|
86682-2
|
Mean fluid intake per day by IV or tube feeding in last 7 days - while not a resident [CMS Assessment] |
|
82635-4
|
Mean phase [Angle] Left ventricle SPECT --resting |
|
82627-1
|
Mean phase [Angle] Left ventricle SPECT --W stress |
|
76530-5
|
Mean pressure Respiratory system airway --on ventilator |
|
20256-4
|
Mean pressure gradient by US.doppler |
|
20255-6
|
Mean pressure gradient by US+Calculated |
|
20259-8
|
Mean pressure gradient/Mean pressure gradient 2 by US.doppler calculated |
|
72688-5
|
Mean score [BSL-23] |
|
89199-4
|
Mean score [ECog.Partner] |
|
89198-6
|
Mean score [ECog] |
|
94052-8
|
Mean score [PCPCM] |
|
91147-9
|
Mean score [PEG] |
|
85145-1
|
Meaning and Purpose Survey - age 18+ - T-score [NIH Toolbox] |
|
82265-0
|
Measured Activity metabolic rate/Measured RMR [Relative energy/Time] |
|
82270-0
|
Measured Activity metabolic rate/Population RMR [Relative energy/Time] |
|
82276-7
|
Measured Activity metabolic rate/Predicted RMR [Relative energy/Time] |
|
82261-9
|
Measured activity metabolic rate/Standard RMR [Relative energy/Time] |
|
74045-6
|
Measure description Narrative |
|
82278-3
|
Measured RMR |
|
72043-3
|
Measurement of arterial pre-pump pressure performed [ESRD] |
|
75240-2
|
Meat fibers [#/area] in Stool by Microscopy low power field |
|
28069-3
|
Meat fibers [#/area] in Stool by Light microscopy |
|
2605-4
|
Meat fibers [Presence] in Stool by Light microscopy |
|
85786-2
|
Methicillin resistance mecA gene [Presence] by NAA with non-probe detection in Positive blood culture |
|
88251-4
|
Methicillin resistance mecA gene [Presence] by Probe in Positive blood culture |
|
48813-0
|
Methicillin resistance mecA gene [Presence] by Molecular method |
|
77666-6
|
Methicillin resistance mecA mRNA [Presence] by FISH in Positive blood culture |
|
92968-7
|
Methicillin resistance mecA+mecC genes [Presence] in Isolate or Specimen by Molecular genetics method |
|
86620-2
|
Methicillin resistance mecA+mecC genes [Presence] in Nose by NAA with probe detection |
|
12532-8
|
Meclizine [Presence] in Serum or Plasma |
|
13904-8
|
Meclizine [Mass/volume] in Serum or Plasma |
|
316-0
|
Meclocycline [Susceptibility] by Disk diffusion (KB) |
|
315-2
|
Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
314-5
|
Meclocycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18942-3
|
Meclocycline [Susceptibility] |
|
317-8
|
Meclocycline [Susceptibility] by Serum bactericidal titer |
|
13905-5
|
Meclofenamate [Mass/volume] in Serum or Plasma |
|
19125-4
|
Meconium [Presence] in Amniotic fluid |
|
35137-9
|
MECP2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
87232-5
|
Medication administration.brief |
|
87231-7
|
Medication administration.extended Document |
|
88363-7
|
Medical equipment or product note |
|
82215-5
|
Medical equipment or product list |
|
10938-9
|
Mediterranean flour moth IgE Ab [Units/volume] in Serum |
|
15858-4
|
Mediterranean flour moth IgE Ab RAST class [Presence] in Serum |
|
85230-1
|
Medical genetics Nurse procedure note |
|
76441-5
|
Medical history relevant to physical therapy treatment |
|
85314-3
|
Extent of medial margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
|
70006-2
|
Medication management note |
|
81193-5
|
Medical microbiology - pathology Consult note |
|
80820-4
|
Medication reconciliation form |
|
94118-7
|
Medical records in response to authorization denial |
|
84190-8
|
Medical toxicology Consult note |
|
84191-6
|
Medical toxicology Note |
|
77604-7
|
Medication treatment plan.brief Document |
|
77603-9
|
Medication treatment plan.extended Document |
|
82116-5
|
Medication usage suggestion [Type] |
|
83010-9
|
Medication usage suggestion [Narrative] |
|
90802-0
|
Medication volume of distribution Calculated |
|
47242-3
|
Medication or other side effects associated with HIV treatment |
|
60486-8
|
MED12 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
3739-0
|
Medazepam [Mass/volume] in Blood |
|
4305-9
|
Medazepam [Mass] of Dose |
|
3740-8
|
Medazepam [Mass/volume] in Urine |
|
60844-8
|
Median power frequency on EEG |
|
45400-9
|
Medicaid number |
|
71510-2
|
Medicaid certified stations Dialysis facility # [ESRD] |
|
69426-5
|
Medical director review of results |
|
74497-9
|
Medical examiner or coroner was contacted [US Standard Certificate of Death] |
|
72185-2
|
Medical history [RHEA] |
|
64285-0
|
Medical history screening form |
|
81352-7
|
Medical Order for Life-Sustaining Treatment, Physician Order for Life-Sustaining Treatment, or a similar medical order is in place [Reported] |
|
11503-0
|
Medical records |
|
80389-0
|
Special medical equipment AndOr resuscitation needs |
|
71512-8
|
Medicare certified services offered Dialysis facility [ESRD] |
|
58211-4
|
Medicare non-therapy Part A - RUG version code [CMS Assessment] |
|
58210-6
|
Medicare non-therapy Part A HIPPS code [CMS Assessment] |
|
45397-7
|
Medicare or comparable number |
|
55065-7
|
Medicare part A - HIPPS code for billing |
|
55066-5
|
Medicare part A - RUG version code |
|
58421-9
|
Medicare short stay assessment [CMS Assessment] |
|
54594-7
|
Medicare-covered stay since the most recent entry [CMS Assessment] |
|
84300-3
|
Medication administered by |
|
19790-5
|
Medication administration Narrative |
|
51963-7
|
Medication assessed [ID] |
|
71573-0
|
Medication authorization NEMSIS |
|
89188-7
|
Medication documentation status |
|
65818-7
|
Medication [Mass/volume] Dose |
|
91383-0
|
Medication duration - Reported |
|
57281-8
|
Medication follow-up [CMS Assessment] |
|
88871-9
|
Medication follow-up in the last 3 days [CMS Assessment] |
|
71469-1
|
Medication frequency Medication [ESRD] |
|
57256-0
|
Medication intervention since admission/reentry [CMS Assessment] |
|
74707-1
|
Medication or other substance was involved [AHRQ] |
|
74064-7
|
Medication or substance contraindication - potential or actual interaction [AHRQ] |
|
74076-1
|
Medication or substance involved [AHRQ] |
|
74052-2
|
Medication or substance was given [AHRQ] |
|
74053-0
|
Medication or substance was prescribed [AHRQ] |
|
93341-6
|
Medication recommendation |
|
45373-8
|
Medication route [Identifier] of Dose |
|
74057-1
|
Medication strength |
|
74075-3
|
Medication type [AHRQ] |
|
19789-7
|
Medications [Identifier] |
|
19564-4
|
Methylenediamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19563-6
|
Methylenediamine cutoff [Mass/volume] in Urine for Screen method |
|
18486-1
|
Methylenediamine [Presence] in Urine |
|
19562-8
|
Methylenediamine [Presence] in Urine by Confirmatory method |
|
19561-0
|
Methylenediamine [Presence] in Urine by Screen method |
|
10914-0
|
Methylenediamine [Mass/volume] in Urine |
|
3805-9
|
MethylePHEDrine [Mass/time] in 24 hour Urine |
|
19576-8
|
MethylePHEDrine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19575-0
|
MethylePHEDrine cutoff [Mass/volume] in Urine for Screen method |
|
4328-1
|
MethylePHEDrine [Mass] of Dose |
|
58348-4
|
MethylePHEDrine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
59706-2
|
MethylePHEDrine [Mass/volume] in Serum or Plasma |
|
20547-6
|
MethylePHEDrine [Mass/volume] in Urine by Confirmatory method |
|
3803-4
|
MethylePHEDrine [Presence] in Urine |
|
16216-4
|
MethylePHEDrine [Presence] in Urine by Confirmatory method |
|
19573-5
|
MethylePHEDrine [Presence] in Urine by Screen method |
|
17273-4
|
MethylePHEDrine [Units/volume] in Urine |
|
3804-2
|
MethylePHEDrine [Mass/volume] in Urine |
|
17274-2
|
Methylergonovine [Mass/volume] in Serum or Plasma |
|
82292-4
|
Meeting recommended guidelines for physical activity |
|
91881-3
|
Location of meeting |
|
80408-8
|
Meets CDC field triage criteria |
|
59923-3
|
Mefenamate [Moles/volume] in Gastric fluid |
|
48278-6
|
Mefenamate triggered leukotriene release [Mass/volume] by Leukocytes |
|
17246-0
|
Mefenamate [Mass/volume] in Serum or Plasma |
|
59921-7
|
Mefenamate [Moles/volume] in Serum or Plasma |
|
59922-5
|
Mefenamate [Moles/volume] in Urine |
|
60314-2
|
Mefenamate [Moles/volume] in Unspecified specimen |
|
3743-2
|
Mefenorex [Mass/time] in 24 hour Urine |
|
4306-7
|
Mefenorex [Mass] of Dose |
|
3741-6
|
Mefenorex [Presence] in Urine |
|
3742-4
|
Mefenorex [Mass/volume] in Urine |
|
17275-9
|
Methylfentanyl [Mass/volume] in Serum or Plasma |
|
29149-2
|
Mefloquine [Mass/volume] in Serum or Plasma |
|
29150-0
|
Mefloquine [Mass/volume] in Urine |
|
36925-6
|
MEFV gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41091-0
|
MEFV gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35138-7
|
MEFV gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
69567-6
|
Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
51644-3
|
Megakaryocytic nuclei [Presence] in Blood by Light microscopy |
|
70028-6
|
Megakaryocytic nuclei/100 leukocytes in Blood by Manual count |
|
40688-4
|
Megakaryocytes [Presence] in Bone marrow by Microscopy |
|
11110-4
|
Megakaryocytes/100 cells in Bone marrow by Manual count |
|
19252-6
|
Megakaryocytes/100 leukocytes in Blood |
|
74229-6
|
Megakaryopoiesis assessment in Bone marrow Narrative |
|
55375-0
|
Megaloblasts [#/volume] in Blood by Manual count |
|
52127-8
|
Megaloblasts/100 cells in Bone marrow |
|
55376-8
|
Megaloblasts/100 leukocytes in Blood by Manual count |
|
74762-6
|
Megasphaera sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
41762-6
|
Megestrol acetate [Mass/volume] in Serum or Plasma |
|
46953-6
|
Megestrol acetate [Mass/volume] in Urine |
|
53187-1
|
Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS |
|
59180-0
|
Monoethylglycinexylidide [Presence] in Urine |
|
34344-2
|
N-methylhistamine [Moles/volume] in 24 hour Urine |
|
26053-9
|
N-methylhistamine [Moles/time] in 24 hour Urine |
|
12714-2
|
N-methylhistamine [Mass/volume] in Urine |
|
34345-9
|
N-methylhistamine [Moles/volume] in Urine |
|
44340-8
|
N-methylhistamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
80152-2
|
N-methylhistamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13781-0
|
N-methylhistamine/Creatinine [Mass Ratio] in Urine |
|
34346-7
|
N-methylhistamine/Creatinine [Molar ratio] in Urine |
|
12543-5
|
Methyl formamide [Mass/volume] in Urine |
|
56660-4
|
Methyl formamide/Creatinine [Ratio] in Urine |
|
13011-2
|
Methyl ethyl ketone [Mass/volume] in Blood |
|
69800-1
|
Methyl ethyl ketone [Mass/volume] in Body fluid |
|
50879-6
|
Methyl ethyl ketone [Moles/volume] in Body fluid |
|
46255-6
|
Methyl ethyl ketone [Mass/volume] in Serum or Plasma |
|
50880-4
|
Methyl ethyl ketone [Moles/volume] in Serum or Plasma |
|
13009-6
|
Methyl ethyl ketone [Mass/volume] in Urine |
|
56639-8
|
Methyl ethyl ketone [Moles/volume] in Urine |
|
58897-0
|
Methyl ethyl ketone/Creatinine [Mass Ratio] in Urine |
|
59189-1
|
Methyl ethyl ketone/Creatinine [Molar ratio] in Urine |
|
47031-0
|
Melan-A Ag [Presence] in Tissue by Immune stain |
|
74489-6
|
Melan-A and Ki67 Ag [Identifier] in Tissue by Immune stain |
|
17248-6
|
Melanin [Units/volume] in Serum or Plasma |
|
2606-2
|
Melanin [Presence] in Urine |
|
17247-8
|
Melanin [Units/volume] in Urine |
|
2607-0
|
Melanin [Mass/volume] in Urine |
|
35132-0
|
MELAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41090-2
|
MELAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
18183-4
|
Melatonin [Mass/time] in 24 hour Urine |
|
11056-9
|
Melatonin [Flow] in 24 hour Urine |
|
49725-5
|
Melatonin [Mass/volume] in Cerebral spinal fluid |
|
27060-3
|
Melatonin [Presence] in Saliva (oral fluid) |
|
78992-5
|
Melatonin [Mass/volume] in Saliva (oral fluid) |
|
12721-7
|
Melatonin [Units/volume] in Serum or Plasma |
|
11055-1
|
Melatonin [Mass/volume] in Serum or Plasma |
|
44760-7
|
Model for end-stage liver disease score |
|
57885-6
|
Honeydew melon triggered histamine release [Units/volume] in Blood |
|
57884-9
|
Honeydew melon IgE Ab [Units/volume] in Serum |
|
57882-3
|
Honeydew melon IgE Ab RAST class [Presence] in Serum |
|
57952-4
|
Honeydew melon IgE Ab/IgE total in Serum |
|
57880-7
|
Honeydew melon IgG Ab [Units/volume] in Serum |
|
57878-1
|
Honeydew melon IgG Ab RAST class [Presence] in Serum |
|
57876-5
|
Honeydew melon IgG4 Ab [Mass/volume] in Serum |
|
63095-4
|
Honeydew melon IgG Ab [Mass/volume] in Serum |
|
88988-1
|
Melperone [Mass/volume] in Serum or Plasma |
|
54318-1
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Amniotic fluid |
|
54317-3
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Cerebral spinal fluid |
|
45222-7
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS |
|
18446-5
|
Methylmalonylcarnitine (C4-DC) [Mass/volume] in Serum or Plasma |
|
39010-4
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma |
|
54319-9
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Urine |
|
53181-4
|
Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
|
54316-5
|
Methylmalonylcarnitine (C4-DC)/Creatinine [Molar ratio] in Urine |
|
51415-8
|
Methylmalonylcarnitine+Succinylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma |
|
59302-0
|
Memantine [Mass/volume] in Blood |
|
59303-8
|
Memantine [Mass/volume] in Body fluid |
|
59304-6
|
Memantine [Mass/volume] in Serum or Plasma |
|
59305-3
|
Memantine [Mass/mass] in Tissue |
|
59306-1
|
Memantine [Mass/volume] in Urine |
|
52037-9
|
Member ID card copy |
|
83240-2
|
Memory/recall ability [CMS Assessment] |
|
88333-0
|
Memory/recall ability during 3 day assessment period [CMS Assessment] |
|
86583-2
|
Memory/recall ability in the last 7 days [CMS Assessment] |
|
75386-3
|
MEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
35288-0
|
MEN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41089-4
|
MEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3129-4
|
Menadione [Mass/volume] in Serum or Plasma |
|
32400-4
|
Menses finding |
|
49033-4
|
Menstrual History - Reported |
|
3146-8
|
Menstrual status |
|
75245-1
|
Mental condition [Norton scale] |
|
77229-3
|
Mental effort load level [NMMDS] |
|
75319-4
|
Mental function Family member |
|
75440-8
|
Mental health Administrative note |
|
84192-4
|
Mental health Admission evaluation note |
|
78246-6
|
Mental health Admission history and physical note |
|
84194-0
|
Mental health Agreement |
|
88358-7
|
Mental health Alert |
|
78504-8
|
Mental health Checklist |
|
84193-2
|
Mental health Conference note |
|
34785-6
|
Mental health Consult note |
|
34864-9
|
Mental health Counseling note |
|
78707-7
|
Mental health Crisis intervention note |
|
84196-5
|
Mental health Custodial care facility Note |
|
75441-6
|
Mental health Diagnostic study note |
|
78261-5
|
Mental health Discharge instructions |
|
78263-1
|
Mental health Discharge summary |
|
78266-4
|
Mental health Discharge teaching note |
|
91391-3
|
Mental health diagnosis |
|
84198-1
|
Mental health Emergency department Note |
|
78279-7
|
Mental health Education note |
|
78296-1
|
Mental health Flowsheet |
|
78305-0
|
Mental health Form |
|
34787-2
|
Mental health Group counseling note |
|
78306-8
|
Mental health History and physical note |
|
84200-5
|
Mental health Hospital Admission evaluation note |
|
84201-3
|
Mental health Hospital Group counseling note |
|
84202-1
|
Mental health Hospital Note |
|
84203-9
|
Mental health Hospital Plan of care note |
|
84195-7
|
Mental health Intensive care unit Note |
|
78309-2
|
Mental health Individual counseling note |
|
78466-0
|
Mental health Initial evaluation note |
|
84205-4
|
Mental health Long term care facility Note |
|
80420-3
|
Mental health Mandatory reporting form |
|
75442-4
|
Mental health Medication management note |
|
34786-4
|
Mental health Note |
|
84206-2
|
Mental health Observation unit Note |
|
84207-0
|
Mental health Outpatient Group counseling note |
|
84208-8
|
Mental health Outpatient Initial evaluation note |
|
75443-2
|
Mental health Outpatient Note |
|
84210-4
|
Mental health Outpatient Plan of care note |
|
84209-6
|
Mental health Outpatient Risk assessment and screening note |
|
84211-2
|
Mental health Outreach note |
|
75444-0
|
Mental health Telephone encounter Note |
|
80742-0
|
Mental health Plan of care note |
|
87239-0
|
Mental health Postoperative evaluation and management note |
|
87240-8
|
Mental health Preoperative evaluation and management note |
|
78472-8
|
Mental health procedure note |
|
34904-3
|
Mental health Progress note |
|
84199-9
|
Mental health Patient's home Note |
|
57143-0
|
Mental health Referral note |
|
78485-0
|
Mental health Restraint note |
|
78486-8
|
Mental health Risk assessment and screening note |
|
84215-3
|
Mental health Telehealth Note |
|
78488-4
|
Mental health Transfer summary note |
|
81376-6
|
Mental health treatment preferences [Reported] |
|
84218-7
|
Mental health Triage note |
|
84216-1
|
Mental health Transplant candidate evaluation note |
|
82822-8
|
Mental illness in household--before 18 years old [ACE] |
|
73788-2
|
Mental status [NSRAS] |
|
17249-4
|
Menthol [Mass/volume] in Blood |
|
3748-1
|
Meperidine [Mass/time] in 24 hour Urine |
|
19535-4
|
Meperidine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19534-7
|
Meperidine cutoff [Mass/volume] in Urine for Screen method |
|
4307-5
|
Meperidine [Mass] of Dose |
|
14826-2
|
Meperidine [Presence] in Gastric fluid |
|
29400-9
|
Meperidine [Mass/volume] in Gastric fluid |
|
73729-6
|
Meperidine [Presence] in Hair |
|
75647-8
|
Meperidine [Presence] in Meconium |
|
72749-5
|
Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74108-2
|
Meperidine [Presence] in Saliva (oral fluid) by Screen method |
|
3744-0
|
Meperidine [Presence] in Serum or Plasma |
|
35617-0
|
Meperidine [Mass/volume] in Serum or Plasma by Screen method |
|
87497-4
|
Meperidine [Presence] in Serum, Plasma or Blood by Screen method |
|
73934-2
|
Meperidine [Mass/volume] in Serum, Plasma or Blood |
|
3745-7
|
Meperidine [Mass/volume] in Serum or Plasma |
|
59924-1
|
Meperidine [Moles/volume] in Serum or Plasma |
|
16253-7
|
Meperidine [Mass/volume] in Urine by Confirmatory method |
|
3746-5
|
Meperidine [Presence] in Urine |
|
16207-3
|
Meperidine [Presence] in Urine by Confirmatory method |
|
19532-1
|
Meperidine [Presence] in Urine by Screen method |
|
3747-3
|
Meperidine [Mass/volume] in Urine |
|
74378-1
|
Meperidine [Mass/volume] in Unknown substance |
|
32088-7
|
Meperidine [Presence] in Unspecified specimen |
|
57864-1
|
Meperidine [Moles/volume] in Unspecified specimen |
|
58386-4
|
Meperidine/Creatinine [Mass Ratio] in Urine |
|
51984-3
|
Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method |
|
72384-1
|
Meperidine+Normeperidine [Presence] in Urine by Confirmatory method |
|
58385-6
|
Meperidine+Normeperidine [Presence] in Urine by Screen method |
|
79237-4
|
Mephedrone cutoff [Mass/volume] in Urine for Confirmatory method |
|
72795-8
|
Mephedrone [Mass/volume] in Urine by Confirmatory method |
|
67838-3
|
Mephedrone [Presence] in Urine by Confirmatory method |
|
72796-6
|
Mephedrone/Creatinine [Mass Ratio] in Urine |
|
72994-7
|
Methylphenidate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72993-9
|
Methylphenidate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3810-9
|
Methylphenidate [Mass/time] in 24 hour Urine |
|
19580-0
|
Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method |
|
19579-2
|
Methylphenidate cutoff [Mass/volume] in Urine for Screen method |
|
4329-9
|
Methylphenidate [Mass] of Dose |
|
61084-0
|
Methylphenidate [Presence] in Gastric fluid |
|
80538-2
|
Methylphenidate [Mass/mass] in Hair |
|
73278-4
|
Methylphenidate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73279-2
|
Methylphenidate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
87806-6
|
Methylphenidate [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87805-8
|
Methylphenidate [Presence] in Saliva (oral fluid) by Screen method |
|
3806-7
|
Methylphenidate [Presence] in Serum or Plasma |
|
3807-5
|
Methylphenidate [Mass/volume] in Serum or Plasma |
|
55552-4
|
Methylphenidate [Moles/volume] in Serum or Plasma |
|
20548-4
|
Methylphenidate [Mass/volume] in Urine by Confirmatory method |
|
3808-3
|
Methylphenidate [Presence] in Urine |
|
19578-4
|
Methylphenidate [Presence] in Urine by Confirmatory method |
|
19577-6
|
Methylphenidate [Presence] in Urine by Screen method |
|
3809-1
|
Methylphenidate [Mass/volume] in Urine |
|
61050-1
|
Methylphenidate [Presence] in Unspecified specimen |
|
72792-5
|
Methylphenidate/Creatinine [Mass Ratio] in Urine |
|
12403-2
|
Mephentermine [Mass/volume] in Blood |
|
26857-3
|
Mephentermine [Mass/mass] in Meconium |
|
26992-8
|
Mephentermine [Mass/volume] in Milk |
|
29597-2
|
Mephentermine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
26772-4
|
Mephentermine [Mass/mass] in Stool |
|
12291-1
|
Mephentermine [Presence] in Urine |
|
26786-4
|
Mephentermine [Mass/volume] in Urine |
|
27300-3
|
Mephentermine [Mass/volume] in Vitreous fluid |
|
4308-3
|
Mephenytoin [Mass] of Dose |
|
3749-9
|
Mephenytoin [Mass/volume] in Serum or Plasma |
|
25468-0
|
Mephenytoin [Moles/volume] in Serum or Plasma |
|
34662-7
|
Mephenytoin+Normephenytoin [Mass/volume] in Serum or Plasma |
|
19541-2
|
Mephobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19540-4
|
Mephobarbital cutoff [Mass/volume] in Urine for Screen method |
|
4309-1
|
Mephobarbital [Mass] of Dose |
|
26906-8
|
Mephobarbital [Mass/mass] in Hair |
|
27003-3
|
Mephobarbital [Mass/mass] in Meconium |
|
27050-4
|
Mephobarbital [Mass/volume] in Milk |
|
16215-6
|
Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3750-7
|
Mephobarbital [Mass/volume] in Serum or Plasma |
|
32089-5
|
Mephobarbital [Moles/volume] in Serum or Plasma |
|
27241-9
|
Mephobarbital [Mass/mass] in Stool |
|
17250-2
|
Mephobarbital [Mass/volume] in Urine by Confirmatory method |
|
12315-8
|
Mephobarbital [Presence] in Urine |
|
19537-0
|
Mephobarbital [Presence] in Urine by Confirmatory method |
|
19536-2
|
Mephobarbital [Presence] in Urine by Screen method |
|
19539-6
|
Mephobarbital [Mass/volume] in Urine |
|
56877-4
|
Mepivacaine IgE Ab [Units/volume] in Serum |
|
17251-0
|
Mepivacaine [Presence] in Serum or Plasma |
|
10541-1
|
Mepivacaine [Mass/volume] in Serum or Plasma |
|
32090-3
|
Mepivacaine [Presence] in Urine |
|
73277-6
|
Methylprednisolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73276-8
|
Methylprednisolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14186-1
|
Methylprednisolone [Mass/volume] in Serum or Plasma |
|
46954-4
|
Methylprednisolone [Mass/volume] in Urine |
|
78856-2
|
Meprobamate [Mass/volume] in Blood by Confirmatory method |
|
79258-0
|
Meprobamate cutoff [Mass/volume] in Urine for Confirmatory method |
|
4310-9
|
Meprobamate [Mass] of Dose |
|
40380-8
|
Meprobamate [Presence] in Gastric fluid |
|
29381-1
|
Meprobamate [Mass/volume] in Gastric fluid |
|
47119-3
|
Meprobamate [Moles/volume] in Gastric fluid |
|
72748-7
|
Meprobamate [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87811-6
|
Meprobamate [Presence] in Saliva (oral fluid) by Screen method |
|
3752-3
|
Meprobamate [Presence] in Serum or Plasma |
|
3753-1
|
Meprobamate [Mass/volume] in Serum or Plasma |
|
25469-8
|
Meprobamate [Moles/volume] in Serum or Plasma |
|
58374-0
|
Meprobamate [Mass/volume] in Urine by Confirmatory method |
|
3754-9
|
Meprobamate [Presence] in Urine |
|
58373-2
|
Meprobamate [Presence] in Urine by Confirmatory method |
|
3755-6
|
Meprobamate [Mass/volume] in Urine |
|
47120-1
|
Meprobamate [Moles/volume] in Urine |
|
32092-9
|
Meprobamate [Presence] in Unspecified specimen |
|
32091-1
|
Meprobamate [Moles/volume] in Unspecified specimen |
|
58372-4
|
Meprobamate/Creatinine [Mass Ratio] in Urine |
|
65330-3
|
MER Ab [Presence] in Serum or Plasma |
|
43639-4
|
Mercaptopurine [Presence] in Blood |
|
17252-8
|
Mercaptopurine [Presence] in Serum or Plasma |
|
11242-5
|
Mercaptopurine [Mass/volume] in Serum or Plasma |
|
30921-1
|
Mercury [Mass/volume] in Urine collected for unspecified duration |
|
13961-8
|
Mercury [Presence] in 24 hour Urine |
|
21383-5
|
Mercury [Mass/volume] in 24 hour Urine |
|
6693-6
|
Mercury [Mass/time] in 24 hour Urine |
|
34337-6
|
Mercury [Moles/volume] in 24 hour Urine |
|
25471-4
|
Mercury [Moles/time] in 24 hour Urine |
|
5685-3
|
Mercury [Mass/volume] in Blood |
|
25170-2
|
Mercury [Moles/volume] in Blood |
|
9693-3
|
Mercury [Mass/volume] in Cerebral spinal fluid |
|
12775-3
|
Mercury [Mass/volume] in Dentin |
|
17255-1
|
Mercury [Mass/volume] in Dialysis fluid |
|
20876-9
|
Mercury [Mass/mass] in Feed |
|
29221-9
|
Mercury [Mass/volume] in Body fluid |
|
17254-4
|
Mercury [Mass/volume] in Food |
|
39583-0
|
Mercury [Presence] in Hair |
|
5686-1
|
Mercury [Mass/mass] in Hair |
|
50876-2
|
Mercury [Moles/mass] in Hair |
|
17253-6
|
Mercury [Mass/volume] in Milk |
|
39584-8
|
Mercury [Presence] in Nail |
|
8204-0
|
Mercury [Mass/mass] in Nail |
|
79143-4
|
Mercury [Moles/mass] in Nail |
|
12774-6
|
Mercury [Mass/volume] in Red Blood Cells |
|
27130-4
|
Mercury [Mass/mass] in Red Blood Cells |
|
50878-8
|
Mercury [Moles/volume] in Red Blood Cells |
|
25470-6
|
Mercury [Moles/volume] in Saliva (oral fluid) |
|
5687-9
|
Mercury [Mass/volume] in Serum or Plasma |
|
32330-3
|
Mercury [Moles/volume] in Serum or Plasma |
|
28063-6
|
Mercury [Mass/volume] in Dentin --2nd specimen |
|
8205-7
|
Mercury [Mass/mass] in Tissue |
|
50877-0
|
Mercury [Moles/mass] in Tissue |
|
19056-1
|
Mercury [Presence] in Urine |
|
5688-7
|
Mercury [Presence] in Urine by Visual.Reinsch |
|
5689-5
|
Mercury [Mass/volume] in Urine |
|
34338-4
|
Mercury [Moles/volume] in Urine |
|
9479-7
|
Mercury [Mass/volume] in Water |
|
23896-4
|
Mercury [Mass/mass] in Unspecified specimen |
|
47121-9
|
Mercury [Moles/mass] in Unspecified specimen |
|
26688-2
|
Mercury/Creatinine [Mass Ratio] in 24 hour Urine |
|
52929-7
|
Mercury/Creatinine [Molar ratio] in 24 hour Urine |
|
13465-0
|
Mercury/Creatinine [Mass Ratio] in Urine |
|
56653-9
|
Mercury/Creatinine [Ratio] in Urine |
|
22680-3
|
Mercury/Creatinine [Molar ratio] in Urine |
|
90980-4
|
Meropenem+Vaborbactam [Susceptibility] by Gradient strip |
|
85427-3
|
Meropenem+Vaborbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88892-5
|
Meropenem+Vaborbactam [Susceptibility] |
|
73289-1
|
Meropenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73288-3
|
Meropenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7029-2
|
Meropenem [Susceptibility] by Gradient strip |
|
6653-0
|
Meropenem [Susceptibility] by Disk diffusion (KB) |
|
6652-2
|
Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6651-4
|
Meropenem [Susceptibility] by Minimum lethal concentration (MLC) |
|
85426-5
|
Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
41406-0
|
Meropenem [Mass/volume] in Serum or Plasma |
|
18943-1
|
Meropenem [Susceptibility] |
|
6654-8
|
Meropenem [Susceptibility] by Serum bactericidal titer |
|
34649-4
|
MERRF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41088-6
|
MERRF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3758-0
|
Mersalyl [Mass/time] in 24 hour Urine |
|
4311-7
|
Mersalyl [Mass] of Dose |
|
3756-4
|
Mersalyl [Presence] in Urine |
|
3757-2
|
Mersalyl [Mass/volume] in Urine |
|
74473-0
|
Middle East respiratory syndrome coronavirus (MERS-CoV) N2 gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74472-2
|
Middle East respiratory syndrome coronavirus (MERS-CoV) N3 gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88199-5
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Aspirate by NAA with probe detection |
|
86578-2
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Blood by NAA with probe detection |
|
88198-7
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
92967-9
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
91830-0
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88889-1
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88197-9
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88196-1
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Stool by NAA with probe detection |
|
91807-8
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86579-0
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Urine by NAA with probe detection |
|
74475-5
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Interpretation] in Unspecified specimen Qualitative by NAA with probe detection |
|
74474-8
|
Middle East respiratory syndrome coronavirus (MERS-CoV) upE gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
19545-3
|
Mescaline cutoff [Mass/volume] in Urine for Confirmatory method |
|
19544-6
|
Mescaline cutoff [Mass/volume] in Urine for Screen method |
|
16145-5
|
Mescaline [Mass/volume] in Serum or Plasma |
|
20543-5
|
Mescaline [Mass/volume] in Urine by Confirmatory method |
|
12296-0
|
Mescaline [Presence] in Urine |
|
19543-8
|
Mescaline [Presence] in Urine by Confirmatory method |
|
19542-0
|
Mescaline [Presence] in Urine by Screen method |
|
9726-1
|
Mescaline [Mass/volume] in Urine |
|
13002-1
|
Mesityl oxide [Mass/volume] in Blood |
|
31168-8
|
Mesityl oxide [Mass/volume] in Urine |
|
27010-8
|
Mesoporphyrin [Mass/time] in 24 hour Stool |
|
75027-3
|
Mesoporphyrin/Porphyrins.total in Stool |
|
14827-0
|
Mesoporphyrin [Moles/volume] in Stool |
|
45310-0
|
Mesoporphyrin [Moles/mass] in Stool |
|
75767-4
|
Mesoridazine [Presence] in Blood or Urine by Screen method |
|
19549-5
|
Mesoridazine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19548-7
|
Mesoridazine cutoff [Mass/volume] in Urine for Screen method |
|
4313-3
|
Mesoridazine [Mass] of Dose |
|
59926-6
|
Mesoridazine [Moles/volume] in Gastric fluid |
|
13566-5
|
Mesoridazine [Presence] in Serum or Plasma |
|
3760-6
|
Mesoridazine [Mass/volume] in Serum or Plasma |
|
25472-2
|
Mesoridazine [Moles/volume] in Serum or Plasma |
|
20544-3
|
Mesoridazine [Mass/volume] in Urine by Confirmatory method |
|
12367-9
|
Mesoridazine [Presence] in Urine |
|
19547-9
|
Mesoridazine [Presence] in Urine by Confirmatory method |
|
19546-1
|
Mesoridazine [Presence] in Urine by Screen method |
|
17256-9
|
Mesoridazine [Mass/volume] in Urine |
|
59925-8
|
Mesoridazine [Moles/volume] in Urine |
|
60315-9
|
Mesoridazine [Moles/volume] in Unspecified specimen |
|
74125-6
|
Mesothelin Ag [Presence] in Tissue by Immune stain |
|
35034-8
|
Mesothelial cells [#/volume] in Cerebral spinal fluid |
|
35079-3
|
Mesothelial cells [#/volume] in Body fluid |
|
68414-2
|
Mesothelial cells [#/volume] in Pericardial fluid by Manual count |
|
35033-0
|
Mesothelial cells [#/volume] in Pleural fluid |
|
68416-7
|
Mesothelial cells [#/volume] in Pleural fluid by Manual count |
|
35032-2
|
Mesothelial cells [#/volume] in Peritoneal fluid |
|
68415-9
|
Mesothelial cells [#/volume] in Peritoneal fluid by Manual count |
|
35035-5
|
Mesothelial cells [#/volume] in Synovial fluid |
|
68417-5
|
Mesothelial cells [#/volume] in Synovial fluid by Manual count |
|
68419-1
|
Mesothelial cells [#/volume] in Vitreous fluid by Manual count |
|
23898-0
|
Mesothelial cells [Presence] in Cerebral spinal fluid by Light microscopy |
|
17257-7
|
Mesothelial cells [Presence] in Body fluid by Light microscopy |
|
74852-5
|
Mesothelial cells/100 cells in Lymph node by Manual count |
|
71640-7
|
Mesothelial cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
71599-5
|
Mesothelial cells/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71607-6
|
Mesothelial cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71626-6
|
Mesothelial cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
21384-3
|
Mesothelial cells [Presence] in Peritoneal fluid by Light microscopy |
|
23897-2
|
Mesothelial cells [Presence] in Unspecified specimen by Light microscopy |
|
40650-4
|
Mesothelial cells/100 leukocytes in Blood by Manual count |
|
30429-5
|
Mesothelial cells/100 leukocytes in Cerebral spinal fluid |
|
12233-3
|
Mesothelial cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
51622-9
|
Mesothelial cells/100 leukocytes in Dialysis fluid by Manual count |
|
28544-5
|
Mesothelial cells/100 leukocytes in Body fluid |
|
12234-1
|
Mesothelial cells/100 leukocytes in Body fluid by Manual count |
|
30430-3
|
Mesothelial cells/100 leukocytes in Pericardial fluid |
|
14828-8
|
Mesothelial cells/100 leukocytes in Pericardial fluid by Manual count |
|
30431-1
|
Mesothelial cells/100 leukocytes in Pleural fluid |
|
14829-6
|
Mesothelial cells/100 leukocytes in Pleural fluid by Manual count |
|
30432-9
|
Mesothelial cells/100 leukocytes in Peritoneal fluid |
|
14830-4
|
Mesothelial cells/100 leukocytes in Peritoneal fluid by Manual count |
|
33365-8
|
Mesothelial cells/100 leukocytes in Synovial fluid |
|
57850-0
|
Mesothelial cells/100 leukocytes in Synovial fluid by Manual count |
|
68418-3
|
Mesothelial cells/100 leukocytes in Vitreous fluid by Manual count |
|
6173-9
|
Mesquite IgE Ab [Units/volume] in Serum |
|
15843-6
|
Mesquite IgE Ab RAST class [Presence] in Serum |
|
61305-9
|
Mesquite IgE Ab/IgE total in Serum |
|
13182-1
|
Mesquite IgG Ab [Units/volume] in Serum |
|
56320-5
|
Mesquite IgG4 Ab [Mass/volume] in Serum |
|
63185-3
|
Mesquite IgG Ab [Mass/volume] in Serum |
|
81357-6
|
Messages to be delivered after death [Reported] |
|
58002-7
|
Mestanolone metabolite [Presence] in Urine |
|
3763-0
|
Mesterolone [Mass/time] in 24 hour Urine |
|
4314-1
|
Mesterolone [Mass] of Dose |
|
3761-4
|
Mesterolone [Presence] in Urine |
|
3762-2
|
Mesterolone [Mass/volume] in Urine |
|
69828-2
|
Methylsuccinate [Moles/volume] in Amniotic fluid |
|
82503-4
|
Methylsuccinate [Moles/volume] in DBS |
|
69829-0
|
Methylsuccinate [Moles/volume] in Serum or Plasma |
|
30479-0
|
Methylsuccinate [Presence] in Urine |
|
13777-8
|
Methylsuccinate/Creatinine [Mass Ratio] in Urine |
|
25117-3
|
Methylsuccinate/Creatinine [Molar ratio] in Urine |
|
2634-4
|
Methyltestosterone [Mass/time] in 24 hour Urine |
|
90926-7
|
MET gene amplification in Blood or Tissue by FISH |
|
92907-5
|
MET gene copy number/Chromosome 7 copy number in Blood or Tissue by FISH |
|
92906-7
|
MET gene copy number/nucleus in Blood or Tissue by FISH |
|
49856-8
|
Methyltestosterone [Presence] in Serum or Plasma |
|
2632-8
|
Methyltestosterone [Presence] in Urine |
|
2633-6
|
Methyltestosterone [Mass/volume] in Urine |
|
15130-8
|
Methionine+Tryptophan [Presence] in Serum or Plasma |
|
15145-6
|
Methionine+Tryptophan [Presence] in Urine |
|
41965-5
|
Type of Metabolism measurement device |
|
41967-1
|
Metabolism measurement device Vendor model code |
|
41968-9
|
Metabolism measurement device Vendor serial number |
|
41969-7
|
Metabolism measurement device Vendor software version |
|
41970-5
|
Metabolism measurement device Type |
|
41966-3
|
Name of Metabolism measurement device |
|
74873-1
|
Metabolic disorder being monitored [Identifier] in DBS |
|
69429-9
|
Metabolic rate --resting |
|
49898-0
|
Metabolic syndrome [Presence] in Serum or Plasma |
|
23751-1
|
Metaldehyde [Mass/volume] in Unspecified specimen |
|
30433-7
|
Metamyelocytes [#/volume] in Blood |
|
66137-1
|
Metamyelocytes [#/volume] in Blood from Fetus by Manual count |
|
739-3
|
Metamyelocytes [#/volume] in Blood by Manual count |
|
35030-6
|
Metamyelocytes [#/volume] in Cerebral spinal fluid |
|
35031-4
|
Metamyelocytes [#/volume] in Body fluid |
|
40568-8
|
Metamyelocytes [#/volume] in Body fluid by Manual count |
|
40651-2
|
Metamyelocytes [Presence] in Blood |
|
56473-2
|
Metamyelocytes [#] in Cerebral spinal fluid by Manual count |
|
76405-0
|
Metamyelocytes [#] in Body fluid by Manual count |
|
11111-2
|
Metamyelocytes/100 cells in Bone marrow by Manual count |
|
71668-8
|
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71655-5
|
Metamyelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71643-1
|
Metamyelocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
74429-2
|
Metamyelocytes.eosinophilic/100 cells in Bone marrow by Manual count |
|
74428-4
|
Metamyelocytes.neutrophilic/100 leukocytes in Blood by Manual count |
|
93952-0
|
Metamyelocytes.neutrophilic/100 leukocytes in Bone marrow by Manual count |
|
28541-1
|
Metamyelocytes/100 leukocytes in Blood |
|
740-1
|
Metamyelocytes/100 leukocytes in Blood by Manual count |
|
30366-9
|
Metamyelocytes/100 leukocytes in Cerebral spinal fluid |
|
33262-7
|
Metamyelocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
17801-2
|
Metamyelocytes/100 leukocytes in Body fluid |
|
33263-5
|
Metamyelocytes/100 leukocytes in Body fluid by Manual count |
|
3766-3
|
Metandienone [Mass/time] in 24 hour Urine |
|
4315-8
|
Metandienone [Mass] of Dose |
|
17258-5
|
Metandienone [Mass/volume] in Serum or Plasma |
|
3764-8
|
Metandienone [Presence] in Urine |
|
3765-5
|
Metandienone [Mass/volume] in Urine |
|
21019-5
|
Metanephrine [Mass/volume] in 24 hour Urine |
|
19049-6
|
Metanephrine [Mass/time] in 24 hour Urine |
|
25955-6
|
Metanephrine [Moles/volume] in 24 hour Urine |
|
11140-1
|
Metanephrine [Moles/time] in 24 hour Urine |
|
32634-8
|
Metanephrine Free [Mass/time] in 24 hour Urine |
|
38494-1
|
Metanephrine Free [Mass/volume] in Serum or Plasma |
|
49700-8
|
Metanephrine Free [Moles/volume] in Serum or Plasma |
|
44337-4
|
Metanephrine Free/Creatinine [Mass Ratio] in Urine |
|
29141-9
|
Metanephrine [Mass/volume] in Serum or Plasma |
|
25473-0
|
Metanephrine [Moles/volume] in Serum or Plasma |
|
11139-3
|
Metanephrine [Mass/volume] in Urine |
|
34339-2
|
Metanephrine [Moles/volume] in Urine |
|
35644-4
|
Metanephrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
47699-4
|
Metanephrine/Creatinine [Molar ratio] in 24 hour Urine |
|
9645-3
|
Metanephrine/Creatinine [Mass Ratio] in Urine |
|
14831-2
|
Metanephrine/Creatinine [Molar ratio] in Urine |
|
45021-3
|
Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma |
|
49282-7
|
Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma Narrative |
|
44013-1
|
Metanephrine and Normetanephrine [Interpretation] in Urine |
|
49283-5
|
Metanephrine and Normetanephrine [Interpretation] in Urine Narrative |
|
19050-4
|
Metanephrines [Mass/volume] in 24 hour Urine |
|
2609-6
|
Metanephrines [Mass/time] in 24 hour Urine |
|
71791-8
|
Metanephrines [Moles/volume] in 24 hour Urine |
|
14833-8
|
Metanephrines [Moles/time] in 24 hour Urine |
|
29142-7
|
Metanephrines [Mass/volume] in Serum or Plasma |
|
25474-8
|
Metanephrines [Moles/volume] in Serum or Plasma |
|
2608-8
|
Metanephrines [Mass/volume] in Urine |
|
14832-0
|
Metanephrines [Moles/volume] in Urine |
|
32655-3
|
Metanephrines/Creatinine [Mass Ratio] in 24 hour Urine |
|
27978-6
|
Metanephrines/Creatinine [Molar ratio] in 24 hour Urine |
|
13771-1
|
Metanephrines/Creatinine [Mass Ratio] in Urine |
|
6949-2
|
Metaproterenol [Mass/volume] in Serum or Plasma |
|
4316-6
|
Metaraminol [Mass] of Dose |
|
3767-1
|
Metaraminol [Mass/volume] in Urine |
|
31175-3
|
Metasystox [Mass/volume] in Blood |
|
35485-2
|
Metasystox [Mass/volume] in Serum or Plasma |
|
21385-0
|
Metasystox [Mass/volume] in Urine |
|
59307-9
|
Metaxalone [Mass/volume] in Blood |
|
59308-7
|
Metaxalone [Mass/volume] in Serum or Plasma |
|
59309-5
|
Metaxalone [Mass/volume] in Urine |
|
87775-3
|
Metaxalone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
3770-5
|
Metenolone [Mass/time] in 24 hour Urine |
|
4317-4
|
Metenolone [Mass] of Dose |
|
3768-9
|
Metenolone [Presence] in Urine |
|
3769-7
|
Metenolone [Mass/volume] in Urine |
|
72996-2
|
metFORMIN induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72995-4
|
metFORMIN induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73287-5
|
metFORMIN induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73286-7
|
metFORMIN induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35698-0
|
metFORMIN [Mass/volume] in Serum or Plasma |
|
55548-2
|
metFORMIN [Moles/volume] in Serum or Plasma |
|
65866-6
|
Methacholine [Mass] of Dose |
|
320-2
|
Methacycline [Susceptibility] by Disk diffusion (KB) |
|
319-4
|
Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
318-6
|
Methacycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18944-9
|
Methacycline [Susceptibility] |
|
321-0
|
Methacycline [Susceptibility] by Serum bactericidal titer |
|
3775-4
|
Methadone [Mass/time] in 24 hour Urine |
|
78770-5
|
Methadone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
31084-7
|
Methadone [Mass/volume] in Bile fluid |
|
72400-5
|
Methadone [Presence] in Blood by Screen method |
|
80532-5
|
Methadone [Mass/volume] in Blood |
|
79249-9
|
Methadone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19553-7
|
Methadone cutoff [Mass/volume] in Urine for Confirmatory method |
|
19552-9
|
Methadone cutoff [Mass/volume] in Urine for Screen method |
|
4318-2
|
Methadone [Mass] of Dose |
|
29285-4
|
Methadone [Presence] in Gastric fluid |
|
29294-6
|
Methadone [Mass/volume] in Gastric fluid |
|
73727-0
|
Methadone [Presence] in Hair |
|
11243-3
|
Methadone [Mass/mass] in Hair |
|
43595-8
|
Methadone [Presence] in Meconium |
|
11025-4
|
Methadone [Mass/volume] in Meconium |
|
29159-1
|
Methadone [Mass/mass] in Meconium |
|
27052-0
|
Methadone [Mass/volume] in Milk |
|
72388-2
|
Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72387-4
|
Methadone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
72626-5
|
Methadone [Presence] in Saliva (oral fluid) by Screen method |
|
72734-7
|
Methadone [Mass/volume] in Saliva (oral fluid) by Screen method |
|
3771-3
|
Methadone [Presence] in Serum or Plasma |
|
47411-4
|
Methadone [Presence] in Serum or Plasma by Confirmatory method |
|
59705-4
|
Methadone [Presence] in Serum or Plasma by Screen method |
|
35618-8
|
Methadone [Mass/volume] in Serum or Plasma by Screen method |
|
3772-1
|
Methadone [Mass/volume] in Serum or Plasma |
|
15108-4
|
Methadone [Moles/volume] in Serum or Plasma |
|
12356-2
|
Methadone [Presence] in Stool |
|
27283-1
|
Methadone [Mass/mass] in Stool |
|
16246-1
|
Methadone [Mass/volume] in Urine by Confirmatory method |
|
3773-9
|
Methadone [Presence] in Urine |
|
16199-2
|
Methadone [Presence] in Urine by Confirmatory method |
|
19550-3
|
Methadone [Presence] in Urine by Screen method |
|
70148-2
|
Methadone [Presence] in Urine by Screen method >150 ng/mL |
|
70149-0
|
Methadone [Presence] in Urine by Screen method >300 ng/mL |
|
70147-4
|
Methadone [Mass/volume] in Urine by Screen method |
|
3774-7
|
Methadone [Mass/volume] in Urine |
|
52958-6
|
Methadone [Moles/volume] in Urine |
|
27207-0
|
Methadone [Mass/volume] in Vitreous fluid |
|
48956-7
|
Methadone [Mass/volume] in Unspecified specimen by Confirmatory method |
|
32093-7
|
Methadone [Presence] in Unspecified specimen |
|
29532-9
|
Methadone [Units/volume] in Unspecified specimen |
|
48957-5
|
Methadone [Mass/volume] in Unspecified specimen |
|
77328-3
|
Methadone [Moles/volume] in Unspecified specimen |
|
78857-0
|
Methadone [Z-score] in Urine |
|
41466-4
|
Methadone/Creatinine [Mass Ratio] in Urine |
|
91039-8
|
Methadone+Metabolite [Presence] in Body fluid by Screen method |
|
91046-3
|
Methadone+Metabolite [Presence] in Hair by Screen method |
|
91030-7
|
Methadone+Metabolite [Presence] in Meconium by Screen method |
|
72475-7
|
Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method |
|
45022-1
|
Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method |
|
91033-1
|
Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method |
|
48403-0
|
Methadone+Metabolite [Mass/volume] in Serum or Plasma |
|
91050-5
|
Methadone+Metabolite [Presence] in Tissue by Screen method |
|
42251-9
|
Methadone+Metabolite [Presence] in Urine by Screen method |
|
3776-2
|
Methamphetamine [Mass/volume] in Blood |
|
79262-2
|
Methamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19557-8
|
Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19556-0
|
Methamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
4319-0
|
Methamphetamine [Mass] of Dose |
|
14834-6
|
Methamphetamine [Presence] in Gastric fluid |
|
40652-0
|
Methamphetamine [Presence] in Hair |
|
40803-9
|
Methamphetamine [Presence] in Hair by Screen method |
|
80533-3
|
Methamphetamine [Mass/mass] in Hair |
|
69022-2
|
Methamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
29286-2
|
Methamphetamine [Presence] in Meconium |
|
15405-4
|
Methamphetamine [Mass/volume] in Meconium |
|
27289-8
|
Methamphetamine [Mass/mass] in Meconium |
|
27116-3
|
Methamphetamine [Mass/volume] in Milk |
|
72735-4
|
Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74646-1
|
Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40804-7
|
Methamphetamine [Presence] in Saliva (oral fluid) by Screen method |
|
17260-1
|
Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3777-0
|
Methamphetamine [Presence] in Serum or Plasma |
|
82966-3
|
Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3778-8
|
Methamphetamine [Mass/volume] in Serum or Plasma |
|
26734-4
|
Methamphetamine [Mass/mass] in Stool |
|
16235-4
|
Methamphetamine [Mass/volume] in Urine by Confirmatory method |
|
3779-6
|
Methamphetamine [Presence] in Urine |
|
19555-2
|
Methamphetamine [Presence] in Urine by Confirmatory method |
|
21386-8
|
Methamphetamine [Presence] in Urine by SAMHSA confirm method |
|
19554-5
|
Methamphetamine [Presence] in Urine by Screen method |
|
3780-4
|
Methamphetamine [Mass/volume] in Urine |
|
55587-0
|
Methamphetamine [Moles/volume] in Urine |
|
27277-3
|
Methamphetamine [Mass/volume] in Vitreous fluid |
|
40381-6
|
Methamphetamine [Presence] in Unspecified specimen |
|
58358-3
|
Methamphetamine/Creatinine [Mass Ratio] in Urine |
|
91042-2
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method |
|
91045-5
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method |
|
91031-5
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Meconium by Screen method |
|
91034-9
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Serum, Plasma or Blood by Screen method |
|
91051-3
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method |
|
91037-2
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
|
14166-3
|
Methane [Mass/volume] in Blood |
|
2610-4
|
Methane [Mass/volume] in Exhaled gas |
|
38705-0
|
Methanol [Mass/volume] in Air |
|
5690-3
|
Methanol [Presence] in Blood |
|
9334-4
|
Methanol [Mass/volume] in Blood |
|
5691-1
|
Methanol [Presence] in Exhaled gas |
|
40532-4
|
Methanol [Presence] in Gastric fluid |
|
23899-8
|
Methanol [Mass/volume] in Gastric fluid |
|
59927-4
|
Methanol [Moles/volume] in Gastric fluid |
|
15407-0
|
Methanol [Presence] in Meconium |
|
5692-9
|
Methanol [Presence] in Serum or Plasma |
|
20579-9
|
Methanol [Presence] in Serum or Plasma by Screen method |
|
5693-7
|
Methanol [Mass/volume] in Serum or Plasma |
|
14835-3
|
Methanol [Moles/volume] in Serum or Plasma |
|
23900-4
|
Methanol [Mass/mass] in Tissue |
|
5694-5
|
Methanol [Presence] in Urine |
|
34181-8
|
Methanol [Presence] in Urine by Confirmatory method |
|
5695-2
|
Methanol [Mass/volume] in Urine |
|
32095-2
|
Methanol [Moles/volume] in Urine |
|
29375-3
|
Methanol [Mass/volume] in Unknown substance |
|
32094-5
|
Methanol [Moles/volume] in Unspecified specimen |
|
46230-9
|
Methanolone [Mass/volume] in Urine |
|
4320-8
|
Methapyrilene [Mass] of Dose |
|
75762-5
|
Methapyrilene [Presence] in Serum or Plasma or Urine by Screen method |
|
3781-2
|
Methapyrilene [Presence] in Serum or Plasma |
|
3782-0
|
Methapyrilene [Mass/volume] in Serum or Plasma |
|
3783-8
|
Methapyrilene [Presence] in Urine |
|
17261-9
|
Methapyrilene [Mass/volume] in Urine |
|
31085-4
|
Methaqualone [Mass/volume] in Bile fluid |
|
19560-2
|
Methaqualone cutoff [Mass/volume] in Urine for Confirmatory method |
|
19559-4
|
Methaqualone cutoff [Mass/volume] in Urine for Screen method |
|
4321-6
|
Methaqualone [Mass] of Dose |
|
50005-8
|
Methaqualone [Presence] in Body fluid by Screen method |
|
40382-4
|
Methaqualone [Presence] in Gastric fluid |
|
29388-6
|
Methaqualone [Mass/volume] in Gastric fluid |
|
59929-0
|
Methaqualone [Moles/volume] in Gastric fluid |
|
13646-5
|
Methaqualone [Mass/mass] in Hair |
|
11026-2
|
Methaqualone [Mass/volume] in Meconium |
|
27262-5
|
Methaqualone [Mass/mass] in Meconium |
|
34182-6
|
Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method |
|
3784-6
|
Methaqualone [Presence] in Serum or Plasma |
|
35619-6
|
Methaqualone [Mass/volume] in Serum or Plasma by Screen method |
|
3785-3
|
Methaqualone [Mass/volume] in Serum or Plasma |
|
25475-5
|
Methaqualone [Moles/volume] in Serum or Plasma |
|
12353-9
|
Methaqualone [Presence] in Stool |
|
16244-6
|
Methaqualone [Mass/volume] in Urine by Confirmatory method |
|
3786-1
|
Methaqualone [Presence] in Urine |
|
18389-7
|
Methaqualone [Presence] in Urine by Confirmatory method |
|
19558-6
|
Methaqualone [Presence] in Urine by Screen method |
|
3787-9
|
Methaqualone [Mass/volume] in Urine |
|
59928-2
|
Methaqualone [Moles/volume] in Urine |
|
27347-4
|
Methaqualone [Mass/volume] in Vitreous fluid |
|
32096-0
|
Methaqualone [Presence] in Unspecified specimen |
|
60316-7
|
Methaqualone [Moles/volume] in Unspecified specimen |
|
42252-7
|
Methaqualone+Metabolite [Presence] in Urine by Screen method |
|
10542-9
|
Metharbital [Mass/volume] in Serum or Plasma |
|
12498-2
|
Metharbital [Presence] in Stool |
|
58004-3
|
Methasterone [Presence] in Urine |
|
10841-5
|
methazolAMIDE [Mass/volume] in Serum or Plasma |
|
79236-6
|
Methcathinone cutoff [Mass/volume] in Urine for Confirmatory method |
|
78858-8
|
Methcathinone [Mass/volume] in Urine by Confirmatory method |
|
79144-2
|
Methcathinone [Presence] in Urine by Screen method |
|
87762-1
|
Methcathinone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
2611-2
|
Methcoproporphyrin [Mass/volume] in Serum or Plasma |
|
45145-0
|
Methdilazine [Presence] in Serum or Plasma |
|
12801-7
|
Methdilazine [Mass/volume] in Serum or Plasma |
|
79241-6
|
Methedrone cutoff [Mass/volume] in Urine for Confirmatory method |
|
79246-5
|
Methedrone [Mass/volume] in Urine by Confirmatory method |
|
17263-5
|
Methemalbumin [Presence] in Serum or Plasma |
|
2612-0
|
Methemalbumin [Mass/volume] in Serum or Plasma |
|
2613-8
|
Methemoglobin [Presence] in Blood |
|
15082-1
|
Methemoglobin [Mass/volume] in Blood |
|
56040-9
|
Methemoglobin [Moles/volume] in Blood |
|
72262-9
|
Methemoglobin [Moles/volume] in Cerebral spinal fluid |
|
2614-6
|
Methemoglobin/Hemoglobin.total in Blood |
|
2615-3
|
Methemoglobin/Hemoglobin.total in Arterial blood |
|
2616-1
|
Methemoglobin/Hemoglobin.total in Capillary blood |
|
55942-7
|
Methemoglobin/Hemoglobin.total in Cord blood |
|
72361-9
|
Methemoglobin/Hemoglobin.total in Arterial cord blood |
|
72360-1
|
Methemoglobin/Hemoglobin.total in Venous cord blood |
|
41607-3
|
Methemoglobin/Hemoglobin.total in Mixed venous blood |
|
2617-9
|
Methemoglobin/Hemoglobin.total in Venous blood |
|
2618-7
|
Methemoglobin/Hemoglobin.total in Red Blood Cells |
|
71883-3
|
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Blood |
|
71882-5
|
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
|
71881-7
|
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood |
|
71880-9
|
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood |
|
71879-1
|
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood |
|
2619-5
|
Methemoglobin [Presence] in Red Blood Cells |
|
4322-4
|
Methicillin [Mass] of Dose |
|
7030-0
|
Methicillin [Susceptibility] by Gradient strip |
|
324-4
|
Methicillin [Susceptibility] by Disk diffusion (KB) |
|
323-6
|
Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
322-8
|
Methicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
92255-9
|
Methicillin [Susceptibility] by Genotype method |
|
3788-7
|
Methicillin [Mass/volume] in Serum or Plasma |
|
18945-6
|
Methicillin [Susceptibility] |
|
325-1
|
Methicillin [Susceptibility] by Serum bactericidal titer |
|
29492-6
|
Methicillin [Mass/volume] in Unspecified specimen |
|
34185-9
|
methIMAzole [Mass/time] in 24 hour Urine |
|
14185-3
|
methIMAzole [Mass/volume] in Serum or Plasma |
|
27098-3
|
Methionine [Presence] in 24 hour Urine |
|
2624-5
|
Methionine [Mass/time] in 24 hour Urine |
|
25956-4
|
Methionine [Moles/volume] in 24 hour Urine |
|
25476-3
|
Methionine [Moles/time] in 24 hour Urine |
|
13405-6
|
Methionine [Mass/volume] in Amniotic fluid |
|
26844-1
|
Methionine [Moles/volume] in Amniotic fluid |
|
2620-3
|
Methionine [Presence] in Blood |
|
13376-9
|
Methionine [Mass/volume] in Cerebral spinal fluid |
|
22648-0
|
Methionine [Moles/volume] in Cerebral spinal fluid |
|
63380-0
|
Methionine [Presence] in DBS |
|
47700-0
|
Methionine [Moles/volume] in DBS |
|
47199-5
|
Methionine [Mass] of Dose |
|
32258-6
|
Methionine [Moles/volume] in Body fluid |
|
55943-5
|
Methionine [Moles/mass] in Hair |
|
81918-5
|
Methionine intake 24 hour Estimated |
|
81919-3
|
Methionine intake 24 hour Measured |
|
2621-1
|
Methionine [Presence] in Serum or Plasma |
|
27953-9
|
Methionine [Units/volume] in Serum or Plasma |
|
2622-9
|
Methionine [Mass/volume] in Serum or Plasma |
|
20651-6
|
Methionine [Moles/volume] in Serum or Plasma |
|
47703-4
|
Methionine/Amino acids.total in Amniotic fluid |
|
47702-6
|
Methionine/Amino acids.total in Cerebral spinal fluid |
|
47705-9
|
Methionine/Amino acids.total in DBS |
|
47701-8
|
Methionine/Amino acids.total in Hair |
|
47704-2
|
Methionine/Amino acids.total in Serum or Plasma |
|
47706-7
|
Methionine/Amino acids.total in Unspecified specimen |
|
17264-3
|
Methionine [Presence] in Urine |
|
2623-7
|
Methionine [Mass/volume] in Urine |
|
26963-9
|
Methionine [Moles/volume] in Urine |
|
32257-8
|
Methionine [Moles/volume] in Vitreous fluid |
|
22716-5
|
Methionine [Moles/volume] in Unspecified specimen |
|
53397-6
|
Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in DBS |
|
44338-2
|
Methionine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56957-4
|
Methionine/Creatinine [Ratio] in 24 hour Urine |
|
25959-8
|
Methionine/Creatinine [Molar ratio] in 24 hour Urine |
|
13772-9
|
Methionine/Creatinine [Mass Ratio] in Urine |
|
30063-2
|
Methionine/Creatinine [Ratio] in Urine |
|
22681-1
|
Methionine/Creatinine [Molar ratio] in Urine |
|
53156-6
|
Methionine/Phenylalanine [Molar ratio] in DBS |
|
47200-1
|
Methionine+Homocysteine [Mass] of Dose |
|
4323-2
|
Methocarbamol [Mass] of Dose |
|
73285-9
|
Methocarbamol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73284-2
|
Methocarbamol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3789-5
|
Methocarbamol [Presence] in Serum or Plasma |
|
17265-0
|
Methocarbamol [Units/volume] in Serum or Plasma |
|
3790-3
|
Methocarbamol [Mass/volume] in Serum or Plasma |
|
55549-0
|
Methocarbamol [Moles/volume] in Serum or Plasma |
|
3791-1
|
Methocarbamol [Presence] in Urine |
|
53667-2
|
Method of best overall fetal weight estimate |
|
53666-4
|
Method of best overall gestational age estimate |
|
71462-6
|
Method of identifying vascular access infection [ESRD] |
|
53664-9
|
Method of prior gestational age estimate |
|
82296-5
|
Method used to measure RMR |
|
77556-9
|
Method used to connect with a patient [NMMDS] |
|
12491-7
|
Methohexital [Presence] in Serum or Plasma |
|
27042-1
|
Methohexital [Mass/volume] in Serum or Plasma |
|
27187-4
|
Methohexital [Mass/volume] in Urine |
|
87650-8
|
Methomyl [Mass/mass] in Unspecified specimen |
|
80969-9
|
Methotrexate free [Mass/volume] in Serum or Plasma |
|
19505-7
|
Methotrimeprazine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19504-0
|
Methotrimeprazine cutoff [Mass/volume] in Urine for Screen method |
|
4296-0
|
Methotrimeprazine [Mass] of Dose |
|
59931-6
|
Methotrimeprazine [Moles/volume] in Gastric fluid |
|
59172-7
|
Methotrimeprazine metabolite [Presence] in Urine |
|
40424-4
|
Methotrimeprazine [Presence] in Serum or Plasma |
|
63482-4
|
Methotrimeprazine [Mass/volume] in Serum or Plasma |
|
48351-1
|
Methotrimeprazine [Moles/volume] in Serum or Plasma |
|
20538-5
|
Methotrimeprazine [Mass/volume] in Urine by Confirmatory method |
|
40422-8
|
Methotrimeprazine [Presence] in Urine |
|
19503-2
|
Methotrimeprazine [Presence] in Urine by Confirmatory method |
|
19502-4
|
Methotrimeprazine [Presence] in Urine by Screen method |
|
3708-5
|
Methotrimeprazine [Mass/volume] in Urine |
|
59930-8
|
Methotrimeprazine [Moles/volume] in Urine |
|
40423-6
|
Methotrimeprazine [Presence] in Unspecified specimen |
|
60317-5
|
Methotrimeprazine [Moles/volume] in Unspecified specimen |
|
55252-1
|
Methoxsalen 0.02 mg/mL given [Volume] |
|
13625-9
|
Methoxsalen [Mass/volume] in Serum or Plasma |
|
2626-0
|
Methoxyacetate [Mass/volume] in Serum or Plasma |
|
44860-5
|
Methoxyacetate/Creatinine [Mass Ratio] in Urine |
|
38607-8
|
Methoxychlor [Mass/volume] in Air |
|
11099-9
|
Methoxychlor [Mass/volume] in Serum or Plasma |
|
17267-6
|
Methoxychlor [Mass/volume] in Urine |
|
38324-0
|
Methoxychlor [Mass/volume] in Water |
|
87647-4
|
Methoxychlor [Mass/mass] in Unspecified specimen |
|
14266-1
|
Methoxyflurane [Mass/volume] in Blood |
|
3800-0
|
Methoxyphenamine [Mass/time] in 24 hour Urine |
|
4325-7
|
Methoxyphenamine [Mass] of Dose |
|
3798-6
|
Methoxyphenamine [Presence] in Urine |
|
3799-4
|
Methoxyphenamine [Mass/volume] in Urine |
|
4326-5
|
Methsuximide [Mass] of Dose |
|
3801-8
|
Methsuximide [Mass/volume] in Serum or Plasma |
|
14837-9
|
Methsuximide [Moles/volume] in Serum or Plasma |
|
10543-7
|
Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
|
55550-8
|
Methsuximide+Normethsuximide [Moles/volume] in Serum or Plasma |
|
18469-7
|
Methyclothiazide [Mass/volume] in Serum or Plasma |
|
12346-3
|
Methyclothiazide [Presence] in Urine |
|
9650-3
|
Methyclothiazide [Mass/volume] in Urine |
|
38708-4
|
Methyl hydrazine [Mass/volume] in Air |
|
38709-2
|
Methyl iodide [Mass/volume] in Air |
|
38747-2
|
Methyl isocyanate [Mass/volume] in Air |
|
53650-8
|
Methyl parathion [Mass/volume] in Gastric fluid |
|
35484-5
|
Methyl parathion [Mass/volume] in Serum or Plasma |
|
18371-5
|
Methyl parathion [Mass/volume] in Urine |
|
87646-6
|
Methyl parathion [Mass/mass] in Unspecified specimen |
|
58003-5
|
Methylandrostenediol [Presence] in Urine |
|
43289-8
|
Methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
|
4327-3
|
Methyldopa [Mass] of Dose |
|
73281-8
|
Methyldopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73280-0
|
Methyldopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3802-6
|
Methyldopa [Mass/volume] in Serum or Plasma |
|
21387-6
|
Methylhippurate [Mass/volume] in Urine |
|
9437-5
|
Methylhippurate [Mass/time] in Urine |
|
13774-5
|
Methylhippurate/Creatinine [Mass Ratio] in Urine |
|
29342-3
|
Methylmalonate [Mass/time] in 24 hour Urine |
|
42520-7
|
Methylmalonate [Moles/volume] in 24 hour Urine |
|
47091-4
|
Methylmalonate [Moles/time] in 24 hour Urine |
|
34627-0
|
Methylmalonate [Moles/volume] in Amniotic fluid |
|
32259-4
|
Methylmalonate [Mass/volume] in Cerebral spinal fluid |
|
54315-7
|
Methylmalonate [Moles/volume] in Cerebral spinal fluid |
|
82385-6
|
Methylmalonate [Moles/volume] in DBS |
|
2629-4
|
Methylmalonate [Mass/volume] in Serum or Plasma |
|
13964-2
|
Methylmalonate [Moles/volume] in Serum or Plasma |
|
29877-8
|
Methylmalonate [Presence] in Urine |
|
2630-2
|
Methylmalonate [Mass/volume] in Urine |
|
32287-5
|
Methylmalonate [Moles/volume] in Urine |
|
13775-2
|
Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
|
25115-7
|
Methylmalonate/Creatinine [Molar ratio] in 24 hour Urine |
|
13776-0
|
Methylmalonate/Creatinine [Mass Ratio] in Urine |
|
56664-6
|
Methylmalonate/Creatinine [Ratio] in Urine |
|
25116-5
|
Methylmalonate/Creatinine [Molar ratio] in Urine |
|
44719-3
|
Methylmalonate/Homocysteine [Mass Ratio] in Serum or Plasma |
|
44720-1
|
Methylmalonate/Homocystine [Molar ratio] in Serum or Plasma |
|
47707-5
|
Methylmalonate/Urea [Molar ratio] in Amniotic fluid |
|
47708-3
|
Methylmalonate/Urea [Molar ratio] in Serum or Plasma |
|
47709-1
|
Methylmalonate/Urea [Molar ratio] in Urine |
|
38545-0
|
Methylmercury [Mass/mass] in Tissue |
|
33934-1
|
Methylmethacrylate IgE Ab [Presence] in Serum |
|
58005-0
|
Methylnortestosterone [Presence] in Urine |
|
79242-4
|
Methylone cutoff [Mass/volume] in Urine for Confirmatory method |
|
72793-3
|
Methylone [Mass/volume] in Urine by Confirmatory method |
|
73686-8
|
Methylone [Presence] in Urine by Screen method |
|
72794-1
|
Methylone/Creatinine [Mass Ratio] in Urine |
|
40862-5
|
Methylparaben IgE Ab [Units/volume] in Serum |
|
18242-8
|
Methyprylon [Mass/time] in 24 hour Urine |
|
19584-2
|
Methyprylon cutoff [Mass/volume] in Urine for Confirmatory method |
|
19583-4
|
Methyprylon cutoff [Mass/volume] in Urine for Screen method |
|
4330-7
|
Methyprylon [Mass] of Dose |
|
40383-2
|
Methyprylon [Presence] in Gastric fluid |
|
47122-7
|
Methyprylon [Moles/volume] in Gastric fluid |
|
3811-7
|
Methyprylon [Presence] in Serum or Plasma |
|
3812-5
|
Methyprylon [Mass/volume] in Serum or Plasma |
|
25478-9
|
Methyprylon [Moles/volume] in Serum or Plasma |
|
20549-2
|
Methyprylon [Mass/volume] in Urine by Confirmatory method |
|
3813-3
|
Methyprylon [Presence] in Urine |
|
16217-2
|
Methyprylon [Presence] in Urine by Confirmatory method |
|
19581-8
|
Methyprylon [Presence] in Urine by Screen method |
|
3814-1
|
Methyprylon [Mass/volume] in Urine |
|
32097-8
|
Methyprylon [Presence] in Unspecified specimen |
|
72992-1
|
Metoclopramide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72991-3
|
Metoclopramide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73275-0
|
Metoclopramide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73274-3
|
Metoclopramide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9774-1
|
Metoclopramide [Mass/volume] in Serum or Plasma |
|
18471-3
|
Metoclopramide [Mass/volume] in Urine |
|
17277-5
|
metOLazone [Mass/volume] in Serum or Plasma |
|
12347-1
|
metOLazone [Presence] in Urine |
|
9651-1
|
metOLazone [Mass/volume] in Urine |
|
72990-5
|
Metoprolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72989-7
|
Metoprolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3818-2
|
Metoprolol [Mass/time] in 24 hour Urine |
|
4331-5
|
Metoprolol [Mass] of Dose |
|
73273-5
|
Metoprolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73272-7
|
Metoprolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35620-4
|
Metoprolol [Presence] in Serum or Plasma by Screen method |
|
3815-8
|
Metoprolol [Mass/volume] in Serum or Plasma |
|
55553-2
|
Metoprolol [Moles/volume] in Serum or Plasma |
|
74916-8
|
Metoprolol [Mass/volume] in Serum or Plasma --trough |
|
3816-6
|
Metoprolol [Presence] in Urine |
|
3817-4
|
Metoprolol [Mass/volume] in Urine |
|
56708-1
|
metroNIDAZOLE IgE Ab [Units/volume] in Serum |
|
73271-9
|
metroNIDAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73270-1
|
metroNIDAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7031-8
|
metroNIDAZOLE [Susceptibility] by Gradient strip |
|
328-5
|
metroNIDAZOLE [Susceptibility] by Disk diffusion (KB) |
|
327-7
|
metroNIDAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
326-9
|
metroNIDAZOLE [Susceptibility] by Minimum lethal concentration (MLC) |
|
10991-8
|
metroNIDAZOLE [Mass/volume] in Serum or Plasma |
|
18946-4
|
metroNIDAZOLE [Susceptibility] |
|
329-3
|
metroNIDAZOLE [Susceptibility] by Serum bactericidal titer |
|
47205-0
|
metyraPONE [Mass] of Dose |
|
17553-9
|
Measles virus Ab [Units/volume] in Cerebral spinal fluid |
|
5242-3
|
Measles virus Ab [Units/volume] in Serum by Immunoassay |
|
46197-0
|
Measles virus Ab [Presence] in Serum |
|
43976-0
|
Measles virus Ab [Presence] in Serum by Immunoassay |
|
7961-6
|
Measles virus Ab [Units/volume] in Serum |
|
17555-4
|
Measles virus Ab [Units/volume] in Serum --1st specimen |
|
17556-2
|
Measles virus Ab [Units/volume] in Serum --2nd specimen |
|
22498-0
|
Measles virus Ab [Titer] in Cerebral spinal fluid |
|
9565-3
|
Measles virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22499-8
|
Measles virus Ab [Titer] in Serum |
|
5243-1
|
Measles virus Ab [Titer] in Serum by Complement fixation |
|
41501-8
|
Measles virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
31875-8
|
Measles virus Ag [Presence] in Cerebral spinal fluid |
|
14534-2
|
Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31876-6
|
Measles virus Ag [Presence] in Cervix |
|
14540-9
|
Measles virus Ag [Presence] in Cervix by Immunofluorescence |
|
31877-4
|
Measles virus Ag [Presence] in Eye |
|
14537-5
|
Measles virus Ag [Presence] in Eye by Immunofluorescence |
|
67806-0
|
Measles virus Ag [Presence] in Isolate by Immunofluorescence |
|
31879-0
|
Measles virus Ag [Presence] in Nose |
|
14538-3
|
Measles virus Ag [Presence] in Nose by Immunofluorescence |
|
31880-8
|
Measles virus Ag [Presence] in Penis |
|
14543-3
|
Measles virus Ag [Presence] in Penis by Immunofluorescence |
|
31881-6
|
Measles virus Ag [Presence] in Serum or Plasma |
|
13328-0
|
Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence |
|
31882-4
|
Measles virus Ag [Presence] in Skin |
|
14536-7
|
Measles virus Ag [Presence] in Skin by Immunofluorescence |
|
31883-2
|
Measles virus Ag [Presence] in Sputum |
|
14539-1
|
Measles virus Ag [Presence] in Sputum by Immunofluorescence |
|
31884-0
|
Measles virus Ag [Presence] in Throat |
|
14535-9
|
Measles virus Ag [Presence] in Throat by Immunofluorescence |
|
31885-7
|
Measles virus Ag [Presence] in Urine sediment |
|
14542-5
|
Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
|
31886-5
|
Measles virus Ag [Presence] in Urethra |
|
14544-1
|
Measles virus Ag [Presence] in Urethra by Immunofluorescence |
|
31878-2
|
Measles virus Ag [Presence] in Vaginal fluid |
|
14541-7
|
Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31887-3
|
Measles virus Ag [Presence] in Unspecified specimen |
|
12232-5
|
Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30939-3
|
Measles virus dose count in combination vaccine |
|
60422-3
|
Measles virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
17554-7
|
Measles virus IgA Ab [Units/volume] in Serum |
|
25299-9
|
Measles virus IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
9566-1
|
Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
41132-2
|
Measles virus IgG Ab [Presence] in Cerebral spinal fluid |
|
40648-8
|
Measles virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
22500-3
|
Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
74418-5
|
Measles virus IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
53536-9
|
Measles virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29242-5
|
Measles virus IgG Ab [Units/volume] in Body fluid |
|
5244-9
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
20479-2
|
Measles virus IgG Ab [Presence] in Serum |
|
35275-7
|
Measles virus IgG Ab [Presence] in Serum by Immunoassay |
|
7962-4
|
Measles virus IgG Ab [Units/volume] in Serum |
|
14304-0
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
22503-7
|
Measles virus IgG Ab [Units/volume] in Serum --1st specimen |
|
14305-7
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22504-5
|
Measles virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
22501-1
|
Measles virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21500-4
|
Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22502-9
|
Measles virus IgG Ab [Titer] in Serum |
|
21501-2
|
Measles virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
44011-5
|
Measles virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
|
44012-3
|
Measles virus IgG and IgM [Interpretation] in Serum |
|
40649-6
|
Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
74417-7
|
Measles virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13283-7
|
Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
74416-9
|
Measles virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
53537-7
|
Measles virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
25421-9
|
Measles virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
21503-8
|
Measles virus IgM Ab [Presence] in Serum |
|
35276-5
|
Measles virus IgM Ab [Presence] in Serum by Immunoassay |
|
7963-2
|
Measles virus IgM Ab [Units/volume] in Serum |
|
22505-2
|
Measles virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21502-0
|
Measles virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22506-0
|
Measles virus IgM Ab [Titer] in Serum |
|
5245-6
|
Measles virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
91780-7
|
Measles virus [Presence] in Lower respiratory specimen by Organism specific culture |
|
85798-7
|
Measles virus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86575-8
|
Measles virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91132-1
|
Measles virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
7964-0
|
Measles virus RNA [Presence] in Nose by NAA with probe detection |
|
86576-6
|
Measles virus RNA [Presence] in Serum by NAA with probe detection |
|
91077-8
|
Measles virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86577-4
|
Measles virus RNA [Presence] in Urine by NAA with probe detection |
|
48508-6
|
Measles virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91786-4
|
Measles virus [Presence] in Upper respiratory specimen by Organism specific culture |
|
76626-1
|
Measles virus [Presence] in Unspecified specimen by Organism specific culture |
|
88876-8
|
Measles virus genotype A vaccine strain N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
88875-0
|
Measles virus genotype A vaccine strain N gene [Presence] in Unspecified specimen by NAA with probe detection |
|
13778-6
|
Mevalonate/Creatinine [Mass Ratio] in Urine |
|
25118-1
|
Mevalonate/Creatinine [Molar ratio] in Urine |
|
48145-7
|
Mevalonolactone/Creatinine [Molar ratio] in Urine |
|
31173-8
|
Mevinphos [Mass/volume] in Blood |
|
35483-7
|
Mevinphos [Mass/volume] in Serum or Plasma |
|
21388-4
|
Mevinphos [Mass/volume] in Urine |
|
87630-0
|
Mevinphos [Mass/mass] in Unspecified specimen |
|
87631-8
|
Mexacarbate [Mass/mass] in Unspecified specimen |
|
7491-4
|
Mexican Firebush IgE Ab [Units/volume] in Serum |
|
6847-8
|
Mexican tea IgE Ab [Units/volume] in Serum |
|
15844-4
|
Mexican tea IgE Ab RAST class [Presence] in Serum |
|
4332-3
|
Mexiletine [Mass] of Dose |
|
29222-7
|
Mexiletine [Mass/volume] in Body fluid |
|
29336-5
|
Mexiletine [Mass/volume] in Gastric fluid |
|
59933-2
|
Mexiletine [Moles/volume] in Gastric fluid |
|
40780-9
|
Mexiletine [Mass/volume] in Serum or Plasma --peak |
|
13567-3
|
Mexiletine [Presence] in Serum or Plasma |
|
3819-0
|
Mexiletine [Mass/volume] in Serum or Plasma |
|
32098-6
|
Mexiletine [Moles/volume] in Serum or Plasma |
|
40779-1
|
Mexiletine [Mass/volume] in Serum or Plasma --trough |
|
29335-7
|
Mexiletine [Mass/volume] in Urine |
|
59932-4
|
Mexiletine [Moles/volume] in Urine |
|
60318-3
|
Mexiletine [Moles/volume] in Unspecified specimen |
|
4333-1
|
Mezlocillin [Mass] of Dose |
|
41702-2
|
Mezlocillin [Susceptibility] by Gradient strip |
|
332-7
|
Mezlocillin [Susceptibility] by Disk diffusion (KB) |
|
331-9
|
Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
330-1
|
Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3820-8
|
Mezlocillin [Mass/volume] in Serum or Plasma |
|
18947-2
|
Mezlocillin [Susceptibility] |
|
333-5
|
Mezlocillin [Susceptibility] by Serum bactericidal titer |
|
54196-1
|
Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54195-3
|
Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54194-6
|
Mezlocillin+Sulbactam [Susceptibility] |
|
6668-8
|
Microscopic observation [Identifier] in Tissue by M'Fadyean stain |
|
668-4
|
Microscopic observation [Identifier] in Unspecified specimen by M'Fadyean stain |
|
38920-5
|
MFN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38904-9
|
MFN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1220-3
|
Mg Ab [Presence] in Serum or Plasma from Blood product unit |
|
1221-1
|
Mg Ab [Presence] in Serum or Plasma from Donor |
|
1222-9
|
Mg Ab [Presence] in Serum or Plasma |
|
1223-7
|
Mg Ag [Presence] on Red Blood Cells from Blood product unit |
|
1224-5
|
Mg Ag [Presence] on Red Blood Cells from Donor |
|
1225-2
|
Mg Ag [Presence] on Red Blood Cells |
|
36319-2
|
MG Breast 4 Views |
|
36962-9
|
MG Breast Axillary |
|
69268-1
|
MG Breast duct Single view W contrast intra duct |
|
39054-2
|
MG Breast duct Views W contrast intra duct |
|
39148-2
|
MG Breast duct Views W contrast intra multiple ducts |
|
46352-1
|
MG Breast duct Views during surgery W contrast intra duct |
|
38095-6
|
MG Breast duct - bilateral Views W contrast intra duct |
|
39146-6
|
MG Breast duct - bilateral Views W contrast intra multiple ducts |
|
49510-1
|
MG Breast duct - left Single view W contrast intra duct |
|
38096-4
|
MG Breast duct - left Views W contrast intra duct |
|
39145-8
|
MG Breast duct - left Views W contrast intra multiple ducts |
|
49509-3
|
MG Breast duct - right Single view W contrast intra duct |
|
38825-6
|
MG Breast duct - right Views W contrast intra duct |
|
39147-4
|
MG Breast duct - right Views W contrast intra multiple ducts |
|
24605-8
|
MG Breast Diagnostic |
|
86367-0
|
MG Breast Diagnostic for clinical call back |
|
86370-4
|
MG Breast Diagnostic for technical call back |
|
24606-6
|
MG Breast Screening |
|
24597-7
|
MG Breast specimen Views |
|
38079-0
|
MG Breast specimen - bilateral Views |
|
38080-8
|
MG Breast specimen - left Views |
|
38821-5
|
MG Breast specimen - right Views |
|
37028-8
|
MG Breast Tangential |
|
37037-9
|
MG Breast True lateral |
|
36625-2
|
MG Breast Views |
|
24604-1
|
MG Breast Diagnostic Limited Views |
|
38070-9
|
MG Breast Views for implant |
|
37539-4
|
MG Breast Grid Views |
|
24610-8
|
MG Breast Limited Views |
|
37542-8
|
MG Breast Magnification Views |
|
69251-7
|
MG Breast Views Post Wire Placement |
|
37551-9
|
MG Breast Spot Views |
|
42680-9
|
MG Breast XCCL |
|
46335-6
|
MG Breast - bilateral Single view |
|
26346-7
|
MG Breast - bilateral Diagnostic |
|
48475-8
|
MG Breast - bilateral Diagnostic for implant |
|
37554-3
|
MG Breast - bilateral Magnification and Spot |
|
37006-4
|
MG Breast - bilateral MLO |
|
86416-5
|
MG Breast - bilateral Guidance for needle localization and Breast specimen Views |
|
26175-0
|
MG Breast - bilateral Screening |
|
48492-3
|
MG Breast - bilateral Screening for implant |
|
37029-6
|
MG Breast - bilateral Tangential |
|
37038-7
|
MG Breast - bilateral True lateral |
|
36626-0
|
MG Breast - bilateral Views |
|
38090-7
|
MG Breast - bilateral Air gap Views |
|
26349-1
|
MG Breast - bilateral Diagnostic Limited Views |
|
38071-7
|
MG Breast - bilateral Views for implant |
|
26287-3
|
MG Breast - bilateral Limited Views |
|
37543-6
|
MG Breast - bilateral Magnification Views |
|
42415-0
|
MG Breast - bilateral Views Post Wire Placement |
|
37016-3
|
MG Breast - bilateral Rolled Views |
|
37552-7
|
MG Breast - bilateral Spot Views |
|
46351-3
|
MG Breast - bilateral Displacement Views for Implant |
|
37052-8
|
MG Breast - bilateral XCCL |
|
46336-4
|
MG Breast - left Single view |
|
36642-7
|
MG Breast - left 2 Views |
|
26347-5
|
MG Breast - left Diagnostic |
|
86368-8
|
MG Breast - left Diagnostic for clinical call back |
|
69150-1
|
MG Breast - left Diagnostic for implant |
|
37005-6
|
MG Breast - left Magnification |
|
38854-6
|
MG Breast - left Magnification and Spot |
|
86348-0
|
MG Breast - left Guidance for needle localization and Breast specimen Views |
|
26176-8
|
MG Breast - left Screening |
|
37030-4
|
MG Breast - left Tangential |
|
38855-3
|
MG Breast - left True lateral |
|
36627-8
|
MG Breast - left Views |
|
38091-5
|
MG Breast - left Air gap Views |
|
26350-9
|
MG Breast - left Diagnostic Limited Views |
|
38072-5
|
MG Breast - left Views for implant |
|
26289-9
|
MG Breast - left Limited Views |
|
42416-8
|
MG Breast - left Views Post Wire Placement |
|
37017-1
|
MG Breast - left Rolled Views |
|
37553-5
|
MG Breast - left Spot Views compression |
|
37053-6
|
MG Breast - left XCCL |
|
46337-2
|
MG Breast - right Single view |
|
37768-9
|
MG Breast - right 2 Views |
|
26348-3
|
MG Breast - right Diagnostic |
|
86369-6
|
MG Breast - right Diagnostic for clinical call back |
|
69259-0
|
MG Breast - right Diagnostic for implant |
|
37773-9
|
MG Breast - right Magnification |
|
37769-7
|
MG Breast - right Magnification and Spot |
|
86360-5
|
MG Breast - right Guidance for needle localization and Breast specimen Views |
|
26177-6
|
MG Breast - right Screening |
|
37770-5
|
MG Breast - right Tangential |
|
37771-3
|
MG Breast - right True lateral |
|
37774-7
|
MG Breast - right Views |
|
26351-7
|
MG Breast - right Diagnostic Limited Views |
|
38820-7
|
MG Breast - right Views for implant |
|
26291-5
|
MG Breast - right Limited Views |
|
37775-4
|
MG Breast - right Rolled Views |
|
38807-4
|
MG Breast - right Spot Views |
|
37772-1
|
MG Breast - right XCCL |
|
46338-0
|
MG Breast - unilateral Single view |
|
86350-6
|
MG Breast - unilateral Single view for clip placement |
|
46350-5
|
MG Breast - unilateral Diagnostic |
|
46356-2
|
MG Breast - unilateral Screening |
|
46339-8
|
MG Breast - unilateral Views |
|
46380-2
|
MG Breast - unilateral Views for implant |
|
24602-5
|
MG Guidance for biopsy of Breast |
|
24594-4
|
MG Guidance for aspiration of cyst of Breast |
|
46387-7
|
MG Guidance for fine needle aspiration of Breast |
|
48735-5
|
MG Guidance for localization of Breast |
|
24595-1
|
MG Guidance for needle localization of mass of Breast |
|
24609-0
|
MG Guidance for percutaneous biopsy.core needle of Breast |
|
24598-5
|
MG Guidance for fluid aspiration of Breast |
|
48740-5
|
MG Guidance for sentinel lymph node injection of Breast |
|
26337-6
|
MG Guidance for biopsy of Breast - bilateral |
|
26343-4
|
MG Guidance for aspiration of cyst of Breast - bilateral |
|
69068-5
|
MG Guidance for needle localization of Breast - bilateral |
|
26315-2
|
MG Guidance for needle localization of mass of Breast - bilateral |
|
26334-3
|
MG Guidance for percutaneous biopsy.core needle of Breast - bilateral |
|
26338-4
|
MG Guidance for biopsy of Breast - left |
|
86353-0
|
MG Guidance for placement of clip in Breast - left |
|
26344-2
|
MG Guidance for aspiration of cyst of Breast - left |
|
86351-4
|
MG Guidance for additional aspiration of cyst of Breast - left |
|
46284-6
|
MG Guidance for fine needle aspiration of Breast - left |
|
42296-4
|
MG Guidance for localization of Breast - left |
|
86357-1
|
MG Guidance for needle localization of Breast - left |
|
86355-5
|
MG Guidance for additional needle localization of Breast - left |
|
26316-0
|
MG Guidance for needle localization of mass of Breast - left |
|
26335-0
|
MG Guidance for percutaneous biopsy.core needle of Breast - left |
|
48736-3
|
MG Guidance for sentinel lymph node injection of Breast - left |
|
86365-4
|
MG Guidance for vacuum biopsy of Breast - left |
|
86363-9
|
MG Guidance for additional vacuum biopsy of Breast - left |
|
26339-2
|
MG Guidance for biopsy of Breast - right |
|
86354-8
|
MG Guidance for placement of clip in Breast - right |
|
26345-9
|
MG Guidance for aspiration of cyst of Breast - right |
|
86352-2
|
MG Guidance for additional aspiration of cyst of Breast - right |
|
46283-8
|
MG Guidance for fine needle aspiration of Breast - right |
|
42297-2
|
MG Guidance for localization of Breast - right |
|
86358-9
|
MG Guidance for needle localization of Breast - right |
|
86356-3
|
MG Guidance for additional needle localization of Breast - right |
|
26317-8
|
MG Guidance for needle localization of mass of Breast - right |
|
26336-8
|
MG Guidance for percutaneous biopsy.core needle of Breast - right |
|
48739-7
|
MG Guidance for sentinel lymph node injection of Breast - right |
|
86366-2
|
MG Guidance for vacuum biopsy of Breast - right |
|
86364-7
|
MG Guidance for additional vacuum biopsy of Breast - right |
|
73573-8
|
Magnesium Ionized [Moles/volume] adjusted to pH 7.4 in Blood by Ion-selective membrane electrode (ISE) |
|
73572-0
|
Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) |
|
32698-3
|
Magnesium Ionized [Mass/volume] in Serum or Plasma |
|
2600-5
|
Magnesium Ionized [Moles/volume] in Serum or Plasma |
|
10793-8
|
Microscopic observation [Identifier] in Tissue by Methyl green stain |
|
24603-3
|
MG stereo Guidance for biopsy of Breast |
|
46296-0
|
MG stereo Guidance for percutaneous biopsy.core needle of Breast |
|
26292-3
|
MG stereo Guidance for biopsy of Breast - bilateral |
|
26293-1
|
MG stereo Guidance for biopsy of Breast - left |
|
86361-3
|
MG stereo Guidance for additional biopsy of Breast - left |
|
46295-2
|
MG stereo Guidance for percutaneous biopsy.core needle of Breast - left |
|
26294-9
|
MG stereo Guidance for biopsy of Breast - right |
|
86362-1
|
MG stereo Guidance for additional biopsy of Breast - right |
|
42433-3
|
MG stereo Guidance for percutaneous biopsy.core needle of Breast - right |
|
93500-7
|
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93498-4
|
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
93501-5
|
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93499-2
|
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
60252-4
|
MGMT gene methylation [Presence] in Tissue by Molecular genetics method |
|
64083-9
|
MGMT gene methylation score in Tissue by Molecular genetics method |
|
10794-6
|
Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |
|
83704-7
|
Mental health Attending Note |
|
75427-5
|
Mental health Case manager Note |
|
84197-3
|
Mental health Custodial care facility Plan of care note |
|
84204-7
|
Mental health Interdisciplinary Note |
|
84217-9
|
Mental health Interdisciplinary Plan of care note |
|
83784-9
|
Mental health Physician Note |
|
83547-0
|
Mental health Nurse practitioner Note |
|
83628-8
|
Mental health Nurse Admission evaluation note |
|
83629-6
|
Mental health Nurse Custodial care facility Note |
|
83630-4
|
Mental health Nurse Group counseling note |
|
83631-2
|
Mental health Nurse Hospital Note |
|
83632-0
|
Mental health Nurse Long term care facility Note |
|
83633-8
|
Mental health Nurse Medication management note |
|
75459-8
|
Mental health Nurse Note |
|
83634-6
|
Mental health Nurse Outpatient Note |
|
83635-3
|
Mental health Nurse Plan of care note |
|
85879-5
|
Mental health Nurse Restraint note |
|
83636-1
|
Mental health Nurse Triage note |
|
83747-6
|
Mental health Physician assistant Note |
|
83761-7
|
Mental health Resident Note |
|
94015-5
|
Mental health screening report |
|
90754-3
|
Mental health Social worker Note |
|
84212-0
|
Mental health Team Conference note |
|
84213-8
|
Mental health Team Consult note |
|
84214-6
|
Mental health Team Note |
|
8611-6
|
Myocardial infarction age by EKG |
|
78926-3
|
Myocardial infarction in past 24 hours |
|
1235-1
|
Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1236-9
|
Mi sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1237-7
|
Mi sup(a) Ab [Presence] in Serum or Plasma |
|
1232-8
|
Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1233-6
|
Mi sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1234-4
|
Mi sup(a) Ag [Presence] on Red Blood Cells |
|
59402-8
|
Mi-1+Mi-2 Ab [Titer] in Serum by Immunofluorescence |
|
63276-0
|
Mi-2 Ab [Presence] in Body fluid by Immunoassay |
|
56637-2
|
Mi-2 Ab [Units/volume] in Serum by Immunoassay |
|
18485-3
|
Mi-2 Ab [Presence] in Serum |
|
56743-8
|
Mi-2 Ab [Presence] in Serum by Immunoblot |
|
88732-3
|
Mi-2 alpha Ab [Units/volume] in Serum by Line blot |
|
82997-8
|
Mi-2 alpha IgG Ab [Presence] in Serum by Line blot |
|
88733-1
|
Mi-2 beta Ab [Units/volume] in Serum by Line blot |
|
82996-0
|
Mi-2 beta IgG Ab [Presence] in Serum by Line blot |
|
70051-8
|
Multiple inhalant allergen IgE Ab [Presence] in Serum by Immunoassay |
|
7492-2
|
Multiple inhalant allergen IgE Ab [Units/volume] in Serum |
|
13012-0
|
Methyl isoamyl ketone [Mass/volume] in Blood |
|
31166-2
|
Methyl isoamyl ketone [Mass/volume] in Urine |
|
2635-1
|
Mianserin [Mass/volume] in Serum or Plasma |
|
25721-2
|
Mianserin [Moles/volume] in Serum or Plasma |
|
72669-5
|
Mianserin [Mass/volume] in Serum or Plasma --trough |
|
2636-9
|
Mianserin [Mass/volume] in Urine |
|
34341-8
|
Mianserin+Normianserin [Mass/volume] in Serum or Plasma |
|
38611-0
|
Methyl isobutyl ketone [Mass/volume] in Air |
|
13013-8
|
Methyl isobutyl ketone [Mass/volume] in Blood |
|
17269-2
|
Methyl isobutyl ketone [Mass/volume] in Urine |
|
58006-8
|
Mibolerone [Presence] in Urine |
|
74346-8
|
MICA*001 IgG Ab [Presence] in Serum |
|
74345-0
|
MICA*002 IgG Ab [Presence] in Serum |
|
74344-3
|
MICA*004 IgG Ab [Presence] in Serum |
|
74343-5
|
MICA*005 IgG Ab [Presence] in Serum |
|
74342-7
|
MICA*006 IgG Ab [Presence] in Serum |
|
74341-9
|
MICA*007 IgG Ab [Presence] in Serum |
|
74340-1
|
MICA*008 IgG Ab [Presence] in Serum |
|
74339-3
|
MICA*009 IgG Ab [Presence] in Serum |
|
74338-5
|
MICA*011 IgG Ab [Presence] in Serum |
|
74337-7
|
MICA*012 IgG Ab [Presence] in Serum |
|
74336-9
|
MICA*015 IgG Ab [Presence] in Serum |
|
74335-1
|
MICA*016 IgG Ab [Presence] in Serum |
|
74334-4
|
MICA*017 IgG Ab [Presence] in Serum |
|
74333-6
|
MICA*018 IgG Ab [Presence] in Serum |
|
74332-8
|
MICA*019 IgG Ab [Presence] in Serum |
|
74331-0
|
MICA*024 IgG Ab [Presence] in Serum |
|
74330-2
|
MICA*028 IgG Ab [Presence] in Serum |
|
74329-4
|
MICA*029 IgG Ab [Presence] in Serum |
|
74328-6
|
MICA*030 IgG Ab [Presence] in Serum |
|
74327-8
|
MICA*033 IgG Ab [Presence] in Serum |
|
74326-0
|
MICA*036 IgG Ab [Presence] in Serum |
|
74325-2
|
MICA*037 IgG Ab [Presence] in Serum |
|
74324-5
|
MICA*041 IgG Ab [Presence] in Serum |
|
74323-7
|
MICA*042 IgG Ab [Presence] in Serum |
|
74322-9
|
MICA*043 IgG Ab [Presence] in Serum |
|
74321-1
|
MICA*046 IgG Ab [Presence] in Serum |
|
74320-3
|
MICA*050 IgG Ab [Presence] in Serum |
|
74319-5
|
MICA*051 IgG Ab [Presence] in Serum |
|
85048-7
|
Micafungin [Susceptibility] by Gradient strip |
|
53812-4
|
Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58418-5
|
Micafungin [Mass/volume] in Serum or Plasma |
|
65340-2
|
Micafungin [Susceptibility] |
|
55686-0
|
Miconazole [Susceptibility] by Gradient strip |
|
54180-5
|
Miconazole [Susceptibility] by Disk diffusion (KB) |
|
25722-0
|
Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
17278-3
|
Miconazole [Mass/volume] in Serum or Plasma |
|
25607-3
|
Miconazole [Susceptibility] |
|
33270-0
|
Microscopic observation [Identifier] in Buffy Coat by Light microscopy |
|
93789-6
|
Time to microorganism growth detection in Specimen |
|
92251-8
|
Microorganism gene detected [Presence] by Molecular method |
|
92250-0
|
Microorganism gene target region [Type] by Molecular method |
|
72375-9
|
Microscopic method - Urine |
|
92248-4
|
Microorganism resistance mutation amino acid change by Molecular method |
|
92247-6
|
Microorganism resistance mutation amino acid change type by Molecular method |
|
92246-8
|
Microorganism resistance mutation detected [Presence] by Molecular method |
|
92245-0
|
Microorganism resistance mutation nucleic acid change by Molecular method |
|
92244-3
|
Microorganism resistance mutation nucleic acid change type by Molecular method |
|
12235-8
|
Microscopic observation [Identifier] in Urine sediment by Light microscopy |
|
49023-5
|
Microalbumin [Mass/time] in Urine collected for unspecified duration |
|
57369-1
|
Microalbumin [Mass/volume] in 12 hour Urine |
|
43607-1
|
Microalbumin [Mass/time] in 12 hour Urine |
|
63474-1
|
Microalbumin [Mass/time] in 18 hour Urine |
|
47558-2
|
Microalbumin/Protein.total in 24 hour Urine |
|
53530-2
|
Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L |
|
53532-8
|
Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L |
|
90000-1
|
Albumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L |
|
30003-8
|
Microalbumin [Mass/volume] in 24 hour Urine |
|
14956-7
|
Microalbumin [Mass/time] in 24 hour Urine |
|
43605-5
|
Microalbumin [Mass/volume] in 4 hour Urine |
|
43606-3
|
Microalbumin [Mass/time] in 4 hour Urine |
|
56553-1
|
Microalbumin [Mass/time] in 8 hour Urine |
|
53529-4
|
Microalbumin [Mass/volume] in Body fluid by Detection limit <= 1.0 mg/L |
|
58448-2
|
Microalbumin ug/min [Mass/time] in 24 hour Urine |
|
53531-0
|
Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L |
|
89999-7
|
Albumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L |
|
77158-4
|
Albumin [Moles/volume] in Urine by Detection limit <= 3.0 mg/L |
|
11218-5
|
Microalbumin [Mass/volume] in Urine by Test strip |
|
14957-5
|
Microalbumin [Mass/volume] in Urine |
|
44292-1
|
Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine |
|
14958-3
|
Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine |
|
77254-1
|
Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L |
|
59159-4
|
Microalbumin/Creatinine [Ratio] in 24 hour Urine |
|
14959-1
|
Microalbumin/Creatinine [Mass Ratio] in Urine |
|
77253-3
|
Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L |
|
89998-9
|
Albumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L |
|
30001-2
|
Microalbumin/Creatinine [Ratio] in Urine by Test strip |
|
30000-4
|
Microalbumin/Creatinine [Ratio] in Urine |
|
62375-1
|
Microarray platform [Identifier] Narrative |
|
62376-9
|
Microarray platform version number Narrative |
|
59464-8
|
Microbiologist review of results |
|
92779-8
|
Micrococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
44692-2
|
Microcalcifications in Breast tumor |
|
30434-5
|
Microcytes [Presence] in Blood |
|
15199-3
|
Microcytes [Presence] in Blood by Automated count |
|
741-9
|
Microcytes [Presence] in Blood by Light microscopy |
|
18422-6
|
Microcytes [Presence] in Urine by Light microscopy |
|
53969-2
|
Microcytes [Presence] in Urine sediment by Light microscopy |
|
74761-8
|
Microcytes/100 erythrocytes in Blood |
|
49028-4
|
Microdeletion syndromes [Identifier] in Blood or Tissue by FISH Nominal |
|
50020-7
|
Microdeletion syndromes in Blood or Tissue by FISH |
|
49063-1
|
Microdeletion syndromes in Unspecified specimen by FISH Nominal |
|
62857-8
|
Micromegakaryocytes [#/volume] in Blood by Manual count |
|
51645-0
|
Micromegakaryocytes [Presence] in Blood by Light microscopy |
|
62858-6
|
Micromegakaryocytes/100 leukocytes in Blood by Manual count |
|
81202-4
|
Micronutrient form Narrative |
|
90426-8
|
Microorganism preliminary growth [Presence] in Blood by Aerobic culture with antimicrobial neutralizer |
|
90427-6
|
Microorganism preliminary growth [Presence] in Blood by Anaerobic culture with antimicrobial neutralizer |
|
90428-4
|
Microorganism preliminary growth [Presence] in Body fluid by Aerobic culture with antimicrobial neutralizer |
|
90431-8
|
Microorganism preliminary growth [Presence] in Body fluid by Anaerobic culture with antimicrobial neutralizer |
|
90435-9
|
Microorganism preliminary growth [Presence] in Blood by Aerobe culture |
|
90437-5
|
Microorganism preliminary growth [Presence] in Blood by Anaerobe culture |
|
90424-3
|
Microorganism preliminary growth detection panel - Body fluid by Culture |
|
90429-2
|
Microorganism preliminary growth [Presence] in Body fluid by Aerobe culture |
|
90430-0
|
Microorganism preliminary growth [Presence] in Body fluid by Anaerobe culture |
|
90436-7
|
Microorganism preliminary growth [Presence] in Body fluid by Organism specific culture |
|
90434-2
|
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Aerobe culture |
|
90432-6
|
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Anaerobe culture |
|
43161-9
|
Microorganism [#/volume] in Unspecified specimen by Viability count |
|
49034-2
|
Microorganism identified in Cervical or vaginal smear or scraping by Cyto stain |
|
92249-2
|
Microorganism gene tested for [Identifier] by Molecular method |
|
89248-9
|
Microorganism identified event index case |
|
76346-6
|
Microorganism identified in Isolate by MS.MALDI-TOF |
|
92253-4
|
Microorganism identified in Isolate or Specimen by Molecular genetics method |
|
92243-5
|
Microorganism resistance mutation tested for by Molecular method |
|
11475-1
|
Microorganism identified in Unspecified specimen by Culture |
|
41852-5
|
Microorganism or agent identified in Unspecified specimen |
|
58437-5
|
Microorganisms seen [Type] in Urine sediment by Light microscopy |
|
75712-0
|
Microscopic description [Description] in Endomyocardium Narrative |
|
57764-3
|
Microscopic exam [Interpretation] of Bone marrow by Cytology |
|
11553-5
|
Microscopic exam [Interpretation] of Sputum by Cytology |
|
11552-7
|
Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology |
|
27045-4
|
Microscopic exam [Interpretation] of Urine by Cytology |
|
88160-7
|
Microsporidia DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88925-3
|
Microsporidia DNA [Presence] in Stool by NAA with probe detection |
|
88924-6
|
Microsporidia DNA [Presence] in Tissue by NAA with probe detection |
|
10690-6
|
Microsporidia identified in Duodenal fluid by Trichrome stain modified |
|
32701-5
|
Microsporidia identified in Stool by Trichrome stain modified |
|
32819-5
|
Microsporidia identified in Stool by Trichrome stain |
|
10857-1
|
Microsporidia identified in Unspecified specimen by Light microscopy |
|
51634-4
|
Reticulocytes.mid [#/volume] in Blood |
|
34420-0
|
Reticulocytes.mid/Reticulocytes.total in Blood |
|
82592-7
|
Reticulocytes.mid light scatter/Reticulocytes.total in Blood by Automated count |
|
59708-8
|
Midazolam [Mass/volume] in Blood by Confirmatory method |
|
59707-0
|
Midazolam [Mass/volume] in Blood |
|
19590-9
|
Midazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19589-1
|
Midazolam cutoff [Mass/volume] in Urine for Screen method |
|
4334-9
|
Midazolam [Mass] of Dose |
|
59710-4
|
Midazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59709-6
|
Midazolam [Mass/volume] in Body fluid |
|
26802-9
|
Midazolam [Mass/mass] in Hair |
|
73269-3
|
Midazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73268-5
|
Midazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27302-9
|
Midazolam [Mass/mass] in Meconium |
|
87814-0
|
Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59711-2
|
Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3821-6
|
Midazolam [Mass/volume] in Serum or Plasma |
|
15109-2
|
Midazolam [Moles/volume] in Serum or Plasma |
|
12440-4
|
Midazolam [Presence] in Stool |
|
27288-0
|
Midazolam [Mass/mass] in Stool |
|
59713-8
|
Midazolam [Mass/mass] in Tissue by Confirmatory method |
|
59712-0
|
Midazolam [Mass/mass] in Tissue |
|
16233-9
|
Midazolam [Mass/volume] in Urine by Confirmatory method |
|
19586-7
|
Midazolam [Presence] in Urine by Confirmatory method |
|
19585-9
|
Midazolam [Presence] in Urine by Screen method |
|
19588-3
|
Midazolam [Mass/volume] in Urine |
|
74381-5
|
Midazolam [Mass/volume] in Unknown substance |
|
26899-5
|
Midazolam [Mass/volume] in Vitreous fluid |
|
48958-3
|
Midazolam [Mass/volume] in Unspecified specimen |
|
86231-8
|
Midazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
54154-0
|
Midbody Ab [Presence] in Serum by Immunofluorescence |
|
54155-7
|
Midbody Ab [Titer] in Serum by Immunofluorescence |
|
45393-6
|
Middle initial |
|
89550-8
|
Middle name Provider |
|
6253-9
|
Midge stinging IgE Ab [Units/volume] in Serum |
|
44589-0
|
IgA.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation |
|
27019-9
|
IgA.monoclonal [Presence] in Serum |
|
55901-3
|
IgA.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
44587-4
|
IgA.monoclonal [Presence] in Serum by Immunofixation |
|
2459-6
|
IgA.monoclonal [Mass/volume] in Serum |
|
44588-2
|
IgA.monoclonal [Presence] in Urine by Immunofixation |
|
55903-9
|
IgD.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
2461-2
|
IgD.monoclonal [Mass/volume] in Serum |
|
55904-7
|
IgE.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
2463-8
|
IgE.monoclonal [Mass/volume] in Serum |
|
44599-9
|
IgG.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation |
|
27018-1
|
IgG.monoclonal [Presence] in Serum |
|
55921-1
|
IgG.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
44597-3
|
IgG.monoclonal [Presence] in Serum by Immunofixation |
|
26814-4
|
IgG.monoclonal [Mass/volume] in Serum |
|
44598-1
|
IgG.monoclonal [Presence] in Urine by Immunofixation |
|
44603-9
|
IgM.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation |
|
27020-7
|
IgM.monoclonal [Presence] in Serum |
|
55924-5
|
IgM.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
44601-3
|
IgM.monoclonal [Presence] in Serum by Immunofixation |
|
2473-7
|
IgM.monoclonal [Mass/volume] in Serum |
|
44602-1
|
IgM.monoclonal [Presence] in Urine by Immunofixation |
|
7493-0
|
Milk evaporated IgE Ab [Units/volume] in Serum |
|
6174-7
|
Milk IgE Ab [Units/volume] in Serum |
|
15846-9
|
Milk IgE Ab RAST class [Presence] in Serum |
|
10941-3
|
Milk powder IgE Ab [Units/volume] in Serum |
|
15848-5
|
Milk powder IgE Ab RAST class [Presence] in Serum |
|
59310-3
|
Milnacipran [Mass/volume] in Blood |
|
59311-1
|
Milnacipran [Mass/volume] in Serum or Plasma |
|
59312-9
|
Milnacipran [Mass/volume] in Urine |
|
87788-6
|
Milnacipran/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73266-9
|
Milrinone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73267-7
|
Milrinone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6176-2
|
Mimosa IgE Ab [Units/volume] in Serum |
|
76250-0
|
Minimum expiratory pressure Respiratory system airway |
|
76251-8
|
Minimum inspiratory pressure Respiratory system airway |
|
1255-9
|
Minor crossmatch [Interpretation] |
|
10943-9
|
Mink epithelium IgE Ab [Units/volume] in Serum |
|
15852-7
|
Mink epithelium IgE Ab RAST class [Presence] in Serum |
|
25225-4
|
Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
34606-4
|
Minocycline [Mass/volume] in Cerebral spinal fluid |
|
4335-6
|
Minocycline [Mass] of Dose |
|
73265-1
|
Minocycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73264-4
|
Minocycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7032-6
|
Minocycline [Susceptibility] by Gradient strip |
|
336-8
|
Minocycline [Susceptibility] by Disk diffusion (KB) |
|
335-0
|
Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
334-3
|
Minocycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
55156-4
|
Minocycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
3822-4
|
Minocycline [Mass/volume] in Serum or Plasma |
|
18948-0
|
Minocycline [Susceptibility] |
|
337-6
|
Minocycline [Susceptibility] by Serum bactericidal titer |
|
49757-8
|
Minocycline [Mass/volume] in Unspecified specimen |
|
73263-6
|
Minoxidil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73262-8
|
Minoxidil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17282-5
|
Minoxidil [Mass/volume] in Serum or Plasma |
|
11190-6
|
Mint IgE Ab [Units/volume] in Serum |
|
15853-5
|
Mint IgE Ab RAST class [Presence] in Serum |
|
70956-8
|
Minutes of hemodialysis completed when BUN drawn [ESRD] |
|
55687-8
|
Miocamycin [Susceptibility] by Gradient strip |
|
340-0
|
Miocamycin [Susceptibility] by Disk diffusion (KB) |
|
339-2
|
Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
338-4
|
Miocamycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18949-8
|
Miocamycin [Susceptibility] |
|
341-8
|
Miocamycin [Susceptibility] by Serum bactericidal titer |
|
78860-4
|
Mirtazapine cutoff [Mass/volume] in Urine for Confirmatory method |
|
73261-0
|
Mirtazapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73260-2
|
Mirtazapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
47980-8
|
Mirtazapine [Presence] in Serum or Plasma |
|
17283-3
|
Mirtazapine [Mass/volume] in Serum or Plasma |
|
55554-0
|
Mirtazapine [Moles/volume] in Serum or Plasma |
|
72668-7
|
Mirtazapine [Mass/volume] in Serum or Plasma --trough |
|
74812-9
|
Mirtazapine [Presence] in Urine |
|
78859-6
|
Mirtazapine [Presence] in Urine by Confirmatory method |
|
49690-1
|
Mirtazapine [Mass/volume] in Urine |
|
62848-7
|
Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma |
|
83104-0
|
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
|
83105-7
|
Mullerian inhibiting substance [Moles/volume] in Serum or Plasma by Immunoassay |
|
38476-8
|
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma |
|
48377-6
|
Mullerian inhibiting substance [Moles/volume] in Serum or Plasma |
|
44687-2
|
Melanoma in situ.location relative to closest uninvolved lateral margin |
|
44689-8
|
Melanoma in situ.location relative to involved lateral margin |
|
79420-6
|
Miscellaneous allergen IgE Ab [Units/volume] in Serum |
|
33536-4
|
Miscellaneous allergen IgE Ab RAST class [Presence] in Serum |
|
50622-0
|
Miscellaneous allergen IgG Ab [Identifier] in Serum |
|
90861-6
|
Missing teeth [#] |
|
92187-4
|
Mission related to the emergency response activation Narrative |
|
7495-5
|
Mite dust IgE Ab [Units/volume] in Serum |
|
88337-1
|
Mite identified in Ear by Light microscopy |
|
88340-5
|
Mite [Presence] in Ear by Light microscopy |
|
23752-9
|
Mite identified in Skin |
|
23232-2
|
Mite identified in Skin by Flotation |
|
23233-0
|
Mite identified in Skin by Parasite sedimentation |
|
76618-8
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-glutamate substrate |
|
76620-4
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-leucine substrate |
|
76616-2
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-pyruvate substrate |
|
76619-6
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2,3-14C-succinate substrate |
|
76617-0
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2-14C-pyruvate substrate |
|
76624-6
|
Mitochondrial respiratory chain enzyme analysis [Interpretation] in Fibroblast Narrative |
|
63279-4
|
Mitochondria Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63277-8
|
Mitochondria Ab [Presence] in Body fluid by Immunofluorescence |
|
58458-1
|
Mitochondria Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
17285-8
|
Mitochondria Ab [Units/volume] in Serum by Immunofluorescence |
|
14236-4
|
Mitochondria Ab [Presence] in Serum |
|
57413-7
|
Mitochondria Ab [Presence] in Serum by Immunoblot |
|
17284-1
|
Mitochondria Ab [Presence] in Serum by Immunofluorescence |
|
8077-0
|
Mitochondria Ab [Units/volume] in Serum |
|
42522-3
|
Mitochondria Ab [Titer] in Cerebral spinal fluid |
|
63280-2
|
Mitochondria Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63278-6
|
Mitochondria Ab [Titer] in Body fluid by Immunofluorescence |
|
20483-4
|
Mitochondria Ab [Titer] in Serum |
|
5247-2
|
Mitochondria Ab [Titer] in Serum by Immunofluorescence |
|
82840-0
|
Mitochondria IgG Ab [Presence] in Serum by Immunofluorescence |
|
63282-8
|
Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89539-1
|
Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63281-0
|
Mitochondria M2 Ab [Presence] in Body fluid by Immunoassay |
|
51715-1
|
Mitochondria M2 Ab [Units/volume] in Serum by Immunoassay |
|
26054-7
|
Mitochondria M2 Ab [Presence] in Serum |
|
63283-6
|
Mitochondria M2 Ab [Presence] in Serum by Immunoassay |
|
56735-4
|
Mitochondria M2 Ab [Presence] in Serum by Immunoblot |
|
49781-8
|
Mitochondria M2 Ab [Units/volume] in Serum |
|
51794-6
|
Mitochondria M2 Ab [Titer] in Serum by Immunofluorescence |
|
82928-3
|
Mitochondria M2 IgG Ab [Presence] in Serum by Line blot |
|
14251-3
|
Mitochondria M2 IgG Ab [Units/volume] in Serum |
|
56632-3
|
Mitochondria M2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
34411-9
|
Mitochondria M4 Ab [Presence] in Serum |
|
53000-6
|
Mitochondria M4 Ab [Units/volume] in Serum |
|
63284-4
|
Mitochondria M5 Ab [Presence] in Serum by Immunofluorescence |
|
63285-1
|
Mitochondria M5 Ab [Titer] in Serum by Immunofluorescence |
|
34412-7
|
Mitochondria M9 Ab [Presence] in Serum |
|
53001-4
|
Mitochondria M9 Ab [Units/volume] in Serum |
|
71774-4
|
Mitogen stimulated gamma interferon [Units/volume] corrected for background in Blood |
|
71772-8
|
Mitogen stimulated gamma interferon [Units/volume] in Blood |
|
74280-9
|
Mitogen stimulated gamma interferon positive control spot count [#] in Blood |
|
13626-7
|
Mitotane [Mass/volume] in Serum or Plasma |
|
44650-0
|
Mitotic count per 10 HPF in Breast tumor |
|
86669-9
|
Mitotic figures [#/area] in Cancer specimen by Light microscopy |
|
44695-5
|
Mitotic index by CAP cancer protocols |
|
85300-2
|
Mitotic rate [Score] in Breast cancer specimen Qualitative by Nottingham |
|
53004-8
|
Mitotic spindle apparatus Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
34677-5
|
Mitotic spindle apparatus Ab [Titer] in Serum or Plasma |
|
53003-0
|
Mitotic spindle apparatus Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
72732-1
|
Mitragynine [Mass/volume] in Urine by Confirmatory method |
|
73995-3
|
Mitragynine [Presence] in Urine by Confirmatory method |
|
72730-5
|
Mitragynine/Creatinine [Mass Ratio] in Urine |
|
75649-4
|
Mitragynine+7-Hydroxymitragynine [Presence] in Urine by Confirmatory method |
|
48283-6
|
Mivacurium triggered leukotriene release [Mass/volume] by Leukocytes |
|
76239-3
|
Mixed apnea duration Respiratory system |
|
53283-8
|
Mixed cellular casts [#/volume] in Urine by Computer assisted method |
|
53289-5
|
Mixed cellular casts [#/area] in Urine by Computer assisted method |
|
88971-7
|
Mixed cellular casts [#/area] in Urine sediment |
|
53848-8
|
Mixed cellular casts [#/area] in Urine sediment by Microscopy high power field |
|
38995-7
|
Mixed cellular casts [#/area] in Urine sediment by Microscopy low power field |
|
50234-4
|
Mixed cellular casts [Presence] in Urine by Computer assisted method |
|
34173-5
|
Mixed cellular casts [Presence] in Urine sediment by Light microscopy |
|
75510-8
|
aPTT.lupus sensitive with 1:1 PNP (LA mix) |
|
91104-0
|
aPTT.factor sensitive with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assay |
|
75509-0
|
aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix) |
|
75513-2
|
dRVVT with 1:1 PNP (LA mix) |
|
75512-4
|
dRVVT with 1:1 PNP actual/normal (normalized LA mix) |
|
50008-2
|
Mixing studies [Interpretation] in Platelet poor plasma Narrative |
|
82425-0
|
Mj Ab [Units/volume] in Serum by Line blot |
|
82426-8
|
Mj Ab [Presence] in Serum by Line blot |
|
82993-7
|
Mj IgG Ab [Presence] in Serum by Line blot |
|
35377-1
|
MJD gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49647-1
|
MJD gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
35376-3
|
MJD gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49648-9
|
MJD gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21764-6
|
MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
52784-6
|
Maximum lysis [Length fraction] in Blood by Thromboelastography |
|
52786-1
|
Maximum lysis.extrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG |
|
52785-3
|
Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed [Length fraction] in Blood by Rotational TEG |
|
52788-7
|
Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG |
|
52787-9
|
Maximum lysis.intrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG |
|
81841-9
|
MLC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80154-8
|
Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS |
|
50322-7
|
MLH-1 Ag [Presence] in Tissue by Immune stain |
|
92676-6
|
MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
79416-4
|
MLH1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
58416-9
|
MLH1 gene methylation [Presence] in Tissue by Molecular genetics method |
|
41086-0
|
MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38536-9
|
MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79570-8
|
MLH1+MSH2+MSH6+PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
38905-6
|
MLL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
35454-8
|
MLL gene rearrangements in Blood or Tissue by Molecular genetics method |
|
78226-8
|
MLL gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78219-3
|
MLL gene rearrangements [Presence] in Blood or Tissue by FISH |
|
35753-3
|
Mitochondrial myopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41087-8
|
Mitochondrial myopathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35351-6
|
Myotonic dystrophy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41080-3
|
Myotonic dystrophy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82885-5
|
Meta methylhippurate [Moles/volume] in Urine |
|
82886-3
|
Meta methylhippurate/Creatinine [Molar ratio] in Urine |
|
75630-4
|
Interstitial collagenase [Mass/volume] in Serum or Plasma |
|
74102-5
|
Matrix metallopeptidase 2 [Mass/volume] in Serum |
|
75631-2
|
Stromelysin-1 [Mass/volume] in Serum or Plasma |
|
90294-0
|
MMP-9 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
58001-9
|
Matrix metallopeptidase 9 [Mass/volume] in Blood |
|
60243-3
|
Matrix metallopeptidase 9 [Mass/volume] in Serum |
|
30940-1
|
Measles virus+Mumps virus+Rubella virus dose count in combination vaccine |
|
81694-2
|
Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain |
|
81691-8
|
DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain |
|
81692-6
|
DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain |
|
81693-4
|
DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain |
|
77991-8
|
MMWR Week [CDC.PHIN] |
|
77992-6
|
MMWR Year [CDC.PHIN] |
|
13014-6
|
Methyl butyl ketone [Mass/volume] in Blood |
|
31165-4
|
Methyl butyl ketone [Mass/volume] in Urine |
|
13311-6
|
MNS group Ag [Type] on Red Blood Cells |
|
85715-1
|
Month of pregnancy when rubella-like symptoms appeared in Mother |
|
75247-7
|
Mobility [Norton scale] |
|
73787-4
|
Mobility [NSRAS] |
|
86602-0
|
Mobility devices normally used during 7 day assessment period [CMS Assessment] |
|
6475-8
|
Mobiluncus sp rRNA [Presence] in Unspecified specimen by Probe |
|
74941-6
|
Moclobemide [Mass/volume] in Serum or Plasma |
|
34413-5
|
Moclobemide [Moles/volume] in Serum or Plasma |
|
74940-8
|
Moclobemide [Mass/volume] in Serum or Plasma --trough |
|
10818-3
|
Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |
|
51985-0
|
Modafinil [Mass/volume] in Serum or Plasma |
|
88664-8
|
Mode of defibrillation |
|
83373-1
|
Mode setting Nebulizer |
|
74717-0
|
Vendor model number |
|
19785-5
|
Endoscopy device Vendor model number |
|
41898-8
|
Vendor device model code of Glucose meter |
|
69991-8
|
Vendor model code Positive airway pressure device |
|
77592-4
|
Moderate physical activity [IPAQ] |
|
88428-8
|
Moderate physical activity.inside chores [IPAQ] |
|
88432-0
|
Moderate physical activity.leisure-time domain [IPAQ] |
|
88420-5
|
Moderate physical activity.work domain [IPAQ] |
|
88427-0
|
Moderate physical activity.yard work [IPAQ] |
|
93125-3
|
Modified 30 seconds Sit to stand --with use of upper extremities |
|
77714-4
|
Modified Hoen and Yahr stage [UPDRS] |
|
91543-9
|
Myelin oligodendrocyte glycoprotein Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
91545-4
|
Myelin oligodendrocyte glycoprotein Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
91542-1
|
Myelin oligodendrocyte glycoprotein Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
91544-7
|
Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding assay immunofluorescent assay |
|
84873-9
|
Myelin oligodendrocyte glycoprotein IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
90248-6
|
Myelin oligodendrocyte glycoprotein IgG1 Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73784-1
|
Moisture [NSRAS] |
|
71451-9
|
Moisture associated skin damage (MASD) [MDSv3] |
|
50397-9
|
Molecular diagnostic overall interpretation [Presence] in Blood or Tissue by Molecular genetics method |
|
50396-1
|
Molecular diagnostic major findings for display [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
15233-0
|
Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
|
23800-6
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
|
41742-8
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk |
|
24485-5
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
61201-0
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab/IgE total in Serum by Multidisk |
|
15234-8
|
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
|
30183-8
|
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk |
|
82083-7
|
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
31004-5
|
Mold Allergen Mix 3 (Staphylococcus aureus enterotoxin A+Staphylococcus aureus enterotoxin B) IgE Ab [Presence] in Serum by Multidisk |
|
51529-6
|
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Presence] in Serum by Multidisk |
|
82085-2
|
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Units/volume] in Serum by Multidisk |
|
82084-5
|
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
51861-3
|
Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Presence] in Serum by Multidisk |
|
51862-1
|
Mold Allergen Mix 7 (Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) IgG Ab [Presence] in Serum by Multidisk |
|
89201-8
|
Molecular lab test method used to determine resistance [Identifier] in Isolate or Specimen |
|
89984-9
|
Molindone [Presence] in Serum or Plasma by Screen method |
|
10340-8
|
Molindone [Mass/volume] in Serum or Plasma |
|
89970-8
|
Molindone [Presence] in Urine by Screen method |
|
42523-1
|
Molindone [Mass/volume] in Urine |
|
87778-7
|
Molindone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
29974-3
|
Molybdenum [Mass/volume] in 24 hour Urine |
|
29975-0
|
Molybdenum [Mass/time] in 24 hour Urine |
|
50884-6
|
Molybdenum [Moles/time] in 24 hour Urine |
|
5696-0
|
Molybdenum [Mass/volume] in Blood |
|
55555-7
|
Molybdenum [Moles/volume] in Blood |
|
20888-4
|
Molybdenum [Mass/mass] in Feed |
|
51199-8
|
Molybdenum [Mass/volume] in Body fluid |
|
5697-8
|
Molybdenum [Mass/mass] in Hair |
|
50881-2
|
Molybdenum [Moles/mass] in Hair |
|
81084-6
|
Molybdenum intake 24 hour Estimated |
|
81085-3
|
Molybdenum intake 24 hour Measured |
|
60101-3
|
Molybdenum [Mass/mass] in Nail |
|
27343-3
|
Molybdenum [Mass/mass] in Red Blood Cells |
|
50883-8
|
Molybdenum [Moles/volume] in Red Blood Cells |
|
5698-6
|
Molybdenum [Mass/volume] in Serum or Plasma |
|
25481-3
|
Molybdenum [Moles/volume] in Serum or Plasma |
|
20887-6
|
Molybdenum [Mass/mass] in Tissue |
|
5699-4
|
Molybdenum [Mass/volume] in Urine |
|
50882-0
|
Molybdenum [Moles/volume] in Urine |
|
20886-8
|
Molybdenum [Mass/volume] in Unspecified specimen |
|
87466-9
|
Molybdenum [Mass/mass] in Unspecified specimen |
|
29976-8
|
Molybdenum/Creatinine [Mass Ratio] in 24 hour Urine |
|
52927-1
|
Molybdenum/Creatinine [Molar ratio] in 24 hour Urine |
|
73583-7
|
Molybdenum/Creatinine [Mass Ratio] in Urine |
|
52928-9
|
Molybdenum/Creatinine [Molar ratio] in Urine |
|
20890-0
|
Monensin [Mass/mass] in Feed |
|
20889-2
|
Monensin [Mass/mass] in Gastric fluid |
|
87464-4
|
Monensin [Mass/volume] in Unspecified specimen |
|
87465-1
|
Monensin [Mass/mass] in Unspecified specimen |
|
7499-7
|
Monkey epithelium IgE Ab [Units/volume] in Serum |
|
21393-4
|
Monkey epithelium IgE Ab RAST class [Presence] in Serum |
|
93361-4
|
Monotypic plasma cells in S phase/100 cells in Bone marrow by Flow cytometry (FC) |
|
93350-7
|
Monocytes.HLA-DR/100 Monocytes in Blood by Flow cytometry (FC) |
|
66132-2
|
Mononuclear+Mesothelial cells/100 leukocytes in Body fluid by Manual count |
|
12919-7
|
Monoamine oxidase [Enzymatic activity/volume] in Blood |
|
12918-9
|
Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma |
|
35029-8
|
Monoblasts [#/volume] in Blood |
|
33839-2
|
Monoblasts [#/volume] in Blood by Manual count |
|
34923-3
|
Monoblasts/100 leukocytes in Blood |
|
33840-0
|
Monoblasts/100 leukocytes in Blood by Manual count |
|
50725-1
|
Monoblasts/100 leukocytes in Bone marrow by Manual count |
|
43162-7
|
Monochloramine [Mass/volume] in Water |
|
54945-1
|
Monochloroacetate [Mass/volume] in Urine |
|
74641-2
|
Monoclonal band 2 observed [Identifier] in Serum or Plasma by Immunofixation |
|
74639-6
|
Monoclonal band 2 observed [Identifier] in Urine by Immunofixation |
|
74640-4
|
Monoclonal band 3 observed [Identifier] in Serum or Plasma by Immunofixation |
|
74638-8
|
Monoclonal band 3 observed [Identifier] in Urine by Immunofixation |
|
13348-8
|
Monoclonal band observed [Identifier] in Serum or Plasma |
|
74665-1
|
Monoclonal band observed [Identifier] in Serum or Plasma by Immunofixation |
|
74666-9
|
Monoclonal band observed [Identifier] in Urine by Immunofixation |
|
80646-3
|
Monocyclohexyl methylphosphonate [Mass/volume] in Blood |
|
54100-3
|
Monocyclohexyl methylphosphonate [Mass/volume] in Urine |
|
26484-6
|
Monocytes [#/volume] in Blood |
|
742-7
|
Monocytes [#/volume] in Blood by Automated count |
|
66143-9
|
Monocytes [#/volume] in Blood from Fetus by Manual count |
|
743-5
|
Monocytes [#/volume] in Blood by Manual count |
|
74399-7
|
Monocytes [#/volume] in Cord blood |
|
35026-4
|
Monocytes [#/volume] in Cerebral spinal fluid |
|
33252-8
|
Monocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
35076-9
|
Monocytes [#/volume] in Body fluid |
|
33251-0
|
Monocytes [#/volume] in Body fluid by Manual count |
|
68420-9
|
Monocytes [#/volume] in Pericardial fluid by Manual count |
|
35028-0
|
Monocytes [#/volume] in Pleural fluid |
|
68422-5
|
Monocytes [#/volume] in Pleural fluid by Manual count |
|
35027-2
|
Monocytes [#/volume] in Peritoneal fluid |
|
68421-7
|
Monocytes [#/volume] in Peritoneal fluid by Manual count |
|
30435-2
|
Monocytes [#/volume] in Synovial fluid |
|
30145-7
|
Monocytes [#/volume] in Synovial fluid by Manual count |
|
68424-1
|
Monocytes [#/volume] in Vitreous fluid by Manual count |
|
11112-0
|
Monocytes/100 cells in Bone marrow by Manual count |
|
71677-9
|
Monocytes/Leukocytes [Pure number fraction] in Blood by Automated count |
|
71672-0
|
Monocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71659-7
|
Monocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71648-0
|
Monocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
71604-3
|
Monocytes/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71614-2
|
Monocytes/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71633-2
|
Monocytes/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71623-3
|
Monocytes/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
72344-5
|
Monocytes/100 round cells in Prostatic fluid by Manual count |
|
72343-7
|
Monocytes/100 round cells in Semen by Manual count |
|
26485-3
|
Monocytes/100 leukocytes in Blood |
|
5905-5
|
Monocytes/100 leukocytes in Blood by Automated count |
|
744-3
|
Monocytes/100 leukocytes in Blood by Manual count |
|
74400-3
|
Monocytes/100 leukocytes in Cord blood |
|
40544-9
|
Monocytes/100 leukocytes in Bronchial specimen by Manual count |
|
26486-1
|
Monocytes/100 leukocytes in Cerebral spinal fluid |
|
10329-1
|
Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
40537-3
|
Monocytes/100 leukocytes in Peritoneal dialysis fluid by Manual count |
|
53519-5
|
Monocytes/100 leukocytes in Dialysis fluid |
|
26487-9
|
Monocytes/100 leukocytes in Body fluid |
|
10330-9
|
Monocytes/100 leukocytes in Body fluid by Manual count |
|
33389-8
|
Monocytes/100 leukocytes in Pericardial fluid |
|
40525-8
|
Monocytes/100 leukocytes in Pericardial fluid by Manual count |
|
33362-5
|
Monocytes/100 leukocytes in Pleural fluid |
|
40521-7
|
Monocytes/100 leukocytes in Pleural fluid by Manual count |
|
26488-7
|
Monocytes/100 leukocytes in Peritoneal fluid |
|
13835-4
|
Monocytes/100 leukocytes in Peritoneal fluid by Manual count |
|
17835-0
|
Monocytes/100 leukocytes in Synovial fluid |
|
17286-6
|
Monocytes/100 leukocytes in Synovial fluid by Manual count |
|
30442-8
|
Monocytes/100 leukocytes in Urine |
|
17287-4
|
Monocytes/100 leukocytes in Urine by Manual count |
|
68423-3
|
Monocytes/100 leukocytes in Vitreous fluid by Manual count |
|
61125-1
|
Monocytes/100 leukocytes in Unspecified specimen by Flow cytometry (FC) |
|
51648-4
|
Monocytoid cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
80647-1
|
Monoethyl methylphosphonate [Mass/volume] in Blood |
|
54102-9
|
Monoethyl methylphosphonate [Mass/volume] in Urine |
|
54944-4
|
Monofluoroacetate [Mass/volume] in Urine |
|
26489-5
|
Mononuclear cells [#/volume] in Cerebral spinal fluid |
|
21396-7
|
Mononuclear cells [#/volume] in Cerebral spinal fluid by Manual count |
|
74139-7
|
Mononuclear cells [#/volume] in Peritoneal dialysis fluid |
|
26490-3
|
Mononuclear cells [#/volume] in Body fluid |
|
71689-4
|
Mononuclear cells [#/volume] in Body fluid by Automated count |
|
21397-5
|
Mononuclear cells [#/volume] in Body fluid by Manual count |
|
55788-4
|
Mononuclear cells [#/volume] in Bone marrow |
|
70046-8
|
Mononuclear cells [#/volume] in Pericardial fluid by Automated count |
|
35018-1
|
Mononuclear cells [#/volume] in Pleural fluid |
|
70043-5
|
Mononuclear cells [#/volume] in Pleural fluid by Automated count |
|
35080-1
|
Mononuclear cells [#/volume] in Peritoneal fluid |
|
70047-6
|
Mononuclear cells [#/volume] in Peritoneal fluid by Automated count |
|
26491-1
|
Mononuclear cells [#/volume] in Synovial fluid |
|
70050-0
|
Mononuclear cells [#/volume] in Synovial fluid by Automated count |
|
21398-3
|
Mononuclear cells [#/volume] in Synovial fluid by Manual count |
|
75655-1
|
Mononuclear cells [#] in Cerebral spinal fluid by Manual count |
|
71610-0
|
Mononuclear cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71629-0
|
Mononuclear cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71619-1
|
Mononuclear cells/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
75656-9
|
Mononuclear cells [#] in Pericardial fluid by Manual count |
|
75657-7
|
Mononuclear cells [#] in Pleural fluid by Manual count |
|
51384-6
|
Mononuclear cells/100 leukocytes in Blood by Manual count |
|
32807-0
|
Mononuclear cells/100 leukocytes in Bronchial specimen |
|
26492-9
|
Mononuclear cells/100 leukocytes in Cerebral spinal fluid |
|
12236-6
|
Mononuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
58802-0
|
Mononuclear cells/100 leukocytes in Peritoneal dialysis fluid |
|
26493-7
|
Mononuclear cells/100 leukocytes in Body fluid |
|
71697-7
|
Mononuclear cells/100 leukocytes in Body fluid by Automated count |
|
9305-4
|
Mononuclear cells/100 leukocytes in Body fluid by Manual count |
|
30443-6
|
Mononuclear cells/100 leukocytes in Gastric fluid |
|
14385-9
|
Mononuclear cells/100 leukocytes in Gastric fluid by Manual count |
|
49782-6
|
Mononuclear cells/100 leukocytes in Pericardial fluid |
|
70037-7
|
Mononuclear cells/100 leukocytes in Pericardial fluid by Automated count |
|
26494-5
|
Mononuclear cells/100 leukocytes in Pleural fluid |
|
70066-6
|
Mononuclear cells/100 leukocytes in Pleural fluid by Automated count |
|
66148-8
|
Mononuclear cells/100 leukocytes in Pleural fluid from Fetus by Manual count |
|
14380-0
|
Mononuclear cells/100 leukocytes in Pleural fluid by Manual count |
|
26495-2
|
Mononuclear cells/100 leukocytes in Peritoneal fluid |
|
70038-5
|
Mononuclear cells/100 leukocytes in Peritoneal fluid by Automated count |
|
14381-8
|
Mononuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
|
26496-0
|
Mononuclear cells/100 leukocytes in Semen |
|
14383-4
|
Mononuclear cells/100 leukocytes in Semen by Manual count |
|
26497-8
|
Mononuclear cells/100 leukocytes in Synovial fluid |
|
70042-7
|
Mononuclear cells/100 leukocytes in Synovial fluid by Automated count |
|
14382-6
|
Mononuclear cells/100 leukocytes in Synovial fluid by Manual count |
|
14384-2
|
Mononuclear cells/100 leukocytes in Urine sediment by Manual count |
|
35025-6
|
Monocytes+Macrophages [#/volume] in Cerebral spinal fluid |
|
35099-1
|
Monocytes+Macrophages [#/volume] in Body fluid |
|
35022-3
|
Monocytes+Macrophages [#/volume] in Pleural fluid |
|
35023-1
|
Monocytes+Macrophages [#/volume] in Peritoneal fluid |
|
35024-9
|
Monocytes+Macrophages [#/volume] in Synovial fluid |
|
72411-2
|
Monocytes+Macrophages [#] in Cerebral spinal fluid by Manual count |
|
32191-9
|
Monocytes+Macrophages [Presence] in Cerebral spinal fluid by Light microscopy |
|
76408-4
|
Monocytes+Macrophages [#] in Body fluid by Manual count |
|
32192-7
|
Monocytes+Macrophages [Presence] in Body fluid by Light microscopy |
|
71639-9
|
Monocytes+Macrophages/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
32193-5
|
Monocytes+Macrophages [Presence] in Pericardial fluid by Light microscopy |
|
32194-3
|
Monocytes+Macrophages [Presence] in Pleural fluid by Light microscopy |
|
32195-0
|
Monocytes+Macrophages [Presence] in Peritoneal fluid by Light microscopy |
|
32196-8
|
Monocytes+Macrophages [Presence] in Synovial fluid by Light microscopy |
|
53126-9
|
Monocytes+Macrophages/100 leukocytes in Blood |
|
32833-6
|
Monocytes+Macrophages/100 leukocytes in Bronchial specimen |
|
32806-2
|
Monocytes+Macrophages/100 leukocytes in Bronchial specimen by Manual count |
|
30436-0
|
Monocytes+Macrophages/100 leukocytes in Cerebral spinal fluid |
|
23904-6
|
Monocytes+Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
|
30437-8
|
Monocytes+Macrophages/100 leukocytes in Body fluid |
|
21394-2
|
Monocytes+Macrophages/100 leukocytes in Body fluid by Manual count |
|
53125-1
|
Monocytes+Macrophages/100 leukocytes in Bone marrow |
|
32027-5
|
Monocytes+Macrophages/100 leukocytes in Pericardial fluid by Manual count |
|
35021-5
|
Monocytes+Macrophages/100 leukocytes in Pleural fluid |
|
32028-3
|
Monocytes+Macrophages/100 leukocytes in Pleural fluid by Manual count |
|
35020-7
|
Monocytes+Macrophages/100 leukocytes in Peritoneal fluid |
|
32029-1
|
Monocytes+Macrophages/100 leukocytes in Peritoneal fluid by Manual count |
|
30438-6
|
Monocytes+Macrophages/100 leukocytes in Synovial fluid |
|
21395-9
|
Monocytes+Macrophages/100 leukocytes in Synovial fluid by Manual count |
|
53127-7
|
Monocytes+Macrophages/100 leukocytes in Tissue |
|
30439-4
|
Monocytes+Macrophages/100 leukocytes in Unspecified specimen |
|
23903-8
|
Monocytes+Macrophages/100 leukocytes in Unspecified specimen by Manual count |
|
49119-1
|
Monosaccharides.sulfated [Presence] in Urine |
|
93360-6
|
Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC) |
|
93359-8
|
Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC) |
|
86900-8
|
Plasma cells monotypic population [Identifier] in Blood by Flow cytometry (FC) |
|
93362-2
|
Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC) |
|
35176-7
|
Monounsaturated fatty acids [Moles/volume] in Serum or Plasma |
|
72988-9
|
Montelukast induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72987-1
|
Montelukast induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73259-4
|
Montelukast induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73258-6
|
Montelukast induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
50635-2
|
Monterey cypress IgE Ab [Units/volume] in Serum |
|
54654-9
|
Mood interview total severity score [Reported PHQ-9 CMS] |
|
3825-7
|
Morazone [Mass/time] in 24 hour Urine |
|
4336-4
|
Morazone [Mass] of Dose |
|
3823-2
|
Morazone [Presence] in Urine |
|
3824-0
|
Morazone [Mass/volume] in Urine |
|
9775-8
|
Moricizine [Mass/volume] in Serum or Plasma |
|
3832-3
|
Morphine [Mass/time] in 24 hour Urine |
|
78768-9
|
Morphine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
27053-8
|
Morphine [Mass/volume] in Cerebral spinal fluid |
|
77773-0
|
Morphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19600-6
|
Morphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19599-0
|
Morphine cutoff [Mass/volume] in Urine for Screen method |
|
4337-2
|
Morphine [Mass] of Dose |
|
31086-2
|
Morphine Free [Mass/volume] in Bile fluid |
|
73972-2
|
Morphine Free [Mass/volume] in Blood |
|
27054-6
|
Morphine Free [Mass/volume] in Cerebral spinal fluid |
|
19604-8
|
Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method |
|
19603-0
|
Morphine Free cutoff [Mass/volume] in Urine for Screen method |
|
29337-3
|
Morphine Free [Mass/volume] in Gastric fluid |
|
46259-8
|
Morphine Free [Presence] in Serum or Plasma by Screen method |
|
11244-1
|
Morphine Free [Mass/volume] in Serum or Plasma |
|
26696-5
|
Morphine Free [Mass/mass] in Stool |
|
20550-0
|
Morphine Free [Mass/volume] in Urine by Confirmatory method |
|
3828-1
|
Morphine Free [Presence] in Urine |
|
19602-2
|
Morphine Free [Presence] in Urine by Confirmatory method |
|
19601-4
|
Morphine Free [Presence] in Urine by Screen method |
|
3829-9
|
Morphine Free [Mass/volume] in Urine |
|
27206-2
|
Morphine Free [Mass/volume] in Vitreous fluid |
|
9438-3
|
Morphine [Presence] in Gastric fluid |
|
40384-0
|
Morphine [Presence] in Hair |
|
80539-0
|
Morphine [Mass/mass] in Hair |
|
73257-8
|
Morphine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73256-0
|
Morphine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
69027-1
|
Morphine [Mass/mass] in Meconium by Confirmatory method |
|
29287-0
|
Morphine [Presence] in Meconium |
|
15370-0
|
Morphine [Mass/volume] in Meconium |
|
26860-7
|
Morphine [Mass/mass] in Meconium |
|
72752-9
|
Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74654-5
|
Morphine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3826-5
|
Morphine [Presence] in Serum or Plasma |
|
17290-8
|
Morphine [Presence] in Serum or Plasma by Confirmatory method |
|
74131-4
|
Morphine [Mass/volume] in Serum, Plasma or Blood |
|
3827-3
|
Morphine [Mass/volume] in Serum or Plasma |
|
15110-0
|
Morphine [Moles/volume] in Serum or Plasma |
|
16251-1
|
Morphine [Mass/volume] in Urine by Confirmatory method |
|
70210-0
|
Morphine [Moles/volume] in Urine by Confirmatory method |
|
3830-7
|
Morphine [Presence] in Urine |
|
16196-8
|
Morphine [Presence] in Urine by Confirmatory method |
|
13648-1
|
Morphine [Presence] in Urine by SAMHSA confirm method |
|
19597-4
|
Morphine [Presence] in Urine by Screen method |
|
3831-5
|
Morphine [Mass/volume] in Urine |
|
74379-9
|
Morphine [Mass/volume] in Unknown substance |
|
32100-0
|
Morphine [Presence] in Unspecified specimen |
|
77332-5
|
Morphine [Moles/volume] in Unspecified specimen |
|
78861-2
|
Morphine [Z-score] in Urine |
|
58392-2
|
Morphine/Creatinine [Mass Ratio] in Urine |
|
48364-4
|
Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma |
|
48363-6
|
Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma |
|
89308-1
|
Morphine-6-Glucuronide [Presence] in Urine by Screen method |
|
18314-5
|
Morphology [Interpretation] in Blood Narrative |
|
51628-6
|
Morphology [Interpretation] in Bone marrow Narrative |
|
62363-7
|
Mosaicism detected |
|
82465-6
|
Mosquito identified [Type] in Environmental specimen |
|
82464-9
|
Mosquito count [#] in Environmental specimen |
|
94074-2
|
Most bothersome concern |
|
71154-9
|
Most food tastes bad to me in the past 7 days [FACIT] |
|
71255-4
|
Most food tastes bad to my child in the past 7 days [FACIT] |
|
74178-5
|
Most nursing staff on this job are very satisfied with the job [NMMDS] |
|
64117-5
|
Most predominant hemoglobin in DBS |
|
86470-2
|
Most recent inpatient discharge date in the last 14 days [CMS Assessment] |
|
93293-9
|
Most severe suicidal ideation 1 month |
|
93279-8
|
Most severe suicidal ideation description 1 month |
|
93280-6
|
Most severe suicidal ideation description Lifetime |
|
93294-7
|
Most severe suicidal ideation Lifetime |
|
7503-6
|
Moth triggered histamine release [Units/volume] in Blood |
|
7502-8
|
Moth IgE Ab [Units/volume] in Serum |
|
15857-6
|
Moth IgE Ab RAST class [Presence] in Serum |
|
85676-5
|
Mother's Previous illness diagnosed by |
|
85706-0
|
Mother's date of exposure to individual with confirmed illness |
|
75185-9
|
Mother had appropriate serologic response following syphilis treatment [CDC.CS] |
|
74025-8
|
Mother identifier |
|
85710-2
|
Mother Knows location of exposure to illness |
|
73765-0
|
Mother Planned to deliver at home [US Standard Certificate of Live Birth] |
|
85702-9
|
Mother Received vaccination for illness of interest |
|
85707-8
|
Mother's Relationship to individual with confirmed illness |
|
85711-0
|
Rubella was serologically confirmed at time of illness in Mother |
|
87301-8
|
Mother was married at any time during pregnancy |
|
73763-5
|
Mother was transferred for maternal medical or fetal indications for delivery [US Standard Certificate of Live Birth] |
|
87303-4
|
Mother WIC food recipient |
|
92014-0
|
Mother's administrative information |
|
75184-2
|
Mother's Amount of benzathine penicillin treatment [CDC.CS] |
|
75202-2
|
Mother's Births.live # [Reported] |
|
88119-3
|
Mother's Bridged race [CDC] |
|
75180-0
|
Mother's Clinical stage of syphilis during pregnancy [CDC.CS] |
|
75170-1
|
Mother's Date first non-treponemal test |
|
75200-6
|
Mother's Date first prenatal visit |
|
75167-7
|
Mother's Date most recent non-treponemal test |
|
75182-6
|
Mother's Date of first syphilis treatment during pregnancy |
|
75173-5
|
Mother's Date of first treponemal test |
|
75176-8
|
Mother's Date of most recent treponemal test |
|
82749-3
|
Date diagnosis confirmed from Mother |
|
82750-1
|
Mother's Diagnosis confirmed before or after delivery |
|
75171-9
|
Mother's First non-treponemal test result [CDC.CS] |
|
75172-7
|
Mother's First non-treponemal test titer |
|
75175-0
|
Mother's First treponemal test result [CDC.CS] |
|
75174-3
|
Mother's First treponemal test type [CDC.CS] |
|
77739-1
|
Mother's Hepatitis B virus surface Ag status |
|
75179-2
|
Mother's HIV status during pregnancy [CDC.CS] |
|
75203-0
|
Mother's Last menstrual period start date before delivery |
|
75257-6
|
Mother's Marital status [CDC.CS] |
|
75168-5
|
Mother's Most recent non-treponemal test result [CDC.CS] |
|
75169-3
|
Mother's Most recent non-treponemal test titer |
|
75178-4
|
Mother's Most recent treponemal result [CDC.CS] |
|
75177-6
|
Mother's Most recent treponemal test type [CDC.CS] |
|
75165-1
|
Mother's Non-treponemal or treponemal test was performed at 28-32 weeks gestation [CDC.CS] |
|
75166-9
|
Mother's Non-treponemal or treponemal test was performed at delivery [CDC.CS] |
|
75164-4
|
Mother's Non-treponemal or treponemal test was performed at first prenatal visit [CDC.CS] |
|
85703-7
|
Mothers Number of deliveries in the U.S. |
|
75201-4
|
Mother's Pregnancies # [Reported] |
|
73775-9
|
Mothers Risk factors in this pregnancy [US Standard Certificate of Live Birth] |
|
87291-1
|
Mothers Source of information |
|
75181-8
|
Mother's Surveillance stage of syphilis during pregnancy [CDC.CS] |
|
88117-7
|
Mother's Tabulated ethnicity [CDC] |
|
75163-6
|
Mother's Trimester of first prenatal visit [CDC.CS] |
|
13130-0
|
Motilin [Units/volume] in Serum or Plasma |
|
13891-7
|
Motilin [Mass/volume] in Serum or Plasma |
|
88313-2
|
Motion sensor alarm used during 7 day assessment period [CMS Assessment] |
|
77689-8
|
Motivation or initiative scale [UPDRS] |
|
70967-5
|
Motor arm Right arm [NIH Stroke Scale] |
|
89180-4
|
Motor function training performed [Identifier] |
|
92560-2
|
Motor function training plan to perform [Identifier] |
|
70968-3
|
Motor leg Leg - right [NIH Stroke Scale] |
|
52050-2
|
Motorized wheelchair attachment |
|
6179-6
|
Mouse epithelium IgE Ab [Units/volume] in Serum |
|
15859-2
|
Mouse epithelium IgE Ab RAST class [Presence] in Serum |
|
19751-7
|
Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
|
51550-2
|
Mouse epithelium, serum proteins + urine proteins IgE Ab RAST class [Presence] in Serum |
|
7504-4
|
Mouse hair IgE Ab [Units/volume] in Serum |
|
65789-0
|
Mouse lipocain native (nMus m) 1 IgE Ab [Units/volume] in Serum |
|
7505-1
|
Mouse multi IgE Ab [Units/volume] in Serum |
|
6180-4
|
Mouse serum proteins IgE Ab [Units/volume] in Serum |
|
15860-0
|
Mouse serum proteins IgE Ab RAST class [Presence] in Serum |
|
6181-2
|
Mouse urine proteins IgE Ab [Units/volume] in Serum |
|
15861-8
|
Mouse urine proteins IgE Ab RAST class [Presence] in Serum |
|
61342-2
|
Mouse urine proteins IgE Ab/IgE total in Serum |
|
45344-9
|
Tick mouth intact [Identifier] |
|
10799-5
|
Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |
|
89177-0
|
Movement system diagnosis |
|
54749-7
|
Moving from seated to standing position in last 7 days [CMS Assessment] |
|
54752-1
|
Moving on and off toilet in last 7 days [CMS Assessment] |
|
44253-3
|
Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2 weeks [Reported.PHQ] |
|
54651-5
|
Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54650-7
|
Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
54904-8
|
Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54672-1
|
Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
4338-0
|
Moxalactam [Mass] of Dose |
|
41703-0
|
Moxalactam [Susceptibility] by Gradient strip |
|
344-2
|
Moxalactam [Susceptibility] by Disk diffusion (KB) |
|
343-4
|
Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
342-6
|
Moxalactam [Susceptibility] by Minimum lethal concentration (MLC) |
|
3833-1
|
Moxalactam [Mass/volume] in Serum or Plasma |
|
18950-6
|
Moxalactam [Susceptibility] |
|
345-9
|
Moxalactam [Susceptibility] by Serum bactericidal titer |
|
88707-5
|
Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
76043-9
|
Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
76044-7
|
Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
76045-4
|
Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
93497-6
|
Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
80540-8
|
Moxifloxacin [Mass/volume] in DBS |
|
73254-5
|
Moxifloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73255-2
|
Moxifloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
31043-3
|
Moxifloxacin [Susceptibility] by Gradient strip |
|
31041-7
|
Moxifloxacin [Susceptibility] by Disk diffusion (KB) |
|
31037-5
|
Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41502-6
|
Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
43751-7
|
Moxifloxacin [Mass/volume] in Serum or Plasma |
|
31039-1
|
Moxifloxacin [Susceptibility] |
|
7211-6
|
Mozzarella Cheese triggered histamine release [Units/volume] in Blood |
|
7209-0
|
Mozzarella Cheese IgE Ab [Units/volume] in Serum |
|
15625-7
|
Mozzarella Cheese IgE Ab RAST class [Presence] in Serum |
|
7210-8
|
Mozzarella Cheese IgG Ab [Units/volume] in Serum |
|
23255-3
|
Mycoplasma bovis Ab [Presence] in Serum |
|
23256-1
|
Mycoplasma bovis Ab [Presence] in Serum by Complement fixation |
|
93623-7
|
Main pulmonary artery Diastolic flow reversal by US.doppler |
|
18020-8
|
Main pulmonary artery Diameter by US |
|
11720-0
|
Main pulmonary artery Peak systolic flow velocity US.doppler |
|
11686-3
|
Main pulmonary artery Mean blood flow velocity US.doppler |
|
18095-0
|
Main pulmonary artery Crossection [Area] by US |
|
76683-2
|
Mean platelet component [Mass/volume] in Blood by calculation |
|
11057-7
|
Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells |
|
81817-9
|
MPI gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
13008-8
|
Methyl propyl ketone [Mass/volume] in Blood |
|
31167-0
|
Methyl propyl ketone [Mass/volume] in Urine |
|
62948-5
|
MPL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
75033-1
|
MPL gene mutations tested for in Bone marrow by Molecular genetics method Nominal |
|
56141-5
|
MPL gene p.Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method |
|
58009-2
|
MPL gene p.Trp515 [Presence] in Blood or Tissue by Molecular genetics method |
|
56142-3
|
MPL gene p.Trp515Leu+Trp515Lys [Presence] in Blood or Tissue by Molecular genetics method |
|
62947-7
|
MPL gene p.Trp515Leu+Trp515Lys+Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method |
|
76684-0
|
Mean platelet dry mass [Entitic mass] in Blood by calculation |
|
79564-1
|
Mucopolysaccharidosis type I newborn screen interpretation |
|
79565-8
|
Mucopolysaccharidosis type I newborn screening comment-discussion |
|
10823-3
|
Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
|
32784-1
|
Mean peroxidase activity index [Presence] in Blood |
|
34654-4
|
MPZ gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41085-2
|
MPZ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85041-2
|
MR Unspecified body region 3D printed model |
|
24556-3
|
MR Abdomen |
|
35949-7
|
MR Abdominal Aorta |
|
36273-1
|
MR Abdominal Aorta WO and W contrast IV |
|
36134-5
|
MR Abdomen W contrast IV |
|
30668-8
|
MR Abdomen WO contrast |
|
24557-1
|
MR Abdomen WO and W contrast IV |
|
72247-0
|
MR Abdomen and Pelvis W contrast PO and WO contrast IV |
|
72246-2
|
MR Abdomen and Pelvis W contrast PO and WO and W contrast IV |
|
36496-8
|
MR Acromioclavicular Joint WO contrast |
|
36931-4
|
MR Adrenal gland |
|
44124-6
|
MR Adrenal gland W contrast IV |
|
36954-6
|
MR Adrenal gland WO contrast |
|
36951-2
|
MR Adrenal gland WO and W contrast IV |
|
24538-1
|
MR Ankle |
|
36115-4
|
MR Ankle Arthrogram |
|
36136-0
|
MR Ankle W contrast IV |
|
30680-3
|
MR Ankle WO contrast |
|
24539-9
|
MR Ankle WO and W contrast IV |
|
37222-7
|
MR Ankle and Foot |
|
26208-9
|
MR Ankle - bilateral |
|
69163-4
|
MR Ankle - bilateral W contrast IV |
|
69164-2
|
MR Ankle - bilateral WO contrast |
|
26187-5
|
MR Ankle - bilateral WO and W contrast IV |
|
26209-7
|
MR Ankle - left |
|
43555-2
|
MR Ankle - left dynamic W contrast IV |
|
36116-2
|
MR Ankle - left Arthrogram |
|
36138-6
|
MR Ankle - left W contrast IV |
|
36427-3
|
MR Ankle - left WO contrast |
|
26188-3
|
MR Ankle - left WO and W contrast IV |
|
26210-5
|
MR Ankle - right |
|
43449-8
|
MR Ankle - right dynamic W contrast IV |
|
36117-0
|
MR Ankle - right Arthrogram |
|
36140-2
|
MR Ankle - right W contrast IV |
|
36429-9
|
MR Ankle - right WO contrast |
|
26189-1
|
MR Ankle - right WO and W contrast IV |
|
43508-1
|
MR Axilla - left |
|
43504-0
|
MR Axilla - left W contrast IV |
|
43509-9
|
MR Axilla - left WO and W contrast IV |
|
43510-7
|
MR Axilla - right |
|
43505-7
|
MR Axilla - right W contrast IV |
|
43511-5
|
MR Axilla - right WO and W contrast IV |
|
37220-1
|
MR Biliary ducts and Pancreatic duct |
|
44125-3
|
MR Biliary ducts and Pancreatic duct W contrast IV |
|
44123-8
|
MR Biliary ducts and Pancreatic duct WO contrast |
|
36944-7
|
MR Biliary ducts and Pancreatic duct WO and W contrast IV |
|
37219-3
|
MR Biliary ducts |
|
42693-2
|
MR Urinary bladder and Urethra cine |
|
39141-7
|
MR Bone marrow |
|
80513-5
|
MR Bone marrow W contrast IV |
|
80512-7
|
MR Bone marrow WO contrast |
|
80514-3
|
MR Bone marrow WO and W contrast IV |
|
24582-9
|
MR Brachial plexus |
|
36239-2
|
MR Brachial plexus W contrast IV |
|
30654-8
|
MR Brachial plexus WO contrast |
|
24583-7
|
MR Brachial plexus WO and W contrast IV |
|
26211-3
|
MR Brachial plexus - bilateral |
|
26190-9
|
MR Brachial plexus - bilateral WO and W contrast IV |
|
26212-1
|
MR Brachial plexus - left |
|
36240-0
|
MR Brachial plexus - left W contrast IV |
|
38833-0
|
MR Brachial plexus - left WO contrast |
|
26191-7
|
MR Brachial plexus - left WO and W contrast IV |
|
26213-9
|
MR Brachial plexus - right |
|
36241-8
|
MR Brachial plexus - right W contrast IV |
|
36516-3
|
MR Brachial plexus - right WO contrast |
|
26192-5
|
MR Brachial plexus - right WO and W contrast IV |
|
24590-2
|
MR Brain |
|
42386-3
|
MR Brain cine for CSF flow |
|
80507-7
|
MR Brain for high grade tumor WO and W contrast IV |
|
80506-9
|
MR Brain for low grade tumor WO and W contrast IV |
|
80510-1
|
MR Brain for metastasis WO and W contrast IV |
|
80505-1
|
MR Brain for new diagnosis tumor WO and W contrast IV |
|
80511-9
|
MR Brain for postoperative |
|
36096-6
|
MR Brain limited W contrast IV |
|
36105-5
|
MR Brain limited WO contrast |
|
37217-7
|
MR Brain stem and Cranial nerves |
|
24586-0
|
MR Brain W anesthesia |
|
24589-4
|
MR Brain W contrast IV |
|
30657-1
|
MR Brain WO contrast |
|
24587-8
|
MR Brain WO and W contrast IV |
|
24588-6
|
MR Brain WO and W contrast IV and W anesthesia |
|
37218-5
|
MR Brain.temporal |
|
48444-4
|
MR Brain.temporal W contrast IV |
|
48453-5
|
MR Brain.temporal WO contrast |
|
48694-4
|
MR Brain.temporal WO and W contrast IV |
|
82128-0
|
MR Brain and Face WO contrast |
|
82129-8
|
MR Brain and Face WO and W contrast IV |
|
43772-3
|
MR Brain and Internal auditory canal |
|
37239-1
|
MR Brain and Internal auditory canal W contrast IV |
|
37278-9
|
MR Brain and Internal auditory canal WO contrast |
|
43769-9
|
MR Brain and Internal auditory canal WO and W contrast IV |
|
37215-1
|
MR Brain and Larynx W contrast IV |
|
37279-7
|
MR Brain and Larynx WO contrast |
|
91591-8
|
MR Brain and Orbit - bilateral W contrast IV |
|
91593-4
|
MR Brain and Orbit - bilateral WO contrast |
|
91592-6
|
MR Brain and Orbit - bilateral WO and W contrast IV |
|
42385-5
|
MR Brain and Pituitary and Sella turcica |
|
42391-3
|
MR Brain and Pituitary and Sella turcica W contrast IV |
|
42393-9
|
MR Brain and Pituitary and Sella turcica WO contrast |
|
42392-1
|
MR Brain and Pituitary and Sella turcica WO and W contrast IV |
|
30794-2
|
MR Breast |
|
37437-1
|
MR Breast dynamic W contrast IV |
|
69190-7
|
MR Breast for implant W contrast IV |
|
69191-5
|
MR Breast for implant WO contrast |
|
69189-9
|
MR Breast for implant WO and W contrast IV |
|
36149-3
|
MR Breast W contrast IV |
|
36436-4
|
MR Breast WO contrast |
|
36276-4
|
MR Breast WO and W contrast IV |
|
30795-9
|
MR Breast - bilateral |
|
36114-7
|
MR Breast - bilateral dynamic W contrast IV |
|
69165-9
|
MR Breast - bilateral for implant |
|
69167-5
|
MR Breast - bilateral for implant W contrast IV |
|
69168-3
|
MR Breast - bilateral for implant WO contrast |
|
69166-7
|
MR Breast - bilateral for implant WO and W contrast IV |
|
36150-1
|
MR Breast - bilateral W contrast IV |
|
36437-2
|
MR Breast - bilateral WO contrast |
|
36277-2
|
MR Breast - bilateral WO and W contrast IV |
|
35954-7
|
MR Breast - left |
|
38057-6
|
MR Breast - left for implant |
|
38064-2
|
MR Breast - left for implant WO contrast |
|
38870-2
|
MR Breast - left for implant WO and W contrast IV |
|
36151-9
|
MR Breast - left W contrast IV |
|
36438-0
|
MR Breast - left WO contrast |
|
36278-0
|
MR Breast - left WO and W contrast IV |
|
35955-4
|
MR Breast - right |
|
38058-4
|
MR Breast - right for implant |
|
38817-3
|
MR Breast - right for implant WO contrast |
|
38062-6
|
MR Breast - right for implant WO and W contrast IV |
|
36152-7
|
MR Breast - right W contrast IV |
|
36439-8
|
MR Breast - right WO contrast |
|
36279-8
|
MR Breast - right WO and W contrast IV |
|
46299-4
|
MR Breast - unilateral |
|
46323-2
|
MR Breast - unilateral W contrast IV |
|
46333-1
|
MR Breast - unilateral WO contrast |
|
43528-9
|
MR Breast - unilateral WO and W contrast IV |
|
38061-8
|
MR Spine Cervical and Spine Thoracic and Spine Lumbar and Sacrum W contrast IV |
|
42698-1
|
MR Cervical and thoracic and lumbar spine |
|
91561-1
|
MR Cervical and thoracic and lumbar spine W contrast IV |
|
30854-4
|
MR Cervical and thoracic and lumbar spine WO contrast |
|
30855-1
|
MR Cervical and thoracic and lumbar spine WO and W contrast IV |
|
43457-1
|
MR Cervical and thoracic spine |
|
89284-4
|
MR Cervical and thoracic spine W contrast IV |
|
43456-3
|
MR Cervical and thoracic spine WO and W contrast IV |
|
30655-5
|
MR Cerebral cisterns |
|
24629-8
|
MR Chest |
|
36156-8
|
MR Chest W contrast IV |
|
36442-2
|
MR Chest WO contrast |
|
36283-0
|
MR Chest WO and W contrast IV |
|
94089-0
|
MR Chest WO and W contrast IV and MRA Chest W contrast IV |
|
36942-1
|
MR Chest and Abdomen W contrast IV |
|
36284-8
|
MR Chest and Abdomen WO and W contrast IV |
|
91523-1
|
MR Chest and Abdomen and Pelvis W contrast IV |
|
91525-6
|
MR Chest and Abdomen and Pelvis WO contrast |
|
91524-9
|
MR Chest and Abdomen and Pelvis WO and W contrast IV |
|
42387-1
|
MR Unspecified body region cine for CSF flow |
|
35961-2
|
MR Clavicle |
|
42694-0
|
MR Clavicle W contrast IV |
|
42302-0
|
MR Clavicle WO contrast |
|
42299-8
|
MR Clavicle WO and W contrast IV |
|
48457-6
|
MR Clavicle - left W contrast IV |
|
48459-2
|
MR Clavicle - left WO contrast |
|
48455-0
|
MR Clavicle - left WO and W contrast IV |
|
48456-8
|
MR Clavicle - right W contrast IV |
|
48458-4
|
MR Clavicle - right WO contrast |
|
48454-3
|
MR Clavicle - right WO and W contrast IV |
|
24935-9
|
MR Cervical spine |
|
24936-7
|
MR Cervical spine W anesthesia |
|
48447-7
|
MR Cervical spine W contrast IT |
|
24938-3
|
MR Cervical spine W contrast IV |
|
42270-9
|
MR Cervical spine W flexion and W extension |
|
30667-0
|
MR Cervical spine WO contrast |
|
48450-1
|
MR Cervical spine WO and W contrast IT |
|
24937-5
|
MR Cervical spine WO and W contrast IV |
|
24674-4
|
MR Elbow |
|
46319-0
|
MR Elbow Arthrogram |
|
36158-4
|
MR Elbow W contrast IV |
|
30796-7
|
MR Elbow WO contrast |
|
24675-1
|
MR Elbow WO and W contrast IV |
|
26220-4
|
MR Elbow - bilateral |
|
69170-9
|
MR Elbow - bilateral W contrast IV |
|
69171-7
|
MR Elbow - bilateral WO contrast |
|
26193-3
|
MR Elbow - bilateral WO and W contrast IV |
|
26221-2
|
MR Elbow - left |
|
43450-6
|
MR Elbow - left dynamic W contrast IV |
|
36118-8
|
MR Elbow - left Arthrogram |
|
36160-0
|
MR Elbow - left W contrast IV |
|
36446-3
|
MR Elbow - left WO contrast |
|
26194-1
|
MR Elbow - left WO and W contrast IV |
|
26222-0
|
MR Elbow - right |
|
43451-4
|
MR Elbow - right dynamic W contrast IV |
|
36119-6
|
MR Elbow - right Arthrogram |
|
36162-6
|
MR Elbow - right W contrast IV |
|
36448-9
|
MR Elbow - right WO contrast |
|
26195-8
|
MR Elbow - right WO and W contrast IV |
|
42390-5
|
MR Endovaginal |
|
69193-1
|
MR Extremity |
|
35953-9
|
MR Face |
|
36148-5
|
MR Face W contrast IV |
|
36435-6
|
MR Face WO contrast |
|
24694-2
|
MR Face WO and W contrast IV |
|
82130-6
|
MR Face and Neck WO contrast |
|
82131-4
|
MR Face and Neck WO and W contrast IV |
|
69172-5
|
MR Femur - bilateral W contrast IV |
|
69173-3
|
MR Femur - bilateral WO contrast |
|
35990-1
|
MR Fetal |
|
24705-6
|
MR Finger |
|
69195-6
|
MR Finger W contrast IV |
|
69196-4
|
MR Finger WO contrast |
|
69194-9
|
MR Finger WO and W contrast IV |
|
26238-6
|
MR Finger - bilateral |
|
26239-4
|
MR Finger - left |
|
69205-3
|
MR Finger - left W contrast IV |
|
69206-1
|
MR Finger - left WO contrast |
|
69204-6
|
MR Finger - left WO and W contrast IV |
|
26240-2
|
MR Finger - right |
|
69215-2
|
MR Finger - right W contrast IV |
|
69216-0
|
MR Finger - right WO contrast |
|
69214-5
|
MR Finger - right WO and W contrast IV |
|
24707-2
|
MR Foot |
|
36179-0
|
MR Foot W contrast IV |
|
30681-1
|
MR Foot WO contrast |
|
30682-9
|
MR Foot WO and W contrast IV |
|
26241-0
|
MR Foot - bilateral |
|
36180-8
|
MR Foot - bilateral W contrast IV |
|
36467-9
|
MR Foot - bilateral WO contrast |
|
36342-4
|
MR Foot - bilateral WO and W contrast IV |
|
26242-8
|
MR Foot - left |
|
36182-4
|
MR Foot - left W contrast IV |
|
36469-5
|
MR Foot - left WO contrast |
|
36344-0
|
MR Foot - left WO and W contrast IV |
|
26243-6
|
MR Foot - right |
|
36184-0
|
MR Foot - right W contrast IV |
|
36471-1
|
MR Foot - right WO contrast |
|
36346-5
|
MR Foot - right WO and W contrast IV |
|
24710-6
|
MR Forearm |
|
36186-5
|
MR Forearm W contrast IV |
|
30683-7
|
MR Forearm WO contrast |
|
30684-5
|
MR Forearm WO and W contrast IV |
|
26244-4
|
MR Forearm - bilateral |
|
69175-8
|
MR Forearm - bilateral W contrast IV |
|
69176-6
|
MR Forearm - bilateral WO contrast |
|
69174-1
|
MR Forearm - bilateral WO and W contrast IV |
|
26245-1
|
MR Forearm - left |
|
36188-1
|
MR Forearm - left W contrast IV |
|
36474-5
|
MR Forearm - left WO contrast |
|
36349-9
|
MR Forearm - left WO and W contrast IV |
|
26246-9
|
MR Forearm - right |
|
36190-7
|
MR Forearm - right W contrast IV |
|
36476-0
|
MR Forearm - right WO contrast |
|
36351-5
|
MR Forearm - right WO and W contrast IV |
|
36936-3
|
MR Guidance for stereotactic biopsy of Brain |
|
30656-3
|
MR Guidance for stereotactic localization of Brain-- W contrast IV |
|
30800-7
|
MR Guidance for stereotactic localization of Brain-- WO contrast |
|
44122-0
|
MR Guidance for stereotactic localization of Brain-- WO and W contrast IV |
|
69192-3
|
MR Guidance for aspiration of cyst of Breast |
|
69169-1
|
MR Guidance for biopsy of Breast - bilateral |
|
69203-8
|
MR Guidance for biopsy of Breast - left |
|
80498-9
|
MR Guidance for needle localization of Breast - left |
|
69213-7
|
MR Guidance for biopsy of Breast - right |
|
80497-1
|
MR Guidance for needle localization of Breast - right |
|
80504-4
|
MR Guidance for biopsy of Unspecified body region |
|
69200-4
|
MR Guidance for biopsy of Chest Pleura |
|
80509-3
|
MR Guidance for placement of clip in Unspecified body region |
|
69197-2
|
MR Guidance for biopsy of Liver |
|
69198-0
|
MR Guidance for biopsy of Muscle |
|
39028-6
|
MR Guidance for needle localization of Unspecified body region |
|
69199-8
|
MR Guidance for biopsy of Pancreas |
|
82123-1
|
MR Guidance for radiation treatment of Unspecified body region |
|
30664-7
|
MR Guidance for radiation treatment of Unspecified body region-- W contrast IV |
|
30665-4
|
MR Guidance for radiation treatment of Unspecified body region-- WO contrast |
|
69201-2
|
MR Guidance for biopsy of Salivary gland |
|
69202-0
|
MR Guidance for biopsy of Thyroid gland |
|
24720-5
|
MR Hand |
|
36192-3
|
MR Hand W contrast IV |
|
30685-2
|
MR Hand WO contrast |
|
30686-0
|
MR Hand WO and W contrast IV |
|
26247-7
|
MR Hand - bilateral |
|
69178-2
|
MR Hand - bilateral W contrast IV |
|
69179-0
|
MR Hand - bilateral WO contrast |
|
69177-4
|
MR Hand - bilateral WO and W contrast IV |
|
26248-5
|
MR Hand - left |
|
36194-9
|
MR Hand - left W contrast IV |
|
36479-4
|
MR Hand - left WO contrast |
|
36354-9
|
MR Hand - left WO and W contrast IV |
|
26249-3
|
MR Hand - right |
|
36196-4
|
MR Hand - right W contrast IV |
|
36481-0
|
MR Hand - right WO contrast |
|
36356-4
|
MR Hand - right WO and W contrast IV |
|
36013-1
|
MR Hip |
|
36120-4
|
MR Hip Arthrogram |
|
36199-8
|
MR Hip W contrast IV |
|
30687-8
|
MR Hip WO contrast |
|
30688-6
|
MR Hip WO and W contrast IV |
|
36017-2
|
MR Hip - bilateral |
|
36202-0
|
MR Hip - bilateral W contrast IV |
|
36486-9
|
MR Hip - bilateral WO contrast |
|
36361-4
|
MR Hip - bilateral WO and W contrast IV |
|
36020-6
|
MR Hip - left |
|
36121-2
|
MR Hip - left Arthrogram |
|
36204-6
|
MR Hip - left W contrast IV |
|
36488-5
|
MR Hip - left WO contrast |
|
69207-9
|
MR Hip - left Arthrogram WO and W contrast |
|
36363-0
|
MR Hip - left WO and W contrast IV |
|
36022-2
|
MR Hip - right |
|
36122-0
|
MR Hip - right Arthrogram |
|
36206-1
|
MR Hip - right W contrast IV |
|
36490-1
|
MR Hip - right WO contrast |
|
69217-8
|
MR Hip - right Arthrogram WO and W contrast |
|
36365-5
|
MR Hip - right WO and W contrast IV |
|
24748-6
|
MR Heart |
|
39140-9
|
MR Heart cine for blood flow velocity mapping |
|
44126-1
|
MR Heart cine for blood flow velocity mapping W contrast IV |
|
37434-8
|
MR Heart cine for function |
|
44127-9
|
MR Heart limited cine for function |
|
36091-7
|
MR Heart limited |
|
36197-2
|
MR Heart W contrast IV |
|
58750-1
|
MR Heart W stress |
|
80500-2
|
MR Heart W stress and WO contrast |
|
58749-3
|
MR Heart W stress and WO and W contrast IV |
|
36482-8
|
MR Heart WO contrast |
|
36357-2
|
MR Heart WO and W contrast IV |
|
35956-2
|
MR Internal auditory canal |
|
36088-3
|
MR Internal auditory canal limited |
|
36155-0
|
MR Internal auditory canal W contrast IV |
|
30658-9
|
MR Internal auditory canal WO contrast |
|
30659-7
|
MR Internal auditory canal WO and W contrast IV |
|
24735-3
|
MR Internal auditory canal and Posterior fossa |
|
24740-3
|
MR Internal auditory canal and Posterior fossa WO and W contrast IV |
|
36083-4
|
MR Inferior vena cava |
|
36545-2
|
MR Inferior vena cava WO contrast |
|
36418-2
|
MR Inferior vena cava WO and W contrast IV |
|
28576-7
|
MR Joint |
|
36812-6
|
MR Joint Arthrogram |
|
36871-2
|
MR Joint WO contrast |
|
36034-7
|
MR Kidney - bilateral |
|
36219-4
|
MR Kidney - bilateral W contrast IV |
|
36504-9
|
MR Kidney - bilateral WO contrast |
|
36378-8
|
MR Kidney - bilateral WO and W contrast IV |
|
36033-9
|
MR Kidney |
|
36113-9
|
MR Kidney W contrast IV |
|
43773-1
|
MR Kidney WO contrast |
|
43775-6
|
MR Kidney WO and W contrast IV |
|
36035-4
|
MR Kidney - left |
|
36220-2
|
MR Kidney - left W contrast IV |
|
36036-2
|
MR Kidney - right |
|
36221-0
|
MR Kidney - right W contrast IV |
|
24802-1
|
MR Knee |
|
36125-3
|
MR Knee Arthrogram |
|
36223-6
|
MR Knee W contrast IV |
|
30691-0
|
MR Knee WO contrast |
|
24803-9
|
MR Knee WO and W contrast IV |
|
26256-8
|
MR Knee - bilateral |
|
36224-4
|
MR Knee - bilateral W contrast IV |
|
36506-4
|
MR Knee - bilateral WO contrast |
|
26199-0
|
MR Knee - bilateral WO and W contrast IV |
|
26257-6
|
MR Knee - left |
|
43452-2
|
MR Knee - left dynamic W contrast IV |
|
36126-1
|
MR Knee - left Arthrogram |
|
36226-9
|
MR Knee - left W contrast IV |
|
36508-0
|
MR Knee - left WO contrast |
|
26200-6
|
MR Knee - left WO and W contrast IV |
|
26258-4
|
MR Knee - right |
|
43453-0
|
MR Knee - right dynamic W contrast IV |
|
36127-9
|
MR Knee - right Arthrogram |
|
36228-5
|
MR Knee - right W contrast IV |
|
36510-6
|
MR Knee - right WO contrast |
|
26201-4
|
MR Knee - right WO and W contrast IV |
|
36045-3
|
MR Larynx |
|
36230-1
|
MR Larynx W contrast IV |
|
48445-1
|
MR Larynx WO contrast |
|
36382-0
|
MR Larynx WO and W contrast IV |
|
30692-8
|
MR Lower extremity |
|
24687-6
|
MR Lower Extremity Joint |
|
36093-3
|
MR Lower Extremity Joint limited |
|
69210-3
|
MR Lower Extremity Joint Arthrogram |
|
36213-7
|
MR Lower Extremity Joint W contrast IV |
|
36497-6
|
MR Lower Extremity Joint WO contrast |
|
36371-3
|
MR Lower Extremity Joint WO and W contrast IV |
|
26227-9
|
MR Lower extremity joint - bilateral |
|
26228-7
|
MR Lower extremity joint - left |
|
36107-1
|
MR Lower extremity joint - left limited WO contrast |
|
36214-5
|
MR Lower extremity joint - left W contrast IV |
|
36498-4
|
MR Lower extremity joint - left WO contrast |
|
36372-1
|
MR Lower extremity joint - left WO and W contrast IV |
|
26229-5
|
MR Lower extremity joint - right |
|
38769-6
|
MR Lower extremity joint - right limited WO contrast |
|
36215-2
|
MR Lower extremity joint - right W contrast IV |
|
36499-2
|
MR Lower extremity joint - right WO contrast |
|
36373-9
|
MR Lower extremity joint - right WO and W contrast IV |
|
39293-6
|
MR Lower extremity W contrast IV |
|
39292-8
|
MR Lower extremity WO contrast |
|
39291-0
|
MR Lower extremity WO and W contrast IV |
|
35975-2
|
MR Lower extremity - bilateral |
|
36163-4
|
MR Lower extremity - bilateral W contrast IV |
|
36451-3
|
MR Lower extremity - bilateral WO contrast |
|
36289-7
|
MR Lower extremity - bilateral WO and W contrast IV |
|
35978-6
|
MR Lower extremity - left |
|
36165-9
|
MR Lower extremity - left W contrast IV |
|
36453-9
|
MR Lower extremity - left WO contrast |
|
36291-3
|
MR Lower extremity - left WO and W contrast IV |
|
35980-2
|
MR Lower extremity - right |
|
36167-5
|
MR Lower extremity - right W contrast IV |
|
36455-4
|
MR Lower extremity - right WO contrast |
|
36333-3
|
MR Lower extremity - right WO and W contrast IV |
|
36046-1
|
MR Liver |
|
36231-9
|
MR Liver W contrast IV |
|
30669-6
|
MR Liver WO contrast |
|
30670-4
|
MR Liver WO and W contrast IV |
|
43448-0
|
MR Liver WO and W ferumoxides IV |
|
24821-1
|
MR Lower leg |
|
36259-0
|
MR Lower leg W contrast IV |
|
30869-2
|
MR Lower leg WO contrast |
|
30870-0
|
MR Lower leg WO and W contrast IV |
|
42696-5
|
MR Lower leg - bilateral |
|
42695-7
|
MR Lower leg - bilateral W contrast IV |
|
69185-7
|
MR Lower leg - bilateral WO contrast |
|
42697-3
|
MR Lower leg - bilateral WO and W contrast IV |
|
36075-0
|
MR Lower leg - left |
|
36261-6
|
MR Lower leg - left W contrast IV |
|
36539-5
|
MR Lower leg - left WO contrast |
|
36410-9
|
MR Lower leg - left WO and W contrast IV |
|
36076-8
|
MR Lower leg - right |
|
36263-2
|
MR Lower leg - right W contrast IV |
|
36541-1
|
MR Lower leg - right WO contrast |
|
36412-5
|
MR Lower leg - right WO and W contrast IV |
|
24968-0
|
MR Lumbar spine |
|
36100-6
|
MR Lumbar spine limited W contrast IV |
|
36111-3
|
MR Lumbar spine limited WO contrast |
|
24977-1
|
MR Lumbar spine W anesthesia |
|
48436-0
|
MR Lumbar spine W contrast IT |
|
30678-7
|
MR Lumbar spine W contrast IV |
|
30679-5
|
MR Lumbar spine WO contrast |
|
48452-7
|
MR Lumbar spine WO and W contrast IT |
|
24967-2
|
MR Lumbar spine WO and W contrast IV |
|
91715-3
|
MR Spine Lumbar and Sacrum W contrast IV |
|
91717-9
|
MR Spine Lumbar and Sacrum WO contrast |
|
91716-1
|
MR Spine Lumbar and Sacrum WO and W contrast IV |
|
48460-0
|
MR Unspecified body region limited |
|
30866-8
|
MR Lumbosacral plexus |
|
37234-2
|
MR Mediastinum |
|
80495-5
|
MR Mediastinum WO contrast |
|
37272-2
|
MR Mediastinum WO and W contrast IV |
|
69211-1
|
MR Nasal bones |
|
30860-1
|
MR Nasopharynx |
|
36233-5
|
MR Nasopharynx W contrast IV |
|
36513-0
|
MR Nasopharynx WO contrast |
|
36384-6
|
MR Nasopharynx WO and W contrast IV |
|
24839-3
|
MR Neck |
|
48461-8
|
MR Neck limited |
|
24841-9
|
MR Neck W contrast IV |
|
30660-5
|
MR Neck WO contrast |
|
24840-1
|
MR Neck WO and W contrast IV |
|
30857-7
|
MR Nerves cranial |
|
36777-1
|
MR Orbit |
|
36820-9
|
MR Orbit W contrast IV |
|
36872-0
|
MR Orbit WO contrast |
|
36842-3
|
MR Orbit WO and W contrast IV |
|
42303-8
|
MR Orbit and Face |
|
39038-5
|
MR Orbit and Face W contrast IV |
|
36956-1
|
MR Orbit and Face WO contrast |
|
39029-4
|
MR Orbit and Face WO and W contrast IV |
|
43530-5
|
MR Orbit and Face and Neck |
|
46321-6
|
MR Orbit and Face and Neck W contrast IV |
|
46332-3
|
MR Orbit and Face and Neck WO contrast |
|
46310-9
|
MR Orbit and Face and Neck WO and W contrast IV |
|
24852-6
|
MR Orbit - bilateral W contrast IV |
|
30661-3
|
MR Orbit - bilateral WO contrast |
|
24851-8
|
MR Orbit - bilateral WO and W contrast IV |
|
38836-3
|
MR Orbit - left |
|
36821-7
|
MR Orbit - left W contrast IV |
|
36873-8
|
MR Orbit - left WO contrast |
|
36843-1
|
MR Orbit - left WO and W contrast IV |
|
36778-9
|
MR Orbit - right |
|
36822-5
|
MR Orbit - right W contrast IV |
|
36874-6
|
MR Orbit - right WO contrast |
|
36844-9
|
MR Orbit - right WO and W contrast IV |
|
43455-5
|
MR Oropharynx |
|
36779-7
|
MR Ovary |
|
36823-3
|
MR Ovary W contrast IV |
|
36875-3
|
MR Ovary WO contrast |
|
36845-6
|
MR Ovary WO and W contrast IV |
|
43506-5
|
MR Ovary - bilateral |
|
80496-3
|
MR Unspecified body region 3D post processing |
|
36052-9
|
MR Pancreas |
|
36236-8
|
MR Pancreas W contrast IV |
|
36515-5
|
MR Pancreas WO contrast |
|
36385-3
|
MR Pancreas WO and W contrast IV |
|
36053-7
|
MR Parathyroid gland |
|
37224-3
|
MR Parotid gland |
|
37241-7
|
MR Parotid gland W contrast IV |
|
37281-3
|
MR Parotid gland WO contrast |
|
37265-6
|
MR Parotid gland WO and W contrast IV |
|
24867-4
|
MR Pelvis |
|
24872-4
|
MR Pelvis and Hip |
|
30671-2
|
MR Pelvis and Hip WO contrast |
|
30672-0
|
MR Pelvis and Hip WO and W contrast IV |
|
26259-2
|
MR Pelvis and Hip - bilateral |
|
26260-0
|
MR Pelvis and Hip - left |
|
26261-8
|
MR Pelvis and Hip - right |
|
72245-4
|
MR Pelvis Defecography W contrast PR |
|
42389-7
|
MR Pelvis Endorectal |
|
80585-3
|
MR Pelvis Endorectal W contrast IV |
|
72244-7
|
MR Pelvis Endorectal WO and W contrast IV |
|
69212-9
|
MR Pelvis limited |
|
36237-6
|
MR Pelvis W contrast IV |
|
30673-8
|
MR Pelvis WO contrast |
|
30674-6
|
MR Pelvis WO and W contrast IV |
|
24880-7
|
MR Pituitary and Sella turcica |
|
36238-4
|
MR Pituitary and Sella turcica W contrast IV |
|
30666-2
|
MR Pituitary and Sella turcica WO contrast |
|
24879-9
|
MR Pituitary and Sella turcica WO and W contrast IV |
|
91718-7
|
MR Unspecified body region Post mortem |
|
36056-0
|
MR Posterior fossa |
|
36243-4
|
MR Posterior fossa W contrast IV |
|
36518-9
|
MR Posterior fossa WO contrast |
|
36388-7
|
MR Posterior fossa WO and W contrast IV |
|
30675-3
|
MR Prostate |
|
42388-9
|
MR Prostate Endorectal |
|
36244-2
|
MR Prostate W contrast IV |
|
36519-7
|
MR Prostate WO contrast |
|
36389-5
|
MR Prostate WO and W contrast IV |
|
43454-8
|
MR Pulmonary system |
|
36059-4
|
MR Sacrum |
|
91594-2
|
MR Sacrum and Sacroiliac joint W contrast IV |
|
91596-7
|
MR Sacrum and Sacroiliac joint WO contrast |
|
91595-9
|
MR Sacrum and Sacroiliac joint WO and W contrast IV |
|
36246-7
|
MR Sacrum W contrast IV |
|
36521-3
|
MR Sacrum WO contrast |
|
36391-1
|
MR Sacrum WO and W contrast IV |
|
36060-2
|
MR Sacrum and Coccyx |
|
36247-5
|
MR Sacrum and Coccyx W contrast IV |
|
36522-1
|
MR Sacrum and Coccyx WO contrast |
|
36392-9
|
MR Sacrum and Coccyx WO and W contrast IV |
|
36933-0
|
MR Salivary gland |
|
80501-0
|
MR Small bowel W contrast PO and WO contrast IV |
|
80503-6
|
MR Small bowel W contrast PO and WO and W contrast IV |
|
36061-0
|
MR Scapula |
|
36248-3
|
MR Scapula - left W contrast IV |
|
36523-9
|
MR Scapula - left WO contrast |
|
36393-7
|
MR Scapula - left WO and W contrast IV |
|
36249-1
|
MR Scapula - right W contrast IV |
|
38770-4
|
MR Scapula - right WO contrast |
|
36394-5
|
MR Scapula - right WO and W contrast IV |
|
36073-5
|
MR Scrotum and testicle |
|
69221-0
|
MR Scrotum and testicle W contrast IV |
|
36535-3
|
MR Scrotum and testicle WO contrast |
|
36406-7
|
MR Scrotum and testicle WO and W contrast IV |
|
24905-2
|
MR Shoulder |
|
36129-5
|
MR Shoulder Arthrogram |
|
36251-7
|
MR Shoulder W contrast IV |
|
30693-6
|
MR Shoulder WO contrast |
|
24906-0
|
MR Shoulder WO and W contrast IV |
|
26266-7
|
MR Shoulder - bilateral |
|
69184-0
|
MR Shoulder - bilateral W contrast IV |
|
36525-4
|
MR Shoulder - bilateral WO contrast |
|
26202-2
|
MR Shoulder - bilateral WO and W contrast IV |
|
26268-3
|
MR Shoulder - left |
|
36130-3
|
MR Shoulder - left Arthrogram |
|
38830-6
|
MR Shoulder - left W contrast IV |
|
38834-8
|
MR Shoulder - left WO contrast |
|
69208-7
|
MR Shoulder - left Arthrogram WO and W contrast |
|
26203-0
|
MR Shoulder - left WO and W contrast IV |
|
26270-9
|
MR Shoulder - right |
|
36132-9
|
MR Shoulder - right Arthrogram |
|
36254-1
|
MR Shoulder - right W contrast IV |
|
36528-8
|
MR Shoulder - right WO contrast |
|
69218-6
|
MR Shoulder - right Arthrogram WO and W contrast |
|
26204-8
|
MR Shoulder - right WO and W contrast IV |
|
36031-3
|
MR Sacroiliac Joint |
|
36218-6
|
MR Sacroiliac Joint W contrast IV |
|
36502-3
|
MR Sacroiliac Joint WO contrast |
|
36376-2
|
MR Sacroiliac Joint WO and W contrast IV |
|
24914-4
|
MR Sinuses |
|
24915-1
|
MR Sinuses W contrast IV |
|
30662-1
|
MR Sinuses WO contrast |
|
30663-9
|
MR Sinuses WO and W contrast IV |
|
48440-2
|
MR Skull base W contrast IV |
|
48687-8
|
MR Skull base WO contrast |
|
69220-2
|
MR Skull base WO and W contrast IV |
|
37253-2
|
MR Soft tissue W contrast IV |
|
37293-8
|
MR Soft tissue WO contrast |
|
36067-7
|
MR Spine |
|
18756-7
|
MR Spine study |
|
36256-6
|
MR Spine W contrast IV |
|
36531-2
|
MR Spine WO contrast |
|
36400-0
|
MR Spine WO and W contrast IV |
|
36070-1
|
MR Spleen |
|
36533-8
|
MR Spleen WO contrast |
|
36404-2
|
MR Spleen WO and W contrast IV |
|
36072-7
|
MR Sternum |
|
36546-0
|
MR Superior vena cava WO contrast |
|
36419-0
|
MR Superior vena cava WO and W contrast IV |
|
94088-2
|
MR Thoracic and lumbar spine WO and W contrast |
|
35950-5
|
MR Thoracic Aorta |
|
35947-1
|
MR Thoracic and abdominal aorta |
|
24702-3
|
MR Thigh |
|
36173-3
|
MR Thigh W contrast IV |
|
36461-2
|
MR Thigh WO contrast |
|
24703-1
|
MR Thigh WO and W contrast IV |
|
26235-2
|
MR Thigh - bilateral |
|
26196-6
|
MR Thigh - bilateral WO and W contrast IV |
|
26236-0
|
MR Thigh - left |
|
36175-8
|
MR Thigh - left W contrast IV |
|
36463-8
|
MR Thigh - left WO contrast |
|
26197-4
|
MR Thigh - left WO and W contrast IV |
|
26237-8
|
MR Thigh - right |
|
36177-4
|
MR Thigh - right W contrast IV |
|
36465-3
|
MR Thigh - right WO contrast |
|
26198-2
|
MR Thigh - right WO and W contrast IV |
|
43507-3
|
MR Thymus gland |
|
42300-4
|
MR Thyroid gland |
|
36536-1
|
MR Thyroid gland WO contrast |
|
36407-5
|
MR Thyroid gland WO and W contrast IV |
|
24999-5
|
MR Temporomandibular joint |
|
37435-5
|
MR Temporomandibular joint cine |
|
37244-1
|
MR Temporomandibular joint W contrast IV |
|
37284-7
|
MR Temporomandibular joint WO contrast |
|
37268-0
|
MR Temporomandibular joint WO and W contrast IV |
|
37228-4
|
MR Temporomandibular joint - bilateral |
|
37245-8
|
MR Temporomandibular joint - bilateral W contrast IV |
|
37285-4
|
MR Temporomandibular joint - bilateral WO contrast |
|
37269-8
|
MR Temporomandibular joint - bilateral WO and W contrast IV |
|
37230-0
|
MR Temporomandibular joint - left |
|
37247-4
|
MR Temporomandibular joint - left W contrast IV |
|
37286-2
|
MR Temporomandibular joint - left WO contrast |
|
37270-6
|
MR Temporomandibular joint - left WO and W contrast IV |
|
37231-8
|
MR Temporomandibular joint - right |
|
37249-0
|
MR Temporomandibular joint - right W contrast IV |
|
37287-0
|
MR Temporomandibular joint - right WO contrast |
|
37271-4
|
MR Temporomandibular joint - right WO and W contrast IV |
|
36780-5
|
MR Toe |
|
91597-5
|
MR Toe WO and W contrast IV |
|
72243-9
|
MR Toes - left W contrast IV |
|
72242-1
|
MR Toes - left WO contrast |
|
72241-3
|
MR Toes - left WO and W contrast IV |
|
72240-5
|
MR Toes - right W contrast IV |
|
72239-7
|
MR Toes - right WO contrast |
|
72238-9
|
MR Toes - right WO and W contrast IV |
|
24980-5
|
MR Thoracic spine |
|
36101-4
|
MR Thoracic spine limited W contrast IV |
|
36112-1
|
MR Thoracic spine limited WO contrast |
|
48439-4
|
MR Thoracic spine W contrast IT |
|
24982-1
|
MR Thoracic spine W contrast IV |
|
36532-0
|
MR Thoracic spine WO contrast |
|
48441-0
|
MR Thoracic spine WO and W contrast IT |
|
24981-3
|
MR Thoracic spine WO and W contrast IV |
|
24688-4
|
MR Upper extremity |
|
30875-9
|
MR Upper extremity.joint |
|
36094-1
|
MR Upper extremity.joint limited |
|
80508-5
|
MR Upper extremity.joint Arthrogram |
|
36216-0
|
MR Upper extremity.joint W contrast IV |
|
36500-7
|
MR Upper extremity.joint WO contrast |
|
36374-7
|
MR Upper extremity.joint WO and W contrast IV |
|
36817-5
|
MR Upper extremity joint - bilateral W contrast IV |
|
36774-8
|
MR Upper extremity joint - left |
|
36818-3
|
MR Upper extremity joint - left W contrast IV |
|
36869-6
|
MR Upper extremity joint - left WO contrast |
|
36840-7
|
MR Upper extremity joint - left WO and W contrast IV |
|
36775-5
|
MR Upper extremity joint - right |
|
36819-1
|
MR Upper extremity joint - right W contrast IV |
|
36870-4
|
MR Upper extremity joint - right WO contrast |
|
36841-5
|
MR Upper extremity joint - right WO and W contrast IV |
|
39037-7
|
MR Upper extremity W contrast IV |
|
39033-6
|
MR Upper extremity WO contrast |
|
39034-4
|
MR Upper extremity WO and W contrast IV |
|
26232-9
|
MR Upper extremity - bilateral |
|
69187-3
|
MR Upper extremity - bilateral W contrast IV |
|
69188-1
|
MR Upper extremity - bilateral WO contrast |
|
69186-5
|
MR Upper extremity - bilateral WO and W contrast IV |
|
26233-7
|
MR Upper extremity - left |
|
38829-8
|
MR Upper extremity - left W contrast IV |
|
38832-2
|
MR Upper extremity - left WO contrast |
|
38831-4
|
MR Upper extremity - left WO and W contrast IV |
|
26234-5
|
MR Upper extremity - right |
|
36171-7
|
MR Upper extremity - right W contrast IV |
|
36459-6
|
MR Upper extremity - right WO contrast |
|
36337-4
|
MR Upper extremity - right WO and W contrast IV |
|
25056-3
|
MR Unspecified body region |
|
36025-5
|
MR Upper arm |
|
36208-7
|
MR Upper arm W contrast IV |
|
30689-4
|
MR Upper arm WO contrast |
|
30690-2
|
MR Upper arm WO and W contrast IV |
|
69180-8
|
MR Upper arm - bilateral |
|
69182-4
|
MR Upper arm - bilateral W contrast IV |
|
69183-2
|
MR Upper arm - bilateral WO contrast |
|
69181-6
|
MR Upper arm - bilateral WO and W contrast IV |
|
36028-9
|
MR Upper arm - left |
|
36210-3
|
MR Upper arm - left W contrast IV |
|
36493-5
|
MR Upper arm - left WO contrast |
|
36368-9
|
MR Upper arm - left WO and W contrast IV |
|
36030-5
|
MR Upper arm - right |
|
36212-9
|
MR Upper arm - right W contrast IV |
|
36495-0
|
MR Upper arm - right WO contrast |
|
36370-5
|
MR Upper arm - right WO and W contrast IV |
|
80584-6
|
MR Urethra Endovaginal WO contrast |
|
42301-2
|
MR Uterus |
|
36265-7
|
MR Uterus W contrast IV |
|
36542-9
|
MR Uterus WO contrast |
|
36413-3
|
MR Uterus WO and W contrast IV |
|
69222-8
|
MR Vena cava |
|
46358-8
|
MR Whole body |
|
80499-7
|
MR Whole body WO and W contrast IV |
|
25033-2
|
MR Wrist |
|
37444-7
|
MR Wrist Arthrogram |
|
37448-8
|
MR Wrist W contrast IV |
|
37460-3
|
MR Wrist WO contrast |
|
25035-7
|
MR Wrist WO and W contrast IV |
|
36008-1
|
MR Wrist and Hand |
|
69209-5
|
MR Wrist - left and Hand - left |
|
69219-4
|
MR Wrist - right and Hand - right |
|
26277-4
|
MR Wrist - bilateral |
|
37449-6
|
MR Wrist - bilateral W contrast IV |
|
37462-9
|
MR Wrist - bilateral WO contrast |
|
26205-5
|
MR Wrist - bilateral WO and W contrast IV |
|
26279-0
|
MR Wrist - left |
|
37445-4
|
MR Wrist - left Arthrogram |
|
37451-2
|
MR Wrist - left W contrast IV |
|
37464-5
|
MR Wrist - left WO contrast |
|
26206-3
|
MR Wrist - left WO and W contrast IV |
|
26281-6
|
MR Wrist - right |
|
37446-2
|
MR Wrist - right Arthrogram |
|
37453-8
|
MR Wrist - right W contrast IV |
|
37466-0
|
MR Wrist - right WO contrast |
|
26207-1
|
MR Wrist - right WO and W contrast IV |
|
25057-1
|
MR Unspecified body region W conscious sedation |
|
49507-7
|
MR Unspecified body region W contrast IV |
|
69223-6
|
MR Unspecified body region WO contrast |
|
42298-0
|
MR Unspecified body region WO and W contrast IV |
|
80502-8
|
MRA Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV |
|
36432-3
|
MRA Abdominal Aorta WO contrast |
|
36272-3
|
MRA Abdominal Aorta WO and W contrast IV |
|
36791-2
|
MRA Abdominal vessels |
|
24533-2
|
MRA Abdominal vessels W contrast IV |
|
36878-7
|
MRA Abdominal vessels WO contrast |
|
36855-5
|
MRA Abdominal vessels WO and W contrast IV |
|
36781-3
|
MRA Abdominal veins |
|
36846-4
|
MRA Abdominal veins WO and W contrast IV |
|
30864-3
|
MRA Abdominal veins and IVC |
|
30861-9
|
MRA Aortic arch and Neck vessels |
|
36792-0
|
MRA Adrenal vessels |
|
36879-5
|
MRA Ankle vessels WO contrast |
|
35951-3
|
MRA Aortic arch |
|
44130-3
|
MRA Aortic arch WO contrast |
|
46360-4
|
MRA Aortic arch WO and W contrast IV |
|
30859-3
|
MRA Carotid vessels and Neck vessels |
|
30865-0
|
MRA Celiac vessels and Superior mesenteric Vessels |
|
30862-7
|
MRA Chest vessels |
|
24659-5
|
MRA Chest vessels W contrast IV |
|
36547-8
|
MRA Chest vessels WO contrast |
|
36420-8
|
MRA Chest vessels WO and W contrast IV |
|
36848-0
|
MRA Chest veins WO and W contrast IV |
|
37235-9
|
MRA Circle of Willis |
|
37254-0
|
MRA Circle of Willis W contrast IV |
|
69161-8
|
MRA Circle of Willis WO and W contrast IV |
|
37501-4
|
MRA Cervical spine vessels W contrast IV |
|
37511-3
|
MRA Cervical spine vessels WO contrast |
|
37506-3
|
MRA Cervical spine vessels WO and W contrast IV |
|
30876-7
|
MRA Extremity veins |
|
36794-6
|
MRA Extremity vessels |
|
30871-8
|
MRA Femoral vessels |
|
30873-4
|
MRA Forearm vessels |
|
30872-6
|
MRA Foot vessels |
|
30856-9
|
MRA Head vessels |
|
36808-4
|
MRA Head vessels limited |
|
24593-6
|
MRA Head vessels W contrast IV |
|
36881-1
|
MRA Head vessels WO contrast |
|
36857-1
|
MRA Head vessels WO and W contrast IV |
|
30858-5
|
MRA Head veins |
|
36826-6
|
MRA Head veins W contrast IV |
|
36876-1
|
MRA Head veins WO contrast |
|
36847-2
|
MRA Head veins WO and W contrast IV |
|
42304-6
|
MRA Head vessels and Neck vessels |
|
36009-9
|
MRA Heart |
|
36082-6
|
MRA Inferior vena cava |
|
36790-4
|
MRA Inferior vena cava + tributaries |
|
36799-5
|
MRA Knee vessels |
|
36800-1
|
MRA Knee vessels - left |
|
38837-1
|
MRA Knee vessels - left WO and W contrast IV |
|
36801-9
|
MRA Knee vessels - right |
|
36862-1
|
MRA Knee vessels - right WO and W contrast IV |
|
30874-2
|
MRA Lower extremity vessels |
|
46324-0
|
MRA Lower extremity vessels W contrast IV |
|
44129-5
|
MRA Lower extremity vessels WO contrast |
|
44128-7
|
MRA Lower extremity vessels WO and W contrast IV |
|
35974-5
|
MRA Lower extremity vessels - bilateral |
|
44135-2
|
MRA Lower extremity vessels - bilateral W contrast IV |
|
36450-5
|
MRA Lower extremity vessels - bilateral WO contrast |
|
36795-3
|
MRA Lower extremity vessels - left |
|
36882-9
|
MRA Lower extremity vessels - left WO contrast |
|
36858-9
|
MRA Lower extremity vessels - left WO and W contrast IV |
|
36796-1
|
MRA Lower extremity vessels - right |
|
38773-8
|
MRA Lower extremity vessels - right WO contrast |
|
36859-7
|
MRA Lower extremity vessels - right WO and W contrast IV |
|
36079-2
|
MRA Lower extremity veins |
|
36416-6
|
MRA Lower extremity veins WO and W contrast IV |
|
36784-7
|
MRA Lower extremity veins - left |
|
36849-8
|
MRA Lower extremity veins - left WO and W contrast IV |
|
36785-4
|
MRA Lower extremity veins - right |
|
36850-6
|
MRA Lower extremity veins - right WO and W contrast IV |
|
24820-3
|
MRA Lower leg vessels W contrast IV |
|
43512-3
|
MRA Lower leg vessels - bilateral W contrast IV |
|
43513-1
|
MRA Lower leg vessels - left |
|
43556-0
|
MRA Lower leg vessels - right |
|
37502-2
|
MRA Lumbar spine vessels W contrast IV |
|
37994-1
|
MRA Lumbar spine vessels WO contrast |
|
37507-1
|
MRA Lumbar spine vessels WO and W contrast IV |
|
36085-9
|
MRA Neck vessels |
|
24844-3
|
MRA Neck vessels W contrast IV |
|
36549-4
|
MRA Neck vessels WO contrast |
|
36423-2
|
MRA Neck vessels WO and W contrast IV |
|
36788-8
|
MRA Neck veins |
|
36827-4
|
MRA Neck veins W contrast IV |
|
36877-9
|
MRA Neck veins WO contrast |
|
36853-0
|
MRA Neck veins WO and W contrast IV |
|
36802-7
|
MRA Orbit vessels |
|
36832-4
|
MRA Orbit vessels W contrast IV |
|
43458-9
|
MRA Orbit vessels WO and W contrast IV |
|
69162-6
|
MRA Pulmonary artery - bilateral W contrast IA |
|
30867-6
|
MRA Pelvis vessels |
|
24873-2
|
MRA Pelvis vessels W contrast IV |
|
36883-7
|
MRA Pelvis vessels WO contrast |
|
36863-9
|
MRA Pelvis vessels WO and W contrast IV |
|
36789-6
|
MRA Pelvis veins |
|
36854-8
|
MRA Pelvis veins WO and W contrast IV |
|
36077-6
|
MRA Portal vein |
|
36543-7
|
MRA Portal vein WO contrast |
|
36414-1
|
MRA Portal vein WO and W contrast IV |
|
36803-5
|
MRA Pulmonary vessels |
|
36275-6
|
MRA Renal artery WO and W contrast IV |
|
36078-4
|
MRA Renal vein |
|
36544-5
|
MRA Renal vein WO contrast |
|
36415-8
|
MRA Renal vein WO and W contrast IV |
|
30868-4
|
MRA Renal vessels |
|
30887-4
|
MRA Renal vessels W contrast IV |
|
44133-7
|
MRA Renal vessels WO contrast |
|
44134-5
|
MRA Renal vessels WO and W contrast IV |
|
36804-3
|
MRA Renal vessels - bilateral |
|
36805-0
|
MRA Shoulder vessels |
|
36806-8
|
MRA Shoulder vessels - left |
|
36864-7
|
MRA Shoulder vessels - left WO and W contrast IV |
|
36807-6
|
MRA Shoulder vessels - right |
|
36865-4
|
MRA Shoulder vessels - right WO and W contrast IV |
|
46359-6
|
MRA Superior mesenteric vessels |
|
44230-1
|
MRA Superior mesenteric vessels WO contrast |
|
44231-9
|
MRA Superior mesenteric vessels WO and W contrast IV |
|
37277-1
|
MRA Spinal veins WO and W contrast IV |
|
37497-5
|
MRA Spine vessels |
|
37500-6
|
MRA Spine vessels W contrast IV |
|
37510-5
|
MRA Spine vessels WO contrast |
|
37505-5
|
MRA Spine vessels WO and W contrast IV |
|
36782-1
|
MRA Subclavian artery |
|
24660-3
|
MRA Thoracic Aorta |
|
35946-3
|
MRA Thoracic and abdominal aorta |
|
44132-9
|
MRA Thoracic and abdominal aorta WO contrast |
|
44131-1
|
MRA Thoracic and abdominal aorta WO and W contrast IV |
|
36433-1
|
MRA Thoracic Aorta WO contrast |
|
36274-9
|
MRA Thoracic Aorta WO and W contrast IV |
|
25003-5
|
MRA Thigh vessels W contrast IV |
|
43514-9
|
MRA Thigh vessels - left WO contrast |
|
43515-6
|
MRA Thigh vessels - right WO contrast |
|
24584-5
|
MRA Thoracic inlet vessels W contrast IV |
|
26181-8
|
MRA Thoracic inlet vessels - bilateral W contrast IV |
|
26182-6
|
MRA Thoracic inlet vessels - left W contrast IV |
|
26183-4
|
MRA Thoracic inlet vessels - right W contrast IV |
|
30888-2
|
MRA Tibioperoneal vessels |
|
49565-5
|
MRA Thoracic spine vessels |
|
37503-0
|
MRA Thoracic spine vessels W contrast IV |
|
37512-1
|
MRA Thoracic spine vessels WO contrast |
|
37508-9
|
MRA Thoracic spine vessels WO and W contrast IV |
|
36084-2
|
MRA Upper extremity vessels |
|
24549-8
|
MRA Upper extremity vessels W contrast IV |
|
36548-6
|
MRA Upper extremity vessels WO contrast |
|
36422-4
|
MRA Upper extremity vessels WO and W contrast IV |
|
36797-9
|
MRA Upper extremity vessels - left |
|
36860-5
|
MRA Upper extremity vessels - left WO and W contrast IV |
|
36798-7
|
MRA Upper extremity vessels - right |
|
36861-3
|
MRA Upper extremity vessels - right WO and W contrast IV |
|
36080-0
|
MRA Upper extremity veins |
|
36417-4
|
MRA Upper extremity veins WO and W contrast IV |
|
36786-2
|
MRA Upper extremity veins - left |
|
36851-4
|
MRA Upper extremity veins - left WO and W contrast IV |
|
36787-0
|
MRA Upper extremity veins - right |
|
36852-2
|
MRA Upper extremity veins - right WO and W contrast IV |
|
36783-9
|
MRA Veins |
|
36081-8
|
MRA Vena cava |
|
43516-4
|
MRA Wrist vessels - left WO contrast |
|
43517-2
|
MRA Wrist vessels - right WO contrast |
|
25058-9
|
MRA Unspecified body region W contrast IV |
|
86621-0
|
Methicillin resistance mecC gene [Presence] by Molecular method |
|
72248-8
|
MRCP Abdomen WO and W contrast IV |
|
58740-2
|
MRCP Abdomen WO contrast |
|
46106-1
|
Medical record number [Identifier] |
|
77101-4
|
MRPL18A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77100-6
|
MRPL18A gene full mutation analysis in Blood or Tissue by Sequencing |
|
77077-6
|
MRPL40 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77076-8
|
MRPL40 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77099-0
|
MRPL44 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77098-2
|
MRPL44 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77095-8
|
MRPS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77094-1
|
MRPS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77097-4
|
MRPS22 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77096-6
|
MRPS22 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77093-3
|
MRRF gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77092-5
|
MRRF gene full mutation analysis in Blood or Tissue by Sequencing |
|
75859-9
|
Modified rankin scale |
|
37442-1
|
MR spectroscopy Brain |
|
37443-9
|
MR spectroscopy Unspecified body region |
|
90001-9
|
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Nose by NAA with probe detection |
|
35492-8
|
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53572-4
|
Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture |
|
52969-3
|
Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture |
|
76081-9
|
Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture |
|
77682-3
|
Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] in Nose by NAA with probe detection |
|
13317-3
|
Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture |
|
74145-4
|
Multiple sclerosis action plan |
|
34115-6
|
Medical student Hospital History and physical note |
|
76082-7
|
Microscopic observation [Identifier] in Bronchoalveolar lavage by Methenamine silver nitrate stain |
|
89658-9
|
Microscopic observation [Identifier] in Lower respiratory specimen by Methenamine silver nitrate stain |
|
6671-2
|
Microscopic observation [Identifier] in Tissue by Methenamine silver nitrate stain |
|
670-0
|
Microscopic observation [Identifier] in Unspecified specimen by Methenamine silver nitrate stain |
|
75439-0
|
Medical student Note |
|
51641-9
|
Mean sphered cell volume [Entitic volume] in Red Blood Cells |
|
17289-0
|
Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum |
|
60464-5
|
Monosodium glutamate (MSG) IgE Ab RAST class [Presence] in Serum |
|
48191-1
|
Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes |
|
50323-5
|
MSH-2 Ag [Presence] in Tissue by Immune stain |
|
89039-2
|
MSH2 gene deletion+duplication and full mutation analysis and EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
|
92675-8
|
MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
79415-6
|
MSH2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
41084-5
|
MSH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38550-0
|
MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32630-6
|
MSH2 gene+MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76063-7
|
MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
58010-0
|
MSH2 gene+MLH1 gene+MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50324-3
|
MSH-6 Ag [Presence] in Tissue by Immune stain |
|
79414-9
|
MSH6 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
38906-4
|
MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38921-3
|
MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81695-9
|
Microsatellite instability [Interpretation] in Cancer specimen Qualitative |
|
81696-7
|
Microsatellite instability markers assessed [#] in Cancer specimen |
|
81697-5
|
Microsatellite instability marker BAT25 in Cancer specimen Qualitative |
|
81698-3
|
Microsatellite instability marker BAT26 in Cancer specimen Qualitative |
|
81704-9
|
Microsatellite instability marker D17S250 in Cancer specimen Qualitative |
|
81702-3
|
Microsatellite instability marker D2S123 in Cancer specimen Qualitative |
|
81703-1
|
Microsatellite instability marker D5S346 in Cancer specimen Qualitative |
|
81709-8
|
Microsatellite markers exhibiting instability [#] in Cancer specimen |
|
81708-0
|
Microsatellite markers exhibiting instability/Microsatellite instability markers assessed in Cancer specimen |
|
81701-5
|
Microsatellite instability marker MONO27 in Cancer specimen Qualitative |
|
81699-1
|
Microsatellite instability marker NR21 in Cancer specimen Qualitative |
|
81700-7
|
Microsatellite instability marker NR24 in Cancer specimen Qualitative |
|
43368-0
|
Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal |
|
62862-8
|
Microsatellite instability [Presence] in Tissue by Immune stain |
|
25957-2
|
Methionine sulfoxide [Moles/volume] in 24 hour Urine |
|
25477-1
|
Methionine sulfoxide [Moles/time] in 24 hour Urine |
|
34340-0
|
Methionine sulfoxide [Moles/volume] in Urine |
|
25958-0
|
Methionine sulfoxide/Creatinine [Molar ratio] in 24 hour Urine |
|
75755-9
|
Methicillin susceptible Staphylococcus aureus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
46743-1
|
Maple syrup urine disease newborn screen interpretation |
|
58230-4
|
Maple syrup urine disease newborn screening comment-discussion |
|
7194-4
|
Mountain Juniper triggered histamine release [Units/volume] in Blood |
|
6178-8
|
Mountain Juniper IgE Ab [Units/volume] in Serum |
|
15615-8
|
Mountain Juniper IgE Ab RAST class [Presence] in Serum |
|
38464-4
|
Mountain Juniper IgE Ab/IgE total in Serum |
|
7193-6
|
Mountain Juniper IgG Ab [Units/volume] in Serum |
|
56323-9
|
Mountain Juniper IgG4 Ab [Mass/volume] in Serum |
|
63181-2
|
Mountain Juniper IgG Ab [Mass/volume] in Serum |
|
61116-0
|
Mitochondria rRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61111-1
|
Mitochondria tRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
93456-2
|
MT-45 [Mass/volume] in Urine by Confirmatory method |
|
21704-2
|
MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38405-7
|
MT-ATP6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
22069-9
|
MT-ATP6 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
40341-0
|
MT-ATP6 gene m.8993T>G [Presence] in Blood or Tissue by Molecular genetics method |
|
46244-0
|
Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation identified by Molecular method |
|
92827-5
|
Mycobacterium tuberculosis complex species identified in Unspecified specimen by Sequencing |
|
46247-3
|
Mycobacterium tuberculosis embB gene ethambutol resistance mutation [Identifier] by Molecular method |
|
72866-7
|
Mycobacterium tuberculosis ethA gene ethionamide resistance mutation [Presence] by Molecular method |
|
72865-9
|
Mycobacterium tuberculosis ethB gene ethionamide resistance mutation [Presence] by Molecular method |
|
72276-9
|
Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
72867-5
|
Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
63072-3
|
Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation [Presence] by Molecular method |
|
48175-4
|
Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular method |
|
46245-7
|
Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation [Identifier] by Molecular method |
|
33634-7
|
Mycobacterium tuberculosis rifAMPin resistance gene [Identifier] in Sputum by NAA with probe detection |
|
89372-7
|
Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation [Presence] by Molecular method |
|
72864-2
|
Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation [Presence] by Molecular method |
|
38609-4
|
Methyl tert-butyl ether [Mass/volume] in Air |
|
18336-8
|
Methyl tert-butyl ether [Mass/volume] in Blood |
|
40346-9
|
MT-CO1 gene m.7445A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
2627-8
|
Methylenetetrahydrofolate dehydrogenase NAD [Enzymatic activity/volume] in Serum |
|
2628-6
|
Methylenetetrahydrofolate dehydrogenase NADP [Enzymatic activity/volume] in Serum |
|
35470-4
|
Mitochondria Genes deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
61108-7
|
Mitochondria DNA complex I targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61114-5
|
Mitochondria DNA complex III targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61115-2
|
Mitochondria DNA complex IV targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34675-9
|
Mitochondria Genes targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40995-3
|
Mitochondria Genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
61109-5
|
Mitochondria DNA complex V targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77079-2
|
MTFMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77078-4
|
MTFMT gene full mutation analysis in Blood or Tissue by Sequencing |
|
28060-2
|
MTHFR gene c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
28005-7
|
MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
74998-6
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Fibroblast |
|
21709-1
|
MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38415-6
|
MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21712-5
|
MTHFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
74984-6
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Lymphoblasts |
|
43723-6
|
5,10-Methylenetetrahydrofolate reductase [Presence] in Serum |
|
1691-5
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum |
|
74999-4
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Leukocytes |
|
19748-3
|
Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Units/volume] in Serum |
|
25960-6
|
Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab RAST class [Presence] in Serum |
|
35122-1
|
MTM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41083-7
|
MTM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40354-3
|
MT-ND1 gene m.3460G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
48027-7
|
MT-ND4 gene c.G15257A [Presence] in Blood or Tissue by Molecular genetics method |
|
21705-9
|
MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
40351-9
|
MT-ND4 gene m.11778G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
21707-5
|
MT-ND4 gene p.Thr109Ala [Presence] in Blood or Tissue by Molecular genetics method |
|
40352-7
|
MT-ND5 gene m.13513G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
74692-5
|
MT-ND6 gene m.14459G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
40353-5
|
MT-ND6 gene m.14484T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
77054-5
|
MTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77053-7
|
MTR gene full mutation analysis in Blood or Tissue by Sequencing |
|
34678-3
|
MT-RNR1 gene m.1555A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
34490-3
|
MT-TK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41082-9
|
MT-TK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40343-6
|
MT-TK gene m.8296A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
21713-3
|
MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
40345-1
|
MT-TK gene m.8356T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40349-3
|
MT-TK gene m.8363G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
21714-1
|
MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
40348-5
|
MT-TL1 gene m.3252T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40347-7
|
MT-TL1 gene m.3256C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
40342-8
|
MT-TL1 gene m.3271T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40350-1
|
MT-TL1 gene m.3291T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
51599-9
|
Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose |
|
3794-5
|
Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose |
|
3795-2
|
Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose |
|
51600-5
|
Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose |
|
3796-0
|
Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose |
|
51611-2
|
Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose |
|
51601-3
|
Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose |
|
3797-8
|
Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose |
|
51602-1
|
Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose |
|
3792-9
|
Methotrexate [Mass/volume] in Cerebral spinal fluid |
|
34628-8
|
Methotrexate [Moles/volume] in Cerebral spinal fluid |
|
4324-0
|
Methotrexate [Mass] of Dose |
|
34599-1
|
Methotrexate [Mass/volume] in Body fluid |
|
73283-4
|
Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73282-6
|
Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3793-7
|
Methotrexate [Mass/volume] in Serum or Plasma |
|
14836-1
|
Methotrexate [Moles/volume] in Serum or Plasma |
|
70098-9
|
Methotrexate [Moles/volume] in Serum or Plasma --10th specimen |
|
70099-7
|
Methotrexate [Moles/volume] in Serum or Plasma --2nd specimen |
|
70100-3
|
Methotrexate [Moles/volume] in Serum or Plasma --3rd specimen |
|
70101-1
|
Methotrexate [Moles/volume] in Serum or Plasma --4th specimen |
|
70102-9
|
Methotrexate [Moles/volume] in Serum or Plasma --5th specimen |
|
70103-7
|
Methotrexate [Moles/volume] in Serum or Plasma --6th specimen |
|
70104-5
|
Methotrexate [Moles/volume] in Serum or Plasma --7th specimen |
|
70105-2
|
Methotrexate [Moles/volume] in Serum or Plasma --8th specimen |
|
70106-0
|
Methotrexate [Moles/volume] in Serum or Plasma --9th specimen |
|
17266-8
|
Methotrexate [Mass/volume] in Urine |
|
81628-0
|
Methotrexate monoglutamate [Moles/volume] in Red Blood Cells |
|
81627-2
|
Methotrexate diglutamate [Moles/volume] in Red Blood Cells |
|
81626-4
|
Methotrexate triglutamate [Moles/volume] in Red Blood Cells |
|
81625-6
|
Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells |
|
81624-9
|
Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells |
|
81631-4
|
Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative |
|
76351-6
|
Methotrexate polyglutamates [Moles/volume] in Red Blood Cells |
|
74126-4
|
Mucin-4 (MUC-4) Ag [Presence] in Tissue by Immune stain |
|
10796-1
|
Microscopic observation [Identifier] in Tissue by Mucicarmine stain |
|
33769-1
|
Mucin clot [Appearance] in Synovial fluid Qualitative --15 minutes post incubation |
|
33770-9
|
Mucin clot [Appearance] in Synovial fluid Qualitative --30 minutes post incubation |
|
6909-6
|
Mucin clot [Appearance] in Synovial fluid Qualitative |
|
10822-5
|
Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |
|
85282-2
|
Mucinous fraction [Area Fraction] in Colorectal cancer specimen by Light microscopy |
|
2637-7
|
Mucoprotein [Mass/volume] in Serum |
|
5248-0
|
Mucor sp Ab [Units/volume] in Serum |
|
7509-3
|
Mucor sp IgG Ab [Units/volume] in Serum |
|
80347-8
|
Mucous membrane integrity of Mucous membrane |
|
51478-6
|
Mucus [#/volume] in Urine by Automated count |
|
50235-1
|
Mucus [#/area] in Urine sediment by Automated count |
|
46421-4
|
Mucus [#/area] in Urine sediment by Microscopy high power field |
|
28545-2
|
Mucus [#/area] in Urine sediment by Microscopy low power field |
|
14329-7
|
Mucus [Presence] in Sputum by Light microscopy |
|
42524-9
|
Mucus [Presence] in Stool by Light microscopy |
|
53321-6
|
Mucus [Presence] in Urine by Automated |
|
88979-0
|
Mucus [Presence] in Urine sediment |
|
8247-9
|
Mucus [Presence] in Urine sediment by Light microscopy |
|
81897-1
|
Monounsaturated fat intake 24 hour Estimated |
|
81899-7
|
Monounsaturated fat intake 24 hour Measured |
|
63458-4
|
Mugwort native (nArt v) 1 IgE Ab [Units/volume] in Serum |
|
81966-4
|
Mugwort native (nArt v) 1 IgE Ab RAST class [Presence] in Serum |
|
65783-3
|
Mugwort native (nArt v) 3 IgE Ab [Units/volume] in Serum |
|
81968-0
|
Mugwort native (nArt v) 3 IgE Ab RAST class [Presence] in Serum |
|
7510-1
|
Mugwort triggered histamine release [Units/volume] in Blood |
|
6183-8
|
Mugwort IgE Ab [Units/volume] in Serum |
|
15863-4
|
Mugwort IgE Ab RAST class [Presence] in Serum |
|
39604-4
|
Mugwort IgE Ab/IgE total in Serum |
|
13188-8
|
Mugwort IgG Ab [Units/volume] in Serum |
|
56325-4
|
Mugwort IgG4 Ab [Mass/volume] in Serum |
|
63208-3
|
Mugwort IgG Ab [Mass/volume] in Serum |
|
48254-7
|
Mugwort triggered leukotriene release [Mass/volume] by Leukocytes |
|
76197-3
|
Multiple sigh breaths delivered 1 minute Ventilator |
|
88080-7
|
Multiple birth set identifier |
|
45371-2
|
Multiple pregnancy |
|
84403-5
|
Multi-specialty program Case manager Note |
|
78252-4
|
Multi-specialty program Consult note |
|
68673-3
|
Multi-specialty program Diagnostic study note |
|
68674-1
|
Multi-specialty program Discharge summary |
|
78268-0
|
Multi-specialty program Education note |
|
78454-6
|
Multi-specialty program Flowsheet |
|
83866-4
|
Multi-specialty program Group counseling note |
|
68676-6
|
Multi-specialty program History and physical note |
|
68681-6
|
Multi-specialty program Hospital Consult note |
|
68682-4
|
Multi-specialty program Hospital Letter |
|
78336-5
|
Multi-specialty program Initial evaluation note |
|
68677-4
|
Multi-specialty program Note |
|
84333-4
|
Multi-specialty program Nurse Note |
|
84404-3
|
Multi-specialty program Telephone encounter Note |
|
80754-5
|
Multi-specialty program Plan of care note |
|
68678-2
|
Multi-specialty program Preoperative evaluation and management note |
|
68679-0
|
Multi-specialty program Progress note |
|
75445-7
|
Multi-specialty program Patient's home Note |
|
78331-6
|
Multi-specialty program Referral note |
|
90753-5
|
Multi-specialty program Social worker Note |
|
85888-6
|
Multi-specialty program Telehealth Note |
|
84069-4
|
Multi-specialty program Telehealth Summary note |
|
68680-8
|
Multi-specialty program Transfer summary note |
|
81949-0
|
Multi-trace element supplement intake 24 hour |
|
81950-8
|
Multivitamin andor mineral supplement intake 24 hour |
|
84070-2
|
Multi-specialty program Telehealth Plan of care note |
|
50325-0
|
MUM-1 Ag [Presence] in Tissue by Immune stain |
|
7133-2
|
Mung Bean IgE Ab [Units/volume] in Serum |
|
7134-0
|
Mung Bean IgG Ab [Units/volume] in Serum |
|
21100-3
|
Mung Bean IgG Ab RAST class [Presence] in Serum |
|
60543-6
|
Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB) |
|
60542-8
|
Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB) |
|
7033-4
|
Mupirocin [Susceptibility] by Gradient strip |
|
35822-6
|
Mupirocin [Susceptibility] by Disk diffusion (KB) |
|
35823-4
|
Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20389-3
|
Mupirocin [Susceptibility] |
|
80282-7
|
Murmur location [Anatomy] by Auscultation |
|
80283-5
|
Murmur radiating to body location [Anatomy] by Auscultation |
|
48553-2
|
Muscle sarcolemma Ab [Units/volume] in Pleural fluid |
|
32702-3
|
Muscle sarcolemma Ab [Presence] in Serum |
|
5251-4
|
Muscle sarcolemma Ab [Units/volume] in Serum |
|
49626-5
|
Muscle sarcolemma Ab [Titer] in Pleural fluid by Immunofluorescence |
|
49627-3
|
Muscle sarcolemma Ab [Titer] in Serum by Immunofluorescence |
|
40562-1
|
Actin muscle specific Ag [Presence] in Tissue by Immune stain |
|
85364-8
|
Muscarinic acetylcholine receptor M3 Ab [Presence] in Serum |
|
65751-0
|
Muscle Pathology biopsy report |
|
80322-1
|
Muscle strength |
|
80328-8
|
Musculoskeletal assessment [Interpretation] |
|
7516-8
|
Mushroom triggered histamine release [Units/volume] in Blood |
|
20891-8
|
Mushroom identified |
|
6848-6
|
Mushroom IgE Ab [Units/volume] in Serum |
|
15866-7
|
Mushroom IgE Ab RAST class [Presence] in Serum |
|
61209-3
|
Mushroom IgE Ab/IgE total in Serum |
|
7515-0
|
Mushroom IgG Ab [Units/volume] in Serum |
|
21403-1
|
Mushroom IgG Ab RAST class [Presence] in Serum |
|
56326-2
|
Mushroom IgG4 Ab [Mass/volume] in Serum |
|
35540-4
|
Mushroom IgG Ab [Mass/volume] in Serum |
|
17294-0
|
Mushroom toxins [Identifier] in Urine |
|
57436-8
|
Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay |
|
38362-0
|
Muscle specific receptor tyrosine kinase Ab [Presence] in Serum |
|
51716-9
|
Muscle specific receptor tyrosine kinase Ab [Moles/volume] in Serum |
|
51763-1
|
Muscle specific receptor tyrosine kinase Ab [Titer] in Serum or Plasma |
|
63537-5
|
Muscle specific receptor tyrosine kinase IgG Ab [Mass/volume] in Serum by Immunoassay |
|
6185-3
|
Mustard IgE Ab [Units/volume] in Serum |
|
15870-9
|
Mustard IgE Ab RAST class [Presence] in Serum |
|
50350-8
|
Mustard IgE Ab/IgE total in Serum |
|
7521-8
|
Mustard IgG Ab [Units/volume] in Serum |
|
21404-9
|
Mustard IgG Ab RAST class [Presence] in Serum |
|
56328-8
|
Mustard IgG4 Ab [Mass/volume] in Serum |
|
60384-5
|
Mustard IgG Ab [Mass/volume] in Serum |
|
54022-9
|
Mutated citrullinated vimentin Ab [Units/volume] in Serum |
|
94076-7
|
Mutations/Megabase [# Ratio] in Tumor |
|
41081-1
|
MUTYH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40959-9
|
MUTYH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
17292-4
|
Mumps virus Ab [Units/volume] in Cerebral spinal fluid |
|
47412-2
|
Mumps virus Ab [Units/volume] in Serum by Immunoassay |
|
31503-6
|
Mumps virus Ab [Presence] in Serum |
|
26942-3
|
Mumps virus Ab [Presence] in Serum by Immunoassay |
|
7965-7
|
Mumps virus Ab [Units/volume] in Serum |
|
30146-5
|
Mumps virus Ab [Presence] in Serum --2nd specimen |
|
22413-9
|
Mumps virus Ab [Titer] in Cerebral spinal fluid |
|
9567-9
|
Mumps virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22414-7
|
Mumps virus Ab [Titer] in Serum |
|
5249-8
|
Mumps virus Ab [Titer] in Serum by Complement fixation |
|
5250-6
|
Mumps virus Ab [Titer] in Serum by Immunofluorescence |
|
31888-1
|
Mumps virus Ag [Presence] in Cerebral spinal fluid |
|
14545-8
|
Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31889-9
|
Mumps virus Ag [Presence] in Cervix |
|
14551-6
|
Mumps virus Ag [Presence] in Cervix by Immunofluorescence |
|
31890-7
|
Mumps virus Ag [Presence] in Eye |
|
14548-2
|
Mumps virus Ag [Presence] in Eye by Immunofluorescence |
|
67807-8
|
Mumps virus Ag [Presence] in Isolate by Immunofluorescence |
|
31892-3
|
Mumps virus Ag [Presence] in Nose |
|
14549-0
|
Mumps virus Ag [Presence] in Nose by Immunofluorescence |
|
31893-1
|
Mumps virus Ag [Presence] in Penis |
|
14554-0
|
Mumps virus Ag [Presence] in Penis by Immunofluorescence |
|
31894-9
|
Mumps virus Ag [Presence] in Serum |
|
6480-8
|
Mumps virus Ag [Presence] in Serum by Immunofluorescence |
|
31895-6
|
Mumps virus Ag [Presence] in Skin |
|
14547-4
|
Mumps virus Ag [Presence] in Skin by Immunofluorescence |
|
31896-4
|
Mumps virus Ag [Presence] in Sputum |
|
14550-8
|
Mumps virus Ag [Presence] in Sputum by Immunofluorescence |
|
31897-2
|
Mumps virus Ag [Presence] in Throat |
|
14546-6
|
Mumps virus Ag [Presence] in Throat by Immunofluorescence |
|
31898-0
|
Mumps virus Ag [Presence] in Urine sediment |
|
14553-2
|
Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence |
|
31899-8
|
Mumps virus Ag [Presence] in Urethra |
|
14555-7
|
Mumps virus Ag [Presence] in Urethra by Immunofluorescence |
|
31891-5
|
Mumps virus Ag [Presence] in Vaginal fluid |
|
14552-4
|
Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31900-4
|
Mumps virus Ag [Presence] in Unspecified specimen |
|
12237-4
|
Mumps virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30941-9
|
Mumps virus dose count in combination vaccine |
|
85807-6
|
Mumps virus genotype in Unspecified specimen |
|
39011-2
|
Mumps virus IgG Ab [Presence] in Cerebral spinal fluid |
|
40737-9
|
Mumps virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13266-2
|
Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
74422-7
|
Mumps virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29241-7
|
Mumps virus IgG Ab [Units/volume] in Body fluid |
|
25418-5
|
Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
22415-4
|
Mumps virus IgG Ab [Presence] in Serum |
|
6476-6
|
Mumps virus IgG Ab [Presence] in Serum by Immunoassay |
|
7966-5
|
Mumps virus IgG Ab [Units/volume] in Serum |
|
24240-4
|
Mumps virus IgG Ab [Units/volume] in Serum --1st specimen |
|
24241-2
|
Mumps virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
22416-2
|
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21401-5
|
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22417-0
|
Mumps virus IgG Ab [Titer] in Serum |
|
6477-4
|
Mumps virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
88454-4
|
Mumps virus IgG+IgM Ab [Interpretation] in Cerebral spinal fluid Qualitative by Immunofluorescence |
|
17293-2
|
Mumps virus IgG+IgM Ab [Units/volume] in Serum |
|
73560-5
|
Mumps virus IgG and IgM [Interpretation] in Serum |
|
41131-4
|
Mumps virus IgM Ab [Presence] in Cerebral spinal fluid |
|
40738-7
|
Mumps virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13267-0
|
Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
74421-9
|
Mumps virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
69766-4
|
Mumps virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
25419-3
|
Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
22418-8
|
Mumps virus IgM Ab [Presence] in Serum |
|
6478-2
|
Mumps virus IgM Ab [Presence] in Serum by Immunoassay |
|
7967-3
|
Mumps virus IgM Ab [Units/volume] in Serum |
|
22419-6
|
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21402-3
|
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22420-4
|
Mumps virus IgM Ab [Titer] in Serum |
|
6479-0
|
Mumps virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
93749-0
|
Mumps virus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
7968-1
|
Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
53603-7
|
Mumps virus RNA [Presence] in Serum by NAA with probe detection |
|
91806-0
|
Mumps virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86580-8
|
Mumps virus RNA [Presence] in Urine by NAA with probe detection |
|
47532-7
|
Mumps virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31504-4
|
Mumps virus soluble Ab [Units/volume] in Cerebral spinal fluid |
|
31505-1
|
Mumps virus soluble Ab [Units/volume] in Serum |
|
31132-4
|
Mumps virus soluble Ab [Titer] in Cerebral spinal fluid |
|
31130-8
|
Mumps virus soluble Ab [Titer] in Serum |
|
85800-1
|
Mumps virus SH gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
91787-2
|
Mumps virus [Presence] in Upper respiratory specimen by Organism specific culture |
|
31506-9
|
Mumps virus particle-bound Ab [Units/volume] in Cerebral spinal fluid |
|
31507-7
|
Mumps virus particle-bound Ab [Units/volume] in Serum |
|
31133-2
|
Mumps virus particle-bound Ab [Titer] in Cerebral spinal fluid |
|
31131-6
|
Mumps virus particle-bound Ab [Titer] in Serum |
|
13921-2
|
Mumps virus [Presence] in Unspecified specimen by Organism specific culture |
|
20269-7
|
Mitral valve Acceleration slope by US.doppler |
|
20270-5
|
Mitral valve Acceleration by US.doppler |
|
81385-7
|
Mitral valve annulus Tissue velocity.A-wave.max by US.tissue doppler |
|
18017-4
|
Mitral valve annulus Diameter by US |
|
80050-8
|
Mitral valve annulus Diameter at end diastole by US.2D.A2C |
|
80051-6
|
Mitral valve annulus Diameter at end diastole by US.2D.A4C |
|
80052-4
|
Mitral valve annulus Diameter at end diastole by US.2D.PLAX |
|
81384-0
|
Mitral valve annulus Tissue velocity.E-wave.max by US.tissue doppler |
|
20264-8
|
Mitral valve annulus Region crossection [Area] by US+Calculated |
|
81383-2
|
Mitral valve annulus Tissue velocity.S-wave.max by US.tissue doppler |
|
80053-2
|
Mitral valve annulus Velocity-time integral during diastole by US.doppler |
|
29470-2
|
Mitral valve annulus Blood velocity-time integral by US.calculated |
|
80065-6
|
Mitral valve A-wave duration by US.doppler |
|
80066-4
|
Mitral valve Maximum A-wave velocity by US.doppler |
|
20278-8
|
Mitral valve Mean blood velocity by US.doppler |
|
82340-1
|
Mitral valve Closure to opening [Time] by US.doppler |
|
18002-6
|
Mitral valve Deceleration slope [Acceleration] by US.doppler |
|
17999-4
|
Mitral valve Deceleration [Time] by US.doppler |
|
18001-8
|
Mitral valve Deceleration.pressure.half time by US.doppler |
|
20273-9
|
Mitral valve Diameter 2 by US |
|
20272-1
|
Mitral valve Diameter by US |
|
20271-3
|
Mitral valve Diastolic filling period by US |
|
81387-3
|
Mitral valve Regurgitant blood duration of 1 to 3 meters per second flow velocity by US.doppler |
|
80069-8
|
Mitral valve Effective orifice area during diastole by US.doppler pressure half time |
|
80067-2
|
Mitral valve Effective orifice area during diastole by US.doppler+Calculated by PISA method |
|
77914-0
|
Mitral valve Effective regurgitant orifice area by US.doppler+Calculated by volumetric method |
|
29448-8
|
Mitral valve Effective regurgitant orifice area by US.doppler+Calculated by PISA method |
|
80071-4
|
Mitral valve Effective regurgitant orifice area during systole by US.doppler+Calculated by PISA method |
|
78191-4
|
Mitral valve E-wave deceleration time by US.doppler |
|
80070-6
|
Mitral valve Maximum E-wave velocity by US.doppler |
|
81386-5
|
Mitral valve Maximum E-wave velocity/Tissue velocity.E-wave.max by US.doppler+tissue doppler |
|
81398-0
|
Mitral valve Maximum E-wave velocity/Flow propagation velocity.E wave by US.M-mode+doppler.A4C |
|
80072-2
|
Mitral valve Flow propagation velocity.E-wave by US.M-mode+doppler.A4C |
|
20274-7
|
Mitral valve Flow [Area] by US+Calculated |
|
81397-2
|
Mitral valve lateral annulus Tissue velocity.A-wave.max by US.tissue doppler |
|
78186-4
|
Mitral valve lateral annulus Tissue velocity.E-wave.max by US.tissue doppler |
|
80054-0
|
Mitral valve lateral annulus Tissue velocity.E-wave.max by US.tissue doppler.A4C |
|
78190-6
|
Mitral valve lateral annulus E-wave/Tissue velocity.E-wave.max by US.doppler+tissue doppler |
|
78188-0
|
Mitral valve lateral annulus Tissue velocity.S-wave.max by US.tissue doppler |
|
82595-0
|
Mitral valve leaflet tip Velocity-time integral (VTI) for the area under A wave by US.doppler |
|
82594-3
|
Mitral valve leaflet tip Velocity-time integral (VTI) for the area under E wave by US.doppler |
|
80068-0
|
Mitral valve Maximum orifice area during diastole by US.2D.PSAX+Measured by planimetry |
|
80074-8
|
Mitral valve Maximum pressure gradient during diastole by US.doppler+Calculated by simplified Bernoulli |
|
80058-1
|
Mitral valve Maximum pressure gradient dur systole by US.doppler+Calculated by simplified Bernoulli |
|
20250-7
|
Mitral valve Maximum regurgitant pressure gradient by US+Calculated |
|
80057-3
|
Mitral valve Maximum regurgitant blood flow rate during systole by US.doppler+Calculated by PISA method |
|
80062-3
|
Mitral valve Maximum regurgitant blood flow velocity during systole by US.doppler continuous wave |
|
80073-0
|
Mitral valve Mean pressure gradient dur diastole by US.doppler+Calculated by simplified Bernoulli |
|
18059-6
|
Mitral valve Mean pressure gradient by US.doppler |
|
78178-1
|
Mitral valve Mean regurgitant pressure gradient by US.doppler |
|
81396-4
|
Mitral valve medial annulus Tissue velocity.A-wave.max by US.tissue doppler |
|
79911-4
|
Mitral valve medial annulus Tissue velocity.E-wave.max by US.tissue doppler.A4C |
|
78189-8
|
Mitral valve medial annulus E-wave/Tissue velocity.E-wave.max by US.doppler+tissue doppler |
|
78185-6
|
Mitral valve medial annulus Tissue velocity.E-wave.max by US.tissue doppler |
|
78187-2
|
Mitral valve medial annulus Tissue velocity.S-wave.max by US.tissue doppler |
|
18097-6
|
Mitral valve Minimum orifice area by US.doppler pressure half time |
|
78179-9
|
Mitral valve Orifice area by US.2D+Measured by planimetry |
|
18098-4
|
Mitral valve Minimum orifice area minor axis by US 2D |
|
17993-7
|
Mitral valve Cardiac output by US.doppler |
|
17978-8
|
Mitral valve Peak A wave by US.doppler |
|
18037-2
|
Mitral valve Peak E wave by US.doppler |
|
18038-0
|
Mitral valve Peak E wave/Peak A wave by US.doppler |
|
18057-0
|
Mitral valve Peak pressure gradient by US.doppler |
|
79912-2
|
Mitral valve Pressure half time during diastole by US.doppler |
|
80059-9
|
Mitral valve PISA radius during systole [Length] by US.2D+doppler |
|
80060-7
|
Mitral valve PISA velocity during systole by US.2D+doppler |
|
18109-9
|
Mitral valve Prosthetic valve type by US |
|
18113-1
|
Mitral valve Regurgitation degree by US.doppler |
|
18035-6
|
Mitral valve regurgitant jet dP/dT (1M/S to 3 M/S) [Pressure rate] by US.doppler continuous wave |
|
20268-9
|
Mitral valve Maximum regurgitant blood flow velocity during systole by US.doppler |
|
81394-9
|
Mitral valve Regurgitant volume by US.doppler+Calculated by volumetric method |
|
29449-6
|
Mitral valve Regurgitant volume by US.doppler+Calculated by PISA method |
|
93628-6
|
Mitral valve Regurgitant blood velocity-time integral by US.doppler |
|
80055-7
|
Mitral valve Regurgitant fraction by US.doppler+Calculated by continuity VTI |
|
81395-6
|
Mitral valve Regurgitant fraction by US.doppler+Calculated by volumetric method |
|
80056-5
|
Mitral valve Regurgitant fraction by US.doppler+Calculated by PISA method |
|
80063-1
|
Mitral valve Regurgitant blood flow volume during systole by US.doppler+Calculated by continuity VTI |
|
80064-9
|
Mitral valve Regurgitant blood flow volume during systole by US.doppler+Calculated by PISA method |
|
77916-5
|
Mitral valve Stenosis degree by US |
|
10795-3
|
Microscopic observation [Identifier] in Tissue by Methyl violet stain |
|
77913-2
|
Mitral valve Vena contracta diameter by US.doppler |
|
80061-5
|
Mitral valve Vena contracta diameter during systole by US.2D+doppler |
|
79913-0
|
Mitral valve Maximum blood flow velocity during diastole by US.doppler |
|
20277-0
|
Mitral valve Maximum blood flow velocity by US.doppler |
|
11708-5
|
Mitral valve Peak systolic flow velocity by US.doppler |
|
20276-2
|
Mitral valve Maximum blood flow velocity during systole by US --for peak half-time calculation |
|
79914-8
|
Mitral valve Velocity-time integral during diastole by US.doppler |
|
18172-7
|
Mitral valve Blood velocity-time integral by US.doppler |
|
81121-6
|
Murray Valley encephalitis virus Ab [Presence] in Serum |
|
81115-8
|
Murray Valley encephalitis virus Ab [Titer] in Serum |
|
81111-7
|
Murray Valley encephalitis virus IgG Ab [Presence] in Serum |
|
81112-5
|
Murray Valley encephalitis virus IgG Ab [Titer] in Serum |
|
81113-3
|
Murray Valley encephalitis virus IgM Ab [Presence] in Serum |
|
81114-1
|
Murray Valley encephalitis virus IgM Ab [Titer] in Serum |
|
81651-2
|
Murray Valley encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47964-2
|
MVK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21715-8
|
MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22068-1
|
MXI1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
81519-1
|
My ability to concentrate has been good in past 7 days [PROMIS] |
|
81513-4
|
My ability to count money has been as good as usual in past 7 days [PROMIS] |
|
81514-2
|
My ability to follow driving directions has been as good as usual in past 7 days [PROMIS] |
|
81511-8
|
My ability to keep track of lists has been as good as usual in past 7 days [PROMIS] |
|
81509-2
|
My ability to remember important dates has been as good as usual in past 7 days [PROMIS] |
|
81510-0
|
My ability to remember names has been as good as usual in past 7 days [PROMIS] |
|
81516-7
|
My ability to remember things that I need to do has been as good as usual in past 7 days [PROMIS] |
|
91438-2
|
My appetite changed in past 7 days [PROMIS.PEDS] |
|
71282-8
|
My arms or legs are weak in the past 4 weeks [FACIT] |
|
71166-3
|
My arms or legs feel weak in the past 7 days [FACIT] |
|
91439-0
|
My back hurt in past 7 days [PROMIS.PEDS] |
|
91340-0
|
My back pain has spread down my leg(s) at some time in the last 2 weeks [STarT Back] |
|
91440-8
|
My body shook in past 7 days [PROMIS.PEDS] |
|
91441-6
|
My breathing was fast in past 7 days [PROMIS.PEDS] |
|
91442-4
|
My breathing was fast, even when I was not exercising or playing hard in past 7 days [PROMIS.PEDS] |
|
90670-1
|
My child and his/her friends helped each other out in past 7 days [PROMIS.PARENTPROXY] |
|
78150-0
|
My child believed in helping our family, no matter what in past 4 weeks [PROMIS.PARENTPROXY] |
|
91411-9
|
My child coughed because of his or her asthma in past 7 days [PROMIS.PARENTPROXY] |
|
90697-4
|
My child could bend over to pick something up in past 7 days [PROMIS.PARENTPROXY] |
|
90703-0
|
My child could carry his/her books in a backpack in past 7 days [PROMIS.PARENTPROXY] |
|
90683-4
|
My child could do sports and exercise that other kids his/her age could do in past 7 days [PROMIS.PARENTPROXY] |
|
90684-2
|
My child could get down on his/her knees without holding on to something in past 7 days [PROMIS.PARENTPROXY] |
|
90698-2
|
My child could get in and out of a car in past 7 days [PROMIS.PARENTPROXY] |
|
90692-5
|
My child could get into bed by himself/herself in past 7 days [PROMIS.PARENTPROXY] |
|
90701-4
|
My child could get out of bed by himself/herself in past 7 days [PROMIS.PARENTPROXY] |
|
90688-3
|
My child could get up from a regular toilet in past 7 days [PROMIS.PARENTPROXY] |
|
90696-6
|
My child could get up from the floor in past 7 days [PROMIS.PARENTPROXY] |
|
90685-9
|
My child could go up one step in past 7 days [PROMIS.PARENTPROXY] |
|
90700-6
|
My child could keep up when he/she played with other kids in past 7 days [PROMIS.PARENTPROXY] |
|
90695-8
|
My child could move his/her legs in past 7 days [PROMIS.PARENTPROXY] |
|
92056-1
|
My child could not stay still for long in past 7 days [PROMIS.PARENTPROXY] |
|
91396-2
|
My child could not stop feeling sad in past 7 days [PROMIS.PARENTPROXY] |
|
90682-6
|
My child could ride a bike in past 7 days [PROMIS.PARENTPROXY] |
|
90686-7
|
My child could run a mile in past 7 days [PROMIS.PARENTPROXY] |
|
90689-1
|
My child could stand up on his/her tiptoes in past 7 days [PROMIS.PARENTPROXY] |
|
90693-3
|
My child could stand up without help in past 7 days [PROMIS.PARENTPROXY] |
|
90690-9
|
My child could turn his/her head all the way to the side in past 7 days [PROMIS.PARENTPROXY] |
|
90691-7
|
My child could walk across the room in past 7 days [PROMIS.PARENTPROXY] |
|
90699-0
|
My child could walk more than one block in past 7 days [PROMIS.PARENTPROXY] |
|
90687-5
|
My child could walk up stairs without holding on to anything in past 7 days [PROMIS.PARENTPROXY] |
|
91397-0
|
My child didn't care about anything in past 7 days [PROMIS.PARENTPROXY] |
|
71252-1
|
My child eats as much as s-he wants in the past 7 days [FACIT] |
|
71253-9
|
My child eats enough to do whatever s-he needs to do in the past 7 days [FACIT] |
|
71263-8
|
My child feels like s-he is getting better in the past 7 days [FACIT] |
|
78149-2
|
My child felt a sense of togetherness with our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
90672-7
|
My child felt accepted by other kids his/her age in past 7 days [PROMIS.PARENTPROXY] |
|
91270-9
|
My child felt active in past 7 days [PROMIS.PARENTPROXY] |
|
91398-8
|
My child felt alone in past 7 days [PROMIS.PARENTPROXY] |
|
89943-5
|
My child felt angry when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91293-1
|
My child felt appreciated in past 7 days [PROMIS.PARENTPROXY] |
|
92053-8
|
My child felt as if he or she needed to move his or her legs a lot in past 7 days [PROMIS.PARENTPROXY] |
|
91276-6
|
My child felt blissful in past 7 days [PROMIS.PARENTPROXY] |
|
91305-3
|
My child felt calm in past 7 days [PROMIS.PARENTPROXY] |
|
91298-0
|
My child felt carefree in past 7 days [PROMIS.PARENTPROXY] |
|
91288-1
|
My child felt cheerful in past 7 days [PROMIS.PARENTPROXY] |
|
91296-4
|
My child felt comfortable in past 7 days [PROMIS.PARENTPROXY] |
|
91356-6
|
My child felt concerned about what was going on in his or her life in past 7 days [PROMIS.PARENTPROXY] |
|
91302-0
|
My child felt content in past 7 days [PROMIS.PARENTPROXY] |
|
91284-0
|
My child felt delighted in past 7 days [PROMIS.PARENTPROXY] |
|
92064-5
|
My child felt dizzy in past 7 days [PROMIS.PARENTPROXY] |
|
91274-1
|
My child felt energetic in past 7 days [PROMIS.PARENTPROXY] |
|
91275-8
|
My child felt enthusiastic in past 7 days [PROMIS.PARENTPROXY] |
|
78142-7
|
My child felt everyone in our family loved each other in past 4 weeks [PROMIS.PARENTPROXY] |
|
78141-9
|
My child felt everyone in our family loved him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
91399-6
|
My child felt everything in his or her life went wrong in past 7 days [PROMIS.PARENTPROXY] |
|
91295-6
|
My child felt fulfilled in past 7 days [PROMIS.PARENTPROXY] |
|
91269-1
|
My child felt full of pep in past 7 days [PROMIS.PARENTPROXY] |
|
90665-1
|
My child felt good about his/her friendships in past 7 days [PROMIS.PARENTPROXY] |
|
91277-4
|
My child felt good in past 7 days [PROMIS.PARENTPROXY] |
|
91301-2
|
My child felt grateful in past 7 days [PROMIS.PARENTPROXY] |
|
91289-9
|
My child felt great in past 7 days [PROMIS.PARENTPROXY] |
|
91287-3
|
My child felt happy in past 7 days [PROMIS.PARENTPROXY] |
|
78130-2
|
My child felt he or she could depend on our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78134-4
|
My child felt he or she could talk to someone in our family if something was bothering him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78133-6
|
My child felt he or she got all the help he or she needed from our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78131-0
|
My child felt he or she got the support he or she needed from our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78146-8
|
My child felt he or she had a strong relationship with our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91291-5
|
My child felt he or she had much to be proud about in past 7 days [PROMIS.PARENTPROXY] |
|
91366-5
|
My child felt he or she had too much going on in past 7 days [PROMIS.PARENTPROXY] |
|
78145-0
|
My child felt he or she really belonged in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78154-2
|
My child felt he or she was really important to our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91267-5
|
My child felt healthy in past 7 days [PROMIS.PARENTPROXY] |
|
91283-2
|
My child felt his or her life was pleasurable in past 7 days [PROMIS.PARENTPROXY] |
|
78124-5
|
My child felt important in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78148-4
|
My child felt it was easy for him or her to be close to everyone in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91285-7
|
My child felt joyful in past 7 days [PROMIS.PARENTPROXY] |
|
91400-2
|
My child felt like he or she couldn't do anything right in past 7 days [PROMIS.PARENTPROXY] |
|
91995-1
|
My child felt like something awful might happen in past 7 days [PROMIS.PARENTPROXY] |
|
91401-0
|
My child felt lonely in past 7 days [PROMIS.PARENTPROXY] |
|
78143-5
|
My child felt loved by our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91280-8
|
My child felt merry in past 7 days [PROMIS.PARENTPROXY] |
|
91917-5
|
My child felt more tired than usual when he/she woke up in the morning in past 7 days [PROMIS.PARENTPROXY] |
|
91997-7
|
My child felt nervous in past 7 days [PROMIS.PARENTPROXY] |
|
78139-3
|
My child felt our family treated him or her fairly in past 4 weeks [PROMIS.PARENTPROXY] |
|
91361-6
|
My child felt overwhelmed in past 7 days [PROMIS.PARENTPROXY] |
|
91304-6
|
My child felt peaceful in past 7 days [PROMIS.PARENTPROXY] |
|
91290-7
|
My child felt pleased in past 7 days [PROMIS.PARENTPROXY] |
|
91299-8
|
My child felt positive in past 7 days [PROMIS.PARENTPROXY] |
|
91292-3
|
My child felt proud in past 7 days [PROMIS.PARENTPROXY] |
|
78123-7
|
My child felt really respected by our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91271-7
|
My child felt refreshed in past 7 days [PROMIS.PARENTPROXY] |
|
91297-2
|
My child felt relaxed in past 7 days [PROMIS.PARENTPROXY] |
|
91294-9
|
My child felt respected in past 7 days [PROMIS.PARENTPROXY] |
|
91402-8
|
My child felt sad in past 7 days [PROMIS.PARENTPROXY] |
|
91303-8
|
My child felt satisfied in past 7 days [PROMIS.PARENTPROXY] |
|
91994-4
|
My child felt scared in past 7 days [PROMIS.PARENTPROXY] |
|
91412-7
|
My child felt scared that he or she might have trouble breathing because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
91362-4
|
My child felt so upset that he or she could not remember what happened or what he or she did in past 7 days [PROMIS.PARENTPROXY] |
|
92075-1
|
My child felt some food coming up into his or her throat in past 7 days [PROMIS.PARENTPROXY] |
|
75905-0
|
My child felt stressed in past 7 days [PROMIS.PARENTPROXY] |
|
91268-3
|
My child felt strong in past 7 days [PROMIS.PARENTPROXY] |
|
91300-4
|
My child felt thankful in past 7 days [PROMIS.PARENTPROXY] |
|
78137-7
|
My child felt that he or she could trust the people in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78152-6
|
My child felt that he or she had similar values and beliefs as others in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91360-8
|
My child felt that his or her problems kept piling up in past 7 days [PROMIS.PARENTPROXY] |
|
78125-2
|
My child felt that our family believed in him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78160-9
|
My child felt that our family loved him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78156-7
|
My child felt that our family really respected him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78144-3
|
My child felt that our family showed that they cared about him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78129-4
|
My child felt that our family understood him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78155-9
|
My child felt that people in our family helped each other in past 4 weeks [PROMIS.PARENTPROXY] |
|
91919-1
|
My child felt tired in past 7 days [PROMIS.PARENTPROXY] |
|
91403-6
|
My child felt too sad to eat in past 7 days [PROMIS.PARENTPROXY] |
|
91914-2
|
My child felt too tired to spend time with his/her friends in past 7 days [PROMIS.PARENTPROXY] |
|
78128-6
|
My child felt totally accepted by our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91365-7
|
My child felt unable to manage things in his or her life in past 7 days [PROMIS.PARENTPROXY] |
|
91359-0
|
My child felt under pressure in past 7 days [PROMIS.PARENTPROXY] |
|
75895-3
|
My child felt uneasy in past 7 days [PROMIS.PARENTPROXY] |
|
91404-4
|
My child felt unhappy in past 7 days [PROMIS.PARENTPROXY] |
|
78147-6
|
My child felt very close to our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91932-4
|
My child felt weak in past 7 days [PROMIS.PARENTPROXY] |
|
91413-5
|
My child felt wheezy because of his or her asthma in past 7 days [PROMIS.PARENTPROXY] |
|
91272-5
|
My child felt wide awake in past 7 days [PROMIS.PARENTPROXY] |
|
91989-4
|
My child felt worried in past 7 days [PROMIS.PARENTPROXY] |
|
71330-5
|
My child forgets things easily in the past 4 weeks [FACIT] |
|
71200-0
|
My child gets ill easily in the past 4 weeks [FACIT] |
|
71270-3
|
My child gets ill easily in the past 7 days [FACIT] |
|
71211-7
|
My child gets nervous - frightened easily in the past 4 weeks [FACIT] |
|
71242-2
|
My child gets nervous - frightened easily in the past 7 days [FACIT] |
|
71198-6
|
My child gets tired easily in the past 4 weeks [FACIT] |
|
71268-7
|
My child gets tired easily in the past 7 days [FACIT] |
|
92001-7
|
My child got scared really easy in past 7 days [PROMIS.PARENTPROXY] |
|
91414-3
|
My child got tired easily because of his or her asthma in past 7 days [PROMIS.PARENTPROXY] |
|
75899-5
|
My child got tired easily in past 7 days [PROMIS.PARENTPROXY] |
|
92072-8
|
My child had a bad stomach ache in past 7 days [PROMIS.PARENTPROXY] |
|
92069-4
|
My child had a headache in past 7 days [PROMIS.PARENTPROXY] |
|
91273-3
|
My child had a lot of energy in past 7 days [PROMIS.PARENTPROXY] |
|
91415-0
|
My child had asthma attacks in past 7 days [PROMIS.PARENTPROXY] |
|
92073-6
|
My child had pain that really bothered him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91416-8
|
My child had trouble breathing because of his or her asthma in past 7 days [PROMIS.PARENTPROXY] |
|
92063-7
|
My child had trouble breathing, even when he or she was not exercising or playing hard in past 7 days [PROMIS.PARENTPROXY] |
|
91363-2
|
My child had trouble concentrating in past 7 days [PROMIS.PARENTPROXY] |
|
89938-5
|
My child had trouble doing schoolwork when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91913-4
|
My child had trouble finishing things because he/she was too tired in past 7 days [PROMIS.PARENTPROXY] |
|
91417-6
|
My child had trouble sleeping at night because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
75906-8
|
My child had trouble sleeping when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91922-5
|
My child had trouble starting things because he/she was too tired in past 7 days [PROMIS.PARENTPROXY] |
|
92051-2
|
My child had trouble staying asleep in past 7 days [PROMIS.PARENTPROXY] |
|
91418-4
|
My child had trouble walking because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
91286-5
|
My child had very strong happy feelings in past 7 days [PROMIS.PARENTPROXY] |
|
75903-5
|
My child has a good life [NIH Toolbox] |
|
90681-8
|
My child has been physically able to do the activities he/she enjoys most in past 7 days [PROMIS.PARENTPROXY] |
|
71260-4
|
My child has been throwing up in the past 7 days [FACIT] |
|
71334-7
|
My child has difficulty using the right words in the past 4 weeks [FACIT] |
|
71220-8
|
My child has fewer friends than others in the past 4 weeks [FACIT] |
|
71247-1
|
My child has fewer friends than others in the past 7 days [FACIT] |
|
71262-0
|
My child has pain in his-her stomach in the past 7 days [FACIT] |
|
71202-6
|
My child has pain in the past 7 days [FACIT] |
|
71332-1
|
My child has to read things several times so s-he can understand them in the past 4 weeks [FACIT] |
|
71196-0
|
My child has trouble getting dressed on his-her own in the past 4 weeks [FACIT] |
|
71266-1
|
My child has trouble getting dressed on his-her own in the past 7 days [FACIT] |
|
71197-8
|
My child has trouble running like other people in the past 4 weeks [FACIT] |
|
71267-9
|
My child has trouble running like other people in the past 7 days [FACIT] |
|
71201-8
|
My child has trouble writing with a pen or pencil in the past 4 weeks [FACIT] |
|
71271-1
|
My child has trouble writing with a pen or pencil in the past 7 days [FACIT] |
|
89944-3
|
My child hurt a lot in past 7 days [PROMIS.PARENTPROXY] |
|
89942-7
|
My child hurt all over his or her body in past 7 days [PROMIS.PARENTPROXY] |
|
71258-8
|
My child is afraid to eat because it may make her-him sick in the past 7 days [FACIT] |
|
71323-0
|
My child is bothered by being shorter than his-her peers in the past 4 weeks [FACIT] |
|
71326-3
|
My child is bothered by headaches in the past 4 weeks [FACIT] |
|
71325-5
|
My child is bothered by poor hearing in the past 4 weeks [FACIT] |
|
71324-8
|
My child is bothered by poor vision in the past 4 weeks [FACIT] |
|
71209-1
|
My child is moody or irritable in the past 4 weeks [FACIT] |
|
71240-6
|
My child is moody or irritable in the past 7 days [FACIT] |
|
71254-7
|
My child is worried about his-her weight in the past 7 days [FACIT] |
|
71256-2
|
My child is worried about how thin s-he is in the past 7 days [FACIT] |
|
78159-1
|
My child knew everyone in our family loved him or her in past 4 weeks [PROMIS.PARENTPROXY] |
|
78153-4
|
My child knew he or she could rely on our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78135-1
|
My child knew he or she could talk to someone in our family about his or her problems in past 4 weeks [PROMIS.PARENTPROXY] |
|
78157-5
|
My child knew he or she could talk to someone in our family if he or she needed to in past 4 weeks [PROMIS.PARENTPROXY] |
|
78138-5
|
My child knew he or she could trust others in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
78126-0
|
My child knew our family was interested in what he or she was doing in past 4 weeks [PROMIS.PARENTPROXY] |
|
78136-9
|
My child knew our family would help if he or she needed it in past 4 weeks [PROMIS.PARENTPROXY] |
|
78158-3
|
My child knew that everyone in our family could be completely trusted in past 4 weeks [PROMIS.PARENTPROXY] |
|
78140-1
|
My child knew that our family would be there if he or she needed them in past 4 weeks [PROMIS.PARENTPROXY] |
|
78132-8
|
My child knew what he or she could expect from others in our family in past 4 weeks [PROMIS.PARENTPROXY] |
|
91281-6
|
My child laughed a lot in past 7 days [PROMIS.PARENTPROXY] |
|
90677-6
|
My child liked being around other kids his/her age in past 7 days [PROMIS.PARENTPROXY] |
|
71195-2
|
My child loses balance or falls down easily in the past 4 weeks [FACIT] |
|
71265-3
|
My child loses balance or falls down easily in the past 7 days [FACIT] |
|
91419-2
|
My child missed school because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
89947-6
|
My child missed school when he or she had pain in past 7 days [PROMIS.PARENTPROXY] |
|
91912-6
|
My child needed to sleep during the day in past 7 days [PROMIS.PARENTPROXY] |
|
71328-9
|
My child needs to work harder than his-her peers to get school work done in the past 4 weeks [FACIT] |
|
71335-4
|
My child often feels inferior to other children in the past 4 weeks [FACIT] |
|
71207-5
|
My child often feels inferior to other people in the past 4 weeks [FACIT] |
|
71238-0
|
My child often feels inferior to other people in the past 7 days [FACIT] |
|
90676-8
|
My child played alone and kept to himself/herself in past 7 days [PROMIS.PARENTPROXY] |
|
71223-2
|
My child prefers to do something alone in the past 4 weeks [FACIT] |
|
71250-5
|
My child prefers to do something alone in the past 7 days [FACIT] |
|
71277-8
|
My child prefers to play alone in the past 7 days [FACIT] |
|
71203-4
|
My child seems happy in the past 4 weeks [FACIT] |
|
71236-4
|
My child seems happy in the past 7 days [FACIT] |
|
71222-4
|
My child seems lonely in the past 4 weeks [FACIT] |
|
71249-7
|
My child seems lonely in the past 7 days [FACIT] |
|
90667-7
|
My child shared with other kids (food, games, pens, etc.) in past 7 days [PROMIS.PARENTPROXY] |
|
91282-4
|
My child smiled a lot in past 7 days [PROMIS.PARENTPROXY] |
|
90678-4
|
My child spent time with his/her friends in past 7 days [PROMIS.PARENTPROXY] |
|
71225-7
|
My child thinks I spoil him-her in the past 7 days [FACIT] |
|
71224-0
|
My child thinks I worry too much about him-her in the past 7 days [FACIT] |
|
92076-9
|
My child threw up in past 7 days [PROMIS.PARENTPROXY] |
|
90694-1
|
My child used a walker, cane or crutches to get around in past 7 days [PROMIS.PARENTPROXY] |
|
90702-2
|
My child used a wheelchair to get around in past 7 days [PROMIS.PARENTPROXY] |
|
91405-1
|
My child wanted to be by himself or herself in past 7 days [PROMIS.PARENTPROXY] |
|
78151-8
|
My child wanted to help our family however he or she could in past 4 weeks [PROMIS.PARENTPROXY] |
|
90668-5
|
My child was a good friend in past 7 days [PROMIS.PARENTPROXY] |
|
90675-0
|
My child was able to count on his/her friends in past 7 days [PROMIS.PARENTPROXY] |
|
90666-9
|
My child was able to have fun with his/her friends in past 7 days [PROMIS.PARENTPROXY] |
|
90674-3
|
My child was able to talk about everything with his or her friends in past 7 days [PROMIS.PARENTPROXY] |
|
91990-2
|
My child was afraid of going to school in past 7 days [PROMIS.PARENTPROXY] |
|
91420-0
|
My child was bothered by asthma when he or she was with friends in past 7 days [PROMIS.PARENTPROXY] |
|
91421-8
|
My child was bothered by the amount of time he or she spent wheezing in past 7 days [PROMIS.PARENTPROXY] |
|
90671-9
|
My child was good at making friends in past 7 days [PROMIS.PARENTPROXY] |
|
91279-0
|
My child was in a good mood in past 7 days [PROMIS.PARENTPROXY] |
|
91278-2
|
My child was in good spirits in past 7 days [PROMIS.PARENTPROXY] |
|
91918-3
|
My child was so tired it was hard for him/her to pay attention in past 7 days [PROMIS.PARENTPROXY] |
|
92060-3
|
My child was sweaty, even when he or she was not exercising or playing hard in past 7 days [PROMIS.PARENTPROXY] |
|
91923-3
|
My child was too tired to do sports or exercise in past 7 days [PROMIS.PARENTPROXY] |
|
91920-9
|
My child was too tired to do things outside in past 7 days [PROMIS.PARENTPROXY] |
|
91911-8
|
My child was too tired to eat in past 7 days [PROMIS.PARENTPROXY] |
|
91929-0
|
My child was too tired to enjoy the things he/she likes to do in past 7 days [PROMIS.PARENTPROXY] |
|
91927-4
|
My child was too tired to focus on his/her work in past 7 days [PROMIS.PARENTPROXY] |
|
91916-7
|
My child was too tired to go out with his/her family in past 7 days [PROMIS.PARENTPROXY] |
|
91924-1
|
My child was too tired to go up and down a lot of stairs in past 7 days [PROMIS.PARENTPROXY] |
|
91910-0
|
My child was too tired to read in past 7 days [PROMIS.PARENTPROXY] |
|
91931-6
|
My child was too tired to take a bath or shower in past 7 days [PROMIS.PARENTPROXY] |
|
91930-8
|
My child was too tired to watch television in past 7 days [PROMIS.PARENTPROXY] |
|
91993-6
|
My child was worried he or she might die in past 7 days [PROMIS.PARENTPROXY] |
|
91999-3
|
My child woke up at night scared in past 7 days [PROMIS.PARENTPROXY] |
|
92000-9
|
My child worried about what could happen to him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91991-0
|
My child worried when he or she was at home in past 7 days [PROMIS.PARENTPROXY] |
|
91998-5
|
My child worried when he or she was away from home in past 7 days [PROMIS.PARENTPROXY] |
|
91992-8
|
My child worried when he or she went to bed at night in past 7 days [PROMIS.PARENTPROXY] |
|
71214-1
|
My child worries about being able to go to college because of his-her illness in the past 4 weeks [FACIT] |
|
71245-5
|
My child worries about being able to go to college because of his-her illness in the past 7 days [FACIT] |
|
71213-3
|
My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 4 weeks [FACIT] |
|
71244-8
|
My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 7 days [FACIT] |
|
71215-8
|
My child worries about getting a job because of his-her illness in the past 4 weeks [FACIT] |
|
71246-3
|
My child worries about getting a job because of his-her illness in the past 7 days [FACIT] |
|
71208-3
|
My child worries about getting another cancer-tumor in the past 4 weeks [FACIT] |
|
71239-8
|
My child worries about getting another cancer-tumor in the past 7 days [FACIT] |
|
71212-5
|
My child worries about having a good life in the future in the past 4 weeks [FACIT] |
|
71243-0
|
My child worries about having a good life in the future in the past 7 days [FACIT] |
|
71210-9
|
My child worries when we go back to the hospital or clinic in the past 4 weeks [FACIT] |
|
71241-4
|
My child worries when we go back to the hospital or clinic in the past 7 days [FACIT] |
|
92074-4
|
My child's appetite changed in past 7 days [PROMIS.PARENTPROXY] |
|
71199-4
|
My child's arms or legs seem weak in the past 4 weeks [FACIT] |
|
71269-5
|
My child's arms or legs seem weak in the past 7 days [FACIT] |
|
91422-6
|
My child's asthma bothered him or her in past 7 days [PROMIS.PARENTPROXY] |
|
92071-0
|
My child's back hurt in past 7 days [PROMIS.PARENTPROXY] |
|
91423-4
|
My child's body felt bad when he or she was out of breath in past 7 days [PROMIS.PARENTPROXY] |
|
92068-6
|
My child's body shook in past 7 days [PROMIS.PARENTPROXY] |
|
92065-2
|
My child's breathing was fast in past 7 days [PROMIS.PARENTPROXY] |
|
92058-7
|
My child's breathing was fast, even when he or she was not exercising or playing hard in past 7 days [PROMIS.PARENTPROXY] |
|
91424-2
|
My child's chest felt tight because of asthma in past 7 days [PROMIS.PARENTPROXY] |
|
92066-0
|
My child's hands shook in past 7 days [PROMIS.PARENTPROXY] |
|
92062-9
|
My child's heart beat faster than usual, even when he or she was not exercising or playing hard in past 7 days [PROMIS.PARENTPROXY] |
|
92061-1
|
My child's heart pounded, even when he or she was not exercising or playing hard in past 7 days [PROMIS.PARENTPROXY] |
|
92067-8
|
My child's legs shook in past 7 days [PROMIS.PARENTPROXY] |
|
92057-9
|
My child's mouth was dry in past 7 days [PROMIS.PARENTPROXY] |
|
92055-3
|
My child's muscles felt tight in past 7 days [PROMIS.PARENTPROXY] |
|
92052-0
|
My child's neck felt tight in past 7 days [PROMIS.PARENTPROXY] |
|
92070-2
|
My child's neck hurt in past 7 days [PROMIS.PARENTPROXY] |
|
92059-5
|
My child's palms were sweaty in past 7 days [PROMIS.PARENTPROXY] |
|
71329-7
|
My child's school performance is worse than it was before s-he was diagnosed in the past 4 weeks [FACIT] |
|
71327-1
|
My child's speech is hard for others to understand in the past 4 weeks [FACIT] |
|
91364-0
|
My child's thoughts went very fast in past 7 days [PROMIS.PARENTPROXY] |
|
92290-6
|
My cigarette smoking bothers others [PROMIS] |
|
90019-1
|
My current treatment meets my expectations [PsoSat] |
|
92308-6
|
My desire to smoke seems overpowering [PROMIS] |
|
81362-6
|
My dislikes and fears [Reported] |
|
94046-0
|
My doctor and I have been through a lot together [PCPCM] |
|
94045-2
|
My doctor or practice knows me as a person [PCPCM] |
|
94047-8
|
My doctor or practice stands up for me [PCPCM] |
|
71119-2
|
My family has trouble understanding when my condition gets worse in the past 7 days [FACIT] |
|
76874-7
|
My family has useful information to help me with my problems [PROMIS] |
|
71157-2
|
My family or friends try to get me to eat more in the past 7 days [FACIT] |
|
78104-7
|
My family showed that they cared about me in past 4 weeks [PROMIS.PEDS] |
|
78099-9
|
My family treated me fairly in past 4 weeks [PROMIS.PEDS] |
|
78086-6
|
My family was interested in what I was doing in past 4 weeks [PROMIS.PEDS] |
|
76748-3
|
My friends have useful information to help me with my problems [PROMIS] |
|
76983-6
|
My future seemed better when I drank in past 30D [PROMIS] |
|
71309-9
|
My grades are worse than they were before I was sick in the past 4 weeks [FACIT] |
|
91443-2
|
My hands shook in past 7 days [PROMIS.PEDS] |
|
71899-9
|
My health is excellent [Veterans RAND] |
|
91444-0
|
My heart beat faster than usual, even when I was not exercising or playing hard in past 7 days [PROMIS.PEDS] |
|
91445-7
|
My heart pounded, even when I was not exercising or playing hard in past 7 days [PROMIS.PEDS] |
|
71033-5
|
My illness has strengthened my faith or spiritual beliefs in the past 7 days [FACIT] |
|
91446-5
|
My legs shook in past 7 days [PROMIS.PEDS] |
|
71026-9
|
My life has been productive in the past 7 days [FACIT] |
|
71031-9
|
My life lacks meaning and purpose in the past 7 days [FACIT] |
|
91245-1
|
My life was pleasurable in past 7 days [PROMIS.PEDS] |
|
81360-0
|
My likes and joys [Reported] |
|
81498-8
|
My memory has been as good as usual in past 7 days [PROMIS] |
|
81497-0
|
My mind has been as sharp as usual in past 7 days [PROMIS] |
|
72704-0
|
My mood rapidly cycled in terms of anxiety, anger, and depression in last week [BSL-23] |
|
71015-2
|
My mouth and throat are dry in the past 7 days [FACIT] |
|
91447-3
|
My mouth was dry in past 7 days [PROMIS.PEDS] |
|
91448-1
|
My muscles felt tight in past 7 days [PROMIS.PEDS] |
|
91449-9
|
My neck felt tight in past 7 days [PROMIS.PEDS] |
|
91450-7
|
My neck hurt in past 7 days [PROMIS.PEDS] |
|
92289-8
|
My need for cigarettes makes me feel disappointed in myself [PROMIS] |
|
78166-6
|
My pain was so bad that I needed to take medicine to treat it in past 7 days [PROMIS.PEDS] |
|
91451-5
|
My palms were sweaty in past 7 days [PROMIS.PEDS] |
|
71188-7
|
My parents spoil me in the past 7 days [FACIT] |
|
71187-9
|
My parents worry too much about me in the past 7 days [FACIT] |
|
71049-1
|
My pharmacist advises me on the adverse - side - effects of my medicines in the past 7 days [FACIT] |
|
71048-3
|
My pharmacist advises me on the proper use of my medicines in the past 7 days [FACIT] |
|
71052-5
|
My pharmacist helps with the arrangements necessary to obtain my medicines in the past 7 days [FACIT] |
|
71051-7
|
My pharmacist is available to answer my questions in the past 7 days [FACIT] |
|
71053-3
|
My pharmacist is aware of my treatment-related needs in the past 7 days [FACIT] |
|
71054-1
|
My pharmacist responds to my treatment-related needs in the past 7 days [FACIT] |
|
94044-5
|
My practice coordinates the care I get from multiple places [PCPCM] |
|
94042-9
|
My practice is able to provide most of my care [PCPCM] |
|
94041-1
|
My practice makes it easy for me to get care [PCPCM] |
|
76955-4
|
My problems seemed worse when I drank in past 30D [PROMIS] |
|
81489-7
|
My problems with memory, concentration, or making mental mistakes have interfered with my ability to do things I enjoy in past 7 days [PROMIS] |
|
81488-9
|
My problems with memory, concentration, or making mental mistakes have interfered with my ability to work in past 7 days [PROMIS] |
|
81490-5
|
My problems with memory, concentration, or making mental mistakes have interfered with the quality of my life in past 7 days [PROMIS] |
|
81476-4
|
My reactions in everyday situations have been slow in past 7 days [PROMIS] |
|
92288-0
|
My smoking makes me feel less attractive [PROMIS] |
|
92287-2
|
My smoking makes me less attractive to other people [PROMIS] |
|
92286-4
|
My smoking makes me respect myself less [PROMIS] |
|
81499-6
|
My thinking has been as fast as usual in past 7 days [PROMIS] |
|
81512-6
|
My thinking has been clear in past 7 days [PROMIS] |
|
81462-4
|
My thinking has been foggy in past 7 days [PROMIS] |
|
81461-6
|
My thinking has been slow in past 7 days [PROMIS] |
|
81480-6
|
My thinking has been slower than usual in past 7 days [PROMIS] |
|
71139-0
|
My thinking is slower than before in the past 7 days [FACIT] |
|
91312-9
|
My thoughts went very fast in past 7 days [PROMIS.PEDS] |
|
92307-8
|
My urges to smoke keep getting stronger if I don't smoke [PROMIS] |
|
78342-3
|
MYB gene deletion [Interpretation] in Blood or Tissue by FISH Narrative |
|
78245-8
|
MYB gene deletion [Presence] in Blood or Tissue by FISH |
|
81865-8
|
MYBPC3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
42794-8
|
MYC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78222-7
|
MYC gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
21750-5
|
MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
78215-1
|
MYC gene rearrangements [Presence] in Blood or Tissue by FISH |
|
93796-1
|
MYCN gene amplification in Tissue by FISH |
|
93797-9
|
MYCN gene copy number/Chromosome 2 copy number in Tissue by FISH |
|
93798-7
|
MYCN gene copy number/nucleus in Tissue by FISH |
|
91590-0
|
Mycobacterium preliminary growth [Presence] in Body fluid by Organism specific culture |
|
90433-4
|
Mycobacterium preliminary growth [Presence] in Sputum by Organism specific culture |
|
90438-3
|
Mycobacterium preliminary growth [Presence] in Tissue by Organism specific culture |
|
614-8
|
Mycobacterial strain [Type] in Isolate by Mycobacterial subtyping |
|
532-2
|
Mycobacterium sp identified in Aspirate by Organism specific culture |
|
76687-3
|
Mycobacterium sp identified in Bronchoalveolar lavage by Organism specific culture |
|
90284-1
|
Mycobacterium sp identified in Bile fluid by Organism specific culture |
|
533-0
|
Mycobacterium sp identified in Blood by Organism specific culture |
|
64412-0
|
Mycobacterium sp [Presence] in Blood by Organism specific culture |
|
9823-6
|
Mycobacterium sp identified in Bronchial specimen by Organism specific culture |
|
88167-2
|
Mycobacterium sp identified in Cornea or Conjunctiva by Organism specific culture |
|
534-8
|
Mycobacterium sp identified in Cerebral spinal fluid by Organism specific culture |
|
30045-9
|
Mycobacterium sp identified in Dialysis fluid by Organism specific culture |
|
21405-6
|
Mycobacterium sp DNA [Presence] in Bronchial specimen by NAA with probe detection |
|
14972-4
|
Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
14973-2
|
Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection |
|
23247-0
|
Mycobacterium sp DNA [Presence] in Tissue by NAA with probe detection |
|
30523-5
|
Mycobacterium sp DNA [Presence] in Urine by NAA with probe detection |
|
14974-0
|
Mycobacterium sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
535-5
|
Mycobacterium sp identified in Body fluid by Organism specific culture |
|
9824-4
|
Mycobacterium sp identified in Gastric fluid by Organism specific culture |
|
89637-3
|
Mycobacterium sp identified in Implanted device by Organism specific culture |
|
9825-1
|
Mycobacterium sp identified in Isolate |
|
67725-2
|
Mycobacterium sp identified in Isolate by HPLC |
|
88183-9
|
Mycobacterium sp identified in Isolate by Sequencing |
|
89636-5
|
Mycobacterium sp identified in Lower respiratory specimen by Organism specific culture |
|
536-3
|
Mycobacterium sp identified in Bone marrow by Organism specific culture |
|
88168-0
|
Mycobacterium sp identified in Ocular fluid by Organism specific culture |
|
53909-8
|
Mycobacterium sp identified in Pleural fluid by Organism specific culture |
|
537-1
|
Mycobacterium sp identified in Peritoneal fluid by Organism specific culture |
|
88266-2
|
Mycobacterium sp rRNA [Identifier] by Probe in Positive blood culture |
|
42716-1
|
Mycobacterium sp rRNA [Identifier] in Isolate by NAA with probe detection |
|
43854-9
|
Mycobacterium sp rRNA [Presence] in Unspecified specimen by Probe |
|
538-9
|
Mycobacterium sp identified in Synovial fluid by Organism specific culture |
|
539-7
|
Mycobacterium sp identified in Sputum by Organism specific culture |
|
540-5
|
Mycobacterium sp identified in Tissue by Organism specific culture |
|
541-3
|
Mycobacterium sp identified in Urine by Organism specific culture |
|
542-1
|
Mycobacterium sp identified in Wound by Organism specific culture |
|
40699-1
|
Mycobacterium sp identified in Unspecified specimen |
|
543-9
|
Mycobacterium sp identified in Unspecified specimen by Organism specific culture |
|
44851-4
|
Mycobacterium sp # 2 identified in Unspecified specimen by Organism specific culture |
|
44852-2
|
Mycobacterium sp # 3 identified in Unspecified specimen by Organism specific culture |
|
44854-8
|
Mycobacterium sp # 4 identified in Unspecified specimen by Organism specific culture |
|
44855-5
|
Mycobacterium sp # 5 identified in Unspecified specimen by Organism specific culture |
|
50941-4
|
Mycobacterium sp [Presence] in Unspecified specimen by Organism specific culture |
|
90306-2
|
Mycobacterium sp identified in Unspecified specimen by Sequencing |
|
7522-6
|
Mycogone sp IgE Ab [Units/volume] in Serum |
|
72986-3
|
Mycophenolate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72985-5
|
Mycophenolate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80697-6
|
Mycophenolate acyl-glucuronide [Mass/volume] in Serum or Plasma |
|
73253-7
|
Mycophenolate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73252-9
|
Mycophenolate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73680-1
|
Mycophenolate [Mass/volume] in Serum or Plasma --peak |
|
55806-4
|
Mycophenolate [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
23905-3
|
Mycophenolate [Mass/volume] in Serum or Plasma |
|
70211-8
|
Mycophenolate [Moles/volume] in Serum or Plasma |
|
72667-9
|
Mycophenolate [Mass/volume] in Serum or Plasma --trough |
|
55807-2
|
Mycophenolate glucuronide [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
23906-1
|
Mycophenolate glucuronide [Mass/volume] in Serum or Plasma |
|
59836-7
|
Mycoplasma sp+Ureaplasma urealyticum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14484-0
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture |
|
14486-5
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture |
|
20902-3
|
Mycoplasma sp+Ureaplasma sp [Presence] in Tissue by Organism specific culture |
|
14487-3
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture |
|
14485-7
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture |
|
687-4
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Unspecified specimen by Organism specific culture |
|
55167-1
|
Mycoplasma sp Ab [Presence] in Cerebral spinal fluid |
|
22428-7
|
Mycoplasma sp Ab [Presence] in Serum |
|
23297-5
|
Mycoplasma sp Ab [Presence] in Serum by Complement fixation |
|
20900-7
|
Mycoplasma sp Ab [Presence] in Serum by Immunoassay |
|
31517-6
|
Mycoplasma sp Ab [Units/volume] in Serum |
|
23754-5
|
Mycoplasma sp Ab [Titer] in Serum |
|
20901-5
|
Mycoplasma sp Ag [Presence] in Isolate by Immune stain |
|
34883-9
|
Mycoplasma sp Ag [Presence] in Tissue by Immune stain |
|
23299-1
|
Mycoplasma sp Ag [Presence] in Unspecified specimen |
|
23298-3
|
Mycoplasma sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
46111-1
|
Mycoplasma sp DNA [Presence] in Body fluid by NAA with probe detection |
|
23301-5
|
Mycoplasma sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20899-1
|
Mycoplasma sp [Presence] in Exudate by Organism specific culture |
|
20898-3
|
Mycoplasma sp [Presence] in Milk by Organism specific culture |
|
23300-7
|
Mycoplasma sp rRNA [Presence] in Unspecified specimen by Probe |
|
20897-5
|
Mycoplasma sp serotype [Identifier] in Isolate |
|
90325-2
|
Mycoplasma suis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
20896-7
|
Mycoplasma sp [Presence] in Tissue by Culture NPIP (National Poultry Improvement Plan) |
|
49110-0
|
Mycoplasma sp identified in Urine by Organism specific culture |
|
40698-3
|
Mycoplasma sp identified in Unspecified specimen |
|
6486-5
|
Mycoplasma sp identified in Unspecified specimen by Organism specific culture |
|
34702-1
|
Mycoplasma sp [Presence] in Unspecified specimen by Hoechst stain |
|
20903-1
|
Mycotoxin identified in Feed |
|
82140-5
|
MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
63287-7
|
Myelin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63286-9
|
Myelin Ab [Presence] in Body fluid by Immunofluorescence |
|
72524-2
|
Myelin Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90834-3
|
Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
56629-9
|
Myelin Ab [Titer] in Serum by Immunofluorescence |
|
17305-4
|
Myelin IgA Ab [Presence] in Serum |
|
8079-6
|
Myelin IgA Ab [Units/volume] in Serum |
|
21407-2
|
Myelin IgA Ab [Titer] in Serum |
|
17306-2
|
Myelin IgG Ab [Presence] in Serum |
|
58011-8
|
Myelin IgG Ab [Presence] in Serum by Immunofluorescence |
|
8080-4
|
Myelin IgG Ab [Units/volume] in Serum |
|
21408-0
|
Myelin IgG Ab [Titer] in Serum |
|
17307-0
|
Myelin IgM Ab [Presence] in Serum |
|
8081-2
|
Myelin IgM Ab [Units/volume] in Serum |
|
21409-8
|
Myelin IgM Ab [Titer] in Serum |
|
10824-1
|
Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |
|
10825-8
|
Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |
|
30444-4
|
Myeloblasts [#/volume] in Blood |
|
746-8
|
Myeloblasts [#/volume] in Blood by Manual count |
|
11113-8
|
Myeloblasts/100 cells in Bone marrow by Manual count |
|
30445-1
|
Myeloblasts/100 leukocytes in Blood |
|
747-6
|
Myeloblasts/100 leukocytes in Blood by Manual count |
|
55436-0
|
Myeloblasts/100 leukocytes in Cerebral spinal fluid by Manual count |
|
30446-9
|
Myelocytes [#/volume] in Blood |
|
66136-3
|
Myelocytes [#/volume] in Blood from Fetus by Manual count |
|
748-4
|
Myelocytes [#/volume] in Blood by Manual count |
|
35017-3
|
Myelocytes [#/volume] in Cerebral spinal fluid |
|
35016-5
|
Myelocytes [#/volume] in Body fluid |
|
40567-0
|
Myelocytes [#/volume] in Body fluid by Manual count |
|
55789-2
|
Myelocytes [#] in Cerebral spinal fluid by Manual count |
|
76402-7
|
Myelocytes [#] in Body fluid by Manual count |
|
11114-6
|
Myelocytes/100 cells in Bone marrow by Manual count |
|
71667-0
|
Myelocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71654-8
|
Myelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
50374-8
|
Myelocytes.eosinophilic/100 cells in Bone marrow by Manual count |
|
74427-6
|
Myelocytes.eosinophilic/100 leukocytes in Blood by Manual count |
|
74426-8
|
Myelocytes.neutrophilic/100 cells in Bone marrow by Manual count |
|
74425-0
|
Myelocytes.neutrophilic/100 leukocytes in Blood by Manual count |
|
26498-6
|
Myelocytes/100 leukocytes in Blood |
|
749-2
|
Myelocytes/100 leukocytes in Blood by Manual count |
|
30447-7
|
Myelocytes/100 leukocytes in Cerebral spinal fluid |
|
30368-5
|
Myelocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
17800-4
|
Myelocytes/100 leukocytes in Body fluid |
|
40653-8
|
Myelocytes/100 leukocytes in Body fluid by Manual count |
|
42926-6
|
Myeloid cells/100 cells in Blood |
|
42925-8
|
Myeloid cells/100 cells in Body fluid |
|
40687-6
|
Myeloid cells/100 cells in Bone marrow by Manual count |
|
43283-1
|
Myeloid cells/100 cells in Tissue |
|
42927-4
|
Myeloid cells/100 cells in Unspecified specimen |
|
11138-5
|
Myeloid cells/Erythroid cells [# Ratio] in Bone marrow |
|
63397-4
|
Myeloperoxidase Ab [Presence] in Body fluid by Immunoassay |
|
63538-3
|
Myeloperoxidase Ab [Units/volume] in Body fluid |
|
46266-3
|
Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay |
|
17316-1
|
Myeloperoxidase Ab [Presence] in Serum |
|
29643-4
|
Myeloperoxidase Ab [Presence] in Serum by Immunoassay |
|
89507-8
|
Myeloperoxidase Ab [Presence] in Serum by Line blot |
|
6969-0
|
Myeloperoxidase Ab [Units/volume] in Serum |
|
51801-9
|
Myeloperoxidase Ab [Titer] in Serum by Immunofluorescence |
|
34959-7
|
Microscopic observation [Identifier] in Blood by Myeloperoxidase stain |
|
57435-0
|
Myeloperoxidase cells [Presence] in Body fluid |
|
61183-0
|
Myeloperoxidase cells/100 cells in Blood |
|
42890-4
|
Myeloperoxidase cells/100 cells in Body fluid |
|
32759-3
|
Myeloperoxidase cells/100 cells in Unspecified specimen |
|
81771-8
|
Myeloperoxidase IgG Ab [Presence] in Serum by Immunoblot |
|
48404-8
|
Myeloperoxidase IgG Ab [Units/volume] in Serum |
|
81787-4
|
Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
72515-0
|
Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
13510-3
|
Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain |
|
66853-3
|
Myeloperoxidase [Moles/volume] in Plasma |
|
48146-5
|
Myeloperoxidase [Units/volume] in Serum |
|
32817-9
|
Microscopic observation [Identifier] in Unspecified specimen by Myeloperoxidase stain |
|
74228-8
|
Myelopoiesis assessment in Bone marrow Narrative |
|
81866-6
|
MYH7 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
49506-9
|
MYOC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
8610-8
|
Myocardial ischemia [Interpretation] by EKG |
|
9872-3
|
Myocardial ischemia [Interpretation] Narrative by EKG |
|
61009-7
|
Myocardial temperature |
|
21412-2
|
Myocardium Ab pattern [Interpretation] in Serum |
|
49307-2
|
Myocardium Ab pattern [Interpretation] in Serum Narrative |
|
30537-5
|
Myocardium Ab [Presence] in Serum |
|
42181-8
|
Myocardium Ab [Presence] in Serum by Immunofluorescence |
|
8083-8
|
Myocardium Ab [Units/volume] in Serum |
|
48554-0
|
Myocardium Ab [Titer] in Pleural fluid by Immunofluorescence |
|
5260-5
|
Myocardium Ab [Titer] in Serum by Immunofluorescence |
|
35277-3
|
Myocardium IgG Ab [Presence] in Serum |
|
56633-1
|
Myocardium IgG Ab [Titer] in Serum by Immunofluorescence |
|
47032-8
|
MyoD1 Ag [Presence] in Tissue by Immune stain |
|
47033-6
|
Myogenin Ag [Presence] in Tissue by Immune stain |
|
68960-4
|
Myoglobin [Presence] in 24 hour Urine |
|
32197-6
|
Myoglobin [Mass/volume] in 24 hour Urine |
|
2642-7
|
Myoglobin [Mass/time] in 24 hour Urine |
|
10505-6
|
Myoglobin Ag [Presence] in Tissue by Immune stain |
|
53833-0
|
Myoglobin [Mass/volume] in Blood |
|
85096-6
|
Myoglobin casts [Presence] in Urine sediment by Light microscopy |
|
83106-5
|
Myoglobin [Mass/volume] in Serum or Plasma by Immunoassay |
|
32331-1
|
Myoglobin [Presence] in Serum or Plasma |
|
2639-3
|
Myoglobin [Mass/volume] in Serum or Plasma |
|
56887-3
|
Myoglobin [Moles/volume] in Serum or Plasma |
|
2640-1
|
Myoglobin [Presence] in Urine |
|
2641-9
|
Myoglobin [Mass/volume] in Urine |
|
11147-6
|
Myoglobin/Creatinine [Mass Ratio] in Urine |
|
72458-3
|
Myosin Ab [Presence] in Serum or Plasma by Immunoblot |
|
75103-2
|
Myristate (C14:0) [Entitic substance] in Red Blood Cells |
|
35157-7
|
Myristate (C14:0) [Moles/volume] in Serum or Plasma |
|
47783-6
|
Myristate (C14:0)/Creatinine [Molar ratio] in Urine |
|
35158-5
|
Myristoleate (C14:1) [Moles/volume] in Serum or Plasma |
|
54341-3
|
Myristoleate (C14:1)/Creatinine [Molar ratio] in Urine |
|
23304-9
|
Myxoma virus Ab [Presence] in Serum |
|
23307-2
|
Myxoma virus Ab [Presence] in Serum by Complement fixation |
|
23303-1
|
Myxoma virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23309-8
|
Myxoma virus Ab [Presence] in Serum by Immunofluorescence |
|
23308-0
|
Myxoma virus Ab [Presence] in Serum by Neutralization test |
|
31523-4
|
Myxoma virus Ab [Units/volume] in Serum |
|
23305-6
|
Myxoma virus Ab [Titer] in Serum |
|
23306-4
|
Myxoma virus Ab [Titer] in Serum by Immunofluorescence |
|
23310-6
|
Myxoma virus Ag [Presence] in Skin by Immune diffusion (ID) |
|
31903-8
|
Myxoma virus Ag [Presence] in Unspecified specimen |
|
23311-4
|
Myxoma virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
1256-7
|
N Ab [Presence] in Serum or Plasma from Blood product unit |
|
1257-5
|
N Ab [Presence] in Serum or Plasma from Donor |
|
1258-3
|
N Ab [Presence] in Serum or Plasma |
|
55336-2
|
N Ab [Titer] in Serum or Plasma |
|
92522-2
|
N Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92484-5
|
N Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1259-1
|
N Ag [Presence] on Red Blood Cells from Blood product unit |
|
1260-9
|
N Ag [Presence] on Red Blood Cells from Donor |
|
1261-7
|
N Ag [Presence] on Red Blood Cells |
|
23756-0
|
Neospora caninum Ab [Units/volume] in Serum by Immunoassay |
|
22432-9
|
Neospora caninum Ab [Presence] in Serum |
|
15492-2
|
Neospora caninum Ab [Presence] in Serum by Immunoassay |
|
20904-9
|
Neospora caninum Ab [Presence] in Serum by Immunofluorescence |
|
31529-1
|
Neospora caninum Ab [Units/volume] in Serum |
|
23758-6
|
Neospora caninum Ab [Titer] in Serum |
|
23757-8
|
Neospora caninum Ab [Titer] in Serum by Immunofluorescence |
|
23760-2
|
Neospora caninum Ag [Presence] in Fixed tissue by Immune stain |
|
23759-4
|
Neospora caninum Ag [Presence] in Tissue by Immune stain |
|
7971-5
|
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid |
|
6625-8
|
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6624-1
|
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
41444-1
|
Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
87758-9
|
Naegleria fowleri DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31525-9
|
Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid |
|
32704-9
|
Neisseria gonorrhoeae Ab [Presence] in Serum |
|
5261-3
|
Neisseria gonorrhoeae Ab [Units/volume] in Serum |
|
42987-8
|
Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid |
|
27021-5
|
Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22430-3
|
Neisseria gonorrhoeae Ab [Titer] in Serum |
|
9568-7
|
Neisseria gonorrhoeae Ab [Titer] in Serum by Complement fixation |
|
31905-3
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen |
|
6487-3
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay |
|
6488-1
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunofluorescence |
|
6489-9
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Latex agglutination |
|
6490-7
|
Neisseria gonorrhoeae Ag [Presence] in Urethra |
|
31906-1
|
Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen |
|
29311-8
|
Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
14127-5
|
Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture |
|
91781-5
|
Neisseria gonorrhoeae [Presence] in Aspirate by Organism specific culture |
|
30099-6
|
Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture |
|
688-2
|
Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture |
|
88224-1
|
Neisseria gonorrhoeae DNA [Presence] in Anorectal by NAA with probe detection |
|
21414-8
|
Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by NAA with probe detection |
|
35735-0
|
Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by NAA with probe detection |
|
47387-6
|
Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
|
57180-2
|
Neisseria gonorrhoeae DNA [Presence] in Nasopharynx by NAA with probe detection |
|
88225-8
|
Neisseria gonorrhoeae DNA [Presence] in Throat by NAA with probe detection |
|
21416-3
|
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
|
21415-5
|
Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection |
|
32705-6
|
Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
50326-8
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
24111-7
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43403-5
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
690-8
|
Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture |
|
692-4
|
Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture |
|
691-6
|
Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture |
|
53762-1
|
Neisseria gonorrhoeae IgG Ab [Titer] in Serum |
|
80368-4
|
Neisseria gonorrhoeae [Presence] in Rectum by Organism specific culture |
|
57458-2
|
Neisseria gonorrhoeae rRNA [Presence] in Anal by NAA with probe detection |
|
33904-4
|
Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by Probe |
|
50388-8
|
Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
|
32198-4
|
Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe |
|
57289-1
|
Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by NAA with probe detection |
|
80366-8
|
Neisseria gonorrhoeae rRNA [Presence] in Rectum by NAA with probe detection |
|
60255-7
|
Neisseria gonorrhoeae rRNA [Presence] in Throat by NAA with probe detection |
|
60256-5
|
Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
|
53927-0
|
Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection |
|
32199-2
|
Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe |
|
53879-3
|
Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
50412-6
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
43305-2
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5028-6
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe |
|
694-0
|
Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture |
|
695-7
|
Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture |
|
696-5
|
Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture |
|
697-3
|
Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture |
|
693-2
|
Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture |
|
698-1
|
Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture |
|
17322-9
|
Neisseria meningitidis Ab [Presence] in Serum |
|
17324-5
|
Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination |
|
6508-6
|
Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid |
|
31911-1
|
Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid |
|
65763-5
|
Neisseria meningitidis Ag [Presence] in Tissue by Immune stain |
|
17323-7
|
Neisseria meningitidis Ag [Presence] in Urine |
|
31912-9
|
Neisseria meningitidis Ag [Presence] in Unspecified specimen |
|
6492-3
|
Neisseria meningitidis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
86581-6
|
Neisseria meningitidis [Presence] in Cerebral spinal fluid by Organism specific culture |
|
85779-7
|
Neisseria meningitidis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93388-7
|
Neisseria meningitidis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
53606-0
|
Neisseria meningitidis DNA [Presence] in Blood by NAA with probe detection |
|
82185-0
|
Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
91803-7
|
Neisseria meningitidis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
71788-4
|
Neisseria meningitidis DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49671-1
|
Neisseria meningitidis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
45183-1
|
Neisseria meningitidis [Identifier] in Isolate by Agglutination |
|
44093-3
|
Neisseria meningitidis [Identifier] in Isolate by Organism specific culture |
|
17331-0
|
Neisseria meningitidis polyvalent Ab [Units/volume] in Serum |
|
17332-8
|
Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid |
|
6509-4
|
Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by Probe |
|
5029-4
|
Neisseria meningitidis rRNA [Presence] in Unspecified specimen by Probe |
|
70172-2
|
Neisseria meningitidis serogroup [Identifier] in Unspecified specimen |
|
73702-3
|
Neisseria meningitidis serosubtype [Type] in Isolate by Immunoassay |
|
13271-2
|
Neisseria meningitidis serogroup A Ab [Units/volume] in Serum |
|
31907-9
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid |
|
6493-1
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
17326-0
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6494-9
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
42369-9
|
Neisseria meningitidis serogroup A Ag [Presence] in Isolate by Agglutination |
|
31908-7
|
Neisseria meningitidis serogroup A Ag [Presence] in Unspecified specimen |
|
6495-6
|
Neisseria meningitidis serogroup A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30094-7
|
Neisseria meningitidis serogroup A Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74539-8
|
Neisseria meningitidis serogroup A DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
28546-0
|
Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
31526-7
|
Neisseria meningitidis serogroup A IgG Ab [Units/volume] in Serum |
|
42986-0
|
Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum |
|
86234-2
|
Neisseria meningitidis serogroup A sacB gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
59421-8
|
Neisseria meningitidis serogroups A+B+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
41845-9
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination |
|
41844-2
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination |
|
41846-7
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination |
|
78514-7
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
31909-5
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid |
|
19133-8
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
33396-3
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum |
|
33397-1
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum by Latex agglutination |
|
32706-4
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine |
|
33398-9
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine by Latex agglutination |
|
31910-3
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen |
|
19259-1
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen by Latex agglutination |
|
42341-8
|
Neisseria meningitidis serogroups A+w135 Ag [Presence] in Body fluid |
|
20487-5
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Cerebral spinal fluid |
|
17321-1
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Urine |
|
32848-4
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Unspecified specimen |
|
32851-8
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Unspecified specimen by Latex agglutination |
|
17327-8
|
Neisseria meningitidis serogroup B Ab [Units/volume] in Serum |
|
24017-6
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid |
|
6496-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
6497-2
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6498-0
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
41503-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Body fluid |
|
42370-7
|
Neisseria meningitidis serogroup B Ag [Presence] in Isolate by Agglutination |
|
43430-8
|
Neisseria meningitidis serogroup B Ag [Presence] in Serum |
|
24018-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Urine |
|
17328-6
|
Neisseria meningitidis serogroup B Ag [Presence] in Urine by Latex agglutination |
|
31913-7
|
Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen |
|
30095-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74538-0
|
Neisseria meningitidis serogroup B DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86235-9
|
Neisseria meningitidis serogroup B synD gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
31914-5
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid |
|
19134-6
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
33399-7
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum |
|
33400-3
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination |
|
32707-2
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine |
|
33401-1
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination |
|
31915-2
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Unspecified specimen |
|
19260-9
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
13272-0
|
Neisseria meningitidis serogroup C Ab [Units/volume] in Serum |
|
31916-0
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid |
|
6499-8
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
17329-4
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6500-3
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
42371-5
|
Neisseria meningitidis serogroup C Ag [Presence] in Isolate by Agglutination |
|
31917-8
|
Neisseria meningitidis serogroup C Ag [Presence] in Unspecified specimen |
|
6501-1
|
Neisseria meningitidis serogroup C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30096-2
|
Neisseria meningitidis serogroup C Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74537-2
|
Neisseria meningitidis serogroup C DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
28547-8
|
Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum by Immunoassay |
|
31527-5
|
Neisseria meningitidis serogroup C IgG Ab [Units/volume] in Serum |
|
42985-2
|
Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum |
|
86236-7
|
Neisseria meningitidis serogroup C synE gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
19022-3
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Cerebral spinal fluid |
|
17325-2
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Urine |
|
32841-9
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Unspecified specimen |
|
32800-5
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
42372-3
|
Neisseria meningitidis serogroup D Ag [Presence] in Isolate by Agglutination |
|
39610-1
|
Neisseria meningitidis serogroup w135 Ab [Mass/volume] in Serum |
|
31918-6
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid |
|
6506-0
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6507-8
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
42368-1
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Isolate by Agglutination |
|
31919-4
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma |
|
17333-6
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma by Latex agglutination |
|
31920-2
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Unspecified specimen |
|
30097-0
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74536-4
|
Neisseria meningitidis serogroup w135 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60465-2
|
Neisseria meningitidis serogroup w135 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86237-5
|
Neisseria meningitidis serogroup w135 synG gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
42373-1
|
Neisseria meningitidis serogroup X Ag [Presence] in Isolate by Agglutination |
|
74535-6
|
Neisseria meningitidis serogroup X DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86238-3
|
Neisseria meningitidis serogroup X xcbB gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
39618-4
|
Neisseria meningitidis serogroup Y Ab [Mass/volume] in Serum |
|
22431-1
|
Neisseria meningitidis serogroup Y Ab [Titer] in Unspecified specimen |
|
6502-9
|
Neisseria meningitidis serogroup Y Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
7972-3
|
Neisseria meningitidis serogroup Y Ab [Presence] in Unspecified specimen |
|
31528-3
|
Neisseria meningitidis serogroup Y Ab [Units/volume] in Unspecified specimen |
|
17330-2
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid |
|
6503-7
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
6504-5
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6505-2
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
42374-9
|
Neisseria meningitidis serogroup Y Ag [Presence] in Isolate by Agglutination |
|
31921-0
|
Neisseria meningitidis serogroup Y Ag [Presence] in Unspecified specimen |
|
30098-8
|
Neisseria meningitidis serogroup Y Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74534-9
|
Neisseria meningitidis serogroup Y DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60466-0
|
Neisseria meningitidis serogroup Y IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86198-9
|
Neisseria meningitidis serogroup Y synF gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
42375-6
|
Neisseria meningitidis serogroup Z Ag [Presence] in Isolate by Agglutination |
|
42376-4
|
Neisseria meningitidis serogroup Z' Ag [Presence] in Isolate by Agglutination |
|
87958-5
|
Neisseria meningitidis [Presence] in Throat by Organism specific culture |
|
91788-0
|
Neisseria meningitidis [Presence] in Upper respiratory specimen by Organism specific culture |
|
16134-9
|
Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture |
|
85628-6
|
Neisseria meningitidis sodC gene [Presence] in Unspecified specimen by NAA with probe detection |
|
7525-9
|
Nigrospora oryzae IgE Ab [Units/volume] in Serum |
|
6187-9
|
Neurospora sitophila IgE Ab [Units/volume] in Serum |
|
25485-4
|
Neurospora sitophila IgE Ab RAST class [Presence] in Serum |
|
63171-3
|
Neurospora sitophila IgG Ab [Mass/volume] in Serum |
|
7526-7
|
Nigrospora sphaerica IgE Ab [Units/volume] in Serum |
|
15873-3
|
Nigrospora sphaerica IgE Ab RAST class [Presence] in Serum |
|
90781-6
|
N,N'-dimethylarginine [Mass/volume] in Serum or Plasma |
|
80981-4
|
N,N-dimethylarginine [Mass/volume] in Serum or Plasma |
|
79595-5
|
N,N'-dimethylarginine [Moles/volume] in Serum or Plasma |
|
74363-3
|
N,N-dimethylarginine [Moles/volume] in Serum or Plasma |
|
79639-1
|
N,N'-dimethylarginine/Creatinine [Molar ratio] in Urine |
|
79635-9
|
N,N-dimethylarginine/Creatinine [Molar ratio] in Urine |
|
50888-7
|
Nitrogen [Moles/time] in 24 hour Body fluid |
|
77358-0
|
Nitrogen [Mass/mass] in 24 hour Stool |
|
16141-4
|
Nitrogen [Mass/time] in 24 hour Stool |
|
77357-2
|
Nitrogen [Moles/mass] in 24 hour Stool |
|
53142-6
|
Nitrogen [Moles/time] in 24 hour Stool |
|
2660-9
|
Nitrogen [Mass/time] in 24 hour Urine |
|
50889-5
|
Nitrogen [Moles/volume] in 24 hour Urine |
|
40388-1
|
Nitrogen [Moles/time] in 24 hour Urine |
|
69424-0
|
Nitrogen [Mass/time] in 72 hour Stool |
|
53554-2
|
Nitrogen [Mass/volume] in Air |
|
18247-7
|
Nitrogen [Mass/volume] in Dialysis fluid |
|
76103-1
|
Nitrogen [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60921-4
|
Nitrogen [VFr/PPres] Airway adaptor --during inspiration |
|
76104-9
|
Nitrogen [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60920-6
|
Nitrogen [VFr/PPres] Airway adaptor --at end expiration |
|
2658-3
|
Nitrogen [Mass/volume] in Exhaled gas |
|
59385-5
|
Nitrogen [Mass/mass] in Stool by Infrared spectroscopy |
|
18246-9
|
Nitrogen [Mass/volume] in Stool |
|
47712-5
|
Nitrogen [Presence] in Sweat |
|
54352-0
|
Nitrogen [Mass/volume] in Urine |
|
2665-8
|
Nitrogen [Mass/time] in Urine |
|
79403-2
|
Nitrogen [Moles/volume] in Urine |
|
60919-8
|
Nitrogen [VFr/PPres] Airway adaptor |
|
76112-2
|
Nitrogen [VFr/PPres] Gas delivery system |
|
59714-6
|
Nitrous oxide [Mass/volume] in Blood |
|
76253-4
|
Nitrous oxide cylinder Pressure |
|
60939-6
|
Nitrous oxide [VFr/PPres] Airway adaptor --during expiration |
|
60861-2
|
Nitrous oxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
62272-0
|
Nitrous oxide [VFr/PPres] Airway adaptor --during inspiration |
|
60862-0
|
Nitrous oxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60901-6
|
Nitrous oxide [VFr/PPres] Airway adaptor --at end expiration |
|
60775-4
|
Nitrous oxide gas delivered during case [Volume] from Gas delivery system |
|
61026-1
|
Nitrous oxide gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76254-2
|
Nitrous oxide pipeline Pressure |
|
59715-3
|
Nitrous oxide [Mass/volume] in Serum or Plasma |
|
60773-9
|
Gas delivery system inspiratory Nitrous oxide setting [VFr/PPres] |
|
62271-2
|
Nitrous oxide [VFr/PPres] Airway adaptor |
|
60860-4
|
Nitrous oxide [VFr/PPres] Gas delivery system |
|
89322-2
|
Norbuprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method |
|
89305-7
|
Norbuprenorphine-3-glucuronide [Presence] in Urine by Screen method |
|
79578-1
|
N6-Acetyl-L-lysine [Moles/volume] in Serum or Plasma |
|
79634-2
|
N6-Acetyl-L-lysine/Creatinine [Molar ratio] in Urine |
|
43423-3
|
Sodium urate [Saturation Fraction] in 24 hour Urine |
|
53129-3
|
Sodium urate crystals [#/area] in Urine sediment by Microscopy high power field |
|
33031-6
|
Sodium urate crystals [#/area] in Urine sediment by Microscopy low power field |
|
16257-8
|
Sodium urate crystals [Presence] in Stone by Infrared spectroscopy |
|
53788-6
|
Sodium urate crystals [Presence] in Urine sediment by Light microscopy |
|
55179-6
|
Sodium urate crystals [Presence] in Unspecified specimen by Light microscopy |
|
54437-9
|
Sodium urate/Total in Stone by Infrared spectroscopy |
|
79591-4
|
N-alpha acetyllysine [Moles/volume] in Serum or Plasma |
|
79627-6
|
N-alpha acetyllysine/Creatinine [Molar ratio] in Urine |
|
78964-4
|
N-acetylaspartylglutamate [Moles/volume] in Cerebral spinal fluid |
|
12405-7
|
Nabumetone [Mass/volume] in Serum or Plasma |
|
74135-5
|
N-acetyl ezogabine [Mass/volume] in Plasma |
|
42233-7
|
Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum |
|
34149-5
|
N-acetyl-L-aspartate [Moles/volume] in Amniotic fluid |
|
74922-6
|
N-acetyl-L-aspartate [Moles/volume] in Cerebral spinal fluid |
|
33212-2
|
N-acetyl-L-aspartate [Mass/volume] in Body fluid |
|
75080-2
|
N-acetyl-L-aspartate [Moles/volume] in Serum or Plasma |
|
33299-9
|
N-acetyl-L-aspartate [Presence] in Urine |
|
13779-4
|
N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine |
|
76023-1
|
N-acetyl-L-aspartate/Creatinine [Molar ratio] in Urine |
|
2368-9
|
Glutamate dehydrogenase.NAD [Enzymatic activity/volume] in Serum or Plasma |
|
35497-7
|
NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue |
|
74590-1
|
NADH cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
2651-8
|
NADH dehydrogenase [Enzymatic activity/volume] in Plasma |
|
2652-6
|
NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
35496-9
|
NADH dehydrogenase [Enzymatic activity/mass] in Tissue |
|
79395-0
|
NADH:ubiquinone reductase [Enzymatic activity/mass] in Fibroblast |
|
79396-8
|
NADH:ubiquinone reductase [Enzymatic activity/mass] in Tissue |
|
3838-0
|
Nadolol [Mass/time] in 24 hour Urine |
|
4341-4
|
Nadolol [Mass] of Dose |
|
12406-5
|
Nadolol [Mass/volume] in Serum or Plasma |
|
55556-5
|
Nadolol [Moles/volume] in Serum or Plasma |
|
3836-4
|
Nadolol [Presence] in Urine |
|
3837-2
|
Nadolol [Mass/volume] in Urine |
|
2369-7
|
Glutamate dehydrogenase.NADP [Enzymatic activity/volume] in Serum or Plasma |
|
10694-8
|
Naegleria sp identified in Tissue by Organism specific culture |
|
10695-5
|
Naegleria sp identified in Tissue by Wet preparation |
|
73251-1
|
Nafcillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73250-3
|
Nafcillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41704-8
|
Nafcillin [Susceptibility] by Gradient strip |
|
348-3
|
Nafcillin [Susceptibility] by Disk diffusion (KB) |
|
347-5
|
Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
346-7
|
Nafcillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
10993-4
|
Nafcillin [Mass/volume] in Serum or Plasma |
|
18951-4
|
Nafcillin [Susceptibility] |
|
349-1
|
Nafcillin [Susceptibility] by Serum bactericidal titer |
|
25232-0
|
Nafcillin [Mass/volume] in Unspecified specimen |
|
24097-8
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2650-0
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum |
|
34164-4
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue |
|
24098-6
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
53877-7
|
NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3841-4
|
Nalbuphine [Mass/time] in 24 hour Urine |
|
19608-9
|
Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19607-1
|
Nalbuphine cutoff [Mass/volume] in Urine for Screen method |
|
4342-2
|
Nalbuphine [Mass] of Dose |
|
17318-7
|
Nalbuphine [Mass/volume] in Serum or Plasma |
|
20551-8
|
Nalbuphine [Mass/volume] in Urine by Confirmatory method |
|
3839-8
|
Nalbuphine [Presence] in Urine |
|
16218-0
|
Nalbuphine [Presence] in Urine by Confirmatory method |
|
19605-5
|
Nalbuphine [Presence] in Urine by Screen method |
|
3840-6
|
Nalbuphine [Mass/volume] in Urine |
|
9777-4
|
Nalbuphine [Mass/volume] in Unspecified specimen |
|
7034-2
|
Nalidixate [Susceptibility] by Gradient strip |
|
352-5
|
Nalidixate [Susceptibility] by Disk diffusion (KB) |
|
351-7
|
Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
350-9
|
Nalidixate [Susceptibility] by Minimum lethal concentration (MLC) |
|
17319-5
|
Nalidixate [Mass/volume] in Serum or Plasma |
|
18952-2
|
Nalidixate [Susceptibility] |
|
353-3
|
Nalidixate [Susceptibility] by Serum bactericidal titer |
|
25261-9
|
Nalidixate [Mass/volume] in Unspecified specimen |
|
4343-0
|
Nalorphine [Mass] of Dose |
|
3842-2
|
Nalorphine [Mass/volume] in Urine |
|
78863-8
|
Naloxol cutoff [Mass/volume] in Urine for Confirmatory method |
|
78862-0
|
Naloxol [Mass/volume] in Urine by Confirmatory method |
|
78864-6
|
Naloxone cutoff [Mass/volume] in Urine for Confirmatory method |
|
87807-4
|
Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
28061-0
|
Naloxone [Mass/volume] in Serum or Plasma |
|
77207-9
|
Naloxone [Mass/volume] in Urine by Confirmatory method |
|
92649-3
|
Naloxone [Presence] in Urine by Confirmatory method |
|
42618-9
|
Naloxone [Presence] in Urine by Screen method |
|
89307-3
|
Naloxone-3-glucuronide [Presence] in Urine by Screen method |
|
78865-3
|
Naltrexol cutoff [Mass/volume] in Urine for Confirmatory method |
|
79377-8
|
Naltrexol [Mass/volume] in Urine by Confirmatory method |
|
19613-9
|
Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method |
|
19612-1
|
Naltrexone cutoff [Mass/volume] in Urine for Screen method |
|
87823-1
|
Naltrexone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87822-3
|
Naltrexone [Presence] in Saliva (oral fluid) by Screen method |
|
10994-2
|
Naltrexone [Mass/volume] in Serum or Plasma |
|
19610-5
|
Naltrexone [Mass/volume] in Urine by Confirmatory method |
|
12309-1
|
Naltrexone [Presence] in Urine |
|
18334-3
|
Naltrexone [Presence] in Urine by Confirmatory method |
|
19609-7
|
Naltrexone [Presence] in Urine by Screen method |
|
19611-3
|
Naltrexone [Mass/volume] in Urine |
|
72789-1
|
Naltrexone/Creatinine [Mass Ratio] in Urine |
|
76696-4
|
Name [Identifier] Facility |
|
87292-9
|
Name not yet chosen |
|
73770-0
|
Name of facility infant transferred to |
|
73777-5
|
Name of facility mother transferred from |
|
71064-0
|
Name of treatment [FACIT] |
|
45395-1
|
Name suffix |
|
3845-5
|
Nandrolone [Mass/time] in 24 hour Urine |
|
4344-8
|
Nandrolone [Mass] of Dose |
|
3843-0
|
Nandrolone [Presence] in Urine |
|
3844-8
|
Nandrolone [Mass/volume] in Urine |
|
60042-9
|
N-acetylprocainamide [Mass/volume] in Blood |
|
4339-8
|
N-acetylprocainamide [Mass] of Dose |
|
17806-1
|
N-acetylprocainamide [Mass/volume] in Body fluid |
|
3834-9
|
N-acetylprocainamide [Mass/volume] in Serum or Plasma |
|
14846-0
|
N-acetylprocainamide [Moles/volume] in Serum or Plasma |
|
17317-9
|
N-acetylprocainamide [Mass/volume] in Urine |
|
29369-6
|
N-acetylprocainamide/Procainamide [Mass Ratio] in Serum or Plasma |
|
38612-8
|
Naphthalene [Mass/volume] in Air |
|
12435-4
|
Naphthalene [Mass/volume] in Serum or Plasma |
|
12436-2
|
Naphthol [Mass/volume] in Serum or Plasma |
|
79233-3
|
Naphyrone cutoff [Mass/volume] in Urine for Confirmatory method |
|
79232-5
|
Naphyrone [Mass/volume] in Urine by Confirmatory method |
|
4345-5
|
Naproxen [Mass] of Dose |
|
59935-7
|
Naproxen [Moles/volume] in Gastric fluid |
|
56700-8
|
Naproxen IgE Ab [Units/volume] in Serum |
|
73249-5
|
Naproxen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73248-7
|
Naproxen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3846-3
|
Naproxen [Mass/volume] in Serum or Plasma |
|
50885-3
|
Naproxen [Moles/volume] in Serum or Plasma |
|
33300-5
|
Naproxen [Presence] in Urine by Screen method |
|
59934-0
|
Naproxen [Moles/volume] in Urine |
|
60319-1
|
Naproxen [Moles/volume] in Unspecified specimen |
|
87784-5
|
Naproxen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
87570-8
|
Narasin [Mass/mass] in Unspecified specimen |
|
50027-2
|
Narcissus IgE Ab [Units/volume] in Serum |
|
38553-4
|
Narcolepsy associated Ag [Presence] in Serum or Plasma |
|
31088-8
|
Narcotics and opioids [Identifier] in Bile fluid |
|
29376-1
|
Narcotics and opioids [Identifier] in Blood |
|
29377-9
|
Narcotics and opioids [Identifier] in Gastric fluid |
|
12554-2
|
Narcotics and opioids [Identifier] in Urine |
|
50398-7
|
Narrative diagnostic report [Interpretation] |
|
77103-0
|
NARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77102-2
|
NARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
76010-8
|
Nasal temperature |
|
93693-0
|
Nonalcoholic steatohepatitis grade in Serum or Plasma Qualitative |
|
93694-8
|
Nonalcoholic steatohepatitis interpretation in Serum or Plasma Qualitative |
|
93692-2
|
Nonalcoholic steatohepatitis score in Serum or Plasma |
|
60838-0
|
Nasopharyngeal temperature |
|
68983-6
|
National (USA) PFGE pattern [Identifier] in Isolate |
|
79514-6
|
N-acetyltyrosine [Moles/volume] in Serum or Plasma |
|
29632-7
|
N-acetyltyrosine [Presence] in Urine |
|
13780-2
|
N-acetyltyrosine/Creatinine [Mass Ratio] in Urine |
|
25119-9
|
N-acetyltyrosine/Creatinine [Molar ratio] in Urine |
|
90259-3
|
NAT2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
58012-6
|
Natalizumab Ab [Presence] in Serum |
|
49598-6
|
Natalizumab Ab [Presence] in Serum by Immunoassay |
|
32597-7
|
Natamycin [Susceptibility] |
|
49487-2
|
Nateglinide [Presence] in Serum or Plasma |
|
49702-4
|
Nateglinide [Mass/volume] in Serum or Plasma |
|
73690-0
|
Nateglinide [Mass/volume] in Urine |
|
74564-6
|
National Quality Forum (NQF) serious reportable event [AHRQ] |
|
77968-6
|
National reporting jurisdiction |
|
44763-1
|
Native inferior vena cava liver graft attachment |
|
93014-9
|
Natural and feet together and tandem stance assessment |
|
81660-3
|
Nausea [Presence] |
|
93903-3
|
Healthcare navigator Discharge summary |
|
93901-7
|
Healthcare navigator Telephone encounter Note |
|
93902-5
|
Healthcare navigator Plan of care note |
|
93900-9
|
Healthcare navigator Progress note |
|
74128-0
|
Neuroblastoma 84 Ag [Presence] in Tissue by Immune stain |
|
32386-5
|
Newborn Birth injury |
|
77182-4
|
Niobium [Mass/volume] in Blood |
|
77181-6
|
Niobium [Moles/volume] in Blood |
|
32416-0
|
Newborn complication |
|
57131-5
|
Newborn conditions with positive markers [Identifier] in DBS |
|
57720-5
|
Newborn conditions with equivocal markers [Identifier] in DBS |
|
21716-6
|
NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22067-3
|
NB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
54108-6
|
Newborn hearing screen of Ear - left |
|
54109-4
|
Newborn hearing screen of Ear - right |
|
54106-0
|
Newborn hearing screen method |
|
49544-0
|
Newborn screening recommended follow-up [Interpretation] |
|
77179-0
|
Niobium [Mass/mass] in Tissue |
|
77220-2
|
Niobium [Moles/mass] in Tissue |
|
77180-8
|
Niobium [Mass/volume] in Urine |
|
77183-2
|
Niobium [Moles/volume] in Urine |
|
77184-0
|
Niobium/Creatinine [Molar ratio] in Urine |
|
82515-8
|
NBN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74001-9
|
NBOMe [Presence] in Urine by Screen method |
|
73739-5
|
Newborn hearing screen reason not performed of Ear - left |
|
73742-9
|
Newborn hearing screen reason not performed of Ear - right |
|
57130-7
|
Newborn screening report - overall interpretation |
|
69969-4
|
Newborn screening report overall laboratory comment |
|
57724-7
|
Newborn screening short narrative summary |
|
32631-4
|
Nitroblue Tetrazolium Test (NBT) [Presence] in Blood |
|
50609-7
|
Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood |
|
79664-9
|
N-carbamoyl beta alanine [Moles/volume] in Cerebral spinal fluid |
|
79656-5
|
N-carbamoyl beta alanine [Moles/volume] in Serum or Plasma |
|
59251-9
|
N-carbamoyl beta alanine/Creatinine [Molar ratio] in Urine |
|
48732-2
|
NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48728-0
|
NCF1+NCF2+CYBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48733-0
|
NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47966-7
|
NCF2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38712-6
|
N-nitrosodimethylamine [Mass/volume] in Air |
|
2094-1
|
Cholesterol.non-esterified [Mass/volume] in Serum or Plasma |
|
54373-6
|
Cholesterol.non-esterified [Moles/volume] in Serum or Plasma |
|
74435-9
|
Cholesterol.non-esterified/Cholesterol.total in Serum or Plasma by Gas chromatography |
|
81359-2
|
Near death thoughts and feelings to be shared [Reported] |
|
83374-9
|
Type of Nebulizer |
|
83375-6
|
Current nebulization cycle time.elapsed Nebulizer |
|
83379-8
|
Current nebulization cycle time.remaining Nebulizer |
|
83381-4
|
Current nebulization cycle volume.given Nebulizer |
|
83384-8
|
Current nebulization cycle volume.remaining Nebulizer |
|
44704-5
|
NEB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82226-2
|
Neck Disability Index [NDI] |
|
48793-4
|
Necroinflammatory activity grade |
|
48792-6
|
Necroinflammatory activity score |
|
88448-6
|
Necroinflammatory activity interpretation in Serum Qualitative |
|
7523-4
|
Nectarine IgE Ab [Units/volume] in Serum |
|
15871-7
|
Nectarine IgE Ab RAST class [Presence] in Serum |
|
7524-2
|
Nectarine IgG Ab [Units/volume] in Serum |
|
56329-6
|
Nectarine IgG4 Ab [Mass/volume] in Serum |
|
63102-8
|
Nectarine IgG Ab [Mass/volume] in Serum |
|
88660-6
|
Needle gauge [Length] Intravascular tube |
|
1769-9
|
Fatty acids.nonesterified [Mass/volume] in Serum or Plasma |
|
15066-4
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
|
50253-4
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --1st specimen fasting |
|
62422-1
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --10th specimen fasting |
|
50254-2
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --2nd specimen fasting |
|
50255-9
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --3rd specimen fasting |
|
50256-7
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --4th specimen fasting |
|
50257-5
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --5th specimen fasting |
|
58480-5
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --6th specimen fasting |
|
58479-7
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --7th specimen fasting |
|
62420-5
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --8th specimen fasting |
|
62421-3
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --9th specimen fasting |
|
12544-3
|
Nefazodone [Mass/volume] in Serum or Plasma |
|
25484-7
|
Nefazodone [Moles/volume] in Serum or Plasma |
|
75231-1
|
Nefazodone [Presence] in Urine |
|
17320-3
|
Nefazodone [Mass/volume] in Urine |
|
34740-1
|
NEFL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41079-5
|
NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74022-5
|
Negative history for disease of interest in family member |
|
6673-8
|
Microscopic observation [Identifier] in Tissue by Neisser stain |
|
672-6
|
Microscopic observation [Identifier] in Unspecified specimen by Neisser stain |
|
43386-2
|
Neisseria sp identified in Anal by Organism specific culture |
|
43385-4
|
Neisseria sp identified in Cervix by Organism specific culture |
|
80369-2
|
Neisseria sp identified in Rectum by Organism specific culture |
|
43383-9
|
Neisseria sp identified in Throat by Organism specific culture |
|
43384-7
|
Neisseria sp identified in Urethra by Organism specific culture |
|
43387-0
|
Neisseria sp identified in Unspecified specimen by Organism specific culture |
|
30294-3
|
Nelfinavir [Susceptibility] by Genotype method |
|
30280-2
|
Nelfinavir [Susceptibility] by Phenotype method |
|
35113-0
|
Nelfinavir M8 [Mass/volume] in Serum or Plasma |
|
51923-1
|
Nelfinavir [Mass/volume] in Serum or Plasma --peak |
|
29120-3
|
Nelfinavir [Units/volume] in Serum or Plasma |
|
32647-0
|
Nelfinavir [Mass/volume] in Serum or Plasma |
|
30309-9
|
Nelfinavir [Susceptibility] |
|
4248-1
|
N-ethylnicotinamide [Mass] of Dose |
|
3620-2
|
N-ethylnicotinamide [Mass/volume] in Urine |
|
78386-0
|
Neonatal perinatal medicine Admission history and physical note |
|
78405-8
|
Neonatal perinatal medicine Consult note |
|
78410-8
|
Neonatal perinatal medicine Discharge instructions |
|
78418-1
|
Neonatal perinatal medicine Discharge summary |
|
78422-3
|
Neonatal perinatal medicine Discharge teaching note |
|
78429-8
|
Neonatal perinatal medicine Education note |
|
78455-3
|
Neonatal perinatal medicine Flowsheet |
|
68683-2
|
Neonatal perinatal medicine History and physical note |
|
68685-7
|
Neonatal perinatal medicine Hospital Consult note |
|
68686-5
|
Neonatal perinatal medicine Hospital Letter |
|
78467-8
|
Neonatal perinatal medicine Initial evaluation note |
|
68684-0
|
Neonatal perinatal medicine Letter |
|
85438-0
|
Neonatal perinatal medicine Note |
|
89880-9
|
Neonatal perinatal medicine Outpatient Note |
|
80760-2
|
Neonatal perinatal medicine Plan of care note |
|
78473-6
|
Neonatal perinatal medicine procedure note |
|
78479-3
|
Neonatal perinatal medicine Progress note |
|
78483-5
|
Neonatal perinatal medicine Referral note |
|
89894-0
|
Neonatal perinatal medicine Telehealth Note |
|
78489-2
|
Neonatal perinatal medicine Transfer summary note |
|
58903-6
|
Neomycin IgE Ab [Units/volume] in Serum |
|
41705-5
|
Neomycin [Susceptibility] by Gradient strip |
|
356-6
|
Neomycin [Susceptibility] by Disk diffusion (KB) |
|
355-8
|
Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
354-1
|
Neomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
10995-9
|
Neomycin [Mass/volume] in Serum or Plasma |
|
18953-0
|
Neomycin [Susceptibility] |
|
357-4
|
Neomycin [Susceptibility] by Serum bactericidal titer |
|
25262-7
|
Neomycin [Mass/volume] in Unspecified specimen |
|
29750-7
|
Neonatal intensive care records |
|
73782-5
|
Neonatal pressure ulcer risk evaluation [NSRAS] |
|
73783-3
|
Neonatal pressure ulcer risk total score [NSRAS] |
|
72146-4
|
Neonatal vital status at delivery [RHEA] |
|
55437-8
|
Neoplastic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
55945-0
|
Neopterin [Moles/volume] in 24 hour Urine |
|
55944-3
|
Neopterin [Moles/time] in 24 hour Urine |
|
34146-1
|
Neopterin [Moles/volume] in Cerebral spinal fluid |
|
4346-3
|
Neopterin [Mass] of Dose |
|
34908-4
|
Neopterin [Mass/volume] in Serum or Plasma |
|
35259-1
|
Neopterin [Mass or Moles/volume] in Serum or Plasma |
|
9740-2
|
Neopterin [Moles/volume] in Serum or Plasma |
|
3847-1
|
Neopterin [Mass/volume] in Urine |
|
55946-8
|
Neopterin [Moles/volume] in Urine |
|
32332-9
|
Neopterin/Biopterin [Molar ratio] in Urine |
|
17334-4
|
Neopterin/Creatinine [Mass Ratio] in Urine |
|
47711-7
|
Neopterin/Creatinine [Molar ratio] in Urine |
|
48874-2
|
Neorickettsia sp [Presence] in Unspecified specimen by Organism specific culture |
|
17335-1
|
Neostigmine [Mass/volume] in Serum or Plasma |
|
78387-8
|
Nephrology Admission history and physical note |
|
83687-4
|
Nephrology Attending Note |
|
34795-5
|
Nephrology Consult note |
|
93962-9
|
Nephrology Diagnostic study note |
|
78411-6
|
Nephrology Discharge instructions |
|
78419-9
|
Nephrology Discharge summary |
|
78423-1
|
Nephrology Discharge teaching note |
|
78430-6
|
Nephrology Education note |
|
83741-9
|
Nephrology Fellow Note |
|
78456-1
|
Nephrology Flowsheet |
|
78463-7
|
Nephrology History and physical note |
|
84220-3
|
Nephrology Hospital Note |
|
84221-1
|
Nephrology Hospital Transfer summary note |
|
78468-6
|
Nephrology Initial evaluation note |
|
34796-3
|
Nephrology Note |
|
83548-8
|
Nephrology Nurse practitioner Note |
|
83583-5
|
Nephrology Nurse Note |
|
83584-3
|
Nephrology Nurse Outpatient Note |
|
84222-9
|
Nephrology Outpatient Note |
|
84224-5
|
Nephrology Telephone encounter Note |
|
80755-2
|
Nephrology Plan of care note |
|
78474-4
|
Nephrology procedure note |
|
78480-1
|
Nephrology Progress note |
|
84219-5
|
Nephrology Patient's home Note |
|
57144-8
|
Nephrology Referral note |
|
83762-5
|
Nephrology Resident Note |
|
84223-7
|
Nephrology Team Note |
|
89032-7
|
Nephrology Telehealth Consult note |
|
89898-1
|
Nephrology Telehealth Note |
|
78490-0
|
Nephrology Transfer summary note |
|
29755-6
|
Nerve conduction study |
|
75098-4
|
Nervonate (C24:1) [Entitic substance] in Red Blood Cells |
|
35170-0
|
Nervonate (C24:1) [Moles/volume] in Serum or Plasma |
|
54942-8
|
N-ethyldiethanolamine [Mass/volume] in Urine |
|
4347-1
|
Netilmicin [Mass] of Dose |
|
7035-9
|
Netilmicin [Susceptibility] by Gradient strip |
|
360-8
|
Netilmicin [Susceptibility] by Disk diffusion (KB) |
|
359-0
|
Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
358-2
|
Netilmicin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3848-9
|
Netilmicin [Mass/volume] in Serum or Plasma --peak |
|
59567-8
|
Netilmicin [Moles/volume] in Serum or Plasma --peak |
|
3849-7
|
Netilmicin [Mass/volume] in Serum or Plasma --random |
|
47385-0
|
Netilmicin [Mass/volume] in Serum or Plasma |
|
59566-0
|
Netilmicin [Moles/volume] in Serum or Plasma |
|
18954-8
|
Netilmicin [Susceptibility] |
|
361-6
|
Netilmicin [Susceptibility] by Serum bactericidal titer |
|
3850-5
|
Netilmicin [Mass/volume] in Serum or Plasma --trough |
|
59565-2
|
Netilmicin [Moles/volume] in Serum or Plasma --trough |
|
25263-5
|
Netilmicin [Mass/volume] in Unspecified specimen |
|
6186-1
|
Nettle IgE Ab [Units/volume] in Serum |
|
15872-5
|
Nettle IgE Ab RAST class [Presence] in Serum |
|
58033-2
|
Nettle IgE Ab/IgE total in Serum |
|
13185-4
|
Nettle IgG Ab [Units/volume] in Serum |
|
56330-4
|
Nettle IgG4 Ab [Mass/volume] in Serum |
|
63191-1
|
Nettle IgG Ab [Mass/volume] in Serum |
|
71495-6
|
Network code Dialysis facility [ESRD] |
|
50327-6
|
Neu-N Ag [Presence] in Tissue by Immune stain |
|
49584-6
|
Neural tube defect risk cutoff in Fetus |
|
48803-1
|
Neural tube defect risk [Likelihood] in Fetus |
|
49838-6
|
Neural tube defect risk [Likelihood] in Population |
|
80314-8
|
Neurological assessment [Interpretation] |
|
83585-0
|
Neurology Nurse Note |
|
83586-8
|
Neurology Nurse Outpatient Note |
|
83659-3
|
Neurological surgery Attending Admission evaluation note |
|
83660-1
|
Neurological surgery Attending Note |
|
83661-9
|
Neurological surgery Attending Preoperative evaluation and management note |
|
83549-6
|
Neurological surgery Nurse practitioner Note |
|
83602-3
|
Neurological surgery Nurse Note |
|
83764-1
|
Neurological surgery Resident Note |
|
89810-6
|
Neurological surgery Team Conference note |
|
84235-1
|
Neurological surgery Admission evaluation note |
|
78388-6
|
Neurological surgery Admission history and physical note |
|
78449-6
|
Neurological surgery Checklist |
|
34798-9
|
Neurological surgery Consult note |
|
68687-3
|
Neurological surgery Diagnostic study note |
|
68688-1
|
Neurological surgery Discharge summary |
|
78431-4
|
Neurological surgery Education note |
|
78457-9
|
Neurological surgery Flowsheet |
|
68690-7
|
Neurological surgery History and physical note |
|
68694-9
|
Neurological surgery Hospital Consult note |
|
68695-6
|
Neurological surgery Hospital Letter |
|
84236-9
|
Neurological surgery Hospital Note |
|
82830-1
|
Neurological surgery Initial evaluation note |
|
34799-7
|
Neurological surgery Note |
|
84237-7
|
Neurological surgery Outpatient Note |
|
78487-6
|
Neurological surgery Surgical operation note |
|
84239-3
|
Neurological surgery Telephone encounter Note |
|
80756-0
|
Neurological surgery Plan of care note |
|
84238-5
|
Neurological surgery Postoperative evaluation and management note |
|
68691-5
|
Neurological surgery Preoperative evaluation and management note |
|
68692-3
|
Neurological surgery procedure note |
|
68693-1
|
Neurological surgery Progress note |
|
57146-3
|
Neurological surgery Referral note |
|
78492-6
|
Neurological surgery Transfer summary note |
|
47034-4
|
Neurofilament Ag [Presence] in Tissue by Immune stain |
|
21417-1
|
Neurokinin A [Units/volume] in Serum or Plasma |
|
49728-9
|
Neurokinin A [Mass/volume] in Serum or Plasma |
|
84225-2
|
Neurology Administrative note |
|
84226-0
|
Neurology Admission evaluation note |
|
78389-4
|
Neurology Admission history and physical note |
|
83688-2
|
Neurology Attending Admission evaluation note |
|
83689-0
|
Neurology Attending Note |
|
34797-1
|
Neurology Consult note |
|
68556-0
|
Neurology Diagnostic study note |
|
78412-4
|
Neurology Discharge instructions |
|
78420-7
|
Neurology Discharge summary |
|
78424-9
|
Neurology Discharge teaching note |
|
78432-2
|
Neurology Education note |
|
78458-7
|
Neurology Flowsheet |
|
78464-5
|
Neurology History and physical note |
|
84227-8
|
Neurology Hospital Note |
|
84228-6
|
Neurology Hospital Transfer summary note |
|
78469-4
|
Neurology Initial evaluation note |
|
34905-0
|
Neurology Note |
|
84229-4
|
Neurology Outpatient Note |
|
84234-4
|
Neurology Telephone encounter Note |
|
80761-0
|
Neurology Plan of care note |
|
78475-1
|
Neurology procedure note |
|
75221-2
|
Neurology Progress note |
|
57145-5
|
Neurology Referral note |
|
83763-3
|
Neurology Resident Note |
|
76641-0
|
Neurology Study report |
|
84230-2
|
Neurology Team Note |
|
84231-0
|
Neurology Telehealth Consult note |
|
84233-6
|
Neurology Telehealth Initial evaluation note |
|
84232-8
|
Neurology Telehealth Note |
|
78491-8
|
Neurology Transfer summary note |
|
17339-3
|
Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
31531-7
|
Neuronal Ab [Presence] in Cerebral spinal fluid |
|
17337-7
|
Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31530-9
|
Neuronal Ab [Units/volume] in Cerebral spinal fluid |
|
32853-4
|
Neuronal Ab [Units/volume] in Serum by Immunoassay |
|
17338-5
|
Neuronal Ab [Units/volume] in Serum by Immunofluorescence |
|
31533-3
|
Neuronal Ab [Presence] in Serum |
|
17336-9
|
Neuronal Ab [Presence] in Serum by Immunofluorescence |
|
31532-5
|
Neuronal Ab [Units/volume] in Serum |
|
31534-1
|
Neuronal IgG Ab [Presence] in Body fluid |
|
17340-1
|
Neuronal IgG Ab [Presence] in Body fluid by Immunoassay |
|
33418-5
|
Neuronal IgG Ab [Presence] in Serum |
|
28560-1
|
Neuronal thread protein [Mass/volume] in Cerebral spinal fluid |
|
49866-7
|
Neuropeptide Y [Mass/volume] in Serum |
|
2654-2
|
Neurophysin [Mass/volume] in Serum or Plasma |
|
85890-2
|
Neuropsychology Consult note |
|
85878-7
|
Neuropsychology Discharge summary |
|
85877-9
|
Neuropsychology Initial evaluation note |
|
85876-1
|
Neuropsychology Note |
|
2655-9
|
Neurotensin [Mass/volume] in Plasma |
|
34971-2
|
Neutrophil associated Ab [Presence] in Blood |
|
24382-4
|
Neutrophil associated Ab [Identifier] in Serum |
|
85376-2
|
Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Blood by Flow cytometry (FC) |
|
85377-0
|
Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Control Blood by Flow cytometry (FC) |
|
34473-9
|
Neutrophils.vacuolated+Segmented [Presence] in Blood |
|
93352-3
|
Neutrophils.CD64/100 Neutrophils in Blood by Flow cytometry (FC) |
|
85373-9
|
Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Blood by Flow cytometry (FC) |
|
85372-1
|
Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Control Blood by Flow cytometry (FC) |
|
85370-5
|
Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Blood by Flow cytometry (FC) |
|
85371-3
|
Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Control Blood by Flow cytometry (FC) |
|
90223-9
|
Neutrophils.immature/Neutrophils.total [Pure number fraction] in Blood |
|
85374-7
|
Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Blood by Flow cytometry (FC) |
|
85375-4
|
Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Control Blood by Flow cytometry (FC) |
|
42666-8
|
Fat.neutral [#/area] in Pleural fluid by Microscopy high power field |
|
42674-2
|
Fat.neutral [#/area] in Urine by Microscopy high power field |
|
12598-9
|
Fat.neutral [Presence] in Stool |
|
59025-7
|
Neutrophil Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
45150-0
|
Neutrophil Ab [Units/volume] in Serum by Immunoassay |
|
17347-6
|
Neutrophil Ab [Units/volume] in Serum by Immunofluorescence |
|
21418-9
|
Neutrophil Ab [Presence] in Serum |
|
41617-2
|
Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) |
|
39587-1
|
Neutrophil Ab [Presence] in Serum by Immunoassay |
|
17346-8
|
Neutrophil Ab [Presence] in Serum by Immunofluorescence |
|
5171-4
|
Neutrophil Ab [Units/volume] in Serum |
|
17348-4
|
Neutrophil IgA Ab [Units/volume] in Serum |
|
17349-2
|
Neutrophil IgG Ab [Units/volume] in Serum |
|
73077-0
|
Neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17350-0
|
Neutrophil IgM Ab [Units/volume] in Serum |
|
73076-2
|
Neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85365-5
|
Neutrophil membrane Ab [Presence] in Serum by Immunofluorescence |
|
85367-1
|
Neutrophil membrane IgG Ab [Presence] in Serum by Immunofluorescence |
|
85366-3
|
Neutrophil membrane IgM Ab [Presence] in Serum by Immunofluorescence |
|
43292-2
|
Neutrophil oxidative burst/unstimulated in Blood |
|
30903-9
|
Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) |
|
26499-4
|
Neutrophils [#/volume] in Blood |
|
751-8
|
Neutrophils [#/volume] in Blood by Automated count |
|
66139-7
|
Neutrophils [#/volume] in Blood from Fetus by Manual count |
|
753-4
|
Neutrophils [#/volume] in Blood by Manual count |
|
74398-9
|
Neutrophils [#/volume] in Cord blood |
|
85369-7
|
Neutrophils [#/volume] in Control Blood by Flow cytometry (FC) |
|
26500-9
|
Neutrophils [#/volume] in Cerebral spinal fluid |
|
754-2
|
Neutrophils [#/volume] in Cerebral spinal fluid by Automated count |
|
755-9
|
Neutrophils [#/volume] in Cerebral spinal fluid by Manual count |
|
32709-8
|
Neutrophils [#/volume] in Body fluid |
|
40566-2
|
Neutrophils [#/volume] in Body fluid by Manual count |
|
67826-8
|
Neutrophils [#/volume] in Pericardial fluid |
|
68425-8
|
Neutrophils [#/volume] in Pericardial fluid by Manual count |
|
26501-7
|
Neutrophils [#/volume] in Pleural fluid |
|
756-7
|
Neutrophils [#/volume] in Pleural fluid by Automated count |
|
67832-6
|
Neutrophils [#/volume] in Pleural fluid from Fetus |
|
757-5
|
Neutrophils [#/volume] in Pleural fluid by Manual count |
|
72347-8
|
Neutrophils [#/volume] in Prostatic fluid by Manual count |
|
26502-5
|
Neutrophils [#/volume] in Peritoneal fluid |
|
758-3
|
Neutrophils [#/volume] in Peritoneal fluid by Automated count |
|
759-1
|
Neutrophils [#/volume] in Peritoneal fluid by Manual count |
|
26503-3
|
Neutrophils [#/volume] in Semen |
|
17359-1
|
Neutrophils [#/volume] in Semen by Manual count |
|
26504-1
|
Neutrophils [#/volume] in Synovial fluid |
|
5906-3
|
Neutrophils [#/volume] in Synovial fluid by Automated count |
|
760-9
|
Neutrophils [#/volume] in Synovial fluid by Manual count |
|
30448-5
|
Neutrophils [#/volume] in Urine |
|
761-7
|
Neutrophils [#/volume] in Urine by Automated count |
|
762-5
|
Neutrophils [#/volume] in Urine by Manual count |
|
68427-4
|
Neutrophils [#/volume] in Vitreous fluid by Manual count |
|
55791-8
|
Neutrophils [#] in Cerebral spinal fluid by Manual count |
|
76411-8
|
Neutrophils [#] in Body fluid by Manual count |
|
11115-3
|
Neutrophils/100 cells in Bone marrow by Manual count |
|
71676-1
|
Neutrophils/Leukocytes [Pure number fraction] in Blood by Automated count |
|
71671-2
|
Neutrophils/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71598-7
|
Neutrophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count |
|
71658-9
|
Neutrophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71606-8
|
Neutrophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71616-7
|
Neutrophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71635-7
|
Neutrophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71625-8
|
Neutrophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
48048-3
|
Neutrophils [Presence] in Nose by Wright stain |
|
16290-9
|
Neutrophils [Presence] in Stool |
|
48050-9
|
Neutrophils [Presence] in Stool by Wright stain |
|
38996-5
|
Neutrophils [Presence] in Urine by Light microscopy |
|
71369-3
|
Neutrophils.dysplastic [Presence] in Blood by Light microscopy |
|
53797-7
|
Neutrophils.immature/100 leukocytes in Blood |
|
59816-9
|
Neutrophils.immature/100 leukocytes in Body fluid |
|
72345-2
|
Neutrophils/100 round cells in Prostatic fluid by Manual count |
|
72342-9
|
Neutrophils/100 round cells in Semen by Manual count |
|
26511-6
|
Neutrophils/100 leukocytes in Blood |
|
770-8
|
Neutrophils/100 leukocytes in Blood by Automated count |
|
23761-0
|
Neutrophils/100 leukocytes in Blood by Manual count |
|
74457-3
|
Neutrophils/100 leukocytes in Cord blood |
|
27930-7
|
Neutrophils/100 leukocytes in Bronchial specimen |
|
56770-1
|
Neutrophils/100 leukocytes in Bronchial specimen by Flow cytometry (FC) |
|
32804-7
|
Neutrophils/100 leukocytes in Bronchial specimen by Manual count |
|
26512-4
|
Neutrophils/100 leukocytes in Cerebral spinal fluid |
|
13516-0
|
Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
14039-2
|
Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy |
|
40536-5
|
Neutrophils/100 leukocytes in Peritoneal dialysis fluid by Manual count |
|
53520-3
|
Neutrophils/100 leukocytes in Dialysis fluid |
|
26513-2
|
Neutrophils/100 leukocytes in Body fluid |
|
12238-2
|
Neutrophils/100 leukocytes in Body fluid by Manual count |
|
13597-0
|
Neutrophils/100 leukocytes in Nose |
|
30454-3
|
Neutrophils/100 leukocytes in Pericardial fluid |
|
14847-8
|
Neutrophils/100 leukocytes in Pericardial fluid by Manual count |
|
30455-0
|
Neutrophils/100 leukocytes in Pleural fluid |
|
14848-6
|
Neutrophils/100 leukocytes in Pleural fluid by Manual count |
|
26514-0
|
Neutrophils/100 leukocytes in Peritoneal fluid |
|
13836-2
|
Neutrophils/100 leukocytes in Peritoneal fluid by Manual count |
|
17836-8
|
Neutrophils/100 leukocytes in Synovial fluid |
|
40491-3
|
Neutrophils/100 leukocytes in Synovial fluid by Manual count |
|
27932-3
|
Neutrophils/100 leukocytes in Sputum |
|
68426-6
|
Neutrophils/100 leukocytes in Vitreous fluid by Manual count |
|
26507-4
|
Band form neutrophils [#/volume] in Blood |
|
30229-9
|
Band form neutrophils [#/volume] in Blood by Automated count |
|
66138-9
|
Band form neutrophils [#/volume] in Blood from Fetus by Manual count |
|
763-3
|
Band form neutrophils [#/volume] in Blood by Manual count |
|
35015-7
|
Band form neutrophils [#/volume] in Cerebral spinal fluid |
|
35014-0
|
Band form neutrophils [#/volume] in Body fluid |
|
40572-0
|
Band form neutrophils [#/volume] in Body fluid by Manual count |
|
35013-2
|
Band form neutrophils [#/volume] in Synovial fluid |
|
34524-9
|
Band form neutrophils [Presence] in Blood by Automated count |
|
55790-0
|
Band form neutrophils [#] in Cerebral spinal fluid by Manual count |
|
76410-0
|
Band form neutrophils [#] in Body fluid by Manual count |
|
11103-9
|
Band form neutrophils/100 cells in Bone marrow by Manual count |
|
71670-4
|
Band form neutrophils/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71657-1
|
Band form neutrophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71645-6
|
Band form neutrophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
26508-2
|
Band form neutrophils/100 leukocytes in Blood |
|
35332-6
|
Band form neutrophils/100 leukocytes in Blood by Automated count |
|
764-1
|
Band form neutrophils/100 leukocytes in Blood by Manual count |
|
26509-0
|
Band form neutrophils/100 leukocytes in Cerebral spinal fluid |
|
12278-8
|
Band form neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
26510-8
|
Band form neutrophils/100 leukocytes in Body fluid |
|
13354-6
|
Band form neutrophils/100 leukocytes in Body fluid by Manual count |
|
33388-0
|
Band form neutrophils/100 leukocytes in Pericardial fluid |
|
33361-7
|
Band form neutrophils/100 leukocytes in Synovial fluid |
|
30449-3
|
Neutrophils.hypersegmented [#/volume] in Blood |
|
766-6
|
Neutrophils.hypersegmented [#/volume] in Blood by Manual count |
|
34199-0
|
Neutrophils.hypersegmented [Presence] in Blood by Automated count |
|
765-8
|
Neutrophils.hypersegmented [Presence] in Blood by Light microscopy |
|
30450-1
|
Neutrophils.hypersegmented/100 leukocytes in Blood |
|
767-4
|
Neutrophils.hypersegmented/100 leukocytes in Blood by Manual count |
|
30451-9
|
Segmented neutrophils [#/volume] in Blood |
|
768-2
|
Segmented neutrophils [#/volume] in Blood by Manual count |
|
35011-6
|
Segmented neutrophils [#/volume] in Cerebral spinal fluid |
|
30452-7
|
Segmented neutrophils [#/volume] in Body fluid |
|
6745-4
|
Segmented neutrophils [#/volume] in Body fluid by Manual count |
|
35012-4
|
Segmented neutrophils [#/volume] in Pleural fluid |
|
35010-8
|
Segmented neutrophils [#/volume] in Peritoneal fluid |
|
35009-0
|
Segmented neutrophils [#/volume] in Synovial fluid |
|
11128-6
|
Segmented neutrophils/100 cells in Bone marrow |
|
71650-6
|
Segmented neutrophils/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
26505-8
|
Segmented neutrophils/100 leukocytes in Blood |
|
32200-8
|
Segmented neutrophils/100 leukocytes in Blood by Automated count |
|
769-0
|
Segmented neutrophils/100 leukocytes in Blood by Manual count |
|
26506-6
|
Segmented neutrophils/100 leukocytes in Cerebral spinal fluid |
|
14107-7
|
Segmented neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
30453-5
|
Segmented neutrophils/100 leukocytes in Body fluid |
|
30230-7
|
Segmented neutrophils/100 leukocytes in Body fluid by Manual count |
|
56960-8
|
Segmented neutrophils/100 leukocytes in Bone marrow by Manual count |
|
33387-2
|
Segmented neutrophils/100 leukocytes in Pericardial fluid |
|
33385-6
|
Segmented neutrophils/100 leukocytes in Pleural fluid |
|
33384-9
|
Segmented neutrophils/100 leukocytes in Peritoneal fluid |
|
33386-4
|
Segmented neutrophils/100 leukocytes in Synovial fluid |
|
18319-4
|
Neutrophils.vacuolated [Presence] in Blood by Light microscopy |
|
30289-3
|
Nevirapine [Susceptibility] by Genotype method |
|
30275-2
|
Nevirapine [Susceptibility] by Phenotype method |
|
51925-6
|
Nevirapine [Mass/volume] in Serum or Plasma --peak |
|
29121-1
|
Nevirapine [Units/volume] in Serum or Plasma |
|
32646-2
|
Nevirapine [Mass/volume] in Serum or Plasma |
|
30311-5
|
Nevirapine [Susceptibility] |
|
91006-7
|
New cases per day Reporting Period mean |
|
48299-2
|
New coccine triggered leukotriene release [Mass/volume] by Leukocytes |
|
71475-8
|
New infection suspected [ESRD] |
|
80729-7
|
New or recurrent stenosis Coronary artery segment |
|
16262-8
|
Newberyite crystals [Presence] in Stone by Infrared spectroscopy |
|
54440-3
|
Newberyite/Total in Stone |
|
92015-7
|
Newborn administrative information |
|
45331-6
|
NF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
21717-4
|
NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21718-2
|
NF1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
45332-4
|
NF2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
78969-3
|
Neurofilament heavy chain Ab [Mass/volume] in Cerebral spinal fluid |
|
78965-1
|
Neurofilament medium chain Ab [Mass/volume] in Cerebral spinal fluid |
|
74103-3
|
Neutrophil gelatinase-associated lipocalin [Mass/volume] in Serum or Plasma by Rapid immunoassay |
|
74099-3
|
Neutrophil gelatinase-associated lipocalin [Mass/volume] in Urine by Rapid immunoassay |
|
2656-7
|
Niacin [Mass/time] in 24 hour Urine |
|
10836-5
|
Niacin [Mass/volume] in Blood |
|
79402-4
|
Niacin [Moles/volume] in Blood |
|
18244-4
|
Niacin [Mass/volume] in Serum or Plasma |
|
34342-6
|
Niacin [Moles/volume] in Serum or Plasma |
|
73247-9
|
Niacin+Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73246-1
|
Niacin+Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51986-8
|
niCARdipine [Presence] in Serum or Plasma |
|
30933-6
|
Nickel [Mass/volume] in Urine collected for unspecified duration |
|
5703-4
|
Nickel [Mass/time] in 24 hour Stool |
|
29936-2
|
Nickel [Mass/volume] in 24 hour Urine |
|
5705-9
|
Nickel [Mass/time] in 24 hour Urine |
|
25961-4
|
Nickel [Moles/volume] in 24 hour Urine |
|
25487-0
|
Nickel [Moles/time] in 24 hour Urine |
|
5700-0
|
Nickel [Mass/volume] in Blood |
|
25169-4
|
Nickel [Moles/volume] in Blood |
|
51200-4
|
Nickel [Mass/volume] in Body fluid |
|
5701-8
|
Nickel [Mass/mass] in Hair |
|
47123-5
|
Nickel [Moles/mass] in Hair |
|
12780-3
|
Nickel [Mass/volume] in Red Blood Cells |
|
50887-9
|
Nickel [Moles/volume] in Red Blood Cells |
|
8207-3
|
Nickel [Mass/volume] in Saliva (oral fluid) |
|
5702-6
|
Nickel [Mass/volume] in Serum or Plasma |
|
25486-2
|
Nickel [Moles/volume] in Serum or Plasma |
|
50886-1
|
Nickel [Moles/mass] in Tissue |
|
5704-2
|
Nickel [Presence] in Urine |
|
14099-6
|
Nickel [Mass/volume] in Urine |
|
12779-5
|
Nickel [Mass/time] in Urine |
|
34343-4
|
Nickel [Moles/volume] in Urine |
|
13649-9
|
Nickel [Mass/volume] in Water |
|
18245-1
|
Nickel [Mass/volume] in Unspecified specimen |
|
87463-6
|
Nickel [Mass/mass] in Unspecified specimen |
|
42001-8
|
Nickel/Creatinine [Mass Ratio] in 24 hour Urine |
|
25962-2
|
Nickel/Creatinine [Molar ratio] in 24 hour Urine |
|
13472-6
|
Nickel/Creatinine [Mass Ratio] in Urine |
|
56654-7
|
Nickel/Creatinine [Ratio] in Urine |
|
52926-3
|
Nickel/Creatinine [Molar ratio] in Urine |
|
52462-9
|
Nickname |
|
27339-1
|
Nicotinamide [Presence] in Blood |
|
4349-7
|
Nicotinamide [Mass] of Dose |
|
56961-6
|
Nicotinamide [Mass/volume] in Serum or Plasma |
|
25488-8
|
Nicotinamide [Moles/volume] in Serum or Plasma |
|
17362-5
|
Nicotinamide [Presence] in Urine |
|
3852-1
|
Nicotinamide [Mass/volume] in Urine |
|
4350-5
|
Nicotine [Mass] of Dose |
|
40387-3
|
Nicotine [Presence] in Gastric fluid |
|
59937-3
|
Nicotine [Moles/volume] in Gastric fluid |
|
40386-5
|
Nicotine [Presence] in Hair |
|
80541-6
|
Nicotine [Mass/mass] in Hair |
|
40385-7
|
Nicotine [Presence] in Meconium |
|
55558-1
|
Nicotine [Moles/volume] in Serum or Plasma by Screen method |
|
3853-9
|
Nicotine [Mass/volume] in Serum or Plasma |
|
55557-3
|
Nicotine [Moles/volume] in Serum or Plasma |
|
12294-5
|
Nicotine [Presence] in Urine |
|
43195-7
|
Nicotine [Presence] in Urine by Confirmatory method |
|
3854-7
|
Nicotine [Mass/volume] in Urine |
|
59936-5
|
Nicotine [Moles/volume] in Urine |
|
43830-9
|
Nicotine [Presence] in Unspecified specimen |
|
87596-3
|
Nicotine [Mass/mass] in Unspecified specimen |
|
60320-9
|
Nicotine [Moles/volume] in Unspecified specimen |
|
43218-7
|
Nicotine+Cotinine [Presence] in Urine |
|
28555-1
|
Nicotine+Cotinine [Presence] in Urine by Confirmatory method |
|
72306-4
|
Nicotinurate [Mass/volume] in Serum or Plasma |
|
42192-5
|
Nidus [Presence] in Stone |
|
43594-1
|
Nidus [Mass] in Stone |
|
62318-1
|
Niemann Pick disease A/B newborn screen interpretation |
|
62319-9
|
Niemann Pick disease A/B newborn screening comment-discussion |
|
73245-3
|
NIFEdipine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73244-6
|
NIFEdipine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9386-4
|
NIFEdipine [Mass/volume] in Serum or Plasma |
|
10637-7
|
Microscopic observation [Identifier] in Tissue by Night blue stain |
|
93828-2
|
Nighttime awakening duration |
|
93827-4
|
Nighttime awakening |
|
3857-0
|
Nikethamide [Mass/time] in 24 hour Urine |
|
4351-3
|
Nikethamide [Mass] of Dose |
|
3855-4
|
Nikethamide [Presence] in Urine |
|
3856-2
|
Nikethamide [Mass/volume] in Urine |
|
35737-6
|
Microscopic observation [Identifier] in Amniotic fluid by Nile blue prusside |
|
75544-7
|
Noninvasive prenatal fetal aneuploidy and microdeletion overall interpretation based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
|
38907-2
|
NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81884-9
|
NIPA1 and REEP1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41078-7
|
NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40428-5
|
NIPBL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
10826-6
|
Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |
|
73640-5
|
Nitazoxanide [Susceptibility] by Disk diffusion (KB) |
|
73617-3
|
Nitazoxanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73595-1
|
Nitazoxanide [Susceptibility] |
|
12538-5
|
Nitrate [Mass/volume] in Blood |
|
32030-9
|
Nitrate [Presence] in Urine |
|
21420-5
|
Nitrate [Mass/volume] in Urine |
|
9480-5
|
Nitrate [Mass/volume] in Water |
|
87461-0
|
Nitrate [Mass/volume] in Unspecified specimen |
|
87462-8
|
Nitrate [Mass/mass] in Unspecified specimen |
|
74100-9
|
Nitrate+Nitrite [Moles/volume] in Serum or Plasma |
|
23762-8
|
Nitrate+Nitrite [Mass/volume] in Unspecified specimen |
|
19623-8
|
Nitrazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19622-0
|
Nitrazepam cutoff [Mass/volume] in Urine for Screen method |
|
4352-1
|
Nitrazepam [Mass] of Dose |
|
76493-6
|
Nitrazepam [Moles/volume] in Gastric fluid |
|
17363-3
|
Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3858-8
|
Nitrazepam [Mass/volume] in Serum or Plasma |
|
14849-4
|
Nitrazepam [Moles/volume] in Serum or Plasma |
|
72666-1
|
Nitrazepam [Mass/volume] in Serum or Plasma --trough |
|
20552-6
|
Nitrazepam [Mass/volume] in Urine by Confirmatory method |
|
19621-2
|
Nitrazepam [Presence] in Urine by Confirmatory method |
|
19620-4
|
Nitrazepam [Presence] in Urine by Screen method |
|
3859-6
|
Nitrazepam [Mass/volume] in Urine |
|
14850-2
|
Nitrazepam [Moles/volume] in Urine |
|
18370-7
|
Nitrite [Mass/volume] in Blood |
|
55947-6
|
Nitrite [Mass/volume] in Dialysis fluid |
|
55948-4
|
Nitrite [Moles/volume] in Serum or Plasma |
|
32710-6
|
Nitrite [Presence] in Urine |
|
5802-4
|
Nitrite [Presence] in Urine by Test strip |
|
50558-6
|
Nitrite [Presence] in Urine by Automated test strip |
|
20407-3
|
Nitrite [Mass/volume] in Urine by Test strip |
|
2657-5
|
Nitrite [Mass/volume] in Urine |
|
13616-8
|
Nitrite [Mass/volume] in Water |
|
87459-4
|
Nitrite [Mass/volume] in Unspecified specimen |
|
87460-2
|
Nitrite [Mass/mass] in Unspecified specimen |
|
38710-0
|
Nitrobenzene [Mass/volume] in Air |
|
4353-9
|
Nitrofurantoin [Mass] of Dose |
|
73243-8
|
Nitrofurantoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73242-0
|
Nitrofurantoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7036-7
|
Nitrofurantoin [Susceptibility] by Gradient strip |
|
364-0
|
Nitrofurantoin [Susceptibility] by Disk diffusion (KB) |
|
363-2
|
Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
362-4
|
Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3860-4
|
Nitrofurantoin [Mass/volume] in Serum or Plasma |
|
18955-5
|
Nitrofurantoin [Susceptibility] |
|
365-7
|
Nitrofurantoin [Susceptibility] by Serum bactericidal titer |
|
87793-6
|
Nitrofurazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20388-5
|
Nitrofurazone [Susceptibility] |
|
2661-7
|
Nitrogen.nonprotein [Presence] in Blood |
|
2662-5
|
Nitrogen.nonprotein [Mass/volume] in Blood |
|
2663-3
|
Nitrogen.nonprotein [Mass/volume] in Serum or Plasma |
|
53091-5
|
Nitrogen.nonprotein [Moles/volume] in Serum or Plasma |
|
73241-2
|
Nitroglycerin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73240-4
|
Nitroglycerin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12404-0
|
Nitroglycerin [Mass/volume] in Serum or Plasma |
|
13016-1
|
Nitrophenol [Units/volume] in Blood |
|
17364-1
|
Nitrophenol [Presence] in Urine |
|
17365-8
|
Nitroprusside [Mass/volume] in Serum or Plasma |
|
32548-0
|
Nitroprusside reacting substances [Presence] in Urine |
|
13892-5
|
Nitrosonaphthol [Presence] in Urine |
|
55688-6
|
Nitroxoline [Susceptibility] by Gradient strip |
|
54181-3
|
Nitroxoline [Susceptibility] by Disk diffusion (KB) |
|
25723-8
|
Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25608-1
|
Nitroxoline [Susceptibility] |
|
87569-0
|
Nivalenol [Mass/mass] in Unspecified specimen |
|
73239-6
|
Nizatidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73238-8
|
Nizatidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17366-6
|
Nizatidine [Mass/volume] in Serum or Plasma |
|
73810-4
|
CD3-CD16+CD56+HLA-DR+ (activated Natural Killer) cells/100 cells.CD3-CD16+CD56+ (Natural killer) cells in Blood by Flow cytometry (FC) |
|
34439-0
|
Natural killer cell function [Units/volume] in Blood |
|
90242-9
|
Natural killer cell cytotoxicity.IL-stimulated 0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90243-7
|
Natural killer cell cytotoxicity.IL-stimulated 1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90244-5
|
Natural killer cell cytotoxicity.IL-stimulated 15:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90245-2
|
Natural killer cell cytotoxicity.IL-stimulated 3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90241-1
|
Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90249-4
|
Natural killer cell cytotoxicity.IL-stimulated 7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
88511-1
|
Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
88514-5
|
Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82729-5
|
Natural killer cell cytotoxicity.100:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82726-1
|
Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
88512-9
|
Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82727-9
|
Natural killer cell cytotoxicity.25:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82724-6
|
Natural killer cell cytotoxicity.3.13:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
88515-2
|
Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
88510-3
|
Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82728-7
|
Natural killer cell cytotoxicity.50:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82725-3
|
Natural killer cell cytotoxicity.6.25:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
88513-7
|
Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
47035-1
|
NKI/C3 Ag [Presence] in Tissue by Immune stain |
|
39738-0
|
NM Abdomen Views W In-111 Satumomab IV |
|
44149-3
|
NM Abdomen and Pelvis Views for shunt patency W Tc-99m MAA inj |
|
44140-2
|
NM Abdomen and Pelvis Views for tumor |
|
81545-6
|
NM Abdomen and Pelvis Views for shunt patency |
|
39857-8
|
NM Adrenal gland Views W I-131 MIBG IV |
|
39624-2
|
NM Adrenal gland Views W I-131 NP59 IV |
|
42158-6
|
NM Adrenal gland Views |
|
39625-9
|
NM Artery Views W Tc-99m DTPA IA |
|
24571-2
|
NM Biliary ducts and Gallbladder Views for patency of biliary structures and ejection fraction W sincalide and W radionuclide IV |
|
24572-0
|
NM Biliary ducts and Gallbladder Views for patency of biliary structures W Tc-99m IV |
|
25018-3
|
NM Urinary bladder Views |
|
39880-0
|
NM Bone 2 Phase Views |
|
39901-4
|
NM Bone 3 Phase Views multiple areas |
|
39902-2
|
NM Bone 3 Phase Views single area |
|
39883-4
|
NM Bone 3 Phase Views |
|
39884-2
|
NM Bone Blood pool |
|
39819-8
|
NM Bone Delayed Views |
|
39822-2
|
NM Bone marrow Limited Views |
|
39824-8
|
NM Bone marrow Views |
|
44146-9
|
NM Bone marrow Views W Tc-99m SC IV |
|
39907-1
|
NM Bone marrow Multiple area Views |
|
41836-8
|
NM Bone Limited Views W In-111 tagged WBC IV |
|
39627-5
|
NM Bone Limited Views |
|
25032-4
|
NM Bone Views W In-111 tagged WBC IV |
|
25031-6
|
NM Bone Views |
|
39820-6
|
NM Bone Views W Sm-153 IV |
|
42700-5
|
NM Bone Views W Tc-99m tagged WBC IV |
|
39812-3
|
NM Bone Views W Tc-99m HMPAO IV |
|
44142-8
|
NM Bone Views W Tc-99m medronate IV |
|
39858-6
|
NM Bone Views for blood flow |
|
39904-8
|
NM Bone Multiple area Views |
|
81597-7
|
NM Bones Views for metastasis W Ra-223 IV |
|
81573-8
|
NM Brain Brain death protocol Views |
|
24591-0
|
NM Brain Brain death protocol Views W Tc-99m HMPAO IV |
|
39859-4
|
NM Brain Delayed Views |
|
81575-3
|
NM Brain GE 4 Views for blood flow |
|
81574-6
|
NM Brain GE 4 Views |
|
81576-1
|
NM Brain LT 4 Views for blood flow |
|
43459-7
|
NM Brain Views during electroconvulsive shock treatment |
|
39634-1
|
NM Brain Limited Views |
|
24730-4
|
NM Brain Views |
|
44150-1
|
NM Brain Views W Tc-99m bicisate IV |
|
39642-4
|
NM Brain Views W Tc-99m glucoheptonate IV |
|
39630-9
|
NM Brain Views W Tc-99m HMPAO IV |
|
39635-8
|
NM Brain Views W Tl-201 IV |
|
39636-6
|
NM Brain Views for blood flow |
|
44148-5
|
NM Brain Views for blood flow W Tc-99m bicisate IV |
|
43642-8
|
NM Brain Views for blood flow W Tc-99m DTPA IV |
|
43643-6
|
NM Brain Views for blood flow W Tc-99m glucoheptonate IV |
|
43550-3
|
NM Brain Views for blood flow and function |
|
43644-4
|
NM Brain Limited Views for blood flow |
|
39643-2
|
NM Brain veins Views |
|
64051-6
|
NM Breast lymphatic vessels - left Views W radionuclide intra lymphatic |
|
64052-4
|
NM Breast lymphatic vessels - right Views W radionuclide intra lymphatic |
|
39645-7
|
NM Breast Limited Views |
|
39646-5
|
NM Breast Views |
|
51389-5
|
NM Breast Views W Tl-201 IV |
|
39874-3
|
NM Cerebral cisterns Delayed Views W radionuclide IT |
|
24663-7
|
NM Cerebral cisterns Views W radionuclide IT |
|
39672-1
|
NM Esophagus Views for motility W radionuclide PO |
|
39673-9
|
NM Esophagus Views for reflux W radionuclide PO |
|
24683-5
|
NM Esophagus+Stomach Views W Tc-99m SC PO |
|
48585-4
|
NM Exhaled gas Gastric emptying time post 100 mg sodium acetate PO |
|
48584-7
|
NM Exhaled gas Gastric emptying time post 100 mg sodium octanoate PO |
|
81590-2
|
NM Extremity veins - bilateral Views for thrombosis |
|
81591-0
|
NM Extremity veins - unilateral Views for thrombosis |
|
79421-4
|
Neuromuscular functional index [CareConnections] |
|
39895-8
|
NM Gallbladder Views for ejection fraction W Tc-99m DISIDA IV |
|
41770-9
|
NM Gallbladder Views W cholecystokinin and W radionuclide IV |
|
39674-7
|
NM Gallbladder Views W Tc-99m DISIDA IV |
|
39689-5
|
NM Gastrointestinal tract Views W Tc-99m SC IV |
|
81544-9
|
NM Gastrointestinal tract Views for gastrointestinal bleeding |
|
24714-8
|
NM Gastrointestinal tract Views for gastrointestinal bleeding W Tc-99m tagged RBC IV |
|
39761-2
|
NM Guidance limited for localization of tumor-- W Tc-99m Sestamibi IV |
|
39620-0
|
NM Guidance for abscess localization limited of Unspecified body region |
|
39758-8
|
NM Guidance for localization of tumor of Breast |
|
39760-4
|
NM Guidance limited for localization of tumor |
|
39953-5
|
NM Guidance for localization of tumor multiple areas of Unspecified body region |
|
81599-3
|
NM Guidance for multiple days for localization of tumor of Whole body |
|
39623-4
|
NM Guidance for abscess localization of Whole body |
|
39763-8
|
NM Guidance for localization of tumor of Whole body |
|
24876-5
|
NM Head to Pelvis Views for shunt patency W Tc-99m DTPA IT |
|
39849-5
|
NM Head to Pelvis Views for shunt patency W radionuclide IT |
|
39848-7
|
NM Head to Pelvis Views for shunt patency W In-111 IT |
|
81611-6
|
NM Head to Pelvis Views for shunt patency |
|
81543-1
|
NM Head Views for CSF leak with rhinorrhea or otorrhea W radionuclide IT |
|
42166-9
|
NM Heart 2 Views at rest and W Tl-201 IV |
|
39861-0
|
NM Heart Blood pool |
|
39860-2
|
NM Heart Blood pool W stress and W radionuclide IV |
|
81612-4
|
NM Heart Blood pool and Ejection fraction and First pass |
|
39863-6
|
NM Heart First pass at rest and W stress and W radionuclide IV |
|
39867-7
|
NM Heart First pass at rest and W radionuclide IV |
|
39866-9
|
NM Heart First pass at rest and W Tc-99m Sestamibi IV |
|
39864-4
|
NM Heart First pass |
|
39869-3
|
NM Heart First pass W stress and W radionuclide IV |
|
39868-5
|
NM Heart First pass W stress and W Tc-99m Sestamibi IV |
|
81563-9
|
NM Heart First pass and Blood pool |
|
39887-5
|
NM Heart First pass and Ejection fraction at rest and W radionuclide IV |
|
39889-1
|
NM Heart First pass and Ejection fraction |
|
39885-9
|
NM Heart First pass and Ventricular volume |
|
39886-7
|
NM Heart First pass and Wall motion at rest and W radionuclide IV |
|
39890-9
|
NM Heart First pass and Wall motion |
|
39888-3
|
NM Heart First pass and Wall motion W stress and W radionuclide IV |
|
39910-5
|
NM Heart First pass and Wall motion and Ejection fraction |
|
39908-9
|
NM Heart First pass and Wall motion and Ventricular volume W stress and W radionuclide IV |
|
39912-1
|
NM Heart First pass and Wall motion and Ventricular volume and Ejection fraction |
|
39909-7
|
NM Heart First pass and Wall motion and Ventricular volume and Ejection fraction W stress and W radionuclide IV |
|
81566-2
|
NM Heart Gated and Blood pool and Ejection fraction and Wall motion W multiple states of exercise |
|
81567-0
|
NM Heart Gated and Blood pool and Ejection fraction and Wall motion W single state of exercise |
|
39924-6
|
NM Heart Gated at rest and W stress and W radionuclide IV |
|
39921-2
|
NM Heart Gated at rest and W radionuclide IV |
|
39920-4
|
NM Heart Gated at rest and W Tc-99m Sestamibi IV |
|
39922-0
|
NM Heart Gated at rest and W Tc-99m pertechnetate IV |
|
39915-4
|
NM Heart Gated |
|
39928-7
|
NM Heart Gated W stress and W radionuclide IV |
|
39927-9
|
NM Heart Gated W stress and W Tc-99m pertechnetate IV |
|
39914-7
|
NM Heart Gated W Tc-99m Sestamibi IV |
|
39923-8
|
NM Heart Gated and Ejection fraction at rest and W radionuclide IV |
|
39917-0
|
NM Heart Gated and Ejection fraction |
|
39919-6
|
NM Heart Gated and First pass |
|
42306-1
|
NM Heart Gated and Wall motion |
|
39929-5
|
NM Heart Gated and Wall motion W stress and W radionuclide IV |
|
39925-3
|
NM Heart Gated and Wall motion and Ejection fraction at rest and W radionuclide IV |
|
39931-1
|
NM Heart Gated and Wall motion and Ejection fraction |
|
43660-0
|
NM Heart Perfusion qualitative at rest and W radionuclide IV |
|
43661-8
|
NM Heart Perfusion quantitative at rest and W radionuclide IV |
|
43658-4
|
NM Heart Perfusion quantitative |
|
39726-5
|
NM Heart Perfusion at rest and W stress and W radionuclide IV |
|
39727-3
|
NM Heart Perfusion at rest and W stress and W Tc-99m Sestamibi IV |
|
39719-0
|
NM Heart Perfusion at rest and W adenosine and W radionuclide IV |
|
43777-2
|
NM Heart Perfusion at rest and W adenosine and W Tl-201 IV |
|
39722-4
|
NM Heart Perfusion at rest and W dipyridamole and W radionuclide IV |
|
39720-8
|
NM Heart Perfusion at rest and W dipyridamole and W Tc-99m Sestamibi IV |
|
39728-1
|
NM Heart Perfusion at rest and W radionuclide IV |
|
39699-4
|
NM Heart Perfusion at rest and W Tc-99m Sestamibi IV |
|
39701-8
|
NM Heart Perfusion W adenosine and W radionuclide IV |
|
39731-5
|
NM Heart Perfusion W adenosine and W Tc-99m Sestamibi IV |
|
39735-6
|
NM Heart Perfusion W adenosine and W Tl-201 IV |
|
39703-4
|
NM Heart Perfusion W dobutamine IV |
|
39702-6
|
NM Heart Perfusion W dobutamine and W Tc-99m Sestamibi IV |
|
39733-1
|
NM Heart Perfusion W dobutamine and W Tl-201 IV |
|
39709-1
|
NM Heart Perfusion W dipyridamole and W Tc-99m IV |
|
39705-9
|
NM Heart Perfusion W dipyridamole and W Tc-99m Sestamibi IV |
|
39708-3
|
NM Heart Perfusion W dipyridamole IV |
|
39707-5
|
NM Heart Perfusion W dipyridamole and W Tl-201 IV |
|
81571-2
|
NM Heart Perfusion W multiple states of exercise |
|
39716-6
|
NM Heart Perfusion |
|
81570-4
|
NM Heart Perfusion W single state of exercise |
|
39730-7
|
NM Heart Perfusion W stress and W radionuclide IV |
|
39732-3
|
NM Heart Perfusion W stress and W Tc-99m Sestamibi IV |
|
39715-8
|
NM Heart Perfusion W stress and W Tl-201 IV |
|
39704-2
|
NM Heart Perfusion W Tc-99m Sestamibi IV |
|
39714-1
|
NM Heart Perfusion W Tl-201 IV |
|
39713-3
|
NM Heart Perfusion W Tl-201 IV and W Tc-99m Tetrofosmin IV |
|
39893-3
|
NM Heart Views for blood flow and shunt detection |
|
39663-0
|
NM Heart Views at rest and W stress and W radionuclide IV |
|
42309-5
|
NM Heart Views at rest and W stress and W Tl-201 IV |
|
39661-4
|
NM Heart Views at rest and W dobutamine and W radionuclide IV |
|
39660-6
|
NM Heart Views at rest and W dipyridamole and W radionuclide IV |
|
24750-2
|
NM Heart Views at rest and W Tl-201 IV |
|
39651-5
|
NM Heart Views W adenosine and W Tl-201 IV |
|
42161-0
|
NM Heart Views W dobutamine IV |
|
39652-3
|
NM Heart Views W dobutamine and W Tl-201 IV |
|
39650-7
|
NM Heart Views |
|
39666-3
|
NM Heart Views W stress and W 201 Th IV |
|
39667-1
|
NM Heart Views W stress and W radionuclide IV |
|
69231-9
|
NM Heart Views W stress and W Tc-99m IV |
|
69232-7
|
NM Heart Views W stress and W Tc-99m Sestamibi IV |
|
44143-6
|
NM Heart Views W Tc-99m tagged RBC IV |
|
39871-9
|
NM Heart Views for blood flow |
|
39870-1
|
NM Heart Views for blood flow W Tc-99m pertechnetate IV |
|
39665-5
|
NM Heart Views for shunt detection |
|
39664-8
|
NM Heart Views for shunt detection W Tc-99m MAA IV |
|
39653-1
|
NM Heart Views for infarct |
|
39657-2
|
NM Heart Views for infarct W Tc-99m PYP IV |
|
39892-5
|
NM Heart Views for infarct and first pass |
|
39891-7
|
NM Heart Views for infarct and first pass W Tc-99m PYP IV |
|
43645-1
|
NM Heart Qualitative Views for infarct |
|
43646-9
|
NM Heart Qualitative and Quantitative Views for infarct |
|
43647-7
|
NM Heart Quantitative Views for infarct |
|
39873-5
|
NM Heart Wall motion |
|
39932-9
|
NM Heart Wall motion and Ejection fraction |
|
39936-0
|
NM Joint Limited Views |
|
24770-0
|
NM Joint Views W In-111 intrajoint |
|
39939-4
|
NM Joint Views |
|
39937-8
|
NM Joint Multiple area Views W radionuclide XXX |
|
39850-3
|
NM Kidney - bilateral Views W I-131 IV |
|
81607-4
|
NM Kidney cortex Views |
|
81604-1
|
NM Kidney Views for glomerular filtration rate |
|
43461-3
|
NM Kidney Views W furosemide IV |
|
24776-7
|
NM Kidney Views |
|
24773-4
|
NM Kidney Views W radionuclide transplant scan |
|
41771-7
|
NM Kidney Views W Tc-99m DMSA IV |
|
39745-5
|
NM Kidney Views W Tc-99m DTPA IV |
|
44234-3
|
NM Kidney Views W Tc-99m glucoheptonate IV |
|
39746-3
|
NM Kidney Views W Tc-99m Mertiatide IV |
|
44233-5
|
NM Kidney Views WO and W Tc-99m DTPA IV |
|
44232-7
|
NM Kidney Views WO and W Tc-99m Mertiatide IV |
|
42261-8
|
NM Kidney Views for blood flow |
|
30877-5
|
NM Kidney+Renal vessels Views |
|
43667-5
|
NM Kidney+Renal vessels Views W Tc-99m DTPA IV |
|
43666-7
|
NM Kidney+Renal vessels Views for blood flow W Tc-99m glucoheptonate IV |
|
24804-7
|
NM Knee Views |
|
26088-5
|
NM Knee - bilateral Views |
|
26089-3
|
NM Knee - left Views |
|
26090-1
|
NM Knee - right Views |
|
39670-5
|
NM Lacrimal duct Views W radionuclide intra lacrimal duct |
|
42709-6
|
NM Liver Blood pool |
|
44144-4
|
NM Liver Views W Xe-133 IH |
|
39693-7
|
NM Liver Views |
|
81609-0
|
NM Liver Views W SIR-spheres intraarterial hepatic injection |
|
39690-3
|
NM Liver Views W Tc-99m tagged RBC IV |
|
69230-1
|
NM Liver Views W Tc-99m SC IV |
|
81610-8
|
NM Liver Views W Theraspheres intraarterial hepatic injection |
|
42262-6
|
NM Liver Views for blood flow |
|
43654-3
|
NM Liver Views for blood flow W Tc-99m tagged RBC IV |
|
43789-7
|
NM Liver and Biliary ducts and Gallbladder Views for patency W Tc-99m IV |
|
43650-1
|
NM Liver and Biliary ducts and Gallbladder Views W cholecystokinin and W radionuclide IV |
|
43557-8
|
NM Liver and Biliary ducts and Gallbladder Views |
|
43651-9
|
NM Liver and Biliary ducts and Gallbladder Views W sincalide and W radionuclide IV |
|
81606-6
|
NM Liver and Biliary ducts and Gallbladder Views W cholecystokinetic IV |
|
39877-6
|
NM Liver and Spleen Views |
|
44141-0
|
NM Liver and Spleen Views W Tc-99m MAA IV |
|
81206-5
|
NM Liver and Spleen Views W Tc-99m SC IV |
|
43653-5
|
NM Liver and Spleen Views for blood flow |
|
81595-1
|
NM Lymph node Views for lymphedema |
|
81593-6
|
NM Lymph node Views |
|
81594-4
|
NM Lymph node - bilateral Views |
|
81542-3
|
NM Lumbar spine Views for CSF leak post lumbar puncture W radionuclide IT |
|
39940-2
|
NM Lung Clearance W Tc-99m DTPA aerosol IH |
|
43656-8
|
NM Lung Perfusion quantitative |
|
39697-8
|
NM Lung Perfusion |
|
43657-6
|
NM Lung Quantitative Views |
|
46361-2
|
NM Lung Ventilation W Xe-133 IH |
|
39837-0
|
NM Lung Ventilation |
|
39834-7
|
NM Lung Ventilation W Tc-99m DTPA aerosol IH |
|
39947-7
|
NM Lung Ventilation and Equilibrium |
|
39944-4
|
NM Lung Ventilation and Equilibrium and Washout |
|
39695-2
|
NM Lung Limited Views |
|
24824-5
|
NM Lung Portable Views |
|
39696-0
|
NM Lung Views W depreotide IV |
|
81596-9
|
NM Lung Quantitative Views Ventilation and Perfusion |
|
39942-8
|
NM Lung Ventilation and Perfusion |
|
39946-9
|
NM Lung Ventilation and Perfusion and Differential |
|
88944-4
|
NM Lung and Liver Views for AV shunt W Tc-99m MAA+W intraarterial hepatic injection |
|
39897-4
|
NM Lung and Liver Views |
|
39865-1
|
NM Left ventricle First pass |
|
24826-0
|
NM Lymphatic vessels Views W radionuclide intra lymphatic |
|
39737-2
|
NM Neck Views |
|
39739-8
|
NM Pancreas Views |
|
39741-4
|
NM Parathyroid gland Delayed Views |
|
39742-2
|
NM Parathyroid gland Views |
|
44145-1
|
NM Parathyroid gland Views W Tc-99m Sestamibi IV |
|
24751-0
|
NM Parathyroid gland Views W TI-201 subtraction Tc-99m IV |
|
69233-5
|
NM Parotid gland Views W Tc-99m pertechnetate IV |
|
39847-9
|
NM Parotid gland Views for blood flow |
|
39744-8
|
NM Prostate Views W Tc-99m capromab pendatide IV |
|
39950-1
|
NM Prostate Multiple area Views W Tc-99m capromab pendatide IV |
|
39619-2
|
NM Pulmonary system Views |
|
24888-0
|
NM Pulmonary system Ventilation and Perfusion W Xe-133 IH and W Tc-99m MAA IV |
|
30697-7
|
NM Pulmonary system Ventilation and Perfusion |
|
39671-3
|
NM Rectum Views W radionuclide PO |
|
43669-1
|
NM Renal vessels Views |
|
43664-2
|
NM Renal vessels Views for blood flow W Tc-99m DTPA IV |
|
43663-4
|
NM Renal vessels Views for blood flow W Tc-99m glucoheptonate IV |
|
43665-9
|
NM Renal vessels Views for blood flow W Tc-99m Mertiatide IV |
|
39747-1
|
NM Salivary gland Views |
|
39899-0
|
NM Salivary gland Views for blood flow |
|
81572-0
|
NM Salivary gland Views for function |
|
39629-1
|
NM Small bowel Views for Meckel's diverticulum |
|
30696-9
|
NM Scrotum and testicle Views |
|
39753-9
|
NM Scrotum and testicle Views W Tc-99m DTPA IV |
|
25001-9
|
NM Scrotum and testicle Views W Tc-99m pertechnetate IV |
|
42308-7
|
NM Scrotum and testicle Views for blood flow |
|
39952-7
|
NM Scrotum and testicle Views for blood flow and function |
|
26091-9
|
NM Scrotum and Testicle - bilateral Views W Tc-99m pertechnetate IV |
|
26092-7
|
NM Scrotum and Testicle - left Views W Tc-99m pertechnetate IV |
|
26093-5
|
NM Scrotum and Testicle - right Views W Tc-99m pertechnetate IV |
|
43562-8
|
NM Skeletal system.axial Views for bone density |
|
43563-6
|
NM Skeletal system.peripheral Views for bone density |
|
24831-0
|
NM Small bowel Views for Meckel's diverticulum W Tc-99m M04 IV |
|
39751-3
|
NM Spleen Views |
|
42263-4
|
NM Spleen Views for blood flow |
|
39752-1
|
NM Spleen Views W radionuclide tagged heat damaged RBC IV |
|
39769-5
|
NM Stomach Views for gastric emptying W radionuclide PO |
|
39768-7
|
NM Stomach Views for gastric emptying W Tc-99m SC PO |
|
39767-9
|
NM Stomach Views for gastric emptying liquid phase W radionuclide PO |
|
81602-5
|
NM Stomach Views for gastric emptying solid phase W radionuclide PO |
|
24997-9
|
NM Stomach Views for gastric emptying solid phase W Tc-99m SC PO |
|
30694-4
|
NM Thyroid gland and uptake single view |
|
43671-7
|
NM Thyroid gland Spot |
|
81582-9
|
NM Thyroid gland Uptake |
|
81581-1
|
NM Thyroid gland Views for dosimetry W radionuclide PO |
|
81580-3
|
NM Thyroid gland Views for therapy W I-131 PO |
|
39754-7
|
NM Thyroid gland Limited Views W I-131 IV |
|
25007-6
|
NM Thyroid gland Views W I-131 IV |
|
30695-1
|
NM Thyroid gland Views |
|
39757-0
|
NM Thyroid gland Views W Tc-99m IV |
|
39756-2
|
NM Thyroid gland Views W Tc-99m Sestamibi IV |
|
42271-7
|
NM Thyroid gland Views and Views uptake W I-123 IV |
|
60527-9
|
NM Thyroid gland Views and Views uptake W I-123 PO |
|
25008-4
|
NM Thyroid gland Views and Views uptake W I-131 IV |
|
69236-8
|
NM Thyroid gland Views and Views uptake W I-131 PO |
|
43672-5
|
NM Thyroid gland Views and Views uptake |
|
39856-0
|
NM Thyroid gland Views for blood flow |
|
44147-7
|
NM Thyroid gland Views and Views uptake W Tc-99m pertechnetate IV |
|
81605-8
|
NM Ureter and Urinary bladder Views |
|
39765-3
|
NM Vein Views W Tc-99m DTPA IV |
|
39766-1
|
NM Vein Views W Tc-99m HDP IV |
|
39764-6
|
NM Vein Views W Tc-99m SC IV |
|
39954-3
|
NM Vein Views for thrombosis |
|
39626-7
|
NM Vein - bilateral Views |
|
43501-6
|
NM Vessel Views |
|
43500-8
|
NM Vessel Views for blood flow |
|
39685-3
|
NM Unspecified body region Views for abscess W Ga-67 IV |
|
42776-5
|
NM Unspecified body region Views for AV shunt |
|
39677-0
|
NM Unspecified body region Views for infection W Ga-67 IV |
|
81592-8
|
NM Views for transplanted kidney |
|
39694-5
|
NM Views for transplanted liver |
|
39679-6
|
NM Unspecified body region Views for tumor W Ga-67 IV |
|
39750-5
|
NM Unspecified body region Views for tumor W Tc-99m Sestamibi IV |
|
39687-9
|
NM Unspecified body region Limited Views W Ga-67 IV |
|
49571-3
|
NM Unspecified body region Limited Views W I-131 MIBG IV |
|
39843-8
|
NM Unspecified body region Limited Views W In-111 Satumomab IV |
|
39688-7
|
NM Unspecified body region Views W Ga-67 IV |
|
39841-2
|
NM Unspecified body region Views W I-131 MIBG IV |
|
39846-1
|
NM Unspecified body region Views W In-111 Satumomab IV |
|
49118-3
|
NM Unspecified body region Views |
|
81585-2
|
NM Unspecified body region Views W tagged WBC IV |
|
81608-2
|
NM Views for blood flow and kidney function W ACE inhibitor PO |
|
81603-3
|
NM Views for blood flow and kidney function W diuretic IV |
|
81546-4
|
NM Views for blood flow and kidney function |
|
43648-5
|
NM Unspecified body region Views for endocrine tumor multiple areas W I-131 MIBG IV |
|
43649-3
|
NM Unspecified body region Views for endocrine tumor multiple areas W In-111 pentetreotide IV |
|
39933-7
|
NM Unspecified body region Views for infection multiple areas W Ga-67 IV |
|
39831-3
|
NM Unspecified body region Limited Views for tumor W Ga-67 IV |
|
39934-5
|
NM Unspecified body region Views for tumor multiple areas W Ga-67 IV |
|
81587-8
|
NM Unspecified body region Limited Views for infection or inflammation |
|
81600-9
|
NM Unspecified body region Limited Views for infection or inflammation W Tc-99m tagged WBC IV |
|
39951-9
|
NM Unspecified body region Views for tumor multiple areas W Tc-99m Sestamibi IV |
|
39935-2
|
NM Unspecified body region Multiple area Views W Ga-67 IV |
|
39949-3
|
NM Unspecified body region Multiple area Views W In-111 Satumomab IV |
|
39882-6
|
NM Whole body Bone 3 Phase Views |
|
39826-3
|
NM Whole body Bone marrow Views |
|
39818-0
|
NM Whole body Bone Views |
|
39686-1
|
NM Whole body Views for lymphoma W Ga-67 IV |
|
42170-1
|
NM Whole body Views for lymphoma |
|
42305-3
|
NM Whole body Views for tumor W Tl-201 IV |
|
39827-1
|
NM Whole body Views for endocrine tumor W I-131 MIBG IV |
|
81598-5
|
NM Whole body Views for thyroid tumor metastasis post therapy |
|
82136-3
|
NM Whole body Views for tumor W I-123 MIBG IV |
|
39875-0
|
NM Whole body Delayed Views W Ga-67 IV |
|
39840-4
|
NM Whole body Delayed Views W I-131 MIBG IV |
|
39842-0
|
NM Whole body Delayed Views W In-111 Satumomab IV |
|
39829-7
|
NM Whole body Views for tumor W Ga-67 IV |
|
42171-9
|
NM Whole body Views for tumor |
|
39683-8
|
NM Whole body Views W Ga-67 IV |
|
39698-6
|
NM Whole body Views W I-131 MIBG IV |
|
39845-3
|
NM Whole body Views W In-111 Satumomab IV |
|
42711-2
|
NM Whole body Views W In-111 tagged WBC IV |
|
42708-8
|
NM Whole body Views W In-111 tiuxetan IV |
|
42175-0
|
NM Whole body Views |
|
81583-7
|
NM Whole body Views W Sm-153 IV |
|
81584-5
|
NM Whole body Views W tagged WBC IV |
|
39669-7
|
NM Whole body Views W Tc-99m Arcitumomab IV |
|
81586-0
|
NM Whole body Views W Y-90 ibritumomab tiuxetan IV |
|
39828-9
|
NM Whole body Views for endocrine tumor W In-111 pentetreotide IV |
|
39830-5
|
NM Whole body Views for infection W Ga-67 IV |
|
81589-4
|
NM Whole body Views for infection or inflammation |
|
81588-6
|
NM Whole body Views for thyroid tumor |
|
39749-7
|
NM Whole body Views for tumor W Tc-99m Sestamibi IV |
|
81601-7
|
NM Unspecified body region Limited Views for thyroid tumor metastasis |
|
12542-7
|
N-methylacetamide [Mass/volume] in Urine |
|
27163-5
|
N-methylacetamide/Creatinine [Mass Ratio] in Urine |
|
82988-7
|
NMDAR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82981-2
|
NMDAR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
80220-7
|
NMDAR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
80221-5
|
NMDAR IgG Ab [Titer] in Serum by Immunofluorescence |
|
90839-2
|
NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93870-4
|
NMDAR subunit 1 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84928-1
|
NMDAR subunit 1 Ab [Presence] in Serum by Immunofluorescence |
|
90840-0
|
NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93502-3
|
NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93503-1
|
NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
35580-0
|
N-methyl valine [Mass/volume] in Blood |
|
54943-6
|
N-methyldiethanolamine [Mass/volume] in Urine |
|
14167-1
|
N-methylimidazoleacetate [Mass/time] in 24 hour Urine |
|
80648-9
|
N-monodesmethyl bedaquiline [Mass/volume] in Serum or Plasma |
|
79614-4
|
N-monomethylarginine [Moles/volume] in Serum or Plasma |
|
79597-1
|
N-monomethylarginine/Creatinine [Molar ratio] in Urine |
|
38713-4
|
N-nitrosomorpholine [Mass/volume] in Air |
|
4348-9
|
Nicomorphine [Mass] of Dose |
|
3851-3
|
Nicomorphine [Mass/volume] in Urine |
|
50666-7
|
Nuclear matrix protein 22 [Presence] in Urine |
|
31134-0
|
Nuclear matrix protein 22 [Units/volume] in Urine |
|
93722-7
|
N-nortramadol [Mass/mass] in Meconium by Confirmatory method |
|
72747-9
|
N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
92904-2
|
N-nortramadol [Mass/volume] in Urine by Confirmatory method |
|
86454-6
|
N-nortramadol [Presence] in Urine |
|
87760-5
|
N-nortramadol/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
76117-1
|
Nitric oxide [VFr/PPres] Airway adaptor --during expiration |
|
76099-1
|
Nitric oxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
76120-5
|
Nitric oxide [VFr/PPres] Airway adaptor --during inspiration |
|
76100-7
|
Nitric oxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
76115-5
|
Nitric oxide [VFr/PPres] Airway adaptor --at end expiration |
|
74369-0
|
Nitric oxide [Moles/volume] in Exhaled gas |
|
76241-9
|
Nitric oxide gas delivered.case [Volume] from Gas delivery system |
|
76123-9
|
Nitric oxide gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
73776-7
|
No prenatal care [US Standard Certificate of Live Birth] |
|
76093-4
|
Nitric oxide [VFr/PPres] Airway adaptor |
|
76111-4
|
Nitric oxide [VFr/PPres] Gas delivery system |
|
75935-7
|
Nitrogen dioxide [VFr/PPres] Airway adaptor --during expiration |
|
76101-5
|
Nitrogen dioxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
75936-5
|
Nitrogen dioxide [VFr/PPres] Airway adaptor --during inspiration |
|
76102-3
|
Nitrogen dioxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
75937-3
|
Nitrogen dioxide [VFr/PPres] Airway adaptor --at end expiration |
|
75934-0
|
Nitrogen dioxide [VFr/PPres] Airway adaptor |
|
76113-0
|
Nitrogen dioxide [VFr/PPres] Gas delivery system |
|
5263-9
|
Nocardia sp Ab [Units/volume] in Serum |
|
91764-1
|
Nocardia sp identified in Aspirate by Organism specific culture |
|
9569-5
|
Nocardia sp IgG Ab [Units/volume] in Serum |
|
89639-9
|
Nocardia sp identified in Implanted device by Organism specific culture |
|
55096-2
|
Nocardia sp identified in Isolate |
|
14226-5
|
Nocardia sp identified in Isolate by Organism specific culture |
|
89638-1
|
Nocardia sp identified in Lower respiratory specimen by Organism specific culture |
|
43365-6
|
Nocardia sp identified in Unspecified specimen by Organism specific culture |
|
38367-9
|
N-octanoylglycine/Creatinine [Mass Ratio] in Urine |
|
41115-7
|
NOD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40429-3
|
NOD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
52066-8
|
Notice of Discharge Medicare Appeal Rights (NODMAR) form |
|
84900-0
|
Other nodule quadrant [Anatomy] in Prostate tumor |
|
17367-4
|
Nomifensine [Mass/volume] in Serum or Plasma |
|
10983-5
|
Norparamethadione [Mass/volume] in Serum or Plasma |
|
27402-7
|
Norparamethadione [Mass/volume] in Urine |
|
57260-2
|
Non-agency caregiver ability and willingness to assist with ADL [CMS Assessment] |
|
57266-9
|
Non-agency caregiver ability and willingness to assist with advocacy or facilitation of patient participation [CMS Assessment] |
|
57261-0
|
Non-agency caregiver ability and willingness to assist with IADL [CMS Assessment] |
|
57264-4
|
Non-agency caregiver ability and willingness to assist with management of equipment [CMS Assessment] |
|
57263-6
|
Non-agency caregiver ability and willingness to assist with medical procedures/treatments [CMS Assessment] |
|
57262-8
|
Non-agency caregiver ability and willingness to assist with medication administration [CMS Assessment] |
|
57265-1
|
Non-agency caregiver ability and willingness to assist with supervision and safety [CMS Assessment] |
|
53207-7
|
Nonanoylcarnitine (C9) [Moles/volume] in DBS |
|
74523-2
|
Nonanoylcarnitine (C9) [Moles/volume] in Serum or Plasma |
|
81777-5
|
Nonanoylcarnitine (C9)/Creatinine [Molar ratio] in Urine |
|
53968-4
|
Erythrocytes.non-dysmorphic [Presence] in Urine sediment by Light microscopy |
|
52072-6
|
Non-emergency transportation attachment |
|
90075-3
|
Non-Enterobacteriaceae identified in Isolate by Organism specific culture |
|
32151-3
|
Microscopic observation [Identifier] in Vaginal fluid by Non-gynecological cytology method |
|
32785-8
|
Microscopic observation [Identifier] in Unspecified specimen by Non-gynecological cytology method |
|
33716-2
|
Non-gynecological cytology method study |
|
47228-2
|
Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
|
43396-1
|
Cholesterol non HDL [Mass/volume] in Serum or Plasma |
|
70204-3
|
Cholesterol non HDL [Moles/volume] in Serum or Plasma |
|
35007-4
|
Nonhematic cells [#/volume] in Cerebral spinal fluid |
|
35008-2
|
Nonhematic cells [#/volume] in Body fluid |
|
30456-8
|
Nonhematic cells/100 leukocytes in Cerebral spinal fluid |
|
13525-1
|
Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
30457-6
|
Nonhematic cells/100 leukocytes in Body fluid |
|
13526-9
|
Nonhematic cells/100 leukocytes in Body fluid by Manual count |
|
77356-4
|
Non-hematopoietic stem cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
77355-6
|
Non-hematopoietic stem cells/100 leukocytes in Body fluid by Manual count |
|
77198-0
|
Noninvasive arteriosclerosis study report |
|
77354-9
|
Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool |
|
77353-1
|
Noninvasive colorectal cancer DNA and occult blood screening [Interpretation] in Stool Narrative |
|
80724-8
|
Estimated Non-liquefied volume [Volume Fraction] in Semen |
|
53246-5
|
Non-medical services attachment |
|
71513-6
|
Non-medicare certified services offered Dialysis facility [ESRD] |
|
72033-4
|
Non-oral vitamin D analog prescribed [ESRD] |
|
80340-3
|
Nonpharmacologic intervention for pain |
|
81187-7
|
Non-regional lymph nodes examined [#] in Specimen |
|
81185-1
|
Non-regional lymph nodes positive [#] in Specimen |
|
93298-8
|
Non-specific active suicidal thoughts Lifetime |
|
93247-5
|
Non-specific active suicidal thoughts 1 month |
|
51485-1
|
Epithelial cells.non-squamous [#/volume] in Urine by Automated count |
|
53294-5
|
Epithelial cells.non-squamous [#/area] in Urine sediment by Automated count |
|
41284-1
|
Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy high power field |
|
53132-7
|
Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy low power field |
|
50225-2
|
Epithelial cells.non-squamous [Presence] in Urine by Automated |
|
53978-3
|
Epithelial cells.non-squamous [Presence] in Urine sediment by Light microscopy |
|
75187-5
|
Non-treponemal test was reactive [CDC.CS] |
|
94084-1
|
Nonverbal pain indicators |
|
93795-3
|
NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
12709-2
|
Norastemizole [Mass/volume] in Serum or Plasma |
|
78866-1
|
Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
77774-8
|
Norbuprenorphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
82370-8
|
Norbuprenorphine [Presence] in Gastric fluid by Screen method |
|
75379-8
|
Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method |
|
72746-1
|
Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
77206-1
|
Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
53880-1
|
Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
66131-4
|
Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method |
|
82374-0
|
Norbuprenorphine [Presence] in Serum or Plasma by Screen method |
|
75370-7
|
Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood |
|
53881-9
|
Norbuprenorphine [Mass/volume] in Serum or Plasma |
|
49751-1
|
Norbuprenorphine [Mass/volume] in Urine by Confirmatory method |
|
58362-5
|
Norbuprenorphine [Presence] in Urine by Confirmatory method |
|
82371-6
|
Norbuprenorphine [Presence] in Urine by Screen method |
|
49753-7
|
Norbuprenorphine [Mass/volume] in Urine |
|
82375-7
|
Norbuprenorphine [Presence] in Unspecified specimen by Screen method |
|
58361-7
|
Norbuprenorphine/Creatinine [Mass Ratio] in Urine |
|
93462-0
|
Norcarfentanil [Mass/volume] in Urine by Confirmatory method |
|
72406-2
|
Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method |
|
13569-9
|
Norchlordiazepoxide [Presence] in Serum or Plasma |
|
9776-6
|
Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
|
33301-3
|
Norchlordiazepoxide [Presence] in Urine by Screen method |
|
27036-3
|
Norchlordiazepoxide [Mass/volume] in Urine |
|
80542-4
|
Norcitalopram [Mass/volume] in DBS |
|
35106-4
|
Norcitalopram [Mass/volume] in Serum or Plasma |
|
26040-6
|
Norcitalopram [Moles/volume] in Serum or Plasma |
|
75232-9
|
Norcitalopram [Presence] in Urine |
|
73584-5
|
Norcitalopram [Mass/volume] in Urine |
|
59939-9
|
Norclobazam [Moles/volume] in Gastric fluid |
|
35107-2
|
Norclobazam [Mass/volume] in Serum or Plasma |
|
14693-6
|
Norclobazam [Moles/volume] in Serum or Plasma |
|
94113-8
|
Norclobazam [Presence] in Urine by Screen method |
|
59938-1
|
Norclobazam [Moles/volume] in Urine |
|
60321-7
|
Norclobazam [Moles/volume] in Unspecified specimen |
|
59941-5
|
Norclomipramine [Moles/volume] in Gastric fluid |
|
13570-7
|
Norclomipramine [Presence] in Serum or Plasma |
|
35621-2
|
Norclomipramine [Mass/volume] in Serum or Plasma by Screen method |
|
3536-0
|
Norclomipramine [Mass/volume] in Serum or Plasma |
|
14694-4
|
Norclomipramine [Moles/volume] in Serum or Plasma |
|
58013-4
|
Norclomipramine [Presence] in Urine |
|
18470-5
|
Norclomipramine [Mass/volume] in Urine |
|
59940-7
|
Norclomipramine [Moles/volume] in Urine |
|
60322-5
|
Norclomipramine [Moles/volume] in Unspecified specimen |
|
58041-5
|
Norclostebol [Presence] in Urine |
|
80543-2
|
Norclozapine [Mass/volume] in DBS |
|
13571-5
|
Norclozapine [Presence] in Serum or Plasma |
|
10992-6
|
Norclozapine [Mass/volume] in Serum or Plasma |
|
14851-0
|
Norclozapine [Moles/volume] in Serum or Plasma |
|
89975-7
|
Norclozapine [Mass/volume] in Urine by Confirmatory method |
|
59171-9
|
Norclozapine [Presence] in Urine |
|
50890-3
|
Norclozapine [Moles/volume] in Urine |
|
73728-8
|
Norcocaine [Presence] in Meconium |
|
49830-3
|
Norcodeine [Mass/volume] in Serum or Plasma |
|
49829-5
|
Norcodeine [Mass/volume] in Urine |
|
86608-7
|
Norcodeine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
77740-9
|
Norcotinine [Mass/volume] in Urine |
|
59717-9
|
Nordiazepam [Mass/volume] in Blood by Confirmatory method |
|
59716-1
|
Nordiazepam [Mass/volume] in Blood |
|
79252-3
|
Nordiazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19627-9
|
Nordiazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19626-1
|
Nordiazepam cutoff [Mass/volume] in Urine for Screen method |
|
4213-5
|
Nordiazepam [Mass] of Dose |
|
59719-5
|
Nordiazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59718-7
|
Nordiazepam [Mass/volume] in Body fluid |
|
61085-7
|
Nordiazepam [Presence] in Gastric fluid |
|
29385-2
|
Nordiazepam [Mass/volume] in Gastric fluid |
|
26840-9
|
Nordiazepam [Mass/mass] in Hair |
|
59720-3
|
Nordiazepam [Mass/mass] in Meconium by Confirmatory method |
|
26891-2
|
Nordiazepam [Mass/mass] in Meconium |
|
72739-6
|
Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72615-8
|
Nordiazepam [Presence] in Saliva (oral fluid) |
|
72377-5
|
Nordiazepam [Mass/volume] in Saliva (oral fluid) |
|
59721-1
|
Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13572-3
|
Nordiazepam [Presence] in Serum or Plasma |
|
35622-0
|
Nordiazepam [Mass/volume] in Serum or Plasma by Screen method |
|
70212-6
|
Nordiazepam [Moles/volume] in Serum or Plasma by Screen method |
|
3537-8
|
Nordiazepam [Mass/volume] in Serum or Plasma |
|
26021-6
|
Nordiazepam [Moles/volume] in Serum or Plasma |
|
59722-9
|
Nordiazepam [Mass/mass] in Stool by Confirmatory method |
|
18248-5
|
Nordiazepam [Mass/volume] in Stool |
|
27239-3
|
Nordiazepam [Mass/mass] in Stool |
|
59723-7
|
Nordiazepam [Mass/mass] in Tissue |
|
74975-4
|
Nordiazepam [Mass/volume] in Serum or Plasma --trough |
|
16228-9
|
Nordiazepam [Mass/volume] in Urine by Confirmatory method |
|
70213-4
|
Nordiazepam [Moles/volume] in Urine by Confirmatory method |
|
3861-2
|
Nordiazepam [Presence] in Urine |
|
16202-4
|
Nordiazepam [Presence] in Urine by Confirmatory method |
|
19624-6
|
Nordiazepam [Presence] in Urine by Screen method |
|
15372-6
|
Nordiazepam [Mass/volume] in Urine |
|
26816-9
|
Nordiazepam [Mass/volume] in Vitreous fluid |
|
61051-9
|
Nordiazepam [Presence] in Unspecified specimen |
|
48959-1
|
Nordiazepam [Mass/volume] in Unspecified specimen |
|
77447-1
|
Nordiazepam [Moles/volume] in Unspecified specimen |
|
58367-4
|
Nordiazepam/Creatinine [Mass Ratio] in Urine |
|
35114-8
|
Nordothiepin [Mass/volume] in Serum or Plasma |
|
4210-1
|
Nordoxepin [Mass] of Dose |
|
29411-6
|
Nordoxepin [Mass/volume] in Gastric fluid |
|
59943-1
|
Nordoxepin [Moles/volume] in Gastric fluid |
|
13573-1
|
Nordoxepin [Presence] in Serum or Plasma |
|
35623-8
|
Nordoxepin [Mass/volume] in Serum or Plasma by Screen method |
|
3862-0
|
Nordoxepin [Mass/volume] in Serum or Plasma |
|
14695-1
|
Nordoxepin [Moles/volume] in Serum or Plasma |
|
58014-2
|
Nordoxepin [Presence] in Urine |
|
12386-9
|
Nordoxepin [Mass/volume] in Urine |
|
59942-3
|
Nordoxepin [Moles/volume] in Urine |
|
60323-3
|
Nordoxepin [Moles/volume] in Unspecified specimen |
|
1602-2
|
Norepinephrine [Mass/volume] in Plasma --10 minutes post standing |
|
47155-7
|
Norepinephrine [Moles/volume] in Plasma --10 minutes post standing |
|
1603-0
|
Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
|
47156-5
|
Norepinephrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO |
|
12525-2
|
Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge |
|
47157-3
|
Norepinephrine [Moles/volume] in Plasma --1 hour post XXX challenge |
|
27221-1
|
Norepinephrine [Mass/volume] in 24 hour Urine |
|
2668-2
|
Norepinephrine [Mass/time] in 24 hour Urine |
|
25963-0
|
Norepinephrine [Moles/volume] in 24 hour Urine |
|
14854-4
|
Norepinephrine [Moles/time] in 24 hour Urine |
|
1604-8
|
Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
|
47158-1
|
Norepinephrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO |
|
12526-0
|
Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge |
|
47159-9
|
Norepinephrine [Moles/volume] in Plasma --2 hours post XXX challenge |
|
1605-5
|
Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
|
47162-3
|
Norepinephrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO |
|
12527-8
|
Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge |
|
47163-1
|
Norepinephrine [Moles/volume] in Plasma --3 hours post XXX challenge |
|
12528-6
|
Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge |
|
47166-4
|
Norepinephrine [Moles/volume] in Plasma --4 hours post XXX challenge |
|
4356-2
|
Norepinephrine [Mass] of Dose |
|
57663-7
|
Norepinephrine [Mass/volume] in Plasma --post XXX challenge |
|
2666-6
|
Norepinephrine [Mass/volume] in Plasma |
|
14852-8
|
Norepinephrine [Moles/volume] in Plasma |
|
1606-3
|
Norepinephrine [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
|
47175-5
|
Norepinephrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO |
|
51429-9
|
Norepinephrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
13426-2
|
Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
47160-7
|
Norepinephrine [Moles/volume] in Plasma --2nd specimen post XXX challenge |
|
17369-0
|
Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
|
47161-5
|
Norepinephrine [Moles/volume] in Urine --2nd specimen post XXX challenge |
|
13427-0
|
Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
|
47164-9
|
Norepinephrine [Moles/volume] in Plasma --3rd specimen post XXX challenge |
|
17370-8
|
Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
|
47165-6
|
Norepinephrine [Moles/volume] in Urine --3rd specimen post XXX challenge |
|
13428-8
|
Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
|
47167-2
|
Norepinephrine [Moles/volume] in Plasma --4th specimen post XXX challenge |
|
17371-6
|
Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge |
|
47168-0
|
Norepinephrine [Moles/volume] in Urine --4th specimen post XXX challenge |
|
13429-6
|
Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
|
47169-8
|
Norepinephrine [Moles/volume] in Plasma --5th specimen post XXX challenge |
|
17372-4
|
Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge |
|
47170-6
|
Norepinephrine [Moles/volume] in Urine --5th specimen post XXX challenge |
|
13430-4
|
Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
|
47171-4
|
Norepinephrine [Moles/volume] in Plasma --6th specimen post XXX challenge |
|
17373-2
|
Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge |
|
47172-2
|
Norepinephrine [Moles/volume] in Urine --6th specimen post XXX challenge |
|
13431-2
|
Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
|
49009-4
|
Norepinephrine [Moles/volume] in Plasma --7th specimen post XXX challenge |
|
17374-0
|
Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge |
|
47174-8
|
Norepinephrine [Moles/volume] in Urine --7th specimen post XXX challenge |
|
17368-2
|
Norepinephrine [Mass/volume] in Plasma --standing |
|
33843-4
|
Norepinephrine [Moles/volume] in Plasma --standing |
|
1601-4
|
Norepinephrine [Mass/volume] in Plasma --supine |
|
33844-2
|
Norepinephrine [Moles/volume] in Plasma --supine |
|
2667-4
|
Norepinephrine [Mass/volume] in Urine |
|
14853-6
|
Norepinephrine [Moles/volume] in Urine |
|
32549-8
|
Norepinephrine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
44341-6
|
Norepinephrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
27977-8
|
Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine |
|
13782-8
|
Norepinephrine/Creatinine [Mass Ratio] in Urine |
|
24523-3
|
Norepinephrine/Creatinine [Molar ratio] in Urine |
|
85099-0
|
Norescitalopram [Mass/volume] in Serum or Plasma |
|
3865-3
|
Norethandrolone [Mass/time] in 24 hour Urine |
|
4357-0
|
Norethandrolone [Mass] of Dose |
|
3863-8
|
Norethandrolone [Presence] in Urine |
|
3864-6
|
Norethandrolone [Mass/volume] in Urine |
|
13907-1
|
Norethindrone [Mass/volume] in Serum or Plasma |
|
49756-0
|
Norethindrone [Mass/volume] in Urine |
|
4358-8
|
Norfenefrine [Mass] of Dose |
|
3866-1
|
Norfenefrine [Mass/volume] in Urine |
|
12431-3
|
Norfenfluramine [Mass/volume] in Serum or Plasma |
|
73937-5
|
Norfentanyl [Mass/volume] in Blood by Confirmatory method |
|
78867-9
|
Norfentanyl cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
77775-5
|
Norfentanyl cutoff [Mass/volume] in Urine for Confirmatory method |
|
61086-5
|
Norfentanyl [Presence] in Gastric fluid |
|
72745-3
|
Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
61052-7
|
Norfentanyl [Presence] in Serum or Plasma |
|
74137-1
|
Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
11074-2
|
Norfentanyl [Mass/volume] in Serum or Plasma |
|
58383-1
|
Norfentanyl [Mass/volume] in Urine by Confirmatory method |
|
43199-9
|
Norfentanyl [Presence] in Urine |
|
43200-5
|
Norfentanyl [Presence] in Urine by Confirmatory method |
|
11075-9
|
Norfentanyl [Mass/volume] in Urine |
|
61053-5
|
Norfentanyl [Presence] in Unspecified specimen |
|
58382-3
|
Norfentanyl/Creatinine [Mass Ratio] in Urine |
|
4359-6
|
Norfloxacin [Mass] of Dose |
|
7037-5
|
Norfloxacin [Susceptibility] by Gradient strip |
|
368-1
|
Norfloxacin [Susceptibility] by Disk diffusion (KB) |
|
367-3
|
Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
366-5
|
Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
41504-2
|
Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
3867-9
|
Norfloxacin [Mass/volume] in Serum or Plasma |
|
18956-3
|
Norfloxacin [Susceptibility] |
|
369-9
|
Norfloxacin [Susceptibility] by Serum bactericidal titer |
|
17375-7
|
Norflunitrazepam [Mass/volume] in Blood |
|
32650-4
|
Norflunitrazepam [Mass/volume] in Serum or Plasma |
|
26039-8
|
Norflunitrazepam [Moles/volume] in Serum or Plasma |
|
27083-5
|
Norflunitrazepam [Mass/volume] in Urine |
|
19631-1
|
Norfluoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19630-3
|
Norfluoxetine cutoff [Mass/volume] in Urine for Screen method |
|
13574-9
|
Norfluoxetine [Presence] in Serum or Plasma |
|
35624-6
|
Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method |
|
3868-7
|
Norfluoxetine [Mass/volume] in Serum or Plasma |
|
14855-1
|
Norfluoxetine [Moles/volume] in Serum or Plasma |
|
20553-4
|
Norfluoxetine [Mass/volume] in Urine by Confirmatory method |
|
19629-5
|
Norfluoxetine [Presence] in Urine by Confirmatory method |
|
19628-7
|
Norfluoxetine [Presence] in Urine by Screen method |
|
12445-3
|
Norfluoxetine [Mass/volume] in Urine |
|
72812-1
|
Norfluoxetine/Creatinine [Mass Ratio] in Urine |
|
90469-8
|
Norfluvoxamine [Mass/volume] in Urine by Confirmatory method |
|
90470-6
|
Norfluvoxamine [Presence] in Urine by Screen method |
|
77776-3
|
Norhydrocodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
78868-7
|
Norhydrocodone cutoff [Mass/volume] in Urine for Confirmatory method |
|
72744-6
|
Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
78363-9
|
Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
61422-2
|
Norhydrocodone [Mass/volume] in Urine by Confirmatory method |
|
61421-4
|
Norhydrocodone [Presence] in Urine by Confirmatory method |
|
89304-0
|
Norhydrocodone [Presence] in Urine by Screen method |
|
61420-6
|
Norhydrocodone/Creatinine [Mass Ratio] in Urine |
|
21421-3
|
Norketamine [Mass/volume] in Serum or Plasma |
|
72799-0
|
Norketamine [Mass/volume] in Urine by Confirmatory method |
|
18322-8
|
Norketamine [Mass/volume] in Urine |
|
72800-6
|
Norketamine/Creatinine [Mass Ratio] in Urine |
|
75914-2
|
aPTT W hexagonal phospholipid/Normal (StaClot LA confirm) |
|
75913-4
|
dRVVT W excess hexagonal phospholipid/Normal (StaClot LA confirm) |
|
66736-0
|
Normalized silica clotting time of Platelet poor plasma |
|
13575-6
|
Normaprotiline [Presence] in Serum or Plasma |
|
35108-0
|
Normaprotiline [Mass/volume] in Serum or Plasma |
|
57858-3
|
Normaprotiline [Moles/volume] in Unspecified specimen |
|
77777-1
|
Normeperidine cutoff [Mass/volume] in Urine for Confirmatory method |
|
61087-3
|
Normeperidine [Presence] in Gastric fluid |
|
72743-8
|
Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
10544-5
|
Normeperidine [Presence] in Serum or Plasma |
|
35625-3
|
Normeperidine [Mass/volume] in Serum or Plasma by Screen method |
|
73933-4
|
Normeperidine [Mass/volume] in Serum, Plasma or Blood |
|
10996-7
|
Normeperidine [Mass/volume] in Serum or Plasma |
|
59944-9
|
Normeperidine [Moles/volume] in Serum or Plasma |
|
58389-8
|
Normeperidine [Mass/volume] in Urine by Confirmatory method |
|
27920-8
|
Normeperidine [Presence] in Urine |
|
58388-0
|
Normeperidine [Presence] in Urine by Confirmatory method |
|
3869-5
|
Normeperidine [Mass/volume] in Urine |
|
61054-3
|
Normeperidine [Presence] in Unspecified specimen |
|
58387-2
|
Normeperidine/Creatinine [Mass Ratio] in Urine |
|
10545-2
|
Normephenytoin [Mass/volume] in Serum or Plasma |
|
26041-4
|
Normephenytoin [Moles/volume] in Serum or Plasma |
|
57462-4
|
Normetanephrine Free [Mass/volume] in Serum or Plasma |
|
40851-8
|
Normetanephrine Free [Moles/volume] in Serum or Plasma |
|
21422-1
|
Normetanephrine [Mass/volume] in 24 hour Urine |
|
2671-6
|
Normetanephrine [Mass/time] in 24 hour Urine |
|
25964-8
|
Normetanephrine [Moles/volume] in 24 hour Urine |
|
15083-9
|
Normetanephrine [Moles/time] in 24 hour Urine |
|
4360-4
|
Normetanephrine [Mass] of Dose |
|
2669-0
|
Normetanephrine [Mass/volume] in Serum or Plasma |
|
25489-6
|
Normetanephrine [Moles/volume] in Serum or Plasma |
|
2670-8
|
Normetanephrine [Mass/volume] in Urine |
|
34347-5
|
Normetanephrine [Moles/volume] in Urine |
|
44342-4
|
Normetanephrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
44924-9
|
Normetanephrine/Creatinine [Molar ratio] in 24 hour Urine |
|
13783-6
|
Normetanephrine/Creatinine [Mass Ratio] in Urine |
|
34348-3
|
Normetanephrine/Creatinine [Molar ratio] in Urine |
|
10546-0
|
Normethsuximide [Mass/volume] in Serum or Plasma |
|
39483-3
|
Normethsuximide [Moles/volume] in Serum or Plasma |
|
34414-3
|
Normianserin [Mass/volume] in Serum or Plasma |
|
74389-8
|
Normirtazapine [Mass/volume] in Blood |
|
74388-0
|
Normirtazapine [Mass/volume] in Body fluid |
|
74385-6
|
Normirtazapine [Mass/mass] in Hair |
|
34415-0
|
Normirtazapine [Mass/volume] in Serum or Plasma |
|
74387-2
|
Normirtazapine [Mass/volume] in Urine |
|
74386-4
|
Normirtazapine [Mass/mass] in Unspecified specimen |
|
715-3
|
Normoblasts [#/volume] in Blood |
|
74454-0
|
Normoblasts [#/volume] in Blood from Fetus |
|
74394-8
|
Normoblasts [#/volume] in Cord blood |
|
33957-2
|
Normoblasts/100 blasts in Blood |
|
51579-1
|
Normoblasts/100 cells in Bone marrow by Manual count |
|
33990-3
|
Normoblasts/100 leukocytes in Blood |
|
74463-1
|
Normoblasts/100 leukocytes in Blood from Fetus |
|
74403-7
|
Normoblasts/100 leukocytes in Cord blood |
|
33364-1
|
Normochromic [Presence] in Blood by Light microscopy |
|
33363-3
|
Normocytic [Presence] in Blood by Light microscopy |
|
7794-1
|
Normocytic/Normochromic polychromasia [Presence] in Blood by Light microscopy |
|
49831-1
|
Normorphine [Mass/volume] in Urine |
|
33917-6
|
Nornicotine [Mass/volume] in Urine |
|
57727-0
|
Norolanzapine [Mass/volume] in Serum or Plasma |
|
74083-7
|
Norolanzapine [Moles/volume] in Serum or Plasma |
|
89968-2
|
Norolanzapine [Mass/volume] in Urine by Confirmatory method |
|
89969-0
|
Norolanzapine [Presence] in Urine by Screen method |
|
79388-5
|
Norovirus genogroup I+II orf1-orf2 junction region [Presence] in Stool by NAA with probe detection |
|
49117-5
|
Norovirus Ag [Presence] in Stool |
|
80375-9
|
Norovirus Ag [Presence] in Stool by Rapid immunoassay |
|
76628-7
|
Norovirus genogroup I and II RNA [Identifier] in Stool by NAA with probe detection |
|
90449-0
|
Norovirus genogroup I and II RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
40863-3
|
Norovirus Genogroup I Ag [Presence] in Stool |
|
54905-5
|
Norovirus Genogroup I RNA [Presence] in Stool by NAA with probe detection |
|
90288-2
|
Norovirus Genogroup I RNA [Presence] in Vomitus by NAA with probe detection |
|
82211-4
|
Norovirus genogroup I+II RNA [Presence] in Stool by NAA with non-probe detection |
|
92692-3
|
Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection |
|
54906-3
|
Norovirus Genogroup II RNA [Presence] in Stool by NAA with probe detection |
|
90289-0
|
Norovirus Genogroup II RNA [Presence] in Vomitus by NAA with probe detection |
|
60427-2
|
Norovirus RNA [Presence] in Isolate by NAA with probe detection |
|
7974-9
|
Norovirus RNA [Presence] in Stool by NAA with probe detection |
|
90287-4
|
Norovirus RNA [Presence] in Vomitus by NAA with probe detection |
|
56748-7
|
Norovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41035-7
|
Norovirus RNA [Presence] in Unspecified specimen by Probe |
|
10696-3
|
Norovirus [Identifier] in Stool by Electron microscopy |
|
7973-1
|
Norovirus [Presence] in Stool by Electron microscopy |
|
77778-9
|
Noroxycodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
77779-7
|
Noroxycodone cutoff [Mass/volume] in Urine for Confirmatory method |
|
72742-0
|
Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
61425-5
|
Noroxycodone [Mass/volume] in Urine by Confirmatory method |
|
61424-8
|
Noroxycodone [Presence] in Urine by Confirmatory method |
|
89303-2
|
Noroxycodone [Presence] in Urine by Screen method |
|
61423-0
|
Noroxycodone/Creatinine [Mass Ratio] in Urine |
|
90894-7
|
Noroxymorphone [Mass/volume] in Urine by Confirmatory method |
|
89302-4
|
Noroxymorphone [Presence] in Urine by Screen method |
|
86609-5
|
Noroxymorphone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
19637-8
|
Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method |
|
19636-0
|
Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method |
|
29387-8
|
Norpropoxyphene [Mass/volume] in Gastric fluid |
|
27211-2
|
Norpropoxyphene [Mass/mass] in Hair |
|
27029-8
|
Norpropoxyphene [Mass/mass] in Meconium |
|
72620-8
|
Norpropoxyphene [Presence] in Saliva (oral fluid) |
|
72619-0
|
Norpropoxyphene [Mass/volume] in Saliva (oral fluid) |
|
3870-3
|
Norpropoxyphene [Presence] in Serum or Plasma |
|
35626-1
|
Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method |
|
10341-6
|
Norpropoxyphene [Mass/volume] in Serum or Plasma |
|
55559-9
|
Norpropoxyphene [Moles/volume] in Serum or Plasma |
|
27041-3
|
Norpropoxyphene [Mass/mass] in Stool |
|
17377-3
|
Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
|
3871-1
|
Norpropoxyphene [Presence] in Urine |
|
17376-5
|
Norpropoxyphene [Presence] in Urine by Confirmatory method |
|
19632-9
|
Norpropoxyphene [Presence] in Urine by Screen method |
|
19635-2
|
Norpropoxyphene [Mass/volume] in Urine |
|
48960-9
|
Norpropoxyphene [Mass/volume] in Unspecified specimen |
|
77334-1
|
Norpropoxyphene [Moles/volume] in Unspecified specimen |
|
58399-7
|
Norpropoxyphene/Creatinine [Mass Ratio] in Urine |
|
88715-8
|
Norquetiapine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
89966-6
|
Norquetiapine [Mass/volume] in Urine by Confirmatory method |
|
89967-4
|
Norquetiapine [Presence] in Urine by Screen method |
|
13557-4
|
Norsertraline [Presence] in Serum or Plasma |
|
6897-3
|
Norsertraline [Mass/volume] in Serum or Plasma |
|
75233-7
|
Norsertraline [Presence] in Urine |
|
74655-2
|
Norsertraline [Mass/volume] in Urine |
|
59330-1
|
Norsibutramine [Mass/volume] in Blood |
|
59333-5
|
Norsibutramine [Mass/volume] in Serum or Plasma |
|
59336-8
|
Norsibutramine [Mass/volume] in Urine |
|
43239-3
|
Norsildenafil [Mass/volume] in Serum or Plasma |
|
86232-6
|
Norsufentanil [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
59348-3
|
Nortamoxifen [Mass/volume] in Blood |
|
59351-7
|
Nortamoxifen [Mass/volume] in Serum or Plasma |
|
81754-4
|
Nortapentadol [Mass/volume] in Urine by Confirmatory method |
|
89306-5
|
Nortapentadol [Presence] in Urine by Screen method |
|
65808-8
|
Nortapentadol [Mass/volume] in Urine |
|
75249-3
|
Norton scale total score |
|
72741-2
|
Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
18340-0
|
Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method |
|
18339-2
|
Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
|
12438-8
|
Nortramadol [Mass/volume] in Serum or Plasma |
|
18338-4
|
Nortramadol [Mass/volume] in Urine |
|
49691-9
|
Nortrimipramine [Presence] in Serum or Plasma |
|
16746-0
|
Nortrimipramine [Mass/volume] in Serum or Plasma |
|
25394-8
|
Nortrimipramine [Moles/volume] in Serum or Plasma |
|
58015-9
|
Nortrimipramine [Presence] in Urine |
|
12444-6
|
Nortrimipramine [Mass/volume] in Urine |
|
77331-7
|
Nortrimipramine [Moles/volume] in Unspecified specimen |
|
3876-0
|
Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose |
|
77886-0
|
Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method |
|
80544-0
|
Nortriptyline [Mass/volume] in DBS |
|
4361-2
|
Nortriptyline [Mass] of Dose |
|
40389-9
|
Nortriptyline [Presence] in Gastric fluid |
|
29407-4
|
Nortriptyline [Mass/volume] in Gastric fluid |
|
59945-6
|
Nortriptyline [Moles/volume] in Gastric fluid |
|
3873-7
|
Nortriptyline [Presence] in Serum or Plasma |
|
35627-9
|
Nortriptyline [Mass/volume] in Serum or Plasma by Screen method |
|
3872-9
|
Nortriptyline [Mass/volume] in Serum or Plasma |
|
14856-9
|
Nortriptyline [Moles/volume] in Serum or Plasma |
|
74924-2
|
Nortriptyline [Mass/volume] in Serum or Plasma --trough |
|
61428-9
|
Nortriptyline [Mass/volume] in Urine by Confirmatory method |
|
3874-5
|
Nortriptyline [Presence] in Urine |
|
61427-1
|
Nortriptyline [Presence] in Urine by Confirmatory method |
|
93496-8
|
Nortriptyline [Presence] in Urine by Screen method |
|
3875-2
|
Nortriptyline [Mass/volume] in Urine |
|
45301-9
|
Nortriptyline [Moles/volume] in Urine |
|
60324-1
|
Nortriptyline [Moles/volume] in Unspecified specimen |
|
61426-3
|
Nortriptyline/Creatinine [Mass Ratio] in Urine |
|
35628-7
|
Norverapamil [Presence] in Serum or Plasma by Screen method |
|
6903-9
|
Norverapamil [Mass/volume] in Serum or Plasma |
|
93451-3
|
Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method |
|
88403-1
|
Not counting any walking you have already mentioned, during the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time [IPAQ] |
|
81372-5
|
Notary |
|
81373-3
|
Notary commission expiration date |
|
81374-1
|
Notary seal ID |
|
81867-4
|
NOTCH3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
34492-9
|
NOTCH3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41077-9
|
NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34109-9
|
Note |
|
71542-5
|
Nothing seems to give me much pleasure in the last 2 weeks or more [M3] |
|
71807-2
|
Nothing seems to give me much pleasure since I took my last screen [M3] |
|
53244-0
|
Notice of privacy practices receipt |
|
41706-3
|
Novobiocin [Susceptibility] by Gradient strip |
|
372-3
|
Novobiocin [Susceptibility] by Disk diffusion (KB) |
|
371-5
|
Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
370-7
|
Novobiocin [Susceptibility] by Minimum lethal concentration (MLC) |
|
17378-1
|
Novobiocin [Mass/volume] in Serum or Plasma |
|
18957-1
|
Novobiocin [Susceptibility] |
|
373-1
|
Novobiocin [Susceptibility] by Serum bactericidal titer |
|
49864-2
|
Novocaine IgE Ab [Units/volume] in Serum |
|
72687-7
|
Now we would like to know in addition the quality of your overall personal state in the course of the last week [BSL-23] |
|
76031-4
|
NPC1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
34505-8
|
NPDC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41076-1
|
NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60487-6
|
NPHP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34512-4
|
NPHS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41075-3
|
NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34513-2
|
NPHS1 gene targeted mutation analysis in Body fluid by Molecular genetics method |
|
41074-6
|
NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal |
|
60488-4
|
NPHS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72311-4
|
NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72335-3
|
NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
54448-6
|
NPM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75034-9
|
NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
72310-6
|
NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72334-6
|
NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
72309-8
|
NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72336-1
|
NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
10797-9
|
Microscopic observation [Identifier] in Tissue by Neutral red stain |
|
34739-3
|
NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41073-8
|
NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21719-0
|
NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85510-6
|
NRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
|
53621-9
|
NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
21720-8
|
NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
83060-4
|
NRAS gene [VCF] in Cancer specimen by Sequencing |
|
30392-5
|
Nucleated erythrocytes [#/volume] in Blood |
|
771-6
|
Nucleated erythrocytes [#/volume] in Blood by Automated count |
|
62248-0
|
Nucleated erythrocytes [#/volume] in Blood from Fetus by Automated count |
|
772-4
|
Nucleated erythrocytes [#/volume] in Blood by Manual count |
|
26459-8
|
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid |
|
62437-9
|
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Automated count |
|
13529-3
|
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
26460-6
|
Nucleated erythrocytes [#/volume] in Body fluid |
|
62439-5
|
Nucleated erythrocytes [#/volume] in Body fluid by Automated count |
|
13530-1
|
Nucleated erythrocytes [#/volume] in Body fluid by Manual count |
|
62438-7
|
Nucleated erythrocytes [#/volume] in Synovial fluid by Automated count |
|
43220-3
|
Nucleated erythrocytes [#/volume] in Synovial fluid by Manual count |
|
34188-3
|
Nucleated erythrocytes [Presence] in Blood |
|
34200-6
|
Nucleated erythrocytes [Presence] in Blood by Automated count |
|
40630-6
|
Nucleated erythrocytes [Presence] in Blood by Light microscopy |
|
55780-1
|
Nucleated erythrocytes [#] in Cerebral spinal fluid by Manual count |
|
56472-4
|
Nucleated erythrocytes [#] in Unspecified specimen by Manual count |
|
26461-4
|
Nucleated erythrocytes/100 erythrocytes in Blood |
|
773-2
|
Nucleated erythrocytes/100 erythrocytes in Blood by Manual count |
|
58413-6
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Automated count |
|
62245-6
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood from Fetus by Automated count |
|
18309-5
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count |
|
66764-2
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Cord blood |
|
19048-8
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood |
|
62441-1
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Cerebral spinal fluid by Automated count |
|
40631-4
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Cerebral spinal fluid by Manual count |
|
62440-3
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid by Automated count |
|
41282-5
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid by Manual count |
|
49229-8
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid |
|
62442-9
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid by Automated count |
|
48040-0
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid by Manual count |
|
68545-3
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid |
|
48778-5
|
Nucleated erythrocytes/100 cells in Cerebral spinal fluid |
|
42215-4
|
Nucleated erythrocytes/100 cells in Bone marrow by Manual count |
|
70170-6
|
Nucleated erythrocytes/100 cells in Pleural fluid |
|
70171-4
|
Nucleated erythrocytes/100 cells in Peritoneal fluid |
|
89065-7
|
Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week |
|
80198-5
|
Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method |
|
80199-3
|
Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method |
|
72609-1
|
Nonsteroidal antiinflammatory drugs [Presence] in Serum or Plasma by Screen method |
|
80200-9
|
Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method |
|
35645-1
|
NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
47967-5
|
NSD1 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
23316-3
|
Nairobi sheep disease virus Ab [Presence] in Serum |
|
23314-8
|
Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23315-5
|
Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence |
|
31524-2
|
Nairobi sheep disease virus Ab [Units/volume] in Serum |
|
23313-0
|
Nairobi sheep disease virus Ab [Titer] in Serum |
|
31904-6
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen |
|
23318-9
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23320-5
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23319-7
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
10477-8
|
Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
|
47053-4
|
Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
44802-7
|
Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid |
|
48164-8
|
Enolase.neuron specific [Mass/volume] in Body fluid |
|
68952-1
|
Enolase.neuron specific [Mass/volume] in Pericardial fluid |
|
19194-0
|
Enolase.neuron specific [Units/volume] in Pleural fluid |
|
68939-8
|
Enolase.neuron specific [Mass/volume] in Pleural fluid |
|
69560-1
|
Enolase.neuron specific [Mass/volume] in Peritoneal fluid |
|
57371-7
|
Enolase.neuron specific [Mass/volume] in Serum or Plasma by Immunoassay |
|
48138-2
|
Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
19193-2
|
Enolase.neuron specific [Units/volume] in Serum or Plasma |
|
2225-1
|
Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma |
|
15060-7
|
Enolase.neuron specific [Mass/volume] in Serum or Plasma |
|
11016-3
|
Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific |
|
10784-7
|
Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |
|
77362-2
|
N-tau methylimidazoleacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
77363-0
|
N-tau methylimidazoleacetate/Creatinine [Molar ratio] in Urine |
|
85098-2
|
Nitisinone [Moles/volume] in DBS by LC/MS/MS |
|
71425-3
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay |
|
77622-9
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Peritoneal dialysis fluid by Immunoassay |
|
77621-1
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay |
|
83107-3
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma by Immunoassay |
|
83108-1
|
Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma by Immunoassay |
|
33762-6
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma |
|
33763-4
|
Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma |
|
93813-4
|
NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method |
|
50774-9
|
Nucleated cells [#/volume] in Blood |
|
50375-5
|
Nucleated cells [#/volume] in Bronchial specimen by Manual count |
|
58470-6
|
Nucleated cells [#/volume] in Cerebral spinal fluid |
|
52816-6
|
Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count |
|
58906-9
|
Nucleated cells [#/volume] in Cerebral spinal fluid by Manual count |
|
52817-4
|
Nucleated cells [#/volume] in Dialysis fluid by Automated count |
|
74813-7
|
Nucleated cells [#/volume] in Dialysis fluid by Manual count |
|
55793-4
|
Nucleated cells [#/volume] in Body fluid |
|
71690-2
|
Nucleated cells [#/volume] in Body fluid by Automated count |
|
74689-1
|
Nucleated cells [#/volume] in Body fluid by Manual count |
|
55792-6
|
Nucleated cells [#/volume] in Bone marrow |
|
82586-9
|
Nucleated cells [#/volume] in Bone marrow by Automated count |
|
52815-8
|
Nucleated cells [#/volume] in Pericardial fluid by Automated count |
|
58905-1
|
Nucleated cells [#/volume] in Pericardial fluid by Manual count |
|
52819-0
|
Nucleated cells [#/volume] in Pleural fluid by Automated count |
|
58904-4
|
Nucleated cells [#/volume] in Pleural fluid by Manual count |
|
52818-2
|
Nucleated cells [#/volume] in Peritoneal fluid by Automated count |
|
51926-4
|
Nucleated cells [#/volume] in Peritoneal fluid by Manual count |
|
53557-5
|
Nucleated cells [#/volume] in Synovial fluid by Manual count |
|
78003-1
|
Nucleated cell dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass |
|
72332-0
|
Nucleated cells/100 round cells in Prostatic fluid by Manual count |
|
72330-4
|
Nucleated cells/100 round cells in Semen by Manual count |
|
90342-7
|
Nuclear medicine Attending Note |
|
90345-0
|
Nuclear medicine Nurse Note |
|
90348-4
|
Nuclear medicine Resident Note |
|
90341-9
|
Nuclear medicine Administrative note |
|
90343-5
|
Nuclear medicine Consult note |
|
85895-1
|
Nuclear medicine Diagnostic study note |
|
90344-3
|
Nuclear medicine Note |
|
90349-2
|
Nuclear medicine Telephone encounter Note |
|
90346-8
|
Nuclear medicine Postoperative evaluation and management note |
|
90347-6
|
Nuclear medicine Preoperative evaluation and management note |
|
90350-0
|
Nuclear medicine procedure note |
|
44645-0
|
Nuclear pleomorphism in Breast tumor Qualitative by Nottingham |
|
82931-7
|
Nuclear pore protein gp210 IgG Ab [Presence] in Serum by Line blot |
|
42331-9
|
Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
70256-3
|
Nuclear IgG Ab [Ratio] in Serum by Immunoassay |
|
31545-7
|
Nuclear IgG Ab [Presence] in Serum |
|
29950-3
|
Nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
21424-7
|
Nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
|
56634-9
|
Nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
54025-2
|
Nuclear pore protein gp210 Ab [Presence] in Serum |
|
56716-4
|
Nuclear pore protein gp210 Ab [Presence] in Serum by Immunoblot |
|
63043-4
|
Nuclei scored in Tissue |
|
83058-8
|
Nucleoprotein expression [Presence] in Control Tissue by Immune stain |
|
63299-2
|
Nucleosome Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89528-4
|
Nucleosome Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63298-4
|
Nucleosome Ab [Presence] in Body fluid by Immunoassay |
|
34416-8
|
Nucleosome Ab [Units/volume] in Serum by Immunoassay |
|
53015-4
|
Nucleosome Ab [Presence] in Serum |
|
63300-8
|
Nucleosome Ab [Presence] in Serum by Immunoassay |
|
89506-0
|
Nucleosome Ab [Presence] in Serum by Line blot |
|
53014-7
|
Nucleosome Ab [Units/volume] in Serum |
|
93194-9
|
NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93195-6
|
NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative |
|
54423-9
|
Transfuse plateletpheresis half units [#] |
|
82844-2
|
Number affected by condition Population |
|
1766-5
|
Aldosterone receptors [#] in Leukocytes |
|
90559-6
|
Apnea + hypopnea [#] |
|
43414-2
|
Blood product units available [#] |
|
44757-3
|
Blood product units given [#] |
|
43412-6
|
Blood product units issued [#] |
|
43413-4
|
Blood product units requested [#] |
|
73699-1
|
Number of prior CCHD screens [#] Qualitative |
|
90553-9
|
Central apnea [#] |
|
90558-8
|
Central hypopnea [#] |
|
50998-4
|
CFTR gene mutations tested for [#] in Blood or Tissue by Molecular genetics method |
|
82843-4
|
Number dead from condition Population |
|
88666-3
|
Number of defibrillation shocks given |
|
78896-8
|
Number of diseased coronary segments on Cardiac angiogram |
|
46997-3
|
HLA Ab cells tested [#] in Serum |
|
46996-5
|
HLA Ab positive cells [#] in Serum |
|
90555-4
|
Hypopnea [#] |
|
85722-7
|
Number of children under the age of 18 living in mother's household during the pregnancy |
|
85720-1
|
Number of children under the age of 18 living in mother's household during the pregnancy who received a rubella vaccine |
|
79552-6
|
Number of incontinent stools |
|
90552-1
|
Mixed apnea [#] |
|
90554-7
|
Oxygen desaturation [#] |
|
90560-4
|
Obstructive apnea [#] |
|
90556-2
|
Obstructive hypopnea [#] |
|
85736-7
|
Number of sexual partners in last 12 months |
|
80397-3
|
Number of weeks postpartum |
|
54418-9
|
Transfuse fresh frozen plasma pediatric units [#] |
|
54421-3
|
Transfuse frozen erythrocytes pediatric units [#] |
|
90557-0
|
Respiratory effort-related arousal [#] |
|
79554-2
|
Number of sanitary pads |
|
79551-8
|
Number of stools |
|
54403-1
|
Transfuse 5% plasma protein fraction units [#] |
|
51885-2
|
Transfuse whole blood autologous units [#] |
|
51893-6
|
Transfuse cryoprecipitate poor plasma units [#] |
|
51881-1
|
Transfuse cryoprecipitate units [#] |
|
51891-0
|
Transfuse factor IX units [#] |
|
51889-4
|
Transfuse factor VIII [#] |
|
51877-9
|
Transfuse fresh frozen plasma units [#] |
|
54415-5
|
Transfuse leukocyte-poor platelets units [#] |
|
51879-5
|
Transfuse packed erythrocytes units [#] |
|
51872-0
|
Transfuse platelet concentrate units [#] |
|
54405-6
|
Transfuse pooled cryoprecipitate units [#] |
|
54407-2
|
Transfuse pooled fresh frozen plasma units [#] |
|
51884-5
|
Transfuse pooled platelets units [#] |
|
51887-8
|
Transfuse Rh immune globulin units [#] |
|
54413-0
|
Transfuse leukocyte-poor plateletpheresis units [#] |
|
51883-7
|
Transfuse whole blood units [#] |
|
51874-6
|
Varicella zoster virus immune globulin ordered [#] in Blood product unit |
|
79550-0
|
Number of voids |
|
54152-4
|
Nuclear mitotic apparatus Ab [Presence] in Serum by Immunofluorescence |
|
34737-7
|
Nuclear mitotic apparatus Ab [Interpretation] in Serum or Plasma |
|
54153-2
|
Nuclear mitotic apparatus Ab [Titer] in Serum by Immunofluorescence |
|
77257-4
|
Number of actual nursing staff by job position in a reporting period [NMMDS] |
|
74467-2
|
Number of allowed answer responses interval Question |
|
77259-0
|
Number of budgeted nursing staff by job position in a reporting period [NMMDS] |
|
77278-0
|
Number of budgeted nursing staff job positions filled in a reporting period [NMMDS] |
|
54953-5
|
Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 2 [CMS Assessment] |
|
54954-3
|
Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 3 [CMS Assessment] |
|
54955-0
|
Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 4 [CMS Assessment] |
|
86752-3
|
Number of days antianxiety received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86756-4
|
Number of days antibiotic received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86755-6
|
Number of days anticoagulant received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86753-1
|
Number of days antidepressant received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86751-5
|
Number of days antipsychotic received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86757-2
|
Number of days diuretic received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86754-9
|
Number of days hypnotic received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
54982-4
|
Number of days injectable substances received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
58127-2
|
Number of days insulin injections were received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
86775-4
|
Number of days of active range of motion in last 7 calendar days [CMS Assessment] |
|
86774-7
|
Number of days of passive range of motion in last 7 calendar days [CMS Assessment] |
|
86776-2
|
Number of days of splint or brace assistance in last 7 calendar days [CMS Assessment] |
|
86782-0
|
Number of days of training and skill practice in amputation or prosthesis care in last 7 calendar days [CMS Assessment] |
|
86777-0
|
Number of days of training and skill practice in bed mobility in last 7 calendar days [CMS Assessment] |
|
86783-8
|
Number of days of training and skill practice in communication in last 7 calendar days [CMS Assessment] |
|
86780-4
|
Number of days of training and skill practice in dressing or grooming in last 7 calendar days [CMS Assessment] |
|
86781-2
|
Number of days of training and skill practice in eating or swallowing in last 7 calendar days [CMS Assessment] |
|
86778-8
|
Number of days of training and skill practice in transfer in last 7 calendar days [CMS Assessment] |
|
86779-6
|
Number of days of training and skill practice in walking in last 7 calendar days [CMS Assessment] |
|
88291-0
|
Number of days opiod received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
55040-0
|
Number of days physician examined the patient in last 14 days [CMS Assessment] |
|
55041-8
|
Number of days physician orders changed in last 14 days [CMS Assessment] |
|
58128-0
|
Number of days the physician changed the resident's insulin orders in last 7 days or since admission/reentry if less than 7 days [CMS Assessment] |
|
90530-7
|
Number of days with at least 15 minutes of occupational therapy during assessment period [CMS Assessment] |
|
45762-2
|
Number of days with at least 15 minutes of occupational therapy in the last 7 days [CMS Assessment] |
|
90550-5
|
Number of days with at least 15 minutes of physical therapy during assessment period [CMS Assessment] |
|
45764-8
|
Number of days with at least 15 minutes of physical therapy in the last 7 days [CMS Assessment] |
|
45768-9
|
Number of days with at least 15 minutes of psychological therapy by any licensed mental health professional in the last 7 days [CMS Assessment] |
|
55036-8
|
Number of days with at least 15 minutes of recreational and music therapy in last 7 days [CMS Assessment] |
|
45766-3
|
Number of days with at least 15 minutes of respiratory therapy in the last 7 days [CMS Assessment] |
|
90551-3
|
Number of days with at least 15 minutes of speech language pathology and audiology services during assessment period [CMS Assessment] |
|
45760-6
|
Number of days with at least 15 minutes of speech language pathology and audiology services in the last 7 days [CMS Assessment] |
|
75856-5
|
Number of falls in the past 12 months [Reported] |
|
54856-0
|
Number of falls since admission or prior assessment - injury except major [CMS Assessment] |
|
54857-8
|
Number of falls since admission or prior assessment - major injury [CMS Assessment] |
|
54855-2
|
Number of falls since admission or prior assessment - no injury [CMS Assessment] |
|
73772-6
|
Number of fetal deaths delivered |
|
73773-4
|
Number of infants in this delivery delivered alive |
|
77264-0
|
Number of new nursing staff by job position in a reporting period [NMMDS] |
|
77266-5
|
Number of new nursing staff by job position who left in a reporting period [NMMDS] |
|
77265-7
|
Number of new nursing staff by job position who remained in a reporting period [NMMDS] |
|
77267-3
|
Number of nursing staff by job position at beginning of a reporting period [NMMDS] |
|
77269-9
|
Number of nursing staff by job position at beginning of a reporting period who left [NMMDS] |
|
77268-1
|
Number of nursing staff by job position at beginning of a reporting period who remained [NMMDS] |
|
77270-7
|
Number of nursing staff by job position who left in a reporting period [NMMDS] |
|
75277-4
|
Number of pressure injuries |
|
54884-2
|
Number of pressure injuries - stage 1 [CMS Assessment] |
|
46536-9
|
Number of pressure injuries - stage 1 Ord [CMS Assessment] |
|
55124-2
|
Number of pressure injuries - stage 2 [CMS Assessment] |
|
55125-9
|
Number of pressure injuries - stage 3 [CMS Assessment] |
|
55126-7
|
Number of pressure injuries - stage 4 [CMS Assessment] |
|
54946-9
|
Number of pressure injuries - unstageable due to coverage of wound bed by slough/eschar [CMS Assessment] |
|
54893-3
|
Number of pressure injuries - unstageable due to non-removable dressing or device [CMS Assessment] |
|
54950-1
|
Number of pressure injuries - unstageable with suspected deep tissue injury in evolution [CMS Assessment] |
|
83260-0
|
Number of pressure injuries noted on prior assessment that have completely closed - stage 1 [CMS Assessment] |
|
54958-4
|
Number of pressure injuries noted on prior assessment that have completely closed - stage 2 [CMS Assessment] |
|
54959-2
|
Number of pressure injuries noted on prior assessment that have completely closed - stage 3 [CMS Assessment] |
|
54960-0
|
Number of pressure injuries noted on prior assessment that have completely closed - stage 4 [CMS Assessment] |
|
54886-7
|
Number of pressure injuries present upon admission/reentry - stage 2 [CMS Assessment] |
|
54887-5
|
Number of pressure injuries present upon admission/reentry - stage 3 [CMS Assessment] |
|
54890-9
|
Number of pressure injuries present upon admission/reentry - stage 4 [CMS Assessment] |
|
54947-7
|
Number of pressure injuries present upon admission/reentry - unstageable due to coverage of wound bed by slough/eschar [CMS Assessment] |
|
54894-1
|
Number of pressure injuries present upon admission/reentry - unstageable due to non-removable dressing [CMS Assessment] |
|
54951-9
|
Number of pressure injuries present upon admission/reentry - unstageable with suspected deep tissue injury in evolution [CMS Assessment] |
|
77263-2
|
Number of productive staff in a reporting period [NMMDS] |
|
85669-0
|
Number of program interruptions [CMS Assessment] |
|
92939-8
|
Number of residence renovations |
|
57233-9
|
Number of stasis ulcers [CMS Assessment] |
|
93681-5
|
Number of times hospitalized in last 6 months |
|
77272-3
|
Number of unfilled nursing staff job positions in a reporting period [NMMDS] |
|
54970-9
|
Number of venous and arterial ulcers in last 7 days [CMS Assessment] |
|
93679-9
|
Number of visits to the emergency department in last 6 months |
|
75612-2
|
Number of visits to this healthcare entity in the last 12 months |
|
9800-4
|
Number of Stones |
|
93084-2
|
NuMoM2b Difficulties in Pregnancy form [NuMoM2b] |
|
74695-8
|
Nurse name |
|
84240-1
|
Nurse Administrative note |
|
34744-3
|
Nurse Admission evaluation note |
|
78390-2
|
Nurse Admission history and physical note |
|
76366-4
|
Nurse age range Provider [NMMDS] |
|
88637-4
|
Nurse Agreement |
|
88359-5
|
Nurse Alert |
|
84241-9
|
Nurse Consult note |
|
78407-4
|
Nurse Counseling note |
|
84242-7
|
Nurse Crisis intervention note |
|
84246-8
|
Nurse Custodial care facility Note |
|
78409-0
|
Nurse Daily or end of shift signout note |
|
85896-9
|
Nurse Diagnostic study note |
|
84245-0
|
Nurse Diagram |
|
78413-2
|
Nurse Discharge instructions |
|
34745-0
|
Nurse Discharge summary |
|
78425-6
|
Nurse Discharge teaching note |
|
84247-6
|
Nurse Evaluation and management of anticoagulation note |
|
83953-0
|
Nurse Evaluation and management of smoking cessation note |
|
84248-4
|
Nurse Emergency department Discharge summary |
|
57053-1
|
Nurse Emergency department Note |
|
84249-2
|
Nurse Emergency department Triage note |
|
57054-9
|
Nurse Emergency department Triage+care note |
|
75446-5
|
Nurse Education note |
|
76356-5
|
Nurse employment position Provider [NMMDS] |
|
76390-4
|
Nurse employment specialty Provider [NMMDS] |
|
75447-3
|
Nurse Fall risk assessment note |
|
75448-1
|
Nurse Flowsheet |
|
90359-1
|
Nurse Fluid management note |
|
84250-0
|
Nurse Group counseling note |
|
84253-4
|
Nurse Hospital Admission evaluation note |
|
84254-2
|
Nurse Hospital Discharge summary |
|
68477-9
|
Nurse Hospital Education note |
|
75449-9
|
Nurse Hospital Note |
|
68476-1
|
Nurse Hospital Restraint note |
|
68482-9
|
Nurse Hospital Transfer summary note |
|
84243-5
|
Nurse Intensive care unit Flowsheet |
|
75450-7
|
Nurse Intensive care unit Note |
|
84244-3
|
Nurse Intensive care unit Plan of care note |
|
87269-7
|
Nurse Immunization note |
|
29753-1
|
Nurse Initial evaluation note |
|
84255-9
|
Nurse Long term care facility Admission evaluation note |
|
88638-2
|
Nurse Long term care facility Agreement |
|
84256-7
|
Nurse Long term care facility Annual evaluation note |
|
84257-5
|
Nurse Long term care facility Discharge summary |
|
84258-3
|
Nurse Long term care facility Initial evaluation note |
|
75451-5
|
Nurse Long term care facility Note |
|
84259-1
|
Nurse Long term care facility Referral note |
|
84260-9
|
Nurse Long term care facility Risk assessment and screening note |
|
88348-8
|
Nurse Long term care facility Transfer summary note |
|
75452-3
|
Nurse Medication management note |
|
34746-8
|
Nurse Note |
|
84261-7
|
Nurse Observation unit Admission evaluation note |
|
84262-5
|
Nurse Observation unit Discharge summary |
|
84263-3
|
Nurse Observation unit Note |
|
84265-8
|
Nurse Outpatient Evaluation and management of anticoagulation note |
|
87270-5
|
Nurse Outpatient Immunization note |
|
84266-6
|
Nurse Outpatient Initial evaluation note |
|
84267-4
|
Nurse Outpatient Medication management note |
|
75453-1
|
Nurse Outpatient Note |
|
84268-2
|
Nurse Outpatient Surgical operation note |
|
84269-0
|
Nurse Outpatient Triage note |
|
84264-1
|
Nurse Surgical operation note |
|
88650-7
|
Nurse Parenteral therapy note |
|
34139-6
|
Nurse Telephone encounter Note |
|
75457-2
|
Nurse Telephone encounter Triage note |
|
64295-9
|
Nurse Plan of care note |
|
84270-8
|
Nurse Postoperative evaluation and management note |
|
83550-4
|
Nurse practitioner Admission evaluation note |
|
78391-0
|
Nurse practitioner Admission history and physical note |
|
78406-6
|
Nurse practitioner Consult note |
|
78408-2
|
Nurse practitioner Counseling note |
|
78414-0
|
Nurse practitioner Discharge instructions |
|
83551-2
|
Nurse practitioner Discharge summary |
|
78426-4
|
Nurse practitioner Discharge teaching note |
|
89554-0
|
Nurse practitioner Evaluation and management of radiation exposure note |
|
78450-4
|
Nurse practitioner Education note |
|
78459-5
|
Nurse practitioner Flowsheet |
|
83552-0
|
Nurse practitioner History and physical note |
|
83554-6
|
Nurse practitioner Hospital Note |
|
28621-1
|
Nurse practitioner Initial evaluation note |
|
83555-3
|
Nurse practitioner Long term care facility Note |
|
75454-9
|
Nurse practitioner Note |
|
83556-1
|
Nurse practitioner Outpatient Note |
|
83557-9
|
Nurse practitioner Telephone encounter Note |
|
80757-8
|
Nurse practitioner Plan of care note |
|
78476-9
|
Nurse practitioner procedure note |
|
28575-9
|
Nurse practitioner Progress note |
|
83553-8
|
Nurse practitioner Patient's home Note |
|
78484-3
|
Nurse practitioner Referral note |
|
34747-6
|
Nurse Preoperative evaluation and management note |
|
75455-6
|
Nurse procedure note |
|
28623-7
|
Nurse Progress note |
|
84252-6
|
Nurse Patient's home Initial evaluation note |
|
84251-8
|
Nurse Patient's home Note |
|
85875-3
|
Nurse Recovery room Discharge summary |
|
85874-6
|
Nurse Recovery room Note |
|
84271-6
|
Nurse Referral note |
|
84272-4
|
Nurse Respite note |
|
85848-0
|
Nurse Restraint note |
|
75456-4
|
Nurse Risk assessment and screening note |
|
61143-4
|
Nurse Summary note |
|
82811-1
|
Nurse summary note - recommended sections |
|
84273-2
|
Nurse Summary of death note |
|
84274-0
|
Nurse Telehealth Note |
|
28651-8
|
Nurse Transfer note |
|
75458-0
|
Nurse Triage note |
|
84275-7
|
Nurse Urgent care center Note |
|
84276-5
|
Nurse Urgent care center Triage note |
|
11543-6
|
Nursery records |
|
76386-2
|
Nursing certification Provider [NMMDS] |
|
34096-8
|
Nursing facility Comprehensive history and physical note |
|
34097-6
|
Nursing facility Conference note |
|
67856-5
|
Nursing facility History and physical note |
|
34119-8
|
Nursing facility Initial evaluation note |
|
34113-1
|
Nursing facility Note |
|
74183-5
|
Nursing job class [NMMDS] |
|
74177-7
|
Nursing staff on this job rarely think of quitting [NMMDS] |
|
77225-1
|
Nursing staff.decision making required level/Nursing staff [NMMDS] |
|
77275-6
|
Nursing staff.involuntary turnover/Nursing staff [NMMDS] |
|
77223-6
|
Nursing staff.knowledge required level/Nursing staff [NMMDS] |
|
77230-1
|
Nursing staff.mental effort load level/Nursing staff [NMMDS] |
|
77232-7
|
Nursing staff.psychological stress load level/Nursing staff [NMMDS] |
|
77228-5
|
Nursing staff.time load level/Nursing staff [NMMDS] |
|
77274-9
|
Nursing staff.voluntary turnover.terminate/Nursing staff [NMMDS] |
|
77261-6
|
Nursing staff.voluntary turnover.transfer/Nursing staff [NMMDS] |
|
77262-4
|
Nursing staff.voluntary turnover/Nursing staff [NMMDS] |
|
30164-8
|
Nut Allergen Mix (Cashew+Pecan or Hickory nut+English walnut) IgE Ab [Presence] in Serum by Multidisk |
|
6188-7
|
Nutmeg IgE Ab [Units/volume] in Serum |
|
15874-1
|
Nutmeg IgE Ab RAST class [Presence] in Serum |
|
7527-5
|
Nutmeg IgG Ab [Units/volume] in Serum |
|
21425-4
|
Nutmeg IgG Ab RAST class [Presence] in Serum |
|
56332-0
|
Nutmeg IgG4 Ab [Mass/volume] in Serum |
|
60385-2
|
Nutmeg IgG Ab [Mass/volume] in Serum |
|
75303-8
|
Nutrition assessment Narrative |
|
75306-1
|
Nutrition status etiology Narrative |
|
75307-9
|
Nutrition status signs and symptoms Narrative |
|
75305-3
|
Nutrition status |
|
84277-3
|
Nutrition and dietetics Administrative note |
|
34800-3
|
Nutrition and dietetics Consult note |
|
78716-8
|
Nutrition and dietetics Counseling note |
|
78415-7
|
Nutrition and dietetics Discharge instructions |
|
84278-1
|
Nutrition and dietetics Discharge summary |
|
78427-2
|
Nutrition and dietetics Discharge teaching note |
|
78451-2
|
Nutrition and dietetics Education note |
|
78460-3
|
Nutrition and dietetics Flowsheet |
|
84279-9
|
Nutrition and dietetics Group counseling note |
|
84284-9
|
Nutrition and dietetics Hospital Note |
|
78470-2
|
Nutrition and dietetics Initial evaluation note |
|
84295-5
|
Nutrition and dietetics Interdisciplinary Plan of care note |
|
84285-6
|
Nutrition and dietetics Long term care facility Initial evaluation note |
|
84286-4
|
Nutrition and dietetics Long term care facility Note |
|
84287-2
|
Nutrition and dietetics Long term care facility Referral note |
|
34801-1
|
Nutrition and dietetics Note |
|
83637-9
|
Nutrition and dietetics Nurse Note |
|
84288-0
|
Nutrition and dietetics Outpatient Initial evaluation note |
|
84289-8
|
Nutrition and dietetics Outpatient Note |
|
84290-6
|
Nutrition and dietetics Outpatient Risk assessment and screening note |
|
84294-8
|
Nutrition and dietetics Telephone encounter Note |
|
80791-7
|
Nutrition and dietetics Plan of care note |
|
78494-2
|
Nutrition and dietetics procedure note |
|
78481-9
|
Nutrition and dietetics Progress note |
|
84283-1
|
Nutrition and dietetics Patient's home Risk assessment and screening note |
|
84280-7
|
Nutrition and dietetics Patient's home Consult note |
|
84281-5
|
Nutrition and dietetics Patient's home Initial evaluation note |
|
84282-3
|
Nutrition and dietetics Patient's home Note |
|
57173-7
|
Nutrition and dietetics Referral note |
|
84291-4
|
Nutrition and dietetics Risk assessment and screening note |
|
84292-2
|
Nutrition and dietetics Team Consult note |
|
84293-0
|
Nutrition and dietetics Team Note |
|
81675-1
|
Nutrition and fluid intake assessment [Interpretation] |
|
73785-8
|
Nutrition [NSRAS] |
|
93178-2
|
Nutritional approaches [CMS Assessment] |
|
71445-1
|
Nutritional approaches during last 7 days - while a resident [CMS Assessment] |
|
71444-4
|
Nutritional approaches during last 7 days - while not a resident [CMS Assessment] |
|
50056-1
|
Nutritional risk index |
|
73806-2
|
Newborn age in hours |
|
89005-3
|
NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29754-9
|
Nystagmogram study |
|
79900-7
|
Nystagmus amplitude Eye |
|
79901-5
|
Nystagmus direction Eye |
|
79767-0
|
Nystagmus frequency Eye |
|
73237-0
|
Nystatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73236-2
|
Nystatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55689-4
|
Nystatin [Susceptibility] by Gradient strip |
|
35824-2
|
Nystatin [Susceptibility] by Disk diffusion (KB) |
|
10697-1
|
Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
10698-9
|
Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18958-9
|
Nystatin [Susceptibility] |
|
14992-2
|
O group [Presence] on Red Blood Cells from Blood product unit |
|
14993-0
|
O group [Presence] on Red Blood Cells from Donor |
|
14994-8
|
O group [Presence] on Red Blood Cells |
|
8006-9
|
Orientia tsutsugamushi Ab [Units/volume] in Serum |
|
22485-7
|
Orientia tsutsugamushi Ab [Titer] in Serum |
|
5323-1
|
Orientia tsutsugamushi Ab [Titer] in Serum by Complement fixation |
|
60268-0
|
Orientia tsutsugamushi DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
48867-6
|
Orientia tsutsugamushi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29687-1
|
Orientia tsutsugamushi Gilliam Ab [Presence] in Serum |
|
29714-3
|
Orientia tsutsugamushi Gilliam Ab [Presence] in Serum by Immunofluorescence |
|
31607-5
|
Orientia tsutsugamushi Gilliam Ab [Units/volume] in Serum |
|
29686-3
|
Orientia tsutsugamushi Gilliam Ab [Titer] in Serum |
|
29713-5
|
Orientia tsutsugamushi Gilliam Ab [Titer] in Serum by Immunofluorescence |
|
49174-6
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid |
|
48897-3
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49173-8
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum |
|
48852-8
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum by Immunofluorescence |
|
49172-0
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid |
|
48896-5
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49171-2
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum |
|
48851-0
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum by Immunofluorescence |
|
31606-7
|
Orientia tsutsugamushi IgG Ab [Units/volume] in Serum |
|
21498-1
|
Orientia tsutsugamushi IgG Ab [Titer] in Serum |
|
33897-0
|
Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma |
|
33896-2
|
Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
29689-7
|
Orientia tsutsugamushi Karp Ab [Presence] in Serum |
|
29716-8
|
Orientia tsutsugamushi Karp Ab [Presence] in Serum by Immunofluorescence |
|
31608-3
|
Orientia tsutsugamushi Karp Ab [Units/volume] in Serum |
|
29688-9
|
Orientia tsutsugamushi Karp Ab [Titer] in Serum |
|
29715-0
|
Orientia tsutsugamushi Karp Ab [Titer] in Serum by Immunofluorescence |
|
49170-4
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid |
|
48898-1
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49169-6
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum |
|
48853-6
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum by Immunofluorescence |
|
49168-8
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid |
|
48899-9
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49167-0
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum |
|
48854-4
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum by Immunofluorescence |
|
29691-3
|
Orientia tsutsugamushi Kato Ab [Presence] in Serum |
|
29718-4
|
Orientia tsutsugamushi Kato Ab [Presence] in Serum by Immunofluorescence |
|
31609-1
|
Orientia tsutsugamushi Kato Ab [Units/volume] in Serum |
|
29690-5
|
Orientia tsutsugamushi Kato Ab [Titer] in Serum |
|
29717-6
|
Orientia tsutsugamushi Kato Ab [Titer] in Serum by Immunofluorescence |
|
49166-2
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid |
|
48900-5
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49165-4
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum |
|
48855-1
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum by Immunofluorescence |
|
49164-7
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid |
|
48901-3
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49163-9
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum |
|
48856-9
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum by Immunofluorescence |
|
29693-9
|
Orientia tsutsugamushi Litchfield Ab [Presence] in Serum |
|
29720-0
|
Orientia tsutsugamushi Litchfield Ab [Presence] in Serum by Immunofluorescence |
|
31610-9
|
Orientia tsutsugamushi Litchfield Ab [Units/volume] in Serum |
|
29692-1
|
Orientia tsutsugamushi Litchfield Ab [Titer] in Serum |
|
29719-2
|
Orientia tsutsugamushi Litchfield Ab [Titer] in Serum by Immunofluorescence |
|
48875-9
|
Orientia tsutsugamushi [Presence] in Unspecified specimen by Organism specific culture |
|
49126-6
|
Orientia tsutsugamushi identified in Unspecified specimen by Sequencing |
|
87641-7
|
o,p'- Dichlorodiphenyltrichloroethane [Mass/mass] in Unspecified specimen |
|
87643-3
|
o,p'- DDD [Mass/mass] in Unspecified specimen |
|
87642-5
|
o,p'- DDE [Mass/mass] in Unspecified specimen |
|
50625-3
|
Ova and parasites identified in Blood or Tissue by Wright stain |
|
10855-5
|
Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
|
91826-8
|
Ova and parasites identified in Lower respiratory specimen by Light microscopy |
|
18494-5
|
Ova and parasites identified in Stool by Concentration--2nd specimen |
|
13319-9
|
Ova and parasites identified in Stool by Light microscopy--2nd specimen |
|
18496-0
|
Ova and parasites identified in Stool by Trichrome stain--2nd specimen |
|
52795-2
|
Ova and parasites identified in Unspecified specimen by Light microscopy--2nd specimen |
|
18493-7
|
Ova and parasites identified in Stool by Concentration--3rd specimen |
|
13320-7
|
Ova and parasites identified in Stool by Light microscopy--3rd specimen |
|
18495-2
|
Ova and parasites identified in Stool by Trichrome stain--3rd specimen |
|
52794-5
|
Ova and parasites identified in Unspecified specimen by Light microscopy--3rd specimen |
|
91768-2
|
Ova and parasites identified in Sputum by Light microscopy |
|
20926-2
|
Ova and parasites identified in Stool by Baerman concentration |
|
10701-1
|
Ova and parasites identified in Stool by Concentration |
|
18307-9
|
Ova and parasites identified in Stool by Iron hematoxylin stain |
|
10702-9
|
Ova and parasites identified in Stool by Immune stain |
|
10703-7
|
Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
|
20925-4
|
Ova and parasites identified in Stool by McMaster concentration |
|
10704-5
|
Ova and parasites identified in Stool by Light microscopy |
|
20924-7
|
Ova and parasites identified in Stool by Parasite sedimentation |
|
43227-8
|
Ova and parasites identified in Stool by Trichrome stain |
|
6674-6
|
Ova and parasites identified in Tissue by Light microscopy |
|
75665-0
|
Ova and parasites identified in Urine by Trichrome stain |
|
26885-4
|
Ova and parasites identified in Unspecified specimen by Concentration |
|
673-4
|
Ova and parasites identified in Unspecified specimen by Light microscopy |
|
53809-0
|
Oxygen.alveolar - arterial [Partial pressure difference] adjusted to patient's actual temperature Respiratory system |
|
59404-4
|
Oxygen capacity [Moles/volume] in Arterial blood |
|
59275-8
|
Oxygen capacity [Volume Fraction] in Arterial blood |
|
60842-2
|
Oxygen consumption (VO2) |
|
76267-4
|
Oxygen consumption (VO2)/Ideal body weight [Volume Rate/Area] |
|
10232-7
|
Oxygen content in Aorta root |
|
19218-7
|
Oxygen content in Arterial blood |
|
55962-5
|
Oxygen content in Cord blood |
|
19219-5
|
Oxygen content in Capillary blood |
|
19221-1
|
Oxygen content in Mixed venous blood |
|
34163-6
|
Oxygen content in Blood |
|
19220-3
|
Oxygen content in Venous blood |
|
10241-8
|
Oxygen content in Coronary sinus |
|
10242-6
|
Oxygen content in Ductus arteriosus |
|
10226-9
|
Oxygen content in Intravascular space |
|
10243-4
|
Oxygen content in Inferior vena cava |
|
10233-5
|
Oxygen content in Left atrium |
|
10238-4
|
Oxygen content in Left ventricle |
|
10245-9
|
Oxygen content in Main pulmonary artery |
|
10244-2
|
Oxygen content in Left pulmonary artery |
|
10246-7
|
Oxygen content in Right pulmonary artery |
|
10247-5
|
Oxygen content in Pulmonary wedge |
|
10235-0
|
Oxygen content in High right atrium |
|
10236-8
|
Oxygen content in Low right atrium |
|
10237-6
|
Oxygen content in Mid right atrium |
|
10234-3
|
Oxygen content in Right atrium |
|
10239-2
|
Oxygen content in Right ventricular outflow tract |
|
10240-0
|
Oxygen content in Right ventricle |
|
10248-3
|
Oxygen content in Superior vena cava |
|
57800-5
|
Oxygen content in Blood by calculation |
|
59274-1
|
Oxygen content in Arterial blood by calculation |
|
64799-0
|
Oxygen content in Capillary blood by calculation |
|
64800-6
|
Oxygen content in Arterial cord blood by calculation |
|
64797-4
|
Oxygen content in Venous cord blood by calculation |
|
64798-2
|
Oxygen content in Mixed venous blood by calculation |
|
60841-4
|
Oxygen content in Venous blood by calculation |
|
76255-9
|
Oxygen cylinder Pressure |
|
90567-9
|
Oxygen desaturation index |
|
60867-9
|
Oxygen [VFr/PPres] Airway adaptor --during expiration |
|
76105-6
|
Oxygen [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
62274-6
|
Oxygen [VFr/PPres] Airway adaptor --during inspiration |
|
76106-4
|
Oxygen [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60943-8
|
Oxygen [VFr/PPres] Airway adaptor --at end expiration |
|
75991-0
|
Oxygen extraction ratio |
|
75998-5
|
Oxygen gas delivered during case [Volume] from Gas delivery system |
|
75999-3
|
Oxygen gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76256-7
|
Oxygen pipeline Pressure |
|
60799-4
|
Gas delivery system inspiratory Oxygen setting [VFr/PPres] |
|
75939-9
|
Oxygen gas setting Infant microenvironment.incubator |
|
93864-7
|
Oxygen gas setting Veterinary cage |
|
74206-4
|
Oxygen therapy was given [NTDS] |
|
60866-1
|
Oxygen [VFr/PPres] Airway adaptor |
|
61018-8
|
Oxygen [VFr/PPres] Gas delivery system |
|
75938-1
|
Oxygen/Gas total Infant microenvironment.incubator |
|
93863-9
|
Oxygen/Gas total Veterinary cage |
|
89301-6
|
oxyMORphone-3-glucuronide [Presence] in Urine by Screen method |
|
57791-6
|
Organic acidemia conditions suspected [Identifier] in DBS |
|
46744-9
|
Organic acidemias newborn screen interpretation |
|
57708-0
|
Organic acidemias defects newborn screening comment-discussion |
|
50030-6
|
Oak wood dust IgE Ab [Units/volume] in Serum |
|
38737-3
|
O-anisidine [Mass/volume] in Air |
|
50040-5
|
Advanced oxidation protein products [Moles/volume] in Serum or Plasma |
|
7539-0
|
Oat triggered histamine release [Units/volume] in Blood |
|
6190-3
|
Oat IgE Ab [Units/volume] in Serum |
|
15885-7
|
Oat IgE Ab RAST class [Presence] in Serum |
|
61226-7
|
Oat IgE Ab/IgE total in Serum |
|
7538-2
|
Oat IgG Ab [Units/volume] in Serum |
|
21426-2
|
Oat IgG Ab RAST class [Presence] in Serum |
|
56333-8
|
Oat IgG4 Ab [Mass/volume] in Serum |
|
51901-7
|
Oat IgG Ab [Mass/volume] in Serum |
|
48220-8
|
Oat triggered leukotriene release [Mass/volume] by Leukocytes |
|
6093-9
|
Oat pollen IgE Ab [Units/volume] in Serum |
|
15886-5
|
Oat pollen IgE Ab RAST class [Presence] in Serum |
|
56334-6
|
Oat pollen IgG4 Ab [Mass/volume] in Serum |
|
7707-3
|
Oat smut IgE Ab [Units/volume] in Serum |
|
56459-1
|
Oat smut IgG4 Ab [Mass/volume] in Serum |
|
7117-5
|
Oat+Barley IgE Ab [Units/volume] in Serum |
|
89442-8
|
Obstetrics Administrative note |
|
89443-6
|
Obstetrics Admission history and physical note |
|
89454-3
|
Obstetrics Attending Note |
|
89444-4
|
Obstetrics Checklist |
|
89227-3
|
Obstetrics Consult note |
|
89236-4
|
Obstetrics Diagnostic study note |
|
89228-1
|
Obstetrics Discharge instructions |
|
89214-1
|
Obstetrics Discharge summary |
|
89229-9
|
Obstetrics Discharge teaching note |
|
89230-7
|
Obstetrics Education note |
|
93086-7
|
Obstetrics Emergency procedure note |
|
57714-8
|
Obstetric estimation of gestational age |
|
89238-0
|
Obstetrics Flowsheet |
|
89213-3
|
Obstetrics History and physical note |
|
89446-9
|
Obstetrics Hospital Consult note |
|
89448-5
|
Obstetrics Hospital Letter |
|
89458-4
|
Obstetrics Hospital Note |
|
89231-5
|
Obstetrics Initial evaluation note |
|
82356-7
|
Obstetrics Midwife Consult note |
|
89241-4
|
Obstetrics Note |
|
89452-7
|
Obstetrics Nurse practitioner Note |
|
89450-1
|
Obstetrics Nurse Note |
|
89462-6
|
Obstetrics Nurse Outpatient Note |
|
89460-0
|
Obstetrics Outpatient Note |
|
89457-6
|
Obstetrics Surgical operation note |
|
89464-2
|
Obstetrics Telephone encounter Note |
|
89240-6
|
Obstetrics Plan of care note |
|
89466-7
|
Obstetrics Postoperative evaluation and management note |
|
89468-3
|
Obstetrics Preoperative evaluation and management note |
|
89232-3
|
Obstetrics procedure note |
|
89233-1
|
Obstetrics Progress note |
|
89234-9
|
Obstetrics Referral note |
|
89456-8
|
Obstetrics Resident Note |
|
89470-9
|
Obstetrics Summary note |
|
89235-6
|
Obstetrics Transfer summary note |
|
12158-2
|
OB ultrasound imaging device Class |
|
11953-7
|
OB ultrasound imaging device Institution inventory number |
|
12160-8
|
OB ultrasound imaging device Vendor model number |
|
12161-6
|
OB ultrasound imaging device Vendor serial number |
|
90354-2
|
Obesity medicine Consult note |
|
90355-9
|
Obesity medicine Group counseling note |
|
90356-7
|
Obesity medicine Initial evaluation note |
|
75430-9
|
Obesity medicine Note |
|
85472-9
|
Obesity medicine Telephone encounter Note |
|
84305-2
|
Obstetrics and Gynecology Administrative note |
|
78718-4
|
Obstetrics and Gynecology Admission history and physical note |
|
83690-8
|
Obstetrics and gynecology Attending Note |
|
78717-6
|
Obstetrics and Gynecology Checklist |
|
34777-3
|
Obstetrics and Gynecology Consult note |
|
68557-8
|
Obstetrics and Gynecology Diagnostic study note |
|
78720-0
|
Obstetrics and Gynecology Discharge instructions |
|
68558-6
|
Obstetrics and Gynecology Discharge summary |
|
78721-8
|
Obstetrics and Gynecology Discharge teaching note |
|
78722-6
|
Obstetrics and Gynecology Education note |
|
78711-9
|
Obstetrics and Gynecology Flowsheet |
|
68560-2
|
Obstetrics and Gynecology History and physical note |
|
68566-9
|
Obstetrics and Gynecology Hospital Consult note |
|
68567-7
|
Obstetrics and Gynecology Hospital Letter |
|
84304-5
|
Obstetrics and Gynecology Hospital Note |
|
78723-4
|
Obstetrics and Gynecology Initial evaluation note |
|
34778-1
|
Obstetrics and Gynecology Note |
|
83558-7
|
Obstetrics and gynecology Nurse practitioner Note |
|
83587-6
|
Obstetrics and gynecology Nurse Note |
|
83588-4
|
Obstetrics and gynecology Nurse Outpatient Note |
|
84384-7
|
Obstetrics and Gynecology Outpatient Note |
|
78719-2
|
Obstetrics and Gynecology Surgical operation note |
|
84386-2
|
Obstetrics and Gynecology Telephone encounter Note |
|
80787-5
|
Obstetrics and Gynecology Plan of care note |
|
84385-4
|
Obstetrics and Gynecology Postoperative evaluation and management note |
|
68562-8
|
Obstetrics and Gynecology Preoperative evaluation and management note |
|
68563-6
|
Obstetrics and Gynecology procedure note |
|
68564-4
|
Obstetrics and Gynecology Progress note |
|
57179-4
|
Obstetrics and Gynecology Referral note |
|
83765-8
|
Obstetrics and gynecology Resident Note |
|
77962-9
|
Obstetrics and Gynecology Summary note |
|
68565-1
|
Obstetrics and Gynecology Transfer summary note |
|
88021-1
|
Objective assessment of cardiovascular disease NYHA |
|
84387-0
|
Observation unit Admission evaluation note |
|
85200-4
|
Observation unit Discharge summary |
|
85201-2
|
Observation unit History and physical note |
|
82610-7
|
Observation unit Note |
|
65844-3
|
Date of observation (non-patient) |
|
93479-4
|
Observation interpretation |
|
75912-6
|
Observation unit stay discharge [NAMCS] |
|
73814-6
|
Obstetric procedures performed [US Standard Certificate of Live Birth] |
|
72186-0
|
Obstetrical risk [RHEA] |
|
76242-7
|
Obstructive apnea duration Respiratory system |
|
90563-8
|
Obstructive apnea hypopnea index |
|
84876-2
|
Obstruction of Bowel [Presence] |
|
70002-1
|
Obstructive apnea index 24 hour |
|
20907-2
|
Organochlorine pesticides [Identifier] in Blood |
|
20912-2
|
Organochlorine pesticides [Presence] in Blood by Screen method |
|
20909-8
|
Organochlorine pesticides [Identifier] in Gastric fluid |
|
20914-8
|
Organochlorine pesticides [Presence] in Gastric fluid by Screen method |
|
20910-6
|
Organochlorine pesticides [Identifier] in Milk |
|
20915-5
|
Organochlorine pesticides [Presence] in Milk by Screen method |
|
9791-5
|
Organochlorine pesticides [Type] in Serum or Plasma |
|
20911-4
|
Organochlorine pesticides [Identifier] in Tissue |
|
20916-3
|
Organochlorine pesticides [Presence] in Tissue by Screen method |
|
17388-0
|
Organochlorine pesticides [Type] in Urine |
|
20908-0
|
Organochlorine pesticides [Identifier] in Unspecified specimen |
|
20913-0
|
Organochlorine pesticides [Presence] in Unspecified specimen by Screen method |
|
43747-5
|
OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
15235-5
|
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
|
73715-5
|
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
|
82086-0
|
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15236-3
|
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk |
|
82088-6
|
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Units/volume] in Serum by Multidisk |
|
82087-8
|
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15237-1
|
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk |
|
82090-2
|
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Units/volume] in Serum by Multidisk |
|
82089-4
|
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15238-9
|
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
82092-8
|
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82091-0
|
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15239-7
|
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
|
73718-9
|
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk |
|
82093-6
|
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15240-5
|
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
|
73716-3
|
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk |
|
82094-4
|
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
85659-1
|
Occupation CDC Census code |
|
84388-8
|
Occupational medicine Admission evaluation note |
|
34803-7
|
Occupational medicine Consult note |
|
87271-3
|
Occupational medicine Immunization note |
|
34802-9
|
Occupational medicine Note |
|
84389-6
|
Occupational medicine Nurse Note |
|
84390-4
|
Occupational medicine Outpatient Note |
|
84392-0
|
Occupational medicine Telephone encounter Note |
|
84391-2
|
Occupational medicine procedure note |
|
57147-1
|
Occupational medicine Referral note |
|
74287-4
|
Occupation [NTDS] |
|
74163-7
|
Usual occupation duration |
|
74288-2
|
Occupation industry [NTDS] |
|
85078-4
|
Occupation industry [Type] |
|
85658-3
|
Occupation [Type] |
|
74166-0
|
Occupational summary note |
|
90527-3
|
Occupational therapy - concurrent minutes during assessment period [CMS Assessment] |
|
58136-3
|
Occupational therapy - concurrent minutes in the last 7 days [CMS Assessment] |
|
85563-5
|
Occupational therapy - concurrent minutes--week 1 [CMS Assessment] |
|
85572-6
|
Occupational therapy - concurrent minutes--week 2 [CMS Assessment] |
|
86764-8
|
Occupational therapy - co-treatment minutes during 7 day assessment period [CMS Assessment] |
|
90528-1
|
Occupational therapy - co-treatment minutes during assessment period [CMS Assessment] |
|
85565-0
|
Occupational therapy - co-treatment minutes--week 1 [CMS Assessment] |
|
85574-2
|
Occupational therapy - co-treatment minutes--week 2 [CMS Assessment] |
|
90529-9
|
Occupational therapy - group minutes during assessment period [CMS Assessment] |
|
58137-1
|
Occupational therapy - group minutes in the last 7 days [CMS Assessment] |
|
85564-3
|
Occupational therapy - group minutes--week 1 [CMS Assessment] |
|
85573-4
|
Occupational therapy - group minutes--week 2 [CMS Assessment] |
|
90531-5
|
Occupational therapy - individual minutes during assessment period [CMS Assessment] |
|
58219-7
|
Occupational therapy - individual minutes in the last 7 days [CMS Assessment] |
|
85562-7
|
Occupational therapy - individual minutes--week 1 [CMS Assessment] |
|
85571-8
|
Occupational therapy - individual minutes--week 2 [CMS Assessment] |
|
93463-8
|
Ocfentanil [Mass/volume] in Urine by Confirmatory method |
|
53883-5
|
OCRL1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
2682-3
|
Ornithine carbamoyltransferase [Enzymatic activity/volume] in Amniotic fluid |
|
78932-1
|
Optical coherence tomography performed |
|
2683-1
|
Ornithine carbamoyltransferase [Enzymatic activity/volume] in Serum |
|
87674-8
|
Optical coherence tomography study report |
|
32617-3
|
Ornithine carbamoyltransferase [Enzymatic activity/mass] in Tissue |
|
53641-7
|
OCT2 Ag [Presence] in Tissue by Immune stain |
|
75118-0
|
Octadecanoate (C18:0) [Entitic substance] in Red Blood Cells |
|
17382-3
|
Octadecanoate (C18:0) [Mass/volume] in Serum or Plasma |
|
35149-4
|
Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma |
|
47779-4
|
Octadecanoate (C18:0)/Creatinine [Molar ratio] in Urine |
|
79706-8
|
Octadecatetraenoate (C18:4w3) [Entitic substance] in Red Blood Cells |
|
79695-3
|
Octadecatetraenoate (C18:4w3) [Moles/volume] in Serum or Plasma |
|
75120-6
|
Octanoate (C8:0) [Entitic substance] in Red Blood Cells |
|
35145-2
|
Octanoate (C8:0) [Moles/volume] in Serum or Plasma |
|
13784-4
|
Octanoate (C8:0)/Creatinine [Mass Ratio] in Urine |
|
25120-7
|
Octanoate (C8:0)/Creatinine [Molar ratio] in Urine |
|
54322-3
|
Octanoylcarnitine (C8) [Moles/volume] in Amniotic fluid |
|
54321-5
|
Octanoylcarnitine (C8) [Moles/volume] in Cerebral spinal fluid |
|
53175-6
|
Octanoylcarnitine (C8) [Moles/volume] in DBS |
|
74592-7
|
Octanoylcarnitine (C8) [Enzymatic activity/mass] in Fibroblast |
|
18448-1
|
Octanoylcarnitine (C8) [Mass/volume] in Serum or Plasma |
|
30540-9
|
Octanoylcarnitine (C8) [Moles/volume] in Serum or Plasma |
|
55950-0
|
Octanoylcarnitine (C8) [Moles/volume] in Urine |
|
88014-6
|
Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88006-2
|
Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
53177-2
|
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
59208-9
|
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Serum or Plasma |
|
53176-4
|
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
59200-6
|
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54320-7
|
Octanoylcarnitine (C8)/Creatinine [Molar ratio] in Urine |
|
79516-1
|
Octenedioate (C8:1) [Moles/volume] in Serum or Plasma |
|
13785-1
|
Octenedioate (C8:1)/Creatinine [Mass Ratio] in Urine |
|
25121-5
|
Octenedioate (C8:1)/Creatinine [Molar ratio] in Urine |
|
55953-4
|
Octenoylcarnitine (C8:1) [Moles/volume] in Amniotic fluid |
|
55952-6
|
Octenoylcarnitine (C8:1) [Moles/volume] in Cerebral spinal fluid |
|
53174-9
|
Octenoylcarnitine (C8:1) [Moles/volume] in DBS |
|
18447-3
|
Octenoylcarnitine (C8:1) [Mass/volume] in Serum or Plasma |
|
30541-7
|
Octenoylcarnitine (C8:1) [Moles/volume] in Serum or Plasma |
|
55954-2
|
Octenoylcarnitine (C8:1) [Moles/volume] in Urine |
|
55951-8
|
Octenoylcarnitine (C8:1)/Creatinine [Molar ratio] in Urine |
|
2672-4
|
Octopamine [Moles/volume] in Urine |
|
10944-7
|
Octopus IgE Ab [Units/volume] in Serum |
|
15888-1
|
Octopus IgE Ab RAST class [Presence] in Serum |
|
58016-7
|
Octreotide [Mass/volume] in Serum or Plasma |
|
79803-3
|
Ocular motility Eye by Finger following |
|
80325-4
|
Oculocephalic reflex [Presence] |
|
14335-4
|
Optical density of Amniotic fluid by Spectrophotometry |
|
10997-5
|
O-desmethylencainide [Mass/volume] in Serum or Plasma |
|
34533-0
|
Odor of Urine |
|
72288-4
|
Odor of Exudate from wound |
|
60102-1
|
Norvenlafaxine [Mass/volume] in Blood |
|
78869-5
|
Norvenlafaxine cutoff [Mass/volume] in Urine for Confirmatory method |
|
60103-9
|
Norvenlafaxine [Mass/volume] in Body fluid |
|
9628-9
|
Norvenlafaxine [Mass/volume] in Serum or Plasma |
|
48362-8
|
Norvenlafaxine [Moles/volume] in Serum or Plasma |
|
60104-7
|
Norvenlafaxine [Mass/mass] in Tissue |
|
72772-7
|
Norvenlafaxine [Mass/volume] in Urine by Confirmatory method |
|
75234-5
|
Norvenlafaxine [Presence] in Urine |
|
53882-7
|
Norvenlafaxine [Mass/volume] in Urine |
|
72773-5
|
Norvenlafaxine/Creatinine [Mass Ratio] in Urine |
|
34965-4
|
Osmotic fragility of Red Blood Cells--0.10% sodium chloride 24 hour 37 degree C incubation |
|
34966-2
|
Osmotic fragility of Red Blood Cells--0.10% sodium chloride |
|
34967-0
|
Osmotic fragility of Red Blood Cells--0.20% sodium chloride 24 hour 37 degree C incubation |
|
34968-8
|
Osmotic fragility of Red Blood Cells--0.20% sodium chloride |
|
31110-0
|
Osmotic fragility of Red Blood Cells--0.30% sodium chloride 24 hour 37 degree C incubation |
|
23911-1
|
Osmotic fragility of Red Blood Cells--0.30% sodium chloride |
|
31109-2
|
Osmotic fragility of Red Blood Cells--0.35% sodium chloride 24 hour 37 degree C incubation |
|
23912-9
|
Osmotic fragility of Red Blood Cells--0.35% sodium chloride |
|
31108-4
|
Osmotic fragility of Red Blood Cells--0.40% sodium chloride 24 hour 37 degree C incubation |
|
23913-7
|
Osmotic fragility of Red Blood Cells--0.40% sodium chloride |
|
31107-6
|
Osmotic fragility of Red Blood Cells--0.45% sodium chloride 24 hour 37 degree C incubation |
|
23914-5
|
Osmotic fragility of Red Blood Cells--0.45% sodium chloride |
|
31106-8
|
Osmotic fragility of Red Blood Cells--0.50% sodium chloride 24 hour 37 degree C incubation |
|
23915-2
|
Osmotic fragility of Red Blood Cells--0.50% sodium chloride |
|
31105-0
|
Osmotic fragility of Red Blood Cells--0.55% sodium chloride 24 hour 37 degree C incubation |
|
23916-0
|
Osmotic fragility of Red Blood Cells--0.55% sodium chloride |
|
23918-6
|
Osmotic fragility of Red Blood Cells--0.60% sodium chloride 24 hour 37 degree C incubation |
|
23917-8
|
Osmotic fragility of Red Blood Cells--0.60% sodium chloride |
|
23920-2
|
Osmotic fragility of Red Blood Cells--0.65% sodium chloride 24 hour 37 degree C incubation |
|
23919-4
|
Osmotic fragility of Red Blood Cells--0.65% sodium chloride |
|
23921-0
|
Osmotic fragility of Red Blood Cells--0.75% sodium chloride 24 hour 37 degree C incubation |
|
30543-3
|
Osmotic fragility of Red Blood Cells--0.75% sodium chloride |
|
31104-3
|
Osmotic fragility of Red Blood Cells--0.85% sodium chloride 24 hour 37 degree C incubation |
|
23922-8
|
Osmotic fragility of Red Blood Cells--0.85% sodium chloride |
|
52125-2
|
Osmotic fragility of Red Blood Cells--0.90% sodium chloride 24 hour 37 degree C incubation |
|
52124-5
|
Osmotic fragility of Red Blood Cells--0.90% sodium chloride |
|
31103-5
|
Osmotic fragility of Red Blood Cells--0.0% sodium chloride 24 hour 37 degree C incubation |
|
23910-3
|
Osmotic fragility of Red Blood Cells--0.0% sodium chloride |
|
40431-9
|
Osmotic fragility [Interpretation] of Red Blood Cells from Control--fresh |
|
32863-3
|
Osmotic fragility [Interpretation] of Red Blood Cells--fresh |
|
50795-4
|
Osmotic fragility full hemolysis of Red Blood Cells |
|
40740-3
|
Osmotic fragility of Red Blood Cells--Incubated |
|
40432-7
|
Osmotic fragility [Interpretation] of Red Blood Cells from Control--Incubated |
|
32862-5
|
Osmotic fragility [Interpretation] of Red Blood Cells--Incubated |
|
4667-2
|
Osmotic fragility of Red Blood Cells |
|
12241-6
|
Osmotic fragility of Red Blood Cells by Diluted RBC |
|
34964-7
|
Osmotic fragility [Interpretation] of Red Blood Cells |
|
50794-7
|
Osmotic fragility beginning hemolysis of Red Blood Cells |
|
40739-5
|
Osmotic fragility of Red Blood Cells--unincubated |
|
33178-5
|
Occipital frontal diameter estimated from gestational age by method of Australian Society of Ultrasound Medicine 2000 (US) |
|
33179-3
|
Occipital frontal diameter estimated from gestational age by method of Chitty 1994 (US) |
|
41408-6
|
Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
72168-8
|
Ofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
41409-4
|
Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
41410-2
|
Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4362-0
|
Ofloxacin [Mass] of Dose |
|
7038-3
|
Ofloxacin [Susceptibility] by Gradient strip |
|
376-4
|
Ofloxacin [Susceptibility] by Disk diffusion (KB) |
|
375-6
|
Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
374-9
|
Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20384-4
|
Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
3877-8
|
Ofloxacin [Mass/volume] in Serum or Plasma |
|
18959-7
|
Ofloxacin [Susceptibility] |
|
377-2
|
Ofloxacin [Susceptibility] by Serum bactericidal titer |
|
25264-3
|
Ofloxacin [Mass/volume] in Unspecified specimen |
|
19492-8
|
Hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19491-0
|
Hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method |
|
16186-9
|
Hydroxyalprazolam [Mass/volume] in Stool |
|
20500-5
|
Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
|
19490-2
|
Hydroxyalprazolam [Presence] in Urine by Confirmatory method |
|
19489-4
|
Hydroxyalprazolam [Presence] in Urine by Screen method |
|
11238-3
|
Hydroxyalprazolam [Mass/volume] in Urine |
|
90467-2
|
Hydroxyaripiprazole [Mass/volume] in Urine by Confirmatory method |
|
90468-0
|
Hydroxyaripiprazole [Presence] in Urine by Screen method |
|
60083-3
|
Hydroxybupropion [Mass/volume] in Blood |
|
78832-3
|
Hydroxybupropion cutoff [Mass/volume] in Urine for Confirmatory method |
|
60084-1
|
Hydroxybupropion [Mass/volume] in Body fluid |
|
9418-5
|
Hydroxybupropion [Mass/volume] in Serum or Plasma |
|
55542-5
|
Hydroxybupropion [Moles/volume] in Serum or Plasma |
|
60085-8
|
Hydroxybupropion [Mass/mass] in Tissue |
|
78831-5
|
Hydroxybupropion [Presence] in Urine by Confirmatory method |
|
89992-2
|
Hydroxybupropion [Presence] in Urine by Screen method |
|
60086-6
|
Hydroxybupropion [Mass/volume] in Urine |
|
2439-8
|
Hydroxycalcidiol [Mass/volume] in Serum |
|
4278-8
|
Hydroxychloroquine [Mass] of Dose |
|
3684-8
|
Hydroxychloroquine [Mass/volume] in Serum or Plasma |
|
55543-3
|
Hydroxychloroquine [Moles/volume] in Serum or Plasma |
|
74986-1
|
Hydroxychloroquine [Mass/volume] in Serum or Plasma --trough |
|
27268-2
|
Hydroxydecanedioate [Presence] in Urine |
|
49906-1
|
Hydroxydecanedioate/Creatinine [Molar ratio] in 24 hour Urine |
|
13761-2
|
Hydroxydecanedioate/Creatinine [Mass Ratio] in Urine |
|
25108-2
|
Hydroxydecanedioate/Creatinine [Molar ratio] in Urine |
|
35581-8
|
Hydroxyethyl valine [Mass/volume] in Blood |
|
59683-3
|
Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method |
|
59682-5
|
Hydroxyethylflurazepam [Mass/volume] in Blood |
|
19496-9
|
Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19495-1
|
Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Screen method |
|
59685-8
|
Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59684-1
|
Hydroxyethylflurazepam [Mass/volume] in Body fluid |
|
26836-7
|
Hydroxyethylflurazepam [Mass/mass] in Hair |
|
59686-6
|
Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method |
|
26936-5
|
Hydroxyethylflurazepam [Mass/mass] in Meconium |
|
16245-3
|
Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
32648-8
|
Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma |
|
59687-4
|
Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method |
|
12604-5
|
Hydroxyethylflurazepam [Presence] in Stool |
|
27247-6
|
Hydroxyethylflurazepam [Mass/mass] in Stool |
|
59689-0
|
Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method |
|
59688-2
|
Hydroxyethylflurazepam [Mass/mass] in Tissue |
|
20532-8
|
Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method |
|
19494-4
|
Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method |
|
19493-6
|
Hydroxyethylflurazepam [Presence] in Urine by Screen method |
|
12602-9
|
Hydroxyethylflurazepam [Mass/volume] in Urine |
|
48953-4
|
Hydroxyethylflurazepam [Mass/volume] in Unspecified specimen |
|
44553-6
|
Hydroxyitraconazole [Presence] in Serum or Plasma |
|
18337-6
|
Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
|
78834-9
|
Hydroxylurasidone cutoff [Mass/volume] in Urine for Confirmatory method |
|
78833-1
|
Hydroxylurasidone [Mass/volume] in Urine by Confirmatory method |
|
6885-8
|
Hydroxylysine [Mass/time] in 24 hour Urine |
|
25932-5
|
Hydroxylysine [Moles/volume] in 24 hour Urine |
|
25443-3
|
Hydroxylysine [Moles/time] in 24 hour Urine |
|
13400-7
|
Hydroxylysine [Mass/volume] in Amniotic fluid |
|
27195-7
|
Hydroxylysine [Moles/volume] in Amniotic fluid |
|
13373-6
|
Hydroxylysine [Mass/volume] in Cerebral spinal fluid |
|
26595-9
|
Hydroxylysine [Moles/volume] in Cerebral spinal fluid |
|
54303-3
|
Hydroxylysine [Moles/volume] in DBS |
|
56034-2
|
Hydroxylysine [Moles/volume] in Body fluid |
|
49849-3
|
Hydroxylysine.free/Creatinine [Molar ratio] in 24 hour Urine |
|
55891-6
|
Hydroxylysine [Moles/mass] in Hair |
|
2441-4
|
Hydroxylysine [Presence] in Serum or Plasma |
|
2442-2
|
Hydroxylysine [Mass/volume] in Serum or Plasma |
|
26610-6
|
Hydroxylysine [Moles/volume] in Serum or Plasma |
|
55890-8
|
Hydroxylysine/Amino acids.total in Hair |
|
17000-1
|
Hydroxylysine [Presence] in Urine |
|
2443-0
|
Hydroxylysine [Mass/volume] in Urine |
|
27291-4
|
Hydroxylysine [Moles/volume] in Urine |
|
56684-4
|
Hydroxylysine/Creatinine [Ratio] in 24 hour Urine |
|
25933-3
|
Hydroxylysine/Creatinine [Molar ratio] in 24 hour Urine |
|
13762-0
|
Hydroxylysine/Creatinine [Mass Ratio] in Urine |
|
30050-9
|
Hydroxylysine/Creatinine [Ratio] in Urine |
|
25109-0
|
Hydroxylysine/Creatinine [Molar ratio] in Urine |
|
4279-6
|
Hydroxymethoxyphenamine [Mass] of Dose |
|
3685-5
|
Hydroxymethoxyphenamine [Mass/volume] in Urine |
|
42538-9
|
Hydroxyperhexiline [Mass/volume] in Serum or Plasma |
|
42539-7
|
Hydroxyperhexiline/Perhexiline [Mass Ratio] in Serum or Plasma |
|
26810-2
|
Hydroxyproline [Presence] in 24 hour Urine |
|
59392-1
|
Hydroxyproline [Mass/volume] in 24 hour Urine |
|
2447-1
|
Hydroxyproline [Mass/time] in 24 hour Urine |
|
25934-1
|
Hydroxyproline [Moles/volume] in 24 hour Urine |
|
14785-0
|
Hydroxyproline [Moles/time] in 24 hour Urine |
|
12720-9
|
Hydroxyproline [Mass/volume] in 2 hour Urine |
|
13401-5
|
Hydroxyproline [Mass/volume] in Amniotic fluid |
|
27181-7
|
Hydroxyproline [Moles/volume] in Amniotic fluid |
|
13374-4
|
Hydroxyproline [Mass/volume] in Cerebral spinal fluid |
|
26596-7
|
Hydroxyproline [Moles/volume] in Cerebral spinal fluid |
|
47651-5
|
Hydroxyproline [Moles/volume] in DBS |
|
32249-5
|
Hydroxyproline [Moles/volume] in Body fluid |
|
30139-0
|
Hydroxyproline Free [Presence] in 24 hour Urine |
|
2450-5
|
Hydroxyproline Free [Mass/time] in 24 hour Urine |
|
32022-6
|
Hydroxyproline Free [Moles/volume] in 24 hour Urine |
|
14784-3
|
Hydroxyproline Free [Moles/time] in 24 hour Urine |
|
2448-9
|
Hydroxyproline Free [Mass/volume] in Serum or Plasma |
|
56685-1
|
Hydroxyproline Free [Moles/volume] in Serum or Plasma |
|
2449-7
|
Hydroxyproline Free [Mass/volume] in Urine |
|
32183-6
|
Hydroxyproline Free [Moles/volume] in Urine |
|
56686-9
|
Hydroxyproline Free/Creatinine [Ratio] in 24 hour Urine |
|
74880-6
|
Hydroxyproline [Moles/volume] in DBS --post therapeutic diet |
|
2445-5
|
Hydroxyproline [Presence] in Serum or Plasma |
|
2446-3
|
Hydroxyproline [Mass/volume] in Serum or Plasma |
|
20647-4
|
Hydroxyproline [Moles/volume] in Serum or Plasma |
|
17001-9
|
Hydroxyproline [Presence] in Urine |
|
2451-3
|
Hydroxyproline [Mass/volume] in Urine |
|
26740-1
|
Hydroxyproline [Moles/volume] in Urine |
|
32250-3
|
Hydroxyproline [Moles/volume] in Vitreous fluid |
|
44386-1
|
Hydroxyproline/Creatinine [Mass Ratio] in 24 hour Urine |
|
56939-2
|
Hydroxyproline/Creatinine [Ratio] in 24 hour Urine |
|
13996-4
|
Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
|
59383-0
|
Hydroxyproline/Creatinine [Mass Ratio] in 2 hour Urine |
|
13763-8
|
Hydroxyproline/Creatinine [Mass Ratio] in Urine |
|
28601-3
|
Hydroxyproline/Creatinine [Ratio] in Urine |
|
25110-8
|
Hydroxyproline/Creatinine [Molar ratio] in Urine |
|
59691-6
|
Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method |
|
59690-8
|
Hydroxytriazolam [Mass/volume] in Blood |
|
20535-1
|
Hydroxytriazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
20536-9
|
Hydroxytriazolam cutoff [Mass/volume] in Urine for Screen method |
|
59693-2
|
Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59692-4
|
Hydroxytriazolam [Mass/volume] in Body fluid |
|
26877-1
|
Hydroxytriazolam [Mass/mass] in Hair |
|
59694-0
|
Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method |
|
26912-6
|
Hydroxytriazolam [Mass/mass] in Meconium |
|
17002-7
|
Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
32649-6
|
Hydroxytriazolam [Mass/volume] in Serum or Plasma |
|
12383-6
|
Hydroxytriazolam [Presence] in Stool |
|
26976-1
|
Hydroxytriazolam [Mass/mass] in Stool |
|
59696-5
|
Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method |
|
59695-7
|
Hydroxytriazolam [Mass/mass] in Tissue |
|
20501-3
|
Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
|
20533-6
|
Hydroxytriazolam [Presence] in Urine by Confirmatory method |
|
19497-7
|
Hydroxytriazolam [Presence] in Urine by Screen method |
|
12432-1
|
Hydroxytriazolam [Mass/volume] in Urine |
|
48954-2
|
Hydroxytriazolam [Mass/volume] in Unspecified specimen |
|
7543-2
|
Oidiodendrum spp IgE Ab [Units/volume] in Serum |
|
15889-9
|
Oidiodendrum spp IgE Ab RAST class [Presence] in Serum |
|
27943-0
|
Interferon omega [Mass/volume] in Serum or Plasma |
|
40790-8
|
Oil palm IgE Ab [Units/volume] in Serum |
|
51577-5
|
Oil palm IgE Ab RAST class [Presence] in Serum |
|
80465-8
|
Oil servings 24 hour Estimated |
|
80466-6
|
Oil servings 24 hour Measured |
|
82430-0
|
OJ Ab [Units/volume] in Serum by Line blot |
|
45152-6
|
OJ Ab [Presence] in Serum |
|
69557-7
|
OJ Ab [Presence] in Serum by Immunoblot |
|
48649-8
|
OJ Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) |
|
83137-0
|
OJ IgG Ab [Presence] in Serum by Line blot |
|
55225-7
|
Okoume IgE Ab [Units/volume] in Serum |
|
7544-0
|
Okra IgE Ab [Units/volume] in Serum |
|
15890-7
|
Okra IgE Ab RAST class [Presence] in Serum |
|
56335-3
|
Okra IgG4 Ab [Mass/volume] in Serum |
|
63149-9
|
Okra IgG Ab [Mass/volume] in Serum |
|
35476-1
|
OKT3 blocking Ab [Titer] in Serum or Plasma by Flow cytometry (FC) |
|
14187-9
|
OKT3 [Mass/volume] in Serum or Plasma |
|
72984-8
|
OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72983-0
|
OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60105-4
|
OLANZapine [Mass/volume] in Blood |
|
77887-8
|
OLANZapine cutoff [Mass/volume] in Urine for Confirmatory method |
|
74832-7
|
OLANZapine [Mass] of Dose |
|
60106-2
|
OLANZapine [Mass/volume] in Body fluid |
|
59946-4
|
OLANZapine [Moles/volume] in Gastric fluid |
|
73235-4
|
OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73234-7
|
OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
89983-1
|
OLANZapine [Presence] in Serum or Plasma by Screen method |
|
12389-3
|
OLANZapine [Mass/volume] in Serum or Plasma |
|
39484-1
|
OLANZapine [Moles/volume] in Serum or Plasma |
|
60107-0
|
OLANZapine [Mass/mass] in Tissue |
|
77888-6
|
OLANZapine [Mass/volume] in Urine by Confirmatory method |
|
40390-7
|
OLANZapine [Presence] in Urine |
|
50891-1
|
OLANZapine [Moles/volume] in Urine |
|
60325-8
|
OLANZapine [Moles/volume] in Unspecified specimen |
|
57222-2
|
Oldest non-epithelialized stage 2 pressure injury present at discharge [CMS Assessment] |
|
55690-2
|
Oleandomycin [Susceptibility] by Gradient strip |
|
380-6
|
Oleandomycin [Susceptibility] by Disk diffusion (KB) |
|
379-8
|
Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
378-0
|
Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18960-5
|
Oleandomycin [Susceptibility] |
|
381-4
|
Oleandomycin [Susceptibility] by Serum bactericidal titer |
|
20906-4
|
Oleandrin [Mass/volume] in Ingesta |
|
20905-6
|
Oleandrin [Mass/volume] in Urine |
|
27108-0
|
Oleate (C18:1w9) [Presence] in Blood |
|
75102-4
|
Oleate (C18:1w9) [Entitic substance] in Red Blood Cells |
|
2673-2
|
Oleate (C18:1w9) [Mass/volume] in Serum or Plasma |
|
35166-8
|
Oleate (C18:1w9) [Moles/volume] in Serum or Plasma |
|
47713-3
|
Oleate (C18:1w9)/Creatinine [Molar ratio] in Urine |
|
55957-5
|
Oleoylcarnitine (C18:1) [Moles/volume] in Amniotic fluid |
|
55956-7
|
Oleoylcarnitine (C18:1) [Moles/volume] in Cerebral spinal fluid |
|
53202-8
|
Oleoylcarnitine (C18:1) [Moles/volume] in DBS |
|
18463-0
|
Oleoylcarnitine (C18:1) [Mass/volume] in Serum or Plasma |
|
30542-5
|
Oleoylcarnitine (C18:1) [Moles/volume] in Serum or Plasma |
|
55958-3
|
Oleoylcarnitine (C18:1) [Moles/volume] in Urine |
|
55955-9
|
Oleoylcarnitine (C18:1)/Creatinine [Molar ratio] in Urine |
|
58800-4
|
Oligoclonal bands [Interpretation] in 24 hour Urine by Isoelectric focusing |
|
35568-5
|
Oligoclonal bands [#] in Cerebral spinal fluid by Electrophoresis |
|
12782-9
|
Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis |
|
49293-4
|
Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
|
49852-7
|
Oligoclonal bands [#] in Cerebral spinal fluid by Isoelectric focusing |
|
32358-4
|
Oligoclonal bands [Presence] in Cerebral spinal fluid |
|
17821-0
|
Oligoclonal bands [Interpretation] in Body fluid by Electrophoresis Narrative |
|
56764-4
|
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing |
|
56762-8
|
Oligoclonal Bands IgG [Presence] in Serum or Plasma |
|
57665-2
|
Oligoclonal Bands IgG [Presence] in Serum or Plasma by Isoelectric focusing |
|
56765-1
|
Oligoclonal Bands IgM [Presence] in Cerebral spinal fluid by Isoelectric focusing |
|
57666-0
|
Oligoclonal Bands IgM [Presence] in Serum or Plasma by Isoelectric focusing |
|
56763-6
|
Oligoclonal Bands IgM [Interpretation] in Serum or Plasma |
|
50059-5
|
Oligoclonal bands/Protein.total in Urine by Electrophoresis |
|
35569-3
|
Oligoclonal bands [#] in Serum or Plasma |
|
56974-9
|
Oligoclonal bands [Interpretation] in Serum or Plasma by Isoelectric focusing |
|
48422-0
|
Oligoclonal bands [Presence] in Serum or Plasma |
|
12783-7
|
Oligoclonal bands [Interpretation] in Serum or Plasma |
|
49294-2
|
Oligoclonal bands [Interpretation] in Serum or Plasma Narrative |
|
38525-2
|
Oligoclonal bands [Mass/volume] in Urine by Electrophoresis |
|
48668-8
|
Protein fractions.oligoclonal bands.intrathecal [Presence] in Serum and CSF |
|
74730-3
|
Oligosaccharides pattern [Interpretation] in 24 hour Urine Narrative |
|
82506-7
|
Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative |
|
53808-2
|
Oligosaccharides pattern [Interpretation] in Serum or Plasma Narrative |
|
33875-6
|
Oligosaccharides pattern [Interpretation] in Urine |
|
49284-3
|
Oligosaccharides pattern [Interpretation] in Urine Narrative |
|
82507-5
|
Oligosaccharides pattern [Interpretation] in Leukocytes by Screen method Narrative |
|
12239-0
|
Oligosaccharides [Presence] in Urine |
|
48147-3
|
Oligosaccharides/Creatinine [Molar ratio] in Urine |
|
58754-3
|
Olive pollen native (nOle e) 1 IgE Ab [Units/volume] in Serum |
|
82029-0
|
Olive pollen native (nOle e) 1 IgE Ab RAST class [Presence] in Serum |
|
66450-8
|
Olive native (nOle e) 2 IgE Ab [Units/volume] in Serum |
|
65779-1
|
Olive pollen native (nOle e) 7 IgE Ab [Units/volume] in Serum |
|
81960-7
|
Olive pollen native (nOle e) 7 IgE Ab RAST class [Presence] in Serum |
|
56727-1
|
Olive recombinant (rOle e) 2 IgE Ab [Units/volume] in Serum |
|
65780-9
|
Olive pollen recombinant (rOle e) 9 IgE Ab [Units/volume] in Serum |
|
81962-3
|
Olive pollen recombinant (rOle e) 9 IgE Ab RAST class [Presence] in Serum |
|
21428-8
|
Olive IgE Ab [Units/volume] in Serum |
|
21429-6
|
Olive IgE Ab RAST class [Presence] in Serum |
|
7546-5
|
Olive IgG Ab [Units/volume] in Serum |
|
56276-9
|
Olive IgG4 Ab [Mass/volume] in Serum |
|
78697-0
|
Olive IgG Ab [Mass/volume] in Serum |
|
6192-9
|
Olive Pollen IgE Ab [Units/volume] in Serum |
|
15892-3
|
Olive Pollen IgE Ab RAST class [Presence] in Serum |
|
58017-5
|
Olive Pollen IgE Ab/IgE total in Serum |
|
56336-1
|
Olive Pollen IgG4 Ab [Mass/volume] in Serum |
|
48246-3
|
Olive Pollen triggered leukotriene release [Mass/volume] by Leukocytes |
|
80253-8
|
Obtuse marginal artery [Presence] on Angiogram |
|
73639-7
|
Omadacycline [Susceptibility] by Disk diffusion (KB) |
|
73616-5
|
Omadacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73594-4
|
Omadacycline [Susceptibility] |
|
82378-1
|
Ombitasvir [Susceptibility] by Genotype method |
|
81900-3
|
Omega-3 fatty acid intake 24 hour Estimated |
|
81901-1
|
Omega-3 fatty acid intake 24 hour Measured |
|
88999-8
|
Omega-3 (EPA+DHA) index risk in Serum or Plasma |
|
88998-0
|
Omega-3 (EPA+DHA) index in Serum or Plasma |
|
72982-2
|
Omeprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72981-4
|
Omeprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73233-9
|
Omeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73232-1
|
Omeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14188-7
|
Omeprazole [Mass/volume] in Serum or Plasma |
|
82887-1
|
Ortho methylhippurate [Moles/volume] in Urine |
|
82888-9
|
Ortho methylhippurate/Creatinine [Molar ratio] in Urine |
|
42722-9
|
OmpC Ab [Presence] in Serum |
|
42724-5
|
OmpC Ab [Presence] in Serum by Immunoassay |
|
42723-7
|
OmpC Ab [Units/volume] in Serum |
|
66482-1
|
OmpC IgA Ab [Units/volume] in Serum by Immunoassay |
|
45148-4
|
OmpC IgA Ab [Presence] in Serum |
|
58706-3
|
OmpC IgA Ab [Presence] in Serum by Immunoassay |
|
2688-0
|
Orotidine-5'-Phosphate decarboxylase [Enzymatic activity/volume] in Serum |
|
84382-1
|
Oral and Maxillofacial Surgery Admission evaluation note |
|
78511-3
|
Oral and Maxillofacial Surgery Admission history and physical note |
|
83662-7
|
Oral and maxillofacial surgery Attending Note |
|
78540-2
|
Oral and Maxillofacial Surgery Checklist |
|
34812-8
|
Oral and Maxillofacial Surgery Consult note |
|
78594-9
|
Oral and Maxillofacial Surgery Education note |
|
78616-0
|
Oral and Maxillofacial Surgery Flowsheet |
|
82834-3
|
Oral and Maxillofacial Surgery Initial evaluation note |
|
34813-6
|
Oral and Maxillofacial Surgery Note |
|
84381-3
|
Oral and Maxillofacial Surgery Outpatient Note |
|
78678-0
|
Oral and Maxillofacial Surgery Surgical operation note |
|
80769-3
|
Oral and Maxillofacial Surgery Plan of care note |
|
84380-5
|
Oral and Maxillofacial Surgery Postoperative evaluation and management note |
|
78715-0
|
Oral and Maxillofacial Surgery Preoperative evaluation and management note |
|
84379-7
|
Oral and Maxillofacial Surgery procedure note |
|
57174-5
|
Oral and Maxillofacial Surgery Referral note |
|
83767-4
|
Oral and maxillofacial surgery Resident Note |
|
78684-8
|
Oral and Maxillofacial Surgery Transfer summary note |
|
76904-2
|
On a typical day when I drank alcohol, I had... [PROMIS] |
|
77237-6
|
On a typical weekday in the past week, how much time did the patient spend playing video games and computer games |
|
77235-0
|
On a typical weekday in the past week, how much time did the patient spend watching TV AndOr DVDs |
|
77238-4
|
On a typical weekend day in the past week, how much time did the patient spend playing video games and computer games |
|
77236-8
|
On a typical weekend day in the past week, how much time did the patient spend watching TV AndOr DVDs |
|
91208-9
|
On a usual day, how physically active was your child in past 7 days [PROMIS.PARENTPROXY] |
|
91220-4
|
On a usual day, how physically active were you in past 7 days [PROMIS.PEDS] |
|
71519-3
|
On transplant waiting list [ESRD] |
|
5264-7
|
Onchocerca sp Ab [Units/volume] in Serum |
|
49771-9
|
Onchocerca sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
87992-4
|
Onchocerca sp IgG Ab [Presence] in Serum by Immunoassay |
|
49784-2
|
Onchocerca sp IgG Ab [Units/volume] in Serum |
|
49785-9
|
Onchocerca sp IgG2 Ab [Units/volume] in Serum by Immunoassay |
|
88573-1
|
Onchocerca sp IgG2 Ab [Presence] in Serum by Immunoassay |
|
51462-0
|
Onchocerca sp IgG2 Ab [Units/volume] in Serum |
|
49786-7
|
Onchocerca sp IgG3 Ab [Units/volume] in Serum by Immunoassay |
|
88574-9
|
Onchocerca sp IgG3 Ab [Presence] in Serum by Immunoassay |
|
51463-8
|
Onchocerca sp IgG3 Ab [Units/volume] in Serum |
|
49783-4
|
Onchocerca sp IgG4 Ab [Units/volume] in Serum by Immunoassay |
|
88575-6
|
Onchocerca sp IgG4 Ab [Presence] in Serum by Immunoassay |
|
51464-6
|
Onchocerca sp IgG4 Ab [Units/volume] in Serum |
|
10699-7
|
Onchocerca sp identified in Tissue by Wet preparation |
|
78392-8
|
Oncology Admission history and physical note |
|
81634-8
|
Oncology Recommended cancer surveillance |
|
74156-1
|
Oncology Plan of care and summary note |
|
34805-2
|
Oncology Consult note |
|
78417-3
|
Oncology Discharge instructions |
|
78421-5
|
Oncology Discharge summary |
|
78428-0
|
Oncology Discharge teaching note |
|
78453-8
|
Oncology Education note |
|
78462-9
|
Oncology Flowsheet |
|
78706-9
|
Oncology Form |
|
78465-2
|
Oncology History and physical note |
|
78471-0
|
Oncology Initial evaluation note |
|
34806-0
|
Oncology Note |
|
80759-4
|
Oncology Plan of care note |
|
78478-5
|
Oncology procedure note |
|
78482-7
|
Oncology Progress note |
|
81633-0
|
Oncology Recommended follow-up tests or procedures |
|
57149-7
|
Oncology Referral note |
|
78493-4
|
Oncology Transfer summary note |
|
73231-3
|
Ondansetron induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73230-5
|
Ondansetron induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
58214-8
|
One or more unhealed pressure injuries stage 1 or higher [CMS Assessment] |
|
30168-9
|
Oneseed Juniper IgE Ab [Units/volume] in Serum |
|
7549-9
|
Onion triggered histamine release [Units/volume] in Blood |
|
6193-7
|
Onion IgE Ab [Units/volume] in Serum |
|
15893-1
|
Onion IgE Ab RAST class [Presence] in Serum |
|
61210-1
|
Onion IgE Ab/IgE total in Serum |
|
7548-1
|
Onion IgG Ab [Units/volume] in Serum |
|
21430-4
|
Onion IgG Ab RAST class [Presence] in Serum |
|
56337-9
|
Onion IgG4 Ab [Mass/volume] in Serum |
|
35541-2
|
Onion IgG Ab [Mass/volume] in Serum |
|
73973-0
|
O-nortramadol [Mass/volume] in Blood |
|
93721-9
|
O-nortramadol [Mass/mass] in Meconium by Confirmatory method |
|
90750-1
|
O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
82974-7
|
O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
92639-4
|
O-nortramadol [Mass/volume] in Urine by Confirmatory method |
|
86453-8
|
O-nortramadol [Presence] in Urine |
|
73774-2
|
Onset of labor [US Standard Certificate of Live Birth] |
|
91984-5
|
Outpatient Care management note |
|
24611-6
|
Outpatient Consultation 2nd opinion |
|
51845-6
|
Outpatient Consult note |
|
85202-0
|
Outpatient Evaluation and management of smoking cessation note |
|
67855-7
|
Outpatient Education note |
|
47247-2
|
HIV Antiretroviral therapy Outpatient encounter-level information section |
|
34120-6
|
Outpatient Initial evaluation note |
|
89430-3
|
Outpatient Medical history screening form |
|
34108-1
|
Outpatient Note |
|
34137-0
|
Outpatient Surgical operation note |
|
9792-3
|
Organophosphate pesticides [Identifier] in Blood |
|
20917-1
|
Organophosphate pesticides [Presence] in Blood by Screen method |
|
20922-1
|
Organophosphate pesticides [Identifier] in Gastric fluid |
|
20919-7
|
Organophosphate pesticides [Presence] in Gastric fluid by Screen method |
|
20923-9
|
Organophosphate pesticides [Identifier] in Tissue |
|
20920-5
|
Organophosphate pesticides [Presence] in Tissue by Screen method |
|
18472-1
|
Organophosphate pesticides [Identifier] in Urine |
|
28042-0
|
Organophosphate pesticides [Mass/volume] in Urine by Screen method |
|
20921-3
|
Organophosphate pesticides [Identifier] in Unspecified specimen |
|
20918-9
|
Organophosphate pesticides [Presence] in Unspecified specimen by Screen method |
|
34131-3
|
Outpatient Progress note |
|
67865-6
|
Outpatient Supervisory note |
|
48601-9
|
OPA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81816-1
|
OPA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
23338-7
|
Ovine pulmonary adenomatosis retrovirus RNA [Presence] in Lung tissue by NAA with probe detection |
|
78763-0
|
OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
78871-1
|
OPC3373 (Metabolite of Ariprazole) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78870-3
|
OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine by Confirmatory method |
|
78872-9
|
OPC3373 (Metabolite of Ariprazole) [Z-score] in Urine |
|
90931-7
|
Openbite teeth [#] |
|
71501-1
|
Open-closed status Dialysis facility [ESRD] |
|
79856-1
|
Opening height Left palpebral fissure |
|
79855-3
|
Opening height Right palpebral fissure |
|
71514-4
|
Opening time Dialysis facility [ESRD] |
|
90858-2
|
Open-spaced teeth [#] |
|
91600-7
|
Operational objectives related to the emergency response activation Reporting Period |
|
61358-8
|
Surgical operation consent Document |
|
11504-8
|
Surgical operation note |
|
10222-8
|
Surgical operation note surgical complications [Interpretation] Narrative |
|
10831-6
|
Surgical operation note complications [Interpretation] |
|
8727-0
|
Surgical operation note indications [Interpretation] |
|
10217-8
|
Surgical operation note indications [Interpretation] Narrative |
|
8719-7
|
Surgical operation note postoperative diagnosis |
|
10218-6
|
Surgical operation note postoperative diagnosis Narrative |
|
8720-5
|
Surgical operation note preoperative diagnosis |
|
10219-4
|
Surgical operation note preoperative diagnosis Narrative |
|
89429-5
|
Surgical operation order |
|
83691-6
|
Ophthalmology Attending Note |
|
83692-4
|
Ophthalmology Attending Surgical operation note |
|
83693-2
|
Ophthalmology Attending Preoperative evaluation and management note |
|
83742-7
|
Ophthalmology Fellow Note |
|
83589-2
|
Ophthalmology Nurse Note |
|
83574-4
|
Ophthalmology Nurse Outpatient Note |
|
83766-6
|
Ophthalmology Resident Note |
|
84409-2
|
Ophthalmology Technician Note |
|
84405-0
|
Ophthalmology Admission evaluation note |
|
78713-5
|
Ophthalmology Admission history and physical note |
|
84055-3
|
Ophthalmology Annual evaluation note |
|
78712-7
|
Ophthalmology Checklist |
|
34807-8
|
Ophthalmology Consult note |
|
78573-3
|
Ophthalmology Diagnostic study note |
|
84406-8
|
Ophthalmology Diagram |
|
68572-7
|
Ophthalmology Discharge summary |
|
78608-7
|
Ophthalmology Education note |
|
78638-4
|
Ophthalmology Flowsheet |
|
68573-5
|
Ophthalmology History and physical note |
|
68575-0
|
Ophthalmology Hospital Consult note |
|
68576-8
|
Ophthalmology Hospital Letter |
|
84407-6
|
Ophthalmology Hospital Note |
|
78647-5
|
Ophthalmology Initial evaluation note |
|
34808-6
|
Ophthalmology Note |
|
75462-2
|
Ophthalmology Outpatient Note |
|
34867-2
|
Ophthalmology Outpatient Postoperative evaluation and management note |
|
84408-4
|
Ophthalmology Outpatient procedure note |
|
78714-3
|
Ophthalmology Surgical operation note |
|
84410-0
|
Ophthalmology Telephone encounter Note |
|
80779-2
|
Ophthalmology Plan of care note |
|
67861-5
|
Ophthalmology Postoperative evaluation and management note |
|
34809-4
|
Ophthalmology Preoperative evaluation and management note |
|
78657-4
|
Ophthalmology procedure note |
|
68574-3
|
Ophthalmology Progress note |
|
84056-1
|
Ophthalmology Patient's home Note |
|
57150-5
|
Ophthalmology Referral note |
|
84412-6
|
Ophthalmology Risk assessment and screening note |
|
78513-9
|
Ophthalmology Summary of encounters note |
|
78512-1
|
Ophthalmology Summary note |
|
85882-9
|
Ophthalmology Teleimaging Consult note |
|
85881-1
|
Ophthalmology Teleimaging Note |
|
68887-9
|
Ophthalmology Transfer summary note |
|
79756-3
|
Ophthalmologic treatment Left eye |
|
79755-5
|
Ophthalmologic treatment Right eye |
|
51691-4
|
Opiates [Presence] in Blood by Screen method |
|
19302-9
|
Opiates confirm method [Identifier] in Urine |
|
50620-4
|
Opiates cutoff [Mass/mass] in Meconium for Confirmatory method |
|
19300-3
|
Opiates cutoff [Mass/volume] in Urine for Confirmatory method |
|
19299-7
|
Opiates cutoff [Mass/volume] in Urine for Screen method |
|
19138-7
|
Opiates cutoff [Mass/volume] in Urine |
|
91043-0
|
Opiates [Presence] in Body fluid by Screen method |
|
8210-7
|
Opiates [Presence] in Gastric fluid |
|
8211-5
|
Opiates [Presence] in Gastric fluid by Confirmatory method |
|
8212-3
|
Opiates [Presence] in Gastric fluid by Screen method |
|
8209-9
|
Opiates [Mass/volume] in Gastric fluid |
|
40528-2
|
Opiates [Presence] in Hair |
|
40805-4
|
Opiates [Presence] in Hair by Screen method |
|
10369-7
|
Opiates [Mass/mass] in Hair |
|
8214-9
|
Opiates [Presence] in Meconium |
|
8215-6
|
Opiates [Presence] in Meconium by Confirmatory method |
|
8216-4
|
Opiates [Presence] in Meconium by Screen method |
|
26744-3
|
Opiates [Mass/mass] in Meconium by Screen method |
|
8213-1
|
Opiates [Mass/volume] in Meconium |
|
29158-3
|
Opiates [Mass/mass] in Meconium |
|
27321-9
|
Opiates [Mass/volume] in Milk |
|
19298-9
|
Opiates positive [Identifier] in Urine by Confirmatory method |
|
74656-0
|
Opiates [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40806-2
|
Opiates [Presence] in Saliva (oral fluid) by Screen method |
|
74167-8
|
Opiates [Mass/volume] in Saliva (oral fluid) by Screen method |
|
19301-1
|
Opiates screen method [Identifier] in Urine |
|
3878-6
|
Opiates [Presence] in Serum or Plasma |
|
8218-0
|
Opiates [Presence] in Serum or Plasma by Confirmatory method |
|
8219-8
|
Opiates [Presence] in Serum or Plasma by Screen method |
|
8217-2
|
Opiates [Mass/volume] in Serum or Plasma |
|
12354-7
|
Opiates [Presence] in Stool |
|
27064-5
|
Opiates [Mass/mass] in Stool |
|
19296-3
|
Opiates tested for in Urine by Screen method Nominal |
|
19297-1
|
Opiates tested for in Urine by Screen method Narrative |
|
91052-1
|
Opiates [Presence] in Tissue by Screen method |
|
5706-7
|
Opiates [Identifier] in Urine |
|
17384-9
|
Opiates [Mass/volume] in Urine by Confirmatory method |
|
3879-4
|
Opiates [Presence] in Urine |
|
18390-5
|
Opiates [Presence] in Urine by Confirmatory method |
|
8221-4
|
Opiates [Presence] in Urine by SAMHSA confirm method |
|
8222-2
|
Opiates [Presence] in Urine by SAMHSA screen method |
|
19295-5
|
Opiates [Presence] in Urine by Screen method |
|
21431-2
|
Opiates [Presence] in Urine by Screen method >2000 ng/mL |
|
70151-6
|
Opiates [Presence] in Urine by Screen method >300 ng/mL |
|
70150-8
|
Opiates [Mass/volume] in Urine by Screen method |
|
8220-6
|
Opiates [Mass/volume] in Urine |
|
52952-9
|
Opiates [Moles/volume] in Urine |
|
8224-8
|
Opiates [Presence] in Unknown substance |
|
8225-5
|
Opiates [Presence] in Unknown substance by Confirmatory method |
|
8226-3
|
Opiates [Presence] in Unknown substance by Screen method |
|
8223-0
|
Opiates [Mass/volume] in Unknown substance |
|
27136-1
|
Opiates [Presence] in Vitreous fluid |
|
34177-6
|
Opiates [Presence] in Unspecified specimen |
|
48961-7
|
Opiates [Mass/volume] in Unspecified specimen |
|
41465-6
|
Opiates/Creatinine [Mass Ratio] in Urine |
|
89424-6
|
Long-term opioid therapy for pain consent Document |
|
90976-2
|
Opipramol [Mass/volume] in Serum or Plasma |
|
23328-8
|
Ovine progressive pneumonia virus Ab [Presence] in Milk |
|
23333-8
|
Ovine progressive pneumonia virus Ab [Presence] in Milk by Immunoassay |
|
23329-6
|
Ovine progressive pneumonia virus Ab [Presence] in Serum |
|
23330-4
|
Ovine progressive pneumonia virus Ab [Presence] in Serum by Immunoassay |
|
23332-0
|
Ovine progressive pneumonia virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31922-8
|
Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen |
|
23334-6
|
Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23335-3
|
Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23337-9
|
Ovine progressive pneumonia virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23336-1
|
Ovine progressive pneumonia virus DNA [Presence] in Unspecified specimen by Polyacrylamide gel electrophoresis (PAGE) |
|
2687-2
|
Orotate phosphoribosyltransferase [Enzymatic activity/volume] in Serum |
|
71486-5
|
Optic disc or retinal nerve fiber layer structural abnormalities Left eye by Ophthalmoscopy |
|
71487-3
|
Optic disc or retinal nerve fiber layer structural abnormalities Right eye by Ophthalmoscopy |
|
73665-2
|
Optochin [Susceptibility] by Disk diffusion (KB) |
|
34810-2
|
Optometry Consult note |
|
78574-1
|
Optometry Diagnostic study note |
|
78605-3
|
Optometry Education note |
|
78617-8
|
Optometry Flowsheet |
|
78648-3
|
Optometry Initial evaluation note |
|
34811-0
|
Optometry Note |
|
84411-8
|
Optometry Outpatient Note |
|
84383-9
|
Optometry Telephone encounter Note |
|
80773-5
|
Optometry Plan of care note |
|
78661-6
|
Optometry procedure note |
|
78667-3
|
Optometry Progress note |
|
57151-3
|
Optometry Referral note |
|
90788-1
|
Optometry Resident Note |
|
84431-6
|
Optometry Technician Note |
|
89405-5
|
Oral hygiene - functional ability [CMS Assessment] |
|
83230-3
|
Oral hygiene - functional ability during 3 day assessment period [CMS Assessment] |
|
89404-8
|
Oral hygiene - functional goal [CMS Assessment] |
|
83229-5
|
Oral hygiene - functional goal during 3 day assessment period [CMS Assessment] |
|
79335-6
|
Hypoglycemics.oral [Presence] in Blood by Screen method |
|
79337-2
|
Hypoglycemics.oral [Presence] in Body fluid by Screen method |
|
79334-9
|
Hypoglycemics.oral [Presence] in Hair by Screen method |
|
79336-4
|
Hypoglycemics.oral [Presence] in Serum or Plasma by Screen method |
|
12330-7
|
Hypoglycemics.oral [Identifier] in Urine |
|
79338-0
|
Hypoglycemics.oral [Presence] in Urine by Screen method |
|
72064-9
|
Oral iron prescribed [ESRD] |
|
79545-0
|
Oral medication fluid intake [Volume] Measured |
|
57258-6
|
Oral medication management - prior ability [CMS Assessment] |
|
84477-9
|
Oral Reading Recognition Test - English - computed score [NIH Toolbox] |
|
84479-5
|
Oral Reading Recognition Test - English - theta score [NIH Toolbox] |
|
84481-1
|
Oral Reading Recognition Test - English - unadjusted scale score [NIH Toolbox] |
|
84476-1
|
Oral Reading Recognition Test - English - national percentile [NIH Toolbox] |
|
84435-7
|
Oral Reading Recognition Test [NIH Toolbox] |
|
84480-3
|
Oral Reading Recognition Test - English - scale score age adjusted [NIH Toolbox] |
|
84478-7
|
Oral Reading Recognition Test - English - scale score fully adjusted [NIH Toolbox] |
|
72031-8
|
Oral vitamin D analog prescribed [ESRD] |
|
7550-7
|
Orange triggered histamine release [Units/volume] in Blood |
|
6194-5
|
Orange IgE Ab [Units/volume] in Serum |
|
15894-9
|
Orange IgE Ab RAST class [Presence] in Serum |
|
61248-1
|
Orange IgE Ab/IgE total in Serum |
|
6730-6
|
Orange IgG Ab [Units/volume] in Serum |
|
21432-0
|
Orange IgG Ab RAST class [Presence] in Serum |
|
56338-7
|
Orange IgG4 Ab [Mass/volume] in Serum |
|
51904-1
|
Orange IgG Ab [Mass/volume] in Serum |
|
48209-1
|
Orange triggered leukotriene release [Mass/volume] by Leukocytes |
|
11196-3
|
Orange roughy IgE Ab [Units/volume] in Serum |
|
21499-9
|
Orange roughy IgE Ab RAST class [Presence] in Serum |
|
7551-5
|
Orange Tree IgE Ab [Units/volume] in Serum |
|
21433-8
|
Orange Tree IgE Ab RAST class [Presence] in Serum |
|
35825-9
|
Orbifloxacin [Susceptibility] by Disk diffusion (KB) |
|
35826-7
|
Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35827-5
|
Orbifloxacin [Susceptibility] |
|
77597-3
|
Orders placed Document |
|
7554-9
|
Oregano triggered histamine release [Units/volume] in Blood |
|
7552-3
|
Oregano IgE Ab [Units/volume] in Serum |
|
15895-6
|
Oregano IgE Ab RAST class [Presence] in Serum |
|
61290-3
|
Oregano IgE Ab/IgE total in Serum |
|
7553-1
|
Oregano IgG Ab [Units/volume] in Serum |
|
21434-6
|
Oregano IgG Ab RAST class [Presence] in Serum |
|
56340-3
|
Oregano IgG4 Ab [Mass/volume] in Serum |
|
60387-8
|
Oregano IgG Ab [Mass/volume] in Serum |
|
6832-0
|
Oregon Ash IgE Ab [Units/volume] in Serum |
|
91670-0
|
Orexin-A [Mass/volume] in Cerebral spinal fluid |
|
91005-9
|
Organization assigned to task |
|
64300-7
|
Organ donation consent Document |
|
44788-8
|
Organ donor |
|
44780-5
|
Organ donor ID number Narrative |
|
85283-0
|
Organ tumor is adherent to [Anatomy] in Colorectal cancer specimen by Light microscopy |
|
17386-4
|
Organic acids [Units/volume] in Blood |
|
33476-3
|
Organic acids pattern [Interpretation] in Cerebral spinal fluid |
|
49285-0
|
Organic acids pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
53136-8
|
Organic acids pattern [Interpretation] in Body fluid |
|
33475-5
|
Organic acids pattern [Interpretation] in Serum or Plasma |
|
49286-8
|
Organic acids pattern [Interpretation] in Serum or Plasma Narrative |
|
33477-1
|
Organic acids pattern [Interpretation] in Urine |
|
49287-6
|
Organic acids pattern [Interpretation] in Urine Narrative |
|
50161-9
|
Organic acids pattern [Interpretation] in Unspecified specimen |
|
10837-3
|
Organic acids [Presence] in Serum or Plasma |
|
17387-2
|
Organic acids [Units/volume] in Serum or Plasma |
|
38172-3
|
Organic acids [Moles/volume] in Serum or Plasma |
|
55818-9
|
Organic acids [Moles/mass] in Stool |
|
2676-5
|
Organic acids [Presence] in Urine |
|
17385-6
|
Organic acids [Units/volume] in Urine |
|
10972-8
|
Organic acids [Mass/volume] in Urine |
|
44343-2
|
Organic acids/Creatinine [Mass Ratio] in Urine |
|
14295-0
|
Organic acids/Creatinine [Molar ratio] in Urine |
|
699-9
|
Organism count [#/volume] in Unspecified specimen by Microscopic count |
|
90052-2
|
Organization Address |
|
90057-1
|
Name of Contact at Organization |
|
90054-8
|
Organization Email address |
|
89919-5
|
Organization Emergency response capabilities |
|
76471-2
|
Organization episode of care unique identifier |
|
90055-5
|
Organization information panel |
|
76469-6
|
Organization name |
|
76468-8
|
Organization NPI |
|
90053-0
|
Organization Phone number |
|
76695-6
|
Organization ZIP code |
|
2677-3
|
Organochloride [Mass/volume] in Blood |
|
25611-5
|
Oriental Cockroach IgE Ab [Units/volume] in Serum |
|
25612-3
|
Oriental Cockroach IgE Ab RAST class [Presence] in Serum |
|
80230-6
|
Orifice area Aortic valve Cardiac catheterization |
|
80231-4
|
Orifice area Mitral valve Cardiac catheterization |
|
48557-3
|
Origin of Stone |
|
41709-7
|
Oritavancin [Susceptibility] by Gradient strip |
|
41707-1
|
Oritavancin [Susceptibility] by Disk diffusion (KB) |
|
41708-9
|
Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41736-0
|
Oritavancin [Susceptibility] |
|
87795-1
|
Ormetoprim+Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87801-7
|
Ormetoprim+Sulfadimethoxine [Susceptibility] |
|
73638-9
|
Ormetroprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
|
73615-7
|
Ormetroprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73593-6
|
Ormetroprim+Sulfamethoxazole [Susceptibility] |
|
55692-8
|
Ornidazole [Susceptibility] by Gradient strip |
|
55693-6
|
Ornidazole [Susceptibility] by Disk diffusion (KB) |
|
55694-4
|
Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55691-0
|
Ornidazole [Susceptibility] |
|
2681-5
|
Ornithine [Mass/time] in 24 hour Urine |
|
25965-5
|
Ornithine [Moles/volume] in 24 hour Urine |
|
25491-2
|
Ornithine [Moles/time] in 24 hour Urine |
|
13408-0
|
Ornithine [Mass/volume] in Amniotic fluid |
|
27219-5
|
Ornithine [Moles/volume] in Amniotic fluid |
|
40829-4
|
Ornithine [Presence] in Blood |
|
13379-3
|
Ornithine [Mass/volume] in Cerebral spinal fluid |
|
22647-2
|
Ornithine [Moles/volume] in Cerebral spinal fluid |
|
47714-1
|
Ornithine [Moles/volume] in DBS |
|
32260-2
|
Ornithine [Moles/volume] in Body fluid |
|
74883-0
|
Ornithine [Moles/volume] in DBS --post therapeutic diet |
|
2678-1
|
Ornithine [Presence] in Serum or Plasma |
|
27335-9
|
Ornithine [Units/volume] in Serum or Plasma |
|
2679-9
|
Ornithine [Mass/volume] in Serum or Plasma |
|
20652-4
|
Ornithine [Moles/volume] in Serum or Plasma |
|
55959-1
|
Ornithine/Amino acids.total in Serum or Plasma |
|
17389-8
|
Ornithine [Presence] in Urine |
|
2680-7
|
Ornithine [Mass/volume] in Urine |
|
27292-2
|
Ornithine [Moles/volume] in Urine |
|
32261-0
|
Ornithine [Moles/volume] in Vitreous fluid |
|
22725-6
|
Ornithine [Moles/volume] in Unspecified specimen |
|
75215-4
|
Ornithine/Citrulline [Molar ratio] in DBS |
|
44344-0
|
Ornithine/Creatinine [Mass Ratio] in 24 hour Urine |
|
57011-9
|
Ornithine/Creatinine [Ratio] in 24 hour Urine |
|
25966-3
|
Ornithine/Creatinine [Molar ratio] in 24 hour Urine |
|
13786-9
|
Ornithine/Creatinine [Mass Ratio] in Urine |
|
30049-1
|
Ornithine/Creatinine [Ratio] in Urine |
|
22682-9
|
Ornithine/Creatinine [Molar ratio] in Urine |
|
81427-7
|
Microscopic observation [Identifier] in Venous blood by Oil red O stain |
|
32812-0
|
Microscopic observation [Identifier] in Bronchial specimen by Oil red O stain |
|
81425-1
|
Microscopic observation [Identifier] in Bone marrow by Oil red O stain |
|
10798-7
|
Microscopic observation [Identifier] in Tissue by Oil red O stain |
|
32798-1
|
Microscopic observation [Identifier] in Unspecified specimen by Oil red O stain |
|
59568-6
|
Orotate [Moles/time] in 24 hour Urine |
|
75126-3
|
Orotate [Moles/volume] in Cerebral spinal fluid |
|
69772-2
|
Orotate [Moles/volume] in Serum or Plasma |
|
30480-8
|
Orotate [Presence] in Urine |
|
26872-2
|
Orotate [Units/volume] in Urine |
|
2686-4
|
Orotate [Mass/volume] in Urine |
|
13963-4
|
Orotate [Moles/volume] in Urine |
|
44345-7
|
Orotate/Creatinine [Molar ratio] in 24 hour Urine |
|
13787-7
|
Orotate/Creatinine [Mass Ratio] in Urine |
|
32262-8
|
Orotate/Creatinine [Ratio] in Urine |
|
17869-9
|
Orotate/Creatinine [Molar ratio] in Urine |
|
75148-7
|
Orotidine [Moles/volume] in Cerebral spinal fluid |
|
75125-5
|
Orotidine [Moles/volume] in Serum or Plasma |
|
12240-8
|
Orotidine [Moles/volume] in Urine |
|
17870-7
|
Orotidine/Creatinine [Molar ratio] in Urine |
|
4363-8
|
Orphenadrine [Mass] of Dose |
|
75763-3
|
Orphenadrine [Presence] in Serum or Plasma or Urine by Screen method |
|
3880-2
|
Orphenadrine [Mass/volume] in Serum or Plasma |
|
55560-7
|
Orphenadrine [Moles/volume] in Serum or Plasma |
|
29288-8
|
Orphenadrine [Presence] in Urine |
|
17390-6
|
Orphenadrine [Mass/volume] in Urine |
|
7555-6
|
Orris root IgE Ab [Units/volume] in Serum |
|
15896-4
|
Orris root IgE Ab RAST class [Presence] in Serum |
|
79422-2
|
Orthopedic functional index [CareConnections] |
|
51717-7
|
Normoblasts Orthochromic/100 cells in Blood by Microscopy |
|
11116-1
|
Normoblasts Orthochromic/100 cells in Bone marrow by Manual count |
|
83663-5
|
Orthopaedic surgery Attending Note |
|
83664-3
|
Orthopaedic surgery Attending Preoperative evaluation and management note |
|
83559-5
|
Orthopaedic surgery Nurse practitioner Note |
|
83603-1
|
Orthopaedic surgery Nurse Note |
|
83604-9
|
Orthopaedic surgery Nurse Outpatient Note |
|
83748-4
|
Orthopaedic surgery Physician assistant Note |
|
83768-2
|
Orthopaedic surgery Resident Note |
|
93893-6
|
Orthopaedic surgery Team Conference note |
|
38670-6
|
Orthocresol [Mass/volume] in Air |
|
17391-4
|
Orthocresol [Mass/volume] in Blood |
|
13026-0
|
Orthocresol [Mass/volume] in Urine |
|
13477-5
|
Orthocresol/Creatinine [Mass Ratio] in Urine |
|
90874-9
|
Orthodontic evaluation summary Document |
|
90866-5
|
Orthodontic preconditions |
|
90875-6
|
Orthodontic service attachment |
|
90868-1
|
Orthognathic surgery consideration summary Narrative |
|
84378-9
|
Orthopaedic surgery Admission evaluation note |
|
78509-7
|
Orthopaedic surgery Admission history and physical note |
|
78541-0
|
Orthopaedic surgery Checklist |
|
34814-4
|
Orthopaedic surgery Consult note |
|
68577-6
|
Orthopaedic surgery Diagnostic study note |
|
68578-4
|
Orthopaedic surgery Discharge summary |
|
78593-1
|
Orthopaedic surgery Education note |
|
78631-9
|
Orthopaedic surgery Flowsheet |
|
68580-0
|
Orthopaedic surgery History and physical note |
|
68585-9
|
Orthopaedic surgery Hospital Letter |
|
84377-1
|
Orthopaedic surgery Hospital Note |
|
82833-5
|
Orthopaedic surgery Initial evaluation note |
|
34815-1
|
Orthopaedic surgery Note |
|
84376-3
|
Orthopaedic surgery Outpatient Note |
|
84375-5
|
Orthopaedic surgery Outpatient procedure note |
|
34868-0
|
Orthopaedic surgery Surgical operation note |
|
84373-0
|
Orthopaedic surgery Telephone encounter Note |
|
80766-9
|
Orthopaedic surgery Plan of care note |
|
85943-9
|
Orthopaedic surgery Postoperative evaluation and management note |
|
68581-8
|
Orthopaedic surgery Preoperative evaluation and management note |
|
84374-8
|
Orthopaedic surgery procedure note |
|
68582-6
|
Orthopaedic surgery Progress note |
|
57175-2
|
Orthopaedic surgery Referral note |
|
89899-9
|
Orthopaedic surgery Telehealth Note |
|
68583-4
|
Orthopaedic surgery Transfer summary note |
|
82951-5
|
Orthopnea [ALSFRS-R] |
|
41853-3
|
Orthopoxvirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10700-3
|
Orthopoxvirus [Identifier] in Skin by Electron microscopy |
|
75465-5
|
Orthotics prosthetics Consult note |
|
84372-2
|
Orthotics prosthetics Education note |
|
75466-3
|
Orthotics prosthetics Note |
|
84370-6
|
Orthotics prosthetics Outpatient Note |
|
84369-8
|
Orthotics prosthetics Telephone encounter Note |
|
84371-4
|
Orthotics prosthetics Patient's home Note |
|
79790-2
|
Oscillatory potentials Left retina by ERG |
|
79789-4
|
Oscillatory potentials Right retina by ERG |
|
60440-5
|
Oseltamivir [Susceptibility] by Genotype method |
|
60441-3
|
Oseltamivir+Zanamivir [Susceptibility] by Genotype method |
|
26748-4
|
Osmium [Mass/volume] in Blood |
|
17392-2
|
Osmium [Mass/volume] in Urine |
|
33264-3
|
Osmol gap of Serum or Plasma |
|
73571-2
|
Osmol gap of Stool |
|
57372-5
|
Osmolality of 12 hour Urine |
|
94004-9
|
Osmolality of Serum or Plasma--1 hour post dose vasopressin |
|
94005-6
|
Osmolality of Urine--1 hour post dose vasopressin |
|
2694-8
|
Osmolality of 24 hour Urine |
|
94013-0
|
Osmolality of Serum or Plasma--2 hours post dose vasopressin |
|
94014-8
|
Osmolality of Urine--2 hours post dose vasopressin |
|
2689-8
|
Osmolality of Amniotic fluid |
|
55361-0
|
Osmolality of Urine--baseline |
|
55960-9
|
Osmolality of Dialysis fluid |
|
15200-9
|
Osmolality of Body fluid |
|
17794-9
|
Osmolality of Hyperal solution |
|
58852-5
|
Osmolality of Urine--1.5 hours post fluid fast |
|
1607-1
|
Osmolality of Urine--12 hours post fluid fast |
|
93990-0
|
Osmolality of Serum or Plasma--1 hour post fluid fast |
|
55359-4
|
Osmolality of Urine--1 hour post fluid fast |
|
93991-8
|
Osmolality of Serum or Plasma--2 hours post fluid fast |
|
55358-6
|
Osmolality of Urine--2 hours post fluid fast |
|
58853-3
|
Osmolality of Urine--30 minutes post fluid fast |
|
93992-6
|
Osmolality of Serum or Plasma--3 hours post fluid fast |
|
55357-8
|
Osmolality of Urine--3 hours post fluid fast |
|
93993-4
|
Osmolality of Serum or Plasma--4 hours post fluid fast |
|
55354-5
|
Osmolality of Urine--4 hours post fluid fast |
|
93994-2
|
Osmolality of Serum or Plasma--5 hours post fluid fast |
|
55356-0
|
Osmolality of Urine--5 hours post fluid fast |
|
93995-9
|
Osmolality of Serum or Plasma--6 hours post fluid fast |
|
55360-2
|
Osmolality of Urine--6 hours post fluid fast |
|
93996-7
|
Osmolality of Serum or Plasma--7 hours post fluid fast |
|
55355-2
|
Osmolality of Urine--7 hours post fluid fast |
|
1608-9
|
Osmolality of Urine--8 hours post fluid fast |
|
2690-6
|
Osmolality of Pleural fluid |
|
2691-4
|
Osmolality of Peritoneal fluid |
|
2692-2
|
Osmolality of Serum or Plasma |
|
18182-6
|
Osmolality of Serum or Plasma by calculation |
|
57731-2
|
Osmolality of Urine--2nd specimen |
|
57732-0
|
Osmolality of Urine--3rd specimen |
|
2693-0
|
Osmolality of Stool |
|
49001-1
|
Osmolality of Sweat |
|
2695-5
|
Osmolality of Urine |
|
48148-1
|
Osmolality of Urine by calculation |
|
48149-9
|
Osmolality.urine/Osmolality.serum |
|
2696-3
|
Osmolality of Unspecified specimen |
|
85382-0
|
Osmolarity in Tear |
|
57012-7
|
Osteoblasts/100 cells in Bone marrow by Manual |
|
21435-3
|
Osteocalcin.bovine [Mass/volume] in Serum or Plasma |
|
2697-1
|
Osteocalcin [Mass/volume] in Serum or Plasma |
|
35218-7
|
Osteocalcin [Mass or Moles/volume] in Serum or Plasma |
|
15084-7
|
Osteocalcin [Moles/volume] in Serum or Plasma |
|
74995-2
|
Osteocalcin [Z-score] in Serum or Plasma |
|
52052-8
|
Osteogenesis stimulator attachment |
|
2698-9
|
Osteonectin [Mass/volume] in Plasma |
|
90265-0
|
Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment |
|
46588-0
|
Ostomy for bowel elimination [OASIS] |
|
86471-0
|
Ostomy for bowel elimination in the last 14 days [CMS Assessment] |
|
34855-7
|
Occupational therapy Consult note |
|
78416-5
|
Occupational therapy Discharge instructions |
|
84393-8
|
Occupational therapy Discharge summary |
|
78383-7
|
Occupational therapy Discharge teaching note |
|
78452-0
|
Occupational therapy Education note |
|
78461-1
|
Occupational therapy Flowsheet |
|
68570-1
|
Occupational therapy Hospital Consult note |
|
68571-9
|
Occupational therapy Hospital Letter |
|
84397-9
|
Occupational therapy Hospital Note |
|
18734-4
|
Occupational therapy Initial evaluation note |
|
84430-8
|
Occupational therapy Interdisciplinary Note |
|
84398-7
|
Occupational therapy Long term care facility Consult note |
|
84399-5
|
Occupational therapy Long term care facility Note |
|
28578-3
|
Occupational therapy Note |
|
84400-1
|
Occupational therapy Outpatient Note |
|
84402-7
|
Occupational therapy Telephone encounter Note |
|
80758-6
|
Occupational therapy Plan of care note |
|
78477-7
|
Occupational therapy procedure note |
|
11507-1
|
Occupational therapy Progress note |
|
84394-6
|
Occupational therapy Patient's home Consult note |
|
84395-3
|
Occupational therapy Patient's home Initial evaluation note |
|
84396-1
|
Occupational therapy Patient's home Note |
|
57148-9
|
Occupational therapy Referral note |
|
84401-9
|
Occupational therapy Risk assessment and screening note |
|
68569-3
|
Occupational therapy Transfer summary note |
|
87568-2
|
Ochratoxin A [Mass/mass] in Unspecified specimen |
|
21721-6
|
OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
43233-6
|
OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21722-4
|
OTC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
81296-6
|
Other genomic reference sequence coding system OID |
|
81295-8
|
Other transcript reference sequence coding system OID |
|
88308-2
|
Other alarm used during 7 day assessment period [CMS Assessment] |
|
44944-7
|
Other alert |
|
46641-7
|
Other alleged impairments [RFC] |
|
46745-6
|
Other amino acidopathies newborn screen interpretation |
|
55617-5
|
Other Antibiotic [Susceptibility] by Gradient strip |
|
45187-2
|
Other Antibiotic [Susceptibility] by Disk diffusion (KB) |
|
21070-8
|
Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
59833-4
|
Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC) |
|
44433-1
|
Other Antibiotic [Mass/volume] in Serum or Plasma --peak |
|
15337-9
|
Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak |
|
23816-2
|
Other Antibiotic [Mass/volume] in Serum or Plasma |
|
23658-8
|
Other Antibiotic [Susceptibility] |
|
15336-1
|
Other Antibiotic [Susceptibility] by Serum bactericidal titer |
|
44434-9
|
Other Antibiotic [Mass/volume] in Serum or Plasma --trough |
|
15338-7
|
Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough |
|
34617-1
|
Other Antibiotic [Mass/volume] in Unspecified specimen |
|
54684-6
|
Other behavioral symptoms not directed toward others in last 7 days [CMS Assessment] |
|
10389-5
|
Blood product.other [Type] |
|
926-6
|
Blood product.other given [Volume] |
|
58443-3
|
Other cells [#/volume] in Blood by Automated count |
|
51585-8
|
Other cells [#/volume] in Blood by Manual count |
|
74450-8
|
Other cells [#/volume] in Cord blood |
|
75354-1
|
Other cells [#/volume] in Pleural fluid by Manual count |
|
75349-1
|
Other cells [#/volume] in Peritoneal fluid by Manual count |
|
75351-7
|
Other cells [#/volume] in Synovial fluid by Manual count |
|
55794-2
|
Other cells [#] in Cerebral spinal fluid by Manual count |
|
58472-2
|
Other cells [#] in Body fluid by Manual count |
|
75271-7
|
Other cells/100 cells in Lymph node by Manual count |
|
51581-7
|
Other cells/100 cells in Bone marrow |
|
21172-2
|
XXX cells/100 cells in Unspecified specimen |
|
50407-6
|
Other cells/100 leukocytes [Identifier] in Cerebral spinal fluid |
|
58409-4
|
Other cells/100 leukocytes in Blood by Automated count |
|
74451-6
|
Other cells/100 leukocytes in Blood from Fetus |
|
51586-6
|
Other cells/100 leukocytes in Blood by Manual count |
|
51927-2
|
Other cells/100 leukocytes in Bronchial specimen by Manual count |
|
75374-9
|
Other cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
91551-2
|
Other cells/100 leukocytes in Dialysis fluid by Manual count |
|
76350-8
|
Other cells/100 leukocytes in Body fluid |
|
75353-3
|
Other cells/100 leukocytes in Body fluid by Manual count |
|
75352-5
|
Other cells/100 leukocytes in Pericardial fluid by Manual count |
|
75356-6
|
Other cells/100 leukocytes in Pleural fluid by Manual count |
|
75350-9
|
Other cells/100 leukocytes in Peritoneal fluid by Manual count |
|
75355-8
|
Other cells/100 leukocytes in Synovial fluid by Manual count |
|
75375-6
|
Other cells/100 leukocytes in Sputum by Manual count |
|
50404-3
|
Other cells/100 leukocytes [Identifier] in Synovial fluid |
|
88865-1
|
Other Chemical [Identifier] in Unspecified specimen |
|
88867-7
|
Other Chemical [Mass/volume] in Unspecified specimen |
|
88866-9
|
Other Chemical [Mass/mass] in Unspecified specimen |
|
71193-7
|
Other children avoid playing with me because I am different in the past 7 days [FACIT] |
|
71276-0
|
Other children avoid playing with my child because s-he is different in the past 7 days [FACIT] |
|
75793-0
|
Other directives that have not otherwise been documented [Reported] |
|
80333-8
|
Other elements in Urine |
|
58441-7
|
Other elements in Urine sediment |
|
58442-5
|
Other elements [Identifier] in Urine sediment by Light microscopy |
|
46756-3
|
Other fatty acid oxidation disorders newborn screen interpretation |
|
67705-4
|
Other feeding types Narrative |
|
76472-0
|
Other health condition |
|
46760-5
|
Other hemoglobinopathies newborn screen interpretation |
|
67703-9
|
Other infant factors that affect newborn screening interpretation Narrative |
|
92706-1
|
Other intervention AndOr service plan to provide [Identifier] |
|
92561-0
|
Other intervention AndOr service provided [Identifier] |
|
90664-4
|
Other kids wanted to be my child's friend in past 7 days [PROMIS.PARENTPROXY] |
|
90673-5
|
Other kids wanted to be with my child in past 7 days [PROMIS.PARENTPROXY] |
|
90669-3
|
Other kids wanted to talk to my child in past 7 days [PROMIS.PARENTPROXY] |
|
67707-0
|
Other maternal factors that affect newborn screening interpretation Narrative |
|
85726-8
|
Other maternal symptoms of illness |
|
30964-1
|
Other medications |
|
85459-6
|
Other mental well-being concerns - visual analog rating [ePCAM] |
|
83333-5
|
Other mental well-being concerns [PCAM] |
|
45042-9
|
XXX microorganism Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
62202-7
|
XXX microorganism DNA [Identifier] in Isolate by NAA with probe detection |
|
62201-9
|
XXX microorganism DNA [Identifier] in Serum or Plasma by NAA with probe detection |
|
40972-2
|
XXX microorganism DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
40971-4
|
XXX microorganism DNA [Presence] in Urine by NAA with probe detection |
|
38347-1
|
XXX microorganism DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
35691-5
|
XXX microorganism DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40440-0
|
XXX microorganism serotype [Identifier] in Isolate by Agglutination |
|
84901-8
|
Other nodule plane [Anatomy] in Prostate tumor |
|
84899-4
|
Other nodules greater than 10mm in diameter [Presence] in Prostate tumor |
|
74227-0
|
Other observations in Bone marrow Narrative |
|
46751-4
|
Other organic acidemias newborn screen interpretation |
|
71455-0
|
Other organic condition related to intellectual disability and developmental disability status [MDSv3] |
|
71184-6
|
Other people avoid hanging out with me because I am different in the past 7 days [FACIT] |
|
71300-8
|
Other people avoid hanging out with me because of my illness history in the past 4 weeks [FACIT] |
|
71221-6
|
Other people avoid hanging out with my child because s-he is different in the past 4 weeks [FACIT] |
|
71248-9
|
Other people avoid hanging out with my child because s-he is different in the past 7 days [FACIT] |
|
81477-2
|
Other people have told me I seemed to have trouble remembering information in past 7 days [PROMIS] |
|
76747-5
|
Other people help me get information when I have a problem [PROMIS] |
|
71298-4
|
Other people pick on - tease me in the past 4 weeks [FACIT] |
|
71182-0
|
Other people pick on - tease me in the past 7 days [FACIT] |
|
71219-0
|
Other people pick on - tease my child in the past 4 weeks [FACIT] |
|
71272-9
|
Other people pick on - tease my child in the past 7 days [FACIT] |
|
86789-5
|
Other physical restraints used in bed during 7 day assessment period [CMS Assessment] |
|
86793-7
|
Other physical restraints used in chair or out of bed used during 7 day assessment period [CMS Assessment] |
|
18326-9
|
Microscopic observation [Identifier] in Cervix by Other stain |
|
18327-7
|
Microscopic observation [Identifier] in Duodenal fluid by Other stain |
|
18328-5
|
Microscopic observation [Identifier] in Body fluid by Other stain |
|
6471-7
|
Microscopic observation [Identifier] in Tissue by Other stain |
|
11546-9
|
Microscopic observation [Identifier] in Unspecified specimen by Other stain |
|
93071-9
|
Other things you are feeling bothered, upset or worried about [NuPDQ] |
|
74726-1
|
Other unique product identifier |
|
74713-9
|
Other unique product identifier [Type] |
|
30961-7
|
Other vaccines given within 4 weeks prior to vaccination that caused adverse reaction [Complex] Set |
|
76966-1
|
Others complained about my drinking in past 30D [PROMIS] |
|
76975-2
|
Others had trouble counting on me when I drank in past 30D [PROMIS] |
|
53884-3
|
OTOF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
84368-0
|
Otolaryngology Admission evaluation note |
|
80733-9
|
Otolaryngology Admission history and physical note |
|
83694-0
|
Otolaryngology Attending Admission evaluation note |
|
83695-7
|
Otolaryngology Attending Note |
|
83696-5
|
Otolaryngology Attending Preoperative evaluation and management note |
|
80732-1
|
Otolaryngology Checklist |
|
34816-9
|
Otolaryngology Consult note |
|
78575-8
|
Otolaryngology Diagnostic study note |
|
84367-2
|
Otolaryngology Discharge summary |
|
78612-9
|
Otolaryngology Education note |
|
78618-6
|
Otolaryngology Flowsheet |
|
84366-4
|
Otolaryngology History and physical note |
|
84365-6
|
Otolaryngology Hospital Note |
|
78649-1
|
Otolaryngology Initial evaluation note |
|
34817-7
|
Otolaryngology Note |
|
83590-0
|
Otolaryngology Nurse Note |
|
83591-8
|
Otolaryngology Nurse Outpatient Note |
|
84364-9
|
Otolaryngology Outpatient Note |
|
34818-5
|
Otolaryngology Surgical operation note |
|
84362-3
|
Otolaryngology Telephone encounter Note |
|
80778-4
|
Otolaryngology Plan of care note |
|
84363-1
|
Otolaryngology Postoperative evaluation and management note |
|
80734-7
|
Otolaryngology Preoperative evaluation and management note |
|
78655-8
|
Otolaryngology procedure note |
|
78669-9
|
Otolaryngology Progress note |
|
57176-0
|
Otolaryngology Referral note |
|
83769-0
|
Otolaryngology Resident Note |
|
89902-1
|
Otolaryngology Telehealth Note |
|
80735-4
|
Otolaryngology Transfer summary note |
|
4364-6
|
Ouabain [Mass] of Dose |
|
3881-0
|
Ouabain [Mass/volume] in Serum or Plasma |
|
82763-4
|
Outdoor activity |
|
82762-6
|
Outdoor activity --8 weeks pre symptom onset or diagnosis |
|
71460-0
|
Outpatient antibiotics prescribed in past month [ESRD] |
|
78025-4
|
Outpatient visit discharge disposition [NHCS] |
|
88644-0
|
Outpatient hospital Consult note |
|
88645-7
|
Outpatient hospital Discharge summary |
|
88646-5
|
Outpatient hospital Note |
|
81678-5
|
Output assessment [Interpretation] |
|
85213-7
|
Outreach note |
|
62488-2
|
Ova1 test [Presence] in Serum |
|
53352-1
|
Oval fat bodies (globules) [#/volume] in Urine by Computer assisted method |
|
72499-7
|
Oval fat bodies (globules) [#/area] in Stool by Microscopy low power field |
|
53354-7
|
Oval fat bodies (globules) [#/area] in Urine by Computer assisted method |
|
33222-1
|
Oval fat bodies (globules) [#/area] in Urine sediment by Automated count |
|
5788-5
|
Oval fat bodies (globules) [#/area] in Urine sediment by Microscopy high power field |
|
50228-6
|
Oval fat bodies (globules) [Presence] in Urine by Computer assisted method |
|
25158-7
|
Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy |
|
7556-4
|
Ovalbumin IgE Ab [Units/volume] in Serum |
|
15897-2
|
Ovalbumin IgE Ab RAST class [Presence] in Serum |
|
774-0
|
Ovalocytes [Presence] in Blood by Light microscopy |
|
12001-4
|
Ovarian artery - left Pulsatility index US.doppler |
|
12016-2
|
Ovarian artery - left Resistivity index US.doppler |
|
12137-6
|
Ovarian artery - left Systolic flow/Diastolic flow US.doppler |
|
11717-6
|
Ovarian artery - left Peak systolic flow velocity US.doppler |
|
11683-0
|
Ovarian artery - left Mean blood flow velocity US.doppler |
|
11658-2
|
Ovarian artery - left Minimal flow velocity US.doppler |
|
12002-2
|
Ovarian artery - right Pulsatility index US.doppler |
|
12017-0
|
Ovarian artery - right Resistivity index US.doppler |
|
12138-4
|
Ovarian artery - right Systolic flow/Diastolic flow US.doppler |
|
11718-4
|
Ovarian artery - right Peak systolic flow velocity US.doppler |
|
11684-8
|
Ovarian artery - right Mean blood flow velocity US.doppler |
|
11659-0
|
Ovarian artery - right Minimal flow velocity US.doppler |
|
17393-0
|
Ovary Ab [Presence] in Serum |
|
21436-1
|
Ovary Ab [Presence] in Serum by Immunofluorescence |
|
13120-1
|
Ovary Ab [Units/volume] in Serum |
|
33246-0
|
Ovary Ab [Titer] in Serum |
|
25725-3
|
Ovary Ab [Titer] in Serum by Immunofluorescence |
|
56962-4
|
Ovary IgG Ab [Presence] in Serum by Immunofluorescence |
|
31546-5
|
Ovary IgG Ab [Units/volume] in Serum |
|
26729-4
|
Ovary IgG Ab [Titer] in Serum by Immunofluorescence |
|
66116-5
|
Ovary Pathology biopsy report |
|
11846-3
|
Ovary largest follicle Maximum diameter US |
|
11829-9
|
Ovary - left Hilum-cortex diameter US |
|
11879-4
|
Ovary - left [#] Follicles US |
|
11840-6
|
Ovary - left Longitudinal diameter US |
|
11857-0
|
Ovary - left Thickeness US |
|
12164-0
|
Ovary - left Volume derived by US |
|
11847-1
|
Ovary - left largest follicle Maximum diameter US |
|
11830-7
|
Ovary - right Hilum-cortex diameter US |
|
11880-2
|
Ovary - right [#] Follicles US |
|
11841-4
|
Ovary - right Longitudinal diameter US |
|
11858-8
|
Ovary - right Thickeness US |
|
12165-7
|
Ovary - right Volume derived by US |
|
11848-9
|
Ovary - right largest follicle Maximum diameter US |
|
89865-0
|
Over the last week, on how many days has your or your child's skin been bleeding because of the eczema [POEM] |
|
89867-6
|
Over the last week, on how many days has your or your child's skin been cracked because of the eczema [POEM] |
|
89868-4
|
Over the last week, on how many days has your or your child's skin been flaking off because of the eczema [POEM] |
|
89863-5
|
Over the last week, on how many days has your or your child's skin been itchy because of eczema [POEM] |
|
89866-8
|
Over the last week, on how many days has your or your child's skin been weeping or oozing clear fluid because of the eczema [POEM] |
|
89869-2
|
Over the last week, on how many days has your or your child's skin felt dry or rough because of the eczema [POEM] |
|
89864-3
|
Over the last week, on how many nights has your or your child's sleep been disturbed because of the eczema [POEM] |
|
75833-4
|
Over the past week, are you able to bend down and pick up clothing from the floor [HAQ] |
|
75828-4
|
Over the past week, are you able to climb up five steps [HAQ] |
|
75824-3
|
Over the past week, are you able to cut your meat [HAQ] |
|
90034-0
|
Over the past week, are you able to deal with feelings of anxiety or being nervous [HAQ] |
|
90035-7
|
Over the past week, are you able to deal with feelings of depression or feeling blue [HAQ] |
|
75839-1
|
Over the past week, are you able to do chores such as vacuuming or yard work [HAQ] |
|
75848-2
|
Over the past week, are you able to do outside work (such as yard work) [HAQII] |
|
75820-1
|
Over the past week, are you able to dress yourself, including shoelaces and buttons [HAQ] |
|
90033-2
|
Over the past week, are you able to get a good night's sleep [HAQ] |
|
75838-3
|
Over the past week, are you able to get in and out of a car [HAQ] |
|
90030-8
|
Over the past week, are you able to get in and out of a car, bus, train, or airplane [HAQ] |
|
75823-5
|
Over the past week, are you able to get in and out of bed [HAQ] |
|
75831-8
|
Over the past week, are you able to get on and off the toilet [HAQ] |
|
75852-4
|
Over the past week, are you able to go up two or more flights of stairs [HAQII] |
|
75825-0
|
Over the past week, are you able to lift a full cup or glass to your mouth [HAQ] |
|
75850-8
|
Over the past week, are you able to lift heavy objects [HAQII] |
|
75851-6
|
Over the past week, are you able to move heavy objects [HAQII] |
|
75826-8
|
Over the past week, are you able to open a new milk carton [HAQ] |
|
75834-2
|
Over the past week, are you able to open car doors [HAQ] |
|
75835-9
|
Over the past week, are you able to open jars which have been previously opened [HAQ] |
|
90032-4
|
Over the past week, are you able to participate in recreational activities and sports as you would like, if you wish [HAQ] |
|
75832-6
|
Over the past week, are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head [HAQ] |
|
75837-5
|
Over the past week, are you able to run errands and shop [HAQ] |
|
75821-9
|
Over the past week, are you able to shampoo your hair [HAQ] |
|
75822-7
|
Over the past week, are you able to stand up from a straight chair [HAQ] |
|
75830-0
|
Over the past week, are you able to take a tub bath [HAQ] |
|
75836-7
|
Over the past week, are you able to turn faucets on and off [HAQ] |
|
75849-0
|
Over the past week, are you able to wait in line for 15 minutes [HAQII] |
|
75827-6
|
Over the past week, are you able to walk outdoors on flat ground [HAQ] |
|
90031-6
|
Over the past week, are you able to walk two miles or three kilometers, if you wish [HAQ] |
|
75829-2
|
Over the past week, are you able to wash and dry your body [HAQ] |
|
94051-0
|
Over time, my practice helps me to meet my goals [PCPCM] |
|
94050-2
|
Over time, my practice helps me to stay healthy [PCPCM] |
|
72352-8
|
Overall emotional well being over the past month [Reported] |
|
72353-6
|
Overall physical well being over the past month [Reported] |
|
54685-3
|
Overall presence of behavioral symptoms in last 7 days [CMS Assessment] |
|
72354-4
|
Overall quality of life over the past month [Reported] |
|
57206-5
|
Overall status [CMS Assessment] |
|
79772-0
|
Overall study interpretation Left retina by EOG |
|
79793-6
|
Overall study interpretation Left retina by ERG |
|
79771-2
|
Overall study interpretation Right retina by EOG |
|
79792-8
|
Overall study interpretation Right retina by ERG |
|
81306-3
|
Variables that apply to the overall study |
|
71940-1
|
Overall summary score [KCCQ] |
|
86924-8
|
Overall summary score [KCCQ-12] |
|
88474-2
|
Overall summary score [SAQ] |
|
91348-3
|
Overall, how bothersome has your back pain been in the last 2 weeks [STarT Back] |
|
90930-9
|
Overbite teeth [#] |
|
90929-1
|
Overjet teeth [#] |
|
23321-3
|
Ovine herpesvirus 2 Ab [Presence] in Serum |
|
23322-1
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Complement fixation |
|
23325-4
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Immunoassay |
|
23324-7
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Immunofluorescence |
|
23326-2
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Immune stain |
|
23327-0
|
Ovine herpesvirus 2 DNA [Presence] in Tissue by NAA with probe detection |
|
7557-2
|
Ovomucoid IgE Ab [Units/volume] in Serum |
|
15898-0
|
Ovomucoid IgE Ab RAST class [Presence] in Serum |
|
11976-8
|
Ovulation date |
|
71499-8
|
Owner Dialysis facility [ESRD] |
|
58018-3
|
Oxabolone [Presence] in Urine |
|
4365-3
|
Oxacillin [Mass] of Dose |
|
73229-7
|
Oxacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73228-9
|
Oxacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7039-1
|
Oxacillin [Susceptibility] by Gradient strip |
|
384-8
|
Oxacillin [Susceptibility] by Disk diffusion (KB) |
|
383-0
|
Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
382-2
|
Oxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3882-8
|
Oxacillin [Mass/volume] in Serum or Plasma |
|
18961-3
|
Oxacillin [Susceptibility] |
|
385-5
|
Oxacillin [Susceptibility] by Serum bactericidal titer |
|
25265-0
|
Oxacillin [Mass/volume] in Unspecified specimen |
|
57373-3
|
Oxalate [Mass/volume] in 12 hour Urine |
|
57375-8
|
Oxalate [Mass/time] in 12 hour Urine |
|
27222-9
|
Oxalate [Mass/volume] in 24 hour Urine |
|
2701-1
|
Oxalate [Mass/time] in 24 hour Urine |
|
34349-1
|
Oxalate [Moles/volume] in 24 hour Urine |
|
14862-7
|
Oxalate [Moles/time] in 24 hour Urine |
|
57374-1
|
Oxalate [Mass/volume] in 2 hour Urine |
|
2702-9
|
Oxalate renal clearance in 24 hour Urine and Serum or Plasma |
|
47715-8
|
Oxalate [Moles/volume] in Dialysis fluid |
|
20928-8
|
Oxalate [Mass/mass] in Plant |
|
2699-7
|
Oxalate [Mass/volume] in Serum or Plasma |
|
15085-4
|
Oxalate [Moles/volume] in Serum or Plasma |
|
12798-5
|
Oxalate [Mass/volume] in Urine --10th specimen post XXX challenge |
|
12790-2
|
Oxalate [Mass/volume] in Urine --2nd specimen post XXX challenge |
|
12791-0
|
Oxalate [Mass/volume] in Urine --3rd specimen post XXX challenge |
|
12792-8
|
Oxalate [Mass/volume] in Urine --4th specimen post XXX challenge |
|
12793-6
|
Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge |
|
12794-4
|
Oxalate [Mass/volume] in Urine --6th specimen post XXX challenge |
|
12795-1
|
Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge |
|
12796-9
|
Oxalate [Mass/volume] in Urine --8th specimen post XXX challenge |
|
12797-7
|
Oxalate [Mass/volume] in Urine --9th specimen post XXX challenge |
|
14861-9
|
Oxalate [Presence] in Stone |
|
20927-0
|
Oxalate [Mass/mass] in Tissue |
|
26796-3
|
Oxalate [Presence] in Urine |
|
2700-3
|
Oxalate [Mass/volume] in Urine |
|
15086-2
|
Oxalate [Moles/volume] in Urine |
|
55961-7
|
Oxalate [Moles/volume] in Water |
|
13788-5
|
Oxalate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13483-3
|
Oxalate/Creatinine [Mass Ratio] in Urine |
|
34350-9
|
Oxalate/Creatinine [Molar ratio] in Urine |
|
73227-1
|
Oxaliplatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73226-3
|
Oxaliplatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
38325-7
|
Oxamyl [Mass/volume] in Water |
|
3885-1
|
Oxandrolone [Mass/time] in 24 hour Urine |
|
4366-1
|
Oxandrolone [Mass] of Dose |
|
3883-6
|
Oxandrolone [Presence] in Urine |
|
3884-4
|
Oxandrolone [Mass/volume] in Urine |
|
87785-2
|
Oxaprozin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
59726-0
|
Oxazepam [Mass/volume] in Blood by Confirmatory method |
|
59725-2
|
Oxazepam [Mass/volume] in Blood |
|
79253-1
|
Oxazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19641-0
|
Oxazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19640-2
|
Oxazepam cutoff [Mass/volume] in Urine for Screen method |
|
4367-9
|
Oxazepam [Mass] of Dose |
|
59728-6
|
Oxazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59727-8
|
Oxazepam [Mass/volume] in Body fluid |
|
61088-1
|
Oxazepam [Presence] in Gastric fluid |
|
94107-0
|
Oxazepam glucuronide [Presence] in Urine by Screen method |
|
26839-1
|
Oxazepam [Mass/mass] in Hair |
|
59729-4
|
Oxazepam [Mass/mass] in Meconium by Confirmatory method |
|
26933-2
|
Oxazepam [Mass/mass] in Meconium |
|
72613-3
|
Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72614-1
|
Oxazepam [Presence] in Saliva (oral fluid) |
|
72378-3
|
Oxazepam [Mass/volume] in Saliva (oral fluid) |
|
59730-2
|
Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
12362-0
|
Oxazepam [Presence] in Serum or Plasma |
|
35629-5
|
Oxazepam [Mass/volume] in Serum or Plasma by Screen method |
|
3886-9
|
Oxazepam [Mass/volume] in Serum or Plasma |
|
29655-8
|
Oxazepam [Moles/volume] in Serum or Plasma |
|
59731-0
|
Oxazepam [Mass/mass] in Stool by Confirmatory method |
|
12381-0
|
Oxazepam [Presence] in Stool |
|
27238-5
|
Oxazepam [Mass/mass] in Stool |
|
59732-8
|
Oxazepam [Mass/mass] in Tissue |
|
82935-8
|
Oxazepam [Mass/volume] in Serum or Plasma --trough |
|
16201-6
|
Oxazepam [Mass/volume] in Urine by Confirmatory method |
|
70214-2
|
Oxazepam [Moles/volume] in Urine by Confirmatory method |
|
12361-2
|
Oxazepam [Presence] in Urine |
|
19639-4
|
Oxazepam [Presence] in Urine by Confirmatory method |
|
19638-6
|
Oxazepam [Presence] in Urine by Screen method |
|
3887-7
|
Oxazepam [Mass/volume] in Urine |
|
26850-8
|
Oxazepam [Mass/volume] in Vitreous fluid |
|
61055-0
|
Oxazepam [Presence] in Unspecified specimen |
|
48962-5
|
Oxazepam [Mass/volume] in Unspecified specimen |
|
77336-6
|
Oxazepam [Moles/volume] in Unspecified specimen |
|
58368-2
|
Oxazepam/Creatinine [Mass Ratio] in Urine |
|
59948-0
|
OXcarbazepine [Moles/volume] in Gastric fluid |
|
73224-8
|
OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73225-5
|
OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35331-8
|
OXcarbazepine [Mass/volume] in Serum or Plasma |
|
25726-1
|
OXcarbazepine [Moles/volume] in Serum or Plasma |
|
72659-6
|
OXcarbazepine [Mass/volume] in Serum or Plasma --trough |
|
88110-2
|
OXcarbazepine [Moles/volume] in Serum or Plasma --trough |
|
59947-2
|
OXcarbazepine [Moles/volume] in Urine |
|
60326-6
|
OXcarbazepine [Moles/volume] in Unspecified specimen |
|
55588-8
|
OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
|
4368-7
|
Oxedrine [Mass] of Dose |
|
3888-5
|
Oxedrine [Mass/volume] in Urine |
|
6196-0
|
Ox-eye daisy IgE Ab [Units/volume] in Serum |
|
15675-2
|
Ox-eye daisy IgE Ab RAST class [Presence] in Serum |
|
56341-1
|
Ox-eye daisy IgG4 Ab [Mass/volume] in Serum |
|
58714-7
|
Oxidants [Presence] in Urine |
|
57801-3
|
Oximetry site Blood |
|
60112-0
|
Oxipurinol [Mass/volume] in Blood |
|
79691-2
|
Oxipurinol [Moles/volume] in Cerebral spinal fluid |
|
13908-9
|
Oxipurinol [Mass/volume] in Serum or Plasma |
|
25492-0
|
Oxipurinol [Moles/volume] in Serum or Plasma |
|
75132-1
|
Oxipurinol/Creatinine [Molar ratio] in Urine |
|
55698-5
|
Oxolinate [Susceptibility] by Gradient strip |
|
55697-7
|
Oxolinate [Susceptibility] by Disk diffusion (KB) |
|
55695-1
|
Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55696-9
|
Oxolinate [Susceptibility] |
|
3892-7
|
Oxprenolol [Mass/time] in 24 hour Urine |
|
4369-5
|
Oxprenolol [Mass] of Dose |
|
3889-3
|
Oxprenolol [Mass/volume] in Serum or Plasma |
|
55561-5
|
Oxprenolol [Moles/volume] in Serum or Plasma |
|
3890-1
|
Oxprenolol [Presence] in Urine |
|
3891-9
|
Oxprenolol [Mass/volume] in Urine |
|
42721-1
|
Oxacillin Resistant Staphylococcus sp isolate [Presence] in Isolate by Latex agglutination |
|
12408-1
|
Oxybutynin [Mass/volume] in Serum or Plasma |
|
12994-0
|
Oxychlordane [Mass/volume] in Blood |
|
60108-8
|
Oxychlordane [Mass/volume] in Body fluid |
|
21437-9
|
Oxychlordane [Mass/volume] in Serum or Plasma |
|
60109-6
|
Oxychlordane [Mass/mass] in Tissue |
|
17394-8
|
Oxychlordane [Mass/volume] in Urine |
|
78767-1
|
oxyCODONE [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
72402-1
|
oxyCODONE [Presence] in Blood by Screen method |
|
79255-6
|
oxyCODONE cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19645-1
|
oxyCODONE cutoff [Mass/volume] in Urine for Confirmatory method |
|
19644-4
|
oxyCODONE cutoff [Mass/volume] in Urine for Screen method |
|
4370-3
|
oxyCODONE [Mass] of Dose |
|
46256-4
|
oxyCODONE Free [Presence] in Serum or Plasma by Screen method |
|
12789-4
|
oxyCODONE Free [Mass/volume] in Serum or Plasma |
|
27293-0
|
oxyCODONE Free [Mass/mass] in Stool |
|
46973-4
|
oxyCODONE Free [Mass/volume] in Urine by Confirmatory method |
|
51954-6
|
oxyCODONE Free [Mass/volume] in Urine |
|
14863-5
|
oxyCODONE [Presence] in Gastric fluid |
|
73753-6
|
oxyCODONE [Presence] in Hair |
|
26722-9
|
oxyCODONE [Mass/mass] in Hair |
|
73222-2
|
oxyCODONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73223-0
|
oxyCODONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68543-8
|
oxyCODONE [Mass/mass] in Meconium by Confirmatory method |
|
73996-1
|
oxyCODONE [Presence] in Meconium by Screen method |
|
26869-8
|
oxyCODONE [Mass/mass] in Meconium |
|
72750-3
|
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74657-8
|
oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method |
|
69356-4
|
oxyCODONE [Presence] in Saliva (oral fluid) by Screen method |
|
72751-1
|
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method |
|
13576-4
|
oxyCODONE [Presence] in Serum or Plasma |
|
77730-0
|
oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
50021-5
|
oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method |
|
3893-5
|
oxyCODONE [Mass/volume] in Serum or Plasma |
|
16249-5
|
oxyCODONE [Mass/volume] in Urine by Confirmatory method |
|
70215-9
|
oxyCODONE [Moles/volume] in Urine by Confirmatory method |
|
10998-3
|
oxyCODONE [Presence] in Urine |
|
19643-6
|
oxyCODONE [Presence] in Urine by Confirmatory method |
|
19642-8
|
oxyCODONE [Presence] in Urine by Screen method |
|
11246-6
|
oxyCODONE [Mass/volume] in Urine |
|
32101-8
|
oxyCODONE [Presence] in Unspecified specimen |
|
57865-8
|
oxyCODONE [Moles/volume] in Unspecified specimen |
|
78873-7
|
oxyCODONE [Z-score] in Urine |
|
58395-5
|
oxyCODONE/Creatinine [Mass Ratio] in Urine |
|
73221-4
|
oxyCODONE+Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73220-6
|
oxyCODONE+Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60276-3
|
oxyCODONE+oxyMORphone cutoff [Mass/volume] in Urine for Screen method |
|
91044-8
|
oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method |
|
91032-3
|
oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method |
|
74658-6
|
oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
71430-3
|
oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method |
|
77731-8
|
oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method |
|
77732-6
|
oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method |
|
91053-9
|
oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method |
|
61197-0
|
oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method |
|
58430-0
|
oxyCODONE+oxyMORphone [Presence] in Urine by Screen method |
|
89014-5
|
Oxygen was used for preoxygenation |
|
75610-6
|
Oxygen therapy at arrival |
|
72263-7
|
Oxyhemoglobin [Moles/volume] in Cerebral spinal fluid |
|
11559-2
|
Fractional oxyhemoglobin in Blood |
|
2714-4
|
Fractional oxyhemoglobin in Arterial blood |
|
2715-1
|
Fractional oxyhemoglobin in Capillary blood |
|
30370-1
|
Fractional oxyhemoglobin in Arterial cord blood |
|
30369-3
|
Fractional oxyhemoglobin in Venous cord blood |
|
34969-6
|
Fractional oxyhemoglobin in Mixed venous blood |
|
2716-9
|
Fractional oxyhemoglobin in Venous blood |
|
2717-7
|
Fractional oxyhemoglobin in Plasma |
|
71840-3
|
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Blood |
|
71839-5
|
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
|
71838-7
|
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood |
|
71837-9
|
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood |
|
71836-1
|
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood |
|
87437-0
|
Oxyhemoglobin [Mass/volume] in Plasma |
|
3896-8
|
Oxymesterone [Mass/time] in 24 hour Urine |
|
4371-1
|
Oxymesterone [Mass] of Dose |
|
3894-3
|
Oxymesterone [Presence] in Urine |
|
3895-0
|
Oxymesterone [Mass/volume] in Urine |
|
3899-2
|
Oxymetholone [Mass/time] in 24 hour Urine |
|
4372-9
|
Oxymetholone [Mass] of Dose |
|
3897-6
|
Oxymetholone [Presence] in Urine |
|
3898-4
|
Oxymetholone [Mass/volume] in Urine |
|
55416-2
|
Oxymetry special circumstances |
|
78765-5
|
oxyMORphone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine |
|
77780-5
|
oxyMORphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19650-1
|
oxyMORphone cutoff [Mass/volume] in Urine for Confirmatory method |
|
19649-3
|
oxyMORphone cutoff [Mass/volume] in Urine for Screen method |
|
46974-2
|
oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method |
|
46258-0
|
oxyMORphone Free [Presence] in Serum or Plasma by Screen method |
|
46975-9
|
oxyMORphone Free [Mass/volume] in Urine by Confirmatory method |
|
51736-7
|
oxyMORphone Free [Mass/volume] in Urine |
|
69028-9
|
oxyMORphone [Mass/mass] in Meconium by Confirmatory method |
|
72766-9
|
oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74659-4
|
oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
12342-2
|
oxyMORphone [Presence] in Serum or Plasma |
|
77729-2
|
oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
60467-8
|
oxyMORphone [Mass/volume] in Serum or Plasma |
|
17395-5
|
oxyMORphone [Mass/volume] in Urine by Confirmatory method |
|
11247-4
|
oxyMORphone [Presence] in Urine |
|
18325-1
|
oxyMORphone [Presence] in Urine by Confirmatory method |
|
19646-9
|
oxyMORphone [Presence] in Urine by Screen method |
|
19648-5
|
oxyMORphone [Mass/volume] in Urine |
|
78874-5
|
oxyMORphone [Z-score] in Urine |
|
58396-3
|
oxyMORphone/Creatinine [Mass Ratio] in Urine |
|
60110-4
|
Oxyphenbutazone [Mass/volume] in Blood |
|
4373-7
|
Oxyphenbutazone [Mass] of Dose |
|
3900-8
|
Oxyphenbutazone [Mass/volume] in Serum or Plasma |
|
55562-3
|
Oxyphenbutazone [Moles/volume] in Serum or Plasma |
|
60111-2
|
Oxyphenbutazone [Mass/volume] in Urine |
|
48043-4
|
Oxyphenisatin cutoff [Mass/mass] in Stool |
|
10891-0
|
Oxyphenisatin [Mass/mass] in Stool |
|
27031-4
|
Oxyphenisatin [Mass/volume] in Urine |
|
55699-3
|
Oxytetracycline [Susceptibility] by Gradient strip |
|
388-9
|
Oxytetracycline [Susceptibility] by Disk diffusion (KB) |
|
387-1
|
Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
386-3
|
Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
17396-3
|
Oxytetracycline [Mass/volume] in Serum or Plasma |
|
18962-1
|
Oxytetracycline [Susceptibility] |
|
389-7
|
Oxytetracycline [Susceptibility] by Serum bactericidal titer |
|
25266-8
|
Oxytetracycline [Mass/volume] in Unspecified specimen |
|
87595-5
|
Oxytetracycline [Mass/mass] in Unspecified specimen |
|
74364-1
|
Oxytocin [Mass/volume] in Saliva (oral fluid) |
|
75035-6
|
Oxytocin [Moles/volume] in Saliva (oral fluid) |
|
35415-9
|
Oxytocin [Units/volume] in Serum or Plasma |
|
2718-5
|
Oxytocin [Mass/volume] in Serum or Plasma |
|
17397-1
|
Oxytriphylline [Mass/volume] in Serum or Plasma |
|
7560-6
|
Oyster triggered histamine release [Units/volume] in Blood |
|
7558-0
|
Oyster IgE Ab [Units/volume] in Serum |
|
15899-8
|
Oyster IgE Ab RAST class [Presence] in Serum |
|
61292-9
|
Oyster IgE Ab/IgE total in Serum |
|
7559-8
|
Oyster IgG Ab [Units/volume] in Serum |
|
21438-7
|
Oyster IgG Ab RAST class [Presence] in Serum |
|
56342-9
|
Oyster IgG4 Ab [Mass/volume] in Serum |
|
60388-6
|
Oyster IgG Ab [Mass/volume] in Serum |
|
7517-6
|
Oyster Mushroom IgE Ab [Units/volume] in Serum |
|
1277-3
|
P Ab [Presence] in Serum or Plasma from Blood product unit |
|
1278-1
|
P Ab [Presence] in Serum or Plasma from Donor |
|
1279-9
|
P Ab [Presence] in Serum or Plasma |
|
76606-3
|
Pseudomonas aeruginosa regA gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76578-4
|
Pseudomonas aeruginosa regA gene [Presence] in XXX.swab by NAA with probe detection |
|
76593-3
|
Pseudomonas aeruginosa regA gene [#/mass] in XXX.tissue by NAA with probe detection |
|
63480-8
|
Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Unspecified specimen by Organism specific culture |
|
17502-6
|
Pseudomonas aeruginosa Ab [Units/volume] in Serum |
|
68976-0
|
Pseudomonas aeruginosa alkaline protease Ab [Titer] in Serum by Immunoassay |
|
92960-4
|
Pseudomonas aeruginosa DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85780-5
|
Pseudomonas aeruginosa DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93386-1
|
Pseudomonas aeruginosa DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92959-6
|
Pseudomonas aeruginosa DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61401-6
|
Pseudomonas aeruginosa DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
68977-8
|
Pseudomonas aeruginosa elastase Ab [Titer] in Serum by Immunoassay |
|
68978-6
|
Pseudomonas aeruginosa exotoxin A Ab [Titer] in Serum by Immunoassay |
|
88268-8
|
Pseudomonas aeruginosa sodA gene [Presence] by Probe in Positive blood culture |
|
6216-6
|
Phoma betae IgE Ab [Units/volume] in Serum |
|
15931-9
|
Phoma betae IgE Ab RAST class [Presence] in Serum |
|
50362-3
|
Phoma betae IgE Ab/IgE total in Serum |
|
30032-7
|
Phoma betae IgG Ab [Units/volume] in Serum |
|
33303-9
|
Phoma betae IgG Ab RAST class [Presence] in Serum |
|
35551-1
|
Phoma betae IgG Ab [Mass/volume] in Serum |
|
42970-4
|
Pseudallescheria boydii IgG Ab [Presence] in Serum |
|
34232-9
|
Pseudallescheria boydii IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
26640-3
|
Paracoccidioides brasiliensis Ab [Presence] in Serum |
|
7976-4
|
Paracoccidioides brasiliensis Ab [Units/volume] in Serum |
|
22435-2
|
Paracoccidioides brasiliensis Ab [Titer] in Serum |
|
5266-2
|
Paracoccidioides brasiliensis Ab [Titer] in Serum by Complement fixation |
|
6211-7
|
Penicillium brevicompactum IgE Ab [Units/volume] in Serum |
|
25493-8
|
Penicillium brevicompactum IgE Ab RAST class [Presence] in Serum |
|
63164-8
|
Penicillium brevicompactum IgG Ab [Mass/volume] in Serum |
|
56967-3
|
Plasmodium falciparum Ab [Presence] in Serum by Immunoassay |
|
5278-7
|
Plasmodium falciparum Ab [Units/volume] in Serum |
|
22441-0
|
Plasmodium falciparum Ab [Titer] in Serum |
|
21465-0
|
Plasmodium falciparum Ab [Titer] in Serum by Immunofluorescence |
|
10709-4
|
Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
|
76772-3
|
Plasmodium falciparum Ag [Presence] in Blood by Rapid immunoassay |
|
41447-4
|
Plasmodium falciparum DNA [Presence] in Blood by NAA with probe detection |
|
56515-0
|
Plasmodium falciparum IgG Ab [Presence] in Serum by Immunofluorescence |
|
51467-9
|
Plasmodium falciparum IgG Ab [Titer] in Serum |
|
49743-8
|
Plasmodium falciparum IgG Ab [Titer] in Serum by Immunofluorescence |
|
57683-5
|
Plasmodium falciparum IgM Ab [Presence] in Serum by Immunoassay |
|
53382-8
|
Plasmodium falciparum IgM Ab [Titer] in Serum |
|
51842-3
|
Plasmodium falciparum IgM Ab [Titer] in Serum by Immunofluorescence |
|
11187-2
|
Penicillium frequentans IgE Ab [Units/volume] in Serum |
|
15923-6
|
Penicillium frequentans IgE Ab RAST class [Presence] in Serum |
|
39580-6
|
Phoma herbarum Ab [Mass/volume] in Serum |
|
13240-7
|
Phoma herbarum IgE Ab [Units/volume] in Serum |
|
17445-8
|
Phoma herbarum IgG Ab [Units/volume] in Serum |
|
26952-2
|
Phoma herbarum IgG Ab [Mass/volume] in Serum |
|
88691-1
|
Pneumocystis jiroveci Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
31932-7
|
Pneumocystis jiroveci Ag [Presence] in Blood |
|
14514-4
|
Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence |
|
31933-5
|
Pneumocystis jiroveci Ag [Presence] in Bronchial specimen |
|
14522-7
|
Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
31934-3
|
Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid |
|
14515-1
|
Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31935-0
|
Pneumocystis jiroveci Ag [Presence] in Eye |
|
14519-3
|
Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence |
|
91824-3
|
Pneumocystis jiroveci Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
31936-8
|
Pneumocystis jiroveci Ag [Presence] in Nose |
|
14520-1
|
Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence |
|
31937-6
|
Pneumocystis jiroveci Ag [Presence] in Serum |
|
6518-5
|
Pneumocystis jiroveci Ag [Presence] in Serum by Immunofluorescence |
|
31938-4
|
Pneumocystis jiroveci Ag [Presence] in Semen |
|
14516-9
|
Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence |
|
31939-2
|
Pneumocystis jiroveci Ag [Presence] in Sputum |
|
6519-3
|
Pneumocystis jiroveci Ag [Presence] in Sputum by Immunofluorescence |
|
31940-0
|
Pneumocystis jiroveci Ag [Presence] in Stool |
|
14517-7
|
Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence |
|
31941-8
|
Pneumocystis jiroveci Ag [Presence] in Throat |
|
14518-5
|
Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence |
|
31942-6
|
Pneumocystis jiroveci Ag [Presence] in Urine |
|
14521-9
|
Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence |
|
31943-4
|
Pneumocystis jiroveci Ag [Presence] in Unspecified specimen |
|
700-5
|
Pneumocystis jiroveci Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
49438-5
|
Pneumocystis jiroveci DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection |
|
49436-9
|
Pneumocystis jiroveci DNA [#/volume] in Blood by NAA with probe detection |
|
49439-3
|
Pneumocystis jiroveci DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection |
|
88688-7
|
Pneumocystis jiroveci DNA [#/volume] in Lower respiratory specimen by NAA with probe detection |
|
49442-7
|
Pneumocystis jiroveci DNA [#/volume] in Bone marrow by NAA with probe detection |
|
49440-1
|
Pneumocystis jiroveci DNA [#/volume] in Serum or Plasma by NAA with probe detection |
|
49437-7
|
Pneumocystis jiroveci DNA [#/volume] in Tissue by NAA with probe detection |
|
49441-9
|
Pneumocystis jiroveci DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
89996-3
|
Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88690-3
|
Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
6521-9
|
Pneumocystis jiroveci DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88689-5
|
Pneumocystis jiroveci [Presence] in Lower respiratory specimen by Calcofluor white |
|
48055-8
|
Pneumocystis jiroveci [Presence] in Unspecified specimen by Calcofluor white |
|
70568-1
|
Plasmodium knowlesi DNA [Presence] in Blood by NAA with probe detection |
|
6305-7
|
Plasmodium malariae Ab [Units/volume] in Serum |
|
22442-8
|
Plasmodium malariae Ab [Titer] in Serum |
|
21466-8
|
Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence |
|
41448-2
|
Plasmodium malariae DNA [Presence] in Blood by NAA with probe detection |
|
9670-1
|
Plasmodium malariae IgG Ab [Units/volume] in Serum |
|
43593-3
|
Plasmodium malariae IgG Ab [Titer] in Serum |
|
49741-2
|
Plasmodium malariae IgG Ab [Titer] in Serum by Immunofluorescence |
|
9671-9
|
Plasmodium malariae IgM Ab [Units/volume] in Serum |
|
93387-9
|
Proteus mirabilis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
61400-8
|
Proteus mirabilis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22440-2
|
Pasteurella multocida Ab [Presence] in Serum |
|
15494-8
|
Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
|
31559-8
|
Pasteurella multocida Ab [Units/volume] in Serum |
|
23342-9
|
Pasteurella multocida Ab [Titer] in Serum |
|
23341-1
|
Pasteurella multocida Ab [Titer] in Serum by Immunoassay |
|
23343-7
|
Pasteurella multocida Ag [Titer] in Unspecified specimen by Agglutination |
|
31930-1
|
Pasteurella multocida Ag [Units/volume] in Unspecified specimen |
|
23344-5
|
Pasteurella multocida rRNA [Presence] in Unspecified specimen by Probe |
|
23763-6
|
Pasteurella multocida serotype [Identifier] in Isolate |
|
20935-3
|
Pasteurella multocida serotype [Identifier] in Isolate by Immune diffusion (ID) |
|
23345-2
|
Pasteurella multocida serotype [Identifier] in Unspecified specimen by Agglutination |
|
23346-0
|
Pasteurella multocida serotype [Identifier] in Unspecified specimen by Immunoelectrophoresis |
|
23347-8
|
Pasteurella multocida serotype [Identifier] in Unspecified specimen by Immunofluorescence |
|
23349-4
|
Pasteurella multocida toxin [Presence] in Unspecified specimen by Immunoassay |
|
29887-7
|
Pasteurella multocida type [Identifier] in Isolate |
|
63483-2
|
Penicillium notatum Ab [Presence] in Serum by Immune diffusion (ID) |
|
39579-8
|
Penicillium notatum Ab [Mass/volume] in Serum |
|
7585-3
|
Penicillium notatum triggered histamine release [Units/volume] in Blood |
|
6212-5
|
Penicillium notatum IgE Ab [Units/volume] in Serum |
|
15924-4
|
Penicillium notatum IgE Ab RAST class [Presence] in Serum |
|
7584-6
|
Penicillium notatum IgG Ab [Units/volume] in Serum |
|
33304-7
|
Penicillium notatum IgG Ab RAST class [Presence] in Serum |
|
26957-1
|
Penicillium notatum IgG Ab [Mass/volume] in Serum |
|
56355-1
|
Penicillium notatum IgG4 Ab [Mass/volume] in Serum |
|
48243-0
|
Penicillium notatum triggered leukotriene release [Mass/volume] by Leukocytes |
|
6560-7
|
Plasmodium ovale Ab [Units/volume] in Serum |
|
22443-6
|
Plasmodium ovale Ab [Titer] in Serum |
|
21467-6
|
Plasmodium ovale Ab [Titer] in Serum by Immunofluorescence |
|
41449-0
|
Plasmodium ovale DNA [Presence] in Blood by NAA with probe detection |
|
51468-7
|
Plasmodium ovale IgG Ab [Titer] in Serum |
|
49744-6
|
Plasmodium ovale IgG Ab [Titer] in Serum by Immunofluorescence |
|
5277-9
|
Penicillium roqueforti Ab [Units/volume] in Serum |
|
17426-8
|
Penicillium roqueforti IgE Ab [Units/volume] in Serum |
|
25967-1
|
Penicillium roqueforti IgE Ab RAST class [Presence] in Serum |
|
82198-3
|
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection |
|
70296-9
|
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with probe detection |
|
82304-7
|
Plesiomonas shigelloides [Presence] in Stool by Culture |
|
88044-3
|
P sup(k) Ab [Presence] in Serum or Plasma from Blood product unit |
|
88045-0
|
P sup(k) Ab [Presence] in Serum or Plasma from Donor |
|
88043-5
|
P sup(k) Ab [Presence] in Serum or Plasma |
|
88047-6
|
P sup(k) Ag [Presence] on Red Blood Cells from Blood product unit |
|
88048-4
|
P sup(k) Ag [Presence] on Red Blood Cells from Donor |
|
88046-8
|
P sup(k) Ag [Presence] on Red Blood Cells |
|
50680-8
|
Paecilomyces variottii IgE Ab [Units/volume] in Serum |
|
5280-3
|
Plasmodium vivax Ab [Units/volume] in Serum |
|
22444-4
|
Plasmodium vivax Ab [Titer] in Serum |
|
21468-4
|
Plasmodium vivax Ab [Titer] in Serum by Immunofluorescence |
|
10711-0
|
Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
|
31931-9
|
Plasmodium vivax Ag [Units/volume] in Blood |
|
41450-8
|
Plasmodium vivax DNA [Presence] in Blood by NAA with probe detection |
|
51469-5
|
Plasmodium vivax IgG Ab [Titer] in Serum |
|
49742-0
|
Plasmodium vivax IgG Ab [Titer] in Serum by Immunofluorescence |
|
9913-5
|
P' wave amplitude in lead AVF |
|
9889-7
|
P wave amplitude in lead AVF |
|
9914-3
|
P' wave amplitude in lead AVL |
|
9890-5
|
P wave amplitude in lead AVL |
|
9915-0
|
P' wave amplitude in lead AVR |
|
9891-3
|
P wave amplitude in lead AVR |
|
9916-8
|
P' wave amplitude in lead I |
|
9892-1
|
P wave amplitude in lead I |
|
9917-6
|
P' wave amplitude in lead II |
|
9893-9
|
P wave amplitude in lead II |
|
9918-4
|
P' wave amplitude in lead III |
|
9894-7
|
P wave amplitude in lead III |
|
9919-2
|
P' wave amplitude in lead V1 |
|
9895-4
|
P wave amplitude in lead V1 |
|
9920-0
|
P' wave amplitude in lead V2 |
|
9896-2
|
P wave amplitude in lead V2 |
|
9921-8
|
P' wave amplitude in lead V3 |
|
9897-0
|
P wave amplitude in lead V3 |
|
9922-6
|
P' wave amplitude in lead V4 |
|
9898-8
|
P wave amplitude in lead V4 |
|
9923-4
|
P' wave amplitude in lead V5 |
|
9899-6
|
P wave amplitude in in lead V5 |
|
9924-2
|
P' wave amplitude in lead V6 |
|
9900-2
|
P wave amplitude in lead V6 |
|
18516-5
|
P wave axis frontal plane Reference beat |
|
18506-6
|
P wave axis horizontal plane Reference beat |
|
8626-4
|
P wave axis |
|
8627-2
|
P wave duration |
|
9901-0
|
P wave duration in lead AVF |
|
9902-8
|
P wave duration in lead AVL |
|
9903-6
|
P wave duration in lead AVR |
|
9904-4
|
P wave duration in lead I |
|
9905-1
|
P wave duration in lead II |
|
9906-9
|
P wave duration in lead III |
|
9907-7
|
P wave duration in lead V1 |
|
9908-5
|
P wave duration in lead V2 |
|
9909-3
|
P wave duration in lead V3 |
|
9910-1
|
P wave duration in lead V4 |
|
9911-9
|
P wave duration in lead V5 |
|
9912-7
|
P wave duration in lead V6 |
|
18512-4
|
P wave offset [Time] Reference beat |
|
18511-6
|
P wave onset [Time] Reference beat |
|
87638-3
|
p,p'- Dichlorodiphenyldichloroethane [Mass/mass] in Unspecified specimen |
|
1286-4
|
P1 Ab [Presence] in Serum or Plasma from Blood product unit |
|
1287-2
|
P1 Ab [Presence] in Serum or Plasma from Donor |
|
1288-0
|
P1 Ab [Presence] in Serum or Plasma |
|
55337-0
|
P1 Ab [Titer] in Serum or Plasma |
|
1289-8
|
P1 Ag [Presence] on Red Blood Cells from Blood product unit |
|
1290-6
|
P1 Ag [Presence] on Red Blood Cells from Donor |
|
1291-4
|
P1 Ag [Presence] on Red Blood Cells |
|
49556-4
|
p16INK4a Ag [Presence] in Tissue by Immune stain |
|
88050-0
|
P2 phenotype [Presence] on Red Blood Cells from Blood product unit |
|
88051-8
|
P2 phenotype [Presence] on Red Blood Cells from Donor |
|
88049-2
|
P2 phenotype [Presence] on Red Blood Cells |
|
74118-1
|
P27 Ag [Presence] in Tissue by Immune stain |
|
74119-9
|
P504S Ag [Presence] in Tissue by Immune stain |
|
74487-0
|
P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain |
|
89006-1
|
p53 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
31149-8
|
P53 protein Ag/100 cells in Tissue by Immune stain |
|
14229-9
|
P53 protein Ag [Presence] in Tissue by Immune stain |
|
48678-7
|
P57 Ag [Presence] in Tissue by Immune stain |
|
2902-5
|
Pyrimidine-5'-Nucleotidase [Presence] in Blood |
|
2903-3
|
Pyrimidine-5'-Nucleotidase [Enzymatic activity/volume] in Blood |
|
44055-2
|
Pyrimidine-5'-Nucleotidase [Enzymatic activity/mass] in Blood |
|
74488-8
|
p63 and Smooth muscle myosin heavy chain and Cytokeratin 8 Ag [Identifier] in Tissue by Immune stain |
|
78525-3
|
Platelet aggregation arachidonate induced in Platelet rich plasma --1.6 mmol/L |
|
53568-2
|
Platelet aggregation arachidonate induced in Platelet rich plasma --500 ug/mL |
|
56007-8
|
Platelet aggregation arachidonate induced in Blood --500 umol/L |
|
56013-6
|
Platelet aggregation arachidonate induced ATP secretion in Blood --500 umol/L |
|
56012-8
|
Platelet aggregation arachidonate induced ATP secretion [Presence] in Blood --500 umol/L |
|
53814-0
|
Platelet aggregation arachidonate induced [Units/volume] in Blood |
|
5993-1
|
Platelet aggregation arachidonate induced in Platelet rich plasma |
|
33531-5
|
Platelet aggregation arachidonate induced in Control Platelet rich plasma |
|
24381-6
|
Platelet aggregation arachidonate induced [Presence] in Platelet rich plasma |
|
49011-0
|
Platelet aggregation arachidonate induced [Units/volume] in Platelet rich plasma |
|
24374-1
|
Platelet associated Ab [Presence] in Blood |
|
45141-9
|
Platelet associated Ab [Presence] in Blood by Flow cytometry (FC) |
|
20281-2
|
Pulmonary artery Acceleration slope by US |
|
83809-4
|
Physician assistant Admission evaluation note |
|
56006-0
|
Platelet aggregation ADP induced in Blood --10 umol/L |
|
79188-9
|
Platelet aggregation ADP induced in Platelet rich plasma --10 umol/L |
|
51728-4
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --10 umol/L |
|
53565-8
|
Platelet aggregation ADP induced in Platelet rich plasma --100 umol/mL |
|
78519-6
|
Platelet aggregation ADP induced in Platelet rich plasma --2 umol/L |
|
50945-5
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --2 umol/L |
|
78520-4
|
Platelet aggregation ADP induced in Platelet rich plasma --2.5 umol/L |
|
55797-5
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --2.5 umol/L |
|
50944-8
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --20 umol/L |
|
53563-3
|
Platelet aggregation ADP induced in Platelet rich plasma --20 umol/mL |
|
78521-2
|
Platelet aggregation ADP induced in Platelet rich plasma --4 umol/L |
|
50946-3
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --4 umol/L |
|
56005-2
|
Platelet aggregation ADP induced in Blood --5 umol/L |
|
78522-0
|
Platelet aggregation ADP induced in Platelet rich plasma --5 umol/L |
|
55798-3
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --5 umol/L |
|
53564-1
|
Platelet aggregation ADP induced in Platelet rich plasma --50 umol/mL |
|
56011-0
|
Platelet aggregation ADP induced ATP secretion in Blood --10 umol/L |
|
56003-7
|
Platelet aggregation ADP induced ATP secretion [Presence] in Blood --10 umol/L |
|
56002-9
|
Platelet aggregation ADP induced ATP secretion in Blood --5 umol/L |
|
56004-5
|
Platelet aggregation ADP induced ATP secretion [Presence] in Blood --5 umol/L |
|
53813-2
|
Platelet aggregation ADP induced [Units/volume] in Blood |
|
33518-2
|
Platelet aggregation ADP induced in Platelet rich plasma --High dose |
|
33528-1
|
Platelet aggregation ADP induced in Control Platelet rich plasma --High dose |
|
33519-0
|
Platelet aggregation ADP induced in Platelet rich plasma --Low dose |
|
33529-9
|
Platelet aggregation ADP induced in Control Platelet rich plasma --Low dose |
|
5992-3
|
Platelet aggregation ADP induced in Platelet rich plasma |
|
24377-4
|
Platelet aggregation ADP induced [Presence] in Platelet rich plasma |
|
49010-2
|
Platelet aggregation ADP induced [Units/volume] in Platelet rich plasma |
|
78688-9
|
Platelet aggregation adenosine diphosphate+prostaglandin E1 induced [Units/volume] in Blood |
|
76284-9
|
Pulmonary artery Blood pressure |
|
5994-9
|
Platelet aggregation calcium ionophore induced in Platelet rich plasma |
|
56008-6
|
Platelet aggregation collagen induced in Blood --1 ug/mL |
|
78526-1
|
Platelet aggregation collagen induced in Platelet rich plasma --1.25 ug/ml |
|
50947-1
|
Platelet aggregation collagen induced [Presence] in Platelet rich plasma --190 ug/mL |
|
56009-4
|
Platelet aggregation collagen induced in Blood --5 ug/mL |
|
78527-9
|
Platelet aggregation collagen induced in Platelet rich plasma --5 ug/mL |
|
53566-6
|
Platelet aggregation collagen induced in Platelet rich plasma --8.0 ug/mL |
|
56015-1
|
Platelet aggregation collagen induced ATP secretion in Blood --1 ug/mL |
|
56016-9
|
Platelet aggregation collagen induced ATP secretion [Presence] in Blood --1 ug/mL |
|
56014-4
|
Platelet aggregation collagen induced ATP secretion in Blood --5 ug/mL |
|
56017-7
|
Platelet aggregation collagen induced ATP secretion [Presence] in Blood --5 ug/mL |
|
78685-5
|
Platelet aggregation collagen induced [Units/volume] in Blood |
|
33520-8
|
Platelet aggregation collagen induced in Platelet rich plasma --High dose |
|
33671-9
|
Platelet aggregation collagen induced lag [Time] in Control Platelet rich plasma --High dose |
|
33670-1
|
Platelet aggregation collagen induced lag [Time] in Platelet rich plasma --High dose |
|
33521-6
|
Platelet aggregation collagen induced in Platelet rich plasma --Low dose |
|
5995-6
|
Platelet aggregation collagen induced in Platelet rich plasma |
|
49999-6
|
Platelet aggregation collagen induced [Identifier] in Platelet rich plasma |
|
24379-0
|
Platelet aggregation collagen induced [Presence] in Platelet rich plasma |
|
83807-8
|
Physician assistant Custodial care facility Note |
|
20282-0
|
Pulmonary artery Deceleration slope [Velocity] by US |
|
20283-8
|
Pulmonary artery Deceleration [Time] by US |
|
11807-5
|
Pulmonary artery Diameter US |
|
83810-2
|
Physician assistant Discharge summary |
|
53567-4
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --0.1 ug/mL |
|
93408-3
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L |
|
78523-8
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --100 umol/L |
|
40594-4
|
Platelet aggregation EPINEPHrine induced [Units/volume] in Platelet rich plasma --100 umol/L |
|
93409-1
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L |
|
40593-6
|
Platelet aggregation EPINEPHrine induced [Units/volume] in Platelet rich plasma --50 umol/L |
|
78524-6
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --6 umol/L |
|
5996-4
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma |
|
33530-7
|
Platelet aggregation EPINEPHrine induced in Control Platelet rich plasma |
|
24378-2
|
Platelet aggregation EPINEPHrine induced [Presence] in Platelet rich plasma |
|
83812-8
|
Physician assistant History and physical note |
|
83814-4
|
Physician assistant Hospital Note |
|
29496-7
|
Platelet associated IgA Ab [Presence] in Blood by Flow cytometry (FC) |
|
13064-1
|
Platelet associated IgA Ab [Units/volume] in Blood |
|
14012-9
|
Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) |
|
29497-5
|
Platelet associated IgG Ab [Presence] in Blood by Flow cytometry (FC) |
|
8089-5
|
Platelet associated IgG Ab [Units/volume] in Blood |
|
47008-8
|
Platelet associated IgG Ab [Presence] in Serum by Immunoassay |
|
33404-5
|
Platelet associated IgG Ab/IgM Ab [Ratio] in Blood |
|
14013-7
|
Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) |
|
29498-3
|
Platelet associated IgM Ab [Presence] in Blood by Flow cytometry (FC) |
|
8090-3
|
Platelet associated IgM Ab [Units/volume] in Blood |
|
83811-0
|
Physician assistant Long term care facility Note |
|
5997-2
|
Platelet aggregation norepinephrine induced in Platelet rich plasma |
|
83806-0
|
Physician assistant Note |
|
83808-6
|
Physician assistant Outpatient Note |
|
17994-5
|
Pulmonary artery Cardiac output by US |
|
13593-9
|
Platelet aggregation prostaglandin induced in Platelet rich plasma |
|
21027-8
|
Platelet aggregation [Interpretation] in Platelet poor plasma |
|
83813-6
|
Physician assistant Patient's home Note |
|
33672-7
|
Platelet aggregation.ristocetin+Control PPP induced in Platelet rich plasma |
|
33674-3
|
Platelet aggregation.ristocetin+Control PRP induced in Platelet poor plasma |
|
56027-6
|
Platelet aggregation ristocetin induced in Blood --1.0 mg/mL |
|
78528-7
|
Platelet aggregation ristocetin induced in Platelet rich plasma --1.25 mg/ml |
|
55800-7
|
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --1000 mg/L |
|
55344-6
|
Platelet aggregation ristocetin induced in Platelet rich plasma --1000 ug/mL |
|
55799-1
|
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --1125 mg/L |
|
33551-3
|
Platelet aggregation ristocetin induced in Platelet rich plasma --1200 ug/mL |
|
93702-9
|
Platelet aggregation ristocetin induced in Platelet rich plasma --15 ug/mL |
|
33550-5
|
Platelet aggregation ristocetin induced in Platelet rich plasma --1500 ug/mL |
|
49485-6
|
Platelet aggregation ristocetin induced in Platelet rich plasma --1800 ug/mL |
|
56010-2
|
Platelet aggregation ristocetin induced in Blood --250 ug/mL |
|
33554-7
|
Platelet aggregation ristocetin induced in Platelet rich plasma --300 ug/mL |
|
93410-9
|
Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL |
|
55801-5
|
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --500 mg/L |
|
79130-1
|
Platelet aggregation ristocetin induced in Platelet rich plasma --500 ug/mL |
|
33553-9
|
Platelet aggregation ristocetin induced in Platelet rich plasma --600 ug/mL |
|
87403-2
|
Platelet aggregation ristocetin induced in Platelet rich plasma --750 ug/mL |
|
53569-0
|
Platelet aggregation ristocetin induced in Platelet rich plasma --800 ug/mL |
|
33552-1
|
Platelet aggregation ristocetin induced in Platelet rich plasma --900 ug/mL |
|
78686-3
|
Platelet aggregation ristocetin induced [Units/volume] in Blood --High dose |
|
33522-4
|
Platelet aggregation ristocetin induced in Platelet rich plasma --High dose |
|
33532-3
|
Platelet aggregation ristocetin induced in Control Platelet rich plasma --High dose |
|
81125-7
|
Platelet aggregation.ristocetin inhibitor [Presence] in Platelet poor plasma |
|
78739-0
|
Platelet aggregation ristocetin induced [Units/volume] in Blood --Low dose |
|
33523-2
|
Platelet aggregation ristocetin induced in Platelet rich plasma --Low dose |
|
33533-1
|
Platelet aggregation ristocetin induced in Control Platelet rich plasma --Low dose |
|
5998-0
|
Platelet aggregation ristocetin induced in Platelet rich plasma |
|
24380-8
|
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma |
|
5999-8
|
Platelet aggregation serotonin induced in Platelet rich plasma |
|
56019-3
|
Platelet aggregation thrombin induced ATP secretion in Blood --1 U/mL |
|
56021-9
|
Platelet aggregation thrombin induced ATP secretion [Presence] in Blood --1 U/mL |
|
56020-1
|
Platelet aggregation thrombin induced ATP secretion in Blood --5 U/mL |
|
56018-5
|
Platelet aggregation thrombin induced ATP secretion [Presence] in Blood --5 U/mL |
|
6000-4
|
Platelet aggregation thrombin induced [Units threshold] in Platelet rich plasma |
|
78687-1
|
Platelet aggregation thrombin receptor activating peptide-6 induced [Units/volume] in Blood |
|
18173-5
|
Pulmonary artery Blood velocity-time integral by US.doppler |
|
13592-1
|
Platelet aggregation XXX induced in Platelet rich plasma |
|
35373-0
|
Platelet aggregation XXX induced in Platelet rich plasma from Donor |
|
34186-7
|
Para aminobenzoate [Mass/time] in 24 hour Urine |
|
9570-3
|
Para aminobenzoate [Mass/volume] in 6 hour Urine --6 hours post 500 mg bentiromide PO |
|
35504-0
|
Para aminobenzoate in 6 hour Urine --6 hours post XXX bentiromide PO |
|
40391-5
|
Para aminobenzoate free [Mass/volume] in Serum or Plasma |
|
18249-3
|
Para aminobenzoate [Mass/volume] in Serum or Plasma |
|
35355-7
|
PABPN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38406-5
|
PABPN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76000-9
|
Paced heart rate by EKG |
|
14038-4
|
Pacific Squid IgE Ab [Units/volume] in Serum |
|
16032-5
|
Pacific Squid IgE Ab RAST class [Presence] in Serum |
|
8628-0
|
Pacing interval Artificial cardiac pacemaker |
|
14302-4
|
Packed erythrocytes units available [#] |
|
51880-3
|
Packed erythrocytes units given [#] |
|
1298-9
|
Packed erythrocytes given [Volume] |
|
60114-6
|
PACLitaxel [Mass/volume] in Serum or Plasma |
|
10509-8
|
Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
|
10553-6
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
|
43718-6
|
Prostatic acid phosphatase [Presence] in Serum |
|
1714-5
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
|
20420-6
|
Prostatic acid phosphatase [Mass/volume] in Serum |
|
1713-7
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Semen |
|
16317-0
|
Prostatic acid phosphatase [Presence] in Vaginal fluid |
|
1712-9
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid |
|
8615-7
|
Premature atrial contractions |
|
46201-0
|
Porcine adenovirus Ab [Presence] in Serum |
|
43339-1
|
Porcine adenovirus Ab [Presence] in Serum by Immunofluorescence |
|
87381-0
|
Porcine adenovirus Ab [Titer] in Serum by Immunoassay |
|
23765-1
|
Porcine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
|
6197-8
|
Paecilomyces sp IgE Ab [Units/volume] in Serum |
|
63163-0
|
Paecilomyces sp IgG Ab [Mass/volume] in Serum |
|
2723-5
|
Para aminohippurate renal clearance in 24 hour Urine and Serum or Plasma |
|
49014-4
|
PAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
70245-6
|
PAH gene.p.Arg408Trp [Presence] in Blood or Tissue by Molecular genetics method |
|
2724-3
|
Para aminohippurate [Mass/volume] in Urine |
|
5980-8
|
Plasminogen activator inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5975-8
|
Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
22758-7
|
Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5974-1
|
Plasminogen activator inhibitor 1 [Units/volume] in Platelet poor plasma by Chromogenic method |
|
5976-6
|
Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
17467-2
|
Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5977-4
|
Plasminogen activator inhibitor 2 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5978-2
|
Plasminogen activator inhibitor 2 [Units/volume] in Platelet poor plasma by Chromogenic method |
|
80317-1
|
Pain assessment [Interpretation] |
|
54828-9
|
Pain assessment interview should be conducted [CMS Assessment] |
|
94085-8
|
Pain category |
|
54830-5
|
Pain frequency in last 5 days [CMS Assessment] |
|
54831-3
|
Pain has made it hard to sleep in last 5 days [CMS Assessment] |
|
82227-0
|
Pain intensity [NDI] |
|
77565-0
|
Pain interference score [BPI Short Form] |
|
83647-8
|
Pain medicine Nurse Note |
|
83648-6
|
Pain medicine Nurse Outpatient Note |
|
83653-6
|
Pain medicine Team Consult note |
|
83654-4
|
Pain medicine Team Note |
|
88639-0
|
Pain medicine Controlled substance agreement |
|
78567-5
|
Pain medicine Consult note |
|
68708-7
|
Pain medicine Diagnostic study note |
|
68709-5
|
Pain medicine Discharge summary |
|
83643-7
|
Pain medicine Emergency department Note |
|
78610-3
|
Pain medicine Education note |
|
78621-0
|
Pain medicine Flowsheet |
|
89433-7
|
Pain medicine Group counseling note |
|
68711-1
|
Pain medicine History and physical note |
|
68716-0
|
Pain medicine Hospital Consult note |
|
68717-8
|
Pain medicine Hospital Letter |
|
83644-5
|
Pain medicine Hospital Note |
|
78651-7
|
Pain medicine Initial evaluation note |
|
83645-2
|
Pain medicine Long term care facility Note |
|
83646-0
|
Pain medicine Medication management note |
|
34858-1
|
Pain medicine Note |
|
83649-4
|
Pain medicine Outpatient Initial evaluation note |
|
83650-2
|
Pain medicine Outpatient Note |
|
83651-0
|
Pain medicine Outpatient procedure note |
|
83655-1
|
Pain medicine Telephone encounter Note |
|
80764-4
|
Pain medicine Plan of care note |
|
68713-7
|
Pain medicine Preoperative evaluation and management note |
|
68714-5
|
Pain medicine procedure note |
|
78668-1
|
Pain medicine Progress note |
|
78672-3
|
Pain medicine Referral note |
|
83652-8
|
Pain medicine Risk assessment and screening note |
|
90714-7
|
Pain medicine Telehealth Consult note |
|
89885-8
|
Pain medicine Telehealth Note |
|
68715-2
|
Pain medicine Transfer summary note |
|
54829-7
|
Pain presence in last 5 days [CMS Assessment] |
|
80316-3
|
Pain scale [Type] |
|
72097-9
|
Pain score [HOOS] |
|
72102-7
|
Pain score [KOOS] |
|
79435-4
|
Pain score change [HOOS] |
|
79440-4
|
Pain score change [KOOS] |
|
72514-3
|
Pain severity - 0-10 verbal numeric rating [Score] - Reported |
|
54833-9
|
Pain severity in last 5 days [CMS Assessment] |
|
75893-8
|
Pain severity in the past week - 0-10 numeric rating [Reported] |
|
90036-5
|
Pain severity in the past week- 0-10 (0.5 increments) numeric rating [Reported] |
|
18019-0
|
Left pulmonary artery Diameter by US |
|
14168-9
|
Palatinase [Enzymatic activity/mass] in Tissue |
|
81314-7
|
Palatinase [Enzymatic activity/mass] in Small intestine Tissue |
|
81845-0
|
PALB2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
60117-9
|
Palladium [Mass/volume] in Blood |
|
51201-2
|
Palladium [Mass/volume] in Body fluid |
|
76648-5
|
Palladium [Mass/mass] in Hair |
|
50892-9
|
Palladium [Moles/mass] in Hair |
|
60118-7
|
Palladium [Mass/volume] in Red Blood Cells |
|
60119-5
|
Palladium [Mass/volume] in Serum or Plasma |
|
60120-3
|
Palladium [Mass/volume] in Urine |
|
78538-6
|
Palliative care Admission history and physical note |
|
78568-3
|
Palliative care Consult note |
|
84360-7
|
Palliative care Counseling note |
|
78579-0
|
Palliative care Discharge instructions |
|
78585-7
|
Palliative care Discharge summary |
|
78587-3
|
Palliative care Discharge teaching note |
|
78599-8
|
Palliative care Education note |
|
78636-8
|
Palliative care Flowsheet |
|
84359-9
|
Palliative care Group counseling note |
|
78643-4
|
Palliative care History and physical note |
|
78650-9
|
Palliative care Initial evaluation note |
|
84356-5
|
Palliative care Long term care facility Note |
|
85435-6
|
Palliative care Note |
|
84355-7
|
Palliative care Outpatient Note |
|
84350-8
|
Palliative care Telephone encounter Note |
|
80780-0
|
Palliative care Plan of care note |
|
82357-5
|
Palliative care procedure note |
|
78663-2
|
Palliative care Progress note |
|
84358-1
|
Palliative care Patient's home Consult note |
|
84357-3
|
Palliative care Patient's home Note |
|
78676-4
|
Palliative care Referral note |
|
84353-2
|
Palliative care Risk assessment and screening note |
|
90755-0
|
Palliative care Social worker Long term care facility Note |
|
90756-8
|
Palliative care Social worker Note |
|
90715-4
|
Palliative care Telehealth Consult note |
|
89886-6
|
Palliative care Telehealth Note |
|
78682-2
|
Palliative care Transfer summary note |
|
83705-4
|
Palliative care Attending Note |
|
83785-6
|
Palliative care Physician Note |
|
83641-1
|
Palliative care Nurse Note |
|
84354-0
|
Palliative care Pharmacist Note |
|
83770-8
|
Palliative care Resident Note |
|
84352-4
|
Palliative care Team Consult note |
|
84351-6
|
Palliative care Team Note |
|
75115-6
|
Palmitate (C16:0) [Entitic substance] in Red Blood Cells |
|
2719-3
|
Palmitate (C16:0) [Mass/volume] in Serum or Plasma |
|
35161-9
|
Palmitate (C16:0) [Moles/volume] in Serum or Plasma |
|
47641-6
|
Palmitate (C16:0)/Creatinine [Molar ratio] in Urine |
|
55873-4
|
Palmitate (C16:0)/Laurate (C12:0) [Molar ratio] in Serum or Plasma |
|
75111-5
|
Palmitoleate (C16:1w7) [Entitic substance] in Red Blood Cells |
|
35162-7
|
Palmitoleate (C16:1w7) [Moles/volume] in Serum or Plasma |
|
55965-8
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Amniotic fluid |
|
55964-1
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Cerebral spinal fluid |
|
53198-8
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS |
|
74600-8
|
Palmitoleylcarnitine (C16:1) [Enzymatic activity/mass] in Fibroblast |
|
30357-8
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Serum or Plasma |
|
55966-6
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Urine |
|
55963-3
|
Palmitoleylcarnitine (C16:1)/Creatinine [Molar ratio] in Urine |
|
59243-6
|
Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
59204-8
|
Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54325-6
|
Palmitoylcarnitine (C16) [Moles/volume] in Amniotic fluid |
|
41040-7
|
Palmitoylcarnitine (C16) [Moles/volume] in Blood |
|
54324-9
|
Palmitoylcarnitine (C16) [Moles/volume] in Cerebral spinal fluid |
|
53199-6
|
Palmitoylcarnitine (C16) [Moles/volume] in DBS |
|
74601-6
|
Palmitoylcarnitine (C16) [Enzymatic activity/mass] in Fibroblast |
|
18460-6
|
Palmitoylcarnitine (C16) [Mass/volume] in Serum or Plasma |
|
30356-0
|
Palmitoylcarnitine (C16) [Moles/volume] in Serum or Plasma |
|
55967-4
|
Palmitoylcarnitine (C16) [Moles/volume] in Urine |
|
88024-5
|
Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88008-8
|
Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
88015-3
|
Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
88009-6
|
Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54323-1
|
Palmitoylcarnitine (C16)/Creatinine [Molar ratio] in Urine |
|
25828-5
|
Palo verde IgE Ab [Units/volume] in Serum |
|
25728-7
|
Palo verde IgE Ab RAST class [Presence] in Serum |
|
12045-1
|
Cervix Study observation palpation |
|
12334-9
|
Para aminophenol [Mass/volume] in Urine |
|
27022-3
|
Para aminophenol/Creatinine [Mass Ratio] in Urine |
|
56659-6
|
Para aminophenol/Creatinine [Ratio] in Urine |
|
38718-3
|
Phthalic anhydride [Mass/volume] in Air |
|
92768-1
|
Candida albicans+glabrata+krusei+parapsilosis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
54158-1
|
Pancytokeratin Ab [Presence] in Serum by Immunofluorescence |
|
54159-9
|
Pancytokeratin Ab [Titer] in Serum by Immunofluorescence |
|
48679-5
|
Pancytokeratin Ag [Presence] in Tissue by Immune stain |
|
7601-8
|
Phthalic anhydride IgE Ab [Units/volume] in Serum |
|
15933-5
|
Phthalic anhydride IgE Ab RAST class [Presence] in Serum |
|
61297-8
|
Phthalic anhydride IgE Ab/IgE total in Serum |
|
18423-4
|
Phthalic anhydride IgG Ab [Units/volume] in Serum |
|
33302-1
|
Phthalic anhydride IgG Ab RAST class [Presence] in Serum |
|
35550-3
|
Phthalic anhydride IgG Ab [Mass/volume] in Serum |
|
18424-2
|
Phthalic anhydride IgM Ab [Units/volume] in Serum |
|
48190-3
|
Phthalic anhydride triggered leukotriene release [Mass/volume] by Leukocytes |
|
63571-4
|
Pancreatic islet cell Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
45171-6
|
Pancreatic islet cell Ab [Units/volume] in Serum by Immunofluorescence |
|
31547-3
|
Pancreatic islet cell Ab [Presence] in Serum |
|
5265-4
|
Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence |
|
8086-1
|
Pancreatic islet cell Ab [Units/volume] in Serum |
|
34652-8
|
Pancreatic islet cell Ab [Moles/volume] in Serum |
|
13927-9
|
Pancreatic islet cell Ab [Titer] in Serum |
|
45225-0
|
Pancreatic islet cell complement fixing Ab [Titer] in Serum by Immunofluorescence |
|
33563-8
|
Pancreatic islet cell IgG Ab [Units/volume] in Serum |
|
56687-7
|
Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence |
|
2721-9
|
Pancreatic polypeptide [Mass/volume] in Serum or Plasma |
|
55226-5
|
Pancreatic polypeptide [Moles/volume] in Serum or Plasma |
|
53029-5
|
Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence |
|
49503-6
|
Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence |
|
72522-6
|
p-ANCA formalin resistant IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
72521-8
|
p-ANCA formalin sensitive IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
37991-7
|
Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay |
|
30539-1
|
Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum |
|
17357-5
|
Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence |
|
8085-3
|
Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum |
|
32787-4
|
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum |
|
14278-6
|
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
|
66115-7
|
Pancreas Pathology biopsy report |
|
49013-6
|
Pancreastatin [Mass/volume] in Serum or Plasma |
|
60121-1
|
Pancuronium [Mass/volume] in Blood |
|
48284-4
|
Pancuronium triggered leukotriene release [Mass/volume] by Leukocytes |
|
60122-9
|
Pancuronium [Mass/volume] in Serum or Plasma |
|
60123-7
|
Pancuronium [Mass/mass] in Tissue |
|
60124-5
|
Pancuronium [Mass/volume] in Urine |
|
53823-1
|
Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
34508-2
|
PANK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41072-0
|
PANK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72980-6
|
Pantoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72979-8
|
Pantoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73219-8
|
Pantoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73218-0
|
Pantoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27351-6
|
Pantothenate [Presence] in Serum, Plasma or Blood |
|
2722-7
|
Pantothenate [Mass/volume] in Serum, Plasma or Blood |
|
75066-1
|
Pantothenate [Moles/volume] in Serum or Plasma |
|
75060-4
|
Pantothenate/Creatinine [Molar ratio] in Urine |
|
69995-9
|
Type of Positive airway pressure device |
|
69998-3
|
Positive airway pressure device Leak |
|
69993-4
|
Positive airway pressure device Vendor serial number |
|
69994-2
|
Positive airway pressure device Vendor software version |
|
69989-2
|
Positive airway pressure device usage 1 month mean |
|
69988-4
|
Positive airway pressure device usage 24 hour |
|
69992-6
|
Positive airway pressure device Vendor name |
|
5969-1
|
Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by Immunoassay |
|
69986-8
|
Pressure.continuous positive airway.95% 24 hour maximum Respiratory system |
|
10945-4
|
Papain IgE Ab [Units/volume] in Serum |
|
21439-5
|
Papain IgE Ab RAST class [Presence] in Serum |
|
50352-4
|
Papain IgE Ab/IgE total in Serum |
|
60125-2
|
Papaverine [Mass/volume] in Blood |
|
73216-4
|
Papaverine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73217-2
|
Papaverine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12550-0
|
Papaverine [Mass/volume] in Serum or Plasma |
|
60126-0
|
Papaverine [Mass/volume] in Urine |
|
6850-2
|
Papaya (Carica papaya) IgE Ab [Units/volume] in Serum |
|
15901-2
|
Papaya (Carica papaya) IgE Ab RAST class [Presence] in Serum |
|
56343-7
|
Papaya (Carica papaya) IgG4 Ab [Mass/volume] in Serum |
|
63131-7
|
Papaya (Carica papaya) IgG Ab [Mass/volume] in Serum |
|
7562-2
|
Paper IgE Ab [Units/volume] in Serum |
|
16104-2
|
Paper Mulberry IgE Ab [Units/volume] in Serum |
|
21399-1
|
Paper Mulberry IgE Ab RAST class [Presence] in Serum |
|
63436-0
|
Paper wasp recombinant (rPol d) 5 IgE Ab [Units/volume] in Serum |
|
82007-6
|
Paper wasp recombinant (rPol d) 5 IgE Ab RAST class [Presence] in Serum |
|
6198-6
|
Paper wasp IgE Ab [Units/volume] in Serum |
|
16080-4
|
Paper wasp IgE Ab RAST class [Presence] in Serum |
|
41204-9
|
Paper wasp IgE Ab/IgE total in Serum |
|
41235-3
|
Paper wasp IgE Ab [Mass/volume] in Serum |
|
6731-4
|
Paper wasp IgG Ab [Units/volume] in Serum |
|
56969-9
|
Paper wasp IgG4 Ab [Units/volume] in Serum |
|
56344-5
|
Paper wasp IgG4 Ab [Mass/volume] in Serum |
|
41219-7
|
Paper wasp IgG Ab [Mass/volume] in Serum |
|
48183-8
|
Paper wasp triggered leukotriene release [Mass/volume] by Leukocytes |
|
76348-2
|
Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma |
|
45273-0
|
Pregnancy associated plasma protein A multiple of the median [Percentile] |
|
32123-2
|
Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma |
|
32046-5
|
Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma |
|
48407-1
|
Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma |
|
7795-8
|
Pappenheimer bodies [Presence] in Blood by Light microscopy |
|
7563-0
|
Paprika IgE Ab [Units/volume] in Serum |
|
15902-0
|
Paprika IgE Ab RAST class [Presence] in Serum |
|
61239-0
|
Paprika IgE Ab/IgE total in Serum |
|
41848-3
|
Paprika IgG Ab [Units/volume] in Serum |
|
56345-2
|
Paprika IgG4 Ab [Mass/volume] in Serum |
|
63114-3
|
Paprika IgG Ab [Mass/volume] in Serum |
|
18021-6
|
Right pulmonary artery Diameter by US |
|
41287-4
|
Epithelial cells.parabasal [Presence] in Vaginal fluid by Light microscopy |
|
41421-9
|
Paragonimus sp Ab [Presence] in Serum by Immunoblot |
|
7977-2
|
Paragonimus sp Ab [Units/volume] in Serum |
|
51465-3
|
Paragonimus sp Ab [Titer] in Pleural fluid |
|
51450-5
|
Paragonimus sp Ab [Titer] in Pleural fluid by Immunoassay |
|
22436-0
|
Paragonimus sp Ab [Titer] in Serum |
|
5267-0
|
Paragonimus sp Ab [Titer] in Serum by Complement fixation |
|
51449-7
|
Paragonimus sp Ab [Titer] in Serum by Immunoassay |
|
24503-5
|
Parakeet droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
17416-9
|
Parakeet droppings Ab [Units/volume] in Serum |
|
7564-8
|
Parakeet droppings IgE Ab [Units/volume] in Serum |
|
23923-6
|
Parakeet droppings IgE Ab RAST class [Presence] in Serum |
|
17417-7
|
Parakeet droppings IgG Ab [Units/volume] in Serum |
|
55605-0
|
Parakeet feather IgE Ab [Presence] in Serum |
|
7565-5
|
Parakeet feather IgE Ab [Units/volume] in Serum |
|
15903-8
|
Parakeet feather IgE Ab RAST class [Presence] in Serum |
|
58915-0
|
Parakeet feather IgG Ab [Mass/volume] in Serum |
|
24502-7
|
Parakeet serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
17418-5
|
Parakeet serum Ab [Units/volume] in Serum |
|
7566-3
|
Parakeet serum IgE Ab [Units/volume] in Serum |
|
23924-4
|
Parakeet serum IgE Ab RAST class [Presence] in Serum |
|
50386-2
|
Parakeet+Parrot droppings IgE Ab/IgE total in Serum |
|
3904-0
|
Paraldehyde [Mass/volume] in Blood |
|
4376-0
|
Paraldehyde [Mass] of Dose |
|
3905-7
|
Paraldehyde [Mass/volume] in Serum or Plasma |
|
55563-1
|
Paraldehyde [Moles/volume] in Serum or Plasma |
|
18391-3
|
Paraldehyde [Mass/volume] in Urine |
|
80326-2
|
Paralysis [Type] |
|
53715-9
|
Paraneoplastic Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
34142-0
|
Paraneoplastic Ab [Presence] in Serum by Immunoblot |
|
61177-2
|
Paraneoplastic Ab [Presence] in Serum by Immunofluorescence |
|
57771-8
|
Paraneoplastic Ab [Interpretation] in Serum Narrative |
|
60129-4
|
Paraoxon [Mass/volume] in Blood |
|
60130-2
|
Paraoxon [Mass/volume] in Body fluid |
|
27279-9
|
Paraoxon [Mass/volume] in Serum or Plasma |
|
60131-0
|
Paraoxon [Mass/mass] in Tissue |
|
21443-7
|
Paraoxon [Mass/volume] in Urine |
|
5708-3
|
Paraquat [Mass/volume] in Blood |
|
20929-6
|
Paraquat [Mass/volume] in Gastric fluid |
|
59070-3
|
Paraquat [Presence] in Serum or Plasma |
|
5709-1
|
Paraquat [Mass/volume] in Serum or Plasma |
|
50893-7
|
Paraquat [Moles/volume] in Serum or Plasma |
|
20930-4
|
Paraquat [Mass/mass] in Tissue |
|
52961-0
|
Paraquat [Presence] in Urine |
|
9827-7
|
Paraquat [Mass/volume] in Urine |
|
24429-3
|
Parasite identified in Blood |
|
91900-1
|
Parasite [Presence] in Blood by Light microscopy |
|
17784-0
|
Parasite identified in Blood by Light microscopy |
|
40656-1
|
Parasite identified in Blood by Thick film |
|
38416-4
|
Parasite identified in Body fluid by Inspection |
|
42807-8
|
Parasite identified in Isolate |
|
53609-4
|
Parasite identified in Bone marrow by Light microscopy |
|
20933-8
|
Parasite identified in Serum by Light microscopy |
|
38402-4
|
Parasite identified in Tissue |
|
41446-6
|
Parasite identified in Unspecified specimen by Culture |
|
20932-0
|
Parasite identified in Unspecified specimen by Inspection |
|
20931-2
|
Parasites [#/volume] in Gastric fluid |
|
33017-5
|
Parasites [#/area] in Urine sediment by Microscopy low power field |
|
38613-6
|
Parathion [Mass/volume] in Air |
|
60132-8
|
Parathion [Mass/volume] in Blood |
|
60133-6
|
Parathion [Mass/volume] in Body fluid |
|
53649-0
|
Parathion [Mass/volume] in Gastric fluid |
|
2728-4
|
Parathion [Mass/volume] in Serum or Plasma |
|
60134-4
|
Parathion [Mass/mass] in Tissue |
|
17419-3
|
Parathion [Mass/volume] in Urine |
|
87659-9
|
Parathion [Mass/mass] in Unspecified specimen |
|
90741-0
|
Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay |
|
86582-4
|
Parechovirus A RNA [Presence] in Blood by NAA with probe detection |
|
82193-4
|
Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
86586-5
|
Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
51669-0
|
Parechovirus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82819-4
|
Parental separation or divorce--before 18 years old [ACE] |
|
52054-4
|
Parenteral nutrition attachment |
|
88651-5
|
Parenteral therapy note |
|
80327-0
|
Paresthesia [Type] |
|
60135-1
|
Pargyline [Mass/volume] in Serum or Plasma |
|
82521-6
|
Paritaprevir [Susceptibility] by Genotype method |
|
11977-6
|
[#] Parity |
|
40476-4
|
PARK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41071-2
|
PARK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77629-4
|
PARK7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7213-2
|
Parmesan Cheese triggered histamine release [Units/volume] in Blood |
|
7212-4
|
Parmesan Cheese IgE Ab [Units/volume] in Serum |
|
15626-5
|
Parmesan Cheese IgE Ab RAST class [Presence] in Serum |
|
56346-0
|
Parmesan Cheese IgG4 Ab [Mass/volume] in Serum |
|
63089-7
|
Parmesan Cheese IgG Ab [Mass/volume] in Serum |
|
55702-5
|
Paromomycin [Susceptibility] by Gradient strip |
|
55701-7
|
Paromomycin [Susceptibility] by Disk diffusion (KB) |
|
53824-9
|
Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
51719-3
|
Paromomycin [Susceptibility] |
|
72978-0
|
PARoxetine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72977-2
|
PARoxetine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60136-9
|
PARoxetine [Mass/volume] in Blood |
|
78875-2
|
PARoxetine cutoff [Mass/volume] in Urine for Confirmatory method |
|
60137-7
|
PARoxetine [Mass/volume] in Body fluid |
|
59950-6
|
PARoxetine [Moles/volume] in Gastric fluid |
|
73215-6
|
PARoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73214-9
|
PARoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13577-2
|
PARoxetine [Presence] in Serum or Plasma |
|
9699-0
|
PARoxetine [Mass/volume] in Serum or Plasma |
|
14867-6
|
PARoxetine [Moles/volume] in Serum or Plasma |
|
60138-5
|
PARoxetine [Mass/mass] in Tissue |
|
72658-8
|
PARoxetine [Mass/volume] in Serum or Plasma --trough |
|
72784-2
|
PARoxetine [Mass/volume] in Urine by Confirmatory method |
|
27109-8
|
PARoxetine [Presence] in Urine |
|
92650-1
|
PARoxetine [Presence] in Urine by Confirmatory method |
|
39591-3
|
PARoxetine [Mass/volume] in Urine |
|
59949-8
|
PARoxetine [Moles/volume] in Urine |
|
32102-6
|
PARoxetine [Presence] in Unspecified specimen |
|
60327-4
|
PARoxetine [Moles/volume] in Unspecified specimen |
|
72785-9
|
PARoxetine/Creatinine [Mass Ratio] in Urine |
|
24501-9
|
Parrot droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
17420-1
|
Parrot droppings Ab [Units/volume] in Serum |
|
6201-8
|
Parrot droppings IgE Ab [Units/volume] in Serum |
|
15907-9
|
Parrot droppings IgE Ab RAST class [Presence] in Serum |
|
43637-8
|
Parrot droppings IgG Ab [Presence] in Serum |
|
55606-8
|
Parrot feather IgE Ab [Presence] in Serum |
|
6202-6
|
Parrot feather IgE Ab [Units/volume] in Serum |
|
15908-7
|
Parrot feather IgE Ab RAST class [Presence] in Serum |
|
50353-2
|
Parrot feather IgE Ab/IgE total in Serum |
|
51548-6
|
Parrot feather IgG Ab [Presence] in Serum |
|
56347-8
|
Parrot feather IgG4 Ab [Mass/volume] in Serum |
|
58913-5
|
Parrot feather IgG Ab [Mass/volume] in Serum |
|
51860-5
|
Parrot serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
|
78368-8
|
Parrot serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
|
24500-1
|
Parrot serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
17421-9
|
Parrot serum Ab [Units/volume] in Serum |
|
7567-1
|
Parrot serum IgE Ab [Units/volume] in Serum |
|
15909-5
|
Parrot serum proteins IgE Ab RAST class [Presence] in Serum |
|
6203-4
|
Parsley IgE Ab [Units/volume] in Serum |
|
15910-3
|
Parsley IgE Ab RAST class [Presence] in Serum |
|
61295-2
|
Parsley IgE Ab/IgE total in Serum |
|
7568-9
|
Parsley IgG Ab [Units/volume] in Serum |
|
21444-5
|
Parsley IgG Ab RAST class [Presence] in Serum |
|
56348-6
|
Parsley IgG4 Ab [Mass/volume] in Serum |
|
63094-7
|
Parsley IgG Ab [Mass/volume] in Serum |
|
7569-7
|
Parsnip IgE Ab [Units/volume] in Serum |
|
15911-1
|
Parsnip IgE Ab RAST class [Presence] in Serum |
|
56349-4
|
Parsnip IgG4 Ab [Mass/volume] in Serum |
|
63150-7
|
Parsnip IgG Ab [Mass/volume] in Serum |
|
71524-3
|
Partial owner organization Dialysis facility [ESRD] |
|
82787-3
|
Participant identifier |
|
55054-1
|
Participation in assessment [CMS Assessment] |
|
55074-9
|
Participation in assessment Family or significant other [CMS Assessment] |
|
58221-3
|
Participation in assessment Guardian or legally authorized representative [CMS Assessment] |
|
86491-8
|
Participation in hobbies, recreational activities limited by heart failure over the past 2 weeks [KCCQ] |
|
86494-2
|
Participation in intimate relationships with loved ones limited by heart failure over the past 2 weeks [KCCQ] |
|
86493-4
|
Participation in visiting family or friends out of your home limited by heart failure over the past 2 weeks [KCCQ] |
|
86492-6
|
Participation in working or doing household chores limited by heart failure over the past 2 weeks [KCCQ] |
|
48685-2
|
Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25215-5
|
Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25216-3
|
Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
54182-1
|
Para aminosalicylate [Susceptibility] by Disk diffusion (KB) |
|
14332-1
|
Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23611-7
|
Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria |
|
9786-5
|
Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain |
|
6675-3
|
Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain |
|
10800-1
|
Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |
|
674-2
|
Microscopic observation [Identifier] in Unspecified specimen by Periodic acid-Schiff stain |
|
23629-9
|
Para aminosalicylate [Susceptibility] |
|
80270-2
|
Passing flatus |
|
10946-2
|
Passion fruit IgE Ab [Units/volume] in Serum |
|
15912-9
|
Passion fruit IgE Ab RAST class [Presence] in Serum |
|
61293-7
|
Passion fruit IgE Ab/IgE total in Serum |
|
69373-9
|
Passive D Ab [Presence] in Serum or Plasma |
|
80430-2
|
Past employer address |
|
80432-8
|
Past employer city |
|
80438-5
|
Past employer country [Location] |
|
80428-6
|
Past employer name [Identifier] |
|
80436-9
|
Past employer postal code [Location] |
|
80434-4
|
Past employer state |
|
52067-6
|
Past filing limit justification |
|
84339-1
|
Pastoral care Team Note |
|
84349-0
|
Pastoral care Consult note |
|
84348-2
|
Pastoral care Counseling note |
|
84347-4
|
Pastoral care Education note |
|
84346-6
|
Pastoral care Group counseling note |
|
68469-6
|
Pastoral care Hospital Consult note |
|
84343-3
|
Pastoral care Hospital Note |
|
84344-1
|
Pastoral care Initial evaluation note |
|
84342-5
|
Pastoral care Long term care facility Note |
|
34906-8
|
Pastoral care Note |
|
84341-7
|
Pastoral care Outpatient Note |
|
84338-3
|
Pastoral care Telephone encounter Note |
|
84337-5
|
Pastoral care Plan of care note |
|
80671-1
|
Pastoral care Progress note |
|
84345-8
|
Pastoral care Patient's home Note |
|
78675-6
|
Pastoral care Referral note |
|
84340-9
|
Pastoral care Risk assessment and screening note |
|
75607-2
|
Paternal sample received Qualitative |
|
48301-6
|
Patent blue V triggered leukotriene release [Mass/volume] by Leukocytes |
|
80901-2
|
Paternal information Narrative |
|
87302-6
|
Paternity acknowledgment form signed Father |
|
78741-6
|
Pathologic casts [#/volume] in Urine by Automated count |
|
78740-8
|
Pathologic casts [#/area] in Urine by Automated count |
|
72224-9
|
Pathologic casts [Presence] in Urine by Automated |
|
33746-9
|
Pathologic findings |
|
21026-0
|
Pathologist interpretation of Blood tests |
|
32813-8
|
Pathologist interpretation of Bronchial specimen tests |
|
21024-5
|
Pathologist interpretation of Cerebral spinal fluid tests |
|
21025-2
|
Pathologist interpretation of Body fluid tests |
|
48038-4
|
Pathologist interpretation of Synovial fluid tests |
|
50595-8
|
Pathologist interpretation of Unspecified specimen tests |
|
34122-2
|
Pathology procedure note |
|
60569-1
|
Pathology Report addendum.synoptic Document |
|
14868-4
|
Pathologist report of Plasma or RBC tests |
|
85341-6
|
Pathology report reviewed [Identifier] in Specimen |
|
35265-8
|
Pathology report addendum in Specimen Narrative |
|
22638-1
|
Pathology report comments [Interpretation] Narrative |
|
22637-3
|
Pathology report final diagnosis Narrative |
|
34574-4
|
Pathology report final diagnosis |
|
83321-0
|
Pathology report intraoperative observation in Specimen Document |
|
73703-1
|
Pathology report preliminary diagnosis [Interpretation] in Specimen |
|
59465-5
|
Pathologist review of results |
|
14869-2
|
Pathologist review of Blood tests |
|
32144-8
|
Pathologist review of serum or plasma results |
|
59853-2
|
Pathology specimen collection date 1 Cancer |
|
59854-0
|
Pathology specimen collection date 2 Cancer |
|
59855-7
|
Pathology specimen collection date 3 Cancer |
|
59856-5
|
Pathology specimen collection date 4 Cancer |
|
59857-3
|
Pathology specimen collection date 5 Cancer |
|
19769-9
|
Pathologist who read Cyto stain of Cervical or vaginal smear or scraping |
|
90947-3
|
Pathology case identifier [Identifier] |
|
60570-9
|
Pathology Consult note |
|
60571-7
|
Pathology Consult note.synoptic |
|
34819-3
|
Pathology Evaluation and management note |
|
76540-4
|
Pathology dx ICD code [Identifier] |
|
84336-7
|
Pathology Letter |
|
83592-6
|
Pathology Nurse Note |
|
84335-9
|
Pathology Outpatient Note |
|
84334-2
|
Pathology Telephone encounter Note |
|
11526-1
|
Pathology study |
|
60568-3
|
Pathology Synoptic report |
|
75877-1
|
Patient activity scale [PAS] |
|
75876-3
|
Patient activity scale II [PASII] |
|
85411-7
|
Patient discharged against medical advice [CMS Assessment] |
|
85415-8
|
Patient discharged alive [CMS Assessment] |
|
76458-9
|
Patient Email address |
|
90852-5
|
Patient Fax number |
|
75894-6
|
Patient global assessment of disease activity - 0-10 (0.5 increments) numeric rating [Reported] |
|
75844-1
|
Patient global assessment of disease activity - 0-10 numeric rating [Reported] |
|
58120-7
|
Patient Health Questionnaire 2 item (PHQ-2) [PHQ.CMS] |
|
44261-6
|
Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] |
|
89206-7
|
Patient Health Questionnaire-9: Modified for Teens [Reported.PHQ.Teen] |
|
89204-2
|
Patient Health Questionnaire-9: Modified for Teens total score [Reported.PHQ.Teen] |
|
52463-7
|
Patient Identification Number or Provider Account Number |
|
57212-3
|
Patient lives alone [CMS Assessment] |
|
57214-9
|
Patient lives in congregated situtation [CMS Assessment] |
|
57213-1
|
Patient lives with other person [CMS Assessment] |
|
86533-7
|
Patient Living will |
|
85198-0
|
Patient Long term care facility Living will |
|
51855-5
|
Patient Note |
|
92664-2
|
Power of attorney and Living will |
|
78029-6
|
Patient Point of origin [NHCS] |
|
77302-8
|
Patient preference for care action |
|
30951-8
|
Patient recovered VAERS |
|
89195-2
|
Patient reported outcome measure name |
|
89194-5
|
Patient reported outcome measure score |
|
89193-7
|
Patient reported outcome measure score interpretation |
|
74081-1
|
Patient safety event [AHRQ] |
|
55750-4
|
Patient safety report Document |
|
75611-4
|
Patient seen in this ED in last 72 hours and discharged |
|
57195-0
|
Patient/caregiver drug education intervention [CMS Assessment] |
|
57257-8
|
Patient/caregiver received high risk drug education [CMS Assessment] |
|
84486-0
|
Pattern Comparison Processing Speed Test - raw score [NIH Toolbox] |
|
84487-8
|
Pattern Comparison Processing Speed Test - unadjusted scale score [NIH Toolbox] |
|
84483-7
|
Pattern Comparison Processing Speed Test - national percentile [NIH Toolbox] |
|
84436-5
|
Pattern Comparison Processing Speed Test [NIH Toolbox] |
|
84484-5
|
Pattern Comparison Processing Speed Test - scale score age adjusted [NIH Toolbox] |
|
84485-2
|
Pattern Comparison Processing Speed Test - scale score fully adjusted [NIH Toolbox] |
|
83377-2
|
Pause time setting Nebulizer |
|
8614-0
|
Pauses |
|
75994-4
|
Pulmonary artery wedge pressure |
|
60994-1
|
Pulmonary artery wedge Diastolic blood pressure |
|
60995-8
|
Pulmonary artery wedge Systolic blood pressure |
|
35296-3
|
PAX3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38407-3
|
PAX3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48680-3
|
PAX5 Ag [Presence] in Tissue by Immune stain |
|
74490-4
|
PAX5 and BCL2 Ag [Identifier] in Tissue by Immune stain |
|
74492-0
|
PAX5 and CD43 Ag [Identifier] in Tissue by Immune stain |
|
74493-8
|
PAX5 and CD5 Ag [Identifier] in Tissue by Immune stain |
|
59064-6
|
PAX6 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
73910-2
|
PAX8 Ag [Presence] in Tissue by Immune stain |
|
74202-3
|
Primary payment source [NTDS] |
|
52034-6
|
Payer letter |
|
52556-8
|
Payment sources |
|
6883-3
|
Glucose.protein bound [Mass/volume] in Serum or Plasma |
|
10878-7
|
Iodine.protein bound [Mass/volume] in Serum or Plasma |
|
18489-5
|
Valproate.protein bound [Mass/volume] in Serum or Plasma |
|
87486-7
|
PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
17472-2
|
Polybrominated biphenyl [Mass/volume] in Serum or Plasma |
|
12245-7
|
Porphobilinogen [Presence] in 24 hour Urine |
|
27382-1
|
Porphobilinogen [Mass/volume] in 24 hour Urine |
|
2810-0
|
Porphobilinogen [Mass/time] in 24 hour Urine |
|
34356-6
|
Porphobilinogen [Moles/volume] in 24 hour Urine |
|
14882-5
|
Porphobilinogen [Moles/time] in 24 hour Urine |
|
12810-8
|
Porphobilinogen deaminase [Enzymatic activity/volume] in Blood |
|
2812-6
|
Porphobilinogen deaminase [Enzymatic activity/volume] in Red Blood Cells |
|
49228-0
|
Porphobilinogen deaminase [Enzymatic activity/mass] in Red Blood Cells |
|
17474-8
|
Porphobilinogen [Moles/volume] in Serum or Plasma |
|
56483-1
|
Porphobilinogen [Mass/mass] in Stool |
|
12916-3
|
Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
|
2813-4
|
Porphobilinogen synthase [Enzymatic activity/volume] in Red Blood Cells |
|
79465-1
|
Porphobilinogen synthase [Enzymatic activity/mass] in Red Blood Cells |
|
12917-1
|
Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma |
|
2809-2
|
Porphobilinogen [Presence] in Urine |
|
24446-7
|
Porphobilinogen [Mass/volume] in Urine |
|
2811-8
|
Porphobilinogen [Moles/volume] in Urine |
|
74441-7
|
Porphobilinogen/Creatinine [Molar ratio] in 24 hour Urine |
|
13797-6
|
Porphobilinogen/Creatinine [Mass Ratio] in Urine |
|
34357-4
|
Porphobilinogen/Creatinine [Molar ratio] in Urine |
|
33307-0
|
Phosphatidylcholine Ab [Presence] in Serum |
|
42739-3
|
Phosphatidylcholine IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42740-1
|
Phosphatidylcholine IgA Ab B2GP1 independent [Multiple of the median] in Serum |
|
14010-3
|
Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay |
|
14242-2
|
Phosphatidylcholine IgA Ab [Presence] in Serum |
|
13075-7
|
Phosphatidylcholine IgA Ab [Units/volume] in Serum |
|
42741-9
|
Phosphatidylcholine IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42742-7
|
Phosphatidylcholine IgG Ab B2GP1 independent [Multiple of the median] in Serum |
|
14008-7
|
Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay |
|
14243-0
|
Phosphatidylcholine IgG Ab [Presence] in Serum |
|
13073-2
|
Phosphatidylcholine IgG Ab [Units/volume] in Serum |
|
42743-5
|
Phosphatidylcholine IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42744-3
|
Phosphatidylcholine IgM Ab B2GP1 independent [Multiple of the median] in Serum |
|
14009-5
|
Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay |
|
14244-8
|
Phosphatidylcholine IgM Ab [Presence] in Serum |
|
13074-0
|
Phosphatidylcholine IgM Ab [Units/volume] in Serum |
|
84135-3
|
Primary care Interdisciplinary Patient's home Plan of care note |
|
2784-7
|
Phosphatidylcholine.saturated [Mass/volume] in Amniotic fluid |
|
76765-7
|
Phosphatidylcholine.saturated [Moles/volume] in Amniotic fluid |
|
50618-8
|
Phosphatidylcholine.saturated/Surfactant.total in Amniotic fluid |
|
93017-2
|
Plasma cells with abnormal marker pattern [#] in Bone marrow by Flow cytometry (FC) |
|
93021-4
|
Plasma cells with abnormal marker pattern/Cells counted in Bone marrow by Flow cytometry (FC) |
|
30165-5
|
Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid |
|
63303-2
|
Parietal cell Ab [Presence] in Gastric fluid by Immunofluorescence |
|
56147-2
|
Parietal cell Ab [Units/volume] in Serum by Immunoassay |
|
14241-4
|
Parietal cell Ab [Presence] in Serum |
|
26969-6
|
Parietal cell Ab [Presence] in Serum by Immunofluorescence |
|
8087-9
|
Parietal cell Ab [Units/volume] in Serum |
|
42527-2
|
Parietal cell Ab [Titer] in Cerebral spinal fluid |
|
63304-0
|
Parietal cell Ab [Titer] in Gastric fluid by Immunofluorescence |
|
27320-1
|
Parietal cell Ab [Titer] in Serum |
|
5271-2
|
Parietal cell Ab [Titer] in Serum by Immunofluorescence |
|
76312-8
|
PCA dose number.max 1 hour Infusion pump |
|
76313-6
|
PCA dose volume.max Infusion pump |
|
31556-4
|
Parietal cell IgG Ab [Presence] in Serum |
|
29963-6
|
Parietal cell IgG Ab [Presence] in Serum by Immunofluorescence |
|
40960-7
|
Parietal cell IgG Ab [Units/volume] in Serum |
|
48406-3
|
Parietal cell IgG Ab [Titer] in Serum |
|
76314-4
|
PCA lockout time Infusion pump |
|
90842-6
|
PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
90841-8
|
PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
84923-2
|
PCA-1 Ab [Units/volume] in Serum by Immunoblot |
|
84924-0
|
PCA-1 Ab [Presence] in Serum by Immunofluorescence |
|
53713-4
|
PCA-1 Ab [Titer] in Cerebral spinal fluid |
|
53717-5
|
PCA-1 Ab [Titer] in Serum |
|
69953-8
|
PCA-1 IgG Ab [Presence] in Serum by Immunoassay |
|
90843-4
|
PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
84925-7
|
PCA-2 Ab [Presence] in Serum by Immunofluorescence |
|
35143-7
|
PCA-2 Ab [Titer] in Cerebral spinal fluid |
|
33925-9
|
PCA-2 Ab [Titer] in Serum |
|
69361-4
|
PCA3 score in Urine by Molecular genetics method |
|
69362-2
|
PCA3 score in Urine Qualitative by Molecular genetics method |
|
51796-1
|
PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
90844-2
|
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90845-9
|
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
88734-9
|
PCA-Tr Ab [Units/volume] in Serum by Line blot |
|
63440-2
|
PCA-Tr Ab [Presence] in Serum by Immunoblot |
|
84926-5
|
PCA-Tr Ab [Presence] in Serum by Immunofluorescence |
|
51748-2
|
PCA-Tr Ab [Titer] in Cerebral spinal fluid |
|
90846-7
|
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
56551-5
|
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
33926-7
|
PCA-Tr Ab [Titer] in Serum |
|
56550-7
|
PCA-Tr Ab [Titer] in Serum by Immunofluorescence |
|
82999-4
|
PCA-Tr IgG Ab [Presence] in Serum or Plasma by Line blot |
|
38752-2
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Air |
|
61175-6
|
Polychlorinated biphenyl.Aroclor 1242 [Mass/volume] in Serum or Plasma |
|
61176-4
|
Polychlorinated biphenyl.Aroclor 1248 [Mass/volume] in Serum or Plasma |
|
12991-6
|
Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma |
|
12990-8
|
Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma |
|
43213-8
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Blood |
|
27015-7
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Body fluid |
|
73993-8
|
Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Confirmatory method |
|
73994-6
|
Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Screen method |
|
5716-6
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma |
|
18251-9
|
Polychlorinated biphenyl (PCB) [Presence] in Tissue |
|
16179-4
|
Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue |
|
5717-4
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Urine |
|
47873-5
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Amniotic fluid cells |
|
47877-6
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Chorionic villus sample |
|
47874-3
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Fibroblast |
|
47876-8
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Placenta |
|
2850-6
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Tissue |
|
47875-0
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Leukocytes |
|
53887-6
|
PCCA gene+PCCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77748-2
|
PCDH15 gene c.733C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
77126-1
|
PCDH15 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77125-3
|
PCDH15 gene full mutation analysis in Blood or Tissue by Sequencing |
|
76137-9
|
Platelet component distribution width [Mass/volume] in Blood by calculation |
|
33050-6
|
Pseudocholinesterase phenotype [Identifier] in Serum or Plasma |
|
80727-1
|
Percutaneous coronary intervention performed |
|
81436-8
|
Percutaneous coronary intervention site |
|
93753-2
|
Porcine cytomegalovirus DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87382-8
|
Porcine cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
38714-2
|
Pentachloronitrobenzene [Mass/volume] in Air |
|
2018-0
|
Carbon dioxide [Partial pressure] in Amniotic fluid |
|
11557-6
|
Carbon dioxide [Partial pressure] in Blood |
|
2019-8
|
Carbon dioxide [Partial pressure] in Arterial blood |
|
2020-6
|
Carbon dioxide [Partial pressure] in Capillary blood |
|
14003-8
|
Carbon dioxide [Partial pressure] in Cord blood |
|
28644-3
|
Carbon dioxide [Partial pressure] in Arterial cord blood |
|
28645-0
|
Carbon dioxide [Partial pressure] in Venous cord blood |
|
19212-0
|
Carbon dioxide [Partial pressure] in Mixed venous blood |
|
2021-4
|
Carbon dioxide [Partial pressure] in Venous blood |
|
2022-2
|
Carbon dioxide [Partial pressure] in Cerebral spinal fluid |
|
59165-1
|
Carbon dioxide [Partial pressure] in Dialysis fluid |
|
2023-0
|
Carbon dioxide [Partial pressure] in Body fluid |
|
53458-6
|
Carbon dioxide [Partial pressure] in Nonbiological fluid |
|
76184-1
|
Carbon dioxide [Partial pressure] in Pulmonary artery |
|
34705-4
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood |
|
32771-8
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood |
|
40620-7
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Capillary blood |
|
47599-6
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Cord blood |
|
49694-3
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood |
|
49695-0
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous cord blood |
|
50981-0
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood |
|
40619-9
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous blood |
|
32306-3
|
Carbon dioxide [Partial pressure] in Urine |
|
58042-3
|
Phencyclidine [Presence] in Blood by Confirmatory method |
|
51692-2
|
Phencyclidine [Presence] in Blood by Screen method |
|
77876-1
|
Phencyclidine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19661-8
|
Phencyclidine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19660-0
|
Phencyclidine cutoff [Mass/volume] in Urine for Screen method |
|
4389-3
|
Phencyclidine [Mass] of Dose |
|
91040-6
|
Phencyclidine [Presence] in Body fluid by Screen method |
|
8228-9
|
Phencyclidine [Presence] in Gastric fluid |
|
8229-7
|
Phencyclidine [Presence] in Gastric fluid by Confirmatory method |
|
8230-5
|
Phencyclidine [Presence] in Gastric fluid by Screen method |
|
8227-1
|
Phencyclidine [Mass/volume] in Gastric fluid |
|
40394-9
|
Phencyclidine [Presence] in Hair |
|
40807-0
|
Phencyclidine [Presence] in Hair by Screen method |
|
10370-5
|
Phencyclidine [Mass/mass] in Hair |
|
92816-8
|
Phencyclidine [Mass/mass] in Meconium by Confirmatory method |
|
8232-1
|
Phencyclidine [Presence] in Meconium |
|
8233-9
|
Phencyclidine [Presence] in Meconium by Confirmatory method |
|
8234-7
|
Phencyclidine [Presence] in Meconium by Screen method |
|
26829-2
|
Phencyclidine [Mass/mass] in Meconium by Screen method |
|
8231-3
|
Phencyclidine [Mass/volume] in Meconium |
|
26859-9
|
Phencyclidine [Mass/mass] in Meconium |
|
26994-4
|
Phencyclidine [Mass/volume] in Milk |
|
72765-1
|
Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74660-2
|
Phencyclidine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40808-8
|
Phencyclidine [Presence] in Saliva (oral fluid) by Screen method |
|
3935-4
|
Phencyclidine [Presence] in Serum or Plasma |
|
8235-4
|
Phencyclidine [Presence] in Serum or Plasma by Confirmatory method |
|
8236-2
|
Phencyclidine [Presence] in Serum or Plasma by Screen method |
|
3934-7
|
Phencyclidine [Mass/volume] in Serum or Plasma |
|
59956-3
|
Phencyclidine [Moles/volume] in Serum or Plasma |
|
12355-4
|
Phencyclidine [Presence] in Stool |
|
91035-6
|
Phencyclidine [Presence] in Tissue by Screen method |
|
16254-5
|
Phencyclidine [Mass/volume] in Urine by Confirmatory method |
|
3936-2
|
Phencyclidine [Presence] in Urine |
|
18392-1
|
Phencyclidine [Presence] in Urine by Confirmatory method |
|
14311-5
|
Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL |
|
8237-0
|
Phencyclidine [Presence] in Urine by SAMHSA confirm method |
|
8238-8
|
Phencyclidine [Presence] in Urine by SAMHSA screen method |
|
19659-2
|
Phencyclidine [Presence] in Urine by Screen method |
|
14310-7
|
Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
|
72825-3
|
Phencyclidine [Mass/volume] in Urine by Screen method |
|
3937-0
|
Phencyclidine [Mass/volume] in Urine |
|
52951-1
|
Phencyclidine [Moles/volume] in Urine |
|
8240-4
|
Phencyclidine [Presence] in Unknown substance |
|
8241-2
|
Phencyclidine [Presence] in Unknown substance by Confirmatory method |
|
8242-0
|
Phencyclidine [Presence] in Unknown substance by Screen method |
|
8239-6
|
Phencyclidine [Mass/volume] in Unknown substance |
|
27131-2
|
Phencyclidine [Presence] in Vitreous fluid |
|
27356-5
|
Phencyclidine [Mass/volume] in Vitreous fluid |
|
32107-5
|
Phencyclidine [Presence] in Unspecified specimen |
|
10915-7
|
Phencyclidine [Mass/volume] in Unspecified specimen |
|
57869-0
|
Phencyclidine [Moles/volume] in Unspecified specimen |
|
58397-1
|
Phencyclidine/Creatinine [Mass Ratio] in Urine |
|
78935-4
|
Percutaneous cardiopulmonary support performed |
|
38672-2
|
P-cresol [Mass/volume] in Air |
|
79524-5
|
P-cresol [Moles/volume] in Serum or Plasma |
|
79507-0
|
P-cresol/Creatinine [Molar ratio] in Urine |
|
56158-9
|
PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
87333-1
|
Porcine circovirus type 2 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing |
|
90887-1
|
Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing |
|
23766-9
|
Porcine circovirus Ag [Presence] in Tissue by Immunofluorescence |
|
23767-7
|
Porcine circovirus Ag [Presence] in Tissue by Immune stain |
|
87323-2
|
Porcine circovirus type 1 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87331-5
|
Porcine circovirus type 2 Ab/Negative control in Serum by Immunoassay |
|
87325-7
|
Porcine circovirus type 2 Ab [Titer] in Serum by Immunoassay |
|
87332-3
|
Porcine circovirus type 2 Ag [Presence] in Tissue by Immune stain |
|
87334-9
|
Porcine circovirus type 2 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
87335-6
|
Porcine circovirus type 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87336-4
|
Porcine circovirus type 2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87326-5
|
Porcine circovirus type 2 IgG Ab [Titer] in Serum by Immunoassay |
|
90889-7
|
Porcine circovirus type 2 IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
87329-9
|
Porcine circovirus type 2 IgG Ab/Positive control in Serum by Immunoassay |
|
87328-1
|
Porcine circovirus type 2 IgG+IgM Ab [Presence] in Serum by Immunofluorescence |
|
87327-3
|
Porcine circovirus type 2 IgG+IgM Ab [Titer] in Serum by Immunofluorescence |
|
87338-0
|
Porcine circovirus type 2 strain identified [Type] in Isolate by Sequencing |
|
87330-7
|
Porcine circovirus type 2 neutralizing antibody [Titer] in Serum by Neutralization test |
|
87337-2
|
Porcine circovirus type 2 RFLP pattern [Type] in Isolate by RFLP |
|
87324-0
|
Porcine circovirus type 2 [Presence] in Unspecified specimen by Organism specific culture |
|
87339-8
|
Porcine circovirus type 2a DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87340-6
|
Porcine circovirus type 2b DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90326-0
|
Porcine circovirus type 2d DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
90327-8
|
Porcine circovirus type 2d DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90888-9
|
Porcine circovirus type 3 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
90328-6
|
Porcine circovirus type 3 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
93755-7
|
Porcine circovirus type 3 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74577-8
|
Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Fibroblast |
|
74578-6
|
Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Tissue |
|
41872-3
|
PDCD10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
86711-9
|
Porcine deltacoronavirus Ag [Presence] in Tissue by Immune stain |
|
90329-4
|
Porcine deltacoronavirus IgG Ab/Positive control in Unspecified specimen by Immunoassay |
|
76340-9
|
Porcine deltacoronavirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
76339-1
|
Porcine deltacoronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86204-5
|
Porcine deltacoronavirus [Presence] in Unspecified specimen by Organism specific culture |
|
82431-8
|
Platelet-derived growth factor receptor Ab [Units/volume] in Serum by Line blot |
|
82432-6
|
Platelet-derived growth factor receptor Ab [Presence] in Serum by Line blot |
|
72315-5
|
Platelet-derived growth factor receptor IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
71357-8
|
PDGFRA gene exon 18 targeted mutation analysis in Blood or Tissue by Sequencing |
|
55092-1
|
PDGFRA gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
77170-9
|
PDGFRA gene p.Asp842Val [Presence] in Blood or Tissue by Molecular genetics method |
|
74120-7
|
PDGFR-alpha Ag [Presence] in Tissue by Immune stain |
|
78227-6
|
PDGFRB gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78220-1
|
PDGFRB gene rearrangements [Presence] in Blood or Tissue by FISH |
|
49557-2
|
PDGFR-beta Ag [Presence] in Tissue by Immune stain |
|
2910-8
|
Pyruvate dehydrogenase.cytochrome [Enzymatic activity/volume] in Serum or Plasma |
|
74579-4
|
Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Fibroblast |
|
74575-2
|
Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Tissue |
|
70251-4
|
Pyruvate dehydrogenase IgG Ab [Units/volume] in Serum by Immunoassay |
|
2911-6
|
Pyruvate dehydrogenase.lipoamide [Enzymatic activity/mass] in Tissue |
|
75403-6
|
PDHA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81798-1
|
Pregnanediolone/Creatinine [Molar ratio] in Urine |
|
82897-0
|
Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82896-2
|
Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
85147-7
|
PD-L1 by clone 22C3 in Tissue by Immune stain Report |
|
83054-7
|
PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative |
|
83052-1
|
PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain |
|
85148-5
|
PD-L1 by clone 28-8 in Tissue by Immune stain Report |
|
83056-2
|
PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative |
|
83055-4
|
PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain |
|
85149-3
|
PD-L1 by clone SP142 in Tissue by Immune stain Report |
|
83057-0
|
PD-L1 by clone SP142 [Presence] in Tissue by Immune stain |
|
82852-5
|
Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine |
|
82853-3
|
Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in Urine |
|
82855-8
|
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82854-1
|
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
32207-3
|
Platelet distribution width [Entitic volume] in Blood by Automated count |
|
74452-4
|
Platelet distribution width [Entitic volume] in Cord blood by Automated count |
|
51631-0
|
Platelet distribution width [Ratio] in Blood |
|
94078-3
|
PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
33588-5
|
Phosphatidylethanolamine Ab [Units/volume] in Serum by Immunoassay |
|
33308-8
|
Phosphatidylethanolamine Ab [Presence] in Serum |
|
33611-5
|
Phosphatidylethanolamine Ab [Units/volume] in Serum |
|
42745-0
|
Phosphatidylethanolamine IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42746-8
|
Phosphatidylethanolamine IgA Ab B2GP1 independent [Multiple of the median] in Serum |
|
17448-2
|
Phosphatidylethanolamine IgA Ab [Presence] in Serum |
|
13078-1
|
Phosphatidylethanolamine IgA Ab [Units/volume] in Serum |
|
42747-6
|
Phosphatidylethanolamine IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42748-4
|
Phosphatidylethanolamine IgG Ab B2GP1 independent [Multiple of the median] in Serum |
|
17449-0
|
Phosphatidylethanolamine IgG Ab [Presence] in Serum |
|
13076-5
|
Phosphatidylethanolamine IgG Ab [Units/volume] in Serum |
|
42749-2
|
Phosphatidylethanolamine IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42750-0
|
Phosphatidylethanolamine IgM Ab B2GP1 independent [Multiple of the median] in Serum |
|
17450-8
|
Phosphatidylethanolamine IgM Ab [Presence] in Serum |
|
13077-3
|
Phosphatidylethanolamine IgM Ab [Units/volume] in Serum |
|
49576-2
|
Phosphatidylethanolamine/Surfactants.total in Amniotic fluid |
|
7574-7
|
Pea triggered histamine release [Units/volume] in Blood |
|
6204-2
|
Pea IgE Ab [Units/volume] in Serum |
|
15913-7
|
Pea IgE Ab RAST class [Presence] in Serum |
|
61300-0
|
Pea IgE Ab/IgE total in Serum |
|
7570-5
|
Pea IgG Ab [Units/volume] in Serum |
|
21445-2
|
Pea IgG Ab RAST class [Presence] in Serum |
|
56277-7
|
Pea IgG4 Ab [Mass/volume] in Serum |
|
60389-4
|
Pea IgG Ab [Mass/volume] in Serum |
|
79166-5
|
Peach natural (nPru p) 3 IgE Ab [Units/volume] in Serum |
|
58776-6
|
Peach recombinant (rPru p) 1 IgE Ab [Units/volume] in Serum |
|
81987-0
|
Peach recombinant (rPru p) 1 IgE Ab RAST class [Presence] in Serum |
|
59391-3
|
Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum |
|
81988-8
|
Peach recombinant (rPru p) 3 IgE Ab RAST class [Presence] in Serum |
|
58775-8
|
Peach recombinant (rPru p) 4 IgE Ab [Units/volume] in Serum |
|
81989-6
|
Peach recombinant (rPru p) 4 IgE Ab RAST class [Presence] in Serum |
|
7576-2
|
Peach triggered histamine release [Units/volume] in Blood |
|
6205-9
|
Peach IgE Ab [Units/volume] in Serum |
|
15916-0
|
Peach IgE Ab RAST class [Presence] in Serum |
|
43591-7
|
Peach IgE Ab/IgE total in Serum |
|
7575-4
|
Peach IgG Ab [Units/volume] in Serum |
|
21446-0
|
Peach IgG Ab RAST class [Presence] in Serum |
|
56350-2
|
Peach IgG4 Ab [Mass/volume] in Serum |
|
60390-2
|
Peach IgG Ab [Mass/volume] in Serum |
|
94120-3
|
Oxygen consumption (VO2)/Heart rate --peak during exercise |
|
60845-5
|
Peak power frequency on EEG |
|
20247-3
|
Peak pressure gradient by US+Calculated |
|
65769-2
|
Peanut native (nAra h) 1 IgE Ab [Units/volume] in Serum |
|
65770-0
|
Peanut native (nAra h) 2 IgE Ab [Units/volume] in Serum |
|
65771-8
|
Peanut native (nAra h) 3 IgE Ab [Units/volume] in Serum |
|
58779-0
|
Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum |
|
81990-4
|
Peanut recombinant (rAra h) 1 IgE Ab RAST class [Presence] in Serum |
|
58778-2
|
Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum |
|
81991-2
|
Peanut recombinant (rAra h) 2 IgE Ab RAST class [Presence] in Serum |
|
58777-4
|
Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum |
|
81992-0
|
Peanut recombinant (rAra h) 3 IgE Ab RAST class [Presence] in Serum |
|
87719-1
|
Peanut recombinant (rAra h) 5 IgE Ab RAST class [Presence] in Serum |
|
90880-6
|
Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum |
|
87718-3
|
Peanut recombinant (rAra h) 6 IgE Ab RAST class [Presence] in Serum |
|
63477-4
|
Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum |
|
81982-1
|
Peanut recombinant (rAra h) 8 IgE Ab RAST class [Presence] in Serum |
|
64965-7
|
Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum |
|
81994-6
|
Peanut recombinant (rAra h) 9 IgE Ab RAST class [Presence] in Serum |
|
7577-0
|
Peanut triggered histamine release [Units/volume] in Blood |
|
6206-7
|
Peanut IgE Ab [Units/volume] in Serum |
|
15917-8
|
Peanut IgE Ab RAST class [Presence] in Serum |
|
61219-2
|
Peanut IgE Ab/IgE total in Serum |
|
6732-2
|
Peanut IgG Ab [Units/volume] in Serum |
|
21447-8
|
Peanut IgG Ab RAST class [Presence] in Serum |
|
56351-0
|
Peanut IgG4 Ab [Mass/volume] in Serum |
|
35542-0
|
Peanut IgG Ab [Mass/volume] in Serum |
|
48218-2
|
Peanut triggered leukotriene release [Mass/volume] by Leukocytes |
|
6207-5
|
Pear IgE Ab [Units/volume] in Serum |
|
15918-6
|
Pear IgE Ab RAST class [Presence] in Serum |
|
61307-5
|
Pear IgE Ab/IgE total in Serum |
|
7578-8
|
Pear IgG Ab [Units/volume] in Serum |
|
21448-6
|
Pear IgG Ab RAST class [Presence] in Serum |
|
56352-8
|
Pear IgG4 Ab [Mass/volume] in Serum |
|
60391-0
|
Pear IgG Ab [Mass/volume] in Serum |
|
7579-6
|
Pear Pollen IgE Ab [Units/volume] in Serum |
|
7402-1
|
Pecan or Hickory Nut triggered histamine release [Units/volume] in Blood |
|
6208-3
|
Pecan or Hickory Nut IgE Ab [Units/volume] in Serum |
|
15773-5
|
Pecan or Hickory Nut IgE Ab RAST class [Presence] in Serum |
|
39594-7
|
Pecan or Hickory Nut IgE Ab/IgE total in Serum |
|
7580-4
|
Pecan or Hickory Nut IgG Ab [Units/volume] in Serum |
|
56353-6
|
Pecan or Hickory Nut IgG4 Ab [Mass/volume] in Serum |
|
63108-5
|
Pecan or Hickory Nut IgG Ab [Mass/volume] in Serum |
|
6209-1
|
Pecan or Hickory Tree IgE Ab [Units/volume] in Serum |
|
15774-3
|
Pecan or Hickory Tree IgE Ab RAST class [Presence] in Serum |
|
61240-8
|
Pecan or Hickory Tree IgE Ab/IgE total in Serum |
|
56354-4
|
Pecan or Hickory Tree IgG4 Ab [Mass/volume] in Serum |
|
81159-6
|
US Pediatric Cervical and thoracic and lumbar spine |
|
81158-8
|
US Pediatric Head |
|
81160-4
|
US.doppler Pediatric limited Head |
|
81164-6
|
US Pediatric limited Hip - bilateral |
|
79906-4
|
Pediatric visual acuity best corrected Left eye |
|
79907-2
|
Pediatric visual acuity best corrected Right eye |
|
79905-6
|
Pediatric visual acuity uncorrected Left eye |
|
79904-9
|
Pediatric visual acuity uncorrected Right eye |
|
71896-5
|
Pediatric blood pressure percentile [Per age, sex and height] |
|
71895-7
|
Pediatric blood pressure screening results |
|
72164-7
|
Pediatric diastolic blood pressure percentile [Per age, sex and height] |
|
72165-4
|
Pediatric systolic blood pressure percentile [Per age, sex and height] |
|
41946-5
|
Type of Pedometer device |
|
41948-1
|
Pedometer device Vendor model code |
|
41978-8
|
Pedometer device Vendor serial number |
|
41947-3
|
Pedometer device Vendor name |
|
78507-1
|
Pediatrics Admission history and physical note |
|
68718-6
|
Pediatric cardiology Diagnostic study note |
|
68719-4
|
Pediatric cardiology Discharge summary |
|
68721-0
|
Pediatric cardiology History and physical note |
|
68727-7
|
Pediatric cardiology Hospital Consult note |
|
68728-5
|
Pediatric cardiology Hospital Letter |
|
68722-8
|
Pediatric cardiology Note |
|
68723-6
|
Pediatric cardiology Preoperative evaluation and management note |
|
68724-4
|
Pediatric cardiology procedure note |
|
68725-1
|
Pediatric cardiology Progress note |
|
68726-9
|
Pediatric cardiology Transfer summary note |
|
78726-7
|
Pediatrics Consult note |
|
68729-3
|
Pediatric critical care medicine Hospital procedure note |
|
68731-9
|
Pediatric dermatology History and physical note |
|
68892-9
|
Pediatric dermatology Hospital Consult note |
|
68893-7
|
Pediatric dermatology Hospital Letter |
|
68889-5
|
Pediatric dermatology Note |
|
68732-7
|
Pediatric dermatology Preoperative evaluation and management note |
|
68890-3
|
Pediatric dermatology procedure note |
|
68891-1
|
Pediatric dermatology Progress note |
|
93963-7
|
Pediatrics Diagnostic study note |
|
78578-2
|
Pediatrics Discharge instructions |
|
68815-0
|
Pediatrics Discharge summary |
|
78590-7
|
Pediatrics Discharge teaching note |
|
78615-2
|
Pediatrics Education note |
|
68733-5
|
Pediatric endocrinology Discharge summary |
|
68735-0
|
Pediatric endocrinology History and physical note |
|
68897-8
|
Pediatric endocrinology Hospital Consult note |
|
68898-6
|
Pediatric endocrinology Hospital Letter |
|
68894-5
|
Pediatric endocrinology Note |
|
68736-8
|
Pediatric endocrinology Preoperative evaluation and management note |
|
68895-2
|
Pediatric endocrinology procedure note |
|
68896-0
|
Pediatric endocrinology Progress note |
|
68737-6
|
Pediatric endocrinology Transfer summary note |
|
78634-3
|
Pediatrics Flowsheet |
|
68738-4
|
Pediatric gastroenterology Discharge summary |
|
68740-0
|
Pediatric gastroenterology History and physical note |
|
68746-7
|
Pediatric gastroenterology Hospital Consult note |
|
68747-5
|
Pediatric gastroenterology Hospital Letter |
|
68741-8
|
Pediatric gastroenterology Note |
|
68742-6
|
Pediatric gastroenterology Preoperative evaluation and management note |
|
68743-4
|
Pediatric gastroenterology procedure note |
|
68744-2
|
Pediatric gastroenterology Progress note |
|
68745-9
|
Pediatric gastroenterology Transfer summary note |
|
68817-6
|
Pediatrics History and physical note |
|
68748-3
|
Pediatric hematology-oncology Diagnostic study note |
|
68749-1
|
Pediatric hematology-oncology Discharge summary |
|
68751-7
|
Pediatric hematology-oncology History and physical note |
|
68757-4
|
Pediatric hematology-oncology Hospital Consult note |
|
68758-2
|
Pediatric hematology-oncology Hospital Letter |
|
68752-5
|
Pediatric hematology-oncology Note |
|
68753-3
|
Pediatric hematology-oncology Preoperative evaluation and management note |
|
68754-1
|
Pediatric hematology-oncology procedure note |
|
68755-8
|
Pediatric hematology-oncology Progress note |
|
68756-6
|
Pediatric hematology-oncology Transfer summary note |
|
68821-8
|
Pediatrics Hospital Consult note |
|
68822-6
|
Pediatrics Hospital Diagnostic study note |
|
68823-4
|
Pediatrics Hospital Discharge summary |
|
68825-9
|
Pediatrics Hospital History and physical note |
|
68826-7
|
Pediatrics Hospital Letter |
|
68827-5
|
Pediatrics Hospital Note |
|
68828-3
|
Pediatrics Hospital Preoperative evaluation and management note |
|
68829-1
|
Pediatrics Hospital procedure note |
|
68830-9
|
Pediatrics Hospital Progress note |
|
68884-6
|
Pediatrics Hospital Transfer summary note |
|
68760-8
|
Pediatric infectious diseases History and physical note |
|
68765-7
|
Pediatric infectious diseases Hospital Consult note |
|
68766-5
|
Pediatric infectious diseases Hospital Letter |
|
68761-6
|
Pediatric infectious diseases Note |
|
68762-4
|
Pediatric infectious diseases Preoperative evaluation and management note |
|
68763-2
|
Pediatric infectious diseases Progress note |
|
68764-0
|
Pediatric infectious diseases Transfer summary note |
|
78644-2
|
Pediatrics Initial evaluation note |
|
68767-3
|
Pediatric nephrology Diagnostic study note |
|
68768-1
|
Pediatric nephrology Discharge summary |
|
68770-7
|
Pediatric nephrology History and physical note |
|
68869-7
|
Pediatric nephrology Hospital Consult note |
|
68870-5
|
Pediatric nephrology Hospital Letter |
|
68866-3
|
Pediatric nephrology Letter |
|
68867-1
|
Pediatric nephrology Note |
|
68771-5
|
Pediatric nephrology Preoperative evaluation and management note |
|
68868-9
|
Pediatric nephrology procedure note |
|
68772-3
|
Pediatric nephrology Transfer summary note |
|
68818-4
|
Pediatrics Note |
|
89879-1
|
Pediatrics Outpatient Note |
|
68773-1
|
Pediatric otolaryngology Discharge summary |
|
68775-6
|
Pediatric otolaryngology History and physical note |
|
68874-7
|
Pediatric otolaryngology Hospital Consult note |
|
68875-4
|
Pediatric otolaryngology Hospital Letter |
|
68871-3
|
Pediatric otolaryngology Note |
|
68776-4
|
Pediatric otolaryngology Preoperative evaluation and management note |
|
68872-1
|
Pediatric otolaryngology procedure note |
|
68873-9
|
Pediatric otolaryngology Progress note |
|
68777-2
|
Pediatric otolaryngology Transfer summary note |
|
80771-9
|
Pediatrics Plan of care note |
|
68819-2
|
Pediatrics Preoperative evaluation and management note |
|
68820-0
|
Pediatrics procedure note |
|
68778-0
|
Pediatric pulmonology Diagnostic study note |
|
68779-8
|
Pediatric pulmonology Discharge summary |
|
68781-4
|
Pediatric pulmonology History and physical note |
|
68787-1
|
Pediatric pulmonology Hospital Consult note |
|
68788-9
|
Pediatric pulmonology Hospital Diagnostic study note |
|
68789-7
|
Pediatric pulmonology Hospital Letter |
|
68782-2
|
Pediatric pulmonology Note |
|
68783-0
|
Pediatric pulmonology Preoperative evaluation and management note |
|
68784-8
|
Pediatric pulmonology procedure note |
|
68785-5
|
Pediatric pulmonology Progress note |
|
68786-3
|
Pediatric pulmonology Transfer summary note |
|
78670-7
|
Pediatrics Referral note |
|
68854-9
|
Pediatric rehabilitation medicine Note |
|
68791-3
|
Pediatric rheumatology History and physical note |
|
68879-6
|
Pediatric rheumatology Hospital Consult note |
|
68880-4
|
Pediatric rheumatology Hospital Letter |
|
68876-2
|
Pediatric rheumatology Note |
|
68792-1
|
Pediatric rheumatology Preoperative evaluation and management note |
|
68877-0
|
Pediatric rheumatology procedure note |
|
68878-8
|
Pediatric rheumatology Progress note |
|
68793-9
|
Pediatric rheumatology Transfer summary note |
|
78724-2
|
Pediatric surgery Admission history and physical note |
|
78544-4
|
Pediatric surgery Checklist |
|
68794-7
|
Pediatric surgery Diagnostic study note |
|
68795-4
|
Pediatric surgery Discharge summary |
|
78606-1
|
Pediatric surgery Education note |
|
78627-7
|
Pediatric surgery Flowsheet |
|
68797-0
|
Pediatric surgery History and physical note |
|
68802-8
|
Pediatric surgery Hospital Consult note |
|
68803-6
|
Pediatric surgery Hospital Letter |
|
82836-8
|
Pediatric surgery Initial evaluation note |
|
68881-2
|
Pediatric surgery Note |
|
78725-9
|
Pediatric surgery Surgical operation note |
|
80767-7
|
Pediatric surgery Plan of care note |
|
68798-8
|
Pediatric surgery Preoperative evaluation and management note |
|
68799-6
|
Pediatric surgery procedure note |
|
68800-2
|
Pediatric surgery Progress note |
|
78673-1
|
Pediatric surgery Referral note |
|
68801-0
|
Pediatric surgery Transfer summary note |
|
89888-2
|
Pediatrics Telehealth Note |
|
68883-8
|
Pediatrics Transfer summary note |
|
68855-6
|
Pediatric transplant hepatology Diagnostic study note |
|
68856-4
|
Pediatric transplant hepatology Discharge summary |
|
68858-0
|
Pediatric transplant hepatology History and physical note |
|
68864-8
|
Pediatric transplant hepatology Hospital Consult note |
|
68865-5
|
Pediatric transplant hepatology Hospital Letter |
|
68859-8
|
Pediatric transplant hepatology Note |
|
68860-6
|
Pediatric transplant hepatology Preoperative evaluation and management note |
|
68861-4
|
Pediatric transplant hepatology procedure note |
|
68862-2
|
Pediatric transplant hepatology Progress note |
|
68863-0
|
Pediatric transplant hepatology Transfer summary note |
|
68804-4
|
Pediatric urology Diagnostic study note |
|
68805-1
|
Pediatric urology Discharge summary |
|
68807-7
|
Pediatric urology History and physical note |
|
68812-7
|
Pediatric urology Hospital Consult note |
|
68813-5
|
Pediatric urology Hospital Letter |
|
68882-0
|
Pediatric urology Note |
|
68808-5
|
Pediatric urology Preoperative evaluation and management note |
|
68809-3
|
Pediatric urology procedure note |
|
68810-1
|
Pediatric urology Progress note |
|
68811-9
|
Pediatric urology Transfer summary note |
|
86695-4
|
Porcine epidemic diarrhea virus Ab/Positive control in Serum by Immunoassay |
|
86693-9
|
Porcine epidemic diarrhea virus IgA Ab/Positive control in Unspecified specimen by Immunoassay |
|
86207-8
|
Porcine epidemic diarrhea virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
86219-3
|
Porcine epidemic diarrhea virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
86694-7
|
Porcine epidemic diarrhea virus IgG Ab/Positive control in Unspecified specimen by Immunoassay |
|
86216-9
|
Porcine epidemic diarrhea virus neutralizing antibody [Titer] in Serum by Neutralization test |
|
85356-4
|
PEDV prototype strain S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86710-1
|
Porcine epidemic diarrhea virus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74752-7
|
Porcine epidemic diarrhea virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86698-8
|
Porcine epidemic diarrhea virus RNA [Nucleotide sequence] in Isolate by Sequencing |
|
76338-3
|
Porcine epidemic diarrhea virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85355-6
|
PEDV S INDEL strain S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
88064-1
|
Porcine epidemic diarrhea virus S1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86201-1
|
Porcine epidemic diarrhea virus gene sequence and phylogenetic analysis in Unspecified specimen Document |
|
86202-9
|
Porcine epidemic diarrhea virus [Presence] in Tissue by Immune stain |
|
86928-9
|
Porcine epidemic diarrhea virus whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
86200-3
|
Porcine epidemic diarrhea virus [Presence] in Unspecified specimen by Organism specific culture |
|
76248-4
|
PEEP Respiratory system --on ventilator |
|
85110-5
|
Peer Rejection Survey version 2.0 - parent report - ages 3-12 - T-score [NIH Toolbox] |
|
69974-4
|
Maximum expiratory gas flow Respiratory system airway Predicted |
|
69976-9
|
Maximum expiratory gas flow Respiratory system airway --post bronchodilation |
|
83368-1
|
Personal best peak expiratory gas flow Respiratory system airway |
|
69975-1
|
Maximum expiratory gas flow Respiratory system airway --pre bronchodilation |
|
71794-2
|
Maximum expiratory gas flow Respiratory system airway --pre therapy |
|
71795-9
|
Maximum expiratory gas flow Respiratory system airway by Peak flow meter --pre therapy |
|
69978-5
|
Maximum expiratory gas flow/Predicted maximum expiratory gas flow Respiratory system airway --post bronchodilation |
|
69977-7
|
Maximum expiratory gas flow/Predicted maximum expiratory gas flow Respiratory system airway --pre bronchodilation |
|
4377-8
|
Pefloxacin [Mass] of Dose |
|
7040-9
|
Pefloxacin [Susceptibility] by Gradient strip |
|
35828-3
|
Pefloxacin [Susceptibility] by Disk diffusion (KB) |
|
390-5
|
Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
3906-5
|
Pefloxacin [Mass/volume] in Serum or Plasma |
|
18963-9
|
Pefloxacin [Susceptibility] |
|
84426-6
|
9-Hole Pegboard Dexterity - scale score age adjusted Hand.dominant [NIH Toolbox] |
|
84425-8
|
9-Hole Pegboard Dexterity - scale score age adjusted Hand.non-dominant [NIH Toolbox] |
|
83158-6
|
9-Hole Pegboard Dexterity - scale score fully adjusted Hand.dominant [NIH Toolbox] |
|
83159-4
|
9-Hole Pegboard Dexterity - scale score fully adjusted Hand.non-dominant [NIH Toolbox] |
|
83141-2
|
9-Hole Pegboard Dexterity Test [NIH Toolbox] |
|
83156-0
|
9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox] |
|
83157-8
|
9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox] |
|
18311-1
|
Pelger Huet cells [Presence] in Blood by Light microscopy |
|
6199-4
|
Pellitory (Parietaria judaica) IgE Ab [Units/volume] in Serum |
|
31001-1
|
Pellitory (Parietaria judaica) IgE Ab RAST class [Presence] in Serum |
|
48250-5
|
Pellitory (Parietaria judaica) triggered leukotriene release [Mass/volume] by Leukocytes |
|
6200-0
|
Pellitory (Parietaria officinalis) IgE Ab [Units/volume] in Serum |
|
43374-8
|
Pellitory (Parietaria officinalis) IgE Ab RAST class [Presence] in Serum |
|
48251-3
|
Pellitory (Parietaria officinalis) triggered leukotriene release [Mass/volume] by Leukocytes |
|
56882-4
|
Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Units/volume] in Serum |
|
81964-9
|
Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab RAST class [Presence] in Serum |
|
7760-2
|
Wall pellitory IgE Ab [Units/volume] in Serum |
|
16073-9
|
Wall pellitory IgE Ab RAST class [Presence] in Serum |
|
42480-4
|
Pelvis Narrative transabdominal US |
|
12388-5
|
Phenylethylmalonamide [Mass/volume] in Serum or Plasma |
|
29289-6
|
Phenylethylmalonamide [Presence] in Urine |
|
29295-3
|
Phenylethylmalonamide [Mass/volume] in Urine |
|
3910-7
|
Pemoline [Mass/time] in 24 hour Urine |
|
60139-3
|
Pemoline [Mass/volume] in Blood |
|
4378-6
|
Pemoline [Mass] of Dose |
|
3907-3
|
Pemoline [Mass/volume] in Serum or Plasma |
|
33349-2
|
Pemoline [Mass/volume] in Urine by Confirmatory method |
|
3908-1
|
Pemoline [Presence] in Urine |
|
33348-4
|
Pemoline [Mass/volume] in Urine by Screen method |
|
3909-9
|
Pemoline [Mass/volume] in Urine |
|
74440-9
|
Pemptoporphyrin [Moles/mass] in Stool |
|
60140-1
|
Penciclovir [Mass/volume] in Blood |
|
60141-9
|
Penciclovir [Mass/volume] in Serum or Plasma |
|
10377-0
|
Pencil cells [Presence] in Blood by Light microscopy |
|
60142-7
|
Pendimethalin [Mass/volume] in Blood |
|
60143-5
|
Pendimethalin [Mass/volume] in Serum or Plasma |
|
60144-3
|
Pendimethalin [Mass/volume] in Urine |
|
82893-9
|
Penfluridol [Mass/volume] in Serum or Plasma |
|
79410-7
|
Penfluridol [Mass/volume] in Serum or Plasma --trough |
|
72976-4
|
Penicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72975-6
|
Penicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4379-4
|
Penicillin G benzathine [Mass] of Dose |
|
51504-9
|
Penicillin G benzathine [Susceptibility] |
|
6851-0
|
Penicillin G IgE Ab [Units/volume] in Serum |
|
15921-0
|
Penicillin G IgE Ab RAST class [Presence] in Serum |
|
49729-7
|
Penicillin G IgG Ab [Mass/volume] in Serum |
|
7041-7
|
Penicillin G [Susceptibility] by Gradient strip |
|
393-9
|
Penicillin G [Susceptibility] by Disk diffusion (KB) |
|
392-1
|
Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
391-3
|
Penicillin G [Susceptibility] by Minimum lethal concentration (MLC) |
|
48201-8
|
Penicillin G triggered leukotriene release [Mass/volume] by Leukocytes |
|
4380-2
|
Penicillin G potassium [Mass] of Dose |
|
4381-0
|
Penicillin G procaine [Mass] of Dose |
|
51503-1
|
Penicillin G procaine [Susceptibility] |
|
3913-1
|
Penicillin G [Mass/volume] in Serum or Plasma |
|
18965-4
|
Penicillin G [Susceptibility] |
|
394-7
|
Penicillin G [Susceptibility] by Serum bactericidal titer |
|
73213-1
|
Penicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73212-3
|
Penicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13968-3
|
Penicillin [Susceptibility] by Disk diffusion (KB) |
|
6932-8
|
Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
85428-1
|
Penicillin [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
85429-9
|
Penicillin [Susceptibility] for pneumonia by Minimum inhibitory concentration (MIC) |
|
77960-3
|
Penicillin Parenteral [Susceptibility] by Disk diffusion (KB) |
|
55136-6
|
Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55137-4
|
Penicillin Parenteral [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
58085-2
|
Penicillin Parenteral [Susceptibility] |
|
58080-3
|
Penicillin Parenteral [Susceptibility] for meningitis |
|
3911-5
|
Penicillin [Mass/volume] in Serum or Plasma |
|
18964-7
|
Penicillin [Susceptibility] |
|
3912-3
|
Penicillin [Mass/volume] in Urine |
|
6210-9
|
Penicillin V IgE Ab [Units/volume] in Serum |
|
15922-8
|
Penicillin V IgE Ab RAST class [Presence] in Serum |
|
39553-3
|
Penicillin V IgE Ab/IgE total in Serum |
|
7042-5
|
Penicillin V [Susceptibility] by Gradient strip |
|
397-0
|
Penicillin V [Susceptibility] by Disk diffusion (KB) |
|
396-2
|
Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
395-4
|
Penicillin V [Susceptibility] by Minimum lethal concentration (MLC) |
|
48200-0
|
Penicillin V triggered leukotriene release [Mass/volume] by Leukocytes |
|
4382-8
|
Penicillin V potassium [Mass] of Dose |
|
3914-9
|
Penicillin V [Mass/volume] in Serum or Plasma |
|
18966-2
|
Penicillin V [Susceptibility] |
|
398-8
|
Penicillin V [Susceptibility] by Serum bactericidal titer |
|
25267-6
|
Penicillin [Mass/volume] in Unspecified specimen |
|
87594-8
|
Penicillin [Mass/mass] in Unspecified specimen |
|
35872-1
|
Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB) |
|
35873-9
|
Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35874-7
|
Penicillin+Novobiocin [Susceptibility] |
|
17427-6
|
Penicillium sp Ab [Units/volume] in Serum |
|
57034-1
|
Penicillium sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
74805-3
|
Penicillium sp IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
51544-5
|
Penicillium sp IgG Ab [Presence] in Serum |
|
7583-8
|
Penicillium sp IgG Ab [Units/volume] in Serum |
|
53801-7
|
Penile vessels by US.doppler |
|
40392-3
|
Pentacarboxylate [Moles/time] in 24 hour Urine |
|
14870-0
|
Pentacarboxylate [Moles/volume] in Plasma |
|
14871-8
|
Pentacarboxylate [Moles/volume] in Stool |
|
45311-8
|
Pentacarboxylate [Moles/mass] in Stool |
|
14872-6
|
Pentacarboxylate [Moles/volume] in Urine |
|
45317-5
|
Pentacarboxylate/Creatinine [Molar ratio] in Urine |
|
38614-4
|
Pentachlorophenol [Mass/volume] in Air |
|
17429-2
|
Pentachlorophenol [Mass/volume] in Blood |
|
20937-9
|
Pentachlorophenol [Mass/mass] in Fat |
|
12338-0
|
Pentachlorophenol [Presence] in Serum or Plasma |
|
5710-9
|
Pentachlorophenol [Mass/volume] in Serum or Plasma |
|
20936-1
|
Pentachlorophenol [Mass/mass] in Tissue |
|
5711-7
|
Pentachlorophenol [Mass/volume] in Urine |
|
38326-5
|
Pentachlorophenol [Mass/volume] in Water |
|
26987-8
|
Pentachlorophenol/Creatinine [Mass Ratio] in Urine |
|
17428-4
|
Pentacarboxylporphyrins [Mass/time] in 24 hour Stool |
|
42002-6
|
Pentacarboxylporphyrins [Mass/volume] in 24 hour Urine |
|
9730-3
|
Pentacarboxylporphyrins [Mass/time] in 24 hour Urine |
|
25968-9
|
Pentacarboxylporphyrins [Moles/volume] in 24 hour Urine |
|
25494-6
|
Pentacarboxylporphyrins [Moles/time] in 24 hour Urine |
|
18250-1
|
Pentacarboxylporphyrins [Mass/volume] in Blood |
|
10881-1
|
Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells |
|
10882-9
|
Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma |
|
74989-5
|
Pentacarboxylporphyrins [Moles/volume] in Serum or Plasma |
|
34351-7
|
Pentacarboxylporphyrins [Mass/mass] in Stool |
|
50894-5
|
Pentacarboxylporphyrins [Moles/mass] in Stool |
|
11222-7
|
Pentacarboxylporphyrins [Presence] in Urine |
|
11221-9
|
Pentacarboxylporphyrins [Mass/volume] in Urine |
|
34352-5
|
Pentacarboxylporphyrins [Moles/volume] in Urine |
|
59819-3
|
Pentacarboxylporphyrins/Creatinine [Molar ratio] in 24 hour Urine |
|
38161-6
|
Pentacarboxylporphyrins/Creatinine [Mass Ratio] in Urine |
|
34353-3
|
Pentacarboxylporphyrins/Creatinine [Molar ratio] in Urine |
|
33624-8
|
Pentacarboxylporphyrin III [Mass/time] in 24 hour Stool |
|
93510-6
|
Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine |
|
74086-0
|
Pentacarboxylporphyrin III [Moles/mass] in Stool |
|
74089-4
|
Pentacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
|
33623-0
|
Pentacarboxylporphyrin I [Mass/time] in 24 hour Stool |
|
93509-8
|
Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine |
|
93710-2
|
Pentacarboxylporphyrin I/Creatinine [Molar ratio] in Urine |
|
75107-3
|
Pentadecanoate [Entitic substance] in Red Blood Cells |
|
48366-9
|
Pentadecanoate [Moles/volume] in Serum or Plasma |
|
48119-2
|
Pentadecanoate/Creatinine [Molar ratio] in Urine |
|
17430-0
|
Pentane [Mass/volume] in Blood |
|
60145-0
|
Pentane [Mass/volume] in Body fluid |
|
60146-8
|
Pentane [Mass/volume] in Serum or Plasma |
|
60147-6
|
Pentane [Mass/mass] in Tissue |
|
60148-4
|
Pentane [Mass/volume] in Urine |
|
10409-1
|
Pentaspan given [Volume] |
|
3919-8
|
Pentazocine [Mass/time] in 24 hour Urine |
|
60149-2
|
Pentazocine [Mass/volume] in Blood |
|
4383-6
|
Pentazocine [Mass] of Dose |
|
60150-0
|
Pentazocine [Mass/volume] in Body fluid |
|
40393-1
|
Pentazocine [Presence] in Gastric fluid |
|
59952-2
|
Pentazocine [Moles/volume] in Gastric fluid |
|
3915-6
|
Pentazocine [Presence] in Serum or Plasma |
|
3916-4
|
Pentazocine [Mass/volume] in Serum or Plasma |
|
55564-9
|
Pentazocine [Moles/volume] in Serum or Plasma |
|
3917-2
|
Pentazocine [Presence] in Urine |
|
16219-8
|
Pentazocine [Presence] in Urine by Confirmatory method |
|
3918-0
|
Pentazocine [Mass/volume] in Urine |
|
59951-4
|
Pentazocine [Moles/volume] in Urine |
|
60328-2
|
Pentazocine [Moles/volume] in Unspecified specimen |
|
86193-0
|
Pentedrone [Mass/volume] in Urine by Confirmatory method |
|
3922-2
|
Pentetrazol [Mass/time] in 24 hour Urine |
|
4384-4
|
Pentetrazol [Mass] of Dose |
|
3920-6
|
Pentetrazol [Presence] in Urine |
|
3921-4
|
Pentetrazol [Mass/volume] in Urine |
|
60151-8
|
PENTobarbital [Mass/volume] in Blood |
|
19658-4
|
PENTobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19657-6
|
PENTobarbital cutoff [Mass/volume] in Urine for Screen method |
|
4385-1
|
PENTobarbital [Mass] of Dose |
|
60152-6
|
PENTobarbital [Mass/volume] in Body fluid |
|
12488-3
|
PENTobarbital [Presence] in Gastric fluid |
|
17431-8
|
PENTobarbital [Mass/volume] in Gastric fluid |
|
26918-3
|
PENTobarbital [Mass/mass] in Hair |
|
27308-6
|
PENTobarbital [Mass/mass] in Meconium |
|
72635-6
|
PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72630-7
|
PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3923-0
|
PENTobarbital [Presence] in Serum or Plasma |
|
35630-3
|
PENTobarbital [Mass/volume] in Serum or Plasma by Screen method |
|
82969-7
|
PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3924-8
|
PENTobarbital [Mass/volume] in Serum or Plasma |
|
32103-4
|
PENTobarbital [Moles/volume] in Serum or Plasma |
|
12499-0
|
PENTobarbital [Presence] in Stool |
|
27243-5
|
PENTobarbital [Mass/mass] in Stool |
|
60153-4
|
PENTobarbital [Mass/mass] in Tissue |
|
16240-4
|
PENTobarbital [Mass/volume] in Urine by Confirmatory method |
|
3925-5
|
PENTobarbital [Presence] in Urine |
|
16193-5
|
PENTobarbital [Presence] in Urine by Confirmatory method |
|
19655-0
|
PENTobarbital [Presence] in Urine by Screen method |
|
3926-3
|
PENTobarbital [Mass/volume] in Urine |
|
32104-2
|
PENTobarbital [Presence] in Unspecified specimen |
|
57866-6
|
PENTobarbital [Moles/volume] in Unspecified specimen |
|
64132-4
|
PENTobarbital/Creatinine [Mass Ratio] in Urine |
|
2734-2
|
Pentoses [Mass/time] in 24 hour Urine |
|
60154-2
|
Pentoxifylline [Mass/volume] in Blood |
|
10892-8
|
Pentoxifylline [Mass/volume] in Serum or Plasma |
|
60155-9
|
Pentoxifylline [Mass/volume] in Urine |
|
86197-1
|
Pentylone [Mass/volume] in Urine by Confirmatory method |
|
35357-3
|
PEO gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38408-1
|
PEO gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76946-3
|
People are careless when they drink [PROMIS] |
|
76947-1
|
People are irresponsible when they drink [PROMIS] |
|
76890-3
|
People are outgoing when they drink [PROMIS] |
|
76948-9
|
People are pushy when they drink [PROMIS] |
|
76949-7
|
People are rude when they drink [PROMIS] |
|
76951-3
|
People are selfish when they drink [PROMIS] |
|
76943-0
|
People do things they regret while drinking [PROMIS] |
|
76898-6
|
People feel happy when they drink [PROMIS] |
|
76942-2
|
People feel sick the day after drinking [PROMIS] |
|
76896-0
|
People forget their problems when they drink [PROMIS] |
|
76883-8
|
People get the wrong idea about my situation [PROMIS] |
|
76891-1
|
People have more desire for sex when they drink [PROMIS] |
|
76893-7
|
People have more fun at social occasions when they drink [PROMIS] |
|
76941-4
|
People have trouble thinking when they drink [PROMIS] |
|
92285-6
|
People I care about respect me less because I smoke [PROMIS] |
|
78115-3
|
People in my family helped each other in past 4 weeks [PROMIS.PEDS] |
|
78087-4
|
People in my family made me feel good about myself in past 4 weeks [PROMIS.PEDS] |
|
78127-8
|
People in our family made my child feel good about himself or herself in past 4 weeks [PROMIS.PARENTPROXY] |
|
76944-8
|
People make bad decisions when they drink [PROMIS] |
|
76892-9
|
People sleep better when they drink [PROMIS] |
|
91099-2
|
People tested [#] Population |
|
92284-9
|
People think I'm foolish for ignoring the warnings about cigarette smoking [PROMIS] |
|
92283-1
|
People think less of me if they see me smoking [PROMIS] |
|
2788-8
|
Phosphoenolpyruvate carboxykinase [Enzymatic activity/volume] in Serum |
|
6213-3
|
Pepper tree IgE Ab [Units/volume] in Serum |
|
15929-3
|
Pepper tree IgE Ab RAST class [Presence] in Serum |
|
56460-9
|
Pepper tree IgG4 Ab [Mass/volume] in Serum |
|
26044-8
|
Pepsin IgE Ab [Units/volume] in Serum |
|
26032-3
|
Pepsin IgE Ab RAST class [Presence] in Serum |
|
80828-7
|
Pepsin A+Pepsinogen A [Mass/volume] in Lower respiratory specimen by Immunoassay |
|
80829-5
|
Pepsin A+Pepsinogen A [Interpretation] in Lower respiratory specimen Narrative |
|
2735-9
|
Pepsinogen [Mass/volume] in Blood |
|
2736-7
|
Pepsinogen I [Mass/volume] in Serum or Plasma |
|
2737-5
|
Pepsinogen I [Mass/volume] in Urine |
|
2738-3
|
Pepsinogen II [Mass/volume] in Serum or Plasma |
|
2739-1
|
Pepsinogen [Mass/volume] in Serum or Plasma |
|
2740-9
|
Pepsins [Enzymatic activity/volume] in Gastric fluid |
|
2741-7
|
Pepsins [Enzymatic activity/volume] in Urine |
|
49858-4
|
Peptide YY [Mass/volume] in Serum or Plasma |
|
82367-4
|
Peripheral deiodinase activity [Moles/time] in Serum or Plasma by Calculated.SPINA |
|
7374-2
|
Perennial rye grass triggered histamine release [Units/volume] in Blood |
|
7369-2
|
Perennial rye grass IgE Ab [Units/volume] in Serum |
|
15749-5
|
Perennial rye grass IgE Ab RAST class [Presence] in Serum |
|
61282-0
|
Perennial rye grass IgE Ab/IgE total in Serum |
|
7370-0
|
Perennial rye grass IgG Ab [Units/volume] in Serum |
|
56357-7
|
Perennial rye grass IgG4 Ab [Mass/volume] in Serum |
|
58923-4
|
Perennial rye grass IgG Ab [Mass/volume] in Serum |
|
48261-2
|
Perennial rye grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
56726-3
|
Perennial rye grass recombinant profilin IgE Ab [Units/volume] in Serum |
|
88895-8
|
Perampanel [Mass/volume] - Serum or Plasma |
|
88989-9
|
Perazine [Mass/volume] in Serum or Plasma |
|
76642-8
|
Percutaneous coronary intervention Study report |
|
90663-6
|
Pulmonary Embolism Rule-out Criteria score interpretation |
|
89545-8
|
PERC Total score |
|
91527-2
|
Perceived Stress Survey - age 18+ - T-score [NIH Toolbox] |
|
84798-8
|
Perceived Stress Survey - parent report - fixed length form - ages 8-12 [NIH Toolbox] |
|
77251-7
|
Percent impairment - confidence [OPTIMAL] |
|
77252-5
|
Percent impairment - difficulty [OPTIMAL] |
|
90897-0
|
Percent of task completed |
|
78900-8
|
Percent stenosis of AV nodal artery by Cardiac angiogram |
|
80915-2
|
Percent stenosis of Coronary artery segment |
|
80239-7
|
Percent stenosis of Coronary artery segment --post procedure |
|
80728-9
|
Percent stenosis of Coronary artery segment --pre procedure |
|
78906-5
|
Percent stenosis of First diagonal artery by Cardiac angiogram |
|
80228-0
|
Percent stenosis of Additional first diagonal artery |
|
78907-3
|
Percent stenosis of Second diagonal artery by Cardiac angiogram |
|
80229-8
|
Percent stenosis of Additional second diagonal artery |
|
78905-7
|
Percent stenosis of Distal left anterior descending artery by Cardiac angiogram |
|
78899-2
|
Percent stenosis of Distal right coronary artery by Cardiac angiogram |
|
78910-7
|
Percent stenosis of Mid and distal left circumflex artery by Cardiac angiogram |
|
78902-4
|
Percent stenosis of Left main coronary artery by Cardiac angiogram |
|
78912-3
|
Percent stenosis of Posterior descending branch from left circumflex artery by Cardiac angiogram |
|
78911-5
|
Percent stenosis of Posterolateral branch from left circumflex artery by Cardiac angiogram |
|
78904-0
|
Percent stenosis of Mid left anterior descending artery by Cardiac angiogram |
|
78898-4
|
Percent stenosis of Mid right coronary artery by Cardiac angiogram |
|
78909-9
|
Percent stenosis of Obtuse marginal artery by Cardiac angiogram |
|
78908-1
|
Percent stenosis of Proximal left circumflex artery by Cardiac angiogram |
|
78903-2
|
Percent stenosis of Proximal left anterior descending artery by Cardiac angiogram |
|
78897-6
|
Percent stenosis of Proximal right coronary artery by Cardiac angiogram |
|
78913-1
|
Percent stenosis of Ramus intermedius branch from left main coronary artery by Cardiac angiogram |
|
78901-6
|
Percent stenosis of Posterior descending branch from right coronary artery by Cardiac angiogram |
|
80227-2
|
Percent stenosis of Posterolateral branch from right coronary artery |
|
6214-1
|
Perch IgE Ab [Units/volume] in Serum |
|
15930-1
|
Perch IgE Ab RAST class [Presence] in Serum |
|
50355-7
|
Perch IgE Ab/IgE total in Serum |
|
7598-6
|
Perch IgG Ab [Units/volume] in Serum |
|
33305-4
|
Perch IgG Ab RAST class [Presence] in Serum |
|
56356-9
|
Perch IgG4 Ab [Mass/volume] in Serum |
|
63088-9
|
Perch IgG Ab [Mass/volume] in Serum |
|
37424-9
|
Perchlorate [Mass/volume] in Unspecified specimen by HPLC |
|
81686-8
|
Performed preoperative time-out assessment |
|
60156-7
|
Perfluorooctanoate [Mass/volume] in Blood |
|
60157-5
|
Perfluorooctanoate [Mass/volume] in Serum or Plasma |
|
74121-5
|
Perforin Ag [Presence] in Tissue by Immune stain |
|
35128-8
|
Perforin [Units/volume] in Leukocytes |
|
72510-1
|
Performance rate Reporting Period Population Calculated |
|
89190-3
|
Performance-based measure name |
|
89191-1
|
Performance-based measure score |
|
89192-9
|
Performance-based measure score interpretation |
|
68989-3
|
Performing laboratory [Address] |
|
68990-1
|
Performing laboratory medical director [Identifier] |
|
68994-3
|
Performing laboratory name |
|
75549-6
|
Performing laboratory phone number |
|
91562-9
|
Performing laboratory identifier Facility |
|
73794-0
|
Perfusion index Blood Postductal Pulse oximetry |
|
73798-1
|
Perfusion index Blood Preductal Pulse oximetry |
|
60158-3
|
Pergolide [Mass/volume] in Blood |
|
11248-2
|
Pergolide [Mass/volume] in Serum or Plasma |
|
60159-1
|
Pergolide [Mass/volume] in Urine |
|
93664-1
|
Pericardial effusion by US |
|
79446-1
|
Pericyazine [Mass/volume] in Serum or Plasma |
|
57867-4
|
Pericyazine [Moles/volume] in Unspecified specimen |
|
32963-1
|
Peridontal risk Gingiva |
|
28629-4
|
Perimetry study |
|
74551-3
|
Perinatal incident that affected a neonate [AHRQ] |
|
81670-2
|
Perineal pad count |
|
72145-6
|
Perineal tear classification [RHEA] |
|
92837-4
|
Perineural invasion [Presence] in Cancer specimen |
|
86603-8
|
Periodontal attachment - recommended CDA R1 set |
|
74030-8
|
Periodontal service attachment |
|
74047-2
|
Periodontal procedure is related to orthodontic treatment plan |
|
74048-0
|
Periodontal procedure is related to restorative treatment |
|
29752-3
|
Perioperative records |
|
75691-6
|
Peripheral sensory neuropathy grade NCICTC |
|
78929-7
|
Peripheral vessels fluoroscopic angiogram performed |
|
44625-2
|
Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols |
|
66111-6
|
Peritoneum Pathology biopsy report |
|
85284-8
|
Peritumoral lymphocytic response in Cancer specimen Qualitative by Light microscopy |
|
72301-5
|
Description of Periwound |
|
89057-4
|
Permission to receive text messages |
|
72169-6
|
Permission to release immunization data from school record |
|
11018-9
|
Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
|
35289-8
|
Peroxide hemolysis of Red Blood Cells |
|
60160-9
|
Perphenazine [Mass/volume] in Blood |
|
4386-9
|
Perphenazine [Mass] of Dose |
|
59955-5
|
Perphenazine [Moles/volume] in Gastric fluid |
|
73211-5
|
Perphenazine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73210-7
|
Perphenazine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26846-6
|
Perphenazine [Presence] in Serum or Plasma |
|
3927-1
|
Perphenazine [Mass/volume] in Serum or Plasma |
|
59953-0
|
Perphenazine [Moles/volume] in Serum or Plasma |
|
74949-9
|
Perphenazine [Mass/volume] in Serum or Plasma --trough |
|
32105-9
|
Perphenazine [Presence] in Urine |
|
3928-9
|
Perphenazine [Mass/volume] in Urine |
|
59954-8
|
Perphenazine [Moles/volume] in Urine |
|
32106-7
|
Perphenazine [Presence] in Unspecified specimen |
|
57868-2
|
Perphenazine [Moles/volume] in Unspecified specimen |
|
81745-2
|
Personal advance care plan R1.0 - recommended CDA sections |
|
48150-7
|
Perseitol/Creatinine [Molar ratio] in Urine |
|
10947-0
|
Persimmon IgE Ab [Units/volume] in Serum |
|
29862-0
|
Persimmon IgE Ab RAST class [Presence] in Serum |
|
72148-0
|
Person attending birth [RHEA] |
|
88081-5
|
Title of person completing the form Provider |
|
88663-0
|
Person who performed defibrillation |
|
71582-1
|
Person performing procedure NEMSIS |
|
93079-2
|
Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby [NuPDQ] |
|
81358-4
|
Person(s) to notify upon death [Reported] |
|
81334-5
|
Patient Personal advance care plan |
|
81367-5
|
Personal advance care plan signer for declarant [Reported] |
|
75281-6
|
Personal belief |
|
82228-8
|
Personal care (washing, dressing, etc) [NDI] |
|
45606-1
|
Personal hygiene - self-performance during 7 day assessment period [CMS Assessment] |
|
45607-9
|
Personal hygiene - support provided during 7 day assessment period [CMS Assessment] |
|
90778-2
|
Personal pronouns - Reported |
|
71730-6
|
Personnel Five-digit postal code |
|
71729-8
|
Personnel Nine-digit postal code |
|
71720-7
|
Personnel Address |
|
71733-0
|
Personnel Address 2 |
|
91691-6
|
Personnel Age |
|
92009-0
|
Personnel Birth date |
|
71726-4
|
Personnel Business phone number |
|
71725-6
|
Personnel Business phone number extension |
|
71723-1
|
Personnel Cell phone number |
|
71732-2
|
Personnel City |
|
91003-4
|
Personnel contact information panel |
|
71735-5
|
Personnel Credentials |
|
71728-0
|
Personnel Email address |
|
71526-8
|
Personnel employment name Dialysis facility [ESRD] |
|
71727-2
|
Personnel Fax number |
|
71739-7
|
Personnel First name |
|
94134-4
|
Personnel Funeral service licensee or other agent assuming custody of the body of the deceased |
|
91694-0
|
Highest level of education of Personnel |
|
71724-9
|
Personnel Home phone number |
|
71516-9
|
Personnel job code Dialysis facility [ESRD] |
|
71528-4
|
Personnel job description Dialysis facility [ESRD] |
|
92035-5
|
Personnel Job experience |
|
91002-6
|
Personnel Job position |
|
71591-2
|
Personnel Job title |
|
71740-5
|
Personnel Last name |
|
71738-9
|
Personnel Middle initial |
|
90093-6
|
Personnel name |
|
71736-3
|
Personnel Name prefix |
|
71737-1
|
Personnel Name suffix |
|
90896-2
|
Personnel Person assigned to task |
|
90058-9
|
Person responsible for generating report |
|
71734-8
|
Personnel Preferred mailing address |
|
91695-7
|
Personnel Qualification |
|
91905-0
|
Personnel Response team leader information panel |
|
91906-8
|
Personnel Response team leader qualification |
|
91904-3
|
Personnel Response team member qualification |
|
91693-2
|
Personnel specialty |
|
71731-4
|
Personnel State |
|
92030-6
|
Personnel Supervisor address |
|
92026-4
|
Personnel Supervisor contact information panel |
|
92029-8
|
Personnel Supervisor email address |
|
92028-0
|
Personnel Supervisor name |
|
92031-4
|
Personnel Supervisor title |
|
71749-6
|
Personnel unique identifier |
|
90660-2
|
Pulmonary Embolism Severity Index score interpretation PESI |
|
89693-6
|
PESI Total score |
|
13020-3
|
Pesticides [Identifier] in Blood |
|
13021-1
|
Pesticides [Identifier] in Gastric fluid |
|
54093-0
|
Pesticides [Presence] in Gastric fluid by Screen method |
|
13019-5
|
Pesticides [Identifier] in Serum or Plasma |
|
13018-7
|
Pesticides [Identifier] in Urine |
|
23764-4
|
Pesticides [Identifier] in Unspecified specimen |
|
81551-4
|
PET+CT Bone from skull base to mid-thigh W 18F-NaF IV |
|
87907-2
|
PET+CT Brain for amyloidosis |
|
92927-3
|
PET+CT Brain for tau protein |
|
86976-8
|
PET+CT Brain metabolic |
|
81559-7
|
PET+CT Unspecified body region for simulation limited |
|
81553-0
|
PET+CT Guidance limited for localization of tumor of Unspecified body region-- W 18F-FDG IV |
|
87905-6
|
PET+CT Guidance for localization of tumor of Head and Neck-- W 18F-FDG IV |
|
82800-4
|
PET+CT Heart W contrast IV |
|
82801-2
|
PET+CT Heart WO contrast |
|
81554-8
|
PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV |
|
89712-4
|
PET+CT Guidance for limited for localization of tumor of Unspecified body region-- W 18F-FDG IV and W contrast IV |
|
87915-5
|
PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and W contrast IV |
|
81552-2
|
PET+CT Whole body Bone W 18F-NaF IV |
|
76660-0
|
Phosphatidylethanol [Presence] in Blood by Screen method |
|
74661-0
|
Phosphatidylethanol [Mass/volume] in Blood |
|
9731-1
|
Phosphoethanolamine [Mass/time] in 24 hour Urine |
|
34355-8
|
Phosphoethanolamine [Moles/volume] in 24 hour Urine |
|
26611-4
|
Phosphoethanolamine [Moles/time] in 24 hour Urine |
|
13410-6
|
Phosphoethanolamine [Mass/volume] in Amniotic fluid |
|
27278-1
|
Phosphoethanolamine [Moles/volume] in Amniotic fluid |
|
26717-9
|
Phosphoethanolamine [Moles/volume] in Blood |
|
11224-3
|
Phosphoethanolamine [Mass/volume] in Cerebral spinal fluid |
|
26597-5
|
Phosphoethanolamine [Moles/volume] in Cerebral spinal fluid |
|
54326-4
|
Phosphoethanolamine [Moles/volume] in DBS |
|
50950-5
|
Phosphoethanolamine IgA Ab [Presence] in Serum or Plasma |
|
50954-7
|
Phosphoethanolamine IgG Ab [Presence] in Serum or Plasma |
|
50953-9
|
Phosphoethanolamine IgM Ab [Presence] in Serum or Plasma |
|
17458-1
|
Phosphoethanolamine [Presence] in Serum or Plasma |
|
2789-6
|
Phosphoethanolamine [Mass/volume] in Serum or Plasma |
|
26612-2
|
Phosphoethanolamine [Moles/volume] in Serum or Plasma |
|
17457-3
|
Phosphoethanolamine [Presence] in Urine |
|
2790-4
|
Phosphoethanolamine [Mass/volume] in Urine |
|
12473-5
|
Phosphoethanolamine [Mass/time] in Urine |
|
25502-6
|
Phosphoethanolamine [Moles/volume] in Urine |
|
44352-3
|
Phosphoethanolamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56966-5
|
Phosphoethanolamine/Creatinine [Ratio] in 24 hour Urine |
|
44351-5
|
Phosphoethanolamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13789-3
|
Phosphoethanolamine/Creatinine [Mass Ratio] in Urine |
|
28604-7
|
Phosphoethanolamine/Creatinine [Ratio] in Urine |
|
25122-3
|
Phosphoethanolamine/Creatinine [Molar ratio] in Urine |
|
23361-9
|
Porcine enterovirus Ab [Presence] in Serum |
|
23363-5
|
Porcine enterovirus Ab [Presence] in Serum by Immunoassay |
|
23362-7
|
Porcine enterovirus Ab [Presence] in Serum by Neutralization test |
|
31944-2
|
Porcine enterovirus Ag [Presence] in Unspecified specimen |
|
23364-3
|
Porcine enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23360-1
|
Porcine enterovirus Ag [Presence] in Unspecified specimen by Neutralization test |
|
88217-5
|
Parechovirus RNA [Presence] in Aspirate by NAA with probe detection |
|
91825-0
|
Parechovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88218-3
|
Parechovirus RNA [Presence] in Stool by NAA with probe detection |
|
88219-1
|
Parechovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
60525-3
|
Parechovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
81838-5
|
PEX1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81835-1
|
PEX7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
6001-2
|
Platelet factor 3 [Units/volume] in Platelet poor plasma |
|
40686-8
|
Platelet factor 3 [Units/volume] in Platelet rich plasma |
|
6003-8
|
Platelet factor 4 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
50747-5
|
Platelet factor 4 Ag [Presence] in Platelet poor plasma by Immunoassay |
|
34701-3
|
Heparin induced platelet Ab [Presence] in Serum |
|
45155-9
|
Heparin induced platelet Ab [Units/volume] in Serum |
|
57761-9
|
Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay |
|
73816-1
|
Heparin induced platelet IgG Ab [Interpretation] in Serum Narrative |
|
73818-7
|
Heparin induced platelet IgG Ab in Serum or Plasma by Immunoassay |
|
73819-5
|
Heparin induced platelet IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
33594-3
|
Platelet factor 4 [Presence] in Platelet poor plasma |
|
6002-0
|
Platelet factor 4 [Units/volume] in Platelet poor plasma |
|
69582-5
|
PFGE restriction enzyme [Identifier] in Isolate |
|
2791-2
|
Phosphofructokinase [Enzymatic activity/volume] in Blood |
|
44052-9
|
Phosphofructokinase [Enzymatic activity/mass] in Blood |
|
11058-5
|
Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells |
|
72664-6
|
Phosphofructokinase [Enzymatic activity/mass] in Red Blood Cells |
|
2792-0
|
Phosphofructokinase [Enzymatic activity/volume] in Serum |
|
2793-8
|
Phosphofructokinase F subunit/Phosphofructokinase.total in Platelets |
|
2794-6
|
Phosphofructokinase F subunit/Phosphofructokinase.total in Leukocytes |
|
2795-3
|
Phosphofructokinase L subunit/Phosphofructokinase.total in Red Blood Cells |
|
2796-1
|
Phosphofructokinase M subunit/Phosphofructokinase.total in Red Blood Cells |
|
41930-9
|
Type of Peak flow meter |
|
41932-5
|
Peak flow meter Vendor model code |
|
41933-3
|
Peak flow meter Vendor serial number |
|
41934-1
|
Peak flow meter Vendor software version |
|
41931-7
|
Peak flow meter Vendor name |
|
82623-0
|
Peak filling rate Left ventricle SPECT --resting |
|
82622-2
|
Peak filling rate Left ventricle SPECT --W stress |
|
2785-4
|
Phosphatidylglycerol [Presence] in Amniotic fluid |
|
27420-9
|
Phosphatidylglycerol [Units/volume] in Amniotic fluid |
|
2786-2
|
Phosphatidylglycerol [Mass/volume] in Amniotic fluid |
|
59807-8
|
Phosphatidylglycerol [Moles/volume] in Amniotic fluid |
|
17451-6
|
Phosphatidylglycerol IgA Ab [Presence] in Serum |
|
13081-5
|
Phosphatidylglycerol IgA Ab [Units/volume] in Serum |
|
17452-4
|
Phosphatidylglycerol IgG Ab [Presence] in Serum |
|
13079-9
|
Phosphatidylglycerol IgG Ab [Units/volume] in Serum |
|
17453-2
|
Phosphatidylglycerol IgM Ab [Presence] in Serum |
|
13080-7
|
Phosphatidylglycerol IgM Ab [Units/volume] in Serum |
|
20499-0
|
Phosphatidylglycerol/Surfactant.total in Amniotic fluid |
|
11059-3
|
Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells |
|
44053-7
|
Phosphoglycerate kinase [Enzymatic activity/mass] in Red Blood Cells |
|
2798-7
|
Phosphoglycerate kinase [Enzymatic activity/volume] in Serum |
|
27378-9
|
pH of 24 hour Urine |
|
50897-8
|
pH of 24 hour Urine by Test strip |
|
53651-6
|
pH of 2 hour Urine |
|
53652-4
|
pH of 4 hour Urine |
|
2743-3
|
pH of Amniotic fluid |
|
53653-2
|
pH of Bile fluid |
|
11558-4
|
pH of Blood |
|
2744-1
|
pH of Arterial blood |
|
2745-8
|
pH of Capillary blood |
|
33913-5
|
pH of Capillary blood from Fetus |
|
14873-4
|
pH of Cord blood |
|
28646-8
|
pH of Arterial cord blood |
|
28647-6
|
pH of Venous cord blood |
|
19213-8
|
pH of Mixed venous blood |
|
2746-6
|
pH of Venous blood |
|
53600-3
|
pH of Blood product unit |
|
10582-5
|
pH of Cervical mucus |
|
9347-6
|
pH combined acid of Gastric fluid |
|
2747-4
|
pH of Cerebral spinal fluid |
|
53654-0
|
pH of Dialysis fluid |
|
92199-9
|
Public health emergency budget breakdown details Reporting Period Document |
|
92200-5
|
Public health emergency budget implementing unit name [Identifier] |
|
92198-1
|
Public health emergency budget source |
|
90064-7
|
Public health emergency event name |
|
92197-3
|
Public health emergency budget [#] Reporting Period |
|
2748-2
|
pH of Body fluid |
|
50896-0
|
pH of Body fluid by Test strip |
|
55976-5
|
pH of Nonbiological fluid |
|
9348-4
|
pH free acid of Gastric fluid |
|
2749-0
|
pH of Gastric fluid |
|
80830-3
|
pH of Lower respiratory specimen |
|
93843-1
|
Primary hyperoxaluria multigene analysis in Blood or Tissue by Molecular genetics method |
|
54217-5
|
Public health notifiable condition |
|
42728-6
|
pH of Ocular fluid |
|
33417-7
|
pH of Pericardial fluid |
|
68382-1
|
pH of Pericardial fluid by Test strip |
|
2750-8
|
pH of Pleural fluid |
|
50895-2
|
pH of Pleural fluid by Test strip |
|
2751-6
|
pH of Peritoneal fluid |
|
68459-7
|
pH of Peritoneal fluid by Test strip |
|
56963-2
|
pH of Saliva (oral fluid) |
|
2753-2
|
pH of Serum or Plasma |
|
2752-4
|
pH of Semen |
|
2754-0
|
pH of Synovial fluid |
|
68381-3
|
pH of Synovial fluid by Test strip |
|
35330-0
|
pH of Body fluid--1st specimen post Sincalide |
|
35329-2
|
pH of Body fluid--2nd specimen post Sincalide |
|
35328-4
|
pH of Body fluid--3rd specimen post Sincalide |
|
35327-6
|
pH of Body fluid--4th specimen post Sincalide |
|
35326-8
|
pH of Body fluid--5th specimen post Sincalide |
|
2755-7
|
pH of Stool |
|
49701-6
|
pH of Blood adjusted to patient's actual temperature |
|
33254-4
|
pH of Arterial blood adjusted to patient's actual temperature |
|
39485-8
|
pH of Capillary blood adjusted to patient's actual temperature |
|
47720-8
|
pH of Cord blood adjusted to patient's actual temperature |
|
49698-4
|
pH of Arterial cord blood adjusted to patient's actual temperature |
|
49699-2
|
pH of Venous cord blood adjusted to patient's actual temperature |
|
50980-2
|
pH of Mixed venous blood adjusted to patient's actual temperature |
|
39486-6
|
pH of Venous blood adjusted to patient's actual temperature |
|
9349-2
|
pH total acid of Gastric fluid |
|
55968-2
|
pH of Total parental nutrition |
|
2756-5
|
pH of Urine |
|
5803-2
|
pH of Urine by Test strip |
|
50560-2
|
pH of Urine by Automated test strip |
|
48037-6
|
pH of Vaginal fluid |
|
72269-4
|
pH of Vaginal fluid by Test strip |
|
42670-0
|
pH of Vitreous fluid |
|
9481-3
|
pH of Water |
|
17433-4
|
pH of Unspecified specimen |
|
82636-2
|
Phase.standard deviation [Angle] Left ventricle SPECT --resting |
|
82628-9
|
Phase.standard deviation [Angle] Left ventricle SPECT --W stress |
|
57742-9
|
Phadiatop infant IgE Ab [Units/volume] in Serum |
|
82024-1
|
Phadiatop infant IgE Ab RAST class [Presence] in Serum |
|
57036-6
|
Phadiatop inhalant allergen IgE Ab [Units/volume] in Serum |
|
7599-4
|
Phadiatop IgE Ab [Units/volume] in Serum |
|
82023-3
|
Phadiatop IgE Ab RAST class [Presence] in Serum |
|
51965-2
|
Pharmacogenetic analysis report Document |
|
90006-8
|
Pharmacogenomics Consult note |
|
93964-5
|
Pharmacogenomics Diagnostic study note |
|
90005-0
|
Pharmacogenomics Outpatient Note |
|
90007-6
|
Pharmacogenomics Progress note |
|
90008-4
|
Pharmacogenomics Telehealth Note |
|
85153-5
|
Pharmacology Admission evaluation note |
|
88360-3
|
Pharmacology Alert |
|
34820-1
|
Pharmacology Consult note |
|
34869-8
|
Pharmacology Counseling note |
|
78583-2
|
Pharmacology Discharge instructions |
|
85154-3
|
Pharmacology Discharge summary |
|
78589-9
|
Pharmacology Discharge teaching note |
|
75467-1
|
Pharmacology Evaluation and management of anticoagulation note |
|
85155-0
|
Pharmacology Evaluation and management of hyperlipidemia note |
|
85156-8
|
Pharmacology Evaluation and management of hypertension note |
|
78601-2
|
Pharmacology Education note |
|
68586-7
|
Pharmacology Hospital Consult note |
|
68587-5
|
Pharmacology Hospital Medication management note |
|
85157-6
|
Pharmacology Hospital Note |
|
82837-6
|
Pharmacology Initial evaluation note |
|
85158-4
|
Pharmacology Letter |
|
85159-2
|
Pharmacology Long term care facility Admission evaluation note |
|
85160-0
|
Pharmacology Long term care facility Medication management note |
|
85161-8
|
Pharmacology Long term care facility Note |
|
75468-9
|
Pharmacology Medication management note |
|
34821-9
|
Pharmacology Note |
|
85162-6
|
Pharmacology Nurse Outpatient Evaluation and management of anticoagulation note |
|
85163-4
|
Pharmacology Outpatient Counseling note |
|
85164-2
|
Pharmacology Outpatient Evaluation and management of anticoagulation note |
|
85165-9
|
Pharmacology Outpatient Evaluation and management of hyperlipidemia note |
|
85166-7
|
Pharmacology Outpatient Medication management note |
|
75469-7
|
Pharmacology Outpatient Note |
|
34132-1
|
Pharmacology Outpatient Progress note |
|
75470-5
|
Pharmacology Telephone encounter Note |
|
80797-4
|
Pharmacology Plan of care note |
|
80569-7
|
Pharmacology Progress note |
|
85167-5
|
Pharmacology Patient's home Medication management note |
|
85168-3
|
Pharmacology Patient's home Note |
|
57152-1
|
Pharmacology Referral note |
|
85169-1
|
Pharmacology Team Note |
|
85170-9
|
Pharmacology Technician Note |
|
93024-8
|
Pharmacist Consult note |
|
73709-8
|
Prescription request Pharmacy Document from Pharmacist |
|
93023-0
|
Pharmacist Plan of care note |
|
82118-1
|
Pharmacogenomics result panel |
|
82637-0
|
Phase bandwidth Left ventricle SPECT --resting |
|
82629-7
|
Phase bandwidth Left ventricle SPECT --W stress |
|
82638-8
|
Phase entropy [Score] Left ventricle SPECT --resting |
|
82630-5
|
Phase entropy [Score] Left ventricle SPECT --W stress |
|
2767-2
|
Phenylalanine [Mass/time] in 24 hour Urine |
|
25969-7
|
Phenylalanine [Moles/volume] in 24 hour Urine |
|
25495-3
|
Phenylalanine [Moles/time] in 24 hour Urine |
|
13409-8
|
Phenylalanine [Mass/volume] in Amniotic fluid |
|
26981-1
|
Phenylalanine [Moles/volume] in Amniotic fluid |
|
49484-9
|
Phenylalanine [Presence] in Blood |
|
12803-3
|
Phenylalanine [Presence] in Blood by Guthrie test |
|
2762-3
|
Phenylalanine [Mass/volume] in Blood |
|
2763-1
|
Phenylalanine [Mass/volume] in Cerebral spinal fluid |
|
22646-4
|
Phenylalanine [Moles/volume] in Cerebral spinal fluid |
|
29571-7
|
Phenylalanine [Presence] in DBS |
|
29572-5
|
Phenylalanine [Mass/volume] in DBS |
|
29573-3
|
Phenylalanine [Moles/volume] in DBS |
|
32263-6
|
Phenylalanine [Moles/volume] in Body fluid |
|
55970-8
|
Phenylalanine [Moles/mass] in Hair |
|
81924-3
|
Phenylalanine intake 24 hour Estimated |
|
81925-0
|
Phenylalanine intake 24 hour Measured |
|
74303-9
|
Phenylalanine [Moles/volume] in DBS --post therapeutic diet |
|
2764-9
|
Phenylalanine [Presence] in Serum or Plasma |
|
27362-3
|
Phenylalanine [Units/volume] in Serum or Plasma |
|
2765-6
|
Phenylalanine [Mass/volume] in Serum or Plasma |
|
14875-9
|
Phenylalanine [Moles/volume] in Serum or Plasma |
|
47723-2
|
Phenylalanine/Amino acids.total in Amniotic fluid |
|
47722-4
|
Phenylalanine/Amino acids.total in Cerebral spinal fluid |
|
55969-0
|
Phenylalanine/Amino acids.total in DBS |
|
47721-6
|
Phenylalanine/Amino acids.total in Hair |
|
47724-0
|
Phenylalanine/Amino acids.total in Serum or Plasma |
|
47725-7
|
Phenylalanine/Amino acids.total in Unspecified specimen |
|
13893-3
|
Phenylalanine [Presence] in Urine |
|
2766-4
|
Phenylalanine [Mass/volume] in Urine |
|
26967-0
|
Phenylalanine [Moles/volume] in Urine |
|
32264-4
|
Phenylalanine [Moles/volume] in Vitreous fluid |
|
22737-1
|
Phenylalanine [Moles/volume] in Unspecified specimen |
|
44348-1
|
Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine |
|
47981-6
|
Phenylalanine/Creatinine [Ratio] in 24 hour Urine |
|
25970-5
|
Phenylalanine/Creatinine [Molar ratio] in 24 hour Urine |
|
44349-9
|
Phenylalanine/Creatinine [Mass Ratio] in Urine |
|
30055-8
|
Phenylalanine/Creatinine [Ratio] in Urine |
|
18475-4
|
Phenylalanine/Creatinine [Molar ratio] in Urine |
|
35572-7
|
Phenylalanine/Tyrosine [Molar ratio] in DBS |
|
74300-5
|
Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet |
|
2768-0
|
Phenylalanine/Tyrosine [Mass Ratio] in Serum or Plasma |
|
32265-1
|
Phenylalanine/Tyrosine [Molar ratio] in Serum or Plasma |
|
41170-2
|
Phenylalanine+Tyrosine [Presence] in Blood |
|
38495-8
|
Phenylalanine+Tyrosine [Presence] in Urine |
|
16105-9
|
Pheasant IgE Ab [Units/volume] in Serum |
|
21456-9
|
Pheasant IgE Ab RAST class [Presence] in Serum |
|
4387-7
|
Phenacetin [Mass] of Dose |
|
3929-7
|
Phenacetin [Mass/volume] in Serum or Plasma |
|
55565-6
|
Phenacetin [Moles/volume] in Serum or Plasma |
|
12368-7
|
Phenacetin [Presence] in Urine |
|
60161-7
|
Phenacemide [Mass/volume] in Blood |
|
11249-0
|
Phenacemide [Mass/volume] in Serum or Plasma |
|
60162-5
|
Phenacemide [Mass/volume] in Urine |
|
3933-9
|
Phenazocine [Mass/time] in 24 hour Urine |
|
4388-5
|
Phenazocine [Mass] of Dose |
|
3931-3
|
Phenazocine [Presence] in Urine |
|
3932-1
|
Phenazocine [Mass/volume] in Urine |
|
17434-2
|
Phenazopyridine [Mass/volume] in Serum or Plasma |
|
3941-2
|
Phendimetrazine [Mass/time] in 24 hour Urine |
|
4390-1
|
Phendimetrazine [Mass] of Dose |
|
26711-2
|
Phendimetrazine [Mass/mass] in Meconium |
|
27102-3
|
Phendimetrazine [Mass/volume] in Milk |
|
29613-7
|
Phendimetrazine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3938-8
|
Phendimetrazine [Mass/volume] in Serum or Plasma |
|
27303-7
|
Phendimetrazine [Mass/mass] in Stool |
|
3939-6
|
Phendimetrazine [Presence] in Urine |
|
3940-4
|
Phendimetrazine [Mass/volume] in Urine |
|
27178-3
|
Phendimetrazine [Mass/volume] in Vitreous fluid |
|
9778-2
|
Phenelzine [Mass/volume] in Serum or Plasma |
|
55566-4
|
Phenelzine [Moles/volume] in Serum or Plasma |
|
401-0
|
Phenethicillin [Susceptibility] by Disk diffusion (KB) |
|
400-2
|
Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
399-6
|
Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
41471-4
|
Phenethicillin [Mass/volume] in Serum or Plasma |
|
18967-0
|
Phenethicillin [Susceptibility] |
|
402-8
|
Phenethicillin [Susceptibility] by Serum bactericidal titer |
|
12331-5
|
Phenethylamine [Presence] in Urine |
|
26045-5
|
Pheneturide [Moles/volume] in Serum or Plasma |
|
4391-9
|
Pheniramine [Mass] of Dose |
|
3942-0
|
Pheniramine [Mass/volume] in Serum or Plasma |
|
55567-2
|
Pheniramine [Moles/volume] in Serum or Plasma |
|
78876-0
|
Pheniramine [Presence] in Urine |
|
17435-9
|
Pheniramine [Mass/volume] in Urine |
|
3946-1
|
Phenmetrazine [Mass/time] in 24 hour Urine |
|
19665-9
|
Phenmetrazine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19664-2
|
Phenmetrazine cutoff [Mass/volume] in Urine for Screen method |
|
4392-7
|
Phenmetrazine [Mass] of Dose |
|
43177-5
|
Phenmetrazine [Presence] in Hair by Screen method |
|
26712-0
|
Phenmetrazine [Mass/mass] in Meconium |
|
27101-5
|
Phenmetrazine [Mass/volume] in Milk |
|
29614-5
|
Phenmetrazine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3943-8
|
Phenmetrazine [Mass/volume] in Serum or Plasma |
|
27290-6
|
Phenmetrazine [Mass/mass] in Stool |
|
20555-9
|
Phenmetrazine [Mass/volume] in Urine by Confirmatory method |
|
3944-6
|
Phenmetrazine [Presence] in Urine |
|
16220-6
|
Phenmetrazine [Presence] in Urine by Confirmatory method |
|
19662-6
|
Phenmetrazine [Presence] in Urine by Screen method |
|
3945-3
|
Phenmetrazine [Mass/volume] in Urine |
|
27250-0
|
Phenmetrazine [Mass/volume] in Vitreous fluid |
|
72974-9
|
PHENobarbital induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72973-1
|
PHENobarbital induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72396-5
|
PHENobarbital [Mass/volume] in Blood by Confirmatory method |
|
19669-1
|
PHENobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19668-3
|
PHENobarbital cutoff [Mass/volume] in Urine for Screen method |
|
4393-5
|
PHENobarbital [Mass] of Dose |
|
29223-5
|
PHENobarbital [Mass/volume] in Body fluid |
|
3951-1
|
PHENobarbital Free [Mass/volume] in Serum or Plasma |
|
12484-2
|
PHENobarbital [Presence] in Gastric fluid |
|
17436-7
|
PHENobarbital [Mass/volume] in Gastric fluid |
|
47124-3
|
PHENobarbital [Moles/volume] in Gastric fluid |
|
26905-0
|
PHENobarbital [Mass/mass] in Hair |
|
73209-9
|
PHENobarbital induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73208-1
|
PHENobarbital induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27235-1
|
PHENobarbital [Mass/mass] in Meconium |
|
27051-2
|
PHENobarbital [Mass/volume] in Milk |
|
72453-4
|
PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72628-1
|
PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
60468-6
|
PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3947-9
|
PHENobarbital [Presence] in Serum or Plasma |
|
35631-1
|
PHENobarbital [Mass/volume] in Serum or Plasma by Screen method |
|
82970-5
|
PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3948-7
|
PHENobarbital [Mass/volume] in Serum or Plasma |
|
14874-2
|
PHENobarbital [Moles/volume] in Serum or Plasma |
|
12501-3
|
PHENobarbital [Presence] in Stool |
|
27240-1
|
PHENobarbital [Mass/mass] in Stool |
|
74926-7
|
PHENobarbital [Mass/volume] in Serum or Plasma --trough |
|
16241-2
|
PHENobarbital [Mass/volume] in Urine by Confirmatory method |
|
3949-5
|
PHENobarbital [Presence] in Urine |
|
16192-7
|
PHENobarbital [Presence] in Urine by Confirmatory method |
|
19666-7
|
PHENobarbital [Presence] in Urine by Screen method |
|
3950-3
|
PHENobarbital [Mass/volume] in Urine |
|
39487-4
|
PHENobarbital [Moles/volume] in Urine |
|
27191-6
|
PHENobarbital [Mass/volume] in Vitreous fluid |
|
32108-3
|
PHENobarbital [Presence] in Unspecified specimen |
|
64133-2
|
PHENobarbital/Creatinine [Mass Ratio] in Urine |
|
57094-5
|
Phenol [Mass/volume] adjusted to specific gravity 1.024 in Urine |
|
38615-1
|
Phenol [Mass/volume] in Air |
|
2757-3
|
Phenol [Mass/volume] in Blood |
|
2758-1
|
Phenol [Mass/volume] in Urine |
|
56647-1
|
Phenol/Creatinine [Ratio] in 24 hour Urine |
|
44347-3
|
Phenol/Creatinine [Molar ratio] in 24 hour Urine |
|
13487-4
|
Phenol/Creatinine [Mass Ratio] in Urine |
|
44346-5
|
Phenol/Creatinine [Molar ratio] in Urine |
|
17438-3
|
Phenolphthalein [Mass/volume] in Blood |
|
48044-2
|
Phenolphthalein cutoff [Mass/mass] in Stool |
|
50357-3
|
Phenolphthalein [Presence] in Serum or Plasma |
|
60163-3
|
Phenolphthalein [Mass/volume] in Serum or Plasma |
|
55568-0
|
Phenolphthalein [Moles/volume] in Serum or Plasma |
|
26868-0
|
Phenolphthalein [Presence] in Stool |
|
16183-6
|
Phenolphthalein [Mass/volume] in Stool |
|
10883-7
|
Phenolphthalein [Mass/mass] in Stool |
|
12317-4
|
Phenolphthalein [Presence] in Urine |
|
17437-5
|
Phenolphthalein [Mass/volume] in Urine |
|
49105-0
|
Phenolphthalein [Mass/volume] in Unspecified specimen |
|
45140-1
|
Phenols [Mass/time] in 24 hour Urine |
|
17439-1
|
Phenols [Mass/volume] in Blood |
|
20938-7
|
Phenols [Mass/volume] in Gastric fluid |
|
59825-0
|
Phenols [Presence] in Urine |
|
2759-9
|
Phenols [Mass/volume] in Urine |
|
49106-8
|
Phenols [Mass/volume] in Unspecified specimen |
|
2760-7
|
Phenolsulphonphthalein [Mass/volume] in Urine |
|
19673-3
|
Phenothiazines cutoff [Mass/volume] in Urine for Confirmatory method |
|
19672-5
|
Phenothiazines cutoff [Mass/volume] in Urine for Screen method |
|
4394-3
|
Phenothiazines [Mass] of Dose |
|
9808-7
|
Phenothiazines [Presence] in Gastric fluid |
|
3952-9
|
Phenothiazines [Presence] in Serum or Plasma |
|
17440-9
|
Phenothiazines [Units/volume] in Serum or Plasma |
|
42528-0
|
Phenothiazines [Mass/volume] in Serum or Plasma |
|
20556-7
|
Phenothiazines [Mass/volume] in Urine by Confirmatory method |
|
3953-7
|
Phenothiazines [Presence] in Urine |
|
16221-4
|
Phenothiazines [Presence] in Urine by Confirmatory method |
|
19670-9
|
Phenothiazines [Presence] in Urine by Screen method |
|
17441-7
|
Phenothiazines [Units/volume] in Urine |
|
3954-5
|
Phenothiazines [Mass/volume] in Urine |
|
34178-4
|
Phenothiazines [Presence] in Unspecified specimen |
|
89200-0
|
Phenotypic lab test method used to determine resistance [Identifier] in Isolate |
|
35109-8
|
Phenprocoumon [Mass/volume] in Serum or Plasma |
|
60164-1
|
Phensuximide [Mass/volume] in Blood |
|
4395-0
|
Phensuximide [Mass] of Dose |
|
3955-2
|
Phensuximide [Mass/volume] in Serum or Plasma |
|
39488-2
|
Phensuximide [Moles/volume] in Serum or Plasma |
|
60165-8
|
Phensuximide [Mass/volume] in Urine |
|
3959-4
|
Phentermine [Mass/time] in 24 hour Urine |
|
3956-0
|
Phentermine [Mass/volume] in Blood |
|
19677-4
|
Phentermine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19676-6
|
Phentermine cutoff [Mass/volume] in Urine for Screen method |
|
4396-8
|
Phentermine [Mass] of Dose |
|
40395-6
|
Phentermine [Presence] in Gastric fluid |
|
43178-3
|
Phentermine [Presence] in Hair by Screen method |
|
26713-8
|
Phentermine [Mass/mass] in Meconium |
|
26990-2
|
Phentermine [Mass/volume] in Milk |
|
92644-4
|
Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
29608-7
|
Phentermine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
32579-5
|
Phentermine [Mass/volume] in Serum or Plasma |
|
55569-8
|
Phentermine [Moles/volume] in Serum or Plasma |
|
27305-2
|
Phentermine [Mass/mass] in Stool |
|
20557-5
|
Phentermine [Mass/volume] in Urine by Confirmatory method |
|
3957-8
|
Phentermine [Presence] in Urine |
|
16222-2
|
Phentermine [Presence] in Urine by Confirmatory method |
|
19674-1
|
Phentermine [Presence] in Urine by Screen method |
|
3958-6
|
Phentermine [Mass/volume] in Urine |
|
27234-4
|
Phentermine [Mass/volume] in Vitreous fluid |
|
64134-0
|
Phentermine/Creatinine [Mass Ratio] in Urine |
|
93340-8
|
PhenX - complete blood count protocol 220501 |
|
93149-3
|
PhenX - bone age protocol 220301 |
|
75062-0
|
Phenylacetate [Moles/volume] in Serum or Plasma |
|
50358-1
|
Phenylacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
13791-9
|
Phenylacetate/Creatinine [Mass Ratio] in Urine |
|
25124-9
|
Phenylacetate/Creatinine [Molar ratio] in Urine |
|
53205-1
|
Phenylacetylcarnitine (PheC2) [Moles/volume] in DBS |
|
90237-9
|
Phenylacetylcarnitine (PheC2) [Moles/volume] in Serum or Plasma |
|
4397-6
|
Phenylbutazone [Mass] of Dose |
|
68454-8
|
Phenylbutazone [Moles/volume] in Gastric fluid |
|
56878-2
|
Phenylbutazone IgE Ab [Units/volume] in Serum |
|
3960-2
|
Phenylbutazone [Mass/volume] in Serum or Plasma |
|
25500-0
|
Phenylbutazone [Moles/volume] in Serum or Plasma |
|
68379-7
|
Phenylbutazone [Moles/volume] in Urine |
|
68962-0
|
Phenylbutazone [Moles/volume] in Unspecified specimen |
|
4398-4
|
Phenylephrine [Mass] of Dose |
|
17442-5
|
Phenylephrine [Mass/volume] in Serum or Plasma |
|
3962-8
|
Phenylephrine [Mass/volume] in Urine |
|
11250-8
|
Phenylethylmalonate [Mass/volume] in Serum or Plasma |
|
12537-7
|
Phenylglyoxylate [Mass/volume] in Urine |
|
56648-9
|
Phenylglyoxylate/Creatinine [Ratio] in 24 hour Urine |
|
13830-5
|
Phenylglyoxylate/Creatinine [Mass Ratio] in Urine |
|
2761-5
|
Phenylketones [Presence] in Blood |
|
2769-8
|
Phenylketones [Presence] in Urine |
|
72437-7
|
Phenyllactate [Moles/volume] in Serum or Plasma |
|
32583-7
|
Phenyllactate [Presence] in Urine |
|
50359-9
|
Phenyllactate/Creatinine [Molar ratio] in 24 hour Urine |
|
13792-7
|
Phenyllactate/Creatinine [Mass Ratio] in Urine |
|
25125-6
|
Phenyllactate/Creatinine [Molar ratio] in Urine |
|
2770-6
|
Phenylpyruvate [Mass/volume] in Blood |
|
2771-4
|
Phenylpyruvate [Mass/volume] in Plasma |
|
72436-9
|
Phenylpyruvate [Moles/volume] in Serum or Plasma |
|
2772-2
|
Phenylpyruvate [Presence] in Urine |
|
2773-0
|
Phenylpyruvate [Mass/volume] in Urine |
|
50361-5
|
Phenylpyruvate/Creatinine [Molar ratio] in 24 hour Urine |
|
13794-3
|
Phenylpyruvate/Creatinine [Mass Ratio] in Urine |
|
25126-4
|
Phenylpyruvate/Creatinine [Molar ratio] in Urine |
|
15373-4
|
Phenyltoloxamine [Mass/volume] in Blood |
|
14189-5
|
Phenyltoloxamine [Mass/volume] in Urine |
|
72972-3
|
Phenytoin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72971-5
|
Phenytoin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
65361-8
|
Phenytoin [Moles/volume] corrected for albumin in Serum or Plasma |
|
4225-9
|
Phenytoin [Mass] of Dose |
|
29224-3
|
Phenytoin [Mass/volume] in Body fluid |
|
10548-6
|
Phenytoin Free/Phenytoin.total in Serum or Plasma |
|
14190-3
|
Phenytoin Free [Mass/volume] in Saliva (oral fluid) |
|
3969-3
|
Phenytoin Free [Mass/volume] in Serum or Plasma |
|
32109-1
|
Phenytoin Free [Moles/volume] in Serum or Plasma |
|
74983-8
|
Phenytoin Free [Mass/volume] in Serum or Plasma --trough |
|
73206-5
|
Phenytoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73207-3
|
Phenytoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14073-1
|
Phenytoin [Mass/volume] in Saliva (oral fluid) |
|
3967-7
|
Phenytoin [Presence] in Serum or Plasma |
|
35632-9
|
Phenytoin [Mass/volume] in Serum or Plasma by Screen method |
|
3968-5
|
Phenytoin [Mass/volume] in Serum or Plasma |
|
14877-5
|
Phenytoin [Moles/volume] in Serum or Plasma |
|
14337-0
|
Phenytoin.total/Phenytoin.free [Mass Ratio] in Serum or Plasma |
|
74976-2
|
Phenytoin [Mass/volume] in Serum or Plasma --trough |
|
12310-9
|
Phenytoin [Presence] in Urine |
|
17444-1
|
Phenytoin [Mass/volume] in Urine |
|
43831-7
|
Phenytoin [Presence] in Unspecified specimen |
|
45154-2
|
Phenylalanine hydroxylase Ab [Units/volume] in Serum |
|
87383-6
|
Porcine hemagglutinating encephalomyelitis virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
53888-4
|
PHEX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
25168-6
|
Perhexiline [Mass/volume] in Serum or Plasma |
|
93875-3
|
Phosphohistone H3 [Presence] in Tissue by Immune stain |
|
14169-7
|
Peptide histidine isoleucine [Mass/volume] in Plasma |
|
34522-3
|
Phosphorylase kinase [Enzymatic activity/volume] in Red Blood Cells |
|
91074-5
|
Phlebovirus sp RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
73720-5
|
Pholcodine IgE Ab [Units/volume] in Serum |
|
81971-4
|
Pholcodine IgE Ab RAST class [Presence] in Serum |
|
4401-6
|
Pholedrine [Mass] of Dose |
|
3970-1
|
Pholedrine [Mass/volume] in Urine |
|
17446-6
|
Phoma sp IgE Ab [Units/volume] in Serum |
|
24517-5
|
Phoma sp IgG Ab [Units/volume] in Serum |
|
42077-8
|
Patient phone number |
|
85209-5
|
Telephone encounter Evaluation and management of smoking cessation note |
|
78290-4
|
Telephone encounter Initial evaluation note |
|
34748-4
|
Telephone encounter Note |
|
71534-2
|
Phone number Dialysis facility [ESRD] |
|
71509-4
|
Phone number extension Dialysis facility [ESRD] |
|
75499-4
|
Telephone encounter Triage note |
|
12547-6
|
Phorate [Mass/volume] in Serum or Plasma |
|
21457-7
|
Phorate [Mass/volume] in Urine |
|
87633-4
|
Phorate [Mass/mass] in Unspecified specimen |
|
38715-9
|
Phosgene [Mass/volume] in Air |
|
35673-3
|
Phosphate [Mass/volume] in Urine collected for unspecified duration |
|
80611-7
|
Phosphate [Moles/volume] in Urine collected for unspecified duration |
|
57348-5
|
Phosphate [Mass/volume] in 12 hour Urine |
|
54922-0
|
Phosphate [Mass/time] in 12 hour Urine |
|
51604-7
|
Phosphate [Moles/time] in 12 hour Urine |
|
58993-7
|
Phosphate [Mass/time] in 18 hour Urine |
|
59167-7
|
Phosphate [Moles/time] in 24 hour Stool |
|
21458-5
|
Phosphate [Mass/volume] in 24 hour Urine |
|
2779-7
|
Phosphate [Mass/time] in 24 hour Urine |
|
35263-3
|
Phosphate [Mass or Moles] in 24 hour Urine |
|
25973-9
|
Phosphate [Moles/volume] in 24 hour Urine |
|
14881-7
|
Phosphate [Moles/time] in 24 hour Urine |
|
57349-3
|
Phosphate [Mass/volume] in 2 hour Urine |
|
38717-5
|
Phosphate [Mass/volume] in Air |
|
14408-9
|
Phosphate [Mass/volume] in Amniotic fluid |
|
2774-8
|
Phosphate [Mass/volume] in Blood |
|
24519-1
|
Phosphate [Moles/volume] in Blood |
|
50058-7
|
Phosphate renal clearance in Urine and Serum or Plasma collected for unspecified duration |
|
2776-3
|
Phosphate renal clearance in 24 hour Urine and Serum or Plasma |
|
13542-6
|
Phosphate [Mass/volume] in Cerebral spinal fluid |
|
48046-7
|
Phosphate cutoff [Mass/mass] in Stool |
|
59037-2
|
Phosphate [Mass/volume] in Peritoneal dialysis fluid |
|
49006-0
|
Phosphate [Moles/volume] in Peritoneal dialysis fluid |
|
2775-5
|
Phosphate [Mass/volume] in Dialysis fluid |
|
35220-3
|
Phosphate [Mass or Moles/volume] in Dialysis fluid |
|
34938-1
|
Phosphate [Moles/volume] in Dialysis fluid |
|
58019-1
|
Phosphate [Mass/volume] in Nonbiological fluid |
|
12242-4
|
Phosphate [Mass/volume] in Body fluid |
|
25501-8
|
Phosphate [Moles/volume] in Body fluid |
|
14407-1
|
Phosphate [Mass/volume] in Gastric fluid |
|
86916-4
|
Phosphate goal [Mass/volume] Serum or Plasma |
|
76656-8
|
Phosphate [Mass/mass] in Hair |
|
50898-6
|
Phosphate [Moles/mass] in Hair |
|
48617-5
|
Phosphate [Mass/volume] in Serum or Plasma --post dialysis |
|
55972-4
|
Phosphate [Moles/volume] in Serum or Plasma --post dialysis |
|
14404-8
|
Phosphate [Mass/volume] in Pleural fluid |
|
48641-5
|
Phosphate [Mass/volume] in Serum or Plasma --pre dialysis |
|
14405-5
|
Phosphate [Mass/volume] in Peritoneal fluid |
|
55973-2
|
Phosphate [Moles/volume] in Peritoneal fluid |
|
27123-9
|
Phosphate [Mass/mass] in Red Blood Cells |
|
24520-9
|
Phosphate [Moles/volume] in Red Blood Cells |
|
74889-7
|
Phosphate [Moles/volume] in Saliva (oral fluid) |
|
2777-1
|
Phosphate [Mass/volume] in Serum or Plasma |
|
35221-1
|
Phosphate [Mass or Moles/volume] in Serum or Plasma |
|
14879-1
|
Phosphate [Moles/volume] in Serum or Plasma |
|
14406-3
|
Phosphate [Mass/volume] in Synovial fluid |
|
17447-4
|
Phosphate [Presence] in Stool |
|
88713-3
|
Phosphate [Mass/volume] in Stool |
|
10884-5
|
Phosphate [Mass/mass] in Stool |
|
59161-0
|
Phosphate [Moles/volume] in Stool |
|
14878-3
|
Phosphate [Presence] in Stone |
|
30544-1
|
Phosphate [Mass/volume] in Total parental nutrition |
|
2780-5
|
Phosphate [Presence] in Urine |
|
2778-9
|
Phosphate [Mass/volume] in Urine |
|
35222-9
|
Phosphate [Mass or Moles/volume] in Urine |
|
13539-2
|
Phosphate [Moles/volume] in Urine |
|
87456-0
|
Phosphate [Mass/volume] in Unspecified specimen |
|
87457-8
|
Phosphate [Mass/mass] in Unspecified specimen |
|
22733-0
|
Phosphate [Moles/volume] in Unspecified specimen |
|
13795-0
|
Phosphate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56965-7
|
Phosphate/Creatinine [Ratio] in 24 hour Urine |
|
25127-2
|
Phosphate/Creatinine [Molar ratio] in 24 hour Urine |
|
11141-9
|
Phosphate/Creatinine [Mass Ratio] in Urine |
|
56964-0
|
Phosphate/Creatinine [Ratio] in Urine |
|
34354-1
|
Phosphate/Creatinine [Molar ratio] in Urine |
|
33306-2
|
Phosphatidate Ab [Presence] in Serum |
|
47030-2
|
Phosphatidate IgA Ab [Units/volume] in Serum by Immunoassay |
|
13072-4
|
Phosphatidate IgA Ab [Units/volume] in Serum |
|
13070-8
|
Phosphatidate IgG Ab [Units/volume] in Serum |
|
47300-9
|
Phosphatidate IgM Ab [Units/volume] in Serum by Immunoassay |
|
13071-6
|
Phosphatidate IgM Ab [Units/volume] in Serum |
|
20940-3
|
Phosphide [Mass/mass] in Feed |
|
20939-5
|
Phosphide [Mass/mass] in Gastrointestinal content |
|
38716-7
|
Phosphine [Mass/volume] in Air |
|
2797-9
|
Phosphoglucomutase [Enzymatic activity/volume] in Serum |
|
2799-5
|
Phosphoglyceromutase [Enzymatic activity/volume] in Serum |
|
7600-0
|
Phospholipase IgE Ab [Units/volume] in Serum |
|
15932-7
|
Phospholipase IgE Ab RAST class [Presence] in Serum |
|
3285-4
|
Phospholipid Ab [Units/volume] in Serum by Immunoassay |
|
19140-3
|
Phospholipid Ab [Presence] in Serum |
|
7800-6
|
Phospholipid Ab [Units/volume] in Serum |
|
17459-9
|
Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay |
|
31561-4
|
Phospholipid IgA Ab [Units/volume] in Serum |
|
3286-2
|
Phospholipid IgG Ab [Units/volume] in Serum by Immunoassay |
|
20428-9
|
Phospholipid IgG Ab [Presence] in Serum |
|
7801-4
|
Phospholipid IgG Ab [Units/volume] in Serum |
|
3287-0
|
Phospholipid IgM Ab [Units/volume] in Serum by Immunoassay |
|
20429-7
|
Phospholipid IgM Ab [Presence] in Serum |
|
7802-2
|
Phospholipid IgM Ab [Units/volume] in Serum |
|
2567-6
|
Phospholipid phosphorus [Mass/volume] in Serum |
|
2568-4
|
Phospholipid [Mass/volume] in Serum or Plasma |
|
15089-6
|
Phospholipid [Moles/volume] in Serum or Plasma |
|
81132-3
|
Phosphorus intake 24 hour Estimated |
|
81946-6
|
Phosphorus intake 24 hour Measured |
|
44830-8
|
Phosphorylase [Enzymatic activity/volume] in Blood |
|
79464-4
|
Phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
|
9732-9
|
Phosphoserine [Mass/time] in 24 hour Urine |
|
9414-4
|
Phosphoserine [Moles/volume] in 24 hour Urine |
|
25503-4
|
Phosphoserine [Moles/time] in 24 hour Urine |
|
13411-4
|
Phosphoserine [Mass/volume] in Amniotic fluid |
|
26824-3
|
Phosphoserine [Moles/volume] in Amniotic fluid |
|
12807-4
|
Phosphoserine [Mass/volume] in Cerebral spinal fluid |
|
26737-7
|
Phosphoserine [Moles/volume] in Cerebral spinal fluid |
|
54489-0
|
Phosphoserine [Moles/volume] in DBS |
|
50951-3
|
Phosphoserine IgA Ab [Presence] in Serum or Plasma |
|
50952-1
|
Phosphoserine IgG Ab [Presence] in Serum or Plasma |
|
50955-4
|
Phosphoserine IgM Ab [Presence] in Serum or Plasma |
|
17461-5
|
Phosphoserine [Presence] in Serum or Plasma |
|
10838-1
|
Phosphoserine [Mass/volume] in Serum or Plasma |
|
20654-0
|
Phosphoserine [Moles/volume] in Serum or Plasma |
|
17460-7
|
Phosphoserine [Presence] in Urine |
|
2802-7
|
Phosphoserine [Mass/volume] in Urine |
|
26738-5
|
Phosphoserine [Moles/volume] in Urine |
|
57013-5
|
Phosphoserine/Creatinine [Ratio] in 24 hour Urine |
|
25974-7
|
Phosphoserine/Creatinine [Molar ratio] in 24 hour Urine |
|
13796-8
|
Phosphoserine/Creatinine [Mass Ratio] in Urine |
|
28600-5
|
Phosphoserine/Creatinine [Ratio] in Urine |
|
25128-0
|
Phosphoserine/Creatinine [Molar ratio] in Urine |
|
72170-4
|
Photographic image |
|
43246-8
|
PHOX2B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
20280-4
|
Pressure half time by US+Calculated |
|
80982-2
|
Phytanoyl CoA hydroxlase [Enzymatic activity/mass] in Fibroblast |
|
87519-5
|
Physical abuse investigation was initiated |
|
82294-0
|
Physical activity guideline used |
|
60869-5
|
Physiological dead space [Volume] Respiratory system --on ventilator |
|
76001-7
|
Physiological dead space [Volume] Respiratory system |
|
60870-3
|
Physiological dead space/Tidal volume Respiratory system --on ventilator |
|
76002-5
|
Physiological dead space/Tidal volume Respiratory system |
|
80271-0
|
Physical findings of Abdomen by Palpation |
|
80104-3
|
Physical findings of Left chorioretina by Ophthalmoscopy |
|
80103-5
|
Physical findings of Right chorioretina by Ophthalmoscopy |
|
51850-6
|
Physical findings of Head and Ears and Eyes and Nose and Throat |
|
79821-5
|
Physical findings of Left macula by Ophthalmoscopy |
|
79820-7
|
Physical findings of Right macula by Ophthalmoscopy |
|
80105-0
|
Physical findings of Left optic nerve by Ophthalmoscopy |
|
80106-8
|
Physical findings of Right optic nerve by Ophthalmoscopy |
|
79902-3
|
Physical findings of Left retinal vessels by Ophthalmoscopy |
|
79903-1
|
Physical findings of Right retinal vessels by Ophthalmoscopy |
|
85910-8
|
Physical findings of Teeth and gum Narrative |
|
75293-1
|
Physical findings of nutrition assessment |
|
76434-0
|
Physical therapist registry ID |
|
87517-9
|
Physical abuse was reported |
|
82815-2
|
Physical abuse--before 18 years old [ACE] |
|
76460-5
|
Physical activity APTA |
|
77242-6
|
Physical activity behavior |
|
54682-0
|
Physical behavioral symptoms directed toward others in last 7 days [CMS Assessment] |
|
75244-4
|
Physical condition [Norton scale] |
|
72045-8
|
Physical examination dialysis access performed prior, during and after cannulation [ESRD] |
|
90928-3
|
Physical findings of Mandible condyle |
|
85457-0
|
Physical health impacting mental well-being - visual analog rating [ePCAM] |
|
83330-1
|
Physical health impacting mental well-being [PCAM] |
|
85456-2
|
Physical health needs that require further investigation - visual analog rating [ePCAM] |
|
83328-5
|
Physical health needs that require further investigation [PCAM] |
|
72195-1
|
Physical limitation score [KCCQ] |
|
88472-6
|
Physical limitation score [SAQ] |
|
82818-6
|
Physical neglect--before 18 years old [ACE] |
|
86786-1
|
Physical restraints used in bed - bed rail used during 7 day assessment period [CMS Assessment] |
|
86788-7
|
Physical restraints used in bed - limb restraint during 7 day assessment period [CMS Assessment] |
|
86787-9
|
Physical restraints used in bed - trunk restraint used during 7 day assessment period [CMS Assessment] |
|
86792-9
|
Physical restraints used in chair or out of bed - chair prevents rising used during 7 day assessment period [CMS Assessment] |
|
86791-1
|
Physical restraints used in chair or out of bed - limb restraint used during 7 day assessment period [CMS Assessment] |
|
86790-3
|
Physical restraints used in chair or out of bed - trunk restraint used during 7 day assessment period [CMS Assessment] |
|
85618-7
|
Physical score [MLHFQ] |
|
92044-7
|
Physical security assessment system details |
|
92043-9
|
Physical security assessment system name |
|
92042-1
|
Physical security assessment system type |
|
93077-6
|
Physical symptom of pregnancy that you are feeling bothered, upset or worried about [NuPDQ] |
|
90532-3
|
Physical therapy - concurrent minutes during assessment period [CMS Assessment] |
|
58139-7
|
Physical therapy - concurrent minutes in the last 7 days [CMS Assessment] |
|
85558-5
|
Physical therapy - concurrent minutes--week 1 [CMS Assessment] |
|
85568-4
|
Physical therapy - concurrent minutes--week 2 [CMS Assessment] |
|
86766-3
|
Physical therapy - co-treatment minutes during 7 day assessment period [CMS Assessment] |
|
90533-1
|
Physical therapy - co-treatment minutes during assessment period [CMS Assessment] |
|
85560-1
|
Physical therapy - co-treatment minutes--week 1 [CMS Assessment] |
|
85570-0
|
Physical therapy - co-treatment minutes--week 2 [CMS Assessment] |
|
90534-9
|
Physical therapy - group minutes during assessment period [CMS Assessment] |
|
58140-5
|
Physical therapy - group minutes in the last 7 days [CMS Assessment] |
|
85559-3
|
Physical therapy - group minutes--week 1 [CMS Assessment] |
|
85569-2
|
Physical therapy - group minutes--week 2 [CMS Assessment] |
|
90535-6
|
Physical therapy - individual minutes during assessment period [CMS Assessment] |
|
58220-5
|
Physical therapy - individual minutes in the last 7 days [CMS Assessment] |
|
85557-7
|
Physical therapy - individual minutes--week 1 [CMS Assessment] |
|
85567-6
|
Physical therapy - individual minutes--week 2 [CMS Assessment] |
|
72175-3
|
Physician assessment necessary [RHEA] |
|
88299-3
|
Physician documented GDR as clinically contraindicated [CMS Assessment] |
|
44953-8
|
Physician follow up NPI [Identifier] |
|
44954-6
|
Physician managing NPI [Identifier] |
|
44951-2
|
Physician NPI [Identifier] |
|
2804-3
|
Phytanate (C16:0(CH3)4) [Mass/volume] in Serum or Plasma |
|
22671-2
|
Phytanate (C16:0(CH3)4) [Moles/volume] in Serum or Plasma |
|
47726-5
|
Phytanate (C16:0(CH3)4)/Creatinine [Molar ratio] in Urine |
|
26047-1
|
Phytate [Moles/volume] in Serum or Plasma |
|
9622-2
|
Phytonadione [Mass/volume] in Serum or Plasma |
|
58793-1
|
Phytonadione [Moles/volume] in Serum or Plasma |
|
33589-3
|
Phosphatidylinositol Ab [Units/volume] in Serum by Immunoassay |
|
33309-6
|
Phosphatidylinositol Ab [Presence] in Serum |
|
33612-3
|
Phosphatidylinositol Ab [Units/volume] in Serum |
|
33637-0
|
Phagocytic index of Blood by Flow cytometry (FC) |
|
15335-3
|
Penile cavernosal artery Pulsativity index by US.calculated |
|
12008-9
|
Pulsatility index US.doppler |
|
17454-0
|
Phosphatidylinositol IgA Ab [Presence] in Serum |
|
13084-9
|
Phosphatidylinositol IgA Ab [Units/volume] in Serum |
|
17455-7
|
Phosphatidylinositol IgG Ab [Presence] in Serum |
|
13082-3
|
Phosphatidylinositol IgG Ab [Units/volume] in Serum |
|
17456-5
|
Phosphatidylinositol IgM Ab [Presence] in Serum |
|
13083-1
|
Phosphatidylinositol IgM Ab [Units/volume] in Serum |
|
49218-1
|
Phosphatidylinositol/Surfactant.total in Amniotic fluid |
|
2787-0
|
Phosphatidylinositol [Mass/volume] in Serum |
|
49574-7
|
Phosphatidylinositol+Phosphatidylserine/Surfactant.total in Amniotic fluid |
|
92735-0
|
Pibrentasvir [Susceptibility] by Genotype method |
|
89403-0
|
Picking up object - functional ability [CMS Assessment] |
|
83190-9
|
Picking up object - functional ability during 3 day assessment period [CMS Assessment] |
|
89402-2
|
Picking up object - functional goal [CMS Assessment] |
|
83189-1
|
Picking up object - functional goal during 3 day assessment period [CMS Assessment] |
|
7602-6
|
Pickleweed IgE Ab [Units/volume] in Serum |
|
21459-3
|
Pickleweed IgE Ab RAST class [Presence] in Serum |
|
17462-3
|
Picloram [Mass/volume] in Urine |
|
38327-3
|
Picloram [Mass/volume] in Water |
|
68460-5
|
Picornavirus Ag [Presence] in Isolate by Immunofluorescence |
|
10706-0
|
Picornavirus [Identifier] in Stool by Electron microscopy |
|
84441-5
|
Picture Sequence Memory Test - computed score [NIH Toolbox] |
|
84443-1
|
Picture Sequence Memory Test - raw score [NIH Toolbox] |
|
84444-9
|
Picture Sequence Memory Test - theta score [NIH Toolbox] |
|
84445-6
|
Picture Sequence Memory Test - unadjusted scale score [NIH Toolbox] |
|
84439-9
|
Picture Sequence Memory Test - national percentile [NIH Toolbox] |
|
84440-7
|
Picture Sequence Memory Test - scale score age adjusted [NIH Toolbox] |
|
84442-3
|
Picture Sequence Memory Test - scale score fully adjusted [NIH Toolbox] |
|
84437-3
|
Picture Sequence Memory Test [NIH Toolbox] |
|
24505-0
|
Pigeon droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
17463-1
|
Pigeon droppings Ab [Units/volume] in Serum |
|
6217-4
|
Pigeon droppings IgE Ab [Units/volume] in Serum |
|
15934-3
|
Pigeon droppings IgE Ab RAST class [Presence] in Serum |
|
38418-0
|
Pigeon droppings IgG Ab [Presence] in Serum |
|
7603-4
|
Pigeon droppings IgG Ab [Units/volume] in Serum |
|
38368-7
|
Pigeon droppings IgG Ab [Mass/volume] in Serum |
|
17464-9
|
Pigeon feather IgE Ab [Presence] in Serum |
|
10948-8
|
Pigeon feather IgE Ab [Units/volume] in Serum |
|
15935-0
|
Pigeon feather IgE Ab RAST class [Presence] in Serum |
|
51549-4
|
Pigeon feather IgG Ab [Presence] in Serum |
|
58912-7
|
Pigeon feather IgG Ab [Mass/volume] in Serum |
|
51859-7
|
Pigeon serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
|
78367-0
|
Pigeon serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
|
42529-8
|
Pigeon serum Ab [Presence] in Cerebral spinal fluid |
|
6733-0
|
Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
17465-6
|
Pigeon serum IgE Ab [Presence] in Serum |
|
19752-5
|
Pigeon serum IgG Ab [Presence] in Serum |
|
74755-0
|
Placental growth factor [Mass/volume] in Serum |
|
7606-7
|
Pigweed triggered histamine release [Units/volume] in Blood |
|
7605-9
|
Pigweed IgG Ab [Units/volume] in Serum |
|
48298-4
|
Pigweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
60033-8
|
PIK3CA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60034-6
|
PIK3CA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85507-2
|
PIK3CA gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
|
63419-6
|
PIK3CA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
83062-0
|
PIK3CA gene [VCF] in Cancer specimen by Sequencing |
|
79519-5
|
Pimelate [Moles/volume] in Serum or Plasma |
|
79494-1
|
Pimelate/Creatinine [Molar ratio] in Urine |
|
54474-2
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in Amniotic fluid |
|
54473-4
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in Cerebral spinal fluid |
|
54475-9
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS |
|
54476-7
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in Urine |
|
54488-2
|
Pimeloylcarnitine (C7-DC)/Creatinine [Molar ratio] in Urine |
|
12410-7
|
Pimozide [Mass/volume] in Serum or Plasma |
|
74981-2
|
Pimozide [Mass/volume] in Serum or Plasma --trough |
|
87779-5
|
Pimozide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
68364-9
|
Pincer cells [Presence] in Blood by Light microscopy |
|
7434-4
|
Pinchot Juniper IgE Ab [Units/volume] in Serum |
|
4402-4
|
Pindolol [Mass] of Dose |
|
3971-9
|
Pindolol [Mass/volume] in Serum or Plasma |
|
7609-1
|
Pine IgE Ab [Units/volume] in Serum |
|
15942-6
|
Pine IgE Ab RAST class [Presence] in Serum |
|
10954-6
|
Pine Nut IgE Ab [Units/volume] in Serum |
|
15943-4
|
Pine Nut IgE Ab RAST class [Presence] in Serum |
|
61330-7
|
Pine Nut IgE Ab/IgE total in Serum |
|
6218-2
|
Pineapple IgE Ab [Units/volume] in Serum |
|
15948-3
|
Pineapple IgE Ab RAST class [Presence] in Serum |
|
61216-8
|
Pineapple IgE Ab/IgE total in Serum |
|
7612-5
|
Pineapple IgG Ab [Units/volume] in Serum |
|
21463-5
|
Pineapple IgG Ab RAST class [Presence] in Serum |
|
56358-5
|
Pineapple IgG4 Ab [Mass/volume] in Serum |
|
60394-4
|
Pineapple IgG Ab [Mass/volume] in Serum |
|
47968-3
|
PINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47255-5
|
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum |
|
77370-5
|
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum or Plasma by Immunoassay |
|
7135-7
|
Pinto Bean IgE Ab [Units/volume] in Serum |
|
15567-1
|
Pinto Bean IgE Ab RAST class [Presence] in Serum |
|
7136-5
|
Pinto Bean IgG Ab [Units/volume] in Serum |
|
21101-1
|
Pinto Bean IgG Ab RAST class [Presence] in Serum |
|
56359-3
|
Pinto Bean IgG4 Ab [Mass/volume] in Serum |
|
60355-5
|
Pinto Bean IgG Ab [Mass/volume] in Serum |
|
76243-5
|
Inspiratory oxygen - expiratory oxygen [Pressure Difference] Airway adaptor |
|
73205-7
|
Pioglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73204-0
|
Pioglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73201-6
|
Piperacillin+Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73200-8
|
Piperacillin+Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7044-1
|
Piperacillin+Tazobactam [Susceptibility] by Gradient strip |
|
413-5
|
Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB) |
|
412-7
|
Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
411-9
|
Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC) |
|
18970-4
|
Piperacillin+Tazobactam [Susceptibility] |
|
414-3
|
Piperacillin+Tazobactam [Susceptibility] by Serum bactericidal titer |
|
35115-5
|
Pipamperone [Mass/volume] in Serum or Plasma |
|
54490-8
|
Pipecolate [Moles/volume] in Amniotic fluid |
|
2805-0
|
Pipecolate [Mass/volume] in Cerebral spinal fluid |
|
54327-2
|
Pipecolate [Moles/volume] in Cerebral spinal fluid |
|
54328-0
|
Pipecolate [Moles/volume] in DBS |
|
2806-8
|
Pipecolate [Mass/volume] in Serum or Plasma |
|
32334-5
|
Pipecolate [Moles/volume] in Serum or Plasma |
|
2807-6
|
Pipecolate [Mass/volume] in Urine |
|
32335-2
|
Pipecolate [Moles/volume] in Urine |
|
33659-4
|
Pipecolate/Creatinine [Ratio] in Urine |
|
47727-3
|
Pipecolate/Creatinine [Molar ratio] in Urine |
|
55703-3
|
Pipemidate [Susceptibility] by Gradient strip |
|
405-1
|
Pipemidate [Susceptibility] by Disk diffusion (KB) |
|
404-4
|
Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
403-6
|
Pipemidate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18968-8
|
Pipemidate [Susceptibility] |
|
406-9
|
Pipemidate [Susceptibility] by Serum bactericidal titer |
|
72970-7
|
Piperacillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72969-9
|
Piperacillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4403-2
|
Piperacillin [Mass] of Dose |
|
73202-4
|
Piperacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73203-2
|
Piperacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7043-3
|
Piperacillin [Susceptibility] by Gradient strip |
|
409-3
|
Piperacillin [Susceptibility] by Disk diffusion (KB) |
|
408-5
|
Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
407-7
|
Piperacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
3972-7
|
Piperacillin [Mass/volume] in Serum or Plasma |
|
18969-6
|
Piperacillin [Susceptibility] |
|
410-1
|
Piperacillin [Susceptibility] by Serum bactericidal titer |
|
25268-4
|
Piperacillin [Mass/volume] in Unspecified specimen |
|
55704-1
|
Piperacillin+Sulbactam [Susceptibility] by Gradient strip |
|
54199-5
|
Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54198-7
|
Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54197-9
|
Piperacillin+Sulbactam [Susceptibility] |
|
3975-0
|
Pipradrol [Mass/time] in 24 hour Urine |
|
4404-0
|
Pipradrol [Mass] of Dose |
|
3973-5
|
Pipradrol [Presence] in Urine |
|
3974-3
|
Pipradrol [Mass/volume] in Urine |
|
35829-1
|
Pirlimycin [Susceptibility] by Disk diffusion (KB) |
|
35830-9
|
Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35831-7
|
Pirlimycin [Susceptibility] |
|
10549-4
|
Pirmenol [Mass/volume] in Serum or Plasma |
|
55708-2
|
Piromidate [Susceptibility] by Gradient strip |
|
55707-4
|
Piromidate [Susceptibility] by Disk diffusion (KB) |
|
55705-8
|
Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55706-6
|
Piromidate [Susceptibility] |
|
56703-2
|
Piroxicam IgE Ab [Units/volume] in Serum |
|
11251-6
|
Piroxicam [Mass/volume] in Serum or Plasma |
|
7613-3
|
Pistachio IgE Ab [Units/volume] in Serum |
|
15949-1
|
Pistachio IgE Ab RAST class [Presence] in Serum |
|
40832-8
|
Pistachio IgE Ab/IgE total in Serum |
|
56360-1
|
Pistachio IgG4 Ab [Mass/volume] in Serum |
|
63110-1
|
Pistachio IgG Ab [Mass/volume] in Serum |
|
7614-1
|
Pitosporium triggered histamine release [Units/volume] in Blood |
|
55407-1
|
Pitting edema severity of Ankle |
|
63551-6
|
Pituitary Ab [Titer] in Serum by Immunofluorescence |
|
417-6
|
Pivampicillin [Susceptibility] by Disk diffusion (KB) |
|
416-8
|
Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
415-0
|
Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18971-2
|
Pivampicillin [Susceptibility] |
|
418-4
|
Pivampicillin [Susceptibility] by Serum bactericidal titer |
|
28659-1
|
Prekallikrein (Fletcher Factor) actual/normal in Platelet poor plasma by Chromogenic method |
|
52759-8
|
Prekallikrein (Fletcher Factor) activity actual/normal in Platelet poor plasma by Coagulation assay |
|
11227-6
|
Pyruvate kinase [Presence] in Blood |
|
71713-2
|
Pyruvate kinase [Enzymatic activity/substance] in Red Blood Cells |
|
6004-6
|
Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
13594-7
|
Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma |
|
6005-3
|
Prekallikrein (Fletcher Factor) [Units/volume] in Platelet poor plasma |
|
4669-8
|
Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma |
|
77626-0
|
Pyruvate kinase [Entitic Catalytic Activity] in Red Blood Cells |
|
2912-4
|
Pyruvate kinase [Enzymatic activity/volume] in Red Blood Cells |
|
32552-2
|
Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells |
|
2913-2
|
Pyruvate kinase [Enzymatic activity/volume] in Serum or Plasma |
|
74542-2
|
Pyruvate kinase/Glucose-6-Phosphate dehydrogenase [Enzymatic activity ratio] in Red Blood Cells |
|
44421-6
|
PKD1 gene+PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46207-7
|
PKD1 gene+PKD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
58020-9
|
PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48968-2
|
PKHD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49215-7
|
PKHD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48029-3
|
PKLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46746-4
|
Phenylketonuria and variants/Biopterin defects newborn screen interpretation |
|
58231-2
|
Phenylketonuria and variants/Biopterin defects newborn screening comment-discussion |
|
33771-7
|
PL-12 Ab [Presence] in Serum |
|
56745-3
|
PL-12 Ab [Presence] in Serum by Immunoblot |
|
33772-5
|
PL-7 Ab [Presence] in Serum |
|
56744-6
|
PL-7 Ab [Presence] in Serum by Immunoblot |
|
82924-2
|
PL-7 IgG Ab [Presence] in Serum by Immunoassay |
|
43369-8
|
PlA1 Ab [Presence] in Platelet rich plasma |
|
58983-8
|
Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Units/volume] in Serum |
|
82009-2
|
Honey bee phospholipase A2 native (nApi m) 1 IgE Ab RAST class [Presence] in Serum |
|
60421-5
|
Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum |
|
60241-7
|
Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab RAST class [Presence] in Serum |
|
73737-9
|
Phospholipase A2 receptor IgG Ab [Units/volume] in Serum by Immunoassay |
|
82926-7
|
Phospholipase A2 receptor IgG Ab [Presence] in Serum by Line blot |
|
82991-1
|
Phospholipase A2 receptor IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
81201-6
|
Phospholipase A2 receptor IgG Ab [Titer] in Serum by Immunofluorescence |
|
73766-8
|
Place where birth occurred [US Standard Certificate of Live Birth] |
|
89493-1
|
Placenta examination findings Document |
|
11994-1
|
Placenta position US |
|
11995-8
|
Narrative Placenta position US |
|
42138-8
|
US Guidance for localization of placenta |
|
89494-9
|
Diagnosis of Placenta |
|
51957-9
|
Placer DNA analysis test identifier [Identifier] |
|
10959-5
|
Plaice IgE Ab [Units/volume] in Serum |
|
15951-7
|
Plaice IgE Ab RAST class [Presence] in Serum |
|
57272-7
|
Plan of care includes depression intervention [CMS Assessment] |
|
57270-1
|
Plan of care includes diabetic foot care [CMS Assessment] |
|
57271-9
|
Plan of care includes fall prevention interventions [CMS Assessment] |
|
57273-5
|
Plan of care includes intervention to monitor and mitigate pain [CMS Assessment] |
|
57274-3
|
Plan of care includes intervention to prevent pressure injuries [CMS Assessment] |
|
57269-3
|
Plan of care includes patient-specific parameters for notifying physician of changes [CMS Assessment] |
|
57275-0
|
Plan of care includes pressure injury treatment - moist healing [CMS Assessment] |
|
18776-5
|
Plan of care note |
|
85592-4
|
Planned location for hemodialysis |
|
92705-3
|
Planned intervention AndOr services duration - time frame |
|
92823-4
|
Planned intervention AndOr services duration - visits |
|
92704-6
|
Planned intervention AndOr services visit frequency |
|
20942-9
|
Plant identified [Type] in Plant |
|
27810-1
|
Plasmin inhibitor actual/normal in Platelet poor plasma by Chromogenic method |
|
28658-3
|
Plasmin inhibitor actual/normal in Platelet poor plasma by Immunoassay |
|
5967-5
|
Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5966-7
|
Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5965-9
|
Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
14298-4
|
Plasma units available [#] |
|
48681-1
|
Plasma cell Ag [Presence] in Tissue by Immune stain |
|
34916-7
|
Plasma cell precursor [#/volume] in Blood |
|
33848-3
|
Plasma cell precursor [#/volume] in Blood by Manual count |
|
34917-5
|
Plasma cell precursor/100 leukocytes in Blood |
|
33849-1
|
Plasma cell precursor/100 leukocytes in Blood by Manual count |
|
30458-4
|
Plasma cells [#/volume] in Blood |
|
24103-4
|
Plasma cells [#/volume] in Blood by Manual count |
|
35006-6
|
Plasma cells [#/volume] in Body fluid |
|
74226-2
|
Plasma cells assessment in Bone marrow Narrative |
|
40743-7
|
Plasma cells [Presence] in Blood by Light microscopy |
|
93019-8
|
Plasma cells [#] in Bone marrow by Flow cytometry (FC) |
|
74849-1
|
Plasma cells/100 cells in Lymph node by Manual count |
|
11118-7
|
Plasma cells/100 cells in Bone marrow by Manual count |
|
71663-9
|
Plasma cells/Leukocytes [Pure number fraction] in Blood |
|
71652-2
|
Plasma cells/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71636-5
|
Plasma cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
13047-6
|
Plasma cells/100 leukocytes in Blood |
|
79426-3
|
Plasma cells/100 leukocytes in Blood by Manual count |
|
74456-5
|
Plasma cells/100 leukocytes in Cord blood |
|
75658-5
|
Plasma cells/100 leukocytes in Bronchial specimen |
|
47413-0
|
Plasma cells/100 leukocytes in Cerebral spinal fluid |
|
51385-3
|
Plasma cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
40541-5
|
Plasma cells/100 leukocytes in Cerebral spinal fluid by Microscopy |
|
17803-8
|
Plasma cells/100 leukocytes in Body fluid |
|
51386-1
|
Plasma cells/100 leukocytes in Body fluid by Manual count |
|
40526-6
|
Plasma cells/100 leukocytes in Pericardial fluid by Manual count |
|
40522-5
|
Plasma cells/100 leukocytes in Pleural fluid by Manual count |
|
40518-3
|
Plasma cells/100 leukocytes in Peritoneal fluid by Manual count |
|
40492-1
|
Plasma cells/100 leukocytes in Synovial fluid by Manual count |
|
10410-9
|
Plasma given [Type] |
|
10411-7
|
Plasma given [Volume] |
|
30898-1
|
Plasma volume by Scintigraphy |
|
35039-7
|
Lymphocytes Plasmacytoid [#/volume] in Blood |
|
33834-3
|
Lymphocytes Plasmacytoid [#/volume] in Blood by Manual count |
|
34921-7
|
Lymphocytes Plasmacytoid/100 leukocytes in Blood |
|
33835-0
|
Lymphocytes Plasmacytoid/100 leukocytes in Blood by Manual count |
|
56968-1
|
Plasmodium sp Ab [Presence] in Serum by Immunofluorescence |
|
5279-5
|
Plasmodium sp Ab [Units/volume] in Serum |
|
25632-1
|
Plasmodium sp Ab [Titer] in Serum |
|
25731-1
|
Plasmodium sp Ab [Titer] in Serum by Immunofluorescence |
|
51865-4
|
Plasmodium sp Ag [Identifier] in Blood |
|
70569-9
|
Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay |
|
50687-3
|
Plasmodium sp Ag [Presence] in Blood |
|
46094-9
|
Plasmodium sp Ag [Presence] in Blood by Immunoassay |
|
51587-4
|
Plasmodium sp [Presence] in Blood by Light microscopy |
|
32206-5
|
Plasmodium sp identified in Blood by Light microscopy |
|
637-9
|
Plasmodium sp identified in Blood by Thick film |
|
10710-2
|
Plasmodium sp identified in Blood by Thin film |
|
47260-5
|
Plasmodium sp DNA [Identifier] in Blood by NAA with probe detection |
|
47085-6
|
Plasmodium sp DNA [Presence] in Blood by NAA with probe detection |
|
53383-6
|
Plasmodium sp IgG Ab [Titer] in Serum |
|
52980-0
|
Plasmodium sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
53556-7
|
Erythrocytes.Plasmodium sp infected/100 erythrocytes in Blood |
|
48427-9
|
Erythrocytes.Plasmodium sp infected/1000 erythrocytes in Blood |
|
50688-1
|
Plasmodium sp lactate dehydrogenase [Identifier] in Blood |
|
53248-1
|
Plasmodium sp lactate dehydrogenase [Presence] in Blood |
|
41451-6
|
Plasmodium stage [Identifier] in Blood by Light microscopy |
|
17280-9
|
Plasmodium sp identified in Tissue by Thick film |
|
83665-0
|
Plastic surgery Attending Admission evaluation note |
|
83666-8
|
Plastic surgery Attending Note |
|
83667-6
|
Plastic surgery Attending Preoperative evaluation and management note |
|
83743-5
|
Plastic surgery Fellow Note |
|
83606-4
|
Plastic surgery Nurse Outpatient Note |
|
83771-6
|
Plastic surgery Resident Note |
|
83850-8
|
Plastic surgery Admission evaluation note |
|
78727-5
|
Plastic surgery Admission history and physical note |
|
78545-1
|
Plastic surgery Checklist |
|
34826-8
|
Plastic surgery Consult note |
|
93966-0
|
Plastic surgery Diagnostic study note |
|
68591-7
|
Plastic surgery Discharge summary |
|
78614-5
|
Plastic surgery Education note |
|
78633-5
|
Plastic surgery Flowsheet |
|
68592-5
|
Plastic surgery History and physical note |
|
68597-4
|
Plastic surgery Hospital Consult note |
|
68598-2
|
Plastic surgery Hospital Letter |
|
83851-6
|
Plastic surgery Hospital Note |
|
82832-7
|
Plastic surgery Initial evaluation note |
|
68593-3
|
Plastic surgery Letter |
|
34827-6
|
Plastic surgery Note |
|
83852-4
|
Plastic surgery Outpatient Note |
|
34870-6
|
Plastic surgery Surgical operation note |
|
83855-7
|
Plastic surgery Telephone encounter Note |
|
80776-8
|
Plastic surgery Plan of care note |
|
83853-2
|
Plastic surgery Postoperative evaluation and management note |
|
68594-1
|
Plastic surgery Preoperative evaluation and management note |
|
83854-0
|
Plastic surgery procedure note |
|
68595-8
|
Plastic surgery Progress note |
|
57155-4
|
Plastic surgery Referral note |
|
68596-6
|
Plastic surgery Transfer summary note |
|
43302-9
|
Platelet glycoprotein Ab [Presence] in Serum by Immunoassay |
|
63479-0
|
Platelet glycoprotein Ia/IIa Ab [Presence] in Blood by Immunoassay |
|
47084-9
|
Platelet glycoprotein Ia/IIa Ab [Presence] in Serum by Immunoassay |
|
48502-9
|
Platelet glycoprotein Ia/IIa IgG Ab [Presence] in Blood by Immunoassay |
|
63478-2
|
Platelet glycoprotein Ib/Ix Ab [Presence] in Blood by Immunoassay |
|
48506-0
|
Platelet glycoprotein Ib/Ix Ab [Presence] in Serum by Immunoassay |
|
48503-7
|
Platelet glycoprotein Ib/Ix IgG Ab [Presence] in Blood by Immunoassay |
|
48594-6
|
Platelet glycoprotein IIb/IIIa Ab [Presence] in Blood by Immunoassay |
|
53815-7
|
Platelet glycoprotein IIb/IIIa Ab [Units/volume] in Blood |
|
50365-6
|
Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum |
|
48505-2
|
Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum by Immunoassay |
|
48504-5
|
Platelet glycoprotein IIb/IIIa IgG Ab [Presence] in Blood by Immunoassay |
|
87757-1
|
Platelet glycoprotein IV Ab [Presence] in Serum or Plasma by Immunoassay |
|
11125-2
|
Platelet morphology finding [Identifier] in Blood |
|
60829-9
|
Pressure.plateau Respiratory system airway |
|
26515-7
|
Platelets [#/volume] in Blood |
|
777-3
|
Platelets [#/volume] in Blood by Automated count |
|
49497-1
|
Platelets [#/volume] in Blood by Estimate |
|
62244-9
|
Platelets [#/volume] in Blood from Fetus by Automated count |
|
778-1
|
Platelets [#/volume] in Blood by Manual count |
|
74464-9
|
Platelets [#/volume] in Capillary blood by Manual count |
|
47284-5
|
Platelets [#/volume] in Cord blood |
|
55802-3
|
Platelets [#/volume] in Cord blood by Estimate |
|
40574-6
|
Platelets [#/volume] in Body fluid by Automated count |
|
26516-5
|
Platelets [#/volume] in Plasma |
|
13056-7
|
Platelets [#/volume] in Plasma by Automated count |
|
74775-8
|
Platelets [#/volume] in Platelet rich plasma by Automated count |
|
79427-1
|
Platelets [#/area] in Blood by Microscopy high power field |
|
24375-8
|
Platelet Ab [Presence] in Serum |
|
41616-4
|
Platelet Ab [Presence] in Serum by Flow cytometry (FC) |
|
57440-0
|
Platelet Ab [Presence] in Serum by Immunofluorescence |
|
5379-3
|
Platelet Ab [Units/volume] in Serum |
|
22759-5
|
Platelet Ab [Titer] in Serum |
|
51640-1
|
Platelet anisocytosis [Presence] in Blood by Light microscopy |
|
9317-9
|
Platelet adequacy [Presence] in Blood by Light microscopy |
|
40741-1
|
Platelet clump [Presence] in Blood by Automated count |
|
7796-6
|
Platelet clump [Presence] in Blood by Light microscopy |
|
14301-6
|
Platelet concentrate units available [#] |
|
51873-8
|
Platelet concentrate units given [#] |
|
13057-5
|
Platelets [Units/volume] in Dialysis fluid |
|
35460-5
|
Platelet genotype [Identifier] in Amniotic fluid |
|
34977-9
|
Platelet genotype [Identifier] in Blood |
|
93313-5
|
Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative |
|
10412-5
|
Platelets given [Type] |
|
1299-7
|
Platelets given [Volume] |
|
31185-2
|
Platelet IgA Ab [Presence] in Serum |
|
13062-5
|
Platelet IgA Ab [Units/volume] in Serum |
|
15400-5
|
Platelet IgG Ab [Presence] in Serum |
|
6927-8
|
Platelet IgG Ab [Presence] in Serum by Flow cytometry (FC) |
|
11570-9
|
Platelet IgG Ab [Units/volume] in Serum |
|
31186-0
|
Platelet IgM Ab [Presence] in Serum |
|
13061-7
|
Platelet IgM Ab [Units/volume] in Serum |
|
73556-3
|
Platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
11126-0
|
Platelets [Morphology] in Bone marrow |
|
55206-7
|
Platelet mass [Volume Fraction] in Blood |
|
18312-9
|
Platelet satellitism [Presence] in Blood by Light microscopy |
|
45370-4
|
Platelet crossmatch [Interpretation] |
|
51637-7
|
Plateletocrit [Volume Fraction] in Blood |
|
15201-7
|
Platelets Large Fragments [#/volume] in Blood by Manual count |
|
51632-8
|
Platelets reticulated [#/volume] in Blood |
|
71692-8
|
Platelets reticulated [#/volume] in Blood by Automated count |
|
51633-6
|
Platelets reticulated/100 platelets in Blood |
|
71693-6
|
Platelets reticulated/100 platelets in Blood by Automated count |
|
52909-9
|
Platinum [Moles/time] in 24 hour Urine |
|
10916-5
|
Platinum [Mass/volume] in Blood |
|
51202-0
|
Platinum [Mass/volume] in Body fluid |
|
5713-3
|
Platinum [Mass/mass] in Hair |
|
50900-0
|
Platinum [Moles/mass] in Hair |
|
60166-6
|
Platinum [Mass/mass] in Nail |
|
60167-4
|
Platinum [Mass/volume] in Red Blood Cells |
|
5714-1
|
Platinum [Mass/volume] in Serum or Plasma |
|
60168-2
|
Platinum [Mass/mass] in Tissue |
|
50899-4
|
Platinum [Moles/mass] in Tissue |
|
5715-8
|
Platinum [Mass/volume] in Urine |
|
52897-6
|
Platinum [Moles/volume] in Urine |
|
9400-3
|
Platinum [Mass/volume] in Unspecified specimen |
|
52924-8
|
Platinum/Creatinine [Molar ratio] in 24 hour Urine |
|
52925-5
|
Platinum/Creatinine [Molar ratio] in Urine |
|
14300-8
|
Plateletpheresis units available [#] |
|
73637-1
|
Plazomicin [Susceptibility] by Disk diffusion (KB) |
|
73614-0
|
Plazomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73592-8
|
Plazomicin [Susceptibility] |
|
92024-9
|
Plazomicin [Mass/volume] in Serum or Plasma --trough |
|
76523-0
|
Plethysmogram Arterial blood Pulse oximetry |
|
66123-1
|
Pleura Pathology biopsy report |
|
28660-9
|
Plasminogen actual/normal in Platelet poor plasma by Chromogenic method |
|
5991-5
|
Plasminogen Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
4668-0
|
Plasminogen Ag [Mass/volume] in Platelet poor plasma |
|
5970-9
|
Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic method |
|
74814-5
|
Plasma cells.centroblasts/100 leukocytes in Blood by Manual count |
|
74820-2
|
Plasma cells.centrocytes/100 leukocytes in Blood by Manual count |
|
80470-8
|
Plant stanol ester intake 24 hour Estimated |
|
80471-6
|
Plant stanol ester intake 24 hour Measured |
|
80899-8
|
Plant sterol ester intake 24 hour Estimated |
|
80900-4
|
Plant sterol ester intake 24 hour Measured |
|
53890-0
|
PLOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77071-9
|
PLOD2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77070-1
|
PLOD2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77113-9
|
PLOD3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77112-1
|
PLOD3 gene full mutation analysis in Blood or Tissue by Sequencing |
|
79345-5
|
Pyridoxal phosphate and pyridoxal and pyridoxine pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79344-8
|
Pyridoxal phosphate and pyridoxal and pyridoxine pattern [Interpretation] in Serum or Plasma Narrative |
|
42179-2
|
PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method |
|
39089-8
|
PLP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85063-6
|
Platelet aggregation inhibitor given [Identifier] --preoperative |
|
93319-2
|
Platelet CD41 actual/normal in Blood by Flow cytometry (FC) |
|
93317-6
|
Platelet CD42a actual/normal in Blood by Flow cytometry (FC) |
|
93316-8
|
Platelet CD42b actual/normal in Blood by Flow cytometry (FC) |
|
93315-0
|
Platelet CD49b actual/normal in Blood by Flow cytometry (FC) |
|
93318-4
|
Platelet CD61 actual/normal in Blood by Flow cytometry (FC) |
|
79768-8
|
Platelet dense bodies [Presence] in Blood by Electron microscopy |
|
93314-3
|
Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC) |
|
6853-6
|
Plum IgE Ab [Units/volume] in Serum |
|
15953-3
|
Plum IgE Ab RAST class [Presence] in Serum |
|
43592-5
|
Plum IgE Ab/IgE total in Serum |
|
7617-4
|
Plum IgG Ab [Units/volume] in Serum |
|
21469-2
|
Plum IgG Ab RAST class [Presence] in Serum |
|
56361-9
|
Plum IgG4 Ab [Mass/volume] in Serum |
|
60395-1
|
Plum IgG Ab [Mass/volume] in Serum |
|
7618-2
|
Plum Pollen IgE Ab [Units/volume] in Serum |
|
17468-0
|
Plutonium [Mass/volume] in Urine |
|
88735-6
|
PM-SCL-100 Ab [Units/volume] in Serum by Line blot |
|
81732-0
|
PM-SCL-100 Ab [Presence] in Serum by Line blot |
|
82925-9
|
PM-SCL-100 IgG Ab [Presence] in Serum by Line blot |
|
61120-2
|
PM-SCL-100 IgG Ab [Units/volume] in Serum |
|
89926-0
|
Physical medicine and rehab Adult day care center Note |
|
83707-0
|
Physical medicine and rehab Administrative note |
|
83708-8
|
Physical medicine and rehab Admission evaluation note |
|
83709-6
|
Physical medicine and rehabilitation Attending Note |
|
83710-4
|
Physical medicine and rehabilitation Case manager Note |
|
83711-2
|
Physical medicine and rehab Conference note |
|
34822-7
|
Physical medicine and rehab Consult note |
|
85894-4
|
Physical medicine and rehab Counseling note |
|
93965-2
|
Physical medicine and rehab Diagnostic study note |
|
83712-0
|
Physical medicine and rehab Discharge summary |
|
83714-6
|
Physical medicine and rehab Education note |
|
78619-4
|
Physical medicine and rehab Flowsheet |
|
83715-3
|
Physical medicine and rehab History and physical note |
|
83718-7
|
Physical medicine and rehab Hospital Admission evaluation note |
|
83719-5
|
Physical medicine and rehab Hospital Note |
|
83717-9
|
Physical medicine and rehab Initial evaluation note |
|
83713-8
|
Physical medicine and rehabilitation Interdisciplinary Note |
|
83734-4
|
Physical medicine and rehabilitation Interdisciplinary Plan of care note |
|
83720-3
|
Physical medicine and rehab Long term care facility Consult note |
|
83721-1
|
Physical medicine and rehab Long term care facility Note |
|
83726-0
|
Physical medicine and rehabilitation Physician Initial evaluation note |
|
83727-8
|
Physical medicine and rehabilitation Physician Note |
|
34823-5
|
Physical medicine and rehab Note |
|
83722-9
|
Physical medicine and rehabilitation Nurse Consult note |
|
83723-7
|
Physical medicine and rehabilitation Nurse Note |
|
83724-5
|
Physical medicine and rehab Outpatient Initial evaluation note |
|
83725-2
|
Physical medicine and rehab Outpatient Note |
|
83733-6
|
Physical medicine and rehab Telephone encounter Note |
|
80786-7
|
Physical medicine and rehab Plan of care note |
|
83728-6
|
Physical medicine and rehab procedure note |
|
89030-1
|
Physical medicine and rehab Progress note |
|
83716-1
|
Physical medicine and rehab Patient's home Note |
|
57153-9
|
Physical medicine and rehab Referral note |
|
83729-4
|
Physical medicine and rehabilitation Resident Note |
|
83730-2
|
Physical medicine and rehab Risk assessment and screening note |
|
90757-6
|
Physical medicine and rehabilitation Social worker Hospital Note |
|
90758-4
|
Physical medicine and rehabilitation Social worker Outpatient hospital Note |
|
83731-0
|
Physical medicine and rehabilitation Team Conference note |
|
83732-8
|
Physical medicine and rehabilitation Team Note |
|
89889-0
|
Physical medicine and rehab Telehealth Note |
|
17471-4
|
PM-1 Ab [Units/volume] in Serum by Immunofluorescence |
|
14131-7
|
PM-1 Ab [Presence] in Serum |
|
17470-6
|
PM-1 Ab [Presence] in Serum by Immunofluorescence |
|
17469-8
|
PM-1 Ab [Units/volume] in Serum |
|
59399-6
|
PM-1 Ab [Titer] in Serum by Immunofluorescence |
|
30459-2
|
Platelet mean diameter [Entitic length] in Blood |
|
775-7
|
Platelet mean diameter [Entitic length] in Blood by Rees-Ecker |
|
76685-7
|
Platelet dry mass distribution width [Entitic mass] in Blood by calculation |
|
4374-5
|
Para methylhippurate [Mass] of Dose |
|
2725-0
|
Para methylhippurate [Mass/volume] in Urine |
|
82891-3
|
Para methylhippurate [Moles/volume] in Urine |
|
82892-1
|
Para methylhippurate/Creatinine [Molar ratio] in Urine |
|
8604-1
|
Type of Cardiac pacemaker prosthetic device by EKG |
|
8602-5
|
Cardiac pacemaker prosthetic device Vendor model number by EKG |
|
8603-3
|
Cardiac pacemaker prosthetic device Vendor serial number by EKG |
|
8613-2
|
Prosthetic cardiac pacemaker [Interpretation] by EKG |
|
9867-3
|
Prosthetic cardiac pacemaker [Interpretation] Narrative by EKG |
|
9859-0
|
Type of Cardiac pacemaker prosthetic lead by EKG |
|
9862-4
|
Cardiac pacemaker prosthetic lead Vendor model number by EKG |
|
9864-0
|
Cardiac pacemaker prosthetic lead Vendor serial number by EKG |
|
56753-7
|
PML Ab [Presence] in Serum by Immunoblot |
|
82923-4
|
PML IgG Ab [Presence] in Serum by Line blot |
|
71796-7
|
Promyelocytic leukemia protein distribution pattern [Interpretation] in Blood or Tissue Qualitative by Immunofluorescence |
|
78971-9
|
Phosphomannomutase 1 [Enzymatic activity/mass] in Fibroblast |
|
78970-1
|
Phosphomannomutase 1 [Enzymatic activity/mass] in Leukocytes |
|
76026-4
|
Phosphomannomutase 2 [Enzymatic activity/mass] in Fibroblast |
|
81818-7
|
PMM2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60127-8
|
Paramethadione [Mass/volume] in Blood |
|
10999-1
|
Paramethadione [Mass/volume] in Serum or Plasma |
|
60128-6
|
Paramethadione [Mass/volume] in Urine |
|
35324-3
|
PMP22 gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
|
35325-0
|
PMP22 gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
|
75384-8
|
PMP22 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
21727-3
|
PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21728-1
|
PMP22 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
50328-4
|
PMS-2 Ag [Presence] in Tissue by Immune stain |
|
79419-8
|
PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
79417-2
|
PMS2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
88736-4
|
PM-SCL-75 Ab [Units/volume] in Serum by Line blot |
|
81733-8
|
PM-SCL-75 Ab [Presence] in Serum by Line blot |
|
72724-8
|
PM-SCL-75 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
28542-9
|
Platelet mean volume [Entitic volume] in Blood |
|
32623-1
|
Platelet mean volume [Entitic volume] in Blood by Automated count |
|
776-5
|
Platelet mean volume [Entitic volume] in Blood by Rees-Ecker |
|
47283-7
|
Platelet mean volume [Entitic volume] in Cord blood |
|
10506-4
|
Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
|
72057-3
|
Pneumococcal vaccination been received |
|
85916-5
|
Pneumococcal vaccination received [CMS Assessment] |
|
55022-8
|
Pneumococcal vaccination up to date [CMS Assessment] |
|
10712-8
|
Pneumocystis sp identified in Lung tissue |
|
18308-7
|
Pneumocystis sp identified in Lung tissue by Immune stain |
|
13326-4
|
Pneumocystis sp identified in Unspecified specimen by Light microscopy |
|
90739-4
|
PHH GPI-Linked WBC and RBC Ag [Interpretation] in Blood Narrative |
|
38749-8
|
P-nitrobiphenyl [Mass/volume] in Air |
|
38750-6
|
Para nitrophenol [Mass/volume] in Air |
|
35482-9
|
Para nitrophenol [Mass/volume] in Serum or Plasma |
|
2726-8
|
Para nitrophenol [Presence] in Urine |
|
2727-6
|
Para nitrophenol [Mass/volume] in Urine |
|
13790-1
|
Para nitrophenol/Creatinine [Mass Ratio] in Urine |
|
25123-1
|
Para nitrophenol/Creatinine [Molar ratio] in Urine |
|
53891-8
|
PNKD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35141-1
|
Purine nucleoside phosphorylase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
79466-9
|
Purine nucleoside phosphorylase [Enzymatic activity/substance] in Red Blood Cells |
|
79467-7
|
Purine nucleoside phosphorylase [Enzymatic activity/volume] in DBS |
|
41070-4
|
Peripheral neuropathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38179-8
|
Peripheral neuropathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47740-6
|
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
|
2899-3
|
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Tissue |
|
47741-4
|
Purine nucleoside phosphorylase [Entitic Catalytic Activity] in Leukocytes |
|
11556-8
|
Oxygen [Partial pressure] in Blood |
|
2703-7
|
Oxygen [Partial pressure] in Arterial blood |
|
2704-5
|
Oxygen [Partial pressure] in Capillary blood |
|
14864-3
|
Oxygen [Partial pressure] in Cord blood |
|
28648-4
|
Oxygen [Partial pressure] in Arterial cord blood |
|
28649-2
|
Oxygen [Partial pressure] in Venous cord blood |
|
19211-2
|
Oxygen [Partial pressure] in Mixed venous blood |
|
2705-2
|
Oxygen [Partial pressure] in Venous blood |
|
3147-6
|
Oxygen [Partial pressure] in Exhaled gas |
|
2706-0
|
Oxygen [Partial pressure] in Body fluid |
|
3148-4
|
Oxygen [Partial pressure] in Gas |
|
3149-2
|
Oxygen [Partial pressure] in Inhaled gas |
|
65343-6
|
Oxygen [Partial pressure] saturation adjusted to 0.5 in Blood |
|
19214-6
|
Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood |
|
19215-3
|
Oxygen [Partial pressure] saturation adjusted to 0.5 in Capillary blood |
|
19217-9
|
Oxygen [Partial pressure] saturation adjusted to 0.5 in Mixed venous blood |
|
19216-1
|
Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood |
|
19254-2
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood |
|
19255-9
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood |
|
19256-7
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Capillary blood |
|
47716-6
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Cord blood |
|
49696-8
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood |
|
49697-6
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous cord blood |
|
19257-5
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood |
|
19258-3
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood |
|
13129-2
|
Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma |
|
93764-9
|
Porcine astrovirus type 3 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
83856-5
|
Podiatry Administrative note |
|
83857-3
|
Podiatry Admission evaluation note |
|
90793-1
|
Podiatry Attending Note |
|
90792-3
|
Podiatry Attending Preoperative evaluation and management note |
|
34828-4
|
Podiatry Consult note |
|
78577-4
|
Podiatry Diagnostic study note |
|
78611-1
|
Podiatry Education note |
|
78630-1
|
Podiatry Flowsheet |
|
83858-1
|
Podiatry History and physical note |
|
83859-9
|
Podiatry Hospital Note |
|
18737-7
|
Podiatry Initial evaluation note |
|
34829-2
|
Podiatry Note |
|
83607-2
|
Podiatry Nurse Note |
|
83608-0
|
Podiatry Nurse Outpatient Note |
|
75480-4
|
Podiatry Outpatient Note |
|
83860-7
|
Podiatry Outpatient Risk assessment and screening note |
|
28624-5
|
Podiatry Operation note |
|
83864-9
|
Podiatry Telephone encounter Note |
|
80775-0
|
Podiatry Plan of care note |
|
83861-5
|
Podiatry Postoperative evaluation and management note |
|
83862-3
|
Podiatry Preoperative evaluation and management note |
|
28625-2
|
Podiatry procedure note |
|
11509-7
|
Podiatry Progress note |
|
57156-2
|
Podiatry Referral note |
|
90790-7
|
Podiatry Resident Note |
|
83863-1
|
Podiatry Risk assessment and screening note |
|
83865-6
|
Podiatry Transfer summary note |
|
3903-2
|
Para hydroxyamphetamine [Mass/time] in 24 hour Urine |
|
19654-3
|
Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19653-5
|
Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method |
|
4375-2
|
Para hydroxyamphetamine [Mass] of Dose |
|
20554-2
|
Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method |
|
3901-6
|
Para hydroxyamphetamine [Presence] in Urine |
|
19652-7
|
Para hydroxyamphetamine [Presence] in Urine by Confirmatory method |
|
19651-9
|
Para hydroxyamphetamine [Presence] in Urine by Screen method |
|
3902-4
|
Para hydroxyamphetamine [Mass/volume] in Urine |
|
38908-0
|
Poikilocytosis [Presence] in Blood by Automated count |
|
779-9
|
Poikilocytosis [Presence] in Blood by Light microscopy |
|
84458-9
|
Able to point to the letter b [NIH Toolbox] |
|
84460-5
|
Able to point to the letter D [NIH Toolbox] |
|
84459-7
|
Able to point to the letter e [NIH Toolbox] |
|
84461-3
|
Able to point to the letter S [NIH Toolbox] |
|
92942-2
|
Poison control record Document |
|
7619-0
|
Poison ivy IgE Ab [Units/volume] in Serum |
|
48976-5
|
POLG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
11191-4
|
Pollock IgE Ab [Units/volume] in Serum |
|
21470-0
|
Pollock IgE Ab RAST class [Presence] in Serum |
|
51718-5
|
Normoblasts Polychromatophilic/100 cells in Blood by Microscopy |
|
11119-5
|
Normoblasts Polychromatophilic/100 cells in Bone marrow by Manual count |
|
10378-8
|
Polychromasia [Presence] in Blood by Light microscopy |
|
93018-0
|
Polyclonal plasma cells [#] in Bone marrow by Flow cytometry (FC) |
|
93358-0
|
Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC) |
|
93020-6
|
Polyclonal plasma cells/Total plasma cells in Bone marrow by Flow cytometry (FC) |
|
35832-5
|
Polymyxin B [Susceptibility] by Gradient strip |
|
421-8
|
Polymyxin B [Susceptibility] by Disk diffusion (KB) |
|
420-0
|
Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
419-2
|
Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC) |
|
17473-0
|
Polymyxin B [Mass/volume] in Serum or Plasma |
|
18972-0
|
Polymyxin B [Susceptibility] |
|
422-6
|
Polymyxin B [Susceptibility] by Serum bactericidal titer |
|
25269-2
|
Polymyxin B [Mass/volume] in Unspecified specimen |
|
33757-6
|
Polyp size additional dimensions |
|
33756-8
|
Polyp size greatest dimension |
|
33758-4
|
Polyp stalk length by CAP cancer protocols |
|
85285-5
|
Polyp in which invasive carcinoma arose [Type] in Colorectal cancer specimen by Light microscopy |
|
84881-2
|
Polyps [Presence] in Specimen |
|
35003-3
|
Polymorphonuclear cells [#/volume] in Blood |
|
35001-7
|
Polymorphonuclear cells [#/volume] in Cerebral spinal fluid |
|
35002-5
|
Polymorphonuclear cells [#/volume] in Body fluid |
|
71698-5
|
Polymorphonuclear cells [#/volume] in Body fluid by Automated count |
|
70045-0
|
Polymorphonuclear cells [#/volume] in Pericardial fluid by Automated count |
|
35000-9
|
Polymorphonuclear cells [#/volume] in Pleural fluid |
|
70044-3
|
Polymorphonuclear cells [#/volume] in Pleural fluid by Automated count |
|
35005-8
|
Polymorphonuclear cells [#/volume] in Peritoneal fluid |
|
70048-4
|
Polymorphonuclear cells [#/volume] in Peritoneal fluid by Automated count |
|
53521-1
|
Polymorphonuclear cells [#/volume] in Semen |
|
35004-1
|
Polymorphonuclear cells [#/volume] in Synovial fluid |
|
70049-2
|
Polymorphonuclear cells [#/volume] in Synovial fluid by Automated count |
|
76497-7
|
Polymorphonuclear cells [#] in Cerebral spinal fluid by Manual count |
|
32034-1
|
Polymorphonuclear cells [Presence] in Cerebral spinal fluid by Wright stain |
|
32035-8
|
Polymorphonuclear cells [Presence] in Body fluid by Wright stain |
|
71608-4
|
Polymorphonuclear cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71627-4
|
Polymorphonuclear cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71617-5
|
Polymorphonuclear cells/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
75659-3
|
Polymorphonuclear cells [#] in Pericardial fluid by Manual count |
|
32036-6
|
Polymorphonuclear cells [Presence] in Pericardial fluid by Wright stain |
|
75661-9
|
Polymorphonuclear cells [#] in Pleural fluid by Manual count |
|
32037-4
|
Polymorphonuclear cells [Presence] in Pleural fluid by Wright stain |
|
75660-1
|
Polymorphonuclear cells [#] in Peritoneal fluid by Manual count |
|
32038-2
|
Polymorphonuclear cells [Presence] in Peritoneal fluid by Wright stain |
|
75662-7
|
Polymorphonuclear cells [#] in Synovial fluid by Manual count |
|
32039-0
|
Polymorphonuclear cells [Presence] in Synovial fluid by Wright stain |
|
20473-5
|
Polymorphonuclear cells [Presence] in Unspecified specimen by Wright stain |
|
34999-3
|
Polymorphonuclear cells/100 leukocytes in Blood |
|
31160-5
|
Polymorphonuclear cells/100 leukocytes in Blood by Manual count |
|
26517-3
|
Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid |
|
12244-0
|
Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
58801-2
|
Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid |
|
26518-1
|
Polymorphonuclear cells/100 leukocytes in Body fluid |
|
71696-9
|
Polymorphonuclear cells/100 leukocytes in Body fluid by Automated count |
|
9306-2
|
Polymorphonuclear cells/100 leukocytes in Body fluid by Manual count |
|
30460-0
|
Polymorphonuclear cells/100 leukocytes in Gastric fluid |
|
14379-2
|
Polymorphonuclear cells/100 leukocytes in Gastric fluid by Manual count |
|
49787-5
|
Polymorphonuclear cells/100 leukocytes in Pericardial fluid |
|
70036-9
|
Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Automated count |
|
49966-5
|
Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Manual count |
|
26519-9
|
Polymorphonuclear cells/100 leukocytes in Pleural fluid |
|
70067-4
|
Polymorphonuclear cells/100 leukocytes in Pleural fluid by Automated count |
|
66147-0
|
Polymorphonuclear cells/100 leukocytes in Pleural fluid from Fetus by Manual count |
|
14374-3
|
Polymorphonuclear cells/100 leukocytes in Pleural fluid by Manual count |
|
26520-7
|
Polymorphonuclear cells/100 leukocytes in Peritoneal fluid |
|
70039-3
|
Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Automated count |
|
14375-0
|
Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
|
26521-5
|
Polymorphonuclear cells/100 leukocytes in Semen |
|
14377-6
|
Polymorphonuclear cells/100 leukocytes in Semen by Manual count |
|
26522-3
|
Polymorphonuclear cells/100 leukocytes in Synovial fluid |
|
70040-1
|
Polymorphonuclear cells/100 leukocytes in Synovial fluid by Automated count |
|
14376-8
|
Polymorphonuclear cells/100 leukocytes in Synovial fluid by Manual count |
|
30461-8
|
Polymorphonuclear cells/100 leukocytes in Stool |
|
14330-5
|
Polymorphonuclear cells/100 leukocytes in Stool by Manual count |
|
30462-6
|
Polymorphonuclear cells/100 leukocytes in Urine |
|
14378-4
|
Polymorphonuclear cells/100 leukocytes in Urine by Manual count |
|
32788-2
|
Polymorphonuclear cells/Monocytes [Ratio] in Blood |
|
28633-6
|
Polysomnography (sleep) study |
|
33779-0
|
IgG+IgM+IgA heavy chain Ag [Presence] in Tissue by Immune stain |
|
12300-0
|
Polythiazide [Presence] in Urine |
|
88350-4
|
Polytrauma Case manager Note |
|
88351-2
|
Polytrauma Consult note |
|
88352-0
|
Polytrauma Education note |
|
88353-8
|
Polytrauma History and physical note |
|
88354-6
|
Polytrauma Note |
|
88355-3
|
Polytrauma Nurse Note |
|
88356-1
|
Polytrauma Telephone encounter Note |
|
35177-5
|
Polyunsaturated fatty acids [Moles/volume] in Serum or Plasma |
|
81131-5
|
Polyunsaturated fat intake 24 hour Estimated |
|
81036-6
|
Polyunsaturated fat intake 24 hour Measured |
|
21471-8
|
Pomegranate IgE Ab [Units/volume] in Serum |
|
21472-6
|
Pomegranate IgE Ab RAST class [Presence] in Serum |
|
81840-1
|
POMGNT1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
63415-4
|
Pompe disease newborn screen interpretation |
|
63416-2
|
Pompe disease newborn screening comment-discussion |
|
51757-3
|
POMT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
51758-1
|
POMT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
78378-7
|
PON1 gene c.575A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
72492-2
|
Paraoxonase-arylesterase 1 (PON1) [Enzymatic activity/volume] in Serum |
|
7610-9
|
Pondorosa Pine IgE Ab [Units/volume] in Serum |
|
927-4
|
Blood product.pooled [Identifier] |
|
54406-4
|
Pooled cryoprecipitate units given [#] |
|
54431-2
|
Pooled cryoprecipitate given [Volume] |
|
54408-0
|
Pooled fresh frozen plasma units given [#] |
|
54432-0
|
Pooled fresh frozen plasma given [Volume] |
|
54404-9
|
Pooled platelet concentrate units given [#] |
|
52118-7
|
Pooled platelets units available [#] |
|
54430-4
|
Pooled platelets given [Volume] |
|
44251-7
|
Poor appetite or overeating in last 2 weeks [Reported.PHQ] |
|
54667-1
|
Poor appetite or overeating in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54645-7
|
Poor appetite or overeating in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54666-3
|
Poor appetite or overeating in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
54644-0
|
Poor appetite or overeating in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
92824-2
|
Source of population allelic frequency data |
|
51900-9
|
Population Summary note |
|
7623-2
|
Poppy Seed IgE Ab [Units/volume] in Serum |
|
15955-8
|
Poppy Seed IgE Ab RAST class [Presence] in Serum |
|
56362-7
|
Poppy Seed IgG4 Ab [Mass/volume] in Serum |
|
63115-0
|
Poppy Seed IgG Ab [Mass/volume] in Serum |
|
82285-8
|
Population RMR |
|
43138-7
|
Population size Investigation |
|
31570-5
|
Porcine influenza virus A Ab [Units/volume] in Serum |
|
42977-9
|
Porcine influenza virus A Ab [Titer] in Serum |
|
23768-5
|
Porcine influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
|
23769-3
|
Porcine influenza virus A Ag [Presence] in Tissue by Immune stain |
|
16103-4
|
Porcine Gelatin IgE Ab [Units/volume] in Serum |
|
21298-5
|
Porcine Gelatin IgE Ab RAST class [Presence] in Serum |
|
7624-0
|
Pork triggered histamine release [Units/volume] in Blood |
|
6219-0
|
Pork IgE Ab [Units/volume] in Serum |
|
15956-6
|
Pork IgE Ab RAST class [Presence] in Serum |
|
61347-1
|
Pork IgE Ab/IgE total in Serum |
|
6734-8
|
Pork IgG Ab [Units/volume] in Serum |
|
21475-9
|
Pork IgG Ab RAST class [Presence] in Serum |
|
56442-7
|
Pork IgG4 Ab [Mass/volume] in Serum |
|
35543-8
|
Pork IgG Ab [Mass/volume] in Serum |
|
48212-5
|
Pork triggered leukotriene release [Mass/volume] by Leukocytes |
|
2808-4
|
Porphobilin [Mass/volume] in Serum |
|
43114-8
|
Porphyrin fractions [Interpretation] in 24 hour Urine |
|
49292-6
|
Porphyrin fractions [Interpretation] in 24 hour Urine Narrative |
|
14171-3
|
Porphyrins [Mass/mass] in 24 hour Stool |
|
9733-7
|
Porphyrins [Mass/time] in 24 hour Stool |
|
15090-4
|
Porphyrins [Moles/time] in 24 hour Stool |
|
12246-5
|
Porphyrins [Presence] in 24 hour Urine |
|
56970-7
|
Porphyrins [Mass/volume] in 24 hour Urine |
|
10885-2
|
Porphyrins [Mass/time] in 24 hour Urine |
|
50901-8
|
Porphyrins [Moles/volume] in 24 hour Urine |
|
40396-4
|
Porphyrins [Moles/time] in 24 hour Urine |
|
56554-9
|
Porphyrins [Mass/time] in 72 hour Stool |
|
17478-9
|
Porphyrins [Presence] in Body fluid |
|
17476-3
|
Porphyrins [Units/volume] in Red Blood Cells |
|
2814-2
|
Porphyrins [Mass/volume] in Red Blood Cells |
|
39784-4
|
Porphyrins [Moles/volume] in Red Blood Cells |
|
14883-3
|
Porphyrins [Interpretation] in Serum or Plasma |
|
49289-2
|
Porphyrins [Interpretation] in Serum or Plasma Narrative |
|
2815-9
|
Porphyrins [Mass/volume] in Serum or Plasma |
|
33311-2
|
Porphyrins [Moles/volume] in Serum or Plasma |
|
2816-7
|
Porphyrins [Presence] in Stool |
|
17477-1
|
Porphyrins [Units/volume] in Stool |
|
14884-1
|
Porphyrins [Interpretation] in Stool |
|
49290-0
|
Porphyrins [Interpretation] in Stool Narrative |
|
2817-5
|
Porphyrins [Mass/volume] in Stool |
|
56512-7
|
Porphyrins [Mass/mass] in Stool |
|
39774-5
|
Porphyrins [Moles/mass] in Stool |
|
2818-3
|
Porphyrins [Presence] in Urine |
|
17475-5
|
Porphyrins [Units/volume] in Urine |
|
44014-9
|
Porphyrins [Interpretation] in Urine |
|
49291-8
|
Porphyrins [Interpretation] in Urine Narrative |
|
11225-0
|
Porphyrins [Mass/volume] in Urine |
|
39771-1
|
Porphyrins [Moles/volume] in Urine |
|
44353-1
|
Porphyrins/Creatinine [Mass Ratio] in 24 hour Urine |
|
38160-8
|
Porphyrins/Creatinine [Mass Ratio] in Urine |
|
57378-2
|
Porphyrins/Creatinine [Molar ratio] in Urine |
|
93037-0
|
Portable medical order form |
|
23773-5
|
Porcine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
|
76244-3
|
Positive pressure phase duration [Time] Ventilator |
|
84880-4
|
Position of rectal tumor in relation to anterior peritoneal reflection [Anatomy] in Tumor |
|
80545-7
|
Posaconazole [Mass/mass] in Hair |
|
54186-2
|
Posaconazole [Susceptibility] by Gradient strip |
|
54189-6
|
Posaconazole [Susceptibility] by Disk diffusion (KB) |
|
54187-0
|
Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
53731-6
|
Posaconazole [Mass/volume] in Serum or Plasma |
|
54188-8
|
Posaconazole [Susceptibility] |
|
88671-3
|
Position AndOr immobilizer used during EMS transport |
|
72155-5
|
Position in womb Fetus [RHEA] |
|
84781-4
|
Positive Affect Survey - age 18+ - T-score [NIH Toolbox] |
|
84795-4
|
Positive Affect Survey - parent report - national percentile [NIH Toolbox] |
|
84794-7
|
Positive Affect Survey - parent report - scale score age adjusted [NIH Toolbox] |
|
84789-7
|
Positive Affect Survey - parent report - scale score fully adjusted [NIH Toolbox] |
|
84788-9
|
Positive Affect Survey - parent report - unadjusted scale score [NIH Toolbox] |
|
84796-2
|
Positive Affect Survey - self-report - national percentile [NIH Toolbox] |
|
84782-2
|
Positive Affect Survey - self-report - scale score age adjusted [NIH Toolbox] |
|
84777-2
|
Positive Affect Survey - self-report - scale score fully adjusted [NIH Toolbox] |
|
84775-6
|
Positive Affect Survey - self-report - unadjusted scale score [NIH Toolbox] |
|
84787-1
|
Positive Affect Survey version 2.0 - ages 13-17 - T-score [NIH Toolbox] |
|
84779-8
|
Positive Affect Survey version 2.0 - ages 8-12 - T-score [NIH Toolbox] |
|
84793-9
|
Positive Affect Survey version 2.0 - parent report - ages 3-7 - T-score [NIH Toolbox] |
|
85108-9
|
Positive Peer Interaction Survey version 2.0 - parent report - ages 3-12 - T-score [NIH Toolbox] |
|
91650-2
|
Positive social interaction score [MOS Social Support Survey] |
|
19819-2
|
Post GI procedure instructions [Instructions] Narrative |
|
90855-8
|
Posterior inter-arch deviation Teeth and gum |
|
85315-0
|
Extent of posterior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
|
45401-7
|
Postal code [Location] |
|
72073-0
|
Post-dialysis target weight for session prescribed [ESRD] |
|
62327-2
|
Post-discharge provider practice address |
|
62328-0
|
Post-discharge provider practice phone number |
|
62323-1
|
Post-discharge provider ID [Identifier] |
|
62324-9
|
Post-discharge provider name in Provider |
|
62325-6
|
Post-discharge provider practice ID |
|
62326-4
|
Post-discharge provider practice name |
|
72144-9
|
Post-natal maternal vital status [RHEA] |
|
67860-7
|
Postoperative evaluation and management note |
|
6940-1
|
Potassium [Moles/time] in unspecified time Stool |
|
32550-6
|
Potassium [Molar amount] in Urine collected for unspecified duration |
|
35677-4
|
Potassium [Moles/volume] in Urine collected for unspecified duration |
|
57355-0
|
Potassium [Moles/volume] in 12 hour Urine |
|
57380-8
|
Potassium [Moles/time] in 12 hour Urine |
|
58996-0
|
Potassium [Moles/time] in 18 hour Urine |
|
93998-3
|
Potassium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
53123-6
|
Potassium [Moles/time] in 1 hour Urine |
|
59162-8
|
Potassium [Moles/volume] in 24 hour Stool |
|
27441-5
|
Potassium [Moles/mass] in 24 hour Stool |
|
6792-6
|
Potassium [Moles/time] in 24 hour Stool |
|
51720-1
|
Potassium [Mass/time] in 24 hour Urine |
|
21476-7
|
Potassium [Moles/volume] in 24 hour Urine |
|
2829-0
|
Potassium [Moles/time] in 24 hour Urine |
|
94007-2
|
Potassium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
57379-0
|
Potassium [Moles/volume] in 2 hour Urine |
|
18372-3
|
Potassium [Moles/time] in 6 hour Urine |
|
2826-6
|
Potassium [Moles/time] in 72 hour Stool |
|
49788-3
|
Potassium [Moles/volume] in Amniotic fluid |
|
32713-0
|
Potassium [Moles/volume] in Arterial blood |
|
39790-1
|
Potassium [Moles/volume] in Capillary blood |
|
75940-7
|
Potassium [Mass/volume] in Blood |
|
41656-0
|
Potassium [Moles/volume] in Mixed venous blood |
|
6298-4
|
Potassium [Moles/volume] in Blood |
|
39789-3
|
Potassium [Moles/volume] in Venous blood |
|
2830-8
|
Potassium renal clearance in 24 hour Urine and Serum or Plasma |
|
2819-1
|
Potassium [Moles/volume] in Cerebral spinal fluid |
|
39785-1
|
Potassium [Moles/volume] in Peritoneal dialysis fluid |
|
2820-9
|
Potassium [Moles/volume] in Dialysis fluid |
|
2821-7
|
Potassium [Moles/volume] in Body fluid |
|
2822-5
|
Potassium [Moles/volume] in Gastric fluid |
|
86919-8
|
Potassium goal [Moles/volume] Serum or Plasma |
|
79710-0
|
Potassium [Mass/mass] in Hair |
|
50902-6
|
Potassium [Moles/mass] in Hair |
|
17795-6
|
Potassium [Moles/volume] in Hyperal solution |
|
81010-1
|
Potassium intake 24 hour Estimated |
|
81009-3
|
Potassium intake 24 hour Measured |
|
60218-5
|
Potassium [Moles/volume] in Mother's milk |
|
29349-8
|
Potassium [Moles/volume] in Serum or Plasma --post dialysis |
|
51618-7
|
Potassium [Moles/volume] in Serum or Plasma --pre dialysis |
|
49789-1
|
Potassium [Moles/volume] in Peritoneal fluid |
|
82722-0
|
Potassium [Mass/volume] in Red Blood Cells |
|
2824-1
|
Potassium [Moles/volume] in Red Blood Cells |
|
2825-8
|
Potassium [Moles/volume] in Saliva (oral fluid) |
|
77142-8
|
Potassium [Moles/volume] in Serum, Plasma or Blood |
|
22760-3
|
Potassium [Mass/volume] in Serum or Plasma |
|
42569-4
|
Potassium [Mass or Moles/volume] in Serum or Plasma |
|
2823-3
|
Potassium [Moles/volume] in Serum or Plasma |
|
14172-1
|
Potassium [Moles/volume] in Synovial fluid |
|
12812-4
|
Potassium [Moles/volume] in Serum or Plasma --2nd specimen |
|
12813-2
|
Potassium [Moles/volume] in Serum or Plasma --3rd specimen |
|
15202-5
|
Potassium [Moles/volume] in Stool |
|
25506-7
|
Potassium [Moles/mass] in Stool |
|
2827-4
|
Potassium [Moles/volume] in Sweat |
|
59733-6
|
Potassium [Mass/mass] in Tissue |
|
30549-0
|
Potassium [Moles/volume] in Total parental nutrition |
|
2828-2
|
Potassium [Moles/volume] in Urine |
|
12814-0
|
Potassium [Moles/volume] in Vitreous fluid |
|
9482-1
|
Potassium [Mass/volume] in Water |
|
87454-5
|
Potassium [Mass/volume] in Unspecified specimen |
|
87455-2
|
Potassium [Mass/mass] in Unspecified specimen |
|
32336-0
|
Potassium [Moles/volume] in Unspecified specimen |
|
13798-4
|
Potassium/Creatinine [Mass Ratio] in 24 hour Urine |
|
56971-5
|
Potassium/Creatinine [Ratio] in 24 hour Urine |
|
56143-1
|
Potassium/Creatinine [Molar ratio] in 24 hour Urine |
|
11148-4
|
Potassium/Creatinine [Mass Ratio] in Urine |
|
43222-9
|
Potassium/Creatinine [Ratio] in Urine |
|
33949-9
|
Potassium/Creatinine [Molar ratio] in Urine |
|
7626-5
|
Potato triggered histamine release [Units/volume] in Blood |
|
6220-8
|
Potato IgE Ab [Units/volume] in Serum |
|
15957-4
|
Potato IgE Ab RAST class [Presence] in Serum |
|
7625-7
|
Potato IgG Ab [Units/volume] in Serum |
|
21479-1
|
Potato IgG Ab RAST class [Presence] in Serum |
|
56429-4
|
Potato IgG4 Ab [Mass/volume] in Serum |
|
35544-6
|
Potato IgG Ab [Mass/volume] in Serum |
|
86597-2
|
Potential indicators of psychosis in last 7 days [CMS Assessment] |
|
93281-4
|
Potential lethality initial/first suicide attempt [C-SSRS] |
|
93272-3
|
Potential lethality most lethal suicide attempt Lifetime [C-SSRS] |
|
93282-2
|
Potential lethality most recent suicide attempt [C-SSRS] |
|
49873-3
|
POU3F4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7631-5
|
Povertyweed IgE Ab [Units/volume] in Serum |
|
15959-0
|
Povertyweed IgE Ab RAST class [Presence] in Serum |
|
56364-3
|
Povertyweed IgG4 Ab [Mass/volume] in Serum |
|
93342-4
|
Power level --peak during exercise |
|
64298-3
|
Power of attorney |
|
52055-1
|
Power operated vehicle attachment |
|
59272-5
|
Power setting Ventilator |
|
75786-4
|
Powers granted to healthcare agent [Reported] |
|
26646-0
|
Powassan virus Ab [Presence] in Serum |
|
74824-4
|
Powassan virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
42975-3
|
Powassan virus Ab [Titer] in Serum |
|
40504-3
|
Powassan virus Ab [Titer] in Serum by Complement fixation |
|
40513-4
|
Powassan virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
53384-4
|
Powassan virus Ab [Presence] in Unspecified specimen |
|
50037-1
|
Powassan virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
29842-2
|
Powassan virus IgG Ab [Presence] in Cerebral spinal fluid |
|
29804-2
|
Powassan virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29854-7
|
Powassan virus IgG Ab [Presence] in Serum |
|
29817-4
|
Powassan virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
31573-9
|
Powassan virus IgG Ab [Units/volume] in Serum |
|
42974-6
|
Powassan virus IgG Ab [Titer] in Serum |
|
29564-2
|
Powassan virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
42973-8
|
Powassan virus IgG Ab [Titer] in Unspecified specimen |
|
30177-0
|
Powassan virus IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
29830-7
|
Powassan virus IgG Ab [Presence] in Unspecified specimen |
|
29791-1
|
Powassan virus IgG Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
31574-7
|
Powassan virus IgG Ab [Units/volume] in Unspecified specimen |
|
29843-0
|
Powassan virus IgM Ab [Presence] in Cerebral spinal fluid |
|
29805-9
|
Powassan virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29855-4
|
Powassan virus IgM Ab [Presence] in Serum |
|
29818-2
|
Powassan virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
31575-4
|
Powassan virus IgM Ab [Units/volume] in Serum |
|
42972-0
|
Powassan virus IgM Ab [Titer] in Serum |
|
29565-9
|
Powassan virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
42971-2
|
Powassan virus IgM Ab [Titer] in Unspecified specimen |
|
30179-6
|
Powassan virus IgM Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
29831-5
|
Powassan virus IgM Ab [Presence] in Unspecified specimen |
|
29792-9
|
Powassan virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
31576-2
|
Powassan virus IgM Ab [Units/volume] in Unspecified specimen |
|
47475-9
|
Powassan virus polyvalent E Ab [Presence] in Unspecified specimen |
|
43687-3
|
Powassan virus polyvalent E Ab [Presence] in Unspecified specimen by Immunoassay |
|
34456-4
|
Powassan virus RNA [Presence] in Blood by NAA with probe detection |
|
34457-2
|
Powassan virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
55144-0
|
Powassan virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
8624-9
|
PP interval |
|
18504-1
|
PP interval mean |
|
3966-9
|
Phenylpropanolamine [Mass/time] in 24 hour Urine |
|
4399-2
|
Phenylpropanolamine [Mass] of Dose |
|
14876-7
|
Phenylpropanolamine [Presence] in Gastric fluid |
|
26714-6
|
Phenylpropanolamine [Mass/mass] in Meconium |
|
26991-0
|
Phenylpropanolamine [Mass/volume] in Milk |
|
3963-6
|
Phenylpropanolamine [Presence] in Serum or Plasma |
|
29601-2
|
Phenylpropanolamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3964-4
|
Phenylpropanolamine [Mass/volume] in Serum or Plasma |
|
27442-3
|
Phenylpropanolamine [Mass/mass] in Stool |
|
3965-1
|
Phenylpropanolamine [Presence] in Urine |
|
17443-3
|
Phenylpropanolamine [Mass/volume] in Urine |
|
27251-8
|
Phenylpropanolamine [Mass/volume] in Vitreous fluid |
|
32333-7
|
Phenylpropanolamine [Presence] in Unspecified specimen |
|
57870-8
|
Phenylpropanolamine [Moles/volume] in Unspecified specimen |
|
61090-7
|
Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid |
|
32153-9
|
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma |
|
72790-9
|
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method |
|
61058-4
|
Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine |
|
33507-5
|
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine |
|
61059-2
|
Alpha-Phenyl-2-Piperidine acetate [Presence] in Unspecified specimen |
|
72791-7
|
Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine |
|
2720-1
|
Palmitoylphosphatidyl choline [Mass/volume] in Plasma |
|
38751-4
|
1,4-Benzenediamine [Mass/volume] in Air |
|
79472-7
|
Phenylpropionylglycine [Moles/volume] in Serum or Plasma |
|
32582-9
|
Phenylpropionylglycine [Presence] in Urine |
|
44350-7
|
Phenylpropionylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
50360-7
|
Phenylpropionylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13793-5
|
Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine |
|
24441-8
|
Phenylpropionylglycine/Creatinine [Molar ratio] in Urine |
|
87385-1
|
Porcine parainfluenza virus 1 F gene [Nucleotide sequence] in Isolate by Sequencing |
|
87384-4
|
Porcine parainfluenza virus 1 HN gene [Nucleotide sequence] in Isolate by Sequencing |
|
90330-2
|
Porcine parainfluenza virus 1 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
87386-9
|
Porcine parainfluenza virus 1 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87387-7
|
Porcine parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48267-9
|
Benzylpenicilloyl-polylysine triggered leukotriene release [Mass/volume] by Leukocytes |
|
80202-5
|
Clotting time of depleted plasma with 1:1 phospholipid by Coagulation assay --after addition of factor X activated |
|
23351-0
|
Peste des petits ruminants virus Ab [Presence] in Serum |
|
23354-4
|
Peste des petits ruminants virus Ab [Presence] in Serum by Immunoassay |
|
31560-6
|
Peste des petits ruminants virus Ab [Units/volume] in Serum |
|
23350-2
|
Peste des petits ruminants virus Ab [Titer] in Serum |
|
23352-8
|
Peste des petits ruminants virus Ab [Titer] in Serum by Neutralization test |
|
23355-1
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoassay |
|
23357-7
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immune diffusion (ID) |
|
23356-9
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoelectrophoresis |
|
34887-0
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunofluorescence |
|
23359-3
|
Peste des petits ruminants virus RNA [Presence] in Tissue by NAA with probe detection |
|
23358-5
|
Peste des petits ruminants virus RNA [Presence] in Tissue by Probe |
|
54584-8
|
PPS Assessment [CMS Assessment] |
|
54585-5
|
PPS Other Medicare Required Assessment - OMRA [CMS Assessment] |
|
59246-9
|
Palmitoyl protein thioesterase [Enzymatic activity/volume] in DBS |
|
74365-8
|
Palmitoyl protein thioesterase [Enzymatic activity/mass] in Fibroblast |
|
34587-6
|
Palmitoyl protein thioesterase [Enzymatic activity/volume] in Serum or Plasma |
|
74935-8
|
Palmitoyl protein thioesterase [Enzymatic activity/mass] in Leukocytes |
|
34647-8
|
PPT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41069-6
|
PPT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
86736-6
|
Porcine parvovirus type 1 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86741-6
|
Porcine parvovirus type 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23366-8
|
Porcine parvovirus Ab [Presence] in Serum |
|
23365-0
|
Porcine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
|
31571-3
|
Porcine parvovirus Ab [Units/volume] in Serum |
|
23770-1
|
Porcine parvovirus Ab [Titer] in Serum |
|
86734-1
|
Porcine parvovirus Ab [Titer] in Serum by Hemagglutination inhibition |
|
23771-9
|
Porcine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
|
86735-8
|
Porcine parvovirus DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86733-3
|
Porcine parvovirus [Presence] in Unspecified specimen by Organism specific culture |
|
85339-0
|
Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain |
|
40557-1
|
Progesterone receptor Ag [Presence] in Tissue by Immune stain |
|
85331-7
|
Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
|
8625-6
|
P-R Interval |
|
44976-9
|
P-R Interval {Electrocardiograph lead} |
|
18520-7
|
P-R Interval Lead AVF |
|
18521-5
|
P-R Interval Lead AVL |
|
18522-3
|
P-R Interval Lead AVR |
|
18523-1
|
P-R Interval Lead I |
|
18524-9
|
P-R Interval Lead II |
|
18525-6
|
P-R Interval Lead III |
|
18526-4
|
P-R Interval Lead V1 |
|
18527-2
|
P-R Interval Lead V2 |
|
18528-0
|
P-R Interval Lead V3 |
|
18529-8
|
P-R Interval Lead V4 |
|
18530-6
|
P-R Interval Lead V5 |
|
18531-4
|
P-R Interval Lead V6 |
|
16113-3
|
Progesterone receptor [Interpretation] in Tissue |
|
10861-3
|
Progesterone receptor [Mass/mass] in Tissue |
|
31207-4
|
Progesterone receptor [Moles/mass] in Tissue |
|
85325-9
|
Cells.progesterone receptor/100 cells in Breast cancer specimen by Immune stain |
|
14230-7
|
Cells.progesterone receptor/100 cells in Tissue by Immune stain |
|
76148-6
|
Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87800-9
|
Pradofloxacin [Susceptibility] |
|
4405-7
|
Practolol [Mass] of Dose |
|
3976-8
|
Practolol [Mass/volume] in Urine |
|
73199-2
|
Pravastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73198-4
|
Pravastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
19681-6
|
Prazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19680-8
|
Prazepam cutoff [Mass/volume] in Urine for Screen method |
|
4406-5
|
Prazepam [Mass] of Dose |
|
3977-6
|
Prazepam [Mass/volume] in Serum or Plasma |
|
48356-0
|
Prazepam [Moles/volume] in Serum or Plasma |
|
17479-7
|
Prazepam [Mass/volume] in Urine by Confirmatory method |
|
19679-0
|
Prazepam [Presence] in Urine by Confirmatory method |
|
19678-2
|
Prazepam [Presence] in Urine by Screen method |
|
12311-7
|
Prazepam [Mass/volume] in Urine |
|
14191-1
|
Prazosin [Mass/volume] in Serum or Plasma |
|
73817-9
|
Percent heparin inhibition [Ratio] in Serum |
|
86927-1
|
Porcine respiratory coronavirus Ab/Negative control in Serum by Immunoassay |
|
23372-6
|
Porcine respiratory coronavirus Ab [Presence] in Serum |
|
23374-2
|
Porcine respiratory coronavirus Ab [Presence] in Serum by Immunoassay |
|
23373-4
|
Porcine respiratory coronavirus Ab [Presence] in Serum by Neutralization test |
|
23377-5
|
Porcine respiratory coronavirus Ag [Presence] in Small intestine Tissue by Immune stain |
|
23376-7
|
Porcine respiratory coronavirus Ag [Presence] in Unspecified specimen by Immune stain |
|
86703-6
|
Porcine respiratory coronavirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23378-3
|
Porcine respiratory coronavirus RNA [Presence] in Unspecified specimen by Probe |
|
74185-0
|
Percent of U.S. Federal Poverty Level |
|
54589-7
|
Preadmission Screening and Resident Review (PASRR) [CMS Assessment] |
|
13985-7
|
Prealbumin/Protein.total in 24 hour Urine by Electrophoresis |
|
53229-1
|
Prealbumin [Mass/time] in 24 hour Urine |
|
33467-2
|
Prealbumin [Mass/volume] in Cord blood |
|
2876-1
|
Prealbumin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
13973-3
|
Prealbumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
|
17810-3
|
Prealbumin/Protein.total in Body fluid by Electrophoresis |
|
13979-0
|
Prealbumin/Protein.total in Serum or Plasma by Electrophoresis |
|
13991-5
|
Prealbumin/Protein.total in Urine by Electrophoresis |
|
72579-6
|
Prealbumin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis |
|
72578-8
|
Prealbumin/Protein.total [Pure mass fraction] in Urine by Electrophoresis |
|
2877-9
|
Prealbumin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
6793-4
|
Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay |
|
46130-1
|
Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry |
|
14338-8
|
Prealbumin [Mass/volume] in Serum or Plasma |
|
77192-3
|
Prealbumin [Moles/volume] in Serum or Plasma |
|
40857-5
|
Prealbumin [Mass/volume] in Urine |
|
80258-7
|
Pre-cardiac catheterization diagnosis |
|
77707-8
|
Predictable off period indicator in the past week [UPDRS] |
|
82286-6
|
Predicted RMR |
|
12727-4
|
Prednisolone [Mass/volume] in Serum or Plasma |
|
46955-1
|
Prednisolone [Mass/volume] in Urine |
|
18252-7
|
Prednisone [Mass/time] in 24 hour Urine |
|
73197-6
|
Prednisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73196-8
|
Prednisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
49709-9
|
Prednisone [Presence] in Serum or Plasma |
|
12434-7
|
Prednisone [Mass/volume] in Serum or Plasma |
|
55570-6
|
Prednisone [Moles/volume] in Serum or Plasma |
|
46956-9
|
Prednisone [Mass/volume] in Urine |
|
88335-5
|
Predominant leukocyte identified [Type] in Ear by Light microscopy |
|
30966-6
|
Pre-existing physician-diagnosed allergies, birth defects, medical conditions |
|
85594-0
|
Preferred type of dialysis if required before transplant |
|
85596-5
|
Preferred kidney failure treatment if kidney disease progresses to kidney failure |
|
93123-8
|
Preferred vaccine type [Identifier] |
|
75776-5
|
Preference on consulting a supportive and palliative care team to help treat physical, emotional, and spiritual discomfort and support family [Reported] |
|
71443-6
|
Preference to avoid asking Q0500B again [MDSv3] |
|
54899-0
|
Preferred language |
|
75780-7
|
Preferred location to spend final days if possible to choose [Reported] |
|
46100-4
|
Pregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
|
13894-1
|
Pregnenolone [Mass/time] in 24 hour Urine |
|
51683-1
|
Pregnenolone [Mass/volume] in Serum or Plasma --baseline |
|
91151-1
|
Pregnancy complication of Family member |
|
91144-6
|
Pregnancy prevention intention - Reported |
|
2837-3
|
Pregnenolone [Mass/volume] in Serum or Plasma |
|
25507-5
|
Pregnenolone [Moles/volume] in Serum or Plasma |
|
2831-6
|
Pregnancy specific protein 1 [Mass/volume] in Serum |
|
51685-6
|
Pregnenolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
51686-4
|
Pregnenolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
51682-3
|
Pregnenolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
51688-0
|
Pregnenolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
51689-8
|
Pregnenolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
51684-9
|
Pregnenolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
51687-2
|
Pregnenolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
77996-7
|
Pregnancy status at time of illness or condition |
|
17480-5
|
Pregnenolone [Mass/volume] in Urine |
|
77781-3
|
Pregabalin cutoff [Mass/volume] in Urine for Confirmatory method |
|
47414-8
|
Pregabalin [Mass/volume] in Serum or Plasma |
|
48349-5
|
Pregabalin [Moles/volume] in Serum or Plasma |
|
64125-8
|
Pregabalin [Mass/volume] in Urine by Confirmatory method |
|
92651-9
|
Pregabalin [Presence] in Urine by Confirmatory method |
|
64137-3
|
Pregabalin [Presence] in Urine by Screen method |
|
64136-5
|
Pregabalin/Creatinine [Mass Ratio] in Urine |
|
87764-7
|
Pregabalin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
11996-6
|
[#] Pregnancies |
|
86645-9
|
Pregnancy intention in the next year - Reported |
|
72154-8
|
Pregnancy risk factors [RHEA] |
|
82810-3
|
Pregnancy status |
|
11449-6
|
Pregnancy status - Reported |
|
90767-5
|
Pregnancy summary Document |
|
2834-0
|
Pregnanediol [Mass/time] in 24 hour Urine |
|
34358-2
|
Pregnanediol [Moles/volume] in 24 hour Urine |
|
14885-8
|
Pregnanediol [Moles/time] in 24 hour Urine |
|
57892-2
|
Pregnanediol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone |
|
57893-0
|
Pregnanediol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone |
|
57888-0
|
Pregnanediol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone |
|
57889-8
|
Pregnanediol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone |
|
2832-4
|
Pregnanediol [Mass/volume] in Amniotic fluid |
|
57890-6
|
Pregnanediol [Mass/volume] in 24 hour Urine --pre dose dexamethasone |
|
57891-4
|
Pregnanediol [Mass/time] in 24 hour Urine --pre dose dexamethasone |
|
57886-4
|
Pregnanediol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone |
|
57887-2
|
Pregnanediol [Mass/time] in 24 hour Urine --pre high dose dexamethasone |
|
2833-2
|
Pregnanediol [Mass/volume] in Urine |
|
15091-2
|
Pregnanediol [Moles/volume] in Urine |
|
34359-0
|
Pregnanediol/Creatinine [Molar ratio] in Urine |
|
82895-4
|
Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82894-7
|
Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
83131-3
|
Pregnanolone [Moles/time] in 24 hour Urine |
|
83132-1
|
Pregnanolone [Moles/volume] in Urine |
|
83133-9
|
Pregnanolone/Creatinine [Molar ratio] in Urine |
|
2836-5
|
Pregnanetriol [Mass/time] in 24 hour Urine |
|
34360-8
|
Pregnanetriol [Moles/volume] in 24 hour Urine |
|
14886-6
|
Pregnanetriol [Moles/time] in 24 hour Urine |
|
2835-7
|
Pregnanetriol [Mass/volume] in Urine |
|
15092-0
|
Pregnanetriol [Moles/volume] in Urine |
|
39566-5
|
Pregnanetriol/Creatinine [Mass Ratio] in 24 hour Urine |
|
30512-8
|
Pregnanetriol/Creatinine [Mass Ratio] in Urine |
|
34361-6
|
Pregnanetriol/Creatinine [Molar ratio] in Urine |
|
82898-8
|
Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82899-6
|
Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
50643-6
|
Pregnanetriolone [Mass/time] in 24 hour Urine |
|
34362-4
|
Pregnanetriolone [Moles/volume] in 24 hour Urine |
|
25732-9
|
Pregnanetriolone [Moles/time] in 24 hour Urine |
|
34363-2
|
Pregnanetriolone [Moles/volume] in Urine |
|
30513-6
|
Pregnanetriolone/Creatinine [Mass Ratio] in Urine |
|
34364-0
|
Pregnanetriolone/Creatinine [Molar ratio] in Urine |
|
82901-0
|
Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82900-2
|
Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
74207-2
|
Prehospital summary Document |
|
88668-9
|
Prehospital therapeutic hypothermia method |
|
74289-0
|
Other pre-hospital transport mode [NTDS] |
|
50260-9
|
Prekeratocytes [Presence] in Blood by Light microscopy |
|
86955-2
|
Preliminary testing affected submission for further testing Specimen |
|
91101-6
|
People with preliminary positive lab results [#] Population |
|
86952-9
|
Preliminary testing done Specimen |
|
86953-7
|
Preliminary testing result Specimen |
|
76517-2
|
Premature infant |
|
73636-3
|
Premafloxacin [Susceptibility] by Disk diffusion (KB) |
|
73613-2
|
Premafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73591-0
|
Premafloxacin [Susceptibility] |
|
77545-2
|
Premorbid estimate # [AmNART] |
|
75204-8
|
Prenatal care indicator [CDC.CS] |
|
85718-5
|
Prenatal care location from Mother |
|
89498-0
|
Prenatal diagnosis |
|
89497-2
|
Mother's Prenatal tests |
|
67862-3
|
Preoperative evaluation and management note |
|
19772-3
|
Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain |
|
93269-9
|
Preparatory acts or suicidal behavior 3 months |
|
93267-3
|
Preparatory acts or suicidal behavior Lifetime |
|
93270-7
|
Preparatory acts or suicidal behaviors # 3 months |
|
93268-1
|
Preparatory acts or suicidal behaviors # Lifetime |
|
57249-5
|
Prepare light meals - functional ability [CMS Assessment] |
|
81354-3
|
Prescribed anticipatory medication [Reported] |
|
70955-0
|
Prescription changed following the peritoneal dialysis adequacy measurement [ESRD] |
|
64288-4
|
Prescription for eyewear |
|
57828-6
|
Prescription list |
|
44787-0
|
Preservation fluid {Organ} |
|
76529-7
|
Pressure Respiratory system airway |
|
76003-3
|
Pressure Respiratory system airway --during inspiration on ventilator |
|
75942-3
|
Airway pressure --during inspiration |
|
75943-1
|
Airway pressure --during respiratory pause |
|
20258-0
|
Mean pressure gradient 2 by US |
|
20257-2
|
Mean pressure gradient 2 by US+Calculated |
|
76164-3
|
Pressure Respiratory system airway --on ventilator |
|
76252-6
|
Pressure Pleural space |
|
76268-2
|
Pressure.ambient Room |
|
76169-2
|
Pressure.baseline Respiratory system airway --on ventilator |
|
76168-4
|
Pressure.baseline setting Ventilator |
|
76531-3
|
Pressure.max Respiratory system airway --on ventilator |
|
61028-7
|
Pressure.min Respiratory system airway |
|
76206-2
|
Pressure.min Respiratory system airway --on ventilator |
|
76259-1
|
Pressure.plateau Respiratory system airway --on ventilator |
|
54957-6
|
Pressure injuries were present on the prior assessment [CMS Assessment] |
|
57221-4
|
Pressure injury assessment was conducted [CMS Assessment] |
|
91150-3
|
Pressure injury stage NPUAP |
|
60952-9
|
Mean airway pressure --during inspiration |
|
80345-2
|
Pressure points examined [Anatomy] of Skin |
|
81636-3
|
Pressure ulcer risk level Braden scale |
|
90981-2
|
Pressure Ulcer Scale for Healing (PUSH) Tool 3.0 total score [PUSH] |
|
72527-5
|
Pressure ulcer stage NPUAP |
|
76240-1
|
Pressure.occlusion 100ms Respiratory system airway |
|
76203-9
|
Pressure.occlusion Respiratory system airway --negative inspiratory force maneuver |
|
93850-6
|
Pretomanid [Susceptibility] |
|
85705-2
|
Mother has had previous deliveries in U.S. |
|
68328-4
|
Previous fetus defect |
|
85696-3
|
Previous rubella disease was serologically confirmed |
|
85693-0
|
Previous rubella virus test result |
|
75460-6
|
Preventive medicine Nurse Note |
|
83867-2
|
Preventive medicine Annual evaluation note |
|
83868-0
|
Preventive medicine Consult note |
|
83869-8
|
Preventive medicine Counseling note |
|
75481-2
|
Preventive medicine Education note |
|
89432-9
|
Preventive medicine Group counseling note |
|
75482-0
|
Preventive medicine Note |
|
75483-8
|
Preventive medicine Outpatient Note |
|
75484-6
|
Preventive medicine Risk assessment and screening note |
|
54592-1
|
Previous assessment reference date for significant correction [CMS Assessment] |
|
86772-1
|
Previous rehabilitation therapy regimen (speech, occupational, and/or physical therapy) ended, and regimen now resumed at exactly the same level for each discipline [CMS Assessment] |
|
34493-7
|
PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
41067-0
|
PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
34491-1
|
PRF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41068-8
|
PRF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34668-4
|
Prilocaine [Mass/volume] in Serum or Plasma |
|
55571-4
|
Prilocaine [Moles/volume] in Serum or Plasma |
|
93780-5
|
Primary mediastinal large B-cell lymphoma [Likelihood] in Tissue |
|
75485-3
|
Primary care Administrative note |
|
83870-6
|
Primary care Admission evaluation note |
|
83871-4
|
Primary care Annual evaluation note |
|
83706-2
|
Primary care Attending Initial evaluation note |
|
75473-9
|
Primary care Attending Note |
|
83703-9
|
Primary care Attending Patient's home Note |
|
83872-2
|
Primary care Case manager Note |
|
83873-0
|
Primary care Consult note |
|
83874-8
|
Primary care Custodial care facility Note |
|
68831-7
|
Primary care Discharge summary |
|
75486-1
|
Primary care Education note |
|
78624-4
|
Primary care Flowsheet |
|
89434-5
|
Primary care Group counseling note |
|
68833-3
|
Primary care History and physical note |
|
68837-4
|
Primary care Hospital Consult note |
|
68838-2
|
Primary care Hospital Letter |
|
87272-1
|
Primary care Immunization note |
|
83875-5
|
Primary care Initial evaluation note |
|
75487-9
|
Primary care Letter |
|
83786-4
|
Primary care Physician History and physical note |
|
75479-6
|
Primary care Physician Note |
|
75488-7
|
Primary care Medication management note |
|
68834-1
|
Primary care Note |
|
83560-3
|
Primary care Nurse practitioner Note |
|
75461-4
|
Primary care Nurse Note |
|
83625-4
|
Primary care Nurse Patient's home Note |
|
83642-9
|
Primary care Nurse Triage note |
|
83749-2
|
Primary care Physician assistant Note |
|
75489-5
|
Primary care Telephone encounter Note |
|
80777-6
|
Primary care Plan of care note |
|
68835-8
|
Primary care Preoperative evaluation and management note |
|
68836-6
|
Primary care procedure note |
|
88692-9
|
Primary care Patient's home Admission evaluation note |
|
84130-4
|
Primary care Patient's home Annual evaluation note |
|
84131-2
|
Primary care Patient's home Consult note |
|
84132-0
|
Primary care Patient's home Discharge summary |
|
84133-8
|
Primary care Patient's home Medication management note |
|
84134-6
|
Primary care Patient's home Note |
|
84136-1
|
Primary care Patient's home Plan of care note |
|
78671-5
|
Primary care Referral note |
|
83772-4
|
Primary care Resident Note |
|
83876-3
|
Primary care Risk assessment and screening note |
|
90759-2
|
Primary care Social worker Note |
|
75495-2
|
Primary care Team Note |
|
83877-1
|
Primary care Triage note |
|
83878-9
|
Primary care Urgent care center Note |
|
71766-0
|
Primary contact email Facility |
|
71752-0
|
Primary contact first name Facility |
|
91704-7
|
Primary contact information panel Facility |
|
71753-8
|
Primary contact last name Facility |
|
71750-4
|
Primary contact phone number extension Facility |
|
71751-2
|
Primary contact phone number Facility |
|
18630-4
|
Primary diagnosis |
|
46639-1
|
Primary diagnosis [RFC] |
|
46511-2
|
Primary diagnosis ICD code [CMS Assessment] |
|
86255-7
|
Primary diagnosis ICD code |
|
76449-8
|
Primary functional limitation |
|
75783-1
|
Primary healthcare agent [Reported] |
|
76442-3
|
Primary health condition |
|
76437-3
|
Primary insurance |
|
76382-1
|
Primary nursing license type Provider [NMMDS] |
|
85402-6
|
Primary payment source [CMS Assessment] |
|
54714-1
|
Primary respondent for daily and activity preferences [CMS Assessment] |
|
71579-7
|
Primary role of unit NEMSIS |
|
10591-6
|
Primary Spermatocytes [#/volume] in Semen |
|
4407-3
|
Primidone [Mass] of Dose |
|
29225-0
|
Primidone [Mass/volume] in Body fluid |
|
47125-0
|
Primidone [Moles/volume] in Gastric fluid |
|
73195-0
|
Primidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73194-3
|
Primidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3978-4
|
Primidone [Mass/volume] in Serum or Plasma |
|
14887-4
|
Primidone [Moles/volume] in Serum or Plasma |
|
74912-7
|
Primidone [Mass/volume] in Serum or Plasma --trough |
|
12387-7
|
Primidone [Mass/volume] in Urine |
|
87767-0
|
Primidone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
10547-8
|
Primidone+PHENobarbital [Mass/volume] in Serum or Plasma |
|
34365-7
|
Primidone+PHENobarbital [Moles/volume] in Serum or Plasma |
|
6221-6
|
Primrose IgE Ab [Units/volume] in Serum |
|
85695-5
|
Prior condition onset year [Date] |
|
83234-5
|
Prior device use [CMS Assessment] |
|
86185-6
|
Prior functioning.ambulation [CMS Assessment] |
|
86187-2
|
Prior functioning.household tasks [CMS Assessment] |
|
85070-1
|
Prior functioning.self care [CMS Assessment] |
|
86186-4
|
Prior functioning.transfer [CMS Assessment] |
|
85400-0
|
Prior living arrangement [CMS Assessment] |
|
79757-1
|
Prior molecular testing related to ophthalmological condition Narrative |
|
52539-4
|
Prior postal code [Location] |
|
85399-4
|
Prior residence |
|
91601-5
|
Priorities related to the emergency response activation Reporting Period |
|
12599-7
|
Pristanate (C15:0(CH3)4) [Mass/volume] in Serum or Plasma |
|
22761-1
|
Pristanate (C15:0(CH3)4) [Moles/volume] in Serum or Plasma |
|
12600-3
|
Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Mass Ratio] in Serum or Plasma |
|
30550-8
|
Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Molar ratio] in Serum or Plasma |
|
55709-0
|
Pristinamycin [Susceptibility] by Gradient strip |
|
35833-3
|
Pristinamycin [Susceptibility] by Disk diffusion (KB) |
|
35834-1
|
Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32383-2
|
Pristinamycin [Susceptibility] |
|
7632-3
|
Privet IgE Ab [Units/volume] in Serum |
|
15960-8
|
Privet IgE Ab RAST class [Presence] in Serum |
|
7633-1
|
Privet IgG Ab [Units/volume] in Serum |
|
63204-2
|
Privet IgG Ab [Mass/volume] in Serum |
|
50682-4
|
PRKCG gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
81869-0
|
PRNP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
57309-7
|
PRNP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81868-2
|
PRNP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
57312-1
|
PRNP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
82770-9
|
Patient reported outcome Computer Adaptive Testing used |
|
27824-2
|
Prothrombin Fragment 1.2 Ag [Moles/volume] in Serum or Plasma by Immunoassay |
|
5900-6
|
Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma |
|
25742-8
|
Prothrombin Fragment 1.2 [Moles/volume] in Serum or Plasma |
|
82782-4
|
Patient reported outcome item identifier |
|
82783-2
|
Patient reported outcome response |
|
82784-0
|
Patient reported outcome response method |
|
81259-4
|
Associated phenotype |
|
73981-3
|
Problem alleviating AndOr exacerbating factors Narrative |
|
77351-5
|
Probability of suspected pulmonary embolism prior to imaging |
|
91578-5
|
Probability of an event occurring |
|
74019-1
|
Probability of developing disease assessed [Likelihood] |
|
3981-8
|
Probenecid [Mass/time] in 24 hour Urine |
|
4408-1
|
Probenecid [Mass] of Dose |
|
27100-7
|
Probenecid [Mass/volume] in Serum or Plasma |
|
3979-2
|
Probenecid [Presence] in Urine |
|
17481-3
|
Probenecid [Units/volume] in Urine |
|
3980-0
|
Probenecid [Mass/volume] in Urine |
|
75326-9
|
Problem |
|
86676-4
|
Problem conditions in last 7 days [CMS Assessment] |
|
75318-6
|
Problem Family member |
|
74701-4
|
Problem that resulted from the equipment or device function problem [AHRQ] |
|
19780-6
|
Procedure description Narrative Endoscopy |
|
89875-9
|
Procedure duration |
|
93815-9
|
PROC gene full mutation analysis in Blood or Tissue by Sequencing |
|
19782-2
|
Procedure monitoring description Endoscopy study Narrative |
|
19781-4
|
Procedure monitoring parameters Endoscopy study |
|
85064-4
|
Procedure(s) performed --preoperative |
|
80245-4
|
Procedure sequence |
|
78944-6
|
Procedure start time |
|
85348-1
|
Procedure used to obtain tumor specimen [Type] in Specimen |
|
78927-1
|
Procedure urgency |
|
89266-1
|
Procedures, Services, or Supplies code |
|
89265-3
|
Procedures, Services, or Supplies modifier |
|
4409-9
|
Procainamide [Mass] of Dose |
|
17805-3
|
Procainamide [Mass/volume] in Body fluid |
|
73193-5
|
Procainamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73192-7
|
Procainamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3982-6
|
Procainamide [Mass/volume] in Serum or Plasma |
|
14888-2
|
Procainamide [Moles/volume] in Serum or Plasma |
|
72657-0
|
Procainamide [Mass/volume] in Serum or Plasma --trough |
|
17482-1
|
Procainamide [Mass/volume] in Urine |
|
3983-4
|
Procainamide+N-acetylprocainamide [Mass/volume] in Serum or Plasma |
|
14889-0
|
Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma |
|
9700-6
|
Procaine [Mass/volume] in Serum or Plasma |
|
55572-2
|
Procaine [Moles/volume] in Serum or Plasma |
|
12301-8
|
Procaine [Presence] in Urine |
|
75241-0
|
Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay |
|
33959-8
|
Procalcitonin [Mass/volume] in Serum or Plasma |
|
64293-4
|
Procedure consent Document |
|
19779-8
|
Procedure Endoscopy |
|
76515-6
|
Requested procedure is appropriate |
|
28570-0
|
Procedure note |
|
86761-4
|
Procedures performed during last 14 days - while a resident [CMS Assessment] |
|
86760-6
|
Procedures performed during last 14 days - while not a resident [CMS Assessment] |
|
75768-2
|
Prochlorperazine [Presence] in Blood or Urine by Screen method |
|
4200-2
|
Prochlorperazine [Mass] of Dose |
|
61105-3
|
Prochlorperazine [Moles/volume] in Gastric fluid |
|
26830-0
|
Prochlorperazine [Presence] in Serum or Plasma |
|
3509-7
|
Prochlorperazine [Mass/volume] in Serum or Plasma |
|
39470-0
|
Prochlorperazine [Moles/volume] in Serum or Plasma |
|
3510-5
|
Prochlorperazine [Presence] in Urine |
|
61103-8
|
Prochlorperazine [Moles/volume] in Urine |
|
61104-6
|
Prochlorperazine [Moles/volume] in Unspecified specimen |
|
10337-4
|
Procollagen type I [Mass/volume] in Serum |
|
25733-7
|
Procollagen type III [Units/volume] in Serum |
|
56627-3
|
Procollagen type III [Mass/volume] in Serum |
|
57756-9
|
Procollagen type III.N-terminal propeptide [Units/volume] in Serum |
|
71792-6
|
Procollagen type III.N-terminal propeptide [Mass/volume] in Serum |
|
47728-1
|
Procollagen type III/Creatinine [Ratio] in Urine |
|
35573-5
|
Procollagen+Collagen [Identifier] in Fibroblast by Electrophoresis |
|
92993-5
|
PROCR gene full mutation analysis in Blood or Tissue by Sequencing |
|
9387-2
|
Procyclidine [Mass/volume] in Serum or Plasma |
|
32110-9
|
Procyclidine [Moles/volume] in Serum or Plasma |
|
12290-3
|
Procyclidine [Presence] in Urine |
|
27103-1
|
Procyclidine [Mass/volume] in Urine |
|
71502-9
|
Profit status Dialysis facility [ESRD] |
|
17484-7
|
Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
47181-3
|
Progesterone [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
17485-4
|
Progesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
47183-9
|
Progesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
12822-3
|
Progesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
47184-7
|
Progesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
57798-1
|
Progesterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
12820-7
|
Progesterone [Mass/volume] in 24 hour Urine |
|
17486-2
|
Progesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
47185-4
|
Progesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
12821-5
|
Progesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
47186-2
|
Progesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
17487-0
|
Progesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
47187-0
|
Progesterone [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
27967-9
|
Progesterone [Mass/volume] in Serum or Plasma --baseline |
|
47189-6
|
Progesterone [Moles/volume] in Serum or Plasma --baseline |
|
14173-9
|
Progesterone Free [Mass/time] in 24 hour Urine |
|
72889-9
|
Progesterone Free [Mass/volume] in Serum or Plasma |
|
72890-7
|
Progesterone Free/Progesterone.total in Serum or Plasma |
|
2838-1
|
Progesterone [Mass/volume] in Saliva (oral fluid) |
|
24109-1
|
Progesterone [Moles/volume] in Saliva (oral fluid) |
|
83109-9
|
Progesterone [Mass/volume] in Serum or Plasma by Immunoassay |
|
83110-7
|
Progesterone [Moles/volume] in Serum or Plasma by Immunoassay |
|
2839-9
|
Progesterone [Mass/volume] in Serum or Plasma |
|
35223-7
|
Progesterone [Mass or Moles/volume] in Serum or Plasma |
|
14890-8
|
Progesterone [Moles/volume] in Serum or Plasma |
|
33852-5
|
Progesterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
33853-3
|
Progesterone [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
33851-7
|
Progesterone [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
47182-1
|
Progesterone [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
12815-7
|
Progesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25508-3
|
Progesterone [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12816-5
|
Progesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25509-1
|
Progesterone [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12817-3
|
Progesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
33854-1
|
Progesterone [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12818-1
|
Progesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
47188-8
|
Progesterone [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12819-9
|
Progesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
47988-1
|
Progesterone [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
17488-8
|
Progesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
47989-9
|
Progesterone [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
17489-6
|
Progesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
47990-7
|
Progesterone [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
17490-4
|
Progesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
47991-5
|
Progesterone [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
17483-9
|
Progesterone [Mass/volume] in Urine |
|
44729-2
|
Progesterone/11-Deoxycorticosterone [Mass Ratio] in Serum or Plasma |
|
44730-0
|
Progesterone/Estradiol (E2) [Mass Ratio] in Serum or Plasma |
|
75328-5
|
Prognosis |
|
92725-1
|
Prognosis for rehabilitation |
|
71500-3
|
Program Dialysis facility [ESRD] |
|
85413-3
|
Program interruption date [CMS Assessment] |
|
85412-5
|
Program interruption(s) [CMS Assessment] |
|
85414-1
|
Program return date [CMS Assessment] |
|
68607-1
|
Progress letter |
|
11506-3
|
Progress note |
|
79758-9
|
Progression of problem since birth |
|
48497-2
|
Pro-hepcidin [Mass/volume] in Serum or Plasma |
|
27956-2
|
Proinsulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
27856-4
|
Proinsulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
27857-2
|
Proinsulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
|
27958-8
|
Proinsulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge |
|
17491-2
|
Proinsulin [Mass/volume] in Serum or Plasma --baseline |
|
47190-4
|
Proinsulin [Moles/volume] in Serum or Plasma --baseline |
|
10451-3
|
Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
|
2840-7
|
Proinsulin [Mass/volume] in Serum or Plasma |
|
27882-0
|
Proinsulin [Moles/volume] in Serum or Plasma |
|
65352-7
|
Proinsulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
65353-5
|
Proinsulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
65354-3
|
Proinsulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
65355-0
|
Proinsulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
65356-8
|
Proinsulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
65357-6
|
Proinsulin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
65358-4
|
Proinsulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
45338-1
|
Proinsulin/Insulin [Ratio] in Serum or Plasma |
|
76451-4
|
Projected goal of limitation |
|
80893-1
|
Projected heparin concentration to reach target ACT [Units/volume] in Blood by calculation |
|
33908-5
|
Prolactin [Moles/volume] in Serum or Plasma --1.5 hours post 200 ug TRH IV |
|
21381-9
|
Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
1609-7
|
Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
|
47868-5
|
Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose metoclopramide |
|
44926-4
|
Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
|
47729-9
|
Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
|
25734-5
|
Prolactin [Mass/volume] in Serum or Plasma --10 minutes post 200 ug TRH IV |
|
12832-2
|
Prolactin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
12834-8
|
Prolactin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
44929-8
|
Prolactin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV |
|
47730-7
|
Prolactin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV |
|
40330-3
|
Prolactin [Mass/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
44928-0
|
Prolactin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
|
48120-0
|
Prolactin [Mass/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
|
25735-2
|
Prolactin [Mass/volume] in Serum or Plasma --1 hour post 200 ug TRH IV |
|
33907-7
|
Prolactin [Moles/volume] in Serum or Plasma --1 hour post 200 ug TRH IV |
|
41609-9
|
Prolactin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
1612-1
|
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
1610-5
|
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose L-dopa PO |
|
47869-3
|
Prolactin [Units/volume] in Serum or Plasma --1 hour post dose metoclopramide |
|
44925-6
|
Prolactin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
|
1611-3
|
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
|
40333-7
|
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
47870-1
|
Prolactin [Mass/volume] in Serum or Plasma --2.5 hours post dose TRH IV |
|
25737-8
|
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post 200 ug TRH IV |
|
12833-0
|
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
40331-1
|
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post dose triple bolus |
|
55502-9
|
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post dose TRH IV |
|
21380-1
|
Prolactin [Mass/time] in 24 hour Urine |
|
25738-6
|
Prolactin [Mass/volume] in Serum or Plasma --2 hours post 200 ug TRH IV |
|
33909-3
|
Prolactin [Moles/volume] in Serum or Plasma --2 hours post 200 ug TRH IV |
|
56496-3
|
Prolactin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
16109-1
|
Prolactin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
1613-9
|
Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose L-dopa PO |
|
44930-6
|
Prolactin [Units/volume] in Serum or Plasma --2 hours post dose TRH IV |
|
47731-5
|
Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV |
|
25739-4
|
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post 200 ug TRH IV |
|
33906-9
|
Prolactin [Moles/volume] in Serum or Plasma --30 minutes post 200 ug TRH IV |
|
41608-1
|
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
1615-4
|
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
|
47871-9
|
Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose metoclopramide |
|
44927-2
|
Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
|
1614-7
|
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
|
40332-9
|
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
17241-1
|
Prolactin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
1617-0
|
Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO |
|
25740-2
|
Prolactin [Mass/volume] in Serum or Plasma --40 minutes post 200 ug TRH IV |
|
17242-9
|
Prolactin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
55503-7
|
Prolactin [Mass/volume] in Serum or Plasma --40 minutes post dose TRH IV |
|
12835-5
|
Prolactin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
1618-8
|
Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
|
25741-0
|
Prolactin [Mass/volume] in Serum or Plasma --50 minutes post 200 ug TRH IV |
|
10507-2
|
Prolactin Ag [Presence] in Tissue by Immune stain |
|
12231-7
|
Prolactin [Mass/volume] in Serum or Plasma --baseline |
|
79398-4
|
Prolactin isoforms pattern [Interpretation] in Serum or Plasma Narrative |
|
19251-8
|
Prolactin [Mass/volume] in Serum or Plasma --post XXX challenge |
|
56972-3
|
Prolactin [Mass/volume] in Serum or Plasma --post precipitation |
|
17243-7
|
Prolactin [Mass/volume] in Serum or Plasma --pre XXX challenge |
|
1621-2
|
Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
|
1619-6
|
Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO |
|
47872-7
|
Prolactin [Units/volume] in Serum or Plasma --pre dose metoclopramide |
|
44931-4
|
Prolactin [Units/volume] in Serum or Plasma --pre dose TRH IV |
|
1620-4
|
Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
|
40329-5
|
Prolactin [Mass/volume] in Serum or Plasma --pre dose triple bolus |
|
51432-3
|
Prolactin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
|
20434-7
|
Prolactin [Units/volume] in Serum or Plasma by 3rd IS |
|
49220-7
|
Prolactin [Mass/volume] in Serum or Plasma by 3rd IS |
|
83111-5
|
Prolactin [Units/volume] in Serum or Plasma by Immunoassay |
|
20568-2
|
Prolactin [Mass/volume] in Serum or Plasma by Immunoassay |
|
15081-3
|
Prolactin [Units/volume] in Serum or Plasma |
|
2842-3
|
Prolactin [Mass/volume] in Serum or Plasma |
|
2841-5
|
Prolactin [Mass/volume] in Semen |
|
25736-0
|
Prolactin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50517-2
|
Prolactin [Mass/volume] in Serum or Plasma --1st specimen |
|
12831-4
|
Prolactin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
12823-1
|
Prolactin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50518-0
|
Prolactin [Mass/volume] in Serum or Plasma --2nd specimen |
|
12824-9
|
Prolactin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50519-8
|
Prolactin [Mass/volume] in Serum or Plasma --3rd specimen |
|
12825-6
|
Prolactin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50520-6
|
Prolactin [Mass/volume] in Serum or Plasma --4th specimen |
|
12826-4
|
Prolactin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50521-4
|
Prolactin [Mass/volume] in Serum or Plasma --5th specimen |
|
12827-2
|
Prolactin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50522-2
|
Prolactin [Mass/volume] in Serum or Plasma --6th specimen |
|
12828-0
|
Prolactin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50523-0
|
Prolactin [Mass/volume] in Serum or Plasma --7th specimen |
|
12829-8
|
Prolactin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50524-8
|
Prolactin [Mass/volume] in Serum or Plasma --8th specimen |
|
12830-6
|
Prolactin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
78985-9
|
Prolactin.dimeric [Units/volume] in Serum or Plasma |
|
78986-7
|
Prolactin.dimeric/Prolactin in Serum or Plasma |
|
78994-1
|
Prolactin monomeric [Units/volume] in Serum or Plasma |
|
42607-2
|
Prolactin monomeric [Mass/volume] in Serum or Plasma |
|
78995-8
|
Prolactin monomeric/Prolactin in Serum or Plasma |
|
50366-4
|
Prolactin monomeric/Prolactin.total in Serum or Plasma |
|
2848-0
|
Proline dipeptidase [Enzymatic activity/mass] in Tissue |
|
2847-2
|
Proline [Mass/time] in 24 hour Urine |
|
25975-4
|
Proline [Moles/volume] in 24 hour Urine |
|
25510-9
|
Proline [Moles/time] in 24 hour Urine |
|
13412-2
|
Proline [Mass/volume] in Amniotic fluid |
|
27033-0
|
Proline [Moles/volume] in Amniotic fluid |
|
2843-1
|
Proline [Mass/volume] in Cerebral spinal fluid |
|
22645-6
|
Proline [Moles/volume] in Cerebral spinal fluid |
|
47732-3
|
Proline [Moles/volume] in DBS |
|
32267-7
|
Proline [Moles/volume] in Body fluid |
|
2844-9
|
Proline [Presence] in Serum or Plasma |
|
2845-6
|
Proline [Mass/volume] in Serum or Plasma |
|
20655-7
|
Proline [Moles/volume] in Serum or Plasma |
|
47734-9
|
Proline/Amino acids.total in Amniotic fluid |
|
47736-4
|
Proline/Amino acids.total in DBS |
|
47733-1
|
Proline/Amino acids.total in Hair |
|
47735-6
|
Proline/Amino acids.total in Serum or Plasma |
|
47737-2
|
Proline/Amino acids.total in Unspecified specimen |
|
17492-0
|
Proline [Presence] in Urine |
|
2846-4
|
Proline [Mass/volume] in Urine |
|
26726-0
|
Proline [Moles/volume] in Urine |
|
32266-9
|
Proline [Moles/volume] in Vitreous fluid |
|
22743-9
|
Proline [Moles/volume] in Unspecified specimen |
|
44398-6
|
Proline/Creatinine [Mass Ratio] in 24 hour Urine |
|
56973-1
|
Proline/Creatinine [Ratio] in 24 hour Urine |
|
25976-2
|
Proline/Creatinine [Molar ratio] in 24 hour Urine |
|
13799-2
|
Proline/Creatinine [Mass Ratio] in Urine |
|
30067-3
|
Proline/Creatinine [Ratio] in Urine |
|
22690-2
|
Proline/Creatinine [Molar ratio] in Urine |
|
53392-7
|
Proline/Phenylalanine [Molar ratio] in DBS |
|
3986-7
|
Prolintane [Mass/time] in 24 hour Urine |
|
4410-7
|
Prolintane [Mass] of Dose |
|
3984-2
|
Prolintane [Presence] in Urine |
|
3985-9
|
Prolintane [Mass/volume] in Urine |
|
79588-0
|
Prolylhydroxyproline [Moles/volume] in Serum or Plasma |
|
79611-0
|
Prolylhydroxyproline/Creatinine [Molar ratio] in Urine |
|
30464-2
|
Prolymphocytes [#/volume] in Blood |
|
6863-5
|
Prolymphocytes [#/volume] in Blood by Manual count |
|
34998-5
|
Prolymphocytes [#/volume] in Body fluid |
|
75663-5
|
Prolymphocytes [Presence] in Blood |
|
11121-1
|
Prolymphocytes/100 cells in Bone marrow by Manual count |
|
30465-9
|
Prolymphocytes/100 leukocytes in Blood |
|
6746-2
|
Prolymphocytes/100 leukocytes in Blood by Manual count |
|
17802-0
|
Prolymphocytes/100 leukocytes in Body fluid |
|
85286-3
|
Promoter methylation testing method [Type] in Cancer specimen |
|
75769-0
|
Promazine [Presence] in Blood or Urine by Screen method |
|
4411-5
|
Promazine [Mass] of Dose |
|
59959-7
|
Promazine [Moles/volume] in Gastric fluid |
|
13578-0
|
Promazine [Presence] in Serum or Plasma |
|
12411-5
|
Promazine [Mass/volume] in Serum or Plasma |
|
59957-1
|
Promazine [Moles/volume] in Serum or Plasma |
|
74819-4
|
Promazine [Presence] in Urine by Screen method |
|
3987-5
|
Promazine [Mass/volume] in Urine |
|
59958-9
|
Promazine [Moles/volume] in Urine |
|
60329-0
|
Promazine [Moles/volume] in Unspecified specimen |
|
75346-7
|
Promethazine [Mass/volume] in Blood by Confirmatory method |
|
75813-6
|
Promethazine [Presence] in Blood or Urine by Screen method |
|
4412-3
|
Promethazine [Mass] of Dose |
|
75270-9
|
Promethazine [Presence] in Serum or Plasma or Urine by Screen method |
|
26736-9
|
Promethazine [Presence] in Serum or Plasma |
|
3988-3
|
Promethazine [Mass/volume] in Serum or Plasma |
|
55573-0
|
Promethazine [Moles/volume] in Serum or Plasma |
|
11000-7
|
Promethazine [Presence] in Urine |
|
3989-1
|
Promethazine [Mass/volume] in Urine |
|
77854-8
|
PROMIS ability to participate in social roles and activities - version 2.0 Tscore |
|
77848-0
|
PROMIS alcohol - alcohol use - version 1.0 Tscore |
|
77785-4
|
PROMIS alcohol - negative consequences - version 1.0 Tscore |
|
77789-6
|
PROMIS alcohol - negative expectancies - version 1.0 Tscore |
|
77786-2
|
PROMIS alcohol - positive expectancies - version 1.0 Tscore |
|
77784-7
|
PROMIS alcohol - positive outcomes - version 1.0 Tscore |
|
89921-1
|
PROMIS anger - version 1.1 T-score |
|
90762-6
|
PROMIS applied cognitive - general concerns - version 1.0 T-score |
|
89680-3
|
PROMIS cancer emotional distress - anxiety - version 1.0 T-score |
|
89669-6
|
PROMIS cancer emotional distress - depression - version 1.0 T-score |
|
89676-1
|
PROMIS cancer fatigue - version 1.0 T-score |
|
89675-3
|
PROMIS cancer pain interference - version 1.1 T-score |
|
89690-2
|
PROMIS cancer physical function - version 1.1 T-score |
|
88851-1
|
PROMIS cognitive function - abilities subset - version 1.0 T-score |
|
81537-3
|
PROMIS cognitive function - abilities subset - version 2.0 T-score |
|
81538-1
|
PROMIS cognitive function - version 2.0 T-score |
|
77853-0
|
PROMIS companionship - version 2.0 Tscore |
|
90410-2
|
PROMIS dyspnea functional limitations - version 1.0 T score |
|
92149-4
|
PROMIS dyspnea severity - version 1.0 T-score |
|
77863-9
|
PROMIS emotional distress - anger - version 1.0 Tscore |
|
77862-1
|
PROMIS emotional distress - anxiety - version 1.0 Tscore |
|
77861-3
|
PROMIS emotional distress - depression - version 1.0 Tscore |
|
77852-2
|
PROMIS emotional support - version 2.0 Tscore |
|
77864-7
|
PROMIS fatigue - version 1.0 Tscore |
|
77851-4
|
PROMIS informational support - version 2.0 Tscore |
|
77850-6
|
PROMIS instrumental support - version 2.0 Tscore |
|
92226-0
|
PROMIS item bank - smoking - emotional and sensory expectancies for all smokers - version 1.0 |
|
92267-4
|
PROMIS item bank - smoking - negative health expectancies for all smokers - version 1.0 |
|
91614-8
|
PROMIS mobility - version 2.0 T-score |
|
77856-3
|
PROMIS pain behavior - version 1.0 Tscore |
|
77865-4
|
PROMIS pain interference - version 1.0 Tscore |
|
89924-5
|
PROMIS pain interference - version 1.1 Tscore |
|
91987-8
|
PROMIS parent proxy anxiety - version 2.0 T-score |
|
91425-9
|
PROMIS parent proxy asthma impact - version 2.0 T-score |
|
90171-0
|
PROMIS parent proxy cognitive function - version 1.0 T-score |
|
91406-9
|
PROMIS parent proxy depressive symptoms - version 2.0 T-score |
|
91934-0
|
PROMIS parent proxy fatigue - version 2.0 T-score |
|
90572-9
|
PROMIS parent proxy life satisfaction - version 1.0 T-Score |
|
92079-3
|
PROMIS parent proxy meaning purpose - version 1.0 T-score |
|
77578-3
|
PROMIS parent proxy mobility - version 1.0 T-score |
|
90705-5
|
PROMIS parent proxy mobility - version 2.0 T-score |
|
91203-0
|
PROMIS parent proxy pain behavior - version 1.0 T-score |
|
89950-0
|
PROMIS parent proxy pain interference - version 2.0 T-score |
|
90680-0
|
PROMIS parent proxy peer relationships - version 2.0 T-score |
|
91216-2
|
PROMIS parent proxy physical activity - version 1.0 T-score |
|
92078-5
|
PROMIS parent proxy physical stress experiences - version 1.0 T-score |
|
91306-1
|
PROMIS parent proxy positive affect - version 1.0 T-score |
|
91368-1
|
PROMIS parent proxy psychological stress experiences - version 1.0 T-score |
|
92614-7
|
PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score |
|
90935-8
|
PROMIS parent proxy short form - cognitive function 7a - version 1.0 raw score |
|
92615-4
|
PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score |
|
90937-4
|
PROMIS parent proxy short form - life satisfaction 4a - version 1.0 raw score |
|
90939-0
|
PROMIS parent proxy short form - life satisfaction 8a - version 1.0 raw score |
|
92611-3
|
PROMIS parent proxy short form - meaning and purpose 4a - version 1.0 raw score |
|
92610-5
|
PROMIS parent proxy short form - meaning and purpose 8a - version 1.0 raw score |
|
90941-6
|
PROMIS parent proxy short form - mobility 8a - version 2.0 raw score |
|
90943-2
|
PROMIS parent proxy short form - pain interference 8a - version 2.0 raw score |
|
90945-7
|
PROMIS parent proxy short form - peer relationship 7a - version 2.0 raw score |
|
92613-9
|
PROMIS parent proxy short form - physical stress experiences 4a - version 1.0 raw score |
|
92612-1
|
PROMIS parent proxy short form - physical stress experiences 8a - version 1.0 raw score |
|
91339-2
|
PROMIS parent proxy strength impact - version 1.0 T-score |
|
91539-7
|
PROMIS pediatric anxiety - version 2.0 T-score |
|
77872-0
|
PROMIS pediatric asthma - version 1.0 Tscore |
|
91537-1
|
PROMIS pediatric asthma impact - version 2.0 T-score |
|
90218-9
|
PROMIS pediatric cognitive function - version 1.0 T-score |
|
91535-5
|
PROMIS pediatric depressive symptoms - version 2.0 T-score |
|
77873-8
|
PROMIS pediatric emotional distress - anxiety - version 1.0 Tscore |
|
77871-2
|
PROMIS pediatric fatigue - version 1.0 Tscore |
|
91533-0
|
PROMIS pediatric fatigue - version 2.0 T-score |
|
90617-2
|
PROMIS pediatric life satisfaction - version 1.0 T-Score |
|
91455-6
|
PROMIS pediatric meaning and purpose - version 1.0 T-score |
|
90884-8
|
PROMIS pediatric mobility - version 2.0 T-score |
|
91935-7
|
PROMIS pediatric pain behavior - version 1.0 T-score |
|
77869-6
|
PROMIS pediatric pain interference - version 1.0 Tscore |
|
89936-9
|
PROMIS pediatric pain interference - version 2.0 Tscore |
|
77868-8
|
PROMIS pediatric peer relationships - version 1.0 Tscore |
|
90707-1
|
PROMIS pediatric peer relationships - version 2.0 T-score |
|
91227-9
|
PROMIS pediatric physical activity - version 1.0 T-score |
|
77867-0
|
PROMIS pediatric physical function - upper extremity - version 1.0 Tscore |
|
77579-1
|
PROMIS pediatric physical function: mobility - version 1.0 T-score |
|
91453-1
|
PROMIS pediatric physical stress experiences - version 1.0 T-score |
|
91354-1
|
PROMIS pediatric positive affect - version 1.0 T-score |
|
91325-1
|
PROMIS pediatric psychological stress experiences - version 1.0 T-score |
|
77842-3
|
PROMIS pediatric short form - asthma 8a - version 1.0 raw score |
|
90948-1
|
PROMIS pediatric short form - cognitive function 7a - version 1.0 raw score |
|
77847-2
|
PROMIS pediatric short form - depressive symptoms - version 1.0 raw score |
|
90950-7
|
PROMIS pediatric short form - depressive symptoms 8a - version 2.0 raw score |
|
77846-4
|
PROMIS pediatric short form - emotional distress - anger - version 1.0 raw score |
|
77845-6
|
PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0 raw score |
|
78170-8
|
PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1 raw score |
|
77840-7
|
PROMIS pediatric short form - fatigue 10a - version 1.0 raw score |
|
90952-3
|
PROMIS pediatric short form - life satisfaction 4a - version 1.0 raw score |
|
90954-9
|
PROMIS pediatric short form - life satisfaction 8a - version 1.0 raw score |
|
90956-4
|
PROMIS pediatric short form - mobility 8a - version 2.0 raw score |
|
92609-7
|
PROMIS pediatric short form - pain behavior 8a - version 1.0 raw score |
|
77839-9
|
PROMIS pediatric short form - pain interference 8a - version 1.0 raw score |
|
90958-0
|
PROMIS pediatric short form - pain interference 8a - version 2.0 raw score |
|
77841-5
|
PROMIS pediatric short form - peer relationships 8a - version 1.0 raw score |
|
90960-6
|
PROMIS pediatric short form - peer relationships 8a - version 2.0 raw score |
|
77844-9
|
PROMIS pediatric short form - physical function - mobility 8a - version 1.0 raw score |
|
77843-1
|
PROMIS pediatric short form - physical function - upper extremity 8a - version 1.0 raw score |
|
91513-2
|
PROMIS pediatric strength impact - version 1.0 T-score |
|
77866-2
|
PROMIS physical function - version 1.0 Tscore |
|
77874-6
|
PROMIS physical function - version 1.2 Tscore |
|
91721-1
|
PROMIS physical function - version 2.0 T-score |
|
77580-9
|
PROMIS physical function w mobility aids - version 1.0 T-score |
|
77858-9
|
PROMIS satisfaction with participation in DSA - version 1.0 Tscore |
|
77857-1
|
PROMIS satisfaction with participation in roles - version 1.0 Tscore |
|
77855-5
|
PROMIS satisfaction with social roles and activities - version 2.0 Tscore |
|
92391-2
|
PROMIS self-efficacy for managing daliy activities - version 1.0 T-score |
|
92329-2
|
PROMIS self-efficacy for managing emotions - version 1.0 T-score |
|
92418-3
|
PROMIS self-efficacy for managing medications and treatments - version 1.0 T-score |
|
92393-8
|
PROMIS self-efficacy for managing social interactions - version 1.0 T-score |
|
92448-0
|
PROMIS self-efficacy for managing symptoms - version 1.0 T-score |
|
77814-2
|
PROMIS short form - ability to participate in social roles and activities 8a - version 2.0 raw score |
|
77795-3
|
PROMIS short form - alcohol - alcohol use 7a - version 1.0 raw score |
|
77794-6
|
PROMIS short form - alcohol - negative consequences 7a - version 1.0 raw score |
|
77793-8
|
PROMIS short form - alcohol - negative expectancies 7a - version 1.0 raw score |
|
77782-1
|
PROMIS short form - alcohol - positive consequences 7a - version 1.0 raw score |
|
77783-9
|
PROMIS short form - alcohol - positive expectancies 7a - version 1.0 raw score |
|
90962-2
|
PROMIS short form - applied cognition - general concerns 4a - version 1.0 raw score |
|
90964-8
|
PROMIS short form - applied cognition - general concerns 6a - version 1.0 raw score |
|
90966-3
|
PROMIS short form - applied cognition - general concerns 8a - version 1.0 raw score |
|
81534-0
|
PROMIS short form - cognitive function - abilities subset 4a - version 2.0 raw score |
|
81535-7
|
PROMIS short form - cognitive function - abilities subset 6a - version 2.0 raw score |
|
81536-5
|
PROMIS short form - cognitive function - abilities subset 8a - version 2.0 raw score |
|
81533-2
|
PROMIS short form - cognitive function 4a - version 2.0 raw score |
|
81532-4
|
PROMIS short form - cognitive function 6a - version 2.0 raw score |
|
81531-6
|
PROMIS short form - cognitive function 8a - version 2.0 raw score |
|
77813-4
|
PROMIS short form - companionship 4a - version 2.0 raw score |
|
77812-6
|
PROMIS short form - companionship 6a - version 2.0 raw score |
|
90968-9
|
PROMIS short form - dyspnea functional limitations 10a - version 1.0 raw score |
|
92606-3
|
PROMIS short form - dyspnea severity 10a - version 1.0 raw score |
|
90970-5
|
PROMIS short form - emotional distress - anger 5a - version 1.1 raw score |
|
77837-3
|
PROMIS short form - emotional distress - anger 8a - version 1.0 raw score |
|
76344-1
|
PROMIS short form - emotional distress - anxiety 4a - version 1.0 |
|
77820-9
|
PROMIS short form - emotional distress - anxiety 4a - version 1.0 raw score |
|
77836-5
|
PROMIS short form - emotional distress - anxiety 7a - version 1.0 raw score |
|
76343-3
|
PROMIS short form - emotional distress - depression 4a - version 1.0 |
|
77821-7
|
PROMIS short form - emotional distress - depression 4a - version 1.0 raw score |
|
77835-7
|
PROMIS short form - emotional distress - depression 8b - version 1.0 raw score |
|
77792-0
|
PROMIS short form - emotional support 4a - version 2.0 raw score |
|
77811-8
|
PROMIS short form - emotional support 6a - version 2.0 raw score |
|
77810-0
|
PROMIS short form - emotional support 8a - version 2.0 raw score |
|
76342-5
|
PROMIS short form - fatigue 4a - version 1.0 |
|
77822-5
|
PROMIS short form - fatigue 4a - version 1.0 raw score |
|
77834-0
|
PROMIS short form - fatigue 7a - version 1.0 raw score |
|
77838-1
|
PROMIS short form - global - version 1.1 raw score |
|
85523-9
|
PROMIS short form - global - version 1.2 raw score |
|
77809-2
|
PROMIS short form - informational support 4a - version 2.0 raw score |
|
77808-4
|
PROMIS short form - informational support 6a - version 2.0 raw score |
|
77807-6
|
PROMIS short form - informational support 8a - version 2.0 raw score |
|
77806-8
|
PROMIS short form - instrumental support 4a - version 2.0 raw score |
|
77805-0
|
PROMIS short form - instrumental support 6a - version 2.0 raw score |
|
77804-3
|
PROMIS short form - instrumental support 8a - version 2.0 raw score |
|
77832-4
|
PROMIS short form - pain behavior 7a - version 1.0 raw score |
|
77825-8
|
PROMIS short form - pain intensity 3a - version 1.0 raw score |
|
90972-1
|
PROMIS short form - pain interference 4a - version 1.0 raw score |
|
90974-7
|
PROMIS short form - pain interference 6a - version 1.0 raw score |
|
77833-2
|
PROMIS short form - pain interference 6b - version 1.0 raw score |
|
75870-6
|
PROMIS short form - pain interference 8a - version 1.0 |
|
77824-1
|
PROMIS short form - pain interference 8a - version 1.0 raw score |
|
77827-4
|
PROMIS short form - physical function 10a - version 1.0 raw score |
|
92608-9
|
PROMIS short form - physical function 10a - version 2.0 raw score |
|
92607-1
|
PROMIS short form - physical function 10b - version 2.0 raw score |
|
77817-5
|
PROMIS short form - physical function 20a - version 1.0 raw score |
|
77819-1
|
PROMIS short form - physical function 4a - version 1.0 raw score |
|
77797-9
|
PROMIS short form - physical function 6b - version 1.2 raw score |
|
77796-1
|
PROMIS short form - physical function 8b - version 1.2 raw score |
|
79064-2
|
PROMIS short form - physical function w mobility aids - version 1.0 raw score |
|
77831-6
|
PROMIS short form - satisfaction with participation in DSA 7a - version 1.0 raw score |
|
77815-9
|
PROMIS short form - satisfaction with participation in social roles 4a - version 1.0 raw score |
|
77830-8
|
PROMIS short form - satisfaction with participation in social roles 7a - version 1.0 raw score |
|
77818-3
|
PROMIS short form - satisfaction with participation in social roles 8a - version 1.0 raw score |
|
77803-5
|
PROMIS short form - satisfaction with social roles and activities 4a - version 2.0 raw score |
|
77802-7
|
PROMIS short form - satisfaction with social roles and activities 6a - version 2.0 raw score |
|
77801-9
|
PROMIS short form - satisfaction with social roles and activities 8a - version 2.0 raw score |
|
92625-3
|
PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score |
|
92624-6
|
PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score |
|
92623-8
|
PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score |
|
92622-0
|
PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score |
|
92621-2
|
PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score |
|
92620-4
|
PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score |
|
92619-6
|
PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score |
|
92618-8
|
PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score |
|
92617-0
|
PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score |
|
92616-2
|
PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score |
|
77826-6
|
PROMIS short form - sleep disturbance 4a - version 1.0 raw score |
|
77816-7
|
PROMIS short form - sleep disturbance 6a - version 1.0 raw score |
|
77829-0
|
PROMIS short form - sleep disturbance 8b - version 1.0 raw score |
|
77828-2
|
PROMIS short form - sleep impairment 8a - version 1.0 raw score |
|
92632-9
|
PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score |
|
92631-1
|
PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score |
|
92630-3
|
PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score |
|
92629-5
|
PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score |
|
92628-7
|
PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score |
|
92627-9
|
PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score |
|
92626-1
|
PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score |
|
77800-1
|
PROMIS short form - social isolation 4a - version 2.0 raw score |
|
77799-5
|
PROMIS short form - social isolation 6a - version 2.0 raw score |
|
77798-7
|
PROMIS short form - social isolation 8a - version 2.0 raw score |
|
92633-7
|
PROMIS short form - upper extremity 7a - version 2.0 raw score |
|
77860-5
|
PROMIS sleep disturbance - version 1.0 Tscore |
|
77859-7
|
PROMIS sleep related impairment - version 1.0 Tscore |
|
92213-8
|
PROMIS smoking - coping expectancies for all smokers - version 1.0 T-score |
|
92225-2
|
PROMIS smoking - emotional and sensory expectancies for all smokers - version 1.0 T-score |
|
92266-6
|
PROMIS smoking - negative health expectancies for all smokers - version 1.0 T-score |
|
92282-3
|
PROMIS smoking - negative psychosocial expectancies for all smokers - version 1.0 T-score |
|
92305-2
|
PROMIS smoking - nicotine dependence for all smokers - version 1.0 T-score |
|
92323-5
|
PROMIS smoking - social motivations for all smokers - version 1.0 T-score |
|
77849-8
|
PROMIS social isolation - version 2.0 Tscore |
|
91612-2
|
PROMIS upper extremity version 2.0 T-score |
|
71970-8
|
PROMIS-10 Global Mental Health (GMH) score |
|
71969-0
|
PROMIS-10 Global Mental Health (GMH) score T-score |
|
71972-4
|
PROMIS-10 Global Physical Health (GPH) score |
|
71971-6
|
PROMIS-10 Global Physical Health (GPH) score T-score |
|
71968-2
|
PROMIS-29 Anxiety score |
|
71967-4
|
PROMIS-29 Anxiety score T-score |
|
71966-6
|
PROMIS-29 Depression score |
|
71965-8
|
PROMIS-29 Depression score T-score |
|
71964-1
|
PROMIS-29 Fatigue score |
|
71963-3
|
PROMIS-29 Fatigue score T-score |
|
71962-5
|
PROMIS-29 Pain interference score |
|
71961-7
|
PROMIS-29 Pain interference score T-score |
|
71960-9
|
PROMIS-29 Physical function score |
|
71959-1
|
PROMIS-29 Physical function score T-score |
|
71958-3
|
PROMIS-29 Satisfaction with participation in social roles score |
|
71957-5
|
PROMIS-29 Satisfaction with participation in social roles score T-score |
|
71956-7
|
PROMIS-29 Sleep disturbance score |
|
71955-9
|
PROMIS-29 Sleep disturbance score T-score |
|
34926-6
|
Promonocytes [#/volume] in Blood |
|
33855-8
|
Promonocytes [#/volume] in Blood by Manual count |
|
34997-7
|
Promonocytes [#/volume] in Body fluid |
|
11122-9
|
Promonocytes/100 cells in Bone marrow by Manual count |
|
30466-7
|
Promonocytes/100 leukocytes in Blood |
|
13599-6
|
Promonocytes/100 leukocytes in Blood by Manual count |
|
17804-6
|
Promonocytes/100 leukocytes in Body fluid |
|
26523-1
|
Promyelocytes [#/volume] in Blood |
|
66135-5
|
Promyelocytes [#/volume] in Blood from Fetus by Manual count |
|
781-5
|
Promyelocytes [#/volume] in Blood by Manual count |
|
34995-1
|
Promyelocytes [#/volume] in Cerebral spinal fluid |
|
34996-9
|
Promyelocytes [#/volume] in Body fluid |
|
40565-4
|
Promyelocytes [#/volume] in Body fluid by Manual count |
|
55803-1
|
Promyelocytes [#] in Cerebral spinal fluid by Manual count |
|
76404-3
|
Promyelocytes [#] in Body fluid by Manual count |
|
11120-3
|
Promyelocytes/100 cells in Bone marrow by Manual count |
|
71666-2
|
Promyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
|
71653-0
|
Promyelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count |
|
71642-3
|
Promyelocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
26524-9
|
Promyelocytes/100 leukocytes in Blood |
|
783-1
|
Promyelocytes/100 leukocytes in Blood by Manual count |
|
30467-5
|
Promyelocytes/100 leukocytes in Cerebral spinal fluid |
|
30371-9
|
Promyelocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
17799-8
|
Promyelocytes/100 leukocytes in Body fluid |
|
40660-3
|
Promyelocytes/100 leukocytes in Body fluid by Manual count |
|
11129-4
|
Pronormoblasts [#/volume] in Blood |
|
26033-1
|
Pronormoblasts/100 cells in Bone marrow |
|
11124-5
|
Pronormoblasts/100 cells in Bone marrow by Manual count |
|
84728-5
|
Can pronounce a [NIH Toolbox] |
|
84488-6
|
Can pronounce abate [NIH Toolbox] |
|
84489-4
|
Can pronounce ablation [NIH Toolbox] |
|
84490-2
|
Can pronounce about [NIH Toolbox] |
|
84491-0
|
Can pronounce abstemiously [NIH Toolbox] |
|
84492-8
|
Can pronounce abysm [NIH Toolbox] |
|
84618-8
|
Can pronounce accrementitial [NIH Toolbox] |
|
84584-2
|
Can pronounce achromatism [NIH Toolbox] |
|
84619-6
|
Can pronounce acolyte [NIH Toolbox] |
|
84697-2
|
Can pronounce acquiescence [NIH Toolbox] |
|
84524-8
|
Can pronounce adjudicate [NIH Toolbox] |
|
84585-9
|
Can pronounce aesthetic [NIH Toolbox] |
|
84620-4
|
Can pronounce all [NIH Toolbox] |
|
84621-2
|
Can pronounce allotment [NIH Toolbox] |
|
84493-6
|
Can pronounce amicability [NIH Toolbox] |
|
84564-4
|
Can pronounce amplify [NIH Toolbox] |
|
84586-7
|
Can pronounce anachronistic [NIH Toolbox] |
|
84729-3
|
Can pronounce ancient [NIH Toolbox] |
|
84525-5
|
Can pronounce androgynous [NIH Toolbox] |
|
84622-0
|
Can pronounce annul [NIH Toolbox] |
|
84661-8
|
Can pronounce annunciating [NIH Toolbox] |
|
84623-8
|
Can pronounce anomalous [NIH Toolbox] |
|
84662-6
|
Can pronounce antagonizing [NIH Toolbox] |
|
84730-1
|
Can pronounce any [NIH Toolbox] |
|
84587-5
|
Can pronounce apocryphal [NIH Toolbox] |
|
84680-8
|
Can pronounce apopemptic [NIH Toolbox] |
|
84624-6
|
Can pronounce appellate [NIH Toolbox] |
|
84731-9
|
Can pronounce art [NIH Toolbox] |
|
84698-0
|
Can pronounce as [NIH Toolbox] |
|
84663-4
|
Can pronounce assuage [NIH Toolbox] |
|
84732-7
|
Can pronounce at [NIH Toolbox] |
|
84681-6
|
Can pronounce automatism [NIH Toolbox] |
|
84494-4
|
Can pronounce bad [NIH Toolbox] |
|
84469-6
|
Can pronounce ballistics [NIH Toolbox] |
|
84495-1
|
Can pronounce band [NIH Toolbox] |
|
84496-9
|
Can pronounce bank [NIH Toolbox] |
|
84497-7
|
Can pronounce be [NIH Toolbox] |
|
84498-5
|
Can pronounce beau [NIH Toolbox] |
|
84499-3
|
Can pronounce beguile [NIH Toolbox] |
|
84500-8
|
Can pronounce belie [NIH Toolbox] |
|
84501-6
|
Can pronounce belligerent [NIH Toolbox] |
|
84502-4
|
Can pronounce bet [NIH Toolbox] |
|
84503-2
|
Can pronounce biscuit [NIH Toolbox] |
|
84504-0
|
Can pronounce both [NIH Toolbox] |
|
84505-7
|
Can pronounce box [NIH Toolbox] |
|
84506-5
|
Can pronounce brobdingnagian [NIH Toolbox] |
|
84507-3
|
Can pronounce bucolic [NIH Toolbox] |
|
84508-1
|
Can pronounce bureau [NIH Toolbox] |
|
84733-5
|
Can pronounce c [NIH Toolbox] |
|
84682-4
|
Can pronounce camp [NIH Toolbox] |
|
84664-2
|
Can pronounce campaign [NIH Toolbox] |
|
84625-3
|
Can pronounce cello [NIH Toolbox] |
|
84588-3
|
Can pronounce chassis [NIH Toolbox] |
|
84589-1
|
Can pronounce choreographer [NIH Toolbox] |
|
84590-9
|
Can pronounce chorus [NIH Toolbox] |
|
84699-8
|
Can pronounce circuitous [NIH Toolbox] |
|
84565-1
|
Can pronounce circumference [NIH Toolbox] |
|
84626-1
|
Can pronounce clarity [NIH Toolbox] |
|
84734-3
|
Can pronounce coercive [NIH Toolbox] |
|
84700-4
|
Can pronounce conscious [NIH Toolbox] |
|
84627-9
|
Can pronounce conviviality [NIH Toolbox] |
|
84526-3
|
Can pronounce credulous [NIH Toolbox] |
|
84735-0
|
Can pronounce crux [NIH Toolbox] |
|
84509-9
|
Can pronounce cucurbitaceous [NIH Toolbox] |
|
84527-1
|
Can pronounce cylindrical [NIH Toolbox] |
|
84528-9
|
Can pronounce d [NIH Toolbox] |
|
84510-7
|
Can pronounce debauchery [NIH Toolbox] |
|
84529-7
|
Can pronounce deferential [NIH Toolbox] |
|
84530-5
|
Can pronounce deliquescence [NIH Toolbox] |
|
84531-3
|
Can pronounce demur [NIH Toolbox] |
|
84532-1
|
Can pronounce deny [NIH Toolbox] |
|
84533-9
|
Can pronounce diamantiferous [NIH Toolbox] |
|
84534-7
|
Can pronounce did [NIH Toolbox] |
|
84535-4
|
Can pronounce dilemma [NIH Toolbox] |
|
84511-5
|
Can pronounce dissolubility [NIH Toolbox] |
|
84536-2
|
Can pronounce doctrine [NIH Toolbox] |
|
84537-0
|
Can pronounce dodecahedral [NIH Toolbox] |
|
84538-8
|
Can pronounce dolorific [NIH Toolbox] |
|
84539-6
|
Can pronounce doting [NIH Toolbox] |
|
84540-4
|
Can pronounce dowager [NIH Toolbox] |
|
84541-2
|
Can pronounce during [NIH Toolbox] |
|
84701-2
|
Can pronounce eccentricities [NIH Toolbox] |
|
84628-7
|
Can pronounce ecclesiastical [NIH Toolbox] |
|
84591-7
|
Can pronounce echelon [NIH Toolbox] |
|
84629-5
|
Can pronounce eclecticism [NIH Toolbox] |
|
84630-3
|
Can pronounce ecstatically [NIH Toolbox] |
|
84542-0
|
Can pronounce edict [NIH Toolbox] |
|
84566-9
|
Can pronounce effete [NIH Toolbox] |
|
84567-7
|
Can pronounce effigial [NIH Toolbox] |
|
84631-1
|
Can pronounce empirical [NIH Toolbox] |
|
84736-8
|
Can pronounce entrepreneur [NIH Toolbox] |
|
84737-6
|
Can pronounce enunciate [NIH Toolbox] |
|
84632-9
|
Can pronounce epilogue [NIH Toolbox] |
|
84738-4
|
Can pronounce era [NIH Toolbox] |
|
84702-0
|
Can pronounce ersatz [NIH Toolbox] |
|
84633-7
|
Can pronounce etymological [NIH Toolbox] |
|
84512-3
|
Can pronounce exacerbating [NIH Toolbox] |
|
84665-9
|
Can pronounce exaggeration [NIH Toolbox] |
|
84666-7
|
Can pronounce excruciating [NIH Toolbox] |
|
84634-5
|
Can pronounce expostulate [NIH Toolbox] |
|
84568-5
|
Can pronounce facetious [NIH Toolbox] |
|
84569-3
|
Can pronounce fascist [NIH Toolbox] |
|
84543-8
|
Can pronounce feed [NIH Toolbox] |
|
84570-1
|
Can pronounce fenestration [NIH Toolbox] |
|
84571-9
|
Can pronounce flux [NIH Toolbox] |
|
84572-7
|
Can pronounce fly [NIH Toolbox] |
|
84573-5
|
Can pronounce foment [NIH Toolbox] |
|
84574-3
|
Can pronounce for [NIH Toolbox] |
|
84575-0
|
Can pronounce forisfamiliate [NIH Toolbox] |
|
84576-8
|
Can pronounce fringillaceous [NIH Toolbox] |
|
84577-6
|
Can pronounce fumigant [NIH Toolbox] |
|
84635-2
|
Can pronounce gel [NIH Toolbox] |
|
84636-0
|
Can pronounce gelastic [NIH Toolbox] |
|
84667-5
|
Can pronounce germane [NIH Toolbox] |
|
84592-5
|
Can pronounce gingham [NIH Toolbox] |
|
84544-6
|
Can pronounce gold [NIH Toolbox] |
|
84593-3
|
Can pronounce have [NIH Toolbox] |
|
84594-1
|
Can pronounce he [NIH Toolbox] |
|
84595-8
|
Can pronounce heat [NIH Toolbox] |
|
84596-6
|
Can pronounce her [NIH Toolbox] |
|
84597-4
|
Can pronounce heretic [NIH Toolbox] |
|
84598-2
|
Can pronounce heuristic [NIH Toolbox] |
|
84599-0
|
Can pronounce hone [NIH Toolbox] |
|
84513-1
|
Can pronounce hyperbole [NIH Toolbox] |
|
84514-9
|
Can pronounce imbroglio [NIH Toolbox] |
|
84545-3
|
Can pronounce imparidigitate [NIH Toolbox] |
|
84683-2
|
Can pronounce imperiousness [NIH Toolbox] |
|
84684-0
|
Can pronounce imperspicuity [NIH Toolbox] |
|
84685-7
|
Can pronounce imprimatur [NIH Toolbox] |
|
84739-2
|
Can pronounce in [NIH Toolbox] |
|
84703-8
|
Can pronounce inauspicious [NIH Toolbox] |
|
84515-6
|
Can pronounce incorrigible [NIH Toolbox] |
|
84516-4
|
Can pronounce indebted [NIH Toolbox] |
|
84546-1
|
Can pronounce innuendo [NIH Toolbox] |
|
84704-6
|
Can pronounce insinuation [NIH Toolbox] |
|
84705-3
|
Can pronounce insouciant [NIH Toolbox] |
|
84637-8
|
Can pronounce interstitial [NIH Toolbox] |
|
84517-2
|
Can pronounce irrevocability [NIH Toolbox] |
|
84706-1
|
Can pronounce is [NIH Toolbox] |
|
84707-9
|
Can pronounce issuant [NIH Toolbox] |
|
84740-0
|
Can pronounce it [NIH Toolbox] |
|
84673-3
|
Can pronounce j [NIH Toolbox] |
|
84674-1
|
Can pronounce joist [NIH Toolbox] |
|
84675-8
|
Can pronounce juncous [NIH Toolbox] |
|
84676-6
|
Can pronounce kayak [NIH Toolbox] |
|
84547-9
|
Can pronounce laid [NIH Toolbox] |
|
84518-0
|
Can pronounce libel [NIH Toolbox] |
|
84638-6
|
Can pronounce lieutenant [NIH Toolbox] |
|
84639-4
|
Can pronounce liver [NIH Toolbox] |
|
84640-2
|
Can pronounce loquacious [NIH Toolbox] |
|
84519-8
|
Can pronounce lugubriousness [NIH Toolbox] |
|
84641-0
|
Can pronounce lull [NIH Toolbox] |
|
84600-6
|
Can pronounce lymph [NIH Toolbox] |
|
84686-5
|
Can pronounce m [NIH Toolbox] |
|
84642-8
|
Can pronounce magniloquently [NIH Toolbox] |
|
84643-6
|
Can pronounce malapropism [NIH Toolbox] |
|
84644-4
|
Can pronounce malevolence [NIH Toolbox] |
|
84645-1
|
Can pronounce manila [NIH Toolbox] |
|
84687-3
|
Can pronounce may [NIH Toolbox] |
|
84688-1
|
Can pronounce meant [NIH Toolbox] |
|
84689-9
|
Can pronounce men [NIH Toolbox] |
|
84690-7
|
Can pronounce mere [NIH Toolbox] |
|
84691-5
|
Can pronounce minion [NIH Toolbox] |
|
84601-4
|
Can pronounce mischievous [NIH Toolbox] |
|
84602-2
|
Can pronounce much [NIH Toolbox] |
|
84692-3
|
Can pronounce munity [NIH Toolbox] |
|
84693-1
|
Can pronounce mystique [NIH Toolbox] |
|
84603-0
|
Can pronounce myth [NIH Toolbox] |
|
84741-8
|
Can pronounce n [NIH Toolbox] |
|
84742-6
|
Can pronounce nature [NIH Toolbox] |
|
84470-4
|
Can pronounce nihilism [NIH Toolbox] |
|
84604-8
|
Can pronounce nonchalant [NIH Toolbox] |
|
84743-4
|
Can pronounce nutate [NIH Toolbox] |
|
84744-2
|
Can pronounce o [NIH Toolbox] |
|
84520-6
|
Can pronounce obsequious [NIH Toolbox] |
|
84583-4
|
Can pronounce of [NIH Toolbox] |
|
84745-9
|
Can pronounce on [NIH Toolbox] |
|
84746-7
|
Can pronounce one [NIH Toolbox] |
|
84747-5
|
Can pronounce or [NIH Toolbox] |
|
84646-9
|
Can pronounce oscillating [NIH Toolbox] |
|
84521-4
|
Can pronounce ostensibly [NIH Toolbox] |
|
84748-3
|
Can pronounce our [NIH Toolbox] |
|
84749-1
|
Can pronounce p [NIH Toolbox] |
|
84647-7
|
Can pronounce palate [NIH Toolbox] |
|
84648-5
|
Can pronounce pale [NIH Toolbox] |
|
84694-9
|
Can pronounce parsimonious [NIH Toolbox] |
|
84482-9
|
Can pronounce pat [NIH Toolbox] |
|
84548-7
|
Can pronounce pedagogue [NIH Toolbox] |
|
84605-5
|
Can pronounce penchant [NIH Toolbox] |
|
84649-3
|
Can pronounce penultimate [NIH Toolbox] |
|
84578-4
|
Can pronounce perfunctorily [NIH Toolbox] |
|
84708-7
|
Can pronounce pernicious [NIH Toolbox] |
|
84709-5
|
Can pronounce perspicuity [NIH Toolbox] |
|
84750-9
|
Can pronounce picayune [NIH Toolbox] |
|
84710-3
|
Can pronounce pious [NIH Toolbox] |
|
84549-5
|
Can pronounce platitudinous [NIH Toolbox] |
|
84606-3
|
Can pronounce plethora [NIH Toolbox] |
|
84751-7
|
Can pronounce poet [NIH Toolbox] |
|
84677-4
|
Can pronounce poky [NIH Toolbox] |
|
84650-1
|
Can pronounce pool [NIH Toolbox] |
|
84711-1
|
Can pronounce poser [NIH Toolbox] |
|
84462-1
|
Can pronounce potable [NIH Toolbox] |
|
84752-5
|
Can pronounce precipice [NIH Toolbox] |
|
84550-3
|
Can pronounce preponderance [NIH Toolbox] |
|
84551-1
|
Can pronounce pseudonym [NIH Toolbox] |
|
84651-9
|
Can pronounce pupil [NIH Toolbox] |
|
84753-3
|
Can pronounce purport [NIH Toolbox] |
|
84754-1
|
Can pronounce quip [NIH Toolbox] |
|
84755-8
|
Can pronounce quixotic [NIH Toolbox] |
|
84756-6
|
Can pronounce r [NIH Toolbox] |
|
84652-7
|
Can pronounce ranunculaceous [NIH Toolbox] |
|
84653-5
|
Can pronounce recalcitrant [NIH Toolbox] |
|
84654-3
|
Can pronounce recapitulatory [NIH Toolbox] |
|
84712-9
|
Can pronounce reconnaissance [NIH Toolbox] |
|
84552-9
|
Can pronounce recrudescence [NIH Toolbox] |
|
84668-3
|
Can pronounce regent [NIH Toolbox] |
|
84669-1
|
Can pronounce regime [NIH Toolbox] |
|
84655-0
|
Can pronounce reliquary [NIH Toolbox] |
|
84757-4
|
Can pronounce renown [NIH Toolbox] |
|
84553-7
|
Can pronounce repudiate [NIH Toolbox] |
|
84713-7
|
Can pronounce resin [NIH Toolbox] |
|
84714-5
|
Can pronounce respite [NIH Toolbox] |
|
84607-1
|
Can pronounce rhythm [NIH Toolbox] |
|
84678-2
|
Can pronounce rock [NIH Toolbox] |
|
84715-2
|
Can pronounce s [NIH Toolbox] |
|
84579-2
|
Can pronounce safe [NIH Toolbox] |
|
84670-9
|
Can pronounce sanguineous [NIH Toolbox] |
|
84716-0
|
Can pronounce satiety [NIH Toolbox] |
|
84580-0
|
Can pronounce saxifragaceous [NIH Toolbox] |
|
84656-8
|
Can pronounce scintillating [NIH Toolbox] |
|
84554-5
|
Can pronounce sedate [NIH Toolbox] |
|
84679-0
|
Can pronounce seek [NIH Toolbox] |
|
84671-7
|
Can pronounce sergeant [NIH Toolbox] |
|
84555-2
|
Can pronounce sesquipedalian [NIH Toolbox] |
|
84556-0
|
Can pronounce side [NIH Toolbox] |
|
84717-8
|
Can pronounce sinew [NIH Toolbox] |
|
84718-6
|
Can pronounce sir [NIH Toolbox] |
|
84695-6
|
Can pronounce some [NIH Toolbox] |
|
84719-4
|
Can pronounce spa [NIH Toolbox] |
|
84720-2
|
Can pronounce stay [NIH Toolbox] |
|
84557-8
|
Can pronounce stevedore [NIH Toolbox] |
|
84581-8
|
Can pronounce stifle [NIH Toolbox] |
|
84608-9
|
Can pronounce stochastic [NIH Toolbox] |
|
84522-2
|
Can pronounce subjugate [NIH Toolbox] |
|
84721-0
|
Can pronounce succinct [NIH Toolbox] |
|
84582-6
|
Can pronounce suffrutescent [NIH Toolbox] |
|
84722-8
|
Can pronounce suite [NIH Toolbox] |
|
84657-6
|
Can pronounce supercilious [NIH Toolbox] |
|
84723-6
|
Can pronounce surreptitious [NIH Toolbox] |
|
84558-6
|
Can pronounce synechdochism [NIH Toolbox] |
|
84609-7
|
Can pronounce synthesis [NIH Toolbox] |
|
84758-2
|
Can pronounce tax [NIH Toolbox] |
|
84759-0
|
Can pronounce tea [NIH Toolbox] |
|
84696-4
|
Can pronounce temerity [NIH Toolbox] |
|
84523-0
|
Can pronounce tenebrous [NIH Toolbox] |
|
84610-5
|
Can pronounce their [NIH Toolbox] |
|
84611-3
|
Can pronounce these [NIH Toolbox] |
|
84612-1
|
Can pronounce this [NIH Toolbox] |
|
84658-4
|
Can pronounce titular [NIH Toolbox] |
|
84760-8
|
Can pronounce to [NIH Toolbox] |
|
84613-9
|
Can pronounce tough [NIH Toolbox] |
|
84761-6
|
Can pronounce town [NIH Toolbox] |
|
84724-4
|
Can pronounce transposition [NIH Toolbox] |
|
84659-2
|
Can pronounce trestle [NIH Toolbox] |
|
84762-4
|
Can pronounce try [NIH Toolbox] |
|
84763-2
|
Can pronounce type [NIH Toolbox] |
|
84764-0
|
Can pronounce u [NIH Toolbox] |
|
84725-1
|
Can pronounce usury [NIH Toolbox] |
|
84765-7
|
Can pronounce utopian [NIH Toolbox] |
|
84559-4
|
Can pronounce valedictory [NIH Toolbox] |
|
84560-2
|
Can pronounce valetudinarian [NIH Toolbox] |
|
84660-0
|
Can pronounce vassal [NIH Toolbox] |
|
84614-7
|
Can pronounce vehement [NIH Toolbox] |
|
84615-4
|
Can pronounce vehicular [NIH Toolbox] |
|
84561-0
|
Can pronounce verisimilitude [NIH Toolbox] |
|
84562-8
|
Can pronounce vicissitude [NIH Toolbox] |
|
84726-9
|
Can pronounce viscera [NIH Toolbox] |
|
84727-7
|
Can pronounce viscous [NIH Toolbox] |
|
84766-5
|
Can pronounce w [NIH Toolbox] |
|
84767-3
|
Can pronounce were [NIH Toolbox] |
|
84616-2
|
Can pronounce whelp [NIH Toolbox] |
|
84563-6
|
Can pronounce would [NIH Toolbox] |
|
84617-0
|
Can pronounce writhe [NIH Toolbox] |
|
84768-1
|
Can pronounce x [NIH Toolbox] |
|
84769-9
|
Can pronounce y [NIH Toolbox] |
|
84770-7
|
Can pronounce you [NIH Toolbox] |
|
84771-5
|
Can pronounce z [NIH Toolbox] |
|
84672-5
|
Can pronounce zeitgeist [NIH Toolbox] |
|
14894-0
|
Propylene glycol [Presence] in Serum or Plasma |
|
12552-6
|
Propylene glycol [Mass/volume] in Serum or Plasma |
|
22668-8
|
Propylene glycol [Moles/volume] in Serum or Plasma |
|
18341-8
|
Propylene glycol [Mass/volume] in Urine |
|
32126-5
|
Propylene glycol [Moles/volume] in Urine |
|
22742-1
|
Propylene glycol [Moles/volume] in Unspecified specimen |
|
46747-2
|
Propionic/Methylmalonic Acidemias newborn screen interpretation |
|
36920-7
|
PROP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
6905-4
|
Propafenone [Mass/volume] in Serum or Plasma |
|
25511-7
|
Propafenone [Moles/volume] in Serum or Plasma |
|
13022-9
|
Propane [Mass/volume] in Blood |
|
17379-9
|
Propanol [Mass/volume] in Blood |
|
73931-8
|
Propanol [Mass/volume] in Urine |
|
45147-6
|
Propiomazine [Presence] in Serum or Plasma |
|
12802-5
|
Propiomazine [Mass/volume] in Serum or Plasma |
|
38721-7
|
Propionaldehyde [Mass/volume] in Air |
|
2849-8
|
Propionate (C3) [Mass/volume] in Serum |
|
54331-4
|
Propionylcarnitine (C3) [Moles/volume] in Amniotic fluid |
|
54330-6
|
Propionylcarnitine (C3) [Moles/volume] in Cerebral spinal fluid |
|
53160-8
|
Propionylcarnitine (C3) [Moles/volume] in DBS |
|
18438-2
|
Propionylcarnitine (C3) [Mass/volume] in Serum or Plasma |
|
30551-6
|
Propionylcarnitine (C3) [Moles/volume] in Serum or Plasma |
|
69774-8
|
Propionylcarnitine (C3) [Moles/volume] in Urine |
|
53162-4
|
Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS |
|
53164-0
|
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
59197-4
|
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
|
53163-2
|
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
59198-2
|
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54329-8
|
Propionylcarnitine (C3)/Creatinine [Molar ratio] in Urine |
|
53161-6
|
Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS |
|
54332-2
|
Propionylglycine [Moles/volume] in Cerebral spinal fluid |
|
47878-4
|
Propionylglycine [Moles/volume] in Plasma |
|
32584-5
|
Propionylglycine [Presence] in Urine |
|
44399-4
|
Propionylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
50367-2
|
Propionylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13800-8
|
Propionylglycine/Creatinine [Mass Ratio] in Urine |
|
24442-6
|
Propionylglycine/Creatinine [Molar ratio] in Urine |
|
59561-1
|
Propofol glucuronide [Mass/volume] in Urine |
|
48285-1
|
Propofol triggered leukotriene release [Mass/volume] by Leukocytes |
|
34673-4
|
Propofol [Mass/volume] in Serum or Plasma |
|
86687-1
|
Proportion of total calories the resident received through parenteral or tube feeding during entire 7 days [CMS Assessment] |
|
86681-4
|
Proportion of total calories the resident received through parenteral or tube feeding in last 7 days - while a resident [CMS Assessment] |
|
86680-6
|
Proportion of total calories the resident received through parenteral or tube feeding in the 7 days - while not a resident [CMS Assessment] |
|
38616-9
|
Propoxur [Mass/volume] in Air |
|
9694-1
|
Propoxur [Mass/volume] in Serum or Plasma |
|
21480-9
|
Propoxur [Mass/volume] in Urine |
|
87753-0
|
Propoxur [Mass/mass] in Unspecified specimen |
|
72401-3
|
Propoxyphene [Presence] in Blood by Screen method |
|
19432-4
|
Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method |
|
19431-6
|
Propoxyphene cutoff [Mass/volume] in Urine for Screen method |
|
9809-5
|
Propoxyphene [Presence] in Gastric fluid |
|
9737-8
|
Propoxyphene [Mass/volume] in Gastric fluid |
|
59961-3
|
Propoxyphene [Moles/volume] in Gastric fluid |
|
11234-2
|
Propoxyphene [Mass/mass] in Hair |
|
73190-1
|
Propoxyphene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73191-9
|
Propoxyphene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73567-0
|
Propoxyphene [Presence] in Meconium by Screen method |
|
11027-0
|
Propoxyphene [Mass/volume] in Meconium |
|
27067-8
|
Propoxyphene [Mass/mass] in Meconium |
|
87817-3
|
Propoxyphene [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72622-4
|
Propoxyphene [Presence] in Saliva (oral fluid) |
|
72617-4
|
Propoxyphene [Presence] in Saliva (oral fluid) by Screen method |
|
72621-6
|
Propoxyphene [Mass/volume] in Saliva (oral fluid) |
|
3542-8
|
Propoxyphene [Presence] in Serum or Plasma |
|
16748-6
|
Propoxyphene [Presence] in Serum or Plasma by Confirmatory method |
|
59734-4
|
Propoxyphene [Presence] in Serum or Plasma by Screen method |
|
35649-3
|
Propoxyphene [Mass/volume] in Serum or Plasma by Screen method |
|
3543-6
|
Propoxyphene [Mass/volume] in Serum or Plasma |
|
32125-7
|
Propoxyphene [Moles/volume] in Serum or Plasma |
|
12357-0
|
Propoxyphene [Presence] in Stool |
|
27281-5
|
Propoxyphene [Mass/mass] in Stool |
|
16242-0
|
Propoxyphene [Mass/volume] in Urine by Confirmatory method |
|
19141-1
|
Propoxyphene [Presence] in Urine |
|
16200-8
|
Propoxyphene [Presence] in Urine by Confirmatory method |
|
19429-0
|
Propoxyphene [Presence] in Urine by Screen method |
|
3545-1
|
Propoxyphene [Mass/volume] in Urine |
|
59960-5
|
Propoxyphene [Moles/volume] in Urine |
|
27190-8
|
Propoxyphene [Mass/volume] in Vitreous fluid |
|
48963-3
|
Propoxyphene [Mass/volume] in Unspecified specimen by Confirmatory method |
|
43811-9
|
Propoxyphene [Presence] in Unspecified specimen |
|
48964-1
|
Propoxyphene [Mass/volume] in Unspecified specimen |
|
60330-8
|
Propoxyphene [Moles/volume] in Unspecified specimen |
|
58398-9
|
Propoxyphene/Creatinine [Mass Ratio] in Urine |
|
73189-3
|
Propoxyphene+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73188-5
|
Propoxyphene+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10533-8
|
Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
|
19438-1
|
Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method |
|
19437-3
|
Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method |
|
72618-2
|
Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid) |
|
47415-5
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method |
|
9626-3
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma |
|
55574-8
|
Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma |
|
19435-7
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
|
19434-0
|
Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method |
|
19433-2
|
Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method |
|
16749-4
|
Propoxyphene + Norpropoxyphene [Units/volume] in Urine |
|
19436-5
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Urine |
|
77335-8
|
Propoxyphene + Norpropoxyphene [Moles/volume] in Unspecified specimen |
|
3990-9
|
Propranolol [Mass/time] in 24 hour Urine |
|
14893-2
|
Propranolol [Moles/time] in 24 hour Urine |
|
4414-9
|
Propranolol [Mass] of Dose |
|
21481-7
|
Propranolol [Mass/volume] in Gastric fluid |
|
59962-1
|
Propranolol [Moles/volume] in Gastric fluid |
|
73187-7
|
Propranolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73186-9
|
Propranolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3991-7
|
Propranolol [Presence] in Serum or Plasma |
|
35633-7
|
Propranolol [Mass/volume] in Serum or Plasma by Screen method |
|
3992-5
|
Propranolol [Mass/volume] in Serum or Plasma |
|
14891-6
|
Propranolol [Moles/volume] in Serum or Plasma |
|
3993-3
|
Propranolol [Presence] in Urine |
|
3994-1
|
Propranolol [Mass/volume] in Urine |
|
14892-4
|
Propranolol [Moles/volume] in Urine |
|
60331-6
|
Propranolol [Moles/volume] in Unspecified specimen |
|
38722-5
|
Propyleneimine [Mass/volume] in Air |
|
3998-2
|
Propylhexedrine [Mass/time] in 24 hour Urine |
|
3995-8
|
Propylhexedrine [Mass/volume] in Blood |
|
4415-6
|
Propylhexedrine [Mass] of Dose |
|
3996-6
|
Propylhexedrine [Presence] in Urine |
|
3997-4
|
Propylhexedrine [Mass/volume] in Urine |
|
9388-0
|
Propylthiouracil [Mass/volume] in Serum or Plasma |
|
27173-4
|
Propylthiouracil [Mass/volume] in Urine |
|
54923-8
|
Propyphenazone IgE Ab [Units/volume] in Serum |
|
48279-4
|
Propyphenazone triggered leukotriene release [Mass/volume] by Leukocytes |
|
11226-8
|
Prorenin [Units/volume] in Plasma |
|
92994-3
|
PROS1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
48161-4
|
PROS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
14004-6
|
Prostaglandin A [Mass/time] in 24 hour Urine |
|
14054-1
|
Prostaglandin D2 [Mass/time] in 24 hour Urine |
|
48785-0
|
Prostaglandin D2 [Mass/volume] in Body fluid |
|
12839-7
|
Prostaglandin D2 [Mass/volume] in Serum or Plasma |
|
12838-9
|
Prostaglandin D2 [Mass/volume] in Urine |
|
2851-4
|
Prostaglandin E [Mass/volume] in Plasma |
|
17493-8
|
Prostaglandin E [Mass/volume] in Serum or Plasma |
|
12837-1
|
Prostaglandin E1 [Mass/volume] in 24 hour Urine |
|
14005-3
|
Prostaglandin E1 [Mass/time] in 24 hour Urine |
|
70093-0
|
Prostaglandin E1 [Mass/volume] in Cerebral spinal fluid |
|
70092-2
|
Prostaglandin E1 [Mass/volume] in Body fluid |
|
2852-2
|
Prostaglandin E1 [Mass/volume] in Serum or Plasma |
|
12836-3
|
Prostaglandin E2 [Mass/volume] in 24 hour Urine |
|
14006-1
|
Prostaglandin E2 [Mass/time] in 24 hour Urine |
|
70091-4
|
Prostaglandin E2 [Mass/volume] in Cerebral spinal fluid |
|
2853-0
|
Prostaglandin E2 [Mass/volume] in Serum or Plasma |
|
2854-8
|
Prostaglandin F [Mass/volume] in Plasma |
|
10583-3
|
Prostaglandin F1 alpha [Moles/volume] in Semen |
|
2855-5
|
Prostaglandin F2 [Mass/volume] in Serum or Plasma |
|
14007-9
|
Prostaglandin F2 alpha [Mass/time] in 24 hour Urine |
|
70094-8
|
Prostaglandin F2 alpha [Mass/volume] in Cerebral spinal fluid |
|
70095-5
|
Prostaglandin F2 alpha [Mass/volume] in Body fluid |
|
14174-7
|
Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma |
|
17494-6
|
Prostaglandin F2 alpha [Mass/volume] in Urine |
|
12840-5
|
Prostaglandin F2 alpha [Moles/volume] in Urine |
|
2856-3
|
Prostaglandin [Mass/volume] in Serum or Plasma |
|
17495-3
|
Prostaglandins [Mass/volume] in Urine |
|
58022-5
|
Prostanozol [Presence] in Urine |
|
48671-2
|
Prostate cancer risk [Likelihood] by Estimated |
|
66117-3
|
Prostate Pathology biopsy report |
|
32551-4
|
Protein [Mass] in Urine collected for unspecified duration |
|
35663-4
|
Protein [Mass/volume] in Urine collected for unspecified duration |
|
12842-1
|
Protein [Mass/volume] in 12 hour Urine |
|
26801-1
|
Protein [Mass/time] in 12 hour Urine |
|
58992-9
|
Protein [Mass/time] in 18 hour Urine |
|
53121-0
|
Protein [Mass/time] in 1 hour Urine |
|
32209-9
|
Protein [Presence] in 24 hour Urine by Test strip |
|
21028-6
|
Protein [Interpretation] in 24 hour Urine |
|
21482-5
|
Protein [Mass/volume] in 24 hour Urine |
|
2889-4
|
Protein [Mass/time] in 24 hour Urine |
|
18373-1
|
Protein [Mass/time] in 6 hour Urine |
|
2878-7
|
Protein [Mass/volume] in Amniotic fluid |
|
27819-2
|
Protein C actual/normal in Platelet poor plasma by Coagulation assay |
|
27818-4
|
Protein C actual/normal in Platelet poor plasma by Chromogenic method |
|
27820-0
|
Protein C Ag actual/normal in Platelet poor plasma by Immunoassay |
|
6009-5
|
Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
4672-2
|
Protein C Ag [Mass/volume] in Platelet poor plasma |
|
58481-3
|
Protein C Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
|
27438-1
|
Protein C Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
|
6011-1
|
Protein C cofactor [Units/volume] in Platelet poor plasma |
|
6010-3
|
Protein C inhibitor [Mass/volume] in Platelet poor plasma by Immunoassay |
|
4671-4
|
Protein C [Mass/volume] in Plasma |
|
6006-1
|
Protein C [Units/volume] in Platelet poor plasma by Chromogenic method |
|
6007-9
|
Protein C [Units/volume] in Platelet poor plasma by Coagulation assay |
|
13050-0
|
Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
|
49639-8
|
Protein C/Coagulation factor X [Mass Ratio] in Platelet poor plasma |
|
6008-7
|
Protein C+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
2879-5
|
Protein [Presence] in Cerebral spinal fluid |
|
2858-9
|
Protein in CSF/Protein in serum |
|
2880-3
|
Protein [Mass/volume] in Cerebral spinal fluid |
|
12843-9
|
Protein [Mass/volume] in Peritoneal dialysis fluid |
|
5920-4
|
Protein [Mass/volume] in Dialysis fluid |
|
2881-1
|
Protein [Mass/volume] in Body fluid |
|
14387-5
|
Protein [Mass/volume] in Gastric fluid |
|
2859-7
|
Protein kinase [Enzymatic activity/volume] in Serum |
|
80832-9
|
Protein [Mass/volume] in Lower respiratory specimen |
|
2860-5
|
Protein nitrogen [Mass/time] in 24 hour Urine |
|
32210-7
|
Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis |
|
49301-5
|
Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis Narrative |
|
13439-5
|
Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis |
|
49295-9
|
Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
|
48423-8
|
Protein Fractions [Interpretation] in Body fluid by Electrophoresis |
|
48424-6
|
Protein Fractions [Interpretation] in Body fluid |
|
12851-2
|
Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis |
|
49296-7
|
Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
|
14895-7
|
Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation |
|
49297-5
|
Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation Narrative |
|
34641-1
|
Protein Fractions [Interpretation] in Serum or Plasma |
|
49298-3
|
Protein Fractions [Interpretation] in Serum or Plasma Narrative |
|
13438-7
|
Protein Fractions [Interpretation] in Urine by Electrophoresis |
|
49299-1
|
Protein Fractions [Interpretation] in Urine by Electrophoresis Narrative |
|
14896-5
|
Protein Fractions [Interpretation] in Urine by Immunofixation |
|
49300-7
|
Protein Fractions [Interpretation] in Urine by Immunofixation Narrative |
|
34435-8
|
Protein Fractions [Interpretation] in Unspecified specimen by Immunofixation |
|
49302-3
|
Protein Fractions [Interpretation] in Unspecified specimen by Immunofixation Narrative |
|
70265-4
|
Protein in pericardial fluid/Protein in serum |
|
33407-8
|
Protein [Mass/volume] in Pericardial fluid |
|
49929-3
|
Protein in pleural fluid/Protein in serum |
|
2882-9
|
Protein [Mass/volume] in Pleural fluid |
|
70267-0
|
Protein in peritoneal fluid/Protein in serum |
|
2883-7
|
Protein [Mass/volume] in Peritoneal fluid |
|
40662-9
|
Protein [Mass/time] in 12 hour Urine --resting |
|
27822-6
|
Protein S actual/normal in Platelet poor plasma by Coagulation assay |
|
31102-7
|
Protein S actual/normal in Platelet poor plasma by Chromogenic method |
|
27823-4
|
Protein S Ag actual/normal in Platelet poor plasma by Immunoassay |
|
72337-9
|
Protein S Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
58482-1
|
Protein S Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
|
18345-9
|
Protein S Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
49640-6
|
Protein S Ag/Coagulation factor X Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
27821-8
|
Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay |
|
4677-1
|
Protein S Free Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5889-1
|
Protein S Free [Units/volume] in Platelet poor plasma by Coagulation assay |
|
5893-3
|
Protein S [Units/volume] in Platelet poor plasma by Chromogenic method |
|
5892-5
|
Protein S [Units/volume] in Platelet poor plasma by Coagulation assay |
|
13052-6
|
Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
5891-7
|
Protein S+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5890-9
|
Protein S+Acarboxy Free Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
77359-8
|
Protein [Mass/volume] in Saliva (oral fluid) |
|
2885-2
|
Protein [Mass/volume] in Serum or Plasma |
|
2884-5
|
Protein [Mass/volume] in Semen |
|
2886-0
|
Protein [Mass/volume] in Synovial fluid |
|
35323-5
|
Protein [Mass/volume] in Body fluid --1st specimen post Sincalide |
|
12844-7
|
Protein [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
|
35322-7
|
Protein [Mass/volume] in Body fluid --2nd specimen post Sincalide |
|
12845-4
|
Protein [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
|
35321-9
|
Protein [Mass/volume] in Body fluid --3rd specimen post Sincalide |
|
12846-2
|
Protein [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
|
35320-1
|
Protein [Mass/volume] in Body fluid --4th specimen post Sincalide |
|
12847-0
|
Protein [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
|
35319-3
|
Protein [Mass/volume] in Body fluid --5th specimen post Sincalide |
|
12848-8
|
Protein [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
|
12849-6
|
Protein [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
|
12850-4
|
Protein [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
|
47739-8
|
Protein [Mass/volume] in Stool |
|
29748-1
|
Protein [Mass/mass] in Tissue |
|
76665-9
|
Protein [Mass/volume] in Cerebral spinal fluid --1st tube |
|
76666-7
|
Protein [Mass/volume] in Cerebral spinal fluid --2nd tube |
|
76667-5
|
Protein [Mass/volume] in Cerebral spinal fluid --3rd tube |
|
76668-3
|
Protein [Mass/volume] in Cerebral spinal fluid --4th tube |
|
40663-7
|
Protein [Mass/time] in 12 hour Urine --upright |
|
2887-8
|
Protein [Presence] in Urine |
|
53525-2
|
Protein [Presence] in Urine by SSA method |
|
20454-5
|
Protein [Presence] in Urine by Test strip |
|
57735-3
|
Protein [Presence] in Urine by Automated test strip |
|
50561-0
|
Protein [Mass/volume] in Urine by Automated test strip |
|
5804-0
|
Protein [Mass/volume] in Urine by Test strip |
|
27298-9
|
Protein [Units/volume] in Urine |
|
50749-1
|
Protein [Interpretation] in Urine |
|
2888-6
|
Protein [Mass/volume] in Urine |
|
32337-8
|
Protein [Mass/volume] in Unspecified specimen |
|
60678-0
|
Protein/Creatinine [Mass Ratio] in 12 hour Urine |
|
13801-6
|
Protein/Creatinine [Mass Ratio] in 24 hour Urine |
|
40486-3
|
Protein/Creatinine [Ratio] in 24 hour Urine |
|
30154-9
|
Protein/Creatinine [Mass Ratio] in Serum or Plasma |
|
2890-2
|
Protein/Creatinine [Mass Ratio] in Urine |
|
34366-5
|
Protein/Creatinine [Ratio] in Urine |
|
11192-2
|
Protamine IgE Ab [Units/volume] in Serum |
|
15961-6
|
Protamine IgE Ab RAST class [Presence] in Serum |
|
50043-9
|
Protein carbonyl/Protein [Ratio] in Serum or Plasma |
|
93746-6
|
Protein catabolic rate based on 24 hour Urine [Calculated] |
|
49048-2
|
Protein feed time |
|
75299-8
|
Protein intake 24 hour Estimated |
|
82156-1
|
Protein intake 24 hour Measured |
|
81910-2
|
Protein intake/Body weight 24 hour Estimated |
|
81911-0
|
Protein intake/Body weight 24 hour Measured |
|
75290-7
|
Protein need [Mass/time] 24 hour Estimated |
|
56037-5
|
Protein phosphatase 3 [Enzymatic activity/volume] in Leukocytes |
|
80463-3
|
Protein servings 24 hour Estimated |
|
80464-1
|
Protein servings 24 hour Measured |
|
57697-5
|
Protein Z Ag [Mass/volume] in Plasma by Immunoassay |
|
63309-9
|
Proteinase 3 Ab [Presence] in Body fluid by Immunoassay |
|
63539-1
|
Proteinase 3 Ab [Units/volume] in Body fluid |
|
46267-1
|
Proteinase 3 Ab [Units/volume] in Serum by Immunoassay |
|
63310-7
|
Proteinase 3 Ab [Presence] in Serum by Immunoassay |
|
63311-5
|
Proteinase 3 Ab [Presence] in Serum by Immunofluorescence |
|
89505-2
|
Proteinase 3 Ab [Presence] in Serum by Line blot |
|
6968-2
|
Proteinase 3 Ab [Units/volume] in Serum |
|
69957-9
|
Proteinase 3 IgG Ab [Presence] in Serum by Immunoassay |
|
48408-9
|
Proteinase 3 IgG Ab [Units/volume] in Serum |
|
74106-6
|
Proteinase 3 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29644-2
|
Proteinase 3 [Presence] in Serum by Immunoassay |
|
22468-3
|
Rickettsia (Proteus OX19) Ab [Presence] in Serum |
|
5303-3
|
Rickettsia (Proteus OX19) Ab [Presence] in Serum by Latex agglutination |
|
31593-7
|
Rickettsia (Proteus OX19) Ab [Units/volume] in Serum |
|
22469-1
|
Rickettsia (Proteus OX19) Ab [Titer] in Serum |
|
21489-0
|
Rickettsia (Proteus OX19) Ab [Titer] in Serum by Latex agglutination |
|
22470-9
|
Rickettsia (Proteus OX2) Ab [Presence] in Serum |
|
5304-1
|
Rickettsia (Proteus OX2) Ab [Presence] in Serum by Latex agglutination |
|
22471-7
|
Rickettsia (Proteus OX2) Ab [Titer] in Serum |
|
21490-8
|
Rickettsia (Proteus OX2) Ab [Titer] in Serum by Latex agglutination |
|
22472-5
|
Rickettsia (Proteus OXK) Ab [Presence] in Serum |
|
5305-8
|
Rickettsia (Proteus OXK) Ab [Presence] in Serum by Latex agglutination |
|
31594-5
|
Rickettsia (Proteus OXK) Ab [Units/volume] in Serum |
|
22473-3
|
Rickettsia (Proteus OXK) Ab [Titer] in Serum |
|
21491-6
|
Rickettsia (Proteus OXK) Ab [Titer] in Serum by Latex agglutination |
|
88267-0
|
Proteus sp atpD gene [Presence] by Probe in Positive blood culture |
|
92962-0
|
Proteus sp DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85776-3
|
Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93393-7
|
Proteus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92961-2
|
Proteus sp DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
63565-6
|
Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
40457-4
|
Prothrombin Ab [Units/volume] in Serum or Plasma |
|
3289-6
|
Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay |
|
27813-5
|
Prothrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3288-8
|
Prothrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
40595-1
|
Prothrombin IgG Ab [Units/volume] in Serum or Plasma |
|
40596-9
|
Prothrombin IgM Ab [Units/volume] in Serum or Plasma |
|
77161-8
|
Prothrombin activity [Units/volume] in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma |
|
5902-2
|
Prothrombin time (PT) |
|
5894-1
|
Prothrombin time (PT) actual/Normal |
|
21242-3
|
Protoporphyrin [Mass/time] in unspecified time Stool |
|
14175-4
|
Protoporphyrin [Mass/mass] in 24 hour Stool |
|
2891-0
|
Protoporphyrin [Mass/time] in 24 hour Stool |
|
25512-5
|
Protoporphyrin [Moles/time] in 24 hour Stool |
|
50368-0
|
Protoporphyrin [Mass/volume] in 24 hour Urine |
|
50372-2
|
Protoporphyrin [Mass/time] in 24 hour Urine |
|
22686-0
|
Protoporphyrin [Moles/time] in 24 hour Urine |
|
2896-9
|
Protoporphyrin [Mass/volume] in Blood |
|
76341-7
|
Protoporphyrin [Moles/volume] in Blood |
|
2897-7
|
Protoporphyrin [Presence] in Red Blood Cells |
|
2898-5
|
Protoporphyrin [Mass/volume] in Red Blood Cells |
|
34418-4
|
Protoporphyrin [Mass/mass] in Red Blood Cells |
|
41017-5
|
Protoporphyrin [Moles/volume] in Red Blood Cells |
|
33053-0
|
Protoporphyrin [Molar ratio] in Red Blood Cells |
|
17501-8
|
Protoporphyrin [Mass/volume] in Serum or Plasma |
|
75028-1
|
Protoporphyrin/Porphyrins.total in Stool |
|
16761-9
|
Protoporphyrin [Mass/volume] in Stool |
|
58932-5
|
Protoporphyrin [Mass/mass] in Stool |
|
29267-2
|
Protoporphyrin [Moles/mass] in Stool |
|
50371-4
|
Protoporphyrin [Mass/volume] in Urine |
|
10713-6
|
Prototheca identified in Unspecified specimen by Culture |
|
38401-6
|
Protozoa identified in Unspecified specimen |
|
4416-4
|
Protriptyline [Mass] of Dose |
|
47126-8
|
Protriptyline [Moles/volume] in Gastric fluid |
|
4000-6
|
Protriptyline [Presence] in Serum or Plasma |
|
3999-0
|
Protriptyline [Mass/volume] in Serum or Plasma |
|
14898-1
|
Protriptyline [Moles/volume] in Serum or Plasma |
|
4002-2
|
Protriptyline [Mass/volume] in Serum or Plasma --trough |
|
4001-4
|
Protriptyline [Presence] in Urine |
|
26978-7
|
Protriptyline [Mass/volume] in Urine |
|
47127-6
|
Protriptyline [Moles/volume] in Urine |
|
77330-9
|
Protriptyline [Moles/volume] in Unspecified specimen |
|
86907-3
|
Provider's perception of patient comprehension of discussion |
|
75279-0
|
Provider responsible for medication monitoring |
|
88078-1
|
Provider assuming care for patient |
|
80405-4
|
Provider Certification [Type] |
|
86803-4
|
Provider Death Registration - recommended CDA R1 sections |
|
86808-3
|
Provider death registration Document |
|
81888-0
|
Provider ethnicity OMB.1997 |
|
76417-5
|
Provider First name |
|
76420-9
|
Provider Graduation year |
|
76398-7
|
Provider has a national provider ID |
|
76419-1
|
Provider Last name |
|
76418-3
|
Provider Middle Initial |
|
87720-9
|
Provider Postal code |
|
77303-6
|
Provider preference for care action |
|
81887-2
|
Provider race OMB.1997 |
|
86637-6
|
Provider role |
|
77219-4
|
Provider satisfaction with healthcare delivery |
|
83848-2
|
Provider stopped treatment |
|
92021-5
|
Provider supplied facility fetal death report Document |
|
92020-7
|
Provider supplied facility live birth report Document |
|
92019-9
|
Provider supplied mother's fetal death report Document |
|
92018-1
|
Provider supplied mother's live birth report Document |
|
88102-9
|
Provider [Type] who performed CPR |
|
93181-6
|
Provision of current reconciled medication list to patient at discharge [CMS Assessment] |
|
93182-4
|
Provision of current reconciled medication list to subsequent provider at discharge [CMS Assessment] |
|
33012-6
|
Provolone Cheese IgE Ab [Units/volume] in Serum |
|
33013-4
|
Provolone Cheese IgE Ab RAST class [Presence] in Serum |
|
93642-7
|
Right ventricular outflow tract proximal Diameter by US.2D.PSAX |
|
80088-8
|
Right ventricular outflow tract proximal Diameter at end diastole by US.2D.parasternal |
|
47867-7
|
Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Fibroblast |
|
47866-9
|
Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells |
|
22451-9
|
PRRSV Ab [Presence] in Serum |
|
23367-6
|
PRRSV Ab [Presence] in Serum by Complement fixation |
|
15495-5
|
PRRSV Ab [Presence] in Serum by Immunoassay |
|
15496-3
|
PRRSV Ab [Presence] in Serum by Immunofluorescence |
|
23368-4
|
PRRSV Ab [Presence] in Serum by Neutralization test |
|
31572-1
|
PRRSV Ab [Units/volume] in Serum |
|
42976-1
|
PRRSV Ab [Titer] in Serum |
|
23772-7
|
PRRSV Ab [Titer] in Serum by Immunofluorescence |
|
85544-5
|
PRRSV Ab/Positive control in Serum or Plasma by Immunoassay |
|
74313-8
|
PRRSV Ab/Positive control in Unspecified specimen by Immunoassay |
|
23370-0
|
PRRSV Ag [Presence] in Tissue by Immune stain |
|
74305-4
|
PRRSV Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23369-2
|
PRRSV Ag [Presence] in Unspecified specimen by Immune stain |
|
85530-4
|
PRRSV European strain IgG Ab [Presence] in Serum by Immunofluorescence |
|
85528-8
|
PRRSV European strain IgG Ab [Titer] in Serum by Immunofluorescence |
|
85549-4
|
PRRSV European strain neutralizing antibody [Presence] in Serum by Neutralization test |
|
85548-6
|
PRRSV European strain neutralizing antibody [Titer] in Serum by Neutralization test |
|
85579-1
|
PRRSV European strain ORF5 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
85540-3
|
PRRSV European strain RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74317-9
|
PRRSV European strain RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85546-0
|
PRRSV European strain RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74306-2
|
PRRSV ORF5 gene sequence homology to Fostera in Isolate by Sequencing |
|
90332-8
|
PRRSV IgA Ab/Positive control in Unspecified specimen by Immunoassay |
|
90331-0
|
PRRSV IgA+IgM/Positive control in Unspecified specimen by Immunoassay |
|
85543-7
|
PRRSV IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay |
|
90333-6
|
PRRSV IgM Ab/Positive control in Unspecified specimen by Immunoassay |
|
74308-8
|
PRRSV ORF5 gene sequence homology to Ingelvac ATP in Isolate by Sequencing |
|
85542-9
|
PRRSV Ingelvac ATP strain ORF5 gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85541-1
|
PRRSV Ingelvac MLV strain ORF5 gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
74309-6
|
PRRSV ORF5 gene sequence homology to Ingelvac MLV in Isolate by Sequencing |
|
74307-0
|
PRRSV ORF5 gene sequence homology to Lelystad in Isolate by Sequencing |
|
85529-6
|
PRRSV North American strain IgG Ab [Presence] in Serum by Immunofluorescence |
|
85525-4
|
PRRSV North American strain IgG Ab [Titer] in Serum by Immunofluorescence |
|
85550-2
|
PRRSV North American strain neutralizing antibody [Presence] in Serum by Neutralization test |
|
85547-8
|
PRRSV North American strain neutralizing antibody [Titer] in Serum by Neutralization test |
|
85539-5
|
PRRSV North American strain RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74318-7
|
PRRSV North American strain RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85545-2
|
PRRSV North American strain RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74304-7
|
PRRSV neutralizing antibody [Titer] in Serum by Neutralization test |
|
74316-1
|
PRRSV ORF5 gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74314-6
|
PRRSV ORF5 gene RNA pattern [Identifier] in Isolate by RFLP |
|
74311-2
|
PRRSV ORF5 gene sequence [Nucleotide sequence] in Isolate by Sequencing |
|
74315-3
|
PRRSV RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23371-8
|
PRRSV RNA [Presence] in Semen by NAA with probe detection |
|
74310-4
|
PRRSV strain identified in Isolate by Sequencing |
|
85531-2
|
PRRSV whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
74312-0
|
PRRSV [Presence] in Unspecified specimen by Organism specific culture |
|
21692-9
|
PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22066-5
|
PRSS1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
76145-2
|
Prulifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
7634-9
|
Prune IgE Ab [Units/volume] in Serum |
|
15962-4
|
Prune IgE Ab RAST class [Presence] in Serum |
|
38519-5
|
Microscopic observation [Identifier] in Blood or Marrow by Prussian blue stain |
|
10802-7
|
Microscopic observation [Identifier] in Tissue by Prussian blue stain |
|
22452-7
|
Pseudorabies virus Ab [Presence] in Serum |
|
15497-1
|
Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
|
15498-9
|
Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
|
23382-5
|
Pseudorabies virus Ab [Presence] in Serum by Neutralization test |
|
31577-0
|
Pseudorabies virus Ab [Units/volume] in Serum |
|
22453-5
|
Pseudorabies virus Ab [Titer] in Serum |
|
15499-7
|
Pseudorabies virus Ab [Titer] in Serum by Neutralization test |
|
23774-3
|
Pseudorabies virus Ag [Presence] in Tissue by Immunofluorescence |
|
31945-9
|
Pseudorabies virus Ag [Presence] in Unspecified specimen |
|
23384-1
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23385-8
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23383-3
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23386-6
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
22454-3
|
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum |
|
15500-2
|
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
|
87342-2
|
Pseudorabies virus DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23387-4
|
Pseudorabies virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29890-1
|
Pseudorabies virus G1 gene deletion Ab [Presence] in Serum |
|
29888-5
|
Pseudorabies virus G1 gene deletion Ab [Presence] in Serum by Immunoassay |
|
87343-0
|
Pseudorabies virus glycoprotein 1 Ab/Negative control in Serum by Immunoassay |
|
87344-8
|
Pseudorabies virus glycoprotein B Ab/Negative control in Serum by Immunoassay |
|
22455-0
|
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum |
|
15501-0
|
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
|
22456-8
|
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum |
|
15502-8
|
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
|
22457-6
|
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum |
|
15503-6
|
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
|
87341-4
|
Pseudorabies virus [Presence] in Unspecified specimen by Organism specific culture |
|
34507-4
|
PRX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41066-2
|
PRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
33310-4
|
Phosphatidylserine Ab [Presence] in Serum |
|
42751-8
|
Phosphatidylserine IgA Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42752-6
|
Phosphatidylserine IgA Ab B2GP1 independent [Multiple of the median] in Serum |
|
32031-7
|
Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay |
|
30500-3
|
Phosphatidylserine IgA Ab [Presence] in Serum |
|
13069-0
|
Phosphatidylserine IgA Ab [Units/volume] in Serum |
|
42753-4
|
Phosphatidylserine IgG Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42754-2
|
Phosphatidylserine IgG Ab B2GP1 independent [Multiple of the median] in Serum |
|
55795-9
|
Phosphatidylserine IgG Ab [Multiple of the median] in Serum |
|
32032-5
|
Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay |
|
11568-3
|
Phosphatidylserine IgG Ab [Presence] in Serum |
|
9326-0
|
Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay |
|
14245-5
|
Phosphatidylserine IgG Ab [Units/volume] in Serum |
|
42755-9
|
Phosphatidylserine IgM Ab B2GP1 dependent [Multiple of the median] in Serum |
|
42756-7
|
Phosphatidylserine IgM Ab B2GP1 independent [Multiple of the median] in Serum |
|
55796-7
|
Phosphatidylserine IgM Ab [Multiple of the median] in Serum |
|
32033-3
|
Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay |
|
11569-1
|
Phosphatidylserine IgM Ab [Presence] in Serum |
|
9327-8
|
Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay |
|
14246-3
|
Phosphatidylserine IgM Ab [Units/volume] in Serum |
|
51802-7
|
Phosphatidylserine IgM Ab [Titer] in Serum by Immunofluorescence |
|
74123-1
|
Phospho-S6 ribosomal protein Ag [Presence] in Tissue by Immune stain |
|
59230-3
|
Prostate specific Ag [Mass/volume] in Cerebral spinal fluid |
|
47738-0
|
Prostate specific Ag [Mass/volume] in Body fluid |
|
59231-1
|
Prostate Specific Ag Free [Mass/volume] in Cerebral spinal fluid |
|
59239-4
|
Prostate Specific Ag Free [Mass/volume] in Body fluid |
|
59235-2
|
Prostate Specific Ag Free/Prostate specific Ag.total in Cerebral spinal fluid |
|
59238-6
|
Prostate Specific Ag Free/Prostate specific Ag.total in Body fluid |
|
59237-8
|
Prostate Specific Ag Free/Prostate specific Ag.total in Pleural fluid |
|
59236-0
|
Prostate Specific Ag Free/Prostate specific Ag.total in Peritoneal fluid |
|
12841-3
|
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
|
72576-2
|
Prostate Specific Ag Free/Prostate specific Ag.total [Pure mass fraction] in Serum or Plasma |
|
59232-9
|
Prostate Specific Ag Free [Mass/volume] in Pleural fluid |
|
59224-6
|
Prostate Specific Ag Free [Mass/volume] in Peritoneal fluid |
|
83113-1
|
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma by Immunoassay |
|
19201-3
|
Prostate Specific Ag Free [Units/volume] in Serum or Plasma |
|
10886-0
|
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
|
19203-9
|
Prostate Specific Ag Free [Moles/volume] in Serum or Plasma |
|
19204-7
|
Prostate Specific Ag Free [Units/volume] in Semen |
|
19205-4
|
Prostate Specific Ag Free [Mass/volume] in Semen |
|
19206-2
|
Prostate Specific Ag Free [Moles/volume] in Semen |
|
59221-2
|
Prostate specific Ag [Mass/volume] in Pleural fluid |
|
59223-8
|
Prostate specific Ag [Mass/volume] in Peritoneal fluid |
|
35741-8
|
Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
|
83112-3
|
Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
19195-7
|
Prostate specific Ag [Units/volume] in Serum or Plasma |
|
2857-1
|
Prostate specific Ag [Mass/volume] in Serum or Plasma |
|
19197-3
|
Prostate specific Ag [Moles/volume] in Serum or Plasma |
|
19198-1
|
Prostate specific Ag [Units/volume] in Semen |
|
19199-9
|
Prostate specific Ag [Mass/volume] in Semen |
|
19200-5
|
Prostate specific Ag [Moles/volume] in Semen |
|
10508-0
|
Prostate specific Ag [Presence] in Tissue by Immune stain |
|
34611-4
|
Prostate specific Ag [Mass/volume] in Urine |
|
48167-1
|
Prostate specific Ag/Creatinine [Mass Ratio] in Urine |
|
15325-4
|
Prostate specific Ag/Prostate volume calculated |
|
15323-9
|
Prostate specific Ag/Prostate volume calculated from height, width and length |
|
15324-7
|
Prostate specific Ag/Prostate volume calculated from planimetry |
|
21729-9
|
PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21730-7
|
PSAP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
81870-8
|
PSEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
35299-7
|
PSEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81871-6
|
PSEN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77628-6
|
PSEN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60526-1
|
Pseudo Pelger Huet cells [Presence] in Blood by Light microscopy |
|
89691-0
|
Pseudocasts [#/area] in Urine by Computer assisted method |
|
33019-1
|
Pseudocasts [#/area] in Urine sediment by Microscopy low power field |
|
53976-7
|
Pseudocasts [Presence] in Urine sediment by Light microscopy |
|
4005-5
|
Pseudoephedrine [Mass/time] in 24 hour Urine |
|
4417-2
|
Pseudoephedrine [Mass] of Dose |
|
61089-9
|
Pseudoephedrine [Presence] in Gastric fluid |
|
73185-1
|
Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73184-4
|
Pseudoephedrine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
61056-8
|
Pseudoephedrine [Presence] in Serum or Plasma |
|
90446-6
|
Pseudoephedrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
9389-8
|
Pseudoephedrine [Mass/volume] in Serum or Plasma |
|
55575-5
|
Pseudoephedrine [Moles/volume] in Serum or Plasma |
|
4003-0
|
Pseudoephedrine [Presence] in Urine |
|
4004-8
|
Pseudoephedrine [Mass/volume] in Urine |
|
61057-6
|
Pseudoephedrine [Presence] in Unspecified specimen |
|
48645-6
|
Pseudomonas sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
79674-8
|
Pseudouridine [Moles/volume] in Cerebral spinal fluid |
|
79657-3
|
Pseudouridine [Moles/volume] in Serum or Plasma |
|
78692-1
|
Pseudouridine/Creatinine [Molar ratio] in Urine |
|
46202-8
|
Psittacid herpesvirus 1 Ab [Presence] in Serum |
|
43340-9
|
Psittacid herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
28024-8
|
Rigid proctosigmoidoscopy Study observation Narrative |
|
28025-5
|
Rigid proctosigmoidoscopy Study observation |
|
19685-7
|
Psilocin cutoff [Mass/volume] in Urine for Confirmatory method |
|
19684-0
|
Psilocin cutoff [Mass/volume] in Urine for Screen method |
|
16146-3
|
Psilocin [Mass/volume] in Serum or Plasma |
|
20558-3
|
Psilocin [Mass/volume] in Urine by Confirmatory method |
|
18414-3
|
Psilocin [Presence] in Urine |
|
19683-2
|
Psilocin [Presence] in Urine by Confirmatory method |
|
19682-4
|
Psilocin [Presence] in Urine by Screen method |
|
18415-0
|
Psilocin [Mass/volume] in Urine |
|
19691-5
|
Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method |
|
19690-7
|
Psilocybin cutoff [Mass/volume] in Urine for Screen method |
|
19688-1
|
Psilocybin [Mass/volume] in Urine by Confirmatory method |
|
17504-2
|
Psilocybin [Presence] in Urine |
|
19687-3
|
Psilocybin [Presence] in Urine by Confirmatory method |
|
19686-5
|
Psilocybin [Presence] in Urine by Screen method |
|
6930-2
|
Psilocybin [Mass/volume] in Urine |
|
17505-9
|
Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma |
|
77214-5
|
Parotid secretory protein IgA Ab [Units/volume] in Serum by Immunoassay |
|
77215-2
|
Parotid secretory protein IgG Ab [Units/volume] in Serum by Immunoassay |
|
77216-0
|
Parotid secretory protein IgM Ab [Units/volume] in Serum by Immunoassay |
|
88888-3
|
Pancreatic stone protein [Mass/volume] in Serum, Plasma or Blood by Rapid immunoassay |
|
85359-8
|
Phosphatidylserine-prothrombin complex IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
85358-0
|
Phosphatidylserine-prothrombin complex IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
87389-3
|
Porcine sapelovirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87390-1
|
Porcine sapelovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87388-5
|
Porcine sapelovirus [Presence] in Unspecified specimen by Organism specific culture |
|
83897-9
|
Psychology Administrative note |
|
34791-4
|
Psychology Consult note |
|
34866-4
|
Psychology Counseling note |
|
83899-5
|
Psychology Custodial care facility Note |
|
93968-6
|
Psychology Diagnostic study note |
|
83898-7
|
Psychology Discharge summary |
|
83900-1
|
Psychology Education note |
|
78641-8
|
Psychology Flowsheet |
|
34793-0
|
Psychology Group counseling note |
|
83901-9
|
Psychology History and physical note |
|
83903-5
|
Psychology Hospital Note |
|
18738-5
|
Psychology Initial evaluation note |
|
83904-3
|
Psychology Long term care facility Note |
|
34792-2
|
Psychology Note |
|
83905-0
|
Psychology Outpatient Note |
|
83908-4
|
Psychology Telephone encounter Note |
|
80770-1
|
Psychology Plan of care note |
|
89812-2
|
Psychology procedure note |
|
11510-5
|
Psychology Progress note |
|
83902-7
|
Psychology Patient's home Note |
|
57158-8
|
Psychology Referral note |
|
83906-8
|
Psychology Risk assessment and screening note |
|
83879-7
|
Psychiatry Administrative note |
|
83880-5
|
Psychiatry Admission evaluation note |
|
34788-0
|
Psychiatry Consult note |
|
34865-6
|
Psychiatry Counseling note |
|
93967-8
|
Psychiatry Diagnostic study note |
|
59259-2
|
Psychiatry Discharge summary |
|
83884-7
|
Psychiatry Emergency department Note |
|
83883-9
|
Psychiatry Education note |
|
78625-1
|
Psychiatry Flowsheet |
|
34790-6
|
Psychiatry Group counseling note |
|
68599-0
|
Psychiatry History and physical note |
|
34102-4
|
Psychiatry Hospital Consult note |
|
83885-4
|
Psychiatry Hospital Group counseling note |
|
83886-2
|
Psychiatry Hospital History and physical note |
|
83887-0
|
Psychiatry Hospital Note |
|
28635-1
|
Psychiatry Initial evaluation note |
|
93899-3
|
Psychiatry Letter |
|
83888-8
|
Psychiatry Long term care facility Consult note |
|
83889-6
|
Psychiatry Medication management note |
|
28628-6
|
Psychiatry Note |
|
83890-4
|
Psychiatry Outpatient Group counseling note |
|
68601-4
|
Psychiatry Outpatient Note |
|
83894-6
|
Psychiatry Telephone encounter Note |
|
80765-1
|
Psychiatry Plan of care note |
|
83891-2
|
Psychiatry procedure note |
|
28627-8
|
Psychiatry Progress note |
|
57157-0
|
Psychiatry Referral note |
|
85872-0
|
Psychiatry Restraint note |
|
83892-0
|
Psychiatry Risk assessment and screening note |
|
90716-2
|
Psychiatry Telehealth Note |
|
83896-1
|
Psychiatry Triage note |
|
83668-4
|
Psychiatry Attending Admission evaluation note |
|
83669-2
|
Psychiatry Attending Hospital Note |
|
75474-7
|
Psychiatry Attending Note |
|
83881-3
|
Psychiatry Case manager Note |
|
83882-1
|
Psychiatry Interdisciplinary Note |
|
83895-3
|
Psychiatry Interdisciplinary Plan of care note |
|
83561-1
|
Psychiatry Nurse practitioner Note |
|
83609-8
|
Psychiatry Nurse Consult note |
|
83610-6
|
Psychiatry Nurse Hospital Note |
|
83611-4
|
Psychiatry Nurse Note |
|
88347-0
|
Psychiatry Nurse procedure note |
|
83773-2
|
Psychiatry Resident Note |
|
11527-9
|
Psychiatry study |
|
83893-8
|
Psychiatry Team Note |
|
77231-9
|
Psychological stress load level [NMMDS] |
|
90789-9
|
Psychology Intern Note |
|
83907-6
|
Psychology Team Note |
|
93686-4
|
Psychosine [Moles/volume] in Cerebral spinal fluid |
|
93688-0
|
Psychosine [Moles/volume] in DBS |
|
93687-2
|
Psychosine [Moles/mass] in Red Blood Cells |
|
80472-4
|
Psyllium intake 24 hour Estimated |
|
80473-2
|
Psyllium intake 24 hour Measured |
|
7635-6
|
Psyllium seed IgE Ab [Units/volume] in Serum |
|
15963-2
|
Psyllium seed IgE Ab RAST class [Presence] in Serum |
|
40091-1
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challenge |
|
51626-0
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --with 1:4 normal plasma 1H post incubation separate tubes |
|
40097-8
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --12 hours post XXX challenge |
|
40098-6
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 day post XXX challenge |
|
33884-8
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
33356-7
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
33883-0
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
|
33894-7
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
|
40090-3
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 hour post XXX challenge |
|
33357-5
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1 hour post incubation |
|
5958-4
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
|
5957-6
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma |
|
33880-6
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
|
33887-1
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma |
|
33886-3
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
|
33885-5
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
|
40092-9
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours post XXX challenge |
|
33895-4
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2 hours post incubation |
|
40087-9
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours pre XXX challenge |
|
40089-5
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --30 minutes post XXX challenge |
|
40093-7
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --3 hours post XXX challenge |
|
40094-5
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --4 hours post XXX challenge |
|
40095-2
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --6 hours post XXX challenge |
|
40096-0
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --8 hours post XXX challenge |
|
84332-6
|
Physical therapy Administrative note |
|
76459-7
|
Physical therapy billing diagnosis code |
|
5964-2
|
Prothrombin time (PT) in Blood by Coagulation assay |
|
46417-2
|
Prothrombin time (PT) in Capillary blood by Coagulation assay |
|
81577-9
|
PT Brain for amyloidosis |
|
81578-7
|
PT Brain metabolic |
|
44138-6
|
PT Brain |
|
40088-7
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --baseline |
|
85847-2
|
Patient Care team information |
|
34824-3
|
Physical therapy Consult note |
|
5901-4
|
Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay |
|
77978-5
|
Patient died from illness of interest |
|
76429-0
|
Physical therapy Discharge date |
|
78582-4
|
Physical therapy Discharge instructions |
|
84331-8
|
Physical therapy Discharge summary |
|
78591-5
|
Physical therapy Discharge teaching note |
|
78604-6
|
Physical therapy Education note |
|
57823-7
|
PT Esophagus |
|
78637-6
|
Physical therapy Flowsheet |
|
92710-3
|
Physical therapy goal |
|
92709-5
|
Physical therapy goal attainment expected duration - time frame |
|
92708-7
|
Physical therapy goal attainment expected duration - visits |
|
92562-8
|
Physical therapy goals panel |
|
82126-4
|
PT Guidance for radiation treatment of Unspecified body region |
|
58742-8
|
PT Head and Neck |
|
92563-6
|
Physical therapy health concerns panel |
|
68590-9
|
Physical therapy Hospital Consult note |
|
84328-4
|
Physical therapy Hospital Discharge summary |
|
84327-6
|
Physical therapy Hospital Initial evaluation note |
|
84326-8
|
Physical therapy Hospital Note |
|
77974-4
|
Patient was hospitalized because of this condition |
|
81564-7
|
PT Heart for sarcoidosis |
|
81565-4
|
PT Heart for tissue viability |
|
44137-8
|
PT Heart |
|
76435-7
|
Patient identifier |
|
33881-4
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
|
53230-9
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
|
34686-6
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma |
|
34682-5
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma |
|
40458-2
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor VIII depleted plasma |
|
34685-8
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor X depleted plasma |
|
5956-8
|
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
5959-2
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
6302-4
|
Prothrombin index in Platelet poor plasma by Coagulation assay |
|
18735-1
|
Physical therapy Initial evaluation note |
|
84325-0
|
Physical therapy Interdisciplinary Note |
|
84314-4
|
Physical therapy Interdisciplinary Plan of care note |
|
76431-6
|
Physical therapy location registry ID |
|
84324-3
|
Physical therapy Long term care facility Consult note |
|
84323-5
|
Physical therapy Long term care facility Note |
|
57822-9
|
PT Lung |
|
84322-7
|
Physical therapy Medication management note |
|
80297-5
|
Patient Memory |
|
80296-7
|
Patient Mood |
|
28579-1
|
Physical therapy Note |
|
52120-3
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 1H post incubation separate tubes |
|
83605-6
|
Physical therapy Nurse Note |
|
84321-9
|
Physical therapy Outpatient Discharge summary |
|
84320-1
|
Physical therapy Outpatient Education note |
|
84319-3
|
Physical therapy Outpatient Initial evaluation note |
|
84318-5
|
Physical therapy Outpatient Note |
|
76433-2
|
Physical therapy organization registry ID |
|
52122-9
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --post heparin neutralization |
|
84315-1
|
Physical therapy Telephone encounter Note |
|
52752-3
|
Prothrombin time (PT) PIVKA insensitive actual/normal in Capillary blood by Coagulation assay |
|
52753-1
|
Prothrombin time (PT) PIVKA insensitive actual/normal in Platelet poor plasma by Coagulation assay |
|
52760-6
|
Prothrombin time (PT) PIVKA sensitive actual/normal in Capillary blood by Coagulation assay |
|
52761-4
|
Prothrombin time (PT) PIVKA sensitive actual/normal in Platelet poor plasma by Coagulation assay |
|
88893-3
|
Prothrombin time (PT) PIVKA sensitive in Platelet poor plasma |
|
80762-8
|
Physical therapy Plan of care note |
|
92564-4
|
Physical therapy plan of care panel |
|
42638-7
|
Prothrombin time (PT) in Platelet poor plasma by Coagulation 1:1 saline |
|
61190-5
|
Prothrombin time (PT) in Platelet poor plasma from Fetus by Coagulation assay |
|
78662-4
|
Physical therapy procedure note |
|
11508-9
|
Physical therapy Progress note |
|
81889-8
|
Physical therapy provider entry-level degree |
|
81890-6
|
Physical therapy provider post-professional degree |
|
76457-1
|
Physical therapy provider residency or fellowship APTA |
|
76422-5
|
Physical therapy provider specialty APTA |
|
76421-7
|
Physical therapy provider type APTA |
|
84330-0
|
Physical therapy Patient's home Initial evaluation note |
|
84329-2
|
Physical therapy Patient's home Note |
|
91149-5
|
Physical therapy Reevaluation note |
|
57154-7
|
Physical therapy Referral note |
|
76439-9
|
Physical therapy referral source APTA |
|
90791-5
|
Physical therapy Resident Note |
|
84317-7
|
Physical therapy Risk assessment and screening note |
|
77218-6
|
Patient satisfaction with healthcare delivery |
|
81893-0
|
Patient satisfaction with healthcare delivery [Score] |
|
58741-0
|
PT Skull base to mid-thigh |
|
78005-6
|
Physical therapy Summary registry report |
|
84316-9
|
Physical therapy Team Note |
|
44139-4
|
PT Whole body |
|
44136-0
|
PT Unspecified body region |
|
81579-5
|
PT perfusion Brain |
|
81568-8
|
PT perfusion Heart W multiple states of exercise |
|
81569-6
|
PT perfusion Heart W single state of exercise |
|
82809-5
|
PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and W contrast IV |
|
82808-7
|
PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and WO contrast |
|
82807-9
|
PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and WO contrast |
|
81555-5
|
PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV |
|
82806-1
|
PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and W contrast IV |
|
82805-3
|
PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and WO contrast |
|
10801-9
|
Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |
|
72260-3
|
Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
38909-8
|
PTCH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38922-1
|
PTCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81710-6
|
PTEN gene [Presence] in Cancer specimen by FISH |
|
47969-1
|
PTEN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85506-4
|
PTEN gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
|
83063-8
|
PTEN gene [VCF] in Cancer specimen by Sequencing |
|
81706-4
|
Phosphatase and tensin homolog (PTEN) protein [Presence] in Cancer specimen by Immune stain |
|
80173-8
|
Pterins pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
80172-0
|
Pterins pattern [Interpretation] in Serum or Plasma Narrative |
|
80171-2
|
Pterins pattern [Interpretation] in Urine Narrative |
|
35567-7
|
Parathyrin [Mass/volume] in Serum or Plasma --10 minutes post excision |
|
47179-7
|
Parathyrin [Moles/volume] in Serum or Plasma --10 minutes post excision |
|
47717-4
|
Parathyrin [Mass/volume] in Serum or Plasma --2 hours post dose calcium |
|
47718-2
|
Parathyrin [Mass/volume] in Serum or Plasma --4 hours post dose calcium |
|
13928-7
|
Parathyrin Ab [Presence] in Serum |
|
63301-6
|
Parathyrin Ab [Presence] in Serum by Immunofluorescence |
|
12799-3
|
Parathyrin Ab [Units/volume] in Serum |
|
63302-4
|
Parathyrin Ab [Titer] in Serum by Immunofluorescence |
|
35566-9
|
Parathyrin [Mass/volume] in Serum or Plasma --baseline |
|
47180-5
|
Parathyrin [Moles/volume] in Serum or Plasma --baseline |
|
47719-0
|
Parathyrin [Mass/volume] in Serum or Plasma --pre dose calcium |
|
2729-2
|
Parathyrin related protein [Mass/volume] in Serum or Plasma |
|
15087-0
|
Parathyrin related protein [Moles/volume] in Serum or Plasma |
|
14865-0
|
Parathyrin [Interpretation] in Serum or Plasma |
|
49288-4
|
Parathyrin [Interpretation] in Serum or Plasma Narrative |
|
32045-7
|
Parathyrin.biointact [Mass/volume] in Serum or Plasma |
|
47093-0
|
Parathyrin.biointact [Moles/volume] in Serum or Plasma |
|
2730-0
|
Parathyrin.C-terminal [Mass/volume] in Serum or Plasma |
|
15088-8
|
Parathyrin.C-terminal [Moles/volume] in Serum or Plasma |
|
40929-2
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --10 minutes post excision |
|
47176-3
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --10 minutes post excision |
|
16163-8
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
33845-9
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
68917-4
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --20 minutes post excision |
|
16164-6
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
33846-7
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
16162-0
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
33847-5
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
38157-4
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --5 minutes post excision |
|
47177-1
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --5 minutes post excision |
|
38158-2
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --baseline |
|
47178-9
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --baseline |
|
59835-9
|
Parathyrin.intact [Mass/volume] in Body fluid |
|
86917-2
|
Parathyrin.intact goal [Mass/volume] Serum or Plasma |
|
70664-8
|
Parathyrin.intact intraoperative percent change in Serum or Plasma |
|
58858-2
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --post XXX challenge |
|
49036-7
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --post excision |
|
2731-8
|
Parathyrin.intact [Mass/volume] in Serum or Plasma |
|
35219-5
|
Parathyrin.intact [Mass or Moles/volume] in Serum or Plasma |
|
14866-8
|
Parathyrin.intact [Moles/volume] in Serum or Plasma |
|
50525-5
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --1st specimen |
|
50526-3
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --2nd specimen |
|
50527-1
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --3rd specimen |
|
50528-9
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --4th specimen |
|
50529-7
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --5th specimen |
|
50530-5
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --6th specimen |
|
50531-3
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --7th specimen |
|
50532-1
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --8th specimen |
|
88106-0
|
Parathyrin.intact [Mass/volume] in Tissue fine needle aspirate |
|
2732-6
|
Parathyrin.mid molecule [Mass/volume] in Serum or Plasma |
|
29390-2
|
Parathyrin.mid molecule [Moles/volume] in Serum or Plasma |
|
2733-4
|
Parathyrin.N-terminal [Mass/volume] in Serum or Plasma |
|
34679-1
|
PTPN11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41065-4
|
PTPN11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53791-0
|
PTPN11 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53792-8
|
PTPN11 gene mutations tier 3 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81142-2
|
PTPN22 gene.c.1858C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
84161-9
|
Patient's home Administrative note |
|
84162-7
|
Patient's home Admission evaluation note |
|
88693-7
|
Patient's home Discharge summary |
|
88694-5
|
Patient's home Discharge teaching note |
|
34107-3
|
Patient's home Education note |
|
85203-8
|
Patient's home History and physical note |
|
34118-0
|
Patient's home Initial evaluation note |
|
85470-3
|
Patient's home Medication management note |
|
75503-3
|
Patient's home Note |
|
84165-0
|
Patient's home Plan of care note |
|
34129-7
|
Patient's home Progress note |
|
85205-3
|
Patient's home Referral note |
|
85204-6
|
Patient's home Risk assessment and screening note |
|
71754-6
|
PTSD score [M3] |
|
50391-2
|
PTT circulating inhibitor [Presence] in Platelet poor plasma |
|
87391-9
|
Porcine teschovirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87392-7
|
Porcine teschovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87399-2
|
Porcine teschovirus [Presence] in Unspecified specimen by Organism specific culture |
|
90083-7
|
Public communication target group |
|
90061-3
|
Public communication document type |
|
90088-6
|
Public communication target region [Location] |
|
90062-1
|
Public communication document |
|
90081-1
|
Public communication document name |
|
90082-9
|
Public communication template |
|
55751-2
|
Public health Case report |
|
83909-2
|
Public health Consult note |
|
78642-6
|
Public health Form |
|
80421-1
|
Public health Mandatory reporting form |
|
83910-0
|
Public health Note |
|
78674-9
|
Public health Referral note |
|
31578-8
|
Pullularia sp Ab [Presence] in Serum |
|
24504-3
|
Pullularia sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
7637-2
|
Pullularia sp IgE Ab [Units/volume] in Serum |
|
7638-0
|
Pullularia sp IgG Ab [Units/volume] in Serum |
|
76285-6
|
Pulmonary capillary Blood pressure |
|
76286-4
|
Pulmonary capillary Diastolic blood pressure |
|
76287-2
|
Pulmonary capillary Mean blood pressure |
|
76288-0
|
Pulmonary capillary Systolic blood pressure |
|
29453-8
|
Pulmonary vein Maximum A wave reversal by US.doppler |
|
93626-0
|
Pulmonary vein Blood flow velocity.S2 wave by Ultrasound.doppler.PW |
|
93627-8
|
Pulmonary vein Blood flow velocity.S1 wave by Ultrasound.doppler.PW |
|
29451-2
|
Pulmonary vein Maximum blood flow velocity during diastole by US.doppler |
|
29450-4
|
Pulmonary vein Maximum blood flow velocity during systole by US.doppler |
|
29464-5
|
Pulmonary vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler |
|
29452-0
|
Pulmonary vein Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived |
|
93665-8
|
Pulmonary valve Regurgitant blood flow pressure half-time by US.doppler |
|
93625-2
|
Pulmonary valve Regurgitant blood flow velocity.early diastole by Ultrasound.doppler.PW |
|
78184-9
|
Pulmonary vein A-wave duration by Ultrasound.doppler.PW |
|
79915-5
|
Pulmonary vein Maximum A-wave velocity by Ultrasound.doppler.PW |
|
79916-3
|
Pulmonary vein Maximum D-wave velocity by Ultrasound.doppler.PW |
|
79917-1
|
Pulmonary vein Maximum S-wave velocity by Ultrasound.doppler.PW |
|
64077-1
|
Pulmonary Attending Hospital Note |
|
68478-7
|
Pulmonary Attending Hospital Progress note |
|
83787-2
|
Pulmonary Attending Note |
|
83788-0
|
Pulmonary Attending Outpatient Note |
|
83789-8
|
Pulmonary Attending procedure note |
|
83911-8
|
Pulmonary Admission evaluation note |
|
34103-2
|
Pulmonary Consult note |
|
80792-5
|
Pulmonary Diagnostic study note |
|
80793-3
|
Pulmonary Education note |
|
80794-1
|
Pulmonary Flowsheet |
|
64062-3
|
Pulmonary Hospital Admission evaluation note |
|
64063-1
|
Pulmonary Hospital Progress note |
|
83914-2
|
Pulmonary Hospital Transfer summary note |
|
80795-8
|
Pulmonary Initial evaluation note |
|
34830-0
|
Pulmonary Note |
|
83915-9
|
Pulmonary Outpatient Note |
|
83916-7
|
Pulmonary Telephone encounter Note |
|
80796-6
|
Pulmonary Plan of care note |
|
85944-7
|
Pulmonary Preoperative evaluation and management note |
|
80798-2
|
Pulmonary procedure note |
|
80819-6
|
Pulmonary Progress note |
|
83912-6
|
Pulmonary Patient's home Consult note |
|
83913-4
|
Pulmonary Patient's home Note |
|
57177-8
|
Pulmonary Referral note |
|
83744-3
|
Pulmonary Fellow Note |
|
64078-9
|
Pulmonary Medical student Hospital Admission evaluation note |
|
64080-5
|
Pulmonary Medical student Hospital Consult note |
|
64079-7
|
Pulmonary Medical student Hospital Progress note |
|
83638-7
|
Pulmonary Nurse Note |
|
83639-5
|
Pulmonary Nurse Outpatient Note |
|
83640-3
|
Pulmonary Nurse procedure note |
|
83774-0
|
Pulmonary Resident Note |
|
20284-6
|
Pulmonic valve distal Mean blood flow velocity by US.doppler |
|
29462-9
|
Pulmonic flow/Systemic flow by US.doppler |
|
20293-7
|
Pulmonic flow/Systemic flow by US.doppler Vmax + aorta calculated |
|
20294-5
|
Pulmonic flow/Systemic flow by US.doppler Vmax + left ventricular outflow tract calculated |
|
20291-1
|
Pulmonic flow/Systemic flow by US.doppler VTI + aorta calculated |
|
20292-9
|
Pulmonic flow/Systemic flow by US.doppler VTI + left ventricular outflow tract calculated |
|
74782-4
|
Pulse intensity Dorsal pedal artery - right by palpation |
|
44974-4
|
Pulse intensity of Unspecified artery palpation |
|
8914-4
|
Pulse wave form Brachial artery - left by US.doppler |
|
8915-1
|
Pulse wave form Brachial artery - right by US.doppler |
|
8916-9
|
Pulse wave form Carotid artery - left by US.doppler |
|
8917-7
|
Pulse wave form Carotid artery - right by US.doppler |
|
8919-3
|
Pulse wave form Dorsal pedal artery by US.doppler |
|
8918-5
|
Pulse wave form Dorsal pedal artery - left by US.doppler |
|
8920-1
|
Pulse wave form Femoral artery - left by US.doppler |
|
8921-9
|
Pulse wave form Femoral artery - right by US.doppler |
|
8922-7
|
Pulse wave form Popliteal artery - left by US.doppler |
|
8923-5
|
Pulse wave form Popliteal artery - right by US.doppler |
|
8925-0
|
Pulse wave form Posterior tibial artery - left by US.doppler |
|
8924-3
|
Pulse wave form Posterior tibial artery - right by US.doppler |
|
8926-8
|
Pulse wave form Radial artery - left by US.doppler |
|
8927-6
|
Pulse wave form Radial artery - right by US.doppler |
|
8928-4
|
Pulse wave form Ulnar artery - left by US.doppler |
|
8929-2
|
Pulse wave form Ulnar artery - right by US.doppler |
|
6854-4
|
Pumpkin IgE Ab [Units/volume] in Serum |
|
15966-5
|
Pumpkin IgE Ab RAST class [Presence] in Serum |
|
39597-0
|
Pumpkin IgE Ab/IgE total in Serum |
|
56468-2
|
Pumpkin IgG4 Ab [Mass/volume] in Serum |
|
63116-8
|
Pumpkin IgG Ab [Mass/volume] in Serum |
|
11193-0
|
Pumpkin Seed IgE Ab [Units/volume] in Serum |
|
15967-3
|
Pumpkin Seed IgE Ab RAST class [Presence] in Serum |
|
61252-3
|
Pumpkin Seed IgE Ab/IgE total in Serum |
|
80313-0
|
Pupil assessment [Interpretation] |
|
75944-9
|
Pupil reaction [Time] Left eye |
|
75945-6
|
Pupil reaction [Time] Right eye |
|
79871-0
|
Pupil shape left eye by slit lamp biomicroscopy |
|
79870-2
|
Pupil shape right eye by slit lamp biomicroscopy |
|
80311-4
|
Pupil shape [Shape] of Left pupil |
|
80312-2
|
Pupil shape [Shape] of Right pupil |
|
87515-3
|
Pupillary response Pupil - bilateral --at admission |
|
79899-1
|
Pupillary response Left pupil |
|
79815-7
|
Pupillary response Right pupil |
|
92201-3
|
Purchase activity Supply |
|
92033-0
|
Purchase cost [#] Supply |
|
52075-9
|
Purchase invoice |
|
79666-4
|
Purine and Pyrimidine pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79659-9
|
Purine and Pyrimidine pattern [Interpretation] in Serum or Plasma Narrative |
|
79677-1
|
Purine and Pyrimidine pattern [Interpretation] in Urine Narrative |
|
85379-6
|
Purine/Pyrimidine [Ratio] in Red Blood Cells by Spectrophotometry |
|
54924-6
|
Purkinje cells Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63312-3
|
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
56736-2
|
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
14247-1
|
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31579-6
|
Purkinje cells Ab [Units/volume] in Cerebral spinal fluid |
|
45172-4
|
Purkinje cells Ab [Units/volume] in Serum by Immunofluorescence |
|
27214-6
|
Purkinje cells Ab [Presence] in Serum |
|
12853-8
|
Purkinje cells Ab [Presence] in Serum by Immunoblot |
|
14249-7
|
Purkinje cells Ab [Presence] in Serum by Immunofluorescence |
|
27068-6
|
Purkinje cells Ab [Units/volume] in Serum |
|
14248-9
|
Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
6970-8
|
Purkinje cells Ab [Titer] in Serum |
|
51721-9
|
Purkinje cells Ab [Titer] in Serum by Immunofluorescence |
|
14250-5
|
Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
31580-4
|
Purkinje cells IgG Ab [Units/volume] in Serum |
|
7778-4
|
Pussy Willow IgE Ab [Units/volume] in Serum |
|
16093-7
|
Pussy Willow IgE Ab RAST class [Presence] in Serum |
|
54689-5
|
Put others at significant risk for physical injury in last 7 days [CMS Assessment] |
|
54686-1
|
Put the resident at significant risk for physical illness or injury in last 7 days [CMS Assessment] |
|
89401-4
|
Putting on and taking off footwear - functional ability [CMS Assessment] |
|
89400-6
|
Putting on and taking off footwear - functional goal [CMS Assessment] |
|
83220-4
|
Putting on/taking off footwear - functional ability during 3 day assessment period [CMS Assessment] |
|
83219-6
|
Putting on/taking off footwear - functional goal during 3 day assessment period [CMS Assessment] |
|
7897-2
|
Hantavirus puumala IgG Ab [Units/volume] in Serum |
|
70059-1
|
Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
22308-1
|
Hantavirus puumala IgG Ab [Titer] in Serum |
|
21322-3
|
Hantavirus puumala IgG Ab [Titer] in Serum by Immunofluorescence |
|
16928-4
|
Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
|
7898-0
|
Hantavirus puumala IgM Ab [Units/volume] in Serum |
|
70058-3
|
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
22309-9
|
Hantavirus puumala IgM Ab [Titer] in Serum |
|
21323-1
|
Hantavirus puumala IgM Ab [Titer] in Serum by Immunofluorescence |
|
88220-9
|
Hantavirus puumala RNA [Presence] in Blood by NAA with probe detection |
|
88216-7
|
Hantavirus puumala RNA [Presence] in Urine by NAA with probe detection |
|
40709-8
|
Polio virus Ab [Units/volume] in Cerebral spinal fluid |
|
16284-2
|
Polio virus Ab [Units/volume] in Serum |
|
42980-3
|
Polio virus Ab [Titer] in Serum |
|
27261-7
|
Polio virus Ab [Titer] in Serum by Complement fixation |
|
17982-0
|
Pulmonic valve Acceleration by US.doppler |
|
18022-4
|
Pulmonic valve annulus Diameter by US |
|
79909-8
|
Pulmonic valve annulus Diameter at end systole by US 2D |
|
11799-4
|
Pulmonic valve Diameter by US |
|
79934-6
|
Pulmonic valve Maximum pressure gradient at end diastole by US.doppler+Calculated by simplified Bernoulli |
|
79918-9
|
Pulmonic valve Regurgitant blood flow velocity at end diastole by US.doppler |
|
18042-2
|
Pulmonic valve Ejection time by US.doppler |
|
79928-8
|
Pulmonic valve Blood flow acceleration time during systole by US.doppler |
|
40783-3
|
Polio virus IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40708-0
|
Polio virus IgG Ab [Titer] in Serum --2nd specimen |
|
40782-5
|
Polio virus IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
|
40781-7
|
Polio virus IgM Ab [Titer] in Serum --1st specimen |
|
60546-9
|
Polio virus identified [Type] in Isolate by Organism specific culture |
|
79935-3
|
Pulmonic valve Maximum pressure gradient dur systole by US.doppler+Calculated by simplified Bernoulli |
|
79919-7
|
Pulmonic valve Maximum regurgitant blood flow velocity.E wave by US.doppler |
|
78182-3
|
Pulmonic valve Maximum regurgitant pressure gradient during diastole by US.doppler |
|
20251-5
|
Pulmonic valve Maximum regurgitant pressure gradient by US.calculated |
|
18060-4
|
Pulmonic valve Mean pressure gradient by US.doppler |
|
18096-8
|
Pulmonic valve Orifice area by US.continuity |
|
18058-8
|
Pulmonic valve Peak pressure gradient by US.doppler |
|
93624-5
|
Pulmonic valve Pressure gradient.early diastole.max by US.doppler |
|
18110-7
|
Pulmonic valve Prosthetic valve type by US |
|
20295-2
|
Pulmonic valve Q-wave to closure [Time] by US |
|
18114-9
|
Pulmonic valve Regurgitation degree by US.doppler |
|
18165-1
|
Pulmonic valve Maximum regurgitant blood flow velocity during diastole by US.doppler |
|
20289-5
|
Pulmonic valve Region orifice area by US.doppler Vmax + area calculated |
|
20290-3
|
Pulmonic valve Region orifice area by US.doppler Vmax + diameter calculated |
|
20287-9
|
Pulmonic valve Region orifice area by US.doppler VTI + area calculated |
|
20288-7
|
Pulmonic valve Region orifice area by US.doppler VTI + diameter calculated |
|
78181-5
|
Pulmonic valve Regurgitant velocity during diastolic rapid inflow by US.doppler |
|
20225-9
|
Pulmonic valve Minimum end diastole regurgitant blood flow velocity by US |
|
78183-1
|
Pulmonic valve Stenosis degree by US |
|
53645-8
|
Polio virus identified in Stool by Organism specific culture |
|
77918-1
|
Pulmonic valve Vena contracta diameter by US.doppler |
|
18162-8
|
Pulmonic valve Maximum blood flow velocity by US.doppler |
|
79920-5
|
Pulmonic valve Maximum blood flow velocity during systole by US.doppler |
|
11710-1
|
Pulmonic valve Peak systolic flow velocity by US.doppler |
|
11678-0
|
Pulmonic valve Mean blood flow velocity by US.doppler |
|
18174-3
|
Pulmonic valve Blood velocity-time integral by US.doppler |
|
79910-6
|
Pulmonic valve Velocity-time integral during systole by US.doppler |
|
73907-8
|
Polio virus identified in Unspecified specimen by Organism specific culture |
|
31564-8
|
Polio virus 1 Ab [Units/volume] in Cerebral spinal fluid |
|
31565-5
|
Polio virus 1 Ab [Units/volume] in Body fluid |
|
30546-6
|
Polio virus 1 Ab [Presence] in Serum |
|
7985-5
|
Polio virus 1 Ab [Units/volume] in Serum |
|
24243-8
|
Polio virus 1 Ab [Titer] in Serum --1st specimen |
|
24169-5
|
Polio virus 1 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24244-6
|
Polio virus 1 Ab [Titer] in Serum --2nd specimen |
|
24170-3
|
Polio virus 1 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22445-1
|
Polio virus 1 Ab [Titer] in Cerebral spinal fluid |
|
18397-0
|
Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
42981-1
|
Polio virus 1 Ab [Titer] in Body fluid |
|
31063-1
|
Polio virus 1 Ab [Titer] in Body fluid by Complement fixation |
|
22446-9
|
Polio virus 1 Ab [Titer] in Serum |
|
5282-9
|
Polio virus 1 Ab [Titer] in Serum by Complement fixation |
|
5281-1
|
Polio virus 1 Ab [Titer] in Serum by Neutralization test |
|
31566-3
|
Polio virus 2 Ab [Units/volume] in Cerebral spinal fluid |
|
31567-1
|
Polio virus 2 Ab [Units/volume] in Body fluid |
|
30547-4
|
Polio virus 2 Ab [Presence] in Serum |
|
7986-3
|
Polio virus 2 Ab [Units/volume] in Serum |
|
24245-3
|
Polio virus 2 Ab [Titer] in Serum --1st specimen |
|
24171-1
|
Polio virus 2 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24246-1
|
Polio virus 2 Ab [Titer] in Serum --2nd specimen |
|
24172-9
|
Polio virus 2 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22447-7
|
Polio virus 2 Ab [Titer] in Cerebral spinal fluid |
|
18398-8
|
Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
42978-7
|
Polio virus 2 Ab [Titer] in Body fluid |
|
31064-9
|
Polio virus 2 Ab [Titer] in Body fluid by Complement fixation |
|
22448-5
|
Polio virus 2 Ab [Titer] in Serum |
|
5284-5
|
Polio virus 2 Ab [Titer] in Serum by Complement fixation |
|
5283-7
|
Polio virus 2 Ab [Titer] in Serum by Neutralization test |
|
31568-9
|
Polio virus 3 Ab [Units/volume] in Cerebral spinal fluid |
|
31569-7
|
Polio virus 3 Ab [Units/volume] in Body fluid |
|
30548-2
|
Polio virus 3 Ab [Presence] in Serum |
|
7987-1
|
Polio virus 3 Ab [Units/volume] in Serum |
|
24247-9
|
Polio virus 3 Ab [Titer] in Serum --1st specimen |
|
24173-7
|
Polio virus 3 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24248-7
|
Polio virus 3 Ab [Titer] in Serum --2nd specimen |
|
24174-5
|
Polio virus 3 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22449-3
|
Polio virus 3 Ab [Titer] in Cerebral spinal fluid |
|
18399-6
|
Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
42979-5
|
Polio virus 3 Ab [Titer] in Body fluid |
|
31065-6
|
Polio virus 3 Ab [Titer] in Body fluid by Complement fixation |
|
22450-1
|
Polio virus 3 Ab [Titer] in Serum |
|
5286-0
|
Polio virus 3 Ab [Titer] in Serum by Complement fixation |
|
5285-2
|
Polio virus 3 Ab [Titer] in Serum by Neutralization test |
|
76126-2
|
Premature ventricular contractions [#] |
|
8616-5
|
Premature ventricular contractions |
|
29427-2
|
Pulmonary vein - left lower Maximum blood flow velocity during diastole by US.doppler |
|
29426-4
|
Pulmonary vein - left lower Maximum blood flow velocity during systole by US.doppler |
|
29428-0
|
Pulmonary vein - left lower Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler |
|
29458-7
|
Pulmonary vein - left lower Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived |
|
29424-9
|
Pulmonary vein - left upper Maximum blood flow velocity during diastole by US.doppler |
|
29423-1
|
Pulmonary vein - left upper Maximum blood flow velocity during systole by US.doppler |
|
29425-6
|
Pulmonary vein - left upper Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler |
|
29457-9
|
Pulmonary vein - left upper Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived |
|
29421-5
|
Pulmonary vein - right lower Maximum blood flow velocity during diastole by US.doppler |
|
29420-7
|
Pulmonary vein - right lower Maximum blood flow velocity during systole by US.doppler |
|
29422-3
|
Pulmonary vein - right lower Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler |
|
29456-1
|
Pulmonary vein - right lower Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived |
|
29418-1
|
Pulmonary vein - right upper Maximum blood flow velocity during diastole by US.doppler |
|
29454-6
|
Pulmonary vein - right upper Maximum blood flow velocity during systole by US.doppler |
|
29419-9
|
Pulmonary vein - right upper Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler |
|
29455-3
|
Pulmonary vein - right upper Maximum blood flow velocity during systole/Maximum blood flow velocity during diastole by US.doppler derived |
|
84448-0
|
Picture Vocabulary Test - English - computed score [NIH Toolbox] |
|
84450-6
|
Picture Vocabulary Test - English - theta score [NIH Toolbox] |
|
84451-4
|
Picture Vocabulary Test - English - unadjusted scale score [NIH Toolbox] |
|
84446-4
|
Picture Vocabulary Test - English - national percentile [NIH Toolbox] |
|
84438-1
|
Picture Vocabulary Test - English [NIH Toolbox] |
|
84447-2
|
Picture Vocabulary Test - English - scale score age adjusted [NIH Toolbox] |
|
84449-8
|
Picture Vocabulary Test - English - scale score fully adjusted [NIH Toolbox] |
|
44617-9
|
PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77196-4
|
Pulse wave velocity |
|
10887-8
|
Pyridinoline [Mass/time] in 24 hour Urine |
|
25977-0
|
Pyridinoline [Moles/volume] in 24 hour Urine |
|
34368-1
|
Pyridinoline [Moles/time] in 24 hour Urine |
|
9381-5
|
Pyridinoline [Mass/time] in 2 hour Urine |
|
34367-3
|
Pyridinoline [Moles/volume] in Urine |
|
48987-2
|
Pyridinoline.free/Creatinine [Molar ratio] in Urine |
|
13803-2
|
Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
|
25130-6
|
Pyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
|
13804-0
|
Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
|
25131-4
|
Pyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
|
13802-4
|
Pyridinoline/Creatinine [Mass Ratio] in Urine |
|
25129-8
|
Pyridinoline/Creatinine [Molar ratio] in Urine |
|
35647-7
|
Pyridinoline+Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
35294-8
|
PYGM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41064-7
|
PYGM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40930-0
|
PYGM gene p.Arg50Ter+Gly205Ser [Presence] in Blood or Tissue by Molecular genetics method |
|
33044-9
|
Pyknosis [Presence] in Blood by Light microscopy |
|
57313-9
|
Pyrazole IgE Ab [Units/volume] in Serum |
|
7640-6
|
Pyrethrum triggered histamine release [Units/volume] in Blood |
|
7639-8
|
Pyrethrum IgE Ab [Units/volume] in Serum |
|
15968-1
|
Pyrethrum IgE Ab RAST class [Presence] in Serum |
|
12412-3
|
Pyridine [Mass/volume] in Serum or Plasma |
|
58955-6
|
Pyridinoline and Deoxypyridinoline [Interpretation] in Urine |
|
9390-6
|
Pyridostigmine [Mass/volume] in Serum or Plasma |
|
75042-2
|
Pyridoxal [Moles/volume] in Cerebral spinal fluid |
|
74442-5
|
Pyridoxal phosphate [Moles/volume] in Blood |
|
75056-2
|
Pyridoxal phosphate [Moles/volume] in Cerebral spinal fluid |
|
30552-4
|
Pyridoxal phosphate [Mass/volume] in Serum or Plasma |
|
62236-5
|
Pyridoxal phosphate [Moles/volume] in Serum or Plasma |
|
30572-2
|
Pyridoxal [Mass/volume] in Serum or Plasma |
|
75041-4
|
Pyridoxal [Moles/volume] in Serum or Plasma |
|
4006-3
|
Pyrilamine [Mass/volume] in Blood |
|
4418-0
|
Pyrilamine [Mass] of Dose |
|
4007-1
|
Pyrilamine [Presence] in Serum or Plasma |
|
4008-9
|
Pyrilamine [Mass/volume] in Serum or Plasma |
|
4009-7
|
Pyrilamine [Presence] in Urine |
|
4010-5
|
Pyrilamine [Mass/volume] in Urine |
|
34669-2
|
Pyrimethamine [Mass/volume] in Serum or Plasma |
|
2904-1
|
Pyrophosphate crystals [#/volume] in Synovial fluid |
|
40664-5
|
Pyrophosphate crystals [Presence] in Body fluid |
|
5805-7
|
Pyrophosphate crystals [Presence] in Synovial fluid by Light microscopy |
|
5806-5
|
Pyrophosphate crystals [Presence] in Urine sediment by Light microscopy |
|
4013-9
|
Pyrovalerone [Mass/time] in 24 hour Urine |
|
4011-3
|
Pyrovalerone [Presence] in Urine |
|
4012-1
|
Pyrovalerone [Mass/volume] in Urine |
|
14176-2
|
Pyrroles [Mass/volume] in Urine |
|
58888-9
|
Pyruvate [Mass/volume] in Blood --10 minutes post XXX challenge |
|
58887-1
|
Pyruvate [Mass/volume] in Blood --15 minutes post XXX challenge |
|
27963-8
|
Pyruvate [Mass/volume] in Blood --1 hour post XXX challenge |
|
58890-5
|
Pyruvate [Mass/volume] in Blood --1 minute post XXX challenge |
|
68951-3
|
Pyruvate [Mass/volume] in Blood --20 minutes post XXX challenge |
|
27968-7
|
Pyruvate [Mass/volume] in Blood --2 hours post XXX challenge |
|
58886-3
|
Pyruvate [Mass/volume] in Blood --30 minutes post XXX challenge |
|
27970-3
|
Pyruvate [Mass/volume] in Blood --3 hours post XXX challenge |
|
58889-7
|
Pyruvate [Mass/volume] in Blood --3 minutes post XXX challenge |
|
27957-0
|
Pyruvate [Mass/volume] in Blood --4 hours post XXX challenge |
|
57377-4
|
Pyruvate [Mass/volume] in Blood --5 minutes post XXX challenge |
|
2906-6
|
Pyruvate [Mass/volume] in Arterial blood |
|
51750-8
|
Pyruvate [Moles/volume] in Arterial blood |
|
2905-8
|
Pyruvate [Mass/volume] in Blood |
|
14121-8
|
Pyruvate [Moles/volume] in Blood |
|
51751-6
|
Pyruvate [Moles/volume] in Venous blood |
|
27959-6
|
Pyruvate [Mass/volume] in Blood --baseline |
|
47879-2
|
Pyruvate carboxylase [Enzymatic activity/mass] in Amniotic fluid cells |
|
47880-0
|
Pyruvate carboxylase [Enzymatic activity/mass] in Fibroblast |
|
47882-6
|
Pyruvate carboxylase [Enzymatic activity/mass] in Placenta |
|
2909-0
|
Pyruvate carboxylase [Enzymatic activity/mass] in Tissue |
|
47881-8
|
Pyruvate carboxylase [Enzymatic activity/mass] in Leukocytes |
|
2907-4
|
Pyruvate [Mass/volume] in Cerebral spinal fluid |
|
14122-6
|
Pyruvate [Moles/volume] in Cerebral spinal fluid |
|
2914-0
|
Pyruvate oxidase [Enzymatic activity/volume] in Serum or Plasma |
|
58895-4
|
Pyruvate [Mass/volume] in Blood --post exercise |
|
12247-3
|
Pyruvate [Mass/volume] in Serum or Plasma |
|
32338-6
|
Pyruvate [Moles/volume] in Serum or Plasma |
|
30481-6
|
Pyruvate [Presence] in Urine |
|
2908-2
|
Pyruvate [Mass/volume] in Urine |
|
44400-0
|
Pyruvate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13805-7
|
Pyruvate/Creatinine [Mass Ratio] in Urine |
|
25132-2
|
Pyruvate/Creatinine [Molar ratio] in Urine |
|
25229-6
|
Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55711-6
|
Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25186-8
|
Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
56026-8
|
Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55710-8
|
Pyrazinamide [Susceptibility] by Gradient strip |
|
425-9
|
Pyrazinamide [Susceptibility] by Disk diffusion (KB) |
|
424-2
|
Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
423-4
|
Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC) |
|
20461-0
|
Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
92242-7
|
Pyrazinamide [Susceptibility] by Genotype method |
|
11001-5
|
Pyrazinamide [Mass/volume] in Serum or Plasma |
|
18973-8
|
Pyrazinamide [Susceptibility] |
|
426-7
|
Pyrazinamide [Susceptibility] by Serum bactericidal titer |
|
25270-0
|
Pyrazinamide [Mass/volume] in Unspecified specimen |
|
8629-8
|
Q wave depth |
|
9925-9
|
Q wave depth in lead AVF |
|
9926-7
|
Q wave depth in lead AVL |
|
9927-5
|
Q wave depth in lead AVR |
|
8630-6
|
Q wave depth lead |
|
9928-3
|
Q wave depth in lead I |
|
9929-1
|
Q wave depth in lead II |
|
9930-9
|
Q wave depth in lead III |
|
9931-7
|
Q wave depth in lead V1 |
|
9932-5
|
Q wave depth in lead V2 |
|
9933-3
|
Q wave depth in lead V3 |
|
9934-1
|
Q wave depth in lead V4 |
|
9935-8
|
Q wave depth in lead V5 |
|
9936-6
|
Q wave depth in lead V6 |
|
8631-4
|
Q wave duration |
|
9937-4
|
Q wave duration in lead AVF |
|
9938-2
|
Q wave duration in lead AVL |
|
9939-0
|
Q wave duration in lead AVR |
|
9940-8
|
Q wave duration in lead I |
|
9941-6
|
Q wave duration in lead II |
|
9942-4
|
Q wave duration in lead III |
|
9943-2
|
Q wave duration in lead V1 |
|
9944-0
|
Q wave duration in lead V2 |
|
9945-7
|
Q wave duration in lead V3 |
|
9946-5
|
Q wave duration in lead V4 |
|
9947-3
|
Q wave duration in lead V5 |
|
9948-1
|
Q wave duration in lead V6 |
|
43163-5
|
Quaternary ammonium compound [Mass/volume] in Unspecified specimen |
|
8632-2
|
QRS axis |
|
18517-3
|
QRS axis.frontal plane Reference beat |
|
18507-4
|
QRS axis.horizontal plane Reference beat |
|
8617-3
|
QRS complex [Interpretation] by EKG |
|
9873-1
|
QRS complex [Interpretation] Narrative by EKG |
|
8633-0
|
QRS duration |
|
44973-6
|
QRS duration {Electrocardiograph lead} |
|
9949-9
|
QRS duration in lead AVF |
|
9950-7
|
QRS duration in lead AVL |
|
9951-5
|
QRS duration in lead AVR |
|
9952-3
|
QRS duration in lead I |
|
9953-1
|
QRS duration in lead II |
|
9954-9
|
QRS duration in lead III |
|
9955-6
|
QRS duration in lead V1 |
|
9956-4
|
QRS duration in lead V2 |
|
9957-2
|
QRS duration in lead V3 |
|
9958-0
|
QRS duration in lead V4 |
|
9959-8
|
QRS duration in lead V5 |
|
9960-6
|
QRS duration in lead V6 |
|
9961-4
|
QRS initial amplitude in lead AVF |
|
9962-2
|
QRS initial amplitude in lead AVL |
|
9963-0
|
QRS initial amplitude in lead AVR |
|
9964-8
|
QRS initial amplitude in lead I |
|
9965-5
|
QRS initial amplitude in lead II |
|
9966-3
|
QRS initial amplitude in lead III |
|
9967-1
|
QRS initial amplitude in lead V1 |
|
9968-9
|
QRS initial amplitude in lead V2 |
|
9969-7
|
QRS initial amplitude in lead V3 |
|
9970-5
|
QRS initial amplitude in lead V4 |
|
9971-3
|
QRS initial amplitude in lead V5 |
|
9972-1
|
QRS initial amplitude in lead V6 |
|
18514-0
|
QRS offset [Time] Reference beat |
|
18513-2
|
QRS onset [Time] Reference beat |
|
9973-9
|
QRS terminal amplitude in lead AVF |
|
9974-7
|
QRS terminal amplitude in lead AVL |
|
9975-4
|
QRS terminal amplitude in lead AVR |
|
9976-2
|
QRS terminal amplitude in lead I |
|
9977-0
|
QRS terminal amplitude in lead II |
|
9978-8
|
QRS terminal amplitude in lead III |
|
9979-6
|
QRS terminal amplitude in lead V1 |
|
9980-4
|
QRS terminal amplitude in lead V2 |
|
9981-2
|
QRS terminal amplitude in lead V3 |
|
9982-0
|
QRS terminal amplitude in lead V4 |
|
9983-8
|
QRS terminal amplitude in lead V5 |
|
9984-6
|
QRS terminal amplitude in lead V6 |
|
8634-8
|
Q-T interval |
|
44975-1
|
Q-T interval {Electrocardiograph lead} |
|
8636-3
|
Q-T interval corrected |
|
76635-2
|
Q-T interval corrected based on Bazett formula |
|
76634-5
|
Q-T interval corrected based on Fridericia formula |
|
18532-2
|
Q-T interval Lead AVF |
|
18533-0
|
Q-T interval Lead AVL |
|
18534-8
|
Q-T interval Lead AVR |
|
18535-5
|
Q-T interval Lead I |
|
18536-3
|
Q-T interval Lead II |
|
18537-1
|
Q-T interval Lead III |
|
18538-9
|
Q-T interval Lead V1 |
|
18539-7
|
Q-T interval Lead V2 |
|
18540-5
|
Q-T interval Lead V3 |
|
18541-3
|
Q-T interval Lead V4 |
|
18542-1
|
Q-T interval Lead V5 |
|
18543-9
|
Q-T interval Lead V6 |
|
7367-6
|
Quack grass IgE Ab [Units/volume] in Serum |
|
15747-9
|
Quack grass IgE Ab RAST class [Presence] in Serum |
|
42799-7
|
Quadrant Breast |
|
91888-8
|
Qualification Volunteer |
|
72093-8
|
Quality of life score [HOOS] |
|
72189-4
|
Quality of life score [KCCQ] |
|
72098-7
|
Quality of life score [KOOS] |
|
88470-0
|
Quality of life score [SAQ] |
|
79431-3
|
Quality of life score change [HOOS] |
|
79436-2
|
Quality of life score change [KOOS] |
|
93088-3
|
Quality of Working Life Questionnaire for Cancer Survivors [Quality of Working Life Questionnaire for Cancer Survivors] |
|
82774-1
|
Quantity prescribed [#] Medication |
|
92034-8
|
Quantity distributed [#] Supply |
|
9391-4
|
Quazepam [Mass/volume] in Serum or Plasma |
|
6222-4
|
Queen Palm IgE Ab [Units/volume] in Serum |
|
15900-4
|
Queen Palm IgE Ab RAST class [Presence] in Serum |
|
50370-6
|
Queen Palm IgE Ab/IgE total in Serum |
|
56365-0
|
Queen Palm IgG4 Ab [Mass/volume] in Serum |
|
86505-5
|
Quest |
|
74468-0
|
Questionnaire form definition Document |
|
74465-6
|
Questionnaire response Document |
|
72968-1
|
QUEtiapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72967-3
|
QUEtiapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
77883-7
|
QUEtiapine cutoff [Mass/volume] in Urine for Confirmatory method |
|
59964-7
|
QUEtiapine [Moles/volume] in Gastric fluid |
|
73183-6
|
QUEtiapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73182-8
|
QUEtiapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59175-0
|
QUEtiapine metabolite [Presence] in Urine |
|
89981-5
|
QUEtiapine [Presence] in Serum or Plasma by Screen method |
|
26776-5
|
QUEtiapine [Mass/volume] in Serum or Plasma |
|
55576-3
|
QUEtiapine [Moles/volume] in Serum or Plasma |
|
74936-6
|
QUEtiapine [Mass/volume] in Serum or Plasma --trough |
|
78877-8
|
QUEtiapine [Mass/volume] in Urine by Confirmatory method |
|
59174-3
|
QUEtiapine [Presence] in Urine |
|
59963-9
|
QUEtiapine [Moles/volume] in Urine |
|
60332-4
|
QUEtiapine [Moles/volume] in Unspecified specimen |
|
10803-5
|
Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |
|
17506-7
|
Quinacrine [Mass/volume] in Serum or Plasma |
|
73181-0
|
Quinapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73180-2
|
Quinapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12546-8
|
Quinethazone [Presence] in Serum or Plasma |
|
12348-9
|
Quinethazone [Presence] in Urine |
|
9392-2
|
Quinethazone [Mass/volume] in Urine |
|
72966-5
|
quiNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72965-7
|
quiNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4014-7
|
quiNIDine [Mass/volume] in Blood |
|
4419-8
|
quiNIDine [Mass] of Dose |
|
29226-8
|
quiNIDine [Mass/volume] in Body fluid |
|
9779-0
|
quiNIDine Free [Mass/volume] in Serum or Plasma |
|
73178-6
|
quiNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73179-4
|
quiNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
21483-3
|
quiNIDine [Mass/volume] in Serum or Plasma --peak |
|
6694-4
|
quiNIDine [Mass/volume] in Serum or Plasma |
|
14899-9
|
quiNIDine [Moles/volume] in Serum or Plasma |
|
4017-0
|
quiNIDine [Mass/volume] in Serum or Plasma --trough |
|
4015-4
|
quiNIDine [Presence] in Urine |
|
17507-5
|
quiNIDine [Mass/volume] in Urine |
|
43832-5
|
quiNIDine [Presence] in Unspecified specimen |
|
4016-2
|
quiNIDine+Quinine [Presence] in Serum or Plasma |
|
18393-9
|
quiNIDine+Quinine [Presence] in Urine |
|
72964-0
|
quiNINE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72963-2
|
quiNINE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4018-8
|
quiNINE [Mass/volume] in Blood |
|
4420-6
|
quiNINE [Mass] of Dose |
|
9810-3
|
quiNINE [Presence] in Gastric fluid |
|
59967-0
|
quiNINE [Moles/volume] in Gastric fluid |
|
33989-5
|
quiNINE induced platelet Ab [Presence] in Serum |
|
73177-8
|
quiNINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73176-0
|
quiNINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4019-6
|
quiNINE [Mass/volume] in Serum or Plasma |
|
59965-4
|
quiNINE [Moles/volume] in Serum or Plasma |
|
4020-4
|
quiNINE [Presence] in Urine |
|
17508-3
|
quiNINE [Units/volume] in Urine |
|
27218-7
|
quiNINE [Mass/volume] in Urine |
|
59966-2
|
quiNINE [Moles/volume] in Urine |
|
43833-3
|
quiNINE [Presence] in Unspecified specimen |
|
57871-6
|
quiNINE [Moles/volume] in Unspecified specimen |
|
25743-6
|
Quinoa IgE Ab [Units/volume] in Serum |
|
25744-4
|
Quinoa IgE Ab RAST class [Presence] in Serum |
|
75077-8
|
Quinolinate [Moles/volume] in Serum or Plasma |
|
48121-8
|
Quinolinate/Creatinine [Molar ratio] in Urine |
|
38724-1
|
Quinoline [Mass/volume] in Air |
|
48296-8
|
Quinoline yellow triggered leukotriene release [Mass/volume] by Leukocytes |
|
33334-4
|
Quinupristin+Dalfopristin [Susceptibility] by Gradient strip |
|
35835-8
|
Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB) |
|
23641-4
|
Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58712-1
|
Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteria |
|
23640-6
|
Quinupristin+Dalfopristin [Susceptibility] |
|
79613-6
|
R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79630-0
|
R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Serum or Plasma Narrative |
|
79580-7
|
R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Urine Narrative |
|
49159-7
|
Rickettsia africae IgG Ab [Titer] in Body fluid |
|
48903-9
|
Rickettsia africae IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49161-3
|
Rickettsia africae IgG Ab [Titer] in Serum |
|
48858-5
|
Rickettsia africae IgG Ab [Titer] in Serum by Immunofluorescence |
|
49160-5
|
Rickettsia africae IgM Ab [Titer] in Body fluid |
|
48902-1
|
Rickettsia africae IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49162-1
|
Rickettsia africae IgM Ab [Titer] in Serum |
|
48857-7
|
Rickettsia africae IgM Ab [Titer] in Serum by Immunofluorescence |
|
29681-4
|
Rickettsia akari Ab [Presence] in Serum |
|
29708-5
|
Rickettsia akari Ab [Presence] in Serum by Immunofluorescence |
|
31595-2
|
Rickettsia akari Ab [Units/volume] in Serum |
|
29680-6
|
Rickettsia akari Ab [Titer] in Serum |
|
29707-7
|
Rickettsia akari Ab [Titer] in Serum by Immunofluorescence |
|
49158-9
|
Rickettsia akari IgG Ab [Titer] in Body fluid |
|
48904-7
|
Rickettsia akari IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49157-1
|
Rickettsia akari IgG Ab [Titer] in Serum |
|
48859-3
|
Rickettsia akari IgG Ab [Titer] in Serum by Immunofluorescence |
|
49156-3
|
Rickettsia akari IgM Ab [Titer] in Body fluid |
|
48905-4
|
Rickettsia akari IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49155-5
|
Rickettsia akari IgM Ab [Titer] in Serum |
|
48860-1
|
Rickettsia akari IgM Ab [Titer] in Serum by Immunofluorescence |
|
26651-0
|
Rhizopus arrhizus Ab [Presence] in Serum |
|
29669-9
|
Rickettsia australis Ab [Presence] in Serum |
|
29649-1
|
Rickettsia australis Ab [Presence] in Serum by Immunofluorescence |
|
31596-0
|
Rickettsia australis Ab [Units/volume] in Serum |
|
29668-1
|
Rickettsia australis Ab [Titer] in Serum |
|
29648-3
|
Rickettsia australis Ab [Titer] in Serum by Immunofluorescence |
|
26624-7
|
Rickettsia conorii Ab [Presence] in Serum |
|
29702-8
|
Rickettsia conorii Ab [Presence] in Serum by Immunofluorescence |
|
31597-8
|
Rickettsia conorii Ab [Units/volume] in Serum |
|
29678-0
|
Rickettsia conorii Ab [Titer] in Serum |
|
29665-7
|
Rickettsia conorii Ab [Titer] in Serum by Immunofluorescence |
|
51804-3
|
Rickettsia conorii IgG Ab [Units/volume] in Serum by Immunoassay |
|
87924-7
|
Rickettsia conorii IgG Ab [Presence] in Serum by Immunoassay |
|
13199-5
|
Rickettsia conorii IgG Ab [Units/volume] in Serum |
|
58809-5
|
Rickettsia conorii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49154-8
|
Rickettsia conorii IgG Ab [Titer] in Body fluid |
|
48907-0
|
Rickettsia conorii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
21492-4
|
Rickettsia conorii IgG Ab [Titer] in Serum |
|
25749-3
|
Rickettsia conorii IgG Ab [Titer] in Serum by Immunofluorescence |
|
51805-0
|
Rickettsia conorii IgM Ab [Units/volume] in Serum by Immunoassay |
|
87923-9
|
Rickettsia conorii IgM Ab [Presence] in Serum by Immunoassay |
|
13200-1
|
Rickettsia conorii IgM Ab [Units/volume] in Serum |
|
49153-0
|
Rickettsia conorii IgM Ab [Titer] in Body fluid |
|
48906-2
|
Rickettsia conorii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
21493-2
|
Rickettsia conorii IgM Ab [Titer] in Serum |
|
25750-1
|
Rickettsia conorii IgM Ab [Titer] in Serum by Immunofluorescence |
|
31587-9
|
Rhodococcus equi Ab [Presence] in Serum |
|
26735-1
|
Rhodococcus equi Ab [Presence] in Serum by Immune diffusion (ID) |
|
31586-1
|
Rhodococcus equi Ab [Units/volume] in Serum |
|
23775-0
|
Rhodococcus equi Ab [Titer] in Serum |
|
29671-5
|
Rickettsia honei Ab [Presence] in Serum |
|
29651-7
|
Rickettsia honei Ab [Presence] in Serum by Immunofluorescence |
|
31598-6
|
Rickettsia honei Ab [Units/volume] in Serum |
|
29670-7
|
Rickettsia honei Ab [Titer] in Serum |
|
29650-9
|
Rickettsia honei Ab [Titer] in Serum by Immunofluorescence |
|
6229-9
|
Rhizopus nigricans IgE Ab [Units/volume] in Serum |
|
15991-3
|
Rhizopus nigricans IgE Ab RAST class [Presence] in Serum |
|
61308-3
|
Rhizopus nigricans IgE Ab/IgE total in Serum |
|
18411-9
|
Rhizopus nigricans IgG Ab [Units/volume] in Serum |
|
33312-0
|
Rhizopus nigricans IgG Ab RAST class [Presence] in Serum |
|
35552-9
|
Rhizopus nigricans IgG Ab [Mass/volume] in Serum |
|
49149-8
|
Rickettsia parkeri IgG Ab [Titer] in Body fluid |
|
48909-6
|
Rickettsia parkeri IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49151-4
|
Rickettsia parkeri IgG Ab [Titer] in Serum |
|
48862-7
|
Rickettsia parkeri IgG Ab [Titer] in Serum by Immunofluorescence |
|
49150-6
|
Rickettsia parkeri IgM Ab [Titer] in Body fluid |
|
48908-8
|
Rickettsia parkeri IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49152-2
|
Rickettsia parkeri IgM Ab [Titer] in Serum |
|
48861-9
|
Rickettsia parkeri IgM Ab [Titer] in Serum by Immunofluorescence |
|
6542-5
|
Rickettsia prowazekii Ab [Units/volume] in Serum by Complement fixation |
|
29683-0
|
Rickettsia prowazekii Ab [Presence] in Serum |
|
29710-1
|
Rickettsia prowazekii Ab [Presence] in Serum by Immunofluorescence |
|
7995-4
|
Rickettsia prowazekii Ab [Units/volume] in Serum |
|
29682-2
|
Rickettsia prowazekii Ab [Titer] in Serum |
|
29709-3
|
Rickettsia prowazekii Ab [Titer] in Serum by Immunofluorescence |
|
31599-4
|
Rickettsia prowazekii IgG Ab [Units/volume] in Serum |
|
49148-0
|
Rickettsia prowazekii IgG Ab [Titer] in Body fluid |
|
48911-2
|
Rickettsia prowazekii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
25603-2
|
Rickettsia prowazekii IgG Ab [Titer] in Serum |
|
25751-9
|
Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunofluorescence |
|
31600-0
|
Rickettsia prowazekii IgM Ab [Units/volume] in Serum |
|
49147-2
|
Rickettsia prowazekii IgM Ab [Titer] in Body fluid |
|
48910-4
|
Rickettsia prowazekii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
25604-0
|
Rickettsia prowazekii IgM Ab [Titer] in Serum |
|
25752-7
|
Rickettsia prowazekii IgM Ab [Titer] in Serum by Immunofluorescence |
|
7996-2
|
Rickettsia prowazekii RNA [Presence] in Serum by NAA with probe detection |
|
26670-0
|
Rhizomucor pusillus Ab [Presence] in Serum |
|
31604-2
|
Rickettsia rickettsii Ab [Presence] in Serum |
|
29706-9
|
Rickettsia rickettsii Ab [Presence] in Serum by Immunofluorescence |
|
31603-4
|
Rickettsia rickettsii Ab [Units/volume] in Serum |
|
29737-4
|
Rickettsia rickettsii Ab [Titer] in Serum |
|
29705-1
|
Rickettsia rickettsii Ab [Titer] in Serum by Immunofluorescence |
|
6543-3
|
Rickettsia rickettsii Ag [Identifier] in Tissue by Immunofluorescence |
|
48868-4
|
Rickettsia rickettsii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
18429-1
|
Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid |
|
42968-8
|
Rickettsia rickettsii IgG Ab [Presence] in Serum |
|
41476-3
|
Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay |
|
8003-6
|
Rickettsia rickettsii IgG Ab [Units/volume] in Serum |
|
47477-5
|
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid |
|
47069-0
|
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49145-6
|
Rickettsia rickettsii IgG Ab [Titer] in Body fluid |
|
48913-8
|
Rickettsia rickettsii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
22482-4
|
Rickettsia rickettsii IgG Ab [Titer] in Serum |
|
5307-4
|
Rickettsia rickettsii IgG Ab [Titer] in Serum by Immunofluorescence |
|
18430-9
|
Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid |
|
42969-6
|
Rickettsia rickettsii IgM Ab [Presence] in Serum |
|
41475-5
|
Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay |
|
8004-4
|
Rickettsia rickettsii IgM Ab [Units/volume] in Serum |
|
47478-3
|
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid |
|
47070-8
|
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49146-4
|
Rickettsia rickettsii IgM Ab [Titer] in Body fluid |
|
48912-0
|
Rickettsia rickettsii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
22483-2
|
Rickettsia rickettsii IgM Ab [Titer] in Serum |
|
5308-2
|
Rickettsia rickettsii IgM Ab [Titer] in Serum by Immunofluorescence |
|
8005-1
|
Rickettsia rickettsii RNA [Presence] in Serum by NAA with probe detection |
|
11482-7
|
Rickettsia rickettsii RNA [Presence] in Tissue by NAA with probe detection |
|
29736-6
|
Rickettsia sibirica Ab [Presence] in Serum |
|
29704-4
|
Rickettsia sibirica Ab [Presence] in Serum by Immunofluorescence |
|
31605-9
|
Rickettsia sibirica Ab [Units/volume] in Serum |
|
29679-8
|
Rickettsia sibirica Ab [Titer] in Serum |
|
29703-6
|
Rickettsia sibirica Ab [Titer] in Serum by Immunofluorescence |
|
17539-8
|
Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination |
|
29685-5
|
Rickettsia typhi Ab [Presence] in Serum |
|
29712-7
|
Rickettsia typhi Ab [Presence] in Serum by Immunofluorescence |
|
22486-5
|
Rickettsia typhi Ab [Units/volume] in Serum |
|
29684-8
|
Rickettsia typhi Ab [Titer] in Serum |
|
29711-9
|
Rickettsia typhi Ab [Titer] in Serum by Immunofluorescence |
|
66718-8
|
Rickettsia typhi and Rickettsia spotted fever group IgG and IgM [Interpretation] in Unspecified specimen |
|
17540-6
|
Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence |
|
22487-3
|
Rickettsia typhi IgA Ab [Units/volume] in Serum |
|
29321-7
|
Rickettsia typhi IgG Ab [Presence] in Body fluid |
|
22488-1
|
Rickettsia typhi IgG Ab [Presence] in Serum |
|
17541-4
|
Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay |
|
56881-6
|
Rickettsia typhi IgG Ab [Presence] in Serum by Immunofluorescence |
|
8007-7
|
Rickettsia typhi IgG Ab [Units/volume] in Serum |
|
24279-2
|
Rickettsia typhi IgG Ab [Titer] in Serum --1st specimen |
|
24205-7
|
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24280-0
|
Rickettsia typhi IgG Ab [Titer] in Serum --2nd specimen |
|
24206-5
|
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
47479-1
|
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid |
|
47065-8
|
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
31076-3
|
Rickettsia typhi IgG Ab [Titer] in Body fluid |
|
48914-6
|
Rickettsia typhi IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
22489-9
|
Rickettsia typhi IgG Ab [Titer] in Serum |
|
5324-9
|
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence |
|
29322-5
|
Rickettsia typhi IgM Ab [Presence] in Body fluid |
|
31611-7
|
Rickettsia typhi IgM Ab [Units/volume] in Body fluid |
|
33001-9
|
Rickettsia typhi IgM Ab [Presence] in Serum |
|
8008-5
|
Rickettsia typhi IgM Ab [Units/volume] in Serum |
|
47480-9
|
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid |
|
47067-4
|
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
31077-1
|
Rickettsia typhi IgM Ab [Titer] in Body fluid |
|
48915-3
|
Rickettsia typhi IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
22490-7
|
Rickettsia typhi IgM Ab [Titer] in Serum |
|
5325-6
|
Rickettsia typhi IgM Ab [Titer] in Serum by Immunofluorescence |
|
10010-7
|
R' wave amplitude in lead AVF |
|
9985-3
|
R wave amplitude in lead AVF |
|
10011-5
|
R' wave amplitude in lead AVL |
|
9986-1
|
R wave amplitude in lead AVL |
|
10012-3
|
R' wave amplitude in lead AVR |
|
9987-9
|
R wave amplitude in lead AVR |
|
10013-1
|
R' wave amplitude in lead I |
|
9988-7
|
R wave amplitude in lead I |
|
10014-9
|
R' wave amplitude in lead II |
|
9989-5
|
R wave amplitude in lead II |
|
10015-6
|
R' wave amplitude in lead III |
|
9990-3
|
R wave amplitude in lead III |
|
10016-4
|
R' wave amplitude in lead V1 |
|
9991-1
|
R wave amplitude in lead V1 |
|
10017-2
|
R' wave amplitude in lead V2 |
|
9992-9
|
R wave amplitude in lead V2 |
|
10018-0
|
R' wave amplitude in lead V3 |
|
9993-7
|
R wave amplitude in lead V3 |
|
10019-8
|
R' wave amplitude in lead V4 |
|
9994-5
|
R wave amplitude in lead V4 |
|
10020-6
|
R' wave amplitude in lead V5 |
|
9995-2
|
R wave amplitude in lead V5 |
|
76636-0
|
R wave amplitude.V5+S wave amplitude.V1 |
|
10021-4
|
R' wave amplitude in lead V6 |
|
9996-0
|
R wave amplitude in lead V6 |
|
76646-9
|
R wave amplitude.V6+S wave amplitude.V1 |
|
9997-8
|
R wave axis |
|
18508-2
|
R wave axis.horizontal plane |
|
10022-2
|
R' wave duration in lead AVF |
|
9998-6
|
R wave duration in lead AVF |
|
10023-0
|
R' wave duration in lead AVL |
|
9999-4
|
R wave duration in lead AVL |
|
10024-8
|
R' wave duration in lead AVR |
|
10000-8
|
R wave duration in lead AVR |
|
10025-5
|
R' wave duration in lead I |
|
10001-6
|
R wave duration in lead I |
|
10026-3
|
R' wave duration in lead II |
|
10002-4
|
R wave duration in lead II |
|
10027-1
|
R' wave duration in lead III |
|
10003-2
|
R wave duration in lead III |
|
10028-9
|
R' wave duration in lead V1 |
|
10004-0
|
R wave duration in lead V1 |
|
10029-7
|
R' wave duration in lead V2 |
|
10005-7
|
R wave duration in lead V2 |
|
10030-5
|
R' wave duration in lead V3 |
|
10006-5
|
R wave duration in lead V3 |
|
10031-3
|
R' wave duration in lead V4 |
|
10007-3
|
R wave duration in lead V4 |
|
10032-1
|
R' wave duration in lead V5 |
|
10008-1
|
R wave duration in lead V5 |
|
10033-9
|
R' wave duration in lead V6 |
|
10009-9
|
R wave duration in lead V6 |
|
17988-7
|
Right atrial Apical 4 chamber [Area] by US 2D |
|
76064-5
|
Rheumatoid arthritis disease activity score confidence interval by VectraDA |
|
75634-6
|
Rheumatoid arthritis disease activity score level Qualitative by VectraDA |
|
75633-8
|
Rheumatoid arthritis disease activity score Calculated by VectraDA |
|
20346-3
|
Right atrial Diastolic filling period by US |
|
80075-5
|
Right atrial Area at end systole by US.2D.A4C+Measured by planimetry |
|
80076-3
|
Right atrial Major axis at end systole [Length] by US.2D.A4C |
|
80078-9
|
Right atrial Minor axis at end systole (by US.2D.A4C)/Body surface area |
|
80077-1
|
Right atrial Minor axis at end systole [Length] by US.2D.A4C |
|
93635-1
|
Right atrial End-systolic volume by US.2D.A4C |
|
82337-7
|
Right atrial Intrachamber pressure estimated by US |
|
20297-8
|
Right atrial Intrachamber diastole pressure by Estimated from jugular venous distention |
|
18069-5
|
Right atrial Intrachamber mean systole pressure by Estimated from jugular venous distention |
|
18070-3
|
Right atrial Intrachamber mean systole pressure by US |
|
17532-3
|
Rheumatoid arthritis nuclear Ab [Presence] in Serum |
|
9839-2
|
Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17533-1
|
Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence |
|
11571-7
|
Rheumatoid arthritis nuclear Ab [Units/volume] in Serum |
|
56977-2
|
Rheumatoid arthritis nuclear Ab [Titer] in Serum by Immunofluorescence |
|
60996-6
|
Right atrial pressure |
|
60997-4
|
Right atrial pressure Diastolic |
|
60998-2
|
Right atrial pressure Systolic |
|
29466-0
|
Right atrial Superior-Inferior [Length] by US.2D.A4C |
|
50960-4
|
Rabbit Ab [Presence] in Serum |
|
50961-2
|
Rabbit Ab [Titer] in Serum |
|
7641-4
|
Rabbit Bush IgE Ab [Units/volume] in Serum |
|
15970-7
|
Rabbit Bush IgE Ab RAST class [Presence] in Serum |
|
43422-5
|
Rabbit dander IgE Ab [Units/volume] in Serum |
|
6223-2
|
Rabbit epithelium IgE Ab [Units/volume] in Serum |
|
15971-5
|
Rabbit epithelium IgE Ab RAST class [Presence] in Serum |
|
39606-9
|
Rabbit epithelium IgE Ab/IgE total in Serum |
|
56367-6
|
Rabbit epithelium IgG4 Ab [Mass/volume] in Serum |
|
39805-7
|
Rabbit hair IgE Ab [Units/volume] in Serum |
|
56366-8
|
Rabbit IgG4 Ab [Mass/volume] in Serum |
|
63113-5
|
Rabbit IgG Ab [Mass/volume] in Serum |
|
7642-2
|
Rabbit meat IgE Ab [Units/volume] in Serum |
|
15969-9
|
Rabbit meat IgE Ab RAST class [Presence] in Serum |
|
10960-3
|
Rabbit serum proteins IgE Ab [Units/volume] in Serum |
|
15972-3
|
Rabbit serum proteins IgE Ab RAST class [Presence] in Serum |
|
10961-1
|
Rabbit urine proteins IgE Ab [Units/volume] in Serum |
|
15973-1
|
Rabbit urine proteins IgE Ab RAST class [Presence] in Serum |
|
73174-5
|
RABEprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73175-2
|
RABEprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
70856-0
|
Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
6523-5
|
Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Neutralization test |
|
70857-8
|
Rabies virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
70859-4
|
Rabies virus Ab [Presence] in Cerebral spinal fluid by Neutralization test |
|
6522-7
|
Rabies virus Ab [Units/volume] in Cerebral spinal fluid |
|
43590-9
|
Rabies virus Ab [Units/volume] in Serum by Immunoassay |
|
6524-3
|
Rabies virus Ab [Units/volume] in Serum by Neutralization test |
|
30553-2
|
Rabies virus Ab [Presence] in Serum |
|
41507-5
|
Rabies virus Ab [Presence] in Serum by Immunoassay |
|
70858-6
|
Rabies virus Ab [Presence] in Serum by Neutralization test |
|
5288-6
|
Rabies virus Ab [Units/volume] in Serum |
|
6525-0
|
Rabies virus Ab [Units/volume] in Tissue by Neutralization test |
|
22458-4
|
Rabies virus Ab [Units/volume] in Tissue |
|
14128-3
|
Rabies virus Ab [Titer] in Serum |
|
43980-2
|
Rabies virus Ab [Titer] in Serum by Neutralization test |
|
6527-6
|
Rabies virus Ab [Units/volume] in Unspecified specimen by Neutralization test |
|
6526-8
|
Rabies virus Ab [Units/volume] in Unspecified specimen |
|
31946-7
|
Rabies virus Ag [Presence] in Brain |
|
23389-0
|
Rabies virus Ag [Presence] in Brain by Immunoassay |
|
23390-8
|
Rabies virus Ag [Presence] in Brain by Immune stain |
|
88211-8
|
Rabies virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
91075-2
|
Rabies virus Ag [Presence] in Saliva (oral fluid) by Immunoassay |
|
6529-2
|
Rabies virus Ag [Units/volume] in Tissue by Immunofluorescence |
|
91076-0
|
Rabies virus Ag [Presence] in Tissue by Immunoassay |
|
6528-4
|
Rabies virus Ag [Presence] in Tissue by Immunofluorescence |
|
6533-4
|
Rabies virus Ag [Units/volume] in Unspecified specimen by Immunofluorescence |
|
31947-5
|
Rabies virus Ag [Presence] in Unspecified specimen |
|
6532-6
|
Rabies virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23391-6
|
Rabies virus Ag [Presence] in Unspecified specimen by Immune stain |
|
31948-3
|
Rabies virus Ag [Units/volume] in Unspecified specimen |
|
23388-2
|
Rabies virus [Presence] in Brain by Light microscopy |
|
70860-2
|
Rabies virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
70861-0
|
Rabies virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
41128-0
|
Rabies virus IgG Ab [Presence] in Serum |
|
86587-3
|
Rabies virus IgG Ab [Presence] in Serum by Immunoassay |
|
40742-9
|
Rabies virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
58023-3
|
Rabies virus IgG Ab [Units/volume] in Serum |
|
70862-8
|
Rabies virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
70863-6
|
Rabies virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
70865-1
|
Rabies virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
70864-4
|
Rabies virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
86588-1
|
Rabies virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
60270-6
|
Rabies virus RNA [Presence] in Isolate by NAA with probe detection |
|
88215-9
|
Rabies virus RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
|
88214-2
|
Rabies virus RNA [Presence] in Tissue by NAA with probe detection |
|
51646-8
|
Rabies virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
51647-6
|
Rabies virus RNA [Presence] in Unspecified specimen by Probe |
|
70866-9
|
Rabies virus strain identified in Unspecified specimen by Immunofluorescence |
|
70867-7
|
Rabies virus strain identified in Unspecified specimen by Sequencing |
|
6536-7
|
Rabies virus identified in Tissue by Organism specific culture |
|
6539-1
|
Rabies virus identified in Unspecified specimen by Organism specific culture |
|
74693-3
|
Race [AHRQ] |
|
86805-9
|
Race and ethnicity information Document |
|
53720-9
|
Race NAPIIA |
|
72826-1
|
Race OMB.1997 |
|
76663-4
|
Race or ethnicity of Provider [NMMDS] |
|
59362-4
|
Race or ethnicity OMB.1997 |
|
73569-6
|
Radiation exposure and protection information [Description] Document Diagnostic imaging |
|
85332-5
|
Radial position in breast [Angle] in Breast cancer specimen |
|
85287-1
|
Radial position of closest mucosal margin involved by invasive carcinoma [Angle] in Colorectal cancer specimen by Light microscopy |
|
85288-9
|
Radial position of closest uninvolved mucosal margin [Angle] in Colorectal cancer specimen by Light microscopy |
|
83697-3
|
Radiation oncology Attending Note |
|
77304-4
|
Radiation dose [Energy/mass] |
|
83593-4
|
Radiation oncology Nurse Education note |
|
83594-2
|
Radiation oncology Nurse Note |
|
34831-8
|
Radiation oncology Consult note |
|
78572-5
|
Radiation oncology Diagnostic study note |
|
78595-6
|
Radiation oncology Education note |
|
78628-5
|
Radiation oncology Flowsheet |
|
83917-5
|
Radiation oncology Hospital Note |
|
68603-0
|
Radiation oncology Hospital Summary note |
|
78653-3
|
Radiation oncology Initial evaluation note |
|
34832-6
|
Radiation oncology Note |
|
83918-3
|
Radiation oncology Outpatient Note |
|
83919-1
|
Radiation oncology Telephone encounter Note |
|
80785-9
|
Radiation oncology Plan of care note |
|
78656-6
|
Radiation oncology procedure note |
|
78665-7
|
Radiation oncology Progress note |
|
57159-6
|
Radiation oncology Referral note |
|
68602-2
|
Radiation oncology Summary note |
|
83775-7
|
Radiation oncology Resident Note |
|
83920-9
|
Radiation oncology Therapist Note |
|
33766-7
|
Radioactivity [Presence] in Urine --pre dose radioactive cyanocobalamin |
|
85255-8
|
Radiology Administrative note |
|
85256-6
|
Radiology Attending Note |
|
18834-2
|
Radiology Comparison study (narrative) |
|
73575-3
|
Radiology Consult note |
|
68604-8
|
Radiology Diagnostic study note |
|
85257-4
|
Radiology Education note |
|
19005-8
|
Radiology Imaging study [Impression] (narrative) |
|
93152-7
|
Radiology Initial evaluation note |
|
75490-3
|
Radiology Note |
|
85258-2
|
Radiology Nurse Education note |
|
85259-0
|
Radiology Nurse Note |
|
85260-8
|
Radiology Nurse procedure note |
|
85263-2
|
Radiology Telephone encounter Note |
|
90351-8
|
Radiology Postoperative evaluation and management note |
|
86450-4
|
Radiology Preoperative evaluation and management note |
|
85261-6
|
Radiology procedure note |
|
18783-1
|
Radiology Study recommendation (narrative) |
|
93151-9
|
Radiology Team Conference note |
|
85262-4
|
Radiology Technician Note |
|
7643-0
|
Radish IgE Ab [Units/volume] in Serum |
|
15974-9
|
Radish IgE Ab RAST class [Presence] in Serum |
|
7644-8
|
Radish IgG Ab [Units/volume] in Serum |
|
21485-8
|
Radish IgG Ab RAST class [Presence] in Serum |
|
56368-4
|
Radish IgG4 Ab [Mass/volume] in Serum |
|
60397-7
|
Radish IgG Ab [Mass/volume] in Serum |
|
93127-9
|
Risk adjustment factor [Score] |
|
82537-2
|
RAF1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
70033-6
|
Ragocytes/100 leukocytes in Synovial fluid by Manual count |
|
17785-7
|
Radioactive iodine.thyroid/Radioactive iodine dose [Ratio] |
|
73750-2
|
RAI1 gene 17p11.2 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
|
51759-9
|
RAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
17510-9
|
Raisin IgE Ab [Units/volume] in Serum |
|
90295-7
|
RalA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
73173-7
|
Raloxifene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73172-9
|
Raloxifene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72525-9
|
Raltegravir [Susceptibility] by Genotype method |
|
61198-8
|
Raltegravir [Susceptibility] by Phenotype method |
|
72835-2
|
Raltegravir [Mass/volume] in Serum or Plasma |
|
59314-5
|
Ramelteon [Mass/volume] in Blood |
|
59316-0
|
Ramelteon [Mass/volume] in Body fluid |
|
59313-7
|
Ramelteon M-II [Mass/volume] in Blood |
|
59315-2
|
Ramelteon M-II [Mass/volume] in Body fluid |
|
59317-8
|
Ramelteon M-II [Mass/volume] in Serum or Plasma |
|
59319-4
|
Ramelteon M-II [Mass/mass] in Tissue |
|
59321-0
|
Ramelteon M-II [Mass/volume] in Urine |
|
59318-6
|
Ramelteon [Mass/volume] in Serum or Plasma |
|
59320-2
|
Ramelteon [Mass/mass] in Tissue |
|
59322-8
|
Ramelteon [Mass/volume] in Urine |
|
72962-4
|
Ramipril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72961-6
|
Ramipril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73171-1
|
Ramipril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73170-3
|
Ramipril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41711-3
|
Ramoplanin [Susceptibility] by Gradient strip |
|
41712-1
|
Ramoplanin [Susceptibility] by Disk diffusion (KB) |
|
41710-5
|
Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41737-8
|
Ramoplanin [Susceptibility] |
|
92851-5
|
Range of motion in the last 7 days Lower extremity [CMS Assessment] |
|
92850-7
|
Range of motion in the last 7 days Upper extremity [CMS Assessment] |
|
54755-4
|
Range of motion Lower extremity [CMS Assessment] |
|
54754-7
|
Range of motion Upper extremity [CMS Assessment] |
|
72960-8
|
raNITIdine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72959-0
|
raNITIdine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14900-5
|
raNITIdine [Presence] in Gastric fluid |
|
73168-7
|
raNITIdine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73169-5
|
raNITIdine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14901-3
|
raNITIdine [Presence] in Serum or Plasma |
|
6950-0
|
raNITIdine [Mass/volume] in Serum or Plasma |
|
14902-1
|
raNITIdine [Presence] in Urine |
|
32127-3
|
raNITIdine [Presence] in Unspecified specimen |
|
11194-8
|
Rape Pollen IgE Ab [Units/volume] in Serum |
|
21486-6
|
Rape Pollen IgE Ab RAST class [Presence] in Serum |
|
11195-5
|
Rapeseed IgE Ab [Units/volume] in Serum |
|
15982-2
|
Rapeseed IgE Ab RAST class [Presence] in Serum |
|
93005-7
|
Rapid alternating hand movements - left+right mean [Score] |
|
79428-9
|
Rapid response team Consult note |
|
89814-8
|
Rapid response team procedure note |
|
89813-0
|
Rapid response team Progress note |
|
43427-4
|
Microscopic observation [Identifier] in Tissue by Rapid stain |
|
78224-3
|
RARA gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78217-7
|
RARA gene rearrangements [Presence] in Blood or Tissue by FISH |
|
81269-3
|
Rash duration |
|
85731-8
|
Rash duration in Mother |
|
7658-8
|
Raspberry triggered histamine release [Units/volume] in Blood |
|
7656-2
|
Raspberry IgE Ab [Units/volume] in Serum |
|
15983-0
|
Raspberry IgE Ab RAST class [Presence] in Serum |
|
7657-0
|
Raspberry IgG Ab [Units/volume] in Serum |
|
56373-4
|
Raspberry IgG4 Ab [Mass/volume] in Serum |
|
63083-0
|
Raspberry IgG Ab [Mass/volume] in Serum |
|
6934-4
|
RAST class [Presence] in Serum |
|
6224-0
|
Rat epithelium IgE Ab [Units/volume] in Serum |
|
15984-8
|
Rat epithelium IgE Ab RAST class [Presence] in Serum |
|
56374-2
|
Rat epithelium IgG4 Ab [Mass/volume] in Serum |
|
19753-3
|
Rat epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
|
43373-0
|
Rat epithelium, serum proteins + urine proteins IgE Ab RAST class [Presence] in Serum |
|
7659-6
|
Rat hair IgE Ab [Units/volume] in Serum |
|
7660-4
|
Rat muliialgro IgE Ab [Units/volume] in Serum |
|
6225-7
|
Rat serum proteins IgE Ab [Units/volume] in Serum |
|
15985-5
|
Rat serum proteins IgE Ab RAST class [Presence] in Serum |
|
6226-5
|
Rat urine proteins IgE Ab [Units/volume] in Serum |
|
15986-3
|
Rat urine proteins IgE Ab RAST class [Presence] in Serum |
|
61346-3
|
Rat urine proteins IgE Ab/IgE total in Serum |
|
75901-9
|
Rate all your child's health care in the last 12 months [AHRQ] |
|
75412-7
|
Rate all your health care in the last 12 months [AHRQ] |
|
54834-7
|
Rate pain severity in last 5 days using verbal descriptor scale [CMS Assessment] |
|
73635-5
|
Razupenem [Susceptibility] by Disk diffusion (KB) |
|
73612-4
|
Razupenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73590-2
|
Razupenem [Susceptibility] |
|
42795-5
|
Retinoblastoma protein [Presence] in Tissue by Immune stain |
|
21731-5
|
RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47416-3
|
RB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21732-3
|
RB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
79629-2
|
R-beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
79615-1
|
R-beta aminoisobutyrate [Moles/volume] in Serum or Plasma |
|
79622-7
|
R-beta aminoisobutyrate/Creatinine [Molar ratio] in Urine |
|
55779-3
|
Erythrocytes [#/volume] in Amniotic fluid |
|
26453-1
|
Erythrocytes [#/volume] in Blood |
|
789-8
|
Erythrocytes [#/volume] in Blood by Automated count |
|
62240-7
|
Erythrocytes [#/volume] in Blood from Fetus by Automated count |
|
790-6
|
Erythrocytes [#/volume] in Blood by Manual count |
|
47280-3
|
Erythrocytes [#/volume] in Cord blood |
|
26454-9
|
Erythrocytes [#/volume] in Cerebral spinal fluid |
|
791-4
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Automated count |
|
792-2
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
81640-5
|
Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count |
|
40534-0
|
Erythrocytes [#/volume] in Peritoneal dialysis fluid by Manual count |
|
57841-9
|
Erythrocytes [#/volume] in Dialysis fluid by Automated count |
|
53517-9
|
Erythrocytes [#/volume] in Dialysis fluid by Manual count |
|
26455-6
|
Erythrocytes [#/volume] in Body fluid |
|
23860-0
|
Erythrocytes [#/volume] in Body fluid by Automated count |
|
6741-3
|
Erythrocytes [#/volume] in Body fluid by Manual count |
|
30387-5
|
Erythrocytes [#/volume] in Gastric fluid |
|
14372-7
|
Erythrocytes [#/volume] in Gastric fluid by Manual count |
|
82588-5
|
Erythrocytes [#/volume] in Bone marrow by Automated count |
|
30388-3
|
Erythrocytes [#/volume] in Pericardial fluid |
|
57842-7
|
Erythrocytes [#/volume] in Pericardial fluid by Automated count |
|
14713-2
|
Erythrocytes [#/volume] in Pericardial fluid by Manual count |
|
26456-4
|
Erythrocytes [#/volume] in Pleural fluid |
|
794-8
|
Erythrocytes [#/volume] in Pleural fluid by Automated count |
|
67831-8
|
Erythrocytes [#/volume] in Pleural fluid from Fetus |
|
793-0
|
Erythrocytes [#/volume] in Pleural fluid by Manual count |
|
26457-2
|
Erythrocytes [#/volume] in Peritoneal fluid |
|
57843-5
|
Erythrocytes [#/volume] in Peritoneal fluid by Automated count |
|
795-5
|
Erythrocytes [#/volume] in Peritoneal fluid by Manual count |
|
30389-1
|
Erythrocytes [#/volume] in Seminal plasma |
|
16828-6
|
Erythrocytes [#/volume] in Seminal plasma by Manual count |
|
43245-0
|
Erythrocytes [#/volume] in Semen by Light microscopy |
|
26458-0
|
Erythrocytes [#/volume] in Synovial fluid |
|
796-3
|
Erythrocytes [#/volume] in Synovial fluid by Automated count |
|
797-1
|
Erythrocytes [#/volume] in Synovial fluid by Manual count |
|
30391-7
|
Erythrocytes [#/volume] in Urine |
|
798-9
|
Erythrocytes [#/volume] in Urine by Automated count |
|
799-7
|
Erythrocytes [#/volume] in Urine by Manual count |
|
20409-9
|
Erythrocytes [#/volume] in Urine by Test strip |
|
57747-8
|
Erythrocytes [#/volume] in Urine by Automated test strip |
|
5808-1
|
Erythrocytes [#/volume] in Urine sediment by Microscopy high power field |
|
68435-7
|
Erythrocytes [#/volume] in Vitreous fluid by Automated count |
|
23859-2
|
Erythrocytes [#/volume] in Unspecified specimen by Light microscopy |
|
51910-8
|
Erythrocytes [#/area] in Bronchoalveolar lavage by Microscopy high power field |
|
58767-5
|
Erythrocytes [#/area] in Semen by Microscopy high power field |
|
75237-8
|
Erythrocytes [#/area] in Synovial fluid by Microscopy high power field |
|
51382-0
|
Erythrocytes [#/area] in Synovial fluid by Light microscopy |
|
46419-8
|
Erythrocytes [#/area] in Urine sediment by Automated count |
|
13945-1
|
Erythrocytes [#/area] in Urine sediment by Microscopy high power field |
|
44242-6
|
Erythrocytes [#/area] in Vaginal fluid by Wet preparation |
|
68902-6
|
Erythrocytes [#/volume] by Light microscopy in Urine sediment collected for unspecified duration |
|
68903-4
|
Erythrocytes by Light microscopy in Urine sediment collected for unspecified duration |
|
68912-5
|
Erythrocytes in 24 hour Urine sediment by Light microscopy |
|
59830-0
|
Erythrocytes in 3 hour Urine sediment by Light microscopy |
|
50670-9
|
Erythrocyte agglutination [Presence] in Blood |
|
19098-3
|
Erythrocytes [Presence] in Amniotic fluid |
|
11273-0
|
Erythrocytes [Morphology] in Blood by Automated count |
|
53285-3
|
RBC casts [#/volume] in Urine by Computer assisted method |
|
33229-6
|
RBC casts [#/area] in Urine by Computer assisted method |
|
88970-9
|
RBC casts [#/area] in Urine sediment |
|
51790-4
|
RBC casts [#/area] in Urine sediment by Microscopy high power field |
|
5807-3
|
RBC casts [#/area] in Urine sediment by Microscopy low power field |
|
53278-8
|
RBC casts [Presence] in Urine by Computer assisted method |
|
33804-6
|
RBC casts [Presence] in Urine sediment by Light microscopy |
|
90738-6
|
Erythrocytes.CD59 complete loss/100 erythrocytes in Blood |
|
33662-8
|
Erythrocytes.CD59 deficient/100 erythrocytes in Blood |
|
75819-3
|
Erythrocyte chromasia [Identifier] in Blood by Light microscopy |
|
53360-4
|
Erythrocyte clumps [#/volume] in Urine by Computer assisted method |
|
53358-8
|
Erythrocyte clumps [#/area] in Urine by Computer assisted method |
|
49505-1
|
Erythrocyte clumps [#/area] in Urine sediment by Automated count |
|
58449-0
|
Erythrocyte clumps [#/area] in Urine sediment by Microscopy high power field |
|
50226-0
|
Erythrocyte clumps [Presence] in Urine by Computer assisted method |
|
63378-4
|
Erythrocyte clumps [Presence] in Urine sediment by Light microscopy |
|
18289-9
|
Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy |
|
88113-6
|
Erythrocytes [Presence] in Cerebral spinal fluid by Gram stain |
|
68901-8
|
Erythrocytes [Presence] in Dialysis fluid |
|
10379-6
|
Erythrocytes.dual population [Presence] in Blood by Light microscopy |
|
38285-3
|
Erythrocytes [Presence] in Duodenal fluid |
|
57960-7
|
Erythrocytes [Morphology] in Body fluid by Light microscopy |
|
34446-5
|
Erythrocytes [Presence] in Body fluid |
|
49121-7
|
Erythrocyte inclusion bodies [Identifier] in Blood |
|
11127-8
|
Erythrocytes [Morphology] in Bone marrow |
|
6742-1
|
Erythrocyte morphology finding [Identifier] in Blood |
|
53974-2
|
Erythrocyte morphology [Interpretation] in Urine sediment by Light microscopy Narrative |
|
72338-7
|
Erythrocytes [Presence] in Prostatic fluid by Light microscopy |
|
18225-3
|
Erythrocyte shape [Morphology] in Blood |
|
18226-1
|
Erythrocyte size [Morphology] in Blood |
|
13627-5
|
Erythrocytes [Presence] in Semen by Light microscopy |
|
18290-7
|
Erythrocytes [Morphology] in Synovial fluid by Light microscopy |
|
14331-3
|
Erythrocytes [Units/volume] in Stool by Manual count |
|
33668-5
|
Erythrocytes [Presence] in Stool |
|
30390-9
|
Erythrocytes [Units/volume] in Stool |
|
76673-3
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --1st tube |
|
46087-3
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --2nd tube |
|
46091-5
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --3rd tube |
|
46092-3
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --4th tube |
|
33051-4
|
Erythrocytes [Presence] in Urine |
|
53292-9
|
Erythrocytes [Presence] in Urine by Automated |
|
32776-7
|
Erythrocytes [Presence] in Urine sediment by Light microscopy |
|
48051-7
|
Erythrocytes [Presence] in Vaginal fluid |
|
72162-1
|
Erythrocytes [Presence] in Unspecified specimen by Gram stain |
|
70124-3
|
Erythrocytes [Presence] in Unspecified specimen by Wet preparation |
|
85378-8
|
Erythrocytes.EMA mean fluorescence intensity actual/normal in Blood by Flow cytometry (FC) |
|
48708-2
|
Erythrocytes.fresh/100 erythrocytes in Cerebral spinal fluid by Manual count |
|
58471-4
|
Erythrocytes.pitted/Erythrocytes.total in Red Blood Cells |
|
77159-2
|
Erythrocytes.ghost cells [Presence] in Blood by Light microscopy |
|
53973-4
|
Erythrocytes.ghost cells [Presence] in Urine sediment by Light microscopy |
|
73930-0
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78879-4
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78878-6
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72469-0
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73922-7
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78881-0
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method |
|
78880-2
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72468-2
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73951-6
|
RCS-4 (synthetic cannabinoid) [Presence] in Blood |
|
48180-4
|
Reference change value 0.95 in unspecified time Population |
|
48181-2
|
Reference change value 0.95 [#] in unspecified time Population |
|
48179-6
|
Reference change value 0.99 in unspecified time Population |
|
48178-8
|
Reference change value 0.99 [#] in unspecified time Population |
|
30897-3
|
Total Erythrocyte Volume by Scintigraphy |
|
62247-2
|
Erythrocyte distribution width [Ratio] in Blood from Fetus by Automated count |
|
47277-9
|
Erythrocyte distribution width [Ratio] in Cord blood |
|
30384-2
|
Erythrocyte distribution width [Entitic volume] |
|
21000-5
|
Erythrocyte distribution width [Entitic volume] by Automated count |
|
788-0
|
Erythrocyte distribution width [Ratio] by Automated count |
|
30385-9
|
Erythrocyte distribution width [Ratio] |
|
76138-7
|
Reticulocyte distribution width [Ratio] in Blood by calculation |
|
77247-5
|
Readiness for change for improved exercise [Reported] |
|
77245-9
|
Readiness for change for improved nutrition [Reported] |
|
77248-3
|
Readiness for change for improved screen-time [Reported] |
|
77246-7
|
Readiness for change for improved sleep patterns [Reported] |
|
64284-3
|
Readiness for duty assessment |
|
64294-2
|
Readiness for duty letter |
|
82230-4
|
Reading [NDI] |
|
43156-9
|
Reagent Lot number |
|
43813-5
|
Reagin Ab [Presence] in Cord blood |
|
22459-2
|
Reagin Ab [Presence] in Cerebral spinal fluid |
|
22460-0
|
Reagin Ab [Units/volume] in Cerebral spinal fluid |
|
22463-4
|
Reagin Ab [Presence] in Serum from Donor |
|
22461-8
|
Reagin Ab [Presence] in Serum |
|
22462-6
|
Reagin Ab [Units/volume] in Serum |
|
46203-6
|
Reagin Ab [Titer] in Cerebral spinal fluid |
|
11084-1
|
Reagin Ab [Titer] in Serum |
|
47476-7
|
Reagin Ab [Titer] in Unspecified specimen |
|
22464-2
|
Reagin Ab [Presence] in Unspecified specimen |
|
73752-8
|
Reagin and Treponema pallidum IgG and IgM [Interpretation] in Serum or Plasma |
|
44634-4
|
Reason invasive component size cannot be determined in Breast tumor Narrative |
|
44628-6
|
Reason specimen size cannot be determined in Breast tumor |
|
30982-3
|
Reason applied by forecast logic to project this vaccine |
|
52454-6
|
Reason for assessment |
|
57200-8
|
Reason for assessment [CMS Assessment] |
|
76462-1
|
Reason for discharge APTA |
|
89073-1
|
Reason for discontinuing aspirin use |
|
83849-0
|
Reason for dose change |
|
19144-5
|
Reason for drug test [Interpretation] |
|
57277-6
|
Reason for emergent care [CMS Assessment] |
|
86947-9
|
Reason for hospitalization |
|
57279-2
|
Reason for hospitalization [CMS Assessment] |
|
71801-5
|
Reason for intervention refusal |
|
57721-3
|
Reason for lab test in Dried blood spot |
|
33035-7
|
Reason for lab test in Semen |
|
91023-2
|
Reason for risk assessment |
|
47239-9
|
Reason for stopping HIV treatment |
|
53577-3
|
Reason for study |
|
44756-5
|
Reason for transplant |
|
71798-3
|
Reason immunization not given |
|
55020-2
|
Reason influenza virus vaccine not received [CMS Assessment] |
|
72113-4
|
Reason medication not given NEMSIS |
|
71800-7
|
Reason medication not prescribed [Reported] |
|
84299-7
|
Reason for missed treatement - Reported |
|
86653-3
|
Reason for no birth control use - Reported --at exit |
|
86650-9
|
Reason for no birth control use - Reported --at intake |
|
45956-0
|
Reason pneumococcal vaccine not received [CMS Assessment] |
|
72112-6
|
Reason procedure not performed NEMSIS |
|
89275-2
|
Reason rescue operation was canceled |
|
93048-7
|
Reason for specimen rejection [Type] |
|
85714-4
|
Reason vaccine not received |
|
87225-9
|
Reasons for inactivation [CMS Assessment] |
|
87217-6
|
Reasons for modification [CMS Assessment] |
|
93285-5
|
Reasons for most severe suicidal ideation 1 month [C-SSRS] |
|
93286-3
|
Reasons for most severe suicidal ideation Lifetime [C-SSRS] |
|
88896-6
|
Reboxetine [Mass/volume] in Serum or Plasma |
|
48352-9
|
Reboxetine [Moles/volume] in Serum or Plasma |
|
34833-4
|
Recreational therapy Consult note |
|
83922-5
|
Recreational therapy Custodial care facility Note |
|
78581-6
|
Recreational therapy Discharge instructions |
|
83921-7
|
Recreational therapy Discharge summary |
|
78588-1
|
Recreational therapy Discharge teaching note |
|
83923-3
|
Recreational therapy Education note |
|
78635-0
|
Recreational therapy Flowsheet |
|
68605-5
|
Recreational therapy Hospital Education note |
|
83924-1
|
Recreational therapy Hospital Note |
|
78646-7
|
Recreational therapy Initial evaluation note |
|
83925-8
|
Recreational therapy Interdisciplinary Note |
|
83926-6
|
Recreational therapy Long term care facility Consult note |
|
83927-4
|
Recreational therapy Long term care facility Note |
|
34834-2
|
Recreational therapy Note |
|
83928-2
|
Recreational therapy Outpatient Note |
|
80784-2
|
Recreational therapy Plan of care note |
|
78664-0
|
Recreational therapy Progress note |
|
57160-4
|
Recreational therapy Referral note |
|
83929-0
|
Recreational therapy Risk assessment and screening note |
|
25377-3
|
Recalcification time in Control Platelet poor plasma by Coagulation assay |
|
3242-5
|
Recalcification time in Platelet poor plasma by Coagulation assay |
|
52737-4
|
Recall - bed [BIMS] |
|
52736-6
|
Recall - blue [BIMS] |
|
52735-8
|
Recall - sock [BIMS] |
|
91515-7
|
Received healthcare in U.S. but outside resident state |
|
71449-3
|
Received non-medication intervention for pain in last 5 days [CMS Assessment] |
|
71448-5
|
Received PRN pain medications or was offered and declined in the last 5 days [CMS Assessment] |
|
71447-7
|
Received scheduled pain medication regimen in last 5 days [CMS Assessment] |
|
46593-0
|
Receives psychiatric nursing [CMS Assessment] |
|
92202-1
|
Recipient of supply [Identifier] Supply |
|
80615-8
|
Recommended follow-up [Identifier] Narrative |
|
19773-1
|
Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
62366-0
|
Recommended follow-up [Identifier] |
|
62385-0
|
Recommendation [Interpretation] Document |
|
71527-6
|
Record status [ESRD] |
|
71539-1
|
Record status ESRD type |
|
8618-1
|
Recording duration by EKG |
|
88727-3
|
Recoverin Ab [Units/volume] in Serum by Line blot |
|
83003-4
|
Recoverin IgG Ab [Presence] in Serum or Plasma by Line blot |
|
82236-1
|
Recreation [NDI] |
|
65755-1
|
Rectum Pathology biopsy report |
|
84878-8
|
Recurrence or distant metastases details Cancer Narrative |
|
7062-3
|
Red Alder IgE Ab [Units/volume] in Serum |
|
56461-7
|
Red Alder IgG4 Ab [Mass/volume] in Serum |
|
7087-0
|
Red Ant IgE Ab [Units/volume] in Serum |
|
21068-2
|
Red Ant IgE Ab RAST class [Presence] in Serum |
|
7146-4
|
Red Beet IgE Ab [Units/volume] in Serum |
|
25345-0
|
Red Beet IgE Ab RAST class [Presence] in Serum |
|
56375-9
|
Red Beet IgG4 Ab [Mass/volume] in Serum |
|
63201-8
|
Red Beet IgG Ab [Mass/volume] in Serum |
|
93739-1
|
Red cabbage IgE Ab [Units/volume] in Serum |
|
7195-1
|
Red Cedar IgE Ab [Units/volume] in Serum |
|
15616-6
|
Red Cedar IgE Ab RAST class [Presence] in Serum |
|
48244-8
|
Red Cedar triggered leukotriene release [Mass/volume] by Leukocytes |
|
19754-1
|
Red Currant IgE Ab [Units/volume] in Serum |
|
25634-7
|
Red Currant IgE Ab RAST class [Presence] in Serum |
|
17511-7
|
Red dye IgE Ab [Units/volume] in Serum |
|
47417-1
|
Red dye IgE Ab RAST class [Presence] in Serum |
|
6117-6
|
Red Imported Fire Ant IgE Ab [Units/volume] in Serum |
|
15537-4
|
Red Imported Fire Ant IgE Ab RAST class [Presence] in Serum |
|
61315-8
|
Red Imported Fire Ant IgE Ab/IgE total in Serum |
|
56260-3
|
Red Imported Fire Ant IgG4 Ab [Mass/volume] in Serum |
|
7129-0
|
Red Kidney Bean IgE Ab [Units/volume] in Serum |
|
15565-5
|
Red Kidney Bean IgE Ab RAST class [Presence] in Serum |
|
7130-8
|
Red Kidney Bean IgG Ab [Units/volume] in Serum |
|
21099-7
|
Red Kidney Bean IgG Ab RAST class [Presence] in Serum |
|
56297-5
|
Red Kidney Bean IgG4 Ab [Mass/volume] in Serum |
|
60354-8
|
Red Kidney Bean IgG Ab [Mass/volume] in Serum |
|
7480-7
|
Red Maple triggered histamine release [Units/volume] in Blood |
|
7479-9
|
Red Maple IgE Ab [Units/volume] in Serum |
|
15834-5
|
Red Maple IgE Ab RAST class [Presence] in Serum |
|
24150-5
|
Red Maple IgG Ab [Units/volume] in Serum |
|
7514-3
|
Red mulberry IgE Ab [Units/volume] in Serum |
|
21400-7
|
Red mulberry IgE Ab RAST class [Presence] in Serum |
|
24142-2
|
Red mulberry IgG Ab [Units/volume] in Serum |
|
7534-1
|
Red Oak IgE Ab [Units/volume] in Serum |
|
15881-6
|
Red Oak IgE Ab RAST class [Presence] in Serum |
|
7595-2
|
Red Pepper triggered histamine release [Units/volume] in Blood |
|
6227-3
|
Red Pepper IgE Ab [Units/volume] in Serum |
|
56462-5
|
Red Pepper IgG4 Ab [Mass/volume] in Serum |
|
7661-2
|
Red Snapper IgE Ab [Units/volume] in Serum |
|
16025-9
|
Red Snapper IgE Ab RAST class [Presence] in Serum |
|
7662-0
|
Red Snapper IgG Ab [Units/volume] in Serum |
|
21524-4
|
Red Snapper IgG Ab RAST class [Presence] in Serum |
|
56376-7
|
Red Snapper IgG4 Ab [Mass/volume] in Serum |
|
60404-1
|
Red Snapper IgG Ab [Mass/volume] in Serum |
|
7368-4
|
Red top grass triggered histamine release [Units/volume] in Blood |
|
6228-1
|
Red top grass IgE Ab [Units/volume] in Serum |
|
15748-7
|
Red top grass IgE Ab RAST class [Presence] in Serum |
|
43941-4
|
Red top grass IgE Ab/IgE total in Serum |
|
56377-5
|
Red top grass IgG4 Ab [Mass/volume] in Serum |
|
7481-5
|
Red+Silver Maple IgE Ab [Units/volume] in Serum |
|
17512-5
|
Redfish IgE Ab [Units/volume] in Serum |
|
38364-6
|
Haloperidol reduced [Mass/volume] in Serum or Plasma |
|
11060-1
|
Reducing substances [Presence] in Stool |
|
57796-5
|
Reducing substances [Presence] in Stool by Post hydrolysis |
|
32211-5
|
Reducing substances [Mass/volume] in Stool |
|
59242-8
|
Reducing substances [Moles/volume] in Stool |
|
5809-9
|
Reducing substances [Presence] in Urine |
|
20626-8
|
Reducing substances [Units/volume] in Urine by Test strip |
|
32147-1
|
Reducing substances [Mass/volume] in Urine |
|
59234-5
|
Reducing substances [Moles/volume] in Urine |
|
7663-8
|
Redwood Dust IgE Ab [Units/volume] in Serum |
|
7664-6
|
Redwood IgE Ab [Units/volume] in Serum |
|
15987-1
|
Redwood IgE Ab RAST class [Presence] in Serum |
|
79748-0
|
Reese-Ellsworth Extraocular retinoblastoma classification at final disease stage Left eye |
|
79747-2
|
Reese-Ellsworth Extraocular retinoblastoma classification at final disease stage Right eye |
|
42216-2
|
Reference lab name [Identifier] |
|
30896-5
|
Reference lab test [Identifier] |
|
49581-2
|
Reference lab test identifier and name [Identifier] |
|
49549-9
|
Reference lab test method |
|
19145-2
|
Reference lab test name |
|
19147-8
|
Reference lab test reference range |
|
19146-0
|
Reference lab test results |
|
69547-8
|
Genomic ref allele [ID] |
|
53045-1
|
Reference sequence alteration [Identifier] |
|
48012-9
|
Reference sequence [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal |
|
18519-9
|
Reference beat |
|
74221-3
|
Referring physician address |
|
58150-4
|
Referral has been made to the local contact agency [CMS Assessment] |
|
57133-1
|
Referral note |
|
81230-5
|
Referring physician phone number |
|
82775-8
|
Refills prescribed [#] Medication |
|
28697-1
|
Refraction comment Eye Narrative Autorefractor.auto |
|
28686-4
|
Refraction comment Eye Narrative Autorefractor.man |
|
28662-5
|
Refraction comment Eye Narrative Autorefractor.sciascopy |
|
81431-9
|
Regurgitation degree Aortic valve Angiography |
|
81432-7
|
Regurgitation degree Mitral valve Angiography |
|
91016-6
|
Regional hospitals closed due to event or incident [#] |
|
91017-4
|
Regional hospitals closed due to event or incident/Total regional hospitals |
|
46507-0
|
Regimen change in past 14 days - ICD code [CMS Assessment] |
|
15232-2
|
Regional Allergen Mix A (Common ragweed+Mugwort+Japenese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk |
|
15258-7
|
Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
|
15256-1
|
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk |
|
82103-3
|
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
|
82102-5
|
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15257-9
|
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
|
82105-8
|
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
|
82104-1
|
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
51525-4
|
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
|
82107-4
|
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
82106-6
|
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15259-5
|
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk |
|
82109-0
|
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
|
82108-2
|
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
51526-2
|
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Presence] in Serum by Multidisk |
|
37988-3
|
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Units/volume] in Serum by Multidisk |
|
82112-4
|
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
76395-3
|
Registered nurse personnel [#] with a national provider ID [NMMDS] |
|
76394-6
|
Registered nurse staff # [NMMDS] |
|
76396-1
|
Registered nurse staff with national provider ID/Registered nurse staff [NMMDS] |
|
89910-4
|
Regular use of birth control when got pregnant |
|
82359-1
|
Reproductive endocrinology and infertility Consult note |
|
82360-9
|
Reproductive endocrinology and infertility Diagnostic study note |
|
82361-7
|
Reproductive endocrinology and infertility Education note |
|
82362-5
|
Reproductive endocrinology and infertility Flowsheet |
|
82363-3
|
Reproductive endocrinology and infertility Initial evaluation note |
|
82364-1
|
Reproductive endocrinology and infertility Plan of care note |
|
82366-6
|
Reproductive endocrinology and infertility procedure note |
|
82365-8
|
Reproductive endocrinology and infertility Progress note |
|
82358-3
|
Reproductive endocrinology and infertility Referral note |
|
10950-4
|
Reindeer epithelium IgE Ab [Units/volume] in Serum |
|
15990-5
|
Reindeer epithelium IgE Ab RAST class [Presence] in Serum |
|
54692-9
|
Rejection of care - presence and frequency in last 7 days [CMS Assessment] |
|
68969-5
|
Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method |
|
75930-8
|
Relative humidity setting Infant microenvironment.incubator |
|
89933-6
|
Relative risk of developing disease assessed |
|
87293-7
|
Relationship to patient's mother |
|
44767-2
|
Relationship of subject to patient |
|
85432-3
|
Contact Relationship to patient |
|
75929-0
|
Relative humidity Infant microenvironment.incubator |
|
64292-6
|
Release of information consent Document |
|
30954-2
|
Relevant diagnostic tests/laboratory data Narrative |
|
19775-6
|
Relevant Hx and Px for procedure Narrative Endoscopy |
|
19776-4
|
Relevant Hx and Px for procedure Endoscopy |
|
53661-5
|
Reliability of last menstrual period observation |
|
91585-0
|
Reliability of information source |
|
81365-9
|
Religious affiliation contact to notify [Reported] |
|
81364-2
|
Religious beliefs [Reported] |
|
93829-0
|
REM sleep duration |
|
49628-1
|
Remnant lipoprotein [Mass/volume] in Serum or Plasma |
|
53274-7
|
Epithelial cells.renal [#/volume] in Urine by Computer assisted method |
|
13653-1
|
Epithelial cells.renal [#/volume] in Urine sediment |
|
33221-3
|
Epithelial cells.renal [#/area] in Urine by Computer assisted method |
|
26052-1
|
Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field |
|
45391-0
|
Epithelial cells.renal [#/area] in Urine sediment by Microscopy low power field |
|
53271-3
|
Epithelial cells.renal [Presence] in Urine by Computer assisted method |
|
90044-9
|
Epithelial cells.renal [Presence] in Urine sediment |
|
12248-1
|
Epithelial cells.renal [Presence] in Urine sediment by Light microscopy |
|
11809-1
|
Renal pelvis - left Diameter US |
|
11811-7
|
Renal pelvis - right Diameter US |
|
30079-8
|
Renal tubular casts [#/area] in Urine by Light microscopy |
|
56577-0
|
Renin [Enzymatic activity/volume] in Plasma --1.5 hours post XXX challenge |
|
56757-8
|
Renin [Enzymatic activity/volume] in Plasma --100 minutes post XXX challenge |
|
56557-2
|
Renin [Enzymatic activity/volume] in Plasma --10 minutes post XXX challenge |
|
13867-7
|
Renin [Enzymatic activity/volume] in Plasma --1 hour post 25 mg captopril PO |
|
56574-7
|
Renin [Enzymatic activity/volume] in Plasma --1 hour post XXX challenge |
|
56580-4
|
Renin [Enzymatic activity/volume] in Plasma --20 minutes post XXX challenge |
|
13868-5
|
Renin [Enzymatic activity/volume] in Plasma --2 hours post 25 mg captopril PO |
|
49331-2
|
Renin [Enzymatic activity/volume] in Plasma --2 hours post XXX challenge |
|
78517-0
|
Renin [Mass/volume] in Plasma --2 hours post XXX challenge |
|
56573-9
|
Renin [Enzymatic activity/volume] in Plasma --30 minutes post XXX challenge |
|
48786-8
|
Renin [Enzymatic activity/volume] in Plasma --30 minutes pre XXX challenge |
|
49330-4
|
Renin [Enzymatic activity/volume] in Plasma --3 hours post XXX challenge |
|
58898-8
|
Renin [Enzymatic activity/volume] in Plasma --4 hours post XXX challenge |
|
77680-7
|
Renin [Mass/volume] in Plasma --4 hours post XXX challenge |
|
1622-0
|
Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO |
|
17513-3
|
Renin [Enzymatic activity/volume] in Plasma --5 hours post XXX challenge |
|
56758-6
|
Renin [Enzymatic activity/volume] in Plasma --70 minutes post XXX challenge |
|
17515-8
|
Renin [Enzymatic activity/volume] in Plasma --baseline |
|
2916-5
|
Renin renal clearance in 24 hour Urine and Serum or Plasma |
|
58811-1
|
Renin [Mass/volume] in Plasma --post XXX challenge |
|
30895-7
|
Renin [Units/volume] in Plasma |
|
2915-7
|
Renin [Enzymatic activity/volume] in Plasma |
|
35570-1
|
Renin [Mass/volume] in Plasma |
|
1623-8
|
Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO |
|
51433-1
|
Renin [Mass/volume] in Plasma --pre or post XXX challenge |
|
25513-3
|
Renin [Enzymatic activity/volume] in Plasma --1st specimen post XXX challenge |
|
12900-7
|
Renin [Enzymatic activity/volume] in Plasma --2nd specimen post XXX challenge |
|
58813-7
|
Renin [Mass/volume] in Plasma --2nd specimen |
|
12901-5
|
Renin [Enzymatic activity/volume] in Plasma --3rd specimen post XXX challenge |
|
58812-9
|
Renin [Mass/volume] in Plasma --3rd specimen |
|
12902-3
|
Renin [Enzymatic activity/volume] in Plasma --4th specimen post XXX challenge |
|
12903-1
|
Renin [Enzymatic activity/volume] in Plasma --5th specimen post XXX challenge |
|
12904-9
|
Renin [Enzymatic activity/volume] in Plasma --6th specimen post XXX challenge |
|
12905-6
|
Renin [Enzymatic activity/volume] in Plasma --7th specimen post XXX challenge |
|
12906-4
|
Renin [Enzymatic activity/volume] in Plasma --8th specimen post XXX challenge |
|
17514-1
|
Renin [Enzymatic activity/volume] in Plasma --9th specimen post XXX challenge |
|
92826-7
|
Renin [Units/volume] in Plasma --supine |
|
17516-6
|
Renin [Enzymatic activity/volume] in Plasma --supine |
|
2917-3
|
Renin [Mass/volume] in Plasma --supine |
|
59024-0
|
Renin [Enzymatic activity/volume] in Plasma --supine+30 minutes post XXX challenge |
|
92825-9
|
Renin [Units/volume] in Plasma --upright |
|
2918-1
|
Renin [Enzymatic activity/volume] in Plasma --upright |
|
47883-4
|
Renin [Mass/volume] in Plasma --upright |
|
56976-4
|
Renin [Mass/volume] in Plasma --upright+1 hour post XXX challenge |
|
56975-6
|
Renin [Mass/volume] in Plasma --upright+30 minutes post XXX challenge |
|
31581-2
|
Reovirus Ab [Units/volume] in Cerebral spinal fluid |
|
31582-0
|
Reovirus Ab [Units/volume] in Body fluid |
|
5293-6
|
Reovirus Ab [Units/volume] in Serum |
|
29354-8
|
Reovirus Ab [Titer] in Cerebral spinal fluid |
|
29413-2
|
Reovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29415-7
|
Reovirus Ab [Titer] in Body fluid |
|
29355-5
|
Reovirus Ab [Titer] in Body fluid by Complement fixation |
|
22465-9
|
Reovirus Ab [Titer] in Serum |
|
11012-2
|
Reovirus Ab [Titer] in Serum by Complement fixation |
|
48328-9
|
Repaglinide [Presence] in Serum or Plasma |
|
38542-7
|
Repaglinide [Mass/volume] in Serum or Plasma |
|
73689-2
|
Repaglinide [Mass/volume] in Urine |
|
52056-9
|
Repair of durable medical equipment attachment |
|
52731-7
|
Repetition of three words # [BIMS] |
|
25015-9
|
Replacement of percutaneous gastrojejunostomy Upper GI tract Document |
|
12011-3
|
Replicate summarization |
|
80563-0
|
Report |
|
92027-2
|
Report action level |
|
90098-5
|
Report distribution frequency |
|
90084-5
|
Report identifier |
|
90085-2
|
Report name |
|
90252-8
|
Report No Events section |
|
72509-3
|
Reporting rate Reporting Period Population Calculated |
|
73983-9
|
Report.section heading Unspecified body region |
|
91582-7
|
Report status |
|
92185-8
|
Report type |
|
88085-6
|
Reportability response report Document Public health |
|
88083-1
|
Reportable condition response brief description Narrative |
|
88084-9
|
Reportable condition response information and summary Document |
|
82267-6
|
Reported Activity metabolic rate/Measured RMR [Relative energy/Time] |
|
82272-6
|
Reported Activity metabolic rate/Population RMR [Relative energy/Time] |
|
82275-9
|
Reported Activity metabolic rate/Predicted RMR [Relative energy/Time] |
|
82263-5
|
Reported activity metabolic rate/Standard RMR [Relative energy/Time] |
|
74547-1
|
Reporter email |
|
91879-7
|
Reporter Information |
|
74546-3
|
Reporter job or position |
|
74549-7
|
Reporter of adverse event or unsafe condition |
|
74572-9
|
Reporter of adverse event or unsafe condition [AHRQ] |
|
74548-9
|
Reporter phone number |
|
77967-8
|
Reporting county |
|
77966-0
|
Reporting state |
|
6683-7
|
Reptilase time |
|
5942-8
|
Reptilase time in Control Platelet poor plasma by Coagulation assay |
|
33526-5
|
Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
68326-8
|
Reptilase time actual/Normal |
|
75477-0
|
Resident Note |
|
92573-5
|
Resident of region that is endemic for the disease of interest |
|
74562-0
|
Rescue intervention was attempted [AHRQ] |
|
88092-2
|
Rescue operation end [Date and time] |
|
83931-6
|
Research Consult note |
|
83932-4
|
Research Discharge summary |
|
83933-2
|
Research Evaluation and management of hypertension note |
|
83934-0
|
Research Initial evaluation note |
|
83935-7
|
Research Medication management note |
|
68839-0
|
Research Note |
|
83936-5
|
Research Nurse Note |
|
83937-3
|
Research Outpatient Note |
|
83939-9
|
Research Telephone encounter Note |
|
83938-1
|
Research procedure note |
|
68840-8
|
Research Progress note |
|
77602-1
|
Research study consent |
|
33730-3
|
Resection completeness in Mesorectum Qualitative by Macroscopy |
|
75617-1
|
Residence [NAMCS] |
|
92940-6
|
Residence renovation completion date |
|
92941-4
|
Residence renovation start date |
|
86797-8
|
Resident (or legally authorized representative) wants to be asked about returning to the community on all assessments [CMS Assessment] |
|
55123-4
|
Resident believes he or she is capable of increased independence in at least some ADLs [CMS Assessment] |
|
70950-1
|
Residual renal function testing performed [ESRD] |
|
84892-9
|
Residual tumor classification [Type] in Cancer specimen |
|
81169-5
|
Residual tumor [Interpretation] Cancer Narrative --postoperative |
|
81453-3
|
Residual volume --post bronchodilation |
|
81452-5
|
Residual volume --pre bronchodilation |
|
94125-2
|
Residual volume/Predicted by Plethysmograph body box |
|
81455-8
|
Residual volume/Total capacity --post bronchodilation |
|
81454-1
|
Residual volume/Total capacity --pre bronchodilation |
|
75632-0
|
Resistin [Mass/volume] in Serum or Plasma |
|
78239-1
|
Resource identifier [URI] for Clinical document |
|
81541-5
|
Resource identifier [URI] for Patient education material |
|
78200-3
|
Resource identifier [URI] for Study |
|
81655-3
|
Respiratory pathogens DNA and RNA identified in Respiratory specimen by NAA with probe detection |
|
90566-1
|
Respiratory disturbance index |
|
80341-1
|
Respiratory effort |
|
90565-3
|
Respiratory effort-related arousal index |
|
91776-5
|
Respiratory Mycoplasma identified in Lower respiratory specimen by Organism specific culture |
|
684-1
|
Respiratory Mycoplasma identified in Sputum by Organism specific culture |
|
685-8
|
Respiratory Mycoplasma identified in Throat by Organism specific culture |
|
686-6
|
Respiratory Mycoplasma identified in Unspecified specimen by Organism specific culture |
|
82127-2
|
Respiratory pathogens DNA and RNA identified in Pleural fluid by NAA with probe detection |
|
92958-8
|
Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with non-probe detection |
|
82125-6
|
Respiratory pathogens DNA and RNA tested for in Pleural fluid by NAA with probe detection |
|
82134-8
|
Respiratory pathogens DNA and RNA tested for in Respiratory specimen by NAA with probe detection |
|
80602-6
|
Respiratory pathogens identified [Type] in Nasopharynx by NAA with probe detection |
|
76269-0
|
Respiratory quotient Respiratory system |
|
76170-0
|
Respiratory rate by Acoustic measurement |
|
76171-8
|
Respiratory rate by Airway flow measurement |
|
76172-6
|
Respiratory rate by Carbon dioxide measurement |
|
89279-4
|
Respiratory rate --during anesthesia |
|
76270-8
|
Respiratory rate by Impedance.transthoracic |
|
76173-4
|
Respiratory rate by Non-airway pressure measurement |
|
76174-2
|
Respiratory rate by Pulse oximetry.plethysmograph |
|
89274-5
|
Respiratory rate --W exercise |
|
89292-7
|
Respiratory rate --W pain |
|
53756-3
|
Respiratory status finding |
|
34837-5
|
Respiratory therapy Consult note |
|
78569-1
|
Respiratory therapy Counseling note |
|
78580-8
|
Respiratory therapy Discharge instructions |
|
85433-1
|
Respiratory therapy Discharge summary |
|
78586-5
|
Respiratory therapy Discharge teaching note |
|
78609-5
|
Respiratory therapy Education note |
|
78640-0
|
Respiratory therapy Flowsheet |
|
68470-4
|
Respiratory therapy Hospital Initial evaluation note |
|
83943-1
|
Respiratory therapy Hospital Note |
|
68479-5
|
Respiratory therapy Hospital Progress note |
|
83940-7
|
Respiratory therapy Intensive care unit Note |
|
78728-3
|
Respiratory therapy Initial evaluation note |
|
83944-9
|
Respiratory therapy Long term care facility Note |
|
34838-3
|
Respiratory therapy Note |
|
83945-6
|
Respiratory therapy Outpatient Note |
|
83946-4
|
Respiratory therapy Telephone encounter Note |
|
80772-7
|
Respiratory therapy Plan of care note |
|
78658-2
|
Respiratory therapy procedure note |
|
83941-5
|
Respiratory therapy Patient's home Consult note |
|
83942-3
|
Respiratory therapy Patient's home Note |
|
57162-0
|
Respiratory therapy Referral note |
|
85323-4
|
Response to neoadjuvant therapy in Breast cancer specimen Qualitative |
|
54245-6
|
Respiratory virus Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
50548-7
|
Respiratory virus DNA+RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
80403-9
|
Respiratory wave amplitude |
|
12413-1
|
Resperine [Mass/volume] in Serum or Plasma |
|
12414-9
|
Resperine [Mass/volume] in Urine |
|
80320-5
|
Respiratory assessment [Interpretation] |
|
82952-3
|
Respiratory insufficiency [ALSFRS-R] |
|
88058-3
|
Respiratory measurements Document |
|
57238-8
|
Respiratory treatments administered at home [CMS Assessment] |
|
85212-9
|
Respite note |
|
83129-7
|
Respondent type |
|
88040-1
|
Response to cancer treatment |
|
75949-8
|
Response entropy [Score] Cerebral cortex Electroencephalogram (EEG) |
|
90112-4
|
Response section or team responsibility |
|
90123-1
|
Response team leader name |
|
90124-9
|
Response team leader title |
|
90125-6
|
Response team member name |
|
90126-4
|
Response team member title |
|
91696-5
|
Response team name |
|
90122-3
|
Response team participation status |
|
91901-9
|
Response team [Type] |
|
54768-7
|
Response to toileting program [CMS Assessment] |
|
54655-6
|
Responsible staff or provider was informed of potential for resident self harm [CMS Assessment] |
|
70007-0
|
Restraint note |
|
46498-2
|
Resumption of care date [CMS Assessment] |
|
72115-9
|
Resuscitation attempted NEMSIS |
|
21733-1
|
RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40693-4
|
RET gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21734-9
|
RET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
90927-5
|
RET gene rearrangements in Blood or Tissue by FISH |
|
10804-3
|
Microscopic observation [Identifier] in Tissue by Reticulin stain |
|
32983-9
|
Retention {Dental arch}.denture.complete Observed |
|
32985-4
|
Retention {Dental arch}.denture.complete - Reported |
|
32984-7
|
Retention {Dental arch}.denture.partial Observed |
|
32986-2
|
Retention {Dental arch}.denture.partial - Reported |
|
82591-9
|
Reticulocytes.low light scatter/Reticulocytes.total in Blood by Automated count |
|
14196-0
|
Reticulocytes [#/volume] in Blood |
|
60474-4
|
Reticulocytes [#/volume] in Blood by Automated count |
|
42758-3
|
Reticulocytes [#/volume] in Blood by calculation |
|
62249-8
|
Reticulocytes [#/volume] in Blood from Fetus by Automated count |
|
66146-2
|
Reticulocytes [#/volume] in Blood from Fetus by Manual count |
|
40665-2
|
Reticulocytes [#/volume] in Blood by Manual count |
|
30156-4
|
Reticulocytes.aggregate/100 erythrocytes in Blood |
|
30155-6
|
Reticulocytes.punctate/100 erythrocytes in Blood |
|
76140-3
|
Reticulocytes.hypochromic/100 erythrocytes in Blood by Automated count |
|
4679-7
|
Reticulocytes/100 erythrocytes in Blood |
|
17849-1
|
Reticulocytes/100 erythrocytes in Blood by Automated count |
|
74397-1
|
Reticulocytes/100 erythrocytes in Cord blood by Automated count |
|
31112-6
|
Reticulocytes/100 erythrocytes in Blood by Manual |
|
12250-7
|
Reticulocytes/1000 erythrocytes hematocrit adjusted in Blood |
|
17848-3
|
Reticulocytes/1000 erythrocytes in Blood by Manual |
|
17521-6
|
Reticulin Ab [Presence] in Serum |
|
57414-5
|
Reticulin Ab [Presence] in Serum by Immunofluorescence |
|
5296-9
|
Reticulin Ab [Units/volume] in Serum |
|
9398-9
|
Reticulin Ab [Titer] in Serum |
|
51722-7
|
Reticulin Ab [Titer] in Serum by Immunofluorescence |
|
14273-7
|
Reticulin IgA Ab [Presence] in Serum |
|
9720-4
|
Reticulin IgA Ab [Titer] in Serum |
|
17522-4
|
Reticulin IgA Ab [Titer] in Serum by Immunofluorescence |
|
31585-3
|
Reticulin IgG Ab [Presence] in Serum |
|
26970-4
|
Reticulin IgG Ab [Presence] in Serum by Immunofluorescence |
|
31584-6
|
Reticulin IgG Ab [Units/volume] in Serum |
|
17523-2
|
Reticulin IgG Ab [Titer] in Serum |
|
17524-0
|
Reticulin IgG Ab [Titer] in Serum by Immunofluorescence |
|
2919-9
|
Reticulin [Mass/volume] in Serum |
|
31111-8
|
Reticulocyte production index |
|
50726-9
|
Reticulum cell/100 cells in Bone marrow by Gomori stain |
|
10827-4
|
Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |
|
87673-0
|
Retinal+retinol+retinoic acid [Mass/mass] in Unspecified specimen |
|
17525-7
|
Retinoate esters [Mass/volume] in Serum or Plasma |
|
2921-5
|
Retinoate [Mass/volume] in Serum or Plasma |
|
18362-4
|
Alpha-2-Retinol binding protein [Mass/time] in 24 hour Urine |
|
1836-6
|
Alpha-2-Retinol binding protein [Mass/volume] in Serum or Plasma |
|
33782-4
|
Alpha-2-Retinol binding protein [Mass/volume] in Urine |
|
38496-6
|
Retinyl palmitate [Mass/volume] in Serum or Plasma |
|
17530-7
|
Retrovirus identified in Unspecified specimen by Organism specific culture |
|
88670-5
|
Return of spontaneous circulation |
|
19822-6
|
Return visit clinic post GI procedure [Location] Narrative |
|
19824-2
|
Return visit conditions |
|
19820-0
|
Return visit post GI procedure [Instructions] Narrative |
|
19823-4
|
Return visit post GI procedure [Telephone number] |
|
19821-8
|
Return visit post GI procedure [Date and time] |
|
22103-6
|
Reticuloendotheliosis virus Ab [Presence] in Serum |
|
15454-2
|
Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay |
|
1303-7
|
Reverse ABO group [Type] |
|
48021-0
|
Reverse primer [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal |
|
19768-1
|
Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
|
90661-0
|
Revised Geneva score interpretation |
|
93083-4
|
Revised Prenatal Distress Questionnaire (NuPDQ) - Concurrent Self-Administered Version |
|
74222-1
|
Reviewed material and summary of stains in Bone marrow Narrative |
|
42703-9
|
RF Less than 1 hour |
|
86406-6
|
RF Unspecified body region Less than 1 hour Views during surgery |
|
42702-1
|
RF Greater than 1 hour |
|
25065-4
|
RF 15 minutes |
|
25068-8
|
RF 1 hour |
|
30642-3
|
RF Unspecified body region Single view |
|
43471-2
|
RF 2 hour |
|
25066-2
|
RF 30 minutes |
|
25067-0
|
RF 45 minutes |
|
43472-0
|
RF 90 minutes |
|
46341-4
|
RF Abdomen Views |
|
37183-1
|
RF Ankle Arthrogram |
|
37184-9
|
RF Ankle - bilateral Arthrogram |
|
37185-6
|
RF Ankle - left Arthrogram |
|
37942-0
|
RF Ankle - right Arthrogram |
|
86373-8
|
RF AV fistula Views W contrast via additional puncture |
|
86391-0
|
RF AV fistula Views W contrast via existing catheter |
|
86382-9
|
RF Biliary ducts Limited Views during surgery |
|
86383-7
|
RF Biliary ducts Views W contrast IV |
|
86376-1
|
RF Biliary ducts Views W contrast via existing catheter |
|
24574-6
|
RF Biliary ducts and Gallbladder Views during surgery W contrast biliary duct |
|
24575-3
|
RF Biliary ducts and Gallbladder Views W contrast percutaneous transhepatic |
|
30647-2
|
RF Biliary ducts and Gallbladder Views W contrast via T-tube |
|
38092-3
|
RF Urinary bladder Views W chain and contrast intra bladder |
|
86401-7
|
RF Urinary bladder Views W contrast intra bladder |
|
37569-1
|
RF Urinary bladder Views W contrast via suprapubic tube |
|
42014-1
|
RF Urinary bladder and Urethra Views W contrast |
|
38100-4
|
RF Urinary bladder and Urethra Views W contrast antegrade |
|
43559-4
|
RF Urinary bladder and Urethra Views W contrast intra bladder during voiding |
|
25017-5
|
RF Urinary bladder and Urethra Views W contrast intra bladder |
|
25020-9
|
RF Urinary bladder and Urethra Views W contrast retrograde via urethra |
|
69076-8
|
RF guidance for percutaneous biopsy of Bone |
|
38125-1
|
RF Cervical and thoracic and lumbar spine Limited Views W contrast IT |
|
30808-0
|
RF Cervical and thoracic and lumbar spine Views W contrast IT |
|
24620-7
|
RF Catheter Views for patency check W contrast via catheter |
|
86398-5
|
RF Cerebral cisterns Views W contrast IT |
|
86439-7
|
RF Cerebral sinuses Views W contrast IV |
|
24656-1
|
RF Chest Single view during surgery |
|
24655-3
|
RF Chest Image intensifier during surgery |
|
30631-6
|
RF Chest Views |
|
37199-7
|
RF Chest Views W contrast PO |
|
24668-6
|
RF Colon Single view for transit Post solid contrast |
|
86381-1
|
RF Colon Screening W air and barium contrast PR |
|
44226-9
|
RF Colon Views for reduction W barium contrast PR |
|
30636-5
|
RF Colon Views for reduction W contrast PR |
|
41797-2
|
RF Colon Limited Views W air and barium contrast PR |
|
46357-0
|
RF Colon Views W air contrast PR |
|
24666-0
|
RF Colon Views W air and barium contrast PR |
|
44227-7
|
RF Colon Views W barium contrast PR |
|
24667-8
|
RF Colon Views W contrast PR |
|
37567-5
|
RF Colon Views W contrast via colostomy |
|
42681-7
|
RF Colon Views W gastrografin PR |
|
24669-4
|
RF Colon Views W water soluble contrast PR |
|
36640-1
|
RF Cervical spine Views |
|
42335-0
|
RF Cervical spine Limited Views W contrast IT |
|
37192-2
|
RF Cervical spine Views W contrast intradisc |
|
24947-4
|
RF Cervical spine Views W contrast IT |
|
38103-8
|
RF Spine Cervical and Spine Lumbar Views W contrast IT |
|
30632-4
|
RF Diaphragm for motion |
|
37186-4
|
RF Elbow Arthrogram |
|
37187-2
|
RF Elbow - bilateral Arthrogram |
|
37188-0
|
RF Elbow - left Arthrogram |
|
37947-9
|
RF Elbow - right Arthrogram |
|
38104-6
|
RF Spine epidural space Views W contrast IT |
|
30633-2
|
RF Esophagus Views W barium contrast PO |
|
24678-5
|
RF Esophagus Views W contrast PO |
|
24679-3
|
RF Esophagus Views W gastrografin PO |
|
86437-1
|
RF Fistula Diagnostic W contrast intra fistula |
|
86385-2
|
RF Gallbladder Views W contrast PO |
|
86384-5
|
RF Gallbladder Views W contrast and fatty meal PO |
|
86378-7
|
RF Gastrointestinal tract Views for fistula |
|
24998-7
|
RF Placement check of gastrostomy tube W contrast via GI tube |
|
42422-6
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Breast |
|
42423-4
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Chest |
|
44223-6
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Ovary |
|
35890-3
|
RF Guidance for biopsy of Abdomen |
|
69241-8
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Abdomen |
|
42017-4
|
RF Guidance for percutaneous replacement of cholecystostomy of Abdomen |
|
35885-3
|
RF Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
|
69242-6
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Appendix |
|
30892-4
|
RF Guidance for placement of catheter in Biliary ducts and Pancreatic duct-- W contrast retrograde |
|
43478-7
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 1.5 hours post contrast retrograde intrabiliary |
|
43474-6
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 15m post contrast retrograde intrabiliary |
|
43477-9
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 1H post contrast retrograde intrabiliary |
|
43473-8
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 2H post contrast retrograde intrabiliary |
|
43475-3
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 30M post contrast retrograde intrabiliary |
|
43476-1
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 45M post contrast retrograde intrabiliary |
|
30815-5
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- W contrast retrograde |
|
36761-5
|
RF Guidance for balloon dilatation of Biliary ducts-- W contrast |
|
44214-5
|
RF Guidance for endoscopy of Biliary ducts-- W contrast retrograde |
|
46372-9
|
RF Guidance for percutaneous drainage and placement of drainage catheter of Biliary ducts |
|
72545-7
|
RF Guidance for percutaneous replacement of drainage tube of Biliary ducts and Gallbladder |
|
24782-5
|
RF Guidance for percutaneous placement of nephroureteral stent of Kidney - bilateral-- W contrast via stent |
|
86397-7
|
RF Guidance for drainage and placement of suprapubic catheter of Urinary bladder |
|
86404-1
|
RF Guidance for fluid aspiration of Urinary bladder |
|
69306-9
|
RF Guidance for aspiration of cyst of Bone |
|
75669-2
|
RF Guidance for biopsy of Bone marrow |
|
38154-1
|
RF Guidance for superficial biopsy of Bone |
|
41803-8
|
RF Guidance for biopsy of Breast |
|
25069-6
|
RF Guidance for biopsy of Unspecified body region |
|
35912-5
|
RF Guidance for placement of catheter in Unspecified body region |
|
24570-4
|
RF Guidance for removal of calculus from Biliary duct common-- W contrast retrograde intra biliary |
|
35889-5
|
RF Guidance for bronchoscopy of Chest |
|
35894-5
|
RF Guidance for biopsy of Chest |
|
69078-4
|
RF Guidance for drainage and placement of drainage catheter of Chest |
|
69127-9
|
RF Guidance for biopsy of Chest Pleura |
|
39362-9
|
RF Guidance for placement of tube in Chest |
|
69073-5
|
RF Guidance for core needle biopsy of Unspecified body region |
|
72541-6
|
RF Guidance for denervation of Spine Cervical Facet Joint |
|
30812-2
|
RF Guidance for injection of Spine Cervical Facet Joint |
|
70918-8
|
RF Guidance for injection of Cervical spine |
|
70923-8
|
RF Guidance for percutaneous vertebroplasty of Cervical spine |
|
24671-0
|
RF Guidance for aspiration of cyst of Unspecified body region |
|
43558-6
|
RF Guidance for change of dialysis catheter in Unspecified body region-- W contrast IV |
|
43537-0
|
RF Guidance for drainage and placement of drainage catheter of Unspecified body region |
|
24680-1
|
RF Guidance for dilation of Esophagus |
|
86403-3
|
RF Guidance for placement of catheter in Fallopian tube |
|
30628-2
|
RF Guidance for removal of foreign body of Unspecified body region |
|
86436-3
|
RF Guidance for treatment of Fistula-- W contrast intra fistula |
|
44215-2
|
RF Guidance for fine needle aspiration of Unspecified body region |
|
64999-6
|
RF Guidance for placement of catheter in Fallopian tube - right-- transcervical |
|
30818-9
|
RF Guidance for placement of catheter in Fallopian tubes-- transcervical |
|
64998-8
|
RF Guidance for placement of catheter in Fallopian tube - left-- transcervical |
|
86377-9
|
RF Guidance for advancement of feeding tube of Gastrointestinal tract |
|
24716-3
|
RF Guidance for placement of decompression tube in Gastrointestinal tract |
|
86413-2
|
RF Guidance for placement of long feeding tube in Gastrointestinal tract |
|
30637-3
|
RF Guidance for placement of tube in Gastrointestinal tract |
|
86407-4
|
RF Guidance of Unspecified body region |
|
35888-7
|
RF Guidance for arthrocentesis of Hip |
|
69133-7
|
RF Guidance for drainage and placement of drainage catheter of Hip |
|
30638-1
|
RF Guidance for injection of Hip |
|
75750-0
|
RF Guidance for biopsy of Intervertebral disc |
|
75749-2
|
RF Guidance for fluid aspiration of Intervertebral disc |
|
25078-7
|
RF Guidance for placement of stent in Intrahepatic portal system |
|
36771-4
|
RF Guidance for injection of Joint |
|
24771-8
|
RF Guidance for arthrocentesis of Joint space |
|
44222-8
|
RF Guidance for procedure of Joint space |
|
72544-0
|
RF Guidance for percutaneous device removal of nephrostomy tube of Kidney - bilateral-- W contrast |
|
86441-3
|
RF Guidance for manometry of Kidney and Ureter and Urinary bladder |
|
88834-7
|
RF Guidance for dilation of nephrostomy tract, ureter, or urethra |
|
35899-4
|
RF Guidance for biopsy of Kidney |
|
44217-8
|
RF Guidance for fine needle aspiration of Kidney |
|
86425-6
|
RF Guidance for manometry of Kidney |
|
39361-1
|
RF Guidance for drainage of abscess and placement of drainage catheter of Liver |
|
35900-0
|
RF Guidance for percutaneous biopsy of Liver |
|
44225-1
|
RF Guidance for biopsy of Liver-- W contrast IV |
|
44220-2
|
RF Guidance for fine needle aspiration of Liver |
|
24718-9
|
RF Guidance for transjugular biopsy of Liver-- W contrast IV |
|
41799-8
|
RF Guidance for placement of tube in Liver |
|
72542-4
|
RF Guidance for denervation of Lumbar Spine Facet Joint |
|
30817-1
|
RF Guidance for injection of Lumbar Spine Facet Joint |
|
70919-6
|
RF Guidance for injection of Lumbar spine |
|
72552-3
|
RF Guidance for kyphoplasty of Lumbar spine |
|
70924-6
|
RF Guidance for percutaneous vertebroplasty of Lumbar spine |
|
24973-0
|
RF Guidance for fluid aspiration of Lumbar spine space |
|
30634-0
|
RF Guidance for biopsy of Lung |
|
69243-4
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Lung |
|
69226-9
|
RF Guidance for biopsy of Muscle |
|
72554-9
|
RF Guidance for trigger point injection of Muscle |
|
69120-4
|
RF Guidance for drainage of abscess and placement of drainage catheter of Neck |
|
39027-8
|
RF Guidance for needle localization of Unspecified body region |
|
86400-9
|
RF Guidance for placement of needle in Unspecified body region |
|
69121-2
|
RF Guidance for aspiration of cyst of Ovary |
|
69122-0
|
RF Guidance for drainage of abscess and placement of drainage catheter of Pancreas |
|
35902-6
|
RF Guidance for biopsy of Pancreas |
|
44218-6
|
RF Guidance for fine needle aspiration of Pancreas |
|
42421-8
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Unspecified body region |
|
24621-5
|
RF Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region |
|
44213-7
|
RF Guidance for endoscopy of Pancreatic duct-- W contrast retrograde |
|
69074-3
|
RF Guidance for biopsy of Pelvis |
|
69244-2
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Pelvis |
|
62450-2
|
RF Guidance for placement of catheter in Peritoneum |
|
41800-4
|
RF Guidance for drainage and placement of drainage catheter of Pharynx |
|
69123-8
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space |
|
37887-7
|
RF Guidance for fluid aspiration of Pleural space |
|
75747-6
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space - bilateral |
|
75751-8
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space - left |
|
75817-7
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space - right |
|
72539-0
|
RF Guidance for denervation of Peripheral nerve |
|
30629-0
|
RF Guidance for procedure of Unspecified body region |
|
41802-0
|
RF Guidance for biopsy of Prostate |
|
69075-0
|
RF Guidance for biopsy of Salivary gland |
|
48435-2
|
RF Guidance for injection of Salivary gland - bilateral |
|
35927-3
|
RF Guidance for injection of Sacroiliac Joint |
|
30646-4
|
RF Guidance for change of tube in Sinus tract-- W contrast |
|
46392-7
|
RF Guidance for injection of Sinuses |
|
26322-8
|
RF Guidance for injection of Spine facet joint - bilateral |
|
26323-6
|
RF Guidance for injection of Spine facet joint - left |
|
26324-4
|
RF Guidance for injection of Spine facet joint - right |
|
72540-8
|
RF Guidance for denervation of Spine facet joint |
|
24931-8
|
RF Guidance for injection of Spine facet joint |
|
37427-2
|
RF Guidance for injection of Spine |
|
35936-4
|
RF Guidance for percutaneous vertebroplasty of Spine |
|
35907-5
|
RF Guidance for biopsy of Spleen |
|
35925-7
|
RF Guidance for endoscopy of Stomach |
|
35926-5
|
RF Guidance for gastrostomy of Stomach |
|
46294-5
|
RF Guidance for percutaneous replacement of drainage tube of Stomach |
|
24996-1
|
RF Guidance for percutaneous replacement of gastrostomy of Stomach |
|
24995-3
|
RF Guidance for placement of tube in Stomach |
|
37494-2
|
RF Guidance for injection of Tendon |
|
69129-5
|
RF Guidance for biopsy of Thyroid gland |
|
44216-0
|
RF Guidance for fine needle aspiration of Thyroid gland |
|
44221-0
|
RF Guidance for deep aspiration.fine needle of Tissue |
|
69124-6
|
RF Guidance for superficial aspiration.fine needle of Tissue |
|
30814-8
|
RF Guidance for injection of Spine Thoracic Facet Joint |
|
72543-2
|
RF Guidance for denervation of Thoracic spine intercostal nerve |
|
70920-4
|
RF Guidance for injection of Thoracic spine |
|
72553-1
|
RF Guidance for kyphoplasty of Thoracic spine |
|
70925-3
|
RF Guidance for percutaneous vertebroplasty of Thoracic spine |
|
86405-8
|
RF Guidance for exchange of tube of Unspecified body region |
|
44224-4
|
RF Guidance for placement of tube in Unspecified body region |
|
72549-9
|
RF Guidance for removal of tunneled CV catheter |
|
86438-9
|
RF Guidance for check of feeding tube of Gastrointestinal tract upper |
|
39047-6
|
RF Hip Single view during surgery |
|
24764-3
|
RF Hip Arthrogram |
|
26070-3
|
RF Hip - bilateral Arthrogram |
|
26071-1
|
RF Hip - left Arthrogram |
|
26072-9
|
RF Hip - right Arthrogram |
|
63314-9
|
Rheumatoid factor IgA [Units/volume] in Body fluid by Immunoassay |
|
33313-8
|
Rheumatoid factor IgA [Units/volume] in Serum |
|
33314-6
|
Rheumatoid factor IgG [Units/volume] in Serum |
|
63315-6
|
Rheumatoid factor IgM [Units/volume] in Body fluid by Immunoassay |
|
9338-5
|
Rheumatoid factor IgM [Units/volume] in Serum by Immunoassay |
|
11573-3
|
Rheumatoid factor IgM [Units/volume] in Serum |
|
33577-8
|
Rheumatoid factor IgM [Titer] in Serum by Nephelometry |
|
37585-7
|
RF Jejunum Views W contrast |
|
37191-4
|
RF Joint Arthrogram |
|
65799-9
|
RF Kidney - bilateral Single view for cyst |
|
24781-7
|
RF Guidance for exchange of nephrostomy tube of Kidney - bilateral-- W contrast |
|
24779-1
|
RF Guidance for percutaneous placement of nephrostomy tube of Kidney - bilateral-- W contrast via tube |
|
46376-0
|
RF Kidney - bilateral Views W contrast antegrade |
|
39349-6
|
RF Kidney - bilateral Views W contrast retrograde |
|
24780-9
|
RF Kidney - bilateral Views W contrast via nephrostomy tube |
|
24783-3
|
RF Kidney - bilateral Views for urodynamics |
|
86380-3
|
RF Kidney and Ureter and Urinary bladder Views for fistula |
|
86392-8
|
RF Kidney and Ureter and Urinary bladder Limited Views W contrast IV |
|
86387-8
|
RF Kidney and Ureter and Urinary bladder Views W contrast antegrade |
|
86372-0
|
RF Kidney and Ureter and Urinary bladder Views W contrast IV |
|
86388-6
|
RF Kidney and Ureter and Urinary bladder Views W contrast retrograde |
|
86390-2
|
RF Kidney and Ureter and Urinary bladder Views W contrast via nephrostomy tube |
|
86389-4
|
RF Kidney and Ureter and Urinary bladder Views during surgery W contrast retrograde |
|
88833-9
|
RF Kidney - bilateral and Ureter Views W contrast retrograde intra ureter |
|
86393-6
|
RF Kidney - bilateral and Ureter - bilateral and Urinary bladder Views W contrast retrograde |
|
88832-1
|
RF Kidney - left and Ureter Views W contrast retrograde intra ureter |
|
65800-5
|
RF Kidney - left Single view for cyst |
|
38872-8
|
RF Kidney - left Views W contrast via nephrostomy tube |
|
65801-3
|
RF Kidney - right Single view for cyst |
|
38112-9
|
RF Kidney - right Views W contrast via nephrostomy tube |
|
88831-3
|
RF Kidney - right and Ureter Views W contrast retrograde intra ureter |
|
24800-5
|
RF Knee Arthrogram |
|
26073-7
|
RF Knee - bilateral Arthrogram |
|
26074-5
|
RF Knee - left Arthrogram |
|
26075-2
|
RF Knee - right Arthrogram |
|
30810-6
|
RF Lacrimal duct Views W contrast intra lacrimal duct |
|
38098-0
|
RF Lacrimal duct - bilateral Views W contrast intra lacrimal duct |
|
38099-8
|
RF Lacrimal duct - left Views W contrast intra lacrimal duct |
|
38827-2
|
RF Lacrimal duct - right Views W contrast intra lacrimal duct |
|
48465-9
|
RF Larynx Views |
|
75670-0
|
RF Lumbar spine epidural space Views W contrast epidural |
|
37193-0
|
RF Lumbar spine Views W contrast intradisc |
|
24974-8
|
RF Lumbar spine Views W contrast IT |
|
24845-0
|
RF Neck Views W contrast intra larynx |
|
38116-0
|
RF Parotid gland Views W contrast intra salivary duct |
|
38097-2
|
RF Parotid gland - left Views W contrast intra salivary duct |
|
38826-4
|
RF Parotid gland - right Views W contrast intra salivary duct |
|
86408-2
|
RF Pelvis Views for urinary pouch |
|
37586-5
|
RF Penis Views W contrast intra corpus cavernosum |
|
86410-8
|
RF Pharynx and Cervical esophagus Views W barium contrast PO |
|
24661-1
|
RF Pleural space Views W contrast intra pleural space |
|
37151-8
|
Portable RF Unspecified body region Views |
|
30811-4
|
RF Posterior fossa Views W contrast IT |
|
86411-6
|
RF Posterior fossa - bilateral Views W contrast IT |
|
86430-6
|
RF Posterior fossa - unilateral Views W contrast IT |
|
24894-8
|
RF Rectum and Urinary bladder Views W contrast PR and intra bladder during defecation and voiding |
|
24893-0
|
RF Rectum Single view post contrast PR during defecation |
|
86409-0
|
RF Rectum Views for rectal dysfunction W barium contrast PR |
|
26067-9
|
RF Salivary gland - bilateral Views W contrast intra salivary duct |
|
26068-7
|
RF Salivary gland - left Views W contrast intra salivary duct |
|
26069-5
|
RF Salivary gland - right Views W contrast intra salivary duct |
|
24902-9
|
RF Salivary gland Views W contrast intra salivary duct |
|
86379-5
|
RF Small bowel Views for loop diversion |
|
69272-3
|
RF Small bowel Views W contrast via ileostomy |
|
24924-3
|
RF Small bowel Views W contrast PO |
|
24923-5
|
RF Small bowel Views W positive contrast via enteroclysis tube |
|
86440-5
|
RF Seminal vesicle Views W contrast intra seminal vesicle |
|
86402-5
|
RF Shoulder Arthrogram limited |
|
24910-2
|
RF Shoulder Arthrogram |
|
26076-0
|
RF Shoulder - bilateral Arthrogram |
|
26077-8
|
RF Shoulder - left Arthrogram |
|
26078-6
|
RF Shoulder - right Arthrogram |
|
24911-0
|
RF Shunt Views |
|
37647-5
|
RF Sacroiliac Joint Arthrogram |
|
37189-8
|
RF Sacroiliac joint - bilateral Arthrogram |
|
37190-6
|
RF Sacroiliac joint - left Arthrogram |
|
37785-3
|
RF Sacroiliac joint - right Arthrogram |
|
24912-8
|
RF Sinus tract Views W contrast intra sinus tract |
|
38094-9
|
RF Spinal cavity Views W contrast |
|
24927-6
|
RF Spine Views W contrast intradisc |
|
37572-5
|
RF Spine Views W contrast IT |
|
24552-2
|
RF Stent Views W contrast intra stent |
|
48698-5
|
RF Submandibular gland - bilateral Views W contrast intra salivary duct |
|
42460-6
|
RF Submandibular gland - left Views W contrast intra salivary duct |
|
48696-9
|
RF Submandibular gland - right Views W contrast intra salivary duct |
|
38153-3
|
RF Submandibular gland Views W contrast intra salivary duct |
|
37973-5
|
RF Testicular vessels Views W contrast |
|
37901-6
|
RF Temporomandibular joint Arthrogram |
|
37409-0
|
RF Temporomandibular joint - bilateral Arthrogram |
|
37410-8
|
RF Temporomandibular joint - left Arthrogram |
|
37818-2
|
RF Temporomandibular joint - right Arthrogram |
|
48464-2
|
RF Trachea Views |
|
75816-9
|
RF Spine.thoracic epidural space Views W contrast epidural |
|
38120-2
|
RF Thoracic spine Limited Views W contrast IT |
|
70933-7
|
RF Thoracic spine Views W contrast intradisc |
|
24985-4
|
RF Thoracic spine Views W contrast IT |
|
43788-9
|
RF Tube Views for patency W contrast via tube |
|
39144-1
|
RF Gastrointestinal tract upper Single view W air contrast PO |
|
24715-5
|
RF Gastrointestinal tract upper Single view W contrast PO |
|
86420-7
|
RF Gastrointestinal tract upper Views W air contrast PO and W barium contrast PO |
|
86386-0
|
RF Gastrointestinal tract upper Views W barium contrast PO |
|
42459-8
|
RF Gastrointestinal tract upper Views W contrast PO |
|
42684-1
|
RF Gastrointestinal tract upper Views W gastrografin PO |
|
42012-5
|
RF Gastrointestinal tract upper Views W water soluble contrast PO |
|
42470-5
|
RF Gastrointestinal tract upper and Gallbladder Single view W contrast PO |
|
41795-6
|
RF Upper gastrointestinal tract and Small bowel Single view W air contrast PO |
|
30809-8
|
RF Upper gastrointestinal tract and Small bowel Single view W contrast PO |
|
86427-2
|
RF Upper gastrointestinal tract and Small bowel Views W air contrast PO and W barium contrast PO |
|
43574-3
|
RF Upper gastrointestinal tract and Small bowel Views W barium contrast PO |
|
42469-7
|
RF Gastrointestinal tract upper and Small bowel and Gallbladder Single view W contrast PO |
|
86443-9
|
RF Ureter Views W contrast intra ureter |
|
25016-7
|
RF Urethra Views W contrast intra urethra |
|
25022-5
|
RF Uterus and Fallopian tubes Views W contrast IU |
|
75853-2
|
RF Vagina Views W contrast VG |
|
39151-6
|
RF Vas deferens Views W contrast intra vas deferens |
|
86395-1
|
RF videography Hypopharynx and Esophagus Views for swallowing function W speech and W barium contrast PO |
|
24681-9
|
RF videography Hypopharynx and Esophagus Views |
|
24682-7
|
RF videography Hypopharynx and Esophagus Views W liquid and paste contrast PO during swallowing |
|
30630-8
|
RF videography Cerebral cisterns Views W contrast |
|
43538-8
|
RF videography Cervical spine Views |
|
24752-8
|
RF videography Heart Views |
|
43536-2
|
RF videography Lumbar spine Views |
|
24855-9
|
RF videography Oropharynx Views |
|
49512-7
|
RF Unspecified body region Views |
|
24631-4
|
RF Unspecified body region Views for central venous catheter placement check |
|
37063-5
|
RF Unspecified body region Views for foreign body |
|
30650-6
|
RF Unspecified body region Views for shunt |
|
25070-4
|
RF Unspecified body region Views during surgery |
|
37565-9
|
RF Unspecified body region Views W barium contrast via fistula |
|
37566-7
|
RF Unspecified body region Views W contrast via catheter |
|
37568-3
|
RF Unspecified body region Views W contrast via fistula |
|
37576-6
|
RF Unspecified body region Views W gastrografin via fistula |
|
86399-3
|
RF Guidance for Views and Guidance for injection of non-vascular shunt of Unspecified body region |
|
25034-0
|
RF Wrist Arthrogram |
|
37570-9
|
RF Wrist - bilateral Arthrogram |
|
37571-7
|
RF Wrist - left Arthrogram |
|
37641-8
|
RF Wrist - right Arthrogram |
|
46435-4
|
Rheumatoid factor and Cyclic citrullinated peptide IgG Ab [Interpretation] in Serum |
|
25014-2
|
RFA Two vessels Views W contrast |
|
25005-0
|
RFA Three vessels Views W contrast |
|
43479-5
|
RFA Abdominal Aorta Runoff W contrast IA |
|
30837-9
|
RFA Abdominal Aorta Views W contrast IA |
|
30839-5
|
RFA Abdominal lymphatic vessels Views W contrast intra lymphatic |
|
30840-3
|
RFA Abdominal lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
69066-9
|
RFA Abdominal vessels Views W contrast IV |
|
37598-0
|
RFA Abdominal and pelvic lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
37597-2
|
RFA Abdominal and pelvic lymphatic vessels Views W contrast intra lymphatic |
|
37596-4
|
RFA Abdominal and pelvic lymphatic vessels - left Views W contrast intra lymphatic |
|
38811-6
|
RFA Abdominal and pelvic lymphatic vessels - right Views W contrast intra lymphatic |
|
25030-8
|
RFA Abdominal arteries Views W contrast IA |
|
37380-3
|
RFA Aortic arch and Brachial artery Views W contrast IA |
|
37379-5
|
RFA Aortic arch and Upper Extremity artery Views W contrast IA |
|
30832-0
|
RFA Adrenal artery Views W contrast IA |
|
30831-2
|
RFA Adrenal artery - bilateral Views W contrast IA |
|
37387-8
|
RFA Adrenal artery - left Views W contrast IA |
|
37939-6
|
RFA Adrenal artery - right Views W contrast IA |
|
30843-7
|
RFA Adrenal vein Views W contrast IV |
|
30844-5
|
RFA Adrenal vein - bilateral Views W contrast IV |
|
86461-1
|
RFA Adrenal vessel Views |
|
37602-0
|
RFA Adrenal vein - left Views W contrast IV |
|
37940-4
|
RFA Adrenal vein - right Views W contrast IV |
|
38861-1
|
RFA Ankle arteries - left Views W contrast IA |
|
37941-2
|
RFA Ankle arteries - right Views W contrast IA |
|
69054-5
|
RFA Aortic arch Views W contrast IA |
|
37594-9
|
RFA Carotid artery and Vertebral artery Views W contrast IA |
|
37587-3
|
RFA Aortic arch and Carotid artery - bilateral and Vertebral artery - bilateral Views W contrast IA |
|
37588-1
|
RFA Common carotid artery - bilateral Views W contrast IA |
|
37589-9
|
RFA Common carotid artery - left Views W contrast IA |
|
37590-7
|
RFA Common carotid artery - right Views W contrast IA |
|
37591-5
|
RFA Aortic arch and External carotid artery - bilateral Views W contrast IA |
|
37592-3
|
RFA Aortic arch and External carotid artery - left Views W contrast IA |
|
37593-1
|
RFA Aortic arch and External carotid artery - right Views W contrast IA |
|
37382-9
|
RFA Aortic arch and Subclavian artery Views W contrast IA |
|
37383-7
|
RFA Aortic arch and Subclavian artery - left Views W contrast IA |
|
38800-9
|
RFA Aortic arch and Subclavian artery - right Views W contrast IA |
|
37385-2
|
RFA Aortic arch and Vertebral artery - left Views W contrast IA |
|
37386-0
|
RFA Aortic arch and Vertebral artery - right Views W contrast IA |
|
30838-7
|
RFA Aorta and Femoral artery - bilateral Runoff W contrast IA |
|
37364-7
|
RFA Aorta and Femoral artery - left Runoff W contrast IA |
|
38799-3
|
RFA Aorta and Femoral artery - right Runoff W contrast IA |
|
24569-6
|
RFA AV shunt Views W contrast IV |
|
24551-4
|
RFA AV fistula Views W contrast IA |
|
58746-9
|
RFA AV fistula Views W contrast IV |
|
39363-7
|
RFA AV fistula Views W contrast retrograde |
|
37411-6
|
RFA Azygos vein Views W contrast IV |
|
24576-1
|
RFA Urinary bladder arteries Views W contrast IA |
|
30828-8
|
RFA Brachial artery Views W contrast IA |
|
69077-6
|
RFA Brachiocephalic artery Views W contrast IA |
|
37388-6
|
RFA Brachial artery - bilateral Views W contrast IA |
|
37389-4
|
RFA Bronchial artery Views W contrast IA |
|
37595-6
|
RFA Coronary arteries Views for graft W contrast IA |
|
37174-0
|
RFA Coronary arteries Views W contrast IA |
|
39098-9
|
RFA Carotid artery.cervical.bilateral Views W contrast IA |
|
38863-7
|
RFA Carotid artery.cervical - left Views W contrast IA |
|
39094-8
|
RFA Carotid artery.cervical Views W contrast IA |
|
37945-3
|
RFA Carotid artery.cervical - right Views W contrast IA |
|
30821-3
|
RFA Carotid artery.external Views W contrast IA |
|
30820-5
|
RFA Carotid artery.external - bilateral Views W contrast IA |
|
37390-2
|
RFA Carotid artery.external - left Views W contrast IA |
|
37948-7
|
RFA Carotid artery.external - right Views W contrast IA |
|
38864-5
|
RFA Carotid artery.internal - left Views W contrast IA |
|
37952-9
|
RFA Carotid artery.internal - right Views W contrast IA |
|
38865-2
|
RFA Carotid artery and Cerebral artery internal - left Views W contrast IA |
|
37953-7
|
RFA Carotid artery and Cerebral artery internal - right Views W contrast IA |
|
39095-5
|
RFA Carotid artery and Cerebral artery Views W contrast IA |
|
38862-9
|
RFA Carotid artery and Cerebral artery - left Views W contrast IA |
|
37944-6
|
RFA Carotid artery and Cerebral artery - right Views W contrast IA |
|
37391-0
|
RFA Carotid arteries and Vertebral artery Views W contrast IA |
|
37392-8
|
RFA Carotid arteries and Vertebral artery - bilateral Views W contrast IA |
|
37393-6
|
RFA Carotid arteries and Vertebral artery - left Views W contrast IA |
|
37943-8
|
RFA Carotid arteries and Vertebral artery - right Views W contrast IA |
|
39097-1
|
RFA Carotid artery - bilateral and Cerebral artery - bilateral Views W contrast IA |
|
37381-1
|
RFA Carotid artery Views W contrast IA |
|
24617-3
|
RFA Carotid arteries Views W contrast IA |
|
26079-4
|
RFA Carotid arteries - bilateral Views W contrast IA |
|
26080-2
|
RFA Carotid arteries - left Views W contrast IA |
|
26081-0
|
RFA Carotid arteries -right Views W contrast IA |
|
86434-8
|
RFA Carotid arteries - unilateral Views W contrast IA |
|
37403-3
|
RFA Celiac artery and Gastric artery - left and Superior mesenteric artery Views W contrast IA |
|
24622-3
|
RFA Celiac artery Views W contrast IA |
|
37394-4
|
RFA Celiac artery and Superior mesenteric artery and Inferior mesenteric artery Views W contrast IA |
|
86431-4
|
RFA Cerebral arteries - bilateral and Cervical arteries - bilateral Views W contrast IA |
|
86432-2
|
RFA Cerebral arteries - unilateral and Cervical arteries - unilateral Views W contrast IA |
|
37173-2
|
RFA Cerebral artery Views W contrast IA |
|
86417-3
|
RFA Cerebral arteries Bilateral Views W contrast IA |
|
86429-8
|
RFA Cerebral arteries - unilateral Views W contrast IA |
|
37195-5
|
RFA Cerebral vein Views W contrast IV |
|
94091-6
|
RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty |
|
94090-8
|
RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty transcatheter placement of stent |
|
30819-7
|
RFA Epidural veins Views W contrast IV |
|
94095-7
|
RFA Extremity vessels Unilateral Views W contrast IV |
|
30848-6
|
RFA Extremity arteries Views W contrast IA |
|
30849-4
|
RFA Extremity arteries - bilateral Views W contrast IA |
|
37395-1
|
RFA Extremity arteries - left Views W contrast IA |
|
37949-5
|
RFA Extremity arteries - right Views W contrast IA |
|
86428-0
|
RFA Extremity arteries - unilateral Views W contrast IA |
|
39055-9
|
RFA Extremity veins Views W contrast IV |
|
37412-4
|
RFA Extremity veins - bilateral Views W contrast IV |
|
37413-2
|
RFA Extremity veins - left Views W contrast IV |
|
37950-3
|
RFA Extremity veins - right Views W contrast IV |
|
86396-9
|
RFA Extremity veins - unilateral Views W contrast IV |
|
30850-2
|
RFA Extremity lymphatic vessels Views W contrast intra lymphatic |
|
30851-0
|
RFA Extremity lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
37599-8
|
RFA Extremity lymphatic vessels - left Views W contrast intra lymphatic |
|
38812-4
|
RFA Extremity lymphatic vessels - right Views W contrast intra lymphatic |
|
42157-8
|
RFA Extremity vessels Views W contrast IV |
|
24699-1
|
RFA Femoral artery Runoff W contrast IA |
|
49511-9
|
RFA Femoral artery Runoff WO and W contrast IA |
|
37175-7
|
RFA Femoral artery Views W contrast IA |
|
37176-5
|
RFA Femoral artery and Popliteal artery Views W contrast IA |
|
26178-4
|
RFA Femoral artery - bilateral Runoff W contrast IA |
|
26179-2
|
RFA Femoral artery - left Runoff W contrast IA |
|
26180-0
|
RFA Femoral artery - right Runoff W contrast IA |
|
37416-5
|
RFA Femoral vein Views W contrast IV |
|
37397-7
|
RFA Gastric artery Views W contrast IA |
|
37398-5
|
RFA Gastric artery - left Views W contrast IA |
|
38801-7
|
RFA Gastric artery right Views W contrast IA |
|
37399-3
|
RFA Gastroduodenal artery Views W contrast IA |
|
25028-2
|
RFA Guidance for placement of catheter for infusion of thrombolytic in Vessel-- W contrast intravascular |
|
69067-7
|
RFA Guidance for angioplasty of Unspecified body region-- W contrast |
|
24554-8
|
RFA Guidance for embolization of Artery-- W contrast IA |
|
24555-5
|
RFA Guidance for placement of stent in Artery |
|
65798-1
|
RFA Guidance for placement of stent in Artery - right |
|
65797-3
|
RFA Guidance for placement of stent in Artery - left |
|
36760-7
|
RFA Guidance for angioplasty of AV shunt-- W contrast |
|
24568-8
|
RFA Guidance for atherectomy of AV fistula-- W contrast IV |
|
24580-3
|
RFA Guidance for angioplasty of Brachiocephalic artery-- W contrast IA |
|
36766-4
|
RFA Guidance for atherectomy of Coronary arteries-- W contrast IA |
|
24614-0
|
RFA Guidance for angioplasty of Carotid artery extracranial-- W contrast IA |
|
24615-7
|
RFA Guidance for angioplasty of Carotid artery.intracranial-- W contrast IA |
|
24684-3
|
RFA Guidance for embolectomy of Extracranial vessels-- W contrast IA |
|
35881-2
|
RFA Guidance for angioplasty of Extremity artery-- W contrast IA |
|
36762-3
|
RFA Guidance for angioplasty of Extremity vessel-- W contrast |
|
24698-3
|
RFA Guidance for angioplasty of Femoral artery-- W contrast IA |
|
36763-1
|
RFA Guidance for angioplasty of Femoral artery and Popliteal artery-- W contrast IA |
|
36764-9
|
RFA Guidance for atherectomy of Femoral vessel and Popliteal artery-- W contrast |
|
25077-9
|
RFA Guidance for placement of catheter in Hepatic artery-- W contrast IA |
|
24553-0
|
RFA Guidance for embolectomy of Intracranial vessel-- W contrast IV |
|
24766-8
|
RFA Guidance for angioplasty of Iliac artery-- W contrast IA |
|
69135-2
|
RFA Guidance for atherectomy of Iliac artery-- W contrast |
|
69134-5
|
RFA Guidance for placement of stent in Iliac artery |
|
26370-7
|
RFA Guidance for angioplasty of Iliac artery - bilateral-- W contrast IA |
|
26371-5
|
RFA Guidance for angioplasty of Iliac artery - left-- W contrast IA |
|
62491-6
|
RFA Guidance for placement of prosthesis in Iliac artery - left-- W contrast IA |
|
26372-3
|
RFA Guidance for angioplasty of Iliac artery - right-- W contrast IA |
|
62492-4
|
RFA Guidance for placement of prosthesis in Iliac artery - right-- W contrast IA |
|
86464-5
|
RFA Guidance for repair of aneurysm or dissection of Infrarenal aorta |
|
42334-3
|
RFA Guidance for injection of Internal thoracic artery - left |
|
35882-0
|
RFA Guidance for angioplasty of Inferior vena cava-- W contrast IV |
|
25026-6
|
RFA Guidance for placement of venous filter in Inferior vena cava-- W contrast IV |
|
37426-4
|
RFA Guidance for angioplasty of Lower extremity vein-- W contrast IV |
|
44219-4
|
RFA Guidance for fine needle aspiration of Lymph node |
|
24832-8
|
RFA Guidance for angioplasty of Mesenteric artery-- W contrast IA |
|
24887-2
|
RFA Guidance for embolectomy of Pulmonary arteries-- W contrast IA |
|
69252-5
|
RFA Guidance for percutaneous transluminal angioplasty of Pulmonary arteries-- W contrast IA |
|
30649-8
|
RFA Guidance for Additional angioplasty of Peripheral artery-- W contrast IA |
|
24882-3
|
RFA Guidance for percutaneous transluminal angioplasty of Popliteal artery-- W contrast IA |
|
41801-2
|
RFA Guidance for placement of catheter in Portal vein-- W contrast IV |
|
51391-1
|
RFA Guidance for placement of TIPS of Portal vein and Hepatic vein |
|
69248-3
|
RFA Guidance for percutaneous transluminal angioplasty of Renal artery-- W contrast IA |
|
25081-1
|
RFA Guidance for angioplasty of Renal vessel-- W contrast IA |
|
69253-3
|
RFA Guidance for atherectomy of Renal vessels-- W contrast |
|
24543-1
|
RFA Guidance for angioplasty of Thoracic and abdominal aorta-- W contrast IA |
|
35883-8
|
RFA Guidance for atherectomy of Thoracic and abdominal aorta-- W contrast IA |
|
43793-9
|
RFA Guidance for angioplasty of Tibioperoneal arteries-- W contrast IA |
|
43794-7
|
RFA Guidance for angioplasty of Tibioperoneal arteries - bilateral-- W contrast IA |
|
43795-4
|
RFA Guidance for angioplasty of Tibioperoneal arteries - left-- W contrast IA |
|
43792-1
|
RFA Guidance for angioplasty of Tibioperoneal arteries - right-- W contrast IA |
|
69301-0
|
RFA Guidance for percutaneous transluminal angioplasty of Upper extremity vein-- W contrast IV |
|
30641-5
|
RFA Guidance for Additional angioplasty of Vein-- W contrast IV |
|
30640-7
|
RFA Guidance for angioplasty of Vein-- W contrast IV |
|
24755-1
|
RFA Guidance for atherectomy of Vein-- W contrast IV |
|
24624-9
|
RFA Guidance for change of CV catheter in Vein-- W contrast IV |
|
72546-5
|
RFA Guidance for removal of CV catheter lumen obstruction of Vein |
|
72547-3
|
RFA Guidance for removal of CV catheter pericatheter obstruction of Vein |
|
24625-6
|
RFA Guidance for placement of CV catheter in Vein-- W contrast IV |
|
72548-1
|
RFA Guidance for removal of CV catheter from Vein-- W contrast IV |
|
24626-4
|
RFA Guidance for reposition of CV catheter in Vein-- W contrast IV |
|
72550-7
|
RFA Guidance for repair of CV catheter with port or pump of Vein |
|
72551-5
|
RFA Guidance for repair of CV catheter without port or pump of Vein |
|
72538-2
|
RFA Guidance for removal of peripherally-inserted central venous catheter from Vein |
|
25024-1
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein |
|
42018-2
|
RFA Guidance for percutaneous transluminal angioplasty of Vein-- W contrast IA |
|
24756-9
|
RFA Guidance for placement of stent in Vein |
|
43763-2
|
RFA Guidance for thrombectomy of Vein-- W contrast IV |
|
26298-0
|
RFA Guidance for atherectomy of Vein - bilateral-- W contrast IV |
|
26331-9
|
RFA Guidance for change of CV catheter in Vein - bilateral-- W contrast IV |
|
26310-3
|
RFA Guidance for placement of CV catheter in Vein - bilateral-- W contrast IV |
|
26295-6
|
RFA Guidance for reposition of CV catheter in Vein - bilateral-- W contrast IV |
|
26304-6
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - bilateral |
|
26301-2
|
RFA Guidance for placement of stent in Vein - bilateral |
|
43761-6
|
RFA Guidance for thrombectomy of Vein - bilateral-- W contrast IV |
|
26299-8
|
RFA Guidance for atherectomy of Vein - left-- W contrast IV |
|
26332-7
|
RFA Guidance for change of CV catheter in Vein - left-- W contrast IV |
|
26311-1
|
RFA Guidance for placement of CV catheter in Vein - left-- W contrast IV |
|
26296-4
|
RFA Guidance for reposition of CV catheter in Vein - left-- W contrast IV |
|
26305-3
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - left |
|
26302-0
|
RFA Guidance for placement of stent in Vein - left |
|
43762-4
|
RFA Guidance for thrombectomy of Vein - left-- W contrast IV |
|
26300-4
|
RFA Guidance for atherectomy of Vein - right-- W contrast IV |
|
26333-5
|
RFA Guidance for change of CV catheter in Vein - right-- W contrast IV |
|
26312-9
|
RFA Guidance for placement of CV catheter in Vein - right-- W contrast IV |
|
26297-2
|
RFA Guidance for reposition of CV catheter in Vein - right-- W contrast IV |
|
26306-1
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - right |
|
26303-8
|
RFA Guidance for placement of stent in Vein - right |
|
43764-0
|
RFA Guidance for thrombectomy of Vein - right-- W contrast IV |
|
36765-6
|
RFA Guidance for atherectomy of Vessel-- W contrast |
|
25073-8
|
RFA Guidance for removal of foreign body from Vessel |
|
39138-3
|
RFA Guidance for vascular access of Vessel |
|
25029-0
|
RFA Guidance for placement of catheter for vasoconstrictor infusion in Vessels |
|
30836-1
|
RFA Guidance for angioplasty of Visceral artery-- W contrast IA |
|
62448-6
|
RFA Head artery - left and Neck artery - left Views W contrast IA |
|
62449-4
|
RFA Head artery - right and Neck artery - right Views W contrast IA |
|
30823-9
|
RFA Head artery and Neck artery Views W contrast IA |
|
30822-1
|
RFA Head artery - bilateral and Neck artery - bilateral Views W contrast IA |
|
25076-1
|
RFA Hepatic artery Views W contrast IA |
|
39093-0
|
RFA Hepatic veins Views W contrast IV |
|
39096-3
|
RFA Hepatic veins Views for hemodynamics W contrast IV |
|
30824-7
|
RFA Intercranial vessel and Neck Vessel Views W contrast |
|
43782-2
|
RFA Iliac artery Views W contrast IA |
|
24862-5
|
RFA Iliac artery Internal Views W contrast IA |
|
37177-3
|
RFA Iliac artery - bilateral Views W contrast IA |
|
37178-1
|
RFA Iliac artery - left Views W contrast IA |
|
37739-0
|
RFA Iliac artery - right Views W contrast IA |
|
37179-9
|
RFA Inferior mesenteric artery Views W contrast IA |
|
37421-5
|
RFA Inferior mesenteric vein Views W contrast IV |
|
37401-7
|
RFA Internal maxillary artery Views W contrast IA |
|
37419-9
|
RFA Intraosseous veins Views W contrast IV |
|
37404-1
|
RFA Internal pudendal artery Views W contrast IA |
|
30829-6
|
RFA Internal thoracic artery Views W contrast IA |
|
64995-4
|
RFA Internal thoracic artery - left Views W contrast IA |
|
65000-2
|
RFA Internal thoracic artery - right Views W contrast IA |
|
30845-2
|
RFA Inferior vena cava Views W contrast IV |
|
86435-5
|
RFA Jugular vein - bilateral Views W contrast IV |
|
86426-4
|
RFA Jugular vein - unilateral Views W contrast IV |
|
37487-6
|
RFA Lower extremity arteries Views W contrast IA |
|
47986-5
|
RFA Lower extremity arteries - left Views W contrast IA |
|
47987-3
|
RFA Lower extremity arteries - right Views W contrast IA |
|
37574-1
|
RFA Lower extremity vessels Views W contrast IV |
|
38853-8
|
RFA Lower extremity vessels - left Views W contrast |
|
37765-5
|
RFA Lower extremity vessels - right Views W contrast |
|
37414-0
|
RFA Lower extremity veins - bilateral Views W contrast IV |
|
37196-3
|
RFA Lower extremity veins - left Views W contrast IV |
|
37767-1
|
RFA Lower extremity veins - right Views W contrast IV |
|
86433-0
|
RFA Lumbar spine intercostal arteries Views W contrast IA |
|
24827-8
|
RFA Lymphatic vessels Views W contrast intra lymphatic |
|
37600-4
|
RFA Lymphatic vessels - left Views W contrast intra lymphatic |
|
38813-2
|
RFA Lymphatic vessels - right Views W contrast intra lymphatic |
|
24833-6
|
RFA Mesenteric artery Views W contrast IA |
|
30825-4
|
RFA Orbit veins Views W contrast IV |
|
37422-3
|
RFA Orbit veins - left Views W contrast IV |
|
37958-6
|
RFA Orbit veins - right Views W contrast IV |
|
39057-5
|
RFA Pulmonary arteries Views W contrast IA |
|
30830-4
|
RFA Pulmonary artery - bilateral Views W contrast IA |
|
37182-3
|
RFA Pulmonary arteries - left Views W contrast IA |
|
24860-9
|
RFA Pancreatic artery Views W contrast IA |
|
37779-6
|
RFA Right pulmonary arteries Views W contrast IA |
|
86412-4
|
RFA Pedal lymphatic vessels Views W contrast intra lymphatic |
|
86374-6
|
RFA Pedal lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
86375-3
|
RFA Pedal lymphatic vessels - unilateral Views W contrast intra lymphatic |
|
39510-3
|
RFA Pelvic lymphatic vessels Views W contrast intra lymphatic |
|
37601-2
|
RFA Pelvic lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
30833-8
|
RFA Pelvis arteries Views W contrast IA |
|
37935-4
|
RFA Pelvis arteries and Lower extremity arteries - bilateral Views W contrast IA |
|
37615-2
|
RFA Pelvis vessels Views W contrast |
|
30648-0
|
RFA Peripheral artery Views for angioplasty W contrast IA |
|
24874-0
|
RFA Peripheral arteries Views W contrast IA |
|
37936-2
|
RFA Peripheral vessels Views W contrast |
|
24685-0
|
RFA Peripheral veins Views W contrast IV |
|
44240-0
|
RFA Peripheral arteries - bilateral Views W contrast IA |
|
30852-8
|
RFA XXX>Peripheral veins - bilateral Views W contrast IV |
|
30816-3
|
RFA Peritoneum Views W contrast percutaneous intraperitoneal |
|
69249-1
|
RFA Popliteal artery Views W contrast IA |
|
37181-5
|
RFA Popliteal artery - left Views W contrast IA |
|
37778-8
|
RFA Popliteal artery - right Views W contrast IA |
|
69250-9
|
RFA Portal vein Views W contrast IV |
|
30841-1
|
RFA Portal vein Views W contrast transhepatic |
|
30842-9
|
RFA Portal vein Views for hemodynamics W contrast transhepatic |
|
86418-1
|
RFA Pulmonary arteries - unilateral Views W contrast IA |
|
25079-5
|
RFA Renal arteries Views W contrast IA |
|
86414-0
|
RFA Renal arteries - unilateral Views W contrast IA |
|
30834-6
|
RFA Renal artery - bilateral Views W contrast IA |
|
62446-0
|
RFA Renal artery - left Views W contrast IA |
|
62447-8
|
RFA Renal artery - right Views W contrast IA |
|
30847-8
|
RFA Renal vein Views W contrast IV |
|
43783-0
|
RFA Renal vein Views for renin sampling W contrast IV |
|
30846-0
|
RFA Renal vein - bilateral Views W contrast IV |
|
25080-3
|
RFA Renal vein - bilateral Views for renin sampling W contrast IV |
|
37640-0
|
RFA Renal vessels Views W contrast |
|
64140-7
|
RFA Renal vessels - left Views W contrast |
|
64141-5
|
RFA Renal vessels - right Views W contrast |
|
37423-1
|
RFA Renal vein - left Views W contrast IV |
|
37959-4
|
RFA Renal vein - right Views W contrast IV |
|
86415-7
|
RFA Renal vein - unilateral Views W contrast IV |
|
37969-3
|
RFA Sinus vein Views W contrast IV |
|
37180-7
|
RFA Superior mesenteric artery Views W contrast IA |
|
37402-5
|
RFA Superior mesenteric artery and Inferior mesenteric artery Views W contrast IA |
|
37972-7
|
RFA Superior mesenteric vein Views W contrast IV |
|
24925-0
|
RFA Spinal artery Views W contrast IA |
|
26082-8
|
RFA Spinal artery - bilateral Views W contrast IA |
|
26083-6
|
RFA Spinal artery - left Views W contrast IA |
|
26084-4
|
RFA Spinal artery - right Views W contrast IA |
|
86460-3
|
RFA Spine vessel Views |
|
24992-0
|
RFA Splenic artery Views W contrast IA |
|
37970-1
|
RFA Splenic vein Views W contrast IV |
|
24991-2
|
RFA Splenic vein and Portal vein Views W contrast IA |
|
24581-1
|
RFA Subclavian artery and Brachial artery Views W contrast IA |
|
37886-9
|
RFA Subclavian artery Views W contrast IA |
|
37405-8
|
RFA Subclavian artery - bilateral Views W contrast IA |
|
37406-6
|
RFA Subclavian artery - left Views W contrast IA |
|
37966-9
|
RFA Subclavian artery - right Views W contrast IA |
|
37971-9
|
RFA Subclavian vein Views W contrast IV |
|
30645-6
|
RFA Superior vena cava Views W contrast IV |
|
24658-7
|
RFA Thoracic and abdominal aorta Views W contrast IA |
|
86394-4
|
RFA Thoracic Aorta Views W contrast IA |
|
38119-4
|
RFA Thoracic artery Views W contrast IA |
|
37489-2
|
RFA Tibioperoneal arteries Views W contrast IA |
|
37977-6
|
RFA Upper extremity arteries Views W contrast IA |
|
37396-9
|
RFA Upper extremity arteries - bilateral Views W contrast IA |
|
37488-4
|
RFA Upper extremity arteries - left Views W contrast IA |
|
37967-7
|
RFA Upper extremity arteries - right Views W contrast IA |
|
37976-8
|
RFA Upper extremity vessels Views W contrast |
|
24550-6
|
RFA Upper extremity veins Views W contrast IV |
|
37415-7
|
RFA Upper extremity veins - bilateral Views W contrast IV |
|
38859-5
|
RFA Upper extremity veins - left Views W contrast IV |
|
37824-0
|
RFA Upper extremity veins - right Views W contrast IV |
|
37979-2
|
RFA Uterine artery Views W contrast IA |
|
37384-5
|
RFA Vertebral artery Views W contrast IA |
|
37407-4
|
RFA Vertebral artery - bilateral Views W contrast IA |
|
37490-0
|
RFA Vertebral artery - left Views W contrast IA |
|
37968-5
|
RFA Vertebral artery - right Views W contrast IA |
|
25023-3
|
RFA Vein Views W contrast IV |
|
26064-6
|
RFA Vein - bilateral Views W contrast IV |
|
26065-3
|
RFA Vein - left Views W contrast IV |
|
26066-1
|
RFA Vein - right Views W contrast IV |
|
25025-8
|
RFA Vena cava Views W contrast IV |
|
86442-1
|
RFA Vertebral artery - unilateral Views W contrast IA |
|
37980-0
|
RFA Vertebral vessels Views W contrast |
|
30639-9
|
RFA Vessel Single view W contrast |
|
25063-9
|
RFA Vessel Single view W contrast IA |
|
25064-7
|
RFA Vessel Views for angioplasty W contrast IA |
|
42156-0
|
RFA Vessels Views W contrast IA |
|
43554-5
|
RFA Vessels - left Views W contrast IV |
|
86419-9
|
RFA Visceral arteries Views W contrast IA |
|
37981-8
|
RFA Visceral vessels Views W contrast |
|
94092-4
|
RFA Views for dialysis fistula W contrast IA |
|
94094-0
|
RFA Unspecified body region Limited Views for therapy or embolization or infusion W contrast via existing catheter |
|
5559-0
|
RFD9 [Units/volume] in Leukocytes |
|
68965-3
|
Rg Ag [Presence] on Red Blood Cells |
|
58072-0
|
Rg sup(a) Ab [Presence] in Serum or Plasma |
|
58071-2
|
Rg sup(a) Ag [Presence] on Red Blood Cells |
|
17531-5
|
Rh [Type] in Amniotic fluid |
|
10331-7
|
Rh [Type] in Blood |
|
14907-0
|
Rh [Type] in Blood from Blood product unit |
|
34961-3
|
Rh [Type] in Blood by Confirmatory method |
|
52792-9
|
Father's Rh Type |
|
54416-3
|
Rh [Type] in Blood from Fetus |
|
14908-8
|
Rh [Type] in Blood from Newborn |
|
14906-2
|
Rh [Type] in Cord blood |
|
88027-8
|
Rh group Ag [Type] on Red Blood Cells |
|
72280-1
|
Rh immune globulin expiration [Date and time] |
|
54411-4
|
Rh immune globulin given Qualitative |
|
10413-3
|
Rh immune globulin given [Volume] |
|
1314-4
|
Rh immune globulin screen [interpretation] |
|
1313-6
|
Rh immune globulin dosage.vials recommended [#] |
|
46277-0
|
RhoGam given by provider [Identifier] |
|
46276-2
|
Rh [Type] in Blood--after transfusion reaction |
|
85505-6
|
Presumptive Rh [Type] in Saliva (oral fluid) by Molecular genetics method |
|
65332-9
|
Rh32 Ab [Presence] in Serum or Plasma |
|
46731-6
|
RHC gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
|
34741-9
|
RHCE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42316-0
|
RHD gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
|
35465-4
|
RHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42325-1
|
RHD+RHC gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
|
23574-7
|
Viral hemorrhagic disease virus Ab [Presence] in Serum |
|
23577-0
|
Viral hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
|
31699-2
|
Viral hemorrhagic disease virus Ab [Units/volume] in Serum |
|
23575-4
|
Viral hemorrhagic disease virus Ab [Titer] in Serum |
|
23578-8
|
Viral hemorrhagic disease virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
23576-2
|
Viral hemorrhagic disease virus Ab [Titer] in Serum by Immunoassay |
|
34886-2
|
Viral hemorrhagic disease virus Ab [Titer] in Serum by Neutralization test |
|
23581-2
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Agglutination |
|
23580-4
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immunoassay |
|
23579-6
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immunofluorescence |
|
23582-0
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immune stain |
|
23573-9
|
Viral hemorrhagic disease virus [Presence] in Tissue by Electron microscopy |
|
48030-1
|
RHE gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
|
88982-4
|
Rheumatoid arthritis disease activity level [CDAI] |
|
90094-4
|
Rheumatoid arthritis disease severity level [RAPID3] |
|
29351-4
|
Rheumatoid factor [Presence] in Cerebral spinal fluid |
|
14034-3
|
Rheumatoid factor [Units/volume] in Cerebral spinal fluid |
|
17534-9
|
Rheumatoid factor [Units/volume] in Body fluid by Immunoassay |
|
15203-3
|
Rheumatoid factor [Units/volume] in Body fluid by Nephelometry |
|
31046-6
|
Rheumatoid factor [Presence] in Body fluid |
|
45156-7
|
Rheumatoid factor [Presence] in Body fluid by Latex agglutination |
|
25745-1
|
Rheumatoid factor [Presence] in Body fluid by Sheep Cell Agglutination |
|
63313-1
|
Rheumatoid factor [Units/volume] in Body fluid by Sheep Cell Agglutination |
|
30231-5
|
Rheumatoid factor [Units/volume] in Body fluid |
|
53562-5
|
Rheumatoid factor [Units/volume] in Pleural fluid |
|
6928-6
|
Rheumatoid factor [Units/volume] in Serum by Immunoassay |
|
15205-8
|
Rheumatoid factor [Units/volume] in Serum by Nephelometry |
|
33910-1
|
Rheumatoid factor [Presence] in Serum |
|
5297-7
|
Rheumatoid factor [Presence] in Serum by Latex agglutination |
|
5298-5
|
Rheumatoid factor [Presence] in Serum by Sheep Cell Agglutination |
|
11572-5
|
Rheumatoid factor [Units/volume] in Serum or Plasma |
|
15206-6
|
Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry |
|
6823-9
|
Rheumatoid factor [Presence] in Synovial fluid by Latex agglutination |
|
13634-1
|
Rheumatoid factor [Units/volume] in Synovial fluid |
|
43932-3
|
Rheumatoid factor [Titer] in Body fluid |
|
25746-9
|
Rheumatoid factor [Titer] in Body fluid by Sheep Cell Agglutination |
|
17857-4
|
Rheumatoid factor [Titer] in Serum |
|
5299-3
|
Rheumatoid factor [Titer] in Serum by Latex agglutination |
|
15204-1
|
Rheumatoid factor [Titer] in Serum by Nephelometry |
|
5300-9
|
Rheumatoid factor [Titer] in Serum by Sheep Cell Agglutination |
|
13930-3
|
Rheumatoid factor [Titer] in Synovial fluid by Agglutination |
|
53924-7
|
Rheumatoid factor [Titer] in Synovial fluid by Latex agglutination |
|
13929-5
|
Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination |
|
83698-1
|
Rheumatology Attending Note |
|
34839-1
|
Rheumatology Consult note |
|
78571-7
|
Rheumatology Diagnostic study note |
|
85434-9
|
Rheumatology Discharge summary |
|
78600-4
|
Rheumatology Education note |
|
83745-0
|
Rheumatology Fellow Note |
|
78639-2
|
Rheumatology Flowsheet |
|
83947-2
|
Rheumatology Hospital Note |
|
78652-5
|
Rheumatology Initial evaluation note |
|
34840-9
|
Rheumatology Note |
|
83595-9
|
Rheumatology Nurse Note |
|
83596-7
|
Rheumatology Nurse Outpatient Note |
|
83948-0
|
Rheumatology Outpatient Note |
|
83949-8
|
Rheumatology Telephone encounter Note |
|
80774-3
|
Rheumatology Plan of care note |
|
78660-8
|
Rheumatology procedure note |
|
78666-5
|
Rheumatology Progress note |
|
57163-8
|
Rheumatology Referral note |
|
83776-5
|
Rheumatology Resident Note |
|
89900-5
|
Rheumatology Telehealth Note |
|
83950-6
|
Rheumatology Transfer summary note |
|
80596-0
|
Rhinovirus 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection |
|
40993-8
|
Rhinovirus Ag [Identifier] in Unspecified specimen by Neutralization test |
|
88213-4
|
Rhinovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
91131-3
|
Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
77025-5
|
Rhinovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92130-4
|
Rhinovirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91793-0
|
Rhinovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40990-4
|
Rhinovirus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
7993-9
|
Rhinovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55222-4
|
Microscopic observation [Identifier] in Aspirate by Rhodamine-auramine fluorochrome stain |
|
53522-9
|
Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain |
|
53906-4
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain |
|
53914-8
|
Microscopic observation [Identifier] in Endometrium by Rhodamine-auramine fluorochrome stain |
|
53912-2
|
Microscopic observation [Identifier] in Body fluid by Rhodamine-auramine fluorochrome stain |
|
53916-3
|
Microscopic observation [Identifier] in Gastric fluid by Rhodamine-auramine fluorochrome stain |
|
53918-9
|
Microscopic observation [Identifier] in Bone marrow by Rhodamine-auramine fluorochrome stain |
|
53915-5
|
Microscopic observation [Identifier] in Pericardial fluid by Rhodamine-auramine fluorochrome stain |
|
53907-2
|
Microscopic observation [Identifier] in Pleural fluid by Rhodamine-auramine fluorochrome stain |
|
53910-6
|
Microscopic observation [Identifier] in Peritoneal fluid by Rhodamine-auramine fluorochrome stain |
|
53913-0
|
Microscopic observation [Identifier] in Synovial fluid by Rhodamine-auramine fluorochrome stain |
|
53904-9
|
Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain |
|
6677-9
|
Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |
|
53905-6
|
Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain |
|
676-7
|
Microscopic observation [Identifier] in Unspecified specimen by Rhodamine-auramine fluorochrome stain |
|
92804-4
|
Rhodotorula spp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
7665-3
|
Rhodotorula spp IgE Ab [Units/volume] in Serum |
|
15992-1
|
Rhodotorula spp IgE Ab RAST class [Presence] in Serum |
|
19148-6
|
RhoGam candidate (yes/no) |
|
51888-6
|
Rh immune globulin units given [#] |
|
7667-9
|
Rhubarb IgE Ab [Units/volume] in Serum |
|
15993-9
|
Rhubarb IgE Ab RAST class [Presence] in Serum |
|
56378-3
|
Rhubarb IgG4 Ab [Mass/volume] in Serum |
|
63105-1
|
Rhubarb IgG Ab [Mass/volume] in Serum |
|
88104-5
|
Rhythmic or arrhythmic heart rate |
|
8619-9
|
Rhythm segment [Interpretation] by EKG |
|
9874-9
|
Rhythm segment [Interpretation] Narrative by EKG |
|
15332-0
|
Penile cavernosal artery Resistance index--baseline by US.calculated |
|
12023-8
|
Resistivity index US.doppler |
|
15333-8
|
Penile cavernosal artery Resistance index--post XXX challenge by US.calculated |
|
80257-9
|
Ramus intermedius branch from left main coronary artery [Presence] on Angiogram |
|
85556-9
|
Rothman Index Calculated |
|
41469-8
|
Ribavirin [Mass/volume] in Serum or Plasma |
|
47884-2
|
Ribitol/Creatinine [Molar ratio] in Urine |
|
2926-4
|
Ribose [Mass/volume] in Serum |
|
32268-5
|
Ribose [Presence] in Urine |
|
63322-2
|
Ribosomal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63320-6
|
Ribosomal Ab [Presence] in Body fluid by Immunofluorescence |
|
31590-3
|
Ribosomal Ab [Presence] in Serum |
|
25747-7
|
Ribosomal Ab [Presence] in Serum by Immunoassay |
|
53009-7
|
Ribosomal Ab [Presence] in Serum by Immunofluorescence |
|
89504-5
|
Ribosomal Ab [Presence] in Serum by Line blot |
|
31589-5
|
Ribosomal Ab [Units/volume] in Serum |
|
63323-0
|
Ribosomal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63321-4
|
Ribosomal Ab [Titer] in Body fluid by Immunofluorescence |
|
13635-8
|
Ribosomal Ab [Titer] in Serum |
|
25748-5
|
Ribosomal Ab [Titer] in Serum by Immunofluorescence |
|
63324-8
|
Ribosomal IgG Ab [Presence] in Serum by Immunoassay |
|
63325-5
|
Ribosomal IgG Ab [Titer] in Serum by Immunoassay |
|
63327-1
|
Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89534-2
|
Ribosomal P Ab [Presence] in Cerebral spinal fluid by Line blot |
|
21487-4
|
Ribosomal P Ab [Units/volume] in Cerebral spinal fluid |
|
63541-7
|
Ribosomal P Ab [Presence] in Body fluid |
|
63326-3
|
Ribosomal P Ab [Presence] in Body fluid by Immunoassay |
|
47301-7
|
Ribosomal P Ab [Units/volume] in Serum by Immunoassay |
|
31592-9
|
Ribosomal P Ab [Presence] in Serum |
|
56732-1
|
Ribosomal P Ab [Presence] in Serum by Immunoblot |
|
13636-6
|
Ribosomal P Ab [Units/volume] in Serum |
|
45226-8
|
Ribosomal P IgG Ab [Presence] in Serum |
|
53892-6
|
Ribosomal P IgG Ab [Units/volume] in Serum |
|
2927-2
|
Ribulose [Mass/volume] in Serum |
|
7669-5
|
Rice triggered histamine release [Units/volume] in Blood |
|
6230-7
|
Rice IgE Ab [Units/volume] in Serum |
|
15994-7
|
Rice IgE Ab RAST class [Presence] in Serum |
|
61291-1
|
Rice IgE Ab/IgE total in Serum |
|
7668-7
|
Rice IgG Ab [Units/volume] in Serum |
|
21488-2
|
Rice IgG Ab RAST class [Presence] in Serum |
|
26428-3
|
Rice IgG4 Ab [Units/volume] in Serum |
|
26429-1
|
Rice IgG4 Ab RAST class [Presence] in Serum |
|
56379-1
|
Rice IgG4 Ab [Mass/volume] in Serum |
|
35545-3
|
Rice IgG Ab [Mass/volume] in Serum |
|
41640-4
|
Ricin toxin IgG Ab [Presence] in Serum by Immunofluorescence |
|
41639-6
|
Ricin toxin IgM Ab [Presence] in Serum by Immunofluorescence |
|
41641-2
|
Ricin toxin [Presence] in Unspecified specimen by Immunofluorescence |
|
35493-6
|
Ricin [Presence] in Unspecified specimen |
|
54934-5
|
Ricinine [Mass/volume] in Urine |
|
5309-0
|
Rickettsia spotted fever group Ab [Units/volume] in Serum by Immunoassay |
|
22474-1
|
Rickettsia spotted fever group Ab [Presence] in Serum |
|
23776-8
|
Rickettsia spotted fever group Ab [Presence] in Serum by Immunofluorescence |
|
5310-8
|
Rickettsia spotted fever group Ab [Presence] in Serum by Latex agglutination |
|
7997-0
|
Rickettsia spotted fever group Ab [Units/volume] in Serum |
|
22475-8
|
Rickettsia spotted fever group Ab [Titer] in Serum |
|
5311-6
|
Rickettsia spotted fever group Ab [Titer] in Serum by Immunofluorescence |
|
54033-6
|
Rickettsia spotted fever group Ag [Presence] in Tissue by Immune stain |
|
48870-0
|
Rickettsia spotted fever group DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5312-4
|
Rickettsia spotted fever group IgG Ab [Units/volume] in Serum by Immunoassay |
|
32999-5
|
Rickettsia spotted fever group IgG Ab [Presence] in Serum |
|
7998-8
|
Rickettsia spotted fever group IgG Ab [Units/volume] in Serum |
|
24281-8
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum --1st specimen |
|
24207-3
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24282-6
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum --2nd specimen |
|
24208-1
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22476-6
|
Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid |
|
21494-0
|
Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22477-4
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum |
|
5313-2
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence |
|
31601-8
|
Rickettsia spotted fever group IgM Ab [Units/volume] in Cerebral spinal fluid |
|
5314-0
|
Rickettsia spotted fever group IgM Ab [Units/volume] in Serum by Immunoassay |
|
33000-1
|
Rickettsia spotted fever group IgM Ab [Presence] in Serum |
|
7999-6
|
Rickettsia spotted fever group IgM Ab [Units/volume] in Serum |
|
70135-9
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
70136-7
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22478-2
|
Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid |
|
21495-7
|
Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22479-0
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum |
|
5315-7
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence |
|
17537-2
|
Rickettsia spotted fever group RNA [Presence] in Serum by NAA with probe detection |
|
17538-0
|
Rickettsia spotted fever group RNA [Presence] in Serum by Probe |
|
22491-5
|
Rickettsia typhus group Ab [Presence] in Serum |
|
5316-5
|
Rickettsia typhus group Ab [Presence] in Serum by Immunoassay |
|
5317-3
|
Rickettsia typhus group Ab [Presence] in Serum by Latex agglutination |
|
8000-2
|
Rickettsia typhus group Ab [Units/volume] in Serum |
|
22492-3
|
Rickettsia typhus group Ab [Titer] in Serum |
|
5318-1
|
Rickettsia typhus group Ab [Titer] in Serum by Immunofluorescence |
|
60272-2
|
Rickettsia typhus group DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
48871-8
|
Rickettsia typhus group DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5319-9
|
Rickettsia typhus group IgG Ab [Units/volume] in Serum by Immunoassay |
|
30555-7
|
Rickettsia typhus group IgG Ab [Presence] in Serum |
|
8001-0
|
Rickettsia typhus group IgG Ab [Units/volume] in Serum |
|
70131-8
|
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
70132-6
|
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22480-8
|
Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid |
|
21496-5
|
Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22493-1
|
Rickettsia typhus group IgG Ab [Titer] in Serum |
|
5320-7
|
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence |
|
31602-6
|
Rickettsia typhus group IgM Ab [Units/volume] in Cerebral spinal fluid |
|
5321-5
|
Rickettsia typhus group IgM Ab [Units/volume] in Serum by Immunoassay |
|
32714-8
|
Rickettsia typhus group IgM Ab [Presence] in Serum |
|
8002-8
|
Rickettsia typhus group IgM Ab [Units/volume] in Serum |
|
70133-4
|
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
70134-2
|
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22481-6
|
Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid |
|
21497-3
|
Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22494-9
|
Rickettsia typhus group IgM Ab [Titer] in Serum |
|
5322-3
|
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence |
|
49128-2
|
Rickettsia typhus group identified in Unspecified specimen by Sequencing |
|
7994-7
|
Rickettsia sp Ab [Units/volume] in Serum |
|
22484-0
|
Rickettsia sp Ab [Titer] in Serum |
|
5306-6
|
Rickettsia sp Ab [Titer] in Serum by Complement fixation |
|
5878-4
|
Rickettsia sp identified in Blood by Organism specific culture |
|
20949-4
|
Rickettsia sp [Presence] in Blood by Light microscopy |
|
53608-6
|
Rickettsia sp DNA [Presence] in Blood by NAA with probe detection |
|
67726-0
|
Rickettsia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
48869-2
|
Rickettsia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48863-5
|
Rickettsia sp DNA [Identifier] in Unspecified specimen by RFLP |
|
6544-1
|
Rickettsia sp identified in Genital specimen by Organism specific culture |
|
35877-0
|
Rickettsia sp IgG Ab [Units/volume] in Serum |
|
35876-2
|
Rickettsia sp IgM Ab [Units/volume] in Serum |
|
6545-8
|
Rickettsia sp identified in Sputum by Organism specific culture |
|
6546-6
|
Rickettsia sp identified in Unspecified specimen by Organism specific culture |
|
49127-4
|
Rickettsia sp identified in Unspecified specimen by Sequencing |
|
42655-1
|
Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25199-1
|
Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25200-7
|
Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25201-5
|
Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
54183-9
|
Rifabutin [Susceptibility] by Disk diffusion (KB) |
|
16100-0
|
Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20386-9
|
Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria |
|
24032-5
|
Rifabutin [Mass/volume] in Serum or Plasma |
|
19149-4
|
Rifabutin [Susceptibility] |
|
16387-3
|
Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25202-3
|
rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25184-3
|
rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25203-1
|
rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55712-4
|
rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25204-9
|
rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
80546-5
|
rifAMPin [Mass/volume] in DBS |
|
4421-4
|
rifAMPin [Mass] of Dose |
|
73166-1
|
rifAMPin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73167-9
|
rifAMPin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7045-8
|
rifAMPin [Susceptibility] by Gradient strip |
|
429-1
|
rifAMPin [Susceptibility] by Disk diffusion (KB) |
|
428-3
|
rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
427-5
|
rifAMPin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20385-1
|
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89489-9
|
rifAMPin [Susceptibility] by Genotype method |
|
4021-2
|
rifAMPin [Mass/volume] in Serum or Plasma |
|
18974-6
|
rifAMPin [Susceptibility] |
|
430-9
|
rifAMPin [Susceptibility] by Serum bactericidal titer |
|
76627-9
|
Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria |
|
73634-8
|
rifAXIMin [Susceptibility] by Disk diffusion (KB) |
|
73611-6
|
rifAXIMin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73589-4
|
rifAXIMin [Susceptibility] |
|
78930-5
|
Right heart catheterization performed |
|
80079-7
|
Right pulmonary artery Diameter at end systole by US 2D |
|
68463-9
|
Rilpivirine [Susceptibility] by Genotype method |
|
72557-2
|
Rilpivirine [Susceptibility] by Phenotype method |
|
80547-3
|
Rilpivirine [Mass/volume] in Serum or Plasma |
|
57658-7
|
Rise time setting Ventilator |
|
73165-3
|
Risedronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73164-6
|
Risedronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
75492-9
|
Risk assessment and screening note |
|
71482-4
|
Risk assessment Document |
|
91024-0
|
Risk assessment report Document Public health |
|
57207-3
|
Risk factors affecting health status and or outcome [CMS Assessment] |
|
57319-6
|
Risk for hospitalization [CMS Assessment] |
|
72136-5
|
Risk for venous thromboembolism |
|
57280-0
|
Risk of developing pressure injuries [CMS Assessment] |
|
88855-2
|
Diagnosis to transplant time duration score for risk calculation |
|
72958-2
|
risperiDONE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72957-4
|
risperiDONE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
77881-1
|
risperiDONE cutoff [Mass/volume] in Urine for Confirmatory method |
|
73163-8
|
risperiDONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73162-0
|
risperiDONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
32128-1
|
risperiDONE [Presence] in Serum or Plasma |
|
9393-0
|
risperiDONE [Mass/volume] in Serum or Plasma |
|
39799-2
|
risperiDONE [Moles/volume] in Serum or Plasma |
|
72656-2
|
risperiDONE [Mass/volume] in Serum or Plasma --trough |
|
77880-3
|
risperiDONE [Mass/volume] in Urine by Confirmatory method |
|
32129-9
|
risperiDONE [Presence] in Urine |
|
32130-7
|
risperiDONE [Presence] in Unspecified specimen |
|
9394-8
|
risperiDONE+9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma |
|
39800-8
|
risperiDONE+9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma |
|
433-3
|
Ristocetin [Susceptibility] by Disk diffusion (KB) |
|
432-5
|
Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
431-7
|
Ristocetin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18975-3
|
Ristocetin [Susceptibility] |
|
434-1
|
Ristocetin [Susceptibility] by Serum bactericidal titer |
|
30293-5
|
Ritonavir [Susceptibility] by Genotype method |
|
30279-4
|
Ritonavir [Susceptibility] by Phenotype method |
|
51929-8
|
Ritonavir [Mass/volume] in Serum or Plasma --peak |
|
29122-9
|
Ritonavir [Units/volume] in Serum or Plasma |
|
31027-6
|
Ritonavir [Mass/volume] in Serum or Plasma |
|
30308-1
|
Ritonavir [Susceptibility] |
|
51930-6
|
Ritonavir [Mass/volume] in Serum or Plasma --trough |
|
82466-4
|
riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
82467-2
|
riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay |
|
68979-4
|
Rivaroxaban [Units/volume] in Platelet poor plasma by Chromogenic method |
|
74871-5
|
Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
74215-5
|
Rivaroxaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
72624-0
|
Rivaroxaban [Mass/volume] in Serum or Plasma |
|
34427-5
|
Methadone.R [Mass/volume] in Serum or Plasma |
|
48365-1
|
Methadone.R [Moles/volume] in Serum or Plasma |
|
81821-1
|
RMRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48706-6
|
Reticulocyte mean volume [Entitic volume] in Reticulocytes |
|
83952-2
|
Registered nurse Hospital Note |
|
75491-1
|
Registered nurse Note |
|
59400-2
|
RNA Ab [Units/volume] in Serum by Immunoassay |
|
18272-5
|
RNA Ab [Units/volume] in Serum |
|
54156-5
|
RNA polymerase I Ab [Presence] in Serum by Immunofluorescence |
|
54157-3
|
RNA polymerase I Ab [Titer] in Serum by Immunofluorescence |
|
13347-0
|
RNA polymerase I+II+III Ab [Presence] in Serum |
|
63329-7
|
RNA polymerase III Ab [Units/volume] in Serum by Immunoassay |
|
89503-7
|
RNA polymerase III Ab [Units/volume] in Serum by Line blot |
|
63328-9
|
RNA polymerase III Ab [Presence] in Serum by Immunoassay |
|
89513-6
|
RNA polymerase III Ab [Presence] in Serum by Line blot |
|
53893-4
|
RNA polymerase III Ab [Units/volume] in Serum |
|
79182-2
|
RNA polymerase III IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
88737-2
|
RNA polymerase III RP11 Ab [Units/volume] in Serum by Line blot |
|
81737-9
|
RNA polymerase III RP11 Ab [Presence] in Serum by Line blot |
|
72317-1
|
RNA polymerase III RP11 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
88738-0
|
RNA polymerase III RP155 Ab [Units/volume] in Serum by Line blot |
|
81738-7
|
RNA polymerase III RP155 Ab [Presence] in Serum by Line blot |
|
72316-3
|
RNA polymerase III RP155 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
2925-6
|
Ribonuclease [Enzymatic activity/volume] in Serum |
|
72346-0
|
Round cells [#/volume] in Prostatic fluid by Manual count |
|
10585-8
|
Round cells [#/volume] in Semen |
|
74691-7
|
Round cells [#/area] in Semen by Microscopy high power field |
|
88115-1
|
Round cells [Presence] in Semen by Light microscopy |
|
86293-8
|
Retinal nerve fiber layer.clock hour 1 thickness Left retina by OCT |
|
86305-0
|
Retinal nerve fiber layer.clock hour 1 thickness Right retina by OCT |
|
86302-7
|
Retinal nerve fiber layer.clock hour 10 thickness Left retina by OCT |
|
86314-2
|
Retinal nerve fiber layer.clock hour 10 thickness Right retina by OCT |
|
86303-5
|
Retinal nerve fiber layer.clock hour 11 thickness Left retina by OCT |
|
86315-9
|
Retinal nerve fiber layer.clock hour 11 thickness Right retina by OCT |
|
86292-0
|
Retinal nerve fiber layer.clock hour 12 thickness Left retina by OCT |
|
86304-3
|
Retinal nerve fiber layer.clock hour 12 thickness Right retina by OCT |
|
86294-6
|
Retinal nerve fiber layer.clock hour 2 thickness Left retina by OCT |
|
86306-8
|
Retinal nerve fiber layer.clock hour 2 thickness Right retina by OCT |
|
86295-3
|
Retinal nerve fiber layer.clock hour 3 thickness Left retina by OCT |
|
86307-6
|
Retinal nerve fiber layer.clock hour 3 thickness Right retina by OCT |
|
86296-1
|
Retinal nerve fiber layer.clock hour 4 thickness Left retina by OCT |
|
86308-4
|
Retinal nerve fiber layer.clock hour 4 thickness Right retina by OCT |
|
86297-9
|
Retinal nerve fiber layer.clock hour 5 thickness Left retina by OCT |
|
86309-2
|
Retinal nerve fiber layer.clock hour 5 thickness Right retina by OCT |
|
86298-7
|
Retinal nerve fiber layer.clock hour 6 thickness Left retina by OCT |
|
86310-0
|
Retinal nerve fiber layer.clock hour 6 thickness Right retina by OCT |
|
86299-5
|
Retinal nerve fiber layer.clock hour 7 thickness Left retina by OCT |
|
86311-8
|
Retinal nerve fiber layer.clock hour 7 thickness Right retina by OCT |
|
86300-1
|
Retinal nerve fiber layer.clock hour 8 thickness Left retina by OCT |
|
86312-6
|
Retinal nerve fiber layer.clock hour 8 thickness Right retina by OCT |
|
86286-2
|
Retinal nerve fiber layer.clock hour 9 thickness Left retina by OCT |
|
86313-4
|
Retinal nerve fiber layer.clock hour 9 thickness Right retina by OCT |
|
86289-6
|
Retinal nerve fiber layer.inferior temporal thickness Left retina by OCT |
|
86287-0
|
Retinal nerve fiber layer.inferior temporal thickness Right retina by OCT |
|
86288-8
|
Retinal nerve fiber layer.inferior thickness Left retina by OCT |
|
86283-9
|
Retinal nerve fiber layer.inferior thickness Right retina by OCT |
|
86290-4
|
Retinal nerve fiber layer.mean thickness Left retina by OCT |
|
86301-9
|
Retinal nerve fiber layer.mean thickness Right retina by OCT |
|
86272-2
|
Retinal nerve fiber layer.nasal inferior thickness Left retina by OCT |
|
86282-1
|
Retinal nerve fiber layer.nasal inferior thickness Right retina by OCT |
|
86281-3
|
Retinal nerve fiber layer.nasal superior thickness Left retina by OCT |
|
86280-5
|
Retinal nerve fiber layer.nasal superior thickness Right retina by OCT |
|
86279-7
|
Retinal nerve fiber layer.nasal thickness Left retina by OCT |
|
86284-7
|
Retinal nerve fiber layer.nasal thickness Right retina by OCT |
|
86277-1
|
Retinal nerve fiber layer.superior thickness Left retina by OCT |
|
86276-3
|
Retinal nerve fiber layer.superior thickness Right retina by OCT |
|
86275-5
|
Retinal nerve fiber layer.temporal superior thickness Left retina by OCT |
|
86274-8
|
Retinal nerve fiber layer.temporal superior thickness Right retina by OCT |
|
86278-9
|
Retinal nerve fiber layer.temporal thickness Left retina by OCT |
|
86273-0
|
Retinal nerve fiber layer.temporal thickness Right retina by OCT |
|
39358-7
|
Cholinesterase.RO 020683 inhibited/Cholinesterase in Serum or Plasma |
|
72567-1
|
Cholinesterase.RO 020683 inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
|
64982-2
|
Cockroach recombinant (rBla g) 1 IgE Ab [Units/volume] in Serum |
|
64983-0
|
Cockroach recombinant (rBla g) 2 IgE Ab [Units/volume] in Serum |
|
66444-1
|
Cockroach recombinant (rBla g) 4 IgE Ab [Units/volume] in Serum |
|
64984-8
|
Cockroach recombinant (rBla g) 5 IgE Ab [Units/volume] in Serum |
|
6078-0
|
Cockroach IgE Ab [Units/volume] in Serum |
|
15647-1
|
Cockroach IgE Ab RAST class [Presence] in Serum |
|
61230-9
|
Cockroach IgE Ab/IgE total in Serum |
|
24139-8
|
Cockroach IgG Ab [Units/volume] in Serum |
|
56266-0
|
Cockroach IgG4 Ab [Mass/volume] in Serum |
|
48238-0
|
Cockroach triggered leukotriene release [Mass/volume] by Leukocytes |
|
73721-3
|
Rocuronium IgE Ab [Units/volume] in Serum |
|
48286-9
|
Rocuronium triggered leukotriene release [Mass/volume] by Leukocytes |
|
73160-4
|
Rofecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73161-2
|
Rofecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
20298-6
|
Region of interest |
|
20181-4
|
Region of interest Area 2 by US |
|
20180-6
|
Region of interest Area by US |
|
20182-2
|
Region of interest Area/Area 2 by US |
|
20203-6
|
Region of interest Circumference 2 by US |
|
20202-8
|
Region of interest Circumference by US |
|
20200-2
|
Region of interest Circumference/Circumference 2 by US |
|
20227-5
|
Region of interest Height by US.M-mode |
|
20231-7
|
Region of interest Length 2 by US |
|
20230-9
|
Region of interest Length by US |
|
20229-1
|
Region of interest Length/Length 2 by US |
|
20357-0
|
Region of interest Pressure gradient 2 by US.doppler |
|
20353-9
|
Region of interest Pressure gradient by US.doppler |
|
20165-7
|
Region of interest Region [Area] by US 2D |
|
20367-9
|
Region of interest Volume 2 by US.2D+Calculated by area-length method |
|
20365-3
|
Region of interest Volume/Volume 2 by US.calculated |
|
20366-1
|
Region of interest Volume by US.2D+Calculated by area-length method |
|
88109-4
|
Role in accident |
|
437-4
|
Rolitetracycline [Susceptibility] by Disk diffusion (KB) |
|
436-6
|
Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
435-8
|
Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18976-1
|
Rolitetracycline [Susceptibility] |
|
438-2
|
Rolitetracycline [Susceptibility] by Serum bactericidal titer |
|
89399-0
|
Roll left and right - functional ability [CMS Assessment] |
|
83218-8
|
Roll left and right - functional ability during 3 day assessment period [CMS Assessment] |
|
89398-2
|
Roll left and right - functional goal [CMS Assessment] |
|
83217-0
|
Roll left and right - functional goal during 3 day assessment period [CMS Assessment] |
|
69570-0
|
Risk of ovarian malignancy algorithm score in Serum or Plasma --postmenopausal |
|
69569-2
|
Risk of ovarian malignancy algorithm score in Serum or Plasma --premenopausal |
|
33014-2
|
Romano Cheese IgE Ab [Units/volume] in Serum |
|
33015-9
|
Romano Cheese IgE Ab RAST class [Presence] in Serum |
|
45403-3
|
Room number [Location] |
|
51203-8
|
Ropivacaine [Mass/volume] in Serum or Plasma |
|
7214-0
|
Roquefort Cheese IgE Ab [Units/volume] in Serum |
|
21180-5
|
Roquefort Cheese IgE Ab RAST class [Presence] in Serum |
|
41714-7
|
Rosamicin [Susceptibility] by Gradient strip |
|
41715-4
|
Rosamicin [Susceptibility] by Disk diffusion (KB) |
|
41713-9
|
Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41738-6
|
Rosamicin [Susceptibility] |
|
6231-5
|
Rose Hip IgE Ab [Units/volume] in Serum |
|
15996-2
|
Rose Hip IgE Ab RAST class [Presence] in Serum |
|
30043-4
|
Rosemary IgE Ab [Units/volume] in Serum |
|
73159-6
|
Rosiglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73158-8
|
Rosiglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
69423-2
|
Rosner index in Platelet poor plasma by Coagulation assay |
|
55713-2
|
Rosoxacin [Susceptibility] by Gradient strip |
|
441-6
|
Rosoxacin [Susceptibility] by Disk diffusion (KB) |
|
440-8
|
Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
439-0
|
Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18977-9
|
Rosoxacin [Susceptibility] |
|
442-4
|
Rosoxacin [Susceptibility] by Serum bactericidal titer |
|
73157-0
|
Rosuvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73156-2
|
Rosuvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
90859-0
|
Rotated teeth [#] |
|
6233-1
|
Rough Pigweed IgE Ab [Units/volume] in Serum |
|
15937-6
|
Rough Pigweed IgE Ab RAST class [Presence] in Serum |
|
56463-3
|
Rough Pigweed IgG4 Ab [Mass/volume] in Serum |
|
63189-5
|
Rough Pigweed IgG Ab [Mass/volume] in Serum |
|
7797-4
|
Rouleaux [Presence] in Blood by Light microscopy |
|
71468-3
|
Route Medication |
|
93183-2
|
Route of current reconciled medication list transmission to patient [CMS Assessment] |
|
93184-0
|
Route of current reconciled medication list transmission to subsequent provider [CMS Assessment] |
|
30958-3
|
Route [Identifier] Vaccine administered |
|
7046-6
|
Roxithromycin [Susceptibility] by Gradient strip |
|
445-7
|
Roxithromycin [Susceptibility] by Disk diffusion (KB) |
|
444-0
|
Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
443-2
|
Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18978-7
|
Roxithromycin [Susceptibility] |
|
446-5
|
Roxithromycin [Susceptibility] by Serum bactericidal titer |
|
80247-0
|
Posterior descending branch from right coronary artery [Presence] on Angiogram |
|
82289-0
|
Rating of perceived exertion [Score] |
|
77120-4
|
RPGR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77119-6
|
RPGR gene full mutation analysis in Blood or Tissue by Sequencing |
|
77118-8
|
RPGRIP1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77117-0
|
RPGRIP1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
82225-4
|
Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Fibroblast |
|
82224-7
|
Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Lymphoblasts |
|
80248-8
|
Posterolateral branch from right coronary artery [Presence] on Angiogram |
|
87925-4
|
Reagin Ab [Titer] in Cerebral spinal fluid by RPR |
|
47360-3
|
Reagin Ab [Presence] in Serum from Donor by RPR |
|
20507-0
|
Reagin Ab [Presence] in Serum by RPR |
|
20508-8
|
Reagin Ab [Units/volume] in Serum by RPR |
|
31147-2
|
Reagin Ab [Titer] in Serum by RPR |
|
59068-7
|
RPS19 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
35290-6
|
RPS6KA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41063-9
|
RPS6KA3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53793-6
|
RPS6KA3 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53794-4
|
RPS6KA3 gene mutations tier 2 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
86467-8
|
Report comment Narrative |
|
86468-6
|
Report comment section |
|
23411-2
|
Rinderpest virus Ab [Presence] in Serum |
|
23410-4
|
Rinderpest virus Ab [Presence] in Serum by Immunoassay |
|
23407-0
|
Rinderpest virus Ab [Presence] in Serum by Neutralization test |
|
31613-3
|
Rinderpest virus Ab [Units/volume] in Serum |
|
23408-8
|
Rinderpest virus Ab [Titer] in Serum |
|
23409-6
|
Rinderpest virus Ab [Titer] in Serum by Neutralization test |
|
31952-5
|
Rinderpest virus Ag [Presence] in Exudate |
|
23415-3
|
Rinderpest virus Ag [Presence] in Exudate by Immune diffusion (ID) |
|
23414-6
|
Rinderpest virus Ag [Presence] in Exudate by Immunoelectrophoresis |
|
23412-0
|
Rinderpest virus Ag [Units/volume] in Tissue by Immunoassay |
|
23416-1
|
Rinderpest virus Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
31953-3
|
Rinderpest virus Ag [Presence] in Unspecified specimen |
|
23413-8
|
Rinderpest virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
31954-1
|
Rinderpest virus Ag [Units/volume] in Unspecified specimen |
|
23417-9
|
Rinderpest virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
12010-5
|
R-R duration US |
|
8637-1
|
R-R interval by EKG |
|
20179-8
|
R-R interval by US --at aortic flow measurement |
|
20263-0
|
R-R interval by US --at mitral flow measurement |
|
20286-1
|
R-R interval by US --at pulmonic flow measurement |
|
20342-2
|
R-R interval by US --at tricuspid flow measurement |
|
24369-1
|
R-R interval by EKG --during XXX measurement |
|
76638-6
|
R-R interval (Maximum value during study) by EKG |
|
18505-8
|
R-R interval (Mean value during study) by EKG |
|
76639-4
|
R-R interval (Minimum value during study) by EKG |
|
76644-4
|
R-R interval.coefficient of variation by EKG |
|
80404-7
|
R-R interval.standard deviation (Heart rate variability) |
|
76643-6
|
R-R interval.standard deviation (Heart rate variability) by EKG |
|
94080-9
|
RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
26672-6
|
Ross River virus Ab [Presence] in Serum |
|
31614-1
|
Ross River virus IgG Ab [Presence] in Serum |
|
24117-4
|
Ross River virus IgG Ab [Presence] in Serum by Immunoassay |
|
31615-8
|
Ross River virus IgM Ab [Presence] in Serum |
|
24120-8
|
Ross River virus IgM Ab [Presence] in Serum by Immunoassay |
|
81117-4
|
Ross River virus RNA [Presence] in Serum by NAA with probe detection |
|
38914-8
|
RS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38925-4
|
RS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77301-0
|
Reason care action performed or not |
|
74482-1
|
Reason for unsatisfactory specimen not related to sample quality of dried blood spot |
|
34525-6
|
Erythrocytes.lytic resistant [Presence] in Blood by Automated count |
|
80597-8
|
Respiratory syncytial virus A 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88204-3
|
Respiratory syncytial virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88595-4
|
Respiratory syncytial virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
77022-2
|
Respiratory syncytial virus A RNA [Presence] in Nasopharynx by NAA with probe detection |
|
91795-5
|
Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
30075-6
|
Respiratory syncytial virus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
52975-0
|
Respiratory syncytial virus Ab [Units/volume] in Serum by Complement fixation |
|
33390-6
|
Respiratory syncytial virus Ab [Presence] in Serum |
|
7990-5
|
Respiratory syncytial virus Ab [Units/volume] in Serum |
|
30147-3
|
Respiratory syncytial virus Ab [Presence] in Serum --1st specimen |
|
24298-2
|
Respiratory syncytial virus Ab [Titer] in Serum --1st specimen |
|
24224-8
|
Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --1st specimen |
|
30148-1
|
Respiratory syncytial virus Ab [Presence] in Serum --2nd specimen |
|
24299-0
|
Respiratory syncytial virus Ab [Titer] in Serum --2nd specimen |
|
24225-5
|
Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
33382-3
|
Respiratory syncytial virus Ab [Titer] in Cerebral spinal fluid |
|
22466-7
|
Respiratory syncytial virus Ab [Titer] in Serum |
|
5294-4
|
Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation |
|
5295-1
|
Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence |
|
77389-5
|
Respiratory syncytial virus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
88909-7
|
Respiratory syncytial virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
33045-6
|
Respiratory syncytial virus Ag [Presence] in Nose |
|
32040-8
|
Respiratory syncytial virus Ag [Presence] in Nose by Immunofluorescence |
|
68966-1
|
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunoassay |
|
72885-7
|
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Rapid immunoassay |
|
77390-3
|
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31949-1
|
Respiratory syncytial virus Ag [Presence] in Throat |
|
5874-3
|
Respiratory syncytial virus Ag [Presence] in Throat by Immunoassay |
|
5875-0
|
Respiratory syncytial virus Ag [Presence] in Throat by Immunofluorescence |
|
50329-2
|
Respiratory syncytial virus Ag [Presence] in Tissue by Immune stain |
|
31950-9
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen |
|
5876-8
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
5877-6
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
80598-6
|
Respiratory syncytial virus B F gene [Presence] in Nasopharynx by NAA with probe detection |
|
88202-7
|
Respiratory syncytial virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88597-0
|
Respiratory syncytial virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
77023-0
|
Respiratory syncytial virus B RNA [Presence] in Nasopharynx by NAA with probe detection |
|
91794-8
|
Respiratory syncytial virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
30076-4
|
Respiratory syncytial virus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88527-7
|
Respiratory syncytial virus identified [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
69929-8
|
Respiratory syncytial virus IgA Ab [Presence] in Serum by Immunoassay |
|
31583-8
|
Respiratory syncytial virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
41012-6
|
Respiratory syncytial virus IgG Ab [Presence] in Serum |
|
40989-6
|
Respiratory syncytial virus IgG Ab [Presence] in Serum by Immunoassay |
|
7991-3
|
Respiratory syncytial virus IgG Ab [Units/volume] in Serum |
|
17517-4
|
Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid |
|
17518-2
|
Respiratory syncytial virus IgG Ab [Titer] in Serum |
|
9573-7
|
Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
69962-9
|
Respiratory syncytial virus IgM Ab [Presence] in Serum by Immunoassay |
|
7992-1
|
Respiratory syncytial virus IgM Ab [Units/volume] in Serum |
|
17519-0
|
Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid |
|
22467-5
|
Respiratory syncytial virus IgM Ab [Titer] in Serum |
|
9574-5
|
Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
91782-3
|
Respiratory syncytial virus identified [Presence] in Lower respiratory specimen by Organism specific culture |
|
14129-1
|
Respiratory syncytial virus [Presence] in Nose by Organism specific culture |
|
76088-4
|
Respiratory syncytial virus RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
88528-5
|
Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60271-4
|
Respiratory syncytial virus RNA [Presence] in Isolate by NAA with probe detection |
|
92957-0
|
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
91133-9
|
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82176-9
|
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76089-2
|
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92131-2
|
Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
85479-4
|
Respiratory syncytial virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40987-0
|
Respiratory syncytial virus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
40988-8
|
Respiratory syncytial virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91785-6
|
Respiratory syncytial virus identified [Presence] in Upper respiratory specimen by Organism specific culture |
|
17520-8
|
Respiratory syncytial virus identified in Unspecified specimen by Organism specific culture |
|
55100-2
|
Respiratory syncytial virus [Presence] in Unspecified specimen by Organism specific culture |
|
85697-1
|
Rubella diagnosis --pre pregnancy |
|
85721-9
|
Rubella vaccine was received by children under the age of 18 in the mother's household during the pregnancy |
|
85716-9
|
Rubella-like illness during the pregnancy in Mother |
|
29968-5
|
Rubidium [Mass/volume] in 24 hour Urine |
|
29969-3
|
Rubidium [Mass/time] in 24 hour Urine |
|
5718-2
|
Rubidium [Mass/volume] in Blood |
|
5719-0
|
Rubidium [Mass/mass] in Hair |
|
60169-0
|
Rubidium [Mass/volume] in Red Blood Cells |
|
5720-8
|
Rubidium [Mass/volume] in Serum or Plasma |
|
5721-6
|
Rubidium [Mass/volume] in Urine |
|
29970-1
|
Rubidium/Creatinine [Mass Ratio] in 24 hour Urine |
|
9576-0
|
Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
39581-4
|
Rubella virus Ab [Presence] in Cerebral spinal fluid |
|
40666-0
|
Rubella virus Ab [Presence] in Cerebral spinal fluid by Latex agglutination |
|
17549-7
|
Rubella virus Ab [Units/volume] in Cerebral spinal fluid |
|
5330-6
|
Rubella virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
51931-4
|
Rubella virus Ab [Units/volume] in Serum by Immunoassay |
|
17550-5
|
Rubella virus Ab [Units/volume] in Serum by Latex agglutination |
|
22496-4
|
Rubella virus Ab [Presence] in Serum |
|
5331-4
|
Rubella virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
43810-1
|
Rubella virus Ab [Presence] in Serum by Immunoassay |
|
89040-0
|
Rubella virus Ab [Presence] in Serum by Immunofluorescence |
|
5332-2
|
Rubella virus Ab [Presence] in Serum by Latex agglutination |
|
8013-5
|
Rubella virus Ab [Units/volume] in Serum |
|
42967-0
|
Rubella virus Ab [Titer] in Cerebral spinal fluid |
|
40542-3
|
Rubella virus Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
|
22497-2
|
Rubella virus Ab [Titer] in Serum |
|
50694-9
|
Rubella virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
5333-0
|
Rubella virus Ab [Titer] in Serum by Latex agglutination |
|
31955-8
|
Rubella virus Ag [Presence] in Cerebral spinal fluid |
|
14523-5
|
Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31956-6
|
Rubella virus Ag [Presence] in Cervix |
|
14529-2
|
Rubella virus Ag [Presence] in Cervix by Immunofluorescence |
|
31957-4
|
Rubella virus Ag [Presence] in Eye |
|
14526-8
|
Rubella virus Ag [Presence] in Eye by Immunofluorescence |
|
31959-0
|
Rubella virus Ag [Presence] in Nose |
|
14527-6
|
Rubella virus Ag [Presence] in Nose by Immunofluorescence |
|
31960-8
|
Rubella virus Ag [Presence] in Penis |
|
14532-6
|
Rubella virus Ag [Presence] in Penis by Immunofluorescence |
|
31961-6
|
Rubella virus Ag [Presence] in Skin |
|
14525-0
|
Rubella virus Ag [Presence] in Skin by Immunofluorescence |
|
31962-4
|
Rubella virus Ag [Presence] in Sputum |
|
14528-4
|
Rubella virus Ag [Presence] in Sputum by Immunofluorescence |
|
31963-2
|
Rubella virus Ag [Presence] in Throat |
|
14524-3
|
Rubella virus Ag [Presence] in Throat by Immunofluorescence |
|
31964-0
|
Rubella virus Ag [Presence] in Urine sediment |
|
14531-8
|
Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence |
|
31965-7
|
Rubella virus Ag [Presence] in Urethra |
|
14533-4
|
Rubella virus Ag [Presence] in Urethra by Immunofluorescence |
|
31958-2
|
Rubella virus Ag [Presence] in Vaginal fluid |
|
14530-0
|
Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31966-5
|
Rubella virus Ag [Presence] in Unspecified specimen |
|
12251-5
|
Rubella virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30942-7
|
Rubella virus dose count in combination vaccine |
|
85796-1
|
Rubella virus E1 gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85690-6
|
Rubella virus genotype in Unspecified specimen |
|
25298-1
|
Rubella virus IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
52986-7
|
Rubella virus IgG Ab avidity [Ratio] in Serum by Immunoassay |
|
34421-8
|
Rubella virus IgG Ab avidity [Ratio] in Serum |
|
17551-3
|
Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
39013-8
|
Rubella virus IgG Ab [Presence] in Cerebral spinal fluid |
|
40668-6
|
Rubella virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13281-1
|
Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
74415-1
|
Rubella virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29343-1
|
Rubella virus IgG Ab [Units/volume] in Body fluid |
|
25514-1
|
Rubella virus IgG Ab [Presence] in Serum |
|
63462-6
|
Rubella virus IgG Ab [Presence] in Serum by Latex agglutination |
|
8014-3
|
Rubella virus IgG Ab [Units/volume] in Serum |
|
20458-6
|
Rubella virus IgG Ab [Interpretation] in Serum |
|
5334-8
|
Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
40667-8
|
Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
13279-5
|
Rubella virus IgG Ab [Units/volume] in Serum --1st specimen |
|
13280-3
|
Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
46110-3
|
Rubella virus IgG Ab [Titer] in Cerebral spinal fluid |
|
41763-4
|
Rubella virus IgG Ab [Titer] in Serum |
|
17552-1
|
Rubella virus IgM Ab [Presence] in Cerebral spinal fluid |
|
40669-4
|
Rubella virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13282-9
|
Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
69765-6
|
Rubella virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
31047-4
|
Rubella virus IgM Ab [Units/volume] in Body fluid |
|
5335-5
|
Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
31616-6
|
Rubella virus IgM Ab [Presence] in Serum |
|
25420-1
|
Rubella virus IgM Ab [Presence] in Serum by Latex agglutination |
|
8015-0
|
Rubella virus IgM Ab [Units/volume] in Serum |
|
24116-6
|
Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
46109-5
|
Rubella virus IgM Ab [Titer] in Cerebral spinal fluid |
|
49107-6
|
Rubella virus IgM Ab [Titer] in Serum |
|
91823-5
|
Rubella virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
60274-8
|
Rubella virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
91792-2
|
Rubella virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86589-9
|
Rubella virus RNA [Presence] in Urine by NAA with probe detection |
|
54091-4
|
Rubella virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6548-2
|
Rubella virus identified in Serum by Organism specific culture |
|
59323-6
|
Rufinamide [Mass/volume] in Serum or Plasma |
|
87768-8
|
Rufinamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
92274-0
|
Rules for using smoked tobacco products inside home |
|
92279-9
|
Rules for using smokeless tobacco products inside home |
|
48428-7
|
Rumenate (C18:2 cis-9 trans-11) [Moles/volume] in Serum or Plasma |
|
91566-0
|
Rumor related to public health emergency Narrative |
|
93817-5
|
Running distance unspecified time |
|
83378-0
|
Run time setting Nebulizer |
|
13177-1
|
Russian olive IgE Ab [Units/volume] in Serum |
|
82028-2
|
Russian olive IgE Ab RAST class [Presence] in Serum |
|
5329-8
|
Rotavirus Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
|
71705-8
|
Rotavirus Ab [Units/volume] in Serum by Immunoassay |
|
71765-2
|
Rotavirus Ab [Presence] in Serum by Immunoassay |
|
5328-0
|
Rotavirus Ab [Units/volume] in Serum |
|
22495-6
|
Rotavirus Ab [Titer] in Serum |
|
9575-2
|
Rotavirus Ab [Titer] in Serum by Complement fixation |
|
71764-5
|
Rotavirus Ab [Titer] in Serum by Immunoassay |
|
17547-1
|
Rotavirus Ag [Presence] in Stool |
|
5879-2
|
Rotavirus Ag [Presence] in Stool by Agglutination |
|
5880-0
|
Rotavirus Ag [Presence] in Stool by Immunoassay |
|
72174-6
|
Rotavirus Ag [Presence] in Stool by Rapid immunoassay |
|
80080-5
|
Right ventricular base Minor axis at end diastole [Length] by US.2D.A4C |
|
20196-2
|
Right ventricular Cardiac index by US 2D pulmonic valve calculated |
|
20199-6
|
Right ventricular Cardiac index by US 2D tricuspid valve calculated |
|
20305-9
|
Right ventricular Diameter during systole by US |
|
71702-5
|
Rotavirus dsRNA [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
|
71701-7
|
Rotavirus dsRNA [Identifier] in Stool by Polyacrylamide gel electrophoresis (PAGE) |
|
8012-7
|
Rotavirus dsRNA [Presence] in Stool by NAA with probe detection |
|
80081-3
|
Right ventricular Area at end diastole by US.2D.A4C+Measured by planimetry |
|
18084-4
|
Right ventricular Minor axis at end diastole [Length] by US 2D |
|
77902-5
|
Right ventricular Minor axis at end diastole [Length] by US.2D.A4C |
|
77901-7
|
Right ventricular Minor axis at end diastole.parasternal long axis [Length] by US 2D |
|
81388-1
|
Right ventricular Ejection fraction by US 3D |
|
79929-6
|
Right ventricular Ejection time by US.doppler |
|
80082-1
|
Right ventricular Area at end systole by US.2D.A4C+Measured by planimetry |
|
18086-9
|
Right ventricular Minor axis at end systole [Length] by US 2D |
|
78175-7
|
Right ventricular Fractional area change by US 2D |
|
79936-1
|
Right ventricular Fractional area change by US.2D.A4C+Measured by planimetry |
|
71704-1
|
Rotavirus IgA Ab [Units/volume] in Serum by Immunoassay |
|
71762-9
|
Rotavirus IgA Ab [Presence] in Serum by Immunoassay |
|
71763-7
|
Rotavirus IgA Ab [Titer] in Serum by Immunoassay |
|
25754-3
|
Rotavirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
25593-5
|
Rotavirus IgG Ab [Presence] in Serum |
|
25753-5
|
Rotavirus IgG Ab [Presence] in Serum by Immunoassay |
|
25599-2
|
Rotavirus IgG Ab [Units/volume] in Serum |
|
71703-3
|
Rotavirus IgG Ab [Titer] in Serum by Immunoassay |
|
25756-8
|
Rotavirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25601-6
|
Rotavirus IgM Ab [Presence] in Serum |
|
25755-0
|
Rotavirus IgM Ab [Presence] in Serum by Immunoassay |
|
25600-8
|
Rotavirus IgM Ab [Units/volume] in Serum |
|
82341-9
|
Right ventricular Intrachamber systolic pressure estimated by US |
|
78180-7
|
Right ventricular Intrachamber.systole.max by US.doppler |
|
71761-1
|
Rotavirus identified in Isolate by Sequencing |
|
93643-5
|
Right ventricular Major axis diastole [Length] by US.2D.A4C |
|
18078-6
|
Right ventricular Major axis diastole maximum [Length] by US 2D |
|
20300-0
|
Right ventricular Mean pressure gradient by US.doppler |
|
80085-4
|
Right ventricular mid-cavity Minor axis at end diastole [Length] by US.2D.A4C |
|
18079-4
|
Right ventricular Minimum major axis during systole [Length] by US 2D |
|
20304-2
|
Right ventricular Minor axis.maximum [Length] by US 2D |
|
80086-2
|
Right ventricular Myocardial performance index (Tei) by US.doppler |
|
20214-3
|
Right ventricular Cardiac output by US 2D tricuspid valve |
|
20299-4
|
Right ventricular Peak pressure gradient by US.doppler |
|
80090-4
|
Right ventricular Pre ejection time by US.doppler+ECG |
|
20301-8
|
Right ventricular Pre ejection time by US |
|
71759-5
|
Rotavirus RNA [Identifier] in Isolate by NAA with probe detection |
|
60273-0
|
Rotavirus RNA [Presence] in Isolate by NAA with probe detection |
|
71700-9
|
Rotavirus RNA [Identifier] in Stool by NAA with probe detection |
|
62859-4
|
Rotavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17548-9
|
Rotavirus RNA [Presence] in Unspecified specimen by Probe |
|
8011-9
|
Rotavirus [Presence] in Stool by Electron microscopy |
|
71760-3
|
Rotavirus identified in Stool by Sequencing |
|
20334-9
|
Right ventricular Stroke volume by US 2D pulmonic valve flow area calculated |
|
20337-2
|
Right ventricular Stroke volume by US 2D tricuspid valve calculated |
|
81389-9
|
Right ventricular Stroke volume by US.continuity.VTI+Diameter |
|
93622-9
|
Right ventricular Systolic time by US.doppler |
|
6547-4
|
Rotavirus identified in Unspecified specimen by Organism specific culture |
|
80083-9
|
Right ventricular anterior wall Thickness at end diastole by US 2D |
|
80084-7
|
Right ventricular anterior wall Thickness at end diastole by US.M-mode |
|
18052-1
|
Right ventricular anterior wall Fractional thickening freewall by US |
|
18153-7
|
Right ventricular anterior wall Thickness during diastole by US |
|
18157-8
|
Right ventricular anterior wall Thickness during systole by US |
|
40992-0
|
Rhinovirus+Enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92956-2
|
Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
92885-3
|
Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82175-1
|
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88721-6
|
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92807-7
|
Rhinovirus+Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40991-2
|
Rhinovirus+Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86199-7
|
Rotavirus A Ag [Presence] in Tissue by Immune stain |
|
79389-3
|
Rotavirus A nsp5 gene [Presence] in Stool by NAA with probe detection |
|
86701-0
|
Rotavirus A RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86697-0
|
Rotavirus A RNA [Nucleotide sequence] in Isolate by Sequencing |
|
82212-2
|
Rotavirus A RNA [Presence] in Stool by NAA with non-probe detection |
|
92693-1
|
Rotavirus A RNA [Presence] in Stool by NAA with probe detection |
|
86692-1
|
Rotavirus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87713-4
|
Rotavirus A VP4 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86217-7
|
Rotavirus A VP6 capsid protein [Presence] in Unspecified specimen by Immunoassay |
|
80675-2
|
Rotavirus A VP6 gene [Presence] in Stool by NAA with probe detection |
|
87712-6
|
Rotavirus A VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86689-7
|
Rotavirus A [Presence] in Unspecified specimen by Organism specific culture |
|
86702-8
|
Rotavirus B RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86696-2
|
Rotavirus B RNA [Nucleotide sequence] in Isolate by Sequencing |
|
86691-3
|
Rotavirus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87711-8
|
Rotavirus B VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86700-2
|
Rotavirus C RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86699-6
|
Rotavirus C RNA [Nucleotide sequence] in Isolate by Sequencing |
|
86690-5
|
Rotavirus C RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87710-0
|
Rotavirus C VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86688-9
|
Rotavirus C [Presence] in Unspecified specimen by Organism specific culture |
|
23397-3
|
Rift valley fever virus Ab [Presence] in Serum |
|
23399-9
|
Rift valley fever virus Ab [Presence] in Serum by Immunoassay |
|
31612-5
|
Rift valley fever virus Ab [Units/volume] in Serum |
|
23400-5
|
Rift valley fever virus Ab [Titer] in Serum |
|
23398-1
|
Rift valley fever virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
23396-5
|
Rift valley fever virus Ab [Titer] in Serum by Neutralization test |
|
23402-1
|
Rift valley fever virus Ag [Presence] in Blood by Neutralization test |
|
71778-5
|
Rift valley fever virus Ag [Presence] in Serum by Immunoassay |
|
23406-2
|
Rift valley fever virus Ag [Presence] in Serum by Immune diffusion (ID) |
|
23405-4
|
Rift valley fever virus Ag [Presence] in Tissue by Immune diffusion (ID) |
|
23404-7
|
Rift valley fever virus Ag [Presence] in Tissue by Immunofluorescence |
|
23401-3
|
Rift valley fever virus Ag [Presence] in Tissue by Neutralization test |
|
31951-7
|
Rift valley fever virus Ag [Presence] in Unspecified specimen |
|
23403-9
|
Rift valley fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
71780-1
|
Rift valley fever virus IgG Ab [Presence] in Serum by Immunoassay |
|
71784-3
|
Rift valley fever virus IgG Ab [Titer] in Serum by Immunoassay |
|
71781-9
|
Rift valley fever virus IgM Ab [Presence] in Serum by Immunoassay |
|
71779-3
|
Rift valley fever virus IgM Ab [Titer] in Serum by Immunoassay |
|
20307-5
|
Right ventricular outflow tract Diameter by US 2D |
|
11805-9
|
Right ventricular outflow tract Diameter US |
|
20303-4
|
Right ventricular outflow tract Mean systole pressure gradient by US.doppler |
|
20306-7
|
Right ventricular outflow tract Region crossection [Area] by US+Calculated |
|
18080-2
|
Right ventricular outflow tract Maximum blood flow velocity during systole by US.doppler |
|
20302-6
|
Right ventricular outflow tract Mean blood flow velocity by US.doppler |
|
18171-9
|
Right ventricular outflow tract Blood velocity-time integral by US.doppler |
|
80089-6
|
Right ventricular outflow tract Velocity-time integral during systole by US.doppler |
|
5903-0
|
Russell viper venom time in Control Platelet poor plasma by Coagulation assay |
|
5904-8
|
Russell viper venom time in Platelet poor plasma by Coagulation assay |
|
52063-5
|
Prescription for durable medical equipment (DME) |
|
57832-8
|
Prescription for diagnostic or specialist care |
|
57829-4
|
Prescription for medical equipment or product |
|
57833-6
|
Prescription for medication |
|
57831-0
|
Prescription for rehabilitation |
|
7673-7
|
Rye triggered histamine release [Units/volume] in Blood |
|
7674-5
|
Rye IgE Ab [Units/volume] in Serum |
|
15998-8
|
Rye IgE Ab RAST class [Presence] in Serum |
|
61312-5
|
Rye IgE Ab/IgE total in Serum |
|
7675-2
|
Rye IgG Ab [Units/volume] in Serum |
|
21505-3
|
Rye IgG Ab RAST class [Presence] in Serum |
|
56443-5
|
Rye IgG4 Ab [Mass/volume] in Serum |
|
51933-0
|
Rye IgG Ab [Mass/volume] in Serum |
|
48222-4
|
Rye triggered leukotriene release [Mass/volume] by Leukocytes |
|
58044-9
|
RYR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
1315-1
|
S Ab [Presence] in Serum or Plasma from Blood product unit |
|
1316-9
|
S Ab [Presence] in Serum or Plasma from Donor |
|
1317-7
|
S Ab [Presence] in Serum or Plasma |
|
33920-0
|
S Ab [Titer] in Serum or Plasma |
|
23419-5
|
Salmonella abortus equi Ab [Presence] in Serum |
|
23418-7
|
Salmonella abortus equi Ab [Presence] in Serum by Agglutination |
|
23421-1
|
Salmonella abortus ovis Ab [Presence] in Serum |
|
23420-3
|
Salmonella abortus ovis Ab [Presence] in Serum by Complement fixation |
|
92521-4
|
S Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92483-7
|
S Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1318-5
|
S Ag [Presence] on Red Blood Cells from Blood product unit |
|
1319-3
|
S Ag [Presence] on Red Blood Cells from Donor |
|
1320-1
|
S Ag [Presence] on Red Blood Cells |
|
76610-5
|
Streptococcus agalactiae cfb gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76582-6
|
Streptococcus agalactiae cfb gene [Presence] in XXX.swab by NAA with probe detection |
|
76597-4
|
Streptococcus agalactiae cfb gene [#/mass] in XXX.tissue by NAA with probe detection |
|
88273-8
|
Streptococcus agalactiae hsp60 gene [Presence] by Probe in Positive blood culture |
|
70070-8
|
Streptococcus anginosus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
92772-3
|
Streptococcus anginosus group DNA [Presence] by NAA with probe detection in Positive blood culture |
|
88274-6
|
Streptococcus anginosus group gyrB gene [Presence] by Probe in Positive blood culture |
|
88551-7
|
Scedosporium apiospermum DNA [Presence] in Aspirate by NAA with probe detection |
|
88549-1
|
Scedosporium apiospermum DNA [Presence] in Isolate by NAA with probe detection |
|
88550-9
|
Scedosporium apiospermum DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88548-3
|
Scedosporium apiospermum DNA [Presence] in Tissue by NAA with probe detection |
|
88557-4
|
Scedosporium apiospermum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22515-1
|
Salmonella arizonae Ab [Presence] in Serum |
|
15504-4
|
Salmonella arizonae Ab [Presence] in Serum by Agglutination |
|
7712-3
|
Spondylocladium atrovirens IgE Ab [Units/volume] in Serum |
|
6550-8
|
Staphylococcus aureus Ab [Units/volume] in Serum |
|
79447-9
|
Staphylococcus aureus capsular polysaccharide enzyme cpe gene [Presence] in Nose by NAA with probe detection |
|
92953-9
|
Staphylococcus aureus DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85765-6
|
Staphylococcus aureus DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92777-2
|
Staphylococcus aureus DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92701-2
|
Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection |
|
92952-1
|
Staphylococcus aureus DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61404-0
|
Staphylococcus aureus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
71786-8
|
Staphylococcus aureus exfoliative toxin A eta gene [Presence] in Unspecified specimen by NAA with probe detection |
|
71787-6
|
Staphylococcus aureus exfoliative toxin B etb gene [Presence] in Unspecified specimen by NAA with probe detection |
|
44878-7
|
Staphylococcus aureus enterotoxin A sea gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25821-0
|
Staphylococcus aureus enterotoxin A IgE Ab [Units/volume] in Serum |
|
26036-4
|
Staphylococcus aureus enterotoxin A IgE Ab RAST class [Presence] in Serum |
|
23934-3
|
Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
|
44880-3
|
Staphylococcus aureus enterotoxin B seb gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25822-8
|
Staphylococcus aureus enterotoxin B IgE Ab [Units/volume] in Serum |
|
25823-6
|
Staphylococcus aureus enterotoxin B IgE Ab RAST class [Presence] in Serum |
|
23933-5
|
Staphylococcus aureus enterotoxin B [Presence] in Unspecified specimen |
|
41855-8
|
Staphylococcus aureus enterotoxin B [Presence] in Unspecified specimen by Immunofluorescence |
|
72823-8
|
Staphylococcus aureus enterotoxin C sec gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25824-4
|
Staphylococcus aureus enterotoxin C IgE Ab [Units/volume] in Serum |
|
25825-1
|
Staphylococcus aureus enterotoxin C IgE Ab RAST class [Presence] in Serum |
|
72822-0
|
Staphylococcus aureus enterotoxin D sed gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25826-9
|
Staphylococcus aureus enterotoxin D IgE Ab [Units/volume] in Serum |
|
25827-7
|
Staphylococcus aureus enterotoxin D IgE Ab RAST class [Presence] in Serum |
|
44879-5
|
Staphylococcus aureus enterotoxin E see gene [Presence] in Unspecified specimen by NAA with probe detection |
|
82574-5
|
Staphylococcus aureus enterotoxin E IgE Ab [Units/volume] in Serum |
|
90882-2
|
Staphylococcus aureus enterotoxin E IgE Ab RAST class [Presence] in Serum |
|
33865-7
|
Staphylococcus aureus enterotoxin [Identifier] in Unspecified specimen |
|
86319-1
|
Staphylococcus aureus [Presence] in Food by Culture |
|
88269-6
|
Staphylococcus aureus gyrB gene [Presence] by Probe in Positive blood culture |
|
7719-8
|
Staphylococcus aureus IgE Ab [Units/volume] in Serum |
|
48816-3
|
Staphylococcus aureus Panton-Valentine leukocidin gene [Presence] in Unspecified specimen by NAA with probe detection |
|
5033-6
|
Staphylococcus aureus rRNA [Presence] in Unspecified specimen by Probe |
|
76605-5
|
Staphylococcus aureus sau3AI gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76577-6
|
Staphylococcus aureus sau3AI gene [Presence] in XXX.swab by NAA with probe detection |
|
76592-5
|
Staphylococcus aureus sau3AI gene [#/mass] in XXX.tissue by NAA with probe detection |
|
44881-1
|
Staphylococcus aureus toxic shock syndrome toxin gene [Presence] in Unspecified specimen by NAA with probe detection |
|
23936-8
|
Staphylococcus aureus toxic shock syndrome toxin 1 Ab [Presence] in Serum |
|
51856-3
|
Staphylococcus aureus TSST-1 IgE Ab [Units/volume] in Serum |
|
51863-9
|
Staphylococcus aureus TSST-1 IgE Ab RAST class [Presence] in Serum |
|
23935-0
|
Staphylococcus aureus toxic shock syndrome toxin 1 [Presence] in Unspecified specimen |
|
50683-2
|
Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
|
85764-9
|
Staphylococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
73558-9
|
Staphylococcus aureus and Staphylococcus sp.coagulase negative rRNA [Identifier] by FISH in Positive blood culture |
|
6252-1
|
Stemphylium botryosum IgE Ab [Units/volume] in Serum |
|
16033-3
|
Stemphylium botryosum IgE Ab RAST class [Presence] in Serum |
|
39601-0
|
Stemphylium botryosum IgE Ab/IgE total in Serum |
|
18412-7
|
Stemphylium botryosum IgG Ab [Units/volume] in Serum |
|
33315-3
|
Stemphylium botryosum IgG Ab RAST class [Presence] in Serum |
|
35553-7
|
Stemphylium botryosum IgG Ab [Mass/volume] in Serum |
|
11602-0
|
Shigella boydii Ab [Units/volume] in Serum |
|
22537-5
|
Shigella boydii Ab [Titer] in Serum |
|
9712-1
|
Shigella boydii Ab [Titer] in Serum by Complement fixation |
|
42256-8
|
Shigella boydii Ag [Presence] in Isolate |
|
31634-9
|
Stachybotrys chartarum IgA Ab [Units/volume] in Serum |
|
26820-1
|
Stachybotrys chartarum IgA Ab [Mass/volume] in Serum |
|
29616-0
|
Stachybotrys chartarum IgE Ab [Units/volume] in Serum |
|
29618-6
|
Stachybotrys chartarum IgE Ab RAST class [Presence] in Serum |
|
42815-1
|
Stachybotrys chartarum IgE Ab [Mass/volume] in Serum |
|
51541-1
|
Stachybotrys chartarum IgG Ab [Presence] in Serum |
|
25779-0
|
Stachybotrys chartarum IgG Ab [Units/volume] in Serum |
|
25780-8
|
Stachybotrys chartarum IgG Ab RAST class [Presence] in Serum |
|
42816-9
|
Stachybotrys chartarum IgG Ab [Mass/volume] in Serum |
|
93757-3
|
Salmonella choleraesuis+infantis+typhimurium Ab/Positive control in Unspecified specimen by Immunoassay |
|
10963-7
|
Spondylocladium citrovirens IgE Ab [Units/volume] in Serum |
|
16028-3
|
Spondylocladium citrovirens IgE Ab RAST class [Presence] in Serum |
|
70071-6
|
Streptococcus constellatus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11596-4
|
Shigella dysenteriae Ab [Units/volume] in Serum |
|
22538-3
|
Shigella dysenteriae Ab [Titer] in Serum |
|
9713-9
|
Shigella dysenteriae Ab [Titer] in Serum by Complement fixation |
|
42257-6
|
Shigella dysenteriae Ag [Presence] in Isolate |
|
70068-2
|
Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82199-1
|
Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection |
|
61370-3
|
Salmonella enterica DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
34423-4
|
Salmonella enteritidis H Ab [Titer] in Serum |
|
34431-7
|
Salmonella enteritidis H Ab [Titer] in Serum by Agglutination |
|
23425-2
|
Salmonella enteritidis IgG Ab [Presence] in Egg yolk |
|
23423-7
|
Salmonella enteritidis IgG Ab [Presence] in Egg yolk by Immunoassay |
|
23422-9
|
Salmonella enteritidis IgG Ab [Presence] in Serum |
|
23424-5
|
Salmonella enteritidis IgG Ab [Presence] in Serum by Immunoassay |
|
23602-6
|
Salmonella enteritidis [Presence] in Stool by Organism specific culture |
|
34891-2
|
Salmonella enteritidis [Presence] in Unspecified specimen by Organism specific culture |
|
92776-4
|
Staphylococcus epidermidis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
61405-7
|
Staphylococcus epidermidis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88270-4
|
Staphylococcus epidermidis hsp60 gene [Presence] by Probe in Positive blood culture |
|
11600-4
|
Shigella flexneri Ab [Units/volume] in Serum |
|
22539-1
|
Shigella flexneri Ab [Titer] in Serum |
|
9714-7
|
Shigella flexneri Ab [Titer] in Serum by Complement fixation |
|
42258-4
|
Shigella flexneri Ag [Presence] in Isolate |
|
41127-2
|
Salmonella gallinarum Ab [Presence] in Blood |
|
23426-0
|
Salmonella gallinarum Ab [Presence] in Blood by Agglutination |
|
23427-8
|
Salmonella gallinarum Ab [Presence] in Serum |
|
23429-4
|
Salmonella gallinarum Ab [Presence] in Serum by Agglutination |
|
23428-6
|
Salmonella gallinarum Ab [Presence] in Serum by Immunoassay |
|
23431-0
|
Salmonella gallinarum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23432-8
|
Salmonella gallinarum rRNA [Presence] in Unspecified specimen by Probe |
|
26657-7
|
Schistosoma haematobium Ab [Presence] in Serum |
|
41422-7
|
Schistosoma haematobium Ab [Presence] in Serum by Immunoblot |
|
70018-7
|
Staphylococcus haemolyticus DNA [Presence] in Blood by NAA with probe detection |
|
20962-7
|
Serpulina hyodysenteria [Presence] in Spiral colon by Organism specific culture |
|
20963-5
|
Serpulina hyodysenteria [Presence] in Stool by Organism specific culture |
|
70069-0
|
Streptococcus intermedius DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41423-5
|
Schistosoma japonicum Ab [Presence] in Serum by Immunoblot |
|
8018-4
|
Schistosoma japonicum Ab [Units/volume] in Serum |
|
22535-9
|
Schistosoma japonicum Ab [Titer] in Serum |
|
6626-6
|
Schistosoma japonicum Ab [Titer] in Serum by Complement fixation |
|
6241-4
|
Dry-rot Fungus IgE Ab [Units/volume] in Serum |
|
25525-7
|
Dry-rot Fungus IgE Ab RAST class [Presence] in Serum |
|
63165-5
|
Dry-rot Fungus IgG Ab [Mass/volume] in Serum |
|
92775-6
|
Staphylococcus lugdunensis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
88271-2
|
Staphylococcus lugdunensis sodA gene [Presence] by Probe in Positive blood culture |
|
93391-1
|
Stenotrophomonas maltophilia DNA [Presence] by NAA with probe detection in Positive blood culture |
|
61403-2
|
Stenotrophomonas maltophilia DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77943-9
|
Schistosoma mansoni+haematobium+intercalatum [Titer] in Serum by Hemagglutination |
|
22536-7
|
Schistosoma mansoni Ab [Presence] in Serum |
|
6627-4
|
Schistosoma mansoni Ab [Presence] in Serum by Immunoassay |
|
8019-2
|
Schistosoma mansoni Ab [Units/volume] in Serum |
|
41424-3
|
Schistosoma mansoni Ab [Presence] in Unspecified specimen by Immunoblot |
|
76604-8
|
Serratia marcescens gyrB gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76576-8
|
Serratia marcescens gyrB gene [Presence] in XXX.swab by NAA with probe detection |
|
76591-7
|
Serratia marcescens gyrB gene [#/mass] in XXX.tissue by NAA with probe detection |
|
92955-4
|
Serratia marcescens DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85777-1
|
Serratia marcescens DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
93392-9
|
Serratia marcescens DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92954-7
|
Serratia marcescens DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61402-4
|
Serratia marcescens DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5367-8
|
Streptobacillus moniliformis Ab [Units/volume] in Serum |
|
75754-2
|
Streptobacillus moniliformis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22532-6
|
Sarcocystis neurona Ab [Presence] in Blood |
|
20958-5
|
Sarcocystis neurona Ab [Presence] in Blood by Immunoblot |
|
22533-4
|
Sarcocystis neurona Ab [Presence] in Body fluid |
|
20956-9
|
Sarcocystis neurona Ab [Presence] in Body fluid by Immunoblot |
|
22534-2
|
Sarcocystis neurona Ab [Presence] in Serum |
|
20957-7
|
Sarcocystis neurona Ab [Presence] in Serum by Immunoblot |
|
39022-9
|
Sarcocystis neurona Ab [Presence] in Serum by Immunofluorescence |
|
20959-3
|
Sarcocystis neurona Ag [Presence] in Tissue by Immune stain |
|
33619-8
|
Deuteroporphyrin.semi-proto [Mass/time] in 24 hour Stool |
|
22516-9
|
Salmonella paratyphi A Ab [Presence] in Serum |
|
11264-9
|
Salmonella paratyphi A Ab [Presence] in Serum by Agglutination |
|
32212-3
|
Salmonella paratyphi A Ab [Titer] in Serum |
|
22517-7
|
Salmonella paratyphi A H Ab [Presence] in Serum |
|
5339-7
|
Salmonella paratyphi A H Ab [Presence] in Serum by Latex agglutination |
|
22518-5
|
Salmonella paratyphi A H Ab [Titer] in Serum |
|
21511-1
|
Salmonella paratyphi A H Ab [Titer] in Serum by Agglutination |
|
21512-9
|
Salmonella paratyphi A H Ab [Titer] in Serum by Immunofluorescence |
|
22519-3
|
Salmonella paratyphi A O Ab [Presence] in Serum |
|
5340-5
|
Salmonella paratyphi A O Ab [Presence] in Serum by Latex agglutination |
|
33316-1
|
Salmonella paratyphi A O Ab [Titer] in Serum |
|
33470-6
|
Salmonella paratyphi A O Ab [Titer] in Serum by Agglutination |
|
22520-1
|
Salmonella paratyphi B Ab [Presence] in Serum |
|
11265-6
|
Salmonella paratyphi B Ab [Presence] in Serum by Agglutination |
|
32213-1
|
Salmonella paratyphi B Ab [Titer] in Serum |
|
22521-9
|
Salmonella paratyphi B H Ab [Presence] in Serum |
|
5341-3
|
Salmonella paratyphi B H Ab [Presence] in Serum by Latex agglutination |
|
31618-2
|
Salmonella paratyphi B H Ab [Units/volume] in Serum |
|
22522-7
|
Salmonella paratyphi B H Ab [Titer] in Serum |
|
21513-7
|
Salmonella paratyphi B H Ab [Titer] in Serum by Agglutination |
|
21514-5
|
Salmonella paratyphi B H Ab [Titer] in Serum by Immunofluorescence |
|
22523-5
|
Salmonella paratyphi B O Ab [Presence] in Serum |
|
5342-1
|
Salmonella paratyphi B O Ab [Presence] in Serum by Latex agglutination |
|
31619-0
|
Salmonella paratyphi B O Ab [Units/volume] in Serum |
|
42964-7
|
Salmonella paratyphi B O Ab [Titer] in Serum |
|
27938-0
|
Salmonella paratyphi B O Ab [Titer] in Serum by Agglutination |
|
48686-0
|
Salmonella paratyphi C Ab [Titer] in Serum |
|
22524-3
|
Salmonella paratyphi C H Ab [Presence] in Serum |
|
5343-9
|
Salmonella paratyphi C H Ab [Presence] in Serum by Latex agglutination |
|
42963-9
|
Salmonella paratyphi C H Ab [Titer] in Serum |
|
34369-9
|
Salmonella paratyphi C H Ab [Titer] in Serum by Agglutination |
|
22525-0
|
Salmonella paratyphi C O Ab [Presence] in Serum |
|
5344-7
|
Salmonella paratyphi C O Ab [Presence] in Serum by Latex agglutination |
|
42962-1
|
Salmonella paratyphi C O Ab [Titer] in Serum |
|
34370-7
|
Salmonella paratyphi C O Ab [Titer] in Serum by Agglutination |
|
36910-8
|
S-phase cells/100 cells in Blood |
|
30913-8
|
S-phase cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
41294-0
|
S-phase cells [Presence] in Unspecified specimen |
|
85759-9
|
Streptococcus pneumoniae Danish serotypes 11A+11D DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85749-0
|
Streptococcus pneumoniae Danish serotypes 22A+22F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85755-7
|
Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85754-0
|
Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86019-7
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum |
|
86020-5
|
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum |
|
86032-0
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86033-8
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --1st specimen |
|
86034-6
|
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --1st specimen |
|
86035-3
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86036-1
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --2nd specimen |
|
86037-9
|
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --2nd specimen |
|
85745-8
|
Streptococcus pneumoniae Danish serotype 19F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86031-2
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86023-9
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum by Immunoassay |
|
86021-3
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86022-1
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum |
|
86024-7
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum |
|
86027-0
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86026-2
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --1st specimen |
|
86025-4
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86030-4
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86029-6
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --2nd specimen |
|
86028-8
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
51668-2
|
Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Pseudomonas aeruginosa DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
62493-2
|
Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Streptococcus agalactiae DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
17648-7
|
Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay |
|
10717-7
|
Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
|
8030-9
|
Streptococcus pneumoniae Ab [Presence] in Serum |
|
6552-4
|
Streptococcus pneumoniae Ab [Presence] in Serum by Immunoassay |
|
17647-9
|
Streptococcus pneumoniae Ab [Units/volume] in Serum |
|
25531-5
|
Streptococcus pneumoniae Ab [Mass/volume] in Serum |
|
20489-1
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid |
|
86590-7
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay |
|
6553-2
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
14322-2
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
73685-0
|
Streptococcus pneumoniae Ag [Presence] in Isolate by Latex agglutination |
|
11086-6
|
Streptococcus pneumoniae Ag [Presence] in Serum |
|
31968-1
|
Streptococcus pneumoniae Ag [Presence] in Sputum |
|
6554-0
|
Streptococcus pneumoniae Ag [Presence] in Sputum by Immunofluorescence |
|
24027-5
|
Streptococcus pneumoniae Ag [Presence] in Urine |
|
77949-6
|
Streptococcus pneumoniae Ag [Presence] in Urine by Rapid immunoassay |
|
31969-9
|
Streptococcus pneumoniae Ag [Presence] in Unspecified specimen |
|
6555-7
|
Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
17652-9
|
Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Latex agglutination |
|
51407-5
|
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum by Immunoassay |
|
51472-9
|
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum |
|
51408-3
|
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum by Immunoassay |
|
51473-7
|
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum |
|
85953-8
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum |
|
85952-0
|
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum |
|
85966-0
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
85967-8
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --1st specimen |
|
85965-2
|
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --1st specimen |
|
85969-4
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
85970-2
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --2nd specimen |
|
85968-6
|
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --2nd specimen |
|
85747-4
|
Streptococcus pneumoniae Danish serotype 1 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85964-5
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
85957-9
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
85955-3
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
85956-1
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum |
|
85954-6
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum |
|
85958-7
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
85960-3
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --1st specimen |
|
85959-5
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --1st specimen |
|
85961-1
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
85963-7
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --2nd specimen |
|
85962-9
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86104-7
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86099-9
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86098-1
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum |
|
86101-3
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86100-5
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --1st specimen |
|
86103-9
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86102-1
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86128-6
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86123-7
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86122-9
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum |
|
86125-2
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86124-5
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --1st specimen |
|
86127-8
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86126-0
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85988-4
|
Streptococcus pneumoniae Danish serotype 12F Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
85973-6
|
Streptococcus pneumoniae Danish serotype 12F Ab [Presence] in Serum |
|
85972-8
|
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum |
|
85971-0
|
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum |
|
85984-3
|
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --1st specimen |
|
85985-0
|
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --1st specimen |
|
85986-8
|
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --2nd specimen |
|
85987-6
|
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --2nd specimen |
|
85976-9
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum by Immunoassay |
|
85974-4
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
85975-1
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum |
|
85977-7
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum |
|
85980-1
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
85979-3
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --1st specimen |
|
85978-5
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --1st specimen |
|
85983-5
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
85982-7
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --2nd specimen |
|
85981-9
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86007-2
|
Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
|
86008-0
|
Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
85990-0
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum |
|
85989-2
|
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum |
|
86002-3
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86003-1
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --1st specimen |
|
86001-5
|
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --1st specimen |
|
86005-6
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86006-4
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --2nd specimen |
|
86004-9
|
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --2nd specimen |
|
85746-6
|
Streptococcus pneumoniae Danish serotype 14 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85994-2
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum by Immunoassay |
|
85992-6
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
85993-4
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum |
|
85991-8
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum |
|
85995-9
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
85997-5
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --1st specimen |
|
85996-7
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --1st specimen |
|
85998-3
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86000-7
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --2nd specimen |
|
85999-1
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
47347-0
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
47356-1
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
40973-0
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum |
|
47357-9
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47501-2
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --1st specimen |
|
47346-2
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47502-0
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85751-6
|
Streptococcus pneumoniae Danish serotype 16F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86015-5
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86010-6
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86009-8
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum |
|
86012-2
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86011-4
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86014-8
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86013-0
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
13136-7
|
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum |
|
26755-9
|
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum |
|
13157-3
|
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --1st specimen |
|
27151-0
|
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --1st specimen |
|
13158-1
|
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --2nd specimen |
|
27121-3
|
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --2nd specimen |
|
25285-8
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
9611-5
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum by Immunoassay |
|
40913-6
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay |
|
17635-4
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum |
|
27395-3
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum |
|
40914-4
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
31647-1
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --1st specimen |
|
30490-7
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --1st specimen |
|
40912-8
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
25289-0
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --2nd specimen |
|
30491-5
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86018-9
|
Streptococcus pneumoniae Danish serotype 18F Ab [Units/volume] in Serum --1st specimen |
|
86017-1
|
Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86016-3
|
Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum |
|
85760-7
|
Streptococcus pneumoniae Danish serotype 19A DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
47348-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
40915-1
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
40974-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum |
|
40916-9
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47503-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --1st specimen |
|
40917-7
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47504-6
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
42367-3
|
Streptococcus pneumoniae Danish serotype 19B IgG Ab [Mass/volume] in Serum |
|
85744-1
|
Streptococcus pneumoniae Danish serotype 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86044-5
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86038-7
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86039-5
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum |
|
86040-3
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86041-1
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86042-9
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86043-7
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86051-0
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86046-0
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86045-2
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum |
|
86048-6
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86047-8
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --1st specimen |
|
86050-2
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86049-4
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86058-5
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86053-6
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86052-8
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum |
|
86055-1
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86054-4
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86057-7
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86056-9
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85750-8
|
Streptococcus pneumoniae Danish serotype 23A DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86059-3
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum |
|
86060-1
|
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum |
|
86072-6
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86073-4
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --1st specimen |
|
86074-2
|
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --1st specimen |
|
86075-9
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86076-7
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --2nd specimen |
|
86077-5
|
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --2nd specimen |
|
85743-3
|
Streptococcus pneumoniae Danish serotype 23F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86071-8
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86063-5
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum by Immunoassay |
|
86061-9
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86062-7
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum |
|
86064-3
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum |
|
86067-6
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86066-8
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --1st specimen |
|
86065-0
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86070-0
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86069-2
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --2nd specimen |
|
86068-4
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86097-3
|
Streptococcus pneumoniae Danish serotype 3 Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86079-1
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum |
|
86078-3
|
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum |
|
86092-4
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86093-2
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --1st specimen |
|
86091-6
|
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --1st specimen |
|
86095-7
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86096-5
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --2nd specimen |
|
86094-0
|
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --2nd specimen |
|
85742-5
|
Streptococcus pneumoniae Danish serotype 3 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86090-8
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86083-3
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
86081-7
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86082-5
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum |
|
86080-9
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum |
|
86084-1
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86086-6
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --1st specimen |
|
86085-8
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86087-4
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86089-0
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --2nd specimen |
|
86088-2
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
47350-4
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
47349-6
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
40969-8
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum |
|
47351-2
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47509-5
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --1st specimen |
|
47352-0
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47510-3
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86106-2
|
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum |
|
86105-4
|
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum |
|
86119-5
|
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --1st specimen |
|
86118-7
|
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --1st specimen |
|
86121-1
|
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --2nd specimen |
|
86120-3
|
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --2nd specimen |
|
85741-7
|
Streptococcus pneumoniae Danish serotype 4 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86117-9
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86110-4
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum by Immunoassay |
|
86108-8
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86109-6
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum |
|
86107-0
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum |
|
86111-2
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86113-8
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --1st specimen |
|
86112-0
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86114-6
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86116-1
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --2nd specimen |
|
86115-3
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85740-9
|
Streptococcus pneumoniae Danish serotype 5 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86135-1
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86129-4
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86130-2
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum |
|
86131-0
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86132-8
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86133-6
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86134-4
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86139-3
|
Streptococcus pneumoniae Danish serotype 6A Ab [Units/volume] in Serum --2nd specimen |
|
86140-1
|
Streptococcus pneumoniae Danish serotype 6A Ab [Mass/volume] in Serum --2nd specimen |
|
86138-5
|
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86137-7
|
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Units/volume] in Serum |
|
86136-9
|
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum |
|
86338-1
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum |
|
86342-3
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum |
|
86341-5
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum --1st specimen |
|
86343-1
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum --1st specimen |
|
86340-7
|
Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum by Immunoassay |
|
86339-9
|
Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum |
|
13133-4
|
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum |
|
34172-7
|
Streptococcus pneumoniae Danish serotype 6B Ab [Mass/volume] in Serum |
|
13145-8
|
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --1st specimen |
|
13146-6
|
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --2nd specimen |
|
25280-9
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
40905-2
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
25295-7
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum |
|
27118-9
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum |
|
40906-0
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
25279-1
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --1st specimen |
|
30498-0
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --1st specimen |
|
40907-8
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
31639-8
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --2nd specimen |
|
30499-8
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85753-2
|
Streptococcus pneumoniae Danish serotypes 6C+6D DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86142-7
|
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum by Immunoassay |
|
86141-9
|
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum |
|
85748-2
|
Streptococcus pneumoniae Danish serotypes 7A+7F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
17640-4
|
Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
|
22555-7
|
Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
13167-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum |
|
26754-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum |
|
17638-8
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
13147-4
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --1st specimen |
|
27150-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --1st specimen |
|
17639-6
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
13148-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --2nd specimen |
|
27120-5
|
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen |
|
25278-3
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
8028-3
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum by Immunoassay |
|
40911-0
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
22552-4
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum |
|
25296-5
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum |
|
27433-2
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
31645-5
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --1st specimen |
|
30501-1
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --1st specimen |
|
27427-4
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
31646-3
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --2nd specimen |
|
30502-9
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86143-5
|
Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum |
|
86144-3
|
Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum by Immunoassay |
|
86145-0
|
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum |
|
86146-8
|
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum |
|
86159-1
|
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --1st specimen |
|
86158-3
|
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --1st specimen |
|
86161-7
|
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --2nd specimen |
|
86160-9
|
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen |
|
86157-5
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86150-0
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum by Immunoassay |
|
86148-4
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86149-2
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum |
|
86147-6
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum |
|
86151-8
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86153-4
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --1st specimen |
|
86152-6
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86154-2
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86156-7
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --2nd specimen |
|
86155-9
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85752-4
|
Streptococcus pneumoniae Danish serotypes 9A+9V DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86181-5
|
Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
86180-7
|
Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
86165-8
|
Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum |
|
86162-5
|
Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum by Immunoassay |
|
86163-3
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum |
|
86164-1
|
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum |
|
86177-3
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86178-1
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --1st specimen |
|
86179-9
|
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --1st specimen |
|
86182-3
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86183-1
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --2nd specimen |
|
86184-9
|
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --2nd specimen |
|
86176-5
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86168-2
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum by Immunoassay |
|
86166-6
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86167-4
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum |
|
86169-0
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum |
|
86172-4
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86171-6
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --1st specimen |
|
86170-8
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --1st specimen |
|
86175-7
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86174-0
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --2nd specimen |
|
86173-2
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --2nd specimen |
|
47037-7
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
|
47508-7
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
40926-8
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay |
|
31650-5
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Units/volume] in Serum |
|
30153-1
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum |
|
40918-5
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47506-1
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --1st specimen |
|
40919-3
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47507-9
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --2nd specimen |
|
92949-7
|
Streptococcus pneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85768-0
|
Streptococcus pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92771-5
|
Streptococcus pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture |
|
53917-1
|
Streptococcus pneumoniae DNA [Presence] in Blood by NAA with probe detection |
|
82187-6
|
Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
92125-4
|
Streptococcus pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
92948-9
|
Streptococcus pneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
49672-9
|
Streptococcus pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17649-5
|
Streptococcus pneumoniae IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
22563-1
|
Streptococcus pneumoniae IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
5368-6
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
43236-9
|
Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum by Immunoassay |
|
8031-7
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum |
|
46205-1
|
Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum |
|
17650-3
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
22562-3
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
|
17651-1
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22564-9
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
|
8032-5
|
Streptococcus pneumoniae IgM Ab [Units/volume] in Serum |
|
85688-0
|
Streptococcus pneumoniae lytA gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
76600-6
|
Streptococcus pneumoniae nanA gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76572-7
|
Streptococcus pneumoniae nanA gene [Presence] in XXX.swab by NAA with probe detection |
|
76587-5
|
Streptococcus pneumoniae nanA gene [#/mass] in XXX.tissue by NAA with probe detection |
|
5035-1
|
Streptococcus pneumoniae rRNA [Presence] in Unspecified specimen by Probe |
|
42771-6
|
Streptococcus pneumoniae serotype IgG Ab [Interpretation] in Serum Narrative |
|
88722-4
|
Streptococcus pneumoniae serotype [Type] in Isolate |
|
73674-4
|
Streptococcus pneumoniae serotype [Type] in Isolate by Agglutination |
|
85496-8
|
Streptococcus pneumoniae serotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
88275-3
|
Streptococcus pneumoniae gryB gene [Presence] by Probe in Positive blood culture |
|
88591-3
|
Scedosporium prolificans DNA [Presence] in Aspirate by NAA with probe detection |
|
88553-3
|
Scedosporium prolificans DNA [Presence] in Isolate by NAA with probe detection |
|
88556-6
|
Scedosporium prolificans DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88554-1
|
Scedosporium prolificans DNA [Presence] in Tissue by NAA with probe detection |
|
88552-5
|
Scedosporium prolificans DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22526-8
|
Salmonella pullorum Ab [Presence] in Serum |
|
15505-1
|
Salmonella pullorum Ab [Presence] in Serum by Agglutination |
|
23434-4
|
Salmonella pullorum Ab [Presence] in Serum by Immunoassay |
|
23433-6
|
Salmonella pullorum Ab [Presence] in Serum by Immune diffusion (ID) |
|
31620-8
|
Salmonella pullorum Ab [Units/volume] in Serum |
|
42961-3
|
Salmonella pullorum Ab [Titer] in Serum |
|
23777-6
|
Salmonella pullorum Ab [Titer] in Serum by Agglutination |
|
23435-1
|
Salmonella pullorum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23436-9
|
Salmonella pullorum rRNA [Presence] in Unspecified specimen by Probe |
|
31970-7
|
Streptococcus pyogenes Ag [Presence] in Serum |
|
11269-8
|
Streptococcus pyogenes Ag [Presence] in Serum by Agglutination |
|
18481-2
|
Streptococcus pyogenes Ag [Presence] in Throat |
|
78012-2
|
Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay |
|
6557-3
|
Streptococcus pyogenes Ag [Presence] in Throat by Immunofluorescence |
|
31971-5
|
Streptococcus pyogenes Ag [Presence] in Unspecified specimen |
|
6558-1
|
Streptococcus pyogenes Ag [Presence] in Unspecified specimen by Immunoassay |
|
6559-9
|
Streptococcus pyogenes Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92947-1
|
Streptococcus pyogenes DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85769-8
|
Streptococcus pyogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92770-7
|
Streptococcus pyogenes DNA [Presence] by NAA with probe detection in Positive blood culture |
|
92946-3
|
Streptococcus pyogenes DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
60489-2
|
Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection |
|
49610-9
|
Streptococcus pyogenes DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
68954-7
|
Streptococcus pyogenes rRNA [Presence] in Throat by Probe |
|
5036-9
|
Streptococcus pyogenes rRNA [Presence] in Unspecified specimen by Probe |
|
11268-0
|
Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
|
17656-0
|
Streptococcus pyogenes [Presence] in Unspecified specimen by Organism specific culture |
|
22566-4
|
Streptococcus pyogenes enzyme Ab [Presence] in Serum |
|
5172-2
|
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Latex agglutination |
|
12259-8
|
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
|
31658-8
|
Streptococcus pyogenes enzyme Ab [Units/volume] in Serum |
|
22567-2
|
Streptococcus pyogenes enzyme Ab [Titer] in Serum |
|
5173-0
|
Streptococcus pyogenes enzyme Ab [Titer] in Serum by Latex agglutination |
|
76609-7
|
Streptococcus pyogenes csrS gene [#/volume] in XXX.body fluid by NAA with probe detection |
|
76581-8
|
Streptococcus pyogenes csrS gene [Presence] in XXX.swab by NAA with probe detection |
|
76596-6
|
Streptococcus pyogenes csrS gene [#/mass] in XXX.tissue by NAA with probe detection |
|
88276-1
|
Streptococcus pyogenes hsp60 gene [Presence] by Probe in Positive blood culture |
|
72268-6
|
Streptococcus pyogenes exotoxin B speB gene [Presence] in Unspecified specimen by NAA with probe detection |
|
42521-5
|
Saccharopolyspora rectivirgula Ab [Presence] in Cerebral spinal fluid |
|
22412-1
|
Saccharopolyspora rectivirgula Ab [Presence] in Serum |
|
6818-9
|
Saccharopolyspora rectivirgula Ab [Presence] in Serum by Immune diffusion (ID) |
|
5246-4
|
Saccharopolyspora rectivirgula Ab [Units/volume] in Serum |
|
21389-2
|
Saccharopolyspora rectivirgula IgE Ab [Units/volume] in Serum |
|
21390-0
|
Saccharopolyspora rectivirgula IgE Ab RAST class [Presence] in Serum |
|
19749-1
|
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum |
|
25479-7
|
Saccharopolyspora rectivirgula IgG Ab [Units/volume] in Serum |
|
25480-5
|
Saccharopolyspora rectivirgula IgG Ab RAST class [Presence] in Serum |
|
34410-1
|
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
26948-0
|
Saccharopolyspora rectivirgula IgG Ab [Mass/volume] in Serum |
|
6251-3
|
Sporobolomyces roseus IgE Ab [Units/volume] in Serum |
|
6138-2
|
Setomelanomma rostrata IgE Ab [Units/volume] in Serum |
|
15769-3
|
Setomelanomma rostrata IgE Ab RAST class [Presence] in Serum |
|
49899-8
|
Setomelanomma rostrata IgE Ab/IgE total in Serum |
|
35555-2
|
Setomelanomma rostrata IgG Ab [Mass/volume] in Serum |
|
9787-3
|
Sarcoptes scabiei identified in Skin by Light microscopy |
|
51471-1
|
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid |
|
49860-0
|
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31633-1
|
Sporothrix schenckii Ab [Units/volume] in Cerebral spinal fluid |
|
26864-9
|
Sporothrix schenckii Ab [Units/volume] in Serum by Latex agglutination |
|
13273-8
|
Sporothrix schenckii Ab [Presence] in Serum |
|
5364-5
|
Sporothrix schenckii Ab [Units/volume] in Serum |
|
27859-8
|
Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid |
|
38345-5
|
Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
|
27937-2
|
Sporothrix schenckii Ab [Titer] in Serum |
|
48339-6
|
Sporothrix schenckii Ag [Presence] in Tissue by Immune stain |
|
13243-1
|
Sporothrix schenckii IgA Ab [Units/volume] in Serum |
|
13241-5
|
Sporothrix schenckii IgG Ab [Units/volume] in Serum |
|
13242-3
|
Sporothrix schenckii IgM Ab [Units/volume] in Serum |
|
7720-6
|
Stemphylium solani IgE Ab [Units/volume] in Serum |
|
16034-1
|
Stemphylium solani IgE Ab RAST class [Presence] in Serum |
|
11611-1
|
Shigella sonnei Ab [Units/volume] in Serum |
|
22540-9
|
Shigella sonnei Ab [Titer] in Serum |
|
9715-4
|
Shigella sonnei Ab [Titer] in Serum by Complement fixation |
|
42259-2
|
Shigella sonnei Ag [Presence] in Isolate |
|
58046-4
|
Strongyloides stercoralis Ab [Titer] in Serum |
|
88913-9
|
Strongyloides stercoralis DNA [Presence] in Stool by NAA with probe detection |
|
8035-8
|
Strongyloides stercoralis IgG Ab [Presence] in Serum |
|
6632-4
|
Strongyloides stercoralis IgG Ab [Presence] in Serum by Immunoassay |
|
86740-8
|
Streptococcus suis Ag [Presence] in Unspecified specimen by Immune stain |
|
86739-0
|
Streptococcus suis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
24430-1
|
Streptococcus suis serotype [Identifier] in Isolate by Agglutination |
|
70021-1
|
Salmonella typhi DNA [Presence] in Blood by NAA with probe detection |
|
22529-2
|
Salmonella typhi H Ab [Presence] in Serum |
|
5345-4
|
Salmonella typhi H Ab [Presence] in Serum by Latex agglutination |
|
42960-5
|
Salmonella typhi H Ab [Titer] in Serum |
|
34371-5
|
Salmonella typhi H Ab [Titer] in Serum by Agglutination |
|
13284-5
|
Salmonella typhi H D Ab [Presence] in Serum |
|
17565-3
|
Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination |
|
31621-6
|
Salmonella typhi H D Ab [Units/volume] in Serum |
|
14227-3
|
Salmonella typhi H D Ab [Titer] in Serum |
|
47388-4
|
Salmonella typhi H D Ab [Titer] in Serum by Agglutination |
|
53956-9
|
Salmonella typhi [Identifier] in Isolate by Agglutination |
|
17566-1
|
Salmonella typhi O Ab [Presence] in Serum |
|
5346-2
|
Salmonella typhi O Ab [Presence] in Serum by Latex agglutination |
|
42959-7
|
Salmonella typhi O Ab [Titer] in Serum |
|
34372-3
|
Salmonella typhi O Ab [Titer] in Serum by Agglutination |
|
13285-2
|
Salmonella typhi O D Ab [Presence] in Serum |
|
17564-6
|
Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination |
|
31622-4
|
Salmonella typhi O D Ab [Units/volume] in Serum |
|
46204-4
|
Salmonella typhi O D Ab [Titer] in Serum |
|
23930-1
|
Salmonella typhi O D Ab [Titer] in Serum by Agglutination |
|
23931-9
|
Salmonella typhi O D [Titer] in Serum by Immunofluorescence |
|
57769-2
|
Salmonella typhi O Vi Ab [Presence] in Serum |
|
22531-8
|
Salmonella typhimurium Ab [Presence] in Serum |
|
15506-9
|
Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
|
31623-2
|
Salmonella typhimurium Ab [Units/volume] in Serum |
|
42958-9
|
Salmonella typhimurium Ab [Titer] in Serum |
|
23778-4
|
Salmonella typhimurium Ab [Titer] in Serum by Agglutination |
|
34424-2
|
Salmonella typhimurium H Ab [Titer] in Serum |
|
34432-5
|
Salmonella typhimurium H Ab [Titer] in Serum by Agglutination |
|
42533-0
|
Saccharomonospora viridis Ab [Presence] in Cerebral spinal fluid |
|
22572-2
|
Saccharomonospora viridis Ab [Presence] in Serum |
|
15209-0
|
Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) |
|
5336-3
|
Saccharomonospora viridis Ab [Units/volume] in Serum |
|
17557-0
|
Saccharomonospora viridis IgG Ab [Units/volume] in Serum |
|
10058-6
|
S' wave amplitude in lead AVF |
|
10034-7
|
S wave amplitude in lead AVF |
|
10059-4
|
S' wave amplitude in lead AVL |
|
10035-4
|
S wave amplitude in lead AVL |
|
10060-2
|
S' wave amplitude in lead AVR |
|
10036-2
|
S wave amplitude in lead AVR |
|
10061-0
|
S' wave amplitude in lead I |
|
10037-0
|
S wave amplitude in lead I |
|
10062-8
|
S' wave amplitude in lead II |
|
10038-8
|
S wave amplitude in lead II |
|
10063-6
|
S' wave amplitude in lead III |
|
10039-6
|
S wave amplitude in lead III |
|
10064-4
|
S' wave amplitude in lead V1 |
|
10040-4
|
S wave amplitude in lead V1 |
|
10065-1
|
S' wave amplitude in lead V2 |
|
10041-2
|
S wave amplitude in lead V2 |
|
10066-9
|
S' wave amplitude in lead V3 |
|
10042-0
|
S wave amplitude in lead V3 |
|
10067-7
|
S' wave amplitude in lead V4 |
|
10043-8
|
S wave amplitude in lead V4 |
|
10068-5
|
S' wave amplitude in lead V5 |
|
10044-6
|
S wave amplitude in lead V5 |
|
10069-3
|
S' wave amplitude in lead V6 |
|
10045-3
|
S wave amplitude in lead V6 |
|
10070-1
|
S' wave duration in lead AVF |
|
10046-1
|
S wave duration in lead AVF |
|
10071-9
|
S' wave duration in lead AVL |
|
10047-9
|
S wave duration in lead AVL |
|
10072-7
|
S' wave duration in lead AVR |
|
10048-7
|
S wave duration in lead AVR |
|
10073-5
|
S' wave duration in lead I |
|
10049-5
|
S wave duration in lead I |
|
10074-3
|
S' wave duration in lead II |
|
10050-3
|
S wave duration in lead II |
|
10075-0
|
S' wave duration in lead III |
|
10051-1
|
S wave duration in lead III |
|
10076-8
|
S' wave duration in lead V1 |
|
10052-9
|
S wave duration in lead V1 |
|
10077-6
|
S' wave duration in lead V2 |
|
10053-7
|
S wave duration in lead V2 |
|
10078-4
|
S' wave duration in lead V3 |
|
10054-5
|
S wave duration in lead V3 |
|
10079-2
|
S' wave duration in lead V4 |
|
10055-2
|
S wave duration in lead V4 |
|
10080-0
|
S' wave duration in lead V5 |
|
10056-0
|
S wave duration in lead V5 |
|
10081-8
|
S' wave duration in lead V6 |
|
10057-8
|
S wave duration in lead V6 |
|
10510-6
|
S-100 Ag [Presence] in Tissue by Immune stain |
|
47274-6
|
S100 calcium binding protein B [Mass/volume] in Cerebral spinal fluid |
|
47275-3
|
S100 calcium binding protein B [Mass/volume] in Serum |
|
85045-3
|
Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC [Identifier] by ARD gradient strip |
|
85042-0
|
Staphylococcus aureus glycopeptide resistant identified [Type] in Isolate |
|
2929-8
|
Saccharides [Presence] in Urine |
|
81781-7
|
Saccharopine [Moles/volume] in Cerebral spinal fluid |
|
79607-8
|
Saccharopine [Moles/volume] in Serum or Plasma |
|
79640-9
|
Saccharopine/Creatinine [Molar ratio] in Urine |
|
81823-7
|
SACS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85141-0
|
Sadness Survey - age 18+ - T-score [NIH Toolbox] |
|
85137-8
|
Sadness Survey version 2.0 - ages 8-17 - T-score [NIH Toolbox] |
|
85117-0
|
Sadness Survey version 2.0 - parent report - ages 3-7 - T-score [NIH Toolbox] |
|
82439-1
|
SUMO-activating enzyme subunit 1 Ab [Units/volume] in Serum by Line blot |
|
82440-9
|
SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot |
|
82992-9
|
SUMO-activating enzyme subunit 1 IgG Ab [Presence] in Serum by Line blot |
|
82441-7
|
SUMO-activating enzyme subunit 2 Ab [Units/volume] in Serum by Line blot |
|
82442-5
|
SUMO-activating enzyme subunit 2 Ab [Presence] in Serum by Line blot |
|
82214-8
|
Safety issue assessment note |
|
88033-6
|
Safety checklist Ventilator Document |
|
7676-0
|
Safflower IgE Ab [Units/volume] in Serum |
|
16001-0
|
Safflower IgE Ab RAST class [Presence] in Serum |
|
7677-8
|
Safflower IgG Ab [Units/volume] in Serum |
|
21506-1
|
Safflower IgG Ab RAST class [Presence] in Serum |
|
56382-5
|
Safflower IgG4 Ab [Mass/volume] in Serum |
|
63117-6
|
Safflower IgG Ab [Mass/volume] in Serum |
|
19755-8
|
Saffron IgE Ab [Units/volume] in Serum |
|
25517-4
|
Saffron IgE Ab RAST class [Presence] in Serum |
|
10805-0
|
Microscopic observation [Identifier] in Tissue by Safranin stain |
|
7681-0
|
Common Sagebrush IgE Ab [Units/volume] in Serum |
|
16003-6
|
Common Sagebrush IgE Ab RAST class [Presence] in Serum |
|
7682-8
|
Common Sagebrush IgG Ab [Units/volume] in Serum |
|
63193-7
|
Common Sagebrush IgG Ab [Mass/volume] in Serum |
|
7678-6
|
Sage IgE Ab [Units/volume] in Serum |
|
16002-8
|
Sage IgE Ab RAST class [Presence] in Serum |
|
7680-2
|
Sage IgG Ab [Units/volume] in Serum |
|
21507-9
|
Sage IgG Ab RAST class [Presence] in Serum |
|
56464-1
|
Sage IgG4 Ab [Mass/volume] in Serum |
|
60399-3
|
Sage IgG Ab [Mass/volume] in Serum |
|
72282-7
|
Sagittal plane body position |
|
80174-6
|
S-adenosylhomocysteine [Moles/volume] in Cerebral spinal fluid |
|
80175-3
|
S-adenosylhomocysteine [Moles/volume] in Serum or Plasma |
|
80176-1
|
S-adenosylhomocysteine/Creatinine [Molar ratio] in Urine |
|
75147-9
|
Succinylaminoimidazole carboxamide riboside [Moles/volume] in Cerebral spinal fluid |
|
75146-1
|
Succinylaminoimidazole carboxamide riboside [Moles/volume] in Serum or Plasma |
|
63553-2
|
Succinylaminoimidazole carboxamide riboside [Presence] in Urine |
|
75138-8
|
Succinylaminoimidazole carboxamide riboside/Creatinine [Molar ratio] in Urine |
|
59735-1
|
Salicylamide [Mass/volume] in Blood |
|
4422-2
|
Salicylamide [Mass] of Dose |
|
34198-2
|
Salicylamide [Mass/volume] in Serum or Plasma --peak |
|
4022-0
|
Salicylamide [Mass/volume] in Serum or Plasma |
|
55577-1
|
Salicylamide [Moles/volume] in Serum or Plasma |
|
34197-4
|
Salicylamide [Mass/volume] in Serum or Plasma --trough |
|
59736-9
|
Salicylamide [Mass/volume] in Urine |
|
17559-6
|
Salicylates [Presence] in Blood |
|
60201-1
|
Salicylates [Mass/volume] in Blood |
|
4423-0
|
Salicylates [Mass] of Dose |
|
29227-6
|
Salicylates [Mass/volume] in Body fluid |
|
80963-2
|
Salicylates free [Mass/volume] in Serum or Plasma |
|
17560-4
|
Salicylates [Presence] in Gastric fluid |
|
29352-2
|
Salicylates [Mass/volume] in Gastric fluid |
|
47128-4
|
Salicylates [Moles/volume] in Gastric fluid |
|
46978-3
|
Salicylates [Mass/volume] in Serum or Plasma by Confirmatory method |
|
4023-8
|
Salicylates [Presence] in Serum or Plasma |
|
35597-4
|
Salicylates [Mass/volume] in Serum or Plasma by Screen method |
|
70216-7
|
Salicylates [Moles/volume] in Serum or Plasma by Screen method |
|
4024-6
|
Salicylates [Mass/volume] in Serum or Plasma |
|
14909-6
|
Salicylates [Moles/volume] in Serum or Plasma |
|
72677-8
|
Salicylates [Mass/volume] in Serum or Plasma --trough |
|
4025-3
|
Salicylates [Presence] in Urine |
|
4026-1
|
Salicylates [Mass/volume] in Urine |
|
22701-7
|
Salicylates [Moles/volume] in Urine |
|
35130-4
|
Salicylates [Presence] in Unspecified specimen |
|
22732-2
|
Salicylates [Moles/volume] in Unspecified specimen |
|
90238-7
|
Salicylcarnitine [Moles/volume] in Serum or Plasma |
|
42610-6
|
Salicylurate [Mass/volume] in Serum or Plasma |
|
79489-1
|
Salicylurate [Moles/volume] in Serum or Plasma |
|
42612-2
|
Salicylurate [Mass/volume] in Urine |
|
79478-4
|
Salicylurate/Creatinine [Molar ratio] in Urine |
|
53206-9
|
Salicylylcarnitine (SalC) [Moles/volume] in DBS |
|
16005-1
|
Saline fish feed IgE Ab RAST class [Presence] in Serum |
|
35836-6
|
Salinomycin [Susceptibility] by Disk diffusion (KB) |
|
35837-4
|
Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35838-2
|
Salinomycin [Susceptibility] |
|
87593-0
|
Salinomycin [Mass/mass] in Unspecified specimen |
|
5337-1
|
Salivary gland Ab [Units/volume] in Serum |
|
9721-2
|
Salivary gland Ab [Titer] in Serum |
|
53021-2
|
Salivary gland Ab [Titer] in Serum by Immunofluorescence |
|
43686-5
|
Salivary gland IgA Ab [Units/volume] in Saliva (oral fluid) |
|
85929-8
|
Salivary gland swelling duration |
|
82941-6
|
Salivation [ALSFRS-R] |
|
77691-4
|
Salivation scale [UPDRS] |
|
43371-4
|
Salmonella and Shigella sp identified in Stool by Organism specific culture |
|
42255-0
|
Salmonella and Shigella sp identified in Unspecified specimen by Organism specific culture |
|
48806-4
|
Salmonella sp+Shigella sp+Escherichia coli enterotoxic identified in Stool by Organism specific culture |
|
6237-2
|
Salmon IgE Ab [Units/volume] in Serum |
|
16006-9
|
Salmon IgE Ab RAST class [Presence] in Serum |
|
39548-3
|
Salmon IgE Ab/IgE total in Serum |
|
7685-1
|
Salmon IgG Ab [Units/volume] in Serum |
|
19045-4
|
Salmon IgG Ab RAST class [Presence] in Serum |
|
56383-3
|
Salmon IgG4 Ab [Mass/volume] in Serum |
|
60400-9
|
Salmon IgG Ab [Mass/volume] in Serum |
|
17561-2
|
Salmon roe IgE Ab [Units/volume] in Serum |
|
17562-0
|
Salmonella sp Ab [Presence] in Serum |
|
11603-8
|
Salmonella sp Ab [Units/volume] in Serum |
|
22527-6
|
Salmonella sp Ab [Titer] in Serum |
|
5338-9
|
Salmonella sp Ab [Titer] in Serum by Latex agglutination |
|
87393-5
|
Salmonella sp Ab/Positive control in Serum by Immunoassay |
|
93385-3
|
Salmonella sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
87394-3
|
Salmonella sp DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49612-5
|
Salmonella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20952-8
|
Salmonella sp identified in Egg by Organism specific culture |
|
9672-7
|
Salmonella sp IgA Ab [Units/volume] in Serum |
|
9673-5
|
Salmonella sp IgG Ab [Units/volume] in Serum |
|
9674-3
|
Salmonella sp IgM Ab [Units/volume] in Serum |
|
59846-6
|
Salmonella sp identified [Type] in Isolate |
|
73672-8
|
Salmonella sp phage type in Isolate |
|
65756-9
|
Salmonella sp serovar [Type] in Isolate |
|
20951-0
|
Salmonella sp serotype [Identifier] in Isolate by Agglutination |
|
56475-7
|
Salmonella sp antigenic formula [Identifier] in Isolate by Agglutination |
|
80678-6
|
Salmonella sp invA+fliC genes [Presence] in Stool by NAA with probe detection |
|
79383-6
|
Salmonella sp rpoD gene [Presence] in Stool by NAA with probe detection |
|
81657-9
|
Salmonella sp spaO gene [Presence] in Stool by NAA with probe detection |
|
20955-1
|
Salmonella sp identified in Stool by Organism specific culture |
|
82301-3
|
Salmonella sp [Presence] in Stool by Culture |
|
20953-6
|
Salmonella sp identified in Tissue by Organism specific culture |
|
17563-8
|
Salmonella sp identified in Unspecified specimen by Organism specific culture |
|
6238-0
|
Salt grass IgE Ab [Units/volume] in Serum |
|
15752-9
|
Salt grass IgE Ab RAST class [Presence] in Serum |
|
56465-8
|
Salt grass IgG4 Ab [Mass/volume] in Serum |
|
7686-9
|
Saltbush IgE Ab [Units/volume] in Serum |
|
16007-7
|
Saltbush IgE Ab RAST class [Presence] in Serum |
|
7196-9
|
Saltcedar IgE Ab [Units/volume] in Serum |
|
15617-4
|
Saltcedar IgE Ab RAST class [Presence] in Serum |
|
65784-1
|
Saltwort native (nSal k) 1 IgE Ab [Units/volume] in Serum |
|
81967-2
|
Saltwort native (nSal k) 1 IgE Ab RAST class [Presence] in Serum |
|
6234-9
|
Saltwort IgE Ab [Units/volume] in Serum |
|
16052-3
|
Saltwort IgE Ab RAST class [Presence] in Serum |
|
61311-7
|
Saltwort IgE Ab/IgE total in Serum |
|
7671-1
|
Saltwort IgG Ab [Units/volume] in Serum |
|
56380-9
|
Saltwort IgG4 Ab [Mass/volume] in Serum |
|
63187-9
|
Saltwort IgG Ab [Mass/volume] in Serum |
|
48252-1
|
Saltwort triggered leukotriene release [Mass/volume] by Leukocytes |
|
59324-4
|
Salvinorin A [Mass/volume] in Blood |
|
59326-9
|
Salvinorin A [Mass/volume] in Serum or Plasma |
|
59328-5
|
Salvinorin A [Mass/volume] in Urine |
|
59325-1
|
Salvinorin B [Mass/volume] in Blood |
|
59327-7
|
Salvinorin B [Mass/volume] in Serum or Plasma |
|
59329-3
|
Salvinorin B [Mass/volume] in Urine |
|
80180-3
|
S-adenosylmethionine and S-adenosylhomocystine pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
80181-1
|
S-adenosylmethionine and S-adenosylhomocystine pattern [Interpretation] in Serum or Plasma Narrative |
|
80177-9
|
S-adenosylmethionine [Moles/volume] in Cerebral spinal fluid |
|
78966-9
|
S-adenosylmethionine [Moles/volume] in Serum or Plasma |
|
80182-9
|
S-adenosylmethionine/Creatinine [Molar ratio] in Urine |
|
70153-2
|
Sample hemolyzed [Presence] of Cerebral spinal fluid Qualitative |
|
20393-5
|
Sample hemolyzed [Presence] of Serum or Plasma Qualitative |
|
70137-5
|
Sample icteric [Presence] of Cerebral spinal fluid Qualitative by Spectrophotometry |
|
20392-7
|
Sample icteric [Presence] of Serum or Plasma Qualitative |
|
20395-0
|
Sample integrity [Type] of Serum or Plasma |
|
20394-3
|
Sample lipemic [Presence] of Serum or Plasma Qualitative |
|
57718-9
|
Sample quality of Dried blood spot |
|
90369-0
|
Sample collection timing related to drug dose |
|
81258-6
|
Sample variant allelic frequency [NFr] |
|
20564-1
|
Oxygen saturation in Blood |
|
2713-6
|
Oxygen saturation Calculated from oxygen partial pressure in Blood |
|
2708-6
|
Oxygen saturation in Arterial blood |
|
51733-4
|
Oxygen saturation Calculated from oxygen partial pressure in Arterial blood |
|
2709-4
|
Oxygen saturation in Capillary blood |
|
51732-6
|
Oxygen saturation Calculated from oxygen partial pressure in Capillary blood |
|
68363-1
|
Oxygen saturation in Cord blood |
|
28642-7
|
Oxygen saturation in Arterial cord blood |
|
28643-5
|
Oxygen saturation in Venous cord blood |
|
74105-8
|
Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood |
|
2711-0
|
Oxygen saturation in Venous blood |
|
51731-8
|
Oxygen saturation Calculated from oxygen partial pressure in Venous blood |
|
71853-6
|
Oxygen saturation [Pure mass fraction] in Blood |
|
71844-5
|
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Blood |
|
71852-8
|
Oxygen saturation [Pure mass fraction] in Arterial blood |
|
71843-7
|
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Arterial blood |
|
71851-0
|
Oxygen saturation [Pure mass fraction] in Capillary blood |
|
71842-9
|
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Capillary blood |
|
71849-4
|
Oxygen saturation [Pure mass fraction] in Cord blood |
|
71848-6
|
Oxygen saturation [Pure mass fraction] in Arterial cord blood |
|
71847-8
|
Oxygen saturation [Pure mass fraction] in Venous cord blood |
|
71846-0
|
Oxygen saturation [Pure mass fraction] in Mixed venous blood |
|
71845-2
|
Oxygen saturation [Pure mass fraction] in Venous blood |
|
71841-1
|
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Venous blood |
|
89277-8
|
Oxygen saturation in Arterial blood by Pulse oximetry --during anesthesia |
|
89272-9
|
Oxygen saturation in Arterial blood by Pulse oximetry --during apnea |
|
89276-0
|
Oxygen saturation in Arterial blood by Pulse oximetry --W exercise |
|
41925-9
|
Type of Oxygen saturation device |
|
41927-5
|
Oxygen saturation device Vendor model code |
|
73802-1
|
Oxygen saturation sensor wrap name |
|
73804-7
|
Oxygen saturation sensor name |
|
73803-9
|
Oxygen saturation sensor type |
|
73800-5
|
Oxygen saturation sensor wrap size |
|
73801-3
|
Oxygen saturation sensor wrap type |
|
41928-3
|
Oxygen saturation device Vendor serial number |
|
41929-1
|
Oxygen saturation device Vendor software version |
|
41926-7
|
Oxygen saturation device Vendor name |
|
73696-7
|
Oxygen saturation.preductal-oxygen saturation.postductal [Mass fraction difference] in Bld.preductal and Bld.postductal |
|
82937-4
|
SAP and XIAP [Interpretation] in Leukocytes by Flow cytometry (FC) |
|
55227-3
|
Sapeli IgE Ab [Units/volume] in Serum |
|
82213-0
|
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection |
|
92694-9
|
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection |
|
72111-8
|
Sapovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
30295-0
|
Saquinavir [Susceptibility] by Genotype method |
|
30281-0
|
Saquinavir [Susceptibility] by Phenotype method |
|
29123-7
|
Saquinavir [Units/volume] in Serum or Plasma |
|
19051-2
|
Saquinavir [Mass/volume] in Serum or Plasma |
|
30310-7
|
Saquinavir [Susceptibility] |
|
51932-2
|
Saquinavir [Mass/volume] in Serum or Plasma --trough |
|
49621-6
|
Saquinavir+Ritonavir [Susceptibility] by Genotype method |
|
58024-1
|
Saquinavir+Ritonavir [Susceptibility] by Phenotype method |
|
73633-0
|
Sarafloxacin [Susceptibility] by Disk diffusion (KB) |
|
73610-8
|
Sarafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73588-6
|
Sarafloxacin [Susceptibility] |
|
9323-7
|
Sarcosine [Moles/volume] in 24 hour Urine |
|
25518-2
|
Sarcosine [Moles/time] in 24 hour Urine |
|
13413-0
|
Sarcosine [Mass/volume] in Amniotic fluid |
|
26932-4
|
Sarcosine [Moles/volume] in Amniotic fluid |
|
13380-1
|
Sarcosine [Mass/volume] in Cerebral spinal fluid |
|
26598-3
|
Sarcosine [Moles/volume] in Cerebral spinal fluid |
|
2930-6
|
Sarcosine [Presence] in Serum or Plasma |
|
2931-4
|
Sarcosine [Mass/volume] in Serum or Plasma |
|
26613-0
|
Sarcosine [Moles/volume] in Serum or Plasma |
|
17568-7
|
Sarcosine [Presence] in Urine |
|
2932-2
|
Sarcosine [Mass/volume] in Urine |
|
26724-5
|
Sarcosine [Moles/volume] in Urine |
|
44401-8
|
Sarcosine/Creatinine [Mass Ratio] in 24 hour Urine |
|
25978-8
|
Sarcosine/Creatinine [Molar ratio] in 24 hour Urine |
|
13806-5
|
Sarcosine/Creatinine [Mass Ratio] in Urine |
|
28610-4
|
Sarcosine/Creatinine [Ratio] in Urine |
|
25133-0
|
Sarcosine/Creatinine [Molar ratio] in Urine |
|
30989-8
|
Sardine (Sardinops melanosticta) IgE Ab [Units/volume] in Serum |
|
31011-0
|
Sardine (Sardinops melanosticta) IgE Ab RAST class [Presence] in Serum |
|
11197-1
|
Sardine (pilchard) IgE Ab [Units/volume] in Serum |
|
16008-5
|
Sardine (pilchard) IgE Ab RAST class [Presence] in Serum |
|
56384-1
|
Sardine (pilchard) IgG4 Ab [Mass/volume] in Serum |
|
63134-1
|
Sardine (pilchard) IgG Ab [Mass/volume] in Serum |
|
7688-5
|
Sardine IgG Ab [Units/volume] in Serum |
|
77107-1
|
SARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77106-3
|
SARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
60426-4
|
SARS coronavirus Ab [Titer] in Serum |
|
42957-1
|
SARS coronavirus IgG Ab [Presence] in Serum |
|
41460-7
|
SARS coronavirus IgG Ab [Presence] in Serum by Immunoassay |
|
42956-3
|
SARS coronavirus IgM Ab [Presence] in Serum |
|
41991-1
|
SARS coronavirus IgM Ab [Presence] in Serum by Immunoassay |
|
60275-5
|
SARS coronavirus RNA [Presence] in Isolate by NAA with probe detection |
|
60534-5
|
SARS coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
41458-1
|
SARS coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33969-7
|
SARS coronavirus Urbani Ab [Units/volume] in Serum by Immunoassay |
|
33972-1
|
SARS coronavirus Urbani Ab [Presence] in Serum |
|
33968-9
|
SARS coronavirus Urbani Ab [Presence] in Serum by Immunoassay |
|
33970-5
|
SARS coronavirus Urbani Ab [Presence] in Serum by Immunofluorescence |
|
33973-9
|
SARS coronavirus Urbani Ab [Units/volume] in Serum |
|
33974-7
|
SARS coronavirus Urbani Ab [Titer] in Serum |
|
33971-3
|
SARS coronavirus Urbani Ab [Titer] in Serum by Immunofluorescence |
|
33966-3
|
SARS coronavirus Urbani RNA [Presence] in Nose by NAA with probe detection |
|
33967-1
|
SARS coronavirus Urbani RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
33975-4
|
SARS coronavirus Urbani RNA [Presence] in Sputum by NAA with probe detection |
|
33965-5
|
SARS coronavirus Urbani RNA [Presence] in Stool by NAA with probe detection |
|
33964-8
|
SARS coronavirus Urbani RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41459-9
|
SARS coronavirus [Presence] in Unspecified specimen |
|
17567-9
|
Sasapyrine [Mass/volume] in Serum or Plasma |
|
35175-9
|
Saturated fatty acids [Moles/volume] in Serum or Plasma |
|
81033-3
|
Saturated fat intake 24 hour Estimated |
|
81136-4
|
Saturated fat intake 24 hour Measured |
|
85508-0
|
Satellite nodules [#] in Colorectal cancer specimen by Light microscopy |
|
84886-1
|
Satellite nodules [Presence] in Colorectal cancer specimen |
|
92838-2
|
Satellite nodules [Presence] in Skin melanoma |
|
89080-6
|
Satisfaction with using ADAPTABLE web site [ADAPTABLE] |
|
49592-9
|
Satratoxin IgM Ab [Units/volume] in Serum by Immunoassay |
|
51470-3
|
Satratoxin IgM Ab [Units/volume] in Serum |
|
7689-3
|
Savinase IgE Ab [Units/volume] in Serum |
|
16009-3
|
Savinase IgE Ab RAST class [Presence] in Serum |
|
11813-3
|
Small bowel Diameter US |
|
79616-9
|
S-beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
79604-5
|
S-beta aminoisobutyrate [Moles/volume] in Serum or Plasma |
|
79619-3
|
S-beta aminoisobutyrate/Creatinine [Molar ratio] in Urine |
|
41764-2
|
SBDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80628-1
|
1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine |
|
87542-7
|
SBT performed by day 2 of stay [CMS Assessment] |
|
14269-5
|
Sec-butyl acetate [Mass/volume] in Blood |
|
65333-7
|
Sc sup(1) Ab [Presence] in Serum or Plasma |
|
92520-6
|
Sc sup(1) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92482-9
|
Sc sup(1) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
85487-7
|
Sc sup(1) Ag [Presence] on Red Blood Cells |
|
65334-5
|
Sc sup(2) Ab [Presence] in Serum or Plasma |
|
92519-8
|
Sc sup(2) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92481-1
|
Sc sup(2) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
85488-5
|
Sc sup(2) Ag [Presence] on Red Blood Cells |
|
47276-1
|
Complement Sc5b-9 Ab [Presence] in Serum or Plasma |
|
13117-7
|
Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma |
|
93244-2
|
Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay |
|
36911-6
|
SCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21768-7
|
SCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21769-5
|
SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
35369-8
|
SCA1 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49641-4
|
SCA1 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
35368-0
|
SCA1 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49642-2
|
SCA1 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21765-3
|
SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49643-0
|
SCA10 gene allele 1.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49644-8
|
SCA10 gene allele 2.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
34494-5
|
SCA10 gene ATTCT repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
48031-9
|
SCA10 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
34203-0
|
SCA12 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49015-1
|
SCA15 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
35367-2
|
SCA2 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49645-5
|
SCA2 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
35366-4
|
SCA2 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49646-3
|
SCA2 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21766-1
|
SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49651-3
|
SCA7 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49652-1
|
SCA7 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21767-9
|
SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
27984-4
|
SCA8 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
74298-1
|
Short-chain acyl-CoA dehydrogenase deficiency newborn screen interpretation |
|
11184-9
|
Scad IgE Ab [Units/volume] in Serum |
|
15829-5
|
Scad IgE Ab RAST class [Presence] in Serum |
|
61320-8
|
Scad IgE Ab/IgE total in Serum |
|
46780-3
|
Short-chain acyl-CoA deficiency (SCAD); ethylmalonic encephalopathy; isobutyryl-CoA dehydrogenase deficiency newborn screen interpretation |
|
7691-9
|
Scallop IgE Ab [Units/volume] in Serum |
|
16011-9
|
Scallop IgE Ab RAST class [Presence] in Serum |
|
39088-0
|
Scallop IgE Ab/IgE total in Serum |
|
7692-7
|
Scallop IgG Ab [Units/volume] in Serum |
|
21516-0
|
Scallop IgG Ab RAST class [Presence] in Serum |
|
56385-8
|
Scallop IgG4 Ab [Mass/volume] in Serum |
|
60401-7
|
Scallop IgG Ab [Mass/volume] in Serum |
|
29923-0
|
Scandium [Mass/volume] in 24 hour Urine |
|
29924-8
|
Scandium [Mass/time] in 24 hour Urine |
|
29925-5
|
Scandium/Creatinine [Mass Ratio] in 24 hour Urine |
|
59228-7
|
Squamous cell carcinoma Ag [Mass/volume] in Cerebral spinal fluid |
|
48165-5
|
Squamous cell carcinoma Ag [Mass/volume] in Body fluid |
|
19209-6
|
Squamous cell carcinoma Ag [Units/volume] in Pleural fluid |
|
59222-0
|
Squamous cell carcinoma Ag [Mass/volume] in Pleural fluid |
|
19210-4
|
Squamous cell carcinoma Ag [Moles/volume] in Pleural fluid |
|
59225-3
|
Squamous cell carcinoma Ag [Mass/volume] in Peritoneal fluid |
|
19207-0
|
Squamous cell carcinoma Ag [Units/volume] in Serum or Plasma |
|
9679-2
|
Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma |
|
19208-8
|
Squamous cell carcinoma Ag [Moles/volume] in Serum or Plasma |
|
72887-3
|
Staphylococcus aureus methicillin resistance SCCmec [Presence] in Nose by NAA with probe detection |
|
80153-0
|
Soluble CD27 [Units/volume] in Cerebral spinal fluid |
|
80155-5
|
Soluble CD27 [Units/volume] in Serum or Plasma |
|
10806-8
|
Microscopic observation [Identifier] in Tissue by Schmorl stain |
|
38910-6
|
Schistocytes [Presence] in Blood by Automated count |
|
800-3
|
Schistocytes [Presence] in Blood by Light microscopy |
|
78011-4
|
Schistocytes/100 cells in Cord blood |
|
51630-2
|
Schistocytes/1000 erythrocytes in Blood by Light microscopy |
|
8020-0
|
Schistosoma sp Ab [Presence] in Serum |
|
6631-6
|
Schistosoma sp Ab [Presence] in Serum by Complement fixation |
|
6630-8
|
Schistosoma sp Ab [Presence] in Serum by Hemagglutination |
|
6629-0
|
Schistosoma sp Ab [Presence] in Serum by Immunoassay |
|
6628-2
|
Schistosoma sp Ab [Presence] in Serum by Immunofluorescence |
|
5347-0
|
Schistosoma sp Ab [Units/volume] in Serum |
|
34594-2
|
Schistosoma sp Ab [Titer] in Serum |
|
25422-7
|
Schistosoma sp Ab [Titer] in Serum by Immunofluorescence |
|
7693-5
|
Schistosoma sp IgE Ab [Units/volume] in Serum |
|
21517-8
|
Schistosoma sp IgE Ab RAST class [Presence] in Serum |
|
27260-9
|
Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31624-0
|
Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
25757-6
|
Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
33317-9
|
Schistosoma sp IgG Ab [Presence] in Serum |
|
13277-9
|
Schistosoma sp IgG Ab [Units/volume] in Serum |
|
13278-7
|
Schistosoma sp IgM Ab [Units/volume] in Serum |
|
76767-3
|
Schistosoma sp identified in Semen by Light microscopy |
|
11085-8
|
Schistosoma sp identified in Stool by Concentration |
|
10715-1
|
Schistosoma sp identified in Urine sediment by Light microscopy |
|
10716-9
|
Schistosoma sp identified in Unspecified specimen by Organism specific culture |
|
77715-1
|
Schwab England activities of daily living scale [UPDRS] |
|
77716-9
|
Schwab England activities of daily living with dyskinesia scale [UPDRS] |
|
62321-5
|
Severe combined immunodeficiency newborn screen interpretation |
|
62322-3
|
Severe combined immunodeficiency newborn screening comment-discussion |
|
83989-4
|
Spinal cord injury medicine Admission evaluation note |
|
83990-2
|
Spinal cord injury medicine Annual evaluation note |
|
83790-6
|
Spinal cord injury medicine Attending Note |
|
83991-0
|
Spinal cord injury medicine Conference note |
|
83992-8
|
Spinal cord injury medicine Consult note |
|
83993-6
|
Spinal cord injury medicine Discharge summary |
|
83994-4
|
Spinal cord injury medicine Education note |
|
83746-8
|
Spinal cord injury medicine Fellow Hospital Note |
|
83995-1
|
Spinal cord injury medicine History and physical note |
|
83999-3
|
Spinal cord injury medicine Hospital Note |
|
83998-5
|
Spinal cord injury medicine Initial evaluation note |
|
84000-9
|
Spinal cord injury medicine Interdisciplinary Note |
|
84011-6
|
Spinal cord injury medicine Interdisciplinary Plan of care note |
|
83791-4
|
Spinal cord injury medicine Physician Note |
|
84001-7
|
Spinal cord injury medicine Note |
|
84002-5
|
Spinal cord injury medicine Nurse Note |
|
84003-3
|
Spinal cord injury medicine Nurse Outpatient Note |
|
84004-1
|
Spinal cord injury medicine Outpatient Annual evaluation note |
|
84005-8
|
Spinal cord injury medicine Outpatient Note |
|
83750-0
|
Spinal cord injury medicine Physician assistant Note |
|
84010-8
|
Spinal cord injury medicine Telephone encounter Note |
|
84006-6
|
Spinal cord injury medicine procedure note |
|
83996-9
|
Spinal cord injury medicine Patient's home Consult note |
|
83997-7
|
Spinal cord injury medicine Patient's home Note |
|
83777-3
|
Spinal cord injury medicine Resident Hospital Note |
|
84007-4
|
Spinal cord injury medicine Risk assessment and screening note |
|
84008-2
|
Spinal cord injury medicine Team Note |
|
84009-0
|
Spinal cord injury medicine Telehealth Note |
|
41765-9
|
SCN1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
58045-6
|
SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81872-4
|
SCN5A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
55139-0
|
SCN5A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43748-3
|
SCO1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43749-1
|
SCO2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
39356-1
|
Cholinesterase.scoline inhibited/Cholinesterase in Serum or Plasma |
|
72566-3
|
Cholinesterase.scoline inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma |
|
11252-4
|
Scopolamine [Mass/volume] in Serum or Plasma |
|
11002-3
|
Scopolamine [Presence] in Urine |
|
17571-1
|
Scopolamine [Mass/volume] in Urine |
|
78372-0
|
ADHD hyperactive symptoms mean score [Calculated] |
|
71827-0
|
Score interpretation [M3] |
|
71756-1
|
Score out of range [M3] |
|
7694-3
|
Scorpion IgE Ab [Units/volume] in Serum |
|
7695-0
|
Scotch broom IgE Ab [Units/volume] in Serum |
|
16012-7
|
Scotch broom IgE Ab RAST class [Presence] in Serum |
|
34571-0
|
aPTT.lupus sensitive (LA screen) |
|
48022-8
|
aPTT.lupus sensitive actual/normal (normalized LA screen) |
|
6303-2
|
dRVVT (LA screen) |
|
15359-3
|
dRVVT actual/normal (normalized LA screen) |
|
73740-3
|
Screening duration of Ear - left |
|
73743-7
|
Screening duration of Ear - right |
|
19771-5
|
Screening techniques [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
55338-8
|
Sd sup(a) Ab [Presence] in Serum or Plasma |
|
55339-6
|
Sd sup(a) Ab [Titer] in Serum or Plasma |
|
55342-0
|
Sd sup(a) Ag [Presence] on Red Blood Cells |
|
81829-4
|
SDHA gene full mutation analysis in Blood or Tissue by Sequencing |
|
82530-7
|
SDHB gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
34510-8
|
SDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41062-1
|
SDHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82532-3
|
SDHB and SDHC and SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
82531-5
|
SDHC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
38911-4
|
SDHC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38923-9
|
SDHC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82529-9
|
SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
34511-6
|
SDHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41061-3
|
SDHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82650-3
|
Summed difference score Myocardium SPECT |
|
82644-6
|
Summed difference score for 17 segment model Myocardium SPECT |
|
82647-9
|
Summed difference score for 20 segment model Myocardium SPECT |
|
82641-2
|
Standard deviation of time to end-systole Left ventricle SPECT --resting |
|
82633-9
|
Standard deviation of time to end-systole Left ventricle SPECT --W stress |
|
52057-7
|
Seat lift mechanism attachment |
|
52058-5
|
Seating system attachment |
|
88479-1
|
Seattle Angina Questionnaire - 7 items [SAQ] |
|
75084-4
|
Sebacate (C8) [Moles/volume] in Serum or Plasma |
|
26835-9
|
Sebacate (C8) [Presence] in Urine |
|
13807-3
|
Sebacate (C8)/Creatinine [Mass Ratio] in Urine |
|
25134-8
|
Sebacate (C8)/Creatinine [Molar ratio] in Urine |
|
53460-2
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Amniotic fluid |
|
53465-1
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Cerebral spinal fluid |
|
53212-7
|
Sebacylcarnitine (C10-DC) [Moles/volume] in DBS |
|
74609-9
|
Sebacylcarnitine (C10-DC) [Enzymatic activity/mass] in Fibroblast |
|
53472-7
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Serum or Plasma |
|
53493-3
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Urine |
|
53509-6
|
Sebacylcarnitine (C10-DC)/Creatinine [Molar ratio] in Urine |
|
72397-3
|
Secobarbital [Mass/volume] in Blood by Confirmatory method |
|
19697-2
|
Secobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
19696-4
|
Secobarbital cutoff [Mass/volume] in Urine for Screen method |
|
4424-8
|
Secobarbital [Mass] of Dose |
|
12489-1
|
Secobarbital [Presence] in Gastric fluid |
|
17573-7
|
Secobarbital [Mass/volume] in Gastric fluid |
|
26930-8
|
Secobarbital [Mass/mass] in Hair |
|
27002-5
|
Secobarbital [Mass/mass] in Meconium |
|
27049-6
|
Secobarbital [Mass/volume] in Milk |
|
72452-6
|
Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72629-9
|
Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
4027-9
|
Secobarbital [Presence] in Serum or Plasma |
|
35634-5
|
Secobarbital [Mass/volume] in Serum or Plasma by Screen method |
|
82968-9
|
Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
4028-7
|
Secobarbital [Mass/volume] in Serum or Plasma |
|
25520-8
|
Secobarbital [Moles/volume] in Serum or Plasma |
|
12500-5
|
Secobarbital [Presence] in Stool |
|
27242-7
|
Secobarbital [Mass/mass] in Stool |
|
16238-8
|
Secobarbital [Mass/volume] in Urine by Confirmatory method |
|
4029-5
|
Secobarbital [Presence] in Urine |
|
16194-3
|
Secobarbital [Presence] in Urine by Confirmatory method |
|
19692-3
|
Secobarbital [Presence] in Urine by Screen method |
|
19695-6
|
Secobarbital [Mass/volume] in Urine |
|
72928-5
|
Secobarbital [Moles/volume] in Urine |
|
26679-1
|
Secobarbital [Mass/volume] in Vitreous fluid |
|
32111-7
|
Secobarbital [Presence] in Unspecified specimen |
|
64135-7
|
Secobarbital/Creatinine [Mass Ratio] of Urine |
|
75785-6
|
Second alternate healthcare agent [Reported] |
|
81370-9
|
Second witness |
|
46763-9
|
Secondary congenital hypothyroidism newborn screen interpretation |
|
89059-0
|
Secondary contact name |
|
46640-9
|
Secondary diagnosis [RFC] |
|
76438-1
|
Secondary insurance |
|
85403-4
|
Secondary payment source [CMS Assessment] |
|
10592-4
|
Secondary Spermatocytes [#/volume] in Semen |
|
47207-6
|
Secretin [Mass] of Dose |
|
2933-0
|
Secretin [Mass/volume] in Plasma |
|
87705-0
|
Sedentary activity 24 hour |
|
48151-5
|
Sedoheptitol/Creatinine [Molar ratio] in Urine |
|
78967-7
|
Sedoheptulose/Creatinine [Molar ratio] in Urine |
|
80999-6
|
Segment(s) affected by lesion Coronary artery segment |
|
74153-8
|
Seizure Disorder action plan |
|
55414-7
|
Seizures per month |
|
12415-6
|
Selegiline [Mass/volume] in Serum or Plasma |
|
30927-8
|
Selenium [Mass/volume] in Urine collected for unspecified duration |
|
47976-6
|
Selenium [Mass/volume] in 24 hour Urine |
|
5727-3
|
Selenium [Mass/time] in 24 hour Urine |
|
52908-1
|
Selenium [Moles/time] in 24 hour Urine |
|
5722-4
|
Selenium [Mass/volume] in Blood |
|
78696-2
|
Selenium [Moles/volume] in Blood |
|
20961-9
|
Selenium [Mass/mass] in Feed |
|
58026-6
|
Selenium [Mass/volume] in Nonbiological fluid |
|
17574-5
|
Selenium [Mass/volume] in Body fluid |
|
20960-1
|
Selenium [Mass/mass] in Gastric fluid |
|
29499-1
|
Selenium [Mass/mass] in Hair |
|
50904-2
|
Selenium [Moles/mass] in Hair |
|
81087-9
|
Selenium intake 24 hour Estimated |
|
81086-1
|
Selenium intake 24 hour Measured |
|
59737-7
|
Selenium [Mass/mass] in Nail |
|
5723-2
|
Selenium [Mass/volume] in Red Blood Cells |
|
52913-1
|
Selenium [Moles/volume] in Red Blood Cells |
|
5724-0
|
Selenium [Mass/volume] in Serum or Plasma |
|
25521-6
|
Selenium [Moles/volume] in Serum or Plasma |
|
54925-3
|
Selenium [Mass/volume] in Semen |
|
5725-7
|
Selenium [Mass/mass] in Tissue |
|
52889-3
|
Selenium [Moles/mass] in Tissue |
|
5726-5
|
Selenium [Mass/volume] in Urine |
|
50903-4
|
Selenium [Moles/volume] in Urine |
|
9483-9
|
Selenium [Mass/volume] in Water |
|
23779-2
|
Selenium [Mass/volume] in Unspecified specimen |
|
87453-7
|
Selenium [Mass/mass] in Unspecified specimen |
|
29917-2
|
Selenium/Creatinine [Mass Ratio] in 24 hour Urine |
|
44402-6
|
Selenium/Creatinine [Molar ratio] in 24 hour Urine |
|
13467-6
|
Selenium/Creatinine [Mass Ratio] in Urine |
|
52923-0
|
Selenium/Creatinine [Molar ratio] in Urine |
|
81375-8
|
Self assessment of health status [Reported] |
|
44943-9
|
Self management |
|
93443-0
|
Self-care abilities |
|
72190-2
|
Self-efficacy score [KCCQ] |
|
85129-5
|
Self-Efficacy Survey version 2.0 - ages 13-17 - T-score [NIH Toolbox] |
|
85126-1
|
Self-Efficacy Survey version 2.0 - ages 8-12 - T-score [NIH Toolbox] |
|
90730-3
|
Self-perception of body weight |
|
6240-6
|
Seminal fluid IgE Ab [Units/volume] in Serum |
|
25522-4
|
Seminal fluid IgE Ab RAST class [Presence] in Serum |
|
44626-0
|
Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols |
|
84895-2
|
Seminal vesicles [Presence] in Specimen |
|
81236-2
|
Send document that conforms to C-CDA R1.1 template |
|
81907-8
|
Send document that conforms to C-CDA R2.0 template |
|
81237-0
|
Send document that conforms to C-CDA R2.1 template |
|
81238-8
|
Send document that conforms to CDP Set 1 R1.0 template |
|
81239-6
|
Send document that conforms to CDP Set 1 R1.1 template |
|
86630-1
|
Send document that conforms to Level 3 EMS R1 template |
|
86626-9
|
Send document that conforms to Level 3 EMS R2 template |
|
86629-3
|
Send document that conforms to Oncology Treatment Plan Summary R1.2 template |
|
86628-5
|
Send document that conforms to Oncology Treatment Plan Summary R1.2.1 template |
|
86627-7
|
Send document that conforms to Oncology Treatment Plan Summary R1.3 template |
|
78919-8
|
Sensory or speech status |
|
77702-9
|
Sensory complaints related to parkinsonism scale [UPDRS] |
|
85347-3
|
Sentinel lymph nodes examined [#] in Cancer specimen by Light microscopy |
|
71538-3
|
Sent to hospital directly from dialysis facility [ESRD] |
|
92830-9
|
Sentinel lymph node extranodal extension [Presence] in Cancer specimen |
|
92832-5
|
Sentinel lymph nodes with metastasis [#] in Cancer specimen |
|
49941-8
|
Sepiapterin [Moles/volume] in Cerebral spinal fluid |
|
75044-8
|
Sepiapterin/Creatinine [Molar ratio] in Urine |
|
65810-4
|
SEPT9 gene methylation [Presence] in Plasma by Molecular genetics method |
|
77067-7
|
SEPT9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75280-8
|
Sequence number in substance administration series |
|
74715-4
|
Vendor serial number |
|
19786-3
|
Endoscopy device Vendor serial number |
|
10951-2
|
Sericin IgE Ab [Units/volume] in Serum |
|
16013-5
|
Sericin IgE Ab RAST class [Presence] in Serum |
|
2938-9
|
Serine [Mass/time] in 24 hour Urine |
|
25979-6
|
Serine [Moles/volume] in 24 hour Urine |
|
25523-2
|
Serine [Moles/time] in 24 hour Urine |
|
13414-8
|
Serine [Mass/volume] in Amniotic fluid |
|
27223-7
|
Serine [Moles/volume] in Amniotic fluid |
|
2934-8
|
Serine [Mass/volume] in Cerebral spinal fluid |
|
22644-9
|
Serine [Moles/volume] in Cerebral spinal fluid |
|
47742-2
|
Serine [Moles/volume] in DBS |
|
32270-1
|
Serine [Moles/volume] in Body fluid |
|
2935-5
|
Serine [Presence] in Serum or Plasma |
|
2936-3
|
Serine [Mass/volume] in Serum or Plasma |
|
20656-5
|
Serine [Moles/volume] in Serum or Plasma |
|
47745-5
|
Serine/Amino acids.total in Amniotic fluid |
|
47744-8
|
Serine/Amino acids.total in Cerebral spinal fluid |
|
47747-1
|
Serine/Amino acids.total in DBS |
|
47743-0
|
Serine/Amino acids.total in Hair |
|
47746-3
|
Serine/Amino acids.total in Serum or Plasma |
|
47748-9
|
Serine/Amino acids.total in Unspecified specimen |
|
17575-2
|
Serine [Presence] in Urine |
|
2937-1
|
Serine [Mass/volume] in Urine |
|
26741-9
|
Serine [Moles/volume] in Urine |
|
32269-3
|
Serine [Moles/volume] in Vitreous fluid |
|
22741-3
|
Serine [Moles/volume] in Unspecified specimen |
|
44403-4
|
Serine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56642-2
|
Serine/Creatinine [Ratio] in 24 hour Urine |
|
25980-4
|
Serine/Creatinine [Molar ratio] in 24 hour Urine |
|
13808-1
|
Serine/Creatinine [Mass Ratio] in Urine |
|
30058-2
|
Serine/Creatinine [Ratio] in Urine |
|
22684-5
|
Serine/Creatinine [Molar ratio] in Urine |
|
85717-7
|
Serologic testing was performed in Mother -- pre pregnancy |
|
85675-7
|
Serologic test result for Mother --pre pregnancy |
|
81177-8
|
Serosal classification [Appearance] in Stomach cancer |
|
81181-0
|
Serosal surface involvement [Presence] in Tumor by Light microscopy |
|
56978-0
|
Serotonin [Mass/volume] in 24 hour Urine |
|
18253-5
|
Serotonin [Mass/time] in 24 hour Urine |
|
25981-2
|
Serotonin [Moles/volume] in 24 hour Urine |
|
32339-4
|
Serotonin [Moles/time] in 24 hour Urine |
|
10511-4
|
Serotonin Ag [Presence] in Tissue by Immune stain |
|
2939-7
|
Serotonin [Mass/volume] in Blood |
|
25524-0
|
Serotonin [Moles/volume] in Blood |
|
71804-9
|
Serotonin [Entitic substance] in Platelets |
|
2940-5
|
Serotonin [Mass/volume] in Plasma |
|
26035-6
|
Serotonin [Moles/volume] in Plasma |
|
42671-8
|
Serotonin [Entitic mass] in Platelets |
|
2941-3
|
Serotonin [Mass/volume] in Platelets |
|
27057-9
|
Serotonin [Mass/volume] in Serum |
|
14910-4
|
Serotonin [Moles/volume] in Serum |
|
17003-5
|
Serotonin [Mass/volume] in Urine |
|
34373-1
|
Serotonin [Moles/volume] in Urine |
|
34374-9
|
Serotonin/Creatinine [Molar ratio] in Urine |
|
21723-2
|
SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38409-9
|
SERPINA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21726-5
|
SERPINA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21724-0
|
SERPINA1 gene p.Glu264Val [Presence] in Blood or Tissue by Molecular genetics method |
|
21725-7
|
SERPINA1 gene p.Glu342Lys [Presence] in Blood or Tissue by Molecular genetics method |
|
69363-0
|
SERPINA10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
68946-3
|
SERPINA10 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
93814-2
|
SERPINC1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
70107-8
|
SERPINC1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
52757-2
|
SERPINE1 gene c.-675 4G+5G [Presence] in Blood or Tissue by Molecular genetics method |
|
52758-0
|
SERPINE1 gene c.-844A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
60577-4
|
SERPINE1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48028-5
|
SERPINE1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77081-8
|
SERPINF1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77080-0
|
SERPINF1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
75380-6
|
SERPING1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
93384-6
|
Serratia sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
88990-7
|
Sertindole [Mass/volume] in Serum or Plasma |
|
72956-6
|
Sertraline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72955-8
|
Sertraline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78882-8
|
Sertraline cutoff [Mass/volume] in Urine for Confirmatory method |
|
32598-5
|
Sertraline [Mass] of Dose |
|
73155-4
|
Sertraline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73154-7
|
Sertraline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13579-8
|
Sertraline [Presence] in Serum or Plasma |
|
6906-2
|
Sertraline [Mass/volume] in Serum or Plasma |
|
14911-2
|
Sertraline [Moles/volume] in Serum or Plasma |
|
74911-9
|
Sertraline [Mass/volume] in Serum or Plasma --trough |
|
92638-6
|
Sertraline [Mass/volume] in Urine by Confirmatory method |
|
32112-5
|
Sertraline [Presence] in Urine |
|
92652-7
|
Sertraline [Presence] in Urine by Confirmatory method |
|
74662-8
|
Sertraline [Mass/volume] in Urine |
|
32113-3
|
Sertraline [Presence] in Unspecified specimen |
|
8262-8
|
Service comment 02 |
|
8264-4
|
Service comment 03 |
|
8265-1
|
Service comment 04 |
|
8266-9
|
Service comment 05 |
|
8267-7
|
Service comment 06 |
|
8268-5
|
Service comment 07 |
|
8269-3
|
Service comment 08 |
|
8270-1
|
Service comment 09 |
|
8252-9
|
Service comment 10 |
|
8253-7
|
Service comment 11 |
|
8254-5
|
Service comment 12 |
|
8255-2
|
Service comment 13 |
|
8256-0
|
Service comment 14 |
|
8257-8
|
Service comment 15 |
|
8258-6
|
Service comment 16 |
|
8259-4
|
Service comment 17 |
|
8260-2
|
Service comment 18 |
|
8261-0
|
Service comment 19 |
|
8263-6
|
Service comment 20 |
|
15412-0
|
Service comment 21 |
|
15413-8
|
Service comment 22 |
|
15414-6
|
Service comment 23 |
|
15415-3
|
Service comment 24 |
|
15416-1
|
Service comment 25 |
|
15417-9
|
Service comment 26 |
|
15418-7
|
Service comment 27 |
|
15419-5
|
Service comment 28 |
|
15420-3
|
Service comment 29 |
|
15421-1
|
Service comment 30 |
|
15422-9
|
Service comment 31 |
|
15423-7
|
Service comment 32 |
|
15424-5
|
Service comment 33 |
|
15425-2
|
Service comment 34 |
|
15426-0
|
Service comment 35 |
|
15427-8
|
Service comment 36 |
|
15428-6
|
Service comment 37 |
|
15429-4
|
Service comment 38 |
|
15430-2
|
Service comment 39 |
|
15431-0
|
Service comment 40 |
|
69868-8
|
Service comment 41 |
|
69869-6
|
Service comment 42 |
|
69870-4
|
Service comment 43 |
|
69871-2
|
Service comment 44 |
|
69872-0
|
Service comment 45 |
|
69873-8
|
Service comment 46 |
|
69874-6
|
Service comment 47 |
|
69875-3
|
Service comment 48 |
|
69876-1
|
Service comment 49 |
|
69877-9
|
Service comment 50 |
|
69878-7
|
Service comment 51 |
|
69879-5
|
Service comment 52 |
|
69880-3
|
Service comment 53 |
|
69881-1
|
Service comment 54 |
|
69882-9
|
Service comment 55 |
|
69883-7
|
Service comment 56 |
|
69884-5
|
Service comment 57 |
|
69885-2
|
Service comment 58 |
|
69886-0
|
Service comment 59 |
|
69887-8
|
Service comment 60 |
|
69888-6
|
Service comment 61 |
|
69889-4
|
Service comment 62 |
|
69890-2
|
Service comment 63 |
|
69891-0
|
Service comment 64 |
|
69892-8
|
Service comment 65 |
|
69893-6
|
Service comment 66 |
|
69894-4
|
Service comment 67 |
|
69895-1
|
Service comment 68 |
|
69896-9
|
Service comment 69 |
|
69897-7
|
Service comment 70 |
|
69898-5
|
Service comment 71 |
|
69899-3
|
Service comment 72 |
|
69900-9
|
Service comment 73 |
|
69901-7
|
Service comment 74 |
|
69902-5
|
Service comment 75 |
|
69903-3
|
Service comment 76 |
|
69904-1
|
Service comment 77 |
|
69905-8
|
Service comment 78 |
|
69906-6
|
Service comment 79 |
|
69907-4
|
Service comment 80 |
|
8251-1
|
Service comment |
|
85453-9
|
Service coordination domain risk level [ePCAM] |
|
85452-1
|
Service coordination total [ePCAM] |
|
81635-5
|
Service AndOr equipment AndOr product note |
|
71583-9
|
Service requested of EMS unit |
|
7697-6
|
Sesame Seed triggered histamine release [Units/volume] in Blood |
|
6242-2
|
Sesame Seed IgE Ab [Units/volume] in Serum |
|
16014-3
|
Sesame Seed IgE Ab RAST class [Presence] in Serum |
|
61313-3
|
Sesame Seed IgE Ab/IgE total in Serum |
|
7696-8
|
Sesame Seed IgG Ab [Units/volume] in Serum |
|
21519-4
|
Sesame Seed IgG Ab RAST class [Presence] in Serum |
|
56386-6
|
Sesame Seed IgG4 Ab [Mass/volume] in Serum |
|
60402-5
|
Sesame Seed IgG Ab [Mass/volume] in Serum |
|
48219-0
|
Sesame Seed triggered leukotriene release [Mass/volume] by Leukocytes |
|
93848-0
|
Setting of exposure to environmental or occupational hazard |
|
83376-4
|
Current set of nebulization cycles time.elapsed Nebulizer |
|
83380-6
|
Current set of nebulization cycles time.remaining Nebulizer |
|
83382-2
|
Current set of nebulization cycles volume.given Nebulizer |
|
83385-5
|
Current set of nebulization cycles volume.remaining Nebulizer |
|
81267-7
|
Setting of exposure to illness |
|
90932-5
|
Severe traumatic deviations impacting orthodontic condition |
|
72350-2
|
Severity of pain on average over the past 1 month [Reported] |
|
47243-1
|
Severity of side effect to HIV treatment |
|
10807-6
|
Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |
|
60782-0
|
Sevoflurane gas delivered during case [Volume] from Gas delivery system |
|
61027-9
|
Sevoflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76018-1
|
Sevoflurane liquid delivered during case [Volume] from Gas delivery system |
|
76019-9
|
Sevoflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
60779-6
|
Gas delivery system inspiratory Sevoflurane setting [VFr/PPres] |
|
60807-5
|
Sevoflurane [VFr/PPres] Airway adaptor --during expiration |
|
76107-2
|
Sevoflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60907-3
|
Sevoflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60864-6
|
Sevoflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60908-1
|
Sevoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60863-8
|
Sevoflurane [VFr/PPres] Airway adaptor |
|
60781-2
|
Sevoflurane [VFr/PPres] Gas delivery system |
|
46098-0
|
Sex |
|
74698-2
|
Sex [AHRQ] |
|
72143-1
|
Sex [HL7.v3] |
|
10587-4
|
Sexual abstinence duration |
|
76689-9
|
Sex assigned at birth |
|
85689-8
|
Sexual activity with known Chlamydia trachomatis AndOr Neisseria gonorhoeae case |
|
86648-3
|
Sexual activity in the last year - Reported |
|
86647-5
|
Sexual activity in the last 3 months - Reported |
|
85656-7
|
Sexual activity with a new partner in past 60D |
|
91692-4
|
Sex of Personnel |
|
81886-4
|
Sex of Provider |
|
76661-8
|
Sex of Provider [NMMDS] |
|
60478-5
|
Sex of Tick |
|
91699-9
|
Sex of Volunteer |
|
83317-8
|
Sexual activity with anonymous partner in the past year |
|
83315-2
|
Sexual activity with a female in the past year |
|
83318-6
|
Sexual activity with known intravenous drug user in the past year |
|
83316-0
|
Sexual activity with a male in the past year |
|
83314-5
|
Sexual activity while intoxicated AndOr high on drugs in the past year |
|
45343-1
|
Sex+stage of tick |
|
82816-0
|
Sexual abuse--before 18 years old [ACE] |
|
76690-7
|
Sexual orientation |
|
34918-3
|
Sezary cells [#/volume] in Blood |
|
33856-6
|
Sezary cells [#/volume] in Blood by Manual count |
|
13048-4
|
Sezary cells [Presence] in Blood by Light microscopy |
|
33056-3
|
Sezary cells [Presence] in Unspecified specimen by Light microscopy |
|
34919-1
|
Sezary cells/100 leukocytes in Blood |
|
33857-4
|
Sezary cells/100 leukocytes in Blood by Manual count |
|
74756-8
|
Soluble fms-like tyrosine kinase-1 [Mass/volume] in Serum |
|
74757-6
|
Soluble fms-like tyrosine kinase-1/placental growth factor [Ratio] in Serum |
|
41060-5
|
SFTPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40961-5
|
SFTPB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40962-3
|
SFTPC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41059-7
|
SFTPC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74541-4
|
Surfactant pulmonary-associated protein D [Mass/volume] in Serum |
|
26647-8
|
Semliki forest virus Ab [Presence] in Serum |
|
74826-9
|
Semliki forest virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
42955-5
|
Semliki forest virus Ab [Titer] in Serum |
|
40512-6
|
Semliki forest virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
46226-7
|
SGCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47970-9
|
SGCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48977-3
|
SGCG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
31661-2
|
Sulfate-3-Glucuronyl paragloboside Ab [Presence] in Serum |
|
31662-0
|
Sulfate-3-Glucuronyl paragloboside Ab [Units/volume] in Serum |
|
31162-1
|
Sulfate-3-Glucuronyl paragloboside Ab [Titer] in Serum |
|
31663-8
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Cerebral spinal fluid |
|
31664-6
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Cerebral spinal fluid |
|
31665-3
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Serum |
|
31666-1
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Serum |
|
76032-2
|
SGSH gene full mutation analysis in Blood or Tissue by Sequencing |
|
47971-7
|
SGSH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35742-6
|
SH2D1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41058-9
|
SH2D1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53895-9
|
SH3BP2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49704-0
|
SH3TC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7404-7
|
Shagbark Hickory IgE Ab [Units/volume] in Serum |
|
21329-8
|
Shagbark Hickory IgE Ab RAST class [Presence] in Serum |
|
72303-1
|
Shape of Nail |
|
9801-2
|
Shape of Stone |
|
11198-9
|
Shark IgE Ab [Units/volume] in Serum |
|
21520-2
|
Shark IgE Ab RAST class [Presence] in Serum |
|
65359-2
|
Sex hormone binding globulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
2942-1
|
Sex hormone binding globulin [Mass/volume] in Serum or Plasma |
|
13967-5
|
Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
|
7698-4
|
Sheep epithelium triggered histamine release [Units/volume] in Blood |
|
6243-0
|
Sheep epithelium IgE Ab [Units/volume] in Serum |
|
16015-0
|
Sheep epithelium IgE Ab RAST class [Presence] in Serum |
|
61344-8
|
Sheep epithelium IgE Ab/IgE total in Serum |
|
19756-6
|
Sheep milk IgE Ab [Units/volume] in Serum |
|
25982-0
|
Sheep milk IgE Ab RAST class [Presence] in Serum |
|
76413-4
|
Sheep prion protein codon 112 [Type] in Blood by Genotype method |
|
76414-2
|
Sheep prion protein codon 136 [Type] in Blood by Genotype method |
|
76412-6
|
Sheep prion protein codon 141 [Type] in Blood by Genotype method |
|
76415-9
|
Sheep prion protein codon 154 [Type] in Blood by Genotype method |
|
76416-7
|
Sheep prion protein codon 171 [Type] in Blood by Genotype method |
|
7699-2
|
Sheep Sorrel triggered histamine release [Units/volume] in Blood |
|
6244-8
|
Sheep Sorrel IgE Ab [Units/volume] in Serum |
|
16016-8
|
Sheep Sorrel IgE Ab RAST class [Presence] in Serum |
|
61309-1
|
Sheep Sorrel IgE Ab/IgE total in Serum |
|
24143-0
|
Sheep Sorrel IgG Ab [Units/volume] in Serum |
|
56387-4
|
Sheep Sorrel IgG4 Ab [Mass/volume] in Serum |
|
19757-4
|
Sheep whey IgE Ab [Units/volume] in Serum |
|
25983-8
|
Sheep whey IgE Ab RAST class [Presence] in Serum |
|
6245-5
|
Sheep wool IgE Ab [Units/volume] in Serum |
|
16017-6
|
Sheep wool IgE Ab RAST class [Presence] in Serum |
|
61314-1
|
Sheep wool IgE Ab/IgE total in Serum |
|
7405-4
|
Shellbark Hickory IgE Ab [Units/volume] in Serum |
|
15775-0
|
Shellbark Hickory IgE Ab RAST class [Presence] in Serum |
|
91703-9
|
Shelter address Facility |
|
91701-3
|
Shelter category Facility |
|
91702-1
|
Shelter name [Identifier] Facility |
|
33764-2
|
Shiga toxin stx gene [Identifier] in Unspecified specimen by NAA with probe detection |
|
43589-1
|
Shigella sp Ab [Presence] in Serum |
|
5350-4
|
Shigella sp Ab [Units/volume] in Serum |
|
46455-2
|
Shigella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20964-3
|
Shigella sp identified in Feed by Organism specific culture |
|
49056-5
|
Shigella sp serotype [Identifier] in Isolate by Agglutination |
|
80350-2
|
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with non-probe detection |
|
70242-3
|
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection |
|
88586-3
|
Shigella sp identified in Stool by Organism specific culture |
|
82300-5
|
Shigella sp [Presence] in Stool by Culture |
|
17576-0
|
Shigella sp identified in Unspecified specimen by Organism specific culture |
|
46454-5
|
Shigella sp [Presence] in Unspecified specimen by Organism specific culture |
|
10956-1
|
Short Leaf Pine IgE Ab [Units/volume] in Serum |
|
15944-2
|
Short Leaf Pine IgE Ab RAST class [Presence] in Serum |
|
90549-7
|
Short stay assessment [CMS Assessment] |
|
7653-9
|
Short+Giant Ragweed IgG Ab [Units/volume] in Serum |
|
48202-6
|
Short+Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
86675-6
|
Shortness of breath in last 7 days [CMS Assessment] |
|
86472-8
|
Shortness of breath limited your ability to do what you wanted over the past 2 weeks [KCCQ] |
|
54616-8
|
Short-term memory OK in last 7 days [CMS Assessment] |
|
91568-6
|
Shot up or injected any non-prescription drugs Lifetime |
|
83248-5
|
Should brief interview for mental status be conducted during 3 day assessment period [CMS Assessment] |
|
56047-4
|
Shoulder Horizontal adduction Active Range of Motion Quantitative |
|
56046-6
|
Shoulder Horizontal adduction Passive Range of Motion Quantitative |
|
54634-1
|
Should resident mood interview be conducted [CMS Assessment] |
|
54615-0
|
Should staff assessment for mental status be conducted [CMS Assessment] |
|
41299-9
|
Shoulder - left Abduction Active Range of Motion Quantitative |
|
41300-5
|
Shoulder - left Abduction Passive Range of Motion Quantitative |
|
41297-3
|
Shoulder - left Extension Active Range of Motion Quantitative |
|
41298-1
|
Shoulder - left Extension Passive Range of Motion Quantitative |
|
41305-4
|
Shoulder - left External rotation Active Range of Motion Quantitative |
|
41306-2
|
Shoulder - left External rotation Passive Range of Motion Quantitative |
|
41295-7
|
Shoulder - left Flexion Active Range of Motion Quantitative |
|
41296-5
|
Shoulder - left Flexion Passive Range of Motion Quantitative |
|
56048-2
|
Shoulder - left Horizontal adduction Active Range of Motion Quantitative |
|
56045-8
|
Shoulder - left Horizontal adduction Passive Range of Motion Quantitative |
|
41303-9
|
Shoulder - left Internal rotation Active Range of Motion Quantitative |
|
41304-7
|
Shoulder - left Internal rotation Passive Range of Motion Quantitative |
|
41311-2
|
Shoulder - right Abduction Active Range of Motion Quantitative |
|
41312-0
|
Shoulder - right Abduction Passive Range of Motion Quantitative |
|
41309-6
|
Shoulder - right Extension Active Range of Motion Quantitative |
|
41310-4
|
Shoulder - right Extension Passive Range of Motion Quantitative |
|
41317-9
|
Shoulder - right External rotation Active Range of Motion Quantitative |
|
41318-7
|
Shoulder - right External rotation Passive Range of Motion Quantitative |
|
41307-0
|
Shoulder - right Flexion Active Range of Motion Quantitative |
|
41308-8
|
Shoulder - right Flexion Passive Range of Motion Quantitative |
|
56044-1
|
Shoulder - right Horizontal adduction Active Range of Motion Quantitative |
|
56043-3
|
Shoulder - right Horizontal adduction Passive Range of Motion Quantitative |
|
41315-3
|
Shoulder - right Internal rotation Active Range of Motion Quantitative |
|
41316-1
|
Shoulder - right Internal rotation Passive Range of Motion Quantitative |
|
89397-4
|
Shower/bathe self - functional ability [CMS Assessment] |
|
83226-1
|
Shower/bathe self - functional ability during 3 day assessment period [CMS Assessment] |
|
89396-6
|
Shower/bathe self - functional goal [CMS Assessment] |
|
83225-3
|
Shower/bathe self - functional goal during 3 day assessment period [CMS Assessment] |
|
86483-5
|
Showering or bathing was limited by heart failure over the past 2 weeks [KCCQ] |
|
34500-9
|
SHOX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41057-1
|
SHOX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
66451-6
|
Shrimp native (nPen i) 11 IgE Ab [Units/volume] in Serum |
|
65794-0
|
Shrimp native (nPen m) 1 IgE Ab [Units/volume] in Serum |
|
65786-6
|
Shrimp native (nPen m) 2 IgE Ab [Units/volume] in Serum |
|
65787-4
|
Shrimp native (nPen m) 4 IgE Ab [Units/volume] in Serum |
|
7701-6
|
Shrimp triggered histamine release [Units/volume] in Blood |
|
6246-3
|
Shrimp IgE Ab [Units/volume] in Serum |
|
16018-4
|
Shrimp IgE Ab RAST class [Presence] in Serum |
|
7700-8
|
Shrimp IgG Ab [Units/volume] in Serum |
|
21521-0
|
Shrimp IgG Ab RAST class [Presence] in Serum |
|
56388-2
|
Shrimp IgG4 Ab [Mass/volume] in Serum |
|
60403-3
|
Shrimp IgG Ab [Mass/volume] in Serum |
|
48214-1
|
Shrimp triggered leukotriene release [Mass/volume] by Leukocytes |
|
58986-1
|
Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Units/volume] in Serum |
|
60236-7
|
Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab RAST class [Presence] in Serum |
|
77200-4
|
SI gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75045-5
|
Sialate [Moles/volume] in Amniotic fluid |
|
75046-3
|
Sialate [Moles/volume] in Cerebral spinal fluid |
|
2943-9
|
Sialate [Mass/volume] in Plasma |
|
75047-1
|
Sialate [Moles/volume] in Serum or Plasma |
|
34598-3
|
Sialate [Presence] in Urine |
|
2944-7
|
Sialate [Mass/volume] in Urine |
|
40452-5
|
Sialate/Creatinine [Ratio] in Urine |
|
76024-9
|
Sialate/Creatinine [Molar ratio] in Urine |
|
24099-4
|
Sialidase [Enzymatic activity/mass] in Fibroblast |
|
2945-4
|
Sialidase [Enzymatic activity/volume] in Serum |
|
2946-2
|
Sialidase [Enzymatic activity/mass] in Tissue |
|
75057-0
|
Sialidase [Enzymatic activity/mass] in Leukocytes |
|
40453-3
|
Sialooligosaccharides [Presence] in Urine |
|
34526-4
|
Sialooligosaccharides/Creatinine [Ratio] in Urine |
|
59332-7
|
Sibutramine [Mass/volume] in Blood |
|
59335-0
|
Sibutramine [Mass/volume] in Serum or Plasma |
|
59338-4
|
Sibutramine [Mass/volume] in Urine |
|
46765-4
|
Sickle cell anemia newborn screen interpretation |
|
46768-8
|
Sickle cell carrier (trait) newborn screen interpretation |
|
801-1
|
Sickle cells [Presence] in Blood by Light microscopy |
|
49964-0
|
Siderocytes [#/volume] in Blood |
|
75376-4
|
Siderocytes per HPF [Presence] in Blood by Light microscopy |
|
70035-1
|
Siderophages/100 leukocytes in Cerebral spinal fluid by Manual count |
|
45137-7
|
IgA.secretory [Mass/volume] in Body fluid |
|
44590-8
|
IgA.secretory [Presence] in Saliva (oral fluid) |
|
33636-2
|
IgA.secretory [Units/volume] in Saliva (oral fluid) |
|
26849-0
|
IgA.secretory [Mass/volume] in Saliva (oral fluid) |
|
12725-8
|
IgA.secretory [Units/volume] in Serum or Plasma |
|
14163-0
|
IgA.secretory [Mass/volume] in Serum or Plasma |
|
68933-1
|
IgA.secretory [Mass/volume] in Sweat |
|
68932-3
|
IgA.secretory [Mass/volume] in Tear |
|
73793-2
|
Signal quality Blood Postductal Pulse oximetry |
|
73797-3
|
Signal quality Blood Preductal Pulse oximetry |
|
75950-6
|
Signal quality index EEG device Calculated |
|
85647-6
|
Signature of person collecting or coordinating collection of assessment information Provider |
|
70127-6
|
Signature verifying assessment completion |
|
85289-7
|
Signet ring cells/100 cells in Colorectal cancer specimen by Light microscopy |
|
92037-1
|
Significant activities related to public health emergency event Reporting Period |
|
54691-1
|
Significantly disrupt care or living environment in last 7 days [CMS Assessment] |
|
54687-9
|
Significantly interfere with the resident's care in last 7 days [CMS Assessment] |
|
54688-7
|
Significantly interfere with the resident's participation in activities or social interactions in last 7 days [CMS Assessment] |
|
54690-3
|
Significantly intrude on the privacy or activity of others in last 7 days [CMS Assessment] |
|
86677-2
|
Signs and symptoms of swallowing disorder in last 7 days [CMS Assessment] |
|
74203-1
|
Signs of life at arrival [NTDS] |
|
71478-2
|
Signs of soft tissue infection present [ESRD] |
|
72954-1
|
Sildenafil citrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72953-3
|
Sildenafil citrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73153-9
|
Sildenafil citrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73152-1
|
Sildenafil citrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
28075-0
|
Sildenafil citrate [Mass/volume] in Serum or Plasma |
|
55578-9
|
Sildenafil citrate [Moles/volume] in Serum or Plasma |
|
43164-3
|
Silica [Mass/volume] in Water |
|
18254-3
|
Silicate [Mass/volume] in Body fluid |
|
5729-9
|
Silicate [Mass/volume] in Serum or Plasma |
|
5730-7
|
Silicate [Mass/mass] in Tissue |
|
5731-5
|
Silicate [Mass/volume] in Urine |
|
50907-5
|
Silicon [Moles/time] in 24 hour Urine |
|
5728-1
|
Silicon [Mass/volume] in Blood |
|
60170-8
|
Silicon [Mass/volume] in Body fluid |
|
51204-6
|
Silicon [Mass/mass] in Hair |
|
50905-9
|
Silicon [Moles/mass] in Hair |
|
60171-6
|
Silicon [Mass/volume] in Red Blood Cells |
|
10829-0
|
Silicon [Mass/volume] in Serum or Plasma |
|
25526-5
|
Silicon [Moles/volume] in Serum or Plasma |
|
52888-5
|
Silicon [Moles/mass] in Tissue |
|
46981-7
|
Silicon [Mass/volume] in Urine |
|
50906-7
|
Silicon [Moles/volume] in Urine |
|
9401-1
|
Silicon [Mass/volume] in Unspecified specimen |
|
44404-2
|
Silicon/Creatinine [Mass Ratio] in Urine |
|
39612-7
|
Silicone IgA Ab [Units/volume] in Serum by Immunoassay |
|
9675-0
|
Silicone IgA Ab [Units/volume] in Serum |
|
9676-8
|
Silicone IgE Ab [Units/volume] in Serum |
|
39614-3
|
Silicone IgE Ab [Units/volume] in Serum by Immunoassay |
|
39611-9
|
Silicone IgG Ab [Units/volume] in Serum by Immunoassay |
|
9677-6
|
Silicone IgG Ab [Units/volume] in Serum |
|
39613-5
|
Silicone IgM Ab [Units/volume] in Serum by Immunoassay |
|
9678-4
|
Silicone IgM Ab [Units/volume] in Serum |
|
6247-1
|
Silk IgE Ab [Units/volume] in Serum |
|
16019-2
|
Silk IgE Ab RAST class [Presence] in Serum |
|
19758-2
|
Silk waste IgE Ab [Units/volume] in Serum |
|
16020-0
|
Silk waste IgE Ab RAST class [Presence] in Serum |
|
10808-4
|
Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |
|
10809-2
|
Microscopic observation [Identifier] in Tissue by Silver nitrate stain |
|
10764-9
|
Microscopic observation [Identifier] in Sputum by Silver stain |
|
20390-1
|
Silver sulfADIAZINE [Susceptibility] |
|
30928-6
|
Silver [Mass/volume] in Urine collected for unspecified duration |
|
29977-6
|
Silver [Mass/volume] in 24 hour Urine |
|
6931-0
|
Silver [Mass/time] in 24 hour Urine |
|
50910-9
|
Silver [Moles/volume] in 24 hour Urine |
|
47129-2
|
Silver [Moles/time] in 24 hour Urine |
|
65776-7
|
Silver birch native (nBet v) 1 IgE Ab [Units/volume] in Serum |
|
30984-9
|
Silver Birch recombinant (rBet v) 1 IgE Ab [Units/volume] in Serum |
|
51573-4
|
Silver Birch recombinant (rBet v) 1 IgE Ab RAST class [Presence] in Serum |
|
61229-1
|
Silver Birch recombinant (rBet v) 1 IgE Ab/IgE total in Serum |
|
34425-9
|
Silver Birch recombinant (rBet v) 1 + 2 IgE Ab [Units/volume] in Serum |
|
30985-6
|
Silver Birch recombinant (rBet v) 2 IgE Ab [Units/volume] in Serum |
|
51574-2
|
Silver Birch recombinant (rBet v) 2 IgE Ab RAST class [Presence] in Serum |
|
51524-7
|
Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Units/volume] in Serum |
|
51576-7
|
Silver Birch recombinant (rBet v) 2 + 4 IgE Ab RAST class [Presence] in Serum |
|
34250-1
|
Silver Birch recombinant (rBet v) 4 IgE Ab [Units/volume] in Serum |
|
51575-9
|
Silver Birch recombinant (rBet v) 4 IgE Ab RAST class [Presence] in Serum |
|
82572-9
|
Silver Birch recombinant (rBet v) 6 IgE Ab [Units/volume] in Serum |
|
82573-7
|
Silver Birch recombinant (rBet v) 6 IgE Ab RAST class [Presence] in Serum |
|
15283-5
|
Silver Birch IgE Ab [Units/volume] in Serum |
|
15579-6
|
Silver Birch IgE Ab RAST class [Presence] in Serum |
|
61228-3
|
Silver Birch IgE Ab/IgE total in Serum |
|
51537-9
|
Silver Birch IgG Ab [Presence] in Serum |
|
25349-2
|
Silver Birch IgG Ab [Units/volume] in Serum |
|
25350-0
|
Silver Birch IgG Ab RAST class [Presence] in Serum |
|
26409-3
|
Silver Birch IgG4 Ab [Units/volume] in Serum |
|
26410-1
|
Silver Birch IgG4 Ab RAST class [Presence] in Serum |
|
48249-7
|
Silver Birch triggered leukotriene release [Mass/volume] by Leukocytes |
|
5732-3
|
Silver [Mass/volume] in Blood |
|
82462-3
|
Silver [Moles/volume] in Blood |
|
17582-8
|
Silver [Mass/volume] in Dialysis fluid |
|
59738-5
|
Silver [Mass/volume] in Body fluid |
|
80145-6
|
Silver [Moles/volume] in Body fluid |
|
5733-1
|
Silver [Mass/mass] in Hair |
|
50908-3
|
Silver [Moles/mass] in Hair |
|
11199-7
|
Silver IgE Ab [Units/volume] in Serum |
|
16021-8
|
Silver IgE Ab RAST class [Presence] in Serum |
|
14133-3
|
Silver Maple IgE Ab [Units/volume] in Serum |
|
15835-2
|
Silver Maple IgE Ab RAST class [Presence] in Serum |
|
59739-3
|
Silver [Mass/mass] in Nail |
|
59740-1
|
Silver [Mass/volume] in Red Blood Cells |
|
52896-8
|
Silver [Moles/volume] in Red Blood Cells |
|
5734-9
|
Silver [Mass/volume] in Serum or Plasma |
|
25527-3
|
Silver [Moles/volume] in Serum or Plasma |
|
59741-9
|
Silver [Mass/mass] in Tissue |
|
78892-7
|
Silver [Moles/mass] in Tissue |
|
5735-6
|
Silver [Mass/volume] in Urine |
|
50909-1
|
Silver [Moles/volume] in Urine |
|
9484-7
|
Silver [Mass/volume] in Water |
|
29978-4
|
Silver/Creatinine [Mass Ratio] in 24 hour Urine |
|
52904-0
|
Silver/Creatinine [Molar ratio] in 24 hour Urine |
|
13476-7
|
Silver/Creatinine [Mass Ratio] in Urine |
|
52905-7
|
Silver/Creatinine [Molar ratio] in Urine |
|
38328-1
|
Simazine [Mass/volume] in Water |
|
82522-4
|
Simeprevir [Susceptibility] by Genotype method |
|
73151-3
|
Simethicone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73150-5
|
Simethicone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
81252-9
|
Discrete genetic variant |
|
81253-7
|
Simple variant name Nominal |
|
81292-5
|
Simple variant [Type] |
|
72952-5
|
Simvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72951-7
|
Simvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73149-7
|
Simvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73148-9
|
Simvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
47202-7
|
Sincalide [Mass] of Dose |
|
26648-6
|
Sindbis virus Ab [Presence] in Serum |
|
74845-9
|
Sindbis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
42954-8
|
Sindbis virus Ab [Titer] in Serum |
|
40503-5
|
Sindbis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
29247-4
|
Sirolimus [Mass/volume] in Blood |
|
80548-1
|
Sirolimus [Mass/volume] in DBS |
|
49737-0
|
Sirolimus [Mass] of Dose |
|
72676-0
|
Sirolimus [Mass/volume] in Plasma --trough |
|
55714-0
|
Sisomicin [Susceptibility] by Gradient strip |
|
449-9
|
Sisomicin [Susceptibility] by Disk diffusion (KB) |
|
448-1
|
Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
447-3
|
Sisomicin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18979-5
|
Sisomicin [Susceptibility] |
|
450-7
|
Sisomicin [Susceptibility] by Serum bactericidal titer |
|
89395-8
|
Sit to lying - functional ability [CMS Assessment] |
|
83216-2
|
Sit to lying - functional ability during 3 day assessment period [CMS Assessment] |
|
89394-1
|
Sit to lying - functional goal [CMS Assessment] |
|
83215-4
|
Sit to lying - functional goal during 3 day assessment period [CMS Assessment] |
|
89393-3
|
Sit to stand - functional ability [CMS Assessment] |
|
83212-1
|
Sit to stand - functional ability during 3 day assessment period [CMS Assessment] |
|
89392-5
|
Sit to stand - functional goal [CMS Assessment] |
|
83211-3
|
Sit to stand - functional goal during 3 day assessment period [CMS Assessment] |
|
44667-4
|
Site of distant metastasis in Breast tumor |
|
31034-2
|
Site Vaccine administered VAERS |
|
33733-7
|
Sites of distant metastasis |
|
93013-1
|
Sitting ability |
|
92842-4
|
Situational report |
|
23437-7
|
Swine influenza virus Ab [Presence] in Serum |
|
23438-5
|
Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
23781-8
|
Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence |
|
23782-6
|
Swine influenza virus Ag [Presence] in Tissue by Immune stain |
|
33729-5
|
Size additional dimension in Tumor |
|
9802-0
|
Size [Entitic volume] of Stone |
|
33728-7
|
Size.maximum dimension in Tumor |
|
66877-2
|
Skin Ab pattern [Interpretation] in Serum |
|
66878-0
|
Skin Ab [Titer] in Serum |
|
66884-8
|
Skin Ab.IgG pattern [Interpretation] in Serum by Guinea pig esophagus substrate |
|
66880-6
|
Skin Ab.IgG pattern [Interpretation] in Serum by Monkey esophagus substrate |
|
86748-1
|
Skin and ulcer/injury treatments during 7 day assessment period [CMS Assessment] |
|
80343-7
|
Skin assessment [Interpretation] |
|
66882-2
|
Skin IgG Ab [Presence] in Serum by Guinea pig esophagus substrate |
|
66881-4
|
Skin IgG Ab [Presence] in Serum by Monkey esophagus substrate |
|
66879-8
|
Skin IgG Ab [Titer] in Serum by Guinea pig esophagus substrate |
|
66883-0
|
Skin IgG Ab [Titer] in Serum by Monkey esophagus substrate |
|
80344-5
|
Skin integrity |
|
46534-4
|
Skin lesion or open wound [CMS Assessment] |
|
65754-4
|
Skin Pathology biopsy report |
|
71450-1
|
Skin tear(s) [MDSv3] |
|
60839-8
|
Skin temperature --in microenvironment |
|
75951-4
|
Skin temperature setting Infant microenvironment |
|
10957-9
|
Slash Pine IgE Ab [Units/volume] in Serum |
|
15945-9
|
Slash Pine IgE Ab RAST class [Presence] in Serum |
|
81874-0
|
SLC12A3 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81824-5
|
SLC12A6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
51652-6
|
SLC14A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81834-4
|
SLC17A5 gene full mutation analysis in Blood or Tissue by Sequencing |
|
34514-0
|
SLC22A18 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41056-3
|
SLC22A18 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60497-5
|
SLC22A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61107-9
|
SLC25A13 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53725-8
|
SLC25A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81832-8
|
SLC26A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41055-5
|
SLC26A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40468-1
|
SLC26A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53722-5
|
SLC26A4 gene p.Glu384Gly [Presence] in Blood by Molecular genetics method |
|
53723-3
|
SLC26A4 gene.p.Leu236Pro [Presence] in Blood by Molecular genetics method |
|
53724-1
|
SLC26A4 gene p.Thr416Pro [Presence] in Blood by Molecular genetics method |
|
71355-2
|
SLC26A5 gene c.-53-2A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
81828-6
|
SLC37A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72696-8
|
SLC40A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50330-0
|
SLC6A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79722-5
|
SLCO1B1 gene product functional interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
93412-5
|
SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77712-8
|
Sleep disturbances indicator in the past week [UPDRS] |
|
93832-4
|
Sleep duration |
|
85866-2
|
Sleep medicine Consult note |
|
85865-4
|
Sleep medicine Diagnostic study note |
|
85864-7
|
Sleep medicine Note |
|
90711-3
|
Sleep medicine Outpatient Note |
|
90712-1
|
Sleep medicine Telehealth Consult note |
|
90713-9
|
Sleep medicine Telehealth Note |
|
89035-0
|
Sleep medicine Physician Note |
|
86485-0
|
Sleep sitting up in a chair or with at least 3 pillows to prop you up because of shortness of breath over the past 2 weeks [KCCQ] |
|
82235-3
|
Sleeping [NDI] |
|
7654-7
|
Slender Ragweed IgE Ab [Units/volume] in Serum |
|
22507-8
|
Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
8021-8
|
Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
17558-8
|
Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
|
8022-6
|
Saint Louis encephalitis virus Ab [Units/volume] in Serum by Complement fixation |
|
20806-6
|
Saint Louis encephalitis virus Ab [Presence] in Serum |
|
74825-1
|
Saint Louis encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
8023-4
|
Saint Louis encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
8024-2
|
Saint Louis encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
|
5365-2
|
Saint Louis encephalitis virus Ab [Units/volume] in Serum |
|
24275-0
|
Saint Louis encephalitis virus Ab [Titer] in Serum --1st specimen |
|
24201-6
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24276-8
|
Saint Louis encephalitis virus Ab [Titer] in Serum --2nd specimen |
|
24202-4
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22509-4
|
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
9577-8
|
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
29796-0
|
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
22510-2
|
Saint Louis encephalitis virus Ab [Titer] in Serum |
|
40502-7
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
40514-2
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
9578-6
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
|
29809-1
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
29822-4
|
Saint Louis encephalitis virus Ab [Titer] in Unspecified specimen |
|
29783-8
|
Saint Louis encephalitis virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
31617-4
|
Saint Louis encephalitis virus Ab [Units/volume] in Unspecified specimen |
|
6549-0
|
Saint Louis encephalitis virus Ag [Units/volume] in Serum |
|
13230-8
|
Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
62435-3
|
Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
43232-8
|
Saint Louis encephalitis virus IgG Ab [Presence] in Serum |
|
52821-6
|
Saint Louis encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
8016-8
|
Saint Louis encephalitis virus IgG Ab [Units/volume] in Serum |
|
22511-0
|
Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21509-5
|
Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22512-8
|
Saint Louis encephalitis virus IgG Ab [Titer] in Serum |
|
10906-6
|
Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
9634-7
|
Saint Louis encephalitis virus IgG Ab [Titer] in Unspecified specimen |
|
49068-0
|
Saint Louis encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
|
49095-3
|
Saint Louis encephalitis virus IgG and IgM [Interpretation] in Serum |
|
42966-2
|
Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
42006-7
|
Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13231-6
|
Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
49144-9
|
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid |
|
48507-8
|
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
62434-6
|
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence |
|
42965-4
|
Saint Louis encephalitis virus IgM Ab [Presence] in Serum |
|
42005-9
|
Saint Louis encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
8017-6
|
Saint Louis encephalitis virus IgM Ab [Units/volume] in Serum |
|
22513-6
|
Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21510-3
|
Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22514-4
|
Saint Louis encephalitis virus IgM Ab [Titer] in Serum |
|
10907-4
|
Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
9635-4
|
Saint Louis encephalitis virus IgM Ab [Titer] in Unspecified specimen |
|
34458-0
|
Saint Louis encephalitis virus RNA [Presence] in Blood by NAA with probe detection |
|
34459-8
|
Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
27950-5
|
Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
|
8025-9
|
Saint Louis encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
|
55145-7
|
Saint Louis encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37984-2
|
Saint Louis encephalitis virus RNA [Presence] in Unspecified specimen by Probe |
|
21031-0
|
Saint Louis encephalitis virus [Interpretation] in Unspecified specimen |
|
20266-3
|
Slope 2 [Velocity] by US.M-mode |
|
20265-5
|
Slope [Velocity] by US.M-mode |
|
20267-1
|
Slope/Slope 2 by US.M-mode+Calculated |
|
83987-8
|
Speech-language pathology Team Note |
|
63210-9
|
Actin smooth muscle Ab [Presence] in Serum by Immunoassay |
|
63211-7
|
Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence |
|
89520-1
|
Actin smooth muscle Ab [Presence] in Serum by Line blot |
|
40563-9
|
Actin smooth muscle Ag [Presence] in Tissue by Immune stain |
|
92004-1
|
Spinal muscular atrophy newborn screen interpretation |
|
81774-2
|
Actin smooth muscle IgG Ab [Presence] in Serum |
|
44706-0
|
Actin smooth muscle IgG Ab [Units/volume] in Serum |
|
92003-3
|
Spinal muscular atrophy newborn screening comment-discussion |
|
77624-5
|
SMAD4 gene full mutation analysis in Blood or Tissue by Sequencing |
|
32208-1
|
Platelets Small [Presence] in Blood by Light microscopy |
|
91322-8
|
Small things upset me in past 7 days [PROMIS.PEDS] |
|
91357-4
|
Small things upset my child in past 7 days [PROMIS.PARENTPROXY] |
|
53896-7
|
SMC1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
20431-3
|
Microscopic observation [Identifier] in Unspecified specimen by Smear |
|
7702-4
|
Smelt IgE Ab [Units/volume] in Serum |
|
33778-2
|
SmIg Ag [Presence] in Tissue by Immune stain |
|
33777-4
|
SmIg cells/100 cells in Unspecified specimen |
|
17226-2
|
SmIg-Cd79 cells/100 cells in Blood |
|
25613-1
|
Smoky Brown Cockroach IgE Ab [Units/volume] in Serum |
|
25614-9
|
Smoky Brown Cockroach IgE Ab RAST class [Presence] in Serum |
|
48682-9
|
Smooth muscle myosin heavy chain Ag [Presence] in Tissue by Immune stain |
|
54453-6
|
Semen analysis test method |
|
92002-5
|
SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection |
|
35462-1
|
SMN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41053-0
|
SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49857-6
|
SMN1 gene+SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54449-4
|
SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82769-1
|
Smoked or non-smoked tobacco |
|
88031-0
|
Smokeless tobacco status |
|
92212-0
|
Smoking allows me to take a break from my problems for a few minutes [PROMIS] |
|
92211-2
|
Smoking calms me down [PROMIS] |
|
92265-8
|
Smoking causes damage to my gums and teeth [PROMIS] |
|
92264-1
|
Smoking causes me to get tired easily [PROMIS] |
|
92224-5
|
Smoking helps me concentrate [PROMIS] |
|
92210-4
|
Smoking helps me deal with anxiety [PROMIS] |
|
92322-7
|
Smoking helps me feel more relaxed when I'm with other people [PROMIS] |
|
92209-6
|
Smoking helps me reduce tension [PROMIS] |
|
92208-8
|
Smoking helps me when I'm upset about something [PROMIS] |
|
92263-3
|
Smoking irritates my mouth and throat [PROMIS] |
|
92321-9
|
Smoking is a part of my self-image [PROMIS] |
|
92223-7
|
Smoking is relaxing [PROMIS] |
|
92262-5
|
Smoking is taking years off my life [PROMIS] |
|
92222-9
|
Smoking is the fastest way to reward myself [PROMIS] |
|
92320-1
|
Smoking makes me feel better in social situations [PROMIS] |
|
92221-1
|
Smoking makes me feel content [PROMIS] |
|
92220-3
|
Smoking makes me less depressed [PROMIS] |
|
92261-7
|
Smoking makes me short of breath [PROMIS] |
|
92260-9
|
Smoking makes me worry about getting emphysema [PROMIS] |
|
92259-1
|
Smoking makes me worry about getting heart troubles [PROMIS] |
|
92258-3
|
Smoking makes my lungs hurt [PROMIS] |
|
92219-5
|
Smoking stimulates me [PROMIS] |
|
7063-1
|
Smooth Alder IgE Ab [Units/volume] in Serum |
|
15523-4
|
Smooth Alder IgE Ab RAST class [Presence] in Serum |
|
41873-1
|
Smooth Alder IgG Ab [Units/volume] in Serum |
|
63203-4
|
Smooth Alder IgG Ab [Mass/volume] in Serum |
|
63357-8
|
Smooth muscle Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63355-2
|
Smooth muscle Ab [Presence] in Body fluid by Immunofluorescence |
|
14252-1
|
Smooth muscle Ab [Presence] in Serum |
|
26971-2
|
Smooth muscle Ab [Presence] in Serum by Immunofluorescence |
|
31629-9
|
Smooth muscle Ab [Units/volume] in Serum |
|
17593-5
|
Smooth muscle Ab [Presence] in Sweat |
|
42530-6
|
Smooth muscle Ab [Titer] in Cerebral spinal fluid |
|
63358-6
|
Smooth muscle Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63356-0
|
Smooth muscle Ab [Titer] in Body fluid by Immunofluorescence |
|
8095-2
|
Smooth muscle Ab [Titer] in Serum |
|
5358-7
|
Smooth muscle Ab [Titer] in Serum by Immunofluorescence |
|
30557-3
|
Smooth muscle IgG Ab [Presence] in Serum |
|
47977-4
|
Smooth muscle IgG Ab [Titer] in Serum |
|
34518-1
|
SMPD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32641-3
|
SMPD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34193-3
|
SMPD1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
41292-4
|
Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma |
|
34993-6
|
Smudge cells [#/volume] in Blood |
|
68437-3
|
Smudge cells [#/volume] in Blood by Manual count |
|
7798-2
|
Smudge cells [Presence] in Blood by Light microscopy |
|
71664-7
|
Smudge cells/Leukocytes [Pure number fraction] in Blood by Manual count |
|
34992-8
|
Smudge cells/100 leukocytes in Blood |
|
14912-0
|
Smudge cells/100 leukocytes in Blood by Manual count |
|
40670-2
|
Smudge cells/100 leukocytes in Body fluid by Manual count |
|
77203-8
|
Smut fungi (Ustilago nuda+Ustilago tritici+Ustilago maydis+Tilletia tritici) IgE Ab [Units/volume] in Serum |
|
80486-4
|
Snacks 24 hour Estimated |
|
80487-2
|
Snacks 24 hour Measured |
|
75952-2
|
SNAP index Cerebral cortex Electroencephalogram (EEG) |
|
21735-6
|
SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21738-0
|
SNCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
21736-4
|
SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method |
|
21737-2
|
SNCA gene p.Ala53Thr [Presence] in Blood or Tissue by Molecular genetics method |
|
90525-7
|
SNF Part A Interrupted Stay [CMS Assessment] |
|
86525-3
|
SNF Part A PPS discharge assessment [CMS Assessment] |
|
52039-5
|
Skilled Nursing Facility (SNF) record |
|
72654-7
|
SNRPN gene 15q11 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
|
33549-7
|
Hantavirus sin nombre Ab [Presence] in Serum |
|
26654-4
|
Hantavirus sin nombre IgG Ab [Presence] in Serum |
|
31408-8
|
Hantavirus sin nombre IgG Ab [Units/volume] in Serum |
|
23867-5
|
Hantavirus sin nombre IgG Ab [Titer] in Serum |
|
26650-2
|
Hantavirus sin nombre IgM Ab [Presence] in Serum |
|
31409-6
|
Hantavirus sin nombre IgM Ab [Units/volume] in Serum |
|
23868-3
|
Hantavirus sin nombre IgM Ab [Titer] in Serum |
|
85449-7
|
Social enviromental domain risk level [ePCAM] |
|
85448-9
|
Social enviromental total [ePCAM] |
|
72351-0
|
Social interaction with other people - family, friends, or others - over the past month [Reported] |
|
76512-3
|
Social isolation score [NHANES] |
|
72196-9
|
Social limitation score [KCCQ] |
|
85463-8
|
Social network - visual analog rating [ePCAM] |
|
83324-4
|
Social network [PCAM] |
|
45396-9
|
Social Security number [Identifier] |
|
87295-2
|
Social Security Number was requested |
|
91663-5
|
Social support index [MOS Social Support Survey] |
|
85111-3
|
Social Withdrawal Survey version 2.0 - parent report - ages 3-12 - T-score [NIH Toolbox] |
|
45333-2
|
Superoxide dismutase [Enzymatic activity/volume] in Blood |
|
44410-9
|
Superoxide dismutase [Presence] in Plasma |
|
2978-5
|
Superoxide dismutase [Enzymatic activity/volume] in Plasma |
|
56479-9
|
Superoxide dismutase [Enzymatic activity/mass] in Red Blood Cells |
|
40833-6
|
SOD1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40859-1
|
SOD1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49710-7
|
SOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44783-9
|
Sodium [Moles/volume] (Maximum value during study) in Serum or Plasma |
|
32553-0
|
Sodium [Molar amount] in Urine collected for unspecified duration |
|
35678-2
|
Sodium [Moles/volume] in Urine collected for unspecified duration |
|
57370-9
|
Sodium [Moles/volume] in 12 hour Urine |
|
18377-2
|
Sodium [Moles/time] in 12 hour Urine |
|
58994-5
|
Sodium [Moles/time] in 18 hour Urine |
|
93997-5
|
Sodium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
53122-8
|
Sodium [Moles/time] in 1 hour Urine |
|
59163-6
|
Sodium [Moles/volume] in 24 hour Stool |
|
27257-5
|
Sodium [Moles/mass] in 24 hour Stool |
|
27419-1
|
Sodium [Moles/time] in 24 hour Stool |
|
92572-7
|
Sodium [Molar amount] in 24 hour Dialysis fluid |
|
2952-0
|
Sodium [Molar amount] in 24 hour Stool |
|
21526-9
|
Sodium [Mass/volume] in 24 hour Urine |
|
21527-7
|
Sodium [Mass/time] in 24 hour Urine |
|
21525-1
|
Sodium [Moles/volume] in 24 hour Urine |
|
2956-1
|
Sodium [Moles/time] in 24 hour Urine |
|
94006-4
|
Sodium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin |
|
26763-3
|
Sodium [Mass/time] in 2 hour Urine |
|
57382-4
|
Sodium [Moles/volume] in 2 hour Urine |
|
74685-9
|
Sodium [Moles/volume] in 4 hour Urine |
|
18376-4
|
Sodium [Moles/time] in 6 hour Urine |
|
2953-8
|
Sodium [Molar amount] in 72 hour Stool |
|
49791-7
|
Sodium [Moles/volume] in Amniotic fluid |
|
56711-5
|
Sodium benzoate IgE Ab [Units/volume] in Serum |
|
48289-3
|
Sodium benzoate triggered leukotriene release [Mass/volume] by Leukocytes |
|
32717-1
|
Sodium [Moles/volume] in Arterial blood |
|
39792-7
|
Sodium [Moles/volume] in Capillary blood |
|
41657-8
|
Sodium [Moles/volume] in Mixed venous blood |
|
2947-0
|
Sodium [Moles/volume] in Blood |
|
39791-9
|
Sodium [Moles/volume] in Venous blood |
|
2957-9
|
Sodium renal clearance in 24 hour Urine and Serum or Plasma |
|
26761-7
|
Sodium renal clearance in 2 hour Urine and Serum or Plasma |
|
2948-8
|
Sodium [Moles/volume] in Cerebral spinal fluid |
|
39787-7
|
Sodium [Moles/volume] in Peritoneal dialysis fluid |
|
2949-6
|
Sodium [Moles/volume] in Dialysis fluid |
|
2950-4
|
Sodium [Moles/volume] in Body fluid |
|
50911-7
|
Sodium [Moles/volume] in Gastric fluid |
|
51419-0
|
Sodium [Moles/volume] corrected for glucose in Serum or Plasma |
|
51205-3
|
Sodium [Mass/mass] in Hair |
|
50912-5
|
Sodium [Moles/mass] in Hair |
|
17796-4
|
Sodium [Moles/volume] in Hyperal solution |
|
81011-9
|
Sodium intake 24 hour Estimated |
|
81012-7
|
Sodium intake 24 hour Measured |
|
13895-8
|
Sodium [Moles/volume] in Milk |
|
60220-1
|
Sodium [Moles/volume] in Mother's milk |
|
48290-1
|
Sodium nitrite triggered leukotriene release [Mass/volume] by Leukocytes |
|
74688-3
|
Sodium [Moles/volume] in Serum or Plasma --post dialysis |
|
72069-8
|
Sodium profiling-modeling prescribed for any dialysis sessions in the reporting month [ESRD] |
|
49790-9
|
Sodium [Moles/volume] in Peritoneal fluid |
|
82812-9
|
Sodium [Mass/volume] in Red Blood Cells |
|
12907-2
|
Sodium [Moles/volume] in Red Blood Cells |
|
72077-1
|
Sodium restriction education received [ESRD] |
|
48292-7
|
Sodium salicylate triggered leukotriene release [Mass/volume] by Leukocytes |
|
56979-8
|
Sodium [Moles/volume] in Saliva (oral fluid) |
|
77139-4
|
Sodium [Moles/volume] in Serum, Plasma or Blood |
|
42570-2
|
Sodium [Mass or Moles/volume] in Serum or Plasma |
|
2951-2
|
Sodium [Moles/volume] in Serum or Plasma |
|
15207-4
|
Sodium [Moles/volume] in Stool |
|
14055-8
|
Sodium [Moles/mass] in Stool |
|
2954-6
|
Sodium [Moles/volume] in Sweat |
|
30558-1
|
Sodium [Moles/volume] in Total parental nutrition |
|
2955-3
|
Sodium [Moles/volume] in Urine |
|
12908-0
|
Sodium [Moles/volume] in Vitreous fluid |
|
9485-4
|
Sodium [Mass/volume] in Water |
|
87451-1
|
Sodium [Mass/volume] in Unspecified specimen |
|
87452-9
|
Sodium [Mass/mass] in Unspecified specimen |
|
32340-2
|
Sodium [Moles/volume] in Unspecified specimen |
|
13809-9
|
Sodium/Creatinine [Mass Ratio] in 24 hour Urine |
|
56980-6
|
Sodium/Creatinine [Ratio] in 24 hour Urine |
|
44405-9
|
Sodium/Creatinine [Molar ratio] in 24 hour Urine |
|
11149-2
|
Sodium/Creatinine [Mass Ratio] in Urine |
|
43223-7
|
Sodium/Creatinine [Ratio] in Urine |
|
33951-5
|
Sodium/Creatinine [Molar ratio] in Urine |
|
44406-7
|
Sodium/Potassium [Molar ratio] in 24 hour Urine |
|
28003-2
|
Sodium/Potassium [Molar ratio] in Serum or Plasma |
|
2958-7
|
Sodium/Potassium [Molar ratio] in Sweat |
|
2959-5
|
Sodium/Potassium [Molar ratio] in Urine |
|
82382-3
|
Sofosbuvir [Susceptibility] by Genotype method |
|
55927-8
|
Interleukin 1 receptor alpha chain soluble [Mass/volume] in Serum or Plasma |
|
9654-5
|
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma |
|
76039-7
|
Interleukin 2 Receptor Soluble [Mass/volume] in Serum or Plasma |
|
34408-5
|
Interleukin 2 Receptor Soluble [Moles/volume] in Serum or Plasma |
|
44422-4
|
Interleukin 2 receptor alpha chain soluble [Units/volume] in Serum or Plasma |
|
7709-9
|
Sole IgE Ab [Units/volume] in Serum |
|
16026-7
|
Sole IgE Ab RAST class [Presence] in Serum |
|
7710-7
|
Sole IgG Ab [Units/volume] in Serum |
|
21528-5
|
Sole IgG Ab RAST class [Presence] in Serum |
|
56389-0
|
Sole IgG4 Ab [Mass/volume] in Serum |
|
60405-8
|
Sole IgG Ab [Mass/volume] in Serum |
|
73632-2
|
Solithromycin [Susceptibility] by Disk diffusion (KB) |
|
73609-0
|
Solithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73587-8
|
Solithromycin [Susceptibility] |
|
32219-8
|
Soluble liver Ab [Units/volume] in Serum by Immunoassay |
|
13925-3
|
Soluble liver Ab [Presence] in Serum |
|
42199-0
|
Soluble liver Ab [Presence] in Serum by Immunoassay |
|
56722-2
|
Soluble liver Ab [Presence] in Serum by Immunoblot |
|
12734-0
|
Soluble liver Ab [Units/volume] in Serum |
|
38420-6
|
Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay |
|
78433-0
|
Soluble liver IgG Ab [Presence] in Serum by Line blot |
|
20965-0
|
Somatic cells [#/volume] in Milk |
|
2486-9
|
Somatomedins [Mass/volume] in Serum or Plasma |
|
10512-2
|
Somatostatin Ag [Presence] in Tissue by Immune stain |
|
2960-3
|
Somatostatin [Presence] in Plasma |
|
2961-1
|
Somatostatin [Mass/volume] in Plasma |
|
49792-5
|
Somatostatin [Moles/volume] in Plasma |
|
49089-6
|
Sonographer [Identifier] |
|
49088-8
|
Sonographer name |
|
73679-3
|
SORAfenib [Mass/volume] in Serum or Plasma |
|
48152-3
|
Sorbitol/Creatinine [Molar ratio] in Urine |
|
7375-9
|
Sorghum grass IgE Ab [Units/volume] in Serum |
|
15753-7
|
Sorghum grass IgE Ab RAST class [Presence] in Serum |
|
82536-4
|
SOS1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
53727-4
|
SOS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
4032-9
|
Sotalol [Mass/time] in 24 hour Urine |
|
4425-5
|
Sotalol [Mass] of Dose |
|
73146-3
|
Sotalol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73147-1
|
Sotalol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12416-4
|
Sotalol [Mass/volume] in Serum or Plasma |
|
55579-7
|
Sotalol [Moles/volume] in Serum or Plasma |
|
72675-2
|
Sotalol [Mass/volume] in Serum or Plasma --trough |
|
4030-3
|
Sotalol [Presence] in Urine |
|
4031-1
|
Sotalol [Mass/volume] in Urine |
|
82280-9
|
Source used to estimate activity metabolic rate |
|
82282-5
|
Source used for population RMR |
|
82277-5
|
Source used for predicted RMR |
|
86643-4
|
Information source for pregnancy status |
|
91564-5
|
Information source for rumor related to public health emergency |
|
71536-7
|
Source of information [ESRD] |
|
82281-7
|
Source used for reported activity metabolic rate |
|
82283-3
|
Source used to adjust activity MET |
|
7655-4
|
Southern Ragweed IgE Ab [Units/volume] in Serum |
|
15980-6
|
Southern Ragweed IgE Ab RAST class [Presence] in Serum |
|
73911-0
|
SOX10 Ag [Presence] in Tissue by Immune stain |
|
89007-9
|
SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
80480-7
|
Soy protein intake 24 hour Estimated |
|
80481-5
|
Soy protein intake 24 hour Measured |
|
73719-7
|
Soybean native (nGly m) 5 IgE Ab [Units/volume] in Serum |
|
81997-9
|
Soybean native (nGly m) 5 IgE Ab RAST class [Presence] in Serum |
|
65772-6
|
Soybean native (nGly m) 6 IgE Ab [Units/volume] in Serum |
|
81998-7
|
Soybean native (nGly m) 6 IgE Ab RAST class [Presence] in Serum |
|
63476-6
|
Soybean recombinant (rGly m) 4 IgE Ab [Units/volume] in Serum |
|
81983-9
|
Soybean recombinant (rGly m) 4 IgE Ab RAST class [Presence] in Serum |
|
7137-3
|
Soybean triggered histamine release [Units/volume] in Blood |
|
7138-1
|
Soybean dust IgE Ab [Units/volume] in Serum |
|
21104-5
|
Soybean dust IgE Ab RAST class [Presence] in Serum |
|
6248-9
|
Soybean IgE Ab [Units/volume] in Serum |
|
15568-9
|
Soybean IgE Ab RAST class [Presence] in Serum |
|
61271-3
|
Soybean IgE Ab/IgE total in Serum |
|
6735-5
|
Soybean IgG Ab [Units/volume] in Serum |
|
21102-9
|
Soybean IgG Ab RAST class [Presence] in Serum |
|
56390-8
|
Soybean IgG4 Ab [Mass/volume] in Serum |
|
35546-1
|
Soybean IgG Ab [Mass/volume] in Serum |
|
48217-4
|
Soybean triggered leukotriene release [Mass/volume] by Leukocytes |
|
2966-0
|
Specific gravity of 24 hour Urine |
|
44933-0
|
Specific gravity of 24 hour Urine by Refractometry |
|
49959-0
|
Specific gravity of Urine adjusted to pH 7.4 |
|
14345-3
|
Specific gravity of Amniotic fluid by Refractometry |
|
14346-1
|
Specific gravity of Cerebral spinal fluid by Refractometry |
|
2964-5
|
Specific gravity of Body fluid |
|
35414-2
|
Specific gravity of Body fluid by Refractometry |
|
14347-9
|
Specific gravity of Gastric fluid by Refractometry |
|
60027-0
|
Specific gravity of Pericardial fluid |
|
68384-7
|
Specific gravity of Pericardial fluid by Refractometry |
|
14349-5
|
Specific gravity of Pleural fluid by Refractometry |
|
14348-7
|
Specific gravity of Peritoneal fluid by Refractometry |
|
53555-9
|
Specific gravity of Red Blood Cells |
|
17598-4
|
Specific gravity of Synovial fluid |
|
14350-3
|
Specific gravity of Synovial fluid by Refractometry |
|
14351-1
|
Specific gravity of Stool by Refractometry |
|
2965-2
|
Specific gravity of Urine |
|
50562-8
|
Specific gravity of Urine by Refractometry automated |
|
5810-7
|
Specific gravity of Urine by Refractometry |
|
5811-5
|
Specific gravity of Urine by Test strip |
|
53326-5
|
Specific gravity of Urine by Automated test strip |
|
14352-9
|
Specific gravity of Water by Refractometry |
|
33513-3
|
Specific gravity of Unspecified specimen |
|
77208-7
|
Salivary gland protein 1 IgA Ab [Units/volume] in Serum by Immunoassay |
|
77210-3
|
Salivary gland protein 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
77209-5
|
Salivary gland protein 1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
54024-5
|
sp100 Ab [Presence] in Serum |
|
59066-1
|
sp100 Ab [Presence] in Serum by Immunoassay |
|
56754-5
|
sp100 Ab [Presence] in Serum by Immunoblot |
|
82932-5
|
sp100 IgG Ab [Presence] in Serum by Line blot |
|
72891-5
|
Staphylococcus protein A spa gene [Presence] in Nose by NAA with probe detection |
|
4465-1
|
Hamster Ova Penetration Test [Interpretation] in Semen |
|
49306-4
|
Hamster Ova Penetration Test [Interpretation] in Semen Narrative |
|
7501-0
|
Spanish Moss IgE Ab [Units/volume] in Serum |
|
7047-4
|
Sparfloxacin [Susceptibility] by Gradient strip |
|
35839-0
|
Sparfloxacin [Susceptibility] by Disk diffusion (KB) |
|
20397-6
|
Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23610-9
|
Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
23628-1
|
Sparfloxacin [Susceptibility] |
|
81433-5
|
Spasm induced Coronary arteries |
|
78931-3
|
Spasm load test performed |
|
81434-3
|
Spasm symptom induced |
|
81875-7
|
SPAST gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
34516-5
|
SPAST gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41052-2
|
SPAST gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53897-5
|
SPAST gene + KIAA0196 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90041-5
|
Specimen collection setting type |
|
74384-9
|
Specimen container [Type] |
|
80581-2
|
Specimen incubation date and time range |
|
82314-6
|
Specimen sent to CDC |
|
44630-2
|
Specimen size additional dimension 1 in Breast tumor |
|
44631-0
|
Specimen size additional dimension 2 in Breast tumor |
|
44629-4
|
Specimen size.maximum dimension in Breast tumor |
|
81147-1
|
Specimen source patient identification [Interpretation] Narrative |
|
85793-8
|
Specimen source subject [Type] |
|
77497-6
|
Specimen temperature device Institution inventory number |
|
80392-4
|
Special accommodation [Type] |
|
83252-7
|
Special treatments, procedures, and programs at admission [CMS Assessment] |
|
93185-7
|
Special treatments, procedures, and programs at discharge [CMS Assessment] |
|
78021-3
|
Specialty care unit Type [NHCS] |
|
88089-8
|
Type of Specialty services available |
|
91700-5
|
Specialty Volunteer |
|
91982-9
|
Specific airway resistance measured/predicted by Plethysmograph body box |
|
93047-9
|
Specimen condition [Type] |
|
68959-6
|
Specimen condition [Interpretation] of Urine Narrative |
|
49070-6
|
Specimen drawn [Date and time] of Cerebral spinal fluid |
|
20506-2
|
Specimen drawn from |
|
19151-0
|
Specimen drawn [Date and time] of Serum or Plasma |
|
49832-9
|
Specimen drawn [Date and time] of Serum or Plasma--1st specimen |
|
49833-7
|
Specimen drawn [Date and time] of Serum or Plasma--2nd specimen |
|
45374-6
|
Specimen expiration date of Blood |
|
33723-8
|
Specimen length |
|
19801-0
|
Specimen obtained [Anatomy] Gastrointestinal tract upper EGD |
|
58400-3
|
Specimen pH acceptable of Urine |
|
8100-0
|
Specimen preparation [Type] of Unspecified specimen |
|
19803-6
|
Specimen site Narrative |
|
19763-2
|
Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
47938-6
|
Specimen source [Identifier] of Body fluid |
|
72923-6
|
Specimen source [Identifier] of Synovial fluid |
|
31208-2
|
Specimen source identified |
|
66746-9
|
Specimen type |
|
19802-8
|
Specimen obtained Gastrointestinal tract upper EGD |
|
19153-6
|
Volume in Urine collected for unspecified duration |
|
21530-1
|
Volume of 10 hour Urine |
|
13620-0
|
Volume of 12 hour Urine |
|
57390-7
|
Volume [Flow] of 12 hour Urine |
|
58989-5
|
Volume of 18 hour Urine |
|
17599-2
|
Volume of 24 hour Peritoneal dialysis fluid |
|
13495-7
|
Volume of 24 hour Dialysis fluid |
|
3158-3
|
Volume [Mass/time] of 24 hour Body fluid |
|
17601-6
|
Volume of 24 hour Sputum |
|
3161-7
|
Volume [Flow] of 24 hour Sputum |
|
17603-2
|
Volume of 24 hour Stool |
|
3162-5
|
Volume [Mass/time] of 24 hour Stool |
|
3164-1
|
Volume [Flow] of 24 hour Stool |
|
17604-0
|
Volume of 24 hour Sweat |
|
3166-6
|
Volume [Flow] of 24 hour Sweat |
|
3167-4
|
Volume of 24 hour Urine |
|
3168-2
|
Volume [Flow] of 24 hour Urine |
|
17605-7
|
Volume of 24 hour Unspecified specimen |
|
3170-8
|
Volume [Flow] of 24 hour Unspecified specimen |
|
13619-2
|
Volume of 2 hour Urine |
|
13494-0
|
Volume of 4 hour Dialysis fluid |
|
18352-5
|
Volume of 4 hour Urine |
|
12255-6
|
Volume of 5 hour Urine |
|
17600-8
|
Volume of 6 hour Urine |
|
3163-3
|
Volume of 72 hour Stool |
|
3165-8
|
Volume [Flow] of 72 hour Stool |
|
40671-0
|
Volume of 72 hour Urine |
|
21529-3
|
Volume of 8 hour Urine |
|
3156-7
|
Volume of Amniotic fluid |
|
3157-5
|
Volume of Blood |
|
32801-3
|
Volume of Bronchial specimen |
|
17607-3
|
Volume of Cerebral spinal fluid |
|
80662-0
|
Volume of Peritoneal dialysis fluid |
|
12457-8
|
Volume of Dialysis fluid |
|
12254-9
|
Volume of Body fluid |
|
57442-6
|
Volume of Semen--post concentration |
|
40691-8
|
Volume of Semen--post washing |
|
34981-1
|
Volume of Pericardial fluid |
|
3159-1
|
Volume of Plasma |
|
34979-5
|
Volume of Pleural fluid |
|
40692-6
|
Volume of Semen--pre washing |
|
72278-5
|
Volume of Prostatic fluid |
|
34978-7
|
Volume of Peritoneal fluid |
|
17602-4
|
Volume of Seminal plasma |
|
3160-9
|
Volume of Semen |
|
34980-3
|
Volume of Synovial fluid |
|
38200-2
|
Volume of Sputum |
|
17606-5
|
Volume of Stool |
|
33514-1
|
Volume of Sweat |
|
28009-9
|
Volume of Urine |
|
68391-2
|
Volume of Vitreous fluid |
|
3169-0
|
Volume of Unspecified specimen |
|
34648-6
|
Weight of unspecified time Stool |
|
25530-7
|
Weight [Mass/time] of 24 hour Stool |
|
3153-4
|
Weight of 24 hour Unspecified specimen |
|
17608-1
|
Weight [Mass/time] of 48 hour Stool |
|
17609-9
|
Weight [Mass/time] of 72 hour Stool |
|
30078-0
|
Weight of Stool |
|
33247-8
|
Weight of Sweat |
|
29638-4
|
Weight of Tissue |
|
3154-2
|
Weight of Unspecified specimen |
|
69238-4
|
SPECT Urinary bladder and Urethra W contrast intra bladder during voiding |
|
39813-1
|
SPECT Bone limited |
|
39821-4
|
SPECT Bone marrow limited |
|
39906-3
|
SPECT Bone marrow multiple areas |
|
39823-0
|
SPECT Bone marrow |
|
39905-5
|
SPECT Bone multiple areas |
|
46366-1
|
SPECT guidance for percutaneous biopsy of Bone |
|
41772-5
|
SPECT Bone W In-111 tagged WBC IV |
|
39879-2
|
SPECT Bone |
|
24578-7
|
SPECT Bones |
|
39637-4
|
SPECT Brain for blood flow |
|
81557-1
|
SPECT Brain W florbetapir IV |
|
39638-2
|
SPECT Brain W I-123 IV |
|
39632-5
|
SPECT Brain |
|
44152-7
|
SPECT Brain W Tc-99m bicisate IV |
|
39640-8
|
SPECT Brain W Tc-99m DTPA IV |
|
39641-6
|
SPECT Brain W Tc-99m glucoheptonate IV |
|
39631-7
|
SPECT Brain W Tc-99m HMPAO IV |
|
81558-9
|
SPECT Brain W Tc-99m IV |
|
39639-0
|
SPECT Brain W Tl-201 IV |
|
39644-0
|
SPECT Breast |
|
39684-6
|
SPECT Unspecified body region for abscess W Ga-67 IV |
|
39811-5
|
SPECT Unspecified body region for abscess |
|
81556-3
|
SPECT Unspecified body region for infection or inflammation |
|
39770-3
|
SPECT Gastrointestinal tract |
|
39621-8
|
SPECT Guidance for abscess localization of Unspecified body region |
|
46384-4
|
SPECT Guidance for superficial biopsy of Bone |
|
46373-7
|
SPECT Guidance for placement of tube in Chest |
|
39759-6
|
SPECT Guidance limited for localization of tumor |
|
39622-6
|
SPECT Guidance for abscess localization of Whole body |
|
39762-0
|
SPECT Guidance for localization of tumor of Whole body |
|
39862-8
|
SPECT Heart blood pool at rest and W radionuclide IV |
|
39656-4
|
SPECT Heart for infarct |
|
39655-6
|
SPECT Heart for infarct W Tc-99m Sestamibi IV |
|
39654-9
|
SPECT Heart for infarct W Tc-99m PYP IV |
|
46396-8
|
SPECT Heart gated at rest and W Tc-99m Sestamibi IV |
|
39916-2
|
SPECT Heart gated |
|
39930-3
|
SPECT Heart gated W stress and W radionuclide IV |
|
46395-0
|
SPECT Heart gated and ejection fraction at rest and W stress and W radionuclide IV |
|
39913-9
|
SPECT Heart gated and ejection fraction |
|
39918-8
|
SPECT Heart gated and wall motion |
|
43659-2
|
SPECT Heart perfusion qualitative at rest and W radionuclide IV |
|
49568-9
|
SPECT Heart perfusion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV |
|
39724-0
|
SPECT Heart perfusion at rest and W stress and W radionuclide IV |
|
39723-2
|
SPECT Heart perfusion at rest and W stress and W Tl-201 IV |
|
39725-7
|
SPECT Heart perfusion at rest and W adenosine and W Tl-201 IV |
|
39718-2
|
SPECT Heart perfusion at rest and W radionuclide IV |
|
39729-9
|
SPECT Heart perfusion at rest and W Tl-201 IV |
|
39700-0
|
SPECT Heart perfusion W adenosine and W radionuclide IV |
|
49567-1
|
SPECT Heart perfusion W adenosine and W Tc-99m Sestamibi IV |
|
39712-5
|
SPECT Heart perfusion |
|
39734-9
|
SPECT Heart perfusion W stress and W radionuclide IV |
|
39736-4
|
SPECT Heart perfusion W stress and W Tc-99m Sestamibi IV |
|
39710-9
|
SPECT Heart perfusion W Tc-99m Sestamibi IV |
|
39711-7
|
SPECT Heart perfusion W Tl-201 IV |
|
49569-7
|
SPECT Heart perfusion and wall motion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV |
|
39662-2
|
SPECT Heart at rest and W stress and W Tc-99m Sestamibi IV |
|
39658-0
|
SPECT Heart at rest and W radionuclide IV |
|
49566-3
|
SPECT Heart at rest and W Tc-99m Sestamibi IV |
|
44154-3
|
SPECT Heart W dipyridamole and W Tc-99m Sestamibi IV |
|
39648-1
|
SPECT Heart W dipyridamole IV |
|
81561-3
|
SPECT Heart W multiple states of exercise |
|
39649-9
|
SPECT Heart |
|
81562-1
|
SPECT Heart W single state of exercise |
|
39668-9
|
SPECT Heart W stress and W radionuclide IV |
|
44151-9
|
SPECT Heart W Tc-99m Sestamibi IV |
|
39647-3
|
SPECT Heart W Tc-99m Tetrofosmin IV |
|
39872-7
|
SPECT Heart wall motion |
|
39938-6
|
SPECT Joint |
|
39852-9
|
SPECT Kidney - bilateral |
|
39851-1
|
SPECT Kidney - bilateral W Tc-99m Mertiatide IV |
|
42310-3
|
SPECT Kidney |
|
44153-5
|
SPECT Kidney W Tc-99m glucoheptonate IV |
|
43655-0
|
SPECT Liver for blood flow |
|
47378-5
|
SPECT Liver blood pool |
|
81613-2
|
SPECT Liver for hemangioma |
|
39692-9
|
SPECT Liver |
|
39691-1
|
SPECT Liver W Tc-99m tagged RBC IV |
|
24817-9
|
SPECT Liver W Tc-99m IV |
|
69229-3
|
SPECT Liver W Tc-99m SC IV |
|
43652-7
|
SPECT Liver and Spleen for blood flow |
|
39876-8
|
SPECT Liver and Spleen |
|
39681-2
|
SPECT Unspecified body region limited W Ga-67 IV |
|
39898-2
|
SPECT Lung ventilation |
|
39838-8
|
SPECT Lung ventilation and perfusion |
|
39740-6
|
SPECT Parathyroid gland |
|
41838-4
|
SPECT Prostate W In-111 Satumomab IV |
|
39743-0
|
SPECT Prostate W Tc-99m capromab pendatide IV |
|
43662-6
|
SPECT Renal vessels for blood flow W Tc-99m glucoheptonate IV |
|
69235-0
|
SPECT Scrotum and testicle for blood flow |
|
39628-3
|
SPECT Small bowel for Meckel's diverticulum |
|
43670-9
|
SPECT Spleen for blood flow |
|
69234-3
|
SPECT Spleen W Tc-99m tagged RBC IV |
|
43673-3
|
SPECT Thyroid gland for blood flow |
|
39755-4
|
SPECT Thyroid gland W I-131 IV |
|
39682-0
|
SPECT Unspecified body region W Ga-67 IV |
|
39881-8
|
SPECT Whole body Bone 3 phase |
|
39825-5
|
SPECT Whole body Bone marrow |
|
39816-4
|
SPECT Whole body Bone |
|
39748-9
|
SPECT Whole body for tumor W Tc-99m Sestamibi IV |
|
39675-4
|
SPECT Whole body for infection W Ga-67 IV |
|
39678-8
|
SPECT Whole body for tumor W Ga-67 IV |
|
69237-6
|
SPECT Whole body for tumor |
|
42292-3
|
SPECT Whole body for tumor W Tl-201 IV |
|
39680-4
|
SPECT Whole body W Ga-67 IV |
|
39839-6
|
SPECT Whole body W I-131 MIBG IV |
|
81560-5
|
SPECT Whole body W In-111 capromab pendetide IV |
|
39844-6
|
SPECT Whole body W In-111 Satumomab IV |
|
81547-2
|
SPECT Whole body W In-111 pentetreotide IV |
|
46297-8
|
SPECT Whole body |
|
41837-6
|
SPECT Whole body W Tc-99m Arcitumomab IV |
|
43526-3
|
SPECT Unspecified body region |
|
81548-0
|
SPECT Unspecified body region W tagged WBC IV |
|
89631-6
|
SPECT+CT Guidance for localization of tumor of Whole body |
|
81549-8
|
SPECT+CT Lymph node |
|
81550-6
|
SPECT+CT Parathyroid gland |
|
90312-0
|
SPECT+CT Skeletal system |
|
89842-9
|
SPECT+CT Whole body |
|
35840-8
|
Spectinomycin [Susceptibility] by Gradient strip |
|
453-1
|
Spectinomycin [Susceptibility] by Disk diffusion (KB) |
|
452-3
|
Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
451-5
|
Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18980-3
|
Spectinomycin [Susceptibility] |
|
454-9
|
Spectinomycin [Susceptibility] by Serum bactericidal titer |
|
82940-8
|
Speech [ALSFRS-R] |
|
57218-0
|
Speech and oral expression of language [CMS Assessment] |
|
80295-9
|
Speech clarity |
|
54600-2
|
Speech clarity.description of speech pattern in last 7 days [CMS Assessment] |
|
93012-3
|
Speech disturbance |
|
52059-3
|
Speech generating device attachment |
|
77690-6
|
Speech scale [UPDRS] |
|
83984-5
|
Speech-language pathology Consult note |
|
78570-9
|
Speech-language pathology Counseling note |
|
78584-0
|
Speech-language pathology Discharge instructions |
|
68841-6
|
Speech-language pathology Discharge summary |
|
78592-3
|
Speech-language pathology Discharge teaching note |
|
78613-7
|
Speech-language pathology Education note |
|
78632-7
|
Speech-language pathology Flowsheet |
|
68843-2
|
Speech-language pathology History and physical note |
|
68846-5
|
Speech-language pathology Hospital Consult note |
|
68847-3
|
Speech-language pathology Hospital Letter |
|
18740-1
|
Speech-language pathology Initial evaluation note |
|
83985-2
|
Speech-language pathology Long term care facility Note |
|
28571-8
|
Speech-language pathology Note |
|
83988-6
|
Speech-language pathology Telephone encounter Note |
|
80782-6
|
Speech-language pathology Plan of care note |
|
68844-0
|
Speech-language pathology Preoperative evaluation and management note |
|
78654-1
|
Speech-language pathology procedure note |
|
11512-1
|
Speech-language pathology Progress note |
|
57165-3
|
Speech-language pathology Referral note |
|
83986-0
|
Speech-language pathology Risk assessment and screening note |
|
34845-8
|
Speech-language pathology+Audiology Consult note |
|
34846-6
|
Speech-language pathology+Audiology Note |
|
90536-4
|
Speech-language pathology and audiology services - concurrent minutes during assessment period [CMS Assessment] |
|
58133-0
|
Speech-language pathology and audiology services - concurrent minutes in the last 7 days [CMS Assessment] |
|
86765-5
|
Speech-language pathology and audiology services - co-treatment minutes during 7 day assessment period [CMS Assessment] |
|
90537-2
|
Speech-language pathology and audiology services - co-treatment minutes during assessment period [CMS Assessment] |
|
90538-0
|
Speech-language pathology and audiology services - group minutes during assessment period [CMS Assessment] |
|
58134-8
|
Speech-language pathology and audiology services - group minutes in the last 7 days [CMS Assessment] |
|
90539-8
|
Speech-language pathology and audiology services - individual minutes during assessment period [CMS Assessment] |
|
58218-9
|
Speech-language pathology and audiology services - individual minutes in the last 7 days [CMS Assessment] |
|
85491-9
|
Speech-language pathology services - concurrent minutes--week 1 [CMS Assessment] |
|
85576-7
|
Speech-language pathology services - concurrent minutes--week 2 [CMS Assessment] |
|
85489-3
|
Speech-language pathology services - co-treatment minutes--week 1 [CMS Assessment] |
|
85578-3
|
Speech-language pathology services - co-treatment minutes--week 2 [CMS Assessment] |
|
85490-1
|
Speech-language pathology services - group minutes--week 1 [CMS Assessment] |
|
85577-5
|
Speech-language pathology services - group minutes--week 2 [CMS Assessment] |
|
85492-7
|
Speech-language pathology services - individual minutes--week 1 [CMS Assessment] |
|
85575-9
|
Speech-language pathology services - individual minutes--week 2 [CMS Assessment] |
|
33002-7
|
Spelt IgE Ab [Units/volume] in Serum |
|
33003-5
|
Spelt IgE Ab RAST class [Presence] in Serum |
|
9780-8
|
Spermatozoa [#/volume] in Semen |
|
51479-4
|
Spermatozoa [#/volume] in Urine by Automated count |
|
53324-0
|
Spermatozoa [#/area] in Urine sediment by Automated count |
|
49111-8
|
Spermatozoa [#/area] in Urine sediment by Microscopy high power field |
|
31630-7
|
Spermatozoa Ab [Presence] in Cervical mucus |
|
5360-3
|
Spermatozoa Ab [Units/volume] in Cervical mucus |
|
31631-5
|
Spermatozoa Ab [Presence] in Serum |
|
5362-9
|
Spermatozoa Ab [Units/volume] in Serum |
|
31632-3
|
Spermatozoa Ab [Presence] in Semen |
|
5361-1
|
Spermatozoa Ab [Units/volume] in Semen |
|
30559-9
|
Spermatozoa Ab [Units/volume] in Unspecified specimen |
|
10602-1
|
Spermatozoa Abnormal Head/100 spermatozoa in Semen |
|
66495-3
|
Spermatozoa Abnormal head shape/100 spermatozoa in Semen |
|
66496-1
|
Spermatozoa Abnormal head size/100 spermatozoa in Semen |
|
10603-9
|
Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
|
15376-7
|
Spermatozoa Abnormal/100 spermatozoa in Semen |
|
10604-7
|
Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
|
66494-6
|
Spermatozoa Acrosome defects/100 spermatozoa in Semen |
|
10605-4
|
Spermatozoa Agglutinated/100 spermatozoa in Semen |
|
33217-1
|
Spermatozoa Agglutinated [Presence] in Semen |
|
10606-2
|
Spermatozoa Amorphous Head/100 spermatozoa in Semen |
|
38497-4
|
Spermatozoa Amorphous Head [Presence] in Semen |
|
61187-1
|
Spermatozoa bent midpiece/100 spermatozoa in Semen |
|
61184-8
|
Spermatozoa broken tail/100 spermatozoa in Semen |
|
10607-0
|
Spermatozoa Coiled Tail/100 spermatozoa in Semen |
|
10608-8
|
Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
|
66497-9
|
Spermatozoa Double forms/100 spermatozoa in Semen |
|
10609-6
|
Spermatozoa Duplicate Head/100 spermatozoa in Semen |
|
10610-4
|
Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
|
38674-8
|
Sperm Head IgA Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38678-9
|
Sperm Head IgG Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38682-1
|
Sperm Head IgM Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
43284-9
|
Spermatozoa IgA binding location [Identifier] in Semen |
|
18400-2
|
Spermatozoa IgA Ab [Units/volume] in Cervical mucus |
|
43288-0
|
Spermatozoa IgA Ab/100 spermatozoa in Serum |
|
47007-0
|
Spermatozoa IgA Ab/100 spermatozoa in Serum by Immunobead |
|
32625-6
|
Spermatozoa IgA Ab [Presence] in Serum |
|
9723-8
|
Spermatozoa IgA Ab [Units/volume] in Serum |
|
32718-9
|
Spermatozoa IgA Ab [Presence] in Semen |
|
18402-8
|
Spermatozoa IgA Ab [Units/volume] in Semen |
|
38686-2
|
Spermatozoa IgA+IgG Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
43287-2
|
Spermatozoa IgG binding location [Identifier] in Semen |
|
18401-0
|
Spermatozoa IgG Ab [Units/volume] in Cervical mucus |
|
43286-4
|
Spermatozoa IgG Ab/100 spermatozoa in Serum |
|
47006-2
|
Spermatozoa IgG Ab/100 spermatozoa in Serum by Immunobead |
|
32626-4
|
Spermatozoa IgG Ab [Presence] in Serum |
|
9724-6
|
Spermatozoa IgG Ab [Units/volume] in Serum |
|
32719-7
|
Spermatozoa IgG Ab [Presence] in Semen |
|
18403-6
|
Spermatozoa IgG Ab [Units/volume] in Semen |
|
43753-3
|
Spermatozoa IgM binding location [Identifier] in Semen |
|
34614-8
|
Spermatozoa IgM Ab [Units/volume] in Cervical mucus |
|
43285-6
|
Spermatozoa IgM Ab/100 spermatozoa in Serum |
|
47005-4
|
Spermatozoa IgM Ab/100 spermatozoa in Serum by Immunobead |
|
33318-7
|
Spermatozoa IgM Ab [Presence] in Serum |
|
9725-3
|
Spermatozoa IgM Ab [Units/volume] in Serum |
|
32720-5
|
Spermatozoa IgM Ab [Presence] in Semen |
|
18404-4
|
Spermatozoa IgM Ab [Units/volume] in Semen |
|
48702-5
|
Spermatozoa Immature/100 spermatozoa in Semen |
|
34657-7
|
Spermatozoa Immotile [#/volume] in Semen |
|
39608-5
|
Spermatozoa Immotile [#/area] in Semen by Microscopy high power field |
|
10611-2
|
Spermatozoa Immotile/100 spermatozoa in Semen |
|
57446-7
|
Spermatozoa Immotile/100 spermatozoa in Semen --post concentration |
|
44248-3
|
Spermatozoa Immotile [#/area] in Vaginal fluid |
|
48372-7
|
Spermatozoa Isolated Head/100 spermatozoa in Semen |
|
10612-0
|
Spermatozoa Large Oval Head/100 spermatozoa in Semen |
|
38675-5
|
Sperm Midpiece IgA Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38679-7
|
Sperm Midpiece IgG Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38683-9
|
Sperm Midpiece IgM Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
42531-4
|
Spermatozoa Motile [#/volume] in Semen |
|
39607-7
|
Spermatozoa Motile [#/area] in Semen by Microscopy high power field |
|
27327-6
|
Spermatozoa Motile/100 spermatozoa in Semen --12 hours post ejaculation |
|
21531-9
|
Spermatozoa Motile/100 spermatozoa in Semen --1 hour post ejaculation |
|
27410-0
|
Spermatozoa Motile/100 spermatozoa in Semen --24 hours post ejaculation |
|
21532-7
|
Spermatozoa Motile/100 spermatozoa in Semen --2 hours post ejaculation |
|
17610-7
|
Spermatozoa Motile [Presence] in Semen --30 minutes post collection |
|
21533-5
|
Spermatozoa Motile/100 spermatozoa in Semen --3 hours post ejaculation |
|
21534-3
|
Spermatozoa Motile/100 spermatozoa in Semen --4 hours post ejaculation |
|
21535-0
|
Spermatozoa Motile/100 spermatozoa in Semen --6 hours post ejaculation |
|
6800-7
|
Spermatozoa Motile/100 spermatozoa in Semen |
|
40696-7
|
Spermatozoa Motile [#/volume] in Semen --post concentration |
|
43155-1
|
Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post concentration |
|
12257-2
|
Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post vasectomy |
|
43378-9
|
Spermatozoa Motile [#/volume] in Semen --post washing |
|
38539-3
|
Spermatozoa Motile/100 spermatozoa in Semen --post washing |
|
38566-6
|
Spermatozoa Motile [Presence] in Semen --post washing |
|
71387-5
|
Spermatozoa Motile [#] in Semen --post ejaculate |
|
38540-1
|
Spermatozoa Motile/100 spermatozoa in Semen --pre washing |
|
38541-9
|
Spermatozoa Motile [Presence] in Semen --pre washing |
|
81282-6
|
Spermatozoa Motile [#] in Semen by Automated count |
|
13942-8
|
Spermatozoa Motile [Presence] in Semen by Light microscopy |
|
44247-5
|
Spermatozoa Motile [#/area] in Vaginal fluid by Wet preparation |
|
10614-6
|
Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
|
10615-3
|
Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
|
10616-1
|
Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
|
10617-9
|
Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
|
10618-7
|
Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
|
10619-5
|
Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
|
81141-4
|
Spermatozoa motility [Score] in Semen by Automated |
|
66498-7
|
Spermatozoa Multiple defects/100 spermatozoa in Semen |
|
10620-3
|
Spermatozoa Nonprogressive/100 spermatozoa in Semen |
|
81283-4
|
Spermatozoa Nonprogressive [#] in Semen by Microscopy |
|
38498-2
|
Spermatozoa Nonviable/100 spermatozoa in Semen |
|
80653-9
|
Spermatozoa Normal chromatin/100 spermatozoa in Semen by Romanowsky stain |
|
10621-1
|
Spermatozoa Normal Head/100 spermatozoa in Semen |
|
42676-7
|
Spermatozoa Normal Motile [#/volume] in Semen |
|
10622-9
|
Spermatozoa Normal/100 spermatozoa in Semen |
|
40695-9
|
Spermatozoa [#/volume] in Semen --post concentration |
|
43154-4
|
Spermatozoa [Presence] in Semen by Light microscopy --post concentration |
|
35436-5
|
Spermatozoa [Presence] in Semen by Light microscopy --post reanastomosis |
|
51623-7
|
Spermatozoa [#/volume] in Semen --post vasectomy |
|
12256-4
|
Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
|
29990-9
|
Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy |
|
38543-5
|
Spermatozoa [#/volume] in Semen --post washing |
|
10601-3
|
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
|
10600-5
|
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
|
10599-9
|
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
|
10623-7
|
Spermatozoa Pin Head/100 spermatozoa in Semen |
|
72517-6
|
Spermatozoa [#] in Semen --post ejaculate |
|
38544-3
|
Spermatozoa [#/volume] in Semen --pre washing |
|
58901-0
|
Spermatozoa Progressive [#/volume] in Semen |
|
38500-5
|
Spermatozoa Progressive Grade 1/100 spermatozoa in Semen |
|
57445-9
|
Spermatozoa Progressive Grade 1/100 spermatozoa in Semen --post concentration |
|
80654-7
|
Spermatozoa Progressive Grade 1+2/100 spermatozoa in Semen |
|
38501-3
|
Spermatozoa Progressive Grade 2/100 spermatozoa in Semen |
|
57444-2
|
Spermatozoa Progressive Grade 2/100 spermatozoa in Semen --post concentration |
|
38503-9
|
Spermatozoa Progressive Grade 3/100 spermatozoa in Semen |
|
57443-4
|
Spermatozoa Progressive Grade 3/100 spermatozoa in Semen --post concentration |
|
38502-1
|
Spermatozoa Progressive Grade 4/100 spermatozoa in Semen |
|
38499-0
|
Spermatozoa Progressive [Presence] in Semen --4 hours post ejaculation |
|
14194-5
|
Spermatozoa Progressive/100 spermatozoa in Semen |
|
57456-6
|
Spermatozoa Progressive [#/volume] in Semen --post concentration |
|
68915-8
|
Spermatozoa Progressive/100 spermatozoa in Semen --post concentration |
|
43376-3
|
Spermatozoa Progressive [Presence] in Semen --post washing |
|
43377-1
|
Spermatozoa Progressive [Presence] in Semen --pre washing |
|
81319-6
|
Spermatozoa Progressive [#] in Semen by Automated count |
|
33032-4
|
Spermatozoa Progressive [Presence] in Semen |
|
10593-2
|
Spermatozoa Pyriform Head/100 spermatozoa in Semen |
|
10624-5
|
Spermatozoa Rapid/100 spermatozoa in Semen |
|
10625-2
|
Spermatozoa Round Head/100 spermatozoa in Semen |
|
51934-8
|
Spermatozoa Slow/100 spermatozoa in Semen --1 hour post ejaculation |
|
10626-0
|
Spermatozoa Slow/100 spermatozoa in Semen |
|
10627-8
|
Spermatozoa Small Oval Head/100 spermatozoa in Semen |
|
9704-8
|
Spermatozoa [Morphology] in Semen |
|
34441-6
|
Spermatozoa [Velocity] in Semen |
|
38677-1
|
Sperm Tail IgA Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38681-3
|
Sperm Tail IgG Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38685-4
|
Sperm Tail IgM Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
10628-6
|
Spermatozoa Tail Swelling/100 spermatozoa in Semen |
|
38676-3
|
Sperm Tail Tip IgA Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38680-5
|
Sperm Tail Tip IgG Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
38684-7
|
Sperm Tail Tip IgM Ab/100 spermatozoa in Unspecified specimen by Immunobead |
|
10594-0
|
Spermatozoa Tapering Head/100 spermatozoa in Semen |
|
61185-5
|
Spermatozoa thick midpiece/100 spermatozoa in Semen |
|
61186-3
|
Spermatozoa thin midpiece/100 spermatozoa in Semen |
|
33232-0
|
Spermatozoa [Presence] in Urine by Automated |
|
8248-7
|
Spermatozoa [Presence] in Urine sediment by Light microscopy |
|
10629-4
|
Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
|
10613-8
|
Spermatozoa Viable/100 spermatozoa in Semen |
|
81138-0
|
Spermatozoa Aggregated [Presence] in Semen |
|
48373-5
|
Spermatozoa Angled Midpiece/100 spermatozoa in Semen |
|
38554-2
|
Spermatozoa.head Motile w IgA/100 spermatozoa in Semen by Immunobead |
|
38555-9
|
Spermatozoa.head Motile w IgG/100 spermatozoa in Semen by Immunobead |
|
38556-7
|
Spermatozoa.head Motile w IgM/100 spermatozoa in Semen by Immunobead |
|
48374-3
|
Spermatozoa Isolated Tail/100 spermatozoa in Semen |
|
38557-5
|
Spermatozoa.midpiece Motile w IgA/100 spermatozoa in Semen by Immunobead |
|
38558-3
|
Spermatozoa.midpiece Motile w IgG/100 spermatozoa in Semen by Immunobead |
|
38559-1
|
Spermatozoa.midpiece Motile w IgM/100 spermatozoa in Semen by Immunobead |
|
81318-8
|
Spermatozoa.normal morphology [#] in Semen by Automated count |
|
48375-0
|
Spermatozoa Short Tail/100 spermatozoa in Semen |
|
38563-3
|
Spermatozoa.tail tip Motile w IgA/100 spermatozoa in Semen by Immunobead |
|
38564-1
|
Spermatozoa.tail tip Motile w IgG/100 spermatozoa in Semen by Immunobead |
|
38565-8
|
Spermatozoa.tail Tip Motile w IgM/100 spermatozoa in Semen by Immunobead |
|
38560-9
|
Spermatozoa.tail Motile w IgA/100 spermatozoa in Semen by Immunobead |
|
38561-7
|
Spermatozoa.tail Motile w IgG/100 spermatozoa in Semen by Immunobead |
|
38562-5
|
Spermatozoa.tail Motile w IgM/100 spermatozoa in Semen by Immunobead |
|
10589-0
|
Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
|
10590-8
|
Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
|
53113-7
|
Spermatids/100 spermatozoa in Semen |
|
10588-2
|
Spermatogonia [#/volume] in Semen |
|
81876-5
|
SPG11 gene deletion+duplication and mutation analysis in Blood or Tissue by Molecular genetics method |
|
81877-3
|
SPG3A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
38532-8
|
SPG3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79838-9
|
Sphere Left eye by Objective refraction --W cycloplegia |
|
79851-2
|
Sphere Left eye by Subjective refraction --W cycloplegia |
|
79837-1
|
Sphere Right eye by Objective refraction --W cycloplegia |
|
79850-4
|
Sphere Right eye by Subjective refraction --W cycloplegia |
|
79840-5
|
Sphere Left eye by Objective refraction --WO cycloplegia |
|
79853-8
|
Sphere Left eye by Subjective refraction --WO cycloplegia |
|
79839-7
|
Sphere Right eye by Objective refraction --WO cycloplegia |
|
79852-0
|
Sphere Right eye by Subjective refraction --WO cycloplegia |
|
802-9
|
Spherocytes [Presence] in Blood by Light microscopy |
|
50674-1
|
Spherocytes [Presence] in Cord blood by Light microscopy |
|
53971-8
|
Spherocytes [Presence] in Urine sediment by Light microscopy |
|
48069-9
|
Spherocytes.micro [Presence] in Blood by Light microscopy |
|
49575-4
|
Sphingomyelin/Surfactant.total in Amniotic fluid |
|
75953-0
|
Spike count Cerebral cortex Electroencephalogram (EEG) |
|
6856-9
|
Spinach IgE Ab [Units/volume] in Serum |
|
16027-5
|
Spinach IgE Ab RAST class [Presence] in Serum |
|
61317-4
|
Spinach IgE Ab/IgE total in Serum |
|
7711-5
|
Spinach IgG Ab [Units/volume] in Serum |
|
21537-6
|
Spinach IgG Ab RAST class [Presence] in Serum |
|
56391-6
|
Spinach IgG4 Ab [Mass/volume] in Serum |
|
60406-6
|
Spinach IgG Ab [Mass/volume] in Serum |
|
92910-9
|
Spinal surgery Consult note |
|
34497-8
|
SPINK1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41051-4
|
SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10630-2
|
Spinnbarkeit [Length] in Cervical mucus |
|
6249-7
|
Spiny lobster IgE Ab [Units/volume] in Serum |
|
15822-0
|
Spiny lobster IgE Ab RAST class [Presence] in Serum |
|
6250-5
|
Spiny Pigweed IgE Ab [Units/volume] in Serum |
|
15938-4
|
Spiny Pigweed IgE Ab RAST class [Presence] in Serum |
|
56392-4
|
Spiny Pigweed IgG4 Ab [Mass/volume] in Serum |
|
56707-3
|
Spiramycin IgE Ab [Units/volume] in Serum |
|
55715-7
|
Spiramycin [Susceptibility] by Gradient strip |
|
457-2
|
Spiramycin [Susceptibility] by Disk diffusion (KB) |
|
456-4
|
Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
455-6
|
Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18981-1
|
Spiramycin [Susceptibility] |
|
458-0
|
Spiramycin [Susceptibility] by Serum bactericidal titer |
|
5363-7
|
Spirillum minus Ab [Units/volume] in Serum |
|
18759-1
|
Spirometry study |
|
72950-9
|
Spironolactone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72949-1
|
Spironolactone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4035-2
|
Spironolactone [Mass/time] in 24 hour Urine |
|
4426-3
|
Spironolactone [Mass] of Dose |
|
73144-8
|
Spironolactone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73145-5
|
Spironolactone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14074-9
|
Spironolactone [Mass/volume] in Serum or Plasma |
|
12318-2
|
Spironolactone [Presence] in Urine |
|
4034-5
|
Spironolactone [Mass/volume] in Urine |
|
66118-1
|
Spleen Pathology biopsy report |
|
82760-0
|
Date of splenectomy |
|
82759-2
|
Reason for splenectomy |
|
85758-1
|
Streptococcus pneumoniae Danish serotypes 12A+12F+44+46 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85756-5
|
Streptococcus pneumoniae Danish serotypes 18A+18B+18C+18F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85757-3
|
Streptococcus pneumoniae Danish serotypes 15A+15F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
50678-2
|
Spondylocladium sp IgE Ab RAST class [Presence] in Serum |
|
63174-7
|
Spondylocladium sp IgG Ab [Mass/volume] in Serum |
|
33700-6
|
Spore [Identifier] in Unspecified specimen by Malachite green stain |
|
72094-6
|
Sport-recreation score [HOOS] |
|
72099-5
|
Sport-recreation score [KOOS] |
|
79432-1
|
Sport-recreation score change [HOOS] |
|
79437-0
|
Sport-recreation score change [KOOS] |
|
78738-2
|
Sports medicine Consult note |
|
78703-6
|
Sports medicine Diagnostic study note |
|
78602-0
|
Sports medicine Education note |
|
78623-6
|
Sports medicine Flowsheet |
|
78704-4
|
Sports medicine Initial evaluation note |
|
89882-5
|
Sports medicine Outpatient Note |
|
80781-8
|
Sports medicine Plan of care note |
|
79267-1
|
Sports medicine procedure note |
|
78705-1
|
Sports medicine Progress note |
|
78700-2
|
Sports medicine Referral note |
|
89901-3
|
Sports medicine Telehealth Note |
|
6857-7
|
Spruce IgE Ab [Units/volume] in Serum |
|
16029-1
|
Spruce IgE Ab RAST class [Presence] in Serum |
|
61298-6
|
Spruce IgE Ab/IgE total in Serum |
|
79326-5
|
Squalene [Moles/volume] in Serum or Plasma |
|
51486-9
|
Epithelial cells.squamous [#/volume] in Urine by Automated count |
|
13654-9
|
Epithelial cells.squamous [#/volume] in Urine sediment |
|
33219-7
|
Epithelial cells.squamous [#/area] in Urine sediment by Automated count |
|
11277-1
|
Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field |
|
45390-2
|
Epithelial cells.squamous [#/area] in Urine sediment by Microscopy low power field |
|
63487-3
|
Epithelial cells.squamous [Presence] in Bronchoalveolar lavage |
|
70122-7
|
Epithelial cells.squamous [Presence] in Body fluid |
|
32822-9
|
Epithelial cells.squamous/100 cells in Bronchial specimen by Light microscopy |
|
14327-1
|
Epithelial cells.squamous [Presence] in Sputum by Light microscopy |
|
53318-2
|
Epithelial cells.squamous [Presence] in Urine by Automated |
|
12258-0
|
Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy |
|
44094-1
|
Epithelial cells.squamous [#/area] in Vaginal fluid by Light microscopy |
|
7713-1
|
Squash IgE Ab [Units/volume] in Serum |
|
16030-9
|
Squash IgE Ab RAST class [Presence] in Serum |
|
6858-5
|
Squid IgE Ab [Units/volume] in Serum |
|
16031-7
|
Squid IgE Ab RAST class [Presence] in Serum |
|
61281-2
|
Squid IgE Ab/IgE total in Serum |
|
56240-5
|
Squid IgG4 Ab [Mass/volume] in Serum |
|
63121-8
|
Squid IgG Ab [Mass/volume] in Serum |
|
60475-1
|
Serotonin release 0.2 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
77728-4
|
Serotonin release 0.2 IU/mL heparin.unfractionated [Units/volume] in Serum |
|
50728-5
|
Serotonin release 0.1 IU/mL heparin.unfractionated [Units/volume] in Serum |
|
50732-7
|
Serotonin release 0.1 U/mL heparin.low molecular weight [Units/volume] in Serum |
|
74005-0
|
Serotonin release 0.5 IU/mL heparin.unfractionated [Units/volume] in Serum |
|
88459-3
|
Serotonin release 1.0 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
50731-9
|
Serotonin release 100 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
50727-7
|
Serotonin release 100 IU/mL heparin.unfractionated [Units/volume] in Serum |
|
88460-1
|
Serotonin release 50 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
50733-5
|
Serotonin release interpretation in Serum |
|
50735-0
|
Serotonin release.heparin.low molecular weight in Serum |
|
50734-3
|
Serotonin release.heparin.porcine in Serum |
|
66488-8
|
Serotonin release.heparin.unfractionated in Serum Narrative |
|
91980-3
|
Specific airway resistance by Plethysmograph body box |
|
33921-8
|
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma |
|
63559-9
|
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunoblot |
|
53010-5
|
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
53031-1
|
Signal Recognition Particle (SRP) Ab [Units/volume] in Serum or Plasma |
|
53011-3
|
Signal Recognition Particle (SRP) Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
82936-6
|
Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum by Line blot |
|
82649-5
|
Summed rest score Myocardium SPECT |
|
82643-8
|
Summed rest score for 17 segment model Myocardium SPECT |
|
82646-1
|
Summed rest score for 20 segment model Myocardium SPECT |
|
82257-7
|
SRY gene deletion in Blood or Tissue by FISH |
|
57310-5
|
SRY gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57314-7
|
SRY gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
93810-0
|
SS18 gene rearrangements in Tissue by FISH |
|
34523-1
|
Succinate semialdehyde dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
94027-0
|
Somatic symptom disorder score |
|
94020-5
|
Somatic symptom disorder screening report |
|
94028-8
|
Somatic symptom disorder severity |
|
66484-7
|
DNA single strand Ab [Units/volume] in Serum by Immunoassay |
|
5132-6
|
DNA single strand Ab [Units/volume] in Serum |
|
42201-4
|
DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay |
|
10360-6
|
DNA single strand IgG Ab [Units/volume] in Serum |
|
10361-4
|
DNA single strand IgM Ab [Units/volume] in Serum |
|
26649-4
|
Snowshoe hare virus Ab [Presence] in Serum |
|
74827-7
|
Snowshoe hare virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
74828-5
|
Snowshoe hare virus Ab [Presence] in Serum by Neutralization test |
|
42952-2
|
Snowshoe hare virus Ab [Titer] in Serum |
|
40511-8
|
Snowshoe hare virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
40510-0
|
Snowshoe hare virus Ab [Titer] in Serum by Immunofluorescence |
|
53385-1
|
Snowshoe hare virus Ab [Presence] in Unspecified specimen |
|
50038-9
|
Snowshoe hare virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
57853-4
|
Snowshoe hare virus IgG Ab [Presence] in Serum by Immunoassay |
|
74829-3
|
Snowshoe hare virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
55379-2
|
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay |
|
74846-7
|
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
42953-0
|
Snowshoe hare virus IgM Ab [Titer] in Serum |
|
40509-2
|
Snowshoe hare virus IgM Ab [Titer] in Serum by Neutralization test |
|
82648-7
|
Summed stress score Myocardium SPECT |
|
82642-0
|
Summed stress score for 17 segment model Myocardium SPECT |
|
82645-3
|
Summed stress score for 20 segment model Myocardium SPECT |
|
60962-8
|
ST amplitude.derived lead V1 |
|
60963-6
|
ST amplitude.derived lead V2 |
|
60964-4
|
ST amplitude.derived lead V3 |
|
60965-1
|
ST amplitude.derived lead V4 |
|
60966-9
|
ST amplitude.derived lead V5 |
|
60967-7
|
ST amplitude.derived lead V6 |
|
60960-2
|
ST amplitude.lead AI |
|
60961-0
|
ST amplitude.lead AS |
|
76056-1
|
ST amplitude.lead aVF |
|
76057-9
|
ST amplitude.lead aVL |
|
76058-7
|
ST amplitude.lead aVR |
|
60968-5
|
ST amplitude.lead ES |
|
76053-8
|
ST amplitude.lead I |
|
76054-6
|
ST amplitude.lead II |
|
76055-3
|
ST amplitude.lead III |
|
60969-3
|
ST amplitude.lead MCL |
|
60970-1
|
ST amplitude.lead MCL1 |
|
60971-9
|
ST amplitude.lead MCL6 |
|
76047-0
|
ST amplitude.lead V1 |
|
76048-8
|
ST amplitude.lead V2 |
|
76049-6
|
ST amplitude.lead V3 |
|
76050-4
|
ST amplitude.lead V4 |
|
76051-2
|
ST amplitude.lead V5 |
|
76052-0
|
ST amplitude.lead V6 |
|
30935-1
|
ST deviation |
|
91546-2
|
ST deviation (Maximum value during study) by EKG |
|
10082-6
|
ST initial amplitude 6 ms in lead AVF |
|
10083-4
|
ST initial amplitude 6 ms in lead AVL |
|
10084-2
|
ST initial amplitude 6 ms in lead AVR |
|
10085-9
|
ST initial amplitude 6 ms in lead I |
|
10086-7
|
ST initial amplitude 6 ms in lead II |
|
10087-5
|
ST initial amplitude 6 ms in lead III |
|
10088-3
|
ST initial amplitude 6 ms in lead V1 |
|
10089-1
|
ST initial amplitude 6 ms in lead V2 |
|
10090-9
|
ST initial amplitude 6 ms in lead V3 |
|
10091-7
|
ST initial amplitude 6 ms in lead V4 |
|
10092-5
|
ST initial amplitude 6 ms in lead V5 |
|
10093-3
|
ST initial amplitude 6 ms in lead V6 |
|
82754-3
|
State of travel |
|
77985-0
|
State or province of exposure to illness |
|
67569-4
|
Streptococcus pyogenes M protein emm gene [Type] in Isolate by Sequencing |
|
18510-8
|
ST segment axis.horizontal plane |
|
10094-1
|
ST slope in lead AVF |
|
10095-8
|
ST slope in lead AVL |
|
10096-6
|
ST slope in lead AVR |
|
10097-4
|
ST slope in lead I |
|
10098-2
|
ST slope in lead II |
|
10099-0
|
ST slope in lead III |
|
10100-6
|
ST slope in lead V1 |
|
10101-4
|
ST slope in lead V2 |
|
10102-2
|
ST slope in lead V3 |
|
10103-0
|
ST slope in lead V4 |
|
10104-8
|
ST slope in lead V5 |
|
10105-5
|
ST slope in lead V6 |
|
10106-3
|
ST wave end displacement in lead AVF |
|
10107-1
|
ST wave end displacement in lead AVL |
|
10108-9
|
ST wave end displacement in lead AVR |
|
10109-7
|
ST wave end displacement in lead I |
|
10110-5
|
ST wave end displacement in lead II |
|
10111-3
|
ST wave end displacement in lead III |
|
10112-1
|
ST wave end displacement in lead V1 |
|
10113-9
|
ST wave end displacement in lead V2 |
|
10114-7
|
ST wave end displacement in lead V3 |
|
10115-4
|
ST wave end displacement in lead V4 |
|
10116-2
|
ST wave end displacement in lead V5 |
|
10117-0
|
ST wave end displacement in lead V6 |
|
10118-8
|
ST wave mid displacement in lead AVF |
|
10119-6
|
ST wave mid displacement in lead AVL |
|
10120-4
|
ST wave mid displacement in lead AVR |
|
10121-2
|
ST wave mid displacement in lead I |
|
10122-0
|
ST wave mid displacement in lead II |
|
10123-8
|
ST wave mid displacement in lead III |
|
10124-6
|
ST wave mid displacement in lead V1 |
|
10125-3
|
ST wave mid displacement in lead V2 |
|
10126-1
|
ST wave mid displacement in lead V3 |
|
10127-9
|
ST wave mid displacement in lead V4 |
|
10128-7
|
ST wave mid displacement in lead V5 |
|
10129-5
|
ST wave mid displacement in lead V6 |
|
63426-1
|
Bacterial heat-stable enterotoxin ST gene [Presence] in Unspecified specimen by NAA with probe detection |
|
16921-9
|
St. Augustine grass IgE Ab [Units/volume] in Serum |
|
90239-5
|
ST2.soluble [Mass/volume] in Serum by Immunoassay |
|
32979-7
|
Stability {Dental arch}.denture.complete Observed |
|
32981-3
|
Stability {Dental arch}.denture.complete - Reported |
|
32980-5
|
Stability {Dental arch}.denture.partial Observed |
|
32982-1
|
Stability {Dental arch}.denture.partial - Reported |
|
77281-4
|
Stability rate [NMMDS] |
|
92191-6
|
Staff [#] Agency |
|
86556-8
|
Staff [#] who declined influenza vaccine |
|
86555-0
|
Staff [#] who had a medical contraindication to the influenza vaccine |
|
86554-3
|
Staff [#] who provided documentation of influenza vaccine receipt |
|
86553-5
|
Staff [#] who received influenza vaccination at the facility |
|
86552-7
|
Staff [#] who worked at facility at least one day from October 1 through March 31 |
|
86557-6
|
Staff [#] with unknown influenza vaccination status |
|
86599-8
|
Staff assessment of daily and activity preferences [CMS Assessment] |
|
54715-8
|
Staff assessment of daily and activity preferences should be conducted [CMS Assessment] |
|
54677-0
|
Staff assessment of resident mood total severity score [Observed PHQ-9 CMS] |
|
58117-3
|
Staff pain assessment interview should be conducted [CMS Assessment] |
|
83283-2
|
Stage 2 pressure injuries not present or at a lesser stage on admission/reentry # [CMS Assessment] |
|
83284-0
|
Stage 3 pressure injuries not present or at a lesser stage on admission/reentry # [CMS Assessment] |
|
83285-7
|
Stage 4 pressure injuries not present or at a lesser stage on admission/reentry # [CMS Assessment] |
|
74063-9
|
Stage in the process that the event originated, regardless of the stage at which it was discovered [AHRQ] |
|
57231-3
|
Stage of most problematic pressure injury [CMS Assessment] |
|
60476-9
|
Stage [Type] in Tick |
|
85072-7
|
Stairs [CMS Assessment] |
|
72829-5
|
Stalwart of Standardization and Vocabulary Curator Virtuoso |
|
70954-3
|
Standard process followed for residual renal function assessed in calculating Kt/V [ESRD] |
|
82284-1
|
Standard RMR |
|
57242-0
|
Standardized depression screening was conducted [CMS Assessment] |
|
57254-5
|
Standardized fall risk assessment was conducted [CMS Assessment] |
|
52060-1
|
Standers/standing frame attachment |
|
84424-1
|
Standing Balance Test - national percentile [NIH Toolbox] |
|
83142-0
|
Standing Balance Test [NIH Toolbox] |
|
83162-8
|
Standing Balance Test computed score [NIH Toolbox] |
|
4038-6
|
Stanozolol [Mass/time] in 24 hour Urine |
|
4427-1
|
Stanozolol [Mass] of Dose |
|
4036-0
|
Stanozolol [Presence] in Urine |
|
4037-8
|
Stanozolol [Mass/volume] in Urine |
|
92049-6
|
Staphylococcus species methicillin resistant identified in Isolate or Specimen by Molecular genetics method |
|
88272-0
|
Staphylococcus sp tuf gene [Presence] by Probe in Positive blood culture |
|
20968-4
|
Staphylococcus sp identified in Cheese by Organism specific culture |
|
92778-0
|
Staphylococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
90076-1
|
Staphylococcus sp identified in Isolate by Organism specific culture |
|
20967-6
|
Staphylococcus sp identified in Milk by Organism specific culture |
|
20966-8
|
Staphylococcus sp identified in Unspecified specimen by Organism specific culture |
|
48417-0
|
Staphylolysin Ab [Units/volume] in Body fluid |
|
5366-0
|
Staphylolysin Ab [Units/volume] in Serum |
|
48418-8
|
Staphylolysin Ab [Titer] in Serum |
|
72362-7
|
Starch granules [#/area] in Urine sediment by Microscopy low power field |
|
2967-8
|
Starch granules [Presence] in Stool by Light microscopy |
|
33861-6
|
Starch granules [Presence] in Urine sediment by Light microscopy |
|
59386-3
|
Starch [Mass/mass] in Stool by Infrared spectroscopy |
|
10924-9
|
Starfruit IgE Ab [Units/volume] in Serum |
|
15601-8
|
Starfruit IgE Ab RAST class [Presence] in Serum |
|
91352-5
|
STarT Back Screening risk level |
|
80914-5
|
Start coordinates Coronary artery segment |
|
76426-6
|
Start date for episode of care |
|
54595-4
|
Start date of most recent Medicare stay [CMS Assessment] |
|
55027-7
|
Start date of occupational therapy [CMS Assessment] |
|
55029-3
|
Start date of physical therapy [CMS Assessment] |
|
55025-1
|
Start date of speech language pathology and audiology services [CMS Assessment] |
|
46497-4
|
Start of care date [CMS Assessment] |
|
57232-1
|
Stasis ulcer [CMS Assessment] |
|
19764-0
|
Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
|
55068-1
|
State case mix - RUG group |
|
55069-9
|
State case mix - RUG version code |
|
75954-8
|
State entropy [Score] Cerebral cortex Electroencephalogram (EEG) |
|
91516-5
|
State where healthcare received outside resident state |
|
46494-1
|
State location of agency branch [CMS Assessment] |
|
77993-4
|
State notifiable condition case identifier |
|
46499-0
|
State of residence |
|
80910-3
|
State or province of birth |
|
57716-3
|
State printed on filter paper card [Identifier] in NBS card |
|
45398-5
|
State provider number for Facility |
|
81382-4
|
Statement of document creator [Reported] |
|
81368-3
|
Statement of witness [Reported] |
|
54674-7
|
States that life isn't worth living, wishes for death, or attempts to harm self in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54673-9
|
States that life isn't worth living, wishes for death, or attempts to harm self in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
89008-7
|
Station name [Identifier] EMS system |
|
91020-8
|
Status of critical regional infrastructure |
|
57229-7
|
Status of most problematic pressure injury [CMS Assessment] |
|
57234-7
|
Status of most problematic stasis ulcer [CMS Assessment] |
|
57236-2
|
Status of most problematic surgical wound [CMS Assessment] |
|
91018-2
|
Status of regional dialysis centers |
|
91019-0
|
Status of regional human shelters |
|
91015-8
|
Status of waste water systems Narrative |
|
91014-1
|
Status of water supply systems Narrative |
|
30286-9
|
Stavudine [Susceptibility] by Genotype method |
|
30272-9
|
Stavudine [Susceptibility] by Phenotype method |
|
29124-5
|
Stavudine [Units/volume] in Serum or Plasma |
|
49227-2
|
Stavudine [Mass/volume] in Serum or Plasma |
|
30302-4
|
Stavudine [Susceptibility] |
|
92272-4
|
Stayed in intensive care unit from Newborn |
|
54335-5
|
Stearoylcarnitine (C18) [Moles/volume] in Amniotic fluid |
|
54334-8
|
Stearoylcarnitine (C18) [Moles/volume] in Cerebral spinal fluid |
|
53241-6
|
Stearoylcarnitine (C18) [Moles/volume] in DBS |
|
30560-7
|
Stearoylcarnitine (C18) [Moles/volume] in Serum or Plasma |
|
69775-5
|
Stearoylcarnitine (C18) [Moles/volume] in Urine |
|
53400-8
|
Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
54333-0
|
Stearoylcarnitine (C18)/Creatinine [Molar ratio] in Urine |
|
10812-6
|
Microscopic observation [Identifier] in Tissue by Steiner stain |
|
43418-3
|
Stem cell product given [Volume] |
|
31029-2
|
Stenbolone [Mass/volume] in Urine |
|
80730-5
|
Stenosis classification Coronary artery segment ACC-AHA |
|
15316-3
|
Volume planimetry Stepsize by - Reported |
|
2969-4
|
Stercobilin [Presence] in Stool |
|
80107-6
|
Stereopsis by Randot |
|
80108-4
|
Stereopsis by Titmus |
|
52029-6
|
Sterilization consent Document |
|
73884-9
|
Steroid fractions interpretation in 24 hour Urine Narrative |
|
79220-0
|
Steroid fractions interpretation in Serum or Plasma Narrative |
|
78743-2
|
Steroid fractions interpretation in Urine Narrative |
|
79327-3
|
Sterols pattern [Interpretation] in Serum or Plasma Narrative |
|
74807-9
|
Transferrin receptor.soluble/log Ferritin index [Mass Ratio] in Serum or Plasma |
|
30248-9
|
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma |
|
33210-6
|
Transferrin receptor.soluble [Moles/volume] in Serum or Plasma |
|
88826-3
|
Stiffness panel [KOOS] |
|
74887-1
|
Stigmastanol [Moles/volume] in Serum or Plasma |
|
74886-3
|
Stigmasterol [Moles/volume] in Serum or Plasma |
|
75207-1
|
Stillbirth indicator [CDC.CS] |
|
17611-5
|
Stimulants [Identifier] in Serum or Plasma |
|
12553-4
|
Stimulants [Identifier] in Urine |
|
59339-2
|
Stiripentol [Mass/volume] in Blood |
|
59340-0
|
Stiripentol [Mass/volume] in Serum or Plasma |
|
59341-8
|
Stiripentol [Mass/volume] in Urine |
|
53795-1
|
STK11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
8026-7
|
Stain method [Type] in Unspecified specimen |
|
66114-0
|
Stomach Pathology biopsy report |
|
81170-3
|
Greater curvature of stomach [Length] in Specimen |
|
81171-1
|
Lesser curvature of stomach [Length] in Specimen |
|
89064-0
|
Type of medication used for stomach upset |
|
10380-4
|
Stomatocytes [Presence] in Blood by Light microscopy |
|
49255-3
|
Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy |
|
40787-4
|
Calculus analysis [Interpretation] in Stone by Infrared spectroscopy |
|
56161-3
|
Calculus analysis with calculus photography [Interpretation] in Stone |
|
14638-1
|
Calculus analysis [Interpretation] in Stone |
|
49252-0
|
Calculus analysis [Interpretation] in Stone Narrative |
|
48265-3
|
Dust Allergen Mix B (Acarus siro+Lepidoglyphus destructor+Tyrophagus putrescentiae+Glycyphagus domesticus) triggered leukotriene release [Mass/volume] by Leukocytes |
|
5227-4
|
Streptococcal hyaluronidase Ab [Presence] in Serum |
|
9716-2
|
Streptococcal hyaluronidase Ab [Titer] in Serum |
|
7722-2
|
Strawberry triggered histamine release [Units/volume] in Blood |
|
6257-0
|
Strawberry IgE Ab [Units/volume] in Serum |
|
16038-2
|
Strawberry IgE Ab RAST class [Presence] in Serum |
|
61266-3
|
Strawberry IgE Ab/IgE total in Serum |
|
7721-4
|
Strawberry IgG Ab [Units/volume] in Serum |
|
21542-6
|
Strawberry IgG Ab RAST class [Presence] in Serum |
|
56393-2
|
Strawberry IgG4 Ab [Mass/volume] in Serum |
|
40835-1
|
Strawberry IgG Ab [Mass/volume] in Serum |
|
5133-4
|
Streptococcal DNAse B [Units/volume] in Serum |
|
14207-5
|
Streptococcal DNAse B [Titer] in Serum |
|
77741-7
|
Streptavidin [Presence] in Serum or Plasma by Immunoblot |
|
6819-7
|
Streptococcus sp Ab [Presence] in Serum |
|
6820-5
|
Streptococcus sp Ab [Titer] in Serum |
|
85766-4
|
Streptococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92774-9
|
Streptococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
70015-3
|
Streptococcus sp DNA [Presence] in Blood by NAA with probe detection |
|
43390-4
|
Streptococcus sp identified in Isolate |
|
43389-6
|
Streptococcus sp identified in Isolate by Organism specific culture |
|
49016-9
|
Streptococcus sp exoenzyme Ab [Units/volume] in Serum |
|
88277-9
|
Streptococcus sp tuf gene [Presence] by Probe in Positive blood culture |
|
38353-9
|
Streptococcus sp identified in Unspecified specimen by Organism specific culture |
|
5369-4
|
Streptokinase Ab [Units/volume] in Serum |
|
34375-6
|
Streptokinase Ab [Titer] in Serum |
|
4681-3
|
Streptokinase [Enzymatic activity/volume] in Plasma |
|
4682-1
|
Streptokinase [Titer] in Serum |
|
2970-2
|
Streptomyces proteinase [Presence] in Serum |
|
48177-0
|
Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25206-4
|
Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25205-6
|
Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
46719-1
|
Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25185-0
|
Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4428-9
|
Streptomycin [Mass] of Dose |
|
35841-6
|
Streptomycin.high potency [Susceptibility] by Gradient strip |
|
7049-0
|
Streptomycin.high potency [Susceptibility] by Disk diffusion (KB) |
|
6933-6
|
Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18983-7
|
Streptomycin.high potency [Susceptibility] |
|
7048-2
|
Streptomycin [Susceptibility] by Gradient strip |
|
461-4
|
Streptomycin [Susceptibility] by Disk diffusion (KB) |
|
460-6
|
Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
459-8
|
Streptomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20462-8
|
Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
4039-4
|
Streptomycin [Mass/volume] in Serum or Plasma |
|
18982-9
|
Streptomycin [Susceptibility] |
|
462-2
|
Streptomycin [Susceptibility] by Serum bactericidal titer |
|
59282-4
|
Stress cardiac echo study report |
|
93038-8
|
Stress is when someone feels tense, nervous, anxious or can't sleep at night because their mind is troubled - how stressed are you [PRAPARE] |
|
18139-6
|
Stress study Stage by US |
|
13931-1
|
Striated muscle Ab [Presence] in Serum |
|
57744-5
|
Striated muscle Ab [Presence] in Serum by Immunofluorescence |
|
31659-6
|
Striated muscle Ab [Units/volume] in Serum |
|
8097-8
|
Striated muscle Ab [Titer] in Serum |
|
5372-8
|
Striated muscle Ab [Titer] in Serum by Immunofluorescence |
|
49692-7
|
Striated muscle IgG Ab [Presence] in Serum by Immunofluorescence |
|
31660-4
|
Striated muscle IgG Ab [Units/volume] in Serum |
|
42217-0
|
Striated muscle IgG Ab [Titer] in Serum |
|
29998-2
|
Striated muscle IgG Ab [Titer] in Serum by Immunofluorescence |
|
5373-6
|
Strongyloides sp Ab [Units/volume] in Serum by Hemagglutination |
|
10718-5
|
Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
|
8034-1
|
Strongyloides sp Ab [Units/volume] in Serum |
|
34376-4
|
Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
80660-4
|
Strongyloides sp IgG Ab [Presence] in Serum by Immunoassay |
|
41125-6
|
Strongyloides sp IgG Ab [Units/volume] in Serum |
|
87995-7
|
Strongyloides sp identified in Stool by Organism specific culture |
|
29971-9
|
Strontium [Mass/volume] in 24 hour Urine |
|
29972-7
|
Strontium [Mass/time] in 24 hour Urine |
|
50915-8
|
Strontium [Moles/time] in 24 hour Urine |
|
60172-4
|
Strontium [Mass/volume] in Blood |
|
51206-1
|
Strontium [Mass/volume] in Body fluid |
|
76647-7
|
Strontium [Mass/mass] in Hair |
|
50913-3
|
Strontium [Moles/mass] in Hair |
|
60173-2
|
Strontium [Mass/volume] in Red Blood Cells |
|
5736-4
|
Strontium [Mass/volume] in Serum or Plasma |
|
60174-0
|
Strontium [Mass/mass] in Tissue |
|
14100-2
|
Strontium [Presence] in Urine |
|
12705-0
|
Strontium [Mass/volume] in Urine |
|
50914-1
|
Strontium [Moles/volume] in Urine |
|
29973-5
|
Strontium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52921-4
|
Strontium/Creatinine [Molar ratio] in 24 hour Urine |
|
17658-6
|
Strontium/Creatinine [Mass Ratio] in Urine |
|
52922-2
|
Strontium/Creatinine [Molar ratio] in Urine |
|
85298-8
|
Body structure included in specimen [Anatomy] in Specimen |
|
85303-6
|
Body structure of origin [Anatomy] in Breast cancer specimen |
|
81304-8
|
Variant analysis method [Type] |
|
81298-2
|
Structural variant cytogenetic location [Identifier] |
|
81290-9
|
Genomic DNA change (gHGVS) |
|
81286-7
|
Structural variant [Identifier] |
|
81302-2
|
Structural variant inner start and end |
|
81291-7
|
Variant ISCN |
|
81300-6
|
Structural variant [Length] |
|
81301-4
|
Structural variant outer start and end |
|
81299-0
|
Structural variant reported arrCGH [Ratio] |
|
81287-5
|
Structural variant reported start-end [NumRange] |
|
81289-1
|
Structural variant [Type] |
|
5741-4
|
Strychnine [Mass/time] in 24 hour Urine |
|
14102-8
|
Strychnine [Mass/volume] in Blood |
|
20969-2
|
Strychnine [Presence] in Gastric fluid |
|
14101-0
|
Strychnine [Mass/volume] in Gastric fluid |
|
59970-4
|
Strychnine [Moles/volume] in Gastric fluid |
|
5737-2
|
Strychnine [Presence] in Serum or Plasma |
|
17659-4
|
Strychnine [Units/volume] in Serum or Plasma |
|
5738-0
|
Strychnine [Mass/volume] in Serum or Plasma |
|
59968-8
|
Strychnine [Moles/volume] in Serum or Plasma |
|
20972-6
|
Strychnine [Mass/mass] in Tissue |
|
5739-8
|
Strychnine [Presence] in Urine |
|
17660-2
|
Strychnine [Units/volume] in Urine |
|
5740-6
|
Strychnine [Mass/volume] in Urine |
|
59969-6
|
Strychnine [Moles/volume] in Urine |
|
20970-0
|
Strychnine [Presence] in Unspecified specimen |
|
23780-0
|
Strychnine [Mass/volume] in Unspecified specimen |
|
57872-4
|
Strychnine [Moles/volume] in Unspecified specimen |
|
21620-0
|
STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
9875-6
|
ST-T segment [Interpretation] Narrative by EKG |
|
8620-7
|
ST-T segment [Interpretation] by EKG |
|
79869-4
|
Study observation Eyelid and Lashes and Adnexa Slit lamp biomicroscopy |
|
8606-6
|
Study duration by EKG |
|
86371-2
|
Study Interpretation of outside study |
|
79858-7
|
Study observation Left anterior chamber Slit lamp biomicroscopy |
|
79857-9
|
Study observation Right anterior chamber Slit lamp biomicroscopy |
|
79860-3
|
Study observation Left conjunctiva+sclera Slit lamp biomicroscopy |
|
79859-5
|
Study observation Right conjunctiva+sclera Slit lamp biomicroscopy |
|
79862-9
|
Study observation Left cornea Slit lamp biomicroscopy |
|
79861-1
|
Study observation Right cornea Slit lamp biomicroscopy |
|
79864-5
|
Study observation Left iris Slit lamp biomicroscopy |
|
79863-7
|
Study observation Right iris Slit lamp biomicroscopy |
|
79812-4
|
Study observation Left ocular fundus Angiography W indocyanine green IV |
|
79811-6
|
Study observation Right ocular fundus Angiography W indocyanine green IV |
|
79810-8
|
Study observation Left ocular fundus Angiography W fluorescein IV |
|
79809-0
|
Study observation Right ocular fundus Angiography W fluorescein IV |
|
79866-0
|
Study observation Left optic lens Slit lamp biomicroscopy |
|
79865-2
|
Study observation Right optic lens Slit lamp biomicroscopy |
|
79819-9
|
Study observation Left retina by OCT |
|
79818-1
|
Study observation Right retina by OCT |
|
79885-0
|
Study observation Left visual pathway VEP |
|
79884-3
|
Study observation Right visual pathway VEP |
|
79873-6
|
Study observation left vitreous body Slit lamp biomicroscopy |
|
79872-8
|
Study observation Right vitreous body Slit lamp biomicroscopy |
|
47045-0
|
Study report |
|
29756-4
|
Peritoneoscopy study |
|
82788-1
|
Study site identifier Clinical trial protocol |
|
9861-6
|
Style Cardiac pacemaker prosthetic lead by EKG |
|
38618-5
|
Styrene [Mass/volume] in Air |
|
8243-8
|
Styrene [Mass/volume] in Blood |
|
54940-2
|
Styrene [Mass/volume] in Serum or Plasma |
|
29897-6
|
Styrene [Mass/volume] in Urine |
|
38329-9
|
Styrene [Mass/volume] in Water |
|
38725-8
|
Styrene-7,8-Oxide [Mass/volume] in Air |
|
75073-7
|
Suberate [Moles/volume] in Serum or Plasma |
|
26831-8
|
Suberate [Presence] in Urine |
|
49960-8
|
Suberate.unsaturated/Creatinine [Molar ratio] in Urine |
|
44408-3
|
Suberate/Creatinine [Molar ratio] in 24 hour Urine |
|
13810-7
|
Suberate/Creatinine [Mass Ratio] in Urine |
|
25135-5
|
Suberate/Creatinine [Molar ratio] in Urine |
|
69778-9
|
Suberylcarnitine (C8-DC) [Moles/volume] in Amniotic fluid |
|
69777-1
|
Suberylcarnitine (C8-DC) [Moles/volume] in Cerebral spinal fluid |
|
53210-1
|
Suberylcarnitine (C8-DC) [Moles/volume] in DBS |
|
74591-9
|
Suberylcarnitine (C8-DC) [Enzymatic activity/mass] in Fibroblast |
|
18453-1
|
Suberylcarnitine (C8-DC) [Mass/volume] in Serum or Plasma |
|
39014-6
|
Suberylcarnitine (C8-DC) [Moles/volume] in Serum or Plasma |
|
69779-7
|
Suberylcarnitine (C8-DC) [Moles/volume] in Urine |
|
69776-3
|
Suberylcarnitine (C8-DC)/Creatinine [Molar ratio] in Urine |
|
79511-2
|
Suberylglycine [Moles/volume] in Serum or Plasma |
|
30482-4
|
Suberylglycine [Presence] in Urine |
|
13811-5
|
Suberylglycine/Creatinine [Mass Ratio] in Urine |
|
24443-4
|
Suberylglycine/Creatinine [Molar ratio] in Urine |
|
81744-5
|
Submitter's laboratory test method [Type] in Specimen |
|
52038-7
|
Subscriber Information including retroactive and presumptive eligibility |
|
89562-3
|
Substance abuse symptoms score [CUBS] |
|
34630-4
|
Substance P [Mass/volume] in Cerebral spinal fluid |
|
2971-0
|
Substance P [Mass/volume] in Serum or Plasma |
|
58454-0
|
Subtelomere analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81878-1
|
Subtelomere analysis in Blood or Tissue by Molecular genetics method |
|
49039-1
|
Subtelomere analysis [Identifier] in Blood or Tissue by FISH Nominal |
|
49040-9
|
Subtelomere analysis [Interpretation] in Blood or Tissue by FISH Narrative |
|
82258-5
|
Subtelomere analysis in Bone marrow by FISH |
|
72653-9
|
Subtelomere analysis.short arm [Interpretation] in Blood or Tissue by FISH Narrative |
|
72652-1
|
Subtelomere analysis.long arm [Interpretation] in Blood or Tissue by FISH Narrative |
|
74588-5
|
Succinate cytochrome C reductase [Enzymatic activity/mass] in Fibroblast |
|
35498-5
|
Succinate cytochrome C reductase [Enzymatic activity/mass] in Tissue |
|
74587-7
|
Succinate cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
35494-4
|
Succinate dehydrogenase [Enzymatic activity/mass] in Tissue |
|
74589-3
|
Succinate dehydrogenase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
35871-3
|
Succinate [Moles/volume] in Serum or Plasma |
|
26798-9
|
Succinate [Presence] in Urine |
|
2972-8
|
Succinate [Mass/volume] in Urine |
|
44409-1
|
Succinate/Creatinine [Molar ratio] in 24 hour Urine |
|
13812-3
|
Succinate/Creatinine [Mass Ratio] in Urine |
|
25136-3
|
Succinate/Creatinine [Molar ratio] in Urine |
|
38912-2
|
Succinylacetone [Moles/volume] in Amniotic fluid |
|
53231-7
|
Succinylacetone [Moles/volume] in DBS |
|
74301-3
|
Succinylacetone [Moles/volume] in DBS --post therapeutic diet |
|
74957-2
|
Succinylacetone [Moles/volume] in Plasma |
|
75079-4
|
Succinylacetone [Moles/volume] in Serum or Plasma |
|
42677-5
|
Succinylacetone [Molar amount] in DBS |
|
30483-2
|
Succinylacetone [Presence] in Urine |
|
2973-6
|
Succinylacetone [Mass/volume] in Urine |
|
13813-1
|
Succinylacetone/Creatinine [Mass Ratio] in Urine |
|
25137-1
|
Succinylacetone/Creatinine [Molar ratio] in Urine |
|
42682-5
|
Succinyladenosine [Moles/volume] in Cerebral spinal fluid |
|
75145-3
|
Succinyladenosine [Moles/volume] in Serum or Plasma |
|
59214-7
|
Succinyladenosine/Creatinine [Molar ratio] in Urine |
|
11201-1
|
Succinylcholine IgE Ab [Units/volume] in Serum |
|
16039-0
|
Succinylcholine IgE Ab RAST class [Presence] in Serum |
|
48193-7
|
Succinylcholine triggered leukotriene release [Mass/volume] by Leukocytes |
|
17661-0
|
Succinylcholine [Mass/volume] in Serum or Plasma |
|
12429-7
|
Succinylcholine [Mass/volume] in Urine |
|
17662-8
|
Succinylpurines [Presence] in Urine |
|
73143-0
|
Sucralfate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73142-2
|
Sucralfate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14178-8
|
Sucrase [Enzymatic activity/mass] in Tissue |
|
30372-7
|
Sucrase [Enzymatic activity/mass] in Small intestine Tissue |
|
13534-3
|
Sucrose hemolysis [Presence] of Blood |
|
40433-5
|
Sucrose hemolysis of Red Blood Cells from Control |
|
13535-0
|
Sucrose hemolysis of Red Blood Cells |
|
12260-6
|
Sucrose hemolysis [Presence] of Red Blood Cells |
|
81049-9
|
Sucrose intake 24 hour Estimated |
|
81050-7
|
Sucrose intake 24 hour Measured |
|
76134-6
|
Sucrose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
|
40672-8
|
Sucrose [Presence] in Stool |
|
51612-0
|
Sucrose [Presence] in Urine |
|
50916-6
|
Sucrose [Moles/volume] in Urine |
|
2974-4
|
Sucrose [Mass/volume] in Unspecified specimen |
|
74443-3
|
Sucrose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
76132-0
|
Sucrose/Creatinine [Molar ratio] in Urine |
|
88107-8
|
Suctioning frequency |
|
94038-7
|
Substance use disorder question consistency score |
|
94029-6
|
Substance use disorder score |
|
94021-3
|
Substance use disorder screening report |
|
94030-4
|
Substance use disorder severity |
|
11019-7
|
Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
|
32815-3
|
Microscopic observation [Identifier] in Unspecified specimen by Sudan black B stain |
|
10763-1
|
Microscopic observation [Identifier] in Body fluid by Sudan black stain |
|
10813-4
|
Microscopic observation [Identifier] in Tissue by Sudan black stain |
|
7376-7
|
Sudan grass IgE Ab [Units/volume] in Serum |
|
15754-5
|
Sudan grass IgE Ab RAST class [Presence] in Serum |
|
77709-4
|
Sudden off period indicator in the past week [UPDRS] |
|
9395-5
|
SUFentanil [Mass/volume] in Serum or Plasma |
|
18435-8
|
SUFentanil [Presence] in Urine |
|
9396-3
|
SUFentanil [Mass/volume] in Urine |
|
86610-3
|
SUFentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
88094-8
|
Sufficiency of procedures performed by bystander |
|
7147-2
|
Sugar Beet IgE Ab [Units/volume] in Serum |
|
53258-0
|
Sugar Beet IgE Ab RAST class [Presence] in Serum |
|
24165-3
|
Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Units/volume] in Serum |
|
15574-7
|
Sugar Beet Seed (Beta vulgaris seed) IgE Ab RAST class [Presence] in Serum |
|
7723-0
|
Sugar Cane IgE Ab [Units/volume] in Serum |
|
16040-8
|
Sugar Cane IgE Ab RAST class [Presence] in Serum |
|
7724-8
|
Sugar Cane IgG Ab [Units/volume] in Serum |
|
21543-4
|
Sugar Cane IgG Ab RAST class [Presence] in Serum |
|
56394-0
|
Sugar Cane IgG4 Ab [Mass/volume] in Serum |
|
35531-3
|
Sugar Cane IgG Ab [Mass/volume] in Serum |
|
50016-5
|
Sugar [Type] of Dose |
|
74448-2
|
Sugars and polyols pattern [Interpretation] in Urine |
|
77050-3
|
SUGCT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77049-5
|
SUGCT gene full mutation analysis in Blood or Tissue by Sequencing |
|
94037-9
|
Suicidal ideation |
|
94034-6
|
Suicidal intent |
|
94035-3
|
Suicide plan |
|
87626-8
|
Suicide prevention note |
|
94036-1
|
Suicide risk factor |
|
93374-7
|
Suicide risk level |
|
89560-7
|
Suicide risk score [CUBS] |
|
4429-7
|
Sulbactam [Mass] of Dose |
|
41717-0
|
Sulbactam [Susceptibility] by Gradient strip |
|
41716-2
|
Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
41718-8
|
Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41739-4
|
Sulbactam [Susceptibility] |
|
10767-2
|
Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |
|
87804-1
|
Sulfachloropyridazine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87802-5
|
Sulfachloropyridazine [Susceptibility] |
|
59742-7
|
sulfADIAZINE [Mass/volume] in Blood |
|
4430-5
|
sulfADIAZINE [Mass] of Dose |
|
17663-6
|
sulfADIAZINE IgE Ab [Units/volume] in Serum |
|
7050-8
|
sulfADIAZINE [Susceptibility] by Gradient strip |
|
465-5
|
sulfADIAZINE [Susceptibility] by Disk diffusion (KB) |
|
464-8
|
sulfADIAZINE [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
463-0
|
sulfADIAZINE [Susceptibility] by Minimum lethal concentration (MLC) |
|
6907-0
|
sulfADIAZINE [Mass/volume] in Serum or Plasma |
|
18984-5
|
sulfADIAZINE [Susceptibility] |
|
466-3
|
sulfADIAZINE [Susceptibility] by Serum bactericidal titer |
|
27216-1
|
sulfADIAZINE [Mass/volume] in Urine |
|
87799-3
|
Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87803-3
|
Sulfadimethoxine [Susceptibility] |
|
17664-4
|
Sulfalazine IgE Ab [Units/volume] in Serum |
|
17665-1
|
Sulfamedraxozole IgE Ab [Units/volume] in Serum |
|
87592-2
|
Sulfamethazine [Mass/mass] in Unspecified specimen |
|
60175-7
|
Sulfamethizole [Mass/volume] in Blood |
|
60176-5
|
Sulfamethizole [Mass/volume] in Serum or Plasma |
|
60177-3
|
Sulfamethizole [Mass/volume] in Urine |
|
72948-3
|
Sulfamethoxazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72947-5
|
Sulfamethoxazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80549-9
|
Sulfamethoxazole [Mass/volume] in DBS |
|
4431-3
|
Sulfamethoxazole [Mass] of Dose |
|
80974-9
|
Sulfamethoxazole free [Mass/volume] in Serum or Plasma |
|
59972-0
|
Sulfamethoxazole [Moles/volume] in Gastric fluid |
|
40694-2
|
Sulfamethoxazole IgE Ab [Presence] in Serum |
|
50031-4
|
Sulfamethoxazole IgE Ab [Units/volume] in Serum |
|
21544-2
|
Sulfamethoxazole IgE Ab RAST class [Presence] in Serum |
|
73140-6
|
Sulfamethoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73141-4
|
Sulfamethoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
11577-4
|
Sulfamethoxazole [Susceptibility] by Gradient strip |
|
469-7
|
Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
|
468-9
|
Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
467-1
|
Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
48281-0
|
Sulfamethoxazole triggered leukotriene release [Mass/volume] by Leukocytes |
|
10342-4
|
Sulfamethoxazole [Mass/volume] in Serum or Plasma |
|
39772-9
|
Sulfamethoxazole [Moles/volume] in Serum or Plasma |
|
18985-2
|
Sulfamethoxazole [Susceptibility] |
|
470-5
|
Sulfamethoxazole [Susceptibility] by Serum bactericidal titer |
|
72674-5
|
Sulfamethoxazole [Mass/volume] in Serum or Plasma --trough |
|
59971-2
|
Sulfamethoxazole [Moles/volume] in Urine |
|
25271-8
|
Sulfamethoxazole [Mass/volume] in Unspecified specimen |
|
60333-2
|
Sulfamethoxazole [Moles/volume] in Unspecified specimen |
|
14075-6
|
Sulfapyridine [Mass/volume] in Serum or Plasma |
|
55580-5
|
Sulfapyridine [Moles/volume] in Serum or Plasma |
|
73139-8
|
sulfaSALAzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73138-0
|
sulfaSALAzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12390-1
|
sulfaSALAzine [Mass/volume] in Serum or Plasma |
|
55581-3
|
sulfaSALAzine [Moles/volume] in Serum or Plasma |
|
43754-1
|
Sulfate [Mass/volume] in Urine collected for unspecified duration |
|
12920-5
|
Sulfate [Mass/volume] in 24 hour Urine |
|
39576-4
|
Sulfate [Mass/time] in 24 hour Urine |
|
26888-8
|
Sulfate [Moles/volume] in 24 hour Urine |
|
26889-6
|
Sulfate [Moles/time] in 24 hour Urine |
|
17666-9
|
Sulfate [Mass/volume] in Dialysis fluid |
|
20973-4
|
Sulfate [Mass/volume] in Gastric fluid |
|
81948-2
|
Sulfate intake 24 hour Estimated |
|
81947-4
|
Sulfate intake 24 hour Measured |
|
17667-7
|
Sulfate.organic/Sulfate.total in Urine |
|
20974-2
|
Sulfate [Mass/volume] in Serum or Plasma |
|
2975-1
|
Sulfate [Mass/volume] in Urine |
|
47780-2
|
Sulfate [Moles/volume] in Urine |
|
9486-2
|
Sulfate [Mass/volume] in Water |
|
87615-1
|
Sulfate [Mass/mass] in Unspecified specimen |
|
87796-9
|
Sulfathiazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87797-7
|
Sulfathiazole [Susceptibility] |
|
87591-4
|
Sulfathiazole [Mass/mass] in Unspecified specimen |
|
34689-0
|
Sulfatidase [Enzymatic activity/volume] in Leukocytes |
|
31667-9
|
Sulfatide Ab [Presence] in Serum |
|
82445-8
|
Sulfatide Ab [Presence] in Serum by Line blot |
|
31668-7
|
Sulfatide Ab [Units/volume] in Serum |
|
17669-3
|
Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay |
|
17668-5
|
Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
31670-3
|
Sulfatide IgG Ab [Presence] in Serum |
|
27894-5
|
Sulfatide IgG Ab [Presence] in Serum by Immunoassay |
|
89500-3
|
Sulfatide IgG Ab [Presence] in Serum by Line blot |
|
31669-5
|
Sulfatide IgG Ab [Units/volume] in Serum |
|
21545-9
|
Sulfatide IgG Ab [Titer] in Cerebral spinal fluid |
|
10866-2
|
Sulfatide IgG Ab [Titer] in Serum |
|
17671-9
|
Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay |
|
17670-1
|
Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
44753-2
|
Sulfatide IgM Ab [Presence] in Serum |
|
82447-4
|
Sulfatide IgM Ab [Presence] in Serum by Line blot |
|
31671-1
|
Sulfatide IgM Ab [Units/volume] in Serum |
|
21546-7
|
Sulfatide IgM Ab [Titer] in Cerebral spinal fluid |
|
10867-0
|
Sulfatide IgM Ab [Titer] in Serum |
|
34646-0
|
Sulfatides [Presence] in Urine |
|
58682-6
|
Sulfatides [Mass/volume] in Urine |
|
4684-7
|
Sulfhemoglobin [Presence] in Blood |
|
4683-9
|
Sulfhemoglobin [Mass/volume] in Blood |
|
4685-4
|
Sulfhemoglobin/Hemoglobin.total in Blood |
|
9350-0
|
Sulfhydryls [Presence] in Urine |
|
9646-1
|
Sulfide [Mass/volume] in Blood |
|
17672-7
|
Sulfide [Mass/volume] in Urine |
|
25226-2
|
Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4432-1
|
Sulfisoxazole [Mass] of Dose |
|
17673-5
|
Sulfisoxazole IgE Ab [Units/volume] in Serum |
|
73137-2
|
Sulfisoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73136-4
|
Sulfisoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
11578-2
|
Sulfisoxazole [Susceptibility] by Gradient strip |
|
473-9
|
Sulfisoxazole [Susceptibility] by Disk diffusion (KB) |
|
472-1
|
Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
471-3
|
Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
9701-4
|
Sulfisoxazole [Mass/volume] in Serum or Plasma |
|
18986-0
|
Sulfisoxazole [Susceptibility] |
|
474-7
|
Sulfisoxazole [Susceptibility] by Serum bactericidal titer |
|
2977-7
|
Sulfite oxidase [Enzymatic activity/volume] in Plasma |
|
58457-3
|
Sulfites [Presence] in Urine by Test strip |
|
47781-0
|
Sulfocysteine [Moles/volume] in Amniotic fluid |
|
54336-3
|
Sulfocysteine [Moles/volume] in Cerebral spinal fluid |
|
54337-1
|
Sulfocysteine [Moles/volume] in DBS |
|
47939-4
|
Sulfocysteine [Moles/volume] in Serum or Plasma |
|
34168-5
|
Sulfocysteine/Creatinine [Ratio] in Urine |
|
33876-4
|
Sulfocysteine/Creatinine [Molar ratio] in Urine |
|
53118-6
|
Sulfonamide crystals [#/area] in Urine sediment by Microscopy high power field |
|
40836-9
|
Sulfonamide crystals [#/area] in Urine sediment by Microscopy low power field |
|
33237-9
|
Sulfonamide crystals [Presence] in Urine by Computer assisted method |
|
5812-3
|
Sulfonamide crystals [Presence] in Urine sediment by Light microscopy |
|
4433-9
|
Sulfonamide [Mass] of Dose |
|
35842-4
|
Sulfonamide [Susceptibility] by Gradient strip |
|
477-0
|
Sulfonamide [Susceptibility] by Disk diffusion (KB) |
|
476-2
|
Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
475-4
|
Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC) |
|
4041-0
|
Sulfonamide [Presence] in Serum or Blood |
|
17674-3
|
Sulfonamide [Units/volume] in Serum or Plasma |
|
4040-2
|
Sulfonamide [Mass/volume] in Serum or Plasma |
|
75650-2
|
Sulfonamide [Moles/volume] in Serum or Plasma |
|
18987-8
|
Sulfonamide [Susceptibility] |
|
478-8
|
Sulfonamide [Susceptibility] by Serum bactericidal titer |
|
17675-0
|
Sulfonamide [Units/volume] in Urine |
|
4042-8
|
Sulfonamide [Mass/volume] in Urine |
|
15374-2
|
Sulfonylurea [Presence] in Serum or Plasma |
|
18255-0
|
Sulfonylurea [Mass/volume] in Serum or Plasma |
|
47391-8
|
Sulfonylurea [Presence] in Urine |
|
18256-8
|
Sulfonylurea [Mass/volume] in Urine |
|
15368-4
|
Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma |
|
34633-8
|
Hypoglycemics.sulfonyluric [Identifier] in Urine |
|
35116-3
|
Sulforidazine [Mass/volume] in Serum or Plasma |
|
87449-5
|
Sulfur [Mass/volume] in Unspecified specimen |
|
87450-3
|
Sulfur [Mass/mass] in Unspecified specimen |
|
73135-6
|
Sulindac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73134-9
|
Sulindac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17676-8
|
Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma |
|
12417-2
|
Sulindac [Mass/volume] in Serum or Plasma |
|
55291-9
|
Sulopenem [Susceptibility] by Disk diffusion (KB) |
|
55290-1
|
Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55289-3
|
Sulopenem [Susceptibility] |
|
57315-4
|
Sulphonamide IgE Ab [Units/volume] in Serum |
|
35117-1
|
Sulpiride [Mass/volume] in Serum or Plasma |
|
74915-0
|
Sulpiride [Mass/volume] in Serum or Plasma --trough |
|
33961-4
|
Sulthiame [Mass/volume] in Serum or Plasma |
|
34377-2
|
Sulthiame [Moles/volume] in Serum or Plasma |
|
59743-5
|
SUMAtriptan [Mass/volume] in Blood |
|
28076-8
|
SUMAtriptan [Mass/volume] in Serum or Plasma |
|
59744-3
|
SUMAtriptan [Mass/volume] in Urine |
|
89997-1
|
SUMF1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
68608-9
|
Summary note |
|
47046-8
|
Summary of death note |
|
34133-9
|
Summary of episode note |
|
75219-6
|
Summary registry report |
|
7714-9
|
Summer Squash IgE Ab [Units/volume] in Serum |
|
21539-2
|
Summer Squash IgE Ab RAST class [Presence] in Serum |
|
7715-6
|
Summer Squash IgG Ab [Units/volume] in Serum |
|
7726-3
|
Sunflower Pollen IgE Ab [Units/volume] in Serum |
|
16041-6
|
Sunflower Pollen IgE Ab RAST class [Presence] in Serum |
|
63195-2
|
Sunflower Pollen IgG Ab [Mass/volume] in Serum |
|
7727-1
|
Sunflower Seed triggered histamine release [Units/volume] in Blood |
|
6258-8
|
Sunflower Seed IgE Ab [Units/volume] in Serum |
|
16042-4
|
Sunflower Seed IgE Ab RAST class [Presence] in Serum |
|
61272-1
|
Sunflower Seed IgE Ab/IgE total in Serum |
|
21547-5
|
Sunflower Seed IgG Ab RAST class [Presence] in Serum |
|
56395-7
|
Sunflower Seed IgG4 Ab [Mass/volume] in Serum |
|
60407-4
|
Sunflower Seed IgG Ab [Mass/volume] in Serum |
|
48192-9
|
Sunset yellow FCF triggered leukotriene release [Mass/volume] by Leukocytes |
|
85316-8
|
Extent of superior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy |
|
92032-2
|
Supervisor phone number |
|
69427-3
|
Supervisor review of results |
|
87707-6
|
Job supervisory level or pay grade |
|
47047-6
|
Supervisory note |
|
74046-4
|
Supplemental information about periodontal condition |
|
91909-2
|
Expiration date of Supply |
|
91903-5
|
Supply identifier |
|
91902-7
|
Supply item [Type] |
|
92196-5
|
Supply owner [Identifier] Supply |
|
91908-4
|
Supply stockpile [#] Supply |
|
91907-6
|
Storage location of Supply |
|
32987-0
|
Support {Dental arch}.denture.complete Observed |
|
32989-6
|
Support {Dental arch}.denture.complete - Reported |
|
32988-8
|
Support {Dental arch}.denture.partial Observed |
|
32990-4
|
Support {Dental arch}.denture.partial - Reported |
|
52061-9
|
Support surface attachment |
|
43750-9
|
SURF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54753-9
|
Surface-to-surface transfer in last 7 days [CMS Assessment] |
|
80902-0
|
Type of surfactant replacement given |
|
30562-3
|
Surfactant/Albumin [Mass Ratio] in Amniotic fluid |
|
83670-0
|
Surgery Attending Admission evaluation note |
|
68480-3
|
Surgery Attending Hospital Progress note |
|
83671-8
|
Surgery Attending Intensive care unit Admission evaluation note |
|
83672-6
|
Surgery Attending Intensive care unit Note |
|
34773-2
|
Surgery Attending Note |
|
83674-2
|
Surgery Attending Outpatient Note |
|
83673-4
|
Surgery Attending Surgical operation note |
|
83675-9
|
Surgery Attending Postoperative evaluation and management note |
|
85948-8
|
Surgery Attending Preoperative evaluation and management note |
|
83843-3
|
Surgery Case manager Note |
|
76467-0
|
Surgical history relevant to physical therapy treatment |
|
83842-5
|
Surgery Interdisciplinary Note |
|
83792-2
|
Surgery Intern Admission evaluation note |
|
33736-0
|
Surgical margin tumor involvement.circumferential by CAP cancer protocols |
|
33754-3
|
Surgical margin tumor involvement.deep in Specimen by CAP cancer protocols Narrative |
|
33735-2
|
Surgical margin tumor involvement.distant by CAP cancer protocols |
|
33751-9
|
Surgical margin tumor involvement.lateral in Specimen by CAP cancer protocols |
|
33760-0
|
Surgical margin tumor involvement.mucosal in Specimen by CAP cancer protocols |
|
33734-5
|
Surgical margin tumor involvement.proximal by CAP cancer protocols |
|
64066-4
|
Surgery Medical student Hospital Admission evaluation note |
|
64068-0
|
Surgery Medical student Hospital Consult note |
|
64067-2
|
Surgery Medical student Hospital Progress note |
|
83562-9
|
Surgery Nurse practitioner Note |
|
80799-0
|
Surgical oncology Admission history and physical note |
|
80800-6
|
Surgical oncology Checklist |
|
80801-4
|
Surgical oncology Consult note |
|
80802-2
|
Surgical oncology Education note |
|
80803-0
|
Surgical oncology Flowsheet |
|
82839-2
|
Surgical oncology Initial evaluation note |
|
80807-1
|
Surgical oncology Surgical operation note |
|
80804-8
|
Surgical oncology Plan of care note |
|
80805-5
|
Surgical oncology Preoperative evaluation and management note |
|
80806-3
|
Surgical oncology Referral note |
|
80808-9
|
Surgical oncology Transfer summary note |
|
83778-1
|
Surgery Resident Admission evaluation note |
|
83779-9
|
Surgery Resident Note |
|
44952-0
|
Surgeon primary NPI [Identifier] Provider |
|
34873-0
|
Surgery Admission evaluation note |
|
78247-4
|
Surgery Admission history and physical note |
|
78503-0
|
Surgery Checklist |
|
34847-4
|
Surgery Consult note |
|
85898-5
|
Surgery Diagnostic study note |
|
84017-3
|
Surgery Discharge summary |
|
78280-5
|
Surgery Education note |
|
78292-0
|
Surgery Flowsheet |
|
34774-0
|
Surgery History and physical note |
|
68606-3
|
Surgery Hospital Postoperative evaluation and management note |
|
64057-3
|
Surgery Hospital Progress note |
|
84012-4
|
Surgery Intensive care unit Admission evaluation note |
|
84013-2
|
Surgery Intensive care unit Discharge summary |
|
84014-0
|
Surgery Intensive care unit Note |
|
84015-7
|
Surgery Intensive care unit procedure note |
|
84016-5
|
Surgery Intensive care unit Transfer summary note |
|
34848-2
|
Surgery Note |
|
83612-2
|
Surgery Nurse Hospital Note |
|
83613-0
|
Surgery Nurse Note |
|
83615-5
|
Surgery Nurse Outpatient Note |
|
85947-0
|
Surgery Nurse Outpatient Preoperative evaluation and management note |
|
83616-3
|
Surgery Nurse Outpatient procedure note |
|
83614-8
|
Surgery Nurse Surgical operation note |
|
34880-5
|
Surgery Nurse Postoperative evaluation and management note |
|
34881-3
|
Surgery Nurse Preoperative evaluation and management note |
|
83617-1
|
Surgery Nurse procedure note |
|
84018-1
|
Surgery Outpatient Discharge summary |
|
84019-9
|
Surgery Outpatient History and physical note |
|
75493-7
|
Surgery Outpatient Note |
|
84020-7
|
Surgery Outpatient Surgical operation note |
|
85945-4
|
Surgery Outpatient Postoperative evaluation and management note |
|
85946-2
|
Surgery Outpatient Preoperative evaluation and management note |
|
84021-5
|
Surgery Outpatient procedure note |
|
34874-8
|
Surgery Surgical operation note |
|
88652-3
|
Surgery Parenteral therapy note |
|
84022-3
|
Surgery Telephone encounter Note |
|
80753-7
|
Surgery Plan of care note |
|
34875-5
|
Surgery Postoperative evaluation and management note |
|
34876-3
|
Surgery Preoperative evaluation and management note |
|
78322-5
|
Surgery procedure note |
|
57166-1
|
Surgery Referral note |
|
78729-1
|
Surgery Transfer summary note |
|
78446-2
|
Surgical critical care Flowsheet |
|
80790-9
|
Surgical critical care Plan of care note |
|
42781-5
|
Surgical operation date Cancer |
|
11529-5
|
Surgical pathology study |
|
81166-1
|
Surgical resection Stomach cancer |
|
57235-4
|
Surgical wound [CMS Assessment] |
|
77283-0
|
Survival rate [NMMDS] |
|
19156-9
|
Susceptibility method [Identifier] in Unspecified specimen |
|
81658-7
|
Suspected organism [Identifier] in Unspecified specimen |
|
73778-3
|
Suspected chromosomal disorder karyotype status [US Standard Certificate of Live Birth] |
|
10814-2
|
Microscopic observation [Identifier] in Tissue by Supravital stain |
|
17413-6
|
Papova virus SV 40 Ab [Units/volume] in Serum |
|
49418-7
|
Papova virus SV 40 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49422-9
|
Papova virus SV 40 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49421-1
|
Papova virus SV 40 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49420-3
|
Papova virus SV 40 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49424-5
|
Papova virus SV 40 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49426-0
|
Papova virus SV 40 DNA [#/volume] (viral load) in Stool by NAA with probe detection |
|
49419-5
|
Papova virus SV 40 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49423-7
|
Papova virus SV 40 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49425-2
|
Papova virus SV 40 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
87346-3
|
Senecavirus A Ab [Titer] in Serum by Immunofluorescence |
|
87347-1
|
Senecavirus A IgG Ab/Positive control in Serum by Immunoassay |
|
87351-3
|
Senecavirus A RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
87350-5
|
Senecavirus A RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87348-9
|
Senecavirus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87349-7
|
Senecavirus A VP1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
87352-1
|
Senecavirus A whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
87345-5
|
Senecavirus A [Presence] in Unspecified specimen by Organism specific culture |
|
18007-5
|
Superior vena cava Diameter by US |
|
23441-9
|
Swine vesicular disease virus Ab [Presence] in Serum |
|
23442-7
|
Swine vesicular disease virus Ab [Presence] in Serum by Immunoassay |
|
23443-5
|
Swine vesicular disease virus Ab [Presence] in Serum by Immunoelectrophoresis |
|
23440-1
|
Swine vesicular disease virus Ab [Presence] in Serum by Neutralization test |
|
31972-3
|
Swine vesicular disease virus Ag [Presence] in Skin |
|
23445-0
|
Swine vesicular disease virus Ag [Presence] in Skin by Complement fixation |
|
23447-6
|
Swine vesicular disease virus Ag [Presence] in Skin by Immunoassay |
|
31973-1
|
Swine vesicular disease virus Ag [Presence] in Unspecified specimen |
|
23446-8
|
Swine vesicular disease virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23444-3
|
Swine vesicular disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23448-4
|
Swine vesicular disease virus RNA [Presence] in Tissue by NAA with probe detection |
|
90751-9
|
Social worker Adult day care center Note |
|
83954-8
|
Social worker Admission evaluation note |
|
83955-5
|
Social worker Annual evaluation note |
|
80672-9
|
Social worker Conference note |
|
34841-7
|
Social worker Consult note |
|
34872-2
|
Social worker Counseling note |
|
83957-1
|
Social worker Custodial care facility Note |
|
83956-3
|
Social worker Discharge summary |
|
83958-9
|
Social worker Emergency department Note |
|
78607-9
|
Social worker Education note |
|
34843-3
|
Social worker Group counseling note |
|
83959-7
|
Social worker History and physical note |
|
83965-4
|
Social worker Hospital Note |
|
18739-3
|
Social worker Initial evaluation note |
|
83967-0
|
Social worker Long term care facility Consult note |
|
83968-8
|
Social worker Long term care facility Discharge summary |
|
83969-6
|
Social worker Long term care facility Initial evaluation note |
|
83970-4
|
Social worker Long term care facility Note |
|
83971-2
|
Social worker Long term care facility Referral note |
|
83972-0
|
Social worker Long term care facility Respite note |
|
83973-8
|
Social worker Long term care facility Risk assessment and screening note |
|
28653-4
|
Social worker Note |
|
83975-3
|
Social worker Outpatient Group counseling note |
|
83976-1
|
Social worker Outpatient Note |
|
83977-9
|
Social worker Outreach note |
|
34844-1
|
Social worker Telephone encounter Note |
|
80788-3
|
Social worker Plan of care note |
|
28656-7
|
Social worker Progress note |
|
83960-5
|
Social worker Patient's home Consult note |
|
83961-3
|
Social worker Patient's home Discharge summary |
|
83962-1
|
Social worker Patient's home Initial evaluation note |
|
83963-9
|
Social worker Patient's home Note |
|
83964-7
|
Social worker Patient's home Referral note |
|
57164-6
|
Social worker Referral note |
|
83978-7
|
Social worker Respite note |
|
83979-5
|
Social worker Risk assessment and screening note |
|
65335-2
|
Sw sup(a) Ab [Presence] in Serum or Plasma |
|
91531-4
|
Social worker Telehealth Note |
|
83981-1
|
Social worker Transfer summary note |
|
83982-9
|
Social worker Transplant candidate evaluation note |
|
7377-5
|
Sweet Vernal grass triggered histamine release [Units/volume] in Blood |
|
6261-2
|
Sweet Vernal grass IgE Ab [Units/volume] in Serum |
|
15755-2
|
Sweet Vernal grass IgE Ab RAST class [Presence] in Serum |
|
61217-6
|
Sweet Vernal grass IgE Ab/IgE total in Serum |
|
56398-1
|
Sweet Vernal grass IgG4 Ab [Mass/volume] in Serum |
|
82942-4
|
Swallowing [ALSFRS-R] |
|
77692-2
|
Swallowing scale [UPDRS] |
|
85846-4
|
Swallowing status [CMS Assessment] |
|
30163-0
|
Sweat Bee IgE Ab [Units/volume] in Serum |
|
21206-8
|
Sweet Clover IgE Ab [Units/volume] in Serum |
|
6260-4
|
Sweet gum IgE Ab [Units/volume] in Serum |
|
15761-0
|
Sweet gum IgE Ab RAST class [Presence] in Serum |
|
49916-0
|
Sweet gum IgE Ab/IgE total in Serum |
|
7629-9
|
Sweet potato triggered histamine release [Units/volume] in Blood |
|
7627-3
|
Sweet potato IgE Ab [Units/volume] in Serum |
|
15958-2
|
Sweet potato IgE Ab RAST class [Presence] in Serum |
|
57987-0
|
Sweet potato IgE Ab/IgE total in Serum |
|
7628-1
|
Sweet potato IgG Ab [Units/volume] in Serum |
|
21548-3
|
Sweet potato IgG Ab RAST class [Presence] in Serum |
|
56397-3
|
Sweet potato IgG4 Ab [Mass/volume] in Serum |
|
60396-9
|
Sweet potato IgG Ab [Mass/volume] in Serum |
|
86479-3
|
Swelling in your feet, ankles or legs when you woke up over the past 2 weeks [KCCQ] |
|
93816-7
|
Swimming distance unspecified time |
|
7409-6
|
Swine triggered histamine release [Units/volume] in Blood |
|
6262-0
|
Swine epithelium IgE Ab [Units/volume] in Serum |
|
16043-2
|
Swine epithelium IgE Ab RAST class [Presence] in Serum |
|
7410-4
|
Swine epithelium IgG Ab [Units/volume] in Serum |
|
19759-0
|
Swine serum albumin IgE Ab [Units/volume] in Serum |
|
25532-3
|
Swine serum albumin IgE Ab RAST class [Presence] in Serum |
|
10952-0
|
Swine urine proteins IgE Ab [Units/volume] in Serum |
|
16044-0
|
Swine urine proteins IgE Ab RAST class [Presence] in Serum |
|
58107-4
|
Swing bed clinical change assessment [CMS Assessment] |
|
7215-7
|
Swiss Cheese IgE Ab [Units/volume] in Serum |
|
15627-3
|
Swiss Cheese IgE Ab RAST class [Presence] in Serum |
|
7216-5
|
Swiss Cheese IgG Ab [Units/volume] in Serum |
|
56399-9
|
Swiss Cheese IgG4 Ab [Mass/volume] in Serum |
|
63103-6
|
Swiss Cheese IgG Ab [Mass/volume] in Serum |
|
88984-0
|
Swollen joint |
|
88980-8
|
Swollen joint # |
|
7728-9
|
Swordfish IgE Ab [Units/volume] in Serum |
|
16045-7
|
Swordfish IgE Ab RAST class [Presence] in Serum |
|
7729-7
|
Swordfish IgG Ab [Units/volume] in Serum |
|
56466-6
|
Swordfish IgG4 Ab [Mass/volume] in Serum |
|
88873-5
|
Sympathomimetics [Presence] in Serum, Plasma or Blood by Confirmatory method |
|
12369-5
|
Sympathomimetics [Identifier] in Urine |
|
29656-6
|
Sympathomimetics [Presence] in Urine |
|
45272-2
|
Sympathomimetics [Presence] in Urine by Confirmatory method |
|
27993-5
|
Sympathomimetics [Mass/volume] in Urine |
|
75325-1
|
Symptom |
|
72192-8
|
Symptom burden score [KCCQ] |
|
85920-7
|
Symptom control rating [CMS Assessment] |
|
94068-4
|
Symptom distress level |
|
75317-8
|
Symptom Family member |
|
72193-6
|
Symptom frequency score [KCCQ] |
|
88471-8
|
Symptom frequency score [SAQ] |
|
80891-5
|
Symptom score [AUASI] |
|
72194-4
|
Symptom stability score [KCCQ] |
|
47244-9
|
Symptom, diagnosis, or opportunistic infection related to HIV treatment |
|
77713-6
|
Symptomatic orthostasis indicator in the past week [UPDRS] |
|
33486-2
|
Patient symptoms [Interpretation] --1.5 hours post dose lactose PO |
|
49234-8
|
Patient symptoms [Interpretation] Narrative--1.5 hours post dose lactose PO |
|
33485-4
|
Patient symptoms [Interpretation] --1 hour post dose lactose PO |
|
49235-5
|
Patient symptoms [Interpretation] Narrative--1 hour post dose lactose PO |
|
33488-8
|
Patient symptoms [Interpretation] --2.5 hours post dose lactose PO |
|
49236-3
|
Patient symptoms [Interpretation] Narrative--2.5 hours post dose lactose PO |
|
33487-0
|
Patient symptoms [Interpretation] --2 hours post dose lactose PO |
|
49237-1
|
Patient symptoms [Interpretation] Narrative--2 hours post dose lactose PO |
|
33484-7
|
Patient symptoms [Interpretation] --30 minutes post dose lactose PO |
|
49238-9
|
Patient symptoms [Interpretation] Narrative--30 minutes post dose lactose PO |
|
35136-1
|
Patient symptoms [Interpretation] --3 hours post dose lactose PO |
|
49239-7
|
Patient symptoms [Interpretation] Narrative--3 hours post dose lactose PO |
|
57239-6
|
Symptoms in heart failure patients [CMS Assessment] |
|
91012-5
|
Population Symptoms related to incident or outbreak |
|
50405-0
|
Patient symptoms [Interpretation] Narrative--after transfusion reaction |
|
33483-9
|
Patient symptoms [Interpretation] --pre dose lactose PO |
|
49240-5
|
Patient symptoms [Interpretation] Narrative--pre dose lactose PO |
|
88108-6
|
Symptoms present for at least 24 hours - Reported |
|
72096-1
|
Symptoms score [HOOS] |
|
72101-9
|
Symptoms score [KOOS] |
|
79434-7
|
Symptoms score change [HOOS] |
|
79439-6
|
Symptoms score change [KOOS] |
|
10514-8
|
Synaptophysin Ag [Presence] in Tissue by Immune stain |
|
84877-0
|
Synchronous tumor site Cancer |
|
13357-9
|
Synovial cells [Units/volume] in Body fluid |
|
35651-9
|
Synovial lining cells/100 cells in Synovial fluid |
|
21550-9
|
Synovial lining cells [Presence] in Synovial fluid by Light microscopy |
|
48072-3
|
Synthetic glucocorticoid drug [Mass/volume] in Unknown substance |
|
83319-4
|
Syphilis neurological involvement |
|
75197-4
|
Syphilis treatment was given and treatment description [CDC.CS] |
|
76318-5
|
Syringe Manufacturer name |
|
76315-1
|
Syringe Volume.actual |
|
12144-2
|
Systolic flow/Diastolic flow US.doppler |
|
76322-7
|
Systolic time ratio |
|
20252-3
|
Maximum systole/Systole 2 maximum by US.doppler |
|
20260-6
|
Mean sytole/Systole 2 mean by US.doppler calculated |
|
79760-5
|
Systemic findings and diseases associated with ophthalmological condition |
|
23459-1
|
Theileria annulata Ab [Presence] in Serum |
|
23460-9
|
Theileria annulata Ab [Presence] in Serum by Immunofluorescence |
|
31680-2
|
Theileria annulata Ab [Units/volume] in Serum |
|
23461-7
|
Theileria annulata Ab [Titer] in Serum |
|
23462-5
|
Theileria annulata Ab [Titer] in Serum by Immunofluorescence |
|
23463-3
|
Theileria annulata rRNA [Presence] in Serum by Probe |
|
5397-5
|
Trypanosoma brucei Ab [Units/volume] in Serum |
|
42947-2
|
Trypanosoma brucei Ab [Titer] in Serum |
|
34383-0
|
Trypanosoma brucei Ab [Titer] in Serum by Immunofluorescence |
|
23507-7
|
Trypanosoma brucei DNA [Presence] in Blood by NAA with probe detection |
|
26617-1
|
Trypanosoma brucei gambiense Ab [Presence] in Serum |
|
41427-6
|
Trypanosoma brucei gambiense Ab [Presence] in Serum by Agglutination |
|
26618-9
|
Trypanosoma brucei rhodesiense Ab [Presence] in Serum |
|
42946-4
|
Trypanosoma brucei rhodesiense Ab [Titer] in Serum |
|
41428-4
|
Trypanosoma brucei rhodesiense Ab [Titer] in Serum by Immunofluorescence |
|
42532-2
|
Thermoactinomyces candidus Ab [Presence] in Cerebral spinal fluid |
|
21560-8
|
Thermoactinomyces candidus Ab [Presence] in Serum |
|
5376-9
|
Thermoactinomyces candidus Ab [Units/volume] in Serum |
|
17715-4
|
Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
13274-6
|
Toxocara canis Ab [Units/volume] in Cerebral spinal fluid |
|
60470-2
|
Toxocara canis Ab [Units/volume] in Body fluid |
|
5386-8
|
Toxocara canis Ab [Units/volume] in Serum by Immunoassay |
|
8038-2
|
Toxocara canis Ab [Units/volume] in Serum |
|
42950-6
|
Toxocara canis Ab [Titer] in Unspecified specimen |
|
41425-0
|
Toxocara canis Ab [Titer] in Unspecified specimen by Immunoassay |
|
49861-8
|
Toxocara canis Ab [Units/volume] in Unspecified specimen by Immunoassay |
|
53386-9
|
Toxocara canis Ab [Units/volume] in Unspecified specimen |
|
9717-0
|
Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay |
|
24028-3
|
Toxocara canis IgA Ab [Presence] in Serum |
|
13276-1
|
Toxocara canis IgA Ab [Units/volume] in Serum |
|
53585-6
|
Toxocara canis IgE Ab [Units/volume] in Serum |
|
9718-8
|
Toxocara canis IgG Ab [Units/volume] in Serum by Immunoassay |
|
24029-1
|
Toxocara canis IgG Ab [Presence] in Serum |
|
40674-4
|
Toxocara canis IgG Ab [Presence] in Serum by Immunoassay |
|
22575-5
|
Toxocara canis IgG Ab [Units/volume] in Serum |
|
9719-6
|
Toxocara canis IgM Ab [Units/volume] in Serum by Immunoassay |
|
24030-9
|
Toxocara canis IgM Ab [Presence] in Serum |
|
40675-1
|
Toxocara canis IgM Ab [Presence] in Serum by Immunoassay |
|
13275-3
|
Toxocara canis IgM Ab [Units/volume] in Serum |
|
45229-2
|
Toxocara cati Ab [Presence] in Serum |
|
10448-9
|
T-cell Ag [Presence] in Tissue by Immune stain |
|
48409-7
|
T cell crossmatch [Presence] in Blood from Donor |
|
46720-9
|
T cell crossmatch [Presence] in Blood |
|
35459-7
|
T cell crossmatch [Interpretation] |
|
23508-5
|
Trypanosoma congolense DNA [Presence] in Blood by NAA with probe detection |
|
60553-5
|
Trypanosoma cruzi Ab [Presence] in Serum from Donor |
|
23785-9
|
Trypanosoma cruzi Ab [Presence] in Serum |
|
57320-4
|
Trypanosoma cruzi Ab [Presence] in Serum by Immunoassay |
|
8045-7
|
Trypanosoma cruzi Ab [Units/volume] in Serum |
|
77952-0
|
Trypanosoma cruzi Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
22599-5
|
Trypanosoma cruzi Ab [Titer] in Serum |
|
5398-3
|
Trypanosoma cruzi Ab [Titer] in Serum by Complement fixation |
|
25813-7
|
Trypanosoma cruzi Ab [Titer] in Serum by Immunofluorescence |
|
49801-4
|
Trypanosoma cruzi DNA [Presence] in Blood by NAA with probe detection |
|
88232-4
|
Trypanosoma cruzi DNA [Presence] in Tissue by NAA with probe detection |
|
90247-8
|
Trypanosoma cruzi IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
59387-1
|
Trypanosoma cruzi IgG Ab [Units/volume] in Serum by Immunoassay |
|
32725-4
|
Trypanosoma cruzi IgG Ab [Presence] in Serum |
|
87994-0
|
Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunoassay |
|
44816-7
|
Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunofluorescence |
|
13291-0
|
Trypanosoma cruzi IgG Ab [Units/volume] in Serum |
|
89995-5
|
Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
|
89994-8
|
Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Rapid immunoassay |
|
14094-7
|
Trypanosoma cruzi IgG Ab [Titer] in Serum |
|
59393-9
|
Trypanosoma cruzi IgG Ab [Titer] in Serum by Immunofluorescence |
|
30104-4
|
Trypanosoma cruzi IgG Ab [Titer] in Unspecified specimen |
|
31691-9
|
Trypanosoma cruzi IgG Ab [Units/volume] in Unspecified specimen |
|
51764-9
|
Trypanosoma cruzi IgG and IgM [Interpretation] in Serum or Plasma |
|
51827-4
|
Trypanosoma cruzi IgM Ab [Units/volume] in Serum by Immunoassay |
|
32726-2
|
Trypanosoma cruzi IgM Ab [Presence] in Serum |
|
87997-3
|
Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunoassay |
|
26989-4
|
Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunofluorescence |
|
13290-2
|
Trypanosoma cruzi IgM Ab [Units/volume] in Serum |
|
15397-3
|
Trypanosoma cruzi IgM Ab [Titer] in Serum |
|
30105-1
|
Trypanosoma cruzi IgM Ab [Titer] in Unspecified specimen |
|
22105-1
|
Theileria equi Ab [Presence] in Serum |
|
20690-4
|
Theileria equi Ab [Presence] in Serum by Complement fixation |
|
23464-1
|
Theileria equi Ab [Presence] in Serum by Immunoassay |
|
23466-6
|
Theileria equi Ab [Presence] in Serum by Immunofluorescence |
|
23465-8
|
Theileria equi rRNA [Presence] in Blood by Probe |
|
23454-2
|
Taylorella equigenitalis Ab [Presence] in Serum |
|
23453-4
|
Taylorella equigenitalis Ab [Presence] in Serum by Complement fixation |
|
31672-9
|
Taylorella equigenitalis Ab [Units/volume] in Serum |
|
42951-4
|
Taylorella equigenitalis Ab [Titer] in Serum |
|
23783-4
|
Taylorella equigenitalis Ab [Titer] in Serum by Complement fixation |
|
31976-4
|
Taylorella equigenitalis Ag [Presence] in Unspecified specimen |
|
23456-7
|
Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Agglutination |
|
23455-9
|
Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23458-3
|
Taylorella equigenitalis DNA [Presence] in Genital specimen by NAA with probe detection |
|
23603-4
|
Taylorella equigenitalis [Presence] in Genital specimen by Organism specific culture |
|
23515-0
|
Trypanosoma equiperdum Ab [Presence] in Serum |
|
23511-9
|
Trypanosoma equiperdum Ab [Presence] in Serum by Complement fixation |
|
23512-7
|
Trypanosoma equiperdum Ab [Presence] in Serum by Immunoassay |
|
23514-3
|
Trypanosoma equiperdum Ab [Presence] in Serum by Immune diffusion (ID) |
|
23513-5
|
Trypanosoma equiperdum Ab [Presence] in Serum by Immunofluorescence |
|
31692-7
|
Trypanosoma equiperdum Ab [Units/volume] in Serum |
|
23517-6
|
Trypanosoma equiperdum Ab [Titer] in Serum |
|
23510-1
|
Trypanosoma equiperdum Ab [Titer] in Serum by Complement fixation |
|
23509-3
|
Trypanosoma equiperdum [Presence] in Body fluid by Light microscopy |
|
23524-2
|
Trypanosoma evansi Ab [Units/volume] in Serum by Immunoassay |
|
23522-6
|
Trypanosoma evansi Ab [Presence] in Serum |
|
23523-4
|
Trypanosoma evansi Ab [Presence] in Serum by Agglutination |
|
23526-7
|
Trypanosoma evansi Ab [Presence] in Serum by Immunofluorescence |
|
23521-8
|
Trypanosoma evansi Ab [Units/volume] in Serum |
|
31979-8
|
Trypanosoma evansi Ag [Presence] in Blood |
|
23528-3
|
Trypanosoma evansi Ag [Presence] in Blood by Immunoassay |
|
23518-4
|
Trypanosoma evansi [Presence] in Aspirate by Thick film |
|
23519-2
|
Trypanosoma evansi [Presence] in Aspirate by Thin film |
|
23520-0
|
Trypanosoma evansi [Presence] in Aspirate by Wet preparation |
|
23529-1
|
Trypanosoma evansi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23530-9
|
Trypanosoma evansi rRNA [Presence] in Unspecified specimen by Probe |
|
23500-2
|
Tritrichomonas foetus Ab [Presence] in Genital mucus |
|
23501-0
|
Tritrichomonas foetus Ab [Presence] in Genital mucus by Agglutination |
|
23503-6
|
Tritrichomonas foetus Ag [Presence] in Placenta by Immune stain |
|
23502-8
|
Tritrichomonas foetus Ag [Presence] in Tissue from Fetus by Immune stain |
|
23505-1
|
Tritrichomonas foetus DNA [Presence] in Genital fluid by NAA with probe detection |
|
23504-4
|
Tritrichomonas foetus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23604-2
|
Tritrichomonas foetus [Presence] in Body fluid by Organism specific culture |
|
23606-7
|
Tritrichomonas foetus [Presence] in Genital fluid by Organism specific culture |
|
23605-9
|
Tritrichomonas foetus [Presence] in Placenta by Organism specific culture |
|
20976-7
|
Tritrichomonas foetus [Presence] in Preputial wash by Organism specific culture |
|
49109-2
|
Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
13287-8
|
Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid |
|
22577-1
|
Toxoplasma gondii Ab [Presence] in Serum |
|
23485-6
|
Toxoplasma gondii Ab [Presence] in Serum by Agglutination |
|
5387-6
|
Toxoplasma gondii Ab [Presence] in Serum by Sabin dye test |
|
23486-4
|
Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination |
|
11598-0
|
Toxoplasma gondii Ab [Units/volume] in Serum |
|
20464-4
|
Toxoplasma gondii Ab [Interpretation] in Serum |
|
87361-2
|
Toxoplasma gondii Ab/Negative control in Serum or Plasma by Immunoassay |
|
42949-8
|
Toxoplasma gondii Ab [Titer] in Serum |
|
23784-2
|
Toxoplasma gondii Ab [Titer] in Serum by Hemagglutination |
|
14923-7
|
Toxoplasma gondii Ab [Units/volume] in Unspecified specimen |
|
35305-2
|
Toxoplasma gondii AC Ab [Units/volume] in Serum by Agglutination |
|
41124-9
|
Toxoplasma gondii AC Ab [Units/volume] in Serum |
|
86737-4
|
Toxoplasma gondii Ag [Presence] in Tissue by Immune stain |
|
90301-3
|
Toxoplasma gondii [Presence] in Amniotic fluid by Organism specific culture |
|
89599-5
|
Toxoplasma gondii [Presence] in Cerebral spinal fluid by Organism specific culture |
|
53611-0
|
Toxoplasma gondii [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
49444-3
|
Toxoplasma gondii DNA [#/volume] in Amniotic fluid by NAA with probe detection |
|
49445-0
|
Toxoplasma gondii DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection |
|
49447-6
|
Toxoplasma gondii DNA [#/volume] in Blood by NAA with probe detection |
|
62465-0
|
Toxoplasma gondii DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection |
|
49446-8
|
Toxoplasma gondii DNA [#/volume] in Bone marrow by NAA with probe detection |
|
49449-2
|
Toxoplasma gondii DNA [#/volume] in Serum or Plasma by NAA with probe detection |
|
49443-5
|
Toxoplasma gondii DNA [#/volume] in Urine by NAA with probe detection |
|
49448-4
|
Toxoplasma gondii DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
27999-2
|
Toxoplasma gondii DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
16279-2
|
Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection |
|
87993-2
|
Toxoplasma gondii DNA [Presence] in Cord blood by NAA with probe detection |
|
42626-2
|
Toxoplasma gondii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
10725-0
|
Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
|
57441-8
|
Toxoplasma gondii DNA [Presence] in Body fluid by NAA with probe detection |
|
87989-0
|
Toxoplasma gondii DNA [Presence] in Bone marrow by NAA with probe detection |
|
88164-9
|
Toxoplasma gondii DNA [Presence] in Ocular fluid by NAA with probe detection |
|
87983-3
|
Toxoplasma gondii DNA [Presence] in Placenta by NAA with probe detection |
|
87984-1
|
Toxoplasma gondii DNA [Presence] in Tissue by NAA with probe detection |
|
29904-0
|
Toxoplasma gondii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35287-2
|
Toxoplasma gondii HS Ab [Units/volume] in Serum by Agglutination |
|
41123-1
|
Toxoplasma gondii HS Ab [Units/volume] in Serum |
|
33265-0
|
Toxoplasma gondii IgA Ab [Units/volume] in Cerebral spinal fluid |
|
10723-5
|
Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
|
33459-9
|
Toxoplasma gondii IgA Ab [Presence] in Serum |
|
74830-1
|
Toxoplasma gondii IgA Ab [Presence] in Serum by Immunoassay |
|
22578-9
|
Toxoplasma gondii IgA Ab [Units/volume] in Serum |
|
60428-0
|
Toxoplasma gondii IgA Ab [Titer] in Serum |
|
14922-9
|
Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay |
|
22579-7
|
Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum |
|
10724-3
|
Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
|
27354-0
|
Toxoplasma gondii IgE Ab [Presence] in Serum |
|
74847-5
|
Toxoplasma gondii IgE Ab [Presence] in Serum by Immunoassay |
|
17716-2
|
Toxoplasma gondii IgE Ab [Units/volume] in Serum |
|
25300-5
|
Toxoplasma gondii IgG Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
56990-5
|
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay |
|
47389-2
|
Toxoplasma gondii IgG Ab avidity [Presence] in Serum |
|
56991-3
|
Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay |
|
34422-6
|
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum |
|
30038-4
|
Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31685-1
|
Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid |
|
30568-0
|
Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
9741-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid |
|
54087-2
|
Toxoplasma gondii IgG Ab [Presence] in DBS |
|
33320-3
|
Toxoplasma gondii IgG Ab [Units/volume] in Body fluid |
|
93860-5
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum from Donor by Immunoassay |
|
93859-7
|
Toxoplasma gondii IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
47390-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum by Sabin dye test |
|
22580-5
|
Toxoplasma gondii IgG Ab [Presence] in Serum |
|
21570-7
|
Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test |
|
40677-7
|
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay |
|
35281-5
|
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunofluorescence |
|
8039-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum |
|
5388-4
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
24242-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum --1st specimen |
|
13286-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen |
|
40786-6
|
Toxoplasma gondii IgG Ab [Titer] in Serum --2nd specimen |
|
22581-3
|
Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid |
|
21569-9
|
Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22582-1
|
Toxoplasma gondii IgG Ab [Titer] in Serum |
|
12261-4
|
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
|
5389-2
|
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunofluorescence |
|
86738-2
|
Toxoplasma gondii IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
17717-0
|
Toxoplasma gondii IgG+IgM Ab [Presence] in Serum |
|
83123-0
|
Toxoplasma gondii IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
31178-7
|
Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31181-1
|
Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid |
|
30569-8
|
Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
18348-3
|
Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid |
|
54088-0
|
Toxoplasma gondii IgM Ab [Presence] in DBS |
|
33321-1
|
Toxoplasma gondii IgM Ab [Units/volume] in Body fluid |
|
40697-5
|
Toxoplasma gondii IgM Ab index [Units/volume] in Serum and CSF |
|
5390-0
|
Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay |
|
25542-2
|
Toxoplasma gondii IgM Ab [Presence] in Serum |
|
33336-9
|
Toxoplasma gondii IgM Ab [Presence] in Serum by Agglutination |
|
8040-8
|
Toxoplasma gondii IgM Ab [Units/volume] in Serum |
|
40678-5
|
Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
35282-3
|
Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
40785-8
|
Toxoplasma gondii IgM Ab [Titer] in Serum --1st specimen |
|
22583-9
|
Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid |
|
21571-5
|
Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22584-7
|
Toxoplasma gondii IgM Ab [Titer] in Serum |
|
12262-2
|
Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
|
5391-8
|
Toxoplasma gondii IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
87982-5
|
Toxoplasma gondii [Presence] in Bone marrow by Organism specific culture |
|
88161-5
|
Toxoplasma gondii [Presence] in Ocular fluid by Organism specific culture |
|
89632-4
|
Toxoplasma gondii [Presence] in Placenta by Organism specific culture |
|
30158-0
|
Toxoplasma gondii [Presence] in Stool |
|
10727-6
|
Toxoplasma gondii identified in Tissue |
|
14838-7
|
Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
|
10726-8
|
Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
|
42343-4
|
Toxoplasma gondii identified in Unspecified specimen by Other stain |
|
31974-9
|
Taenia hydatigena Ag [Presence] in Stool |
|
23449-2
|
Taenia hydatigena Ag [Presence] in Stool by Immunoassay |
|
26037-2
|
Trichophyton mentagrophytes var goetzii IgE Ab [Units/volume] in Serum |
|
26038-0
|
Trichophyton mentagrophytes var goetzii IgE Ab RAST class [Presence] in Serum |
|
63167-1
|
Trichophyton mentagrophytes IgG Ab [Mass/volume] in Serum |
|
25801-2
|
Trichophyton mentagrophytes var interdigitale IgE Ab [Units/volume] in Serum |
|
25802-0
|
Trichophyton mentagrophytes var interdigitale IgE Ab RAST class [Presence] in Serum |
|
23470-8
|
Theileria mutans Ab [Presence] in Serum |
|
23468-2
|
Theileria mutans Ab [Presence] in Serum by Immunoassay |
|
23469-0
|
Theileria mutans Ab [Presence] in Serum by Immunofluorescence |
|
31681-0
|
Theileria mutans Ab [Units/volume] in Serum |
|
23471-6
|
Theileria mutans Ab [Titer] in Serum |
|
23467-4
|
Theileria mutans Ab [Titer] in Serum by Immunofluorescence |
|
23473-2
|
Theileria mutans DNA [Presence] in Serum by NAA with probe detection |
|
23472-4
|
Theileria mutans rRNA [Presence] in Serum by Probe |
|
13288-6
|
Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence |
|
22585-4
|
Treponema pallidum Ab [Units/volume] in Blood |
|
49800-6
|
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Hemagglutination |
|
22586-2
|
Treponema pallidum Ab [Presence] in Cerebral spinal fluid |
|
50689-9
|
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Hemagglutination |
|
9826-9
|
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
51474-5
|
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid |
|
39015-3
|
Treponema pallidum Ab [Units/volume] in Body fluid by Hemagglutination |
|
47511-1
|
Treponema pallidum Ab [Units/volume] in Body fluid |
|
46206-9
|
Treponema pallidum Ab [Presence] in Serum from Donor |
|
43238-5
|
Treponema pallidum Ab [Presence] in Serum from Donor by Immunofluorescence |
|
63464-2
|
Treponema pallidum Ab [Units/volume] in Serum by Immunoassay |
|
17724-6
|
Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence |
|
5392-6
|
Treponema pallidum Ab [Units/volume] in Serum by Immobilization |
|
17725-3
|
Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination |
|
22587-0
|
Treponema pallidum Ab [Presence] in Serum |
|
24312-1
|
Treponema pallidum Ab [Presence] in Serum by Agglutination |
|
8041-6
|
Treponema pallidum Ab [Presence] in Serum by Hemagglutination |
|
24110-9
|
Treponema pallidum Ab [Presence] in Serum by Immunoassay |
|
57032-5
|
Treponema pallidum Ab [Presence] in Serum by Immunoblot |
|
5393-4
|
Treponema pallidum Ab [Presence] in Serum by Immunofluorescence |
|
17723-8
|
Treponema pallidum Ab [Presence] in Serum by Immobilization |
|
11597-2
|
Treponema pallidum Ab [Units/volume] in Serum |
|
51475-2
|
Treponema pallidum Ab [Titer] in Cerebral spinal fluid |
|
50695-6
|
Treponema pallidum Ab [Titer] in Cerebral spinal fluid by Hemagglutination |
|
22590-4
|
Treponema pallidum Ab [Titer] in Serum |
|
26009-1
|
Treponema pallidum Ab [Titer] in Serum by Hemagglutination |
|
34382-2
|
Treponema pallidum Ab [Titer] in Serum by Immunofluorescence |
|
5394-2
|
Treponema pallidum Ab [Titer] in Serum by Latex agglutination |
|
71793-4
|
Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination |
|
41122-3
|
Treponema pallidum Ab [Units/volume] in Unspecified specimen |
|
53605-2
|
Treponema pallidum DNA [Presence] in Blood by NAA with probe detection |
|
49799-0
|
Treponema pallidum DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91846-6
|
Treponema pallidum DNA [Presence] in Genital specimen by NAA with probe detection |
|
41163-7
|
Treponema pallidum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47051-8
|
Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
58031-6
|
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid |
|
58751-9
|
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
47512-9
|
Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid |
|
47513-7
|
Treponema pallidum IgG Ab [Presence] in Serum from Donor |
|
47361-1
|
Treponema pallidum IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
51838-1
|
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay |
|
17727-9
|
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
6561-5
|
Treponema pallidum IgG Ab [Presence] in Serum |
|
47238-1
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay |
|
40679-3
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunoblot |
|
17726-1
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
|
22592-0
|
Treponema pallidum IgG Ab [Units/volume] in Serum |
|
34147-9
|
Treponema pallidum IgG+IgM Ab [Presence] in Serum |
|
47236-5
|
Treponema pallidum IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
47063-3
|
Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
69946-2
|
Treponema pallidum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
47514-5
|
Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51839-9
|
Treponema pallidum IgM Ab [Units/volume] in Serum by Immunoassay |
|
17728-7
|
Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
6562-3
|
Treponema pallidum IgM Ab [Presence] in Serum |
|
47237-3
|
Treponema pallidum IgM Ab [Presence] in Serum by Immunoassay |
|
40680-1
|
Treponema pallidum IgM Ab [Presence] in Serum by Immunoblot |
|
17729-5
|
Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence |
|
22594-6
|
Treponema pallidum IgM Ab [Units/volume] in Serum |
|
76766-5
|
Treponema pallidum polA gene [Presence] in Genital specimen by NAA with probe detection |
|
29310-0
|
Treponema pallidum [Presence] in Unspecified specimen by Immunofluorescence |
|
23474-0
|
Theileria parva Ab [Presence] in Serum |
|
23477-3
|
Theileria parva Ab [Presence] in Serum by Immunoassay |
|
23475-7
|
Theileria parva Ab [Presence] in Serum by Immunofluorescence |
|
31682-8
|
Theileria parva Ab [Units/volume] in Serum |
|
23478-1
|
Theileria parva Ab [Titer] in Serum |
|
23476-5
|
Theileria parva Ab [Titer] in Serum by Immunofluorescence |
|
23480-7
|
Theileria parva DNA [Presence] in Serum by NAA with probe detection |
|
23479-9
|
Theileria parva rRNA [Presence] in Serum by Probe |
|
11203-7
|
Trichosporon pullulans IgE Ab [Units/volume] in Serum |
|
51567-6
|
Trichosporon pullulans IgE Ab RAST class [Presence] in Serum |
|
6256-2
|
Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum |
|
16037-4
|
Tyrophagus putrescentiae IgE Ab RAST class [Presence] in Serum |
|
48232-3
|
Tyrophagus putrescentiae triggered leukotriene release [Mass/volume] by Leukocytes |
|
69939-7
|
Trichophyton rubrum DNA [Presence] in Nail by NAA with probe detection |
|
6860-1
|
Trichophyton rubrum IgE Ab [Units/volume] in Serum |
|
16061-4
|
Trichophyton rubrum IgE Ab RAST class [Presence] in Serum |
|
35556-0
|
Trichophyton rubrum IgG Ab [Mass/volume] in Serum |
|
21561-6
|
Thermoactinomyces sacchari Ab [Presence] in Serum |
|
35318-5
|
Thermoactinomyces sacchari Ab [Presence] in Serum by Immune diffusion (ID) |
|
5377-7
|
Thermoactinomyces sacchari Ab [Units/volume] in Serum |
|
5374-4
|
Taenia saginata Ab [Units/volume] in Serum by Immunoassay |
|
8036-6
|
Taenia saginata Ab [Units/volume] in Serum |
|
58455-7
|
Taenia solium Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
5375-1
|
Taenia solium adult Ab [Units/volume] in Serum by Immunoassay |
|
10719-3
|
Taenia solium adult Ab [Units/volume] in Serum by Immunoblot |
|
8037-4
|
Taenia solium adult Ab [Units/volume] in Serum |
|
48804-9
|
Taenia solium Ag [Presence] in Stool |
|
56486-4
|
Taenia solium IgG Ab [Units/volume] in Serum by Immunoassay |
|
44804-3
|
Taenia solium IgG Ab [Units/volume] in Serum by Immunoblot |
|
56485-6
|
Taenia solium IgG Ab [Presence] in Serum by Immunoassay |
|
57455-8
|
Taenia solium IgG Ab [Units/volume] in Serum |
|
56665-3
|
Taenia solium IgG Ab [Titer] in Serum by Immunofluorescence |
|
9602-4
|
Taenia solium larva 14kD Ab [Presence] in Serum by Immunoblot |
|
9603-2
|
Taenia solium larva 18kD Ab [Presence] in Serum by Immunoblot |
|
9604-0
|
Taenia solium larva 21kD Ab [Presence] in Serum by Immunoblot |
|
9605-7
|
Taenia solium larva 24kD Ab [Presence] in Serum by Immunoblot |
|
9606-5
|
Taenia solium larva 39-42kD Ab [Presence] in Serum by Immunoblot |
|
9607-3
|
Taenia solium larva 50kD Ab [Presence] in Serum by Immunoblot |
|
49798-2
|
Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56480-7
|
Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
35349-0
|
Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
16708-0
|
Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid |
|
5120-1
|
Taenia solium larva Ab [Units/volume] in Serum by Hemagglutination |
|
22238-0
|
Taenia solium larva Ab [Presence] in Serum |
|
56984-8
|
Taenia solium larva Ab [Presence] in Serum by Immunoassay |
|
9600-8
|
Taenia solium larva Ab [Presence] in Serum by Immunoblot |
|
7850-1
|
Taenia solium larva Ab [Units/volume] in Serum |
|
41462-3
|
Taenia solium larva Ab [Presence] in Unspecified specimen by Immunoblot |
|
88920-4
|
Taenia solium larva Ag [Presence] in Serum by Immunoassay |
|
53602-9
|
Taenia solium larva Ag [Units/volume] in Serum |
|
88912-1
|
Taenia solium larva DNA [Presence] in Blood by NAA with probe detection |
|
59388-9
|
Taenia solium larva DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
88911-3
|
Taenia solium larva DNA [Presence] in Tissue by NAA with probe detection |
|
7844-4
|
Taenia solium larva IgA Ab [Presence] in Cerebral spinal fluid |
|
7845-1
|
Taenia solium larva IgA Ab [Presence] in Serum |
|
7846-9
|
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid |
|
88919-6
|
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6373-5
|
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
35391-2
|
Taenia solium larva IgG Ab [Units/volume] in Cerebral spinal fluid |
|
24040-8
|
Taenia solium larva IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot |
|
24039-0
|
Taenia solium larva IgG band pattern [Interpretation] in Serum by Immunoblot |
|
25389-8
|
Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay |
|
7847-7
|
Taenia solium larva IgG Ab [Presence] in Serum |
|
6374-3
|
Taenia solium larva IgG Ab [Presence] in Serum by Immunoblot |
|
25337-7
|
Taenia solium larva IgG Ab [Units/volume] in Serum |
|
7848-5
|
Taenia solium larva IgM Ab [Presence] in Cerebral spinal fluid |
|
16706-4
|
Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid |
|
7849-3
|
Taenia solium larva IgM Ab [Presence] in Serum |
|
16707-2
|
Taenia solium larva IgM Ab [Units/volume] in Serum |
|
9601-6
|
Taenia solium larva 13kD Ab [Presence] in Serum by Immunoblot |
|
41426-8
|
Trichinella spiralis Ab [Units/volume] in Serum by Immunoassay |
|
22595-3
|
Trichinella spiralis Ab [Presence] in Serum |
|
19253-4
|
Trichinella spiralis Ab [Presence] in Serum by Immunoassay |
|
17732-9
|
Trichinella spiralis Ab [Presence] in Serum by Latex agglutination |
|
8042-4
|
Trichinella spiralis Ab [Units/volume] in Serum |
|
22596-1
|
Trichinella spiralis Ab [Titer] in Serum |
|
25993-7
|
Trichinella spiralis Ab [Titer] in Serum by Immunofluorescence |
|
5395-9
|
Trichinella spiralis Ab [Titer] in Serum by Latex agglutination |
|
87985-8
|
Trichinella spiralis DNA [Presence] in Tissue by NAA with probe detection |
|
17733-7
|
Trichinella spiralis IgA Ab [Presence] in Serum |
|
13922-0
|
Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay |
|
25423-5
|
Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay |
|
8043-2
|
Trichinella spiralis IgG Ab [Presence] in Serum |
|
6563-1
|
Trichinella spiralis IgG Ab [Presence] in Serum by Immunoassay |
|
17734-5
|
Trichinella spiralis IgG Ab [Units/volume] in Serum |
|
53387-7
|
Trichinella spiralis IgG Ab [Titer] in Serum |
|
52979-2
|
Trichinella spiralis IgG Ab [Titer] in Serum by Immunofluorescence |
|
17735-2
|
Trichinella spiralis IgM Ab [Presence] in Serum |
|
13923-8
|
Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay |
|
23499-7
|
Trichinella spiralis [Presence] in Tissue by Light microscopy |
|
79347-1
|
Sulfate.total/Creatinine [Molar ratio] in Urine |
|
54927-9
|
Tetranychus urticae IgE Ab [Units/volume] in Serum |
|
46422-2
|
Trichomonas vaginalis [#/area] in Urine sediment by Microscopy high power field |
|
31978-0
|
Trichomonas vaginalis Ag [Presence] in Genital specimen |
|
6566-4
|
Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunoassay |
|
6567-2
|
Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunofluorescence |
|
41511-7
|
Trichomonas vaginalis Ag [Presence] in Vaginal fluid |
|
90303-9
|
Trichomonas vaginalis [Presence] in Cervix by Light microscopy |
|
14366-9
|
Trichomonas vaginalis [Presence] in Cervix by Wet preparation |
|
90302-1
|
Trichomonas vaginalis DNA [Presence] in Cervix by NAA with probe detection |
|
91844-1
|
Trichomonas vaginalis DNA [Presence] in Genital specimen by NAA with probe detection |
|
92685-7
|
Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection |
|
62461-9
|
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
92700-4
|
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe |
|
54144-1
|
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
69937-1
|
Trichomonas vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6564-9
|
Trichomonas vaginalis [Presence] in Genital specimen by Complement fixation |
|
91790-6
|
Trichomonas vaginalis [Presence] in Genital specimen by Organism specific culture |
|
91845-8
|
Trichomonas vaginalis [Presence] in Genital specimen by Light microscopy |
|
6565-6
|
Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation |
|
72277-7
|
Trichomonas vaginalis [Presence] in Prostatic fluid by Light microscopy |
|
70166-4
|
Trichomonas vaginalis rRNA [Presence] in Cervix by NAA with probe detection |
|
6568-0
|
Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe |
|
70167-2
|
Trichomonas vaginalis rRNA [Presence] in Urine by NAA with probe detection |
|
70165-6
|
Trichomonas vaginalis rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
46154-1
|
Trichomonas vaginalis rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33243-7
|
Trichomonas vaginalis [Presence] in Urine by Computer assisted method |
|
81316-2
|
Trichomonas vaginalis [Presence] in Urine sediment by Organism specific culture |
|
5813-1
|
Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy |
|
14368-5
|
Trichomonas vaginalis [Presence] in Urethra by Wet preparation |
|
90285-8
|
Trichomonas vaginalis [Presence] in Vaginal fluid by Organism specific culture |
|
90286-6
|
Trichomonas vaginalis [Presence] in Vaginal fluid by Light microscopy |
|
14367-7
|
Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation |
|
44244-2
|
Trichomonas vaginalis [#/area] in Vaginal fluid by Wet preparation |
|
76705-3
|
Trichomonas vaginalis [Presence] in Unspecified specimen by Gram stain |
|
32766-8
|
Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation |
|
39569-9
|
Trichoderma viride Ab [Mass/volume] in Serum |
|
6267-9
|
Trichoderma viride IgE Ab [Units/volume] in Serum |
|
16059-8
|
Trichoderma viride IgE Ab RAST class [Presence] in Serum |
|
26986-0
|
Trichoderma viride IgG Ab [Presence] in Serum |
|
30071-5
|
Trichoderma viride IgG Ab [Units/volume] in Serum |
|
49687-7
|
Trichoderma viride IgG Ab [Mass/volume] in Serum |
|
56406-2
|
Trichoderma viride IgG4 Ab [Mass/volume] in Serum |
|
42534-8
|
Thermoactinomyces vulgaris Ab [Presence] in Cerebral spinal fluid |
|
22573-0
|
Thermoactinomyces vulgaris Ab [Presence] in Serum |
|
6821-3
|
Thermoactinomyces vulgaris Ab [Presence] in Serum by Immune diffusion (ID) |
|
5378-5
|
Thermoactinomyces vulgaris Ab [Units/volume] in Serum |
|
56728-9
|
Thermoactinomyces vulgaris IgE Ab [Units/volume] in Serum |
|
25539-8
|
Thermoactinomyces vulgaris IgG Ab RAST class [Presence] in Serum |
|
19761-6
|
Thermoactinomyces vulgaris IgG Ab [Presence] in Serum |
|
25538-0
|
Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum |
|
34190-9
|
Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum |
|
40473-1
|
Thermoactinomyces vulgaris 1 Ab [Presence] in Serum |
|
35317-7
|
Thermoactinomyces vulgaris 1 Ab [Presence] in Serum by Immune diffusion (ID) |
|
30111-9
|
Thermoactinomyces vulgaris 2 Ab [Presence] in Serum |
|
10130-3
|
T' wave amplitude in lead AVF |
|
10142-8
|
T wave amplitude in lead AVF |
|
10131-1
|
T' wave amplitude in lead AVL |
|
10143-6
|
T wave amplitude in lead AVL |
|
10132-9
|
T' wave amplitude in lead AVR |
|
10144-4
|
T wave amplitude in lead AVR |
|
10133-7
|
T' wave amplitude in lead I |
|
10145-1
|
T wave amplitude in lead I |
|
10134-5
|
T' wave amplitude in lead II |
|
10146-9
|
T wave amplitude in lead II |
|
10135-2
|
T' wave amplitude in lead III |
|
10147-7
|
T wave amplitude in lead III |
|
10136-0
|
T' wave amplitude in lead V1 |
|
10148-5
|
T wave amplitude in lead V1 |
|
10137-8
|
T' wave amplitude in lead V2 |
|
10149-3
|
T wave amplitude in lead V2 |
|
10138-6
|
T' wave amplitude in lead V3 |
|
10150-1
|
T wave amplitude in lead V3 |
|
10139-4
|
T' wave amplitude in lead V4 |
|
10151-9
|
T wave amplitude in lead V4 |
|
10140-2
|
T' wave amplitude in lead V5 |
|
10152-7
|
T wave amplitude in lead V5 |
|
10141-0
|
T' wave amplitude in lead V6 |
|
10153-5
|
T wave amplitude in lead V6 |
|
8638-9
|
T wave axis |
|
18518-1
|
T wave axis.frontal plane Reference beat |
|
18509-0
|
T wave axis.horizontal plane Reference beat |
|
18515-7
|
T wave offset [Time] Reference beat |
|
59071-1
|
Tropheryma whippelii Ab [Presence] in Serum |
|
42602-3
|
Tropheryma whippelii DNA [Presence] in Blood by NAA with probe detection |
|
42536-3
|
Tropheryma whippelii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
89650-6
|
Tropheryma whippelii DNA [Presence] in Implanted device by NAA with probe detection |
|
88140-9
|
Tropheryma whippelii DNA [Presence] in Ocular fluid by NAA with probe detection |
|
91057-0
|
Tropheryma whippelii DNA [Presence] in Stool by NAA with probe detection |
|
29607-9
|
Tropheryma whippelii DNA [Presence] in Tissue by NAA with probe detection |
|
46725-8
|
Tropheryma whippelii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70276-1
|
t(1;11)(p32;q23)(EPS15,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
81849-2
|
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
81848-4
|
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Bone marrow by Molecular genetics method |
|
21799-2
|
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21775-2
|
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
77030-5
|
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript in Blood or Tissue by FISH |
|
21800-8
|
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21776-0
|
t(1;19)(q23.3;p13.3)(PBX1,TCF3) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72312-2
|
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
62203-5
|
t(10;11)(p12;q23)(MLLT10,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77037-0
|
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript in Blood or Tissue by FISH |
|
21801-6
|
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
72368-4
|
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21777-8
|
t(11;14)(q13;q32)(CCND1,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72725-5
|
t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
|
70283-7
|
t(11;17)(q23;q21)(MLL,MLLT6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70284-5
|
t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
87826-4
|
t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
77036-2
|
t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by FISH |
|
70285-2
|
t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21802-4
|
t(11;19)(q23;p13.3)(MLL,MLLT1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21778-6
|
t(11;19)(q23;p13.3)(MLL,MLLT1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
21803-2
|
t(11;22)(q24;q12.2)(FLI1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21779-4
|
t(11;22)(q24;q12.2)(FLI1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
21804-0
|
t(11;22)(p13;q12.2)(WT1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21780-2
|
t(11;22)(p13;q12.2)(WT1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
21805-7
|
t(12;16)(q13;p11.2)(DDIT3,FUS) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21781-0
|
t(12;16)(q13;p11.2)(DDIT3,FUS) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
77039-6
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript in Blood or Tissue by FISH |
|
21806-5
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
48821-3
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21782-8
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72218-1
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72217-3
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
21807-3
|
t(12;22)(q13;q12.2)(ATF1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21783-6
|
t(12;22)(q13;q12.2)(ATF1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
70286-0
|
t(12;22)(p13;q12.1)(ETV6,MN1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77033-9
|
t(14;16)(q32;q23)(IGH,MAF) fusion transcript in Blood or Tissue by FISH |
|
77038-8
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript in Blood or Tissue by FISH |
|
21808-1
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21809-9
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
|
60576-6
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
49793-3
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Bone marrow by Molecular genetics method |
|
21810-7
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
|
60584-0
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
49794-1
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Bone marrow by Molecular genetics method |
|
21784-4
|
t(14;18)(q32;q21.3)(IGH,BCL2) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
77035-4
|
t(14;18)(q32;q21)(IGH,MALT1) fusion transcript in Blood or Tissue by FISH |
|
90043-1
|
t(14;20)(q32;q12)(IGH,MAFB) fusion transcript in Blood or Tissue by FISH |
|
60589-9
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
72216-5
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72212-4
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
60588-1
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
72215-7
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72211-6
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
72214-0
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72213-2
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
77031-3
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript in Blood or Tissue by FISH |
|
21551-7
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75011-7
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21785-1
|
t(15;17)(q24.1;q21.1)(PML,RARA) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72274-4
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
82903-6
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
70287-8
|
t(16;21)(p11.2;q22.3)(FUS,ERG) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70288-6
|
t(17;19)(q22;p13.3)(HLF,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21812-3
|
t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21786-9
|
t(2;13)(q36.1;q14.4)(PAX3,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
79209-3
|
t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
90305-4
|
t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
21813-1
|
t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21787-7
|
t(2;5)(p23;q35.1)(ALK,NPM1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
21814-9
|
t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21788-5
|
t(21;22)(q22.3;q12.2)(ERG,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
70278-7
|
t(3;21)(q26;q22.3)(MECOM,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70277-9
|
t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21815-6
|
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75012-5
|
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21789-3
|
t(4;11)(q21.3;q23)(AFF1,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72313-0
|
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72726-3
|
t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
|
21816-4
|
t(5;12)(q33.1;p13)(PDGFRB,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21790-1
|
t(5;12)(q33.1;p13)(PDGFRB,ETV6) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
70279-5
|
t(5;17)(q25.1;q21.1)(NPM1,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70280-3
|
t(6;11)(q27;q23)(MLLT4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77042-0
|
t(6;9)(p22;q34)(DEK,NUP214) fusion transcript in Blood or Tissue by FISH |
|
21817-2
|
t(6;9)(p22;q34)(DEK,NUP214) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21791-9
|
t(6;9)(p22;q34)(DEK,NUP214) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
77032-1
|
t(8;14)(q24;q32)(MYC,IGH) fusion transcript in Blood or Tissue by FISH |
|
21818-0
|
t(8;14)(q24;q32)(MYC,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21792-7
|
t(8;14)(q24;q32)(MYC,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
77040-4
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript in Blood or Tissue by FISH |
|
21819-8
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75013-3
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21793-5
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72207-4
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72208-2
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
21820-6
|
t(9;11)(p22;q23)(MLLT3,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21794-3
|
t(9;11)(p22;q23)(MLLT3,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
70282-9
|
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75014-1
|
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
50014-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by Molecular genetics method |
|
51867-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by FISH |
|
21821-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75892-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21822-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
|
75020-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method |
|
82904-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21823-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
|
21795-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
46434-7
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
50195-7
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue by Molecular genetics method |
|
82905-1
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Bone marrow by Molecular genetics method |
|
21824-8
|
t(9;22)(q22;q12.2)(NR4A3,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21796-8
|
t(9;22)(q22;q12.2)(NR4A3,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
70281-1
|
t(9;9)(q34;q34)(NUP214,SET) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75015-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
69381-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
|
52130-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
75016-6
|
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
69382-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
|
52131-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
54926-1
|
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method |
|
75018-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75017-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
49795-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75019-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
52132-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
69963-7
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
49796-6
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method |
|
42714-6
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
49797-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
74041-5
|
BCR-ABL1 p210 Major Molecular Response (MMR) [Presence] in Blood or Tissue by Molecular genetics method --post treatment |
|
69380-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
|
55147-3
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
63422-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70275-3
|
t(X;11)(q13.1;q23)(FOXO4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21825-5
|
t(X;18)(q11.2;p11.23)(SS18,SSX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21797-6
|
t(X;18)(q11.2;p11.23)(SS18,SSX1) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
21826-3
|
t(X;18)(q11.2;p11.22)(SS18,SSX2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
21798-4
|
t(X;18)(q11.2;p11.22)(SS18,SSX2) cells/Cells.total in Blood or Tissue by Molecular genetics method |
|
72665-3
|
Trans,trans-muconic acid [Mass/volume] in Urine |
|
87567-4
|
T-2 toxin [Mass/mass] in Unspecified specimen |
|
43172-6
|
Triiodothyronine (T3) Ab [Presence] in Serum |
|
5396-7
|
Triiodothyronine (T3) Ab [Units/volume] in Serum |
|
26879-7
|
Triiodothyronine (T3) [Mass/volume] in Saliva (oral fluid) |
|
83124-8
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay |
|
83125-5
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma by Immunoassay |
|
3053-6
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma |
|
35231-0
|
Triiodothyronine (T3) [Mass or Moles/volume] in Serum or Plasma |
|
14930-2
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
|
12953-6
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
47191-2
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12954-4
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
47192-0
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12955-1
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
47193-8
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12956-9
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
47194-6
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12957-7
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
47195-3
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
12958-5
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
47196-1
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
12959-3
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
47197-9
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
3055-1
|
Triiodothyronine (T3)/Triiodothyronine (T3) uptake index [Ratio] in Serum or Plasma |
|
57899-7
|
Triiodothyronine (T3)/Triiodothyronine (T3).reverse [Ratio] in Serum or Plasma |
|
70152-4
|
Triiodothyronine (T3)/Thyroxine (T4) [Mass Ratio] in Serum or Plasma |
|
40295-8
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
40328-7
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
58839-2
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
58840-0
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma --baseline |
|
40327-9
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
65351-9
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
29239-1
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis |
|
83127-1
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Immunoassay |
|
83126-3
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay |
|
3051-0
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma |
|
35230-2
|
Triiodothyronine (T3) Free [Mass or Moles/volume] in Serum or Plasma |
|
14928-6
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
|
25803-8
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25804-6
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25805-3
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25806-1
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25807-9
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25808-7
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
25809-5
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25810-3
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25811-1
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
3052-8
|
Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma |
|
14929-4
|
Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
|
17743-6
|
Triiodothyronine resin uptake (T3RU) in Serum or Plasma --1 hour post XXX challenge |
|
3050-2
|
Triiodothyronine resin uptake (T3RU) in Serum or Plasma |
|
3054-4
|
Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma |
|
12931-2
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
90796-4
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine |
|
90797-2
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine |
|
90798-0
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine |
|
90799-8
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine |
|
90800-4
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine |
|
38356-2
|
Thyroxine (T4) Ab [Presence] in Serum |
|
9580-2
|
Thyroxine (T4) Ab [Units/volume] in Serum |
|
11062-7
|
Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma |
|
14123-4
|
Thyroxine (T4).albumin bound/Albumin [Mass Ratio] in Serum or Plasma |
|
20451-1
|
Thyroxine (T4) [Presence] in Blood |
|
3025-4
|
Thyroxine (T4) [Mass/volume] in Blood |
|
27891-1
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --baseline |
|
38506-2
|
Thyroxine (T4) [Presence] in DBS |
|
31144-9
|
Thyroxine (T4) [Mass/volume] in DBS |
|
31145-6
|
Thyroxine (T4) [Moles/volume] in DBS |
|
56988-9
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
27989-3
|
Thyroxine (T4) free [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
56986-3
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
56989-7
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
58837-6
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
58836-8
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
56987-1
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
73557-1
|
Thyroxine (T4) free [Mass/volume] in Cord blood |
|
27987-7
|
Thyroxine (T4) free [Units/volume] in Serum or Plasma --baseline |
|
58838-4
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --baseline |
|
53349-7
|
Thyroxine (T4) free [Mass/volume] in DBS |
|
53350-5
|
Thyroxine (T4) free [Moles/volume] in DBS |
|
6892-4
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis |
|
70217-5
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis |
|
83122-2
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay |
|
83121-4
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay |
|
3024-7
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma |
|
35228-6
|
Thyroxine (T4) free [Mass or Moles/volume] in Serum or Plasma |
|
14920-3
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
|
25790-7
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
25791-5
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
25792-3
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
25793-1
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
25794-9
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
25795-6
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
25796-4
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
25797-2
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
25798-0
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
14014-5
|
Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma |
|
14015-2
|
Thyroxine (T4).prealbumin bound/Prealbumin [Mass Ratio] in Serum or Plasma |
|
27000-9
|
Thyroxine (T4) [Mass/volume] in Saliva (oral fluid) |
|
83119-8
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma by Immunoassay |
|
83120-6
|
Thyroxine (T4) [Moles/volume] in Serum or Plasma by Immunoassay |
|
3026-2
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma |
|
35226-0
|
Thyroxine (T4) [Mass or Moles/volume] in Serum or Plasma |
|
14921-1
|
Thyroxine (T4) [Moles/volume] in Serum or Plasma |
|
12923-9
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
12924-7
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
12925-4
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
12926-2
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
12927-0
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
12928-8
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
12929-6
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
12930-4
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
14016-0
|
Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma |
|
3028-8
|
Thyroxine (T4)/Triiodothyronine (T3) uptake index [Mass Ratio] in Serum or Plasma |
|
3027-0
|
Thyroxine (T4)/Thyroxine binding globulin [Mass Ratio] in Serum or Plasma |
|
3020-5
|
Thyroxine binding globulin [Mass/volume] in Blood |
|
3021-3
|
Thyroxine binding globulin [Mass/volume] in Serum or Plasma |
|
35227-8
|
Thyroxine binding globulin [Mass or Moles/volume] in Serum or Plasma |
|
27980-2
|
Thyroxine binding globulin [Moles/volume] in Serum or Plasma |
|
50681-6
|
Thyroxine binding protein pattern [Interpretation] in Serum or Plasma by Electrophoresis |
|
18011-7
|
Aorta arch and Neck Diameter by US |
|
80978-0
|
Tabulated ethnicity [CDC] |
|
80977-2
|
Tabulated race [CDC] |
|
90422-7
|
TACI cells/100 CD19 cells in Blood |
|
9359-1
|
Tacrine [Mass/volume] in Serum or Plasma |
|
72946-7
|
Tacrolimus induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72945-9
|
Tacrolimus induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
92730-1
|
Tacrolimus [Mass/volume] in Blood --1 hour post dose |
|
92729-3
|
Tacrolimus [Mass/volume] in Blood --2 hours post dose |
|
59823-5
|
Tacrolimus [Mass/volume] in Serum or Plasma --2 hours post dose |
|
92728-5
|
Tacrolimus [Mass/volume] in Blood --4 hours post dose |
|
59822-7
|
Tacrolimus [Mass/volume] in Serum or Plasma --4 hours post dose |
|
74096-9
|
Tacrolimus [Mass/volume] in Blood by Immunoassay |
|
76494-4
|
Tacrolimus [Moles/volume] in Blood by Immunoassay |
|
74097-7
|
Tacrolimus [Mass/volume] in Blood by LC/MS/MS |
|
92727-7
|
Tacrolimus [AUC] in Blood |
|
11253-2
|
Tacrolimus [Mass/volume] in Blood |
|
80550-7
|
Tacrolimus [Mass/volume] in DBS |
|
32594-4
|
Tacrolimus [Mass] of Dose |
|
73133-1
|
Tacrolimus induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73132-3
|
Tacrolimus induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
32721-3
|
Tacrolimus [Mass/volume] in Serum or Plasma |
|
77348-1
|
Tacrolimus [Mass/volume] in Blood --trough |
|
33929-1
|
Tacrolimus [Mass/volume] in Serum or Plasma --trough |
|
59342-6
|
Tadalafil [Mass/volume] in Blood |
|
59343-4
|
Tadalafil [Mass/volume] in Serum or Plasma |
|
59344-2
|
Tadalafil [Mass/volume] in Urine |
|
31975-6
|
Taenia sp Ag [Presence] in Stool |
|
23450-0
|
Taenia sp Ag [Presence] in Stool by Immunoassay |
|
88910-5
|
Taenia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23452-6
|
Taenia sp eggs [Presence] in Stool by NAA with probe detection |
|
23451-8
|
Taenia sp eggs [Presence] in Stool by Probe |
|
77683-1
|
Thrombin activatable fibrinolysis inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
89909-6
|
Takes creatine supplements |
|
87677-1
|
Taking an active role in my child's health care is the most important thing that affects his/her health Parent [PAM] |
|
86938-8
|
Taking an active role in my own health care is the most important thing that affects my health [PAM] |
|
87691-2
|
Taking an active role in this person's health care is one of the most important factors in determining her/his health and ability to function Caregiver [PAM] |
|
481-2
|
Talampicillin [Susceptibility] by Disk diffusion (KB) |
|
480-4
|
Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
479-6
|
Talampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18988-6
|
Talampicillin [Susceptibility] |
|
482-0
|
Talampicillin [Susceptibility] by Serum bactericidal titer |
|
12490-9
|
Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma |
|
59347-5
|
Tamoxifen [Mass/volume] in Blood |
|
73131-5
|
Tamoxifen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73130-7
|
Tamoxifen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93872-0
|
Tamoxifen metabolites pattern [Interpretation] in Serum or Plasma |
|
13909-7
|
Tamoxifen [Mass/volume] in Serum or Plasma |
|
73129-9
|
Tamsulosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73128-1
|
Tamsulosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
91648-6
|
Tangible support score [MOS Social Support Survey] |
|
89300-8
|
Tapentadol glucuronide [Presence] in Urine by Screen method |
|
75362-4
|
Tapentadol glucuronide [Mass/volume] in Urine by Screen method |
|
79145-9
|
Tapentadol [Presence] in Blood by Confirmatory method |
|
79146-7
|
Tapentadol [Presence] in Blood by Screen method |
|
59352-5
|
Tapentadol [Mass/volume] in Blood |
|
77879-5
|
Tapentadol cutoff [Mass/volume] in Urine for Confirmatory method |
|
79240-8
|
Tapentadol cutoff [Mass/volume] in Urine for Screen method |
|
59353-3
|
Tapentadol [Mass/volume] in Body fluid |
|
87819-9
|
Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87818-1
|
Tapentadol [Presence] in Saliva (oral fluid) by Screen method |
|
75347-5
|
Tapentadol [Mass/volume] in Serum, Plasma or Blood |
|
59354-1
|
Tapentadol [Mass/volume] in Serum or Plasma |
|
59355-8
|
Tapentadol [Mass/mass] in Tissue |
|
58402-9
|
Tapentadol [Mass/volume] in Urine by Confirmatory method |
|
58401-1
|
Tapentadol [Presence] in Urine by Confirmatory method |
|
72485-6
|
Tapentadol [Presence] in Urine by Screen method |
|
65807-0
|
Tapentadol [Mass/volume] in Urine |
|
61429-7
|
Tapentadol/Creatinine [Mass Ratio] in Urine |
|
7733-9
|
Tapioca IgE Ab [Units/volume] in Serum |
|
16048-1
|
Tapioca IgE Ab RAST class [Presence] in Serum |
|
7734-7
|
Tapioca IgG Ab [Units/volume] in Serum |
|
77633-6
|
TARDBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60749-9
|
Target enflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60756-4
|
Target halothane [VFr/PPres] Airway adaptor --at end expiration |
|
60763-0
|
Target isoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60796-0
|
Target oxygen [VFr/PPres] Airway adaptor --at end expiration |
|
60776-2
|
Target sevoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
34138-8
|
Targeted history and physical note |
|
10381-2
|
Target cells [Presence] in Blood by Light microscopy |
|
11202-9
|
Tarragon IgE Ab [Units/volume] in Serum |
|
16049-9
|
Tarragon IgE Ab RAST class [Presence] in Serum |
|
56709-9
|
Tartrazine IgE Ab [Units/volume] in Serum |
|
48293-5
|
Tartrazine triggered leukotriene release [Mass/volume] by Leukocytes |
|
90059-7
|
Task description Narrative |
|
90895-4
|
Task identifier |
|
14182-0
|
Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
77064-4
|
TAT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77063-6
|
TAT gene full mutation analysis in Blood or Tissue by Sequencing |
|
49558-0
|
TAU 3 Ag [Presence] in Tissue by Immune stain |
|
49559-8
|
TAU 4 Ag [Presence] in Tissue by Immune stain |
|
30160-6
|
Tau protein [Mass/volume] in Cerebral spinal fluid |
|
34159-4
|
Tau protein [Presence] in Body fluid |
|
58463-1
|
Tau protein/Protein.total in Cerebral spinal fluid |
|
32559-7
|
Tau protein [Mass/volume] in Serum |
|
41027-4
|
Tau protein/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid |
|
9324-5
|
Taurine [Moles/volume] in 24 hour Urine |
|
25533-1
|
Taurine [Moles/time] in 24 hour Urine |
|
13415-5
|
Taurine [Mass/volume] in Amniotic fluid |
|
27310-2
|
Taurine [Moles/volume] in Amniotic fluid |
|
17679-2
|
Taurine [Presence] in Cerebral spinal fluid |
|
2979-3
|
Taurine [Mass/volume] in Cerebral spinal fluid |
|
26614-8
|
Taurine [Moles/volume] in Cerebral spinal fluid |
|
47782-8
|
Taurine [Moles/volume] in DBS |
|
32271-9
|
Taurine [Moles/volume] in Body fluid |
|
15208-2
|
Taurine [Presence] in Nose |
|
2980-1
|
Taurine [Presence] in Serum or Plasma |
|
26896-1
|
Taurine [Units/volume] in Serum or Plasma |
|
2981-9
|
Taurine [Mass/volume] in Serum or Plasma |
|
20657-3
|
Taurine [Moles/volume] in Serum or Plasma |
|
17678-4
|
Taurine [Presence] in Urine |
|
2982-7
|
Taurine [Mass/volume] in Urine |
|
30563-1
|
Taurine [Moles/volume] in Urine |
|
33214-8
|
Taurine [Moles/volume] in Vitreous fluid |
|
44411-7
|
Taurine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56985-5
|
Taurine/Creatinine [Ratio] in 24 hour Urine |
|
25985-3
|
Taurine/Creatinine [Molar ratio] in 24 hour Urine |
|
13814-9
|
Taurine/Creatinine [Mass Ratio] in Urine |
|
28595-7
|
Taurine/Creatinine [Ratio] in Urine |
|
25138-9
|
Taurine/Creatinine [Molar ratio] in Urine |
|
72944-2
|
Tazobactam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72943-4
|
Tazobactam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73127-3
|
Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73126-5
|
Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41720-4
|
Tazobactam [Susceptibility] by Gradient strip |
|
41719-6
|
Tazobactam [Susceptibility] by Disk diffusion (KB) |
|
41721-2
|
Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41740-2
|
Tazobactam [Susceptibility] |
|
32561-3
|
Tuberculosis reaction wheal [Diameter] --1 day post dose mammalian tuberculin intradermal |
|
23537-4
|
Tuberculosis reaction wheal [Diameter] --2 days post dose mammalian tuberculin intradermal |
|
43419-1
|
Tuberculosis reaction wheal [Diameter] --3 days post 1 TU intradermal |
|
1647-7
|
Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal |
|
1648-5
|
Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal |
|
23538-2
|
Tuberculosis reaction wheal [Diameter] --3 days post dose avian tuberculin intradermal |
|
23539-0
|
Tuberculosis reaction wheal [Diameter] --3 days post dose mammalian tuberculin intradermal |
|
31383-3
|
European tick borne encephalitis virus Ab [Units/volume] in Serum |
|
26061-2
|
European tick borne encephalitis virus Ab [Titer] in Serum |
|
26058-8
|
European tick borne encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
69927-2
|
European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
69928-0
|
European tick borne encephalitis virus IgG Ab index [Units/volume] in Serum and CSF by Immunoassay |
|
26059-6
|
European tick borne encephalitis virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
69926-4
|
European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
26062-0
|
European tick borne encephalitis virus IgG Ab [Units/volume] in Serum |
|
69924-9
|
European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
69925-6
|
European tick borne encephalitis virus IgM Ab index [Units/volume] in Serum and CSF by Immunoassay |
|
26060-4
|
European tick borne encephalitis virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
69923-1
|
European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
26063-8
|
European tick borne encephalitis virus IgM Ab [Units/volume] in Serum |
|
86519-6
|
European tick borne encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
|
46764-7
|
Thyroid binding globulin deficiency newborn screen interpretation |
|
77617-9
|
Toe brachial index - left |
|
77618-7
|
Toe brachial index - right |
|
57449-1
|
Tubular basement membrane Ab [Units/volume] in Serum |
|
57661-1
|
Tubular basement membrane Ab [Titer] in Serum by Immunofluorescence |
|
48822-1
|
Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
|
48823-9
|
Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
56547-3
|
Tubular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
|
89657-1
|
Microscopic observation [Identifier] in Lower respiratory specimen by Toluidine blue O stain |
|
81424-4
|
Microscopic observation [Identifier] in Bone marrow by Toluidine blue O stain |
|
6678-7
|
Microscopic observation [Identifier] in Tissue by Toluidine blue O stain |
|
677-5
|
Microscopic observation [Identifier] in Unspecified specimen by Toluidine blue O stain |
|
33981-2
|
TBP gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
54165-6
|
Tumor necrosis factor binding protein [Units/volume] in Serum |
|
14270-3
|
Tert-butyl acetate [Mass/volume] in Blood |
|
38913-0
|
TBX5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38924-7
|
TBX5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75992-8
|
Transcutaneous monitor Heater power |
|
76005-8
|
Transcutaneous monitor sensor temperature |
|
17736-0
|
Trichloroacetate [Mass/volume] in Blood |
|
13898-2
|
Trichloroacetate [Mass/volume] in Serum or Plasma |
|
93327-5
|
Taurocholate [Moles/volume] in Serum or Plasma |
|
3041-1
|
Trichloroacetate [Mass/volume] in Urine |
|
26770-8
|
Trichloroacetate/Creatinine [Mass Ratio] in Urine |
|
56646-3
|
Trichloroacetate/Creatinine [Ratio] in Urine |
|
93328-3
|
Taurochenodeoxycholate [Moles/volume] in Serum or Plasma |
|
38707-6
|
Trichloroethane [Mass/volume] in Air |
|
13938-6
|
Trichloroethane [Mass/volume] in Blood |
|
56783-4
|
Trichloroethane [Moles/volume] in Blood |
|
13637-4
|
Trichloroethane [Mass/volume] in Serum or Plasma |
|
17737-8
|
Trichloroethane [Mass/volume] in Urine |
|
38333-1
|
Trichloroethane [Mass/volume] in Water |
|
80722-2
|
Lymphocyte T-cell and B-cell and Natural killer subsets [Interpretation] in Blood Narrative |
|
80719-8
|
T-cell naive and memory and effector (CD27 and CD45RA) subsets [Interpretation] in Blood Narrative |
|
13024-5
|
Trichlorofluoroethane [Mass/volume] in Blood |
|
13023-7
|
Trichlorofluoromethane [Mass/volume] in Blood |
|
49481-5
|
TCL-1A Ag [Presence] in Tissue by Immune stain |
|
60195-5
|
Trichlormethiazide [Mass/volume] in Blood |
|
60196-3
|
Trichlormethiazide [Mass/volume] in Serum or Plasma |
|
12349-7
|
Trichlormethiazide [Presence] in Urine |
|
9653-7
|
Trichlormethiazide [Mass/volume] in Urine |
|
38533-6
|
TCOF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74682-6
|
Trichloroethanol.free [Mass/volume] in Blood |
|
23540-8
|
Turkey enteritis coronavirus [Presence] in Serum by Immunofluorescence |
|
17740-2
|
Trichlorophenoxyacetate [Presence] in Blood |
|
17741-0
|
Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
|
46960-1
|
TCR alpha beta Ag [Presence] in Tissue by Immune stain |
|
50975-2
|
TCR alpha beta cells [#/volume] in Blood |
|
32860-9
|
TCR alpha beta cells/100 cells in Unspecified specimen |
|
80713-1
|
TCR alpha beta cells/100 CD3 cells in Blood |
|
46961-9
|
TCR gamma delta Ag [Presence] in Tissue by Immune stain |
|
50976-0
|
TCR gamma delta cells [#/volume] in Blood |
|
59042-2
|
TCR gamma delta cells/100 cells in Tissue |
|
32861-7
|
TCR gamma delta cells/100 cells in Unspecified specimen |
|
80714-9
|
TCR gamma delta cells/100 CD3 cells in Blood |
|
21751-3
|
TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
60582-4
|
TCRB gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
60581-6
|
TCRB gene rearrangements [Presence] in Body fluid by Molecular genetics method |
|
60583-2
|
TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
|
56880-8
|
TCRB gene+TCRD gene+TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
46998-1
|
TCRB and HC gene rearrangements in Blood or Tissue by Molecular genetics method |
|
21752-1
|
TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
21753-9
|
TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
60579-0
|
TCRG gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
60578-2
|
TCRG gene rearrangements [Presence] in Body fluid by Molecular genetics method |
|
60580-8
|
TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
|
19723-6
|
Trichlorothiazide cutoff [Mass/volume] in Urine for Confirmatory method |
|
19722-8
|
Trichlorothiazide cutoff [Mass/volume] in Urine for Screen method |
|
19720-2
|
Trichlorothiazide [Mass/volume] in Urine by Confirmatory method |
|
17742-8
|
Trichlorothiazide [Presence] in Urine |
|
19719-4
|
Trichlorothiazide [Presence] in Urine by Confirmatory method |
|
19718-6
|
Trichlorothiazide [Presence] in Urine by Screen method |
|
19721-0
|
Trichlorothiazide [Mass/volume] in Urine |
|
13025-2
|
Trichlorotrifluoroethane [Mass/volume] in Blood |
|
38625-0
|
Trichloroethylene [Mass/volume] in Air |
|
21579-8
|
Trichloroethylene [Mass/volume] in Blood |
|
9793-1
|
Trichloroethylene [Mass/volume] in Urine |
|
38344-8
|
Trichloroethylene [Mass/volume] in Water |
|
93326-7
|
Taurodeoxycholate [Moles/volume] in Serum or Plasma |
|
78351-4
|
Tetradecadienoate (C14:2) [Entitic substance] in Red Blood Cells |
|
35148-6
|
Tetradecadienoate (C14:2) [Moles/volume] in Serum or Plasma |
|
40472-3
|
Tetradecadienoate (C14:2)/Creatinine [Mass Ratio] in Urine |
|
69793-8
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Amniotic fluid |
|
69792-0
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Cerebral spinal fluid |
|
53190-5
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS |
|
74603-2
|
Tetradecadienoylcarnitine (C14:2) [Enzymatic activity/mass] in Fibroblast |
|
18456-4
|
Tetradecadienoylcarnitine (C14:2) [Mass/volume] in Serum or Plasma |
|
30564-9
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Serum or Plasma |
|
69794-6
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Urine |
|
69791-2
|
Tetradecadienoylcarnitine (C14:2)/Creatinine [Molar ratio] in Urine |
|
50333-4
|
Tetradecanedioate/Creatinine [Mass Ratio] in Urine |
|
50061-1
|
Tetradecanedioate/Creatinine [Molar ratio] in Urine |
|
54340-5
|
Tetradecanoylcarnitine (C14) [Moles/volume] in Amniotic fluid |
|
54339-7
|
Tetradecanoylcarnitine (C14) [Moles/volume] in Cerebral spinal fluid |
|
53192-1
|
Tetradecanoylcarnitine (C14) [Moles/volume] in DBS |
|
74606-5
|
Tetradecanoylcarnitine (C14) [Enzymatic activity/mass] in Fibroblast |
|
30565-6
|
Tetradecanoylcarnitine (C14) [Moles/volume] in Serum or Plasma |
|
54338-9
|
Tetradecanoylcarnitine (C14)/Creatinine [Molar ratio] in Urine |
|
50062-9
|
Tetradecenedioate/Creatinine [Molar ratio] in Urine |
|
53191-3
|
Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS |
|
74605-7
|
Tetradecenoylcarnitine (C14:1) [Enzymatic activity/mass] in Fibroblast |
|
18457-2
|
Tetradecenoylcarnitine (C14:1) [Mass/volume] in Serum or Plasma |
|
30566-4
|
Tetradecenoylcarnitine (C14:1) [Moles/volume] in Serum or Plasma |
|
88025-2
|
Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88011-2
|
Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
53194-7
|
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS |
|
59194-1
|
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Serum or Plasma |
|
70159-9
|
Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS |
|
53195-4
|
Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
53193-9
|
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
88010-4
|
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
81780-9
|
Tetradecenoylcarnitine (C14:1)/Creatinine [Molar ratio] in Urine |
|
17712-1
|
Toluene diisocyanate [Mass/volume] in Blood |
|
13847-9
|
Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Blood by Immunoperoxidase stain |
|
20628-4
|
Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Unspecified specimen by Immunoperoxidase stain |
|
57439-2
|
Terminal deoxyribonucleotidyl transferase cells [Presence] in Body fluid |
|
52996-6
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Blood by Flow cytometry (FC) |
|
56900-4
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Cerebral spinal fluid by Flow cytometry (FC) |
|
30116-8
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Cerebral spinal fluid by Immunoperoxidase stain |
|
52997-4
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Body fluid by Flow cytometry (FC) |
|
42620-5
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Bone marrow |
|
52998-2
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Tissue by Flow cytometry (FC) |
|
38435-4
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Unspecified specimen |
|
38516-1
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Unspecified specimen by Immunoassay |
|
30117-6
|
Terminal deoxyribonucleotidyl transferase cells/100 cells in Unspecified specimen by Immunoperoxidase stain |
|
2983-5
|
Terminal deoxyribonucleotidyl transferase [Enzymatic activity/volume] in Plasma |
|
11021-3
|
Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
|
32816-1
|
Microscopic observation [Identifier] in Unspecified specimen by Terminal deoxynucleotidyl transferase stain |
|
5565-7
|
Terminal deoxyribonucleotidyl transferase [Units/volume] in Leukocytes |
|
6264-6
|
Tea IgE Ab [Units/volume] in Serum |
|
16050-7
|
Tea IgE Ab RAST class [Presence] in Serum |
|
7735-4
|
Tea IgG Ab [Units/volume] in Serum |
|
21553-3
|
Tea IgG Ab RAST class [Presence] in Serum |
|
56401-3
|
Tea IgG4 Ab [Mass/volume] in Serum |
|
49723-0
|
Tea IgG Ab [Mass/volume] in Serum |
|
78928-9
|
Teaching physician name |
|
84023-1
|
Team Conference note |
|
84025-6
|
Team Custodial care facility Note |
|
84024-9
|
Team Discharge summary |
|
84028-0
|
Team Letter |
|
84029-8
|
Team Long term care facility Conference note |
|
84030-6
|
Team Long term care facility Note |
|
84031-4
|
Team Long term care facility Referral note |
|
75494-5
|
Team Note |
|
84032-2
|
Team Outpatient Note |
|
84033-0
|
Team Telephone encounter Note |
|
84034-8
|
Team Plan of care note |
|
84026-4
|
Team Patient's home Conference note |
|
84027-2
|
Team Patient's home Note |
|
73631-4
|
Tedizolid [Susceptibility] by Disk diffusion (KB) |
|
73608-2
|
Tedizolid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73586-0
|
Tedizolid [Susceptibility] |
|
10858-9
|
Teichoate Ab [Presence] in Serum |
|
31673-7
|
Teichoate Ab [Units/volume] in Serum |
|
22571-4
|
Teichoate Ab [Titer] in Serum |
|
10358-0
|
Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
|
4435-4
|
Teicoplanin [Mass] of Dose |
|
80968-1
|
Teicoplanin free [Mass/volume] in Serum or Plasma |
|
7051-6
|
Teicoplanin [Susceptibility] by Gradient strip |
|
485-3
|
Teicoplanin [Susceptibility] by Disk diffusion (KB) |
|
484-6
|
Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
483-8
|
Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC) |
|
34378-0
|
Teicoplanin [Mass/volume] in Serum or Plasma --peak |
|
25534-9
|
Teicoplanin [Moles/volume] in Serum or Plasma --peak |
|
4043-6
|
Teicoplanin [Mass/volume] in Serum or Plasma |
|
18989-4
|
Teicoplanin [Susceptibility] |
|
486-1
|
Teicoplanin [Susceptibility] by Serum bactericidal titer |
|
34379-8
|
Teicoplanin [Mass/volume] in Serum or Plasma --trough |
|
25535-6
|
Teicoplanin [Moles/volume] in Serum or Plasma --trough |
|
72860-0
|
Telaprevir [Susceptibility] by Genotype method |
|
85051-1
|
Telavancin [Susceptibility] by Gradient strip |
|
73630-6
|
Telavancin [Susceptibility] by Disk diffusion (KB) |
|
72894-9
|
Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88886-7
|
Telavancin [Susceptibility] |
|
56792-5
|
Telbivudine [Susceptibility] by Genotype method |
|
85208-7
|
Telehealth Consult note |
|
85207-9
|
Telehealth Education note |
|
85206-1
|
Telehealth Initial evaluation note |
|
75496-0
|
Telehealth Note |
|
75497-8
|
Telehealth Progress note |
|
75498-6
|
Telehealth Summary note |
|
85863-9
|
Teleimaging Note |
|
46569-0
|
Telephone use - functional ability [CMS Assessment] |
|
41722-0
|
Telithromycin [Susceptibility] by Gradient strip |
|
35843-2
|
Telithromycin [Susceptibility] by Disk diffusion (KB) |
|
35844-0
|
Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35845-7
|
Telithromycin [Susceptibility] |
|
29915-6
|
Tellurium [Mass/time] in 24 hour Urine |
|
52886-9
|
Tellurium [Moles/time] in 24 hour Urine |
|
16140-6
|
Tellurium [Mass/volume] in Blood |
|
60178-1
|
Tellurium [Mass/mass] in Hair |
|
60179-9
|
Tellurium [Mass/mass] in Nail |
|
60180-7
|
Tellurium [Mass/volume] in Red Blood Cells |
|
12706-8
|
Tellurium [Mass/volume] in Serum or Plasma |
|
60181-5
|
Tellurium [Mass/mass] in Tissue |
|
17681-8
|
Tellurium [Presence] in Urine |
|
5742-2
|
Tellurium [Mass/volume] in Urine |
|
52895-0
|
Tellurium [Moles/volume] in Urine |
|
29939-6
|
Tellurium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52920-6
|
Tellurium/Creatinine [Molar ratio] in 24 hour Urine |
|
52919-8
|
Tellurium/Creatinine [Molar ratio] in Urine |
|
73125-7
|
Telmisartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73124-0
|
Telmisartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35463-9
|
Telomere analysis [Identifier] in Blood or Tissue Nominal |
|
489-5
|
Temafloxacin [Susceptibility] by Disk diffusion (KB) |
|
488-7
|
Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
487-9
|
Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18990-2
|
Temafloxacin [Susceptibility] |
|
490-3
|
Temafloxacin [Susceptibility] by Serum bactericidal titer |
|
59746-8
|
Temazepam [Mass/volume] in Blood by Confirmatory method |
|
59745-0
|
Temazepam [Mass/volume] in Blood |
|
19701-2
|
Temazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19700-4
|
Temazepam cutoff [Mass/volume] in Urine for Screen method |
|
59748-4
|
Temazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59747-6
|
Temazepam [Mass/volume] in Body fluid |
|
61091-5
|
Temazepam [Presence] in Gastric fluid |
|
94106-2
|
Temazepam glucuronide [Presence] in Urine by Screen method |
|
26834-2
|
Temazepam [Mass/mass] in Hair |
|
59749-2
|
Temazepam [Mass/mass] in Meconium by Confirmatory method |
|
26937-3
|
Temazepam [Mass/mass] in Meconium |
|
72738-8
|
Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72634-9
|
Temazepam [Presence] in Saliva (oral fluid) |
|
57302-2
|
Temazepam [Mass/volume] in Saliva (oral fluid) |
|
59750-0
|
Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13580-6
|
Temazepam [Presence] in Serum or Plasma |
|
10343-2
|
Temazepam [Mass/volume] in Serum or Plasma |
|
29654-1
|
Temazepam [Moles/volume] in Serum or Plasma |
|
59751-8
|
Temazepam [Mass/mass] in Stool by Confirmatory method |
|
16184-4
|
Temazepam [Mass/volume] in Stool |
|
27249-2
|
Temazepam [Mass/mass] in Stool |
|
59752-6
|
Temazepam [Mass/mass] in Tissue |
|
20559-1
|
Temazepam [Mass/volume] in Urine by Confirmatory method |
|
61060-0
|
Temazepam [Presence] in Urine |
|
16206-5
|
Temazepam [Presence] in Urine by Confirmatory method |
|
19698-0
|
Temazepam [Presence] in Urine by Screen method |
|
12382-8
|
Temazepam [Mass/volume] in Urine |
|
26898-7
|
Temazepam [Mass/volume] in Vitreous fluid |
|
61061-8
|
Temazepam [Presence] in Unspecified specimen |
|
48965-8
|
Temazepam [Mass/volume] in Unspecified specimen |
|
77329-1
|
Temazepam [Moles/volume] in Unspecified specimen |
|
58369-0
|
Temazepam/Creatinine [Mass Ratio] in Urine |
|
60182-3
|
Temephos [Mass/volume] in Urine |
|
54190-4
|
Temocillin [Susceptibility] by Gradient strip |
|
493-7
|
Temocillin [Susceptibility] by Disk diffusion (KB) |
|
492-9
|
Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
491-1
|
Temocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18991-0
|
Temocillin [Susceptibility] |
|
494-5
|
Temocillin [Susceptibility] by Serum bactericidal titer |
|
11534-5
|
Temperature charts |
|
75961-3
|
Temperature control mode Infant microenvironment |
|
76006-6
|
Temperature difference |
|
81673-6
|
Temperature of Extremity |
|
75955-5
|
Temperature Infant microenvironment.incubator |
|
78934-7
|
Temporary pacing performed |
|
75957-1
|
Temperature setting Infant microenvironment.incubator |
|
93862-1
|
Temperature setting Veterinary cage |
|
44968-6
|
Temperature of Skin palpation |
|
43741-8
|
Temperature of Semen |
|
58681-8
|
Temperature of Urine |
|
93861-3
|
Temperature Veterinary cage |
|
75956-3
|
Temperature sensor [Resistance] Infant microenvironment |
|
54609-3
|
Temporal orientation - current day of the week [BIMS] |
|
52733-3
|
Temporal orientation - current month [BIMS] |
|
52732-5
|
Temporal orientation - current year [BIMS] |
|
80290-0
|
Temporal orientation - person |
|
80291-8
|
Temporal orientation - place |
|
80292-6
|
Temporal orientation - time |
|
80293-4
|
Temporal orientation assessment [Interpretation] |
|
88983-2
|
Tender joint |
|
88981-6
|
Tender joint # |
|
41396-3
|
Tenofovir [Susceptibility] by Genotype method |
|
34644-5
|
Tenofovir [Susceptibility] by Phenotype method |
|
38374-5
|
Tenofovir [Mass/volume] in Serum or Plasma |
|
33627-1
|
Tenofovir [Susceptibility] |
|
68910-9
|
Teratozoospermia index in Semen |
|
72942-6
|
Terazosin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72941-8
|
Terazosin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60183-1
|
Terazosin [Mass/volume] in Blood |
|
73123-2
|
Terazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73122-4
|
Terazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60184-9
|
Terazosin [Mass/volume] in Serum or Plasma |
|
10720-1
|
Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
10721-9
|
Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18992-8
|
Terbinafine [Susceptibility] |
|
31174-6
|
Terbufos [Mass/volume] in Blood |
|
35481-1
|
Terbufos [Mass/volume] in Serum or Plasma |
|
21554-1
|
Terbufos [Mass/volume] in Urine |
|
87754-8
|
Terbufos [Mass/mass] in Unspecified specimen |
|
9702-2
|
Terbutaline [Mass/volume] in Serum or Plasma |
|
29634-3
|
Terbutaline [Presence] in Urine |
|
55196-0
|
Terconazole [Susceptibility] |
|
12418-0
|
Terfenadine [Mass/volume] in Serum or Plasma |
|
12419-8
|
Terfenadine [Mass/volume] in Urine |
|
44828-2
|
Teriflunomide [Mass/volume] in Serum or Plasma |
|
7736-2
|
Termamyl IgE Ab [Units/volume] in Serum |
|
82019-1
|
Termamyl IgE Ab RAST class [Presence] in Serum |
|
17682-6
|
Terpineol [Presence] in Blood |
|
82621-4
|
Time to end-systole Left ventricle SPECT |
|
62364-5
|
Test performance information in Unspecified specimen Narrative |
|
91690-8
|
Testing services available at Facility |
|
72152-2
|
Tested for HIV [RHEA] |
|
72182-9
|
Tested for HIV Significant other [RHEA] |
|
13932-9
|
Testes IgG Ab [Titer] in Serum |
|
72041-7
|
Testing of arteriovenous graft for access dysfunction performed [ESRD] |
|
72040-9
|
Testing of arteriovenous graft performed using static venous pressure [ESRD] |
|
66124-9
|
Testis Pathology biopsy report |
|
58027-4
|
Testolactone [Presence] in Urine |
|
17688-3
|
Testosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
47940-2
|
Testosterone [Mass/volume] in Serum or Plasma --12 hours post 5000 U HCG IM |
|
17689-1
|
Testosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
47942-8
|
Testosterone [Mass/volume] in Serum or Plasma --1 day post 5000 U HCG IM |
|
47941-0
|
Testosterone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
12922-1
|
Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
26826-8
|
Testosterone [Mass/volume] in 24 hour Urine |
|
2989-2
|
Testosterone [Mass/time] in 24 hour Urine |
|
25986-1
|
Testosterone [Moles/volume] in 24 hour Urine |
|
15095-3
|
Testosterone [Moles/time] in 24 hour Urine |
|
47943-6
|
Testosterone [Mass/volume] in Serum or Plasma --2 days post 5000 U HCG IM |
|
17690-9
|
Testosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
17691-7
|
Testosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
47945-1
|
Testosterone [Mass/volume] in Serum or Plasma --3 days post 5000 U HCG IM |
|
58851-7
|
Testosterone [Mass/volume] in Serum or Plasma --3 days post XXX challenge |
|
12921-3
|
Testosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
40326-1
|
Testosterone [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus |
|
17692-5
|
Testosterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
17693-3
|
Testosterone [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
|
47944-4
|
Testosterone [Mass/volume] in Serum or Plasma --4 hours post 5000 U HCG IM |
|
55518-5
|
Testosterone [Moles/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone |
|
1638-6
|
Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM |
|
2992-6
|
Testosterone [Mass/volume] in Amniotic fluid |
|
93730-0
|
Testosterone [Moles/volume] in Amniotic fluid |
|
30123-4
|
Testosterone.bound [Mass/volume] in Serum or Plasma |
|
58835-0
|
Testosterone [Mass/volume] in Serum or Plasma --baseline |
|
55519-3
|
Testosterone [Moles/volume] in Serum or Plasma --baseline |
|
59233-7
|
Testosterone [Moles/volume] in Cerebral spinal fluid |
|
59240-2
|
Testosterone [Moles/volume] in Body fluid |
|
17685-9
|
Testosterone Free [Mass/volume] in Dialysis fluid |
|
15432-8
|
Testosterone Free/Testosterone.total in Serum or Plasma |
|
49043-3
|
Testosterone Free/Testosterone.total in Serum or Plasma by Detection limit <= 1.0 ng/dL |
|
70240-7
|
Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
|
49042-5
|
Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
|
25987-9
|
Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
2991-8
|
Testosterone Free [Mass/volume] in Serum or Plasma |
|
35225-2
|
Testosterone Free [Mass or Moles/volume] in Serum or Plasma |
|
14914-6
|
Testosterone Free [Moles/volume] in Serum or Plasma |
|
72409-6
|
Testosterone [Moles/volume] in Serum or Plasma --post dose HCG |
|
59219-6
|
Testosterone [Moles/volume] in Pleural fluid |
|
1639-4
|
Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM |
|
47946-9
|
Testosterone [Mass/volume] in Serum or Plasma --pre dose corticotropin |
|
72410-4
|
Testosterone [Moles/volume] in Serum or Plasma --pre dose HCG |
|
40325-3
|
Testosterone [Moles/volume] in Serum or Plasma --pre dose triple bolus |
|
51421-6
|
Testosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
59229-5
|
Testosterone [Moles/volume] in Peritoneal fluid |
|
27306-0
|
Testosterone [Presence] in Saliva (oral fluid) |
|
2984-3
|
Testosterone [Mass/volume] in Saliva (oral fluid) |
|
48357-8
|
Testosterone [Moles/volume] in Saliva (oral fluid) |
|
70239-9
|
Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
|
49041-7
|
Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
|
83116-4
|
Testosterone [Mass/volume] in Serum or Plasma by Immunoassay |
|
83115-6
|
Testosterone [Moles/volume] in Serum or Plasma by Immunoassay |
|
2986-8
|
Testosterone [Mass/volume] in Serum or Plasma |
|
35224-5
|
Testosterone [Mass or Moles/volume] in Serum or Plasma |
|
14913-8
|
Testosterone [Moles/volume] in Serum or Plasma |
|
21555-8
|
Testosterone [Mass/volume] adjusted for sex hormone binding globulin in Serum or Plasma |
|
2985-0
|
Testosterone [Mass/volume] in Semen |
|
10631-0
|
Testosterone [Moles/volume] in Semen |
|
59995-1
|
Testosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
59994-4
|
Testosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
58810-3
|
Testosterone [Mass/volume] in Serum or Plasma --2nd specimen |
|
59993-6
|
Testosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
59992-8
|
Testosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
59991-0
|
Testosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
59990-2
|
Testosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
59989-4
|
Testosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
59988-6
|
Testosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
2987-6
|
Testosterone [Presence] in Urine |
|
2988-4
|
Testosterone [Mass/volume] in Urine |
|
15094-6
|
Testosterone [Moles/volume] in Urine |
|
17686-7
|
Testosterone.weakly bound [Mass/volume] in Serum or Plasma |
|
76352-4
|
Testosterone/Cortisol [Molar ratio] in Serum or Plasma |
|
26827-6
|
Testosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
13486-6
|
Testosterone/Creatinine [Mass Ratio] in Urine |
|
34380-6
|
Testosterone/Creatinine [Molar ratio] in Urine |
|
17687-5
|
Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma |
|
31030-0
|
Testosterone/Epitestosterone [Mass Ratio] in Urine |
|
73570-4
|
Testosterone/Epitestosterone [Interpretation] in Urine Qualitative |
|
6891-6
|
Testosterone.free+weakly bound/Testosterone.total in Serum or Plasma |
|
51005-7
|
Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma by High sensitivity method |
|
2990-0
|
Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma |
|
41018-3
|
Testosterone.free+weakly bound [Moles/volume] in Serum or Plasma |
|
62260-5
|
Tetracycline resistance tetK + tetM genes [Presence] by Molecular method |
|
4436-2
|
Tetracaine [Mass] of Dose |
|
4044-4
|
Tetracaine [Mass/volume] in Serum or Plasma |
|
38753-0
|
Tetrachloroethane [Mass/volume] in Air |
|
17697-4
|
Tetrachloroethane [Mass/volume] in Blood |
|
10815-9
|
Microscopic observation [Identifier] in Tissue by Tetrachrome stain |
|
4437-0
|
Tetracycline [Mass] of Dose |
|
49855-0
|
Tetracycline IgE Ab [Units/volume] in Serum |
|
73121-6
|
Tetracycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73120-8
|
Tetracycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7052-4
|
Tetracycline [Susceptibility] by Gradient strip |
|
497-8
|
Tetracycline [Susceptibility] by Disk diffusion (KB) |
|
496-0
|
Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
495-2
|
Tetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
48271-1
|
Tetracycline triggered leukotriene release [Mass/volume] by Leukocytes |
|
4045-1
|
Tetracycline [Mass/volume] in Serum or Plasma |
|
18993-6
|
Tetracycline [Susceptibility] |
|
498-6
|
Tetracycline [Susceptibility] by Serum bactericidal titer |
|
25272-6
|
Tetracycline [Mass/volume] in Unspecified specimen |
|
87590-6
|
Tetracycline [Mass/mass] in Unspecified specimen |
|
17698-2
|
Tetraethyl lead [Mass/volume] in Blood |
|
35579-2
|
Tetrahydrofuran [Mass/volume] in Urine |
|
58028-2
|
Tetrahydrogestrinone [Presence] in Urine |
|
10932-2
|
Tetramin IgE Ab [Units/volume] in Serum |
|
16051-5
|
Tetramin IgE Ab RAST class [Presence] in Serum |
|
80649-7
|
Tetramethylenedisulfotetramine [Mass/volume] in Urine |
|
72302-3
|
Texture of Nail |
|
9803-8
|
Texture of Stone |
|
72487-2
|
TF gene full mutation analysis in Blood or Tissue by Sequencing |
|
77091-7
|
TFB1M gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77090-9
|
TFB1M gene full mutation analysis in Blood or Tissue by Sequencing |
|
86926-3
|
Transmissible gastroenteritis virus Ab/Negative control in Serum by Immunoassay |
|
23487-2
|
Transmissible gastroenteritis virus Ab [Presence] in Serum |
|
23491-4
|
Transmissible gastroenteritis virus Ab [Presence] in Serum by Immunoassay |
|
23488-0
|
Transmissible gastroenteritis virus Ab [Presence] in Serum by Neutralization test |
|
31686-9
|
Transmissible gastroenteritis virus Ab [Units/volume] in Serum |
|
23489-8
|
Transmissible gastroenteritis virus Ab [Titer] in Serum |
|
23492-2
|
Transmissible gastroenteritis virus Ab [Titer] in Serum by Neutralization test |
|
23494-8
|
Transmissible gastroenteritis virus Ag [Presence] in Stool by Immunoassay |
|
23497-1
|
Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
|
23496-3
|
Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immune stain |
|
31977-2
|
Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen |
|
23495-5
|
Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23493-0
|
Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
86218-5
|
Transmissible gastroenteritis virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23498-9
|
Transmissible gastroenteritis virus RNA [Presence] in Unspecified specimen by Probe |
|
74129-8
|
Transforming growth factor alpha Ag [Presence] in Tissue by Immune stain |
|
53840-5
|
TGFB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49853-5
|
Transforming growth factor beta 1 [Mass/volume] in Serum or Plasma |
|
47972-5
|
TGFBR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53899-1
|
TGFBR1 gene+TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47973-3
|
TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
69573-4
|
Tiglylcarnitine+methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
|
48602-7
|
TGM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41050-6
|
TH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40430-1
|
TH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
73839-3
|
11-Dehydrotetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
73840-1
|
11-Dehydrotetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
73838-5
|
11-Dehydrotetrahydrocorticosterone [Moles/volume] in Urine |
|
81797-3
|
11-Dehydrotetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
13618-4
|
Tetrahydroaldosterone [Mass/time] in 24 hour Urine |
|
32570-4
|
Tetrahydroaldosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
30515-1
|
Tetrahydroaldosterone/Creatinine [Mass Ratio] in Urine |
|
30929-4
|
Thallium [Mass/volume] in Urine collected for unspecified duration |
|
21558-2
|
Thallium [Mass/volume] in 24 hour Urine |
|
5746-3
|
Thallium [Mass/time] in 24 hour Urine |
|
50918-2
|
Thallium [Moles/volume] in 24 hour Urine |
|
42224-6
|
Thallium [Moles/time] in 24 hour Urine |
|
32114-1
|
Thallium [Presence] in Blood |
|
5743-0
|
Thallium [Mass/volume] in Blood |
|
25173-6
|
Thallium [Moles/volume] in Blood |
|
51207-9
|
Thallium [Mass/volume] in Body fluid |
|
15408-8
|
Thallium [Mass/mass] in Hair |
|
50917-4
|
Thallium [Moles/mass] in Hair |
|
15409-6
|
Thallium [Mass/mass] in Nail |
|
60185-6
|
Thallium [Mass/volume] in Red Blood Cells |
|
47130-0
|
Thallium [Moles/volume] in Red Blood Cells |
|
5744-8
|
Thallium [Mass/volume] in Serum or Plasma |
|
25537-2
|
Thallium [Moles/volume] in Serum or Plasma |
|
20975-9
|
Thallium [Mass/mass] in Tissue |
|
5745-5
|
Thallium [Mass/volume] in Urine |
|
42225-3
|
Thallium [Moles/volume] in Urine |
|
38311-7
|
Thallium [Mass/volume] in Water |
|
87614-4
|
Thallium [Mass/mass] in Unspecified specimen |
|
29938-8
|
Thallium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52918-0
|
Thallium/Creatinine [Molar ratio] in 24 hour Urine |
|
13469-2
|
Thallium/Creatinine [Mass Ratio] in Urine |
|
42226-1
|
Thallium/Creatinine [Molar ratio] in Urine |
|
9579-4
|
Tetrahydrocorticosterone [Mass/time] in 24 hour Urine |
|
73887-2
|
Tetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
73888-0
|
Tetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
73889-8
|
Tetrahydrocorticosterone [Moles/volume] in Urine |
|
82907-7
|
Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in 24 hour Urine |
|
82906-9
|
Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in Urine |
|
50644-4
|
Tetrahydrocorticosterone/Creatinine [Mass Ratio] in Urine |
|
81796-5
|
Tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
92995-0
|
THBD gene full mutation analysis in Blood or Tissue by Sequencing |
|
74794-9
|
Thyroid hormone binding ratio (THBR) in Serum or Plasma |
|
58047-2
|
Tetrahydrocannabinol [Presence] in Blood by Confirmatory method |
|
19418-3
|
Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method |
|
19417-5
|
Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method |
|
4438-8
|
Tetrahydrocannabinol [Mass] of Dose |
|
8163-8
|
Tetrahydrocannabinol [Presence] in Gastric fluid |
|
8164-6
|
Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method |
|
8165-3
|
Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method |
|
8162-0
|
Tetrahydrocannabinol [Mass/volume] in Gastric fluid |
|
80551-5
|
Tetrahydrocannabinol [Mass/mass] in Hair |
|
8167-9
|
Tetrahydrocannabinol [Presence] in Meconium |
|
8168-7
|
Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method |
|
8169-5
|
Tetrahydrocannabinol [Presence] in Meconium by Screen method |
|
8166-1
|
Tetrahydrocannabinol [Mass/volume] in Meconium |
|
26893-8
|
Tetrahydrocannabinol [Mass/mass] in Meconium |
|
44049-5
|
Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method |
|
51791-2
|
Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method |
|
73935-9
|
Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3528-7
|
Tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
|
12351-3
|
Tetrahydrocannabinol [Presence] in Stool |
|
18432-5
|
Tetrahydrocannabinol [Presence] in Stool by Screen method |
|
26731-0
|
Tetrahydrocannabinol [Mass/mass] in Stool |
|
14313-1
|
Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
3426-4
|
Tetrahydrocannabinol [Presence] in Urine |
|
19416-7
|
Tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
|
17872-3
|
Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL |
|
8174-5
|
Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method |
|
8175-2
|
Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method |
|
19415-9
|
Tetrahydrocannabinol [Presence] in Urine by Screen method |
|
21557-4
|
Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL |
|
21556-6
|
Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL |
|
14312-3
|
Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL |
|
3530-3
|
Tetrahydrocannabinol [Mass/volume] in Urine |
|
27193-2
|
Tetrahydrocannabinol [Mass/volume] in Vitreous fluid |
|
43834-1
|
Tetrahydrocannabinol [Presence] in Unspecified specimen |
|
13478-3
|
Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
|
16116-6
|
Tetrahydrocortisone [Mass/time] in 24 hour Urine |
|
73893-0
|
Tetrahydrocortisone [Moles/volume] in 24 hour Urine |
|
56657-0
|
Tetrahydrocortisone [Moles/time] in 24 hour Urine |
|
4439-6
|
Tetrahydrocortisone [Mass] of Dose |
|
12325-7
|
Tetrahydrocortisone [Presence] in Urine |
|
4046-9
|
Tetrahydrocortisone [Mass/volume] in Urine |
|
73894-8
|
Tetrahydrocortisone [Moles/volume] in Urine |
|
30514-4
|
Tetrahydrocortisone/Creatinine [Mass Ratio] in Urine |
|
81795-7
|
Tetrahydrocortisone/Creatinine [Molar ratio] in Urine |
|
2996-7
|
Tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine |
|
73842-7
|
Tetrahydrodeoxycortisol [Moles/volume] in 24 hour Urine |
|
73843-5
|
Tetrahydrodeoxycortisol [Moles/time] in 24 hour Urine |
|
73841-9
|
Tetrahydrodeoxycortisol [Moles/volume] in Urine |
|
81793-2
|
Tetrahydrodeoxycortisol/Creatinine [Molar ratio] in 24 hour Urine |
|
44412-5
|
Tetrahydrodeoxycortisol/Creatinine [Mass Ratio] in Urine |
|
93325-9
|
Taurohyodeoxycholate [Moles/volume] in Serum or Plasma |
|
82860-8
|
11-Deoxytetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
82859-0
|
11-Deoxytetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
82858-2
|
11-Deoxytetrahydrocorticosterone [Moles/volume] in Urine |
|
83130-5
|
11-Deoxytetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
75058-8
|
Thymidine phosphorylase [Enzymatic activity/volume] in DBS |
|
33988-7
|
Thymidine phosphorylase [Enzymatic activity/mass] in Leukocytes |
|
71172-1
|
The cancer-tumor experience has taught me to appreciate life in the past 7 days [FACIT] |
|
71206-7
|
The cancer-tumor experience has taught my child to appreciate life in the past 7 days [FACIT] |
|
71171-3
|
The cancer-tumor experience makes me a stronger person in the past 7 days [FACIT] |
|
71205-9
|
The cancer-tumor experience makes my child a stronger person in the past 7 days [FACIT] |
|
94049-4
|
The care I get in this practice is informed by knowledge of my community [PCPCM] |
|
94048-6
|
The care I get takes into account knowledge of my family [PCPCM] |
|
90024-1
|
The current treatment has been going on for too long without success [PsoSat] |
|
72700-8
|
The idea of death had a certain fascination for me in last week [BSL-23] |
|
92304-5
|
The idea of not having any cigarettes causes me stress [PROMIS] |
|
71288-5
|
The illness experience has taught me to appreciate life in the past 4 weeks [FACIT] |
|
71231-5
|
The illness experience has taught my child to appreciate life in the past 4 weeks [FACIT] |
|
71287-7
|
The illness experience makes me a stronger person in the past 4 weeks [FACIT] |
|
71232-3
|
The illness experience makes my child a stronger person in the past 4 weeks [FACIT] |
|
76909-1
|
The largest number of drinks that I had in a single day in past 30D was... [PROMIS] |
|
76815-0
|
The quality of my work is as good as I want it to be (include work at home) [PROMIS] |
|
90023-3
|
The side effects are causing me discomfort [PsoSat] |
|
71353-7
|
The thought of harming myself has occurred to me in the past 7 days [EPDS] |
|
90025-8
|
The treament itself is putting a great strain on me [PsoSat] |
|
17699-0
|
Thebaine [Mass/volume] in Serum or Plasma |
|
23482-3
|
Theileria sp [Presence] in Blood by Giemsa stain |
|
23483-1
|
Theileria sp [Presence] in Tissue by Giemsa stain |
|
12302-6
|
Theobromine [Presence] in Serum or Plasma |
|
31169-6
|
Theobromine [Mass/volume] in Serum or Plasma |
|
12303-4
|
Theobromine [Presence] in Urine |
|
4047-7
|
Theophylline [Mass/volume] in Blood |
|
13581-4
|
Theophylline [Mass/volume] in Cerebral spinal fluid |
|
4440-4
|
Theophylline [Mass] of Dose |
|
13582-2
|
Theophylline [Mass/volume] in Body fluid |
|
80967-3
|
Theophylline free [Mass/volume] in Serum or Plasma |
|
21559-0
|
Theophylline [Mass/volume] in Gastric fluid |
|
32115-8
|
Theophylline [Moles/volume] in Serum or Plasma --peak |
|
4048-5
|
Theophylline [Mass/volume] in Saliva (oral fluid) |
|
35596-6
|
Theophylline [Mass/volume] in Serum or Plasma by Screen method |
|
4049-3
|
Theophylline [Mass/volume] in Serum or Plasma |
|
35238-5
|
Theophylline [Mass or Moles/volume] in Serum or Plasma |
|
14915-3
|
Theophylline [Moles/volume] in Serum or Plasma |
|
72673-7
|
Theophylline [Mass/volume] in Serum or Plasma --trough |
|
32116-6
|
Theophylline [Moles/volume] in Serum or Plasma --trough |
|
33323-7
|
Theophylline [Presence] in Urine by Screen method |
|
17700-6
|
Theophylline [Mass/volume] in Urine |
|
46081-6
|
Theophylline [Moles/volume] in Urine |
|
87789-4
|
Theophylline/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
34577-7
|
Apheresis.therapeutic [Interpretation] |
|
89179-6
|
Therapeutic exercise performed [Identifier] |
|
92565-1
|
Therapeutic exercise plan to perform [Identifier] |
|
19812-7
|
Therapeutic intervention Endoscopy procedure |
|
19813-5
|
Therapeutic intervention [Description] Endoscopy procedure Narrative |
|
19815-0
|
Therapeutic results [Description] Endoscopy procedure Narrative |
|
19814-3
|
Therapeutic results [Interpretation] Endoscopy procedure |
|
46466-9
|
Therapeutic substance administered at home [CMS Assessment] |
|
57268-5
|
Therapy need # [CMS Assessment] |
|
76871-3
|
There are people I can talk to [PROMIS] |
|
90022-5
|
There has been no progress in my treatment for quite some time [PsoSat] |
|
10638-5
|
Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
|
10639-3
|
Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
|
13198-7
|
Thermoactinomyces Ab [Units/volume] in Serum |
|
31683-6
|
Thermoactinomyces IgG Ab [Units/volume] in Serum |
|
26949-8
|
Thermoactinomyces IgG Ab [Mass/volume] in Serum |
|
71566-4
|
These symptoms affect my relationships with friends or family [M3] |
|
71567-2
|
These symptoms have led to my using alcohol to get by [M3] |
|
71568-0
|
These symptoms have led to my using drugs [M3] |
|
71565-6
|
These symptoms interfere with work or school [M3] |
|
60851-3
|
Theta frequency relative power on EEG |
|
2995-9
|
Tetrahydrocortisol [Mass/time] in 24 hour Urine |
|
73891-4
|
Tetrahydrocortisol [Moles/volume] in 24 hour Urine |
|
73892-2
|
Tetrahydrocortisol [Moles/time] in 24 hour Urine |
|
73890-6
|
Tetrahydrocortisol [Moles/volume] in Urine |
|
82908-5
|
Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82909-3
|
Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in Urine |
|
50645-1
|
Tetrahydrocortisol/Creatinine [Mass Ratio] in Urine |
|
81794-0
|
Tetrahydrocortisol/Creatinine [Molar ratio] in Urine |
|
82857-4
|
Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in 24 hour Urine |
|
82856-6
|
Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in Urine |
|
75048-9
|
Tetrahydrofolate [Moles/volume] in Cerebral spinal fluid |
|
2997-5
|
Tetrahydrofolate [Mass/volume] in Plasma |
|
54184-7
|
Thiacetazone [Susceptibility] by Disk diffusion (KB) |
|
54204-3
|
Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32384-0
|
Thiacetazone [Susceptibility] |
|
41724-6
|
Thiamphenicol [Susceptibility] by Gradient strip |
|
41723-8
|
Thiamphenicol [Susceptibility] by Disk diffusion (KB) |
|
41725-3
|
Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54169-8
|
Thiamphenicol [Susceptibility] |
|
12492-5
|
Thiamylal [Presence] in Serum or Plasma |
|
19311-0
|
Thiazides confirm method [Identifier] in Urine |
|
19309-4
|
Thiazides cutoff [Mass/volume] in Urine for Confirmatory method |
|
19308-6
|
Thiazides cutoff [Mass/volume] in Urine for Screen method |
|
19307-8
|
Thiazides positive [Identifier] in Urine by Confirmatory method |
|
19310-2
|
Thiazides screen method [Identifier] in Urine |
|
19304-5
|
Thiazides tested for in Urine by Screen method Nominal |
|
19305-2
|
Thiazides tested for in Urine by Screen method Narrative |
|
12343-0
|
Thiazides [Identifier] in Urine |
|
20414-9
|
Thiazides [Mass/volume] in Urine by Confirmatory method |
|
19306-0
|
Thiazides [Presence] in Urine by Confirmatory method |
|
19303-7
|
Thiazides [Presence] in Urine by Screen method |
|
17701-4
|
Thiazides [Mass/volume] in Urine |
|
60186-4
|
Thiethylperazine [Mass/volume] in Blood |
|
60187-2
|
Thiethylperazine [Mass/volume] in Serum or Plasma |
|
60188-0
|
Thiethylperazine [Mass/volume] in Urine |
|
77653-4
|
Microscopic observation [Identifier] in Anorectal Cyto stain.thin prep |
|
50389-6
|
Microscopic observation [Identifier] in Bronchial brush by Cyto stain.thin prep |
|
18500-9
|
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
|
39086-4
|
Microscopic observation [Identifier] in Vaginal fluid by Cyto stain.thin prep |
|
71349-5
|
Things have been getting on top of me in the past 7 days [EPDS] |
|
81361-8
|
Things that make me laugh [Reported] |
|
81363-4
|
Things that matter to me [Reported] |
|
91456-4
|
Thinking about my life, I always have hope [PROMIS.PEDS] |
|
91457-2
|
Thinking about my life, I am full of hope [PROMIS.PEDS] |
|
91458-0
|
Thinking about my life, I am positive about my future [PROMIS.PEDS] |
|
91459-8
|
Thinking about my life, I am satisfied with my purpose in life [PROMIS.PEDS] |
|
91460-6
|
Thinking about my life, I can do almost anything if I have enough faith in myself [PROMIS.PEDS] |
|
91461-4
|
Thinking about my life, I can reach my goals in life [PROMIS.PEDS] |
|
91462-2
|
Thinking about my life, I expect amazing things to happen to me [PROMIS.PEDS] |
|
91463-0
|
Thinking about my life, I expect things to work out for the best [PROMIS.PEDS] |
|
91464-8
|
Thinking about my life, I expect to achieve my goals [PROMIS.PEDS] |
|
91465-5
|
Thinking about my life, I expect to achieve what I want in life [PROMIS.PEDS] |
|
91466-3
|
Thinking about my life, I expect to be successful in the future [PROMIS.PEDS] |
|
91467-1
|
Thinking about my life, I expect to enjoy my future life [PROMIS.PEDS] |
|
91468-9
|
Thinking about my life, I expect to have a family in the future [PROMIS.PEDS] |
|
91469-7
|
Thinking about my life, I expect to have a job in the future [PROMIS.PEDS] |
|
91470-5
|
Thinking about my life, I expect to have a long life [PROMIS.PEDS] |
|
91471-3
|
Thinking about my life, I expect to have success in the future [PROMIS.PEDS] |
|
91472-1
|
Thinking about my life, I expect to succeed at what I try to do [PROMIS.PEDS] |
|
91473-9
|
Thinking about my life, I feel hopeful about my future [PROMIS.PEDS] |
|
91474-7
|
Thinking about my life, I feel hopeful about my plans for the future [PROMIS.PEDS] |
|
91475-4
|
Thinking about my life, I have a clear purpose in life [PROMIS.PEDS] |
|
91476-2
|
Thinking about my life, I have a reason for living [PROMIS.PEDS] |
|
91477-0
|
Thinking about my life, I have goals for myself [PROMIS.PEDS] |
|
91478-8
|
Thinking about my life, I have hope [PROMIS.PEDS] |
|
91479-6
|
Thinking about my life, I have things I need to do in life [PROMIS.PEDS] |
|
91480-4
|
Thinking about my life, I have things I want to accomplish in life [PROMIS.PEDS] |
|
91481-2
|
Thinking about my life, I have things I want to do in life [PROMIS.PEDS] |
|
91482-0
|
Thinking about my life, I know what makes my life meaningful [PROMIS.PEDS] |
|
91483-8
|
Thinking about my life, I know where I am going in life [PROMIS.PEDS] |
|
91484-6
|
Thinking about my life, I look forward to what will happen in the future [PROMIS.PEDS] |
|
91485-3
|
Thinking about my life, I make plans for my future [PROMIS.PEDS] |
|
91486-1
|
Thinking about my life, I try to find meaning in life [PROMIS.PEDS] |
|
91487-9
|
Thinking about my life, I try to find purpose in life [PROMIS.PEDS] |
|
91488-7
|
Thinking about my life, I want to do what is important [PROMIS.PEDS] |
|
91489-5
|
Thinking about my life, I want to make the most out of my life [PROMIS.PEDS] |
|
91490-3
|
Thinking about my life, my life has meaning [PROMIS.PEDS] |
|
91491-1
|
Thinking about my life, my life has purpose [PROMIS.PEDS] |
|
91492-9
|
Thinking about my life, my life is filled with important things [PROMIS.PEDS] |
|
91493-7
|
Thinking about my life, my life is filled with meaning [PROMIS.PEDS] |
|
91494-5
|
Thinking about my life, my life is filled with purpose [PROMIS.PEDS] |
|
91495-2
|
Thinking about my life, my life is filled with things that interest me [PROMIS.PEDS] |
|
91496-0
|
Thinking about my life, my life is important [PROMIS.PEDS] |
|
91497-8
|
Thinking about my life, people will remember me when I die [PROMIS.PEDS] |
|
91498-6
|
Thinking about my life, the things I have done in the past will help me in the future [PROMIS.PEDS] |
|
91499-4
|
Thinking about my life, when bad things happen, I expect them to get better [PROMIS.PEDS] |
|
91346-7
|
Thinking about the last 2 weeks, I feel that my back pain is terrible and it's never going to get any better [STarT Back] |
|
91347-5
|
Thinking about the last 2 weeks, in general I have not enjoyed all the things I used to enjoy [STarT Back] |
|
91344-2
|
Thinking about the last 2 weeks, it's not really safe for a person with a condition like mine to be physically active [STarT Back] |
|
90624-8
|
Thinking about the past 4 weeks, I enjoyed my life [PROMIS] |
|
90645-3
|
Thinking about the past 4 weeks, I enjoyed my life more than most kids enjoyed their lives [PROMIS] |
|
90632-1
|
Thinking about the past 4 weeks, I felt extremely positive about my life [PROMIS] |
|
90629-7
|
Thinking about the past 4 weeks, I felt good about my life [PROMIS] |
|
90627-1
|
Thinking about the past 4 weeks, I felt positive about my life [PROMIS] |
|
90630-5
|
Thinking about the past 4 weeks, I felt very good about my life [PROMIS] |
|
90647-9
|
Thinking about the past 4 weeks, I got the things I wanted in life [PROMIS] |
|
90628-9
|
Thinking about the past 4 weeks, I had a good life [PROMIS] |
|
90625-5
|
Thinking about the past 4 weeks, I had a lot of fun [PROMIS] |
|
90626-3
|
Thinking about the past 4 weeks, I had fun [PROMIS] |
|
90648-7
|
Thinking about the past 4 weeks, I had what I needed in life [PROMIS] |
|
90649-5
|
Thinking about the past 4 weeks, I had what I wanted in life [PROMIS] |
|
90623-0
|
Thinking about the past 4 weeks, I liked the way I lived my life [PROMIS] |
|
90644-6
|
Thinking about the past 4 weeks, I lived as well as other kids [PROMIS] |
|
90620-6
|
Thinking about the past 4 weeks, I lived my life well [PROMIS] |
|
90640-4
|
Thinking about the past 4 weeks, I was happy with my family life [PROMIS] |
|
90631-3
|
Thinking about the past 4 weeks, I was happy with my life [PROMIS] |
|
90638-8
|
Thinking about the past 4 weeks, I was happy with my life at home [PROMIS] |
|
90639-6
|
Thinking about the past 4 weeks, I was happy with my life at school [PROMIS] |
|
90636-2
|
Thinking about the past 4 weeks, I was happy with my life in my community [PROMIS] |
|
90637-0
|
Thinking about the past 4 weeks, I was happy with my life in my neighborhood [PROMIS] |
|
90641-2
|
Thinking about the past 4 weeks, I was happy with my social life [PROMIS] |
|
90650-3
|
Thinking about the past 4 weeks, I was happy with the way things were [PROMIS] |
|
90635-4
|
Thinking about the past 4 weeks, I was satified with my free time [PROMIS] |
|
90633-9
|
Thinking about the past 4 weeks, I was satisfied with my life [PROMIS] |
|
90619-8
|
Thinking about the past 4 weeks, I was satisfied with my life in general [PROMIS] |
|
90634-7
|
Thinking about the past 4 weeks, I was satisfied with my skills and talents [PROMIS] |
|
90642-0
|
Thinking about the past 4 weeks, I was satisfied with the friends I have [PROMIS] |
|
90579-4
|
Thinking about the past 4 weeks, my child enjoyed his/her life [PROMIS.PARENTPROXY] |
|
90600-8
|
Thinking about the past 4 weeks, my child enjoyed his/her life more than most kids enjoyed their lives [PROMIS.PARENTPROXY] |
|
90587-7
|
Thinking about the past 4 weeks, my child felt extremely positive about his/her life [PROMIS.PARENTPROXY] |
|
90584-4
|
Thinking about the past 4 weeks, my child felt good about his/her life [PROMIS.PARENTPROXY] |
|
90599-2
|
Thinking about the past 4 weeks, my child felt he/she lived as well as other kids [PROMIS.PARENTPROXY] |
|
90575-2
|
Thinking about the past 4 weeks, my child felt he/she lived his/her life well [PROMIS.PARENTPROXY] |
|
90582-8
|
Thinking about the past 4 weeks, my child felt positive about his/her life [PROMIS.PARENTPROXY] |
|
90601-6
|
Thinking about the past 4 weeks, my child felt that his/her life was better than most kids' lives [PROMIS.PARENTPROXY] |
|
90585-1
|
Thinking about the past 4 weeks, my child felt very good about his/her life [PROMIS.PARENTPROXY] |
|
90602-4
|
Thinking about the past 4 weeks, my child got the things he/she wanted in life [PROMIS.PARENTPROXY] |
|
90583-6
|
Thinking about the past 4 weeks, my child had a good life [PROMIS.PARENTPROXY] |
|
90580-2
|
Thinking about the past 4 weeks, my child had a lot of fun [PROMIS.PARENTPROXY] |
|
90581-0
|
Thinking about the past 4 weeks, my child had fun [PROMIS.PARENTPROXY] |
|
90603-2
|
Thinking about the past 4 weeks, my child had what he/she needed in life [PROMIS.PARENTPROXY] |
|
90604-0
|
Thinking about the past 4 weeks, my child had what he/she wanted in life [PROMIS.PARENTPROXY] |
|
90578-6
|
Thinking about the past 4 weeks, my child liked the way he/she lived his/her life [PROMIS.PARENTPROXY] |
|
90595-0
|
Thinking about the past 4 weeks, my child was happy with his/her family life [PROMIS.PARENTPROXY] |
|
90586-9
|
Thinking about the past 4 weeks, my child was happy with his/her life [PROMIS.PARENTPROXY] |
|
90593-5
|
Thinking about the past 4 weeks, my child was happy with his/her life at home [PROMIS.PARENTPROXY] |
|
90594-3
|
Thinking about the past 4 weeks, my child was happy with his/her life at school [PROMIS.PARENTPROXY] |
|
90596-8
|
Thinking about the past 4 weeks, my child was happy with his/her social life [PROMIS.PARENTPROXY] |
|
90591-9
|
Thinking about the past 4 weeks, my child was happy with life in his/her community [PROMIS.PARENTPROXY] |
|
90592-7
|
Thinking about the past 4 weeks, my child was happy with life in his/her neighborhood [PROMIS.PARENTPROXY] |
|
90605-7
|
Thinking about the past 4 weeks, my child was happy with the way things were [PROMIS.PARENTPROXY] |
|
90590-1
|
Thinking about the past 4 weeks, my child was satisfied with his/her free time [PROMIS.PARENTPROXY] |
|
90588-5
|
Thinking about the past 4 weeks, my child was satisfied with his/her life [PROMIS.PARENTPROXY] |
|
90574-5
|
Thinking about the past 4 weeks, my child was satisfied with his/her life in general [PROMIS.PARENTPROXY] |
|
90589-3
|
Thinking about the past 4 weeks, my child was satisfied with his/her skills and talents [PROMIS.PARENTPROXY] |
|
90597-6
|
Thinking about the past 4 weeks, my child was satisfied with the friends he/she has [PROMIS.PARENTPROXY] |
|
90606-5
|
Thinking about the past 4 weeks, my child's life situation was excellent [PROMIS.PARENTPROXY] |
|
90598-4
|
Thinking about the past 4 weeks, my child's life was as good as most kids' lives [PROMIS.PARENTPROXY] |
|
90612-3
|
Thinking about the past 4 weeks, my child's life was excellent [PROMIS.PARENTPROXY] |
|
90609-9
|
Thinking about the past 4 weeks, my child's life was going very well [PROMIS.PARENTPROXY] |
|
90610-7
|
Thinking about the past 4 weeks, my child's life was good [PROMIS.PARENTPROXY] |
|
90611-5
|
Thinking about the past 4 weeks, my child's life was great [PROMIS.PARENTPROXY] |
|
90573-7
|
Thinking about the past 4 weeks, my child's life was ideal [PROMIS.PARENTPROXY] |
|
90608-1
|
Thinking about the past 4 weeks, my child's life was just right [PROMIS.PARENTPROXY] |
|
90613-1
|
Thinking about the past 4 weeks, my child's life was outstanding [PROMIS.PARENTPROXY] |
|
90614-9
|
Thinking about the past 4 weeks, my child's life was the best [PROMIS.PARENTPROXY] |
|
90577-8
|
Thinking about the past 4 weeks, my child's life was worthwhile [PROMIS.PARENTPROXY] |
|
90576-0
|
Thinking about the past 4 weeks, my child's life went well [PROMIS.PARENTPROXY] |
|
90651-1
|
Thinking about the past 4 weeks, my life situation was excellent [PROMIS] |
|
90643-8
|
Thinking about the past 4 weeks, my life was as good as most kids' lives [PROMIS] |
|
90646-1
|
Thinking about the past 4 weeks, my life was better than most kids' lives [PROMIS] |
|
90657-8
|
Thinking about the past 4 weeks, my life was excellent [PROMIS] |
|
90654-5
|
Thinking about the past 4 weeks, my life was going very well [PROMIS] |
|
90655-2
|
Thinking about the past 4 weeks, my life was good [PROMIS] |
|
90656-0
|
Thinking about the past 4 weeks, my life was great [PROMIS] |
|
90618-0
|
Thinking about the past 4 weeks, my life was ideal [PROMIS] |
|
90653-7
|
Thinking about the past 4 weeks, my life was just right [PROMIS] |
|
90658-6
|
Thinking about the past 4 weeks, my life was outstanding [PROMIS] |
|
90659-4
|
Thinking about the past 4 weeks, my life was the best [PROMIS] |
|
90622-2
|
Thinking about the past 4 weeks, my life was worthwhile [PROMIS] |
|
90621-4
|
Thinking about the past 4 weeks, my life went well [PROMIS] |
|
90607-3
|
Thinking about the past 4 weeks, the conditions of my child's life were excellent [PROMIS.PARENTPROXY] |
|
90652-9
|
Thinking about the past 4 weeks, the conditions of my life were excellent [PROMIS] |
|
92110-6
|
Thinking about your child's life, my child always has hope [PROMIS.PARENTPROXY] |
|
92106-4
|
Thinking about your child's life, my child can do almost anything if he or she has enough faith in himself or herself [PROMIS.PARENTPROXY] |
|
92097-5
|
Thinking about your child's life, my child can reach his or her goals in life [PROMIS.PARENTPROXY] |
|
92124-7
|
Thinking about your child's life, my child expects amazing things to happen to him or her [PROMIS.PARENTPROXY] |
|
92123-9
|
Thinking about your child's life, my child expects things to work out for the best [PROMIS.PARENTPROXY] |
|
92099-1
|
Thinking about your child's life, my child expects to achieve his or her goals [PROMIS.PARENTPROXY] |
|
92116-3
|
Thinking about your child's life, my child expects to achieve what he or she wants in life [PROMIS.PARENTPROXY] |
|
92120-5
|
Thinking about your child's life, my child expects to be successful in the future [PROMIS.PARENTPROXY] |
|
92119-7
|
Thinking about your child's life, my child expects to enjoy his or her future life [PROMIS.PARENTPROXY] |
|
92121-3
|
Thinking about your child's life, my child expects to have a family in the future [PROMIS.PARENTPROXY] |
|
92122-1
|
Thinking about your child's life, my child expects to have a job in the future [PROMIS.PARENTPROXY] |
|
92118-9
|
Thinking about your child's life, my child expects to have a long life [PROMIS.PARENTPROXY] |
|
92117-1
|
Thinking about your child's life, my child expects to have success in the future [PROMIS.PARENTPROXY] |
|
92114-8
|
Thinking about your child's life, my child expects to succeed at what he or she tries to do [PROMIS.PARENTPROXY] |
|
92086-8
|
Thinking about your child's life, my child has a clear purpose in life [PROMIS.PARENTPROXY] |
|
92083-5
|
Thinking about your child's life, my child has a reason for living [PROMIS.PARENTPROXY] |
|
92105-6
|
Thinking about your child's life, my child has goals for himself or herself [PROMIS.PARENTPROXY] |
|
92112-2
|
Thinking about your child's life, my child has hope [PROMIS.PARENTPROXY] |
|
92102-3
|
Thinking about your child's life, my child has things he or she needs to do in life [PROMIS.PARENTPROXY] |
|
92101-5
|
Thinking about your child's life, my child has things he or she wants to accomplish in life [PROMIS.PARENTPROXY] |
|
92103-1
|
Thinking about your child's life, my child has things he or she wants to do in life [PROMIS.PARENTPROXY] |
|
92111-4
|
Thinking about your child's life, my child is full of hope [PROMIS.PARENTPROXY] |
|
92108-0
|
Thinking about your child's life, my child is hopeful about his or her future [PROMIS.PARENTPROXY] |
|
92109-8
|
Thinking about your child's life, my child is hopeful about his or her plans for the future [PROMIS.PARENTPROXY] |
|
92107-2
|
Thinking about your child's life, my child is positive about his or her future [PROMIS.PARENTPROXY] |
|
92082-7
|
Thinking about your child's life, my child is satisfied with his or her purpose in life [PROMIS.PARENTPROXY] |
|
92085-0
|
Thinking about your child's life, my child knows what makes his or her life meaningful [PROMIS.PARENTPROXY] |
|
92098-3
|
Thinking about your child's life, my child knows where he or she is going in life [PROMIS.PARENTPROXY] |
|
92115-5
|
Thinking about your child's life, my child looks forward to what will happen in the future [PROMIS.PARENTPROXY] |
|
92104-9
|
Thinking about your child's life, my child makes plans for his or her future [PROMIS.PARENTPROXY] |
|
92091-8
|
Thinking about your child's life, my child thinks his or her life has meaning [PROMIS.PARENTPROXY] |
|
92088-4
|
Thinking about your child's life, my child thinks his or her life has purpose [PROMIS.PARENTPROXY] |
|
92090-0
|
Thinking about your child's life, my child thinks his or her life is filled with meaning [PROMIS.PARENTPROXY] |
|
92087-6
|
Thinking about your child's life, my child thinks his or her life is filled with purpose [PROMIS.PARENTPROXY] |
|
92094-2
|
Thinking about your child's life, my child thinks his or her life is important [PROMIS.PARENTPROXY] |
|
92092-6
|
Thinking about your child's life, my child tries to find meaning in life [PROMIS.PARENTPROXY] |
|
92089-2
|
Thinking about your child's life, my child tries to find purpose in life [PROMIS.PARENTPROXY] |
|
92093-4
|
Thinking about your child's life, my child wants to do what is important [PROMIS.PARENTPROXY] |
|
92096-7
|
Thinking about your child's life, my child wants to make the most out of his or her life [PROMIS.PARENTPROXY] |
|
92095-9
|
Thinking about your child's life, my child's life is filled with important things [PROMIS.PARENTPROXY] |
|
92084-3
|
Thinking about your child's life, my child's life is filled with things that interest him or her [PROMIS.PARENTPROXY] |
|
92081-9
|
Thinking about your child's life, people will remember my child when he or she dies [PROMIS.PARENTPROXY] |
|
92100-7
|
Thinking about your child's life, the things my child has done in the past will help him or her in the future [PROMIS.PARENTPROXY] |
|
92113-0
|
Thinking about your child's life, when bad things happen, my child expects them to get better [PROMIS.PARENTPROXY] |
|
38427-1
|
Thiocyanate [Mass/time] in 24 hour Urine |
|
3001-5
|
Thiocyanate [Mass/volume] in Blood |
|
59974-6
|
Thiocyanate [Moles/volume] in Gastric fluid |
|
3003-1
|
Thiocyanate [Presence] in Serum or Plasma |
|
3002-3
|
Thiocyanate [Mass/volume] in Serum or Plasma |
|
14916-1
|
Thiocyanate [Moles/volume] in Serum or Plasma |
|
3004-9
|
Thiocyanate [Mass/volume] in Urine |
|
59973-8
|
Thiocyanate [Moles/volume] in Urine |
|
60334-0
|
Thiocyanate [Moles/volume] in Unspecified specimen |
|
21562-4
|
Thiocyanate/Creatinine [Mass Ratio] in Urine |
|
29243-3
|
Thiodiglycolate [Mass/volume] in Urine |
|
29244-1
|
Thiodiglycolate/Creatinine [Mass Ratio] in Urine |
|
34381-4
|
Thioguanine [Mass/volume] in Serum or Plasma |
|
74908-5
|
3-ketoacyl-CoA thiolase [Enzymatic activity/mass] in Fibroblast |
|
4441-2
|
Thiopental [Mass] of Dose |
|
56697-6
|
Thiopental IgE Ab [Units/volume] in Serum |
|
4050-1
|
Thiopental [Mass/volume] in Serum or Plasma |
|
32117-4
|
Thiopental [Moles/volume] in Serum or Plasma |
|
16223-0
|
Thiopental [Presence] in Urine by Confirmatory method |
|
12370-3
|
Thiopental [Mass/volume] in Urine |
|
75770-8
|
Thioridazine [Presence] in Blood or Urine by Screen method |
|
19709-5
|
Thioridazine cutoff [Mass/volume] in Urine for Confirmatory method |
|
19708-7
|
Thioridazine cutoff [Mass/volume] in Urine for Screen method |
|
4442-0
|
Thioridazine [Mass] of Dose |
|
31087-0
|
Thioridazine [Mass/volume] in Gastric fluid |
|
47131-8
|
Thioridazine [Moles/volume] in Gastric fluid |
|
13583-0
|
Thioridazine [Presence] in Serum or Plasma |
|
4052-7
|
Thioridazine [Mass/volume] in Serum or Plasma |
|
14917-9
|
Thioridazine [Moles/volume] in Serum or Plasma |
|
20560-9
|
Thioridazine [Mass/volume] in Urine by Confirmatory method |
|
12319-0
|
Thioridazine [Presence] in Urine |
|
19707-9
|
Thioridazine [Presence] in Urine by Confirmatory method |
|
19706-1
|
Thioridazine [Presence] in Urine by Screen method |
|
4053-5
|
Thioridazine [Mass/volume] in Urine |
|
47132-6
|
Thioridazine [Moles/volume] in Urine |
|
9647-9
|
Thiosulfate [Mass/volume] in Blood |
|
3005-6
|
Thiosulfate renal clearance in 24 hour Urine and Serum or Plasma |
|
21564-0
|
Thiosulfate [Mass/volume] in Serum or Plasma |
|
12420-6
|
Thiosulfate [Mass/volume] in Urine |
|
75049-7
|
Thiosulfate [Moles/volume] in Urine |
|
12421-4
|
Thiosulfate/Creatinine [Mass Ratio] in Urine |
|
32274-3
|
Thiosulfate/Creatinine [Ratio] in Urine |
|
29404-1
|
Thiothixene [Mass/volume] in Gastric fluid |
|
89980-7
|
Thiothixene [Presence] in Serum or Plasma by Screen method |
|
6696-9
|
Thiothixene [Mass/volume] in Serum or Plasma |
|
12320-8
|
Thiothixene [Presence] in Urine |
|
29403-3
|
Thiothixene [Mass/volume] in Urine |
|
57873-2
|
Thiothixene [Moles/volume] in Unspecified specimen |
|
81371-7
|
Third witness |
|
76525-5
|
Thoracic fluid conductivity [Fluid Conductance] Chest |
|
76652-7
|
Thorium [Mass/mass] in Hair |
|
50920-8
|
Thorium [Moles/mass] in Hair |
|
12707-6
|
Thorium [Mass/volume] in Serum or Plasma |
|
50919-0
|
Thorium [Moles/mass] in Tissue |
|
17703-0
|
Thorium [Mass/volume] in Urine |
|
77687-2
|
Thought disorder scale [UPDRS] |
|
81333-7
|
Thoughts on antibiotics [Reported] |
|
77352-3
|
Thoughts on artificial nutrition and hydration [Reported] |
|
75779-9
|
Thoughts on cardiopulmonary resuscitation (CPR) [Reported] |
|
81353-5
|
Thoughts on hastening death [Reported] |
|
81330-3
|
Thoughts on intubation [Reported] |
|
81332-9
|
Thoughts on IV fluid and support [Reported] |
|
81349-3
|
Thoughts on life-sustaining procedures if pregnant [Reported] |
|
75781-5
|
Thoughts on organ and tissue donations [Reported] |
|
81350-1
|
Thoughts on pain management [Reported] |
|
81329-5
|
Thoughts on resuscitation [Reported] |
|
81331-1
|
Thoughts on tube feeding [Reported] |
|
75782-3
|
Thoughts regarding autopsy [Reported] |
|
44260-8
|
Thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks [Reported.PHQ] |
|
54653-1
|
Thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54652-3
|
Thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
47974-1
|
THRB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48032-7
|
THRB gene p.Ala317Thr [Presence] in Blood or Tissue by Molecular genetics method |
|
75614-8
|
Three level triage system [NAMCS] |
|
48153-1
|
Threitol/Creatinine [Molar ratio] in Urine |
|
48154-9
|
Threo-4,5-Dihydrohexanoate/Creatinine [Molar ratio] in Urine |
|
48155-6
|
Threo-4,5-Dihydrohexanolactone/Creatinine [Molar ratio] in Urine |
|
48156-4
|
Threo-4-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
34692-4
|
Threoamino alcohol [Mass/volume] in Serum or Plasma |
|
3010-6
|
Threonine [Mass/time] in 24 hour Urine |
|
25988-7
|
Threonine [Moles/volume] in 24 hour Urine |
|
25540-6
|
Threonine [Moles/time] in 24 hour Urine |
|
13416-3
|
Threonine [Mass/volume] in Amniotic fluid |
|
27179-1
|
Threonine [Moles/volume] in Amniotic fluid |
|
3006-4
|
Threonine [Mass/volume] in Cerebral spinal fluid |
|
22643-1
|
Threonine [Moles/volume] in Cerebral spinal fluid |
|
47784-4
|
Threonine [Moles/volume] in DBS |
|
32273-5
|
Threonine [Moles/volume] in Body fluid |
|
81045-7
|
Threonine intake 24 hour Estimated |
|
81046-5
|
Threonine intake 24 hour Measured |
|
3007-2
|
Threonine [Presence] in Serum or Plasma |
|
26897-9
|
Threonine [Units/volume] in Serum or Plasma |
|
3008-0
|
Threonine [Mass/volume] in Serum or Plasma |
|
20658-1
|
Threonine [Moles/volume] in Serum or Plasma |
|
47787-7
|
Threonine/Amino acids.total in Amniotic fluid |
|
47786-9
|
Threonine/Amino acids.total in Cerebral spinal fluid |
|
47789-3
|
Threonine/Amino acids.total in DBS |
|
47785-1
|
Threonine/Amino acids.total in Hair |
|
47788-5
|
Threonine/Amino acids.total in Serum or Plasma |
|
47790-1
|
Threonine/Amino acids.total in Unspecified specimen |
|
17704-8
|
Threonine [Presence] in Urine |
|
3009-8
|
Threonine [Mass/volume] in Urine |
|
27322-7
|
Threonine [Moles/volume] in Urine |
|
32272-7
|
Threonine [Moles/volume] in Vitreous fluid |
|
22740-5
|
Threonine [Moles/volume] in Unspecified specimen |
|
44413-3
|
Threonine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56641-4
|
Threonine/Creatinine [Ratio] in 24 hour Urine |
|
25989-5
|
Threonine/Creatinine [Molar ratio] in 24 hour Urine |
|
13815-6
|
Threonine/Creatinine [Mass Ratio] in Urine |
|
30057-4
|
Threonine/Creatinine [Ratio] in Urine |
|
22688-6
|
Threonine/Creatinine [Molar ratio] in Urine |
|
87148-3
|
Guidance for injection of thrombin for pseudoaneurysm |
|
3243-3
|
Thrombin time |
|
68325-0
|
Thrombin time actual/Normal |
|
90878-0
|
Thromboembolism Telephone encounter Note |
|
90877-2
|
Thromboembolism procedure note |
|
90876-4
|
Thromboembolism Progress note |
|
90879-8
|
Thromboembolism Team Conference note |
|
4686-2
|
Thromboglobulin [Mass/volume] in Plasma |
|
88659-8
|
Timing of thrombolytic administration in relation to cardiac arrest |
|
43237-7
|
Thrombopoietin [Mass/volume] in Platelet poor plasma by Immunoassay |
|
80988-9
|
Thrombus Stent |
|
71042-6
|
Throughout the course of my day, I feel a sense of thankfulness for my life in the past 7 days [FACIT] |
|
71043-4
|
Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life in the past 7 days [FACIT] |
|
82861-6
|
11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82862-4
|
11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
93339-0
|
THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
93689-8
|
THSD7A IgG Ab [Titer] in Serum or Plasma by Cell binding assay immunofluorescent assay |
|
81742-9
|
Th-To Ab [Units/volume] in Serum by Line blot |
|
81743-7
|
Th-To Ab [Presence] in Serum by Line blot |
|
72314-8
|
Th-To IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
7737-0
|
Thyme IgE Ab [Units/volume] in Serum |
|
16053-1
|
Thyme IgE Ab RAST class [Presence] in Serum |
|
41851-7
|
Thyme IgG Ab [Units/volume] in Serum |
|
56402-1
|
Thyme IgG4 Ab [Mass/volume] in Serum |
|
63125-9
|
Thyme IgG Ab [Mass/volume] in Serum |
|
75156-0
|
Thymidine [Moles/volume] in Cerebral spinal fluid |
|
44934-8
|
Thymidine kinase [Enzymatic activity/volume] in Serum |
|
48162-2
|
Thymidine [Moles/volume] in Serum or Plasma |
|
59215-4
|
Thymidine/Creatinine [Molar ratio] in Urine |
|
75153-7
|
Thymine [Moles/volume] in Cerebral spinal fluid |
|
75121-4
|
Thymine [Moles/volume] in Serum or Plasma |
|
48157-2
|
Thymine/Creatinine [Molar ratio] in Urine |
|
86950-3
|
Thymus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
82368-2
|
Thyroid secretory capacity [Moles/time] in Serum or Plasma by Calculated.SPINA |
|
63360-2
|
Thyroglobulin Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63359-4
|
Thyroglobulin Ab [Units/volume] in Body fluid by Immunoassay |
|
53921-3
|
Thyroglobulin Ab [Units/volume] in Lymph node fine needle aspirate |
|
15210-8
|
Thyroglobulin Ab [Presence] in Serum |
|
5380-1
|
Thyroglobulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
56536-6
|
Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
8098-6
|
Thyroglobulin Ab [Units/volume] in Serum or Plasma |
|
53919-7
|
Thyroglobulin Ab [Units/volume] in Tissue fine needle aspirate |
|
38504-7
|
Thyroglobulin Ab [Titer] in Serum by Immunofluorescence |
|
5381-9
|
Thyroglobulin Ab [Titer] in Serum by Latex agglutination |
|
10515-5
|
Thyroglobulin Ag [Presence] in Tissue by Immune stain |
|
56635-6
|
Thyroglobulin IgG Ab [Units/volume] in Serum |
|
83117-2
|
Thyroglobulin IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
17705-5
|
Thyroglobulin IgM Ab [Units/volume] in Serum |
|
53920-5
|
Thyroglobulin [Mass/volume] in Lymph node fine needle aspirate |
|
38505-4
|
Thyroglobulin recovery in Serum or Plasma |
|
48387-5
|
Thyroglobulin recovery [Presence] in Serum or Plasma |
|
3013-0
|
Thyroglobulin [Mass/volume] in Serum or Plasma |
|
14918-7
|
Thyroglobulin [Moles/volume] in Serum or Plasma |
|
53922-1
|
Thyroglobulin [Mass/volume] in Tissue fine needle aspirate |
|
63412-1
|
Thyroid colloidal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63407-1
|
Thyroid colloidal Ab [Presence] in Serum by Immunofluorescence |
|
17797-2
|
Thyroid colloidal Ab [Units/volume] in Serum |
|
63413-9
|
Thyroid colloidal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
34642-9
|
Thyroid colloidal Ab [Titer] in Serum |
|
66120-7
|
Thyroid Pathology biopsy report |
|
63362-8
|
Thyroperoxidase Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63361-0
|
Thyroperoxidase Ab [Units/volume] in Body fluid by Immunoassay |
|
56477-3
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
32042-4
|
Thyroperoxidase Ab [Presence] in Serum or Plasma |
|
5382-7
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
8099-4
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma |
|
14296-8
|
Thyroperoxidase Ab [Moles/volume] in Serum or Plasma |
|
17706-3
|
Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
|
32786-6
|
Thyroperoxidase Ab [Titer] in Serum or Plasma |
|
5383-5
|
Thyroperoxidase Ab [Titer] in Serum or Plasma by Latex agglutination |
|
83118-0
|
Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
18332-7
|
Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma |
|
17707-1
|
Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma |
|
48700-9
|
Thyrotropin releasing hormone [Mass] of Dose |
|
3018-9
|
Thyrotropin releasing hormone [Mass/volume] in Plasma |
|
70096-3
|
Thyrotropin releasing hormone [Mass/volume] in Urine |
|
21565-7
|
tiaGABine [Mass/volume] in Serum or Plasma |
|
87769-6
|
tiaGABine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
35846-5
|
Tiamulin [Susceptibility] by Disk diffusion (KB) |
|
35847-3
|
Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35848-1
|
Tiamulin [Susceptibility] |
|
87589-8
|
Tiamulin [Mass/mass] in Unspecified specimen |
|
90977-0
|
Tianeptine [Mass/volume] in Serum or Plasma |
|
2500-7
|
Iron binding capacity [Mass/volume] in Serum or Plasma |
|
35215-3
|
Iron binding capacity [Mass or Moles/volume] in Serum or Plasma |
|
14800-7
|
Iron binding capacity [Moles/volume] in Serum or Plasma |
|
4443-8
|
Ticarcillin [Mass] of Dose |
|
7053-2
|
Ticarcillin [Susceptibility] by Gradient strip |
|
501-7
|
Ticarcillin [Susceptibility] by Disk diffusion (KB) |
|
500-9
|
Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
499-4
|
Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
4054-3
|
Ticarcillin [Mass/volume] in Serum or Plasma |
|
18994-4
|
Ticarcillin [Susceptibility] |
|
502-5
|
Ticarcillin [Susceptibility] by Serum bactericidal titer |
|
25254-4
|
Ticarcillin [Mass/volume] in Unspecified specimen |
|
7054-0
|
Ticarcillin+Clavulanate [Susceptibility] by Gradient strip |
|
505-8
|
Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
504-1
|
Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
503-3
|
Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18995-1
|
Ticarcillin+Clavulanate [Susceptibility] |
|
506-6
|
Ticarcillin+Clavulanate [Susceptibility] by Serum bactericidal titer |
|
55719-9
|
Ticarcillin+Sulbactam [Susceptibility] by Gradient strip |
|
55718-1
|
Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55716-5
|
Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55717-3
|
Ticarcillin+Sulbactam [Susceptibility] |
|
82755-0
|
Geographic location where tick bite occurred |
|
45342-3
|
Tick identified in Unspecified specimen |
|
45341-5
|
Tick # 2 identified in Unspecified specimen |
|
45340-7
|
Tick # 3 identified in Unspecified specimen |
|
45339-9
|
Tick # 4 identified in Unspecified specimen |
|
38726-6
|
Titanium tetrachloride [Mass/volume] in Air |
|
11003-1
|
Ticlopidine [Mass/volume] in Serum or Plasma |
|
17709-7
|
Ticlopidine [Presence] in Urine |
|
82652-9
|
Transient ischemic dilation Left ventricle SPECT |
|
88739-8
|
TIF1-gamma Ab [Units/volume] in Serum by Line blot |
|
82448-2
|
TIF1-gamma Ab [Presence] in Serum by Line blot |
|
82995-2
|
TIF1-gamma IgG Ab [Presence] in Serum by Line blot |
|
42354-1
|
Tigecycline [Susceptibility] by Gradient strip |
|
42356-6
|
Tigecycline [Susceptibility] by Disk diffusion (KB) |
|
42355-8
|
Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55158-0
|
Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
42357-4
|
Tigecycline [Susceptibility] |
|
53170-7
|
Tiglylcarnitine (C5:1) [Moles/volume] in DBS |
|
51416-6
|
Tiglylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
|
81770-0
|
Tiglylcarnitine (C5:1)/Creatinine [Molar ratio] in Urine |
|
54342-1
|
Tiglylglycine [Moles/volume] in Cerebral spinal fluid |
|
47954-3
|
Tiglylglycine [Moles/volume] in Plasma |
|
30484-0
|
Tiglylglycine [Presence] in Urine |
|
13816-4
|
Tiglylglycine/Creatinine [Mass Ratio] in Urine |
|
24444-2
|
Tiglylglycine/Creatinine [Molar ratio] in Urine |
|
32572-0
|
Tilapia IgE Ab [Units/volume] in Serum |
|
32573-8
|
Tilapia IgE Ab RAST class [Presence] in Serum |
|
88375-1
|
Tildipirosin [Susceptibility] by Disk diffusion (KB) |
|
88377-7
|
Tildipirosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35849-9
|
Tilmicosin [Susceptibility] by Disk diffusion (KB) |
|
35850-7
|
Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35851-5
|
Tilmicosin [Susceptibility] |
|
87588-0
|
Tilmicosin [Mass/mass] in Unspecified specimen |
|
20340-6
|
Time 2 by US |
|
46097-2
|
Time corticotropin given |
|
82311-2
|
Time between start of treatment and onset of adverse event |
|
44766-4
|
Time clamp removed from artery |
|
44765-6
|
Time clamp removed from portal vein |
|
44776-3
|
Time cross clamp applied {Organ} |
|
88657-2
|
Time elapsed since stroke |
|
76299-7
|
Time interval between start of doses Infusion pump |
|
77227-7
|
Time load level [NMMDS] |
|
20338-0
|
Time by US.M-mode |
|
43742-6
|
Time next dose |
|
45375-3
|
Time of analysis of unspecified specimen |
|
81955-7
|
Time of death [ClockTime] |
|
88065-8
|
Time of defibrillation |
|
88069-0
|
Time of initial encounter |
|
88665-5
|
Time of return of spontaneous circulation |
|
45377-9
|
Time of transfusion reaction |
|
63572-2
|
Time received in laboratory in Semen |
|
44777-1
|
Time removed from cold {Organ} |
|
77557-7
|
Time required to gather essential resources for a patient encounter [NMMDS] |
|
77558-5
|
Time required to gather essential resources for all patient encounters in a Report Period [NMMDS] |
|
45356-3
|
Time Rh immune globulin given |
|
89423-8
|
Time to rise from chair, walk 10 feet and back, and return to sitting [TUG] |
|
77549-4
|
Time to access a patient [NMMDS] |
|
77550-2
|
Time to access all patients in a Report Period [NMMDS] |
|
80526-7
|
Time to max urine flow by Uroflowmetry |
|
20339-8
|
Time by US |
|
20341-4
|
Time/Time 2 by US |
|
81001-0
|
TIMI grade Coronary artery segment --post procedure |
|
81000-2
|
TIMI grade Coronary artery segment --pre procedure |
|
74558-8
|
Timing of harm assessment [AHRQ] |
|
4444-6
|
Timolol [Mass] of Dose |
|
73119-0
|
Timolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73118-2
|
Timolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4056-8
|
Timolol [Mass/volume] in Serum or Plasma |
|
55582-1
|
Timolol [Moles/volume] in Serum or Plasma |
|
30994-8
|
Timothy recombinant (rPhl p) 1 IgE Ab [Units/volume] in Serum |
|
51555-1
|
Timothy recombinant (rPhl p) 1 IgE Ab RAST class [Presence] in Serum |
|
34429-1
|
Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Units/volume] in Serum |
|
51562-7
|
Timothy recombinant (rPhl p) 1 + 5b IgE Ab RAST class [Presence] in Serum |
|
31000-3
|
Timothy recombinant (rPhl p) 11 IgE Ab [Units/volume] in Serum |
|
51560-1
|
Timothy recombinant (rPhl p) 11 IgE Ab RAST class [Presence] in Serum |
|
34428-3
|
Timothy recombinant (rPhl p) 12 IgE Ab [Units/volume] in Serum |
|
51561-9
|
Timothy recombinant (rPhl p) 12 IgE Ab RAST class [Presence] in Serum |
|
30995-5
|
Timothy recombinant (rPhl p) 2 IgE Ab [Units/volume] in Serum |
|
51556-9
|
Timothy recombinant (rPhl p) 2 IgE Ab RAST class [Presence] in Serum |
|
30996-3
|
Timothy recombinant (rPhl p) 5 IgE Ab [Units/volume] in Serum |
|
51564-3
|
Timothy recombinant (rPhl p) 5 IgE Ab RAST class [Presence] in Serum |
|
58981-2
|
Timothy recombinant (rPhl p) 5b IgE Ab [Units/volume] in Serum |
|
30998-9
|
Timothy recombinant (rPhl p) 6 IgE Ab [Units/volume] in Serum |
|
51558-5
|
Timothy recombinant (rPhl p) 6 IgE Ab RAST class [Presence] in Serum |
|
30999-7
|
Timothy recombinant (rPhl p) 7 IgE Ab [Units/volume] in Serum |
|
51559-3
|
Timothy recombinant (rPhl p) 7 IgE Ab RAST class [Presence] in Serum |
|
34430-9
|
Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Units/volume] in Serum |
|
51563-5
|
Timothy recombinant (rPhl p) 7 + 12 IgE Ab RAST class [Presence] in Serum |
|
7738-8
|
Timothy triggered histamine release [Units/volume] in Blood |
|
6265-3
|
Timothy IgE Ab [Units/volume] in Serum |
|
16054-9
|
Timothy IgE Ab RAST class [Presence] in Serum |
|
61296-0
|
Timothy IgE Ab/IgE total in Serum |
|
51535-3
|
Timothy IgG Ab [Presence] in Serum |
|
10953-8
|
Timothy IgG Ab [Units/volume] in Serum |
|
26430-9
|
Timothy IgG4 Ab [Units/volume] in Serum |
|
26431-7
|
Timothy IgG4 Ab RAST class [Presence] in Serum |
|
56403-9
|
Timothy IgG4 Ab [Mass/volume] in Serum |
|
81782-5
|
Timothy IgG Ab [Mass/volume] in Serum |
|
48260-4
|
Timothy triggered leukotriene release [Mass/volume] by Leukocytes |
|
30997-1
|
Timothy native (nPhl p) 4 IgE Ab [Units/volume] in Serum |
|
51557-7
|
Timothy native (nPhl p) 4 IgE Ab RAST class [Presence] in Serum |
|
74101-7
|
Tissue inhibitor of metalloproteinases 1 [Mass/volume] in Serum or Plasma by Immunoassay |
|
29979-2
|
Tin [Mass/volume] in 24 hour Urine |
|
29980-0
|
Tin [Mass/time] in 24 hour Urine |
|
50923-2
|
Tin [Moles/time] in 24 hour Urine |
|
5747-1
|
Tin [Mass/volume] in Blood |
|
80650-5
|
Tin [Moles/volume] in Blood |
|
51208-7
|
Tin [Mass/volume] in Body fluid |
|
51209-5
|
Tin [Mass/mass] in Hair |
|
50922-4
|
Tin [Moles/mass] in Hair |
|
60189-8
|
Tin [Mass/mass] in Nail |
|
60190-6
|
Tin [Mass/volume] in Red Blood Cells |
|
5748-9
|
Tin [Mass/volume] in Serum or Plasma |
|
60191-4
|
Tin [Mass/mass] in Tissue |
|
12708-4
|
Tin [Mass/volume] in Urine |
|
50921-6
|
Tin [Moles/volume] in Urine |
|
29981-8
|
Tin/Creatinine [Mass Ratio] in 24 hour Urine |
|
52916-4
|
Tin/Creatinine [Molar ratio] in 24 hour Urine |
|
17710-5
|
Tin/Creatinine [Mass Ratio] in Urine |
|
52917-2
|
Tin/Creatinine [Molar ratio] in Urine |
|
55722-3
|
Tinidazole [Susceptibility] by Gradient strip |
|
55721-5
|
Tinidazole [Susceptibility] by Disk diffusion (KB) |
|
55720-7
|
Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54928-7
|
Tinidazole [Susceptibility] |
|
43737-6
|
Tipranavir [Susceptibility] by Genotype method |
|
49667-9
|
Tipranavir [Susceptibility] by Phenotype method |
|
57383-2
|
Tipranavir [Mass/volume] in Serum |
|
42535-5
|
Tipranavir [Susceptibility] |
|
49622-4
|
Tipranavir+Ritonavir [Susceptibility] by Genotype method |
|
58029-0
|
Tipranavir+Ritonavir [Susceptibility] by Phenotype method |
|
73117-4
|
Tirofiban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73116-6
|
Tirofiban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
66121-5
|
Tissue Pathology biopsy report |
|
81672-8
|
Tissue perfusion assessment [Interpretation] |
|
63441-0
|
Tissue polypeptide Ag [Units/volume] in Serum or Plasma |
|
14179-6
|
Tissue polypeptide Ag [Mass/volume] in Serum or Plasma |
|
44651-8
|
Tissue cores.positive.carcinoma in Tissue core |
|
44654-2
|
Tissue involved by tumor in Prostate tumor |
|
55073-1
|
Tissue type Pressure injury.Largest at most advanced stage [CMS Assessment] |
|
86903-2
|
Tissue type Pressure injury.most advanced stage [CMS Assessment] |
|
29928-9
|
Titanium [Mass/volume] in 24 hour Urine |
|
29929-7
|
Titanium [Mass/time] in 24 hour Urine |
|
59753-4
|
Titanium [Mass/volume] in Blood |
|
76495-1
|
Titanium [Moles/volume] in Blood |
|
51210-3
|
Titanium [Mass/volume] in Body fluid |
|
59754-2
|
Titanium [Mass/mass] in Hair |
|
50926-5
|
Titanium [Moles/mass] in Hair |
|
59755-9
|
Titanium [Mass/volume] in Red Blood Cells |
|
52894-3
|
Titanium [Moles/volume] in Red Blood Cells |
|
8244-6
|
Titanium [Mass/volume] in Serum or Plasma |
|
50924-0
|
Titanium [Moles/volume] in Serum or Plasma |
|
59756-7
|
Titanium [Mass/mass] in Tissue |
|
50925-7
|
Titanium [Moles/mass] in Tissue |
|
5749-7
|
Titanium [Mass/volume] in Urine |
|
49108-4
|
Titanium [Mass/volume] in Unspecified specimen |
|
29930-5
|
Titanium/Creatinine [Mass Ratio] in 24 hour Urine |
|
88740-6
|
Titin Ab [Units/volume] in Serum by Line blot |
|
82449-0
|
Titin Ab [Presence] in Serum by Line blot |
|
83000-0
|
Titin IgG Ab [Presence] in Serum or Plasma by Line blot |
|
85650-0
|
Title of person collecting or coordinating collection of assessment information Provider |
|
56489-8
|
Acidity.titratable [Moles/time] in 24 hour Urine |
|
14583-9
|
Acidity.titratable [Mass/volume] in Gastric fluid |
|
26813-6
|
Acidity.titratable [Moles/volume] in Gastric fluid |
|
1716-0
|
Acidity.titratable [Mass/volume] in Urine |
|
74092-8
|
Acidity.titratable [Moles/volume] in Urine |
|
59757-5
|
tiZANidine [Mass/volume] in Blood |
|
47975-8
|
tiZANidine [Mass/volume] in Serum or Plasma |
|
87774-6
|
tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73629-8
|
Tizoxanide [Susceptibility] by Disk diffusion (KB) |
|
73607-4
|
Tizoxanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73585-2
|
Tizoxanide [Susceptibility] |
|
89085-5
|
Total lung capacity measured/predicted by Plethysmograph body box |
|
81451-7
|
Total lung capacity --post bronchodilation |
|
82618-0
|
Total lung capacity by Helium rebreathing --post bronchodilation |
|
81450-9
|
Total lung capacity --pre bronchodilation |
|
82617-2
|
Total lung capacity by Helium rebreathing --pre bronchodilation |
|
93324-2
|
Taurolithocholate [Moles/volume] in Serum or Plasma |
|
65336-0
|
Tm Ab [Presence] in Serum or Plasma |
|
7746-1
|
Trimellitic anhydride (TMA) IgE Ab [Units/volume] in Serum |
|
16063-0
|
Trimellitic anhydride (TMA) IgE Ab RAST class [Presence] in Serum |
|
61321-6
|
Trimellitic anhydride (TMA) IgE Ab/IgE total in Serum |
|
17744-4
|
Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum |
|
61142-6
|
Trimellitic anhydride (TMA) IgG Ab [Mass/volume] in Serum |
|
17745-1
|
Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum |
|
90360-9
|
Trimethylamine N-oxide [Moles/volume] in Serum or Plasma by LC/MS/MS |
|
93765-6
|
Trimethylamine N-oxide [Molar amount] in Serum |
|
94077-5
|
Tumor mutation burden [Interpretation] |
|
29637-6
|
Time last dose of Dose |
|
92660-0
|
Time range until next menstrual period |
|
10632-8
|
Time until next menstrual period |
|
77751-6
|
TMEM216 gene c.218G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
79329-9
|
Trimethyllysine [Moles/volume] in Cerebral spinal fluid |
|
79330-7
|
Trimethyllysine [Moles/volume] in DBS |
|
79328-1
|
Trimethyllysine [Moles/volume] in Serum or Plasma |
|
79331-5
|
Trimethyllysine/Creatinine [Molar ratio] in Urine |
|
60204-5
|
Trimethadione [Mass/volume] in Blood |
|
4454-5
|
Trimethadione [Mass] of Dose |
|
4078-2
|
Trimethadione [Mass/volume] in Serum or Plasma |
|
60205-2
|
Trimethadione [Mass/volume] in Urine |
|
7057-3
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient strip |
|
517-3
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
|
516-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
515-7
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
20387-7
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria |
|
18998-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility] |
|
518-1
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Serum bactericidal titer |
|
80629-9
|
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Blood |
|
54099-7
|
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Urine |
|
80406-2
|
Date and time of initial encounter |
|
69488-5
|
TNFRSF13B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
69487-7
|
TNFRSF13B gene full mutation analysis in Blood or Tissue by Sequencing |
|
57758-5
|
TNFRSF13B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57754-4
|
TNFRSF13B gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
41049-8
|
TNFRSF1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40463-2
|
TNFRSF1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75629-6
|
Tumor necrosis factor receptor superfamily member 1A [Mass/volume] in Serum or Plasma |
|
81880-7
|
TNNT2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
81881-5
|
TNNT3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75332-7
|
To what extent do you agree or disagree with cultural factors contributing to the phenomenon of complexity [NMMDS] |
|
75336-8
|
To what extent do you agree or disagree with physical factors contributing to the phenomenon of complexity [NMMDS] |
|
75334-3
|
To what extent do you agree or disagree with psychosocial factors contributing to the phenomenon of complexity [NMMDS] |
|
88003-9
|
TOAST Classification of subtypes of acute ischemic stroke |
|
72166-2
|
Tobacco smoking status |
|
7740-4
|
Tobacco triggered histamine release [Units/volume] in Blood |
|
6859-3
|
Tobacco IgE Ab [Units/volume] in Serum |
|
16056-4
|
Tobacco IgE Ab RAST class [Presence] in Serum |
|
7739-6
|
Tobacco IgG Ab [Units/volume] in Serum |
|
56404-7
|
Tobacco IgG4 Ab [Mass/volume] in Serum |
|
63180-4
|
Tobacco IgG Ab [Mass/volume] in Serum |
|
81228-9
|
Tobacco product |
|
81229-7
|
Tobacco smoking status for tobacco smoker |
|
88029-4
|
Tobacco use duration |
|
54845-3
|
Tobacco use in last 7 days [CMS Assessment] |
|
88028-6
|
Tobacco use panel |
|
25227-0
|
Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
52962-8
|
Tobramycin [Mass/volume] in Cerebral spinal fluid |
|
4445-3
|
Tobramycin [Mass] of Dose |
|
13584-8
|
Tobramycin [Mass/volume] in Body fluid |
|
80966-5
|
Tobramycin free [Mass/volume] in Serum or Plasma |
|
56705-7
|
Tobramycin IgE Ab [Units/volume] in Serum |
|
73115-8
|
Tobramycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73114-1
|
Tobramycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7055-7
|
Tobramycin [Susceptibility] by Gradient strip |
|
509-0
|
Tobramycin [Susceptibility] by Disk diffusion (KB) |
|
508-2
|
Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
507-4
|
Tobramycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
25800-4
|
Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
59380-6
|
Tobramycin [Mass/volume] in Serum or Plasma --post dialysis |
|
4057-6
|
Tobramycin [Mass/volume] in Serum or Plasma --peak |
|
22751-2
|
Tobramycin [Moles/volume] in Serum or Plasma --peak |
|
31094-6
|
Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
|
31096-1
|
Tobramycin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
|
4058-4
|
Tobramycin [Mass/volume] in Serum or Plasma --random |
|
22750-4
|
Tobramycin [Moles/volume] in Serum or Plasma --random |
|
35670-9
|
Tobramycin [Mass/volume] in Serum or Plasma |
|
50927-3
|
Tobramycin [Moles/volume] in Serum or Plasma |
|
18996-9
|
Tobramycin [Susceptibility] |
|
510-8
|
Tobramycin [Susceptibility] by Serum bactericidal titer |
|
31095-3
|
Tobramycin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
|
4059-2
|
Tobramycin [Mass/volume] in Serum or Plasma --trough |
|
35239-3
|
Tobramycin [Mass or Moles/volume] in Serum or Plasma --trough |
|
22752-0
|
Tobramycin [Moles/volume] in Serum or Plasma --trough |
|
17808-7
|
Tobramycin [Mass/volume] in Urine |
|
4446-1
|
Tocainide [Mass] of Dose |
|
4060-0
|
Tocainide [Mass/volume] in Serum or Plasma |
|
39794-3
|
Tocainide [Moles/volume] in Serum or Plasma |
|
87672-2
|
Tocopherol+tocotrienol [Mass/mass] in Unspecified specimen |
|
74544-8
|
Tocopherols [Entitic substance] in Red Blood Cells |
|
47791-9
|
Tocopherols [Mass/volume] in Serum or Plasma |
|
29747-3
|
Tocopherols [Moles/volume] in Serum or Plasma |
|
59250-1
|
Tocopherols/Cholesterol [Molar ratio] in Serum or Plasma |
|
60833-1
|
Toe temperature |
|
83208-9
|
Toilet transfer - functional ability during 3 day assessment period [CMS Assessment] |
|
89390-9
|
Toilet transfer - functional goal [CMS Assessment] |
|
83207-1
|
Toilet transfer - functional goal during 3 day assessment period [CMS Assessment] |
|
57244-6
|
Toilet transferring - functional ability [CMS Assessment] |
|
45604-6
|
Toilet use - self-performance during 7 day assessment period [CMS Assessment] |
|
45605-3
|
Toilet use - support provided during 7 day assessment period [CMS Assessment] |
|
83183-4
|
Toileting |
|
57245-3
|
Toileting hygiene - functional ability [CMS Assessment] |
|
83228-7
|
Toileting hygiene - functional ability during 3 day assessment period [CMS Assessment] |
|
89389-1
|
Toileting hygiene - functional goal [CMS Assessment] |
|
83227-9
|
Toileting hygiene - functional goal during 3 day assessment period [CMS Assessment] |
|
39567-3
|
Tolazamide [Mass/volume] in 24 hour Urine |
|
21566-5
|
Tolazamide [Presence] in Serum or Plasma |
|
9629-7
|
Tolazamide [Mass/volume] in Serum or Plasma |
|
27166-8
|
Tolazamide [Mass/volume] in Urine |
|
48323-0
|
Tolazamide [Presence] in Unspecified specimen |
|
6951-8
|
Tolazamide [Mass/volume] in Unspecified specimen |
|
39568-1
|
Tolbutamide [Mass/volume] in 24 hour Urine |
|
4447-9
|
Tolbutamide [Mass] of Dose |
|
4448-7
|
Tolbutamide.IV [Mass] of Dose |
|
21567-3
|
Tolbutamide [Presence] in Serum or Plasma |
|
4061-8
|
Tolbutamide [Mass/volume] in Serum or Plasma |
|
32118-2
|
Tolbutamide [Moles/volume] in Serum or Plasma |
|
27170-0
|
Tolbutamide [Mass/volume] in Urine |
|
48321-4
|
Tolbutamide [Presence] in Unspecified specimen |
|
6952-6
|
Tolbutamide [Mass/volume] in Unspecified specimen |
|
12441-2
|
Tolmetin [Mass/volume] in Serum or Plasma |
|
73112-5
|
Tolterodine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73113-3
|
Tolterodine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
38621-9
|
Toluene [Mass/volume] in Air |
|
9637-0
|
Toluene [Mass/volume] in Blood |
|
5750-5
|
Toluene [Mass/volume] in Serum or Plasma |
|
9638-8
|
Toluene [Mass/volume] in Urine |
|
38313-3
|
Toluene [Mass/volume] in Water |
|
7742-0
|
Tomato triggered histamine release [Units/volume] in Blood |
|
6266-1
|
Tomato IgE Ab [Units/volume] in Serum |
|
16057-2
|
Tomato IgE Ab RAST class [Presence] in Serum |
|
40841-9
|
Tomato IgE Ab/IgE total in Serum |
|
6736-3
|
Tomato IgG Ab [Units/volume] in Serum |
|
21568-1
|
Tomato IgG Ab RAST class [Presence] in Serum |
|
56405-4
|
Tomato IgG4 Ab [Mass/volume] in Serum |
|
35547-9
|
Tomato IgG Ab [Mass/volume] in Serum |
|
48213-3
|
Tomato triggered leukotriene release [Mass/volume] by Leukocytes |
|
28673-2
|
Tonometry comment [Interpretation] Eye Narrative |
|
28630-2
|
Tonometry study |
|
63070-7
|
TOP2A gene 17q21-22 deletion and duplication mutation analysis [Presence] in Tissue by FISH |
|
63068-1
|
TOP2A gene copy number/Chromosome 17 copy number in Tissue by FISH |
|
63069-9
|
TOP2A gene [Interpretation] in Tissue Narrative |
|
72940-0
|
Topiramate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72939-2
|
Topiramate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60192-2
|
Topiramate [Mass/volume] in Blood |
|
32595-1
|
Topiramate [Mass] of Dose |
|
80965-7
|
Topiramate free [Mass/volume] in Serum or Plasma |
|
73111-7
|
Topiramate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73110-9
|
Topiramate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
49516-8
|
Topiramate [Mass/volume] in Serum or Plasma --peak |
|
17713-9
|
Topiramate [Mass/volume] in Serum or Plasma |
|
25541-4
|
Topiramate [Moles/volume] in Serum or Plasma |
|
49517-6
|
Topiramate [Mass/volume] in Serum or Plasma --trough |
|
60193-0
|
Topiramate [Mass/volume] in Urine |
|
87770-4
|
Topiramate/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73678-5
|
Topotecan [Mass/volume] in Serum or Plasma --trough |
|
34489-5
|
TOR1A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
34495-2
|
TOR1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38411-5
|
TOR1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10722-7
|
Torovirus [Identifier] in Stool by Electron microscopy |
|
76146-0
|
Tosufloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
78018-9
|
Toscana virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
77951-2
|
Toscana virus IgG Ab [Presence] in Serum by Immunoassay |
|
78019-7
|
Toscana virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
77950-4
|
Toscana virus IgM Ab [Presence] in Serum by Immunoassay |
|
88598-8
|
Toscana virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
86591-5
|
Toscana virus RNA [Presence] in Serum by NAA with probe detection |
|
76637-8
|
Total beats during EKG |
|
44652-6
|
Total number of cores in Tissue core |
|
33767-5
|
Acidity.total [Moles/volume] in Gastric fluid |
|
93001-6
|
Total ataxia score SARA |
|
32670-2
|
Cells Counted Total [#] in Amniotic fluid |
|
11282-1
|
Cells Counted Total [#] in Blood |
|
61181-4
|
Cells Counted Total [#] in Blood from Fetus |
|
67837-5
|
Cells Counted Total [#] in Bronchial specimen |
|
19075-1
|
Cells Counted Total [#] in Cerebral spinal fluid |
|
38256-4
|
Cells Counted Total [#] in Body fluid |
|
38257-2
|
Cells Counted Total [#] in Bone marrow |
|
32165-3
|
Cells Counted Total [#] in Pericardial fluid |
|
38258-0
|
Cells Counted Total [#] in Pleural fluid |
|
61194-7
|
Cells Counted Total [#] in Pleural fluid from Fetus |
|
38259-8
|
Cells Counted Total [#] in Peritoneal fluid |
|
38260-6
|
Cells Counted Total [#] in Synovial fluid |
|
19076-9
|
Cells Counted Total [#] in Unspecified specimen |
|
77244-2
|
Total combined household income range in last year |
|
71748-8
|
Total dialysis stations Facility # [ESRD] |
|
83388-9
|
Total dynamic PEEP Respiratory system |
|
4531-0
|
Complement total hemolytic [Units/volume] in Blood |
|
13834-7
|
Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) |
|
82323-7
|
Total interval score [HOOSJR] |
|
82332-8
|
Total interval score [KOOSJR] |
|
86335-7
|
Total interval score change [HOOSJR] |
|
86336-5
|
Total interval score change [KOOSJR] |
|
44618-7
|
Total linear mm of carcinoma |
|
45852-1
|
Total minutes of psychological therapy by any licensed mental health professional in the last 7 days [CMS Assessment] |
|
55035-0
|
Total minutes of recreational and music therapy in last 7 days [CMS Assessment] |
|
45767-1
|
Total minutes of respiratory therapy in the last 7 days [CMS Assessment] |
|
77551-0
|
Total number of patient encounters in a reporting period [NMMDS] |
|
75331-9
|
Total number of staff completing the environmental conditions survey [NMMDS] |
|
74171-0
|
Total number of staff completing the job satisfaction survey [NMMDS] |
|
52839-8
|
Total patient population # |
|
76247-6
|
Total PEEP Respiratory system |
|
77594-0
|
Total physical activity [IPAQ] |
|
77595-7
|
Total physical activity score [IPAQ] |
|
88425-4
|
Total physical activity.active transportation domain [IPAQ] |
|
88429-6
|
Total physical activity.domestic and garden domain [IPAQ] |
|
88433-8
|
Total physical activity.leisure-time domain [IPAQ] |
|
88422-1
|
Total physical activity.work domain [IPAQ] |
|
75941-5
|
Total power of power spectrum on EEG |
|
72127-4
|
Total score - Ages and Stages Questionnaires 10 months [ASQ] |
|
72126-6
|
Total score - Ages and Stages Questionnaires 12 months [ASQ] |
|
72125-8
|
Total score - Ages and Stages Questionnaires 14 months [ASQ] |
|
72124-1
|
Total score - Ages and Stages Questionnaires 16 months [ASQ] |
|
72123-3
|
Total score - Ages and Stages Questionnaires 18 months [ASQ] |
|
72132-4
|
Total score - Ages and Stages Questionnaires 2 months [ASQ] |
|
72122-5
|
Total score - Ages and Stages Questionnaires 20 months [ASQ] |
|
72121-7
|
Total score - Ages and Stages Questionnaires 22 months [ASQ] |
|
72120-9
|
Total score - Ages and Stages Questionnaires 24 months [ASQ] |
|
72119-1
|
Total score - Ages and Stages Questionnaires 27 months [ASQ] |
|
72118-3
|
Total score - Ages and Stages Questionnaires 30 months [ASQ] |
|
72117-5
|
Total score - Ages and Stages Questionnaires 33 months [ASQ] |
|
72116-7
|
Total score - Ages and Stages Questionnaires 36 months [ASQ] |
|
72131-6
|
Total score - Ages and Stages Questionnaires 4 months [ASQ] |
|
72130-8
|
Total score - Ages and Stages Questionnaires 6 months [ASQ] |
|
72129-0
|
Total score - Ages and Stages Questionnaires 8 months [ASQ] |
|
72128-2
|
Total score - Ages and Stages Questionnaires 9 months [ASQ] |
|
79124-4
|
Total score - Informant interview [GPCOG] |
|
79114-5
|
Total score - Patient examination [GPCOG] |
|
82153-8
|
Total score [ACE.BRFSS] |
|
82668-5
|
Total score [ACT] |
|
71722-3
|
Total score [AD8] |
|
82953-1
|
Total score [ALSFRS-R] |
|
75624-7
|
Total score [AUDIT] |
|
75626-2
|
Total score [AUDIT-C] |
|
72173-8
|
Total score [BOMC] |
|
84772-3
|
Total score [BSDS] |
|
72689-3
|
Total score [BSL-23] |
|
72636-4
|
Total score [BSL-SUPP] |
|
75847-4
|
Total score [CDAI] |
|
75698-1
|
Total score [COOP.WONCA] |
|
75810-2
|
Total score [COOP] |
|
89907-0
|
Total score [CRQ-SAI] |
|
89904-7
|
Total score [CRQ-SAS] |
|
90221-3
|
Total score [CUDOS] |
|
82665-1
|
Total score [DAST] |
|
82667-7
|
Total score [DAST-10] |
|
75874-8
|
Total score [HAQ-DI] |
|
75875-5
|
Total score [HAQII] |
|
76504-0
|
Total score [HARK] |
|
71483-2
|
Total score [HKOI] |
|
71493-1
|
Total score [IQCODE] |
|
71777-7
|
Total score [M3] |
|
84773-1
|
Total score [MDQ] |
|
72233-0
|
Total score [Mini-Cog] |
|
71938-5
|
Total score [MLHFQ] |
|
72106-8
|
Total score [MMSE] |
|
72172-0
|
Total score [MoCA] |
|
82237-9
|
Total score [NDI] |
|
72089-6
|
Total score [NIH Stroke Scale] |
|
93087-5
|
Total score [NuPDQ] |
|
88175-5
|
Total score [PAM] |
|
75840-9
|
Total score [PAS] |
|
75841-7
|
Total score [PASII] |
|
89870-0
|
Total score [POEM] |
|
90027-4
|
Total score [PsoSat] |
|
93112-1
|
Total score [Quality of Working Life Questionnaire for Cancer Survivors] |
|
89436-0
|
Total score [Rose Dyspnea Scale] |
|
75845-8
|
Total score [SDAI] |
|
71492-3
|
Total score [SLUMS] |
|
91351-7
|
Total score [STarT Back] |
|
88176-3
|
Total score Caregiver [PAM] |
|
89548-2
|
Total score Revised Geneva Score |
|
91392-1
|
Total score ORT |
|
88174-8
|
Total score Parent [PAM] |
|
89547-4
|
Total score Wells pulmonary embolism risk calculator |
|
72191-0
|
Total symptom score [KCCQ] |
|
74795-6
|
Total thyroxine binding capacity in Serum or Plasma |
|
38622-7
|
Toxaphene [Mass/volume] in Air |
|
17714-7
|
Toxaphene [Mass/volume] in Serum or Plasma |
|
38330-7
|
Toxaphene [Mass/volume] in Water |
|
87632-6
|
Toxaphene [Mass/mass] in Unspecified specimen |
|
803-7
|
Toxic granules [Presence] in Blood by Light microscopy |
|
10692-2
|
Mushroom.toxic identified in Food by Light microscopy |
|
10691-4
|
Mushroom.toxic identified by Inspection |
|
10693-0
|
Mushroom.toxic identified in Vomitus by Light microscopy |
|
10708-6
|
Toxic Plant identified in Vomitus by Light microscopy |
|
10707-8
|
Toxic Plant identified in Plant specimen by Inspection |
|
32148-9
|
Toxic substance identified in Urine |
|
69050-3
|
Toxicologist review of results |
|
77743-3
|
Toxocara sp Ab [Presence] in Ocular fluid by Immunoassay |
|
43225-2
|
Toxocara sp Ab [Units/volume] in Serum by Immunoassay |
|
26660-1
|
Toxocara sp Ab [Presence] in Serum |
|
40830-2
|
Toxocara sp Ab [Units/volume] in Serum |
|
21739-8
|
TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35744-2
|
TP73L gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
5989-9
|
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis |
|
5988-1
|
Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis |
|
5990-7
|
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis |
|
5973-3
|
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis |
|
5972-5
|
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
|
5971-7
|
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5986-5
|
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method |
|
5987-3
|
Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
43636-0
|
Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method |
|
5983-2
|
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis |
|
5982-4
|
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
|
5981-6
|
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay |
|
82625-5
|
Time to peak filling rate Left ventricle SPECT --resting |
|
82653-7
|
Time to peak filling rate/RR interval Left ventricle SPECT --resting |
|
11063-5
|
Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
|
44054-5
|
Triosephosphate isomerase [Enzymatic activity/mass] in Red Blood Cells |
|
3058-5
|
Triosephosphate isomerase [Enzymatic activity/volume] in Serum |
|
93193-1
|
TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53819-9
|
Thiopurine methyltransferase [Enzymatic activity/volume] in Blood |
|
49654-7
|
TPMT gene c.238G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
71356-0
|
TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
49655-4
|
TPMT gene c.460G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
49653-9
|
TPMT gene c.719A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
79468-5
|
Thiopurine methyltransferase [Enzymatic activity/substance] in Red Blood Cells |
|
41048-0
|
TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
36922-3
|
TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80738-8
|
TPMT gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
63454-3
|
TPMT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
79713-4
|
TPMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
91142-0
|
TPMT activity in RBC by production of 6-MMP riboside |
|
91143-8
|
TPMT activity in RBC by production of 6-MTG riboside |
|
91141-2
|
TPMT activity in RBC by production of 6-MMP |
|
21563-2
|
Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
43421-7
|
Thiopurine methyltransferase [Enzymatic activity/mass] in Red Blood Cells |
|
81812-0
|
TPP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19185-8
|
Tissue polypeptide specific Ag [Units/volume] in Pleural fluid |
|
19184-1
|
Tissue polypeptide specific Ag [Units/volume] in Serum or Plasma |
|
25799-8
|
Tissue polypeptide specific Ag [Units/volume] in Urine |
|
65337-8
|
Tr sup(a) Ab [Presence] in Serum or Plasma |
|
78223-5
|
TRA+TRD gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78216-9
|
TRA+TRD gene rearrangements [Presence] in Blood or Tissue by FISH |
|
89086-3
|
Tracheostomy tube diameter |
|
21740-6
|
TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21741-4
|
TRAF3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
7743-8
|
Tragacanth IgE Ab [Units/volume] in Serum |
|
16058-0
|
Tragacanth IgE Ab RAST class [Presence] in Serum |
|
79147-5
|
traMADol [Presence] in Blood by Confirmatory method |
|
79148-3
|
traMADol [Presence] in Blood by Screen method |
|
73932-6
|
traMADol [Mass/volume] in Blood |
|
19713-7
|
traMADol cutoff [Mass/volume] in Urine for Confirmatory method |
|
19712-9
|
traMADol cutoff [Mass/volume] in Urine for Screen method |
|
73109-1
|
traMADol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73108-3
|
traMADol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93720-1
|
traMADol [Mass/mass] in Meconium by Confirmatory method |
|
93719-3
|
traMADol [Presence] in Meconium by Screen method |
|
72740-4
|
traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74110-8
|
traMADol [Presence] in Saliva (oral fluid) by Screen method |
|
12437-0
|
traMADol [Mass/volume] in Serum or Plasma |
|
48355-2
|
traMADol [Moles/volume] in Serum or Plasma |
|
20561-7
|
traMADol [Mass/volume] in Urine by Confirmatory method |
|
43219-5
|
traMADol [Presence] in Urine |
|
17718-8
|
traMADol [Presence] in Urine by Confirmatory method |
|
19710-3
|
traMADol [Presence] in Urine by Screen method |
|
17719-6
|
traMADol [Mass/volume] in Urine |
|
58404-5
|
traMADol/Creatinine [Mass Ratio] in Urine |
|
33046-4
|
Tranquilizers [Presence] in Serum or Plasma by Screen method |
|
33047-2
|
Tranquilizers [Presence] in Urine by Screen method |
|
10414-1
|
Transfuse albumin [Volume] |
|
50669-1
|
Transfuse antithrombin [Volume] |
|
10427-3
|
Transfuse whole blood autologous [Volume] |
|
53275-4
|
Transitional cells [#/volume] in Urine by Computer assisted method |
|
33220-5
|
Transitional cells [#/area] in Urine by Computer assisted method |
|
30089-7
|
Transitional cells [#/area] in Urine sediment by Microscopy high power field |
|
46136-8
|
Transitional cells [#/area] in Urine sediment by Microscopy low power field |
|
53272-1
|
Transitional cells [Presence] in Urine by Computer assisted method |
|
8249-5
|
Transitional cells [Presence] in Urine sediment by Light microscopy |
|
30007-9
|
Transfuse cryoprecipitate poor plasma [Volume] |
|
10417-4
|
Transfuse cryoprecipitate [Volume] |
|
10424-0
|
Transfuse erythrocytes [Volume] |
|
10418-2
|
Transfuse factor IX [Volume] |
|
10419-0
|
Transfuse factor VIII [Volume] |
|
81034-1
|
Trans fat intake 24 hour Estimated |
|
81035-8
|
Trans fat intake 24 hour Measured |
|
30006-1
|
Transfuse granulocytes [Volume] |
|
54427-0
|
Transfuse frozen erythrocytes newborn units [Volume] |
|
17721-2
|
Trans nonachlor [Mass/volume] in Blood |
|
23937-6
|
Trans nonachlor [Mass/volume] in Serum or Plasma |
|
17720-4
|
Trans nonachlor [Mass/volume] in Urine |
|
10416-6
|
Transfuse blood product other [Volume] |
|
10421-6
|
Transfuse Pentaspan [Volume] |
|
10422-4
|
Transfuse plasma [Volume] |
|
10423-2
|
Transfuse platelets [Volume] |
|
14303-2
|
Transfuse plateletpheresis [Volume] |
|
10425-7
|
Transfuse Rh immune globulin [Volume] |
|
10420-8
|
Transfuse immune serum globulin [Volume] |
|
10426-5
|
Transfuse whole blood [Volume] |
|
38294-5
|
Trans-1,2-Dichloroethylene [Mass/volume] in Water |
|
78887-7
|
Trans-3-Hydroxycotinine [Mass/volume] in Saliva (oral fluid) |
|
35140-3
|
Trans-3-Hydroxycotinine [Mass/volume] in Serum or Plasma |
|
33916-8
|
Trans-3-Hydroxycotinine [Mass/volume] in Urine |
|
75059-6
|
Transaldolase [Enzymatic activity/mass] in Fibroblast |
|
73731-2
|
Transaldolase [Enzymatic activity/mass] in Lymphoblasts |
|
3029-6
|
Transcobalamin I [Mass/volume] in Serum |
|
59211-3
|
Transcobalamin I+Transcobalamin III [Moles/volume] in Serum |
|
3030-4
|
Transcobalamin II [Mass/volume] in Serum |
|
32341-0
|
Transcobalamin II [Moles/volume] in Serum |
|
3031-2
|
Transcobalamin III [Mass/volume] in Serum |
|
3032-0
|
Transcobalamin [Mass/volume] in Serum |
|
18378-0
|
Transcortin [Mass/volume] in Cerebral spinal fluid |
|
3033-8
|
Transcortin [Mass/volume] in Serum |
|
51958-7
|
Transcript reference sequence [ID] |
|
12156-6
|
Transducer site |
|
32770-0
|
Transfusion band number |
|
10415-8
|
Transfuse blood exchange transfusion [Volume] |
|
14687-8
|
Transfusion date |
|
1321-9
|
Transfusion duration |
|
50010-8
|
Transfusion end time |
|
14924-5
|
Transfusion reaction [Interpretation] in Plasma or RBC Narrative |
|
50011-6
|
Transfusion start time |
|
1322-7
|
Transfusion volume |
|
45590-7
|
Transfer - self-performance during 7 day assessment period [CMS Assessment] |
|
45591-5
|
Transfer - support provided during 7 day assessment period [CMS Assessment] |
|
74199-1
|
Transferred from another acute care facility [NTDS] |
|
18761-7
|
Transfer summary note |
|
77305-1
|
Transferred from of Facility |
|
80413-8
|
Transferred to [Location] |
|
74977-0
|
Transferrin [Mass/time] in 24 hour Urine |
|
3034-6
|
Transferrin [Mass/volume] in Serum or Plasma |
|
35229-4
|
Transferrin [Mass or Moles/volume] in Serum or Plasma |
|
22674-6
|
Transferrin [Moles/volume] in Serum or Plasma |
|
3035-3
|
Transferrin [Mass/volume] in Urine |
|
86271-4
|
Transferrin.gastrointestinal [Mass/volume] in Stool by Immunoassay |
|
83185-9
|
Transferring |
|
57246-1
|
Transferring - functional ability [CMS Assessment] |
|
89428-7
|
Blood or blood product transfusion consent Document |
|
55197-8
|
Transfusion status Qualitative |
|
79875-1
|
Transillumination Left iris Slit lamp biomicroscopy |
|
79874-4
|
Transillumination Right iris Slit lamp biomicroscopy |
|
34609-8
|
Transketolase [Enzymatic activity/mass] in Blood |
|
3036-1
|
Transketolase [Enzymatic activity/volume] in Serum |
|
76522-2
|
Transmission Arterial blood Pulse oximetry |
|
76520-6
|
Transmission.infrared Arterial blood Pulse oximetry |
|
76521-4
|
Transmission.red Arterial blood Pulse oximetry |
|
48368-5
|
trans-Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma |
|
71518-5
|
Transplant referral [ESRD] |
|
44758-1
|
Transplant risk factors |
|
83676-7
|
Transplant surgery Attending Note |
|
83841-7
|
Transplant surgery Case manager Note |
|
83780-7
|
Transplant surgery Resident Note |
|
78731-7
|
Transplant surgery Admission history and physical note |
|
78539-4
|
Transplant surgery Checklist |
|
84035-5
|
Transplant surgery Consult note |
|
78598-0
|
Transplant surgery Education note |
|
78629-3
|
Transplant surgery Flowsheet |
|
68849-9
|
Transplant surgery History and physical note |
|
68852-3
|
Transplant surgery Hospital Consult note |
|
68853-1
|
Transplant surgery Hospital Letter |
|
70238-1
|
Transplant surgery Hospital Progress note |
|
82835-0
|
Transplant surgery Initial evaluation note |
|
68848-1
|
Transplant surgery Note |
|
84036-3
|
Transplant surgery Outpatient Note |
|
78244-1
|
Transplant surgery Surgical operation note |
|
84037-1
|
Transplant surgery Telephone encounter Note |
|
80763-6
|
Transplant surgery Plan of care note |
|
68850-7
|
Transplant surgery Preoperative evaluation and management note |
|
68851-5
|
Transplant surgery procedure note |
|
78677-2
|
Transplant surgery Referral note |
|
78683-0
|
Transplant surgery Transfer summary note |
|
88079-9
|
Transport start time |
|
77596-5
|
Transportation summary Document |
|
75920-9
|
Transthoracic impedance |
|
48369-3
|
trans-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
|
4449-5
|
Tranylcypromine [Mass] of Dose |
|
47979-0
|
Tranylcypromine [Presence] in Serum or Plasma |
|
10344-0
|
Tranylcypromine [Mass/volume] in Serum or Plasma |
|
55583-9
|
Tranylcypromine [Moles/volume] in Serum or Plasma |
|
58030-8
|
Tranylcypromine [Presence] in Urine |
|
4062-6
|
Tranylcypromine [Mass/volume] in Urine |
|
11020-5
|
Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
|
32824-5
|
Microscopic observation [Identifier] in Unspecified specimen by Tartrate-resistant acid phosphatase stain |
|
53894-2
|
TRAPPC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60801-8
|
Trapped lung volume --at end expiration |
|
78732-5
|
Trauma Consult note |
|
93969-4
|
Trauma Diagnostic study note |
|
89815-5
|
Trauma Initial evaluation note |
|
89036-8
|
Trauma Note |
|
90708-9
|
Trauma Outpatient Note |
|
78240-9
|
Trauma Surgical operation note |
|
89817-1
|
Trauma procedure note |
|
87513-8
|
Trauma Process of care measures Document |
|
89816-3
|
Trauma Progress note |
|
74198-3
|
Trauma Summary registry report |
|
89561-5
|
Trauma symptoms score [CUBS] |
|
82764-2
|
Country of travel outside the U.S. [Location] 2 years |
|
85709-4
|
Traveled outside the U.S. during first trimester of pregnancy of Mother |
|
82752-7
|
Date travel started |
|
78885-1
|
traZODone cutoff [Mass/volume] in Urine for Confirmatory method |
|
4450-3
|
traZODone [Mass] of Dose |
|
40402-0
|
traZODone [Presence] in Gastric fluid |
|
59976-1
|
traZODone [Moles/volume] in Gastric fluid |
|
4063-4
|
traZODone [Presence] in Serum or Plasma |
|
35635-2
|
traZODone [Mass/volume] in Serum or Plasma by Screen method |
|
4064-2
|
traZODone [Mass/volume] in Serum or Plasma |
|
14925-2
|
traZODone [Moles/volume] in Serum or Plasma |
|
72672-9
|
traZODone [Mass/volume] in Serum or Plasma --trough |
|
92637-8
|
traZODone [Mass/volume] in Urine by Confirmatory method |
|
4065-9
|
traZODone [Presence] in Urine |
|
92653-5
|
traZODone [Presence] in Urine by Confirmatory method |
|
16281-8
|
traZODone [Units/volume] in Urine |
|
27059-5
|
traZODone [Mass/volume] in Urine |
|
59975-3
|
traZODone [Moles/volume] in Urine |
|
60335-7
|
traZODone [Moles/volume] in Unspecified specimen |
|
82494-6
|
TRBV10 gene segments/TRBV gene segments.total in Blood |
|
82493-8
|
TRBV11 gene segments/TRBV gene segments.total in Blood |
|
82492-0
|
TRBV12 gene segments/TRBV gene segments.total in Blood |
|
82491-2
|
TRBV13 gene segments/TRBV gene segments.total in Blood |
|
82490-4
|
TRBV14 gene segments/TRBV gene segments.total in Blood |
|
82489-6
|
TRBV15 gene segments/TRBV gene segments.total in Blood |
|
82488-8
|
TRBV16 gene segments/TRBV gene segments.total in Blood |
|
82487-0
|
TRBV18 gene segments/TRBV gene segments.total in Blood |
|
82486-2
|
TRBV19 gene segments/TRBV gene segments.total in Blood |
|
82501-8
|
TRBV2 gene segments/TRBV gene segments.total in Blood |
|
82485-4
|
TRBV20-1 gene segment/TRBV gene segments.total in Blood |
|
82484-7
|
TRBV24-1 gene segment/TRBV gene segments.total in Blood |
|
82483-9
|
TRBV25 gene segments/TRBV gene segments.total in Blood |
|
82482-1
|
TRBV27 gene segment/TRBV gene segments.total in Blood |
|
82481-3
|
TRBV28 gene segment/TRBV gene segments.total in Blood |
|
82480-5
|
TRBV29 gene segments/TRBV gene segments.total in Blood |
|
82479-7
|
TRBV30 gene segment/TRBV gene segments.total in Blood |
|
82500-0
|
TRBV3-1 gene segment/TRBV gene segments.total in Blood |
|
82499-5
|
TRBV4 gene segments/TRBV gene segments.total in Blood |
|
82498-7
|
TRBV5 gene segments/TRBV gene segments.total in Blood |
|
82497-9
|
TRBV6 gene segments/TRBV gene segments.total in Blood |
|
82496-1
|
TRBV7 gene segments/TRBV gene segments.total in Blood |
|
82495-3
|
TRBV9 gene segments/TRBV gene segments.total in Blood |
|
38417-2
|
Trans-cinnamoylglycine/Creatinine [Mass Ratio] in Urine |
|
93774-8
|
Trans-cinnamoylglycine/Creatinine [Molar ratio] in Urine |
|
91547-0
|
Treadmill angina [Identifier] |
|
72184-5
|
Treated for syphillis [RHEA] |
|
72183-7
|
Treated for syphillis Significant other [RHEA] |
|
46552-6
|
Treated for urinary tract infection in past 14 days [CMS Assessment] |
|
88057-5
|
Treatment for abnormal Pap test |
|
90045-6
|
Treatment history of specimen [Identifier] in Semen |
|
87535-1
|
Challenges to maintaining treatments or health behaviors |
|
87536-9
|
Treatment or health behavior affected by challenges |
|
62320-7
|
T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection |
|
92008-2
|
T-cell receptor excision circle [Multiple of the median] in DBS |
|
92006-6
|
T-cell receptor excision circle [Cycle Threshold #] in DBS |
|
92007-4
|
T-cell receptor excision circle [Z-score] in DBS |
|
15269-4
|
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk |
|
71371-9
|
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Units/volume] in Serum by Multidisk |
|
82038-1
|
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
24512-6
|
Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab [Units/volume] in Serum by Multidisk |
|
24513-4
|
Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15263-7
|
Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk |
|
15265-2
|
Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk |
|
15262-9
|
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk |
|
30184-6
|
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Units/volume] in Serum by Multidisk |
|
24479-8
|
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15260-3
|
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk |
|
82111-6
|
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Units/volume] in Serum by Multidisk |
|
82110-8
|
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
23797-4
|
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Presence] in Serum by Multidisk |
|
82031-6
|
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Units/volume] in Serum by Multidisk |
|
24489-7
|
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15264-5
|
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk |
|
82032-4
|
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Units/volume] in Serum by Multidisk |
|
24490-5
|
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
51527-0
|
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
|
24491-3
|
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
|
24492-1
|
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15266-0
|
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
|
69959-5
|
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
|
82033-2
|
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15267-8
|
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk |
|
82035-7
|
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Units/volume] in Serum by Multidisk |
|
82034-0
|
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15268-6
|
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk |
|
30182-0
|
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Units/volume] in Serum by Multidisk |
|
82036-5
|
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15270-2
|
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk |
|
50653-5
|
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Units/volume] in Serum by Multidisk |
|
82037-3
|
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
7744-6
|
Tree of Heaven IgE Ab [Units/volume] in Serum |
|
21578-0
|
Tree of Heaven IgE Ab RAST class [Presence] in Serum |
|
3038-7
|
Trehalase [Enzymatic activity/volume] in Urine |
|
77701-1
|
Tremor scale [UPDRS] |
|
73565-4
|
Trenbolone [Presence] in Urine |
|
10893-6
|
Trenbolone [Mass/volume] in Urine |
|
89253-9
|
Trend |
|
26658-5
|
Treponema sp Ab [Presence] in Serum |
|
75190-9
|
Treponemal test was reactive [CDC.CS] |
|
6465-9
|
Microscopic observation [Identifier] in Duodenal fluid by Trichrome stain |
|
6469-1
|
Microscopic observation [Identifier] in Stool by Trichrome stain |
|
6473-3
|
Microscopic observation [Identifier] in Tissue by Trichrome stain |
|
678-3
|
Microscopic observation [Identifier] in Unspecified specimen by Trichrome stain |
|
75500-9
|
Triage note |
|
82789-9
|
Trial early withdrawal date |
|
82778-2
|
Trial enrollment date |
|
82790-7
|
Trial invitation code |
|
54767-9
|
Trial of toileting program has been attempted on admission or reentry or since urinary incontinence was noted in this facility [CMS Assessment] |
|
82779-0
|
Trial participation end date |
|
41767-5
|
Triamcinolone acetonide [Mass/volume] in Serum or Plasma |
|
46958-5
|
Triamcinolone acetonide [Mass/volume] in Urine |
|
73107-5
|
Triamcinolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73106-7
|
Triamcinolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41766-7
|
Triamcinolone [Mass/volume] in Serum or Plasma |
|
46957-7
|
Triamcinolone [Mass/volume] in Urine |
|
4067-5
|
Triamterene [Mass/time] in 24 hour Urine |
|
60194-8
|
Triamterene [Mass/volume] in Blood |
|
16260-2
|
Triamterene crystals [Presence] in Stone by Infrared spectroscopy |
|
4451-1
|
Triamterene [Mass] of Dose |
|
73104-2
|
Triamterene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73105-9
|
Triamterene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
43690-7
|
Triamterene/Total in Stone |
|
10551-0
|
Triamterene [Mass/volume] in Serum or Plasma |
|
4068-3
|
Triamterene [Presence] in Urine |
|
17730-3
|
Triamterene [Units/volume] in Urine |
|
4066-7
|
Triamterene [Mass/volume] in Urine |
|
91664-3
|
Triangle bur ragweed (Ambrosia deltoidea) IgE Ab [Units/volume] in Serum |
|
59759-1
|
Triazolam [Mass/volume] in Blood by Confirmatory method |
|
59758-3
|
Triazolam [Mass/volume] in Blood |
|
79245-7
|
Triazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
19717-8
|
Triazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
19716-0
|
Triazolam cutoff [Mass/volume] in Urine for Screen method |
|
4452-9
|
Triazolam [Mass] of Dose |
|
59761-7
|
Triazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59760-9
|
Triazolam [Mass/volume] in Body fluid |
|
61092-3
|
Triazolam [Presence] in Gastric fluid |
|
26945-6
|
Triazolam [Mass/mass] in Hair |
|
73102-6
|
Triazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73103-4
|
Triazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26913-4
|
Triazolam [Mass/mass] in Meconium |
|
78883-6
|
Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59762-5
|
Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61064-2
|
Triazolam [Presence] in Serum or Plasma |
|
4069-1
|
Triazolam [Mass/volume] in Serum or Plasma |
|
14926-0
|
Triazolam [Moles/volume] in Serum or Plasma |
|
12384-4
|
Triazolam [Presence] in Stool |
|
27286-4
|
Triazolam [Mass/mass] in Stool |
|
59764-1
|
Triazolam [Mass/mass] in Tissue by Confirmatory method |
|
59763-3
|
Triazolam [Mass/mass] in Tissue |
|
16232-1
|
Triazolam [Mass/volume] in Urine by Confirmatory method |
|
14192-9
|
Triazolam [Presence] in Urine |
|
16224-8
|
Triazolam [Presence] in Urine by Confirmatory method |
|
19714-5
|
Triazolam [Presence] in Urine by Screen method |
|
4070-9
|
Triazolam [Mass/volume] in Urine |
|
26686-6
|
Triazolam [Mass/volume] in Vitreous fluid |
|
61093-1
|
Triazolam [Presence] in Unspecified specimen |
|
48966-6
|
Triazolam [Mass/volume] in Unspecified specimen |
|
77327-5
|
Triazolam [Moles/volume] in Unspecified specimen |
|
26661-9
|
Trichinella sp Ab [Presence] in Serum |
|
33587-7
|
Trichinella sp IgA Ab [Units/volume] in Serum |
|
32723-9
|
Trichinella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
56992-1
|
Trichinella sp IgG Ab [Presence] in Serum by Immunofluorescence |
|
32768-4
|
Trichinella sp IgG Ab [Units/volume] in Serum |
|
27426-6
|
Trichinella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
31687-7
|
Trichinella sp IgM Ab [Units/volume] in Serum |
|
53355-4
|
Trichomonas sp [#/volume] in Urine by Computer assisted method |
|
53357-0
|
Trichomonas sp [#/area] in Urine by Computer assisted method |
|
33905-1
|
Trichomonas sp [#/area] in Urine sediment by Microscopy high power field |
|
43367-2
|
Trichomonas sp [#/area] in Urine sediment by Microscopy low power field |
|
10728-4
|
Trichomonas sp identified in Genital specimen by Organism specific culture |
|
80725-5
|
Trichomonas sp [Presence] in Semen by Light microscopy |
|
50237-7
|
Trichomonas sp [Presence] in Urine by Computer assisted method |
|
32724-7
|
Trichomonas sp [Presence] in Urine by Light microscopy |
|
68458-9
|
Trichomonas sp identified in Unspecified specimen by Organism specific culture |
|
7745-3
|
Trichophyton sp IgE Ab [Units/volume] in Serum |
|
16060-6
|
Trichophyton sp IgE Ab RAST class [Presence] in Serum |
|
33324-5
|
Trichophyton sp IgG Ab RAST class [Presence] in Serum |
|
16062-2
|
Trichosporon spp IgE Ab RAST class [Presence] in Serum |
|
49116-7
|
Trichosporon sp DNA [Units/volume] in Serum by NAA with probe detection |
|
49593-7
|
Trichothecene IgA Ab [Units/volume] in Serum by Immunoassay |
|
53388-5
|
Trichothecene IgA Ab [Units/volume] in Serum |
|
49597-8
|
Trichothecene IgE Ab [Units/volume] in Serum by Immunoassay |
|
53389-3
|
Trichothecene IgE Ab [Units/volume] in Serum |
|
49594-5
|
Trichothecene IgG Ab [Units/volume] in Serum by Immunoassay |
|
53390-1
|
Trichothecene IgG Ab [Units/volume] in Serum |
|
49595-2
|
Trichothecene IgM Ab [Units/volume] in Serum by Immunoassay |
|
53391-9
|
Trichothecene IgM Ab [Units/volume] in Serum |
|
60197-1
|
Triclopyr [Mass/volume] in Serum or Plasma |
|
33620-6
|
Tricarboxylporphyrin 1 [Mass/time] in 24 hour Stool |
|
33621-4
|
Tricarboxylporphyrin 3 [Mass/time] in 24 hour Stool |
|
80146-4
|
Tricyclic antidepressants [Presence] in Blood by Screen method |
|
19320-1
|
Tricyclic antidepressants confirm method [Identifier] in Urine |
|
19318-5
|
Tricyclic antidepressants cutoff [Mass/volume] in Urine for Confirmatory method |
|
19317-7
|
Tricyclic antidepressants cutoff [Mass/volume] in Urine for Screen method |
|
80147-2
|
Tricyclic antidepressants [Presence] in Body fluid by Screen method |
|
29228-4
|
Tricyclic antidepressants [Mass/volume] in Body fluid |
|
78893-5
|
Tricyclic antidepressants [Presence] in Gastric fluid |
|
78891-9
|
Tricyclic antidepressants [Presence] in Hair |
|
19316-9
|
Tricyclic antidepressants positive [Identifier] in Urine by Confirmatory method |
|
19319-3
|
Tricyclic antidepressants screen method [Identifier] in Urine |
|
4073-3
|
Tricyclic antidepressants [Presence] in Serum or Plasma |
|
80148-0
|
Tricyclic antidepressants [Presence] in Serum or Plasma by Screen method |
|
10552-8
|
Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
|
15111-8
|
Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
|
19313-6
|
Tricyclic antidepressants tested for in Urine by Screen method Nominal |
|
19314-4
|
Tricyclic antidepressants tested for in Urine by Screen method Narrative |
|
16181-0
|
Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method |
|
11004-9
|
Tricyclic antidepressants [Presence] in Urine |
|
19315-1
|
Tricyclic antidepressants [Presence] in Urine by Confirmatory method |
|
6799-1
|
Tricyclic antidepressants [Presence] in Urine by Immunoassay |
|
19312-8
|
Tricyclic antidepressants [Presence] in Urine by Screen method |
|
80149-8
|
Tricyclic antidepressants [Presence] in Urine by Screen method >1000 ng/mL |
|
78889-3
|
Tricyclic antidepressants [Presence] in Urine by Screen method >300 ng/mL |
|
20663-1
|
Tricyclic antidepressants [Mass/volume] in Urine by Screen method |
|
50543-8
|
Tricyclic antidepressants [Mass/volume] in Urine |
|
34176-8
|
Tricyclic antidepressants [Presence] in Unspecified specimen |
|
58403-7
|
Tricyclic antidepressants/Creatinine [Mass Ratio] in Urine |
|
35411-8
|
Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
|
38731-6
|
Triethylamine [Mass/volume] in Air |
|
38732-4
|
Trifluralin [Mass/volume] in Air |
|
60198-9
|
Trifluralin [Mass/volume] in Blood |
|
60199-7
|
Trifluralin [Mass/volume] in Serum or Plasma |
|
60200-3
|
Trifluralin [Mass/volume] in Urine |
|
75771-6
|
Trifluoperazine [Presence] in Blood or Urine by Screen method |
|
32596-9
|
Trifluoperazine [Mass] of Dose |
|
13585-5
|
Trifluoperazine [Presence] in Serum or Plasma |
|
4074-1
|
Trifluoperazine [Mass/volume] in Serum or Plasma |
|
39795-0
|
Trifluoperazine [Moles/volume] in Serum or Plasma |
|
12321-6
|
Trifluoperazine [Presence] in Urine |
|
89965-8
|
Trifluoperazine [Presence] in Urine by Screen method |
|
45146-8
|
Triflupromazine [Presence] in Serum or Plasma |
|
12422-2
|
Triflupromazine [Mass/volume] in Serum or Plasma |
|
12322-4
|
Triflupromazine [Presence] in Urine |
|
35362-3
|
Triglyceride in Chylomicrons [Presence] in Serum or Plasma |
|
35363-1
|
Triglyceride in Chylomicrons [Mass/volume] in Serum or Plasma |
|
87213-5
|
Triggered care area included in care plan [CMS Assessment] |
|
77360-6
|
Triglyceride [Mass/mass] in 24 hour Stool |
|
77361-4
|
Triglyceride [Mass/time] in 24 hour Stool |
|
59571-0
|
Triglyceride [Moles/time] in 24 hour Urine |
|
14445-1
|
Triglyceride [Mass/volume] in Amniotic fluid |
|
3043-7
|
Triglyceride [Mass/volume] in Blood |
|
70218-3
|
Triglyceride [Moles/volume] in Blood |
|
14446-9
|
Triglyceride [Mass/volume] in Cerebral spinal fluid |
|
59036-4
|
Triglyceride [Mass/volume] in Peritoneal dialysis fluid |
|
12228-3
|
Triglyceride [Mass/volume] in Body fluid |
|
29766-3
|
Triglyceride [Moles/volume] in Body fluid |
|
53527-8
|
Triglyceride in HDL 2 [Moles/volume] in Serum or Plasma |
|
53528-6
|
Triglyceride in HDL 3 [Moles/volume] in Serum or Plasma |
|
53526-0
|
Triglyceride in VLDL [Moles/volume] in Serum or Plasma |
|
1644-4
|
Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
|
30524-3
|
Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting |
|
3048-6
|
Triglyceride [Mass/volume] in Serum or Plasma --fasting |
|
47210-0
|
Triglyceride [Moles/volume] in Serum or Plasma --fasting |
|
70259-7
|
Triglyceride in pericardial fluid/Triglyceride in serum |
|
69947-0
|
Triglyceride [Moles/volume] in Pericardial fluid |
|
70269-6
|
Triglyceride in pleural fluid/Triglyceride in serum |
|
9619-8
|
Triglyceride [Mass/volume] in Pleural fluid |
|
39801-6
|
Triglyceride [Moles/volume] in Pleural fluid |
|
30570-6
|
Triglyceride [Percentile] |
|
70260-5
|
Triglyceride in peritoneal fluid/Triglyceride in serum |
|
14447-7
|
Triglyceride [Mass/volume] in Peritoneal fluid |
|
66769-1
|
Triglyceride [Moles/volume] in Peritoneal fluid |
|
12951-0
|
Triglyceride [Mass/volume] in Serum or Plasma by calculation |
|
28554-4
|
Triglyceride [Presence] in Serum or Plasma |
|
2571-8
|
Triglyceride [Mass/volume] in Serum or Plasma |
|
35217-9
|
Triglyceride [Mass or Moles/volume] in Serum or Plasma |
|
14927-8
|
Triglyceride [Moles/volume] in Serum or Plasma |
|
14448-5
|
Triglyceride [Mass/volume] in Semen |
|
14449-3
|
Triglyceride [Mass/volume] in Synovial fluid |
|
51605-4
|
Triglyceride [Moles/volume] in Synovial fluid |
|
14450-1
|
Triglyceride [Mass/volume] in Urine |
|
59572-8
|
Triglyceride [Moles/volume] in Urine |
|
22731-4
|
Triglyceride [Moles/volume] in Unspecified specimen |
|
44733-4
|
Triglyceride/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
|
55607-6
|
Triglyceride/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
3044-5
|
Triglyceride+ester in HDL [Mass/volume] in Serum or Plasma |
|
3045-2
|
Triglyceride+ester in IDL [Mass/volume] in Serum or Plasma |
|
3046-0
|
Triglyceride+ester in LDL [Mass/volume] in Serum or Plasma |
|
3047-8
|
Triglyceride+ester in VLDL [Mass/volume] in Serum or Plasma |
|
9703-0
|
Trihexyphenidyl [Mass/volume] in Serum or Plasma |
|
10345-7
|
Trihexyphenidyl [Mass/volume] in Urine |
|
4077-4
|
Trimeperidine [Mass/time] in 24 hour Urine |
|
4453-7
|
Trimeperidine [Mass] of Dose |
|
4075-8
|
Trimeperidine [Presence] in Urine |
|
4076-6
|
Trimeperidine [Mass/volume] in Urine |
|
79149-1
|
Trimeprazine [Mass/volume] in Body fluid |
|
80150-6
|
Trimeprazine [Mass/mass] in Hair |
|
17746-9
|
Trimeprazine [Presence] in Serum or Plasma |
|
12423-0
|
Trimeprazine [Mass/volume] in Serum or Plasma |
|
39482-5
|
Trimeprazine [Moles/volume] in Serum or Plasma |
|
12323-2
|
Trimeprazine [Presence] in Urine |
|
78888-5
|
Trimeprazine [Mass/volume] in Urine |
|
81271-9
|
Trimester at onset of illness |
|
17748-5
|
Trimethylamine [Presence] in Urine |
|
3056-9
|
Trimethylamine [Mass/volume] in Urine |
|
21580-6
|
Trimethobenzamide [Mass/volume] in Unspecified specimen |
|
72938-4
|
Trimethoprim induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72937-6
|
Trimethoprim induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80552-3
|
Trimethoprim [Mass/volume] in DBS |
|
4455-2
|
Trimethoprim [Mass] of Dose |
|
80973-1
|
Trimethoprim free [Mass/volume] in Serum or Plasma |
|
18258-4
|
Trimethoprim IgE Ab [Units/volume] in Serum |
|
73100-0
|
Trimethoprim induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73101-8
|
Trimethoprim induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7056-5
|
Trimethoprim [Susceptibility] by Gradient strip |
|
513-2
|
Trimethoprim [Susceptibility] by Disk diffusion (KB) |
|
512-4
|
Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
511-6
|
Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC) |
|
23614-1
|
Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria |
|
48195-2
|
Trimethoprim triggered leukotriene release [Mass/volume] by Leukocytes |
|
4079-0
|
Trimethoprim [Presence] in Serum or Plasma |
|
11005-6
|
Trimethoprim [Mass/volume] in Serum or Plasma |
|
55584-7
|
Trimethoprim [Moles/volume] in Serum or Plasma |
|
18997-7
|
Trimethoprim [Susceptibility] |
|
514-0
|
Trimethoprim [Susceptibility] by Serum bactericidal titer |
|
4080-8
|
Trimethoprim [Presence] in Urine |
|
17747-7
|
Trimethoprim [Mass/volume] in Urine |
|
25812-9
|
Trimipramine+Nortrimipramine [Moles/volume] in Serum or Plasma |
|
77337-4
|
Trimipramine+Nortrimipramine [Moles/volume] in Unspecified specimen |
|
4456-0
|
Trimipramine [Mass] of Dose |
|
40403-8
|
Trimipramine [Presence] in Gastric fluid |
|
29402-5
|
Trimipramine [Mass/volume] in Gastric fluid |
|
47133-4
|
Trimipramine [Moles/volume] in Gastric fluid |
|
4082-4
|
Trimipramine [Presence] in Serum or Plasma |
|
4083-2
|
Trimipramine [Mass/volume] in Serum or Plasma |
|
14931-0
|
Trimipramine [Moles/volume] in Serum or Plasma |
|
4084-0
|
Trimipramine [Presence] in Urine |
|
12443-8
|
Trimipramine [Mass/volume] in Urine |
|
47134-2
|
Trimipramine [Moles/volume] in Urine |
|
60336-5
|
Trimipramine [Moles/volume] in Unspecified specimen |
|
16466-5
|
Bile acid.trihydroxy [Mass/volume] in Serum or Plasma |
|
38188-9
|
Bile acid.trihydroxy [Moles/volume] in Serum or Plasma |
|
3057-7
|
Triokinase [Enzymatic activity/volume] in Plasma |
|
60206-0
|
Tripelennamine [Mass/volume] in Blood |
|
4457-8
|
Tripelennamine [Mass] of Dose |
|
40404-6
|
Tripelennamine [Presence] in Gastric fluid |
|
75764-1
|
Tripelennamine [Presence] in Serum or Plasma or Urine by Screen method |
|
4085-7
|
Tripelennamine [Mass/volume] in Serum or Plasma |
|
55585-4
|
Tripelennamine [Moles/volume] in Serum or Plasma |
|
14193-7
|
Tripelennamine [Presence] in Urine |
|
27280-7
|
Tripelennamine [Mass/volume] in Urine |
|
34674-2
|
Tripeptide aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
|
72498-9
|
Tripeptidyl peptidase I [Enzymatic activity/volume] in DBS |
|
74576-0
|
Tripeptidyl peptidase I [Enzymatic activity/mass] in Fibroblast |
|
76038-9
|
Tripeptidyl peptidase I [Enzymatic activity/mass] in Leukocytes |
|
53811-6
|
Triple phosphate [Saturation Fraction] in 24 hour Urine |
|
53298-6
|
Triple phosphate crystals [#/volume] in Urine by Computer assisted method |
|
53308-3
|
Triple phosphate crystals [#/area] in Urine by Computer assisted method |
|
46137-6
|
Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field |
|
33020-9
|
Triple phosphate crystals [#/area] in Urine sediment by Microscopy low power field |
|
13496-5
|
Triple phosphate crystals [type] in Stone by Light microscopy |
|
16265-1
|
Triple phosphate crystals [Presence] in Stone by Infrared spectroscopy |
|
33238-7
|
Triple phosphate crystals [Presence] in Urine by Computer assisted method |
|
5814-9
|
Triple phosphate crystals [Presence] in Urine sediment by Light microscopy |
|
32143-0
|
Triple phosphate/Total in Stone |
|
75765-8
|
Triprolidine [Presence] in Serum or Plasma or Urine by Screen method |
|
12424-8
|
Triprolidine [Mass/volume] in Serum or Plasma |
|
67816-9
|
Trisomy 18 + Trisomy 13 risk [Likelihood] in Fetus |
|
39585-5
|
Tritium [Presence] in 24 hour Urine |
|
28074-3
|
Tritium [Presence] in Urine |
|
74836-8
|
Transplant type [Anatomy] |
|
85214-5
|
Transplant candidate evaluation note |
|
521-5
|
Troleandomycin [Susceptibility] by Disk diffusion (KB) |
|
520-7
|
Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
519-9
|
Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18999-3
|
Troleandomycin [Susceptibility] |
|
522-3
|
Troleandomycin [Susceptibility] by Serum bactericidal titer |
|
17749-3
|
Tromethamine [Mass/volume] in Serum or Plasma |
|
57316-2
|
Tropomyosin IgE Ab [Units/volume] in Serum |
|
57305-5
|
Tropomyosin IgE Ab [Mass/volume] in Serum |
|
42757-5
|
Troponin I.cardiac [Mass/volume] in Blood |
|
49563-0
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
|
89578-9
|
Troponin I.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method |
|
89579-7
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method |
|
16255-2
|
Troponin I.cardiac [Units/volume] in Serum or Plasma |
|
76399-5
|
Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
10839-9
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma |
|
48426-1
|
Troponin T.cardiac [Presence] in Blood |
|
48425-3
|
Troponin T.cardiac [Mass/volume] in Blood |
|
6597-9
|
Troponin T.cardiac [Mass/volume] in Venous blood |
|
89575-5
|
Troponin T.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method |
|
67151-1
|
Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method |
|
33204-9
|
Troponin T.cardiac [Presence] in Serum or Plasma |
|
6598-7
|
Troponin T.cardiac [Mass/volume] in Serum or Plasma |
|
35852-3
|
Trospectinomycin [Susceptibility] by Disk diffusion (KB) |
|
35853-1
|
Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35854-9
|
Trospectinomycin [Susceptibility] |
|
44252-5
|
Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks [Reported.PHQ] |
|
54671-3
|
Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54649-9
|
Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54670-5
|
Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
54648-1
|
Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
54663-0
|
Trouble falling or staying asleep, or sleeping too much in last 2 weeks.frequency [Observed PHQ-9 CMS] |
|
54641-6
|
Trouble falling or staying asleep, or sleeping too much in last 2 weeks.frequency [Reported PHQ-9 CMS] |
|
54662-2
|
Trouble falling or staying asleep, or sleeping too much in last 2 weeks.presence [Observed PHQ-9 CMS] |
|
54640-8
|
Trouble falling or staying asleep, or sleeping too much in last 2 weeks.presence [Reported PHQ-9 CMS] |
|
6268-7
|
Trout IgE Ab [Units/volume] in Serum |
|
16064-8
|
Trout IgE Ab RAST class [Presence] in Serum |
|
61289-5
|
Trout IgE Ab/IgE total in Serum |
|
7747-9
|
Trout IgG Ab [Units/volume] in Serum |
|
21581-4
|
Trout IgG Ab RAST class [Presence] in Serum |
|
56407-0
|
Trout IgG4 Ab [Mass/volume] in Serum |
|
60409-0
|
Trout IgG Ab [Mass/volume] in Serum |
|
7058-1
|
Trovafloxacin [Susceptibility] by Gradient strip |
|
35855-6
|
Trovafloxacin [Susceptibility] by Disk diffusion (KB) |
|
23643-0
|
Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23642-2
|
Trovafloxacin [Susceptibility] |
|
38927-0
|
TRPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38931-2
|
TRPS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85215-2
|
Transplant donor evaluation note |
|
90079-5
|
Were you trying to get pregnant |
|
25424-3
|
Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence |
|
23533-3
|
Trypanosoma sp Ab [Presence] in Serum |
|
23532-5
|
Trypanosoma sp Ab [Presence] in Serum by Agglutination |
|
23531-7
|
Trypanosoma sp Ab [Presence] in Serum by Immunoassay |
|
23534-1
|
Trypanosoma sp Ab [Presence] in Serum by Immunofluorescence |
|
5399-1
|
Trypanosoma sp Ab [Units/volume] in Serum |
|
31980-6
|
Trypanosoma sp Ag [Presence] in Blood |
|
23535-8
|
Trypanosoma sp Ag [Presence] in Blood by Immunoassay |
|
10859-7
|
Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
|
23536-6
|
Trypanosoma sp identified in Blood by Concentration |
|
10730-0
|
Trypanosoma sp identified in Blood by Organism specific culture |
|
10729-2
|
Trypanosoma sp identified in Blood by Light microscopy |
|
10731-8
|
Trypanosoma sp identified in Blood by Thick film |
|
10732-6
|
Trypanosoma sp identified in Blood by Thin film |
|
10733-4
|
Trypanosoma sp identified in Blood by Wet preparation |
|
14839-5
|
Trypanosoma sp identified in Buffy Coat by Light microscopy |
|
14840-3
|
Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
|
3062-7
|
Trypsin [Enzymatic activity/time] in 24 hour Stool |
|
10517-1
|
Trypsin Ag [Presence] in Tissue by Immune stain |
|
3059-3
|
Trypsin [Enzymatic activity/volume] in Duodenal fluid |
|
3060-1
|
Trypsin [Enzymatic activity/volume] in Serum or Plasma |
|
33325-2
|
Trypsin [Mass/volume] in Serum or Plasma |
|
35312-8
|
Trypsin [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide |
|
35311-0
|
Trypsin [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide |
|
35310-2
|
Trypsin [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide |
|
35309-4
|
Trypsin [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide |
|
35308-6
|
Trypsin [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide |
|
26960-5
|
Trypsin [Presence] in Stool |
|
3063-5
|
Trypsin [Enzymatic activity/volume] in Stool |
|
33669-3
|
Trypsin [Titer] in Stool |
|
3064-3
|
Trypsin+Trypsinogen [Mass/volume] in Serum or Plasma |
|
51935-5
|
Trypsinogen I Free [Presence] in DBS |
|
48633-2
|
Trypsinogen I Free [Mass/volume] in DBS |
|
3067-6
|
Trypsinogen I Free [Mass/volume] in Serum or Plasma |
|
3065-0
|
Trypsinogen [Presence] in Serum or Plasma |
|
17750-1
|
Trypsinogen [Enzymatic activity/volume] in Serum or Plasma |
|
3066-8
|
Trypsinogen [Mass/volume] in Serum or Plasma |
|
17751-9
|
Tryptamine [Mass/volume] in Serum or Plasma |
|
45334-0
|
Tryptase [Mass/volume] in Body fluid |
|
7748-7
|
Tryptase IgE Ab [Units/volume] in Serum |
|
12733-2
|
Tryptase [Enzymatic activity/volume] in Serum or Plasma |
|
21582-2
|
Tryptase [Mass/volume] in Serum or Plasma |
|
51834-0
|
Tryptase [Moles/volume] in Serum or Plasma |
|
60539-4
|
Tryptase.beta [Mass/volume] in Serum or Plasma |
|
41870-7
|
Tryptase.mature [Enzymatic activity/volume] in Serum or Plasma |
|
9325-2
|
Tryptophan [Moles/volume] in 24 hour Urine |
|
25546-3
|
Tryptophan [Moles/time] in 24 hour Urine |
|
13418-9
|
Tryptophan [Mass/volume] in Amniotic fluid |
|
27135-3
|
Tryptophan [Moles/volume] in Amniotic fluid |
|
3068-4
|
Tryptophan [Mass/volume] in Cerebral spinal fluid |
|
26602-3
|
Tryptophan [Moles/volume] in Cerebral spinal fluid |
|
53159-0
|
Tryptophan [Moles/volume] in DBS |
|
32275-0
|
Tryptophan [Moles/volume] in Body fluid |
|
3073-4
|
Tryptophan Free [Mass/volume] in Serum or Plasma |
|
81922-7
|
Tryptophan intake 24 hour Estimated |
|
81923-5
|
Tryptophan intake 24 hour Measured |
|
74767-5
|
Tryptophan [Moles/volume] in Platelet rich plasma |
|
3069-2
|
Tryptophan [Presence] in Serum or Plasma |
|
27334-2
|
Tryptophan [Units/volume] in Serum or Plasma |
|
3070-0
|
Tryptophan [Mass/volume] in Serum or Plasma |
|
20659-9
|
Tryptophan [Moles/volume] in Serum or Plasma |
|
17752-7
|
Tryptophan [Presence] in Urine |
|
3072-6
|
Tryptophan [Mass/volume] in Urine |
|
34384-8
|
Tryptophan [Moles/volume] in Urine |
|
44414-1
|
Tryptophan/Creatinine [Mass Ratio] in 24 hour Urine |
|
56993-9
|
Tryptophan/Creatinine [Ratio] in 24 hour Urine |
|
25994-5
|
Tryptophan/Creatinine [Molar ratio] in 24 hour Urine |
|
13817-2
|
Tryptophan/Creatinine [Mass Ratio] in Urine |
|
28608-8
|
Tryptophan/Creatinine [Ratio] in Urine |
|
25139-7
|
Tryptophan/Creatinine [Molar ratio] in Urine |
|
58769-1
|
Trisomy 13 risk [Likelihood] in Fetus |
|
49582-0
|
Trisomy 18 risk cutoff in Fetus |
|
43994-3
|
Trisomy 18 risk [Likelihood] in Fetus |
|
88004-7
|
Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency [Likelihood] in Fetus |
|
49583-8
|
Trisomy 21 risk cutoff in Fetus |
|
43995-0
|
Trisomy 21 risk [Likelihood] in Fetus |
|
49030-0
|
Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus |
|
49059-9
|
Trisomy 21+Trisomy 18 risk [Likelihood] in Fetus |
|
47222-5
|
Trisomy 21 risk based on maternal age+Alpha-1-Fetoprotein+Choriogonadotropin+Estriol.unconjugated [Likelihood] in Fetus |
|
87410-7
|
Thymidine synthase activity interpretation in Blood or Tissue Qualitative |
|
29010-6
|
Tear secretion comment [Interpretation] Left eye Narrative Schirmer test |
|
29009-8
|
Tear secretion comment [Interpretation] Right eye Narrative Schirmer test |
|
34650-2
|
TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41047-2
|
TSC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48979-9
|
TSC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48980-7
|
TSC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81882-3
|
TSC2 and PKD1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
74037-3
|
Transmissible spongiform encephalopathy [Identifier] in Brain by Light microscopy |
|
38275-4
|
Transmissible spongiform encephalopathy [Presence] in Brain by Light microscopy |
|
12938-7
|
Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
47947-7
|
Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post dose lutenizing releasing hormone IV |
|
13869-3
|
Thyrotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
|
33260-1
|
Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH |
|
12933-8
|
Thyrotropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
12934-6
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
47948-5
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose lutenizing releasing hormone IV |
|
44935-5
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV |
|
13870-1
|
Thyrotropin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV |
|
40397-2
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
58834-3
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
47949-3
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose lutenizing releasing hormone IV |
|
44936-3
|
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV |
|
29317-5
|
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
47950-1
|
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose lutenizing releasing hormone IV |
|
14998-9
|
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
|
1641-0
|
Thyrotropin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
|
33259-3
|
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH |
|
40398-0
|
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
77623-7
|
Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
48077-2
|
Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post dose lutenizing releasing hormone IV |
|
12935-3
|
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
50541-2
|
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose TRH |
|
24459-0
|
Thyrotropin [Mass/volume] in Serum or Plasma --20 minutes post dose TRH |
|
40399-8
|
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
|
58833-5
|
Thyrotropin [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge |
|
12939-5
|
Thyrotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
47951-9
|
Thyrotropin [Units/volume] in Serum or Plasma --2 hours post dose lutenizing releasing hormone IV |
|
13871-9
|
Thyrotropin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV |
|
33261-9
|
Thyrotropin [Units/volume] in Serum or Plasma --2 hours post dose TRH |
|
29316-7
|
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
47952-7
|
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose lutenizing releasing hormone IV |
|
25990-3
|
Thyrotropin [Moles/volume] in Serum or Plasma --30 minutes post dose TRH IN |
|
14997-1
|
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
|
1640-2
|
Thyrotropin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
|
33258-5
|
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH |
|
40400-4
|
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
12940-3
|
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
56594-5
|
Thyrotropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
|
12936-1
|
Thyrotropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
12937-9
|
Thyrotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
11033-8
|
Thyrotropin [Mass/volume] in Serum or Plasma --45 minutes post dose TRH IV |
|
57854-2
|
Thyrotropin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge |
|
90801-2
|
Thyrotropin [Units/volume] in Serum or Plasma --6 hours post dose levothyroxine |
|
35134-6
|
Thyrotropin Ab [Presence] in Serum |
|
5384-3
|
Thyrotropin Ab [Units/volume] in Serum |
|
10516-3
|
Thyrotropin Ag [Presence] in Tissue by Immune stain |
|
45173-2
|
Thyrotropin.alpha subunit [Mass/volume] in Serum or Plasma |
|
13897-4
|
Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma |
|
14919-5
|
Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum |
|
40673-6
|
Thyrotropin binding inhibitory immunoglobulins [Units/volume] in Serum |
|
3017-1
|
Thyrotropin binding inhibitory immunoglobulins [Mass/volume] in Serum |
|
20452-9
|
Thyrotropin [Presence] in Blood |
|
3015-5
|
Thyrotropin [Units/volume] in Blood |
|
69561-9
|
Thyrotropin [Units/volume] in Cord blood |
|
14255-4
|
Thyrotropin blocking Ab [Units/volume] in Serum |
|
14999-7
|
Thyrotropin [Units/volume] in Serum or Plasma --baseline |
|
1642-8
|
Thyrotropin [Mass/volume] in Serum or Plasma --baseline |
|
29574-1
|
Thyrotropin [Presence] in DBS |
|
29575-8
|
Thyrotropin [Units/volume] in DBS |
|
12932-0
|
Thyrotropin [Units/volume] in Serum or Plasma --post XXX challenge |
|
17786-5
|
Thyrotropin [Interpretation] in Unspecified specimen--post dose TRH |
|
55362-8
|
Thyrotropin [Units/volume] in Serum or Plasma --pre XXX challenge |
|
47953-5
|
Thyrotropin [Units/volume] in Serum or Plasma --pre dose lutenizing releasing hormone IV |
|
25991-1
|
Thyrotropin [Moles/volume] in Serum or Plasma --pre dose TRH IN |
|
15000-3
|
Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV |
|
1643-6
|
Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
|
33269-2
|
Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH |
|
40401-2
|
Thyrotropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
|
65360-0
|
Thyrotropin [Units/volume] in Serum or Plasma --pre or post XXX challenge |
|
34054-7
|
Thyrotropin [Units/volume] in Serum or Plasma --pre or post dose TRH |
|
63363-6
|
Thyrotropin receptor Ab [Units/volume] in Blood from Fetus |
|
63364-4
|
Thyrotropin receptor Ab [Units/volume] in Cord blood |
|
63366-9
|
Thyrotropin receptor Ab [Units/volume] in Cerebral spinal fluid |
|
63365-1
|
Thyrotropin receptor Ab [Units/volume] in Body fluid |
|
57416-0
|
Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay |
|
82659-4
|
Thyrotropin receptor Ab [Presence] in Serum |
|
5385-0
|
Thyrotropin receptor Ab [Units/volume] in Serum |
|
26998-5
|
Thyrotropin [Units/volume] in Saliva (oral fluid) |
|
11580-8
|
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
|
11579-0
|
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
|
3016-3
|
Thyrotropin [Units/volume] in Serum or Plasma |
|
27975-2
|
Thyrotropin [Mass/volume] in Serum or Plasma |
|
14297-6
|
Thyrotropin [Moles/volume] in Serum or Plasma |
|
25789-9
|
Thyrotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50533-9
|
Thyrotropin [Units/volume] in Serum or Plasma --1st specimen |
|
12941-1
|
Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50534-7
|
Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen |
|
12942-9
|
Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50535-4
|
Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen |
|
12943-7
|
Thyrotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50536-2
|
Thyrotropin [Units/volume] in Serum or Plasma --4th specimen |
|
12944-5
|
Thyrotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50537-0
|
Thyrotropin [Units/volume] in Serum or Plasma --5th specimen |
|
12945-2
|
Thyrotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50538-8
|
Thyrotropin [Units/volume] in Serum or Plasma --6th specimen |
|
12946-0
|
Thyrotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50539-6
|
Thyrotropin [Units/volume] in Serum or Plasma --7th specimen |
|
12947-8
|
Thyrotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50540-4
|
Thyrotropin [Units/volume] in Serum or Plasma --8th specimen |
|
12948-6
|
Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
30166-3
|
Thyroid stimulating immunoglobulins actual/normal in Serum |
|
17708-9
|
Thyroid stimulating immunoglobulins [Presence] in Serum |
|
30567-2
|
Thyroid stimulating immunoglobulins [Units/volume] in Serum |
|
3014-8
|
Thyroid stimulating immunoglobulins [Mass/volume] in Serum |
|
32214-9
|
Thyroid stimulating immunoglobulins [Moles/volume] in Serum |
|
21032-8
|
Thrombin time [Interpretation] in Blood |
|
5955-0
|
Thrombin time in Control Platelet poor plasma by Coagulation assay |
|
46224-2
|
Thrombin time in Platelet poor plasma by Coagulation assay --after addition of heparinase |
|
54219-1
|
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
|
46717-5
|
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of bovine thrombin |
|
33525-7
|
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
33673-5
|
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate |
|
51868-8
|
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of XXX |
|
12533-6
|
Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine |
|
12534-4
|
Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine |
|
38620-1
|
Tetrachloroethylene [Mass/volume] in Air |
|
11100-5
|
Tetrachloroethylene [Mass/volume] in Blood |
|
56626-5
|
Tetrachloroethylene [Moles/volume] in Blood |
|
17432-6
|
Tetrachloroethylene [Mass/volume] in Serum or Plasma |
|
43206-2
|
Tetrachloroethylene [Mass/volume] in Urine |
|
38312-5
|
Tetrachloroethylene [Mass/volume] in Water |
|
40564-7
|
Thyroid transcription factor 1 Ag [Presence] in Tissue by Immune stain |
|
53023-8
|
Tissue transglutaminase Ab [Presence] in Serum |
|
54929-5
|
Tissue transglutaminase Ab [Titer] in Serum by Immunofluorescence |
|
46128-5
|
Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay |
|
35285-6
|
Tissue transglutaminase IgA Ab [Presence] in Serum |
|
35280-7
|
Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay |
|
31017-7
|
Tissue transglutaminase IgA Ab [Units/volume] in Serum |
|
69727-6
|
Tissue transglutaminase IgA + Gliadin peptides IgA and IgG [Interpretation] in Serum Narrative |
|
56537-4
|
Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay |
|
53026-1
|
Tissue transglutaminase IgG Ab [Presence] in Serum |
|
32998-7
|
Tissue transglutaminase IgG Ab [Units/volume] in Serum |
|
35880-4
|
Tissue transglutaminase IgM Ab [Units/volume] in Serum |
|
35307-8
|
TTR gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35306-0
|
TTR gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75381-4
|
TTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
48033-5
|
TTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49708-1
|
TTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
92887-9
|
Torque teno virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
92886-1
|
Torque teno virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
32365-9
|
Torque teno virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
19157-7
|
Tube number of Cerebral spinal fluid |
|
42765-8
|
Tube number of Body fluid |
|
41610-7
|
Tube number of Pericardial fluid |
|
41612-3
|
Tube number of Pleural fluid |
|
41611-5
|
Tube number of Peritoneal fluid |
|
46963-5
|
Tube number of Serum, Plasma or Blood |
|
41613-1
|
Tube number of Semen |
|
41614-9
|
Tube number of Synovial fluid |
|
83390-5
|
Tube cuff pressure Intubation tube --at end expiration |
|
11276-3
|
Tubular cells [Presence] in Urine sediment by Light microscopy |
|
93323-4
|
Tauroursodeoxycholate [Moles/volume] in Serum or Plasma |
|
76149-4
|
Tulathromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87798-5
|
Tulathromycin [Susceptibility] |
|
6269-5
|
Tulip IgE Ab [Units/volume] in Serum |
|
40690-0
|
Tumor Ag 90 [Units/volume] in Serum |
|
85232-7
|
Tumor board Consult note |
|
85231-9
|
Tumor board Note |
|
33742-8
|
Tumor border configuration [Type] in Specimen |
|
85296-2
|
Tumor budding [Presence] in Cancer specimen by Light microscopy |
|
85297-0
|
Tumor buds [#/area] in Cancer specimen by Light microscopy |
|
33737-8
|
Distance of tumor from closest margin |
|
81175-2
|
Distance of tumor from closest margin [Length] in Specimen by Macroscopy |
|
81183-6
|
Distance of tumor from closest distal margin [Length] in Specimen by Light microscopy |
|
81182-8
|
Distance of tumor from closest proximal margin [Length] in Specimen by Light microscopy |
|
44693-0
|
Tumor infiltrating lymphocytes |
|
44660-9
|
Tumor involvement by ulceration by CAP cancer protocols |
|
86667-3
|
Level of tumor invasion in Skin melanoma Qualitative by Clark |
|
84874-7
|
Perforation into peritoneal cavity |
|
84879-6
|
Tumor perforation [Presence] by Macroscopy |
|
84875-4
|
Tumor perforation [Type] |
|
44633-6
|
Tumor pigmentation |
|
44653-4
|
Tumor quantitation.incidental in Prostate tumor by CAP cancer protocols |
|
92834-1
|
Tumor regression at peripheral margin [Presence] in Skin melanoma |
|
44694-8
|
Tumor regression by CAP cancer protocols |
|
81189-3
|
Tumor regression [Type] in Tumor --post preoperative therapy |
|
84891-1
|
Tumor response to neoadjuvant therapy |
|
33725-3
|
Tumor site |
|
81188-5
|
Tumor site of Stomach cancer |
|
81174-5
|
Tumor type in Stomach cancer by Macroscopy |
|
7750-3
|
Tuna triggered histamine release [Units/volume] in Blood |
|
6270-3
|
Tuna IgE Ab [Units/volume] in Serum |
|
16065-5
|
Tuna IgE Ab RAST class [Presence] in Serum |
|
39547-5
|
Tuna IgE Ab/IgE total in Serum |
|
7749-5
|
Tuna IgG Ab [Units/volume] in Serum |
|
19047-0
|
Tuna IgG Ab RAST class [Presence] in Serum |
|
56408-8
|
Tuna IgG4 Ab [Mass/volume] in Serum |
|
60410-8
|
Tuna IgG Ab [Mass/volume] in Serum |
|
59765-8
|
Tungsten [Mass/volume] in Blood |
|
76655-0
|
Tungsten [Mass/mass] in Hair |
|
59766-6
|
Tungsten [Mass/volume] in Red Blood Cells |
|
12483-4
|
Tungsten [Presence] in Serum or Plasma |
|
17753-5
|
Tungsten [Mass/volume] in Serum or Plasma |
|
54941-0
|
Tungsten [Mass/volume] in Urine |
|
74002-7
|
Tungsten/Creatinine [Mass Ratio] in 24 hour Urine |
|
72297-5
|
Tunneling clock position of Wound |
|
72296-7
|
Tunneling [Length] of Wound |
|
72298-3
|
Tunneling of Wound |
|
74793-1
|
Thyroid hormone uptake (T-uptake) in Serum or Plasma |
|
33326-0
|
Turbidity [Presence] of Amniotic fluid Qualitative |
|
20512-0
|
Turbidity [Presence] of Cerebral spinal fluid Qualitative |
|
20513-8
|
Turbidity [Presence] of Body fluid Qualitative |
|
40681-9
|
Turbidity [Presence] of Serum or Plasma Qualitative |
|
48053-3
|
Turbidity [Presence] of Synovial fluid Qualitative |
|
20627-6
|
Turbidity [Presence] of Urine Qualitative |
|
87442-0
|
Turbidity of Water |
|
39109-4
|
Turgor [Interpretation] of Skin |
|
7752-9
|
Turkey triggered histamine release [Units/volume] in Blood |
|
55608-4
|
Turkey feather IgE Ab [Presence] in Serum |
|
7753-7
|
Turkey feather IgE Ab [Units/volume] in Serum |
|
21584-8
|
Turkey feather IgE Ab RAST class [Presence] in Serum |
|
7751-1
|
Turkey IgG Ab [Units/volume] in Serum |
|
21583-0
|
Turkey IgG Ab RAST class [Presence] in Serum |
|
56409-6
|
Turkey IgG4 Ab [Mass/volume] in Serum |
|
60411-6
|
Turkey IgG Ab [Mass/volume] in Serum |
|
6271-1
|
Turkey meat IgE Ab [Units/volume] in Serum |
|
16066-3
|
Turkey meat IgE Ab RAST class [Presence] in Serum |
|
40845-0
|
Turkey meat IgE Ab/IgE total in Serum |
|
30041-8
|
Turmeric IgE Ab [Units/volume] in Serum |
|
77697-1
|
Turning in bed and adjusting bed clothes scale [UPDRS] |
|
54751-3
|
Turning around and facing the opposite direction while walking in last 7 days [CMS Assessment] |
|
82947-3
|
Turning in bed and adjusting bed clothes [ALSFRS-R] |
|
7754-5
|
Turnip IgE Ab [Units/volume] in Serum |
|
16067-1
|
Turnip IgE Ab RAST class [Presence] in Serum |
|
77276-4
|
Turnover rate [NMMDS] |
|
83166-9
|
Number of turns in 2 minutes [NIH Toolbox] |
|
12549-2
|
Turpentine [Mass/volume] in Serum or Plasma |
|
12555-9
|
Turpentine [Mass/volume] in Urine |
|
20343-0
|
Tricuspid valve Acceleration slope by US |
|
17983-8
|
Tricuspid valve Acceleration by US.doppler |
|
79922-1
|
Tricuspid valve annulus Tissue velocity.A-wave.max by US.tissue doppler |
|
18023-2
|
Tricuspid valve annulus Diameter by US |
|
80091-2
|
Tricuspid valve annulus Diameter at end diastole by US.2D.A4C |
|
79924-7
|
Tricuspid valve annulus Tissue velocity.E-wave.max by US.tissue doppler |
|
77903-3
|
Tricuspid valve annulus Excursion distance during systole by US.M-mode |
|
20344-8
|
Tricuspid valve annulus Region crossection [Area] by US.calculated |
|
79926-2
|
Tricuspid valve annulus Tissue velocity.S-wave.max by US.tissue doppler |
|
79923-9
|
Tricuspid valve Maximum A-wave velocity by US.doppler |
|
79930-4
|
Tricuspid valve Closure to opening [Time] by US.doppler |
|
20345-5
|
Tricuspid valve Deceleration slope [Velocity] by US |
|
18000-0
|
Tricuspid valve Deceleration [Time] by US.doppler |
|
11801-8
|
Tricuspid valve Diameter by US |
|
81094-5
|
Tricuspid valve Effective regurgitant orifice area by US.doppler+Calculated by volumetric method |
|
81093-7
|
Tricuspid valve Effective regurgitant orifice area by US.doppler+Calculated by PISA method |
|
79925-4
|
Tricuspid valve Maximum E-wave velocity by US.doppler |
|
20347-1
|
Tricuspid valve Flow [Area] by US.calculated |
|
79931-2
|
Tricuspid valve Blood flow deceleration time during diastole by US.doppler |
|
18055-4
|
Tricuspid valve Maximum pressure gradient during diastole by US.doppler |
|
79939-5
|
Tricuspid valve Maximum pressure gradient during diastole by US.doppler+Calculated by simplified Bernoulli |
|
79937-9
|
Tricuspid valve Maximum pressure gradient dur systole by US.doppler.CW+Calculated by simplified Bernoulli |
|
18065-3
|
Tricuspid valve Maximum regurgitant pressure gradient dur systole by US.doppler |
|
79921-3
|
Tricuspid valve Maximum regurgitant blood flow velocity during systole by US.doppler continuous wave |
|
18056-2
|
Tricuspid valve Mean pressure gradient dur diastole by US.doppler |
|
79938-7
|
Tricuspid valve Mean pressure gradient dur diastole by US.doppler+Calculated by simplified Bernoulli |
|
81091-1
|
Tricuspid valve Orifice area by US 2D |
|
81092-9
|
Tricuspid valve Orifice area by US.doppler |
|
20348-9
|
Tricuspid valve orifice Diameter.4 chamber by US |
|
18030-7
|
Tricuspid valve Peak A wave by US.doppler |
|
18031-5
|
Tricuspid valve Peak E wave by US.doppler |
|
18039-8
|
Tricuspid valve Peak E wave/Peak A wave by US.doppler |
|
18032-3
|
Tricuspid valve Pressure half time during diastole by US.doppler |
|
20349-7
|
Tricuspid valve Pressure half time velocity maximum by US |
|
79932-0
|
Tricuspid valve PISA radius during systole [Length] by US.2D+doppler |
|
18111-5
|
Tricuspid valve Prosthetic valve type by US |
|
20296-0
|
Tricuspid valve Q-wave to open [Time] by US |
|
18115-6
|
Tricuspid valve Regurgitation degree by US.doppler |
|
18034-9
|
Tricuspid valve regurgitant jet dP/dT (1 M/S to 3 M/S).systole [Pressure rate] by US.doppler |
|
18166-9
|
Tricuspid valve Maximum regurgitant blood flow velocity during systole by US.doppler |
|
93618-7
|
Tricuspid valve Regurgitant volume by US.doppler+Calculated by PISA method |
|
20254-9
|
Tricuspid valve Peak regurgitant blood flow 2 by US.doppler |
|
20262-2
|
Tricuspid valve Mean Regurgitant blood flow 2 by US |
|
93620-3
|
Tricuspid valve Regurgitant blood velocity-time integral by US.doppler |
|
20261-4
|
Tricuspid valve Mean regurgitant blood flow velocity by US |
|
93621-1
|
Tricuspid valve Regurgitant orifice area by US.doppler.color |
|
77917-3
|
Tricuspid valve Vena contracta diameter by US.doppler |
|
79933-8
|
Tricuspid valve Vena contracta diameter during systole by US.2D+doppler |
|
79927-0
|
Tricuspid valve Maximum blood flow velocity during diastole by US.doppler |
|
18161-0
|
Tricuspid valve Maximum blood flow velocity by US.doppler |
|
11712-7
|
Tricuspid valve Peak systolic flow velocity by US.doppler |
|
20350-5
|
Tricuspid valve Mean blood flow velocity by US.doppler |
|
18175-0
|
Tricuspid valve Velocity-time integral during diastole by US.doppler |
|
31688-5
|
Trivittatus virus Ab [Units/volume] in Cerebral spinal fluid |
|
31689-3
|
Trivittatus virus Ab [Units/volume] in Serum |
|
29834-9
|
Trivittatus virus Ab [Titer] in Cerebral spinal fluid |
|
29795-2
|
Trivittatus virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
29846-3
|
Trivittatus virus Ab [Titer] in Serum |
|
29808-3
|
Trivittatus virus Ab [Titer] in Serum by Neutralization test |
|
29821-6
|
Trivittatus virus Ab [Titer] in Unspecified specimen |
|
29782-0
|
Trivittatus virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
31690-1
|
Trivittatus virus Ab [Units/volume] in Unspecified specimen |
|
35356-5
|
TWIST1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41046-4
|
TWIST1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85687-2
|
Treated for Chlamydia trachomatis or Neisseria gonorrhoeae in last 3 to 12 months |
|
84298-9
|
Treatment stopped for at least 1 week |
|
3011-4
|
Thromboxane alpha 2 [Mass/volume] in Serum |
|
3012-2
|
Thromboxane beta 2 [Mass/volume] in Serum or Plasma |
|
82910-1
|
Thromboxane beta 2 [Moles/volume] in Serum or Plasma |
|
12548-4
|
Tybamate [Mass/volume] in Serum or Plasma |
|
35856-4
|
Tylosin [Susceptibility] by Disk diffusion (KB) |
|
35857-2
|
Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35858-0
|
Tylosin [Susceptibility] |
|
87587-2
|
Tylosin [Mass/mass] in Unspecified specimen |
|
87586-4
|
Tylvalosin [Mass/mass] in Unspecified specimen |
|
94079-1
|
TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
43585-9
|
TYMP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72065-6
|
Type intravenous iron prescribed [ESRD] |
|
72032-6
|
Type non-oral vitamin D analog prescribed [ESRD] |
|
90524-0
|
Type of assessment for state payment [CMS Assessment] |
|
79736-5
|
Type of Congenital cranial dysinnervation syndrome (CCDS) suspected |
|
79754-8
|
Type of Corneal dystrophy suspected |
|
81663-7
|
Diet [Type] |
|
75525-6
|
Type of encounter [MSCDM] |
|
79801-7
|
Type of ERG recording electrode |
|
79802-5
|
Type of ERG reference electrode |
|
79735-7
|
Type of Evidence supporting myopathy |
|
79823-1
|
Type of Glaucoma by Ophthalmoscopy |
|
80225-6
|
Type of Left coronary artery catheter |
|
74073-8
|
Type of nutritional product [AHRQ] |
|
79891-8
|
Type of Nystagmus |
|
79841-3
|
Type of Objective refraction method |
|
79765-4
|
Type of Ocular alignment by Cover test |
|
79868-6
|
Type of Opacity Left optic lens by Slit lamp biomicroscopy |
|
79867-8
|
Type of Opacity Right optic lens by Slit lamp biomicroscopy |
|
79824-9
|
Type of Ophthalmoscopy method |
|
79908-0
|
Type of Pediatric visual acuity exam method |
|
80226-4
|
Type of Pigtail catheter |
|
80224-9
|
Type of Right coronary artery catheter |
|
58198-3
|
Type of record [CMS Assessment] |
|
79759-7
|
Type of Strabismus |
|
79854-6
|
Type of Subjective refraction method |
|
91389-7
|
Type of substance abused by Family member |
|
79764-7
|
Type of Tonometer |
|
79806-6
|
Type of Visual field exam method |
|
72063-1
|
Type oral iron prescribed [ESRD] |
|
72030-0
|
Type oral vitamin D analog prescribed [ESRD] |
|
30956-7
|
Type [Identifier] Vaccine |
|
30978-1
|
Type Form VAERS |
|
46748-0
|
Tyrosinemias newborn screen interpretation |
|
35293-0
|
TYR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41045-6
|
TYR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3075-9
|
Tyramine [Mass/volume] in Cerebral spinal fluid |
|
81936-7
|
Tyramine intake 24 hour Estimated |
|
81937-5
|
Tyramine intake 24 hour Measured |
|
3076-7
|
Tyramine [Mass/volume] in Urine |
|
3082-5
|
Tyrosine aminotransferase [Mass/volume] in Plasma |
|
77087-5
|
TYROBP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77086-7
|
TYROBP gene full mutation analysis in Blood or Tissue by Sequencing |
|
3081-7
|
Tyrosine [Mass/time] in 24 hour Urine |
|
25995-2
|
Tyrosine [Moles/volume] in 24 hour Urine |
|
25547-1
|
Tyrosine [Moles/time] in 24 hour Urine |
|
13417-1
|
Tyrosine [Mass/volume] in Amniotic fluid |
|
30069-9
|
Tyrosine [Moles/volume] in Amniotic fluid |
|
17754-3
|
Tyrosine [Presence] in Blood |
|
3077-5
|
Tyrosine [Mass/volume] in Blood |
|
53304-2
|
Tyrosine crystals [#/volume] in Urine by Computer assisted method |
|
53314-1
|
Tyrosine crystals [#/area] in Urine by Computer assisted method |
|
88969-1
|
Tyrosine crystals [#/area] in Urine sediment |
|
53119-4
|
Tyrosine crystals [#/area] in Urine sediment by Microscopy high power field |
|
33021-7
|
Tyrosine crystals [#/area] in Urine sediment by Microscopy low power field |
|
50238-5
|
Tyrosine crystals [Presence] in Urine by Computer assisted method |
|
5815-6
|
Tyrosine crystals [Presence] in Urine sediment by Light microscopy |
|
13381-9
|
Tyrosine [Mass/volume] in Cerebral spinal fluid |
|
22642-3
|
Tyrosine [Moles/volume] in Cerebral spinal fluid |
|
45032-0
|
Tyrosine [Mass/volume] in DBS |
|
35571-9
|
Tyrosine [Moles/volume] in DBS |
|
32277-6
|
Tyrosine [Moles/volume] in Body fluid |
|
81938-3
|
Tyrosine intake 24 hour Estimated |
|
81939-1
|
Tyrosine intake 24 hour Measured |
|
74302-1
|
Tyrosine [Moles/volume] in DBS --post therapeutic diet |
|
3078-3
|
Tyrosine [Presence] in Serum or Plasma |
|
27361-5
|
Tyrosine [Units/volume] in Serum or Plasma |
|
3079-1
|
Tyrosine [Mass/volume] in Serum or Plasma |
|
20660-7
|
Tyrosine [Moles/volume] in Serum or Plasma |
|
47794-3
|
Tyrosine/Amino acids.total in Amniotic fluid |
|
47793-5
|
Tyrosine/Amino acids.total in Cerebral spinal fluid |
|
47796-8
|
Tyrosine/Amino acids.total in DBS |
|
47792-7
|
Tyrosine/Amino acids.total in Hair |
|
47795-0
|
Tyrosine/Amino acids.total in Serum or Plasma |
|
47797-6
|
Tyrosine/Amino acids.total in Unspecified specimen |
|
13901-4
|
Tyrosine [Presence] in Urine |
|
3080-9
|
Tyrosine [Mass/volume] in Urine |
|
26966-2
|
Tyrosine [Moles/volume] in Urine |
|
32276-8
|
Tyrosine [Moles/volume] in Vitreous fluid |
|
22739-7
|
Tyrosine [Moles/volume] in Unspecified specimen |
|
44415-8
|
Tyrosine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56994-7
|
Tyrosine/Creatinine [Ratio] in 24 hour Urine |
|
25996-0
|
Tyrosine/Creatinine [Molar ratio] in 24 hour Urine |
|
13818-0
|
Tyrosine/Creatinine [Mass Ratio] in Urine |
|
30054-1
|
Tyrosine/Creatinine [Ratio] in Urine |
|
22685-2
|
Tyrosine/Creatinine [Molar ratio] in Urine |
|
74481-3
|
Tyrosine/Phenylalanine [Molar ratio] in DBS |
|
74299-9
|
Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet |
|
32186-9
|
Microscopic observation [Identifier] in Penis by Tzanck smear |
|
32187-7
|
Microscopic observation [Identifier] in Skin by Tzanck smear |
|
45043-7
|
Microscopic observation [Identifier] in Unspecified specimen by Tzanck smear |
|
1323-5
|
U Ab [Presence] in Serum or Plasma from Blood product unit |
|
1324-3
|
U Ab [Presence] in Serum or Plasma from Donor |
|
1325-0
|
U Ab [Presence] in Serum or Plasma |
|
92518-0
|
U Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92480-3
|
U Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1326-8
|
U Ag [Presence] on Red Blood Cells from Blood product unit |
|
1327-6
|
U Ag [Presence] on Red Blood Cells from Donor |
|
1328-4
|
U Ag [Presence] on Red Blood Cells |
|
11204-5
|
Ulocladium chartarum IgE Ab [Units/volume] in Serum |
|
16069-7
|
Ulocladium chartarum IgE Ab RAST class [Presence] in Serum |
|
2197-2
|
Dehydroepiandrosterone (DHEA).unconjugated [Mass/time] in 24 hour Urine |
|
2196-4
|
Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma |
|
2246-7
|
Estradiol (E2).unconjugated [Mass/time] in 24 hour Urine |
|
34288-1
|
Estradiol (E2).unconjugated [Moles/volume] in 24 hour Urine |
|
15062-3
|
Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine |
|
34289-9
|
Estradiol (E2).unconjugated [Moles/volume] in Urine |
|
34290-7
|
Estradiol (E2).unconjugated/Creatinine [Molar ratio] in Urine |
|
21264-7
|
Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma |
|
2249-1
|
Estriol (E3).unconjugated [Mass/volume] in Amniotic fluid |
|
44004-0
|
Estriol (E3).unconjugated [Multiple of the median] in Amniotic fluid |
|
20466-9
|
Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma |
|
27259-1
|
Estriol (E3).unconjugated [Presence] in Serum or Plasma |
|
2250-9
|
Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma |
|
15064-9
|
Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
|
21265-4
|
Estriol (E3).unconjugated [Multiple of the median] unadjusted in Serum or Plasma |
|
2262-4
|
Estrone (E1).unconjugated [Mass/time] in 24 hour Urine |
|
2260-8
|
Estrone (E1).unconjugated [Mass/volume] in Amniotic fluid |
|
14160-6
|
Estrone (E1).unconjugated/Estrone (E1).total in Serum or Plasma |
|
2261-6
|
Estrone (E1).unconjugated [Mass/volume] in Serum or Plasma |
|
91843-3
|
Ureaplasma parvum DNA [Presence] in Genital specimen by NAA with probe detection |
|
69933-0
|
Ureaplasma parvum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
69934-8
|
Ureaplasma urealyticum+Ureaplasma parvum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91842-5
|
Ureaplasma urealyticum DNA [Presence] in Genital specimen by NAA with probe detection |
|
51988-4
|
Ureaplasma urealyticum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17852-5
|
Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture |
|
57662-9
|
U1 small nuclear ribonucleoprotein Ab [Units/volume] in Serum by Immunoassay |
|
53022-0
|
U1 small nuclear ribonucleoprotein Ab [Presence] in Serum |
|
63367-7
|
U1 small nuclear ribonucleoprotein Ab [Titer] in Serum by Immunoassay |
|
56548-1
|
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoassay |
|
40467-3
|
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoblot |
|
38369-5
|
U1 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum |
|
33983-8
|
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum |
|
63316-4
|
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay |
|
53032-9
|
U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum |
|
82450-8
|
U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot |
|
59026-5
|
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum |
|
81768-4
|
U1 small nuclear ribonucleoprotein 70kD IgG Ab [Units/volume] in Serum by Immunoassay |
|
88741-4
|
U1 small nuclear ribonucleoprotein A Ab [Units/volume] in Serum by Line blot |
|
54032-8
|
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum |
|
82451-6
|
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot |
|
88742-2
|
U1 small nuclear ribonucleoprotein C Ab [Units/volume] in Serum by Line blot |
|
54023-7
|
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum |
|
82452-4
|
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot |
|
68549-5
|
U2 small nuclear ribonucleoprotein Ab [Presence] in Serum |
|
45157-5
|
U2 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum |
|
93459-6
|
U-47700 [Mass/volume] in Urine by Confirmatory method |
|
35291-4
|
UBE3A gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
|
51987-6
|
Coenzyme Q10 [Presence] in Serum or Plasma |
|
18209-7
|
Coenzyme Q10 [Units/volume] in Serum or Plasma |
|
27923-2
|
Coenzyme Q10 [Mass/volume] in Serum or Plasma |
|
75050-5
|
Coenzyme Q10 [Moles/volume] in Serum or Plasma |
|
81157-0
|
Coenzyme Q10.reduced [Mass/volume] in Serum or Plasma |
|
81156-2
|
Coenzyme Q10.reduced/Coenzyme Q10 in Serum or Plasma |
|
60219-3
|
Coenzyme Q10/Protein [Molar ratio] in Tissue |
|
74122-3
|
Ubiquitin Ag [Presence] in Tissue by Immune stain |
|
74711-3
|
Unique device identifier |
|
3099-9
|
Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/volume] in Plasma |
|
79469-3
|
Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/mass] in Red Blood Cells |
|
10518-9
|
Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
|
3275-5
|
Heparin unfractionated [Mass/time] in 24 hour Urine |
|
80892-3
|
Heparin unfractionated [Units/volume] in Blood by Heparin protamine titration |
|
3274-8
|
Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3273-0
|
Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
66483-9
|
Heparin unfractionated [Units/volume] in Platelet poor plasma |
|
51951-2
|
UGT1A1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51952-0
|
UGT1A1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93844-9
|
UGT1A1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
34509-0
|
UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41044-9
|
UGT1A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79718-3
|
UGT1A1 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
93845-6
|
UGT1A1 gene TA repeats and c.211G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
72508-5
|
UGT1A1 gene c.A(TA)7TAA(*28) [Presence] in Blood or Tissue by Molecular genetics method |
|
72878-2
|
UGT2B15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
72881-6
|
UGT2B15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
2501-5
|
Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma |
|
35216-1
|
Iron binding capacity.unsaturated [Mass or Moles/volume] in Serum or Plasma |
|
22753-8
|
Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma |
|
63429-5
|
Bacterial beta-glucuronidase uidA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
86747-3
|
Ulcers, wounds and skin problems [CMS Assessment] |
|
88696-0
|
Ulcers, wounds and skin problems in the last 7 days [CMS Assessment] |
|
12157-4
|
Ultrasonographer gravidity number |
|
61002-2
|
Umbilical artery blood pressure |
|
61011-3
|
Umbilical vein blood pressure |
|
61003-0
|
Umbilical vein Diastolic blood pressure |
|
61004-8
|
Umbilical vein Mean blood pressure |
|
61005-5
|
Umbilical vein Systolic blood pressure |
|
89492-3
|
Umbilical cord examination findings Document |
|
60490-0
|
UMOD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79470-1
|
Uridine monophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells |
|
43358-1
|
UNC13D gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85914-0
|
Underlying resolved condition ICD code [CMS Assessment] |
|
86254-0
|
Underlying resolved condition.multiple coding ICD code [CMS Assessment] |
|
72294-2
|
Undermining clock position of Wound |
|
72295-9
|
Undermining of Wound |
|
72293-4
|
Undermining [Length] of Wound |
|
85521-3
|
Undersea and hyperbaric medicine Note |
|
85466-1
|
Understand health and well-being and what they need to do to manage their health - visual analog rating [ePCAM] |
|
83337-6
|
Understand health and well-being and what they need to do to manage their health [PCAM] |
|
86487-6
|
Understand what things you are able to do to keep your heart failure symptoms from getting worse [KCCQ] |
|
57217-2
|
Understanding of verbal content [CMS Assessment] |
|
87503-9
|
Understanding verbal and non-verbal content during 3 day assessment period [CMS Assessment] |
|
83249-3
|
Understanding verbal content during 3 day assessment period [CMS Assessment] |
|
54602-8
|
Understanding verbal content in last 7 days [CMS Assessment] |
|
81366-7
|
Unfinished business [Reported] |
|
85918-1
|
Unhealed pressure injury at stage 2 or higher or designated as unstageable [CMS Assessment] |
|
1270-8
|
Unidentified Ab [Presence] in Serum or Plasma |
|
48704-1
|
Unidentified cells [#/volume] in Blood |
|
34987-8
|
Unidentified cells [#/volume] in Cerebral spinal fluid |
|
32201-6
|
Unidentified cells [#/volume] in Cerebral spinal fluid by Manual count |
|
34988-6
|
Unidentified cells [#/volume] in Body fluid |
|
34986-0
|
Unidentified cells [#/volume] in Pericardial fluid |
|
32202-4
|
Unidentified cells [#/volume] in Pericardial fluid by Manual count |
|
34989-4
|
Unidentified cells [#/volume] in Pleural fluid |
|
32203-2
|
Unidentified cells [#/volume] in Pleural fluid by Manual count |
|
34990-2
|
Unidentified cells [#/volume] in Peritoneal fluid |
|
32204-0
|
Unidentified cells [#/volume] in Peritoneal fluid by Manual count |
|
34991-0
|
Unidentified cells [#/volume] in Synovial fluid |
|
32205-7
|
Unidentified cells [#/volume] in Synovial fluid by Manual count |
|
43415-9
|
Unidentified cells/100 cells in Bone marrow |
|
71638-1
|
Unidentified cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
44097-4
|
Unidentified cells/100 leukocytes in Blood |
|
44096-6
|
Unidentified cells/100 leukocytes in Blood by Automated count |
|
44095-8
|
Unidentified cells/100 leukocytes in Blood by Manual count |
|
30468-3
|
Unidentified cells/100 leukocytes in Cerebral spinal fluid |
|
13527-7
|
Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
34985-2
|
Unidentified cells/100 leukocytes in Body fluid |
|
13528-5
|
Unidentified cells/100 leukocytes in Body fluid by Manual count |
|
74236-1
|
Unidentified cells/100 leukocytes in Pericardial fluid by Manual count |
|
34983-7
|
Unidentified cells/100 leukocytes in Pleural fluid |
|
34982-9
|
Unidentified cells/100 leukocytes in Peritoneal fluid |
|
34984-5
|
Unidentified cells/100 leukocytes in Synovial fluid |
|
25154-6
|
Unidentified crystals [#/area] in Urine sediment by Microscopy high power field |
|
40482-2
|
Unidentified crystals [#/area] in Urine sediment by Microscopy low power field |
|
5783-6
|
Unidentified crystals [Presence] in Urine sediment by Light microscopy |
|
57723-9
|
Unique bar code number of Current sample |
|
57711-4
|
Unique bar code number of Initial sample |
|
80398-1
|
Unique identifier for Current sample |
|
89873-4
|
Unique identifier [Identifier] of Initial sample |
|
86526-1
|
Unit certification or licensure designation Facility [CMS Assessment] |
|
77708-6
|
Unpredictable off period indicator in the past week [UPDRS] |
|
35078-5
|
Unspecified cells [#/volume] in Body fluid |
|
71637-3
|
Unspecified cells/Leukocytes [Pure number fraction] in Body fluid by Manual count |
|
30469-1
|
Unspecified cells/100 leukocytes in Body fluid |
|
13355-3
|
Unspecified cells/100 leukocytes in Body fluid by Manual count |
|
53297-8
|
Crystals unspecified [#/volume] in Urine by Computer assisted method |
|
53307-5
|
Crystals unspecified [#/area] in Urine by Computer assisted method |
|
53334-9
|
Crystals unspecified [Presence] in Urine by Computer assisted method |
|
83286-5
|
Unstageable pressure injuries due to non-removable dressing not present or at a lesser stage on admission/reentry # [CMS Assessment] |
|
83288-1
|
Unstageable pressure injury due to deep tissue injury not present or at a lesser stage on admission/reentry # [CMS Assessment] |
|
83287-3
|
Unstageable pressure injury due to slough/eschar not present or at a lesser stage on admission/reenty # [CMS Assessment] |
|
88661-4
|
Number of unsuccessful attempts |
|
5985-7
|
Plasminogen activator urokinase type [Units/volume] in Platelet poor plasma |
|
21464-3
|
Plasminogen activator urokinase type [Presence] in Tissue |
|
5984-0
|
Plasminogen activator urokinase type [Units/volume] in Urine |
|
7755-2
|
Upholstery dust IgE Ab [Units/volume] in Serum |
|
89388-3
|
Upper body dressing - functional ability [CMS Assessment] |
|
83224-6
|
Upper body dressing - functional ability during 3 day assessment period [CMS Assessment] |
|
89387-5
|
Upper body dressing - functional goal [CMS Assessment] |
|
83223-8
|
Upper body dressing - functional goal during 3 day assessment period [CMS Assessment] |
|
92997-6
|
Upper segment [Length] |
|
92996-8
|
Upper segment/Lower segment |
|
73955-7
|
UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood |
|
72471-6
|
UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method |
|
73945-8
|
UR-144 (synthetic cannabinoid) [Presence] in Blood |
|
73957-3
|
UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72472-4
|
UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
53451-1
|
Uracil arabinoside [Mass/volume] in Serum or Plasma |
|
75128-9
|
Uracil [Moles/volume] in Cerebral spinal fluid |
|
75152-9
|
Uracil [Moles/volume] in Serum or Plasma |
|
30485-7
|
Uracil [Presence] in Urine |
|
13819-8
|
Uracil/Creatinine [Mass Ratio] in Urine |
|
25140-5
|
Uracil/Creatinine [Molar ratio] in Urine |
|
41165-2
|
Uranium 235/Uranium 238 [Mass Ratio] in 24 hour Urine |
|
41286-6
|
Uranium 235/Uranium 238 [Mass Ratio] in Urine |
|
21585-5
|
Uranium [Mass/volume] in 24 hour Urine |
|
21586-3
|
Uranium [Mass/time] in 24 hour Urine |
|
50930-7
|
Uranium [Moles/time] in 24 hour Urine |
|
5751-3
|
Uranium [Mass/volume] in Blood |
|
77185-7
|
Uranium [Mass/mass] in Dentin |
|
43420-9
|
Uranium dose assessment [Interpretation] in Urine |
|
49304-9
|
Uranium dose assessment [Interpretation] in Urine Narrative |
|
51211-1
|
Uranium [Mass/volume] in Body fluid |
|
77186-5
|
Uranium [Mass/mass] in Hair |
|
50929-9
|
Uranium [Moles/mass] in Hair |
|
5752-1
|
Uranium [Mass/volume] in Urine |
|
50928-1
|
Uranium [Moles/volume] in Urine |
|
29989-1
|
Uranium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52902-4
|
Uranium/Creatinine [Molar ratio] in 24 hour Urine |
|
39540-0
|
Uranium/Creatinine [Mass Ratio] in Urine |
|
52903-2
|
Uranium/Creatinine [Molar ratio] in Urine |
|
32555-5
|
Urate [Molar amount] in Urine collected for unspecified duration |
|
57332-9
|
Urate [Mass/volume] in 12 hour Urine |
|
57387-3
|
Urate [Mass/time] in 12 hour Urine |
|
58990-3
|
Urate [Mass/time] in 18 hour Urine |
|
42678-3
|
Urate [Saturation Fraction] in 24 hour Urine |
|
21587-1
|
Urate [Mass/volume] in 24 hour Urine |
|
3087-4
|
Urate [Mass/time] in 24 hour Urine |
|
35253-4
|
Urate [Mass or Moles/volume] in 24 hour Urine |
|
25997-8
|
Urate [Moles/volume] in 24 hour Urine |
|
14935-1
|
Urate [Moles/time] in 24 hour Urine |
|
57386-5
|
Urate [Mass/volume] in 2 hour Urine |
|
17755-0
|
Urate [Mass/time] in 2 hour Urine |
|
17756-8
|
Urate [Mass/time] in 4 hour Urine |
|
18379-8
|
Urate [Mass/time] in 6 hour Urine |
|
3083-3
|
Urate [Mass/volume] in Amniotic fluid |
|
74979-6
|
Urate [Moles/volume] in Bronchoalveolar lavage |
|
49961-6
|
Urate renal clearance in Urine and Serum or Plasma collected for unspecified duration |
|
3088-2
|
Urate renal clearance in 24 hour Urine and Serum or Plasma |
|
49962-4
|
Urate renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
|
53301-8
|
Urate crystals [#/volume] in Urine by Computer assisted method |
|
53311-7
|
Urate crystals [#/area] in Urine by Computer assisted method |
|
46138-4
|
Urate crystals [#/area] in Urine sediment by Microscopy high power field |
|
40485-5
|
Urate crystals [#/area] in Urine sediment by Microscopy low power field |
|
40682-7
|
Urate crystals [Presence] in Body fluid by Light microscopy |
|
5816-4
|
Urate crystals [Presence] in Synovial fluid by Light microscopy |
|
16269-3
|
Urate crystals [Presence] in Stone by Infrared spectroscopy |
|
59279-0
|
Urate crystals [Presence] in Stone by X-ray diffraction |
|
10828-2
|
Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |
|
59839-1
|
Urate crystals [Presence] in Tissue by Light microscopy |
|
33233-8
|
Urate crystals [Presence] in Urine by Computer assisted method |
|
5817-2
|
Urate crystals [Presence] in Urine sediment by Light microscopy |
|
13902-2
|
Urate [Mass/volume] in Cerebral spinal fluid |
|
75139-6
|
Urate [Moles/volume] in Cerebral spinal fluid |
|
49003-7
|
Urate [Mass/volume] in Peritoneal dialysis fluid |
|
16259-4
|
Urate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
|
59280-8
|
Urate dihydrate crystals [Presence] in Stone by X-ray diffraction |
|
54436-1
|
Urate dihydrate/Total in Stone |
|
53612-8
|
Urate [Mass/volume] in Body fluid |
|
25548-9
|
Urate [Moles/volume] in Body fluid |
|
32149-7
|
Urate/Total in Stone |
|
60469-4
|
Urate [Mass/volume] in Pleural fluid |
|
3084-1
|
Urate [Mass/volume] in Serum or Plasma |
|
35232-8
|
Urate [Mass or Moles/volume] in Serum or Plasma |
|
14933-6
|
Urate [Moles/volume] in Serum or Plasma |
|
3085-8
|
Urate [Mass/volume] in Synovial fluid |
|
39788-5
|
Urate [Moles/volume] in Synovial fluid |
|
14932-8
|
Urate [Presence] in Stone |
|
3086-6
|
Urate [Mass/volume] in Urine |
|
35233-6
|
Urate [Mass or Moles/volume] in Urine |
|
14934-4
|
Urate [Moles/volume] in Urine |
|
32343-6
|
Urate [Moles/volume] in Unspecified specimen |
|
13820-6
|
Urate/Creatinine [Mass Ratio] in 24 hour Urine |
|
75642-9
|
Urate/Creatinine [Molar ratio] in 24 hour Urine |
|
3089-0
|
Urate/Creatinine [Mass Ratio] in Urine |
|
34385-5
|
Urate/Creatinine [Molar ratio] in Urine |
|
32556-3
|
Urea [Molar amount] in Urine collected for unspecified duration |
|
55609-2
|
Urea [Moles/volume] in Urine collected for unspecified duration |
|
57389-9
|
Urea [Mass/volume] in 12 hour Urine |
|
57385-7
|
Urea [Mass/time] in 12 hour Urine |
|
74082-9
|
Urea [Moles/time] in 12 hour Urine |
|
58991-1
|
Urea [Mass/time] in 18 hour Urine |
|
53137-6
|
Urea [Moles/time] in 1 hour Urine |
|
57388-1
|
Urea [Mass/volume] in 24 hour Peritoneal dialysis fluid |
|
39779-4
|
Urea [Moles/volume] in 24 hour Dialysis fluid |
|
40405-3
|
Urea [Moles/time] in 24 hour Dialysis fluid |
|
40406-1
|
Urea [Moles/time] in 24 hour Body fluid |
|
59168-5
|
Urea [Moles/time] in 24 hour Stool |
|
63481-6
|
Urea [Mass/volume] in 24 hour Urine |
|
48999-7
|
Urea [Mass/time] in 24 hour Urine |
|
25998-6
|
Urea [Moles/volume] in 24 hour Urine |
|
25550-5
|
Urea [Moles/time] in 24 hour Urine |
|
45303-5
|
Urea [Moles/volume] in Dialysis fluid --2 hour specimen |
|
45304-3
|
Urea [Moles/volume] in Dialysis fluid --4 hour specimen |
|
3090-8
|
Urea [Mass/volume] in Amniotic fluid |
|
72927-7
|
Urea [Moles/volume] in Arterial blood |
|
20977-5
|
Urea [Mass/volume] in Blood |
|
72903-8
|
Urea [Moles/volume] in Blood |
|
72926-9
|
Urea [Moles/volume] in Venous blood |
|
29891-9
|
Helicobacter pylori [Presence] in Stomach by urea breath test |
|
29892-7
|
Helicobacter pylori [Quantitative] in Stomach by urea breath test |
|
3098-1
|
Urea renal clearance in 24 hour Urine and Serum or Plasma |
|
50063-7
|
Urea renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
|
59187-5
|
Urea renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma |
|
58831-9
|
Urea [Moles/volume] in Cerebral spinal fluid |
|
58885-5
|
Urea [Mass/volume] in Peritoneal dialysis fluid |
|
39780-2
|
Urea [Moles/volume] in Peritoneal dialysis fluid |
|
45302-7
|
Urea [Moles/volume] in Dialysis fluid |
|
20979-1
|
Urea [Mass/mass] in Feed |
|
57392-3
|
Urea [Mass/volume] in Body fluid |
|
25549-7
|
Urea [Moles/volume] in Body fluid |
|
20978-3
|
Urea [Mass/volume] in Gastric fluid |
|
12268-9
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
|
48622-5
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
|
12979-1
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
|
12970-0
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
78536-0
|
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
12266-3
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
12971-8
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
78537-8
|
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
12267-1
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
|
12968-4
|
Urea nitrogen [Mass/volume] in Dialysis fluid --4 hour specimen |
|
14393-3
|
Urea nitrogen [Mass/volume] in Amniotic fluid |
|
12969-2
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --baseline |
|
48791-8
|
Urea nitrogen peritoneal dialysis clearance/1.73 sq M |
|
14000-4
|
Urea nitrogen [Mass/volume] in Cerebral spinal fluid |
|
17757-6
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid |
|
14936-9
|
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
|
5918-8
|
Urea nitrogen [Mass/volume] in Dialysis fluid |
|
35241-9
|
Urea nitrogen [Mass or Moles/volume] in Dialysis fluid |
|
3093-2
|
Urea nitrogen [Mass/volume] in Body fluid |
|
14397-4
|
Urea nitrogen [Mass/volume] in Gastric fluid |
|
79265-5
|
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
|
14394-1
|
Urea nitrogen [Mass/volume] in Pleural fluid |
|
12981-7
|
Urea nitrogen [Mass Ratio] in Peritoneal dialysis fluid --post dialysis/pre dialysis |
|
12265-5
|
Urea nitrogen [Mass/volume] in Peritoneal fluid |
|
14396-6
|
Urea nitrogen [Mass/volume] in Synovial fluid |
|
12972-6
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
|
26749-2
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
|
12974-2
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
|
12973-4
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
|
12975-9
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
|
12976-7
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
|
12978-3
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
|
12977-5
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
|
17758-4
|
Urea nitrogen [Mass/volume] in Vitreous fluid |
|
44735-9
|
Urea nitrogen/Creatinine [Mass Ratio] in Body fluid |
|
57752-8
|
Urea [Mass/volume] in Peritoneal dialysis fluid --overnight |
|
46243-2
|
Urea [Moles/volume] in Dialysis fluid --overnight |
|
39776-0
|
Urea [Moles/volume] in Serum or Plasma --post dialysis |
|
56995-4
|
Urea [Mass/volume] in Pleural fluid |
|
77010-7
|
Urea [Molar ratio] in Serum or Plasma --post dialysis/pre dialysis |
|
39777-8
|
Urea [Moles/volume] in Serum or Plasma --pre dialysis |
|
49802-2
|
Urea [Mass/volume] in Peritoneal fluid |
|
39781-0
|
Urea [Moles/volume] in Peritoneal fluid |
|
54456-9
|
Urea reduction ratio in Serum or Plasma |
|
71339-6
|
Urea renal clearance/1.73 sq M--hemodialysis Urine and Serum or Plasma [ESRD] |
|
77136-0
|
Urea [Moles/volume] in Serum, Plasma or Blood |
|
3091-6
|
Urea [Mass/volume] in Serum or Plasma |
|
42571-0
|
Urea [Mass or Moles/volume] in Serum or Plasma |
|
22664-7
|
Urea [Moles/volume] in Serum or Plasma |
|
47798-4
|
Urea [Moles/volume] in Stool |
|
3092-4
|
Urea [Mass/volume] in Urine |
|
22700-9
|
Urea [Moles/volume] in Urine |
|
75364-0
|
Urea [Moles/volume] in Vitreous fluid |
|
23786-7
|
Urea [Mass/volume] in Unspecified specimen |
|
87613-6
|
Urea [Mass/mass] in Unspecified specimen |
|
22738-9
|
Urea [Moles/volume] in Unspecified specimen |
|
56996-2
|
Urea/Creatinine [Mass Ratio] in 24 hour Urine |
|
25999-4
|
Urea/Creatinine [Molar ratio] in 24 hour Urine |
|
56997-0
|
Urea/Creatinine [Mass Ratio] in Serum or Plasma |
|
39783-6
|
Urea/Creatinine [Molar ratio] in Serum or Plasma |
|
40487-1
|
Urea/Creatinine [Ratio] in Urine |
|
59786-4
|
Urea/Creatinine [Molar ratio] in Urine |
|
68547-9
|
Ureaplasma sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32368-3
|
Ureaplasma sp identified in Unspecified specimen by Organism specific culture |
|
42640-3
|
Urease [Presence] in Tissue --1 day post incubation |
|
43805-1
|
Urease [Presence] in Tissue --1 hour post incubation |
|
43806-9
|
Urease [Presence] in Tissue --20 minutes post incubation |
|
43855-6
|
Urease [Presence] in Tissue --2 hours post incubation |
|
43808-5
|
Urease [Presence] in Tissue --30 minutes post incubation |
|
42636-1
|
Urease [Presence] in Tissue --3 hours post incubation |
|
43807-7
|
Urease [Presence] in Tissue --4 hours post incubation |
|
66491-2
|
Urease [Presence] in Tissue --2nd specimen |
|
66492-0
|
Urease [Presence] in Tissue --3rd specimen |
|
32637-1
|
Urease [Presence] in Tissue |
|
81776-7
|
Ureidopropionate/Creatinine [Molar ratio] in Urine |
|
85211-1
|
Urgent care center Discharge instructions |
|
75504-1
|
Urgent care center Note |
|
85210-3
|
Urgent care center Triage note |
|
75130-5
|
Uridine [Moles/volume] in Cerebral spinal fluid |
|
75159-4
|
Uridine [Moles/volume] in Serum or Plasma |
|
59216-2
|
Uridine/Creatinine [Molar ratio] in Urine |
|
3100-5
|
Uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
|
3101-3
|
Uridyl transferase [Enzymatic activity/mass] in Tissue |
|
69051-1
|
Urinalysis specialist review of results |
|
54770-3
|
Urinary continence in last 7 days [CMS Assessment] |
|
46553-4
|
Urinary incontinence or urinary catheter present [CMS Assessment] |
|
90077-9
|
Urinary pathogens identified in Isolate by Organism specific culture |
|
80334-6
|
Urine collection device |
|
80519-2
|
Maximum Urine flow by Uroflowmetry |
|
80522-6
|
Mean urine flow by Uroflowmetry |
|
19159-3
|
Urinalysis specimen collection method |
|
11279-7
|
Urine sediment comments by Light microscopy Narrative |
|
32344-4
|
Urobilin [Presence] in Stool |
|
3102-1
|
Urobilin [Mass/volume] in Stool |
|
3103-9
|
Urobilin [Presence] in Urine |
|
3104-7
|
Urobilin [Mass/volume] in Urine |
|
6893-2
|
Urobilinogen [Mass/time] in 24 hour Stool |
|
28007-3
|
Urobilinogen [Units] in 24 hour Urine |
|
12269-7
|
Urobilinogen [Presence] in 24 hour Urine |
|
3108-8
|
Urobilinogen [Mass/time] in 24 hour Urine |
|
3109-6
|
Urobilinogen [Mass/time] in 2 hour Urine |
|
17761-8
|
Urobilinogen [Mass/time] in 48 hour Stool |
|
25551-3
|
Urobilinogen [Presence] in Body fluid |
|
3105-4
|
Urobilinogen [Presence] in Stool |
|
38507-0
|
Urobilinogen [Units/mass] in Stool |
|
3106-2
|
Urobilinogen [Mass/volume] in Stool |
|
21588-9
|
Urobilinogen [Mass/mass] in Stool |
|
82575-2
|
Urobilinogen [Moles/mass] in Stool |
|
13658-0
|
Urobilinogen [Presence] in Urine |
|
5818-0
|
Urobilinogen [Presence] in Urine by Test strip |
|
62487-4
|
Urobilinogen [Presence] in Urine by Automated test strip |
|
50563-6
|
Urobilinogen [Mass/volume] in Urine by Automated test strip |
|
60025-4
|
Urobilinogen [Moles/volume] in Urine by Automated test strip |
|
19161-9
|
Urobilinogen [Units/volume] in Urine by Test strip |
|
20405-7
|
Urobilinogen [Mass/volume] in Urine by Test strip |
|
34928-2
|
Urobilinogen [Moles/volume] in Urine by Test strip |
|
32727-0
|
Urobilinogen [Units/volume] in Urine |
|
3107-0
|
Urobilinogen [Mass/volume] in Urine |
|
35236-9
|
Urobilinogen [Mass or Moles/volume] in Urine |
|
34927-4
|
Urobilinogen [Moles/volume] in Urine |
|
18381-4
|
Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood |
|
3114-6
|
Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Plasma |
|
18476-2
|
Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells |
|
18380-6
|
Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells |
|
49596-0
|
Uroporphyrinogen decarboxylase [Units/volume] in Red Blood Cells |
|
80521-8
|
Uroflowmetry Study report |
|
84038-9
|
Urology Administrative note |
|
84039-7
|
Urology Admission evaluation note |
|
78733-3
|
Urology Admission history and physical note |
|
83699-9
|
Urology Attending Admission evaluation note |
|
83700-5
|
Urology Attending Note |
|
83701-3
|
Urology Attending Preoperative evaluation and management note |
|
78734-1
|
Urology Checklist |
|
34851-6
|
Urology Consult note |
|
78576-6
|
Urology Diagnostic study note |
|
84040-5
|
Urology Discharge summary |
|
78603-8
|
Urology Education note |
|
78622-8
|
Urology Flowsheet |
|
84041-3
|
Urology History and physical note |
|
84042-1
|
Urology Hospital Note |
|
78645-9
|
Urology Initial evaluation note |
|
84043-9
|
Urology Interdisciplinary Note |
|
34852-4
|
Urology Note |
|
83563-7
|
Urology Nurse practitioner Note |
|
83597-5
|
Urology Nurse Note |
|
83598-3
|
Urology Nurse Outpatient Note |
|
83599-1
|
Urology Nurse procedure note |
|
75501-7
|
Urology Outpatient Note |
|
84044-7
|
Urology Outpatient procedure note |
|
34877-1
|
Urology Surgical operation note |
|
83751-8
|
Urology Physician assistant Note |
|
84046-2
|
Urology Telephone encounter Note |
|
80783-4
|
Urology Plan of care note |
|
84045-4
|
Urology Postoperative evaluation and management note |
|
78735-8
|
Urology Preoperative evaluation and management note |
|
78659-0
|
Urology procedure note |
|
75220-4
|
Urology Progress note |
|
57168-7
|
Urology Referral note |
|
83781-5
|
Urology Resident Note |
|
89033-5
|
Urology Telehealth Consult note |
|
89903-9
|
Urology Telehealth Note |
|
78736-6
|
Urology Transfer summary note |
|
3110-4
|
Uronate [Mass/volume] in Urine |
|
41032-4
|
Uroporphyrin [Mass/time] in unspecified time Stool |
|
9735-2
|
Uroporphyrin/Porphyrins.total in 24 hour Stool |
|
50932-3
|
Uroporphyrin/Porphyrins.total in 24 hour Urine |
|
72573-9
|
Uroporphyrin/Porphyrins.total [Pure substance fraction] in 24 hour Urine |
|
14181-2
|
Uroporphyrin [Mass/mass] in 24 hour Stool |
|
17381-5
|
Uroporphyrin [Mass/time] in 24 hour Stool |
|
25552-1
|
Uroporphyrin [Moles/time] in 24 hour Stool |
|
12270-5
|
Uroporphyrin [Presence] in 24 hour Urine |
|
32216-4
|
Uroporphyrin [Mass/volume] in 24 hour Urine |
|
3113-8
|
Uroporphyrin [Mass/time] in 24 hour Urine |
|
26000-0
|
Uroporphyrin [Moles/volume] in 24 hour Urine |
|
15096-1
|
Uroporphyrin [Moles/time] in 24 hour Urine |
|
14180-4
|
Uroporphyrin [Mass/volume] in Red Blood Cells |
|
32345-1
|
Uroporphyrin [Moles/volume] in Red Blood Cells |
|
14274-5
|
Uroporphyrin [Mass/volume] in Serum or Plasma |
|
22662-1
|
Uroporphyrin [Moles/volume] in Serum or Plasma |
|
56484-9
|
Uroporphyrin [Mass/mass] in Stool |
|
32346-9
|
Uroporphyrin [Moles/mass] in Stool |
|
3112-0
|
Uroporphyrin [Presence] in Urine |
|
11228-4
|
Uroporphyrin [Mass/volume] in Urine |
|
12808-2
|
Uroporphyrin [Mass/time] in Urine |
|
25166-0
|
Uroporphyrin [Moles/volume] in Urine |
|
38165-7
|
Uroporphyrin/Creatinine [Mass Ratio] in 24 hour Urine |
|
32043-2
|
Uroporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
|
38508-8
|
Uroporphyrin/Creatinine [Mass Ratio] in Urine |
|
45319-1
|
Uroporphyrin/Creatinine [Molar ratio] in Urine |
|
26691-6
|
Uroporphyrin 1 isomer [Mass/time] in 24 hour Stool |
|
79126-9
|
Uroporphyrin 1 isomer [Mass/time] in 24 hour Urine |
|
40407-9
|
Uroporphyrin 1 isomer [Moles/time] in 24 hour Urine |
|
3111-2
|
Uroporphyrin 1 isomer [Mass/volume] in Red Blood Cells |
|
14940-1
|
Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma |
|
14941-9
|
Uroporphyrin 1 isomer [Moles/volume] in Stool |
|
50931-5
|
Uroporphyrin 1 isomer [Moles/mass] in Stool |
|
14942-7
|
Uroporphyrin 1 isomer [Moles/volume] in Urine |
|
59817-7
|
Uroporphyrin 1 isomer/Creatinine [Molar ratio] in 24 hour Urine |
|
79127-7
|
Uroporphyrin 1 isomer/Creatinine [Mass Ratio] in Urine |
|
58684-2
|
Uroporphyrin 1 isomer/Creatinine [Molar ratio] in Urine |
|
33585-1
|
Uroporphyrin 3 isomer [Mass/time] in 24 hour Stool |
|
79128-5
|
Uroporphyrin 3 isomer [Mass/time] in 24 hour Urine |
|
40408-7
|
Uroporphyrin 3 isomer [Moles/time] in 24 hour Urine |
|
14943-5
|
Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma |
|
14944-3
|
Uroporphyrin 3 isomer [Moles/volume] in Stool |
|
45312-6
|
Uroporphyrin 3 isomer [Moles/mass] in Stool |
|
14945-0
|
Uroporphyrin 3 isomer [Moles/volume] in Urine |
|
59818-5
|
Uroporphyrin 3 isomer/Creatinine [Molar ratio] in 24 hour Urine |
|
79129-3
|
Uroporphyrin 3 isomer/Creatinine [Mass Ratio] in Urine |
|
45318-3
|
Uroporphyrin 3 isomer/Creatinine [Molar ratio] in Urine |
|
12811-6
|
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood |
|
3115-3
|
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Plasma |
|
11066-8
|
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells |
|
73098-6
|
Ursodeoxycholate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73099-4
|
Ursodeoxycholate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55159-8
|
Ursodeoxycholate [Moles/volume] in Serum or Plasma |
|
81162-0
|
US Guidance for needle localization Breast - left and MG Views Breast specimen |
|
81163-8
|
US Guidance for needle localization Breast - right and MG Views Breast specimen |
|
24558-9
|
US Abdomen |
|
69276-4
|
US Abdominal Aorta |
|
79374-5
|
US Abdominal Aorta for screening |
|
12028-7
|
Fetal Abdomen Study observation US |
|
12029-5
|
Fetal Abdomen Narrative Study observation US |
|
49513-5
|
Fetal Abdomen Narrative Study observation, multiple fetuses US |
|
30704-1
|
US Abdomen limited |
|
24532-4
|
US Abdomen RUQ |
|
39494-0
|
US Abdominal wall |
|
12030-3
|
Fetal Abdominal wall Study observation US |
|
12031-1
|
Fetal Abdominal wall Narrative Study observation US |
|
12038-6
|
Fetal Aortic arch Study observation US |
|
12039-4
|
Fetal Aortic arch Narrative Study observation US |
|
69277-2
|
US Adrenal gland |
|
24542-3
|
US Anus |
|
12032-9
|
Fetal Aorta ascending Study observation US |
|
12033-7
|
Fetal Aorta ascending Narrative Study observation US |
|
12034-5
|
Fetal Aorta descending Study observation US |
|
12035-2
|
Fetal Aorta descending Narrative Study observation US |
|
12036-0
|
Fetal Aorta Study observation US |
|
12037-8
|
Fetal Aorta Narrative Study observation US |
|
24548-0
|
US Appendix |
|
46375-2
|
US Artery |
|
12071-7
|
Fetal Aortic valve Study observation US |
|
12072-5
|
Fetal Aortic valve Narrative Study observation US |
|
39040-1
|
US AV fistula |
|
80852-7
|
US Axilla |
|
72529-1
|
US Axilla - left |
|
72528-3
|
US Axilla - right |
|
38021-2
|
US Biliary ducts and Gallbladder |
|
25019-1
|
US Urinary bladder |
|
12118-6
|
Fetal Urinary bladder Study observation US |
|
12119-4
|
Fetal Urinary bladder Narrative Study observation US |
|
69280-6
|
US Urinary bladder limited |
|
69388-7
|
US Urinary bladder post void |
|
44163-4
|
US Brachial plexus |
|
24601-7
|
US Breast |
|
30853-6
|
US Breast duct W contrast intra duct |
|
24599-3
|
US Breast limited |
|
42132-1
|
US Breast screening |
|
24596-9
|
US Breast specimen |
|
26214-7
|
US Breast - bilateral |
|
26286-5
|
US Breast - bilateral limited |
|
26215-4
|
US Breast - left |
|
26288-1
|
US Breast - left limited |
|
26216-2
|
US Breast - right |
|
26290-7
|
US Breast - right limited |
|
24616-5
|
US Carotid arteries |
|
38015-4
|
US Carotid arteries limited |
|
26217-0
|
US Carotid arteries - bilateral |
|
26218-8
|
US Carotid arteries - left |
|
42149-5
|
US Carotid arteries - left limited |
|
26219-6
|
US Carotid arteries -right |
|
42151-1
|
US Carotid arteries -right limited |
|
43552-9
|
US Carotid arteries - unilateral |
|
18140-4
|
Central cardiovascular Study observation by US |
|
18141-2
|
Central cardiovascular Study observation Narrative by US |
|
18146-1
|
Central cardiovascular Overall Study observation Narrative by US |
|
18147-9
|
Central cardiovascular Overall Study observation by US |
|
12040-2
|
Fetal Cerebellum Study observation US |
|
12041-0
|
Fetal Cerebellum Narrative Study observation US |
|
46374-5
|
US Cerebral arteries |
|
12042-8
|
Fetal Cerebrum Study observation US |
|
12043-6
|
Fetal Cerebrum Narrative Study observation US |
|
12046-9
|
Cervix Study observation US |
|
24630-6
|
US Chest |
|
69281-4
|
US Chest limited |
|
38016-2
|
US Chest wall |
|
12047-7
|
Fetal Colon Study observation US |
|
12048-5
|
Fetal Colon Narrative Study observation US |
|
12049-3
|
Fetal Cranium Study observation US |
|
12050-1
|
Fetal Cranium Narrative Study observation US |
|
70926-1
|
US Cervical spine |
|
69400-0
|
US Guidance for chorionic villus sampling |
|
34970-4
|
Ultrasound date |
|
12051-9
|
Fetal Diaphragm Study observation US |
|
12052-7
|
Fetal Diaphragm Narrative Study observation US |
|
24672-8
|
US Diaphragm for motion |
|
24818-7
|
US Diaphragm and Liver |
|
12053-5
|
Fetal ductal arch Study observation US |
|
12054-3
|
Fetal ductal arch Narrative Study observation US |
|
80855-0
|
US Extremity musculoskeletal tissue |
|
80854-3
|
US Extremity musculoskeletal tissue limited |
|
24693-4
|
US Extremity |
|
44173-3
|
US Extremity artery limited |
|
69293-9
|
US Extremity artery - left |
|
69297-0
|
US Extremity artery - right |
|
39526-9
|
US Extremity limited |
|
42145-3
|
US Extremity vein - left |
|
42144-6
|
US Extremity vein - right |
|
41835-0
|
US Extremity veins - left |
|
41816-0
|
US Extremity veins - right |
|
26223-8
|
US Extremity - bilateral |
|
53689-6
|
Fetal Extremities Narrative Study observation US |
|
26225-3
|
US Extremity - left |
|
62451-0
|
US Extremity - left limited |
|
26230-3
|
US Extremity - right |
|
62452-8
|
US Extremity - right limited |
|
69286-3
|
US Eye limited |
|
24853-4
|
US Eye+Orbit - bilateral |
|
12055-0
|
Fetal Face Study observation US |
|
12056-8
|
Fetal Face Narrative Study observation US |
|
69389-5
|
US Femoral artery and Popliteal artery |
|
69399-4
|
US Femoral vein and Popliteal vein |
|
38134-3
|
US Femoral vessels |
|
38128-5
|
US Femoral vessels - bilateral |
|
38037-8
|
US Femur - left |
|
38048-5
|
US Femur - right |
|
12129-3
|
Fetal [Interpretation] Study observation general US |
|
12130-1
|
Fetal Narrative [Interpretation] Study observation general US |
|
42452-3
|
Fetal Narrative [Interpretation] Study observation.general 1st trimester US |
|
42453-1
|
Fetal Narrative [Interpretation] Study observation.general 2nd trimester US |
|
42454-9
|
Fetal Narrative [Interpretation] Study observation.general 3rd trimester US |
|
30707-4
|
Fetal Narrative [Interpretation] Study observation.general.follow-up US |
|
30708-2
|
Fetal Narrative [Interpretation] Study observation.general.limited US |
|
42451-5
|
Fetal Narrative [Interpretation] Study observation.general transvaginal 1st trimester US |
|
42479-6
|
Fetal Narrative [Interpretation] Study observation general, multiple fetuses US |
|
42464-8
|
Fetal Narrative [Interpretation] Study observation.general 1st trimester, multiple fetuses US |
|
42465-5
|
Fetal Narrative [Interpretation] Study observation.general 2nd trimester, multiple fetuses US |
|
42466-3
|
Fetal Narrative [Interpretation] Study observation.general 3rd trimester, multiple fetuses US |
|
42467-1
|
Fetal Narrative [Interpretation] Study observation.general.limited, multiple fetuses US |
|
39527-7
|
US Unspecified body region for foreign body |
|
80869-1
|
US for pregnancy in first trimester |
|
80866-7
|
US for pregnancy in second or third trimester |
|
80868-3
|
US for pregnancy with fetal abnormality |
|
11525-3
|
US for pregnancy |
|
39032-8
|
US for transplanted kidney |
|
69300-2
|
US for transplanted kidney limited |
|
39454-4
|
US for transplanted liver |
|
39509-5
|
US for transplanted pancreas |
|
24711-4
|
US Gallbladder |
|
38020-4
|
US Gallbladder limited |
|
38022-0
|
US Gallbladder W cholecystokinin |
|
53688-8
|
Fetal Genitalia Narrative Study observation US |
|
53687-0
|
Fetal Gastrointestinal tract Narrative Study observation US |
|
39415-5
|
US Gastrointestinal tract |
|
39450-2
|
US Gastrointestinal tract W contrast PO |
|
24719-7
|
US Groin |
|
80898-0
|
US Groin and Pseudoaneurysm |
|
39416-3
|
US Genitourinary tract |
|
44169-1
|
US Guidance for drainage of abscess and placement of drainage catheter of Peritoneal space |
|
41809-5
|
US Guidance for drainage and placement of drainage catheter of Retroperitoneum |
|
44166-7
|
US Guidance for drainage of abscess and placement of drainage catheter of Subphrenic space |
|
37913-1
|
US Guidance for biopsy of Abdomen |
|
24559-7
|
US Guidance for drainage and placement of drainage catheter of Abdomen |
|
58743-6
|
US Guidance for ablation of tissue of Unspecified body region |
|
39451-0
|
US Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
|
42705-4
|
US Guidance for drainage of abscess and placement of drainage catheter of Appendix |
|
43565-1
|
US Guidance for deep biopsy of Bone |
|
42135-4
|
US Guidance for superficial biopsy of Bone |
|
37914-9
|
US Guidance for biopsy of Breast |
|
30653-0
|
US Guidance for aspiration of cyst of Breast |
|
42448-1
|
US Guidance for excisional biopsy of Breast |
|
30652-2
|
US Guidance for fine needle biopsy of Breast |
|
44160-0
|
US Guidance for fine needle aspiration of Breast |
|
24600-9
|
US Guidance for needle localization of Breast |
|
80841-0
|
US Guidance for placement of needle in Breast |
|
42456-4
|
US Guidance for placement of needle wire in Breast |
|
30651-4
|
US Guidance for percutaneous biopsy.core needle of Breast |
|
43756-6
|
US Guidance for fluid aspiration of Breast |
|
37912-3
|
US Guidance for biopsy of Breast - bilateral |
|
38012-1
|
US Guidance for aspiration of cyst of Breast - bilateral |
|
43759-0
|
US Guidance for localization of Breast - bilateral |
|
26313-7
|
US Guidance for needle localization of Breast - bilateral |
|
69278-0
|
US Guidance for fluid aspiration of Breast - bilateral |
|
42449-9
|
US Guidance for biopsy of Breast - left |
|
42450-7
|
US Guidance for aspiration of cyst of Breast - left |
|
80842-8
|
US Guidance for additional aspiration of cyst of Breast - left |
|
80844-4
|
US Guidance for fine needle biopsy of Breast - left |
|
38026-1
|
US Guidance for fine needle aspiration of Breast - left |
|
43758-2
|
US Guidance for localization of Breast - left |
|
26314-5
|
US Guidance for needle localization of Breast - left |
|
38023-8
|
US Guidance for percutaneous biopsy.core needle of Breast - left |
|
69292-1
|
US Guidance for fluid aspiration of Breast - left |
|
80843-6
|
US Guidance for vacuum biopsy of Breast - left |
|
42457-2
|
US Guidance for biopsy of Breast - right |
|
42458-0
|
US Guidance for aspiration of cyst of Breast - right |
|
80846-9
|
US Guidance for additional aspiration of cyst of Breast - right |
|
80848-5
|
US Guidance for fine needle biopsy of Breast - right |
|
38033-7
|
US Guidance for fine needle aspiration of Breast - right |
|
43760-8
|
US Guidance for localization of Breast - right |
|
26318-6
|
US Guidance for needle localization of Breast - right |
|
38025-3
|
US Guidance for percutaneous biopsy.core needle of Breast - right |
|
69296-2
|
US Guidance for fluid aspiration of Breast - right |
|
80847-7
|
US Guidance for vacuum biopsy of Breast - right |
|
25059-7
|
US Guidance for biopsy of Unspecified body region |
|
38766-2
|
US Guidance for biopsy of transplanted kidney |
|
38765-4
|
US Guidance for biopsy of transplanted liver |
|
80880-8
|
US Guidance for injection of Carpal tunnel |
|
37915-6
|
US Guidance for biopsy of Chest |
|
38142-6
|
US Guidance for drainage and placement of drainage catheter of Chest |
|
37921-4
|
US Guidance for needle localization of Chest |
|
42333-5
|
US Guidance for biopsy of Chest Pleura |
|
42140-4
|
US Guidance for placement of tube in Chest |
|
38024-6
|
US Guidance for core needle biopsy of Unspecified body region |
|
69391-1
|
US Guidance for cordocentesis |
|
70915-4
|
US Guidance for aspiration of CSF of Cervical spine |
|
30698-5
|
US Guidance for aspiration of cyst of Unspecified body region |
|
46282-0
|
US Guidance for aspiration or injection of cyst of Unspecified body region |
|
24670-2
|
US Guidance for biopsy of cyst of Unspecified body region |
|
30699-3
|
US Guidance for drainage and placement of drainage catheter of Unspecified body region |
|
80853-5
|
US Guidance for injection of Elbow |
|
42463-0
|
US Guidance for biopsy of Endomyocardium |
|
69387-9
|
US Guidance for biopsy of Epididymis |
|
24692-6
|
US Guidance for drainage and placement of drainage catheter of Extremity |
|
72537-4
|
US Guidance for vascular sclerotherapy of Extremity vein - bilateral |
|
72533-3
|
US Guidance for ambulatory phlebectomy of Extremity vein - left |
|
72535-8
|
US Guidance for laser ablation of Extremity vein - left |
|
72645-5
|
US Guidance for vascular sclerotherapy of Extremity vein - left |
|
72532-5
|
US Guidance for ambulatory phlebectomy of Extremity vein - right |
|
72534-1
|
US Guidance for laser ablation of Extremity vein - right |
|
72644-8
|
US Guidance for vascular sclerotherapy of Extremity vein - right |
|
72536-6
|
US Guidance for vascular sclerotherapy of Extremity veins - bilateral |
|
72643-0
|
US Guidance for vascular sclerotherapy of Extremity veins - left |
|
72642-2
|
US Guidance for vascular sclerotherapy of Extremity veins - right |
|
26325-1
|
US Guidance for drainage and placement of drainage catheter of Extremity - bilateral |
|
26326-9
|
US Guidance for drainage and placement of drainage catheter of Extremity - left |
|
26327-7
|
US Guidance for drainage and placement of drainage catheter of Extremity - right |
|
37608-7
|
US Guidance for localization of foreign body of Eye |
|
38018-8
|
US Guidance for fine needle aspiration of Unspecified body region |
|
80882-4
|
US Guidance of Unspecified body region-- during surgery |
|
72530-9
|
US Guidance for injection of Joint |
|
26340-0
|
US Guidance for biopsy of Kidney - bilateral |
|
26328-5
|
US Guidance for drainage and placement of drainage catheter of Kidney - bilateral |
|
44156-8
|
US Guidance for ablation of tissue of Kidney |
|
44167-5
|
US Guidance for drainage of abscess and placement of drainage catheter of Kidney |
|
24772-6
|
US Guidance for biopsy of Kidney |
|
38126-9
|
US Guidance for aspiration of cyst of Kidney |
|
42478-8
|
US Guidance for drainage of cyst and placement of drainage catheter of Kidney |
|
24896-3
|
US Guidance for drainage and placement of drainage catheter of Kidney |
|
44159-2
|
US Guidance for fine needle aspiration of Kidney |
|
75672-6
|
US Guidance for placement of nephrostomy tube in Kidney |
|
48434-5
|
US Guidance for fluid aspiration of Kidney |
|
26341-8
|
US Guidance for biopsy of Kidney - left |
|
26329-3
|
US Guidance for drainage and placement of drainage catheter of Kidney - left |
|
26342-6
|
US Guidance for biopsy of Kidney - right |
|
26330-1
|
US Guidance for drainage and placement of drainage catheter of Kidney - right |
|
44155-0
|
US Guidance for ablation of tissue of Liver |
|
42133-9
|
US Guidance for drainage of abscess and placement of drainage catheter of Liver |
|
24816-1
|
US Guidance for biopsy of Liver |
|
44158-4
|
US Guidance for fine needle aspiration of Liver |
|
69279-8
|
US Guidance for core needle biopsy of Lymph node |
|
69287-1
|
US Guidance for fluid aspiration of Lymph node |
|
43797-0
|
US Guidance for superficial biopsy of Lymph node |
|
70916-2
|
US Guidance for aspiration of CSF of Lumbar spine |
|
44161-8
|
US Guidance for biopsy of Lung |
|
92678-2
|
US Guidance for elastography of Lung |
|
92679-0
|
US Guidance for elastography of lesion of Lung |
|
92680-8
|
US Guidance for additional elastography of lesion of Lung |
|
42137-0
|
US Guidance for biopsy of Mediastinum |
|
37917-2
|
US Guidance for percutaneous biopsy of Muscle |
|
43564-4
|
US Guidance for superficial biopsy of Muscle |
|
37918-0
|
US Guidance for biopsy of Neck |
|
38032-9
|
US Guidance for needle localization of Unspecified body region |
|
64993-9
|
US Guidance for placement of needle in Unspecified body region |
|
46369-5
|
US Guidance for biopsy of Ovary |
|
39452-8
|
US Guidance for fluid aspiration of Ovary |
|
37919-8
|
US Guidance for biopsy of Pancreas |
|
38133-5
|
US Guidance for aspiration of cyst of Pancreas |
|
44172-5
|
US Guidance for drainage and placement of drainage catheter of Pancreas |
|
44157-6
|
US Guidance for fine needle aspiration of Pancreas |
|
62494-0
|
US Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region |
|
30878-3
|
US Guidance for fluid aspiration of Unspecified body region |
|
44168-3
|
US Guidance for drainage of abscess and placement of drainage catheter of Pelvis |
|
46370-3
|
US Guidance for biopsy of Pelvis |
|
24868-2
|
US Guidance for drainage and placement of drainage catheter of Pelvis |
|
30703-3
|
US Guidance for fluid aspiration of Pericardial space |
|
42706-2
|
US Guidance for injection of Pleural space |
|
24662-9
|
US Guidance for fluid aspiration of Pleural space |
|
24883-1
|
US Guidance for percutaneous biopsy of Prostate |
|
46288-7
|
US Guidance for biopsy of Prostate |
|
41798-0
|
US Guidance for drainage and placement of drainage catheter of Prostate |
|
38017-0
|
US Guidance for FNA of Prostate |
|
44162-6
|
US Guidance for biopsy of Retroperitoneum |
|
82124-9
|
US Guidance for radiation treatment of Unspecified body region |
|
43487-8
|
US Guidance for placement of radiation therapy fields in Unspecified body region |
|
37920-6
|
US Guidance for biopsy of Salivary gland |
|
38132-7
|
US Guidance for biopsy of Scrotum and testicle |
|
69396-0
|
US Guidance for biopsy of Spinal cord |
|
38127-7
|
US Guidance for aspiration of CSF of Spine |
|
38030-3
|
US Guidance for biopsy of Spleen |
|
25009-2
|
US Guidance for biopsy of Thyroid gland |
|
46285-3
|
US Guidance for core needle biopsy of Thyroid gland |
|
42447-3
|
US Guidance for aspiration of cyst of Thyroid gland |
|
38019-6
|
US Guidance for fine needle aspiration of Thyroid gland |
|
30702-5
|
US Guidance for injection of Thyroid gland |
|
42134-7
|
US Guidance for fluid aspiration of Thyroid gland |
|
38135-0
|
US Guidance for deep aspiration.fine needle of Tissue |
|
38136-8
|
US Guidance for superficial aspiration.fine needle of Tissue |
|
70917-0
|
US Guidance for aspiration of CSF of Thoracic spine |
|
30644-9
|
US Guidance for placement of tunneled CV catheter |
|
42141-2
|
US Guidance for removal of tunneled CV catheter |
|
24537-3
|
US Guidance for aspiration of amniotic fluid of Uterus |
|
39139-1
|
US Guidance for vascular access of Unspecified body region |
|
30643-1
|
US Guidance for placement of CV catheter in Vein |
|
81165-3
|
US Guidance for peripheral venous access of Vein |
|
24731-2
|
US Head |
|
12069-1
|
Fetal Head Study observation US |
|
12070-9
|
Fetal Head Narrative Study observation US |
|
24732-0
|
US Head during surgery |
|
38034-5
|
US Head limited |
|
12060-0
|
Fetal Fourth ventricle Narrative Study observation US |
|
12059-2
|
Fetal Fourth ventricle Study observation US |
|
12057-6
|
Fetal Choroid plexus Study observation US |
|
12058-4
|
Fetal Choroid plexus Narrative Study observation US |
|
12061-8
|
Fetal Intracranial anatomy Study observation US |
|
12062-6
|
Fetal Intracranial anatomy Narrative Study observation US |
|
44164-2
|
US Head and Neck |
|
80858-4
|
US Head and neck soft tissue |
|
85475-2
|
US Heart Transesophageal |
|
59281-6
|
US Heart Transthoracic |
|
24760-1
|
US Hip |
|
30711-6
|
US Hip developmental joint assessment |
|
30712-4
|
US Hip WO developmental joint assessment |
|
43566-9
|
US Hip and Thigh |
|
26250-1
|
US Hip - bilateral |
|
26251-9
|
US Hip - left |
|
26252-7
|
US Hip - right |
|
42148-7
|
US Heart |
|
53660-7
|
Fetal Heart Narrative Study observation US |
|
42707-0
|
US Heart limited |
|
12073-3
|
Fetal Atrium Study observation US |
|
12074-1
|
Fetal Atrium Narrative Study observation US |
|
12075-8
|
Fetal Heart chambers Study observation US |
|
12076-6
|
Fetal Heart chambers Narrative Study observation US |
|
18143-8
|
Heart chambers Study observation Narrative by US |
|
18142-0
|
Heart chambers Study observation by US |
|
12077-4
|
Fetal Heart great vessels Study observation US |
|
12078-2
|
Fetal Heart great vessels Narrative Study observation US |
|
12086-5
|
Fetal Heart valves Study observation US |
|
12087-3
|
Fetal Heart valves Narrative Study observation US |
|
18144-6
|
Heart valves Study observation Narrative by US |
|
18145-3
|
Heart valves Study observation by US |
|
38129-3
|
US Iliac vessels - bilateral |
|
38137-6
|
US Iliac vessels - left |
|
38141-8
|
US Iliac vessels - right |
|
12092-3
|
Fetal Intestine Study observation US |
|
12093-1
|
Fetal Intestine Narrative Study observation US |
|
12120-2
|
Fetal Inferior vena cava Study observation US |
|
12121-0
|
Fetal Inferior vena cava Narrative Study observation US |
|
12079-0
|
Fetal Interventricular septum Study observation US |
|
12080-8
|
Fetal Interventricular septum Narrative Study observation US |
|
43774-9
|
US Kidney - bilateral |
|
69402-6
|
US Kidney - bilateral and Urinary bladder |
|
38036-0
|
US Kidney |
|
12098-0
|
Fetal Kidney Study observation US |
|
12099-8
|
Fetal Kidney Narrative Study observation US |
|
38035-2
|
US Kidney limited |
|
38038-6
|
US Kidney - left |
|
12094-9
|
Fetal Kidney - left Study observation US |
|
12095-6
|
Fetal Kidney - left Narrative Study observation US |
|
38049-3
|
US Kidney - right |
|
12096-4
|
Fetal Kidney - right Study observation US |
|
12097-2
|
Fetal Kidney - right Narrative Study observation US |
|
30709-0
|
US Lower extremity |
|
48693-6
|
US Lower extremity artery |
|
41812-9
|
US Lower extremity artery limited |
|
38130-1
|
US Lower extremity artery - bilateral |
|
41834-3
|
US Lower extremity artery - left |
|
41815-2
|
US Lower extremity artery - right |
|
80861-8
|
US Lower extremity soft tissue |
|
46363-8
|
US Lower extremity vein |
|
46364-6
|
US Lower extremity vein - bilateral |
|
48692-8
|
US Lower extremity vein - left |
|
48691-0
|
US Lower extremity vein - right |
|
69385-3
|
US Lower extremity veins - bilateral |
|
69392-9
|
US Lower extremity veins - left |
|
80860-0
|
US Lower extremity veins - unilateral limited |
|
38013-9
|
US Lower extremity - bilateral |
|
38040-2
|
US Lower extremity - left |
|
38039-4
|
US Lower extremity - left limited |
|
38051-9
|
US Lower extremity - right |
|
38050-1
|
US Lower extremity - right limited |
|
12100-4
|
Fetal Limbs Study observation US |
|
12101-2
|
Fetal Limbs Narrative Study observation US |
|
28614-6
|
US Liver |
|
30706-6
|
US Liver during surgery |
|
80838-6
|
US Liver limited |
|
39522-8
|
US guidance for percutaneous biopsy of Lymph node |
|
69393-7
|
US Lumbar spine |
|
12063-4
|
Fetal Lateral cerebral ventricles Study observation US |
|
12064-2
|
Fetal Lateral cerebral ventricles Narrative Study observation US |
|
12088-1
|
Fetal Left ventricular outflow tract Study observation US |
|
12089-9
|
Fetal Left ventricular outflow tract Narrative Study observation US |
|
38043-6
|
US Mastoid |
|
38044-4
|
US Mediastinum |
|
69394-5
|
US Mesenteric arteries |
|
80834-5
|
US for multiple gestation pregnancy in first trimester |
|
80836-0
|
US for multiple gestation pregnancy in second or third trimester |
|
80833-7
|
US for multiple gestation pregnancy limited |
|
80837-8
|
US for multiple gestation pregnancy with fetal abnormality |
|
12081-6
|
Fetal Mitral valve Study observation US |
|
12082-4
|
Fetal Mitral valve Narrative Study observation US |
|
24842-7
|
US Neck |
|
53686-2
|
Fetal Neck Narrative Study observation US |
|
25060-5
|
US Unspecified body region No charge |
|
12102-0
|
Fetal Nuchal fold Study observation US |
|
12103-8
|
Fetal Nuchal fold Narrative Study observation US |
|
69390-3
|
US Ovary |
|
80871-7
|
US Ovary for torsion |
|
12104-6
|
Fetal Pulmonary artery Study observation US |
|
12105-3
|
Fetal Pulmonary artery Narrative Study observation US |
|
24859-1
|
US Pancreas |
|
80839-4
|
US Pancreas limited |
|
38045-1
|
US Parathyroid gland |
|
38138-4
|
US Parotid gland |
|
24869-0
|
US Pelvis |
|
80862-6
|
US Pelvis for in vitro fertilization |
|
38046-9
|
US Pelvis limited |
|
42455-6
|
US Pelvis transabdominal and transvaginal |
|
24677-7
|
US Pelvis transvaginal |
|
38140-0
|
US Penis |
|
80875-8
|
US Penis soft tissue |
|
38139-2
|
US Penis vessels |
|
24881-5
|
US Popliteal space |
|
26262-6
|
US Popliteal space - bilateral |
|
26263-4
|
US Popliteal space - left |
|
26264-2
|
US Popliteal space - right |
|
80870-9
|
US for pregnancy limited |
|
24884-9
|
US Prostate transrectal |
|
80876-6
|
US Prostate transrectal for volume measurement |
|
12106-1
|
Fetal Pulmonary vein Study observation US |
|
12107-9
|
Fetal Pulmonary vein Narrative Study observation US |
|
12083-2
|
Fetal Pulmonic valve Study observation US |
|
24889-8
|
US Pylorus for pyloric stenosis |
|
24892-2
|
US Rectum |
|
69294-7
|
US Renal artery |
|
69295-4
|
US Renal vessels |
|
24531-6
|
US Retroperitoneum |
|
38047-7
|
US Retroperitoneum limited |
|
12090-7
|
Fetal Right ventricular outflow tract Study observation US |
|
12091-5
|
Fetal Right ventricular outflow tract Narrative Study observation US |
|
38053-5
|
US Sacrum |
|
69298-8
|
US Salivary gland |
|
12108-7
|
Fetal Small bowel Study observation US |
|
12109-5
|
Fetal Small bowel Narrative Study observation US |
|
12159-0
|
Ultrasound scan quality |
|
25002-7
|
US Scrotum and testicle |
|
80877-4
|
US Scrotum and testicle for torsion |
|
69299-6
|
US Scrotum and testicle limited |
|
26271-7
|
US Scrotum and Testicle - bilateral |
|
26272-5
|
US Scrotum and Testicle - left |
|
26273-3
|
US Scrotum and Testicle - right |
|
24907-8
|
US Shoulder |
|
26265-9
|
US Shoulder - bilateral |
|
26267-5
|
US Shoulder - left |
|
26269-1
|
US Shoulder - right |
|
53690-4
|
Fetal Skeletal system Narrative Study observation US |
|
24926-8
|
US Spine |
|
12110-3
|
Fetal Spine Study observation US |
|
12111-1
|
Fetal Spine Narrative Study observation US |
|
24990-4
|
US Spleen |
|
80840-2
|
US Spleen limited |
|
12112-9
|
Fetal Stomach Study observation US |
|
12113-7
|
Fetal Stomach Narrative Study observation US |
|
12131-9
|
[Interpretation] Study observation general US |
|
12132-7
|
Narrative [Interpretation] Study observation general US |
|
38131-9
|
US Subclavian vessels - bilateral |
|
42468-9
|
US Surgical specimen |
|
12122-8
|
Fetal Superior vena cava Study observation US |
|
12123-6
|
Fetal Superior vena cava Narrative Study observation US |
|
24547-2
|
US Thoracic and abdominal aorta |
|
38011-3
|
US Thoracic and abdominal aorta limited |
|
80835-2
|
US transabdominal and transvaginal for multiple gestation pregnancy in first trimester |
|
80867-5
|
US transabdominal and transvaginal for pregnancy in first trimester |
|
39453-6
|
US Tendon |
|
12114-5
|
Fetal Thorax Study observation US |
|
12115-2
|
Fetal Thorax Narrative Study observation US |
|
25010-0
|
US Thyroid gland |
|
70927-9
|
US Thoracic spine |
|
12084-0
|
Fetal Tricuspid valve Study observation US |
|
12085-7
|
Fetal Tricuspid valve Narrative Study observation US |
|
80865-9
|
US transvaginal for pregnancy |
|
30710-8
|
US Upper extremity |
|
48448-5
|
US Upper extremity artery |
|
41813-7
|
US Upper extremity artery limited |
|
38014-7
|
US Upper extremity artery - bilateral |
|
41833-5
|
US Upper extremity artery - left |
|
41814-5
|
US Upper extremity artery - right |
|
80881-6
|
US Upper extremity soft tissue |
|
48690-2
|
US Upper extremity vein - bilateral |
|
48689-4
|
US Upper extremity vein - left |
|
48688-6
|
US Upper extremity vein - right |
|
69395-2
|
US Upper extremity veins |
|
80895-6
|
US Upper extremity veins - bilateral |
|
80879-0
|
US Upper extremity veins - unilateral limited |
|
38041-0
|
US Upper extremity - left |
|
38052-7
|
US Upper extremity - right |
|
12116-0
|
Fetal Umbilical cord Study observation US |
|
12117-8
|
Fetal Umbilical cord Narrative Study observation US |
|
25061-3
|
US Unspecified body region |
|
30705-8
|
US Uterus and Fallopian tubes |
|
42143-8
|
US Uterus and Fallopian tubes W saline IU |
|
12124-4
|
Fetal Vena cava Study observation US |
|
12125-1
|
Fetal Vena cava Narrative Study observation US |
|
39036-9
|
US Vein |
|
39045-0
|
US Vein limited |
|
39030-2
|
US Vein - bilateral |
|
38054-3
|
US Visceral artery |
|
25036-5
|
US Wrist |
|
26278-2
|
US Wrist - bilateral |
|
26280-8
|
US Wrist - left |
|
26282-4
|
US Wrist - right |
|
30701-7
|
US Unspecified body region during surgery |
|
12126-9
|
Unspecified body region Narrative Study observation US |
|
12128-5
|
Fetal Yolk sac Narrative Study observation US |
|
72221-5
|
Fetal Yolk sac Study observation US |
|
12067-5
|
Fetal Head Third Ventricle Study observation US |
|
12068-3
|
Fetal Head Third Ventricle Narrative Study observation US |
|
12065-9
|
Fetal Posterior fossa Study observation US |
|
12066-7
|
Fetal Posterior fossa Narrative Study observation US |
|
81894-8
|
Liver ultrasound attenuation by transient elastography |
|
77615-3
|
Liver stiffness by US.transient elastography |
|
88658-0
|
Use of supplemental oxygen |
|
79761-3
|
Use of supplemental oxygen --at birth |
|
88695-2
|
Used bowel toileting program in the last 7 days [CMS Assessment] |
|
91572-8
|
Used erectile dysfunction drug in past 12 months |
|
77128-7
|
USH1C gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77127-9
|
USH1C gene full mutation analysis in Blood or Tissue by Sequencing |
|
53901-5
|
USH2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87409-9
|
Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
88992-3
|
Ustekinumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
87408-1
|
Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
83245-1
|
Usual ability to swallow during 3 day assessment period [CMS Assessment] |
|
80264-5
|
Usual consistency of Stool |
|
74162-9
|
Usual industry duration |
|
77694-8
|
Utensils scale [UPDRS] |
|
12006-3
|
Uterine artery - left Pulsatility index US.doppler |
|
12021-2
|
Uterine artery - left Resistivity index US.doppler |
|
12142-6
|
Uterine artery - left Systolic flow/Diastolic flow US.doppler |
|
11724-2
|
Uterine artery - left Peak systolic flow velocity US.doppler |
|
11690-5
|
Uterine artery - left Mean blood flow US.doppler |
|
11663-2
|
Uterine artery - left Minimal flow velocity US.doppler |
|
12007-1
|
Uterine artery - right Pulsatility index US.doppler |
|
12022-0
|
Uterine artery - right Resistivity index US.doppler |
|
12143-4
|
Uterine artery - right Systolic flow/Diastolic flow US.doppler |
|
11725-9
|
Uterine artery - right Peak systolic flow velocity US.doppler |
|
11691-3
|
Uterine artery - right Mean blood flow US.doppler |
|
11664-0
|
Uterine artery - right Minimal flow velocity US.doppler |
|
11865-3
|
Uterus Diameter transverse US |
|
11881-0
|
Uterus Fundal height Tape measure |
|
11842-2
|
Uterus Longitudinal diameter US |
|
66113-2
|
Uterus Pathology biopsy report |
|
11859-6
|
Uterus Thickeness US |
|
33192-6
|
Uterus Volume derived from length, width and thickness (US) |
|
24465-7
|
Urea nitrogen [Mass/time] in 12 hour Urine |
|
19158-5
|
Urea nitrogen comment - 24 hour Urine Narrative |
|
12967-6
|
Urea nitrogen [Mass/volume] in 24 hour Urine |
|
3096-5
|
Urea nitrogen [Mass/time] in 24 hour Urine |
|
33355-9
|
Urea nitrogen [Moles/volume] in 24 hour Urine |
|
14939-3
|
Urea nitrogen [Moles/time] in 24 hour Urine |
|
51735-9
|
Urea nitrogen renal clearance in 24 hour Urine and Serum or Plasma |
|
13506-1
|
Urea nitrogen renal clearance in Urine and Serum or Plasma |
|
3095-7
|
Urea nitrogen [Mass/volume] in Urine |
|
35235-1
|
Urea nitrogen [Mass or Moles/volume] in Urine |
|
14938-5
|
Urea nitrogen [Moles/volume] in Urine |
|
35657-6
|
Urea nitrogen/Body weight [Mass/kg/time] in 24 hour Urine |
|
13821-4
|
Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine |
|
44416-6
|
Urea nitrogen/Creatinine [Mass Ratio] in Urine |
|
1329-2
|
V Ab [Presence] in Serum or Plasma from Blood product unit |
|
1330-0
|
V Ab [Presence] in Serum or Plasma from Donor |
|
1331-8
|
V Ab [Presence] in Serum or Plasma |
|
55340-4
|
V Ab [Titer] in Serum or Plasma |
|
92517-2
|
V Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92479-5
|
V Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1332-6
|
V Ag [Presence] on Red Blood Cells from Blood product unit |
|
1333-4
|
V Ag [Presence] on Red Blood Cells from Donor |
|
1334-2
|
V Ag [Presence] on Red Blood Cells |
|
79384-4
|
Vibrio cholerae+parahaemolyticus rfbL+trkH+tnaA genes [Presence] in Stool by NAA with probe detection |
|
82200-7
|
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with non-probe detection |
|
92686-5
|
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection |
|
31698-4
|
Vibrio cholerae Ab [Units/volume] in Serum |
|
5405-6
|
Vibrio cholerae Ab [Mass/volume] in Serum |
|
53942-9
|
Vibrio cholerae toxin ctx gene [Presence] in Unspecified specimen by NAA with probe detection |
|
82201-5
|
Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection |
|
61371-1
|
Vibrio cholerae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53941-1
|
Vibrio cholerae toxin Ag [Presence] in Isolate |
|
41857-4
|
Vibrio parahaemolyticus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80237-1
|
V wave amplitude [Pressure] Left atrium Cardiac catheterization |
|
80233-0
|
V wave amplitude [Pressure] Pulmonary artery wedge Cardiac catheterization |
|
80235-5
|
V wave amplitude [Pressure] Right atrium Cardiac catheterization |
|
38932-0
|
VA Compensation and Pension (C and P) examination acromegaly |
|
38933-8
|
VA Compensation and Pension (C and P) examination aid and attendance/housebound |
|
38934-6
|
VA Compensation and Pension (C and P) examination arrhythmias |
|
38936-1
|
VA Compensation and Pension (C and P) examination audio |
|
38937-9
|
VA Compensation and Pension (C and P) examination bones fractures/bone disease |
|
38938-7
|
VA Compensation and Pension (C and P) examination brain/spinal cord |
|
38939-5
|
VA Compensation and Pension (C and P) examination chronic fatigue syndrome |
|
38940-3
|
VA Compensation and Pension (C and P) examination cold injury protocol |
|
38941-1
|
VA Compensation and Pension (C and P) examination cranial nerves |
|
38942-9
|
VA Compensation and Pension (C and P) examination Cushings syndrome |
|
38943-7
|
VA Compensation and Pension (C and P) examination dental/oral |
|
38944-5
|
VA Compensation and Pension (C and P) examination diabetes mellitus |
|
38956-9
|
VA Compensation and Pension (C and P) examination disability in gulf war veterans |
|
38946-0
|
VA Compensation and Pension (C and P) examination ear disease |
|
38949-4
|
VA Compensation and Pension (C and P) examination epilepsy/narcolepsy |
|
38950-2
|
VA Compensation and Pension (C and P) examination esophagus/hiatal hernia |
|
38966-8
|
VA Compensation and Pension (C and P) examination extremity joints |
|
38951-0
|
VA Compensation and Pension (C and P) examination eye |
|
38952-8
|
VA Compensation and Pension (C and P) examination feet |
|
38953-6
|
VA Compensation and Pension (C and P) examination fibromyalgia |
|
38954-4
|
VA Compensation and Pension (C and P) examination general medical |
|
38969-2
|
VA Compensation and Pension (C and P) examination general mental disorders |
|
38955-1
|
VA Compensation and Pension (C and P) examination genitourinary |
|
38957-7
|
VA Compensation and Pension (C and P) examination gynecological conditions/disorders of the breast |
|
38958-5
|
VA Compensation and Pension (C and P) examination hand/thumb/fingers |
|
38959-3
|
VA Compensation and Pension (C and P) examination heart |
|
38960-1
|
VA Compensation and Pension (C and P) examination hemic disorders |
|
38961-9
|
VA Compensation and Pension (C and P) examination HIV-related illness |
|
38962-7
|
VA Compensation and Pension (C and P) examination hypertension |
|
38963-5
|
VA Compensation and Pension (C and P) examination infectious/immune/nutritional disabilities |
|
38964-3
|
VA Compensation and Pension (C and P) examination initial evaluation post-traumatic stress disorder |
|
38965-0
|
VA Compensation and Pension (C and P) examination large/small intestines |
|
38967-6
|
VA Compensation and Pension (C and P) examination liver/gall bladder/pancreas |
|
38968-4
|
VA Compensation and Pension (C and P) examination lymphatic disorders |
|
38947-8
|
VA Compensation and Pension (C and P) examination mental health eating disorders |
|
38935-3
|
VA Compensation and Pension (C and P) examination miscellaneous arteries/veins |
|
38945-2
|
VA Compensation and Pension (C and P) examination miscellaneous digestive conditions |
|
38948-6
|
VA Compensation and Pension (C and P) examination miscellaneous endocrine diseases |
|
38972-6
|
VA Compensation and Pension (C and P) examination miscellaneous neurological disorders |
|
38980-9
|
VA Compensation and Pension (C and P) examination miscellaneous respiratory diseases |
|
38970-0
|
VA Compensation and Pension (C and P) examination mouth/lips/tongue |
|
38971-8
|
VA Compensation and Pension (C and P) examination muscles |
|
38973-4
|
VA Compensation and Pension (C and P) examination nose/sinus/larynx/pharynx |
|
38979-1
|
VA Compensation and Pension (C and P) examination obstructive/restrictive/interstitial respiratory diseases |
|
38974-2
|
VA Compensation and Pension (C and P) examination peripheral nerves |
|
38975-9
|
VA Compensation and Pension (C and P) examination prisoner of war protocol |
|
38976-7
|
VA Compensation and Pension (C and P) examination pulmonary tuberculosis/mycobacterial diseases |
|
38977-5
|
VA Compensation and Pension (C and P) examination rectum/anus |
|
38978-3
|
VA Compensation and Pension (C and P) examination residuals of amputations |
|
38981-7
|
VA Compensation and Pension (C and P) examination review evaluation post-traumatic stress disorder |
|
38982-5
|
VA Compensation and Pension (C and P) examination scars |
|
38983-3
|
VA Compensation and Pension (C and P) examination sense of smell/taste |
|
38984-1
|
VA Compensation and Pension (C and P) examination skin diseases other than scars |
|
38985-8
|
VA Compensation and Pension (C and P) examination social/industrial survey |
|
38986-6
|
VA Compensation and Pension (C and P) examination spine |
|
38987-4
|
VA Compensation and Pension (C and P) examination stomach/duodenum/peritoneal adhesions |
|
38988-2
|
VA Compensation and Pension (C and P) examination thyroid/parathyroid diseases |
|
85217-8
|
VA Compensation and Pension (C and P) multiple examination |
|
77277-2
|
Vacancy rate [NMMDS] |
|
82745-1
|
Doses of vaccine given [#] --pre symptom onset |
|
78352-2
|
Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells |
|
35167-6
|
Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
|
30962-5
|
Vaccinated at VAERS |
|
85713-6
|
Vaccinated based on recommended guidelines |
|
30948-4
|
Vaccination adverse event Narrative |
|
30949-2
|
Vaccination adverse event outcome VAERS |
|
30945-0
|
Vaccination contraindication/precaution |
|
72059-9
|
Vaccination exclusion |
|
72029-2
|
Vaccination exclusion - medical reason |
|
72085-4
|
Vaccination exclusion - patient reason [ESRD] |
|
46250-7
|
Vaccination take-response date |
|
46249-9
|
Vaccination take-response type |
|
30979-9
|
Vaccines due next [Complex] Set |
|
30955-9
|
Vaccines given on same date as vaccine causing adverse event Set |
|
5400-7
|
Vaccinia virus Ab [Units/volume] in Serum |
|
35390-4
|
Vaccinia virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
73096-0
|
valACYclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73097-8
|
valACYclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73094-5
|
Valdecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73095-2
|
Valdecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93466-1
|
Valerylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
24445-9
|
Valerylglycine/Creatinine [Molar ratio] in Urine |
|
73093-7
|
valGANciclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73092-9
|
valGANciclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
74960-6
|
valGANciclovir [Mass/volume] in Plasma --trough |
|
94081-7
|
Validation error details Document |
|
94082-5
|
Validation error summary Document |
|
3120-3
|
Valine [Mass/time] in 24 hour Urine |
|
26001-8
|
Valine [Moles/volume] in 24 hour Urine |
|
25553-9
|
Valine [Moles/time] in 24 hour Urine |
|
13419-7
|
Valine [Mass/volume] in Amniotic fluid |
|
26873-0
|
Valine [Moles/volume] in Amniotic fluid |
|
41169-4
|
Valine [Presence] in Blood |
|
3116-1
|
Valine [Mass/volume] in Cerebral spinal fluid |
|
22649-8
|
Valine [Moles/volume] in Cerebral spinal fluid |
|
47799-2
|
Valine [Moles/volume] in DBS |
|
32279-2
|
Valine [Moles/volume] in Body fluid |
|
81047-3
|
Valine intake 24 hour Estimated |
|
81048-1
|
Valine intake 24 hour Measured |
|
74884-8
|
Valine [Moles/volume] in DBS --post therapeutic diet |
|
3117-9
|
Valine [Presence] in Serum or Plasma |
|
3118-7
|
Valine [Mass/volume] in Serum or Plasma |
|
20661-5
|
Valine [Moles/volume] in Serum or Plasma |
|
47802-4
|
Valine/Amino acids.total in Amniotic fluid |
|
47801-6
|
Valine/Amino acids.total in Cerebral spinal fluid |
|
47804-0
|
Valine/Amino acids.total in DBS |
|
47800-8
|
Valine/Amino acids.total in Hair |
|
47803-2
|
Valine/Amino acids.total in Serum or Plasma |
|
47805-7
|
Valine/Amino acids.total in Unspecified specimen |
|
9623-0
|
Valine [Presence] in Urine |
|
3119-5
|
Valine [Mass/volume] in Urine |
|
26961-3
|
Valine [Moles/volume] in Urine |
|
32278-4
|
Valine [Moles/volume] in Vitreous fluid |
|
22729-8
|
Valine [Moles/volume] in Unspecified specimen |
|
44417-4
|
Valine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56998-8
|
Valine/Creatinine [Ratio] in 24 hour Urine |
|
26002-6
|
Valine/Creatinine [Molar ratio] in 24 hour Urine |
|
13822-2
|
Valine/Creatinine [Mass Ratio] in Urine |
|
30064-0
|
Valine/Creatinine [Ratio] in Urine |
|
22692-8
|
Valine/Creatinine [Molar ratio] in Urine |
|
53151-7
|
Valine/Phenylalanine [Molar ratio] in DBS |
|
7535-8
|
Valley Oak IgE Ab [Units/volume] in Serum |
|
15882-4
|
Valley Oak IgE Ab RAST class [Presence] in Serum |
|
72936-8
|
Valproate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72935-0
|
Valproate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
21590-5
|
Valproate.bound/Valproate.total in Serum or Plasma |
|
4458-6
|
Valproate [Mass] of Dose |
|
29229-2
|
Valproate [Mass/volume] in Body fluid |
|
32283-4
|
Valproate Free/Valproate.total in Serum or Plasma |
|
15375-9
|
Valproate Free [Mass/volume] in Saliva (oral fluid) |
|
4087-3
|
Valproate Free [Mass/volume] in Serum or Plasma |
|
32119-0
|
Valproate Free [Moles/volume] in Serum or Plasma |
|
73091-1
|
Valproate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73090-3
|
Valproate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73677-7
|
Valproate [Mass/volume] in Serum or Plasma --peak |
|
4086-5
|
Valproate [Mass/volume] in Serum or Plasma |
|
14946-8
|
Valproate [Moles/volume] in Serum or Plasma |
|
4088-1
|
Valproate [Mass/volume] in Serum or Plasma --trough |
|
17762-6
|
Valproate [Mass/volume] in Urine |
|
73088-7
|
Valsartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73089-5
|
Valsartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
20361-2
|
Heart valve Region [Area] by US.doppler velocity + area calculated |
|
20362-0
|
Heart valve Region [Area] by US.doppler velocity + diameter calculated |
|
20359-6
|
Heart valve Region [Area] by US.doppler VTI + area calculated |
|
20360-4
|
Heart valve Region [Area] by US.doppler VTI + diameter calculated |
|
69379-6
|
Vancomycin resistance vanA and vanB and vanC1 and vanC2 genes [Identifier] by Molecular method |
|
88252-2
|
Vancomycin resistance vanA gene [Presence] by Probe in Positive blood culture |
|
48814-8
|
Vancomycin resistance vanA gene [Presence] by Molecular method |
|
85787-0
|
Vancomycin resistance vanA + vanB genes [Presence] by NAA with non-probe detection in Positive blood culture |
|
62261-3
|
Vancomycin resistance vanA + vanB genes [Presence] by Molecular method |
|
29931-3
|
Vanadium [Mass/volume] in 24 hour Urine |
|
29932-1
|
Vanadium [Mass/time] in 24 hour Urine |
|
50937-2
|
Vanadium [Moles/time] in 24 hour Urine |
|
5753-9
|
Vanadium [Mass/volume] in Blood |
|
50933-1
|
Vanadium [Moles/volume] in Blood |
|
51212-9
|
Vanadium [Mass/volume] in Body fluid |
|
5754-7
|
Vanadium [Mass/mass] in Hair |
|
50934-9
|
Vanadium [Moles/mass] in Hair |
|
5755-4
|
Vanadium [Mass/volume] in Red Blood Cells |
|
50935-6
|
Vanadium [Moles/volume] in Red Blood Cells |
|
5756-2
|
Vanadium [Mass/volume] in Serum or Plasma |
|
52893-5
|
Vanadium [Moles/volume] in Serum or Plasma |
|
60207-8
|
Vanadium [Mass/mass] in Tissue |
|
5757-0
|
Vanadium [Mass/volume] in Urine |
|
50936-4
|
Vanadium [Moles/volume] in Urine |
|
87447-9
|
Vanadium [Mass/volume] in Unspecified specimen |
|
87448-7
|
Vanadium [Mass/mass] in Unspecified specimen |
|
29933-9
|
Vanadium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52900-8
|
Vanadium/Creatinine [Molar ratio] in 24 hour Urine |
|
13831-3
|
Vanadium/Creatinine [Mass Ratio] in Urine |
|
52901-6
|
Vanadium/Creatinine [Molar ratio] in Urine |
|
88253-0
|
Vancomycin resistance vanB gene [Presence] by Probe in Positive blood culture |
|
72421-1
|
Vancomycin resistance vanB gene [Presence] by Molecular method |
|
72837-8
|
Vancomycin resistance vanC1 gene [Presence] by Molecular method |
|
72836-0
|
Vancomycin resistance vanC2+vanC3 genes [Presence] by Molecular method |
|
72934-3
|
Vancomycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72933-5
|
Vancomycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
25228-8
|
Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
13586-3
|
Vancomycin [Mass/volume] in Cerebral spinal fluid |
|
4459-4
|
Vancomycin [Mass] of Dose |
|
13587-1
|
Vancomycin [Mass/volume] in Body fluid |
|
50938-0
|
Vancomycin [Moles/volume] in Body fluid |
|
4089-9
|
Vancomycin Free [Mass/volume] in Serum or Plasma |
|
73086-1
|
Vancomycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73087-9
|
Vancomycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7059-9
|
Vancomycin [Susceptibility] by Gradient strip |
|
525-6
|
Vancomycin [Susceptibility] by Disk diffusion (KB) |
|
524-9
|
Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
523-1
|
Vancomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23615-8
|
Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
92241-9
|
Vancomycin [Susceptibility] by Genotype method |
|
59381-4
|
Vancomycin [Mass/volume] in Serum or Plasma --post dialysis |
|
39092-2
|
Vancomycin [Mass/volume] in Cerebral spinal fluid --peak |
|
4090-7
|
Vancomycin [Mass/volume] in Serum or Plasma --peak |
|
39796-8
|
Vancomycin [Moles/volume] in Serum or Plasma --peak |
|
4091-5
|
Vancomycin [Mass/volume] in Serum or Plasma --random |
|
20578-1
|
Vancomycin [Mass/volume] in Serum or Plasma |
|
31012-8
|
Vancomycin [Moles/volume] in Serum or Plasma |
|
19000-9
|
Vancomycin [Susceptibility] |
|
526-4
|
Vancomycin [Susceptibility] by Serum bactericidal titer |
|
4092-3
|
Vancomycin [Mass/volume] in Serum or Plasma --trough |
|
39797-6
|
Vancomycin [Moles/volume] in Serum or Plasma --trough |
|
75753-4
|
Vancomycin resistance vanD gene [Presence] by Molecular method |
|
7756-0
|
Vanilla IgE Ab [Units/volume] in Serum |
|
16071-3
|
Vanilla IgE Ab RAST class [Presence] in Serum |
|
61324-0
|
Vanilla IgE Ab/IgE total in Serum |
|
6861-9
|
Vanilla IgG Ab [Units/volume] in Serum |
|
21591-3
|
Vanilla IgG Ab RAST class [Presence] in Serum |
|
56410-4
|
Vanilla IgG4 Ab [Mass/volume] in Serum |
|
60412-4
|
Vanilla IgG Ab [Mass/volume] in Serum |
|
75076-0
|
Vanillate [Moles/volume] in Serum or Plasma |
|
48158-0
|
Vanillate/Creatinine [Molar ratio] in Urine |
|
79512-0
|
Vanilloylglycine [Moles/volume] in Serum or Plasma |
|
79483-4
|
Vanilloylglycine/Creatinine [Molar ratio] in Urine |
|
77631-0
|
VAPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
59357-4
|
Vardenafil [Mass/volume] in Blood |
|
59359-0
|
Vardenafil [Mass/volume] in Serum or Plasma |
|
59361-6
|
Vardenafil [Mass/volume] in Urine |
|
93344-0
|
Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal |
|
83005-9
|
Variant category |
|
82122-3
|
Variant coding system [Identifier] |
|
93345-7
|
Genetic variant effect on drug resistance in Blood or Tissue Narrative |
|
93346-5
|
Genetic variant effect on drug sensitivity in Blood or Tissue Narrative |
|
93349-9
|
Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal |
|
93343-2
|
Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal |
|
93368-9
|
Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative |
|
26477-0
|
Variant lymphocytes [#/volume] in Blood |
|
43743-4
|
Variant lymphocytes [#/volume] in Blood by Automated count |
|
66144-7
|
Variant lymphocytes [#/volume] in Blood from Fetus by Manual count |
|
734-4
|
Variant lymphocytes [#/volume] in Blood by Manual count |
|
35043-9
|
Variant lymphocytes [#/volume] in Cerebral spinal fluid |
|
35045-4
|
Variant lymphocytes [#/volume] in Body fluid |
|
40573-8
|
Variant lymphocytes [#/volume] in Body fluid by Manual count |
|
35042-1
|
Variant lymphocytes [#/volume] in Pleural fluid |
|
35041-3
|
Variant lymphocytes [#/volume] in Peritoneal fluid |
|
35044-7
|
Variant lymphocytes [#/volume] in Synovial fluid |
|
15192-8
|
Variant lymphocytes [Presence] in Blood by Automated count |
|
733-6
|
Variant lymphocytes [Presence] in Blood by Light microscopy |
|
11107-0
|
Variant lymphocytes/100 cells in Bone marrow by Manual count |
|
71665-4
|
Variant lymphocytes/Leukocytes [Pure number fraction] in Blood by Manual count |
|
13046-8
|
Variant lymphocytes/100 leukocytes in Blood |
|
42250-1
|
Variant lymphocytes/100 leukocytes in Blood by Automated count |
|
735-1
|
Variant lymphocytes/100 leukocytes in Blood by Manual count |
|
32832-8
|
Variant lymphocytes/100 leukocytes in Bronchial specimen |
|
32805-4
|
Variant lymphocytes/100 leukocytes in Bronchial specimen by Manual count |
|
30416-2
|
Variant lymphocytes/100 leukocytes in Cerebral spinal fluid |
|
13517-8
|
Variant lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
30417-0
|
Variant lymphocytes/100 leukocytes in Body fluid |
|
13518-6
|
Variant lymphocytes/100 leukocytes in Body fluid by Manual count |
|
33409-4
|
Variant lymphocytes/100 leukocytes in Pericardial fluid |
|
33370-8
|
Variant lymphocytes/100 leukocytes in Pleural fluid |
|
33369-0
|
Variant lymphocytes/100 leukocytes in Peritoneal fluid |
|
33371-6
|
Variant lymphocytes/100 leukocytes in Synovial fluid |
|
93367-1
|
Variant of unknown significance [Identifier] in Blood or Tissue Nominal |
|
41856-6
|
Variola virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80666-1
|
Vascular neurology Consult note |
|
89034-3
|
Vascular neurology Initial evaluation note |
|
80668-7
|
Vascular neurology Surgical operation note |
|
80669-5
|
Vascular neurology procedure note |
|
80667-9
|
Vascular neurology Progress note |
|
71461-8
|
Vascular infection source [ESRD] |
|
83677-5
|
Vascular surgery Attending Admission evaluation note |
|
83678-3
|
Vascular surgery Attending Note |
|
83679-1
|
Vascular surgery Attending Preoperative evaluation and management note |
|
83564-5
|
Vascular surgery Nurse practitioner Note |
|
83618-9
|
Vascular surgery Nurse Note |
|
83619-7
|
Vascular surgery Nurse Outpatient Note |
|
83752-6
|
Vascular surgery Physician assistant Note |
|
83782-3
|
Vascular surgery Resident Note |
|
89825-4
|
Vascular surgery Team Conference note |
|
83840-9
|
Vascular surgery Technician Note |
|
84047-0
|
Vascular surgery Admission evaluation note |
|
78510-5
|
Vascular surgery Admission history and physical note |
|
78542-8
|
Vascular surgery Checklist |
|
34853-2
|
Vascular surgery Consult note |
|
85440-6
|
Vascular surgery Discharge summary |
|
78597-2
|
Vascular surgery Education note |
|
78620-2
|
Vascular surgery Flowsheet |
|
84048-8
|
Vascular surgery History and physical note |
|
84049-6
|
Vascular surgery Hospital Note |
|
82838-4
|
Vascular surgery Initial evaluation note |
|
84050-4
|
Vascular surgery Note |
|
34854-0
|
Vascular surgery Outpatient Note |
|
84051-2
|
Vascular surgery Outpatient Postoperative evaluation and management note |
|
78243-3
|
Vascular surgery Surgical operation note |
|
84054-6
|
Vascular surgery Telephone encounter Note |
|
80768-5
|
Vascular surgery Plan of care note |
|
84052-0
|
Vascular surgery Postoperative evaluation and management note |
|
78737-4
|
Vascular surgery Preoperative evaluation and management note |
|
84053-8
|
Vascular surgery procedure note |
|
85441-4
|
Vascular surgery Progress note |
|
57169-5
|
Vascular surgery Referral note |
|
78680-6
|
Vascular surgery Transfer summary note |
|
58893-9
|
Vasopressin [Mass/volume] in Plasma --1.5 hours post XXX challenge |
|
56527-5
|
Vasopressin [Mass/volume] in Plasma --1 hour post XXX challenge |
|
26928-2
|
Vasopressin [Presence] in 24 hour Urine |
|
58922-6
|
Vasopressin [Mass/volume] in Plasma --2 hours post XXX challenge |
|
49332-0
|
Vasopressin [Mass/volume] in Plasma --30 minutes post XXX challenge |
|
58894-7
|
Vasopressin [Mass/volume] in Plasma --baseline |
|
14949-2
|
Vasopressin [Moles/volume] in Plasma |
|
3126-0
|
Vasopressin [Mass/volume] in Serum or Plasma |
|
47198-7
|
Vasopressin [Mass/volume] in Plasma --1st specimen post XXX challenge |
|
12982-5
|
Vasopressin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
13903-0
|
Vasopressin [Mass/volume] in Urine |
|
81441-8
|
Vital capacity [Volume] Respiratory system --post bronchodilation |
|
81440-0
|
Vital capacity [Volume] Respiratory system --pre bronchodilation |
|
82615-6
|
Vital capacity [Volume] Respiratory system by Spirometry --pre bronchodilation |
|
75627-0
|
Vascular cell adhesion molecule 1 [Mass/volume] in Serum or Plasma |
|
24754-4
|
Administration of vasodilator into catheter Vein |
|
26376-4
|
Administration of vasodilator into catheter Vein - bilateral |
|
26377-2
|
Administration of vasodilator into catheter Vein - left |
|
26378-0
|
Administration of vasodilator into catheter Vein - right |
|
51783-9
|
Reagin Ab [Presence] in Cord blood by VDRL |
|
5290-2
|
Reagin Ab [Presence] in Cerebral spinal fluid by VDRL |
|
5289-4
|
Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL |
|
31146-4
|
Reagin Ab [Titer] in Cerebral spinal fluid by VDRL |
|
21030-2
|
Reagin Ab [Presence] in Serum from Donor by VDRL |
|
5292-8
|
Reagin Ab [Presence] in Serum by VDRL |
|
5291-0
|
Reagin Ab [Units/volume] in Serum by VDRL |
|
50690-7
|
Reagin Ab [Titer] in Serum by VDRL |
|
14904-7
|
Reagin Ab [Presence] in Unspecified specimen by VDRL |
|
47235-7
|
Reagin Ab [Titer] in Unspecified specimen by VDRL |
|
94119-5
|
Expired minute volume/Carbon dioxide production during exercise |
|
7758-6
|
Veal triggered histamine release [Units/volume] in Blood |
|
7757-8
|
Veal IgE Ab [Units/volume] in Serum |
|
16072-1
|
Veal IgE Ab RAST class [Presence] in Serum |
|
48288-5
|
Vecuronium triggered leukotriene release [Mass/volume] by Leukocytes |
|
86899-2
|
Vedolizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
86898-4
|
Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
90805-3
|
Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
|
23554-9
|
Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Immunofluorescence |
|
23553-1
|
Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by NAA with probe detection |
|
23552-3
|
Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Neutralization test |
|
23544-0
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum |
|
23541-6
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
|
23542-4
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
23545-7
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
|
6571-4
|
Venezuelan equine encephalitis virus Ab [Units/volume] in Serum |
|
22607-6
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum |
|
23787-5
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23543-2
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
43341-7
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Immunoassay |
|
20980-9
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
31983-0
|
Venezuelan equine encephalitis virus Ag [Presence] in Serum |
|
6572-2
|
Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
|
6573-0
|
Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
|
31984-8
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen |
|
23551-5
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23550-7
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
|
23549-9
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23548-1
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
8050-7
|
Venezuelan equine encephalitis virus IgG Ab [Units/volume] in Serum |
|
23546-5
|
Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum |
|
23547-3
|
Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
8051-5
|
Venezuelan equine encephalitis virus IgM Ab [Units/volume] in Serum |
|
28070-1
|
Vegetable fibers [#/area] in Stool by Light microscopy |
|
55835-3
|
Vegetable fibers [Presence] in Stool by Light microscopy |
|
80459-1
|
Vegetable servings 24 hour Estimated |
|
80460-9
|
Vegetable servings 24 hour Measured |
|
49482-3
|
Vascular endothelial growth factor Ag [Presence] in Tissue by Immune stain |
|
34694-0
|
Vascular endothelial growth factor [Mass/volume] in Serum or Plasma |
|
75628-8
|
Vascular endothelial growth factor A [Mass/volume] in Serum or Plasma |
|
82911-9
|
Vascular endothelial growth factor D [Mass/volume] in Serum or Plasma |
|
88074-0
|
Vehicle name [Identifier] EMS unit |
|
58081-1
|
Vel Ab [Presence] in Serum or Plasma |
|
58082-9
|
Vel Ag [Presence] on Red Blood Cells |
|
20364-6
|
Velocity slope 2 by US |
|
20363-8
|
Velocity slope by US |
|
20369-5
|
Velocity slope/Velocity slope 2 by US.doppler calculated |
|
75986-0
|
Velocity index Aorta Non-invasive impedance cardiography (NI-ICG) |
|
82520-8
|
Velpatasvir [Susceptibility] by Genotype method |
|
6272-9
|
Velvet grass IgE Ab [Units/volume] in Serum |
|
15756-0
|
Velvet grass IgE Ab RAST class [Presence] in Serum |
|
56411-2
|
Velvet grass IgG4 Ab [Mass/volume] in Serum |
|
48257-0
|
Velvet grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
74716-2
|
Vendor firmware version |
|
78042-9
|
Vendor FISH product name [Identifier] in Blood or Tissue |
|
79799-3
|
Vendor name [Identifier] Electroretinography device |
|
59841-7
|
Vendor name [Identifier] in Unspecified specimen |
|
7759-4
|
Venison IgE Ab [Units/volume] in Serum |
|
21599-6
|
Venison IgE Ab RAST class [Presence] in Serum |
|
56412-0
|
Venison IgG4 Ab [Mass/volume] in Serum |
|
63098-8
|
Venison IgG Ab [Mass/volume] in Serum |
|
72932-7
|
Venlafaxine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72931-9
|
Venlafaxine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60208-6
|
Venlafaxine [Mass/volume] in Blood |
|
78886-9
|
Venlafaxine cutoff [Mass/volume] in Urine for Confirmatory method |
|
60209-4
|
Venlafaxine [Mass/volume] in Body fluid |
|
59978-7
|
Venlafaxine [Moles/volume] in Gastric fluid |
|
73085-3
|
Venlafaxine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73084-6
|
Venlafaxine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13588-9
|
Venlafaxine [Presence] in Serum or Plasma |
|
9630-5
|
Venlafaxine [Mass/volume] in Serum or Plasma |
|
34386-3
|
Venlafaxine [Moles/volume] in Serum or Plasma |
|
60210-2
|
Venlafaxine [Mass/mass] in Tissue |
|
72774-3
|
Venlafaxine [Mass/volume] in Urine by Confirmatory method |
|
32120-8
|
Venlafaxine [Presence] in Urine |
|
18467-1
|
Venlafaxine [Mass/volume] in Urine |
|
59977-9
|
Venlafaxine [Moles/volume] in Urine |
|
32121-6
|
Venlafaxine [Presence] in Unspecified specimen |
|
60337-3
|
Venlafaxine [Moles/volume] in Unspecified specimen |
|
72775-0
|
Venlafaxine/Creatinine [Mass Ratio] in Urine |
|
75987-8
|
Venous blood temperature |
|
33740-2
|
Venous.large vessel.invasion [Identifier] in Specimen by CAP cancer protocols |
|
33761-8
|
Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols |
|
88035-1
|
Ventilator alarm settings Document |
|
76296-3
|
Ventilator airway circuit leakage volume |
|
76526-3
|
Ventilation rate by Carbon dioxide measurement |
|
88034-4
|
Ventilator settings Document |
|
88036-9
|
Ventilator alarm events Document |
|
94124-5
|
Ventilatory threshold [Volume Rate Content] |
|
9876-4
|
Ventricular morphology [Interpretation] Narrative by EKG |
|
8622-3
|
Ventricular morphology [Interpretation] by EKG |
|
94126-0
|
Ventilatory equivalent for carbon dioxide --W exercise |
|
4460-2
|
Verapamil [Mass] of Dose |
|
73083-8
|
Verapamil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73082-0
|
Verapamil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4093-1
|
Verapamil [Presence] in Serum or Plasma |
|
4094-9
|
Verapamil [Mass/volume] in Serum or Plasma |
|
55586-2
|
Verapamil [Moles/volume] in Serum or Plasma |
|
4095-6
|
Verapamil [Presence] in Urine |
|
17767-5
|
Verapamil [Mass/volume] in Urine |
|
54683-8
|
Verbal behavioral symptoms directed toward others in last 7 days [CMS Assessment] |
|
81681-9
|
Verified two types of patient identification |
|
81685-0
|
Verified availability of correct implants and any special equipment or requirements |
|
81683-5
|
Verified procedure |
|
81682-7
|
Verified side andor site of procedure |
|
81684-3
|
Verified patient position |
|
20981-7
|
Verotoxin identified in Isolate |
|
79763-9
|
Vertical diameter Left cornea |
|
79762-1
|
Vertical diameter Right cornea |
|
8621-5
|
Ventricular ectopics |
|
30073-1
|
Voltage-gated calcium channel Ab [Presence] in Serum |
|
31024-3
|
Voltage-gated calcium channel Ab [Moles/volume] in Serum |
|
41261-9
|
Voltage-gated calcium channel IgG Ab [Presence] in Serum |
|
12724-1
|
Voltage-gated calcium channel IgG Ab [Units/volume] in Serum |
|
41201-5
|
Voltage-gated calcium channel IgG Ab [Moles/volume] in Serum |
|
33979-6
|
Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum |
|
33980-4
|
Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum |
|
68913-3
|
Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid |
|
68943-0
|
Voltage-gated potassium channel Ab [Units/volume] in Serum |
|
41871-5
|
Voltage-gated potassium channel Ab [Moles/volume] in Serum |
|
82533-1
|
VHL gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
69489-3
|
VHL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
82528-1
|
VHL gene full mutation analysis in Blood or Tissue by Sequencing |
|
34502-5
|
VHL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41043-1
|
VHL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60347-2
|
Viable CD34 cells [#/volume] in Body fluid |
|
60345-6
|
Viable CD34 cells/100 cells in Body fluid |
|
60346-4
|
Viable CD34 cells/100 CD34 cells in Body fluid |
|
80698-4
|
Viable CD34 cells/100 CD34 cells in Hematopoietic progenitor cells from Blood product unit |
|
33193-4
|
Viable cells/100 cells in Blood |
|
33195-9
|
Viable cells/100 cells in Bone marrow |
|
33194-2
|
Viable cells/100 cells in Unspecified specimen |
|
6578-9
|
Vibrio sp identified in Blood by Organism specific culture |
|
80680-2
|
Vibrio cholerae toxin ctxA gene [Presence] in Stool by NAA with probe detection |
|
49609-1
|
Vibrio sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
6579-7
|
Vibrio sp identified in Stool by Organism specific culture |
|
6580-5
|
Vibrio sp identified in Water by Organism specific culture |
|
6581-3
|
Vibrio sp identified in Unspecified specimen by Organism specific culture |
|
92050-4
|
Video EEG study report |
|
30042-6
|
Vigabatrin [Mass/volume] in Serum or Plasma |
|
25816-0
|
Vigabatrin [Moles/volume] in Serum or Plasma |
|
74939-0
|
Vigabatrin [Mass/volume] in Serum or Plasma --trough |
|
77593-2
|
Vigorous physical activity [IPAQ] |
|
88431-2
|
Vigorous physical activity.leisure-time domain [IPAQ] |
|
88419-7
|
Vigorous physical activity.work domain [IPAQ] |
|
88426-2
|
Vigorous physical activity.yard work [IPAQ] |
|
90978-8
|
Vilazodone [Mass/volume] in Serum or Plasma |
|
89988-0
|
Vilazodone [Mass/volume] in Urine by Confirmatory method |
|
75235-2
|
Vilazodone [Presence] in Urine |
|
89989-8
|
Vilazodone [Presence] in Urine by Screen method |
|
47038-5
|
Villin Ag [Presence] in Tissue by Immune stain |
|
55345-3
|
VIM gene methylation [Presence] in Stool by Molecular genetics method |
|
54011-2
|
Vimentin Ab [Presence] in Serum by Immunofluorescence |
|
54012-0
|
Vimentin Ab [Titer] in Serum by Immunofluorescence |
|
10519-7
|
Vimentin Ag [Presence] in Tissue by Immune stain |
|
87420-6
|
Vinculin Ab [Units/volume] in Serum by Immunoassay |
|
54013-8
|
Vinculin Ab [Presence] in Serum by Immunofluorescence |
|
54014-6
|
Vinculin Ab [Titer] in Serum by Immunofluorescence |
|
38733-2
|
Vinyl acetate [Mass/volume] in Air |
|
38734-0
|
Vinyl bromide [Mass/volume] in Air |
|
38626-8
|
Vinyl chloride [Mass/volume] in Air |
|
17768-3
|
Vinyl chloride [Mass/volume] in Blood |
|
13640-8
|
Vinyl chloride [Mass/volume] in Urine |
|
38335-6
|
Vinyl chloride [Mass/volume] in Water |
|
529-8
|
Viomycin [Susceptibility] by Disk diffusion (KB) |
|
528-0
|
Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
527-2
|
Viomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23616-6
|
Viomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
19001-7
|
Viomycin [Susceptibility] |
|
530-6
|
Viomycin [Susceptibility] by Serum bactericidal titer |
|
18259-2
|
Vasoactive intestinal peptide [Mass/time] in 24 hour Urine |
|
46962-7
|
Vasoactive intestinal peptide Ag [Presence] in Tissue by Immune stain |
|
55205-9
|
Vasoactive intestinal peptide [Mass/volume] in Cerebral spinal fluid |
|
51989-2
|
Vasoactive intestinal peptide [Presence] in Serum or Plasma |
|
3125-2
|
Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma |
|
53523-7
|
Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma |
|
11270-6
|
Viral inclusion bodies [Identifier] in Unspecified specimen by Cyto stain |
|
10735-9
|
Viral sequencing [Identifier] in Serum by Sequencing |
|
615-5
|
Viral strain [Type] in Isolate by Viral subtyping |
|
6164-8
|
Virginia Live Oak IgE Ab [Units/volume] in Serum |
|
15880-8
|
Virginia Live Oak IgE Ab RAST class [Presence] in Serum |
|
56413-8
|
Virginia Live Oak IgG4 Ab [Mass/volume] in Serum |
|
10958-7
|
Virginia Scrub Pine IgE Ab [Units/volume] in Serum |
|
15946-7
|
Virginia Scrub Pine IgE Ab RAST class [Presence] in Serum |
|
55723-1
|
Virginiamycin [Susceptibility] by Gradient strip |
|
35859-8
|
Virginiamycin [Susceptibility] by Disk diffusion (KB) |
|
35860-6
|
Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35861-4
|
Virginiamycin [Susceptibility] |
|
87585-6
|
Virginiamycin [Mass/mass] in Unspecified specimen |
|
11484-3
|
Virus identified in Amniotic fluid by Culture |
|
5883-4
|
Virus identified in Blood by Culture |
|
14489-9
|
Virus identified in Blood by Immunofluorescence |
|
5884-2
|
Virus identified in Cerebral spinal fluid by Culture |
|
10736-7
|
Virus identified in Cerebral spinal fluid by Electron microscopy |
|
14488-1
|
Virus identified in Cerebral spinal fluid by Immunofluorescence |
|
14452-7
|
Virus identified in Cervix by Culture |
|
14493-1
|
Virus identified in Cervix by Immunofluorescence |
|
14451-9
|
Virus identified in Eye by Culture |
|
14492-3
|
Virus identified in Eye by Immunofluorescence |
|
40479-8
|
Virus identified in Body fluid by Culture |
|
40480-6
|
Virus identified in Genital specimen by Culture |
|
42808-6
|
Virus identified in Isolate |
|
6608-4
|
Virus identified in Isolate by Culture |
|
86337-3
|
Virus identified in Isolate by Shell vial culture |
|
87709-2
|
Virus identified in Lower respiratory specimen by Culture |
|
72374-2
|
Virus identified in Lung tissue by Culture |
|
14454-3
|
Virus identified in Nose by Culture |
|
72373-4
|
Virus identified in Nasopharynx by Culture |
|
14459-2
|
Virus identified in Penis by Culture |
|
14497-2
|
Virus identified in Penis by Immunofluorescence |
|
14455-0
|
Virus identified in Pleural fluid by Culture |
|
14456-8
|
Virus identified in Peritoneal fluid by Culture |
|
5885-9
|
Virus identified in Skin by Culture |
|
6583-9
|
Virus identified in Semen by Culture |
|
14490-7
|
Virus identified in Semen by Immunofluorescence |
|
14458-4
|
Virus identified in Sputum by Culture |
|
14496-4
|
Virus identified in Sputum by Immunofluorescence |
|
5886-7
|
Virus identified in Stool by Culture |
|
10737-5
|
Virus identified in Stool by Electron microscopy |
|
5887-5
|
Virus identified in Throat by Culture |
|
14491-5
|
Virus identified in Throat by Immunofluorescence |
|
5888-3
|
Virus identified in Tissue by Culture |
|
10738-3
|
Virus identified in Tissue by Electron microscopy |
|
89655-5
|
Virus identified in Tissue by Shell vial culture |
|
14457-6
|
Virus identified in Urine by Culture |
|
14495-6
|
Virus identified in Urine sediment by Immunofluorescence |
|
14460-0
|
Virus identified in Urethra by Culture |
|
14498-0
|
Virus identified in Urethra by Immunofluorescence |
|
14453-5
|
Virus identified in Vaginal fluid by Culture |
|
14494-9
|
Virus identified in Vaginal fluid by Immunofluorescence |
|
41461-5
|
Virus identified in Unspecified specimen |
|
6584-7
|
Virus identified in Unspecified specimen by Culture |
|
17975-4
|
Virus # 2 identified in Unspecified specimen by Culture |
|
17976-2
|
Virus # 3 identified in Unspecified specimen by Culture |
|
10739-1
|
Virus identified in Unspecified specimen by Electron microscopy |
|
12272-1
|
Virus identified in Unspecified specimen by Immunofluorescence |
|
50024-9
|
Virus identified in Unspecified specimen by Shell vial culture |
|
79881-9
|
Visual acuity best corrected Left eye by Snellen eye chart |
|
79880-1
|
Visual acuity best corrected Right eye by Snellen eye chart |
|
79877-7
|
Visual acuity best corrected Left eye by ETDRS eye chart |
|
79876-9
|
Visual acuity best corrected Right eye by ETDRS eye chart |
|
79883-5
|
Visual acuity uncorrected Left eye by Snellen eye chart |
|
79882-7
|
Visual acuity uncorrected Right eye by Snellen eye chart |
|
79879-3
|
Visual acuity uncorrected Left eye by ETDRS eye chart |
|
79878-5
|
Visual acuity uncorrected Right eye by ETDRS eye chart |
|
41862-4
|
Viscosity of Semen--20 minutes post collection |
|
38509-6
|
Viscosity of Semen Qualitative--30 minutes post collection |
|
4690-4
|
Viscosity of Blood |
|
79333-1
|
Viscosity of Cervical mucus Qualitative |
|
41264-3
|
Viscosity of Cerebral spinal fluid Qualitative |
|
3127-8
|
Viscosity of Body fluid |
|
41245-2
|
Viscosity of Pericardial fluid Qualitative |
|
4691-2
|
Viscosity of Plasma |
|
41263-5
|
Viscosity of Pleural fluid Qualitative |
|
41262-7
|
Viscosity of Peritoneal fluid Qualitative |
|
3128-6
|
Viscosity of Serum |
|
41241-1
|
Viscosity of Serum Qualitative |
|
9631-3
|
Viscosity of Semen |
|
32789-0
|
Viscosity of Semen Qualitative |
|
41238-7
|
Viscosity of Synovial fluid |
|
14950-0
|
Viscosity of Synovial fluid Qualitative |
|
41226-2
|
Viscosity of Water |
|
41208-0
|
Viscosity+Liquefaction [Identifier] of Semen |
|
73707-2
|
Visceral fat [Area] Measured |
|
57215-6
|
Vision [CMS Assessment] |
|
93310-1
|
Vision.ability to see in adequate light during 3 day assessment period [CMS Assessment] |
|
54603-6
|
Vision.ability to see in adequate light in last 7 days [CMS Assessment] |
|
76428-2
|
Visit charge in dollars |
|
76427-4
|
Visit date |
|
73980-5
|
Visit duration |
|
86530-3
|
Visit notification note |
|
71066-5
|
Visits you would like to rate [FACIT] |
|
28631-0
|
Visual acuity study |
|
79733-2
|
Visual convergence exam Eye |
|
79808-2
|
Visual field defects Left eye by Confrontation |
|
79807-4
|
Visual field defects Right eye by Confrontation |
|
79805-8
|
Visual field defects Left eye |
|
79804-1
|
Visual field defects Right eye |
|
1624-6
|
Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units |
|
17528-1
|
Retinol [Mass/volume] in Serum or Plasma --3 hours post dose |
|
1625-3
|
Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units |
|
17529-9
|
Retinol [Mass/volume] in Serum or Plasma --6 hours post dose |
|
2922-3
|
Retinol [Mass/volume] in Blood |
|
17526-5
|
Retinyl esters [Mass/volume] in Serum or Plasma |
|
20947-8
|
Retinol [Mass/mass] in Feed |
|
17527-3
|
Retinol Free [Mass/volume] in Serum or Plasma |
|
81072-1
|
Vitamin A intake 24 hour Estimated |
|
81073-9
|
Vitamin A intake 24 hour Measured |
|
20946-0
|
Retinol [Mass/mass] in Liver |
|
1626-1
|
Retinol [Mass/volume] in Serum or Plasma --pre 5000 units |
|
2923-1
|
Retinol [Mass/volume] in Serum or Plasma |
|
14905-4
|
Retinol [Moles/volume] in Serum or Plasma |
|
20948-6
|
Retinol [Mass/mass] in Tissue |
|
27149-4
|
Thiamine [Presence] in Blood |
|
2998-3
|
Thiamine [Mass/volume] in Blood |
|
32554-8
|
Thiamine [Moles/volume] in Blood |
|
49115-9
|
Thiamine.free [Mass/volume] in Blood |
|
81927-6
|
Vitamin B1 (Thiamine) intake 24 hour Estimated |
|
81928-4
|
Vitamin B1 (Thiamine) intake 24 hour Measured |
|
74444-1
|
Thiamine pyrophosphate [Moles/volume] in Blood |
|
3000-7
|
Thiamine pyrophosphate [Mass/volume] in Serum |
|
2999-1
|
Thiamine [Mass/volume] in Serum or Plasma |
|
20468-5
|
Thiamine [Moles/volume] in Serum or Plasma |
|
26916-7
|
Cobalamin (Vitamin B12) [Presence] in Blood |
|
16695-9
|
Cobalamin (Vitamin B12) [Mass/volume] in Blood |
|
2169-1
|
Cobalamin (Vitamin B12) renal clearance in 24 hour Urine and Serum or Plasma |
|
54377-7
|
Cobalamin (Vitamin B12) [Mass/volume] in Body fluid |
|
54376-9
|
Cobalamin (Vitamin B12) [Moles/volume] in Body fluid |
|
81062-2
|
Vitamin B12 intake 24 hour Estimated |
|
81063-0
|
Vitamin B12 intake 24 hour Measured |
|
30904-7
|
Cobalamin (Vitamin B12) [Units/volume] in 24 hour Urine --post dose cyanocobalamin |
|
1460-5
|
Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin |
|
30906-2
|
Cobalamin (Vitamin B12) [Units/volume] in 24 hour Urine --post dose cyanocobalamin+intrinsic factor |
|
30905-4
|
Cobalamin (Vitamin B12) [Ratio] in 24 hour Urine --post dose cyanocobalamin+intrinsic factor/post dose cyanocobalamin |
|
16696-7
|
Cobalamin (Vitamin B12) [Mass/volume] in Urine --post XXX challenge |
|
35201-3
|
Cobalamin (Vitamin B12) [Mass or Moles/volume] in Serum |
|
2132-9
|
Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma |
|
14685-2
|
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
|
55850-2
|
Cobalamin (Vitamin B12) [Mass/volume] in Urine |
|
54378-5
|
Cobalamin (Vitamin B12) [Moles/volume] in Urine |
|
2171-7
|
Cobalamin (Vitamin B12).unsaturated Binding Capacity [Mass/volume] in Serum or Plasma |
|
15052-4
|
Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma |
|
1888-7
|
Aquacobalamin [Mass/volume] in Serum or Plasma |
|
55883-3
|
Hydroxocobalamin [Mass/volume] in Body fluid |
|
55882-5
|
Hydroxocobalamin [Moles/volume] in Body fluid |
|
2440-6
|
Hydroxocobalamin [Mass/volume] in Serum or Plasma |
|
55881-7
|
Hydroxocobalamin [Moles/volume] in Serum or Plasma |
|
55885-8
|
Hydroxocobalamin [Mass/volume] in Urine |
|
55884-1
|
Hydroxocobalamin [Moles/volume] in Urine |
|
18374-9
|
Riboflavin [Mass/volume] in 24 hour Urine |
|
27099-1
|
Riboflavin [Presence] in Blood |
|
6695-1
|
Riboflavin [Mass/volume] in Blood |
|
73723-9
|
Riboflavin [Moles/volume] in Blood |
|
81070-5
|
Vitamin B2 (Riboflavin) intake 24 hour Estimated |
|
81071-3
|
Vitamin B2 (Riboflavin) intake 24 hour Measured |
|
2924-9
|
Riboflavin [Mass/volume] in Serum or Plasma |
|
49038-3
|
Riboflavin [Moles/volume] in Serum or Plasma |
|
81135-6
|
Vitamin B3 (Niacin) intake 24 hour Estimated |
|
81067-1
|
Vitamin B3 (Niacin) intake 24 hour Measured |
|
81068-9
|
Vitamin B5 (Pantothenate) intake 24 hour Estimated |
|
81069-7
|
Vitamin B5 (Pantothenate) intake 24 hour Measured |
|
26915-9
|
Pyridoxine [Presence] in Blood |
|
2901-7
|
Pyridoxine congeners [Mass/volume] in Serum or Plasma |
|
75043-0
|
Pyridoxine [Moles/volume] in Cerebral spinal fluid |
|
47203-5
|
Pyridoxine [Mass] of Dose |
|
81064-8
|
Vitamin B6 intake 24 hour Estimated |
|
81065-5
|
Vitamin B6 intake 24 hour Measured |
|
26056-2
|
Pyridoxine [Moles/volume] in Serum or Plasma --post 250 mg pyridoxine PO |
|
26057-0
|
Pyridoxine [Mass/volume] in Serum or Plasma --post pyridoxine PO |
|
26055-4
|
Pyridoxine [Moles/volume] in Serum or Plasma --pre 250 mg pyridoxine PO |
|
2900-9
|
Pyridoxine [Mass/volume] in Serum or Plasma |
|
39786-9
|
Pyridoxine [Moles/volume] in Serum or Plasma |
|
81017-6
|
Vitamin B7 (Biotin) intake 24 hour Estimated |
|
81018-4
|
Vitamin B7 (Biotin) intake 24 hour Measured |
|
81066-3
|
Vitamin B9 (Folate) intake 24 hour Estimated |
|
81134-9
|
Vitamin B9 (Folate) intake 24 hour Measured |
|
1905-9
|
Ascorbate [Mass/time] in 24 hour Urine |
|
34246-9
|
Ascorbate [Moles/volume] in 24 hour Urine |
|
15033-4
|
Ascorbate [Moles/time] in 24 hour Urine |
|
1902-6
|
Ascorbate [Mass/volume] in Blood |
|
81074-7
|
Vitamin C intake 24 hour Estimated |
|
81075-4
|
Vitamin C intake 24 hour Measured |
|
16409-5
|
Ascorbate [Mass/volume] in Serum or Plasma --post dose |
|
47135-9
|
Ascorbate [Moles/volume] in Serum or Plasma --post dose |
|
1369-8
|
Ascorbate [Mass/time] in 24 hour Urine --post dose PO |
|
4131-9
|
Ascorbate.PO [Mass] of Dose |
|
1903-4
|
Ascorbate [Mass/volume] in Serum or Plasma |
|
14622-5
|
Ascorbate [Moles/volume] in Serum or Plasma |
|
59398-8
|
Ascorbate [Mass/volume] in Semen |
|
56779-2
|
Ascorbate [Moles/volume] in Semen |
|
1904-2
|
Ascorbate [Presence] in Urine |
|
5768-7
|
Ascorbate [Mass/volume] in Urine by Test strip |
|
16408-7
|
Ascorbate [Mass/volume] in Urine |
|
34247-7
|
Ascorbate [Moles/volume] in Urine |
|
12482-6
|
Ascorbate [Mass/volume] in Leukocytes |
|
60286-2
|
Ascorbate [Moles/volume] in Unspecified specimen |
|
34248-5
|
Ascorbate/Creatinine [Molar ratio] in Urine |
|
54351-2
|
Ascorbate+Dehydroascorbate [Mass/volume] in Serum or Plasma |
|
54350-4
|
Ascorbate+Dehydroascorbate [Moles/volume] in Serum or Plasma |
|
81929-2
|
Vitamin D intake 24 hour Estimated |
|
81930-0
|
Vitamin D intake 24 hour Measured |
|
35365-6
|
Vitamin D+Metabolites [Mass/volume] in Serum or Plasma |
|
81076-2
|
Vitamin E intake 24 hour Estimated |
|
81077-0
|
Vitamin E intake 24 hour Measured |
|
81078-8
|
Vitamin K intake 24 hour Estimated |
|
81079-6
|
Vitamin K intake 24 hour Measured |
|
80339-5
|
Vital signs assessment [Interpretation] |
|
75186-7
|
Vital status [CDC.CS] |
|
75527-2
|
Vital status at discharge |
|
92276-5
|
Vital status from Newborn |
|
4466-9
|
Vital stain used for semen analysis |
|
2236-8
|
Calciferol (Vit D2) [Mass/volume] in Serum or Plasma |
|
47094-8
|
Calciferol (Vit D2) [Moles/volume] in Serum or Plasma |
|
1990-1
|
Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma |
|
33958-0
|
Cholecalciferol (Vit D3) [Moles/volume] in Serum or Plasma |
|
87671-4
|
Cholecalciferol (Vit D3) [Mass/mass] in Unspecified specimen |
|
3130-2
|
Vitronectin [Mass/volume] in Plasma |
|
72507-7
|
VKORC1 gene c.1173C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
50722-8
|
VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72512-7
|
VKORC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46753-0
|
Very long chain hydroxy acyl dehydrogenase deficiency newborn screen interpretation |
|
75101-6
|
Fatty acids.very long chain C22:0 (Docosanoate) [Entitic substance] in Red Blood Cells |
|
74615-6
|
Fatty acids.very long chain C22:0 (Docosanoate) [Mass/mass] in Fibroblast |
|
53859-5
|
Fatty acids.very long chain C22:0 (Docosanoate) [Mass/volume] in Serum or Plasma |
|
30194-5
|
Fatty acids.very long chain C22:0 (Docosanoate) [Moles/volume] in Serum or Plasma |
|
75104-0
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Entitic substance] in Red Blood Cells |
|
74613-1
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/mass] in Fibroblast |
|
53860-3
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/volume] in Serum or Plasma |
|
30195-2
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Moles/volume] in Serum or Plasma |
|
74583-6
|
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast |
|
1773-1
|
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
|
30196-0
|
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma |
|
50060-3
|
Fatty acids.very long chain C24:0 (Tetracosanoate)/Creatinine [Molar ratio] in Urine |
|
75096-8
|
Fatty acids.very long chain C26:0 (Hexacosanoate) [Entitic substance] in Red Blood Cells |
|
74614-9
|
Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/mass] in Fibroblast |
|
33403-7
|
Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/volume] in Serum or Plasma |
|
30197-8
|
Fatty acids.very long chain C26:0 (Hexacosanoate) [Moles/volume] in Serum or Plasma |
|
74582-8
|
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast |
|
1774-9
|
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
|
30198-6
|
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma |
|
54294-4
|
Fatty acids.very long chain C26:0 (Hexacosanoate)/Creatinine [Molar ratio] in Urine |
|
75105-7
|
Fatty acids.very long chain C26:1 (Hexacosenoate) [Entitic substance] in Red Blood Cells |
|
54446-0
|
Fatty acids.very long chain C26:1 (Hexacosenoate) [Mass/volume] in Serum or Plasma |
|
33036-5
|
Fatty acids.very long chain C26:1 (Hexacosenoate) [Moles/volume] in Serum or Plasma |
|
38538-5
|
Fatty acids.very long chain C26:1 (Hexacosenoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
|
79707-6
|
Fatty acids.very long chain C26:1 (Hexacosenoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma |
|
33478-9
|
Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma |
|
49263-7
|
Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma Narrative |
|
17080-3
|
Fatty acids.very long chain [Identifier] in Serum or Plasma |
|
34169-3
|
Fatty acids.very long chain [Mass/volume] in Serum or Plasma |
|
12215-0
|
Fatty acids.very long chain [Moles/volume] in Serum or Plasma |
|
75109-9
|
Fatty acids.very long chain.C22:1n9 (Erucate) [Entitic substance] in Red Blood Cells |
|
54445-2
|
Fatty acids.very long chain.C22:1n9 (Erucate) [Mass/volume] in Serum or Plasma |
|
79701-9
|
Fatty acids.very long chain.C22:1n9 (Erucate) [Moles/volume] in Serum or Plasma |
|
41999-4
|
Lipoprotein.pre-beta [Presence] in Body fluid |
|
17084-5
|
Lipoprotein.pre-beta [Mass/volume] in Body fluid |
|
43728-5
|
Lipoprotein.pre-beta.subparticle.large [Moles/volume] in Serum or Plasma |
|
92721-0
|
Lipoprotein.pre-beta.subparticle.medium [Moles/volume] in Serum |
|
33414-4
|
Lipoprotein.pre-beta/total Lipoprotein in Pleural fluid |
|
15123-3
|
Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma |
|
27355-7
|
Lipoprotein.pre-beta [Presence] in Pleural fluid |
|
9621-4
|
Lipoprotein.pre-beta [Mass/volume] in Pleural fluid |
|
14816-3
|
Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis |
|
17847-5
|
Lipoprotein.pre-beta [Presence] in Serum or Plasma |
|
62254-8
|
Lipoprotein.pre-beta [Entitic length] in Serum or Plasma |
|
2575-9
|
Lipoprotein.pre-beta [Mass/volume] in Serum or Plasma |
|
92720-2
|
Lipoprotein.pre-beta.subparticle.small [Moles/volume] in Serum |
|
56777-6
|
Lipoprotein.pre-beta/Lipoprotein.beta [Mass Ratio] in Serum or Plasma |
|
44718-5
|
Lipoprotein.pre-beta/Triglyceride [Mass Ratio] in Serum or Plasma |
|
50192-4
|
Cholesterol in VLDL 1+2+3 [Mass/volume] in Serum or Plasma |
|
49624-0
|
Cholesterol in VLDL 1+2 [Mass/volume] in Serum or Plasma |
|
47218-3
|
Cholesterol in VLDL 3+4 [Mass/volume] in Serum or Plasma |
|
46986-6
|
Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma |
|
70203-5
|
Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma |
|
47219-1
|
Cholesterol in VLDL 5+6 [Mass/volume] in Serum or Plasma |
|
66499-5
|
Cholesterol in VLDL.beta [Mass/volume] in Serum or Plasma |
|
13458-5
|
Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation |
|
66126-4
|
Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation |
|
49133-2
|
Cholesterol in VLDL [Mass/volume] in Serum or Plasma by Electrophoresis |
|
48618-3
|
Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate |
|
2091-7
|
Cholesterol in VLDL [Mass/volume] in Serum or Plasma |
|
35199-9
|
Cholesterol in VLDL [Mass or Moles/volume] in Serum or Plasma |
|
25371-6
|
Cholesterol in VLDL [Moles/volume] in Serum or Plasma |
|
34695-7
|
Cholesterol in VLDL/Triglyceride [Ratio] in Serum or Plasma |
|
50948-9
|
Vanillylmandelate and Creatinine [Interpretation] in 24 hour Urine Narrative |
|
26706-2
|
Vanillylmandelate [Mass/volume] in 24 hour Urine |
|
3122-9
|
Vanillylmandelate [Mass/time] in 24 hour Urine |
|
26003-4
|
Vanillylmandelate [Moles/volume] in 24 hour Urine |
|
14947-6
|
Vanillylmandelate [Moles/time] in 24 hour Urine |
|
79400-8
|
Vanillylmandelate [Moles/volume] in Cerebral spinal fluid |
|
3121-1
|
Vanillylmandelate [Mass/volume] in Serum |
|
75064-6
|
Vanillylmandelate [Moles/volume] in Serum or Plasma |
|
9624-8
|
Vanillylmandelate [Mass/volume] in Urine |
|
15097-9
|
Vanillylmandelate [Moles/volume] in Urine |
|
66767-5
|
Vanillylmandelate/Body weight [Moles/kg/time] in 24 hour Urine |
|
30571-4
|
Vanillylmandelate/Creatinine [Mass Ratio] in 24 hour Urine |
|
26004-2
|
Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine |
|
3124-5
|
Vanillylmandelate/Creatinine [Mass Ratio] in Urine |
|
14948-4
|
Vanillylmandelate/Creatinine [Molar ratio] in Urine |
|
44418-2
|
Vanillylmandelate/Creatine [Mass Ratio] in 24 hour Urine |
|
56645-5
|
Vanillylmandelate/Creatine [Ratio] in 24 hour Urine |
|
3123-7
|
Vanillylmandelate/Creatine [Mass Ratio] in Urine |
|
20351-3
|
Maximum blood flow velocity by US.doppler |
|
33869-9
|
Maximum blood flow velocity Kidney artery/Aorta by US |
|
33868-1
|
Maximum blood flow velocity ICA at maximum stenosis/Maximum blood flow velocity unobstructed CCA by US |
|
15328-8
|
Penile cavernosal artery Peak systolic flow--baseline by US.doppler |
|
15329-6
|
Penile cavernosal artery Peak systolic flow--post XXX challenge by US.doppler |
|
34141-2
|
Maximum blood flow rate by US |
|
33878-0
|
Mean blood flow rate by US |
|
62849-5
|
Venlafaxine+Norvenlafaxine [Mass/volume] in Serum or Plasma |
|
48350-3
|
Venlafaxine+Norvenlafaxine [Moles/volume] in Serum or Plasma |
|
72678-6
|
Venlafaxine+Norvenlafaxine [Mass/volume] in Serum or Plasma --trough |
|
94122-9
|
Oxygen consumption (VO2)/Body weight [Volume Rate Content] --peak during exercise |
|
84313-6
|
Vocational rehabilitation Admission evaluation note |
|
84312-8
|
Vocational rehabilitation Consult note |
|
84311-0
|
Vocational rehabilitation Counseling note |
|
84309-4
|
Vocational rehabilitation Custodial care facility Note |
|
84310-2
|
Vocational rehabilitation Discharge summary |
|
85935-5
|
Vocational rehabilitation Education note |
|
84308-6
|
Vocational rehabilitation Initial evaluation note |
|
86213-6
|
Vocational rehabilitation Medical clearance note |
|
75502-5
|
Vocational rehabilitation Note |
|
84306-0
|
Vocational rehabilitation Plan of care note |
|
85936-3
|
Vocational rehabilitation Risk assessment and screening note |
|
80332-0
|
Voiding pattern |
|
80524-2
|
Voiding time by Uroflowmetry |
|
13004-7
|
Hydrocarbons.halogenated.volatile [Identifier] in Blood |
|
75959-7
|
Volume expired per minute Respiratory system |
|
75960-5
|
Inspired minute Volume |
|
4096-4
|
Volatile drugs negative [Identifier] in Urine by Screen method |
|
14951-8
|
Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
|
4097-2
|
Volatile drugs positive [Identifier] in Urine by Screen method |
|
41266-8
|
Volatiles and gases [Identifier] in Blood |
|
74133-0
|
Volatiles and gases [Presence] in Blood |
|
41214-8
|
Volatiles and gases [Identifier] in Gastric fluid by Screen method |
|
32044-0
|
Volatiles and gases [Identifier] in Serum or Plasma |
|
12983-3
|
Volatiles and gases [Identifier] in Urine |
|
40474-9
|
Volatiles and gases [Identifier] in Unspecified specimen |
|
15321-3
|
Urinary bladder Volume by derived by EMP (US) |
|
15309-8
|
Urinary bladder Volume by derived from height, width and length (US) |
|
15317-1
|
Kidney - left Volume by derived by automated ultrasound testing (US) |
|
15304-9
|
Kidney - left Volume by derived from height, width and length (US) |
|
15310-6
|
Kidney - left Volume by derived.from ROT (US) |
|
15318-9
|
Kidney - right Volume by derived by automated ultrasound testing (US) |
|
15305-6
|
Kidney - right Volume by derived from height, width and length (US) |
|
15311-4
|
Kidney - right Volume by derived.from ROT (US) |
|
15308-0
|
Prostate Volume by derived from height, width and length (US) |
|
15315-5
|
Prostate Volume by derived by planimetry (US) |
|
15314-8
|
Prostate Volume by derived.from ROT (US) |
|
15326-2
|
Prostate Adenoma Volume by derived from height, width and length (US) |
|
15327-0
|
Prostate Adenoma Volume by derived by planimetry (US) |
|
44759-9
|
Volume Peritoneal fluid Estimated |
|
15319-7
|
Testis - left Volume by derived by automated ultrasound testing (US) |
|
15306-4
|
Testis - left Volume by derived from height, width and length (US) |
|
15312-2
|
Testis - left Volume by derived.from ROT (US) |
|
15320-5
|
Testis - right Volume by derived by automated ultrasound testing (US) |
|
15307-2
|
Testis - right Volume by derived from height, width and length (US) |
|
15313-0
|
Testis - right Volume by derived.from ROT (US) |
|
91698-1
|
Volunteer age |
|
91889-6
|
Volunteer contact information panel |
|
91697-3
|
Volunteer Name |
|
91894-6
|
Volunteer Phone number |
|
81224-8
|
Vomiting [CCC] |
|
48595-3
|
von Willebrand evaluation [Interpretation] in Platelet poor plasma |
|
53902-3
|
Voriconazole [Mass/volume] in Cerebral spinal fluid |
|
80553-1
|
Voriconazole [Mass/volume] in DBS |
|
73081-2
|
Voriconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73080-4
|
Voriconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35862-2
|
Voriconazole [Susceptibility] by Gradient strip |
|
41200-7
|
Voriconazole [Susceptibility] by Disk diffusion (KB) |
|
35863-0
|
Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41199-1
|
Voriconazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
80651-3
|
Voriconazole N-oxide [Mass/volume] in Serum or Plasma |
|
38370-3
|
Voriconazole [Mass/volume] in Serum or Plasma |
|
32379-0
|
Voriconazole [Susceptibility] |
|
73676-9
|
Voriconazole [Mass/volume] in Serum or Plasma --trough |
|
90979-6
|
Vortioxetine [Mass/volume] in Serum or Plasma |
|
89986-4
|
Vortioxetine [Mass/volume] in Urine by Confirmatory method |
|
89987-2
|
Vortioxetine [Presence] in Urine by Screen method |
|
92734-3
|
Voxilaprevir [Susceptibility] by Genotype method |
|
48600-1
|
VPS13B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76274-0
|
Ventilation-perfusion index Respiratory system |
|
72014-4
|
VR-12 Bodily pain (BP) score - oblique method |
|
72022-7
|
VR-12 Bodily pain (BP) score - oblique method T-score |
|
72013-6
|
VR-12 General health (GH) score - oblique method |
|
72021-9
|
VR-12 General health (GH) score - oblique method T-score |
|
72026-8
|
VR-12 Mental component summary (MCS) score - oblique method T-score |
|
72028-4
|
VR-12 Mental component summary (MCS) score - orthogonal method T-score |
|
79443-8
|
VR-12 Mental component summary (MCS) score change - oblique method |
|
79444-6
|
VR-12 Mental component summary (MCS) score change - orthogonal method |
|
72009-4
|
VR-12 Mental health (MH) score - oblique method |
|
72017-7
|
VR-12 Mental health (MH) score - oblique method T-score |
|
72025-0
|
VR-12 Physical component summary (PCS) score - oblique method T-score |
|
72027-6
|
VR-12 Physical component summary (PCS) score - orthogonal method T-score |
|
79441-2
|
VR-12 Physical component summary (PCS) score change - oblique method |
|
79442-0
|
VR-12 Physical component summary (PCS) score change - orthogonal method |
|
72016-9
|
VR-12 Physical functioning (PF) score - oblique method |
|
72024-3
|
VR-12 Physical functioning (PF) score - oblique method T-score |
|
72010-2
|
VR-12 Role emotion (RE) score - oblique method |
|
72018-5
|
VR-12 Role emotion (RE) score - oblique method T-score |
|
72015-1
|
VR-12 Role physical (RP) score - oblique method |
|
72023-5
|
VR-12 Role physical (RP) score - oblique method T-score |
|
72011-0
|
VR-12 Social functioning (SF) score - oblique method |
|
72019-3
|
VR-12 Social functioning (SF) score - oblique method T-score |
|
72012-8
|
VR-12 Vitality (VT) score - oblique method |
|
72020-1
|
VR-12 Vitality (VT) score - oblique method T-score |
|
71978-1
|
VR-36 Bodily pain (BP) score - oblique method |
|
71986-4
|
VR-36 Bodily pain (BP) score - oblique method T-score |
|
71996-3
|
VR-36 Bodily pain (BP) score - orthogonal method |
|
72004-5
|
VR-36 Bodily pain (BP) score - orthogonal method T-score |
|
71977-3
|
VR-36 General health (GH) score - oblique method |
|
71985-6
|
VR-36 General health (GH) score - oblique method T-score |
|
71995-5
|
VR-36 General health (GH) score - orthogonal method |
|
72003-7
|
VR-36 General health (GH) score - orthogonal method T-score |
|
71990-6
|
VR-36 Mental component summary (MCS) score - oblique method T-score |
|
72008-6
|
VR-36 Mental component summary (MCS) score - orthogonal method T-score |
|
71973-2
|
VR-36 Mental health (MH) score - oblique method |
|
71981-5
|
VR-36 Mental health (MH) score - oblique method T-score |
|
71991-4
|
VR-36 Mental health (MH) score - orthogonal method |
|
71999-7
|
VR-36 Mental health (MH) score - orthogonal method T-score |
|
71989-8
|
VR-36 Physical component summary (PCS) score - oblique method T-score |
|
72007-8
|
VR-36 Physical component summary (PCS) score - orthogonal method T-score |
|
71980-7
|
VR-36 Physical functioning (PF) score - oblique method |
|
71988-0
|
VR-36 Physical functioning (PF) score - oblique method T-score |
|
71998-9
|
VR-36 Physical functioning (PF) score - orthogonal method |
|
72006-0
|
VR-36 Physical functioning (PF) score - orthogonal method T-score |
|
71974-0
|
VR-36 Role emotion (RE) score - oblique method |
|
71982-3
|
VR-36 Role emotion (RE) score - oblique method T-score |
|
71992-2
|
VR-36 Role emotion (RE) score - orthogonal method |
|
72000-3
|
VR-36 Role emotion (RE) score - orthogonal method T-score |
|
71979-9
|
VR-36 Role physical (RP) score - oblique method |
|
71987-2
|
VR-36 Role physical (RP) score - oblique method T-score |
|
71997-1
|
VR-36 Role physical (RP) score - orthogonal method |
|
72005-2
|
VR-36 Role physical (RP) score - orthogonal method T-score |
|
71975-7
|
VR-36 Social functioning (SF) score - oblique method |
|
71983-1
|
VR-36 Social functioning (SF) score - oblique method T-score |
|
71993-0
|
VR-36 Social functioning (SF) score - orthogonal method |
|
72001-1
|
VR-36 Social functioning (SF) score - orthogonal method T-score |
|
71976-5
|
VR-36 Vitality (VT) score - oblique method |
|
71984-9
|
VR-36 Vitality (VT) score - oblique method T-score |
|
71994-8
|
VR-36 Vitality (VT) score - orthogonal method |
|
72002-9
|
VR-36 Vitality (VT) score - orthogonal method T-score |
|
59150-3
|
Vancomycin resistant enterococcus [Presence] in Anal by Organism specific culture |
|
59152-9
|
Vancomycin resistant enterococcus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
59151-1
|
Vancomycin resistant enterococcus [Presence] in Urine by Organism specific culture |
|
13316-5
|
Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture |
|
78004-9
|
Staphylococcus aureus.vancomycin resistance [Susceptibility] Qualitative |
|
92516-4
|
VS Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92478-7
|
VS Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93913-2
|
VS Ag [Presence] on Red Blood Cells |
|
18005-9
|
Ventricular septal Defect diameter by US |
|
18008-3
|
Ventricular septal Defect.pressure gradient.systole.maximum by US.doppler |
|
18009-1
|
Ventricular septal Defect.pressure gradient.systole.mean by US.doppler |
|
29461-1
|
Ventricular septal Defect.velocity.systole.maximum by US.doppler |
|
78956-0
|
Ventricular septal Segmental wall motion by Cardiac angiogram |
|
47517-8
|
Vesicular stomatitis Alagoas virus Ab [Titer] in Serum |
|
45124-5
|
Vesicular stomatitis Alagoas virus Ab [Titer] in Serum by Neutralization test |
|
45125-2
|
Vesicular stomatitis Alagoas virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45126-0
|
Vesicular stomatitis Alagoas virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23561-4
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum |
|
23564-8
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Complement fixation |
|
23563-0
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Immunoassay |
|
23562-2
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Neutralization test |
|
31696-8
|
Vesicular stomatitis Indiana virus Ab [Units/volume] in Serum |
|
42945-6
|
Vesicular stomatitis Indiana virus Ab [Titer] in Serum |
|
23788-3
|
Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Complement fixation |
|
23789-1
|
Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Neutralization test |
|
45118-7
|
Vesicular stomatitis Indiana virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45120-3
|
Vesicular stomatitis Indiana virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
78531-1
|
Vesicular stomatitis Indiana virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
39023-7
|
Vesicular stomatitis Indiana virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23565-5
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum |
|
23568-9
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Complement fixation |
|
23566-3
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Immunoassay |
|
23567-1
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Neutralization test |
|
31697-6
|
Vesicular stomatitis New Jersey virus Ab [Units/volume] in Serum |
|
42944-9
|
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum |
|
23790-9
|
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Complement fixation |
|
23791-7
|
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Neutralization test |
|
45128-6
|
Vesicular stomatitis New Jersey virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45127-8
|
Vesicular stomatitis New Jersey virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
78530-3
|
Vesicular stomatitis New Jersey virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
39024-5
|
Vesicular stomatitis New Jersey virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23555-6
|
Vesicular stomatitis virus Ab [Presence] in Serum |
|
31985-5
|
Vesicular stomatitis virus Ag [Presence] in Skin |
|
23559-8
|
Vesicular stomatitis virus Ag [Presence] in Skin by Complement fixation |
|
23557-2
|
Vesicular stomatitis virus Ag [Presence] in Skin by Immunoassay |
|
31986-3
|
Vesicular stomatitis virus Ag [Presence] in Throat |
|
23560-6
|
Vesicular stomatitis virus Ag [Presence] in Throat by Complement fixation |
|
23558-0
|
Vesicular stomatitis virus Ag [Presence] in Throat by Immunoassay |
|
23570-5
|
Vesicular stomatitis virus serotype [Identifier] in Tissue by Complement fixation |
|
23571-3
|
Vesicular stomatitis virus serotype [Identifier] in Tissue by Immunoassay |
|
23569-7
|
Vesicular stomatitis virus serotype [Identifier] in Unspecified specimen by Complement fixation |
|
23572-1
|
Vesicular stomatitis virus serotype [Identifier] in Unspecified specimen by Immunoassay |
|
76222-9
|
Tidal volume Ventilator --on ventilator |
|
57655-3
|
Tidal volume.exhaled maximum setting Ventilator alarm |
|
75958-9
|
Tidal volume expired Respiratory system airway |
|
76007-4
|
Tidal volume expired Respiratory system airway --on ventilator |
|
76221-1
|
Tidal volume.inspired |
|
57654-6
|
Tidal volume.inspired maximum setting Ventilator alarm |
|
57653-8
|
Tidal volume.spontaneous minimum setting Ventilator alarm |
|
20358-8
|
Blood velocity-time integral 2 by US.doppler |
|
20372-9
|
Velocity-time integral 2 XXX by US.doppler |
|
20354-7
|
Blood velocity-time integral by US.doppler |
|
20370-3
|
Velocity-time integral.XXX by US.doppler |
|
20371-1
|
Velocity-time integral.XXX/Velocity-time integral 2 by US.doppler |
|
58084-5
|
Vw Ab [Presence] in Serum or Plasma |
|
58083-7
|
Vw Ag [Presence] on Red Blood Cells |
|
27816-8
|
von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay |
|
6012-9
|
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
41867-3
|
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma |
|
50377-1
|
von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay |
|
89366-9
|
von Willebrand factor collagen binding adhesion inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
50378-9
|
von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay |
|
93371-3
|
von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method |
|
53622-7
|
von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method |
|
34590-0
|
von Willebrand factor (vWf) cleaving protease inhibitor [Presence] in Platelet poor plasma |
|
40824-5
|
von Willebrand factor (vWf) cleaving protease inhibitor [Units/volume] in Platelet poor plasma |
|
34589-2
|
von Willebrand factor (vWf) cleaving protease [Presence] in Platelet poor plasma |
|
40970-6
|
VWF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41768-3
|
VWF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
24376-6
|
von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoassay |
|
6013-7
|
von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot |
|
32217-2
|
von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma |
|
41210-6
|
VWF gene p.Arg816Trp [Presence] in Blood or Tissue by Molecular genetics method |
|
41209-8
|
VWF gene.p.Arg854Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
41268-4
|
VWF gene.p.Thr791Met [Presence] in Blood by Molecular genetics method |
|
89367-7
|
von Willebrand factor.ristocetin cofactor inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
74808-7
|
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay --immediately after 1:1 addition of normal plasma |
|
74809-5
|
von Willebrand factor (vWf).activity actual/normal in Control Platelet poor plasma by Immunoassay |
|
68324-3
|
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay |
|
73978-9
|
von Willebrand factor (vWf).activity [Units/volume] in Platelet poor plasma by Immunoassay |
|
6014-5
|
von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation |
|
4680-5
|
von Willebrand factor (vWf) ristocetin cofactor [Units/volume] in Platelet poor plasma |
|
81643-9
|
von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma |
|
80632-3
|
2-Methylpropyl methylphosphonate [Mass/volume] in Blood |
|
54101-1
|
2-Methylpropyl methylphosphonate [Mass/volume] in Urine |
|
51875-3
|
Varicella zoster virus immune globulin units given [#] |
|
10428-1
|
Varicella zoster virus immune globulin given [Volume] |
|
9636-2
|
Varicella zoster virus Ab [Presence] in Cerebral spinal fluid |
|
31694-3
|
Varicella zoster virus Ab [Units/volume] in Cerebral spinal fluid |
|
52978-4
|
Varicella zoster virus Ab [Units/volume] in Serum by Complement fixation |
|
47419-7
|
Varicella zoster virus Ab [Units/volume] in Serum by Immunoassay |
|
22600-1
|
Varicella zoster virus Ab [Presence] in Serum |
|
43978-6
|
Varicella zoster virus Ab [Presence] in Serum by Immunoassay |
|
12271-3
|
Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
|
8046-5
|
Varicella zoster virus Ab [Units/volume] in Serum |
|
21592-1
|
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid |
|
33327-8
|
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
26723-7
|
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
21594-7
|
Varicella zoster virus Ab [Titer] in Serum |
|
5401-5
|
Varicella zoster virus Ab [Titer] in Serum by Complement fixation |
|
44771-4
|
Varicella zoster virus Ab [Titer] in Serum by Immunofluorescence |
|
5402-3
|
Varicella zoster virus Ab [Titer] in Serum by Latex agglutination |
|
93786-2
|
Varicella zoster virus Ab.IgM+total [Presence] in Cerebral spinal fluid |
|
89589-6
|
Varicella zoster virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
67812-8
|
Varicella zoster virus Ag [Presence] in Isolate by Immunofluorescence |
|
91774-0
|
Varicella zoster virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
31981-4
|
Varicella zoster virus Ag [Presence] in Skin |
|
5881-8
|
Varicella zoster virus Ag [Presence] in Skin by Immunofluorescence |
|
86592-3
|
Varicella zoster virus Ag [Presence] in Tissue by Immunofluorescence |
|
31982-2
|
Varicella zoster virus Ag [Presence] in Unspecified specimen |
|
5882-6
|
Varicella zoster virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
86509-7
|
Varicella zoster virus clade [Type] in Unspecified specimen by Molecular genetics method |
|
88135-9
|
Varicella zoster virus [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
49454-2
|
Varicella zoster virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49455-9
|
Varicella zoster virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
92848-1
|
Varicella zoster virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
47002-1
|
Varicella zoster virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49453-4
|
Varicella zoster virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
47003-9
|
Varicella zoster virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49450-0
|
Varicella zoster virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49452-6
|
Varicella zoster virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49451-8
|
Varicella zoster virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86593-1
|
Varicella zoster virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
88536-8
|
Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection |
|
29248-2
|
Varicella zoster virus DNA [Presence] in Blood by NAA with probe detection |
|
88132-6
|
Varicella zoster virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82188-4
|
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
21598-8
|
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
35399-5
|
Varicella zoster virus DNA [Presence] in Eye by NAA with probe detection |
|
87961-9
|
Varicella zoster virus DNA [Presence] in Body fluid by NAA with probe detection |
|
88565-7
|
Varicella zoster virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88134-2
|
Varicella zoster virus DNA [Presence] in Ocular fluid by NAA with probe detection |
|
8049-9
|
Varicella zoster virus DNA [Presence] in Serum by NAA with probe detection |
|
92888-7
|
Varicella zoster virus DNA [Presence] in Skin by NAA with probe detection |
|
35400-1
|
Varicella zoster virus DNA [Presence] in Tissue by NAA with probe detection |
|
91791-4
|
Varicella zoster virus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
11483-5
|
Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
30943-5
|
Varicella zoster virus dose count in combination vaccine |
|
58755-0
|
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
17765-9
|
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
42537-1
|
Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid |
|
17764-2
|
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
53534-4
|
Varicella zoster virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29249-0
|
Varicella zoster virus IgG Ab [Units/volume] in Body fluid |
|
5403-1
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
17763-4
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
19162-7
|
Varicella zoster virus IgG Ab [Presence] in Serum |
|
15410-4
|
Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
|
41512-5
|
Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
8047-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum |
|
14306-5
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
22603-5
|
Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen |
|
14307-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22604-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
22601-9
|
Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21595-4
|
Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22602-7
|
Varicella zoster virus IgG Ab [Titer] in Serum |
|
6569-8
|
Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
69930-6
|
Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
31695-0
|
Varicella zoster virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
74414-4
|
Varicella zoster virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
53535-1
|
Varicella zoster virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
5404-9
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
17766-7
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
21597-0
|
Varicella zoster virus IgM Ab [Presence] in Serum |
|
29662-4
|
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay |
|
43588-3
|
Varicella zoster virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
8048-1
|
Varicella zoster virus IgM Ab [Units/volume] in Serum |
|
57322-0
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57323-8
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22605-0
|
Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21596-2
|
Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22606-8
|
Varicella zoster virus IgM Ab [Titer] in Serum |
|
6570-6
|
Varicella zoster virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
91784-9
|
Varicella zoster virus [Presence] in Lower respiratory specimen by Organism specific culture |
|
88136-7
|
Varicella zoster virus [Presence] in Ocular fluid by Organism specific culture |
|
73656-1
|
Varicella zoster virus ORF28 genotype [Identifier] |
|
73657-9
|
Varicella zoster virus ORF36 genotype [Identifier] |
|
10734-2
|
Varicella zoster virus identified in Skin by Electron microscopy |
|
43693-1
|
Varicella zoster virus identified in Skin by Shell vial culture |
|
86502-2
|
Varicella zoster virus strain DNA [Type] in Unspecified specimen by NAA with probe detection |
|
82746-9
|
Varicella zoster virus strain [Type] in Isolate |
|
10860-5
|
Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture |
|
22617-5
|
Wuchereria bancrofti Ab [Presence] in Serum |
|
6633-2
|
Wuchereria bancrofti Ab [Presence] in Serum by Immunoassay |
|
11582-4
|
Wuchereria bancrofti Ab [Units/volume] in Serum |
|
59850-8
|
Wuchereria bancrofti Ag [Units/volume] in Serum by Immunoassay |
|
25555-4
|
Wuchereria bancrofti Ag [Presence] in Serum |
|
41463-1
|
Wuchereria bancrofti+Brugia malayi Ag [Presence] in Serum by Immunoassay |
|
88182-1
|
Wuchereria bancrofti+Brugia malayi IgG1 Ab [Presence] in Serum by Immunoassay |
|
88181-3
|
Wuchereria bancrofti+Brugia malayi IgG2 Ab [Presence] in Serum by Immunoassay |
|
88180-5
|
Wuchereria bancrofti+Brugia malayi IgG3 Ab [Presence] in Serum by Immunoassay |
|
88179-7
|
Wuchereria bancrofti+Brugia malayi IgG4 Ab [Presence] in Serum by Immunoassay |
|
93453-9
|
W-15 [Mass/volume] in Urine by Confirmatory method |
|
93454-7
|
W-18 [Mass/volume] in Urine by Confirmatory method |
|
93452-1
|
W-19 [Mass/volume] in Urine by Confirmatory method |
|
35178-3
|
Omega 3 fatty acids (w3) [Moles/volume] in Serum or Plasma |
|
35179-1
|
Omega 6 fatty acids (w6) [Moles/volume] in Serum or Plasma |
|
90910-1
|
Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Mass Ratio] in Blood |
|
48382-6
|
Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Molar ratio] in Serum or Plasma |
|
10819-1
|
Microscopic observation [Identifier] in Tissue by Wade stain |
|
89386-7
|
Walk 10 feet - functional ability [CMS Assessment] |
|
83204-8
|
Walk 10 feet - functional ability during 3 day assessment period [CMS Assessment] |
|
89385-9
|
Walk 10 feet - functional goal [CMS Assessment] |
|
83203-0
|
Walk 10 feet - functional goal during 3 day assessment period [CMS Assessment] |
|
89384-2
|
Walk 150 feet - functional ability [CMS Assessment] |
|
83200-6
|
Walk 150 feet - functional ability during 3 day assessment period [CMS Assessment] |
|
89383-4
|
Walk 150 feet - functional goal [CMS Assessment] |
|
83199-0
|
Walk 150 feet - functional goal during 3 day assessment period [CMS Assessment] |
|
89382-6
|
Walk 50 feet with two turns - functional ability [CMS Assessment] |
|
83202-2
|
Walk 50 feet with two turns - functional ability during 3 day assessment period [CMS Assessment] |
|
89381-8
|
Walk 50 feet with two turns - functional goal [CMS Assessment] |
|
83201-4
|
Walk 50 feet with two turns - functional goal during 3 day assessment period [CMS Assessment] |
|
83167-7
|
Walk distance score 2 minutes [NIH Toolbox] |
|
45594-9
|
Walk in corridor - self-performance during 7 day assessment period [CMS Assessment] |
|
45595-6
|
Walk in corridor - support provided during 7 day assessment period [CMS Assessment] |
|
45592-3
|
Walk in room - self-performance during 7 day assessment period [CMS Assessment] |
|
45593-1
|
Walk in room - support provided during 7 day assessment period [CMS Assessment] |
|
54750-5
|
Walking (with assistive device if used) in last 7 days [CMS Assessment] |
|
82948-1
|
Walking [ALSFRS-R] |
|
86474-4
|
Walking 1 block on level ground was limited by heart failure over the past 2 weeks [KCCQ] |
|
89380-0
|
Walking 10 feet on uneven surfaces - functional ability [CMS Assessment] |
|
83198-2
|
Walking 10 feet on uneven surfaces - functional ability during 3 day assessment period [CMS Assessment] |
|
89379-2
|
Walking 10 feet on uneven surfaces - functional goal [CMS Assessment] |
|
83197-4
|
Walking 10 feet on uneven surfaces - functional goal during 3 day assessment period [CMS Assessment] |
|
77699-7
|
Walking freeze scale [UPDRS] |
|
88480-9
|
Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4 weeks [SAQ] |
|
77591-6
|
Walking physical activity [IPAQ] |
|
88424-7
|
Walking physical activity.active transportation domain [IPAQ] |
|
88430-4
|
Walking physical activity.leisure-time domain [IPAQ] |
|
88421-3
|
Walking physical activity.work domain [IPAQ] |
|
77700-3
|
Walking scale [UPDRS] |
|
7761-0
|
Walleye Pike IgE Ab [Units/volume] in Serum |
|
21460-1
|
Walleye Pike IgE Ab RAST class [Presence] in Serum |
|
7762-8
|
Walnut triggered histamine release [Units/volume] in Blood |
|
6273-7
|
Walnut IgE Ab [Units/volume] in Serum |
|
16074-7
|
Walnut IgE Ab RAST class [Presence] in Serum |
|
41198-3
|
Walnut IgE Ab/IgE total in Serum |
|
7767-7
|
Walnut IgG Ab [Units/volume] in Serum |
|
56414-6
|
Walnut IgG4 Ab [Mass/volume] in Serum |
|
63120-0
|
Walnut IgG Ab [Mass/volume] in Serum |
|
88314-0
|
Wander/elopement alarm used during 7 day assessment period [CMS Assessment] |
|
54693-7
|
Wandering - presence and frequency in last 7 days [CMS Assessment] |
|
54694-5
|
Wandering places resident at significant risk of getting to a potentially dangerous place in last 7 days [CMS Assessment] |
|
54695-2
|
Wandering significantly intrudes on the privacy or activities of others in last 7 days [CMS Assessment] |
|
58149-6
|
Wants to talk to someone about the possibility of returning to the community [CMS Assessment] |
|
72930-1
|
Warfarin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72929-3
|
Warfarin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4461-0
|
Warfarin [Mass] of Dose |
|
29383-7
|
Warfarin [Mass/volume] in Gastric fluid |
|
59980-3
|
Warfarin [Moles/volume] in Gastric fluid |
|
73078-8
|
Warfarin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73079-6
|
Warfarin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41184-3
|
Warfarin [Presence] in Serum or Plasma |
|
4098-0
|
Warfarin [Mass/volume] in Serum or Plasma |
|
39798-4
|
Warfarin [Moles/volume] in Serum or Plasma |
|
12282-0
|
Warfarin [Presence] in Urine |
|
29382-9
|
Warfarin [Mass/volume] in Urine |
|
59979-5
|
Warfarin [Moles/volume] in Urine |
|
74107-4
|
Warfarin [Presence] in Unspecified specimen by Screen method |
|
87605-2
|
Warfarin [Mass/mass] in Unspecified specimen |
|
60338-1
|
Warfarin [Moles/volume] in Unspecified specimen |
|
44779-7
|
Warm ischemic time {Organ} |
|
88672-1
|
Warming method |
|
71458-4
|
Was erythropoiesis-stimulating agent prescribed [ESRD] |
|
57759-3
|
WAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57755-1
|
WAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
85651-8
|
Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during 3 day assessment period [CAM.CMS] |
|
71087-1
|
Was the treatment staff thorough in examining and treating you [FACIT] |
|
85652-6
|
Wash upper body - functional ability during 3 day assessment period [CMS Assessment] |
|
85653-4
|
Wash upper body - functional goal during 3 day assessment period [CMS Assessment] |
|
51869-6
|
Washed packed erythrocytes given [Volume] |
|
82651-1
|
Washout rate [Ratio] Myocardium SPECT |
|
13176-3
|
Wasp venom IgE Ab [Units/volume] in Serum |
|
33922-6
|
Wasp venom IgE Ab RAST class [Presence] in Serum |
|
13178-9
|
Wasp venom IgG Ab [Units/volume] in Serum |
|
26432-5
|
Wasp venom IgG4 Ab [Units/volume] in Serum or Plasma |
|
26433-3
|
Wasp venom IgG4 Ab RAST class [Presence] in Serum |
|
77285-5
|
Wastage rate [NMMDS] |
|
91762-5
|
Watch record details Narrative |
|
92186-6
|
Watch team report Document |
|
7769-3
|
Water Chestnut IgE Ab [Units/volume] in Serum |
|
23938-4
|
Water Chestnut IgE Ab RAST class [Presence] in Serum |
|
7400-5
|
Water Hemp IgE Ab [Units/volume] in Serum |
|
15771-9
|
Water Hemp IgE Ab RAST class [Presence] in Serum |
|
59016-6
|
Water [Mass/mass] in Stool by Infrared spectroscopy |
|
7770-1
|
Watermelon IgE Ab [Units/volume] in Serum |
|
16083-8
|
Watermelon IgE Ab RAST class [Presence] in Serum |
|
57940-9
|
Watermelon IgE Ab/IgE total in Serum |
|
7771-9
|
Watermelon IgG Ab [Units/volume] in Serum |
|
21601-0
|
Watermelon IgG Ab RAST class [Presence] in Serum |
|
56415-3
|
Watermelon IgG4 Ab [Mass/volume] in Serum |
|
41205-6
|
Watermelon IgG Ab [Mass/volume] in Serum |
|
6015-2
|
Wattle IgE Ab [Units/volume] in Serum |
|
15519-2
|
Wattle IgE Ab RAST class [Presence] in Serum |
|
56458-3
|
Wattle IgG4 Ab [Mass/volume] in Serum |
|
7140-7
|
Wax Bean IgE Ab [Units/volume] in Serum |
|
41868-1
|
Waxy casts [#/volume] in Urine by Computer assisted method |
|
41187-6
|
Waxy casts [#/volume] in Urine sediment |
|
33230-4
|
Waxy casts [#/area] in Urine by Computer assisted method |
|
88968-3
|
Waxy casts [#/area] in Urine sediment |
|
41223-9
|
Waxy casts [#/area] in Urine sediment by Microscopy high power field |
|
5819-8
|
Waxy casts [#/area] in Urine sediment by Microscopy low power field |
|
41190-0
|
Waxy casts [Presence] in Urine by Computer assisted method |
|
33862-4
|
Waxy casts [Presence] in Urine sediment by Light microscopy |
|
44098-2
|
Microscopic observation [Identifier] in Unspecified specimen by Wayson stain |
|
26464-8
|
Leukocytes [#/volume] in Blood |
|
6690-2
|
Leukocytes [#/volume] in Blood by Automated count |
|
33028-2
|
Leukocytes [#/volume] in Blood from Blood product unit |
|
49498-9
|
Leukocytes [#/volume] in Blood by Estimate |
|
62239-9
|
Leukocytes [#/volume] in Blood from Fetus by Automated count |
|
804-5
|
Leukocytes [#/volume] in Blood by Manual count |
|
47281-1
|
Leukocytes [#/volume] in Cord blood |
|
30401-4
|
Leukocytes [#/volume] in Bronchial specimen |
|
14810-6
|
Leukocytes [#/volume] in Bronchial specimen by Manual count |
|
92635-2
|
Leukocytes [#/volume] in Buffy Coat |
|
26465-5
|
Leukocytes [#/volume] in Cerebral spinal fluid |
|
805-2
|
Leukocytes [#/volume] in Cerebral spinal fluid by Automated count |
|
806-0
|
Leukocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
49928-5
|
Leukocytes [#/volume] in Peritoneal dialysis fluid |
|
40533-2
|
Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count |
|
53518-7
|
Leukocytes [#/volume] in Dialysis fluid |
|
68368-0
|
Leukocytes [#/volume] in Dialysis fluid by Automated count |
|
57847-6
|
Leukocytes [#/volume] in Dialysis fluid by Manual count |
|
26466-3
|
Leukocytes [#/volume] in Body fluid |
|
57845-0
|
Leukocytes [#/volume] in Body fluid by Automated count |
|
6743-9
|
Leukocytes [#/volume] in Body fluid by Manual count |
|
30402-2
|
Leukocytes [#/volume] in Gastric fluid |
|
14373-5
|
Leukocytes [#/volume] in Gastric fluid by Manual count |
|
82587-7
|
Leukocytes [#/volume] in Bone marrow by Automated count |
|
30403-0
|
Leukocytes [#/volume] in Pericardial fluid |
|
57846-8
|
Leukocytes [#/volume] in Pericardial fluid by Automated count |
|
14811-4
|
Leukocytes [#/volume] in Pericardial fluid by Manual count |
|
33765-9
|
Leukocytes [#/volume] in Blood Product unit.platelet pheresis by Automated count |
|
26467-1
|
Leukocytes [#/volume] in Pleural fluid |
|
807-8
|
Leukocytes [#/volume] in Pleural fluid by Automated count |
|
62251-4
|
Leukocytes [#/volume] in Pleural fluid from Fetus by Automated count |
|
808-6
|
Leukocytes [#/volume] in Pleural fluid by Manual count |
|
72348-6
|
Leukocytes [#/volume] in Prostatic fluid by Manual count |
|
26468-9
|
Leukocytes [#/volume] in Peritoneal fluid |
|
809-4
|
Leukocytes [#/volume] in Peritoneal fluid by Automated count |
|
810-2
|
Leukocytes [#/volume] in Peritoneal fluid by Manual count |
|
10579-1
|
Leukocytes [#/volume] in Semen |
|
811-0
|
Leukocytes [#/volume] in Semen by Automated count |
|
812-8
|
Leukocytes [#/volume] in Semen by Manual count |
|
26469-7
|
Leukocytes [#/volume] in Synovial fluid |
|
813-6
|
Leukocytes [#/volume] in Synovial fluid by Automated count |
|
814-4
|
Leukocytes [#/volume] in Synovial fluid by Manual count |
|
30404-8
|
Leukocytes [#/volume] in Stool |
|
13349-6
|
Leukocytes [#/volume] in Stool by Manual count |
|
30405-5
|
Leukocytes [#/volume] in Urine |
|
51487-7
|
Leukocytes [#/volume] in Urine by Automated count |
|
24122-4
|
Leukocytes [#/volume] in Urine by Manual count |
|
20408-1
|
Leukocytes [#/volume] in Urine by Test strip |
|
58805-3
|
Leukocytes [#/volume] in Urine by Automated test strip |
|
68434-0
|
Leukocytes [#/volume] in Vitreous fluid by Automated count |
|
20584-9
|
Leukocytes [#/volume] in Unspecified specimen by Automated count |
|
53227-5
|
Leukocytes [#/area] in Cervix by Wet preparation |
|
12224-2
|
Leukocytes [#/area] in Nose by Microscopy high power field |
|
49224-9
|
Leukocytes [#/area] in Semen by Microscopy high power field |
|
12225-9
|
Leukocytes [#/area] in Sputum by Microscopy high power field |
|
51770-6
|
Leukocytes [#/area] in Stool by Microscopy high power field |
|
46702-7
|
Leukocytes [#/area] in Urine sediment by Automated count |
|
5821-4
|
Leukocytes [#/area] in Urine sediment by Microscopy high power field |
|
45383-7
|
Leukocytes [#/area] in Urine sediment by Microscopy low power field |
|
53226-7
|
Leukocytes [#/area] in Urethra by Wet preparation |
|
44092-5
|
Leukocytes [#/area] in Vaginal fluid by Wet preparation |
|
53225-9
|
Leukocytes [#/area] in Unspecified specimen by Wet preparation |
|
63555-7
|
Leukocytes [#/volume] by Microscopy high power field in Urine sediment collected for unspecified duration |
|
60433-0
|
Leukocytes by Light microscopy in Urine sediment collected for unspecified duration |
|
18407-7
|
Leukocytes in 12 hour Urine sediment by Light microscopy |
|
63554-0
|
Leukocytes in 24 hour Urine sediment by Microscopy |
|
59829-2
|
Leukocytes in 3 hour Urine sediment by Light microscopy |
|
34469-7
|
Leukocytes [Presence] in Bile fluid by Light microscopy |
|
53286-1
|
WBC casts [#/volume] in Urine by Computer assisted method |
|
33228-8
|
WBC casts [#/area] in Urine by Computer assisted method |
|
88976-6
|
WBC casts [#/area] in Urine sediment |
|
49103-5
|
WBC casts [#/area] in Urine sediment by Microscopy high power field |
|
5820-6
|
WBC casts [#/area] in Urine sediment by Microscopy low power field |
|
53279-6
|
WBC casts [Presence] in Urine by Computer assisted method |
|
33825-1
|
WBC casts [Presence] in Urine sediment by Light microscopy |
|
33768-3
|
Leukocyte clumps [#/volume] in Urine by Automated count |
|
50233-6
|
Leukocyte clumps [#/area] in Urine sediment by Automated count |
|
46420-6
|
Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field |
|
53317-4
|
Leukocyte clumps [Presence] in Urine by Automated |
|
67848-2
|
Leukocyte clumps [Presence] in Urine sediment by Light microscopy |
|
88114-4
|
Leukocytes [Presence] in Cerebral spinal fluid by Gram stain |
|
88343-9
|
Leukocytes [Presence] in Ear by Light microscopy |
|
32782-5
|
Leukocyte esterase+Nitrite [Presence] in Urine by Test strip |
|
34445-7
|
Leukocytes [Presence] in Body fluid |
|
30411-3
|
Leukocytes Left Shift [Presence] in Blood |
|
17790-7
|
Leukocytes Left Shift [Presence] in Blood by Automated count |
|
11157-5
|
Leukocytes [Morphology] in Bone marrow |
|
11156-7
|
Leukocyte morphology finding [Identifier] in Blood |
|
61179-8
|
Leukocyte morphology finding [Identifier] in Blood from Fetus |
|
14105-1
|
Leukocytes [Presence] in Nose by Light microscopy |
|
12227-5
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood |
|
33256-9
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count |
|
61182-2
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood from Fetus |
|
66768-3
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Cord blood |
|
48034-3
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Cerebral spinal fluid |
|
48052-5
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Body fluid |
|
55784-3
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Bone marrow |
|
70126-8
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Pleural fluid |
|
30406-3
|
Leukocytes other [#/volume] in Blood |
|
51383-8
|
Leukocytes other [#/volume] in Blood by Automated count |
|
66145-4
|
Leukocytes other [#/volume] in Blood from Fetus by Manual count |
|
729-4
|
Leukocytes other [#/volume] in Blood by Manual count |
|
26470-5
|
Leukocytes other [#/volume] in Cerebral spinal fluid |
|
13351-2
|
Leukocytes other [#/volume] in Cerebral spinal fluid by Manual count |
|
35051-2
|
Leukocytes other [#/volume] in Body fluid |
|
67830-0
|
Leukocytes other [#/volume] in Pericardial fluid |
|
68428-2
|
Leukocytes other [#/volume] in Pericardial fluid by Manual count |
|
35052-0
|
Leukocytes other [#/volume] in Pleural fluid |
|
67836-7
|
Leukocytes other [#/volume] in Pleural fluid from Fetus |
|
68430-8
|
Leukocytes other [#/volume] in Pleural fluid by Manual count |
|
35054-6
|
Leukocytes other [#/volume] in Peritoneal fluid |
|
68429-0
|
Leukocytes other [#/volume] in Peritoneal fluid by Manual count |
|
35053-8
|
Leukocytes other [#/volume] in Synovial fluid |
|
68431-6
|
Leukocytes other [#/volume] in Synovial fluid by Manual count |
|
68433-2
|
Leukocytes other [#/volume] in Vitreous fluid by Manual count |
|
15190-2
|
Leukocytes other [Identifier] in Blood by Automated count |
|
71601-9
|
Leukocytes other/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count |
|
71611-8
|
Leukocytes other/Leukocytes [Pure number fraction] in Pleural fluid by Manual count |
|
71630-8
|
Leukocytes other/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count |
|
71620-9
|
Leukocytes other/Leukocytes [Pure number fraction] in Synovial fluid by Manual count |
|
26471-3
|
Leukocytes other/100 leukocytes in Blood |
|
40646-2
|
Leukocytes other/100 leukocytes in Blood by Automated count |
|
730-2
|
Leukocytes other/100 leukocytes in Blood by Manual count |
|
32808-8
|
Leukocytes other/100 leukocytes in Bronchial specimen |
|
40543-1
|
Leukocytes other/100 leukocytes in Bronchial specimen by Manual count |
|
26472-1
|
Leukocytes other/100 leukocytes in Cerebral spinal fluid |
|
13523-6
|
Leukocytes other/100 leukocytes in Cerebral spinal fluid by Manual count |
|
40535-7
|
Leukocytes other/100 leukocytes in Peritoneal dialysis fluid by Manual count |
|
26473-9
|
Leukocytes other/100 leukocytes in Body fluid |
|
13524-4
|
Leukocytes other/100 leukocytes in Body fluid by Manual count |
|
30407-1
|
Leukocytes other/100 leukocytes in Pericardial fluid |
|
14857-7
|
Leukocytes other/100 leukocytes in Pericardial fluid by Manual count |
|
30408-9
|
Leukocytes other/100 leukocytes in Pleural fluid |
|
14858-5
|
Leukocytes other/100 leukocytes in Pleural fluid by Manual count |
|
30409-7
|
Leukocytes other/100 leukocytes in Peritoneal fluid |
|
14859-3
|
Leukocytes other/100 leukocytes in Peritoneal fluid by Manual count |
|
30410-5
|
Leukocytes other/100 leukocytes in Synovial fluid |
|
14860-1
|
Leukocytes other/100 leukocytes in Synovial fluid by Manual count |
|
68432-4
|
Leukocytes other/100 leukocytes in Vitreous fluid by Manual count |
|
32825-2
|
Leukocytes [Presence] in Semen |
|
32142-2
|
Leukocytes [Presence] in Synovial fluid by Light microscopy |
|
48973-2
|
Leukocytes [Presence] in Stool by Methylene blue stain --2nd specimen |
|
14328-9
|
Leukocytes [Presence] in Sputum by Light microscopy |
|
42327-7
|
Leukocytes [Presence] in Stool by Methylene blue stain |
|
13655-6
|
Leukocytes [Presence] in Stool by Light microscopy |
|
50672-5
|
Leukocyte toxic vacuoles [Presence] in Blood by Light microscopy |
|
76674-1
|
Leukocytes [#/volume] in Cerebral spinal fluid --1st tube |
|
46088-1
|
Leukocytes [#/volume] in Cerebral spinal fluid --2nd tube |
|
46089-9
|
Leukocytes [#/volume] in Cerebral spinal fluid --3rd tube |
|
46090-7
|
Leukocytes [#/volume] in Cerebral spinal fluid --4th tube |
|
33052-2
|
Leukocytes [Presence] in Urine |
|
53316-6
|
Leukocytes [Presence] in Urine by Automated |
|
53964-3
|
Leukocytes [Presence] in Urine by Visual |
|
20455-2
|
Leukocytes [Presence] in Urine sediment by Light microscopy |
|
12226-7
|
Leukocytes [Presence] in Vaginal fluid by Wet preparation |
|
72163-9
|
Leukocytes [Presence] in Unspecified specimen by Gram stain |
|
32761-9
|
Leukocytes [Presence] in Unspecified specimen by Wet preparation |
|
52999-0
|
Leukocytes.disintegrated [#/volume] in Blood |
|
68378-9
|
Leukocytes.disintegrated/100 leukocytes in Blood |
|
55599-5
|
Leukocytes.disintegrated/100 leukocytes in Cerebral spinal fluid by Manual count |
|
55598-7
|
Leukocytes.disintegrated/100 leukocytes in Body fluid by Manual count |
|
48705-8
|
Leukocytes+Platelets [Morphology] in Blood |
|
92943-0
|
Severe weather event [Type] |
|
71508-6
|
Website Dialysis facility [ESRD] |
|
15271-0
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk |
|
24480-6
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Units/volume] in Serum by Multidisk |
|
24481-4
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
61202-8
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab/IgE total in Serum by Multidisk |
|
15272-8
|
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk |
|
24493-9
|
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
|
24494-7
|
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15261-1
|
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk |
|
73710-6
|
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Units/volume] in Serum by Multidisk |
|
82039-9
|
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15273-6
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk |
|
82041-5
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Units/volume] in Serum by Multidisk |
|
82040-7
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
46709-2
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Mass/volume] in Serum by Multidisk |
|
15274-4
|
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
|
63197-8
|
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk |
|
82042-3
|
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15275-1
|
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk |
|
63198-6
|
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Units/volume] in Serum by Multidisk |
|
82043-1
|
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
15276-9
|
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
|
82045-6
|
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk |
|
82044-9
|
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab RAST class [Presence] in Serum by Multidisk |
|
7309-8
|
Weeping Fig IgE Ab [Units/volume] in Serum |
|
22610-0
|
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
20986-6
|
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
20984-1
|
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31705-7
|
Western equine encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
|
22611-8
|
Western equine encephalitis virus Ab [Presence] in Serum |
|
23583-8
|
Western equine encephalitis virus Ab [Presence] in Serum by Agglutination |
|
20985-8
|
Western equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
|
23586-1
|
Western equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
20983-3
|
Western equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
|
23585-3
|
Western equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
|
5406-4
|
Western equine encephalitis virus Ab [Units/volume] in Serum |
|
24285-9
|
Western equine encephalitis virus Ab [Titer] in Serum --1st specimen |
|
24211-5
|
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24286-7
|
Western equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
|
24212-3
|
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
17769-1
|
Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
9314-6
|
Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
41175-1
|
Western equine encephalitis virus Ab [Titer] in Body fluid |
|
17770-9
|
Western equine encephalitis virus Ab [Titer] in Serum |
|
41183-5
|
Western equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23584-6
|
Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
9581-0
|
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
|
20982-5
|
Western equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
23792-5
|
Western equine encephalitis virus Ab [Presence] in Unspecified specimen |
|
31987-1
|
Western equine encephalitis virus Ag [Presence] in Serum |
|
6585-4
|
Western equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
|
6586-2
|
Western equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
|
31988-9
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen |
|
23591-1
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23590-3
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23589-5
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
41260-1
|
Western equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid |
|
31706-5
|
Western equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
41244-5
|
Western equine encephalitis virus IgG Ab [Presence] in Serum |
|
8052-3
|
Western equine encephalitis virus IgG Ab [Units/volume] in Serum |
|
22613-4
|
Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
9315-3
|
Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22614-2
|
Western equine encephalitis virus IgG Ab [Titer] in Serum |
|
6957-5
|
Western equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
49066-4
|
Western equine encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid |
|
49082-1
|
Western equine encephalitis virus IgG and IgM [Interpretation] in Serum |
|
41259-3
|
Western equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
34956-3
|
Western equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
23587-9
|
Western equine encephalitis virus IgM Ab [Presence] in Serum |
|
23588-7
|
Western equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
8053-1
|
Western equine encephalitis virus IgM Ab [Units/volume] in Serum |
|
22615-9
|
Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
9316-1
|
Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22616-7
|
Western equine encephalitis virus IgM Ab [Titer] in Serum |
|
6958-3
|
Western equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
26690-8
|
Western equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
|
54036-9
|
Western equine encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41907-7
|
Weighing device Vendor model code |
|
41908-5
|
Weighing device Vendor software version |
|
41906-9
|
Weighing device Vendor name |
|
29463-7
|
Body weight |
|
74006-8
|
Weight difference [Mass difference] --pre dialysis - post dialysis |
|
71442-8
|
Weight gain [MDSv3] |
|
86678-0
|
Weight gain of 5% or more in the last month or gain of 10% or more in last 6 months [CMS Assessment] |
|
54863-6
|
Weight loss of 5% or more in the last month or loss of 10% or more in last 6 months [CMS Assessment] |
|
76543-8
|
Weight management summary report |
|
3141-9
|
Body weight Measured |
|
79348-9
|
Body weight --used for drug calculation |
|
75292-3
|
Body weight - Reported --usual |
|
58229-6
|
Body weight Measured --when specimen taken |
|
90038-1
|
Weighted score [RAPID3] |
|
59283-2
|
Well child visit note |
|
90662-8
|
Wells pulmonary embolism risk score interpretation |
|
71079-8
|
Were you able to talk to your doctor-s when you needed to [FACIT] |
|
71090-5
|
Were you encouraged to participate in decisions about your health care [FACIT] |
|
82145-4
|
Were your parents separated or divorced--before 18 years old [ACE.BRFSS] |
|
65338-6
|
WES sup(b) Ab [Presence] in Serum or Plasma |
|
15657-0
|
Cotton western IgE Ab RAST class [Presence] in Serum |
|
7255-3
|
Western Cottonwood IgE Ab [Units/volume] in Serum |
|
15660-4
|
Western Cottonwood IgE Ab RAST class [Presence] in Serum |
|
7435-1
|
Western Juniper IgE Ab [Units/volume] in Serum |
|
21353-8
|
Western Juniper IgE Ab RAST class [Presence] in Serum |
|
6275-2
|
Western Ragweed IgE Ab [Units/volume] in Serum |
|
15981-4
|
Western Ragweed IgE Ab RAST class [Presence] in Serum |
|
56372-6
|
Western Ragweed IgG4 Ab [Mass/volume] in Serum |
|
24146-3
|
Western Water Hemp IgG Ab [Units/volume] in Serum |
|
56416-1
|
Western Water Hemp IgG4 Ab [Mass/volume] in Serum |
|
24511-8
|
Western wheatgrass IgE Ab [Units/volume] in Serum |
|
24516-7
|
Western wheatgrass IgE Ab RAST class [Presence] in Serum |
|
7611-7
|
Western White Pine IgE Ab [Units/volume] in Serum |
|
14318-0
|
Microscopic observation [Identifier] in Cervix by Wet preparation |
|
6466-7
|
Microscopic observation [Identifier] in Duodenal fluid by Wet preparation |
|
23901-2
|
Microscopic observation [Identifier] in Body fluid by Wet preparation |
|
14317-2
|
Microscopic observation [Identifier] in Genital specimen by Wet preparation |
|
6470-9
|
Microscopic observation [Identifier] in Stool by Wet preparation |
|
6680-3
|
Microscopic observation [Identifier] in Tissue by Wet preparation |
|
57851-8
|
Microscopic observation [Identifier] in Urethra by Wet preparation |
|
14319-8
|
Microscopic observation [Identifier] in Vaginal fluid by Wet preparation |
|
680-9
|
Microscopic observation [Identifier] in Unspecified specimen by Wet preparation |
|
41042-3
|
WFS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40475-6
|
WFS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
83344-2
|
What action is required [PCAM] |
|
83345-9
|
What action will be taken [PCAM] |
|
75260-0
|
What is your level of pain right now [PROMIS] |
|
91145-3
|
What number best describes how pain has interfered with your enjoyment of life during the past week |
|
91146-1
|
What number best describes how pain has interfered with your general activity during the past week |
|
71190-3
|
What would be important about how you feel about eating, food, and how food affects your life in the past 7 days [FACIT] |
|
32558-9
|
Mumps reaction wheal [Diameter] --1 day post 0.1 mL mumps intradermal |
|
32557-1
|
Candida albicans reaction wheal [Diameter] --1 day post 50 ug Candida albicans intradermal |
|
32568-8
|
Trichophyton reaction wheal [Diameter] --1 day post 50 ug trichophyton intradermal |
|
41181-9
|
Candida albicans reaction wheal [Diameter] --1 day post Candida albicans intradermal |
|
23136-5
|
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --1 day post dose intradermal |
|
41179-3
|
Mumps reaction wheal [Diameter] --1 day post dose mumps intradermal |
|
41177-7
|
Trichophyton reaction wheal [Diameter] --1 day post dose trichophyton intradermal |
|
22941-9
|
Brucella reaction wheal [Diameter] --2 days post 0.1 mL brucellin intradermal |
|
30203-4
|
Candida albicans reaction wheal [Diameter] --2 days post 0.1 mL Candida albicans intradermal |
|
30227-3
|
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post 0.1 mL histoplasmin intradermal |
|
30228-1
|
Mumps reaction wheal [Diameter] --2 days post 0.1 mL mumps intradermal |
|
30232-3
|
Trichophyton reaction wheal [Diameter] --2 days post 0.1ml trichophyton intradermal |
|
32567-0
|
Candida albicans reaction wheal [Diameter] --2 days post 50 ug Candida albicans intradermal |
|
32560-5
|
Trichophyton reaction wheal [Diameter] --2 days post 50 ug trichophyton intradermal |
|
41180-1
|
Candida albicans reaction wheal [Diameter] --2 days post Candida albicans intradermal |
|
41182-7
|
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post histoplasmin intradermal |
|
23137-3
|
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post dose intradermal |
|
41178-5
|
Mumps reaction wheal [Diameter] --2 days post dose mumps intradermal |
|
41176-9
|
Trichophyton reaction wheal [Diameter] --2 days post dose trichophyton intradermal |
|
22942-7
|
Brucella reaction wheal [Diameter] --3 days post 0.1 mL brucellin intradermal |
|
23151-4
|
Leishmania reaction wheal [Diameter] --3 days post 0.1 mL leishmanin intradermal |
|
5930-3
|
Mumps reaction wheal [Diameter] --3 days post 0.1 mL mumps intradermal |
|
5929-5
|
Candida albicans reaction wheal [Diameter] --3 days post 50 ug Candida albicans intradermal |
|
5931-1
|
Trichophyton reaction wheal [Diameter] --3 days post 50 ug trichophyton intradermal |
|
23138-1
|
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --3 days post dose intradermal |
|
23506-9
|
Tritrichomonas foetus reaction wheal [Diameter] --post 0.1 mL tricin intradermal |
|
66452-4
|
Wheat native (nTri a) 18 IgE Ab [Units/volume] in Serum |
|
51008-1
|
Wheat native (nTri a) 19 IgE Ab [Units/volume] in Serum |
|
82583-6
|
Wheat native (nTri a) 19+20+21 IgE Ab [Units/volume] in Serum |
|
82605-7
|
Wheat native (nTri a) 19+20+21 IgE Ab RAST class [Presence] in Serum |
|
65774-2
|
Wheat native (nTri a) aA/TI IgE Ab [Units/volume] in Serum |
|
64966-5
|
Wheat recombinant (rTri a) 14 IgE Ab [Units/volume] in Serum |
|
81999-5
|
Wheat recombinant (rTri a) 14 IgE Ab RAST class [Presence] in Serum |
|
58752-7
|
Wheat recombinant (rTri a) 19 IgE Ab [Units/volume] in Serum |
|
81986-2
|
Wheat recombinant (rTri a) 19 IgE Ab RAST class [Presence] in Serum |
|
7772-7
|
Wheat triggered histamine release [Units/volume] in Blood |
|
11161-7
|
Wheat Bran IgE Ab [Units/volume] in Serum |
|
21123-5
|
Wheat Bran IgE Ab RAST class [Presence] in Serum |
|
25354-2
|
Wheat Bran IgG Ab [Units/volume] in Serum |
|
25355-9
|
Wheat Bran IgG Ab RAST class [Presence] in Serum |
|
26411-9
|
Wheat Bran IgG4 Ab [Units/volume] in Serum |
|
26412-7
|
Wheat Bran IgG4 Ab RAST class [Presence] in Serum |
|
21603-6
|
Wheat dust IgE Ab [Units/volume] in Serum |
|
21604-4
|
Wheat dust IgE Ab RAST class [Presence] in Serum |
|
7379-1
|
Wheat grass IgG Ab [Units/volume] in Serum |
|
6276-0
|
Wheat IgE Ab [Units/volume] in Serum |
|
16085-3
|
Wheat IgE Ab RAST class [Presence] in Serum |
|
41207-2
|
Wheat IgE Ab/IgE total in Serum |
|
6737-1
|
Wheat IgG Ab [Units/volume] in Serum |
|
21602-8
|
Wheat IgG Ab RAST class [Presence] in Serum |
|
56417-9
|
Wheat IgG4 Ab [Mass/volume] in Serum |
|
35537-0
|
Wheat IgG Ab [Mass/volume] in Serum |
|
48223-2
|
Wheat triggered leukotriene release [Mass/volume] by Leukocytes |
|
7708-1
|
Wheat smut IgE Ab [Units/volume] in Serum |
|
7672-9
|
Wheat Stem Rust IgE Ab [Units/volume] in Serum |
|
16088-7
|
Wheat Stem Rust IgE Ab RAST class [Presence] in Serum |
|
89378-4
|
Wheel 150 feet - functional ability [CMS Assessment] |
|
83235-2
|
Wheel 150 feet - functional ability during 3 day assessment period [CMS Assessment] |
|
89377-6
|
Wheel 150 feet - functional goal [CMS Assessment] |
|
83236-0
|
Wheel 150 feet - functional goal during 3 day assessment period [CMS Assessment] |
|
89376-8
|
Wheel 50 feet with two turns - functional ability [CMS Assessment] |
|
83188-3
|
Wheel 50 feet with two turns - functional ability during 3 day assessment period [CMS Assessment] |
|
89375-0
|
Wheel 50 feet with two turns - functional goal [CMS Assessment] |
|
83187-5
|
Wheel 50 feet with two turns - functional goal during 3 day assessment period [CMS Assessment] |
|
87690-4
|
When all is said and done, I am responsible for seeing that this person's health is managed properly Caregiver [PAM] |
|
87676-3
|
When all is said and done, I am the person who is responsible for taking care of my child's health Parent [PAM] |
|
86944-6
|
When all is said and done, I am the person who is responsible for taking care of my health [PAM] |
|
46591-4
|
When anxious [OASIS] |
|
86495-9
|
When anxious within the last 14 days [CMS Assessment] |
|
58104-1
|
When confused within the last 14 days [CMS Assessment] |
|
92207-0
|
When I am worrying about something, a cigarette is helpful [PROMIS] |
|
92303-7
|
When I go too long without a cigarette I feel impatient [PROMIS] |
|
92302-9
|
When I go too long without a cigarette I get strong urges that are hard to get rid of [PROMIS] |
|
92301-1
|
When I go without a cigarette for a few hours, I experience craving [PROMIS] |
|
90190-0
|
When I have a big project to do, I have trouble deciding where to start in past 4 weeks [PROMIS.PEDS] |
|
92300-3
|
When I haven't been able to smoke for a few hours, the craving gets intolerable [PROMIS] |
|
71313-1
|
When I play games or sports, I react more slowly than most people my age in the past 4 weeks [FACIT] |
|
92299-7
|
When I run out of cigarettes, I find it almost unbearable [PROMIS] |
|
71307-3
|
When I speak, people have trouble understanding me in the past 4 weeks [FACIT] |
|
92218-7
|
When I stop what I'm doing to have a cigarette it feels like 'my time' [PROMIS] |
|
71286-9
|
When I try to do something, I usually believe I will do it well in the past 4 weeks [FACIT] |
|
71170-5
|
When I try to do something, I usually believe I will do it well in the past 7 days [FACIT] |
|
91948-0
|
When I was in pain I argued with people in past 7 days [PROMIS] |
|
91971-2
|
When I was in pain I asked for help getting around in past 7 days [PROMIS] |
|
91978-7
|
When I was in pain I asked for help with doing things in past 7 days [PROMIS] |
|
91969-6
|
When I was in pain I asked for medicine in past 7 days [PROMIS] |
|
91960-5
|
When I was in pain I asked people to bring me things (food, games) in past 7 days [PROMIS] |
|
91977-9
|
When I was in pain I asked people to let me be by myself in past 7 days [PROMIS] |
|
91950-6
|
When I was in pain I asked to see a doctor in past 7 days [PROMIS] |
|
91954-8
|
When I was in pain I avoided lifting or carrying heavy things in past 7 days [PROMIS] |
|
91961-3
|
When I was in pain I avoided standing in past 7 days [PROMIS] |
|
91947-2
|
When I was in pain I avoided using the part of my body that hurt in past 7 days [PROMIS] |
|
91972-0
|
When I was in pain I became quiet in past 7 days [PROMIS] |
|
91951-4
|
When I was in pain I complained in past 7 days [PROMIS] |
|
91959-7
|
When I was in pain I couldn't stay still in past 7 days [PROMIS] |
|
91975-3
|
When I was in pain I cried in past 7 days [PROMIS] |
|
91966-2
|
When I was in pain I didn't let anyone touch me in past 7 days [PROMIS] |
|
91962-1
|
When I was in pain I didn't want anyone to touch me in past 7 days [PROMIS] |
|
91937-3
|
When I was in pain I felt my body get tense in past 7 days [PROMIS] |
|
91963-9
|
When I was in pain I got angry at people in past 7 days [PROMIS] |
|
91945-6
|
When I was in pain I got mad and threw or hit something in past 7 days [PROMIS] |
|
91955-5
|
When I was in pain I had to stop what I was doing in past 7 days [PROMIS] |
|
91938-1
|
When I was in pain I lay down in past 7 days [PROMIS] |
|
91973-8
|
When I was in pain I limped in the past 7 days [PROMIS] |
|
91964-7
|
When I was in pain I moved slower in past 7 days [PROMIS] |
|
91949-8
|
When I was in pain I pulled away if someone touched me where it hurt in past 7 days [PROMIS] |
|
91965-4
|
When I was in pain I rubbed my body where it hurt in past 7 days [PROMIS] |
|
91946-4
|
When I was in pain I said mean words to people in past 7 days [PROMIS] |
|
91944-9
|
When I was in pain I sighed in past 7 days [PROMIS] |
|
91970-4
|
When I was in pain I stayed away from other people in past 7 days [PROMIS] |
|
91953-0
|
When I was in pain I stayed near to someone who cares about me in past 7 days [PROMIS] |
|
91967-0
|
When I was in pain I talked about my pain in past 7 days [PROMIS] |
|
91968-8
|
When I was in pain I tightened my jaw in past 7 days [PROMIS] |
|
91942-3
|
When I was in pain I told people I couldn't do my usual chores in past 7 days [PROMIS] |
|
91943-1
|
When I was in pain I took breaks from what I was doing in past 7 days [PROMIS] |
|
91979-5
|
When I was in pain I tried not to move in past 7 days [PROMIS] |
|
91952-2
|
When I was in pain I tried to rest or relax in past 7 days [PROMIS] |
|
91957-1
|
When I was in pain I tried to think of something nice or fun in past 7 days [PROMIS] |
|
91974-6
|
When I was in pain I used something for support (cane, crutches, wheelchair) to move from place to place in past 7 days [PROMIS] |
|
91958-9
|
When I was in pain I was restless in past 7 days [PROMIS] |
|
91956-3
|
When I was in pain I went to sleep in past 7 days [PROMIS] |
|
91976-1
|
When I was in pain I yelled for someone to help me in past 7 days [PROMIS] |
|
91941-5
|
When I was in pain it showed on my face in past 7 days [PROMIS] |
|
92206-2
|
When I'm angry, a cigarette can calm me down [PROMIS] |
|
92298-9
|
When I'm really craving a cigarette, it feels like I'm in the grip of some unknown force that I cannot control [PROMIS] |
|
92205-4
|
When I'm upset with someone, a cigarette helps me cope [PROMIS] |
|
75183-4
|
When mother received first dose of benzathine penicillin [CDC.CS] |
|
71261-2
|
When my child eats, s-he seems to get full quickly in the past 7 days [FACIT] |
|
71333-9
|
When my child plays games or sports, s-he reacts more slowly than his-her peers in the past 4 weeks [FACIT] |
|
71204-2
|
When my child tries to do something, s-he usually believes s-he will do it well in the past 4 weeks [FACIT] |
|
71237-2
|
When my child tries to do something, s-he usually believes s-he will do it well in the past 7 days [FACIT] |
|
91188-3
|
When my child was in pain he or she argued with people in past 7 days [PROMIS.PARENTPROXY] |
|
91162-8
|
When my child was in pain he or she asked for help getting around in past 7 days [PROMIS.PARENTPROXY] |
|
91154-5
|
When my child was in pain he or she asked for help with doing things in past 7 days [PROMIS.PARENTPROXY] |
|
91165-1
|
When my child was in pain he or she asked for medicine in past 7 days [PROMIS.PARENTPROXY] |
|
91200-6
|
When my child was in pain he or she asked for someone to help him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91176-8
|
When my child was in pain he or she asked people to bring him or her things (food, games) in past 7 days [PROMIS.PARENTPROXY] |
|
91155-2
|
When my child was in pain he or she asked people to let him or her be by himself or herself in past 7 days [PROMIS.PARENTPROXY] |
|
91186-7
|
When my child was in pain he or she asked to see a doctor in past 7 days [PROMIS.PARENTPROXY] |
|
91182-6
|
When my child was in pain he or she avoided lifting or carrying heavy things in past 7 days [PROMIS.PARENTPROXY] |
|
91175-0
|
When my child was in pain he or she avoided standing in past 7 days [PROMIS.PARENTPROXY] |
|
91189-1
|
When my child was in pain he or she avoided using the part of his or her body that hurt in past 7 days [PROMIS.PARENTPROXY] |
|
91161-0
|
When my child was in pain he or she became quiet in past 7 days [PROMIS.PARENTPROXY] |
|
91185-9
|
When my child was in pain he or she complained in past 7 days [PROMIS.PARENTPROXY] |
|
91177-6
|
When my child was in pain he or she couldn't stay still in past 7 days [PROMIS.PARENTPROXY] |
|
91158-6
|
When my child was in pain he or she cried in past 7 days [PROMIS.PARENTPROXY] |
|
91170-1
|
When my child was in pain he or she didn't let anyone touch him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91174-3
|
When my child was in pain he or she didn't want anyone to touch him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91202-2
|
When my child was in pain he or she felt his or her body get tense in past 7 days [PROMIS.PARENTPROXY] |
|
91173-5
|
When my child was in pain he or she got angry at people in past 7 days [PROMIS.PARENTPROXY] |
|
91191-7
|
When my child was in pain he or she got mad and threw or hit something in past 7 days [PROMIS.PARENTPROXY] |
|
91163-6
|
When my child was in pain he or she groaned in past 7 days [PROMIS.PARENTPROXY] |
|
91192-5
|
When my child was in pain he or she had a fixed or dazed expression in past 7 days [PROMIS.PARENTPROXY] |
|
91194-1
|
When my child was in pain he or she had circles under his or her eyes in past 7 days [PROMIS.PARENTPROXY] |
|
91193-3
|
When my child was in pain he or she had tears in his or her eyes in past 7 days [PROMIS.PARENTPROXY] |
|
91181-8
|
When my child was in pain he or she had to stop what he or she was doing in past 7 days [PROMIS.PARENTPROXY] |
|
91201-4
|
When my child was in pain he or she lay down in past 7 days [PROMIS.PARENTPROXY] |
|
91160-2
|
When my child was in pain he or she limped in past 7 days [PROMIS.PARENTPROXY] |
|
91172-7
|
When my child was in pain he or she moved slower in past 7 days [PROMIS.PARENTPROXY] |
|
91156-0
|
When my child was in pain he or she moved stiffly in past 7 days [PROMIS.PARENTPROXY] |
|
91167-7
|
When my child was in pain he or she protected the part of his or her body that hurt in past 7 days [PROMIS.PARENTPROXY] |
|
91187-5
|
When my child was in pain he or she pulled away if someone touched him or her where it hurt in past 7 days [PROMIS.PARENTPROXY] |
|
91171-9
|
When my child was in pain he or she rubbed his or her body where it hurt in past 7 days [PROMIS.PARENTPROXY] |
|
91190-9
|
When my child was in pain he or she said mean words to people in past 7 days [PROMIS.PARENTPROXY] |
|
91166-9
|
When my child was in pain he or she screamed in past 7 days [PROMIS.PARENTPROXY] |
|
91195-8
|
When my child was in pain he or she sighed in past 7 days [PROMIS.PARENTPROXY] |
|
91164-4
|
When my child was in pain he or she stayed away from other people in past 7 days [PROMIS.PARENTPROXY] |
|
91183-4
|
When my child was in pain he or she stayed near to someone who cares about him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91169-3
|
When my child was in pain he or she talked about his or her pain in past 7 days [PROMIS.PARENTPROXY] |
|
91168-5
|
When my child was in pain he or she tightened his or her jaw in past 7 days [PROMIS.PARENTPROXY] |
|
91197-4
|
When my child was in pain he or she told people he or she couldn't do his or her usual chores in past 7 days [PROMIS.PARENTPROXY] |
|
91199-0
|
When my child was in pain he or she told people he or she couldn't do things with them in past 7 days [PROMIS.PARENTPROXY] |
|
91196-6
|
When my child was in pain he or she took breaks from what he or she was doing in past 7 days [PROMIS.PARENTPROXY] |
|
91152-9
|
When my child was in pain he or she tried not to move in past 7 days [PROMIS.PARENTPROXY] |
|
91184-2
|
When my child was in pain he or she tried to rest or relax in past 7 days [PROMIS.PARENTPROXY] |
|
91179-2
|
When my child was in pain he or she tried to think of something nice or fun in past 7 days [PROMIS.PARENTPROXY] |
|
91159-4
|
When my child was in pain he or she used something for support (cane, crutches, wheelchair) to move from place to place in past 7 days [PROMIS.PARENTPROXY] |
|
91178-4
|
When my child was in pain he or she was restless in past 7 days [PROMIS.PARENTPROXY] |
|
91180-0
|
When my child was in pain he or she went to sleep in past 7 days [PROMIS.PARENTPROXY] |
|
91157-8
|
When my child was in pain he or she yelled for someone to help him or her in past 7 days [PROMIS.PARENTPROXY] |
|
91153-7
|
When my child was in pain his or her face looked sad in past 7 days [PROMIS.PARENTPROXY] |
|
91198-2
|
When my child was in pain it showed on his or her face in past 7 days [PROMIS.PARENTPROXY] |
|
57241-2
|
When urinary incontinence occurs [CMS Assessment] |
|
90143-9
|
When your child has a big project to do, he or she has trouble deciding where to start in past 4 weeks [PROMIS.PARENTPROXY] |
|
91939-9
|
WhenI was in pain I asked for someone to help me in past 7 days [PROMIS] |
|
91940-7
|
WhenI was in pain I told people I couldn't do things with them in past 7 days [PROMIS] |
|
72060-7
|
Where was vaccine received |
|
81908-6
|
Whey intake 24 hour Estimated |
|
81909-4
|
Whey intake 24 hour Measured |
|
10939-7
|
Whiff IgE Ab [Units/volume] in Serum |
|
15840-2
|
Whiff IgE Ab RAST class [Presence] in Serum |
|
7064-9
|
White Alder IgE Ab [Units/volume] in Serum |
|
15521-8
|
White Alder IgE Ab RAST class [Presence] in Serum |
|
7098-7
|
White Ash triggered histamine release [Units/volume] in Blood |
|
6278-6
|
White Ash IgE Ab [Units/volume] in Serum |
|
15546-5
|
White Ash IgE Ab RAST class [Presence] in Serum |
|
42594-2
|
White Ash IgE Ab/IgE total in Serum |
|
24140-6
|
White Ash IgG Ab [Units/volume] in Serum |
|
56420-3
|
White Ash IgG4 Ab [Mass/volume] in Serum |
|
63184-6
|
White Ash IgG Ab [Mass/volume] in Serum |
|
6279-4
|
White Bean IgE Ab [Units/volume] in Serum |
|
15569-7
|
White Bean IgE Ab RAST class [Presence] in Serum |
|
57913-6
|
White Bean IgE Ab/IgE total in Serum |
|
7141-5
|
White Bean IgG Ab [Units/volume] in Serum |
|
56421-1
|
White Bean IgG4 Ab [Mass/volume] in Serum |
|
63079-8
|
White Bean IgG Ab [Mass/volume] in Serum |
|
41874-9
|
White Birch IgE Ab [Units/volume] in Serum |
|
43841-6
|
White Birch IgE Ab RAST class [Presence] in Serum |
|
61227-5
|
White Birch IgE Ab/IgE total in Serum |
|
56422-9
|
White Birch IgG4 Ab [Mass/volume] in Serum |
|
21148-2
|
White Cedar IgE Ab [Units/volume] in Serum |
|
7301-5
|
White Elm triggered histamine release [Units/volume] in Blood |
|
6109-3
|
White Elm IgE Ab [Units/volume] in Serum |
|
15697-6
|
White Elm IgE Ab RAST class [Presence] in Serum |
|
61322-4
|
White Elm IgE Ab/IgE total in Serum |
|
13183-9
|
White Elm IgG Ab [Units/volume] in Serum |
|
56174-6
|
White Elm IgG4 Ab [Mass/volume] in Serum |
|
58032-4
|
White Elm IgG Ab [Mass/volume] in Serum |
|
7407-0
|
White Hickory IgE Ab [Units/volume] in Serum |
|
15776-8
|
White Hickory IgE Ab RAST class [Presence] in Serum |
|
24137-2
|
White Hickory IgG Ab [Units/volume] in Serum |
|
56423-7
|
White Hickory IgG4 Ab [Mass/volume] in Serum |
|
6281-0
|
White mulberry IgE Ab [Units/volume] in Serum |
|
15864-2
|
White mulberry IgE Ab RAST class [Presence] in Serum |
|
61286-1
|
White mulberry IgE Ab/IgE total in Serum |
|
7513-5
|
White mulberry IgG Ab [Units/volume] in Serum |
|
58008-4
|
White mulberry IgG Ab RAST class [Presence] in Serum |
|
56425-2
|
White mulberry IgG4 Ab [Mass/volume] in Serum |
|
63202-6
|
White mulberry IgG Ab [Mass/volume] in Serum |
|
7537-4
|
White Oak triggered histamine release [Units/volume] in Blood |
|
6189-5
|
White Oak IgE Ab [Units/volume] in Serum |
|
15875-8
|
White Oak IgE Ab RAST class [Presence] in Serum |
|
50369-8
|
White Oak IgE Ab/IgE total in Serum |
|
7536-6
|
White Oak IgG Ab [Units/volume] in Serum |
|
56426-0
|
White Oak IgG4 Ab [Mass/volume] in Serum |
|
63182-0
|
White Oak IgG Ab [Mass/volume] in Serum |
|
48247-1
|
White Oak triggered leukotriene release [Mass/volume] by Leukocytes |
|
7596-0
|
White Pepper IgE Ab [Units/volume] in Serum |
|
23927-7
|
White Pepper IgE Ab RAST class [Presence] in Serum |
|
7597-8
|
White Pepper IgG Ab [Units/volume] in Serum |
|
21454-4
|
White Pepper IgG Ab RAST class [Presence] in Serum |
|
7622-4
|
White Poplar triggered histamine release [Units/volume] in Blood |
|
21473-4
|
White Poplar IgE Ab [Units/volume] in Serum |
|
21474-2
|
White Poplar IgE Ab RAST class [Presence] in Serum |
|
56428-6
|
White Poplar IgG4 Ab [Mass/volume] in Serum |
|
24159-6
|
White+Black Pepper IgE Ab [Units/volume] in Serum |
|
24158-8
|
White+Black Pepper IgG Ab [Units/volume] in Serum |
|
6280-2
|
Whitefaced Hornet IgE Ab [Units/volume] in Serum |
|
15782-6
|
Whitefaced Hornet IgE Ab RAST class [Presence] in Serum |
|
61259-8
|
Whitefaced Hornet IgE Ab/IgE total in Serum |
|
7417-9
|
Whitefaced Hornet IgG Ab [Units/volume] in Serum |
|
44315-0
|
Whitefaced Hornet IgG Ab RAST class [Presence] in Serum |
|
41193-4
|
Whitefaced Hornet IgG4 Ab [Presence] in Serum |
|
56424-5
|
Whitefaced Hornet IgG4 Ab [Mass/volume] in Serum |
|
49745-3
|
Whitefaced Hornet IgG Ab [Mass/volume] in Serum |
|
7775-0
|
Whitefish IgE Ab [Units/volume] in Serum |
|
16090-3
|
Whitefish IgE Ab RAST class [Presence] in Serum |
|
7776-8
|
Whitefish IgG Ab [Units/volume] in Serum |
|
21605-1
|
Whitefish IgG Ab RAST class [Presence] in Serum |
|
56430-2
|
Whitefish IgG4 Ab [Mass/volume] in Serum |
|
61127-7
|
Whitefish IgG Ab [Mass/volume] in Serum |
|
17771-7
|
Whitefish roe IgE Ab [Units/volume] in Serum |
|
83343-4
|
Who needs to be involved [PCAM] |
|
51876-1
|
Whole blood units given [#] |
|
1335-9
|
Whole blood given [Volume] |
|
54419-7
|
Whole blood pediatric units given [#] |
|
7293-4
|
Whole Egg triggered histamine release [Units/volume] in Blood |
|
7291-8
|
Whole Egg IgE Ab [Units/volume] in Serum |
|
15690-1
|
Whole Egg IgE Ab RAST class [Presence] in Serum |
|
41288-2
|
Whole Egg IgE Ab/IgE total in Serum |
|
7292-6
|
Whole Egg IgG Ab [Units/volume] in Serum |
|
56255-3
|
Whole Egg IgG4 Ab [Mass/volume] in Serum |
|
45201-1
|
Whole Egg IgG Ab [Mass/volume] in Serum |
|
86205-2
|
Whole exome sequence analysis in Blood or Tissue by Molecular genetics method |
|
86206-0
|
Whole genome sequence analysis in Blood or Tissue by Molecular genetics method |
|
46695-3
|
Why conclusions are not supported by the evidence in file [RFC] |
|
70981-6
|
Why you did not do this in the past 7 days [FACIT] |
|
89088-9
|
WIC services recipient |
|
15299-1
|
Urinary bladder Width by US |
|
15287-6
|
Kidney - left Width by US |
|
15290-0
|
Kidney - right Width by US |
|
86902-4
|
Width Pressure injury.largest stage 3 or 4 [CMS Assessment] |
|
15302-3
|
Prostate Width by US |
|
9805-3
|
Width of Stone |
|
15293-4
|
Testis - left Width by US |
|
15296-7
|
Testis - right Width by US |
|
7542-4
|
Wild Oats IgE Ab [Units/volume] in Serum |
|
23909-5
|
Wild Oats IgE Ab RAST class [Presence] in Serum |
|
7777-6
|
Wild Rice IgE Ab [Units/volume] in Serum |
|
15995-4
|
Wild Rice IgE Ab RAST class [Presence] in Serum |
|
16922-7
|
Wild rye grass IgE Ab [Units/volume] in Serum |
|
15751-1
|
Wild rye grass IgE Ab RAST class [Presence] in Serum |
|
6284-4
|
Wild Silk IgE Ab [Units/volume] in Serum |
|
85595-7
|
Will hospice care be provided |
|
89075-6
|
Willing to change aspirin dose |
|
6285-1
|
Willow IgE Ab [Units/volume] in Serum |
|
16091-1
|
Willow IgE Ab RAST class [Presence] in Serum |
|
61310-9
|
Willow IgE Ab/IgE total in Serum |
|
80479-9
|
Wine intake 24 hour |
|
50186-6
|
Wine vinegar IgE Ab [Units/volume] in Serum |
|
56431-0
|
Wine vinegar IgG4 Ab [Mass/volume] in Serum |
|
63139-0
|
Wine vinegar IgG Ab [Mass/volume] in Serum |
|
7779-2
|
Wingscale IgE Ab [Units/volume] in Serum |
|
16094-5
|
Wingscale IgE Ab RAST class [Presence] in Serum |
|
7780-0
|
Winterfat IgE Ab [Units/volume] in Serum |
|
93299-6
|
Wish to be dead Lifetime |
|
93246-7
|
Wish to be dead 1 month |
|
75333-5
|
Within the last month, how often have you experienced cultural factors [NMMDS] |
|
75337-6
|
Within the last month, how often have you experienced physical factors [NMMDS] |
|
75335-0
|
Within the last month, how often have you experienced psychosocial factors [NMMDS] |
|
76501-6
|
Within the last year, have you been afraid of your partner or ex-partner [HARK] |
|
76500-8
|
Within the last year, have you been humiliated or emotionally abused in other ways by your partner or ex-partner [HARK] |
|
76503-2
|
Within the last year, have you been kicked, hit, slapped, or otherwise physically hurt by your partner or ex-partner [HARK] |
|
76502-4
|
Within the last year, have you been raped or forced to have any kind of sexual activity by your partner or ex-partner [HARK] |
|
88123-5
|
Within the past 12 months the food we bought just didn't last and we didn't have money to get more [U.S. FSS] |
|
88122-7
|
Within the past 12 months we worried whether our food would run out before we got money to buy more [U.S. FSS] |
|
81339-4
|
Witness and notary Document |
|
86214-4
|
Womens health Annual evaluation note |
|
85871-2
|
Womens health Consult note |
|
85869-6
|
Womens health Education note |
|
85868-8
|
Womens health Group counseling note |
|
85867-0
|
Womens health History and physical note |
|
85870-4
|
Womens health Note |
|
85892-8
|
Womens health Nurse practitioner Note |
|
85862-1
|
Womens health Nurse Note |
|
85861-3
|
Womens health Nurse Outpatient Note |
|
85860-5
|
Womens health Outpatient History and physical note |
|
85859-7
|
Womens health Outpatient Letter |
|
85858-9
|
Womens health Outpatient Note |
|
85855-5
|
Womens health Telephone encounter Note |
|
85857-1
|
Womens health procedure note |
|
85856-3
|
Womens health Risk assessment and screening note |
|
72305-6
|
Wound closure type |
|
94086-6
|
Wound shape |
|
39558-2
|
West Nile virus Ab [Presence] in Cerebral spinal fluid |
|
41206-4
|
West Nile virus Ab [Units/volume] in Cerebral spinal fluid |
|
41194-2
|
West Nile virus Ab [Units/volume] in Serum by Immunoassay |
|
41232-0
|
West Nile virus Ab [Presence] in Serum |
|
75404-4
|
West Nile virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
39555-8
|
West Nile virus Ab [Units/volume] in Serum |
|
41224-7
|
West Nile virus Ab [Titer] in Cerebral spinal fluid |
|
29570-9
|
West Nile virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
41225-4
|
West Nile virus Ab [Titer] in Serum |
|
55380-0
|
West Nile virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
29568-3
|
West Nile virus Ab [Titer] in Serum by Neutralization test |
|
29781-2
|
West Nile virus Ab [Titer] in Unspecified specimen |
|
29779-6
|
West Nile virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
33468-0
|
West Nile virus Ab [Presence] in Unspecified specimen |
|
36897-7
|
West Nile virus Ab [Presence] in Unspecified specimen by Immunoassay |
|
31700-8
|
West Nile virus Ab [Units/volume] in Unspecified specimen |
|
50015-7
|
West Nile virus Ag [Presence] in Blood or Marrow from Donor |
|
32371-7
|
West Nile virus Ag [Presence] in Tissue by Immune stain |
|
41643-8
|
West Nile virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
60028-8
|
West Nile virus IgG Ab avidity [Presence] in Serum by Immunoassay |
|
60029-6
|
West Nile virus IgG Ab avidity [Presence] in Serum by Immunofluorescence |
|
39572-3
|
West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
41236-1
|
West Nile virus IgG Ab [Presence] in Cerebral spinal fluid |
|
77953-8
|
West Nile virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
29537-8
|
West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
38997-3
|
West Nile virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
31701-6
|
West Nile virus IgG Ab [Presence] in Serum |
|
29566-7
|
West Nile virus IgG Ab [Presence] in Serum by Immunoassay |
|
60030-4
|
West Nile virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
29535-2
|
West Nile virus IgG Ab [Units/volume] in Serum |
|
33328-6
|
West Nile virus IgG Ab [Titer] in Cerebral spinal fluid |
|
41196-7
|
West Nile virus IgG Ab [Titer] in Body fluid |
|
33329-4
|
West Nile virus IgG Ab [Titer] in Serum |
|
31702-4
|
West Nile virus IgG Ab [Presence] in Unspecified specimen |
|
30178-8
|
West Nile virus IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
41211-4
|
West Nile virus IgG+IgM Ab [Presence] in Serum |
|
39573-1
|
West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31703-2
|
West Nile virus IgM Ab [Presence] in Cerebral spinal fluid |
|
29569-1
|
West Nile virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
29538-6
|
West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
62436-1
|
West Nile virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
38166-5
|
West Nile virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
31704-0
|
West Nile virus IgM Ab [Presence] in Serum |
|
29567-5
|
West Nile virus IgM Ab [Presence] in Serum by Immunoassay |
|
29536-0
|
West Nile virus IgM Ab [Units/volume] in Serum |
|
33330-2
|
West Nile virus IgM Ab [Titer] in Cerebral spinal fluid |
|
43342-5
|
West Nile virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
41195-9
|
West Nile virus IgM Ab [Titer] in Body fluid |
|
33331-0
|
West Nile virus IgM Ab [Titer] in Serum |
|
43343-3
|
West Nile virus IgM Ab [Titer] in Serum by Immunoassay |
|
29780-4
|
West Nile virus IgM Ab [Presence] in Unspecified specimen |
|
29778-8
|
West Nile virus IgM Ab [Presence] in Unspecified specimen by Immunoassay |
|
41642-0
|
West Nile virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
81097-8
|
West Nile virus Kunjin strain Ab [Presence] in Serum |
|
81096-0
|
West Nile virus Kunjin strain IgM Ab [Presence] in Serum |
|
81650-4
|
West Nile virus Kunjin strain RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
36901-7
|
West Nile virus NS5 Ab [Presence] in Unspecified specimen |
|
36898-5
|
West Nile virus NS5 Ab [Presence] in Unspecified specimen by Immunoassay |
|
36900-9
|
West Nile virus polyvalent E Ab [Presence] in Unspecified specimen |
|
36896-9
|
West Nile virus polyvalent E Ab [Presence] in Unspecified specimen by Immunoassay |
|
34460-6
|
West Nile virus RNA [Presence] in Blood by NAA with probe detection |
|
34461-4
|
West Nile virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
87395-0
|
West Nile virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
41212-2
|
West Nile virus RNA [Presence] in Serum from Donor by NAA with probe detection |
|
32361-8
|
West Nile virus RNA [Presence] in Serum by NAA with probe detection |
|
74857-4
|
West Nile virus RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
32370-9
|
West Nile virus RNA [Presence] in Tissue by NAA with probe detection |
|
34892-0
|
West Nile virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37985-9
|
West Nile virus RNA [Presence] in Unspecified specimen by Probe |
|
93955-3
|
Wound, Ostomy, and Continence Care Consult note |
|
93970-2
|
Wound, Ostomy, and Continence Care Diagnostic study note |
|
93954-6
|
Wound, Ostomy, and Continence Care Outpatient Note |
|
90411-0
|
Words I wanted to use have seemed to be on the tip of my tongue in past 7 days [PROMIS] |
|
82233-8
|
Work [NDI] |
|
74160-3
|
Work days per week |
|
87512-0
|
Work hours per day |
|
74161-1
|
Work hours per week |
|
74159-5
|
Work schedule NIOSH |
|
16930-0
|
Helminth IgE Ab [Units/volume] in Serum |
|
10671-6
|
Helminth identified in Unspecified specimen |
|
14789-2
|
Helminth identified in Unspecified specimen by Macro/micro identification |
|
90300-5
|
Helminth identified in Unspecified specimen by NAA with probe detection |
|
14790-0
|
Helminth identified in Unspecified specimen by Permanent mount |
|
10672-4
|
Helminth+Arthropod identified in Unspecified specimen |
|
14788-4
|
Helminth+Arthropod identified in Unspecified specimen by Rearing/Culture |
|
6286-9
|
Wormwood IgE Ab [Units/volume] in Serum |
|
16095-2
|
Wormwood IgE Ab RAST class [Presence] in Serum |
|
7781-8
|
Wormwood IgG Ab [Units/volume] in Serum |
|
56432-8
|
Wormwood IgG4 Ab [Mass/volume] in Serum |
|
91345-9
|
Worrying thoughts have been going through my mind a lot of the time in the last 2 weeks [STarT Back] |
|
71105-1
|
Would you choose this clinic or office again [FACIT] |
|
71062-4
|
Would you choose this treatment again [FACIT] |
|
71104-4
|
Would you recommend this clinic or office to others [FACIT] |
|
71061-6
|
Would you recommend this treatment to others with your illness [FACIT] |
|
81666-0
|
Wound number [Identifier] |
|
80338-7
|
Wound assessment [Interpretation] |
|
72370-0
|
Area of identified wound bed appearance/Area of wound bed of Wound base |
|
89255-4
|
Wound bed area identified by color/Area of wound bed |
|
84303-7
|
Wound care management Consult note |
|
89820-5
|
Wound care management Initial evaluation note |
|
46215-0
|
Wound care management Note |
|
89818-9
|
Wound care management Telephone encounter Note |
|
89821-3
|
Wound care management Progress note |
|
84302-9
|
Wound care management Nurse Note |
|
89819-7
|
Wound care management Team Conference note |
|
88676-2
|
Wound coverage status |
|
72300-7
|
Wound type |
|
94083-3
|
Wound volume |
|
58074-6
|
Wr sup(a) Ab [Presence] in Serum or Plasma |
|
58073-8
|
Wr sup(a) Ag [Presence] on Red Blood Cells |
|
65339-4
|
Wr sup(b) Ab [Presence] in Serum or Plasma |
|
10355-6
|
Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
|
6682-9
|
Microscopic observation [Identifier] in Tissue by Wright Giemsa stain |
|
682-5
|
Microscopic observation [Identifier] in Unspecified specimen by Wright Giemsa stain |
|
53786-0
|
Microscopic observation [Identifier] in Stool by Wright stain |
|
6681-1
|
Microscopic observation [Identifier] in Tissue by Wright stain |
|
53785-2
|
Microscopic observation [Identifier] in Urine by Wright stain |
|
681-7
|
Microscopic observation [Identifier] in Unspecified specimen by Wright stain |
|
6679-5
|
Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |
|
679-1
|
Microscopic observation [Identifier] in Unspecified specimen by Warthin-Starry stain |
|
53728-2
|
WS2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46729-0
|
Weight container+Specimen of Stool |
|
9804-6
|
Weight of Stone |
|
46728-2
|
Weight of Water |
|
50331-8
|
WT-1 Ag [Presence] in Tissue by Immune stain |
|
72503-6
|
WT1 gene exon 1+2 transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
21742-2
|
WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21743-0
|
WT1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
77606-2
|
Weight-for-length Per age and sex |
|
48684-5
|
X and Y chromosome [Interpretation] in Blood or Marrow by FISH--post bone marrow transplant |
|
35455-5
|
X chromosome inactivation [Identifier] in Blood or Tissue Narrative |
|
48730-6
|
X linked heterotaxy [Identifier] in Blood or Tissue by FISH Narrative |
|
43249-2
|
X ray dye crystals [Presence] in Urine sediment by Light microscopy |
|
85269-9
|
X-linked adrenoleukodystrophy newborn screen interpretation |
|
85268-1
|
X-linked adrenoleukodystrophy newborn screening comment-discussion |
|
41213-0
|
Xanthan gum IgE Ab [Units/volume] in Serum |
|
41227-0
|
Xanthine [Moles/time] in 24 hour Urine |
|
75129-7
|
Xanthine [Moles/volume] in Cerebral spinal fluid |
|
43250-0
|
Xanthine derivatives [Presence] in Urine |
|
58036-5
|
Xanthine/Total in Stone |
|
41228-8
|
Xanthine [Presence] in Serum |
|
3131-0
|
Xanthine [Mass/volume] in Serum |
|
75144-6
|
Xanthine [Moles/volume] in Serum or Plasma |
|
3132-8
|
Xanthine [Mass/volume] in Urine |
|
72897-2
|
Xanthine [Moles/volume] in Urine |
|
41230-4
|
Xanthine [Presence] in Unspecified specimen |
|
38371-1
|
Xanthine/Creatinine [Molar ratio] in Urine |
|
13532-7
|
Xanthochromia [Presence] of Cerebral spinal fluid Qualitative |
|
12273-9
|
Xanthochromia [Presence] of Body fluid Qualitative |
|
80184-5
|
Xanthopterin [Moles/volume] in Cerebral spinal fluid |
|
80183-7
|
Xanthopterin [Moles/volume] in Serum or Plasma |
|
80185-2
|
Xanthopterin/Creatinine [Molar ratio] in Urine |
|
41220-5
|
Xanthurenate [Presence] in 24 hour Urine |
|
41240-3
|
Xanthurenate [Presence] in Serum or Plasma |
|
41615-6
|
Xanthurenate [Mass/volume] in Serum or Plasma |
|
41248-6
|
Xanthurenate [Presence] in Urine |
|
3133-6
|
Xanthurenate [Mass/volume] in Urine |
|
41231-2
|
Xanthurenate+Kynurenate [Presence] in 24 hour Urine |
|
41221-3
|
Xanthurenate+Kynurenate [Mass/time] in 24 hour Urine |
|
76118-9
|
Xenon [VFr/PPres] Airway adaptor --during expiration |
|
76108-0
|
Xenon [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
76121-3
|
Xenon [VFr/PPres] Airway adaptor --during inspiration |
|
76109-8
|
Xenon [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
76116-3
|
Xenon [VFr/PPres] Airway adaptor --at end expiration |
|
76124-7
|
Xenon gas delivered during case [Volume] from Gas delivery system |
|
76125-4
|
Xenon gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76094-2
|
Xenon [VFr/PPres] Airway adaptor |
|
76114-8
|
Xenon [VFr/PPres] Gas delivery system |
|
1336-7
|
Xg sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1337-5
|
Xg sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1338-3
|
Xg sup(a) Ab [Presence] in Serum or Plasma |
|
55341-2
|
Xg sup(a) Ab [Titer] in Serum or Plasma |
|
1339-1
|
Xg sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1340-9
|
Xg sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1341-7
|
Xg sup(a) Ag [Presence] on Red Blood Cells |
|
41218-9
|
Xipamid [Presence] in Urine |
|
88023-7
|
XLR-11 N-(4-hydroxypentyl) (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
82295-7
|
Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by FISH |
|
81873-2
|
Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
36550-2
|
XR Abdomen Single view |
|
41793-1
|
XR Abdomen Single view during surgery |
|
36641-9
|
XR Abdomen 2 Views |
|
83015-8
|
XR Abdomen 2 Views for renal calculus |
|
36293-9
|
XR Abdomen 3 Views |
|
24799-9
|
XR Abdomen AP |
|
24561-3
|
XR Abdomen AP left lateral-decubitus |
|
24563-9
|
XR Abdomen AP right lateral-decubitus |
|
24796-5
|
XR Abdomen AP and AP left lateral-decubitus |
|
24794-0
|
XR Abdomen AP and Lateral |
|
69065-1
|
XR Abdomen AP and Lateral crosstable |
|
38084-0
|
XR Abdomen AP and Left posterior oblique |
|
37119-5
|
XR Abdomen AP and Oblique |
|
24797-3
|
XR Abdomen AP and Oblique prone |
|
79350-5
|
XR Abdomen GE 3 Views |
|
83016-6
|
XR Abdomen GE 3 Views AP and Oblique and Cone |
|
24562-1
|
XR Abdomen Left lateral-decubitus and Right lateral-decubitus |
|
36591-6
|
XR Abdomen Lateral |
|
36984-3
|
XR Abdomen Lateral crosstable |
|
36995-9
|
XR Abdomen Left lateral |
|
38069-1
|
XR Abdomen Left posterior oblique |
|
36607-0
|
XR Abdomen Oblique |
|
37015-5
|
XR Abdomen PA prone |
|
36996-7
|
XR Abdomen Right lateral |
|
37131-0
|
XR Abdomen Right lateral and Left lateral |
|
37138-5
|
XR Abdomen Right oblique and Left oblique |
|
39323-1
|
XR Abdomen Right posterior oblique |
|
37085-8
|
XR Abdomen Supine and Lateral-decubitus |
|
24798-1
|
XR Abdomen Supine and Upright |
|
37046-0
|
XR Abdomen Upright |
|
42019-0
|
XR Abdomen upright and left lateral decubitus |
|
37636-8
|
XR Abdomen Views |
|
72256-1
|
XR Abdomen Views for motility W radioopaque markers |
|
37297-9
|
XR Abdomen and Fetal Single view for fetal age |
|
39327-2
|
XR Abdomen and Fetal Views for fetal age |
|
37467-8
|
XR Acromioclavicular Joint 10 degree cephalic angle |
|
24536-5
|
XR Acromioclavicular Joint Views |
|
37577-4
|
XR Acromioclavicular Joint Views W weight |
|
37582-4
|
XR Acromioclavicular Joint Views WO weight |
|
37579-0
|
XR Acromioclavicular Joint Views WO and W weight |
|
37848-9
|
XR Acromioclavicular Joint Zanca |
|
26136-2
|
XR Acromioclavicular joint - bilateral Views |
|
37578-2
|
XR Acromioclavicular joint - bilateral Views W weight |
|
69055-2
|
XR Acromioclavicular joint - bilateral Views WO weight |
|
37580-8
|
XR Acromioclavicular joint - bilateral Views WO and W weight |
|
37056-9
|
XR Acromioclavicular joint - bilateral Zanca |
|
36665-8
|
XR Acromioclavicular joint - left 2 Views |
|
36583-3
|
XR Acromioclavicular joint - left AP |
|
26137-0
|
XR Acromioclavicular joint - left Views |
|
37581-6
|
XR Acromioclavicular joint - left Views WO and W weight |
|
37057-7
|
XR Acromioclavicular joint - left Zanca |
|
37661-6
|
XR Acromioclavicular joint - right 2 Views |
|
37662-4
|
XR Acromioclavicular joint - right AP |
|
26138-8
|
XR Acromioclavicular joint - right Views |
|
37663-2
|
XR Acromioclavicular joint - right Views WO and W weight |
|
37810-9
|
XR Acromioclavicular joint - right Zanca |
|
37635-0
|
XR Acetabulum 3 Views |
|
24535-7
|
XR Acetabulum Views |
|
26133-9
|
XR Acetabulum - bilateral Views |
|
37064-3
|
XR Acetabulum - left 2 Views |
|
26134-7
|
XR Acetabulum - left Views |
|
37664-0
|
XR Acetabulum - right 2 Views |
|
26135-4
|
XR Acetabulum - right Views |
|
36644-3
|
XR and RF Chest 2 Views and Views |
|
36321-8
|
XR and RF Chest 4 Views and Views |
|
39066-6
|
XR and RF Chest AP and Lateral and Views |
|
47367-8
|
XR and RF Chest GE 4 Views and Views |
|
36751-6
|
XR and RF Chest PA and Lateral and Views |
|
36551-0
|
XR Ankle Single view |
|
83018-2
|
XR Ankle 1 or 2 Views |
|
24540-7
|
XR Ankle 2 Views |
|
36294-7
|
XR Ankle 3 Views |
|
36317-6
|
XR Ankle 4 Views |
|
36571-8
|
XR Ankle AP |
|
30779-3
|
XR Ankle AP and Lateral |
|
37095-7
|
XR Ankle AP and Lateral and Mortise |
|
39072-4
|
XR Ankle AP and Lateral and oblique |
|
44210-3
|
XR Ankle GE 3 Views |
|
36592-4
|
XR Ankle Lateral |
|
37007-2
|
XR Ankle Mortise |
|
24541-5
|
XR Ankle Views |
|
37486-8
|
XR Ankle Broden Views W manual stress |
|
37201-1
|
XR Ankle Views W standing |
|
37556-8
|
XR Ankle Views W manual stress |
|
51395-2
|
XR Ankle and Foot - left Views |
|
51394-5
|
XR Ankle and Foot - right Views |
|
26385-5
|
XR Ankle - bilateral 2 Views |
|
36295-4
|
XR Ankle - bilateral 3 Views |
|
42273-3
|
XR Ankle - bilateral 6 Views |
|
36684-9
|
XR Ankle - bilateral AP and Lateral |
|
39330-6
|
XR Ankle - bilateral AP and Lateral W standing |
|
37096-5
|
XR Ankle - bilateral AP and Lateral and Mortise |
|
36720-1
|
XR Ankle - bilateral AP and Lateral and oblique |
|
42417-6
|
XR Ankle - bilateral AP and Lateral and Oblique and (View W manual stress) |
|
48480-8
|
XR Ankle - bilateral GE 3 Views |
|
49570-5
|
XR Ankle - bilateral GE 6 Views |
|
37134-4
|
XR Ankle - bilateral Lateral and Mortise |
|
26097-6
|
XR Ankle - bilateral Views |
|
37202-9
|
XR Ankle - bilateral Views W standing |
|
37557-6
|
XR Ankle - bilateral Views W manual stress |
|
69307-7
|
XR Ankle - left Single view |
|
26386-3
|
XR Ankle - left 2 Views |
|
38841-3
|
XR Ankle - left 2 Views W standing |
|
38840-5
|
XR Ankle - left 2 Views W manual stress |
|
36296-2
|
XR Ankle - left 3 Views |
|
69138-6
|
XR Ankle - left 3 Views W standing |
|
36685-6
|
XR Ankle - left AP and Lateral |
|
42380-6
|
XR Ankle - left AP and Lateral W standing |
|
37097-3
|
XR Ankle - left AP and Lateral and Mortise |
|
36721-9
|
XR Ankle - left AP and Lateral and oblique |
|
69137-8
|
XR Ankle - left AP and Lateral and oblique W standing |
|
42418-4
|
XR Ankle - left AP and Lateral and Oblique and (View W manual stress) |
|
46390-1
|
XR Ankle - left GE 3 Views |
|
37135-1
|
XR Ankle - left Lateral and Mortise |
|
42382-2
|
XR Ankle - left Lateral and Mortise and Broden W manual stress |
|
37475-1
|
XR Ankle - left Mortise W manual stress |
|
26098-4
|
XR Ankle - left Views |
|
37474-4
|
XR Ankle - left Lateral Views W manual stress |
|
37203-7
|
XR Ankle - left Views W standing |
|
37558-4
|
XR Ankle - left Views W manual stress |
|
69314-3
|
XR Ankle - right Single view |
|
26387-1
|
XR Ankle - right 2 Views |
|
37675-6
|
XR Ankle - right 2 Views W standing |
|
37672-3
|
XR Ankle - right 2 Views W manual stress |
|
37665-7
|
XR Ankle - right 3 Views |
|
69254-1
|
XR Ankle - right 3 Views W standing |
|
37667-3
|
XR Ankle - right AP and Lateral |
|
39368-6
|
XR Ankle - right AP and Lateral W standing |
|
37666-5
|
XR Ankle - right AP and Lateral and Mortise |
|
37668-1
|
XR Ankle - right AP and Lateral and oblique |
|
39371-0
|
XR Ankle - right AP and Lateral and oblique W standing |
|
39369-4
|
XR Ankle - right AP and Lateral and Oblique and (View W manual stress) |
|
46347-1
|
XR Ankle - right GE 3 Views |
|
37670-7
|
XR Ankle - right Lateral and Mortise |
|
37671-5
|
XR Ankle - right Mortise W manual stress |
|
26099-2
|
XR Ankle - right Views |
|
37669-9
|
XR Ankle - right Lateral Views W manual stress |
|
37676-4
|
XR Ankle - right Views W standing |
|
37673-1
|
XR Ankle - right Views W manual stress |
|
39370-2
|
XR Ankle - right Views and (View W manual stress) |
|
39372-8
|
XR Ankle - right Views and Mortise |
|
24573-8
|
XR Biliary ducts and Gallbladder Views W contrast IV |
|
85151-9
|
XR Bone age |
|
24577-9
|
XR Bone Views during surgery |
|
43518-0
|
XR Bones Survey Views |
|
83020-8
|
XR Bones Complete Survey Views |
|
37365-4
|
XR Bones Survey Views for metastasis |
|
38089-9
|
XR Bones Limited Survey Views for metastasis |
|
43519-8
|
XR Bones Limited Survey Views |
|
37362-1
|
XR Bones Bone age Views |
|
24579-5
|
XR Long bones Survey Views |
|
39518-6
|
XR Long bones Limited Survey Views |
|
69158-4
|
XR Breast Diagnostic for implant |
|
69159-2
|
XR Breast Screening for implant |
|
43784-8
|
XR Cervical and thoracic and lumbar spine 2 Views |
|
39067-4
|
XR Cervical and thoracic and lumbar spine AP and Lateral |
|
83028-1
|
XR Cervical and thoracic and lumbar spine GE 2 Views |
|
38008-9
|
XR Cervical and thoracic and lumbar spine Views |
|
37361-3
|
XR Cervical and thoracic spine AP and Lateral |
|
37481-9
|
XR Cervical and thoracic spine Views |
|
93136-0
|
XR Capitate Bone development stage |
|
36554-4
|
XR Chest Single view |
|
41790-7
|
XR Chest Single view during surgery |
|
38001-4
|
XR Chest Single view W expiration |
|
38002-2
|
XR Chest Single view W inspiration |
|
36643-5
|
XR Chest 2 Views |
|
37067-6
|
XR Chest 2 Views W nipple markers |
|
42009-1
|
XR Chest 2 Views and Apical lordotic |
|
43467-0
|
XR Chest 2 Views and Right oblique and Left oblique |
|
83024-0
|
XR Chest 2 Views and Views Lateral-decubitus |
|
36298-8
|
XR Chest 3 Views |
|
36320-0
|
XR Chest 4 Views |
|
36572-6
|
XR Chest AP |
|
43561-0
|
XR Chest AP and Abdomen Upright |
|
30734-8
|
XR Chest AP lateral-decubitus |
|
24637-1
|
XR Chest AP left lateral-decubitus |
|
43466-2
|
XR Chest AP right lateral-decubitus |
|
24653-8
|
XR Chest AP and AP right lateral-decubitus |
|
36687-2
|
XR Chest AP and Lateral |
|
39070-8
|
XR Chest AP and Lateral and Apical lordotic |
|
39074-0
|
XR Chest AP and Lateral and Right oblique and Left oblique |
|
24642-1
|
XR Chest AP and PA upright |
|
24640-5
|
XR Chest Apical lordotic |
|
8294-1
|
XR Chest Diameter.anterior-posterior |
|
8295-8
|
XR Chest Diameter.anterior-posterior W expiration |
|
8296-6
|
XR Chest Diameter.anterior-posterior W inspiration |
|
38181-4
|
XR Chest Diameter.lateral |
|
46348-9
|
XR Chest GE 2 and PA and Lateral |
|
47368-6
|
XR Chest GE 4 and PA and Lateral |
|
44211-1
|
XR Chest GE 4 Views |
|
36620-3
|
XR Chest Left anterior oblique |
|
39051-8
|
XR Chest Lateral |
|
39341-3
|
XR Chest Lateral and PA W inspiration and expiration |
|
30737-1
|
XR Chest Left lateral |
|
24639-7
|
XR Chest Left lateral upright |
|
37008-0
|
XR Chest Left oblique |
|
30740-5
|
XR Chest Oblique |
|
42011-7
|
XR Chest PA and Abdomen AP |
|
43463-9
|
XR Chest PA and Abdomen Supine and Upright |
|
43532-1
|
XR Chest PA and Abdomen Upright |
|
24648-8
|
XR Chest PA upright |
|
36750-8
|
XR Chest PA and AP lateral-decubitus |
|
36759-9
|
XR Chest PA and Apical lordotic |
|
42272-5
|
XR Chest PA and Lateral |
|
24647-0
|
XR Chest PA and Lateral upright |
|
37143-5
|
XR Chest PA and Lateral and AP lateral-decubitus |
|
37144-3
|
XR Chest PA and Lateral and AP left lateral-decubitus |
|
37145-0
|
XR Chest PA and Lateral and AP right lateral-decubitus |
|
37146-8
|
XR Chest PA and Lateral and Left oblique |
|
30741-3
|
XR Chest PA and Lateral and Lordotic upright |
|
30744-7
|
XR Chest PA and Lateral and Oblique |
|
24643-9
|
XR Chest PA and Lateral and Oblique upright |
|
36758-1
|
XR Chest PA and Lateral and Oblique and Apical lordotic |
|
37147-6
|
XR Chest PA and Lateral and Right oblique |
|
30742-1
|
XR Chest PA and Lateral and Right oblique and Left oblique |
|
37141-9
|
XR Chest PA and Right lateral |
|
24646-2
|
XR Chest PA and Right lateral and Right oblique and Left oblique upright |
|
37150-0
|
XR Chest PA and Right oblique and Left oblique |
|
24650-4
|
XR Chest Right lateral-decubitus and Left lateral-decubitus |
|
38068-3
|
XR Chest Right anterior oblique |
|
37010-6
|
XR Chest Right oblique |
|
41792-3
|
XR Chest Right oblique and Left oblique |
|
24651-2
|
XR Chest Right oblique and Left oblique upright |
|
42414-3
|
XR Chest Right oblique and Left oblique W nipple markers |
|
83017-4
|
XR Chest View and Abdomen Supine and Upright |
|
30745-4
|
XR Chest Views |
|
24635-5
|
XR Chest PA upright Views W inspiration and expiration |
|
37200-3
|
XR Chest Views W contrast PO |
|
30736-3
|
XR Chest Views W inspiration and expiration |
|
38093-1
|
XR Chest Views W nipple markers |
|
42699-9
|
XR Chest and Abdomen Single view |
|
42269-1
|
XR Chest and Abdomen Views |
|
83019-0
|
XR Chest and Abdomen and Pelvis View babygram |
|
36555-1
|
XR Clavicle Single view |
|
36645-0
|
XR Clavicle 2 Views |
|
69079-2
|
XR Clavicle 45 degree cephalic angle |
|
36573-4
|
XR Clavicle AP |
|
24664-5
|
XR Clavicle Views |
|
37469-4
|
XR Clavicle - bilateral 45 degree cephalic angle |
|
26106-5
|
XR Clavicle - bilateral Views |
|
36646-8
|
XR Clavicle - left 2 Views |
|
37470-2
|
XR Clavicle - left 45 degree cephalic angle |
|
37121-1
|
XR Clavicle - left AP and Serendipity |
|
26107-3
|
XR Clavicle - left Views |
|
37679-8
|
XR Clavicle - right 2 Views |
|
38803-3
|
XR Clavicle - right 45 degree cephalic angle |
|
37680-6
|
XR Clavicle - right AP and Serendipity |
|
26108-1
|
XR Clavicle - right Views |
|
36647-6
|
XR Coccyx 2 Views |
|
36688-0
|
XR Coccyx AP and Lateral |
|
83025-7
|
XR Coccyx GE 2 Views |
|
30883-3
|
XR Coccyx Views |
|
25062-1
|
XR Unspecified body region Comparison view |
|
24940-9
|
XR Cervical spine Single view |
|
36669-0
|
XR Cervical spine 2 Views |
|
43539-6
|
XR Cervical spine 2 or 3 Views |
|
24941-7
|
XR Cervical spine 3 Views |
|
36331-7
|
XR Cervical spine 4 Views |
|
83023-2
|
XR Cervical spine 4 or 5 Views |
|
24939-1
|
XR Cervical spine 5 Views |
|
69080-0
|
XR Cervical spine 5 Views W flexion and W extension |
|
69081-8
|
XR Cervical spine 5 Views and Swimmers |
|
42691-6
|
XR Cervical spine 6 Views |
|
36680-7
|
XR Cervical spine 7 Views |
|
30725-6
|
XR Cervical spine AP |
|
24942-5
|
XR Cervical spine AP and Lateral |
|
36734-2
|
XR Cervical spine AP and Lateral and oblique |
|
37099-9
|
XR Cervical spine AP and Lateral and Oblique and Odontoid |
|
38083-2
|
XR Cervical spine AP and Lateral and Oblique and Odontoid and Swimmers |
|
37103-9
|
XR Cervical spine AP and Lateral and Odontoid |
|
37098-1
|
XR Cervical spine AP and Oblique and (Lateral W flexion and W extension) |
|
37100-5
|
XR Cervical spine AP and Oblique and Odontoid and (Lateral W flexion and W extension) |
|
37104-7
|
XR Cervical spine AP and Odontoid and (Lateral W flexion and W extension) |
|
37120-3
|
XR Cervical spine AP and Odontoid and Lateral crosstable |
|
79351-3
|
XR Cervical spine GE 2 Views |
|
44212-9
|
XR Cervical spine GE 4 Views |
|
79352-1
|
XR Cervical spine GE 6 Views |
|
24943-3
|
XR Cervical spine Lateral |
|
36997-5
|
XR Cervical spine Lateral W extension |
|
36998-3
|
XR Cervical spine Lateral W flexion |
|
36989-2
|
XR Cervical spine Lateral crosstable |
|
37139-3
|
XR Cervical spine Oblique and (Lateral W flexion and W extension) |
|
24944-1
|
XR Cervical spine Swimmers |
|
83021-6
|
XR Cervical spine 2 or 3 views and (Views W flexion and W extension) |
|
24946-6
|
XR Cervical spine Views |
|
37133-6
|
XR Cervical spine Lateral Views W flexion and W extension |
|
42710-4
|
XR Cervical spine Limited Views |
|
36748-2
|
XR Cervical spine Oblique Views |
|
24945-8
|
XR Cervical spine Views W flexion and W extension |
|
42164-4
|
XR Cervical spine Views and Oblique |
|
24948-2
|
XR Spine Cervical Odontoid and Cervical axis AP |
|
83022-4
|
XR Cervical spine 2 or 3 views and (Views W flexion and W extension) and Views oblique |
|
43785-5
|
XR Spine cervicothoracic junction AP and Lateral |
|
43781-4
|
XR Spine cervicothoracic junction Views |
|
36556-9
|
XR Elbow Single view |
|
83026-5
|
XR Elbow 1 or 2 Views |
|
36648-4
|
XR Elbow 2 Views |
|
36299-6
|
XR Elbow 3 Views |
|
36689-8
|
XR Elbow AP and Lateral |
|
36722-7
|
XR Elbow AP and Lateral and oblique |
|
79353-9
|
XR Elbow GE 3 Views |
|
83027-3
|
XR Elbow GE 4 Views |
|
36979-3
|
XR Elbow Jones |
|
37998-2
|
XR Elbow Radial head capitellar |
|
24676-9
|
XR Elbow Views |
|
36608-8
|
XR Elbow Oblique Views |
|
46381-0
|
XR Elbow and Radius and Ulna Views |
|
36649-2
|
XR Elbow - bilateral 2 Views |
|
36300-2
|
XR Elbow - bilateral 3 Views |
|
36322-6
|
XR Elbow - bilateral 4 Views |
|
36690-6
|
XR Elbow - bilateral AP and Lateral |
|
36723-5
|
XR Elbow - bilateral AP and Lateral and oblique |
|
48481-6
|
XR Elbow - bilateral GE 3 Views |
|
37999-0
|
XR Elbow - bilateral Radial head capitellar |
|
26109-9
|
XR Elbow - bilateral Views |
|
36740-9
|
XR Elbow - bilateral Oblique Views |
|
69056-0
|
XR Elbow - bilateral Views and Obliques |
|
46389-3
|
XR Elbow - bilateral Views and Radial head capitellar |
|
69308-5
|
XR Elbow - left Single view |
|
36650-0
|
XR Elbow - left 2 Views |
|
38844-7
|
XR Elbow - left 2 Oblique Views |
|
36301-0
|
XR Elbow - left 3 Views |
|
36323-4
|
XR Elbow - left 4 Views |
|
36691-4
|
XR Elbow - left AP and Lateral |
|
36724-3
|
XR Elbow - left AP and Lateral and oblique |
|
46344-8
|
XR Elbow - left GE 3 Views |
|
36980-1
|
XR Elbow - left Jones |
|
38000-6
|
XR Elbow - left Radial head capitellar |
|
26110-7
|
XR Elbow - left Views |
|
41826-9
|
XR Elbow - left Limited Views |
|
36741-7
|
XR Elbow - left Oblique Views |
|
69315-0
|
XR Elbow - right Single view |
|
37681-4
|
XR Elbow - right 2 Views |
|
37686-3
|
XR Elbow - right 2 Oblique Views |
|
37682-2
|
XR Elbow - right 3 Views |
|
37683-0
|
XR Elbow - right 4 Views |
|
37684-8
|
XR Elbow - right AP and Lateral |
|
37685-5
|
XR Elbow - right AP and Lateral and oblique |
|
46345-5
|
XR Elbow - right GE 3 Views |
|
38777-9
|
XR Elbow - right Jones |
|
38006-3
|
XR Elbow - right Radial head capitellar |
|
26111-5
|
XR Elbow - right Views |
|
41785-7
|
XR Elbow - right Limited Views |
|
37687-1
|
XR Elbow - right Oblique Views |
|
39373-6
|
XR Elbow - right Views and Oblique |
|
37198-9
|
XR Esophagus Views W contrast PO |
|
42153-7
|
XR Extremity Single view |
|
37637-6
|
XR Extremity Views |
|
44199-8
|
XR Facial bones 1 or 2 Views |
|
36297-0
|
XR Facial bones 3 Views |
|
36318-4
|
XR Facial bones 4 Views |
|
36675-7
|
XR Facial bones 5 Views |
|
48479-0
|
XR Facial bones GE 3 Views |
|
37164-1
|
XR Facial bones Lateral and Caldwell and Waters |
|
37165-8
|
XR Facial bones Lateral and Caldwell and Waters and Submentovertex |
|
37166-6
|
XR Facial bones Lateral and Caldwell and Waters and Submentovertex and Towne |
|
24695-9
|
XR Facial bones Views |
|
36737-5
|
XR Facial bones Limited Views |
|
83029-9
|
XR Facial bones and Zygomatic arch 1 or 2 Views |
|
37303-5
|
XR Facial bones and Zygomatic arch Views |
|
36559-3
|
XR Femur Single view |
|
36652-6
|
XR Femur 2 Views |
|
36302-8
|
XR Femur 3 Views |
|
36575-9
|
XR Femur AP |
|
36693-0
|
XR Femur AP and Lateral |
|
36593-2
|
XR Femur Lateral |
|
36609-6
|
XR Femur Oblique |
|
24704-9
|
XR Femur Views |
|
24700-7
|
XR Femur and Tibia Views for leg length |
|
39490-8
|
XR Femur and Tibia - right Views for leg length |
|
36653-4
|
XR Femur - bilateral 2 Views |
|
36694-8
|
XR Femur - bilateral AP and Lateral |
|
26118-0
|
XR Femur - bilateral Views |
|
36560-1
|
XR Femur - left Single view |
|
36654-2
|
XR Femur - left 2 Views |
|
36324-2
|
XR Femur - left 4 Views |
|
36695-5
|
XR Femur - left AP and Lateral |
|
26120-6
|
XR Femur - left Views |
|
38845-4
|
XR Femur - left Views W standing |
|
37689-7
|
XR Femur - right Single view |
|
37690-5
|
XR Femur - right 2 Views |
|
37691-3
|
XR Femur - right 4 Views |
|
37692-1
|
XR Femur - right AP and Lateral |
|
26122-2
|
XR Femur - right Views |
|
37693-9
|
XR Femur - right Views W standing |
|
37060-1
|
XR Fetal Views |
|
36655-9
|
XR Finger 2 Views |
|
36303-6
|
XR Finger 3 Views |
|
36725-0
|
XR Finger AP and Lateral and oblique |
|
79354-7
|
XR Finger GE 2 Views |
|
39078-1
|
XR Finger PA and Lateral and Oblique |
|
24706-4
|
XR Finger Views |
|
36596-5
|
XR Finger second Lateral |
|
36612-0
|
XR Finger second Oblique |
|
30780-1
|
XR Finger second Views |
|
37521-2
|
XR Finger second - bilateral Views |
|
43489-4
|
XR Finger second - left GE 3 Views |
|
37522-0
|
XR Finger second - left Views |
|
43494-4
|
XR Finger second - right GE 3 Views |
|
38144-2
|
XR Finger second - right Views |
|
36578-3
|
XR Finger third AP |
|
36597-3
|
XR Finger third Lateral |
|
36613-8
|
XR Finger third Oblique |
|
30781-9
|
XR Finger third Views |
|
93139-4
|
XR Distal phalanx of third finger Bone development stage |
|
93140-2
|
XR Middle phalanx of third finger Bone development stage |
|
93143-6
|
XR Proximal phalanx of third finger Bone development stage |
|
37523-8
|
XR Finger third - bilateral Views |
|
43490-2
|
XR Finger third - left GE 3 Views |
|
37524-6
|
XR Finger third - left Views |
|
43495-1
|
XR Finger third - right GE 3 Views |
|
38145-9
|
XR Finger third - right Views |
|
36577-5
|
XR Finger fourth AP |
|
36595-7
|
XR Finger fourth Lateral |
|
36611-2
|
XR Finger fourth Oblique |
|
30782-7
|
XR Finger fourth Views |
|
37519-6
|
XR Finger fourth - bilateral Views |
|
43491-0
|
XR Finger fourth - left GE 3 Views |
|
37520-4
|
XR Finger fourth - left Views |
|
43496-9
|
XR Finger fourth - right GE 3 Views |
|
38146-7
|
XR Finger fourth - right Views |
|
36576-7
|
XR Finger fifth AP |
|
36594-0
|
XR Finger fifth Lateral |
|
36610-4
|
XR Finger fifth Oblique |
|
30783-5
|
XR Finger fifth Views |
|
93138-6
|
XR Distal phalanx of fifth finger Bone development stage |
|
93141-0
|
XR Middle phalanx of fifth finger Bone development stage |
|
93142-8
|
XR Proximal phalanx of fifth finger Bone development stage |
|
37517-0
|
XR Finger fifth - bilateral Views |
|
43492-8
|
XR Finger fifth - left GE 3 Views |
|
37518-8
|
XR Finger fifth - left Views |
|
43497-7
|
XR Finger fifth - right GE 3 Views |
|
38147-5
|
XR Finger fifth - right Views |
|
36726-8
|
XR Finger - bilateral AP and Lateral and oblique |
|
26124-8
|
XR Finger - bilateral Views |
|
36656-7
|
XR Finger - left 2 Views |
|
36304-4
|
XR Finger - left 3 Views |
|
36727-6
|
XR Finger - left AP and Lateral and oblique |
|
26125-5
|
XR Finger - left Views |
|
37694-7
|
XR Finger - right 2 Views |
|
37695-4
|
XR Finger - right 3 Views |
|
37696-2
|
XR Finger - right AP and Lateral and oblique |
|
26126-3
|
XR Finger - right Views |
|
36561-9
|
XR Foot Single view |
|
83030-7
|
XR Foot 1 or 2 Views |
|
30784-3
|
XR Foot 2 Views |
|
36305-1
|
XR Foot 3 Views |
|
79355-4
|
XR Foot 3 Views W standing |
|
36579-1
|
XR Foot AP |
|
39069-0
|
XR Foot AP and Lateral |
|
39068-2
|
XR Foot AP and Lateral W standing |
|
36728-4
|
XR Foot AP and Lateral and oblique |
|
39076-5
|
XR Foot AP and Oblique |
|
44188-1
|
XR Foot GE 3 Views |
|
36976-9
|
XR Foot Harris |
|
37001-5
|
XR Foot Lateral W standing |
|
36614-6
|
XR Foot Oblique |
|
42398-8
|
XR Foot Oblique and (AP and Lateral W standing) |
|
24709-8
|
XR Foot Views |
|
30785-0
|
XR Foot Views W forced dorsiflexion |
|
24708-0
|
XR Foot Views W standing |
|
36657-5
|
XR Foot - bilateral 2 Views |
|
37068-4
|
XR Foot - bilateral 2 Views W standing |
|
36306-9
|
XR Foot - bilateral 3 Views |
|
36947-0
|
XR Foot - bilateral 3 Views W standing |
|
36580-9
|
XR Foot - bilateral AP |
|
36696-3
|
XR Foot - bilateral AP and Lateral |
|
39331-4
|
XR Foot - bilateral AP and Lateral W standing |
|
36729-2
|
XR Foot - bilateral AP and Lateral and oblique |
|
48478-2
|
XR Foot - bilateral GE 3 Views |
|
26127-1
|
XR Foot - bilateral Views |
|
26094-3
|
XR Foot - bilateral Views W standing |
|
69309-3
|
XR Foot - left Single view |
|
38846-2
|
XR Foot - left 2 Views |
|
37069-2
|
XR Foot - left 2 Views W standing |
|
36307-7
|
XR Foot - left 3 Views |
|
43499-3
|
XR Foot - left 3 or 4 Views |
|
36948-8
|
XR Foot - left 3 Views W standing |
|
36697-1
|
XR Foot - left AP and Lateral |
|
39332-2
|
XR Foot - left AP and Lateral W standing |
|
36730-0
|
XR Foot - left AP and Lateral and oblique |
|
39334-8
|
XR Foot - left AP and Lateral and oblique W standing |
|
48477-4
|
XR Foot - left GE 3 Views |
|
36598-1
|
XR Foot - left Lateral |
|
36615-3
|
XR Foot - left Oblique |
|
26128-9
|
XR Foot - left Views |
|
38003-0
|
XR Foot - left Views AP W standing |
|
26095-0
|
XR Foot - left Views W standing |
|
37559-2
|
XR Foot - left Views W manual stress |
|
69316-8
|
XR Foot - right Single view |
|
37697-0
|
XR Foot - right 2 Views |
|
37698-8
|
XR Foot - right 2 Views W standing |
|
37699-6
|
XR Foot - right 3 Views |
|
43483-7
|
XR Foot - right 3 or 4 Views |
|
37700-2
|
XR Foot - right 3 Views W standing |
|
37701-0
|
XR Foot - right AP and Lateral |
|
39374-4
|
XR Foot - right AP and Lateral W standing |
|
37702-8
|
XR Foot - right AP and Lateral and oblique |
|
39375-1
|
XR Foot - right AP and Lateral and oblique W standing |
|
48476-6
|
XR Foot - right GE 3 Views |
|
37703-6
|
XR Foot - right Lateral |
|
37704-4
|
XR Foot - right Oblique |
|
26129-7
|
XR Foot - right Views |
|
38815-7
|
XR Foot - right Views AP W standing |
|
26096-8
|
XR Foot - right Views W standing |
|
37705-1
|
XR Foot - right Views W manual stress |
|
42409-3
|
XR Foot sesamoid bones AP and Lateral |
|
42399-6
|
XR Foot sesamoid bones Views |
|
42395-4
|
XR Foot sesamoid bones - bilateral Axial |
|
42400-2
|
XR Foot sesamoid bones - bilateral Views |
|
42396-2
|
XR Foot sesamoid bones - left Axial |
|
43641-0
|
XR Foot sesamoid bones - left Views |
|
42434-1
|
XR Foot sesamoid bones - right Views |
|
24713-0
|
XR Gallbladder Views 48H post contrast PO |
|
24712-2
|
XR Gallbladder Views W contrast PO |
|
42383-0
|
XR Gallbladder Views W contrast PO and W contrast PO |
|
37575-8
|
XR Gallbladder Views W contrast and fatty meal PO |
|
39149-0
|
XR Gastrointestinal tract and Pulmonary system Single view for foreign body |
|
37532-9
|
XR Great toe - bilateral Views |
|
37533-7
|
XR Great toe - left Views |
|
37584-0
|
XR Great toe - left Views W standing |
|
38152-5
|
XR Great toe - right Views |
|
38810-8
|
XR Great toe - right Views W standing |
|
46371-1
|
XR Guidance for change of percutaneous tube in Unspecified body region-- W contrast |
|
93135-2
|
XR Hamate Bone development stage |
|
36563-5
|
XR Hand Single view |
|
79356-2
|
XR Hand 1 or 2 Views |
|
24721-3
|
XR Hand 2 Views |
|
24722-1
|
XR Hand 3 Views |
|
69130-3
|
XR Hand AP and Lateral |
|
24723-9
|
XR Hand Arthritis |
|
36965-2
|
XR Hand Ball Catcher |
|
79357-0
|
XR Hand GE 3 Views |
|
36599-9
|
XR Hand Lateral |
|
36616-1
|
XR Hand Oblique |
|
36621-1
|
XR Hand PA |
|
36755-7
|
XR Hand PA and Lateral and Oblique |
|
39079-9
|
XR Hand PA and Oblique |
|
28582-5
|
XR Hand Views |
|
26388-9
|
XR Hand - bilateral 2 Views |
|
26379-8
|
XR Hand - bilateral 3 Views |
|
48474-1
|
XR Hand - bilateral AP and Lateral |
|
69057-8
|
XR Hand - bilateral AP and Lateral and oblique |
|
26355-8
|
XR Hand - bilateral Arthritis |
|
37471-0
|
XR Hand - bilateral Bora |
|
36966-0
|
XR Hand - bilateral Brewerton |
|
36600-5
|
XR Hand - bilateral Lateral |
|
36622-9
|
XR Hand - bilateral PA |
|
36752-4
|
XR Hand - bilateral PA and Lateral |
|
37142-7
|
XR Hand - bilateral PA and Lateral and Ball Catcher |
|
36756-5
|
XR Hand - bilateral PA and Lateral and Oblique |
|
36629-4
|
XR Hand - bilateral Views |
|
69310-1
|
XR Hand - left Single view |
|
26389-7
|
XR Hand - left 2 Views |
|
26380-6
|
XR Hand - left 3 Views |
|
38847-0
|
XR Hand - left AP and Lateral |
|
38848-8
|
XR Hand - left AP and Lateral and oblique |
|
26356-6
|
XR Hand - left Arthritis |
|
37472-8
|
XR Hand - left Bora |
|
36967-8
|
XR Hand - left Brewerton |
|
47370-2
|
XR Hand - left GE 3 Views |
|
36601-3
|
XR Hand - left Lateral |
|
36623-7
|
XR Hand - left PA |
|
36753-2
|
XR Hand - left PA and Lateral |
|
36757-3
|
XR Hand - left PA and Lateral and Oblique |
|
36630-2
|
XR Hand - left Views |
|
41830-1
|
XR Hand - left Limited Views |
|
69318-4
|
XR Hand - right Single view |
|
26390-5
|
XR Hand - right 2 Views |
|
26381-4
|
XR Hand - right 3 Views |
|
37710-1
|
XR Hand - right AP and Lateral |
|
37711-9
|
XR Hand - right AP and Lateral and oblique |
|
26357-4
|
XR Hand - right Arthritis |
|
38804-1
|
XR Hand - right Bora |
|
38775-3
|
XR Hand - right Brewerton |
|
47371-0
|
XR Hand - right GE 3 Views |
|
37712-7
|
XR Hand - right Lateral |
|
37714-3
|
XR Hand - right PA |
|
37713-5
|
XR Hand - right PA and Lateral |
|
37715-0
|
XR Hand - right PA and Lateral and Oblique |
|
37716-8
|
XR Hand - right Views |
|
41789-9
|
XR Hand - right Limited Views |
|
91720-3
|
XR Head to Abdomen Views for shunt patency |
|
36564-3
|
XR Calcaneus Single view |
|
36661-7
|
XR Calcaneus 2 Views |
|
36731-8
|
XR Calcaneus AP and Lateral and oblique |
|
24612-4
|
XR Calcaneus Views |
|
37996-6
|
XR Calcaneus Broden Views |
|
37022-1
|
XR Calcaneus Ski jump Views |
|
37205-2
|
XR Calcaneus Views W standing |
|
37058-5
|
XR Calcaneus - bilateral Single view W standing |
|
48433-7
|
XR Calcaneus - bilateral 2 Views |
|
36686-4
|
XR Calcaneus - bilateral AP and Lateral |
|
36975-1
|
XR Calcaneus - bilateral Harris |
|
26100-8
|
XR Calcaneus - bilateral Views |
|
37995-8
|
XR Calcaneus - bilateral Broden Views |
|
37021-3
|
XR Calcaneus - bilateral Ski jump Views |
|
69311-9
|
XR Calcaneus - left Single view |
|
36662-5
|
XR Calcaneus - left 2 Views |
|
36701-1
|
XR Calcaneus - left AP and Lateral |
|
36977-7
|
XR Calcaneus - left Harris |
|
26101-6
|
XR Calcaneus - left Views |
|
37997-4
|
XR Calcaneus - left Broden Views |
|
37023-9
|
XR Calcaneus - left Ski jump Views |
|
37206-0
|
XR Calcaneus - left Views W standing |
|
69319-2
|
XR Calcaneus - right Single view |
|
37718-4
|
XR Calcaneus - right 2 Views |
|
37719-2
|
XR Calcaneus - right AP and Lateral |
|
38776-1
|
XR Calcaneus - right Harris |
|
26102-4
|
XR Calcaneus - right Views |
|
38814-0
|
XR Calcaneus - right Broden Views |
|
38778-7
|
XR Calcaneus - right Ski jump Views |
|
37720-0
|
XR Calcaneus - right Views W standing |
|
83033-1
|
XR Hip single view during surgery |
|
24761-9
|
XR Hip Single view |
|
36663-3
|
XR Hip 2 Views |
|
36581-7
|
XR Hip AP |
|
36702-9
|
XR Hip AP and Lateral |
|
37091-6
|
XR Hip AP and Lateral frog |
|
37086-6
|
XR Hip AP and Lateral crosstable |
|
69132-9
|
XR Hip Danelius Miller |
|
36973-6
|
XR Hip Friedman |
|
79361-2
|
XR Hip GE 2 Views |
|
83032-3
|
XR Hip GE 2 Views preoperative |
|
36981-9
|
XR Hip Judet |
|
36602-1
|
XR Hip Lateral |
|
30786-8
|
XR Hip Lateral frog |
|
36985-0
|
XR Hip Lateral crosstable |
|
36617-9
|
XR Hip Oblique |
|
37039-5
|
XR Hip True lateral |
|
24762-7
|
XR Hip Views |
|
47372-8
|
XR Hip Views during surgery |
|
69131-1
|
XR Hip Views and Danelius Miller |
|
37049-4
|
XR Hip Von Rosen |
|
26400-2
|
XR Hip - bilateral Single view |
|
37059-3
|
XR Hip - bilateral Single view W standing |
|
69058-6
|
XR Hip - bilateral 2 Views |
|
36308-5
|
XR Hip - bilateral 3 Views |
|
36703-7
|
XR Hip - bilateral AP and Lateral |
|
37092-4
|
XR Hip - bilateral AP and Lateral frog |
|
79358-8
|
XR Hip - bilateral GE 4 Views |
|
36982-7
|
XR Hip - bilateral Judet |
|
36993-4
|
XR Hip - bilateral Lateral frog |
|
36986-8
|
XR Hip - bilateral Lateral crosstable |
|
36618-7
|
XR Hip - bilateral Oblique |
|
26130-5
|
XR Hip - bilateral Views |
|
69059-4
|
XR Hip - bilateral Views and Lateral crosstable |
|
26401-0
|
XR Hip - left Single view |
|
38065-9
|
XR Hip - left Single view during surgery |
|
37207-8
|
XR Hip - left Single view W standing |
|
36664-1
|
XR Hip - left 2 Views |
|
36309-3
|
XR Hip - left 3 Views |
|
36582-5
|
XR Hip - left AP |
|
36704-5
|
XR Hip - left AP and Lateral |
|
42404-4
|
XR Hip - left AP and Lateral Views for measurement |
|
37093-2
|
XR Hip - left AP and Lateral frog |
|
37087-4
|
XR Hip - left AP and Lateral crosstable |
|
69141-0
|
XR Hip - left Danelius Miller |
|
79359-6
|
XR Hip - left GE 2 Views |
|
36983-5
|
XR Hip - left Judet |
|
36603-9
|
XR Hip - left Lateral |
|
36994-2
|
XR Hip - left Lateral frog |
|
38066-7
|
XR Hip - left Lateral during surgery |
|
36987-6
|
XR Hip - left Lateral crosstable |
|
37545-1
|
XR Hip - left Oblique crosstable |
|
37040-3
|
XR Hip - left True lateral |
|
26131-3
|
XR Hip - left Views |
|
69140-2
|
XR Hip - left Views and Danelius Miller |
|
69139-4
|
XR Hip - left Views and Lateral crosstable |
|
26402-8
|
XR Hip - right Single view |
|
38818-1
|
XR Hip - right Single view during surgery |
|
37731-7
|
XR Hip - right Single view W standing |
|
37721-8
|
XR Hip - right 2 Views |
|
37722-6
|
XR Hip - right 3 Views |
|
37726-7
|
XR Hip - right AP |
|
39512-9
|
XR Hip - right AP and Danelius Miller |
|
37725-9
|
XR Hip - right AP and Lateral |
|
37724-2
|
XR Hip - right AP and Lateral frog |
|
37723-4
|
XR Hip - right AP and Lateral crosstable |
|
39514-5
|
XR Hip - right Danelius Miller |
|
79360-4
|
XR Hip - right GE 2 Views |
|
37732-5
|
XR Hip - right Judet |
|
37730-9
|
XR Hip - right Lateral |
|
37729-1
|
XR Hip - right Lateral frog |
|
38819-9
|
XR Hip - right Lateral during surgery |
|
37727-5
|
XR Hip - right Lateral crosstable |
|
37728-3
|
XR Hip - right Oblique crosstable |
|
38772-0
|
XR Hip - right True lateral |
|
26132-1
|
XR Hip - right Views |
|
39513-7
|
XR Hip - right Views and Danelius Miller |
|
39377-7
|
XR Hip - right Views and Lateral crosstable |
|
36565-0
|
XR Humerus Single view |
|
42008-3
|
XR Humerus Single view during surgery |
|
24765-0
|
XR Humerus 2 Views |
|
36706-0
|
XR Humerus AP and Lateral |
|
37485-0
|
XR Humerus AP and Transthoracic |
|
37319-1
|
XR Humerus bicipital groove Views |
|
37321-7
|
XR Humerus bicipital groove - bilateral Views |
|
37320-9
|
XR Humerus bicipital groove - left Views |
|
38797-7
|
XR Humerus bicipital groove - right Views |
|
79362-0
|
XR Humerus GE 2 Views |
|
37031-2
|
XR Humerus Transthoracic |
|
28567-6
|
XR Humerus Views |
|
26391-3
|
XR Humerus - bilateral 2 Views |
|
36707-8
|
XR Humerus - bilateral AP and Lateral |
|
37032-0
|
XR Humerus - bilateral Transthoracic |
|
37062-7
|
XR Humerus - bilateral Views |
|
69312-7
|
XR Humerus - left Single view |
|
26392-1
|
XR Humerus - left 2 Views |
|
36708-6
|
XR Humerus - left AP and Lateral |
|
37033-8
|
XR Humerus - left Transthoracic |
|
36632-8
|
XR Humerus - left Views |
|
36744-1
|
XR Humerus - left Oblique Views |
|
69320-0
|
XR Humerus - right Single view |
|
26393-9
|
XR Humerus - right 2 Views |
|
37736-6
|
XR Humerus - right AP and Lateral |
|
38007-1
|
XR Humerus - right Transthoracic |
|
37738-2
|
XR Humerus - right Views |
|
37737-4
|
XR Humerus - right Oblique Views |
|
36628-6
|
XR Internal auditory canal Views |
|
30787-6
|
XR Joint Single view |
|
43480-3
|
XR Joint Lateral Views W manual stress |
|
43481-1
|
XR Joint Views W flexion and W extension |
|
24778-3
|
XR Kidney - bilateral 3 Serial Views WO and W contrast IV |
|
24788-2
|
XR Kidney - bilateral Views W contrast IV |
|
43485-2
|
XR Kidney Views during surgery W contrast retrograde |
|
37137-7
|
XR Kidney Limited Views W contrast IV |
|
38101-2
|
XR Kidney Views W contrast antegrade |
|
37607-9
|
XR Kidney Views W contrast IV |
|
38105-3
|
XR Kidney Views W contrast retrograde |
|
38102-0
|
XR Kidney Views W contrast antegrade via pyelostomy |
|
42405-1
|
XR Knee (AP W standing) and (Lateral W extension) |
|
44198-0
|
XR Knee 1 or 2 Views |
|
83035-6
|
XR Knee 1 or 2 Views during surgery |
|
24806-2
|
XR Knee 2 Views |
|
30788-4
|
XR Knee 3 Views |
|
30789-2
|
XR Knee 4 Views |
|
36584-1
|
XR Knee AP |
|
24807-0
|
XR Knee AP W standing |
|
36709-4
|
XR Knee AP and Lateral |
|
24805-4
|
XR Knee AP and Lateral W standing |
|
37090-8
|
XR Knee AP and Lateral crosstable |
|
39071-6
|
XR Knee AP and Lateral and Merchants |
|
37115-3
|
XR Knee AP and Lateral and Oblique and Tunnel |
|
39073-2
|
XR Knee AP and Lateral and Right oblique and Left oblique |
|
37106-2
|
XR Knee AP and Lateral and Sunrise |
|
37111-2
|
XR Knee AP and Lateral and Sunrise and tunnel |
|
37112-0
|
XR Knee AP and Lateral and Tunnel |
|
24808-8
|
XR Knee AP and PA W standing |
|
91598-3
|
XR Knee GE 2 Views |
|
79364-6
|
XR Knee GE 4 Views |
|
44195-6
|
XR Knee GE 5 Views |
|
36978-5
|
XR Knee Holmblad |
|
36604-7
|
XR Knee Lateral |
|
36988-4
|
XR Knee Lateral crosstable |
|
37004-9
|
XR Knee Laurin |
|
24801-3
|
XR Knee Merchants |
|
38086-5
|
XR Knee Merchants 30 and 45 and 60 degrees |
|
37154-2
|
XR Knee Oblique and Sunrise |
|
37155-9
|
XR Knee Oblique and Sunrise and Tunnel |
|
37476-9
|
XR Knee PA 45 degree flexion |
|
37477-7
|
XR Knee PA 45 degree flexion W standing |
|
37018-9
|
XR Knee Rosenberg W standing |
|
43780-6
|
XR Knee Sunrise |
|
69136-0
|
XR Knee Sunrise and Tunnel |
|
30790-0
|
XR Knee Tunnel |
|
28565-0
|
XR Knee Views |
|
36619-5
|
XR Knee Oblique Views |
|
24809-6
|
XR Knee Views W standing |
|
37560-0
|
XR Knee Views W manual stress |
|
36566-8
|
XR Knee - bilateral Single view |
|
26394-7
|
XR Knee - bilateral 2 Views |
|
36945-4
|
XR Knee - bilateral 2 Views W standing |
|
69060-2
|
XR Knee - bilateral 2 Views and Sunrise |
|
69061-0
|
XR Knee - bilateral 2 Views and Tunnel |
|
36310-1
|
XR Knee - bilateral 3 Views |
|
36325-9
|
XR Knee - bilateral 4 Views |
|
69062-8
|
XR Knee - bilateral 4 Views W standing |
|
69063-6
|
XR Knee - bilateral 4 Views and Sunrise and Tunnel |
|
36678-1
|
XR Knee - bilateral 6 Views |
|
36682-3
|
XR Knee - bilateral 8 Views |
|
36585-8
|
XR Knee - bilateral AP |
|
26358-2
|
XR Knee - bilateral AP W standing |
|
36590-8
|
XR Knee - bilateral AP and Lateral |
|
26364-0
|
XR Knee - bilateral AP and Lateral W standing |
|
79363-8
|
XR Knee - bilateral AP and Lateral and Merchants and (Views W standing) |
|
36732-6
|
XR Knee - bilateral AP and Lateral and oblique |
|
37102-1
|
XR Knee - bilateral AP and Lateral and Oblique and Sunrise |
|
37118-7
|
XR Knee - bilateral AP and Lateral and Oblique and Sunrise and Tunnel |
|
37107-0
|
XR Knee - bilateral AP and Lateral and Sunrise |
|
37116-1
|
XR Knee - bilateral AP and Lateral and Sunrise and tunnel |
|
37113-8
|
XR Knee - bilateral AP and Lateral and Tunnel |
|
26361-6
|
XR Knee - bilateral AP and PA W standing |
|
44197-2
|
XR Knee - bilateral GE 5 Views W standing |
|
36605-4
|
XR Knee - bilateral Lateral |
|
36999-1
|
XR Knee - bilateral Lateral W extension |
|
26283-2
|
XR Knee - bilateral Merchants |
|
37020-5
|
XR Knee - bilateral Rosenberg W standing |
|
37027-0
|
XR Knee - bilateral Sunrise |
|
38088-1
|
XR Knee - bilateral Sunrise 20 and 40 and 60 degrees |
|
37163-3
|
XR Knee - bilateral Sunrise and Tunnel |
|
69064-4
|
XR Knee - bilateral Sunrise and (Views W standing) |
|
37041-1
|
XR Knee - bilateral Tunnel |
|
36635-1
|
XR Knee - bilateral Views |
|
37540-2
|
XR Knee - bilateral Holmblad Views W standing |
|
36745-8
|
XR Knee - bilateral Oblique Views |
|
46378-6
|
XR Knee - bilateral PA Views W standing and W flexion |
|
26085-1
|
XR Knee - bilateral Views W standing |
|
37561-8
|
XR Knee - bilateral Views W manual stress |
|
51387-9
|
XR Knee - bilateral Views and (AP W standing) |
|
36567-6
|
XR Knee - left Single view |
|
47373-6
|
XR Knee - left 1 or 2 Views |
|
26395-4
|
XR Knee - left 2 Views |
|
38871-0
|
XR Knee - left 2 Oblique Views |
|
38851-2
|
XR Knee - left 2 Views W standing |
|
69142-8
|
XR Knee - left 2 Views and Sunrise |
|
41819-4
|
XR Knee - left 2 Views and Tunnel |
|
69143-6
|
XR Knee - left 2 views and (Tunnel W standing) |
|
36311-9
|
XR Knee - left 3 Views |
|
36326-7
|
XR Knee - left 4 Views |
|
38852-0
|
XR Knee - left 4 Views W standing |
|
69144-4
|
XR Knee - left 4 views and (AP W standing) |
|
69145-1
|
XR Knee - left 4 views and Tunnel |
|
36676-5
|
XR Knee - left 5 Views |
|
48462-6
|
XR Knee - left AP |
|
26359-0
|
XR Knee - left AP W standing |
|
36710-2
|
XR Knee - left AP and Lateral |
|
26365-7
|
XR Knee - left AP and Lateral W standing |
|
69146-9
|
XR Knee - left AP and Lateral crosstable |
|
36733-4
|
XR Knee - left AP and Lateral and oblique |
|
69147-7
|
XR Knee - left AP and Lateral and Right oblique and Left oblique |
|
37108-8
|
XR Knee - left AP and Lateral and Sunrise |
|
37117-9
|
XR Knee - left AP and Lateral and Sunrise and tunnel |
|
37114-6
|
XR Knee - left AP and Lateral and Tunnel |
|
26362-4
|
XR Knee - left AP and PA W standing |
|
43498-5
|
XR Knee - left GE 3 Views |
|
47374-4
|
XR Knee - left GE 4 Views |
|
36606-2
|
XR Knee - left Lateral |
|
37000-7
|
XR Knee - left Lateral W extension |
|
37002-3
|
XR Knee - left Lateral W standing |
|
26284-0
|
XR Knee - left Merchants |
|
37014-8
|
XR Knee - left PA W standing |
|
37019-7
|
XR Knee - left Rosenberg W standing |
|
43779-8
|
XR Knee - left Sunrise |
|
38087-3
|
XR Knee - left Sunrise 20 and 40 and 60 degrees |
|
37156-7
|
XR Knee - left Sunrise and Tunnel |
|
39345-4
|
XR Knee - left Sunrise and (Tunnel W standing) |
|
69149-3
|
XR Knee - left Sunrise and (Views W standing) |
|
37042-9
|
XR Knee - left Tunnel |
|
37043-7
|
XR Knee - left Tunnel W standing |
|
36636-9
|
XR Knee - left Views |
|
37484-3
|
XR Knee - left Views AP W manual stress |
|
36746-6
|
XR Knee - left Oblique Views |
|
26086-9
|
XR Knee - left Views W standing |
|
37562-6
|
XR Knee - left Views W manual stress |
|
69148-5
|
XR Knee - left Views and Tunnel |
|
37741-6
|
XR Knee - right Single view |
|
47375-1
|
XR Knee - right 1 or 2 Views |
|
26396-2
|
XR Knee - right 2 Views |
|
39382-7
|
XR Knee - right 2 views and (Tunnel W standing) |
|
38108-7
|
XR Knee - right 2 Oblique Views |
|
37762-2
|
XR Knee - right 2 Views W standing |
|
42430-9
|
XR Knee - right 2 views and (Views W standing) |
|
39378-5
|
XR Knee - right 2 Views and Oblique |
|
39379-3
|
XR Knee - right 2 Views and Sunrise |
|
39380-1
|
XR Knee - right 2 Views and Sunrise and Tunnel |
|
39381-9
|
XR Knee - right 2 Views and Tunnel |
|
37742-4
|
XR Knee - right 3 Views |
|
39383-5
|
XR Knee - right 3 Views and Sunrise |
|
37743-2
|
XR Knee - right 4 Views |
|
37763-0
|
XR Knee - right 4 Views W standing |
|
39384-3
|
XR Knee - right 4 views and (AP W standing) |
|
39385-0
|
XR Knee - right 4 Views and Oblique |
|
39387-6
|
XR Knee - right 4 Views and Sunrise and Tunnel |
|
39386-8
|
XR Knee - right 4 views and Tunnel |
|
37744-0
|
XR Knee - right 5 Views |
|
48463-4
|
XR Knee - right AP |
|
26360-8
|
XR Knee - right AP W standing |
|
37745-7
|
XR Knee - right AP and Lateral |
|
26366-5
|
XR Knee - right AP and Lateral W standing |
|
37748-1
|
XR Knee - right AP and Lateral and oblique |
|
39388-4
|
XR Knee - right AP and Lateral and Right oblique and Left oblique |
|
37749-9
|
XR Knee - right AP and Lateral and Sunrise |
|
37740-8
|
XR Knee - right AP and Lateral and Sunrise and tunnel |
|
37747-3
|
XR Knee - right AP and Lateral and Tunnel |
|
26363-2
|
XR Knee - right AP and PA W standing |
|
43482-9
|
XR Knee - right GE 3 Views |
|
47376-9
|
XR Knee - right GE 4 Views |
|
37751-5
|
XR Knee - right Lateral |
|
37750-7
|
XR Knee - right Lateral W extension |
|
37754-9
|
XR Knee - right Lateral W standing |
|
47377-7
|
XR Knee - right LE 4 Views |
|
26285-7
|
XR Knee - right Merchants |
|
42431-7
|
XR Knee - right PA 30 degree flexion W standing |
|
37755-6
|
XR Knee - right PA W standing |
|
37752-3
|
XR Knee - right Rosenberg W standing |
|
69256-6
|
XR Knee - right Sunrise |
|
38824-9
|
XR Knee - right Sunrise 20 and 40 and 60 degrees |
|
42432-5
|
XR Knee - right Sunrise and (Views W standing) |
|
37759-8
|
XR Knee - right Sunrise and Tunnel |
|
69255-8
|
XR Knee - right Sunrise and (Tunnel W standing) |
|
37761-4
|
XR Knee - right Tunnel |
|
37756-4
|
XR Knee - right Tunnel W standing |
|
37758-0
|
XR Knee - right Views |
|
37746-5
|
XR Knee - right Views AP W manual stress |
|
37757-2
|
XR Knee - right Oblique Views |
|
26087-7
|
XR Knee - right Views W standing |
|
37753-1
|
XR Knee - right Views W manual stress |
|
39390-0
|
XR Knee - right Views and Oblique |
|
39391-8
|
XR Knee - right Views and Sunrise |
|
39389-2
|
XR Knee - right Views and Tunnel |
|
36651-8
|
XR Lower extremity 2 Views |
|
36574-2
|
XR Lower extremity AP |
|
36692-2
|
XR Lower extremity AP and Lateral |
|
83036-4
|
XR Lower extremity GE 2 Views |
|
24686-8
|
XR Lower extremity Views |
|
37204-5
|
XR Lower extremity Views W standing |
|
36557-7
|
XR Lower extremity - bilateral Single view |
|
44205-3
|
XR Lower extremity - bilateral Single view W standing |
|
44177-4
|
XR Lower extremity - bilateral AP W standing |
|
26112-3
|
XR Lower extremity - bilateral Views |
|
36558-5
|
XR Lower extremity - left Single view |
|
38850-4
|
XR Lower extremity - left Single view W standing |
|
38849-6
|
XR Lower extremity - left AP W standing |
|
26113-1
|
XR Lower extremity - left Views |
|
37764-8
|
XR Lower extremity - right Single view |
|
37734-1
|
XR Lower extremity - right Single view W standing |
|
69257-4
|
XR Lower extremity - right 2 Views |
|
37733-3
|
XR Lower extremity - right AP W standing |
|
69258-2
|
XR Lower extremity - right AP and Lateral |
|
26114-9
|
XR Lower extremity - right Views |
|
37515-4
|
XR Spine lumbosacral junction Lateral spot |
|
37516-2
|
XR Spine lumbosacral junction Lateral spot W standing |
|
37300-1
|
XR Spine lumbosacral junction True AP |
|
46340-6
|
XR Spine lumbosacral junction Views |
|
42411-9
|
XR Lumbar spine (AP^W R-bending and W L-bending) and (Lateral^W flexion and W extension) |
|
42401-0
|
XR Lumbar spine Lumbar (AP W R-bending and W L-bending and WO bending) and Lateral |
|
30773-6
|
XR Lumbar spine Single view |
|
83037-2
|
XR Lumbar spine Single view during surgery |
|
36670-8
|
XR Lumbar spine 2 Views |
|
48469-1
|
XR Lumbar spine 2 or 3 Views |
|
36946-2
|
XR Lumbar spine 2 Views W standing |
|
30775-1
|
XR Lumbar spine 3 Views |
|
36949-6
|
XR Lumbar spine 3 Views W standing |
|
36332-5
|
XR Lumbar spine 4 Views |
|
30797-5
|
XR Lumbar spine 5 Views |
|
39063-3
|
XR Lumbar spine 5 Views W flexion and W extension |
|
37073-4
|
XR Lumbar spine 5 Views W standing |
|
36681-5
|
XR Lumbar spine 7 Views |
|
30777-7
|
XR Lumbar spine AP |
|
42378-0
|
XR Lumbar spine AP W left bending |
|
42379-8
|
XR Lumbar spine AP W right bending |
|
24970-6
|
XR Lumbar spine AP and Lateral |
|
39333-0
|
XR Lumbar spine AP and Lateral W standing |
|
36735-9
|
XR Lumbar spine AP and Lateral and oblique |
|
37101-3
|
XR Lumbar spine AP and Lateral and Oblique and Spot |
|
42410-1
|
XR Lumbar spine AP and Lateral and Oblique and Spot W standing |
|
37105-4
|
XR Lumbar spine AP and Lateral and Spot |
|
47382-7
|
XR Lumbar spine GE 4 Views |
|
44196-4
|
XR Lumbar spine GE 5 Views W right bending and W left bending |
|
83038-0
|
XR Lumbar spine Greater than 4 views and (Greater than 1 view W R-bending and W L-bending) |
|
24969-8
|
XR Lumbar spine Lateral |
|
37003-1
|
XR Lumbar spine Lateral W standing |
|
36990-0
|
XR Lumbar spine Lateral crosstable |
|
37009-8
|
XR Lumbar spine Left oblique |
|
30778-5
|
XR Lumbar spine Oblique |
|
44178-2
|
XR Lumbar spine oblique and (views W right bending and W left bending) |
|
37011-4
|
XR Lumbar spine Right oblique |
|
24972-2
|
XR Lumbar spine Views |
|
42403-6
|
XR Lumbar spine Views AP W right bending and W left bending |
|
42408-5
|
XR Lumbar spine Views AP W right bending and W left bending and WO bending |
|
42406-9
|
XR Lumbar spine Views AP W and WO left bending |
|
42407-7
|
XR Lumbar spine Views AP W and WO right bending |
|
37132-8
|
XR Lumbar spine Lateral Views W flexion and W extension |
|
39340-5
|
XR Lumbar spine Lateral Views W standing and W flexion and W extension |
|
43791-3
|
XR Lumbar spine Oblique Views |
|
24971-4
|
XR Lumbar spine Views W flexion and W extension |
|
42413-5
|
XR Lumbar spine Views W right bending and W left bending |
|
37208-6
|
XR Lumbar spine Views W standing |
|
42163-6
|
XR Lumbar spine Views and Oblique |
|
37259-9
|
XR Spine Lumbar and Sacrum 3 Views |
|
48473-3
|
XR Spine Lumbar and Sacrum 4 Views |
|
37355-5
|
XR Spine Lumbar and Sacrum 5 Views |
|
79371-1
|
XR Spine Lumbar and Sacrum GE 2 Views |
|
79372-9
|
XR Spine Lumbar and Sacrum GE 4 Views |
|
79349-7
|
XR Spine Lumbar and Sacrum GE 6 Views |
|
37340-7
|
XR Spine Lumbar and Sacrum Views |
|
37260-7
|
XR Spine Lumbar and Sacrum and Coccyx 3 Views |
|
37356-3
|
XR Spine Lumbar and Sacrum and Coccyx 5 Views |
|
37341-5
|
XR Spine Lumbar and Sacrum and Coccyx Views |
|
37261-5
|
XR Lumbar spine and Sacrum and SI joint and Coccyx 3 Views |
|
37357-1
|
XR Lumbar spine and Sacrum and SI joint and Coccyx 5 Views |
|
37342-3
|
XR Lumbar spine and Sacrum and SI joint and Coccyx Views |
|
37257-3
|
XR Spine Lumbar and Sacroiliac Joint 3 Views |
|
37353-0
|
XR Spine Lumbar and Sacroiliac Joint 5 Views |
|
24975-5
|
XR Spine.lumbar and Sacroiliac joint - bilateral Views |
|
93133-7
|
XR Lunate Bone development stage |
|
24825-2
|
XR Lung Views W contrast intrabronchial |
|
30813-0
|
XR Lung - bilateral Views W contrast intrabronchial |
|
64996-2
|
XR Lung - left Views W contrast intrabronchial |
|
64997-0
|
XR Lung - right Views W contrast intrabronchial |
|
43521-4
|
XR Mandible 1 or 2 Views |
|
36312-7
|
XR Mandible 3 Views |
|
36327-5
|
XR Mandible 4 Views |
|
36711-0
|
XR Mandible AP and Lateral |
|
47379-3
|
XR Mandible GE 4 Views |
|
47380-1
|
XR Mandible LE 3 Views |
|
36754-0
|
XR Mandible PA and Lateral |
|
37148-4
|
XR Mandible PA and Lateral and Oblique and Towne |
|
24829-4
|
XR Mandible Views |
|
36738-3
|
XR Mandible Limited Views |
|
36747-4
|
XR Mandible Oblique Views |
|
36838-1
|
XR Mastoid 3 Views |
|
36839-9
|
XR Mastoid 4 Views |
|
36890-2
|
XR Mastoid 5 Views |
|
47381-9
|
XR Mastoid GE 3 Views |
|
37153-4
|
XR Mastoid Stenver and Arcelin |
|
24830-2
|
XR Mastoid Views |
|
36893-6
|
XR Mastoid Limited Views |
|
47983-2
|
XR Mastoid - bilateral 1 or 2 Views |
|
83039-8
|
XR Mastoid - bilateral GE 3 Views |
|
37541-0
|
XR Mastoid - bilateral Law and Mayer and Stenver and Towne |
|
26139-6
|
XR Mastoid - bilateral Views |
|
42007-5
|
XR Mastoid - bilateral Limited Views |
|
48489-9
|
XR Mastoid - left 1 or 2 Views |
|
48470-9
|
XR Mastoid - left 3 Views |
|
26140-4
|
XR Mastoid - left Views |
|
48488-1
|
XR Mastoid - right 1 or 2 Views |
|
48471-7
|
XR Mastoid - right 3 Views |
|
26141-2
|
XR Mastoid - right Views |
|
36637-7
|
XR Maxilla Views |
|
93147-7
|
XR First metacarpal Bone development stage |
|
93146-9
|
XR Third metacarpal Bone development stage |
|
93145-1
|
XR Fifth metacarpal Bone development stage |
|
37604-6
|
XR Nasal bones 3 Views |
|
37605-3
|
XR Nasal bones Lateral and Waters |
|
24834-4
|
XR Nasal bones Views |
|
38118-6
|
XR Neck 2 Lateral Views |
|
42439-0
|
XR Neck AP |
|
42438-2
|
XR Neck AP and Lateral |
|
24843-5
|
XR Neck Lateral |
|
42441-6
|
XR Neck Magnification |
|
37639-2
|
XR Neck Views |
|
37332-4
|
XR Olecranon - left Views |
|
38798-5
|
XR Olecranon - right Views |
|
37609-5
|
XR Optic foramen 4 Views |
|
24846-8
|
XR Optic foramen Views |
|
26142-0
|
XR Optic foramen - bilateral Views |
|
26143-8
|
XR Optic foramen - left Views |
|
26144-6
|
XR Optic foramen - right Views |
|
36886-0
|
XR Orbit Views |
|
44208-7
|
XR Orbit Views for foreign body |
|
43529-7
|
XR Orbit and Facial bones Views |
|
37612-9
|
XR Orbit - bilateral 4 Views |
|
48747-0
|
XR Orbit - bilateral GE 4 Views |
|
24854-2
|
XR Orbit - bilateral Views |
|
30720-7
|
XR Orbit - bilateral Views for foreign body |
|
37613-7
|
XR Orbit - bilateral Waters |
|
36887-8
|
XR Orbit - left Views |
|
42311-1
|
XR Orbit - left Views for foreign body |
|
38774-6
|
XR Orbit - right Views |
|
42312-9
|
XR Orbit - right Views for foreign body |
|
37614-5
|
XR Patella Single view |
|
24861-7
|
XR Patella 2 Views |
|
69239-2
|
XR Patella Sunrise |
|
30791-8
|
XR Patella Views |
|
26397-0
|
XR Patella - bilateral 2 Views |
|
36712-8
|
XR Patella - bilateral AP and Lateral |
|
37109-6
|
XR Patella - bilateral AP and Lateral and Sunrise |
|
69069-3
|
XR Patella - bilateral Sunrise |
|
36638-5
|
XR Patella - bilateral Views |
|
69152-7
|
XR Patella - left Single view |
|
26398-8
|
XR Patella - left 2 Views |
|
36713-6
|
XR Patella - left AP and Lateral |
|
37110-4
|
XR Patella - left AP and Lateral and Sunrise |
|
37149-2
|
XR Patella - left PA and Lateral and Sunrise |
|
36639-3
|
XR Patella - left Views |
|
69260-8
|
XR Patella - right Single view |
|
26399-6
|
XR Patella - right 2 Views |
|
69261-6
|
XR Patella - right 3 Views |
|
37776-2
|
XR Patella - right AP and Lateral |
|
38786-0
|
XR Patella - right AP and Lateral and Sunrise |
|
38790-2
|
XR Patella - right PA and Lateral and Sunrise |
|
37777-0
|
XR Patella - right Views |
|
37616-0
|
XR Pelvis Single view |
|
43522-2
|
XR Pelvis 1 or 2 Views |
|
37633-5
|
XR Pelvis Single view W standing |
|
37617-8
|
XR Pelvis 2 Views |
|
30766-0
|
XR Pelvis 3 Views |
|
36705-2
|
XR Pelvis and Hip AP and Lateral |
|
30770-2
|
XR Pelvis and Hip AP and Lateral frog |
|
37089-0
|
XR Pelvis and Hip AP and Lateral crosstable |
|
92677-4
|
XR Pelvis and Hip GE 4 Views |
|
30767-8
|
XR Pelvis and Hip Views |
|
42167-7
|
XR Pelvis and Hip - bilateral AP and Lateral frog |
|
30768-6
|
XR Pelvis and Hip - bilateral Views |
|
30769-4
|
XR Pelvis and Hip - bilateral Maximum abduction Views |
|
37583-2
|
XR Pelvis and Hip - bilateral Views and Lateral frog |
|
42685-8
|
XR Pelvis and Hip - left 2 Views |
|
37094-0
|
XR Pelvis and Hip - left AP and Lateral frog |
|
37088-2
|
XR Pelvis and Hip - left AP and Lateral crosstable |
|
36631-0
|
XR Pelvis and Hip - left Views |
|
42686-6
|
XR Pelvis and Hip - right 2 Views |
|
38785-2
|
XR Pelvis and Hip - right AP and Lateral frog |
|
38784-5
|
XR Pelvis and Hip - right AP and Lateral crosstable |
|
38771-2
|
XR Pelvis and Hip - right Views |
|
37622-8
|
XR Pelvis AP |
|
83031-5
|
XR Pelvis AP and Hip - bilateral GE 2 Views |
|
37634-3
|
XR Pelvis AP 20 degree cephalic angle |
|
42420-0
|
XR Pelvis AP W standing |
|
37618-6
|
XR Pelvis AP and Inlet |
|
37623-6
|
XR Pelvis AP and Inlet and Outlet |
|
39065-8
|
XR Pelvis AP and Inlet and Outlet and Oblique |
|
37619-4
|
XR Pelvis AP and Judet |
|
37620-2
|
XR Pelvis AP and Lateral |
|
37624-4
|
XR Pelvis AP and Lateral and oblique |
|
37621-0
|
XR Pelvis AP and Oblique |
|
37625-1
|
XR Pelvis Ferguson |
|
43543-8
|
XR Pelvis GE 3 Views |
|
37628-5
|
XR Pelvis Inlet |
|
30771-0
|
XR Pelvis Inlet and Outlet |
|
37627-7
|
XR Pelvis Inlet and Outlet and Oblique |
|
37629-3
|
XR Pelvis Lateral |
|
37626-9
|
XR Pelvis Lateral frog |
|
37631-9
|
XR Pelvis Outlet |
|
24871-6
|
XR Pelvis Pelvimetry |
|
30885-8
|
XR Pelvis symphysis pubis Views |
|
28561-9
|
XR Pelvis Views |
|
37630-1
|
XR Pelvis Oblique Views |
|
39360-3
|
XR Pelvis Views and Inlet and Outlet |
|
39511-1
|
XR Pelvis Views and Oblique |
|
37256-5
|
XR Pelvis and Spine Lumbar 3 Views |
|
37351-4
|
XR Pelvis and Spine Lumbar 5 Views |
|
47984-0
|
XR Pelvis and Spine Lumbar Views |
|
24745-2
|
XR Petrous part of temporal bone Views |
|
36588-2
|
Portable XR Abdomen AP |
|
24560-5
|
Portable XR Abdomen AP left lateral-decubitus |
|
24564-7
|
Portable XR Abdomen AP upright |
|
24792-4
|
Portable XR Abdomen AP and AP left lateral-decubitus |
|
24793-2
|
Portable XR Abdomen AP and Lateral |
|
30763-7
|
Portable XR Abdomen AP and Lateral crosstable |
|
37076-7
|
Portable XR Abdomen Supine and Lateral-decubitus |
|
24795-7
|
Portable XR Abdomen Supine and Upright |
|
30765-2
|
Portable XR Acetabulum Views |
|
30764-5
|
Portable XR Acetabulum - bilateral Views |
|
41823-6
|
Portable XR Ankle - left Views |
|
41782-4
|
Portable XR Ankle - right Views |
|
44203-8
|
Portable XR Cervical and thoracic and lumbar spine Views |
|
36589-0
|
Portable XR Chest AP single view |
|
30735-5
|
Portable XR Chest AP lateral-decubitus |
|
24636-3
|
Portable XR Chest AP left lateral-decubitus |
|
24652-0
|
Portable XR Chest AP right lateral-decubitus |
|
43778-0
|
Portable XR Chest AP supine |
|
36960-3
|
Portable XR Chest AP upright |
|
24654-6
|
Portable XR Chest AP and AP right lateral-decubitus |
|
30738-9
|
Portable XR Chest Left lateral |
|
24638-9
|
Portable XR Chest Left lateral upright |
|
24641-3
|
Portable XR Chest Left oblique |
|
30739-7
|
Portable XR Chest Oblique |
|
24644-7
|
Portable XR Chest PA and Lateral upright |
|
30743-9
|
Portable XR Chest PA and Lateral and Right oblique and Left oblique |
|
24645-4
|
Portable XR Chest PA and Right lateral and Right oblique and Left oblique upright |
|
24649-6
|
Portable XR Chest Right lateral-decubitus and Left lateral-decubitus |
|
30733-0
|
Portable XR Chest Right oblique and Left oblique |
|
30746-2
|
Portable XR Chest Views |
|
24632-2
|
Portable XR Chest Views AP |
|
24634-8
|
Portable XR Chest Views W inspiration and expiration |
|
30724-9
|
Portable XR Cervical spine Single view |
|
30727-2
|
Portable XR Cervical spine AP |
|
30726-4
|
Portable XR Cervical spine AP and Lateral |
|
37079-1
|
Portable XR Cervical spine AP and Lateral and Odontoid |
|
44187-3
|
Portable XR Cervical spine AP and Oblique and Odontoid and (Lateral W flexion and W extension) |
|
36991-8
|
Portable XR Cervical spine Lateral crosstable |
|
37171-6
|
Portable XR Cervical spine Views |
|
30729-8
|
Portable XR Spine Cervical Odontoid and Cervical axis AP |
|
44184-0
|
Portable XR Elbow 2 Views |
|
41827-7
|
Portable XR Elbow - left Views |
|
41786-5
|
Portable XR Elbow - right Views |
|
41773-3
|
Portable XR Facial bones Views |
|
44185-7
|
Portable XR Femur AP and Lateral |
|
41818-6
|
Portable XR Femur - left Views |
|
41778-2
|
Portable XR Femur - right Views |
|
44186-5
|
Portable XR Foot AP and Lateral |
|
44182-4
|
Portable XR Hand 2 Views |
|
44193-1
|
Portable XR Hand GE 3 Views |
|
43570-1
|
Portable XR Hand Views |
|
41829-3
|
Portable XR Hand - left Views |
|
41788-1
|
Portable XR Hand - right Views |
|
44176-6
|
Portable XR Hip Single view |
|
37077-5
|
Portable XR Hip AP and Lateral crosstable |
|
37168-2
|
Portable XR Hip Views |
|
37075-9
|
Portable XR Hip Views AP |
|
41817-8
|
Portable XR Hip - left AP and Lateral |
|
37169-0
|
Portable XR Hip - left Views |
|
41777-4
|
Portable XR Hip - right AP and Lateral |
|
38796-9
|
Portable XR Hip - right Views |
|
37170-8
|
Portable XR Humerus Views |
|
41825-1
|
Portable XR Humerus - left Views |
|
41784-0
|
Portable XR Humerus - right Views |
|
44202-0
|
Portable XR Knee 1 or 2 Views |
|
41820-2
|
Portable XR Knee - left Views |
|
41779-0
|
Portable XR Knee - right Views |
|
30774-4
|
Portable XR Lumbar spine Single view |
|
36674-0
|
Portable XR Lumbar spine 2 Views |
|
30776-9
|
Portable XR Lumbar spine 3 Views |
|
37078-3
|
Portable XR Lumbar spine AP and Lateral |
|
36992-6
|
Portable XR Lumbar spine Lateral crosstable |
|
37172-4
|
Portable XR Lumbar spine Views |
|
41774-1
|
Portable XR Neck Lateral |
|
30792-6
|
Portable XR Patella Views |
|
41775-8
|
Portable XR Pelvis Single view |
|
44201-2
|
Portable XR Pelvis 1 or 2 Views |
|
41776-6
|
Portable XR Pelvis and Hip - right AP and Lateral frog |
|
44192-3
|
Portable XR Pelvis GE 3 Views |
|
30772-8
|
Portable XR Pelvis Views |
|
44183-2
|
Portable XR Radius and Ulna 2 Views |
|
30747-0
|
Portable XR Ribs Views |
|
41831-9
|
Portable XR Ribs - left Views |
|
41791-5
|
Portable XR Ribs - right Views |
|
44239-2
|
Portable XR Ribs - unilateral GE 3 Views and Chest PA |
|
30749-6
|
Portable XR Shoulder Single view |
|
46391-9
|
Portable XR Shoulder Views |
|
41824-4
|
Portable XR Shoulder - left Views |
|
41783-2
|
Portable XR Shoulder - right Views |
|
30722-3
|
Portable XR Skull Single view |
|
30723-1
|
Portable XR Skull Views |
|
70932-9
|
Portable XR Thoracic spine Single view |
|
30755-3
|
Portable XR Thoracic spine AP |
|
30754-6
|
Portable XR Thoracic spine AP and Lateral |
|
30757-9
|
Portable XR Thoracic spine Lateral |
|
30759-5
|
Portable XR Thoracic spine Oblique |
|
41828-5
|
Portable XR Wrist - left Views |
|
41787-3
|
Portable XR Wrist - right Views |
|
30731-4
|
Portable XR Zygomatic arch Views |
|
30730-6
|
Portable XR Zygomatic arch - bilateral Views |
|
93129-5
|
XR Radius Bone development stage |
|
36658-3
|
XR Radius and Ulna 2 Views |
|
36698-9
|
XR Radius and Ulna AP and Lateral |
|
24891-4
|
XR Radius and Ulna Views |
|
36659-1
|
XR Radius and Ulna - bilateral 2 Views |
|
36699-7
|
XR Radius and Ulna - bilateral AP and Lateral |
|
26146-1
|
XR Radius and Ulna - bilateral Views |
|
36742-5
|
XR Radius and Ulna - bilateral Oblique Views |
|
36660-9
|
XR Radius and Ulna - left 2 Views |
|
36700-3
|
XR Radius and Ulna - left AP and Lateral |
|
26148-7
|
XR Radius and Ulna - left Views |
|
36743-3
|
XR Radius and Ulna - left Oblique Views |
|
69317-6
|
XR Radius and Ulna - right Single view |
|
37707-7
|
XR Radius and Ulna - right 2 Views |
|
37708-5
|
XR Radius and Ulna - right AP and Lateral |
|
26150-3
|
XR Radius and Ulna - right Views |
|
37709-3
|
XR Radius and Ulna - right Oblique Views |
|
39376-9
|
XR Radius and Ulna - right Views and Oblique |
|
39060-9
|
XR Ribs 2 Views |
|
48468-3
|
XR Ribs - bilateral 2 Views and Chest PA |
|
39062-5
|
XR Ribs 3 Views |
|
37937-0
|
XR Ribs anterior Views |
|
39064-1
|
XR Ribs Anterior and Lateral |
|
38868-6
|
XR Ribs anterior and posterior - left Views |
|
37962-8
|
XR Ribs anterior and posterior - right Views |
|
38073-3
|
XR Ribs anterior - bilateral Views |
|
38074-1
|
XR Ribs anterior - left Views |
|
37963-6
|
XR Ribs anterior - right Views |
|
39050-0
|
XR Ribs AP |
|
44191-5
|
XR Ribs GE 3 Views and Chest PA |
|
39053-4
|
XR Ribs Lateral |
|
39489-0
|
XR Ribs lower posterior Views |
|
42381-4
|
XR Ribs lower posterior - left Views |
|
39493-2
|
XR Ribs lower posterior - right Views |
|
38866-0
|
XR Ribs lower - left Views |
|
37938-8
|
XR Ribs posterior Views |
|
39352-0
|
XR Ribs posterior - bilateral Views |
|
38869-4
|
XR Ribs posterior - left Views |
|
37964-4
|
XR Ribs posterior - right Views |
|
39351-2
|
XR Ribs upper anterior and posterior - left Views |
|
39491-6
|
XR Ribs upper anterior and posterior - right Views |
|
39353-8
|
XR Ribs upper posterior - left Views |
|
39492-4
|
XR Ribs upper posterior - right Views |
|
38867-8
|
XR Ribs upper - left Views |
|
37961-0
|
XR Ribs upper - right Views |
|
24899-7
|
XR Ribs Views |
|
42165-1
|
XR Ribs Views and Chest PA |
|
37960-2
|
XR Ribs lower - right Views |
|
69071-9
|
XR Ribs - bilateral and Chest Views |
|
42687-4
|
XR Ribs - bilateral 2 Views |
|
36313-5
|
XR Ribs - bilateral 3 Views |
|
36328-3
|
XR Ribs - bilateral 4 Views |
|
39099-7
|
XR Ribs - bilateral 4 Views and Chest PA |
|
69070-1
|
XR Ribs - bilateral Anterior and Lateral |
|
36958-7
|
XR Ribs - bilateral AP |
|
79365-3
|
XR Ribs - bilateral GE 3 Views |
|
48485-7
|
XR Ribs - bilateral GE 3 Views and Chest PA |
|
26151-1
|
XR Ribs - bilateral Views |
|
41811-1
|
XR Ribs - bilateral Views and Chest PA |
|
39326-4
|
XR Ribs - left and Chest Views |
|
42313-7
|
XR Ribs - left Single view |
|
37066-8
|
XR Ribs - left 2 Views |
|
36314-3
|
XR Ribs - left 3 Views |
|
38856-1
|
XR Ribs - left Anterior and Lateral |
|
36959-5
|
XR Ribs - left AP |
|
48486-5
|
XR Ribs - left GE 3 Views and Chest PA |
|
38857-9
|
XR Ribs - left Lateral |
|
26152-9
|
XR Ribs - left Views |
|
41832-7
|
XR Ribs - left Views and Chest PA |
|
42314-5
|
XR Ribs - right Single view |
|
37780-4
|
XR Ribs - right 2 Views |
|
37781-2
|
XR Ribs - right 3 Views |
|
37782-0
|
XR Ribs - right Anterior and Lateral |
|
37783-8
|
XR Ribs - right AP |
|
48484-0
|
XR Ribs - right GE 3 Views and Chest PA |
|
37784-6
|
XR Ribs - right Lateral |
|
26153-7
|
XR Ribs - right Views |
|
42010-9
|
XR Ribs - right Views and Chest PA |
|
79366-1
|
XR Ribs - unilateral and Chest 2 Views |
|
83040-6
|
XR Ribs - unilateral 2 Views |
|
83041-4
|
XR Ribs - unilateral 2 Views and Chest Single view |
|
83042-2
|
XR Ribs - unilateral 2 Views and Chest AP |
|
37651-7
|
XR Sacrum 2 Views |
|
37652-5
|
XR Sacrum AP and Lateral |
|
83044-8
|
XR Sacrum GE 2 Views |
|
30884-1
|
XR Sacrum Views |
|
69264-0
|
XR Sacrum Views W standing |
|
44179-0
|
XR Sacrum and Coccyx 2 Views |
|
39061-7
|
XR Sacrum and Coccyx 3 Views |
|
79367-9
|
XR Sacrum and Coccyx GE 2 Views |
|
24665-2
|
XR Sacrum and Coccyx Views |
|
39058-3
|
XR Salivary gland Views |
|
37881-0
|
XR Sternoclavicular Joint 3 Views |
|
37882-8
|
XR Sternoclavicular Joint 4 Views |
|
37880-2
|
XR Sternoclavicular Joint AP |
|
37846-3
|
XR Sternoclavicular Joint Serendipity |
|
48482-4
|
XR Sternoclavicular joint - bilateral GE 3 Views |
|
37298-7
|
XR Sternoclavicular joint - bilateral Serendipity |
|
37323-3
|
XR Sternoclavicular joint - bilateral Views |
|
37299-5
|
XR Sternoclavicular joint - left Serendipity |
|
37324-1
|
XR Sternoclavicular joint - left Views |
|
37808-3
|
XR Sternoclavicular joint - right Serendipity |
|
37965-1
|
XR Sternoclavicular joint - right Views |
|
93132-9
|
XR Scaphoid Bone development stage |
|
37654-1
|
XR Scapula Single view |
|
37655-8
|
XR Scapula 2 Views |
|
39048-4
|
XR Scapula AP |
|
83045-5
|
XR Scapula AP and Lateral |
|
39366-0
|
XR Scapula Lateral and outlet |
|
24903-7
|
XR Scapula Views |
|
37656-6
|
XR Scapula Y |
|
36714-4
|
XR Scapula - bilateral AP and Lateral |
|
26154-5
|
XR Scapula - bilateral Views |
|
37055-1
|
XR Scapula - bilateral Y |
|
36666-6
|
XR Scapula - left 2 Views |
|
36715-1
|
XR Scapula - left AP and Lateral |
|
37124-5
|
XR Scapula - left AP and Y |
|
26155-2
|
XR Scapula - left Views |
|
37054-4
|
XR Scapula - left Y |
|
37787-9
|
XR Scapula - right 2 Views |
|
37788-7
|
XR Scapula - right AP and Lateral |
|
37789-5
|
XR Scapula - right AP and Y |
|
26156-0
|
XR Scapula - right Views |
|
37790-3
|
XR Scapula - right Y |
|
30748-8
|
XR Shoulder Single view |
|
37840-6
|
XR Shoulder 2 Views |
|
24908-6
|
XR Shoulder 3 Views |
|
69265-7
|
XR Shoulder 4 Views |
|
30750-4
|
XR Shoulder 5 Views |
|
37842-2
|
XR Shoulder AP |
|
39402-3
|
XR Shoulder AP internal rotation and AP external rotation |
|
39321-5
|
XR Shoulder AP internal rotation and AP external rotation and Axillary |
|
39401-5
|
XR Shoulder AP and Grashey and Axillary |
|
37841-4
|
XR Shoulder AP and Lateral |
|
37839-8
|
XR Shoulder AP and Lateral and Axillary |
|
39077-3
|
XR Shoulder AP and Transthoracic |
|
69266-5
|
XR Shoulder AP and Y |
|
37849-7
|
XR Shoulder Axillary |
|
39403-1
|
XR Shoulder Axillary and Transcapular |
|
37843-0
|
XR Shoulder Garth |
|
79370-3
|
XR Shoulder GE 2 Views |
|
37844-8
|
XR Shoulder Grashey |
|
69267-3
|
XR Shoulder Grashey and Axillary and Y |
|
37845-5
|
XR Shoulder Outlet |
|
39516-0
|
XR Shoulder Stryker Notch |
|
39517-8
|
XR Shoulder Stryker Notch and West Point |
|
24909-4
|
XR Shoulder Views |
|
30751-2
|
XR Shoulder West Point |
|
37847-1
|
XR Shoulder Y |
|
36568-4
|
XR Shoulder - bilateral Single view |
|
36667-4
|
XR Shoulder - bilateral 2 Views |
|
37468-6
|
XR Shoulder - bilateral 30 degree caudal angle |
|
26382-2
|
XR Shoulder - bilateral 3 Views |
|
36329-1
|
XR Shoulder - bilateral 4 Views |
|
36586-6
|
XR Shoulder - bilateral AP |
|
39329-8
|
XR Shoulder - bilateral AP internal rotation and AP external rotation |
|
39336-3
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary |
|
39337-1
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary and Outlet |
|
39344-7
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary and Y |
|
39343-9
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Y |
|
39346-2
|
XR Shoulder - bilateral AP internal rotation and West Point |
|
37080-9
|
XR Shoulder - bilateral AP and Axillary |
|
37081-7
|
XR Shoulder - bilateral AP and Axillary and Outlet |
|
39339-7
|
XR Shoulder - bilateral AP and Axillary and Outlet and 30 degree caudal angle |
|
37126-0
|
XR Shoulder - bilateral AP and Axillary and Y |
|
36716-9
|
XR Shoulder - bilateral AP and Lateral |
|
46349-7
|
XR Shoulder - bilateral AP and Transthoracic |
|
36963-7
|
XR Shoulder - bilateral Axillary |
|
37127-8
|
XR Shoulder - bilateral Axillary and Y |
|
37035-3
|
XR Shoulder - bilateral Grashey |
|
37161-7
|
XR Shoulder - bilateral Grashey and Axillary and Outlet and Zanca |
|
39350-4
|
XR Shoulder - bilateral Grashey and Outlet and Serendipity |
|
37012-2
|
XR Shoulder - bilateral Outlet |
|
37152-6
|
XR Shoulder - bilateral Outlet and Y |
|
37024-7
|
XR Shoulder - bilateral Stryker Notch |
|
37047-8
|
XR Shoulder - bilateral Velpeau axillary |
|
26157-8
|
XR Shoulder - bilateral Views |
|
37050-2
|
XR Shoulder - bilateral West Point |
|
36569-2
|
XR Shoulder - left Single view |
|
36668-2
|
XR Shoulder - left 2 Views |
|
26383-0
|
XR Shoulder - left 3 Views |
|
69154-3
|
XR Shoulder - left 3 Views and Axillary |
|
69155-0
|
XR Shoulder - left 3 Views and Y |
|
36330-9
|
XR Shoulder - left 4 Views |
|
36677-3
|
XR Shoulder - left 5 Views |
|
36679-9
|
XR Shoulder - left 6 Views |
|
36587-4
|
XR Shoulder - left AP |
|
39328-0
|
XR Shoulder - left AP internal rotation and AP external rotation |
|
39335-5
|
XR Shoulder - left AP internal rotation and AP external rotation and Axillary |
|
39338-9
|
XR Shoulder - left AP internal rotation and AP external rotation and Axillary and Y |
|
39348-8
|
XR Shoulder - left AP internal rotation and AP external rotation and Y |
|
39325-6
|
XR Shoulder - left AP internal rotation and Grashey and Axillary and Outlet |
|
39347-0
|
XR Shoulder - left AP internal rotation and West Point |
|
37082-5
|
XR Shoulder - left AP and Axillary and Outlet |
|
37083-3
|
XR Shoulder - left AP and Axillary and Outlet and Zanca |
|
37084-1
|
XR Shoulder - left AP and Axillary and Y |
|
69153-5
|
XR Shoulder - left AP and Grashey and Axillary |
|
37122-9
|
XR Shoulder - left AP and Stryker Notch |
|
38082-4
|
XR Shoulder - left AP and Transthoracic |
|
37123-7
|
XR Shoulder - left AP and West Point |
|
36961-1
|
XR Shoulder - left AP and West Point and Outlet |
|
37125-2
|
XR Shoulder - left AP and Y |
|
36964-5
|
XR Shoulder - left Axillary |
|
37128-6
|
XR Shoulder - left Axillary and Y |
|
36974-4
|
XR Shoulder - left Garth |
|
79368-7
|
XR Shoulder - left GE 2 Views |
|
37473-6
|
XR Shoulder - left Grashey |
|
37160-9
|
XR Shoulder - left Grashey and Axillary |
|
37158-3
|
XR Shoulder - left Grashey and Axillary and Outlet |
|
37538-6
|
XR Shoulder - left Grashey and Axillary and Y |
|
37157-5
|
XR Shoulder - left Grashey and Outlet |
|
37162-5
|
XR Shoulder - left Grashey and Outlet and Serendipity |
|
37167-4
|
XR Shoulder - left Grashey and West Point |
|
69156-8
|
XR Shoulder - left Grashey and Y |
|
37136-9
|
XR Shoulder - left Lateral and Y |
|
37013-0
|
XR Shoulder - left Outlet |
|
37140-1
|
XR Shoulder - left Outlet and Y |
|
37025-4
|
XR Shoulder - left Stryker Notch |
|
37034-6
|
XR Shoulder - left Transthoracic |
|
37048-6
|
XR Shoulder - left Velpeau axillary |
|
26158-6
|
XR Shoulder - left Views |
|
42412-7
|
XR Shoulder - left 90 degree abduction Views |
|
38004-8
|
XR Shoulder - left Grashey Views WO and W weight |
|
37051-0
|
XR Shoulder - left West Point |
|
38858-7
|
XR Shoulder - left Y |
|
37792-9
|
XR Shoulder - right Single view |
|
37793-7
|
XR Shoulder - right 2 Views |
|
26384-8
|
XR Shoulder - right 3 Views |
|
39393-4
|
XR Shoulder - right 3 Views and Axillary |
|
39394-2
|
XR Shoulder - right 3 Views and Y |
|
37794-5
|
XR Shoulder - right 4 Views |
|
37795-2
|
XR Shoulder - right 5 Views |
|
37796-0
|
XR Shoulder - right 6 Views |
|
37798-6
|
XR Shoulder - right AP |
|
39395-9
|
XR Shoulder - right AP internal rotation and AP external rotation |
|
39397-5
|
XR Shoulder - right AP internal rotation and AP external rotation and West Point |
|
39396-7
|
XR Shoulder - right AP internal rotation and West Point |
|
38781-1
|
XR Shoulder - right AP and Axillary and Outlet |
|
38782-9
|
XR Shoulder - right AP and Axillary and Outlet and Zanca |
|
38783-7
|
XR Shoulder - right AP and Axillary and Y |
|
69262-4
|
XR Shoulder - right AP and Grashey and Axillary |
|
37797-8
|
XR Shoulder - right AP and Stryker Notch |
|
38822-3
|
XR Shoulder - right AP and Transthoracic |
|
38787-8
|
XR Shoulder - right AP and West Point |
|
37799-4
|
XR Shoulder - right AP and West Point and Outlet |
|
38788-6
|
XR Shoulder - right AP and Y |
|
37800-0
|
XR Shoulder - right Axillary |
|
37807-5
|
XR Shoulder - right Axillary and Y |
|
37801-8
|
XR Shoulder - right Garth |
|
79369-5
|
XR Shoulder - right GE 2 Views |
|
38805-8
|
XR Shoulder - right Grashey |
|
38793-6
|
XR Shoulder - right Grashey and Axillary |
|
37806-7
|
XR Shoulder - right Grashey and Axillary and Outlet |
|
38789-4
|
XR Shoulder - right Grashey and Axillary and Y |
|
38791-0
|
XR Shoulder - right Grashey and Outlet |
|
38794-4
|
XR Shoulder - right Grashey and Outlet and Serendipity |
|
38795-1
|
XR Shoulder - right Grashey and West Point |
|
43790-5
|
XR Shoulder - right Grashey and Y |
|
37803-4
|
XR Shoulder - right Lateral and Y |
|
37802-6
|
XR Shoulder - right Outlet |
|
37804-2
|
XR Shoulder - right Outlet and Y |
|
37791-1
|
XR Shoulder - right Stryker Notch |
|
38779-5
|
XR Shoulder - right Transthoracic |
|
39392-6
|
XR Shoulder - right Internal rotation and External rotation and Axillary |
|
38780-3
|
XR Shoulder - right Velpeau axillary |
|
26159-4
|
XR Shoulder - right Views |
|
38816-5
|
XR Shoulder - right Grashey Views WO and W weight |
|
37809-1
|
XR Shoulder - right West Point |
|
37805-9
|
XR Shoulder - right Y |
|
48467-5
|
XR Sacroiliac Joint 1 or 2 Views |
|
44181-6
|
XR Sacroiliac Joint 2 or 3 Views |
|
37648-3
|
XR Sacroiliac Joint 3 Views |
|
37649-1
|
XR Sacroiliac Joint AP and Oblique |
|
37650-9
|
XR Sacroiliac Joint Ferguson |
|
44189-9
|
XR Sacroiliac Joint GE 3 Views |
|
24900-3
|
XR Sacroiliac Joint Views |
|
37646-7
|
XR Sacroiliac Joint Limited Views |
|
83043-0
|
XR Sacroiliac joint - bilateral 1 or 2 Views |
|
48746-2
|
XR Sacroiliac joint - bilateral GE 3 Views |
|
36633-6
|
XR Sacroiliac joint - bilateral Views |
|
36634-4
|
XR Sacroiliac joint - left Views |
|
37786-1
|
XR Sacroiliac joint - right Views |
|
37851-3
|
XR Sinuses Single view |
|
43523-0
|
XR Sinuses 1 or 2 Views |
|
37853-9
|
XR Sinuses 2 Views |
|
37854-7
|
XR Sinuses 3 Views |
|
39404-9
|
XR Sinuses 3 Views and Submentovertex |
|
37855-4
|
XR Sinuses 4 Views |
|
37856-2
|
XR Sinuses 5 Views |
|
37857-0
|
XR Sinuses Caldwell |
|
37852-1
|
XR Sinuses Caldwell and Waters |
|
43486-0
|
XR Sinuses GE 3 Views |
|
37858-8
|
XR Sinuses Lateral |
|
37864-6
|
XR Sinuses Lateral and Caldwell and Waters |
|
37862-0
|
XR Sinuses Lateral and Waters |
|
30721-5
|
XR Sinuses PA and Lateral |
|
37860-4
|
XR Sinuses PA and Lateral and Caldwell and Waters |
|
37859-6
|
XR Sinuses PA and Lateral and Waters |
|
37861-2
|
XR Sinuses Submentovertex |
|
24916-9
|
XR Sinuses Views |
|
44209-5
|
XR Sinuses Limited Views |
|
37863-8
|
XR Sinuses Waters |
|
38117-8
|
XR Sinuses Waters upright |
|
24917-7
|
XR Skull Single view |
|
37867-9
|
XR Skull 2 Views |
|
24918-5
|
XR Skull 3 Views |
|
37868-7
|
XR Skull 4 Views |
|
24922-7
|
XR Skull 5 Views |
|
69269-9
|
XR Skull AP |
|
24919-3
|
XR Skull AP and Lateral |
|
46377-8
|
XR Skull GE 3 Views |
|
48487-3
|
XR Skull GE 4 Views |
|
43524-8
|
XR Skull GE 5 Views |
|
24920-1
|
XR Skull Lateral |
|
37872-9
|
XR Skull Lateral crosstable |
|
37871-1
|
XR Skull Lateral and Caldwell and Waters and Towne |
|
37869-5
|
XR Skull Lateral and Towne |
|
43470-4
|
XR Skull LE 3 Views |
|
83046-3
|
XR Skull LE 3 AP and Lateral Views |
|
69270-7
|
XR Skull PA |
|
69271-5
|
XR Skull PA and Lateral and Waters and Towne |
|
39519-4
|
XR Skull PA and Right lateral and Left lateral |
|
39521-0
|
XR Skull PA and Right lateral and Left lateral and Caldwell and Towne |
|
39520-2
|
XR Skull PA and Right lateral and Left lateral and Towne |
|
37026-2
|
XR Skull Submentovertex |
|
93605-4
|
XR Skull to Coccyx 2 or 3 Views |
|
93606-2
|
XR Skull to Coccyx 4 or 5 Views |
|
93607-0
|
XR Skull to Coccyx GE 6 Views |
|
37870-3
|
XR Skull Towne |
|
28564-3
|
XR Skull Views |
|
48466-7
|
XR Skull Limited Views |
|
24921-9
|
XR Skull Waters |
|
48695-1
|
XR Skull base Single view |
|
48697-7
|
XR Skull base Views |
|
37338-1
|
XR Skull and Facial bones and Mandible Views |
|
43787-1
|
XR Skull and Facial bones and Mandible Views for dental measurement |
|
37875-2
|
XR Spine Single view |
|
37879-4
|
XR Spine 2 Views |
|
37876-0
|
XR Spine 4 Views |
|
37877-8
|
XR Spine AP |
|
24928-4
|
XR Spine AP and Lateral |
|
44194-9
|
XR Spine GE 4 Views W right bending and W left bending |
|
39052-6
|
XR Spine Lateral |
|
42442-4
|
XR Spine Lateral W standing |
|
37878-6
|
XR Spine Lateral crosstable |
|
42689-0
|
XR Spine Oblique |
|
28613-8
|
XR Spine Views |
|
48748-8
|
XR Spine Oblique Views |
|
42690-8
|
XR Spine Views W flexion and W extension |
|
30713-2
|
XR Spine Views W right bending and W left bending |
|
42435-8
|
XR Sella turcica 2 Views |
|
42436-6
|
XR Sella turcica Lateral and Towne |
|
42159-4
|
XR Sella turcica Views |
|
37883-6
|
XR Sternum 2 Views |
|
83047-1
|
XR Sternum GE 2 Views |
|
39406-4
|
XR Sternum Lateral and right anterior oblique |
|
39405-6
|
XR Sternum Lateral and right oblique and left oblique |
|
37884-4
|
XR Sternum PA and Lateral and Oblique |
|
24994-6
|
XR Sternum Views |
|
72876-6
|
XR Surgical specimen Views |
|
42425-9
|
XR Thoracic and lumbar spine AP Views for scoliosis W standing and W right bending and W left bending and WO bending |
|
38121-0
|
XR Thoracic and lumbar spine Single view |
|
24984-7
|
XR Thoracic and lumbar spine 2 Views |
|
37658-2
|
XR Thoracic and lumbar spine 2 Views for scoliosis |
|
39049-2
|
XR Thoracic and lumbar spine AP |
|
30714-0
|
XR Thoracic and lumbar spine AP for scoliosis |
|
42428-3
|
XR Thoracic and lumbar spine AP for scoliosis W standing in brace |
|
42426-7
|
XR Thoracic and lumbar spine AP for scoliosis W sitting |
|
37659-0
|
XR Thoracic and lumbar spine AP for scoliosis W standing |
|
42429-1
|
XR Thoracic and lumbar spine AP for scoliosis W standing and W right bending |
|
38123-6
|
XR Thoracic and lumbar spine AP and Lateral |
|
30715-7
|
XR Thoracic and lumbar spine AP and lateral for scoliosis |
|
42424-2
|
XR Thoracic and lumbar spine AP and lateral for scoliosis W sitting |
|
39367-8
|
XR Thoracic and lumbar spine AP and lateral for scoliosis W standing |
|
44206-1
|
XR Thoracic and lumbar spine for scoliosis single view |
|
30716-5
|
XR Thoracic and lumbar spine Lateral Views for scoliosis |
|
42427-5
|
XR Thoracic and lumbar spine Lateral for scoliosis W sitting |
|
37660-8
|
XR Thoracic and lumbar spine Lateral for scoliosis W standing |
|
42692-4
|
XR Thoracic and lumbar spine Views |
|
43569-3
|
XR Thoracic and lumbar spine AP Views for scoliosis upright and supine |
|
24930-0
|
XR Thoracic and lumbar spine Views for scoliosis |
|
24929-2
|
XR Thoracic and lumbar spine Views for scoliosis W flexion and W extension |
|
30717-3
|
XR Thoracic and lumbar spine Views for scoliosis W standing |
|
38124-4
|
XR Thoracic and lumbar spine Views W standing |
|
42472-1
|
XR Thoracic and lumbar spine AP Views for scoliosis in traction |
|
46386-9
|
XR Teeth Bitewing Views |
|
37888-5
|
XR Thumb 3 Views |
|
37890-1
|
XR Thumb AP |
|
37889-3
|
XR Thumb AP and Lateral |
|
37891-9
|
XR Thumb Lateral |
|
37892-7
|
XR Thumb Oblique |
|
25006-8
|
XR Thumb Views |
|
93137-8
|
XR Distal phalanx of thumb Bone development stage |
|
93144-4
|
XR Proximal phalanx of thumb Bone development stage |
|
26160-2
|
XR Thumb - bilateral Views |
|
37563-4
|
XR Thumb - bilateral Views W manual stress |
|
36315-0
|
XR Thumb - left 3 Views |
|
36736-7
|
XR Thumb - left AP and Lateral and oblique |
|
43488-6
|
XR Thumb - left GE 3 Views |
|
26161-0
|
XR Thumb - left Views |
|
37564-2
|
XR Thumb - left Views W manual stress |
|
37812-5
|
XR Thumb - right 3 Views |
|
37813-3
|
XR Thumb - right AP and Lateral and oblique |
|
43493-6
|
XR Thumb - right GE 3 Views |
|
26162-8
|
XR Thumb - right Views |
|
37814-1
|
XR Thumb - right Views W manual stress |
|
37894-3
|
XR Tibia and Fibula Single view |
|
37895-0
|
XR Tibia and Fibula 2 Views |
|
37897-6
|
XR Tibia and Fibula AP |
|
37896-8
|
XR Tibia and Fibula AP and Lateral |
|
83048-9
|
XR Tibia and Fibula GE 3 Views |
|
37893-5
|
XR Tibia and Fibula Lateral |
|
25011-8
|
XR Tibia and Fibula Views |
|
36894-4
|
XR Tibia and Fibula Oblique Views |
|
37899-2
|
XR Tibia and Fibula Views W standing |
|
36671-6
|
XR Tibia and Fibula - bilateral 2 Views |
|
36717-7
|
XR Tibia and Fibula - bilateral AP and Lateral |
|
26163-6
|
XR Tibia and Fibula - bilateral Views |
|
69313-5
|
XR Tibia and Fibula - left Single view |
|
36672-4
|
XR Tibia and Fibula - left 2 Views |
|
38874-4
|
XR Tibia and Fibula - left 2 Oblique Views |
|
36718-5
|
XR Tibia and Fibula - left AP and Lateral |
|
26164-4
|
XR Tibia and Fibula - left Views |
|
36749-0
|
XR Tibia and Fibula - left Oblique Views |
|
69321-8
|
XR Tibia and Fibula - right Single view |
|
37815-8
|
XR Tibia and Fibula - right 2 Views |
|
38114-5
|
XR Tibia and Fibula - right 2 Oblique Views |
|
37816-6
|
XR Tibia and Fibula - right AP and Lateral |
|
26165-1
|
XR Tibia and Fibula - right Views |
|
37817-4
|
XR Tibia and Fibula - right Oblique Views |
|
39398-3
|
XR Tibia and Fibula - right Views and Oblique |
|
37513-9
|
XR Tibia - bilateral 10 degree caudal angle |
|
37514-7
|
XR Tibia - left 10 degree caudal angle |
|
38806-6
|
XR Tibia - right 10 degree caudal angle |
|
69273-1
|
XR Spine thoracolumbar junction 2 Views |
|
37974-3
|
XR Spine thoracolumbar junction AP and Lateral |
|
37975-0
|
XR Spine thoracolumbar junction Views |
|
25000-1
|
XR Temporomandibular joint Views |
|
37350-6
|
XR Temporomandibular joint - bilateral 5 Views |
|
37546-9
|
XR Temporomandibular joint - bilateral Open and Closed mouth |
|
37325-8
|
XR Temporomandibular joint - bilateral Views |
|
48491-5
|
XR Temporomandibular joint - left Open and Closed mouth |
|
30889-0
|
XR Temporomandibular joint - left Views |
|
48490-7
|
XR Temporomandibular joint - right Open and Closed mouth |
|
30890-8
|
XR Temporomandibular joint - right Views |
|
48699-3
|
XR Temporomandibular joint - unilateral Open and Closed mouth |
|
37534-5
|
XR Toe second - left Views |
|
38148-3
|
XR Toe second - right Views |
|
37535-2
|
XR Toe third - left Views |
|
38149-1
|
XR Toe third - right Views |
|
37531-1
|
XR Toe fourth - left Views |
|
38150-9
|
XR Toe fourth - right Views |
|
37530-3
|
XR Toe fifth - left Views |
|
38151-7
|
XR Toe fifth - right Views |
|
79373-7
|
XR Toe GE 2 Views |
|
37902-4
|
XR Toes 2 Views |
|
39075-7
|
XR Toes AP and Oblique |
|
25013-4
|
XR Toes Views |
|
37348-0
|
XR Toes - bilateral 2 Views |
|
26166-9
|
XR Toes - bilateral Views |
|
36673-2
|
XR Toes - left 2 Views |
|
36316-8
|
XR Toes - left 3 Views |
|
36719-3
|
XR Toes - left AP and Lateral |
|
26167-7
|
XR Toes - left Views |
|
37209-4
|
XR Toes - left Views W standing |
|
37821-6
|
XR Toes - right 2 Views |
|
37820-8
|
XR Toes - right 3 Views |
|
37822-4
|
XR Toes - right AP and Lateral |
|
26168-5
|
XR Toes - right Views |
|
37823-2
|
XR Toes - right Views W standing |
|
30762-9
|
XR tomography Abdomen |
|
35939-8
|
XR tomography Ankle |
|
35943-0
|
XR tomography Ankle - left |
|
37674-9
|
XR tomography Ankle - right |
|
24657-9
|
XR tomography Chest |
|
35959-6
|
XR tomography Clavicle |
|
36068-5
|
XR tomography Cervical spine |
|
35963-8
|
XR tomography Elbow |
|
35964-6
|
XR tomography Elbow - bilateral |
|
35967-9
|
XR tomography Elbow - left |
|
37688-9
|
XR tomography Elbow - right |
|
35970-3
|
XR tomography Extremity |
|
35985-1
|
XR tomography Femur |
|
35986-9
|
XR tomography Femur - bilateral |
|
35988-5
|
XR tomography Femur - left |
|
38768-8
|
XR tomography Femur - right |
|
35992-7
|
XR tomography Foot |
|
35995-0
|
XR tomography Foot - left |
|
37706-9
|
XR tomography Foot - right |
|
36001-6
|
XR tomography Gallbladder |
|
36003-2
|
XR tomography Hand |
|
36006-5
|
XR tomography Hand - left |
|
37717-6
|
XR tomography Hand - right |
|
36011-5
|
XR tomography Calcaneus |
|
36012-3
|
XR tomography Hip |
|
36015-6
|
XR tomography Hip - bilateral |
|
36019-8
|
XR tomography Hip - left |
|
37735-8
|
XR tomography Hip - right |
|
36024-8
|
XR tomography Humerus |
|
24767-6
|
XR tomography Internal auditory canal |
|
26253-5
|
XR tomography Internal auditory canal - bilateral |
|
26254-3
|
XR tomography Internal auditory canal - left |
|
26255-0
|
XR tomography Internal auditory canal - right |
|
24789-0
|
XR tomography Kidney - bilateral |
|
30760-3
|
XR tomography Kidney - bilateral 3 views W contrast IV |
|
24790-8
|
XR tomography Kidney - bilateral W contrast IV |
|
39359-5
|
XR tomography Kidney - bilateral WO contrast |
|
24787-4
|
XR tomography Kidney - bilateral WO contrast and 10M post contrast IV |
|
24784-1
|
XR tomography Kidney - bilateral WO and W contrast IV |
|
36032-1
|
XR tomography Kidney |
|
36038-8
|
XR tomography Knee |
|
36039-6
|
XR tomography Knee - bilateral |
|
36042-0
|
XR tomography Knee - left |
|
37760-6
|
XR tomography Knee - right |
|
36044-6
|
XR tomography Larynx |
|
35972-9
|
XR tomography Lower extremity |
|
35977-8
|
XR tomography Lower extremity - left |
|
37766-3
|
XR tomography Lower extremity - right |
|
36069-3
|
XR tomography Lumbar spine |
|
36048-7
|
XR tomography Mandible |
|
24828-6
|
XR tomography Mandible Panoramic |
|
36776-3
|
XR tomography Mastoid |
|
37233-4
|
XR tomography Mediastinum |
|
37606-1
|
XR tomography Nasal bones |
|
37611-1
|
XR tomography Orbit - bilateral |
|
37632-7
|
XR tomography Pelvis |
|
37653-3
|
XR tomography Sacrum |
|
37850-5
|
XR tomography Shoulder |
|
36065-1
|
XR tomography Shoulder - left |
|
37811-7
|
XR tomography Shoulder - right |
|
37866-1
|
XR tomography Sinuses |
|
37874-5
|
XR tomography Skull |
|
42437-4
|
XR tomography Sella turcica |
|
37885-1
|
XR tomography Sternum |
|
37898-4
|
XR tomography Tibia and Fibula |
|
30719-9
|
XR tomography Temporomandibular joint |
|
37227-6
|
XR tomography Temporomandibular joint - bilateral |
|
37229-2
|
XR tomography Temporomandibular joint - left |
|
37819-0
|
XR tomography Temporomandibular joint - right |
|
37911-5
|
XR tomography Thoracic spine |
|
39408-0
|
XR tomography Thoracic spine AP |
|
39409-8
|
XR tomography Thoracic spine lateral |
|
37923-0
|
XR tomography Upper extremity |
|
25071-2
|
XR tomography Unspecified body region |
|
37932-1
|
XR tomography Wrist |
|
37429-8
|
XR tomography Wrist - bilateral |
|
37432-2
|
XR tomography Wrist - left |
|
37644-2
|
XR tomography Wrist - right |
|
44238-4
|
XR Trachea Views |
|
93131-1
|
XR Trapezium Bone development stage |
|
93130-3
|
XR Trapezoid Bone development stage |
|
93134-5
|
XR Triquetrum Bone development stage |
|
37904-0
|
XR Thoracic spine Single view |
|
37905-7
|
XR Thoracic spine 2 Views |
|
69274-9
|
XR Thoracic spine 2 Views W standing |
|
37906-5
|
XR Thoracic spine 3 Views |
|
42443-2
|
XR Thoracic spine 3 Views W standing |
|
48472-5
|
XR Thoracic spine 3 Views and Swimmers |
|
37907-3
|
XR Thoracic spine 4 Views |
|
39413-0
|
XR Thoracic spine 4 Views and Oblique |
|
39407-2
|
XR Thoracic spine 5 Views and Oblique |
|
30752-0
|
XR Thoracic spine AP |
|
39410-6
|
XR Thoracic spine AP W left bending |
|
39411-4
|
XR Thoracic spine AP W right bending |
|
30753-8
|
XR Thoracic spine AP and Lateral |
|
37908-1
|
XR Thoracic spine AP and Lateral and oblique |
|
38009-7
|
XR Thoracic spine AP and Lateral and Swimmers |
|
30756-1
|
XR Thoracic spine Lateral |
|
37909-9
|
XR Thoracic spine Lateral W hyperextension |
|
37910-7
|
XR Thoracic spine Lateral W standing |
|
37903-2
|
XR Thoracic spine Lateral crosstable |
|
30758-7
|
XR Thoracic spine Oblique |
|
24983-9
|
XR Thoracic spine Views |
|
42445-7
|
XR Thoracic spine Views AP W left bending and WO bending |
|
42444-0
|
XR Thoracic spine Views AP W right bending and W left bending and WO bending |
|
42446-5
|
XR Thoracic spine Views AP W right bending and WO bending |
|
38010-5
|
XR Thoracic spine Lateral Views W flexion and W extension |
|
48749-6
|
XR Thoracic spine Oblique Views |
|
69275-6
|
XR Thoracic spine Views W standing |
|
39414-8
|
XR Thoracic spine Views and Oblique |
|
39412-2
|
XR Thoracic spine Views and Swimmers |
|
37922-2
|
XR Upper extremity 2 Views |
|
83049-7
|
XR Upper extremity GE 2 Views |
|
24689-2
|
XR Upper extremity Views |
|
26115-6
|
XR Upper extremity - bilateral Views |
|
26116-4
|
XR Upper extremity - left Views |
|
26117-2
|
XR Upper extremity - right Views |
|
93148-5
|
XR Ulna Bone development stage |
|
43468-8
|
XR Unspecified body region Views |
|
43469-6
|
XR Unspecified body region Views for foreign body |
|
42402-8
|
XR Unspecified body region Post morten Views |
|
39056-7
|
XR Unspecified body region Views W manual stress |
|
42160-2
|
XR Unspecified body region Views for shunt patency |
|
37924-8
|
XR Wrist Single view |
|
83050-5
|
XR Wrist 1 or 2 Views |
|
69302-8
|
XR Wrist Single view W clenched fist |
|
37925-5
|
XR Wrist 2 Views |
|
37926-3
|
XR Wrist 3 Views |
|
38155-8
|
XR Wrist 4 Views |
|
38156-6
|
XR Wrist 6 Views |
|
30793-4
|
XR Wrist AP and Lateral |
|
37927-1
|
XR Wrist AP and Lateral and oblique |
|
37928-9
|
XR Wrist Brewerton |
|
44190-7
|
XR Wrist GE 3 Views |
|
37930-5
|
XR Wrist Lateral |
|
37931-3
|
XR Wrist PA |
|
42812-8
|
XR Wrist scaphoid single view |
|
69303-6
|
XR Wrist Ulnar deviation and Radial deviation |
|
24619-9
|
XR Wrist Views |
|
37929-7
|
XR Wrist Lateral Views W flexion and W extension |
|
38107-9
|
XR Wrist Scaphoid Views |
|
69304-4
|
XR Wrist Ulnar deviation Views |
|
48737-1
|
XR Wrist and Hand 3 Views |
|
93189-9
|
XR Wrist and Hand Total skeletal maturity score |
|
24724-7
|
XR Wrist and Hand Bone age Views |
|
48738-9
|
XR Wrist - bilateral and Hand - bilateral 3 Views |
|
26352-5
|
XR Wrist - bilateral and Hand - bilateral Bone age Views |
|
51392-9
|
XR Wrist - left and Hand - left Views |
|
26353-3
|
XR Wrist - left and Hand - left Bone age Views |
|
51388-7
|
XR Wrist - right and Hand - right Views |
|
26354-1
|
XR Wrist - right and Hand - right Bone age Views |
|
42419-2
|
XR Wrist - bilateral Single view |
|
36968-6
|
XR Wrist - bilateral Single view W clenched fist |
|
37482-7
|
XR Wrist - bilateral 2 Views |
|
37454-6
|
XR Wrist - bilateral 3 Views |
|
37070-0
|
XR Wrist - bilateral 4 Views |
|
48483-2
|
XR Wrist - bilateral GE 3 Views |
|
36624-5
|
XR Wrist - bilateral PA |
|
37547-7
|
XR Wrist - bilateral PA and Lateral |
|
37549-3
|
XR Wrist - bilateral PA and Lateral and Oblique |
|
42813-6
|
XR Wrist - bilateral scaphoid single view |
|
37045-2
|
XR Wrist - bilateral Ulnar deviation |
|
69072-7
|
XR Wrist - bilateral Ulnar deviation and Radial deviation |
|
26169-3
|
XR Wrist - bilateral Views |
|
36739-1
|
XR Wrist - bilateral Limited Views |
|
37544-4
|
XR Wrist - bilateral Oblique Views |
|
37304-3
|
XR Wrist - bilateral Scaphoid Views |
|
43796-2
|
XR Wrist - bilateral Carpal tunnel Views |
|
36570-0
|
XR Wrist - left Single view |
|
37483-5
|
XR Wrist - left 2 Views |
|
38843-9
|
XR Wrist - left 2 Carpal tunnel Views |
|
37455-3
|
XR Wrist - left 3 Views |
|
69151-9
|
XR Wrist - left 3 Scaphoid Views |
|
37071-8
|
XR Wrist - left 4 Views |
|
37072-6
|
XR Wrist - left 5 Views |
|
37074-2
|
XR Wrist - left 6 Views |
|
36683-1
|
XR Wrist - left 8 Views |
|
38860-3
|
XR Wrist - left AP and Lateral |
|
38842-1
|
XR Wrist - left Carpal tunnel |
|
46346-3
|
XR Wrist - left GE 3 Views |
|
36971-0
|
XR Wrist - left Lateral W extension |
|
36972-8
|
XR Wrist - left Lateral W flexion |
|
39324-9
|
XR Wrist - left PA W clenched fist |
|
37548-5
|
XR Wrist - left PA and Lateral |
|
37550-1
|
XR Wrist - left PA and Lateral and Oblique |
|
42814-4
|
XR Wrist - left scaphoid single view |
|
37044-5
|
XR Wrist - left Ulnar deviation |
|
37555-0
|
XR Wrist - left Ulnar deviation and Radial deviation |
|
26170-1
|
XR Wrist - left Views |
|
69157-6
|
XR Wrist - left Lateral Views W flexion and W extension |
|
38838-9
|
XR Wrist - left Limited Views |
|
38839-7
|
XR Wrist - left Oblique Views |
|
37302-7
|
XR Wrist - left Scaphoid Views |
|
37825-7
|
XR Wrist - right Single view |
|
37826-5
|
XR Wrist - right 2 Views |
|
37678-0
|
XR Wrist - right 2 Carpal tunnel Views |
|
37827-3
|
XR Wrist - right 3 Views |
|
39399-1
|
XR Wrist - right 3 Views and Carpal tunnel |
|
39364-5
|
XR Wrist - right 3 Views and Radial deviation |
|
39365-2
|
XR Wrist - right 3 Views and Ulnar deviation |
|
37828-1
|
XR Wrist - right 4 Views |
|
37829-9
|
XR Wrist - right 5 Views |
|
37830-7
|
XR Wrist - right 6 Views |
|
37831-5
|
XR Wrist - right 8 Views |
|
37832-3
|
XR Wrist - right AP and Lateral |
|
37677-2
|
XR Wrist - right Carpal tunnel |
|
46343-0
|
XR Wrist - right GE 3 Views |
|
37833-1
|
XR Wrist - right Lateral W extension |
|
37834-9
|
XR Wrist - right Lateral W flexion |
|
69263-2
|
XR Wrist - right PA W clenched fist |
|
37835-6
|
XR Wrist - right PA and Lateral |
|
37836-4
|
XR Wrist - right PA and Lateral and Oblique |
|
42811-0
|
XR Wrist - right scaphoid single view |
|
37645-9
|
XR Wrist - right Ulnar deviation |
|
38808-2
|
XR Wrist - right Ulnar deviation and Radial deviation |
|
26171-9
|
XR Wrist - right Views |
|
39515-2
|
XR Wrist - right Lateral Views W flexion and W extension |
|
37642-6
|
XR Wrist - right Limited Views |
|
37643-4
|
XR Wrist - right Oblique Views |
|
38115-2
|
XR Wrist - right Scaphoid Views |
|
39400-7
|
XR Wrist - right Views and Carpal tunnel |
|
69305-1
|
XR Zygomatic arch 2 Views |
|
37933-9
|
XR Zygomatic arch 3 Views |
|
37934-7
|
XR Zygomatic arch 4 Views |
|
25074-6
|
XR Zygomatic arch Views |
|
26172-7
|
XR Zygomatic arch - bilateral Views |
|
26173-5
|
XR Zygomatic arch - left Views |
|
26174-3
|
XR Zygomatic arch - right Views |
|
42397-0
|
XR.stereoscopic Chest Frontal Views |
|
42471-3
|
XR.stereoscopic Pelvis Single view |
|
42473-9
|
XR.stereoscopic Sinuses Waters |
|
42474-7
|
XR.stereoscopic Skull Single view |
|
77727-6
|
XXX allergen triggered histamine release [Units/volume] in Blood |
|
61406-5
|
XXX blood group Ab [Titer] in Serum or Plasma |
|
50970-3
|
XXX blood group Ab [Titer] in Serum or Plasma by Antihuman globulin |
|
50962-0
|
XXX blood group IgG Ab [Titer] in Serum or Plasma |
|
50963-8
|
XXX blood group IgM Ab [Titer] in Serum or Plasma |
|
48132-5
|
Xylitol/Creatinine [Molar ratio] in Urine |
|
13028-6
|
Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
25817-8
|
Xylose [Moles/volume] in Serum or Plasma --1.5 hours post dose xylose PO |
|
46428-9
|
Xylose [Mass/volume] in Serum or Plasma --15 minutes post 25 g xylose PO |
|
9772-5
|
Xylose [Mass/volume] in Blood --1 hour post 25 g xylose PO |
|
14952-6
|
Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO |
|
10452-1
|
Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
|
15001-1
|
Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
|
41258-5
|
Xylose [Mass/volume] in Urine --1 hour post 25 g xylose PO |
|
23939-2
|
Xylose [Mass/volume] in Blood --1 hour post 5 g xylose PO |
|
23945-9
|
Xylose [Moles/volume] in Blood --1 hour post 5 g xylose PO |
|
51793-8
|
Xylose [Mass/volume] in Serum or Plasma --1 hour post 5 g xylose PO |
|
33871-5
|
Xylose [Moles/volume] in Serum or Plasma --1 hour post 5 g xylose PO |
|
23940-0
|
Xylose [Mass/volume] in Blood --1 hour post dose xylose PO |
|
23946-7
|
Xylose [Moles/volume] in Blood --1 hour post dose xylose PO |
|
10453-9
|
Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
|
25818-6
|
Xylose [Moles/volume] in Serum or Plasma --1 hour post dose xylose PO |
|
29328-2
|
Xylose [Mass/volume] in Blood --2.5 hours post dose xylose PO |
|
1645-1
|
Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO |
|
14953-4
|
Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO |
|
10454-7
|
Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
|
15002-9
|
Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
|
41257-7
|
Xylose [Mass/volume] in Urine --2 hours post 25 g xylose PO |
|
23942-6
|
Xylose [Mass/volume] in Blood --2 hours post 5 g xylose PO |
|
22624-1
|
Xylose [Moles/volume] in Blood --2 hours post 5 g xylose PO |
|
29913-1
|
Xylose [Mass/volume] in Serum or Plasma --2 hours post 5 g xylose PO |
|
34053-9
|
Xylose [Moles/volume] in Serum or Plasma --2 hours post 5 g xylose PO |
|
41191-8
|
Xylose [Mass/time] in 2 hour Urine --2 hours post dose xylose PO |
|
23943-4
|
Xylose [Mass/volume] in Blood --2 hours post dose xylose PO |
|
22625-8
|
Xylose [Moles/volume] in Blood --2 hours post dose xylose PO |
|
41173-6
|
Xylose [Mass/volume] in Serum or Plasma --2 hours post dose xylose PO |
|
26005-9
|
Xylose [Moles/volume] in Serum or Plasma --2 hours post dose xylose PO |
|
10455-4
|
Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
|
51609-6
|
Xylose [Moles/volume] in Blood --30 minutes post XXX challenge |
|
51608-8
|
Xylose [Moles/volume] in Blood --30 minutes post dose xylose PO |
|
41197-5
|
Xylose [Mass/volume] in Serum or Plasma --30 minutes post dose xylose PO |
|
10869-6
|
Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO |
|
41256-9
|
Xylose [Mass/volume] in Serum or Plasma --3 hours post 25 g xylose PO |
|
41255-1
|
Xylose [Mass/volume] in Urine --3 hours post 25 g xylose PO |
|
51607-0
|
Xylose [Moles/volume] in Blood --3 hours post XXX challenge |
|
13029-4
|
Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
51606-2
|
Xylose [Moles/volume] in Blood --3 hours post dose xylose PO |
|
10870-4
|
Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO |
|
41254-4
|
Xylose [Mass/volume] in Serum or Plasma --4 hours post 25 g xylose PO |
|
41253-6
|
Xylose [Mass/volume] in Urine --4 hours post 25 g xylose PO |
|
13030-2
|
Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
10871-2
|
Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO |
|
41252-8
|
Xylose [Mass/volume] in Serum or Plasma --5 hours post 25 g xylose PO |
|
41251-0
|
Xylose [Mass/volume] in Urine --5 hours post 25 g xylose PO |
|
41620-6
|
Xylose [Moles/volume] in Urine --5 hours post 5 g xylose PO |
|
13031-0
|
Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
41185-0
|
Xylose [Mass/volume] in Serum or Plasma --5 hours post dose xylose PO |
|
41237-9
|
Xylose [Mass/volume] in Urine --5 hours post dose xylose PO |
|
12274-7
|
Xylose [Mass/time] in 5 hour Urine |
|
44085-9
|
Xylose absorption [Interpretation] in Urine and Serum or Plasma |
|
49241-3
|
Xylose absorption [Interpretation] in Urine and Serum or Plasma Narrative |
|
3134-4
|
Xylose [Mass/volume] in Blood |
|
10872-0
|
Xylose [Mass/volume] in Blood --baseline |
|
30575-5
|
Xylose [Mass/volume] in Serum or Plasma --baseline |
|
25819-4
|
Xylose [Moles/volume] in Serum or Plasma --baseline |
|
41250-2
|
Xylose [Mass/volume] in Urine --baseline |
|
22630-8
|
Xylose/Xylose dose in 5 hour Urine --post 25 g xylose PO |
|
22626-6
|
Xylose [Mass/time] in 5 hour Urine --post 25 g xylose PO |
|
22628-2
|
Xylose [Moles/time] in 5 hour Urine --post 25 g xylose PO |
|
22631-6
|
Xylose/Xylose dose in 5 hour Urine --post 5 g xylose PO |
|
22627-4
|
Xylose [Mass/time] in 5 hour Urine --post 5 g xylose PO |
|
22629-0
|
Xylose [Moles/time] in 5 hour Urine --post 5 g xylose PO |
|
10456-2
|
Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
|
41189-2
|
Xylose [Mass/volume] in Serum or Plasma --fasting |
|
40296-6
|
Xylose [Moles/volume] in Serum or Plasma --fasting |
|
41188-4
|
Xylose [Mass/volume] in Urine --fasting |
|
1646-9
|
Xylose [Mass/time] in 5 hour Urine --post dose PO |
|
14954-2
|
Xylose [Moles/time] in 5 hour Urine --post dose PO |
|
22632-4
|
Xylose/Xylose dose in 5 hour Urine --post dose xylose PO |
|
41267-6
|
Xylose [Mass/volume] in Serum or Plasma --post dose xylose PO |
|
4462-8
|
Xylose.PO [Mass] of Dose |
|
29999-0
|
Xylose [Mass/volume] in Serum or Plasma |
|
32347-7
|
Xylose [Moles/volume] in Serum or Plasma |
|
21606-9
|
Xylose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
26812-8
|
Xylose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
26739-3
|
Xylose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
26709-6
|
Xylose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
27008-2
|
Xylose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
27016-5
|
Xylose [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
27006-6
|
Xylose [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
27005-8
|
Xylose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
47806-5
|
Xylose [Presence] in Urine |
|
3135-1
|
Xylose [Mass/volume] in Urine |
|
25556-2
|
Xylose [Moles/volume] in Urine |
|
75051-3
|
Xylose/Creatinine [Molar ratio] in Urine |
|
3136-9
|
Xylulose [Mass/volume] in Serum |
|
74012-6
|
Number of years alcohol consumed [Time] |
|
71359-4
|
Y chromosome AZFa region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
71360-2
|
Y chromosome AZFb region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
71361-0
|
Y chromosome AZFc region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
35456-3
|
Y chromosome deletion [Identifier] in Blood or Tissue Nominal |
|
40948-2
|
Yersinia enterocolitica O:3 Ab [Presence] in Cerebral spinal fluid |
|
40932-6
|
Yersinia enterocolitica O:3 Ab [Presence] in Serum |
|
5407-2
|
Yersinia enterocolitica O:3 Ab [Units/volume] in Serum |
|
6959-1
|
Yersinia enterocolitica O:3 Ab [Titer] in Serum |
|
40577-9
|
Yersinia enterocolitica O:3 Ab [Titer] in Serum by Agglutination |
|
40953-2
|
Yersinia enterocolitica O:3 Ab [Titer] in Serum by Complement fixation |
|
30100-2
|
Yersinia enterocolitica O:3 Ab [Titer] in Unspecified specimen |
|
77956-1
|
Yersinia enterocolitica O:3 IgG Ab [Presence] in Serum by Agglutination |
|
40949-0
|
Yersinia enterocolitica O:5 Ab [Presence] in Cerebral spinal fluid |
|
40933-4
|
Yersinia enterocolitica O:5 Ab [Presence] in Serum |
|
6960-9
|
Yersinia enterocolitica O:5 Ab [Titer] in Serum |
|
48312-3
|
Yersinia enterocolitica O:5 Ab [Titer] in Serum by Agglutination |
|
30101-0
|
Yersinia enterocolitica O:5 Ab [Titer] in Unspecified specimen |
|
31707-3
|
Yersinia enterocolitica O:5 Ab [Units/volume] in Unspecified specimen |
|
42943-1
|
Yersinia enterocolitica O:5,27 Ab [Titer] in Serum |
|
40575-3
|
Yersinia enterocolitica O:5,27 Ab [Titer] in Serum by Agglutination |
|
40950-8
|
Yersinia enterocolitica O:8 Ab [Presence] in Cerebral spinal fluid |
|
40934-2
|
Yersinia enterocolitica O:8 Ab [Presence] in Serum |
|
5408-0
|
Yersinia enterocolitica O:8 Ab [Units/volume] in Serum |
|
6961-7
|
Yersinia enterocolitica O:8 Ab [Titer] in Serum |
|
40576-1
|
Yersinia enterocolitica O:8 Ab [Titer] in Serum by Agglutination |
|
40954-0
|
Yersinia enterocolitica O:8 Ab [Titer] in Serum by Complement fixation |
|
30102-8
|
Yersinia enterocolitica O:8 Ab [Titer] in Unspecified specimen |
|
40951-6
|
Yersinia enterocolitica O:9 Ab [Presence] in Cerebral spinal fluid |
|
40935-9
|
Yersinia enterocolitica O:9 Ab [Presence] in Serum |
|
5409-8
|
Yersinia enterocolitica O:9 Ab [Units/volume] in Serum |
|
6962-5
|
Yersinia enterocolitica O:9 Ab [Titer] in Serum |
|
48313-1
|
Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination |
|
40955-7
|
Yersinia enterocolitica O:9 Ab [Titer] in Serum by Complement fixation |
|
30103-6
|
Yersinia enterocolitica O:9 Ab [Titer] in Unspecified specimen |
|
77957-9
|
Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination |
|
79385-1
|
Yersinia enterocolitica recN gene [Presence] in Stool by NAA with probe detection |
|
43930-7
|
Yersinia enterocolitica Ab [Presence] in Cerebral spinal fluid |
|
40941-7
|
Yersinia enterocolitica Ab [Presence] in Serum |
|
31708-1
|
Yersinia enterocolitica Ab [Units/volume] in Serum |
|
6963-3
|
Yersinia enterocolitica Ab [Titer] in Serum |
|
40498-8
|
Yersinia enterocolitica Ab [Titer] in Serum by Agglutination |
|
58797-2
|
Yersinia enterocolitica Ab [Titer] in Serum by Complement fixation |
|
82202-3
|
Yersinia enterocolitica DNA [Presence] in Stool by NAA with non-probe detection |
|
92723-6
|
Yersinia enterocolitica DNA [Presence] in Stool by NAA with probe detection |
|
6964-1
|
Yersinia enterocolitica IgA Ab [Units/volume] in Serum by Immunoassay |
|
40945-8
|
Yersinia enterocolitica IgA Ab [Presence] in Serum |
|
22619-1
|
Yersinia enterocolitica IgA Ab [Units/volume] in Serum |
|
6965-8
|
Yersinia enterocolitica IgG Ab [Units/volume] in Serum by Immunoassay |
|
40946-6
|
Yersinia enterocolitica IgG Ab [Presence] in Serum |
|
22620-9
|
Yersinia enterocolitica IgG Ab [Units/volume] in Serum |
|
6966-6
|
Yersinia enterocolitica IgM Ab [Units/volume] in Serum by Immunoassay |
|
22621-7
|
Yersinia enterocolitica IgM Ab [Units/volume] in Serum |
|
73673-6
|
Yersinia enterocolitica serotype [Type] in Isolate by Agglutination |
|
82298-1
|
Yersinia enterocolitica [Presence] in Unspecified specimen by Culture |
|
82590-1
|
Years of education [#] - Reported |
|
33706-3
|
Yersinia pestis Ab [Presence] in Serum |
|
33689-1
|
Yersinia pestis Ab [Presence] in Serum by Hemagglutination inhibition |
|
33707-1
|
Yersinia pestis Ab [Titer] in Serum |
|
33690-9
|
Yersinia pestis Ab [Titer] in Serum by Immunoassay |
|
47518-6
|
Yersinia pestis Ab [Presence] in Unspecified specimen |
|
45045-2
|
Yersinia pestis Ab [Presence] in Unspecified specimen by Hemagglutination |
|
33688-3
|
Yersinia pestis Ag [Presence] in Isolate by Immunofluorescence |
|
33687-5
|
Yersinia pestis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
33692-5
|
Yersinia pestis DNA [Presence] in Isolate by NAA with probe detection |
|
33691-7
|
Yersinia pestis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33686-7
|
Yersinia pestis [Presence] in Isolate by Organism specific culture |
|
33693-3
|
Yersinia pestis [Presence] in Isolate by Phage lysis |
|
33685-9
|
Yersinia pestis [Presence] in Unspecified specimen by Organism specific culture |
|
85692-2
|
Year previously tested for rubella virus immunity [Date] |
|
40497-0
|
Yersinia pseudotuberculosis 1 Ab [Titer] in Serum |
|
40496-2
|
Yersinia pseudotuberculosis 2 Ab [Titer] in Serum |
|
40495-4
|
Yersinia pseudotuberculosis 3 Ab [Titer] in Serum |
|
43586-7
|
Yersinia pseudotuberculosis Ab [Presence] in Cerebral spinal fluid |
|
40936-7
|
Yersinia pseudotuberculosis Ab [Presence] in Serum |
|
58935-8
|
Yersinia pseudotuberculosis Ab [Presence] in Serum by Agglutination |
|
5410-6
|
Yersinia pseudotuberculosis Ab [Units/volume] in Serum |
|
6967-4
|
Yersinia pseudotuberculosis Ab [Titer] in Serum |
|
40494-7
|
Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination |
|
29038-7
|
YAG comment [Interpretation] Left eye Narrative |
|
29034-6
|
YAG comment [Interpretation] Right eye Narrative |
|
7782-6
|
Yam IgE Ab in Serum |
|
82003-5
|
Yam IgE Ab RAST class in Serum |
|
89066-5
|
Year aspirin regimen began [Date] |
|
85704-5
|
Year of previous delivery in the U.S. [Date] from Mother |
|
51481-0
|
Yeast [#/volume] in Urine by Automated count |
|
78742-4
|
Yeast [#/area] in Urine by Automated count |
|
5822-2
|
Yeast [#/area] in Urine sediment by Microscopy high power field |
|
41215-5
|
Yeast [#/area] in Urine sediment by Microscopy low power field |
|
55320-6
|
Yeast [Presence] in Bronchial specimen by KOH preparation |
|
53266-3
|
Yeast.budding [#/volume] in Urine by Computer assisted method |
|
53269-7
|
Yeast.budding [#/area] in Urine by Computer assisted method |
|
41172-8
|
Yeast.budding [#/area] in Urine sediment by Microscopy high power field |
|
50240-1
|
Yeast.budding [Presence] in Urine by Computer assisted method |
|
21033-6
|
Yeast.budding [Presence] in Urine sediment |
|
41242-9
|
Yeast [Presence] in Cerebral spinal fluid by Light microscopy |
|
14369-3
|
Yeast [Presence] in Cervix by Wet preparation |
|
41243-7
|
Yeast [#/area] in Body fluid by Microscopy high power field |
|
41222-1
|
Yeast [Presence] in Body fluid by Light microscopy |
|
53571-6
|
Yeast identified in Genital specimen by Organism specific culture |
|
18483-8
|
Yeast [Presence] in Genital specimen by Organism specific culture |
|
12275-4
|
Yeast [Presence] in Genital specimen by Wet preparation |
|
53265-5
|
Yeast.hyphae [#/volume] in Urine by Computer assisted method |
|
53268-9
|
Yeast.hyphae [#/area] in Urine by Computer assisted method |
|
41861-6
|
Yeast.hyphae [#/area] in Urine sediment by Microscopy high power field |
|
41864-0
|
Yeast.hyphae [Presence] in Urine by Computer assisted method |
|
41865-7
|
Yeast.hyphae [Presence] in Urine sediment by Light microscopy |
|
70125-0
|
Yeast.hyphae [Presence] in Unspecified specimen by KOH preparation |
|
44812-6
|
Yeast.hyphae [Presence] in Unspecified specimen by Wet preparation |
|
90078-7
|
Yeast identified in Isolate by Organism specific culture |
|
5791-9
|
Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field |
|
20456-0
|
Fungi.yeastlike [Presence] in Urine sediment by Light microscopy |
|
55314-9
|
Yeast [Presence] in Nail by KOH preparation |
|
55319-8
|
Yeast.pseudohyphae [Presence] in Bronchial specimen by KOH preparation |
|
55310-7
|
Yeast.pseudohyphae [Presence] in Nail by KOH preparation |
|
55311-5
|
Yeast.pseudohyphae [Presence] in Skin by KOH preparation |
|
55309-9
|
Yeast.pseudohyphae [Presence] in Sputum by KOH preparation |
|
41863-2
|
Yeast.pseudohyphae [Presence] in Urine sediment by Light microscopy |
|
55312-3
|
Yeast.pseudohyphae [Presence] in Vaginal fluid by KOH preparation |
|
55308-1
|
Yeast.pseudohyphae [Presence] in Unspecified specimen by KOH preparation |
|
55317-2
|
Yeast [Presence] in Skin by KOH preparation |
|
55316-4
|
Yeast [Presence] in Sputum by KOH preparation |
|
41186-8
|
Yeast [Presence] in Stool |
|
17773-3
|
Yeast [Presence] in Stool by Light microscopy |
|
91779-9
|
Yeast identified in Upper respiratory specimen by Organism specific culture |
|
87831-4
|
Yeast [Presence] in Urine |
|
72223-1
|
Yeast [Presence] in Urine by Automated |
|
32356-8
|
Yeast [Presence] in Urine sediment by Light microscopy |
|
14371-9
|
Yeast [Presence] in Urethra by Wet preparation |
|
55313-1
|
Yeast [Presence] in Vaginal fluid by KOH preparation |
|
14370-1
|
Yeast [Presence] in Vaginal fluid by Wet preparation |
|
44246-7
|
Yeast [#/area] in Vaginal fluid by Wet preparation |
|
18482-0
|
Yeast [Presence] in Unspecified specimen by Organism specific culture |
|
74759-2
|
Yeast [Presence] in Unspecified specimen by Gram stain |
|
55315-6
|
Yeast [Presence] in Unspecified specimen by KOH preparation |
|
32765-0
|
Yeast [Presence] in Unspecified specimen by Wet preparation |
|
7142-3
|
Yellow Bean IgG Ab [Units/volume] in Serum |
|
21105-2
|
Yellow Bean IgG Ab RAST class [Presence] in Serum |
|
7283-5
|
Yellow Dock triggered histamine release [Units/volume] in Blood |
|
6738-9
|
Yellow Dock IgE Ab [Units/volume] in Serum |
|
15684-4
|
Yellow Dock IgE Ab RAST class [Presence] in Serum |
|
13186-2
|
Yellow Dock IgG Ab [Units/volume] in Serum |
|
63192-9
|
Yellow Dock IgG Ab [Mass/volume] in Serum |
|
17774-1
|
Yellow dye IgE Ab [Units/volume] in Serum |
|
48604-3
|
Yellow dye IgE Ab RAST class [Presence] in Serum |
|
6288-5
|
Yellow Hornet IgE Ab [Units/volume] in Serum |
|
15783-4
|
Yellow Hornet IgE Ab RAST class [Presence] in Serum |
|
39544-2
|
Yellow Hornet IgE Ab/IgE total in Serum |
|
6739-7
|
Yellow Hornet IgG Ab [Units/volume] in Serum |
|
41192-6
|
Yellow Hornet IgG4 Ab [Presence] in Serum |
|
56433-6
|
Yellow Hornet IgG4 Ab [Mass/volume] in Serum |
|
49740-4
|
Yellow Hornet IgG Ab [Mass/volume] in Serum |
|
6740-5
|
Yellow Jacket IgE Ab [Units/volume] in Serum |
|
16082-0
|
Yellow Jacket IgE Ab RAST class [Presence] in Serum |
|
41203-1
|
Yellow Jacket IgE Ab/IgE total in Serum |
|
40943-3
|
Yellow Jacket IgE Ab [Mass/volume] in Serum |
|
7768-5
|
Yellow Jacket IgG Ab [Units/volume] in Serum |
|
40952-4
|
Yellow Jacket IgG4 Ab [Presence] in Serum |
|
57000-2
|
Yellow Jacket IgG4 Ab [Units/volume] in Serum |
|
56434-4
|
Yellow Jacket IgG4 Ab [Mass/volume] in Serum |
|
41229-6
|
Yellow Jacket IgG Ab [Mass/volume] in Serum |
|
48184-6
|
Yellow Jacket triggered leukotriene release [Mass/volume] by Leukocytes |
|
7716-4
|
Yellow Squash IgE Ab [Units/volume] in Serum |
|
7717-2
|
Yellow Squash IgG Ab [Units/volume] in Serum |
|
40931-8
|
Yersinia sp Ab [Presence] in Serum |
|
40956-5
|
Yersinia sp Ab [Presence] in Serum by Complement fixation |
|
5411-4
|
Yersinia sp Ab [Units/volume] in Serum |
|
40940-9
|
Yersinia sp Ab [Titer] in Serum |
|
20987-4
|
Yersinia sp identified in Dairy product by Organism specific culture |
|
48646-4
|
Yersinia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
57001-0
|
Yersinia sp IgA Ab [Units/volume] in Serum by Immunoassay |
|
41400-3
|
Yersinia sp IgA Ab [Presence] in Serum by Immunoblot |
|
17775-8
|
Yersinia sp IgA Ab [Units/volume] in Serum |
|
40938-3
|
Yersinia sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
41401-1
|
Yersinia sp IgG Ab [Presence] in Serum by Immunoblot |
|
17776-6
|
Yersinia sp IgG Ab [Units/volume] in Serum |
|
40939-1
|
Yersinia sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
48410-5
|
Yersinia sp IgM Ab [Presence] in Serum by Immunoblot |
|
17777-4
|
Yersinia sp IgM Ab [Units/volume] in Serum |
|
42942-3
|
Yersinia sp IgM Ab [Titer] in Serum |
|
40942-5
|
Yersinia sp IgM Ab [Titer] in Serum by Immunoassay |
|
28549-4
|
Yersinia sp identified in Stool by Organism specific culture |
|
701-3
|
Yersinia sp identified in Unspecified specimen by Organism specific culture |
|
73664-5
|
Yersinia adhesion protein YadA [Presence] in Isolate |
|
77308-5
|
Yesterday, did the patient eat French fries or chips [IHE.HW] |
|
77393-7
|
Yesterday, how many 8-ounce portions of milk did the patient drink # |
|
77296-2
|
Yesterday, how many times did the patient drink 100% fruit juice # |
|
77297-0
|
Yesterday, how many times did the patient drink any punch, Kool-Aid, Tampico, other fruit-flavored drinks, or sports drinks # |
|
77300-2
|
Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks # |
|
77295-4
|
Yesterday, how many times did the patient drink bottles or glasses of water # |
|
77294-7
|
Yesterday, how many times did the patient eat any vegetables # |
|
77298-8
|
Yesterday, how many times did the patient eat food from any type of restaurant? # |
|
77299-6
|
Yesterday, how many times the patient eat fruit # |
|
77315-0
|
Yesterday, what percent of snacks were healthy |
|
7786-7
|
Yew IgE Ab [Units/volume] in Serum |
|
41239-5
|
Yellow fever virus Ab [Presence] in Cerebral spinal fluid |
|
6588-8
|
Yellow fever virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
6591-2
|
Yellow fever virus Ab [Units/volume] in Serum by Neutralization test |
|
41249-4
|
Yellow fever virus Ab [Presence] in Serum |
|
8054-9
|
Yellow fever virus Ab [Units/volume] in Serum |
|
41247-8
|
Yellow fever virus Ab [Titer] in Serum --1st specimen |
|
41246-0
|
Yellow fever virus Ab [Titer] in Serum --2nd specimen |
|
71783-5
|
Yellow fever virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
22618-3
|
Yellow fever virus Ab [Titer] in Serum |
|
6587-0
|
Yellow fever virus Ab [Titer] in Serum by Complement fixation |
|
6589-6
|
Yellow fever virus Ab [Titer] in Serum by Immunofluorescence |
|
6590-4
|
Yellow fever virus Ab [Titer] in Serum by Latex agglutination |
|
6592-0
|
Yellow fever virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
41217-1
|
Yellow fever virus IgG Ab [Presence] in Serum |
|
77954-6
|
Yellow fever virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
8055-6
|
Yellow fever virus IgG Ab [Units/volume] in Serum |
|
71782-7
|
Yellow fever virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6593-8
|
Yellow fever virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
41216-3
|
Yellow fever virus IgM Ab [Presence] in Serum |
|
77955-3
|
Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
8056-4
|
Yellow fever virus IgM Ab [Units/volume] in Serum |
|
77959-5
|
Yellow fever virus ns5 gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
90459-9
|
Yellow fever virus RNA [Presence] in Blood by NAA with probe detection |
|
8057-2
|
Yellow fever virus RNA [Presence] in Serum by NAA with probe detection |
|
58076-1
|
Yk sup(a) Ab [Presence] in Serum or Plasma |
|
58075-3
|
Yk sup(a) Ag [Presence] on Red Blood Cells |
|
48663-9
|
YKL-40 [Mass/volume] in Serum |
|
7787-5
|
Yogurt IgE Ab [Units/volume] in Serum |
|
21609-3
|
Yogurt IgE Ab RAST class [Presence] in Serum |
|
7788-3
|
Yogurt IgG Ab [Units/volume] in Serum |
|
56435-1
|
Yogurt IgG4 Ab [Mass/volume] in Serum |
|
63141-6
|
Yogurt IgG Ab [Mass/volume] in Serum |
|
40944-1
|
Yohimbine [Mass/volume] in Serum or Plasma |
|
86486-8
|
You know what to do, or whom to call, if your heart failure gets worse [KCCQ] |
|
90150-4
|
Your child forgets things easily in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90151-2
|
Your child forgets things easily in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90156-1
|
Your child forgets to bring things to and from school that he or she needs for homework in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90157-9
|
Your child forgets to bring things to and from school that he or she needs for homework in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90158-7
|
Your child forgets what he or she is going to say in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90159-5
|
Your child forgets what he or she is going to say in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90138-9
|
Your child forgets what his or her parents or teachers ask him or her to do in past 4 weeks [PROMIS.PARENTPROXY] |
|
90154-6
|
Your child has a hard time keeping track of his or her homework in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90155-3
|
Your child has a hard time keeping track of his or her homework in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90144-7
|
Your child has to read things several times to understand them in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90145-4
|
Your child has to read things several times to understand them in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90162-9
|
Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90163-7
|
Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90168-6
|
Your child has to work really hard to pay attention or he or she makes mistakes in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90169-4
|
Your child has to work really hard to pay attention or he or she makes mistakes in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90136-3
|
Your child has trouble keeping track of what he or she is doing if he or she gets interrupted in past 4 weeks [PROMIS.PARENTPROXY] |
|
90166-0
|
Your child has trouble paying attention to the teacher in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90167-8
|
Your child has trouble paying attention to the teacher in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90142-1
|
Your child has trouble remembering the date or day of the week in past 4 weeks [PROMIS.PARENTPROXY] |
|
90135-5
|
Your child has trouble remembering the names of people he or she has just met in past 4 weeks [PROMIS.PARENTPROXY] |
|
90140-5
|
Your child has trouble remembering the names of people he or she knows in past 4 weeks [PROMIS.PARENTPROXY] |
|
90164-5
|
Your child has trouble remembering to do things like school projects or chores in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90165-2
|
Your child has trouble remembering to do things like school projects or chores in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90128-0
|
Your child has trouble remembering where he or she put things, like his or her watch or his or her homework in past 4 weeks [PROMIS.PARENTPROXY] |
|
90146-2
|
Your child reacts slower than most people his or her age when he or she plays games in past 4 weeks - frequency [PROMIS.PARENTPROXY] |
|
90147-0
|
Your child reacts slower than most people his or her age when he or she plays games in past 4 weeks - severity [PROMIS.PARENTPROXY] |
|
90139-7
|
Your child walks into a room and forgets what he or she wanted to get or do in past 4 weeks [PROMIS.PARENTPROXY] |
|
90744-4
|
Youth Risk Behavior Survey - body weight panel [CDC] |
|
1342-5
|
Yt sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1343-3
|
Yt sup(a) Ab [Presence] in Serum or Plasma from Donor |
|
1344-1
|
Yt sup(a) Ab [Presence] in Serum or Plasma |
|
1345-8
|
Yt sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1346-6
|
Yt sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
1347-4
|
Yt sup(a) Ag [Presence] on Red Blood Cells |
|
1348-2
|
Yt sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
|
1349-0
|
Yt sup(b) Ab [Presence] in Serum or Plasma from Donor |
|
1350-8
|
Yt sup(b) Ab [Presence] in Serum or Plasma |
|
1351-6
|
Yt sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
|
1352-4
|
Yt sup(b) Ag [Presence] on Red Blood Cells from Donor |
|
1353-2
|
Yt sup(b) Ag [Presence] on Red Blood Cells |
|
51778-9
|
YY1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79163-2
|
Z-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma |
|
30285-1
|
Zalcitabine [Susceptibility] by Genotype method |
|
30271-1
|
Zalcitabine [Susceptibility] by Phenotype method |
|
29125-2
|
Zalcitabine [Units/volume] in Serum or Plasma |
|
30301-6
|
Zalcitabine [Susceptibility] |
|
32574-6
|
Zaleplon [Mass/volume] in Serum or Plasma |
|
74663-6
|
Zaleplon [Mass/volume] in Urine |
|
87776-1
|
Zaleplon/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
75029-9
|
Zanamivir [Susceptibility] by Genotype method |
|
49113-4
|
ZAP70 Ag [Presence] in Tissue by Immune stain |
|
46722-5
|
ZAP70 cells [Presence] in Blood |
|
53619-3
|
ZAP70 cells [Presence] in Bone marrow |
|
46235-8
|
ZAP70 cells/100 cells in Blood |
|
46233-3
|
ZAP70 cells/100 cells in Body fluid |
|
46234-1
|
ZAP70 cells/100 cells in Bone marrow |
|
46231-7
|
ZAP70 cells/100 cells in Tissue |
|
46232-5
|
ZAP70 cells/100 cells in Unspecified specimen |
|
53618-5
|
ZAP70 cells [Presence] in Unspecified specimen |
|
47399-1
|
ZAP70+CD19+ cells/100 cells in Blood |
|
87564-1
|
Zearalenone [Mass/mass] in Unspecified specimen |
|
87565-8
|
Zearalenol [Mass/mass] in Unspecified specimen |
|
90847-5
|
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
88743-0
|
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Serum by Line blot |
|
38915-5
|
Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum |
|
83002-6
|
Zinc finger protein of the cerebellum 4 IgG Ab [Presence] in Serum or Plasma by Line blot |
|
30282-8
|
Zidovudine [Susceptibility] by Genotype method |
|
30268-7
|
Zidovudine [Susceptibility] by Phenotype method |
|
29126-0
|
Zidovudine [Units/volume] in Serum or Plasma |
|
6894-0
|
Zidovudine [Mass/volume] in Serum or Plasma |
|
531-4
|
Zidovudine [Susceptibility] |
|
81149-7
|
Zika virus envelope E gene [Presence] in Amniotic fluid by NAA with probe detection |
|
80826-1
|
Zika virus envelope E gene [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
80825-3
|
Zika virus envelope E gene [Presence] in Serum by NAA with probe detection |
|
81148-9
|
Zika virus envelope E gene [Presence] in Urine by NAA with probe detection |
|
87439-6
|
Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay |
|
91080-2
|
Zika virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
89590-4
|
Zika virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
80618-2
|
Zika virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
80823-8
|
Zika virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
82731-1
|
Zika virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
80619-0
|
Zika virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
80824-6
|
Zika virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
91678-3
|
Zika virus IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
89591-2
|
Zika virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
87622-7
|
Zika virus IgM Ab [Presence] in Unspecified specimen by Immunoassay |
|
80821-2
|
Zika virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test |
|
80822-0
|
Zika virus neutralizing antibody [Presence] in Serum by Neutralization test |
|
80624-0
|
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --1st specimen |
|
80622-4
|
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
|
80625-7
|
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --2nd specimen |
|
80623-2
|
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
|
80621-6
|
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
|
80620-8
|
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test |
|
86321-7
|
Zika virus neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86320-9
|
Zika virus neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
83069-5
|
Zika virus non-structural protein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
89370-1
|
Zika virus non-structural protein 1 IgM Ab [Interpretation] in Serum by Immunoassay |
|
89369-3
|
Zika virus non-structural protein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
85621-1
|
Zika virus RNA [Presence] in Amniotic fluid by NAA with probe detection |
|
91078-6
|
Zika virus RNA [Presence] in Blood by NAA with probe detection |
|
90462-3
|
Zika virus RNA [Presence] in Cord blood by NAA with probe detection |
|
86594-9
|
Zika virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91079-4
|
Zika virus RNA [Presence] in Placenta by NAA with probe detection |
|
86190-6
|
Zika virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
85622-9
|
Zika virus RNA [Presence] in Serum by NAA with probe detection |
|
85623-7
|
Zika virus RNA [Presence] in Urine by NAA with probe detection |
|
79190-5
|
Zika virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
4099-8
|
Zimelidine [Mass/volume] in Serum or Plasma |
|
48431-1
|
Zinc [Molar amount] in unspecified time Semen |
|
30930-2
|
Zinc [Mass/volume] in Urine collected for unspecified duration |
|
21610-1
|
Zinc [Mass/volume] in 24 hour Urine |
|
5765-3
|
Zinc [Mass/time] in 24 hour Urine |
|
34388-9
|
Zinc [Moles/volume] in 24 hour Urine |
|
22689-4
|
Zinc [Moles/time] in 24 hour Urine |
|
27106-4
|
Zinc [Presence] in Blood |
|
8245-3
|
Zinc [Mass/volume] in Blood |
|
58037-3
|
Zinc [Mass/volume] in Cerebral spinal fluid |
|
32348-5
|
Zinc [Moles/volume] in Cerebral spinal fluid |
|
5760-4
|
Zinc [Mass/volume] in Dialysis fluid |
|
11028-8
|
Zinc [Mass/volume] in Body fluid |
|
40947-4
|
Zinc [Presence] in Hair |
|
13652-3
|
Zinc [Mass/mass] in Hair |
|
50939-8
|
Zinc [Moles/mass] in Hair |
|
81089-5
|
Zinc intake 24 hour Estimated |
|
81088-7
|
Zinc intake 24 hour Measured |
|
29245-8
|
Zinc [Mass/mass] in Nail |
|
20988-2
|
Zinc phosphide [Mass/mass] in Gastrointestinal content |
|
20989-0
|
Zinc phosphide [Mass/mass] in Unspecified specimen |
|
5761-2
|
Zinc [Mass/volume] in Red Blood Cells |
|
27125-4
|
Zinc [Mass/mass] in Red Blood Cells |
|
25557-0
|
Zinc [Moles/volume] in Red Blood Cells |
|
40937-5
|
Zinc [Presence] in Serum or Plasma |
|
5763-8
|
Zinc [Mass/volume] in Serum or Plasma |
|
14955-9
|
Zinc [Moles/volume] in Serum or Plasma |
|
5762-0
|
Zinc [Mass/volume] in Semen |
|
10633-6
|
Zinc [Moles/volume] in Semen |
|
10917-3
|
Zinc [Mass/mass] in Stool |
|
18260-0
|
Zinc [Presence] in Tissue |
|
16180-2
|
Zinc [Mass/mass] in Tissue |
|
52910-7
|
Zinc [Moles/mass] in Tissue |
|
40957-3
|
Zinc [Presence] in Urine |
|
5764-6
|
Zinc [Mass/volume] in Urine |
|
34387-1
|
Zinc [Moles/volume] in Urine |
|
9487-0
|
Zinc [Mass/volume] in Water |
|
17778-2
|
Zinc [Mass/volume] in Leukocytes |
|
10918-1
|
Zinc [Mass/volume] in Unspecified specimen |
|
87446-1
|
Zinc [Mass/mass] in Unspecified specimen |
|
43973-7
|
Zinc [Moles/volume] in Unspecified specimen |
|
27201-3
|
Zinc/Creatinine [Mass Ratio] in 24 hour Urine |
|
50940-6
|
Zinc/Creatinine [Molar ratio] in 24 hour Urine |
|
13473-4
|
Zinc/Creatinine [Mass Ratio] in Urine |
|
34389-7
|
Zinc/Creatinine [Molar ratio] in Urine |
|
59767-4
|
Ziprasidone [Mass/volume] in Blood |
|
77878-7
|
Ziprasidone cutoff [Mass/volume] in Urine for Confirmatory method |
|
89979-9
|
Ziprasidone [Presence] in Serum or Plasma by Screen method |
|
33946-5
|
Ziprasidone [Mass/volume] in Serum or Plasma |
|
77877-9
|
Ziprasidone [Mass/volume] in Urine by Confirmatory method |
|
89964-1
|
Ziprasidone [Presence] in Urine by Screen method |
|
87780-3
|
Ziprasidone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
76658-4
|
Zirconium [Mass/mass] in Hair |
|
27032-2
|
Zirconium [Mass/volume] in Serum or Plasma |
|
77187-3
|
Zirconium [Mass/volume] in Urine |
|
77188-1
|
Zirconium [Moles/volume] in Urine |
|
6974-0
|
Zirconium [Mass/volume] in Unspecified specimen |
|
77189-9
|
Zirconium/Creatinine [Molar ratio] in Urine |
|
76083-5
|
Microscopic observation [Presence] in Bronchoalveolar lavage by Acid fast stain.Ziehl-Neelsen |
|
58943-2
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain.Ziehl-Neelsen |
|
58944-0
|
Microscopic observation [Identifier] in Body fluid by Acid fast stain.Ziehl-Neelsen |
|
642-9
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Ziehl-Neelsen |
|
58942-4
|
Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Ziehl-Neelsen |
|
58945-7
|
Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain.Ziehl-Neelsen |
|
63433-7
|
Microscopic observation [Identifier] in Synovial fluid by Acid fast stain.Ziehl-Neelsen |
|
79375-2
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--2nd specimen |
|
79376-0
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--3rd specimen |
|
647-8
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen |
|
6657-1
|
Microscopic observation [Identifier] in Tissue by Acid fast stain.Ziehl-Neelsen |
|
652-8
|
Microscopic observation [Identifier] in Urine by Acid fast stain.Ziehl-Neelsen |
|
656-9
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Ziehl-Neelsen |
|
76651-9
|
Zinc transporter 8 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
82453-2
|
Zo Ab [Presence] in Serum by Line blot |
|
60211-0
|
Zolazepam [Mass/volume] in Blood |
|
60212-8
|
Zolazepam [Mass/volume] in Serum or Plasma |
|
60213-6
|
Zolazepam [Mass/volume] in Urine |
|
60214-4
|
ZOLMitriptan [Mass/volume] in Blood |
|
34443-2
|
ZOLMitriptan [Mass/volume] in Serum or Plasma |
|
60215-1
|
ZOLMitriptan [Mass/volume] in Urine |
|
74664-4
|
Zolpidem [Mass/volume] in Blood |
|
72768-5
|
Zolpidem phenyl-4-carboxylate [Mass/volume] in Urine by Confirmatory method |
|
94103-9
|
Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method |
|
72769-3
|
Zolpidem phenyl-4-carboxylate/Creatinine [Mass Ratio] in Urine |
|
87821-5
|
Zolpidem [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87820-7
|
Zolpidem [Presence] in Saliva (oral fluid) by Screen method |
|
6953-4
|
Zolpidem [Mass/volume] in Serum or Plasma |
|
25559-6
|
Zolpidem [Moles/volume] in Serum or Plasma |
|
72770-1
|
Zolpidem [Mass/volume] in Urine by Confirmatory method |
|
33338-5
|
Zolpidem [Presence] in Urine |
|
53787-8
|
Zolpidem [Presence] in Urine by Confirmatory method |
|
94104-7
|
Zolpidem [Presence] in Urine by Screen method |
|
33339-3
|
Zolpidem [Mass/volume] in Urine |
|
33340-1
|
Zolpidem [Moles/volume] in Urine |
|
72771-9
|
Zolpidem/Creatinine [Mass Ratio] in Urine |
|
60216-9
|
Zomepirac [Mass/volume] in Blood |
|
12545-0
|
Zomepirac [Mass/volume] in Serum or Plasma |
|
29620-2
|
Zonisamide [Mass/volume] in Serum or Plasma |
|
87771-2
|
Zonisamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
59982-9
|
Zopiclone [Moles/volume] in Gastric fluid |
|
74392-2
|
Zopiclone [Mass/mass] in Hair |
|
80554-9
|
Zopiclone [Mass/volume] in Serum or Plasma |
|
48379-2
|
Zopiclone [Moles/volume] in Serum or Plasma |
|
59176-8
|
Zopiclone [Presence] in Urine |
|
59981-1
|
Zopiclone [Moles/volume] in Urine |
|
60339-9
|
Zopiclone [Moles/volume] in Unspecified specimen |
|
89043-4
|
Zopiclone-N-oxide [Mass/volume] in Urine |
|
88991-5
|
Zotepine [Mass/volume] in Serum or Plasma |
|
2893-6
|
Protoporphyrin.zinc [Presence] in Blood |
|
33007-6
|
Protoporphyrin.zinc [Mass/volume] in Blood |
|
2894-4
|
Protoporphyrin.zinc [Presence] in Red Blood Cells |
|
2895-1
|
Protoporphyrin.zinc [Mass/volume] in Red Blood Cells |
|
34417-6
|
Protoporphyrin.zinc [Mass/mass] in Red Blood Cells |
|
71797-5
|
Protoporphyrin.zinc [Moles/volume] in Red Blood Cells |
|
29763-0
|
Protoporphyrin.zinc [Molar ratio] in Red Blood Cells |
|
4539-3
|
Erythrocyte sedimentation rate Zeta by Zetafuge |
|
7718-0
|
Zucchini IgE Ab [Units/volume] in Serum |
|
21540-0
|
Zucchini IgE Ab RAST class [Presence] in Serum |
|
18425-9
|
Zucchini IgG Ab [Units/volume] in Serum |
|
21541-8
|
Zucchini IgG Ab RAST class [Presence] in Serum |
|
56436-9
|
Zucchini IgG4 Ab [Mass/volume] in Serum |
|
60414-0
|
Zucchini IgG Ab [Mass/volume] in Serum |
|
48412-1
|
Zygomycete sp Ag [Presence] in Tissue by Immune stain |
|
55198-6
|
Zygosity DNA [Identifier] in Buccal by Molecular genetics method Nominal |